<SEC-DOCUMENT>0000731766-22-000008.txt : 20220215
<SEC-HEADER>0000731766-22-000008.hdr.sgml : 20220215
<ACCEPTANCE-DATETIME>20220215165018
ACCESSION NUMBER:		0000731766-22-000008
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		136
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220215
DATE AS OF CHANGE:		20220215

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UNITEDHEALTH GROUP INC
		CENTRAL INDEX KEY:			0000731766
		STANDARD INDUSTRIAL CLASSIFICATION:	HOSPITAL & MEDICAL SERVICE PLANS [6324]
		IRS NUMBER:				411321939
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-10864
		FILM NUMBER:		22639873

	BUSINESS ADDRESS:	
		STREET 1:		UNITEDHEALTH GROUP CENTER
		STREET 2:		9900 BREN ROAD EAST
		CITY:			MINNEAPOLIS
		STATE:			MN
		ZIP:			55343
		BUSINESS PHONE:		9529361300

	MAIL ADDRESS:	
		STREET 1:		9900 BREN ROAD EAST
		CITY:			MINNETONKA
		STATE:			MN
		ZIP:			55343

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	UNITED HEALTHCARE CORP/
		DATE OF NAME CHANGE:	20000309

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	UNITED HEALTHCARE CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>unh-20211231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:7520997a-16df-4345-81d3-205a3336ef85,g:00a8925a-3c66-4bad-89d3-86af384cff11,d:2ccd90ac94a94cd9ab3abb1e6abc40a5--><html xmlns:unh="http://www.uhc.com/20211231" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>unh-20211231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV80L2ZyYWc6ZjE1Mzc5M2UxYmE3NGFlZWE4YWIwNjlhMmE3MzQ0YmEvdGFibGU6Zjc4NGMyN2Y0ZDU5NGY5NmI3ZWEyMzIzNjNhM2EyZWIvdGFibGVyYW5nZTpmNzg0YzI3ZjRkNTk0Zjk2YjdlYTIzMjM2M2EzYTJlYl8zLTEtMS0xLTA_6d1eea25-6999-4661-9d7c-d6b19accbad0">false</ix:nonNumeric><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV80L2ZyYWc6ZjE1Mzc5M2UxYmE3NGFlZWE4YWIwNjlhMmE3MzQ0YmEvdGFibGU6Zjc4NGMyN2Y0ZDU5NGY5NmI3ZWEyMzIzNjNhM2EyZWIvdGFibGVyYW5nZTpmNzg0YzI3ZjRkNTk0Zjk2YjdlYTIzMjM2M2EzYTJlYl80LTEtMS0xLTA_6a91db0e-4342-4813-9a9a-3bfaace9960c">2021</ix:nonNumeric><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV80L2ZyYWc6ZjE1Mzc5M2UxYmE3NGFlZWE4YWIwNjlhMmE3MzQ0YmEvdGFibGU6Zjc4NGMyN2Y0ZDU5NGY5NmI3ZWEyMzIzNjNhM2EyZWIvdGFibGVyYW5nZTpmNzg0YzI3ZjRkNTk0Zjk2YjdlYTIzMjM2M2EzYTJlYl81LTEtMS0xLTA_8b0804ad-907f-4c58-9172-91b4cf1b3df5">FY</ix:nonNumeric><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV80L2ZyYWc6ZjE1Mzc5M2UxYmE3NGFlZWE4YWIwNjlhMmE3MzQ0YmEvdGFibGU6Zjc4NGMyN2Y0ZDU5NGY5NmI3ZWEyMzIzNjNhM2EyZWIvdGFibGVyYW5nZTpmNzg0YzI3ZjRkNTk0Zjk2YjdlYTIzMjM2M2EzYTJlYl82LTEtMS0xLTA_6d4d5293-337b-478b-a6eb-308325ab2e2b">0000731766</ix:nonNumeric><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV80L2ZyYWc6ZjE1Mzc5M2UxYmE3NGFlZWE4YWIwNjlhMmE3MzQ0YmEvdGFibGU6Zjc4NGMyN2Y0ZDU5NGY5NmI3ZWEyMzIzNjNhM2EyZWIvdGFibGVyYW5nZTpmNzg0YzI3ZjRkNTk0Zjk2YjdlYTIzMjM2M2EzYTJlYl83LTEtMS0xLTA_94dc5913-991e-4a34-84bd-c5ef9f93a43c">12/31</ix:nonNumeric><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfMS0xLTEtMS0w_cd489fad-1c5b-4893-b468-e73221992628">954</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfMS0zLTEtMS0w_100d6026-f680-428c-9d0d-d1889bb0cb6a">990</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfMi0xLTEtMS0w_a8a1a6d9-a1ee-4fcd-ae23-776c49bf6798">993</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfMi0zLTEtMS0w_7fba9ec2-d364-4d56-ada5-07c2ca355f94">1,047</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfMy0xLTEtMS0w_7feea1c0-f85d-4ceb-b48c-c62630d60222">5,992</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfMy0zLTEtMS0w_837423b5-9d58-42e0-ac18-dca71d0fe18f">5,230</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfNC0xLTEtMS0w_4554415d-bc90-4a49-a90b-58719fe031d3">5,636</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfNC0zLTEtMS0w_9c51db6b-e5ba-47f4-8cba-c45941454a96">5,455</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfNi0xLTEtMS0w_0cefcf86-30b9-4e4c-8690-5b8dca0428c1">0.01</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfNi0xLTEtMS0w_f2a5959a-b7bb-4002-83d8-9fe5345a6a50">0.01</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfNi0zLTEtMS0w_1e83ec71-e40f-4d35-9ea3-f0c5cf2920c0">0.01</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfNi0zLTEtMS0w_4b9143cc-cd11-4fbb-af24-fef381dec6dc">0.01</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfNy0xLTEtMS0w_b6a46e0e-e291-43e6-b6ba-dd3457680c27">3,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfNy0xLTEtMS0w_b710e1cb-4cb8-4111-a217-d08f10723224">3,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfNy0zLTEtMS0w_b4956f39-29cb-46dc-85ba-dfc4ab28a797">3,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfOC0xLTEtMS0w_6b30c6b2-a7fc-4b84-ad58-b5c499bdfd59">941</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfOC0xLTEtMS0w_be3aa7f8-6357-43e5-b24d-fa7a2403b8ce">941</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfOC0zLTEtMS0w_98ee3a52-56dc-4701-a22d-c694d8461279">946</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfOC0zLTEtMS0w_9b4c0280-584f-4cf8-899e-44cedd4eb1ea">946</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="3" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfOS0xLTEtMS0w_2f6ea2ed-ad7d-4724-baa0-3eca12b9d678">0.001</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="3" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfOS0xLTEtMS0w_61a92059-4fc3-4a28-8d72-c707d47c9c95">0.001</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="3" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfOS0zLTEtMS0w_f7df6b1d-6ca8-4a30-9eb7-fa9a38bdaacf">0.001</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfMTAtMS0xLTEtMA_26baf73b-9e2d-4d06-b8f3-cf6be835555b">10</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfMTAtMS0xLTEtMA_7d978865-acc5-46e7-a376-63878037b686">10</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfMTAtMy0xLTEtMA_f6f0a2c0-c7e2-499f-a4b1-5b7bbc72eb6f">10</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfMTEtMS0xLTEtMA_172d1ede-890b-4967-9b94-916a7101cbad">&#8212;</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfMTEtMS0xLTEtMA_736d7ec3-fbb5-4f5a-bec7-a0b9c1f4f80b">&#8212;</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfMTEtMS0xLTEtMA_c0f5091a-e351-4941-b53a-a213e87f83a1">&#8212;</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfMTEtMS0xLTEtMA_df787b4c-dc7f-40cd-a60f-846e1a77954d">&#8212;</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfMTEtMy0xLTEtMA_4fb0da1a-38f8-436d-b4ba-7228c76dda9b">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85NC9mcmFnOjk5MjcwZWQyNDZiMDQ2MDA5YjM4NmQ1YWE3YjllYzUyL3RhYmxlOjA1Yjg2NzYyYTFkOTQ3OWM4MWI2NzBlN2M1MGJiYWRhL3RhYmxlcmFuZ2U6MDViODY3NjJhMWQ5NDc5YzgxYjY3MGU3YzUwYmJhZGFfMS0yLTEtMS0w_269041d2-db31-48fa-ba22-d07337ace4db">5.60</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85NC9mcmFnOjk5MjcwZWQyNDZiMDQ2MDA5YjM4NmQ1YWE3YjllYzUyL3RhYmxlOjA1Yjg2NzYyYTFkOTQ3OWM4MWI2NzBlN2M1MGJiYWRhL3RhYmxlcmFuZ2U6MDViODY3NjJhMWQ5NDc5YzgxYjY3MGU3YzUwYmJhZGFfMS00LTEtMS0w_04128702-012a-4135-9f00-1922cd7236eb">4.83</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="3" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85NC9mcmFnOjk5MjcwZWQyNDZiMDQ2MDA5YjM4NmQ1YWE3YjllYzUyL3RhYmxlOjA1Yjg2NzYyYTFkOTQ3OWM4MWI2NzBlN2M1MGJiYWRhL3RhYmxlcmFuZ2U6MDViODY3NjJhMWQ5NDc5YzgxYjY3MGU3YzUwYmJhZGFfMS02LTEtMS0w_d31352b5-e293-4127-aa36-2a74722e0422">4.14</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="ie667c3a41af649e28b76eb6f34ded8a2_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMDkvZnJhZzowMTNlOGRmNzJkYzQ0MjI2OGY1Mjk4YWJkMjJjYWNjMi90YWJsZTpmZTg5YmU5YjQ4OTI0OTlmYmIxOWJjZjI0NzI2N2M5Zi90YWJsZXJhbmdlOmZlODliZTliNDg5MjQ5OWZiYjE5YmNmMjQ3MjY3YzlmXzQtMS0xLTEtMjEyNzI_1cfc340b-c55f-454e-b7d4-bcd6e088b7ab">10</ix:nonFraction><ix:nonNumeric contextRef="i0cf2e2ded57848acbd7f4ce7b8849c5d_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTcvZnJhZzoyNzA4MDU3MzhiZjc0MzA5ODVmOTgzMjNiMGZkMzIxNy90ZXh0cmVnaW9uOjI3MDgwNTczOGJmNzQzMDk4NWY5ODMyM2IwZmQzMjE3XzQzOA_eb1bf801-8e88-43f4-addf-b3432e5c7bdc">P4Y</ix:nonNumeric><ix:nonNumeric contextRef="i4d96f9ce242e4c3d8115ee3621f39cbe_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTcvZnJhZzoyNzA4MDU3MzhiZjc0MzA5ODVmOTgzMjNiMGZkMzIxNy90ZXh0cmVnaW9uOjI3MDgwNTczOGJmNzQzMDk4NWY5ODMyM2IwZmQzMjE3XzM4NDgyOTA2OTg0NDE_e5312511-99bf-4e41-b5f9-1d6cc88b8bfd">P4Y</ix:nonNumeric><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzgvZnJhZzpjMDc4YWY2ZjNhOGE0OTMxYmM2NjNjYjZhMjEwYTkzYy90YWJsZTo3ZjI1MmU4ZWViYzg0ZDhmYTMyNTcyNWRmZjgxYTJlMi90YWJsZXJhbmdlOjdmMjUyZThlZWJjODRkOGZhMzI1NzI1ZGZmODFhMmUyXzMtMS0xLTEtMA_80b6a583-23ef-4b10-8b7f-9d93ff692909">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzgvZnJhZzpjMDc4YWY2ZjNhOGE0OTMxYmM2NjNjYjZhMjEwYTkzYy90YWJsZTo3ZjI1MmU4ZWViYzg0ZDhmYTMyNTcyNWRmZjgxYTJlMi90YWJsZXJhbmdlOjdmMjUyZThlZWJjODRkOGZhMzI1NzI1ZGZmODFhMmUyXzMtMi0xLTEtMA_635f590d-0256-42e6-b1a9-cc4f2150aa67">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzgvZnJhZzpjMDc4YWY2ZjNhOGE0OTMxYmM2NjNjYjZhMjEwYTkzYy90YWJsZTo3ZjI1MmU4ZWViYzg0ZDhmYTMyNTcyNWRmZjgxYTJlMi90YWJsZXJhbmdlOjdmMjUyZThlZWJjODRkOGZhMzI1NzI1ZGZmODFhMmUyXzQtMS0xLTEtMA_9041fef3-cc5a-4b29-9c33-a180650e9216">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzgvZnJhZzpjMDc4YWY2ZjNhOGE0OTMxYmM2NjNjYjZhMjEwYTkzYy90YWJsZTo3ZjI1MmU4ZWViYzg0ZDhmYTMyNTcyNWRmZjgxYTJlMi90YWJsZXJhbmdlOjdmMjUyZThlZWJjODRkOGZhMzI1NzI1ZGZmODFhMmUyXzQtMi0xLTEtMA_3b8c86a0-c2ad-4b15-bc2f-f4c75a0e0ae8">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i7a1b38442cb3432c99552784de780fe5_D20210101-20211231" decimals="-6" name="unh:FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzgvZnJhZzpjMDc4YWY2ZjNhOGE0OTMxYmM2NjNjYjZhMjEwYTkzYy90YWJsZTo3ZjI1MmU4ZWViYzg0ZDhmYTMyNTcyNWRmZjgxYTJlMi90YWJsZXJhbmdlOjdmMjUyZThlZWJjODRkOGZhMzI1NzI1ZGZmODFhMmUyXzUtMS0xLTEtMA_10a5b669-29b0-4f2f-85cd-879f9f4ef2b4">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i69a743b9a5d84ecd862ffaa1626c672b_D20200101-20201231" decimals="-6" name="unh:FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzgvZnJhZzpjMDc4YWY2ZjNhOGE0OTMxYmM2NjNjYjZhMjEwYTkzYy90YWJsZTo3ZjI1MmU4ZWViYzg0ZDhmYTMyNTcyNWRmZjgxYTJlMi90YWJsZXJhbmdlOjdmMjUyZThlZWJjODRkOGZhMzI1NzI1ZGZmODFhMmUyXzUtMi0xLTEtMA_f1d329a3-ab47-4100-af7b-53210213c241">&#8212;</ix:nonFraction><ix:nonNumeric contextRef="i72998cdf5b13475480213110198dde60_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODcvZnJhZzo2ZmIxZmYxOGY0ZmI0ZmJmODc4NmNkZDg3ZWUxODY2Mi90YWJsZTo3Y2VhNDg2OWVlNjU0MDQ2OWU0YTAwYjIzMDg3NjQ2YS90YWJsZXJhbmdlOjdjZWE0ODY5ZWU2NTQwNDY5ZTRhMDBiMjMwODc2NDZhXzItMS0xLTEtMA_1c9a8690-5ac1-4478-973f-d555f8b32282">9</ix:nonNumeric><ix:nonNumeric contextRef="i2ecd4e0cb3384d4c8ddd20890ad9e997_D20200101-20201231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODcvZnJhZzo2ZmIxZmYxOGY0ZmI0ZmJmODc4NmNkZDg3ZWUxODY2Mi90YWJsZTo3Y2VhNDg2OWVlNjU0MDQ2OWU0YTAwYjIzMDg3NjQ2YS90YWJsZXJhbmdlOjdjZWE0ODY5ZWU2NTQwNDY5ZTRhMDBiMjMwODc2NDZhXzItMi0xLTEtMA_08721db3-0c63-4574-a0c7-d8ac398fdcfa">11</ix:nonNumeric><ix:nonNumeric contextRef="i1ded218b083944e188cd4579765a2a84_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODcvZnJhZzo2ZmIxZmYxOGY0ZmI0ZmJmODc4NmNkZDg3ZWUxODY2Mi90YWJsZTo3Y2VhNDg2OWVlNjU0MDQ2OWU0YTAwYjIzMDg3NjQ2YS90YWJsZXJhbmdlOjdjZWE0ODY5ZWU2NTQwNDY5ZTRhMDBiMjMwODc2NDZhXzMtMS0xLTEtMA_65aa1e79-951b-419f-9d21-d21079af4f4a">5</ix:nonNumeric><ix:nonNumeric contextRef="i2b4f1188393845f8827897acb0c3916c_D20200101-20201231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODcvZnJhZzo2ZmIxZmYxOGY0ZmI0ZmJmODc4NmNkZDg3ZWUxODY2Mi90YWJsZTo3Y2VhNDg2OWVlNjU0MDQ2OWU0YTAwYjIzMDg3NjQ2YS90YWJsZXJhbmdlOjdjZWE0ODY5ZWU2NTQwNDY5ZTRhMDBiMjMwODc2NDZhXzMtMi0xLTEtMA_43fc90a7-6c79-424a-bacd-637c4820491f">10</ix:nonNumeric><ix:nonNumeric contextRef="iaa52ad981c7743b1818a805ee0a0b5fe_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODcvZnJhZzo2ZmIxZmYxOGY0ZmI0ZmJmODc4NmNkZDg3ZWUxODY2Mi90YWJsZTo3Y2VhNDg2OWVlNjU0MDQ2OWU0YTAwYjIzMDg3NjQ2YS90YWJsZXJhbmdlOjdjZWE0ODY5ZWU2NTQwNDY5ZTRhMDBiMjMwODc2NDZhXzQtMS0xLTEtMA_e58a45a5-f4c1-4e1b-a00b-54b3c851865c">11</ix:nonNumeric><ix:nonNumeric contextRef="i7a251ae641a244f982ee84dc33f39c98_D20200101-20201231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODcvZnJhZzo2ZmIxZmYxOGY0ZmI0ZmJmODc4NmNkZDg3ZWUxODY2Mi90YWJsZTo3Y2VhNDg2OWVlNjU0MDQ2OWU0YTAwYjIzMDg3NjQ2YS90YWJsZXJhbmdlOjdjZWE0ODY5ZWU2NTQwNDY5ZTRhMDBiMjMwODc2NDZhXzQtMi0xLTEtMA_6792457a-9cc0-4275-8c92-bb21cdd9e4e0">10</ix:nonNumeric><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODcvZnJhZzo2ZmIxZmYxOGY0ZmI0ZmJmODc4NmNkZDg3ZWUxODY2Mi90YWJsZTo3Y2VhNDg2OWVlNjU0MDQ2OWU0YTAwYjIzMDg3NjQ2YS90YWJsZXJhbmdlOjdjZWE0ODY5ZWU2NTQwNDY5ZTRhMDBiMjMwODc2NDZhXzUtMS0xLTEtMA_7931b4ce-7af2-4005-aac0-54b0a114ffa6">8</ix:nonNumeric><ix:nonNumeric contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODcvZnJhZzo2ZmIxZmYxOGY0ZmI0ZmJmODc4NmNkZDg3ZWUxODY2Mi90YWJsZTo3Y2VhNDg2OWVlNjU0MDQ2OWU0YTAwYjIzMDg3NjQ2YS90YWJsZXJhbmdlOjdjZWE0ODY5ZWU2NTQwNDY5ZTRhMDBiMjMwODc2NDZhXzUtMi0xLTEtMA_d4624460-f34e-4c9f-a953-e6cb7b5f50b3">11</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="ibd92e268e96f4727813026fb9f3f2f8f_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzYtMS0xLTEtMA_98206065-be78-4f82-b6ae-79e89edb4feb">2.125</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="ie6c00455b2e34b31b4063ebbf2107d3a_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzgtMS0xLTEtMA_e62f4290-b218-49ed-9504-8cc19bef2052">3.150</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="id372eeef8e344178a1dbfa89af46c45e_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzktMS0xLTEtMA_0618055b-943f-4e21-9827-331da7721279">3.375</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="ib8da81de7fee4af4be76cb170e34ee08_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzEwLTEtMS0xLTA_d46c4371-c76e-47a3-be01-0ac1ae43be5a">2.875</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i8172aeed31f44528a74a1c8dbfd1ca1a_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzExLTEtMS0xLTA_c5cc5d75-a498-4396-83b1-84131ff0bb90">2.875</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i7e3cddf201a14b228f50c7a4b6a5839e_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzEyLTEtMS0xLTA_978f4047-052c-48a5-a305-ef6f40ff97ba">3.350</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i93168a5ed89f448f8f66c9c0a2283b35_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzEzLTEtMS0xLTA_5c83d6aa-ea7f-447a-b1dd-a7b0c881b5e0">2.375</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i84b80aaa2de74ba09b15b98ebeeb295d_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzE0LTEtMS0xLTA_94b1efe2-8cdf-41df-8978-36a62d884ae9">&#8212;</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i7548e5a838a4421695679910bd4f2c0a_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzE1LTEtMS0xLTA_1707fdc3-895f-4dfc-82bb-51c3aae1e95a">2.750</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i597c8e442da543bf8a7372bc0ec54f9d_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzE2LTEtMS0xLTA_73277404-d1ee-4c7d-9071-3a83b22ff01c">2.875</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="iedb8d09cef364b1293599d28f7c67748_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzE3LTEtMS0xLTA_e900f2f0-5056-42ba-a85b-e5dcd6209ea5">3.500</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i886286b365bb4971a2f13e2f846af74a_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzE4LTEtMS0xLTA_7c07be14-e36b-4b24-9715-f5092fce1131">3.500</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="if18a2f7f6b0b40f1ad62bd0e830e8b8f_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzE5LTEtMS0xLTQ4OQ_5835ecff-155c-443d-862e-5e4b5a19934a">0.550</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="ic1ec0d84eddf49dc97d2a21dd8cee234_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzE5LTEtMS0xLTA_f86a389c-567d-40c5-9675-41e93a00e7f5">2.375</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i315d80ec5a9b4d33b1d8d34a78cae609_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzIwLTEtMS0xLTA_c6a554db-fba0-41d4-bacb-324b492e0721">3.750</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i786f913ccf164a438f57c04ee49ad2b7_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzIxLTEtMS0xLTA_3536f785-0321-4b90-ae5f-91d9fd7be0f7">3.700</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i1a3471e5bd4648d0aa81686260fbc921_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzIyLTEtMS0xLTA_3e8c31c7-c497-4a56-95f6-0b82533221b4">1.250</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="id8044edfa2384079929b35102a9b7cad_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzIzLTEtMS0xLTA_4e682d5c-e148-422b-8dc8-ec1cbede1271">3.100</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="iec7c13902a5a4ee19961a3eed138f023_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzI1LTEtMS0xLTUwMQ_1e3bc6bc-a48a-48e4-9372-fceecaacd774">1.150</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i6f817c64d72746f4a7600550a38be49c_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzI0LTEtMS0xLTA_237e12bb-496c-426d-a5f5-123783c703d6">3.450</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="icae9b0e4795648ce9e80f348899da659_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzI1LTEtMS0xLTA_6da4d575-9ba5-4c96-b408-1cce540978f2">3.375</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i31ec009da13047b6b79197c66fda5b6f_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzI2LTEtMS0xLTA_5d38b603-7a94-4776-965a-1859eccf152d">2.950</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i85149ce8b76548558e9c825e775cee26_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzI3LTEtMS0xLTA_e73ef6a3-f93a-4756-8e71-189884e93042">3.850</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="ia7cb4d01a77147bea64135beacd75967_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzI4LTEtMS0xLTA_29f893d0-fa81-4de9-95d6-602804f8f736">3.875</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i89ffd37b253a491e85cd53a3418e5384_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzI5LTEtMS0xLTA_4076487e-c6fc-4b43-8d48-8d8d9c7437e9">2.875</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i792128c572ef443698af3751346cf9ff_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzMwLTEtMS0xLTA_fcee0f9a-63aa-4c1a-aed3-64b8fe08f773">2.000</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="ib9a4bd31faa04ee1b247e1f86a34f265_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzMzLTEtMS0xLTUxNg_4a7819e0-2577-4166-8e56-6e331cca936d">2.300</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="ic45826f8bd334acd9a357972ff7747c0_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzMxLTEtMS0xLTA_533aea48-66fa-4402-8ebe-23b7047f3851">4.625</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="ibe281588c47246929092124b77f5b494_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzMyLTEtMS0xLTA_ccd9b429-ad15-4982-953a-390dee56a322">5.800</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i042493d5f213402dbb064b91d1c75e28_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzMzLTEtMS0xLTA_d4134705-1a72-4c5a-834d-c2d36d673871">6.500</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i5ac1e2d38c684f80a23cf559e9f5ff07_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzM0LTEtMS0xLTA_a46ca38d-a35e-4d92-8d41-acc285521eee">6.625</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i5bb559f948de43229cd7e5cae903c0c3_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzM1LTEtMS0xLTA_7375e3ae-71ae-4795-b574-ee8644368f67">6.875</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="iada0e5e85dc241e48cf116319f7a75c6_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzM2LTEtMS0xLTA_81d5a673-794b-48bf-8676-8cf7f6cc279c">3.500</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i6019aef8fb074093b331027b9c2adb61_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzM3LTEtMS0xLTA_c7215a4d-4570-435d-9812-e1b6f9764bc1">2.750</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="iba9a7a93d2b645cea2c51c984287da3f_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzM4LTEtMS0xLTA_7ebb632a-b12a-4446-9e64-cd0779783fd3">5.700</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="ib4f641b3624849f2adeb7cd37bcab7ca_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzM5LTEtMS0xLTA_d3805231-b3ca-4a54-a1b5-ef9315ee13bd">5.950</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="ib3668395d3b640cf8ba0bda86da26e60_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzQzLTEtMS0xLTUzMg_523a2d2c-f9d8-43cc-a764-16199cb5080a">3.050</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i5c821b276174476b9517c3bbb9157232_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzQwLTEtMS0xLTA_cbc7bb60-bdc8-47b5-bc89-e35fe7863395">4.625</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i3057e59415b14c1fbbc0e75f70f19a41_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzQxLTEtMS0xLTA_7fee7a11-daad-42d9-ad15-692588b88794">4.375</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="ica9c4076825647eaad198c486084ebb6_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzQyLTEtMS0xLTA_3a4df45d-1506-4695-ace7-527479545fa0">3.950</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i8aa1ed6f3b9547d785049322c036163a_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzQzLTEtMS0xLTA_552ee9a8-fdbd-4019-b480-a8e697e850cf">4.250</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="idd43a6fb78154c23ac9111d56d6fc58a_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzQ0LTEtMS0xLTA_f217e45b-e848-4b21-8dde-7b3572a0632d">4.750</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i37706a7a25134a80b7681dbe80d0a08f_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzQ1LTEtMS0xLTA_3b560a1a-2068-4dec-8a70-41c1e58005e2">4.200</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i6a47e7cab2b747b19f8ad6dd5577eb65_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzQ2LTEtMS0xLTA_430c2468-85e6-429e-a9fe-245e208869ce">4.250</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i980dd94826d240d68ca80fc74c96e9c1_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzQ3LTEtMS0xLTA_3da76b5c-9a12-47ce-85a2-a9f0a8f0cd86">3.750</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="ie56f8e65458741cba5353670ff8dce7e_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzQ4LTEtMS0xLTA_28da9974-759e-47e6-b1f4-cf56c32cf419">4.250</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i076316df7acd4f5f97a07a2468548d05_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzQ5LTEtMS0xLTA_4b0c3077-e251-46af-bd25-4592306d65f7">4.450</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i5dc454ca8f924d03b29dd33f0388905d_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzUwLTEtMS0xLTA_34a9cad7-7e43-4073-ac6a-b25c503b67ff">3.700</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i43a9150b986245ea926eba8cf8dd88c4_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzUxLTEtMS0xLTA_a985f1e6-a915-4770-aea7-ed0d4f87ff85">2.900</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="id7d2521c88c843bbab7e44fbe1b07950_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzU2LTEtMS0xLTU0Ng_ef31f573-1011-4534-b219-78e2a397ac6a">3.250</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="if6fda2fd6f8d48768196072f7bb18858_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzUyLTEtMS0xLTA_86bad8a9-2ab7-4926-881b-c9c6bdc74ac5">3.875</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i3d6a2a39f8a84b30913e25aac3e3a548_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzUzLTEtMS0xLTA_c8b6e13e-ee41-42df-9d40-1e531bda1320">3.125</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i0561a17f67884087afe8d954a4e80ace_I20211231" decimals="-6" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZToyMzgyMWI5MmY0MmI0ZmEyYjg0ZjIxMWVlYzg1NWU2Ni90YWJsZXJhbmdlOjIzODIxYjkyZjQyYjRmYTJiODRmMjExZWVjODU1ZTY2XzEtMS0xLTEtMA_3019e8c8-f7df-4ffe-b7c6-d1b5ff5d8e58">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="ia6ef4bc76d4e41ef824e2e1bc29be3e8_I20211231" decimals="-6" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZToyMzgyMWI5MmY0MmI0ZmEyYjg0ZjIxMWVlYzg1NWU2Ni90YWJsZXJhbmdlOjIzODIxYjkyZjQyYjRmYTJiODRmMjExZWVjODU1ZTY2XzItMS0xLTEtMA_cf562ebc-2a68-4b9d-b9af-8836b5f45245">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i3bbc78e491bd48b2bdc3d2454d729af8_I20211231" decimals="-6" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZToyMzgyMWI5MmY0MmI0ZmEyYjg0ZjIxMWVlYzg1NWU2Ni90YWJsZXJhbmdlOjIzODIxYjkyZjQyYjRmYTJiODRmMjExZWVjODU1ZTY2XzMtMS0xLTEtMA_8dbb6ef0-50c6-4195-a686-9b0ad6416ed0">&#8212;</ix:nonFraction><ix:nonNumeric contextRef="i9bd8ec4f14f94dc98096c091b92e4751_D20210101-20211231" name="us-gaap:LineOfCreditFacilityExpirationPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZToyMzgyMWI5MmY0MmI0ZmEyYjg0ZjIxMWVlYzg1NWU2Ni90YWJsZXJhbmdlOjIzODIxYjkyZjQyYjRmYTJiODRmMjExZWVjODU1ZTY2XzUtMS0xLTEtMA_bb9960fe-4ac9-40aa-af95-94b9f26a2d77">5</ix:nonNumeric><ix:nonNumeric contextRef="i0ef9be25372d4e00bd34d251579f4577_D20210101-20211231" name="us-gaap:LineOfCreditFacilityExpirationPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZToyMzgyMWI5MmY0MmI0ZmEyYjg0ZjIxMWVlYzg1NWU2Ni90YWJsZXJhbmdlOjIzODIxYjkyZjQyYjRmYTJiODRmMjExZWVjODU1ZTY2XzYtMS0xLTEtMA_8d6f1246-979f-4b1c-b771-a6296f71c08e">3</ix:nonNumeric><ix:nonNumeric contextRef="i26faa7bce6f44c1ba49361994ef7383d_D20210101-20211231" name="us-gaap:LineOfCreditFacilityExpirationPeriod" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZToyMzgyMWI5MmY0MmI0ZmEyYjg0ZjIxMWVlYzg1NWU2Ni90YWJsZXJhbmdlOjIzODIxYjkyZjQyYjRmYTJiODRmMjExZWVjODU1ZTY2XzctMS0xLTEtMA_9e063743-65b0-475a-a31f-5e88c35244d0">364</ix:nonNumeric><ix:nonNumeric contextRef="i594ed33a64c84c5383f969319b50d190_D20210101-20211231" name="us-gaap:TaxCreditCarryforwardExpirationDate" format="ixt:date-month-day-year" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDIvZnJhZzoyYzg1YTcyMTRhNzM0NWUyOTMzZjcyYTA2MWVmNTljNi90YWJsZTpiMDI0YWNlYjgxZGU0N2RmYTE2YTc3Zjg1NmYzN2I2OC90YWJsZXJhbmdlOmIwMjRhY2ViODFkZTQ3ZGZhMTZhNzdmODU2ZjM3YjY4XzEtMC0xLTEtMA_55debad8-dfd5-4d7d-a073-8f49400616b5">1/1/2023</ix:nonNumeric><ix:nonNumeric contextRef="i065ef157d8a74b71a4c8ba538486d487_D20210101-20211231" name="us-gaap:TaxCreditCarryforwardExpirationDate" format="ixt:date-month-day-year" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDIvZnJhZzoyYzg1YTcyMTRhNzM0NWUyOTMzZjcyYTA2MWVmNTljNi90YWJsZTpiMDI0YWNlYjgxZGU0N2RmYTE2YTc3Zjg1NmYzN2I2OC90YWJsZXJhbmdlOmIwMjRhY2ViODFkZTQ3ZGZhMTZhNzdmODU2ZjM3YjY4XzEtMS0xLTEtMA_0ee63faa-eaaf-4c45-ada3-96afe30ee80a">1/1/2037</ix:nonNumeric><ix:nonNumeric contextRef="i74609445052240d09613244522e25dba_D20210101-20211231" name="us-gaap:TaxCreditCarryforwardExpirationDate" format="ixt:date-month-day-year" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDIvZnJhZzoyYzg1YTcyMTRhNzM0NWUyOTMzZjcyYTA2MWVmNTljNi90YWJsZTpiMDI0YWNlYjgxZGU0N2RmYTE2YTc3Zjg1NmYzN2I2OC90YWJsZXJhbmdlOmIwMjRhY2ViODFkZTQ3ZGZhMTZhNzdmODU2ZjM3YjY4XzMtMC0xLTEtMA_6de9531a-9edc-4755-9c16-5fb793bf03d6">1/1/2022</ix:nonNumeric><ix:nonNumeric contextRef="i1c6d80d4f8bb448a8552137452437d96_D20210101-20211231" name="us-gaap:TaxCreditCarryforwardExpirationDate" format="ixt:date-month-day-year" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDIvZnJhZzoyYzg1YTcyMTRhNzM0NWUyOTMzZjcyYTA2MWVmNTljNi90YWJsZTpiMDI0YWNlYjgxZGU0N2RmYTE2YTc3Zjg1NmYzN2I2OC90YWJsZXJhbmdlOmIwMjRhY2ViODFkZTQ3ZGZhMTZhNzdmODU2ZjM3YjY4XzMtMS0xLTEtMA_e4d55878-4ba7-4b11-ade8-d2b0ce97ff30">1/1/2041</ix:nonNumeric><ix:nonNumeric contextRef="i594ed33a64c84c5383f969319b50d190_D20210101-20211231" name="us-gaap:OpenTaxYear" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDIvZnJhZzoyYzg1YTcyMTRhNzM0NWUyOTMzZjcyYTA2MWVmNTljNi90YWJsZTpiMDI0YWNlYjgxZGU0N2RmYTE2YTc3Zjg1NmYzN2I2OC90YWJsZXJhbmdlOmIwMjRhY2ViODFkZTQ3ZGZhMTZhNzdmODU2ZjM3YjY4XzYtMC0xLTEtMA_5fdea5ca-2322-4038-a4c0-bd7616617a41">2017</ix:nonNumeric><ix:nonNumeric contextRef="i065ef157d8a74b71a4c8ba538486d487_D20210101-20211231" name="us-gaap:OpenTaxYear" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDIvZnJhZzoyYzg1YTcyMTRhNzM0NWUyOTMzZjcyYTA2MWVmNTljNi90YWJsZTpiMDI0YWNlYjgxZGU0N2RmYTE2YTc3Zjg1NmYzN2I2OC90YWJsZXJhbmdlOmIwMjRhY2ViODFkZTQ3ZGZhMTZhNzdmODU2ZjM3YjY4XzYtMS0xLTEtMA_b5c35318-f3ca-492c-961b-11b235ed07c5">2020</ix:nonNumeric><ix:nonNumeric contextRef="i74609445052240d09613244522e25dba_D20210101-20211231" name="us-gaap:OpenTaxYear" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDIvZnJhZzoyYzg1YTcyMTRhNzM0NWUyOTMzZjcyYTA2MWVmNTljNi90YWJsZTpiMDI0YWNlYjgxZGU0N2RmYTE2YTc3Zjg1NmYzN2I2OC90YWJsZXJhbmdlOmIwMjRhY2ViODFkZTQ3ZGZhMTZhNzdmODU2ZjM3YjY4XzgtMC0xLTEtMA_c6a227fa-c31f-4179-af9f-3d8befa4c5d7">2014</ix:nonNumeric><ix:nonNumeric contextRef="i1c6d80d4f8bb448a8552137452437d96_D20210101-20211231" name="us-gaap:OpenTaxYear" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDIvZnJhZzoyYzg1YTcyMTRhNzM0NWUyOTMzZjcyYTA2MWVmNTljNi90YWJsZTpiMDI0YWNlYjgxZGU0N2RmYTE2YTc3Zjg1NmYzN2I2OC90YWJsZXJhbmdlOmIwMjRhY2ViODFkZTQ3ZGZhMTZhNzdmODU2ZjM3YjY4XzgtMS0xLTEtMA_42bfab5d-3f6b-4e4c-a819-e2501d86c0b7">2021</ix:nonNumeric><ix:nonNumeric contextRef="i44dc783f612e43b28b4d406b49e67429_D20210101-20211231" name="us-gaap:OpenTaxYear" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDIvZnJhZzoyYzg1YTcyMTRhNzM0NWUyOTMzZjcyYTA2MWVmNTljNi90YWJsZTpiMDI0YWNlYjgxZGU0N2RmYTE2YTc3Zjg1NmYzN2I2OC90YWJsZXJhbmdlOmIwMjRhY2ViODFkZTQ3ZGZhMTZhNzdmODU2ZjM3YjY4XzEwLTAtMS0xLTA_e63a5ea2-8365-4dcc-87d9-a6d3304191c9">2015</ix:nonNumeric><ix:nonNumeric contextRef="i500f988f0d5d4732a1a3d4b8ebab6285_D20210101-20211231" name="us-gaap:OpenTaxYear" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDIvZnJhZzoyYzg1YTcyMTRhNzM0NWUyOTMzZjcyYTA2MWVmNTljNi90YWJsZTpiMDI0YWNlYjgxZGU0N2RmYTE2YTc3Zjg1NmYzN2I2OC90YWJsZXJhbmdlOmIwMjRhY2ViODFkZTQ3ZGZhMTZhNzdmODU2ZjM3YjY4XzEwLTEtMS0xLTA_5e054c0f-aedc-4d62-9e93-4b352d231e41">2021</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="icdb1414efe6043419f08c3bf8694fb7b_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzEtMS0xLTEtMA_a60737d5-82d3-451a-abe5-d1a8c8cfc2bf">0.007</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i15c2564b16d64dc19f85f7ab4f89e02b_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzEtMi0xLTEtMA_6c282770-0a2d-4ec3-afe3-317031892f75">0.012</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i43a2150e723d483a91bbb0bdde5cae0d_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzEtNC0xLTEtMA_1127d95b-f7ae-46ae-94ea-829bd9de702f">0.002</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="icb0b5f4d103946b6ae23ad68bcab60b9_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzEtNS0xLTEtMA_c3ebcb18-1849-416a-8cfb-a626b3857cf4">0.014</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i98a30b5367174ca1bdd6a71ace6b060b_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzEtNy0xLTEtMA_64a00a3e-14c8-4e8c-8b1e-79b87b98b047">0.015</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i88c7c3b5d7e240e8a09d2f62902528c7_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzEtOC0xLTEtMA_4421de73-d13d-4d98-a282-2d93580b9703">0.025</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="icdb1414efe6043419f08c3bf8694fb7b_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzItMS0xLTEtMA_30dc256e-277d-47e4-b964-7398aef80d7c">0.292</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i15c2564b16d64dc19f85f7ab4f89e02b_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzItMi0xLTEtMA_5c3d88f8-7f90-410a-a9cf-4f3c5f409718">0.298</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i43a2150e723d483a91bbb0bdde5cae0d_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzItNC0xLTEtMA_6e58df34-e34c-46fa-b782-12646a018571">0.222</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="icb0b5f4d103946b6ae23ad68bcab60b9_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzItNS0xLTEtMA_08b54a72-0928-452b-8607-60dae9ccf927">0.295</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i98a30b5367174ca1bdd6a71ace6b060b_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzItNy0xLTEtMA_94c0d482-05eb-4d3a-837e-e872843e3720">0.194</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i88c7c3b5d7e240e8a09d2f62902528c7_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzItOC0xLTEtMA_8783f117-90bb-44dc-a823-66423e0cbd5b">0.216</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="icdb1414efe6043419f08c3bf8694fb7b_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzMtMS0xLTEtMA_a930f907-f0b3-423a-83e7-c63ca1e43c6c">0.013</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i15c2564b16d64dc19f85f7ab4f89e02b_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzMtMi0xLTEtMA_d7653de9-79ea-4f09-98c6-6ae78cbb1ffb">0.015</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i43a2150e723d483a91bbb0bdde5cae0d_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzMtNC0xLTEtMA_4240c65f-b1ba-4f94-9dff-0c98e7c45a77">0.014</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="icb0b5f4d103946b6ae23ad68bcab60b9_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzMtNS0xLTEtMA_9ea9ce87-1194-4b4c-a1ce-a178f5579566">0.017</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i98a30b5367174ca1bdd6a71ace6b060b_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzMtNy0xLTEtMA_5c2ef978-3fbe-4f9d-a5c0-10a08b895e87">0.014</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i88c7c3b5d7e240e8a09d2f62902528c7_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzMtOC0xLTEtMA_f6ace01b-ee02-4dd8-acae-eb4e5c8ee399">0.018</ix:nonFraction><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzUtMS0xLTEtMA_509e8e56-c499-4507-82f6-3102f9d27c14">4.802054794520548</ix:nonNumeric><ix:nonNumeric contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzUtNC0xLTEtMA_e618be85-1579-4f23-a094-7c6a008b538a">5.102511415525115</ix:nonNumeric><ix:nonNumeric contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzUtNy0xLTEtMA_b81141a4-d144-4ea2-9741-dc8807427dd6">5.302054794520548</ix:nonNumeric><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzgtMS0xLTEtMA_da7313e5-49e1-4c50-bc09-21592d328754">6.299315068493151</ix:nonNumeric><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzktMS0xLTEtMA_745f6969-d20c-456f-b00a-9ff850c1fddf">4.6995433789954335</ix:nonNumeric><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzEwLTEtMS0xLTA_ceb11579-0a34-4546-b730-94211b37eeaf">6.202283105022831</ix:nonNumeric><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzEyLTEtMS0xLTA_92e8ade8-d83f-43f4-917d-8d7f884cd969">1.2993150684931507</ix:nonNumeric><ix:nonFraction unitRef="usdPerShare" contextRef="i2749835a349545f38d76efb02e97a939_I20211231" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzQvZnJhZzo0ZDk0Y2E3YTBhMjg0MTViOGRlZTRmODU2M2VlNzBhNy90YWJsZTo0MTliNjRmYmRlZDQ0YzkzYTI0OTQzNDdiNGQzNWU3Zi90YWJsZXJhbmdlOjQxOWI2NGZiZGVkNDRjOTNhMjQ5NDM0N2I0ZDM1ZTdmXzEtMS0xLTEtMA_7f75dc3e-d374-4190-88dd-8353068f5436">0.01</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzQvZnJhZzo0ZDk0Y2E3YTBhMjg0MTViOGRlZTRmODU2M2VlNzBhNy90YWJsZTo0MTliNjRmYmRlZDQ0YzkzYTI0OTQzNDdiNGQzNWU3Zi90YWJsZXJhbmdlOjQxOWI2NGZiZGVkNDRjOTNhMjQ5NDM0N2I0ZDM1ZTdmXzEtMy0xLTEtMA_f419bad8-d917-4d78-9ce8-9bc2059c4441">0.01</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i2749835a349545f38d76efb02e97a939_I20211231" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzQvZnJhZzo0ZDk0Y2E3YTBhMjg0MTViOGRlZTRmODU2M2VlNzBhNy90YWJsZTo0MTliNjRmYmRlZDQ0YzkzYTI0OTQzNDdiNGQzNWU3Zi90YWJsZXJhbmdlOjQxOWI2NGZiZGVkNDRjOTNhMjQ5NDM0N2I0ZDM1ZTdmXzItMS0xLTEtMA_9806846c-f170-47b6-b59f-cdcc0ece6eb9">3,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzQvZnJhZzo0ZDk0Y2E3YTBhMjg0MTViOGRlZTRmODU2M2VlNzBhNy90YWJsZTo0MTliNjRmYmRlZDQ0YzkzYTI0OTQzNDdiNGQzNWU3Zi90YWJsZXJhbmdlOjQxOWI2NGZiZGVkNDRjOTNhMjQ5NDM0N2I0ZDM1ZTdmXzItMy0xLTEtMA_019b5f2b-5b4f-4b2f-b194-0f682a877ce4">3,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i2749835a349545f38d76efb02e97a939_I20211231" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzQvZnJhZzo0ZDk0Y2E3YTBhMjg0MTViOGRlZTRmODU2M2VlNzBhNy90YWJsZTo0MTliNjRmYmRlZDQ0YzkzYTI0OTQzNDdiNGQzNWU3Zi90YWJsZXJhbmdlOjQxOWI2NGZiZGVkNDRjOTNhMjQ5NDM0N2I0ZDM1ZTdmXzMtMS0xLTEtMA_fa17f1be-45e1-4939-8b1c-faa7cd2151b4">941</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzQvZnJhZzo0ZDk0Y2E3YTBhMjg0MTViOGRlZTRmODU2M2VlNzBhNy90YWJsZTo0MTliNjRmYmRlZDQ0YzkzYTI0OTQzNDdiNGQzNWU3Zi90YWJsZXJhbmdlOjQxOWI2NGZiZGVkNDRjOTNhMjQ5NDM0N2I0ZDM1ZTdmXzMtMy0xLTEtMA_0bb2a3af-aba6-4b8e-a1b4-356b717876a0">946</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i2749835a349545f38d76efb02e97a939_I20211231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzQvZnJhZzo0ZDk0Y2E3YTBhMjg0MTViOGRlZTRmODU2M2VlNzBhNy90YWJsZTo0MTliNjRmYmRlZDQ0YzkzYTI0OTQzNDdiNGQzNWU3Zi90YWJsZXJhbmdlOjQxOWI2NGZiZGVkNDRjOTNhMjQ5NDM0N2I0ZDM1ZTdmXzQtMS0xLTEtMA_424d44f6-0c33-473f-8252-b369af69aec4">941</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzQvZnJhZzo0ZDk0Y2E3YTBhMjg0MTViOGRlZTRmODU2M2VlNzBhNy90YWJsZTo0MTliNjRmYmRlZDQ0YzkzYTI0OTQzNDdiNGQzNWU3Zi90YWJsZXJhbmdlOjQxOWI2NGZiZGVkNDRjOTNhMjQ5NDM0N2I0ZDM1ZTdmXzQtMy0xLTEtMA_ca4e45d8-8132-4b89-96d7-d5d706110ae3">946</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i2749835a349545f38d76efb02e97a939_I20211231" decimals="3" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzQvZnJhZzo0ZDk0Y2E3YTBhMjg0MTViOGRlZTRmODU2M2VlNzBhNy90YWJsZTo0MTliNjRmYmRlZDQ0YzkzYTI0OTQzNDdiNGQzNWU3Zi90YWJsZXJhbmdlOjQxOWI2NGZiZGVkNDRjOTNhMjQ5NDM0N2I0ZDM1ZTdmXzUtMS0xLTEtMA_451abca6-a90b-4893-b87b-cecc47ef7ee4">0.001</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231" decimals="3" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzQvZnJhZzo0ZDk0Y2E3YTBhMjg0MTViOGRlZTRmODU2M2VlNzBhNy90YWJsZTo0MTliNjRmYmRlZDQ0YzkzYTI0OTQzNDdiNGQzNWU3Zi90YWJsZXJhbmdlOjQxOWI2NGZiZGVkNDRjOTNhMjQ5NDM0N2I0ZDM1ZTdmXzUtMy0xLTEtMA_bc0ad3e6-cd7b-45b0-9cfc-7b54ceba174d">0.001</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i2749835a349545f38d76efb02e97a939_I20211231" decimals="-6" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzQvZnJhZzo0ZDk0Y2E3YTBhMjg0MTViOGRlZTRmODU2M2VlNzBhNy90YWJsZTo0MTliNjRmYmRlZDQ0YzkzYTI0OTQzNDdiNGQzNWU3Zi90YWJsZXJhbmdlOjQxOWI2NGZiZGVkNDRjOTNhMjQ5NDM0N2I0ZDM1ZTdmXzYtMS0xLTEtMA_d8ba6077-b7dc-428b-8e5a-d6455fc77369">10</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231" decimals="-6" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzQvZnJhZzo0ZDk0Y2E3YTBhMjg0MTViOGRlZTRmODU2M2VlNzBhNy90YWJsZTo0MTliNjRmYmRlZDQ0YzkzYTI0OTQzNDdiNGQzNWU3Zi90YWJsZXJhbmdlOjQxOWI2NGZiZGVkNDRjOTNhMjQ5NDM0N2I0ZDM1ZTdmXzYtMy0xLTEtMA_5deaafbd-ccd1-4510-8b1b-7695f791fbbe">10</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i2749835a349545f38d76efb02e97a939_I20211231" decimals="-6" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzQvZnJhZzo0ZDk0Y2E3YTBhMjg0MTViOGRlZTRmODU2M2VlNzBhNy90YWJsZTo0MTliNjRmYmRlZDQ0YzkzYTI0OTQzNDdiNGQzNWU3Zi90YWJsZXJhbmdlOjQxOWI2NGZiZGVkNDRjOTNhMjQ5NDM0N2I0ZDM1ZTdmXzctMS0xLTEtMA_4dad2ec1-3261-483c-b907-83caa9d59552">&#8212;</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231" decimals="-6" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzQvZnJhZzo0ZDk0Y2E3YTBhMjg0MTViOGRlZTRmODU2M2VlNzBhNy90YWJsZTo0MTliNjRmYmRlZDQ0YzkzYTI0OTQzNDdiNGQzNWU3Zi90YWJsZXJhbmdlOjQxOWI2NGZiZGVkNDRjOTNhMjQ5NDM0N2I0ZDM1ZTdmXzctMy0xLTEtMA_cba0df00-04f4-4e7a-bf5a-7ca7a683463d">&#8212;</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i2749835a349545f38d76efb02e97a939_I20211231" decimals="-6" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzQvZnJhZzo0ZDk0Y2E3YTBhMjg0MTViOGRlZTRmODU2M2VlNzBhNy90YWJsZTo0MTliNjRmYmRlZDQ0YzkzYTI0OTQzNDdiNGQzNWU3Zi90YWJsZXJhbmdlOjQxOWI2NGZiZGVkNDRjOTNhMjQ5NDM0N2I0ZDM1ZTdmXzgtMS0xLTEtMA_afe4f209-1663-4fd5-a8f5-e3c614885eac">&#8212;</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231" decimals="-6" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzQvZnJhZzo0ZDk0Y2E3YTBhMjg0MTViOGRlZTRmODU2M2VlNzBhNy90YWJsZTo0MTliNjRmYmRlZDQ0YzkzYTI0OTQzNDdiNGQzNWU3Zi90YWJsZXJhbmdlOjQxOWI2NGZiZGVkNDRjOTNhMjQ5NDM0N2I0ZDM1ZTdmXzgtMy0xLTEtMA_6fbd6793-f480-4832-b78f-d9c506082aa3">&#8212;</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="unh-20211231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8eb94eb0b4484ca996ca09b316c723b4_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i884d1b7f798047438f1fdf140f8c5b0c_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ia9973178a1474e659ee68ed2ce06eb70_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8980da815bc14d658ecbcb83b1249903_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22e79815a5ab4c57ac20424b76b26acf_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87aa1e3370624fd2bcbec006cd442de0_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f930a7c88bf48e19ee77868a67beb2c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebfb5141726d4790b2d5d6623285f2f3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb730d55174e422ba5041871ed73019a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93c9b8bdda4a422883687239d22ec90b_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7de78e50178f4dd78f67556f70d9e637_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8eae67f0f11a4c898fa1dedd55840500_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i315e24e23ae44a01836f60086f1fd315_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5ac330194c449fd8d7d91f71917f488_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bca26759d4145299e751f4f22f5f1fd_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i870730cd9dfc45bb89971499ab4cdd48_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i509cd57b44304b8fb05235033e28b2bf_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28a6344b404a41c18ed41602af107cc3_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c99cfb64bc04618a8af89c6e3780c50_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93754eb2a7814682a663dc4a8233c401_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2ffd7130e2647e2b0e793e2a0f526a3_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i930490d923ac4f958c17a0c16169ecfd_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01af9c575b984fbb810a65816e8f5c90_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ac3cd6c11db4467b4b8b2a362706d03_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f76f41fc9da46f2a0884ca2b30659d4_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieebefefe33444454986842a74b0799e9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i070f515f1b0a4ce9b417c2adcffa3bc0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79b55573683d48f8b6dfa7e39455622e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ca981dc06144e079639ca1af5c729c7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia27e856d3af841b3a28c74b0c8109477_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d57e9b440f94b42ade5424c81274932_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i530caf840d4847f1ac553be5f7b336b2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c49e5bd973a474d93bece3aedf4801f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fbd0b79127d43b29830dc7504fbbbd4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f099b39a9db4d7e8c625a6989f76ace_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3300d5a2eaaa4e0386e185cd95eae562_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0378ff590db1498e8fec3c3e08138eb1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79edb1e59c054995bf5b8fe22cb060d1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i072d7c898f4243b8a611602a0b370dfd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c34096fce714d0c84c9883d2dbaae66_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5cc85a29e8934045a37d5be367d3db92_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied02258caa3547f1ac9db1ebac75e7b5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1d7badbbfe74d128af9048d86a399ee_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7634c8268a7641f091bbd4593b6b3229_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2af08b82a1804b45b92fd387d2d6ebc7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78db576697a6474084de5301358e552a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54c9ed4fe57143d089532919ce622309_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c38985e71104ebf84a399c4c16d84b9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f46a298bc1a4e6da1439ecf4feef723_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a8e9219ee4b4394808f55b5e8635651_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd650c47786d472789666a390d70daa2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i205c8dfff92c4b7b93596e6594ee9ef4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i593bf0b079e04f058cf0f21f5585b069_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic04e77b5e9904fcc9c97df541ef3f22a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cb7b25ac2db413db39f0363a9eed1e3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i275d8d15f1794b78972e85e3f1725cd4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e144bfae9ce400699c59ff4175549af_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7a74722ffca455e8f8b9d9120092a96_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie667c3a41af649e28b76eb6f34ded8a2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">unh:EmployeeStockPurchasePlanESPPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i3cc841fcdfd546358ed335a1f5de7e7e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">unh:ProductsandservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f67f540a2f34e649bdb094c7c1cf41d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">unh:ProductsandservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifafacde0705d4f258c784fe3cb74d22f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46bb0d0f79554481a30ef5011a4f84b3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="unh:PharmaceuticalmanufacturerrebatesreceivableAxis">unh:PharmaceuticalManufacturerRebatesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id24643699baf4fca9b1c7b6874e25228_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="unh:PharmaceuticalmanufacturerrebatesreceivableAxis">unh:PharmaceuticalManufacturerRebatesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e70f543d656432ab29e3070fc195a80_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="unh:MedicarePartDPharmacyBenefitsContractAxis">unh:MedicarePartDReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic913811c9e844fe4af3ff284c1deabc6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="unh:MedicarePartDPharmacyBenefitsContractAxis">unh:MedicarePartDReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1ff1cf727f44188aa9fc2cdae7f314c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">unh:UsefulLifeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8384e266805d4927b90e345df1e3f524_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87b309e50f2a486dadbe07f2c0015862_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i122210b356e34cd393cb6d0422f9ff20_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c578a943465456dbb16da796df70705_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic338e78c17b54bdd9e1a900148c7981c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">unh:CapitalizedsoftwareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff76c7d81e324fd3855a24b45c0f6feb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">unh:CapitalizedsoftwareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea339ff4f3c94a45a63d0fe4f74ba6f4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie60f9bda7240423e99aefddba5815436_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib55d7c02a76f495eadd39abf177a36b9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">unh:RedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb906a7e10bf4c67a37f412d39862ee2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">unh:RedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91c331befb394cb6b31c1d43cedab05f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">unh:RedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d71c28a51a741d4b83d1e2cb290100d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">unh:RedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7962e972c7344539b9b1d82ad79a7df_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">unh:RedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0cf2e2ded57848acbd7f4ce7b8849c5d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d96f9ce242e4c3d8115ee3621f39cbe_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">unh:StockOptionsandSARsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5bcfc870d824827bb66dd636d076fd1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24678048e47943bb91d8def4d5f22212_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60063fc646f547e0ac686bc7d0b92112_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5a1b74f16184b9bb2add4cab25e29f2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b784ace82c244c5867ac2f828eb7a57_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a312b80055e4af7bc076c9e6f9c43e6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe8be8f0fb534e25be1cc040ead9f99f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib130b8ba2819452594b22d15469baacb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ec806aa176a4bbb99266b4a32cf1ded_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieda9939b5a6c4fdeb0d28e0580ab8d78_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb56bbdb5bca464cb867242d3ed1b377_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b1ef8f174f64af8b548c0044b97ecb5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="positions"><xbrli:measure>unh:positions</xbrli:measure></xbrli:unit><xbrli:context id="ifc7213ff01b448239792e43a61300d38_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1b66727575a4e678ac30b674426f585_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib817a90dc86742a28badd4c87a39b501_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba871229a901424484cc7c291cbe9f0e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5dd5e25d23aa4a7fa951ebebaba203a1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6eeef3734fae442a8264a01cb7372550_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bea540206e64b51b2cbf141a4999d50_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f98b30125864fdca705b2901d65b24b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ba7717a6c87435994ca841d4dafcd86_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i786c6b4857764efd94186e77e3b6f938_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8922e827b09149b5b48d5d53a1d3064f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40294d1cde8d40b497abb9effe028d71_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic74a5a57b68545f68727915480210bea_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbc6b84573cd460bb185c06c93cab313_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide094d54765b442b88523b9454527fbd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfc2226cf4444ab1a84562eb064b98c2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ac0596304be4b85b623b402780f1b8d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a09033b49c14106baa0f691507e4246_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4b3aa9a235e41d0be50be982749d992_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63ceb3ccbcf14457b98cb6eef7d4b50f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd8f7f5f7a214e6c9819ee8745d58190_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d22c5f5de67464fa6cda436b26c58dc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2e7820a9e9b45a3ace8daf2bf6b3576_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i143f48c7749c46eaa1530838b78b041b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8da1637a90d94f7d8cbbb9e89200393e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a84715d70a74fceaa59165cb7cfb450_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacd4e95ed0ff45e8b463cde8fb162e36_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1274175ecdc4c66979e1169bb16b496_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i348ad0bbc326423b98599f12852d34af_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35f826dbcf4d42b4be8664b7331fb199_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic303a9fd1e74453b8a529be93a4f56bf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0ea67d91b6d434599e098210b7a488c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i073d903c845f4731bd55974d4b29f4b6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf644ee782e74842af3129b8232dcaed_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf26e2e8c57f4e7a89bfb1c2baf068a5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic45c1b0462fc4790975a0e25b80a5726_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14c36d9932b54db0b6a4f835644eb0aa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68adcae3162f47ae8c5f0bb4ef470545_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09e58021d29540878f244a567f9a5ced_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4bfd62c299df4d94bbf76c712ccec550_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3d58ed074c84089913ffdffc57c1d73_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd5d40328bb047cb90c2611b44a7f743_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9032d6bd2554be797457d71b15c021a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if59af989581341269c0f798a7a8a56ff_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72edef7745bb4e80901cf10381b12375_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e1d0ee68a90487188c597f675ea6962_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie134d5521b5441d7a99c70ae3d64e701_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2205792a33d644b0a632f4d4f33237f4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5545c49f50ec48edb1474b999af271fc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff86380602ce4f588a2f94a05eaab292_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae7403f6fc564452803f560b78d46801_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadc9e4cd75f14dd7a16f6026ec702279_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69b798301dcb496d99d84a6592b8549b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic505ff42be0a4bcb9d166dd3d36bcef1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c5e5fa052504d4cb045b94a02d5a58f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e9f6e4d1d1345d5807de27d47ac5f59_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4b8d6e218734867ad53588492384845_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79898441c75b41d5ac9f1f9da1f4e5d9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85d7067f865b4342b9d8d877f735ac59_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f2864e94d7849f79bce61f0d550474d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a1b38442cb3432c99552784de780fe5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69a743b9a5d84ecd862ffaa1626c672b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9004c5f31284db6a840b518fa6c4f58_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedbc8a127a984a2b9f57050fc010853d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i552ab3ba177642ab8b64fa5712f45dd8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebe8572afa0a4d7da446aa8d4ab62eb8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib78936422dda4cf88cb3cbc4dd220121_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0a9e47794c54540ad3d61b206a2a5cf_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80e3cb189ce045d08f4e6301ab039bfe_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9dcd135114fe40ad9bbefb48db0ba475_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ddeff676a684e46b6072017bc1e9416_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26d61444d51b4f20823b0b809247d33c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafa155f646d841c8b93f03aacf967154_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id05f41ba34f2466392338fadddf9dd1d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9739896064149b98b26a61eeaa6550f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61c10c93e0f54b55a26f3573ba827569_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0bdaeb0614d4e2c9380f7415853f763_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf94dc7fd3204a588aba8704a0d1a90a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3183b05d67943c3b4034e58b9be0447_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13c92c68c2ea480ea5701676b9b826f9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i202cb135dc1e4e3daca6dd5059f0cf19_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d5fa92bbec547a085cba2fb930f6bc6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85448c57b2cc45b2ab8f29ae7d7c6a2a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if966e9f805794457af9a0eed34e96495_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb823f0ecf2f4061a477b16abf75cdc2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">unh:TrademarksandTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ec08aacf770472c93dbac44374b8a68_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">unh:TrademarksandTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3203585470194543898607ba99a6eec0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica15e60f135045e5b3209b00ecdc8ec6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ef9cd7ab1654b62b1ab409dcb38f85f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f34678550484e8eaa1d6f032590a9cd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72998cdf5b13475480213110198dde60_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ecd4e0cb3384d4c8ddd20890ad9e997_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ded218b083944e188cd4579765a2a84_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">unh:TrademarksandTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b4f1188393845f8827897acb0c3916c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">unh:TrademarksandTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa52ad981c7743b1818a805ee0a0b5fe_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a251ae641a244f982ee84dc33f39c98_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e7bca7f64a8424489d83e9c4b27fbba_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if47ca87b4cab4485a2e7830a82f298c2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1db8094151d340e583b4cbe1a3165397_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86f3f2448f524de3913d85ac9788450f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i379ecb26e0e846348f402effa72a9eb2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cb0c74d57b1477fa31da545e505e6d8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.700notesdueFebruary2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5c8f497804347fc9f0f8a62f4499752_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.700notesdueFebruary2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd92e268e96f4727813026fb9f3f2f8f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.125notesdueMarch2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4248de2739cf40dca665ae10381e03b2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.125notesdueMarch2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb03d5528d1145cfb99fcf592801d116_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:FloatingratenotesdueJune2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63fb7f8ae0fd40038163eafaa15d201d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:FloatingratenotesdueJune2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6c00455b2e34b31b4063ebbf2107d3a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.150notesdueJune2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76cb2d4454a64645abe47553a65a92de_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.150notesdueJune2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id372eeef8e344178a1dbfa89af46c45e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.375notesdueNovember2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ba481f8e0d74c10bc0588b4835f8af5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.375notesdueNovember2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8da81de7fee4af4be76cb170e34ee08_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2875NotesDueDecember2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i096ea40c3d4c42ba8a127cef33efd254_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2875NotesDueDecember2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8172aeed31f44528a74a1c8dbfd1ca1a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.875notesdueMarch2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84e7e1ef880e481483e8d4914556cf84_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.875notesdueMarch2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e3cddf201a14b228f50c7a4b6a5839e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3350NotesDueJuly2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c80b9e731e44c0697a1b7a31a23bf17_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3350NotesDueJuly2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93168a5ed89f448f8f66c9c0a2283b35_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.375notesdueOctober2022MemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92d32861403b4fa0bc059b43eb0e9edf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.375notesdueOctober2022MemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84b80aaa2de74ba09b15b98ebeeb295d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:ZeroCouponNotesDueNovember2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdb4994c14104e3ebccd784f009aa1ae_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:ZeroCouponNotesDueNovember2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7548e5a838a4421695679910bd4f2c0a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2750NotesDueFebruary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib120d5bbaa93472eb64fb119097cdf6f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2750NotesDueFebruary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i597c8e442da543bf8a7372bc0ec54f9d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2875NotesDueMarch2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie880ffc901ab4104b4cfd303f4831b1f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2875NotesDueMarch2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedb8d09cef364b1293599d28f7c67748_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.500notesdueJune2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia859c1517f2441d58ef162b5ff01d64c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.500notesdueJune2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i886286b365bb4971a2f13e2f846af74a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.500notesdueFebruary2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07e2a1c9ec8442cea51615552b249524_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.500notesdueFebruary2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if18a2f7f6b0b40f1ad62bd0e830e8b8f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A0550NotesDueMay2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30c9ff85e8394406aa2fcf8c8e0dbf28_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A0550NotesDueMay2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1ec0d84eddf49dc97d2a21dd8cee234_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.375notesdueAugust2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb4e09db805a48c9a9980ed388f9d691_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.375notesdueAugust2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i315d80ec5a9b4d33b1d8d34a78cae609_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.750notesdueJuly2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba6f227255b343d1ac18d3836772b9ad_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.750notesdueJuly2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i786f913ccf164a438f57c04ee49ad2b7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.700notesdueDecember2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bde9da88b2241dc9f725c1d621be4d6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.700notesdueDecember2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a3471e5bd4648d0aa81686260fbc921_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A1250NotesDueJanuary2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7deed358f93647928f915f8ee952b69f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A1250NotesDueJanuary2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8044edfa2384079929b35102a9b7cad_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.100notesdueMarch2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1344e7e2b6414a7890e692110596b117_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.100notesdueMarch2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec7c13902a5a4ee19961a3eed138f023_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A1150NotesDueMay2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2c36e71284047c4a3930eb5b853ea20_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A1150NotesDueMay2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f817c64d72746f4a7600550a38be49c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.450notesdueJanuary2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3f75705b4c54f55b71495dc9a78510d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.450notesdueJanuary2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icae9b0e4795648ce9e80f348899da659_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.375notesdueApril2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e4451b5d59c467f9a4e28097256ff50_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.375notesdueApril2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31ec009da13047b6b79197c66fda5b6f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.950notesdueOctober2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icae10e63208f4e10877dfc05154784ab_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.950notesdueOctober2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85149ce8b76548558e9c825e775cee26_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.850notesdueJune2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff612dcf0de24f99834b8502366648da_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.850notesdueJune2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7cb4d01a77147bea64135beacd75967_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.875notesdueDecember2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibab3629772cb483797b33dd7cac92661_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.875notesdueDecember2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89ffd37b253a491e85cd53a3418e5384_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.875notesdueAugust2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70db3b468bcd459e93e65ee79271966b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.875notesdueAugust2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i792128c572ef443698af3751346cf9ff_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2000NotesDueMay2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd61ed081c424fe89d2e0c20559932f2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2000NotesDueMay2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9a4bd31faa04ee1b247e1f86a34f265_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2300NotesDueMay2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01f8d0ea95854e9da64e602eecf75925_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2300NotesDueMay2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic45826f8bd334acd9a357972ff7747c0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.625notesdueJuly2035Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1594b131d7cc4f158302396c98e0ebd8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.625notesdueJuly2035Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe281588c47246929092124b77f5b494_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5.800notesdueMarch2036Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4474b87a11cf47a0bf686a80b83dcb59_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5.800notesdueMarch2036Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i042493d5f213402dbb064b91d1c75e28_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A6500NotesDueJune2037Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c1062a7e2f149f5badaba59158717fd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A6500NotesDueJune2037Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ac1e2d38c684f80a23cf559e9f5ff07_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A6625NotesDueNovember2037Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5db4929602c4ffd9189617d404f73d2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A6625NotesDueNovember2037Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bb559f948de43229cd7e5cae903c0c3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A6.875notesdueFebruary2038Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie12a20b3450a4ef28232fc38f2583a41_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A6.875notesdueFebruary2038Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iada0e5e85dc241e48cf116319f7a75c6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.500notesdueAugust2039Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a8fbc7bad4d46d98e6ee62b8a2075c8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.500notesdueAugust2039Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6019aef8fb074093b331027b9c2adb61_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2750NotesDueMay2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ce09d75289f41078948230ae4e2acf1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2750NotesDueMay2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba9a7a93d2b645cea2c51c984287da3f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5.700notesdueOctober2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife79ad90a728499a81be122ba5a2043f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5.700notesdueOctober2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4f641b3624849f2adeb7cd37bcab7ca_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5.950notesdueFebruary2041Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a3553569a45473daba65988c3a74356_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5.950notesdueFebruary2041Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3668395d3b640cf8ba0bda86da26e60_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3050NotesDueMay2041Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9de83ae9a2be49cca2565c7797dfdb8a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3050NotesDueMay2041Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c821b276174476b9517c3bbb9157232_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.625notesdueNovember2041Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a4bb23357c64364aa0ece690aa5ec74_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.625notesdueNovember2041Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3057e59415b14c1fbbc0e75f70f19a41_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.375notesdueMarch2042Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e8e99b43b324defa304dd9967162f65_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.375notesdueMarch2042Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica9c4076825647eaad198c486084ebb6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3950NotesDueOctober2042Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f1727e520ff46c0bfcd3cb930e2e50d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3950NotesDueOctober2042Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8aa1ed6f3b9547d785049322c036163a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4250NotesDueMarch2043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44ad24710d1a4e13bd0afb488b206cfa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4250NotesDueMarch2043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd43a6fb78154c23ac9111d56d6fc58a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.750notesdueJuly2045Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50006b1b20aa424bbbcfb16934763e3e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.750notesdueJuly2045Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37706a7a25134a80b7681dbe80d0a08f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.200notesdueJanuary2047Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied6c1c554b9b4094a5e58395009e98e3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.200notesdueJanuary2047Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a47e7cab2b747b19f8ad6dd5577eb65_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.250notesdueApril2047Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cfc628d12b54f618f9ea7acd8dae9c6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.250notesdueApril2047Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i980dd94826d240d68ca80fc74c96e9c1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.750notesdueOctober2047Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91851bb701054679b7700165881a5c2e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.750notesdueOctober2047Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie56f8e65458741cba5353670ff8dce7e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.250notesdueJune2048Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9a9dbbc743449a2bc095746eaf4f94d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.250notesdueJune2048Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i076316df7acd4f5f97a07a2468548d05_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.450notesdueDecember2048Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81143b21d99c4e8da9cc8f4dba61ce25_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.450notesdueDecember2048Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5dc454ca8f924d03b29dd33f0388905d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.700notesdueAugust2049Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cbf53962caa43fba596a6987b79829b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.700notesdueAugust2049Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43a9150b986245ea926eba8cf8dd88c4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2900NotesDueMay2050Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66c9a6ec6acf4ae18dde8b5ddd77ada8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2900NotesDueMay2050Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7d2521c88c843bbab7e44fbe1b07950_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3250NotesDueMay2051Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87de305d4b6d41f69ebc5ea26f269dd9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3250NotesDueMay2051Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6fda2fd6f8d48768196072f7bb18858_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.875notesdueAugust2059Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4bbff1e3c5384def9f3f958af9c4560e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.875notesdueAugust2059Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d6a2a39f8a84b30913e25aac3e3a548_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3125NotesDueMay2060Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie20afa3af1a64c6f892497e7a1ac5f08_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3125NotesDueMay2060Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48f8f3c144a149269121679c024b2bfa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e1bde434ad049b7a20e4a7cd97ed39d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0561a17f67884087afe8d954a4e80ace_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="unh:CreditFacilityNameAxis">unh:FiveYear56BillionCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6ef4bc76d4e41ef824e2e1bc29be3e8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="unh:CreditFacilityNameAxis">unh:ThreeYear56BillionCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bbc78e491bd48b2bdc3d2454d729af8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="unh:CreditFacilityNameAxis">unh:A364Day38BillionCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i601523d6552745a68902337be3e9c7fd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f5ffdfb69764138906dbd2bf76bb89e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bd8ec4f14f94dc98096c091b92e4751_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="unh:CreditFacilityNameAxis">unh:FiveYear56BillionCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ef9be25372d4e00bd34d251579f4577_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="unh:CreditFacilityNameAxis">unh:ThreeYear56BillionCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26faa7bce6f44c1ba49361994ef7383d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="unh:CreditFacilityNameAxis">unh:A364Day38BillionCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafeb038504b84584996f9cd39f452b04_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">unh:NOLsExpirationBeginning2022Through2037Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8b73857161d431fabb907fdd770e42f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">unh:NOLsIndefiniteCarryforwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i594ed33a64c84c5383f969319b50d190_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i065ef157d8a74b71a4c8ba538486d487_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74609445052240d09613244522e25dba_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44dc783f612e43b28b4d406b49e67429_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c6d80d4f8bb448a8552137452437d96_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i500f988f0d5d4732a1a3d4b8ebab6285_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i195ad038ae66447ea9bbab80147223bf_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="unh:DividendFrequencyAxis">unh:ExtraordinaryDividendsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92e4aa62eb95430a95cec0efea49c225_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="unh:DividendFrequencyAxis">unh:ExtraordinaryDividendsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb118b1801aa4f9894e91cda550c9801_I20180601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-06-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1465a6c04dd4bcbacfb6ca471dbee92_D20210323-20210323"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-23</xbrli:startDate><xbrli:endDate>2021-03-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4fddf633266448b9691078c6f0ac482_D20210629-20210629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-29</xbrli:startDate><xbrli:endDate>2021-06-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97719cae15984487921a22e3d5be41e8_D20210921-20210921"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-21</xbrli:startDate><xbrli:endDate>2021-09-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f7827d6bf5f49a0af03b71e2d704cea_D20211214-20211214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-14</xbrli:startDate><xbrli:endDate>2021-12-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1da1045e098d44dda00d3afb43712521_D20210601-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">unh:EmployeeStockPurchasePlanESPPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9373eeb7b5f04135b63071c869773f31_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">unh:EmployeeStockPurchasePlanESPPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b0b8b22a5064df79ec4e0a1452381f2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id63338cb4c6e49dbb4d3876bbbbc7fba_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76d17528cf2346ec89da7e8be44862de_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">unh:StockOptionsandSARsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8735916cccf8489cb02dce2be01b4b17_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">unh:StockOptionsandSARsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb47f60aa85f4d24ba37cab9c6946e24_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5d9a9a4874549718469d7c60db06cc1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45d815b9650e4498a5b6941af134494e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief665df606e14a618e22e519299e9750_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">unh:EmployeeStockPurchasePlanESPPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b0f0d7d245e4cbda78fe9b5b60cd842_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">unh:EmployeeStockPurchasePlanESPPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icdb1414efe6043419f08c3bf8694fb7b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15c2564b16d64dc19f85f7ab4f89e02b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43a2150e723d483a91bbb0bdde5cae0d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb0b5f4d103946b6ae23ad68bcab60b9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98a30b5367174ca1bdd6a71ace6b060b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88c7c3b5d7e240e8a09d2f62902528c7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if755137cc0244794b9c613b644590d23_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CommitmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i234fb0970ed146d6a6b5a0a8e14b119b_D20220101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d57fae043fc43048dd28cf40011078c_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab8d98a2b1f747909b4f89b860b8d491_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">unh:RevenuesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:CMSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6286320b787e4be4ae57d4beaf6bc896_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">unh:RevenuesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:CMSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cde2ac06fab4d7d9e153f395956be16_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">unh:RevenuesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:CMSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie251b137801e4de19d84d38991f2fc4c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cdd4b2069a14aa79f9ff108267e0050_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0aa4f7c6ad7c4399ac91bad12d6477ed_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9934c4a6735f409c90ddb14ad693c228_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i738afd6f13b1403abb02fff8dfe35e83_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee4705fe81d9455197bc18142d417d2a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e535292ef33468993675998c2605663_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic990f91ed37540749f170b9884cdaa28_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3229a037bb842319e936ad6b2a51f54_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d0f7160671347419a34952ffc8558f7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92f08c3054b742748f6b0f913e60627d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c2c9211b22745b98ab1ab28b8337c59_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1530a49a61da49318357204f5b8d80a1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6279b453c9048b8ad104e810416cbe4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb1b161f7dee4b48b64861165d69a88c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8400a403196b4b1a958b56a508d6d9b0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1bfbb3548674a669b5b6862fa055067_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9094967184f474f86b50dde16f3fe77_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ebf459d7ca4411a991115796de7f6d5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if946d85193d24f7eab19007d8ced36a7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i213b700417474af9b2ba5f4aa8d32fdb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d1cef4ce9714d94a507aa88c10ea8e0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife9ac604777648d1aef36fd158860f8b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3defa0ac8fe4ab8af3c5b1f321e4ac8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief7cdc8becb546ea9d8c89af57c961d9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia88cef480a724f0f9f76711ad5e858fe_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide28f350116d433e9a4361d7809e1736_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie48fc3492bf64059adc2061a1f6feeff_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c0a8f96f3fb4705b212d6fd60611c3b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b8cf1603c4345e1a2f17d91305ba20d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fca052182cd4adcae25d8c3d38cd9c8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ca8c63efcb348f6bb49eb114aa1ed4b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4ca79e1283c473bbdcfa153dd38f371_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie14d3261f5ce4d5ca55b14d4eefcad6f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e37d9f4072942d3ba64046e6f17b292_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ed0869af41147eb8333f00d982aa0fc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfdfc0f71a2c4bbc8d894e75a883058c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbc6824afba44fe3aedc3c732de59fed_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife381aeab14b4f16b57316de303fa1dc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7fc59569fab4373bc61b6d246fec133_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c2c251890924c728ecbe00f7c589b5d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b8078f333f54e939e1e3226c81d9047_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0945fba67234634866077d9614c0b72_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9989fc2842a47be8b2f3c34eadc9a60_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if184c0bbcb7247febb4f087da3c892c6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e418b78bbe046c6aa713f2359794876_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id04de182af82446c8a35182aaf2b48c5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc410a001b324c2894fbec26bfef7b86_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f15426e9ba74458aebc54c25df28187_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18674f2c4d12424c968d20476457dd0b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0a3d0d7510f4b139641910dd08967c1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9ed61319c0a45798da15c42c3e38cd0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17627bd9a4c5409e9c94b533f8f5ae1c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2cc2e00b67f4fcf82476fd51fd0699e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ba88a0ee30c45278b5ace52700290ad_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0594531b29c14219bef65d8cd283fc9e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87c3f11df32b441eb7fee715e6d92010_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i451a7a7915ff449fbc9bd1d7c005293d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb1b06cf327e4bfca58345b40abc554a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4e9e37ffd9442649f7208882a987c32_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i476fc79de3284b55b364793f612b1a19_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97e70d750485412480c983dd5791128d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i097c78c5b5544597a305bc89df54bd95_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied275047eb1f45e5a90acc5936ce8821_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8618f261f45e45c98738e7bb3e6bda9d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i026c8094e6214ea8a156691c9176a6a0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if36ef5c1313e4865b5b21c968b7637ce_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bb1779f53f54fe7a529d721403d381e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c78ced66e794cfd90dfb9d9b04070c6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib88407875cb54f609ca6d2c491acde2a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a6318238dc84a50b52e2aa5ce8fab33_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27c98317ad344b9499d3c32c021c9f7e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb5025c996f04acfb22d6284a0a6eda9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8061ff53692d49e09adca8578d72d4cc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7288d5a2ace47fead21082bff05e780_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60cedc1d72954901a048fe79a192b8c1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7df7d80b21d94258923146d050c70aa8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf0af36cf92d48a0b98b4f9034ffb32d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icacb7b0bda5541ac9648de164759144a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81a2f35fd1414929bcea4c64d9b78904_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a16d027033644d5b0b62819b881ff74_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d4de446cb684fb98b6beb87c8a76032_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54812316cf0241ad80e1416a9adb8137_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81f09e67922c4373afc90c08de19f39f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6457702d9d2444e2bd3006604563b0c7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0fdc75afbab4fee9a53cbbd8a5ee695_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b17e0bd3b914d2bbf6bf114349486a0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5087b2a7612d4c559bb8832aa4ef4e1f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97c4cc1a264b40839a4392c3a86f7175_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8dc352162fbe4ed18df7bd7477ea0efd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf5ca22db7484acf8738fe8c4096beaa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0ddb85685644e32aaa72bd4c99df7d3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i765e712ac4354f6b9977ebd8a5137668_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9ce56590e08493a92f4e98ff05295de_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae958eee276045ee967123983469f6ed_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c5071fb5c87448187540e1a182c3bf1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61970d2504044d078cdd34efba0cd162_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i859e241a022540eca1b22afddbe55e1b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ec7b4d30d5e48deb9045b349aaf4dd4_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1b5e284b10548f2b4cea7ea557161f0_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifef7b0e583964ad39d94daea6cea3366_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia58c1f8d468c437393baf523e864a524_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0a43f969e6045adbb4d7a5ed18144fe_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e4f8878a34a4cb4bc6c14d692445406_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e0a9e0b05964d5b81c4faaf9261f866_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7daf143ec32478b96d361bc8bbcb4a7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4466e0b3d7e4d21b0cdb371895ed5bc_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40e8a322046c48e9bb4d5a3f9d8d69bc_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i665d6130ef0b4aa8b4c4151cae26a10c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieab8464742d34bbab93c7d73240b238a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0bf9cb13150a4db19778cd757e617679_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1556f868d6143eaa08d050b665df1a1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd51ec9383cd46588877c19834efb15a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bcf02a9e58b4aa7bf1bbb8dd1ab6cb2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c79ad983a524d509a081c39abd43c4a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33d20e2cf6204d4097b19633f98c100e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9fb83dc51774898890f78347ad88320_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e782903147c4e9bbf36b4ecb9601b62_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13864f629b874a0ca8c1ae8f96420ee4_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19c1e613e77143c39c1a29089613da3f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia069a517828549fcad85e8b0f07df91a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i664db88488f9454c91beba797474bd74_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9899068118274125a66eb1295dc7f180_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62a850c94958453b97ee49874206807a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8dbca3a853c54c32a188e60371e49401_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1401b070d66b4858bebfe8622b519047_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e7b35ab4daa4d56a1ac8eed3dddbaa8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c0c40f3739a4f6aa750404ae32e1139_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c9b94d35868406a8c01569c6271992d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2cf4b896e2b44e084b69d51f3b09f38_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e31b11ef5824cbf953e4b36353741b6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5775495e739143f9a2489ad44e260280_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ba56749e5db4d4999936c411d19cea8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i143c69172b0543d3b4f8228cf2e657be_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3e99423fe064b3f85abf9b78c7b60ef_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff8807e405c94f48aee4ee4cab179452_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29eb19ec363740be8a47282feb2589dd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i102814ed2a624a4287acce41b5fcf861_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92959f478cee4d23a50a998881bfc026_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id234ee9b314c4d5c9bfefe600cb9a7b9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf02709d1a9e4cd3a38c535c74010235_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibddd22dd4e7e4da592ff5a6b614f587a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i035eb292920443f587744a9f748e42c8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2749835a349545f38d76efb02e97a939_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34c97cfea3194601b8f8a80d672db6f5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id83f942037b1489881b85513b8a2fbf4_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_1"></div><div style="min-height:18pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.609%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:0.3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="margin-top:0.3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-top:0.3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">________________________________________________________&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">Form <ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGV4dHJlZ2lvbjplOWMzODA5MjJiOGM0ZjY5OTg3NDM1OTY0ZDk4NDRkZV8xNDU_12c639df-ea53-4b26-af25-82813aee01d5">10-K</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________________________&#160; </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.005%"><tr><td style="width:1.0%"></td><td style="width:4.269%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.531%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGFibGU6ZThhMzY4YmExMTg0NGUzZmFmNmM5NDg1NTM3Mjc5ZjUvdGFibGVyYW5nZTplOGEzNjhiYTExODQ0ZTNmYWY2Yzk0ODU1MzcyNzlmNV8wLTAtMS0xLTA_f85d36fd-4267-497e-98e4-bf6790c10eb7">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGV4dHJlZ2lvbjplOWMzODA5MjJiOGM0ZjY5OTg3NDM1OTY0ZDk4NDRkZV8yMzU_ed71b3f7-aea0-4944-a888-7d3393f7ec42">December 31, 2021</ix:nonNumeric></span></div><div style="margin-top:0.3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.005%"><tr><td style="width:1.0%"></td><td style="width:4.269%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.531%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">or</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGFibGU6OTAyNTQ3NTlhMGQ0NGJmY2FlOWJiMTcxMmUyZjVlMDgvdGFibGVyYW5nZTo5MDI1NDc1OWEwZDQ0YmZjYWU5YmIxNzEyZTJmNWUwOF8yLTAtMS0xLTA_17b6ba1e-e6f3-4dbd-8417-7bd604e4b5c1">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the transition period from _____ to _____</span></td></tr></table></div><div style="margin-top:0.3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Commission file number: <ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGV4dHJlZ2lvbjplOWMzODA5MjJiOGM0ZjY5OTg3NDM1OTY0ZDk4NDRkZV8yNjU_909f9456-3fba-469a-ba8e-5c7f78a79b2f">1-10864</ix:nonNumeric> </span></div><div style="margin-bottom:0.3pt;margin-top:0.3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">__________________________________________________________&#160;</span></div><div style="text-align:center"><img src="unh-20211231_g1.jpg" alt="unh-20211231_g1.jpg" style="height:44px;margin-bottom:5pt;vertical-align:text-bottom;width:253px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGV4dHJlZ2lvbjplOWMzODA5MjJiOGM0ZjY5OTg3NDM1OTY0ZDk4NDRkZV8zMzE_ec6af570-b794-4888-b114-f9029f19549c">UnitedHealth Group Incorporated</ix:nonNumeric> </span></div><div style="margin-top:0.3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:46.223%"><tr><td style="width:1.0%"></td><td style="width:26.787%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.787%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.746%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGFibGU6MGVmNjczNTljY2I2NDA5ZjliNjRhZDU3MGY2ZjI5YjMvdGFibGVyYW5nZTowZWY2NzM1OWNjYjY0MDlmOWI2NGFkNTcwZjZmMjliM18wLTAtMS0xLTA_872735c5-335f-4d03-ac24-e2a4f90b1af4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGFibGU6MGVmNjczNTljY2I2NDA5ZjliNjRhZDU3MGY2ZjI5YjMvdGFibGVyYW5nZTowZWY2NzM1OWNjYjY0MDlmOWI2NGFkNTcwZjZmMjliM18wLTMtMS0xLTA_6f10f343-4fad-4c46-9d69-6f0705c91aa4">41-1321939</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGFibGU6MGVmNjczNTljY2I2NDA5ZjliNjRhZDU3MGY2ZjI5YjMvdGFibGVyYW5nZTowZWY2NzM1OWNjYjY0MDlmOWI2NGFkNTcwZjZmMjliM18zLTAtMS0xLTA_d9a6e0f3-130b-4b42-a0e7-db72400de1ca">UnitedHealth Group Center</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGFibGU6MGVmNjczNTljY2I2NDA5ZjliNjRhZDU3MGY2ZjI5YjMvdGFibGVyYW5nZTowZWY2NzM1OWNjYjY0MDlmOWI2NGFkNTcwZjZmMjliM18zLTMtMS0xLTA_a3894db0-cbec-4200-819d-35ee949420e0">55343</ix:nonNumeric></span></td></tr><tr style="height:12pt"><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGFibGU6MGVmNjczNTljY2I2NDA5ZjliNjRhZDU3MGY2ZjI5YjMvdGFibGVyYW5nZTowZWY2NzM1OWNjYjY0MDlmOWI2NGFkNTcwZjZmMjliM180LTAtMS0xLTA_578372ba-3a86-4bd6-9b79-4604383e85ab">9900 Bren Road East</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGFibGU6MGVmNjczNTljY2I2NDA5ZjliNjRhZDU3MGY2ZjI5YjMvdGFibGVyYW5nZTowZWY2NzM1OWNjYjY0MDlmOWI2NGFkNTcwZjZmMjliM181LTAtMS0xLTA_84a75223-593e-4753-a796-9895864c8db7">Minnetonka,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGFibGU6MGVmNjczNTljY2I2NDA5ZjliNjRhZDU3MGY2ZjI5YjMvdGFibGVyYW5nZTowZWY2NzM1OWNjYjY0MDlmOWI2NGFkNTcwZjZmMjliM181LTEtMS0xLTA_210071dd-99f4-4728-96e5-6a2b5f7b3add">Minnesota</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-bottom:0.3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGV4dHJlZ2lvbjplOWMzODA5MjJiOGM0ZjY5OTg3NDM1OTY0ZDk4NDRkZV8zOTM_611273c8-517d-4017-86b6-9181bb1b1b6f">952</ix:nonNumeric>) <ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGV4dHJlZ2lvbjplOWMzODA5MjJiOGM0ZjY5OTg3NDM1OTY0ZDk4NDRkZV8zOTc_4e547c38-f4a4-4516-ba98-69c61ab89634">936-1300</ix:nonNumeric> </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">______________________________________________________&#160;&#160;</span></div><div style="margin-top:0.3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.453%"><tr><td style="width:1.0%"></td><td style="width:28.739%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.847%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.660%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGFibGU6NDUyYzIwMzdmMGQwNGE0YzlkOTZjMTIxYWQ0MGY4M2MvdGFibGVyYW5nZTo0NTJjMjAzN2YwZDA0YTRjOWQ5NmMxMjFhZDQwZjgzY18xLTAtMS0xLTA_3993d300-a503-4b55-b074-b8b691606733">Common Stock, $.01 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGFibGU6NDUyYzIwMzdmMGQwNGE0YzlkOTZjMTIxYWQ0MGY4M2MvdGFibGVyYW5nZTo0NTJjMjAzN2YwZDA0YTRjOWQ5NmMxMjFhZDQwZjgzY18xLTItMS0xLTA_ed196255-f046-485e-abc4-8eaf729cf7a4">UNH</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGFibGU6NDUyYzIwMzdmMGQwNGE0YzlkOTZjMTIxYWQ0MGY4M2MvdGFibGVyYW5nZTo0NTJjMjAzN2YwZDA0YTRjOWQ5NmMxMjFhZDQwZjgzY18xLTQtMS0xLTA_b58a5f49-876a-4cdf-80b1-a7ff1f3f1c44">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:0.3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(g) of the Act: None</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> _________________________________________________________</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="margin-bottom:0.3pt;margin-top:0.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160;&#160;&#160;<ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGV4dHJlZ2lvbjplOWMzODA5MjJiOGM0ZjY5OTg3NDM1OTY0ZDk4NDRkZV84MjI_fb39e533-3d16-4eb6-b380-bcfdb5a8c90c">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:0.3pt;margin-top:0.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or Section&#160;15(d) of the Act.&#160;&#160;&#160;&#160;&#160;Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGV4dHJlZ2lvbjplOWMzODA5MjJiOGM0ZjY5OTg3NDM1OTY0ZDk4NDRkZV85Njc_0a0b333d-c172-4aa1-82c9-464c8079c3af">No</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-bottom:0.3pt;margin-top:0.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days. <ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGV4dHJlZ2lvbjplOWMzODA5MjJiOGM0ZjY5OTg3NDM1OTY0ZDk4NDRkZV8xMzE3_68c4da41-07e3-42be-9673-7da20ae753a6">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:0.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGV4dHJlZ2lvbjplOWMzODA5MjJiOGM0ZjY5OTg3NDM1OTY0ZDk4NDRkZV8xNjMy_d97f5d25-ccc6-47e5-bcb7-273fac85f675">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.869%"><tr><td style="width:1.0%"></td><td style="width:19.760%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.159%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.407%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.760%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.537%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.277%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.358%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.542%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGFibGU6ZTFjYzBlZWZlMzUwNDYxYzg5NmUzNjEzNWJhMWUwZTgvdGFibGVyYW5nZTplMWNjMGVlZmUzNTA0NjFjODk2ZTM2MTM1YmExZTBlOF8wLTAtMS0xLTA_5ac258cb-0d3e-4184-b678-9108586a2824">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGFibGU6ZTFjYzBlZWZlMzUwNDYxYzg5NmUzNjEzNWJhMWUwZTgvdGFibGVyYW5nZTplMWNjMGVlZmUzNTA0NjFjODk2ZTM2MTM1YmExZTBlOF8xLTEtMS0xLTA_a90f0f52-03f5-4bc4-a2a7-a7ceb147d38a">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGFibGU6ZTFjYzBlZWZlMzUwNDYxYzg5NmUzNjEzNWJhMWUwZTgvdGFibGVyYW5nZTplMWNjMGVlZmUzNTA0NjFjODk2ZTM2MTM1YmExZTBlOF8xLTctMS0xLTA_18bd64ed-fc5a-43dd-a046-b5cbff72350b">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:0.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.&#160;<ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGV4dHJlZ2lvbjplOWMzODA5MjJiOGM0ZjY5OTg3NDM1OTY0ZDk4NDRkZV8xNjQ5MjY3NDQ1Mjg0_2f280c61-3241-45c5-ab72-e2f28183485c">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:0.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).&#160;&#160;&#160;&#160;Yes&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGV4dHJlZ2lvbjplOWMzODA5MjJiOGM0ZjY5OTg3NDM1OTY0ZDk4NDRkZV8yNzA5_012688c0-3aae-4d15-8018-751a5d7c3f3d">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">No&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-bottom:0.3pt;margin-top:0.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The aggregate market value of voting stock held by non-affiliates of the registrant as of June&#160;30, 2021 was $<ix:nonFraction unitRef="usd" contextRef="i8eb94eb0b4484ca996ca09b316c723b4_I20210630" decimals="0" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGV4dHJlZ2lvbjplOWMzODA5MjJiOGM0ZjY5OTg3NDM1OTY0ZDk4NDRkZV8yODI1_2ada8146-5b81-4990-9d07-9ef265502bde">376,162,785,060</ix:nonFraction> (based on the last reported sale price of $400.44 per share on June&#160;30, 2021 as reported on the  on the New York Stock Exchange), excluding only shares of voting stock held beneficially by directors, executive officers and subsidiaries of the registrant. </span></div><div style="margin-top:0.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">As of January 31, 2022, there were <ix:nonFraction unitRef="shares" contextRef="i884d1b7f798047438f1fdf140f8c5b0c_I20220131" decimals="0" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGV4dHJlZ2lvbjplOWMzODA5MjJiOGM0ZjY5OTg3NDM1OTY0ZDk4NDRkZV8zMDk1_9863530e-eb0e-4f2f-b377-d3d32fd06c75">940,899,146</ix:nonFraction> shares of the registrant&#8217;s Common Stock, $.01 par value per share, issued and outstanding.</span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="margin-top:0.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGV4dHJlZ2lvbjplOWMzODA5MjJiOGM0ZjY5OTg3NDM1OTY0ZDk4NDRkZV8xNjQ5MjY3NDQ1Mjgz_96118fa7-d5d3-4f03-bc1e-8d49b32d62ca" escape="true">The information required by Part III of this report, to the extent not set forth herein, is incorporated by reference from the registrant&#8217;s definitive proxy statement relating to its 2022 Annual Meeting of Shareholders. Such proxy statement will be filed with the Securities and Exchange Commission within 120 days after the end of the fiscal year to which this report relates.</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.609%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt"><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITEDHEALTH GROUP</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Table of Contents</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.684%"><tr><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:72.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part I</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_13">Business</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_13">1</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_22">Risk Factors</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_22">11</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1B. </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_25">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_25">22</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_28">Properties</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_28">22</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_31">Legal Proceedings</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_31">22</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_34">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_34">22</a></span></div></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part II</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_40">Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_40">23</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_49">[Reserved]</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_49">24</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 7.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_52">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_52">25</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 7A.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_70">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_70">35</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 8.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_73">Financial Statement</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_73">s</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_73"> and Supplementary Data</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_73">37</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_226">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_226">67</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9A.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_229">Controls and Procedures</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_229">67</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9B. </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_244">Other Information</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_244">70</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9C.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_2785">Disclosure Regarding Foreign Jurisdictions That Prevent Inspections</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_2785">70</a></span></div></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part III</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 10.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_250">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_250">70</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 11.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_253">Executive Compensation</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_253">70</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 12.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_256">Security Ownership of Certain Beneficial Owners and Management and Related S</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_256">tock</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_256">holder Matters</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_256">71</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 13.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_259">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_259">71</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 14.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_262">Principal Account</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_262">ant</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_262"> Fees and Services</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_262">71</a></span></div></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part IV</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 15.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_268">Exhibit and Financial Statement Schedules</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_268">72</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 16.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_289">Form 10-K Summary</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_289">80</a></span></div></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_292">Signatures</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_292">81</a></span></div></td></tr></table></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt;text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_13"></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160; 1.&#160;&#160;&#160;&#160;BUSINESS </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">OUR BUSINESSES</span></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_16"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; &#8220;its,&#8221; &#8220;UnitedHealth Group,&#8221; or the &#8220;Company&#8221; used in this report refer to UnitedHealth Group Incorporated and its subsidiaries.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealth Group Incorporated is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our two distinct, yet complementary business platforms &#8212; Optum and UnitedHealthcare &#8212; are working to help build a modern, high-performing health system through improved access, affordability, outcomes and experiences for the individuals and organizations we are privileged to serve.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ability to analyze complex data and apply deep health care expertise and insights allows us to serve people, care providers, businesses, communities and governments with more innovative products and complete, end-to-end offerings for many of the biggest challenges facing health care today.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Optum combines clinical expertise, technology and data to empower people, partners and providers with the guidance and tools they need to achieve better health. Optum serves the broad health care marketplace, including payers, care providers, employers, governments, life sciences companies and consumers, through its Optum Health, Optum Insight and Optum Rx businesses. These businesses improve overall health system performance by optimizing care quality and delivery, reducing costs and improving consumer and provider experience, leveraging distinctive capabilities in data and analytics, pharmacy care services, health care operations, population health and health care delivery.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealthcare offers a full range of health benefits, enabling affordable coverage, simplifying the health care experience, improving consumer health, advancing health equity and delivering access to high-quality care. UnitedHealthcare Employer &amp; Individual serves employers ranging from sole proprietorships to large, multi-site and national employers, public sector employers and individual consumers. UnitedHealthcare Medicare&#160;&amp; Retirement delivers health and well-being benefits for Medicare beneficiaries and retirees. UnitedHealthcare Community&#160;&amp; State manages health care benefit programs on behalf of state Medicaid and community programs and their participants. UnitedHealthcare Global provides health and dental benefits and hospital and clinical services to employer groups and individuals in South America, and through other diversified global health services.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have four reportable segments: </span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Optum Health; </span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Optum Insight;</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Optum Rx; and</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">UnitedHealthcare, which includes UnitedHealthcare Employer&#160;&amp; Individual, UnitedHealthcare Medicare&#160;&amp; Retirement, UnitedHealthcare Community&#160;&amp; State and UnitedHealthcare Global. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Optum</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Optum is an information and technology-enabled health services business serving the broad health care marketplace, including:</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:23.5pt">Those who need care: consumers who need the right care, information, resources, products and engagement to improve their health, achieve their health goals and receive an improved patient experience that is personalized and holistic and delivered in all care settings, including in-home and virtually.</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:23.5pt">Those who provide care: pharmacies, hospitals, physicians and other health care facilities seeking to improve the health system and reduce the administrative burden allowing for providers to focus time on patients leading to the best possible patient care and experiences while achieving better health outcomes at lower costs. Improved health outcomes are achieved by leveraging our clinical expertise, data and analytics to better predict, prevent and intercept consumers&#8217; health conditions and ensure they receive the best evidence-based care.</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:23.5pt">Those who pay for care: employers; health plans; and state, federal and municipal agencies devoted to ensuring the populations they sponsor receive high-quality care, administered and delivered efficiently and effectively, all while driving health equity so that every individual, family and community has access to the care they need.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:23.15pt">Those who innovate for care: global life sciences organizations dedicated to developing more effective approaches to care, enabling technologies and medicines to improve care delivery and health outcomes.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Optum operates three business segments leveraging distinctive capabilities in health care delivery, population health, health care operations, data and analytics and pharmacy care services:</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Optum Health delivers care, care management, wellness and consumer engagement, and health financial services;</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Optum Insight offers data, analytics, research, consulting, technology and managed services solutions; and </span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Optum Rx provides a diversified array of pharmacy care services. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Optum Health</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Optum Health provides health and wellness care, addressing the physical, emotional and health-related financial needs of 100 million consumers, through a national health care delivery platform which engages people in the most appropriate care settings, including clinical sites, in-home and virtual. Optum Health delivers local primary, in-home, specialty, surgical and urgent care; helps patients and providers navigate and address complex, chronic and behavioral health needs; offers post-acute care planning services; and serves consumers and care providers through advanced, on-demand digital health technologies, such as telehealth and remote patient monitoring, and innovative health care financial services. Optum Health works directly with consumers, care delivery systems, providers, employers, payers, and government entities to provide high quality accessible and equitable care with improved outcomes and reduced total cost of care. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Optum Health enables care providers to transition from traditional fee-for-service payment models to performance-based delivery and payment models designed to improve patient health outcomes and experience through value-based care. Through strategic partnerships, alliances and ownership arrangements, Optum Health helps care providers adopt new approaches and technologies improving the coordination of care across providers to serve patients more comprehensively. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Optum Health offers its products on a risk basis, assuming responsibility for health care costs in exchange for a monthly premium, on an administrative fee basis, managing or administering products and services in exchange for a monthly fee, and on a fee-for-service basis, delivering medical services to patients in exchange for a contracted fee.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Optum Financial, including Optum Bank, serves consumers through 8 million health savings and other accounts and has more than $19 billion in assets under management as of December 31, 2021. During 2021, Optum Financial processed $264 billion in digital medical payments to physicians and other health care providers. Organizations across the health system rely on Optum Financial to manage and improve payment flows through its highly automated, scalable, digital payment systems. For financial services offerings, Optum Health charges fees and earns investment income on managed funds.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Optum Health sells its products primarily through its direct sales force, strategic collaborations and external producers in three key areas: employers, including large, mid-sized and small employers; payers including health plans, third-party administrators (TPAs), underwriter/stop-loss carriers and individual product intermediaries; and government entities including the U.S. Departments of Health and Human Services (HHS), Veterans Affairs, Defense, and other federal, state and local health care agencies.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Optum Insight</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Optum Insight connects the health care system with services, analytics and platforms that make clinical, administrative and financial processes easier for all participants in the health care system. Hospital systems, physicians, health plans, state governments, life sciences companies and other organizations comprising the health care industry depend on Optum Insight to help them improve performance, reduce costs, advance quality, meet compliance mandates and modernize their core operating systems to meet the changing needs of the health system. Optum Insight serves the needs of health systems (such as physicians and hospital systems), health plans, state governments and life sciences companies.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Systems. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Serves hospitals, physicians and other care providers to improve revenue and growth, better coordinate care and reduce administrative costs through technology and services to improve population health management, patient engagement, revenue cycle management and strategic growth plans. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Plans. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Serves health plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">by improving financial performance and enhancing outcomes through proactive analytics, a comprehensive payment integrity portfolio and technology-enabled and staff-supported risk and quality services. Optum Insight helps health plans navigate a dynamic environment defined by shifts in employer vs. government-sponsored coverage, the demand for affordable benefit plans and the need to leverage new technology to reduce complexity. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">State Governments. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provides advanced technology and analytics services to modernize the administration of critical safety net programs, such as Medicaid, while improving cost predictability. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Life Sciences Companies. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Combines data and analytics expertise with comprehensive technologies and health care knowledge to help life sciences companies, including those in pharmaceuticals and medical technology, adopt a more comprehensive approach to advancing therapeutic discoveries and improving clinical outcomes. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of Optum Insight&#8217;s software and information products and professional services are delivered over extended periods, often several years. Optum Insight maintains an order backlog to track unearned revenues under these long-term arrangements. The backlog consists of estimated revenue from signed contracts, other legally binding agreements and anticipated contract renewals based on historical experience with Optum Insight&#8217;s customers. Optum Insight&#8217;s aggregate backlog as of December 31, 2021 was approximately $22.4 billion, of which $12.1 billion is expected to be realized within the next 12 months. The aggregate backlog includes $8.9 billion related to affiliated agreements. Optum Insight&#8217;s aggregate backlog as of December 31, 2020, was $20.2 billion. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Optum Insight&#8217;s products and services are sold primarily through a direct sales force. Optum Insight&#8217;s products are also supported and distributed through an array of alliances and business partnerships with other technology vendors, who integrate and interface Optum Insight&#8217;s products with their applications.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Optum Rx</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Optum Rx provides a full spectrum of pharmacy care services through its network of more than 67,000 retail pharmacies, through home delivery, specialty and community health pharmacies and through the provision of in-home and community-based infusion services. It also offers a direct-to-consumer business. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Optum Rx manages a broad range of prescription drug spend, including widely available retail drugs as well as limited and ultra-limited distribution drugs in oncology, HIV, pain management and ophthalmology. Optum Rx serves the growing pharmacy needs of people with behavioral health and substance use disorders. In 2021, Optum Rx managed $112 billion in pharmaceutical spending, including $45 billion in specialty pharmaceutical spending.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Optum Rx serves health benefits providers, large national employer plans, unions and trusts, purchasing coalitions and government entities. Optum Rx&#8217;s sales distribution system consists primarily of health insurance brokers and other health care consultants and direct sales. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Optum Rx offers multiple clinical programs, digital tools and services to help clients manage overall pharmacy and health care costs in a clinically appropriate manner which are designed to promote better health outcomes, and to help target inappropriate utilization and non-adherence to medication. Optum Rx provides various utilization management, medication management, quality assurance, adherence and counseling programs to complement each client&#8217;s plan design and clinical strategies. Optum Rx offers a distinctive approach to integrating the management of medical and pharmaceutical care by using data and advanced analytics to help improve comprehensive decision-making, elevate quality, close gaps in care and reduce costs for customers and people served.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealthcare</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through its health benefits offerings, UnitedHealthcare is enabling better health, creating a better health care experience for its customers and helping to control rising health care costs. UnitedHealthcare&#8217;s market position is built on:</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">strong local-market relationships;</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">the breadth of product offerings, based upon extensive expertise in distinct market segments in health care;</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">service and advanced technology, including digital consumer engagement; </span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">competitive medical and operating cost positions;</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">effective clinical engagement; and</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">innovation for customers and consumers.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealthcare uses Optum&#8217;s capabilities to help coordinate and provide patient care, improve affordability of medical care, analyze cost trends, manage pharmacy care services, work with care providers more effectively and create a simpler and more satisfying consumer and physician experience.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, UnitedHealthcare arranges for discounted access to care through networks which, as of December 31, 2021, include 1.5 million physicians and other health care professionals and more than 7,000 hospitals and other facilities.</span></div><div style="margin-top:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealthcare is subject to extensive government regulation. See further discussion of our regulatory environment below under </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_19">&#8220;Government Regulation&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_52">Part II, Item 7, &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.&#8221;</a></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">UnitedHealthcare Employer&#160;&amp; Individual</span></div><div style="margin-top:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealthcare Employer &amp; Individual offers a comprehensive array of consumer-oriented health benefit plans and services nationwide for large national employers, public sector employers, mid-sized employers, small businesses, and individual consumers. As of December 31, 2021, UnitedHealthcare Employer &amp; Individual provides access to medical services for 26.6 million people on behalf of our customers and alliance partners, including employer customers, serving people across all 50 states, the District of Columbia and most U.S. territories. Products are offered through affiliates licensed as insurance companies, health maintenance organizations (HMOs), or TPAs. Large employer groups typically use self-funded arrangements where UnitedHealthcare Employer &amp; Individual earns a service fee. Smaller employer groups and individuals are more likely to purchase risk-based products because they are less willing or unable to bear a greater potential liability for health care expenditures. </span></div><div style="margin-top:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through its risk-based product offerings, UnitedHealthcare Employer&#160;&amp; Individual assumes the risk of both medical and administrative costs for its customers in return for a monthly premium which is typically a fixed rate per individual served for a one-year period. When providing administrative and other management services to customers who elect to self-fund the health care costs of their employees and employees&#8217; dependents, UnitedHealthcare Employer&#160;&amp; Individual receives a fixed monthly service fee per individual served. These customers retain the risk of financing medical benefits for their employees and employees&#8217; dependents, while UnitedHealthcare Employer&#160;&amp; Individual provides services such as coordination and facilitation of medical and related services to customers, consumers and health care professionals, administration of transaction processing and access to a contracted network of physicians, hospitals and other health care professionals, including dental and vision professionals. </span></div><div style="margin-top:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated purchasing capacity represented by the individuals served by UnitedHealth Group makes it possible for UnitedHealthcare Employer&#160;&amp; Individual to contract for cost-effective access to a large number of conveniently located care professionals and facilities. UnitedHealthcare Employer&#160;&amp; Individual has relationships with network care providers who integrate data and analytics, implement value-based payment arrangements and care management programs that enable us to jointly better manage health care and improve quality across populations. UnitedHealthcare Employer&#160;&amp; Individual&#8217;s comprehensive and integrated pharmacy care services promote lower costs by using formulary programs to produce better unit costs, encouraging consumers to use drugs offering improved value and outcomes, helping consumers take actions to improve their health and supporting the appropriate use of drugs based on clinical evidence through physician and consumer education programs.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">UnitedHealthcare Employer &amp; Individual typically distributes its products through a variety of channels, dependent upon the specific product, including: through consultants or direct sales, in collaboration with brokers and agents, through wholesale agents or agencies who contract with health insurance carriers to distribute individual or group benefits, through</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">professional employer organizations and associations and through both multi-carrier and its own proprietary private exchange marketplaces. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealthcare Employer &amp; Individual&#8217;s diverse product portfolio offers employers a continuum of benefit designs, price points and approaches to consumer engagement which provides the flexibility to meet a full spectrum of their coverage needs. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">UnitedHealthcare Employer&#160;&amp; Individual&#8217;s major product families include consumer engagement products, such as high-deductible consumer driven benefit plans and a variety of innovative consumer centric products; traditional products; clinical and pharmacy products; and specialty benefits, such as vision, dental, hearing, accident protection, critical illness, disability and hospital indemnity offerings.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Each medical plan has a core set of clinical programs embedded in the offering, with additional services available depending on offering type (risk-based or self-funded), line of business (such as small business, key accounts, public sector, national accounts or individual consumers) and clinical need. UnitedHealthcare Employer&#160;&amp; Individual&#8217;s clinical programs include: wellness programs, decision support, utilization management, case and disease management, complex condition management, on-site programs, incentives to reinforce positive behavior change, mental health/substance use disorder management and employee assistance programs.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">UnitedHealthcare Medicare&#160;&amp; Retirement</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealthcare Medicare&#160;&amp; Retirement provides health and well-being services to individuals age 50 and older, addressing their unique needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues common among older people. UnitedHealthcare Medicare&#160;&amp; Retirement is fully dedicated to serving this growing market segment, providing products and services in all 50 states, the District of Columbia and most U.S. territories. UnitedHealthcare Medicare&#160;&amp; Retirement has distinct benefit designs, pricing, underwriting, clinical program management and marketing capabilities dedicated to health products and services in this market.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealthcare Medicare&#160;&amp; Retirement offers a selection of products allowing people choice in obtaining the health coverage and services they need as their circumstances change. UnitedHealthcare Medicare&#160;&amp; Retirement is positioned to serve seniors who find affordable, network-based care provided through Medicare Advantage plans to meet their unique health care needs. For those who prefer traditional fee-for-service Medicare, UnitedHealthcare Medicare&#160;&amp; Retirement offers both Medicare </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplement and Medicare Prescription Drug Benefit (Medicare Part D) programs to expand their government-sponsored Medicare by providing additional benefits and coverage options. UnitedHealthcare Medicare&#160;&amp; Retirement offerings include care management and health system navigator services, clinical management programs, nurse health line services, 24-hour access to health care information, access to discounted health services from a network of care providers and administrative services. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealthcare Medicare&#160;&amp; Retirement has extensive distribution capabilities and experience, including direct marketing to consumers on behalf of its key clients, including AARP, the nation&#8217;s largest membership organization dedicated to the needs of people age 50 and over, and state and U.S. government agencies. Products are also offered through agents, employer groups and digital channels.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealthcare Medicare&#160;&amp; Retirement&#8217;s major product categories include:</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicare Advantage.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealthcare Medicare&#160;&amp; Retirement provides health care coverage for seniors and other eligible Medicare beneficiaries through the Medicare Advantage program administered by the Centers for Medicare&#160;&amp; Medicaid Services (CMS), including Medicare Advantage HMO plans, Preferred Provider Organization (PPO) plans, Point-of-Service plans, Private-Fee-for-Service plans and Special Needs Plans (SNPs). Under the Medicare Advantage program, UnitedHealthcare Medicare&#160;&amp; Retirement provides health insurance coverage in exchange for a fixed monthly premium per member from CMS plus, in some cases, monthly consumer premiums. Premium amounts received from CMS vary based on the geographic areas in which individuals reside; demographic factors such as age, gender and institutionalized status; and the health status of the individual. Medicare Advantage plans are designed to compete at the local level, taking into account consumer and care provider preferences, competitor offerings, our quality and cost initiatives, our historical financial results and the long-term payment rate outlook for each geographic area. UnitedHealthcare Medicare&#160;&amp; Retirement served 6.5 million people through its Medicare Advantage products as of December&#160;31, 2021.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealthcare Medicare &amp; Retirement&#8217;s senior-focused care management model operates at a medical cost level below traditional Medicare, while helping seniors live healthier lives. We have continued to enhance our offerings, focusing on more digital and physical care resources in the home, expanding our concierge navigation services and enabling the home as a safe and effective setting of care. For example, through our HouseCalls program, nurse practitioners performed more than 2.1 million clinical preventive home care visits in 2021 to address unmet care opportunities and close gaps in care. Our Navigate4Me program provides a single point of contact and a direct line of support for individuals as they go through their health care experiences. For high-risk patients in certain care settings and programs, UnitedHealthcare Medicare &amp; Retirement uses proprietary, automated medical record software and digital therapeutics for remote monitoring enabling clinical care teams to capture and track patient data and clinical encounters, creating a comprehensive set of care information bridging capabilities across home, hospital and nursing home care settings. Proprietary predictive modeling tools help identify people at high risk and enable care managers to create individualized care plans to help them obtain the right care, in the right place, at the right time.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Medicare Part D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> UnitedHealthcare Medicare&#160;&amp; Retirement provides Medicare Part D benefits to beneficiaries through its Medicare Advantage and stand-alone Medicare Part D plans. The stand-alone Medicare Part D plans address a large spectrum of people&#8217;s needs and preferences for their prescription drug coverage, including low-cost prescription options. Each of the plans includes the majority of the drugs covered by Medicare and provides varying levels of coverage to meet the diverse needs of Medicare beneficiaries. As of December&#160;31, 2021, UnitedHealthcare enrolled 9.5 million people in the Medicare Part D programs, including 3.7&#160;million individuals in stand-alone Medicare Part D plans, with the remainder in Medicare Advantage plans incorporating Medicare Part D coverage. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Medicare Supplement.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">UnitedHealthcare Medicare&#160;&amp; Retirement is currently serving 4.4 million seniors nationwide through various Medicare Supplement products in association with AARP. UnitedHealthcare Medicare&#160;&amp; Retirement offers a full range of supplemental products at diverse price points. These products cover various levels of coinsurance and deductible gaps to which seniors are exposed in the traditional Medicare program.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium revenues from CMS represented 36% of UnitedHealth Group&#8217;s total consolidated revenues for the year ended December&#160;31, 2021, most of which were generated by UnitedHealthcare Medicare&#160;&amp; Retirement. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">UnitedHealthcare Community&#160;&amp; State</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealthcare Community &amp; State is dedicated to serving state programs caring for the economically disadvantaged, the medically underserved and those without the benefit of employer-funded health care coverage, typically in exchange for a monthly premium per member from the state program. UnitedHealthcare Community &amp; State&#8217;s primary customers oversee Medicaid plans, including Temporary Assistance to Needy Families (TANF); Children&#8217;s Health Insurance Programs (CHIP); Dual SNPs (DSNPs); Long-Term Services and Supports (LTSS); Aged, Blind and Disabled; and other federal, state and community health care programs. As of December&#160;31, 2021, UnitedHealthcare Community &amp; State participated in programs in 32 states and the District of Columbia, and served 7.7 million people; including nearly 1.4 million people through Medicaid expansion programs in 18 states under the Patient Protection and Affordable Care Act (ACA).</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">States using managed care services for Medicaid beneficiaries select health plans by using a formal bid process or by awarding individual contracts. A number of factors are considered by UnitedHealthcare Community &amp; State when choosing programs for participation, including the state&#8217;s commitment and consistency of support for its Medicaid managed care program in terms of service, innovation and funding; the eligible population base, both immediate and long term; and the structure of the projected program. UnitedHealthcare Community &amp; State works with its state customers to advocate for actuarially sound rates, commensurate with medical cost trends.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These health plans and care programs are designed to address the complex needs of the populations they serve, including the chronically ill, people with disabilities and people with a higher risk of medical, behavioral and social conditions. UnitedHealthcare Community &amp; State administers benefits for the unique needs of children, pregnant women, adults, seniors and those who are institutionalized or are nursing home eligible. These individuals often live in medically underserved areas and are less likely to have a consistent relationship with the medical community or a care provider. They also often face significant social and economic challenges.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealthcare Community &amp; State leverages the national capabilities of UnitedHealth Group locally, supporting effective care management, strong regulatory partnerships, greater administrative efficiency, improved clinical outcomes and the ability to adapt to a changing national and local market environment. UnitedHealthcare Community &amp; State coordinates resources among family, physicians, other health care providers, and government and community-based agencies and organizations to facilitate continuous and effective care and often addresses other social determinants affecting people&#8217;s health status and health system usage. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although approximately 80% of the people in state Medicaid programs are served by managed care, there remains significant growth opportunity as this population represents only approximately 55% of total Medicaid spending. UnitedHealthcare Community &amp; State&#8217;s business development opportunities include entering fee-for-service markets converting to managed care; and growing in existing managed care markets, including state expansions to populations with more complex needs requiring more sophisticated models of care, including DSNP and LTSS programs. Our offerings to state expansion cover more medically complex populations, including integrated care management of physical, behavioral, long-term care services and supports, and social services by applying strong data analytics and community-based collaboration. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealthcare Community &amp; State continues to evolve its clinical model to enhance quality and the clinical experience for the people it serves. The model enables UnitedHealthcare Community &amp; State to quickly identify the people who could benefit most from more highly coordinated care. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">UnitedHealthcare Global</span></div><div style="margin-top:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealthcare Global serves 7.8 million people with medical and dental benefits, typically in exchange for a monthly premium per member, residing principally in Brazil, Chile, Colombia and Peru, but also in more than 150 other countries. UnitedHealthcare Global serves multinational and local businesses, governments, insurers and individuals and their families through health insurance plans for local populations, care delivery services, benefit plans and risk and assistance solutions. UnitedHealthcare Global offers health care delivery in our principal markets through over 50 hospitals, and more than 200 outpatient and ambulatory clinics and surgery centers to UnitedHealthcare Global members and consumers served by the external payer market.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Brazil, Amil provides health benefits to 3.4 million people and dental benefits to nearly 2.3 million people. Empresas Banm&#233;dica provides health benefits and health care services to approximately 2.1 million people in Chile, Colombia and Peru. Lus&#237;adas Sa&#250;de provides clinical services to people in Portugal through an owned network of hospitals and outpatient clinics. </span></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_19"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">GOVERNMENT REGULATION </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our businesses are subject to comprehensive U.S. federal and state and international laws and regulations. We are regulated by agencies which generally have discretion to issue regulations and interpret and enforce laws and rules. The regulations can vary significantly among jurisdictions and the interpretation of them are subject to frequent change. Domestic U.S. and international governments continue to consider and enact various legislative and regulatory proposals which could materially impact certain aspects of the health care system. New laws, regulations and rules, or changes in the interpretation of existing laws, regulations and rules, including as a result of changes in the political climate, could adversely affect our businesses. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we fail to comply with, are alleged to have failed to comply with, or fail to respond quickly and appropriately to changes in, applicable laws, regulations and rules, our business, results of operations, financial position and cash flows could be materially and adversely affected. See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_22">Part I, Item&#160;1A, &#8220;Risk Factors&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of the risks related to our compliance with federal, state and international laws and regulations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">U.S. Federal Laws and Regulation </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to various levels of U.S. federal regulation. For example, when we contract with the federal government, we are subject to federal laws and regulations relating to the award, administration and performance of U.S. government contracts. CMS regulates our UnitedHealthcare businesses and certain aspects of our Optum businesses. Payments by CMS to our businesses are subject to regulations, including those governing fee-for-service and the submission of information relating to the health status of enrollees for purposes of determining the amounts of certain payments to us. CMS also has the right to audit our performance to determine our compliance with CMS contracts and regulations and the quality of care we provide to Medicare beneficiaries. Our commercial business is further subject to CMS audits related to medical loss ratios (MLRs) and risk adjustment data.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealthcare Community &amp; State has Medicaid and CHIP contracts subject to federal regulations regarding services to be provided to Medicaid enrollees, payment for those services and other aspects of these programs. There are many regulations affecting Medicare and Medicaid compliance, and the regulatory environment with respect to these programs is complex. In addition, our businesses are subject to laws and regulations relating to consumer protection, anti-fraud and abuse, anti-kickbacks, false claims, prohibited referrals, inappropriate reduction or limitation of health care services, anti-money laundering, securities and antitrust compliance. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Privacy, Security and Data Standards Regulation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Certain of our operations are subject to regulation under the administrative simplification provisions of the Health Insurance Portability and Accountability Act of 1996, as amended (HIPAA), which apply to both the group and individual health insurance markets, including self-funded employee benefit plans. Federal regulations related to HIPAA contain minimum standards for electronic transactions and code sets and for the privacy and security of protected health information.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our businesses must comply with the Health Information Technology for Economic and Clinical Health Act (HITECH) which regulates matters relating to privacy, security and data standards. HITECH imposes requirements on uses and disclosures of health information; includes contracting requirements for HIPAA business associate agreements; extends parts of HIPAA privacy and security provisions to business associates; adds federal data breach notification requirements for covered entities and business associates and reporting requirements to HHS and the Federal Trade Commission (FTC) and, in some cases, to the local media; strengthens enforcement and imposes higher financial penalties for HIPAA violations and, in certain cases, imposes criminal penalties for individuals, including employees. In the conduct of our business, depending on the circumstances, we may act as either a covered entity or a business associate.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The use and disclosure of individually identifiable health data by our businesses are also regulated in some instances by other federal laws, including the Gramm-Leach-Bliley Act (GLBA) or state statutes implementing GLBA. These federal laws and state statutes generally require insurers to provide customers with notice regarding how their non-public personal health and financial information is used and the opportunity to &#8220;opt out&#8221; of certain disclosures before the insurer shares such information with a third party, and generally prescribe safeguards for the protection of personal information. Neither the GLBA nor HIPAA privacy regulations preempt more stringent state laws and regulations, which may apply to us, as discussed below. Federal consumer protection laws may also apply in some instances to privacy and security practices related to personally identifiable information.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ERISA. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Employee Retirement Income Security Act of 1974, as amended (ERISA), regulates how our services are provided to or through certain types of employer-sponsored health benefit plans. ERISA is a set of laws and regulations subject to interpretation by the U.S. Department of Labor (DOL) as well as the federal courts. ERISA sets forth standards on how our business units may do business with employers who sponsor employee health benefit plans, particularly those who maintain self-funded plans. Regulations established by the DOL subject us to additional requirements for administration of benefits, claims payment and member appeals under health care plans governed by ERISA. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">State Laws and Regulation </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Regulation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our insurance and HMO subsidiaries must be licensed by the jurisdictions in which they conduct business. All of the states in which our subsidiaries offer insurance and HMO products regulate those products and operations. The states require periodic financial reports and establish minimum capital or restricted cash reserve requirements. The National Association of Insurance Commissioners (NAIC) has adopted model regulations, which require expanded governance practices and risk and solvency assessment reporting. Most states have adopted these or similar measures to expand the scope of regulations relating to corporate governance and internal control activities of HMOs and insurance companies. We are required to maintain a risk management framework and file a confidential self-assessment report with state insurance regulators. We file reports annually with Connecticut, our lead regulator, and with New York, as required by the state&#8217;s regulation.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our health plans and insurance companies are regulated under state insurance holding company regulations. Such regulations generally require registration with applicable state departments of insurance and the filing of reports describing capital structure, ownership, financial condition, certain affiliated transactions and general business operations. Most state insurance </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">holding company laws and regulations require prior regulatory approval of acquisitions and material affiliated transfers of assets, as well as transactions between the regulated companies and their parent holding companies or affiliates. These laws may restrict the ability of our regulated subsidiaries to pay dividends to our holding companies. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our business activity is subject to other health care-related regulations and requirements, including PPO, Managed Care Organization (MCO), utilization review (UR), TPA, pharmacy care services, durable medical equipment or care provider-related regulations and licensure requirements. These regulations differ from state to state and may contain network, contracting, product and rate, licensing and financial and reporting requirements. There are laws and regulations which set specific standards for delivery of services, appeals, grievances and payment of claims, adequacy of health care professional networks, fraud prevention, protection of consumer health information, pricing and underwriting practices and covered benefits and services. State health care anti-fraud and abuse prohibitions encompass a wide range of activities, including kickbacks for referral of members, billing for unnecessary medical services and improper marketing. Certain of our businesses are subject to state general agent, broker and sales distribution laws and regulations. UnitedHealthcare Community &amp; State and certain of our Optum businesses are subject to regulation by state Medicaid agencies which oversee the provision of benefits to our Medicaid and CHIP beneficiaries and to our beneficiaries dually eligible for Medicare and Medicaid. We also contract with state governmental entities and are subject to state laws and regulations relating to the award, administration and performance of state government contracts. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">State Privacy and Security Regulations. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of states have adopted laws and regulations which may affect our privacy and security practices, such as state laws governing the use, disclosure and protection of social security numbers and protected health information or which are designed to implement GLBA or protect credit card account data. State and local authorities increasingly focus on the importance of protecting individuals from identity theft, with a significant number of states enacting laws requiring businesses to meet minimum cyber-security standards and notify individuals of security breaches involving personal information. State consumer protection laws may also apply to privacy and security practices related to personally identifiable information, including information related to consumers and care providers. Different approaches to state privacy and insurance regulation and varying enforcement philosophies may materially and adversely affect our ability to standardize our products and services across state lines. See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_22">Part I, Item&#160;1A, &#8220;Risk Factors&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of the risks related to compliance with state privacy and security regulations. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate Practice of Medicine and Fee-Splitting Laws. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our businesses function as direct medical service providers and, as such, are subject to additional laws and regulations. Some states have corporate practice of medicine laws prohibiting specific types of entities from practicing medicine or employing physicians to practice medicine. Moreover, some states prohibit certain entities from engaging in fee-splitting practices, which involve sharing in the fees or revenues of a professional practice. These prohibitions may be statutory or regulatory, or may be imposed through judicial or regulatory interpretation. The laws, regulations and interpretations in certain states have been subject to limited judicial and regulatory interpretation and are subject to change.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pharmacy and Pharmacy Benefits Management (PBM) Regulations </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Optum Rx&#8217;s businesses include home delivery, specialty and compounding pharmacies, as well as clinic-based pharmacies which must be licensed as pharmacies in the states in which they are located. Certain of our pharmacies must also register with the U.S.&#160;Drug Enforcement Administration (DEA) and individual state controlled substance authorities to dispense controlled substances. In addition to adhering to the laws and regulations in the states where our pharmacies are located, we also are required to comply with laws and regulations in some non-resident states where we deliver pharmaceuticals, including those requiring us to register with the board of pharmacy in the non-resident state. These non-resident states generally expect our  pharmacies to follow the laws of the state in which the pharmacies are located, but some non-resident states also require us to comply with their laws where pharmaceuticals are delivered. Additionally, certain of our pharmacies which participate in programs for Medicare and state Medicaid providers are required to comply with applicable Medicare and Medicaid provider rules and regulations. Other laws and regulations affecting our pharmacies include federal and state statutes and regulations governing the labeling, packaging, advertising and adulteration of prescription drugs and dispensing of controlled substances. See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_22">Part I, Item&#160;1A, &#8220;Risk Factors&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of the risks related to our pharmacy care services businesses.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal and state legislation of PBM activities affects both our ability to limit access to a pharmacy provider network or remove network providers. Additionally, many states limit our ability to manage and establish maximum allowable costs for generic prescription drugs. With respect to formulary services, a number of government entities, including CMS, HHS and state departments of insurance, regulate the administration of prescription drug benefits offered through federal or state exchanges. Many states also regulate the scope of prescription drug coverage, as well as the delivery channels to receive such prescriptions, for insurers, MCOs and Medicaid managed care plans. These regulations could limit or preclude (i) certain plan designs, (ii) limited networks, (iii) requirements to use particular care providers or distribution channel, (iv) copayment differentials among providers and (v) formulary tiering practices.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legislation seeking to regulate PBM activities introduced or enacted at the federal or state level could impact our business practices with others in the pharmacy supply chain, including pharmaceutical manufacturers and network providers. Additionally, organizations like the NAIC periodically issue model regulations while credentialing organizations, like the National Committee for Quality Assurance (NCQA) and the Utilization Review Accreditation Commission (URAC), may establish standards impacting PBM pharmacy activities. Although these model regulations and standards do not have the force of law, they may influence states to adopt their recommendations and impact the services we deliver to our clients. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consumer Protection Laws</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our businesses participate in direct-to-consumer activities and are subject to regulations applicable to online communications and other general consumer protection laws and regulations such as the Federal Tort Claims Act, the Federal Postal Service Act and the FTC&#8217;s Telemarketing Sales Rule. Most states also have similar consumer protection laws. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain laws, such as the Telephone Consumer Protection Act, give the FTC, the Federal Communications Commission (FCC) and state attorneys general the ability to regulate, and&#160;bring enforcement actions relating to, telemarketing practices and certain automated outbound contacts such as phone calls, texts or emails.&#160;Under certain circumstances, these laws may provide consumers with a private right of action. Violations of these laws could result in substantial statutory penalties and other sanctions.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Banking Regulation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Optum Bank is subject to regulation by federal banking regulators, including the Federal Deposit Insurance Corporation, which performs annual examinations to ensure the bank is operating in accordance with federal safety and soundness requirements, and the Consumer Financial Protection Bureau, which may perform periodic examinations to ensure the bank is in compliance with applicable consumer protection statutes, regulations and agency guidelines.&#160;Optum Bank is also subject to supervision and regulation by the Utah State Department of Financial Institutions, which carries out annual examinations to ensure the bank is operating in accordance with state safety and soundness requirements and performs periodic examinations of the bank&#8217;s compliance with applicable state banking statutes, regulations and agency guidelines.&#160;In the event of unfavorable examination results from any of these agencies, the bank could become subject to increased operational expenses and capital requirements, enhanced governmental oversight and monetary penalties.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-U.S.  Regulation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our businesses operate internationally and are subject to regulation in the jurisdictions in which they are organized or conduct business. These regulatory regimes vary from jurisdiction to jurisdiction. In addition, our non-U.S. businesses and operations are subject to U.S. laws regulating the conduct and activities of U.S.-based businesses operating abroad, such as the Foreign Corrupt Practices Act (FCPA), which prohibits offering, promising, providing or authorizing others to give anything of value to a foreign government official to obtain or retain business or otherwise secure a business advantage. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COMPETITION </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a diversified health care company, we operate in highly competitive markets across the full expanse of health care benefits and services, including organizations ranging from startups to highly sophisticated Fortune 50 global enterprises, for-profit and non-profit companies, and private and government-sponsored entities. New entrants and business combinations also contribute to a dynamic and competitive environment. We compete fundamentally on the quality and value we provide to those we serve which can include elements such as product and service innovation; use of technology; consumer and provider engagement and satisfaction; and sales, marketing and pricing. See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_22">Part I, Item&#160;1A, &#8220;Risk Factors&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional discussion of our risks related to competition. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">INTELLECTUAL PROPERTY RIGHTS</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have obtained trademark registration for the UnitedHealth Group, Optum and UnitedHealthcare names and logos. We own registrations for certain of our other trademarks in the United States and abroad. We hold a portfolio of patents and have patent applications pending from time to time. We are not substantially dependent on any single patent or group of related patents.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise noted, trademarks appearing in this report are trademarks owned by us. We disclaim any proprietary interest in the marks and names of others.</span></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">HUMAN CAPITAL RESOURCES</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our 350,000 employees, as of December 31, 2021, including nearly 135,000 clinical professionals, are guided by our mission to help people live healthier lives and help make the health system work better for everyone. Our mission and cultural values of integrity, compassion, relationships, innovation and performance align with our long-term business strategy to increase access to care, make care more affordable, enhance the care experience and improve health outcomes. Our mission and values attract individuals who are determined to make a difference &#8211; individuals whose talent, innovation, engagement and empowerment are critical in our ability to achieve our mission. Similar to other businesses, in 2021 we have experienced moderately higher levels of employment attrition and COVID-19 continues to drive unplanned absences, but due to increased recruiting capacity and upgraded digital capabilities our workforce continues to be able to meet the needs of those we serve. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are committed to developing our people and culture by creating an inclusive environment where people of diverse backgrounds, experiences and perspectives make us better. Our approach is data-driven and leader led, including enterprise and business scorecards ensuring our leaders are accountable for a consistent focus on hiring, developing, advancing and retaining diverse talent. We have embedded inclusion and diversity throughout our culture, including in our talent acquisition and talent management practices; leadership development; careers; learning and skills; and systems and processes. We strive to maintain a sustainable and diverse talent pipeline by building strong strategic partnerships and outreach through early career programs, internships and apprenticeships. We support career coaching, mentorship and accelerated leadership development programs to ensure mobility and advancement for our diverse talent. To foster an engaged workforce and an inclusive culture, we invest in a broad array of learning and culture development</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">programs. We rely on a shared leadership framework, which clearly and objectively defines our expectations, enables an environment where everyone has the opportunity to learn and grow, and helps us identify, develop and deploy talent to help achieve our mission.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We prioritize pay equity by regularly evaluating and reviewing our compensation practices by gender, ethnicity and race. Receiving on-going feedback from our team members is another way to strengthen and reinforce a culture of inclusion. Our Employee Experience Index measures an employee&#8217;s sense of commitment and belonging to the Company and is a metric in the Stewardship section of our annual incentive plan. Our Sustainability Report, which can be accessed on our website at www.unitedheatlhgroup.com, provides further details on our people and culture.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">INFORMATION ABOUT OUR EXECUTIVE OFFICERS</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following sets forth certain information regarding our executive officers as of February 10, 2022, including the business experience of each executive officer during the past five years:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.759%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.049%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Age</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Position</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Andrew P. Witty</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dirk C. McMahon</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Operating Officer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John F. Rex</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patricia L. Lewis</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Human Resources Officer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas E. Roos</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President and Chief Accounting Officer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marianne D. Short</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Legal Officer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brian R. Thompson</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer of UnitedHealthcare</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors elects executive officers annually. Our executive officers serve until their successors are duly elected and qualified, or until their earlier death, resignation, removal or disqualification.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mr. Witty</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as Chief Executive Officer and a member of the Board of Directors of UnitedHealth Group since February 2021. Previously, Mr. Witty served as Chief Executive Officer of Optum beginning in July 2018, President of UnitedHealth Group from November 2019 to February 2021 and as a UnitedHealth Group director from August 2017 to March 2018. From April 2020 to November 2020, Mr. Witty took an unpaid leave of absence to serve as a Global Envoy for the World Health Organization&#8217;s COVID-19 efforts. Prior to joining UnitedHealth Group, he was Chief Executive Officer and a board member of GlaxoSmithKline, a global pharmaceutical company, from 2008 to April 2017.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mr. McMahon </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has served as President and Chief Operating Officer of UnitedHealth Group since February 2021. In addition, Mr. McMahon previously served as Chief Executive Officer of UnitedHealthcare June 2019 to April 2021, President and Chief Operating Officer of Optum from April 2017 to June 2019 and Executive Vice President, Operations at UnitedHealth Group from November 2014 to April 2017. Mr. McMahon also served as Chief Executive Officer of Optum Rx from November 2011 to November 2014. Prior to 2011, he held various positions in UnitedHealthcare in operations, technology and finance.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mr. Rex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as Executive Vice President and Chief Financial Officer of UnitedHealth Group since June 2016. From March 2012 to June 2016, Mr. Rex served as Executive Vice President and Chief Financial Officer of Optum. Prior to joining Optum in 2012, Mr. Rex was a Managing Director at JP Morgan, a global financial services firm.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ms. Lewis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as Executive Vice President and Chief Human Resources Officer of UnitedHealth Group since October 2019. Prior to joining UnitedHealth Group, Ms. Lewis served at Lockheed Martin Corporation, a global security and aerospace company, where she was Senior Vice President and Chief Human Resources Officer from December 2014 to October 2019. Prior to joining Lockheed Martin Corporation in 2011, Ms. Lewis held various positions in Human Resources at International Business Machines Corporation, a global technology company, and DuPont De Nemours, Inc, a global diversified chemicals company. Ms. Lewis currently serves as a director of Lear, Inc.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mr. Roos</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as Senior Vice President and Chief Accounting Officer of UnitedHealth Group since August 2015. Prior to joining UnitedHealth Group, Mr. Roos was a Partner at Deloitte &amp; Touche LLP, an independent registered public accounting firm, from September 2007 to August 2015.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ms. Short</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as Executive Vice President and Chief Legal Officer of UnitedHealth Group from January 2013 to January 2021 and from June 2021 to present. Prior to joining UnitedHealth Group, Ms. Short served as the Managing Partner at Dorsey &amp; Whitney LLP, an international law firm, from January 2007 to December 2012. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mr. Thompson</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as Chief Executive Officer of UnitedHealthcare since April 2021. Prior to this role, he served as Chief Executive Officer of UnitedHealthcare's government programs including Medicare &amp; Retirement and Community &amp; State from 2017 to 2021; as Chief Financial Officer of UnitedHealthcare&#8217;s Employer &amp; Individual and Medicare &amp; Retirement businesses from 2010 to 2017; as Financial Controller of UnitedHealthcare's Employer &amp; Individual business from 2008 to 2010; and as Director, Corporate Development from 2004 to 2008.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Additional Information</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our executive offices are located at UnitedHealth Group Center, 9900 Bren Road East, Minnetonka, Minnesota 55343; our telephone number is (952)&#160;936-1300. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You can access our website at www.unitedhealthgroup.com to learn more about our company. From the site you can download and print copies of our annual reports to shareholders, annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, along with amendments to those reports. You can also download from our website our certificate of incorporation and bylaws; corporate governance policies, including our Principles of Governance; Board of Directors Committee Charters; Code of Conduct; and annual sustainability report. We make periodic reports and amendments available, free of charge, on our website, as soon as reasonably practicable after we file or furnish these reports to the Securities and Exchange Commission (SEC). We will also provide a copy of any of our corporate governance policies published on our website free of charge, upon request. To request a copy of any of these documents, please submit your request to: UnitedHealth Group Incorporated, 9900 Bren Road East, Minnetonka, MN 55343, Attn: Corporate Secretary. Information on or linked to our website is neither part of nor incorporated by reference into this Annual Report on Form 10-K or any other SEC filings.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our transfer agent, Equiniti (EQ), can help you with a variety of shareholder-related services, including change of address, lost stock certificates, transfer of stock to another person and other administrative services. You can write to our transfer agent at: EQ Shareowner Services, P.O. Box 64854, St. Paul, Minnesota 55164-0854, or telephone (800)&#160;401-1957 or (651)&#160;450-4064. </span></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_22"></div><div style="margin-top:13.5pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A.&#160;&#160;&#160;&#160;RISK FACTORS </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CAUTIONARY STATEMENTS</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The statements, estimates, projections or outlook contained in this Annual Report on Form 10-K include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA). When used in this Annual Report on Form 10-K and in future filings by us with the SEC, in our news releases, presentations to securities analysts or investors, and in oral statements made by or with the approval of one of our executive officers, the words &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;estimate,&#8221; &#8220;anticipate,&#8221; &#8220;forecast,&#8221; &#8220;outlook,&#8221; &#8220;plan,&#8221; &#8220;project,&#8221; &#8220;should&#8221; or similar words or phrases are intended to identify such forward-looking statements. These statements are intended to take advantage of the &#8220;safe harbor&#8221; provisions of the PSLRA. These forward-looking statements involve risks and uncertainties which may cause our actual results to differ materially from the expectations expressed or implied in the forward-looking statements. Any forward-looking statement in this report speaks only as of the date of this report and, except as required by law, we undertake no obligation to update any forward-looking statement to reflect events or circumstances, including unanticipated events, after the date of this report.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion contains cautionary statements regarding our business, which investors and others should consider. We do not undertake to address in future filings or communications regarding our business or results of operations how any of these factors may have caused our results to differ from discussions or information contained in previous filings or </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">communications. In addition, any of the matters discussed below may have affected past, as well as current, forward-looking statements about future results. Any or all forward-looking statements in this Annual Report on Form 10-K and in any other public filings or statements we make may turn out to be wrong. Our forward-looking statements can be affected by inaccurate assumptions we might make or by known or unknown risks and uncertainties. Many factors discussed below will be important in determining our future results. By their nature, forward-looking statements are not guarantees of future performance or results and are subject to risks, uncertainties and assumptions which are difficult to predict or quantify. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Business and Our Industry</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are subject to risks associated with public health crises, large-scale medical emergencies and pandemics, such as the COVID-19 pandemic, which could continue to have a material adverse effect on our business, results of operations, financial condition and financial performance. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ongoing COVID-19 pandemic continues to impact health systems, businesses, governments and customer and consumer activities. The future impact to our business is primarily dependent upon the ultimate pacing, intensity and duration of the crisis, the severity of new variants of the COVID-19 virus, and the effectiveness and extent of administration of vaccinations and treatments, factors which remain uncertain at this time. These factors continue to affect the related treatment, testing, coverage and other services we provide for the people we serve. We may experience an increase in medical care costs as people seek care which was deferred during the pandemic and individuals with chronic conditions may require additional care needs resulting from missed treatments. The premiums and fees we charge, including premiums dependent upon documented health conditions, may not be sufficient to cover the medical and administrative costs associated with COVID-19 and other care services. Similarly, state and federal mandates for coverage may result in additional incurred expenses that are not associated with increases in government reimbursement (such as requirements for insurers to cover at-home COVID-19 testing).We have experienced and may continue to experience reduced demand for certain services Optum provides to care providers, health plans and employers as a result of reduced clinical and claims activity and changes in business priorities resulting from COVID-19. In addition, our care delivery business may continue to be adversely impacted by COVID-19 infections and exposures affecting providers we employ, resulting in reduced capacity to handle demand for care and related partial or full closures of our facilities. Our non-clinical workforce may also be adversely impacted by COVID-19 infections and exposures impacting our business operations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has resulted in some of our customers having to temporarily or permanently close or severely curtail their operations, and unfavorable economic conditions resulting from the pandemic may continue to impact our clients, customers, health care providers, third party vendors and federal and state entities and programs. Among other impacts, we have experienced and may continue to experience loss of commercial and pharmacy care services members due to customer reductions in workforce and an adverse impact on the timing and collectability of premium payments. In addition, governments have modified, and may continue to modify, regulatory standards around various aspects of health care in response to COVID-19, which may adversely affect our ability to ensure timely compliance and meet various contractual obligations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further disruptions in public and private infrastructure, including supply chains providing medical supplies and pharmaceutical products, could disrupt our business operations or increase our operating costs. Additionally, the enactment of emergency powers by governments could disrupt our business operations, including by restricting pharmaceuticals or other supplies, and could increase the risk of shortages of necessary items.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we cannot predict the pacing, intensity and duration of COVID-19, the pandemic&#8217;s disruption to business activities, employment and economic effects, and near and long-term impacts on the patterns of care and services across the healthcare system could continue to have material and adverse effects on our business, results of operations, financial position or cash flows.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we fail to estimate, price for and manage our medical costs or set benefit designs in an effective manner, the profitability of our risk-based products and services could decline and could materially and adversely affect our results of operations, financial position and cash flows. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our risk-based benefit products, we assume the risk of both medical and administrative costs for our customers in return for monthly premiums. We generally use approximately 80% to 85% of our premium revenues to pay the costs of health care services delivered to these customers. The profitability of our products depends in large part on our ability to predict, price for and effectively manage medical costs. Our Optum Health business negotiates value-based arrangements with commercial third-party payers which are also included in premium revenues. Under a typical arrangement, Optum Health receives a fixed percentage of a third-party payer&#8217;s premiums to cover all or a defined portion of the medical costs provided to members. Premium revenues from risk-based products comprise nearly 80% of our total consolidated revenues. If we fail to predict accurately, or effectively price for or manage, the costs of providing care under risk-based arrangements, our results of operations could be materially and adversely affected.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manage medical costs through underwriting criteria, product design, negotiation of competitive provider contracts and care management programs. Total medical costs are affected by the number of individual services rendered, the cost of each service and the type of service rendered. Our premium revenue on commercial policies and Medicaid contracts is typically based on a fixed monthly rate per individual served for a 12-month period and is generally priced one to six months before the contract commences. Our revenue on certain Medicare policies is based on bids submitted to CMS in June the year before the contract year. Although we base the commercial and Medicaid premiums we charge and our Medicare bids on our estimates of future medical costs over the fixed contract period, many factors may cause actual costs to exceed those estimated and reflected in premiums or bids. These factors may include medical cost inflation, increased use of services, increased cost of individual services, large-scale medical emergencies, the potential effects of climate change, pandemics, such as COVID-19, the introduction of new or costly drugs, treatments and technology, new treatment guidelines, newly mandated benefits or other regulatory changes and insured population characteristics. Relatively small differences between predicted and actual medical costs or utilization rates as a percentage of revenues can result in significant changes in our financial results. For example, if our 2021 medical costs for commercial insured products had been 1% higher than our actual medical costs, without proportionally higher revenues from such products, our annual net earnings for 2021 would have been reduced by approximately $330 million, excluding any offsetting impact from risk adjustment or from reduced premium rebates due to minimum MLRs.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the financial results we report for any particular period include estimates of costs incurred for which claims are still outstanding. These estimates involve an extensive degree of judgment. If these estimates prove inaccurate, our results of operations could be materially and adversely affected.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we fail to maintain properly the integrity or availability of our data or successfully consolidate, integrate, upgrade or expand our existing information systems, or if our technology products do not operate as intended, our business could be materially and adversely affected. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business depends on the integrity and timeliness of the data we use to serve our members, customers and health care professionals and to operate our business. The volume of health care data generated, and the uses of data, including electronic health records, are rapidly expanding. Our ability to implement new and innovative services, price adequately our products and services, provide effective service to our customers in an efficient and uninterrupted fashion, and report accurately our results of operations depends on the integrity of the data in our information systems. In addition, connectivity among technologies is becoming increasingly important and recent trends toward greater consumer engagement in health care require new and enhanced technologies, including more sophisticated applications for mobile devices. Our information systems require an ongoing commitment of significant resources to maintain, protect and enhance existing systems and develop new systems to keep pace with continuing changes in information processing technology, evolving systems and regulatory standards and changing customer preferences. If the data we rely upon to run our businesses is found to be inaccurate or unreliable or if we fail to maintain or protect our information systems and data integrity effectively, we could experience failures in our health, wellness and information technology products; lose existing customers; have difficulty attracting new customers; experience problems in determining medical cost estimates and establishing appropriate pricing; have difficulty preventing, detecting and controlling fraud; have disputes with customers, physicians and other health care professionals; become subject to regulatory sanctions or penalties; incur increases in operating expenses; or suffer other adverse consequences. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We periodically consolidate, integrate, upgrade and expand our information systems&#8217; capabilities as a result of technology initiatives and recently enacted regulations, changes in our system platforms and integration of new business acquisitions. Our process of consolidating the number of systems we operate, upgrading and expanding our information systems&#8217; capabilities, enhancing our systems and developing new systems to keep pace with continuing changes in information processing technology may not be successful. Failure to protect, consolidate and integrate our systems successfully could result in higher than expected costs and diversion of management&#8217;s time and energy, which could materially and adversely affect our results of operations, financial position and cash flows.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our businesses sell and install software products which may contain unexpected design defects or may encounter unexpected complications during installation or when used with other technologies utilized by the customer. A failure of our technology products to operate as intended and in a seamless fashion with other products could materially and adversely affect our results of operations, financial position and cash flows.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Uncertain and rapidly evolving U.S. federal and state, non-U.S. and international laws and regulations related to health data and the health information technology market may alter the competitive landscape or present compliance challenges and could materially and adversely affect the configuration of our information systems and platforms, and our ability to compete in this market.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we sustain cyber-attacks or other privacy or data security incidents resulting in security breaches disrupting our operations or resulting in the unintended dissemination of protected personal information or proprietary or confidential </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">information, we could suffer a loss of revenue and increased costs, exposure to significant liability, reputational harm and other serious negative consequences.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We routinely process, store and transmit large amounts of data in our operations, including protected personal information subject to privacy, security or data breach notification laws, as well as proprietary or confidential information relating to our business or third parties. Some of the data we process, store and transmit may be outside of the United States due to our information technology systems and international business operations. We are regularly the target of attempted cyber-attacks and other security threats and may be subject to breaches of the information technology systems we use. We have programs in place which are intended to detect, contain and respond to data security incidents and provide employee awareness training regarding phishing, malware and other cyber risks to protect against cyber risks and security breaches. However, because the techniques used to obtain unauthorized access, disable or degrade service, or sabotage systems change frequently and are increasing in sophistication, we may be unable to anticipate these techniques, detect breaches for long periods of time or implement adequate preventive measures. Experienced computer programmers and hackers may be able to penetrate our security controls and access, misappropriate or otherwise compromise protected personal information or proprietary or confidential information or that of third parties, create system disruptions or cause system shutdowns, negatively affecting our operations. They also may be able to develop and deploy viruses, worms and other malicious software programs attacking our systems or otherwise exploit any security vulnerabilities. Hardware, software, or applications we develop or procure from third parties may contain defects in design or manufacture or other problems which could unexpectedly compromise information security. In addition, we are subject to heightened vulnerability to cybersecurity attacks associated with increased numbers of employees working from home. Our facilities and services may also be vulnerable to security incidents or security attacks; acts of vandalism or theft; coordinated attacks by activist entities; financial fraud schemes; misplaced or lost data; human error; malicious social engineering; or other events which could negatively affect our systems, our customers&#8217; data, proprietary or confidential information relating to our business or third parties, or our operations. In certain circumstances we may rely on third-party vendors to process, store and transmit large amounts of data for our business whose operations are subject to similar risks.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The costs to eliminate or address the foregoing security threats and vulnerabilities before or after a cyber-incident could be material. Our remediation efforts may not be successful and could result in interruptions, delays, or cessation of service and loss of existing or potential customers. In addition, breaches of our security measures and the unauthorized dissemination of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sensitive personal information, proprietary information or confidential information about us or our customers or other third parties, could expose our customers&#8217; private information and our customers to the risk of financial or medical identity theft, or expose us or other third parties to a risk of loss or misuse of this information, result in litigation and liability, including regulatory penalties, for us, damage our brand and reputation, or otherwise harm our business.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we fail to compete effectively to maintain or increase our market share, including maintaining or increasing enrollments in businesses providing health benefits, our results of operations, financial position and cash flows</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">could be materially and adversely affected. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our businesses face significant competition in all of the geographic markets in which we operate. In particular geographies or segments, our competitors, compared to us, may have greater capabilities, resources or market share; a more established reputation; superior supplier or health care professional arrangements; better existing business relationships; lower profit margin or financial return expectations; or other factors which give such competitors a competitive advantage. Our competitive position may also be adversely affected by significant merger and acquisition activity in the industries in which we operate, both among our competitors and suppliers. Consolidation may make it more difficult for us to retain or increase our customer base, improve the terms on which we do business with our suppliers, or maintain or increase profitability. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, our success in the health care marketplace will depend on our ability to develop and deliver innovative and potentially disruptive products and services to satisfy evolving market demands. If we do not continue to innovate and provide products and services, which are useful and relevant to health care payers, consumers and our customers, we may not remain competitive, and we risk losing market share to existing competitors and disruptive new market entrants. For example, new direct-to-consumer business models from competing businesses may make it more difficult for us to directly engage consumers in the selection and management of their health care benefits and health care usage. We may face challenges from new technologies and market entrants which could affect our existing relationship with health plan enrollees in these areas. Any failure by us to continue to develop innovative care models, including accelerating the transition of care to value-based models and expanding access to virtual care, could result in competitive disadvantages and loss of market share. Additionally, our competitive position could be adversely affected by a failure to develop satisfactory data and analytics capabilities or provide services focused on these capabilities to our clients. Our business, results of operations, financial position and cash flows could be materially and adversely affected if we do not compete effectively in our markets, if we set rates too high or too low in highly competitive markets, if we do not design and price our products properly and competitively, if we fail to realize competitive advantages resulting from collaboration between our businesses, if we are unable to innovate and deliver products and services demonstrating value to our customers, if we do not provide a satisfactory level of services, if membership or </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">demand for other services does not increase as we expect or declines, or if we lose accounts with more profitable products while retaining or increasing membership in accounts with less profitable products.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we fail to develop and maintain satisfactory relationships with health care payers, physicians, hospitals and other service providers, our business could be materially and adversely affected. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We depend substantially on our continued ability to contract with health care payers (as a service provider to those payers), as well as physicians, hospitals, pharmaceutical benefit service providers, pharmaceutical manufacturers and other service providers at competitive prices. Any failure by us to develop and maintain satisfactory relationships with health care providers, whether in-network or out-of-network, could materially and adversely affect our business, results of operations, financial position and cash flows. In addition, certain activities related to network design, provider participation in networks and provider payments could result in disputes, which may be costly, divert management&#8217;s attention from our operations and result in negative publicity.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In any particular market, physicians and health care providers could refuse to contract with us, demand higher payments, or take other actions which could result in higher medical costs, less desirable products for customers or difficulty meeting regulatory or accreditation requirements. In some markets, certain health care providers, particularly hospitals, physician and hospital organizations or multi-specialty physician groups, may have significant market positions or near monopolies which could result in diminished bargaining power on our part. In addition, ACOs; practice management companies (which aggregate physician practices for administrative efficiency); and other organizational structures adopted by physicians, hospitals and other care providers may change the way in which these providers do business with us and may change the competitive landscape. Such organizations or groups of physicians may compete directly with us, which could adversely affect our business, and our results of operations, financial position and cash flows by impacting our relationships with these providers or affecting the way we price our products and estimate our costs, which might require us to incur costs to change our operations. In addition, if these providers refuse to contract with us, use their market position to negotiate favorable contracts or place us at a competitive disadvantage, our ability to market products or to be profitable in those areas could be materially and adversely affected. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our health care benefits businesses have risk-based arrangements with some physicians, hospitals and other health care providers. These arrangements limit our exposure to the risk of increasing medical costs, but expose us to risk related to the adequacy of the financial and medical care resources of the health care provider. To the extent a risk-based health care provider organization faces financial difficulties or otherwise is unable to perform its obligations under the arrangement, we may be held responsible for unpaid health care claims which should have been the responsibility of the health care provider and for which we have already paid the provider. Further, payment or other disputes between a primary care provider and specialists with whom the primary care provider contracts could result in a disruption in the provision of services to our members or a reduction in the services available to our members. Health care providers with which we contract may not properly manage the costs of services, maintain financial solvency or avoid disputes with other providers. Any of these events could have a material adverse effect on the provision of services to our members and our operations. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some providers render services to our members who do not have contracts with us. In those cases, we do not have a pre-established understanding about the amount of compensation due to the provider for services rendered to our members. In some states, the amount of compensation due to these out-of-network providers is defined by law or regulation, but in other cases the amount is either not defined or is established by a standard which does not clearly specify dollar terms. In some instances, providers may believe they are underpaid for their services and may either litigate or arbitrate their dispute with us.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of some of our businesses, including Optum Health and UnitedHealthcare Global, depend on maintaining satisfactory relationships with physicians as our employees, independent contractors or joint venture partners. The physicians who practice medicine or contract with our affiliated physician organizations could terminate their provider contracts or otherwise become unable or unwilling to continue practicing medicine or contracting with us. We face and will likely continue to face heightened competition in the markets where we operate to acquire or manage physician practices or to employ or contract with individual physicians. If we are unable to maintain or grow satisfactory relationships with physicians, or to acquire, recruit or, in some instances, employ physicians, or to retain enrollees following the departure of a physician, our revenues could be materially and adversely affected. In addition, our affiliated physician organizations contract with competitors of UnitedHealthcare. Our businesses could suffer if our affiliated physician organizations fail to maintain relationships with these companies, or fail to adequately price their contracts with these third-party payers.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, physicians, hospitals, pharmaceutical benefit service providers, pharmaceutical manufacturers and certain health care providers are customers of our Optum businesses. Physicians also provide medical services at facilities owned by our Optum businesses. Given the importance of health care providers and other constituents to our businesses, failure to maintain satisfactory relationships with them could materially and adversely affect our results of operations, financial position and cash flows. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are routinely subject to various legal actions, which could damage our reputation and, if resolved unfavorably, could result in substantial penalties or monetary damages and materially and adversely affect our results of operations, financial position and cash flows.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are routinely made party to a variety of legal actions related to, among other matters, the design, management and delivery of our product and service offerings. These matters have included or could in the future include matters related to health care benefits coverage and payment claims (including disputes with enrollees, customers and contracted and non-contracted physicians, hospitals and other health care professionals), tort claims (including claims related to the delivery of health care services, such as medical malpractice by staff at our affiliates&#8217; facilities, or by health care practitioners who are employed by us, have contractual relationships with us, or serve as providers to our managed care networks, including as a result of a failure to adhere to applicable clinical, quality and/or patient safety standards), antitrust claims (including as a result of changes in the enforcement of antitrust laws), whistleblower claims (including claims under the False Claims Act or similar statutes), contract and labor disputes, tax claims and claims related to disclosure of certain business practices. In addition, certain of our pharmacy services operations are subject to the clinical quality, patient safety and other risks inherent in the dispensing, packaging and distribution of drugs, including claims related to purported dispensing and other operational errors. We may also be party to certain class action lawsuits brought by health care professional groups and consumers. We operate in jurisdictions outside of the United States where contractual rights, tax positions and applicable regulations may be subject to interpretation or uncertainty to a greater degree than in the United States, and therefore subject to dispute by customers, government authorities or others. Any failure by us to adhere to the laws and regulations applicable to our businesses could subject us to civil and criminal penalties. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are largely self-insured with regard to litigation risks, including claims of medical malpractice against our affiliated physicians and us. Although we record liabilities for our estimates of the probable costs resulting from self-insured matters, it is possible the level of actual losses will significantly exceed the liabilities recorded. Additionally, physicians and other healthcare providers have become subject to an increasing number of legal actions alleging medical malpractice and general professional liabilities.  Even in states that have imposed caps on damages for such actions, litigants are seeking recoveries under new theories of liability that might not be subject to the caps on damages. Many of these actions involve large claims and significant defense costs and, if these actions are asserted against us, could result in substantial monetary damages or damage to our reputation. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict the outcome of significant legal actions in which we are involved and are incurring expenses in resolving these matters. The legal actions we face or may face in the future could further increase our cost of doing business and materially and adversely affect our results of operations, financial position and cash flows. In addition, certain legal actions could result in adverse publicity which could damage our reputation and materially and adversely affect our ability to retain our current business or grow our market share in some markets and businesses.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Any failure by us to manage successfully our strategic alliances or complete, manage or integrate acquisitions and other significant strategic transactions or relationships domestically or outside the United States could materially and adversely affect our business, prospects, results of operations, financial position and cash flows. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our business strategy, we frequently engage in discussions with third parties regarding possible investments, acquisitions, divestitures, strategic alliances, joint ventures and outsourcing transactions and often enter into agreements relating to such transactions. For example, we have a strategic alliance with AARP under which we provide AARP-branded Medicare Supplement insurance to AARP members and other AARP-branded products and services to Medicare beneficiaries.&#160;If we fail to meet the needs of our alliance or joint venture partners, including by developing additional products and services, providing high levels of service, pricing our products and services competitively or responding effectively to applicable federal and state regulatory changes, our alliances and joint ventures could be damaged or terminated which in turn could adversely impact our reputation, business and results of operations. Further, if we fail to identify and successfully complete transactions, which further our strategic objectives, we may be required to expend resources to develop products and technology internally, we may be placed at a competitive disadvantage or we may be adversely affected by negative market perceptions, any of which may have a material adverse effect on our results of operations, financial position or cash flows.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Success in completing acquisitions is also dependent on effectively integrating the acquired business into our existing operations, including our internal control environment and culture, or otherwise leveraging its operations which may present challenges different from those presented by organic growth and may be difficult for us to manage. In addition, even with appropriate diligence, pre-acquisition practices of an acquired business may expose us to legal challenges and investigations. For example, in January 2021, an indictment for alleged violations of antitrust laws was issued by the DOJ against our subsidiary, Surgical Care Affiliates (SCA), based on conduct alleged to have begun more than five years prior to our acquisition. We are vigorously defending this lawsuit, but if SCA is found liable, we may be subject to criminal fines or reputational harm. If we cannot successfully integrate these acquisitions and realize contemplated revenue growth opportunities </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and cost savings, our business, prospects, results of operations, financial position and cash flows could be materially and adversely affected. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we expand and operate our business outside of the United States, we are presented with challenges differing from those presented by acquisitions of domestic businesses, including challenges in adapting to new markets, languages, business, labor and cultural practices and regulatory environments. Adapting to these challenges could require us to devote significant senior management attention and other resources to the acquired businesses before we realize anticipated synergies or other benefits from the acquired businesses. These challenges vary widely by country and, outside of the United States, may include political instability, government intervention, discriminatory regulation and currency exchange controls or other restrictions, which could prevent us from transferring funds from these operations out of the countries in which our acquired businesses operate, or converting local currencies we hold into U.S. dollars or other currencies. If we are unable to manage successfully our non-U.S. acquisitions, our business, prospects, results of operations and financial position could be materially and adversely affected. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency exchange rates and fluctuations may have an impact on our shareholders&#8217; equity from period to period, which could adversely affect our debt to debt-plus-equity ratio, and our future revenues, costs and cash flows from international operations. Any measures we may implement to reduce the effect of volatile currencies may be costly or ineffective.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our sales performance will suffer if we do not adequately attract, retain and provide support to a network of independent producers and consultants. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products and services are sold in part through nonexclusive producers and consultants for whose services and allegiance we must compete. Our sales would be materially and adversely affected if we are unable to attract, retain and support such independent producers and consultants or if our sales strategy is not appropriately aligned across distribution channels. Our relationships with producers could be materially and adversely impacted by changes in our business practices and the nature of our relationships to address these pressures, including potential reductions in commission levels.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unfavorable economic conditions could materially and adversely affect our revenues and our results of operations. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unfavorable economic conditions may impact demand for certain of our products and services. For example, high unemployment during the early stages of the COVID-19 pandemic has caused lower enrollment or lower rates of renewal in our employer group benefits and pharmacy services plans. Unfavorable economic conditions also have caused and could continue to cause employers to stop offering certain health care coverage as an employee benefit or elect to offer this coverage on a voluntary, employee-funded basis as a means to reduce their operating costs. In addition, unfavorable economic conditions could adversely impact our ability to increase premiums or result in the cancellation by certain customers of our products and services. These conditions could lead to a decrease in our membership levels and premium and fee revenues and could materially and adversely affect our results of operations, financial position and cash flows. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During a prolonged unfavorable economic environment, state and federal budgets could be materially and adversely affected, resulting in reduced reimbursements or payments in our federal and state government health care coverage programs, including Medicare, Medicaid and CHIP. A reduction in state Medicaid reimbursement rates could be implemented retroactively to apply to payments already negotiated or received from the government and could materially and adversely affect our results of operations, financial position and cash flows. In addition, state and federal budgetary pressures could cause the affected governments to impose new or a higher level of taxes or assessments for our commercial programs, such as premium taxes on health insurance and surcharges or fees on select fee-for-service and capitated medical claims. Any of these developments or actions could materially and adversely affect our results of operations, financial position and cash flows. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A prolonged unfavorable economic environment also could adversely impact the financial position of hospitals and other care providers which could materially and adversely affect our contracted rates with these parties and increase our medical costs or materially and adversely affect their ability to purchase our service offerings. Further, unfavorable economic conditions could adversely impact the customers of our Optum businesses, including health plans, hospitals, care providers, employers and others which could, in turn, materially and adversely affect Optum&#8217;s financial results.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our failure to attract, develop, retain, and manage the succession of key employees and executives could adversely affect our business, results of operations and future performance. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are dependent on our ability to attract, develop and retain qualified employees and executives, including those with diverse backgrounds, experiences and skill sets, to operate and expand our business. Experienced and highly skilled employees and executives in the health care and technology industries are in high demand and the market for their services is extremely competitive. We may have difficulty in replacing key executives because of the limited number of qualified individuals in these industries with the breadth of skills and experience required to operate and successfully expand our business. Adverse changes to our corporate culture, which seeks to foster integrity, compassion, relationships, innovation and performance, could harm our business operations and our ability to retain key employees and executives. While we have development and succession plans in place for our key employees and executives, these plans do not guarantee the services of our key employees and executives </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">will continue to be available to us. If we are unable to attract, develop, retain and effectively manage the development and succession plans for key employees and executives, our business, results of operations and future performance could be adversely affected. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our investment portfolio may suffer losses which could adversely affect our results of operations, financial position and cash flows. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Market fluctuations could impair our profitability and capital position. Volatility in interest rates affects our interest income and the market value of our investments in debt securities of varying maturities which constitute the vast majority of the fair value of our investments as of December&#160;31, 2021. Relatively low interest rates on investments, such as those experienced during recent years, have adversely impacted our investment income. In addition, a delay in payment of principal or interest by issuers, or defaults by issuers (primarily issuers of our investments in corporate and municipal bonds), could reduce our investment income and require us to write down the value of our investments which could adversely affect our profitability and equity. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investments may not produce total positive returns and we may sell investments at prices which are less than their carrying values. Changes in the value of our investment assets, as a result of interest rate fluctuations, changes in issuer financial conditions, illiquidity or otherwise, could have an adverse effect on our equity. In addition, if it became necessary for us to liquidate our investment portfolio on an accelerated basis, such an action could have an adverse effect on our results of operations and the capital position of our regulated subsidiaries. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If the value of our intangible assets is materially impaired, our results of operations, equity and credit ratings could be materially and adversely affected. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, our goodwill and other intangible assets had a carrying value of $86 billion, representing 40% of our total consolidated assets. We periodically evaluate our goodwill and other intangible assets to determine whether all or a portion of their carrying values may be impaired, in which case a charge to earnings may be necessary. The value of our goodwill may be materially and adversely impacted if businesses we acquire perform in a manner inconsistent with our assumptions. In addition, from time to time we divest businesses, and any such divestiture could result in significant asset impairment and disposition charges, including those related to goodwill and other intangible assets. Any future evaluations requiring an impairment of our goodwill and other intangible assets could materially and adversely affect our results of operations and equity in the period in which the impairment occurs. A material decrease in equity could, in turn, adversely affect our credit ratings. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we are not able to protect our proprietary rights to our databases, software and related products, our ability to market our knowledge and information-related businesses could be hindered and our results of operations, financial position and cash flows could be materially and adversely affected. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on our agreements with customers, confidentiality agreements with employees and third parties, and our trademarks, trade secrets, copyrights and patents to protect our proprietary rights. These legal protections and precautions may not prevent misappropriation of our proprietary information. In addition, substantial litigation regarding intellectual property rights exists in the software industry, and we expect software products to be increasingly subject to third-party infringement claims as the number of products and competitors in this industry segment grows. Such litigation and misappropriation of our proprietary information could hinder our ability to market and sell products and services and our results of operations, financial position and cash flows could be materially and adversely affected. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Any downgrades in our credit ratings could adversely affect our business, financial condition and results of operations. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Claims paying ability, financial strength and debt ratings by Nationally Recognized Statistical Rating Organizations are important factors in establishing the competitive position of insurance companies. Ratings information is broadly disseminated and generally used by customers and creditors. We believe our claims paying ability and financial strength ratings are important factors in marketing our products to certain of our customers. Our credit ratings impact both the cost and availability of future borrowings. Each of the credit rating agencies reviews its ratings periodically. Our ratings reflect each credit rating agency&#8217;s opinion of our financial strength, operating performance and ability to meet our debt obligations or obligations to policyholders. We may not be able to maintain our current credit ratings in the future. Any downgrades in our credit ratings could materially increase our costs of or ability to access funds in the debt capital markets and otherwise materially increase our operating costs.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to the Regulation of Our Business</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our business activities are highly regulated and new laws or regulations or changes in existing laws or regulations or their enforcement or application could materially and adversely affect our business.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are regulated by federal, state and local governments in the United States and other countries where we do business. Our insurance and HMO subsidiaries must be licensed by and are subject to regulation in the jurisdictions in which they conduct </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">business. For example, states require periodic financial reports and enforce minimum capital or restricted cash reserve requirements. Health plans and insurance companies are also regulated under state insurance holding company regulations and some of our activities may be subject to other health care-related regulations and requirements, including those relating to PPOs, MCOs, UR and TPA-related regulations and licensure requirements. Under state guaranty association laws, certain insurance companies can be assessed (up to prescribed limits) for certain obligations to the policyholders and claimants of impaired or insolvent insurance companies which write the same line or similar lines of business. Any such assessment could expose our insurance entities and other insurers to the risk they would be required to pay a portion of an impaired or insolvent insurance company&#8217;s claims through state guaranty associations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our businesses provide products or services to government agencies. For example, some of our Optum and UnitedHealthcare businesses hold government contracts or provide services related to government contracts and are subject to U.S. federal and state and non U.S. self-referral, anti-kickback, medical necessity, risk adjustment, false claims and other laws and regulations governing government contractors and the use of government funds. Our relationships with these government agencies are subject to the terms of contracts we hold with the agencies and to laws and regulations regarding government contracts. Among others, certain laws and regulations restrict or prohibit companies from performing work for government agencies which might be viewed as an actual or potential conflict of interest. These laws may limit our ability to pursue and perform certain types of work, thereby materially and adversely affecting our results of operations, financial position and cash flows. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our Optum businesses are also subject to regulations distinct from those faced by our insurance and HMO subsidiaries, some of which could impact our relationships with physicians, hospitals and customers. These regulations include state telemedicine regulations; debt collection laws; banking regulations; distributor and producer licensing requirements; state corporate practice of medicine doctrines; fee-splitting rules; and health care facility licensure and certificate of need requirements. These risks and uncertainties may materially and adversely affect our ability to market or provide our products and services, or to do so at targeted operating margins, or may increase the regulatory burdens under which we operate.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The laws and rules governing our businesses and interpretations of those laws and rules are subject to frequent change. For example, legislative, administrative and public policy changes to the ACA have been and likely will continue to be considered, and we cannot predict if the ACA will be further modified. Litigation challenges have been brought seeking to invalidate the ACA in whole or in part and future litigation challenges are possible. Further, the integration into our businesses of entities we acquire may affect the way in which existing laws and rules apply to us, including by subjecting us to laws and rules which did not previously apply to us. The broad latitude given to the agencies administering, interpreting and enforcing current and future regulations governing our businesses could force us to change how we do business, restrict revenue and enrollment growth, increase our health care and administrative costs and capital requirements, or expose us to increased liability in courts for coverage determinations, contract interpretation and other actions.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also must obtain and maintain regulatory approvals to market many of our products and services, increase prices for certain regulated products and services and complete certain acquisitions and dispositions or integrate certain acquisitions. For example, premium rates for our health insurance and managed care products are subject to regulatory review or approval in many states and by the federal government. Additionally, we must submit data on all proposed rate increases on many of our products to HHS for monitoring purposes. Geographic and product expansions of our businesses may be subject to state and federal regulatory approvals. Delays in obtaining necessary approvals or our failure to obtain or maintain adequate approvals could materially and adversely affect our results of operations, financial position and cash flows. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our businesses operate internationally and are subject to regulation in the jurisdictions in which they are organized or conduct business. These regulatory regimes encompass, among other matters, local and cross-border taxation, licensing, tariffs, intellectual property, investment, capital (including minimum solvency margin and reserve requirements), management control, labor, anti-fraud, anti-corruption and privacy and data protection regulations (including requirements for cross-border data transfers) which vary by jurisdiction. We currently operate outside of the United States and in the future may acquire or commence additional businesses based outside of the United States, increasing our exposure to non-U.S. regulatory regimes.&#160;For example, our UnitedHealthcare Global business subjects us to Brazilian laws and regulations affecting hospitals, managed care and insurance industries and to regulation by Brazilian regulators, including the national regulatory agency for private health insurance and plans, the Ag&#234;ncia Nacional de Sa&#250;de Suplementar, while our Banm&#233;dica business is subject to Chilean, Colombian and Peruvian laws, regulations and regulators applicable to hospitals and private insurance. Any international regulator may take an approach to the interpretation, implementation and enforcement of industry regulations which could differ from the approach taken by U.S. regulators. In addition, our non-U.S. businesses and operations are subject to U.S. laws regulating the conduct and activities of U.S.-based businesses operating abroad, such as the FCPA, which prohibits offering, promising, providing or authorizing others to give anything of value to a foreign government official to obtain or retain business or otherwise secure a business advantage. Our failure to comply with U.S. or non-U.S. laws and regulations governing our conduct outside the United States or to establish constructive relations with non-U.S. regulators could adversely </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">affect our ability to market our products and services, or to do so at targeted operating margins which may have a material adverse effect on our business, financial condition and results of operations. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The health care industry is regularly subject to negative publicity, including as a result of governmental investigations, adverse media coverage and political debate surrounding industry regulation. Negative publicity may adversely affect our stock price and damage our reputation in various markets.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As a result of our participation in various government health care programs, both as a payer and as a service provider to payers, we are exposed to additional risks associated with program funding, enrollments, payment adjustments, audits and government investigations which could materially and adversely affect our business, results of operations, financial position and cash flows. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We participate in various federal, state and local government health care benefit programs, including as a payer in Medicare Advantage, Medicare Part D, various Medicaid programs and CHIP, and receive substantial revenues from these programs. Certain of our Optum businesses also provide services to payers participating in government health care programs. A reduction or less than expected increase, or a protracted delay, in government funding for these programs or change in allocation methodologies, or termination of the contract at the option of the government, may materially and adversely affect our results of operations, financial position and cash flows.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The government health care programs in which we participate generally are subject to frequent changes, including changes which may reduce the number of persons enrolled or eligible for coverage, reduce the amount of reimbursement or payment levels, reduce our participation in certain service areas or markets, or increase our administrative or medical costs under such programs. Revenues for these programs depend on periodic funding from the federal government or applicable state governments and allocation of the funding through various payment mechanisms. Funding for these government programs depends on many factors outside of our control, including general economic conditions and budgetary constraints at the federal or applicable state level. For example, CMS has in the past reduced or frozen Medicare Advantage benchmarks, and additional cuts to Medicare Advantage benchmarks are possible. In addition, from time to time, CMS makes changes to the way it calculates Medicare Advantage risk adjustment payments.&#160;Although we have adjusted members&#8217; benefits and premiums on a selective basis, ceased to offer benefit plans in certain counties, and intensified both our medical and operating cost management in response to the benchmark reductions and other funding pressures, these or other strategies may not fully address the funding pressures in the Medicare Advantage program. In addition, payers in the Medicare Advantage program may be subject to reductions in payments from CMS as a result of decreased funding or recoupment pursuant to government audit. States have also made changes in rates and reimbursements for Medicaid members and audits can result in unexpected recoupments.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Medicaid managed care program, state Medicaid agencies seek bids from eligible health plans to continue their participation in the acute care Medicaid health programs. If we are not successful in obtaining renewals of state Medicaid managed care contracts, we risk losing the members who were enrolled in those Medicaid plans. Under the Medicare Part D program, to qualify for automatic enrollment of low income members, our bids must result in an enrollee premium below a regional benchmark, which is calculated by the government after all regional bids are submitted. If the enrollee premium is not below the government benchmark, we risk losing the members who were auto-assigned to us and will not have additional members auto-assigned to us. In general, our bids are based upon certain assumptions regarding enrollment, utilization, medical costs and other factors. If any of these assumptions is materially incorrect, either as a result of unforeseen changes to the programs on which we bid, implementation of material program or policy changes after our bid submission, or submission by our competitors at lower rates than our bids, our results of operations, financial position and cash flows could be materially and adversely affected.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of the government health care coverage programs in which we participate are subject to the prior satisfaction of certain conditions or performance standards or benchmarks. For example, as part of the ACA, CMS has a system providing various quality bonus payments to Medicare Advantage plans meeting certain quality star ratings at the individual plan or local contract level. The star rating system considers various measures adopted by CMS, including, among others, quality of care, preventive services, chronic illness management, handling of appeals and customer satisfaction. Plans must have a rating of four stars or higher to qualify for bonus payments. If we do not maintain or continue to improve our star ratings, our plans may not be eligible for quality bonuses and we may experience a negative impact on our revenues and the benefits our plans can offer, which could materially and adversely affect the marketability of our plans, our membership levels, results of operations, financial position and cash flows. Any changes in standards or care delivery models applying to government health care programs, including Medicare and Medicaid, or our inability to improve our quality scores and star ratings to meet government performance requirements&#160;or to match the performance of our competitors could result in limitations to our participation in or exclusion from these or other government programs, which in turn could materially and adversely affect our results of operations, financial position and cash flows.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS uses various payment mechanisms to allocate funding for Medicare programs, including adjustment of monthly capitation payments to Medicare Advantage plans and Medicare Part D plans according to the predicted health status of each beneficiary as supported by data from health care providers for Medicare Advantage plans, as well as, for Medicare Part D plans, risk-sharing provisions based on a comparison of costs forecasted in our annual bids to actual prescription drug costs. Some state Medicaid programs utilize a similar process. For example, our UnitedHealthcare Medicare &amp; Retirement and UnitedHealthcare Community &amp; State businesses submit information relating to the health status of enrollees to CMS or state agencies for purposes of determining the amount of certain payments to us. CMS and the Office of Inspector General for HHS periodically perform risk adjustment data validation (RADV) audits of selected Medicare health plans to validate the coding practices of and supporting documentation maintained by health care providers. Certain of our local plans have been selected for such audits, which in the past have resulted and in the future could result in retrospective adjustments to payments made to our health plans, fines, corrective action plans or other adverse action by CMS.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have been and in the future may become involved in routine, regular and special governmental investigations, audits, reviews and assessments. Such investigations, audits, reviews or assessments sometimes arise out of, or prompt claims by private litigants or whistleblowers who, among other allegations, may claim we failed to disclose certain business practices or, as a government contractor, submitted false or erroneous claims to the government. Governmental investigations, audits, reviews and assessments could lead to government actions, which have resulted in, and in the future could result in, adverse publicity, the assessment of damages, civil or criminal fines or penalties, or other sanctions, including restrictions or changes in the way we conduct business, loss of licensure or exclusion from participation in government programs, any of which could have a material adverse effect on our business, results of operations, financial position and cash flows. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our businesses providing pharmacy care services face regulatory and operational risks and uncertainties which may differ from the risks of our other businesses.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide pharmacy care services through our Optum Rx and UnitedHealthcare businesses. Each business is subject to federal and state anti-kickback, beneficiary inducement and other laws governing the relationships of the business with pharmaceutical manufacturers, physicians, pharmacies, customers and consumers. In addition, federal and state legislatures regularly consider new regulations for the industry which could materially affect current industry practices, including potential new legislation and regulations regarding the receipt or disclosure of rebates and other fees from pharmaceutical companies, the development and use of formularies and other utilization management tools, the use of average wholesale prices or other pricing benchmarks, pricing for specialty pharmaceuticals, limited access to networks and pharmacy network reimbursement methodologies. Additionally, various governmental agencies have conducted investigations into certain PBM practices, which have resulted in other PBMs agreeing to civil penalties, including the payment of money and entry into corporate integrity agreements. As a provider of pharmacy benefit management services, Optum Rx is also subject to an increasing number of licensure, registration and other laws and accreditation standards. Optum Rx also conducts business through home delivery, specialty and compounding pharmacies, pharmacies located in community mental health centers and home infusion, which subjects it to extensive federal, state and local laws and regulations, including those of the DEA and individual state controlled substance authorities, the Food and Drug Administration (FDA) and Boards of Pharmacy. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We could face potential claims in connection with purported errors by our home delivery, specialty or compounding or clinic-based pharmacies or the provision of home infusion services, including as a result of the risks inherent in the packaging and distribution of pharmaceuticals and other health care products. Disruptions from any of our home delivery, specialty pharmacy or home infusion services could materially and adversely affect our results of operations, financial position and cash flows.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our pharmacy care services businesses provide services to sponsors of health benefit plans subject to ERISA. A private party or the DOL, which is the agency that enforces ERISA, could assert the fiduciary obligations imposed by the statute apply to some or all of the services provided by our pharmacy care services businesses even where those businesses are not contractually obligated to assume fiduciary obligations. If a court were to determine fiduciary obligations apply, we could be subject to claims for breaches of fiduciary obligations or claims we entered into certain prohibited transactions.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we fail to comply with applicable privacy, security and data laws, regulations and standards, including with respect to third-party service providers utilizing protected personal information on our behalf, our business, reputation, results of operations, financial position and cash flows could be materially and adversely affected. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The collection, maintenance, protection, use, transmission, disclosure and disposal of protected personal information are regulated at the federal, state, international and industry levels and addressed in requirements imposed on us by contracts with customers. These laws, rules and requirements are subject to change. Compliance with new privacy and security laws, regulations and requirements may result in increased operating costs, and may constrain or require us to alter our business model or operations. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internationally, many of the jurisdictions in which we operate have established their own data security and privacy legal framework with which we or our customers must comply. We expect there will continue to be new proposed laws, regulations </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and industry standards concerning privacy, data protection and information security in the European Union, Brazil, Chile, India and other jurisdictions, and we cannot yet determine the impacts such future laws, regulations and standards may have on our businesses or the businesses of our customers. For example, effective May 2018, the European Union&#8217;s General Data Protection Regulation (GDPR) overhauled data protection laws in the European Union. GDPR has imposed more stringent European Union data protection requirements on us or our customers, and prescribed greater penalties for noncompliance. Brazilian privacy legislation, similar in certain respects to GDPR, took effect in September 2020.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our businesses are also subject to the Payment Card Industry Data Security Standard, which is a multifaceted security standard designed to protect payment card account data. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HIPAA requires business associates as well as covered entities to comply with certain privacy and security requirements. While we provide for appropriate protections through our contracts with our third-party service providers and in certain cases assess their security controls, we have limited oversight or control over their actions and practices. Several of our businesses act as business associates to their covered entity customers and, as a result, collect, use, disclose and maintain protected personal information in order to provide services to these customers. HHS administers its audit program to assess HIPAA compliance efforts by covered entities and business associates. An audit resulting in findings or allegations of noncompliance could have a material adverse effect on our results of operations, financial position and cash flows.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our Optum businesses, we maintain a database of administrative and clinical data statistically de-identified in accordance with HIPAA standards. Noncompliance or findings of noncompliance with applicable laws, regulations or requirements, or the occurrence of any privacy or security breach involving the misappropriation, loss or other unauthorized disclosure of protected personal information, whether by us or by one of our third-party service providers, could have a material adverse effect on our reputation and business and, among other consequences, could subject us to mandatory disclosure to the media, loss of existing or new customers, significant increases in the cost of managing and remediating privacy or security incidents, and material fines, penalties and litigation awards. Any of these consequences could have a material and adverse effect on our results of operations, financial position and cash flows.</span></div><div style="margin-top:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restrictions on our ability to obtain funds from our regulated subsidiaries could materially and adversely affect our results of operations, financial position and cash flows. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because we operate as a holding company, we are dependent on dividends and administrative expense reimbursements from our subsidiaries to fund our obligations. Many of these subsidiaries are regulated by state departments of insurance or similar regulatory authorities. We are also required by law or regulation to maintain specific prescribed minimum amounts of capital in these subsidiaries. The levels of capitalization required depend primarily on the volume of premium revenues generated by the applicable subsidiary. In most states, we are required to seek approval by state regulatory authorities before we transfer money or pay dividends from our regulated subsidiaries exceeding specified amounts. An inability of our regulated subsidiaries to pay dividends to their parent companies in the desired amounts or at the time of our choosing could adversely affect our ability to reinvest in our business through capital expenditures or business acquisitions, as well as our ability to maintain our corporate quarterly dividend payment, repurchase shares of our common stock and repay our debt. If we are unable to obtain sufficient funds from our subsidiaries to fund our obligations, our results of operations, financial position and cash flows could be materially and adversely affected.</span></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_25"></div><div style="margin-top:13.5pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1B.&#160;&#160;&#160;&#160;UNRESOLVED STAFF COMMENTS </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None. </span></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_28"></div><div style="margin-top:13.5pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROPERTIES </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To support our business operations in the United States and other countries we own and lease real properties. Our various reportable segments use these facilities for their respective business purposes, and we believe these current facilities are suitable for their respective uses and are adequate for our anticipated future needs.</span></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_31"></div><div style="margin-top:13.5pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.&#160;&#160;&#160;&#160;LEGAL PROCEEDINGS</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item 3 is incorporated herein by reference to the information set forth under the captions &#8220;Legal Matters&#8221; and &#8220;Governmental Investigations, Audits and Reviews&#8221; in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_217">Note 12 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_217"> and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_217">Supplementary</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_217"> Data</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_217">&#8221;</a></span></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_34"></div><div style="margin-top:13.5pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MINE SAFETY DISCLOSURES</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not Applicable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span><br/></span></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_37"></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_40"></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MARKET AND HOLDERS</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is traded on the New York Stock Exchange (NYSE) under the symbol UNH. On January 31, 2022, there were 10,644 registered holders of record of our common stock. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DIVIDEND POLICY </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, the Company&#8217;s Board of Directors increased the Company&#8217;s quarterly cash dividend to shareholders to an annual rate of $5.80 compared to $5.00 per share, which the Company had paid since June 2020. Declaration and payment of future quarterly dividends is at the discretion of the Board and may be adjusted as business needs or market conditions change.</span></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_43"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ISSUER PURCHASES OF EQUITY SECURITIES</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 1997, our Board of Directors adopted a share repurchase program, which the Board evaluates periodically. There is no established expiration date for the program. During the fourth quarter of 2021, we repurchased 2.3 million shares at an average price of $447.99 per share. As of December 31, 2021, we had Board authorization to purchase up to 45 million shares of our common stock.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_46"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PERFORMANCE GRAPH</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following performance graph compares the cumulative five-year total return to shareholders on our common stock relative to the cumulative total returns of the S&amp;P Health Care Index, the Dow Jones US Industrial Average Index and the S&amp;P 500 index for the five-year period ended December&#160;31, 2021. The comparisons assume the investment of $100 on December&#160;31, 2016 in our common stock and in each index, and dividends were reinvested when paid. </span></div><div style="margin-top:6pt;text-align:center"><img src="unh-20211231_g2.jpg" alt="unh-20211231_g2.jpg" style="height:573px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:34.289%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.329%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/16</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/17</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/18</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/19</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/20</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/21</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">UnitedHealth Group</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.00</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">139.82</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">160.13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">192.13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">232.87</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">338.16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">S&amp;P Health Care Index</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.00</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">122.08</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">129.97</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">157.04</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">178.15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">224.70</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dow Jones US Industrial Average</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.00</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">128.11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">123.65</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">154.99</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">170.06</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">205.68</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">S&amp;P 500 Index</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.00</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">121.83</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">116.49</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">153.17</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">181.35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">233.41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The stock price performance included in this graph is not necessarily indicative of future stock price performance. </span></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_49"></div><div style="margin-top:15pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;6. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">[Reserved]</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-72pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_52"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;7. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion should be read together with the accompanying </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_73">Consolidated Financial Statements and Notes to the Consolidated Financial Statements thereto included in Part II Item 8, &#8220;Financial Statements</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_73"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_73">and Supplementary Data</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221; Readers are cautioned the statements, estimates, projections or outlook contained in this report, including discussions regarding financial prospects, economic conditions, trends and uncertainties contained in this Item 7, may constitute forward-looking statements within the meaning of the PSLRA. These forward-looking statements involve risks and uncertainties which may cause our actual results to differ materially from the expectations expressed or implied in the forward-looking statements. A description of some of the risks and uncertainties can be found further below in this Item 7 and in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_22">Part I, Item 1A, &#8220;Risk Factors.&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discussions of year-over-year comparisons between 2020 and 2019 are not included in this Form 10-K and can be found in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176621000013/unh-20201231.htm">Part II, Item 7, &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Company&#8217;s Form 10-K for the fiscal year ended&#160;December 31, 2020.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EXECUTIVE OVERVIEW </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealth Group is a diversified health care company with a mission to help people live healthier lives and help make the health system work better for everyone. Our two complementary businesses &#8212; Optum and UnitedHealthcare &#8212; are driven by this unified mission and vision to improve health care access, affordability, experiences and outcomes for the individuals and organizations we are privileged to serve.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have four reportable segments across our two business platforms, Optum and UnitedHealthcare:</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Optum Health;</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Optum Insight;</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Optum Rx; and</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">UnitedHealthcare, which includes UnitedHealthcare Employer&#160;&amp; Individual, UnitedHealthcare Medicare&#160;&amp; Retirement, UnitedHealthcare Community&#160;&amp; State and UnitedHealthcare Global.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further information on our business and reportable segments is presented in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_13">Part I, Item 1, &#8220;Business&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and in</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_223"> Note 13 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_223"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_223">and Supplementary Data</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_223">.</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_223">&#8221;</a></span></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_55"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Trends</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our businesses participate in the United States, South America and certain other international health markets. In the United States, health care spending has grown consistently for many years and comprises 18% of gross domestic product (GDP). We expect overall spending on health care to continue to grow in the future, due to inflation, medical technology and pharmaceutical advancement, regulatory requirements, demographic trends in the population and national interest in health and well-being. The rate of market growth may be affected by a variety of factors, including macroeconomic conditions, such as the economic impact of COVID-19, and regulatory changes, which could impact our results of operations, including our continued efforts to control health care costs.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pricing Trends.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> To price our health care benefit products, we start with our view of expected future costs, including any potential impacts from COVID-19. We frequently evaluate and adjust our approach in each of the local markets we serve, considering relevant factors, such as product positioning, price competitiveness and environmental, competitive, legislative and regulatory considerations, including minimum MLR thresholds. We will continue seeking to balance growth and profitability across all of these dimensions. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The commercial risk market remains highly competitive in the small group, large group and individual segments. We expect broad-based competition to continue as the industry adapts to individual and employer needs.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare Advantage funding continues to be pressured, as discussed below in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_58">&#8220;Regulatory Trends and Uncertainties.&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect Medicaid revenue growth due to anticipated changes in mix and pricing trends; we also believe the payment rate environment creates the risk of continued downward pressure on Medicaid margin percentages. We continue to take a prudent, market-sustainable posture for both new business and maintenance of existing relationships. We continue to advocate for actuarially sound rates commensurate with our medical cost trends and we remain dedicated to partnering with those states that are committed to the long-term viability of their programs.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical Cost Trends. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our medical cost trends primarily relate to changes in unit costs, health system utilization and prescription drug costs. COVID-19 related care costs as well as the deferral of care have impacted medical cost trends in 2021 and may continue to do so in 2022 and subsequent years. Future medical cost trends may be impacted by increased consumer demand for care, potentially even higher acuity care, due to the temporary deferral of care since the onset of the pandemic. We endeavor to mitigate those increases by engaging physicians and consumers with information and helping them make clinically sound choices, with the objective of helping them achieve high-quality, affordable care. The continued uncertain impact of COVID-19 may impact our ability to estimate medical costs payable, which has resulted in, and could continue to result in, increased variability to medical cost reserve development.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Delivery System and Payment Modernization.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The health care market continues to change based on demographic shifts, new regulations, political forces and both payer and patient expectations. Health plans and care providers are being called upon to work together to close gaps in care and improve overall care quality, improve the health of populations and reduce costs. We continue to see a greater number of people enrolled in plans with underlying performance-based care provider payment models rewarding high-quality, affordable care and foster collaboration. We work together with clinicians to leverage our data and analytics to provide the necessary information to close gaps in care and improve overall health outcomes for patients.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This trend is creating needs for health management services which can coordinate care around the primary care physician, including new primary care channels, and for investments in new clinical and administrative information and management systems, which we believe provide growth opportunities for our Optum business platform. </span></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_58"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulatory Trends and Uncertainties</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following is a summary of management&#8217;s view of the trends and uncertainties related to regulatory matters. For additional information regarding regulatory trends and uncertainties, see </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_19">Part I, Item&#160;1 &#8220;Business - Government Regulation&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_22">Item&#160;1A, &#8220;Risk Factors.&#8221;</a></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare Advantage Rates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Final 2022 Medicare Advantage rates resulted in an increase in industry base rates of approximately 4.1%, short of the industry forward medical cost trend, creating continued pressure in the Medicare Advantage program. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ongoing Medicare Advantage funding pressure places continued importance on effective medical management and ongoing improvements in administrative efficiency. There are a number of adjustments we have made to partially offset these rate pressures and reductions. In some years, these adjustments impact the majority of the seniors we serve through Medicare Advantage. For example, we seek to intensify our medical and operating cost management, make changes to the size and composition of our care provider networks, adjust members' benefits and implement or increase the member premiums supplementing the monthly payments we receive from the government. Additionally, we decide annually on a county-by-county basis where we will offer Medicare Advantage plans.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Medicare Advantage rates are currently enhanced by CMS quality bonuses in certain counties based on our local plans&#8217; Star ratings. The level of Star ratings from CMS, based upon specified clinical and operational performance standards, will impact future quality bonuses. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ACA Tax (Health Insurance Tax). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Insurance Tax was permanently repealed by Congress, effective January 1, 2021. The permanent repeal of the tax impacts year-over-year comparability of our financial statements, including revenues, operating costs, medical care ratio (MCR), operating cost ratio, effective tax rate and cash flows from operations.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 Trends and Uncertainties</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to evolve and the ultimate impact on our business, results of operations, financial condition and cash flows remains uncertain. In 2021, overall care activity continued to increase, including a mix of temporary deferral of care activity and COVID-19 related care costs. The temporary deferral of care was more than offset by COVID-19 related care and testing costs, rebate requirements and other revenue impacts and general economic impacts. In future periods, care patterns may moderately exceed normal baselines as previously deferred care is obtained and acuity temporarily rises due to missed regular care. From time to time, health system capacity may be subject to possible increased volatility due to the pandemic. Specific trends and uncertainties related to our two business platforms are as follows:</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Optum.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> COVID-19 related care costs continued to impact our Optum Health value-based care delivery businesses, which were partially offset by the continued temporary deferral of care. The temporary deferral of care reduced fee-for-service care delivery volume, as well as Optum Insight and Optum Rx volume-based business activity, although we expect the impact to continue decreasing as care returns to, and potentially exceeds, normal levels. We believe COVID-19 will continue to influence customer and consumer behavior, both during and after the pandemic, which could impact how and where care is delivered and the manner in which consumers wish to receive their prescription drugs or infusion services. As a result of the dynamic situation and broad-reaching impact to the health system, the ultimate impact of COVID-19 on our Optum businesses is uncertain.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">UnitedHealthcare.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In 2021, we continued expanded benefit coverage in areas such as COVID-19 related care and testing, telemedicine, and pharmacy; we also continued to assist our customers, care providers, members and communities in addressing the COVID-19 crisis. UnitedHealthcare&#8217;s 2021 results of operations were negatively impacted by COVID-19 related care and testing, rebate requirements and other revenue impacts, as well as broader economic impacts, partially offset by the continued deferral of care. The increase in people served through Medicaid was attributable in part to continuing action by states to ease eligibility redetermination requirements due to the COVID-19 public health emergency.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disrupted care patterns, as a result of the pandemic, have affected and may continue to temporarily affect the ability to obtain complete member health status information, impacting revenue in businesses utilizing risk adjustment methodologies. The ultimate overall impact is uncertain and dependent on the future pacing, intensity and duration of the pandemic, the severity of new variants of the COVID-19 virus, the effectiveness and extent of administration of vaccination and treatments and general economic uncertainty.</span></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_61"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SELECTED OPERATING PERFORMANCE ITEMS</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents a summary of select 2021 year-over-year operating comparisons to 2020.</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Consolidated revenues increased by 12%, UnitedHealthcare revenues increased 11% and Optum revenues grew 14%. </span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">UnitedHealthcare served 2.1 million more people domestically, primarily driven by growth in community and senior programs.</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Earnings from operations increased by 7%, including an increase of 19% at Optum, partially offset by a decrease of 3% at UnitedHealthcare.</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Diluted earnings per common share increased 13% to $18.08. </span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Cash flows from operations were $22.3 billion.</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Return on equity was 25.2%.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RESULTS SUMMARY</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our consolidated results of operations and other financial information:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:43.164%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.522%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except percentages and per share data)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">226,233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">201,478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">189,699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,437&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,603&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,973&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment and other income</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">287,597&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">257,141&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">242,155&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,456&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">186,911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">159,396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">156,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27,515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42,579&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41,704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35,193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31,034&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,745&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,720&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">263,627&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">234,736&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">222,470&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,891&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,970&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,405&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,685&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,565&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,660)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,663)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,704)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,310&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,742&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,981&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,568&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,578)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,973)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,742)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,732&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,769&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,239&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,963&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings attributable to noncontrolling interests</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(447)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(366)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(400)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings attributable to UnitedHealth Group common shareholders</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,285&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,403&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,839&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,882&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted earnings per share attributable to UnitedHealth Group common shareholders</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.08&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16.03&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14.33&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.05&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical care ratio (a)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">82.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">79.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">82.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating cost ratio</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating margin</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings margin (b)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Return on equity (c)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%;text-decoration:underline">________ </span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:18.13pt">Medical care ratio is calculated as medical costs divided by premium revenue.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.68pt">Net earnings margin attributable to UnitedHealth Group shareholders.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:18.13pt">Return on equity is calculated as net earnings attributable to UnitedHealth Group common shareholders divided by average shareholders&#8217; equity. Average shareholders&#8217; equity is calculated using the shareholders&#8217; equity balance at the end of the preceding year and the shareholders&#8217; equity balances at the end of each of the four quarters of the year presented.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 RESULTS OF OPERATIONS COMPARED TO 2020 RESULTS</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Financial Results</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increases in revenues were primarily driven by the increase in the number of individuals served through Medicare Advantage, Medicaid and commercial offerings; pricing trends; and organic and acquisition growth across the Optum business, primarily due to expansion in care delivery. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical Costs and MCR</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical costs increased as a result of growth in people served through Medicare Advantage, Medicaid and commercial offerings, as well as increased COVID-19 related care costs and medical cost trends, partially offset by higher temporary care deferrals. The MCR increased due to increased COVID-19 related care costs and the permanent repeal of the Health Insurance Tax, partially offset by increased temporary care deferrals. Medical costs and the MCR were also impacted by increased prior year favorable reserve development.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Cost Ratio</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operating cost ratio decreased primarily due to the permanent repeal of the Health Insurance Tax, COVID-19 impacts on revenue and operating costs in the prior year and operating efficiency gains, partially offset by business mix.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax Rate</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate decreased primarily due to the permanent repeal of the nondeductible Health Insurance Tax.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reportable Segments</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_223">Note 13 of Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_223"> and Supplement</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_223">ary Data</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_223"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_223">&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information on our segments. We utilize various metrics to evaluate and manage our reportable segments, including individuals served by UnitedHealthcare by major market segment and funding arrangement, people served by Optum Health and adjusted scripts for Optum Rx. These metrics are the main drivers of revenue, earnings and cash flows at each business. The metrics also allow management and investors to evaluate and understand business mix, including the mix of care delivered through accountable care models at Optum Health, customer penetration and pricing trends when comparing the metrics to revenue by segment.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a summary of the reportable segment financial information:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:43.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.060%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.060%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.060%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.273%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except percentages)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenues</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">UnitedHealthcare</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">222,899&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">193,842&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Optum Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54,065&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39,808&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,317&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,257&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Optum Insight</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,006&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Optum Rx</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">91,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87,498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74,288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,816&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Optum eliminations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,013)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,800)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,661)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(213)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Optum</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">155,565&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">136,308&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">112,950&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,257&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Eliminations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(90,867)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(80,042)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(64,637)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(10,825)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Consolidated revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">287,597&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">257,141&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">242,155&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,456&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Earnings from operations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">UnitedHealthcare</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(384)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Optum Health</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,462&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,434&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,963&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,028&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Optum Insight</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,725&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,494&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Optum Rx</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,902&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Optum</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,995&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,046&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,359&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,949&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Consolidated earnings from operations</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,970&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,405&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,685&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,565&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating margin</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">UnitedHealthcare</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Optum Health</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Optum Insight</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Optum Rx</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Optum</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Consolidated operating margin</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">UnitedHealthcare</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes UnitedHealthcare revenues by business:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:48.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.697%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except percentages)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Employer &amp; Individual</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,023&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,872&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,945&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,151&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Medicare &amp; Retirement</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,788&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Community &amp; State</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,979&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,487&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,790&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Global</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,752&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,855&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">593&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total UnitedHealthcare revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222,899&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,875&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,842&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,024&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the number of individuals served by our UnitedHealthcare businesses, by major market segment and funding arrangement:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:45.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.580%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-based</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,985&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,575&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee-based</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,595&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total commercial</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,580&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,220&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,760&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Advantage</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,490&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,710&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,270&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">780&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,035&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Supplement (Standardized)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,460&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total community and senior</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,540&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,790&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,670&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total UnitedHealthcare - domestic medical</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,120&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,010&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,430&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,110&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,720&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total UnitedHealthcare - medical</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,630&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,435&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,150&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,195&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental Data:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Part D stand-alone</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,045&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(345)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial business increased primarily due to acquisitions in risk-based and fee-based offerings and organic growth in innovative products. Medicare Advantage increased due to growth in people served through individual and group Medicare Advantage plans. The increase in people served through Medicaid was primarily driven by states continuing to ease redetermination requirements due to COVID-19, new state-based awards and growth in people served through Dual Special Needs Plans.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealthcare&#8217;s revenues increased due to growth in the number of individuals served through Medicare Advantage and Medicaid, including a greater mix of people with higher acuity needs, and an increase in the number of individuals served through commercial benefits, partially offset by the permanent repeal of the Health Insurance Tax and the impacts of COVID-19 on risk adjusted business. Earnings from operations decreased due to increased COVID-19 related care costs and the impacts of COVID-19 on risk adjusted business, partially offset by higher temporary deferral of care and growth in people served across our domestic businesses. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Optum</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenues and earnings from operations increased due to growth across the Optum businesses. The results by segment were as follows:</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Optum Health</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues at Optum Health increased primarily due to organic growth in value-based arrangements, acquisitions in care delivery and the impact of COVID-19 at our fee-based businesses as consumers resumed elective care. Earnings from operations increased due to the factors impacting revenues as well as cost management initiatives and increased investment income. COVID-19 related care costs and temporary care deferrals affected earnings from operations at our value-based and fee-based businesses in offsetting manners. Optum Health served approximately 100 million people as of December 31, 2021 compared to 98 million people as of December 31, 2020.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Optum Insight</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues and earnings from operations at Optum Insight increased due to growth in technology and managed services, including expanding relationships serving health systems. Earnings from operations also increased due to productivity gains and cost management initiatives.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Optum Rx</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues and earnings from operations at Optum Rx increased due to higher script volumes from growth in people served, increased utilization and organic growth in pharmacy care services. Earnings from operations also increased as a result of continued supply chain and cost management initiatives. Optum Rx fulfilled 1.4 billion and 1.3 billion adjusted scripts in 2021 and 2020, respectively. In addition to the factors contributing to revenue growth, adjusted scripts also increased due to the dispensing of COVID-19 vaccines.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_64"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LIQUIDITY, FINANCIAL CONDITION AND CAPITAL RESOURCES</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Introduction</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manage our liquidity and financial position in the context of our overall business strategy. We continually forecast and manage our cash, investments, working capital balances and capital structure to meet the short-term and long-term obligations of our businesses while seeking to maintain liquidity and financial flexibility. Cash flows generated from operating activities are principally from earnings before noncash expenses. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our regulated subsidiaries generate significant cash flows from operations and are subject to, among other things, minimum levels of statutory capital, as defined by their respective jurisdictions, and restrictions on the timing and amount of dividends paid to their parent companies.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. regulated subsidiaries paid their parent companies dividends of $8.0 billion and $8.3 billion in 2021 and 2020, respectively. </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_205">See </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_205">Note 10 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_205"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_205">and Supplementary Data</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_205">&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further detail concerning our regulated subsidiary dividends.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our nonregulated businesses also generate significant cash flows from operations available for general corporate use. Cash flows generated by these entities, combined with dividends from our regulated entities and financing through the issuance of long-term debt as well as issuance of commercial paper or the ability to draw under our committed credit facilities, further strengthen our operating and financial flexibility. We use these cash flows to expand our businesses through acquisitions, reinvest in our businesses through capital expenditures, repay debt and return capital to our shareholders through dividends and repurchases of our common stock.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Summary of our Major Sources and Uses of Cash and Cash Equivalents</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:56.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.899%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sources of cash:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash provided by operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuances of long-term debt and short-term borrowings, net of repayments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,994&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from common share issuances</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer funds administered</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,055)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total sources of cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,801&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,877&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,726&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uses of cash:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for acquisitions, net of cash assumed</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,821)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,139)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,343)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,318&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,280)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,584)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,932)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(696)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common share repurchases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,250)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(750)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property, equipment and capitalized software</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,454)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,051)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,071)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(403)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of investments, net of sales and maturities </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,843)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,836)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,504)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of redeemable noncontrolling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,338)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(618)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,338)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,549)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(965)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(619)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(584)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total uses of cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,285)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,825)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,587)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase in cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,454&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,936&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,482)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 Cash Flows Compared to 2020 Cash Flows</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows provided by operating activities were largely consistent, with higher net earnings being offset by changes in working capital accounts. Other significant changes in sources or uses of cash year-over-year included decreased customer funds administered and increased purchases of redeemable noncontrolling interests, share repurchases and cash dividends paid, partially offset by decreased cash paid for acquisitions and net purchases of investments.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Condition</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, our cash, cash equivalent, available-for-sale debt securities and equity securities balances of $65.1 billion included $21.4 billion of cash and cash equivalents (of which $2.8 billion was available for general corporate use), $40.2 billion of debt securities and $3.5 billion of equity securities. Given the significant portion of our portfolio held in cash equivalents, we do not anticipate fluctuations in the aggregate fair value of our financial assets to have a material impact on our liquidity or capital position. Other sources of liquidity, primarily from operating cash flows and our commercial paper program, which is fully supported by our bank credit facilities, reduce the need to sell investments during adverse market conditions. See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_175">Note 4 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_175"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_175">and Supplementary Data</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_175">&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further detail concerning our fair value measurements.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our available-for-sale debt portfolio had a weighted-average duration of 3.9 years and a weighted-average credit rating of &#8220;Double A&#8221; as of December&#160;31, 2021. When multiple credit ratings are available for an individual security, the average of the available ratings is used to determine the weighted-average credit rating.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Capital Resources and Uses of Liquidity</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Requirements. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s cash requirements within the next twelve months include medical costs payable, accounts payable and accrued liabilities, short-term borrowings and current maturities of long-term debt, other current liabilities, and purchase commitments and other obligations. We expect the cash required to meet these obligations to be primarily generated through cash flows from current operations; cash available for general corporate use; and the realization of current assets, such as accounts receivable. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our long-term cash requirements under our various contractual obligations and commitments include:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Debt Obligations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_193">Note 8 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_193"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_193">and Supplementary Data</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_193">&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> for further detail of our long-term debt and the timing of expected future payments. Interest coupon payments are typically paid semi-annually.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:13.8pt">Operating leases.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_217">Note 12 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_217"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_217">and Supplementary Data</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_217">&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> for further detail of our obligations and the timing of expected future payments.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:13.8pt">Purchase and other obligations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> These include $4.7 billion, $2.7 billion of which is expected to be paid within the next twelve months, of fixed or minimum commitments under existing purchase obligations for goods and services, including agreements cancelable with the payment of an early termination penalty, and remaining capital commitments for venture capital funds and other funding commitments. These amounts exclude agreements cancelable without penalty and liabilities to the extent recorded in our Consolidated Balance Sheets as of December 31, 2021.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:13.8pt">Other Liabilities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> These include other long-term liabilities reflected in our Consolidated Balance Sheets as of December 31, 2021, including obligations associated with certain employee benefit programs, unrecognized tax benefits and various long-term liabilities, which have some inherent uncertainty in the timing of these payments.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:13.8pt">Redeemable noncontrolling interests.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_154">Note 2 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_154"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_154">and Supplementary Data</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_154">&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> for further detail. We do not have any material required redemptions in the next twelve months.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect the cash required to meet our long-term obligations to be primarily generated through future cash flows from operations. However, we also have the ability to generate cash to satisfy both our current and long-term requirements through the issuance of commercial paper,  issuance of long-term debt, or drawing under our committed credit facilities or the ability to sell investments. We believe our capital resources are sufficient to meet future, short-term and long-term, liquidity needs.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-Term Borrowings.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our revolving bank credit facilities provide liquidity support for our commercial paper borrowing program, which facilitates the private placement of senior unsecured debt through independent broker-dealers, and are available for general corporate purposes. For more information on our commercial paper and bank credit facilities, see </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_193">Note 8 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_193"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_193">and Supplementary Data</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_193">.</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_193">&#8221;</a></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revolving bank credit facilities contain various covenants, including covenants requiring us to maintain a defined debt to debt-plus-shareholders&#8217; equity ratio of not more than 60%, subject to increase in certain circumstances set forth in the applicable credit agreement. As of December 31, 2021, our debt to debt-plus-shareholders&#8217; equity ratio, as defined and calculated under the credit facilities, was 36%.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Term Debt.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Periodically, we access capital markets to issue long-term debt for general corporate purposes, such as, to meet our working capital requirements, to refinance debt, to finance acquisitions or for share repurchases. For more information on our debt, see </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_193">Note 8 of the Notes to the Consolidated Financial Statements included in Part II, Item 8 &#8220;Financial Statements</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_193"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_193">and Supplementary Data</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_193">.</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_193">&#8221;</a></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Ratings.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our credit ratings as of December&#160;31, 2021 were as follows: </span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"><tr><td style="width:1.0%"></td><td style="width:22.045%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.763%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.434%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.763%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.175%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.615%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.653%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.208%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.257%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Moody&#8217;s</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">S&amp;P Global</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fitch</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">A.M. Best</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ratings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outlook</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ratings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outlook</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ratings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outlook</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ratings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outlook</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured debt</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A+</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stable</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">P-2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A-1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AMB-1+</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The availability of financing in the form of debt or equity is influenced by many factors, including our profitability, operating cash flows, debt levels, credit ratings, debt covenants and other contractual restrictions, regulatory requirements and economic and market conditions. A significant downgrade in our credit ratings or adverse conditions in the capital markets may increase the cost of borrowing for us or limit our access to capital.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Program.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As of December&#160;31, 2021, we had Board authorization to purchase up to 45 million shares of our common stock. For more information on our share repurchase program, see </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_205">Note 10 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements.</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_205">and Supplementary Data</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_205">.</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_205">&#8221;</a></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, the Company&#8217;s Board of Directors increased the Company&#8217;s quarterly cash dividend to shareholders to an annual rate of $5.80 compared to $5.00 per share, which the Company had paid since June 2020. For more information on our dividend, see </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_205">Note 10 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements.</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_205">and Supplementary Data</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_205">.</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_205">&#8221;</a></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pending Acquisitions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In 2021, we entered into agreements to acquire multiple companies in the health care sector, most notably, Change Healthcare (NASDAQ: CHNG), subject to regulatory approval and other customary closing conditions. Additionally, in January 2022, we entered into agreements to acquire multiple companies in the health care sector, subject to regulatory approval and other customary closing conditions. The total anticipated capital required for these acquisitions, excluding the payoff of acquired indebtedness, is approximately $12 billion.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not have other significant contractual obligations or commitments requiring cash resources. However, we continually evaluate opportunities to expand our operations, which include internal development of new products, programs and technology applications and may include acquisitions.</span></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_67"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CRITICAL ACCOUNTING ESTIMATES</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Critical accounting estimates are those estimates requiring management to make challenging, subjective or complex judgments, often because they must estimate the effects of matters inherently uncertain and may change in subsequent periods. Critical accounting estimates involve judgments and uncertainties which are sufficiently sensitive and may result in materially different results under different assumptions and conditions. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medical Costs Payable</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical costs and medical costs payable include estimates of our obligations for medical care services rendered on behalf of consumers, but for which claims have either not yet been received or processed. Depending on the health care professional and type of service, the typical billing lag for services can be up to 90 days from the date of service. Approximately 90% of claims related to medical care services are known and settled within 90 days from the date of service and substantially all within twelve months. As of December&#160;31, 2021, our days outstanding in medical payables was 47 days, calculated as total medical payables divided by total medical costs times the number of days in the period. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In each reporting period, our operating results include the effects of more completely developed medical costs payable estimates associated with previously reported periods. If the revised estimate of prior period medical costs is less than the previous estimate, we will decrease reported medical costs in the current period (favorable development). If the revised estimate of prior period medical costs is more than the previous estimate, we will increase reported medical costs in the current period (unfavorable development). Medical costs in 2021, 2020 and 2019 included favorable medical cost development related to prior years of $1.7 billion, $880 million and $580 million, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In developing our medical costs payable estimates, we apply different estimation methods depending on the month for which incurred claims are being estimated. For example, for the most recent two months, we estimate claim costs incurred by applying observed medical cost trend factors to the average per member per month (PMPM) medical costs incurred in prior months for which more complete claim data is available, supplemented by a review of near-term completion factors.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Completion Factors.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A completion factor is an actuarial estimate, based upon historical experience and analysis of current trends, of the percentage of incurred claims during a given period adjudicated by us at the date of estimation. Completion factors are the most significant factors we use in developing our medical costs payable estimates for periods prior to the most recent two months. Completion factors include judgments in relation to claim submissions such as the time from date of service </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to claim receipt, claim levels and processing cycles, as well as other factors. Our judgments also consider the impacts of COVID-19 on these factors. If actual claims submission rates from providers (which can be influenced by a number of factors, including provider mix and electronic versus manual submissions) or our claim processing patterns are different than estimated, our reserve estimates may be significantly impacted.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table illustrates the sensitivity of these factors and the estimated potential impact on our medical costs payable estimates for those periods as of December&#160;31, 2021: &#160;</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:75.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.595%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Completion Factors<br/>(Decrease) Increase in Factors</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase (Decrease)<br/>In Medical Costs Payable</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.75)%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.50)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.25)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(226)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(452)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(676)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical Cost Per Member Per Month Trend Factors.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Medical cost PMPM trend factors are significant factors we use in developing our medical costs payable estimates for the most recent two months. Medical cost trend factors are developed through a comprehensive analysis of claims incurred in prior months, provider contracting and expected unit costs, benefit design and a review of a broad set of health care utilization indicators, which included consideration of COVID-19. These factors include but are not limited to pharmacy utilization trends, inpatient hospital authorization data and influenza incidence data from the National Centers for Disease Control. We also consider macroeconomic variables such as GDP growth, employment and disposable income. A large number of factors can cause the medical cost trend to vary from our estimates, including: our ability and practices to manage medical and pharmaceutical costs, changes in level and mix of services utilized; mix of benefits offered, including the impact of co-pays and deductibles; changes in medical practices; and catastrophes, epidemics and pandemics, such as COVID-19. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table illustrates the sensitivity of these factors and the estimated potential impact on our medical costs payable estimates for the most recent two months as of December&#160;31, 2021: </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:75.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.595%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medical Cost PMPM Quarterly Trend<br/>Increase (Decrease) in Factors</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase (Decrease)<br/>In Medical Costs Payable</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(298)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(597)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(895)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The completion factors and medical costs PMPM trend factors analyses above include outcomes considered reasonably likely based on our historical experience estimating liabilities for incurred but not reported benefit claims. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management believes the amount of medical costs payable is reasonable and adequate to cover our liability for unpaid claims as of December&#160;31, 2021; however, actual claim payments may differ from established estimates as discussed above. Assuming a hypothetical 1% difference between our December&#160;31, 2021 estimates of medical costs payable and actual medical costs payable, excluding AARP Medicare Supplement Insurance and any potential offsetting impact from premium rebates, 2021 net earnings would have increased or decreased by approximately $184 million. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more detail related to our medical cost estimates, see </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_121">Note 2 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_121"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_121">and Supplementary Data</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_121">.&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate goodwill for impairment annually or more frequently when an event occurs or circumstances change indicating the carrying value may not be recoverable. When testing goodwill for impairment, we may first assess qualitative factors to determine if it is more likely than not the carrying value of a reporting unit exceeds its estimated fair value. During a qualitative analysis, we consider the impact of changes, if any, to the following factors: macroeconomic, industry and market factors; cost </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">factors; changes in overall financial performance; and any other relevant events and uncertainties impacting a reporting unit. If our qualitative assessment indicates a goodwill impairment is more likely than not, we perform additional quantitative analyses. We may also elect to skip the qualitative testing and proceed directly to the quantitative testing. For reporting units where a quantitative analysis is performed, we perform a test measuring the fair values of the reporting units and comparing them to their aggregate carrying values, including goodwill. If the fair value is less than the carrying value of the reporting unit, an impairment is recognized for the difference, up to the carrying amount of goodwill.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the fair values of our reporting units using a discounted cash flow method or a weighted combination of discounted cash flows and a market-based method. The discounted cash flow method includes assumptions about a wide variety of internal and external factors. Significant assumptions used in the discounted cash flow method include financial projections of free cash flow, including revenue trends, medical costs trends, operating productivity, income taxes and capital levels; long-term growth rates for determining terminal value beyond the discretely forecasted periods; and discount rates. Financial projections and long-term growth rates used for our reporting units are consistent with, and use inputs from, our internal long-term business plan and strategies. Discount rates are determined for each reporting unit and include consideration of the implied risk inherent in their forecasts. Our most significant estimate in the discount rate determinations involves our adjustments to the peer company weighted average costs of capital reflecting reporting unit-specific factors. We have not made any adjustments to decrease a discount rate below the calculated peer company weighted average cost of capital for any reporting unit. Company-specific adjustments to discount rates are subjective and thus are difficult to measure with certainty. The passage of time and the availability of additional information regarding areas of uncertainty with respect to the reporting units&#8217; operations could cause these assumptions to change in the future. Additionally, as part of our quantitative impairment testing, we perform various sensitivity analyses on certain key assumptions, such as discount rates, cash flow projections and peer company multiples to analyze the potential for a material impact. The market-based method requires determination of an appropriate peer group whose securities are traded on an active market. The peer group is used to derive market multiples to estimate fair value. As of October 1, 2021, we completed our annual impairment tests for goodwill with all of our reporting units having fair values substantially in excess of their carrying values. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LEGAL MATTERS</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A description of our legal proceedings is presented in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_217">Note 12 of Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_217"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_217">and Supplementary Data</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_217">.&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CONCENTRATIONS OF CREDIT RISK</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in financial instruments such as marketable securities and accounts receivable may subject us to concentrations of credit risk. Our investments in marketable securities are managed under an investment policy authorized by our Board of Directors. This policy limits the amounts which may be invested in any one issuer and generally limits our investments to U.S. government and agency securities, state and municipal securities and corporate debt obligations of investment grade. Concentrations of credit risk with respect to accounts receivable are limited due to the large number of employer groups and other customers constituting our client base. As of December&#160;31, 2021, there were no significant concentrations of credit risk.</span></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_70"></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7A.&#160;&#160;&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary market risks are exposures to changes in interest rates impacting our investment income and interest expense and the fair value of certain of our fixed-rate investments and debt, as well as foreign currency exchange rate risk of the U.S. dollar primarily to the Brazilian real and Chilean peso.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, we had $25 billion of financial assets on which the interest rates received vary with market interest rates, which may significantly impact our investment income. Also as of December&#160;31, 2021, $7 billion of our financial liabilities, which include debt and deposit liabilities, were at interest rates which vary with market rates, either directly or through the use of related interest rate swap contracts.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our fixed-rate investments and debt also varies with market interest rates. As of December&#160;31, 2021, $37 billion of our investments were fixed-rate debt securities and $45 billion of our debt was non-swapped fixed-rate term debt. An increase in market interest rates decreases the market value of fixed-rate investments and fixed-rate debt. Conversely, a decrease in market interest rates increases the market value of fixed-rate investments and fixed-rate debt.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manage exposure to market interest rates by diversifying investments across different fixed-income market sectors and debt across maturities, as well as by matching a portion of our floating-rate assets and liabilities, either directly or through the use of interest rate swap contracts. Unrealized gains and losses on investments in available-for-sale debt securities are reported in comprehensive income.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the impact of hypothetical changes in market interest rates across the entire yield curve by 1% point or 2% points as of December&#160;31, 2021 and 2020 on our investment income and interest expense per annum and the fair value of our investments and debt (in millions, except percentages):</span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:38.164%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.961%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase (Decrease) in Market Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investment<br/>Income&#160;Per<br/>Annum</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest<br/>Expense&#160;Per<br/>Annum</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value&#160;of<br/>Financial Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value&#160;of<br/>Financial Liabilities </span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 %</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,080)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,664)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,564)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,723)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,857&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,892&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase (Decrease) in Market Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investment<br/>Income&#160;Per<br/>Annum</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest<br/>Expense&#160;Per<br/>Annum</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value&#160;of<br/>Financial Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value&#160;of<br/>Financial Liabilities </span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,020)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,700)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,499)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,744)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Note: Given the low absolute level of short-term market rates on our floating-rate assets and liabilities as of December 31, 2021 and 2020, the assumed hypothetical change in interest rates does not reflect the full 100 and 200 basis point reduction in interest income or interest expense, as the rates are assumed not to fall below zero. As of December&#160;31, 2021 and 2020, some of our investments had interest rates below 2% so the assumed hypothetical change in the fair value of investments does not reflect the full 200 basis point reduction.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have an exposure to changes in the value of foreign currencies, primarily the Brazilian real and the Chilean peso, to the U.S. dollar in translation of UnitedHealthcare Global&#8217;s operating results at the average exchange rate over the accounting period, and UnitedHealthcare Global&#8217;s assets and liabilities at the exchange rate at the end of the accounting period. The gains or losses resulting from translating foreign assets and liabilities into U.S. dollars are included in equity and comprehensive income. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An appreciation of the U.S. dollar against the Brazilian real or Chilean peso reduces the carrying value of the net assets denominated in those currencies. For example, as of December&#160;31, 2021, a hypothetical 10% and 25% increase in the value of the U.S. dollar against those currencies would have caused a reduction in net assets of approximately $520 million and $1.1 billion, respectively. We manage exposure to foreign currency earnings risk primarily by conducting our international business operations in their functional currencies.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, we had $<ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-8" name="us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83MC9mcmFnOjcwZTg4ZjQ3NTg2MzQ2ODg5MDI0YzYwYjc1OWFmMjQ3L3RleHRyZWdpb246NzBlODhmNDc1ODYzNDY4ODkwMjRjNjBiNzU5YWYyNDdfMzU1Nw_d469ae36-0045-4bb2-b4f9-f6899f6130e3">3.5</ix:nonFraction> billion of investments in equity securities, primarily consisting of investments in employee savings plan related investments, other venture investments and non-U.S. dollar fixed-income funds. Valuations in non-U.S. dollar funds are subject to foreign exchange rates.&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_73"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 8.&#160;&#160;&#160;&#160;FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:85.850%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.950%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_76">R</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_76">eport of Independent Registered Public Accounting Firm </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_76">(</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_76">PCAOB ID No</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_76"> </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83My9mcmFnOjA5OGE5NzI3MjA4YzQ5NjNhOTdmNGVkZDFiYzAyZTM5L3RhYmxlOmI1MTUwYjZjMjFiODQyOWM5YmE1MGJlYmNmOTBkMjk5L3RhYmxlcmFuZ2U6YjUxNTBiNmMyMWI4NDI5YzliYTUwYmViY2Y5MGQyOTlfMi0wLTEtMS0yMTA4OS90ZXh0cmVnaW9uOmNhNzlmNmFiMTAwZTQ4YjI4MTA2MGM4MWZhZjAxZTc2XzkzNDU4NDg4MzY1MTI_f3eb62e8-4b1f-4840-9029-847328e6b233">34</ix:nonNumeric></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_76">)</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_76">38</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_79">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_79">40</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_85">Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_85">41</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_88">Consolidated Statements of Comprehensive Income</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_88">42</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_91">Consolidated Statements of Changes in Equity</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_91">43</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_97">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_97">44</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_100">Notes to the Consolidated Financial Statements</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_100">45</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_103">1.     Description of Business</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_103">45</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_106">2.     Basis of Presentation, Use of Estimates and Significant Accounting Policies</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_106">45</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_169">3.     Investments</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_169">50</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_175">4.     Fair Value</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_175">51</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_181">5.     Property, Equipment and Capitalized Software</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_181">54</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_184">6.     Goodwill and Other Intangible Assets</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_184">54</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_190">7.     Medical Costs Payable</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_190">55</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_193">8.     Short-Term Borrowings and Long-Term Debt</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_193">57</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_199">9.     Income Taxes</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_199">58</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_205">10.   Shareholders&#8217; Equity</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_205">60</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_211">11.   Share-Based Compensation</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_211">61</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_217">12.   Commitments and Contingencies</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_217">63</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_223">13.   Segment Financial Information</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_223">64</a></span></div></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_76"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the shareholders and the Board of Directors of UnitedHealth Group Incorporated and Subsidiaries:</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of UnitedHealth Group Incorporated and Subsidiaries (the "Company") as of December 31, 2021 and 2020, the related consolidated statements of operations, comprehensive income, changes in equity and cash flows for each of the three years in the period ended December 31, 2021, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2021, in conformity with accounting principles generally accepted in the United States of America.</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company&#8217;s internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control &#8212; Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission, and our report dated February 15, 2022 expressed an unqualified opinion on the Company&#8217;s internal control over financial reporting.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Audit Matters</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matters communicated below are matters arising from the current-period audit of the financial statements that were communicated or required to be communicated to the audit and finance committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Incurred but not Reported (IBNR) Claim Liability - Refer to Notes 2 and 7 to the financial statements.</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Audit Matter Description</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical costs payable includes estimates of the Company&#8217;s obligations for medical care services rendered on behalf of insured consumers, for which claims have either not yet been received or processed. These estimates are referred to as incurred but not reported (IBNR) claim liabilities. At December 31, 2021 the Company&#8217;s IBNR balance was $17 billion. The Company develops IBNR estimates using an actuarial model that requires management to exercise certain judgments in developing its estimates. Judgments made by management include medical cost per member per month trend factors and completion factors, which include assumptions over the time from date of service to claim receipt, the impact of claim levels, processing cycles, and consideration of COVID-19. </span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We identified the IBNR claim liability as a critical audit matter because of the significant assumptions made by management in estimating the liability. This required complex auditor judgment, and an increased extent of effort, including the involvement of actuarial specialists in performing procedures to evaluate the reasonableness of management&#8217;s methods, assumptions and judgments in developing the liability. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">How the Critical Audit Matter Was Addressed in the Audit</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit procedures included the following, among others: </span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We tested the effectiveness of controls over management&#8217;s estimate of the IBNR claim liability balance, including controls over the judgments in both the completion factors and the medical cost per member per month trend factors, as well as controls over the claims and membership data used in the estimation process.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We tested the underlying claims and membership data and other information that served as the basis for the actuarial analysis, to test that the inputs to the actuarial estimate were complete and accurate.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">With the assistance of actuarial specialists, we evaluated the reasonableness of the actuarial methods and assumptions used by management to estimate the IBNR claim liability by: </span></div><div style="margin-top:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Performing an overlay of the historical claims data used in management&#8217;s current year model to the data used in prior periods to validate that there were no material changes to the claims data tested in prior periods. </span></div><div style="margin-top:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Developing an independent estimate of the IBNR claim liability and comparing our estimate to management&#8217;s estimate. </span></div><div style="margin-top:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Performing a retrospective review comparing management&#8217;s prior year estimate of IBNR to claims processed in 2021 with dates of service in 2020 or prior.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill - Refer to Notes 2 and 6 to the financial statements.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Audit Matter Description </span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, the Company&#8217;s goodwill balance was $76 billion. As discussed in Note 2 of the financial statements, for reporting units where a quantitative analysis is performed, the Company performs an annual impairment test measuring the fair values of the reporting units and comparing them to their aggregate carrying values including goodwill. The estimates of the reporting unit fair values are calculated using a discounted cash flow method or a weighted combination of discounted cash flows and a market-based method. The discounted cash flow method includes assumptions about revenue trends, medical cost trends, and operating costs as well as discount rates. The market-based method requires determination of an appropriate group of peer companies whose securities are traded on an active market. The annual impairment test indicated that the fair values of the reporting units exceeded the carrying values as of the impairment testing date; therefore, no impairment was recognized. </span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We identified a critical audit matter related to the quantitative analysis performed for such reporting units because of the significant assumptions made by management to estimate the fair value of the reporting unit. This required increased auditor judgment and extent of effort, including involvement of fair value specialists to evaluate the reasonableness of management&#8217;s estimates and assumptions related to peer company selection and financial projections, which can be impacted by regulatory and macro-economic factors. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">How the Critical Audit Matter Was Addressed in the Audit</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit procedures related to the valuation, business, and market assumptions including the discount rate, financial forecasts, and peer group used by management to estimate the fair value of reporting units where a quantitative analysis was performed,  included the following, among others: </span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We tested the effectiveness of controls over management&#8217;s annual goodwill impairment assessment, including those over the determination of the fair value such as controls related to management&#8217;s financial forecasts, as well as controls over the selection of discount rates, company specific risks, peer companies, and market multiples.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We evaluated management&#8217;s ability to forecast and meet future revenue, medical cost trend, and operating costs by comparing:</span></div><div style="margin-top:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Actual results to historical forecasts.</span></div><div style="margin-top:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Forecasted information to: internal communications to management and the Board of Directors, industry and economic trends, and analyst reports of revenue and earnings expectations for the Company and its peers.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We evaluated the impact of changes in management&#8217;s forecasts from the October 1, 2021 annual measurement date to December 31, 2021.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We evaluated management&#8217;s selection of peer companies and market multiples. </span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">With the assistance of our fair value specialists, we evaluated the reasonableness of (1) the valuation methodologies, including testing the mathematical accuracy of the calculation, (2) the weighting of such valuation methodologies, and (3) discount rate and company specific risks by:</span></div><div style="margin-top:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Testing the source information underlying the determination of the discount rate and the mathematical accuracy of the calculation.</span></div><div style="margin-top:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Developing a range of independent discount rate estimates and comparing to those selected by management.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:42.105%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/ <ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83Ni9mcmFnOjM0NWNkODRiOTVkNTQ0N2RiODRlYzBkZTcwMDFkNzFmL3RhYmxlOmYwYjAwYmIwZTRhMDRkOTliOTM0YjA2NDE0NjIzNjE0L3RhYmxlcmFuZ2U6ZjBiMDBiYjBlNGEwNGQ5OWI5MzRiMDY0MTQ2MjM2MTRfMC0wLTEtMS0yMTExMi90ZXh0cmVnaW9uOjViMzhlYjBmNzhkYzQ3MDE4NjFmZjdhMzNhYzdhOTU5XzkzNDU4NDg4MzYyMzY_e4332571-04c3-4b63-adca-b78c0cd54131">DELOITTE &amp; TOUCHE LLP</ix:nonNumeric></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83Ni9mcmFnOjM0NWNkODRiOTVkNTQ0N2RiODRlYzBkZTcwMDFkNzFmL3RhYmxlOmYwYjAwYmIwZTRhMDRkOTliOTM0YjA2NDE0NjIzNjE0L3RhYmxlcmFuZ2U6ZjBiMDBiYjBlNGEwNGQ5OWI5MzRiMDY0MTQ2MjM2MTRfMi0wLTEtMS0yMTEyNA_652e842c-90f7-490a-9ab6-9c41d76c230a">Minneapolis, Minnesota</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 15, 2022</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company's auditor since 2002.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_79"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealth Group</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Balance Sheets</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:73.973%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMy0yLTEtMS0w_cd779409-64a3-43a5-99df-f09eedb6fd8f">21,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMy00LTEtMS0w_3b70c74f-302b-4189-8671-8a4dc30e1087">16,921</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfNC0yLTEtMS0w_d246d18a-65ab-41e4-b7b1-f871a34fc673">2,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfNC00LTEtMS0w_0fb6a32c-edad-42f3-ba83-445a82ba184b">2,860</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net of allowances of $<ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfNS0wLTEtMS0wL3RleHRyZWdpb246YTljMjI1NGNhNTkyNGQ1YmI0Njg5MzkyMWZiNmZmOTRfNDY_cd489fad-1c5b-4893-b468-e73221992628">954</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfNS0wLTEtMS0wL3RleHRyZWdpb246YTljMjI1NGNhNTkyNGQ1YmI0Njg5MzkyMWZiNmZmOTRfNTM_100d6026-f680-428c-9d0d-d1889bb0cb6a">990</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfNS0yLTEtMS0w_fe639807-2e4d-40f7-97ed-6c3303260600">14,216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfNS00LTEtMS0w_bae96f7f-c97e-4364-a49b-b975959adfcc">12,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current receivables, net of allowances of $<ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfNi0wLTEtMS0wL3RleHRyZWdpb246MmNjMTUzZWFmZmQ3NGIwYThjOWUyNWVlNTliOTJjNjZfNTI_a8a1a6d9-a1ee-4fcd-ae23-776c49bf6798">993</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfNi0wLTEtMS0wL3RleHRyZWdpb246MmNjMTUzZWFmZmQ3NGIwYThjOWUyNWVlNTliOTJjNjZfNTk_7fba9ec2-d364-4d56-ada5-07c2ca355f94">1,047</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfNi0yLTEtMS0w_9f393130-55a8-4ca5-b943-73a5d394fb2f">13,866</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfNi00LTEtMS0w_705fdf72-22b1-49da-b588-2ad598df14a7">12,534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets under management</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="unh:AarpAssetsUnderManagement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfNy0yLTEtMS0w_8fba91ca-a4c0-4588-9fa5-2cb25793fb85">4,449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="unh:AarpAssetsUnderManagement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfNy00LTEtMS0w_de759241-dcb9-4097-9183-fcf139564d6d">4,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfOC0yLTEtMS0w_9055607d-a816-48ce-9428-4016a20c1f8f">5,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfOC00LTEtMS0w_1b2c3d0e-533e-472b-b2b0-0127ac0872c0">4,457</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfOS0yLTEtMS0w_a55e3d19-1def-4418-88b0-40ef21c9a793">61,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfOS00LTEtMS0w_0ef10525-84ce-4e60-92a8-e03ec87f89ff">53,718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTAtMi0xLTEtMA_2c9255a5-92ab-4744-8bee-2e2e118b31d2">43,114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTAtNC0xLTEtMA_aafee307-2639-4d45-97ab-cb5c58cbd637">41,242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, equipment and capitalized software, net of accumulated depreciation and amortization of $<ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjUyYWZjZDM2MWM4NTQ0NTFiZmQ5MDk2MDkyN2E3ZjkyXzEwMg_7feea1c0-f85d-4ceb-b48c-c62630d60222">5,992</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjUyYWZjZDM2MWM4NTQ0NTFiZmQ5MDk2MDkyN2E3ZjkyXzEwOQ_837423b5-9d58-42e0-ac18-dca71d0fe18f">5,230</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTEtMi0xLTEtMA_b920a0f9-65b2-4632-b4e1-3b3b886ec679">8,969</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTEtNC0xLTEtMA_f8fcb175-6ae4-41c4-9747-df62a2529c6e">8,626</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTItMi0xLTEtMA_50cf4417-7b17-4068-8d9f-e4da2a760006">75,795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTItNC0xLTEtMA_0f405123-c4b2-4836-93a8-477c01afb986">71,337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net of accumulated amortization of $<ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTMtMC0xLTEtMC90ZXh0cmVnaW9uOmE5YTk0YTBjNGZhYjRiNmRhNmViYTliNjNkYTRjNjA5XzY0_4554415d-bc90-4a49-a90b-58719fe031d3">5,636</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTMtMC0xLTEtMC90ZXh0cmVnaW9uOmE5YTk0YTBjNGZhYjRiNmRhNmViYTliNjNkYTRjNjA5Xzcx_9c51db6b-e5ba-47f4-8cba-c45941454a96">5,455</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTMtMi0xLTEtMA_cb03cd61-862b-4a6f-9bb4-111f52ec40b2">10,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTMtNC0xLTEtMA_3b236b86-73c5-4520-b7f8-c668d12015ea">10,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTQtMi0xLTEtMA_f0398067-896e-407d-bc08-bdfb2c094514">12,526</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTQtNC0xLTEtMA_91c472a7-21b7-4123-98d3-47f4368473f8">11,510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTUtMi0xLTEtMA_a249f825-efbe-4d35-a708-baccc2b38522">212,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTUtNC0xLTEtMA_5a34ce02-d7a4-4568-93dd-0f3b8341736d">197,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities, redeemable noncontrolling interests and equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTgtMi0xLTEtMA_6c2e5410-2fa6-47f6-86c2-9704e03333a2">24,483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTgtNC0xLTEtMA_e8a50c98-af6f-478b-a032-caf0caa32279">21,872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTktMi0xLTEtMA_ab1b0837-6954-4f6c-b0d9-90e89653d181">24,643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTktNC0xLTEtMA_5bf9aeee-ab0d-4b5a-b802-faaa122833b5">22,495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term borrowings and current maturities of long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjAtMi0xLTEtMA_84629d91-2934-4724-a334-8caa95815ee6">3,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjAtNC0xLTEtMA_2579b1e1-59e6-4d3f-bfd5-b63549cc67d8">4,819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:DeferredRevenueCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjEtMi0xLTEtMA_77db71dd-f0e7-4896-a587-9187a8b6cd46">2,571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:DeferredRevenueCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjEtNC0xLTEtMA_9ad665e9-10d5-4a1f-a566-8d0586461f8d">2,842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjItMi0xLTEtMA_322407d0-67af-4537-b4b0-4864549f2716">22,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjItNC0xLTEtMA_0755851c-d0a9-4cb2-8b97-f99dd2cae94f">20,392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjMtMi0xLTEtMA_ea00d442-30cf-4eac-9c63-e23ef1de75fb">78,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjMtNC0xLTEtMA_5a4d7ecf-ca29-46d0-a1c8-3d80f2b68a38">72,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, less current maturities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjQtMi0xLTEtMA_8234ac10-440a-428a-8099-e46380151cc4">42,383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjQtNC0xLTEtMA_0dca2ff1-ff7a-4ea6-adcd-006decfb2f83">38,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjUtMi0xLTEtMA_e362fd27-32ff-4357-9344-fafe13542fa9">3,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjUtNC0xLTEtMA_66ea0ca9-2363-45dd-8ee6-abff2f770436">3,367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjYtMi0xLTEtMA_4a11b7bc-c169-46a2-b189-cb59629277cb">11,787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjYtNC0xLTEtMA_2bd1a15b-e6e3-4787-b790-b655121c6adf">12,315</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjctMi0xLTEtMA_cb171a3a-edc0-4bef-b735-49edc0c60b2a">135,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjctNC0xLTEtMA_796924f4-8950-4cc3-9fc2-67c0df13c930">126,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_217">Commitments and contingencies (Note 12)</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjgtMi0xLTEtMA_8d87ec26-a91c-4d2e-a5b7-96a066aa088f"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjgtNC0xLTEtMA_002b4f07-229a-4124-8032-c451112e2db7"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjktMi0xLTEtMA_817a9b98-a5bb-4e4f-ba62-912f6efc7247">1,434</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjktNC0xLTEtMA_a03892c9-9d86-4334-b067-49716b1a3644">2,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="3" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOjA1ODYxYjFmMmE1NzQxNmFiOGQyN2JmNWIyZjM1NTU0XzIx_2f6ea2ed-ad7d-4724-baa0-3eca12b9d678"><ix:nonFraction unitRef="usdPerShare" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="3" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOjA1ODYxYjFmMmE1NzQxNmFiOGQyN2JmNWIyZjM1NTU0XzIx_61a92059-4fc3-4a28-8d72-c707d47c9c95">0.001</ix:nonFraction></ix:nonFraction> par value - <ix:nonFraction unitRef="shares" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOjA1ODYxYjFmMmE1NzQxNmFiOGQyN2JmNWIyZjM1NTU0XzM2_26baf73b-9e2d-4d06-b8f3-cf6be835555b"><ix:nonFraction unitRef="shares" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOjA1ODYxYjFmMmE1NzQxNmFiOGQyN2JmNWIyZjM1NTU0XzM2_7d978865-acc5-46e7-a376-63878037b686">10</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOjA1ODYxYjFmMmE1NzQxNmFiOGQyN2JmNWIyZjM1NTU0XzU4_172d1ede-890b-4967-9b94-916a7101cbad"><ix:nonFraction unitRef="shares" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOjA1ODYxYjFmMmE1NzQxNmFiOGQyN2JmNWIyZjM1NTU0XzU4_736d7ec3-fbb5-4f5a-bec7-a0b9c1f4f80b"><ix:nonFraction unitRef="shares" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOjA1ODYxYjFmMmE1NzQxNmFiOGQyN2JmNWIyZjM1NTU0XzU4_c0f5091a-e351-4941-b53a-a213e87f83a1"><ix:nonFraction unitRef="shares" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOjA1ODYxYjFmMmE1NzQxNmFiOGQyN2JmNWIyZjM1NTU0XzU4_df787b4c-dc7f-40cd-a60f-846e1a77954d">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued or outstanding</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzEtMi0xLTEtMA_4750b41a-afa5-4e8d-b43f-9de7bf8046a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzEtNC0xLTEtMA_3e355a9f-6ba4-4174-b989-b3cd195f2956">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:31.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjRhZDBhZjZlZTMxNDRmOTZiYzIyOGQyMmUxMDVlOGRlXzM4NDgyOTA2OTczMTQ_0cefcf86-30b9-4e4c-8690-5b8dca0428c1"><ix:nonFraction unitRef="usdPerShare" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjRhZDBhZjZlZTMxNDRmOTZiYzIyOGQyMmUxMDVlOGRlXzM4NDgyOTA2OTczMTQ_f2a5959a-b7bb-4002-83d8-9fe5345a6a50">0.01</ix:nonFraction></ix:nonFraction> par value - <ix:nonFraction unitRef="shares" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjRhZDBhZjZlZTMxNDRmOTZiYzIyOGQyMmUxMDVlOGRlXzMz_b6a46e0e-e291-43e6-b6ba-dd3457680c27"><ix:nonFraction unitRef="shares" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjRhZDBhZjZlZTMxNDRmOTZiYzIyOGQyMmUxMDVlOGRlXzMz_b710e1cb-4cb8-4111-a217-d08f10723224">3,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjRhZDBhZjZlZTMxNDRmOTZiYzIyOGQyMmUxMDVlOGRlXzU1_6b30c6b2-a7fc-4b84-ad58-b5c499bdfd59"><ix:nonFraction unitRef="shares" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjRhZDBhZjZlZTMxNDRmOTZiYzIyOGQyMmUxMDVlOGRlXzU1_be3aa7f8-6357-43e5-b24d-fa7a2403b8ce">941</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjRhZDBhZjZlZTMxNDRmOTZiYzIyOGQyMmUxMDVlOGRlXzYy_98ee3a52-56dc-4701-a22d-c694d8461279"><ix:nonFraction unitRef="shares" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjRhZDBhZjZlZTMxNDRmOTZiYzIyOGQyMmUxMDVlOGRlXzYy_9b4c0280-584f-4cf8-899e-44cedd4eb1ea">946</ix:nonFraction></ix:nonFraction> issued and outstanding</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzItMi0xLTEtMA_40733e8d-01cc-4337-9f3a-108496902af9">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzItNC0xLTEtMA_34fcfdc9-9510-45a1-8384-925e5c854087">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:AdditionalPaidInCapital" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzMtMi0xLTEtMA_a662bbb7-fa0a-4dc0-8719-75364e9908cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:AdditionalPaidInCapital" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzMtNC0xLTEtMA_9300a829-73a4-489f-87b8-726029e0a67d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzQtMi0xLTEtMA_df064f52-3d6b-40ee-b5e9-2b60d3034258">77,134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzQtNC0xLTEtMA_26c09d0b-c91b-4ca5-b80f-74bd2e6962c0">69,295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzUtMi0xLTEtMA_df855533-e7b2-47f4-872f-06d46ea890f4">5,384</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzUtNC0xLTEtMA_8b1599b9-743f-4995-aa64-723efba42fd4">3,814</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonredeemable noncontrolling interests</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzYtMi0xLTEtMA_a3af60e6-417f-4b17-b845-eb6b6a16f0b4">3,285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzYtNC0xLTEtMA_0ac44cbe-720a-4af0-a3d6-1cc4d12c802e">2,837</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzctMi0xLTEtMA_ae5229a1-71f3-4620-be7a-dea1521f9c8d">75,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzctNC0xLTEtMA_6ae34ebf-5e32-485c-ba15-68d69f856f3d">68,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities, redeemable noncontrolling interests and equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzgtMi0xLTEtMA_b6730042-72c5-4e72-934a-b7b0b77ae231">212,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzgtNC0xLTEtMA_b89e151b-49a4-44dd-846a-a52b4a96d7aa">197,289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:4.5pt;text-align:center"><span><br/></span></div><div style="margin-top:4.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_100"> Notes to the Consolidated Financial Statements </a></span></div><div style="margin-top:6pt;text-align:center"><span><br/></span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_85"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealth Group</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Operations</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:65.322%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.310%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.312%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMy0yLTEtMS0w_84bb5df9-b17a-446f-a239-8d275cb02aff">226,233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMy00LTEtMS0w_5acaac04-5d09-403a-9f67-411f85598f85">201,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMy02LTEtMS0w_dac321e7-aa5e-41f0-be60-096afdb1c38d">189,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8980da815bc14d658ecbcb83b1249903_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfNC0yLTEtMS0w_af511d2e-18c9-491b-a546-8f34367c74eb">34,437</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22e79815a5ab4c57ac20424b76b26acf_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfNC00LTEtMS0w_a8eb0764-a395-443e-a12d-c4ff65e4dc88">34,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87aa1e3370624fd2bcbec006cd442de0_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfNC02LTEtMS0w_adecf77d-d893-484a-856e-4dd8a34d82cc">31,597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f930a7c88bf48e19ee77868a67beb2c_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfNS0yLTEtMS0w_a3d6036a-d1dc-4534-9d15-6ba13a6783ae">24,603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebfb5141726d4790b2d5d6623285f2f3_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfNS00LTEtMS0w_7abb88c9-5968-432d-a733-f3143f1474ec">20,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb730d55174e422ba5041871ed73019a_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfNS02LTEtMS0w_cec69175-b9ff-458f-8aae-5d0ff2b493d4">18,973</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment and other income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfNi0yLTEtMS0w_a78d4780-ab87-4bde-8808-5e4c9892b15d">2,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfNi00LTEtMS0w_86518046-fa03-418a-8db5-1051371b28b3">1,502</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfNi02LTEtMS0w_3e0ca0b1-398c-47d1-a11c-f5a1ce085338">1,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfNy0yLTEtMS0w_cfc3e30d-3844-4e9a-a001-4c4c4b440033">287,597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfNy00LTEtMS0w_d27847eb-10a6-4c25-b9a8-93d260f6a870">257,141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfNy02LTEtMS0w_4fa7fe33-1973-4ae4-b1e4-48aa4013b73e">242,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfOS0yLTEtMS0w_7c465397-6454-44ee-ae82-d5f8850ca869">186,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfOS00LTEtMS0w_44b6f981-f673-4913-9914-99ed678effc4">159,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfOS02LTEtMS0w_ebb56291-f8dd-486e-ba08-26e46c15b9cf">156,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTAtMi0xLTEtMA_04938e77-5935-4192-80e3-688806d6e2ce">42,579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTAtNC0xLTEtMA_3c4bdd97-6002-4f5e-95ce-a9e0e212a531">41,704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTAtNi0xLTEtMA_293c3220-3884-4017-a98e-172e83428b65">35,193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTEtMi0xLTEtMA_4ff535ee-5b02-4667-a7e0-eb25c9256e5b">31,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTEtNC0xLTEtMA_1b5d2cf8-7028-4f86-91a0-083b19fd046c">30,745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTEtNi0xLTEtMA_76e5b4e6-6a93-47f1-af9f-82b76ec9c242">28,117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTItMi0xLTEtMA_d19f8b56-e8b8-4f51-9b82-e9aaca64d2f2">3,103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTItNC0xLTEtMA_7105bf44-36f2-4850-99ad-bf47435bd015">2,891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTItNi0xLTEtMA_066a0ac1-2282-465f-a12c-30796bd66abf">2,720</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTMtMi0xLTEtMA_f86a9bb9-07f4-4b84-88b9-1d4ebea737bc">263,627</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTMtNC0xLTEtMA_e693363b-122c-47bd-9bc3-bc35b0941cac">234,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTMtNi0xLTEtMA_6a1e2409-b46b-4c1e-9526-3a7f450065b2">222,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTQtMi0xLTEtMA_cd39d0f8-2ad8-4bb3-9408-4aeaff1a3db0">23,970</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTQtNC0xLTEtMA_f0e01243-5474-47be-b9c3-198162de19a3">22,405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTQtNi0xLTEtMA_dfba6d52-a48a-40f8-82ec-81d1a1ca4276">19,685</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTUtMi0xLTEtMA_d4845875-fd81-42dd-9b1b-e2ef36a61e75">1,660</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTUtNC0xLTEtMA_f5f46206-687c-4f97-9b97-31c3731983bf">1,663</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTUtNi0xLTEtMA_13300a3a-0adf-4234-89b8-8ab3fd4945fc">1,704</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTYtMi0xLTEtMA_9281586d-3223-45d2-af23-704e75bad888">22,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTYtNC0xLTEtMA_828eada2-c344-4da9-924f-df268314feec">20,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTYtNi0xLTEtMA_416e46ef-bc98-4801-9ce6-72c47797048b">17,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTctMi0xLTEtMA_93e49c7b-2437-433b-a94f-0162476df7ee">4,578</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTctNC0xLTEtMA_2fb68ca1-8986-4660-8891-bb2bf68c66f7">4,973</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTctNi0xLTEtMA_ad7e301e-1abf-44c4-b973-cdd01592cfd3">3,742</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTgtMi0xLTEtMA_e4b384bb-daa4-461e-9482-6b00b75b0e8a">17,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTgtNC0xLTEtMA_2ee587ba-3afb-4601-bfab-5d78d0114921">15,769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTgtNi0xLTEtMA_4951c554-0edd-4f5e-a511-560a3690d1cf">14,239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings attributable to noncontrolling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTktMi0xLTEtMA_503fd3f9-d945-4352-9156-d97556f2bc6a">447</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTktNC0xLTEtMA_f4262f76-f3e9-43ef-b868-12015de69824">366</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTktNi0xLTEtMA_08851fde-1fc6-48fb-9358-5fd4e5b69c75">400</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earnings attributable to UnitedHealth Group common shareholders</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjAtMi0xLTEtMA_4aee8033-5e5a-4013-8960-daa778badb4c">17,285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjAtNC0xLTEtMA_ee204361-e344-4c19-ab0c-4ba72592a9d8">15,403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjAtNi0xLTEtMA_5953d854-2df7-43aa-84c8-f1009ac1fe9b">13,839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to UnitedHealth Group common shareholders:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjItMi0xLTEtMA_c7fd744b-3556-4585-9349-b215e7ebccce">18.33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjItNC0xLTEtMA_1225d87e-116e-4ce9-9d2c-069c76a7a7bc">16.23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjItNi0xLTEtMA_565144c9-c0e1-41bc-96c2-921923b3e4a9">14.55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjMtMi0xLTEtMA_8dea8a96-d56d-4db1-971d-5a6f9b7d3438">18.08</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjMtNC0xLTEtMA_df4a3622-81a7-4280-9d95-d49350121fc5">16.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjMtNi0xLTEtMA_842c3d2f-9cb1-4c3d-8aea-52e142c036fd">14.33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic weighted-average number of common shares outstanding</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjQtMi0xLTEtMA_3246699a-1997-4c73-8ed8-182685c89db3">943</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjQtNC0xLTEtMA_205470cb-de33-46ab-9043-3927ebf0d32a">949</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjQtNi0xLTEtMA_2c8331fb-3cc8-4528-887d-836ce939ef6d">951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dilutive effect of common share equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjUtMi0xLTEtMA_c9a20dc4-6909-432d-811c-b0ddda7d07c3">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjUtNC0xLTEtMA_b62f8151-2113-40a7-a087-5656fab54ab6">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjUtNi0xLTEtMA_0f22de38-e445-46ef-a209-fd860709879b">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted weighted-average number of common shares outstanding</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjYtMi0xLTEtMA_d622010a-fea6-48e9-a20d-f4a81fee96cf">956</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjYtNC0xLTEtMA_714ae457-85b8-42f0-aa13-4bd5a9f5df32">961</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjYtNi0xLTEtMA_f61af70c-1384-485e-ae5a-290d147cb604">966</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjctMi0xLTEtMA_cc3c82fd-bf00-4a1e-b7bf-0f56902c8690">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjctNC0xLTEtMA_42fe91fe-e5fb-4ce3-89fb-3ab5b2888aa0">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjctNi0xLTEtMA_dc76cbcf-5fcb-456b-add4-62db65469903">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:4.5pt;text-align:center"><span><br/></span></div><div style="margin-top:4.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_100">Notes to the Consolidated Financial Statements </a></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_88"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealth Group</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Comprehensive Income</span></div><div style="margin-top:6pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:62.776%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.210%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfMi0yLTEtMS0w_d1b775f9-8f03-4f39-a82c-553525bc59a8">17,732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfMi00LTEtMS0w_cba8a737-d740-41a5-948f-c912e8895720">15,769</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfMi02LTEtMS0w_5790b2a5-41ad-44f7-8bb1-34d5b41f1e57">14,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross unrealized (losses) gains on investment securities during the period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfNC0yLTEtMS0w_ca8e7161-874d-43d9-a3b9-e801062307f1">1,028</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfNC00LTEtMS0w_a6a10aee-748c-4284-a3d1-8d070834b7b2">1,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfNC02LTEtMS0w_9d70a8cb-80f1-4d52-ae9e-a7610f3bc88c">1,212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax effect</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfNS0yLTEtMS0w_f002813b-3d60-48e1-9f87-94fedfcc594d">248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfNS00LTEtMS0w_38aaac48-7344-4f4f-b524-b028fc6373b2">253</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfNS02LTEtMS0w_f7b7ee4d-1d8e-4f0b-9f98-c38af737cfb3">279</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unrealized (losses) gains, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfNi0yLTEtMS0w_7b72882e-794c-4198-96da-0502c47f81d0">780</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfNi00LTEtMS0w_757352ad-7e31-44fb-9e48-25063f8cf1f3">805</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfNi02LTEtMS0w_16eada1d-9c66-4596-80b6-5b19081f7722">933</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross reclassification adjustment for net realized gains included in net earnings</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfNy0yLTEtMS0w_fbde91f2-19c0-4c44-a2ce-907844af38bb">173</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfNy00LTEtMS0w_0b405597-0cae-4184-8c94-f6c8257bdb57">75</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfNy02LTEtMS0w_af7224ba-c02a-4d0e-b860-231e9bda1b4e">104</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax effect</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfOC0yLTEtMS0w_017f5c2b-a073-4302-957c-d848a9831ce5">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfOC00LTEtMS0w_1e263733-26ce-47f8-b3f4-4acf5834d1ca">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfOC02LTEtMS0w_80d0b0f6-0900-4306-9f0d-3d0d6a42cc7f">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:33.75pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassification adjustment, net of tax</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfOS0yLTEtMS0w_432187fb-d203-4f13-8463-56e818e7eb8e">133</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfOS00LTEtMS0w_5047e6f0-d872-43e2-b58f-2e145cbc567d">58</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfOS02LTEtMS0w_9de5155d-b018-4772-b8cb-737e9b65f5da">80</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:22.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total foreign currency translation losses</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfMTAtMi0xLTEtMA_4117f5e2-1718-482a-a13f-1f8f42d91346">657</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfMTAtNC0xLTEtMA_cdd7b14a-831a-4634-b842-ede723b91284">983</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfMTAtNi0xLTEtMA_e9a00377-b50f-41c0-b3c7-8c3b46da6d6e">271</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfMTEtMi0xLTEtMA_2f6b7c72-5210-47b4-ab8d-c9ac29146d0b">1,570</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfMTEtNC0xLTEtMA_7e26b505-a92d-40fd-86eb-cff686d52c88">236</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfMTEtNi0xLTEtMA_d13bb762-b9ff-4335-beb0-8821a9597805">582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfMTItMi0xLTEtMA_8684aa2a-4e8b-4e20-9b70-a37c09091c09">16,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfMTItNC0xLTEtMA_11ab1a39-d1cb-4189-83d6-de735be0569b">15,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfMTItNi0xLTEtMA_61e4450c-84ff-4590-9540-068683aa3d6a">14,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to noncontrolling interests</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfMTMtMi0xLTEtMA_742bbc2e-9007-41bc-a034-b0b3f9135290">447</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfMTMtNC0xLTEtMA_76c293c2-2310-4887-bd00-44e605761fea">366</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfMTMtNi0xLTEtMA_afa7a0d8-c4d7-4130-b6c8-e28a462a1fc3">400</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive income attributable to UnitedHealth Group common shareholders</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfMTQtMi0xLTEtMA_0c695b77-f975-4180-b346-2b2dd3b9731f">15,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfMTQtNC0xLTEtMA_e4c44450-6144-4bca-9356-a603391b4b00">15,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfMTQtNi0xLTEtMA_c04c110c-3b51-4534-8134-d591d46388b5">14,421</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:4.5pt;text-align:center"><span><br/></span></div><div style="margin-top:4.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_100">Notes to the Consolidated Financial Statements </a></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_91"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealth Group</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Changes in Equity</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:25.409%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.938%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.116%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.294%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.411%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.154%"></td><td style="width:0.1%"></td></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive (Loss) Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nonredeemable<br/>Noncontrolling <br/>Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Equity</span></td></tr><tr style="height:45pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Unrealized  (Losses) Gains on Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at January 1, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i93c9b8bdda4a422883687239d22ec90b_I20181231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMi0yLTEtMS0w_1536e54d-f8c7-4d67-9e34-9abe2ba881e8">960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93c9b8bdda4a422883687239d22ec90b_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMi00LTEtMS0w_1f013b55-fba0-4c20-9640-93f7139b5129">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7de78e50178f4dd78f67556f70d9e637_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMi02LTEtMS0w_84ba604e-d2fd-4734-b38c-87052e57ebf6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8eae67f0f11a4c898fa1dedd55840500_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMi04LTEtMS0w_87ec9127-2f2a-49d9-a870-19b4cedf15fd">55,846</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i315e24e23ae44a01836f60086f1fd315_I20181231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMi0xMC0xLTEtMA_582bb0d6-3cfd-4f42-932b-8323948a12ab">264</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5ac330194c449fd8d7d91f71917f488_I20181231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMi0xMi0xLTEtMA_4bfb2456-43f4-4b73-b222-210f43536dba">3,896</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bca26759d4145299e751f4f22f5f1fd_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMi0xNC0xLTEtMA_d5129e12-70e7-4626-8f32-c3dad4f271d8">2,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i870730cd9dfc45bb89971499ab4cdd48_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMi0xNi0xLTEtMA_c9804287-c4bf-4836-91dd-2e7c4bc0aad4">54,319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustment to adopt ASU 2016-02</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i509cd57b44304b8fb05235033e28b2bf_I20181231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMy04LTEtMS0w_0f8076e3-08ec-4aa0-8d6f-bb8989c948f4">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28a6344b404a41c18ed41602af107cc3_I20181231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMy0xNC0xLTEtMjYy_6a7ffbd5-9f56-4361-8d24-8f20ed2c9b20">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c99cfb64bc04618a8af89c6e3780c50_I20181231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMy0xNi0xLTEtMA_25aaafda-af24-4fa0-9240-8ad82068cca9">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93754eb2a7814682a663dc4a8233c401_D20190101-20191231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfNC04LTEtMS0w_1361a854-9211-4299-a023-037b6ac3eb3c">13,839</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2ffd7130e2647e2b0e793e2a0f526a3_D20190101-20191231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfNC0xNC0xLTEtMA_ff1537e6-217e-4955-a321-2230950f3315">285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfNC0xNi0xLTEtMA_8b9ff98e-b51c-42de-bc13-1e9e1d4c7204">14,124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i930490d923ac4f958c17a0c16169ecfd_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfNS0xMC0xLTEtMA_3a6fb7f6-b374-4754-a5ee-cb533ca9f1d6">853</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01af9c575b984fbb810a65816e8f5c90_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfNS0xMi0xLTEtMA_6245ef6e-99e2-4af9-b334-688de559d384">271</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfNS0xNi0xLTEtMA_466b84fc-176a-4bfb-91d9-0cde7f999d60">582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuances of common stock, and related tax effects</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4ac3cd6c11db4467b4b8b2a362706d03_D20190101-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfNi0yLTEtMS0w_21b6bab8-ff3c-48b0-8b34-52ec760b848f">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ac3cd6c11db4467b4b8b2a362706d03_D20190101-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfNi00LTEtMS0w_b26af06c-f5e8-4a50-ba77-0b738c5d120a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f76f41fc9da46f2a0884ca2b30659d4_D20190101-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfNi02LTEtMS0w_27887a10-6d34-456d-af97-425bda005a5a">696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfNi0xNi0xLTEtMA_505f49cc-11e3-416f-b4c3-a0c4a8685839">696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f76f41fc9da46f2a0884ca2b30659d4_D20190101-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfNy02LTEtMS0w_053ab6b9-633d-4c2c-bfff-425477787766">673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfNy0xNi0xLTEtMA_7b9c9acc-58c4-433f-97dc-159f1ca742c1">673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common share repurchases</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i4ac3cd6c11db4467b4b8b2a362706d03_D20190101-20191231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfOC0yLTEtMS0w_d359bc6d-dbed-4838-a2f2-0daf24985186">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ac3cd6c11db4467b4b8b2a362706d03_D20190101-20191231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfOC00LTEtMS0w_bb9cbedd-2687-417b-8e9a-5b5f92b0c6f2">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f76f41fc9da46f2a0884ca2b30659d4_D20190101-20191231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfOC02LTEtMS0w_30781c14-b6e2-4822-a77a-e83367c07d1e">937</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93754eb2a7814682a663dc4a8233c401_D20190101-20191231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfOC04LTEtMS0w_f914aa78-d995-43a5-a464-3ed6f3f2f9e8">4,562</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfOC0xNi0xLTEtMA_817bc9c1-1778-4425-b38c-7d948332cbef">5,500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividends paid on common shares ($<ix:nonFraction unitRef="usdPerShare" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="3" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfOS0wLTEtMS0wL3RleHRyZWdpb246MmJjYWM2ZWMyM2E2NDEwNjk3N2VkYTJjYTQ3ZjY2M2NfNDM_d31352b5-e293-4127-aa36-2a74722e0422">4.14</ix:nonFraction> per share)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93754eb2a7814682a663dc4a8233c401_D20190101-20191231" decimals="-6" name="us-gaap:DividendsCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfOS04LTEtMS0w_43d438c7-897c-4dde-a7a5-f0b4c3783bd8">3,932</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:DividendsCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfOS0xNi0xLTEtMA_1496a7d7-56d6-4266-a614-6c0c9c087b10">3,932</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Redeemable noncontrolling interest fair value and other adjustments</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f76f41fc9da46f2a0884ca2b30659d4_D20190101-20191231" decimals="-6" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTAtNi0xLTEtMA_1a93c176-5624-4e27-a05c-b81a6c1f7c71">316</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTAtMTYtMS0xLTA_a3a4b933-261b-479c-81a2-9e45ad981d92">316</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition and other adjustments of nonredeemable noncontrolling interests</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f76f41fc9da46f2a0884ca2b30659d4_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTEtNi0xLTEtNDY2_a17ad38e-9a29-4c67-a000-99c7f2902e31">109</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2ffd7130e2647e2b0e793e2a0f526a3_D20190101-20191231" decimals="-6" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTEtMTQtMS0xLTA_58aa8e8e-c530-43bd-9db5-a3e6c2f34bda">196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTEtMTYtMS0xLTA_11dd09ad-9728-4af1-9f28-df562c9d8ab2">87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to nonredeemable noncontrolling interest</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2ffd7130e2647e2b0e793e2a0f526a3_D20190101-20191231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTItMTQtMS0xLTA_88b84e0f-3e5d-43c9-8047-13ae8fa80908">279</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTItMTYtMS0xLTA_213fb459-341b-408c-a773-9d9c06676b6f">279</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieebefefe33444454986842a74b0799e9_I20191231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTMtMi0xLTEtMA_d37c969c-2bf7-469f-8df2-6b0a12b49cb0">948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieebefefe33444454986842a74b0799e9_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTMtNC0xLTEtMA_d73d0079-f3ae-4de8-89de-792124993091">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i070f515f1b0a4ce9b417c2adcffa3bc0_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTMtNi0xLTEtMA_7f5de4a1-2722-4fad-9a87-e1c71906efa7">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79b55573683d48f8b6dfa7e39455622e_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTMtOC0xLTEtMA_e167a745-c988-4bca-8795-52a565f9bd1a">61,178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ca981dc06144e079639ca1af5c729c7_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTMtMTAtMS0xLTA_365b6c59-808f-4368-9779-fece65e69f0d">589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia27e856d3af841b3a28c74b0c8109477_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTMtMTItMS0xLTA_1f7eacc0-359e-45d5-bace-224f5c91d52c">4,167</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d57e9b440f94b42ade5424c81274932_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTMtMTQtMS0xLTA_6d3d55c2-2bbf-428a-8477-d0a03439e3b7">2,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530caf840d4847f1ac553be5f7b336b2_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTMtMTYtMS0xLTA_e4063157-2398-48c6-929f-d559dadeef33">60,436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustment to adopt ASU 2016-13</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c49e5bd973a474d93bece3aedf4801f_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTQtOC0xLTEtMA_a8364a36-6b7d-411c-9382-41481046e08e">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fbd0b79127d43b29830dc7504fbbbd4_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTQtMTYtMS0xLTA_48469549-32f4-4771-935c-46720089b36f">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f099b39a9db4d7e8c625a6989f76ace_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTUtOC0xLTEtMA_3b0970ea-55ee-4f59-b12b-2bb8e5a7438e">15,403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3300d5a2eaaa4e0386e185cd95eae562_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTUtMTQtMS0xLTA_f46f7090-4af1-4f8d-8d8d-c55bd17e221c">254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTUtMTYtMS0xLTA_2354324e-3465-4e0e-8bf6-b212c361c6be">15,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0378ff590db1498e8fec3c3e08138eb1_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTYtMTAtMS0xLTA_5f2f258c-17ba-487c-920d-ebbfab4007b4">747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i79edb1e59c054995bf5b8fe22cb060d1_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTYtMTItMS0xLTA_b8eb23c5-d99a-48b7-b166-45e83aa76df1">983</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTYtMTYtMS0xLTA_f6182a48-014f-4bd9-b7d9-96156edcc2f3">236</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuances of common stock, and related tax effects</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i072d7c898f4243b8a611602a0b370dfd_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTctMi0xLTEtMA_67137168-f702-4edd-a115-14eee6f8f733">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i072d7c898f4243b8a611602a0b370dfd_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTctNC0xLTEtMA_e8408338-6a1b-4d26-9031-6b0fb66ba444">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c34096fce714d0c84c9883d2dbaae66_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTctNi0xLTEtMA_4ccaba06-dc87-47c4-a45d-37f9d7e1ebf8">1,119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTctMTYtMS0xLTA_ec4e349d-33a5-444b-b27a-c1e1a383461e">1,120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c34096fce714d0c84c9883d2dbaae66_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTgtNi0xLTEtMA_9ec51186-1939-4a41-aef5-daf09dd602f7">647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTgtMTYtMS0xLTA_d7587761-855c-4d2d-8f0d-4d656e14958d">647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common share repurchases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i072d7c898f4243b8a611602a0b370dfd_D20200101-20201231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTktMi0xLTEtMA_a1a31b35-43d2-494b-ba26-7deea196a708">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i072d7c898f4243b8a611602a0b370dfd_D20200101-20201231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTktNC0xLTEtMA_ceb1ddb3-5db9-4db6-b294-42be485a3dc7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c34096fce714d0c84c9883d2dbaae66_D20200101-20201231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTktNi0xLTEtMA_79a822b8-b30f-4a7b-92cc-c6eeffdd1de8">1,576</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4f099b39a9db4d7e8c625a6989f76ace_D20200101-20201231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTktOC0xLTEtMA_fb08c910-83b2-4906-b255-a5df701d75cf">2,674</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTktMTYtMS0xLTA_ba9637e9-7350-472a-aa3d-a19ed5235784">4,250</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividends paid on common shares ($<ix:nonFraction unitRef="usdPerShare" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjAtMC0xLTEtMC90ZXh0cmVnaW9uOjM2ZmJjMzRjNzdiMTQ4NWNiZWI2ZGVkY2FmNzBiZmUwXzQz_04128702-012a-4135-9f00-1922cd7236eb">4.83</ix:nonFraction> per share)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4f099b39a9db4d7e8c625a6989f76ace_D20200101-20201231" decimals="-6" name="us-gaap:DividendsCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjAtOC0xLTEtMA_b8facc05-1eac-4fb0-9eff-f265532e92d7">4,584</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:DividendsCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjAtMTYtMS0xLTA_9e39a1db-50d8-412a-a410-ec8056bf5df4">4,584</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Redeemable noncontrolling interest fair value and other adjustments</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c34096fce714d0c84c9883d2dbaae66_D20200101-20201231" decimals="-6" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjEtNi0xLTEtMA_161a33eb-88e7-4fde-a6dc-0a0d8a006636">197</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjEtMTYtMS0xLTA_8dafd4a7-690b-4486-aad1-ea59a79e538c">197</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition and other adjustments of nonredeemable noncontrolling interests </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3300d5a2eaaa4e0386e185cd95eae562_D20200101-20201231" decimals="-6" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjItMTQtMS0xLTA_97be5030-b712-4acf-9143-7c6a94cce4ca">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjItMTYtMS0xLTA_e10dcb4a-a40c-40d6-a423-e02a268b85c8">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to nonredeemable noncontrolling interest</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3300d5a2eaaa4e0386e185cd95eae562_D20200101-20201231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjMtMTQtMS0xLTA_ddbd358a-23fe-4eb4-8143-4806ad413364">277</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjMtMTYtMS0xLTA_9268fe56-5980-49bb-841d-e621072cac23">277</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5cc85a29e8934045a37d5be367d3db92_I20201231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjQtMi0xLTEtMA_39ff40b9-7ebf-4f45-a15a-500081818cd5">946</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cc85a29e8934045a37d5be367d3db92_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjQtNC0xLTEtMA_f2db6d16-2ec8-4b4f-a03c-0df85e410322">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied02258caa3547f1ac9db1ebac75e7b5_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjQtNi0xLTEtMA_49e088ca-cb47-4458-9f6e-180537406d6d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1d7badbbfe74d128af9048d86a399ee_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjQtOC0xLTEtMA_93e53bd5-3826-4a42-aa10-7333cc0c7a10">69,295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7634c8268a7641f091bbd4593b6b3229_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjQtMTAtMS0xLTA_dc884c44-7b00-486d-b2b5-265e4ac1943c">1,336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2af08b82a1804b45b92fd387d2d6ebc7_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjQtMTItMS0xLTA_03ea6177-e3a4-4324-b0cc-ffb3f6271f2b">5,150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78db576697a6474084de5301358e552a_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjQtMTQtMS0xLTA_7e140b41-9f67-4ce0-984f-2506fe77c1dd">2,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjQtMTYtMS0xLTA_2b17c3ca-26dc-43da-a2f0-f69fcbc59615">68,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54c9ed4fe57143d089532919ce622309_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjYtOC0xLTEtMA_5fb7afcd-faec-4ca1-a722-b155aa997fff">17,285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c38985e71104ebf84a399c4c16d84b9_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjYtMTQtMS0xLTA_cf811a5a-c79f-4829-91a0-46a8f1a751bb">360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjYtMTYtMS0xLTA_032ed9ce-8e69-4172-acf4-e92e38aaad76">17,645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f46a298bc1a4e6da1439ecf4feef723_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjctMTAtMS0xLTA_e1ed8a92-d951-4e1f-b5c5-60332982ea9c">913</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a8e9219ee4b4394808f55b5e8635651_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjctMTItMS0xLTA_4839f76d-f893-4d7c-b013-30a363a14ed4">657</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjctMTYtMS0xLTA_c8d6e4a5-d4d6-440d-9c62-5454d07132c2">1,570</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuances of common stock, and related tax effects</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icd650c47786d472789666a390d70daa2_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjgtMi0xLTEtMA_da9ac4af-2f2a-4956-8bc0-65aa5c4af364">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd650c47786d472789666a390d70daa2_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjgtNC0xLTEtMA_a4bf3bbf-3f69-4634-80b5-4a322289fe00">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i205c8dfff92c4b7b93596e6594ee9ef4_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjgtNi0xLTEtMA_1c0bd8ec-d898-4f3e-9f17-ece8c4409e94">1,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjgtMTYtMS0xLTA_2aaf89e2-9981-4303-b76e-e314c1464f98">1,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i205c8dfff92c4b7b93596e6594ee9ef4_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjktNi0xLTEtMA_6e9cd138-5644-4faa-ab2c-5314295e0119">729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjktMTYtMS0xLTA_2bcbc161-5c68-4cec-880d-0e90022ceaa8">729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common share repurchases</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="icd650c47786d472789666a390d70daa2_D20210101-20211231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzAtMi0xLTEtMA_77f38013-c8a0-42e8-92f4-f494d515f50c">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd650c47786d472789666a390d70daa2_D20210101-20211231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzAtNC0xLTEtMA_76018f15-bb43-4764-94d7-d7f0a89468fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i205c8dfff92c4b7b93596e6594ee9ef4_D20210101-20211231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzAtNi0xLTEtMA_4e003e97-2e14-46cd-833b-6ac26655dc6b">940</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54c9ed4fe57143d089532919ce622309_D20210101-20211231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzAtOC0xLTEtMA_d7c6ee6a-2c40-4021-a79b-c8420de699da">4,060</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzAtMTYtMS0xLTA_df911d72-3349-491a-bc29-1dea89b660c3">5,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividends paid on common shares ($<ix:nonFraction unitRef="usdPerShare" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOmUwMTAyOTI3OTYxNDQ0MWQ5YzQ0YTljMjU5OWI3NTdlXzQz_269041d2-db31-48fa-ba22-d07337ace4db">5.60</ix:nonFraction> per share)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54c9ed4fe57143d089532919ce622309_D20210101-20211231" decimals="-6" name="us-gaap:DividendsCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzEtOC0xLTEtMA_8933048f-4203-4aa8-9fc5-f103cf1f998f">5,280</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:DividendsCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzEtMTYtMS0xLTA_53e2f265-b7e1-442d-b607-b122b73803c7">5,280</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests fair value and other adjustments</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i205c8dfff92c4b7b93596e6594ee9ef4_D20210101-20211231" decimals="-6" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzItNi0xLTEtMA_471c41f7-2294-4490-b119-b3d74b3e6ca4">889</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54c9ed4fe57143d089532919ce622309_D20210101-20211231" decimals="-6" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzEtOC0xLTEtMTYwMzI_22ab4000-ac67-4deb-a4ee-e7f07b32cae6">106</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzItMTYtMS0xLTA_33e3fc79-388b-4f87-a5c8-4851282ded78">995</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition and other adjustments of nonredeemable noncontrolling interests </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c38985e71104ebf84a399c4c16d84b9_D20210101-20211231" decimals="-6" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzMtMTQtMS0xLTA_027ecbd1-cee3-40a6-b69a-cb71d7fa94d8">407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzMtMTYtMS0xLTA_ce78427e-9245-4058-8411-759a05b6961a">407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to nonredeemable noncontrolling interests</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c38985e71104ebf84a399c4c16d84b9_D20210101-20211231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzQtMTQtMS0xLTA_ca1e730c-33f7-49fe-a733-134914a57271">319</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzQtMTYtMS0xLTA_c038639f-7100-44bc-9067-b2d3d09e62af">319</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i593bf0b079e04f058cf0f21f5585b069_I20211231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzUtMi0xLTEtMA_66ebe40f-54ae-4feb-b790-a36333ac99d5">941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i593bf0b079e04f058cf0f21f5585b069_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzUtNC0xLTEtMA_d084e4e8-8d44-4fc5-8c1e-92f41292588d">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic04e77b5e9904fcc9c97df541ef3f22a_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzUtNi0xLTEtMA_b96e9c15-ea2f-420e-bfa9-9b0b4dc8e5ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cb7b25ac2db413db39f0363a9eed1e3_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzUtOC0xLTEtMA_f45b4a05-b4b3-4dfb-92e0-fede6c6e3996">77,134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i275d8d15f1794b78972e85e3f1725cd4_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzUtMTAtMS0xLTA_ea74d519-a55a-45ee-bc39-bc6bc4e931d9">423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e144bfae9ce400699c59ff4175549af_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzUtMTItMS0xLTA_debe1f3d-94b2-48e6-8f7d-c7a82e15101e">5,807</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7a74722ffca455e8f8b9d9120092a96_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzUtMTQtMS0xLTA_3f6d53dd-23ec-4bb8-aeee-0614e730a197">3,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzUtMTYtMS0xLTA_682a4d0d-c599-45ff-be77-7b9f6c30a242">75,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_100">Notes to the Consolidated Financial Statements </a></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_97"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealth Group</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Cash Flows</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:66.007%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.327%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMy0yLTEtMS0w_35292c4d-3afa-481d-b53a-49a362b9eb13">17,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMy00LTEtMS0w_86cab7c3-2366-4c78-906f-e6944ddffa66">15,769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMy02LTEtMS0w_cdce61c2-1dfb-4c9d-b560-1fbbe4be71f6">14,239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncash items:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfNS0yLTEtMS0w_64bce8a2-012e-40b7-90f3-5f762e8f5b5f">3,103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfNS00LTEtMS0w_7a57e0d1-af85-4fdb-b165-316137b5ace2">2,891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfNS02LTEtMS0w_800aa3f4-1e14-4700-bc87-7f864d887558">2,720</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfNi0yLTEtMS0w_67a88c1c-7ea1-4758-a315-bfe776ae2b3e">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfNi00LTEtMS0w_0a44d238-c1ed-496b-86f8-79c727ddb35a">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfNi02LTEtMS0w_da260a01-459a-4713-adcc-e63c9a66de0a">230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfNy0yLTEtMS0w_bd9a32a1-858a-4b77-b5d8-c916b3e30d90">800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfNy00LTEtMS0w_ef74bf32-6622-4a8b-a1ec-41485fbc8e2d">679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfNy02LTEtMS0w_78adf477-915c-4aa6-b7e7-cb4ebed2157c">697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfOC0yLTEtMS0w_fcb61773-5737-4ff2-ae51-6117d5432f15">944</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfOC00LTEtMS0w_e30ca8e0-c53e-4224-a641-811dbb6ce992">52</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfOC02LTEtMS0w_ab60e37c-6a33-49ad-84e1-18bab71c7561">106</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net change in other operating items, net of effects from acquisitions and changes in AARP balances:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTAtMi0xLTEtMA_26c70c2b-cdbc-4858-91e6-614ff1cf3e38">1,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTAtNC0xLTEtMA_6ed531c9-bef9-407c-a519-e868582304c6">688</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTAtNi0xLTEtMA_4bb131d3-6ed5-472c-8779-94a343444db6">162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTEtMi0xLTEtMA_8934f4d6-279d-4d60-8227-fb5fcaa9ce92">1,031</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTEtNC0xLTEtMA_567de8fa-93ec-406b-955a-31d6ff07ba8e">2,195</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTEtNi0xLTEtMA_c5f21ade-9eb1-45e8-a53d-851759ae9269">1,563</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medical costs payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTItMi0xLTEtMA_d6f4f18c-f9cd-4768-8fef-9236cbf36a22">2,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTItNC0xLTEtMA_2713896d-601f-45a8-8109-e762c9989483">152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTItNi0xLTEtMA_f5738dad-e521-4e11-86e9-36a3fc9b4885">1,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable and other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTMtMi0xLTEtMA_3651311b-76bf-49f2-9719-768e9477bc46">1,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTMtNC0xLTEtMA_78ace464-c26b-443d-ae7c-867075818caa">5,348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTMtNi0xLTEtMA_eb84e24b-9a5b-4612-bc1e-4bcff3790694">733</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTQtMi0xLTEtMA_c3d6b8e4-0ed1-4200-8bb9-ab293c51519a">310</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTQtNC0xLTEtMA_3e905d3e-0cb3-4961-95d2-ecffbff4e68e">278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTQtNi0xLTEtMA_185a46c2-d902-4511-9317-6458785c1305">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flows from operating activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTUtMi0xLTEtMA_74ff1acd-241e-4481-9505-6ac9d70e5dcd">22,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTUtNC0xLTEtMA_67633833-5fc2-4cd2-b83d-e4bc5c5f80c1">22,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTUtNi0xLTEtMA_15835d5c-7ab1-40ca-8d1c-1d589a2faaa3">18,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTctMi0xLTEtMA_01a8cb67-ed5d-4049-aed5-e747184ebbf2">17,139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTctNC0xLTEtMA_67a4325d-78d7-42d3-8d5b-6116e69115d8">16,577</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTctNi0xLTEtMA_e5ad9d06-33af-4cb9-b8d4-a3c32ffe5001">18,131</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales of investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTgtMi0xLTEtMA_6f916f50-043f-42ba-bbec-c11d1151d6bf">7,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTgtNC0xLTEtMA_21baa01a-85c8-49e1-bbfe-a866ef185cee">6,489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTgtNi0xLTEtMA_57cb239e-1b1f-4ef1-9e17-6e5a03690369">8,536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Maturities of investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTktMi0xLTEtMA_784edaa5-fb00-4e9f-a9a1-abb47f640f4b">8,251</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTktNC0xLTEtMA_925b9a65-dba0-4ab8-b942-d6cfad213aff">7,252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTktNi0xLTEtMA_24dc7fe1-d540-4a18-b899-e5fe6b62146c">7,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for acquisitions, net of cash assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjAtMi0xLTEtMA_a616ffb4-e5a5-4660-9d4b-c06bf0268427">4,821</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjAtNC0xLTEtMA_1be9c265-301c-4bce-90b9-8fc09f9fec19">7,139</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjAtNi0xLTEtMA_ee935b5b-560c-413d-bd5d-348bdba358a2">8,343</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of property, equipment and capitalized software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjEtMi0xLTEtMA_e28b2445-1ea6-4a36-94bd-f5bf57ec2b40">2,454</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjEtNC0xLTEtMA_ee26d16e-2887-40ad-83fe-58dac44c6ebc">2,051</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjEtNi0xLTEtMA_6888329d-6f28-4357-8531-dfd8cba50108">2,071</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjItMi0xLTEtMA_d43fffa9-3aba-4322-b1c7-8752a42141cf">1,254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjItNC0xLTEtMA_a9bc9fba-4137-4f1e-981b-b8dc8ea14e9d">506</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjItNi0xLTEtMA_729a55b7-bcf6-4537-a660-5b6e5e46c286">219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flows used for investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjMtMi0xLTEtMA_97469cac-a6ec-4b7e-af79-c37f20d3ab03">10,372</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjMtNC0xLTEtMA_2d758d97-fdee-489e-bed1-8e861290e85b">12,532</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjMtNi0xLTEtMA_f57178d3-5668-4d3f-bf21-5c968b8866be">12,699</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common share repurchases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjUtMi0xLTEtMA_fe42e92f-e3fa-470f-9b88-34fbdfdca89e">5,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjUtNC0xLTEtMA_f3311762-4783-42c2-87d6-534a9472b81f">4,250</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjUtNi0xLTEtMA_ee0c3ee2-3747-4d45-8a37-37d2a2d2101d">5,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjYtMi0xLTEtMA_f39cc00d-886f-49a8-8043-a77a24c8eb14">5,280</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjYtNC0xLTEtMA_237d303f-bc64-4357-9f08-75eef74513fb">4,584</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjYtNi0xLTEtMA_88037948-4e6e-4200-8309-e1b5836e5eef">3,932</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from common stock issuances</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjctMi0xLTEtMA_37b71e01-6cdb-41fc-ba86-0c534172c4db">1,355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjctNC0xLTEtMA_3240f7b4-cdac-4869-b380-007774314653">1,440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjctNi0xLTEtMA_b155768d-fda9-4571-85ca-56c016726b8a">1,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayments of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjgtMi0xLTEtMA_1cdb9f19-6c87-4cc2-a550-f999f9b056a7">3,150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjgtNC0xLTEtMA_7880e0ea-f460-4296-a246-7c424023314c">3,150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjgtNi0xLTEtMA_305ebeca-1e92-4ecf-bae4-c91a3b9e7466">1,750</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Repayments of) proceeds from short-term borrowings, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfCommercialPaper" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjktMi0xLTEtMA_fb1fc911-2729-49e6-86d3-651c185f4ded">1,302</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfCommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjktNC0xLTEtMA_f518c580-8d5a-4905-92f7-f09049b82f1e">872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfCommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjktNi0xLTEtMA_26591415-7345-4351-abf6-73cb25e89f27">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from issuance of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzAtMi0xLTEtMA_fa4eb38e-793c-43ef-9dee-4f70391a3765">6,933</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzAtNC0xLTEtMA_68a584b4-dca5-475d-9e2d-0672aa624988">4,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzAtNi0xLTEtMA_001deb4c-4800-4d0c-a714-8c7a704b9ef9">5,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer funds administered</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInDeposits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzEtMi0xLTEtMA_b9174154-9b26-4bc3-b2ef-9c050f3ea5a9">622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInDeposits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzEtNC0xLTEtMA_1719a3cb-4ae6-4269-b963-d967582a7d31">1,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:IncreaseDecreaseInDeposits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzEtNi0xLTEtMA_40aeb6aa-6cba-43e6-ae79-935bb797db84">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of redeemable noncontrolling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzItMi0xLTEtMTY5MTI_4090781e-1e9b-45b9-a01d-3cb98e127728">1,338</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzItNC0xLTEtMTY5MTg_ec0c021c-5f0f-451d-8ccb-4f1b436c7192">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzItNi0xLTEtMTY5MjQ_d9ce41cc-2239-4c16-be43-00733168d4af">618</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzItMi0xLTEtMA_29e39349-a0ed-4d4e-83ad-4b4973700802">295</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzItNC0xLTEtMA_11fbaf25-ee6b-467c-8179-11594b7e9820">459</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzItNi0xLTEtMA_11baee78-61b7-4b38-bdd4-217b18ff4fc1">619</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flows used for financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzMtMi0xLTEtMA_624d0b5a-54f1-4e56-84a8-f018361a42b1">7,455</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzMtNC0xLTEtMA_e8117081-ec91-45d1-8754-920595520fee">3,590</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzMtNi0xLTEtMA_1488ab9c-4115-4950-b5a6-f09de2dba2e8">5,625</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzQtMi0xLTEtMA_63ce3dc8-de18-4183-84cf-7e40d9b4ca2c">62</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzQtNC0xLTEtMA_8a4507bd-9ec7-4a02-9b33-6ba619dd45eb">116</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzQtNi0xLTEtMA_17db1578-3350-4e9e-a1b4-de858c0ab406">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Increase in cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzUtMi0xLTEtMA_2061f027-1a73-4b1e-b3cc-37e597296498">4,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzUtNC0xLTEtMA_33327d1d-3a72-45a4-8c60-a6d286fc80fd">5,936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzUtNi0xLTEtMA_ca192c55-b1b5-40ea-b8cc-fc9a114c3ae7">119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and cash equivalents, beginning of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzYtMi0xLTEtMA_3b70c74f-302b-4189-8671-8a4dc30e1087">16,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530caf840d4847f1ac553be5f7b336b2_I20191231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzYtNC0xLTEtMA_e9d89e32-79c5-4cfd-9ceb-39d9f3fcf936">10,985</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i870730cd9dfc45bb89971499ab4cdd48_I20181231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzYtNi0xLTEtMA_05ccc3bc-123d-4bc2-8e88-2c40f568865d">10,866</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and cash equivalents, end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzctMi0xLTEtMA_53a2148d-9bdc-453c-9219-45fe74c6dd53">21,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzctNC0xLTEtMA_bc5b4131-68af-4b6f-b09f-9ac32cf29f96">16,921</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530caf840d4847f1ac553be5f7b336b2_I20191231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzctNi0xLTEtMA_70e624c7-7b26-408b-ad2e-38e312dc8044">10,985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supplemental cash flow disclosures</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfNDAtMi0xLTEtMA_e2350b48-c049-49da-b63c-15b8d0682f95">1,653</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfNDAtNC0xLTEtMA_d57d7184-b74a-4cd1-a096-084be3812954">1,704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfNDAtNi0xLTEtMA_40a4b21d-20c7-4596-9000-55b47efb05f9">1,627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfNDEtMi0xLTEtMA_39b4937a-cfe0-4f04-97e9-34e97192ee70">3,966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfNDEtNC0xLTEtMA_b38b9b97-dffd-43b0-b84b-739a5091c323">4,935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfNDEtNi0xLTEtMA_8292fdbe-fbeb-48aa-b162-9f3e8000a696">3,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span><br/></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_100">Notes to the Consolidated Financial Statements </a></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_100"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealth Group</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_103"></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:NatureOfOperations" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMDMvZnJhZzpiMWZlODMxZjQ1YTA0ZTNhODdkNTUwNTdmYTM2Mzc0Yy90ZXh0cmVnaW9uOmIxZmU4MzFmNDVhMDRlM2E4N2Q1NTA1N2ZhMzYzNzRjXzE2NDkyNjc0NDMyODE_708d631f-6056-4d78-be58-ccb124b860f3" continuedAt="ib900810aeb7e4b9db4f87330b3143a78" escape="true">Description of Business</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib900810aeb7e4b9db4f87330b3143a78">UnitedHealth Group Incorporated (individually and together with its subsidiaries, &#8220;UnitedHealth Group&#8221; and &#8220;the Company&#8221;) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone. Our two distinct, yet complementary business platforms &#8212; Optum and UnitedHealthcare &#8212; are working to help build a modern, high-performing health system through improved access, affordability, outcomes and experiences for the individuals and organizations we are privileged to serve.</ix:continuation></span></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_106"></div><div style="margin-top:15pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMDYvZnJhZzo5NjBjMjc5MzI4ZTU0OWE2YTA3NDBhYzljOWVhNmMzNC90ZXh0cmVnaW9uOjk2MGMyNzkzMjhlNTQ5YTZhMDc0MGFjOWM5ZWE2YzM0XzE2NDkyNjc0NDIyMzE_eb6d4a2f-9b4b-4cfc-9d9b-95b2c442dbfb" continuedAt="i97cf482261c74a319974f67755816c32" escape="true">Basis of Presentation, Use of Estimates and Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="i97cf482261c74a319974f67755816c32" continuedAt="iaffffa95707d4af29b38df5d2166ade6"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMDYvZnJhZzo5NjBjMjc5MzI4ZTU0OWE2YTA3NDBhYzljOWVhNmMzNC90ZXh0cmVnaW9uOjk2MGMyNzkzMjhlNTQ5YTZhMDc0MGFjOWM5ZWE2YzM0XzE2NDkyNjc0NDIyMzI_ef55980a-95cc-4257-84dc-a37693d0ae92" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has prepared the Consolidated Financial Statements according to U.S. Generally Accepted Accounting Principles (GAAP) and has included the accounts of UnitedHealth Group and its subsidiaries.</span></div></ix:nonNumeric></ix:continuation><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_115"></div><ix:continuation id="iaffffa95707d4af29b38df5d2166ade6" continuedAt="i8058aaa44d2e470c96ae93eca8ccd39e"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMTUvZnJhZzphYWQzMDJhZTBkZWY0NWQzOGJhZTBmNjk4MTUwNjU1MS90ZXh0cmVnaW9uOmFhZDMwMmFlMGRlZjQ1ZDM4YmFlMGY2OTgxNTA2NTUxXzE2NDkyNjc0NDIyMjY_1976e540-ce15-4df2-869a-7fd9037b7b92" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These Consolidated Financial Statements include certain amounts based on the Company&#8217;s best estimates and judgments. The Company&#8217;s most significant estimates relate to estimates and judgments for medical costs payable and goodwill. Certain of these estimates require the application of complex assumptions and judgments, often because they involve matters inherently uncertain and will likely change in subsequent periods. The impact of any change in estimates is included in earnings in the period in which the estimate is adjusted.</span></div></ix:nonNumeric></ix:continuation><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_118"></div><ix:continuation id="i8058aaa44d2e470c96ae93eca8ccd39e" continuedAt="i77364ab30e904085929a09970b5f1c5e"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMTgvZnJhZzo2MjY0NTM4YWJjZmU0Y2Q0YjI2YzliZGZiY2Y1MjFhMC90ZXh0cmVnaW9uOjYyNjQ1MzhhYmNmZTRjZDRiMjZjOWJkZmJjZjUyMWEwXzE2NDkyNjc0NTY1Njk_a7bfaac9-d7cc-4950-aa2c-27ccf9a8e26a" continuedAt="i4955414555814bba9739f173153fe393" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Premiums</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium revenues are primarily derived from risk-based health insurance arrangements in which the premium is typically at a fixed rate per individual served for a one-year period, and the Company assumes the economic risk of funding its customers&#8217; health care and related administrative costs.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium revenues are recognized in the period in which eligible individuals are entitled to receive health care benefits. Health care premium payments received from the Company&#8217;s customers in advance of the service period are recorded as unearned revenues. Fully insured commercial products of U.S. health plans, Medicare Advantage and Medicare Prescription Drug Benefit (Medicare Part D) plans with medical loss ratios (MLRs) as calculated under the definitions in the Patient Protection and Affordable Care Act (ACA) and related federal and state regulations and implementing regulation, falling below certain targets are required to rebate ratable portions of their premiums annually. Commercial premiums within the Company&#8217;s individual and small group markets are also subject to the ACA risk adjustment program. Medicare Advantage premium revenue includes the impact of the Centers for Medicare &amp; Medicaid Services (CMS) quality bonuses based on plans&#8217; Star rating. Certain of the Company&#8217;s Medicaid business is also subject to state minimum MLR rebates.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium revenues are recognized based on the estimated premiums earned, net of projected rebates, because the Company is able to reasonably estimate the ultimate premiums of these contracts. The Company also records premium revenues for certain value-based arrangements at its Optum Health care delivery businesses. Under these value-based arrangements, the Company enters into agreements with health plans to stand ready to deliver, integrate, direct and control certain health care services for the individuals enrolled. In exchange, the Company receives a premium that is typically paid on a per-member per-month basis. The Company considers these value-based arrangements to represent a single performance obligation where premium revenues are recognized in the period in which health care services are made available.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Medicare Advantage and Medicare Part D premium revenues are subject to periodic adjustment under CMS&#8217; risk adjustment payment methodology. CMS deploys a risk adjustment model which apportions premiums paid to all health plans according to health severity and certain demographic factors. The CMS risk adjustment model provides higher per member payments for enrollees diagnosed with certain conditions and lower payments for enrollees who are healthier. Under this risk adjustment methodology, CMS calculates the risk adjusted premium payment using diagnosis and encounter data from hospital inpatient, hospital outpatient and physician treatment settings. The Company and health care providers collect, capture and submit the necessary and available data to CMS within prescribed deadlines. The Company estimates risk adjustment premium revenues based upon the data submitted and expected to be submitted to CMS. Risk adjustment data for the Company&#8217;s plans are subject to review by the government, including audit by regulators. See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_217">Note 12</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding these audits.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><ix:continuation id="i77364ab30e904085929a09970b5f1c5e" continuedAt="i920a4de290ba46e0a382e7b13a989d3e"><ix:continuation id="i4955414555814bba9739f173153fe393"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Products and Services</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Company&#8217;s Optum Rx pharmacy care services business, the majority of revenues are derived from products sold through a contracted network of retail pharmacies or home delivery, specialty and community health pharmacies. Product revenues include the cost of pharmaceuticals (net of rebates), a negotiated dispensing fee and customer co-payments for drugs dispensed through the Company&#8217;s home delivery, specialty and community pharmacies. For the years ended December 31, 2021 and 2020, the Company recognized revenue and cost of products sold for retail pharmacy co-payments related to its Optum Rx business. Revenue recognized in prior periods related to retail pharmacy transactions excludes the member&#8217;s applicable co-payment. There was no impact on earnings from operations, net earnings, earnings per share or total equity. Pharmacy products are billed to customers based on the number of transactions occurring during the billing period. Product revenues are recognized when the prescriptions are dispensed. The Company has entered into contracts in which it is primarily obligated to pay its network pharmacy providers for benefits provided to their customers regardless of whether the Company is paid. The Company is also involved in establishing the prices charged by retail pharmacies, determining which drugs will be included in formulary listings and selecting which retail pharmacies will be included in the network offered to plan sponsors&#8217; members and accordingly, are reported on a gross basis.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services revenue are comprised of a number of services and products sold through Optum. Optum Health&#8217;s service revenues include net patient service revenues recorded based upon established billing rates, less allowances for contractual adjustments, and are recognized as services are provided. For its financial services offerings, Optum Health charges fees and earns investment income on managed funds. Optum Insight provides software and information products, advisory consulting arrangements and managed services outsourcing contracts, which may be delivered over several years. Optum Insight revenues are generally recognized over time and measured each period based on the progress to date as services are performed or made available to customers.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services revenue also consists of fees derived from services performed for customers who self-insure the health care costs of their employees and employees&#8217; dependents. Under service fee contracts, the Company receives monthly, a fixed fee per employee, which is recognized as revenue as the Company performs, or makes available, the applicable services to the customer. The customers retain the risk of financing health care costs for their employees and employees&#8217; dependents, and the Company administers the payment of customer funds to physicians and other health care professionals from customer-funded bank accounts. As the Company has neither the obligation for funding the health care costs, nor the primary responsibility for providing the medical care, the Company does not recognize premium revenue and medical costs for these contracts in its Consolidated Financial Statements. For these fee-based customer arrangements, the Company provides coordination and facilitation of medical services; transaction processing; customer, consumer and care professional services; and access to contracted networks of physicians, hospitals and other health care professionals. These services are performed throughout the contract period. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, accounts receivables related to products and services were $<ix:nonFraction unitRef="usd" contextRef="i3cc841fcdfd546358ed335a1f5de7e7e_I20211231" decimals="-8" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMTgvZnJhZzo2MjY0NTM4YWJjZmU0Y2Q0YjI2YzliZGZiY2Y1MjFhMC90ZXh0cmVnaW9uOjYyNjQ1MzhhYmNmZTRjZDRiMjZjOWJkZmJjZjUyMWEwXzYzODI_e9d91946-4648-4c3f-a9d3-92d734e1f1d8">5.4</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i6f67f540a2f34e649bdb094c7c1cf41d_I20201231" decimals="-8" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMTgvZnJhZzo2MjY0NTM4YWJjZmU0Y2Q0YjI2YzliZGZiY2Y1MjFhMC90ZXh0cmVnaW9uOjYyNjQ1MzhhYmNmZTRjZDRiMjZjOWJkZmJjZjUyMWEwXzYzODk_6e640024-034e-4f2b-b053-fefb99a784c7">5.3</ix:nonFraction> billion, respectively. In 2021 and 2020, the Company had no material bad-debt expense and there were no material contract assets, contract liabilities or deferred contract costs recorded on the Consolidated Balance Sheets as of December&#160;31, 2021 or 2020.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2021, 2020 and 2019, revenue recognized from performance obligations related to prior periods (for example, due to changes in transaction price) was not material.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue expected to be recognized in any future year related to remaining performance obligations, excluding revenue pertaining to contracts having an original expected duration of one year or less, contracts where revenue is recognized as invoiced and contracts with variable consideration related to undelivered performance obligations, is not material.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_223">Note 13</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for disaggregation of revenue by segment and type.</span></div></ix:continuation></ix:continuation><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_121"></div><ix:continuation id="i920a4de290ba46e0a382e7b13a989d3e" continuedAt="if96416fc52f848ba88f51eb9a5f6644e"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMjEvZnJhZzplZjgwNDdhYTA0MWY0YWIxYTkxYTYwM2E2N2E5YWVkMS90ZXh0cmVnaW9uOmVmODA0N2FhMDQxZjRhYjFhOTFhNjAzYTY3YTlhZWQxXzE2NDkyNjc0NDQzMjk_db244709-efdc-449d-b801-86743cee351a" continuedAt="if2c431ee982d4ae2b7af09f5e6d55f46" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical Costs and Medical Costs Payable </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimate of medical costs payable represents management&#8217;s best estimate of its liability for unpaid medical costs as of December&#160;31, 2021.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each period, the Company re-examines previously established medical costs payable estimates based on actual claim submissions and other changes in facts and circumstances. As more complete claim information becomes available, the Company adjusts the amount of the estimates and includes the changes in estimates in medical costs in the period in which the change is identified. Approximately <ix:nonFraction unitRef="number" contextRef="ifafacde0705d4f258c784fe3cb74d22f_I20211231" decimals="INF" name="unh:ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMjEvZnJhZzplZjgwNDdhYTA0MWY0YWIxYTkxYTYwM2E2N2E5YWVkMS90ZXh0cmVnaW9uOmVmODA0N2FhMDQxZjRhYjFhOTFhNjAzYTY3YTlhZWQxXzU5MQ_d4447673-f11d-4591-9079-67d488a3d9a3">90</ix:nonFraction>% of claims related to medical care services are known and settled within 90 days from the date of service and substantially all within twelve months.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical costs and medical costs payable include estimates of the Company&#8217;s obligations for medical care services rendered on behalf of consumers, but for which claims have either not yet been received, processed, or paid. The Company develops estimates for medical care services incurred but not reported (IBNR), which includes estimates for claims which have not been received or fully processed, using an actuarial process consistently applied, centrally controlled and automated. The actuarial </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><ix:continuation id="if96416fc52f848ba88f51eb9a5f6644e" continuedAt="i733ca0d60d1e4716a9726cffb8d21fef"><ix:continuation id="if2c431ee982d4ae2b7af09f5e6d55f46"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">models consider factors such as time from date of service to claim processing, seasonal variances in medical care consumption, health care professional contract rate changes, medical care utilization and other medical cost trends, membership volume and demographics, the introduction of new technologies, benefit plan changes, and business mix changes related to products, customers and geography. Judgments related to these factors contemplated the impact of COVID-19.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In developing its medical costs payable estimates, the Company applies different estimation methods depending on which incurred claims are being estimated. For the most recent two months, the Company estimates claim costs incurred by applying observed medical cost trend factors to the average per member per month (PMPM) medical costs incurred in prior months for which more complete claim data are available, supplemented by a review of near-term completion factors (actuarial estimates, based upon historical experience and analysis of current trends, of the percentage of incurred claims during a given period adjudicated by the Company at the date of estimation). For months prior to the most recent two months, the Company applies the completion factors to actual claims adjudicated-to-date to estimate the expected amount of ultimate incurred claims for those months.</span></div></ix:continuation></ix:continuation><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_124"></div><ix:continuation id="i733ca0d60d1e4716a9726cffb8d21fef" continuedAt="i83eedb84629944cb9abbb42bb150a943"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:CostOfSalesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMjQvZnJhZzoyNzg1MjI0ZmJhNWM0NGM0Yjk0ZDc1MmI1MTcyNDU4YS90ZXh0cmVnaW9uOjI3ODUyMjRmYmE1YzQ0YzRiOTRkNzUyYjUxNzI0NThhXzE2NDkyNjc0NDI1NDg_ecb65db8-9e9e-4072-add1-540caf2f5122" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Products Sold </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s cost of products sold includes the cost of pharmaceuticals dispensed to unaffiliated customers either directly at its home delivery, specialty and community pharmacy locations, or indirectly through its nationwide network of participating pharmacies. Rebates attributable to unaffiliated clients are accrued as rebates receivable and a reduction of cost of products sold, with a corresponding payable for the amounts of the rebates to be remitted to those unaffiliated clients in accordance with their contracts and recorded in the Consolidated Statements of Operations as a reduction of product revenue. Cost of products sold also includes the cost of personnel to support the Company&#8217;s transaction processing services, system sales, maintenance and professional services.</span></div></ix:nonNumeric></ix:continuation><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_127"></div><ix:continuation id="i83eedb84629944cb9abbb42bb150a943" continuedAt="i023a4345f45c4c6481883440ca1d6847"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMjcvZnJhZzo2MGJkNDZhY2ViYTc0YTZkOTQxNWZjN2RiNGYwMDY4Ny90ZXh0cmVnaW9uOjYwYmQ0NmFjZWJhNzRhNmQ5NDE1ZmM3ZGI0ZjAwNjg3XzE2NDkyNjc0NDQwNTI_d3d2242e-92d3-4bbb-894d-471b087127ce" continuedAt="ifd49239a3a3d49a3abedbdc9f234e43d" escape="true">Cash, Cash Equivalents and Investments </ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ifd49239a3a3d49a3abedbdc9f234e43d">Cash and cash equivalents are highly liquid investments having an original maturity of three months or less. The fair value of cash and cash equivalents approximates their carrying value because of the short maturity of the instruments.</ix:continuation> </span></div><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:InvestmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMjcvZnJhZzo2MGJkNDZhY2ViYTc0YTZkOTQxNWZjN2RiNGYwMDY4Ny90ZXh0cmVnaW9uOjYwYmQ0NmFjZWJhNzRhNmQ5NDE1ZmM3ZGI0ZjAwNjg3XzE2NDkyNjc0NDQwNTM_829f95ff-e092-4bfd-9138-a94b3024f038" continuedAt="i814ef38657504a01a7d1020283911cbc" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments with maturities of less than one year are classified as short-term. Because of regulatory requirements, certain investments are included in long-term investments regardless of their maturity date. The Company classifies these investments as held-to-maturity and reports them at amortized cost. Substantially all other investments are classified as available-for-sale and reported at fair value based on quoted market prices, where available. Equity investments, with certain exceptions, are measured at fair value with changes in fair value recognized in net earnings.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company excludes unrealized gains and losses on investments in available-for-sale debt securities from net earnings and reports them as comprehensive income and, net of income tax effects, as a separate component of equity. To calculate realized gains and losses on the sale of debt securities, the Company specifically identifies the cost of each investment sold. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates an available-for-sale debt security for credit-related impairment by considering the present value of expected cash flows relative to a security&#8217;s amortized cost, the extent to which fair value is less than amortized cost, the financial condition and near-term prospects of the issuer and specific events or circumstances which may influence the operations of the issuer. Credit-related impairments are recorded as an allowance, with an offset to investment and other income. Non-credit related impairments are recorded through other comprehensive income. If the Company intends to sell an impaired security, or will likely be required to sell a security before recovery of the entire amortized cost, the entire impairment is included in net earnings.</span></div></ix:nonNumeric><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i814ef38657504a01a7d1020283911cbc">New information and the passage of time can change these judgments. The Company manages its investment portfolio to limit its exposure to any one issuer or market sector, and largely limits its investments to investment grade quality. Securities downgraded below policy minimums after purchase will be disposed of in accordance with the Company&#8217;s investment policy.</ix:continuation> </span></div></ix:continuation><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_130"></div><ix:continuation id="i023a4345f45c4c6481883440ca1d6847" continuedAt="i738cdd74a4764f4ea8db504209e9ae3e"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="unh:AARPAssetsUnderManagementPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMzAvZnJhZzphYTVmMjAyODI2M2M0ODlkYjUzMGFkMGM2MTc2YmY4Mi90ZXh0cmVnaW9uOmFhNWYyMDI4MjYzYzQ4OWRiNTMwYWQwYzYxNzZiZjgyXzE2NDkyNjc0NDMzMDg_d92405b6-44c3-49eb-b2c4-60dfe4e3c1ad" continuedAt="i0e4eb3bd7a0f4745a64d544bf66e3b9c" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Under Management </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides health insurance products and services to members of AARP under a Supplemental Health Insurance Program (the AARP Program) and to AARP members and non-members under separate Medicare Advantage and Medicare Part D arrangements. The products and services under the AARP Program include supplemental Medicare benefits, hospital indemnity insurance, including insurance for individuals between 50 to 64 years of age, and other related products. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Company&#8217;s agreement with AARP, program assets are managed separately from the Company&#8217;s general investment portfolio and are used to pay costs associated with the AARP Program. These assets are invested at the Company&#8217;s discretion, within investment guidelines approved by AARP. The Company does not guarantee any rates of return on these investments and, upon any transfer of the AARP Program contract to another entity, the Company would transfer cash equal in amount to the fair value of these investments at the date of transfer to the entity. Because the purpose of these assets is to fund the medical costs payable, the rate stabilization fund (RSF) liabilities and other related liabilities associated with this AARP contract, assets under management are classified as current assets, consistent with the classification of these liabilities.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i738cdd74a4764f4ea8db504209e9ae3e" continuedAt="ibf90498979414a04a5331f1d18f193ea"><ix:continuation id="i0e4eb3bd7a0f4745a64d544bf66e3b9c">The effects of changes in other balance sheet amounts associated with the AARP Program also accrue to the overall benefit of the AARP policyholders through the RSF balance. Accordingly, the Company excludes the effect of such changes in its Consolidated Statements of Cash Flows.</ix:continuation></ix:continuation></span></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_133"></div><ix:continuation id="ibf90498979414a04a5331f1d18f193ea" continuedAt="i7c0a3227244f41bea8da2c10508f3977"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMzMvZnJhZzplMTNlMzgwNWM2NzA0NDIzYWU0YzRjZTI3OTgzNDJiOC90ZXh0cmVnaW9uOmUxM2UzODA1YzY3MDQ0MjNhZTRjNGNlMjc5ODM0MmI4XzE2NDkyNjc0NDI4Nzk_d6657d9a-934e-4fd2-9ae4-3a507c70aa50" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Current Receivables </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current receivables include amounts due from pharmaceutical manufacturers for rebates and Medicare Part D drug discounts, accrued interest and other miscellaneous amounts due to the Company. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s pharmacy care services businesses contract with pharmaceutical manufacturers, some of which provide rebates based on use of the manufacturers&#8217; products by its affiliated and unaffiliated clients. The Company accrues rebates as they are earned by its clients on a monthly basis based on the terms of the applicable contracts, historical data and current estimates. The pharmacy care services businesses bill these rebates to the manufacturers on a monthly or quarterly basis depending on the contractual terms and record rebates attributable to affiliated clients as a reduction to medical costs. The Company generally receives rebates two to five months after billing. As of December&#160;31, 2021 and 2020, total pharmaceutical manufacturer rebates receivable included in other receivables in the Consolidated Balance Sheets amounted to $<ix:nonFraction unitRef="usd" contextRef="i46bb0d0f79554481a30ef5011a4f84b3_I20211231" decimals="-8" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMzMvZnJhZzplMTNlMzgwNWM2NzA0NDIzYWU0YzRjZTI3OTgzNDJiOC90ZXh0cmVnaW9uOmUxM2UzODA1YzY3MDQ0MjNhZTRjNGNlMjc5ODM0MmI4XzEwNjI_a85f8ce1-b4ba-496c-888d-c9718b146885">7.2</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="id24643699baf4fca9b1c7b6874e25228_I20201231" decimals="-8" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMzMvZnJhZzplMTNlMzgwNWM2NzA0NDIzYWU0YzRjZTI3OTgzNDJiOC90ZXh0cmVnaW9uOmUxM2UzODA1YzY3MDQ0MjNhZTRjNGNlMjc5ODM0MmI4XzEwNjk_12e7575b-2550-461f-b5f5-980ce2e4a884">6.3</ix:nonFraction> billion, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, the Company&#8217;s Medicare Part D receivables amounted to $<ix:nonFraction unitRef="usd" contextRef="i9e70f543d656432ab29e3070fc195a80_I20211231" decimals="-8" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMzMvZnJhZzplMTNlMzgwNWM2NzA0NDIzYWU0YzRjZTI3OTgzNDJiOC90ZXh0cmVnaW9uOmUxM2UzODA1YzY3MDQ0MjNhZTRjNGNlMjc5ODM0MmI4XzExNTg_32eded15-63e0-48a2-95c7-377030e6019b">3.4</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="ic913811c9e844fe4af3ff284c1deabc6_I20201231" decimals="-8" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMzMvZnJhZzplMTNlMzgwNWM2NzA0NDIzYWU0YzRjZTI3OTgzNDJiOC90ZXh0cmVnaW9uOmUxM2UzODA1YzY3MDQ0MjNhZTRjNGNlMjc5ODM0MmI4XzExNjU_4121dd30-4f16-48cc-8be5-116a0d005414">2.9</ix:nonFraction> billion, respectively.</span></div></ix:nonNumeric></ix:continuation><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_136"></div><ix:continuation id="i7c0a3227244f41bea8da2c10508f3977" continuedAt="ie425b66a1b03412bbe5815e41048f518"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMzYvZnJhZzoxNTI1MDc5MmNmZGI0NzlkYmM5NDNhOWFhZGM3YWEyOS90ZXh0cmVnaW9uOjE1MjUwNzkyY2ZkYjQ3OWRiYzk0M2E5YWFkYzdhYTI5XzE2NDkyNjc0NDI0MTQ_d815d13a-60e4-4b07-8589-6d5d69a57f51" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Equipment and Capitalized Software </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, equipment and capitalized software are stated at cost, net of accumulated depreciation and amortization. Capitalized software consists of certain costs incurred in the development of internal-use software, including external direct costs of materials and services and applicable payroll costs of employees devoted to specific software development. </span></div><ix:nonNumeric contextRef="ia1ff1cf727f44188aa9fc2cdae7f314c_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMzYvZnJhZzoxNTI1MDc5MmNmZGI0NzlkYmM5NDNhOWFhZGM3YWEyOS90ZXh0cmVnaW9uOjE1MjUwNzkyY2ZkYjQ3OWRiYzk0M2E5YWFkYzdhYTI5Xzc0MA_98f3bad7-3316-4e03-8715-63a7614ff1c2" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company calculates depreciation and amortization using the straight-line method over the estimated useful lives of the assets. The useful lives for property, equipment and capitalized software are: </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:57.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.689%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8384e266805d4927b90e345df1e3f524_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMzYvZnJhZzoxNTI1MDc5MmNmZGI0NzlkYmM5NDNhOWFhZGM3YWEyOS90YWJsZTowYThiN2E4ZmEyYzk0ZTIxOWM0YmZkNTk0OTgwNDY1Mi90YWJsZXJhbmdlOjBhOGI3YThmYTJjOTRlMjE5YzRiZmQ1OTQ5ODA0NjUyXzAtMS0xLTEtMjEyMTQvdGV4dHJlZ2lvbjpkMGM1OGU5NjY3ZGY0YjlkODY1OGI1NjYxOGExNTZkYV85MzQ1ODQ4ODM2MTE0_a5abd49c-40a9-406b-b16b-955a249529e0">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i87b309e50f2a486dadbe07f2c0015862_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMzYvZnJhZzoxNTI1MDc5MmNmZGI0NzlkYmM5NDNhOWFhZGM3YWEyOS90YWJsZTowYThiN2E4ZmEyYzk0ZTIxOWM0YmZkNTk0OTgwNDY1Mi90YWJsZXJhbmdlOjBhOGI3YThmYTJjOTRlMjE5YzRiZmQ1OTQ5ODA0NjUyXzAtMS0xLTEtMjEyMTQvdGV4dHJlZ2lvbjpkMGM1OGU5NjY3ZGY0YjlkODY1OGI1NjYxOGExNTZkYV85MzQ1ODQ4ODM2MTE5_b3d4cca5-e8b2-40d4-96e2-f564edbd41ab">10</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i122210b356e34cd393cb6d0422f9ff20_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMzYvZnJhZzoxNTI1MDc5MmNmZGI0NzlkYmM5NDNhOWFhZGM3YWEyOS90YWJsZTowYThiN2E4ZmEyYzk0ZTIxOWM0YmZkNTk0OTgwNDY1Mi90YWJsZXJhbmdlOjBhOGI3YThmYTJjOTRlMjE5YzRiZmQ1OTQ5ODA0NjUyXzEtMS0xLTEtMjEyMzUvdGV4dHJlZ2lvbjowZmZiMmJiYWFmNzg0ZmFhOWI4NzI4ZWQ3ZDIyOWI4NF85MzQ1ODQ4ODM2MTE2_15d45fce-2207-4f3a-9f3f-0cb58cee382b">35</ix:nonNumeric>&#160;to&#160;<ix:nonNumeric contextRef="i3c578a943465456dbb16da796df70705_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMzYvZnJhZzoxNTI1MDc5MmNmZGI0NzlkYmM5NDNhOWFhZGM3YWEyOS90YWJsZTowYThiN2E4ZmEyYzk0ZTIxOWM0YmZkNTk0OTgwNDY1Mi90YWJsZXJhbmdlOjBhOGI3YThmYTJjOTRlMjE5YzRiZmQ1OTQ5ODA0NjUyXzEtMS0xLTEtMjEyMzUvdGV4dHJlZ2lvbjowZmZiMmJiYWFmNzg0ZmFhOWI4NzI4ZWQ3ZDIyOWI4NF85MzQ1ODQ4ODM2MTIx_6d78afa6-8178-46ed-b3f5-dca6212c16c8">40</ix:nonNumeric>&#160;years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic338e78c17b54bdd9e1a900148c7981c_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMzYvZnJhZzoxNTI1MDc5MmNmZGI0NzlkYmM5NDNhOWFhZGM3YWEyOS90YWJsZTowYThiN2E4ZmEyYzk0ZTIxOWM0YmZkNTk0OTgwNDY1Mi90YWJsZXJhbmdlOjBhOGI3YThmYTJjOTRlMjE5YzRiZmQ1OTQ5ODA0NjUyXzItMS0xLTEtMjEyNDcvdGV4dHJlZ2lvbjoxNmI2ODVlMWM1ZDM0MGY2YjE0ZjhjMWQyNWUyNmVlZF85MzQ1ODQ4ODM2MTEz_fd0f44c0-b21b-4a22-86e5-ba93db6b2fe7">3</ix:nonNumeric> to <ix:nonNumeric contextRef="iff76c7d81e324fd3855a24b45c0f6feb_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMzYvZnJhZzoxNTI1MDc5MmNmZGI0NzlkYmM5NDNhOWFhZGM3YWEyOS90YWJsZTowYThiN2E4ZmEyYzk0ZTIxOWM0YmZkNTk0OTgwNDY1Mi90YWJsZXJhbmdlOjBhOGI3YThmYTJjOTRlMjE5YzRiZmQ1OTQ5ODA0NjUyXzItMS0xLTEtMjEyNDcvdGV4dHJlZ2lvbjoxNmI2ODVlMWM1ZDM0MGY2YjE0ZjhjMWQyNWUyNmVlZF85MzQ1ODQ4ODM2MTE3_d3bfca00-82fe-4a11-ba37-e381fb4718b9">5</ix:nonNumeric> years</span></div></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements are depreciated over the shorter of the remaining lease term or their estimated useful economic life.</span></div></ix:nonNumeric></ix:continuation><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_139"></div><ix:continuation id="ie425b66a1b03412bbe5815e41048f518" continuedAt="i90e0e6a38f2748e0bfac7ed658230f59"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMzkvZnJhZzozOWM0MWQ2MGNlMTY0YmE0ODc3NjQwMmU1YjNiMTU1OS90ZXh0cmVnaW9uOjM5YzQxZDYwY2UxNjRiYTQ4Nzc2NDAyZTViM2IxNTU5XzE2NDkyNjc0NDI0MDk_06b579e6-4d07-4bdf-b3aa-39cd8ddceb6f" continuedAt="i7e1e7a149b6041b88d7890c857871845" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases facilities and equipment under long-term operating leases which are non-cancelable and expire on various dates. At the lease commencement date, lease right-of-use (ROU) assets and lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term, which includes all fixed obligations arising from the lease contract. If an interest rate is not implicit in a lease, the Company utilizes its incremental borrowing rate for a period closely matching the lease term. </span></div></ix:nonNumeric><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7e1e7a149b6041b88d7890c857871845">The Company&#8217;s ROU assets are included in other assets, and lease liabilities are included in other current liabilities and other liabilities in the Company&#8217;s Consolidated Balance Sheet.</ix:continuation> </span></div></ix:continuation><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_142"></div><ix:continuation id="i90e0e6a38f2748e0bfac7ed658230f59" continuedAt="i5050299f94804e5992c20c755c158ff1"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNDIvZnJhZzo4MGIxODQ1ZGY0MWI0NzI1ODBkOTllYjg1NDE0NzFjOS90ZXh0cmVnaW9uOjgwYjE4NDVkZjQxYjQ3MjU4MGQ5OWViODU0MTQ3MWM5XzE2NDkyNjc0NDI5ODE_dfa717bc-0e1f-4836-a3e9-08e5b80dde94" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To determine whether goodwill is impaired, annually or more frequently if needed, the Company performs impairment tests. The Company may first assess qualitative factors to determine if it is more likely than not the carrying value of a reporting unit exceeds its estimated fair value. The Company may also elect to skip the qualitative testing and proceed directly to the quantitative testing. When performing quantitative testing, the Company first estimates the fair values of its reporting units using discounted cash flows or a weighted combination of discounted cash flows and a market-based method. To determine fair values, the Company must make assumptions about a wide variety of internal and external factors. Significant assumptions used in the impairment analysis include financial projections of free cash flow (including significant assumptions about operations, capital requirements and income taxes), long-term growth rates for determining terminal value, discount rates and the selection of comparable peer companies. If the fair value is less than the carrying value of the reporting unit, an impairment is recognized for the difference, up to the carrying amount of goodwill.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was <ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNDIvZnJhZzo4MGIxODQ1ZGY0MWI0NzI1ODBkOTllYjg1NDE0NzFjOS90ZXh0cmVnaW9uOjgwYjE4NDVkZjQxYjQ3MjU4MGQ5OWViODU0MTQ3MWM5XzI3NDg3NzkwNzA3NjE_03c5c1e2-44ff-45b9-ac9b-0d1afa1cc1ad"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNDIvZnJhZzo4MGIxODQ1ZGY0MWI0NzI1ODBkOTllYjg1NDE0NzFjOS90ZXh0cmVnaW9uOjgwYjE4NDVkZjQxYjQ3MjU4MGQ5OWViODU0MTQ3MWM5XzI3NDg3NzkwNzA3NjE_ba9ce637-86b9-4584-af00-5b46b639167e"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNDIvZnJhZzo4MGIxODQ1ZGY0MWI0NzI1ODBkOTllYjg1NDE0NzFjOS90ZXh0cmVnaW9uOjgwYjE4NDVkZjQxYjQ3MjU4MGQ5OWViODU0MTQ3MWM5XzI3NDg3NzkwNzA3NjE_d0c5f157-8d4b-4035-8d65-106e58ed7f2f">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> impairment of goodwill during the years ended December&#160;31, 2021, 2020 and 2019.</span></div></ix:nonNumeric></ix:continuation><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_145"></div><ix:continuation id="i5050299f94804e5992c20c755c158ff1" continuedAt="i1e3866aef47a413985ab4b62c0091d86"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNDUvZnJhZzphYjBjMWU2OGU3YmE0MDEzYTMwNzQyZjliNDQ4NmE5OS90ZXh0cmVnaW9uOmFiMGMxZTY4ZTdiYTQwMTNhMzA3NDJmOWI0NDg2YTk5XzE2NDkyNjc0NDIwNTA_69feec5e-e86d-4dca-8031-f8b338242974" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s intangible assets are subject to impairment tests when events or circumstances indicate an intangible asset (or asset group) may be impaired. The Company&#8217;s indefinite-lived intangible assets are also tested for impairment annually. There was <ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNDUvZnJhZzphYjBjMWU2OGU3YmE0MDEzYTMwNzQyZjliNDQ4NmE5OS90ZXh0cmVnaW9uOmFiMGMxZTY4ZTdiYTQwMTNhMzA3NDJmOWI0NDg2YTk5XzI3NDg3NzkwNjk4MzA_1253ce9f-76cb-4ae9-bb13-efe8a43107b3"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNDUvZnJhZzphYjBjMWU2OGU3YmE0MDEzYTMwNzQyZjliNDQ4NmE5OS90ZXh0cmVnaW9uOmFiMGMxZTY4ZTdiYTQwMTNhMzA3NDJmOWI0NDg2YTk5XzI3NDg3NzkwNjk4MzA_2f0dbf89-08b9-4b7a-8f38-5cfd2c78789e"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNDUvZnJhZzphYjBjMWU2OGU3YmE0MDEzYTMwNzQyZjliNDQ4NmE5OS90ZXh0cmVnaW9uOmFiMGMxZTY4ZTdiYTQwMTNhMzA3NDJmOWI0NDg2YTk5XzI3NDg3NzkwNjk4MzA_d8903477-080f-47a2-9473-9d7b480d6dcd">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> impairment of intangible assets during the years ended December&#160;31, 2021, 2020 and 2019.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_148"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><ix:continuation id="i1e3866aef47a413985ab4b62c0091d86" continuedAt="i361e71af8a644188b4d305ac21c89ade"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="unh:OtherLiabilitiesCurrentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNDgvZnJhZzoyODYxMGYxMjlkNTc0MTBkYjhmYjg3ZmI3ZDI4ODA1Yi90ZXh0cmVnaW9uOjI4NjEwZjEyOWQ1NzQxMGRiOGZiODdmYjdkMjg4MDViXzE2NDkyNjc0NDIxNjc_55133aba-cda7-4067-922a-59dd6e5c85bd" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Current Liabilities </span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities include health savings account deposits ($<ix:nonFraction unitRef="usd" contextRef="iea339ff4f3c94a45a63d0fe4f74ba6f4_I20211231" decimals="-8" name="us-gaap:DemandDepositAccounts" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNDgvZnJhZzoyODYxMGYxMjlkNTc0MTBkYjhmYjg3ZmI3ZDI4ODA1Yi90ZXh0cmVnaW9uOjI4NjEwZjEyOWQ1NzQxMGRiOGZiODdmYjdkMjg4MDViXzQzOTgwNDY1MTE1MTk_86c9e3bc-572c-4351-8d15-792a8b0f5bfb">11.4</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="ie60f9bda7240423e99aefddba5815436_I20201231" decimals="-8" name="us-gaap:DemandDepositAccounts" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNDgvZnJhZzoyODYxMGYxMjlkNTc0MTBkYjhmYjg3ZmI3ZDI4ODA1Yi90ZXh0cmVnaW9uOjI4NjEwZjEyOWQ1NzQxMGRiOGZiODdmYjdkMjg4MDViXzQzOTgwNDY1MTE1MDM_95d12898-94d1-4fa8-81b8-8bc9adb27f28">10.2</ix:nonFraction> billion as of December&#160;31, 2021 and 2020, respectively), accruals for premium rebates payable, the RSF associated with the AARP Program, the current portion of future policy benefits and customer balances.</span></div></ix:nonNumeric></ix:continuation><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_151"></div><ix:continuation id="i361e71af8a644188b4d305ac21c89ade" continuedAt="i82addbdeb231453dacc683d336a28e3f"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:CapitalizationOfDeferredPolicyAcquisitionCostsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTEvZnJhZzphZDE0ZTNkMTFjZDY0YjA5OWUzN2I3MWM3OTJhMzhjOC90ZXh0cmVnaW9uOmFkMTRlM2QxMWNkNjRiMDk5ZTM3YjcxYzc5MmEzOGM4XzE2NDkyNjc0NDE5ODI_5cc74be7-2b87-4e0a-87c1-9a00efd15ffc" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Policy Acquisition Costs</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s short duration health insurance contracts typically have a one-year term and may be canceled by the customer with at least <ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="unh:NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTEvZnJhZzphZDE0ZTNkMTFjZDY0YjA5OWUzN2I3MWM3OTJhMzhjOC90ZXh0cmVnaW9uOmFkMTRlM2QxMWNkNjRiMDk5ZTM3YjcxYzc5MmEzOGM4XzE2Nw_54beb61c-378a-4d75-8353-3d4194230c38"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="unh:NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTEvZnJhZzphZDE0ZTNkMTFjZDY0YjA5OWUzN2I3MWM3OTJhMzhjOC90ZXh0cmVnaW9uOmFkMTRlM2QxMWNkNjRiMDk5ZTM3YjcxYzc5MmEzOGM4XzI3NDg3NzkwNjk3NTk_9f6e7788-2f87-4152-b4e6-2013865f1e0c">30</ix:nonNumeric></ix:nonNumeric> days&#8217; notice. Costs related to the acquisition and renewal of short duration customer contracts are primarily charged to expense as incurred.</span></div></ix:nonNumeric></ix:continuation><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_154"></div><ix:continuation id="i82addbdeb231453dacc683d336a28e3f" continuedAt="i5290dd5b08354f6494932d89261812ec"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTQvZnJhZzo1MmU1NWZlN2RkMmI0OWUxOTZjZDllZTk3NTcxNmQ2NS90ZXh0cmVnaW9uOjUyZTU1ZmU3ZGQyYjQ5ZTE5NmNkOWVlOTc1NzE2ZDY1XzE2NDkyNjc0NDIwMDc_aa021dc1-ee6c-4aad-b78c-b472d01e8e51" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redeemable Noncontrolling Interests</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redeemable noncontrolling interests in the Company&#8217;s subsidiaries whose redemption is outside the control of the Company are classified as temporary equity. <ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:RedeemableNoncontrollingInterestTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTQvZnJhZzo1MmU1NWZlN2RkMmI0OWUxOTZjZDllZTk3NTcxNmQ2NS90ZXh0cmVnaW9uOjUyZTU1ZmU3ZGQyYjQ5ZTE5NmNkOWVlOTc1NzE2ZDY1XzMzOQ_afed4725-3d52-4137-8526-c3a3b272c886" continuedAt="i24386cd2d615438cbcd0144869e404bc" escape="true">The following table provides details of the Company's redeemable noncontrolling interests&#8217; activity for the years ended December&#160;31, 2021 and 2020:</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt"><ix:continuation id="i24386cd2d615438cbcd0144869e404bc"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.215%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.014%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib55d7c02a76f495eadd39abf177a36b9_I20201231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTQvZnJhZzo1MmU1NWZlN2RkMmI0OWUxOTZjZDllZTk3NTcxNmQ2NS90YWJsZTo4MTkxMjRmOTZiZTY0YTMxYjgyODg4Y2RlZDIzYjA3Ny90YWJsZXJhbmdlOjgxOTEyNGY5NmJlNjRhMzFiODI4ODhjZGVkMjNiMDc3XzEtMi0xLTEtMA_8f4056b8-0265-4826-b18d-e13a06fcd58d">2,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb906a7e10bf4c67a37f412d39862ee2_I20191231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTQvZnJhZzo1MmU1NWZlN2RkMmI0OWUxOTZjZDllZTk3NTcxNmQ2NS90YWJsZTo4MTkxMjRmOTZiZTY0YTMxYjgyODg4Y2RlZDIzYjA3Ny90YWJsZXJhbmdlOjgxOTEyNGY5NmJlNjRhMzFiODI4ODhjZGVkMjNiMDc3XzEtNC0xLTEtMA_0919f580-1f23-4d84-87e6-1857fa0cd0eb">1,726</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c331befb394cb6b31c1d43cedab05f_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTQvZnJhZzo1MmU1NWZlN2RkMmI0OWUxOTZjZDllZTk3NTcxNmQ2NS90YWJsZTo4MTkxMjRmOTZiZTY0YTMxYjgyODg4Y2RlZDIzYjA3Ny90YWJsZXJhbmdlOjgxOTEyNGY5NmJlNjRhMzFiODI4ODhjZGVkMjNiMDc3XzItMi0xLTEtMA_a82a853d-ee3c-4cf8-94ce-745b5f60158e">87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d71c28a51a741d4b83d1e2cb290100d_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTQvZnJhZzo1MmU1NWZlN2RkMmI0OWUxOTZjZDllZTk3NTcxNmQ2NS90YWJsZTo4MTkxMjRmOTZiZTY0YTMxYjgyODg4Y2RlZDIzYjA3Ny90YWJsZXJhbmdlOjgxOTEyNGY5NmJlNjRhMzFiODI4ODhjZGVkMjNiMDc3XzItNC0xLTEtMA_4a3643de-6fb9-48e6-bf40-76e45a873020">112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c331befb394cb6b31c1d43cedab05f_D20210101-20211231" decimals="-6" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTQvZnJhZzo1MmU1NWZlN2RkMmI0OWUxOTZjZDllZTk3NTcxNmQ2NS90YWJsZTo4MTkxMjRmOTZiZTY0YTMxYjgyODg4Y2RlZDIzYjA3Ny90YWJsZXJhbmdlOjgxOTEyNGY5NmJlNjRhMzFiODI4ODhjZGVkMjNiMDc3XzMtMi0xLTEtMA_e406a097-7053-4277-bbf2-8bc81761fdf7">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d71c28a51a741d4b83d1e2cb290100d_D20200101-20201231" decimals="-6" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTQvZnJhZzo1MmU1NWZlN2RkMmI0OWUxOTZjZDllZTk3NTcxNmQ2NS90YWJsZTo4MTkxMjRmOTZiZTY0YTMxYjgyODg4Y2RlZDIzYjA3Ny90YWJsZXJhbmdlOjgxOTEyNGY5NmJlNjRhMzFiODI4ODhjZGVkMjNiMDc3XzMtNC0xLTEtMA_b4ceef39-41ba-4aad-be80-db70f9b48c0c">321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemptions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91c331befb394cb6b31c1d43cedab05f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:MinorityInterestDecreaseFromRedemptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTQvZnJhZzo1MmU1NWZlN2RkMmI0OWUxOTZjZDllZTk3NTcxNmQ2NS90YWJsZTo4MTkxMjRmOTZiZTY0YTMxYjgyODg4Y2RlZDIzYjA3Ny90YWJsZXJhbmdlOjgxOTEyNGY5NmJlNjRhMzFiODI4ODhjZGVkMjNiMDc3XzQtMi0xLTEtMA_0cd599b6-48ac-4038-8729-feac29e99840">1,338</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d71c28a51a741d4b83d1e2cb290100d_D20200101-20201231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromRedemptions" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTQvZnJhZzo1MmU1NWZlN2RkMmI0OWUxOTZjZDllZTk3NTcxNmQ2NS90YWJsZTo4MTkxMjRmOTZiZTY0YTMxYjgyODg4Y2RlZDIzYjA3Ny90YWJsZXJhbmdlOjgxOTEyNGY5NmJlNjRhMzFiODI4ODhjZGVkMjNiMDc3XzQtNC0xLTEtMA_22b4d4ed-72d9-47c9-876f-5fe26c0896f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91c331befb394cb6b31c1d43cedab05f_D20210101-20211231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTQvZnJhZzo1MmU1NWZlN2RkMmI0OWUxOTZjZDllZTk3NTcxNmQ2NS90YWJsZTo4MTkxMjRmOTZiZTY0YTMxYjgyODg4Y2RlZDIzYjA3Ny90YWJsZXJhbmdlOjgxOTEyNGY5NmJlNjRhMzFiODI4ODhjZGVkMjNiMDc3XzUtMi0xLTEtMA_fe7ffd36-104f-4258-9aed-1c034ac275d8">255</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d71c28a51a741d4b83d1e2cb290100d_D20200101-20201231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTQvZnJhZzo1MmU1NWZlN2RkMmI0OWUxOTZjZDllZTk3NTcxNmQ2NS90YWJsZTo4MTkxMjRmOTZiZTY0YTMxYjgyODg4Y2RlZDIzYjA3Ny90YWJsZXJhbmdlOjgxOTEyNGY5NmJlNjRhMzFiODI4ODhjZGVkMjNiMDc3XzUtNC0xLTEtMA_707ca617-335f-45c7-b9e4-305c40842717">149</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value and other adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c331befb394cb6b31c1d43cedab05f_D20210101-20211231" decimals="-6" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTQvZnJhZzo1MmU1NWZlN2RkMmI0OWUxOTZjZDllZTk3NTcxNmQ2NS90YWJsZTo4MTkxMjRmOTZiZTY0YTMxYjgyODg4Y2RlZDIzYjA3Ny90YWJsZXJhbmdlOjgxOTEyNGY5NmJlNjRhMzFiODI4ODhjZGVkMjNiMDc3XzYtMi0xLTEtMA_a7c73fde-440e-404c-98d1-1fe13cfb774a">701</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d71c28a51a741d4b83d1e2cb290100d_D20200101-20201231" decimals="-6" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTQvZnJhZzo1MmU1NWZlN2RkMmI0OWUxOTZjZDllZTk3NTcxNmQ2NS90YWJsZTo4MTkxMjRmOTZiZTY0YTMxYjgyODg4Y2RlZDIzYjA3Ny90YWJsZXJhbmdlOjgxOTEyNGY5NmJlNjRhMzFiODI4ODhjZGVkMjNiMDc3XzYtNC0xLTEtMA_e74b042b-67ca-4314-95c9-50160a977692">201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests, end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7962e972c7344539b9b1d82ad79a7df_I20211231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTQvZnJhZzo1MmU1NWZlN2RkMmI0OWUxOTZjZDllZTk3NTcxNmQ2NS90YWJsZTo4MTkxMjRmOTZiZTY0YTMxYjgyODg4Y2RlZDIzYjA3Ny90YWJsZXJhbmdlOjgxOTEyNGY5NmJlNjRhMzFiODI4ODhjZGVkMjNiMDc3XzctMi0xLTEtMA_6e1c97a0-9dd1-43ff-8a41-f867fb276db1">1,434</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib55d7c02a76f495eadd39abf177a36b9_I20201231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTQvZnJhZzo1MmU1NWZlN2RkMmI0OWUxOTZjZDllZTk3NTcxNmQ2NS90YWJsZTo4MTkxMjRmOTZiZTY0YTMxYjgyODg4Y2RlZDIzYjA3Ny90YWJsZXJhbmdlOjgxOTEyNGY5NmJlNjRhMzFiODI4ODhjZGVkMjNiMDc3XzctNC0xLTEtMA_8f4056b8-0265-4826-b18d-e13a06fcd58d">2,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:nonNumeric></ix:continuation><div style="margin-top:6pt;text-align:center"><span><br/></span></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_157"></div><ix:continuation id="i5290dd5b08354f6494932d89261812ec" continuedAt="i729a8323407a4557b8bfdf9b454cd2ac"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTcvZnJhZzoyNzA4MDU3MzhiZjc0MzA5ODVmOTgzMjNiMGZkMzIxNy90ZXh0cmVnaW9uOjI3MDgwNTczOGJmNzQzMDk4NWY5ODMyM2IwZmQzMjE3XzE2NDkyNjc0NDI4ODY_65316dd8-a33f-42ed-a62a-6aa057b4b5ab" continuedAt="i1ebada94f001407d92a7ca7dd9d694b5" escape="true">Share-Based Compensation</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1ebada94f001407d92a7ca7dd9d694b5">The Company recognizes compensation expense for share-based awards, including stock options and restricted stock and restricted stock units (collectively, restricted shares), on a straight-line basis over the related service period (generally the vesting period) of the award, or to an employee&#8217;s eligible retirement date under the award agreement, if earlier. Restricted shares vest ratably, primarily over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTcvZnJhZzoyNzA4MDU3MzhiZjc0MzA5ODVmOTgzMjNiMGZkMzIxNy90ZXh0cmVnaW9uOjI3MDgwNTczOGJmNzQzMDk4NWY5ODMyM2IwZmQzMjE3XzQzOA_eb1bf801-8e88-43f4-addf-b3432e5c7bdc">four</span> years and compensation expense related to restricted shares is based on the share price on the date of grant. Stock options vest ratably primarily over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTcvZnJhZzoyNzA4MDU3MzhiZjc0MzA5ODVmOTgzMjNiMGZkMzIxNy90ZXh0cmVnaW9uOjI3MDgwNTczOGJmNzQzMDk4NWY5ODMyM2IwZmQzMjE3XzM4NDgyOTA2OTg0NDE_e5312511-99bf-4e41-b5f9-1d6cc88b8bfd">four</span> years and may be exercised up to <ix:nonNumeric contextRef="i4d96f9ce242e4c3d8115ee3621f39cbe_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTcvZnJhZzoyNzA4MDU3MzhiZjc0MzA5ODVmOTgzMjNiMGZkMzIxNy90ZXh0cmVnaW9uOjI3MDgwNTczOGJmNzQzMDk4NWY5ODMyM2IwZmQzMjE3XzM4NDgyOTA2OTg0NjA_804f51fe-a216-44d3-9ecd-c3062eb4848a">10</ix:nonNumeric> years from the date of grant. Compensation expense related to stock options is based on the fair value at the date of grant, which is estimated on the date of grant using a binomial option-pricing model. Under the Company&#8217;s Employee Stock Purchase Plan (ESPP), eligible employees are allowed to purchase the Company&#8217;s stock at a discounted price, which is 90% of the market price of the Company&#8217;s common stock at the end of the six-month purchase period. Share-based compensation expense for all programs is recognized in operating costs in the Consolidated Statements of Operations.</ix:continuation> </span></div></ix:continuation><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_160"></div><ix:continuation id="i729a8323407a4557b8bfdf9b454cd2ac" continuedAt="i7e468bf8e4b244e8a6caa3b0b86ffb4a"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjAvZnJhZzo4ZTMxY2M3MDhmOGU0ZTcyOTM4YzJhZTFjYWU3NTY1MC90ZXh0cmVnaW9uOjhlMzFjYzcwOGY4ZTRlNzI5MzhjMmFlMWNhZTc1NjUwXzE2NDkyNjc0NDI4MDI_ec1c94d4-881f-4a08-92dc-be4c03b74484" continuedAt="i97028787eabc453ea1f2394fbdb0732a" escape="true">Net Earnings Per Common Share </ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i97028787eabc453ea1f2394fbdb0732a">The Company computes basic earnings per common share attributable to UnitedHealth Group common shareholders by dividing net earnings attributable to UnitedHealth Group common shareholders by the weighted-average number of common shares outstanding during the period. The Company determines diluted net earnings per common share attributable to UnitedHealth Group common shareholders using the weighted-average number of common shares outstanding during the period, adjusted for potentially dilutive shares associated with stock options, restricted shares and the ESPP (collectively, common stock equivalents), using the treasury stock method. The treasury stock method assumes a hypothetical issuance of shares to settle the share-based awards, with the assumed proceeds used to purchase common stock at the average market price for the period. Assumed proceeds include the amount the employee must pay upon exercise and the average unrecognized compensation cost. The difference between the number of shares assumed issued and number of shares assumed purchased represents the dilutive shares.</ix:continuation> </span></div></ix:continuation><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_163"></div><ix:continuation id="i7e468bf8e4b244e8a6caa3b0b86ffb4a"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:IndustrySpecificPoliciesInsuranceCompaniesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjMvZnJhZzpjYTI2NWY1YjMwMzE0ZWI1YWI4OTJiOGZjODVkNDI3Mi90ZXh0cmVnaW9uOmNhMjY1ZjViMzAzMTRlYjVhYjg5MmI4ZmM4NWQ0MjcyXzE2NDkyNjc0NDMxMzQ_96d7a3b2-c63e-4ee3-a0af-1d7187f6862f" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ACA Tax</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Insurance Tax was permanently repealed by Congress, effective January 1, 2021. The permanent repeal of the tax impacts year-over-year comparability of our financial statements, including revenues, operating costs, medical care ratio (MCR), operating cost ratio, effective tax rate and cash flows from operations.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_169"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90ZXh0cmVnaW9uOmI3ZjA4OGU5MmIxNTQxMjQ4NjY5ZWY4MjhjMGI1YWE2XzM4NDgyOTA3MDE2ODc_5b486bfb-a0f9-4231-baf7-bfc512d7679a" continuedAt="i1810a6bbe7d54eab8947f3c6ebe45d20" escape="true">Investments</ix:nonNumeric></span></div><ix:continuation id="i1810a6bbe7d54eab8947f3c6ebe45d20" continuedAt="i706c7cd05b7b4089b74721666cb4cf98"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90ZXh0cmVnaW9uOmI3ZjA4OGU5MmIxNTQxMjQ4NjY5ZWY4MjhjMGI1YWE2XzIyOTI_8cd25faf-4ad9-4097-96c5-ebbeddb7a5f6" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of debt securities by major security type is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.020%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - available-for-sale:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5bcfc870d824827bb66dd636d076fd1_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzMtMi0xLTEtMA_d6a15a9b-27d6-4eb7-9a27-996687f0d51c">3,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5bcfc870d824827bb66dd636d076fd1_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzMtNC0xLTEtMA_86339829-a6f0-4efc-a51a-1edec91b75ae">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5bcfc870d824827bb66dd636d076fd1_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzMtNi0xLTEtMA_9115f8eb-1db3-40e5-95af-6c2d93e5b47f">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5bcfc870d824827bb66dd636d076fd1_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzMtOC0xLTEtMA_d329e4c9-9d95-4ff2-9666-ab8f4f55ea81">3,198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24678048e47943bb91d8def4d5f22212_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzQtMi0xLTEtMA_37612247-5c8c-4d9a-94a3-0b67bcbc4e2d">6,829</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24678048e47943bb91d8def4d5f22212_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzQtNC0xLTEtMA_948904b9-af69-4f72-9713-0434f6248ba2">297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24678048e47943bb91d8def4d5f22212_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzQtNi0xLTEtMA_7d254b7f-e8b0-42e7-928f-fecbd6c4f4fc">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24678048e47943bb91d8def4d5f22212_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzQtOC0xLTEtMA_c7f9d7a3-db97-458b-83b0-a1158a8d7337">7,106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60063fc646f547e0ac686bc7d0b92112_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzUtMi0xLTEtMA_1e74e644-b63d-458b-9b52-a288db9fa011">20,947</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60063fc646f547e0ac686bc7d0b92112_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzUtNC0xLTEtMA_be7252bf-9ee6-4a6e-9614-0a88fe959b99">372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i60063fc646f547e0ac686bc7d0b92112_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzUtNi0xLTEtMA_b4fee5a0-b06c-4a43-9385-556ca01aa795">145</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60063fc646f547e0ac686bc7d0b92112_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzUtOC0xLTEtMA_f5f5fc86-77f9-47cd-861b-19f1a1c1e024">21,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5a1b74f16184b9bb2add4cab25e29f2_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzYtMi0xLTEtMA_96c68b4c-a20b-4af9-86be-ffa922d0714d">5,868</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5a1b74f16184b9bb2add4cab25e29f2_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzYtNC0xLTEtMA_3eca7272-916b-4f73-b37d-627c4959d4ec">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5a1b74f16184b9bb2add4cab25e29f2_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzYtNi0xLTEtMA_c74ca133-76ee-4c62-ae27-461e12f9c364">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5a1b74f16184b9bb2add4cab25e29f2_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzYtOC0xLTEtMA_bfda935f-8028-4715-967a-d8e9d9755c6c">5,901</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b784ace82c244c5867ac2f828eb7a57_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzctMi0xLTEtMA_180379ed-62ad-47e4-b691-24136adce3a3">2,819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b784ace82c244c5867ac2f828eb7a57_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzctNC0xLTEtMA_0ccb90aa-244f-4967-8348-ded932d6e1ea">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b784ace82c244c5867ac2f828eb7a57_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzctNi0xLTEtMA_1ae1bb62-289b-4b9b-8e68-6a9a02e770c1">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b784ace82c244c5867ac2f828eb7a57_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzctOC0xLTEtMA_438305d4-1023-4835-999f-8f6f2786cea0">2,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzgtMi0xLTEtMA_bc74dd95-474b-4c88-af1a-4d3663e8548a">39,669</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzgtNC0xLTEtMA_d8461dfa-c667-489f-89cd-6092eadfecde">822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzgtNi0xLTEtMA_d5f622ab-fe42-4391-9639-f58c828269eb">274</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzgtOC0xLTEtMA_a7f68502-b639-4623-b1f7-0bd086543f50">40,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - held-to-maturity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5bcfc870d824827bb66dd636d076fd1_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzEwLTItMS0xLTA_e613af3f-88cc-47c3-ad8f-d0929288d6ce">511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5bcfc870d824827bb66dd636d076fd1_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzEwLTQtMS0xLTA_e1a32dd2-2595-4318-a5b9-165179aeca69">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5bcfc870d824827bb66dd636d076fd1_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzEwLTYtMS0xLTA_aeeb33ef-e5ce-4fce-8573-3f55552b0280">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5bcfc870d824827bb66dd636d076fd1_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzEwLTgtMS0xLTA_eaba0b67-17f9-47de-beca-4081d7a02527">511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24678048e47943bb91d8def4d5f22212_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzExLTItMS0xLTA_c46abaf2-3819-4dc6-bcad-fec77b661b0f">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24678048e47943bb91d8def4d5f22212_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzExLTQtMS0xLTA_9b3c898d-1175-48af-80f9-8083583ebd31">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24678048e47943bb91d8def4d5f22212_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzExLTYtMS0xLTA_d9515035-50e0-4c42-874b-051b0b4f7fb7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24678048e47943bb91d8def4d5f22212_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzExLTgtMS0xLTA_d2c2043c-e8de-4f9e-a811-e6725a81a256">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60063fc646f547e0ac686bc7d0b92112_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzEyLTItMS0xLTA_24425d42-efa8-4b0d-b8da-6d789f426c29">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60063fc646f547e0ac686bc7d0b92112_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzEyLTQtMS0xLTA_54209a30-d2bf-4d36-b086-b1d2e732f717">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60063fc646f547e0ac686bc7d0b92112_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzEyLTYtMS0xLTA_d4aef2ee-5213-42e4-b225-f00fa6db7094">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60063fc646f547e0ac686bc7d0b92112_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzEyLTgtMS0xLTA_b8eafd06-a10f-4f29-8050-56e09e75070a">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - held-to-maturity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzEzLTItMS0xLTA_3eac97b2-bab9-4c25-b408-8c5c12b13910">641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzEzLTQtMS0xLTA_0b54b58b-f428-43fb-a95e-b8d3a6b6a817">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzEzLTYtMS0xLTA_5ae5671c-77f9-4d5d-800f-76146f627d17">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzEzLTgtMS0xLTA_4c8782c8-debe-4775-a885-9e820a21cadc">643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="unh:InvestmentsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzE0LTItMS0xLTA_9e32d799-5017-4e13-bedd-ff66c2d38aad">40,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="unh:InvestmentsGrossUnrealizedGains" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzE0LTQtMS0xLTA_be6d3f1a-4d38-41a5-8e96-322d5acb7481">826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="unh:InvestmentsGrossUnrealizedLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzE0LTYtMS0xLTA_8b83d9cc-af64-429f-9d74-d522a226373e">276</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzE0LTgtMS0xLTA_0aaceea8-9ab8-44c3-8282-4f9178c95f5a">40,860</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - available-for-sale:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a312b80055e4af7bc076c9e6f9c43e6_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzE3LTItMS0xLTA_7592cc29-e297-4892-bc79-36d42fdc69a9">3,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a312b80055e4af7bc076c9e6f9c43e6_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzE3LTQtMS0xLTA_c411abd0-9a11-4405-8738-ec88cf5dc157">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a312b80055e4af7bc076c9e6f9c43e6_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzE3LTYtMS0xLTA_2edb8478-ac06-41f1-ab7b-4d156aa985a8">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a312b80055e4af7bc076c9e6f9c43e6_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzE3LTgtMS0xLTA_c88d8985-1690-4eb0-8761-1d3c3a4106b6">3,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe8be8f0fb534e25be1cc040ead9f99f_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzE4LTItMS0xLTA_e3066cfe-6496-42a8-b861-b0c3cf3b95e0">6,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe8be8f0fb534e25be1cc040ead9f99f_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzE4LTQtMS0xLTA_b84923aa-d9cb-423e-831d-95c900833378">435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe8be8f0fb534e25be1cc040ead9f99f_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzE4LTYtMS0xLTA_106f98d5-05a2-4ac2-948e-be62dcd902c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe8be8f0fb534e25be1cc040ead9f99f_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzE4LTgtMS0xLTA_0e974396-5ecf-47fa-bb48-e99fdc2f2f49">7,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib130b8ba2819452594b22d15469baacb_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzE5LTItMS0xLTA_f9205c4d-89eb-40fe-81de-480bc3df6ceb">18,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib130b8ba2819452594b22d15469baacb_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzE5LTQtMS0xLTA_664b0672-443e-4a65-aeed-3da931263ac1">863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib130b8ba2819452594b22d15469baacb_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzE5LTYtMS0xLTA_8730db54-a484-4597-bc7a-ac9721378002">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib130b8ba2819452594b22d15469baacb_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzE5LTgtMS0xLTA_4b5cb011-b3a9-4168-a8a4-e7d8231ec5f4">19,737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ec806aa176a4bbb99266b4a32cf1ded_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzIwLTItMS0xLTA_6df887e3-3334-41e9-a124-09e68a5bfd93">6,849</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ec806aa176a4bbb99266b4a32cf1ded_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzIwLTQtMS0xLTA_c55100fc-1b83-4ba7-a0a5-43b10a9677fc">245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ec806aa176a4bbb99266b4a32cf1ded_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzIwLTYtMS0xLTA_5ca58eaa-2272-4797-a208-055ad4d77f81">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ec806aa176a4bbb99266b4a32cf1ded_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzIwLTgtMS0xLTA_da1e0a68-9ea6-4422-a0ec-454471b2089e">7,091</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieda9939b5a6c4fdeb0d28e0580ab8d78_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzIxLTItMS0xLTA_57db3b78-41a9-4afd-9815-9f16cb5d0c6e">2,116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieda9939b5a6c4fdeb0d28e0580ab8d78_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzIxLTQtMS0xLTA_a9afbf7d-2be5-4d03-94b0-65ff23152d0c">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieda9939b5a6c4fdeb0d28e0580ab8d78_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzIxLTYtMS0xLTA_db671980-a679-49cb-8e5e-7f4f2bdd350d">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieda9939b5a6c4fdeb0d28e0580ab8d78_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzIxLTgtMS0xLTA_d850130d-e78d-4471-bf40-bb651888edb7">2,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzIyLTItMS0xLTA_3f59cff1-d70f-475e-85f0-09bc5de5a1a6">38,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzIyLTQtMS0xLTA_90ef326a-37fc-4b83-9a38-46e00cbe706e">1,771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzIyLTYtMS0xLTA_efec8289-b3a4-4a6d-a06c-77d430e9fc30">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzIyLTgtMS0xLTA_b95af02d-3a0d-4c05-8dfb-dadaa92d36b0">39,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - held-to-maturity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a312b80055e4af7bc076c9e6f9c43e6_I20201231" decimals="-6" name="us-gaap:HeldToMaturitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI0LTItMS0xLTA_5cd09321-e335-4361-acc1-53f5fb31bc1d">420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a312b80055e4af7bc076c9e6f9c43e6_I20201231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI0LTQtMS0xLTA_63d3c7a8-4358-4326-8d5d-b9ce09607ba9">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a312b80055e4af7bc076c9e6f9c43e6_I20201231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI0LTYtMS0xLTA_efc4e8c2-dc11-4a1e-9e9b-f7cfb884c145">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a312b80055e4af7bc076c9e6f9c43e6_I20201231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI0LTgtMS0xLTA_0bd23f19-d8b4-4bb3-815a-c93d03985511">426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe8be8f0fb534e25be1cc040ead9f99f_I20201231" decimals="-6" name="us-gaap:HeldToMaturitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI1LTItMS0xLTA_4596c782-5843-4e39-913b-3ba27fb4247d">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe8be8f0fb534e25be1cc040ead9f99f_I20201231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI1LTQtMS0xLTA_51188778-b67f-4605-bef3-918dc230d0a3">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe8be8f0fb534e25be1cc040ead9f99f_I20201231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI1LTYtMS0xLTA_3b9669ea-5625-4ebc-b4a2-7e84da0c8eec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe8be8f0fb534e25be1cc040ead9f99f_I20201231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI1LTgtMS0xLTA_70a05fbd-eeac-4ce6-bcb9-9e534a98e17e">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib130b8ba2819452594b22d15469baacb_I20201231" decimals="-6" name="us-gaap:HeldToMaturitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI2LTItMS0xLTA_6deca221-c3b3-4e42-851c-0e080b5ec3ab">187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib130b8ba2819452594b22d15469baacb_I20201231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI2LTQtMS0xLTA_b2c02182-cd5e-4d44-a55a-90f668fa33a0">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib130b8ba2819452594b22d15469baacb_I20201231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI2LTYtMS0xLTA_275f9d46-dfac-473f-8053-553e76ffaed8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib130b8ba2819452594b22d15469baacb_I20201231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI2LTgtMS0xLTA_499101b9-fa8f-44f3-a9e2-c6127eae4d96">188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - held-to-maturity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:HeldToMaturitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI3LTItMS0xLTA_ad35a187-0f03-4b16-8af2-f263d559cf39">638</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI3LTQtMS0xLTA_08688de6-efba-4a41-bee6-da7b06d1047c">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI3LTYtMS0xLTA_9e13e78e-621b-4bbe-b3d3-22f32dd27db5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI3LTgtMS0xLTA_cdd69689-feea-4068-8c24-b25ec8e2ea94">647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="unh:InvestmentsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI4LTItMS0xLTA_49682584-2e9c-4cc6-918e-3ea3b7e8923c">38,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="unh:InvestmentsGrossUnrealizedGains" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI4LTQtMS0xLTA_32cecc54-5e84-41af-bbd6-07015e50fbe4">1,780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="unh:InvestmentsGrossUnrealizedLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI4LTYtMS0xLTA_3312f664-bd8e-4c74-aef8-61a19d4c2bd8">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI4LTgtMS0xLTA_4755b8ec-dc10-4416-aabc-27611d286cfd">40,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nearly all of the Company&#8217;s investments in mortgage-backed securities were rated &#8220;Triple A&#8221; as of December&#160;31, 2021. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company held $<ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-8" name="us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90ZXh0cmVnaW9uOmI3ZjA4OGU5MmIxNTQxMjQ4NjY5ZWY4MjhjMGI1YWE2XzIwOQ_d469ae36-0045-4bb2-b4f9-f6899f6130e3">3.5</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-8" name="us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90ZXh0cmVnaW9uOmI3ZjA4OGU5MmIxNTQxMjQ4NjY5ZWY4MjhjMGI1YWE2XzIxNg_78447059-7d1f-49f5-87da-3873334863b4">2.3</ix:nonFraction> billion of equity securities as of December&#160;31, 2021 and 2020, respectively. The Company&#8217;s investments in equity securities primarily consist of employee savings plan related investments, other venture investments and shares of Brazilian real denominated fixed-income funds with readily determinable fair values. Additionally, the Company&#8217;s investments included $<ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-8" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90ZXh0cmVnaW9uOmI3ZjA4OGU5MmIxNTQxMjQ4NjY5ZWY4MjhjMGI1YWE2XzUyOQ_7a23633b-b4f2-465c-b43a-4cb3d0c86091"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-8" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90ZXh0cmVnaW9uOmI3ZjA4OGU5MmIxNTQxMjQ4NjY5ZWY4MjhjMGI1YWE2XzUyOQ_8c6c55d3-4616-4431-9a1e-2233503d79e3">1.3</ix:nonFraction></ix:nonFraction> billion of equity method investments in operating businesses in the health care sector, as of both December&#160;31, 2021 and 2020. The allowance for credit losses on held-to-maturity securities as of December&#160;31, 2021 and 2020 was not material. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><ix:continuation id="i706c7cd05b7b4089b74721666cb4cf98"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90ZXh0cmVnaW9uOmI3ZjA4OGU5MmIxNTQxMjQ4NjY5ZWY4MjhjMGI1YWE2XzIyOTE_ddf96170-0173-494c-9f76-bf85eb11a145" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost and fair value of debt securities as of December&#160;31, 2021, by contractual maturity, were as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:61.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.563%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.713%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Held-to-Maturity</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in one year or less</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzItMi0xLTEtMA_df6b0289-e1b5-46f4-b09c-3f3555513646">2,603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzItNC0xLTEtMA_8a5514fd-c51a-4f8b-a724-a1f084b61ba1">2,614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzItNi0xLTEtMA_f7094195-0d9e-4d43-9a37-9979da19484d">235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzItOC0xLTEtMA_80ffda75-d6f2-4a4f-8b18-9e7bbfcc690a">236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzMtMi0xLTEtMA_ad6cf685-016b-453d-be0c-4eb89a9b7b21">12,885</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzMtNC0xLTEtMA_ec3f2bd8-5d80-4367-aad3-b350c324be5d">13,065</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzMtNi0xLTEtMA_00fa0c3f-902c-4eb9-bf26-d8b819e1298d">355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzMtOC0xLTEtMA_aa20ee22-c2c9-4f4c-897a-319e2de87646">354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after five years through ten years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzQtMi0xLTEtMA_24e3bee9-34f4-4ed6-abb3-a63af79d7438">11,342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzQtNC0xLTEtMA_822bc773-bdbd-4479-a626-9581f0299875">11,524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzQtNi0xLTEtMA_42a0326b-7cf6-4711-9c52-3daa6a480ce1">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzQtOC0xLTEtMA_b613627a-f4db-4570-8383-e1f3f62dff34">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after ten years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzUtMi0xLTEtMA_43ce6558-17bc-4461-bb5f-17414d917a24">4,152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzUtNC0xLTEtMA_5f566ecf-88e1-4daf-9a75-7d93da67517d">4,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzUtNi0xLTEtMA_7a1d19c2-b400-414a-be2b-ea06a274a752">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzUtOC0xLTEtMA_e7bc7184-6a27-4b5d-bf8a-0348ace24e09">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5a1b74f16184b9bb2add4cab25e29f2_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzYtMi0xLTEtMA_6851d58e-c54b-41d8-9359-126fa7f1ac47">5,868</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5a1b74f16184b9bb2add4cab25e29f2_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzYtNC0xLTEtMA_f9533816-4543-40c4-ae02-cd46f27ea446">5,901</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b784ace82c244c5867ac2f828eb7a57_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzctMi0xLTEtMA_26830bfe-264b-4980-99ca-313f5012ac58">2,819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b784ace82c244c5867ac2f828eb7a57_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzctNC0xLTEtMA_a232bcc2-4534-4f9c-9c2f-89b198e62bc0">2,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzgtMi0xLTEtMA_957898dd-9227-4327-af1e-31f774dda22f">39,669</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzgtNC0xLTEtMA_799f7d4c-084f-473d-8aeb-677de10ebe94">40,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzgtNi0xLTEtMA_ba638490-cea4-4b68-9ef6-389ad2fe36a5">641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzgtOC0xLTEtMA_6b66966c-ff1e-4bd1-9e02-bb3856116bb7">643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90ZXh0cmVnaW9uOmI3ZjA4OGU5MmIxNTQxMjQ4NjY5ZWY4MjhjMGI1YWE2XzIzMjE_d8fb2cca-6841-472e-b811-a22669db813d" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of available-for-sale debt securities with gross unrealized losses by major security type and length of time that individual securities have been in a continuous unrealized loss position were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:35.649%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.714%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less Than 12 Months</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5bcfc870d824827bb66dd636d076fd1_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzMtMi0xLTEtMA_7b966efc-543a-455e-be70-7adeabcc5b80">1,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5bcfc870d824827bb66dd636d076fd1_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzMtNC0xLTEtMA_84b46554-7d40-43f4-b915-833e5c8a225d">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5bcfc870d824827bb66dd636d076fd1_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzMtNi0xLTEtMA_9ceb6276-b25d-414f-9701-0b160677418d">249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5bcfc870d824827bb66dd636d076fd1_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzMtOC0xLTEtMA_2d2f56e4-d469-44ba-96f7-b7f96adfed50">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5bcfc870d824827bb66dd636d076fd1_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzMtMTAtMS0xLTA_a7243662-8515-4bb0-ad53-f4d1bd3c5d2a">2,225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5bcfc870d824827bb66dd636d076fd1_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzMtMTItMS0xLTA_d7699383-5a3d-42c6-8d86-afe741d8b206">31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24678048e47943bb91d8def4d5f22212_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzQtMi0xLTEtMTY2OTE_db0dd31d-cd8a-4ef8-92c5-c80d6778e545">1,386</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24678048e47943bb91d8def4d5f22212_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzQtNC0xLTEtMTY3Mzk_0ddb2c63-e27b-48a3-9860-15bb8ad150b8">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24678048e47943bb91d8def4d5f22212_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzQtNi0xLTEtMTY3Mzk_73b03c2e-842e-4e94-a092-4d71560262df">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24678048e47943bb91d8def4d5f22212_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzQtOC0xLTEtMTY3Mzk_0a9ae9d7-185f-4993-b213-f20b38c128f1">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24678048e47943bb91d8def4d5f22212_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzQtMTAtMS0xLTE2NzQ4_cc3efa06-f008-46b8-ad8b-db40265bda62">1,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24678048e47943bb91d8def4d5f22212_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzQtMTItMS0xLTE2NzUx_d077a3ef-1e87-4d2f-a99b-fe7559fcddc7">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60063fc646f547e0ac686bc7d0b92112_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzQtMi0xLTEtMA_66e19f3d-de07-4599-a2a2-c0c18d5b5d3d">9,357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i60063fc646f547e0ac686bc7d0b92112_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzQtNC0xLTEtMA_24c1cca3-f162-40df-853f-799ff1377406">130</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60063fc646f547e0ac686bc7d0b92112_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzQtNi0xLTEtMA_02f7a992-f321-4f43-b95b-446fca8b16b0">376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i60063fc646f547e0ac686bc7d0b92112_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzQtOC0xLTEtMA_e138ee2b-9603-48ca-baf8-92423459c350">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60063fc646f547e0ac686bc7d0b92112_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzQtMTAtMS0xLTA_2713ab15-2f3d-44f4-b38a-40f92d77af11">9,733</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i60063fc646f547e0ac686bc7d0b92112_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzQtMTItMS0xLTA_3facef96-6615-4543-a718-64e10970202a">145</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5a1b74f16184b9bb2add4cab25e29f2_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzUtMi0xLTEtMA_f1aa1992-507d-4a6d-8c99-bfc0b6a12e0e">3,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5a1b74f16184b9bb2add4cab25e29f2_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzUtNC0xLTEtMA_683d996c-cad2-4093-a2c0-0f2a9ee90939">52</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5a1b74f16184b9bb2add4cab25e29f2_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzUtNi0xLTEtMA_8afec91a-b666-4989-bf38-691c2a9bf42f">116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5a1b74f16184b9bb2add4cab25e29f2_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzUtOC0xLTEtMA_a561558e-3035-4b06-9ab3-2099b1e39860">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5a1b74f16184b9bb2add4cab25e29f2_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzUtMTAtMS0xLTA_1c98f0a7-48d6-406f-b090-1f376bc79b20">3,194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5a1b74f16184b9bb2add4cab25e29f2_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzUtMTItMS0xLTA_8d4b7fb8-9907-470e-9ba3-7ae539381ba6">55</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b784ace82c244c5867ac2f828eb7a57_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzYtMi0xLTEtMA_6aad3b53-9d5f-44ab-ac30-0b2e3010f570">1,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b784ace82c244c5867ac2f828eb7a57_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzYtNC0xLTEtMA_a2b68c71-fe7b-44de-9073-f826314082d6">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b784ace82c244c5867ac2f828eb7a57_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzYtNi0xLTEtMA_7db91c0c-dc1c-46c0-b9f3-07e7ef56c496">114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b784ace82c244c5867ac2f828eb7a57_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzYtOC0xLTEtMA_faab119d-94e7-4cf2-a0dc-ec20bd5e15c8">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b784ace82c244c5867ac2f828eb7a57_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzYtMTAtMS0xLTA_686db627-0802-42a3-8c66-3d45ec50b9a9">1,435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b784ace82c244c5867ac2f828eb7a57_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzYtMTItMS0xLTA_2cd26bac-37bb-4552-a6e7-2d654d684806">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb56bbdb5bca464cb867242d3ed1b377_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzctMi0xLTEtMA_13c333a4-826b-4d45-8937-098d84104b85">17,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb56bbdb5bca464cb867242d3ed1b377_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzctNC0xLTEtMA_1542bfbf-c66f-4e67-8bac-9227f80b7262">237</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb56bbdb5bca464cb867242d3ed1b377_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzctNi0xLTEtMA_d6269244-62b5-468c-8979-8d7832ea0ac2">886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb56bbdb5bca464cb867242d3ed1b377_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzctOC0xLTEtMA_428187d0-739d-4e35-a4ae-5bffd2f0cc7c">37</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb56bbdb5bca464cb867242d3ed1b377_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzctMTAtMS0xLTA_06d42440-14e8-4669-a825-b52b447b9749">18,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb56bbdb5bca464cb867242d3ed1b377_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzctMTItMS0xLTA_7bc99032-ee0f-4d8a-84c9-8a714fa4627f">274</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a312b80055e4af7bc076c9e6f9c43e6_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzktMi0xLTEtMA_c61d612b-f9b7-48e7-a5c2-ec30acc08606">346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a312b80055e4af7bc076c9e6f9c43e6_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzktNC0xLTEtMA_9d38cdf7-ac06-4ac3-83ff-e09e72a22413">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a312b80055e4af7bc076c9e6f9c43e6_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzktMTAtMS0xLTA_90535aa9-463a-44af-8784-bc5bc964c62c">346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a312b80055e4af7bc076c9e6f9c43e6_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzktMTItMS0xLTA_73b10106-94fc-4f51-9aea-7bbf29ae9b90">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib130b8ba2819452594b22d15469baacb_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzExLTItMS0xLTA_bfe5e1aa-22f4-4322-92ed-3d78586f78a4">1,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib130b8ba2819452594b22d15469baacb_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzExLTQtMS0xLTA_8ad6b5d1-ace2-4882-a9aa-5537ddd4567d">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib130b8ba2819452594b22d15469baacb_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzExLTYtMS0xLTA_0a83ded4-d141-436d-88ad-6ce53661b710">456</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib130b8ba2819452594b22d15469baacb_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzExLTgtMS0xLTA_c567ccc8-f665-4c95-af78-3edefe11a856">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib130b8ba2819452594b22d15469baacb_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzExLTEwLTEtMS0w_a11a5a79-0058-4db9-b527-44f0613ae72e">1,729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib130b8ba2819452594b22d15469baacb_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzExLTEyLTEtMS0w_0e22503e-ade2-4c6d-8c30-632f1bc2fc3a">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ec806aa176a4bbb99266b4a32cf1ded_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzEyLTItMS0xLTA_5c9f79fe-f203-4445-909b-320425b56f50">601</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ec806aa176a4bbb99266b4a32cf1ded_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzEyLTQtMS0xLTA_490a7473-c029-430c-b7c2-650dd23f50b8">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ec806aa176a4bbb99266b4a32cf1ded_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzEyLTYtMS0xLTA_6aa06fed-7b38-40b1-80e8-74b9798c175e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ec806aa176a4bbb99266b4a32cf1ded_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzEyLTgtMS0xLTA_5dff5318-413c-4260-b60a-2859df46a37f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ec806aa176a4bbb99266b4a32cf1ded_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzEyLTEwLTEtMS0w_18dfa5cc-7ef5-4019-aaa3-889dfe2dde92">601</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ec806aa176a4bbb99266b4a32cf1ded_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzEyLTEyLTEtMS0w_a2986f43-91f9-4380-8b7c-dbb229221142">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieda9939b5a6c4fdeb0d28e0580ab8d78_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzEzLTItMS0xLTA_b87c6235-aa3e-4def-ad91-6d9502170dcf">195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieda9939b5a6c4fdeb0d28e0580ab8d78_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzEzLTQtMS0xLTA_69fc2f96-97fa-4b71-8d40-2af5965f2078">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieda9939b5a6c4fdeb0d28e0580ab8d78_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzEzLTYtMS0xLTA_2993d70e-91d5-4bff-a2a0-66bd6a887f44">93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieda9939b5a6c4fdeb0d28e0580ab8d78_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzEzLTgtMS0xLTA_9bd22f35-9b0b-48e6-a39f-43cf9cbb475e">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieda9939b5a6c4fdeb0d28e0580ab8d78_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzEzLTEwLTEtMS0w_08859f15-a50c-4c98-ac84-ee095a724ad3">288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieda9939b5a6c4fdeb0d28e0580ab8d78_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzEzLTEyLTEtMS0w_d7fd8e8a-02cc-444b-b5f2-c8b27e55b3b3">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b1ef8f174f64af8b548c0044b97ecb5_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzE0LTItMS0xLTA_8a61b7cb-76e9-4ab2-bbc3-3b3c6a3c8cc8">2,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b1ef8f174f64af8b548c0044b97ecb5_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzE0LTQtMS0xLTA_71623319-9393-4c69-9a9c-a73f8397746b">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b1ef8f174f64af8b548c0044b97ecb5_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzE0LTYtMS0xLTA_4d756db4-44eb-494f-99d3-c0f44724185b">549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b1ef8f174f64af8b548c0044b97ecb5_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzE0LTgtMS0xLTA_901c1b39-6e4d-457c-bf39-41c11a20e4f3">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b1ef8f174f64af8b548c0044b97ecb5_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzE0LTEwLTEtMS0w_6ad56532-4a43-454f-b1c1-f4e15917c054">2,964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b1ef8f174f64af8b548c0044b97ecb5_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzE0LTEyLTEtMS0w_49008f0a-4fc8-43c0-a715-71dd006b6816">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s unrealized losses from all securities as of December&#160;31, 2021 were generated from approximately <ix:nonFraction unitRef="positions" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90ZXh0cmVnaW9uOmI3ZjA4OGU5MmIxNTQxMjQ4NjY5ZWY4MjhjMGI1YWE2XzExNjE_605935f7-8172-4309-8703-bbaed346ea8c">13,000</ix:nonFraction> positions out of a total of <ix:nonFraction unitRef="number" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="0" name="us-gaap:InvestmentOwnedBalanceContracts" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90ZXh0cmVnaW9uOmI3ZjA4OGU5MmIxNTQxMjQ4NjY5ZWY4MjhjMGI1YWE2XzExOTI_8750222a-d710-4db4-b167-8b5c003fd7d2">39,000</ix:nonFraction> positions. The Company believes it will collect the timely principal and interest due on its debt securities having an amortized cost in excess of fair value. The unrealized losses were primarily caused by interest rate increases and not by unfavorable changes in the credit quality associated with these securities which impacted the Company&#8217;s assessment on collectability of principal and interest. At each reporting period, the Company evaluates available-for-sale debt securities for any credit-related impairment when the fair value of the investment is less than its amortized cost. The Company evaluated the expected cash flows, the underlying credit quality and credit ratings of the issuers noting no significant credit deterioration since purchase. As of December&#160;31, 2021, the Company did not have the intent to sell any of the securities in an unrealized loss position. Therefore, the Company believes these losses to be temporary. The allowance for credit losses on available-for-sale debt securities as of December&#160;31, 2021 and 2020 was not material.</span></div></ix:continuation><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_175"></div><div style="margin-top:15pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90ZXh0cmVnaW9uOmUzYzE3YjU2ZGI2ZTQ4YzdiMjBhMTY2Mjk1M2IzMmVjXzYzMzM_24781cde-2806-4296-82e3-9942062cf9ea" continuedAt="i2892069e60d94705a19f4849a1ca54e7" escape="true">Fair Value</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2892069e60d94705a19f4849a1ca54e7" continuedAt="i0e7b409c6484496181ec322be163c556"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90ZXh0cmVnaW9uOmUzYzE3YjU2ZGI2ZTQ4YzdiMjBhMTY2Mjk1M2IzMmVjXzYzMzE_915cd04a-a155-4c82-850d-3b1d3418191b" continuedAt="i98b141c1d9c040ef97a534f4da137872" escape="true">Certain assets and liabilities are measured at fair value in the Consolidated Financial Statements or have fair values disclosed in the Notes to the Consolidated Financial Statements. These assets and liabilities are classified into one of three levels of a hierarchy defined by GAAP. In instances in which the inputs used to measure fair value fall into different levels of the fair value hierarchy, the fair value measurement is categorized in its entirety based on the lowest level input which is significant to the fair value measurement in its entirety. The Company&#8217;s assessment of the significance of a particular item to the fair value measurement in its entirety requires judgment, including the consideration of inputs specific to the asset or liability. </ix:nonNumeric></ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><ix:continuation id="i0e7b409c6484496181ec322be163c556" continuedAt="ic3042f017c834be29671617c89d15263"><ix:continuation id="i98b141c1d9c040ef97a534f4da137872" continuedAt="i6c396ef44d024098951812a5d94e6f12"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value hierarchy is summarized as follows:</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Quoted prices (unadjusted) for identical assets/liabilities in active markets. </span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Other observable inputs, either directly or indirectly, including:</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Quoted prices for similar assets/liabilities in active markets;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Quoted prices for identical or similar assets/liabilities in inactive markets (e.g., few transactions, limited information, noncurrent prices, high variability over time);</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inputs other than quoted prices observable for the asset/liability (e.g., interest rates, yield curves, implied volatilities, credit spreads); and</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inputs corroborated by other observable market data.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Unobservable inputs cannot be corroborated by observable market data.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers in or out of Level 3 financial assets or liabilities during the years ended December&#160;31, 2021 or 2020.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nonfinancial assets and liabilities or financial assets and liabilities measured at fair value on a nonrecurring basis are subject to fair value adjustments only in certain circumstances, such as when the Company records an impairment. For the year ended December 31, 2021, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNiUnrealizedGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90ZXh0cmVnaW9uOmUzYzE3YjU2ZGI2ZTQ4YzdiMjBhMTY2Mjk1M2IzMmVjXzI3NDg3NzkwNzYwMTc_5fbf7248-6f2d-42b5-87ee-e70378f2e0ee">840</ix:nonFraction> million of unrealized gains in investment and other income related to fair value adjustments on equity securities primarily in our venture portfolio, based on transactions of the same or similar security. There were no other significant fair value adjustments for these assets and liabilities recorded during the years ended December&#160;31, 2021 or 2020.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following methods and assumptions were used to estimate the fair value and determine the fair value hierarchy classification of each class of financial instrument included in the tables below:</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of cash and cash equivalents approximates fair value as maturities are less than three months. Fair values of cash equivalent instruments which do not trade on a regular basis in active markets are classified as Level 2.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt and Equity Securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Fair values of debt and equity securities are based on quoted market prices, where available. The Company obtains one price for each security primarily from a third-party pricing service (pricing service), which generally uses quoted or other observable inputs for the determination of fair value. The pricing service normally derives the security prices through recently reported trades for identical or similar securities, and, if necessary, makes adjustments through the reporting date based upon available observable market information. For securities not actively traded, the pricing service may use quoted market prices of comparable instruments or discounted cash flow analyses, incorporating inputs currently observable in the markets for similar securities. Inputs often used in the valuation methodologies include, but are not limited to, benchmark yields, credit spreads, default rates, prepayment speeds and nonbinding broker quotes. As the Company is responsible for the determination of fair value, it performs quarterly analyses on the prices received from the pricing service to determine whether the prices are reasonable estimates of fair value. Specifically, the Company compares the prices received from the pricing service to prices reported by a secondary pricing source, such as its custodian, its investment consultant and third-party investment advisors. Additionally, the Company compares changes in the reported market values and returns to relevant market indices to test the reasonableness of the reported prices. The Company&#8217;s internal price verification procedures and reviews of fair value methodology documentation provided by independent pricing services have not historically resulted in adjustment to the prices obtained from the pricing service.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair values of debt securities which do not trade on a regular basis in active markets but are priced using other observable inputs are classified as Level&#160;2. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value estimates for Level 1 and Level 2 equity securities are based on quoted market prices for actively traded equity securities and/or other market data for the same or comparable instruments and transactions in establishing the prices. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of Level 3 investments in corporate bonds, which are not a significant portion of our investments, are estimated using valuation techniques relying heavily on management assumptions and qualitative observations. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout the procedures discussed above in relation to the Company&#8217;s processes for validating third-party pricing information, the Company validates the understanding of assumptions and inputs used in security pricing and determines the proper classification in the hierarchy based on such understanding.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Under Management.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Assets under management consists of debt securities and other investments held to fund costs associated with the AARP Program and are priced and classified using the same methodologies as the Company&#8217;s investments in debt and equity securities.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><ix:continuation id="ic3042f017c834be29671617c89d15263" continuedAt="i3308a871a64a417ea0ce5091025ef440"><div style="margin-top:6pt"><ix:continuation id="i6c396ef44d024098951812a5d94e6f12"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Term Debt. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company&#8217;s long-term debt are estimated and classified using the same methodologies as the Company&#8217;s investments in debt securities.</span></ix:continuation></div><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90ZXh0cmVnaW9uOmUzYzE3YjU2ZGI2ZTQ4YzdiMjBhMTY2Mjk1M2IzMmVjXzYyODY_3cc3b284-7787-490e-a55d-bd965594fcab" escape="true"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a summary of fair value measurements by level and carrying values for items measured at fair value on a recurring basis in the Consolidated Balance Sheets:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:53.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable<br/>Inputs<br/>(Level 3)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Fair and Carrying<br/>Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc7213ff01b448239792e43a61300d38_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzItMi0xLTEtMA_761dcc77-c610-437c-866d-bab89af668b0">21,359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1b66727575a4e678ac30b674426f585_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzItNC0xLTEtMA_0a2676e6-764f-43f5-a9bc-5a28d0794258">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib817a90dc86742a28badd4c87a39b501_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzItNi0xLTEtMA_09b76d8a-1b27-45e1-88d9-9b3c2ef2834b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzItOC0xLTEtMA_e712babb-826c-4562-98ab-a66eed443458">21,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - available-for-sale:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba871229a901424484cc7c291cbe9f0e_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzQtMi0xLTEtMA_be9e95df-2b05-46a5-a693-ab5192e75a5c">3,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dd5e25d23aa4a7fa951ebebaba203a1_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzQtNC0xLTEtMA_c85f2e74-0873-4831-8731-66ce453a1bc6">181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6eeef3734fae442a8264a01cb7372550_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzQtNi0xLTEtMA_303f452c-0004-4cdf-b5c9-d79cce5c5107">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5bcfc870d824827bb66dd636d076fd1_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzQtOC0xLTEtMA_2dc9424b-068a-424f-91f8-5b9c38d1b0ad">3,198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bea540206e64b51b2cbf141a4999d50_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzUtMi0xLTEtMA_8790d84e-2cd9-4513-844f-53a33204ecb7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f98b30125864fdca705b2901d65b24b_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzUtNC0xLTEtMA_6ac675f3-66ee-46b7-b488-6326a8ca49b6">7,106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ba7717a6c87435994ca841d4dafcd86_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzUtNi0xLTEtMA_b335f9bd-eec0-4536-9180-c6adf1f69fa2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24678048e47943bb91d8def4d5f22212_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzUtOC0xLTEtMA_237a755b-64fc-4713-a96e-96908800ca9f">7,106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i786c6b4857764efd94186e77e3b6f938_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzYtMi0xLTEtMA_6bacdf0e-d620-4160-add5-7878df1600ef">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8922e827b09149b5b48d5d53a1d3064f_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzYtNC0xLTEtMA_6b879bd6-6719-42d2-8b8a-a40228e893ac">20,916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40294d1cde8d40b497abb9effe028d71_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzYtNi0xLTEtMA_dc003885-5e33-4c17-b030-751bad26c95a">218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60063fc646f547e0ac686bc7d0b92112_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzYtOC0xLTEtMA_80c30d6c-c6cb-4ccf-9d5b-2a212bac4d81">21,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic74a5a57b68545f68727915480210bea_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzctMi0xLTEtMA_d479be85-2da8-408a-97b3-67a69a3ef023">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbc6b84573cd460bb185c06c93cab313_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzctNC0xLTEtMA_2a3ddf9d-28e1-40f4-8d6b-f4218b1fb952">5,901</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide094d54765b442b88523b9454527fbd_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzctNi0xLTEtMA_db79eef3-8aef-4969-97d5-58749302146d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5a1b74f16184b9bb2add4cab25e29f2_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzctOC0xLTEtMA_58884cab-e845-4461-97a6-b7285775a85d">5,901</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfc2226cf4444ab1a84562eb064b98c2_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzgtMi0xLTEtMA_3de5ba42-a1cf-4e62-b14d-26d57f86dab4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ac0596304be4b85b623b402780f1b8d_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzgtNC0xLTEtMA_9138fbe0-6832-4f44-8f1e-0eed5afee683">2,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a09033b49c14106baa0f691507e4246_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzgtNi0xLTEtMA_6ae7279c-48ff-4a02-99be-fb4ed661f9d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b784ace82c244c5867ac2f828eb7a57_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzgtOC0xLTEtMA_e7e79b6d-8e3e-4a97-8407-902bcd39ffd4">2,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4b3aa9a235e41d0be50be982749d992_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzktMi0xLTEtMA_cc3cbacd-4acc-41cd-82ab-3aa13736a839">3,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63ceb3ccbcf14457b98cb6eef7d4b50f_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzktNC0xLTEtMA_8893f9ec-c6de-4d4b-8443-02245b2259c2">36,942</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd8f7f5f7a214e6c9819ee8745d58190_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzktNi0xLTEtMA_a018667d-40d8-4437-85ea-1a800fac63f5">218</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb56bbdb5bca464cb867242d3ed1b377_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzktOC0xLTEtMA_7068b88b-5cbe-497a-a99a-edcbfc79b9b9">40,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc7213ff01b448239792e43a61300d38_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzEwLTItMS0xLTA_90796714-7229-4d9f-aaab-baf7b9dacef4">2,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1b66727575a4e678ac30b674426f585_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzEwLTQtMS0xLTA_a0f20bf6-d62c-4a85-8c9d-ab37f192c772">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib817a90dc86742a28badd4c87a39b501_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzEwLTYtMS0xLTA_5dcd5d38-89e9-4dbb-9a4a-7014ceb35e57">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzEwLTgtMS0xLTA_6c4792d8-e91b-434a-aa73-4ce2c787fdde">2,177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets under management</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc7213ff01b448239792e43a61300d38_I20211231" decimals="-6" name="unh:AarpAssetsUnderManagement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzExLTItMS0xLTA_4891ea50-90ac-489a-acea-0d9e0300a7bf">1,972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1b66727575a4e678ac30b674426f585_I20211231" decimals="-6" name="unh:AarpAssetsUnderManagement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzExLTQtMS0xLTA_be0fa03a-bffc-4d62-aee6-6bba131b65ec">2,376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib817a90dc86742a28badd4c87a39b501_I20211231" decimals="-6" name="unh:AarpAssetsUnderManagement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzExLTYtMS0xLTA_b61181dd-f83d-433c-b88e-26c4433010d6">101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="unh:AarpAssetsUnderManagement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzExLTgtMS0xLTA_851f0f52-c65a-4452-9c1e-897d37b13a60">4,449</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc7213ff01b448239792e43a61300d38_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzEyLTItMS0xLTA_7ec53537-8190-4249-93ff-dc5e30cf5aec">28,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1b66727575a4e678ac30b674426f585_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzEyLTQtMS0xLTA_70f4e7d1-518f-4d4a-8fe9-969e852e04f9">39,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib817a90dc86742a28badd4c87a39b501_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzEyLTYtMS0xLTA_3857157e-cfeb-4002-88c3-cbaa038239a1">383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzEyLTgtMS0xLTA_65344938-e306-4c79-b802-a186eaeb6e8e">68,218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage of total assets at fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d22c5f5de67464fa6cda436b26c58dc_I20201231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzE1LTItMS0xLTA_d1023599-dc22-420f-ac14-ef59322c0d0a">16,841</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2e7820a9e9b45a3ace8daf2bf6b3576_I20201231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzE1LTQtMS0xLTA_db779ade-662c-4139-87e8-8762dc15c7e3">80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i143f48c7749c46eaa1530838b78b041b_I20201231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzE1LTYtMS0xLTA_a1c6c4e6-efd0-4933-bcea-92c859000c3b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzE1LTgtMS0xLTA_cabbabfa-22cf-43a0-926b-57b2ebece494">16,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - available-for-sale:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8da1637a90d94f7d8cbbb9e89200393e_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzE3LTItMS0xLTA_10531667-315b-4432-bbfa-c9794d5e4f19">3,241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a84715d70a74fceaa59165cb7cfb450_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzE3LTQtMS0xLTA_5ab6c0e8-674c-48b6-825d-a85066c6adea">224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacd4e95ed0ff45e8b463cde8fb162e36_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzE3LTYtMS0xLTA_16e864e7-2dcb-4978-aa4a-adfcc0140751">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a312b80055e4af7bc076c9e6f9c43e6_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzE3LTgtMS0xLTA_0b9f1b99-4959-4663-83c1-209b1c61f102">3,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1274175ecdc4c66979e1169bb16b496_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzE4LTItMS0xLTA_cb25eb5d-b8e4-4d09-99b4-b7ff190145d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i348ad0bbc326423b98599f12852d34af_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzE4LTQtMS0xLTA_2c173b86-9e24-4748-8a0e-6ab94d94d077">7,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35f826dbcf4d42b4be8664b7331fb199_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzE4LTYtMS0xLTA_62ca5ba3-b237-4513-a41d-09ea766c2ada">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe8be8f0fb534e25be1cc040ead9f99f_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzE4LTgtMS0xLTA_048132a3-875b-4cfe-8bc2-e866965ff718">7,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic303a9fd1e74453b8a529be93a4f56bf_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzE5LTItMS0xLTA_01a07b90-337f-49ff-bdf6-40ee3fa65bde">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0ea67d91b6d434599e098210b7a488c_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzE5LTQtMS0xLTA_db7a29a5-5d99-41cc-ba09-ec455b0e999a">19,424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i073d903c845f4731bd55974d4b29f4b6_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzE5LTYtMS0xLTA_c9d7dffb-8a38-4fc7-a944-edc2ca539349">288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib130b8ba2819452594b22d15469baacb_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzE5LTgtMS0xLTA_560f28ab-daf1-4234-ae20-2f2346de1730">19,737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf644ee782e74842af3129b8232dcaed_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzIwLTItMS0xLTA_d41ddbb2-97aa-4e1b-9d5e-c665158630a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf26e2e8c57f4e7a89bfb1c2baf068a5_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzIwLTQtMS0xLTA_504607b0-04e3-48af-8967-f7898d504a23">7,091</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic45c1b0462fc4790975a0e25b80a5726_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzIwLTYtMS0xLTA_a2e688a1-268c-4b45-8716-aebab7b727e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ec806aa176a4bbb99266b4a32cf1ded_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzIwLTgtMS0xLTA_ca9e8e2d-dbd6-4db2-b6ea-1f5d46f5c7a4">7,091</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14c36d9932b54db0b6a4f835644eb0aa_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzIxLTItMS0xLTA_a8e294d9-db8b-4ddb-85aa-28a91b0a7cba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68adcae3162f47ae8c5f0bb4ef470545_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzIxLTQtMS0xLTA_ed494a0c-2e3b-4085-b5f8-1b7ecdfa9b90">2,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e58021d29540878f244a567f9a5ced_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzIxLTYtMS0xLTA_4d46f759-dee2-46c0-bfbb-7e7a3e00040f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieda9939b5a6c4fdeb0d28e0580ab8d78_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzIxLTgtMS0xLTA_c10c420e-9aea-4cd2-bb62-63917a83ed73">2,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bfd62c299df4d94bbf76c712ccec550_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzIyLTItMS0xLTA_8f865bd3-cd01-47a5-83b2-9952238c0125">3,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3d58ed074c84089913ffdffc57c1d73_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzIyLTQtMS0xLTA_fa553838-7546-40eb-86c8-3017c2b529df">36,274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd5d40328bb047cb90c2611b44a7f743_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzIyLTYtMS0xLTA_4246100a-d420-4d97-82c9-518598c1b7f0">288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b1ef8f174f64af8b548c0044b97ecb5_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzIyLTgtMS0xLTA_52faa28e-c418-4c87-a034-7511def3d491">39,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d22c5f5de67464fa6cda436b26c58dc_I20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzIzLTItMS0xLTA_8472b3c2-ea03-4ca5-a961-17d1713b84d1">1,795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2e7820a9e9b45a3ace8daf2bf6b3576_I20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzIzLTQtMS0xLTA_41a9d4a0-a327-4d79-8d9c-dcd9cfec9b47">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i143f48c7749c46eaa1530838b78b041b_I20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzIzLTYtMS0xLTA_036dde7c-baca-4224-bb2a-4d14959523b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzIzLTgtMS0xLTA_530d9ecd-c47d-4cc5-a5f6-d43d01200f25">1,828</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets under management</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d22c5f5de67464fa6cda436b26c58dc_I20201231" decimals="-6" name="unh:AarpAssetsUnderManagement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzI0LTItMS0xLTA_70b2bbbf-6deb-4896-8bf4-4962e6597dcc">1,774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2e7820a9e9b45a3ace8daf2bf6b3576_I20201231" decimals="-6" name="unh:AarpAssetsUnderManagement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzI0LTQtMS0xLTA_7d2829ba-f4ef-4b88-8571-f50ae6efba07">2,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i143f48c7749c46eaa1530838b78b041b_I20201231" decimals="-6" name="unh:AarpAssetsUnderManagement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzI0LTYtMS0xLTA_340fab40-9406-4c98-81ee-073219ad152b">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="unh:AarpAssetsUnderManagement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzI0LTgtMS0xLTA_48778e29-6caa-4153-83c5-5a8b1ded1c5e">4,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d22c5f5de67464fa6cda436b26c58dc_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzI1LTItMS0xLTA_3082bd5f-953d-4c84-aba3-7844ed4faa5e">23,676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2e7820a9e9b45a3ace8daf2bf6b3576_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzI1LTQtMS0xLTA_be5ab1e9-2afd-4c42-955f-727ebbd741cf">38,637</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i143f48c7749c46eaa1530838b78b041b_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzI1LTYtMS0xLTA_bcf19f90-bcd7-483c-92d4-2568a41335e8">340</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzI1LTgtMS0xLTA_e65bc120-6d6d-47e8-bf7a-2fa4c866fb9f">62,653</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage of total assets at fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90ZXh0cmVnaW9uOmUzYzE3YjU2ZGI2ZTQ4YzdiMjBhMTY2Mjk1M2IzMmVjXzYzMTQ_0ffb1f89-6a91-431f-846d-3109734f8c55" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a summary of fair value measurements by level and carrying values for certain financial instruments not measured at fair value on a recurring basis in the Consolidated Balance Sheets:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:41.462%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.654%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable<br/>Inputs<br/>(Level 3)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Carrying Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - held-to-maturity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9032d6bd2554be797457d71b15c021a_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzItMi0xLTEtMA_472a9c3d-fd38-45a6-be72-b1710178f0b4">534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if59af989581341269c0f798a7a8a56ff_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzItNC0xLTEtMA_ad1c06ec-3382-40d9-8696-118e54b3310b">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72edef7745bb4e80901cf10381b12375_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzItNi0xLTEtMA_0ce0aff9-1ae1-4166-8ef8-db809a8052a4">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e1d0ee68a90487188c597f675ea6962_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzItOC0xLTEtMA_798782f5-b8b2-4625-948a-ca43ee98a902">643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:HeldToMaturitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzItMTAtMS0xLTA_eac7cdba-57c1-45aa-ab37-cf8ed7097158">641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and other financing obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie134d5521b5441d7a99c70ae3d64e701_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzMtMi0xLTEtMTg3NjQ_ea538946-7f52-41dd-bf7b-efb57c8d787d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2205792a33d644b0a632f4d4f33237f4_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzMtNC0xLTEtMTg3NjQ_e1e68a28-fd1b-4361-98e5-f2ba911ee778">52,583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5545c49f50ec48edb1474b999af271fc_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzMtNi0xLTEtMTg3NjQ_ba81f22e-18d6-4353-8cd6-b7ebef03a75c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff86380602ce4f588a2f94a05eaab292_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzMtOC0xLTEtMTg3NjQ_8d124d38-b355-4399-bf44-4589c86130e4">52,583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae7403f6fc564452803f560b78d46801_I20211231" decimals="-6" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzMtMTAtMS0xLTE4NzY0_b2338548-406c-4b03-94d0-8b974d0090ac">46,003</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - held-to-maturity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadc9e4cd75f14dd7a16f6026ec702279_I20201231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzUtMi0xLTEtMA_41788034-adfa-424e-b27b-cebfb133c0c7">466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69b798301dcb496d99d84a6592b8549b_I20201231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzUtNC0xLTEtMA_b5b0ae08-f1c0-423c-845b-774c27c410bf">108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic505ff42be0a4bcb9d166dd3d36bcef1_I20201231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzUtNi0xLTEtMA_0d3d7d86-3153-4b06-b832-e6f4cb6cb949">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c5e5fa052504d4cb045b94a02d5a58f_I20201231" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzUtOC0xLTEtMA_86648b8f-4cb4-432f-b0c7-3ac24edac7e6">647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:HeldToMaturitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzUtMTAtMS0xLTA_50bfd46a-aadd-4171-80a5-f6728dded933">638</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and other financing obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e9f6e4d1d1345d5807de27d47ac5f59_I20201231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzYtMi0xLTEtMTg3Njk_e0303c83-43b4-4043-accf-4e34cdf1bdc2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4b8d6e218734867ad53588492384845_I20201231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzYtNC0xLTEtMTg3Njk_65f262a2-9701-416d-84bd-6bc8fc1520ee">51,254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79898441c75b41d5ac9f1f9da1f4e5d9_I20201231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzYtNi0xLTEtMTg3Njk_880b6858-9bda-4c7c-850b-bdf2796947b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85d7067f865b4342b9d8d877f735ac59_I20201231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzYtOC0xLTEtMTg3Njk_1f361d69-ab2c-437f-9365-5ea02a746b26">51,254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f2864e94d7849f79bce61f0d550474d_I20201231" decimals="-6" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzYtMTAtMS0xLTE4NzY5_5289d523-86a4-4b31-a82b-1e0be68033cc">42,171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3308a871a64a417ea0ce5091025ef440">The carrying amounts reported on the Consolidated Balance Sheets for other current financial assets and liabilities approximate fair value because of their short-term nature. These assets and liabilities are not listed in the table above.</ix:continuation> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_181"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90ZXh0cmVnaW9uOjMwNDY5MDliMDIyMTRiMTRhMmFiZjExNDc1MDEzMzA0XzM1OQ_47f3b30a-f975-4df3-b74c-22dca7c65c24" continuedAt="i6747f9f6426443d38776375500da93c0" escape="true">Property, Equipment and Capitalized Software</ix:nonNumeric></span></div><ix:continuation id="i6747f9f6426443d38776375500da93c0" continuedAt="i790cc0cf518d406188bb1bd80fe40ee4"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90ZXh0cmVnaW9uOjMwNDY5MDliMDIyMTRiMTRhMmFiZjExNDc1MDEzMzA0XzM2Ng_d9def371-02e6-4ea1-9196-47081d52a333" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of property, equipment and capitalized software is as follows: </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:70.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.225%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land and improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:LandAndLandImprovements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzEtMi0xLTEtMA_ada21ac5-5596-4e02-8b46-88aeb2bf6475">502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:LandAndLandImprovements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzEtNC0xLTEtMA_5cdbb8f2-d35d-4697-8dd5-7035b1647226">533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:BuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzItMi0xLTEtMA_b9d45cf1-dda8-44dd-9168-fd62557f2076">4,882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:BuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzItNC0xLTEtMA_5c9497c9-e836-4f0c-b226-44b10128dc50">4,759</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzMtMi0xLTEtMA_f4202312-3242-44ae-9374-585d1078f21a">1,851</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzMtNC0xLTEtMA_215ae353-63f1-4142-9b37-6ccf8d2ce34b">1,767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:FurnitureAndFixturesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzQtMi0xLTEtMA_c759a4b7-bad9-4d4f-9499-53d458f1eff6">2,014</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:FurnitureAndFixturesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzQtNC0xLTEtMA_4096003a-1a65-47c3-80b9-5ba27233f3f7">1,787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentOtherAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzUtMi0xLTEtMA_b5da5c40-628b-4fc5-82cf-51a2ca05e01b">3,857</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentOtherAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzUtNC0xLTEtMA_dc7bfe58-5c44-4669-8394-bb9e870c7cbc">3,364</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="unh:PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzYtMi0xLTEtMA_894469da-7f42-4255-ac34-52a651c6d2d3">5,392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="unh:PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzYtNC0xLTEtMA_751c89a6-296f-498a-a551-7ea0bbe43204">5,482</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:CapitalizedComputerSoftwareGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzctMi0xLTEtMA_e0a233e9-f3fb-42a3-b195-09261cf72f41">5,712</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:CapitalizedComputerSoftwareGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzctNC0xLTEtMA_9d032e38-1fdb-48a9-81b9-7f6dd9788937">5,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzgtMi0xLTEtMA_7df20839-adbd-467b-a865-bab10a920be4">2,135</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzgtNC0xLTEtMA_bb015796-1b99-43fe-af56-bfabc20cf06c">1,866</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:CapitalizedComputerSoftwareNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzktMi0xLTEtMA_8b0dcc4b-13d9-4ad0-a8f4-13fbfe9c5de4">3,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:CapitalizedComputerSoftwareNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzktNC0xLTEtMA_3c85c25f-147a-4229-86ab-ed1291c42ec7">3,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, equipment and capitalized software, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzEwLTItMS0xLTA_a7480433-91dd-496d-9cfc-023509da7404">8,969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzEwLTQtMS0xLTA_b4843854-3aa9-4df5-b1a7-bf38d36eba3a">8,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"><ix:continuation id="i790cc0cf518d406188bb1bd80fe40ee4" continuedAt="i981c37d44ee94bb39691fd1e00b9f256">&#160;</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i981c37d44ee94bb39691fd1e00b9f256">Depreciation expense for property and equipment for the years ended December&#160;31, 2021, 2020 and 2019 was $<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90ZXh0cmVnaW9uOjMwNDY5MDliMDIyMTRiMTRhMmFiZjExNDc1MDEzMzA0XzIxNg_3945868c-3188-47ae-b87b-e49fe9f331bb">996</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90ZXh0cmVnaW9uOjMwNDY5MDliMDIyMTRiMTRhMmFiZjExNDc1MDEzMzA0XzIyMA_cdb82c09-7bbd-4561-8d9a-d848b93a4bdb">997</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90ZXh0cmVnaW9uOjMwNDY5MDliMDIyMTRiMTRhMmFiZjExNDc1MDEzMzA0XzIyNw_6a57c540-99d1-41d8-a166-4d3dfcb3c2d8">995</ix:nonFraction> million, respectively. Amortization expense for capitalized software for the years ended December&#160;31, 2021, 2020 and 2019 was $<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:CapitalizedComputerSoftwareAmortization1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90ZXh0cmVnaW9uOjMwNDY5MDliMDIyMTRiMTRhMmFiZjExNDc1MDEzMzA0XzMyOQ_d892c49e-05c6-4df2-a3d1-2c65294a3f19">923</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:CapitalizedComputerSoftwareAmortization1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90ZXh0cmVnaW9uOjMwNDY5MDliMDIyMTRiMTRhMmFiZjExNDc1MDEzMzA0XzMzMw_b02df6f1-60c0-44ed-819c-031ae2a68a5f">814</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:CapitalizedComputerSoftwareAmortization1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90ZXh0cmVnaW9uOjMwNDY5MDliMDIyMTRiMTRhMmFiZjExNDc1MDEzMzA0XzM0MA_51d2c913-7338-4674-92bb-773275540f71">721</ix:nonFraction> million, respectively.</ix:continuation> </span></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_184"></div><div style="margin-top:15pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90ZXh0cmVnaW9uOjMxY2JlZmMzZjAyYzQ5YjM5NTExYWQ0NGE1MDRhMzBkXzczNQ_29fbfc08-9fc0-4c1e-8bb3-910dff501408" continuedAt="i046f2ac29fe9490494503458c649277d" escape="true">Goodwill and Other Intangible Assets</ix:nonNumeric></span></div><ix:continuation id="i046f2ac29fe9490494503458c649277d" continuedAt="i9241fa12a6464d918b92235c27c2eba3"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90ZXh0cmVnaW9uOjMxY2JlZmMzZjAyYzQ5YjM5NTExYWQ0NGE1MDRhMzBkXzczMQ_4883b578-cc19-4d9b-86dc-d2a040dccf6f" escape="true"><div style="margin-bottom:4pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill, by reportable segment, were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:32.820%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.171%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.973%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">UnitedHealthcare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Optum Health</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Optum Insight</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Optum Rx</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9004c5f31284db6a840b518fa6c4f58_I20191231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzEtMi0xLTEtMA_304d94eb-7fa4-4a6c-aefd-fc405ac446f8">27,228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedbc8a127a984a2b9f57050fc010853d_I20191231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzEtNC0xLTEtMA_5a09aaf7-f886-46b1-9bcf-dc5085846195">15,342</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i552ab3ba177642ab8b64fa5712f45dd8_I20191231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzEtNi0xLTEtMA_f16d29b7-9506-4208-86a6-71fa0dda4c63">8,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebe8572afa0a4d7da446aa8d4ab62eb8_I20191231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzEtOC0xLTEtMA_f46a2d32-e394-4236-85b6-01256c547c5e">14,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530caf840d4847f1ac553be5f7b336b2_I20191231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzEtMTAtMS0xLTA_ec7fb2d9-4cf7-42c5-8186-f4fbc47c7219">65,659</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib78936422dda4cf88cb3cbc4dd220121_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzItMi0xLTEtMA_fe92c519-a900-4b90-a28c-7bf618fa15a5">1,180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0a9e47794c54540ad3d61b206a2a5cf_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzItNC0xLTEtMA_440eab1a-c158-41df-b34f-43b81652aaed">4,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e3cb189ce045d08f4e6301ab039bfe_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzItNi0xLTEtMA_514b861c-02a3-46d0-ae91-7d569b1f3c6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcd135114fe40ad9bbefb48db0ba475_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzItOC0xLTEtMA_543845a5-e3d4-4151-bf26-10ff02865c36">699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzItMTAtMS0xLTA_3e568a8c-507b-4baf-893f-dd396289179e">6,379</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency effects and other adjustments, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib78936422dda4cf88cb3cbc4dd220121_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzMtMi0xLTEtMA_0a31416d-ae29-4056-8839-7fbb58b251a6">623</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0a9e47794c54540ad3d61b206a2a5cf_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzMtNC0xLTEtMA_8d6e1bfb-e21d-4319-a617-e8181d188b77">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80e3cb189ce045d08f4e6301ab039bfe_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzMtNi0xLTEtMA_23e3090e-1b55-4ce8-ac5e-e639f414da41">119</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dcd135114fe40ad9bbefb48db0ba475_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzMtOC0xLTEtMA_c5161850-00af-48ea-849a-4d662212708f">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzMtMTAtMS0xLTA_84f06ac5-e69b-4266-949b-8c489771c210">701</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31,&#160;2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ddeff676a684e46b6072017bc1e9416_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzQtMi0xLTEtMA_8232c450-2e45-42fc-89b6-7646056ba93b">27,785</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26d61444d51b4f20823b0b809247d33c_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzQtNC0xLTEtMA_c8bf1538-3573-4437-b7ff-268e39f13462">19,844</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa155f646d841c8b93f03aacf967154_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzQtNi0xLTEtMA_7be37ece-a85c-47e0-ae49-ab3f2b0beddf">8,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id05f41ba34f2466392338fadddf9dd1d_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzQtOC0xLTEtMA_a8af00e2-d5e2-4105-bce0-863937edd8ef">15,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzQtMTAtMS0xLTA_2ba3957e-1beb-46e8-9c5f-af4ea049c715">71,337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9739896064149b98b26a61eeaa6550f_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzUtMi0xLTEtMA_8d20fee4-5690-49d4-a9e7-ee4e1a29e5df">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61c10c93e0f54b55a26f3573ba827569_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzUtNC0xLTEtMA_be81702d-47c6-4538-8a9f-df9cda4509e9">4,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0bdaeb0614d4e2c9380f7415853f763_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzUtNi0xLTEtMA_7c80c102-a835-4d36-81e9-edb7e412eb0b">96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf94dc7fd3204a588aba8704a0d1a90a_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzUtOC0xLTEtMA_3f12eed1-a415-4e6e-adf0-aefe1f211f74">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzUtMTAtMS0xLTA_9f07b557-3abe-47e1-bdc0-b62720e60a8e">4,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency effects and other adjustments, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9739896064149b98b26a61eeaa6550f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzYtMi0xLTEtMA_98cacd11-2c77-4927-94b2-838acf453eda">456</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61c10c93e0f54b55a26f3573ba827569_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzYtNC0xLTEtMA_8721e99a-a96b-4ce9-8c22-b46603d1f5ad">268</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0bdaeb0614d4e2c9380f7415853f763_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzYtNi0xLTEtMA_b4824b42-976a-443f-bd99-8ed7016b3e8d">350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf94dc7fd3204a588aba8704a0d1a90a_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzYtOC0xLTEtMA_e6c9a62f-0d30-4a77-bc27-f97ac9fbcaca">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzYtMTAtMS0xLTA_49746f23-7eae-487b-8efc-b51092e28b51">346</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31,&#160;2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3183b05d67943c3b4034e58b9be0447_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzctMi0xLTEtMA_ff67cd7a-470a-4b61-8eb0-39ead12317a3">27,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13c92c68c2ea480ea5701676b9b826f9_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzctNC0xLTEtMA_44504082-6741-4428-971d-21e317eeb9ce">24,224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i202cb135dc1e4e3daca6dd5059f0cf19_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzctNi0xLTEtMA_1b3b068a-360e-4c80-9c54-beccc71ed3a6">8,619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d5fa92bbec547a085cba2fb930f6bc6_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzctOC0xLTEtMA_be0f2cf6-60cb-4212-add7-a169d0da65d6">15,563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzctMTAtMS0xLTA_783aea37-9647-49c3-b56e-0811ba65d728">75,795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90ZXh0cmVnaW9uOjMxY2JlZmMzZjAyYzQ5YjM5NTExYWQ0NGE1MDRhMzBkXzcyMQ_655125d3-acb4-4d2b-9d60-73da38610529" escape="true"><div style="margin-bottom:4pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross carrying value, accumulated amortization and net carrying value of other intangible assets were as follows: </span></div><div style="margin-bottom:6pt;margin-top:4.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:39.575%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.563%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.563%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.563%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85448c57b2cc45b2ab8f29ae7d7c6a2a_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzItMi0xLTEtMA_df94c079-8db3-4ca4-97c1-56d3d2d4312a">13,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i85448c57b2cc45b2ab8f29ae7d7c6a2a_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzItNC0xLTEtMA_fda7b981-5abc-4e6f-a8dc-4216735364dc">4,697</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85448c57b2cc45b2ab8f29ae7d7c6a2a_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzItNi0xLTEtMA_5c9a849d-7db6-4b23-b4e7-d5744da06d6f">8,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if966e9f805794457af9a0eed34e96495_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzItOC0xLTEtMA_a7c29b75-d1b6-47c9-aa76-d09508cab843">13,428</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if966e9f805794457af9a0eed34e96495_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzItMTAtMS0xLTA_3231e0ab-aaf5-4cc6-a405-fbc56b05e3a9">4,575</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if966e9f805794457af9a0eed34e96495_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzItMTItMS0xLTA_a10c7dd8-1d4f-4763-a36d-468958e37cbb">8,853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb823f0ecf2f4061a477b16abf75cdc2_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzMtMi0xLTEtMA_faf0273e-b19b-4ff3-a72d-b2fe450c25bc">1,630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb823f0ecf2f4061a477b16abf75cdc2_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzMtNC0xLTEtMA_0d91675d-55cd-4bc1-986c-3fac5cceb90e">739</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb823f0ecf2f4061a477b16abf75cdc2_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzMtNi0xLTEtMA_8e57d80b-6ad6-43ab-bf92-cc9165a47413">891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ec08aacf770472c93dbac44374b8a68_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzMtOC0xLTEtMA_69abd9c9-1fde-437f-b4c2-04ca3c729f19">1,597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ec08aacf770472c93dbac44374b8a68_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzMtMTAtMS0xLTA_becee4d1-3edb-4a5d-8e14-d2740322468e">624</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ec08aacf770472c93dbac44374b8a68_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzMtMTItMS0xLTA_ceba0f11-84f0-4061-b1fc-db8307be00f2">973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and other indefinite-lived</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3203585470194543898607ba99a6eec0_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzQtMi0xLTEtMA_0df5732a-81d4-4089-bccf-f35c9eb941b1">617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3203585470194543898607ba99a6eec0_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzQtNC0xLTEtMA_132b765e-1a42-49a3-8406-615bef0de282">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3203585470194543898607ba99a6eec0_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzQtNi0xLTEtMA_5f86a8c0-8a51-4142-87c5-6c4952a4b0a8">617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica15e60f135045e5b3209b00ecdc8ec6_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzQtOC0xLTEtMA_c48e2f40-0c76-483e-84a5-39f1b5b70f92">680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica15e60f135045e5b3209b00ecdc8ec6_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzQtMTAtMS0xLTA_a1c30b6c-1b85-4a99-865f-87ec09eb8e9b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica15e60f135045e5b3209b00ecdc8ec6_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzQtMTItMS0xLTA_bcf45e73-6b6d-42a3-a38f-9876ecf8a038">680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ef9cd7ab1654b62b1ab409dcb38f85f_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzUtMi0xLTEtMA_4cc38a60-8471-441b-b46f-cfdd50acccc1">422</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ef9cd7ab1654b62b1ab409dcb38f85f_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzUtNC0xLTEtMA_586af9a7-4f85-4adf-8718-6ec58cc99a79">200</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ef9cd7ab1654b62b1ab409dcb38f85f_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzUtNi0xLTEtMA_b68c5303-f1fe-4fe7-b6aa-7903fb06e728">222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f34678550484e8eaa1d6f032590a9cd_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzUtOC0xLTEtMA_3854a737-b234-4276-8f1b-843e9300137a">606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f34678550484e8eaa1d6f032590a9cd_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzUtMTAtMS0xLTA_d8c5bb3b-2cd2-4cb6-8fb1-618dbe12f0b8">256</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f34678550484e8eaa1d6f032590a9cd_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzUtMTItMS0xLTA_db90c98a-4af4-4592-9a40-9ac78b8ecf00">350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzYtMi0xLTEtMA_a0c6415d-291a-4596-ace6-46324cb23b57">15,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzYtNC0xLTEtMA_e5793a35-6b84-4a87-bcef-bd1617e675ab">5,636</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzYtNi0xLTEtMA_dc7219dd-86b6-4239-93fa-4be4856c0356">10,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzYtOC0xLTEtMA_1e10e195-c95e-4557-aadf-d69ead95a951">16,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzYtMTAtMS0xLTA_fbc5a4c5-499e-447f-a67e-a6724e0d8b4b">5,455</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzYtMTItMS0xLTA_db19e385-3d71-4807-83af-37ba2e473bb0">10,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><ix:continuation id="i9241fa12a6464d918b92235c27c2eba3" continuedAt="i9e636b5a90d24849a07dc216c713e1dc"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90ZXh0cmVnaW9uOjMxY2JlZmMzZjAyYzQ5YjM5NTExYWQ0NGE1MDRhMzBkXzcyMg_759d0181-eb58-4a3a-8df5-84ca3e589292" escape="true"><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition date fair values and weighted-average useful lives assigned to finite-lived intangible assets acquired in business combinations consisted of the following by year of acquisition:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:59.252%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.535%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Useful Life</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72998cdf5b13475480213110198dde60_D20210101-20211231" decimals="-6" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo1MmYxMTgyMDJmMTY0ZTkzYWE2MjA1MGYzMDM4ZjE3Mi90YWJsZXJhbmdlOjUyZjExODIwMmYxNjRlOTNhYTYyMDUwZjMwMzhmMTcyXzItMi0xLTEtMA_82bf0998-c50b-4435-afdd-cffcd6d0fc83">484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ecd4e0cb3384d4c8ddd20890ad9e997_D20200101-20201231" decimals="-6" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo1MmYxMTgyMDJmMTY0ZTkzYWE2MjA1MGYzMDM4ZjE3Mi90YWJsZXJhbmdlOjUyZjExODIwMmYxNjRlOTNhYTYyMDUwZjMwMzhmMTcyXzItNi0xLTEtMA_86d13025-e0cc-4ea7-9547-e1b987ba6aa2">1,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ded218b083944e188cd4579765a2a84_D20210101-20211231" decimals="-6" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo1MmYxMTgyMDJmMTY0ZTkzYWE2MjA1MGYzMDM4ZjE3Mi90YWJsZXJhbmdlOjUyZjExODIwMmYxNjRlOTNhYTYyMDUwZjMwMzhmMTcyXzMtMi0xLTEtMA_88a073bc-b1aa-431f-875b-251d7541bd77">147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4f1188393845f8827897acb0c3916c_D20200101-20201231" decimals="-6" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo1MmYxMTgyMDJmMTY0ZTkzYWE2MjA1MGYzMDM4ZjE3Mi90YWJsZXJhbmdlOjUyZjExODIwMmYxNjRlOTNhYTYyMDUwZjMwMzhmMTcyXzMtNi0xLTEtMA_249f49c9-98c9-4ba3-8cab-fe624fedd1de">514</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa52ad981c7743b1818a805ee0a0b5fe_D20210101-20211231" decimals="-6" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo1MmYxMTgyMDJmMTY0ZTkzYWE2MjA1MGYzMDM4ZjE3Mi90YWJsZXJhbmdlOjUyZjExODIwMmYxNjRlOTNhYTYyMDUwZjMwMzhmMTcyXzQtMi0xLTEtMA_da84f182-2b32-47d0-a1c1-18242c8071af">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a251ae641a244f982ee84dc33f39c98_D20200101-20201231" decimals="-6" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo1MmYxMTgyMDJmMTY0ZTkzYWE2MjA1MGYzMDM4ZjE3Mi90YWJsZXJhbmdlOjUyZjExODIwMmYxNjRlOTNhYTYyMDUwZjMwMzhmMTcyXzQtNi0xLTEtMA_4a06236c-a838-4271-847c-d97fd87a8097">95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquired finite-lived intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo1MmYxMTgyMDJmMTY0ZTkzYWE2MjA1MGYzMDM4ZjE3Mi90YWJsZXJhbmdlOjUyZjExODIwMmYxNjRlOTNhYTYyMDUwZjMwMzhmMTcyXzUtMi0xLTEtMA_35344c6a-678f-45c9-aa37-5120d9e0f140">660</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo1MmYxMTgyMDJmMTY0ZTkzYWE2MjA1MGYzMDM4ZjE3Mi90YWJsZXJhbmdlOjUyZjExODIwMmYxNjRlOTNhYTYyMDUwZjMwMzhmMTcyXzUtNi0xLTEtMA_8af20816-115d-45df-a3b5-80117298fe71">1,722</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 years</span></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90ZXh0cmVnaW9uOjMxY2JlZmMzZjAyYzQ5YjM5NTExYWQ0NGE1MDRhMzBkXzcxNA_dca73a80-1a0d-47fa-b582-c92452c5aced" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated full year amortization expense relating to intangible assets for each of the next five years ending December 31 is as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:90.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTplYzFhNWY2MWQzZGU0NzRmODhjNDlmOGY0OTQwNDJkMS90YWJsZXJhbmdlOmVjMWE1ZjYxZDNkZTQ3NGY4OGM0OWY4ZjQ5NDA0MmQxXzEtMi0xLTEtMA_94d0a10e-a74d-442e-bc1a-93f2c2d4c3f1">1,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTplYzFhNWY2MWQzZGU0NzRmODhjNDlmOGY0OTQwNDJkMS90YWJsZXJhbmdlOmVjMWE1ZjYxZDNkZTQ3NGY4OGM0OWY4ZjQ5NDA0MmQxXzItMi0xLTEtMA_fb1fd14f-b5b8-4fa5-a122-c7a4913f2a25">1,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTplYzFhNWY2MWQzZGU0NzRmODhjNDlmOGY0OTQwNDJkMS90YWJsZXJhbmdlOmVjMWE1ZjYxZDNkZTQ3NGY4OGM0OWY4ZjQ5NDA0MmQxXzMtMi0xLTEtMA_b2413a16-398c-4bff-b47f-3e5e4a897753">972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTplYzFhNWY2MWQzZGU0NzRmODhjNDlmOGY0OTQwNDJkMS90YWJsZXJhbmdlOmVjMWE1ZjYxZDNkZTQ3NGY4OGM0OWY4ZjQ5NDA0MmQxXzQtMi0xLTEtMA_fad5401f-33a0-4fc5-8e79-058a97c0b3c8">892</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTplYzFhNWY2MWQzZGU0NzRmODhjNDlmOGY0OTQwNDJkMS90YWJsZXJhbmdlOmVjMWE1ZjYxZDNkZTQ3NGY4OGM0OWY4ZjQ5NDA0MmQxXzUtMi0xLTEtMA_45949922-3f77-4837-856e-6baf08f99722">757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9e636b5a90d24849a07dc216c713e1dc">Amortization expense relating to intangible assets for the years ended December&#160;31, 2021, 2020 and 2019 was $<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-8" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90ZXh0cmVnaW9uOjMxY2JlZmMzZjAyYzQ5YjM5NTExYWQ0NGE1MDRhMzBkXzY3Nw_5e5d1d42-3dce-4b44-b477-3ba9027be990">1.2</ix:nonFraction> billion, $<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-8" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90ZXh0cmVnaW9uOjMxY2JlZmMzZjAyYzQ5YjM5NTExYWQ0NGE1MDRhMzBkXzY4MQ_17d906e2-0bf8-4b2f-a9ae-8f2f1c4cfdab">1.1</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-8" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90ZXh0cmVnaW9uOjMxY2JlZmMzZjAyYzQ5YjM5NTExYWQ0NGE1MDRhMzBkXzY4OA_ccf806c8-3af5-4062-a053-2cbcbb2310d0">1.0</ix:nonFraction> billion, respectively.</ix:continuation> </span></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_190"></div><div style="margin-top:15pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90ZXh0cmVnaW9uOjFkMTJlYWQzMmI0MDRhNTA4ZmYxNTI5MGVmZThkMDI2XzY1MQ_572b3759-325c-48cc-aaec-e3772707ab41" continuedAt="ia009c607573d4cbd9d579fd51ecf6b68" escape="true">Medical Costs Payable</ix:nonNumeric></span></div><ix:continuation id="ia009c607573d4cbd9d579fd51ecf6b68" continuedAt="i2d29a293a6374ae989c031190deeabb2"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90ZXh0cmVnaW9uOjFkMTJlYWQzMmI0MDRhNTA4ZmYxNTI5MGVmZThkMDI2XzY2Mw_6303abf9-e764-40f2-8984-38862c69818b" escape="true"><div style="margin-bottom:4pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in medical costs payable for the years ended December&#160;31: </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:65.029%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.458%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs payable, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzEtMi0xLTEtMA_d2ebff8f-8824-4295-991c-d31c84c3e431">21,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530caf840d4847f1ac553be5f7b336b2_I20191231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzEtNC0xLTEtMA_46808ad0-be0d-465a-aa11-414f37acea40">21,690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i870730cd9dfc45bb89971499ab4cdd48_I20181231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzEtNi0xLTEtMA_588bb723-d175-41dd-9de6-eecdd90f7826">19,891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzItMi0xLTEtMA_b6981e3e-f381-4e50-bf9c-c83737812fd7">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzItNC0xLTEtMA_b7ce3ef7-2908-49d1-ac14-e5b5c1ee5329">316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzItNi0xLTEtMA_1f971050-22a5-4508-bd66-20865eaec766">679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported medical costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzQtMi0xLTEtMA_bda4a872-e576-484c-bb63-dc1d1bb23325">188,631</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzQtNC0xLTEtMA_5f410904-6cbb-4495-ad5f-d00553233849">160,276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzQtNi0xLTEtMA_f5f7a17e-b800-4666-84fa-b5d73b0d7469">157,020</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzUtMi0xLTEtMA_5d2029ad-caa8-42ae-80b0-58d937abf637">1,720</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzUtNC0xLTEtMA_f2edad6c-ffa6-45dc-b83d-41f1b49fbaec">880</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzUtNi0xLTEtMA_653abd6a-56ed-4f28-b7e7-8674edcc6ad3">580</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reported medical costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzYtMi0xLTEtMA_7a0a4d1b-518d-4d51-89f6-6950f32babbf">186,911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzYtNC0xLTEtMA_1f264b97-5236-48b7-b8d4-e017c230474f">159,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzYtNi0xLTEtMA_970159f0-4cef-43ff-ad30-53b250c65861">156,440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical payments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for current year</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzgtMi0xLTEtMA_8d2920cd-53a2-4be5-9fc8-58d2fa0d768d">165,524</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzgtNC0xLTEtMA_56a7806b-97ec-4391-a23b-f097fa56e050">139,974</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzgtNi0xLTEtMA_70a32f07-867d-429d-9d01-0e5e449924b3">137,155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for prior years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzktMi0xLTEtMA_db319ece-de75-4978-9c2b-26d39e9a4061">18,864</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzktNC0xLTEtMA_452b529e-3b9e-43f0-a06e-7f5cff237dae">19,556</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzktNi0xLTEtMA_e488ee8a-8725-45af-8326-deff4a5f4418">18,165</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total medical payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzEwLTItMS0xLTA_85ced31e-4b34-4831-96e1-89abdf62e628">184,388</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzEwLTQtMS0xLTA_07f12336-4ab3-4caf-aff7-b9e924c4b25a">159,530</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzEwLTYtMS0xLTA_2de54e22-b60b-43dc-8002-ca36ba4333ff">155,320</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs payable, end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzExLTItMS0xLTA_12d78814-6456-463e-866f-a7a7ed3310b7">24,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzExLTQtMS0xLTA_8d1225e0-5847-4139-ac72-f0b6d2a08285">21,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530caf840d4847f1ac553be5f7b336b2_I20191231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzExLTYtMS0xLTA_00893d70-60bd-4528-9a09-c04b2fd714ce">21,690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the years ended December&#160;31, 2021, 2020 and 2019 medical cost reserve development was primarily driven by lower than expected health system utilization levels. Additionally, medical cost reserve development in the year ended December 31, 2021 was driven by the uncertainty of care patterns due to the disruption of the health care system caused by COVID-19.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><ix:continuation id="i2d29a293a6374ae989c031190deeabb2"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical costs payable included IBNR of $<ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-8" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90ZXh0cmVnaW9uOjFkMTJlYWQzMmI0MDRhNTA4ZmYxNTI5MGVmZThkMDI2XzQ0NQ_0de0e82e-bfe1-4989-8dbc-44e26337d76b">17.1</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-8" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90ZXh0cmVnaW9uOjFkMTJlYWQzMmI0MDRhNTA4ZmYxNTI5MGVmZThkMDI2XzQ1Mg_a73f9d31-b972-48bb-b082-a0ef4efe9bab">14.8</ix:nonFraction> billion at December&#160;31, 2021 and 2020, respectively. Substantially all of the IBNR balance as of December&#160;31, 2021 relates to the current year. <ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90ZXh0cmVnaW9uOjFkMTJlYWQzMmI0MDRhNTA4ZmYxNTI5MGVmZThkMDI2XzY1Ng_b850741a-6307-4c9f-9d22-d254f544531a" continuedAt="if8ba9c1d0d99479a9477c6bea341bef8" escape="true">The following is information about incurred and paid medical cost development as of December&#160;31, 2021: </ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:4.5pt"><ix:continuation id="if8ba9c1d0d99479a9477c6bea341bef8"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:54.031%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.826%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.160%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.164%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Incurred Medical Costs</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e7bca7f64a8424489d83e9c4b27fbba_I20201231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo5NmJjMDQwYTljNDc0OWNiOWNkNzM0YjA2ODc1YTU5Zi90YWJsZXJhbmdlOjk2YmMwNDBhOWM0NzQ5Y2I5Y2Q3MzRiMDY4NzVhNTlmXzMtMi0xLTEtMA_2cbd60de-d045-4f0f-819c-36e29b652090">160,276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if47ca87b4cab4485a2e7830a82f298c2_I20211231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo5NmJjMDQwYTljNDc0OWNiOWNkNzM0YjA2ODc1YTU5Zi90YWJsZXJhbmdlOjk2YmMwNDBhOWM0NzQ5Y2I5Y2Q3MzRiMDY4NzVhNTlmXzMtNC0xLTEtMA_d3c1c34b-daa6-4c99-b73e-8834ad9aac74">159,140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1db8094151d340e583b4cbe1a3165397_I20211231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo5NmJjMDQwYTljNDc0OWNiOWNkNzM0YjA2ODc1YTU5Zi90YWJsZXJhbmdlOjk2YmMwNDBhOWM0NzQ5Y2I5Y2Q3MzRiMDY4NzVhNTlmXzQtNC0xLTEtMA_8e04349e-efeb-4cbb-ace8-b762c48e9cd1">188,631</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifafacde0705d4f258c784fe3cb74d22f_I20211231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo5NmJjMDQwYTljNDc0OWNiOWNkNzM0YjA2ODc1YTU5Zi90YWJsZXJhbmdlOjk2YmMwNDBhOWM0NzQ5Y2I5Y2Q3MzRiMDY4NzVhNTlmXzUtNC0xLTEtMA_adca65fd-12b5-4e34-9b37-d0766244a181">347,771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Cumulative Medical Payments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e7bca7f64a8424489d83e9c4b27fbba_I20201231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo5NmJjMDQwYTljNDc0OWNiOWNkNzM0YjA2ODc1YTU5Zi90YWJsZXJhbmdlOjk2YmMwNDBhOWM0NzQ5Y2I5Y2Q3MzRiMDY4NzVhNTlmXzEwLTItMS0xLTA_f350a443-41ea-40da-9341-e11297b9d9b4">139,974</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if47ca87b4cab4485a2e7830a82f298c2_I20211231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo5NmJjMDQwYTljNDc0OWNiOWNkNzM0YjA2ODc1YTU5Zi90YWJsZXJhbmdlOjk2YmMwNDBhOWM0NzQ5Y2I5Y2Q3MzRiMDY4NzVhNTlmXzEwLTQtMS0xLTA_6fa5d919-9c3f-44e0-80cb-0eff719017f2">158,182</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1db8094151d340e583b4cbe1a3165397_I20211231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo5NmJjMDQwYTljNDc0OWNiOWNkNzM0YjA2ODc1YTU5Zi90YWJsZXJhbmdlOjk2YmMwNDBhOWM0NzQ5Y2I5Y2Q3MzRiMDY4NzVhNTlmXzExLTQtMS0xLTA_933d7505-757e-45cc-abf1-78861dc6996c">165,524</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifafacde0705d4f258c784fe3cb74d22f_I20211231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo5NmJjMDQwYTljNDc0OWNiOWNkNzM0YjA2ODc1YTU5Zi90YWJsZXJhbmdlOjk2YmMwNDBhOWM0NzQ5Y2I5Y2Q3MzRiMDY4NzVhNTlmXzEyLTQtMS0xLTA_067bf180-9008-47ad-86bd-bf367514c46c">323,706</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net remaining outstanding liabilities prior to 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifafacde0705d4f258c784fe3cb74d22f_I20211231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo5NmJjMDQwYTljNDc0OWNiOWNkNzM0YjA2ODc1YTU5Zi90YWJsZXJhbmdlOjk2YmMwNDBhOWM0NzQ5Y2I5Y2Q3MzRiMDY4NzVhNTlmXzEzLTQtMS0xLTA_bf528481-2f98-4c75-8ab7-7ae1131f642c">418</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total medical costs payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifafacde0705d4f258c784fe3cb74d22f_I20211231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo5NmJjMDQwYTljNDc0OWNiOWNkNzM0YjA2ODc1YTU5Zi90YWJsZXJhbmdlOjk2YmMwNDBhOWM0NzQ5Y2I5Y2Q3MzRiMDY4NzVhNTlmXzE0LTQtMS0xLTA_4d296f51-b3f5-48b7-8289-e03323e0fa0c">24,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="margin-top:9pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_193"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90ZXh0cmVnaW9uOjU4ODcyNTgwOGZiYjRmYTVhMDEyOTUzNGVhMGZlMDQyXzE2NDkyNjc0NDMzMzc_921e28e6-75ed-4bfc-9f72-bc0e24a241e7" continuedAt="i857dea9472244ea3844aab9dbea1e0cc" escape="true">Short-Term Borrowings and Long-Term Debt </ix:nonNumeric></span></div><ix:continuation id="i857dea9472244ea3844aab9dbea1e0cc" continuedAt="i836c8e3bbc204e99bd4af33cb9df1749"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90ZXh0cmVnaW9uOjU4ODcyNTgwOGZiYjRmYTVhMDEyOTUzNGVhMGZlMDQyXzE2NDkyNjc0NDMzMzY_f4cf66fb-a95c-419b-ac1f-da3ab097db9e" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term borrowings and senior unsecured long-term debt consisted of the following:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.338%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.453%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Carrying Value As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(in millions, except percentages)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86f3f2448f524de3913d85ac9788450f_I20211231" decimals="-6" name="us-gaap:CommercialPaper" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzItNC0xLTEtMA_2233e912-43be-4b50-8d76-823211ad4007">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i379ecb26e0e846348f402effa72a9eb2_I20201231" decimals="-6" name="us-gaap:CommercialPaper" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzItMTAtMS0xLTA_3df36912-3a64-4eef-9793-c5231b5dfa17">1,296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i8cb0c74d57b1477fa31da545e505e6d8_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzctMC0xLTEtMC90ZXh0cmVnaW9uOjRiMzE1MmM2YzVhYjQ1YTM4MjE5ZmEwNDc1OTgyY2I2XzQzOTgwNDY1MTEyMjE_9f396a51-75cb-49f3-a55b-0b601bf89f5f">400</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i8cb0c74d57b1477fa31da545e505e6d8_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzctMC0xLTEtMC90ZXh0cmVnaW9uOjRiMzE1MmM2YzVhYjQ1YTM4MjE5ZmEwNDc1OTgyY2I2XzI3NDg3NzkwNjk1NzU_4979c605-e01b-4a20-b378-c6a608115255">4.700</ix:nonFraction>% notes due February 2021 </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cb0c74d57b1477fa31da545e505e6d8_I20211231" decimals="-6" name="us-gaap:UnsecuredDebtCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzctNC0xLTEtMA_2c348e73-246f-4cbc-813b-90d39f54efe1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5c8f497804347fc9f0f8a62f4499752_I20201231" decimals="-6" name="us-gaap:UnsecuredDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzctMTAtMS0xLTA_4fb85f23-96d2-4ec3-addb-8607854076ad">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ibd92e268e96f4727813026fb9f3f2f8f_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzgtMC0xLTEtMC90ZXh0cmVnaW9uOjE0ZTFjMTk1M2E5NzQ3ZWNhZjY2MzZmZDExOGI3ZTI1XzQzOTgwNDY1MTExNTY_5134b3e7-1b4b-4fd4-9d35-3f3b621d6956">750</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="ibd92e268e96f4727813026fb9f3f2f8f_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzgtMC0xLTEtMC90ZXh0cmVnaW9uOjE0ZTFjMTk1M2E5NzQ3ZWNhZjY2MzZmZDExOGI3ZTI1XzQ_98206065-be78-4f82-b6ae-79e89edb4feb">2.125</ix:nonFraction>% notes due March 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd92e268e96f4727813026fb9f3f2f8f_I20211231" decimals="-6" name="us-gaap:UnsecuredDebtCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzgtNC0xLTEtMA_0b2a709b-cc57-409e-8b20-f97fbe25898d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4248de2739cf40dca665ae10381e03b2_I20201231" decimals="-6" name="us-gaap:UnsecuredDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzgtMTAtMS0xLTA_8c8c3d55-3ee5-47a2-af1d-ce8d51c5744d">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ifb03d5528d1145cfb99fcf592801d116_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzUtMC0xLTEtMTg0NjgvdGV4dHJlZ2lvbjplYWI1YTFlZjdjMmY0Y2FiODlhYzNmNDc4NmE2NTBiYV80Mzk4MDQ2NTExMTY4_f0a0c900-c0c7-4461-9bad-16c2f014cbc9">350</ix:nonFraction> million Floating rate notes due June 2021</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb03d5528d1145cfb99fcf592801d116_I20211231" decimals="-6" name="us-gaap:UnsecuredDebtCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzktNC0xLTEtMA_9cbcc705-673e-4278-b47a-7b1d6faf56de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63fb7f8ae0fd40038163eafaa15d201d_I20201231" decimals="-6" name="us-gaap:UnsecuredDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzktMTAtMS0xLTA_f44031f9-d96f-4e5c-95da-4d757ff02cf7">350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ie6c00455b2e34b31b4063ebbf2107d3a_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzEwLTAtMS0xLTAvdGV4dHJlZ2lvbjpkNGQ1MDk4ZDFmYzQ0ZWEwYmIzMWIxOWMwNzI2ODBkNV80Mzk4MDQ2NTExMTY5_f54975be-d7a4-49fb-bd3f-696c8c0b2b0f">400</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="ie6c00455b2e34b31b4063ebbf2107d3a_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzEwLTAtMS0xLTAvdGV4dHJlZ2lvbjpkNGQ1MDk4ZDFmYzQ0ZWEwYmIzMWIxOWMwNzI2ODBkNV80_e62f4290-b218-49ed-9504-8cc19bef2052">3.150</ix:nonFraction>% notes due June 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6c00455b2e34b31b4063ebbf2107d3a_I20211231" decimals="-6" name="us-gaap:UnsecuredDebtCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzEwLTQtMS0xLTA_16144119-1920-45cd-bef3-ea5cf23ea559">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cb2d4454a64645abe47553a65a92de_I20201231" decimals="-6" name="us-gaap:UnsecuredDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzEwLTEwLTEtMS0w_a23bdcff-d42b-4c39-bb97-3b1db911ccaf">400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="id372eeef8e344178a1dbfa89af46c45e_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzExLTAtMS0xLTAvdGV4dHJlZ2lvbjo4ZjczNmFjNzBlNmU0ODEzYmYyZGM0MDgxNThjMTJkNV80Mzk4MDQ2NTExMTc0_f1f34f74-116b-4b0d-b60a-862d8056a847">500</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="id372eeef8e344178a1dbfa89af46c45e_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzExLTAtMS0xLTAvdGV4dHJlZ2lvbjo4ZjczNmFjNzBlNmU0ODEzYmYyZGM0MDgxNThjMTJkNV80_0618055b-943f-4e21-9827-331da7721279">3.375</ix:nonFraction>% notes due November 2021 </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id372eeef8e344178a1dbfa89af46c45e_I20211231" decimals="-6" name="us-gaap:UnsecuredDebtCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzExLTQtMS0xLTA_c94d12ae-0a9b-4bd7-a598-bc52aee5a02f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ba481f8e0d74c10bc0588b4835f8af5_I20201231" decimals="-6" name="us-gaap:UnsecuredDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzExLTEwLTEtMS0w_27f5ffb1-2aab-4824-9a2b-4236d2623965">507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ib8da81de7fee4af4be76cb170e34ee08_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzEyLTAtMS0xLTAvdGV4dHJlZ2lvbjpjYWUxMDQxNmVkMDU0MzcxOGIzMjRkNDkwNTY1MjE0YV80Mzk4MDQ2NTExMTU5_22cff608-8dc4-4e3c-b2a0-e9d5aaba8930">750</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="ib8da81de7fee4af4be76cb170e34ee08_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzEyLTAtMS0xLTAvdGV4dHJlZ2lvbjpjYWUxMDQxNmVkMDU0MzcxOGIzMjRkNDkwNTY1MjE0YV80_d46c4371-c76e-47a3-be01-0ac1ae43be5a">2.875</ix:nonFraction>% notes due December 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8da81de7fee4af4be76cb170e34ee08_I20211231" decimals="-6" name="us-gaap:UnsecuredDebtCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzEyLTQtMS0xLTA_3e6b1091-1d64-48ed-9207-b1174115c360">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i096ea40c3d4c42ba8a127cef33efd254_I20201231" decimals="-6" name="us-gaap:UnsecuredDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzEyLTEwLTEtMS0w_f49d82bf-217f-4167-81b2-604341df7e90">762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i8172aeed31f44528a74a1c8dbfd1ca1a_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzEzLTAtMS0xLTAvdGV4dHJlZ2lvbjo2N2Y4MTM3NGZlOTk0ZmIzYmM1Yzc5M2ViYzdmMmFjN180Mzk4MDQ2NTExMTYx_c1598bd6-ac30-4086-887c-56d8ce86910b">1,100</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i8172aeed31f44528a74a1c8dbfd1ca1a_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzEzLTAtMS0xLTAvdGV4dHJlZ2lvbjo2N2Y4MTM3NGZlOTk0ZmIzYmM1Yzc5M2ViYzdmMmFjN180_c5cc5d75-a498-4396-83b1-84131ff0bb90">2.875</ix:nonFraction>% notes due March 2022 </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8172aeed31f44528a74a1c8dbfd1ca1a_I20211231" decimals="-6" name="us-gaap:UnsecuredDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzEzLTQtMS0xLTA_3c9b2372-3ef1-422c-948b-552a68b565c2">1,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84e7e1ef880e481483e8d4914556cf84_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzEzLTEwLTEtMS0w_f30c891f-833d-4ac0-8a36-98aeaa8f27d8">1,113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i7e3cddf201a14b228f50c7a4b6a5839e_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE0LTAtMS0xLTAvdGV4dHJlZ2lvbjpkOTIyODVlZTUwZmQ0YzkwYTk5MTBkZGY2NWMzM2ZiM180Mzk4MDQ2NTExMTU5_a3098a45-469b-4bba-9d41-7067a560e62e">1,000</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i7e3cddf201a14b228f50c7a4b6a5839e_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE0LTAtMS0xLTAvdGV4dHJlZ2lvbjpkOTIyODVlZTUwZmQ0YzkwYTk5MTBkZGY2NWMzM2ZiM180_978f4047-052c-48a5-a305-ef6f40ff97ba">3.350</ix:nonFraction>% notes due July 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e3cddf201a14b228f50c7a4b6a5839e_I20211231" decimals="-6" name="us-gaap:UnsecuredDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE0LTQtMS0xLTA_5b7627be-3c71-4a5d-a4d6-114994f5e8fa">999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c80b9e731e44c0697a1b7a31a23bf17_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE0LTEwLTEtMS0w_a9fca77a-ba7f-446f-bab3-5d684c4856c9">999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i93168a5ed89f448f8f66c9c0a2283b35_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE1LTAtMS0xLTAvdGV4dHJlZ2lvbjo3YzU4MGUyNjUyNTA0MTMyYjk3NDIxNTQ2MTcwNTIyZF80Mzk4MDQ2NTExMTU4_44b127b2-b55d-4045-872a-bead60c41ccc">900</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i93168a5ed89f448f8f66c9c0a2283b35_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE1LTAtMS0xLTAvdGV4dHJlZ2lvbjo3YzU4MGUyNjUyNTA0MTMyYjk3NDIxNTQ2MTcwNTIyZF80_5c83d6aa-ea7f-447a-b1dd-a7b0c881b5e0">2.375</ix:nonFraction>% notes due October 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93168a5ed89f448f8f66c9c0a2283b35_I20211231" decimals="-6" name="us-gaap:UnsecuredDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE1LTQtMS0xLTA_8e6c8eb1-8246-46f3-a22e-f2b1c0c78af6">899</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92d32861403b4fa0bc059b43eb0e9edf_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE1LTEwLTEtMS0w_301223b1-6e45-4602-b43d-f56d8d9f3c17">897</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i84b80aaa2de74ba09b15b98ebeeb295d_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE2LTAtMS0xLTAvdGV4dHJlZ2lvbjo5MjNhZjAyYzE2NWM0OWJhOWU2MjgwNDg4NmZhMTExMV80Mzk4MDQ2NTExMTc5_add601e5-4e4e-4e9f-b675-9c29307e68dd">15</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i84b80aaa2de74ba09b15b98ebeeb295d_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE2LTAtMS0xLTAvdGV4dHJlZ2lvbjo5MjNhZjAyYzE2NWM0OWJhOWU2MjgwNDg4NmZhMTExMV80_94b1efe2-8cdf-41df-8978-36a62d884ae9">0.000</ix:nonFraction>% notes due November 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84b80aaa2de74ba09b15b98ebeeb295d_I20211231" decimals="-6" name="us-gaap:UnsecuredDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE2LTQtMS0xLTA_d6354f7c-872b-4c00-b364-0487706479c5">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdb4994c14104e3ebccd784f009aa1ae_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE2LTEwLTEtMS0w_e7571510-efef-4140-a999-636f52b15af8">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i7548e5a838a4421695679910bd4f2c0a_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE3LTAtMS0xLTAvdGV4dHJlZ2lvbjplNjViZGIwZWM2MTA0ZmQ3OTYyMzc4OGRlNmEzNTE3NF80Mzk4MDQ2NTExMTU5_47544c7f-610d-4480-b40f-eefd35dbedb9">625</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i7548e5a838a4421695679910bd4f2c0a_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE3LTAtMS0xLTAvdGV4dHJlZ2lvbjplNjViZGIwZWM2MTA0ZmQ3OTYyMzc4OGRlNmEzNTE3NF80_1707fdc3-895f-4dfc-82bb-51c3aae1e95a">2.750</ix:nonFraction>% notes due February 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7548e5a838a4421695679910bd4f2c0a_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE3LTQtMS0xLTA_59296a88-b547-4113-a386-dd91b2e9418f">632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib120d5bbaa93472eb64fb119097cdf6f_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE3LTEwLTEtMS0w_e5e5bc97-ebb1-44cc-93a1-fe419fc82f35">644</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i597c8e442da543bf8a7372bc0ec54f9d_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE4LTAtMS0xLTAvdGV4dHJlZ2lvbjpkMDIxOTczZjc5NzQ0MmRhYTkzNjdmMzJhYmI5ZWQ5Yl80Mzk4MDQ2NTExMTU3_9145b886-c270-49ce-b8a1-1d4bb4dc4314">750</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i597c8e442da543bf8a7372bc0ec54f9d_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE4LTAtMS0xLTAvdGV4dHJlZ2lvbjpkMDIxOTczZjc5NzQ0MmRhYTkzNjdmMzJhYmI5ZWQ5Yl80_73277404-d1ee-4c7d-9071-3a83b22ff01c">2.875</ix:nonFraction>% notes due March 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i597c8e442da543bf8a7372bc0ec54f9d_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE4LTQtMS0xLTA_72d4e48f-e299-4b5e-81b4-aec6190640d2">768</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie880ffc901ab4104b4cfd303f4831b1f_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE4LTEwLTEtMS0w_be204862-6ca3-4621-8c27-47c6340f5a65">789</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="iedb8d09cef364b1293599d28f7c67748_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE5LTAtMS0xLTAvdGV4dHJlZ2lvbjpmZjcyMjEwMWZkMjk0MzczOTc5MTA3MDU1M2QzMDFjY180Mzk4MDQ2NTExMTU2_63d9d312-3d63-48df-8b27-bca26236948f">750</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="iedb8d09cef364b1293599d28f7c67748_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE5LTAtMS0xLTAvdGV4dHJlZ2lvbjpmZjcyMjEwMWZkMjk0MzczOTc5MTA3MDU1M2QzMDFjY180_e900f2f0-5056-42ba-a85b-e5dcd6209ea5">3.500</ix:nonFraction>% notes due June 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedb8d09cef364b1293599d28f7c67748_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE5LTQtMS0xLTA_82297cab-862a-4e5a-87ec-659190c454a8">749</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia859c1517f2441d58ef162b5ff01d64c_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE5LTEwLTEtMS0w_2116ffa9-4bc2-43e7-b1e8-52bc021a9e60">748</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i886286b365bb4971a2f13e2f846af74a_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIwLTAtMS0xLTAvdGV4dHJlZ2lvbjplODlkNTI3ZDYzMzA0MjY0YmViYjA3MmJmMzE0N2FiM180Mzk4MDQ2NTExMTU5_b6e76edb-418c-4c32-a64d-5f5cec5813ab">750</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i886286b365bb4971a2f13e2f846af74a_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIwLTAtMS0xLTAvdGV4dHJlZ2lvbjplODlkNTI3ZDYzMzA0MjY0YmViYjA3MmJmMzE0N2FiM180_7c07be14-e36b-4b24-9715-f5092fce1131">3.500</ix:nonFraction>% notes due February 2024</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i886286b365bb4971a2f13e2f846af74a_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIwLTQtMS0xLTA_41a5e7fb-bf19-43c2-a2c6-66721f84b442">748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07e2a1c9ec8442cea51615552b249524_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIwLTEwLTEtMS0w_e679221d-4160-416b-9ff7-a9ba7a181520">747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="if18a2f7f6b0b40f1ad62bd0e830e8b8f_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIxLTAtMS0xLTQ5Mi90ZXh0cmVnaW9uOjAyYWNkODE5NGFmYTQyZDY5YjQ4YTIxMzI4MzMzNzAxXzQzOTgwNDY1MTExODU_173a91e0-be26-4065-9882-91fe37a49b0f">1,000</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="if18a2f7f6b0b40f1ad62bd0e830e8b8f_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIxLTAtMS0xLTQ5Mi90ZXh0cmVnaW9uOjAyYWNkODE5NGFmYTQyZDY5YjQ4YTIxMzI4MzMzNzAxXzE2NDkyNjc0NDE2OTk_5835ecff-155c-443d-862e-5e4b5a19934a">0.550</ix:nonFraction>% notes due May 2024</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18a2f7f6b0b40f1ad62bd0e830e8b8f_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIxLTQtMS0xLTQ5NQ_d92e60ce-b418-4359-8813-208b0b94dd96">996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30c9ff85e8394406aa2fcf8c8e0dbf28_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIxLTEwLTEtMS00OTU_74ac4a44-e833-4230-ab90-2bef9f8cc1c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ic1ec0d84eddf49dc97d2a21dd8cee234_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIxLTAtMS0xLTAvdGV4dHJlZ2lvbjpmY2E1OGQ5ZWE4ZDE0YmYxOWZmZjBkNWNmZTMzZjIzY180Mzk4MDQ2NTExMTU3_678a9319-81bd-49e0-b8cf-30601e9d0db0">750</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="ic1ec0d84eddf49dc97d2a21dd8cee234_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIxLTAtMS0xLTAvdGV4dHJlZ2lvbjpmY2E1OGQ5ZWE4ZDE0YmYxOWZmZjBkNWNmZTMzZjIzY180_f86a389c-567d-40c5-9675-41e93a00e7f5">2.375</ix:nonFraction>% notes due August 2024</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1ec0d84eddf49dc97d2a21dd8cee234_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIxLTQtMS0xLTA_256cfc6c-776e-4116-a677-3e46bf3c9f01">748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb4e09db805a48c9a9980ed388f9d691_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIxLTEwLTEtMS0w_e4976fc6-f414-4274-986d-7e1e4887cae7">747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i315d80ec5a9b4d33b1d8d34a78cae609_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIyLTAtMS0xLTAvdGV4dHJlZ2lvbjo0ZGM3OGVjZTE3Mjc0NTViOGEzYmU1NDVmZTI4NzJhZV80Mzk4MDQ2NTExMTYw_448c6411-9f44-4952-a52c-a5c99a37fb83">2,000</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i315d80ec5a9b4d33b1d8d34a78cae609_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIyLTAtMS0xLTAvdGV4dHJlZ2lvbjo0ZGM3OGVjZTE3Mjc0NTViOGEzYmU1NDVmZTI4NzJhZV80_c6a554db-fba0-41d4-bacb-324b492e0721">3.750</ix:nonFraction>% notes due July 2025</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i315d80ec5a9b4d33b1d8d34a78cae609_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIyLTQtMS0xLTA_4f244f3f-d0e6-4d15-ab47-0373eb71c4de">1,994</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba6f227255b343d1ac18d3836772b9ad_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIyLTEwLTEtMS0w_33ae92bd-f656-4c81-8c00-18c5b5d0cc4b">1,992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i786f913ccf164a438f57c04ee49ad2b7_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIzLTAtMS0xLTAvdGV4dHJlZ2lvbjo1MzZhY2VlZjgwMWE0ZThkOTg5ZTQ3OGZkMTEyOWI0Nl80Mzk4MDQ2NTExMTU5_346746e2-6fd1-441e-b88e-d60a0944210b">300</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i786f913ccf164a438f57c04ee49ad2b7_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIzLTAtMS0xLTAvdGV4dHJlZ2lvbjo1MzZhY2VlZjgwMWE0ZThkOTg5ZTQ3OGZkMTEyOWI0Nl80_3536f785-0321-4b90-ae5f-91d9fd7be0f7">3.700</ix:nonFraction>% notes due December 2025</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i786f913ccf164a438f57c04ee49ad2b7_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIzLTQtMS0xLTA_33a20b4a-7c2c-4a1e-a534-985627251dc0">299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde9da88b2241dc9f725c1d621be4d6_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIzLTEwLTEtMS0w_56069a12-1fe1-4d5b-9677-93af6a2548be">298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i1a3471e5bd4648d0aa81686260fbc921_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI0LTAtMS0xLTAvdGV4dHJlZ2lvbjpmZDE4N2JhMDgyMmI0NmMyYTUwY2MwOTY0ZDk5ZDA2Y180Mzk4MDQ2NTExMTc0_6c7e6f89-ff0b-444b-8e23-b3255a9b05ba">500</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i1a3471e5bd4648d0aa81686260fbc921_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI0LTAtMS0xLTAvdGV4dHJlZ2lvbjpmZDE4N2JhMDgyMmI0NmMyYTUwY2MwOTY0ZDk5ZDA2Y180_3e8c31c7-c497-4a56-95f6-0b82533221b4">1.250</ix:nonFraction>% notes due January 2026</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a3471e5bd4648d0aa81686260fbc921_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI0LTQtMS0xLTA_c0e1b003-39c2-48ca-adda-e44d493c9cf0">497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7deed358f93647928f915f8ee952b69f_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI0LTEwLTEtMS0w_a398eb33-eb45-405a-8cdb-e1a9f636d21c">496</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="id8044edfa2384079929b35102a9b7cad_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI1LTAtMS0xLTAvdGV4dHJlZ2lvbjo0MDg4YTZlNjk1NzM0ZTg5ODA2NjNkMGQ5ODU2ZjZmYV80Mzk4MDQ2NTExMTYw_5cc2283b-279e-499e-88ef-d278eca4d566">1,000</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="id8044edfa2384079929b35102a9b7cad_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI1LTAtMS0xLTAvdGV4dHJlZ2lvbjo0MDg4YTZlNjk1NzM0ZTg5ODA2NjNkMGQ5ODU2ZjZmYV80_4e682d5c-e148-422b-8dc8-ec1cbede1271">3.100</ix:nonFraction>% notes due March 2026</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8044edfa2384079929b35102a9b7cad_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI1LTQtMS0xLTA_aec0f4a6-fc23-4b3b-9299-00e701fcda9a">997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1344e7e2b6414a7890e692110596b117_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI1LTEwLTEtMS0w_4ce61177-613e-4fb2-b5ab-52f849f488cf">997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="iec7c13902a5a4ee19961a3eed138f023_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI3LTAtMS0xLTUwNi90ZXh0cmVnaW9uOjcyYTM1MzU1Zjc4ZDRlNWI5ZWRiZjZhMTU3MDM2NGRkXzQzOTgwNDY1MTExNzE_2ecd57df-ff24-49f0-9377-e6991b11602a">1,000</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="iec7c13902a5a4ee19961a3eed138f023_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI3LTAtMS0xLTUwNi90ZXh0cmVnaW9uOjcyYTM1MzU1Zjc4ZDRlNWI5ZWRiZjZhMTU3MDM2NGRkXzE2NDkyNjc0NDE2OTk_1e3bc6bc-a48a-48e4-9372-fceecaacd774">1.150</ix:nonFraction>% notes due May 2026</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec7c13902a5a4ee19961a3eed138f023_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI3LTQtMS0xLTUwOQ_6e5960a7-f727-4122-a8de-3fb86bfd56a9">972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c36e71284047c4a3930eb5b853ea20_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI3LTEwLTEtMS01MDk_3555ae0f-e73f-404a-be96-d311f6e04817">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i6f817c64d72746f4a7600550a38be49c_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI2LTAtMS0xLTAvdGV4dHJlZ2lvbjo3Y2IwYWYyMWM4NDE0NGUwODA1ODM1NzBhNDdmMzkxYV80Mzk4MDQ2NTExMTU4_9cf66ed2-6872-4f14-b87e-f8a25827207d">750</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i6f817c64d72746f4a7600550a38be49c_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI2LTAtMS0xLTAvdGV4dHJlZ2lvbjo3Y2IwYWYyMWM4NDE0NGUwODA1ODM1NzBhNDdmMzkxYV80_237e12bb-496c-426d-a5f5-123783c703d6">3.450</ix:nonFraction>% notes due January 2027</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f817c64d72746f4a7600550a38be49c_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI2LTQtMS0xLTA_a5312750-4278-4808-81cb-bdd50792633d">747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3f75705b4c54f55b71495dc9a78510d_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI2LTEwLTEtMS0w_03498fcc-afd3-4edb-b8ca-928623d9f01f">747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="icae9b0e4795648ce9e80f348899da659_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI3LTAtMS0xLTAvdGV4dHJlZ2lvbjpkNGM5YjUwNjNmNDc0OWZmYWY3OTM0YTdjNTUwNzliYl80Mzk4MDQ2NTExMTU2_5eb639c9-3fec-4708-a3bc-9bb727ab77d3">625</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="icae9b0e4795648ce9e80f348899da659_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI3LTAtMS0xLTAvdGV4dHJlZ2lvbjpkNGM5YjUwNjNmNDc0OWZmYWY3OTM0YTdjNTUwNzliYl80_6da4d575-9ba5-4c96-b408-1cce540978f2">3.375</ix:nonFraction>% notes due April 2027</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae9b0e4795648ce9e80f348899da659_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI3LTQtMS0xLTA_e383b053-a040-4ff8-93ff-1a24a3937e23">621</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e4451b5d59c467f9a4e28097256ff50_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI3LTEwLTEtMS0w_23ffd16d-2932-493f-ae7f-9104a1db0961">620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i31ec009da13047b6b79197c66fda5b6f_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI4LTAtMS0xLTAvdGV4dHJlZ2lvbjplMTg4YWI2MGZiZjU0OGI5YmY0NTA4MjliYWIxMGQzMl80Mzk4MDQ2NTExMTU4_665516b1-92c6-4068-82fa-c861ca6b82f6">950</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i31ec009da13047b6b79197c66fda5b6f_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI4LTAtMS0xLTAvdGV4dHJlZ2lvbjplMTg4YWI2MGZiZjU0OGI5YmY0NTA4MjliYWIxMGQzMl80_5d38b603-7a94-4776-965a-1859eccf152d">2.950</ix:nonFraction>% notes due October 2027</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31ec009da13047b6b79197c66fda5b6f_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI4LTQtMS0xLTA_b3ec82ae-456f-4874-94f0-8cae13871721">942</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae10e63208f4e10877dfc05154784ab_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI4LTEwLTEtMS0w_e6277f2d-08df-4916-a375-90f077124216">940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i85149ce8b76548558e9c825e775cee26_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI5LTAtMS0xLTAvdGV4dHJlZ2lvbjo0N2VhZTMyNWJkMjc0ZWNhYjQ2NmJlZTgxZDgwMTljN180Mzk4MDQ2NTExMTU5_3cb37009-7188-4233-b0e8-91c5d3d80270">1,150</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i85149ce8b76548558e9c825e775cee26_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI5LTAtMS0xLTAvdGV4dHJlZ2lvbjo0N2VhZTMyNWJkMjc0ZWNhYjQ2NmJlZTgxZDgwMTljN180_e73ef6a3-f93a-4756-8e71-189884e93042">3.850</ix:nonFraction>% notes due June 2028</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85149ce8b76548558e9c825e775cee26_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI5LTQtMS0xLTA_119249a9-8098-43d3-b112-a25905fdcaba">1,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff612dcf0de24f99834b8502366648da_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI5LTEwLTEtMS0w_f8b81b10-06bc-44a6-a072-df6d2ff22c76">1,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ia7cb4d01a77147bea64135beacd75967_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzMwLTAtMS0xLTAvdGV4dHJlZ2lvbjo5M2ZlZTUzZmUwOTM0ZDVlYTc0YmI5ZjFmYzU5OTQ0OF80Mzk4MDQ2NTExMTU5_1ccdb744-84ed-4f83-bd92-dc76d620b60e">850</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="ia7cb4d01a77147bea64135beacd75967_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzMwLTAtMS0xLTAvdGV4dHJlZ2lvbjo5M2ZlZTUzZmUwOTM0ZDVlYTc0YmI5ZjFmYzU5OTQ0OF80_29f893d0-fa81-4de9-95d6-602804f8f736">3.875</ix:nonFraction>% notes due December 2028</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7cb4d01a77147bea64135beacd75967_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzMwLTQtMS0xLTA_d67c6953-3a86-4596-8e3b-ef896dc7d584">844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibab3629772cb483797b33dd7cac92661_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzMwLTEwLTEtMS0w_84e701b8-c11b-46da-9e05-a9a773879c82">844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i89ffd37b253a491e85cd53a3418e5384_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzMxLTAtMS0xLTAvdGV4dHJlZ2lvbjo4MmExYWJhMGU3NTI0NDE1OTVhNzc5NDhiOTJmMTE5M180Mzk4MDQ2NTExMTYx_6688921c-ccff-4cd9-beb6-92e26946ce22">1,000</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i89ffd37b253a491e85cd53a3418e5384_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzMxLTAtMS0xLTAvdGV4dHJlZ2lvbjo4MmExYWJhMGU3NTI0NDE1OTVhNzc5NDhiOTJmMTE5M180_4076487e-c6fc-4b43-8d48-8d8d9c7437e9">2.875</ix:nonFraction>% notes due August 2029</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89ffd37b253a491e85cd53a3418e5384_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzMxLTQtMS0xLTA_028a0457-c153-4578-9e82-fe594c02c856">1,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70db3b468bcd459e93e65ee79271966b_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzMxLTEwLTEtMS0w_f7a0b715-7fd8-4828-933f-d68e1fa3a8c4">1,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i792128c572ef443698af3751346cf9ff_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzMyLTAtMS0xLTAvdGV4dHJlZ2lvbjpmNmY2NDMyNDYyMjI0NTMzOTE3MDg3MTg1ZTEyNDQ4MV80Mzk4MDQ2NTExMTU4_7f7ee836-abf2-47fc-9eb3-4f605dbc5cfc">1,250</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i792128c572ef443698af3751346cf9ff_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzMyLTAtMS0xLTAvdGV4dHJlZ2lvbjpmNmY2NDMyNDYyMjI0NTMzOTE3MDg3MTg1ZTEyNDQ4MV80_fcee0f9a-63aa-4c1a-aed3-64b8fe08f773">2.000</ix:nonFraction>% notes due May 2030</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i792128c572ef443698af3751346cf9ff_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzMyLTQtMS0xLTA_24d7cfc5-621d-4e60-a793-93b8168823a3">1,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd61ed081c424fe89d2e0c20559932f2_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzMyLTEwLTEtMS0w_8f7c58b2-5168-468d-af26-a4e84fcdccf0">1,234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ib9a4bd31faa04ee1b247e1f86a34f265_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM1LTAtMS0xLTUyMS90ZXh0cmVnaW9uOmVmY2Y4NjJlMmExOTRiMzM5OTE0MmIxYTZmMjFiMDIwXzQzOTgwNDY1MTExNzE_8c12acd4-1b20-4a12-9e6a-81a69b6e263d">1,500</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="ib9a4bd31faa04ee1b247e1f86a34f265_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM1LTAtMS0xLTUyMS90ZXh0cmVnaW9uOmVmY2Y4NjJlMmExOTRiMzM5OTE0MmIxYTZmMjFiMDIwXzE2NDkyNjc0NDE2OTk_4a7819e0-2577-4166-8e56-6e331cca936d">2.300</ix:nonFraction>% notes due May 2031</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9a4bd31faa04ee1b247e1f86a34f265_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM1LTQtMS0xLTUyNA_b842085a-49ba-4d60-bc80-8082b077405b">1,482</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01f8d0ea95854e9da64e602eecf75925_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM1LTEwLTEtMS01MjQ_a9527c15-8c2e-4de1-abd3-543e6c7bf408">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ic45826f8bd334acd9a357972ff7747c0_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjo0MTAwOWI3ODExMTc0YjQ5YjljMWJhYWUzYjQ4NmQ0NF80Mzk4MDQ2NTExMTU5_b3550d3c-6f04-4533-89aa-8bf0e8051b5f">1,000</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="ic45826f8bd334acd9a357972ff7747c0_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjo0MTAwOWI3ODExMTc0YjQ5YjljMWJhYWUzYjQ4NmQ0NF80_533aea48-66fa-4402-8ebe-23b7047f3851">4.625</ix:nonFraction>% notes due July 2035</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic45826f8bd334acd9a357972ff7747c0_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzMzLTQtMS0xLTA_05004469-46f8-4870-bba4-d0e5e08a4506">993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1594b131d7cc4f158302396c98e0ebd8_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzMzLTEwLTEtMS0w_6d24fbdd-caf9-44ec-b899-2283f9753da6">992</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ibe281588c47246929092124b77f5b494_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjpjNzY3NGE3ODJkY2U0ODI0OGFkOGZmMDZlMDBiM2U0Zl80Mzk4MDQ2NTExMTU2_2b273285-3959-489e-96d0-2f134d817ef9">850</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="ibe281588c47246929092124b77f5b494_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjpjNzY3NGE3ODJkY2U0ODI0OGFkOGZmMDZlMDBiM2U0Zl80_ccd9b429-ad15-4982-953a-390dee56a322">5.800</ix:nonFraction>% notes due March 2036</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe281588c47246929092124b77f5b494_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM0LTQtMS0xLTA_b7262169-3edd-4e03-883c-88618a69ac5b">839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4474b87a11cf47a0bf686a80b83dcb59_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM0LTEwLTEtMS0w_d9cc5bad-58e5-4dd7-8ebc-b9ba3772c5f8">839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i042493d5f213402dbb064b91d1c75e28_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM1LTAtMS0xLTAvdGV4dHJlZ2lvbjo0Y2U1MmEwZWEyYWQ0YzZmYTA4N2FiYzYzNzk5NTRkZF80Mzk4MDQ2NTExMTU1_708c63d3-ef54-44cf-8fea-2034aafecebf">500</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i042493d5f213402dbb064b91d1c75e28_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM1LTAtMS0xLTAvdGV4dHJlZ2lvbjo0Y2U1MmEwZWEyYWQ0YzZmYTA4N2FiYzYzNzk5NTRkZF80_d4134705-1a72-4c5a-834d-c2d36d673871">6.500</ix:nonFraction>% notes due June 2037</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i042493d5f213402dbb064b91d1c75e28_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM1LTQtMS0xLTA_3af14d0d-85cd-4300-b621-5a2f3ac5ab19">492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c1062a7e2f149f5badaba59158717fd_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM1LTEwLTEtMS0w_395f70d4-9d82-4377-8660-12d4bf5045d9">492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i5ac1e2d38c684f80a23cf559e9f5ff07_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM2LTAtMS0xLTAvdGV4dHJlZ2lvbjoxMjhiM2FhZWU1ODM0YWMwYWVjYTEzNDY4ZWIzMTAzYl80Mzk4MDQ2NTExMTU5_d1b53379-2d29-46a6-864f-2d85944bbbe9">650</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i5ac1e2d38c684f80a23cf559e9f5ff07_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM2LTAtMS0xLTAvdGV4dHJlZ2lvbjoxMjhiM2FhZWU1ODM0YWMwYWVjYTEzNDY4ZWIzMTAzYl80_a46ca38d-a35e-4d92-8d41-acc285521eee">6.625</ix:nonFraction>% notes due November 2037</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ac1e2d38c684f80a23cf559e9f5ff07_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM2LTQtMS0xLTA_80371288-d16a-4c0b-b5f4-401c9150fc15">642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5db4929602c4ffd9189617d404f73d2_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM2LTEwLTEtMS0w_1fe783ba-2fa5-4b2d-a8a7-834ce273768f">641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i5bb559f948de43229cd7e5cae903c0c3_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM3LTAtMS0xLTAvdGV4dHJlZ2lvbjo0MDEzNjNlNmM1OTU0YzkzYjMxZjQ0ODZkYzNiMWU1ZF80Mzk4MDQ2NTExMTYz_b2448a19-f54d-409f-86c3-425582718c8e">1,100</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i5bb559f948de43229cd7e5cae903c0c3_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM3LTAtMS0xLTAvdGV4dHJlZ2lvbjo0MDEzNjNlNmM1OTU0YzkzYjMxZjQ0ODZkYzNiMWU1ZF80_7375e3ae-71ae-4795-b574-ee8644368f67">6.875</ix:nonFraction>% notes due February 2038</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bb559f948de43229cd7e5cae903c0c3_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM3LTQtMS0xLTA_1d0efeb3-3521-4047-bf4b-1249710a97b9">1,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie12a20b3450a4ef28232fc38f2583a41_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM3LTEwLTEtMS0w_7cb1fd38-dc71-4ea1-b7df-af14e48920a4">1,077</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="iada0e5e85dc241e48cf116319f7a75c6_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM4LTAtMS0xLTAvdGV4dHJlZ2lvbjo4Njc0NTM4YTA0NDg0NmIxYjI3ZmM0YmE1YjJmZDdkYV80Mzk4MDQ2NTExMTc3_24d4f529-fdb5-4947-9fe5-70e161fb6a45">1,250</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="iada0e5e85dc241e48cf116319f7a75c6_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM4LTAtMS0xLTAvdGV4dHJlZ2lvbjo4Njc0NTM4YTA0NDg0NmIxYjI3ZmM0YmE1YjJmZDdkYV80_81d5a673-794b-48bf-8676-8cf7f6cc279c">3.500</ix:nonFraction>% notes due August 2039</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iada0e5e85dc241e48cf116319f7a75c6_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM4LTQtMS0xLTA_9be20d95-163b-4ee9-be30-c0271449fd88">1,242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a8fbc7bad4d46d98e6ee62b8a2075c8_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM4LTEwLTEtMS0w_1d52f0b8-34aa-49e7-889b-58f4c8fa6ce1">1,241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i6019aef8fb074093b331027b9c2adb61_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM5LTAtMS0xLTAvdGV4dHJlZ2lvbjpkNDA0ZTJjNTMyNDk0YWQ5OWY0YjJmYWQ4ODY2ZDFlZl80Mzk4MDQ2NTExMTU4_2e843e65-54c3-4c93-a64b-c94136a0af6a">1,000</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i6019aef8fb074093b331027b9c2adb61_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM5LTAtMS0xLTAvdGV4dHJlZ2lvbjpkNDA0ZTJjNTMyNDk0YWQ5OWY0YjJmYWQ4ODY2ZDFlZl80_c7215a4d-4570-435d-9812-e1b6f9764bc1">2.750</ix:nonFraction>% notes due May 2040</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6019aef8fb074093b331027b9c2adb61_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM5LTQtMS0xLTA_525c8a67-cc7a-4ff3-9e4d-1395873b8821">966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ce09d75289f41078948230ae4e2acf1_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM5LTEwLTEtMS0w_f35a42a2-e93b-4149-9c89-11b3832c58b1">964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="iba9a7a93d2b645cea2c51c984287da3f_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQwLTAtMS0xLTAvdGV4dHJlZ2lvbjo3Nzk3NWY4YmYyY2E0ZDY1YWVkNzAzNzM4ZTFhZjA2N180Mzk4MDQ2NTExMTU4_9b86533d-db87-478e-b50d-2d8d8a4b002f">300</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="iba9a7a93d2b645cea2c51c984287da3f_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQwLTAtMS0xLTAvdGV4dHJlZ2lvbjo3Nzk3NWY4YmYyY2E0ZDY1YWVkNzAzNzM4ZTFhZjA2N180_7ebb632a-b12a-4446-9e64-cd0779783fd3">5.700</ix:nonFraction>% notes due October 2040</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba9a7a93d2b645cea2c51c984287da3f_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQwLTQtMS0xLTA_b15cc0a5-01c0-4ec8-8539-5b5a00663cc5">296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife79ad90a728499a81be122ba5a2043f_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQwLTEwLTEtMS0w_5de4f56e-1275-4c2d-ba15-dfe2fa224957">296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ib4f641b3624849f2adeb7cd37bcab7ca_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQxLTAtMS0xLTAvdGV4dHJlZ2lvbjphZTIxNDE1MzEzNjg0YTcxODE1NjFmYmNkNjBiYzk2Nl80Mzk4MDQ2NTExMTU5_4834c239-80de-40ef-b00f-828330896c07">350</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="ib4f641b3624849f2adeb7cd37bcab7ca_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQxLTAtMS0xLTAvdGV4dHJlZ2lvbjphZTIxNDE1MzEzNjg0YTcxODE1NjFmYmNkNjBiYzk2Nl80_d3805231-b3ca-4a54-a1b5-ef9315ee13bd">5.950</ix:nonFraction>% notes due February 2041</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f641b3624849f2adeb7cd37bcab7ca_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQxLTQtMS0xLTA_9c835814-bde5-4c68-8cd6-a9e44e023dd7">346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a3553569a45473daba65988c3a74356_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQxLTEwLTEtMS0w_130a1735-7db6-4d91-a9bf-4c499609a7de">346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ib3668395d3b640cf8ba0bda86da26e60_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ1LTAtMS0xLTUzNS90ZXh0cmVnaW9uOjNmZTc3NmQyYzE4YTRjODBiNWI2MGZmZTdlMzM5ZmZkXzQzOTgwNDY1MTExNzM_4601df99-df0d-4abf-b41c-7e905625f00c">1,500</ix:nonFraction> million  <ix:nonFraction unitRef="number" contextRef="ib3668395d3b640cf8ba0bda86da26e60_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ1LTAtMS0xLTUzNS90ZXh0cmVnaW9uOjNmZTc3NmQyYzE4YTRjODBiNWI2MGZmZTdlMzM5ZmZkXzE2NDkyNjc0NDE2OTk_523a2d2c-f9d8-43cc-a764-16199cb5080a">3.050</ix:nonFraction>% notes due May 2041</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3668395d3b640cf8ba0bda86da26e60_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ1LTQtMS0xLTUzOA_ba2ab9b5-fd7c-4058-9aa5-c80551ad310d">1,483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9de83ae9a2be49cca2565c7797dfdb8a_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ1LTEwLTEtMS01Mzg_1d26f558-6c26-4ede-88d6-3a810ec38194">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i5c821b276174476b9517c3bbb9157232_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQyLTAtMS0xLTAvdGV4dHJlZ2lvbjo0YTI5NGM4ZWM0M2I0Y2Q5YmI1N2MxMjExOTkyYjJkYV80Mzk4MDQ2NTExMTU5_92102034-c144-4b43-8b17-b97dc7354e33">600</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i5c821b276174476b9517c3bbb9157232_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQyLTAtMS0xLTAvdGV4dHJlZ2lvbjo0YTI5NGM4ZWM0M2I0Y2Q5YmI1N2MxMjExOTkyYjJkYV80_cbc7bb60-bdc8-47b5-bc89-e35fe7863395">4.625</ix:nonFraction>% notes due November 2041</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c821b276174476b9517c3bbb9157232_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQyLTQtMS0xLTA_c55a6943-0021-4099-83e1-ff035825feb1">589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a4bb23357c64364aa0ece690aa5ec74_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQyLTEwLTEtMS0w_07a2c2df-b745-449c-91c8-0e6ab4a31e2d">589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i3057e59415b14c1fbbc0e75f70f19a41_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQzLTAtMS0xLTAvdGV4dHJlZ2lvbjplYTc3ODJmYTAyNzc0NzFlYTYzNTM2OGZjM2NhMzRhYl80Mzk4MDQ2NTExMTcw_6174bb23-bc04-4ca1-970e-94ed89144b33">502</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i3057e59415b14c1fbbc0e75f70f19a41_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQzLTAtMS0xLTAvdGV4dHJlZ2lvbjplYTc3ODJmYTAyNzc0NzFlYTYzNTM2OGZjM2NhMzRhYl80_7fee7a11-daad-42d9-ad15-692588b88794">4.375</ix:nonFraction>% notes due March 2042</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3057e59415b14c1fbbc0e75f70f19a41_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQzLTQtMS0xLTA_0dc0fef9-beda-4c03-b148-1051afbe68e9">485</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8e99b43b324defa304dd9967162f65_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQzLTEwLTEtMS0w_6ba7228d-d71f-4af9-ab3b-7f27f7fc4f73">485</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ica9c4076825647eaad198c486084ebb6_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ0LTAtMS0xLTAvdGV4dHJlZ2lvbjowYmQ2ZGQwODc3ZmI0YzFlOTg0NzQ0ZGI3NWIxYjkxYV80Mzk4MDQ2NTExMTc0_9e8bad8d-91c4-4d54-8d8c-73a7b25345d3">625</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="ica9c4076825647eaad198c486084ebb6_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ0LTAtMS0xLTAvdGV4dHJlZ2lvbjowYmQ2ZGQwODc3ZmI0YzFlOTg0NzQ0ZGI3NWIxYjkxYV80_3a4df45d-1506-4695-ace7-527479545fa0">3.950</ix:nonFraction>% notes due October 2042</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica9c4076825647eaad198c486084ebb6_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ0LTQtMS0xLTA_818670fe-a115-4ede-bf3d-9bc228604fcd">608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f1727e520ff46c0bfcd3cb930e2e50d_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ0LTEwLTEtMS0w_ce5940b8-931a-40f9-a0bf-fa1deb623eeb">608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i8aa1ed6f3b9547d785049322c036163a_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ1LTAtMS0xLTAvdGV4dHJlZ2lvbjoxYTBjMDI5YjA3OTk0NzdjYWFkOTVmNTE5M2U0M2M2Ml80Mzk4MDQ2NTExMTU2_104d8b28-93c1-41a6-b73c-1fd67a46d290">750</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i8aa1ed6f3b9547d785049322c036163a_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ1LTAtMS0xLTAvdGV4dHJlZ2lvbjoxYTBjMDI5YjA3OTk0NzdjYWFkOTVmNTE5M2U0M2M2Ml80_552ee9a8-fdbd-4019-b480-a8e697e850cf">4.250</ix:nonFraction>% notes due March 2043</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa1ed6f3b9547d785049322c036163a_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ1LTQtMS0xLTA_5aeb6b2d-2287-4630-b439-60e3eb4580bc">736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44ad24710d1a4e13bd0afb488b206cfa_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ1LTEwLTEtMS0w_889f143f-1ac6-4a51-9e7a-a4fb6680ee16">735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="idd43a6fb78154c23ac9111d56d6fc58a_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ2LTAtMS0xLTAvdGV4dHJlZ2lvbjo3MWJkZDEwYzBkMjA0OTA2ODYzMjFkNDdlODAzM2JiZF80Mzk4MDQ2NTExMTU5_c5c2c591-b5e8-4335-b154-67925aea57eb">2,000</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="idd43a6fb78154c23ac9111d56d6fc58a_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ2LTAtMS0xLTAvdGV4dHJlZ2lvbjo3MWJkZDEwYzBkMjA0OTA2ODYzMjFkNDdlODAzM2JiZF80_f217e45b-e848-4b21-8dde-7b3572a0632d">4.750</ix:nonFraction>% notes due July 2045</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd43a6fb78154c23ac9111d56d6fc58a_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ2LTQtMS0xLTA_4c3d5f2b-9268-41df-be8f-13d0229b0c08">1,974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50006b1b20aa424bbbcfb16934763e3e_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ2LTEwLTEtMS0w_69fbf839-0a7c-49bd-925e-f24ec9ccda3a">1,974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i37706a7a25134a80b7681dbe80d0a08f_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ3LTAtMS0xLTAvdGV4dHJlZ2lvbjo4MmE0NGNmODllNWI0MjI0YWNmZGQ4NTQ1YTBmOWVhN180Mzk4MDQ2NTExMTU4_7a8d9776-7dc3-46b5-bbe9-94250a8d64c7">750</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i37706a7a25134a80b7681dbe80d0a08f_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ3LTAtMS0xLTAvdGV4dHJlZ2lvbjo4MmE0NGNmODllNWI0MjI0YWNmZGQ4NTQ1YTBmOWVhN180_3b560a1a-2068-4dec-8a70-41c1e58005e2">4.200</ix:nonFraction>% notes due January 2047</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37706a7a25134a80b7681dbe80d0a08f_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ3LTQtMS0xLTA_4d8a4015-4f69-4edb-ad23-4897cf611fb7">739</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied6c1c554b9b4094a5e58395009e98e3_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ3LTEwLTEtMS0w_60ab0ec4-581b-4a28-b1f1-c8c3586885c4">738</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i6a47e7cab2b747b19f8ad6dd5577eb65_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ4LTAtMS0xLTAvdGV4dHJlZ2lvbjoyOTY5ODUwM2NhM2Q0YmRkOGQ2NDRmYWM1YWFkZjI4OV80Mzk4MDQ2NTExMTU2_d7cbde43-c1ab-468a-9c40-797900a2a1c2">725</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i6a47e7cab2b747b19f8ad6dd5577eb65_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ4LTAtMS0xLTAvdGV4dHJlZ2lvbjoyOTY5ODUwM2NhM2Q0YmRkOGQ2NDRmYWM1YWFkZjI4OV80_430c2468-85e6-429e-a9fe-245e208869ce">4.250</ix:nonFraction>% notes due April 2047</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a47e7cab2b747b19f8ad6dd5577eb65_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ4LTQtMS0xLTA_93e657c0-6865-4d5e-bb1c-a4ba351bb6b0">718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cfc628d12b54f618f9ea7acd8dae9c6_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ4LTEwLTEtMS0w_5f6e47cb-6519-4653-96bd-293443462bac">717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i980dd94826d240d68ca80fc74c96e9c1_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ5LTAtMS0xLTAvdGV4dHJlZ2lvbjo1ZDE0NzlhYjRiMGU0M2FlODhhMzAyNGMzMTA2Mjk4MF80Mzk4MDQ2NTExMTU4_77324d5f-68fc-43e9-86b7-652e32e44bc2">950</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i980dd94826d240d68ca80fc74c96e9c1_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ5LTAtMS0xLTAvdGV4dHJlZ2lvbjo1ZDE0NzlhYjRiMGU0M2FlODhhMzAyNGMzMTA2Mjk4MF80_3da76b5c-9a12-47ce-85a2-a9f0a8f0cd86">3.750</ix:nonFraction>% notes due October 2047</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i980dd94826d240d68ca80fc74c96e9c1_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ5LTQtMS0xLTA_e54350db-e10b-4274-b1c0-6475d31494d3">934</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91851bb701054679b7700165881a5c2e_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ5LTEwLTEtMS0w_241582d9-0b70-4434-9cdd-2d0b9ab4ec0a">934</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ie56f8e65458741cba5353670ff8dce7e_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzUwLTAtMS0xLTAvdGV4dHJlZ2lvbjplNzdhZTMyYmFmYTI0MjUyYWM3NmVkOWVhZjE5ZTk5Y180Mzk4MDQ2NTExMTU5_d904e86c-6e67-4cc3-9d34-36e5323a20d9">1,350</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="ie56f8e65458741cba5353670ff8dce7e_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzUwLTAtMS0xLTAvdGV4dHJlZ2lvbjplNzdhZTMyYmFmYTI0MjUyYWM3NmVkOWVhZjE5ZTk5Y180_28da9974-759e-47e6-b1f4-cf56c32cf419">4.250</ix:nonFraction>% notes due June 2048</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie56f8e65458741cba5353670ff8dce7e_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzUwLTQtMS0xLTA_30dafab0-5037-4f5e-bb30-26e07c585ce0">1,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9a9dbbc743449a2bc095746eaf4f94d_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzUwLTEwLTEtMS0w_1da13777-7885-4f6e-a72c-fe56ecaa2f81">1,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i076316df7acd4f5f97a07a2468548d05_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzUxLTAtMS0xLTAvdGV4dHJlZ2lvbjpmNzVjNTlmNjk3MjQ0YmMxYWFlZDI2MzIzYTE2MzMzM180Mzk4MDQ2NTExMTgx_07bc9126-dbe8-4370-958e-b60ecdef8c5f">1,100</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i076316df7acd4f5f97a07a2468548d05_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzUxLTAtMS0xLTAvdGV4dHJlZ2lvbjpmNzVjNTlmNjk3MjQ0YmMxYWFlZDI2MzIzYTE2MzMzM180_4b0c3077-e251-46af-bd25-4592306d65f7">4.450</ix:nonFraction>% notes due December 2048</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i076316df7acd4f5f97a07a2468548d05_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzUxLTQtMS0xLTA_42a7b9bd-6629-4c75-a9cd-44c0831cdc54">1,087</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81143b21d99c4e8da9cc8f4dba61ce25_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzUxLTEwLTEtMS0w_feca9483-160c-41cb-929d-79e96814d7b8">1,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i5dc454ca8f924d03b29dd33f0388905d_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzUyLTAtMS0xLTAvdGV4dHJlZ2lvbjo3Y2IwODY3NTU1ZGI0MDFhYjE3N2MzY2I0MWYzZDQyMl80Mzk4MDQ2NTExMTcx_8944e74c-6ebc-49f4-b908-1bf821dd4d6b">1,250</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i5dc454ca8f924d03b29dd33f0388905d_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzUyLTAtMS0xLTAvdGV4dHJlZ2lvbjo3Y2IwODY3NTU1ZGI0MDFhYjE3N2MzY2I0MWYzZDQyMl80_34a9cad7-7e43-4073-ac6a-b25c503b67ff">3.700</ix:nonFraction>% notes due August 2049</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc454ca8f924d03b29dd33f0388905d_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzUyLTQtMS0xLTA_9319b911-d473-489b-a32f-56415377cc5a">1,236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cbf53962caa43fba596a6987b79829b_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzUyLTEwLTEtMS0w_e42993bf-937a-45c0-ba37-b31567e88175">1,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i43a9150b986245ea926eba8cf8dd88c4_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzUzLTAtMS0xLTAvdGV4dHJlZ2lvbjpiMzhmZTRhMGFmZDE0ODZhODQ4NDU3YWIyZjZiNDIyMV80Mzk4MDQ2NTExMTU4_a0c2292d-9b52-425e-a66f-78dcf154a729">1,250</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i43a9150b986245ea926eba8cf8dd88c4_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzUzLTAtMS0xLTAvdGV4dHJlZ2lvbjpiMzhmZTRhMGFmZDE0ODZhODQ4NDU3YWIyZjZiNDIyMV80_a985f1e6-a915-4770-aea7-ed0d4f87ff85">2.900</ix:nonFraction>% notes due May 2050</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43a9150b986245ea926eba8cf8dd88c4_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzUzLTQtMS0xLTA_fd218b59-2b10-4611-8e5f-98de386e0743">1,209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66c9a6ec6acf4ae18dde8b5ddd77ada8_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzUzLTEwLTEtMS0w_21e3b714-6536-43db-ace1-5d8e9a8f7eff">1,208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="id7d2521c88c843bbab7e44fbe1b07950_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzU4LTAtMS0xLTU0OS90ZXh0cmVnaW9uOjFlMTJlOWYxNWY0ZTQ4ZWViOGI2NWExMmNlMDdjMGFiXzQzOTgwNDY1MTExODU_fab21222-2d68-4ef7-8c86-ebf8726d1da3">2,000</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="id7d2521c88c843bbab7e44fbe1b07950_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzU4LTAtMS0xLTU0OS90ZXh0cmVnaW9uOjFlMTJlOWYxNWY0ZTQ4ZWViOGI2NWExMmNlMDdjMGFiXzE2NDkyNjc0NDE3MTM_ef31f573-1011-4534-b219-78e2a397ac6a">3.250</ix:nonFraction>% notes due May 2051</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7d2521c88c843bbab7e44fbe1b07950_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzU4LTQtMS0xLTU1Mg_63f080c2-8f2e-427c-88fc-51bc1bb954b3">1,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87de305d4b6d41f69ebc5ea26f269dd9_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzU4LTEwLTEtMS01NTI_fb7bc672-7a43-47fa-a46f-af39f48ee670">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="if6fda2fd6f8d48768196072f7bb18858_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzU0LTAtMS0xLTAvdGV4dHJlZ2lvbjpiOTIyMjRlMzcwOGM0MGIwYTA5NTU0MTdmYmRkNDExZl80Mzk4MDQ2NTExMTYx_40c9397a-9eda-4f4b-9ea3-cd4e167fb42c">1,250</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="if6fda2fd6f8d48768196072f7bb18858_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzU0LTAtMS0xLTAvdGV4dHJlZ2lvbjpiOTIyMjRlMzcwOGM0MGIwYTA5NTU0MTdmYmRkNDExZl80_86bad8a9-2ab7-4926-881b-c9c6bdc74ac5">3.875</ix:nonFraction>% notes due August 2059</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6fda2fd6f8d48768196072f7bb18858_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzU0LTQtMS0xLTA_efe03cc2-b150-4209-a8c2-71bf5d476e8b">1,228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bbff1e3c5384def9f3f958af9c4560e_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzU0LTEwLTEtMS0w_8130ea91-a7b3-4967-a041-c74d04dd9618">1,228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i3d6a2a39f8a84b30913e25aac3e3a548_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzU1LTAtMS0xLTAvdGV4dHJlZ2lvbjphNDliNGVmMWI5ZDM0NzUwYjk2ZmQwNjIzNWRhYmYxMl80Mzk4MDQ2NTExMTU4_191a65d0-0f57-489d-ab2f-65e7423ca6d7">1,000</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i3d6a2a39f8a84b30913e25aac3e3a548_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzU1LTAtMS0xLTAvdGV4dHJlZ2lvbjphNDliNGVmMWI5ZDM0NzUwYjk2ZmQwNjIzNWRhYmYxMl80_c8b6e13e-ee41-42df-9d40-1e531bda1320">3.125</ix:nonFraction>% notes due May 2060</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d6a2a39f8a84b30913e25aac3e3a548_I20211231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzU1LTQtMS0xLTA_6699e1a7-7fb8-4746-8373-1725f5cc6eae">965</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie20afa3af1a64c6f892497e7a1ac5f08_I20201231" decimals="-6" name="us-gaap:UnsecuredLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzU1LTEwLTEtMS0w_381a3411-727e-46a7-b6ac-883f3ea4c05d">965</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Total short-term borrowings and long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzU2LTQtMS0xLTA_b66f321e-4809-4a5f-9af8-0244b8e51e13">44,632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzU2LTEwLTEtMS0w_e6b64abd-abd7-491c-a7e9-e9edc234e0e0">42,280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><ix:continuation id="i836c8e3bbc204e99bd4af33cb9df1749"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt obligations also included $<ix:nonFraction unitRef="usd" contextRef="i48f8f3c144a149269121679c024b2bfa_I20211231" decimals="-8" name="us-gaap:OtherLongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90ZXh0cmVnaW9uOjU4ODcyNTgwOGZiYjRmYTVhMDEyOTUzNGVhMGZlMDQyXzI3NDg3NzkwNzExODM_99d78482-68df-4467-b174-eda3e75fab7f">1.4</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i7e1bde434ad049b7a20e4a7cd97ed39d_I20201231" decimals="-8" name="us-gaap:OtherLongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90ZXh0cmVnaW9uOjU4ODcyNTgwOGZiYjRmYTVhMDEyOTUzNGVhMGZlMDQyXzE5Mw_386638ce-6f52-4cbb-9a42-13bfce434445">1.2</ix:nonFraction> billion of other financing obligations, of which $<ix:nonFraction unitRef="usd" contextRef="i48f8f3c144a149269121679c024b2bfa_I20211231" decimals="-6" name="us-gaap:OtherLongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90ZXh0cmVnaW9uOjU4ODcyNTgwOGZiYjRmYTVhMDEyOTUzNGVhMGZlMDQyXzI1OA_4a5baff4-eeeb-4049-b795-de78872e5427">611</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i7e1bde434ad049b7a20e4a7cd97ed39d_I20201231" decimals="-6" name="us-gaap:OtherLongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90ZXh0cmVnaW9uOjU4ODcyNTgwOGZiYjRmYTVhMDEyOTUzNGVhMGZlMDQyXzI2NQ_80805b07-e3ca-4cf3-a721-e14471bd612e">354</ix:nonFraction> million were current as of December&#160;31, 2021 and 2020, respectively. </span></div><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90ZXh0cmVnaW9uOjU4ODcyNTgwOGZiYjRmYTVhMDEyOTUzNGVhMGZlMDQyXzE2NDI_9209c51e-7255-4b0d-9dc0-bbe95c2ac72a" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of short-term borrowings and long-term debt for the years ending December&#160;31 are as follows: </span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:87.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZTo4Y2JhY2I4MjA3MDQ0YmZiYjMyZjFiOWM4YzRmNmJjOS90YWJsZXJhbmdlOjhjYmFjYjgyMDcwNDRiZmJiMzJmMWI5YzhjNGY2YmM5XzEtMi0xLTEtMA_c7c58bf4-ffde-4751-8b30-7e9220f3bc0c">3,626</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZTo4Y2JhY2I4MjA3MDQ0YmZiYjMyZjFiOWM4YzRmNmJjOS90YWJsZXJhbmdlOjhjYmFjYjgyMDcwNDRiZmJiMzJmMWI5YzhjNGY2YmM5XzItMi0xLTEtMA_b41e1116-1496-4699-9b2d-ad647e7b3567">2,277</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZTo4Y2JhY2I4MjA3MDQ0YmZiYjMyZjFiOWM4YzRmNmJjOS90YWJsZXJhbmdlOjhjYmFjYjgyMDcwNDRiZmJiMzJmMWI5YzhjNGY2YmM5XzMtMi0xLTEtMA_5ed734f2-577a-442f-af3f-43993e29ebb0">2,652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZTo4Y2JhY2I4MjA3MDQ0YmZiYjMyZjFiOWM4YzRmNmJjOS90YWJsZXJhbmdlOjhjYmFjYjgyMDcwNDRiZmJiMzJmMWI5YzhjNGY2YmM5XzQtMi0xLTEtMA_38d6f51c-e0f4-4dc6-9a67-2c796b448f70">2,452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZTo4Y2JhY2I4MjA3MDQ0YmZiYjMyZjFiOWM4YzRmNmJjOS90YWJsZXJhbmdlOjhjYmFjYjgyMDcwNDRiZmJiMzJmMWI5YzhjNGY2YmM5XzUtMi0xLTEtMA_7feae462-f594-4d80-9526-9ef912997ffb">2,652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZTo4Y2JhY2I4MjA3MDQ0YmZiYjMyZjFiOWM4YzRmNmJjOS90YWJsZXJhbmdlOjhjYmFjYjgyMDcwNDRiZmJiMzJmMWI5YzhjNGY2YmM5XzYtMi0xLTEtMA_56c16f4b-2a0a-44a9-a1d1-95cb750ea929">32,829</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-Term Borrowings</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper consists of short-duration, senior unsecured debt privately placed on a discount basis through broker-dealers.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has $<ix:nonFraction unitRef="usd" contextRef="i0561a17f67884087afe8d954a4e80ace_I20211231" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90ZXh0cmVnaW9uOjU4ODcyNTgwOGZiYjRmYTVhMDEyOTUzNGVhMGZlMDQyXzcwNQ_e6b91973-5847-4789-8c64-f6c3ed92c5a5">5.6</ix:nonFraction> billion five-year, $<ix:nonFraction unitRef="usd" contextRef="ia6ef4bc76d4e41ef824e2e1bc29be3e8_I20211231" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90ZXh0cmVnaW9uOjU4ODcyNTgwOGZiYjRmYTVhMDEyOTUzNGVhMGZlMDQyXzcxOQ_3fe12b63-4a55-417a-b8af-ce2899e672ab">5.6</ix:nonFraction> billion three-year and $<ix:nonFraction unitRef="usd" contextRef="i3bbc78e491bd48b2bdc3d2454d729af8_I20211231" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90ZXh0cmVnaW9uOjU4ODcyNTgwOGZiYjRmYTVhMDEyOTUzNGVhMGZlMDQyXzczNw_1da6151f-9c5b-48bb-9a27-aaca41ef4fbc">3.8</ix:nonFraction> billion 364-day revolving bank credit facilities with 24 banks, which mature in December 2026, December 2024 and December 2022, respectively. These facilities provide full liquidity support for the Company&#8217;s commercial paper program and are available for general corporate purposes. As of December&#160;31, 2021, no amounts had been drawn on any of the bank credit facilities. The annual interest rates, which are variable based on term, are calculated based on one-month Term Secured Overnight Financing Rate (SOFR) plus a SOFR Adjustment of 10 basis points plus a credit spread based on the Company&#8217;s senior unsecured credit ratings. If amounts had been drawn on the bank credit facilities as of December&#160;31, 2021, annual interest rates would have ranged from <ix:nonFraction unitRef="number" contextRef="i601523d6552745a68902337be3e9c7fd_D20210101-20211231" decimals="3" name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90ZXh0cmVnaW9uOjU4ODcyNTgwOGZiYjRmYTVhMDEyOTUzNGVhMGZlMDQyXzEzNzE_8eeda170-7d3d-4e7f-a68c-7760ca3a7a68">0.8</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i3f5ffdfb69764138906dbd2bf76bb89e_D20210101-20211231" decimals="3" name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90ZXh0cmVnaW9uOjU4ODcyNTgwOGZiYjRmYTVhMDEyOTUzNGVhMGZlMDQyXzEzNzc_725b08d1-5279-409a-b9db-8e5d0f06939c">0.9</ix:nonFraction>%.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Covenants</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s bank credit facilities contain various covenants, including requiring the Company to maintain a debt to debt-plus-shareholders&#8217; equity ratio of not more than 60%. The Company was in compliance with its debt covenants as of December&#160;31, 2021.</span></div></ix:continuation><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_199"></div><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90ZXh0cmVnaW9uOmFkYzIxNzZhYjIxNzRmZTA5MjZmMTkwN2I4NTI2YzRlXzMzODY_7992adf3-2cf9-45f6-8ddf-e934d5485f19" continuedAt="icc3b25a56d4d41a990843bb7deed60f4" escape="true">Income Taxes </ix:nonNumeric></span></div><ix:continuation id="icc3b25a56d4d41a990843bb7deed60f4" continuedAt="idffedaa2b64c4e3495a84ddbc3860388"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current income tax provision reflects the tax consequences of revenues and expenses currently taxable or deductible on various income tax returns for the year reported. The deferred income tax provision or benefit generally reflects the net change in deferred income tax assets and liabilities during the year, excluding any deferred income tax assets and liabilities of acquired businesses. <ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90ZXh0cmVnaW9uOmFkYzIxNzZhYjIxNzRmZTA5MjZmMTkwN2I4NTI2YzRlXzMzNjM_c97bdf42-6f6a-431d-bfb6-6edcf268e4bc" continuedAt="i10a7ec5e4c6542ba9784466e71b5baec" escape="true">The components of the provision for income taxes for the years ended December&#160;31 are as follows:</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt"><ix:continuation id="i10a7ec5e4c6542ba9784466e71b5baec"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:75.405%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.948%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.948%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.097%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Provision:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTowZjBiZDE1NjAyNDc0ODNmYTU3MzE0Y2U2NmY2ZDlhMy90YWJsZXJhbmdlOjBmMGJkMTU2MDI0NzQ4M2ZhNTczMTRjZTY2ZjZkOWEzXzItMi0xLTEtMA_b9068826-981e-46e6-a726-742a98ce2ddb">3,451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTowZjBiZDE1NjAyNDc0ODNmYTU3MzE0Y2U2NmY2ZDlhMy90YWJsZXJhbmdlOjBmMGJkMTU2MDI0NzQ4M2ZhNTczMTRjZTY2ZjZkOWEzXzItNC0xLTEtMA_c284e775-62e9-421d-9263-98c250809b7e">4,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTowZjBiZDE1NjAyNDc0ODNmYTU3MzE0Y2U2NmY2ZDlhMy90YWJsZXJhbmdlOjBmMGJkMTU2MDI0NzQ4M2ZhNTczMTRjZTY2ZjZkOWEzXzItNi0xLTEtMA_bf363d4a-7e56-4e3e-8171-17f92e95861b">2,629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTowZjBiZDE1NjAyNDc0ODNmYTU3MzE0Y2U2NmY2ZDlhMy90YWJsZXJhbmdlOjBmMGJkMTU2MDI0NzQ4M2ZhNTczMTRjZTY2ZjZkOWEzXzMtMi0xLTEtMA_f4adf8fd-9c21-4d02-a7f1-c31b4fe48463">481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTowZjBiZDE1NjAyNDc0ODNmYTU3MzE0Y2U2NmY2ZDlhMy90YWJsZXJhbmdlOjBmMGJkMTU2MDI0NzQ4M2ZhNTczMTRjZTY2ZjZkOWEzXzMtNC0xLTEtMA_460a2816-2284-4798-9c31-964995b89e35">392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTowZjBiZDE1NjAyNDc0ODNmYTU3MzE0Y2U2NmY2ZDlhMy90YWJsZXJhbmdlOjBmMGJkMTU2MDI0NzQ4M2ZhNTczMTRjZTY2ZjZkOWEzXzMtNi0xLTEtMA_3e4c683b-cf0f-4a44-ad3d-6b334325cee4">319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTowZjBiZDE1NjAyNDc0ODNmYTU3MzE0Y2U2NmY2ZDlhMy90YWJsZXJhbmdlOjBmMGJkMTU2MDI0NzQ4M2ZhNTczMTRjZTY2ZjZkOWEzXzQtMi0xLTEtMA_825a232b-0d63-494d-aa20-b42a0a2bbaff">516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTowZjBiZDE1NjAyNDc0ODNmYTU3MzE0Y2U2NmY2ZDlhMy90YWJsZXJhbmdlOjBmMGJkMTU2MDI0NzQ4M2ZhNTczMTRjZTY2ZjZkOWEzXzQtNC0xLTEtMA_18424d93-91ce-4611-bad0-2020a2d730c6">491</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTowZjBiZDE1NjAyNDc0ODNmYTU3MzE0Y2U2NmY2ZDlhMy90YWJsZXJhbmdlOjBmMGJkMTU2MDI0NzQ4M2ZhNTczMTRjZTY2ZjZkOWEzXzQtNi0xLTEtMA_dbddef3b-6c81-40af-bcc8-70b846f8004d">564</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current provision</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTowZjBiZDE1NjAyNDc0ODNmYTU3MzE0Y2U2NmY2ZDlhMy90YWJsZXJhbmdlOjBmMGJkMTU2MDI0NzQ4M2ZhNTczMTRjZTY2ZjZkOWEzXzUtMi0xLTEtMA_3cec638a-cd7e-48a0-98fb-9250a8d6fda5">4,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTowZjBiZDE1NjAyNDc0ODNmYTU3MzE0Y2U2NmY2ZDlhMy90YWJsZXJhbmdlOjBmMGJkMTU2MDI0NzQ4M2ZhNTczMTRjZTY2ZjZkOWEzXzUtNC0xLTEtMA_2b5d5b3a-84d8-4e55-b929-0b541d1128ee">4,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTowZjBiZDE1NjAyNDc0ODNmYTU3MzE0Y2U2NmY2ZDlhMy90YWJsZXJhbmdlOjBmMGJkMTU2MDI0NzQ4M2ZhNTczMTRjZTY2ZjZkOWEzXzUtNi0xLTEtMA_58070a9f-bbf4-4bdb-9f46-82fa380b5c22">3,512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred provision (benefit)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTowZjBiZDE1NjAyNDc0ODNmYTU3MzE0Y2U2NmY2ZDlhMy90YWJsZXJhbmdlOjBmMGJkMTU2MDI0NzQ4M2ZhNTczMTRjZTY2ZjZkOWEzXzYtMi0xLTEtMA_d1ed3769-0f92-4fb5-a6d6-d2358e6cbf6d">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTowZjBiZDE1NjAyNDc0ODNmYTU3MzE0Y2U2NmY2ZDlhMy90YWJsZXJhbmdlOjBmMGJkMTU2MDI0NzQ4M2ZhNTczMTRjZTY2ZjZkOWEzXzYtNC0xLTEtMA_ced7ebee-0bf8-40b3-9575-bba392a38d72">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTowZjBiZDE1NjAyNDc0ODNmYTU3MzE0Y2U2NmY2ZDlhMy90YWJsZXJhbmdlOjBmMGJkMTU2MDI0NzQ4M2ZhNTczMTRjZTY2ZjZkOWEzXzYtNi0xLTEtMA_cfe000fe-d40a-48b4-9fa2-13296f69b945">230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTowZjBiZDE1NjAyNDc0ODNmYTU3MzE0Y2U2NmY2ZDlhMy90YWJsZXJhbmdlOjBmMGJkMTU2MDI0NzQ4M2ZhNTczMTRjZTY2ZjZkOWEzXzctMi0xLTEtMA_9b948110-43f8-4903-b982-1ab9d37e0446">4,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTowZjBiZDE1NjAyNDc0ODNmYTU3MzE0Y2U2NmY2ZDlhMy90YWJsZXJhbmdlOjBmMGJkMTU2MDI0NzQ4M2ZhNTczMTRjZTY2ZjZkOWEzXzctNC0xLTEtMA_87f12374-6a7b-4473-8bd5-0e1b616bd934">4,973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTowZjBiZDE1NjAyNDc0ODNmYTU3MzE0Y2U2NmY2ZDlhMy90YWJsZXJhbmdlOjBmMGJkMTU2MDI0NzQ4M2ZhNTczMTRjZTY2ZjZkOWEzXzctNi0xLTEtMA_fa953ac1-85bd-4096-9115-782ac5653881">3,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90ZXh0cmVnaW9uOmFkYzIxNzZhYjIxNzRmZTA5MjZmMTkwN2I4NTI2YzRlXzMzNjA_e789957a-ec66-4b2a-9ff0-83a86abd2374" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of the tax provision at the U.S. federal statutory rate to the provision for income taxes and the effective tax rate for the years ended December&#160;31 is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:47.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.711%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except percentages)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax provision at the U.S. federal statutory rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzEtMi0xLTEtMA_3bfe103b-4554-49c5-ab25-4f2aa5bbd583">4,685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzEtNC0xLTEtMA_768bec25-9d2a-48fd-847c-1252d97b9edb">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzEtNi0xLTEtMA_3ccccbba-28f4-494b-9f7f-44b9b445819f">4,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzEtOC0xLTEtMA_9ca8cf1e-54fe-4e0b-88a4-1c577c3cac95">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzEtMTAtMS0xLTA_e0fc5a15-3578-4406-a50d-7e029699e0cd">3,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzEtMTItMS0xLTA_3bbc1a76-5c39-4def-9d09-38ac78351086">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzItMi0xLTEtMA_b28ddc87-4214-4e4d-b973-7f8e4eb52f23">419</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzItNC0xLTEtMA_69a39e03-a04c-4b2c-acee-d9d06618499a">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzItNi0xLTEtMA_d24fda1e-064b-4ab1-aa46-44b99f58df13">315</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzItOC0xLTEtMA_df7f3d69-8463-4172-9c23-9f5db74ac6d8">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzItMTAtMS0xLTA_5225b840-c5b1-4177-8242-3ad050b13ea6">271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzItMTItMS0xLTA_5d5de823-5292-4791-828a-8870ff86b668">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based awards - excess tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" sign="-" name="unh:EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzMtMi0xLTEtMA_05590a99-3547-40b2-8e50-f2e78202a266">100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="3" sign="-" name="unh:EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzMtNC0xLTEtMA_4e660c1d-1a2f-42d5-aa91-20f45a20cb10">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" sign="-" name="unh:EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzMtNi0xLTEtMA_09cecb95-87f4-47c1-9518-5fc448955afc">130</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="3" sign="-" name="unh:EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzMtOC0xLTEtMA_40a5eb82-7b3e-4fd6-92a9-5c9fde15f3ce">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" sign="-" name="unh:EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzMtMTAtMS0xLTA_d7daa753-0ecf-4b07-943d-06e6dd2248d8">132</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="3" sign="-" name="unh:EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzMtMTItMS0xLTA_f59af26f-45fd-4214-a841-9c7302999206">0.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzQtMi0xLTEtMA_c2556acf-a18e-45f8-b014-ac290dcce3ed">144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzQtNC0xLTEtMA_7b509ce1-a0e1-4a7c-bdf7-0924bcbb007d">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzQtNi0xLTEtMA_10a8760d-8aa5-491b-9a8a-141588f2165d">134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzQtOC0xLTEtMA_0fb93d4a-8d8b-42c8-bd5f-40fb62ec831c">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzQtMTAtMS0xLTA_d02a85c5-afea-41ef-a206-6f8c83c0813c">119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzQtMTItMS0xLTA_0d4287ad-1c63-4552-be8b-87feeb4f6eb7">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health insurance tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="unh:EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzUtMi0xLTEtMA_5444fc1b-8272-4644-abb7-7113d276e0ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="3" name="unh:EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzUtNC0xLTEtMA_c9fd04df-80e5-4f6e-a4c8-7711dee6e5b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="unh:EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzUtNi0xLTEtMA_aa841326-7c91-49dc-a66d-f6a66bcc7daf">626</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="3" name="unh:EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzUtOC0xLTEtMA_465f484f-75f4-4264-a8d3-2ae021271196">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="unh:EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzUtMTAtMS0xLTA_3aa6d672-5909-4e1d-a712-728b90645884">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="3" name="unh:EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzUtMTItMS0xLTA_d88f7984-c7f1-4742-8990-a4fc16545f5b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzYtMi0xLTEtMA_f76c7b5c-686c-4a36-bfa4-daad4beb770a">246</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzYtNC0xLTEtMA_1c5a70ca-4a34-42e6-b68c-0546cbcdc977">1.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzYtNi0xLTEtMA_d1bab9c2-27c5-4739-971c-1ff24b1d2bea">164</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzYtOC0xLTEtMA_b1f8c670-6d48-43dc-8609-125773ebf7a1">0.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzYtMTAtMS0xLTA_28f1befb-ba17-4546-846a-a93f050d6e58">214</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzYtMTItMS0xLTA_45dbac10-7303-49f9-9b2f-6f07838a712f">1.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzctMi0xLTEtMA_746328b1-8ec9-4284-9de9-d071570a732e">324</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzctNC0xLTEtMA_b869687a-0a71-4800-b099-c65aa6ba2836">1.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzctNi0xLTEtMA_c7616c1e-5856-495d-8129-7168a39e9559">164</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzctOC0xLTEtMA_dbc40233-4f37-4d2b-974d-009aa710e845">0.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzctMTAtMS0xLTA_6e5e7c93-1692-491b-85d2-820784cb6c59">78</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzctMTItMS0xLTA_fc0198cc-1512-40cc-97e4-6babde447262">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzgtMi0xLTEtMA_06dab998-1b36-433e-b954-23f43ab3e75a">4,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzgtNC0xLTEtMA_ed0bbb2f-1324-4609-9561-5ca87625d14f">20.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzgtNi0xLTEtMA_2df9d69b-1bd2-431d-abc7-eb182dda0359">4,973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzgtOC0xLTEtMA_2af3691f-faff-4afc-89fb-c66c379000c3">24.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzgtMTAtMS0xLTA_0b7f1d02-0392-4a8c-bc4d-6b0d14458adc">3,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzgtMTItMS0xLTA_a8a90e02-7050-43a4-a406-513fb1717532">20.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><ix:continuation id="idffedaa2b64c4e3495a84ddbc3860388" continuedAt="i75bea5dcddb2444cac9406792d5cecde"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income tax assets and liabilities are recognized for the differences between the financial and income tax reporting bases of assets and liabilities based on enacted tax rates and laws. <ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90ZXh0cmVnaW9uOmFkYzIxNzZhYjIxNzRmZTA5MjZmMTkwN2I4NTI2YzRlXzMzNzA_da3928b3-546e-4dd7-bb55-c45b316e7af3" continuedAt="ic7a7cd270d7d4450b14ad0673740a0b0" escape="true">The components of deferred income tax assets and liabilities as of December&#160;31 are as follows:</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt"><ix:continuation id="ic7a7cd270d7d4450b14ad0673740a0b0"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:73.643%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.795%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and allowances</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzItMi0xLTEtMA_36d07069-2118-4ab2-8ca1-6ee767a61b8f">723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzItNC0xLTEtMA_4d46469e-5c58-4c49-82cc-d1bf0e45d4d3">815</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal and state net operating loss carryforwards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzMtMi0xLTEtMA_70904e06-25d1-490b-b0e3-049e7a14cd99">287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzMtNC0xLTEtMA_074d354a-bf51-4789-881c-eab832872f59">276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzQtMi0xLTEtMA_513d6363-7d95-4874-8104-4a94fbb1052b">117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzQtNC0xLTEtMA_cb8b1380-bdcd-4ddf-94d5-2384264ecff2">98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nondeductible liabilities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="unh:DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzUtMi0xLTEtMA_a855663b-938e-4911-9e9e-74f89b454fd2">296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="unh:DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzUtNC0xLTEtMA_68bb5735-f75e-4495-9d64-f868e00a3a34">252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. tax loss carryforwards</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzYtMi0xLTEtMA_4374a154-201d-4b4d-b098-decff91b4fde">435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzYtNC0xLTEtMA_ea4f72f8-6624-4d05-90d2-07e3ae1cab0c">340</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="unh:DeferredTaxAssetsLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzctMi0xLTEtMA_c24b272f-b604-499f-aeca-a62be6a276cf">1,284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="unh:DeferredTaxAssetsLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzctNC0xLTEtMA_0bc906b9-f28c-4ce1-a7cb-9fba164eafa0">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other-domestic</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="unh:DeferredTaxAssetOtherDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzgtMi0xLTEtMA_c50a64aa-fdf1-477d-acb8-ec4964874e4a">228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="unh:DeferredTaxAssetOtherDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzgtNC0xLTEtMA_ca18c97f-68e1-44b7-b407-66a7f89ed6c2">126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other-non-U.S.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="unh:DeferredTaxAssetOtherForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzktMi0xLTEtMA_9b7005ad-58ca-455d-a2c5-2089238f14fe">376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="unh:DeferredTaxAssetOtherForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzktNC0xLTEtMA_55db8007-7270-4e18-8cf1-1ba2f8e9c4b2">454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzEwLTItMS0xLTA_1cc6f329-b11c-4fd3-86de-d50428cc37c8">3,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzEwLTQtMS0xLTA_7ff1c467-a320-4afe-8201-30e3bfdaf6d8">3,561</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowances</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzExLTItMS0xLTA_2e843d55-7034-45ed-8955-a1a347a0b0fd">198</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzExLTQtMS0xLTA_4d22fdae-0b40-4753-a334-20f0cde1df60">170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzEyLTItMS0xLTA_3604feea-5415-4340-88e2-c9f68b24a3ee">3,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzEyLTQtMS0xLTA_70f7d65e-d7c7-4b99-889d-b18f5363d793">3,391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal and state intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzE0LTItMS0xLTA_72592cea-af3d-450c-8cbb-3abd9ceaae84">2,658</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzE0LTQtMS0xLTA_0faa29ee-68d0-408c-ba51-dcbd3d4a2f3b">2,588</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. goodwill and intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="unh:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzE1LTItMS0xLTA_eec02db2-362e-4567-a586-0b092acaae50">512</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="unh:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzE1LTQtMS0xLTA_8f25245d-4dc8-484a-bddd-dc6d52eb1f15">606</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzE2LTItMS0xLTA_55e60379-b7d7-4240-b7cd-be438a6ae032">833</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzE2LTQtMS0xLTA_0a787dff-1c2b-4ad3-8b26-18b89f523f74">731</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzE3LTItMS0xLTA_4ac80a1f-e9e1-4fcc-be21-b4b63dc4a0a9">349</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzE3LTQtMS0xLTA_560bd559-c670-4bd5-9ca7-5df3a64acc74">346</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPrepaidExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzE4LTItMS0xLTA_227d56bf-fee1-440c-9499-466cbc152ff3">256</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPrepaidExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzE4LTQtMS0xLTA_61173b56-e5b1-4485-9707-a6dc498b0c44">216</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside basis in partnerships</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzE5LTItMS0xLTA_5ccdb943-4529-4681-a498-0a4db1e7a164">565</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzE5LTQtMS0xLTA_ff3a2cde-8311-4a80-b374-172dba414247">342</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease right-of-use asset</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzIwLTItMS0xLTA_c88cb8f5-66ba-4fba-8184-f9203278707b">1,267</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzIwLTQtMS0xLTA_83f4726b-1868-4f03-8389-55cb576e772a">1,179</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gains on investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="unh:DeferredTaxLiabilityOtherDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzIxLTItMS0xLTA_ab32b41e-62b2-4ce1-b061-b4d2d5d60aea">125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="unh:DeferredTaxLiabilityOtherDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzIxLTQtMS0xLTA_5ea71cbe-1c6f-42fc-a7c1-886d0f93a9fa">400</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other-non-U.S.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="unh:DeferredTaxLiabilityOtherForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzIyLTItMS0xLTA_c739a396-bc41-4f23-afc3-419551702a5f">248</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="unh:DeferredTaxLiabilityOtherForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzIyLTQtMS0xLTA_1a4e76c7-45f2-4588-aedb-7eb4051ddba2">350</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzIzLTItMS0xLTA_2434c555-b2c0-4d61-ba43-a0b9923766b3">6,813</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzIzLTQtMS0xLTA_7487673e-5368-4aa9-91ec-c9ec2f135dec">6,758</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred income tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzI0LTItMS0xLTA_388f656f-4896-4eed-a577-ff9ed52c9e1b">3,265</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzI0LTQtMS0xLTA_0c90f847-b52e-4888-8e90-c5cfb574f8a2">3,367</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuation allowances are provided when it is considered more likely than not deferred tax assets will not be realized. The valuation allowances primarily relate to future tax benefits on certain federal, state and non-U.S. net operating loss carryforwards. Gross federal net operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="iafeb038504b84584996f9cd39f452b04_I20211231" decimals="-6" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90ZXh0cmVnaW9uOmFkYzIxNzZhYjIxNzRmZTA5MjZmMTkwN2I4NTI2YzRlXzEzMDA_fdc99182-cdac-4fa3-9aa5-158b57fa3ac6">42</ix:nonFraction> million expire beginning in 2023 through 2037 and $<ix:nonFraction unitRef="usd" contextRef="if8b73857161d431fabb907fdd770e42f_I20211231" decimals="-6" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90ZXh0cmVnaW9uOmFkYzIxNzZhYjIxNzRmZTA5MjZmMTkwN2I4NTI2YzRlXzEzNDE_2ae8069b-b01b-436e-bcf6-72c976132c16">295</ix:nonFraction> million have an indefinite carryforward period; state net operating loss carryforwards expire beginning in 2022 through 2041, with some having an indefinite carryforward period. Substantially all of the non-U.S. tax loss carryforwards have indefinite carryforward periods. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company&#8217;s undistributed earnings from non-U.S. subsidiaries are intended to be indefinitely reinvested in non-U.S. operations, and therefore no U.S. deferred taxes have been recorded. Taxes payable on the remittance of such earnings would be minimal.</span></div><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90ZXh0cmVnaW9uOmFkYzIxNzZhYjIxNzRmZTA5MjZmMTkwN2I4NTI2YzRlXzMzODg_3385f33f-40c8-437a-aba3-f7be88e638e8" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of unrecognized tax benefits as of December&#160;31 is as follows: </span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:71.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.123%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.123%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.272%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross unrecognized tax benefits, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzEtMi0xLTEtMA_6a5cf128-5038-4c84-bfc8-6f7bbda3dc4d">1,829</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530caf840d4847f1ac553be5f7b336b2_I20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzEtNC0xLTEtMA_1e28b515-9bf8-471d-b593-49ae470344a1">1,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i870730cd9dfc45bb89971499ab4cdd48_I20181231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzEtNi0xLTEtMA_d40cad28-6e44-4c02-99a8-c2858d876bdd">1,056</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross increases:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year tax positions</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzMtMi0xLTEtMA_8c30d15d-6551-4c4f-8b37-e464901ba803">538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzMtNC0xLTEtMA_a6fd5a17-22ae-4dc2-a4e4-4d50901c2ddf">416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzMtNi0xLTEtMA_504088f2-eaea-4bff-abc6-8b048861b9af">512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year tax positions</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzQtMi0xLTEtMA_efb48165-eb37-4d4a-92a5-605a10fbe4f9">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzQtNC0xLTEtMA_ec658288-4b0e-4f5f-9e52-14a66cd4c5c7">120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzQtNi0xLTEtMA_19b8008d-3368-44c4-8e6d-9d18c5eb2f96">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross decreases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year tax positions</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzYtMi0xLTEtMA_a1a0abab-9eb3-4ed4-aa4e-851bb41894cf">47</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzYtNC0xLTEtMA_317c4dd7-ae38-4101-8d9c-472e365c75a9">130</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzYtNi0xLTEtMA_d80cfb38-652c-47c0-aec2-5660a9d3e477">96</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzctMi0xLTEtMA_0d4ee3fd-8705-4314-a5d4-a300d6e6fb35">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzctNC0xLTEtMA_41e1e619-d801-4102-87db-09eaa0d1d6fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzctNi0xLTEtMA_be52faae-495c-483b-8a08-1d00d86a4e7c">46</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statute of limitations lapses</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzgtMi0xLTEtMA_0ff3b6f7-6f74-4b1f-87b8-3f8409a46f1f">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzgtNC0xLTEtMA_40832896-24e5-45e2-80f0-945b958352b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzgtNi0xLTEtMA_55f85fc8-f880-4c52-adba-f2e092dd465d">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross unrecognized tax benefits, end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzktMi0xLTEtMA_149f7963-6c00-4669-8d2f-82130b0e0d99">2,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzktNC0xLTEtMA_94b07953-c12a-46c9-81ed-9ccb3f1ca6ef">1,829</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530caf840d4847f1ac553be5f7b336b2_I20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzktNi0xLTEtMA_66626bfc-a0d2-4fd9-b185-73f244bedf40">1,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><ix:continuation id="i75bea5dcddb2444cac9406792d5cecde"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes it is reasonably possible its liability for unrecognized tax benefits will decrease in the next twelve months by $<ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90ZXh0cmVnaW9uOmFkYzIxNzZhYjIxNzRmZTA5MjZmMTkwN2I4NTI2YzRlXzIxMjI_134e518a-2f0c-4551-99fe-866b6f4b668f">42</ix:nonFraction> million as a result of audit settlements and the expiration of statutes of limitations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies net interest and penalties associated with uncertain income tax positions as income taxes within its Consolidated Statements of Operations. During the years ended December&#160;31, 2021, 2020 and 2019, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90ZXh0cmVnaW9uOmFkYzIxNzZhYjIxNzRmZTA5MjZmMTkwN2I4NTI2YzRlXzI0MjU_dc147eab-a0d8-426d-b025-b233041f70fd">66</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90ZXh0cmVnaW9uOmFkYzIxNzZhYjIxNzRmZTA5MjZmMTkwN2I4NTI2YzRlXzI0Mjk_87958a8f-491d-43ab-a40b-fc27071cd2ce">52</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90ZXh0cmVnaW9uOmFkYzIxNzZhYjIxNzRmZTA5MjZmMTkwN2I4NTI2YzRlXzI0MzY_fbbf25b1-8da5-45d8-98c6-94bf2b8eed2f">19</ix:nonFraction> million of net interest and penalties, respectively. The Company had $<ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90ZXh0cmVnaW9uOmFkYzIxNzZhYjIxNzRmZTA5MjZmMTkwN2I4NTI2YzRlXzI0OTY_24489e26-e382-448b-aad0-9c630d3d4fa4">194</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90ZXh0cmVnaW9uOmFkYzIxNzZhYjIxNzRmZTA5MjZmMTkwN2I4NTI2YzRlXzI1MDM_5c740960-89a9-4aba-95bd-e849952ce920">128</ix:nonFraction> million of accrued interest and penalties for uncertain tax positions as of December&#160;31, 2021 and 2020, respectively. These amounts are not included in the reconciliation above. As of December&#160;31, 2021, there were $<ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90ZXh0cmVnaW9uOmFkYzIxNzZhYjIxNzRmZTA5MjZmMTkwN2I4NTI2YzRlXzI2ODA_5c71e267-de4f-4392-8b14-fa05abd3c247">1.2</ix:nonFraction> billion of unrecognized tax benefits which, if recognized, would affect the effective tax rate.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company currently files income tax returns in the United States, various states and localities and non-U.S. jurisdictions. The U.S. Internal Revenue Service (IRS) has completed exams on the consolidated income tax returns for fiscal years 2016 and prior. The Company&#8217;s <ix:nonNumeric contextRef="i594ed33a64c84c5383f969319b50d190_D20210101-20211231" name="us-gaap:OpenTaxYear" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90ZXh0cmVnaW9uOmFkYzIxNzZhYjIxNzRmZTA5MjZmMTkwN2I4NTI2YzRlXzI3NDg3NzkwNzI4Njc_5fdea5ca-2322-4038-a4c0-bd7616617a41">2017</ix:nonNumeric> through <ix:nonNumeric contextRef="i065ef157d8a74b71a4c8ba538486d487_D20210101-20211231" name="us-gaap:OpenTaxYear" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90ZXh0cmVnaW9uOmFkYzIxNzZhYjIxNzRmZTA5MjZmMTkwN2I4NTI2YzRlXzI3NDg3NzkwNzI4NzQ_b5c35318-f3ca-492c-961b-11b235ed07c5">2020</ix:nonNumeric> tax years are under review by the IRS under its Compliance Assurance Program. With the exception of a few states, the Company is no longer subject to income tax examinations prior to the <ix:nonNumeric contextRef="i74609445052240d09613244522e25dba_D20210101-20211231" name="us-gaap:OpenTaxYear" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90ZXh0cmVnaW9uOmFkYzIxNzZhYjIxNzRmZTA5MjZmMTkwN2I4NTI2YzRlXzMyNDc_c6a227fa-c31f-4179-af9f-3d8befa4c5d7">2014</ix:nonNumeric> tax year. In general, the Company is subject to examination in non-U.S. jurisdictions for years <ix:nonNumeric contextRef="i44dc783f612e43b28b4d406b49e67429_D20210101-20211231" name="us-gaap:OpenTaxYear" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90ZXh0cmVnaW9uOmFkYzIxNzZhYjIxNzRmZTA5MjZmMTkwN2I4NTI2YzRlXzMzNDY_e63a5ea2-8365-4dcc-87d9-a6d3304191c9">2015</ix:nonNumeric> and forward.</span></div></ix:continuation><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_205"></div><div style="margin-top:15pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90ZXh0cmVnaW9uOjMzMzI1MTVmM2U4NjRkMzM5YTkyY2Y3YjZjNjliNjRjXzE2NDkyNjc0NDUxMTM_96fac73c-a832-4d60-b236-1323715199f4" continuedAt="i0d848e4844134e82a3e8b766cceabc8b" escape="true">Shareholders' Equity</ix:nonNumeric></span></div><ix:continuation id="i0d848e4844134e82a3e8b766cceabc8b" continuedAt="idad923102a2f4b05b5c317d7ffcebf64"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory Capital and Dividend Restrictions</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s regulated insurance and health maintenance organization (HMO) subsidiaries are subject to regulations and standards in their respective jurisdictions. These standards, among other things, require these subsidiaries to maintain specified levels of statutory capital, as defined by each jurisdiction, and restrict the timing and amount of dividends and other distributions which may be paid to their parent companies. In the United States, most of these state regulations and standards are generally consistent with model regulations established by the National Association of Insurance Commissioners. These standards generally permit dividends to be paid from statutory unassigned surplus of the regulated subsidiary and are limited based on the regulated subsidiary&#8217;s level of statutory net income and statutory capital and surplus. These dividends are referred to as &#8220;ordinary dividends&#8221; and generally may be paid without prior regulatory approval. If the dividend, together with other dividends paid within the preceding twelve months, exceeds a specified statutory limit or is paid from sources other than earned surplus, it is generally considered an &#8220;extraordinary dividend&#8221; and must receive prior regulatory approval. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2021, the Company&#8217;s domestic insurance and HMO subsidiaries paid their parent companies dividends of $<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-8" name="us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90ZXh0cmVnaW9uOjMzMzI1MTVmM2U4NjRkMzM5YTkyY2Y3YjZjNjliNjRjXzE0MzI_9d3a86f3-c6d7-4eb4-80e7-b0ca33de6cae">8.0</ix:nonFraction> billion, including $<ix:nonFraction unitRef="usd" contextRef="i195ad038ae66447ea9bbab80147223bf_D20210101-20211231" decimals="-8" name="us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90ZXh0cmVnaW9uOjMzMzI1MTVmM2U4NjRkMzM5YTkyY2Y3YjZjNjliNjRjXzE0NDY_cd0502cb-18e4-48e9-a721-070d0415de04">4.7</ix:nonFraction> billion of extraordinary dividends. For the year ended December&#160;31, 2020, the Company&#8217;s domestic insurance and HMO subsidiaries paid their parent companies dividends of $<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-8" name="us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90ZXh0cmVnaW9uOjMzMzI1MTVmM2U4NjRkMzM5YTkyY2Y3YjZjNjliNjRjXzE1OTU_8e41ebda-616f-4320-a0cc-65b450575987">8.3</ix:nonFraction> billion, including $<ix:nonFraction unitRef="usd" contextRef="i92e4aa62eb95430a95cec0efea49c225_D20200101-20201231" decimals="-8" name="us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90ZXh0cmVnaW9uOjMzMzI1MTVmM2U4NjRkMzM5YTkyY2Y3YjZjNjliNjRjXzE2MDk_3a777c57-8043-4e8a-9f35-8b5869a2b178">4.2</ix:nonFraction> billion of extraordinary dividends.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's global financially regulated subsidiaries had estimated aggregate statutory capital and surplus of $<ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-8" name="us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90ZXh0cmVnaW9uOjMzMzI1MTVmM2U4NjRkMzM5YTkyY2Y3YjZjNjliNjRjXzE3NTM_0b994a80-36ba-4a30-8aed-4fe74e819837">30.7</ix:nonFraction> billion as of December&#160;31, 2021. The estimated statutory capital and surplus necessary to satisfy regulatory requirements of the Company's global financially regulated subsidiaries was approximately $<ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-8" name="us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90ZXh0cmVnaW9uOjMzMzI1MTVmM2U4NjRkMzM5YTkyY2Y3YjZjNjliNjRjXzE5MzI_047b8453-358f-4278-af76-f73f69e22460">13.0</ix:nonFraction> billion as of December&#160;31, 2021.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Optum Bank must meet minimum capital requirements of the Federal Deposit Insurance Corporation (FDIC) under the capital adequacy rules to which it is subject. At December&#160;31, 2021, the Company believes Optum Bank met the FDIC requirements to be considered &#8220;Well Capitalized.&#8221;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Program</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under its Board of Directors&#8217; authorization, the Company maintains a share repurchase program. The objectives of the share repurchase program are to optimize the Company&#8217;s capital structure and cost of capital, thereby improving returns to shareholders, as well as to offset the dilutive impact of share-based awards. Repurchases may be made from time to time in open market purchases or other types of transactions (including prepaid or structured share repurchase programs), subject to certain Board restrictions. In June 2018, the Board renewed the Company&#8217;s share repurchase program with an authorization to repurchase up to <ix:nonFraction unitRef="shares" contextRef="ifb118b1801aa4f9894e91cda550c9801_I20180601" decimals="-6" name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90ZXh0cmVnaW9uOjMzMzI1MTVmM2U4NjRkMzM5YTkyY2Y3YjZjNjliNjRjXzI4NjA_aea0439f-c370-49c5-a2c6-efbf78fe7e8f">100</ix:nonFraction> million shares of its common stock.</span></div><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:ScheduleOfStockByClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90ZXh0cmVnaW9uOjMzMzI1MTVmM2U4NjRkMzM5YTkyY2Y3YjZjNjliNjRjXzM0MzQ_7daca0b1-7ee0-47b1-876a-efc3e031ca97" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of common share repurchases for the years ended December&#160;31, 2021 and 2020 is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:18.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common share repurchases, shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90YWJsZTo2MWY2MWU0NzhhZDM0MjNmOWQ2NWEwYmUzZDcxMmQxMS90YWJsZXJhbmdlOjYxZjYxZTQ3OGFkMzQyM2Y5ZDY1YTBiZTNkNzEyZDExXzItNC0xLTEtMA_25e75740-d859-4b88-a98b-79f8fdd99a84">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90YWJsZTo2MWY2MWU0NzhhZDM0MjNmOWQ2NWEwYmUzZDcxMmQxMS90YWJsZXJhbmdlOjYxZjYxZTQ3OGFkMzQyM2Y5ZDY1YTBiZTNkNzEyZDExXzItNi0xLTEtMA_966ae36a-1e0a-4cd4-87d4-7d40679361cf">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common share repurchases, average price per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90YWJsZTo2MWY2MWU0NzhhZDM0MjNmOWQ2NWEwYmUzZDcxMmQxMS90YWJsZXJhbmdlOjYxZjYxZTQ3OGFkMzQyM2Y5ZDY1YTBiZTNkNzEyZDExXzMtNC0xLTEtMA_985fc94a-d22d-4049-9d0f-53f493267a4b">389.92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90YWJsZTo2MWY2MWU0NzhhZDM0MjNmOWQ2NWEwYmUzZDcxMmQxMS90YWJsZXJhbmdlOjYxZjYxZTQ3OGFkMzQyM2Y5ZDY1YTBiZTNkNzEyZDExXzMtNi0xLTEtMA_42f2b132-f5fa-417f-9382-488a927bfdcc">300.58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common share repurchases, aggregate cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90YWJsZTo2MWY2MWU0NzhhZDM0MjNmOWQ2NWEwYmUzZDcxMmQxMS90YWJsZXJhbmdlOjYxZjYxZTQ3OGFkMzQyM2Y5ZDY1YTBiZTNkNzEyZDExXzQtNC0xLTEtMA_9f9d439d-02db-4154-acd7-572d29e3f57b">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90YWJsZTo2MWY2MWU0NzhhZDM0MjNmOWQ2NWEwYmUzZDcxMmQxMS90YWJsZXJhbmdlOjYxZjYxZTQ3OGFkMzQyM2Y5ZDY1YTBiZTNkNzEyZDExXzQtNi0xLTEtMA_4c2bebb2-6726-462d-8d2f-e9d8d69841a6">4,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Board authorized shares remaining</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90YWJsZTo2MWY2MWU0NzhhZDM0MjNmOWQ2NWEwYmUzZDcxMmQxMS90YWJsZXJhbmdlOjYxZjYxZTQ3OGFkMzQyM2Y5ZDY1YTBiZTNkNzEyZDExXzUtNC0xLTEtMA_50be0df7-2404-46d8-a6b9-b64b7112ccaf">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="INF" name="us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90YWJsZTo2MWY2MWU0NzhhZDM0MjNmOWQ2NWEwYmUzZDcxMmQxMS90YWJsZXJhbmdlOjYxZjYxZTQ3OGFkMzQyM2Y5ZDY1YTBiZTNkNzEyZDExXzUtNi0xLTEtMA_24481942-41ce-42b6-bf5d-f1929aa8565d">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><ix:continuation id="idad923102a2f4b05b5c317d7ffcebf64"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, the Company&#8217;s Board of Directors increased the Company&#8217;s quarterly cash dividend to shareholders to an annual rate of $5.80 compared to $5.00 per share, which the Company had paid since June 2020. Declaration and payment of future quarterly dividends is at the discretion of the Board and may be adjusted as business needs or market conditions change.</span></div><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:DividendsDeclaredTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90ZXh0cmVnaW9uOjMzMzI1MTVmM2U4NjRkMzM5YTkyY2Y3YjZjNjliNjRjXzE2NDkyNjc0NDUxNTA_2b2b3576-c62e-4c12-9b1d-ec1f1be906ba" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides details of the Company&#8217;s 2021 dividend payments:</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.785%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payment Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Amount Paid</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 23</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib1465a6c04dd4bcbacfb6ca471dbee92_D20210323-20210323" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90YWJsZTpjNDZjNTc4ODM4ZWQ0ODc2OTcyMmNiODQxZTM5YTU1Yi90YWJsZXJhbmdlOmM0NmM1Nzg4MzhlZDQ4NzY5NzIyY2I4NDFlMzlhNTViXzItMi0xLTEtMA_352f57d3-3585-4bb9-a8f0-6207f94208fe">1.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1465a6c04dd4bcbacfb6ca471dbee92_D20210323-20210323" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90YWJsZTpjNDZjNTc4ODM4ZWQ0ODc2OTcyMmNiODQxZTM5YTU1Yi90YWJsZXJhbmdlOmM0NmM1Nzg4MzhlZDQ4NzY5NzIyY2I4NDFlMzlhNTViXzItNC0xLTEtMA_c6c807a3-4345-428c-a4e8-58a18ecf56cc">1,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 29</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id4fddf633266448b9691078c6f0ac482_D20210629-20210629" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90YWJsZTpjNDZjNTc4ODM4ZWQ0ODc2OTcyMmNiODQxZTM5YTU1Yi90YWJsZXJhbmdlOmM0NmM1Nzg4MzhlZDQ4NzY5NzIyY2I4NDFlMzlhNTViXzMtMi0xLTEtMA_46238ba0-0f53-4571-a66d-215c5f0b2a31">1.45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4fddf633266448b9691078c6f0ac482_D20210629-20210629" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90YWJsZTpjNDZjNTc4ODM4ZWQ0ODc2OTcyMmNiODQxZTM5YTU1Yi90YWJsZXJhbmdlOmM0NmM1Nzg4MzhlZDQ4NzY5NzIyY2I4NDFlMzlhNTViXzMtNC0xLTEtMA_ea846d6b-87b3-418c-bd3e-da325787a386">1,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 21</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i97719cae15984487921a22e3d5be41e8_D20210921-20210921" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90YWJsZTpjNDZjNTc4ODM4ZWQ0ODc2OTcyMmNiODQxZTM5YTU1Yi90YWJsZXJhbmdlOmM0NmM1Nzg4MzhlZDQ4NzY5NzIyY2I4NDFlMzlhNTViXzQtMi0xLTEtMA_73895876-5ad5-4126-988c-bb50718d2648">1.45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97719cae15984487921a22e3d5be41e8_D20210921-20210921" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90YWJsZTpjNDZjNTc4ODM4ZWQ0ODc2OTcyMmNiODQxZTM5YTU1Yi90YWJsZXJhbmdlOmM0NmM1Nzg4MzhlZDQ4NzY5NzIyY2I4NDFlMzlhNTViXzQtNC0xLTEtMA_74f146aa-6364-4390-b322-850632672cdc">1,367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 14</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8f7827d6bf5f49a0af03b71e2d704cea_D20211214-20211214" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90YWJsZTpjNDZjNTc4ODM4ZWQ0ODc2OTcyMmNiODQxZTM5YTU1Yi90YWJsZXJhbmdlOmM0NmM1Nzg4MzhlZDQ4NzY5NzIyY2I4NDFlMzlhNTViXzUtMi0xLTEtMA_c5979d1d-f4e8-46f4-b999-ced7892764be">1.45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f7827d6bf5f49a0af03b71e2d704cea_D20211214-20211214" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90YWJsZTpjNDZjNTc4ODM4ZWQ0ODc2OTcyMmNiODQxZTM5YTU1Yi90YWJsZXJhbmdlOmM0NmM1Nzg4MzhlZDQ4NzY5NzIyY2I4NDFlMzlhNTViXzUtNC0xLTEtMA_08bb7641-cd86-4fdd-906c-3177dd129e4b">1,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_211"></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90ZXh0cmVnaW9uOjA4MmMzNzgxYTczODQwZmE4N2Y1YWFkMzUyNWVjZjJjXzIxNjE_0eca219a-8cbf-4f90-9aab-5ceff6aba2c3" continuedAt="i0e537979519b4666b90fdf6a3fcbe2dd" escape="true">Share-Based Compensation</ix:nonNumeric></span></div><ix:continuation id="i0e537979519b4666b90fdf6a3fcbe2dd" continuedAt="i09195c1987324574ba7588f306aabbf6"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s outstanding share-based awards consist mainly of non-qualified stock options and restricted shares. As of December&#160;31, 2021, the Company had <ix:nonFraction unitRef="shares" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90ZXh0cmVnaW9uOjA4MmMzNzgxYTczODQwZmE4N2Y1YWFkMzUyNWVjZjJjXzI3NQ_ec2101ee-3cc9-4c26-bcfa-d9ea33ec491a">64</ix:nonFraction> million shares available for future grants of share-based awards under the 2020 Stock Incentive Plan. In June 2021, the Company&#8217;s shareholders approved <ix:nonFraction unitRef="shares" contextRef="i1da1045e098d44dda00d3afb43712521_D20210601-20210630" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90ZXh0cmVnaW9uOjA4MmMzNzgxYTczODQwZmE4N2Y1YWFkMzUyNWVjZjJjXzI3NDg3NzkwNzE5MDU_c50fb5b2-c22a-4a51-9059-2db333ff9e05">15</ix:nonFraction>&#160;million additional shares under the ESPP. As of December&#160;31, 2021, there were <ix:nonFraction unitRef="shares" contextRef="i9373eeb7b5f04135b63071c869773f31_I20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90ZXh0cmVnaW9uOjA4MmMzNzgxYTczODQwZmE4N2Y1YWFkMzUyNWVjZjJjXzM3Nw_40bae015-55d0-4e64-aac7-1a2b352f9f81">18</ix:nonFraction>&#160;million shares of common stock available for issuance under the ESPP. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90ZXh0cmVnaW9uOjA4MmMzNzgxYTczODQwZmE4N2Y1YWFkMzUyNWVjZjJjXzIxMzI_698fea1d-0cd2-4f21-8846-d7cf14ef226a" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activity for the year ended December&#160;31, 2021 is summarized in the table below:</span></div><div style="margin-bottom:6pt;margin-top:4.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:44.434%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.955%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual&#160;Life</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic&#160;Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTozOThmMWE3NWYxZWU0YjEwOTdjZmY0OWZjZGNmODA5Yi90YWJsZXJhbmdlOjM5OGYxYTc1ZjFlZTRiMTA5N2NmZjQ5ZmNkY2Y4MDliXzItMS0xLTEtMA_237fd639-791d-44f9-a07e-81a8b92184d5">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTozOThmMWE3NWYxZWU0YjEwOTdjZmY0OWZjZGNmODA5Yi90YWJsZXJhbmdlOjM5OGYxYTc1ZjFlZTRiMTA5N2NmZjQ5ZmNkY2Y4MDliXzItMy0xLTEtMA_201ab0fe-1c39-439e-98d1-d22a749b7e9e">211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTozOThmMWE3NWYxZWU0YjEwOTdjZmY0OWZjZGNmODA5Yi90YWJsZXJhbmdlOjM5OGYxYTc1ZjFlZTRiMTA5N2NmZjQ5ZmNkY2Y4MDliXzMtMS0xLTEtMA_76bb098d-09fa-4129-92d1-de78ec1f6665">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTozOThmMWE3NWYxZWU0YjEwOTdjZmY0OWZjZGNmODA5Yi90YWJsZXJhbmdlOjM5OGYxYTc1ZjFlZTRiMTA5N2NmZjQ5ZmNkY2Y4MDliXzMtMy0xLTEtMA_9cfab9f8-f792-4a1f-b08a-261f053bb20c">329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTozOThmMWE3NWYxZWU0YjEwOTdjZmY0OWZjZGNmODA5Yi90YWJsZXJhbmdlOjM5OGYxYTc1ZjFlZTRiMTA5N2NmZjQ5ZmNkY2Y4MDliXzQtMS0xLTEtMA_0d258a16-d66b-4d3a-ba30-7add22892f8d">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTozOThmMWE3NWYxZWU0YjEwOTdjZmY0OWZjZGNmODA5Yi90YWJsZXJhbmdlOjM5OGYxYTc1ZjFlZTRiMTA5N2NmZjQ5ZmNkY2Y4MDliXzQtMy0xLTEtMA_ae7ee625-7987-4bc9-b9e3-ecfe98dbceeb">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTozOThmMWE3NWYxZWU0YjEwOTdjZmY0OWZjZGNmODA5Yi90YWJsZXJhbmdlOjM5OGYxYTc1ZjFlZTRiMTA5N2NmZjQ5ZmNkY2Y4MDliXzUtMS0xLTEtMA_55eb580b-9fdd-4987-9786-bd0aa18cd36e">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTozOThmMWE3NWYxZWU0YjEwOTdjZmY0OWZjZGNmODA5Yi90YWJsZXJhbmdlOjM5OGYxYTc1ZjFlZTRiMTA5N2NmZjQ5ZmNkY2Y4MDliXzUtMy0xLTEtMA_57dda6e2-75f3-4310-b246-e075dc7f8732">297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTozOThmMWE3NWYxZWU0YjEwOTdjZmY0OWZjZGNmODA5Yi90YWJsZXJhbmdlOjM5OGYxYTc1ZjFlZTRiMTA5N2NmZjQ5ZmNkY2Y4MDliXzYtMS0xLTEtMA_5deb13ab-9a40-4676-90e4-67c83f369262">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTozOThmMWE3NWYxZWU0YjEwOTdjZmY0OWZjZGNmODA5Yi90YWJsZXJhbmdlOjM5OGYxYTc1ZjFlZTRiMTA5N2NmZjQ5ZmNkY2Y4MDliXzYtMy0xLTEtMA_17a48d0c-7648-4bc9-bccf-52544dcb137b">241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTozOThmMWE3NWYxZWU0YjEwOTdjZmY0OWZjZGNmODA5Yi90YWJsZXJhbmdlOjM5OGYxYTc1ZjFlZTRiMTA5N2NmZjQ5ZmNkY2Y4MDliXzYtNy0xLTEtMA_84685074-8fca-4924-8447-429708f2cc62">6,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at end of period</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTozOThmMWE3NWYxZWU0YjEwOTdjZmY0OWZjZGNmODA5Yi90YWJsZXJhbmdlOjM5OGYxYTc1ZjFlZTRiMTA5N2NmZjQ5ZmNkY2Y4MDliXzctMS0xLTEtMA_484d6bad-cdef-47bf-817d-177ba3bc4ba0">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTozOThmMWE3NWYxZWU0YjEwOTdjZmY0OWZjZGNmODA5Yi90YWJsZXJhbmdlOjM5OGYxYTc1ZjFlZTRiMTA5N2NmZjQ5ZmNkY2Y4MDliXzctMy0xLTEtMA_b5fbe614-d2dc-43a9-9a5a-24e03a9d8d6d">179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTozOThmMWE3NWYxZWU0YjEwOTdjZmY0OWZjZGNmODA5Yi90YWJsZXJhbmdlOjM5OGYxYTc1ZjFlZTRiMTA5N2NmZjQ5ZmNkY2Y4MDliXzctNy0xLTEtMA_c31ab6f9-1db8-4877-a8c5-41c2bbf32144">3,932</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest, end of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTozOThmMWE3NWYxZWU0YjEwOTdjZmY0OWZjZGNmODA5Yi90YWJsZXJhbmdlOjM5OGYxYTc1ZjFlZTRiMTA5N2NmZjQ5ZmNkY2Y4MDliXzgtMS0xLTEtMA_a6e8e46f-fd3a-45d5-9ee6-cb1136672126">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTozOThmMWE3NWYxZWU0YjEwOTdjZmY0OWZjZGNmODA5Yi90YWJsZXJhbmdlOjM5OGYxYTc1ZjFlZTRiMTA5N2NmZjQ5ZmNkY2Y4MDliXzgtMy0xLTEtMA_d1e8ad42-caee-43c0-8c3e-b1a9e321a28c">240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTozOThmMWE3NWYxZWU0YjEwOTdjZmY0OWZjZGNmODA5Yi90YWJsZXJhbmdlOjM5OGYxYTc1ZjFlZTRiMTA5N2NmZjQ5ZmNkY2Y4MDliXzgtNy0xLTEtMA_ae51d83b-fbb1-42a6-88d9-84f99e8ac2f8">6,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Shares</span></div><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90ZXh0cmVnaW9uOjA4MmMzNzgxYTczODQwZmE4N2Y1YWFkMzUyNWVjZjJjXzIxNDM_c610883a-cd76-48a8-93d6-b3d24943e767" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted share activity for the year ended December&#160;31, 2021 is summarized in the table below:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.446%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.153%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(shares in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant Date<br/>Fair Value<br/>per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8b0b8b22a5064df79ec4e0a1452381f2_I20201231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTpiNGQxMjUzODE5NzM0MWY4ODQxNzZkNjI2ZGYxYjZhOC90YWJsZXJhbmdlOmI0ZDEyNTM4MTk3MzQxZjg4NDE3NmQ2MjZkZjFiNmE4XzEtMi0xLTEtMA_980bb514-4ad5-4f74-ae3a-5e6047beb69f">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8b0b8b22a5064df79ec4e0a1452381f2_I20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTpiNGQxMjUzODE5NzM0MWY4ODQxNzZkNjI2ZGYxYjZhOC90YWJsZXJhbmdlOmI0ZDEyNTM4MTk3MzQxZjg4NDE3NmQ2MjZkZjFiNmE4XzEtNC0xLTEtMA_cc4bc676-57dd-4886-8560-9340a750d690">256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0cf2e2ded57848acbd7f4ce7b8849c5d_D20210101-20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTpiNGQxMjUzODE5NzM0MWY4ODQxNzZkNjI2ZGYxYjZhOC90YWJsZXJhbmdlOmI0ZDEyNTM4MTk3MzQxZjg4NDE3NmQ2MjZkZjFiNmE4XzItMi0xLTEtMA_d4bee4cb-5b98-4b61-b8fa-b3a4aff729be">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0cf2e2ded57848acbd7f4ce7b8849c5d_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTpiNGQxMjUzODE5NzM0MWY4ODQxNzZkNjI2ZGYxYjZhOC90YWJsZXJhbmdlOmI0ZDEyNTM4MTk3MzQxZjg4NDE3NmQ2MjZkZjFiNmE4XzItNC0xLTEtMA_b61667a5-9eb5-4771-8696-4970595ea09a">352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0cf2e2ded57848acbd7f4ce7b8849c5d_D20210101-20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTpiNGQxMjUzODE5NzM0MWY4ODQxNzZkNjI2ZGYxYjZhOC90YWJsZXJhbmdlOmI0ZDEyNTM4MTk3MzQxZjg4NDE3NmQ2MjZkZjFiNmE4XzMtMi0xLTEtMA_c55d5549-4516-452f-906d-617a95188e12">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0cf2e2ded57848acbd7f4ce7b8849c5d_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTpiNGQxMjUzODE5NzM0MWY4ODQxNzZkNjI2ZGYxYjZhOC90YWJsZXJhbmdlOmI0ZDEyNTM4MTk3MzQxZjg4NDE3NmQ2MjZkZjFiNmE4XzMtNC0xLTEtMA_464c61c4-731c-4162-9008-4c7a714651c9">246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id63338cb4c6e49dbb4d3876bbbbc7fba_I20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTpiNGQxMjUzODE5NzM0MWY4ODQxNzZkNjI2ZGYxYjZhOC90YWJsZXJhbmdlOmI0ZDEyNTM4MTk3MzQxZjg4NDE3NmQ2MjZkZjFiNmE4XzQtMi0xLTEtMA_b54c3962-cd70-4a6b-8169-6b1ed04cf97d">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id63338cb4c6e49dbb4d3876bbbbc7fba_I20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTpiNGQxMjUzODE5NzM0MWY4ODQxNzZkNjI2ZGYxYjZhOC90YWJsZXJhbmdlOmI0ZDEyNTM4MTk3MzQxZjg4NDE3NmQ2MjZkZjFiNmE4XzQtNC0xLTEtMA_a6b68301-0d23-4059-8339-e93792c3a86c">303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><ix:continuation id="i09195c1987324574ba7588f306aabbf6"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90ZXh0cmVnaW9uOjA4MmMzNzgxYTczODQwZmE4N2Y1YWFkMzUyNWVjZjJjXzIxNTU_263de050-9d7e-4394-b158-a0f4659c8325" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Share-Based Compensation Data</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:65.029%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.458%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share amounts)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value of shares granted, per share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4d96f9ce242e4c3d8115ee3621f39cbe_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzMtMi0xLTEtMA_a95eff77-57da-4188-be57-c7efabf1da2c">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i76d17528cf2346ec89da7e8be44862de_D20200101-20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzMtNC0xLTEtMA_d90512e4-5bb5-43da-96a7-0e9aecc63726">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8735916cccf8489cb02dce2be01b4b17_D20190101-20191231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzMtNi0xLTEtMA_3e386ce8-2075-4787-b584-11a21dc09af5">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intrinsic value of stock options exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d96f9ce242e4c3d8115ee3621f39cbe_D20210101-20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzQtMi0xLTEtMA_151ef78c-ce7c-4bd7-bf36-ceeb362bd87a">1,519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76d17528cf2346ec89da7e8be44862de_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzQtNC0xLTEtMA_3776314c-8aec-428c-9511-92a884c43528">1,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8735916cccf8489cb02dce2be01b4b17_D20190101-20191231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzQtNi0xLTEtMA_3db6654d-dca8-49af-9add-08b97a1d8c0c">1,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restricted Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value of shares granted, per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifb47f60aa85f4d24ba37cab9c6946e24_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzYtMi0xLTEtMA_0be7daa8-7707-43a2-a7fd-89ca73822337">352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie5d9a9a4874549718469d7c60db06cc1_D20200101-20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzYtNC0xLTEtMA_7aa049b4-8b47-471b-b6fd-fa26e063d317">303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i45d815b9650e4498a5b6941af134494e_D20190101-20191231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzYtNi0xLTEtMA_d9214ef6-03e0-412b-8b47-6dac4f770d18">259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of restricted shares vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb47f60aa85f4d24ba37cab9c6946e24_D20210101-20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzctMi0xLTEtMA_631a8797-6113-4973-b249-38da29f38998">560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5d9a9a4874549718469d7c60db06cc1_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzctNC0xLTEtMA_86287309-4ec1-46a0-87e4-3a1bc17dc16c">574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45d815b9650e4498a5b6941af134494e_D20190101-20191231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzctNi0xLTEtMA_7c366895-0357-4ad8-a26a-91484874b6eb">545</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Employee Stock Purchase Plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of shares purchased</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie667c3a41af649e28b76eb6f34ded8a2_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzktMi0xLTEtMA_30c2fdeb-de3c-449b-bdd3-9e3590d44cd3">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ief665df606e14a618e22e519299e9750_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzktNC0xLTEtMA_c9210947-0942-433c-ac7d-57aaf18d97d8">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7b0f0d7d245e4cbda78fe9b5b60cd842_D20190101-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzktNi0xLTEtMA_cfbca729-e122-4b5c-9de1-a5ddf293cb51">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Share-Based Compensation Items</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense, before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzExLTItMS0xLTA_84f71946-1318-4736-8078-dc6d7f4231ba">800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzExLTQtMS0xLTA_0ffccf95-3bc4-4b74-94c0-2844177cb88a">679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzExLTYtMS0xLTA_01c62bd1-a059-4263-ba4e-2941d90add10">697</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense, net of tax effects</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzEyLTItMS0xLTA_0ec70c16-4ea2-4948-b2e0-1ac2eb923dde">719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzEyLTQtMS0xLTA_06ef622a-cd8f-421d-871d-a9c0b3fefb99">619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzEyLTYtMS0xLTA_67704649-18ef-4877-8d41-03d871e7208b">641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit realized from share-based award exercises</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzEzLTItMS0xLTA_7e919b95-941e-4e7a-b6a8-99625d5ce702">173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzEzLTQtMS0xLTA_0f454634-2e25-437b-8379-148ae1afee78">208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzEzLTYtMS0xLTA_9f47e42e-7b9e-4d7f-be7d-6aaf76871e2f">201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:78.665%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized compensation expense related to share awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTo2NmEzYmE4NzRjMmM0NjM4OWMxNDk0MTFjMTI2NGRlMC90YWJsZXJhbmdlOjY2YTNiYTg3NGMyYzQ2Mzg5YzE0OTQxMWMxMjY0ZGUwXzEtMi0xLTEtMA_27a55d9a-f993-450d-bb68-8dc0a952c97a">905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average years to recognize compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation Recognition and Estimates</span></div><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90ZXh0cmVnaW9uOjA4MmMzNzgxYTczODQwZmE4N2Y1YWFkMzUyNWVjZjJjXzIxMzQ_c9b09aba-8555-426c-8d5f-6a91debd7166" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal assumptions the Company used in calculating grant-date fair value for stock options were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.567%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7% - 1.2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2% - 1.4%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5% - 2.5%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.2% - 29.8%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.2% - 29.5%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.4% - 21.6%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3% - 1.5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4% - 1.7%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4% - 1.8%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeiture rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="3" name="unh:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTo1MmIyYjE5OGRkNGU0NDc5YmYxOTE3ZDZjY2RhNTA0MC90YWJsZXJhbmdlOjUyYjJiMTk4ZGQ0ZTQ0NzliZjE5MTdkNmNjZGE1MDQwXzUtMi0xLTEtMA_47ee0be9-a09a-44c3-a2e3-a319014e9375">5.0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="3" name="unh:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTo1MmIyYjE5OGRkNGU0NDc5YmYxOTE3ZDZjY2RhNTA0MC90YWJsZXJhbmdlOjUyYjJiMTk4ZGQ0ZTQ0NzliZjE5MTdkNmNjZGE1MDQwXzUtNC0xLTEtMA_f3b34136-c254-40bc-854f-f1b5f6baccd5">5.0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="INF" name="unh:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTo1MmIyYjE5OGRkNGU0NDc5YmYxOTE3ZDZjY2RhNTA0MC90YWJsZXJhbmdlOjUyYjJiMTk4ZGQ0ZTQ0NzliZjE5MTdkNmNjZGE1MDQwXzUtNi0xLTEtMA_d2e0f456-9784-4d6f-932c-5c1490d2ff2c">5.0</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life in years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-free interest rates are based on U.S. Treasury yields in effect at the time of grant. Expected volatilities are based on the historical volatility of the Company&#8217;s common stock and the implied volatility from exchange-traded options on the Company&#8217;s common stock. Expected dividend yields are based on the per share cash dividend paid by the Company. The Company uses historical data to estimate option exercises and forfeitures within the valuation model. The expected lives of options granted represents the period of time the awards granted are expected to be outstanding based on historical exercise patterns.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Employee Benefit Plans </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers a 401(k) plan for its employees. Compensation expense related to this plan was not material for 2021, 2020 and 2019.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company maintains non-qualified, deferred compensation plans, which allow certain members of senior management and executives to defer portions of their salary or bonus. The deferrals are recorded within long-term investments with an approximately equal amount in other liabilities in the Consolidated Balance Sheets. The total deferrals are distributable based upon termination of employment or other periods, as elected under each plan and were $<ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90ZXh0cmVnaW9uOjA4MmMzNzgxYTczODQwZmE4N2Y1YWFkMzUyNWVjZjJjXzIwOTE_7bd18f82-582d-4e28-b13c-b9735a3dff27">1.8</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90ZXh0cmVnaW9uOjA4MmMzNzgxYTczODQwZmE4N2Y1YWFkMzUyNWVjZjJjXzIwOTg_7d9057c5-bd13-499a-9ddb-3cb5c793521b">1.6</ix:nonFraction> billion as of December&#160;31, 2021 and 2020, respectively.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span><br/></span></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_217"></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90ZXh0cmVnaW9uOjNkNWQwODk4MzJhODQ4YTE5NzAxNzY2MTQ1OGNhZmUxXzU4NDk_b5af8282-2a2d-4966-8080-1c2a2ff8d0d8" continuedAt="i91eb1c0c16a24a1d893e217436806454" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="i91eb1c0c16a24a1d893e217436806454" continuedAt="iab675dc5c8c54816aad9b1f7497dd986"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease costs were $<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-8" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90ZXh0cmVnaW9uOjNkNWQwODk4MzJhODQ4YTE5NzAxNzY2MTQ1OGNhZmUxXzcz_8f08326e-cf00-4df7-9f34-47a723b3a76e">1.2</ix:nonFraction> billion, $<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-8" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90ZXh0cmVnaW9uOjNkNWQwODk4MzJhODQ4YTE5NzAxNzY2MTQ1OGNhZmUxXzc3_fe610d69-03c4-4dba-9c06-8353679ba668">1.1</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-8" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90ZXh0cmVnaW9uOjNkNWQwODk4MzJhODQ4YTE5NzAxNzY2MTQ1OGNhZmUxXzg0_6155f0fe-4499-40c2-9ab1-b9ee323cf81a">1.0</ix:nonFraction> billion for the years ended December&#160;31, 2021, 2020 and 2019, respectively, and included immaterial variable and short-term lease costs for the year ended December 31, 2021, 2020 and 2019. Cash payments made on the Company&#8217;s operating lease liabilities were $<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90ZXh0cmVnaW9uOjNkNWQwODk4MzJhODQ4YTE5NzAxNzY2MTQ1OGNhZmUxXzMxNg_5d058058-3ebf-44aa-be29-406cb9bbb0b4">921</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90ZXh0cmVnaW9uOjNkNWQwODk4MzJhODQ4YTE5NzAxNzY2MTQ1OGNhZmUxXzMyMw_6a0b8302-fbd7-4638-8c72-52f7a430adf8">865</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90ZXh0cmVnaW9uOjNkNWQwODk4MzJhODQ4YTE5NzAxNzY2MTQ1OGNhZmUxXzI3NDg3NzkwNzg0ODI_b484a064-ecdc-40e6-b1db-100dcceb5494">746</ix:nonFraction>&#160;million for the years ended December&#160;31, 2021, 2020 and 2019, respectively, which were classified within operating activities in the Consolidated Statements of Cash Flows. As of December&#160;31, 2021, the Company&#8217;s weighted-average remaining lease term and weighted-average discount rate for its operating leases were <ix:nonNumeric contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90ZXh0cmVnaW9uOjNkNWQwODk4MzJhODQ4YTE5NzAxNzY2MTQ1OGNhZmUxXzU5Ng_b2192fb7-dad4-4f5a-bbde-ff8072ce6bd5">8.7</ix:nonNumeric> years and <ix:nonFraction unitRef="number" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90ZXh0cmVnaW9uOjNkNWQwODk4MzJhODQ4YTE5NzAxNzY2MTQ1OGNhZmUxXzYwOQ_49ce87ab-7a8b-4f88-8e93-2e5eea083382">2.9</ix:nonFraction>%, respectively.</span></div><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90ZXh0cmVnaW9uOjNkNWQwODk4MzJhODQ4YTE5NzAxNzY2MTQ1OGNhZmUxXzU4NDY_084e2547-98ff-48c4-8b39-acb990e1e9f4" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, future minimum annual lease payments under all non-cancelable operating leases were as follows: </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:81.330%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.738%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Future Minimum Lease Payments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90YWJsZTo5NTdiMTFhYWNhMGE0NzZhYTk4YjQwZDg5MzgyNDg3Yy90YWJsZXJhbmdlOjk1N2IxMWFhY2EwYTQ3NmFhOThiNDBkODkzODI0ODdjXzEtMi0xLTEtMA_49bff575-9ff6-4b52-8c4b-ea56c9aaaaae">870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90YWJsZTo5NTdiMTFhYWNhMGE0NzZhYTk4YjQwZDg5MzgyNDg3Yy90YWJsZXJhbmdlOjk1N2IxMWFhY2EwYTQ3NmFhOThiNDBkODkzODI0ODdjXzItMi0xLTEtMA_06f73d3e-3e28-4866-8ac8-254cb0794590">763</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90YWJsZTo5NTdiMTFhYWNhMGE0NzZhYTk4YjQwZDg5MzgyNDg3Yy90YWJsZXJhbmdlOjk1N2IxMWFhY2EwYTQ3NmFhOThiNDBkODkzODI0ODdjXzMtMi0xLTEtMA_8b02f129-d208-4a6a-b19c-be27dc485a36">616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90YWJsZTo5NTdiMTFhYWNhMGE0NzZhYTk4YjQwZDg5MzgyNDg3Yy90YWJsZXJhbmdlOjk1N2IxMWFhY2EwYTQ3NmFhOThiNDBkODkzODI0ODdjXzQtMi0xLTEtMA_7f0dd846-6a4c-44cc-b74f-8a527b5e5fa1">510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90YWJsZTo5NTdiMTFhYWNhMGE0NzZhYTk4YjQwZDg5MzgyNDg3Yy90YWJsZXJhbmdlOjk1N2IxMWFhY2EwYTQ3NmFhOThiNDBkODkzODI0ODdjXzUtMi0xLTEtMA_2be2b1a0-18bd-433f-af9c-766451c0f3d1">407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90YWJsZTo5NTdiMTFhYWNhMGE0NzZhYTk4YjQwZDg5MzgyNDg3Yy90YWJsZXJhbmdlOjk1N2IxMWFhY2EwYTQ3NmFhOThiNDBkODkzODI0ODdjXzYtMi0xLTEtMA_8857375a-338a-4147-9578-77bf8506b9d2">1,716</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90YWJsZTo5NTdiMTFhYWNhMGE0NzZhYTk4YjQwZDg5MzgyNDg3Yy90YWJsZXJhbmdlOjk1N2IxMWFhY2EwYTQ3NmFhOThiNDBkODkzODI0ODdjXzctMi0xLTEtMA_471511da-16a8-4b4d-8ab5-d4bc262f53c6">4,882</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90YWJsZTo5NTdiMTFhYWNhMGE0NzZhYTk4YjQwZDg5MzgyNDg3Yy90YWJsZXJhbmdlOjk1N2IxMWFhY2EwYTQ3NmFhOThiNDBkODkzODI0ODdjXzgtMi0xLTEtMA_8bfc0613-7bf6-469e-a557-d3dd707ff77e">609</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if755137cc0244794b9c613b644590d23_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90YWJsZTo5NTdiMTFhYWNhMGE0NzZhYTk4YjQwZDg5MzgyNDg3Yy90YWJsZXJhbmdlOjk1N2IxMWFhY2EwYTQ3NmFhOThiNDBkODkzODI0ODdjXzktMi0xLTEtMA_ba0f40f7-33bc-48ca-8c6e-30a54c71c88d">4,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Commitments</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides guarantees related to its service level under certain contracts. If minimum standards are not met, the Company may be financially at risk up to a stated percentage of the contracted fee or a stated dollar amount. None of the amounts accrued, paid or charged to income for service level guarantees were material as of December&#160;31, 2021, 2020 or 2019. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company had outstanding, undrawn letters of credit with financial institutions of $<ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90ZXh0cmVnaW9uOjNkNWQwODk4MzJhODQ4YTE5NzAxNzY2MTQ1OGNhZmUxXzEyMDM_e7030e0d-e71f-41df-b2c6-2ff7b25b8506">181</ix:nonFraction> million and surety bonds outstanding with insurance companies of $<ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-8" name="unh:SuretyBondsOutstanding" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90ZXh0cmVnaW9uOjNkNWQwODk4MzJhODQ4YTE5NzAxNzY2MTQ1OGNhZmUxXzEyNjM_5c9fdbfb-de45-458f-9118-a5d74fdcd009">1.3</ix:nonFraction> billion, primarily to bond contractual performance. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pending Acquisitions</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:OtherCommitmentsDescription" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90ZXh0cmVnaW9uOjNkNWQwODk4MzJhODQ4YTE5NzAxNzY2MTQ1OGNhZmUxXzI3NDg3NzkwNzkzOTE_f70d8705-8989-409d-b532-5aaa5f01357f">In 2021, we entered into agreements to acquire multiple companies in the health care sector, most notably, Change Healthcare (NASDAQ: CHNG), subject to regulatory approval and other customary closing conditions.</ix:nonNumeric> <ix:nonNumeric contextRef="i234fb0970ed146d6a6b5a0a8e14b119b_D20220101-20220131" name="us-gaap:SubsequentEventDescription" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90ZXh0cmVnaW9uOjNkNWQwODk4MzJhODQ4YTE5NzAxNzY2MTQ1OGNhZmUxXzI3NDg3NzkwNzkzOTI_d91e404d-4d7c-4e23-8edf-b904e68e157b">Additionally, in January 2022, we entered into agreements to acquire multiple companies in the health care sector, subject to regulatory approval and other customary closing conditions.</ix:nonNumeric> The total anticipated capital required for these acquisitions, excluding the payoff of acquired indebtedness, is approximately $<ix:nonFraction unitRef="usd" contextRef="i3d57fae043fc43048dd28cf40011078c_I20220131" decimals="-6" name="us-gaap:OtherCommitment" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90ZXh0cmVnaW9uOjNkNWQwODk4MzJhODQ4YTE5NzAxNzY2MTQ1OGNhZmUxXzI3NDg3NzkwNzkzODU_c67f2890-de24-4cc3-836f-a7dfd66a6fd4">12</ix:nonFraction>&#160;billion.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Matters</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is frequently made party to a variety of legal actions and regulatory inquiries, including class actions and suits brought by members, care providers, consumer advocacy organizations, customers and regulators, relating to the Company&#8217;s businesses, including management and administration of health benefit plans and other services. These matters include medical malpractice, employment, intellectual property, antitrust, privacy and contract claims and claims related to health care benefits coverage and other business practices.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records liabilities for its estimates of probable costs resulting from these matters where appropriate. Estimates of costs resulting from legal and regulatory matters involving the Company are inherently difficult to predict, particularly where the matters: involve indeterminate claims for monetary damages or may involve fines, penalties or punitive damages; present novel legal theories or represent a shift in regulatory policy; involve a large number of claimants or regulatory bodies; are in the early stages of the proceedings; or could result in a change in business practices. Accordingly, the Company is often unable to estimate the losses or ranges of losses for those matters where there is a reasonable possibility or it is probable a loss may be incurred.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Government Investigations, Audits and Reviews</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been involved or is currently involved in various governmental investigations, audits and reviews. These include routine, regular and special investigations, audits and reviews by CMS, state insurance and health and welfare departments, state attorneys general, the Office of the Inspector General, the Office of Personnel Management, the Office of </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><ix:continuation id="iab675dc5c8c54816aad9b1f7497dd986"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Civil Rights, the Government Accountability Office, the Federal Trade Commission, U.S. Congressional committees, the U.S. Department of Justice (DOJ), the SEC, the IRS, the U.S. Drug Enforcement Administration, the U.S. Department of Labor, the FDIC, the Defense Contract Audit Agency and other governmental authorities. Similarly, our international businesses are also subject to investigations, audits and reviews by applicable foreign governments, including South American and other non-U.S. governmental authorities. Certain of the Company&#8217;s businesses have been reviewed or are currently under review, including for, among other matters, compliance with coding and other requirements under the Medicare risk-adjustment model. CMS has selected certain of the Company&#8217;s local plans for risk adjustment data validation (RADV) audits to validate the coding practices of and supporting documentation maintained by health care providers and such audits may result in retrospective adjustments to payments made to the Company&#8217;s health plans.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 14, 2017, the DOJ announced its decision to pursue certain claims within a lawsuit initially asserted against the Company and filed under seal by a whistleblower in 2011. The whistleblower&#8217;s complaint, which was unsealed on February 15, 2017, alleges the Company made improper risk adjustment submissions and violated the False Claims Act. On February 12, 2018, the court granted in part and denied in part the Company&#8217;s motion to dismiss. In May 2018, DOJ moved to dismiss the Company&#8217;s counterclaims, which were filed in March 2018, and moved for partial summary judgment. In March 2019, the court denied the government&#8217;s motion for partial summary judgment and dismissed the Company&#8217;s counterclaims without prejudice. The Company cannot reasonably estimate the outcome which may result from this matter given its procedural status.</span></div></ix:continuation><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_223"></div><div style="margin-top:15pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90ZXh0cmVnaW9uOjI5ZjUxMmRkY2JmNDQ2YzViOWZjOWFjN2UzNDM1NGNhXzU1MTY_8329e1b0-602e-4c8a-b77b-46d7ddd79155" continuedAt="idf806d9688184ec4b9114682e824dbdb" escape="true">Segment Financial Information</ix:nonNumeric></span></div><ix:continuation id="idf806d9688184ec4b9114682e824dbdb" continuedAt="i5bc2f2f82dfb46ec92387e1bd4dfcdd0"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Factors used to determine the Company&#8217;s reportable segments include the nature of operating activities, economic characteristics, existence of separate senior management teams and the type of information used by the Company&#8217;s chief operating decision maker to evaluate its results of operations. Reportable segments with similar economic characteristics, products and services, customers, distribution methods and operational processes which operate in a similar regulatory environment are combined.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a description of the types of products and services from which each of the Company&#8217;s <ix:nonFraction unitRef="number" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="0" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90ZXh0cmVnaW9uOjI5ZjUxMmRkY2JmNDQ2YzViOWZjOWFjN2UzNDM1NGNhXzY0MQ_f8b89d88-d8fe-4699-8537-2e8ea21e6e4c">four</ix:nonFraction> reportable segments derives its revenues:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">UnitedHealthcare </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">includes the combined results of operations of UnitedHealthcare Employer&#160;&amp; Individual, UnitedHealthcare Medicare&#160;&amp; Retirement, UnitedHealthcare Community&#160;&amp; State and UnitedHealthcare Global. The U.S. businesses share significant common assets, including a contracted network of physicians, health care professionals, hospitals and other facilities, information technology and consumer engagement infrastructure and other resources. UnitedHealthcare Employer&#160;&amp; Individual offers an array of consumer-oriented health benefit plans and services for large national employers, public sector employers, mid-sized employers, small businesses, sole proprietorships and individuals nationwide. UnitedHealthcare Medicare&#160;&amp; Retirement provides health care coverage and health and well-being services to individuals age 50 and older, addressing their unique needs for preventive and acute health care services as well as services dealing with chronic disease and other specialized issues for older individuals. UnitedHealthcare Community &amp; State provides diversified health care benefits products and services to state programs caring for the economically disadvantaged, the medically underserved and those without the benefit of employer-funded health care coverage. UnitedHealthcare Community &amp; State&#8217;s primary customers oversee Medicaid plans, the Children&#8217;s Health Insurance Program and other federal, state and community health care programs. UnitedHealthcare Global provides health and dental benefits and hospital and clinical services to employer groups and individuals in South America, and other diversified global health businesses.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Optum Health</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> focuses on care delivery, care management, wellness and consumer engagement, and health financial services. Optum Health is building a comprehensive, connected health care delivery and engagement platform by directly providing high-quality care, helping people manage chronic and complex health needs, and proactively engaging consumers in managing their health through in-person, in-home, virtual and digital clinical platforms. Optum Health offers access to networks of care provider specialists, health management services, care delivery, consumer engagement and financial services.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Optum Insight</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brings together advanced analytics, technology and health care expertise to deliver integrated services and solutions. Hospital systems, physicians, health plans, governments, life sciences companies and other organizations comprising the health care industry depend on Optum Insight to help them improve performance, achieve efficiency, reduce costs, meet compliance mandates and modernize their core operating systems to meet the changing needs of the health system.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Optum Rx </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">offers pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, purchasing and clinical capabilities, and develops programs in areas such as step therapy, formulary management, drug adherence and disease/drug therapy management. Optum Rx integrates </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><ix:continuation id="i5bc2f2f82dfb46ec92387e1bd4dfcdd0" continuedAt="id88865d52c6245179c7029a04c56ec9c"><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pharmacy and medical care and is positioned to serve patients with complex clinical needs and consumers looking for a better digital pharmacy experience with transparent pricing.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s accounting policies for reportable segment operations are consistent with those described in the Summary of Significant Accounting Policies (see </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_106">Note 2</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). Transactions between reportable segments principally consist of sales of pharmacy care products and services to UnitedHealthcare customers by Optum Rx, certain product offerings and care management and local and in-home care delivery services sold to UnitedHealthcare by Optum Health, and health information and technology solutions, consulting and other services sold to UnitedHealthcare by Optum Insight. These transactions are recorded at management&#8217;s estimate of fair value. Transactions with affiliated customers are eliminated in consolidation. Assets and liabilities jointly used are assigned to each reportable segment using estimates of pro-rata usage. Cash and investments are assigned so each reportable segment has working capital and/or at least minimum specified levels of regulatory capital. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a percentage of the Company&#8217;s total consolidated revenues, premium revenues from CMS were <ix:nonFraction unitRef="number" contextRef="iab8d98a2b1f747909b4f89b860b8d491_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90ZXh0cmVnaW9uOjI5ZjUxMmRkY2JmNDQ2YzViOWZjOWFjN2UzNDM1NGNhXzQ4ODQ_f4f233f1-55e5-44de-b3fa-0ac56f996329">36</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i6286320b787e4be4ae57d4beaf6bc896_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90ZXh0cmVnaW9uOjI5ZjUxMmRkY2JmNDQ2YzViOWZjOWFjN2UzNDM1NGNhXzQ4ODg_9916b598-77ad-4799-be89-258be581fe5c">36</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i1cde2ac06fab4d7d9e153f395956be16_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90ZXh0cmVnaW9uOjI5ZjUxMmRkY2JmNDQ2YzViOWZjOWFjN2UzNDM1NGNhXzQ4OTU_dd291f63-262e-4afc-9d9b-4afdffaef160">33</ix:nonFraction>% for 2021, 2020 and 2019, respectively, most of which were generated by UnitedHealthcare Medicare &amp; Retirement and included in the UnitedHealthcare segment. U.S. customer revenue represented approximately <ix:nonFraction unitRef="number" contextRef="ie251b137801e4de19d84d38991f2fc4c_D20210101-20211231" decimals="2" name="unh:DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90ZXh0cmVnaW9uOjI5ZjUxMmRkY2JmNDQ2YzViOWZjOWFjN2UzNDM1NGNhXzUwOTY_aa94c0d6-233e-4b10-99ea-705397e4633a">97</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i0cdd4b2069a14aa79f9ff108267e0050_D20200101-20201231" decimals="2" name="unh:DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90ZXh0cmVnaW9uOjI5ZjUxMmRkY2JmNDQ2YzViOWZjOWFjN2UzNDM1NGNhXzUxMDA_1985d6a0-2e8d-403c-b0c3-748bfb4d9179">97</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i0aa4f7c6ad7c4399ac91bad12d6477ed_D20190101-20191231" decimals="2" name="unh:DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90ZXh0cmVnaW9uOjI5ZjUxMmRkY2JmNDQ2YzViOWZjOWFjN2UzNDM1NGNhXzUxMDc_80ce28ff-832e-4100-8f07-f8c5531c3950">96</ix:nonFraction>% of consolidated total revenues for 2021, 2020 and 2019, respectively. Long-lived fixed assets located in the United States represented approximately <ix:nonFraction unitRef="number" contextRef="i9934c4a6735f409c90ddb14ad693c228_I20211231" decimals="2" name="unh:DisclosureonGeographicAreasPercentageofLongLivedAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90ZXh0cmVnaW9uOjI5ZjUxMmRkY2JmNDQ2YzViOWZjOWFjN2UzNDM1NGNhXzUyNTM_f1cb56f2-d1f1-4a82-9bb1-1c5f8a6e7f50">78</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i738afd6f13b1403abb02fff8dfe35e83_I20201231" decimals="2" name="unh:DisclosureonGeographicAreasPercentageofLongLivedAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90ZXh0cmVnaW9uOjI5ZjUxMmRkY2JmNDQ2YzViOWZjOWFjN2UzNDM1NGNhXzUyNjA_8f416617-7f5b-4d17-8cf5-e2fe414514df">75</ix:nonFraction>% of the total long-lived fixed assets as of December&#160;31, 2021 and 2020, respectively. The non-U.S. revenues and fixed assets are primarily related to UnitedHealthcare Global. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><ix:continuation id="id88865d52c6245179c7029a04c56ec9c"><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90ZXh0cmVnaW9uOjI5ZjUxMmRkY2JmNDQ2YzViOWZjOWFjN2UzNDM1NGNhXzU1MTg_a9785db1-4f9f-4ef0-a311-a501d43b2f0d" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the reportable segment financial information:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:24.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.282%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.105%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.164%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.289%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">UnitedHealthcare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum Health</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum Insight</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum Rx</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum Eliminations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Corporate&#160;and<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenues - unaffiliated customers:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee4705fe81d9455197bc18142d417d2a_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQtMi0xLTEtMA_254fe404-9eac-4946-b126-b32af455f10f">212,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e535292ef33468993675998c2605663_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQtNC0xLTEtMA_4850b9fc-2cfd-42d5-8eea-c8c41fd143c4">13,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic990f91ed37540749f170b9884cdaa28_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQtNi0xLTEtMA_584718df-cf91-4621-be7d-1cfb1db397e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3229a037bb842319e936ad6b2a51f54_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQtOC0xLTEtMA_abe005a6-9c84-4dea-b9b8-7e85e4b2f5de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d0f7160671347419a34952ffc8558f7_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQtMTAtMS0xLTA_34e5fd74-a559-4524-b0ed-6d762b272c25">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92f08c3054b742748f6b0f913e60627d_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQtMTItMS0xLTA_56c8227c-388d-4c6f-8fe7-df0d0af1d156">13,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2c9211b22745b98ab1ab28b8337c59_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQtMTQtMS0xLTA_9cb6dc9a-8c8d-459c-afc6-3c86b28807dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1530a49a61da49318357204f5b8d80a1_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQtMTYtMS0xLTA_c4f53b15-ea6d-44c7-8316-ac02a4a25ec5">226,233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6279b453c9048b8ad104e810416cbe4_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzUtMi0xLTEtMA_b56aa502-9288-4e97-a1df-669c1f304fd5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb1b161f7dee4b48b64861165d69a88c_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzUtNC0xLTEtMA_b5e801be-5228-44d5-9fbc-6b8d322dc350">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8400a403196b4b1a958b56a508d6d9b0_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzUtNi0xLTEtMA_6e92d79f-bd93-4a89-8910-1459fc507ead">159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1bfbb3548674a669b5b6862fa055067_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzUtOC0xLTEtMA_d744762d-7212-4da2-b0a8-79802c43b6d3">34,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9094967184f474f86b50dde16f3fe77_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzUtMTAtMS0xLTA_a097864c-9d48-41cb-8d44-4c86f440a12b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ebf459d7ca4411a991115796de7f6d5_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzUtMTItMS0xLTA_217b7464-b3cd-47a4-8aed-de24dc5e2d00">34,437</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if946d85193d24f7eab19007d8ced36a7_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzUtMTQtMS0xLTA_7b7a004e-b247-464d-bc9d-4bdbd214d700">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i213b700417474af9b2ba5f4aa8d32fdb_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzUtMTYtMS0xLTA_03f38a6d-4bc4-40e2-96e8-382680a323ef">34,437</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d1cef4ce9714d94a507aa88c10ea8e0_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzYtMi0xLTEtMA_a6a729b3-233e-4c56-8f6c-0dcdad140b3c">9,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife9ac604777648d1aef36fd158860f8b_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzYtNC0xLTEtMA_0e124d8b-1c80-4ce3-af1c-f70041078e52">9,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3defa0ac8fe4ab8af3c5b1f321e4ac8_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzYtNi0xLTEtMA_a577a830-47ef-46d2-a1bc-2b46c16afb70">3,936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief7cdc8becb546ea9d8c89af57c961d9_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzYtOC0xLTEtMA_518cf940-ec08-47ad-b3c1-dcf90018e74d">1,112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia88cef480a724f0f9f76711ad5e858fe_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzYtMTAtMS0xLTA_375060c0-06f0-4237-a4e5-95d73e3af79e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide28f350116d433e9a4361d7809e1736_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzYtMTItMS0xLTA_0792a5dd-2605-4b79-b0c4-5200d7a2cae4">14,942</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie48fc3492bf64059adc2061a1f6feeff_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzYtMTQtMS0xLTA_f76e526d-9c5d-4359-a09e-c40e22c815b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c0a8f96f3fb4705b212d6fd60611c3b_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzYtMTYtMS0xLTA_11bc06b9-d709-4b6b-bbf0-31dba585e919">24,603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues - unaffiliated customers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee4705fe81d9455197bc18142d417d2a_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzctMi0xLTEtMA_817172a2-c7ae-4bd3-a0ec-432888d799b9">222,042</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e535292ef33468993675998c2605663_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzctNC0xLTEtMA_27c7ab59-c349-49be-a470-37cbad7971e9">23,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic990f91ed37540749f170b9884cdaa28_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzctNi0xLTEtMA_eeb7f06a-90f2-4e40-a2c4-b8bbee34dcf1">4,095</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3229a037bb842319e936ad6b2a51f54_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzctOC0xLTEtMA_afdd14d7-8eaf-468b-89d4-4c569e9f613b">35,358</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d0f7160671347419a34952ffc8558f7_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzctMTAtMS0xLTA_f64f5bbc-bc72-407a-94df-eac4d8336111">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92f08c3054b742748f6b0f913e60627d_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzctMTItMS0xLTA_d7fe79aa-dfb1-4fd5-8c26-10f6cb0ff486">63,231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2c9211b22745b98ab1ab28b8337c59_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzctMTQtMS0xLTA_66a43ee1-4d2a-4d11-b985-bf4e0d640a58">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1530a49a61da49318357204f5b8d80a1_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzctMTYtMS0xLTA_eec1f730-5bec-44c2-b8e4-12eb97ca8f53">285,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues - affiliated customers</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b8cf1603c4345e1a2f17d91305ba20d_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzgtMi0xLTEtMA_1cf41fb1-f622-463d-bfa0-499197ca3e4a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fca052182cd4adcae25d8c3d38cd9c8_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzgtNC0xLTEtMA_e9e11246-f649-40f6-a956-1b6148cd819d">29,234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ca8c63efcb348f6bb49eb114aa1ed4b_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzgtNi0xLTEtMA_5b3cde7c-7bdf-4fd8-8c00-9774840146ef">7,867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4ca79e1283c473bbdcfa153dd38f371_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzgtOC0xLTEtMA_80cf6698-aacc-478e-bb2a-7564b90db965">55,779</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie14d3261f5ce4d5ca55b14d4eefcad6f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzgtMTAtMS0xLTA_93cc6223-d132-490d-95e8-063abca15505">2,013</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e37d9f4072942d3ba64046e6f17b292_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzgtMTItMS0xLTA_31d331ff-214f-4647-9a98-15b07f0d156d">90,867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ed0869af41147eb8333f00d982aa0fc_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzgtMTQtMS0xLTA_98dee048-b122-473e-b6d2-f48353f839c9">90,867</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfdfc0f71a2c4bbc8d894e75a883058c_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzgtMTYtMS0xLTA_c0e89528-c3ef-4025-948f-8205fc57596b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment and other income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbc6824afba44fe3aedc3c732de59fed_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzktMi0xLTEtMA_660fe6a2-f75e-43db-b6cd-66987ceae43e">857</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife381aeab14b4f16b57316de303fa1dc_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzktNC0xLTEtMA_9bda6989-3569-41fc-9aeb-8c668b0e6cc6">1,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7fc59569fab4373bc61b6d246fec133_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzktNi0xLTEtMA_1bafa4e8-15e1-412b-97e9-5d38704f6ea7">237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c2c251890924c728ecbe00f7c589b5d_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzktOC0xLTEtMA_f2311eea-5ec1-43f2-9c53-8e818dad614e">177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b8078f333f54e939e1e3226c81d9047_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzktMTAtMS0xLTA_cba26300-6c0e-4297-97e5-5632cb189042">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0945fba67234634866077d9614c0b72_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzktMTItMS0xLTA_1e068c74-b7dd-45b1-b1f9-994e9003d039">1,467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9989fc2842a47be8b2f3c34eadc9a60_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzktMTQtMS0xLTA_6285b742-adeb-423b-8ee7-063e24969023">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzktMTYtMS0xLTA_6a46d76a-54f6-4d6e-9a83-391fd94e1ca6">2,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbc6824afba44fe3aedc3c732de59fed_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEwLTItMS0xLTA_2bd11889-2f7b-4343-b899-1fbb5e06d8b1">222,899</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife381aeab14b4f16b57316de303fa1dc_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEwLTQtMS0xLTA_f674b49b-ee3a-42c3-bcd8-41f8b40b1fb9">54,065</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7fc59569fab4373bc61b6d246fec133_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEwLTYtMS0xLTA_bad65c7c-e614-4050-9076-8a0e42390cee">12,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c2c251890924c728ecbe00f7c589b5d_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEwLTgtMS0xLTA_18449649-0060-4a01-9743-9f0c882d486b">91,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b8078f333f54e939e1e3226c81d9047_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEwLTEwLTEtMS0w_1a9fd057-19e0-489c-8346-3d6bdaade925">2,013</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0945fba67234634866077d9614c0b72_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEwLTEyLTEtMS0w_12815d97-e9c2-40c1-8a18-7871329d93c1">155,565</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9989fc2842a47be8b2f3c34eadc9a60_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEwLTE0LTEtMS0w_4d999101-561a-477d-822a-b7dc9bc59247">90,867</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEwLTE2LTEtMS0w_02b5562d-3de9-4965-9159-91ec385cab37">287,597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbc6824afba44fe3aedc3c732de59fed_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzExLTItMS0xLTA_aeb69945-6f2a-41f4-b997-db95420ec5d2">11,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife381aeab14b4f16b57316de303fa1dc_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzExLTQtMS0xLTA_4439357b-35f6-4ed3-85c3-598eab8d5beb">4,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7fc59569fab4373bc61b6d246fec133_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzExLTYtMS0xLTA_f2f0d5eb-7993-4676-8981-1942fa5c2028">3,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c2c251890924c728ecbe00f7c589b5d_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzExLTgtMS0xLTA_a9801263-67a0-4ccb-bb0a-d6a62f15ef01">4,135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b8078f333f54e939e1e3226c81d9047_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzExLTEwLTEtMS0w_54ba91e5-2c6d-42fa-9954-106fd9e18d53">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0945fba67234634866077d9614c0b72_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzExLTEyLTEtMS0w_3265bb37-4c3f-46f8-a1d6-343905ab1b79">11,995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9989fc2842a47be8b2f3c34eadc9a60_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzExLTE0LTEtMS0w_38461d5c-0412-4b42-89e3-551547edb3dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzExLTE2LTEtMS0w_1bfca614-6f72-4977-aff7-5a97c4ed64c7">23,970</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbc6824afba44fe3aedc3c732de59fed_D20210101-20211231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEyLTItMS0xLTA_86bb3d09-4530-40b8-bb6a-8cd3ce60cade">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife381aeab14b4f16b57316de303fa1dc_D20210101-20211231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEyLTQtMS0xLTA_d0bba8ac-907c-432f-ad43-9eb622cce53a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7fc59569fab4373bc61b6d246fec133_D20210101-20211231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEyLTYtMS0xLTA_dc572d40-bf65-4ff5-b26d-26814b8553ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c2c251890924c728ecbe00f7c589b5d_D20210101-20211231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEyLTgtMS0xLTA_ad830245-6285-4c46-a4b9-f41e19f6d016">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b8078f333f54e939e1e3226c81d9047_D20210101-20211231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEyLTEwLTEtMS0w_322a1b3f-aff3-44ea-b18c-b58a27e41422">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0945fba67234634866077d9614c0b72_D20210101-20211231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEyLTEyLTEtMS0w_78178e66-3d1c-494e-aaba-07663c90307a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9989fc2842a47be8b2f3c34eadc9a60_D20210101-20211231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEyLTE0LTEtMS0w_1178dd81-39a1-4c4a-bf84-23150d0fe861">1,660</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEyLTE2LTEtMS0w_25d57ef8-2974-43a3-a86c-a8669266d263">1,660</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbc6824afba44fe3aedc3c732de59fed_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEzLTItMS0xLTA_50efedf8-8435-49a3-bd2b-e0375bd5bb8c">11,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife381aeab14b4f16b57316de303fa1dc_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEzLTQtMS0xLTA_07005428-b75f-47e8-9e69-7064055d5a69">4,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7fc59569fab4373bc61b6d246fec133_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEzLTYtMS0xLTA_392875e1-56f9-4dbd-8650-843fa7709189">3,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c2c251890924c728ecbe00f7c589b5d_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEzLTgtMS0xLTA_e3c70791-956c-46be-b7f2-c10197f66437">4,135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b8078f333f54e939e1e3226c81d9047_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEzLTEwLTEtMS0w_ecd39790-b1f0-4afc-b74a-0691ef10f6d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0945fba67234634866077d9614c0b72_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEzLTEyLTEtMS0w_56f03e16-a3c3-4fb3-8361-91f40795f7b3">11,995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9989fc2842a47be8b2f3c34eadc9a60_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEzLTE0LTEtMS0w_d18edd58-26c2-4215-83dd-c3e13823176e">1,660</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEzLTE2LTEtMS0w_95ebf0ee-4135-4ced-8713-a022b55ca02a">22,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if184c0bbcb7247febb4f087da3c892c6_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE0LTItMS0xLTA_6244f55c-1cfc-4b5a-9540-8bc349b049a9">102,967</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e418b78bbe046c6aa713f2359794876_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE0LTQtMS0xLTA_ad4a689c-516c-436c-909c-e85900be8dd8">60,474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id04de182af82446c8a35182aaf2b48c5_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE0LTYtMS0xLTA_8d21564e-cac5-4905-b894-01188678ee38">16,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc410a001b324c2894fbec26bfef7b86_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE0LTgtMS0xLTA_bc4f4fe8-bd09-4511-80b3-c9d5ebc751c4">40,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f15426e9ba74458aebc54c25df28187_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE0LTEwLTEtMS0w_7c120959-f462-48df-a121-ef632ea1ad99">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18674f2c4d12424c968d20476457dd0b_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE0LTEyLTEtMS0w_39f6368d-e8c1-4432-9ee1-88e09348ee0c">117,523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0a3d0d7510f4b139641910dd08967c1_I20211231" decimals="-6" sign="-" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE0LTE0LTEtMS0w_019aa947-ad72-43ef-ad80-74ab184bad8f">8,284</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE0LTE2LTEtMS0w_5d8896e9-80f4-4221-ad19-aeab4ad9f10c">212,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property, equipment and capitalized software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbc6824afba44fe3aedc3c732de59fed_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE1LTItMS0xLTA_b89ebd05-5167-47bb-8122-b6225fc6bb73">795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife381aeab14b4f16b57316de303fa1dc_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE1LTQtMS0xLTA_922e3f49-3b81-4b35-97a2-c4be8d7a3232">791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7fc59569fab4373bc61b6d246fec133_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE1LTYtMS0xLTA_0ce110e4-dae2-4f8b-9e86-70d25e0996bd">567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c2c251890924c728ecbe00f7c589b5d_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE1LTgtMS0xLTA_65416fad-2f5a-4e71-8843-6e3277025ca0">301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b8078f333f54e939e1e3226c81d9047_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE1LTEwLTEtMS0w_623efbb4-b744-43eb-80a9-35ed81443359">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0945fba67234634866077d9614c0b72_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE1LTEyLTEtMS0w_220d2690-f127-451f-998c-4c3ff9fbe073">1,659</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9989fc2842a47be8b2f3c34eadc9a60_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE1LTE0LTEtMS0w_aaa4aaed-a300-4867-b7a2-95ee2f56a647">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE1LTE2LTEtMS0w_e36904dc-4db7-4559-8409-5eed5792a39c">2,454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbc6824afba44fe3aedc3c732de59fed_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE2LTItMS0xLTA_e77fecd7-3828-4ead-9689-9903372ed851">1,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife381aeab14b4f16b57316de303fa1dc_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE2LTQtMS0xLTA_988d2056-1810-4d06-a211-6eda89390d19">818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7fc59569fab4373bc61b6d246fec133_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE2LTYtMS0xLTA_40d6be81-9265-4788-b2a4-05243a179fcb">684</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c2c251890924c728ecbe00f7c589b5d_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE2LTgtMS0xLTA_c70e7b62-6d51-43b3-a55e-bca76ee812a7">597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b8078f333f54e939e1e3226c81d9047_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE2LTEwLTEtMS0w_0fd452d6-7a82-452c-8111-4145595f3e4f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0945fba67234634866077d9614c0b72_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE2LTEyLTEtMS0w_3353ed40-9f51-48a2-92f5-e5238c4ad55b">2,099</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9989fc2842a47be8b2f3c34eadc9a60_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE2LTE0LTEtMS0w_09c4869a-aee9-4441-a55a-e329901e1f30">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE2LTE2LTEtMS0w_c63bcadf-d1d3-451f-b813-cc0e045baf2c">3,103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenues - unaffiliated customers:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9ed61319c0a45798da15c42c3e38cd0_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE5LTItMS0xLTA_a9f8f003-dcc4-4302-a169-5956dfaed566">191,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17627bd9a4c5409e9c94b533f8f5ae1c_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE5LTQtMS0xLTA_c2566ea0-656b-4cb7-8b1f-25871ce4f787">9,799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2cc2e00b67f4fcf82476fd51fd0699e_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE5LTYtMS0xLTA_b4e493af-1dce-4d2a-b292-c44a8020df78">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ba88a0ee30c45278b5ace52700290ad_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE5LTgtMS0xLTA_66a5803f-387a-4855-8dc7-100a87119082">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0594531b29c14219bef65d8cd283fc9e_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE5LTEwLTEtMS0w_fbdfe234-917c-4545-8295-576563bcd55c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87c3f11df32b441eb7fee715e6d92010_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE5LTEyLTEtMS0w_954d9a2a-5d3e-4946-81e9-6ad29669b054">9,799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i451a7a7915ff449fbc9bd1d7c005293d_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE5LTE0LTEtMS0w_c0558cca-d535-4348-b3b8-ace82ac3971d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b06cf327e4bfca58345b40abc554a_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE5LTE2LTEtMS0w_3de370a9-b90c-4104-b269-04ca416658f6">201,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4e9e37ffd9442649f7208882a987c32_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIwLTItMS0xLTA_e371319f-89b5-42b6-a509-b667b9fc52a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i476fc79de3284b55b364793f612b1a19_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIwLTQtMS0xLTA_5833ec67-240d-46f4-a48e-d68b5fdcd83b">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97e70d750485412480c983dd5791128d_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIwLTYtMS0xLTA_79a657d4-d77a-4e2c-ae6a-64e11e106d6a">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i097c78c5b5544597a305bc89df54bd95_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIwLTgtMS0xLTA_2054758f-534e-4233-9e51-428874e9fe15">33,977</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied275047eb1f45e5a90acc5936ce8821_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIwLTEwLTEtMS0w_c4823e90-1256-4da6-91f4-81157c9f1cfe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8618f261f45e45c98738e7bb3e6bda9d_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIwLTEyLTEtMS0w_098d84de-2680-48df-a411-f96a34520147">34,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i026c8094e6214ea8a156691c9176a6a0_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIwLTE0LTEtMS0w_742c14fe-b7db-44cd-859e-6c66fb1065c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if36ef5c1313e4865b5b21c968b7637ce_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIwLTE2LTEtMS0w_3343190e-c6da-44f5-a413-985510d99e1a">34,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bb1779f53f54fe7a529d721403d381e_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIxLTItMS0xLTA_c6940316-66e5-478b-a79b-dd086ce5a881">8,464</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c78ced66e794cfd90dfb9d9b04070c6_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIxLTQtMS0xLTA_beb7102f-808a-4d7a-98f5-6f1f018d654c">6,815</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib88407875cb54f609ca6d2c491acde2a_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIxLTYtMS0xLTA_a0c698c7-79c3-46f6-ba1e-58ef6e215ffd">3,687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a6318238dc84a50b52e2aa5ce8fab33_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIxLTgtMS0xLTA_f40bbbeb-53ed-4e31-9a9e-59955cb97c60">1,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c98317ad344b9499d3c32c021c9f7e_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIxLTEwLTEtMS0w_0767a1ad-1885-4988-93c7-0e5d263f9178">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb5025c996f04acfb22d6284a0a6eda9_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIxLTEyLTEtMS0w_d397d764-e1e9-4cb7-9dda-c384d55b5b27">11,552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8061ff53692d49e09adca8578d72d4cc_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIxLTE0LTEtMS0w_a3460156-cf81-42fb-8982-d03903430ae0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7288d5a2ace47fead21082bff05e780_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIxLTE2LTEtMS0w_b8755544-8634-4949-9dcb-c212c5a01889">20,016</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues - unaffiliated customers</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9ed61319c0a45798da15c42c3e38cd0_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIyLTItMS0xLTA_0c0c79fa-f8ab-43cc-818c-0fc3100e0021">200,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17627bd9a4c5409e9c94b533f8f5ae1c_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIyLTQtMS0xLTA_321469cc-d4d5-40c6-8fe6-2f8dbaa0e511">16,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2cc2e00b67f4fcf82476fd51fd0699e_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIyLTYtMS0xLTA_867e9208-3a18-4c3d-a363-92424ebd8996">3,822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ba88a0ee30c45278b5ace52700290ad_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIyLTgtMS0xLTA_5c955d24-bf66-46a7-a1c7-94649f258525">35,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0594531b29c14219bef65d8cd283fc9e_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIyLTEwLTEtMS0w_3807fc3d-ee7d-4a02-904e-768dc044e6e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87c3f11df32b441eb7fee715e6d92010_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIyLTEyLTEtMS0w_5869dcba-c008-48cb-a45c-420f98054143">55,496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i451a7a7915ff449fbc9bd1d7c005293d_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIyLTE0LTEtMS0w_1c2c57f8-c15f-47e2-ada5-0f9f105d10fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1b06cf327e4bfca58345b40abc554a_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIyLTE2LTEtMS0w_6cd90f70-b6d2-4ff3-be1a-34b7aadd6157">255,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues - affiliated customers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60cedc1d72954901a048fe79a192b8c1_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIzLTItMS0xLTA_33ebbc2f-9e41-4c62-b03b-761892fc24f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7df7d80b21d94258923146d050c70aa8_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIzLTQtMS0xLTA_4c0647f3-4bf3-4b0d-b8f3-ecb9c748d397">22,481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf0af36cf92d48a0b98b4f9034ffb32d_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIzLTYtMS0xLTA_4b02be3e-42f2-4fc8-9a4a-38e758e157fd">6,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icacb7b0bda5541ac9648de164759144a_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIzLTgtMS0xLTA_0d6f8583-e000-44a4-97f7-c9ea500b76ac">52,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81a2f35fd1414929bcea4c64d9b78904_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIzLTEwLTEtMS0w_0ffecc2a-c08b-413d-9d67-8e286286fba7">1,800</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a16d027033644d5b0b62819b881ff74_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIzLTEyLTEtMS0w_74ceb8e5-143c-4b72-9baa-95a1d3e712bf">80,042</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d4de446cb684fb98b6beb87c8a76032_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIzLTE0LTEtMS0w_aff5f549-ffa3-4534-a7ac-9452bf8e1c99">80,042</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54812316cf0241ad80e1416a9adb8137_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIzLTE2LTEtMS0w_84143772-f056-4cf2-b145-6bba2fd7fc75">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment and other income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81f09e67922c4373afc90c08de19f39f_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI0LTItMS0xLTA_9675c173-0d0f-480e-8d8c-24fce6f4c865">732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6457702d9d2444e2bd3006604563b0c7_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI0LTQtMS0xLTA_d8935f10-17e9-48de-8ea0-a3f22c0a2047">680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0fdc75afbab4fee9a53cbbd8a5ee695_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI0LTYtMS0xLTA_d0d6f2bb-9f91-4ec1-99ac-449d79405309">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b17e0bd3b914d2bbf6bf114349486a0_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI0LTgtMS0xLTA_249f4e05-c708-4a83-9886-f075ca15bff4">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5087b2a7612d4c559bb8832aa4ef4e1f_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI0LTEwLTEtMS0w_02204cf7-e784-4bf3-9fdf-a1d14bebcd95">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97c4cc1a264b40839a4392c3a86f7175_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI0LTEyLTEtMS0w_986fb7db-05f7-4955-8c06-cbb8c3ee9f90">770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dc352162fbe4ed18df7bd7477ea0efd_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI0LTE0LTEtMS0w_75673edf-fcef-4d38-a912-ae1f1fd39d43">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI0LTE2LTEtMS0w_7133f253-56a5-444b-a65d-da1ada1c674f">1,502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81f09e67922c4373afc90c08de19f39f_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI1LTItMS0xLTA_d72c6fc4-d2ba-4582-8bff-e1a65f0da9c0">200,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6457702d9d2444e2bd3006604563b0c7_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI1LTQtMS0xLTA_4761b38f-ef64-4ed4-8e02-bb3822798d1a">39,808</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0fdc75afbab4fee9a53cbbd8a5ee695_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI1LTYtMS0xLTA_4218116c-a578-4af4-ad66-d083d1cb74ce">10,802</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b17e0bd3b914d2bbf6bf114349486a0_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI1LTgtMS0xLTA_f9d0c604-a774-493b-b43d-35b10687db7c">87,498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5087b2a7612d4c559bb8832aa4ef4e1f_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI1LTEwLTEtMS0w_402c8272-2a37-405a-accf-1537a0aa462c">1,800</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97c4cc1a264b40839a4392c3a86f7175_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI1LTEyLTEtMS0w_b79d0e3c-31bb-4983-b8cb-6d49ca945f09">136,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dc352162fbe4ed18df7bd7477ea0efd_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI1LTE0LTEtMS0w_74432812-c691-4ef4-af16-b89eafe3cfc0">80,042</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI1LTE2LTEtMS0w_97179eb6-6334-4bd5-8522-d4b13ada49c3">257,141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81f09e67922c4373afc90c08de19f39f_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI2LTItMS0xLTA_625f5606-57ef-498b-b9b2-1129ed09a1f2">12,359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6457702d9d2444e2bd3006604563b0c7_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI2LTQtMS0xLTA_fd16c1f7-5c3f-45b8-b280-d64c5f6d9647">3,434</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0fdc75afbab4fee9a53cbbd8a5ee695_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI2LTYtMS0xLTA_d3f415e9-7517-4416-8f67-76a880f1a1e9">2,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b17e0bd3b914d2bbf6bf114349486a0_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI2LTgtMS0xLTA_f44e6ed4-7ddc-46c8-8628-07f20cf2adbe">3,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5087b2a7612d4c559bb8832aa4ef4e1f_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI2LTEwLTEtMS0w_79b8a3a5-8d85-4f62-b177-ffac2ef5fdfe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97c4cc1a264b40839a4392c3a86f7175_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI2LTEyLTEtMS0w_5052fe2b-8cfa-494b-9964-5d0086f6227b">10,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dc352162fbe4ed18df7bd7477ea0efd_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI2LTE0LTEtMS0w_af43eee2-3b7d-4628-be65-4605780f1431">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI2LTE2LTEtMS0w_69bb2b56-d2b5-4afd-beeb-ac50d41e1e51">22,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81f09e67922c4373afc90c08de19f39f_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI3LTItMS0xLTA_49ee3d53-8893-4333-b84d-447dc94d2272">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6457702d9d2444e2bd3006604563b0c7_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI3LTQtMS0xLTA_bd37d71b-f654-4322-9044-2d5d65967b75">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0fdc75afbab4fee9a53cbbd8a5ee695_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI3LTYtMS0xLTA_a6ff616b-db10-443c-a2dd-f1be6686caa6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b17e0bd3b914d2bbf6bf114349486a0_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI3LTgtMS0xLTA_6f8e37cc-a624-4803-b526-b645179ddf7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5087b2a7612d4c559bb8832aa4ef4e1f_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI3LTEwLTEtMS0w_e5d90bdb-d4ea-44b2-9274-2831a8d7f215">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97c4cc1a264b40839a4392c3a86f7175_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI3LTEyLTEtMS0w_3928d6f5-eb9b-4b11-9959-44ee1787af82">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dc352162fbe4ed18df7bd7477ea0efd_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI3LTE0LTEtMS0w_779d68c7-10be-426a-b293-f7a47f41a73f">1,663</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI3LTE2LTEtMS0w_f33ed376-d783-4f09-8a02-619cc8e7dbe3">1,663</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81f09e67922c4373afc90c08de19f39f_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI4LTItMS0xLTA_1d7a359e-30d3-481f-b414-414375a41f43">12,359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6457702d9d2444e2bd3006604563b0c7_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI4LTQtMS0xLTA_a1f95103-b880-4c76-8975-43ade43b6aa4">3,434</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0fdc75afbab4fee9a53cbbd8a5ee695_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI4LTYtMS0xLTA_6bc0c3a0-8591-4efc-8855-1a5fb1098036">2,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b17e0bd3b914d2bbf6bf114349486a0_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI4LTgtMS0xLTA_9ab21f25-0b8b-4637-ae28-bb711899ff1c">3,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5087b2a7612d4c559bb8832aa4ef4e1f_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI4LTEwLTEtMS0w_0f30df6d-e905-426c-826b-ec86cf5b5ec7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97c4cc1a264b40839a4392c3a86f7175_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI4LTEyLTEtMS0w_19b7bcdb-359f-4341-8398-a65d92dc5406">10,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dc352162fbe4ed18df7bd7477ea0efd_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI4LTE0LTEtMS0w_2d50dfee-8c52-4f28-8a8c-c3d1c4bbba6a">1,663</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI4LTE2LTEtMS0w_0bafcba8-e975-4ebd-8c2c-4689559ec892">20,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5ca22db7484acf8738fe8c4096beaa_I20201231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI5LTItMS0xLTA_5f1872e2-fcf6-45b0-bf18-bc2251916821">98,229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0ddb85685644e32aaa72bd4c99df7d3_I20201231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI5LTQtMS0xLTA_48d98f32-9621-4772-8299-eff8d67d108e">52,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i765e712ac4354f6b9977ebd8a5137668_I20201231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI5LTYtMS0xLTA_8e9d02ac-b061-41be-8c92-b3e976caaa4d">15,425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9ce56590e08493a92f4e98ff05295de_I20201231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI5LTgtMS0xLTA_f204f499-5f70-420d-8513-352e026e380b">39,280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae958eee276045ee967123983469f6ed_I20201231" decimals="-6" name="us-gaap:Assets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI5LTEwLTEtMS0w_c2902824-ab18-4f3a-9d66-d84d964f1c30">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c5071fb5c87448187540e1a182c3bf1_I20201231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI5LTEyLTEtMS0w_ecc93ae9-2797-4e4b-8e50-dce22cbe22ae">106,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61970d2504044d078cdd34efba0cd162_I20201231" decimals="-6" sign="-" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI5LTE0LTEtMS0w_59030165-d1ef-4d89-b7bd-bee81b650b34">7,718</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI5LTE2LTEtMS0w_e2047296-3155-47e0-ba82-3b14c241e32e">197,289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property, equipment and capitalized software</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81f09e67922c4373afc90c08de19f39f_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzMwLTItMS0xLTA_5b8879fb-e07d-4884-8bed-ce22b811f809">687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6457702d9d2444e2bd3006604563b0c7_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzMwLTQtMS0xLTA_63082be0-74a9-46b7-887e-16f93facc48c">715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0fdc75afbab4fee9a53cbbd8a5ee695_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzMwLTYtMS0xLTA_ee09efcf-6218-4ddb-85c7-cdaddc20de96">461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b17e0bd3b914d2bbf6bf114349486a0_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzMwLTgtMS0xLTA_c1204989-92fc-4fee-9295-70ba9e0eb8d7">188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5087b2a7612d4c559bb8832aa4ef4e1f_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzMwLTEwLTEtMS0w_c19f9977-71fc-4da4-9f2f-a2976e4a78b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97c4cc1a264b40839a4392c3a86f7175_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzMwLTEyLTEtMS0w_e6922445-330c-41a2-8e2a-0c8595a8a5d2">1,364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dc352162fbe4ed18df7bd7477ea0efd_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzMwLTE0LTEtMS0w_017add6d-6c6e-4d3f-901f-799b1dcb5af3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzMwLTE2LTEtMS0w_f5556050-46ac-47d9-bc4a-df8670b6c52b">2,051</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81f09e67922c4373afc90c08de19f39f_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzMxLTItMS0xLTA_beee2871-efde-4a41-a555-0e1b96f720d2">920</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6457702d9d2444e2bd3006604563b0c7_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzMxLTQtMS0xLTA_09a7590d-6e01-41a2-a6a2-d19e0e4f09c7">703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0fdc75afbab4fee9a53cbbd8a5ee695_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzMxLTYtMS0xLTA_d25b3778-0368-4e93-9c5a-4b82daf16076">670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b17e0bd3b914d2bbf6bf114349486a0_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzMxLTgtMS0xLTA_0e80e276-4c4a-46fa-91fe-060779540712">598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5087b2a7612d4c559bb8832aa4ef4e1f_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzMxLTEwLTEtMS0w_96840a3a-9416-4f29-9b33-e6c31df47bda">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97c4cc1a264b40839a4392c3a86f7175_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzMxLTEyLTEtMS0w_9fc59399-2b36-4cde-a513-2b97eb740637">1,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dc352162fbe4ed18df7bd7477ea0efd_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzMxLTE0LTEtMS0w_435b9b15-104a-48aa-a276-b3027d0f32c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzMxLTE2LTEtMS0w_b2089db1-0841-48b0-b645-dbba195527ab">2,891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenues - unaffiliated customers:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i859e241a022540eca1b22afddbe55e1b_D20190101-20191231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM0LTItMS0xLTA_4e25113e-3445-49fc-812e-7f0d11eb284f">183,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ec7b4d30d5e48deb9045b349aaf4dd4_D20190101-20191231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM0LTQtMS0xLTA_0819ac27-0327-4194-bd97-f1702a27e69a">5,916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1b5e284b10548f2b4cea7ea557161f0_D20190101-20191231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM0LTYtMS0xLTA_9e0063c5-383e-48a1-9f2e-f1b65293a396">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifef7b0e583964ad39d94daea6cea3366_D20190101-20191231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM0LTgtMS0xLTA_de468a02-3405-4d59-8c68-7c84c0f5f60f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia58c1f8d468c437393baf523e864a524_D20190101-20191231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM0LTEwLTEtMS0w_f81c4383-58c6-43c6-9d74-c1a93834f2f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0a43f969e6045adbb4d7a5ed18144fe_D20190101-20191231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM0LTEyLTEtMS0w_7e5eea3e-d1b1-42d3-aa5e-191a73362983">5,916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e4f8878a34a4cb4bc6c14d692445406_D20190101-20191231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM0LTE0LTEtMS0w_e3178edd-39ff-4450-85b6-b8a020b755af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e0a9e0b05964d5b81c4faaf9261f866_D20190101-20191231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM0LTE2LTEtMS0w_0e7fc078-1681-4c74-8b21-de35dd07b14b">189,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7daf143ec32478b96d361bc8bbcb4a7_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM1LTItMS0xLTA_a903cd08-8f10-4c01-8ca2-920af1d3763e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4466e0b3d7e4d21b0cdb371895ed5bc_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM1LTQtMS0xLTA_2f7f5fe4-c140-40e7-86bc-9804367aa995">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e8a322046c48e9bb4d5a3f9d8d69bc_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM1LTYtMS0xLTA_d063a537-b9fc-4ba6-8cc3-1e4d21e2ee2f">116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i665d6130ef0b4aa8b4c4151cae26a10c_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM1LTgtMS0xLTA_1a6d9bcc-1846-4046-9b48-601fec4eba0b">31,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieab8464742d34bbab93c7d73240b238a_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM1LTEwLTEtMS0w_4232d87f-77f3-4eed-b575-4f42886185a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bf9cb13150a4db19778cd757e617679_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM1LTEyLTEtMS0w_f4ad497a-9f51-40bf-b6dc-227cc74c1e33">31,597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1556f868d6143eaa08d050b665df1a1_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM1LTE0LTEtMS0w_959549e3-b25f-4df3-8317-d24b5199a98d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd51ec9383cd46588877c19834efb15a_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM1LTE2LTEtMS0w_284e1d3e-9264-4b72-9761-f714cda89c91">31,597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bcf02a9e58b4aa7bf1bbb8dd1ab6cb2_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM2LTItMS0xLTA_b2526319-2e9d-45e7-92a8-55af43b4c65d">8,922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c79ad983a524d509a081c39abd43c4a_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM2LTQtMS0xLTA_23d8f7d5-84bb-43e6-a08a-3bf8bd9ae7b5">5,732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33d20e2cf6204d4097b19633f98c100e_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM2LTYtMS0xLTA_af38ff9a-3613-4720-aa73-a33c775a3875">3,630</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9fb83dc51774898890f78347ad88320_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM2LTgtMS0xLTA_10522ae8-86b3-4151-9e9b-2bf9bf32f809">689</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e782903147c4e9bbf36b4ecb9601b62_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM2LTEwLTEtMS0w_1e71183a-b9c1-4214-9805-e8430a873b22">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13864f629b874a0ca8c1ae8f96420ee4_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM2LTEyLTEtMS0w_952d1d29-876d-4406-9b0f-bae89a6bf32e">10,051</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19c1e613e77143c39c1a29089613da3f_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM2LTE0LTEtMS0w_ebc49219-524b-49b1-9152-09db337eed3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia069a517828549fcad85e8b0f07df91a_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM2LTE2LTEtMS0w_af76f1cb-336a-4cb0-b6d3-92de432d2219">18,973</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues - unaffiliated customers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i859e241a022540eca1b22afddbe55e1b_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM3LTItMS0xLTA_402891bf-a4ba-47de-bafd-3dfae179a29c">192,705</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ec7b4d30d5e48deb9045b349aaf4dd4_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM3LTQtMS0xLTA_bf241ef0-3a11-4d75-8cc2-aab7b98cac35">11,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1b5e284b10548f2b4cea7ea557161f0_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM3LTYtMS0xLTA_03115437-40f2-473c-9c44-a3c541e3e2fc">3,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifef7b0e583964ad39d94daea6cea3366_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM3LTgtMS0xLTA_ceba1b87-3633-47bd-8744-c70985d422e9">32,139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia58c1f8d468c437393baf523e864a524_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM3LTEwLTEtMS0w_a776b4f2-8eca-4a0a-92e4-fe082b6d588b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0a43f969e6045adbb4d7a5ed18144fe_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM3LTEyLTEtMS0w_b06032a4-e235-4481-953a-42f1ee6e3cbc">47,564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e4f8878a34a4cb4bc6c14d692445406_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM3LTE0LTEtMS0w_9fe90ed7-927c-461c-bd1a-b315f7ee1b59">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e0a9e0b05964d5b81c4faaf9261f866_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM3LTE2LTEtMS0w_22eac0b8-e566-40d3-b4f2-2372b5a1cd7f">240,269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues - affiliated customers</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i664db88488f9454c91beba797474bd74_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM4LTItMS0xLTA_74c7dab8-1ac5-44fa-b658-651b6bb7835e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9899068118274125a66eb1295dc7f180_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM4LTQtMS0xLTA_39f015f8-5385-4a4e-b213-be764806d5d0">17,966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a850c94958453b97ee49874206807a_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM4LTYtMS0xLTA_a607bdb8-06ca-4a3b-952e-dad7c68d0864">6,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbca3a853c54c32a188e60371e49401_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM4LTgtMS0xLTA_dc304660-5225-4f11-9cf3-f5cba35ebdf8">42,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1401b070d66b4858bebfe8622b519047_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM4LTEwLTEtMS0w_5f6be02e-e67d-4a0c-a207-3f66435aa421">1,661</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e7b35ab4daa4d56a1ac8eed3dddbaa8_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM4LTEyLTEtMS0w_deeef42a-3cf2-4bcb-bca2-27a6ec2d6509">64,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c0c40f3739a4f6aa750404ae32e1139_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM4LTE0LTEtMS0w_00f4bf0a-3a56-41b0-99d9-297c21e50f0e">64,637</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c9b94d35868406a8c01569c6271992d_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM4LTE2LTEtMS0w_3f4b8d4b-c839-47ea-859b-a7d526c3fac6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment and other income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2cf4b896e2b44e084b69d51f3b09f38_D20190101-20191231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM5LTItMS0xLTA_32bdc3d7-0f3a-4e9c-bd87-fd71a792d68c">1,137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e31b11ef5824cbf953e4b36353741b6_D20190101-20191231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM5LTQtMS0xLTA_b510f746-cff2-49ad-ac91-272eec5df694">672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5775495e739143f9a2489ad44e260280_D20190101-20191231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM5LTYtMS0xLTA_d4b43573-7bcf-4b80-b9a4-f7f27f0495cf">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ba56749e5db4d4999936c411d19cea8_D20190101-20191231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM5LTgtMS0xLTA_5976c29f-933a-4c2f-861f-20f817078e59">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i143c69172b0543d3b4f8228cf2e657be_D20190101-20191231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM5LTEwLTEtMS0w_38ee8de4-3e7b-4318-95be-d33381e2ab57">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3e99423fe064b3f85abf9b78c7b60ef_D20190101-20191231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM5LTEyLTEtMS0w_5e259870-87d4-4862-a5ae-57b55fff7b29">749</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff8807e405c94f48aee4ee4cab179452_D20190101-20191231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM5LTE0LTEtMS0w_6bf19a70-3c58-40fb-8080-9e08d707f2af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM5LTE2LTEtMS0w_1d25b10c-0f01-47a4-99f3-ee0bd5534d4c">1,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2cf4b896e2b44e084b69d51f3b09f38_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQwLTItMS0xLTA_f40e0cf7-ad9e-451c-8b0b-c3ce56608bd5">193,842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e31b11ef5824cbf953e4b36353741b6_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQwLTQtMS0xLTA_c8409075-0c0e-4307-a5fb-960d908aa0b9">30,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5775495e739143f9a2489ad44e260280_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQwLTYtMS0xLTA_4f92c735-ecbf-4274-88cd-07bde335a006">10,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ba56749e5db4d4999936c411d19cea8_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQwLTgtMS0xLTA_6ed87383-37cd-49da-a7ea-fede9f64d749">74,288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i143c69172b0543d3b4f8228cf2e657be_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQwLTEwLTEtMS0w_ec44f9a4-16f2-4cbd-abf4-e0726785fcdf">1,661</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3e99423fe064b3f85abf9b78c7b60ef_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQwLTEyLTEtMS0w_5872ea9a-c0a8-452e-8af4-60fbfedca561">112,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff8807e405c94f48aee4ee4cab179452_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQwLTE0LTEtMS0w_e052aa19-20fe-403f-8a3c-1e6b8a1e4595">64,637</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQwLTE2LTEtMS0w_6098081e-cfa1-4278-9967-6240f0e1cf84">242,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2cf4b896e2b44e084b69d51f3b09f38_D20190101-20191231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQxLTItMS0xLTA_6c4eecf2-9819-4964-af5b-9edde8eb8116">10,326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e31b11ef5824cbf953e4b36353741b6_D20190101-20191231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQxLTQtMS0xLTA_da6d5d03-f85e-4730-9bdd-7b2aa4f25a4d">2,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5775495e739143f9a2489ad44e260280_D20190101-20191231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQxLTYtMS0xLTA_c0134d05-3bcf-4008-b663-a9649fa99ff8">2,494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ba56749e5db4d4999936c411d19cea8_D20190101-20191231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQxLTgtMS0xLTA_18d1199d-c7f8-4662-aa28-65e0cb8d1de5">3,902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i143c69172b0543d3b4f8228cf2e657be_D20190101-20191231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQxLTEwLTEtMS0w_19475784-1532-47a1-9c4c-972be69ea679">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3e99423fe064b3f85abf9b78c7b60ef_D20190101-20191231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQxLTEyLTEtMS0w_a3afee08-85ef-48e6-82cf-03108693efce">9,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff8807e405c94f48aee4ee4cab179452_D20190101-20191231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQxLTE0LTEtMS0w_f0cba4b1-d107-411d-99c1-f21c968fdafb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQxLTE2LTEtMS0w_af984955-3893-4e04-abfa-864d70f37752">19,685</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2cf4b896e2b44e084b69d51f3b09f38_D20190101-20191231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQyLTItMS0xLTA_4d82a3ab-0f40-4bb6-b440-b25d0510a350">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e31b11ef5824cbf953e4b36353741b6_D20190101-20191231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQyLTQtMS0xLTA_84352a66-d557-4c08-8585-f53d2aa0aa51">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5775495e739143f9a2489ad44e260280_D20190101-20191231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQyLTYtMS0xLTA_bf61889c-77fc-4f8a-8016-45853a53ff60">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ba56749e5db4d4999936c411d19cea8_D20190101-20191231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQyLTgtMS0xLTA_29f570d8-41d8-42f0-a0cd-cb7ee78dca2b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i143c69172b0543d3b4f8228cf2e657be_D20190101-20191231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQyLTEwLTEtMS0w_97cf3a7f-3cc1-4c60-a801-ba815dd61afc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3e99423fe064b3f85abf9b78c7b60ef_D20190101-20191231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQyLTEyLTEtMS0w_eceb5c98-c2df-4de4-8240-f0163b3f1815">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff8807e405c94f48aee4ee4cab179452_D20190101-20191231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQyLTE0LTEtMS0w_dc07fe14-bdd5-4d14-9e52-5a9c346c6d95">1,704</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQyLTE2LTEtMS0w_9050d5de-9e38-48dc-9b13-62f1494624e6">1,704</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2cf4b896e2b44e084b69d51f3b09f38_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQzLTItMS0xLTA_42b9fb70-b026-4df8-a5c6-2ab28005e0af">10,326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e31b11ef5824cbf953e4b36353741b6_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQzLTQtMS0xLTA_8d1c335f-642d-4714-92d7-7728a784a048">2,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5775495e739143f9a2489ad44e260280_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQzLTYtMS0xLTA_b1290d42-1e84-45f8-888a-1e87cb78072a">2,494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ba56749e5db4d4999936c411d19cea8_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQzLTgtMS0xLTA_24bc2d16-958b-420b-a6c8-a17c15fddaf3">3,902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i143c69172b0543d3b4f8228cf2e657be_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQzLTEwLTEtMS0w_1a312802-2593-4949-9b78-7463fb19b557">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3e99423fe064b3f85abf9b78c7b60ef_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQzLTEyLTEtMS0w_937f1ef4-bdbf-48c4-b6d0-3f0db327ddf6">9,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff8807e405c94f48aee4ee4cab179452_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQzLTE0LTEtMS0w_243732ea-6684-484c-bcba-217fda124720">1,704</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQzLTE2LTEtMS0w_df644d91-58e9-4e10-9cb8-6f314db68153">17,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29eb19ec363740be8a47282feb2589dd_I20191231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ0LTItMS0xLTA_b668330f-5d32-416a-b8de-5e1714a69abb">88,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i102814ed2a624a4287acce41b5fcf861_I20191231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ0LTQtMS0xLTA_b5a169e3-6388-4d40-94d2-8f7da449b616">40,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92959f478cee4d23a50a998881bfc026_I20191231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ0LTYtMS0xLTA_4fcfcded-11d8-4b43-bca6-92331f14858e">15,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id234ee9b314c4d5c9bfefe600cb9a7b9_I20191231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ0LTgtMS0xLTA_61b8809f-a0e7-456d-8f2c-22657f76d3b2">36,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf02709d1a9e4cd3a38c535c74010235_I20191231" decimals="-6" name="us-gaap:Assets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ0LTEwLTEtMS0w_d58b88d9-4cf0-44fb-8145-3fe377b0d689">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibddd22dd4e7e4da592ff5a6b614f587a_I20191231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ0LTEyLTEtMS0w_15844cda-ac7b-418e-86fd-c46063d2b7e1">91,971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i035eb292920443f587744a9f748e42c8_I20191231" decimals="-6" sign="-" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ0LTE0LTEtMS0w_efa4055b-0661-4837-966d-4cdd82da843c">6,332</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530caf840d4847f1ac553be5f7b336b2_I20191231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ0LTE2LTEtMS0w_e7f12190-9de0-4513-98fa-6d6d1269cb0b">173,889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property, equipment and capitalized software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2cf4b896e2b44e084b69d51f3b09f38_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ1LTItMS0xLTA_f3cb0f01-6330-4dab-9e87-4603edb64171">841</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e31b11ef5824cbf953e4b36353741b6_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ1LTQtMS0xLTA_625d8141-7614-48cb-85af-f82f1f4e06a3">573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5775495e739143f9a2489ad44e260280_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ1LTYtMS0xLTA_521299d0-c54b-4537-b2d3-9208dcd4bc5d">495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ba56749e5db4d4999936c411d19cea8_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ1LTgtMS0xLTA_e62dc54b-91e0-4aad-952e-fa7186e45cb4">162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i143c69172b0543d3b4f8228cf2e657be_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ1LTEwLTEtMS0w_8420682b-ae12-45e3-96a2-6462f14cc6a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3e99423fe064b3f85abf9b78c7b60ef_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ1LTEyLTEtMS0w_6b0b0061-dcee-4ec5-b6eb-0ca0f4dcaebc">1,230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff8807e405c94f48aee4ee4cab179452_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ1LTE0LTEtMS0w_eaece852-83be-43c8-85b1-3b181b555ef4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ1LTE2LTEtMS0w_ad652d7b-b426-4f4c-acea-52ed0606f887">2,071</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2cf4b896e2b44e084b69d51f3b09f38_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ2LTItMS0xLTA_eff207ed-3064-4689-99df-74a08eec509a">926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e31b11ef5824cbf953e4b36353741b6_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ2LTQtMS0xLTA_3cc526aa-6d35-48f4-aa20-9a97be354e40">565</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5775495e739143f9a2489ad44e260280_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ2LTYtMS0xLTA_adb2ec69-7baf-47be-ba28-4b433d65272c">672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ba56749e5db4d4999936c411d19cea8_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ2LTgtMS0xLTA_df4d5e25-d863-47d9-bc97-b3384f1ef11c">557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i143c69172b0543d3b4f8228cf2e657be_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ2LTEwLTEtMS0w_a91a74b6-1ec3-432a-8e40-064b7c7c70e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3e99423fe064b3f85abf9b78c7b60ef_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ2LTEyLTEtMS0w_b4636a2d-327f-4b3d-801d-5af5990bdf38">1,794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff8807e405c94f48aee4ee4cab179452_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ2LTE0LTEtMS0w_e5469910-45b9-472a-9c46-8898518451ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ2LTE2LTEtMS0w_943fe164-b7f0-46b0-90a6-f9cba6a8f98b">2,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_226"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;9.&#160;&#160;&#160;&#160;CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_229"></div><div style="margin-top:13.5pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;9A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONTROLS AND PROCEDURES </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES</span></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_232"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (Exchange Act) designed to provide reasonable assurance the information required to be disclosed by us in reports we file or submit under the Exchange Act is (i)&#160;recorded, processed, summarized and reported within the time periods specified in SEC rules&#160;and forms; and (ii)&#160;accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the filing of this Annual Report on Form 10-K, management evaluated, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of the design and operation of our disclosure controls and procedures as of December&#160;31, 2021. Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer concluded our disclosure controls and procedures were effective at the reasonable assurance level as of December&#160;31, 2021.</span></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_235"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes in our internal control over financial reporting during the quarter ended December&#160;31, 2021 which have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_238"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Management on Internal Control Over Financial Reporting as of December&#160;31, 2021 </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management of UnitedHealth Group Incorporated and Subsidiaries (the Company) is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934. The Company&#8217;s internal control system is designed to provide reasonable assurance to our management and board of directors regarding the reliability of financial reporting and the preparation of consolidated financial statements for external purposes in accordance with generally accepted accounting principles. The Company&#8217;s internal control over financial reporting includes those policies and procedures that (i)&#160;pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; (ii)&#160;provide reasonable assurance that transactions are recorded as necessary to permit preparation of consolidated financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (iii)&#160;provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company&#8217;s assets that could have a material effect on the consolidated financial statements. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management assessed the effectiveness of the Company&#8217;s internal control over financial reporting as of December&#160;31, 2021. In making this assessment, we used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control-Integrated Framework (2013). Based on our assessment and the COSO criteria, we believe that, as of December&#160;31, 2021, the Company maintained effective internal control over financial reporting. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s independent registered public accounting firm has audited the Company&#8217;s internal control over financial reporting as of December&#160;31, 2021, as stated in the </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_241">Report of Independent Registered Public Accounting Firm</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, appearing under Item&#160;9A. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_241"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM  </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the shareholders and the Board of Directors of UnitedHealth Group Incorporated and Subsidiaries:</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on Internal Control over Financial Reporting </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the internal control over financial reporting of UnitedHealth Group Incorporated and subsidiaries (the &#8220;Company&#8221;) as of December 31, 2021, based on criteria established in Internal Control &#8212; Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control &#8212; Integrated Framework (2013) issued by COSO. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements as of and for the year ended December 31, 2021, of the Company and our report dated February 15, 2022, expressed an unqualified opinion on those financial statements. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion  </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Report of Management on Internal Control Over Financial Reporting as of December 31, 2021. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control over Financial Reporting </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:42.105%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ DELOITTE&#160;&amp; TOUCHE LLP</span></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minneapolis, Minnesota</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 15, 2022</span></td></tr></table></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_244"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;9B. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER INFORMATION </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None. </span></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_2785"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">ITEM 9C.&#160;&#160;&#160;&#160;DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not Applicable.</span></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_247"></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_250"></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160; 10.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DIRECTORS OF THE REGISTRANT</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following sets forth certain information regarding our directors as of February 15, 2022, including their name and principal occupation or employment:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Richard T. Burke</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">F. William McNabb III</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and Chair<br/>Senior Connect Acquisition Corp.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Former Chairman and Chief Executive Officer <br/>The Vanguard Group, Inc.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Timothy P. Flynn</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valerie C. Montgomery Rice, M.D.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retired Chair<br/>KPMG International</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer<br/>Morehouse School of Medicine</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Paul. R Garcia</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">John H. Noseworthy, M.D.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retired Chair and Chief Executive Officer<br/>Global Payments Inc.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Former Chief Executive Officer and President</span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mayo Clinic</span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stephen J. Hemsley</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gail R. Wilensky, Ph.D.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chair<br/>UnitedHealth Group</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Fellow <br/>Project HOPE</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Michele J. Hooper</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Andrew P. Witty</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lead Independent Director<br/>UnitedHealth Group<br/>President and Chief Executive Officer<br/>The Directors&#8217; Council</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer<br/>UnitedHealth Group</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to General Instruction G(3) to Form 10-K and the Instruction to Item&#160;401 of Regulation S-K, information regarding our executive officers is provided in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_13">Part I, Item&#160;1</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> under the caption &#8220;Information About our Executive Officers.&#8221; </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted a code of ethics applicable to our principal executive officer and other senior financial officers, who include our principal financial officer, principal accounting officer, controller and persons performing similar functions. The code of ethics, entitled Code of Conduct: Our Principles of Ethics and Integrity, is posted on our website at www.unitedhealthgroup.com. For information about how to obtain the Code of Conduct, see </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_13">Part I, Item 1, &#8220;Business.&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We intend to satisfy the SEC&#8217;s disclosure requirements regarding amendments to, or waivers of, the code of ethics for our senior financial officers by posting such information on our website indicated above.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remaining information required by Items 401, 405, 406 and 407(c)(3), (d)(4) and (d)(5) of Regulation S-K will be included under the headings &#8220;Corporate Governance&#8221; and &#8220;Proposal 1-Election of Directors&#8221; in our definitive proxy statement for our 2022 Annual Meeting of Shareholders, and such required information is incorporated herein by reference. </span></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_253"></div><div style="margin-top:15pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160; 11.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE COMPENSATION </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by Items&#160;402 and 407(e)(4) and (e)(5) of Regulation S-K will be included under the headings &#8220;Executive Compensation,&#8221; &#8220;Director Compensation,&#8221; &#8220;Corporate Governance - Risk Oversight&#8221; and &#8220;Compensation Committee Interlocks and Insider Participation&#8221; in our definitive proxy statement for our 2022 Annual Meeting of Shareholders, and such required information is incorporated herein by reference. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_256"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:15pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160; 12.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Compensation Plan Information</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth certain information as of December 31, 2021, concerning shares of common stock authorized for issuance under all of our equity compensation plans:</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.435%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Plan category</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(a)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Number of securities</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">to be issued upon exercise of outstanding options, warrants and rights</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(b)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Weighted-average exercise price of outstanding options, warrants and rights</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(c)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Number of securities</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">remaining available for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">future issuance under</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">equity compensation plans (excluding securities reflected in column (a))</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation plans approved by shareholders </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation plans not approved by shareholders </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Consists of the UnitedHealth Group Incorporated 2020 Stock Incentive Plan, as amended and the UnitedHealth Group 1993 Employee Stock Purchase Plan, as amended.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Excludes 111,000 shares underlying stock options assumed by us in connection with acquisitions. These options have a weighted-average exercise price of $282 and an average remaining term of approximately 3 years. These options are administered pursuant to the terms of the plans under which the options originally were granted. No future awards will be granted under these acquired plans.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Includes 18 million shares of common stock available for future issuance under the 1993 Employee Stock Purchase Plan as of December 31, 2021, and 64 million shares available under the 2020 Stock Incentive Plan as of December 31, 2021. Shares available under the 2020 Stock Incentive Plan may become the subject of future awards in the form of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards and other stock-based awards.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by Item 403 of Regulation S-K will be included under the heading &#8220;Security Ownership of Certain Beneficial Owners and Management&#8221; in our definitive proxy statement for our 2022 Annual Meeting of Shareholders, and such required information is incorporated herein by reference.</span></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_259"></div><div style="margin-top:15pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160; 13.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by Items 404 and 407(a) of Regulation S-K will be included under the headings &#8220;Certain Relationships and Transactions&#8221; and &#8220;Corporate Governance&#8221; in our definitive proxy statement for our 2022 Annual Meeting of Shareholders, and such required information is incorporated herein by reference. </span></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_262"></div><div style="margin-top:15pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160; 14.&#160;&#160;&#160;&#160;PRINCIPAL ACCOUNTANT FEES AND SERVICES </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by Item&#160;9(e) of Schedule 14A will be included under the heading &#8220;Disclosure of Fees Paid to Independent Registered Public Accounting Firm&#8221; in our definitive proxy statement for our 2022 Annual Meeting of Shareholders, and such required information is incorporated herein by reference. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div><div style="margin-top:6pt"><span><br/></span></div></div><div><span><br/></span></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_265"></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_268"></div><div style="-sec-extract:summary;margin-top:3pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160; 15.&#160;&#160;&#160;&#160;EXHIBIT AND FINANCIAL STATEMENT SCHEDULES </span></div><div style="margin-top:4.5pt;padding-left:31.5pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. Financial Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements are included under Item&#160;8 of this report:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_76">Reports of Independent Registered Public Accounting Firm.</a></span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_79">Consolidated Balance Sheets as of December 31, 2021 and 2020.</a></span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_85">Consolidated Statements of Operations for the years ended December 31, 2021, 2020, and 2019.</a></span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_88">Consolidated Statements of Comprehensive Income for the years ended December 31, 2021, 2020, and 2019.</a></span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_91">Consolidated Statements of Changes in Equity for the years ended December 31, 2021, 2020, and 2019.</a></span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_97">Consolidated Statements of Cash Flows for the years ended December 31, 2021, 2020, and 2019.</a></span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_100">Notes to the Consolidated Financial Statements.</a></span></div><div style="margin-top:6pt;padding-left:31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. Financial Statement Schedules </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following financial statement schedule of the Company is included in Item&#160;15(c): </span></div><div style="margin-top:4.5pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_271">Schedule I - Condensed Financial Information of Registrant (Parent Company Only). </a></span></div><div style="margin-top:4.5pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All other schedules for which provision is made in the applicable accounting regulations of the SEC are not required under the related instructions, are inapplicable, or the required information is included in the consolidated financial statements, and therefore have been omitted.</span></div><div style="margin-top:4.5pt;padding-left:31.5pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The following exhibits are filed or incorporated by reference herein in response to Item&#160;601 of Regulation S-K. The Company files Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K pursuant to the Securities Exchange Act of 1934 under Commission File No. 1&#8209;10864.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EXHIBIT INDEX**</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.370%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176615000027/unhex31delawarecertificate.htm">3.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176615000027/unhex31delawarecertificate.htm">Certificate of Incorporation of UnitedHealth Group Incorporated (incorporated by reference to Exhibit 3.1 to UnitedHealth Group Incorporated&#8217;s Registration Statement on Form 8-A/A, Commission File No. 1-10864, filed on July 1, 2015)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/731766/000073176621000010/bylawsexhibit.htm">3.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176621000010/bylawsexhibit.htm">Amended and Restated Bylaws of UnitedHealth Group Incorporated, effective February 23, 2021 (incorporated by reference to Exhibit 3.2 to UnitedHealth Group Incorporated&#8217;s Current Report on Form 8-K filed on February 26, 2021)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/0001045969-99-000009.txt">4.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/0001045969-99-000009.txt">Senior Indenture, dated as of November 15, 1998, between United HealthCare Corporation and The Bank of New York (incorporated by reference to Exhibit 4.1 to UnitedHealth Group Incorporated&#8217;s Registration Statement on Form S-3/A, SEC File Number 333-66013, filed on January 11, 1999)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000091205701539251/a2063056zex-4_1.htm">4.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000091205701539251/a2063056zex-4_1.htm">Amendment, dated as of November 6, 2000, to Senior Indenture, dated as of November 15, 1998, between the UnitedHealth Group Incorporated and The Bank of New York (incorporated by reference to Exhibit 4.1 to UnitedHealth Group Incorporated&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2001)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312507171261/dex43.htm">4.3</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312507171261/dex43.htm">Instrument of Resignation, Appointment and Acceptance of Trustee, dated January 8, 2007, pursuant to the Senior Indenture, dated as of November 15, 1988, amended as of November 6, 2000, among UnitedHealth Group Incorporated, The Bank of New York and Wilmington Trust Company (incorporated by reference to Exhibit 4.3 to UnitedHealth Group Incorporated&#8217;s Quarterly Report on Form 10-Q for the quarter ended June&#160;30, 2007)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312508018563/dex41.htm">4.4</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312508018563/dex41.htm">Indenture, dated as of February 4, 2008, between UnitedHealth Group Incorporated and U.S. Bank National Association (incorporated by reference to Exhibit 4.1 to UnitedHealth Group Incorporated&#8217;s Registration Statement on Form S-3, SEC File Number 333-149031, filed on February 4, 2008)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176620000006/unhex4512312019.htm">4.5</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176620000006/unhex4512312019.htm">Description of Common Stock (incorporated by reference to Exhibit 4.5 to UnitedHealth Group Incorporated&#8217;s Annual Report on Form 10-K for the year ended December 31, 2019)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176620000029/exhibit41.htm">10.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176620000029/exhibit41.htm">UnitedHealth Group 2020 Stock Incentive Plan (incorporated by </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176620000029/exhibit41.htm">UnitedHealth Group 2020 Stock Incentive Plan (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Registration Statement on Form S-8, SEC File Number 333-238854, filed on June 1, 2020)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176620000029/0000731766-20-000029-index.htm"> </a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex10212312021.htm">10.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex10212312021.htm">Form of Agreement for Restricted Stock Unit Award to Executives under UnitedHealth Group Incorporated&#8217;s 2020 Stock Incentive Plan</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex10312312021.htm">10.3</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex10312312021.htm">Form of Agreement for Nonqualified Stock Option Award to Executives under UnitedHealth Group Incorporated&#8217;s 2020 Stock Incentive Plan</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.370%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex104123121.htm">10.4</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex104123121.htm">Form of Agreement for Performance-Based Restricted Stock Unit Award to Executives under UnitedHealth Group Incorporated&#8217;s 2020 Stock Incentive Plan</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex10512312021.htm">10.5</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex10512312021.htm">Form of Agreement for Restricted Stock Unit Award under UnitedHealth Group Incorporated&#8217;s 2020 Stock Incentive Plan (Witty)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex10612312021.htm">10.6</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex10612312021.htm">Form of Agreement for Nonqualified Stock Option Award under UnitedHealth Group Incorporated&#8217;s 2020 Stock Incentive Plan (Witty)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex10712312021.htm">10.7</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex10712312021.htm">Form of Agreement for Performance-Based Restricted Stock Unit Award under UnitedHealth Group Incorporated&#8217;s 2020 Stock Incentive Plan (Witty)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex108123121.htm">10.8</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex108123121.htm">Form of Agreement for Restricted Stock Unit Award under UnitedHealth Group Incorporated&#8217;s 2020 Stock Incentive Plan (Short)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhexhibit109.htm">10.9</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhexhibit109.htm">Form of Agreement for Nonqualified Stock Option Award under UnitedHealth Group Incorporated&#8217;s 2020 Stock Incentive Plan (Short)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhexhibit1010.htm">10.10</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhexhibit1010.htm">Form of Agreement for Performance-Based Restricted Stock Unit Award under UnitedHealth Group Incorporated&#8217;s 2020 Stock Incentive Plan (Short)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhexhibit1011.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhexhibit1011.htm">11</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhexhibit1011.htm">Form of Agreement for Deferred Stock Unit Award to Non-Employee Directors under UnitedHealth Group Incorporated&#8217;s 2020 Stock Incentive Plan</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176615000028/exhibit101.htm">10.12</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176615000028/exhibit101.htm">Form of Indemnification Agreement (incorporated by reference to Exhibit 10.1 to UnitedHealth Group Incorporated&#8217;s Current Report on Form 8-K filed on July 1, 2015)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312509025587/dex1012.htm">10.1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312509025587/dex1012.htm">3</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312509025587/dex1012.htm">Amended and Restated UnitedHealth Group Incorporated Executive Incentive Plan (2009 Statement), effective as of December 31, 2008 (incorporated by reference to Exhibit 10.12 to UnitedHealth Group Incorporated&#8217;s Annual Report on Form 10-K for the year ended December 31, 2008)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312509025587/dex1013.htm">10.1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312509025587/dex1013.htm">4</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312509025587/dex1013.htm">Amended and Restated UnitedHealth Group Incorporated 2008 Executive Incentive Plan, effective as of December 31, 2008 (incorporated by reference to Exhibit 10.13 to UnitedHealth Group Incorporated&#8217;s Annual Report on Form 10-K for the year ended December 31, 2008)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176613000005/unhex10111231201210k.htm">10.1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176613000005/unhex10111231201210k.htm">5</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176613000005/unhex10111231201210k.htm">Amendment, dated as of December 21, 2012, of Amended and Restated UnitedHealth Group Incorporated 2008 Executive Incentive Plan (incorporated by reference to Exhibit 10.11 to UnitedHealth Group Incorporated&#8217;s Annual Report on Form 10-K for the year ended December 31, 2012)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176615000049/unhex1039302015.htm">10.1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176615000049/unhex1039302015.htm">6</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176615000049/unhex1039302015.htm">Second Amendment, dated as of November 5, 2015, of Amended and Restated UnitedHealth Group Incorporated 2008 Executive Incentive Plan (incorporated by reference to Exhibit 10.3 to UnitedHealth Group Incorporated&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2015)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000013/unhex101112312020.htm">10.1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000013/unhex101112312020.htm">7</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000013/unhex101112312020.htm">UnitedHealth Group Executive Savings Plan (202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000013/unhex101112312020.htm">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000013/unhex101112312020.htm"> Statement)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000013/unhex101112312020.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000013/unhex101112312020.htm">(incorporated by reference to Exhibit 10.11 to UnitedHealth Group Incorporated&#8217;s Annual Report on Form 10-K for the year ended December 31, 2020)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000013/unhex101212312020.htm">10.1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000013/unhex101212312020.htm">8</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000013/unhex101212312020.htm">Summary of Non-Management Director Compensation, effective as of September 1, 2020</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000013/unhex101212312020.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000013/unhex101212312020.htm">(incorporated by reference to Exhibit 10.12 to UnitedHealth Group Incorporated&#8217;s Annual Report on Form 10-K for the year ended December 31, 2020)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312509025587/dex1018.htm">10.1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312509025587/dex1018.htm">9</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312509025587/dex1018.htm">UnitedHealth Group Directors&#8217; Compensation Deferral Plan (2009 Statement) (incorporated by reference to Exhibit 10.18 to UnitedHealth Group Incorporated&#8217;s Annual Report on Form 10-K for the year ended December 31, 2008)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312510027229/dex1020.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312510027229/dex1020.htm">20</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312510027229/dex1020.htm">Amendment to the UnitedHealth Group Directors&#8217; Compensation Deferral Plan, effective as of January 1, 2010 (incorporated by reference to Exhibit 10.20 to UnitedHealth Group Incorporated&#8217;s Annual Report on Form 10-K for the year ended December 31, 2009)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312510246111/dex102.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312510246111/dex102.htm">21</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312510246111/dex102.htm">First Amendment to UnitedHealth Group Directors&#8217; Compensation Deferral Plan (incorporated by reference to Exhibit 10.2 to UnitedHealth Group Incorporated&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2010)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176615000034/unh7232015catplansex43.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176615000034/unh7232015catplansex43.htm">22</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176615000034/unh7232015catplansex43.htm">Catamaran Corporation Third Amended and Restated Long-Term Incentive Plan, as amended (incorporated by reference to Exhibit 4.3 to UnitedHealth Group Incorporated&#8217;s Registration Statement on Form S-8, SEC File Number 333-205824, filed on July 23, 2015)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176615000034/unh7232015catplansex44.htm">10.2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176615000034/unh7232015catplansex44.htm">3</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176615000034/unh7232015catplansex44.htm">Catalyst Health Solutions, Inc. 2006 Stock Incentive Plan, as amended (incorporated by reference to Exhibit 4.4 to UnitedHealth Group Incorporated&#8217;s Registration Statement on Form S-8, SEC File Number 333-205824, filed on July 23, 2015)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312517044357/d314258dex44.htm">10.2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312517044357/d314258dex44.htm">4</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312517044357/d314258dex44.htm">Audax Health Solutions, Inc. 2010 Equity Incentive Plan, as amended (incorporated by reference to Exhibit 4.4 to UnitedHealth Group Incorporated&#8217;s Post-Effective Amendment No. 1 to Registration Statement on Form S-8, SEC File Number 333-205826, filed on February 15, 2017)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312517096410/d333512dex43.htm">10.2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312517096410/d333512dex43.htm">5</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312517096410/d333512dex43.htm">Surgical Care Affiliates, Inc. 2016 Omnibus Long-Term Incentive Plan (incorporated by reference to Exhibit 4.3 to UnitedHealth Group Incorporated&#8217;s Post-Effective Amendment No. 1 on Form S-8 to Registration Statement on Form S-4, SEC File Number 333-216153, filed on March 27, 2017)</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.370%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312517096410/d333512dex44.htm">10.2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312517096410/d333512dex44.htm">6</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312517096410/d333512dex44.htm">Surgical Care Affiliates, Inc. 2013 Omnibus Long-Term Incentive Plan (incorporated by reference to Exhibit 4.4 to UnitedHealth Group Incorporated&#8217;s Post-Effective Amendment No. 1 on Form S-8 to Registration Statement on Form S-4, SEC File Number 333-216153, filed on March 27, 2017)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312517096410/d333512dex45.htm">10.2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312517096410/d333512dex45.htm">7</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312517096410/d333512dex45.htm">Surgical Care Affiliates, Inc. Management Equity Incentive Plan (incorporated by reference to Exhibit 4.5 to UnitedHealth Group Incorporated&#8217;s Post-Effective Amendment No. 1 on Form S-8 to Registration Statement on Form S-4, SEC File Number 333-216153, filed on March 27, 2017)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312517096410/d333512dex46.htm">10.2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312517096410/d333512dex46.htm">8</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000119312517096410/d333512dex46.htm">Surgical Care Affiliates, Inc. Directors and Consultants Equity Incentive Plan (incorporated by reference to Exhibit 4.6 to UnitedHealth Group Incorporated&#8217;s Post-Effective Amendment No. 1 on Form S-8 to Registration Statement on Form S-4, SEC File Number 333-216153, filed on March 27, 2017)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1157377/000119312515222859/d941681dex101.htm">10.2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1157377/000119312515222859/d941681dex101.htm">9</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1157377/000119312515222859/d941681dex101.htm">The Advisory Board Company Amended and Restated 2009 Stock Incentive Plan (incorporated by reference to Exhibit 10.1 to The Advisory Board Company&#8217;s Current Report on Form 8-K filed on June 15, 2015)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1157377/000129993305006023/exhibit1.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1157377/000129993305006023/exhibit1.htm">30</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1157377/000129993305006023/exhibit1.htm">The Advisory Board Company 2005 Stock Incentive Plan (incorporated by reference to Exhibit 10.1 to The Advisory Board Company&#8217;s Current Report on Form 8-K filed on November 17, 2005)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176615000016/unhex1013312015.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176615000016/unhex1013312015.htm">31</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176615000016/unhex1013312015.htm">Amended and Restated Employment Agreement, effective as of December 1, 2014, between United HealthCare Services, Inc. and David Wichmann (incorporated by reference to Exhibit 10.1 to UnitedHealth Group Incorporated&#8217;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2015)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176617000045/unhex1029302017.htm">10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176617000045/unhex1029302017.htm">32</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176617000045/unhex1029302017.htm">Amendment to Employment Agreement, effective as of August 16, 2017, between United HealthCare Services, Inc. and David Wichmann (incorporated by reference to Exhibit 10.2 to UnitedHealth Group Incorporated&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2017)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176616000081/unhex1016302016.htm">10.3</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176616000081/unhex1016302016.htm">3</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176616000081/unhex1016302016.htm">Amended and Restated Employment Agreement, dated as of June 7, 2016, between United HealthCare Services, Inc. and John Rex (incorporated by reference to Exhibit 10.1 to UnitedHealth Group Incorporated&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2016)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000004/exhibit502.htm">10.3</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000004/exhibit502.htm">4</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000004/exhibit502.htm">Amended and Restate</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000004/exhibit502.htm">d</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000004/exhibit502.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000004/exhibit502.htm">Employment Agreement, </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000004/exhibit502.htm">dated</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000004/exhibit502.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000004/exhibit502.htm">February 3</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000004/exhibit502.htm">, 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000004/exhibit502.htm">21</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000004/exhibit502.htm">, between </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000004/exhibit502.htm">the </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000004/exhibit502.htm">Company</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000004/exhibit502.htm"> and Andrew</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000004/exhibit502.htm"> P</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000004/exhibit502.htm"> Witty (incorporated by reference to Exhibit </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000004/exhibit502.htm">5.02</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000004/exhibit502.htm"> to UnitedHealth Group Incorporated&#8217;s</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000004/exhibit502.htm"> Current</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000004/exhibit502.htm"> Report on Form </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000004/exhibit502.htm">8</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000004/exhibit502.htm">-K </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000004/exhibit502.htm">filed on Februa</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000004/exhibit502.htm">ry 8</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000004/exhibit502.htm">, 2021</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000731766/000073176621000004/exhibit502.htm">)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176620000006/unhex104412312019.htm">10.3</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176620000006/unhex104412312019.htm">5</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176620000006/unhex104412312019.htm">Amended and Restated Employment Agreement, effective as of March 16, 2015, between United HealthCare Services, Inc. and Dirk McMahon (incorporated by reference to Exhibit 10.44 to UnitedHealth Group Incorporated&#8217;s Annual Report on Form 10-K for the year ended December 31, 2019</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176620000006/unhex104412312019.htm">)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176620000006/unhex104412312019.htm"> </a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176620000006/unhex104512312019.htm">10.3</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176620000006/unhex104512312019.htm">6</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176620000006/unhex104512312019.htm">Amendment to Employment Agreement, effective as of May 31, 2017, between United HealthCare Services, Inc. and Dirk McMahon (incorporated by reference to Exhibit 10.45 to UnitedHealth Group Incorporated&#8217;s Annual Report on Form 10-K for the year ended December 31, 2019)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176620000006/unhex104612312019.htm">10.3</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176620000006/unhex104612312019.htm">7</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176620000006/unhex104612312019.htm">Amendment to Employment Agreement, effective as of March 12, 2019, between United HealthCare Services, Inc. and Dirk McMahon (incorporated by reference to Exhibit 10.46 to UnitedHealth Group Incorporated&#8217;s Annual Report on Form 10-K for the year ended December 31, 2019)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhexhibit1038.htm">10.38</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhexhibit1038.htm">Amended and Restated Employment Agreement, effective as of February 12, 2018, between United HealthCare Services, Inc. and Brian R. Thompson</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176614000008/unhex103412312013.htm">10.3</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176614000008/unhex103412312013.htm">9</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/731766/000073176614000008/unhex103412312013.htm">Employment Agreement, effective as of January 1, 2013, between United HealthCare Services, Inc. and Marianne D. Short (incorporated by reference to Exhibit 10.34 to UnitedHealth Group Incorporated&#8217;s Annual Report on Form 10-K for the year ended December 31, 2013)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhexhibit1040.htm">10.40</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhexhibit1040.htm">Amendment to Employment Agreement, effective as of June 5, 2018, between United HealthCare Services, Inc. and Marianne D. Short</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statement regarding computation of per share earnings (incorporated by reference to the information contained under the heading &#8220;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_160">Net Earnings Per Common Share</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; in Note 2 of Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements and Supplementary Data&#8221;)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex21112312021.htm">21.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex21112312021.htm">Subsidiaries of UnitedHealth Group Incorporated</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex23112312021.htm">23.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex23112312021.htm">Consent of Independent Registered Public Accounting Firm</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex24112312021.htm">24.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex24112312021.htm">Power of Attorney</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex31112312021.htm">31.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex31112312021.htm">Certifications pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex32112312021.htm">32.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="unhex32112312021.htm">Certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document. </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document. </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document.</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.370%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and embedded within Exhibit 101).</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">_______________________________________________</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:3.260%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.789%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denotes management contracts and compensation plans in which certain directors and named executive officers participate and which are being filed pursuant to Item&#160;601(b)(10)(iii)(A) of Regulation S-K.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pursuant to Item&#160;601(b)(4)(iii) of Regulation S-K, copies of instruments defining the rights of certain holders of long-term debt are not filed. The Company will furnish copies thereof to the SEC upon request.</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Financial Statement Schedule </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Schedule I - Condensed Financial Information of Registrant (Parent Company Only).</span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_271"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Schedule I </span></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the shareholders and the Board of Directors of UnitedHealth Group Incorporated and Subsidiaries: </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Financial Statement Schedule</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the consolidated financial statements of UnitedHealth Group Incorporated and Subsidiaries (the &#8220;Company&#8221;) as of December 31, 2021 and 2020, and for each of the three years in the period ended December 31, 2021, and the Company&#8217;s internal control over financial reporting as of December 31, 2021, and have issued our reports thereon dated February 15, 2022; such reports are included elsewhere in this Form 10-K. Our audits also included the financial statement schedule of the Company listed in the Index at Item 15. This financial statement schedule is the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statement schedule based on our audits. In our opinion, the financial statement schedule, when considered in relation to the consolidated financial statements taken as a whole, presents fairly, in all material respects, the information set forth therein.</span></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:42.105%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;DELOITTE &amp; TOUCHE LLP</span></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minneapolis, Minnesota</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 15, 2022</span></td></tr></table></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div><div style="margin-top:6pt"><span><br/></span></div></div><ix:nonNumeric contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231" name="us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90ZXh0cmVnaW9uOmU5NDlkMjQ5MzlkMjQ2M2RhY2UwNjc5OWQ0NWQ5YjRhXzE3OTY_c37a65f4-7163-4ab2-a226-0512d85b457e" continuedAt="icb02e125983542eb92023ce194e46b73" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Schedule I </span></div><ix:nonNumeric contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" name="srt:ScheduleOfCondensedBalanceSheetTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90ZXh0cmVnaW9uOmU5NDlkMjQ5MzlkMjQ2M2RhY2UwNjc5OWQ0NWQ5YjRhXzE3ODU_42b7df84-a3a8-44cb-aeea-0bcfd18ddd57" escape="true"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Financial Information of Registrant </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Parent Company Only) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealth Group </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Balance Sheets </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:67.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.982%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2749835a349545f38d76efb02e97a939_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzMtMi0xLTEtMA_8f42a967-9db9-44fa-97bd-ddf6bf084fbb">2,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzMtNC0xLTEtMA_2210ed6b-8bcb-4ccd-b4f4-aee584ef9ee5">258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2749835a349545f38d76efb02e97a939_I20211231" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzQtMi0xLTEtMA_c313db08-b0cb-46d8-b299-c48504f21a12">503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzQtNC0xLTEtMA_e9fe3590-55fa-459b-bdf4-5aced942cd30">562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2749835a349545f38d76efb02e97a939_I20211231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzUtMi0xLTEtMA_57dfb9f7-5bfb-47f1-8194-41601df45972">2,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231" decimals="-6" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzUtNC0xLTEtMA_d425f1c7-c997-4f9d-9c78-821c4b37e5cb">820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net assets of subsidiaries</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2749835a349545f38d76efb02e97a939_I20211231" decimals="-6" name="unh:EquityinNetAssetsofSubsidiaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzYtMi0xLTEtMA_8c46dabe-b2b1-48a4-95f7-b21565996a79">116,907</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231" decimals="-6" name="unh:EquityinNetAssetsofSubsidiaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzYtNC0xLTEtMA_0ac06439-22ea-429a-9d24-ce012771b050">107,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term notes receivable from subsidiaries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2749835a349545f38d76efb02e97a939_I20211231" decimals="-6" name="us-gaap:NotesReceivableRelatedPartiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzctMi0xLTEtMA_36149449-264e-4372-a23a-3c4fa01af4dd">5,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231" decimals="-6" name="us-gaap:NotesReceivableRelatedPartiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzctNC0xLTEtMA_b8f586de-2180-49d0-a65f-b011320b4cb9">5,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2749835a349545f38d76efb02e97a939_I20211231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzgtMi0xLTEtMA_09c3bd08-c6bd-4fd9-8ff0-52a31aa5de02">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzgtNC0xLTEtMA_d94a9797-bbd3-4035-93e8-d67db704d374">342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2749835a349545f38d76efb02e97a939_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzktMi0xLTEtMA_8d94d92b-641f-4a68-bef9-0e3fdcd87446">125,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzktNC0xLTEtMA_e8093adc-00eb-4d36-9fbe-edc512f9f625">113,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2749835a349545f38d76efb02e97a939_I20211231" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzEzLTItMS0xLTA_9b830aa0-0b29-4055-a976-eb570bb2bbcb">605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzEzLTQtMS0xLTA_9951c9e7-9022-4ba9-bc33-610a69c74373">589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of notes payable to subsidiaries</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2749835a349545f38d76efb02e97a939_I20211231" decimals="-6" name="us-gaap:NotesPayableRelatedPartiesClassifiedCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzE0LTItMS0xLTA_312e2c3b-6792-4e22-ada3-ee798a4d405f">8,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231" decimals="-6" name="us-gaap:NotesPayableRelatedPartiesClassifiedCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzE0LTQtMS0xLTA_bf3e03b7-f0d5-4c79-b187-b689fdb77c11">4,882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term borrowings and current maturities of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2749835a349545f38d76efb02e97a939_I20211231" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzE1LTItMS0xLTA_9e990061-3ea1-4788-9f5e-869b554e3a8f">3,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzE1LTQtMS0xLTA_58411851-048b-4021-bd20-a3e9108d2a06">4,465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2749835a349545f38d76efb02e97a939_I20211231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzE2LTItMS0xLTA_8b6592d6-9aa1-4efb-b457-3a3f6bc9562f">11,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzE2LTQtMS0xLTA_21c38f72-e1aa-4237-9ced-b371d9bc9d57">9,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, less current maturities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2749835a349545f38d76efb02e97a939_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzE3LTItMS0xLTA_b0b8113a-3b50-4e9b-852d-bccf09198151">41,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzE3LTQtMS0xLTA_87b6464a-e2a8-4a32-b09d-e06387fc9b45">37,815</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2749835a349545f38d76efb02e97a939_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzE5LTItMS0xLTA_a4e7f1e1-0f14-4518-834b-c109fc5a8c77">187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzE5LTQtMS0xLTA_b31896ed-7f46-49ba-8ada-73a5ff781c3d">655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2749835a349545f38d76efb02e97a939_I20211231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzIwLTItMS0xLTA_16ab621f-8a2f-4bc9-ae36-8b539d3dce1e">53,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzIwLTQtMS0xLTA_012a7175-2d51-40bc-a1b4-75134945134a">48,406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 4) </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders&#8217; equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $0.001 par value -10 shares authorized; no shares issued or outstanding</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2749835a349545f38d76efb02e97a939_I20211231" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzIzLTItMS0xLTA_b06e34b0-5ce2-4977-8852-be96e4094bfe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzIzLTQtMS0xLTA_38013886-a6d6-40c8-a402-c3399d0cec91">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $0.01 par value - 3,000 shares authorized; 941 and 946 issued and outstanding</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2749835a349545f38d76efb02e97a939_I20211231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzI0LTItMS0xLTA_a958c44b-efe1-4272-b278-a02c7d2c7714">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzI0LTQtMS0xLTA_51c33143-21c2-4400-9d9e-7481fdd17693">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2749835a349545f38d76efb02e97a939_I20211231" decimals="-6" name="us-gaap:AdditionalPaidInCapital" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzI1LTItMS0xLTA_8cbb0b1e-5677-4bb0-a57f-4f02e5f271f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231" decimals="-6" name="us-gaap:AdditionalPaidInCapital" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzI1LTQtMS0xLTA_1e53cacc-2321-4592-9dd5-4a19ffb8a280">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2749835a349545f38d76efb02e97a939_I20211231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzI2LTItMS0xLTA_8d2f7990-e15b-4101-bdc1-912f1d6d1dc7">77,134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzI2LTQtMS0xLTA_682f5306-b8b9-4553-8d6a-2706c90cb3e0">69,295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2749835a349545f38d76efb02e97a939_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzI3LTItMS0xLTA_90e65cb4-1499-4bd2-b137-665950935991">5,384</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzI3LTQtMS0xLTA_083ac841-4502-40f3-832e-d7a0d5e0ebbd">3,814</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total UnitedHealth Group shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2749835a349545f38d76efb02e97a939_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzI4LTItMS0xLTA_2fe72154-6c0d-443d-b856-b5cb307b61a0">71,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzI4LTQtMS0xLTA_389e2284-3ed9-415c-8a13-7552db387df7">65,491</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2749835a349545f38d76efb02e97a939_I20211231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzI5LTItMS0xLTA_1ad6147f-bba4-414c-b3a9-dc650dd379ac">125,289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzI5LTQtMS0xLTA_bd0004ec-4192-4dae-86cd-8aa6de6a32e0">113,897</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_277">Notes to the Condensed Financial Statements of Registrant</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div><div style="margin-top:6pt"><span><br/></span></div></div><ix:continuation id="icb02e125983542eb92023ce194e46b73" continuedAt="i22bfbb640f0c4d3982b0a81ee8ccc033"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Schedule I </span></div><ix:nonNumeric contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" name="srt:CondensedStatementOfComprehensiveIncomeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90ZXh0cmVnaW9uOmU5NDlkMjQ5MzlkMjQ2M2RhY2UwNjc5OWQ0NWQ5YjRhXzE3ODY_013c9138-7129-414f-bdc1-6a7b7f8bc62a" escape="true"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Financial Information of Registrant </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Parent Company Only) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealth Group </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Comprehensive Income </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:58.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment and other income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzMtMi0xLTEtMA_2521bcb1-9887-4fa2-9d96-fc0fb0a81df1">494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzMtNC0xLTEtMA_4a42d8c1-9540-46e1-8fa0-372104954b0a">194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzMtNi0xLTEtMA_7ffc3d1c-83db-4504-b437-5251ae59c603">209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzQtMi0xLTEtMA_c6d655ed-36e1-4ad2-82b1-7fbe14e66e29">494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzQtNC0xLTEtMA_14170c15-acbc-43e6-9ef3-506b5204406a">194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzQtNi0xLTEtMA_a753fbcb-97e3-49f3-b4f1-6a850d5d7643">209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" decimals="-6" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzYtMi0xLTEtMA_8af8d391-8bc3-463b-aca0-1c61bc8e4215">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231" decimals="-6" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzYtNC0xLTEtMA_f987059b-0918-4539-987a-40b888321d48">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231" decimals="-6" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzYtNi0xLTEtMA_f2319542-ae61-4e55-a0ba-565505f50bbc">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzctMi0xLTEtMA_c9222328-645b-4d20-99b6-c3778e90a108">1,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzctNC0xLTEtMA_8a38f196-9f15-48c7-b674-436d39ac280b">1,594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzctNi0xLTEtMA_4bc1bd7c-8f68-41e6-9c17-b4f8ad351b2f">1,580</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzgtMi0xLTEtMA_9053e383-d902-45e9-80f4-7f67ddaf652d">1,623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzgtNC0xLTEtMA_b55d75ec-b7f7-48a4-bf22-250ce31dceb5">1,621</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzgtNi0xLTEtMA_d46a0dbe-abe2-4297-a36f-2a6bbd65abbe">1,618</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzktMi0xLTEtMA_dc3f7fc4-0e7f-4246-8fbb-52c08e433f4c">1,129</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzktNC0xLTEtMA_7d3b4b1c-254d-49ec-8703-87ed44b1dbc6">1,427</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzktNi0xLTEtMA_aeceb625-cd8f-415c-a011-0c584b3db867">1,409</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzEwLTItMS0xLTA_2d486c83-259b-4dda-b663-f61e90f7816a">231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzEwLTQtMS0xLTA_dacb1b17-8453-42fb-9acf-4f2e47873a36">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzEwLTYtMS0xLTA_b4124b1c-f100-4bf5-a974-484489b42b7e">293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss of parent company</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" decimals="-6" name="unh:LossofParentCompany" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzExLTItMS0xLTA_a25809c8-6efa-4e3c-a701-0f2ca794cd95">898</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231" decimals="-6" name="unh:LossofParentCompany" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzExLTQtMS0xLTA_a30658f7-6ba2-413c-91a6-6746a551316c">1,127</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231" decimals="-6" name="unh:LossofParentCompany" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzExLTYtMS0xLTA_5452a617-e75b-482c-90a0-370e8fd73ee1">1,116</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in undistributed income of subsidiaries</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzEyLTItMS0xLTA_9d03e5ba-dfd4-45c7-a874-827896c16820">18,183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzEyLTQtMS0xLTA_a8c80c05-9342-418c-a83c-45cae0f0193a">16,530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzEyLTYtMS0xLTA_4e61be21-b41d-4929-8ffc-821347ffde63">14,955</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzEzLTItMS0xLTA_3c204f99-6205-4671-bc20-c50408de4e81">17,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzEzLTQtMS0xLTA_11e671f3-e542-48d0-b598-5766be6607e7">15,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzEzLTYtMS0xLTA_1315e030-20ce-4d3d-bb16-33c7ae2eae6d">13,839</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzE0LTItMS0xLTA_e183aa0a-c3fd-4d40-938a-253be223d231">1,570</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzE0LTQtMS0xLTA_26a76ab7-3ca9-451a-bd92-b7978e8cffb8">236</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzE0LTYtMS0xLTA_7f9f5c04-f2b7-43ef-a7a2-18d32bdbb471">582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzE1LTItMS0xLTA_0178ddbe-4d24-45e4-b599-a847e041f756">15,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzE1LTQtMS0xLTA_67dac72b-1eda-45a6-bec5-f4d3f8e55f41">15,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzE1LTYtMS0xLTA_f5e92953-c03f-4263-bf37-743693e6bba6">14,421</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_277">Notes to the Condensed Financial Statements of Registrant</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div><div style="margin-top:6pt"><span><br/></span></div></div><ix:continuation id="i22bfbb640f0c4d3982b0a81ee8ccc033" continuedAt="ida6406434af7467a97df2875e607822a"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Schedule I </span></div><ix:nonNumeric contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" name="srt:ScheduleOfCondensedCashFlowStatementTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90ZXh0cmVnaW9uOmU5NDlkMjQ5MzlkMjQ2M2RhY2UwNjc5OWQ0NWQ5YjRhXzE3ODk_1299aba0-4f25-4874-a652-2d46dcfc5b0f" escape="true"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Financial Information of Registrant </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Parent Company Only) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealth Group </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Cash Flows </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:65.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.297%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating activities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzMtMi0xLTEtMA_c9124d3a-742b-49ef-af08-bdacf3402595">11,439</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzMtNC0xLTEtMA_b91c9196-426b-47c0-9121-296a587f0a89">8,842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzMtNi0xLTEtMA_1ddc9e39-424f-43a5-a2d3-6e1cbc4c027b">9,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuances of notes to subsidiaries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:PaymentsToFundLongtermLoansToRelatedParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzUtMi0xLTEtMA_b68cd58e-9767-4b7a-9572-4ba8a77b35af">444</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:PaymentsToFundLongtermLoansToRelatedParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzUtNC0xLTEtMA_1c64732e-0810-41c5-9d52-e278ac1ed3a0">628</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:PaymentsToFundLongtermLoansToRelatedParties" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzUtNi0xLTEtMA_9b287ca2-1cb8-4482-89dc-3013047f8a1a">2,722</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of notes to subsidiaries</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromCollectionOfLongtermLoansToRelatedParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzYtMi0xLTEtMA_9f5d8bec-8186-4ec5-9bd4-e3c6c8b4774b">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromCollectionOfLongtermLoansToRelatedParties" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzYtNC0xLTEtMA_3aeba3c0-3357-478f-b06b-0f99701c467c">1,089</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromCollectionOfLongtermLoansToRelatedParties" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzYtNi0xLTEtMA_b6bd4e60-9cfa-45a5-beba-c99de606d81a">2,249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for acquisitions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzctMi0xLTEtMA_993c7bae-af84-4d01-aabe-adbcfb826bf1">4,953</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzctNC0xLTEtMA_a0843268-7790-438e-b27b-9355eaf50863">7,706</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzctNi0xLTEtMA_4e82eaf9-d38f-49bb-9563-6ed50e63f170">9,645</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return of capital to parent company</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromContributionsFromAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzgtMi0xLTEtMA_869f2c4d-e0d9-4e72-ace2-10cfe308a08d">245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromContributionsFromAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzgtNC0xLTEtMA_f0a84211-e985-4e07-91b6-c3104d0ee558">943</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromContributionsFromAffiliates" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzgtNi0xLTEtMA_6e123866-07fb-493c-887a-28fff6ad8a39">4,497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital contributions to subsidiaries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" decimals="-6" name="unh:Capitalcontributionstosubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzktMi0xLTEtMA_35c2a66e-920e-4f6c-9a92-f3d0e3587fb0">747</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231" decimals="-6" name="unh:Capitalcontributionstosubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzktNC0xLTEtMA_5241b6f1-8c14-421d-bb25-1987b686cb85">43</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231" decimals="-6" name="unh:Capitalcontributionstosubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzktNi0xLTEtMA_67635867-f998-4c5b-8673-0477680a1629">803</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzEwLTItMS0xLTA_7d944bc9-e28c-4414-bc46-fa22ac2720a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzEwLTQtMS0xLTA_d99618dd-0319-4c32-be38-82056a422648">143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzEwLTYtMS0xLTA_3538d727-4cd9-48d7-ae35-8e2c9eb21264">490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows used for investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzExLTItMS0xLTA_c3e0c03d-1c78-4b7d-8b4b-1dffba0648ca">5,862</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzExLTQtMS0xLTA_c51ae457-8796-4007-835b-a36e147dd198">6,202</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzExLTYtMS0xLTA_f88e511a-2a60-400e-abfa-02c5ec50f253">5,934</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock repurchases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzEzLTItMS0xLTA_6c337393-15df-448c-8f67-baa206396655">5,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzEzLTQtMS0xLTA_162b2cd2-ff23-4eca-8a74-4d8126ef4099">4,250</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzEzLTYtMS0xLTA_54527a19-a4fd-4abe-898f-67fb9fdd21fb">5,500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from common stock issuances</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzE0LTItMS0xLTA_9b718829-f2e6-4d59-8a7b-7b8e7e97e8e5">1,355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzE0LTQtMS0xLTA_52ebb8f7-884a-461d-8c2d-331179933a48">1,440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzE0LTYtMS0xLTA_f0943b68-d274-434e-b50e-d239c62b1f4a">1,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzE1LTItMS0xLTA_9ca112d0-5793-4dae-b5c4-af0a896d93e7">5,280</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzE1LTQtMS0xLTA_d64a08a2-73c2-4e3d-8f3d-d8dd98b8b3cd">4,584</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzE1LTYtMS0xLTA_747e6d9f-8d29-4b46-9eca-876493c4dbb8">3,932</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Repayments of) proceeds from short-term borrowings, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfCommercialPaper" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzE2LTItMS0xLTA_8f60d68f-6b67-4f07-b13f-d6f10d2b17a9">1,302</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfCommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzE2LTQtMS0xLTA_3adf331e-bcc1-4962-be13-a18469bbf489">872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfCommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzE2LTYtMS0xLTA_2e8eac05-d582-4602-a04c-7df60d3bfb34">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzE3LTItMS0xLTA_40ae7318-a850-4b70-be83-d77f5889c422">6,933</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzE3LTQtMS0xLTA_882ab5bd-2d14-4c4c-b98a-316c48b1630c">4,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzE3LTYtMS0xLTA_3d3d03d6-7595-44e2-aedf-6ac1cf68b91b">5,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzE4LTItMS0xLTA_03518a14-e8b3-4235-aaf8-89fe8270e0f0">3,150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzE4LTQtMS0xLTA_ae1e7bbc-273c-492e-8920-55657b5810cd">3,150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzE4LTYtMS0xLTA_0f7e1f5b-88b2-4206-8451-ddada8b24195">1,750</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from notes from subsidiaries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzE5LTItMS0xLTA_40ed537e-5400-43e8-9bd5-e123e3453576">3,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzE5LTQtMS0xLTA_88790039-40a5-4956-bb52-4c9e789f4b30">2,818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzE5LTYtMS0xLTA_310a7e0a-c2c4-4a76-ba7b-5e87d3927390">1,207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzIwLTItMS0xLTA_00926713-d085-470d-a5db-aa0f5272c32c">447</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzIwLTQtMS0xLTA_2199a129-894b-4f0f-922d-0d2f2885bb5f">438</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzIwLTYtMS0xLTA_f836b209-550b-42df-bec9-43001abb1d8a">535</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows used for financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzIxLTItMS0xLTA_fe181336-09ed-486e-b7eb-6415bd181708">3,668</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzIxLTQtMS0xLTA_3ccdb76d-0ae5-4065-b72e-5c2ea9aa974c">2,428</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzIxLTYtMS0xLTA_a59d9c6c-689b-4d6b-8c53-5cfeab694b34">3,729</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase (decrease) in cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzIyLTItMS0xLTA_f27511f0-71d1-4af5-9b35-7f6bb34b2cd5">1,909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231" decimals="-6" name="us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzIyLTQtMS0xLTA_f425def2-7fd3-4d1c-a616-048040e83687">212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzIyLTYtMS0xLTA_062e7d13-f716-4724-9dce-b658312bec97">388</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzIzLTItMS0xLTA_5c6c0449-f502-4ebe-972c-e5bfdf644d97">258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34c97cfea3194601b8f8a80d672db6f5_I20191231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzIzLTQtMS0xLTA_0132f8ba-8445-448a-ba9f-05cee7c6d0c1">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id83f942037b1489881b85513b8a2fbf4_I20181231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzIzLTYtMS0xLTA_333540e0-cfcb-4e4b-b545-23b8b21f5d8c">434</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents, end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2749835a349545f38d76efb02e97a939_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzI0LTItMS0xLTA_f06dda94-866b-4fb7-9e82-ec1415f92313">2,167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzI0LTQtMS0xLTA_e998ca51-3463-41c1-acfa-a5ab78e9b651">258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34c97cfea3194601b8f8a80d672db6f5_I20191231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzI0LTYtMS0xLTA_967a1485-de34-4650-b53a-f974f3c30f6f">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental cash flow disclosures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" decimals="-6" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzI3LTItMS0xLTA_d8053e68-3063-4fbf-b7cf-c7b8b593f45a">1,575</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231" decimals="-6" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzI3LTQtMS0xLTA_3ad66243-a966-4b1a-8add-a1b42975abc1">1,633</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231" decimals="-6" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzI3LTYtMS0xLTA_914ab45b-1a92-4dd1-9d25-a48dab4b5329">1,506</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzI4LTItMS0xLTA_a8841eb0-ceea-4866-bc1c-2ecda7c11415">3,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzI4LTQtMS0xLTA_581505f2-909b-435a-a974-501b46b7de24">4,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzI4LTYtMS0xLTA_b1c64d8f-dab7-4dfd-935f-b9fb91dd5ebc">2,590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:9pt;text-align:center"><ix:continuation id="ida6406434af7467a97df2875e607822a" continuedAt="i92d1c8d804944ed89b64e8316293f04e"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_277">Notes to the Condensed Financial Statements of Registrant</a></span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_277"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div><div style="margin-top:6pt"><span><br/></span></div></div><ix:continuation id="i92d1c8d804944ed89b64e8316293f04e" continuedAt="i3b55053be87a4c6b94e06b67ed5a4894"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Schedule I </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Financial Information of Registrant </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Parent Company Only) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealth Group </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Financial Statements </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzcvZnJhZzpiNzI2NGEwODkxY2U0YTJmYjkxNDMzZDVmOGNjNzI5MS90ZXh0cmVnaW9uOmI3MjY0YTA4OTFjZTRhMmZiOTE0MzNkNWY4Y2M3MjkxXzU5Mg_64f0693c-c9d1-4454-b9d7-ede806d2e415" continuedAt="i3e6b42e6ca2848609a03a5033293f158" escape="true">Basis of Presentation </ix:nonNumeric></span></div><div style="margin-top:4.5pt"><ix:continuation id="i3e6b42e6ca2848609a03a5033293f158"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealth Group&#8217;s parent company financial information has been derived from its consolidated financial statements and should be read in conjunction with the consolidated financial statements included in this Form&#160;10-K. The accounting policies for the registrant are the same as those described in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_106">Note 2 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements.</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_106">and Supplementary Data</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_106">.</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_106">&#8221;</a></span></ix:continuation></div></ix:continuation><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_280"></div><ix:continuation id="i3b55053be87a4c6b94e06b67ed5a4894" continuedAt="i06e9bd474bf149408ca7e6dfbcbe2b92"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" name="us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yODAvZnJhZzozODJjNzhkNzFlZmE0MDgxYjQxNTQwZWNkM2MzZDJhYS90ZXh0cmVnaW9uOjM4MmM3OGQ3MWVmYTQwODFiNDE1NDBlY2QzYzNkMmFhXzU1Ng_8137f2c6-cc99-4e34-9b94-ce411ce1d721" continuedAt="i65efd30b96a54870b3c2289b114e379c" escape="true">Subsidiary Transactions </ix:nonNumeric></span></div><div style="margin-top:6pt"><ix:continuation id="i65efd30b96a54870b3c2289b114e379c"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment in Subsidiaries. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealth Group&#8217;s investment in subsidiaries is stated at cost plus equity in undistributed earnings of subsidiaries.</span></ix:continuation></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends and Capital Distributions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cash dividends received from subsidiaries and included in Cash Flows from Operating Activities in the Condensed Statements of Cash Flows were $<ix:nonFraction unitRef="usd" contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" decimals="-8" name="us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yODAvZnJhZzozODJjNzhkNzFlZmE0MDgxYjQxNTQwZWNkM2MzZDJhYS90ZXh0cmVnaW9uOjM4MmM3OGQ3MWVmYTQwODFiNDE1NDBlY2QzYzNkMmFhXzM2NA_271fdb6f-2005-469e-88c5-3d99633c4527">10.8</ix:nonFraction> billion, $<ix:nonFraction unitRef="usd" contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231" decimals="-8" name="us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yODAvZnJhZzozODJjNzhkNzFlZmE0MDgxYjQxNTQwZWNkM2MzZDJhYS90ZXh0cmVnaW9uOjM4MmM3OGQ3MWVmYTQwODFiNDE1NDBlY2QzYzNkMmFhXzM2OA_c0e0bd15-b694-45de-8eb1-42bd530be181">10.0</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231" decimals="-8" name="us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yODAvZnJhZzozODJjNzhkNzFlZmE0MDgxYjQxNTQwZWNkM2MzZDJhYS90ZXh0cmVnaW9uOjM4MmM3OGQ3MWVmYTQwODFiNDE1NDBlY2QzYzNkMmFhXzM3NQ_aed135a9-1f70-4508-941c-d4809511c793">5.6</ix:nonFraction> billion in 2021, 2020 and 2019, respectively. Additionally, $<ix:nonFraction unitRef="usd" contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" decimals="-8" name="us-gaap:ProceedsFromContributionsFromAffiliates" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yODAvZnJhZzozODJjNzhkNzFlZmE0MDgxYjQxNTQwZWNkM2MzZDJhYS90ZXh0cmVnaW9uOjM4MmM3OGQ3MWVmYTQwODFiNDE1NDBlY2QzYzNkMmFhXzQzMA_4387ae37-7e49-47d8-a626-c912ccf4b200">0.2</ix:nonFraction> billion, $<ix:nonFraction unitRef="usd" contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231" decimals="-8" name="us-gaap:ProceedsFromContributionsFromAffiliates" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yODAvZnJhZzozODJjNzhkNzFlZmE0MDgxYjQxNTQwZWNkM2MzZDJhYS90ZXh0cmVnaW9uOjM4MmM3OGQ3MWVmYTQwODFiNDE1NDBlY2QzYzNkMmFhXzQzNA_79cb6386-1d87-453f-940e-fa9a9a1f4851">0.9</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231" decimals="-8" name="us-gaap:ProceedsFromContributionsFromAffiliates" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yODAvZnJhZzozODJjNzhkNzFlZmE0MDgxYjQxNTQwZWNkM2MzZDJhYS90ZXh0cmVnaW9uOjM4MmM3OGQ3MWVmYTQwODFiNDE1NDBlY2QzYzNkMmFhXzQ0MQ_e38be681-b671-4ec7-b12c-b7fcfb553a67">4.5</ix:nonFraction> billion in cash were received as a return of capital to the parent company during 2021, 2020 and 2019, respectively.</span></div></ix:continuation><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_283"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;<ix:continuation id="i06e9bd474bf149408ca7e6dfbcbe2b92" continuedAt="icc457a11e4f649739fb5e41f6302dbd2">Short-Term Borrowings and Long-Term Debt </ix:continuation></span></div><ix:continuation id="icc457a11e4f649739fb5e41f6302dbd2" continuedAt="ifaa6cf7601374cb39110fedff5edc9fb"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discussion of short-term borrowings and long-term debt can be found in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_193">Note 8 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_193"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_193">and Supplementary Data</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_193">.&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Long-term debt obligations of the parent company do not include other financing obligations at subsidiaries which totaled $<ix:nonFraction unitRef="usd" contextRef="i48f8f3c144a149269121679c024b2bfa_I20211231" decimals="-8" name="us-gaap:OtherLongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yODMvZnJhZzo5MzM5MDdkOWI4MGI0YWYwYmFlZDNmNzlkMmI2YTQ2My90ZXh0cmVnaW9uOjkzMzkwN2Q5YjgwYjRhZjBiYWVkM2Y3OWQyYjZhNDYzXzM2MA_99d78482-68df-4467-b174-eda3e75fab7f">1.4</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i7e1bde434ad049b7a20e4a7cd97ed39d_I20201231" decimals="-8" name="us-gaap:OtherLongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yODMvZnJhZzo5MzM5MDdkOWI4MGI0YWYwYmFlZDNmNzlkMmI2YTQ2My90ZXh0cmVnaW9uOjkzMzkwN2Q5YjgwYjRhZjBiYWVkM2Y3OWQyYjZhNDYzXzE2NDkyNjc0NDI0NDc_386638ce-6f52-4cbb-9a42-13bfce434445">1.2</ix:nonFraction> billion at December&#160;31, 2021 and 2020.</span></div><ix:nonNumeric contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yODMvZnJhZzo5MzM5MDdkOWI4MGI0YWYwYmFlZDNmNzlkMmI2YTQ2My90ZXh0cmVnaW9uOjkzMzkwN2Q5YjgwYjRhZjBiYWVkM2Y3OWQyYjZhNDYzXzY3MA_60e0735a-dc87-4f56-8687-d51dddba720c" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of short-term borrowings and long-term debt for the years ending December 31 are as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:87.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2749835a349545f38d76efb02e97a939_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yODMvZnJhZzo5MzM5MDdkOWI4MGI0YWYwYmFlZDNmNzlkMmI2YTQ2My90YWJsZTo0N2Y0MTk4ZmE3MzA0OTViOWQ1N2ZjN2VjZDk4NTliOS90YWJsZXJhbmdlOjQ3ZjQxOThmYTczMDQ5NWI5ZDU3ZmM3ZWNkOTg1OWI5XzEtMi0xLTEtMA_4b69056f-cc65-43d4-af76-535e66a3b465">3,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2749835a349545f38d76efb02e97a939_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yODMvZnJhZzo5MzM5MDdkOWI4MGI0YWYwYmFlZDNmNzlkMmI2YTQ2My90YWJsZTo0N2Y0MTk4ZmE3MzA0OTViOWQ1N2ZjN2VjZDk4NTliOS90YWJsZXJhbmdlOjQ3ZjQxOThmYTczMDQ5NWI5ZDU3ZmM3ZWNkOTg1OWI5XzItMi0xLTEtMA_29f9ed8e-9b02-48a8-8f1f-c3e3c235725d">2,125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2749835a349545f38d76efb02e97a939_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yODMvZnJhZzo5MzM5MDdkOWI4MGI0YWYwYmFlZDNmNzlkMmI2YTQ2My90YWJsZTo0N2Y0MTk4ZmE3MzA0OTViOWQ1N2ZjN2VjZDk4NTliOS90YWJsZXJhbmdlOjQ3ZjQxOThmYTczMDQ5NWI5ZDU3ZmM3ZWNkOTg1OWI5XzMtMi0xLTEtMA_1c913c9f-af5e-4b9e-96bb-11b4547c78cb">2,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2749835a349545f38d76efb02e97a939_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yODMvZnJhZzo5MzM5MDdkOWI4MGI0YWYwYmFlZDNmNzlkMmI2YTQ2My90YWJsZTo0N2Y0MTk4ZmE3MzA0OTViOWQ1N2ZjN2VjZDk4NTliOS90YWJsZXJhbmdlOjQ3ZjQxOThmYTczMDQ5NWI5ZDU3ZmM3ZWNkOTg1OWI5XzQtMi0xLTEtMA_e3b59378-5557-465f-a3b7-e973b83cf1bd">2,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2749835a349545f38d76efb02e97a939_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yODMvZnJhZzo5MzM5MDdkOWI4MGI0YWYwYmFlZDNmNzlkMmI2YTQ2My90YWJsZTo0N2Y0MTk4ZmE3MzA0OTViOWQ1N2ZjN2VjZDk4NTliOS90YWJsZXJhbmdlOjQ3ZjQxOThmYTczMDQ5NWI5ZDU3ZmM3ZWNkOTg1OWI5XzUtMi0xLTEtMA_64e9f9e5-4b87-473a-9cbb-73864034e1ea">2,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2749835a349545f38d76efb02e97a939_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yODMvZnJhZzo5MzM5MDdkOWI4MGI0YWYwYmFlZDNmNzlkMmI2YTQ2My90YWJsZTo0N2Y0MTk4ZmE3MzA0OTViOWQ1N2ZjN2VjZDk4NTliOS90YWJsZXJhbmdlOjQ3ZjQxOThmYTczMDQ5NWI5ZDU3ZmM3ZWNkOTg1OWI5XzYtMi0xLTEtMA_b1e83049-1ddc-4ae2-9699-cfd95d5ab8fc">32,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealth Group&#8217;s parent company had notes payable to subsidiaries of $<ix:nonFraction unitRef="usd" contextRef="i2749835a349545f38d76efb02e97a939_I20211231" decimals="-8" name="us-gaap:NotesPayable" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yODMvZnJhZzo5MzM5MDdkOWI4MGI0YWYwYmFlZDNmNzlkMmI2YTQ2My90ZXh0cmVnaW9uOjkzMzkwN2Q5YjgwYjRhZjBiYWVkM2Y3OWQyYjZhNDYzXzU3Mw_a36c449e-463c-41f0-9cf4-1a16dc8f0332">8.1</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231" decimals="-8" name="us-gaap:NotesPayable" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yODMvZnJhZzo5MzM5MDdkOWI4MGI0YWYwYmFlZDNmNzlkMmI2YTQ2My90ZXh0cmVnaW9uOjkzMzkwN2Q5YjgwYjRhZjBiYWVkM2Y3OWQyYjZhNDYzXzU4MA_9ffc4776-e0a4-473b-bbb1-b4e2d2b02908">4.9</ix:nonFraction> billion as of December 31, 2021 and 2020, respectively, which included on-demand features.</span></div></ix:continuation><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_286"></div><ix:continuation id="ifaa6cf7601374cb39110fedff5edc9fb"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.    Commitments and Contingencies</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain regulated subsidiaries are guaranteed by UnitedHealth Group&#8217;s parent company in the event of insolvency. UnitedHealth Group&#8217;s parent company also provides guarantees related to its service level under certain contracts. None of the amounts accrued, paid or charged to income for service level guarantees were material as of December&#160;31, 2021, 2020 or 2019.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a summary of commitments and contingencies, see </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_217">Note 12 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements.</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_217">and Supplementary Data</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_217">&#8221;</a></span></div></ix:continuation><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_289"></div><div style="margin-top:15pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160; 16.&#160;&#160;&#160;&#160;FORM 10-K SUMMARY</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><div id="i2ccd90ac94a94cd9ab3abb1e6abc40a5_292"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_7">Table of Contents</a></span></div><div style="margin-top:6pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated: February 15, 2022 </span></div><div style="margin-top:6pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:40.643%"><tr><td style="width:1.0%"></td><td style="width:9.331%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.469%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UNITEDHEALTH GROUP INCORPORATED</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NDREW</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> P. W</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ITTY</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Andrew P. Witty<br/>Chief Executive Officer</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:38.782%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.189%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Signature</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NDREW</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> P. W</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ITTY</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director and Chief Executive Officer<br/>(principal executive officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 15, 2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Andrew P. Witty</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;J</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OHN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> F. R</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EX</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief&#160;Financial&#160;Officer<br/>(principal financial officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 15, 2022</span></td></tr><tr style="height:18pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">John F. Rex</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HOMAS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> E. R</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OOS</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President and<br/>Chief Accounting Officer<br/>(principal accounting officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 15, 2022</span></td></tr><tr style="height:21pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Thomas E. Roos</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 15, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Richard T. Burke</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 15, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Timothy P. Flynn</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 15, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Paul R. Garcia</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 15, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stephen J. Hemsley</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 15, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Michele J. Hooper</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 15, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">F. William McNabb III</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 15, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valerie C. Montgomery Rice, M.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 15, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">John H. Noseworthy, M.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 15, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gail R. Wilensky, Ph.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:42.543%"><tr><td style="width:1.0%"></td><td style="width:9.896%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.904%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*By</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ANNETTE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> L. S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">MITH</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dannette L. Smith<br/>As Attorney-in-Fact</span></td></tr></table></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>2
<FILENAME>unhex10212312021.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i91e755d6a604444f893d1386b30ebf9e_33"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.2</font></div></div><div style="text-align:center"><img alt="uhglogo2019a022.jpg" src="uhglogo2019a022.jpg" style="height:71px;margin-bottom:5pt;vertical-align:text-bottom;width:404px"></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">RESTRICTED STOCK UNIT AWARD</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.666%"><tr><td style="width:1.0%"></td><td style="width:31.417%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.422%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.368%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.422%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Award Date</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(mm&#47;dd&#47;yyyy)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#GrantDate#</font></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Number of Units</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#QuantityGranted#</font></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Final Vesting Date</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(mm&#47;dd&#47;yyyy)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#GrantCustom2#</font></div></td></tr></table></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">THIS CERTIFIES THAT UnitedHealth Group Incorporated (the &#8220;Company&#8221;) has on the award date specified above (the &#8220;Award Date&#8221;) granted to</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#ParticipantName#</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(&#8220;Participant&#8221;) an award (the &#8220;Award&#8221;) to receive that number of restricted stock units (the &#8220;RSUs&#8221;) indicated above in the box labeled &#8220;Number of Units,&#8221; each RSU representing the right to receive one share of UnitedHealth Group Incorporated Common Stock, $.01 par value per share (the &#8220;Common Stock&#8221;), subject to certain restrictions and on the terms and conditions contained in this Award and the UnitedHealth Group Incorporated 2020 Stock Incentive Plan (the &#8220;Plan&#8221;).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Participant acknowledges and agrees that the Company may deliver, by electronic mail, the use of the Internet, including through the website of the agent appointed by the Compensation and Human Resources Committee of the Board of Directors of the Company (the &#8220;Committee&#8221;) to administer the Plan, the Company intranet web pages or otherwise, any information concerning the Company&#59; the Award&#59; the Plan, pursuant to which the Company granted the Award&#59; and any information required by the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A copy of the Plan is available upon request.  In the event of any conflict between the terms of the Plan and this Award certificate, the terms of the Plan shall govern.  Any terms not defined herein shall have the meaning set forth in the Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">* * * * *</font></div><div style="text-align:center"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt;text-decoration:underline">Rights of the Participant with Respect to the RSUs.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">No Shareholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The RSUs granted pursuant to this Award certificate do not and shall not entitle Participant to any rights of a shareholder of Common Stock, except as provided below.  The rights of Participant with respect to the RSUs shall remain forfeitable at all times prior to the date on which such rights become vested, and the restrictions with respect to the RSUs lapse, in accordance with Section 2, 3 or 4.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Conversion of RSUs&#59; Issuance of Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  No shares of Common Stock shall be issued to Participant prior to the date on which the RSUs vest, and the restrictions with respect to the RSUs lapse, in accordance with Section 2, 3 or 4.  Neither this Section 1(b) nor any action taken pursuant to or in accordance with this Section 1(b) shall be construed to create a trust of any kind.  After any RSUs vest pursuant to Section 2, 3 or 4, the Company shall promptly cause to be issued shares of Common Stock to Participant or in the name of Participant&#8217;s legal representatives, beneficiaries or heirs, as the case may be, in payment of such vested whole RSUs, at the times provided in Section 2, 3 or 4, as applicable.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Dividends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If a cash dividend is declared and paid by the Company with respect to the Common Stock, Participant shall be credited as of the applicable dividend payment date with an additional number of whole and&#47;or fractional RSUs (the &#8220;Dividend Units&#8221;) equal to (A) the total cash dividend Participant would have received had Participant&#8217;s RSUs (and any previously credited Dividend Units with respect thereto) been actual shares of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.2</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Common Stock, divided by (B) the Fair Market Value of a share of Common Stock as of the applicable dividend payment date.  As of each vesting date pursuant to Sections 2, 3 or 4, the number of Dividend Units paid on the RSUs vesting on such vesting date shall become vested, earned and payable in the form of shares of Common Stock&#59; provided, however, that any vested Dividend Units not converted into a whole share of Common Stock may be converted into a fractional Dividend Unit or a cash payment.  To the extent Participant&#8217;s rights to any unvested RSUs are forfeited, the Dividend Units paid on such forfeited RSUs shall also be forfeited.  The terms of this Award certificate shall apply to all Dividend Units paid on the RSUs.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Subject to the terms and conditions of this Award certificate, __% of the RSUs shall vest, and the restrictions with respect to the RSUs shall lapse, on each of the __________ anniversaries of the grant date if Participant remains continuously employed by the Company or any Affiliate until the respective vesting dates.  Any RSUs that vest pursuant to this Section 2 shall be paid to Participant no later than March 15th of the year following the year in which the vesting event occurs (which payment schedule is intended to comply with the &#8220;short-term deferral&#8221; exemption from the application of Section 409A of the Code).</font></div><div style="text-align:justify;text-indent:18pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt;text-decoration:underline">Early Vesting On Certain Terminations On or After Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Notwithstanding the other vesting provisions contained in Section 2 and Section 4, but subject to the other terms and conditions set forth herein, all of the RSUs shall become immediately and unconditionally vested if, on or within two years after the effective date of a Change in Control, the Participant ceases to be an employee of the Company or any Affiliate as a result of a termination of employment (i) by the Participant for Good Reason, (ii) by the Company or any Affiliate without Cause, (iii) at a time when Participant is eligible for Retirement (as defined below), (iv) due to Participant&#8217;s Disability (as defined below), or (v) in the circumstances described in Section 4(c)&#59; provided that in the case of a termination for Good Reason, the RSUs shall vest if the Participant gives written notice of the circumstances constituting Good Reason within two years after the effective date of the Change in Control, if the Company fails to cure the circumstances constituting Good Reason within 60 days of the receipt of such notice and the Participant resigns within 30 days after the end of the cure period, all as provided in Section 3(d).  Any RSUs that vest pursuant to this Section 3 shall be paid to Participant in a lump sum within thirty (30) days after the date of Participant&#8217;s Separation from Service.  For purposes of this Award&#58;</font></div><div style="text-align:justify;text-indent:18pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)         &#8220;Affiliate&#8221; shall mean (i) any entity that, directly or indirectly through one or more intermediaries, is controlled by the Company and (ii) any entity in which the Company has a significant equity interest, as determined by the Committee.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)        &#8220;Change in Control&#8221; shall mean the sale of all or substantially all of the Company&#8217;s assets or any merger, reorganization, or exchange or tender offer which, in each case, will result in a change in the power to elect 50% or more of the members of the Board of Directors of the Company&#59; provided, however, that such a sale, merger, or other event must also constitute either (i) a &#8220;change in the ownership&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(v), (ii) a &#8220;change in the effective control&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(vi)(A)(1) (replacing &#8220;30 percent&#8221; with &#8220;50 percent&#8221; as used in such regulation), or (iii) a change &#8220;in the ownership of a substantial portion of the assets&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(vii).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)         &#8220;Cause&#8221; shall mean Participant&#8217;s (a) material failure to follow the Company&#8217;s reasonable direction or to perform any duties reasonably required on material matters, (b) material violation of, or failure to act upon or report known or suspected violations of, the Company&#8217;s Code of Conduct, as may be amended from time to time, (c) conviction of any felony, (d) commission of any criminal, fraudulent, or dishonest act in connection with Participant&#8217;s employment, (e) breach of any of the Restrictive Covenants in Section 8 of this Award certificate or a material breach of any employment agreement between Participant and the Company or any Affiliate, if any, or (f) conduct that is materially detrimental to the Company&#8217;s interests.  The Company will, within 120 days of discovery of the conduct, give Participant written notice specifying the conduct constituting Cause in reasonable detail and Participant will have 60 days to remedy such conduct, if such conduct is reasonably capable of being remedied.  In any instance where the Company may have grounds for Cause, failure by the Company to provide written notice of the grounds for Cause within 120 days of discovery shall be a waiver of its right to assert the subject conduct as a basis for termination for Cause. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)       &#8220;Good Reason&#8221; shall mean the occurrence of any of the following without Participant&#8217;s written consent, in each case, when compared to the arrangements in effect immediately prior to the Change in Control&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.2</font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">any reduction in Participant&#8217;s base salary or target bonus expressed as a percentage of the Participant&#8217;s base salary, other than a reduction that is pursuant to a general reduction affecting a group of employees&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.8pt">a change in the principal location at which the Participant is required to perform his or her duties, if the new location is 50 miles or more further from the Participant&#8217;s principal residence than the original location&#59; or </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:21.03pt">a material diminution in Participant&#8217;s duties, responsibilities, or authority.</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant will, within 120 days of discovery of such circumstances, give the Company written notice specifying the circumstances constituting Good Reason in reasonable detail and, upon receipt of such notice, the Company shall have 60 days to cure the circumstances constituting Good Reason.  Failure by Participant to provide written notice of the grounds for Good Reason within 120 days of discovery, or failure by the Participant to resign within 30 days after the end of the Company&#8217;s 60 day cure period, shall be a waiver of Participant&#8217;s right to assert the subject circumstance as a basis for termination for Good Reason.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)          &#8220;Separation from Service&#8221; shall mean when Participant dies, retires, or otherwise has a termination of employment with the Company that constitutes a &#8220;separation from service&#8221; within the meaning of Treasury Regulation Section 1.409A-1(h)(1), without regard to the optional alternative definitions available thereunder.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)          </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Possible Acceleration of Vesting and Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If the Award is terminated pursuant to a Change in Control and is not assumed by a party to the Change in Control (and no such party issues a new award in substitution for the Award, as determined by the Committee), the Committee may provide for immediate vesting of the Award, and the issuance of shares of Common Stock, securities of a party to the Change in Control, or cash, or any combination thereof, in full satisfaction of the Award.  Notwithstanding anything in the Plan or any other agreement to the contrary, there is no discretion to change the time of payment of the RSUs (in connection with a Change in Control, similar event, or otherwise) except as expressly provided in this Section 3 or as otherwise permitted under, and would not result in any tax, penalty or interest under, Section 409A of the Code.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 409A - Possible Six-Month Delay in Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Notwithstanding any provision of this Award certificate to the contrary, if payment of the RSUs is triggered by Participant&#8217;s Separation from Service as provided in this Section 3 or Section 4 and, as of the date of such Separation from Service, Participant is a &#8220;specified employee&#8221; (within the meaning of Section 409A of the Code and determined pursuant to procedures adopted by the Company), Participant shall not be entitled to such payment of the RSUs until the earlier of (i) the date which is six (6) months after Participant&#8217;s Separation from Service for any reason other than death, or (ii) the date of Participant&#8217;s death.  Any amounts otherwise payable to Participant upon or in the six (6) month period following Participant&#8217;s Separation from Service that are not so paid by reason of this Section 3(g) shall be paid (without interest) as soon as practicable (and in all events within thirty (30) days) after the date that is six (6) months after Participant&#8217;s Separation from Service (or, if earlier, as soon as practicable, and in all events within thirty (30) days, after the date of Participant&#8217;s death).  The provisions of this Section 3(g) shall only apply if, and to the extent, required to avoid the imputation of any tax, penalty, or interest pursuant to Section 409A of the Code.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt;text-decoration:underline">Termination of Employment.</font></div><div style="text-align:justify;text-indent:-18pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Termination of Employment Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Except as expressly provided in Section 3 or this Section 4, if, prior to vesting of the RSUs pursuant to Section 2, Participant ceases to be an employee of the Company or any Affiliate for any reason (voluntary or involuntary), and does not continue after such cessation of service to be either an employee of the Company or any Affiliate, then Participant&#8217;s rights to all of the unvested RSUs shall be immediately and irrevocably forfeited on the date of termination.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(b)          </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Death or Permanent Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. If Participant dies while employed by the Company or any Affiliate, or if Participant receives disability benefits under the long-term disability insurance program of the Company or the Affiliate by which the Participant is employed for a period of at least three months (&#8220;Disability&#8221;), then all unvested RSUs shall become immediately vested, and the restrictions with respect to all of the RSUs shall </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.2</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">lapse, as of the date of such death or Disability.  Any RSUs that vest pursuant to this Section 4(b) shall be paid to Participant or Participant&#8217;s estate not later than 90 days after the date of such death or Disability.  Notwithstanding the foregoing, if the condition that results in Participant receiving Disability benefits is not a medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than 12 months, then the RSUs shall become immediately vested as provided above, but settlement shall be on the dates on which the RSUs would have vested under the original vesting schedule set forth in Section 2. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(c)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.  If Participant&#8217;s employment with the Company or any Affiliate terminates at a time when Participant is not eligible for Retirement (and other than due to Participant&#8217;s death or Disability) and, in the circumstances, Participant is entitled to severance or separation pay, the following provisions of this Section 4(c) will apply.  If Participant is entitled to severance under the Company&#8217;s severance pay plan as in effect on the date hereof, then the RSUs shall continue to vest, and the restrictions with respect to the RSUs shall continue to lapse, for the period of such severance that Participant is eligible to receive.  If Participant is entitled to severance under an employment agreement entered into with the Company or an Affiliate, then vesting of the RSUs, and lapsing of their restrictions, shall continue for the period of such severance that Participant would be entitled to receive under that agreement as of the date hereof.  If Participant is entitled to separation pay under a plan or agreement other than under the Company&#8217;s severance pay plan or an employment agreement entered into with the Company or an Affiliate, then vesting of the RSUs, and lapsing of their restrictions, shall continue for three months.  In any case, should Participant&#8217;s severance or separation pay be paid in a lump sum versus bi-weekly payments, the RSUs shall continue to vest for the period of time in which severance or separation pay would have been paid had it been paid bi-weekly.  Any RSUs that vest pursuant to this Section 4(c) shall be paid to Participant on the dates on which the RSUs would have vested under the original vesting schedule set forth in Section 2.  For avoidance of doubt, any RSUs that are unvested on the date of termination of Participant&#8217;s employment and do not vest under the schedule set forth in Section 2 during the applicable severance or separation pay period identified above in this Section 4(c) shall be forfeited.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(d)          </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Retirement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> If Participant ceases to be an employee of the Company or any Affiliate and Participant is eligible for Retirement at the time of such termination of employment, then the vesting of the RSUs shall continue as if such termination of employment had not occurred, subject to provisions set out in Section 7 below.  Any RSUs that vest pursuant to this Section 4(d) shall be paid to Participant on the dates on which the RSUs would have vested under the original vesting schedule set forth in Section 2.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(e)       For purposes of this Award certificate, &#8220;Retirement&#8221; means the termination of employment of a Participant who is age 55 or older with at least ten years of Recognized Employment with the Company or any Affiliate other than by reason of (i) death or Disability or (ii) Cause.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(f)         For purposes of this Award certificate, &#8220;Recognized Employment&#8221; shall include only employment since the Participant&#8217;s most recent date of hire by the Company or any Affiliate, and shall not include employment with a company acquired by the Company or any Affiliate before the date of such acquisition. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt;text-decoration:underline">Restriction on Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant may not transfer the RSUs except by will or by the laws of descent and distribution.  Notwithstanding the foregoing, the Award may be transferred to an alternate payee pursuant to the terms of a domestic relations order (as such terms are defined by Section 414(p) of the Code), provided that (i) the Participant is an employee at the time the domestic relations order is entered, (ii) the Award was outstanding at the time the domestic relations order is entered, and (iii) the transfer otherwise satisfies all requirements of the Plan and any limitations and requirements established by the Committee.  Any attempt to otherwise transfer the RSUs shall be void.</font></div><div style="text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt;text-decoration:underline">Special Restriction on Transfer for Certain Participants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant is an officer of the Company within the meaning of Section 16 of the Securities Exchange Act of 1934 and Rule 16a-1 issued thereunder, as such status is reasonably determined from time to time by the Board of Directors of the Company (a &#8220;Section 16 Officer&#8221;), at any time that shares of Common Stock are issued upon the vesting of RSUs and the Company has theretofore communicated Participant&#8217;s status as a Section 16 Officer to Participant, the following special transfer restrictions apply to Participant&#8217;s Award.  One-third (1&#47;3) of the net number of any shares of Common Stock acquired by Participant upon the vesting of RSUs at a time when Participant </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.2</font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">is a Section 16 Officer (including any shares of Common Stock or other securities into which such shares may be converted or exchanged as a result of any adjustment made pursuant to this Award or Section 7 of the Plan) must be retained, and may not be sold or otherwise transferred, for a period of at least one year following the applicable vesting date.  For purposes of this Award, the &#8220;net number of any shares of Common Stock acquired&#8221; shall mean the number of shares issued upon vesting of RSUs after reduction for any shares of Common Stock withheld by or tendered to the Company, or sold on the market, to cover any federal, state, local, or other payroll, withholding, income, or other applicable tax withholding required in connection with the issuance of the shares.  The restrictions of this Section 6 are in addition to, and not in lieu of, the restrictions imposed under other Company policies and applicable laws.</font></div><div style="text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt;text-decoration:underline">Forfeiture of RSUs and Shares of Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This Section 7 sets forth circumstances under which Participant shall forfeit all or a portion of the RSUs, or be required to repay the Company for the value realized in respect of all or a portion of the RSUs.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(a)          </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Violation of Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.  If Participant violates any provision of the Restrictive Covenants set forth in Section 8 below, then any unvested RSUs shall be immediately and irrevocably forfeited without any payment therefor.  In addition, for any RSUs that vested within one year prior to Participant&#8217;s termination of employment with the Company or any Affiliate or at any time after such termination of employment, the Participant shall be required, upon demand, to repay or otherwise reimburse the Company (including by forfeiting any deferred compensation credits in respect of such RSUs under the Company&#8217;s non-qualified compensation deferral plans) an amount having a value equal to the aggregate Fair Market Value of the shares of Common Stock underlying such RSUs on the date the RSUs became vested.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(b)          </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Fraud</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If the Board determines that Participant has engaged in fraud that, in whole or in part, caused the need for a material restatement of the Company&#8217;s consolidated financial statements, then any RSUs that have not yet been settled in shares of Common Stock (including any deferred compensation credits under the Company&#8217;s non-qualified compensation deferral plans in respect of RSUs that have previously become vested) shall be immediately and irrevocably forfeited without any payment therefore.  In addition, for any RSUs that became vested during the 12-month period following the first public issuance or filing with the Securities Exchange Commission (whichever occurs first) of the incorrect financial statements, Participant shall be required, upon demand, to repay or otherwise reimburse the Company (including by forfeiting any deferred compensation credits in respect of such RSUs under the Company&#8217;s non-qualified compensation deferral plans) an amount having a value equal to the aggregate Fair Market Value of the shares of Common Stock underlying such RSUs on the date the RSUs became vested.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(c)         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">In General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.  This Section 7 does not constitute the Company&#8217;s exclusive remedy for Participant&#8217;s violation of the Restrictive Covenants or commission of fraudulent conduct.  As the forfeiture and repayment provisions are not adequate remedies at law, the Company may seek any additional legal or equitable remedy, including injunctive relief, for any such violations, except that, if unvested RSUs continue to vest under Section 4 following the termination of Participant&#8217;s employment with the Company or any Affiliate, then, with respect to the Restrictive Covenants in Sections 8 (c) or (d) below, the maximum period of time to which Company shall be entitled to injunctive relief is a total of two (2) years following the termination of Participant&#8217;s employment with the Company or any Affiliate, not counting any time period that Participant is in violation of the Restrictive Covenants in Sections 8(c) or (d) below and during which time the running of the time periods for the restrictions set forth in Sections 8(c) and (d) of this Agreement shall be tolled as permitted by applicable law such that the running of the two (2) year time period shall commence only once Participant is in compliance with the Restrictive Covenants.  The provisions in this Section 7 are essential economic conditions to the Company&#8217;s grant of RSUs to Participant.  By receiving the grant of RSUs hereunder, Participant agrees that the Company may deduct from any amounts it owes Participant from time to time (such as wages or other compensation, deferred compensation credits, vacation pay, any severance or other payments owed following a termination of employment, as well as any other amounts owed to the Participant by the Company) to the extent of any amounts Participant owes the Company under this section.  The provisions of this Section 7 and any amounts repayable by Participant hereunder are intended to be in addition to any rights to repayment the Company may have under Section 304 of the Sarbanes-Oxley Act of 2002, Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and other applicable law.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.2</font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt;text-decoration:underline">Assignment and Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. In consideration of the terms of this Award certificate and the Company&#8217;s sharing of Confidential Information with the Participant, which the Participant agrees constitute adequate and sufficient mutually-agreed consideration, the Participant agrees to the Assignment and Restrictive Covenants set forth below in this Section 8. </font></div><div style="text-align:justify;text-indent:-18pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(a)          </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Assignment of Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Participant agree to assign and hereby assigns to Company all rights, titles and interests Participant may have in or to any invention, innovation, computer program, software, database, discovery, idea, writing, improvement, process, technique or other works (collectively &#34;Intellectual Property&#34;) whether or not patentable or registrable under copyright or similar statutes, created or conceived by Participant, either alone or jointly with others, during Participant&#8217;s employment that&#58; (i) relates in any manner to the actual or anticipated business, research, or development of Company&#59; (ii) results from work assigned to or performed by Participant for Company&#59; and&#47;or (iii) is conceived of or made with the use of Company systems, equipment, supplies, materials, facilities, computer programs, confidential information and&#47;or trade secret information (collectively &#8220;Company Resources&#8221;).  This assignment does not apply to Intellectual Property that meets all of the following criteria&#58; (i) no Company Resources were used in its creation&#59; (ii) the Intellectual Property was developed entirely on Participants own time&#59; (iii) at the time of conception or reduction to practice the Intellectual Property does not relate to Company&#8217;s business, actual or anticipated research or development&#59; and (iv) the Intellectual Property does not result from any work performed by Participant for Company.  Participant shall disclose to Company all Intellectual Property developed during Participant's employment so that Company may determine any rights it many have in such Intellectual Property. </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(b)          </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Non-Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.  Participant has or will be given access to and provided with sensitive, confidential, proprietary and&#47;or trade secret information (collectively, &#8220;Confidential Information&#8221;) in the course of Participant&#8217;s employment.  Examples of Confidential Information include inventions, new product or marketing plans, business strategies and plans, merger and acquisition targets, financial and pricing information, computer programs, source codes, models and data bases, analytical models, customer lists and information, and supplier and vendor lists and other information which is not generally available to the public.  Participant shall not disclose or use Confidential Information, either during or after Participant&#8217;s employment with the Company, except (i) as necessary to perform Participant&#8217;s duties, (ii) as the Company may consent in writing, or (iii) as permitted by Section 8(g) below.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(c)      </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Non-Solicitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. During Participant&#8217;s employment and for two years after the later of (i) the termination of Participant&#8217;s employment with the Company for any reason whatsoever or (ii) the last scheduled vesting date under Section 4, Participant shall not, without the Company&#8217;s prior written consent, directly or indirectly, for Participant or for any other person or entity, as agent, employee, officer, director, consultant, owner, principal, partner, shareholder, or in any other individual or representative capacity&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)       Solicit or conduct business with any business competitive with the Company from any person or entity&#58; (A) who was a Company provider or customer within the 12 months before Participant&#8217;s employment termination and with whom Participant had contact regarding the Company&#8217;s activity, products or services, or for whom Participant provided services or supervised employees who provided those services, or about whom Participant learned Confidential Information during employment related to the Company&#8217;s provision of products and services to such person or entity, or (B) was a prospective provider or customer the Company solicited within the 12 months before Participant&#8217;s employment termination and with whom Participant had contact for the purposes of soliciting the person or entity to become a provider or customer of the Company, or supervised employees who had those contacts, or about whom Participant learned Confidential Information during employment related to the Company&#8217;s provision of products and services to such person or entity&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)         Raid, hire, employ, recruit or solicit any Company employee or consultant who possesses Confidential Information of the Company to leave the Company&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.2</font></div></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iii)    Induce or influence any Company employee, consultant, or provider who possesses Confidential Information of the Company to terminate his, her or its employment or other relationship with the Company&#59; or</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iv)        Assist anyone in any of the activities listed above.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(d)      </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Non-Competition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.  During Participant&#8217;s employment and for one year after the later of (i) the termination of Participant&#8217;s employment with the Company for any reason whatsoever or (ii) the last scheduled vesting date under Section 4, Participant shall not, without the Company&#8217;s prior written consent, directly or indirectly, for Participant or for any other person or entity, as agent, employee, officer, director, consultant, owner, principal, partner, shareholder, or in any other individual or representative capacity&#58;</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)       Engage in or participate in any activity that competes, directly or indirectly, with any Company activity, product or service that Participant engaged in, participated in, or had Confidential Information about during Participant&#8217;s last 36 months of employment with the Company&#59; or</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)         Assist anyone in any of the activities listed above.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(e)          </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Geographic Scope</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)           Participant&#8217;s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">obligations under subsections 8(c) and (d) of this &#8220;Assignments and Restrictive Covenants&#8221; section shall apply on a nationwide basis anywhere in the United States.</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)          Participant&#8217;s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">obligations under this &#8220;Assignments and Restrictive Covenants&#8221; section shall also apply in any country outside the United States with respect to which Participant had responsibility for any UnitedHealth Group activity, product or service in that country.  </font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(f)         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Return of Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Participant agrees that all tangible materials (whether originals or duplicates), including, but not limited to, notebooks, computers, files, reports, proposals, price lists, lists of actual or potential customers or suppliers, talent lists, formulae, prototypes, tools, equipment, models, specifications, technical data, methodologies, research results, test results, financial data, contracts, agreements, correspondence, documents, computer disks, software, computer printouts, information stored electronically, memoranda, and notes, in Participant&#8217;s possession, custody, or control which in any way relate to the Company&#8217;s business and which are furnished to Participant by or on behalf of the Company or which are prepared, compiled or acquired by Participant while working with or employed by the Company shall be the sole property of the Company.  At any time upon the request of the Company, and in any event promptly upon termination of Participant&#8217;s employment with the Company, but in any event no later than two (2) business days after such termination, Participant shall deliver all such materials to the Company and shall not retain any originals or copies (including electronically) of such materials.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(g)          </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">No Restriction on Protected Activities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Nothing in this Award certificate prohibits Participant from disclosing information in good faith to any governmental agency, legislative body, or official regarding an alleged violation of law or regulation or otherwise protected under applicable law, including, without limitation, the National Labor Relations Act, the Defend Trade Secrets Act, and any rule or regulation promulgated by the Securities and Exchange Commission, the National Labor Relations Board, the Equal Employment Opportunity Commission, or any other federal, state, or local government agency.  Participant acknowledges that, through this Section 8(g), the Company has provided Participant with written notice that, pursuant to the Defend Trade Secrets Act, 8 USC &#167; 1833(b), an employee, consultant, or contractor of an employer may not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of an employer&#8217;s trade secrets, so long as such disclosure is made solely&#58; (a) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating a suspected violation of law&#59; and&#47;or (b) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.  Additionally, Participant understands that, pursuant to 18 USC &#167; 1831 et seq., an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose a trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual files any document </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.2</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order.  The foregoing immunities provided under 18 USC &#167; 1831 et seq. do not apply to any disclosure of Confidential Information or trade secrets of an employer&#8217;s clients, customers, or counterparties, or of any other third parties. For purposes of this paragraph solely, &#8220;trade secret&#8221; has the meaning set forth in 18 USC &#167; 1839.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(h)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Exceptions for Attorneys</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.  Notwithstanding the foregoing, this Section 8 will apply only to the extent permissible under provisions of the ABA Model Rules of Professional Conduct, or any applicable state counterpart regarding restrictions on the right to practice law.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(i)          </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Acknowledgment of Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. By accepting the Award, Participant agrees that the provisions of this Section 8 are reasonable and necessary to protect the legitimate interests of the Company.  Participant further acknowledges that Participant&#8217;s obligations under this Section 8 are in addition to, and do not limit, any and all obligations concerning the same subject matter arising under any applicable law, including, without limitation, common law and statutory law relating to fiduciary duties and trade secrets.  To the extent Participant and the Company agree at any time to enter into separate agreements containing restrictive covenants or assignment of intellectual property with different or inconsistent terms than those contained herein, Participant and the Company acknowledge and agree that such different or inconsistent terms shall not in any way affect or have relevance to the Assignment and Restrictive Covenants contained herein.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt;text-decoration:underline">Adjustments to RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In the event that any dividend or other distribution (whether in the form of cash,  shares of Common Stock, other securities, or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase, or exchange of Common Stock or other securities of the Company or other similar corporate transaction or event affecting the Common Stock would be reasonably likely to result in the diminution or enlargement of any of the benefits or potential benefits intended to be made available under the Award (including, without limitation, the benefits or potential benefits of provisions relating to the vesting of the RSUs), the Committee shall, in such manner as it shall deem equitable or appropriate in order to prevent such diminution or enlargement of any such benefits or potential benefits, make adjustments to the Award, including adjustments in the number and type of shares of Common Stock Participant would have received upon vesting of the RSUs.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.5pt;text-decoration:underline">Tax Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(a)          </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Withholdings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> In order to comply with all applicable federal, state, and local tax laws or regulations, the Company may take such action as it deems appropriate to ensure that all applicable federal, state, and local payroll, withholding, income, or other taxes, which are the sole and absolute responsibility of Participant, are withheld or collected from Participant.  Participant is liable and responsible for all taxes owed in connection with the Award, regardless of any action the Company takes with respect to any tax withholding obligations that arise in connection with the Award.  The ultimate tax liability, which is the Participant&#8217;s responsibility, may exceed the amount withheld by the Company.  On each applicable vesting date, Participant will be deemed to have elected to satisfy Participant&#8217;s required federal, state, and local payroll, withholding, income, or other tax withholding obligations arising from the receipt of shares or the lapse of restrictions relating to the RSUs, by having the Company withhold a portion of the shares of Common Stock otherwise to be delivered having a Fair Market Value equal to the amount of such taxes (but not in excess of the maximum amount required to be withheld under applicable laws or regulations).</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(b)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.  It is intended that this Award and any amounts payable under this Award shall either be exempt from or comply with Section 409A of the Code (including the Treasury regulations and other published guidance relating thereto) so as not to subject Participant to payment of any additional tax, penalty, or interest imposed under Section 409A of the Code.  The provisions of this Award certificate shall be construed and interpreted to avoid the imputation of any such additional tax, penalty, or interest under Section 409A of the Code yet preserve (to the nearest extent reasonably possible) the intended benefit payable to Participant.  To the extent that the time or form of payment of any benefit pursuant to this Award would violate the terms of Section 409A, the Committee may revise the time or form of payment to conform to Section 409A.  Notwithstanding the foregoing, in no event shall the Company, any Affiliate, the members of the Committee, or any other person have any liability for any additional tax, penalty or interest imposed on Participant by reason of Section 409A or otherwise.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.2</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.5pt;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(a)          </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">At-Will Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.  This Award certificate does not confer on Participant any right to continued employment or any other relationship with the Company or any Affiliate, nor will it interfere in any way with the right of the Company to terminate Participant at any time.  Participant&#8217;s employment with the Company is at will.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(b)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">No Trust or Fiduciary Relationship</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.  Neither the Plan nor this Award certificate shall create or be construed to create a trust or separate fund of any kind or a fiduciary relationship between the Company or any Affiliate and Participant or any other person.  To the extent that any person acquires a right to receive payments from the Company or any Affiliate pursuant to an Award, such right shall be no greater than the right of any unsecured creditor of the Company or any Affiliate.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(c)          </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Securities Law Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company shall not be required to deliver any shares of Common Stock upon the vesting of any RSUs until the requirements of any federal or state securities laws, rules, or regulations or other laws or rules (including the rules of any securities exchange) as may be determined by the Company to be applicable have been and continue to be satisfied (including an effective registration of the shares under federal and state securities laws).</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(d)          </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Original Instrument</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.  An original record of this Award certificate and all the terms hereof, executed by the Company, is held on file by the Company.  To the extent there is any conflict between the terms contained in any copy of this Award certificate and the terms contained in the original held by the Company, the terms of the original held by the Company shall control.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(e)          </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Survival of Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.  The Restrictive Covenants in Section 8 of this Award certificate and the provisions regarding the forfeiture of RSUs and shares of Common Stock shall survive termination of the RSUs and termination of Participant&#8217;s relationship with the Company as set forth in Section 8.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(f)          </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Choice of Law, Injunctive Relief, Attorney&#8217;s Fees and Jury Trial</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Participant consents to the law of Minnesota exclusively being applied to any matter arising out of or relating to this Award certificate, without regard to its conflict of law principles, and exclusively to personal and subject matter jurisdiction in the state and federal courts of Minnesota for any dispute relating to this Award certificate or Participant&#8217;s relationship with the Company.  In the event of a breach or a threatened breach of this Award by Participant, Participant acknowledges that the Company will face irreparable injury which may be difficult to calculate in dollar terms and that the Company shall be entitled, in addition to remedies otherwise available at law or in equity, to temporary restraining orders and preliminary injunctions and final injunctions without the posting of a bond enjoining such breach or threatened breach.  Should the Company successfully enforce any portion of this Award certificate before a trier of fact or in an arbitration proceeding, the Company shall be entitled to all of its reasonable attorney&#8217;s fees and costs incurred as a result of enforcing this Award certificate against Participant. Participant waives all rights or entitlement to a jury trial for any matter arising out of or relating to this Award certificate.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(g)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">No Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.  No waiver of any breach of any provision of this Award certificate by the Company shall be effective unless it is in writing, and no waiver shall be construed to be a waiver of any succeeding breach or as a modification of such provision.  The provisions of this Award certificate shall be severable, and if any provision of this Award certificate is found by any court or arbitrator to be unenforceable, in whole or in part, the remainder of this Award certificate shall nevertheless be enforceable and binding on the parties.  Participant also agrees that a court or arbitrator may modify any invalid, overbroad or unenforceable term of this Award certificate so that such term, as modified, is valid and enforceable under applicable law, and that a court or arbitrator is authorized to extend the length of the Restrictive Covenants in Section 8 of this Award certificate for any period of time in which Participant is in breach of the Restrictive Covenants or as necessary to protect the legitimate business interests of Company. Further, Participant affirmatively states that Participant has not, will not, and cannot rely on any representations not expressly made herein.  The terms of this Award certificate shall not be amended by Participant or Company except by the express written consent of the Company and Participant.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(h)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Consideration Period&#59; Right to Consult with Counsel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  By the Participant&#8217;s acceptance below, the Participant acknowledges and agrees that the Company provided the Participant with at least ten (10) business days to review and consider this Award certificate and that voluntarily accepting this Award certificate before the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.2</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">expiration of ten (10) business days shall serve as a waiver of the ten (10) day review period. The Participant has the right and is advised to consult with counsel of his&#47; her choice before signing this document.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(i)          </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Assignability and Change of Position</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.  The rights and&#47;or obligations herein may be assigned by the Company without Participant&#8217;s consent and shall bind and inure to the benefit of the Company&#8217;s successors, assigns, and representatives.  If the Company makes any assignment of the rights and&#47;or obligations herein, Participant agrees that this Award certificate shall remain binding upon Participant in any event.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Offer Date&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#GrantDate#</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By</font><img alt="image.jpg" src="image.jpg" style="height:43px;margin-bottom:5pt;vertical-align:text-bottom;width:128px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, on behalf of UnitedHealth Group Incorporated</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Acceptance Date&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#AcceptanceDate#</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Signed Electronically&#47;Signed Manually&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#Signature#</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>3
<FILENAME>unhex10312312021.htm
<DESCRIPTION>EX-10.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i300ed6b634b34bdcb2dcebf02a28c913_33"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.3</font></div></div><div style="text-align:center"><img alt="uhglogo2019a023.jpg" src="uhglogo2019a023.jpg" style="height:71px;margin-bottom:5pt;vertical-align:text-bottom;width:404px"></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">NONQUALIFIED STOCK OPTION AWARD</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.743%"><tr><td style="width:1.0%"></td><td style="width:15.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.792%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.689%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Award Date</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(mm&#47;dd&#47;yyyy)</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#GrantDate#</font></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Option Shares</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">#QuantityGranted#</font></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Exercise Price</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">$</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">#GrantPrice#</font></div><div style="text-align:center"><font><br></font></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Expiration Date</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(mm&#47;dd&#47;yyyy)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#ExpirationDate#</font></div></td></tr></table></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">THIS CERTIFIES THAT UnitedHealth Group Incorporated (the &#8220;Company&#8221;) has on the award date specified above (the &#8220;Award Date&#8221;) granted to</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#ParticipantName#</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(the &#8220;Participant&#8221;) the option (the &#8220;Option&#8221;) to purchase that number of shares of UnitedHealth Group Incorporated Common Stock, $.01 par value per share (the &#8220;Common Stock&#8221;), indicated above (the &#8220;Option Shares&#8221;). The Option that this Award represents will expire on the expiration date indicated above (the &#8220;Expiration Date&#8221;), unless it is terminated prior to that time in accordance with this Award. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Option Shares represented by this Award shall become exercisable as follows&#58;  __% on each of the __________ anniversaries, unless the Option shall have terminated or the vesting shall have accelerated as provided in this Award. Once the Option has become exercisable for all or a portion of the Option Shares, it will remain exercisable for all or such portion of the Option Shares, as the case may be, until the Option expires or is terminated as provided in this Award. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By accepting this Award, the Participant acknowledges that the Participant will not have any of the rights of a shareholder with respect to the Option Shares until the Option has been duly exercised and the exercise price indicated above (the &#8220;Exercise Price&#8221;) and applicable withholding taxes paid in accordance with this Award. The Participant further acknowledges and agrees that the Company may deliver, by electronic mail, the use of the Internet, including through the website of the agent appointed by the Compensation and Human Resources Committee of the Board of Directors of the Company (the &#8220;Committee&#8221;) to administer the UnitedHealth Group Incorporated 2020 Stock Incentive Plan (the &#8220;Plan&#8221;), the Company intranet web pages or otherwise, any information concerning the Company, this Award, the Plan pursuant to which the Company granted this Award, and any information required by the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This Option is subject to the further terms and conditions set forth below and to the terms of the Plan. A copy of the Plan is available upon request. In the event of any conflict between the terms of the Plan and this Award, the terms of the Plan shall govern. Any terms not defined herein shall have the meaning set forth in the Plan. </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">* * * * * </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Nonqualified Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The Company does not intend that the Option shall be an Incentive Stock Option governed by the provisions of Section 422 of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;). </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Termination of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The Option shall terminate on the Expiration Date. The Option shall terminate prior to the Expiration Date if the Participant ceases to be employed by the Company or any Affiliate, except that&#58; </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">General. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Except as expressly provided in Section 10 or this Section 2, if prior to vesting of the Option as set forth herein, the Participant ceases to be an employee of the Company or any Affiliate for any reason </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.3</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(voluntary or involuntary), then the Participant may, at any time within the period set forth in the applicable provision below, exercise the Option to the extent of the full number of Option Shares which were exercisable and which the Participant was entitled to purchase under the Option on the date of the termination of his or her employment. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Death or Long-Term Disability. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If the Participant dies while employed by the Company or any Affiliate, or if the Participant&#8217;s employment by the Company or any Affiliate is terminated due to the Participant&#8217;s failure to return to work as the result of a long-term disability which renders the Participant incapable of performing his or her duties as determined under the provisions of the long-term disability insurance program of the Company or the Affiliate by which the Participant is employed (&#8220;Disability&#8221;), then&#58; (i) all unvested Option Shares hereunder shall immediately vest and be exercisable, and (ii) the Participant (or the Participant&#8217;s personal representatives, administrators or guardians, as applicable, or any person or persons to whom the Option is transferred by will or the applicable laws of descent and distribution) may, at any time within the shorter of (1) the Expiration Date of the Option, or (2) a period of five years after the Participant&#8217;s death or Disability or for such other longer period established at the discretion of the Committee, exercise the Option. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Severance. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Subject to Section 10, if Participant&#8217;s employment with the Company or any Affiliate terminates at a time when Participant is not eligible for Retirement (as defined below) and, in the circumstances, Participant is entitled to severance or separation pay, the following provisions will apply.  If the Participant is entitled to severance under the Company&#8217;s severance pay plan as in effect on the date hereof and the Participant is not eligible for Retirement (as defined below) at the time of termination of employment, then the Option shall continue to vest and become exercisable for the period of such severance. If Participant is entitled to severance or separation pay under an employment agreement entered into with the Company or an Affiliate on or prior to the date hereof, then the Option shall continue to vest and become exercisable for the period of such severance or separation pay that Participant is entitled to receive under that agreement as in effect on the date hereof. In either case, should the Participant be paid in a lump sum versus bi-weekly payments, the Option shall continue to vest for the time in which severance or separation pay would have been paid had it been paid bi-weekly. If the Participant is entitled to severance or separation pay under a plan or agreement other than under the Company&#8217;s severance pay plan or an employment agreement entered into with the Company or an Affiliate, then vesting of the Option shall continue for three months from the date of termination, regardless of the period for which severance or separation pay is payable. Any portion of the Option that vests after the Participant&#8217;s termination of employment pursuant to this Section 2(c) may be exercised during the Exercise Period (as defined below). For avoidance of doubt, any Options that are unvested on the date of termination of Participant&#8217;s employment and do not vest under the schedule set forth herein during the applicable severance or separation pay period identified above in this Section 2(c) shall be forfeited.  For the purposes of this Section 2(c), &#8220;Exercise Period&#8221; shall mean the greater of&#58; (i) a period of three months after the date of termination of the Participant&#8217;s employment&#59; (ii) a period of three months after vesting ceases as provided in Section 2(c) if Participant receives severance or separation pay&#59; or (iii) such other longer period established at the discretion of the Committee, but in no event later than the Expiration Date determined without regard to this Section 2(c).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Retirement. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If the Participant&#8217;s employment by the Company or any Affiliate is terminated and at the time of termination the Participant is eligible for Retirement, then (i) the Option shall continue to vest and become exercisable as if such termination of employment had not occurred and (ii) the Participant may, at any time within the shorter of (1) the Expiration Date of the Option, or (2) a period of five years after such termination of employment or for such other longer period established at the discretion of the Committee, exercise the Option to the extent of the full number of Option Shares which are then exercisable.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)        Anything else contained in this Award certificate notwithstanding, the Option shall in no event be exercisable after the Expiration Date. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)        For purposes of this Award, &#8220;Retirement&#8221; means the termination of employment of a Participant who is age 55 or older with at least ten years of Recognized Employment with the Company or any Affiliate other than by reason of (i) death or Disability or (ii) Cause.    </font></div><div style="text-align:justify;text-indent:37.05pt"><font><br></font></div><div style="text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)       For purposes of this Award, &#8220;Recognized Employment&#8221; shall include only employment since the Participant&#8217;s most recent date of hire by the Company or any Affiliate, and shall not include employment with a company acquired by the Company or any Affiliate before the date of such acquisition.  </font></div><div style="text-align:justify;text-indent:37.05pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.3</font></div></div><div style="text-align:justify;text-indent:34.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3.          </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Forfeiture of Option and&#47;or Recoupment of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. This section sets forth circumstances under which the Participant shall forfeit all or a portion of the Options, or be required to repay the Company for the value realized in respect of all or a portion of the Options. </font></div><div style="text-align:justify;text-indent:34.55pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Violation of Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If the Participant violates any provision of the Restrictive Covenants in Section 4 of this Award certificate, then any (i) unvested Options and (ii) Options that vested within one year prior to the Participant&#8217;s termination of employment with the Company or any Affiliate or at any time after such termination of employment and that have not been exercised shall be immediately cancelled and rendered null and void without any payment therefor (the &#8220;Forfeited Options&#8221;).  If any such Forfeited Options have been exercised prior to the Participant&#8217;s violation of the Restrictive Covenants, the Participant shall be required to repay or otherwise reimburse the Company, upon demand, an amount in cash or Common Stock having a value equal to the amount described in this Section 3(a) below. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To the extent that such Option Shares have been sold, the amount shall be the aggregate proceeds received from such sale of the net Option Shares acquired after payment of the Exercise Price and any applicable taxes (&#8220;Net Option Shares&#8221;). To the extent that the Net Option Shares have not been sold at the time Company demand is made, the amount shall be the aggregate Fair Market Value of the Net Option Shares on the date the Forfeited Options were exercised. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Fraud</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If the Board determines that the Participant has engaged in fraud that, in whole or in part, caused the need for a material restatement of the Company&#8217;s consolidated financial statements, then any vested and unvested Options then held by the Participant shall be immediately cancelled and rendered null and void without any payment therefor.  In addition, for any Options that were exercised during the 12-month period following the first public issuance or filing with the Securities Exchange Commission (whichever occurs first) of the incorrect financial statements (the &#8220;Covered Options&#8221;), the Participant shall be required to repay or otherwise reimburse the Company, upon demand, an amount in cash or Common Stock having a value equal to the amount described in this Section 3(b) below, depending on whether the Participant still holds the Option Shares acquired upon exercise of the Covered Options.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To the extent that such Option Shares have been sold, the amount shall be the aggregate proceeds received from such sale of the Net Option Shares. To the extent that the Net Option Shares have not been sold at the time Company demand is made, the amount shall be the aggregate Fair Market Value of the Net Option Shares on the date the Covered Options were exercised.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (c)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">In General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This section does not constitute the Company&#8217;s exclusive remedy for the Participant&#8217;s violation of the Restrictive Covenants or commission of fraudulent conduct.  As the forfeiture and repayment provisions are not adequate remedies at law, the Company may seek any additional legal or equitable remedy, including injunctive relief, for any such violations, except that, if unvested Option Shares continue to vest under Section 2 following the termination of Participant&#8217;s employment with the Company or any Affiliate, then, with respect to the Restrictive Covenants in Sections 4 (c) or (d) below, the maximum period of time to which Company shall be entitled to injunctive relief is a total of two (2) years following the termination of Participant&#8217;s employment with the Company or any Affiliate, not counting any time period that Participant is in violation of the Restrictive Covenants in Sections 4(c) or (d) below and during which time the running of the time periods for the restrictions set forth in Sections 4(c) and (d) of this Agreement shall be tolled as permitted by applicable law such that the running of the two (2) year time period shall commence only once Participant is in compliance with the Restrictive Covenants. The provisions in this section are essential economic conditions to the Company&#8217;s grant of Options to the Participant.  By receiving the grant of Options hereunder, the Participant agrees that the Company may deduct from any amounts it owes the Participant from time to time (such as wages or other compensation, deferred compensation credits, vacation pay, any severance or other payments owed following a termination of employment, as well as any other amounts owed to the Participant by the Company) to the extent of any amounts the Participant owes the Company under this section. The provisions of this section and any amounts repayable by the Participant hereunder are intended to be in addition to any rights to repayment the Company may have under Section 304 of the Sarbanes-Oxley Act of 2002, Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and other applicable law.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt">Assignment and Restrictive Covenants.  In consideration of the terms of this Award certificate and the Company&#8217;s sharing of Confidential Information with the Participant, which the Participant agrees constitute </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.3</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">adequate and sufficient mutually-agreed consideration, the Participant agrees to the Restrictive Covenants set forth below in this Section 4. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Assignment of Intellectual Property.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  Participant agree to assign and hereby assigns to Company all rights, titles and interests Participant may have in or to any invention, innovation, computer program, software, database, discovery, idea, writing, improvement, process, technique or other works (collectively &#34;Intellectual Property&#34;) whether or not patentable or registrable under copyright or similar statutes, created or conceived by Participant, either alone or jointly with others, during Participant&#8217;s employment that&#58; (i) relates in any manner to the actual or anticipated business, research, or development of Company&#59; (ii) results from work assigned to or performed by Participant for Company&#59; and&#47;or (iii) is conceived of or made with the use of Company systems, equipment, supplies, materials, facilities, computer programs, confidential information and&#47;or trade secret information (collectively &#8220;Company Resources&#8221;).  This assignment does not apply to Intellectual Property that meets all of the following criteria&#58; (i) no Company Resources were used in its creation&#59; (ii) the Intellectual Property was developed entirely on Participants own time&#59; (iii) at the time of conception or reduction to practice the Intellectual Property does not relate to Company&#8217;s business, actual or anticipated research or development&#59; and (iv) the Intellectual Property does not result from any work performed by Participant for Company.  Participant shall disclose to Company all Intellectual Property developed during Participant's employment so that Company may determine any rights it many have in such Intellectual Property.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Non-Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant has or will be given access to and provided with sensitive, confidential, proprietary and&#47;or trade secret information (collectively, &#8220;Confidential Information&#8221;) in the course of Participant&#8217;s employment.  Examples of Confidential Information include inventions, new product or marketing plans, business strategies and plans, merger and acquisition targets, financial and pricing information, computer programs, source codes, models and data bases, analytical models, customer lists and information, and supplier and vendor lists and other information which is not generally available to the public.  Participant shall not disclose or use Confidential Information, either during or after Participant&#8217;s employment with the Company, except (i) as necessary to perform Participant&#8217;s duties, (ii) as the Company may consent in writing, or (iii) as permitted by Section 4(g) below.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Non-Solicitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  During Participant&#8217;s employment and for two years after the later of (i) the termination of Participant&#8217;s employment with the Company for any reason whatsoever or (ii) the last scheduled vesting date under this Award certificate, Participant shall not, without the Company&#8217;s prior written consent, directly or indirectly, for Participant or for any other person or entity, as agent, employee, officer, director, consultant, owner, principal, partner, shareholder, or in any other individual or representative capacity&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)       Solicit or conduct business with any business competitive with the Company from any person or entity&#58; (A) who was a Company provider or customer within the 12 months before Participant&#8217;s employment termination and with whom Participant had contact regarding the Company&#8217;s activity, products or services, or for whom Participant provided services or supervised employees who provided those services, or about whom Participant learned Confidential Information during employment related to the Company&#8217;s provision of products and services to such person or entity, or (B) was a prospective provider or customer the Company solicited within the 12 months before Participant&#8217;s employment termination and with whom Participant had contact for the purposes of soliciting the person or entity to become a provider or customer of the Company, or supervised employees who had those contacts, or about whom Participant learned Confidential Information during employment related to the Company&#8217;s provision of products and services to such person or entity&#59;</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)        Raid, hire, employ, recruit or solicit any Company employee or consultant who possesses Confidential Information of the Company to leave the Company&#59;</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iii)     Induce or influence any Company employee, consultant, or provider who possesses Confidential Information of the Company to terminate his, her or its employment or other   relationship with the Company&#59; or</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iv)        Assist anyone in any of the activities listed above.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.3</font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Non-Competition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  During Participant&#8217;s employment and for one year after the later of (i) the termination of Participant&#8217;s employment with the Company for any reason whatsoever or (ii) the last scheduled vesting date under this Award certificate, Participant shall not, without the Company&#8217;s prior written consent, directly or indirectly, for Participant or for any other person or entity, as agent, employee, officer, director, consultant, owner, principal, partner, shareholder, or in any other individual or representative capacity&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)       Engage in or participate in any activity that competes, directly or indirectly, with any Company activity, product or service that Participant engaged in, participated in, or had Confidential Information about during Participant&#8217;s last 36 months of employment with the Company&#59; or</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)         Assist anyone in any of the activities listed above.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Geographic Scope</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)           Participant&#8217;s obligations under subsections 4(c) and (d) of this &#8220;Assignments and Restrictive Covenants&#8221; section shall apply on a nationwide basis anywhere in the United States.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)         Participant&#8217;s obligations under this &#8220;Assignments and Restrictive Covenants&#8221; section shall also apply in any country outside the United States with respect to which Participant had responsibility for any UnitedHealth Group activity, product or service in that country.  </font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (f)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Return of Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Participant agrees that all tangible materials (whether originals or duplicates), including, but not limited to, notebooks, computers, files, reports, proposals, price lists, lists of actual or potential customers or suppliers, talent lists, formulae, prototypes, tools, equipment, models, specifications, technical data, methodologies, research results, test results, financial data, contracts, agreements, correspondence, documents, computer disks, software, computer printouts, information stored electronically, memoranda, and notes, in Participant&#8217;s possession, custody, or control which in any way relate to the Company&#8217;s business and which are furnished to Participant by or on behalf of the Company or which are prepared, compiled or acquired by Participant while working with or employed by the Company shall be the sole property of the Company.  At any time upon the request of the Company, and in any event promptly upon termination of Participant&#8217;s employment with the Company, but in any event no later than two (2) business days after such termination, Participant shall deliver all such materials to the Company and shall not retain any originals or copies (including electronically) of such materials.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">No Restriction on Protected Activities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Nothing in this Award certificate prohibits Participant from disclosing information in good faith to any governmental agency, legislative body, or official regarding an alleged violation of law or regulation or otherwise protected under applicable law, including, without limitation, the National Labor Relations Act, the Defend Trade Secrets Act, and any rule or regulation promulgated by the Securities and Exchange Commission, the National Labor Relations Board, the Equal Employment Opportunity Commission, or any other federal, state, or local government agency.  Participant acknowledges that, through this Section 4(g), the Company has provided Participant with written notice that, pursuant to the Defend Trade Secrets Act, 8 USC &#167; 1833(b), an employee, consultant, or contractor of an employer may not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of an employer&#8217;s trade secrets, so long as such disclosure is made solely&#58; (a) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating a suspected violation of law&#59; and&#47;or (b) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.  Additionally, Participant understands that, pursuant to 18 USC &#167; 1831 et seq., an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose a trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order.  The foregoing immunities provided under 18 USC &#167; 1831 et seq. do not apply to any disclosure of Confidential Information or trade secrets of an employer&#8217;s clients, customers, or counterparties, or of any other third parties. For purposes of this paragraph solely, &#8220;trade secret&#8221; has the meaning set forth in 18 USC &#167; 1839.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.3</font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(h)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Exceptions for Attorneys</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Notwithstanding the foregoing, this Section 4 will apply only to the extent permissible under provisions of the ABA Model Rules of Professional Conduct, or any applicable state counterpart regarding restrictions on the right to practice law.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Acknowledgment of Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. By accepting the Award, Participant agrees that the provisions of this Section 4 are reasonable and necessary to protect the legitimate interests of the Company.  Participant further acknowledges that Participant&#8217;s obligations under this Section 4 are in addition to, and do not limit, any and all obligations concerning the same subject matter arising under any applicable law, including, without limitation, common law and statutory law relating to fiduciary duties and trade secrets.  To the extent Participant and the Company agree at any time to enter into separate agreements containing restrictive covenants or assignment of intellectual property with different or inconsistent terms than those contained herein, Participant and the Company acknowledge and agree that such different or inconsistent terms shall not in any way affect or have relevance to the Assignment and Restrictive Covenants contained herein.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Manner of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </font></div><div style="text-align:justify;text-indent:37.05pt"><font><br></font></div><div style="text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">In General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  On the terms set forth herein, the Option may be exercised by the Participant in whole or in part from time to time by delivering notice of exercise (in a form and manner acceptable to the Company) to the Company or the Committee&#8217;s designated agent, accompanied by payment of the Exercise Price and any applicable withholding taxes in cash or its equivalent, or by any of the following methods, subject to such limitations and restrictions as the Committee may establish (i) by a cashless exercise program established pursuant to Regulation T of the Federal Reserve Board, (ii) by delivery of shares of Common Stock already owned by the Participant, (iii) by withholding shares of Common Stock from the total number of shares of Common Stock acquired upon exercise under the Option having a fair market value, on the exercise date, equal to the aggregate Exercise Price and any applicable withholding taxes, or (iv) by a combination of any of the preceding methods or such other methods as the Committee may permit.</font></div><div style="text-align:justify;text-indent:37.05pt"><font><br></font></div><div style="text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Automatic Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  To the extent the vested and exercisable portion of the Option remains unexercised as of the close of business on the date the Option expires (the Expiration Date or such earlier date that is the last date on which the Option may be exercised pursuant to the terms of this Award certificate), that portion of the Option will be exercised without any action by the Participant in accordance with the terms of this Certificate if the Fair Market Value of a Share on that date is at least $0.01 greater than the Exercise Price and the exercise will result in Participant receiving at least one Share. </font></div><div style="text-align:justify;text-indent:37.05pt"><font><br></font></div><div style="text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Satisfaction of Securities Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Notwithstanding anything to the contrary in this Award certificate, the Company shall not be required to issue or deliver any shares of Common Stock upon exercise of any Option until the requirements of any federal or state securities laws, rules or regulations or other laws or rules (including the rules of any securities exchange) as may be determined by the Company to be applicable have been and continue to be satisfied (including an effective registration of the shares under federal and state securities laws).</font></div><div style="text-align:justify;text-indent:37.05pt"><font><br></font></div><div style="text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Tax Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In order to comply with all applicable federal or state income tax laws or regulations, the Company may take such action as it deems appropriate to ensure that all applicable federal or state payroll, withholding, income or other taxes, which are the sole and absolute responsibility of Participant, are withheld or collected from Participant.  Participant is liable and responsible for all taxes owed in connection with the Award, regardless of any action the Company takes with respect to any tax withholding obligations that arise in connection with the Award.  The ultimate tax liability, which is the Participant&#8217;s responsibility, may exceed the amount withheld by the Company.  To the extent Participant elects to satisfy Participant&#8217;s required federal, state, and local payroll, withholding, income, or other tax withholding obligations by having the Company withhold a portion of the shares of Common Stock otherwise to be delivered, the fair market value of the shares withheld may not exceed the maximum amount required to be withheld under applicable laws or regulations.</font></div><div style="text-align:justify;text-indent:37.05pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">No Guarantee of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. This Award does not confer on the Participant any right to continued employment or any other relationship with the Company or any Affiliate, nor will it interfere in any way with the right of the Company to terminate Participant at any time.  Participant&#8217;s employment with the Company is at will.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">7.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">No Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. During the Participant&#8217;s lifetime, only the Participant can exercise the Option. The Participant may not transfer the Option except by will or the laws of descent and distribution.  Notwithstanding the foregoing, the Option may be transferred to an alternate payee pursuant to the terms of a domestic relations order (as </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.3</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">such terms are defined by Section 414(p) of the Code), provided that (i) the Participant is an employee at the time the domestic relations order is entered, (ii) the Option was outstanding at the time the domestic relations order is entered, and (iii) the transfer otherwise satisfies all requirements of the Plan and any limitations and requirements established by the Committee.   Any attempt to otherwise transfer the Option shall be void. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt;text-decoration:underline">Special Restriction on Transfer for Certain Participants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If the Participant is an officer of the Company within the meaning of Section 16 of the Securities Exchange Act of 1934 and Rule 16a-1 issued thereunder, as such status is reasonably determined from time to time by the Board of Directors of the Company (a &#8220;Section 16 Officer&#8221;), at any time that the Option is exercised in whole or in part and the Company has theretofore communicated the Participant&#8217;s status as a Section 16 Officer to the Participant, the following special transfer restrictions apply to any shares of Common Stock acquired upon the exercise of the Option.  One-third (1&#47;3) of the net number of any shares of Common Stock acquired upon the exercise of the Option at a time when the Participant is a Section 16 Officer (including any shares of Common Stock or other securities subject to the Option following any adjustment made pursuant to the Option or Section 7 of the Plan) must be retained, and may not be sold or otherwise transferred, for a period of at least one year following the date the Option is exercised.  For purposes of the Option, the &#8220;net number of any shares of Common Stock acquired&#8221; shall mean the number of shares of Common Stock received with respect to the particular exercise after reduction for any shares of Common Stock withheld by or tendered to the Company, or sold on the market, to cover the Exercise Price of the Option and&#47;or to cover any federal, state, local or other payroll, withholding, income or other applicable tax withholding required in connection with the exercise of the Option.  The restrictions of this Section 8 are in addition to, and not in lieu of, the restrictions imposed under other Company policies and applicable laws. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt;text-decoration:underline">Adjustments to Option Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. In the event that any dividend or other distribution (whether in the form of cash, shares of Common Stock, other securities or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase or exchange of Shares or other securities of the Company or other similar corporate transaction or event affecting the Shares would be reasonably likely to result in the diminution or enlargement of any of the benefits or potential benefits intended to be made available under the Option (including, without limitation, the benefits or potential benefits of provisions relating to the term, vesting or exercisability of the Option), the Committee shall, in such manner as it shall deem equitable or appropriate in order to prevent such diminution or enlargement of any such benefits or potential benefits, adjust any or all of (a) the number and type of shares (or other securities or other property) subject to the Option and (b) the exercise price with respect to the Option&#59; provided, however, that the number of shares covered by the Option shall always be a whole number. Without limiting the foregoing, if any capital reorganization or reclassification of the capital stock of the Company, or consolidation or merger of the Company with another entity, or the sale of all or substantially all of the Company&#8217;s assets to another entity, shall be effected in such a way that holders of the Company&#8217;s Common Stock shall be entitled to receive stock, securities, cash or other assets with respect to or in exchange for such shares, the Participant shall have the right to purchase and receive upon the basis and upon the terms and conditions specified in this Award certificate and in lieu of the shares of Common Stock of the Company immediately theretofore purchasable and receivable upon the exercise of the Option, with appropriate adjustments to prevent diminution or enlargement of benefits or potential benefits intended to be made available under the Option, such shares of stock, other securities, cash or other assets as would have been issued or delivered to the Participant if the Participant had exercised the Option and had received such shares of Common Stock prior to such reorganization, reclassification, consolidation, merger or sale. The Company shall not effect any such reorganization, consolidation, merger or sale unless prior to the consummation thereof the successor entity (if other than the Company) resulting from such reorganization, consolidation or merger or the entity purchasing such assets shall assume by written instrument the obligation to deliver to the Participant such shares of stock, securities, cash or other assets as, in accordance with the foregoing provisions, the Participant may be entitled to purchase or receive. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.5pt;text-decoration:underline">Certain Terminations on or After Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Notwithstanding the other vesting provisions set forth herein, but subject to the other terms and conditions set forth herein, the Option shall become fully vested and exercisable if, on or within two years after the effective date of a Change in Control, the Participant ceases to be an employee of the Company or any Affiliate as a result of a termination of employment (i) by the Participant for Good Reason, (ii) by the Company or any Affiliate without Cause, (iii) at a time when Participant is eligible for Retirement, (iv) due to Participant&#8217;s Disability, or (v) in the circumstances described in Section 2(c)&#59; provided that in the case of a termination for Good Reason, the Option shall vest if the Participant gives written notice of the circumstances constituting Good Reason within two years after the effective date of the Change in Control, if the Company fails to cure the circumstances constituting Good Reason within 60 days of the receipt of such notice and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.3</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">the Participant resigns within 30 days after the end of the cure period, all as provided in Section 10(d).  For purposes of this Award certificate&#58;</font></div><div style="text-align:justify;text-indent:37.05pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)   &#8220;Affiliate&#8221; shall mean (i) any entity that, directly or indirectly through one or more intermediaries, is controlled by the Company and (ii) any entity in which the Company has a significant equity interest, as determined by the Committee. </font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)     &#8220;Cause&#8221; shall mean Participant&#8217;s (a) material failure to follow the Company&#8217;s reasonable direction or to perform any duties reasonably required on material matters, (b) material violation of, or failure to act upon or report known or suspected violations of, the Company&#8217;s Code of Conduct, as may be amended from time to time, (c) conviction of any felony, (d) commission of any criminal, fraudulent, or dishonest act in connection with Participant&#8217;s employment, (e) breach of any of the Restrictive Covenants in Section 4 of this Award certificate or a material breach of any employment agreement between Participant and the Company or any Affiliate, if any, or (f) conduct that is materially detrimental to the Company&#8217;s interests.  The Company will, within 120 days of discovery of the conduct, give Participant written notice specifying the conduct constituting Cause in reasonable detail and Participant will have 60 days to remedy such conduct, if such conduct is reasonably capable of being remedied.  In any instance where the Company may have grounds for Cause, failure by the Company to provide written notice of the grounds for Cause within 120 days of discovery shall be a waiver of its right to assert the subject conduct as a basis for termination for Cause.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)      &#8220;Change in Control&#8221; shall mean the sale of all or substantially all of the Company&#8217;s assets or any merger, reorganization, or exchange or tender offer which, in each case, will result in a change in the power to elect 50% or more of the members of the Board of Directors of the Company&#59; provided, however, that such a sale, merger or other event must also constitute either (i) a &#8220;change in the ownership&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(v), (ii) a &#8220;change in the effective control&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(vi)(A)(1) (replacing &#8220;30 percent&#8221; with &#8220;50 percent&#8221; as used in such regulation), or (iii) a change &#8220;in the ownership of a substantial portion of the assets&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(vii).</font></div><div style="text-align:justify;text-indent:73.05pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)    &#8220;Good Reason&#8221; shall mean the occurrence of any of the following without Participant&#8217;s written consent, in each case, when compared to the arrangements in effect immediately prior to the Change in Control&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)          any reduction in Participant&#8217;s base salary or target bonus expressed as a percentage of the Participant&#8217;s base salary, other than a reduction that is pursuant to a general reduction affecting a group of employees&#59;</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)          a change in the principal location at which the Participant is required to perform his or her duties, if the new location is 50 miles or more further from the Participant&#8217;s principal residence than the original location&#59; or</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iii)         a material diminution in Participant&#8217;s duties, responsibilities or authority.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant will, within 120 days of discovery of such circumstances, give the Company written notice specifying the circumstances constituting Good Reason in reasonable detail and, upon receipt of such notice, the Company shall have 60 days to cure the circumstances constituting Good Reason.  Failure by Participant to provide written notice of the grounds for Good Reason within 120 days of discovery, or failure by the Participant to resign within 30 days after the end of the Company&#8217;s 60 day cure period, shall be a waiver of Participant&#8217;s right to assert the subject circumstance as a basis for termination for Good Reason.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Possible Acceleration of Vesting&#59; Payment in Satisfaction of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If the Option is terminated pursuant to a Change in Control and is not assumed by a party to the Change in Control (and no such party issues a new award in substitution for the Award, as determined by the Committee), the Committee may provide for immediate vesting of the Option, and the issuance of shares of Common Stock, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.3</font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">securities of a party to the Change in Control, or cash, or any combination thereof, in full satisfaction of the Option.  </font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.5pt;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)     </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">No Trust</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Neither the Plan nor the Option shall create or be construed to create a trust or separate fund of any kind or a fiduciary relationship between the Company and Participant or any other Person.  To the extent that any Person acquires a right to receive payments from the Company or any Affiliate pursuant to an Award, such right shall be no greater than the right of any unsecured creditor of the Company or any Affiliate.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Record of Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  An original record of this Award certificate and all the terms hereof, executed by the Company, is held on file by the Company. To the extent there is any conflict between the terms contained in this Award certificate and the terms contained in the original held by the Company, the terms of the original held by the Company shall control. </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)      </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Survival</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The Restrictive Covenants in Section 4 and the provisions regarding the forfeiture of Options and recoupment of shares of Common Stock shall survive termination of the Option.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)     </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Choice of Law, Injunctive Relief, Attorney&#8217;s Fees and Jury Trial</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant consents to the law of Minnesota exclusively being applied to any matter arising out of or relating to this Award certificate, without regard to its conflict of law principles, and exclusively to personal and subject matter jurisdiction in the state and federal courts of Minnesota for any dispute relating to this Award certificate or Participant&#8217;s relationship with the Company.  In the event of a breach or a threatened breach of this Award by Participant, Participant acknowledges that the Company will face irreparable injury which may be difficult to calculate in dollar terms and that the Company shall be entitled, in addition to remedies otherwise available at law or in equity, to temporary restraining orders and preliminary injunctions and final injunctions without the posting of a bond enjoining such breach or threatened breach.  Should the Company successfully enforce any portion of this Award certificate before a trier of fact or in an arbitration proceeding, the Company shall be entitled to all of its reasonable attorney&#8217;s fees and costs incurred as a result of enforcing this Award certificate against Participant. Participant waives all rights or entitlement to a jury trial for any matter arising out of or relating to this Award certificate.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Code Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  It is intended that this Award and any amounts payable under this Award shall either be exempt from or comply with Code Section 409A (including the Treasury regulations and other published guidance relating thereto) so as not to subject Participant to payment of any additional tax, penalty or interest imposed under Code Section 409A. The provisions of this Award certificate shall be construed and interpreted to avoid the imputation of any such additional tax, penalty or interest under Code Section 409A yet preserve (to the nearest extent reasonably possible) the intended benefit payable to Participant.  To the extent that the time or form of payment of any benefit pursuant to this Award would violate the terms of Section 409A, the Committee may revise the time or form of payment to conform to Section 409A.  Notwithstanding the foregoing, in no event shall the Company, any Affiliate, the members of the Committee, or any other person have any liability for any additional tax, penalty or interest imposed on Participant by reason of Section 409A or otherwise.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">No Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  No waiver of any breach of any provision of this Award certificate by the Company shall be effective unless it is in writing, and no waiver shall be construed to be a waiver of any succeeding breach or as a modification of such provision.  The provisions of this Award certificate shall be severable, and if any provision of this Award certificate is found by any court or arbitrator to be unenforceable, in whole or in part, the remainder of this Award certificate shall nevertheless be enforceable and binding on the parties.  Participant also agrees that a court or arbitrator may modify any invalid, overbroad or unenforceable term of this Award certificate so that such term, as modified, is valid and enforceable under applicable law, and that a court or arbitrator is authorized to extend the length of the Restrictive Covenants in Section 4 of this Award certificate for any period of time in which Participant is in breach of the Restrictive Covenants or as necessary to protect the legitimate business interests of Company. Further, Participant affirmatively states that Participant has not, will not, and cannot rely on any representations not expressly made herein.  The terms of this Award certificate shall not be amended by Participant or Company except by the express written consent of the Company and Participant.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.3</font></div></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Consideration Period&#59; Right to Consult with Counsel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  By the Participant&#8217;s acceptance below, the Participant acknowledges and agrees that the Company provided the Participant with at least ten (10) business days to review and consider this Award certificate and that voluntarily accepting this Award certificate before the expiration of ten (10) business days shall serve as a waiver of the ten (10) day review period. The Participant has the right and is advised to consult with counsel of his&#47; her choice before signing this document.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(h)      </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Assignability and Change of Position</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The rights and&#47;or obligations herein may be assigned by the Company without Participant&#8217;s consent and shall bind and inure to the benefit of the Company&#8217;s successors, assigns, and representatives.  If the Company makes any assignment of the rights and&#47;or obligations herein, Participant agrees that this Award certificate shall remain binding upon Participant in any event.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Offer Date&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#GrantDate#</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By</font><img alt="image1.jpg" src="image1.jpg" style="height:43px;margin-bottom:5pt;vertical-align:text-bottom;width:128px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, on behalf of UnitedHealth Group Incorporated</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Acceptance Date&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#AcceptanceDate#</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Signed Electronically&#47;Signed Manually&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#Signature#</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>4
<FILENAME>unhex104123121.htm
<DESCRIPTION>EX-10.4
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i5587ffe037474c1884a784360e850252_33"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.4</font></div></div><div style="text-align:center"><img alt="uhglogo2019a02b.jpg" src="uhglogo2019a02b.jpg" style="height:71px;margin-bottom:5pt;vertical-align:text-bottom;width:404px"></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">PERFORMANCE-BASED RESTRICTED STOCK UNIT AWARD</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.666%"><tr><td style="width:1.0%"></td><td style="width:31.417%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.422%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.368%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.422%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Award Date</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(mm&#47;dd&#47;yyyy)</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#GrantDate#</font></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Target Number of Performance-Based Units</font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#QuantityGranted#</font></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Performance Period</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(mm&#47;dd&#47;yyyy)</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">mm&#47;dd&#47;yyyy &#8211; mm&#47;dd&#47;yyyy</font></div></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">THIS CERTIFIES THAT UnitedHealth Group Incorporated (the &#8220;Company&#8221;) has on the award date specified above (the &#8220;Award Date&#8221;) granted to</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#ParticipantName#</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(&#8220;Participant&#8221;) an award (the &#8220;Award&#8221;) to be eligible to receive a number of Performance-Based Restricted Stock units (the &#8220;PRSUs&#8221;), the target number of which is indicated above in the box labeled &#8220;Target Number of Performance-Based Units,&#8221; each PRSU representing the right to receive one share of UnitedHealth Group Incorporated Common Stock, $.01 par value per share (the &#8220;Common Stock&#8221;), subject to certain restrictions and on the terms and conditions contained in this Award and the UnitedHealth Group Incorporated 2020 Stock Incentive Plan (the &#8220;Plan&#8221;). </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Participant acknowledges and agrees that the Company may deliver, by electronic mail, the use of the Internet, including through the website of the agent appointed by the Compensation and Human Resources Committee of the Board of Directors of the Company (the &#8220;Committee&#8221;) to administer the Plan, the Company intranet web pages or otherwise, any information concerning the Company&#59; the Award, the Plan, pursuant to which the Company granted the Award, and any information required by the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A copy of the Plan is available upon request. In the event of any conflict between the terms of the Plan and this Award, the terms of the Plan shall govern. Any terms not defined herein shall have the meaning set forth in the Plan.  </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">* * * * * </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Rights of the Participant with Respect to the PRSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">No Shareholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The PRSUs granted pursuant to this Award do not and shall not entitle Participant to any rights of a shareholder of Common Stock. The rights of Participant with respect to the PRSUs shall remain forfeitable at all times prior to the date on which such rights become vested, and the restrictions with respect to the PRSUs lapse, in accordance with Section 2, 3 or 4. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Conversion of PRSUs&#59; Issuance of Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. No shares of Common Stock shall be issued to Participant prior to the date on which the PRSUs vest, and the restrictions with respect to the PRSUs lapse, in accordance with Section 2, 3 or 4. Neither this Section 1(b) nor any action taken pursuant to or in accordance with this Section 1(b) shall be construed to create a trust of any kind. After any PRSUs vest pursuant to Section 2, 3 or 4, the Company shall promptly cause to be issued shares of Common Stock to Participant or in the name of Participant&#8217;s legal representatives, beneficiaries or heirs, as the case may be, in payment of such vested whole PRSUs, such shares of Common Stock shall be issued promptly, and in any event, no later than March 15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> of the year following the year in which the vesting event occurs (which payment schedule is intended to comply with the &#8220;short-term deferral&#8221; exemption from the application of Section 409A of the Code). </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.4</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Subject to the terms and conditions of this Award, including without limitation the terms set forth in Attachment 1, the PRSUs shall vest and the restrictions with respect to the PRSUs shall lapse (i) if Participant has remained continuously employed with the Company or any Affiliate from the Award Date through and including the end of the Performance Period, and (ii) if and to the extent the Performance Vesting Criteria described in Attachment 1 have been achieved during the Performance Period.  Regardless of whether Participant meets the continuous employment or service criterion described in subpart (i) of this Section 2, if and to the extent the Performance Vesting Criteria have not been achieved by the end of the Performance Period, the Participant&#8217;s rights to the PRSUs shall be immediately and irrevocably forfeited on that date.  The Committee will determine in its sole discretion the extent, if any, to which the Performance Vesting Criteria have been met, and it will retain sole discretion to reduce the number of PRSUs that would otherwise vest as a result of the performance measured against the Performance Vesting Criteria.  Any vesting that may occur pursuant to this Section 2 will be effective on the date on which the Committee has certified the extent to which the Performance Vesting Criteria in subpart (ii) of this Section 2 were satisfied.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Certain Terminations on or After Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Notwithstanding the other vesting provisions contained in Section 2, but subject to the other terms and conditions set forth herein, the PRSUs described in this Award will become immediately and unconditionally vested, and the restrictions with respect thereto shall lapse if, on or within two years after the effective date of a Change in Control, the Participant ceases to be an employee of the Company or any Affiliate as a result of a termination of employment (i) by the Participant for Good Reason, (ii) by the Company or any Affiliate without Cause, (iii) at a time when Participant is eligible for Retirement, (iv) due to Participant&#8217;s Disability, or (v) in the circumstances described in Section 4(c)&#59; provided that in the case of a termination for Good Reason, the PRSUs shall vest if the Participant gives written notice of the circumstances constituting Good Reason within two years after the effective date of the Change in Control, if the Company fails to cure the circumstances constituting Good Reason within 60 days of the receipt of such notice and the Participant resigns within 30 days after the end of the cure period, all as provided in Section 3(d).  Upon a Change in Control, the Committee will determine&#58; (i) the extent, if any, to which the Performance Vesting Criteria have been met, and (ii) the number of the PRSUs that will vest and convert into shares of Common Stock in the event of Participant&#8217;s termination of employment in accordance with this Section 3. For purposes of this Award certificate&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)       &#8220;Affiliate&#8221; shall mean (i) any entity that, directly or indirectly through one or more intermediaries, is controlled by the Company and (ii) any entity in which the Company has a significant equity interest, as determined by the Committee.      </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       &#8220;Cause&#8221; shall mean Participant&#8217;s (a) material failure to follow the Company&#8217;s reasonable direction or to perform any duties reasonably required on material matters, (b) material violation of, or failure to act upon or report known or suspected violations of, the Company&#8217;s Code of Conduct, as may be amended from time to time, (c) conviction of any felony, (d) commission of any criminal, fraudulent, or dishonest act in connection with Participant&#8217;s employment, (e) breach of any of the Restrictive Covenants in Section 8 of this Award certificate or a material breach of any employment agreement between Participant and the Company or any Affiliate, if any, or (f) conduct that is materially detrimental to the Company&#8217;s interests.  The Company will, within 120 days of discovery of the conduct, give Participant written notice specifying the conduct constituting Cause in reasonable detail and Participant will have 60 days to remedy such conduct, if such conduct is reasonably capable of being remedied.  In any instance where the Company may have grounds for Cause, failure by the Company to provide written notice of the grounds for Cause within 120 days of discovery shall be a waiver of its right to assert the subject conduct as a basis for termination for Cause.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)       &#8220;Change in Control&#8221; shall mean the sale of all or substantially all of the Company&#8217;s assets or any merger, reorganization, or exchange or tender offer which, in each case, will result in a change in the power to elect 50% or more of the members of the Board of Directors of the Company&#59; provided, however, that such a sale, merger or other event must also constitute either (i) a &#8220;change in the ownership&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(v), (ii) a &#8220;change in the effective control&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(vi)(A)(1) (replacing &#8220;30 percent&#8221; with &#8220;50 percent&#8221; as used in such regulation), or (iii) a change &#8220;in the ownership of a substantial portion of the assets&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(vii).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)       &#8220;Good Reason&#8221; shall mean the occurrence of any of the following without Participant&#8217;s written consent, in each case, when compared to the arrangements in effect immediately prior to the Change in Control&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.4</font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">any reduction in Participant&#8217;s base salary or target bonus expressed as a percentage of the Participant&#8217;s base salary, other than a reduction that is pursuant to a general reduction affecting a group of employees&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.8pt">a change in the principal location at which the Participant is required to perform his or her duties, if the new location is 50 miles or more further from the Participant&#8217;s principal residence than the original location&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:21.03pt">a material diminution in Participant&#8217;s duties, responsibilities or authority.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant will, within 120 days of discovery of such circumstances, give the Company written notice specifying the circumstances constituting Good Reason in reasonable detail and, upon receipt of such notice, the Company shall have 60 days to cure the circumstances constituting Good Reason.  Failure by Participant to provide written notice of the grounds for Good Reason within 120 days of discovery, or failure by the Participant to resign within 30 days after the end of the Company&#8217;s 60 day cure period, shall be a waiver of Participant&#8217;s right to assert the subject circumstance as a basis for termination for Good Reason.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)        &#8220;Separation from Service&#8221; shall mean when Participant dies, retires, or otherwise has a termination of employment with the Company that constitutes a &#8220;separation from service&#8221; within the meaning of Treasury Regulation Section 1.409A-1(h)(1), without regard to the optional alternative definitions available thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Possible Acceleration of Vesting and Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If the Award is terminated pursuant to a Change in Control and is not assumed by a party to the Change in Control (and no such party issues a new award in substitution for the Award, as determined by the Committee), the Committee may provide for immediate vesting of the Award, and the issuance of shares of Common Stock, securities of a party to the Change in Control, or cash, or any combination thereof, in full satisfaction of the Award.  Notwithstanding anything in the Plan or any other agreement to the contrary, there is no discretion to change the time of payment of the PRSUs (in connection with a Change in Control, similar event, or otherwise) except as expressly provided in this Section 3 or as otherwise permitted under, and would not result in any tax, penalty or interest under, Section 409A of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 409A - Possible Six-Month Delay in Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Notwithstanding any provision of this Award certificate to the contrary, if payment of the PRSUs is triggered by Participant&#8217;s Separation from Service as provided in this Section 3 or Section 4 and, as of the date of such Separation from Service, Participant is a &#8220;specified employee&#8221; (within the meaning of Section 409A of the Code and determined pursuant to procedures adopted by the Company), Participant shall not be entitled to such payment of the PRSUs until the earlier of (i) the date which is six (6) months after Participant&#8217;s Separation from Service for any reason other than death, or (ii) the date of Participant&#8217;s death.  Any amounts otherwise payable to Participant upon or in the six (6) month period following Participant&#8217;s Separation from Service that are not so paid by reason of this Section 3(g) shall be paid (without interest) as soon as practicable (and in all events within thirty (30) days) after the date that is six (6) months after Participant&#8217;s Separation from Service (or, if earlier, as soon as practicable, and in all events within thirty (30) days, after the date of Participant&#8217;s death).  The provisions of this Section 3(g) shall only apply if, and to the extent, required to avoid the imputation of any tax, penalty, or interest pursuant to Section 409A of the Code.</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Termination of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Termination of Employment Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Subject to the provisions of this Section 4, if, prior to vesting of the PRSUs pursuant to Section 2 or 3, Participant ceases to be an employee of the Company or any Affiliate, for any reason (voluntary or involuntary), then Participant&#8217;s rights to all of the unvested PRSUs shall be immediately and irrevocably forfeited on the date of termination. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Death or Long-Term Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. If Participant dies while employed by the Company or any Affiliate, or if Participant&#8217;s employment by the Company or any Affiliate is terminated due to Participant&#8217;s failure to return to work as the result of a long-term disability which renders Participant incapable of performing his or her duties as determined under the provisions of the long-term disability insurance program of the Company or the Affiliate by which the Participant is employed (&#8220;Disability&#8221;), then following the end of the Performance Period, if </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.4</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and to the extent the Committee, in accordance with Section 2 above, determines that the Performance Vesting Criteria has been met, such that some number of PRSUs will vest and the restrictions with respect thereto will lapse, Participant will vest in the number of PRSUs that would have vested had Participant been employed through the end of the Performance Period, and the restrictions with respect thereto will lapse.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant&#8217;s employment ends at a time when the Participant is not eligible for Retirement (as defined below) and in connection with that separation from employment the Company or an Affiliate pays the Participant severance benefits pursuant to an employment agreement with Participant that is in effect on the date of this Award or pursuant to any Company severance policy, plan or program in effect on the date of this Award, then following the end of the Performance Period, if and to the extent the Committee, in accordance with Section 2 above, determines that the Performance Vesting Criteria has been met, such that some number of PRSUs will vest and the restrictions with respect thereto will lapse, Participant will vest in a pro rata number of PRSUs, and the restrictions with respect thereto will lapse.  Such pro rationing shall be based on the number of full months of the Performance Period that Participant was employed prior to the date of termination plus the number of full months during which the Participant is entitled to receive severance or separation pay either the Company&#8217;s severance plan as in effect on the date hereof, or under an employment agreement between Participant and the Company or an Affiliate that is in effect on the date of this Award (provided that in no event shall such sum exceed the number of months in the Performance Period).  In either case, should Participant&#8217;s severance or separation pay be paid in a lump sum versus bi-weekly payments, the number of full months taken into account shall be based on the period of time over which severance or separation pay would have been paid had it been paid bi-weekly.  If Participant is entitled to severance or separation pay under a plan or agreement other than under the Company&#8217;s severance pay plan or an employment agreement entered into with the Company or an Affiliate, such pro rationing shall be based on the number of full months of the Performance Period that Participant was employed prior to the date of termination plus an additional three months, but not more than the number of months in the Performance Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If the Participant&#8217;s employment ends and at the time of separation from employment the Participant is eligible for Retirement (the &#8220;Retirement Date&#8221;), and at least one year of the Performance Period of this Award is completed at or prior to the Retirement Date, then following the end of the Performance Period, if and to the extent the Committee, in accordance with Section 2 above, determines that the Performance Vesting Criteria has been met, such that some number of PRSUs will vest and the restrictions with respect thereto will lapse, Participant will vest in the full number of PRSUs and the restrictions with respect thereto will lapse as if the Participant had been continuously employed throughout the entire Performance Period. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)        For purposes of this Award certificate, &#8220;Retirement&#8221; means the termination of employment of a Participant who is age 55 or older with at least ten years of Recognized Employment with the Company or any Affiliate other than by reason of (i) death or Disability or (ii) Cause.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)        For purposes of this Award certificate, &#8220;Recognized Employment&#8221; shall include only employment since the Participant&#8217;s most recent date of hire by the Company or any Affiliate, and shall not include employment with a company acquired by UnitedHealth Group or any Affiliate before the date of such acquisition.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Restriction on Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant may not transfer the PRSUs except by will or by the laws of descent and distribution.  Notwithstanding the foregoing, the Award may be transferred to an alternate payee pursuant to the terms of a domestic relations order (as such terms are defined by Section 414(p) of the Code), provided that (i) the Participant is an employee at the time the domestic relations order is entered, (ii) the Award was outstanding at the time the domestic relations order is entered, and (iii) the transfer otherwise satisfies all requirements of the Plan and any limitations and requirements established by the Committee.  Any attempt to otherwise transfer the PRSUs shall be void.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Special Restriction on Transfer for Certain Participants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. If Participant is an officer of the Company within the meaning of Section 16 of the Securities Exchange Act of 1934 and Rule 16a-1 issued thereunder, as such status is reasonably determined from time to time by the Board of Directors of the Company (a &#8220;Section 16 Officer&#8221;), at any time that shares of Common Stock are issued upon vesting of the PRSUs and the Company has theretofore communicated Participant&#8217;s status as a Section 16 Officer to Participant, the following special transfer restrictions apply to Participant&#8217;s Award. One-third (1&#47;3) of the net number of any shares of Common Stock acquired by Participant upon vesting of the PRSUs at a time when Participant is a Section 16 Officer (including any shares of Common Stock or other securities into which such shares may be converted or exchanged as a result of any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.4</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">adjustment made pursuant to this Award or Section 7 of the Plan) must be retained, and may not be sold or otherwise transferred, for a period of at least one year following the issuance date. For purposes of this Award certificate, the &#8220;net number of any shares of Common Stock acquired&#8221; shall mean the number of shares issued with respect to the Award after reduction for any shares of Common Stock withheld by or tendered to the Company, or sold on the market, to cover any federal, state, local or other payroll, withholding, income or other applicable tax withholding required in connection with the issuance of the shares. The restrictions of this Section 6 are in addition to, and not in lieu of, the restrictions imposed under other Company policies and applicable laws.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">7.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Forfeiture of PRSUs and Shares of Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This Section 7 sets forth circumstances under which Participant shall forfeit all or a portion of the PRSUs, or be required to repay the Company for the value realized in respect of all or a portion of the PRSUs.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Violation of Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant violates any provision of the Restrictive Covenants set forth in Section 8 below, then any unvested PRSUs shall be immediately and irrevocably forfeited without any payment therefor.  In addition, for any PRSUs that vested within one year prior to Participant&#8217;s termination of employment with the Company or any Affiliate or at any time after such termination of employment, the Participant shall be required, upon demand, to repay or otherwise reimburse the Company (including by forfeiting any deferred compensation credits in respect of such PRSUs under the Company&#8217;s non-qualified compensation deferral plans) an amount having a value equal to the aggregate Fair Market Value of the shares of Common Stock underlying such PRSUs on the date the PRSUs became vested.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Fraud</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If the Board determines that Participant has engaged in fraud that, in whole or in part, caused the need for a material restatement of the Company&#8217;s consolidated financial statements, then any PRSUs that have not yet been settled in shares of Common Stock (including any deferred compensation credits under the Company&#8217;s non-qualified compensation deferral plans in respect of PRSUs that have previously become vested) shall be immediately and irrevocably forfeited without any payment therefore.  In addition, for any PRSUs that became vested during the 12-month period following the first public issuance or filing with the Securities Exchange Commission (whichever occurs first) of the incorrect financial statements, Participant shall be required, upon demand, to repay or otherwise reimburse the Company (including by forfeiting any deferred compensation credits in respect of such PRSUs under the Company&#8217;s non-qualified compensation deferral plans) an amount having a value equal to the aggregate Fair Market Value of the shares of Common Stock underlying such PRSUs on the date the PRSUs became vested.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">In General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This Section 7 does not constitute the Company&#8217;s exclusive remedy for Participant&#8217;s violation of the Restrictive Covenants or commission of fraudulent conduct.  As the forfeiture and repayment provisions are not adequate remedies at law, the Company may seek any additional legal or equitable remedy, including injunctive relief, for any such violations, except that, if unvested PRSUs continue to vest under Section 4 following the termination of Participant&#8217;s employment with the Company or any Affiliate, then, with respect to the Restrictive Covenants in Sections 8 (c) or (d) below, the maximum period of time to which Company shall be entitled to injunctive relief is a total of two (2) years following the termination of Participant&#8217;s employment with the Company or any Affiliate, not counting any time period that Participant is in violation of the Restrictive Covenants in Sections 8(c) or (d) below and during which time the running of the time periods for the restrictions set forth in Sections 8(c) and (d) of this Agreement shall be tolled as permitted by applicable law such that the running of the two (2) year time period shall commence only once Participant is in compliance with the Restrictive Covenants.  The provisions in this Section 7 are essential economic conditions to the Company&#8217;s grant of PRSUs to Participant.  By receiving the grant of PRSUs hereunder, Participant agrees that the Company may deduct from any amounts it owes Participant from time to time (such as wages or other compensation, deferred compensation credits, vacation pay, any severance or other payments owed following a termination of employment, as well as any other amounts owed to the Participant by the Company) to the extent of any amounts Participant owes the Company under this section.  The provisions of this Section 7 and any amounts repayable by Participant hereunder are intended to be in addition to any rights to repayment the Company may have under Section 304 of the Sarbanes-Oxley Act of 2002, Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and other applicable law.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">8.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Assignment and Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In consideration of the terms of this Award certificate and the Company&#8217;s sharing of Confidential Information with the Participant, which the Participant agrees constitute adequate and sufficient mutually-agreed consideration, the Participant agrees to the Assignment and Restrictive Covenants set forth below in this Section 8. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.4</font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Assignment of Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant agree to assign and hereby assigns to Company all rights, titles and interests Participant may have in or to any invention, innovation, computer program, software, database, discovery, idea, writing, improvement, process, technique or other works (collectively &#34;Intellectual Property&#34;) whether or not patentable or registrable under copyright or similar statutes, created or conceived by Participant, either alone or jointly with others, during Participant&#8217;s employment that&#58; (i) relates in any manner to the actual or anticipated business, research, or development of Company&#59; (ii) results from work assigned to or performed by Participant for Company&#59; and&#47;or (iii) is conceived of or made with the use of Company systems, equipment, supplies, materials, facilities, computer programs, confidential information and&#47;or trade secret information (collectively &#8220;Company Resources&#8221;).  This assignment does not apply to Intellectual Property that meets all of the following criteria&#58; (i) no Company Resources were used in its creation&#59; (ii) the Intellectual Property was developed entirely on Participants own time&#59; (iii) at the time of conception or reduction to practice the Intellectual Property does not relate to Company&#8217;s business, actual or anticipated research or development&#59; and (iv) the Intellectual Property does not result from any work performed by Participant for Company.  Participant shall disclose to Company all Intellectual Property developed during Participant's employment so that Company may determine any rights it many have in such Intellectual Property.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Non-Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant has or will be given access to and provided with sensitive, confidential, proprietary and&#47;or trade secret information (collectively, &#8220;Confidential Information&#8221;) in the course of Participant&#8217;s employment.  Examples of Confidential Information include inventions, new product or marketing plans, business strategies and plans, merger and acquisition targets, financial and pricing information, computer programs, source codes, models and data bases, analytical models, customer lists and information, and supplier and vendor lists and other information which is not generally available to the public.  Participant shall not disclose or use Confidential Information, either during or after Participant&#8217;s employment with the Company, except (i) as necessary to perform Participant&#8217;s duties, (ii) as the Company may consent in writing, or (iii) as permitted by Section 8(f) below.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Non-Solicitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  During Participant&#8217;s employment and for two years after the later of (i) the termination of Participant&#8217;s employment with the Company for any reason whatsoever or (ii) the last scheduled vesting date under Section 4, Participant shall not, without the Company&#8217;s prior written consent, directly or indirectly, for Participant or for any other person or entity, as agent, employee, officer, director, consultant, owner, principal, partner, shareholder, or in any other individual or representative capacity&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">Solicit or conduct business with any business competitive with the Company from any person or entity&#58; (A) who was a Company provider or customer within the 12 months before Participant&#8217;s employment termination and with whom Participant had contact regarding the Company&#8217;s activity, products or services, or for whom Participant provided services or supervised employees who provided those services, or about whom Participant learned Confidential Information during employment related to the Company&#8217;s provision of products and services to such person or entity, or (B) was a prospective provider or customer the Company solicited within the 12 months before Participant&#8217;s employment termination and with whom Participant had contact for the purposes of soliciting the person or entity to become a provider or customer of the Company, or supervised employees who had those contacts, or about whom Participant learned Confidential Information during employment related to the Company&#8217;s provision of products and services to such person or entity&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.8pt">Raid, hire, employ, recruit or solicit any Company employee or consultant who possesses Confidential Information of the Company to leave the Company&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:21.03pt">Induce or influence any Company employee, consultant, or provider who possesses Confidential Information of the Company to terminate his, her or its employment or other relationship with the Company&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:21.57pt">Assist anyone in any of the activities listed above.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Non-Competition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  During Participant&#8217;s employment and for one year after the later of (i) the termination of Participant&#8217;s employment with the Company for any reason whatsoever or (ii) the last scheduled vesting date under Section 4, Participant shall not, without the Company&#8217;s prior written consent, directly or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.4</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">indirectly, for Participant or for any other person or entity, as agent, employee, officer, director, consultant, owner, principal, partner, shareholder, or in any other individual or representative capacity&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">Engage in or participate in any activity that competes, directly or indirectly, with any Company activity, product or service that Participant engaged in, participated in, or had Confidential Information about during Participant&#8217;s last 36 months of employment with the Company&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.8pt">Assist anyone in any of the activities listed above.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Geographic Scope</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">Participant&#8217;s obligations under subsections 4(c) and (d) of this &#8220;Assignments and Restrictive Covenants&#8221; section shall apply on a nationwide basis anywhere in the United States.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.8pt">Participant&#8217;s obligations under this &#8220;Assignments and Restrictive Covenants&#8221; section shall also apply in any country outside the United States with respect to which Participant had responsibility for any UnitedHealth Group activity, product or service in that country.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Return of Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Participant agrees that all tangible materials (whether originals or duplicates), including, but not limited to, notebooks, computers, files, reports, proposals, price lists, lists of actual or potential customers or suppliers, talent lists, formulae, prototypes, tools, equipment, models, specifications, technical data, methodologies, research results, test results, financial data, contracts, agreements, correspondence, documents, computer disks, software, computer printouts, information stored electronically, memoranda, and notes, in Participant&#8217;s possession, custody, or control which in any way relate to the Company&#8217;s business and which are furnished to Participant by or on behalf of the Company or which are prepared, compiled or acquired by Participant while working with or employed by the Company shall be the sole property of the Company.  At any time upon the request of the Company, and in any event promptly upon termination of Participant&#8217;s employment with the Company, but in any event no later than two (2) business days after such termination, Participant shall deliver all such materials to the Company and shall not retain any originals or copies (including electronically) of such materials.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">No Restriction on Protected Activities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Nothing in this Award certificate prohibits Participant from disclosing information in good faith to any governmental agency, legislative body, or official regarding an alleged violation of law or regulation or otherwise protected under applicable law, including, without limitation, the National Labor Relations Act, the Defend Trade Secrets Act, and any rule or regulation promulgated by the Securities and Exchange Commission, the National Labor Relations Board, the Equal Employment Opportunity Commission, or any other federal, state, or local government agency.  Participant acknowledges that, through this Section 8(f), the Company has provided Participant with written notice that, pursuant to the Defend Trade Secrets Act, 8 USC &#167; 1833(b), an employee, consultant, or contractor of an employer may not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of an employer&#8217;s trade secrets, so long as such disclosure is made solely&#58; (a) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating a suspected violation of law&#59; and&#47;or (b) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.  Additionally, Participant understands that, pursuant to 18 USC &#167; 1831 et seq., an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose a trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order.  The foregoing immunities provided under 18 USC &#167; 1831 et seq. do not apply to any disclosure of Confidential Information or trade secrets of an employer&#8217;s clients, customers, or counterparties, or of any other third parties. For purposes of this paragraph solely, &#8220;trade secret&#8221; has the meaning set forth in 18 USC &#167; 1839.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(h)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Exceptions for Attorneys</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Notwithstanding the foregoing, this Section 8 will apply only to the extent permissible under provisions of the ABA Model Rules of Professional Conduct, or any applicable state counterpart regarding restrictions on the right to practice law.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.4</font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Acknowledgment of Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. By accepting the Award, Participant agrees that the provisions of this Section 8 are reasonable and necessary to protect the legitimate interests of the Company.  Participant further acknowledges that Participant&#8217;s obligations under this Section 8 are in addition to, and do not limit, any and all obligations concerning the same subject matter arising under any applicable law, including, without limitation, common law and statutory law relating to fiduciary duties and trade secrets.  To the extent Participant and the Company agree at any time to enter into separate agreements containing restrictive covenants or assignment of intellectual property with different or inconsistent terms than those contained herein, Participant and the Company acknowledge and agree that such different or inconsistent terms shall not in any way affect or have relevance to the Assignment and Restrictive Covenants contained herein.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">9.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Adjustments to PRSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In the event that any dividend or other distribution (whether in the form of cash,  shares of Common Stock, other securities or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase or exchange of Common Stock or other securities of the Company or other similar corporate transaction or event affecting the Common Stock would be reasonably likely to result in the diminution or enlargement of any of the benefits or potential benefits intended to be made available under the Award (including, without limitation, the benefits or potential benefits of provisions relating to the vesting of the PRSUs), the Committee shall, in such manner as it shall deem equitable or appropriate in order to prevent such diminution or enlargement of any such benefits or potential benefits, make adjustments to the Award, including adjustments in the number and type of shares of Common Stock Participant would have received upon vesting of the PRSUs. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">10.       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Tax Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In order to comply with all applicable federal or state income tax laws or regulations, the Company may take such action as it deems appropriate to ensure that all applicable federal or state payroll, withholding, income or other taxes, which are the sole and absolute responsibility of Participant, are withheld or collected from Participant.  Participant is liable and responsible for all taxes owed in connection with the Award, regardless of any action the Company takes with respect to any tax withholding obligations that arise in connection with the Award.  The ultimate tax liability, which is the Participant&#8217;s responsibility, may exceed the amount withheld by the Company.  On each applicable vesting date, Participant will be deemed to have elected to satisfy Participant&#8217;s required federal, state, and local payroll, withholding, income, or other tax withholding obligations arising from the receipt of shares or the lapse of restrictions relating to the PRSUs, by having the Company withhold a portion of the shares of Common Stock otherwise to be delivered having a Fair Market Value equal to the amount of such taxes (but not in excess of the maximum amount required to be withheld under applicable laws or regulations).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  It is intended that this Award and any amounts payable under this Award shall either be exempt from or comply with Section 409A of the Code (including the Treasury regulations and other published guidance relating thereto) so as not to subject Participant to payment of any additional tax, penalty, or interest imposed under Section 409A of the Code.  The provisions of this Award certificate shall be construed and interpreted to avoid the imputation of any such additional tax, penalty, or interest under Section 409A of the Code yet preserve (to the nearest extent reasonably possible) the intended benefit payable to Participant.  To the extent that the time or form of payment of any benefit pursuant to this Award would violate the terms of Section 409A, the Committee may revise the time or form of payment to conform to Section 409A.  Notwithstanding the foregoing, in no event shall the Company, any Affiliate, the members of the Committee, or any other person have any liability for any additional tax, penalty or interest imposed on Participant by reason of Section 409A or otherwise.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">11.       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)       This Award does not confer on Participant any right to continued employment or any other relationship with the Company or any Affiliate, nor will it interfere in any way with the right of the Company to terminate Participant at any time.  Participant&#8217;s employment with the Company is at will.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       Neither the Plan nor this Award shall create or be construed to create a trust or separate fund of any kind or a fiduciary relationship between the Company and Participant or any other Person.  To the extent that any Person acquires a right to receive payments from the Company or any Affiliate pursuant to an Award, such right shall be no greater than the right of any unsecured creditor of the Company or any Affiliate.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.4</font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)       The Company shall not be required to deliver any shares of Common Stock upon the vesting of any PRSUs until the requirements of any federal or state securities laws, rules or regulations or other laws or rules (including the rules of any securities exchange) as may be determined by the Company to be applicable have been and continue to be satisfied (including an effective registration of the shares under federal and state securities laws). </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)       An original record of this Award and all the terms hereof, executed by the Company, is held on file by the Company. To the extent there is any conflict between the terms contained in this Award and the terms contained in the original held by the Company, the terms of the original held by the Company shall control. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)        The Restrictive Covenants in Section 8 and the provisions regarding the forfeiture of PRSUs and shares of Common Stock shall survive termination of the PRSUs.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Choice of Law, Injunctive Relief, Attorney&#8217;s Fees and Jury Trial</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant consents to the law of Minnesota exclusively being applied to any matter arising out of or relating to this Award certificate, without regard to its conflict of law principles, and exclusively to personal and subject matter jurisdiction in the state and federal courts of Minnesota for any dispute relating to this Award certificate or Participant&#8217;s relationship with the Company.  In the event of a breach or a threatened breach of this Award by Participant, Participant acknowledges that the Company will face irreparable injury which may be difficult to calculate in dollar terms and that the Company shall be entitled, in addition to remedies otherwise available at law or in equity, to temporary restraining orders and preliminary injunctions and final injunctions without the posting of a bond enjoining such breach or threatened breach.  Should the Company successfully enforce any portion of this Award certificate before a trier of fact or in an arbitration proceeding, the Company shall be entitled to all of its reasonable attorney&#8217;s fees and costs incurred as a result of enforcing this Award certificate against Participant. Participant waives all rights or entitlement to a jury trial for any matter arising out of or relating to this Award certificate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">No Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  No waiver of any breach of any provision of this Award certificate by the Company shall be effective unless it is in writing, and no waiver shall be construed to be a waiver of any succeeding breach or as a modification of such provision.  The provisions of this Award certificate shall be severable, and if any provision of this Award certificate is found by any court or arbitrator to be unenforceable, in whole or in part, the remainder of this Award certificate shall nevertheless be enforceable and binding on the parties.  Participant also agrees that a court or arbitrator may modify any invalid, overbroad or unenforceable term of this Award certificate so that such term, as modified, is valid and enforceable under applicable law, and that a court or arbitrator is authorized to extend the length of the Restrictive Covenants in Section 8 of this Award certificate for any period of time in which Participant is in breach of the Restrictive Covenants or as necessary to protect the legitimate business interests of Company. Further, Participant affirmatively states that Participant has not, will not, and cannot rely on any representations not expressly made herein.  The terms of this Award certificate shall not be amended by Participant or Company except by the express written consent of the Company and Participant.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(h)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Consideration Period&#59; Right to Consult with Counsel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  By the Participant&#8217;s acceptance below, the Participant acknowledges and agrees that the Company provided the Participant with at least ten (10) business days to review and consider this Award certificate and that voluntarily accepting this Award certificate before the expiration of ten (10) business days shall serve as a waiver of the ten (10) day review period. The Participant has the right and is advised to consult with counsel of his&#47; her choice before signing this document.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Assignability and Change of Position</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The rights and&#47;or obligations herein may be assigned by the Company without Participant&#8217;s consent and shall bind and inure to the benefit of the Company&#8217;s successors, assigns, and representatives.  If the Company makes any assignment of the rights and&#47;or obligations herein, Participant agrees that this Award certificate shall remain binding upon Participant in any event.</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Offer Date&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#GrantDate#</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By </font><img alt="strausssignaturea.jpg" src="strausssignaturea.jpg" style="height:37px;margin-bottom:5pt;vertical-align:text-bottom;width:127px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, on behalf of UnitedHealth Group Incorporated</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.4</font></div></div><div style="margin-bottom:12pt;text-align:right;text-indent:17.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Acceptance Date&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#AcceptanceDate#</font></div><div style="margin-bottom:12pt;text-align:right;text-indent:17.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Signed Electronically&#47;Signed Manually&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#Signature#</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>5
<FILENAME>unhex10512312021.htm
<DESCRIPTION>EX-10.5
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i8afbc099f8994c99b43b364d61e50eeb_33"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.5</font></div></div><div style="margin-bottom:12pt;text-align:center"><img alt="uhglogo2019a021.jpg" src="uhglogo2019a021.jpg" style="height:71px;margin-bottom:5pt;vertical-align:text-bottom;width:404px"></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">RESTRICTED STOCK UNIT AWARD</font></div><div style="margin-bottom:12pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.666%"><tr><td style="width:1.0%"></td><td style="width:31.417%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.422%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.368%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.422%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Award Date</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(mm&#47;dd&#47;yyyy)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#GrantDate#</font></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Number of Units</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#QuantityGranted#</font></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Final Vesting Date</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(mm&#47;dd&#47;yyyy)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#GrantCustom2#</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">THIS CERTIFIES THAT UnitedHealth Group Incorporated (the &#8220;Company&#8221;) has on the award date specified above (the &#8220;Award Date&#8221;) granted to</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">#ParticipantName#</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(&#8220;Participant&#8221;) an award (the &#8220;Award&#8221;) to receive that number of restricted stock units (the &#8220;RSUs&#8221;) indicated above in the box labeled &#8220;Number of Units,&#8221; each RSU representing the right to receive one share of UnitedHealth Group Incorporated Common Stock, $.01 par value per share (the &#8220;Common Stock&#8221;), subject to certain restrictions and on the terms and conditions contained in this Award and the UnitedHealth Group Incorporated 2020 Stock Incentive Plan (the &#8220;Plan&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Participant acknowledges and agrees that the Company may deliver, by electronic mail, the use of the Internet, including through the website of the agent appointed by the Compensation and Human Resources Committee of the Board of Directors of the Company (the &#8220;Committee&#8221;) to administer the Plan, the Company intranet web pages or otherwise, any information concerning the Company&#59; the Award&#59; the Plan, pursuant to which the Company granted the Award&#59; and any information required by the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A copy of the Plan is available upon request.  In the event of any conflict between the terms of the Plan and this Award certificate, the terms of the Plan shall govern.  Any terms not defined herein shall have the meaning set forth in the Plan.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">* * * * *</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt;text-decoration:underline">Rights of the Participant with Respect to the RSUs.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:6.91pt;text-decoration:underline">No Shareholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The RSUs granted pursuant to this Award certificate do not and shall not entitle Participant to any rights of a shareholder of Common Stock, except as provided below.  The rights of Participant with respect to the RSUs shall remain forfeitable at all times prior to the date on which such rights become vested, and the restrictions with respect to the RSUs lapse, in accordance with Section 2, 3 or 4.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:6.34pt;text-decoration:underline">Conversion of RSUs&#59; Issuance of Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  No shares of Common Stock shall be issued to Participant prior to the date on which the RSUs vest, and the restrictions with respect to the RSUs lapse, in accordance with Section 2, 3 or 4.  Neither this Section 1(b) nor any action taken pursuant to or in accordance with this Section 1(b) shall be construed to create a trust of any kind.  After any RSUs vest pursuant to Section 2, 3 or 4, the Company shall promptly cause to be issued shares of Common Stock to Participant or in the name of Participant&#8217;s legal representatives, beneficiaries or heirs, as the case may be, in payment of such vested whole RSUs, at the times provided in Section 2, 3 or 4, as applicable.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:6.91pt;text-decoration:underline">Dividends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If a cash dividend is declared and paid by the Company with respect to the Common Stock, Participant shall be credited as of the applicable dividend payment date with an additional number of whole and&#47;or fractional RSUs (the &#8220;Dividend Units&#8221;) equal to (A) the total cash dividend Participant would have received had Participant&#8217;s RSUs (and any previously credited Dividend Units with respect thereto) been actual shares of Common Stock, divided by (B) the Fair Market Value of a share of Common Stock as of the applicable dividend payment date.  As of each vesting date pursuant to Sections 2, 3 or 4, the number of Dividend Units paid on the RSUs vesting on such vesting date shall become vested, earned and payable in the form of shares of Common Stock&#59; provided, however, that any vested Dividend Units not converted into a whole share of Common Stock may be converted into a fractional Dividend Unit or a cash payment.  To the extent Participant&#8217;s rights to any unvested RSUs are forfeited, the Dividend Units paid on such forfeited RSUs shall also be forfeited.  The terms of this Award certificate shall apply to all Dividend Units paid on the RSUs.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Subject to the terms and conditions of this Award certificate, __% of the RSUs shall vest, and the restrictions with respect to the RSUs shall lapse, on each of the __________ anniversaries of the grant date if Participant remains continuously employed by the Company or any Affiliate until the respective vesting dates.  Any RSUs that vest pursuant to this Section 2 shall be paid to Participant no later than March 15th of the year following the year in which the vesting event occurs (which payment schedule is intended to comply with the &#8220;short-term deferral&#8221; exemption from the application of Section 409A of the Code).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Early Vesting On Certain Terminations On or After Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Notwithstanding the other vesting provisions contained in Section 2 and Section 4, but subject to the other terms and conditions set forth herein, all of the RSUs shall become immediately and unconditionally vested if, on or within two years after the effective date of a Change in Control, the Participant ceases to be an employee of the Company or any Affiliate as a result of a termination of employment (i) by the Participant for Good Reason, (ii) by the Company or any Affiliate without Cause, (iii) at a time when Participant is eligible for Retirement (as defined below), (iv) due to Participant&#8217;s Disability (as defined below), or (v) in the circumstances described in Section 4(c)&#59; provided that in the case of a termination for Good Reason, the RSUs shall vest if the Participant gives written notice of the circumstances constituting Good Reason within two years after the effective date of the Change in Control, if the Company fails to cure the circumstances constituting Good Reason within 60 days of the receipt of such notice and the Participant resigns within 30 days after the end of the cure period, all as provided in Section 3(d).  Any RSUs that vest pursuant to this Section 3 shall be paid to Participant in a lump sum within thirty (30) days after the date of Participant&#8217;s Separation from Service.  For purposes of this Award&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt">&#8220;Affiliate&#8221; shall mean (i) any entity that, directly or indirectly through one or more intermediaries, is controlled by the Company and (ii) any entity in which the Company has a significant equity interest, as determined by the Committee.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt"> &#8220;Change in Control&#8221; shall mean the sale of all or substantially all of the Company&#8217;s assets or any merger, reorganization, or exchange or tender offer which, in each case, will result in a change in the power to elect 50% or more of the members of the Board of Directors of the Company&#59; provided, however, that such a sale, merger, or other event must also constitute either (i) a &#8220;change in the ownership&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(v), (ii) a &#8220;change in the effective control&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(vi)(A)(1) (replacing &#8220;30 percent&#8221; with &#8220;50 percent&#8221; as used in such regulation), or (iii) a change &#8220;in the ownership of a substantial portion of the assets&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(vii).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt">&#8220;Cause&#8221; shall mean Participant&#8217;s (a) material failure to follow the Company&#8217;s reasonable direction or to perform any duties reasonably required on material matters, (b) material violation of, or failure to act upon or report known or suspected violations of, the Company&#8217;s Code of Conduct, as may be amended from time to time, (c) conviction of any felony, (d) commission of any criminal, fraudulent, or dishonest act in connection with Participant&#8217;s employment, (e) breach of any of the Restrictive Covenants in Section 8 of this Award certificate or a material breach of any employment agreement between Participant and the Company or any Affiliate, if any, or (f) conduct that is materially detrimental to the Company&#8217;s interests.  The Company will, within 120 days of discovery of the conduct, give Participant </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">written notice specifying the conduct constituting Cause in reasonable detail and Participant will have 60 days to remedy such conduct, if such conduct is reasonably capable of being remedied.  In any instance where the Company may have grounds for Cause, failure by the Company to provide written notice of the grounds for Cause within 120 days of discovery shall be a waiver of its right to assert the subject conduct as a basis for termination for Cause. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt">&#8220;Good Reason&#8221; shall mean the occurrence of any of the following without Participant&#8217;s written consent, in each case, when compared to the arrangements in effect immediately prior to the Change in Control&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">any reduction in Participant&#8217;s base salary or target bonus expressed as a percentage of the Participant&#8217;s base salary, other than a reduction that is pursuant to a general reduction affecting a group of employees&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.8pt">a change in the principal location at which the Participant is required to perform his or her duties, if the new location is 50 miles or more further from the Participant&#8217;s principal residence than the original location&#59; </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:21.03pt">a material diminution in Participant&#8217;s duties, responsibilities, or authority&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:21.57pt">a change in Participant&#8217;s reporting relationship.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant will, within 120 days of discovery of such circumstances, give the Company written notice specifying the circumstances constituting Good Reason in reasonable detail and, upon receipt of such notice, the Company shall have 60 days to cure the circumstances constituting Good Reason.  Failure by Participant to provide written notice of the grounds for Good Reason within 120 days of discovery, or failure by the Participant to resign within 30 days after the end of the Company&#8217;s 60 day cure period, shall be a waiver of Participant&#8217;s right to assert the subject circumstance as a basis for termination for Good Reason.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt">Separation from Service&#8221; shall mean when Participant dies, retires, or otherwise has a termination of employment with the Company that constitutes a &#8220;separation from service&#8221; within the meaning of Treasury Regulation Section 1.409A-1(h)(1), without regard to the optional alternative definitions available thereunder.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.01pt;text-decoration:underline">Possible Acceleration of Vesting and Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If the Award is terminated pursuant to a Change in Control and is not assumed by a party to the Change in Control (and no such party issues a new award in substitution for the Award, as determined by the Committee), the Committee may provide for immediate vesting of the Award, and the issuance of shares of Common Stock, securities of a party to the Change in Control, or cash, or any combination thereof, in full satisfaction of the Award.  Notwithstanding anything in the Plan or any other agreement to the contrary, there is no discretion to change the time of payment of the RSUs (in connection with a Change in Control, similar event, or otherwise) except as expressly provided in this Section 3 or as otherwise permitted under, and would not result in any tax, penalty or interest under, Section 409A of the Code.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">Section 409A - Possible Six-Month Delay in Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Notwithstanding any provision of this Award certificate to the contrary, if payment of the RSUs is triggered by Participant&#8217;s Separation from Service as provided in this Section 3 or Section 4 and, as of the date of such Separation from Service, Participant is a &#8220;specified employee&#8221; (within the meaning of Section 409A of the Code and determined pursuant to procedures adopted by the Company), Participant shall not be entitled to such payment of the RSUs until the earlier of (i) the date which is six (6) months after Participant&#8217;s Separation from Service for any reason other than death, or (ii) the date of Participant&#8217;s death.  Any amounts otherwise payable to Participant upon or in the six (6) month period following Participant&#8217;s Separation from Service that are not so paid by reason of this Section 3(g) shall be paid (without interest) as soon as practicable (and in all events within thirty (30) days) after the date that is six (6) months after Participant&#8217;s Separation from Service (or, if earlier, as soon as practicable, and in all events within thirty (30) days, after the date of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant&#8217;s death).  The provisions of this Section 3(g) shall only apply if, and to the extent, required to avoid the imputation of any tax, penalty, or interest pursuant to Section 409A of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Termination of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">Termination of Employment Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Except as expressly provided in Section 3 or this Section 4, if, prior to vesting of the RSUs pursuant to Section 2, Participant ceases to be an employee of the Company or any Affiliate for any reason (voluntary or involuntary), and does not continue after such cessation of service to be either an employee of the Company or any Affiliate, then Participant&#8217;s rights to all of the unvested RSUs shall be immediately and irrevocably forfeited on the date of termination.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">Death or Permanent Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant dies while employed by the Company or any Affiliate, or if Participant receives disability benefits under the long-term disability insurance program of the Company or the Affiliate by which the Participant is employed for a period of at least three months (&#8220;Disability&#8221;), then all unvested RSUs shall become immediately vested, and the restrictions with respect to all of the RSUs shall lapse, as of the date of such death or Disability.  Any RSUs that vest pursuant to this Section 4(b) shall be paid to Participant or Participant&#8217;s estate not later than 90 days after the date of such death or Disability.  Notwithstanding the foregoing, if the condition that results in Participant receiving Disability benefits is not a medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than 12 months, then the RSUs shall become immediately vested as provided above, but settlement shall be on the dates on which the RSUs would have vested under the original vesting schedule set forth in Section 2. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant&#8217;s employment with the Company or any Affiliate terminates at a time when Participant is not eligible for Retirement (and other than due to Participant&#8217;s death or Disability) and, in the circumstances, Participant is entitled to severance or separation pay, the following provisions of this Section 4(c) will apply.  If Participant is entitled to severance under the Company&#8217;s severance pay plan as in effect on the date hereof, then the RSUs shall continue to vest, and the restrictions with respect to the RSUs shall continue to lapse, for the period of such severance that Participant is eligible to receive.  If Participant is entitled to severance under an employment agreement entered into with the Company or an Affiliate, then vesting of the RSUs, and lapsing of their restrictions, shall continue for the period of such severance that Participant would be entitled to receive under that agreement as of the date hereof.  If Participant is entitled to separation pay under a plan or agreement other than under the Company&#8217;s severance pay plan or an employment agreement entered into with the Company or an Affiliate, then vesting of the RSUs, and lapsing of their restrictions, shall continue for three months.  In any case, should Participant&#8217;s severance or separation pay be paid in a lump sum versus bi-weekly payments, the RSUs shall continue to vest for the period of time in which severance or separation pay would have been paid had it been paid bi-weekly.  Any RSUs that vest pursuant to this Section 4(c) shall be paid to Participant on the dates on which the RSUs would have vested under the original vesting schedule set forth in Section 2.  For avoidance of doubt, any RSUs that are unvested on the date of termination of Participant&#8217;s employment and do not vest under the schedule set forth in Section 2 during the applicable severance or separation pay period identified above in this Section 4(c) shall be forfeited.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">Retirement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> If Participant ceases to be an employee of the Company or any Affiliate and Participant is eligible for Retirement at the time of such termination of employment, then the vesting of the RSUs shall continue as if such termination of employment had not occurred, subject to provisions set out in Section 7 below.  Any RSUs that vest pursuant to this Section 4(d) shall be paid to Participant on the dates on which the RSUs would have vested under the original vesting schedule set forth in Section 2.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt">For purposes of this Award certificate, &#8220;Retirement&#8221; means the termination of employment of a Participant who is age 55 or older with at least ten years of Recognized Employment with the Company or any Affiliate other than by reason of (i) death or Disability or (ii) Cause. Notwithstanding the terms of any other agreement heretofore or hereafter entered into between the parties that reference retirement, Participant and the Company acknowledge and agree that for purposes of calculating years of service for retirement eligibility, Participant will receive three point seven (3.7) years of service credit for each year he remains employed with the Company after February 3, 2021. If, prior to February 3, 2023, Participant is terminated by the Company without Cause or if Participant terminates employment for Good </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Reason, as defined in Participant&#8217;s employment agreement effective February 3, 2021, Participant will be deemed to have met the applicable age and service requirements and will be retirement eligible.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.01pt">For purposes of this Award certificate, &#8220;Recognized Employment&#8221; shall include only employment since the Participant&#8217;s most recent date of hire by the Company or any Affiliate, and shall not include employment with a company acquired by the Company or any Affiliate before the date of such acquisition. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Restriction on Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant may not transfer the RSUs except by will or by the laws of descent and distribution.  Notwithstanding the foregoing, the Award may be transferred to an alternate payee pursuant to the terms of a domestic relations order (as such terms are defined by Section 414(p) of the Code), provided that (i) the Participant is an employee at the time the domestic relations order is entered, (ii) the Award was outstanding at the time the domestic relations order is entered, and (iii) the transfer otherwise satisfies all requirements of the Plan and any limitations and requirements established by the Committee.  Any attempt to otherwise transfer the RSUs shall be void.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Special Restriction on Transfer for Certain Participants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant is an officer of the Company within the meaning of Section 16 of the Securities Exchange Act of 1934 and Rule 16a-1 issued thereunder, as such status is reasonably determined from time to time by the Board of Directors of the Company (a &#8220;Section 16 Officer&#8221;), at any time that shares of Common Stock are issued upon the vesting of RSUs and the Company has theretofore communicated Participant&#8217;s status as a Section 16 Officer to Participant, the following special transfer restrictions apply to Participant&#8217;s Award.  One-third (1&#47;3) of the net number of any shares of Common Stock acquired by Participant upon the vesting of RSUs at a time when Participant is a Section 16 Officer (including any shares of Common Stock or other securities into which such shares may be converted or exchanged as a result of any adjustment made pursuant to this Award or Section 7 of the Plan) must be retained, and may not be sold or otherwise transferred, for a period of at least one year following the applicable vesting date.  For purposes of this Award, the &#8220;net number of any shares of Common Stock acquired&#8221; shall mean the number of shares issued upon vesting of RSUs after reduction for any shares of Common Stock withheld by or tendered to the Company, or sold on the market, to cover any federal, state, local, or other payroll, withholding, income, or other applicable tax withholding required in connection with the issuance of the shares.  The restrictions of this Section 6 are in addition to, and not in lieu of, the restrictions imposed under other Company policies and applicable laws.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Forfeiture of RSUs and Shares of Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This Section 7 sets forth circumstances under which Participant shall forfeit all or a portion of the RSUs, or be required to repay the Company for the value realized in respect of all or a portion of the RSUs.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">Violation of Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant violates any provision of the Restrictive Covenants set forth in Section 8 below, then any unvested RSUs shall be immediately and irrevocably forfeited without any payment therefor.  In addition, for any RSUs that vested within one year prior to Participant&#8217;s termination of employment with the Company or any Affiliate or at any time after such termination of employment, the Participant shall be required, upon demand, to repay or otherwise reimburse the Company (including by forfeiting any deferred compensation credits in respect of such RSUs under the Company&#8217;s non-qualified compensation deferral plans) an amount having a value equal to the aggregate Fair Market Value of the shares of Common Stock underlying such RSUs on the date the RSUs became vested.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">Fraud</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If the Board determines that Participant has engaged in fraud that, in whole or in part, caused the need for a material restatement of the Company&#8217;s consolidated financial statements, then any RSUs that have not yet been settled in shares of Common Stock (including any deferred compensation credits under the Company&#8217;s non-qualified compensation deferral plans in respect of RSUs that have previously become vested) shall be immediately and irrevocably forfeited without any payment therefore.  In addition, for any RSUs that became vested during the 12-month period following the first public issuance or filing with the Securities Exchange Commission (whichever occurs first) of the incorrect financial statements, Participant shall be required, upon demand, to repay or otherwise reimburse the Company (including by forfeiting any deferred compensation credits in respect of such RSUs under the Company&#8217;s non-qualified compensation deferral plans) an amount having a value equal to the aggregate </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Market Value of the shares of Common Stock underlying such RSUs on the date the RSUs became vested.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">In General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This Section 7 does not constitute the Company&#8217;s exclusive remedy for Participant&#8217;s violation of the Restrictive Covenants or commission of fraudulent conduct.  As the forfeiture and repayment provisions are not adequate remedies at law, the Company may seek any additional legal or equitable remedy, including injunctive relief, for any such violations, except that, if unvested RSUs continue to vest under Section 4 following the termination of Participant&#8217;s employment with the Company or any Affiliate, then, with respect to the Restrictive Covenants in Sections 8 (c) or (d) below, the maximum period of time to which Company shall be entitled to injunctive relief is a total of two (2) years following the termination of Participant&#8217;s employment with the Company or any Affiliate, not counting any time period that Participant is in violation of the Restrictive Covenants in Sections 8(c) or (d) below and during which time the running of the time periods for the restrictions set forth in Sections 8(c) and (d) of this Agreement shall be tolled as permitted by applicable law such that the running of the two (2) year time period shall commence only once Participant is in compliance with the Restrictive Covenants.  The provisions in this Section 7 are essential economic conditions to the Company&#8217;s grant of RSUs to Participant.  By receiving the grant of RSUs hereunder, Participant agrees that the Company may deduct from any amounts it owes Participant from time to time (such as wages or other compensation, deferred compensation credits, vacation pay, any severance or other payments owed following a termination of employment, as well as any other amounts owed to the Participant by the Company) to the extent of any amounts Participant owes the Company under this section.  The provisions of this Section 7 and any amounts repayable by Participant hereunder are intended to be in addition to any rights to repayment the Company may have under Section 304 of the Sarbanes-Oxley Act of 2002, Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and other applicable law.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Assignment and Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In consideration of the terms of this Award certificate and the Company&#8217;s sharing of Confidential Information with the Participant, which the Participant agrees constitute adequate and sufficient mutually-agreed consideration, the Participant agrees to the Assignment and Restrictive Covenants set forth below in this Section 8. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">Assignment of Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant agree to assign and hereby assigns to Company all rights, titles and interests Participant may have in or to any invention, innovation, computer program, software, database, discovery, idea, writing, improvement, process, technique or other works (collectively &#8220;Intellectual Property&#8221;) whether or not patentable or registrable under copyright or similar statutes, created or conceived by Participant, either alone or jointly with others, during Participant&#8217;s employment that&#58; (i) relates in any manner to the actual or anticipated business, research, or development of Company&#59; (ii) results from work assigned to or performed by Participant for Company&#59; and&#47;or (iii) is conceived of or made with the use of Company systems, equipment, supplies, materials, facilities, computer programs, confidential information and&#47;or trade secret information (collectively &#8220;Company Resources&#8221;).  This assignment does not apply to Intellectual Property that meets all of the following criteria&#58; (i) no Company Resources were used in its creation&#59; (ii) the Intellectual Property was developed entirely on Participants own time&#59; (iii) at the time of conception or reduction to practice the Intellectual Property does not relate to Company&#8217;s business, actual or anticipated research or development&#59; and (iv) the Intellectual Property does not result from any work performed by Participant for Company.  Participant shall disclose to Company all Intellectual Property developed during Participant's employment so that Company may determine any rights it many have in such Intellectual Property. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">Non-Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant has or will be given access to and provided with sensitive, confidential, proprietary and&#47;or trade secret information (collectively, &#8220;Confidential Information&#8221;) in the course of Participant&#8217;s employment.  Examples of Confidential Information include inventions, new product or marketing plans, business strategies and plans, merger and acquisition targets, financial and pricing information, computer programs, source codes, models and data bases, analytical models, customer lists and information, and supplier and vendor lists and other information which is not generally available to the public.  Participant shall not disclose or use Confidential Information, either during or after Participant&#8217;s employment with the Company, except (i) as necessary to perform Participant&#8217;s duties, (ii) as the Company may consent in writing, or (iii) as permitted by Section 8(g) below.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">Non-Solicitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  During Participant&#8217;s employment and for two years after the later of (i) the termination of Participant&#8217;s employment with the Company for any reason whatsoever or (ii) the last scheduled vesting date under Section 4, Participant shall not, without the Company&#8217;s prior written consent, directly or indirectly, for Participant or for any other person or entity, as agent, employee, officer, director, consultant, owner, principal, partner, shareholder, or in any other individual or representative capacity&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">Solicit or conduct business with any business competitive with the Company from any person or entity&#58; (A) who was a Company provider or customer within the 12 months before Participant&#8217;s employment termination and with whom Participant had contact regarding the Company&#8217;s activity, products or services, or for whom Participant provided services or supervised employees who provided those services, or about whom Participant learned Confidential Information during employment related to the Company&#8217;s provision of products and services to such person or entity, or (B) was a prospective provider or customer the Company solicited within the 12 months before Participant&#8217;s employment termination and with whom Participant had contact for the purposes of soliciting the person or entity to become a provider or customer of the Company, or supervised employees who had those contacts, or about whom Participant learned Confidential Information during employment related to the Company&#8217;s provision of products and services to such person or entity&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.8pt">Raid, hire, employ, recruit or solicit any Company employee or consultant who possesses Confidential Information of the Company to leave the Company&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:21.03pt">Induce or influence any Company employee, consultant, or provider who possesses Confidential Information of the Company to terminate his, her or its employment or other relationship with the Company&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:21.57pt">Assist anyone in any of the activities listed above.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">Non-Competition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  During Participant&#8217;s employment and for one year after the later of (i) the termination of Participant&#8217;s employment with the Company for any reason whatsoever or (ii) the last scheduled vesting date under Section 4, Participant shall not, without the Company&#8217;s prior written consent, directly or indirectly, for Participant or for any other person or entity, as agent, employee, officer, director, consultant, owner, principal, partner, shareholder, or in any other individual or representative capacity&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">Engage in or participate in any activity that competes, directly or indirectly, with any Company activity, product or service that Participant engaged in, participated in, or had Confidential Information about during Participant&#8217;s last 36 months of employment with the Company&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.8pt">Assist anyone in any of the activities listed above.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">Geographic Scope</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">Participant&#8217;s obligations under subsections 8(c) and (d) of this &#8220;Assignments and Restrictive Covenants&#8221; section shall apply on a nationwide basis anywhere in the United States.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.8pt">Participant&#8217;s obligations under this &#8220;Assignments and Restrictive Covenants&#8221; section shall also apply in any country outside the United States with respect to which Participant had responsibility for any UnitedHealth Group activity, product or service in that country.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.01pt;text-decoration:underline">Return of Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Participant agrees that all tangible materials (whether originals or duplicates), including, but not limited to, notebooks, computers, files, reports, proposals, price lists, lists of actual or potential customers or suppliers, talent lists, formulae, prototypes, tools, equipment, models, specifications, technical data, methodologies, research results, test results, financial data, contracts, agreements, correspondence, documents, computer disks, software, computer printouts, information stored </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">electronically, memoranda, and notes, in Participant&#8217;s possession, custody, or control which in any way relate to the Company&#8217;s business and which are furnished to Participant by or on behalf of the Company or which are prepared, compiled or acquired by Participant while working with or employed by the Company shall be the sole property of the Company.  At any time upon the request of the Company, and in any event promptly upon termination of Participant&#8217;s employment with the Company, but in any event no later than two (2) business days after such termination, Participant shall deliver all such materials to the Company and shall not retain any originals or copies (including electronically) of such materials.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">No Restriction on Protected Activities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Nothing in this Award certificate prohibits Participant from disclosing information in good faith to any governmental agency, legislative body, or official regarding an alleged violation of law or regulation or otherwise protected under applicable law, including, without limitation, the National Labor Relations Act, the Defend Trade Secrets Act, and any rule or regulation promulgated by the Securities and Exchange Commission, the National Labor Relations Board, the Equal Employment Opportunity Commission, or any other federal, state, or local government agency.  Participant acknowledges that, through this Section 8(g), the Company has provided Participant with written notice that, pursuant to the Defend Trade Secrets Act, 8 USC &#167; 1833(b), an employee, consultant, or contractor of an employer may not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of an employer&#8217;s trade secrets, so long as such disclosure is made solely&#58; (a) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating a suspected violation of law&#59; and&#47;or (b) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.  Additionally, Participant understands that, pursuant to 18 USC &#167; 1831 et seq., an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose a trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order.  The foregoing immunities provided under 18 USC &#167; 1831 et seq. do not apply to any disclosure of Confidential Information or trade secrets of an employer&#8217;s clients, customers, or counterparties, or of any other third parties. For purposes of this paragraph solely, &#8220;trade secret&#8221; has the meaning set forth in 18 USC &#167; 1839.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">Exceptions for Attorneys</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Notwithstanding the foregoing, this Section 8 will apply only to the extent permissible under provisions of the ABA Model Rules of Professional Conduct, or any applicable state counterpart regarding restrictions on the right to practice law.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt;text-decoration:underline">Acknowledgment of Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. By accepting the Award, Participant agrees that the provisions of this Section 8 are reasonable and necessary to protect the legitimate interests of the Company.  Participant further acknowledges that Participant&#8217;s obligations under this Section 8 are in addition to, and do not limit, any and all obligations concerning the same subject matter arising under any applicable law, including, without limitation, common law and statutory law relating to fiduciary duties and trade secrets.  To the extent Participant and the Company agree at any time to enter into separate agreements containing restrictive covenants or assignment of intellectual property with different or inconsistent terms than those contained herein, Participant and the Company acknowledge and agree that such different or inconsistent terms shall not in any way affect or have relevance to the Assignment and Restrictive Covenants contained herein.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Adjustments to RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In the event that any dividend or other distribution (whether in the form of cash,  shares of Common Stock, other securities, or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase, or exchange of Common Stock or other securities of the Company or other similar corporate transaction or event affecting the Common Stock would be reasonably likely to result in the diminution or enlargement of any of the benefits or potential benefits intended to be made available under the Award (including, without limitation, the benefits or potential benefits of provisions relating to the vesting of the RSUs), the Committee shall, in such manner as it shall deem equitable or appropriate in order to prevent such diminution or enlargement of any such benefits or potential benefits, make adjustments to the Award, including adjustments in the number and type of shares of Common Stock Participant would have received upon vesting of the RSUs.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Tax Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">Responsibility for Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant acknowledges that, regardless of any action taken by the Company or any Affiliate employing Participant (the &#8220;Employer&#8221;), the ultimate liability for any or all federal, state, local or foreign income tax, social insurance, payroll tax, fringe benefits tax, payment on account or other tax related items related to Participant's participation in the Plan and legally applicable to Participant (&#8220;Tax-Related Items&#8221;) is and remains Participant&#8217;s responsibility and may exceed the amount actually withheld by the Company and&#47;or Employer.  Participant further acknowledges that the Company and&#47;or the Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Awards, including, but not limited to, the grant or vesting of the Awards, the delivery of the shares of Common Stock, the subsequent sale of shares of Common Stock acquired at vesting and the receipt of any dividends or dividend equivalents&#59; and (ii) do not commit to structure the terms of the grant or any aspect of the Awards to reduce or eliminate Participant&#8217;s liability for Tax-Related Items.  Further, if Participant has relocated to a different jurisdiction between the Award Date and the date of any taxable event, Participant acknowledges that the Company and&#47;or the Employer (or former Employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Prior to the relevant taxable event, Participant shall pay or make adequate arrangements satisfactory to the Company and&#47;or the Employer (in its sole discretion) to satisfy all tax withholding and payment on account obligations for Tax-Related Items of the Company and&#47;or the Employer.  In this regard, Participant authorizes the Company and the Employer, or either of them, in such entity&#8217;s sole discretion, to satisfy the obligations with regard to all Tax-Related Items legally payable by Participant (with respect to the Award granted hereunder as well as any equity awards previously received by Participant under any Company stock plan) by one or a combination of the following&#58; (i) requiring Participant to pay Tax-Related Items in cash with a cashier&#8217;s check or certified check or by wire transfer of immediately available funds&#59; (ii) withholding cash from Participant&#8217;s wages or other compensation payable to Participant by the Company and&#47;or the Employer&#59; (iii) withholding from the proceeds of the sale of shares of Common Stock otherwise issuable to Participant upon vesting of the Awards either through a voluntary sale or through a mandatory sale arranged by the Company (on Participant&#8217;s behalf and at Participant&#8217;s direction pursuant to this authorization without further consent)&#59; or (iv) withholding in shares of Common Stock otherwise issuable to Participant upon vesting of the Awards.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Depending on the withholding method, the Company may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding rates or other applicable withholding rates, including maximum applicable rates, in which case Participant may receive a refund of any over-withheld amount in cash and will have no entitlement to the Common Stock equivalent.  If the obligation for Tax-Related Items is satisfied by withholding in shares of Common Stock, for tax purposes, Participant is deemed to have been issued the full number of shares of Common Stock subject to the vested Award, notwithstanding that a number of the shares of Common Stock are held back solely for the purpose of paying the Tax-Related Items.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant shall pay to the Company or the Employer any amount of Tax-Related Items that the Company or the Employer may be required to withhold as a result of Participant&#8217;s participation in the Plan that are not satisfied by any of the means previously described.  The Company may refuse to deliver the shares of Common Stock to Participant if Participant fails to comply with Participant&#8217;s obligations in connection with the Tax-Related Items as described in this Section.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Further, without limitation to the foregoing, if Participant is subject to tax in the United Kingdom, Participant agrees that Participant is liable for all Tax-Related Items and hereby covenants to pay all such Tax-Related Items, as and when requested by the Company or the Employer or by Her Majesty&#8217;s Revenue and Customs (&#8220;HMRC&#8221;) (or any other tax authority or any other relevant authority).  Participant also agrees to indemnify and keep indemnified the Company and the Employer against any Tax-Related Items that they are required to pay or withhold or have paid or will pay to HMRC (or any other tax authority or any other relevant authority) on Participant&#8217;s behalf.  Notwithstanding the foregoing, Participant understands and agrees that if Participant is a director or an executive officer of the Company (as within the meaning of Section 13(k) of the U.S. Securities and Exchange Act of 1934, as amended), Participant may not be able to indemnify the Company for the amount of any Tax-Related Items not collected from or paid by Participant, if the indemnification could be considered a loan.  In this case, the Tax-Related Items not collected or paid </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">may constitute a benefit to Participant on which additional income tax and national insurance contributions (&#8220;NICs&#8221;) may be payable.  Participant understands and agrees that Participant will be responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self-assessment regime and for paying to the Company and&#47;or the Employer (as appropriate) the amount of any NICs due on this additional benefit which the Company or the Employer may recover from Participant by any of the means referred to in this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  It is intended that this Award and any amounts payable under this Award shall either be exempt from or comply with Section 409A of the Code (including the Treasury regulations and other published guidance relating thereto) so as not to subject Participant to payment of any additional tax, penalty, or interest imposed under Section 409A of the Code.  The provisions of this Award certificate shall be construed and interpreted to avoid the imputation of any such additional tax, penalty, or interest under Section 409A of the Code yet preserve (to the nearest extent reasonably possible) the intended benefit payable to Participant.  To the extent that the time or form of payment of any benefit pursuant to this Award would violate the terms of Section 409A, the Committee may revise the time or form of payment to conform to Section 409A.  Notwithstanding the foregoing, in no event shall the Company, any Affiliate, the members of the Committee, or any other person have any liability for any additional tax, penalty or interest imposed on Participant by reason of Section 409A or otherwise.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">11.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">At-Will Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This Award certificate does not confer on Participant any right to continued employment or any other relationship with the Company or any Affiliate, nor will it interfere in any way with the right of the Company to terminate Participant at any time.  Participant&#8217;s employment with the Company is at will.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">No Trust or Fiduciary Relationship</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Neither the Plan nor this Award certificate shall create or be construed to create a trust or separate fund of any kind or a fiduciary relationship between the Company or any Affiliate and Participant or any other person.  To the extent that any person acquires a right to receive payments from the Company or any Affiliate pursuant to an Award, such right shall be no greater than the right of any unsecured creditor of the Company or any Affiliate.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">Securities Law Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The Company shall not be required to deliver any shares of Common Stock upon the vesting of any RSUs until the requirements of any federal or state securities laws, rules, or regulations or other laws or rules (including the rules of any securities exchange) as may be determined by the Company to be applicable have been and continue to be satisfied (including an effective registration of the shares under federal and state securities laws).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">Original Instrument</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  An original record of this Award certificate and all the terms hereof, executed by the Company, is held on file by the Company.  To the extent there is any conflict between the terms contained in any copy of this Award certificate and the terms contained in the original held by the Company, the terms of the original held by the Company shall control.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">Survival of Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The Restrictive Covenants in Section 8 of this Award certificate and the provisions regarding the forfeiture of RSUs and shares of Common Stock shall survive termination of the RSUs and termination of Participant&#8217;s relationship with the Company as set forth in Section 8.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.01pt;text-decoration:underline">Choice of Law, Injunctive Relief, Attorney&#8217;s Fees and Jury Trial</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant consents to the law of Minnesota exclusively being applied to any matter arising out of or relating to this Award certificate, without regard to its conflict of law principles, and exclusively to personal and subject matter jurisdiction in the state and federal courts of Minnesota for any dispute relating to this Award certificate or Participant&#8217;s relationship with the Company.  In the event of a breach or a threatened breach of this Award by Participant, Participant acknowledges that the Company will face irreparable injury which may be difficult to calculate in dollar terms and that the Company shall be entitled, in addition to remedies otherwise available at law or in equity, to temporary restraining orders and preliminary injunctions and final injunctions without the posting of a bond enjoining such breach or threatened breach.  Should the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Company successfully enforce any portion of this Award certificate before a trier of fact or in an arbitration proceeding, the Company shall be entitled to all of its reasonable attorney&#8217;s fees and costs incurred as a result of enforcing this Award certificate against Participant. Participant waives all rights or entitlement to a jury trial for any matter arising out of or relating to this Award certificate.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">No Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  No waiver of any breach of any provision of this Award certificate by the Company shall be effective unless it is in writing, and no waiver shall be construed to be a waiver of any succeeding breach or as a modification of such provision.  The provisions of this Award certificate shall be severable, and if any provision of this Award certificate is found by any court or arbitrator to be unenforceable, in whole or in part, the remainder of this Award certificate shall nevertheless be enforceable and binding on the parties.  Participant also agrees that a court or arbitrator may modify any invalid, overbroad or unenforceable term of this Award certificate so that such term, as modified, is valid and enforceable under applicable law, and that a court or arbitrator is authorized to extend the length of the Restrictive Covenants in Section 8 of this Award certificate for any period of time in which Participant is in breach of the Restrictive Covenants or as necessary to protect the legitimate business interests of Company. Further, Participant affirmatively states that Participant has not, will not, and cannot rely on any representations not expressly made herein.  The terms of this Award certificate shall not be amended by Participant or Company except by the express written consent of the Company and Participant.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">Consideration Period&#59; Right to Consult with Counsel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  By the Participant&#8217;s acceptance below, the Participant acknowledges and agrees that the Company provided the Participant with at least ten (10) business days to review and consider this Award certificate and that voluntarily accepting this Award certificate before the expiration of ten (10) business days shall serve as a waiver of the ten (10) day review period. The Participant has the right and is advised to consult with counsel of his&#47; her choice before signing this document.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt;text-decoration:underline">Assignability and Change of Position</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The rights and&#47;or obligations herein may be assigned by the Company without Participant&#8217;s consent and shall bind and inure to the benefit of the Company&#8217;s successors, assigns, and representatives.  If the Company makes any assignment of the rights and&#47;or obligations herein, Participant agrees that this Award certificate shall remain binding upon Participant in any event.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;text-decoration:underline">Data Privacy Notice and Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;padding-left:24.91pt;text-decoration:underline">Declaration of Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  By accepting the RSUs via the Company&#8217;s acceptance procedure, Participant is declaring that Participant agrees with the data processing practices described herein and consent to the collection, processing and use of Data by the Company and the transfer of Data to the recipients mentioned below, including recipients located in countries which may not have a similar level of protection from the perspective of the data protection laws in Participant's country.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;padding-left:24.34pt;text-decoration:underline">Data Collection and Usage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  The Company and the Employer may collect, process and use certain personal information about Participant, including, but not limited to, Participant's name, home address and telephone number, email address, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any shares or directorships held in the Company, details of all RSUs or any other entitlement to shares awarded, canceled, settled, vested, unvested or outstanding in Participant's favor (&#8220;Data&#8221;), for the purposes of implementing, administering and managing the Plan.  The legal basis, where required, for the processing of Data is Participant's consent. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;padding-left:24.91pt;text-decoration:underline">Plan Administration Service Providers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  The Company will transfer Data to Fidelity Stock Plan Services, LLC, which is assisting the Company with the implementation, administration and management of the Plan.  The Company may select different or additional service providers in the future and may share Data with such other provider(s) serving in a similar manner.  Participant may be asked to agree on separate terms and data processing practices with Fidelity Stock Plan Services, LLC, with such agreement being a condition to the ability to participate in the Plan.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;padding-left:24.34pt;text-decoration:underline">International Data Transfers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  Participant understands that his or her country of residence may have enacted data privacy laws that are different from the laws governing the Company or its service providers.  As a result, in the absence of appropriate safeguards such as standard data protection clauses, the processing of Data in, or the transfer of Data to, the United States or, as the case may be, other countries might not be subject to substantive data processing principles or supervision by data protection authorities.  In addition, Participant might not have enforceable rights regarding the processing or transfer of Participant's Data in and&#47;or to such countries.  The Company&#8217;s legal basis for the transfer of Data is Participant's consent.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;padding-left:24.91pt;text-decoration:underline">Data Retention</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  The Company will hold and use the Data only as long as is necessary to implement, administer and manage Participant's participation in the Plan, or as required to comply with legal or regulatory obligations, including under tax, exchange control, labor and securities laws.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;padding-left:26.01pt;text-decoration:underline">Voluntariness and Consequences of Consent Denial or Withdrawal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  Participation in the Plan is voluntary and Participant is providing the consents herein on a purely voluntary basis.  Participant understands that Participant may withdraw consent at any time with future effect for any or no reason.  If Participant does not consent, or if Participant later seek to revoke consent, Participant's salary from or employment and career with the Employer will not be affected&#59; the only consequence of refusing or withdrawing consent is that the Company would not be able to offer RSUs to Participant or otherwise administer or maintain Participant's participation in the Plan.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;padding-left:24.34pt;text-decoration:underline">Data Subject Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  Participant understands that data subject rights vary depending on the applicable law and that, depending on where Participant is based and subject to the conditions set out in the applicable law, Participant may have, without limitation, the rights to (i) request access or copies of Data the Company processes, (ii) rectification of incorrect Data, (iii) deletion of Data, (iv) restrictions on processing of Data, (v) portability of Data, (vi) lodge complaints with competent authorities in Participant's jurisdiction, and&#47;or (vii) receive a list with the names and addresses of any potential recipients of Data.  To receive clarification regarding these rights or to exercise these rights, Participant understands that Participant can contact his or her local human resources representative.</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.147%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">By clicking the &#8220;Accept&#8221; or similar button implemented into the relevant web page or platform, Participant declares, without limitation, Participant's consent to the data processing operations described in this Agreement. Participant understands and acknowledges that Participant may withdraw consent at any time with future effect for any or no reason as described in sub-section (f) above.</font></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">13.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Nature of Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.  In accepting the Awards, Participant acknowledges and agrees that&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt">the grant of RSUs hereunder, and any future grant of RSUs under the Plan is entirely exceptional, voluntary and occasional, and at the sole discretion of the Company.  Neither this Award of RSUs nor any past or future Award of RSUs by the Company shall be deemed to create any contractual or other obligation to Award any right to receive future grants of RSUs, benefits in lieu of RSUs, even if RSUs have been granted in the past&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt">all decisions with respect to future RSUs or other equity award grants, if any, shall be at the sole discretion of the Company&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt">the Plan is established voluntarily by the Company, and the Awards granted thereunder is discretionary in nature and it may be modified, amended, suspended or terminated by the Company at any time, to the extent permitted by the Plan&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt">Participant&#8217;s participation in the Plan is voluntary&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt">the Awards and shares of Common Stock subject to the Awards, and the income from and value of same, are an extraordinary item of compensation outside the scope of Participant&#8217;s employment.  As such, the RSUs and shares of Common Stock acquired under the Plan, and the income </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">from and value of same, are not part of normal or expected compensation for purposes of calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-term service awards, holiday pay, pension or retirement or welfare benefits or similar mandatory payments and in no event should be considered as compensation for, or relating in any way to, past services for the Company or the Employer&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.01pt">the RSUs and the shares of Common Stock subject to the RSUs, and the income from and value of same, are not intended to replace any pension rights or compensation&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt">the future value of the underlying shares of Common Stock is unknown and cannot be predicted with certainty&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt">the value of the shares of Common Stock acquired upon vesting&#47;settlement of the Awards may increase or decrease in value&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">no claim or entitlement to compensation or damages shall arise from the forfeiture of the Award resulting from termination of Participant&#8217;s employment or continuous service with the Company or any Affiliate (for any reason whatsoever, and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where Participant is employed or the terms of his or her employment agreement, if any)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">for purposes of this Award, Participant&#8217;s employment will be considered terminated as of the date Participant is no longer actively providing services to the Company or any Affiliate (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where Participant is employed or the terms of Participant&#8217;s employment or service agreement, if any), and unless otherwise expressly provided in this Agreement or determined by the Company, Participant&#8217;s right to vest in this Award under the Plan or Agreement, if any, will terminate as of such date and will not be extended by any notice period (e.g., Participant&#8217;s period of service would not include any contractual notice period or any period of &#8220;garden leave&#8221; or similar period mandated under employment laws in the jurisdiction where Participant is employed or the terms of Participant&#8217;s employment or service agreement, if any).  The Committee shall have the exclusive discretion to determine when Participant is no longer actively providing services for purposes of his or her Award grant (including whether Participant may still be considered to be providing services while on a leave of absence)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt">if Participant is providing services outside the U.S., neither the Company, the Employer nor any other Affiliate shall be liable for any foreign exchange rate fluctuation between Participant&#8217;s local currency and the U.S. Dollar that may affect the value of the RSUs or of any amounts due to the Participant pursuant to the vesting&#47;settlement of the RSUs or the subsequent sale of shares of Common Stock acquired upon vesting&#47;settlement&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">unless otherwise provided in the Plan or by the Company in its discretion, the Awards and the benefits evidenced by this Agreement do not create any entitlement to have the Awards or any such benefits transferred to, or assumed by, another company nor to be exchanged, cashed out or substituted for, in connection with any corporate transaction affecting the shares of Common Stock&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:21.57pt">the Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding Participant&#8217;s participation in the Plan or Participant&#8217;s acquisition or sale of the underlying shares of Common Stock&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt">Participant should consult with Participant&#8217;s own personal tax, legal and financial advisors regarding his or her participation in the Plan before taking any action related to the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">14.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Insider Trading Restrictions and Market Abuse Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant acknowledges that, depending on Participant&#8217;s or Participant&#8217;s broker&#8217;s country of residence or where the Company shares of Common Stock are listed, Participant may be subject to insider trading restrictions and&#47;or market abuse laws, which may affect his or her ability to accept, acquire, sell or otherwise dispose of Company shares of Common Stock, rights to the shares of Common Stock (e.g., RSUs) or rights linked to the value of shares of Common Stock (e.g., phantom awards, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">futures) during such times as Participant is considered to have &#8220;inside information&#8221; regarding the Company as defined by the laws or regulations in Participant&#8217;s country.  Local insider trading laws and regulations may prohibit the cancellation or amendment of orders Participant placed before Participant possessed inside information. Furthermore, Participant could be prohibited from (i) disclosing the inside information to any third party (other than on a &#8220;need to know&#8221; basis) and (ii) &#8220;tipping&#8221; third parties or causing them otherwise to buy or sell securities.  Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy.  Participant acknowledges that it is Participant&#8217;s responsibility to comply with any applicable restrictions, and that Participant should speak to his or her personal advisor on this matter.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">15.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Imposition of Other Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The Company reserves the right to impose other requirements on Participant&#8217;s participation in the Plan, on the Award and on any shares of Common Stock acquired under the Plan, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">16.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Electronic Acknowledgment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">An authorized representative of the Company has signed the Agreement below.  Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through the current on-line system, or any other on-line system or electronic means that the Company may decide, in its sole discretion, to use in the future.  Participant acknowledges and agrees that Participant has carefully reviewed this Agreement and the Plan and these documents set forth the entire understanding between Participant and the Company regarding this Award and supersede all prior or contemporaneous oral and written agreements with respect thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant's designation&#47;election via the current plan administrator&#8217;s website that Participant has read and accepted the terms of this Agreement and the terms and conditions of the Plan is considered Participant's electronic signature and his or her express consent to this Agreement and the terms and conditions set forth in the Plan.</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Offer Date&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#GrantDate#</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By </font><img alt="strausssignature1.jpg" src="strausssignature1.jpg" style="height:43px;margin-bottom:5pt;vertical-align:text-bottom;width:128px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, on behalf of UnitedHealth Group Incorporated</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Acceptance Date&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#AcceptanceDate#</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Signed Electronically&#47;Signed Manually&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#Signature#</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>6
<FILENAME>unhex10612312021.htm
<DESCRIPTION>EX-10.6
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i5ec74cce010c4fa8b1bdc5099ba699ba_33"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.6</font></div></div><div style="margin-bottom:12pt;text-align:center"><img alt="uhglogo2019a023a.jpg" src="uhglogo2019a023a.jpg" style="height:71px;margin-bottom:5pt;vertical-align:text-bottom;width:404px"></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">NONQUALIFIED STOCK OPTION AWARD</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.750%"><tr><td style="width:1.0%"></td><td style="width:24.541%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.705%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.583%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.543%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Award Date</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(mm&#47;dd&#47;yyyy)</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#GrantDate#</font></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Option Shares</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#QuantityGranted#</font></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Exercise Price</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">$</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#GrantPrice#</font></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Expiration Date</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(mm&#47;dd&#47;yyyy)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#ExpirationDate#</font></div></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">THIS CERTIFIES THAT UnitedHealth Group Incorporated (the &#8220;Company&#8221;) has on the award date specified above (the &#8220;Award Date&#8221;) granted to</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#ParticipantName#</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(the &#8220;Participant&#8221;) the option (the &#8220;Option&#8221;) to purchase that number of shares of UnitedHealth Group Incorporated Common Stock, $.01 par value per share (the &#8220;Common Stock&#8221;), indicated above (the &#8220;Option Shares&#8221;). The Option that this Award represents will expire on the expiration date indicated above (the &#8220;Expiration Date&#8221;), unless it is terminated prior to that time in accordance with this Award. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Option Shares represented by this Award shall become exercisable as follows&#58;  __% on each of the __________ anniversaries, unless the Option shall have terminated or the vesting shall have accelerated as provided in this Award. Once the Option has become exercisable for all or a portion of the Option Shares, it will remain exercisable for all or such portion of the Option Shares, as the case may be, until the Option expires or is terminated as provided in this Award. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By accepting this Award, the Participant acknowledges that the Participant will not have any of the rights of a shareholder with respect to the Option Shares until the Option has been duly exercised and the exercise price indicated above (the &#8220;Exercise Price&#8221;) and applicable withholding taxes paid in accordance with this Award. The Participant further acknowledges and agrees that the Company may deliver, by electronic mail, the use of the Internet, including through the website of the agent appointed by the Compensation and Human Resources Committee of the Board of Directors of the Company (the &#8220;Committee&#8221;) to administer the UnitedHealth Group Incorporated 2020 Stock Incentive Plan (the &#8220;Plan&#8221;), the Company intranet web pages or otherwise, any information concerning the Company, this Award, the Plan pursuant to which the Company granted this Award, and any information required by the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This Option is subject to the further terms and conditions set forth below and to the terms of the Plan. A copy of the Plan is available upon request. In the event of any conflict between the terms of the Plan and this Award, the terms of the Plan shall govern. Any terms not defined herein shall have the meaning set forth in the Plan. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">* * * * * </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Nonqualified Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The Company does not intend that the Option shall be an Incentive Stock Option governed by the provisions of Section 422 of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;). </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Termination of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The Option shall terminate on the Expiration Date. The Option shall terminate prior to the Expiration Date if the Participant ceases to be employed by the Company or any Affiliate, except that&#58; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">General. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Except as expressly provided in Section 10 or this Section 2, if prior to vesting of the Option as set forth herein, the Participant ceases to be an employee of the Company or any Affiliate for any reason (voluntary or involuntary), then the Participant may, at any time within the period set forth in the applicable provision below, exercise the Option to the extent of the full number of Option Shares which were exercisable and which the Participant was entitled to purchase under the Option on the date of the termination of his or her employment. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Death or Long-Term Disability. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If the Participant dies while employed by the Company or any Affiliate, or if the Participant&#8217;s employment by the Company or any Affiliate is terminated due to the Participant&#8217;s failure to return to work as the result of a long-term disability which renders the Participant incapable of performing his or her duties as determined under the provisions of the long-term disability insurance program of the Company or the Affiliate by which the Participant is employed (&#8220;Disability&#8221;), then&#58; (i) all unvested Option Shares hereunder shall immediately vest and be exercisable, and (ii) the Participant (or the Participant&#8217;s personal representatives, administrators or guardians, as applicable, or any person or persons to whom the Option is transferred by will or the applicable laws of descent and distribution) may, at any time within the shorter of (1) the Expiration Date of the Option, or (2) a period of five years after the Participant&#8217;s death or Disability or for such other longer period established at the discretion of the Committee, exercise the Option. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Severance. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Subject to Section 10, if Participant&#8217;s employment with the Company or any Affiliate terminates at a time when Participant is not eligible for Retirement (as defined below) and, in the circumstances, Participant is entitled to severance or separation pay, the following provisions will apply.  If the Participant is entitled to severance under the Company&#8217;s severance pay plan as in effect on the date hereof and the Participant is not eligible for Retirement (as defined below) at the time of termination of employment, then the Option shall continue to vest and become exercisable for the period of such severance. If Participant is entitled to severance or separation pay under an employment agreement entered into with the Company or an Affiliate on or prior to the date hereof, then the Option shall continue to vest and become exercisable for the period of such severance or separation pay that Participant is entitled to receive under that agreement as in effect on the date hereof. In either case, should the Participant be paid in a lump sum versus bi-weekly payments, the Option shall continue to vest for the time in which severance or separation pay would have been paid had it been paid bi-weekly. If the Participant is entitled to severance or separation pay under a plan or agreement other than under the Company&#8217;s severance pay plan or an employment agreement entered into with the Company or an Affiliate, then vesting of the Option shall continue for three months from the date of termination, regardless of the period for which severance or separation pay is payable. Any portion of the Option that vests after the Participant&#8217;s termination of employment pursuant to this Section 2(c) may be exercised during the Exercise Period (as defined below).  For avoidance of doubt, any Options that are unvested on the date of termination of Participant&#8217;s employment and do not vest under the schedule set forth herein during the applicable severance or separation pay period identified above in this Section 2(c) shall be forfeited.  For the purposes of this Section 2(c), &#8220;Exercise Period&#8221; shall mean the greater of&#58; (i) a period of three months after the date of termination of the Participant&#8217;s employment&#59; (ii) a period of three months after vesting ceases as provided in Section 2(c) if Participant receives severance or separation pay&#59; or (iii) such other longer period established at the discretion of the Committee, but in no event later than the Expiration Date determined without regard to this Section 2(c).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Retirement. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If the Participant&#8217;s employment by the Company or any Affiliate is terminated and at the time of termination the Participant is eligible for Retirement, then (i) the Option shall continue to vest and become exercisable as if such termination of employment had not occurred and (ii) the Participant may, at any time within the shorter of (1) the Expiration Date of the Option, or (2) a period of five years after such termination of employment or for such other longer period established at the discretion of the Committee, exercise the Option to the extent of the full number of Option Shares which are then exercisable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)        Anything else contained in this Award certificate notwithstanding, the Option shall in no event be exercisable after the Expiration Date. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)        For purposes of this Award, &#8220;Retirement&#8221; means the termination of employment of a Participant who is age 55 or older with at least ten years of Recognized Employment with the Company or any Affiliate other than by reason of (i) death or Disability or (ii) Cause. Notwithstanding the terms of any other agreement heretofore or hereafter entered into between the parties that reference retirement, Participant and the Company acknowledge and agree that for purposes of calculating years of service for retirement eligibility, Participant will receive three point seven (3.7) years of service credit for each year he remains employed with the Company after February 3, 2021. If, prior to February 3, 2023, Participant is terminated by the Company without Cause or if Participant terminates employment for Good Reason, as defined in Participant&#8217;s employment agreement effective February 3, 2021, Participant will be deemed to have met the applicable age and service requirements and will be retirement eligible.   </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)       For purposes of this Award, &#8220;Recognized Employment&#8221; shall include only employment since the Participant&#8217;s most recent date of hire by the Company or any Affiliate, and shall not include employment with a company acquired by the Company or any Affiliate before the date of such acquisition.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:34.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3.          </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Forfeiture of Option and&#47;or Recoupment of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. This section sets forth circumstances under which the Participant shall forfeit all or a portion of the Options, or be required to repay the Company for the value realized in respect of all or a portion of the Options. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Violation of Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If the Participant violates any provision of the Restrictive Covenants in Section 4 of this Award certificate, then any (i) unvested Options and (ii) Options that vested within one year prior to the Participant&#8217;s termination of employment with the Company or any Affiliate or at any time after such termination of employment and that have not been exercised shall be immediately cancelled and rendered null and void without any payment therefor (the &#8220;Forfeited Options&#8221;).  If any such Forfeited Options have been exercised prior to the Participant&#8217;s violation of the Restrictive Covenants, the Participant shall be required to repay or otherwise reimburse the Company, upon demand, an amount in cash or Common Stock having a value equal to the amount described in this Section 3(a) below. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To the extent that such Option Shares have been sold, the amount shall be the aggregate proceeds received from such sale of the net Option Shares acquired after payment of the Exercise Price and any applicable taxes (&#8220;Net Option Shares&#8221;). To the extent that the Net Option Shares have not been sold at the time Company demand is made, the amount shall be the aggregate Fair Market Value of the Net Option Shares on the date the Forfeited Options were exercised. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Fraud</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If the Board determines that the Participant has engaged in fraud that, in whole or in part, caused the need for a material restatement of the Company&#8217;s consolidated financial statements, then any vested and unvested Options then held by the Participant shall be immediately cancelled and rendered null and void without any payment therefor.  In addition, for any Options that were exercised during the 12-month period following the first public issuance or filing with the Securities Exchange Commission (whichever occurs first) of the incorrect financial statements (the &#8220;Covered Options&#8221;), the Participant shall be required to repay or otherwise reimburse the Company, upon demand, an amount in cash or Common Stock having a value equal to the amount described in this Section 3(b) below, depending on whether the Participant still holds the Option Shares acquired upon exercise of the Covered Options.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To the extent that such Option Shares have been sold, the amount shall be the aggregate proceeds received from such sale of the Net Option Shares. To the extent that the Net Option Shares have not been sold at the time Company demand is made, the amount shall be the aggregate Fair Market Value of the Net Option Shares on the date the Covered Options were exercised. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (c)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">In General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This section does not constitute the Company&#8217;s exclusive remedy for the Participant&#8217;s violation of the Restrictive Covenants or commission of fraudulent conduct.  As the forfeiture and repayment provisions are not adequate remedies at law, the Company may seek any additional legal or equitable remedy, including injunctive relief, for any such violations, except that, if unvested Option Shares continue to vest under Section 2 following the termination of Participant&#8217;s employment with the Company or any Affiliate, then, with respect to the Restrictive Covenants in Sections 4 (c) or (d) below, the maximum period of time to which Company shall be entitled to injunctive relief is a total of two (2) years following the termination of Participant&#8217;s employment with the Company or any Affiliate, not counting any time period that Participant is in violation of the Restrictive </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Covenants in Sections 4(c) or (d) below and during which time the running of the time periods for the restrictions set forth in Sections 4(c) and (d) of this Agreement shall be tolled as permitted by applicable law such that the running of the two (2) year time period shall commence only once Participant is in compliance with the Restrictive Covenants.  The provisions in this section are essential economic conditions to the Company&#8217;s grant of Options to the Participant.  By receiving the grant of Options hereunder, the Participant agrees that the Company may deduct from any amounts it owes the Participant from time to time (such as wages or other compensation, deferred compensation credits, vacation pay, any severance or other payments owed following a termination of employment, as well as any other amounts owed to the Participant by the Company) to the extent of any amounts the Participant owes the Company under this section. The provisions of this section and any amounts repayable by the Participant hereunder are intended to be in addition to any rights to repayment the Company may have under Section 304 of the Sarbanes-Oxley Act of 2002, Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and other applicable law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4.         Assignment and Restrictive Covenants.  In consideration of the terms of this Award certificate and the Company&#8217;s sharing of Confidential Information with the Participant, which the Participant agrees constitute adequate and sufficient mutually-agreed consideration, the Participant agrees to the Restrictive Covenants set forth below in this Section 4.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:24.91pt">Assignment of Intellectual Property.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  Participant agree to assign and hereby assigns to Company all rights, titles and interests Participant may have in or to any invention, innovation, computer program, software, database, discovery, idea, writing, improvement, process, technique or other works (collectively &#34;Intellectual Property&#34;) whether or not patentable or registrable under copyright or similar statutes, created or conceived by Participant, either alone or jointly with others, during Participant&#8217;s employment that&#58; (i) relates in any manner to the actual or anticipated business, research, or development of Company&#59; (ii) results from work assigned to or performed by Participant for Company&#59; and&#47;or (iii) is conceived of or made with the use of Company systems, equipment, supplies, materials, facilities, computer programs, confidential information and&#47;or trade secret information (collectively &#8220;Company Resources&#8221;).  This assignment does not apply to Intellectual Property that meets all of the following criteria&#58; (i) no Company Resources were used in its creation&#59; (ii) the Intellectual Property was developed entirely on Participants own time&#59; (iii) at the time of conception or reduction to practice the Intellectual Property does not relate to Company&#8217;s business, actual or anticipated research or development&#59; and (iv) the Intellectual Property does not result from any work performed by Participant for Company.  Participant shall disclose to Company all Intellectual Property developed during Participant's employment so that Company may determine any rights it many have in such Intellectual Property.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:24.34pt">Non-Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant has or will be given access to and provided with sensitive, confidential, proprietary and&#47;or trade secret information (collectively, &#8220;Confidential Information&#8221;) in the course of Participant&#8217;s employment.  Examples of Confidential Information include inventions, new product or marketing plans, business strategies and plans, merger and acquisition targets, financial and pricing information, computer programs, source codes, models and data bases, analytical models, customer lists and information, and supplier and vendor lists and other information which is not generally available to the public.  Participant shall not disclose or use Confidential Information, either during or after Participant&#8217;s employment with the Company, except (i) as necessary to perform Participant&#8217;s duties, (ii) as the Company may consent in writing, or (iii) as permitted by Section 4(g) below.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:24.91pt">Non-Solicitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  During Participant&#8217;s employment and for two years after the later of (i) the termination of Participant&#8217;s employment with the Company for any reason whatsoever or (ii) the last scheduled vesting date under this Award certificate, Participant shall not, without the Company&#8217;s prior written consent, directly or indirectly, for Participant or for any other person or entity, as agent, employee, officer, director, consultant, owner, principal, partner, shareholder, or in any other individual or representative capacity&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">Solicit or conduct business with any business competitive with the Company from any person or entity&#58; (A) who was a Company provider or customer within the 12 months before Participant&#8217;s employment termination and with whom Participant had contact regarding the Company&#8217;s activity, products or services, or for whom Participant provided services or supervised employees who provided those services, or about whom </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant learned Confidential Information during employment related to the Company&#8217;s provision of products and services to such person or entity, or (B) was a prospective provider or customer the Company solicited within the 12 months before Participant&#8217;s employment termination and with whom Participant had contact for the purposes of soliciting the person or entity to become a provider or customer of the Company, or supervised employees who had those contacts, or about whom Participant learned Confidential Information during employment related to the Company&#8217;s provision of products and services to such person or entity&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.8pt">Raid, hire, employ, recruit or solicit any Company employee or consultant who possesses Confidential Information of the Company to leave the Company&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:21.03pt">Induce or influence any Company employee, consultant, or provider who possesses Confidential Information of the Company to terminate his, her or its employment or other relationship with the Company&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:21.57pt">Assist anyone in any of the activities listed above.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:24.34pt">Non-Competition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  During Participant&#8217;s employment and for one year after the later of (i) the termination of Participant&#8217;s employment with the Company for any reason whatsoever or (ii) the last scheduled vesting date under this Award certificate, Participant shall not, without the Company&#8217;s prior written consent, directly or indirectly, for Participant or for any other person or entity, as agent, employee, officer, director, consultant, owner, principal, partner, shareholder, or in any other individual or representative capacity&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">Engage in or participate in any activity that competes, directly or indirectly, with any Company activity, product or service that Participant engaged in, participated in, or had Confidential Information about during Participant&#8217;s last 36 months of employment with the Company&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.8pt">Assist anyone in any of the activities listed above.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:24.91pt">Geographic Scope</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">Participant&#8217;s obligations under subsections 4(c) and (d) of this &#8220;Assignments and Restrictive Covenants&#8221; section shall apply on a nationwide basis anywhere in the United States.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.8pt">Participant&#8217;s obligations under this &#8220;Assignments and Restrictive Covenants&#8221; section shall also apply in any country outside the United States with respect to which Participant had responsibility for any UnitedHealth Group activity, product or service in that country.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:26.01pt">Return of Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Participant agrees that all tangible materials (whether originals or duplicates), including, but not limited to, notebooks, computers, files, reports, proposals, price lists, lists of actual or potential customers or suppliers, talent lists, formulae, prototypes, tools, equipment, models, specifications, technical data, methodologies, research results, test results, financial data, contracts, agreements, correspondence, documents, computer disks, software, computer printouts, information stored electronically, memoranda, and notes, in Participant&#8217;s possession, custody, or control which in any way relate to the Company&#8217;s business and which are furnished to Participant by or on behalf of the Company or which are prepared, compiled or acquired by Participant while working with or employed by the Company shall be the sole property of the Company.  At any time upon the request of the Company, and in any event promptly upon termination of Participant&#8217;s employment with the Company, but in any event no later than two (2) business days after such termination, Participant shall deliver all such materials to the Company and shall not retain any originals or copies (including electronically) of such materials.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:24.34pt">No Restriction on Protected Activities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Nothing in this Award certificate prohibits Participant from disclosing information in good faith to any governmental agency, legislative body, or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">official regarding an alleged violation of law or regulation or otherwise protected under applicable law, including, without limitation, the National Labor Relations Act, the Defend Trade Secrets Act, and any rule or regulation promulgated by the Securities and Exchange Commission, the National Labor Relations Board, the Equal Employment Opportunity Commission, or any other federal, state, or local government agency.  Participant acknowledges that, through this Section 4(g), the Company has provided Participant with written notice that, pursuant to the Defend Trade Secrets Act, 8 USC &#167; 1833(b), an employee, consultant, or contractor of an employer may not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of an employer&#8217;s trade secrets, so long as such disclosure is made solely&#58; (a) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating a suspected violation of law&#59; and&#47;or (b) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.  Additionally, Participant understands that, pursuant to 18 USC &#167; 1831 et seq., an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose a trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order.  The foregoing immunities provided under 18 USC &#167; 1831 et seq. do not apply to any disclosure of Confidential Information or trade secrets of an employer&#8217;s clients, customers, or counterparties, or of any other third parties. For purposes of this paragraph solely, &#8220;trade secret&#8221; has the meaning set forth in 18 USC &#167; 1839.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:24.34pt">Exceptions for Attorneys</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Notwithstanding the foregoing, this Section 4 will apply only to the extent permissible under provisions of the ABA Model Rules of Professional Conduct, or any applicable state counterpart regarding restrictions on the right to practice law.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:26.57pt">Acknowledgment of Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. By accepting the Award, Participant agrees that the provisions of this Section 4 are reasonable and necessary to protect the legitimate interests of the Company.  Participant further acknowledges that Participant&#8217;s obligations under this Section 4 are in addition to, and do not limit, any and all obligations concerning the same subject matter arising under any applicable law, including, without limitation, common law and statutory law relating to fiduciary duties and trade secrets.  To the extent Participant and the Company agree at any time to enter into separate agreements containing restrictive covenants or assignment of intellectual property with different or inconsistent terms than those contained herein, Participant and the Company acknowledge and agree that such different or inconsistent terms shall not in any way affect or have relevance to the Assignment and Restrictive Covenants contained herein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Manner of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">In General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  On the terms set forth herein, the Option may be exercised by the Participant in whole or in part from time to time by delivering notice of exercise (in a form and manner acceptable to the Company) to the Company or the Committee&#8217;s designated agent, accompanied by payment of the Exercise Price and any applicable withholding taxes in cash or its equivalent, or by any of the following methods, subject to such limitations and restrictions as the Committee may establish (i) by a cashless exercise program established pursuant to Regulation T of the Federal Reserve Board, (ii) by delivery of shares of Common Stock already owned by the Participant, (iii) by withholding shares of Common Stock from the total number of shares of Common Stock acquired upon exercise under the Option having a fair market value, on the exercise date, equal to the aggregate Exercise Price and any applicable withholding taxes, or (iv) by a combination of any of the preceding methods or such other methods as the Committee may permit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Automatic Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  To the extent the vested and exercisable portion of the Option remains unexercised as of the close of business on the date the Option expires (the Expiration Date or such earlier date that is the last date on which the Option may be exercised pursuant to the terms of this Award certificate), that portion of the Option will be exercised without any action by the Participant in accordance with the terms of this Certificate if the Fair Market Value of a Share on that date is at least $0.01 greater than the Exercise Price and the exercise will result in Participant receiving at least one Share. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Satisfaction of Securities Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Notwithstanding anything to the contrary in this Award certificate, the Company shall not be required to issue or deliver any shares of Common Stock upon exercise of any Option </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">until the requirements of any federal or state securities laws, rules or regulations or other laws or rules (including the rules of any securities exchange) as may be determined by the Company to be applicable have been and continue to be satisfied (including an effective registration of the shares under federal and state securities laws).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Responsibility for Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant acknowledges that, regardless of any action taken by the Company or any Affiliate employing Participant (the &#8220;Employer&#8221;), the ultimate liability for all income tax, social insurance, payroll tax, fringe benefits tax, payment on account or other tax&#8209;related items related to Participant&#8217;s participation in the Plan and legally applicable to Participant (&#8220;Tax-Related Items&#8221;) is and remains Participant's responsibility and may exceed the amount actually withheld by the Company or the Employer.  Participant further acknowledges that the Company and&#47;or the Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of this Option, including, but not limited to, the grant, vesting or exercise of the Option, the subsequent sale of shares of Common Stock acquired pursuant to the exercise of the Option and the receipt of any dividends&#59; and (ii) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the Option to reduce or eliminate Participant&#8217;s liability for Tax-Related Items or achieve any particular tax result.  Further, if Participant is subject to Tax-Related Items in more than one jurisdiction between the grant date and the date of any relevant taxable or tax withholding event, as applicable, Participant acknowledges that the Company and&#47;or the Employer (or former Employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.   </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Prior to the relevant taxable or tax withholding event, as applicable, Participant shall pay or make adequate arrangements satisfactory to the Company and&#47;or the Employer to satisfy all Tax-Related Items.  In this regard, Participant authorizes the Company and&#47;or the Employer, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items by (i) withholding from Participant's wages or other cash compensation paid to Participant by the Company and&#47;or the Employer, and&#47;or (ii) withholding from proceeds of the sale of shares of Common Stock acquired upon exercise of the Option either through a voluntary sale or through a mandatory sale arranged by the Company (on Participant's behalf pursuant to this authorization without further consent). Participant shall pay to the Company or the Employer any amount of Tax-Related Items that the Company or the Employer may be required to withhold as a result of Participant&#8217;s participation in the Plan that are not satisfied by any of the means previously described.  The Company may refuse to deliver the shares of Common Stock to Participant if Participant fails to comply with Participant&#8217;s obligations in connection with the Tax-Related Items as described in this Section.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Depending on the withholding method, the Company may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding amounts or other applicable withholding rates, including maximum applicable rates, in which case Participant may receive a refund of any over-withheld amount in cash and will have no entitlement to the Common Stock equivalent.  If the obligation for Tax-Related Items is satisfied by withholding in shares of Common Stock, for tax purposes, Participant is deemed to have been issued the full number of shares of Common Stock subject to the exercised Award, notwithstanding that a number of shares of Common Stock are held back solely for the purpose of paying the Tax-Related Items.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Further, without limitation to the foregoing, if Participant is subject to tax in the United Kingdom, Participant agrees that Participant is liable for all Tax-Related Items and hereby covenants to pay all such Tax-Related Items, as and when requested by the Company or the Employer or by Her Majesty&#8217;s Revenue and Customs (&#8220;HMRC&#8221;) (or any other tax authority or any other relevant authority).  Participant also agrees to indemnify and keep indemnified the Company and the Employer against any Tax-Related Items that they are required to pay or withhold or have paid or will pay to HMRC (or any other tax authority or any other relevant authority) on Participant&#8217;s behalf.  Notwithstanding the foregoing, Participant understands and agrees that if Participant is a director or an executive officer of the Company (as within the meaning of Section 13(k) of the U.S. Securities and Exchange Act of 1934, as amended), Participant may not be able to indemnify the Company for the amount of any Tax-Related Items not collected from or paid by Participant, if the indemnification could be considered a loan.  In this case, the Tax-Related Items not collected or paid may constitute a benefit to Participant on which additional income tax and national insurance contributions (&#8220;NICs&#8221;) may be payable.  Participant understands and agrees that Participant will be responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self-assessment regime and for paying to the Company and&#47;or the Employer (as appropriate) the amount of any NICs due on this additional benefit which the Company or the Employer may recover from Participant by any of the means referred to in this Section 6.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">7.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">No Guarantee of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. This Award does not confer on the Participant any right to continued employment or any other relationship with the Company or any Affiliate, nor will it interfere in any way with the right of the Company to terminate Participant at any time.  Participant&#8217;s employment with the Company is at will.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">8.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Nature of Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  By accepting the Award, Participant acknowledges the following&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt">the Plan is established voluntarily by the Company, and the Option granted thereunder is discretionary in nature and it may be modified, amended, suspended or terminated by the Company at any time, to the extent permitted by the Plan&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt">the grant of the Option, hereunder, and any future grant of Options under the Plan is entirely exceptional, voluntary and occasional, and at the sole discretion of the Company.  Neither this Award of the Option nor any past or future Award of Options by the Company shall be deemed to create any contractual or other obligation to Award any right to receive future grants of Options, or benefits in lieu of Options, even if Options have been granted in the past&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt">all decisions with respect to future Option or other award grants, if any, will be at the sole discretion of Company&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt">Participant&#8217;s participation in the Plan is voluntary&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt">the Option and any shares of Common Stock acquired under the Plan, and the income from and value of the same, are not intended to replace any pension rights or compensation&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.01pt">the Option and shares of Common Stock acquired under the Plan, and the income from and value of same, are an extraordinary item of compensation outside of the scope of Participant&#8217;s employment.  As such, the Options and shares of Common Stock acquired under the Plan, and the income from and value of same, are not part of normal or expected compensation for purposes of calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-term service awards, holiday pay, pension or retirement or welfare benefits or similar mandatory payments and in no event should be considered as compensation for, or relating in any way to, past services for the Company or the Employer&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt">the future value of the underlying Option Shares is unknown and cannot be predicted with certainty&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt">if the underlying Option Shares do not increase in value, the Option will have no value&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">if Participant exercises the Option and acquires Option Shares, the value of those Shares may increase or decrease in value, even below the Exercise Price&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">no claim or entitlement to compensation or damages shall arise from forfeiture of the Option resulting from the termination of Participant's employment or other service relationship with the Company or any Affiliate (for any reason whatsoever, and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where Participant is employed or the terms of Participant&#8217;s employment agreement, if any)&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt">for purposes of this Award, Participant&#8217;s employment will be considered terminated as of the date Participant is no longer actively providing services to the Company or any Affiliate (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where Participant is employed or the terms of Participant&#8217;s employment or service agreement, if any), and unless otherwise expressly provided in this Agreement or determined by the Company, (i) Participant&#8217;s right to vest in the Option under the Plan, if any, will terminate as of such date and will not be extended by any notice period (e.g., Participant&#8217;s period of service would not include any contractual notice period or any period of &#8220;garden leave&#8221; or similar period mandated under employment laws in the jurisdiction where Participant is employed or the terms of Participant&#8217;s employment or service agreement, if any)&#59; and (ii) the period (if any) during which Participant may exercise the Option after such termination of employment will commence on the date Participant ceases to actively provide services and will not be extended by any notice period mandated under employment laws in the jurisdiction where Participant is employed or terms of Participant&#8217;s employment or service agreement, if any&#59; the Committee </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">shall have the exclusive discretion to determine when Participant is no longer actively providing services for purposes of Participant&#8217;s Option grant (including whether Participant may still be considered to be providing services while on a leave of absence)&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">if Participant is providing services outside the U.S., neither the Company, the Employer nor any other Affiliate shall be liable for any foreign exchange rate fluctuation between Participant&#8217;s local currency and the U.S. Dollar that may affect the value of the Option or of any amounts due to Participant pursuant to the exercise of the Option or the subsequent sale of any shares of Common Stock acquired upon exercise&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:21.57pt">unless otherwise provided in the Plan or by the Company in its discretion, the Options and the benefits evidenced by this Agreement do not create any entitlement to have the Options or any such benefits transferred to, or assumed by, another company nor to be exchanged, cashed out or substituted for, in connection with any corporate transaction affecting the Option Shares&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt">the Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding Participant&#8217;s participation in the Plan&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt">Participant should consult with his or her own personal tax, legal and financial advisors regarding participation in the Plan before taking any action related to the Plan.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:28.5pt;text-decoration:underline">No Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. During the Participant&#8217;s lifetime, only the Participant can exercise the Option. The Participant may not transfer the Option except by will or the laws of descent and distribution.  Notwithstanding the foregoing, the Option may be transferred to an alternate payee pursuant to the terms of a domestic relations order (as such terms are defined by Section 414(p) of the Code), provided that (i) the Participant is an employee at the time the domestic relations order is entered, (ii) the Option was outstanding at the time the domestic relations order is entered, and (iii) the transfer otherwise satisfies all requirements of the Plan and any limitations and requirements established by the Committee.   Any attempt to otherwise transfer the Option shall be void. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.5pt;text-decoration:underline">Special Restriction on Transfer for Certain Participants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If the Participant is an officer of the Company within the meaning of Section 16 of the Securities Exchange Act of 1934 and Rule 16a-1 issued thereunder, as such status is reasonably determined from time to time by the Board of Directors of the Company (a &#8220;Section 16 Officer&#8221;), at any time that the Option is exercised in whole or in part and the Company has theretofore communicated the Participant&#8217;s status as a Section 16 Officer to the Participant, the following special transfer restrictions apply to any shares of Common Stock acquired upon the exercise of the Option.  One-third (1&#47;3) of the net number of any shares of Common Stock acquired upon the exercise of the Option at a time when the Participant is a Section 16 Officer (including any shares of Common Stock or other securities subject to the Option following any adjustment made pursuant to the Option or Section 7 of the Plan) must be retained, and may not be sold or otherwise transferred, for a period of at least one year following the date the Option is exercised.  For purposes of the Option, the &#8220;net number of any shares of Common Stock acquired&#8221; shall mean the number of shares of Common Stock received with respect to the particular exercise after reduction for any shares of Common Stock withheld by or tendered to the Company, or sold on the market, to cover the Exercise Price of the Option and&#47;or to cover any federal, state, local or other payroll, withholding, income or other applicable tax withholding required in connection with the exercise of the Option.  The restrictions of this Section 8 are in addition to, and not in lieu of, the restrictions imposed under other Company policies and applicable laws. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.5pt;text-decoration:underline">Adjustments to Option Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. In the event that any dividend or other distribution (whether in the form of cash, shares of Common Stock, other securities or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase or exchange of Shares or other securities of the Company or other similar corporate transaction or event affecting the Shares would be reasonably likely to result in the diminution or enlargement of any of the benefits or potential benefits intended to be made available under the Option (including, without limitation, the benefits or potential benefits of provisions relating to the term, vesting or exercisability of the Option), the Committee shall, in such manner as it shall deem equitable or appropriate in order to prevent such diminution or enlargement of any such benefits or potential benefits, adjust any or all of (a) the number and type of shares (or other securities or other property) subject to the Option and (b) the exercise price with respect to the Option&#59; provided, however, that the number of shares covered by the Option shall always be a whole number. Without limiting the foregoing, if any capital reorganization or reclassification of the capital stock of the Company, or consolidation or merger of the Company with another entity, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">or the sale of all or substantially all of the Company&#8217;s assets to another entity, shall be effected in such a way that holders of the Company&#8217;s Common Stock shall be entitled to receive stock, securities, cash or other assets with respect to or in exchange for such shares, the Participant shall have the right to purchase and receive upon the basis and upon the terms and conditions specified in this Award certificate and in lieu of the shares of Common Stock of the Company immediately theretofore purchasable and receivable upon the exercise of the Option, with appropriate adjustments to prevent diminution or enlargement of benefits or potential benefits intended to be made available under the Option, such shares of stock, other securities, cash or other assets as would have been issued or delivered to the Participant if the Participant had exercised the Option and had received such shares of Common Stock prior to such reorganization, reclassification, consolidation, merger or sale. The Company shall not effect any such reorganization, consolidation, merger or sale unless prior to the consummation thereof the successor entity (if other than the Company) resulting from such reorganization, consolidation or merger or the entity purchasing such assets shall assume by written instrument the obligation to deliver to the Participant such shares of stock, securities, cash or other assets as, in accordance with the foregoing provisions, the Participant may be entitled to purchase or receive. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.5pt;text-decoration:underline">Certain Terminations on or After Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Notwithstanding the other vesting provisions set forth herein, but subject to the other terms and conditions set forth herein, the Option shall become fully vested and exercisable if, on or within two years after the effective date of a Change in Control, the Participant ceases to be an employee of the Company or any Affiliate as a result of a termination of employment (i) by the Participant for Good Reason, (ii) by the Company or any Affiliate without Cause, (iii) at a time when Participant is eligible for Retirement, (iv) due to Participant&#8217;s Disability, or (v) in the circumstances described in Section 2(c)&#59; provided that in the case of a termination for Good Reason, the Option shall vest if the Participant gives written notice of the circumstances constituting Good Reason within two years after the effective date of the Change in Control, if the Company fails to cure the circumstances constituting Good Reason within 60 days of the receipt of such notice and the Participant resigns within 30 days after the end of the cure period, all as provided in Section 10(d).  For purposes of this Award certificate&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:73.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)       &#8220;Affiliate&#8221; shall mean (i) any entity that, directly or indirectly through one or more intermediaries, is controlled by the Company and (ii) any entity in which the Company has a significant equity interest, as determined by the Committee.            </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:73.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       &#8220;Cause&#8221; shall mean Participant&#8217;s (a) material failure to follow the Company&#8217;s reasonable direction or to perform any duties reasonably required on material matters, (b) material violation of, or failure to act upon or report known or suspected violations of, the Company&#8217;s Code of Conduct, as may be amended from time to time, (c) conviction of any felony, (d) commission of any criminal, fraudulent, or dishonest act in connection with Participant&#8217;s employment, (e) breach of any of the Restrictive Covenants in Section 4 of this Award certificate or a material breach of any employment agreement between Participant and the Company or any Affiliate, if any, or (f) conduct that is materially detrimental to the Company&#8217;s interests.  The Company will, within 120 days of discovery of the conduct, give Participant written notice specifying the conduct constituting Cause in reasonable detail and Participant will have 60 days to remedy such conduct, if such conduct is reasonably capable of being remedied.  In any instance where the Company may have grounds for Cause, failure by the Company to provide written notice of the grounds for Cause within 120 days of discovery shall be a waiver of its right to assert the subject conduct as a basis for termination for Cause.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:73.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)       &#8220;Change in Control&#8221; shall mean the sale of all or substantially all of the Company&#8217;s assets or any merger, reorganization, or exchange or tender offer which, in each case, will result in a change in the power to elect 50% or more of the members of the Board of Directors of the Company&#59; provided, however, that such a sale, merger or other event must also constitute either (i) a &#8220;change in the ownership&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(v), (ii) a &#8220;change in the effective control&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(vi)(A)(1) (replacing &#8220;30 percent&#8221; with &#8220;50 percent&#8221; as used in such regulation), or (iii) a change &#8220;in the ownership of a substantial portion of the assets&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(vii).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:73.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)       &#8220;Good Reason&#8221; shall mean the occurrence of any of the following without Participant&#8217;s written consent, in each case, when compared to the arrangements in effect immediately prior to the Change in Control&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)        any reduction in Participant&#8217;s base salary or target bonus expressed as a percentage of the Participant&#8217;s base salary, other than a reduction that is pursuant to a general reduction affecting a group of employees&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)       a change in the principal location at which the Participant is required to perform his or her duties, if the new location is 50 miles or more further from the Participant&#8217;s principal residence than the original location&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iii)      a material diminution in Participant&#8217;s duties, responsibilities or authority&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iv)      a change in Participant&#8217;s reporting relationship.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant will, within 120 days of discovery of such circumstances, give the Company written notice specifying the circumstances constituting Good Reason in reasonable detail and, upon receipt of such notice, the Company shall have 60 days to cure the circumstances constituting Good Reason.  Failure by Participant to provide written notice of the grounds for Good Reason within 120 days of discovery, or failure by the Participant to resign within 30 days after the end of the Company&#8217;s 60 day cure period, shall be a waiver of Participant&#8217;s right to assert the subject circumstance as a basis for termination for Good Reason.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Possible Acceleration of Vesting&#59; Payment in Satisfaction of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If the Option is terminated pursuant to a Change in Control and is not assumed by a party to the Change in Control (and no such party issues a new award in substitution for the Award, as determined by the Committee), the Committee may provide for immediate vesting of the Option, and the issuance of shares of Common Stock, securities of a party to the Change in Control, or cash, or any combination thereof, in full satisfaction of the Option.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.5pt;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">No Trust</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Neither the Plan nor the Option shall create or be construed to create a trust or separate fund of any kind or a fiduciary relationship between the Company and Participant or any other Person.  To the extent that any Person acquires a right to receive payments from the Company or any Affiliate pursuant to an Award, such right shall be no greater than the right of any unsecured creditor of the Company or any Affiliate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Record of Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  An original record of this Award certificate and all the terms hereof, executed by the Company, is held on file by the Company. To the extent there is any conflict between the terms contained in this Award certificate and the terms contained in the original held by the Company, the terms of the original held by the Company shall control. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Survival</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The Restrictive Covenants in Section 4 and the provisions regarding the forfeiture of Options and recoupment of shares of Common Stock shall survive termination of the Option.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Choice of Law, Injunctive Relief, Attorney&#8217;s Fees and Jury Trial</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant consents to the law of Minnesota exclusively being applied to any matter arising out of or relating to this Award certificate, without regard to its conflict of law principles, and exclusively to personal and subject matter jurisdiction in the state and federal courts of Minnesota for any dispute relating to this Award certificate or Participant&#8217;s relationship with the Company.  In the event of a breach or a threatened breach of this Award by Participant, Participant acknowledges that the Company will face irreparable injury which may be difficult to calculate in dollar terms and that the Company shall be entitled, in addition to remedies otherwise available at law or in equity, to temporary restraining orders and preliminary injunctions and final injunctions without the posting of a bond enjoining such breach or threatened breach.  Should the Company successfully enforce any portion of this Award certificate before a trier of fact or in an arbitration proceeding, the Company shall be entitled to all of its reasonable attorney&#8217;s fees and costs incurred as a result of enforcing this Award certificate against Participant. Participant waives all rights or entitlement to a jury trial for any matter arising out of or relating to this Award certificate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Code Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  It is intended that this Award and any amounts payable under this Award shall either be exempt from or comply with Code Section 409A (including the Treasury regulations and other published guidance relating thereto) so as not to subject Participant to payment of any additional tax, penalty or interest imposed under Code Section 409A. The provisions of this Award certificate shall be construed and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">interpreted to avoid the imputation of any such additional tax, penalty or interest under Code Section 409A yet preserve (to the nearest extent reasonably possible) the intended benefit payable to Participant.  To the extent that the time or form of payment of any benefit pursuant to this Award would violate the terms of Section 409A, the Committee may revise the time or form of payment to conform to Section 409A.  Notwithstanding the foregoing, in no event shall the Company, any Affiliate, the members of the Committee, or any other person have any liability for any additional tax, penalty or interest imposed on Participant by reason of Section 409A or otherwise.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">No Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  No waiver of any breach of any provision of this Award certificate by the Company shall be effective unless it is in writing, and no waiver shall be construed to be a waiver of any succeeding breach or as a modification of such provision.  The provisions of this Award certificate shall be severable, and if any provision of this Award certificate is found by any court or arbitrator to be unenforceable, in whole or in part, the remainder of this Award certificate shall nevertheless be enforceable and binding on the parties.  Participant also agrees that a court or arbitrator may modify any invalid, overbroad or unenforceable term of this Award certificate so that such term, as modified, is valid and enforceable under applicable law, and that a court or arbitrator is authorized to extend the length of the Restrictive Covenants in Section 4 of this Award certificate for any period of time in which Participant is in breach of the Restrictive Covenants or as necessary to protect the legitimate business interests of Company. Further, Participant affirmatively states that Participant has not, will not, and cannot rely on any representations not expressly made herein.  The terms of this Award certificate shall not be amended by Participant or Company except by the express written consent of the Company and Participant.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Consideration Period&#59; Right to Consult with Counsel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  By the Participant&#8217;s acceptance below, the Participant acknowledges and agrees that the Company provided the Participant with at least ten (10) business days to review and consider this Award certificate and that voluntarily accepting this Award certificate before the expiration of ten (10) business days shall serve as a waiver of the ten (10) day review period. The Participant has the right and is advised to consult with counsel of his&#47; her choice before signing this document.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(h)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Assignability and Change of Position</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The rights and&#47;or obligations herein may be assigned by the Company without Participant&#8217;s consent and shall bind and inure to the benefit of the Company&#8217;s successors, assigns, and representatives.  If the Company makes any assignment of the rights and&#47;or obligations herein, Participant agrees that this Award certificate shall remain binding upon Participant in any event.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;padding-left:23.5pt;text-decoration:underline">Data Privacy Notice and Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;padding-left:24.34pt;text-decoration:underline">Declaration of Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  By accepting the Award via the Company&#8217;s acceptance procedure, Participant is declaring that Participant agrees with the data processing practices described herein and consent to the collection, processing and use of Data by the Company and the transfer of Data to the recipients mentioned below, including recipients located in countries which may not have a similar level of protection from the perspective of the data protection laws in the Participant's country.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;padding-left:23.78pt;text-decoration:underline">Data Collection and Usage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  The Company and the Employer may collect, process and use certain personal information about Participant, including, but not limited to, Participant's name, home address and telephone number, email address, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any shares or directorships held in the Company, details of all Options or any other entitlement to shares awarded, canceled, settled, vested, unvested or outstanding in Participant's favor (&#8220;Data&#8221;), for the purposes of implementing, administering and managing the Plan.  The legal basis, where required, for the processing of Data is the Participant's consent. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;padding-left:24.91pt;text-decoration:underline">Plan Administration Service Providers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  The Company will transfer Data to Fidelity Stock Plan Services, LLC, which is assisting the Company with the implementation, administration and management of the Plan.  The Company may select different or additional service providers in the future and may share Data with such other provider(s) serving in a similar manner.  Participant may be asked to agree on separate terms and data processing practices with Fidelity Stock Plan Services, LLC, with such agreement being a condition to the ability to participate in the Plan.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;padding-left:23.78pt;text-decoration:underline">International Data Transfers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  Participant understands that his or her country of residence may have enacted data privacy laws that are different from the laws governing the Company or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">its service providers.  As a result, in the absence of appropriate safeguards such as standard data protection clauses, the processing of Data in, or the transfer of Data to, the United States or, as the case may be, other countries might not be subject to substantive data processing principles or supervision by data protection authorities.  In addition, Participant might not have enforceable rights regarding the processing or transfer of the Participant's Data in and&#47;or to such countries.  The Company&#8217;s legal basis for the transfer of Data is the Participant's consent.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;padding-left:24.91pt;text-decoration:underline">Data Retention</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  The Company will hold and use the Data only as long as is necessary to implement, administer and manage the Participant's participation in the Plan, or as required to comply with legal or regulatory obligations, including under tax, exchange control, labor and securities laws.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;padding-left:26.01pt;text-decoration:underline">Voluntariness and Consequences of Consent Denial or Withdrawal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  Participation in the Plan is voluntary and Participant is providing the consents herein on a purely voluntary basis.  Participant understands that the Participant may withdraw consent at any time with future effect for any or no reason.  If Participant does not consent, or if Participant later seek to revoke consent, the Participant's salary from or employment and career with the Employer will not be affected&#59; the only consequence of refusing or withdrawing consent is that the Company would not be able to offer Options to the Participant or otherwise administer or maintain the Participant's participation in the Plan.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;padding-left:24.34pt;text-decoration:underline">Data Subject Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  Participant understands that data subject rights vary depending on the applicable law and that, depending on where the Participant is based and subject to the conditions set out in the applicable law, Participant may have, without limitation, the rights to (i) request access or copies of Data the Company processes, (ii) rectification of incorrect Data, (iii) deletion of Data, (iv) restrictions on processing of Data, (v) portability of Data, (vi) lodge complaints with competent authorities in the Participant's jurisdiction, and&#47;or (vii) receive a list with the names and addresses of any potential recipients of Data.  To receive clarification regarding these rights or to exercise these rights, the Participant understands that Participant can contact his or her local human resources representative.</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">By clicking the &#8220;Accept&#8221; or similar button implemented into the relevant web page or platform, Participant declares, without limitation, the Participant's consent to the data processing operations described in this Agreement. Participant understands and acknowledges that Participant may withdraw consent at any time with future effect for any or no reason as described in sub-section (f) above.</font></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.5pt;text-decoration:underline">Imposition of Other Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The Company reserves the right to impose other requirements on Participant&#8217;s participation in the Plan, on the Option and on any Option Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.5pt;text-decoration:underline">Insider Trading Restrictions and Market Abuse Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  Participant acknowledges that, depending on Participant&#8217;s or Participant&#8217;s broker&#8217;s country of residence or where the Company shares of Common Stock are listed, Participant may be subject to insider trading restrictions and&#47;or market abuse laws, which may affect his or her ability to accept, acquire, sell or otherwise dispose of Company shares of Common Stock, rights to Option Shares (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g.,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Options) or rights linked to the value of shares of Common Stock (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g., </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">phantom awards, futures) during such times as Participant is considered to have &#8220;inside information&#8221; regarding the Company as defined by the laws or regulations in Participant&#8217;s country.  Local insider trading laws and regulations may prohibit the cancellation or amendment of orders Participant placed before Participant possessed inside information.  Furthermore, Participant could be prohibited from (i) disclosing the inside information to any third party (other than on a &#8220;need to know&#8221; basis) and (ii) &#8220;tipping&#8221; third parties or causing them otherwise to buy or sell securities.  Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy.  Participant acknowledges that it is Participant&#8217;s responsibility to comply with any applicable restrictions, and that Participant should speak to his or her personal advisor on this matter.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.5pt">Electronic Acknowledgment.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">An authorized representative of the Company has signed the Agreement below.  Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through the current on-line system, or any other on-line system or electronic means that the Company may decide, in its sole discretion, to use in the future.  Participant acknowledges and agrees that Participant has carefully reviewed this Agreement and the Plan and these documents set forth the entire understanding between Participant and the Company regarding this Award and supersede all prior or contemporaneous oral and written agreements with respect thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant's designation&#47;election via the current plan administrator&#8217;s website that Participant has read and accepted the terms of this Agreement and the terms and conditions of the Plan is considered Participant's electronic signature and his or her express consent to this Agreement and the terms and conditions set forth in the Plan.</font></div><div style="margin-bottom:12pt;text-align:right;text-indent:43.19pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Offer Date&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#GrantDate#</font></div><div style="margin-bottom:12pt;text-align:right;text-indent:42.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By</font><img alt="strausssignature2.jpg" src="strausssignature2.jpg" style="height:37px;margin-bottom:5pt;vertical-align:text-bottom;width:86px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, on behalf of UnitedHealth Group Incorporated</font></div><div style="margin-bottom:12pt;text-align:right;text-indent:42.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Acceptance Date&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#AcceptanceDate#</font></div><div style="margin-bottom:12pt;text-align:right;text-indent:42.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Signed Electronically&#47;Signed Manually&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#Signature#</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.7
<SEQUENCE>7
<FILENAME>unhex10712312021.htm
<DESCRIPTION>EX-10.7
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="idfb4a5e84c5a4435802ad623da0086eb_33"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.7</font></div></div><div style="margin-bottom:12pt;text-align:center"><img alt="uhglogo2019a022a.jpg" src="uhglogo2019a022a.jpg" style="height:71px;margin-bottom:5pt;vertical-align:text-bottom;width:404px"></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">PERFORMANCE-BASED RESTRICTED STOCK UNIT AWARD</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.826%"><tr><td style="width:1.0%"></td><td style="width:31.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.417%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.313%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.417%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.793%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Award Date</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(mm&#47;dd&#47;yyyy)</font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#GrantDate#</font></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:21pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Target Number of Performance-Based Units</font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#QuantityGranted#</font></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Performance Period</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(mm&#47;dd&#47;yyyy)</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">mm&#47;dd&#47;yyyy &#8211; mm&#47;dd&#47;yyyy</font></div></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">THIS CERTIFIES THAT UnitedHealth Group Incorporated (the &#8220;Company&#8221;) has on the award date specified above (the &#8220;Award Date&#8221;) granted to</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#ParticipantName#</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(&#8220;Participant&#8221;) an award (the &#8220;Award&#8221;) to be eligible to receive a number of Performance-Based Restricted Stock units (the &#8220;PRSUs&#8221;), the target number of which is indicated above in the box labeled &#8220;Target Number of Performance-Based Units,&#8221; each PRSU representing the right to receive one share of UnitedHealth Group Incorporated Common Stock, $.01 par value per share (the &#8220;Common Stock&#8221;), subject to certain restrictions and on the terms and conditions contained in this Award and the UnitedHealth Group Incorporated 2020 Stock Incentive Plan (the &#8220;Plan&#8221;). </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Participant acknowledges and agrees that the Company may deliver, by electronic mail, the use of the Internet, including through the website of the agent appointed by the Compensation and Human Resources Committee of the Board of Directors of the Company (the &#8220;Committee&#8221;) to administer the Plan, the Company intranet web pages or otherwise, any information concerning the Company&#59; the Award, the Plan, pursuant to which the Company granted the Award, and any information required by the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A copy of the Plan is available upon request. In the event of any conflict between the terms of the Plan and this Award, the terms of the Plan shall govern. Any terms not defined herein shall have the meaning set forth in the Plan.  </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">* * * * * </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Rights of the Participant with Respect to the PRSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">No Shareholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The PRSUs granted pursuant to this Award do not and shall not entitle Participant to any rights of a shareholder of Common Stock. The rights of Participant with respect to the PRSUs shall remain forfeitable at all times prior to the date on which such rights become vested, and the restrictions with respect to the PRSUs lapse, in accordance with Section 2, 3 or 4. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Conversion of PRSUs&#59; Issuance of Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. No shares of Common Stock shall be issued to Participant prior to the date on which the PRSUs vest, and the restrictions with respect to the PRSUs lapse, in accordance with Section 2, 3 or 4. Neither this Section 1(b) nor any action taken pursuant to or in accordance with this Section 1(b) shall be construed to create a trust of any kind. After any PRSUs vest pursuant to Section 2, 3 or 4, the Company shall promptly cause to be issued shares of Common Stock to Participant or in the name of Participant&#8217;s legal representatives, beneficiaries or heirs, as the case may be, in payment of such vested whole PRSUs, such shares of Common Stock shall be issued promptly, and in any event, no later than March 15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">year following the year in which the vesting event occurs (which payment schedule is intended to comply with the &#8220;short-term deferral&#8221; exemption from the application of Section 409A of the Code). </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Subject to the terms and conditions of this Award, including without limitation the terms set forth in Attachment 1, the PRSUs shall vest and the restrictions with respect to the PRSUs shall lapse (i) if Participant has remained continuously employed with the Company or any Affiliate from the Award Date through and including the end of the Performance Period, and (ii) if and to the extent the Performance Vesting Criteria described in Attachment 1 have been achieved during the Performance Period.  Regardless of whether Participant meets the continuous employment or service criterion described in subpart (i) of this Section 2, if and to the extent the Performance Vesting Criteria have not been achieved by the end of the Performance Period, the Participant&#8217;s rights to the PRSUs shall be immediately and irrevocably forfeited on that date.  The Committee will determine in its sole discretion the extent, if any, to which the Performance Vesting Criteria have been met, and it will retain sole discretion to reduce the number of PRSUs that would otherwise vest as a result of the performance measured against the Performance Vesting Criteria.  Any vesting that may occur pursuant to this Section 2 will be effective on the date on which the Committee has certified the extent to which the Performance Vesting Criteria in subpart (ii) of this Section 2 were satisfied.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Certain Terminations on or After Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Notwithstanding the other vesting provisions contained in Section 2, but subject to the other terms and conditions set forth herein, the PRSUs described in this Award will become immediately and unconditionally vested, and the restrictions with respect thereto shall lapse if, on or within two years after the effective date of a Change in Control, the Participant ceases to be an employee of the Company or any Affiliate as a result of a termination of employment (i) by the Participant for Good Reason, (ii) by the Company or any Affiliate without Cause, (iii) at a time when Participant is eligible for Retirement, (iv) due to Participant&#8217;s Disability, or (v) in the circumstances described in Section 4(c)&#59; provided that in the case of a termination for Good Reason, the PRSUs shall vest if the Participant gives written notice of the circumstances constituting Good Reason within two years after the effective date of the Change in Control, if the Company fails to cure the circumstances constituting Good Reason within 60 days of the receipt of such notice and the Participant resigns within 30 days after the end of the cure period, all as provided in Section 3(d).  Upon a Change in Control, the Committee will determine&#58; (i) the extent, if any, to which the Performance Vesting Criteria have been met, and (ii) the number of the PRSUs that will vest and convert into shares of Common Stock in the event of Participant&#8217;s termination of employment in accordance with this Section 3. For purposes of this Award certificate&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        &#8220;Affiliate&#8221; shall mean (i) any entity that, directly or indirectly through one or more intermediaries, is controlled by the Company and (ii) any entity in which the Company has a significant equity interest, as determined by the Committee.            </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       &#8220;Cause&#8221; shall mean Participant&#8217;s (a) material failure to follow the Company&#8217;s reasonable direction or to perform any duties reasonably required on material matters, (b) material violation of, or failure to act upon or report known or suspected violations of, the Company&#8217;s Code of Conduct, as may be amended from time to time, (c) conviction of any felony, (d) commission of any criminal, fraudulent, or dishonest act in connection with Participant&#8217;s employment, (e) breach of any of the Restrictive Covenants in Section 8 of this Award certificate or a material breach of any employment agreement between Participant and the Company or any Affiliate, if any, or (f) conduct that is materially detrimental to the Company&#8217;s interests.  The Company will, within 120 days of discovery of the conduct, give Participant written notice specifying the conduct constituting Cause in reasonable detail and Participant will have 60 days to remedy such conduct, if such conduct is reasonably capable of being remedied.  In any instance where the Company may have grounds for Cause, failure by the Company to provide written notice of the grounds for Cause within 120 days of discovery shall be a waiver of its right to assert the subject conduct as a basis for termination for Cause.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)        &#8220;Change in Control&#8221; shall mean the sale of all or substantially all of the Company&#8217;s assets or any merger, reorganization, or exchange or tender offer which, in each case, will result in a change in the power to elect 50% or more of the members of the Board of Directors of the Company&#59; provided, however, that such a sale, merger or other event must also constitute either (i) a &#8220;change in the ownership&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(v), (ii) a &#8220;change in the effective control&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(vi)(A)(1) (replacing &#8220;30 percent&#8221; with &#8220;50 percent&#8221; as used in such regulation), or (iii) a change &#8220;in the ownership of a substantial portion of the assets&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(vii).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)       &#8220;Good Reason&#8221; shall mean the occurrence of any of the following without Participant&#8217;s written consent, in each case, when compared to the arrangements in effect immediately prior to the Change in Control&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)        any reduction in Participant&#8217;s base salary or target bonus expressed as a percentage of the Participant&#8217;s base salary, other than a reduction that is pursuant to a general reduction affecting a group of employees&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)       a change in the principal location at which the Participant is required to perform his or her duties, if the new location is 50 miles or more further from the Participant&#8217;s principal residence than the original location&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iii)      a material diminution in Participant&#8217;s duties, responsibilities or authority&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iv)      a change in Participant&#8217;s reporting relationship.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant will, within 120 days of discovery of such circumstances, give the Company written notice specifying the circumstances constituting Good Reason in reasonable detail and, upon receipt of such notice, the Company shall have 60 days to cure the circumstances constituting Good Reason.  Failure by Participant to provide written notice of the grounds for Good Reason within 120 days of discovery, or failure by the Participant to resign within 30 days after the end of the Company&#8217;s 60 day cure period, shall be a waiver of Participant&#8217;s right to assert the subject circumstance as a basis for termination for Good Reason.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)        &#8220;Separation from Service&#8221; shall mean when Participant dies, retires, or otherwise has a termination of employment with the Company that constitutes a &#8220;separation from service&#8221; within the meaning of Treasury Regulation Section 1.409A-1(h)(1), without regard to the optional alternative definitions available thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Possible Acceleration of Vesting and Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If the Award is terminated pursuant to a Change in Control and is not assumed by a party to the Change in Control (and no such party issues a new award in substitution for the Award, as determined by the Committee), the Committee may provide for immediate vesting of the Award, and the issuance of shares of Common Stock, securities of a party to the Change in Control, or cash, or any combination thereof, in full satisfaction of the Award.  Notwithstanding anything in the Plan or any other agreement to the contrary, there is no discretion to change the time of payment of the PRSUs (in connection with a Change in Control, similar event, or otherwise) except as expressly provided in this Section 3 or as otherwise permitted under, and would not result in any tax, penalty or interest under, Section 409A of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 409A - Possible Six-Month Delay in Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Notwithstanding any provision of this Award certificate to the contrary, if payment of the PRSUs is triggered by Participant&#8217;s Separation from Service as provided in this Section 3 or Section 4 and, as of the date of such Separation from Service, Participant is a &#8220;specified employee&#8221; (within the meaning of Section 409A of the Code and determined pursuant to procedures adopted by the Company), Participant shall not be entitled to such payment of the PRSUs until the earlier of (i) the date which is six (6) months after Participant&#8217;s Separation from Service for any reason other than death, or (ii) the date of Participant&#8217;s death.  Any amounts otherwise payable to Participant upon or in the six (6) month period following Participant&#8217;s Separation from Service that are not so paid by reason of this Section 3(g) shall be paid (without interest) as soon as practicable (and in all events within thirty (30) days) after the date that is six (6) months after Participant&#8217;s Separation from Service (or, if earlier, as soon as practicable, and in all events within thirty (30) days, after the date of Participant&#8217;s death).  The provisions of this Section 3(g) shall only apply if, and to the extent, required to avoid the imputation of any tax, penalty, or interest pursuant to Section 409A of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Termination of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Termination of Employment Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Subject to the provisions of this Section 4, if, prior to vesting of the PRSUs pursuant to Section 2 or 3, Participant ceases to be an employee of the Company or any Affiliate, for any reason (voluntary or involuntary), then Participant&#8217;s rights to all of the unvested PRSUs shall be immediately and irrevocably forfeited on the date of termination. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Death or Long-Term Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. If Participant dies while employed by the Company or any Affiliate, or if Participant&#8217;s employment by the Company or any Affiliate is terminated due to Participant&#8217;s failure to return to work as the result of a long-term disability which renders Participant incapable of performing his or her duties as determined under the provisions of the long-term disability insurance program of the Company or the Affiliate by which the Participant is employed (&#8220;Disability&#8221;), then following the end of the Performance Period, if and to the extent the Committee, in accordance with Section 2 above, determines that the Performance Vesting Criteria has been met, such that some number of PRSUs will vest and the restrictions with respect thereto will lapse, Participant will vest in the number of PRSUs that would have vested had Participant been employed through the end of the Performance Period, and the restrictions with respect thereto will lapse.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant&#8217;s employment ends at a time when the Participant is not eligible for Retirement (as defined below) and in connection with that separation from employment the Company or an Affiliate pays the Participant severance benefits pursuant to an employment agreement with Participant that is in effect on the date of this Award or pursuant to any Company severance policy, plan or program in effect on the date of this Award, then following the end of the Performance Period, if and to the extent the Committee, in accordance with Section 2 above, determines that the Performance Vesting Criteria has been met, such that some number of PRSUs will vest and the restrictions with respect thereto will lapse, Participant will vest in a pro rata number of PRSUs, and the restrictions with respect thereto will lapse.  Such pro rationing shall be based on the number of full months of the Performance Period that Participant was employed prior to the date of termination plus the number of full months during which the Participant is entitled to receive severance or separation pay either the Company&#8217;s severance plan as in effect on the date hereof, or under an employment agreement between Participant and the Company or an Affiliate that is in effect on the date of this Award (provided that in no event shall such sum exceed the number of months in the Performance Period).  In either case, should Participant&#8217;s severance or separation pay be paid in a lump sum versus bi-weekly payments, the number of full months taken into account shall be based on the period of time over which severance or separation pay would have been paid had it been paid bi-weekly.  If Participant is entitled to severance or separation pay under a plan or agreement other than under the Company&#8217;s severance pay plan or an employment agreement entered into with the Company or an Affiliate, such pro rationing shall be based on the number of full months of the Performance Period that Participant was employed prior to the date of termination plus an additional three months, but not more than the number of months in the Performance Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If the Participant&#8217;s employment ends and at the time of separation from employment the Participant is eligible for Retirement (the &#8220;Retirement Date&#8221;), and at least one year of the Performance Period of this Award is completed at or prior to the Retirement Date, then following the end of the Performance Period, if and to the extent the Committee, in accordance with Section 2 above, determines that the Performance Vesting Criteria has been met, such that some number of PRSUs will vest and the restrictions with respect thereto will lapse, Participant will vest in the full number of PRSUs and the restrictions with respect thereto will lapse as if the Participant had been continuously employed throughout the entire Performance Period. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)        For purposes of this Award certificate, &#8220;Retirement&#8221; means the termination of employment of a Participant who is age 55 or older with at least ten years of Recognized Employment with the Company or any Affiliate other than by reason of (i) death or Disability or (ii) Cause. Notwithstanding the terms of any other agreement heretofore or hereafter entered into between the parties that reference retirement, Participant and the Company acknowledge and agree that for purposes of calculating years of service for retirement eligibility, Participant will receive three point seven (3.7) years of service credit for each year he remains employed with the Company after February 3, 2021. If, prior to February 3, 2023, Participant is terminated by the Company without Cause or if Participant terminates employment for Good Reason, as defined in Participant&#8217;s employment agreement effective February 3, 2021, Participant will be deemed to have met the applicable age and service requirements and will be retirement eligible. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)        For purposes of this Award certificate, &#8220;Recognized Employment&#8221; shall include only employment since the Participant&#8217;s most recent date of hire by the Company or any Affiliate, and shall not include employment with a company acquired by UnitedHealth Group or any Affiliate before the date of such acquisition.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Restriction on Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant may not transfer the PRSUs except by will or by the laws of descent and distribution.  Notwithstanding the foregoing, the Award may be transferred to an alternate payee pursuant to the terms of a domestic relations order (as such terms are defined by Section 414(p) of the Code), provided that (i) the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant is an employee at the time the domestic relations order is entered, (ii) the Award was outstanding at the time the domestic relations order is entered, and (iii) the transfer otherwise satisfies all requirements of the Plan and any limitations and requirements established by the Committee.  Any attempt to otherwise transfer the PRSUs shall be void.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Special Restriction on Transfer for Certain Participants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. If Participant is an officer of the Company within the meaning of Section 16 of the Securities Exchange Act of 1934 and Rule 16a-1 issued thereunder, as such status is reasonably determined from time to time by the Board of Directors of the Company (a &#8220;Section 16 Officer&#8221;), at any time that shares of Common Stock are issued upon vesting of the PRSUs and the Company has theretofore communicated Participant&#8217;s status as a Section 16 Officer to Participant, the following special transfer restrictions apply to Participant&#8217;s Award. One-third (1&#47;3) of the net number of any shares of Common Stock acquired by Participant upon vesting of the PRSUs at a time when Participant is a Section 16 Officer (including any shares of Common Stock or other securities into which such shares may be converted or exchanged as a result of any adjustment made pursuant to this Award or Section 7 of the Plan) must be retained, and may not be sold or otherwise transferred, for a period of at least one year following the issuance date. For purposes of this Award certificate, the &#8220;net number of any shares of Common Stock acquired&#8221; shall mean the number of shares issued with respect to the Award after reduction for any shares of Common Stock withheld by or tendered to the Company, or sold on the market, to cover any federal, state, local or other payroll, withholding, income or other applicable tax withholding required in connection with the issuance of the shares. The restrictions of this Section 6 are in addition to, and not in lieu of, the restrictions imposed under other Company policies and applicable laws.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">7.         Forfeiture of PRSUs and Shares of Common Stock.  This Section 7 sets forth circumstances under which Participant shall forfeit all or a portion of the PRSUs, or be required to repay the Company for the value realized in respect of all or a portion of the PRSUs.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Violation of Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant violates any provision of the Restrictive Covenants set forth in Section 8 below, then any unvested PRSUs shall be immediately and irrevocably forfeited without any payment therefor.  In addition, for any PRSUs that vested within one year prior to Participant&#8217;s termination of employment with the Company or any Affiliate or at any time after such termination of employment, the Participant shall be required, upon demand, to repay or otherwise reimburse the Company (including by forfeiting any deferred compensation credits in respect of such PRSUs under the Company&#8217;s non-qualified compensation deferral plans) an amount having a value equal to the aggregate Fair Market Value of the shares of Common Stock underlying such PRSUs on the date the PRSUs became vested.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Fraud</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If the Board determines that Participant has engaged in fraud that, in whole or in part, caused the need for a material restatement of the Company&#8217;s consolidated financial statements, then any PRSUs that have not yet been settled in shares of Common Stock (including any deferred compensation credits under the Company&#8217;s non-qualified compensation deferral plans in respect of PRSUs that have previously become vested) shall be immediately and irrevocably forfeited without any payment therefore.  In addition, for any PRSUs that became vested during the 12-month period following the first public issuance or filing with the Securities Exchange Commission (whichever occurs first) of the incorrect financial statements, Participant shall be required, upon demand, to repay or otherwise reimburse the Company (including by forfeiting any deferred compensation credits in respect of such PRSUs under the Company&#8217;s non-qualified compensation deferral plans) an amount having a value equal to the aggregate Fair Market Value of the shares of Common Stock underlying such PRSUs on the date the PRSUs became vested.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">In General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This Section 7 does not constitute the Company&#8217;s exclusive remedy for Participant&#8217;s violation of the Restrictive Covenants or commission of fraudulent conduct.  As the forfeiture and repayment provisions are not adequate remedies at law, the Company may seek any additional legal or equitable remedy, including injunctive relief, for any such violations, except that, if unvested PRSUs continue to vest under Section 4 following the termination of Participant&#8217;s employment with the Company or any Affiliate, then, with respect to the Restrictive Covenants in Sections 8 (c) or (d) below, the maximum period of time to which Company shall be entitled to injunctive relief is a total of two (2) years following the termination of Participant&#8217;s employment with the Company or any Affiliate, not counting any time period that Participant is in violation of the Restrictive Covenants in Sections 8(c) or (d) below and during which time the running of the time periods for the restrictions set forth in Sections 8(c) and (d) of this Agreement shall be tolled as permitted by applicable law such that the running of the two (2) year time period shall commence only once Participant is in compliance with the Restrictive </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Covenants.  The provisions in this Section 7 are essential economic conditions to the Company&#8217;s grant of PRSUs to Participant.  By receiving the grant of PRSUs hereunder, Participant agrees that the Company may deduct from any amounts it owes Participant from time to time (such as wages or other compensation, deferred compensation credits, vacation pay, any severance or other payments owed following a termination of employment, as well as any other amounts owed to the Participant by the Company) to the extent of any amounts Participant owes the Company under this section.  The provisions of this Section 7 and any amounts repayable by Participant hereunder are intended to be in addition to any rights to repayment the Company may have under Section 304 of the Sarbanes-Oxley Act of 2002, Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and other applicable law.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">8.        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"> Assignment and Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In consideration of the terms of this Award certificate and the Company&#8217;s sharing of Confidential Information with the Participant, which the Participant agrees constitute adequate and sufficient mutually-agreed consideration, the Participant agrees to the Assignment and Restrictive Covenants set forth below in this Section 8. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">Assignment of Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant agree to assign and hereby assigns to Company all rights, titles and interests Participant may have in or to any invention, innovation, computer program, software, database, discovery, idea, writing, improvement, process, technique or other works (collectively &#8220;Intellectual Property&#8221;) whether or not patentable or registrable under copyright or similar statutes, created or conceived by Participant, either alone or jointly with others, during Participant&#8217;s employment that&#58; (i) relates in any manner to the actual or anticipated business, research, or development of Company&#59; (ii) results from work assigned to or performed by Participant for Company&#59; and&#47;or (iii) is conceived of or made with the use of Company systems, equipment, supplies, materials, facilities, computer programs, confidential information and&#47;or trade secret information (collectively &#8220;Company Resources&#8221;).  This assignment does not apply to Intellectual Property that meets all of the following criteria&#58; (i) no Company Resources were used in its creation&#59; (ii) the Intellectual Property was developed entirely on Participants own time&#59; (iii) at the time of conception or reduction to practice the Intellectual Property does not relate to Company&#8217;s business, actual or anticipated research or development&#59; and (iv) the Intellectual Property does not result from any work performed by Participant for Company.  Participant shall disclose to Company all Intellectual Property developed during Participant's employment so that Company may determine any rights it many have in such Intellectual Property.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">Non-Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant has or will be given access to and provided with sensitive, confidential, proprietary and&#47;or trade secret information (collectively, &#8220;Confidential Information&#8221;) in the course of Participant&#8217;s employment.  Examples of Confidential Information include inventions, new product or marketing plans, business strategies and plans, merger and acquisition targets, financial and pricing information, computer programs, source codes, models and data bases, analytical models, customer lists and information, and supplier and vendor lists and other information which is not generally available to the public.  Participant shall not disclose or use Confidential Information, either during or after Participant&#8217;s employment with the Company, except (i) as necessary to perform Participant&#8217;s duties, (ii) as the Company may consent in writing, or (iii) as permitted by Section 8(g) below.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">Non-Solicitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  During Participant&#8217;s employment and for two years after the later of (i) the termination of Participant&#8217;s employment with the Company for any reason whatsoever or (ii) the last scheduled vesting date under Section 4, Participant shall not, without the Company&#8217;s prior written consent, directly or indirectly, for Participant or for any other person or entity, as agent, employee, officer, director, consultant, owner, principal, partner, shareholder, or in any other individual or representative capacity&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">Solicit or conduct business with any business competitive with the Company from any person or entity&#58; (A) who was a Company provider or customer within the 12 months before Participant&#8217;s employment termination and with whom Participant had contact regarding the Company&#8217;s activity, products or services, or for whom Participant provided services or supervised employees who provided those services, or about whom Participant learned Confidential Information during employment related to the Company&#8217;s provision of products and services to such person or entity, or (B) was a prospective provider or customer the Company solicited within the 12 months before Participant&#8217;s employment termination and with whom Participant had contact for the purposes of soliciting the person or entity to become a provider or customer of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Company, or supervised employees who had those contacts, or about whom Participant learned Confidential Information during employment related to the Company&#8217;s provision of products and services to such person or entity&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.8pt">Raid, hire, employ, recruit or solicit any Company employee or consultant who possesses Confidential Information of the Company to leave the Company&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:21.03pt">Induce or influence any Company employee, consultant, or provider who possesses Confidential Information of the Company to terminate his, her or its employment or other relationship with the Company&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:21.57pt">Assist anyone in any of the activities listed above.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">Non-Competition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  During Participant&#8217;s employment and for one year after the later of (i) the termination of Participant&#8217;s employment with the Company for any reason whatsoever or (ii) the last scheduled vesting date under Section 4, Participant shall not, without the Company&#8217;s prior written consent, directly or indirectly, for Participant or for any other person or entity, as agent, employee, officer, director, consultant, owner, principal, partner, shareholder, or in any other individual or representative capacity&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">Engage in or participate in any activity that competes, directly or indirectly, with any Company activity, product or service that Participant engaged in, participated in, or had Confidential Information about during Participant&#8217;s last 36 months of employment with the Company&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.8pt">Assist anyone in any of the activities listed above.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">Geographic Scope</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">Participant&#8217;s obligations under subsections 4(c) and (d) of this &#8220;Assignment and Restrictive Covenants&#8221; section shall apply on a nationwide basis anywhere in the United States.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.8pt">Participant&#8217;s obligations under this &#8220;Assignment and Restrictive Covenants&#8221; section shall also apply in any country outside the United States with respect to which Participant had responsibility for any UnitedHealth Group activity, product or service in that country.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.01pt;text-decoration:underline">Return of Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Participant agrees that all tangible materials (whether originals or duplicates), including, but not limited to, notebooks, computers, files, reports, proposals, price lists, lists of actual or potential customers or suppliers, talent lists, formulae, prototypes, tools, equipment, models, specifications, technical data, methodologies, research results, test results, financial data, contracts, agreements, correspondence, documents, computer disks, software, computer printouts, information stored electronically, memoranda, and notes, in Participant&#8217;s possession, custody, or control which in any way relate to the Company&#8217;s business and which are furnished to Participant by or on behalf of the Company or which are prepared, compiled or acquired by Participant while working with or employed by the Company shall be the sole property of the Company.  At any time upon the request of the Company, and in any event promptly upon termination of Participant&#8217;s employment with the Company, but in any event no later than two (2) business days after such termination, Participant shall deliver all such materials to the Company and shall not retain any originals or copies (including electronically) of such materials.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">No Restriction on Protected Activities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Nothing in this Award certificate prohibits Participant from disclosing information in good faith to any governmental agency, legislative body, or official regarding an alleged violation of law or regulation or otherwise protected under applicable law, including, without limitation, the National Labor Relations Act, the Defend Trade Secrets Act, and any rule or regulation promulgated by the Securities and Exchange Commission, the National Labor Relations Board, the Equal Employment Opportunity Commission, or any other federal, state, or local government agency.  Participant acknowledges that, through this Section 8(g), the Company has provided Participant with written notice that, pursuant to the Defend Trade Secrets Act, 8 USC &#167; 1833(b), an employee, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">consultant, or contractor of an employer may not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of an employer&#8217;s trade secrets, so long as such disclosure is made solely&#58; (a) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating a suspected violation of law&#59; and&#47;or (b) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.  Additionally, Participant understands that, pursuant to 18 USC &#167; 1831 et seq., an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose a trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order.  The foregoing immunities provided under 18 USC &#167; 1831 et seq. do not apply to any disclosure of Confidential Information or trade secrets of an employer&#8217;s clients, customers, or counterparties, or of any other third parties. For purposes of this paragraph solely, &#8220;trade secret&#8221; has the meaning set forth in 18 USC &#167; 1839.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">Exceptions for Attorneys</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Notwithstanding the foregoing, this Section 8 will apply only to the extent permissible under provisions of the ABA Model Rules of Professional Conduct, or any applicable state counterpart regarding restrictions on the right to practice law.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt;text-decoration:underline">Acknowledgment of Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. By accepting the Award, Participant agrees that the provisions of this Section 8 are reasonable and necessary to protect the legitimate interests of the Company.  Participant further acknowledges that Participant&#8217;s obligations under this Section 8 are in addition to, and do not limit, any and all obligations concerning the same subject matter arising under any applicable law, including, without limitation, common law and statutory law relating to fiduciary duties and trade secrets.  To the extent Participant and the Company agree at any time to enter into separate agreements containing restrictive covenants or assignment of intellectual property with different or inconsistent terms than those contained herein, Participant and the Company acknowledge and agree that such different or inconsistent terms shall not in any way affect or have relevance to the Assignment and Restrictive Covenants contained herein.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">9.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Adjustments to PRSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In the event that any dividend or other distribution (whether in the form of cash,  shares of Common Stock, other securities or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase or exchange of Common Stock or other securities of the Company or other similar corporate transaction or event affecting the Common Stock would be reasonably likely to result in the diminution or enlargement of any of the benefits or potential benefits intended to be made available under the Award (including, without limitation, the benefits or potential benefits of provisions relating to the vesting of the PRSUs), the Committee shall, in such manner as it shall deem equitable or appropriate in order to prevent such diminution or enlargement of any such benefits or potential benefits, make adjustments to the Award, including adjustments in the number and type of shares of Common Stock Participant would have received upon vesting of the PRSUs. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">10.       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Tax Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">Responsibility for Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant acknowledges that, regardless of any action taken by the Company or any Affiliate employing Participant (the &#8220;Employer&#8221;), the ultimate liability for any or all federal, state, local or foreign income tax, social insurance, payroll tax, fringe benefits tax, payment on account or other tax related items related to Participant's participation in the Plan and legally applicable to Participant (&#8220;Tax-Related Items&#8221;) is and remains Participant&#8217;s responsibility and may exceed the amount actually withheld by the Company and&#47;or Employer.  Participant further acknowledges that the Company and&#47;or the Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Awards, including, but not limited to, the grant or vesting of the Awards, the delivery of the shares of Common Stock, the subsequent sale of shares of Common Stock acquired at vesting and the receipt of any dividends or dividend equivalents&#59; and (ii) do not commit to structure the terms of the grant or any aspect of the Awards to reduce or eliminate Participant&#8217;s liability for Tax-Related Items.  Further, if Participant has relocated to a different jurisdiction between the Award Date and the date of any taxable event, Participant acknowledges that the Company and&#47;or the Employer (or former Employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Prior to the relevant taxable event, Participant shall pay or make adequate arrangements satisfactory to the Company and&#47;or the Employer (in its sole discretion) to satisfy all tax withholding and payment on account obligations for Tax-Related Items of the Company and&#47;or the Employer.  In this regard, Participant authorizes the Company and the Employer, or either of them, in such entity&#8217;s sole discretion, to satisfy the obligations with regard to all Tax-Related Items legally payable by Participant (with respect to the Award granted hereunder as well as any equity awards previously received by Participant under any Company stock plan) by one or a combination of the following&#58; (i) requiring Participant to pay Tax-Related Items in cash with a cashier&#8217;s check or certified check or by wire transfer of immediately available funds&#59; (ii) withholding cash from Participant&#8217;s wages or other compensation payable to Participant by the Company and&#47;or the Employer&#59; (iii) withholding from the proceeds of the sale of shares of Common Stock otherwise issuable to Participant upon vesting of the Awards either through a voluntary sale or through a mandatory sale arranged by the Company (on Participant&#8217;s behalf and at Participant&#8217;s direction pursuant to this authorization without further consent)&#59; or (iv) withholding in shares of Common Stock otherwise issuable to Participant upon vesting of the Awards.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Depending on the withholding method, the Company may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding rates or other applicable withholding rates, including maximum applicable rates, in which case Participant may receive a refund of any over-withheld amount in cash and will have no entitlement to the Common Stock equivalent.  If the obligation for Tax-Related Items is satisfied by withholding in shares of Common Stock, for tax purposes, Participant is deemed to have been issued the full number of shares of Common Stock subject to the vested Award, notwithstanding that a number of the shares of Common Stock are held back solely for the purpose of paying the Tax-Related Items.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant shall pay to the Company or the Employer any amount of Tax-Related Items that the Company or the Employer may be required to withhold as a result of Participant&#8217;s participation in the Plan that are not satisfied by any of the means previously described.  The Company may refuse to deliver the shares of Common Stock to Participant if Participant fails to comply with Participant&#8217;s obligations in connection with the Tax-Related Items as described in this Section.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Further, without limitation to the foregoing, if Participant is subject to tax in the United Kingdom, Participant agrees that Participant is liable for all Tax-Related Items and hereby covenants to pay all such Tax-Related Items, as and when requested by the Company or the Employer or by Her Majesty&#8217;s Revenue and Customs (&#8220;HMRC&#8221;) (or any other tax authority or any other relevant authority).  Participant also agrees to indemnify and keep indemnified the Company and the Employer against any Tax-Related Items that they are required to pay or withhold or have paid or will pay to HMRC (or any other tax authority or any other relevant authority) on Participant&#8217;s behalf.  Notwithstanding the foregoing, Participant understands and agrees that if Participant is a director or an executive officer of the Company (as within the meaning of Section 13(k) of the U.S. Securities and Exchange Act of 1934, as amended), Participant may not be able to indemnify the Company for the amount of any Tax-Related Items not collected from or paid by Participant, if the indemnification could be considered a loan.  In this case, the Tax-Related Items not collected or paid may constitute a benefit to Participant on which additional income tax and national insurance contributions (&#8220;NICs&#8221;) may be payable.  Participant understands and agrees that Participant will be responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self-assessment regime and for paying to the Company and&#47;or the Employer (as appropriate) the amount of any NICs due on this additional benefit which the Company or the Employer may recover from Participant by any of the means referred to in this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  It is intended that this Award and any amounts payable under this Award shall either be exempt from or comply with Section 409A of the Code (including the Treasury regulations and other published guidance relating thereto) so as not to subject Participant to payment of any additional tax, penalty, or interest imposed under Section 409A of the Code.  The provisions of this Award certificate shall be construed and interpreted to avoid the imputation of any such additional tax, penalty, or interest under Section 409A of the Code yet preserve (to the nearest extent reasonably possible) the intended benefit payable to Participant.  To the extent that the time or form of payment of any benefit pursuant to this Award would violate the terms of Section 409A, the Committee may revise the time or form of payment to conform to Section 409A.  Notwithstanding the foregoing, in no event shall the Company, any Affiliate, the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">members of the Committee, or any other person have any liability for any additional tax, penalty or interest imposed on Participant by reason of Section 409A or otherwise.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">11.       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">At-Will Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This Award does not confer on Participant any right to continued employment or any other relationship with the Company or any Affiliate, nor will it interfere in any way with the right of the Company to terminate Participant at any time.  Participant&#8217;s employment with the Company is at will.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">No Trust or Fiduciary Relationship</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Neither the Plan nor this Award shall create or be construed to create a trust or separate fund of any kind or a fiduciary relationship between the Company and Participant or any other Person.  To the extent that any Person acquires a right to receive payments from the Company or any Affiliate pursuant to an Award, such right shall be no greater than the right of any unsecured creditor of the Company or any Affiliate.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Securities Law Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The Company shall not be required to deliver any shares of Common Stock upon the vesting of any PRSUs until the requirements of any federal or state securities laws, rules or regulations or other laws or rules (including the rules of any securities exchange) as may be determined by the Company to be applicable have been and continue to be satisfied (including an effective registration of the shares under federal and state securities laws). </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Original Instrument</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  An original record of this Award and all the terms hereof, executed by the Company, is held on file by the Company. To the extent there is any conflict between the terms contained in this Award and the terms contained in the original held by the Company, the terms of the original held by the Company shall control. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Survival of Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The Restrictive Covenants in Section 8 and the provisions regarding the forfeiture of PRSUs and shares of Common Stock shall survive termination of the PRSUs.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Choice of Law, Injunctive Relief, Attorney&#8217;s Fees and Jury Trial</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant consents to the law of Minnesota exclusively being applied to any matter arising out of or relating to this Award certificate, without regard to its conflict of law principles, and exclusively to personal and subject matter jurisdiction in the state and federal courts of Minnesota for any dispute relating to this Award certificate or Participant&#8217;s relationship with the Company.  In the event of a breach or a threatened breach of this Award by Participant, Participant acknowledges that the Company will face irreparable injury which may be difficult to calculate in dollar terms and that the Company shall be entitled, in addition to remedies otherwise available at law or in equity, to temporary restraining orders and preliminary injunctions and final injunctions without the posting of a bond enjoining such breach or threatened breach.  Should the Company successfully enforce any portion of this Award certificate before a trier of fact or in an arbitration proceeding, the Company shall be entitled to all of its reasonable attorney&#8217;s fees and costs incurred as a result of enforcing this Award certificate against Participant. Participant waives all rights or entitlement to a jury trial for any matter arising out of or relating to this Award certificate.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">No Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  No waiver of any breach of any provision of this Award certificate by the Company shall be effective unless it is in writing, and no waiver shall be construed to be a waiver of any succeeding breach or as a modification of such provision.  The provisions of this Award certificate shall be severable, and if any provision of this Award certificate is found by any court or arbitrator to be unenforceable, in whole or in part, the remainder of this Award certificate shall nevertheless be enforceable and binding on the parties.  Participant also agrees that a court or arbitrator may modify any invalid, overbroad or unenforceable term of this Award certificate so that such term, as modified, is valid and enforceable under applicable law, and that a court or arbitrator is authorized to extend the length of the Restrictive Covenants in Section 8 of this Award certificate for any period of time in which Participant is in breach of the Restrictive Covenants or as necessary to protect the legitimate business interests of Company. Further, Participant affirmatively states that Participant has not, will not, and cannot rely on any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">representations not expressly made herein.  The terms of this Award certificate shall not be amended by Participant or Company except by the express written consent of the Company and Participant.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(h)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Consideration Period&#59; Right to Consult with Counsel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  By the Participant&#8217;s acceptance below, the Participant acknowledges and agrees that the Company provided the Participant with at least ten (10) business days to review and consider this Award certificate and that voluntarily accepting this Award certificate before the expiration of ten (10) business days shall serve as a waiver of the ten (10) day review period. The Participant has the right and is advised to consult with counsel of his&#47; her choice before signing this document.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Assignability and Change of Position</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The rights and&#47;or obligations herein may be assigned by the Company without Participant&#8217;s consent and shall bind and inure to the benefit of the Company&#8217;s successors, assigns, and representatives.  If the Company makes any assignment of the rights and&#47;or obligations herein, Participant agrees that this Award certificate shall remain binding upon Participant in any event.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">12.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;text-decoration:underline">Data Privacy Notice and Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;padding-left:24.91pt;text-decoration:underline">Declaration of Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  By accepting the PRSUs via the Company&#8217;s acceptance procedure, Participant is declaring that Participant agrees with the data processing practices described herein and consent to the collection, processing and use of Data by the Company and the transfer of Data to the recipients mentioned below, including recipients located in countries which may not have a similar level of protection from the perspective of the data protection laws in Participant's country.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;padding-left:24.34pt;text-decoration:underline">Data Collection and Usage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  The Company and the Employer may collect, process and use certain personal information about Participant, including, but not limited to, Participant's name, home address and telephone number, email address, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any shares or directorships held in the Company, details of all PRSUs or any other entitlement to shares awarded, canceled, settled, vested, unvested or outstanding in Participant's favor (&#8220;Data&#8221;), for the purposes of implementing, administering and managing the Plan.  The legal basis, where required, for the processing of Data is Participant's consent. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;padding-left:24.91pt;text-decoration:underline">Plan Administration Service Providers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  The Company will transfer Data to Fidelity Stock Plan Services, LLC, which is assisting the Company with the implementation, administration and management of the Plan.  The Company may select different or additional service providers in the future and may share Data with such other provider(s) serving in a similar manner.  Participant may be asked to agree on separate terms and data processing practices with Fidelity Stock Plan Services, LLC, with such agreement being a condition to the ability to participate in the Plan.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;padding-left:24.34pt;text-decoration:underline">International Data Transfers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  Participant understands that his or her country of residence may have enacted data privacy laws that are different from the laws governing the Company or its service providers.  As a result, in the absence of appropriate safeguards such as standard data protection clauses, the processing of Data in, or the transfer of Data to, the United States or, as the case may be, other countries might not be subject to substantive data processing principles or supervision by data protection authorities.  In addition, Participant might not have enforceable rights regarding the processing or transfer of Participant's Data in and&#47;or to such countries.  The Company&#8217;s legal basis for the transfer of Data is Participant's consent.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;padding-left:24.91pt;text-decoration:underline">Data Retention</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  The Company will hold and use the Data only as long as is necessary to implement, administer and manage Participant's participation in the Plan, or as required to comply with legal or regulatory obligations, including under tax, exchange control, labor and securities laws.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;padding-left:26.01pt;text-decoration:underline">Voluntariness and Consequences of Consent Denial or Withdrawal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  Participation in the Plan is voluntary and Participant is providing the consents herein on a purely voluntary basis.  Participant understands that Participant may withdraw consent at any time with future effect for any or no reason.  If Participant does not consent, or if Participant later seek to revoke consent, Participant's </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">salary from or employment and career with the Employer will not be affected&#59; the only consequence of refusing or withdrawing consent is that the Company would not be able to offer PRSUs to Participant or otherwise administer or maintain Participant's participation in the Plan.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;padding-left:24.34pt;text-decoration:underline">Data Subject Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">.  Participant understands that data subject rights vary depending on the applicable law and that, depending on where Participant is based and subject to the conditions set out in the applicable law, Participant may have, without limitation, the rights to (i) request access or copies of Data the Company processes, (ii) rectification of incorrect Data, (iii) deletion of Data, (iv) restrictions on processing of Data, (v) portability of Data, (vi) lodge complaints with competent authorities in Participant's jurisdiction, and&#47;or (vii) receive a list with the names and addresses of any potential recipients of Data.  To receive clarification regarding these rights or to exercise these rights, Participant understands that Participant can contact his or her local human resources representative.</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.147%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">By clicking the &#8220;Accept&#8221; or similar button implemented into the relevant web page or platform, Participant declares, without limitation, Participant's consent to the data processing operations described in this Agreement. Participant understands and acknowledges that Participant may withdraw consent at any time with future effect for any or no reason as described in sub-section (f) above.</font></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">13.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Nature of Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In accepting the Awards, Participant acknowledges and agrees that&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt">the grant of PRSUs hereunder, and any future grant of PRSUs under the Plan is entirely exceptional, voluntary and occasional, and at the sole discretion of the Company.  Neither this Award of PRSUs nor any past or future Award of PRSUs by the Company shall be deemed to create any contractual or other obligation to Award any right to receive future grants of PRSUs, benefits in lieu of PRSUs, even if PRSUs have been granted in the past&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt">all decisions with respect to future PRSUs or other equity award grants, if any, shall be at the sole discretion of the Company&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt">the Plan is established voluntarily by the Company, and the Awards granted thereunder is discretionary in nature and it may be modified, amended, suspended or terminated by the Company at any time, to the extent permitted by the Plan&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt">Participant&#8217;s participation in the Plan is voluntary&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt">the Awards and shares of Common Stock subject to the Awards, and the income from and value of same, are an extraordinary item of compensation outside the scope of Participant&#8217;s employment.  As such, the PRSUs and shares of Common Stock acquired under the Plan, and the income from and value of same, are not part of normal or expected compensation for purposes of calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-term service awards, holiday pay, pension or retirement or welfare benefits or similar mandatory payments and in no event should be considered as compensation for, or relating in any way to, past services for the Company or the Employer&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.01pt">the PRSUs and the shares of Common Stock subject to the PRSUs, and the income from and value of same, are not intended to replace any pension rights or compensation&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt">the future value of the underlying shares of Common Stock is unknown and cannot be predicted with certainty&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt">the value of the shares of Common Stock acquired upon vesting&#47;settlement of the Awards may increase or decrease in value&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">no claim or entitlement to compensation or damages shall arise from the forfeiture of the Award resulting from termination of Participant&#8217;s employment or continuous service with the Company or any Affiliate (for any reason whatsoever, and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where Participant is employed or the terms of his or her employment agreement, if any)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">for purposes of this Award, Participant&#8217;s employment will be considered terminated as of the date Participant is no longer actively providing services to the Company or any Affiliate (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where Participant is employed or the terms of Participant&#8217;s employment or service agreement, if any), and unless otherwise expressly provided in this Agreement or determined by the Company, Participant&#8217;s right to vest in this Award under the Plan or Agreement, if any, will terminate as of such date and will not be extended by any notice period (e.g., Participant&#8217;s period of service would not include any contractual notice period or any period of &#8220;garden leave&#8221; or similar period mandated under employment laws in the jurisdiction where Participant is employed or the terms of Participant&#8217;s employment or service agreement, if any).  The Committee shall have the exclusive discretion to determine when Participant is no longer actively providing services for purposes of his or her Award grant (including whether Participant may still be considered to be providing services while on a leave of absence)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt">if Participant is providing services outside the U.S., neither the Company, the Employer nor any other Affiliate shall be liable for any foreign exchange rate fluctuation between Participant&#8217;s local currency and the U.S. Dollar that may affect the value of the PRSUs or of any amounts due to the Participant pursuant to the vesting&#47;settlement of the PRSUs or the subsequent sale of shares of Common Stock acquired upon vesting&#47;settlement&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">unless otherwise provided in the Plan or by the Company in its discretion, the Awards and the benefits evidenced by this Agreement do not create any entitlement to have the Awards or any such benefits transferred to, or assumed by, another company nor to be exchanged, cashed out or substituted for, in connection with any corporate transaction affecting the shares of Common Stock&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:21.57pt">the Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding Participant&#8217;s participation in the Plan or Participant&#8217;s acquisition or sale of the underlying shares of Common Stock&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt">Participant should consult with Participant&#8217;s own personal tax, legal and financial advisors regarding his or her participation in the Plan before taking any action related to the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">14.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Insider Trading Restrictions and Market Abuse Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant acknowledges that, depending on Participant&#8217;s or Participant&#8217;s broker&#8217;s country of residence or where the Company shares of Common Stock are listed, Participant may be subject to insider trading restrictions and&#47;or market abuse laws, which may affect his or her ability to accept, acquire, sell or otherwise dispose of Company shares of Common Stock, rights to the shares of Common Stock (e.g., PRSUs) or rights linked to the value of shares of Common Stock (e.g., phantom awards, futures) during such times as Participant is considered to have &#8220;inside information&#8221; regarding the Company as defined by the laws or regulations in Participant&#8217;s country.  Local insider trading laws and regulations may prohibit the cancellation or amendment of orders Participant placed before Participant possessed inside information. Furthermore, Participant could be prohibited from (i) disclosing the inside information to any third party (other than on a &#8220;need to know&#8221; basis) and (ii) &#8220;tipping&#8221; third parties or causing them otherwise to buy or sell securities.  Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy.  Participant acknowledges that it is Participant&#8217;s responsibility to comply with any applicable restrictions, and that Participant should speak to his or her personal advisor on this matter.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">15.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Imposition of Other Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The Company reserves the right to impose other requirements on Participant&#8217;s participation in the Plan, on the Award and on any shares of Common Stock acquired under the Plan, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">16.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Electronic Acknowledgment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">An authorized representative of the Company has signed the Agreement below.  Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through the current on-line system, or any other on-line system or electronic means that the Company may decide, in its sole discretion, to use in the future.  Participant acknowledges and agrees that Participant has carefully reviewed this Agreement and the Plan and these documents set forth the entire understanding between Participant and the Company regarding this Award and supersede all prior or contemporaneous oral and written agreements with respect thereto.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant's designation&#47;election via the current plan administrator&#8217;s website that Participant has read and accepted the terms of this Agreement and the terms and conditions of the Plan is considered Participant's electronic signature and his or her express consent to this Agreement and the terms and conditions set forth in the Plan.</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Offer Date&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#GrantDate#</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By </font><img alt="strausssignature1b.jpg" src="strausssignature1b.jpg" style="height:37px;margin-bottom:5pt;vertical-align:text-bottom;width:127px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, on behalf of UnitedHealth Group Incorporated</font></div><div style="margin-bottom:12pt;text-align:right;text-indent:17.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Acceptance Date&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#AcceptanceDate#</font></div><div style="margin-bottom:12pt;text-align:right;text-indent:17.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Signed Electronically&#47;Signed Manually&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#Signature#</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.8
<SEQUENCE>8
<FILENAME>unhex108123121.htm
<DESCRIPTION>EX-10.8
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ic4c5be6bc08b4b119d981dc20304dafb_33"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">               </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                          </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div></div><div style="margin-bottom:12pt;text-align:center"><img alt="uhglogo2019a02d.jpg" src="uhglogo2019a02d.jpg" style="height:71px;margin-bottom:5pt;vertical-align:text-bottom;width:404px"></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">RESTRICTED STOCK UNIT AWARD</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.666%"><tr><td style="width:1.0%"></td><td style="width:31.417%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.422%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.368%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.422%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Award Date</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(mm&#47;dd&#47;yyyy)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#GrantDate#</font></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Number of Units</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#QuantityGranted#</font></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Final Vesting Date</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(mm&#47;dd&#47;yyyy)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#GrantCustom2#</font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">THIS CERTIFIES THAT UnitedHealth Group Incorporated (the &#8220;Company&#8221;) has on the award date specified above (the &#8220;Award Date&#8221;) granted to</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#ParticipantName#</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(&#8220;Participant&#8221;) an award (the &#8220;Award&#8221;) to receive that number of restricted stock units (the &#8220;RSUs&#8221;) indicated above in the box labeled &#8220;Number of Units,&#8221; each RSU representing the right to receive one share of UnitedHealth Group Incorporated Common Stock, $.01 par value per share (the &#8220;Common Stock&#8221;), subject to certain restrictions and on the terms and conditions contained in this Award and the UnitedHealth Group Incorporated 2020 Stock Incentive Plan (the &#8220;Plan&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Participant acknowledges and agrees that the Company may deliver, by electronic mail, the use of the Internet, including through the website of the agent appointed by the Compensation and Human Resources Committee of the Board of Directors of the Company (the &#8220;Committee&#8221;) to administer the Plan, the Company intranet web pages or otherwise, any information concerning the Company&#59; the Award&#59; the Plan, pursuant to which the Company granted the Award&#59; and any information required by the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A copy of the Plan is available upon request.  In the event of any conflict between the terms of the Plan and this Award certificate, the terms of the Plan shall govern.  Any terms not defined herein shall have the meaning set forth in the Plan.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">* * * * *</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt;text-decoration:underline">Rights of the Participant with Respect to the RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">No Shareholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The RSUs granted pursuant to this Award certificate do not and shall not entitle Participant to any rights of a shareholder of Common Stock, except as provided below.  The rights of Participant with respect to the RSUs shall remain forfeitable at all times prior to the date on which such rights become vested, and the restrictions with respect to the RSUs lapse, in accordance with Section 2, 3 or 4.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">Conversion of RSUs&#59; Issuance of Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  No shares of Common Stock shall be issued to Participant prior to the date on which the RSUs vest, and the restrictions with respect to the RSUs lapse, in accordance with Section 2, 3 or 4.  Neither this Section 1(b) nor any action taken pursuant to or in accordance with this Section 1(b) shall be construed to create a trust of any kind.  After any RSUs vest pursuant to Section 2, 3 or 4, the Company shall promptly cause to be issued shares of Common Stock to Participant or in the name of Participant&#8217;s legal representatives, beneficiaries or heirs, as the case may be, in payment of such vested whole RSUs, at the times provided in Section 2, 3 or 4, as applicable.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">Dividends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If a cash dividend is declared and paid by the Company with respect to the Common Stock, Participant shall be credited as of the applicable dividend payment date with an additional number of whole and&#47;or fractional RSUs (the &#8220;Dividend Units&#8221;) equal to (A) the total cash dividend </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant would have received had Participant&#8217;s RSUs (and any previously credited Dividend Units with respect thereto) been actual shares of Common Stock, divided by (B) the Fair Market Value of a share of Common Stock as of the applicable dividend payment date.  As of each vesting date pursuant to Sections 2, 3 or 4, the number of Dividend Units paid on the RSUs vesting on such vesting date shall become vested, earned and payable in the form of shares of Common Stock&#59; provided, however, that any vested Dividend Units not converted into a whole share of Common Stock may be converted into a fractional Dividend Unit or a cash payment.  To the extent Participant&#8217;s rights to any unvested RSUs are forfeited, the Dividend Units paid on such forfeited RSUs shall also be forfeited.  The terms of this Award certificate shall apply to all Dividend Units paid on the RSUs.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Subject to the terms and conditions of this Award certificate, __% of the RSUs shall vest, and the restrictions with respect to the RSUs shall lapse, on each of the __________ anniversaries of the grant date if Participant remains continuously employed by the Company or any Affiliate until the respective vesting dates.  Any RSUs that vest pursuant to this Section 2 shall be paid to Participant no later than March 15th of the year following the year in which the vesting event occurs (which payment schedule is intended to comply with the &#8220;short-term deferral&#8221; exemption from the application of Section 409A of the Code).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Early Vesting On Certain Terminations On or After Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Notwithstanding the other vesting provisions contained in Section 2 and Section 4, but subject to the other terms and conditions set forth herein, all of the RSUs shall become immediately and unconditionally vested if, on or within two years after the effective date of a Change in Control, the Participant ceases to be an employee of the Company or any Affiliate as a result of a termination of employment (i) by the Participant for Good Reason, (ii) by the Company or any Affiliate without Cause, (iii) at a time when Participant is eligible for Retirement (as defined below), (iv) due to Participant&#8217;s Disability (as defined below), or (v) in the circumstances described in Section 4(c)&#59; provided that in the case of a termination for Good Reason, the RSUs shall vest if the Participant gives written notice of the circumstances constituting Good Reason within two years after the effective date of the Change in Control, if the Company fails to cure the circumstances constituting Good Reason within 60 days of the receipt of such notice and the Participant resigns within 30 days after the end of the cure period, all as provided in Section 3(d).  Any RSUs that vest pursuant to this Section 3 shall be paid to Participant in a lump sum within thirty (30) days after the date of Participant&#8217;s Separation from Service.  For purposes of this Award&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt">&#8220;Affiliate&#8221; shall mean (i) any entity that, directly or indirectly through one or more intermediaries, is controlled by the Company and (ii) any entity in which the Company has a significant equity interest, as determined by the Committee.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt"> &#8220;Change in Control&#8221; shall mean the sale of all or substantially all of the Company&#8217;s assets or any merger, reorganization, or exchange or tender offer which, in each case, will result in a change in the power to elect 50% or more of the members of the Board of Directors of the Company&#59; provided, however, that such a sale, merger, or other event must also constitute either (i) a &#8220;change in the ownership&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(v), (ii) a &#8220;change in the effective control&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(vi)(A)(1) (replacing &#8220;30 percent&#8221; with &#8220;50 percent&#8221; as used in such regulation), or (iii) a change &#8220;in the ownership of a substantial portion of the assets&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(vii).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt">&#8220;Cause&#8221; shall mean Participant&#8217;s (a) material failure to follow the Company&#8217;s reasonable direction or to perform any duties reasonably required on material matters, (b) material violation of, or failure to act upon or report known or suspected violations of, the Company&#8217;s Code of Conduct, as may be amended from time to time, (c) conviction of any felony, (d) commission of any criminal, fraudulent, or dishonest act in connection with Participant&#8217;s employment, (e) breach of any of the Restrictive Covenants in Section 8 of this Award certificate or a material breach of any employment agreement between Participant and the Company or any Affiliate, if any, or (f) conduct that is materially detrimental to the Company&#8217;s interests.  The Company will, within 120 days of discovery of the conduct, give Participant written notice specifying the conduct constituting Cause in reasonable detail and Participant will have 60 days to remedy such conduct, if such conduct is reasonably capable of being remedied.  In any instance where the Company may have grounds for Cause, failure by the Company to provide written notice of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">grounds for Cause within 120 days of discovery shall be a waiver of its right to assert the subject conduct as a basis for termination for Cause. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt">&#8220;Good Reason&#8221; shall mean the occurrence of any of the following without Participant&#8217;s written consent, in each case, when compared to the arrangements in effect immediately prior to the Change in Control&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">any reduction in Participant&#8217;s base salary or target bonus expressed as a percentage of the Participant&#8217;s base salary, other than a reduction that is pursuant to a general reduction affecting a group of employees&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.8pt">a change in the principal location at which the Participant is required to perform his or her duties, if the new location is 50 miles or more further from the Participant&#8217;s principal residence than the original location&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:21.03pt">a material diminution in Participant&#8217;s duties, responsibilities, or authority&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:21.57pt">a change in Participant&#8217;s reporting relationship.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant will, within 120 days of discovery of such circumstances, give the Company written notice specifying the circumstances constituting Good Reason in reasonable detail and, upon receipt of such notice, the Company shall have 60 days to cure the circumstances constituting Good Reason.  Failure by Participant to provide written notice of the grounds for Good Reason within 120 days of discovery, or failure by the Participant to resign within 30 days after the end of the Company&#8217;s 60 day cure period, shall be a waiver of Participant&#8217;s right to assert the subject circumstance as a basis for termination for Good Reason.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt">&#8220;Separation from Service&#8221; shall mean when Participant dies, retires, or otherwise has a termination of employment with the Company that constitutes a &#8220;separation from service&#8221; within the meaning of Treasury Regulation Section 1.409A-1(h)(1), without regard to the optional alternative definitions available thereunder.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.01pt;text-decoration:underline">Possible Acceleration of Vesting and Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If the Award is terminated pursuant to a Change in Control and is not assumed by a party to the Change in Control (and no such party issues a new award in substitution for the Award, as determined by the Committee), the Committee may provide for immediate vesting of the Award, and the issuance of shares of Common Stock, securities of a party to the Change in Control, or cash, or any combination thereof, in full satisfaction of the Award.  Notwithstanding anything in the Plan or any other agreement to the contrary, there is no discretion to change the time of payment of the RSUs (in connection with a Change in Control, similar event, or otherwise) except as expressly provided in this Section 3 or as otherwise permitted under, and would not result in any tax, penalty or interest under, Section 409A of the Code.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">Section 409A - Possible Six-Month Delay in Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Notwithstanding any provision of this Award certificate to the contrary, if payment of the RSUs is triggered by Participant&#8217;s Separation from Service as provided in this Section 3 or Section 4 and, as of the date of such Separation from Service, Participant is a &#8220;specified employee&#8221; (within the meaning of Section 409A of the Code and determined pursuant to procedures adopted by the Company), Participant shall not be entitled to such payment of the RSUs until the earlier of (i) the date which is six (6) months after Participant&#8217;s Separation from Service for any reason other than death, or (ii) the date of Participant&#8217;s death.  Any amounts otherwise payable to Participant upon or in the six (6) month period following Participant&#8217;s Separation from Service that are not so paid by reason of this Section 3(g) shall be paid (without interest) as soon as practicable (and in all events within thirty (30) days) after the date that is six (6) months after Participant&#8217;s Separation from Service (or, if earlier, as soon as practicable, and in all events within thirty (30) days, after the date of Participant&#8217;s death).  The provisions of this Section 3(g) shall only apply if, and to the extent, required to avoid the imputation of any tax, penalty, or interest pursuant to Section 409A of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Termination of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">Termination of Employment Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Except as expressly provided in Section 3 or this Section 4, if, prior to vesting of the RSUs pursuant to Section 2, Participant ceases to be an employee of the Company or any Affiliate for any reason (voluntary or involuntary), and does not continue after such cessation of service to be either an employee of the Company or any Affiliate, then Participant&#8217;s rights to all of the unvested RSUs shall be immediately and irrevocably forfeited on the date of termination.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">Death or Permanent Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant dies while employed by the Company or any Affiliate, or if Participant receives disability benefits under the long-term disability insurance program of the Company or the Affiliate by which the Participant is employed for a period of at least three months (&#8220;Disability&#8221;), then all unvested RSUs shall become immediately vested, and the restrictions with respect to all of the RSUs shall lapse, as of the date of such death or Disability.  Any RSUs that vest pursuant to this Section 4(b) shall be paid to Participant or Participant&#8217;s estate not later than 90 days after the date of such death or Disability.  Notwithstanding the foregoing, if the condition that results in Participant receiving Disability benefits is not a medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than 12 months, then the RSUs shall become immediately vested as provided above, but settlement shall be on the dates on which the RSUs would have vested under the original vesting schedule set forth in Section 2. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant&#8217;s employment with the Company or any Affiliate terminates at a time when Participant is not eligible for Retirement (and other than due to Participant&#8217;s death or Disability) and, in the circumstances, Participant is entitled to severance or separation pay, the following provisions of this Section 4(c) will apply.  If Participant is entitled to severance under the Company&#8217;s severance pay plan as in effect on the date hereof, then the RSUs shall continue to vest, and the restrictions with respect to the RSUs shall continue to lapse, for the period of such severance that Participant is eligible to receive.  If Participant is entitled to severance under an employment agreement entered into with the Company or an Affiliate, then vesting of the RSUs, and lapsing of their restrictions, shall continue for the period of such severance that Participant would be entitled to receive under that agreement as of the date hereof.  If Participant is entitled to separation pay other than under the Company&#8217;s severance pay plan or an employment agreement entered into with the Company or an Affiliate, then vesting of the RSUs, and lapsing of their restrictions, shall continue for the lesser of the period (i) Participant would have received payments under the Company&#8217;s severance pay plan as in effect on the date hereof, had Participant been eligible for such payments, or (ii) of separation pay.  In any case, should Participant&#8217;s severance or separation pay be paid in a lump sum versus bi-weekly payments, the RSUs shall continue to vest for the period of time in which severance or separation pay would have been paid had it been paid bi-weekly.  Any RSUs that vest pursuant to this Section 4(c) shall be paid to Participant on the dates on which the RSUs would have vested under the original vesting schedule set forth in Section 2.  For avoidance of doubt, any RSUs that are unvested on the date of termination of Participant&#8217;s employment and do not vest under the schedule set forth in Section 2 during the applicable severance or separation pay period identified above in this Section 4(c) shall be forfeited.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">Retirement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> If Participant ceases to be an employee of the Company or any Affiliate and Participant is eligible for Retirement at the time of such termination of employment, then the vesting of the RSUs shall continue as if such termination of employment had not occurred, subject to provisions set out in Section 7 below.  Any RSUs that vest pursuant to this Section 4(d) shall be paid to Participant on the dates on which the RSUs would have vested under the original vesting schedule set forth in Section 2.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt">For purposes of this Award certificate, &#8220;Retirement&#8221; means the termination of employment of a Participant who is age 55 or older with at least ten years of Recognized Employment with the Company or any Affiliate other than by reason of (i) death or Disability or (ii) Cause.  Notwithstanding the terms of any other agreement heretofore or hereafter entered into between the parties that reference retirement, Participant and the Company acknowledge and agree that for purposes of calculating years of service for retirement eligibility, Participant will receive two and one half years of service credit for each year she remains employed with the Company after June 5, 2018.  In addition, prior to the date upon which Participant becomes eligible for retirement, if Participant&#8217;s employment is terminated by the Company without Cause or if Participant terminates employment for Good Reason, Participant will be deemed to have met the applicable age and service requirements and will be retirement eligible.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.01pt">For purposes of this Award certificate, &#8220;Recognized Employment&#8221; shall include only employment since the Participant&#8217;s most recent date of hire by the Company or any Affiliate, and shall not include employment with a company acquired by the Company or any Affiliate before the date of such acquisition. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Restriction on Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant may not transfer the RSUs except by will or by the laws of descent and distribution.  Notwithstanding the foregoing, the Award may be transferred to an alternate payee pursuant to the terms of a domestic relations order (as such terms are defined by Section 414(p) of the Code), provided that (i) the Participant is an employee at the time the domestic relations order is entered, (ii) the Award was outstanding at the time the domestic relations order is entered, and (iii) the transfer otherwise satisfies all requirements of the Plan and any limitations and requirements established by the Committee.  Any attempt to otherwise transfer the RSUs shall be void.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Special Restriction on Transfer for Certain Participants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant is an officer of the Company within the meaning of Section 16 of the Securities Exchange Act of 1934 and Rule 16a-1 issued thereunder, as such status is reasonably determined from time to time by the Board of Directors of the Company (a &#8220;Section 16 Officer&#8221;), at any time that shares of Common Stock are issued upon the vesting of RSUs and the Company has theretofore communicated Participant&#8217;s status as a Section 16 Officer to Participant, the following special transfer restrictions apply to Participant&#8217;s Award.  One-third (1&#47;3) of the net number of any shares of Common Stock acquired by Participant upon the vesting of RSUs at a time when Participant is a Section 16 Officer (including any shares of Common Stock or other securities into which such shares may be converted or exchanged as a result of any adjustment made pursuant to this Award or Section 7 of the Plan) must be retained, and may not be sold or otherwise transferred, for a period of at least one year following the applicable vesting date.  For purposes of this Award, the &#8220;net number of any shares of Common Stock acquired&#8221; shall mean the number of shares issued upon vesting of RSUs after reduction for any shares of Common Stock withheld by or tendered to the Company, or sold on the market, to cover any federal, state, local, or other payroll, withholding, income, or other applicable tax withholding required in connection with the issuance of the shares.  The restrictions of this Section 6 are in addition to, and not in lieu of, the restrictions imposed under other Company policies and applicable laws.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Forfeiture of RSUs and Shares of Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This Section 7 sets forth circumstances under which Participant shall forfeit all or a portion of the RSUs, or be required to repay the Company for the value realized in respect of all or a portion of the RSUs.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">Violation of Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant violates any provision of the Restrictive Covenants set forth in Section 8 below, then any unvested RSUs shall be immediately and irrevocably forfeited without any payment therefor.  In addition, for any RSUs that vested within one year prior to Participant&#8217;s termination of employment with the Company or any Affiliate or at any time after such termination of employment, the Participant shall be required, upon demand, to repay or otherwise reimburse the Company (including by forfeiting any deferred compensation credits in respect of such RSUs under the Company&#8217;s non-qualified compensation deferral plans) an amount having a value equal to the aggregate Fair Market Value of the shares of Common Stock underlying such RSUs on the date the RSUs became vested.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">Fraud</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If the Board determines that Participant has engaged in fraud that, in whole or in part, caused the need for a material restatement of the Company&#8217;s consolidated financial statements, then any RSUs that have not yet been settled in shares of Common Stock (including any deferred compensation credits under the Company&#8217;s non-qualified compensation deferral plans in respect of RSUs that have previously become vested) shall be immediately and irrevocably forfeited without any payment therefore.  In addition, for any RSUs that became vested during the 12-month period following the first public issuance or filing with the Securities Exchange Commission (whichever occurs first) of the incorrect financial statements, Participant shall be required, upon demand, to repay or otherwise reimburse the Company (including by forfeiting any deferred compensation credits in respect of such RSUs under the Company&#8217;s non-qualified compensation deferral plans) an amount having a value equal to the aggregate Fair Market Value of the shares of Common Stock underlying such RSUs on the date the RSUs became vested.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">In General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This Section 7 does not constitute the Company&#8217;s exclusive remedy for Participant&#8217;s violation of the Restrictive Covenants or commission of fraudulent conduct.  As the forfeiture and repayment provisions are not adequate remedies at law, the Company may seek any additional legal or equitable remedy, including injunctive relief, for any such violations.  The provisions in this Section 7 are essential economic conditions to the Company&#8217;s grant of RSUs to Participant.  By receiving the grant of RSUs hereunder, Participant agrees that the Company may deduct from any amounts it owes Participant from time to time (such as wages or other compensation, deferred compensation credits, vacation pay, any severance or other payments owed following a termination of employment, as well as any other amounts owed to the Participant by the Company) to the extent of any amounts Participant owes the Company under this section.  The provisions of this Section 7 and any amounts repayable by Participant hereunder are intended to be in addition to any rights to repayment the Company may have under Section 304 of the Sarbanes-Oxley Act of 2002, Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and other applicable law.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In consideration of the terms of this Award certificate and the Company&#8217;s sharing of Confidential Information with the Participant, which the Participant agrees constitute adequate and sufficient mutually-agreed consideration, the Participant agrees to the Restrictive Covenants set forth below in this Section 8. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">Non-Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant has or will be given access to and provided with sensitive, confidential, proprietary and&#47;or trade secret information (collectively, &#8220;Confidential Information&#8221;) in the course of Participant&#8217;s employment.  Examples of Confidential Information include inventions, new product or marketing plans, business strategies and plans, merger and acquisition targets, financial and pricing information, computer programs, source codes, models and data bases, analytical models, customer lists and information, and supplier and vendor lists and other information which is not generally available to the public.  Participant shall not disclose or use Confidential Information, either during or after Participant&#8217;s employment with the Company, except (i) as necessary to perform Participant&#8217;s duties, (ii) as the Company may consent in writing, or (iii) as permitted by Section 8(f) below.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">Non-Solicitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  During Participant&#8217;s employment and for two years after the later of (i) the termination of Participant&#8217;s employment with the Company for any reason whatsoever or (ii) the last scheduled vesting date under Section 4, Participant shall not, without the Company&#8217;s prior written consent, directly or indirectly, for Participant or for any other person or entity, as agent, employee, officer, director, consultant, owner, principal, partner, shareholder, or in any other individual or representative capacity&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">Solicit or conduct business with any business competitive with the Company from any person or entity&#58; (A) who was a Company provider or customer within the 12 months before Participant&#8217;s employment termination and with whom Participant had contact regarding the Company&#8217;s activity, products or services, or for whom Participant provided services or supervised employees who provided those services, or about whom Participant learned Confidential Information during employment related to the Company&#8217;s provision of products and services to such person or entity, or (B) was a prospective provider or customer the Company solicited within the 12 months before Participant&#8217;s employment termination and with whom Participant had contact for the purposes of soliciting the person or entity to become a provider or customer of the Company, or supervised employees who had those contacts, or about whom Participant learned Confidential Information during employment related to the Company&#8217;s provision of products and services to such person or entity&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.8pt">Raid, hire, employ, recruit or solicit any Company employee or consultant who possesses Confidential Information of the Company to leave the Company&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:21.03pt">Induce or influence any Company employee, consultant, or provider who possesses Confidential Information of the Company to terminate his, her or its employment or other relationship with the Company&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:21.57pt">Assist anyone in any of the activities listed above.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">Non-Competition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  During Participant&#8217;s employment and for one year after the later of (i) the termination of Participant&#8217;s employment with the Company for any reason whatsoever or (ii) the last scheduled vesting date under Section 4, Participant shall not, without the Company&#8217;s prior written consent, directly or indirectly, for Participant or for any other person or entity, as agent, employee, officer, director, consultant, owner, principal, partner, shareholder, or in any other individual or representative capacity&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">Engage in or participate in any activity that competes, directly or indirectly, with any Company activity, product or service that Participant engaged in, participated in, or had Confidential Information about during Participant&#8217;s last 36 months of employment with the Company&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.8pt">Assist anyone in any of the activities listed above.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">Geographic Scope</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">Participant&#8217;s obligations under this &#8220;Restrictive Covenants&#8221; section shall apply on a nationwide basis anywhere in the United States.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.8pt">Participant&#8217;s obligations under this &#8220;Restrictive Covenants&#8221; section shall also apply in any country outside the United States with respect to which Participant had responsibility for any UnitedHealth Group activity, product or service in that country.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">Return of Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Participant agrees that all tangible materials (whether originals or duplicates), including, but not limited to, notebooks, computers, files, reports, proposals, price lists, lists of actual or potential customers or suppliers, talent lists, formulae, prototypes, tools, equipment, models, specifications, technical data, methodologies, research results, test results, financial data, contracts, agreements, correspondence, documents, computer disks, software, computer printouts, information stored electronically, memoranda, and notes, in Participant&#8217;s possession, custody, or control which in any way relate to the Company&#8217;s business and which are furnished to Participant by or on behalf of the Company or which are prepared, compiled or acquired by Participant while working with or employed by the Company shall be the sole property of the Company.  At any time upon the request of the Company, and in any event promptly upon termination of Participant&#8217;s employment with the Company, but in any event no later than two (2) business days after such termination, Participant shall deliver all such materials to the Company and shall not retain any originals or copies (including electronically) of such materials.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.01pt;text-decoration:underline">No Restriction on Protected Activities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Nothing in this Award certificate prohibits Participant from disclosing information in good faith to any governmental agency, legislative body, or official regarding an alleged violation of law or regulation or otherwise protected under applicable law, including, without limitation, the National Labor Relations Act, the Defend Trade Secrets Act, and any rule or regulation promulgated by the Securities and Exchange Commission, the National Labor Relations Board, the Equal Employment Opportunity Commission, or any other federal, state, or local government agency.  Participant acknowledges that, through this Section 8(f), the Company has provided Participant with written notice that, pursuant to the Defend Trade Secrets Act, 8 USC &#167; 1833(b), an employee, consultant, or contractor of an employer may not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of an employer&#8217;s trade secrets, so long as such disclosure is made solely&#58; (a) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating a suspected violation of law&#59; and&#47;or (b) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.  Additionally, Participant understands that, pursuant to 18 USC &#167; 1831 et seq., an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose a trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order.  The foregoing immunities provided under 18 USC &#167; 1831 et seq. do not apply to any disclosure of Confidential Information or trade secrets of an employer&#8217;s clients, customers, or counterparties, or of any other third parties. For purposes of this paragraph solely, &#8220;trade secret&#8221; has the meaning set forth in 18 USC &#167; 1839.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">Exceptions for Attorneys</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Notwithstanding the foregoing, this Section 8 will apply only to the extent permissible under provisions of the ABA Model Rules of Professional Conduct, or any applicable state counterpart regarding restrictions on the right to practice law.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">Acknowledgment of Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. By accepting the Award, Participant agrees that the provisions of this Section 8 are reasonable and necessary to protect the legitimate interests of the Company.  Participant further acknowledges that Participant&#8217;s obligations under this Section 8 are in addition to, and do not limit, any and all obligations concerning the same subject matter arising under any applicable law, including, without limitation, common law and statutory law relating to fiduciary duties and trade secrets.  To the extent Participant and the Company agree at any time to enter into separate agreements containing restrictive covenants with different or inconsistent terms than those contained herein, Participant and the Company acknowledge and agree that such different or inconsistent terms shall not in any way affect or have relevance to the Restrictive Covenants contained herein.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Adjustments to RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In the event that any dividend or other distribution (whether in the form of cash,  shares of Common Stock, other securities, or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase, or exchange of Common Stock or other securities of the Company or other similar corporate transaction or event affecting the Common Stock would be reasonably likely to result in the diminution or enlargement of any of the benefits or potential benefits intended to be made available under the Award (including, without limitation, the benefits or potential benefits of provisions relating to the vesting of the RSUs), the Committee shall, in such manner as it shall deem equitable or appropriate in order to prevent such diminution or enlargement of any such benefits or potential benefits, make adjustments to the Award, including adjustments in the number and type of shares of Common Stock Participant would have received upon vesting of the RSUs.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Tax Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">Withholdings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In order to comply with all applicable federal, state, and local tax laws or regulations, the Company may take such action as it deems appropriate to ensure that all applicable federal, state, and local payroll, withholding, income, or other taxes, which are the sole and absolute responsibility of Participant, are withheld or collected from Participant.  Participant is liable and responsible for all taxes owed in connection with the Award, regardless of any action the Company takes with respect to any tax withholding obligations that arise in connection with the Award.  The ultimate tax liability, which is the Participant&#8217;s responsibility, may exceed the amount withheld by the Company.  On each applicable vesting date, Participant will be deemed to have elected to satisfy Participant&#8217;s required federal, state, and local payroll, withholding, income, or other tax withholding obligations arising from the receipt of shares or the lapse of restrictions relating to the RSUs, by having the Company withhold a portion of the shares of Common Stock otherwise to be delivered having a Fair Market Value equal to the amount of such taxes (but not in excess of the maximum amount required to be withheld under applicable laws or regulations).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  It is intended that this Award and any amounts payable under this Award shall either be exempt from or comply with Section 409A of the Code (including the Treasury regulations and other published guidance relating thereto) so as not to subject Participant to payment of any additional tax, penalty, or interest imposed under Section 409A of the Code.  The provisions of this Award certificate shall be construed and interpreted to avoid the imputation of any such additional tax, penalty, or interest under Section 409A of the Code yet preserve (to the nearest extent reasonably possible) the intended benefit payable to Participant.  To the extent that the time or form of payment of any benefit pursuant to this Award would violate the terms of Section 409A, the Committee may revise the time or form of payment to conform to Section 409A.  Notwithstanding the foregoing, in no event shall the Company, any Affiliate, the members of the Committee, or any other person have any liability for any additional tax, penalty or interest imposed on Participant by reason of Section 409A or otherwise.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">11.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">At-Will Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This Award certificate does not confer on Participant any right to continued employment or any other relationship with the Company or any Affiliate, nor will it interfere in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">any way with the right of the Company to terminate Participant at any time.  Participant&#8217;s employment with the Company is at will.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">No Trust or Fiduciary Relationship</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Neither the Plan nor this Award certificate shall create or be construed to create a trust or separate fund of any kind or a fiduciary relationship between the Company or any Affiliate and Participant or any other person.  To the extent that any person acquires a right to receive payments from the Company or any Affiliate pursuant to an Award, such right shall be no greater than the right of any unsecured creditor of the Company or any Affiliate.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">Securities Law Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The Company shall not be required to deliver any shares of Common Stock upon the vesting of any RSUs until the requirements of any federal or state securities laws, rules, or regulations or other laws or rules (including the rules of any securities exchange) as may be determined by the Company to be applicable have been and continue to be satisfied (including an effective registration of the shares under federal and state securities laws).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">Original Instrument</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  An original record of this Award certificate and all the terms hereof, executed by the Company, is held on file by the Company.  To the extent there is any conflict between the terms contained in any copy of this Award certificate and the terms contained in the original held by the Company, the terms of the original held by the Company shall control.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.91pt;text-decoration:underline">Survival of Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The Restrictive Covenants in Section 8 of this Award certificate and the provisions regarding the forfeiture of RSUs and shares of Common Stock shall survive termination of the RSUs and termination of Participant&#8217;s relationship with the Company as set forth in Section 8.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.01pt;text-decoration:underline">Choice of Law, Injunctive Relief, Attorney&#8217;s Fees and Jury Trial</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant consents to the law of Minnesota exclusively being applied to any matter arising out of or relating to this Award certificate, without regard to its conflict of law principles, and exclusively to personal and subject matter jurisdiction in the state and federal courts of Minnesota for any dispute relating to this Award certificate or Participant&#8217;s relationship with the Company.  In the event of a breach or a threatened breach of this Award by Participant, Participant acknowledges that the Company will face irreparable injury which may be difficult to calculate in dollar terms and that the Company shall be entitled, in addition to remedies otherwise available at law or in equity, to temporary restraining orders and preliminary injunctions and final injunctions without the posting of a bond enjoining such breach or threatened breach.  Should the Company successfully enforce any portion of this Award certificate before a trier of fact or in an arbitration proceeding, the Company shall be entitled to all of its reasonable attorney&#8217;s fees and costs incurred as a result of enforcing this Award certificate against Participant. Participant waives all rights or entitlement to a jury trial for any matter arising out of or relating to this Award certificate.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">No Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  No waiver of any breach of any provision of this Award certificate by the Company shall be effective unless it is in writing, and no waiver shall be construed to be a waiver of any succeeding breach or as a modification of such provision.  The provisions of this Award certificate shall be severable, and if any provision of this Award certificate is found by any court or arbitrator to be unenforceable, in whole or in part, the remainder of this Award certificate shall nevertheless be enforceable and binding on the parties.  Participant also agrees that a court or arbitrator may modify any invalid, overbroad or unenforceable term of this Award certificate so that such term, as modified, is valid and enforceable under applicable law, and that a court or arbitrator is authorized to extend the length of the Restrictive Covenants in Section 8 of this Award certificate for any period of time in which Participant is in breach of the Restrictive Covenants or as necessary to protect the legitimate business interests of Company. Further, Participant affirmatively states that Participant has not, will not, and cannot rely on any representations not expressly made herein.  The terms of this Award certificate shall not be amended by Participant or Company except by the express written consent of the Company and Participant.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:24.34pt;text-decoration:underline">Consideration Period&#59; Right to Consult with Counsel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  By the Participant&#8217;s acceptance below, the Participant acknowledges and agrees that the Company provided the Participant with at least ten (10) business days to review and consider this Award certificate and that voluntarily accepting this Award certificate before the expiration of ten (10) business days shall serve as a waiver of the ten (10) day review </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">period. The Participant has the right and is advised to consult with counsel of his&#47; her choice before signing this document.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt;text-decoration:underline">Assignability and Change of Position</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The rights and&#47;or obligations herein may be assigned by the Company without Participant&#8217;s consent and shall bind and inure to the benefit of the Company&#8217;s successors, assigns, and representatives.  If the Company makes any assignment of the rights and&#47;or obligations herein, Participant agrees that this Award certificate shall remain binding upon Participant in any event.</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Offer Date&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#GrantDate#</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By </font><img alt="strausssignatureb.jpg" src="strausssignatureb.jpg" style="height:37px;margin-bottom:5pt;vertical-align:text-bottom;width:127px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, on behalf of UnitedHealth Group Incorporated</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Acceptance Date&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#AcceptanceDate#</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Signed Electronically&#47;Signed Manually&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#Signature#</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.9
<SEQUENCE>9
<FILENAME>unhexhibit109.htm
<DESCRIPTION>EX-10.9
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="id8b3c4dc72324403b2623fa7296beada_33"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.9</font></div></div><div style="text-align:center"><img alt="uhglogo2019a02.jpg" src="uhglogo2019a02.jpg" style="height:71px;margin-bottom:5pt;vertical-align:text-bottom;width:404px"></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">NONQUALIFIED STOCK OPTION AWARD</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.750%"><tr><td style="width:1.0%"></td><td style="width:24.541%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.705%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.583%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.543%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Award Date<br>(mm&#47;dd&#47;yyyy)</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Option Shares</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Exercise Price</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Expiration Date<br>(mm&#47;dd&#47;yyyy)</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"><br><br></font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#Grant Date#</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#QuantityGran</font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">ted#</font></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">$#GrantPrice#</font></div></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#Expiration Date#</font></td></tr></table></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">THIS CERTIFIES THAT UnitedHealth Group Incorporated (the &#8220;Company&#8221;) has on the award date specified above (the &#8220;Award Date&#8221;) granted to</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#ParticipantName#</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(the &#8220;Participant&#8221;) the option (the &#8220;Option&#8221;) to purchase that number of shares of UnitedHealth Group Incorporated Common Stock, $.01 par value per share (the &#8220;Common Stock&#8221;), indicated above (the &#8220;Option Shares&#8221;). The Option that this Award represents will expire on the expiration date indicated above (the &#8220;Expiration Date&#8221;), unless it is terminated prior to that time in accordance with this Award. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Option Shares represented by this Award shall become exercisable as follows&#58;  __% on each of the __________ anniversaries, unless the Option shall have terminated or the vesting shall have accelerated as provided in this Award. Once the Option has become exercisable for all or a portion of the Option Shares, it will remain exercisable for all or such portion of the Option Shares, as the case may be, until the Option expires or is terminated as provided in this Award. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By accepting this Award, the Participant acknowledges that the Participant will not have any of the rights of a shareholder with respect to the Option Shares until the Option has been duly exercised and the exercise price indicated above (the &#8220;Exercise Price&#8221;) and applicable withholding taxes paid in accordance with this Award. The Participant further acknowledges and agrees that the Company may deliver, by electronic mail, the use of the Internet, including through the website of the agent appointed by the Compensation and Human Resources Committee of the Board of Directors of the Company (the &#8220;Committee&#8221;) to administer the UnitedHealth Group Incorporated 2020 Stock Incentive Plan (the &#8220;Plan&#8221;), the Company intranet web pages or otherwise, any information concerning the Company, this Award, the Plan pursuant to which the Company granted this Award, and any information required by the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This Option is subject to the further terms and conditions set forth below and to the terms of the Plan. A copy of the Plan is available upon request. In the event of any conflict between the terms of the Plan and this Award, the terms of the Plan shall govern. Any terms not defined herein shall have the meaning set forth in the Plan. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">* * * * * </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Nonqualified Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The Company does not intend that the Option shall be an Incentive Stock Option governed by the provisions of Section 422 of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;). </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Termination of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The Option shall terminate on the Expiration Date. The Option shall terminate prior to the Expiration Date if the Participant ceases to be employed by the Company or any Affiliate, except that&#58; </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">General. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Except as expressly provided in Section 10 or this Section 2, if prior to vesting of the Option as set forth herein, the Participant ceases to be an employee of the Company or any Affiliate for any reason (voluntary or involuntary), then the Participant may, at any time within the period set forth in the applicable provision below, exercise the Option to the extent of the full number of Option Shares which were exercisable and which the Participant was entitled to purchase under the Option on the date of the termination of his or her employment. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Death or Long-Term Disability. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If the Participant dies while employed by the Company or any Affiliate, or if the Participant&#8217;s employment by the Company or any Affiliate is terminated due to the Participant&#8217;s failure to return to work as the result of a long-term disability which renders the Participant incapable of performing his or her duties as determined under the provisions of the long-term disability insurance program of the Company or the Affiliate by which the Participant is employed (&#8220;Disability&#8221;), then&#58; (i) all unvested Option Shares hereunder shall immediately vest and be exercisable, and (ii) the Participant (or the Participant&#8217;s personal representatives, administrators or guardians, as applicable, or any person or persons to whom the Option is transferred by will or the applicable laws of descent and distribution) may, at any time within the shorter of (1) the Expiration Date of the Option, or (2) a period of five years after the Participant&#8217;s death or Disability or for such other longer period established at the discretion of the Committee, exercise the Option. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Severance. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Subject to Section 10, if Participant&#8217;s employment with the Company or any Affiliate terminates at a time when Participant is not eligible for Retirement (as defined below) and, in the circumstances, Participant is entitled to severance or separation pay, the following provisions will apply.  If the Participant is entitled to severance under the Company&#8217;s severance pay plan as in effect on the date hereof and the Participant is not eligible for Retirement (as defined below) at the time of termination of employment, then the Option shall continue to vest and become exercisable for the period of such severance. If Participant is entitled to severance under an employment agreement entered into with the Company or an Affiliate, then the Option shall continue to vest and become exercisable for the period of such severance that Participant is entitled to receive as of the date hereof. If the Participant is entitled to separation pay other than under the Company&#8217;s severance pay plan or an employment agreement entered into with the Company or an Affiliate, then vesting of the Option shall continue for the lesser of the period (i) the Participant would have received payments under the severance pay plan as in effect on the date hereof, had the Participant been eligible for such payments&#59; or (ii) of separation pay. In either case, should the Participant be paid in a lump sum versus bi-</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">weekly payments, the Option shall continue to vest for the time in which severance or separation pay would have been paid had it been paid bi-weekly.  Any portion of the Option that vests after the Participant&#8217;s termination of employment pursuant to this Section 2(c) may be exercised during the Exercise Period (as defined below).  For avoidance of doubt, any Options that are unvested on the date of termination of Participant&#8217;s employment and do not vest under the schedule set forth herein during the applicable severance or separation pay period identified above in this Section 2(c) shall be forfeited.  For the purposes of this Section 2(c), &#8220;Exercise Period&#8221; shall mean the greater of&#58; (i) a period of three months after the date of termination of the Participant&#8217;s employment&#59; (ii) a period of three months after vesting ceases as provided in Section 2(c) if Participant receives severance or separation pay&#59; or (iii) such other longer period established at the discretion of the Committee.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Retirement. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If the Participant&#8217;s employment by the Company or any Affiliate is terminated and at the time of termination the Participant is eligible for Retirement, then (i) the Option shall continue to vest and become exercisable as if such termination of employment had not occurred and (ii) the Participant may, at any time within the shorter of (1) the Expiration Date of the Option, or (2) a period of five years after such termination of employment or for such other longer period established at the discretion of the Committee, exercise the Option to the extent of the full number of Option Shares which are then exercisable.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)        Anything else contained in this Award certificate notwithstanding, the Option shall in no event be exercisable after the Expiration Date.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)        For purposes of this Award, &#8220;Retirement&#8221; means the termination of employment of a Participant who is age 55 or older with at least ten years of Recognized Employment with the Company or any Affiliate other than by reason of (i) death or Disability or (ii) Cause.  Notwithstanding the terms of any other agreement heretofore or hereafter entered into between the parties that reference retirement, Participant and the Company acknowledge and agree that for purposes of calculating years of service for retirement eligibility, Participant will receive two and one half years of service credit for each year she remains employed with the Company after June 5, 2018.  In addition, prior to the date upon which Participant becomes eligible for retirement, if Participant&#8217;s employment is terminated by the Company without Cause or if Participant terminates employment for Good Reason, Participant will be deemed to have met the applicable age and service requirements and will be retirement eligible.  </font></div><div style="text-align:justify;text-indent:37.05pt"><font><br></font></div><div style="text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)       For purposes of this Award, &#8220;Recognized Employment&#8221; shall include only employment since the Participant&#8217;s most recent date of hire by the Company or any Affiliate, and shall not include employment with a company acquired by the Company or any Affiliate before the date of such acquisition.  </font></div><div style="text-align:justify;text-indent:37.05pt"><font><br></font></div><div style="text-align:justify;text-indent:34.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3.          </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Forfeiture of Option and&#47;or Recoupment of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. This section sets forth circumstances under which the Participant shall forfeit all or a portion of the Options, or be required to repay the Company for the value realized in respect of all or a portion of the Options. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Violation of Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If the Participant violates any provision of the Restrictive Covenants in Section 4 of this Award certificate, then any (i) unvested Options and (ii) Options that vested within one year prior to the Participant&#8217;s termination of employment with the Company or any Affiliate or at any time after such termination of employment and that have not been exercised shall be immediately cancelled and rendered null and void without any payment therefor (the &#8220;Forfeited Options&#8221;).  If any such Forfeited Options have been exercised prior to the Participant&#8217;s violation of the Restrictive Covenants, the Participant shall be required to repay or otherwise reimburse the Company, upon demand, an amount in cash or Common Stock having a value equal to the amount described in this Section 3(a) below. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To the extent that such Option Shares have been sold, the amount shall be the aggregate proceeds received from such sale of the net Option Shares acquired after payment of the Exercise Price and any applicable taxes (&#8220;Net Option Shares&#8221;). To the extent that the Net Option Shares have not been sold at the time Company demand is made, the amount shall be the aggregate Fair Market Value of the Net Option Shares on the date the Forfeited Options were exercised. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Fraud</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If the Board determines that the Participant has engaged in fraud that, in whole or in part, caused the need for a material restatement of the Company&#8217;s consolidated financial statements, then any vested and unvested Options then held by the Participant shall be immediately cancelled and rendered null and void without any payment therefor.  In addition, for any Options that were exercised during the 12-month period following the first public issuance or filing with the Securities Exchange Commission (whichever occurs first) of the incorrect financial statements (the &#8220;Covered Options&#8221;), the Participant shall be required to repay or otherwise reimburse the Company, upon demand, an amount in cash or Common Stock having a value equal to the amount described in this Section 3(b) below, depending on whether the Participant still holds the Option Shares acquired upon exercise of the Covered Options.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To the extent that such Option Shares have been sold, the amount shall be the aggregate proceeds received from such sale of the Net Option Shares. To the extent that the Net Option Shares have not been sold at the time Company demand is made, the amount shall be the aggregate Fair Market Value of the Net Option Shares on the date the Covered Options were exercised. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (c)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">In General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This section does not constitute the Company&#8217;s exclusive remedy for the Participant&#8217;s violation of the Restrictive Covenants or commission of fraudulent conduct.  As the forfeiture and repayment provisions are not adequate remedies at law, the Company may seek any additional legal or equitable remedy, including injunctive relief, for any such violations. The provisions in this section are essential economic conditions to the Company&#8217;s grant of Options to the Participant.  By receiving the grant of Options hereunder, the Participant agrees that the Company may deduct from any amounts it owes the Participant from time to time (such as wages or other compensation, deferred compensation credits, vacation pay, any severance or other payments owed following a termination of employment, as well as any other amounts owed to the Participant by the Company) to the extent of any amounts the Participant owes the Company under this section. The provisions of this section and any amounts repayable by </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">the Participant hereunder are intended to be in addition to any rights to repayment the Company may have under Section 304 of the Sarbanes-Oxley Act of 2002, Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and other applicable law.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In consideration of the terms of this Award certificate and the Company&#8217;s sharing of Confidential Information with the Participant, which the Participant agrees constitute adequate and sufficient mutually-agreed consideration, the Participant agrees to the Restrictive Covenants set forth below in this Section 4. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Non-Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant has or will be given access to and provided with sensitive, confidential, proprietary and&#47;or trade secret information (collectively, &#8220;Confidential Information&#8221;) in the course of Participant&#8217;s employment.  Examples of Confidential Information include inventions, new product or marketing plans, business strategies and plans, merger and acquisition targets, financial and pricing information, computer programs, source codes, models and data bases, analytical models, customer lists and information, and supplier and vendor lists and other information which is not generally available to the public.  Participant shall not disclose or use Confidential Information, either during or after Participant&#8217;s employment with the Company, except (i) as necessary to perform Participant&#8217;s duties, (ii) as the Company may consent in writing, or (iii) as permitted by Section 4(f) below.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Non-Solicitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  During Participant&#8217;s employment and for two years after the later of (i) the termination of Participant&#8217;s employment with the Company for any reason whatsoever or (ii) the last scheduled vesting date under this Award certificate, Participant shall not, without the Company&#8217;s prior written consent, directly or indirectly, for Participant or for any other person or entity, as agent, employee, officer, director, consultant, owner, principal, partner, shareholder, or in any other individual or representative capacity&#58;</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">Solicit or conduct business with any business competitive with the Company from any person or entity&#58; (A) who was a Company provider or customer within the 12 months before Participant&#8217;s employment termination and with whom Participant had contact regarding the Company&#8217;s activity, products or services, or for whom Participant provided services or supervised employees who provided those services, or about whom Participant learned Confidential Information during employment related to the Company&#8217;s provision of products and services to such person or entity, or (B) was a prospective provider or customer the Company solicited within the 12 months before Participant&#8217;s employment termination and with whom Participant had contact for the purposes of soliciting the person or entity to become a provider or customer of the Company, or supervised employees who had those contacts, or about whom Participant learned Confidential Information during employment related to the Company&#8217;s provision of products and services to such person or entity&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.8pt">Raid, hire, employ, recruit or solicit any Company employee or consultant who possesses Confidential Information of the Company to leave the Company&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:21.03pt">Induce or influence any Company employee, consultant, or provider who possesses Confidential Information of the Company to terminate his, her or its employment or other relationship with the Company&#59; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:21.57pt">Assist anyone in any of the activities listed above.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Non-Competition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  During Participant&#8217;s employment and for one year after the later of (i) the termination of Participant&#8217;s employment with the Company for any reason whatsoever or (ii) the last scheduled vesting date under this Award certificate, Participant shall not, without the Company&#8217;s prior written consent, directly or indirectly, for Participant or for any other person or entity, as agent, employee, officer, director, consultant, owner, principal, partner, shareholder, or in any other individual or representative capacity&#58;</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">Engage in or participate in any activity that competes, directly or indirectly, with any Company activity, product or service that Participant engaged in, participated in, or had Confidential Information about during Participant&#8217;s last 36 months of employment with the Company&#59; or</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.8pt">Assist anyone in any of the activities listed above.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Geographic Scope</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)      Participant&#8217;s obligations under this &#8220;Restrictive Covenants&#8221; section shall apply on a nationwide basis anywhere in the United States.</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)        Participant&#8217;s obligations under this &#8220;Restrictive Covenants&#8221; section shall also apply in any country outside the United States with respect to which Participant had responsibility for any UnitedHealth Group activity, product or service in that country.  </font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (e)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Return of Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Participant agrees that all tangible materials (whether originals or duplicates), including, but not limited to, notebooks, computers, files, reports, proposals, price lists, lists of actual or potential customers or suppliers, talent lists, formulae, prototypes, tools, equipment, models, specifications, technical data, methodologies, research results, test results, financial data, contracts, agreements, correspondence, documents, computer disks, software, computer printouts, information stored electronically, memoranda, and notes, in Participant&#8217;s possession, custody, or control which in any way relate to the Company&#8217;s business and which are furnished to Participant by or on behalf of the Company or which are prepared, compiled or acquired by Participant while working with or employed by the Company shall be the sole property of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Company.  At any time upon the request of the Company, and in any event promptly upon termination of Participant&#8217;s employment with the Company, but in any event no later than two (2) business days after such termination, Participant shall deliver all such materials to the Company and shall not retain any originals or copies (including electronically) of such materials.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">No Restriction on Protected Activities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Nothing in this Award certificate prohibits Participant from disclosing information in good faith to any governmental agency, legislative body, or official regarding an alleged violation of law or regulation or otherwise protected under applicable law, including, without limitation, the National Labor Relations Act, the Defend Trade Secrets Act, and any rule or regulation promulgated by the Securities and Exchange Commission, the National Labor Relations Board, the Equal Employment Opportunity Commission, or any other federal, state, or local government agency.  Participant acknowledges that, through this Section 4(f), the Company has provided Participant with written notice that, pursuant to the Defend Trade Secrets Act, 8 USC &#167; 1833(b), an employee, consultant, or contractor of an employer may not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of an employer&#8217;s trade secrets, so long as such disclosure is made solely&#58; (a) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating a suspected violation of law&#59; and&#47;or (b) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.  Additionally, Participant understands that, pursuant to 18 USC &#167; 1831 et seq., an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose a trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order.  The foregoing immunities provided under 18 USC &#167; 1831 et seq. do not apply to any disclosure of Confidential Information or trade secrets of an employer&#8217;s clients, customers, or counterparties, or of any other third parties. For purposes of this paragraph solely, &#8220;trade secret&#8221; has the meaning set forth in 18 USC &#167; 1839.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Exceptions for Attorneys</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Notwithstanding the foregoing, this Section 4 will apply only to the extent permissible under provisions of the ABA Model Rules of Professional Conduct, or any applicable state counterpart regarding restrictions on the right to practice law.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(h)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Acknowledgment of Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. By accepting the Award, Participant agrees that the provisions of this Section 4 are reasonable and necessary to protect the legitimate interests of the Company.  Participant further acknowledges that Participant&#8217;s obligations under this Section 4 are in addition to, and do not limit, any and all obligations concerning the same subject matter arising under any applicable law, including, without limitation, common law and statutory law relating to fiduciary duties and trade secrets.  To the extent Participant and the Company agree at any time to enter into separate agreements containing restrictive </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">covenants with different or inconsistent terms than those contained herein, Participant and the Company acknowledge and agree that such different or inconsistent terms shall not in any way affect or have relevance to the Restrictive Covenants contained herein.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Manner of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </font></div><div style="text-align:justify;text-indent:37.05pt"><font><br></font></div><div style="text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">In General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  On the terms set forth herein, the Option may be exercised by the Participant in whole or in part from time to time by delivering notice of exercise (in a form and manner acceptable to the Company) to the Company or the Committee&#8217;s designated agent, accompanied by payment of the Exercise Price and any applicable withholding taxes in cash or its equivalent, or by any of the following methods, subject to such limitations and restrictions as the Committee may establish (i) by a cashless exercise program established pursuant to Regulation T of the Federal Reserve Board, (ii) by delivery of shares of Common Stock already owned by the Participant, (iii) by withholding shares of Common Stock from the total number of shares of Common Stock acquired upon exercise under the Option having a fair market value, on the exercise date, equal to the aggregate Exercise Price and any applicable withholding taxes, or (iv) by a combination of any of the preceding methods or such other methods as the Committee may permit.</font></div><div style="text-align:justify;text-indent:37.05pt"><font><br></font></div><div style="text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Automatic Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  To the extent the vested and exercisable portion of the Option remains unexercised as of the close of business on the date the Option expires (the Expiration Date or such earlier date that is the last date on which the Option may be exercised pursuant to the terms of this Award certificate), that portion of the Option will be exercised without any action by the Participant in accordance with the terms of this Certificate if the Fair Market Value of a Share on that date is at least $0.01 greater than the Exercise Price and the exercise will result in Participant receiving at least one Share. </font></div><div style="text-align:justify;text-indent:37.05pt"><font><br></font></div><div style="text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Satisfaction of Securities Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Notwithstanding anything to the contrary in this Award certificate, the Company shall not be required to issue or deliver any shares of Common Stock upon exercise of any Option until the requirements of any federal or state securities laws, rules or regulations or other laws or rules (including the rules of any securities exchange) as may be determined by the Company to be applicable have been and continue to be satisfied (including an effective registration of the shares under federal and state securities laws).</font></div><div style="text-align:justify;text-indent:37.05pt"><font><br></font></div><div style="text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Tax Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In order to comply with all applicable federal or state income tax laws or regulations, the Company may take such action as it deems appropriate to ensure that all applicable federal or state payroll, withholding, income or other taxes, which are the sole and absolute responsibility of Participant, are withheld or collected from Participant.  Participant is liable and responsible for all taxes owed in connection with the Award, regardless of any action the Company takes with respect to any tax withholding obligations that arise in connection with the Award.  The ultimate tax liability, which is the Participant&#8217;s responsibility, may exceed the amount withheld by the Company.  To the extent Participant elects to satisfy Participant&#8217;s required federal, state, and local payroll, withholding, income, or other tax withholding obligations by having the Company withhold a portion of the shares of Common Stock otherwise to be delivered, the fair </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">market value of the shares withheld may not exceed the  maximum amount required to be withheld under applicable laws or regulations.</font></div><div style="text-align:justify;text-indent:37.05pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">No Guarantee of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. This Award does not confer on the Participant any right to continued employment or any other relationship with the Company or any Affiliate, nor will it interfere in any way with the right of the Company to terminate Participant at any time.  Participant&#8217;s employment with the Company is at will.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">7.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">No Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. During the Participant&#8217;s lifetime, only the Participant can exercise the Option. The Participant may not transfer the Option except by will or the laws of descent and distribution.  Notwithstanding the foregoing, the Option may be transferred to an alternate payee pursuant to the terms of a domestic relations order (as such terms are defined by Section 414(p) of the Code), provided that (i) the Participant is an employee at the time the domestic relations order is entered, (ii) the Option was outstanding at the time the domestic relations order is entered, and (iii) the transfer otherwise satisfies all requirements of the Plan and any limitations and requirements established by the Committee.   Any attempt to otherwise transfer the Option shall be void. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">8.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Special Restriction on Transfer for Certain Participants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If the Participant is an officer of the Company within the meaning of Section 16 of the Securities Exchange Act of 1934 and Rule 16a-1 issued thereunder, as such status is reasonably determined from time to time by the Board of Directors of the Company (a &#8220;Section 16 Officer&#8221;), at any time that the Option is exercised in whole or in part and the Company has theretofore communicated the Participant&#8217;s status as a Section 16 Officer to the Participant, the following special transfer restrictions apply to any shares of Common Stock acquired upon the exercise of the Option.  One-third (1&#47;3) of the net number of any shares of Common Stock acquired upon the exercise of the Option at a time when the Participant is a Section 16 Officer (including any shares of Common Stock or other securities subject to the Option following any adjustment made pursuant to the Option or Section 7 of the Plan) must be retained, and may not be sold or otherwise transferred, for a period of at least one year following the date the Option is exercised.  For purposes of the Option, the &#8220;net number of any shares of Common Stock acquired&#8221; shall mean the number of shares of Common Stock received with respect to the particular exercise after reduction for any shares of Common Stock withheld by or tendered to the Company, or sold on the market, to cover the Exercise Price of the Option and&#47;or to cover any federal, state, local or other payroll, withholding, income or other applicable tax withholding required in connection with the exercise of the Option.  The restrictions of this Section 8 are in addition to, and not in lieu of, the restrictions imposed under other Company policies and applicable laws. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">9.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Adjustments to Option Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. In the event that any dividend or other distribution (whether in the form of cash, shares of Common Stock, other securities or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase or exchange of Shares or other securities of the Company or other similar corporate transaction or event affecting the Shares would be reasonably likely to result in the diminution or enlargement of any of the benefits or potential benefits intended to be made available under the Option (including, without limitation, the benefits or potential benefits of provisions relating to the term, vesting or exercisability of the Option), the Committee shall, in such manner as it shall </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">deem equitable or appropriate in order to prevent such diminution or enlargement of any such benefits or potential benefits, adjust any or all of (a) the number and type of shares (or other securities or other property) subject to the Option and (b) the exercise price with respect to the Option&#59; provided, however, that the number of shares covered by the Option shall always be a whole number. Without limiting the foregoing, if any capital reorganization or reclassification of the capital stock of the Company, or consolidation or merger of the Company with another entity, or the sale of all or substantially all of the Company&#8217;s assets to another entity, shall be effected in such a way that holders of the Company&#8217;s Common Stock shall be entitled to receive stock, securities, cash or other assets with respect to or in exchange for such shares, the Participant shall have the right to purchase and receive upon the basis and upon the terms and conditions specified in this Award certificate and in lieu of the shares of Common Stock of the Company immediately theretofore purchasable and receivable upon the exercise of the Option, with appropriate adjustments to prevent diminution or enlargement of benefits or potential benefits intended to be made available under the Option, such shares of stock, other securities, cash or other assets as would have been issued or delivered to the Participant if the Participant had exercised the Option and had received such shares of Common Stock prior to such reorganization, reclassification, consolidation, merger or sale. The Company shall not effect any such reorganization, consolidation, merger or sale unless prior to the consummation thereof the successor entity (if other than the Company) resulting from such reorganization, consolidation or merger or the entity purchasing such assets shall assume by written instrument the obligation to deliver to the Participant such shares of stock, securities, cash or other assets as, in accordance with the foregoing provisions, the Participant may be entitled to purchase or receive. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:37.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">10.       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Certain Terminations on or After Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Notwithstanding the other vesting provisions set forth herein, but subject to the other terms and conditions set forth herein, the Option shall become fully vested and exercisable if, on or within two years after the effective date of a Change in Control, the Participant ceases to be an employee of the Company or any Affiliate as a result of a termination of employment (i) by the Participant for Good Reason, (ii) by the Company or any Affiliate without Cause, (iii) at a time when Participant is eligible for Retirement, (iv) due to Participant&#8217;s Disability, or (v) in the circumstances described in Section 2(c)&#59; provided that in the case of a termination for Good Reason, the Option shall vest if the Participant gives written notice of the circumstances constituting Good Reason within two years after the effective date of the Change in Control, if the Company fails to cure the circumstances constituting Good Reason within 60 days of the receipt of such notice and the Participant resigns within 30 days after the end of the cure period, all as provided in Section 10(d).  For purposes of this Award certificate&#58;</font></div><div style="text-align:justify;text-indent:37.05pt"><font><br></font></div><div style="text-align:justify;text-indent:73.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        &#8220;Affiliate&#8221; shall mean (i) any entity that, directly or indirectly through one or more intermediaries, is controlled by the Company and (ii) any entity in which the Company has a significant equity interest, as determined by the Committee.   </font></div><div style="text-align:justify;text-indent:73.05pt"><font><br></font></div><div style="text-align:justify;text-indent:73.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       &#8220;Cause&#8221; shall mean Participant&#8217;s (a) material failure to follow the Company&#8217;s reasonable direction or to perform any duties reasonably required on </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">material matters, (b) material violation of, or failure to act upon or report known or suspected violations of, the Company&#8217;s Code of Conduct, as may be amended from time to time, (c) conviction of any felony, (d) commission of any criminal, fraudulent, or dishonest act in connection with Participant&#8217;s employment, (e) breach of any of the Restrictive Covenants in Section 4 of this Award certificate or a material breach of any employment agreement between Participant and the Company or any Affiliate, if any, or (f) conduct that is materially detrimental to the Company&#8217;s interests.  The Company will, within 120 days of discovery of the conduct, give Participant written notice specifying the conduct constituting Cause in reasonable detail and Participant will have 60 days to remedy such conduct, if such conduct is reasonably capable of being remedied.  In any instance where the Company may have grounds for Cause, failure by the Company to provide written notice of the grounds for Cause within 120 days of discovery shall be a waiver of its right to assert the subject conduct as a basis for termination for Cause.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:73.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)        &#8220;Change in Control&#8221; shall mean the sale of all or substantially all of the Company&#8217;s assets or any merger, reorganization, or exchange or tender offer which, in each case, will result in a change in the power to elect 50% or more of the members of the Board of Directors of the Company&#59; provided, however, that such a sale, merger or other event must also constitute either (i) a &#8220;change in the ownership&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(v), (ii) a &#8220;change in the effective control&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(vi)(A)(1) (replacing &#8220;30 percent&#8221; with &#8220;50 percent&#8221; as used in such regulation), or (iii) a change &#8220;in the ownership of a substantial portion of the assets&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(vii).</font></div><div style="text-align:justify;text-indent:73.05pt"><font><br></font></div><div style="text-align:justify;text-indent:73.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)       &#8220;Good Reason&#8221; shall mean the occurrence of any of the following without Participant&#8217;s written consent, in each case, when compared to the arrangements in effect immediately prior to the Change in Control&#58;</font></div><div style="text-align:justify;text-indent:73.05pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">any reduction in Participant&#8217;s base salary or target bonus expressed as a percentage of the Participant&#8217;s base salary, other than a reduction that is pursuant to a general reduction affecting a group of employees&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.8pt">a change in the principal location at which the Participant is required to perform his or her duties, if the new location is 50 miles or more further from the Participant&#8217;s principal residence than the original location&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:21.03pt">a material diminution in Participant&#8217;s duties, responsibilities or authority&#59; or</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:21.57pt">a change in Participant&#8217;s reporting relationship.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant will, within 120 days of discovery of such circumstances, give the Company written notice specifying the circumstances constituting Good Reason in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">reasonable detail and, upon receipt of such notice, the Company shall have 60 days to cure the circumstances constituting Good Reason.  Failure by Participant to provide written notice of the grounds for Good Reason within 120 days of discovery, or failure by the Participant to resign within 30 days after the end of the Company&#8217;s 60 day cure period, shall be a waiver of Participant&#8217;s right to assert the subject circumstance as a basis for termination for Good Reason.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Possible Acceleration of Vesting&#59; Payment in Satisfaction of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If the Option is terminated pursuant to a Change in Control and is not assumed by a party to the Change in Control (and no such party issues a new award in substitution for the Award, as determined by the Committee), the Committee may provide for immediate vesting of the Option, and the issuance of shares of Common Stock, securities of a party to the Change in Control, or cash, or any combination thereof, in full satisfaction of the Option.  </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">11.       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">No Trust</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Neither the Plan nor the Option shall create or be construed to create a trust or separate fund of any kind or a fiduciary relationship between the Company and Participant or any other Person.  To the extent that any Person acquires a right to receive payments from the Company or any Affiliate pursuant to an Award, such right shall be no greater than the right of any unsecured creditor of the Company or any Affiliate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Record of Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  An original record of this Award certificate and all the terms hereof, executed by the Company, is held on file by the Company. To the extent there is any conflict between the terms contained in this Award certificate and the terms contained in the original held by the Company, the terms of the original held by the Company shall control. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Survival</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The Restrictive Covenants in Section 4 and the provisions regarding the forfeiture of Options and recoupment of shares of Common Stock shall survive termination of the Option.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Choice of Law, Injunctive Relief, Attorney&#8217;s Fees and Jury Trial</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant consents to the law of Minnesota exclusively being applied to any matter arising out of or relating to this Award certificate, without regard to its conflict of law principles, and exclusively to personal and subject matter jurisdiction in the state and federal courts of Minnesota for any dispute relating to this Award certificate or Participant&#8217;s relationship with the Company.  In the event of a breach or a threatened breach of this Award by Participant, Participant acknowledges that the Company will face irreparable injury which may be difficult to calculate in dollar terms and that the Company shall be entitled, in addition to remedies otherwise available at law or in equity, to temporary restraining orders and preliminary injunctions and final injunctions without the posting of a bond enjoining such breach or threatened breach.  Should the Company successfully enforce any portion of this Award certificate before a trier of fact or in an arbitration proceeding, the Company shall be entitled to all of its reasonable attorney&#8217;s fees and costs incurred as a result of enforcing this Award certificate against Participant. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant waives all rights or entitlement to a jury trial for any matter arising out of or relating to this Award certificate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Code Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  It is intended that this Award and any amounts payable under this Award shall either be exempt from or comply with Code Section 409A (including the Treasury regulations and other published guidance relating thereto) so as not to subject Participant to payment of any additional tax, penalty or interest imposed under Code Section 409A. The provisions of this Award certificate shall be construed and interpreted to avoid the imputation of any such additional tax, penalty or interest under Code Section 409A yet preserve (to the nearest extent reasonably possible) the intended benefit payable to Participant.  To the extent that the time or form of payment of any benefit pursuant to this Award would violate the terms of Section 409A, the Committee may revise the time or form of payment to conform to Section 409A.  Notwithstanding the foregoing, in no event shall the Company, any Affiliate, the members of the Committee, or any other person have any liability for any additional tax, penalty or interest imposed on Participant by reason of Section 409A or otherwise.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">No Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  No waiver of any breach of any provision of this Award certificate by the Company shall be effective unless it is in writing, and no waiver shall be construed to be a waiver of any succeeding breach or as a modification of such provision.  The provisions of this Award certificate shall be severable, and if any provision of this Award certificate is found by any court or arbitrator to be unenforceable, in whole or in part, the remainder of this Award certificate shall nevertheless be enforceable and binding on the parties.  Participant also agrees that a court or arbitrator may modify any invalid, overbroad or unenforceable term of this Award certificate so that such term, as modified, is valid and enforceable under applicable law, and that a court or arbitrator is authorized to extend the length of the Restrictive Covenants in Section 4 of this Award certificate for any period of time in which Participant is in breach of the Restrictive Covenants or as necessary to protect the legitimate business interests of Company. Further, Participant affirmatively states that Participant has not, will not, and cannot rely on any representations not expressly made herein.  The terms of this Award certificate shall not be amended by Participant or Company except by the express written consent of the Company and Participant.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Consideration Period&#59; Right to Consult with Counsel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  By the Participant&#8217;s acceptance below, the Participant acknowledges and agrees that the Company provided the Participant with at least ten (10) business days to review and consider this Award certificate and that voluntarily accepting this Award certificate before the expiration of ten (10) business days shall serve as a waiver of the ten (10) day review period. The Participant has the right and is advised to consult with counsel of his&#47; her choice before signing this document.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(h)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Assignability and Change of Position</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The rights and&#47;or obligations herein may be assigned by the Company without Participant&#8217;s consent and shall bind and inure to the benefit of the Company&#8217;s successors, assigns, and representatives.  If the Company makes any assignment of the rights and&#47;or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">obligations herein, Participant agrees that this Award certificate shall remain binding upon Participant in any event.</font></div><div style="text-align:right;text-indent:42.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Offer Date&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#GrantDate#</font></div><div style="text-align:right;text-indent:42.75pt"><font><br></font></div><div style="text-align:right;text-indent:42.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By,</font><img alt="strausssignaturee.jpg" src="strausssignaturee.jpg" style="height:40px;margin-bottom:5pt;vertical-align:text-bottom;width:100px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> on behalf of UnitedHealth Group Incorporated</font></div><div style="text-align:right;text-indent:42.75pt"><font><br></font></div><div style="text-align:right;text-indent:42.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Acceptance Date&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#AcceptanceDate#</font></div><div style="text-align:right;text-indent:42.75pt"><font><br></font></div><div style="text-align:right;text-indent:42.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Signed Electronically&#47;Signed Manually&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#Signature#</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.10
<SEQUENCE>10
<FILENAME>unhexhibit1010.htm
<DESCRIPTION>EX-10.10
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i9108618616c24fef9a0327d5ba2eb071_33"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.10</font></div></div><div style="text-align:center"><img alt="uhglogo2019a02c.jpg" src="uhglogo2019a02c.jpg" style="height:71px;margin-bottom:5pt;vertical-align:text-bottom;width:404px"></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">PERFORMANCE-BASED RESTRICTED STOCK UNIT AWARD</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.416%"><tr><td style="width:1.0%"></td><td style="width:27.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.089%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.922%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Award Date<br>(mm&#47;dd&#47;yyyy)</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Target Number of <br>Performance-Based <br>Units</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Performance Period<br>(mm&#47;dd&#47;yyyy)</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#GrantDate#</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#QuantityGranted#</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">mm&#47;dd&#47;yyyy &#8211; <br>mm&#47;dd&#47;yyyy</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">THIS CERTIFIES THAT UnitedHealth Group Incorporated (the &#8220;Company&#8221;) has on the award date specified above (the &#8220;Award Date&#8221;) granted to</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#ParticipantName#</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(&#8220;Participant&#8221;) an award (the &#8220;Award&#8221;) to be eligible to receive a number of Performance-Based Restricted Stock units (the &#8220;PRSUs&#8221;), the target number of which is indicated above in the box labeled &#8220;Target Number of Performance-Based Units,&#8221; each PRSU representing the right to receive one share of UnitedHealth Group Incorporated Common Stock, $.01 par value per share (the &#8220;Common Stock&#8221;), subject to certain restrictions and on the terms and conditions contained in this Award and the UnitedHealth Group Incorporated 2020 Stock Incentive Plan (the &#8220;Plan&#8221;). </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Participant acknowledges and agrees that the Company may deliver, by electronic mail, the use of the Internet, including through the website of the agent appointed by the Compensation and Human Resources Committee of the Board of Directors of the Company (the &#8220;Committee&#8221;) to administer the Plan, the Company intranet web pages or otherwise, any information concerning the Company&#59; the Award, the Plan, pursuant to which the Company granted the Award, and any information required by the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A copy of the Plan is available upon request. In the event of any conflict between the terms of the Plan and this Award, the terms of the Plan shall govern. Any terms not defined herein shall have the meaning set forth in the Plan.  </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">* * * * * </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Rights of the Participant with Respect to the PRSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">No Shareholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The PRSUs granted pursuant to this Award do not and shall not entitle Participant to any rights of a shareholder of Common </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Stock. The rights of Participant with respect to the PRSUs shall remain forfeitable at all times prior to the date on which such rights become vested, and the restrictions with respect to the PRSUs lapse, in accordance with Section 2, 3 or 4. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Conversion of PRSUs&#59; Issuance of Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. No shares of Common Stock shall be issued to Participant prior to the date on which the PRSUs vest, and the restrictions with respect to the PRSUs lapse, in accordance with Section 2, 3 or 4. Neither this Section 1(b) nor any action taken pursuant to or in accordance with this Section 1(b) shall be construed to create a trust of any kind. After any PRSUs vest pursuant to Section 2, 3 or 4, the Company shall promptly cause to be issued shares of Common Stock to Participant or in the name of Participant&#8217;s legal representatives, beneficiaries or heirs, as the case may be, in payment of such vested whole PRSUs, such shares of Common Stock shall be issued promptly, and in any event, no later than March 15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> of the year following the year in which the vesting event occurs (which payment schedule is intended to comply with the &#8220;short-term deferral&#8221; exemption from the application of Section 409A of the Code). </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Subject to the terms and conditions of this Award, including without limitation the terms set forth in Attachment 1, the PRSUs shall vest and the restrictions with respect to the PRSUs shall lapse (i) if Participant has remained continuously employed with the Company or any Affiliate from the Award Date through and including the end of the Performance Period, and (ii) if and to the extent the Performance Vesting Criteria described in Attachment 1 have been achieved during the Performance Period.  Regardless of whether Participant meets the continuous employment or service criterion described in subpart (i) of this Section 2, if and to the extent the Performance Vesting Criteria have not been achieved by the end of the Performance Period, the Participant&#8217;s rights to the PRSUs shall be immediately and irrevocably forfeited on that date.  The Committee will determine in its sole discretion the extent, if any, to which the Performance Vesting Criteria have been met, and it will retain sole discretion to reduce the number of PRSUs that would otherwise vest as a result of the performance measured against the Performance Vesting Criteria.  Any vesting that may occur pursuant to this Section 2 will be effective on the date on which the Committee has certified the extent to which the Performance Vesting Criteria in subpart (ii) of this Section 2 were satisfied.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Certain Terminations on or After Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Notwithstanding the other vesting provisions contained in Section 2, but subject to the other terms and conditions set forth herein, the PRSUs described in this Award will become immediately and unconditionally vested, and the restrictions with respect thereto shall lapse if, on or within two years after the effective date of a Change in Control, the Participant ceases to be an employee of the Company or any Affiliate as a result of a termination of employment (i) by the Participant for Good Reason, (ii) by the Company or any Affiliate without Cause, (iii) at a time when Participant is eligible for Retirement, (iv) due to Participant&#8217;s Disability, or (v) in the circumstances described in Section 4(c)&#59; provided that in the case of a termination for Good Reason, the PRSUs shall vest if the Participant gives written notice of the circumstances constituting Good Reason within two years after the effective date of the Change in Control, if the Company fails to cure the circumstances constituting </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Good Reason within 60 days of the receipt of such notice and the Participant resigns within 30 days after the end of the cure period, all as provided in Section 3(d).  Upon a Change in Control, the Committee will determine&#58; (i) the extent, if any, to which the Performance Vesting Criteria have been met, and (ii) the number of the PRSUs that will vest and convert into shares of Common Stock in the event of Participant&#8217;s termination of employment in accordance with this Section 3. For purposes of this Award certificate&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        &#8220;Affiliate&#8221; shall mean (i) any entity that, directly or indirectly through one or more intermediaries, is controlled by the Company and (ii) any entity in which the Company has a significant equity interest, as determined by the Committee.      </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       &#8220;Cause&#8221; shall mean Participant&#8217;s (a) material failure to follow the Company&#8217;s reasonable direction or to perform any duties reasonably required on material matters, (b) material violation of, or failure to act upon or report known or suspected violations of, the Company&#8217;s Code of Conduct, as may be amended from time to time, (c) conviction of any felony, (d) commission of any criminal, fraudulent, or dishonest act in connection with Participant&#8217;s employment, (e) breach of any of the Restrictive Covenants in Section 8 of this Award certificate or a material breach of any employment agreement between Participant and the Company or any Affiliate, if any, or (f) conduct that is materially detrimental to the Company&#8217;s interests.  The Company will, within 120 days of discovery of the conduct, give Participant written notice specifying the conduct constituting Cause in reasonable detail and Participant will have 60 days to remedy such conduct, if such conduct is reasonably capable of being remedied.  In any instance where the Company may have grounds for Cause, failure by the Company to provide written notice of the grounds for Cause within 120 days of discovery shall be a waiver of its right to assert the subject conduct as a basis for termination for Cause.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)        &#8220;Change in Control&#8221; shall mean the sale of all or substantially all of the Company&#8217;s assets or any merger, reorganization, or exchange or tender offer which, in each case, will result in a change in the power to elect 50% or more of the members of the Board of Directors of the Company&#59; provided, however, that such a sale, merger or other event must also constitute either (i) a &#8220;change in the ownership&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(v), (ii) a &#8220;change in the effective control&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(vi)(A)(1) (replacing &#8220;30 percent&#8221; with &#8220;50 percent&#8221; as used in such regulation), or (iii) a change &#8220;in the ownership of a substantial portion of the assets&#8221; of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(vii).</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)       &#8220;Good Reason&#8221; shall mean the occurrence of any of the following without Participant&#8217;s written consent, in each case, when compared to the arrangements in effect immediately prior to the Change in Control&#58;</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:26.57pt">any reduction in Participant&#8217;s base salary or target bonus expressed as a percentage of the Participant&#8217;s base salary, other than a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">reduction that is pursuant to a general reduction affecting a group of employees&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.8pt">a change in the principal location at which the Participant is required to perform his or her duties, if the new location is 50 miles or more further from the Participant&#8217;s principal residence than the original location&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iii)&#160;&#160;&#160;&#160;a material diminution in Participant&#8217;s duties, responsibilities or authority&#59; or</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iv)&#160;&#160;&#160;&#160;a change in Participant&#8217;s reporting relationship.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant will, within 120 days of discovery of such circumstances, give the Company written notice specifying the circumstances constituting Good Reason in reasonable detail and, upon receipt of such notice, the Company shall have 60 days to cure the circumstances constituting Good Reason.  Failure by Participant to provide written notice of the grounds for Good Reason within 120 days of discovery, or failure by the Participant to resign within 30 days after the end of the Company&#8217;s 60 day cure period, shall be a waiver of Participant&#8217;s right to assert the subject circumstance as a basis for termination for Good Reason.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)        &#8220;Separation from Service&#8221; shall mean when Participant dies, retires, or otherwise has a termination of employment with the Company that constitutes a &#8220;separation from service&#8221; within the meaning of Treasury Regulation Section 1.409A-1(h)(1), without regard to the optional alternative definitions available thereunder.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Possible Acceleration of Vesting and Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If the Award is terminated pursuant to a Change in Control and is not assumed by a party to the Change in Control (and no such party issues a new award in substitution for the Award, as determined by the Committee), the Committee may provide for immediate vesting of the Award, and the issuance of shares of Common Stock, securities of a party to the Change in Control, or cash, or any combination thereof, in full satisfaction of the Award.  Notwithstanding anything in the Plan or any other agreement to the contrary, there is no discretion to change the time of payment of the PRSUs (in connection with a Change in Control, similar event, or otherwise) except as expressly provided in this Section 3 or as otherwise permitted under, and would not result in any tax, penalty or interest under, Section 409A of the Code.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Section 409A - Possible Six-Month Delay in Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Notwithstanding any provision of this Award certificate to the contrary, if payment of the PRSUs is triggered by Participant&#8217;s Separation from Service as provided in this Section 3 or Section 4 and, as of the date of such Separation from Service, Participant is a &#8220;specified employee&#8221; (within the meaning of Section 409A of the Code and determined pursuant to procedures adopted by the Company), Participant shall not be entitled to such payment of the PRSUs until the earlier of (i) the date which is six (6) months after Participant&#8217;s Separation from Service for any reason </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">other than death, or (ii) the date of Participant&#8217;s death.  Any amounts otherwise payable to Participant upon or in the six (6) month period following Participant&#8217;s Separation from Service that are not so paid by reason of this Section 3(g) shall be paid (without interest) as soon as practicable (and in all events within thirty (30) days) after the date that is six (6) months after Participant&#8217;s Separation from Service (or, if earlier, as soon as practicable, and in all events within thirty (30) days, after the date of Participant&#8217;s death).  The provisions of this Section 3(g) shall only apply if, and to the extent, required to avoid the imputation of any tax, penalty, or interest pursuant to Section 409A of the Code.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Termination of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Termination of Employment Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Subject to the provisions of this Section 4, if, prior to vesting of the PRSUs pursuant to Section 2 or 3, Participant ceases to be an employee of the Company or any Affiliate, for any reason (voluntary or involuntary), then Participant&#8217;s rights to all of the unvested PRSUs shall be immediately and irrevocably forfeited on the date of termination. </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Death or Long-Term Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. If Participant dies while employed by the Company or any Affiliate, or if Participant&#8217;s employment by the Company or any Affiliate is terminated due to Participant&#8217;s failure to return to work as the result of a long-term disability which renders Participant incapable of performing his or her duties as determined under the provisions of the long-term disability insurance program of the Company or the Affiliate by which the Participant is employed (&#8220;Disability&#8221;), then following the end of the Performance Period, if and to the extent the Committee, in accordance with Section 2 above, determines that the Performance Vesting Criteria has been met, such that some number of PRSUs will vest and the restrictions with respect thereto will lapse, Participant will vest in the number of PRSUs that would have vested had Participant been employed through the end of the Performance Period, and the restrictions with respect thereto will lapse.  </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant&#8217;s employment ends at a time when the Participant is not eligible for Retirement (as defined below) and in connection with that separation from employment the Company or an Affiliate pays the Participant severance benefits pursuant to an employment agreement with Participant that is in effect on the date of this Award or pursuant to any Company severance policy, plan or program in effect on the date of this Award, then following the end of the Performance Period, if and to the extent the Committee, in accordance with Section 2 above, determines that the Performance Vesting Criteria has been met, such that some number of PRSUs will vest and the restrictions with respect thereto will lapse, Participant will vest in a pro rata number of PRSUs, and the restrictions with respect thereto will lapse.  Such pro rationing shall be based on the number of full months of the Performance Period that Participant was employed prior to the date of termination plus the number of full months during which the Participant is entitled to receive severance benefits under an employment agreement that is in effect on the date of this Award or pursuant to any Company severance policy, plan or program in effect on the date of this Award (provided that in no event shall such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">sum exceed the number of months in the Performance Period).  In any case, should Participant&#8217;s severance or separation pay be paid in a lump sum versus bi-weekly payments, the number of full months taken into account shall be based on the period of time over which severance or separation pay would have been paid had it been paid bi-weekly.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If the Participant&#8217;s employment ends and at the time of separation from employment the Participant is eligible for Retirement (the &#8220;Retirement Date&#8221;), and at least one year of the Performance Period of this Award is completed at or prior to the Retirement Date, then following the end of the Performance Period, if and to the extent the Committee, in accordance with Section 2 above, determines that the Performance Vesting Criteria has been met, such that some number of PRSUs will vest and the restrictions with respect thereto will lapse, Participant will vest in the full number of PRSUs and the restrictions with respect thereto will lapse as if the Participant had been continuously employed throughout the entire Performance Period. </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)        For purposes of this Award certificate, &#8220;Retirement&#8221; means the termination of employment of a Participant who is age 55 or older with at least ten years of Recognized Employment with the Company or any Affiliate other than by reason of (i) death or Disability or (ii) Cause.  Notwithstanding the terms of any other agreement heretofore or hereafter entered into between the parties that reference retirement, Participant and the Company acknowledge and agree that for purposes of calculating years of service for retirement eligibility, Participant will receive two and one half years of service credit for each year she remains employed with the Company after June 5, 2018.  In addition, prior to the date upon which Participant becomes eligible for retirement, if Participant&#8217;s employment is terminated by the Company without Cause or if Participant terminates employment for Good Reason, Participant will be deemed to have met the applicable age and service requirements and will be retirement eligible.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)        For purposes of this Award certificate, &#8220;Recognized Employment&#8221; shall include only employment since the Participant&#8217;s most recent date of hire by the Company or any Affiliate, and shall not include employment with a company acquired by UnitedHealth Group or any Affiliate before the date of such acquisition.  </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Restriction on Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant may not transfer the PRSUs except by will or by the laws of descent and distribution.  Notwithstanding the foregoing, the Award may be transferred to an alternate payee pursuant to the terms of a domestic relations order (as such terms are defined by Section 414(p) of the Code), provided that (i) the Participant is an employee at the time the domestic relations order is entered, (ii) the Award was outstanding at the time the domestic relations order is entered, and (iii) the transfer otherwise satisfies all requirements of the Plan and any limitations and requirements established by the Committee.  Any attempt to otherwise transfer the PRSUs shall be void.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Special Restriction on Transfer for Certain Participants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. If Participant is an officer of the Company within the meaning of Section 16 of the Securities Exchange Act of 1934 </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and Rule 16a-1 issued thereunder, as such status is reasonably determined from time to time by the Board of Directors of the Company (a &#8220;Section 16 Officer&#8221;), at any time that shares of Common Stock are issued upon vesting of the PRSUs and the Company has theretofore communicated Participant&#8217;s status as a Section 16 Officer to Participant, the following special transfer restrictions apply to Participant&#8217;s Award. One-third (1&#47;3) of the net number of any shares of Common Stock acquired by Participant upon vesting of the PRSUs at a time when Participant is a Section 16 Officer (including any shares of Common Stock or other securities into which such shares may be converted or exchanged as a result of any adjustment made pursuant to this Award or Section 7 of the Plan) must be retained, and may not be sold or otherwise transferred, for a period of at least one year following the issuance date. For purposes of this Award certificate, the &#8220;net number of any shares of Common Stock acquired&#8221; shall mean the number of shares issued with respect to the Award after reduction for any shares of Common Stock withheld by or tendered to the Company, or sold on the market, to cover any federal, state, local or other payroll, withholding, income or other applicable tax withholding required in connection with the issuance of the shares. The restrictions of this Section 6 are in addition to, and not in lieu of, the restrictions imposed under other Company policies and applicable laws.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">7.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Forfeiture of PRSUs and Shares of Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This Section 7 sets forth circumstances under which Participant shall forfeit all or a portion of the PRSUs, or be required to repay the Company for the value realized in respect of all or a portion of the PRSUs.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Violation of Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If Participant violates any provision of the Restrictive Covenants set forth in Section 8 below, then any unvested PRSUs shall be immediately and irrevocably forfeited without any payment therefor.  In addition, for any PRSUs that vested within one year prior to Participant&#8217;s termination of employment with the Company or any Affiliate or at any time after such termination of employment, the Participant shall be required, upon demand, to repay or otherwise reimburse the Company (including by forfeiting any deferred compensation credits in respect of such PRSUs under the Company&#8217;s non-qualified compensation deferral plans) an amount having a value equal to the aggregate Fair Market Value of the shares of Common Stock underlying such PRSUs on the date the PRSUs became vested.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Fraud</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  If the Board determines that Participant has engaged in fraud that, in whole or in part, caused the need for a material restatement of the Company&#8217;s consolidated financial statements, then any PRSUs that have not yet been settled in shares of Common Stock (including any deferred compensation credits under the Company&#8217;s non-qualified compensation deferral plans in respect of PRSUs that have previously become vested) shall be immediately and irrevocably forfeited without any payment therefore.  In addition, for any PRSUs that became vested during the 12-month period following the first public issuance or filing with the Securities Exchange Commission (whichever occurs first) of the incorrect financial statements, Participant shall be required, upon demand, to repay or otherwise reimburse the Company (including by forfeiting any deferred compensation credits in respect of such PRSUs under the Company&#8217;s non-qualified </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">compensation deferral plans) an amount having a value equal to the aggregate Fair Market Value of the shares of Common Stock underlying such PRSUs on the date the PRSUs became vested.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">In General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This Section 7 does not constitute the Company&#8217;s exclusive remedy for Participant&#8217;s violation of the Restrictive Covenants or commission of fraudulent conduct.  As the forfeiture and repayment provisions are not adequate remedies at law, the Company may seek any additional legal or equitable remedy, including injunctive relief, for any such violations.  The provisions in this Section 7 are essential economic conditions to the Company&#8217;s grant of PRSUs to Participant.  By receiving the grant of PRSUs hereunder, Participant agrees that the Company may deduct from any amounts it owes Participant from time to time (such as wages or other compensation, deferred compensation credits, vacation pay, any severance or other payments owed following a termination of employment, as well as any other amounts owed to the Participant by the Company) to the extent of any amounts Participant owes the Company under this section.  The provisions of this Section 7 and any amounts repayable by Participant hereunder are intended to be in addition to any rights to repayment the Company may have under Section 304 of the Sarbanes-Oxley Act of 2002, Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and other applicable law.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">8.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In consideration of the terms of this Award certificate and the Company&#8217;s sharing of Confidential Information with the Participant, which the Participant agrees constitute adequate and sufficient mutually-agreed consideration, the Participant agrees to the Restrictive Covenants set forth below in this Section 8. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Non-Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant has or will be given access to and provided with sensitive, confidential, proprietary and&#47;or trade secret information (collectively, &#8220;Confidential Information&#8221;) in the course of Participant&#8217;s employment.  Examples of Confidential Information include inventions, new product or marketing plans, business strategies and plans, merger and acquisition targets, financial and pricing information, computer programs, source codes, models and data bases, analytical models, customer lists and information, and supplier and vendor lists and other information which is not generally available to the public.  Participant shall not disclose or use Confidential Information, either during or after Participant&#8217;s employment with the Company, except (i) as necessary to perform Participant&#8217;s duties, (ii) as the Company may consent in writing, or (iii) as permitted by Section 8(f) below.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Non-Solicitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  During Participant&#8217;s employment and for two years after the later of (i) the termination of Participant&#8217;s employment with the Company for any reason whatsoever or (ii) the last scheduled vesting date under Section 4, Participant shall not, without the Company&#8217;s prior written consent, directly or indirectly, for Participant or for any other person or entity, as agent, employee, officer, director, consultant, owner, principal, partner, shareholder, or in any other individual or representative capacity&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:8.57pt">Solicit or conduct business with any business competitive with the Company from any person or entity&#58; (A) who was a Company provider or customer within the 12 months before Participant&#8217;s employment termination and with whom Participant had contact regarding the Company&#8217;s activity, products or services, or for whom Participant provided services or supervised employees who provided those services, or about whom Participant learned Confidential Information during employment related to the Company&#8217;s provision of products and services to such person or entity, or (B) was a prospective provider or customer the Company solicited within the 12 months before Participant&#8217;s employment termination and with whom Participant had contact for the purposes of soliciting the person or entity to become a provider or customer of the Company, or supervised employees who had those contacts, or about whom Participant learned Confidential Information during employment related to the Company&#8217;s provision of products and services to such person or entity&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.8pt">Raid, hire, employ, recruit or solicit any Company employee or consultant who possesses Confidential Information of the Company to leave the Company&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:3.03pt">Induce or influence any Company employee, consultant, or provider who possesses Confidential Information of the Company to terminate his, her or its employment or other relationship with the Company&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:3.57pt">Assist anyone in any of the activities listed above.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Non-Competition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  During Participant&#8217;s employment and for one year after the later of (i) the termination of Participant&#8217;s employment with the Company for any reason whatsoever or (ii) the last scheduled vesting date under Section 4, Participant shall not, without the Company&#8217;s prior written consent, directly or indirectly, for Participant or for any other person or entity, as agent, employee, officer, director, consultant, owner, principal, partner, shareholder, or in any other individual or representative capacity&#58;</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:8.57pt">Engage in or participate in any activity that competes, directly or indirectly, with any Company activity, product or service that Participant engaged in, participated in, or had Confidential Information about during Participant&#8217;s last 36 months of employment with the Company&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.8pt">Assist anyone in any of the activities listed above.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)      </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Geographic Scope</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:8.57pt">Participant&#8217;s obligations under this &#8220;Restrictive Covenants&#8221; section shall apply on a nationwide basis anywhere in the United States.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.8pt">Participant&#8217;s obligations under this &#8220;Restrictive Covenants&#8221; section shall also apply in any country outside the United States with respect to which Participant had responsibility for any UnitedHealth Group activity, product or service in that country. </font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Return of Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Participant agrees that all tangible materials (whether originals or duplicates), including, but not limited to, notebooks, computers, files, reports, proposals, price lists, lists of actual or potential customers or suppliers, talent lists, formulae, prototypes, tools, equipment, models, specifications, technical data, methodologies, research results, test results, financial data, contracts, agreements, correspondence, documents, computer disks, software, computer printouts, information stored electronically, memoranda, and notes, in Participant&#8217;s possession, custody, or control which in any way relate to the Company&#8217;s business and which are furnished to Participant by or on behalf of the Company or which are prepared, compiled or acquired by Participant while working with or employed by the Company shall be the sole property of the Company.  At any time upon the request of the Company, and in any event promptly upon termination of Participant&#8217;s employment with the Company, but in any event no later than two (2) business days after such termination, Participant shall deliver all such materials to the Company and shall not retain any originals or copies (including electronically) of such materials.  </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">No Restriction on Protected Activities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Nothing in this Award certificate prohibits Participant from disclosing information in good faith to any governmental agency, legislative body, or official regarding an alleged violation of law or regulation or otherwise protected under applicable law, including, without limitation, the National Labor Relations Act, the Defend Trade Secrets Act, and any rule or regulation promulgated by the Securities and Exchange Commission, the National Labor Relations Board, the Equal Employment Opportunity Commission, or any other federal, state, or local government agency.  Participant acknowledges that, through this Section 8(f), the Company has provided Participant with written notice that, pursuant to the Defend Trade Secrets Act, 8 USC &#167; 1833(b), an employee, consultant, or contractor of an employer may not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of an employer&#8217;s trade secrets, so long as such disclosure is made solely&#58; (a) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating a suspected violation of law&#59; and&#47;or (b) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.  Additionally, Participant understands that, pursuant to 18 USC &#167; 1831 et seq., an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose a trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">pursuant to court order.  The foregoing immunities provided under 18 USC &#167; 1831 et seq. do not apply to any disclosure of Confidential Information or trade secrets of an employer&#8217;s clients, customers, or counterparties, or of any other third parties. For purposes of this paragraph solely, &#8220;trade secret&#8221; has the meaning set forth in 18 USC &#167; 1839.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Exceptions for Attorneys</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Notwithstanding the foregoing, this Section 8 will apply only to the extent permissible under provisions of the ABA Model Rules of Professional Conduct, or any applicable state counterpart regarding restrictions on the right to practice law.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(h)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Acknowledgment of Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. By accepting the Award, Participant agrees that the provisions of this Section 8 are reasonable and necessary to protect the legitimate interests of the Company.  Participant further acknowledges that Participant&#8217;s obligations under this Section 8 are in addition to, and do not limit, any and all obligations concerning the same subject matter arising under any applicable law, including, without limitation, common law and statutory law relating to fiduciary duties and trade secrets.  To the extent Participant and the Company agree at any time to enter into separate agreements containing restrictive covenants with different or inconsistent terms than those contained herein, Participant and the Company acknowledge and agree that such different or inconsistent terms shall not in any way affect or have relevance to the Restrictive Covenants contained herein.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">9.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Adjustments to PRSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In the event that any dividend or other distribution (whether in the form of cash,  shares of Common Stock, other securities or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase or exchange of Common Stock or other securities of the Company or other similar corporate transaction or event affecting the Common Stock would be reasonably likely to result in the diminution or enlargement of any of the benefits or potential benefits intended to be made available under the Award (including, without limitation, the benefits or potential benefits of provisions relating to the vesting of the PRSUs), the Committee shall, in such manner as it shall deem equitable or appropriate in order to prevent such diminution or enlargement of any such benefits or potential benefits, make adjustments to the Award, including adjustments in the number and type of shares of Common Stock Participant would have received upon vesting of the PRSUs. </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">10.       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Tax Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In order to comply with all applicable federal or state income tax laws or regulations, the Company may take such action as it deems appropriate to ensure that all applicable federal or state payroll, withholding, income or other taxes, which are the sole and absolute responsibility of Participant, are withheld or collected from Participant.  Participant is liable and responsible for all taxes owed in connection with the Award, regardless of any action the Company takes with respect to any tax withholding obligations that arise in connection with the Award.  The ultimate tax liability, which is the Participant&#8217;s responsibility, may exceed the amount withheld by the Company.  On each applicable vesting date, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Participant will be deemed to have elected to satisfy Participant&#8217;s required federal, state, and local payroll, withholding, income, or other tax withholding obligations arising from the receipt of shares or the lapse of restrictions relating to the PRSUs, by having the Company withhold a portion of the shares of Common Stock otherwise to be delivered having a Fair Market Value equal to the amount of such taxes (but not in excess of the maximum amount required to be withheld under applicable laws or regulations).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  It is intended that this Award and any amounts payable under this Award shall either be exempt from or comply with Section 409A of the Code (including the Treasury regulations and other published guidance relating thereto) so as not to subject Participant to payment of any additional tax, penalty, or interest imposed under Section 409A of the Code.  The provisions of this Award certificate shall be construed and interpreted to avoid the imputation of any such additional tax, penalty, or interest under Section 409A of the Code yet preserve (to the nearest extent reasonably possible) the intended benefit payable to Participant.  To the extent that the time or form of payment of any benefit pursuant to this Award would violate the terms of Section 409A, the Committee may revise the time or form of payment to conform to Section 409A.  Notwithstanding the foregoing, in no event shall the Company, any Affiliate, the members of the Committee, or any other person have any liability for any additional tax, penalty or interest imposed on Participant by reason of Section 409A or otherwise.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">11.       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)        This Award does not confer on Participant any right to continued employment or any other relationship with the Company or any Affiliate, nor will it interfere in any way with the right of the Company to terminate Participant at any time.  Participant&#8217;s employment with the Company is at will.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)        Neither the Plan nor this Award shall create or be construed to create a trust or separate fund of any kind or a fiduciary relationship between the Company and Participant or any other Person.  To the extent that any Person acquires a right to receive payments from the Company or any Affiliate pursuant to an Award, such right shall be no greater than the right of any unsecured creditor of the Company or any Affiliate.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(c)        The Company shall not be required to deliver any shares of Common Stock upon the vesting of any PRSUs until the requirements of any federal or state securities laws, rules or regulations or other laws or rules (including the rules of any securities exchange) as may be determined by the Company to be applicable have been and continue to be satisfied (including an effective registration of the shares under federal and state securities laws). </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)       An original record of this Award and all the terms hereof, executed by the Company, is held on file by the Company. To the extent there is any conflict between the terms contained in this Award and the terms contained in the original held by the Company, the terms of the original held by the Company shall control. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(e)        The Restrictive Covenants in Section 8 and the provisions regarding the forfeiture of PRSUs and shares of Common Stock shall survive termination of the PRSUs.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(f)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Choice of Law, Injunctive Relief, Attorney&#8217;s Fees and Jury Trial</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  Participant consents to the law of Minnesota exclusively being applied to any matter arising out of or relating to this Award certificate, without regard to its conflict of law principles, and exclusively to personal and subject matter jurisdiction in the state and federal courts of Minnesota for any dispute relating to this Award certificate or Participant&#8217;s relationship with the Company.  In the event of a breach or a threatened breach of this Award by Participant, Participant acknowledges that the Company will face irreparable injury which may be difficult to calculate in dollar terms and that the Company shall be entitled, in addition to remedies otherwise available at law or in equity, to temporary restraining orders and preliminary injunctions and final injunctions without the posting of a bond enjoining such breach or threatened breach.  Should the Company successfully enforce any portion of this Award certificate before a trier of fact or in an arbitration proceeding, the Company shall be entitled to all of its reasonable attorney&#8217;s fees and costs incurred as a result of enforcing this Award certificate against Participant. Participant waives all rights or entitlement to a jury trial for any matter arising out of or relating to this Award certificate.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(g)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">No Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  No waiver of any breach of any provision of this Award certificate by the Company shall be effective unless it is in writing, and no waiver shall be construed to be a waiver of any succeeding breach or as a modification of such provision.  The provisions of this Award certificate shall be severable, and if any provision of this Award certificate is found by any court or arbitrator to be unenforceable, in whole or in part, the remainder of this Award certificate shall nevertheless be enforceable and binding on the parties.  Participant also agrees that a court or arbitrator may modify any invalid, overbroad or unenforceable term of this Award certificate so that such term, as modified, is valid and enforceable under applicable law, and that a court or arbitrator is authorized to extend the length of the Restrictive Covenants in Section 8 of this Award certificate for any period of time in which Participant is in breach of the Restrictive Covenants or as necessary to protect the legitimate business interests of Company. Further, Participant affirmatively states that Participant has not, will not, and cannot rely on any representations not expressly made herein.  The terms of this Award certificate shall not be amended by Participant or Company except by the express written consent of the Company and Participant.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(h)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Consideration Period&#59; Right to Consult with Counsel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  By the Participant&#8217;s acceptance below, the Participant acknowledges and agrees that the Company provided the Participant with at least ten (10) business days to review and consider this Award certificate and that voluntarily accepting this Award certificate before the expiration of ten (10) business days shall serve as a waiver of the ten (10) day review period. The Participant has the right and is advised to consult with counsel of his&#47; her choice before signing this document.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Assignability and Change of Position</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The rights and&#47;or obligations herein may be assigned by the Company without Participant&#8217;s consent and shall bind and inure to the benefit of the Company&#8217;s successors, assigns, and representatives.  If the Company makes any assignment of the rights and&#47;or obligations herein, Participant agrees that this Award certificate shall remain binding upon Participant in any event.</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Offer Date&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#GrantDate#</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By ,</font><img alt="strausssignature.jpg" src="strausssignature.jpg" style="height:40px;margin-bottom:5pt;vertical-align:text-bottom;width:100px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> on behalf of UnitedHealth Group Incorporated</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right;text-indent:17.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Acceptance Date&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#AcceptanceDate#</font></div><div style="text-align:right;text-indent:17.1pt"><font><br></font></div><div style="text-align:right;text-indent:17.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Signed Electronically&#47;Signed Manually&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#Signature#</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.11
<SEQUENCE>11
<FILENAME>unhexhibit1011.htm
<DESCRIPTION>EX-10.11
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i2428ea6cbf5248989c4a35f8a06c2b98_33"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.11</font></div></div><div style="text-align:center"><img alt="uhglogo2019a021a.jpg" src="uhglogo2019a021a.jpg" style="height:71px;margin-bottom:5pt;vertical-align:text-bottom;width:404px"></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NON-EMPLOYEE DIRECTOR</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DEFERRED STOCK UNIT AWARD</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Award Number&#58; </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#ClientGrantID#</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:61.057%"><tr><td style="width:1.0%"></td><td style="width:47.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.837%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.145%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Award Date</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#GrantDate#</font></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Number of Units</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">#QuantityGranted#</font></div></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THIS CERTIFIES THAT UnitedHealth Group Incorporated (the &#8220;Company&#8221;) has on the award date specified above (the &#8220;Award Date&#8221;) granted to</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">#ParticipantName#</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;Participant&#8221;) an award (the &#8220;Award&#8221;) to receive that number of deferred stock units (the &#8220;Deferred Stock Units&#8221;) indicated above in the box labeled &#8220;Number of Units,&#8221; each Deferred Stock Unit representing the right to receive one share of UnitedHealth Group Incorporated Common Stock, $.01 par value per share (the &#8220;Common Stock&#8221;), subject to the terms and conditions contained in this Award and the UnitedHealth Group Incorporated 2020 Stock Incentive Plan, as amended (the &#8220;Plan&#8221;). </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Participant acknowledges and agrees that the Company may deliver, by electronic mail, the use of the Internet, including through the website of the agent appointed by the Compensation and Human Resources Committee of the Board of Directors of the Company (the &#8220;Committee&#8221;) to administer the Plan, the Company intranet web pages or otherwise, any information concerning the Company&#59; the Award&#59; the Plan, pursuant to which the Company granted the Award&#59; and any information required by the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A copy of the Plan is available upon request.  In the event of any conflict between the terms of the Plan and this Award certificate, the terms of the Plan shall govern.  Any terms not defined herein shall have the meaning set forth in the Plan.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* * * * * </font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Rights of the Participant with Respect to the Deferred Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Deferred Stock Units granted pursuant to this Award do not and shall not entitle Participant to any rights of a shareholder of Common Stock.  No shares of Common Stock shall be issued to Participant in settlement of Deferred Stock Units prior to the time specified in Section 3.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Deferred Stock Units granted pursuant to this Award are 100% vested as of the Award Date.</font></div><div style="text-indent:18pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Conversion of Deferred Stock Units&#59; Issuance of Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Upon Participant&#8217;s departure from the Company&#8217;s Board of Directors for any reason (with such departure being considered a &#8220;separation from service&#8221; as set forth in Treasury Regulation Section 1.409A-1(h)) (&#8220;Departure Date&#8221;), the Company shall promptly cause to be issued shares of Common Stock in Participant&#8217;s name (or in the name of Participant&#8217;s legal representatives, beneficiaries or heirs, as the case may be), in payment of whole Deferred Stock Units.  In no event shall settlement occur later than ninety (90) days following Participant&#8217;s Departure Date, unless such payment is deferred in accordance with the terms and conditions of the Company&#8217;s non-qualified deferred compensation plans and in compliance with Section 409A of the Internal Revenue Code of 1986 and its accompanying regulations (&#8220;Code Section 409A&#8221;).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-indent:18pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Restriction on Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Participant may not transfer the Deferred Stock Units except by will or by the laws of descent and distribution.  Notwithstanding the foregoing, the Deferred Stock Units may be transferred to an alternate payee pursuant to the terms of a domestic relations order (as such terms are defined by Section 414(p) of the Code), provided that (i) the Participant is a member of the Board of Directors at the time the domestic relations order is entered, (ii) the Award was outstanding at the time the domestic relations order is entered, and (iii) the transfer otherwise satisfies all requirements of the Plan and any limitations and requirements established by the Committee.  Any attempt to otherwise transfer the Deferred Stock Units shall be void.  Participant may specify to whom the Company shall deliver any such shares of Common Stock which are otherwise payable to Participant in settlement of such Deferred Stock Units, subject to the requirements of any applicable law.</font></div><div style="text-indent:18pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If a cash dividend is declared and paid by the Company with respect to the Common Stock, the Participant shall be credited as of the applicable dividend payment date with an additional number of Deferred Stock Units (the &#8220;Dividend Units&#8221;) equal to (A) the total cash dividend the Participant would have received had the Participant&#8217;s Deferred Stock Units (and any previously credited Dividend Units with respect thereto) been actual shares of Common Stock, divided by (B) the Fair Market Value of a share of Common Stock as of the applicable dividend payment date, rounded up to the nearest whole number if the calculation results in a fraction. As of the conversion date pursuant to Section 3, the number of Dividend Units paid on the Deferred Stock Units converting on such conversion date shall also convert into the form of shares of Common Stock.  The terms of this Award certificate shall apply to all Dividend Units paid on the Deferred Stock Units.</font></div><div style="text-indent:18pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Adjustments to Deferred Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In the event that any dividend or other distribution (whether in the form of cash, shares of Common Stock, other securities or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase or exchange of Common Stock or other securities of the Company or other similar corporate transaction or event affecting the Common Stock would be reasonably likely to result in the diminution or enlargement</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of any of the benefits or potential benefits intended to be made available under the Award, the Committee shall, in such manner as it shall deem equitable or appropriate in order to prevent such diminution or enlargement of any such benefits or potential benefits, make adjustments to the Award&#59; provided, however, that the number of shares into which the Deferred Stock Units may be converted shall be rounded up to the nearest whole number.  Without limiting the foregoing, if any capital reorganization or reclassification of the capital stock of the Company, or consolidation or merger of the Company with another entity, or the sale of all or substantially all of the Company&#8217;s assets to another entity, shall be effected in such a way that holders of the Company&#8217;s Common Stock shall be entitled to receive stock, securities, cash or other assets with respect to or in exchange for such shares, Participant shall have the right to receive upon the terms and conditions specified in this certificate and in lieu of the shares of Common Stock of the Company immediately theretofore receivable upon the settlement of the Deferred Stock Units, with appropriate adjustments to prevent diminution or enlargement of benefits or potential benefits intended to be made available under the Award, such shares of stock, other securities, cash or other assets as would have been issued or delivered to Participant if Participant had received such shares of Common Stock prior to such reorganization, reclassification, consolidation, merger or sale.  The Company shall not effect any such reorganization, consolidation, merger or sale unless prior to the consummation thereof the successor entity (if other than the Company) resulting from such reorganization, consolidation or merger or the entity purchasing such assets shall assume by written instrument the obligation to deliver to Participant such shares of stock, securities, cash or other assets as, in accordance with the foregoing provisions, Participant may be entitled to receive.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">No Other Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  This Award does not confer on Participant any right with respect to the continuance of any relationship with the Company or its Affiliates. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unfunded Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Neither the Plan nor this Award shall create or be construed to create a trust or separate fund of any kind or a fiduciary relationship between the Company or any Affiliate and Participant or any other Person.  To the extent that any Person acquires a right to receive payments from the Company or any Affiliate pursuant to an Award, such right shall be no greater than the right of any unsecured creditor of the Company or any Affiliate.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compliance with Securities Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Company shall not be required to deliver any shares of Common Stock underlying any Deferred Stock Units until the requirements of any federal or state securities laws, rules or regulations or other laws or rules (including the rules of any securities exchange) as may be determined by the Company to be applicable have been and continue to be satisfied (including an effective registration of the shares under federal and state securities laws).  The Company will use its best efforts to complete all actions necessary for such compliance so that settlement can occur within the period specified in Section 3&#59; provided that if such compliance causes settlement within such period to be administratively impractical within the meaning of Treasury Regulation Section 1.409A-1(b)(4)(ii), settlement shall occur as soon as administratively practical.  To the extent an Award is subject to Code Section 409A,</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> settlement shall occur at the earliest date at which the Company anticipates that such settlement will not cause a violation of applicable law.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Document Conflict</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  An original record of this Award and all the terms hereof is held on file by the Company.  To the extent there is any conflict between the terms contained in this Award and the terms contained in the original held by the Company, the terms of the original held by the Company shall control. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If a court or arbitrator decides that any provision of this Award is invalid or overbroad, Participant agrees that the court or arbitrator should narrow such provision so that it is enforceable or, if narrowing is not possible or permissible, such provision should be considered severed and the other provisions of this Award should be unaffected.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Entire Agreement&#59; Modification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  This Award document and the Plan constitute the entire agreement between the parties with respect to the terms and supersede all prior or written or oral negotiations, commitments, representations and agreements with respect thereto.  The terms and conditions set forth in this Award document may only be modified or amended in writing, signed by both parties.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Governing Law.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The validity, construction and effect of this Award and any rules and regulations relating to this Award shall be determined in accordance with the laws of the State of Minnesota (without regard to its conflict of law principles).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Code Section 409A.  </font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160; It is intended that any amounts payable under the Award shall either be exempt from or comply with Section 409A of the Code (including the Treasury regulations and other published guidance relating thereto) so as not to subject Participant to payment of any additional tax, penalty or interest imposed under Section 409A of the Code.  The provisions of this Award certificate shall be construed and interpreted to avoid the imputation of any such additional tax, penalty or interest under Section 409A of the Code yet preserve (to the nearest extent reasonably possible) the intended benefit payable to Participant.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:31.5pt;text-indent:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;Notwithstanding any provision of this Award certificate to the contrary, if payment of the Deferred Stock Units is triggered by Participant&#8217;s separation from service (within the meaning of Section 409A of the Code) and, as of the date of such separation from service, Participant is a &#8220;specified employee&#8221; (within the meaning of Section 409A of the Code and determined pursuant to procedures adopted by the Company), Participant shall not be entitled to such payment of the Deferred Stock Units until the earlier of (i) the date which is six (6) months after Participant&#8217;s separation from service for any reason other than death, or (ii) the date of Participant&#8217;s death.  Any amounts otherwise payable to Participant upon or in the six (6) month period following Participant&#8217;s separation from service that are not so paid by reason of this Section 7(h)(ii) shall be paid (without interest) as soon as practicable (and in all events within thirty (30) days) after the date that </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is six (6) months after Participant&#8217;s separation from service (or, if earlier, as soon as practicable, and in all events within thirty (30) days, after the date of Participant&#8217;s death).  The provisions of this Section 7(h)(ii) shall only apply if, and to the extent, required to avoid the imputation of any tax, penalty or interest pursuant to Section 409A of the Code.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.03pt">To the extent that the time or form of payment of any benefit pursuant to this Award would violate the terms of Section 409A, the Committee may revise the time or form of payment to conform to Section 409A.  Notwithstanding the foregoing, in no event shall the Company, any Affiliate, the members of the Committee, or any other person have any liability for any additional tax, penalty or interest imposed on Participant by reason of Section 409A or otherwise.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.38
<SEQUENCE>12
<FILENAME>unhexhibit1038.htm
<DESCRIPTION>EX-10.38
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i1b10676ae7394ba783aebc542fd926b0_33"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.38</font></div></div><div style="text-align:center;text-indent:11.85pt"><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">AMENDED AND RESTATED</font></div><div style="text-align:center;text-indent:11.85pt"><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">EMPLOYMENT AGREEMENT</font></div><div style="text-align:center;text-indent:11.85pt"><font><br></font></div><div style="text-indent:31.5pt"><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">This </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">Agreement </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">is between Brian </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">R. Thompson (&#34;Executive&#34;) and United </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">HealthCare Services, Inc. (&#34;UnitedHealth Group&#34;), and is effective as of the last date executed below (the &#34;Effective </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">Date&#34;)</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">. </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">This </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">Agreement's </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">purposes </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">are </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">to </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">set </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">forth </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">certain </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">terms </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">of Executive's employment </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">by UnitedHealth Group or one of its </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">affiliates </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">and </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">to </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">protect UnitedHealth </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">Group's</font><font style="color:#999999;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%"> </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">knowledge</font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">, </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">expertise, </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">customer relationships, and confidential </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">information. Unless </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">the context otherwise requires</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">, &#34;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">UnitedHealth Group&#34; includes </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">all its affiliated </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">entities. </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">This </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">Agreement </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">amends and restates the August 15, </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">2010 </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">Employment Agreement between </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">Executive </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">and </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">UnitedHealth </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">Group</font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:106%">.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">1.</font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt;text-decoration:underline">Employment </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">and </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Duties.</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">A.</font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%;padding-left:6.34pt;text-decoration:underline">Employment.</font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%"> </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">UnitedHealth </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">Group hereby </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">employs Executive, and </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">Exe</font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">cutive accepts </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">employment, </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">under </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">this </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">Agreement's </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">terms.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">B.</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%;padding-left:7pt;text-decoration:underline">Title </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%;text-decoration:underline">and Duties.</font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%"> </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">Exe</font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">cutiv</font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">e </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">will be </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">employed as Chief </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">Executive </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">Officer, </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">Medicare</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%"> and Retirement. </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">Executive </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">will </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">perform such dutie</font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">s, </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">and exercise such supervision and control, as </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">are </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">commonly </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">associated </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">with </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">Exec</font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">utiv</font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">e's </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">position, as </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">well </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">as perform such </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">other </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">duties </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">as are </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">reasonably </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">assigned </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">to </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">Executive. Executive </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">will devote substantially all </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">of Executive&#8217;s </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">business time </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">and energy </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">to </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">Executive</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">'</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">s </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">duties. </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">Executive will </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">maintain operations </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">in </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">Executive</font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">' s </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">area </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">of re</font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">sp</font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">onsibility, and make </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">every </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">reasonable </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">effort to ensure </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">that the employees within that </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">area of responsibility act, </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">in compliance </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">with </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">applicable </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">law and UnitedHealth Group</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">'</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">s </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">Code</font><font style="color:#828282;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%"> </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">of </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">Conduct, </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">as amended </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">from </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">time </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">to time. </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">Executive </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">is </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">subject </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">to </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">all of </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">Unit</font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">e</font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">dHealth Group</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">' </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">s </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">employment </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">policies </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">and </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">procedures (except as specifically superseded </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">b</font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">y </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">this </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">Agreement).</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt;text-decoration:underline">Compensation </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">and Benefits</font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">A.</font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:6.34pt;text-decoration:underline">Base </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Salary</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. Effective </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">February 18</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">, </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2018</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">, </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Executive's annual </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">base salary </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">will </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">be $650,000</font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">, </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">le</font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">ss </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">applicable </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">withholding</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">s </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">and </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">d</font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">educt</font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">ion</font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">s, </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">payable according to UnitedHealth </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Group's regular payroll </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">schedule. </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Periodic </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">adjustments </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">to </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Executive's base salary </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">may be made in </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">UnitedHealth </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Group</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">'</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">s sole discretion</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">B.</font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%;padding-left:7pt;text-decoration:underline">Incentive </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%;text-decoration:underline">Compensation.</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%"> </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">Exec</font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">utive</font><font style="color:#828282;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%"> </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">will be </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">e</font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">ligibl</font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">e </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">to </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">participate </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">in </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">discretion and </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">in </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">accordance with </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">the plans&#8217; </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">terms and conditions.  Executive</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">' </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">s target </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">bonus </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">potential </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">will be 100% </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">of annual </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">base </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">salary</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">, </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">subject </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">to periodic </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">adjustments </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">in </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">UnitedHealth Group</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">'</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">s </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">incentive </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">compensation plans </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">in </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">UnitedHealth Group's </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">discretion</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">C.</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%;padding-left:7pt;text-decoration:underline">Employee Benefits</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%;text-decoration:underline">.</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%"> </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">Executive will </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">be </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">eligible to participate </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">in UnitedHealth Group</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">' </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">s employee welfare</font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">, </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">retirement </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">and stock incentive</font><font style="color:#b5b5b5;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%"> </font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">plans on </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">the </font><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">same </font><font style="color:#111111;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">basis</font></div><div><font><br></font></div><div style="text-indent:139.8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:72pt"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">as other similarly situated executives, in accordance with the terms of the plans. Executive will be eligible for Paid Time Off in accordance with UnitedHealth Group's policies. UnitedHealth Group reserves the  right to  amend  or discontinue any plan or policy at any time in its sole discretion. In addition to the Company's generally available benefits, UnitedHealth Group shall provide Executive, at UnitedHealth Group's expense during the term of Executive's employment, a $2 million face value term life insurance policy and a long term disability policy which covers 60% of base salary in the event of a qualifying long term disability, subject to the policy terms.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">3.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt;text-decoration:underline">Termination of Employment.</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">A.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;padding-left:6.34pt;text-decoration:underline">By Mutual Agreement.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%"> The parties may terminate Executive's employment at any time by mutual agreement.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">B.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;padding-left:7pt;text-decoration:underline">By UnitedHealth Group without Cause</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">. UnitedHealth Group may terminate Executive's employment without Cause upon 90 days' prior written notice.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">C.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;padding-left:7pt;text-decoration:underline">By UnitedHealth Group with Cause</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">. UnitedHealth Group may terminate Executive's employment at any time for Cause. &#34;Cause&#34; means Executive's </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">(a)</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%"> material failure to </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">follow UnitedHealth </font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">Group's reasonable direction or to perform any duties reasonably required on material matters, (b) material violation of, or</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:103%"> </font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">failure to act upon or report known or </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">suspected </font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">violations of, UnitedHealth Group's Code of Conduct, as amended from time to time, (c) conviction of any felony, (d) commission of any criminal, fraudulent, or dishonest act </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">in </font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">connection with Executive's employment, (e) material breach of this Agreement, or </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">(f)</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%"> conduct that is materially detrimental to UnitedHealth Group's interests. UnitedHealth Group will, within 120 days of discovery of the conduct, give Executive written notice specifying </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">the </font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">conduct constituting Cause in reasonable detail and Executive will have 60 days to remedy such conduct, if such conduct is reasonably capable of being remedied. In any instance </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">where </font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">the Company may have grounds for Cause, failure by the Company to provide written notice of </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">the </font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">grounds for Cause within 120 days of discovery shall be a waiver of its right to assert the subject conduct as a basis for termination for Cause.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">D.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;padding-left:6.34pt;text-decoration:underline">By Executive without Good Reason.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">   Executive may terminate Executive's employment at any time </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">for </font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">any reason, including due to Executive's retirement.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">E.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;padding-left:7.67pt;text-decoration:underline">By Executive for Good Reason.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%"> Executive may terminate </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">Executive's</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%"> employment for Good Reason, as defined below. </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">Executive </font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">must give UnitedHealth Group written notice </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">specifying </font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">in reasonable detail the circumstances constituting Good Reason, within 120 days of becoming </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">aware </font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">of such circumstances, or </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">such </font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">circumstances will not constitute Good Reason. If</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:142.55pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:72pt"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">the circumstances constituting Good Reason are reasonably capable of being remedied, UnitedHealth Group will have 60 days to remedy such circumstances. &#34;Good Reason&#34; will exist if UnitedHealth Group takes any of the following actions, without Executive</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">' </font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">s consent&#58; (a) reduces Executive's base salary or target bonus percentage other than in connection with a general reduction affecting a group of employees&#59; (b) moves Executive's primary work location more than 50 miles&#59; or (c) makes changes that substantially diminish Executive's </font><font style="color:#181818;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">duties </font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">or responsibilities.</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:67.5pt;text-indent:-13.5pt"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">F.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;padding-left:3.83pt;text-decoration:underline">Due to Executive's Death or Disability.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%"> Executive's employment will terminate automatically if Executive dies, effective as of the date of Executive's death. UnitedHealth Group may terminate Executive's employment due to Executive's disability that renders Executive incapable of performing the essential functions of Executive's job, with or without reasonable accommodation. Executive will not be entitled to Severance Benefits under Section 4 in the event of termination due to Executive's death or disability.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt;text-decoration:underline">Severance Benefits.</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%;padding-left:6.34pt"> </font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%;text-decoration:underline">Circumstances under Which Severance  Benefits Payable.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%"> Executive will be entitled to Severance Benefits only if Executive's employment is terminated by UnitedHealth Group without Cause </font><font style="color:#181818;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">or </font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">if Executive terminates employment for Good Reason. Whether Executive has had a termination of employment will be determined in a manner consistent with the definition of &#34;Separation from Service&#34; under Section 409A of the Internal Revenue Code of 1986 and its accompanying regulations (&#34;Section 409A&#8221;) and will be referred to herein as a &#34;Termination.&#34; </font><font style="color:#181818;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">For</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%"> purposes of this Agreement, Executive will be considered to have experienced a Termination as of the date that the facts and circumstances indicate that it is reasonably anticipated that Executive will provide no further services after such date or that the level of bona fide services that </font><font style="color:#181818;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">Executive </font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">is expected to perform permanently decreases to no more than 20% of the average level of bona </font><font style="color:#181818;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">fide</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%"> services that Executive performed over the immediately preceding </font><font style="color:#181818;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">36-month </font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">period In consideration of the Severance Benefits in this Agreement, Executive waives any payments or benefits to which Executive otherwise might be or become </font><font style="color:#181818;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">entitled</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%"> under any UnitedHealth Group severance plan or program.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">B.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%;padding-left:7pt;text-decoration:underline">Severance Benefits.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%"> Subject </font><font style="color:#181818;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">to </font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">Section 4.C, </font><font style="color:#181818;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">Executive shall </font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">be entitled to the following Severance Benefits if Executive experiences a Termination under the circumstances described in Section 4.A above&#58;</font></div><div><font><br></font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(i)</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:6.69pt">Two times Executive's annualized base salary as of Executive's Termination.</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(ii)</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:3.36pt">Any bonus or incentive compensation paid or payable to Executive for the two most recent calendar years (excluding equity-related awards, payments under any</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:108pt"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">long-term or similar benefit plan, or any other special or one-time bonus or incentive compensation payments)&#59; provided, however, that if termination occurs within two years following the Effective Date, the amount payable under this paragraph will be two times Executive's target incentive.</font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">(iii)</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%;padding-left:0.03pt"> $12,000 lump sum payment, minus applicable deductions, to offset costs of COBRA, which amount will be paid within 60 days following Termination.</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">(iv)</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%;padding-left:0.69pt"> Outplacement services consistent with those provided to similarly situated executives provided by an outplacement firm selected by UnitedHealth Group.</font></div><div><font><br></font></div><div style="padding-left:108pt"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%">The Severance Benefits in Sections 4.B.(i)-(ii) will be paid out, minus applicable deductions, including deductions for tax withholding, in equal bi-weekly payments cm the regular payroll cycle over the 24-month period following Executive's Termination. Commencement of payments shall begin on the first payroll date that is at least 60 days after the date of Executive's Termination (the </font><font style="color:#181818;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%">&#34;Starting </font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%">Date''), provided that Executive has satisfied the requirement in Section 4.C. The first payment on the Starting Date shall include those payments that would have been previously paid if the payments of the severance compensation had begun on the first payroll date following the date of Executive's Termination. Executive's entitlement to the payments of the severance compensation described in Sections 4.B(i)-(ii) shall be treated as the entitlement to a series of separate payments for purposes of Section 409A.</font></div><div><font><br></font></div><div style="padding-left:108pt"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">If Executive is a &#34;Specified Employee&#34; (within the meaning of Section 409A and determined pursuant to procedures adopted by UnitedHealth Group) at the time of Executive's Termination and any amount that would be paid to Executive during the six-month period following Termination constitutes &#34;Deferred Compensation&#34; (within the meaning of Section 409A). such amount shall not be paid </font><font style="color:#181818;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">to </font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">Executive until the later of (i) six months after the date of Executive's Termination, and (ii) the payment date or commencement date specified in this Agreement for such payment(s). On the first regular payroll date following the </font><font style="color:#181818;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">expiration </font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">of such six-month period (or if </font><font style="color:#181818;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">Executive </font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">dies during the six-month period, the first payroll date following the death), all payments that were delayed pursuant to the preceding sentence shall be paid to </font><font style="color:#181818;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">Executive </font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">in a single lump sum and thereafter all payments shall be made as if there had been no such delay. All Severance Benefits described in Section 4.B </font><font style="color:#181818;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">shall be </font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">paid by, and no further severance compensation shall be paid or payable after, December 31 of the second calendar year following the year in which Executive's Termination occurs.</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">C.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%;padding-left:7pt;text-decoration:underline">Separation Agreement and Release Required.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%"> In order to receive any Severance Benefits under this Agreement, Executive must timely sign a separation agreement and release of claims in a form determined by UnitedHealth Group in its discretion.</font><font style="color:#181818;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%"> UnitedHealth </font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">Group shall provide to Executive a form of separation </font><font style="color:#181818;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">agreement </font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">and</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font><br></font></div><div style="padding-left:72pt"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">release of claims no later than three (3) days following Executive's date of Termination. If Executive does not timely execute and deliver to UnitedHealth Group such separation agreement and release, or if Executive does so, but then revokes it if permitted by and within the time required by applicable law, UnitedHealth Group will have no obligation to pay severance compensation to Executive.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">5.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt;text-decoration:underline">Property Rights, Confidentiality. Non-Disparagement, and Restrictive Covenants.</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">A.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:6.34pt;text-decoration:underline">UnitedHealth Group's Property</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font></div><div><font><br></font></div><div style="padding-left:117pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">i.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%;padding-left:20.67pt;text-decoration:underline">Assignment of Property Rights.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">  Executive must promptly disclose in writing to UnitedHealth Group all inventions</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">, </font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">discoveries, processes, procedures, methods and works of authorship, whether or not patentable or copyrightable, that Executive alone or jointly conceives, makes, discovers, writes or creates, during Working hours or on Executive's own time, during this Agreement's term (the &#34;Works&#34;). Executive hereby assigns to UnitedHealth Group all Executive's rights, including copyrights and patent rights, to all Works. Execu</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">t</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">ive must assist UnitedHealth Group as it reasonably requires to perfect, protect, and use its rights to the Works. This provision does not apply to any Work for which no UnitedHealth Group equipment, supplies, facility or trade secret information was used and&#58; (1) which does not relate directly to UnitedHealth Group&#8217;s business or actual or demonstrably anticipated research or development, or (2) which does not result from any work performed for UnitedHealth Group.</font></div><div style="padding-left:81pt;text-indent:-9pt"><font><br></font></div><div style="padding-left:117pt;text-indent:-27pt"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">ii.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%;padding-left:17.34pt;text-decoration:underline">No Removal of Property.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%"> Executive may not remove from UnitedHealth Group's premises any UnitedHealth Group records, documents</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">, </font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">data or other property, in either original or duplicate form, except as necessary in the ordinary course of UnitedHealth Group</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">' </font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">s business.</font></div><div style="padding-left:81pt;text-indent:-9pt"><font><br></font></div><div style="padding-left:117pt;text-indent:-27pt"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">iii.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%;padding-left:14.01pt;text-decoration:underline">Return of Property.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%"> Executive must immediately deliver to UnitedHealth Group, upon termination of employment</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">, </font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">or at any other time at UnitedHealth Group's request, all UnitedHealth Group property, including records, documents, data, and equipment, and all copies of any such property, including any records or data Executive prepared during employment.</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">B.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%;padding-left:7pt;text-decoration:underline">Confidential Information.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%"> Executive will be giv</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">e</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">n access to and provided with sensitive, confidential</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">, </font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">proprietary and trade secret information (&#34;Confidential Information'') in the course of Executive</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">'</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">s employment. Examples of Confidential Information include&#58; inventions&#59; n</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">e</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">w product or marketing plans&#59; business strategies and plans&#59; merger and acquisition targets&#59; financial and pricing information&#59; computer programs</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">, </font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">source codes, models and databases&#59; analytical models&#59; customer lists and information&#59; and supplier and vendor lists and other</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:72pt"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">information which is not generally available to the public. Executive agrees not to disclose or use Confidential Information</font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">, </font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">either during or after Executive's employment with UnitedHealth Group, except as necessary to perform Executive's UnitedHealth Group duties or as UnitedHealth Group may consent in writing.</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">C.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%;padding-left:7pt;text-decoration:underline">Non-Disparagement</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">. Executive agrees not to criticize, make any negative comments about or otherwise disparage UnitedHealth Group or those associated with it, whether orally, in writing or otherwise, directly or by implication, to any person or entity, including UnitedHealth Group customers or agents</font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">.</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">D.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%;padding-left:6.34pt;text-decoration:underline">Restrictive Covenants.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%"> Executive agrees to the restrictive covenants in this Section in consideration of Executive's employment and  UnitedHealth Group's  promises  in this Agreement, including providing Executive access to Confidential Information. The restrictive covenants in this Section apply during Executive's employment and for 24 months following termination of employment for any reason. Executive agrees that he&#47;she will not, without UnitedHealth Group's prior written consent, directly or indirectly, for Executive or for any other person or entity, as agent, employee, officer, director, consultant, owner, principal, partner or shareholder,  or in any other individual or representative capacity, engage in any of the following activities&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">i.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:29.67pt;text-decoration:underline">Non-Solicitation</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. Executive will not&#58;</font></div><div><font><br></font></div><div style="padding-left:121.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9.2pt">Solicit or conduct business with any business competitive with UnitedHealth Group from any person or entity&#58; (l) who was a UnitedHealth Group provider or customer within the 12 months before Executive's employment termination and with whom Executive had contact regarding UnitedHealth Group's activity, products or services, or for whom Executive provided services or supervised employees Who provided those services&#59; or about whom Executive learned Confidential Information during employment related to UnitedHealth Group</font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">'</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">s provision of  products and services to such person or entity, or (2) was a prospective provider or customer UnitedHealth Group solicited within the 12 months before Executive's employment termination and with whom Executive had contact for the purposes of soliciting the person or entity to become a provider or customer of UnitedHealth Group</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">, </font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or supervised employees who had those contacts, or about whom Executive learned Confidential Information during employment related to UnitedHealth Group's provision of products and services to such person or entity&#59;</font></div><div style="padding-left:85.5pt;text-indent:-4.5pt"><font><br></font></div><div style="padding-left:121.5pt;text-indent:-22.5pt"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:8.52pt">Raid, hire, employ</font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">recruit or solicit any UnitedHealth Group employee or consultant who possesses Confidential Information of</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:121.5pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:108%">UnitedHealth </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:108%">Group to </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:108%">leave </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:108%">UnitedHealth </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:108%">Group to </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:108%">join a competitor&#59;</font></div><div style="padding-left:85.5pt"><font><br></font></div><div style="padding-left:121.5pt;text-indent:-27pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:108%">(c)</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:108%;padding-left:13.7pt">Induce </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:108%">or </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:108%">influence </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:108%">any </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:108%">UnitedHealth Group </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:108%">employee</font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:108%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:108%">consultant</font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:108%">,</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:108%"> or </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:108%">provider </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:108%">who possesses </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:108%">Confidential </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:108%">Information of </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:108%">UnitedHealth</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:108%"> Group to terminate his, her </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:108%">or </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:108%">its </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:108%">employment or </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:108%">other relationship</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:108%"> with UnitedHealth </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:108%">Group&#59; or</font></div><div style="padding-left:85.5pt;text-indent:-9pt"><font><br></font></div><div style="padding-left:121.5pt;text-indent:-27pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:108%">(d)</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:108%;padding-left:13.02pt">A</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:108%">ssist anyone in any of </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:108%">the activities listed </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:108%">above.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">ii.</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:8.34pt;text-decoration:underline">Non-Competition.</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Executive </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">will </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">not&#58;</font></div><div><font><br></font></div><div style="padding-left:117pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">(a)</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%;padding-left:9.2pt">Engage in </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">or participate in </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">any activity </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">that competes</font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">directly </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">or</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%"> indirectly, </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">with </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">any </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">UnitedHealth Group activity</font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">, </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">product </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">or</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%"> service that </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">Executive </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">engaged in, </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">participated </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">in, </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">or </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">had</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%"> Confidential </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">Information </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">about </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">during </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">Executive's </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">last 36 </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">months</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%"> of </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">employment with UnitedHealth Group&#59; </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">or</font></div><div style="padding-left:81pt;text-indent:-4.5pt"><font><br></font></div><div style="padding-left:117pt;text-indent:-22.5pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">(b)</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%;padding-left:8.52pt">Assist anyone in any </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">of </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">the </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">activities </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">listed above.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">iii.</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%;padding-left:5.01pt">Because  </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">UnitedHealth  Group</font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">'</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">s </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">business competes on </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">a </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">nationwide basis, the </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">Executive's obligations </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">under this </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">&#34;Restrictive Covenants&#34; </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">s</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">ection shall </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">apply </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">on a </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">nationwide basis </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">anywhere in </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">the </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">United States.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">iv.</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%;padding-left:5.67pt">To the extent </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">E</font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">x</font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">ecutive </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">and </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">UnitedHealth Group agree at </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">any </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">time </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">to </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">enter </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">into </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">separate </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">agreements containing </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">restrictive covenants </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">with different </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">or </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">inconsistent terms than </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">those contained </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">herein</font><font style="color:#676767;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">  </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">Executive and UnitedHealth </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">Group </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">acknowledge </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">and </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">agree </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">that </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">such different </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">or inconsistent terms shall not </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">in </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">any </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">way affect or </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">have relevance to the Restrictive </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">Covenants contained </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">herein.</font></div><div><font><br></font></div><div><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Executive agrees that </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the provisions </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">of </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">this </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5 ar</font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">e </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">reasonable </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">necessary to protect </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">legitimate interests of </font><font style="color:#1f1f1f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">UnitedHealth </font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Group.</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">E.</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%;padding-left:43.67pt;text-decoration:underline">Cooperation and Indemnification</font><font style="color:#0e0e0e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">. Executive agrees to cooperate fully (i) with UnitedHealth Group in the investigation, prosecution or defense of any potential claims or concerns regarding UnitedHealth Group's business about which Executive has  relevant knowledge, including by providing truthful information  and testimony as reasonably requested by UnitedHealth Group, and (ii) with all government authorities on matters pertaining to any investigation, litigation or administrative proceeding concerning UnitedHealth Group. UnitedHealth Group  will reimburse Executive for any reasonable travel and out-of-pocket expenses incurred by Executive in providing such cooperation. UnitedHealth Group will indemnify Executive, in accordance with the Minnesota Business Corporation  Act,  for all</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:72pt"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">claims and other covered matters arising in connection with  Executive's employment.</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:67.5pt;text-indent:-49.5pt"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%">F.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%;padding-left:39.83pt;text-decoration:underline">Injunctive Relief.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:101%"> Executive agrees that (a) legal remedies (money damages) for any breach of Section 5 will be inadequate, (b) UnitedHealth Group will suffer immediate and irreparable harm from any such breach, and (c) UnitedHealth Group will be entitled to injunctive relief from a court in addition to any legal remedies UnitedHealth Group may seek in arbitration. If an arbitrator or court determines that Executive has breached any provision of Section 5, Executive agrees to pay to UnitedHealth Group its reasonable costs and attorney's fees incurred in enforcing that provision.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">6.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt;text-decoration:underline">Miscellaneous</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">A.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%;padding-left:6.34pt;text-decoration:underline">Tax Withholding.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%"> All compensation payable under this Agreement will be subject  to applicable tax withholding and other required or authorized deductions.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">B.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%;padding-left:7pt;text-decoration:underline">Assignment.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%"> Executive may not assign this Agreement. UnitedHealth Group may assign this Agreement. Any successor to UnitedHealth Group will be deemed to be UnitedHealth Group under this Agreement.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">C.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%;padding-left:7pt;text-decoration:underline">Entire Agreement&#58; Amendment.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%"> This Agreement contains the parties' entire agreement regarding its subject matter and may only be amended in a writing signed by the parties. This Agreement supersedes any and all prior oral or written employment agreements (including letters and memoranda) between Executive and UnitedHealth Group or its predecessors. This Agreement does not supersede the terms of any stock option, restricted stock, or stock appreciation rights plan or award.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">D.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%;padding-left:6.34pt;text-decoration:underline">Choice of </font><font style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%;text-decoration:underline">L</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%;text-decoration:underline">aw</font><font style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">. </font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">Minnesota law governs this Agreement.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">E.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%;padding-left:7.67pt;text-decoration:underline">Waivers&#58; Other Rights.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%"> No party's failure to exercise, or delay in exercising, any right or remedy under this Agreement will be a waiv</font><font style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">e</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">r of such right or remed</font><font style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">y</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">, nor will any single or partial exercise of any right or remedy preclude any other or further exercise of such right or remedy. Nothing in this Agreement prohibits Executive from making disclosures that ate protected under law or reporting violations of state or federal law or regulation to governmental agencies or entities.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">F.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%;padding-left:8.33pt;text-decoration:underline">Narrowed Enforcement and Severability.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%"> If a court </font><font style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">o</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">r arbitrator decides that </font><font style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">a</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">ny provision of this Agreement is invalid or overbroad, the parties agree that the court or arbitrator should narrow such provision so that it is enforceable or, if narrowing is not possible or permissibl</font><font style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">e, </font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">such provision should be considered severed and the other provisions of this Agreement should be unaffected.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#151513;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">G.</font><font style="color:#151513;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%;padding-left:6.34pt;text-decoration:underline">Dispute Resolution and Remedies.</font><font style="color:#151513;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%"> Except for injunctive relief under Section 5.F, any dispute between the parties relating to this Agreement or to Executive&#8217;s employment will be resolved by binding arbitration under UnitedHealth Group's </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">Employment</font><font style="color:#151513;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%"> Arbitration Policy, as it may be amended from time to time. The arbitrator(s) may not vary this Agreement&#8217;s terms and must apply applicable law.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#151513;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%;text-decoration:underline">H.</font><font style="color:#151513;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%;padding-left:6.34pt;text-decoration:underline">Payment of Deferred Compensation - Section  409A.</font><font style="color:#151513;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">  To the extent applicable, it is intended that the compensation arrangements under this Agreement be in full compliance with Section 409A. This Agreement shall be construed in a manner to give effect to such intention. In no event whatsoever shall UnitedHealth Group be liable for any tax, interest or penalties that may be imposed on Executive under Section 409A. UnitedHealth Group shall have no obligation to indemnify or otherwise hold Executive</font><font style="color:#8c8c8c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%"> </font><font style="color:#151513;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:105%">harmless from any such taxes, interest or penalties, or</font></div><div style="padding-left:72pt"><font style="color:#151513;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">from liability for any damages related thereto.</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-22.5pt"><font style="color:#151513;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">I.</font><font style="color:#151513;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:15.51pt;text-decoration:underline">Electronic Transmission&#47;Counterparts</font><font style="color:#151513;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. The executed version of this Agreement may be delivered by facsimile or email, and upon receipt, such transmission shall be deemed delivery of an original. </font><font style="color:#2f2f2f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">This</font><font style="color:#151513;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> Agreement may be executed in two or more counterparts, each of which shall be deemed to be an original, and all of which together will constitute one document.</font></div><div style="padding-left:36pt;text-indent:-4.5pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.243%"><tr><td style="width:1.0%"></td><td style="width:8.651%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.012%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.719%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">United HealthCare Services, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Executive</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; D. Ellen Wilson</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Brian R. Thompson</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2&#47;12&#47;2018</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2&#47;09&#47;2018</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.40
<SEQUENCE>13
<FILENAME>unhexhibit1040.htm
<DESCRIPTION>EX-10.40
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i33418e39db214a0f93adc198481d212c_33"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit 10.40</font></div></div><div style="text-align:center"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">AMENDMENT TO EMPLOYMENT AGREEMENT</font></div><div><font><br></font></div><div><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This AMENDMENT TO EMPLOYMENT AGREEMENT (the &#8220;Amendment&#8221;) modifies certain terms and conditions of the Employment Agreement effective January 1, 2013 between Marianne Short and United HealthCare Services, Inc. (&#8220;UnitedHealth Group&#8221;). Accordingly, Executive&#8217;s Employment Agreement is amended, effective June 5, 2018, as set forth below.</font></div><div><font><br></font></div><div><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The following paragraph is hereby added to </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Section 6.C&#58;</font></div><div><font><br></font></div><div style="padding-left:22.5pt"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the terms of any other agreement heretofore or hereafter entered into between the parties that reference retirement, Executive and UnitedHealth Group acknowledge and agree that for purposes of calculating years of service for retirement eligibility, Executive will receive two and one half years of service credit for each year she remains employed with UnitedHealth Group after June 5, 2018. In addition, prior to the date upon which Executive becomes eligible for retirement, if Executive's employment is terminated by UnitedHealth Group without Cause or if Executive terminates employment for Good Reason. Executive will be deemed to have met the applicable age and service requirements and will be retirement eligible. UnitedHealth Group agrees that this revised retirement definition will be reflected in and become part of Executive's outstanding and future issued equity award certificates. </font></div><div style="padding-left:22.5pt"><font><br></font></div><div><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except as expressly set forth in this Amendment, the Employment Agreement remains in full force and effect according to its terms.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.243%"><tr><td style="width:1.0%"></td><td style="width:8.651%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.012%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.719%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">United HealthCare Services, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Executive</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Dannette L. Smith</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Marianne Short</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Its&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Secretary to the Board</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6&#47;15&#47;2018</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6-18-18</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>14
<FILENAME>unhex21112312021.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i290ef08dbcb644af81349464b3cafea3_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 21.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Subsidiaries of the Company</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Listed below are subsidiaries of UnitedHealth Group Incorporated as of December&#160;31, 2021. Those subsidiaries not listed would not, in the aggregate, constitute a &#8220;significant subsidiary&#8221; of UnitedHealth Group Incorporated, as that term is defined in Rule&#160;1-02(w) of Regulation&#160;S-X. </font></div><div><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of Entity</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">State of Jurisdiction or Domicile</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Doing Business As</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1070715 B.C. Unlimited Liability Company</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">British Columbia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1st Avenue Pharmacy, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1st Avenue Pharmacy<br>Genoa Healthcare</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310 Canyon Medical, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4C Medical Group, PLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4C MSO LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5995 Minnetonka, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABCO International Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AbleTo Behavioral Health Services, P.C.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connecticut</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AbleTo, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accurate Rx Pharmacy Consulting, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Missouri</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abacus<br>Abacus 340B Management<br>Diplomat Specialty Infusion Group</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ACN Group IPA of New York, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ACN Group of California, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Administradora Cl&#237;nica La Colina S.A.S.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colombia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Administradora Country S.A.S.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colombia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Administradora M&#233;dica Centromed S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Surgery Center of Clifton, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Surgical Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Surgical Hospital, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advocate Condell Ambulatory Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advocate Southwest Ambulatory Surgery Center, L.L.C.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advocate-SCA Partners, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AHN Accountable Care Organization, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AHN Central Services, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AHN Target Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aliansalud Entidad Promotora de Salud S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colombia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Savers Insurance Company</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Savers Life Insurance Company of California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance Surgical Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AdventHealth Surgery Center - Lake Mary</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allina Health Heart and Vascular Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnesota</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allina Health Surgery Center-Brooklyn Park, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnesota</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aloha Surgical Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ambient Healthcare, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ambient Holdings, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">American Health Network of Indiana Care Organization, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">American Health Network of Indiana II, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HealthCare Network</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">American Health Network of Indiana, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">American Health Network of Kentucky, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kentucky</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">American Health Network of Ohio Care Organization, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">American Health Network of Ohio II, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">American Health Network of Ohio, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">American Physicians, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AmeriChoice Corporation</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AmeriChoice of New Jersey, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amico Sa&#250;de Ltda.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amil Assist&#234;ncia M&#233;dica Internacional S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AMIL International S.&#225;.r.l.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Luxembourg</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">An&#225;lisis Cl&#237;nicos ML S.A.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peru</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Angiografia e Hemodin&#226;mica Madre Theodora Ltda.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anne Arundel-SCA Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anne Arundel-SCA Surgicenter, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Antelope Valley Surgery Center, L.P.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Apothecary Holdings, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AppleCare Medical Management, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APS &#8211; Assist&#234;ncia Personalizada &#224; Sa&#250;de Ltda.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aquitania Chilean Holding SpA</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arcadia JV Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arcadia Outpatient Surgery Center, L.P.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ArchWell Health MSO, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ArchWell Health Professional Services Holding Co.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ArchWell Health Professional Services of Alabama, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alabama</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Archwell Health Professional Services of Arizona, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Archwell Health Professional Services of Nebraska, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nebraska</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ArchWell Health Professional Services of North Carolina, P.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Carolina</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ArchWell Health Professional Services of Oklahoma, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oklahoma</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ArchWell Health, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arise Physician Group</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona Physicians IPA, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Community Plan</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arlington Surgery Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASC Holdings of New Jersey, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASC Network, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASC Operators-East Bay, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASC Operators-San Francisco, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASC Operators-San Luis Obispo, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASC Operators-Santa Rosa, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASC Operators-South Bay, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aspectus, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Massachusetts</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Associa&#231;&#227;o Lus&#237;adas Knowledge Center &#8211; Health Education and Research</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portugal</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASV-HOPCo-SCA Cornerstone, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASV-HOPCo-SCA Florida, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Audax Health Solutions, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aurora Hospitalist, P.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Austin Center For Outpatient Surgery, L.P.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aventura Medical Tower Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Avery Parent Holdings, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aveta Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AxelaCare Intermediate Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alaska Business License #2143943</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AxelaCare, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">B.R.A.S.S. Partnership in Commendam</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Louisiana</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ball Outpatient Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Banm&#233;dica Colombia S.A.S.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colombia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Banm&#233;dica Internacional SpA</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Banm&#233;dica S.A.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barranca Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beach Surgical Holdings II, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beach Surgical Holdings III, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beach Surgical Holdings LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beaver Medical Group, P.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bedford Physicians Risk Retention Group, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vermont</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Behavioral Healthcare Options, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beltway Surgery Centers, L.L.C.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit Administration for the Self Employed, L.L.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Iowa</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefitter Insurance Solutions, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bergan Mercy Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nebraska</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bergen-Passaic Cataract Laser and Surgery Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bessler, MD, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bind Benefits, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BIND</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bind LH Holdings, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bind Re, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Birmingham Outpatient Surgery Center, Ltd.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alabama</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Birmingham Outpatient Surgical Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bloomfield ASC, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connecticut</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blue Ridge Day Surgery Center, L.P.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blue Ridge GP, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Carolina</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blue Ridge Properties, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Boca Raton Outpatient Surgery &#38; Laser Center, LTD.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bordeaux (Barbados) Holdings I, SRL</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barbados</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bordeaux (Barbados) Holdings II, SRL</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barbados</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bordeaux (Barbados) Holdings III, S.r.l.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barbados</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bordeaux Holding SpA</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bordeaux International Holdings, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bordeaux UK Holdings I Limited</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bordeaux UK Holdings II Limited</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bordeaux UK Holdings III Limited</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BOSC Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bosque Medical Center Ltda.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brandon Ambulatory Surgery Center, LC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BriovaRx Infusion Services 102, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BriovaRx of Florida, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BriovaRx of Florida</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BriovaRx of Maine, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maine</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BriovaRx</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BriovaRx of Massachusetts, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Massachusetts</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BSC Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cabin Enterprises, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cabin Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California Medical Group Insurance Company, Risk Retention Group</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Camp Hill Ambulatory Centers</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Camp Hill-SCA Centers, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital City Medical Group, L.L.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Louisiana</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Holding Company, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Care Improvement Plus Group Management, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Care Improvement Plus of Texas Insurance Company</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Care Improvement Plan</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Care Improvement Plus South Central Insurance Company</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arkansas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Care Improvement Plus Wisconsin Insurance Company</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wisconsin</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Care Logistics, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Care Logistics LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CareMount Dental Member, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CareMount Health Solutions ACO, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CareMount Health Solutions Employer, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CareMount Health Solutions, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CareMount Holding, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CareMount Medical Foundation, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CareMount Value Partners IPA, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum IPA of New York</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carr, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Casa de Sa&#250;de Santa Therezinha Ltda.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Castle Ambulatory Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hawaii</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Castle Rock SurgiCenter, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Catalyst360, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CATALYST360 INSURANCE SERVICES, LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Catamaran 2 Unlimited Company</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dublin</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Catamaran Finance (Ireland) Unlimited Company</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dublin</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Catamaran S.&#225;.r.l.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Luxembourg</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CCEC Anesthesia Management, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CDC Holdings Colombia S.A.S.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colombia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cedar Park JV Partners, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cedar Park Surgery Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cemed Care &#8211; Empresa de Atendimento Cl&#237;nico Geral Ltda.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Center for Quality Improvement, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Center for Restorative Surgery at Maple Grove, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnesota</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Center for Surgery of North Coast L.P.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Central Indiana Care Organization, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Central Ohio Care Organization, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CentrifyHealth, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CentriHealth Corporation</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ontario</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centro de Entrenamiento Capacitaci&#243;n en Reanimaci&#243;n y Prevenci&#243;n Limitada</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centro de Servicios Compartidos Banm&#233;dica SpA</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centro M&#233;dico Hospitalar Pitangueiras Ltda.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centro Odontol&#243;gico Americano S.A.C.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peru</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centromed Quilpu&#233; S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centros M&#233;dicos y Dentales Multimed Ltda.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centura-SCA Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centurion Casualty Company</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nebraska</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Channel Islands Surgicenter Properties, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Channel Islands Surgicenter, L.P.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charleston Surgery Center Limited Partnership</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Carolina</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charleston Surgery Properties, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charlotte Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Carolina</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charlotte Surgery Properties, LTD.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Carolina</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charlotte-SC, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chatham Orthopaedic ASC, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Childrens Surgery Center LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Citrus Regional Surgery Center, L.P.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claims Management Systems, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Solutions Systems</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cleburne Surgical Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cl&#237;nica Alameda SpA</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cl&#237;nica B&#237;o B&#237;o SpA</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cl&#237;nica Ciudad del Mar S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cl&#237;nica D&#225;vila y Servicios M&#233;dicos S.p.A.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cl&#237;nica del Country S.A.S.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colombia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cl&#237;nica Iquique S.A.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cl&#237;nica M&#233;dico Cir&#250;rgica de Santa Tecla, S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portugal</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cl&#237;nica Portoazul S.A.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colombia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cl&#237;nica San Felipe S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peru</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cl&#237;nica S&#225;nchez Ferrer S.A.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peru</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cl&#237;nica Santa Mar&#237;a S.p.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cl&#237;nica Vespucio S.A.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical Partners of Colorado Springs, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinton Partners, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CLISA &#8211; Cl&#237;nica de Santo Ant&#243;nio, S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portugal</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CMO &#8211; Centro M&#233;dico de Oftalmologia S&#47;S Ltda.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CMS &#8211; Central de Manipula&#231;&#227;o e Servi&#231;os Farmac&#234;uticos Ltda.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Coachella Valley Physicians of PrimeCare, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Coalition for Advanced Pharmacy Services, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cobranzas Banm&#233;dica SpA</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cogent Healthcare IPA of New York, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cogent Healthcare Management of New York, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cogent Healthcare of Arizona, P.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cogent Healthcare of California, Prof. Corp.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cogent Healthcare of Georgia, P.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cogent Healthcare of Illinois, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cogent Healthcare of Iowa, P.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Iowa</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cogent Healthcare of Jackson, MS, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mississippi</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cogent Healthcare of Jacksonville, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cogent Healthcare of Mississippi, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mississippi</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cogent Healthcare of Missouri, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Missouri</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cogent Healthcare of Montana, P.C.</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montana</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cogent Healthcare of New Jersey, P.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cogent Healthcare of North Carolina, P.C.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Carolina</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cogent Healthcare of Oregon, P.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oregon</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cogent Healthcare of Pennsylvania, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cogent Healthcare of Pensacola, L.L.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cogent Healthcare of Tennessee, P.C.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cogent Healthcare of Virginia, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Virginia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cogent Healthcare of Washington, P.C.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cogent Healthcare, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cogent Medical Care, P.C.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cogent Patient Safety Organization, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cogent&#47;Endion Medical Care of New York, P.C.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COI &#8211; Cl&#237;nicas Oncol&#243;gicas Integradas S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaborative Care Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaborative Care Services, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaborative Realty, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colmedica Medicina Prepagada S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colombia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colonial Outpatient Surgery Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado Innovative Physician Solutions, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado Springs Surgery Center, Ltd.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comfort Care Transportation, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive Hospital Physicians of Florida, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connecticut Surgery Center, Limited Partnership</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connecticut</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connecticut Surgery Properties, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connecticut Surgical Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ConnectYourCare, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ConnectYourCare, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consorcio Regenero S.A.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Constructora Inmobiliaria Magapoq S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumer Wellness Solutions, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuum Physicians Group of Washington, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuum Physicians Group, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cornell Surgicenter, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oregon</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cornerstone Surgery Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cornerstone Surgicare, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corpus Christi Endoscopy Center, L.L.P.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Country Scan Ltda.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colombia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Critical Care Physician of New York, P.C.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Critical Care Physicians of Illinois, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Critical Care Physicians of New Jersey, PC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Critical Care Physicians of Pennsylvania, P.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross Timbers Surgery Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curaspan Health Group, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cypress Care, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Workers Compensation Services of Georgia</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dallas Inpatient Specialist, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Damon Dialysis, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danbury Surgical Center, L.P.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Day-Op Surgery Consulting Company, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DBP Services of New York IPA, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare Network IPA</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dental Benefit Providers of California, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dental Benefit Providers of Illinois, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dental Benefit Providers, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DBP Services<br>DBP Services Inc.</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denton Endoscopy Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denton Surgery Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derry Surgical Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Hampshire</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagn&#243;stico Ecotomogr&#225;fico Centromed Ltda.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diasn&#243;stico por Im&#225;genes Centromed Ltda.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive Disease Center, L.P.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilab Medicina Nuclear Ltda.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diplomat Blocker, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diplomat Corporate Properties, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diplomat Pharmacy, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diplomat Specialty Pharmacy</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diplomat Specialty Pharmacy Great Lakes Distribution Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diplomat Specialty Pharmacy</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diplomat Specialty Pharmacy of Chicago, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diplomat Specialty Pharmacy</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diplomat Specialty Pharmacy of Ft. Lauderdale, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diplomat Specialty Pharmacy</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diplomat Specialty Pharmacy of Los Angeles County, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diplomat Specialty Pharmacy</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distance Learning Network, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">i3CME<br>OptumHealth Education</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divisadero Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">divvyMED, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIVVY DOSE<br>divvyDOSE<br>DIVVYDOSE LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DocASAP India Technologies Private Limited</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delhi (NCT)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DocASAP US, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DocASAP, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Doctor + S.A.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peru</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dry Creek Surgery Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DSP Flint Real Estate, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DSP-Building C, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DTC Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCC Convalescent Center at Inverness<br>OCC Surgery Center at Inverness</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dublin Surgery Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Duluth Surgical Suites, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnesota</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Durable Medical Equipment, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Massachusetts</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DWIC of Tampa Bay, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Doctor's Walk-In Clinics<br>MedExpress<br>MedExpress Urgent Care - Cape Coral, SW Pine Island Rd<br>MedExpress Urgent Care - Carrollwood<br>MedExpress Urgent Care - Clearwater<br>MedExpress Urgent Care - Clewiston, W Sugarland Hwy<br>MedExpress Urgent Care - Deland, N Woodland Blvd<br>MedExpress Urgent Care - Fort Meyers, S Cleveland Ave<br>MedExpress Urgent Care - Golden Gate, Collier Blvd.<br>MedExpress Urgent Care - Hudson, State Road 52<br>MedExpress Urgent Care - Jacksonville, Atlantic Blvd.<br>MedExpress Urgent Care - Jacksonville, Merrill Rd<br>MedExpress Urgent Care - Lakeland, N Road 98<br>MedExpress Urgent Care - Largo<br>MedExpress Urgent Care - Lehigh Acres, Homestead Rd N<br>MedExpress Urgent Care - Lutz<br>MedExpress Urgent Care - Mylan - Fountainbleau Aviation<br>MedExpress Urgent Care - Mylan - Rectrix Aerodrome Centers<br>MedExpress Urgent Care - New Tampa<br>MedExpress Urgent Care - North Port, Tuscola Blvd<br>MedExpress Urgent Care - Northside<br>MedExpress Urgent Care - Palm Beach Gardens<br>MedExpress Urgent Care - Port Charlotte, Tamiami Trl<br>MedExpress Urgent Care - Vero Beach, US Highway 1<br>MedExpress Urgent Care - West Tampa<br>MedExpress Urgent Care-Brandon</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E Street Endoscopy, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Coast Endoscopy Center</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ear Professionals International Corporation</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPIC Hearing Healthcare<br>UnitedHealthcare Hearing</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">East Bay Endoscopy Center, L.P.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">East Brunswick Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Echo Locum Tenens, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">eCode Solutions, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Electronic Network Systems, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elual Participa&#231;&#245;es S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EM Orange Tree LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerald Coast Surgery Center, L.P.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emisar Pharma Services LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emmaus Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emmaus Surgical Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Empire Physician Management Company, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emprem&#233;dica S. A.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peru</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endion Hospitalist North, P.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endion Hospitalist of Western New York, P.C.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endion Medical Healthcare, P.C.</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endion Medical Services, P.C.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy Center Affiliates, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Enterprise Life Insurance Company</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EP Campus I, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPIC Health Plan</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPIC Management Services, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equian Parent Corp.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equian, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Casualty Recovery Solutions</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Esho &#8211; Empresa de Servi&#231;os Hospitalares S.A.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Everett MSO, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Everett Clinic</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excelsior Insurance Brokerage, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Health Resources, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Surgery Center, L.L.C.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye Clinic Oftalmologia Cl&#237;nico Cir&#250;rgica e Diagn&#243;stico Ltda.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye Specialists Surgery Centers LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marion Eye Specialists Surgery Center<br>Muncie Eye Specialists Surgery Center</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Family Health Care Services</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southwest Medical Associates Home Health</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Family Home Hospice, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare Palliative Care<br>Southwest Medical Associates Hospice and Palliative Care</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ferrell Physician Services, P.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fideicomiso Cl&#237;nica Barranquilla Portoazul FA-517</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colombia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Coast Orthopedic Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Family Insurance, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florence Surgery Center, L.P.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FMG Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For Health of Arizona, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Geriatrix of Arizona<br>INSPIRIS of Arizona</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For Health, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fort Sutter Medical Building, a California Limited Partnership</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fort Worth Endoscopy Centers, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fortified Provider Network, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foundation Surgery Affiliate General of Huntingdon Valley, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oklahoma</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foundation Surgery Affiliate of Huntingdon Valley, L.P.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oklahoma</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Franklin Surgical Center LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Freedom Life Insurance Company of America</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Freeway Surgicenter of Houston, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frontier Medex Tanzania Limited</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tanzania</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FrontierMEDEX Kenya Limited</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nairobi</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FrontierMEDEX US, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FrontierMEDEX, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnesota</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Global</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fundaci&#243;n Banm&#233;dica</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gadsden Surgery Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gainesville Surgery Center, L.P.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gainesville Surgery Properties, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Genoa Healthcare LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alaska Business License #1073614</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Genoa Healthcare, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Genoa of Arkansas, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arkansas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Genoa Technology (Canada) Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">British Columbia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Genoa Technology, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Genoa Telepsychiatry, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1DocWay, Inc.</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Genoa, QoL Wholesale, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">gethealthinsurance.com Agency Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gladiolus Surgery Center, L.L.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GLBESC, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glenwood Surgical Center, L.P.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glenwood-SC, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global One Ventures, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">G1<br>Global 1</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Golden Gate Endoscopy Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Golden Outlook, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Golden Outlook<br>Golden Outlook Insurance Services</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Golden Rule Financial Corporation</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Golden Rule Insurance Company</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Golden Triangle Surgicenter, L.P.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grandview Surgery Center, LTD.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grants Pass Surgery Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oregon</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater New Haven ASC, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connecticut</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greensboro Specialty Surgery Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Carolina</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greenville Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greenway Surgical Suites, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnesota</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grossmont Surgery Center, L.P.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grove Place Surgery Center, L.L.C.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">H&#38;W Indemnity (SPC), Ltd.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grand Cayman</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">H.I. Investments Holding Company, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Harken Health Insurance Company</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wisconsin</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Harrison Endo Surgical Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hawthorn Place Outpatient Surgery Center, L.P.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hays JV Partners, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hays Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HCentive Technology India Private Limited</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delhi (NCT)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">hCentive, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HCP ACO California, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HCP ACO California, LLC<br>HealthCare Partners ACO<br>Optum California ACO</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care-ONE Insurance Agency, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Inventures Employment Solutions, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Inventures, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Plan of Nevada, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Plan of Nevada HPN</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HealthCare Partners Affiliates Medical Group</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HealthCare Partners ASC-LB, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Medical Group-Surgery Center, Long Beach<br>HealthCare Partners ASC-LB, LLC<br>Optum Surgery Center</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HealthCare Partners Management Services California, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HealthCare Partners Services, LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HealthCare Partners RE, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HealthCare Partners RE, LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare Solutions, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Healthcare Solutions of Georgia</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HealthEast Surgery Center-Maplewood, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnesota</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HealthFirst IPA, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HealthMarkets Group, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HealthMarkets Insurance Agency, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HealthMarkets Services, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HealthMarkets, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HealthMarkets, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthplex America, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthplex Dental Services, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthplex I.P.A., Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthplex Insurance Company</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthplex of CT, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connecticut</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthplex of DC, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">District of Columbia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthplex of MD, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthplex of ME, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maine</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthplex of NC, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Carolina</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthplex of NJ, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthplex of TX, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthplex, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthplex Management Services, Inc.</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HealthScope Benefits, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HEALTHSCOPE BENEFIT ADMINISTRATORS</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HealthSCOPE Holdings, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heartland Heart and Vascular, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Help Seguros de Vida S.A.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Help Service S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Help SpA</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hemonefro &#8211; Hemodi&#225;lise e Nefrologia Ltda</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HFHS-SCA Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Highlands Ranch Healthcare, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedExpress Urgent Care<br>MedExpress Urgent Care Fort Collins Boardwalk Dr<br>MedExpress Urgent Care Glendale Leetsdale Dr<br>MedExpress Urgent Care Longmont S Main St<br>Optum Virtual Care</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HMG Holding Corporation</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HMG Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HMP of Baltimore &#8211; USH, P.C.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home Medical S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Honodav SpA</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospice Inspiris Holdings, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitais Associados de Pernambuco Ltda.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital Alvorada Taguatinga Ltda.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital Ana Costa S.A.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital de Cl&#237;nicas de Jacarepagu&#225; Ltda.</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital Santa Helena S.A.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physician of Broome County, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physician of New York - Binghamton, P.C.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physician of New York - Buffalo, P.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physician of New York - Newburgh, P.C.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physician of New York - Nyack, P.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physician of New York - Patchogue, P.C.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Alabama &#8211; TCG, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alabama</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Alabama &#8211; TCS, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alabama</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Alaska &#8211; TCG, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alaska</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Alaska &#8211; TCS, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alaska</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Arizona - Goodyear, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Arizona - Nogales, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Arizona - Phoenix II, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Arizona - Phoenix, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Arizona - Sierra Vista, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Arizona &#8211; TCG, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Arizona &#8211; TCS, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Arizona - Tucson II, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Arizona - Tucson, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Arkansas &#8211; TCG, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arkansas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Arkansas &#8211; TCS, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arkansas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Buncombe County, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Carolina</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of California - Apple Valley, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of California - Bakersfield, PC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of California - Camarillo, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of California - Crescent City, PC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of California - Fairfield, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of California - Fremont, PC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of California - Grass Valley, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of California - Jackson, PC</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of California - Oceanside, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of California - Oxnard, PC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of California - Salinas, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of California - San Bernardino II, PC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of California - San Bernardino, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of California - San Leandro, PC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of California - Sonoma, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of California - Stockton II, PC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of California - Stockton, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of California &#8211; TCG, PC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of California &#8211; TCS, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of California - Thousand Oaks, PC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of California - Vacaville, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of California, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Colorado - Brighton, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Colorado - Denver, PC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Colorado &#8211; TCG, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Colorado &#8211; TCS, PC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Connecticut - Manchester, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connecticut</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Connecticut - Rockville, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connecticut</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Connecticut &#8211; TCG, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connecticut</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Connecticut &#8211; TCS, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connecticut</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Connecticut - Wallingford, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connecticut</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Connecticut, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connecticut</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of DC &#8211; TCG, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">District of Columbia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of DC &#8211; TCS, PC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">District of Columbia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of DC, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">District of Columbia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Delaware &#8211; TCG, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Delaware &#8211; TCS, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Florida - Ft. Lauderdale, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Florida - Jacksonville II, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Florida - Jacksonville, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Florida - Palm Coast, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Florida &#8211; TCG, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Florida &#8211; TCS, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Fredericksburg, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Virginia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Georgia - Atlanta, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Georgia - East Point, PC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Georgia - Lavonia, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Georgia - Savannah, PC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Georgia &#8211; TCG, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Georgia &#8211; TCS, PC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Hawaii - Kealakekua, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hawaii</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Hawaii &#8211; TCG, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hawaii</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Hawaii &#8211; TCS, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hawaii</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Idaho - Nampa, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Idaho</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Idaho &#8211; TCG, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Idaho</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Idaho &#8211; TCS, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Idaho</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Illinois - Downers Grove, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Illinois - Elmhurst, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Illinois - Rockford, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Illinois &#8211; TCG, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Illinois &#8211; TCS, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Illinois - Winfield, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Indiana - Clinton, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Indiana - Mishawaka, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Indiana &#8211; TCG, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Indiana &#8211; TCS, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Indiana - Terre Haute, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Indiana, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Iowa - Cedar Rapids, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Iowa</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Iowa - Mason City, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Iowa</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Iowa &#8211; TCG, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Iowa</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Iowa &#8211; TCS, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Iowa</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Iowa, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Iowa</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Kansas &#8211; TCG, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kansas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Kansas &#8211; TCS, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kansas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Kansas - Topeka, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kansas</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Kansas - Wichita II, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kansas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Kansas - Wichita, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kansas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Louisiana - Alexandria, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Louisiana</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Louisiana - Bossier City, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Louisiana</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Louisiana - Lake Charles, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Louisiana</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Louisiana - Shreveport, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Louisiana</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Louisiana &#8211; TCG, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Louisiana</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Louisiana &#8211; TCS, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Louisiana</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Maine - Bangor, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maine</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Maine - Lewiston, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maine</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Maine &#8211; TCG, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maine</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Maine &#8211; TCS, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maine</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Maryland - Cheverly, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Maryland - Cumberland, PC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Maryland - Frederick, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Maryland - Laurel, PC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Maryland - Rockville, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Maryland &#8211; TCG, PC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Maryland &#8211; TCS, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Maryland, P.C.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Massachusetts - Brockton, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Massachusetts</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Massachusetts - Dorchester, PC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Massachusetts</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Massachusetts - Framingham, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Massachusetts</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Massachusetts - Holyoke, PC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Massachusetts</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Massachusetts - Natick, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Massachusetts</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Massachusetts - Norwood, PC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Massachusetts</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Massachusetts - Springfield, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Massachusetts</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Massachusetts - Stoughton, PC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Massachusetts</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Massachusetts - Taunton, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Massachusetts</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Massachusetts &#8211; TCG, PC</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Massachusetts</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Massachusetts &#8211; TCS, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Massachusetts</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Massachusetts - Worcester, PC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Massachusetts</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Michigan - Alpena, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Michigan - Dowagiac, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Michigan - Escanaba, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Michigan - Grand Blanc, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Michigan - Grayling, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Michigan - Kalamazoo, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Michigan - Plainwell, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Michigan - Port Huron, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Michigan - Saginaw, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Michigan - Tawas City, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Michigan &#8211; TCG, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Michigan &#8211; TCS, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Michigan, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Minnesota &#8211; TCG, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnesota</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Minnesota &#8211; TCS, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnesota</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Mississippi &#8211; TCG, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mississippi</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Mississippi &#8211; TCS, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mississippi</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Mississippi, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mississippi</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Missouri - Bridgeton, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Missouri</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Missouri - Richmond Heights, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Missouri</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Missouri &#8211; TCG, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Missouri</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Missouri &#8211; TCS, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Missouri</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Montana - Billings, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montana</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Montana - Butte, PC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montana</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Montana - Miles City, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montana</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Montana - Missoula, PC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montana</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Montana &#8211; TCG, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montana</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Montana &#8211; TCS, PC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montana</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Multiple Practice Sites, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Nebraska &#8211; TCG, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nebraska</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Nebraska &#8211; TCS, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nebraska</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Nevada - Henderson (Bessler), PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Nevada - Henderson II (Bessler), PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Nevada - Las Vegas (Bessler), PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Nevada - Las Vegas II (Bessler), PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Nevada &#8211; TCG (Bessler), PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Nevada &#8211; TCS (Bessler), PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of New Hampshire &#8211; TCG, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Hampshire</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of New Hampshire &#8211; TCS, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Hampshire</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of New Jersey - Hackensack, PC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of New Jersey - Paterson, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of New Jersey - TCG, PC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of New Jersey &#8211; TCS, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of New Mexico - Clovis, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Mexico</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of New Mexico - Rio Rancho, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Mexico</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of New Mexico - TCG, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Mexico</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of New Mexico - TCS, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Mexico</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of New York, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of North Carolina - Burlington, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Carolina</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of North Carolina - Clyde, PC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Carolina</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of North Carolina - Elizabeth City, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Carolina</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of North Carolina - Jacksonville, PC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Carolina</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of North Carolina - New Bern, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Carolina</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of North Carolina - Rocky Mount, PC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Carolina</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of North Carolina &#8211; TCG, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Carolina</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of North Carolina &#8211; TCS, PC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Carolina</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of North Carolina, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Carolina</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of North Dakota &#8211; TCG, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Dakota</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of North Dakota &#8211; TCS, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Dakota</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Ohio - Akron, Professional Corporation</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Ohio - Batavia, Professional Corporation</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Ohio - Canton, Professional Corporation</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Ohio - Cincinnati II, Professional Corporation</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Ohio - Cincinnati III, Professional Corporation</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Ohio - Cincinnati, Professional Corporation</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Ohio - Circleville, Professional Corporation</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Ohio - Columbus II, Professional Corporation</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Ohio - Columbus, Professional Corporation</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Ohio - Dover, Professional Corporation</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Ohio - East Liverpool, Professional Corporation</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Ohio - Fairfield, Professional Corporation</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Ohio - Martins Ferry, Professional Corporation</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Ohio &#8211; TCG, Professional Corporation</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Ohio &#8211; TCS, Professional Corporation</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Ohio - Westerville, Professional Corporation</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Ohio - Youngstown, Professional Corporation</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Ohio, Professional Corporation</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Oklahoma - Oklahoma City, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oklahoma</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Oklahoma &#8211; TCG, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oklahoma</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Oklahoma &#8211; TCS, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oklahoma</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Oregon - Portland, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oregon</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Oregon &#8211; TCG, PC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oregon</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Oregon &#8211; TCS, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oregon</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Pennsylvania &#8211; TCG, PC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Pennsylvania &#8211; TCS, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Pennsylvania, P.C.</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Rhode Island &#8211; TCG, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhode Island</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Rhode Island &#8211; TCS, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhode Island</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Richland County, Ltd.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of San Luis Obispo County, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of South Carolina - Aiken, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Carolina</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of South Carolina - Rock Hill, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Carolina</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of South Carolina &#8211; TCG, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Carolina</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of South Carolina &#8211; TCS, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Carolina</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of South Dakota &#8211; TCG, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Dakota</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of South Dakota &#8211; TCS, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Dakota</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Tennessee &#8211; Columbia, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Tennessee &#8211; Franklin, PC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Tennessee &#8211; TCG, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Tennessee &#8211; TCS, PC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas - Amarillo, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas - Atlanta, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas - Austin II, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas - Austin, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas - Bryan, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas - Burnet, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas - Corpus Christi II, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas - Corpus Christi, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas - Cypress, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas - Dallas, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas - El Paso II, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas - El Paso III, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas - El Paso, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas - Fort Worth II, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas - Fort Worth, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas - Fredericksburg, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas - Houston, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas - Humble, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas - Kerrville, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas - Kyle, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas - Livingston, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas - Lubbock, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas - Lufkin, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas - Mount Pleasant, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas - Plainview, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas - Rockwall, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas - Round Rock, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas - San Antonio II, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas - San Antonio III, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas - San Antonio IV, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas - San Antonio V, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas - San Antonio VI, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas - San Antonio VII, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas - San Antonio, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas - San Marcos, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas &#8211; TCG, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas &#8211; TCS, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas - Texarkana, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas - Tyler, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Texas, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Utah &#8211; TCG, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Utah &#8211; TCS, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Vermont &#8211; TCG, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vermont</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Vermont &#8211; TCS, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vermont</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Virginia - Alexandria, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Virginia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Virginia - Front Royal II, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Virginia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Virginia - Front Royal, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Virginia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Virginia - Mechanicsville, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Virginia</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Virginia - Midlothian, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Virginia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Virginia - Richmond II, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Virginia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Virginia - Richmond, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Virginia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Virginia &#8211; TCG, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Virginia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Virginia &#8211; TCS, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Virginia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Virginia - Winchester, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Virginia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Virginia, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Virginia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Washington - Arlington, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Washington - Auburn, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Washington - Bellingham, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Washington - Bremerton, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Washington - Burien, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Washington - Coupeville, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Washington - Enumclaw, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Washington - Federal Way, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Washington - Gig Harbor, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Washington - Lakewood, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Washington - Mount Vernon, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Washington - Puyallup, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Washington - Tacoma II, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Washington - Tacoma III, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Washington - Tacoma, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Washington &#8211; TCG, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Washington &#8211; TCS, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Washington - Vancouver, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Washington County, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of West Virginia &#8211; Martinsburg, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Virginia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of West Virginia &#8211; South Charleston, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Virginia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of West Virginia &#8211; TCG, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Virginia</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of West Virginia &#8211; TCS, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Virginia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of West Virginia &#8211; Wheeling, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Virginia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of West Virginia, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Virginia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Wisconsin, Ltd.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wisconsin</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Wyoming - Casper, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wyoming</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Wyoming &#8211; TCG, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wyoming</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalist Medicine Physicians of Wyoming &#8211; TCS, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wyoming</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitalists Management Group, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Humedica, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hygeia Corporation</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hygeia Corporation (Ontario)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ontario</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IEC Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IHD Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois Independent Care Network, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imagen Technologies, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impel Consulting Experts, L.L.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impel Management Services, L.L.C.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana Care Organization, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana Endoscopy Centers, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inland Surgery Center, L.P.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inmobiliaria Apoquindo 3001 S.A.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inmobiliaria Apoquindo 3600 Ltda.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inmobiliaria Apoquindo S.A.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inmobiliaria Cl&#237;nica Santa Mar&#237;a S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inmobiliaria e Inversiones Alameda S.A.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inmobiliaria Vi&#241;amed Ltda.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">INOV8 Surgical at Memorial City, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">INOV8 Surgical</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inpatient Services, P.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inpatient Specialists of California, P.C.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">inPharmative, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">INSPIRIS of Texas Physician Group</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Clinic<br>Optum Clinic + Medical Spa<br>Optum Clinic + Urgent Care</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inspiris, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instituto Radium de Cammpinas Ltda</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inter-Hospital Physicians Association, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oregon</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Success-Rx<br>The Portland IPA</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Healthcare Services, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">InTouch Pharmacy LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inversiones Cl&#237;nicas Santa Mar&#237;a SpA</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ironman Holdco, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ironman Intermediate Holdco, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Isapre Banm&#233;dica S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Johnston Surgicare, L.P.</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhode Island</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Joliet Surgery Center Limited Partnership</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jordan Ridge Family Medicine, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Primary Care - Jordan Ridge</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Joyable, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JPM Healthcare LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kansal, Inc., A Professional Corporation</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Knox Diagnostic Imaging Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kokomo Outpatient Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">La Esperanza del Per&#250; S.A.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peru</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratorio ROE S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peru</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratorios M&#233;dicos Amed Quilpu&#233; S.A.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Landmark Group Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Landmark Health Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Landmark Health NY IPA, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Landmark Health NY PO, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Landmark Health of California, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Landmark Health of Massachusetts, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Landmark Health of North Carolina, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Carolina</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Landmark Health of Oregon, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Landmark Health of Pennsylvania, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Landmark Health of Washington, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Landmark Health Technologies Private Limited</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Karnataka</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Landmark Health, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Landmark India, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Landmark Intermediate Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Landmark Medical of Idaho, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Idaho</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Landmark Medical of Massachusetts, PLLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Massachusetts</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Landmark Medical of Tennessee, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Landmark MSO, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Landmark Primary Care, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laser Acquisition Holdings III, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LDI Holding Company, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LDI Diplomat Holding Company, LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LDI Management Services, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leehar Distributors, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CastiaRx<br>CastiaRx Administrators, LLC<br>CastiaRx of Missouri<br>CastiaRx Pharmacy<br>CastiaRx Specialty Pharmacy<br>Leehar Distributors Missouri, LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lemhi Ventures Fund I, LP</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lemhi Ventures Fund II, LP</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level2 Medical Services, P.C. Alaska</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alaska</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lexington Surgery Center, Ltd.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kentucky</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LGH-A&#47;Golf ASTC, L.L.C.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liberty Anesthesia Services, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lifeprint Accountable Care Organization, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LifePrint Health, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum<br>Optum Care Network-Arizona<br>Optum Care Networks-Arizona<br>Optum Community Center Layton<br>Optum Community Center Sandy<br>Optum Community Center West Valley<br>Optum Utah<br>OptumCare Medical Network<br>Optumcare Network of Indiana<br>OptumCare Network of Ohio</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LifeWell. Ltd. Co.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Limestone Medical Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litom&#233;dica S.A.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colombia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Logan Surgical Suites, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lotten-Eyes Oftalmologia Clinica e Cirurgica Ltda.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Louisville S.C., Ltd.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kentucky</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Louisville-SC Properties, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kentucky</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loyola Ambulatory Surgery Center at Oakbrook, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loyola Ambulatory Surgery Center at Oakbrook, L.P.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lus&#237;adas - Parcerias Cascais, S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portugal</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lus&#237;adas A.C.E.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portugal</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lus&#237;adas Algarve, S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portugal</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lus&#237;adas, S.A.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portugal</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lus&#237;adas, SGPS, S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portugal</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lutheran Campus ASC, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Main Line Spine Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MAMSI Life and Health Insurance Company</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed Care of North America, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MCNA Dental Plans</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed Physical Network, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mansfield Endoscopy Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March Holdings, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March Vision Care IPA, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March Vision Care of Texas, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March Vision Care, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marin Health Ventures, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marin Specialty Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marin Surgery Holdings, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marlin Holding Company LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland Ambulatory Centers, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland-SCA Centers, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Massachusetts Assurance Company, Ltd. PIC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grand Cayman</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Massachusetts Avenue Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKenzie Surgery Center, L.P.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MCNA Health Care Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MCNA Insurance Company</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MCNA Dental Plans</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MCNA Systems Corp.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MD Ops, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHIEF<br>Community Health Information Exchange Foundation</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MD-Individual Practice Association, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ME AHS UC LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedExpress Primary Care West Virginia, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Virginia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedExpress Urgent Care Alabama, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alabama</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedExpress Urgent Care Maine, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maine</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Virtual Care</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedExpress Urgent Care New Hampshire, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Hampshire</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedExpress Urgent Care of Boynton Beach, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedExpress Urgent Care - Boca Raton<br>MedExpress Urgent Care - Coral Springs<br>MedExpress Urgent Care - Palm Beach Gardens<br>MedExpress Urgent Care - Royal Palm Beach</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedExpress Urgent Care, Inc. - Ohio</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Clinic of North Texas PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USMD Physician Services</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Hilfe S.A.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Support Los Angeles, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Surgical Centers of America, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Transportation Services, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MTS</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSynergies, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Melbourne Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Memorial City Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Memorial City Partners, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Memorial Houston Surgery Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MemorialCare Surgical Center at Orange Coast, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MemorialCare Surgical Center at Saddleback, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mesquite Liberty, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Metro I Stone Management, Ltd.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MGH&#47;SCA, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MHC Real Estate Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Miami Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Midlands Orthopaedics Surgery Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Carolina</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Midwest Center for Day Surgery, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mid-West National Life Insurance Company of Tennessee</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mile High SurgiCenter, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mississippi Medical Plaza, L.C.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nebraska</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mobile Medical Services of New Jersey, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mobile-SC, LTD.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alabama</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Modality Accountable Care Organisation Limited</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moen, M.D., P.C.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mohawk Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Monarch Management Services, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Geriatric Care &#38; Family Practice Associates<br>Optum</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montgomery Surgery Center Limited Partnership</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Monument Health, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moore Orthopaedic Clinic Outpatient Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Carolina</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Morris County Surgical Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MSLA Management LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mt. Pleasant Surgery Center, L.P.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Multiangio Ltda.</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Murrells Inlet ASC, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Carolina</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Muskogee Surgical Investors, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oklahoma</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mustang Razorback Holdings, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">My Wellness Solutions, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NAMM Holdings, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Naperville Surgical Centre, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">National Foundation Life Insurance Company</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">National Pacific Dental, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">National Surgery Centers, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Navigator Health, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">naviHealth Care at Home, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">naviHealth Coordinated Care SC, P.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">naviHealth Coordinated Care, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">naviHealth Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">naviHealth Michigan HBPC, P.C.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">naviHealth SM Holdings, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">naviHealth, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nebraska Spine Hospital, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nebraska</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neighborhood Health Partnership, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netwerkes, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada Pacific Dental</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Orleans Regional Physician Hospital Organization, L.L.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Louisiana</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peoples Health<br>Peoples Health Network</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New West Physicians, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elk Ridge Family Medicine<br>HEALTHFIRST PHYSICIANS<br>New West Physicians<br>Physician Alliance of the Rockies</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York Proton Management, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Newton Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Niagara Hospitalist, P.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nomad Buyer, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North American Medical Management California, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Coast Surgery Center, Ltd., a California Limited Partnership</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Dallas Surgical Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Kitsap Ambulatory Surgery Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Puget Sound Oncology Equipment Leasing Company, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Northern Nevada Health Network, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Northern Rockies Surgery Center, L.P.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Northern Rockies Surgicenter, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montana</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Northern Utah Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Northwest Hills JV Partners, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Northwest Medical Group Alliance, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Northwest Spine and Laser Surgery Center LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oregon</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NW Spine and Laser Surgery Center</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Northwest Surgicare, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Northwest Surgicare, Ltd., an Illinois Limited Partnership</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NPN IPA Washington, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NSC Channel Islands, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NSC Greensboro West, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NSC Greensboro, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NSC Lancaster, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NSC Seattle, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NSC Upland, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OC Cardiology Practice Partners, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCC MSO, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Omesa SpA</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OmniClaim, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oncocare S.A.C.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peru</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One World Surgery</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ophthalmology Surgery Center of Dallas, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optimum Choice, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Bank, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exante Bank, Inc.<br>OptumHealth Bank, Inc.</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Biometrics, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Care Networks, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Care Network of Ohio<br>Optum Care Network of Oregon<br>Optum Care Networks of Kentucky<br>OptumCare Network of Connecticut</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Care of New York Management, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Care Services Company</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Care, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedExpress Payroll Arkansas</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Clinics Holdings, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Clinics Intermediate Holdings, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Compounding Services, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Digital Health Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Direct To Consumer, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Financial, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Frontier Therapies Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Frontier Therapies II, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Frontier Therapies, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alaska Business License #2143853</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Genomics, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Global Solutions (India) Private Limited</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Telangana</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Global Solutions (Philippines), Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phillipines</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Global Solutions Colombia S.A.S.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colombia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Global Solutions International B.V.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Government Solutions, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Growth Partners Holdings, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Evercare Hospice<br>Evercare Hospice and Palliative Care<br>Evercare Hospice and Palliative Care of Colorado Springs<br>Evercare Hospice and Palliative Care of Denver<br>Evercare Palliative Care<br>Evercare Palliative Services<br>Evercare Palliative Services of Colorado Springs<br>Evercare Palliative Services of Denver<br>Evercare Palliative Services of Dover<br>Evercare Palliative Services of Vienna</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Growth Partners, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Health &#38; Technology (Hong Kong) Limited</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hong Kong</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Health &#38; Technology (India) Private Limited</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Karnataka</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Health &#38; Technology (Singapore) Pte. Ltd.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Health &#38; Technology (US), LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Missouri</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Health &#38; Technology Holdings (US), Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Missouri</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Health &#38; Technology Servi&#231;os do Brasil Ltda.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Health and Technology FZ-LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dubai</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Health Plan of California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Healthcare Partners Plan, Inc.</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Health Services (Canada) Ltd.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">British Columbia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interlock Employee and Family Assistance<br>Optum International</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Health Solutions (Australia) Pty Ltd</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Victoria</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum<br>Optum International<br>OptumInsight</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Health Solutions (UK) Limited</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Healthcare of Illinois, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Hospice Pharmacy Services, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HospiScript Services<br>Optum Hospice Pharmacy Services<br>Optum Hospice Pharmacy Services Administrator</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 100, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Care of New Jersey Inc.</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 101, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 103, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 200, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Carolina</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 201, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 202, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 203, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 204, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 205, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 206, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alabama</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 207, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alabama</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 208, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Carolina</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 209, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AxelaCare</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 301, LP</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oklahoma</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AxelaCare</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 302, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nebraska</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 305, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Services 305, LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 308, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AxelaCare</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 401, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 402, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 403, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 404, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oregon</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 500, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alaska Business License #2120394<br>Optum Infusion Services 500<br>Optum Services 500, Inc.</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 501, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 550, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Services 550, LLC</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 551, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connecticut</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diplomat Specialty Infusion Group</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 553, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Carolina</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diplomat Specialty Infusion Group</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Infusion Services 554, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diplomat Specialty Infusion Group</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Insurance of Ohio, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Labs Topaz, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Labs, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phillipines</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Labs, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Query Lab<br>QueryRx<br>UnitedHealth Group Research &#38; Development</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Life Sciences (Canada) Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ontario</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Management Consulting (Shanghai) Co., Ltd.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Networks of New Jersey, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare Network of New Jersey<br>OrthoNet of the Mid-Atlantic</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum of New York, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Operations (Ireland) Unlimited Company</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Oregon MSO, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Palliative and Hospice Care of Pennsylvania, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Evercare Hospice &#38; Palliative Care</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Palliative and Hospice Care of Texas, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Evercare Hospice &#38; Palliative Care</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Perks LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Pharma Services Holdings, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Pharmacy 601, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Pharmacy 700, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BriovaRx Specialty</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Pharmacy 701, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alaska Business License #2143945</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Pharmacy 702, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Pharmacy 704, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Pharmacy 705, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alabama</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Pharmacy 706, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Pharmacy 707, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Pharmacy 800, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Pharmacy 801, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Pharmacy 803, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Pharmacy 805, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Pharmacy 806, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Public Sector Solutions, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumServe Community Care Services</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Rocket, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum SCA CS JV Holdings, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Senior Services, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alabama</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SeniorScript</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Services (Ireland) Limited</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dublin</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Services (Puerto Rico) LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Puerto Rico</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Services, Inc.</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Solutions UK Holdings Limited</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Technology, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum UK Solutions Group Limited</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Venture Global Partners II, LP</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Venture Global Partners, LP</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Venture Partners II, LP</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Venture Partners III, LP</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Venture Partners, LP</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Washington Network, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Women's and Children's Health, LLC</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum360 Services, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum360 Solutions, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum360, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare ACO New Mexico, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM Care ACO, LLC</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare ACO West, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare Clinical Trials, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HCP Clinical Research<br>HCP Clinical Research, LLC</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare Colorado ASC, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive Disease Endoscopy<br>Optum Digestive Disease<br>Optum Endoscopy</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare Colorado Springs, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado Springs Health Partners<br>Digestive Disease Clinic<br>Optum<br>Optum Digestive Disease</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare Colorado, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HealthCare Partners Colorado, LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare Endoscopy Center New Mexico, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Mexico</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare Florida CI, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare Florida, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ameridrug<br>Apopka Family Medicine<br>Associated Family Medicine Sabal Palm<br>DaVita Medical Florida<br>DaVita Medical Group<br>DaVita Medical Group - North Westmonte<br>DaVita Medical Group Florida<br>DaVita Pharmacy<br>HCP Care Partners<br>Healthcare Partners Georgia<br>JSA Best Group<br>JSA Healthcare Corporation<br>JSA Medical Group Bayway<br>JSA Medical Group Northeast<br>JSA Medical Group Skyway<br>Lake Mary Family Medicine<br>Northside Family Medicine<br>Optum<br>South Seminole Family Medicine<br>Tuscawilla Family Medicine</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare Holdings Colorado, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Medical California<br>DaVita Medical Holdings California, LLC<br>HealthCare Partners Holdings, LLC</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare Management, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HealthCare Partners<br>HealthCare Partners, LLC<br>Magan Medical Clinic<br>Optum</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare New Mexico, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABQ Health Partners, LLC<br>DaVita Medical Group</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare New York IPA, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare Portland, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oregon</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GreenField Health System, LLC</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare South Florida, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DaVita Medical Group<br>DaVita Medical Group Florida<br>Optum</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare Specialty Practices, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumHealth Care Solutions, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumHealth Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumHealth International B.V.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumInsight Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumInsight India Private Limited</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tamil Nadu</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumInsight Life Sciences, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Innovus<br>QualityMetric Incorporated</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumInsight, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ingenix<br>Ingenix, Inc.<br>Optum</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx Administrative Services, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alaska Business License #2143946</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx Discount Card Services, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alaska Business License #1039765 (qualification)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx Group Holdings, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx Health Solutions, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx Holdings I, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx Home Delivery of Ohio, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx at Nationwide<br>OptumRx of Ohio</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx IPA III, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx NY IPA, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx of Pennsylvania, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FutureScripts Secure</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx PBM of Illinois, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx PBM of Maryland, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alaska Business License #1048672<br>OptumRx PBM Administrator of Maryland</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx PBM of Pennsylvania, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FutureScripts</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx PBM of Wisconsin, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wisconsin</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx PBM Administrator of Wisconsin</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx PD of Pennsylvania, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx Pharmacy of Nevada, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Culinary<br>Culinary Pharmacy</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx Pharmacy, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumRx, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alaska Business License #2084085 FirstLine Medical<br>Alaska Business License #2108686 FirstLine Benefits<br>Alaska Business License 2084037 (qualification)<br>Alaska Business License 969517 (OptumRx)<br>FirstLine Benefits<br>FristLine Medical<br>OptumRx<br>OptumRx PBM Administrator of California<br>OptumRx Pharmacy at Collins Aerospace<br>OptumRx, Inc.</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumServe Health Services, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wisconsin</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LHI<br>Logistics Health<br>Logistics Health, Inc.<br>OptumServe Health Services, Inc.</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumServe Technology Services, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum<br>Optum, Inc.<br>QSSI<br>Quality Software Services<br>Quality Software Services, Inc.</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oregon Healthcare Resources, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oregon</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oregon Outpatient Surgery Center, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oregon</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orlando Center for Outpatient Surgery, L.P.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orthology Inc.</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OrthoNet Holdings, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OrthoNet LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OrthoNet of New York</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OrthoNet New York IPA, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OrthoNet of the South, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OrthoNet West, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orthopedic Center of Palm Beach County, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orthopedic Surgery Center of Palm Beach County, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orthopro Management, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OrthoWest MSO, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OSB &#8211; Tecnologia e Servi&#231;os de Suporte Lda.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paran&#225;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ovations, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Owensboro Ambulatory Surgical Facility, Ltd.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kentucky</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oxford Benefit Management, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connecticut</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oxford Health Insurance, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oxford Health Plans (CT), Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connecticut</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oxford Health Plans (NJ), Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oxford Health Plans (NY), Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oxford Health Plans LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oxford Agency - Oxford Health Plans Inc.</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">P2P Link, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pacific Cardiovascular Associates Medical Group, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pacific Casualty Company, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hawaii</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PacifiCare Life and Health Insurance Company</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthOne</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PacifiCare Life Assurance Company</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthOne</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PacifiCare of Arizona, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PacifiCare<br>Secure Horizons</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PacifiCare of Colorado, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprecare, Inc.<br>Secure Horizons</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pac&#237;fico S.A. Entidad Prestadora de Salud</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peru</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Panama City Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Park Hill Surgery Center, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Parkway Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patient Care Associates, L.L.C.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patrimonio Aut&#243;nomo Nueva Cl&#237;nica</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colombia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment Resolution Services, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AIM HEALTHCARE SERVICES</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PCCCV, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peninsula Eye Surgery Center, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Penzo Enterprises, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peoples Health, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Louisiana</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perham Physical Therapy, LTD</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnesota</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perimeter Center for Outpatient Surgery, L.P.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Technologies, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nebraska</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PHC Subsidiary Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physician Alliance of the Rockies, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physicians Day Surgery Center, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physicians Health Choice of Texas, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physicians Health Choice</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physicians Health Plan of Maryland, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physicians' Surgery Center of Downey, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pinnacle III, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plano de Sa&#250;de Ana Costa Ltda.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus One Health Management Puerto Rico, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Puerto Rico</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus One Holdings, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PMI Acquisition, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PMSI Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PMSI Settlement Solutions, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Settlement Solutions</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PMSI, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum<br>Optum Workers Compensation Services of Florida</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pocono Ambulatory Surgery Center, Limited</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Polar II Fundo de Investimento em Participa&#231;&#245;es Multiestrat&#233;gia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Polo Holdco, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">POMCO Network, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">POMCO, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EM Risk Management<br>Pomco<br>Pomco Group Benefit Administrators</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pomerado Outpatient Surgical Center, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pomerado Outpatient Surgical Center, L.P.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Post-Acute Care Center for Research, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PPH Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PPH Management Company, L.L.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PPH-Columbia, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PPH-Gardendale, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Practice Partners in Healthcare, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred Care Network of Florida, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred Care Network, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred Care Partners Holding, Corp.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred Care Partners Medical Group, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred Care Partners, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PreferredOne Administrative Services, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnesota</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PreferredOne</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PreferredOne Insurance Company</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnesota</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premier Choice ACO, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premier Surgery Center of Louisville, L.P.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiere Medical Resources, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Presidio Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prime Health, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Med One Works</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PrimeCare Medical Network, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PrimeCare of Citrus Valley, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PrimeCare of Corona, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PrimeCare of Hemet Valley, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PrimeCare of Inland Valley, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PrimeCare of Moreno Valley, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PrimeCare of Redlands, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PrimeCare of Riverside, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PrimeCare of San Bernardino, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PrimeCare of Sun City, Inc.</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PrimeCare of Temecula, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PrimeDoc of Richmond, P.C.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Virginia</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PrimeDoc St. Francis, P.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Virginia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Procura Management, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Managed Care Services</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional Coverage Services, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Progressive Enterprises Holdings, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Progressive Medical, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Workers Compensation Services of Ohio<br>PMI Medical Solutions, LLC<br>PMI Solutions, LLC<br>Progressive Medical Solutions, LLC<br>Progressive Medical, LLC of Ohio</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ProHEALTH Care Associates of New Jersey LLP</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ProHEALTH Care Associates, L.L.P.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ProHEALTH Medical Management, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ProHealth Physicians ACO, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connecticut</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ProHealth Physicians, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connecticut</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ProHealth Proton Center Management, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ProHealth&#47;CareMount Dental Management, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Promotora Country S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colombia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pronounced Health Solutions, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prosemedic S.A.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peru</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prospero Benefits Management,  LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prospero Care Management, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prospero Management Services, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Providence &#38; SCA Development, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Providence &#38; SCA Off-Campus Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Providence &#38; SCA On-Campus Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Providence &#38; SCA Outreach Markets Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PS Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pulse Platform, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">QoL Acquisition Holdings Corp.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R Cubed, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RABessler, M.D., P.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rally Health, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real Appeal, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redding Surgery Center, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redlands Ambulatory Surgery Center</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redlands-SCA Surgery Centers, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reliant Medical Group The Endoscopy Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Massachusetts</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reliant Medical Group, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Massachusetts</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reliant MSO, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ReMedics, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research Surgical Center LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Center of the Rockies</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Resonancia Magn&#233;tica de Colombia Ltda.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colombia</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Resonancia Magn&#233;tica del Country S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colombia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RightCare Solutions, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">River Valley ASC, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connecticut</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Riverside Corporate Wellness, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wisconsin</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Riverside Electronic Healthcare Resources, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Riverside Medical Management, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Riverside Surgical Center of Meadowlands, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Riverside Surgical Center of Rutherford</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Riverside Surgical Center of Newark, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Robert A. Bessler, MD, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROC Surgery LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rockville Eye Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Palisades Eye Surgery Center</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rocky Mountain Health Maintenance Organization, Incorporated</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rocky Mountain Health Plans<br>Rocky Mountain HMO</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROCS Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rush Oak Brook Surgery Center, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RX Ricardo Campos Ltda.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sacred Heart ASC, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Summit Surgery Center</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Saden S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sage Medical, Prof. LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Dakota</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salem JV Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salem Surgery Center, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oregon</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salveo Specialty Pharmacy, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">San Diego Endoscopy Center</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">San Diego Sports and Minimally Invasive Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">San Francisco Endoscopy Center LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">San Luis Obispo Surgery Center, a California Limited Partnership</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sand Lake SurgiCenter, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sand Lake Surgery Center</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Santa Barbara Endoscopy Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Santa Cruz Endoscopy Center, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Santa Helena Assist&#234;ncia M&#233;dica S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Santa Rosa Surgery Center, L.P.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Santos Administra&#231;&#227;o e Participa&#231;&#245;es S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sanvello Health Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sanvello Health Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sanvello Health Limited</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SC Affiliates, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA AHN JV Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Alaska Surgery Center, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alaska</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Athens, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Austin Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Austin Medical Center Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Aventura Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Bloomfield Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA BOSC Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Cedar Park Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Clifton, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Colorado Springs Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Community Service Foundation</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alabama</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Cottonwood Holdings, LLC</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Danbury Surgical Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Denver Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Development, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Duluth Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Duncanville Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Duncanville MSO, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA eCode Solutions Private Limited</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uttar Pradesh</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Englewood Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA ESSC Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Global One Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Greenway Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Grove Creek Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Guilford Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Hays Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Health Value Enterprise, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Heartland Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA High Point Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA HoldCo, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Holding Company, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Holdings, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA IEC Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Indiana Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Lutheran Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Maple Grove Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Mohawk Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Murrells Inlet, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Northern Utah Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Northwest Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA of Clarksville, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Outside New Jersey, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Pacific Holdings, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Pacific Surgery Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Palisades Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Pennsylvania Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Pinnacle Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Premier Surgery Center of Louisville, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Providence Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Rockledge JV, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA ROCS Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Rush Oak Brook Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Sage Medical MSO, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Sage Medical, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA San Diego Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Skyway Holdings, LLC</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA South Ogden Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Southwestern PA, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Specialists of Florida, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Specialty Holdings of Connecticut, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA SSSC Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Stonegate Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Surgery Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Surgicare of Laguna Hills, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Teammate Support Network</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alabama</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA West Health Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Westgreen Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA Woodbury Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Albuquerque Surgery Properties, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Mexico</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Alliance, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Anne Arundel, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-AppleCare Partners, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Bethesda, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Blue Ridge, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Bonita Springs, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Brandon, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Castle Rock, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Central Florida, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Charleston, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Chatham, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Chevy Chase, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Citrus, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Colonial Partners, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Colorado Springs, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Connecticut Partners, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Davenport, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Denver Physicians Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Denver, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Derry, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Doral, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Downey, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Dry Creek, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Dublin, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Encinitas, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Eugene, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-First Coast, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Florence, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Fort Collins, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Fort Walton, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Franklin, LLC</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Frederick, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Freeway Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Ft. Myers, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Gainesville, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Gladiolus, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Glenwood Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Grants Pass, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Grove Place, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Hagerstown, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Hamden, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Hilton Head, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Honolulu, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Houston Executive, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCAI Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Illinois, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-IT Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-JPM Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Kissing Camels Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Main Street, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Marina del Rey, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-MC VBP, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Mecklenburg Development Corp.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Carolina</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Memorial City, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Memorial, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Merritt, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Midlands, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Midway Management, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Mobile, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Mokena, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Morris Avenue, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Morris County, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Mt. Pleasant, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Naperville, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Naples, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-New Jersey, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Newport Beach, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scanner Centromed S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Northeast Georgia Health, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Palm Beach MSO Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Palm Beach, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Panama City Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Paoli, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Phoenix, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Pocono, LLC</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Portland, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Practice Partners Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-River Valley, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Riverside Partners, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Riverside, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Rockville, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Sacred Heart Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-San Diego, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-San Luis Obispo, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Sand Lake, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Santa Rosa, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Somerset, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-South Jersey, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Sparta, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Spartanburg Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-St. Louis Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-St. Louis, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-St. Lucie, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Surgicare, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-SwiftPath, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Verta, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-VLR Holdings Company, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Wake Forest, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Western Connecticut, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Westover Hills, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Winchester, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Winter Park, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCA-Woodlands Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCLHS-SCA Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCP Specialty Infusion, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Seashore Surgical Institute, L.L.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Seisa Servi&#231;os Integrados de Sa&#250;de Ltda.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senate Street Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Benefits, L.L.C.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Serquinox Holdings LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Servicios de Entrenamiento en Competencias Cl&#237;nicas Ltda.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Servicios Integrados de Salud Ltda.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Servicios M&#233;dicos Amed Quilpu&#233; S.A.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Servicios M&#233;dicos B&#237;o B&#237;o Ltda.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Servicios M&#233;dicos Ciudad del Mar Ltda.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Servicios M&#233;dicos Santa Mar&#237;a Ltda.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Servicios M&#233;dicos Vespucio Ltda.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Servicl&#237;nica Inmobiliaria S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Servicl&#237;nica S.A. (Ex Los Leones, La Calera)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Servisalud Inmobiliaria S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Servisalud S.A. (Ex Los Carrera, Quilpu&#233;)</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shark Holdings, P.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SHC Atlanta, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SHC Austin, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SHC Hawthorn, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SHC Melbourne, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sierra Dental Plan, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sierra Health and Life Insurance Company, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sierra Health Services, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sierra Health-Care Options, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sierra Home Medical Products, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southwest Medical Associates, Inc.<br>Southwest Medical Pharmacy &#38; Home Medical Equipment<br>THC of Nevada</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sierra Nevada Administrators, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sistema de Administraci&#243;n Hospitalaria S.A.C.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peru</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SJ East Campus ASC, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denver Convalescent &#38; Recovery Center<br>Denver Surgery Center</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Small Business Insurance Advisors, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sobam &#8211; Centro M&#233;dico Hospitalar S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sociedad de Inversiones Santa Mar&#237;a SpA</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solstice Administration Services, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solstice Administrators of Alabama, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alabama</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solstice Administrators of Arizona, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solstice Administrators of Missouri, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Missouri</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solstice Administrators of North Carolina, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Carolina</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solstice Administrators of Texas, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solstice Administrators, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solstice Benefit Services, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solstice Benefits, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solstice Health Insurance Company</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solstice Healthplans of Arizona, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solstice Healthplans of Colorado, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solstice Healthplans of New Jersey, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solstice Healthplans of Ohio, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solstice Healthplans of Tennessee, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solstice Healthplans of Texas, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solstice Healthplans, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solstice of Illinois, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solstice of Minnesota, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnesota</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solstice of New York, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Solutran, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Somerset Outpatient Surgery, L.L.C.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Inpatient Physicians &#8211; Michigan, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Inpatient Physicians Medical Group, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Inpatient Physicians of Ohio, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Inpatient Physicians of Texas I, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Inpatient Physicians, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Intensivists of Nevada (RBessler, M.D.), PLLC</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Kenwood Hospitalists of Cincinnati, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Kenwood Hospitalists of Cincinnati, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Physicians Advisory Services, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Physicians Alaska Hospitalist Group, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Physicians Anesthesiology of Texas, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Physicians Emergency Medicine of Arizona, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Physicians Emergency Medicine of Georgia, P.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Physicians Emergency Medicine of Illinois, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Physicians Emergency Medicine of Kansas, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kansas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Physicians Emergency Medicine of Kentucky, PLLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kentucky</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Physicians Emergency Medicine of Louisiana, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Louisiana</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Physicians Emergency Medicine of Michigan, PLLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Physicians Emergency Medicine of Nevada (Bessler), PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Physicians Emergency Medicine of South Carolina, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Carolina</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Physicians Emergency Medicine of Southern California, P.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Physicians Emergency Medicine of Texas, PLLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Physicians Emergency Medicine of Washington, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Physicians Emergency Medicine of West Virginia, PLLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Virginia</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Physicians Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Physicians Intensivists of Arizona, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Physicians Intensivists of Georgia, PC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Physicians Intensivists of South Carolina, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Carolina</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Physicians Intensivists of Virginia, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Virginia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Physicians Intensivists of Washington, PLLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Physicians of Florida IV, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Physicians of Georgia III, P.C.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Physicians of Hawaii, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hawaii</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Physicians of Idaho, PLLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Idaho</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Physicians of Illinois, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Physicians of Indiana, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Physicians of Iowa, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Iowa</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Physicians of Kankakee, Illinois, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Physicians of Massachusetts II, P.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Massachusetts</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Physicians of Massachusetts, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Massachusetts</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Physicians of New Jersey, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Physicians of New York, PLLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Physicians of North Carolina, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Carolina</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Physicians of South Carolina, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Carolina</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Physicians of Wyoming, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wyoming</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Physicians Palliative Care of Maryland, P.C.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sound Physicians Telemedicine, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Arlington Surgical Providers, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South County Surgical Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Missouri</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Sound Inpatient Physicians, PLLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Massachusetts</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southern California Medical Practice Concepts, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southland Hospitalists, P.C.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southwest Medical Associates, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumCare<br>OptumCare Community Center<br>Sierra Home Medical Products, Inc.<br>Southwest Hospitalist Services Group<br>Southwest Medical Pharmacy &#38; Home Medical Equipment</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southwest Michigan Health Network Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southwest Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southwest Surgical Center, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnesota</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orthopaedic Institute Surgery Center</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Space Coast Surgical Center, Ltd.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merritt Island Surgery Center</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spartanburg Surgery Center, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Carolina</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialists in Urology Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialized Pharmaceuticals, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Benefits, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EyeFit<br>EyeFit Vision Center<br>EyeFit Vision Centers</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Billing Solutions, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Surgical Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spectera of New York, IPA, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spectera, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sports and Spinal Physical Therapy, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">District of Columbia</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SRPS, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SSSC Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">St. Cloud Outpatient Surgery, Ltd., a Minnesota Limited Partnership</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnesota</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">St. Cloud Surgical Center, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">St. Louis Cardiovascular Institute, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Missouri</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">St. Louis Specialty Surgical Center, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Missouri</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stonegate JV Partners, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stonegate Surgery Center, L.P.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Summer Street ASC, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connecticut</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SunSurgery, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Center at Cherry Creek, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Center at Cottonwood, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Center at Grove Creek, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Center at Kissing Camels, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Center at South Ogden, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Center at St. Vincent, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oregon</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Center Holding, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Center of Boca Raton, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Center of Colorado Springs, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Center of Des Moines, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Center of Easton, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Center of Ellicott City, Inc.</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Center of Fairfield County, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Center of Fort Collins, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Center of Lexington, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Center of Louisville, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Center of Maui, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Center of Mt. Scott, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oregon</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Center of Muskogee, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Center of Rockville, L.L.C.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Center of Southern Pines, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Center of The Woodlands, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Centers of Des Moines, Ltd., an Iowa Limited Partnership</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Iowa</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Centers-West Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Care Affiliates Political Action Committee</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alabama</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Care Affiliates, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Care Partners of Melbourne, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Caregivers of Fort Worth, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Center of Greensboro, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Carolina</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Center of San Diego, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Center of South Jersey, Limited Partnership</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Center of Tuscaloosa Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alabama</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Eye Experts, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Massachusetts</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Health Of Orlando, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Health, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Hospital Holdings of Oklahoma, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Management Solutions, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgicare of Central Jersey, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgicare of Jackson, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgicare of Jackson, Ltd., a Mississippi Limited Partnership</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mississippi</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgicare of Joliet, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgicare of La Veta, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgicare of La Veta, Ltd., a California Limited Partnership</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgicare of Minneapolis, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgicare of Minneapolis, Ltd., a Minnesota Limited Partnership</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnesota</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgicare of Mobile, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgicare of Mobile, Ltd.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alabama</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgicare of Oceanside, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgicare of Owensboro, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgicare of Salem, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgicare, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indiana</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgicenters of Southern California, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SVHS-SCA Florida JV, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Symphonix Health Holdings LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">T.M. Carr, M.D., P.C.</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TeamMD Holdings, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TeamMD Iowa, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TeamMD Physicians of Texas, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Alief Clinic</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TeamUP Insurance Services, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tecnolog&#237;a de Informaci&#243;n en Salud S.A.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas Health Craig Ranch Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas Health Flower Mound Orthopedic Surgery Center, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas Health Orthopedic Surgery Center Alliance, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas Health Surgery Center Alliance, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas Health Surgery Center Bedford, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas Health Surgery Center Chisholm Trail, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas Health Surgery Center Irving, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas Health Surgery Center Las Colinas, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas Health Surgery Center Preston Plaza, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas Health Surgery Center Rockwall, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas Health Surgery Center Southwest Fort Worth, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas Health Surgery Center Waxahachie, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas Health Surgery Center Willow Park, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Advisory Board Company</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Delaware Advisory Board Company</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Alaska Hospitalist Group, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alaska</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Chesapeake Life Insurance Company</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oklahoma</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Eye Surgery Center of the Carolinas, L.P.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Carolina</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Intensivist Group of Langhorne, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Lewin Group, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Carolina</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lewin</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Outpatient Surgery Center of Hilton Head, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Carolina</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Polyclinic MSO, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Surgery Center of Easton, L.P.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Surgical Center of Connecticut, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connecticut</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Surgical Center of the Treasure Coast, L.L.C.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas Johnson Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Rivers Holdings, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Rivers Surgical Care, L.P.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">THR-SCA Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tmesys, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Topimagem Diagn&#243;stico por Imagem Ltda.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trails Edge Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trauma Surgery Affiliates, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Travel Express Incorporated</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasure Valley Emerald Properties, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasure Valley Hospital Limited Partnership</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Idaho</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tri-City Medical Center ASC Operators, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tri-County Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trinity Cardiovascular Care, PLLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tufts Health Freedom Insurance Company</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Hampshire</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tufts Health Freedom Plan<br>UnitedHealthcare Freedom Plans</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tufts Health Freedom Plans, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tuscaloosa Surgical Center, L.P.</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alabama</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Behavioral Health Plan, California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OptumHealth Behavioral Solutions of California</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UCSD Ambulatory Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UCSD Center for Surgery of Encinitas, L.P.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UCSD Surgical Center of San Diego, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UCSD-SCA Holdings I, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UCSD-SCA Holdings II, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UHC Finance (Ireland) Unlimited Company</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dublin</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UHC International Services, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UHC of California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PacifiCare<br>PacifiCare of California<br>Secure Horizons<br>UnitedHealthcare of California</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UHCG &#8211; FZE</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dubai</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UHCG Holdings (Ireland) Limited</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UHCG Services (Ireland) Limited</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UHG Brasil Participa&#231;&#245;es S.A.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UHG Holdings UK IV Limited</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UHG Holdings UK V Limited</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">England</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UHG Holdings UK VI Limited</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UHIC Holdings, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OneNet PPO</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UMR, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiserv Health - Wausau Benefits</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unidad M&#233;dica Diagn&#243;stico S.A.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colombia</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unimerica Insurance Company</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wisconsin</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unimerica Life Insurance Company</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unimerica Life Insurance Company of New York</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unison Health Plan of Delaware, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Community Plan</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Behavioral Health</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Strategies<br>Optum Idaho<br>OptumHealth Behavioral Solutions<br>Plan 21, Incorporated<br>Plan 21, INCORPORATED<br>United Behavioral Health (Inc.)<br>United Behavioral Health, Inc.</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Behavioral Health of New York, I.P.A., Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Group Reinsurance, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grand Turk</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Health Foundation</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnesota</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United HealthCare Services, Inc.</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnesota</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AmeriChoice<br>EverCare<br>Evercare<br>Health Professionals Review<br>Healthmarc<br>HealthPro<br>Institute for Human Resources<br>UHC Management Company<br>UHC Management Company, Inc.<br>United HealthCare Corporation<br>United HealthCare Management Company, Inc.<br>United HealthCare Management Services<br>United HealthCare Services of Minnesota<br>United HealthCare Services of Minnesota, Inc.<br>United Resource Networks<br>United Resource Networks, Inc.<br>UnitedHealthcare<br>UnitedHealthcare MedicareStore</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United in Advancing Health Equity Foundation</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnesota</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Medical Park ASC, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Iowa</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Resource Networks IPA of New York, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealth Advisors, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maine</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UHA Insurance Agency, LLC<br>UnitedHealthcare</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealth Group Employee Assistance Fund</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnesota</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealth Group Incorporated</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealth Group International Finance (Ireland) Unlimited Company</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealth International, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealth Military &#38; Veterans Services, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Benefits of Texas, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Health Plan of Texas, Inc.</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Benefits Plan of California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Children's Foundation, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Community Plan of California, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Community Plan of Georgia, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Community Plan of Ohio, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Community Plan</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Community Plan of Texas, L.L.C.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Community Plan, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Consulting &#38; Assistance Service (Beijing) Co., Ltd.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Europe S.&#225; r.l.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Luxembourg</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Global Medical (UK) Limited</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Insurance Company</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connecticut</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Community Plan of Texas</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Insurance Company of America</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Insurance Company of Illinois</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Insurance Company of New York</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Insurance Company of the River Valley</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Insurance Designated Activity Company</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Integrated Services, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Community Plan</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare International Asia, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare International I B.V.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare International II S.&#225; r.l.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Luxembourg</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare International III B.V.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare International III S.&#225; r.l.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Luxembourg</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare International IV S.&#225; r.l.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Luxembourg</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare International VII S.&#224; r.l.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Luxembourg</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare International VIII S.&#224; r.l.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Luxembourg</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare International X S.&#224; r.l.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Luxembourg</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Life Insurance Company</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wisconsin</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of Alabama, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alabama</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of Arizona, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of Arkansas, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arkansas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Complete Health</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of Colorado, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MetraHealth Care Plan</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of Florida, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Community and State Plan of Florida<br>UnitedHealthcare Community Plan<br>UnitedHealthcare Community Plan of Florida</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of Georgia, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Georgia</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United HealthCare of Georgia</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of Illinois, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Community Plan of Minnesota</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of Kentucky, Ltd.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kentucky</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of Louisiana, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Louisiana</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Community Plan</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of Mississippi, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mississippi</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of New England, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhode Island</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of New Mexico, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Mexico</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of New York, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Community Plan</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of North Carolina, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Carolina</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of Ohio, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of Oklahoma, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oklahoma</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PacifiCare<br>PacifiCare Health Options<br>PacifiCare of Oklahoma<br>Secure Horizons<br>UnitedHealthcare Community Plan of Oklahoma</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of Oregon, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oregon</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of Pennsylvania, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Community Plan for Families<br>UnitedHealthcare Community Plan for Kids<br>UnitedHealthcare Community Plan of Pennsylvania<br>UnitedHealthcare Dual Complete</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of South Carolina, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Carolina</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of Texas, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of the Mid-Atlantic, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Community Plan of Virginia</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of the Midlands, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nebraska</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of the Midwest, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Missouri</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of the Rockies, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of Utah, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of Idaho, Inc.</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of Washington, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PacifiCare<br>Secure Horizons<br>UnitedHealthcare<br>UnitedHealthcare Community Plan</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare of Wisconsin, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wisconsin</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Parekh Insurance TPA Private Limited</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maharashtra</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Plan of the River Valley, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Service LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Specialty Benefits, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maine</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Specialty Benefits<br>WorkUp, LLC</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unity Health Network, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UPHT-SCA Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upland Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upland Outpatient Surgical Center, L.P.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urgent Care Holdings, Inc.</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urgent Care MSO, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology Associates of North Texas, P.L.L.C.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USHEALTH Academy, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USHEALTH Administrators, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USHEALTH Advisors, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USHEALTH Career Agency, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USHEALTH Funding, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USHEALTH Group, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USMD Administrative Services, L.L.C.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USMD Affiliated Services</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USMD Physician Services</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USMD ASC IV1, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USMD ASC IV2, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USMD Holdings, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USMD Hospital at Arlington, L.P.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USMD Hospital at Fort Worth, L.P.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USMD Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USMD PPM, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valley Hospital, L.L.C.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valley Physicians Network, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vascular Labs of the Rockies ASC, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vascular Labs of the Rockies, PLLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Verta Management Services, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Via Vitae MSO, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vida Integra S.p.A.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vida Tres S.A.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Virtua-SCA Holdings II, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Virtua-SCA Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vivify Health Canada, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">British Columbia</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vivify Health, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VPay Benefits Corporation</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VPay Intermediate Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VPay, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wake Forest Ambulatory Ventures, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Carolina</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Walnut Creek Endoscopy Center LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Walnut Hill Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wauwatosa Outpatient Surgery Center, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wauwatosa Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wayland Square Surgicare Acquisition, L.P.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhode Island</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wayland Square Surgicare GP, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhode Island</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Waypoint Minnesota PC</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnesota</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WellMed Medical Management of Florida, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum of Hialeah<br>Optum of Little Havana<br>Optum of Red Road<br>Optum of Westchester<br>WellMed at 9th Ave North<br>WellMed at Apollo Beach<br>WellMed at Apollo Beach Blvd.<br>WellMed at Apopka<br>WellMed at Bartow<br>WellMed at Bay Area<br>WellMed at Bayside<br>WellMed at Brandon Regional<br>WellMed at Carrollwood<br>WellMed at Countryway<br>WellMed at Countryway Blvd.<br>WellMed at Cypress Village Blvd.<br>WellMed at Cyprus Village<br>WellMed at Davenport<br>WellMed at Deltona<br>WellMed at Downtown Clearwater<br>WellMed at Dr. Phillips<br>WellMed at Elk Mountain<br>WellMed at Elk Mountain Dr<br>WellMed at Flamingo<br>WellMed at Fort Pierce<br>WellMed at Gunn<br>WellMed at Gunn Hwy.<br>WellMed at Haines City<br>WellMed at Haverford<br>WellMed at Haverford Ave.<br>WellMed at Hillmoor<br>WellMed at Kenwood<br>WellMed at Lake Copeland<br>WellMed at Lakeshore<br>WellMed at Lakewood<br>WellMed at Lawnwood<br>WellMed at Linbaugh<br>WellMed at Linebaugh Ave.<br>WellMed at Longwood<br>WellMed at N. Tamiami Trail<br>WellMed at New Tampa<br>WellMed at North Carrollwood<br>WellMed at North Florida Ave.<br>WellMed at Oak Commons<br>WellMed at Pelican<br>WellMed at Piper<br>WellMed at Plant City - Family Practice Center<br>WellMed at Port St. Lucie West<br>WellMed at Sandlake Commons<br>WellMed at Sanford<br>WellMed at SE Lakeland<br>WellMed at Sebastian<br>WellMed at Semoran<br>WellMed at Sheldon<br>WellMed at Sheldon Rd.<br>WellMed at South Habana<br>WellMed at South Stuart<br>WellMed at Sun City Plaza<br>WellMed at Sun Lake<br>WellMed at Tarpon Springs<br>WellMed at Trinity<br>WellMed at Wesley Chapel<br>WellMed Medical Group</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WellMed Medical Management, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Coast Endoscopy Holdings, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Western Connecticut Orthopedic Surgical Center, LLC</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connecticut</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Westgreen Surgical Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Houston Orthopedic &#38; Spine Surgery Center</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WestHealth JV Holdings, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WestHealth Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnesota</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WESTMED Practice Partners LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wilson Creek Surgical Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Winchester Endoscopy, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Winter Park Surgery Center, L.P.</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Winter Park, LLC</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Woodbury Surgery Center, LLC</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minnesota</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XAS Infusion Suites, Inc.</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diplomat Specialty Infusion Group</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XLHealth Corporation</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XLHealth</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XLHealth Corporation India Private Limited</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Karnataka</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>15
<FILENAME>unhex23112312021.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i53398bd4c7fd4f55be967ca6e0b6ee4e_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 23.1</font></div><div><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">We consent to the incorporation by reference in Registration Statement No. 333-236600 on Form S-3, No. 333-105877 on Form S-4, Nos. 333-174436, 333-174437, 333-193962, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">333-205826, 333-221642, 333-224253, 333-224254, 333-234018, 333-236349, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">333-238854, 333-260604 and 333-260606 on Form S-8 and Post-Effective Amendment on Form S-8 to Registration Statement File No. 333-216153 on Form S-4 of our reports dated February 15, 2022, relating to the financial statements of UnitedHealth Group Incorporated and the effectiveness of UnitedHealth Group's internal control over financial reporting, appearing in this Annual Report on Form 10-K for the year ended December 31, 2021.</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:42.105%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:39pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;S&#47; DELOITTE&#160;&#38; TOUCHE LLP</font></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minneapolis, Minnesota</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 15, 2022</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.1
<SEQUENCE>16
<FILENAME>unhex24112312021.htm
<DESCRIPTION>EX-24.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i55c8aeae198441b5bf6aff97c2249e8f_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 24.1</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">POWER OF ATTORNEY</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Dannette L. Smith, Kuai H. Leong and Faraz A. Choudhry, and each of them, his or her true and lawful attorneys-in-fact and agents, each acting alone, with full power of substitution and resubstitution, to sign, execute and file with the Securities and Exchange Commission (or any other governmental or regulatory authority), for us and in our names in the capacities indicated below, an Annual Report on Form 10-K for the year ended December 31, 2021 for UnitedHealth Group Incorporated, and any and all amendments thereto, with all exhibits and any and all documents required to be filed with respect thereto, granting unto said attorneys-in-fact and agents and each of them, full power and authority to do and to perform each and every act and thing necessary or desirable to be done in and about the premises in order to effectuate the same as fully to all intents and purposes as he or she might or could do if personally present, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, may lawfully do or cause to be done by virtue hereof. </font></div><div><font><br></font></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">IN WITNESS WHEREOF, the undersigned have executed this Power of Attorney as of the date set forth below. </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.147%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; Richard T. Burke</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; F. William McNabb III</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Richard T. Burke</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">F. William McNabb III</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Director</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Director</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dated&#58; February 15, 2022</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dated&#58; February 15, 2022</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; Timothy P. Flynn</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; Valerie C. Montgomery Rice, M.D.</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Timothy P. Flynn</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Valerie C. Montgomery Rice, M.D.</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Director</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Director</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dated&#58; February 15, 2022</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dated&#58; February 15, 2022</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; Paul R. Garcia</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; John H. Noseworthy, M.D.</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Paul R. Garcia</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">John H. Noseworthy, M.D.</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Director</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Director</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dated&#58; February 15, 2022</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dated&#58; February 15, 2022</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; Stephen J. Hemsley</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; Gail R. Wilensky, Ph.D.</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Stephen J. Hemsley</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Gail R. Wilensky, Ph.D.</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Director</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Director</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dated&#58; February 15, 2022</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dated&#58; February 15, 2022</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; Michele J. Hooper</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Michele J. Hooper</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Director</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dated&#58; February 15, 2022</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>17
<FILENAME>unhex31112312021.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i87e412fa9390464bbd7c218b9864dfdf_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.1 </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS PURSUANT TO SECTION 302 OF THE </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SARBANES-OXLEY ACT OF 2002 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Executive Officer </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;I, Andrew P. Witty, certify that&#58;</font></div><div style="margin-top:6pt;padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this report on Form 10-K of UnitedHealth Group Incorporated (the &#8220;registrant&#8221;)&#59;</font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="margin-top:6pt;padding-left:72pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:43.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 15, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NDREW</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> P. W</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ITTY</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Andrew P. Witty<br>Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Financial Officer </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, John F. Rex certify that&#58;</font></div><div style="margin-top:6pt;padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this report on Form 10-K of UnitedHealth Group Incorporated (the &#8220;registrant&#8221;)&#59;</font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="margin-top:6pt;padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:45.967%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.833%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 15, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;    J</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OHN</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> F. R</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EX</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">John F. Rex<br>Executive Vice President and Chief Financial Officer</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>18
<FILENAME>unhex32112312021.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="icc83f0c5324849c3bcd3eb3d09c8831f_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.1 </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350, </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 </font></div><div style="margin-top:4.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Executive Officer </font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the report of UnitedHealth Group Incorporated (the &#8220;Company&#8221;) on Form 10-K for the period ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Andrew P. Witty, certify pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58; </font></div><div style="padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">The Report fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:44.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.220%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 15, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NDREW</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> P. W</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ITTY</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Andrew P. Witty<br>Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Financial Officer </font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the report of UnitedHealth Group Incorporated (the &#8220;Company&#8221;) on Form 10-K for the period ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, John F. Rex, certify pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58; </font></div><div style="padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">The Report fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:44.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.220%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 15, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;    J</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OHN</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> F. R</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EX</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">John F. Rex<br>Executive Vice President and Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>19
<FILENAME>unh-20211231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:7520997a-16df-4345-81d3-205a3336ef85,g:00a8925a-3c66-4bad-89d3-86af384cff11-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:unh="http://www.uhc.com/20211231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.uhc.com/20211231">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="unh-20211231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="unh-20211231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="unh-20211231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="unh-20211231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="AuditorInformation" roleURI="http://www.uhc.com/role/AuditorInformation">
        <link:definition>0101101 - Document - Auditor Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CoverDocument" roleURI="http://www.uhc.com/role/CoverDocument">
        <link:definition>0002001 - Document - Cover Document</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.uhc.com/role/ConsolidatedBalanceSheets">
        <link:definition>1001002 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetParenthetical" roleURI="http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical">
        <link:definition>1002003 - Statement - Consolidated Balance Sheet (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofOperations" roleURI="http://www.uhc.com/role/ConsolidatedStatementsofOperations">
        <link:definition>1003004 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncome" roleURI="http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome">
        <link:definition>1004005 - Statement - Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofChangesinEquity" roleURI="http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity">
        <link:definition>1005006 - Statement - Consolidated Statements of Changes in Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementofChangesinEquityParentheticals" roleURI="http://www.uhc.com/role/ConsolidatedStatementofChangesinEquityParentheticals">
        <link:definition>1006007 - Statement - Consolidated Statement of Changes in Equity (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.uhc.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>1007008 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionofBusinessNotes" roleURI="http://www.uhc.com/role/DescriptionofBusinessNotes">
        <link:definition>2101102 - Disclosure - Description of Business (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes" roleURI="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes">
        <link:definition>2102103 - Disclosure - Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies" roleURI="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies">
        <link:definition>2203201 - Disclosure - Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables" roleURI="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables">
        <link:definition>2304301 - Disclosure - Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails" roleURI="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails">
        <link:definition>2405401 - Disclosure - Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails" roleURI="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails">
        <link:definition>2406402 - Disclosure - Basis of Presentation, Uses of Estimates and Significant Accounting Policies Useful lives for property, equipment and capitalized software (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails" roleURI="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails">
        <link:definition>2407403 - Disclosure - Basis of Presentation, Uses of Estimates and Significant Accounting Policies Redeemable Noncontrolling Interests (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsNotes" roleURI="http://www.uhc.com/role/InvestmentsNotes">
        <link:definition>2108104 - Disclosure - Investments (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsTables" roleURI="http://www.uhc.com/role/InvestmentsTables">
        <link:definition>2309302 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsNarrativeDetails" roleURI="http://www.uhc.com/role/InvestmentsNarrativeDetails">
        <link:definition>2410404 - Disclosure - Investments (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsShortTermandLongTermInvestmentsDetails" roleURI="http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails">
        <link:definition>2411405 - Disclosure - Investments (Short-Term and Long-Term Investments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" roleURI="http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails">
        <link:definition>2412406 - Disclosure - Investments (Amortized Cost and Fair Value of Available-for-Sale Debt Securities by Contractual Maturity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails" roleURI="http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails">
        <link:definition>2413407 - Disclosure - Investments (Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time That Individual Securities Have Been in a Continuous Unrealized Loss Position) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueNotes" roleURI="http://www.uhc.com/role/FairValueNotes">
        <link:definition>2114105 - Disclosure - Fair Value (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueFairValuePolicies" roleURI="http://www.uhc.com/role/FairValueFairValuePolicies">
        <link:definition>2215202 - Disclosure - Fair Value Fair Value (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueTables" roleURI="http://www.uhc.com/role/FairValueTables">
        <link:definition>2316303 - Disclosure - Fair Value (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueNarrativeDetails" roleURI="http://www.uhc.com/role/FairValueNarrativeDetails">
        <link:definition>2417408 - Disclosure - Fair Value (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" roleURI="http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails">
        <link:definition>2418409 - Disclosure - Fair Value (Financial Assets and Liabilities, Measured at Fair Value on a Recurring Basis) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails" roleURI="http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails">
        <link:definition>2419410 - Disclosure - Fair Value (Financial Assets and Liabilities, Not Measured at Fair Value on a Recurring Basis) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandCapitalizedSoftwareNotes" roleURI="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNotes">
        <link:definition>2120106 - Disclosure - Property, Plant, and Capitalized Software (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandCapitalizedSoftwareTables" roleURI="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareTables">
        <link:definition>2321304 - Disclosure - Property, Plant, and Capitalized Software (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandCapitalizedSoftwareNarrativeDetails" roleURI="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNarrativeDetails">
        <link:definition>2422411 - Disclosure - Property, Plant, and Capitalized Software (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails" roleURI="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails">
        <link:definition>2423412 - Disclosure - Property, Plant, and Capitalized Software Property Plant and Equipment Table (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNotes" roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsNotes">
        <link:definition>2124107 - Disclosure - Goodwill and Intangible Assets (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsTables" roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsTables">
        <link:definition>2325305 - Disclosure - Goodwill and Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNarrativeDetails" roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsNarrativeDetails">
        <link:definition>2426413 - Disclosure - Goodwill and Intangible Assets (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails" roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails">
        <link:definition>2427414 - Disclosure - Goodwill and Intangible Assets Changes in the Carrying Amount of Goodwill by Reporting Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails" roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails">
        <link:definition>2428415 - Disclosure - Goodwill and Intangible Assets Gross carrying value, accumulated amortization and net carrying value of intangible assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails" roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails">
        <link:definition>2429416 - Disclosure - Goodwill and Intangible Assets Weighted-average useful lives assigned to finite-lived intangible assets acquired in business combinations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails" roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails">
        <link:definition>2430417 - Disclosure - Goodwill and Intangible Assets Amortization Expense relating to Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalCostsPayableNotes" roleURI="http://www.uhc.com/role/MedicalCostsPayableNotes">
        <link:definition>2131108 - Disclosure - Medical Costs Payable (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalCostsPayableTables" roleURI="http://www.uhc.com/role/MedicalCostsPayableTables">
        <link:definition>2332306 - Disclosure - Medical Costs Payable (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalCostsPayableNarrativeDetails" roleURI="http://www.uhc.com/role/MedicalCostsPayableNarrativeDetails">
        <link:definition>2433418 - Disclosure - Medical Costs Payable (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalCostsPayableRollforwardDetails" roleURI="http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails">
        <link:definition>2434419 - Disclosure - Medical Costs Payable Rollforward (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails" roleURI="http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails">
        <link:definition>2435420 - Disclosure - Medical Costs Payable, Incurred and Paid Medical Cost Development (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShortTermBorrowingsandLongTermDebtNotes" roleURI="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNotes">
        <link:definition>2136109 - Disclosure - Short-Term Borrowings and Long-Term Debt (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShortTermBorrowingsandLongTermDebtTables" roleURI="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtTables">
        <link:definition>2337307 - Disclosure - Short-Term Borrowings and Long-Term Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShortTermBorrowingsandLongTermDebtNarrativeDetails" roleURI="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails">
        <link:definition>2438421 - Disclosure - Short-Term Borrowings and Long-Term Debt (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShortTermBorrowingsandLongTermDebtDetails" roleURI="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails">
        <link:definition>2439422 - Disclosure - Short-Term Borrowings and Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails" roleURI="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails">
        <link:definition>2440423 - Disclosure - Short-Term Borrowings and Long-Term Debt Maturities of commercial paper and long-term debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNotes" roleURI="http://www.uhc.com/role/IncomeTaxesNotes">
        <link:definition>2141110 - Disclosure - Income Taxes (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.uhc.com/role/IncomeTaxesTables">
        <link:definition>2342308 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.uhc.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>2443424 - Disclosure - Income Taxes (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails" roleURI="http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails">
        <link:definition>2444425 - Disclosure - Income Taxes Reconciliation of Provision for Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails" roleURI="http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails">
        <link:definition>2445426 - Disclosure - Income Tax Reconciliation of the tax provision at the U.S. Federal Statutory Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>2446427 - Disclosure - Income Taxes Components of Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails" roleURI="http://www.uhc.com/role/IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails">
        <link:definition>2447428 - Disclosure - Income Taxes Reconciliation of the beginning and ending amount of unrecognized tax benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityNotes" roleURI="http://www.uhc.com/role/ShareholdersEquityNotes">
        <link:definition>2148111 - Disclosure - Shareholders' Equity (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityTables" roleURI="http://www.uhc.com/role/ShareholdersEquityTables">
        <link:definition>2349309 - Disclosure - Shareholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityNarrativeDetails" roleURI="http://www.uhc.com/role/ShareholdersEquityNarrativeDetails">
        <link:definition>2450429 - Disclosure - Shareholders' Equity (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityShareRepurchasesDetails" roleURI="http://www.uhc.com/role/ShareholdersEquityShareRepurchasesDetails">
        <link:definition>2451430 - Disclosure - Shareholders' Equity Share Repurchases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityDividendsDetails" roleURI="http://www.uhc.com/role/ShareholdersEquityDividendsDetails">
        <link:definition>2452431 - Disclosure - Shareholders' Equity Dividends (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationNotes" roleURI="http://www.uhc.com/role/ShareBasedCompensationNotes">
        <link:definition>2153112 - Disclosure - Share-Based Compensation (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationTables" roleURI="http://www.uhc.com/role/ShareBasedCompensationTables">
        <link:definition>2354310 - Disclosure - Share-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationNarrativeDetails" roleURI="http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails">
        <link:definition>2455432 - Disclosure - Share-Based Compensation (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationStockOptionActivityDetails" roleURI="http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails">
        <link:definition>2456433 - Disclosure - Share-Based Compensation (Stock Option Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationRestrictedShareActivityDetails" roleURI="http://www.uhc.com/role/ShareBasedCompensationRestrictedShareActivityDetails">
        <link:definition>2457434 - Disclosure - Share-Based Compensation (Restricted Share Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationOtherShareBasedCompensationDataDetails" roleURI="http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails">
        <link:definition>2458435 - Disclosure - Share-Based Compensation Other Share-Based Compensation Data (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails" roleURI="http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails">
        <link:definition>2459436 - Disclosure - Share-Based Compensation (Share-Based Compensation Principal Fair Value Assumptions) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesNotes" roleURI="http://www.uhc.com/role/CommitmentsandContingenciesNotes">
        <link:definition>2160113 - Disclosure - Commitments and Contingencies (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesTables" roleURI="http://www.uhc.com/role/CommitmentsandContingenciesTables">
        <link:definition>2361311 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesNarrativeDetails" roleURI="http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails">
        <link:definition>2462437 - Disclosure - Commitments and Contingencies (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesFutureLeasePaymentsDetails" roleURI="http://www.uhc.com/role/CommitmentsandContingenciesFutureLeasePaymentsDetails">
        <link:definition>2463438 - Disclosure - Commitments and Contingencies Future Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentFinancialInformationNotes" roleURI="http://www.uhc.com/role/SegmentFinancialInformationNotes">
        <link:definition>2164114 - Disclosure - Segment Financial Information (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentFinancialInformationTables" roleURI="http://www.uhc.com/role/SegmentFinancialInformationTables">
        <link:definition>2365312 - Disclosure - Segment Financial Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentFinancialInformationNarrativeDetails" roleURI="http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails">
        <link:definition>2466439 - Disclosure - Segment Financial Information (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentFinancialInformationDetails" roleURI="http://www.uhc.com/role/SegmentFinancialInformationDetails">
        <link:definition>2467440 - Disclosure - Segment Financial Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleINotes" roleURI="http://www.uhc.com/role/ScheduleINotes">
        <link:definition>2168115 - Disclosure - Schedule I (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIPolicies" roleURI="http://www.uhc.com/role/ScheduleIPolicies">
        <link:definition>2269203 - Disclosure - Schedule I (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleITables" roleURI="http://www.uhc.com/role/ScheduleITables">
        <link:definition>2370313 - Disclosure - Schedule I (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIDetails" roleURI="http://www.uhc.com/role/ScheduleIDetails">
        <link:definition>2471441 - Disclosure - Schedule I (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleICondensedBalanceSheetsDetails" roleURI="http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails">
        <link:definition>2472442 - Disclosure - Schedule I Condensed Balance Sheets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIBalanceSheetDocumentDetails" roleURI="http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails">
        <link:definition>2473443 - Disclosure - Schedule I Balance Sheet Document (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleICondensedStatementofComprehensiveIncomeDetails" roleURI="http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails">
        <link:definition>2474444 - Disclosure - Schedule I Condensed Statement of Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIStatementofCashFlowsDetails" roleURI="http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails">
        <link:definition>2475445 - Disclosure - Schedule I Statement of Cash Flows (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails" roleURI="http://www.uhc.com/role/ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails">
        <link:definition>2476446 - Disclosure - Schedule I Maturities of Short-Term Borrowings and Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="unh_A3050NotesDueMay2041Member" abstract="true" name="A3050NotesDueMay2041Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A3.375notesdueApril2027Member" abstract="true" name="A3.375notesdueApril2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_LossofParentCompany" abstract="false" name="LossofParentCompany" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_CapitalizedsoftwareMember" abstract="true" name="CapitalizedsoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A1250NotesDueJanuary2026Member" abstract="true" name="A1250NotesDueJanuary2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A2750NotesDueMay2040Member" abstract="true" name="A2750NotesDueMay2040Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days" abstract="false" name="ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="unh_ThreeYear56BillionCreditFacilityMember" abstract="true" name="ThreeYear56BillionCreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_ScheduleIBalanceSheetParentheticalAbstract" abstract="true" name="ScheduleIBalanceSheetParentheticalAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="unh_A3.450notesdueJanuary2027Member" abstract="true" name="A3.450notesdueJanuary2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_AuditorInformationAbstract" abstract="true" name="AuditorInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="unh_ScheduleIMaturitiesofCommercialPaperandLongTermDebtAbstract" abstract="true" name="ScheduleIMaturitiesofCommercialPaperandLongTermDebtAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="unh_EquityinNetAssetsofSubsidiaries" abstract="false" name="EquityinNetAssetsofSubsidiaries" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_A3.500notesdueFebruary2024Member" abstract="true" name="A3.500notesdueFebruary2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A2875NotesDueMarch2023Member" abstract="true" name="A2875NotesDueMarch2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_Capitalcontributionstosubsidiaries" abstract="false" name="Capitalcontributionstosubsidiaries" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_PharmaceuticalManufacturerRebatesReceivableMember" abstract="true" name="PharmaceuticalManufacturerRebatesReceivableMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A0550NotesDueMay2024Member" abstract="true" name="A0550NotesDueMay2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A4.375notesdueMarch2042Member" abstract="true" name="A4.375notesdueMarch2042Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A2900NotesDueMay2050Member" abstract="true" name="A2900NotesDueMay2050Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_PharmaceuticalmanufacturerrebatesreceivableAxis" abstract="true" name="PharmaceuticalmanufacturerrebatesreceivableAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="unh_AARPAssetsUnderManagementPolicyTextBlock" abstract="false" name="AARPAssetsUnderManagementPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="unh_A6.875notesdueFebruary2038Member" abstract="true" name="A6.875notesdueFebruary2038Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A2300NotesDueMay2031Member" abstract="true" name="A2300NotesDueMay2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_ShareholdersEquityAbstract" abstract="true" name="ShareholdersEquityAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="unh_ProductsandservicesMember" abstract="true" name="ProductsandservicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A2.875notesdueAugust2029Member" abstract="true" name="A2.875notesdueAugust2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A2750NotesDueFebruary2023Member" abstract="true" name="A2750NotesDueFebruary2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_FiveYear56BillionCreditFacilityMember" abstract="true" name="FiveYear56BillionCreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_PharmaceuticalmanufacturerrebatesreceivableDomain" abstract="true" name="PharmaceuticalmanufacturerrebatesreceivableDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_DeferredTaxLiabilityOtherForeign" abstract="false" name="DeferredTaxLiabilityOtherForeign" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_InvestmentLineItems" abstract="true" name="InvestmentLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="unh_MedicarePartDPharmacyBenefitsContractAxis" abstract="true" name="MedicarePartDPharmacyBenefitsContractAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="unh_A3350NotesDueJuly2022Member" abstract="true" name="A3350NotesDueJuly2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_UsefulLifeMember" abstract="true" name="UsefulLifeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_DebtAbstract" abstract="true" name="DebtAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="unh_CoverPageAbstract" abstract="true" name="CoverPageAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="unh_A3950NotesDueOctober2042Member" abstract="true" name="A3950NotesDueOctober2042Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_IntersegmentMember" abstract="true" name="IntersegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A2000NotesDueMay2030Member" abstract="true" name="A2000NotesDueMay2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_MedicarePartDPharmacyBenefitsContractDomain" abstract="true" name="MedicarePartDPharmacyBenefitsContractDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_ShareRepurchasesTable" abstract="true" name="ShareRepurchasesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="unh_A2.875notesdueMarch2022Member" abstract="true" name="A2.875notesdueMarch2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A3.500notesdueAugust2039Member" abstract="true" name="A3.500notesdueAugust2039Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A3.700notesdueDecember2025Member" abstract="true" name="A3.700notesdueDecember2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_DeferredTaxAssetOtherForeign" abstract="false" name="DeferredTaxAssetOtherForeign" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_FairValueAbstract" abstract="true" name="FairValueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="unh_MedicarePartDReceivablesMember" abstract="true" name="MedicarePartDReceivablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_ZeroCouponNotesDueNovember2022Member" abstract="true" name="ZeroCouponNotesDueNovember2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_DeferredTaxAssetOtherDomestic" abstract="false" name="DeferredTaxAssetOtherDomestic" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_A4.625notesdueNovember2041Member" abstract="true" name="A4.625notesdueNovember2041Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_RedeemableNoncontrollingInterestsMember" abstract="true" name="RedeemableNoncontrollingInterestsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_InvestmentsGrossUnrealizedGains" abstract="false" name="InvestmentsGrossUnrealizedGains" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_NOLsExpirationBeginning2022Through2037Member" abstract="true" name="NOLsExpirationBeginning2022Through2037Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_OptuminsightMember" abstract="true" name="OptuminsightMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_DividendFrequencyDomain" abstract="true" name="DividendFrequencyDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A3.875notesdueDecember2028Member" abstract="true" name="A3.875notesdueDecember2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_TrademarksandTechnologyMember" abstract="true" name="TrademarksandTechnologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract" abstract="false" name="NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="unh_MedicalCostsAndMedicalCostsPayableDomain" abstract="true" name="MedicalCostsAndMedicalCostsPayableDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A2.375notesdueAugust2024Member" abstract="true" name="A2.375notesdueAugust2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_InvestmentsGrossUnrealizedLosses" abstract="false" name="InvestmentsGrossUnrealizedLosses" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_A2.125notesdueMarch2021Member" abstract="true" name="A2.125notesdueMarch2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_CreditFacilityNameAxis" abstract="true" name="CreditFacilityNameAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="unh_A3250NotesDueMay2051Member" abstract="true" name="A3250NotesDueMay2051Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_DividendFrequencyAxis" abstract="true" name="DividendFrequencyAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="unh_ScheduleIAbstract" abstract="true" name="ScheduleIAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="unh_EmployeeStockPurchasePlanESPPMember" abstract="true" name="EmployeeStockPurchasePlanESPPMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_CMSMember" abstract="true" name="CMSMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A3.850notesdueJune2028Member" abstract="true" name="A3.850notesdueJune2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A4.250notesdueApril2047Member" abstract="true" name="A4.250notesdueApril2047Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A3.750notesdueJuly2025Member" abstract="true" name="A3.750notesdueJuly2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_OtherShareBasedCompensationDataAbstract" abstract="true" name="OtherShareBasedCompensationDataAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="unh_A3.750notesdueOctober2047Member" abstract="true" name="A3.750notesdueOctober2047Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A3.875notesdueAugust2059Member" abstract="true" name="A3.875notesdueAugust2059Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A3.700notesdueAugust2049Member" abstract="true" name="A3.700notesdueAugust2049Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_RevenuesMember" abstract="true" name="RevenuesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A3.100notesdueMarch2026Member" abstract="true" name="A3.100notesdueMarch2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_DeferredTaxAssetsLeaseLiability" abstract="false" name="DeferredTaxAssetsLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_A3.375notesdueNovember2021Member" abstract="true" name="A3.375notesdueNovember2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_SuretyBondsOutstanding" abstract="false" name="SuretyBondsOutstanding" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="unh_A4.200notesdueJanuary2047Member" abstract="true" name="A4.200notesdueJanuary2047Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_IncomeTaxAbstract" abstract="true" name="IncomeTaxAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="unh_A364Day38BillionCreditFacilityMember" abstract="true" name="A364Day38BillionCreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_MedicalCostsAndMedicalCostsPayableAxis" abstract="true" name="MedicalCostsAndMedicalCostsPayableAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="unh_DescriptionofBusinessAbstract" abstract="true" name="DescriptionofBusinessAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="unh_TotalOptumMember" abstract="true" name="TotalOptumMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_ShareRepurchasesTableLineItems" abstract="true" name="ShareRepurchasesTableLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="unh_A3.150notesdueJune2021Member" abstract="true" name="A3.150notesdueJune2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_StockOptionsandSARsMember" abstract="true" name="StockOptionsandSARsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers" abstract="false" name="DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="unh_A4.750notesdueJuly2045Member" abstract="true" name="A4.750notesdueJuly2045Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_OptumhealthMember" abstract="true" name="OptumhealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A2875NotesDueDecember2021Member" abstract="true" name="A2875NotesDueDecember2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_OptumrxMember" abstract="true" name="OptumrxMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_ExternalCustomersMember" abstract="true" name="ExternalCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A6625NotesDueNovember2037Member" abstract="true" name="A6625NotesDueNovember2037Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A5.700notesdueOctober2040Member" abstract="true" name="A5.700notesdueOctober2040Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_NOLsIndefiniteCarryforwardMember" abstract="true" name="NOLsIndefiniteCarryforwardMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_FloatingratenotesdueJune2021Member" abstract="true" name="FloatingratenotesdueJune2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A4.250notesdueJune2048Member" abstract="true" name="A4.250notesdueJune2048Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_InvestmentsAmortizedCost" abstract="false" name="InvestmentsAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_A2.375notesdueOctober2022MemberMember" abstract="true" name="A2.375notesdueOctober2022MemberMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign" abstract="false" name="DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_A5.800notesdueMarch2036Member" abstract="true" name="A5.800notesdueMarch2036Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A5.950notesdueFebruary2041Member" abstract="true" name="A5.950notesdueFebruary2041Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_CreditFacilityNameDomain" abstract="true" name="CreditFacilityNameDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_UnitedhealthcareMember" abstract="true" name="UnitedhealthcareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A3.500notesdueJune2023Member" abstract="true" name="A3.500notesdueJune2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_BasisofpresentationAbstract" abstract="true" name="BasisofpresentationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis" abstract="false" name="FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_A4.700notesdueFebruary2021Member" abstract="true" name="A4.700notesdueFebruary2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_InvestmentTable" abstract="true" name="InvestmentTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="unh_A6500NotesDueJune2037Member" abstract="true" name="A6500NotesDueJune2037Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_ExtraordinaryDividendsMember" abstract="true" name="ExtraordinaryDividendsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet" abstract="false" name="PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_A1150NotesDueMay2026Member" abstract="true" name="A1150NotesDueMay2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities" abstract="false" name="DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_A3125NotesDueMay2060Member" abstract="true" name="A3125NotesDueMay2060Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_GoodwillandIntangibleAssetsAbstract" abstract="true" name="GoodwillandIntangibleAssetsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="unh_DisclosureonGeographicAreasPercentageofLongLivedAssets" abstract="false" name="DisclosureonGeographicAreasPercentageofLongLivedAssets" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="unh_OtherLiabilitiesCurrentPolicyTextBlock" abstract="false" name="OtherLiabilitiesCurrentPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="unh_AarpAssetsUnderManagement" abstract="false" name="AarpAssetsUnderManagement" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_A2.950notesdueOctober2027Member" abstract="true" name="A2.950notesdueOctober2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_DeferredTaxLiabilityOtherDomestic" abstract="false" name="DeferredTaxLiabilityOtherDomestic" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="unh_A4250NotesDueMarch2043Member" abstract="true" name="A4250NotesDueMarch2043Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A4.450notesdueDecember2048Member" abstract="true" name="A4.450notesdueDecember2048Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="unh_A4.625notesdueJuly2035Member" abstract="true" name="A4.625notesdueJuly2035Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>20
<FILENAME>unh-20211231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:7520997a-16df-4345-81d3-205a3336ef85,g:00a8925a-3c66-4bad-89d3-86af384cff11-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.uhc.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="unh-20211231.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.uhc.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_8bc85dfd-0a02-47cb-86eb-f8c273e4f8de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_5ab534e3-a80a-471e-a0c4-ce836b2e752f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8bc85dfd-0a02-47cb-86eb-f8c273e4f8de" xlink:to="loc_us-gaap_AssetsCurrent_5ab534e3-a80a-471e-a0c4-ce836b2e752f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_747dc609-588d-478a-b576-b405d3dc8ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8bc85dfd-0a02-47cb-86eb-f8c273e4f8de" xlink:to="loc_us-gaap_LongTermInvestments_747dc609-588d-478a-b576-b405d3dc8ad1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_78332cec-7b79-42fb-a353-684fbb619681" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8bc85dfd-0a02-47cb-86eb-f8c273e4f8de" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_78332cec-7b79-42fb-a353-684fbb619681" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_acbc6b3f-8aec-47cb-87d9-765ad5730368" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8bc85dfd-0a02-47cb-86eb-f8c273e4f8de" xlink:to="loc_us-gaap_Goodwill_acbc6b3f-8aec-47cb-87d9-765ad5730368" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2010b45b-ca40-4bcd-9783-963211d75dd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8bc85dfd-0a02-47cb-86eb-f8c273e4f8de" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2010b45b-ca40-4bcd-9783-963211d75dd5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_e5d09e0c-0e96-43f8-8d75-cc326f126818" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8bc85dfd-0a02-47cb-86eb-f8c273e4f8de" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_e5d09e0c-0e96-43f8-8d75-cc326f126818" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6ba9e1ed-4cf4-4e7f-aa07-b2806db98ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_29976f06-43d6-4709-b32c-4edf8d28fd9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6ba9e1ed-4cf4-4e7f-aa07-b2806db98ebf" xlink:to="loc_us-gaap_PreferredStockValue_29976f06-43d6-4709-b32c-4edf8d28fd9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_a2e0456a-7283-41f2-9e7e-a098d7533a24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6ba9e1ed-4cf4-4e7f-aa07-b2806db98ebf" xlink:to="loc_us-gaap_CommonStockValue_a2e0456a-7283-41f2-9e7e-a098d7533a24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_c69ab8fa-f85e-4cb6-8912-048bb3288605" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6ba9e1ed-4cf4-4e7f-aa07-b2806db98ebf" xlink:to="loc_us-gaap_AdditionalPaidInCapital_c69ab8fa-f85e-4cb6-8912-048bb3288605" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_577fea0c-9315-4142-a409-9bac798f26dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6ba9e1ed-4cf4-4e7f-aa07-b2806db98ebf" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_577fea0c-9315-4142-a409-9bac798f26dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_848a7ad1-7955-44ce-a658-a3140a43c67a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6ba9e1ed-4cf4-4e7f-aa07-b2806db98ebf" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_848a7ad1-7955-44ce-a658-a3140a43c67a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_c607a2cd-c66e-4cf4-a546-0aee83d1165a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6ba9e1ed-4cf4-4e7f-aa07-b2806db98ebf" xlink:to="loc_us-gaap_MinorityInterest_c607a2cd-c66e-4cf4-a546-0aee83d1165a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_d2d0518c-7e80-496c-82fc-b30bbcad680f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_b312e723-571b-47bf-a8e5-f21d0f36c81e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d2d0518c-7e80-496c-82fc-b30bbcad680f" xlink:to="loc_us-gaap_LiabilitiesCurrent_b312e723-571b-47bf-a8e5-f21d0f36c81e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_7de94ab3-37f4-4222-9302-981b6c754b17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d2d0518c-7e80-496c-82fc-b30bbcad680f" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_7de94ab3-37f4-4222-9302-981b6c754b17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_ee8b96de-ad1f-40af-8a66-fcc92adddfe1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d2d0518c-7e80-496c-82fc-b30bbcad680f" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_ee8b96de-ad1f-40af-8a66-fcc92adddfe1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_2cc97b6e-c756-4a37-9e32-85aa818aa19f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d2d0518c-7e80-496c-82fc-b30bbcad680f" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_2cc97b6e-c756-4a37-9e32-85aa818aa19f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_08ad3b05-2c23-4ed4-bd3e-4ea973fdecac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d3485a44-a5e9-4d6f-b12c-911c01a80ad7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_08ad3b05-2c23-4ed4-bd3e-4ea973fdecac" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d3485a44-a5e9-4d6f-b12c-911c01a80ad7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_49324739-f5b5-4da9-bfab-1df898e46903" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_08ad3b05-2c23-4ed4-bd3e-4ea973fdecac" xlink:to="loc_us-gaap_ShortTermInvestments_49324739-f5b5-4da9-bfab-1df898e46903" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_cbb6a60d-bece-43ce-8e04-1428dbcbec44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_08ad3b05-2c23-4ed4-bd3e-4ea973fdecac" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_cbb6a60d-bece-43ce-8e04-1428dbcbec44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_bf158814-66d9-4054-bf55-8a3e0deea6ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_08ad3b05-2c23-4ed4-bd3e-4ea973fdecac" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_bf158814-66d9-4054-bf55-8a3e0deea6ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_AarpAssetsUnderManagement_4c7f1b7c-c481-4282-ad02-0ae7aac9327a" xlink:href="unh-20211231.xsd#unh_AarpAssetsUnderManagement"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_08ad3b05-2c23-4ed4-bd3e-4ea973fdecac" xlink:to="loc_unh_AarpAssetsUnderManagement_4c7f1b7c-c481-4282-ad02-0ae7aac9327a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_deb830b9-0ed7-44f5-835c-2c3667046777" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_08ad3b05-2c23-4ed4-bd3e-4ea973fdecac" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_deb830b9-0ed7-44f5-835c-2c3667046777" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_3bd7daa7-dfe1-4c5b-b654-1718c40b30a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_9eee2572-ee7e-4ce4-b490-778beaa6d363" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3bd7daa7-dfe1-4c5b-b654-1718c40b30a1" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_9eee2572-ee7e-4ce4-b490-778beaa6d363" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_a2697cdf-ec73-47e2-86cc-65caf53dbd3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3bd7daa7-dfe1-4c5b-b654-1718c40b30a1" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_a2697cdf-ec73-47e2-86cc-65caf53dbd3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_6508fc55-6508-43e9-be69-f1e98f9dde31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3bd7daa7-dfe1-4c5b-b654-1718c40b30a1" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_6508fc55-6508-43e9-be69-f1e98f9dde31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_d67d5a1b-d6c8-4a05-944b-ff56d2169ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3bd7daa7-dfe1-4c5b-b654-1718c40b30a1" xlink:to="loc_us-gaap_LongTermDebtCurrent_d67d5a1b-d6c8-4a05-944b-ff56d2169ae6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_5b917172-3edc-4f09-b6f6-59862fd80664" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3bd7daa7-dfe1-4c5b-b654-1718c40b30a1" xlink:to="loc_us-gaap_DeferredRevenueCurrent_5b917172-3edc-4f09-b6f6-59862fd80664" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_0387ae98-6990-440b-9f15-937c1da5662d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_eb908edd-23d6-4fe1-93ac-b980835b15b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_0387ae98-6990-440b-9f15-937c1da5662d" xlink:to="loc_us-gaap_Liabilities_eb908edd-23d6-4fe1-93ac-b980835b15b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_f430c065-90e4-46b3-aac8-4fce142b6a6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_0387ae98-6990-440b-9f15-937c1da5662d" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_f430c065-90e4-46b3-aac8-4fce142b6a6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e2010f59-8f30-44ed-9d68-5884ec540aad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_0387ae98-6990-440b-9f15-937c1da5662d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e2010f59-8f30-44ed-9d68-5884ec540aad" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="unh-20211231.xsd#ConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://www.uhc.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_da92f8bd-2f9b-41df-b45e-dc4ee4f9f93f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c36563b7-8eac-455e-b783-8e648edf6f18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_da92f8bd-2f9b-41df-b45e-dc4ee4f9f93f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c36563b7-8eac-455e-b783-8e648edf6f18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_07959e62-df30-471a-ba00-839b6bebbd73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_da92f8bd-2f9b-41df-b45e-dc4ee4f9f93f" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_07959e62-df30-471a-ba00-839b6bebbd73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_2dfcf85e-356b-4278-8311-22c0174646c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4d9ac892-40b6-4fce-81a8-028d9924a4bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_2dfcf85e-356b-4278-8311-22c0174646c9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4d9ac892-40b6-4fce-81a8-028d9924a4bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c51de3bb-e173-4dc0-b305-96ad70fff157" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_2dfcf85e-356b-4278-8311-22c0174646c9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c51de3bb-e173-4dc0-b305-96ad70fff157" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4678209a-8424-488a-8361-23f6fa585562" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a91f6397-a1ed-4113-b8fc-da5e20a724b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_4678209a-8424-488a-8361-23f6fa585562" xlink:to="loc_us-gaap_ProfitLoss_a91f6397-a1ed-4113-b8fc-da5e20a724b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_aa653825-6daa-4d40-b6fe-b61a84c6f1b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_4678209a-8424-488a-8361-23f6fa585562" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_aa653825-6daa-4d40-b6fe-b61a84c6f1b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_c093fcbd-d5f4-4693-94a6-da46dbb81442" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_15b6b395-1fd2-45b1-a65d-cf115e2c539f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_c093fcbd-d5f4-4693-94a6-da46dbb81442" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_15b6b395-1fd2-45b1-a65d-cf115e2c539f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_63af4973-7ce2-4800-8a82-a616e2162479" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_c093fcbd-d5f4-4693-94a6-da46dbb81442" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_63af4973-7ce2-4800-8a82-a616e2162479" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_fe5312fd-0128-4ad4-b651-871e1ae533e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_c093fcbd-d5f4-4693-94a6-da46dbb81442" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_fe5312fd-0128-4ad4-b651-871e1ae533e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_c9c2084a-e106-4688-9c52-9b1750b9268e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_c093fcbd-d5f4-4693-94a6-da46dbb81442" xlink:to="loc_us-gaap_DepreciationAndAmortization_c9c2084a-e106-4688-9c52-9b1750b9268e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_0283a58d-26e7-43b8-9d56-698732ec896a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_e8ab191b-fc66-442a-b84c-e3fbafe408dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_0283a58d-26e7-43b8-9d56-698732ec896a" xlink:to="loc_us-gaap_PremiumsEarnedNet_e8ab191b-fc66-442a-b84c-e3fbafe408dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5df16836-557a-46c2-852c-016a28065d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_0283a58d-26e7-43b8-9d56-698732ec896a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5df16836-557a-46c2-852c-016a28065d7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_4ed6d2d0-e896-48e7-bd5d-273035783ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_0283a58d-26e7-43b8-9d56-698732ec896a" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_4ed6d2d0-e896-48e7-bd5d-273035783ed1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6404dd01-eb2d-4602-a3d7-9665aba3460e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_fcc2fcda-c1a9-4a08-beb9-389238c020dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_6404dd01-eb2d-4602-a3d7-9665aba3460e" xlink:to="loc_us-gaap_Revenues_fcc2fcda-c1a9-4a08-beb9-389238c020dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_eddfd74d-d166-4184-9b6c-3556c4bcdb18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_6404dd01-eb2d-4602-a3d7-9665aba3460e" xlink:to="loc_us-gaap_CostsAndExpenses_eddfd74d-d166-4184-9b6c-3556c4bcdb18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a945266d-0e61-4cdd-9c4c-ab1cb21b2727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a750f4bd-bd8e-4660-a37a-798f9044f940" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a945266d-0e61-4cdd-9c4c-ab1cb21b2727" xlink:to="loc_us-gaap_OperatingIncomeLoss_a750f4bd-bd8e-4660-a37a-798f9044f940" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_c47aa910-0898-46cc-b551-784faafbc483" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a945266d-0e61-4cdd-9c4c-ab1cb21b2727" xlink:to="loc_us-gaap_InterestExpense_c47aa910-0898-46cc-b551-784faafbc483" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="unh-20211231.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_52d8e86a-9cf8-49f8-971f-565c2930f0a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_05e80d16-4d83-42bf-bac7-19afcc1cd283" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_52d8e86a-9cf8-49f8-971f-565c2930f0a6" xlink:to="loc_us-gaap_ProfitLoss_05e80d16-4d83-42bf-bac7-19afcc1cd283" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3b160907-d913-4813-ac02-358158fbd8a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_52d8e86a-9cf8-49f8-971f-565c2930f0a6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3b160907-d913-4813-ac02-358158fbd8a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_89e4754e-8496-49d2-899f-ad8eba8544cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_2e5c9d03-bd39-4600-a0dd-2191187813ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_89e4754e-8496-49d2-899f-ad8eba8544cd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_2e5c9d03-bd39-4600-a0dd-2191187813ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_cdc2b5ed-79fb-4ede-849a-4a9d84080877" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_89e4754e-8496-49d2-899f-ad8eba8544cd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_cdc2b5ed-79fb-4ede-849a-4a9d84080877" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_303f0b61-0017-4497-b56e-e53b93e4807e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_6a08defd-1fe0-43f5-acab-285c91501122" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_303f0b61-0017-4497-b56e-e53b93e4807e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_6a08defd-1fe0-43f5-acab-285c91501122" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_b11671da-e693-472a-874a-1cd68c55a959" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_303f0b61-0017-4497-b56e-e53b93e4807e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_b11671da-e693-472a-874a-1cd68c55a959" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_23b3a278-0639-4196-8183-1b1f7b3ba9f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_303f0b61-0017-4497-b56e-e53b93e4807e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_23b3a278-0639-4196-8183-1b1f7b3ba9f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_080feb9d-738a-4953-8753-d4178c99a92d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2f844e82-4ae4-4830-945f-70696094cec3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_080feb9d-738a-4953-8753-d4178c99a92d" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2f844e82-4ae4-4830-945f-70696094cec3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2c2c3d89-a52f-4c18-ab1b-defef9b71680" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_080feb9d-738a-4953-8753-d4178c99a92d" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2c2c3d89-a52f-4c18-ab1b-defef9b71680" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_9702a15c-b19c-45f4-b370-b2ec33ef2498" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_6130a975-fae5-4fe8-982e-589e09aab2b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_9702a15c-b19c-45f4-b370-b2ec33ef2498" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_6130a975-fae5-4fe8-982e-589e09aab2b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_ff369a9f-a65b-4fdb-bd25-5249b5d96b10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_9702a15c-b19c-45f4-b370-b2ec33ef2498" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_ff369a9f-a65b-4fdb-bd25-5249b5d96b10" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="unh-20211231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.uhc.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8552bd28-9fef-4ab4-83f2-bff1be98d025" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_169273a7-140b-4a0f-8c8b-7be8ece5ca82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8552bd28-9fef-4ab4-83f2-bff1be98d025" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_169273a7-140b-4a0f-8c8b-7be8ece5ca82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_46c128be-0692-465c-a45f-9676d5916463" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8552bd28-9fef-4ab4-83f2-bff1be98d025" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_46c128be-0692-465c-a45f-9676d5916463" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c2d39723-d2f4-4d4a-8e83-937378f45390" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8552bd28-9fef-4ab4-83f2-bff1be98d025" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c2d39723-d2f4-4d4a-8e83-937378f45390" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_e6a73c1a-d01c-48a9-acc1-88151774ef43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8552bd28-9fef-4ab4-83f2-bff1be98d025" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_e6a73c1a-d01c-48a9-acc1-88151774ef43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_211bd2f3-1957-4920-b007-1941491ee018" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_4619b410-f81a-494d-bbd9-1a8557ae4201" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_211bd2f3-1957-4920-b007-1941491ee018" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_4619b410-f81a-494d-bbd9-1a8557ae4201" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_629d7172-a9f5-4a3b-98dc-4d6c148a3418" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_211bd2f3-1957-4920-b007-1941491ee018" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_629d7172-a9f5-4a3b-98dc-4d6c148a3418" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_53de6da9-d6a6-4cae-a31b-90b864b6882e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_211bd2f3-1957-4920-b007-1941491ee018" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_53de6da9-d6a6-4cae-a31b-90b864b6882e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_8a24aa59-a3ca-461c-a4d4-59f697fcb2ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_211bd2f3-1957-4920-b007-1941491ee018" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_8a24aa59-a3ca-461c-a4d4-59f697fcb2ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e84a7e0f-64af-4427-b512-e07779b18d96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_211bd2f3-1957-4920-b007-1941491ee018" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e84a7e0f-64af-4427-b512-e07779b18d96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_5c817116-163a-4135-b1c6-634a29319032" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_211bd2f3-1957-4920-b007-1941491ee018" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_5c817116-163a-4135-b1c6-634a29319032" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_192eaac3-b96b-44eb-b977-1cea73e88e98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_2b266cec-474d-4997-a409-6fc261039120" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_192eaac3-b96b-44eb-b977-1cea73e88e98" xlink:to="loc_us-gaap_ProfitLoss_2b266cec-474d-4997-a409-6fc261039120" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_ee38826f-aa45-4eaf-8872-a47a8c61e29a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_192eaac3-b96b-44eb-b977-1cea73e88e98" xlink:to="loc_us-gaap_DepreciationAndAmortization_ee38826f-aa45-4eaf-8872-a47a8c61e29a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c99bea62-dfed-4c0b-baa7-4bf4802c469a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_192eaac3-b96b-44eb-b977-1cea73e88e98" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c99bea62-dfed-4c0b-baa7-4bf4802c469a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_d268f4ac-048b-4602-ad0d-9eaa34ef9fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_192eaac3-b96b-44eb-b977-1cea73e88e98" xlink:to="loc_us-gaap_ShareBasedCompensation_d268f4ac-048b-4602-ad0d-9eaa34ef9fb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_29674d46-b219-46ff-bf29-8a6d3a1e072d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_192eaac3-b96b-44eb-b977-1cea73e88e98" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_29674d46-b219-46ff-bf29-8a6d3a1e072d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_f83ef32e-e73d-483f-9aae-1435c6bb64b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_192eaac3-b96b-44eb-b977-1cea73e88e98" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_f83ef32e-e73d-483f-9aae-1435c6bb64b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_1d7e3dac-203c-4030-8f98-29aac9788cd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_192eaac3-b96b-44eb-b977-1cea73e88e98" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_1d7e3dac-203c-4030-8f98-29aac9788cd7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_fecaf22a-8831-4bf0-a1a9-cd0eb093336d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_192eaac3-b96b-44eb-b977-1cea73e88e98" xlink:to="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_fecaf22a-8831-4bf0-a1a9-cd0eb093336d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_15ba38f0-cc3d-4ae5-97ea-ddf5d9daec59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_192eaac3-b96b-44eb-b977-1cea73e88e98" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_15ba38f0-cc3d-4ae5-97ea-ddf5d9daec59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_66c546e6-f739-4212-bd53-ab7f411895ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_192eaac3-b96b-44eb-b977-1cea73e88e98" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_66c546e6-f739-4212-bd53-ab7f411895ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b0dad191-dfa5-4361-ab4a-f9544075f55e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_f7a42171-efa9-47de-8af5-e99176fc150c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b0dad191-dfa5-4361-ab4a-f9544075f55e" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_f7a42171-efa9-47de-8af5-e99176fc150c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_35b380d1-ccdf-4622-a843-4d47bcec9991" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b0dad191-dfa5-4361-ab4a-f9544075f55e" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_35b380d1-ccdf-4622-a843-4d47bcec9991" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_07a782d6-667b-4db8-a466-315c6d7baeb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b0dad191-dfa5-4361-ab4a-f9544075f55e" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_07a782d6-667b-4db8-a466-315c6d7baeb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_d70f263c-8705-4716-92f8-43c7a1c78bd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b0dad191-dfa5-4361-ab4a-f9544075f55e" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_d70f263c-8705-4716-92f8-43c7a1c78bd8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_63a54e9a-dd0c-4475-9cb6-5bc506570fab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b0dad191-dfa5-4361-ab4a-f9544075f55e" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_63a54e9a-dd0c-4475-9cb6-5bc506570fab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_8b1474ce-4b54-4d2c-b73d-e69fb31030de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b0dad191-dfa5-4361-ab4a-f9544075f55e" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_8b1474ce-4b54-4d2c-b73d-e69fb31030de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeposits_1329144b-68d8-4598-8e6e-7bbcad8bc32a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeposits"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b0dad191-dfa5-4361-ab4a-f9544075f55e" xlink:to="loc_us-gaap_IncreaseDecreaseInDeposits_1329144b-68d8-4598-8e6e-7bbcad8bc32a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_975524ea-d417-480b-a2f4-69054e390ef2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b0dad191-dfa5-4361-ab4a-f9544075f55e" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_975524ea-d417-480b-a2f4-69054e390ef2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_d5e0840c-2eeb-4f64-b06d-008c5cbfcd51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b0dad191-dfa5-4361-ab4a-f9544075f55e" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_d5e0840c-2eeb-4f64-b06d-008c5cbfcd51" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#InvestmentsShortTermandLongTermInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_dd924d1b-0fb9-4040-91c1-2ed0a1d34312" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_08affac5-32bf-4b8c-a473-6d0586996caf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_dd924d1b-0fb9-4040-91c1-2ed0a1d34312" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_08affac5-32bf-4b8c-a473-6d0586996caf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_14dfeb22-f3d2-4a14-8aa4-53baac3f4de5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_dd924d1b-0fb9-4040-91c1-2ed0a1d34312" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_14dfeb22-f3d2-4a14-8aa4-53baac3f4de5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ffa9d33c-0d9b-4c06-9b36-2f84b3a293a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_dd924d1b-0fb9-4040-91c1-2ed0a1d34312" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ffa9d33c-0d9b-4c06-9b36-2f84b3a293a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_InvestmentsAmortizedCost_7d6b012d-0b0c-4a5a-b4e9-381f03ccf89d" xlink:href="unh-20211231.xsd#unh_InvestmentsAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_InvestmentsGrossUnrealizedGains_67712342-9d47-4055-a902-eeab7981561c" xlink:href="unh-20211231.xsd#unh_InvestmentsGrossUnrealizedGains"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_unh_InvestmentsAmortizedCost_7d6b012d-0b0c-4a5a-b4e9-381f03ccf89d" xlink:to="loc_unh_InvestmentsGrossUnrealizedGains_67712342-9d47-4055-a902-eeab7981561c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_InvestmentsGrossUnrealizedLosses_44662200-e602-4cf9-aac5-d2e568a5b0f2" xlink:href="unh-20211231.xsd#unh_InvestmentsGrossUnrealizedLosses"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_unh_InvestmentsAmortizedCost_7d6b012d-0b0c-4a5a-b4e9-381f03ccf89d" xlink:to="loc_unh_InvestmentsGrossUnrealizedLosses_44662200-e602-4cf9-aac5-d2e568a5b0f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_cae4d917-f75f-4538-9463-150aa62a0a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_unh_InvestmentsAmortizedCost_7d6b012d-0b0c-4a5a-b4e9-381f03ccf89d" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_cae4d917-f75f-4538-9463-150aa62a0a3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_43de81a4-374d-4005-8562-b18d159b4502" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_def34060-715d-4a35-8264-7b7edb4ecbd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecurities_43de81a4-374d-4005-8562-b18d159b4502" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_def34060-715d-4a35-8264-7b7edb4ecbd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_211bd2ee-59bd-4966-92be-a63eacfa0586" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecurities_43de81a4-374d-4005-8562-b18d159b4502" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_211bd2ee-59bd-4966-92be-a63eacfa0586" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_c2fa9d89-1466-4e4a-b947-575bbb615308" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecurities_43de81a4-374d-4005-8562-b18d159b4502" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_c2fa9d89-1466-4e4a-b947-575bbb615308" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails"/>
  <link:calculationLink xlink:role="http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_e35cd991-3855-4d79-a2ee-9874d56bc51e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_3fbf80d9-de6a-4ec4-a78f-ed5078f862ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_e35cd991-3855-4d79-a2ee-9874d56bc51e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_3fbf80d9-de6a-4ec4-a78f-ed5078f862ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_fe643960-a9db-4300-abf0-3b5f881084b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_e35cd991-3855-4d79-a2ee-9874d56bc51e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_fe643960-a9db-4300-abf0-3b5f881084b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_b10b5801-f400-4f3a-bd9b-1794df23b274" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_f67443a6-2255-4f9d-8147-98e0f442d6e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_b10b5801-f400-4f3a-bd9b-1794df23b274" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_f67443a6-2255-4f9d-8147-98e0f442d6e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_169f1036-a087-4214-b38a-8a11b71340db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_b10b5801-f400-4f3a-bd9b-1794df23b274" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_169f1036-a087-4214-b38a-8a11b71340db" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails"/>
  <link:calculationLink xlink:role="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet_68bfed1a-6f79-476a-89b2-70d2c0e34af7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareGross_d1e69c71-05f1-435e-b7a0-ea91bb852521" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareNet_68bfed1a-6f79-476a-89b2-70d2c0e34af7" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareGross_d1e69c71-05f1-435e-b7a0-ea91bb852521" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_923a7b6b-0c77-4c7c-850a-ae6850d934e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareNet_68bfed1a-6f79-476a-89b2-70d2c0e34af7" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_923a7b6b-0c77-4c7c-850a-ae6850d934e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet_21261cf8-e288-4202-bb4f-11eb02001aec" xlink:href="unh-20211231.xsd#unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovements_3c0fe3b9-cb1f-40ff-8051-96d445fa054d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandAndLandImprovements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet_21261cf8-e288-4202-bb4f-11eb02001aec" xlink:to="loc_us-gaap_LandAndLandImprovements_3c0fe3b9-cb1f-40ff-8051-96d445fa054d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_f4d2e81c-d19b-458e-8b30-0e615cf62c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet_21261cf8-e288-4202-bb4f-11eb02001aec" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_f4d2e81c-d19b-458e-8b30-0e615cf62c7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_07f6be5d-5568-420f-992c-435f0df63212" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet_21261cf8-e288-4202-bb4f-11eb02001aec" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_07f6be5d-5568-420f-992c-435f0df63212" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_bd0a0e42-c5fc-4726-a078-af57726ffb66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet_21261cf8-e288-4202-bb4f-11eb02001aec" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_bd0a0e42-c5fc-4726-a078-af57726ffb66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation_06f7b0e7-2088-4d53-b1af-ea71b968cddc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet_21261cf8-e288-4202-bb4f-11eb02001aec" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation_06f7b0e7-2088-4d53-b1af-ea71b968cddc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f0ea950b-d6d5-4435-9024-d6d8e398a028" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet_56ca5fa7-11c9-4761-846d-d76ba70c0f97" xlink:href="unh-20211231.xsd#unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_f0ea950b-d6d5-4435-9024-d6d8e398a028" xlink:to="loc_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet_56ca5fa7-11c9-4761-846d-d76ba70c0f97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet_2aed8fef-9450-487b-9fa1-6f1985d4e9da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_f0ea950b-d6d5-4435-9024-d6d8e398a028" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareNet_2aed8fef-9450-487b-9fa1-6f1985d4e9da" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails"/>
  <link:calculationLink xlink:role="http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d7ab1e43-1a18-4426-9ce3-c647aaa9fa4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_e2863515-fb29-4ff3-bb4d-558859a71129" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d7ab1e43-1a18-4426-9ce3-c647aaa9fa4f" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_e2863515-fb29-4ff3-bb4d-558859a71129" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_b41e6cb2-1dc9-45c4-aa10-5f374fe85ed4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d7ab1e43-1a18-4426-9ce3-c647aaa9fa4f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_b41e6cb2-1dc9-45c4-aa10-5f374fe85ed4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#MedicalCostsPayableRollforwardDetails"/>
  <link:calculationLink xlink:role="http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_64fec513-5919-4881-af55-ff7fc0e0bc2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_19fbf0da-8d19-41d3-90f2-0e81c0717d9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_64fec513-5919-4881-af55-ff7fc0e0bc2f" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_19fbf0da-8d19-41d3-90f2-0e81c0717d9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_52bf8144-ea61-4adf-9387-0b58d647ab77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_64fec513-5919-4881-af55-ff7fc0e0bc2f" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_52bf8144-ea61-4adf-9387-0b58d647ab77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_5f4f85a1-4be1-471d-9f3f-5344e6b62106" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_fac2b8c7-bd42-427c-a9da-3d47578e806f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_5f4f85a1-4be1-471d-9f3f-5344e6b62106" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_fac2b8c7-bd42-427c-a9da-3d47578e806f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_9148dc3c-a709-43c0-b18f-48a82ce0641b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_5f4f85a1-4be1-471d-9f3f-5344e6b62106" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_9148dc3c-a709-43c0-b18f-48a82ce0641b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_fa6a3cbb-35ba-4e29-9d4e-d70cc4fd304d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_7dff78e6-d03f-4e6a-ba59-7e2024be1a36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_fa6a3cbb-35ba-4e29-9d4e-d70cc4fd304d" xlink:to="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_7dff78e6-d03f-4e6a-ba59-7e2024be1a36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_ce667f86-a31d-4424-bc5c-a5e7448034df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_fa6a3cbb-35ba-4e29-9d4e-d70cc4fd304d" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_ce667f86-a31d-4424-bc5c-a5e7448034df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_c309113f-42c9-4620-af1c-8ed93fcc153a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_fa6a3cbb-35ba-4e29-9d4e-d70cc4fd304d" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_c309113f-42c9-4620-af1c-8ed93fcc153a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_128df5f3-9c1d-4e51-a0bf-e49776200ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_1668abe9-8075-4af8-b2ff-0299060b267c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_128df5f3-9c1d-4e51-a0bf-e49776200ab9" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_1668abe9-8075-4af8-b2ff-0299060b267c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_44feec82-e780-47d8-8dea-63bb79135fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_128df5f3-9c1d-4e51-a0bf-e49776200ab9" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_44feec82-e780-47d8-8dea-63bb79135fcd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails"/>
  <link:calculationLink xlink:role="http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7e1c7936-c6fe-4dff-a008-9cf96fe694f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_4e08a100-9539-4716-913f-f697134e1732" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_7e1c7936-c6fe-4dff-a008-9cf96fe694f1" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_4e08a100-9539-4716-913f-f697134e1732" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_79330a0e-fd48-40ce-ba9c-83848bac8487" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_7e1c7936-c6fe-4dff-a008-9cf96fe694f1" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_79330a0e-fd48-40ce-ba9c-83848bac8487" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount_8b317612-c06e-43e6-bff7-fc9e5984100e" xlink:href="unh-20211231.xsd#unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_7e1c7936-c6fe-4dff-a008-9cf96fe694f1" xlink:to="loc_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount_8b317612-c06e-43e6-bff7-fc9e5984100e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_84068ed4-393a-43e8-9423-f9eef8015c9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_7e1c7936-c6fe-4dff-a008-9cf96fe694f1" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_84068ed4-393a-43e8-9423-f9eef8015c9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount_f3d7a5f2-e1af-466f-b042-54680ac74df1" xlink:href="unh-20211231.xsd#unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_7e1c7936-c6fe-4dff-a008-9cf96fe694f1" xlink:to="loc_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount_f3d7a5f2-e1af-466f-b042-54680ac74df1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_7f9a6ff1-d2af-4c25-9909-c57553e254b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_7e1c7936-c6fe-4dff-a008-9cf96fe694f1" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_7f9a6ff1-d2af-4c25-9909-c57553e254b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_6c6da794-1ed8-40ad-87fd-0ffeff8236fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_7e1c7936-c6fe-4dff-a008-9cf96fe694f1" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_6c6da794-1ed8-40ad-87fd-0ffeff8236fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cef3bb04-dc39-47af-980a-b3d8cd6e88e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_ed7b6c86-f48a-43c9-bee1-fa13bf910985" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cef3bb04-dc39-47af-980a-b3d8cd6e88e4" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_ed7b6c86-f48a-43c9-bee1-fa13bf910985" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_f2463b8b-a97d-4e95-9973-9ac5cc9e297f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cef3bb04-dc39-47af-980a-b3d8cd6e88e4" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_f2463b8b-a97d-4e95-9973-9ac5cc9e297f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent_9f9efe08-2272-45a6-a557-78384c16c247" xlink:href="unh-20211231.xsd#unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cef3bb04-dc39-47af-980a-b3d8cd6e88e4" xlink:to="loc_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent_9f9efe08-2272-45a6-a557-78384c16c247" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_f3afdd13-98ae-4964-b0a7-35e1c75e0ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cef3bb04-dc39-47af-980a-b3d8cd6e88e4" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_f3afdd13-98ae-4964-b0a7-35e1c75e0ed0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent_a19b4b5e-79af-41f0-a0be-b571a27a69f6" xlink:href="unh-20211231.xsd#unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cef3bb04-dc39-47af-980a-b3d8cd6e88e4" xlink:to="loc_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent_a19b4b5e-79af-41f0-a0be-b571a27a69f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_858e811b-ebe2-4bb9-b19c-bbaf00ab8d53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cef3bb04-dc39-47af-980a-b3d8cd6e88e4" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_858e811b-ebe2-4bb9-b19c-bbaf00ab8d53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_fcd59ed3-8ceb-4ad2-9887-7d7cf611b9a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cef3bb04-dc39-47af-980a-b3d8cd6e88e4" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_fcd59ed3-8ceb-4ad2-9887-7d7cf611b9a2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_8188bb3c-1a49-400d-a95c-bb8649447caa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_6a2d8bf7-81f2-43b3-93d9-7b3ff83f037e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_8188bb3c-1a49-400d-a95c-bb8649447caa" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_6a2d8bf7-81f2-43b3-93d9-7b3ff83f037e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_6fc8fb81-a19c-443a-8dc7-93e11f139d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_8188bb3c-1a49-400d-a95c-bb8649447caa" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_6fc8fb81-a19c-443a-8dc7-93e11f139d2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_42f59f03-90b5-48a9-bc00-7c21970d25f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_8188bb3c-1a49-400d-a95c-bb8649447caa" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_42f59f03-90b5-48a9-bc00-7c21970d25f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities_ff738f7f-fe50-483f-b60b-0ee2d990ffbf" xlink:href="unh-20211231.xsd#unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_8188bb3c-1a49-400d-a95c-bb8649447caa" xlink:to="loc_unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities_ff738f7f-fe50-483f-b60b-0ee2d990ffbf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_598a95b8-6617-49cd-ab53-1a8df0da3b89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_8188bb3c-1a49-400d-a95c-bb8649447caa" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_598a95b8-6617-49cd-ab53-1a8df0da3b89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxAssetsLeaseLiability_223b1107-5fab-47ac-a27e-bd00e42ad684" xlink:href="unh-20211231.xsd#unh_DeferredTaxAssetsLeaseLiability"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_8188bb3c-1a49-400d-a95c-bb8649447caa" xlink:to="loc_unh_DeferredTaxAssetsLeaseLiability_223b1107-5fab-47ac-a27e-bd00e42ad684" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxAssetOtherDomestic_c8816beb-7fba-4f27-bf4c-7f8e4a5a6016" xlink:href="unh-20211231.xsd#unh_DeferredTaxAssetOtherDomestic"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_8188bb3c-1a49-400d-a95c-bb8649447caa" xlink:to="loc_unh_DeferredTaxAssetOtherDomestic_c8816beb-7fba-4f27-bf4c-7f8e4a5a6016" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxAssetOtherForeign_fbe0ec6a-aba0-4a02-9817-51978398f208" xlink:href="unh-20211231.xsd#unh_DeferredTaxAssetOtherForeign"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_8188bb3c-1a49-400d-a95c-bb8649447caa" xlink:to="loc_unh_DeferredTaxAssetOtherForeign_fbe0ec6a-aba0-4a02-9817-51978398f208" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_163bea60-d6ab-4e3f-9a22-6976e30a7753" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_be987f20-6285-423d-bc40-d2bfe43f0e62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_163bea60-d6ab-4e3f-9a22-6976e30a7753" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_be987f20-6285-423d-bc40-d2bfe43f0e62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign_4fda5241-467f-4583-bbd5-cc7a36b4392c" xlink:href="unh-20211231.xsd#unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_163bea60-d6ab-4e3f-9a22-6976e30a7753" xlink:to="loc_unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign_4fda5241-467f-4583-bbd5-cc7a36b4392c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware_27abfea9-3724-45d6-9527-3779cc1c02a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_163bea60-d6ab-4e3f-9a22-6976e30a7753" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware_27abfea9-3724-45d6-9527-3779cc1c02a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_21b47b08-fa9c-4418-8dcc-c95357b33e45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_163bea60-d6ab-4e3f-9a22-6976e30a7753" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_21b47b08-fa9c-4418-8dcc-c95357b33e45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_121f6f6e-37c8-443d-9b6e-6672bbeaf0ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_163bea60-d6ab-4e3f-9a22-6976e30a7753" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_121f6f6e-37c8-443d-9b6e-6672bbeaf0ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates_0ac23faf-5e2a-44a1-95e6-607b1f727e9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_163bea60-d6ab-4e3f-9a22-6976e30a7753" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates_0ac23faf-5e2a-44a1-95e6-607b1f727e9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_f78efce1-fb62-4a79-851d-f5e568456d56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_163bea60-d6ab-4e3f-9a22-6976e30a7753" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_f78efce1-fb62-4a79-851d-f5e568456d56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxLiabilityOtherDomestic_54500501-9c7e-4800-bc24-7eff1d61bb3a" xlink:href="unh-20211231.xsd#unh_DeferredTaxLiabilityOtherDomestic"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_163bea60-d6ab-4e3f-9a22-6976e30a7753" xlink:to="loc_unh_DeferredTaxLiabilityOtherDomestic_54500501-9c7e-4800-bc24-7eff1d61bb3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxLiabilityOtherForeign_1e517d7d-9978-490d-9ac6-bef401ecf76c" xlink:href="unh-20211231.xsd#unh_DeferredTaxLiabilityOtherForeign"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_163bea60-d6ab-4e3f-9a22-6976e30a7753" xlink:to="loc_unh_DeferredTaxLiabilityOtherForeign_1e517d7d-9978-490d-9ac6-bef401ecf76c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_978fb1d5-ce12-469f-acf8-77e0bc9f623d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_1199d284-860c-4e3b-af42-c2bb10c631a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_978fb1d5-ce12-469f-acf8-77e0bc9f623d" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_1199d284-860c-4e3b-af42-c2bb10c631a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_58664c90-505b-49e7-b6af-467d8d904605" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_978fb1d5-ce12-469f-acf8-77e0bc9f623d" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_58664c90-505b-49e7-b6af-467d8d904605" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_e6083d80-9eea-43cb-8db2-cd4adc2392a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_425119a3-dcce-4d0f-9e3b-f439a80b7f48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_e6083d80-9eea-43cb-8db2-cd4adc2392a6" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_425119a3-dcce-4d0f-9e3b-f439a80b7f48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_51f6e96c-3ac5-4ad8-8519-98a25aad91da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_e6083d80-9eea-43cb-8db2-cd4adc2392a6" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_51f6e96c-3ac5-4ad8-8519-98a25aad91da" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/SegmentFinancialInformationDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#SegmentFinancialInformationDetails"/>
  <link:calculationLink xlink:role="http://www.uhc.com/role/SegmentFinancialInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_281f49e2-18f2-40cf-b714-e4ce926866c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_2401b9cb-52e1-4223-953d-8aed7bcaad66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_281f49e2-18f2-40cf-b714-e4ce926866c2" xlink:to="loc_us-gaap_PremiumsEarnedNet_2401b9cb-52e1-4223-953d-8aed7bcaad66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e5d5acb0-fc73-4a5f-9433-67002258f679" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_281f49e2-18f2-40cf-b714-e4ce926866c2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e5d5acb0-fc73-4a5f-9433-67002258f679" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>21
<FILENAME>unh-20211231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:7520997a-16df-4345-81d3-205a3336ef85,g:00a8925a-3c66-4bad-89d3-86af384cff11-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.uhc.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="unh-20211231.xsd#ConsolidatedBalanceSheets"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ConsolidatedBalanceSheets" xlink:type="extended" id="i9fe321b2b977407f8edb57802ea1d6c5_ConsolidatedBalanceSheets">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_7df42859-acdc-45ce-8435-2770f2d7e2cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_76d189f8-d315-4937-b447-f3151c8ee433" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_7df42859-acdc-45ce-8435-2770f2d7e2cc" xlink:to="loc_us-gaap_StatementTable_76d189f8-d315-4937-b447-f3151c8ee433" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_d59627a3-7f9a-4152-ab2e-1d5a77406c38" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_76d189f8-d315-4937-b447-f3151c8ee433" xlink:to="loc_srt_StatementScenarioAxis_d59627a3-7f9a-4152-ab2e-1d5a77406c38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_d59627a3-7f9a-4152-ab2e-1d5a77406c38_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_d59627a3-7f9a-4152-ab2e-1d5a77406c38" xlink:to="loc_srt_ScenarioUnspecifiedDomain_d59627a3-7f9a-4152-ab2e-1d5a77406c38_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_56dc730f-255e-4049-b44a-bda3780df5a1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_d59627a3-7f9a-4152-ab2e-1d5a77406c38" xlink:to="loc_srt_ScenarioUnspecifiedDomain_56dc730f-255e-4049-b44a-bda3780df5a1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical" xlink:type="simple" xlink:href="unh-20211231.xsd#ConsolidatedBalanceSheetParenthetical"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical" xlink:type="extended" id="i0f82b4ecdd304990bf493f74c5a3586a_ConsolidatedBalanceSheetParenthetical">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a5b673ed-7604-425d-9eb1-c817340e846c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_ecae745b-1ee2-422c-b28e-a84337ca78dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a5b673ed-7604-425d-9eb1-c817340e846c" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_ecae745b-1ee2-422c-b28e-a84337ca78dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_964afacf-0f2f-4fcf-bb11-87a063ef1279" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a5b673ed-7604-425d-9eb1-c817340e846c" xlink:to="loc_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_964afacf-0f2f-4fcf-bb11-87a063ef1279" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1666e914-35c7-45c7-afc3-cf48ec288bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a5b673ed-7604-425d-9eb1-c817340e846c" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1666e914-35c7-45c7-afc3-cf48ec288bf9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8c8a4a05-f159-4e60-95a7-d26f53b281fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a5b673ed-7604-425d-9eb1-c817340e846c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8c8a4a05-f159-4e60-95a7-d26f53b281fb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_d1f6ce55-92a7-474f-947f-6ac66a267ea6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a5b673ed-7604-425d-9eb1-c817340e846c" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_d1f6ce55-92a7-474f-947f-6ac66a267ea6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_133303dd-c71b-4a39-86d7-e07f47914607" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a5b673ed-7604-425d-9eb1-c817340e846c" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_133303dd-c71b-4a39-86d7-e07f47914607" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_35cf81c8-c7f7-47d0-b324-a0431d76ee20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a5b673ed-7604-425d-9eb1-c817340e846c" xlink:to="loc_us-gaap_CommonStockSharesIssued_35cf81c8-c7f7-47d0-b324-a0431d76ee20" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_14e21cb1-6847-4537-acde-e41a5bdf2921" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a5b673ed-7604-425d-9eb1-c817340e846c" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_14e21cb1-6847-4537-acde-e41a5bdf2921" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_9345af9d-9e2f-4091-8ac9-5ee6172b3836" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a5b673ed-7604-425d-9eb1-c817340e846c" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_9345af9d-9e2f-4091-8ac9-5ee6172b3836" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_535b75fd-7726-46d8-9cd9-9c66e5ba02f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a5b673ed-7604-425d-9eb1-c817340e846c" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_535b75fd-7726-46d8-9cd9-9c66e5ba02f5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_e507729e-b2f6-40ef-bc42-ba5cb9d025f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a5b673ed-7604-425d-9eb1-c817340e846c" xlink:to="loc_us-gaap_PreferredStockSharesIssued_e507729e-b2f6-40ef-bc42-ba5cb9d025f6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_38d953db-df7d-4f09-9290-47ad9763dab9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a5b673ed-7604-425d-9eb1-c817340e846c" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_38d953db-df7d-4f09-9290-47ad9763dab9" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_3c56ac78-9b74-4f60-b208-2a5ca3f69a80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_a5b673ed-7604-425d-9eb1-c817340e846c" xlink:to="loc_us-gaap_StatementTable_3c56ac78-9b74-4f60-b208-2a5ca3f69a80" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_1ce3708d-d1db-4edb-8d5b-b58ed9ecdbf2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_3c56ac78-9b74-4f60-b208-2a5ca3f69a80" xlink:to="loc_srt_StatementScenarioAxis_1ce3708d-d1db-4edb-8d5b-b58ed9ecdbf2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_1ce3708d-d1db-4edb-8d5b-b58ed9ecdbf2_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_1ce3708d-d1db-4edb-8d5b-b58ed9ecdbf2" xlink:to="loc_srt_ScenarioUnspecifiedDomain_1ce3708d-d1db-4edb-8d5b-b58ed9ecdbf2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_39edcc0b-f995-45e0-99e7-cd735544055b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_1ce3708d-d1db-4edb-8d5b-b58ed9ecdbf2" xlink:to="loc_srt_ScenarioUnspecifiedDomain_39edcc0b-f995-45e0-99e7-cd735544055b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_85a0b3df-5b8d-4157-b3e6-2b7941cd6781" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_3c56ac78-9b74-4f60-b208-2a5ca3f69a80" xlink:to="loc_us-gaap_StatementClassOfStockAxis_85a0b3df-5b8d-4157-b3e6-2b7941cd6781" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_85a0b3df-5b8d-4157-b3e6-2b7941cd6781_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_85a0b3df-5b8d-4157-b3e6-2b7941cd6781" xlink:to="loc_us-gaap_ClassOfStockDomain_85a0b3df-5b8d-4157-b3e6-2b7941cd6781_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_86d2238a-2ef5-43b6-9a1c-93cb33c16808" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_85a0b3df-5b8d-4157-b3e6-2b7941cd6781" xlink:to="loc_us-gaap_ClassOfStockDomain_86d2238a-2ef5-43b6-9a1c-93cb33c16808" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="unh-20211231.xsd#ConsolidatedStatementsofOperations"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ConsolidatedStatementsofOperations" xlink:type="extended" id="i7dec9be643564e848005111c0e36bb4d_ConsolidatedStatementsofOperations">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e2ad1497-f1a7-4bb9-9d69-5ae8cc6444f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4bbaa0a0-c69b-4338-bac3-d3f2bad2a315" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e2ad1497-f1a7-4bb9-9d69-5ae8cc6444f7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4bbaa0a0-c69b-4338-bac3-d3f2bad2a315" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b4ae93b2-4f59-4d91-b91d-846b98422929" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_e2ad1497-f1a7-4bb9-9d69-5ae8cc6444f7" xlink:to="loc_us-gaap_StatementTable_b4ae93b2-4f59-4d91-b91d-846b98422929" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4a2df1cb-22b9-46b0-afa8-1ffd264f602a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_b4ae93b2-4f59-4d91-b91d-846b98422929" xlink:to="loc_srt_ProductOrServiceAxis_4a2df1cb-22b9-46b0-afa8-1ffd264f602a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4a2df1cb-22b9-46b0-afa8-1ffd264f602a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_4a2df1cb-22b9-46b0-afa8-1ffd264f602a" xlink:to="loc_srt_ProductsAndServicesDomain_4a2df1cb-22b9-46b0-afa8-1ffd264f602a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d285831c-b904-49ae-8c7e-cc3cbb6237aa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_4a2df1cb-22b9-46b0-afa8-1ffd264f602a" xlink:to="loc_srt_ProductsAndServicesDomain_d285831c-b904-49ae-8c7e-cc3cbb6237aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_2e85ea58-7d55-4e89-97bf-52308df17de3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d285831c-b904-49ae-8c7e-cc3cbb6237aa" xlink:to="loc_us-gaap_ProductMember_2e85ea58-7d55-4e89-97bf-52308df17de3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_cfddcda2-c6a4-4c99-bf57-acc32b176bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d285831c-b904-49ae-8c7e-cc3cbb6237aa" xlink:to="loc_us-gaap_ServiceMember_cfddcda2-c6a4-4c99-bf57-acc32b176bf1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="unh-20211231.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended" id="i718d9558a73a4f7c97f291cf1fcd2dc0_ConsolidatedStatementsofComprehensiveIncome">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3cded938-e49f-427c-93d2-6f8b41b05a54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_368d8d2c-2261-4aba-a43e-df774c51b3ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3cded938-e49f-427c-93d2-6f8b41b05a54" xlink:to="loc_us-gaap_ProfitLoss_368d8d2c-2261-4aba-a43e-df774c51b3ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_6364597e-dd52-4b6f-ad6f-4dc4f13d3d24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3cded938-e49f-427c-93d2-6f8b41b05a54" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_6364597e-dd52-4b6f-ad6f-4dc4f13d3d24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_9dc26824-99a5-4cbe-8e4c-2cdf85e6ae7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_6364597e-dd52-4b6f-ad6f-4dc4f13d3d24" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_9dc26824-99a5-4cbe-8e4c-2cdf85e6ae7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_21c311d3-c75e-4538-a6ae-89581c05068b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_6364597e-dd52-4b6f-ad6f-4dc4f13d3d24" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_21c311d3-c75e-4538-a6ae-89581c05068b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_c80ebe42-1cba-41db-a97f-3f801b8e3eab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_6364597e-dd52-4b6f-ad6f-4dc4f13d3d24" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_c80ebe42-1cba-41db-a97f-3f801b8e3eab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_69f85c78-7a38-4a77-90db-dccba540a89b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_6364597e-dd52-4b6f-ad6f-4dc4f13d3d24" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_69f85c78-7a38-4a77-90db-dccba540a89b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_c9e42a95-4561-4bfe-acdd-4f19df42dd68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_6364597e-dd52-4b6f-ad6f-4dc4f13d3d24" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_c9e42a95-4561-4bfe-acdd-4f19df42dd68" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_7409c26d-f304-4447-9b45-54bbcb045096" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_6364597e-dd52-4b6f-ad6f-4dc4f13d3d24" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_7409c26d-f304-4447-9b45-54bbcb045096" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_9f79813a-165b-4169-90aa-aac14cf9616c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_6364597e-dd52-4b6f-ad6f-4dc4f13d3d24" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_9f79813a-165b-4169-90aa-aac14cf9616c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d2f36062-0d8e-4b0b-9e3d-62498e38c214" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_6364597e-dd52-4b6f-ad6f-4dc4f13d3d24" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d2f36062-0d8e-4b0b-9e3d-62498e38c214" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_836256e4-4191-4a47-b6c2-41dc68669868" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_6364597e-dd52-4b6f-ad6f-4dc4f13d3d24" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_836256e4-4191-4a47-b6c2-41dc68669868" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_d585ffbb-d380-45a1-881c-e2729ce39925" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3cded938-e49f-427c-93d2-6f8b41b05a54" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_d585ffbb-d380-45a1-881c-e2729ce39925" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_b2c4e295-6b7b-4cd4-b408-b52e38edea1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3cded938-e49f-427c-93d2-6f8b41b05a54" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_b2c4e295-6b7b-4cd4-b408-b52e38edea1b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8ca0aadf-ca7e-4b88-8694-38be5867ba8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_3cded938-e49f-427c-93d2-6f8b41b05a54" xlink:to="loc_us-gaap_StatementTable_8ca0aadf-ca7e-4b88-8694-38be5867ba8d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_1d6cc92f-a670-4f40-8f84-58104227fe0b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_8ca0aadf-ca7e-4b88-8694-38be5867ba8d" xlink:to="loc_srt_StatementScenarioAxis_1d6cc92f-a670-4f40-8f84-58104227fe0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_1d6cc92f-a670-4f40-8f84-58104227fe0b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_1d6cc92f-a670-4f40-8f84-58104227fe0b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_1d6cc92f-a670-4f40-8f84-58104227fe0b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_1c4c8fde-cb74-49ea-b1e0-39980831645e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_1d6cc92f-a670-4f40-8f84-58104227fe0b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_1c4c8fde-cb74-49ea-b1e0-39980831645e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity" xlink:type="simple" xlink:href="unh-20211231.xsd#ConsolidatedStatementsofChangesinEquity"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity" xlink:type="extended" id="i5eec536aa7934736a9074cda6fead52f_ConsolidatedStatementsofChangesinEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e8ddaf1c-54b2-40e7-8195-bb2d8144dfaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5cb1fc16-903b-46ef-9df7-1c3c752659f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e8ddaf1c-54b2-40e7-8195-bb2d8144dfaf" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5cb1fc16-903b-46ef-9df7-1c3c752659f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d9c63de6-7721-45b9-a685-9888607420d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e8ddaf1c-54b2-40e7-8195-bb2d8144dfaf" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_d9c63de6-7721-45b9-a685-9888607420d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_591b3c05-027a-4130-b855-34eb48e8f716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e8ddaf1c-54b2-40e7-8195-bb2d8144dfaf" xlink:to="loc_us-gaap_NetIncomeLoss_591b3c05-027a-4130-b855-34eb48e8f716" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest_223fff4f-8f32-4d14-acdd-d8f37d9d321a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e8ddaf1c-54b2-40e7-8195-bb2d8144dfaf" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest_223fff4f-8f32-4d14-acdd-d8f37d9d321a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_5b871b95-998a-4d9c-8c33-e13067a5f32b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e8ddaf1c-54b2-40e7-8195-bb2d8144dfaf" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_5b871b95-998a-4d9c-8c33-e13067a5f32b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ce0567d8-1bd6-48a4-a486-b7d47bb83ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e8ddaf1c-54b2-40e7-8195-bb2d8144dfaf" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ce0567d8-1bd6-48a4-a486-b7d47bb83ba6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_fed58c23-cde8-4c79-b9ba-a5355ca13129" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e8ddaf1c-54b2-40e7-8195-bb2d8144dfaf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_fed58c23-cde8-4c79-b9ba-a5355ca13129" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_99e841ee-a56b-43f7-8af1-f5f87f9d812c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e8ddaf1c-54b2-40e7-8195-bb2d8144dfaf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_99e841ee-a56b-43f7-8af1-f5f87f9d812c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_a9a53ef5-d2fc-4d4b-a0df-e725e33312cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e8ddaf1c-54b2-40e7-8195-bb2d8144dfaf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_a9a53ef5-d2fc-4d4b-a0df-e725e33312cf" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_09b49042-d600-4b2a-bb59-641ef8fc8126" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e8ddaf1c-54b2-40e7-8195-bb2d8144dfaf" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_09b49042-d600-4b2a-bb59-641ef8fc8126" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_b9fe5ca6-8779-47bb-b696-f3fcbd1d5366" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e8ddaf1c-54b2-40e7-8195-bb2d8144dfaf" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_b9fe5ca6-8779-47bb-b696-f3fcbd1d5366" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCash_4c3191b1-3799-4d45-9668-c4020a04676a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e8ddaf1c-54b2-40e7-8195-bb2d8144dfaf" xlink:to="loc_us-gaap_DividendsCash_4c3191b1-3799-4d45-9668-c4020a04676a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_96aa2b02-d46e-4d11-bb03-ef63ffb8c83a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e8ddaf1c-54b2-40e7-8195-bb2d8144dfaf" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_96aa2b02-d46e-4d11-bb03-ef63ffb8c83a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue_705e23f2-feb0-4327-a695-ab63facff8f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestChangeInRedemptionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e8ddaf1c-54b2-40e7-8195-bb2d8144dfaf" xlink:to="loc_us-gaap_MinorityInterestChangeInRedemptionValue_705e23f2-feb0-4327-a695-ab63facff8f5" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_fadbe2d9-9f5b-42a9-a4ce-bdd01e509320" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e8ddaf1c-54b2-40e7-8195-bb2d8144dfaf" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_fadbe2d9-9f5b-42a9-a4ce-bdd01e509320" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_c260ae7e-390c-4b11-bb04-e2bc3376881d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e8ddaf1c-54b2-40e7-8195-bb2d8144dfaf" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_c260ae7e-390c-4b11-bb04-e2bc3376881d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0d0dd48f-c595-47dd-99c9-cf0780bc3dba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_c0c4f064-6226-47fa-8951-e9b99dfe0226" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7494c47f-2917-438d-9378-2417f3f59ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_e8ddaf1c-54b2-40e7-8195-bb2d8144dfaf" xlink:to="loc_us-gaap_StatementTable_7494c47f-2917-438d-9378-2417f3f59ed0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_57df6dce-6358-4e5d-afb6-f052f33487a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_7494c47f-2917-438d-9378-2417f3f59ed0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_57df6dce-6358-4e5d-afb6-f052f33487a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_57df6dce-6358-4e5d-afb6-f052f33487a6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_57df6dce-6358-4e5d-afb6-f052f33487a6" xlink:to="loc_us-gaap_EquityComponentDomain_57df6dce-6358-4e5d-afb6-f052f33487a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6ced3318-af15-46b4-8df2-8ac48e341834" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_57df6dce-6358-4e5d-afb6-f052f33487a6" xlink:to="loc_us-gaap_EquityComponentDomain_6ced3318-af15-46b4-8df2-8ac48e341834" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_1e77c640-850c-472a-9ea1-4b64e891f02d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6ced3318-af15-46b4-8df2-8ac48e341834" xlink:to="loc_us-gaap_CommonStockMember_1e77c640-850c-472a-9ea1-4b64e891f02d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_a52ed880-5a8a-4c21-9293-3efbde9c0c23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6ced3318-af15-46b4-8df2-8ac48e341834" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_a52ed880-5a8a-4c21-9293-3efbde9c0c23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_0a253107-5f64-4549-a532-b97bbe0afe0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6ced3318-af15-46b4-8df2-8ac48e341834" xlink:to="loc_us-gaap_RetainedEarningsMember_0a253107-5f64-4549-a532-b97bbe0afe0e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_4ce81494-80e0-4e06-bfc5-e931aab39bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6ced3318-af15-46b4-8df2-8ac48e341834" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_4ce81494-80e0-4e06-bfc5-e931aab39bf9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_c3741b80-1dd3-472e-a845-7782269fc69f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6ced3318-af15-46b4-8df2-8ac48e341834" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_c3741b80-1dd3-472e-a845-7782269fc69f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_29f1e8c0-9da3-486a-be85-40d5fc95fafd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6ced3318-af15-46b4-8df2-8ac48e341834" xlink:to="loc_us-gaap_NoncontrollingInterestMember_29f1e8c0-9da3-486a-be85-40d5fc95fafd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_4b845d52-873e-4c18-ba8c-f4f0547d7354" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_7494c47f-2917-438d-9378-2417f3f59ed0" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_4b845d52-873e-4c18-ba8c-f4f0547d7354" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_4b845d52-873e-4c18-ba8c-f4f0547d7354_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_4b845d52-873e-4c18-ba8c-f4f0547d7354" xlink:to="loc_us-gaap_TypeOfAdoptionMember_4b845d52-873e-4c18-ba8c-f4f0547d7354_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_3cc1c793-8243-490c-ba4a-73e32309fc98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_4b845d52-873e-4c18-ba8c-f4f0547d7354" xlink:to="loc_us-gaap_TypeOfAdoptionMember_3cc1c793-8243-490c-ba4a-73e32309fc98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_7d9c2168-5247-4545-8f95-ef145e032a78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_3cc1c793-8243-490c-ba4a-73e32309fc98" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_7d9c2168-5247-4545-8f95-ef145e032a78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member_2dbecc61-fd77-4313-937a-3d9992624395" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_3cc1c793-8243-490c-ba4a-73e32309fc98" xlink:to="loc_us-gaap_AccountingStandardsUpdate201613Member_2dbecc61-fd77-4313-937a-3d9992624395" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/DescriptionofBusinessNotes" xlink:type="simple" xlink:href="unh-20211231.xsd#DescriptionofBusinessNotes"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/DescriptionofBusinessNotes" xlink:type="extended" id="i5f216428f5d747848d1dbcd7e069fca0_DescriptionofBusinessNotes">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e1a28531-178c-4d7e-845c-0191b2db8f84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_7a54aa5a-4aec-4530-9323-561d194b2309" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e1a28531-178c-4d7e-845c-0191b2db8f84" xlink:to="loc_us-gaap_NatureOfOperations_7a54aa5a-4aec-4530-9323-561d194b2309" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_3ce9a554-e44b-4179-bf9c-68fb5f09d09f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_e1a28531-178c-4d7e-845c-0191b2db8f84" xlink:to="loc_us-gaap_StatementTable_3ce9a554-e44b-4179-bf9c-68fb5f09d09f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_1a8d50c5-bfe1-454c-ac28-b94eedffaed5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_3ce9a554-e44b-4179-bf9c-68fb5f09d09f" xlink:to="loc_srt_StatementScenarioAxis_1a8d50c5-bfe1-454c-ac28-b94eedffaed5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_1a8d50c5-bfe1-454c-ac28-b94eedffaed5_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_1a8d50c5-bfe1-454c-ac28-b94eedffaed5" xlink:to="loc_srt_ScenarioUnspecifiedDomain_1a8d50c5-bfe1-454c-ac28-b94eedffaed5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_eaad79fd-f7ea-4fa0-9126-a964af2cf5df" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_1a8d50c5-bfe1-454c-ac28-b94eedffaed5" xlink:to="loc_srt_ScenarioUnspecifiedDomain_eaad79fd-f7ea-4fa0-9126-a964af2cf5df" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes" xlink:type="simple" xlink:href="unh-20211231.xsd#BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes" xlink:type="extended" id="i739fc135e29946be97104b9d9e2a7014_BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e0c0da1c-22d5-42d7-9d19-0ecc5d86d15c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_87e55198-713b-49dd-827d-a9d2e0477ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e0c0da1c-22d5-42d7-9d19-0ecc5d86d15c" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_87e55198-713b-49dd-827d-a9d2e0477ae4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b1af3b02-f497-41b9-a50e-2d01c40d203a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_e0c0da1c-22d5-42d7-9d19-0ecc5d86d15c" xlink:to="loc_us-gaap_StatementTable_b1af3b02-f497-41b9-a50e-2d01c40d203a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_b4ba586e-ddf0-4cdb-996a-62eac4954e1e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_b1af3b02-f497-41b9-a50e-2d01c40d203a" xlink:to="loc_srt_StatementScenarioAxis_b4ba586e-ddf0-4cdb-996a-62eac4954e1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_b4ba586e-ddf0-4cdb-996a-62eac4954e1e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_b4ba586e-ddf0-4cdb-996a-62eac4954e1e" xlink:to="loc_srt_ScenarioUnspecifiedDomain_b4ba586e-ddf0-4cdb-996a-62eac4954e1e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_3d703223-697a-486d-8371-0a83fc642a8a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_b4ba586e-ddf0-4cdb-996a-62eac4954e1e" xlink:to="loc_srt_ScenarioUnspecifiedDomain_3d703223-697a-486d-8371-0a83fc642a8a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="unh-20211231.xsd#BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies" xlink:type="extended" id="i92102d36b624409a8f4dc451788fe93d_BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_4d1b80f5-69c8-4abb-a051-3825f1449b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_4d1b80f5-69c8-4abb-a051-3825f1449b6d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_5d7ca98c-6d10-4aa1-8c40-42b035664f06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:to="loc_us-gaap_UseOfEstimates_5d7ca98c-6d10-4aa1-8c40-42b035664f06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_dfb30f49-03d0-44f0-8b14-224aa2b17f28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_dfb30f49-03d0-44f0-8b14-224aa2b17f28" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy_213cb910-a290-42fe-9f86-570239c11bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:to="loc_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy_213cb910-a290-42fe-9f86-570239c11bf6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock_d7abeab7-9cd4-40d3-b3ac-f1837322ca86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:to="loc_us-gaap_CostOfSalesPolicyTextBlock_d7abeab7-9cd4-40d3-b3ac-f1837322ca86" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_9353b737-9d50-4035-b280-fbfc049f960c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_9353b737-9d50-4035-b280-fbfc049f960c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_625be443-ab99-485c-8153-1b85d6eddfee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_625be443-ab99-485c-8153-1b85d6eddfee" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_AARPAssetsUnderManagementPolicyTextBlock_94b9d45a-27b3-49c4-ad6c-a9337cd11f2e" xlink:href="unh-20211231.xsd#unh_AARPAssetsUnderManagementPolicyTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:to="loc_unh_AARPAssetsUnderManagementPolicyTextBlock_94b9d45a-27b3-49c4-ad6c-a9337cd11f2e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_0bb3d9dd-1375-4dc8-a501-ce8cb0cba3e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_0bb3d9dd-1375-4dc8-a501-ce8cb0cba3e3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_ff92d072-2c17-47cf-b9f7-49c8f50b04e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_ff92d072-2c17-47cf-b9f7-49c8f50b04e5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_c0033f20-b050-443a-98e4-5b66f2dc8347" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_c0033f20-b050-443a-98e4-5b66f2dc8347" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_5540d28c-af86-4e50-aa7b-0e190efa3a76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_5540d28c-af86-4e50-aa7b-0e190efa3a76" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_30f31908-9d86-4cc6-92b2-6c9e93bb0ea9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_30f31908-9d86-4cc6-92b2-6c9e93bb0ea9" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OtherLiabilitiesCurrentPolicyTextBlock_afac6a39-cb2b-4326-926c-9b3a2597ecf0" xlink:href="unh-20211231.xsd#unh_OtherLiabilitiesCurrentPolicyTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:to="loc_unh_OtherLiabilitiesCurrentPolicyTextBlock_afac6a39-cb2b-4326-926c-9b3a2597ecf0" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy_1ddfb32d-a5d5-4904-92c1-454bee657cbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:to="loc_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy_1ddfb32d-a5d5-4904-92c1-454bee657cbe" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_eb14c2eb-5238-4611-996c-0f42e5b9ab3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:to="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_eb14c2eb-5238-4611-996c-0f42e5b9ab3c" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_c888b8a8-153d-417e-99ba-f1dddd7e38ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_c888b8a8-153d-417e-99ba-f1dddd7e38ed" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_cdfe945e-7d02-4fc3-9c81-704653442b9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_cdfe945e-7d02-4fc3-9c81-704653442b9f" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndustrySpecificPoliciesInsuranceCompaniesTextBlock_6e33bf9e-da62-45b3-87a8-c6583ea60baf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndustrySpecificPoliciesInsuranceCompaniesTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:to="loc_us-gaap_IndustrySpecificPoliciesInsuranceCompaniesTextBlock_6e33bf9e-da62-45b3-87a8-c6583ea60baf" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_417eb582-cdba-4058-9eb0-07cc029395a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:to="loc_us-gaap_StatementTable_417eb582-cdba-4058-9eb0-07cc029395a7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_df878edf-5a04-4b18-9414-5cb5c73f5a4e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_417eb582-cdba-4058-9eb0-07cc029395a7" xlink:to="loc_srt_StatementScenarioAxis_df878edf-5a04-4b18-9414-5cb5c73f5a4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_df878edf-5a04-4b18-9414-5cb5c73f5a4e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_df878edf-5a04-4b18-9414-5cb5c73f5a4e" xlink:to="loc_srt_ScenarioUnspecifiedDomain_df878edf-5a04-4b18-9414-5cb5c73f5a4e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_2e1912dc-e7f5-40ad-98ef-5c181545a2c2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_df878edf-5a04-4b18-9414-5cb5c73f5a4e" xlink:to="loc_srt_ScenarioUnspecifiedDomain_2e1912dc-e7f5-40ad-98ef-5c181545a2c2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="unh-20211231.xsd#BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables" xlink:type="extended" id="ib8ca2a48e00e44929a570554a3d49d7d_BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_70d3df52-2997-4f71-a225-e47427620e70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_39651d6e-d1c7-455b-bfb6-40f002ef8d2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_70d3df52-2997-4f71-a225-e47427620e70" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_39651d6e-d1c7-455b-bfb6-40f002ef8d2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_10d2bdfa-9834-4688-a8ae-78f07c62cf57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_70d3df52-2997-4f71-a225-e47427620e70" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_10d2bdfa-9834-4688-a8ae-78f07c62cf57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_3de527b1-a364-4e81-af6a-642fb422cb1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_70d3df52-2997-4f71-a225-e47427620e70" xlink:to="loc_us-gaap_StatementTable_3de527b1-a364-4e81-af6a-642fb422cb1f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_84e75579-5a2e-4676-af16-9a6b8bb1dc28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_3de527b1-a364-4e81-af6a-642fb422cb1f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_84e75579-5a2e-4676-af16-9a6b8bb1dc28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_84e75579-5a2e-4676-af16-9a6b8bb1dc28_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_84e75579-5a2e-4676-af16-9a6b8bb1dc28" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_84e75579-5a2e-4676-af16-9a6b8bb1dc28_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f7d32bd-ad90-4ef6-97e5-ad34b3a60b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_84e75579-5a2e-4676-af16-9a6b8bb1dc28" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f7d32bd-ad90-4ef6-97e5-ad34b3a60b3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_UsefulLifeMember_b9618cb2-95ab-45fc-8153-dabcf16426e5" xlink:href="unh-20211231.xsd#unh_UsefulLifeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f7d32bd-ad90-4ef6-97e5-ad34b3a60b3c" xlink:to="loc_unh_UsefulLifeMember_b9618cb2-95ab-45fc-8153-dabcf16426e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_0031fa47-64b9-48fc-bc36-4b97e786882f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_3de527b1-a364-4e81-af6a-642fb422cb1f" xlink:to="loc_srt_StatementScenarioAxis_0031fa47-64b9-48fc-bc36-4b97e786882f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_0031fa47-64b9-48fc-bc36-4b97e786882f_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_0031fa47-64b9-48fc-bc36-4b97e786882f" xlink:to="loc_srt_ScenarioUnspecifiedDomain_0031fa47-64b9-48fc-bc36-4b97e786882f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_8eef1d38-32d7-4570-887b-e4c17443ff8b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_0031fa47-64b9-48fc-bc36-4b97e786882f" xlink:to="loc_srt_ScenarioUnspecifiedDomain_8eef1d38-32d7-4570-887b-e4c17443ff8b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails" xlink:type="extended" id="if53debdfd5a14e409271a2191f80a037_BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b7f8a202-fc19-45d4-9e67-493035786589" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_28249be3-2941-47c4-99c3-790dc4d87ef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b7f8a202-fc19-45d4-9e67-493035786589" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_28249be3-2941-47c4-99c3-790dc4d87ef1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days_50eaa7e0-fc56-4175-ae1a-7c97b18f3e83" xlink:href="unh-20211231.xsd#unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b7f8a202-fc19-45d4-9e67-493035786589" xlink:to="loc_unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days_50eaa7e0-fc56-4175-ae1a-7c97b18f3e83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_b943d611-a811-414c-8581-cc4e30a4c59d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b7f8a202-fc19-45d4-9e67-493035786589" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_b943d611-a811-414c-8581-cc4e30a4c59d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositAccounts_b454d367-31ca-45dc-9447-e7ae391aca87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DemandDepositAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b7f8a202-fc19-45d4-9e67-493035786589" xlink:to="loc_us-gaap_DemandDepositAccounts_b454d367-31ca-45dc-9447-e7ae391aca87" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_008f59b2-5697-45b7-a92b-0551a1be4de6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b7f8a202-fc19-45d4-9e67-493035786589" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_008f59b2-5697-45b7-a92b-0551a1be4de6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_c505893d-f264-4795-9f0d-b64957abfd44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b7f8a202-fc19-45d4-9e67-493035786589" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_c505893d-f264-4795-9f0d-b64957abfd44" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract_a536b741-e8f9-4b5f-9ece-0d6f0340e38b" xlink:href="unh-20211231.xsd#unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b7f8a202-fc19-45d4-9e67-493035786589" xlink:to="loc_unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract_a536b741-e8f9-4b5f-9ece-0d6f0340e38b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_29c16edb-070a-49a7-be5c-284086d78842" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b7f8a202-fc19-45d4-9e67-493035786589" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_29c16edb-070a-49a7-be5c-284086d78842" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_d0831239-4982-47b4-b6a9-1045cf8d16a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b7f8a202-fc19-45d4-9e67-493035786589" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_d0831239-4982-47b4-b6a9-1045cf8d16a3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_32fd37cd-76fa-44b6-bfcd-eb8b1326f975" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b7f8a202-fc19-45d4-9e67-493035786589" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_32fd37cd-76fa-44b6-bfcd-eb8b1326f975" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1e344fff-4f13-45d0-a431-e821f049eec3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b7f8a202-fc19-45d4-9e67-493035786589" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1e344fff-4f13-45d0-a431-e821f049eec3" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_6b307657-bce7-4d16-a632-43c7cfce6468" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b7f8a202-fc19-45d4-9e67-493035786589" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_6b307657-bce7-4d16-a632-43c7cfce6468" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_20310919-0d2f-4318-a648-a51ade26bc65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_b7f8a202-fc19-45d4-9e67-493035786589" xlink:to="loc_us-gaap_StatementTable_20310919-0d2f-4318-a648-a51ade26bc65" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_MedicarePartDPharmacyBenefitsContractAxis_dba16c5c-d691-4c5f-bda7-38cf9c46ff44" xlink:href="unh-20211231.xsd#unh_MedicarePartDPharmacyBenefitsContractAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_20310919-0d2f-4318-a648-a51ade26bc65" xlink:to="loc_unh_MedicarePartDPharmacyBenefitsContractAxis_dba16c5c-d691-4c5f-bda7-38cf9c46ff44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_MedicarePartDPharmacyBenefitsContractDomain_dba16c5c-d691-4c5f-bda7-38cf9c46ff44_default" xlink:href="unh-20211231.xsd#unh_MedicarePartDPharmacyBenefitsContractDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_unh_MedicarePartDPharmacyBenefitsContractAxis_dba16c5c-d691-4c5f-bda7-38cf9c46ff44" xlink:to="loc_unh_MedicarePartDPharmacyBenefitsContractDomain_dba16c5c-d691-4c5f-bda7-38cf9c46ff44_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_MedicarePartDPharmacyBenefitsContractDomain_f60f8caa-d6c0-4098-adfb-45035a928ab5" xlink:href="unh-20211231.xsd#unh_MedicarePartDPharmacyBenefitsContractDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_unh_MedicarePartDPharmacyBenefitsContractAxis_dba16c5c-d691-4c5f-bda7-38cf9c46ff44" xlink:to="loc_unh_MedicarePartDPharmacyBenefitsContractDomain_f60f8caa-d6c0-4098-adfb-45035a928ab5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_MedicarePartDReceivablesMember_81fd756b-5569-4934-b846-f9caae921b2e" xlink:href="unh-20211231.xsd#unh_MedicarePartDReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_unh_MedicarePartDPharmacyBenefitsContractDomain_f60f8caa-d6c0-4098-adfb-45035a928ab5" xlink:to="loc_unh_MedicarePartDReceivablesMember_81fd756b-5569-4934-b846-f9caae921b2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_PharmaceuticalmanufacturerrebatesreceivableAxis_a3317001-e864-46ac-8ecf-bfdb22b82f5f" xlink:href="unh-20211231.xsd#unh_PharmaceuticalmanufacturerrebatesreceivableAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_20310919-0d2f-4318-a648-a51ade26bc65" xlink:to="loc_unh_PharmaceuticalmanufacturerrebatesreceivableAxis_a3317001-e864-46ac-8ecf-bfdb22b82f5f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_PharmaceuticalmanufacturerrebatesreceivableDomain_a3317001-e864-46ac-8ecf-bfdb22b82f5f_default" xlink:href="unh-20211231.xsd#unh_PharmaceuticalmanufacturerrebatesreceivableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_unh_PharmaceuticalmanufacturerrebatesreceivableAxis_a3317001-e864-46ac-8ecf-bfdb22b82f5f" xlink:to="loc_unh_PharmaceuticalmanufacturerrebatesreceivableDomain_a3317001-e864-46ac-8ecf-bfdb22b82f5f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_PharmaceuticalmanufacturerrebatesreceivableDomain_a365d158-904b-458c-ad48-a638fac0ff2b" xlink:href="unh-20211231.xsd#unh_PharmaceuticalmanufacturerrebatesreceivableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_unh_PharmaceuticalmanufacturerrebatesreceivableAxis_a3317001-e864-46ac-8ecf-bfdb22b82f5f" xlink:to="loc_unh_PharmaceuticalmanufacturerrebatesreceivableDomain_a365d158-904b-458c-ad48-a638fac0ff2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_PharmaceuticalManufacturerRebatesReceivableMember_ad10a164-7d89-4b5f-82e7-990c4dc56593" xlink:href="unh-20211231.xsd#unh_PharmaceuticalManufacturerRebatesReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_unh_PharmaceuticalmanufacturerrebatesreceivableDomain_a365d158-904b-458c-ad48-a638fac0ff2b" xlink:to="loc_unh_PharmaceuticalManufacturerRebatesReceivableMember_ad10a164-7d89-4b5f-82e7-990c4dc56593" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_16b2691f-2c31-4439-9067-9abaab9a6441" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_20310919-0d2f-4318-a648-a51ade26bc65" xlink:to="loc_srt_ProductOrServiceAxis_16b2691f-2c31-4439-9067-9abaab9a6441" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_16b2691f-2c31-4439-9067-9abaab9a6441_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_16b2691f-2c31-4439-9067-9abaab9a6441" xlink:to="loc_srt_ProductsAndServicesDomain_16b2691f-2c31-4439-9067-9abaab9a6441_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1e8e27cb-52c5-44aa-a190-7a471cc159cc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_16b2691f-2c31-4439-9067-9abaab9a6441" xlink:to="loc_srt_ProductsAndServicesDomain_1e8e27cb-52c5-44aa-a190-7a471cc159cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_28f3dbe6-1d6d-4878-9f0c-88395ed5ec22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1e8e27cb-52c5-44aa-a190-7a471cc159cc" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_28f3dbe6-1d6d-4878-9f0c-88395ed5ec22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ProductsandservicesMember_7e84cf41-71e9-4a77-a672-f052371e2503" xlink:href="unh-20211231.xsd#unh_ProductsandservicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1e8e27cb-52c5-44aa-a190-7a471cc159cc" xlink:to="loc_unh_ProductsandservicesMember_7e84cf41-71e9-4a77-a672-f052371e2503" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_84cb4828-4a7b-4881-870c-b5da36ccb6c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_20310919-0d2f-4318-a648-a51ade26bc65" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_84cb4828-4a7b-4881-870c-b5da36ccb6c7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_84cb4828-4a7b-4881-870c-b5da36ccb6c7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_84cb4828-4a7b-4881-870c-b5da36ccb6c7" xlink:to="loc_us-gaap_TypeOfAdoptionMember_84cb4828-4a7b-4881-870c-b5da36ccb6c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_27da5aba-4d13-417a-a0c3-ec556db13b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_84cb4828-4a7b-4881-870c-b5da36ccb6c7" xlink:to="loc_us-gaap_TypeOfAdoptionMember_27da5aba-4d13-417a-a0c3-ec556db13b1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_333d2156-8c28-450c-af92-67722c9fee3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_27da5aba-4d13-417a-a0c3-ec556db13b1e" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_333d2156-8c28-450c-af92-67722c9fee3c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_17e4563b-be41-4efc-bfd3-2e96458a4719" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_20310919-0d2f-4318-a648-a51ade26bc65" xlink:to="loc_us-gaap_AwardTypeAxis_17e4563b-be41-4efc-bfd3-2e96458a4719" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_17e4563b-be41-4efc-bfd3-2e96458a4719_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_17e4563b-be41-4efc-bfd3-2e96458a4719" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_17e4563b-be41-4efc-bfd3-2e96458a4719_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_713a7887-4920-4f52-a7e0-c6904c4e8f0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_17e4563b-be41-4efc-bfd3-2e96458a4719" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_713a7887-4920-4f52-a7e0-c6904c4e8f0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_d65001bf-b6fb-49a5-817b-d3acb8521d77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_713a7887-4920-4f52-a7e0-c6904c4e8f0c" xlink:to="loc_us-gaap_RestrictedStockMember_d65001bf-b6fb-49a5-817b-d3acb8521d77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EmployeeStockPurchasePlanESPPMember_252eb4a3-baac-4fbb-b7e7-610771ed2207" xlink:href="unh-20211231.xsd#unh_EmployeeStockPurchasePlanESPPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_713a7887-4920-4f52-a7e0-c6904c4e8f0c" xlink:to="loc_unh_EmployeeStockPurchasePlanESPPMember_252eb4a3-baac-4fbb-b7e7-610771ed2207" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_StockOptionsandSARsMember_92de2494-3c72-4776-870a-7682a8d89ace" xlink:href="unh-20211231.xsd#unh_StockOptionsandSARsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_713a7887-4920-4f52-a7e0-c6904c4e8f0c" xlink:to="loc_unh_StockOptionsandSARsMember_92de2494-3c72-4776-870a-7682a8d89ace" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a9fa3141-6e43-4019-a15f-15e21c6e815c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_20310919-0d2f-4318-a648-a51ade26bc65" xlink:to="loc_srt_RangeAxis_a9fa3141-6e43-4019-a15f-15e21c6e815c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a9fa3141-6e43-4019-a15f-15e21c6e815c_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a9fa3141-6e43-4019-a15f-15e21c6e815c" xlink:to="loc_srt_RangeMember_a9fa3141-6e43-4019-a15f-15e21c6e815c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_69c78c59-a690-4275-aba5-358710e48fdb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a9fa3141-6e43-4019-a15f-15e21c6e815c" xlink:to="loc_srt_RangeMember_69c78c59-a690-4275-aba5-358710e48fdb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b8e7b3e8-6b1d-43d1-b126-0a46e0d14d34" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_69c78c59-a690-4275-aba5-358710e48fdb" xlink:to="loc_srt_MinimumMember_b8e7b3e8-6b1d-43d1-b126-0a46e0d14d34" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e2d58757-9a57-483a-86a5-3eab62a07fc3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_69c78c59-a690-4275-aba5-358710e48fdb" xlink:to="loc_srt_MaximumMember_e2d58757-9a57-483a-86a5-3eab62a07fc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f35fd73e-afdd-432f-99e7-81671b4c92e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_20310919-0d2f-4318-a648-a51ade26bc65" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f35fd73e-afdd-432f-99e7-81671b4c92e3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f35fd73e-afdd-432f-99e7-81671b4c92e3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f35fd73e-afdd-432f-99e7-81671b4c92e3" xlink:to="loc_us-gaap_EquityComponentDomain_f35fd73e-afdd-432f-99e7-81671b4c92e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9883ab72-a7cc-4936-bced-7347e6452387" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f35fd73e-afdd-432f-99e7-81671b4c92e3" xlink:to="loc_us-gaap_EquityComponentDomain_9883ab72-a7cc-4936-bced-7347e6452387" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_e7c745a9-b69c-463c-933f-671ad1a65327" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9883ab72-a7cc-4936-bced-7347e6452387" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_e7c745a9-b69c-463c-933f-671ad1a65327" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_d4cfef05-8c6d-43dc-9b49-32712f092783" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_20310919-0d2f-4318-a648-a51ade26bc65" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_d4cfef05-8c6d-43dc-9b49-32712f092783" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d4cfef05-8c6d-43dc-9b49-32712f092783_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d4cfef05-8c6d-43dc-9b49-32712f092783" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d4cfef05-8c6d-43dc-9b49-32712f092783_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b667c017-7fe5-4fff-b139-790ef7a9f3ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d4cfef05-8c6d-43dc-9b49-32712f092783" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b667c017-7fe5-4fff-b139-790ef7a9f3ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_a06c6f54-d63a-4bd0-ba2d-84a4ed2d6945" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b667c017-7fe5-4fff-b139-790ef7a9f3ad" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_a06c6f54-d63a-4bd0-ba2d-84a4ed2d6945" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails" xlink:type="extended" id="i192ef08ad8814a86bffce47f93f67aa7_BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_739edf64-307f-4505-9e59-586f73d23443" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_692b363c-f5d8-4418-8157-a76405914bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_739edf64-307f-4505-9e59-586f73d23443" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_692b363c-f5d8-4418-8157-a76405914bc0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_26413153-2218-4f33-8561-3548257ceb6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_739edf64-307f-4505-9e59-586f73d23443" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_26413153-2218-4f33-8561-3548257ceb6a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f69be435-0383-4fd1-8509-2f68125a2ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_26413153-2218-4f33-8561-3548257ceb6a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f69be435-0383-4fd1-8509-2f68125a2ba6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f69be435-0383-4fd1-8509-2f68125a2ba6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f69be435-0383-4fd1-8509-2f68125a2ba6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f69be435-0383-4fd1-8509-2f68125a2ba6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6fb235e9-cc5d-4c8d-95c7-06d87e6b8d4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f69be435-0383-4fd1-8509-2f68125a2ba6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6fb235e9-cc5d-4c8d-95c7-06d87e6b8d4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_5af8eeb6-8635-4298-b61a-262f9b0f2799" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6fb235e9-cc5d-4c8d-95c7-06d87e6b8d4f" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_5af8eeb6-8635-4298-b61a-262f9b0f2799" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_1773b05c-9b00-4fbe-9e56-304c17cab50d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6fb235e9-cc5d-4c8d-95c7-06d87e6b8d4f" xlink:to="loc_us-gaap_BuildingMember_1773b05c-9b00-4fbe-9e56-304c17cab50d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_CapitalizedsoftwareMember_4ee509a3-06cd-44dc-a0be-4c92ed00a12e" xlink:href="unh-20211231.xsd#unh_CapitalizedsoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6fb235e9-cc5d-4c8d-95c7-06d87e6b8d4f" xlink:to="loc_unh_CapitalizedsoftwareMember_4ee509a3-06cd-44dc-a0be-4c92ed00a12e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_65691fdb-414c-489e-805c-ab747eae80ed" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_26413153-2218-4f33-8561-3548257ceb6a" xlink:to="loc_srt_RangeAxis_65691fdb-414c-489e-805c-ab747eae80ed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_65691fdb-414c-489e-805c-ab747eae80ed_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_65691fdb-414c-489e-805c-ab747eae80ed" xlink:to="loc_srt_RangeMember_65691fdb-414c-489e-805c-ab747eae80ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e19158d1-07bf-4a70-b13b-bc85d9e3ebcd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_65691fdb-414c-489e-805c-ab747eae80ed" xlink:to="loc_srt_RangeMember_e19158d1-07bf-4a70-b13b-bc85d9e3ebcd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0228ea85-345d-4e07-bbb2-b1ba606488ca" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e19158d1-07bf-4a70-b13b-bc85d9e3ebcd" xlink:to="loc_srt_MinimumMember_0228ea85-345d-4e07-bbb2-b1ba606488ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_01eb6184-0a52-4574-8dc4-46c9f60db69a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e19158d1-07bf-4a70-b13b-bc85d9e3ebcd" xlink:to="loc_srt_MaximumMember_01eb6184-0a52-4574-8dc4-46c9f60db69a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails" xlink:type="extended" id="i8e8cdf4b102e4486aa7a893933e2fab9_BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_73303512-224a-44b7-b1b1-3cb20ebd0077" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_f6ae144d-59fb-4744-885e-1460f526a779" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_73303512-224a-44b7-b1b1-3cb20ebd0077" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_f6ae144d-59fb-4744-885e-1460f526a779" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_3dcea132-a828-4905-8ebe-5188a99d502b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_73303512-224a-44b7-b1b1-3cb20ebd0077" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_3dcea132-a828-4905-8ebe-5188a99d502b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_83f73d9e-4c57-4574-b1da-d0986dcfcaf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_73303512-224a-44b7-b1b1-3cb20ebd0077" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_83f73d9e-4c57-4574-b1da-d0986dcfcaf9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_078fbaf8-b1f7-4472-b832-f12c19ddfb06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_73303512-224a-44b7-b1b1-3cb20ebd0077" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_078fbaf8-b1f7-4472-b832-f12c19ddfb06" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_93618153-9296-4b4d-a7f4-83450ffcbb96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_73303512-224a-44b7-b1b1-3cb20ebd0077" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_93618153-9296-4b4d-a7f4-83450ffcbb96" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue_574fbc1b-36b7-422c-b092-1dd8462bb051" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestChangeInRedemptionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_73303512-224a-44b7-b1b1-3cb20ebd0077" xlink:to="loc_us-gaap_MinorityInterestChangeInRedemptionValue_574fbc1b-36b7-422c-b092-1dd8462bb051" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_690419b8-f743-49f5-ad1f-d52bb6e24f49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_6fe07c7c-121e-4f36-bd3a-fb0d5f58158d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MinorityInterestLineItems_73303512-224a-44b7-b1b1-3cb20ebd0077" xlink:to="loc_us-gaap_MinorityInterestTable_6fe07c7c-121e-4f36-bd3a-fb0d5f58158d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_7ee69604-f275-4289-9131-3b7f1278309a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_6fe07c7c-121e-4f36-bd3a-fb0d5f58158d" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_7ee69604-f275-4289-9131-3b7f1278309a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_7ee69604-f275-4289-9131-3b7f1278309a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7ee69604-f275-4289-9131-3b7f1278309a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_7ee69604-f275-4289-9131-3b7f1278309a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_ebe1758a-df00-4d52-9607-4e6b8211a0bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7ee69604-f275-4289-9131-3b7f1278309a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_ebe1758a-df00-4d52-9607-4e6b8211a0bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_RedeemableNoncontrollingInterestsMember_65cb798c-efe0-4931-bd2c-6868b95261d5" xlink:href="unh-20211231.xsd#unh_RedeemableNoncontrollingInterestsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ebe1758a-df00-4d52-9607-4e6b8211a0bd" xlink:to="loc_unh_RedeemableNoncontrollingInterestsMember_65cb798c-efe0-4931-bd2c-6868b95261d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b8ac47c5-e9d2-4d2c-a4fe-03c770e01f19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_6fe07c7c-121e-4f36-bd3a-fb0d5f58158d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b8ac47c5-e9d2-4d2c-a4fe-03c770e01f19" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b8ac47c5-e9d2-4d2c-a4fe-03c770e01f19_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b8ac47c5-e9d2-4d2c-a4fe-03c770e01f19" xlink:to="loc_us-gaap_EquityComponentDomain_b8ac47c5-e9d2-4d2c-a4fe-03c770e01f19_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_511fb292-a9c6-4e5e-b885-598e6a681862" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b8ac47c5-e9d2-4d2c-a4fe-03c770e01f19" xlink:to="loc_us-gaap_EquityComponentDomain_511fb292-a9c6-4e5e-b885-598e6a681862" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/InvestmentsTables" xlink:type="simple" xlink:href="unh-20211231.xsd#InvestmentsTables"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/InvestmentsTables" xlink:type="extended" id="iea99685e30504e16a34f4fac3db8a6b0_InvestmentsTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_bcb7cd2b-5ed4-47d7-9792-6e78f27fd536" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_40b788f0-af8a-458d-a646-6e0fc7a34b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bcb7cd2b-5ed4-47d7-9792-6e78f27fd536" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_40b788f0-af8a-458d-a646-6e0fc7a34b6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_1ddfe873-f7af-4741-8390-8f2fd494a3c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bcb7cd2b-5ed4-47d7-9792-6e78f27fd536" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_1ddfe873-f7af-4741-8390-8f2fd494a3c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_8a08d92b-c578-4d47-b49e-976596b13394" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bcb7cd2b-5ed4-47d7-9792-6e78f27fd536" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_8a08d92b-c578-4d47-b49e-976596b13394" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_cda7c685-951c-4692-886f-9587dc9dabdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_bcb7cd2b-5ed4-47d7-9792-6e78f27fd536" xlink:to="loc_us-gaap_StatementTable_cda7c685-951c-4692-886f-9587dc9dabdc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_8b8d181f-e166-446c-9282-32d4043e57e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_cda7c685-951c-4692-886f-9587dc9dabdc" xlink:to="loc_us-gaap_InvestmentTypeAxis_8b8d181f-e166-446c-9282-32d4043e57e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_8b8d181f-e166-446c-9282-32d4043e57e2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_8b8d181f-e166-446c-9282-32d4043e57e2" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_8b8d181f-e166-446c-9282-32d4043e57e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_8b272045-e1e4-41cf-a1f9-c2c91c609b5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_8b8d181f-e166-446c-9282-32d4043e57e2" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_8b272045-e1e4-41cf-a1f9-c2c91c609b5f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/InvestmentsNarrativeDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#InvestmentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/InvestmentsNarrativeDetails" xlink:type="extended" id="i45a7019a8dae4fbb9927f5eb125d4c44_InvestmentsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_unh_InvestmentLineItems_a7319841-ad2f-436a-b576-c386720ce479" xlink:href="unh-20211231.xsd#unh_InvestmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_fe3158b5-838f-4888-afa7-cf3f3ffdf9b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_unh_InvestmentLineItems_a7319841-ad2f-436a-b576-c386720ce479" xlink:to="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_fe3158b5-838f-4888-afa7-cf3f3ffdf9b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_3c8d7e34-4f8b-4fba-81d2-770bf0268b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_unh_InvestmentLineItems_a7319841-ad2f-436a-b576-c386720ce479" xlink:to="loc_us-gaap_EquityMethodInvestments_3c8d7e34-4f8b-4fba-81d2-770bf0268b0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_4b240ec6-5ac4-415b-a382-6da1027189b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_unh_InvestmentLineItems_a7319841-ad2f-436a-b576-c386720ce479" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_4b240ec6-5ac4-415b-a382-6da1027189b0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedBalanceContracts_e23f434e-ae77-4b0a-b582-1e95cff3acff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentOwnedBalanceContracts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_unh_InvestmentLineItems_a7319841-ad2f-436a-b576-c386720ce479" xlink:to="loc_us-gaap_InvestmentOwnedBalanceContracts_e23f434e-ae77-4b0a-b582-1e95cff3acff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_InvestmentTable_511a1181-16c9-425f-8f8c-115340b4cd6c" xlink:href="unh-20211231.xsd#unh_InvestmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_unh_InvestmentLineItems_a7319841-ad2f-436a-b576-c386720ce479" xlink:to="loc_unh_InvestmentTable_511a1181-16c9-425f-8f8c-115340b4cd6c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_eabb5313-0994-431b-a2eb-9bc1db7e48b7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_unh_InvestmentTable_511a1181-16c9-425f-8f8c-115340b4cd6c" xlink:to="loc_srt_StatementScenarioAxis_eabb5313-0994-431b-a2eb-9bc1db7e48b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_eabb5313-0994-431b-a2eb-9bc1db7e48b7_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_eabb5313-0994-431b-a2eb-9bc1db7e48b7" xlink:to="loc_srt_ScenarioUnspecifiedDomain_eabb5313-0994-431b-a2eb-9bc1db7e48b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_b0c4d734-7b29-407f-b631-ba9c9f71e2b8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_eabb5313-0994-431b-a2eb-9bc1db7e48b7" xlink:to="loc_srt_ScenarioUnspecifiedDomain_b0c4d734-7b29-407f-b631-ba9c9f71e2b8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#InvestmentsShortTermandLongTermInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails" xlink:type="extended" id="i072d934267844ddbae0a7e52f5b19609_InvestmentsShortTermandLongTermInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_92204d97-685e-4adb-8740-111dac6c6f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_fe7ac68f-4264-44cb-b593-a7228cd2d85f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92204d97-685e-4adb-8740-111dac6c6f2b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_fe7ac68f-4264-44cb-b593-a7228cd2d85f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_00ca3f96-aba3-4e3c-8878-32c2dbe9096a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92204d97-685e-4adb-8740-111dac6c6f2b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_00ca3f96-aba3-4e3c-8878-32c2dbe9096a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_20014d55-5fed-452f-83e0-33ed08bc4936" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92204d97-685e-4adb-8740-111dac6c6f2b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_20014d55-5fed-452f-83e0-33ed08bc4936" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_47606991-13f2-46c7-8dad-b31baa6635f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92204d97-685e-4adb-8740-111dac6c6f2b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_47606991-13f2-46c7-8dad-b31baa6635f0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_43daa193-0fcf-476b-a083-fe94a09a5e22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92204d97-685e-4adb-8740-111dac6c6f2b" xlink:to="loc_us-gaap_HeldToMaturitySecurities_43daa193-0fcf-476b-a083-fe94a09a5e22" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_236080ed-5ee1-4b08-a410-6d2cb99c605a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92204d97-685e-4adb-8740-111dac6c6f2b" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_236080ed-5ee1-4b08-a410-6d2cb99c605a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_67d9db7e-192c-497a-a0e5-7de86df9d261" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92204d97-685e-4adb-8740-111dac6c6f2b" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_67d9db7e-192c-497a-a0e5-7de86df9d261" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_d1e36bff-b643-4c1b-a7b3-6548293e59fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92204d97-685e-4adb-8740-111dac6c6f2b" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_d1e36bff-b643-4c1b-a7b3-6548293e59fe" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_InvestmentsAmortizedCost_3a77ade5-dfd7-4214-b0a8-67cf1f13c365" xlink:href="unh-20211231.xsd#unh_InvestmentsAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92204d97-685e-4adb-8740-111dac6c6f2b" xlink:to="loc_unh_InvestmentsAmortizedCost_3a77ade5-dfd7-4214-b0a8-67cf1f13c365" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_InvestmentsGrossUnrealizedGains_46585019-9640-4c5c-8eda-6c4c2e1bc698" xlink:href="unh-20211231.xsd#unh_InvestmentsGrossUnrealizedGains"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92204d97-685e-4adb-8740-111dac6c6f2b" xlink:to="loc_unh_InvestmentsGrossUnrealizedGains_46585019-9640-4c5c-8eda-6c4c2e1bc698" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_InvestmentsGrossUnrealizedLosses_07418d77-cd38-416f-ab19-4fe439af4272" xlink:href="unh-20211231.xsd#unh_InvestmentsGrossUnrealizedLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92204d97-685e-4adb-8740-111dac6c6f2b" xlink:to="loc_unh_InvestmentsGrossUnrealizedLosses_07418d77-cd38-416f-ab19-4fe439af4272" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_4173fd85-15ef-4b8f-97e8-f22397401192" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92204d97-685e-4adb-8740-111dac6c6f2b" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_4173fd85-15ef-4b8f-97e8-f22397401192" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_65d6b098-90a6-4dd9-8f3f-63058fb14f97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92204d97-685e-4adb-8740-111dac6c6f2b" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_65d6b098-90a6-4dd9-8f3f-63058fb14f97" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_c38ff9de-9173-471f-a68a-d62d59095910" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_65d6b098-90a6-4dd9-8f3f-63058fb14f97" xlink:to="loc_us-gaap_FinancialInstrumentAxis_c38ff9de-9173-471f-a68a-d62d59095910" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c38ff9de-9173-471f-a68a-d62d59095910_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_c38ff9de-9173-471f-a68a-d62d59095910" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c38ff9de-9173-471f-a68a-d62d59095910_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_458d3d6c-86d3-4986-8c64-c341076135c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_c38ff9de-9173-471f-a68a-d62d59095910" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_458d3d6c-86d3-4986-8c64-c341076135c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_0a107e2d-780e-49b9-9da0-0a90822d2c8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_458d3d6c-86d3-4986-8c64-c341076135c8" xlink:to="loc_us-gaap_DebtSecuritiesMember_0a107e2d-780e-49b9-9da0-0a90822d2c8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_471f2b99-412f-4ce2-818f-49988f4df72e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_0a107e2d-780e-49b9-9da0-0a90822d2c8c" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_471f2b99-412f-4ce2-818f-49988f4df72e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_f77fed37-3cd7-4038-b14a-3d8dfebd4775" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_0a107e2d-780e-49b9-9da0-0a90822d2c8c" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_f77fed37-3cd7-4038-b14a-3d8dfebd4775" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_d50afd64-87c9-4018-b5c7-7dc484da087c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_0a107e2d-780e-49b9-9da0-0a90822d2c8c" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_d50afd64-87c9-4018-b5c7-7dc484da087c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_1533719a-282d-47e1-9b08-8a9fb43cfcb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_0a107e2d-780e-49b9-9da0-0a90822d2c8c" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_1533719a-282d-47e1-9b08-8a9fb43cfcb3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_a2bc621a-85ed-4117-800a-03af5d6b7bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_0a107e2d-780e-49b9-9da0-0a90822d2c8c" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_a2bc621a-85ed-4117-800a-03af5d6b7bcc" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="extended" id="ib1595e64bf2a4c6f9ce19381cf24350f_InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_fd4d3394-5934-4361-965c-0974fecebf15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_fd4d3394-5934-4361-965c-0974fecebf15" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_26d6c501-220c-42c8-bd0b-cea1d8c2b78c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_26d6c501-220c-42c8-bd0b-cea1d8c2b78c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_53b5033e-76d5-4342-b51f-4203d7737924" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_53b5033e-76d5-4342-b51f-4203d7737924" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_ec5d691f-cf54-413e-9ef3-617772a2e6fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_ec5d691f-cf54-413e-9ef3-617772a2e6fd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_810ea558-f9e5-4375-b9d9-631d9b316cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_810ea558-f9e5-4375-b9d9-631d9b316cb6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f1f272c3-f6d5-466d-80bc-6fb10b3a3378" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f1f272c3-f6d5-466d-80bc-6fb10b3a3378" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_8a2d7a15-722a-4bac-bfab-e979ade09756" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_8a2d7a15-722a-4bac-bfab-e979ade09756" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_59fce7ad-15e2-4d4f-9ee5-5ddea117fbf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_59fce7ad-15e2-4d4f-9ee5-5ddea117fbf9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_d97a3dff-e1cb-4f27-8939-c4944571d5f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_d97a3dff-e1cb-4f27-8939-c4944571d5f8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_b9539bad-670e-4059-93d5-161844ae4b48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_b9539bad-670e-4059-93d5-161844ae4b48" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_611678df-6eef-4e60-9874-f1d5e97dd1e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_611678df-6eef-4e60-9874-f1d5e97dd1e5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount_5081c766-1353-4599-af0c-95f9fb8d3865" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount_5081c766-1353-4599-af0c-95f9fb8d3865" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue_6e459337-7b8f-49c4-b9ba-6c510e7d56b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue_6e459337-7b8f-49c4-b9ba-6c510e7d56b8" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount_c2a4d966-cd08-43e6-9afa-18720811eaaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount_c2a4d966-cd08-43e6-9afa-18720811eaaa" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_344ce490-be1e-4ecd-82c3-ea5685950646" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_344ce490-be1e-4ecd-82c3-ea5685950646" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount_6c438c7d-5dfa-49e0-b591-0a00d40f82f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount_6c438c7d-5dfa-49e0-b591-0a00d40f82f6" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_1c9a4bc1-745b-4ab1-a833-0b130d50e4ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_1c9a4bc1-745b-4ab1-a833-0b130d50e4ef" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount_be760ac4-bfcf-475e-9064-02ab0754733f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount_be760ac4-bfcf-475e-9064-02ab0754733f" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue_96422f81-649d-41d1-82ac-c23bec736a6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue_96422f81-649d-41d1-82ac-c23bec736a6a" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_a915b4c4-1057-415c-86b2-4a9018f87a05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_a915b4c4-1057-415c-86b2-4a9018f87a05" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_201394e7-9de2-4696-b8ea-0a7d41ee5914" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_HeldToMaturitySecurities_201394e7-9de2-4696-b8ea-0a7d41ee5914" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_b0005ad6-4a43-4875-bb97-eb4d187b83a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_b0005ad6-4a43-4875-bb97-eb4d187b83a1" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_e9efaa44-5ef8-4854-a813-ee790bd1ca1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_e9efaa44-5ef8-4854-a813-ee790bd1ca1d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_53951514-961d-4cb0-84e9-5a50dc9ca0c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_e9efaa44-5ef8-4854-a813-ee790bd1ca1d" xlink:to="loc_us-gaap_FinancialInstrumentAxis_53951514-961d-4cb0-84e9-5a50dc9ca0c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53951514-961d-4cb0-84e9-5a50dc9ca0c6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_53951514-961d-4cb0-84e9-5a50dc9ca0c6" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53951514-961d-4cb0-84e9-5a50dc9ca0c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1a3736e5-8c06-4901-a622-179041a2e456" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_53951514-961d-4cb0-84e9-5a50dc9ca0c6" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1a3736e5-8c06-4901-a622-179041a2e456" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_47f5a9d2-cbfd-43b3-80c9-14498059ad7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1a3736e5-8c06-4901-a622-179041a2e456" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_47f5a9d2-cbfd-43b3-80c9-14498059ad7a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_bc7d8fee-9619-4859-9557-4ade9d26ddb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1a3736e5-8c06-4901-a622-179041a2e456" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_bc7d8fee-9619-4859-9557-4ade9d26ddb3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails" xlink:type="extended" id="i8ecab5bcfb81469f953c193dfb88a3ae_InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_f034ebe1-d72e-46cc-bfc9-d2d9a53bf00d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_d2362ee4-117d-4845-a0cf-596cd38707ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_f034ebe1-d72e-46cc-bfc9-d2d9a53bf00d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_d2362ee4-117d-4845-a0cf-596cd38707ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_4c92d80e-319c-46de-87e1-d07c7e9c9f89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_f034ebe1-d72e-46cc-bfc9-d2d9a53bf00d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_4c92d80e-319c-46de-87e1-d07c7e9c9f89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_be46aba4-649e-4a49-98ef-716c08d8eab8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_f034ebe1-d72e-46cc-bfc9-d2d9a53bf00d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_be46aba4-649e-4a49-98ef-716c08d8eab8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_d4c38b51-787d-4a88-9b2d-856a28d0df93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_f034ebe1-d72e-46cc-bfc9-d2d9a53bf00d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_d4c38b51-787d-4a88-9b2d-856a28d0df93" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_adc2935f-0e8e-40e0-96c6-04a6c5bcff91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_f034ebe1-d72e-46cc-bfc9-d2d9a53bf00d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_adc2935f-0e8e-40e0-96c6-04a6c5bcff91" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_764c091f-ee37-4426-9d6e-c4673b7c8c66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_f034ebe1-d72e-46cc-bfc9-d2d9a53bf00d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_764c091f-ee37-4426-9d6e-c4673b7c8c66" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_cae3525e-e54f-44e1-83c9-5c94ebca526a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_f034ebe1-d72e-46cc-bfc9-d2d9a53bf00d" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_cae3525e-e54f-44e1-83c9-5c94ebca526a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_66c416db-107e-478f-b692-c23bc1719423" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_cae3525e-e54f-44e1-83c9-5c94ebca526a" xlink:to="loc_us-gaap_FinancialInstrumentAxis_66c416db-107e-478f-b692-c23bc1719423" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_66c416db-107e-478f-b692-c23bc1719423_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_66c416db-107e-478f-b692-c23bc1719423" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_66c416db-107e-478f-b692-c23bc1719423_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2b910c4d-77e5-4c1c-9b3e-6683352a545f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_66c416db-107e-478f-b692-c23bc1719423" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2b910c4d-77e5-4c1c-9b3e-6683352a545f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_23e63908-2e75-48c6-a0ab-ec1f9bd42f3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2b910c4d-77e5-4c1c-9b3e-6683352a545f" xlink:to="loc_us-gaap_DebtSecuritiesMember_23e63908-2e75-48c6-a0ab-ec1f9bd42f3a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_f29a7d41-54d2-4e91-9470-8916203bd7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_23e63908-2e75-48c6-a0ab-ec1f9bd42f3a" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_f29a7d41-54d2-4e91-9470-8916203bd7a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_b5989112-a5e8-45c9-b59d-12c4dfa33ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_23e63908-2e75-48c6-a0ab-ec1f9bd42f3a" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_b5989112-a5e8-45c9-b59d-12c4dfa33ca1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_691e1436-f02d-4ed0-8a5c-eea7f8b58bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_23e63908-2e75-48c6-a0ab-ec1f9bd42f3a" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_691e1436-f02d-4ed0-8a5c-eea7f8b58bbe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_51cbb9c4-7bff-4051-97e6-8baa315a1814" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_23e63908-2e75-48c6-a0ab-ec1f9bd42f3a" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_51cbb9c4-7bff-4051-97e6-8baa315a1814" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_c113d2e1-5b90-4619-9012-4f1971c8cb12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_23e63908-2e75-48c6-a0ab-ec1f9bd42f3a" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_c113d2e1-5b90-4619-9012-4f1971c8cb12" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/FairValueFairValuePolicies" xlink:type="simple" xlink:href="unh-20211231.xsd#FairValueFairValuePolicies"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/FairValueFairValuePolicies" xlink:type="extended" id="i8e0ad31754d640a8932d9c5c516b7432_FairValueFairValuePolicies">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_414fb3bb-2fb8-4604-b4ef-4dcd19940676" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_9a5d4ecd-b84b-48f8-b910-808c25ffe147" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_414fb3bb-2fb8-4604-b4ef-4dcd19940676" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_9a5d4ecd-b84b-48f8-b910-808c25ffe147" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e43cb70d-e018-491c-ba78-6e855e845606" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_414fb3bb-2fb8-4604-b4ef-4dcd19940676" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e43cb70d-e018-491c-ba78-6e855e845606" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_41796d3d-f181-45c5-b4ec-34ea2e55334d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e43cb70d-e018-491c-ba78-6e855e845606" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_41796d3d-f181-45c5-b4ec-34ea2e55334d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_41796d3d-f181-45c5-b4ec-34ea2e55334d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_41796d3d-f181-45c5-b4ec-34ea2e55334d" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_41796d3d-f181-45c5-b4ec-34ea2e55334d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_fd64f965-d88c-4008-b61e-1cc6080d9cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_41796d3d-f181-45c5-b4ec-34ea2e55334d" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_fd64f965-d88c-4008-b61e-1cc6080d9cd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7600332a-41ed-4b2d-96b9-bc49aff93857" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e43cb70d-e018-491c-ba78-6e855e845606" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7600332a-41ed-4b2d-96b9-bc49aff93857" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7600332a-41ed-4b2d-96b9-bc49aff93857_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7600332a-41ed-4b2d-96b9-bc49aff93857" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7600332a-41ed-4b2d-96b9-bc49aff93857_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_41b3d42f-0e6a-447e-9954-f9c548cf3f86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7600332a-41ed-4b2d-96b9-bc49aff93857" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_41b3d42f-0e6a-447e-9954-f9c548cf3f86" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/FairValueTables" xlink:type="simple" xlink:href="unh-20211231.xsd#FairValueTables"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/FairValueTables" xlink:type="extended" id="i0e1100430b0148b799b1ca05efa3dd3b_FairValueTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b33ef1c1-8aa7-411f-94ba-95995597bd5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_84ffc9ea-0e54-448a-ad53-8860e78c22ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b33ef1c1-8aa7-411f-94ba-95995597bd5d" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_84ffc9ea-0e54-448a-ad53-8860e78c22ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock_d95de85d-c926-4746-b646-6b4bec182156" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b33ef1c1-8aa7-411f-94ba-95995597bd5d" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock_d95de85d-c926-4746-b646-6b4bec182156" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_099cd5e9-1156-4d52-9dde-e80232e93ded" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b33ef1c1-8aa7-411f-94ba-95995597bd5d" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_099cd5e9-1156-4d52-9dde-e80232e93ded" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0ae0e469-7702-45d9-b905-64bd57c93269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_099cd5e9-1156-4d52-9dde-e80232e93ded" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0ae0e469-7702-45d9-b905-64bd57c93269" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0ae0e469-7702-45d9-b905-64bd57c93269_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0ae0e469-7702-45d9-b905-64bd57c93269" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0ae0e469-7702-45d9-b905-64bd57c93269_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7155e047-d0a8-4a84-a92a-e804bf779503" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0ae0e469-7702-45d9-b905-64bd57c93269" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7155e047-d0a8-4a84-a92a-e804bf779503" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/FairValueNarrativeDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#FairValueNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/FairValueNarrativeDetails" xlink:type="extended" id="i9f2aa8b94dd942b991103afd77669527_FairValueNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_67dec37e-233f-4eb4-b522-482c7e4a4590" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_925e0a8f-08d6-4e86-b442-e15a9a342865" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_67dec37e-233f-4eb4-b522-482c7e4a4590" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_925e0a8f-08d6-4e86-b442-e15a9a342865" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_a077766f-3c4f-4985-9ebf-0d6381feb8c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_67dec37e-233f-4eb4-b522-482c7e4a4590" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_a077766f-3c4f-4985-9ebf-0d6381feb8c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis_f447dd49-c237-4c15-a84d-05bb82cee5a8" xlink:href="unh-20211231.xsd#unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_67dec37e-233f-4eb4-b522-482c7e4a4590" xlink:to="loc_unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis_f447dd49-c237-4c15-a84d-05bb82cee5a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGain_2f324045-b931-42e6-a94b-f5188119e05c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_67dec37e-233f-4eb4-b522-482c7e4a4590" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGain_2f324045-b931-42e6-a94b-f5188119e05c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_94026bfd-46e8-4a9c-94ed-e6383bca5a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_67dec37e-233f-4eb4-b522-482c7e4a4590" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_94026bfd-46e8-4a9c-94ed-e6383bca5a4b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0e8fc953-cc46-4807-9757-4c27d4dfa348" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_94026bfd-46e8-4a9c-94ed-e6383bca5a4b" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0e8fc953-cc46-4807-9757-4c27d4dfa348" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_0e8fc953-cc46-4807-9757-4c27d4dfa348_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0e8fc953-cc46-4807-9757-4c27d4dfa348" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_0e8fc953-cc46-4807-9757-4c27d4dfa348_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_54912a87-fdda-43c2-8921-5515fc6b6680" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0e8fc953-cc46-4807-9757-4c27d4dfa348" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_54912a87-fdda-43c2-8921-5515fc6b6680" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_411a14ae-ebdb-48f2-9805-19daf87e7c88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_54912a87-fdda-43c2-8921-5515fc6b6680" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_411a14ae-ebdb-48f2-9805-19daf87e7c88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_b1090da7-baa3-4b9f-b322-f9f6d0eec7d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_94026bfd-46e8-4a9c-94ed-e6383bca5a4b" xlink:to="loc_us-gaap_FinancialInstrumentAxis_b1090da7-baa3-4b9f-b322-f9f6d0eec7d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b1090da7-baa3-4b9f-b322-f9f6d0eec7d8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_b1090da7-baa3-4b9f-b322-f9f6d0eec7d8" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b1090da7-baa3-4b9f-b322-f9f6d0eec7d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cb661c27-3ac7-48f4-b84c-41ca20e49787" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_b1090da7-baa3-4b9f-b322-f9f6d0eec7d8" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cb661c27-3ac7-48f4-b84c-41ca20e49787" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_2da03928-3cf0-4900-ae59-1492eec09918" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cb661c27-3ac7-48f4-b84c-41ca20e49787" xlink:to="loc_us-gaap_DebtSecuritiesMember_2da03928-3cf0-4900-ae59-1492eec09918" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6310669c-ab68-490d-85ea-88bb2d5336ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_94026bfd-46e8-4a9c-94ed-e6383bca5a4b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6310669c-ab68-490d-85ea-88bb2d5336ce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6310669c-ab68-490d-85ea-88bb2d5336ce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6310669c-ab68-490d-85ea-88bb2d5336ce" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6310669c-ab68-490d-85ea-88bb2d5336ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_28793581-eb71-4d5a-b263-eba643e6e638" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6310669c-ab68-490d-85ea-88bb2d5336ce" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_28793581-eb71-4d5a-b263-eba643e6e638" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_b6e0a614-2816-4427-bca7-ea8adc30ee63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_28793581-eb71-4d5a-b263-eba643e6e638" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_b6e0a614-2816-4427-bca7-ea8adc30ee63" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended" id="i5c75b3dce6f0463984f67730f35b70c2_FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_32a974d5-5a73-4bd8-9c7c-8a142fd4bbee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_80c9d662-3bc1-4146-b705-49c3219a56ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_32a974d5-5a73-4bd8-9c7c-8a142fd4bbee" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_80c9d662-3bc1-4146-b705-49c3219a56ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0a57c2fe-e9eb-4216-a4d0-01f4a0482d65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_32a974d5-5a73-4bd8-9c7c-8a142fd4bbee" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0a57c2fe-e9eb-4216-a4d0-01f4a0482d65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_9ea6c865-db5a-4561-95b8-7a0619af732f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_32a974d5-5a73-4bd8-9c7c-8a142fd4bbee" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_9ea6c865-db5a-4561-95b8-7a0619af732f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_AarpAssetsUnderManagement_f9cb07be-00c0-45d3-8383-b257ac73468c" xlink:href="unh-20211231.xsd#unh_AarpAssetsUnderManagement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_32a974d5-5a73-4bd8-9c7c-8a142fd4bbee" xlink:to="loc_unh_AarpAssetsUnderManagement_f9cb07be-00c0-45d3-8383-b257ac73468c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_2cdf3029-03f4-495a-9a0c-30772022a36f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_32a974d5-5a73-4bd8-9c7c-8a142fd4bbee" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_2cdf3029-03f4-495a-9a0c-30772022a36f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_94a8bbb2-b8ef-4e96-ba16-23d6f70d084d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_32a974d5-5a73-4bd8-9c7c-8a142fd4bbee" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_94a8bbb2-b8ef-4e96-ba16-23d6f70d084d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_152486e7-21ab-4196-b816-148df5e21abd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_94a8bbb2-b8ef-4e96-ba16-23d6f70d084d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_152486e7-21ab-4196-b816-148df5e21abd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_152486e7-21ab-4196-b816-148df5e21abd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_152486e7-21ab-4196-b816-148df5e21abd" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_152486e7-21ab-4196-b816-148df5e21abd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a31255c0-d743-4385-9722-70883f5451cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_152486e7-21ab-4196-b816-148df5e21abd" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a31255c0-d743-4385-9722-70883f5451cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_caded8c2-1aa0-4a85-a17e-7102c2e6985f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a31255c0-d743-4385-9722-70883f5451cd" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_caded8c2-1aa0-4a85-a17e-7102c2e6985f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_1dc43219-564e-4ed8-abe0-822786d44dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a31255c0-d743-4385-9722-70883f5451cd" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_1dc43219-564e-4ed8-abe0-822786d44dbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_999e82e0-5fce-436f-ade7-69262a1d1240" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a31255c0-d743-4385-9722-70883f5451cd" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_999e82e0-5fce-436f-ade7-69262a1d1240" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_c6ecff36-f0eb-40f4-8b32-497c4db4d536" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_94a8bbb2-b8ef-4e96-ba16-23d6f70d084d" xlink:to="loc_us-gaap_FinancialInstrumentAxis_c6ecff36-f0eb-40f4-8b32-497c4db4d536" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c6ecff36-f0eb-40f4-8b32-497c4db4d536_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_c6ecff36-f0eb-40f4-8b32-497c4db4d536" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c6ecff36-f0eb-40f4-8b32-497c4db4d536_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8ebfe453-1283-455d-9d79-763ded39aa2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_c6ecff36-f0eb-40f4-8b32-497c4db4d536" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8ebfe453-1283-455d-9d79-763ded39aa2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_0ad63e5f-f06f-4fa0-9200-070554b10e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8ebfe453-1283-455d-9d79-763ded39aa2c" xlink:to="loc_us-gaap_DebtSecuritiesMember_0ad63e5f-f06f-4fa0-9200-070554b10e3a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_42bf2aa4-14d8-4152-8db4-3562a0201cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_0ad63e5f-f06f-4fa0-9200-070554b10e3a" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_42bf2aa4-14d8-4152-8db4-3562a0201cc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_d8a4de7c-03a5-47cc-8ad2-ff566f601aef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_0ad63e5f-f06f-4fa0-9200-070554b10e3a" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_d8a4de7c-03a5-47cc-8ad2-ff566f601aef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_3a1410d6-04cb-45f4-951a-dbc13202beea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_0ad63e5f-f06f-4fa0-9200-070554b10e3a" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_3a1410d6-04cb-45f4-951a-dbc13202beea" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_2e58dbaa-99e3-49d9-8420-bb6b830c6357" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_0ad63e5f-f06f-4fa0-9200-070554b10e3a" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_2e58dbaa-99e3-49d9-8420-bb6b830c6357" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_27258e66-e8aa-4cd0-9db9-372191da5467" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_0ad63e5f-f06f-4fa0-9200-070554b10e3a" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_27258e66-e8aa-4cd0-9db9-372191da5467" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended" id="i6720eeb4200647c9a60974a4c9f0e3a0_FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_fb7da5e1-7543-4a1f-a83f-114c87467072" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_47735721-fe91-424f-9802-302b7b8b0ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_fb7da5e1-7543-4a1f-a83f-114c87467072" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_47735721-fe91-424f-9802-302b7b8b0ddc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_c8edc8a4-453c-4b0a-8eac-e5c2a5d72954" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_fb7da5e1-7543-4a1f-a83f-114c87467072" xlink:to="loc_us-gaap_HeldToMaturitySecurities_c8edc8a4-453c-4b0a-8eac-e5c2a5d72954" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_197fa1bf-8f23-4777-9911-a01957f59694" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_fb7da5e1-7543-4a1f-a83f-114c87467072" xlink:to="loc_us-gaap_DebtInstrumentFairValue_197fa1bf-8f23-4777-9911-a01957f59694" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_4a7f68eb-f0a4-4a55-b8b6-e7358fe320b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_fb7da5e1-7543-4a1f-a83f-114c87467072" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_4a7f68eb-f0a4-4a55-b8b6-e7358fe320b2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e0f8905c-f4ff-4afb-b40c-6bb244b98074" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_fb7da5e1-7543-4a1f-a83f-114c87467072" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e0f8905c-f4ff-4afb-b40c-6bb244b98074" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_433c981a-ef11-45e2-9660-0e00515460a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e0f8905c-f4ff-4afb-b40c-6bb244b98074" xlink:to="loc_us-gaap_DebtInstrumentAxis_433c981a-ef11-45e2-9660-0e00515460a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_433c981a-ef11-45e2-9660-0e00515460a6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_433c981a-ef11-45e2-9660-0e00515460a6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_433c981a-ef11-45e2-9660-0e00515460a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e59cd08e-dd9c-4de5-8456-be364287d6ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_433c981a-ef11-45e2-9660-0e00515460a6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e59cd08e-dd9c-4de5-8456-be364287d6ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_0f48fb2b-d276-406a-9ec7-97c3c29f5add" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e59cd08e-dd9c-4de5-8456-be364287d6ce" xlink:to="loc_us-gaap_LongTermDebtMember_0f48fb2b-d276-406a-9ec7-97c3c29f5add" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_377f5889-57a8-4f8d-a8c1-b20fa2eac41c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e0f8905c-f4ff-4afb-b40c-6bb244b98074" xlink:to="loc_us-gaap_FinancialInstrumentAxis_377f5889-57a8-4f8d-a8c1-b20fa2eac41c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_377f5889-57a8-4f8d-a8c1-b20fa2eac41c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_377f5889-57a8-4f8d-a8c1-b20fa2eac41c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_377f5889-57a8-4f8d-a8c1-b20fa2eac41c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c6eeb23d-d689-48d9-b055-cbb23af02fa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_377f5889-57a8-4f8d-a8c1-b20fa2eac41c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c6eeb23d-d689-48d9-b055-cbb23af02fa7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_6e0e6906-99a9-4082-87a0-99fae2f5afc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c6eeb23d-d689-48d9-b055-cbb23af02fa7" xlink:to="loc_us-gaap_DebtSecuritiesMember_6e0e6906-99a9-4082-87a0-99fae2f5afc1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1d7ca528-e650-405d-b399-db033194f4f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e0f8905c-f4ff-4afb-b40c-6bb244b98074" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1d7ca528-e650-405d-b399-db033194f4f4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_1d7ca528-e650-405d-b399-db033194f4f4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1d7ca528-e650-405d-b399-db033194f4f4" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_1d7ca528-e650-405d-b399-db033194f4f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_72e9a48e-520a-4fab-bc79-ee1b5e44c385" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1d7ca528-e650-405d-b399-db033194f4f4" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_72e9a48e-520a-4fab-bc79-ee1b5e44c385" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_eb691087-83bd-42f3-8165-e7daa79c0d83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_72e9a48e-520a-4fab-bc79-ee1b5e44c385" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_eb691087-83bd-42f3-8165-e7daa79c0d83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_09141ee4-ea53-4bf0-a6b6-d122ef7a75c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e0f8905c-f4ff-4afb-b40c-6bb244b98074" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_09141ee4-ea53-4bf0-a6b6-d122ef7a75c5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_09141ee4-ea53-4bf0-a6b6-d122ef7a75c5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_09141ee4-ea53-4bf0-a6b6-d122ef7a75c5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_09141ee4-ea53-4bf0-a6b6-d122ef7a75c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f9055a2a-786f-44cd-a0c1-296a3cf195f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_09141ee4-ea53-4bf0-a6b6-d122ef7a75c5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f9055a2a-786f-44cd-a0c1-296a3cf195f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_4d3a7891-d9bb-4931-8590-5c9d7ae6902a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f9055a2a-786f-44cd-a0c1-296a3cf195f1" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_4d3a7891-d9bb-4931-8590-5c9d7ae6902a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_12602550-1e39-4495-b0fa-b93b6879eed2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f9055a2a-786f-44cd-a0c1-296a3cf195f1" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_12602550-1e39-4495-b0fa-b93b6879eed2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_a46e1869-1c8b-477b-9b1a-a231d62eb06b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f9055a2a-786f-44cd-a0c1-296a3cf195f1" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_a46e1869-1c8b-477b-9b1a-a231d62eb06b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNotes" xlink:type="simple" xlink:href="unh-20211231.xsd#PropertyPlantandCapitalizedSoftwareNotes"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNotes" xlink:type="extended" id="idd8b14805beb4475ab7c84c7a129afcf_PropertyPlantandCapitalizedSoftwareNotes">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_edf912c6-5191-4534-ae2c-861b8f159d34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_94d0e307-6704-47d7-b18c-547239788276" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_edf912c6-5191-4534-ae2c-861b8f159d34" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_94d0e307-6704-47d7-b18c-547239788276" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5d0bb504-d88d-46a0-bdbf-32f991e5d182" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_edf912c6-5191-4534-ae2c-861b8f159d34" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5d0bb504-d88d-46a0-bdbf-32f991e5d182" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e67a437d-e007-4337-ba41-f03283f28e60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5d0bb504-d88d-46a0-bdbf-32f991e5d182" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e67a437d-e007-4337-ba41-f03283f28e60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e67a437d-e007-4337-ba41-f03283f28e60_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e67a437d-e007-4337-ba41-f03283f28e60" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e67a437d-e007-4337-ba41-f03283f28e60_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6c470600-4932-4754-ae95-b3d9ca1bb35e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e67a437d-e007-4337-ba41-f03283f28e60" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6c470600-4932-4754-ae95-b3d9ca1bb35e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_15182c1e-a5f0-46a6-8a83-5c447a19d980" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5d0bb504-d88d-46a0-bdbf-32f991e5d182" xlink:to="loc_srt_RangeAxis_15182c1e-a5f0-46a6-8a83-5c447a19d980" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_15182c1e-a5f0-46a6-8a83-5c447a19d980_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_15182c1e-a5f0-46a6-8a83-5c447a19d980" xlink:to="loc_srt_RangeMember_15182c1e-a5f0-46a6-8a83-5c447a19d980_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c6e29403-1862-4225-aa90-08c3cb7e412d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_15182c1e-a5f0-46a6-8a83-5c447a19d980" xlink:to="loc_srt_RangeMember_c6e29403-1862-4225-aa90-08c3cb7e412d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareTables" xlink:type="simple" xlink:href="unh-20211231.xsd#PropertyPlantandCapitalizedSoftwareTables"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareTables" xlink:type="extended" id="i0b5f14bc286948f2ac7c27905ebe9711_PropertyPlantandCapitalizedSoftwareTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1e560d9b-d853-44db-8bf7-c504121281ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_c114da07-51c8-48b1-87d2-bb998bcf8536" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1e560d9b-d853-44db-8bf7-c504121281ac" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_c114da07-51c8-48b1-87d2-bb998bcf8536" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_99845447-f05c-40b6-9d43-8445859cd258" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1e560d9b-d853-44db-8bf7-c504121281ac" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_99845447-f05c-40b6-9d43-8445859cd258" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fbd12361-ee2c-4189-be32-c28ea0bee7ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_99845447-f05c-40b6-9d43-8445859cd258" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fbd12361-ee2c-4189-be32-c28ea0bee7ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_fbd12361-ee2c-4189-be32-c28ea0bee7ce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fbd12361-ee2c-4189-be32-c28ea0bee7ce" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_fbd12361-ee2c-4189-be32-c28ea0bee7ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_16ec7f10-8eca-485b-af42-9501a4122022" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fbd12361-ee2c-4189-be32-c28ea0bee7ce" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_16ec7f10-8eca-485b-af42-9501a4122022" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_28e549b8-beab-40ac-ba66-8a4f14bead98" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_99845447-f05c-40b6-9d43-8445859cd258" xlink:to="loc_srt_RangeAxis_28e549b8-beab-40ac-ba66-8a4f14bead98" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_28e549b8-beab-40ac-ba66-8a4f14bead98_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_28e549b8-beab-40ac-ba66-8a4f14bead98" xlink:to="loc_srt_RangeMember_28e549b8-beab-40ac-ba66-8a4f14bead98_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a90cd075-9ccb-439d-98ac-83f3ddf5605c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_28e549b8-beab-40ac-ba66-8a4f14bead98" xlink:to="loc_srt_RangeMember_a90cd075-9ccb-439d-98ac-83f3ddf5605c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNarrativeDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#PropertyPlantandCapitalizedSoftwareNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNarrativeDetails" xlink:type="extended" id="i85151e9a3d7841adbba51b7ef2bb1cc4_PropertyPlantandCapitalizedSoftwareNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_db30081e-8497-4d31-b036-f19330f33eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_c0e7001b-c981-4fea-a656-eb6aeeda9ea3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_db30081e-8497-4d31-b036-f19330f33eeb" xlink:to="loc_us-gaap_Depreciation_c0e7001b-c981-4fea-a656-eb6aeeda9ea3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_d9a137cf-5759-4596-a6a5-97f923f2b625" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_db30081e-8497-4d31-b036-f19330f33eeb" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_d9a137cf-5759-4596-a6a5-97f923f2b625" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_758dea8d-e335-4c24-8377-20c5032391d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_db30081e-8497-4d31-b036-f19330f33eeb" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_758dea8d-e335-4c24-8377-20c5032391d4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_256094f2-0c31-44ae-aedc-87e6d57158af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_758dea8d-e335-4c24-8377-20c5032391d4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_256094f2-0c31-44ae-aedc-87e6d57158af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_256094f2-0c31-44ae-aedc-87e6d57158af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_256094f2-0c31-44ae-aedc-87e6d57158af" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_256094f2-0c31-44ae-aedc-87e6d57158af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_90a4044d-71cc-42bd-adf8-3decc05a1046" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_256094f2-0c31-44ae-aedc-87e6d57158af" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_90a4044d-71cc-42bd-adf8-3decc05a1046" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails" xlink:type="extended" id="i4f6ec137a1b34a8f8dc03bd085a090f2_PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d69390fd-d799-4ac3-9616-cd793d50a8fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovements_33f248c6-7797-431f-8f29-5c1cc8d6834a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandAndLandImprovements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d69390fd-d799-4ac3-9616-cd793d50a8fc" xlink:to="loc_us-gaap_LandAndLandImprovements_33f248c6-7797-431f-8f29-5c1cc8d6834a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_dd5f4347-d58a-4b5c-ba96-a8ef26f8e447" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d69390fd-d799-4ac3-9616-cd793d50a8fc" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_dd5f4347-d58a-4b5c-ba96-a8ef26f8e447" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_020d5f8a-23bc-4374-bbea-044e86334d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d69390fd-d799-4ac3-9616-cd793d50a8fc" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_020d5f8a-23bc-4374-bbea-044e86334d0e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_ed862bbf-c15b-4b55-8101-f205aa5316f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d69390fd-d799-4ac3-9616-cd793d50a8fc" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_ed862bbf-c15b-4b55-8101-f205aa5316f0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation_1dd44442-93d4-4bfd-8902-54ac43b40482" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d69390fd-d799-4ac3-9616-cd793d50a8fc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation_1dd44442-93d4-4bfd-8902-54ac43b40482" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet_3b423068-6147-4a8f-935a-a3a332cda310" xlink:href="unh-20211231.xsd#unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d69390fd-d799-4ac3-9616-cd793d50a8fc" xlink:to="loc_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet_3b423068-6147-4a8f-935a-a3a332cda310" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareGross_6ee1210b-0a64-43a0-8c9d-0b1df09c5139" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d69390fd-d799-4ac3-9616-cd793d50a8fc" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareGross_6ee1210b-0a64-43a0-8c9d-0b1df09c5139" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_a5f7c9e4-8850-435b-aa04-67f4fc2cb0a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d69390fd-d799-4ac3-9616-cd793d50a8fc" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_a5f7c9e4-8850-435b-aa04-67f4fc2cb0a5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet_fb6801cc-a04e-4992-af06-f804f90c3fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d69390fd-d799-4ac3-9616-cd793d50a8fc" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareNet_fb6801cc-a04e-4992-af06-f804f90c3fe9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_c0b35841-d333-4329-ab6f-c16d3ea360ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d69390fd-d799-4ac3-9616-cd793d50a8fc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_c0b35841-d333-4329-ab6f-c16d3ea360ce" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_759c3a87-cc0a-4774-8446-b6a38cab4d21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d69390fd-d799-4ac3-9616-cd793d50a8fc" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_759c3a87-cc0a-4774-8446-b6a38cab4d21" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f66684dd-0dd8-4a45-8606-2ee1fec965b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_759c3a87-cc0a-4774-8446-b6a38cab4d21" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f66684dd-0dd8-4a45-8606-2ee1fec965b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f66684dd-0dd8-4a45-8606-2ee1fec965b1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f66684dd-0dd8-4a45-8606-2ee1fec965b1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f66684dd-0dd8-4a45-8606-2ee1fec965b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_be689434-93c8-4b40-83ae-f8c4d16f1b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f66684dd-0dd8-4a45-8606-2ee1fec965b1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_be689434-93c8-4b40-83ae-f8c4d16f1b0b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsNotes" xlink:type="simple" xlink:href="unh-20211231.xsd#GoodwillandIntangibleAssetsNotes"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/GoodwillandIntangibleAssetsNotes" xlink:type="extended" id="i5a6a7bd5048647f2871af3b1ce1d398d_GoodwillandIntangibleAssetsNotes">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_22fd01b9-41ba-4f77-8d6a-7d101aec750f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_1d2f5ef9-8257-4cea-8c9b-929b75d23196" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_22fd01b9-41ba-4f77-8d6a-7d101aec750f" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_1d2f5ef9-8257-4cea-8c9b-929b75d23196" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_57eb1a7b-6306-438a-aa89-c9d684103b7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_22fd01b9-41ba-4f77-8d6a-7d101aec750f" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_57eb1a7b-6306-438a-aa89-c9d684103b7d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_6115ac75-9a8e-4e0c-a3a9-bc5b345b9a6f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_57eb1a7b-6306-438a-aa89-c9d684103b7d" xlink:to="loc_srt_ConsolidationItemsAxis_6115ac75-9a8e-4e0c-a3a9-bc5b345b9a6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_6115ac75-9a8e-4e0c-a3a9-bc5b345b9a6f_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_6115ac75-9a8e-4e0c-a3a9-bc5b345b9a6f" xlink:to="loc_srt_ConsolidationItemsDomain_6115ac75-9a8e-4e0c-a3a9-bc5b345b9a6f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_05f14c21-4d5a-4e87-9de9-4574f614a1ac" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_6115ac75-9a8e-4e0c-a3a9-bc5b345b9a6f" xlink:to="loc_srt_ConsolidationItemsDomain_05f14c21-4d5a-4e87-9de9-4574f614a1ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d34bcf54-70e3-420f-a0cf-e899b285aca1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_57eb1a7b-6306-438a-aa89-c9d684103b7d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d34bcf54-70e3-420f-a0cf-e899b285aca1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d34bcf54-70e3-420f-a0cf-e899b285aca1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d34bcf54-70e3-420f-a0cf-e899b285aca1" xlink:to="loc_us-gaap_SegmentDomain_d34bcf54-70e3-420f-a0cf-e899b285aca1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c8fb5aaa-2ce5-4c11-b778-bfd1235ba558" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d34bcf54-70e3-420f-a0cf-e899b285aca1" xlink:to="loc_us-gaap_SegmentDomain_c8fb5aaa-2ce5-4c11-b778-bfd1235ba558" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6bc4bb8f-5471-4178-ba45-23038441a8ad" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_57eb1a7b-6306-438a-aa89-c9d684103b7d" xlink:to="loc_srt_RangeAxis_6bc4bb8f-5471-4178-ba45-23038441a8ad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6bc4bb8f-5471-4178-ba45-23038441a8ad_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6bc4bb8f-5471-4178-ba45-23038441a8ad" xlink:to="loc_srt_RangeMember_6bc4bb8f-5471-4178-ba45-23038441a8ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_524f28cb-474b-491d-a2a1-7d67b9d9e27d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6bc4bb8f-5471-4178-ba45-23038441a8ad" xlink:to="loc_srt_RangeMember_524f28cb-474b-491d-a2a1-7d67b9d9e27d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsTables" xlink:type="simple" xlink:href="unh-20211231.xsd#GoodwillandIntangibleAssetsTables"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/GoodwillandIntangibleAssetsTables" xlink:type="extended" id="i5b54c45ea1bc4447b30ce2d520af60c4_GoodwillandIntangibleAssetsTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_e1127096-54ec-4056-b0f6-30ae488b088f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_a6d727a9-049c-4fbb-9cef-cee4254854b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_e1127096-54ec-4056-b0f6-30ae488b088f" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_a6d727a9-049c-4fbb-9cef-cee4254854b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock_5ff8f11e-02de-4b57-981f-79ec6b13b85c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_e1127096-54ec-4056-b0f6-30ae488b088f" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock_5ff8f11e-02de-4b57-981f-79ec6b13b85c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_568b4cd2-42c0-4b98-ac51-cbb3cd1f137d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_e1127096-54ec-4056-b0f6-30ae488b088f" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_568b4cd2-42c0-4b98-ac51-cbb3cd1f137d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_01331c16-4c7e-4c64-b176-3d18f9c3c8e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_e1127096-54ec-4056-b0f6-30ae488b088f" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_01331c16-4c7e-4c64-b176-3d18f9c3c8e1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_82a44e70-d30f-4d04-90b4-0a0eb2935f00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_e1127096-54ec-4056-b0f6-30ae488b088f" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_82a44e70-d30f-4d04-90b4-0a0eb2935f00" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_93f4c2c2-4dbd-47b7-8c8d-51055ccd1c0d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_82a44e70-d30f-4d04-90b4-0a0eb2935f00" xlink:to="loc_srt_ConsolidationItemsAxis_93f4c2c2-4dbd-47b7-8c8d-51055ccd1c0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_93f4c2c2-4dbd-47b7-8c8d-51055ccd1c0d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_93f4c2c2-4dbd-47b7-8c8d-51055ccd1c0d" xlink:to="loc_srt_ConsolidationItemsDomain_93f4c2c2-4dbd-47b7-8c8d-51055ccd1c0d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_82d57910-1a29-4cf0-94ac-485477e1c722" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_93f4c2c2-4dbd-47b7-8c8d-51055ccd1c0d" xlink:to="loc_srt_ConsolidationItemsDomain_82d57910-1a29-4cf0-94ac-485477e1c722" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#GoodwillandIntangibleAssetsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="extended" id="i4dcd852299b24a108672ebcea71696f9_GoodwillandIntangibleAssetsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_85c4f87f-bd30-42a2-886a-627676ac1253" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_a0a11d74-e6c2-49c3-98c2-42cc0de8d78c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_85c4f87f-bd30-42a2-886a-627676ac1253" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_a0a11d74-e6c2-49c3-98c2-42cc0de8d78c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb1879c2-af83-4b95-bc19-ee6ca8aef09a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_85c4f87f-bd30-42a2-886a-627676ac1253" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb1879c2-af83-4b95-bc19-ee6ca8aef09a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_449a2108-fdc0-48c7-b4ec-1a094c72e9c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb1879c2-af83-4b95-bc19-ee6ca8aef09a" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_449a2108-fdc0-48c7-b4ec-1a094c72e9c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_449a2108-fdc0-48c7-b4ec-1a094c72e9c3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_449a2108-fdc0-48c7-b4ec-1a094c72e9c3" xlink:to="loc_us-gaap_TypeOfAdoptionMember_449a2108-fdc0-48c7-b4ec-1a094c72e9c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_f5e2f3ce-c8cf-46df-891e-e7b029966285" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_449a2108-fdc0-48c7-b4ec-1a094c72e9c3" xlink:to="loc_us-gaap_TypeOfAdoptionMember_f5e2f3ce-c8cf-46df-891e-e7b029966285" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails" xlink:type="extended" id="icb0859be297246959ff07b06864a0e93_GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_85195817-8cd5-4994-aecc-671a86238afb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ec94c90a-3fc6-4fd9-a3c7-12a53dffb7e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_85195817-8cd5-4994-aecc-671a86238afb" xlink:to="loc_us-gaap_Goodwill_ec94c90a-3fc6-4fd9-a3c7-12a53dffb7e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_c250f403-7483-48b2-ac4d-6ee75cd22734" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_85195817-8cd5-4994-aecc-671a86238afb" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_c250f403-7483-48b2-ac4d-6ee75cd22734" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_f388d04e-4485-4c0d-960c-62f6cdd0ffd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_85195817-8cd5-4994-aecc-671a86238afb" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_f388d04e-4485-4c0d-960c-62f6cdd0ffd4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1182bae0-137c-4186-bcd3-ea212928e089" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_63ff997f-1968-4928-89fd-3b543b3a52d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_85195817-8cd5-4994-aecc-671a86238afb" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_63ff997f-1968-4928-89fd-3b543b3a52d8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_fa22aa02-b837-4807-b157-f9685c66832c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_63ff997f-1968-4928-89fd-3b543b3a52d8" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_fa22aa02-b837-4807-b157-f9685c66832c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fa22aa02-b837-4807-b157-f9685c66832c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fa22aa02-b837-4807-b157-f9685c66832c" xlink:to="loc_us-gaap_SegmentDomain_fa22aa02-b837-4807-b157-f9685c66832c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ebae5209-1429-4501-94a8-8c28ef5b4907" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fa22aa02-b837-4807-b157-f9685c66832c" xlink:to="loc_us-gaap_SegmentDomain_ebae5209-1429-4501-94a8-8c28ef5b4907" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_UnitedhealthcareMember_c8289048-520d-45f4-a37b-fd810d9336b3" xlink:href="unh-20211231.xsd#unh_UnitedhealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ebae5209-1429-4501-94a8-8c28ef5b4907" xlink:to="loc_unh_UnitedhealthcareMember_c8289048-520d-45f4-a37b-fd810d9336b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OptumhealthMember_494adef0-2ca5-4c89-b047-15eefdda223a" xlink:href="unh-20211231.xsd#unh_OptumhealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ebae5209-1429-4501-94a8-8c28ef5b4907" xlink:to="loc_unh_OptumhealthMember_494adef0-2ca5-4c89-b047-15eefdda223a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OptuminsightMember_1534ae91-d19e-4876-9249-5edd787a73f9" xlink:href="unh-20211231.xsd#unh_OptuminsightMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ebae5209-1429-4501-94a8-8c28ef5b4907" xlink:to="loc_unh_OptuminsightMember_1534ae91-d19e-4876-9249-5edd787a73f9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OptumrxMember_a1bac54e-8d34-43c3-96ca-9a7152da894f" xlink:href="unh-20211231.xsd#unh_OptumrxMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ebae5209-1429-4501-94a8-8c28ef5b4907" xlink:to="loc_unh_OptumrxMember_a1bac54e-8d34-43c3-96ca-9a7152da894f" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails" xlink:type="extended" id="id6e33e8e6dec4fd59b2f49b23fa7e1da_GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_83051d7f-c559-466e-9820-c1e9058500f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_fa96f268-3b8e-43cc-a3a9-164ed3c3e464" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_83051d7f-c559-466e-9820-c1e9058500f6" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_fa96f268-3b8e-43cc-a3a9-164ed3c3e464" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ad2b28d3-5c42-477b-a81c-2ea945a9112e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_83051d7f-c559-466e-9820-c1e9058500f6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ad2b28d3-5c42-477b-a81c-2ea945a9112e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1c6b8278-665e-42e5-8e8a-2cbd20c19a67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_83051d7f-c559-466e-9820-c1e9058500f6" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1c6b8278-665e-42e5-8e8a-2cbd20c19a67" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_72d8470f-ac51-4d3f-b8b0-a3db4aa71b06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_83051d7f-c559-466e-9820-c1e9058500f6" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_72d8470f-ac51-4d3f-b8b0-a3db4aa71b06" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c59a28e0-b002-490b-8b0d-e84fc5eab491" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_72d8470f-ac51-4d3f-b8b0-a3db4aa71b06" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c59a28e0-b002-490b-8b0d-e84fc5eab491" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c59a28e0-b002-490b-8b0d-e84fc5eab491_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c59a28e0-b002-490b-8b0d-e84fc5eab491" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c59a28e0-b002-490b-8b0d-e84fc5eab491_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_52dfab9c-f26b-48fe-b1ea-0ec64076f75c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c59a28e0-b002-490b-8b0d-e84fc5eab491" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_52dfab9c-f26b-48fe-b1ea-0ec64076f75c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_cf391810-0231-413b-ace8-e723845bf5a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_52dfab9c-f26b-48fe-b1ea-0ec64076f75c" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_cf391810-0231-413b-ace8-e723845bf5a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_TrademarksandTechnologyMember_4ea3bef0-2a14-44d4-a2bb-6178c0ffa9ff" xlink:href="unh-20211231.xsd#unh_TrademarksandTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_52dfab9c-f26b-48fe-b1ea-0ec64076f75c" xlink:to="loc_unh_TrademarksandTechnologyMember_4ea3bef0-2a14-44d4-a2bb-6178c0ffa9ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_78defe9e-ef1c-4dc7-a8e8-86fe4082e9fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_52dfab9c-f26b-48fe-b1ea-0ec64076f75c" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_78defe9e-ef1c-4dc7-a8e8-86fe4082e9fd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_552c7ce2-206d-4b47-9c3d-9899fbf16053" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_52dfab9c-f26b-48fe-b1ea-0ec64076f75c" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_552c7ce2-206d-4b47-9c3d-9899fbf16053" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails" xlink:type="extended" id="id198c933756b40f19696c7307ff3bfed_GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c77bbfc3-e34e-40f6-9d36-e9e8c7a132a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_32d9091b-0b08-4349-8c12-aba1fc37bcd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c77bbfc3-e34e-40f6-9d36-e9e8c7a132a8" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_32d9091b-0b08-4349-8c12-aba1fc37bcd4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_38eaac47-dae8-4c00-b4cf-05ca077c885f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c77bbfc3-e34e-40f6-9d36-e9e8c7a132a8" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_38eaac47-dae8-4c00-b4cf-05ca077c885f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7df2eaf4-4e18-47fa-bf6e-fdc6ed16876a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c77bbfc3-e34e-40f6-9d36-e9e8c7a132a8" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7df2eaf4-4e18-47fa-bf6e-fdc6ed16876a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_998c5025-8aa0-43ad-a46e-c616f116df15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7df2eaf4-4e18-47fa-bf6e-fdc6ed16876a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_998c5025-8aa0-43ad-a46e-c616f116df15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_998c5025-8aa0-43ad-a46e-c616f116df15_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_998c5025-8aa0-43ad-a46e-c616f116df15" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_998c5025-8aa0-43ad-a46e-c616f116df15_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_afa62837-e18a-4e32-852b-34ca2e5010ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_998c5025-8aa0-43ad-a46e-c616f116df15" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_afa62837-e18a-4e32-852b-34ca2e5010ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_3a1a90f7-fb63-494f-aeaa-6f40090dff3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_afa62837-e18a-4e32-852b-34ca2e5010ad" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_3a1a90f7-fb63-494f-aeaa-6f40090dff3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_TrademarksandTechnologyMember_c0824776-448c-4e41-9dce-3ed164be6639" xlink:href="unh-20211231.xsd#unh_TrademarksandTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_afa62837-e18a-4e32-852b-34ca2e5010ad" xlink:to="loc_unh_TrademarksandTechnologyMember_c0824776-448c-4e41-9dce-3ed164be6639" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_9fffe5f9-6ffb-4aa4-8ccd-e12ef7b41f32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_afa62837-e18a-4e32-852b-34ca2e5010ad" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_9fffe5f9-6ffb-4aa4-8ccd-e12ef7b41f32" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails" xlink:type="extended" id="i18dbadb7a4e54fa38c045fc22a06b9bd_GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f4c5d8ab-0e1c-44a9-9bc3-13857a77b922" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_d20268d2-bb31-4f90-8f66-525b30d06be5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f4c5d8ab-0e1c-44a9-9bc3-13857a77b922" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_d20268d2-bb31-4f90-8f66-525b30d06be5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_f8eb973c-a93a-4bf3-9cfd-8779801914eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f4c5d8ab-0e1c-44a9-9bc3-13857a77b922" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_f8eb973c-a93a-4bf3-9cfd-8779801914eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_86e15edb-dafd-43a0-a5b1-1abc1192b411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f4c5d8ab-0e1c-44a9-9bc3-13857a77b922" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_86e15edb-dafd-43a0-a5b1-1abc1192b411" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_cb7e30d7-1864-452d-a8ea-496b9320ce48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f4c5d8ab-0e1c-44a9-9bc3-13857a77b922" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_cb7e30d7-1864-452d-a8ea-496b9320ce48" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0a4ceb11-27f0-40f7-8ab4-450230819321" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f4c5d8ab-0e1c-44a9-9bc3-13857a77b922" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0a4ceb11-27f0-40f7-8ab4-450230819321" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_947c2d87-cc94-4f19-a806-07d70e822663" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f4c5d8ab-0e1c-44a9-9bc3-13857a77b922" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_947c2d87-cc94-4f19-a806-07d70e822663" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_74c08c93-e76f-4ee7-b8c9-bdfbc55a2ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_947c2d87-cc94-4f19-a806-07d70e822663" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_74c08c93-e76f-4ee7-b8c9-bdfbc55a2ebf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_74c08c93-e76f-4ee7-b8c9-bdfbc55a2ebf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_74c08c93-e76f-4ee7-b8c9-bdfbc55a2ebf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_74c08c93-e76f-4ee7-b8c9-bdfbc55a2ebf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7e53a04f-48e5-4e06-bc48-080c33b9f067" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_74c08c93-e76f-4ee7-b8c9-bdfbc55a2ebf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7e53a04f-48e5-4e06-bc48-080c33b9f067" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/MedicalCostsPayableNarrativeDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#MedicalCostsPayableNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/MedicalCostsPayableNarrativeDetails" xlink:type="extended" id="i5b2eba4bed114e8d919fc034e3cf2c5a_MedicalCostsPayableNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d76c510c-4c0a-41b7-9ad1-305152358971" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_3a6658b5-ec7a-4d32-9923-e3a0218af4f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_d76c510c-4c0a-41b7-9ad1-305152358971" xlink:to="loc_us-gaap_StatementTable_3a6658b5-ec7a-4d32-9923-e3a0218af4f2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_MedicalCostsAndMedicalCostsPayableAxis_94cd1e1a-3145-4268-82be-10b3f7f03e3b" xlink:href="unh-20211231.xsd#unh_MedicalCostsAndMedicalCostsPayableAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_3a6658b5-ec7a-4d32-9923-e3a0218af4f2" xlink:to="loc_unh_MedicalCostsAndMedicalCostsPayableAxis_94cd1e1a-3145-4268-82be-10b3f7f03e3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_MedicalCostsAndMedicalCostsPayableDomain_94cd1e1a-3145-4268-82be-10b3f7f03e3b_default" xlink:href="unh-20211231.xsd#unh_MedicalCostsAndMedicalCostsPayableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_unh_MedicalCostsAndMedicalCostsPayableAxis_94cd1e1a-3145-4268-82be-10b3f7f03e3b" xlink:to="loc_unh_MedicalCostsAndMedicalCostsPayableDomain_94cd1e1a-3145-4268-82be-10b3f7f03e3b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_MedicalCostsAndMedicalCostsPayableDomain_259aafc8-5872-4042-aab5-73c70b7745a5" xlink:href="unh-20211231.xsd#unh_MedicalCostsAndMedicalCostsPayableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_unh_MedicalCostsAndMedicalCostsPayableAxis_94cd1e1a-3145-4268-82be-10b3f7f03e3b" xlink:to="loc_unh_MedicalCostsAndMedicalCostsPayableDomain_259aafc8-5872-4042-aab5-73c70b7745a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_efec9bf4-e119-40b7-8283-98e104f7a263" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_unh_MedicalCostsAndMedicalCostsPayableDomain_259aafc8-5872-4042-aab5-73c70b7745a5" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_efec9bf4-e119-40b7-8283-98e104f7a263" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_92040aa1-7383-4cba-8a39-4d3e1be4e8ff" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_3a6658b5-ec7a-4d32-9923-e3a0218af4f2" xlink:to="loc_srt_StatementScenarioAxis_92040aa1-7383-4cba-8a39-4d3e1be4e8ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_92040aa1-7383-4cba-8a39-4d3e1be4e8ff_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_92040aa1-7383-4cba-8a39-4d3e1be4e8ff" xlink:to="loc_srt_ScenarioUnspecifiedDomain_92040aa1-7383-4cba-8a39-4d3e1be4e8ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_b2280e41-27e1-41eb-baac-c24aa98c8a96" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_92040aa1-7383-4cba-8a39-4d3e1be4e8ff" xlink:to="loc_srt_ScenarioUnspecifiedDomain_b2280e41-27e1-41eb-baac-c24aa98c8a96" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#MedicalCostsPayableRollforwardDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails" xlink:type="extended" id="iddcdb56af4224fbdabea176f1010588d_MedicalCostsPayableRollforwardDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems_c1d6b96c-b8ef-4627-ae47-ba505d29aac1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_fdd15fc3-7e3d-42ae-aa3e-7460d44d96a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems_c1d6b96c-b8ef-4627-ae47-ba505d29aac1" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_fdd15fc3-7e3d-42ae-aa3e-7460d44d96a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_47e5476b-5879-488c-89a9-00299aa6fe04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems_c1d6b96c-b8ef-4627-ae47-ba505d29aac1" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_47e5476b-5879-488c-89a9-00299aa6fe04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_f2193232-432a-46dc-8b71-8907fba48a11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems_c1d6b96c-b8ef-4627-ae47-ba505d29aac1" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_f2193232-432a-46dc-8b71-8907fba48a11" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_a60e4f3a-71d4-493c-b271-d14f3af5f13f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_f2193232-432a-46dc-8b71-8907fba48a11" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_a60e4f3a-71d4-493c-b271-d14f3af5f13f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_7788c20a-99e5-442d-841c-145a097e81e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_f2193232-432a-46dc-8b71-8907fba48a11" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_7788c20a-99e5-442d-841c-145a097e81e5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_2138c875-159c-4f6a-9dd0-ddd035d57bee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_f2193232-432a-46dc-8b71-8907fba48a11" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_2138c875-159c-4f6a-9dd0-ddd035d57bee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_357ac804-2974-4c37-be2e-608a924c5ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems_c1d6b96c-b8ef-4627-ae47-ba505d29aac1" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_357ac804-2974-4c37-be2e-608a924c5ae4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_f2a90cdd-3555-47d6-a9ad-e122a5225738" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_357ac804-2974-4c37-be2e-608a924c5ae4" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_f2a90cdd-3555-47d6-a9ad-e122a5225738" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_c6e37870-9858-42c2-8805-fb6ee38133e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_357ac804-2974-4c37-be2e-608a924c5ae4" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_c6e37870-9858-42c2-8805-fb6ee38133e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_61a09674-614d-40d9-9fcf-32608e236c68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_357ac804-2974-4c37-be2e-608a924c5ae4" xlink:to="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_61a09674-614d-40d9-9fcf-32608e236c68" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_35ff5a72-b67d-455a-aff3-96b329403898" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable_9604572f-1e92-4c33-9ceb-acd4291700f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems_c1d6b96c-b8ef-4627-ae47-ba505d29aac1" xlink:to="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable_9604572f-1e92-4c33-9ceb-acd4291700f9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_146a52e1-2eda-4cbf-9588-a9204a1f4797" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable_9604572f-1e92-4c33-9ceb-acd4291700f9" xlink:to="loc_srt_ProductOrServiceAxis_146a52e1-2eda-4cbf-9588-a9204a1f4797" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_146a52e1-2eda-4cbf-9588-a9204a1f4797_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_146a52e1-2eda-4cbf-9588-a9204a1f4797" xlink:to="loc_srt_ProductsAndServicesDomain_146a52e1-2eda-4cbf-9588-a9204a1f4797_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_63d2ff9e-7505-49b7-b295-010109809bec" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_146a52e1-2eda-4cbf-9588-a9204a1f4797" xlink:to="loc_srt_ProductsAndServicesDomain_63d2ff9e-7505-49b7-b295-010109809bec" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails" xlink:type="extended" id="i0823e6d1880644819664a063c1fca9b4_MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d234e9d8-de97-42b1-8dd2-338cce13ca63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_a80fd257-69c1-4125-9258-db1871e4313d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d234e9d8-de97-42b1-8dd2-338cce13ca63" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_a80fd257-69c1-4125-9258-db1871e4313d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_321a3da6-db8c-4755-84ba-0b7eb32489ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d234e9d8-de97-42b1-8dd2-338cce13ca63" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_321a3da6-db8c-4755-84ba-0b7eb32489ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_ab43bcb3-7103-407e-beac-45b72eff364b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d234e9d8-de97-42b1-8dd2-338cce13ca63" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_ab43bcb3-7103-407e-beac-45b72eff364b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_25242624-4d98-4249-bddb-fe5869cf56c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d234e9d8-de97-42b1-8dd2-338cce13ca63" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_25242624-4d98-4249-bddb-fe5869cf56c1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_00917ab8-083b-4cd1-9a10-fcf75737aae1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_d234e9d8-de97-42b1-8dd2-338cce13ca63" xlink:to="loc_us-gaap_StatementTable_00917ab8-083b-4cd1-9a10-fcf75737aae1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f8cf9982-a66b-4c1c-a7a5-5ee85bb99569" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_00917ab8-083b-4cd1-9a10-fcf75737aae1" xlink:to="loc_srt_ProductOrServiceAxis_f8cf9982-a66b-4c1c-a7a5-5ee85bb99569" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f8cf9982-a66b-4c1c-a7a5-5ee85bb99569_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_f8cf9982-a66b-4c1c-a7a5-5ee85bb99569" xlink:to="loc_srt_ProductsAndServicesDomain_f8cf9982-a66b-4c1c-a7a5-5ee85bb99569_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_cc015a40-19d4-49e6-ba04-a684b45b15b9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_f8cf9982-a66b-4c1c-a7a5-5ee85bb99569" xlink:to="loc_srt_ProductsAndServicesDomain_cc015a40-19d4-49e6-ba04-a684b45b15b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_2a97b0f6-b18f-42b1-9a9e-6d58a26101cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_cc015a40-19d4-49e6-ba04-a684b45b15b9" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_2a97b0f6-b18f-42b1-9a9e-6d58a26101cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_a866362e-67fd-448b-ae1e-873f12f9c797" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_00917ab8-083b-4cd1-9a10-fcf75737aae1" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_a866362e-67fd-448b-ae1e-873f12f9c797" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_a866362e-67fd-448b-ae1e-873f12f9c797_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_a866362e-67fd-448b-ae1e-873f12f9c797" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_a866362e-67fd-448b-ae1e-873f12f9c797_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_a55c21f9-5fb4-4782-ba32-dc68d28bbf6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_a866362e-67fd-448b-ae1e-873f12f9c797" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_a55c21f9-5fb4-4782-ba32-dc68d28bbf6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member_0865f013-3fbb-4a90-965e-65c9d6ffa892" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_a55c21f9-5fb4-4782-ba32-dc68d28bbf6a" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member_0865f013-3fbb-4a90-965e-65c9d6ffa892" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member_7695895a-c73e-4a00-9255-75bb97d79003" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_a55c21f9-5fb4-4782-ba32-dc68d28bbf6a" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member_7695895a-c73e-4a00-9255-75bb97d79003" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtTables" xlink:type="simple" xlink:href="unh-20211231.xsd#ShortTermBorrowingsandLongTermDebtTables"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtTables" xlink:type="extended" id="i8552fab7b3514221b543a0bb6561f832_ShortTermBorrowingsandLongTermDebtTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_8c2019c3-e138-4da5-8658-962676eed166" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_97a75ac1-6335-4779-b488-fd69d5828c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8c2019c3-e138-4da5-8658-962676eed166" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_97a75ac1-6335-4779-b488-fd69d5828c3c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_4b1e4edb-8546-4184-a564-3c2bc015a3dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8c2019c3-e138-4da5-8658-962676eed166" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_4b1e4edb-8546-4184-a564-3c2bc015a3dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a57ff2c6-2101-463c-8d85-95cb2340c1bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8c2019c3-e138-4da5-8658-962676eed166" xlink:to="loc_us-gaap_DebtInstrumentTable_a57ff2c6-2101-463c-8d85-95cb2340c1bf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_e5ccc464-6b11-4247-8562-25c380155525" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a57ff2c6-2101-463c-8d85-95cb2340c1bf" xlink:to="loc_srt_StatementScenarioAxis_e5ccc464-6b11-4247-8562-25c380155525" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_e5ccc464-6b11-4247-8562-25c380155525_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_e5ccc464-6b11-4247-8562-25c380155525" xlink:to="loc_srt_ScenarioUnspecifiedDomain_e5ccc464-6b11-4247-8562-25c380155525_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_64cffac0-6f64-4e04-a224-c6752c1b77cc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_e5ccc464-6b11-4247-8562-25c380155525" xlink:to="loc_srt_ScenarioUnspecifiedDomain_64cffac0-6f64-4e04-a224-c6752c1b77cc" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#ShortTermBorrowingsandLongTermDebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails" xlink:type="extended" id="i7592755ebd2543e799395e1f80bfb82d_ShortTermBorrowingsandLongTermDebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d544cb56-8052-4752-aa90-905217a192fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2d46179a-d27a-4a5c-ab48-98ca20e670b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d544cb56-8052-4752-aa90-905217a192fe" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2d46179a-d27a-4a5c-ab48-98ca20e670b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebt_c7f39cfe-871f-4f9b-b946-17375e25db96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d544cb56-8052-4752-aa90-905217a192fe" xlink:to="loc_us-gaap_OtherLongTermDebt_c7f39cfe-871f-4f9b-b946-17375e25db96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebtCurrent_e1920a43-9419-48f3-af97-b33f582b81e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d544cb56-8052-4752-aa90-905217a192fe" xlink:to="loc_us-gaap_OtherLongTermDebtCurrent_e1920a43-9419-48f3-af97-b33f582b81e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_f9759577-f341-40be-97f6-8681e2f7e033" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d544cb56-8052-4752-aa90-905217a192fe" xlink:to="loc_us-gaap_LineOfCredit_f9759577-f341-40be-97f6-8681e2f7e033" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_851bf584-d955-46e2-ba28-58e1d66ae816" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d544cb56-8052-4752-aa90-905217a192fe" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_851bf584-d955-46e2-ba28-58e1d66ae816" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_ec9024b2-5606-468c-a037-de981859ad3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d544cb56-8052-4752-aa90-905217a192fe" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_ec9024b2-5606-468c-a037-de981859ad3e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityExpirationPeriod_5c04b777-211c-4a62-b0bc-6ee398fec14e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d544cb56-8052-4752-aa90-905217a192fe" xlink:to="loc_us-gaap_LineOfCreditFacilityExpirationPeriod_5c04b777-211c-4a62-b0bc-6ee398fec14e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_ebb197a2-bd65-400f-b5db-61b31a659114" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d544cb56-8052-4752-aa90-905217a192fe" xlink:to="loc_us-gaap_DebtInstrumentTable_ebb197a2-bd65-400f-b5db-61b31a659114" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_980d4535-b026-441b-bb60-6714479751ce" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ebb197a2-bd65-400f-b5db-61b31a659114" xlink:to="loc_srt_ConsolidatedEntitiesAxis_980d4535-b026-441b-bb60-6714479751ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_980d4535-b026-441b-bb60-6714479751ce_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_980d4535-b026-441b-bb60-6714479751ce" xlink:to="loc_srt_ConsolidatedEntitiesDomain_980d4535-b026-441b-bb60-6714479751ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_b651afa8-d51b-4d40-9661-143438a0265a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_980d4535-b026-441b-bb60-6714479751ce" xlink:to="loc_srt_ConsolidatedEntitiesDomain_b651afa8-d51b-4d40-9661-143438a0265a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_5fc8b0b8-cb52-421e-812c-4d66815ee042" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_b651afa8-d51b-4d40-9661-143438a0265a" xlink:to="loc_srt_SubsidiariesMember_5fc8b0b8-cb52-421e-812c-4d66815ee042" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_CreditFacilityNameAxis_28c401c5-12db-4d5d-8a30-5a1e8f073cc1" xlink:href="unh-20211231.xsd#unh_CreditFacilityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ebb197a2-bd65-400f-b5db-61b31a659114" xlink:to="loc_unh_CreditFacilityNameAxis_28c401c5-12db-4d5d-8a30-5a1e8f073cc1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_CreditFacilityNameDomain_28c401c5-12db-4d5d-8a30-5a1e8f073cc1_default" xlink:href="unh-20211231.xsd#unh_CreditFacilityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_unh_CreditFacilityNameAxis_28c401c5-12db-4d5d-8a30-5a1e8f073cc1" xlink:to="loc_unh_CreditFacilityNameDomain_28c401c5-12db-4d5d-8a30-5a1e8f073cc1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_CreditFacilityNameDomain_fa479131-0e1a-48f8-9825-f3acda72f4a3" xlink:href="unh-20211231.xsd#unh_CreditFacilityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_unh_CreditFacilityNameAxis_28c401c5-12db-4d5d-8a30-5a1e8f073cc1" xlink:to="loc_unh_CreditFacilityNameDomain_fa479131-0e1a-48f8-9825-f3acda72f4a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A364Day38BillionCreditFacilityMember_82369944-8d2e-4d22-b4cd-fd5a254bf8fc" xlink:href="unh-20211231.xsd#unh_A364Day38BillionCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_unh_CreditFacilityNameDomain_fa479131-0e1a-48f8-9825-f3acda72f4a3" xlink:to="loc_unh_A364Day38BillionCreditFacilityMember_82369944-8d2e-4d22-b4cd-fd5a254bf8fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_FiveYear56BillionCreditFacilityMember_09772a93-9d7c-4b13-92e6-de09b770dc0c" xlink:href="unh-20211231.xsd#unh_FiveYear56BillionCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_unh_CreditFacilityNameDomain_fa479131-0e1a-48f8-9825-f3acda72f4a3" xlink:to="loc_unh_FiveYear56BillionCreditFacilityMember_09772a93-9d7c-4b13-92e6-de09b770dc0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ThreeYear56BillionCreditFacilityMember_883bf011-e5ef-4759-ae88-8b78c50e0596" xlink:href="unh-20211231.xsd#unh_ThreeYear56BillionCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_unh_CreditFacilityNameDomain_fa479131-0e1a-48f8-9825-f3acda72f4a3" xlink:to="loc_unh_ThreeYear56BillionCreditFacilityMember_883bf011-e5ef-4759-ae88-8b78c50e0596" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_51521e80-f851-4f36-b10b-7689be3d2e41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ebb197a2-bd65-400f-b5db-61b31a659114" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_51521e80-f851-4f36-b10b-7689be3d2e41" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_51521e80-f851-4f36-b10b-7689be3d2e41_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_51521e80-f851-4f36-b10b-7689be3d2e41" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_51521e80-f851-4f36-b10b-7689be3d2e41_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_83ae0a68-2e2d-467e-9735-55ed3860a179" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_51521e80-f851-4f36-b10b-7689be3d2e41" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_83ae0a68-2e2d-467e-9735-55ed3860a179" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_52810d3d-f771-4253-a3a3-866f913ee258" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_83ae0a68-2e2d-467e-9735-55ed3860a179" xlink:to="loc_us-gaap_CommercialPaperMember_52810d3d-f771-4253-a3a3-866f913ee258" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_453cd831-521b-4d2b-9770-24b95c8c7dad" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ebb197a2-bd65-400f-b5db-61b31a659114" xlink:to="loc_srt_RangeAxis_453cd831-521b-4d2b-9770-24b95c8c7dad" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_453cd831-521b-4d2b-9770-24b95c8c7dad_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_453cd831-521b-4d2b-9770-24b95c8c7dad" xlink:to="loc_srt_RangeMember_453cd831-521b-4d2b-9770-24b95c8c7dad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_16d5e9a9-351b-4a9e-bee9-a0a52f6a1d6c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_453cd831-521b-4d2b-9770-24b95c8c7dad" xlink:to="loc_srt_RangeMember_16d5e9a9-351b-4a9e-bee9-a0a52f6a1d6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4a479fc5-5488-4d1d-84ab-adaaf10a8cba" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_16d5e9a9-351b-4a9e-bee9-a0a52f6a1d6c" xlink:to="loc_srt_MinimumMember_4a479fc5-5488-4d1d-84ab-adaaf10a8cba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8b014300-fc1b-461d-af1d-9e657228a3ec" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_16d5e9a9-351b-4a9e-bee9-a0a52f6a1d6c" xlink:to="loc_srt_MaximumMember_8b014300-fc1b-461d-af1d-9e657228a3ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_c693ba48-726d-4d36-b2f0-61e188b28189" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ebb197a2-bd65-400f-b5db-61b31a659114" xlink:to="loc_us-gaap_CreditFacilityAxis_c693ba48-726d-4d36-b2f0-61e188b28189" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_c693ba48-726d-4d36-b2f0-61e188b28189_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_c693ba48-726d-4d36-b2f0-61e188b28189" xlink:to="loc_us-gaap_CreditFacilityDomain_c693ba48-726d-4d36-b2f0-61e188b28189_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_8907e84f-eee0-48d0-b7cc-d9e9ab82635b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_c693ba48-726d-4d36-b2f0-61e188b28189" xlink:to="loc_us-gaap_CreditFacilityDomain_8907e84f-eee0-48d0-b7cc-d9e9ab82635b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_d586ddb0-293d-4747-b947-68f2d4183245" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_8907e84f-eee0-48d0-b7cc-d9e9ab82635b" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_d586ddb0-293d-4747-b947-68f2d4183245" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#ShortTermBorrowingsandLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails" xlink:type="extended" id="id4d9d67eafd14753ad9222fe3bf5a36d_ShortTermBorrowingsandLongTermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_14a2cb0b-e50a-4c49-8dd7-28a7d373f9c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f0b4c06b-dca6-45e9-8c8f-f45735303f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_14a2cb0b-e50a-4c49-8dd7-28a7d373f9c4" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f0b4c06b-dca6-45e9-8c8f-f45735303f7d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_8184500c-adbe-4825-bce7-412468f063db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_14a2cb0b-e50a-4c49-8dd7-28a7d373f9c4" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_8184500c-adbe-4825-bce7-412468f063db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredLongTermDebt_5018c335-5fd6-481e-8294-fe8558f68c10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_14a2cb0b-e50a-4c49-8dd7-28a7d373f9c4" xlink:to="loc_us-gaap_UnsecuredLongTermDebt_5018c335-5fd6-481e-8294-fe8558f68c10" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtCurrent_5787ae33-94ec-486d-8a4b-61d1f523f8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_14a2cb0b-e50a-4c49-8dd7-28a7d373f9c4" xlink:to="loc_us-gaap_UnsecuredDebtCurrent_5787ae33-94ec-486d-8a4b-61d1f523f8dc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_bd6def07-04f6-4f42-aa65-6a6641b1e01f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_14a2cb0b-e50a-4c49-8dd7-28a7d373f9c4" xlink:to="loc_us-gaap_CommercialPaper_bd6def07-04f6-4f42-aa65-6a6641b1e01f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_af98bba7-097b-410e-9361-05d2c8bc6d25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_14a2cb0b-e50a-4c49-8dd7-28a7d373f9c4" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_af98bba7-097b-410e-9361-05d2c8bc6d25" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a0efd5ce-8bdf-4c93-9e28-e32d2c7b1ba3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_14a2cb0b-e50a-4c49-8dd7-28a7d373f9c4" xlink:to="loc_us-gaap_DebtInstrumentTable_a0efd5ce-8bdf-4c93-9e28-e32d2c7b1ba3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_aea240b5-a6c2-4a63-a38a-ef4054c3a586" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a0efd5ce-8bdf-4c93-9e28-e32d2c7b1ba3" xlink:to="loc_us-gaap_DebtInstrumentAxis_aea240b5-a6c2-4a63-a38a-ef4054c3a586" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_aea240b5-a6c2-4a63-a38a-ef4054c3a586_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_aea240b5-a6c2-4a63-a38a-ef4054c3a586" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_aea240b5-a6c2-4a63-a38a-ef4054c3a586_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_aea240b5-a6c2-4a63-a38a-ef4054c3a586" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_96efb4b9-67d0-438b-b7c2-e83114577f44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_us-gaap_CommercialPaperMember_96efb4b9-67d0-438b-b7c2-e83114577f44" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.700notesdueFebruary2021Member_f6f4b031-967e-40fe-abed-70e4dda40b90" xlink:href="unh-20211231.xsd#unh_A4.700notesdueFebruary2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A4.700notesdueFebruary2021Member_f6f4b031-967e-40fe-abed-70e4dda40b90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2.125notesdueMarch2021Member_f430266f-66ae-4fe7-a307-1a40b67a085e" xlink:href="unh-20211231.xsd#unh_A2.125notesdueMarch2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A2.125notesdueMarch2021Member_f430266f-66ae-4fe7-a307-1a40b67a085e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_FloatingratenotesdueJune2021Member_461d9488-2af8-48dc-917f-7147e9792557" xlink:href="unh-20211231.xsd#unh_FloatingratenotesdueJune2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_FloatingratenotesdueJune2021Member_461d9488-2af8-48dc-917f-7147e9792557" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.150notesdueJune2021Member_a416fb13-0a19-43eb-85b1-dbcd0ca59904" xlink:href="unh-20211231.xsd#unh_A3.150notesdueJune2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3.150notesdueJune2021Member_a416fb13-0a19-43eb-85b1-dbcd0ca59904" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.375notesdueNovember2021Member_bf9383ed-6ce1-4a47-8ab4-21bc8883a72c" xlink:href="unh-20211231.xsd#unh_A3.375notesdueNovember2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3.375notesdueNovember2021Member_bf9383ed-6ce1-4a47-8ab4-21bc8883a72c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2875NotesDueDecember2021Member_fb4027f1-d183-4c81-abfe-e4d0faffa694" xlink:href="unh-20211231.xsd#unh_A2875NotesDueDecember2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A2875NotesDueDecember2021Member_fb4027f1-d183-4c81-abfe-e4d0faffa694" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2.875notesdueMarch2022Member_1b3acf75-b79a-4bf6-85ba-604b37fa8a63" xlink:href="unh-20211231.xsd#unh_A2.875notesdueMarch2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A2.875notesdueMarch2022Member_1b3acf75-b79a-4bf6-85ba-604b37fa8a63" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3350NotesDueJuly2022Member_cb755898-270b-4466-8e5d-96637ce26059" xlink:href="unh-20211231.xsd#unh_A3350NotesDueJuly2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3350NotesDueJuly2022Member_cb755898-270b-4466-8e5d-96637ce26059" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2.375notesdueOctober2022MemberMember_b1001ce7-8049-43e7-b4ad-5562fd5e11c3" xlink:href="unh-20211231.xsd#unh_A2.375notesdueOctober2022MemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A2.375notesdueOctober2022MemberMember_b1001ce7-8049-43e7-b4ad-5562fd5e11c3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ZeroCouponNotesDueNovember2022Member_9d95165a-efbe-4be2-95f5-118a3d71a199" xlink:href="unh-20211231.xsd#unh_ZeroCouponNotesDueNovember2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_ZeroCouponNotesDueNovember2022Member_9d95165a-efbe-4be2-95f5-118a3d71a199" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2750NotesDueFebruary2023Member_6fd3697f-cea5-4e4a-ad5e-6c9d6c37e80a" xlink:href="unh-20211231.xsd#unh_A2750NotesDueFebruary2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A2750NotesDueFebruary2023Member_6fd3697f-cea5-4e4a-ad5e-6c9d6c37e80a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2875NotesDueMarch2023Member_9813f225-4c0e-4a9c-bf3b-072867c5cfa5" xlink:href="unh-20211231.xsd#unh_A2875NotesDueMarch2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A2875NotesDueMarch2023Member_9813f225-4c0e-4a9c-bf3b-072867c5cfa5" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.500notesdueJune2023Member_5469dca2-0650-4b07-a0b1-a818aae48eb3" xlink:href="unh-20211231.xsd#unh_A3.500notesdueJune2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3.500notesdueJune2023Member_5469dca2-0650-4b07-a0b1-a818aae48eb3" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.500notesdueFebruary2024Member_84d0c6e7-886f-43f6-b3a6-bbbb7f6b3308" xlink:href="unh-20211231.xsd#unh_A3.500notesdueFebruary2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3.500notesdueFebruary2024Member_84d0c6e7-886f-43f6-b3a6-bbbb7f6b3308" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A0550NotesDueMay2024Member_a90c3d91-ddda-4463-abb9-8fbd4585a350" xlink:href="unh-20211231.xsd#unh_A0550NotesDueMay2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A0550NotesDueMay2024Member_a90c3d91-ddda-4463-abb9-8fbd4585a350" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2.375notesdueAugust2024Member_3f3c4797-31de-4a5c-b627-9126516d4b2b" xlink:href="unh-20211231.xsd#unh_A2.375notesdueAugust2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A2.375notesdueAugust2024Member_3f3c4797-31de-4a5c-b627-9126516d4b2b" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.750notesdueJuly2025Member_df03d0d9-8858-4a66-8648-9c8b9749a0ea" xlink:href="unh-20211231.xsd#unh_A3.750notesdueJuly2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3.750notesdueJuly2025Member_df03d0d9-8858-4a66-8648-9c8b9749a0ea" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.700notesdueDecember2025Member_758e3f30-212f-4aa9-85ac-40f6f9250219" xlink:href="unh-20211231.xsd#unh_A3.700notesdueDecember2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3.700notesdueDecember2025Member_758e3f30-212f-4aa9-85ac-40f6f9250219" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A1250NotesDueJanuary2026Member_b63831c8-d3a1-4f9f-b656-cb5da2ee088a" xlink:href="unh-20211231.xsd#unh_A1250NotesDueJanuary2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A1250NotesDueJanuary2026Member_b63831c8-d3a1-4f9f-b656-cb5da2ee088a" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.100notesdueMarch2026Member_34756099-39ca-4889-9524-7cd98bc002d5" xlink:href="unh-20211231.xsd#unh_A3.100notesdueMarch2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3.100notesdueMarch2026Member_34756099-39ca-4889-9524-7cd98bc002d5" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A1150NotesDueMay2026Member_39c383b5-adf3-4c08-a283-d0c494c30a50" xlink:href="unh-20211231.xsd#unh_A1150NotesDueMay2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A1150NotesDueMay2026Member_39c383b5-adf3-4c08-a283-d0c494c30a50" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.450notesdueJanuary2027Member_c01a092a-2df2-4bff-bbe7-5fad885ebe43" xlink:href="unh-20211231.xsd#unh_A3.450notesdueJanuary2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3.450notesdueJanuary2027Member_c01a092a-2df2-4bff-bbe7-5fad885ebe43" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.375notesdueApril2027Member_a46cc29c-a871-47ea-89e1-bfe6f8d82efc" xlink:href="unh-20211231.xsd#unh_A3.375notesdueApril2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3.375notesdueApril2027Member_a46cc29c-a871-47ea-89e1-bfe6f8d82efc" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2.950notesdueOctober2027Member_6f283e7b-1f71-4a74-bb91-54b02b73dca1" xlink:href="unh-20211231.xsd#unh_A2.950notesdueOctober2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A2.950notesdueOctober2027Member_6f283e7b-1f71-4a74-bb91-54b02b73dca1" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.850notesdueJune2028Member_4b4ca5a9-1ff8-4336-b60e-677f02bd12f2" xlink:href="unh-20211231.xsd#unh_A3.850notesdueJune2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3.850notesdueJune2028Member_4b4ca5a9-1ff8-4336-b60e-677f02bd12f2" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.875notesdueDecember2028Member_b3f59b15-5157-416c-9633-15ad4e97418b" xlink:href="unh-20211231.xsd#unh_A3.875notesdueDecember2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3.875notesdueDecember2028Member_b3f59b15-5157-416c-9633-15ad4e97418b" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2.875notesdueAugust2029Member_b63e7446-4213-4a55-bde9-a31d1834ead1" xlink:href="unh-20211231.xsd#unh_A2.875notesdueAugust2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A2.875notesdueAugust2029Member_b63e7446-4213-4a55-bde9-a31d1834ead1" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2000NotesDueMay2030Member_3683d7e5-5665-424b-bbf0-413c9081a50b" xlink:href="unh-20211231.xsd#unh_A2000NotesDueMay2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A2000NotesDueMay2030Member_3683d7e5-5665-424b-bbf0-413c9081a50b" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2300NotesDueMay2031Member_09393c22-9e76-4fae-b12a-ee75a4cf78b9" xlink:href="unh-20211231.xsd#unh_A2300NotesDueMay2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A2300NotesDueMay2031Member_09393c22-9e76-4fae-b12a-ee75a4cf78b9" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.625notesdueJuly2035Member_f928bcff-8dfc-4e5b-814c-28c7ffff7c68" xlink:href="unh-20211231.xsd#unh_A4.625notesdueJuly2035Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A4.625notesdueJuly2035Member_f928bcff-8dfc-4e5b-814c-28c7ffff7c68" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A5.800notesdueMarch2036Member_f15c2a2d-62c9-48e9-a172-9ea3be7dab68" xlink:href="unh-20211231.xsd#unh_A5.800notesdueMarch2036Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A5.800notesdueMarch2036Member_f15c2a2d-62c9-48e9-a172-9ea3be7dab68" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A6500NotesDueJune2037Member_d6caafd6-16d5-4adb-8d7e-c32946218ce6" xlink:href="unh-20211231.xsd#unh_A6500NotesDueJune2037Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A6500NotesDueJune2037Member_d6caafd6-16d5-4adb-8d7e-c32946218ce6" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A6625NotesDueNovember2037Member_47841660-1f87-4e25-a2ae-bdbff9d70dc4" xlink:href="unh-20211231.xsd#unh_A6625NotesDueNovember2037Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A6625NotesDueNovember2037Member_47841660-1f87-4e25-a2ae-bdbff9d70dc4" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A6.875notesdueFebruary2038Member_a2670e1e-86c9-4c21-acd2-fa692de9cc1e" xlink:href="unh-20211231.xsd#unh_A6.875notesdueFebruary2038Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A6.875notesdueFebruary2038Member_a2670e1e-86c9-4c21-acd2-fa692de9cc1e" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.500notesdueAugust2039Member_976d7857-71ab-46a4-8580-6728c5bc2292" xlink:href="unh-20211231.xsd#unh_A3.500notesdueAugust2039Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3.500notesdueAugust2039Member_976d7857-71ab-46a4-8580-6728c5bc2292" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2750NotesDueMay2040Member_32ffbd56-c68c-4a35-961e-4e4e822bcc5c" xlink:href="unh-20211231.xsd#unh_A2750NotesDueMay2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A2750NotesDueMay2040Member_32ffbd56-c68c-4a35-961e-4e4e822bcc5c" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A5.700notesdueOctober2040Member_f44384c9-a5cb-47d6-95bd-df89c9cee81b" xlink:href="unh-20211231.xsd#unh_A5.700notesdueOctober2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A5.700notesdueOctober2040Member_f44384c9-a5cb-47d6-95bd-df89c9cee81b" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A5.950notesdueFebruary2041Member_705e95a3-0739-4410-b2f0-cbaf0bc913c9" xlink:href="unh-20211231.xsd#unh_A5.950notesdueFebruary2041Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A5.950notesdueFebruary2041Member_705e95a3-0739-4410-b2f0-cbaf0bc913c9" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3050NotesDueMay2041Member_d16bd996-3097-40e6-ad4b-ebfcd668e0e1" xlink:href="unh-20211231.xsd#unh_A3050NotesDueMay2041Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3050NotesDueMay2041Member_d16bd996-3097-40e6-ad4b-ebfcd668e0e1" xlink:type="arc" order="39"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.625notesdueNovember2041Member_65cfcd5b-5fe0-4151-9e86-de509030886b" xlink:href="unh-20211231.xsd#unh_A4.625notesdueNovember2041Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A4.625notesdueNovember2041Member_65cfcd5b-5fe0-4151-9e86-de509030886b" xlink:type="arc" order="40"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.375notesdueMarch2042Member_082043eb-99bf-45af-bbed-ee81f101d2b6" xlink:href="unh-20211231.xsd#unh_A4.375notesdueMarch2042Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A4.375notesdueMarch2042Member_082043eb-99bf-45af-bbed-ee81f101d2b6" xlink:type="arc" order="41"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3950NotesDueOctober2042Member_636e9117-15c9-475e-925f-7965e7ba9252" xlink:href="unh-20211231.xsd#unh_A3950NotesDueOctober2042Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3950NotesDueOctober2042Member_636e9117-15c9-475e-925f-7965e7ba9252" xlink:type="arc" order="42"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4250NotesDueMarch2043Member_ea7a1119-c960-4e38-a149-df516f99566e" xlink:href="unh-20211231.xsd#unh_A4250NotesDueMarch2043Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A4250NotesDueMarch2043Member_ea7a1119-c960-4e38-a149-df516f99566e" xlink:type="arc" order="43"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.750notesdueJuly2045Member_ed69cd72-97de-438c-8e2b-200268c9e1a4" xlink:href="unh-20211231.xsd#unh_A4.750notesdueJuly2045Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A4.750notesdueJuly2045Member_ed69cd72-97de-438c-8e2b-200268c9e1a4" xlink:type="arc" order="44"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.200notesdueJanuary2047Member_e486173c-d298-45eb-a65e-9010927a3c29" xlink:href="unh-20211231.xsd#unh_A4.200notesdueJanuary2047Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A4.200notesdueJanuary2047Member_e486173c-d298-45eb-a65e-9010927a3c29" xlink:type="arc" order="45"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.250notesdueApril2047Member_68afd59e-68d1-4939-b52d-43ce4226e3de" xlink:href="unh-20211231.xsd#unh_A4.250notesdueApril2047Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A4.250notesdueApril2047Member_68afd59e-68d1-4939-b52d-43ce4226e3de" xlink:type="arc" order="46"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.750notesdueOctober2047Member_cd13973a-f8e6-4118-8fc0-0737c6937bb0" xlink:href="unh-20211231.xsd#unh_A3.750notesdueOctober2047Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3.750notesdueOctober2047Member_cd13973a-f8e6-4118-8fc0-0737c6937bb0" xlink:type="arc" order="47"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.250notesdueJune2048Member_350e4cf7-97ca-4ded-9634-767d906aa7b4" xlink:href="unh-20211231.xsd#unh_A4.250notesdueJune2048Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A4.250notesdueJune2048Member_350e4cf7-97ca-4ded-9634-767d906aa7b4" xlink:type="arc" order="48"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.450notesdueDecember2048Member_36861449-589e-4c6a-8307-7a7207d7705b" xlink:href="unh-20211231.xsd#unh_A4.450notesdueDecember2048Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A4.450notesdueDecember2048Member_36861449-589e-4c6a-8307-7a7207d7705b" xlink:type="arc" order="49"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.700notesdueAugust2049Member_ee9805a9-7880-4db4-be6f-370a771dff4a" xlink:href="unh-20211231.xsd#unh_A3.700notesdueAugust2049Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3.700notesdueAugust2049Member_ee9805a9-7880-4db4-be6f-370a771dff4a" xlink:type="arc" order="50"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2900NotesDueMay2050Member_3713c5de-ef30-493b-919e-128d402a4090" xlink:href="unh-20211231.xsd#unh_A2900NotesDueMay2050Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A2900NotesDueMay2050Member_3713c5de-ef30-493b-919e-128d402a4090" xlink:type="arc" order="51"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3250NotesDueMay2051Member_c195cbe7-3562-4182-a078-16e62e0f081b" xlink:href="unh-20211231.xsd#unh_A3250NotesDueMay2051Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3250NotesDueMay2051Member_c195cbe7-3562-4182-a078-16e62e0f081b" xlink:type="arc" order="52"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.875notesdueAugust2059Member_0379bea0-3b80-4c9f-9216-288100e2efc9" xlink:href="unh-20211231.xsd#unh_A3.875notesdueAugust2059Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3.875notesdueAugust2059Member_0379bea0-3b80-4c9f-9216-288100e2efc9" xlink:type="arc" order="53"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3125NotesDueMay2060Member_04bddbfa-dbf0-48f6-851d-8b9d26364294" xlink:href="unh-20211231.xsd#unh_A3125NotesDueMay2060Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3125NotesDueMay2060Member_04bddbfa-dbf0-48f6-851d-8b9d26364294" xlink:type="arc" order="54"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails" xlink:type="extended" id="i7812d7e549794ce98196e4f4ec0fb68d_ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_bcb46ac1-b068-4125-a7e9-66c9a983d9f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_da8d8df2-28fe-4870-8c23-55eb1325906a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bcb46ac1-b068-4125-a7e9-66c9a983d9f1" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_da8d8df2-28fe-4870-8c23-55eb1325906a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_10144255-3a1e-4956-8740-1e7741e840f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bcb46ac1-b068-4125-a7e9-66c9a983d9f1" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_10144255-3a1e-4956-8740-1e7741e840f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_b456b93e-2d28-4564-9437-f73e8eb6b847" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bcb46ac1-b068-4125-a7e9-66c9a983d9f1" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_b456b93e-2d28-4564-9437-f73e8eb6b847" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_f4729564-b9b7-41c7-97c6-1a0886715b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bcb46ac1-b068-4125-a7e9-66c9a983d9f1" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_f4729564-b9b7-41c7-97c6-1a0886715b5a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_528df00c-dcd5-422f-a9a1-21f89ec5141c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bcb46ac1-b068-4125-a7e9-66c9a983d9f1" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_528df00c-dcd5-422f-a9a1-21f89ec5141c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_177c7047-5a1d-4ba0-ac16-4a8690836ca8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bcb46ac1-b068-4125-a7e9-66c9a983d9f1" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_177c7047-5a1d-4ba0-ac16-4a8690836ca8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_d2f11ddd-48d2-42fc-8b01-3988d36c752d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bcb46ac1-b068-4125-a7e9-66c9a983d9f1" xlink:to="loc_us-gaap_DebtInstrumentTable_d2f11ddd-48d2-42fc-8b01-3988d36c752d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7d7cbb1d-fbbb-4548-aca6-6457e4bdceb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d2f11ddd-48d2-42fc-8b01-3988d36c752d" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7d7cbb1d-fbbb-4548-aca6-6457e4bdceb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7d7cbb1d-fbbb-4548-aca6-6457e4bdceb7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7d7cbb1d-fbbb-4548-aca6-6457e4bdceb7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7d7cbb1d-fbbb-4548-aca6-6457e4bdceb7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0ae8a3d7-4062-45d9-ba69-1d90fb4c09bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7d7cbb1d-fbbb-4548-aca6-6457e4bdceb7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0ae8a3d7-4062-45d9-ba69-1d90fb4c09bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_fe7ce3dd-9082-43cd-9c89-f6d179df7bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d2f11ddd-48d2-42fc-8b01-3988d36c752d" xlink:to="loc_us-gaap_DebtInstrumentAxis_fe7ce3dd-9082-43cd-9c89-f6d179df7bfa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fe7ce3dd-9082-43cd-9c89-f6d179df7bfa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_fe7ce3dd-9082-43cd-9c89-f6d179df7bfa" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fe7ce3dd-9082-43cd-9c89-f6d179df7bfa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ce9286d9-5866-4cbc-b6a4-f6a8f7be2a8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_fe7ce3dd-9082-43cd-9c89-f6d179df7bfa" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ce9286d9-5866-4cbc-b6a4-f6a8f7be2a8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_1c666f30-a883-4190-8ba5-c5e33610c62a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d2f11ddd-48d2-42fc-8b01-3988d36c752d" xlink:to="loc_us-gaap_VariableRateAxis_1c666f30-a883-4190-8ba5-c5e33610c62a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_1c666f30-a883-4190-8ba5-c5e33610c62a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_1c666f30-a883-4190-8ba5-c5e33610c62a" xlink:to="loc_us-gaap_VariableRateDomain_1c666f30-a883-4190-8ba5-c5e33610c62a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_bf53337c-f591-4a2f-8079-f0b6f4260261" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_1c666f30-a883-4190-8ba5-c5e33610c62a" xlink:to="loc_us-gaap_VariableRateDomain_bf53337c-f591-4a2f-8079-f0b6f4260261" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_d7703f95-f4d9-42a3-804c-778dd29fbb54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d2f11ddd-48d2-42fc-8b01-3988d36c752d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_d7703f95-f4d9-42a3-804c-778dd29fbb54" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_d7703f95-f4d9-42a3-804c-778dd29fbb54_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_d7703f95-f4d9-42a3-804c-778dd29fbb54" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_d7703f95-f4d9-42a3-804c-778dd29fbb54_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_4b4f542b-d121-4fb8-8d64-77a21ba027e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_d7703f95-f4d9-42a3-804c-778dd29fbb54" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_4b4f542b-d121-4fb8-8d64-77a21ba027e0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/IncomeTaxesNotes" xlink:type="simple" xlink:href="unh-20211231.xsd#IncomeTaxesNotes"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/IncomeTaxesNotes" xlink:type="extended" id="ie3c8cc656db745ed9d9491246ffef6a7_IncomeTaxesNotes">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLineItems_0cfe9bbb-dedd-4c23-88eb-bbd75b429095" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_fae7c604-a3cd-467f-960e-81376a956d13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_0cfe9bbb-dedd-4c23-88eb-bbd75b429095" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_fae7c604-a3cd-467f-960e-81376a956d13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationTable_5127d1f5-60e0-46e5-b499-4b6dc69f8e52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_0cfe9bbb-dedd-4c23-88eb-bbd75b429095" xlink:to="loc_us-gaap_IncomeTaxExaminationTable_5127d1f5-60e0-46e5-b499-4b6dc69f8e52" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_c9a64e24-140d-4d60-ba49-27767b0a04fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_5127d1f5-60e0-46e5-b499-4b6dc69f8e52" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_c9a64e24-140d-4d60-ba49-27767b0a04fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_c9a64e24-140d-4d60-ba49-27767b0a04fb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_c9a64e24-140d-4d60-ba49-27767b0a04fb" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_c9a64e24-140d-4d60-ba49-27767b0a04fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_ff0ed0a4-d5f0-49b4-86b2-a91fdf1a883c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_c9a64e24-140d-4d60-ba49-27767b0a04fb" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_ff0ed0a4-d5f0-49b4-86b2-a91fdf1a883c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="unh-20211231.xsd#IncomeTaxesTables"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/IncomeTaxesTables" xlink:type="extended" id="i61742b6d17474152bdf5df047f704643_IncomeTaxesTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_ed239622-c250-4c10-b337-d3459258195a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_03768234-e6b5-4c14-b896-8daf8ae8ced4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ed239622-c250-4c10-b337-d3459258195a" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_03768234-e6b5-4c14-b896-8daf8ae8ced4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_624b8090-9fbb-45cd-b9e8-470695ea5a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ed239622-c250-4c10-b337-d3459258195a" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_624b8090-9fbb-45cd-b9e8-470695ea5a6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_a443d91e-e6dd-47f4-ae23-c6c640f30775" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ed239622-c250-4c10-b337-d3459258195a" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_a443d91e-e6dd-47f4-ae23-c6c640f30775" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock_0a4023b2-e6a7-4925-856a-64bf96c8e272" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ed239622-c250-4c10-b337-d3459258195a" xlink:to="loc_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock_0a4023b2-e6a7-4925-856a-64bf96c8e272" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_92a015e9-7f55-4447-9456-afa2f33b5983" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ed239622-c250-4c10-b337-d3459258195a" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_92a015e9-7f55-4447-9456-afa2f33b5983" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_dab0bc0b-8b50-4db6-8e0c-905739104f00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_92a015e9-7f55-4447-9456-afa2f33b5983" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_dab0bc0b-8b50-4db6-8e0c-905739104f00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_dab0bc0b-8b50-4db6-8e0c-905739104f00_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_dab0bc0b-8b50-4db6-8e0c-905739104f00" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_dab0bc0b-8b50-4db6-8e0c-905739104f00_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_4ff9655b-0fd2-43ce-bdc1-8d2f749184e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_dab0bc0b-8b50-4db6-8e0c-905739104f00" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_4ff9655b-0fd2-43ce-bdc1-8d2f749184e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_9d334950-f44e-40c4-9cf4-f55c0e1fd804" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_92a015e9-7f55-4447-9456-afa2f33b5983" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_9d334950-f44e-40c4-9cf4-f55c0e1fd804" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_9d334950-f44e-40c4-9cf4-f55c0e1fd804_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_9d334950-f44e-40c4-9cf4-f55c0e1fd804" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_9d334950-f44e-40c4-9cf4-f55c0e1fd804_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_6aacce63-abbe-4cc0-b708-280ff62bf5a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_9d334950-f44e-40c4-9cf4-f55c0e1fd804" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_6aacce63-abbe-4cc0-b708-280ff62bf5a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_f89430b8-82e6-475f-bfdc-d85b4499e473" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_92a015e9-7f55-4447-9456-afa2f33b5983" xlink:to="loc_us-gaap_TaxPeriodAxis_f89430b8-82e6-475f-bfdc-d85b4499e473" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_f89430b8-82e6-475f-bfdc-d85b4499e473_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_f89430b8-82e6-475f-bfdc-d85b4499e473" xlink:to="loc_us-gaap_TaxPeriodDomain_f89430b8-82e6-475f-bfdc-d85b4499e473_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_5fc0dc24-8ce6-4903-a538-3b35fa51f2b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_f89430b8-82e6-475f-bfdc-d85b4499e473" xlink:to="loc_us-gaap_TaxPeriodDomain_5fc0dc24-8ce6-4903-a538-3b35fa51f2b7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" id="ie5100faaf7d241baa8357b62b3f032dc_IncomeTaxesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_1dd3860e-9253-42c8-92cf-99706decb535" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_96034f6e-f1f4-4bad-a60a-c3a32a61fdee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_1dd3860e-9253-42c8-92cf-99706decb535" xlink:to="loc_us-gaap_OperatingLossCarryforwards_96034f6e-f1f4-4bad-a60a-c3a32a61fdee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardExpirationDate_ec6fb3c4-9888-44e3-baa2-b64c352da45a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardExpirationDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_1dd3860e-9253-42c8-92cf-99706decb535" xlink:to="loc_us-gaap_TaxCreditCarryforwardExpirationDate_ec6fb3c4-9888-44e3-baa2-b64c352da45a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_d0291fc4-0def-4250-b39b-3d5e9bce7bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_1dd3860e-9253-42c8-92cf-99706decb535" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_d0291fc4-0def-4250-b39b-3d5e9bce7bdc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_acf2ba17-994c-44ac-9200-3852dd97662d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_1dd3860e-9253-42c8-92cf-99706decb535" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_acf2ba17-994c-44ac-9200-3852dd97662d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OpenTaxYear_638bb682-21f5-49d6-a222-b3bc0405c3a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OpenTaxYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_1dd3860e-9253-42c8-92cf-99706decb535" xlink:to="loc_us-gaap_OpenTaxYear_638bb682-21f5-49d6-a222-b3bc0405c3a3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_d34e2d3e-53b5-4a50-920a-d238c85380b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_1dd3860e-9253-42c8-92cf-99706decb535" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_d34e2d3e-53b5-4a50-920a-d238c85380b0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0b3cef5f-344c-4aa3-b481-537a5fe4c00d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_1dd3860e-9253-42c8-92cf-99706decb535" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0b3cef5f-344c-4aa3-b481-537a5fe4c00d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_2345db35-50d8-4ccc-b8f0-4c759a9fe1c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_1dd3860e-9253-42c8-92cf-99706decb535" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_2345db35-50d8-4ccc-b8f0-4c759a9fe1c3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_8633b809-aa20-470b-8eb2-bac21aadd685" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_2345db35-50d8-4ccc-b8f0-4c759a9fe1c3" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_8633b809-aa20-470b-8eb2-bac21aadd685" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_8633b809-aa20-470b-8eb2-bac21aadd685_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_8633b809-aa20-470b-8eb2-bac21aadd685" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_8633b809-aa20-470b-8eb2-bac21aadd685_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_5872e200-6976-4539-8b92-6e9a1332e056" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_8633b809-aa20-470b-8eb2-bac21aadd685" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_5872e200-6976-4539-8b92-6e9a1332e056" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_NOLsExpirationBeginning2022Through2037Member_982d93ed-fe05-43ae-8cae-e7ca0a6e0ca5" xlink:href="unh-20211231.xsd#unh_NOLsExpirationBeginning2022Through2037Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_5872e200-6976-4539-8b92-6e9a1332e056" xlink:to="loc_unh_NOLsExpirationBeginning2022Through2037Member_982d93ed-fe05-43ae-8cae-e7ca0a6e0ca5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_NOLsIndefiniteCarryforwardMember_f8dfe4ae-9351-4f0a-a42a-7bc3f5a2f5af" xlink:href="unh-20211231.xsd#unh_NOLsIndefiniteCarryforwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_5872e200-6976-4539-8b92-6e9a1332e056" xlink:to="loc_unh_NOLsIndefiniteCarryforwardMember_f8dfe4ae-9351-4f0a-a42a-7bc3f5a2f5af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_4a37f52a-cefa-4133-9e63-20cf2dcad4c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_2345db35-50d8-4ccc-b8f0-4c759a9fe1c3" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_4a37f52a-cefa-4133-9e63-20cf2dcad4c0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_4a37f52a-cefa-4133-9e63-20cf2dcad4c0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_4a37f52a-cefa-4133-9e63-20cf2dcad4c0" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_4a37f52a-cefa-4133-9e63-20cf2dcad4c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_f51ecb9f-2c40-4d12-b41d-3c5c8858c462" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_4a37f52a-cefa-4133-9e63-20cf2dcad4c0" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_f51ecb9f-2c40-4d12-b41d-3c5c8858c462" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_026851ad-1264-4e72-b0c6-2efe5c995153" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_f51ecb9f-2c40-4d12-b41d-3c5c8858c462" xlink:to="loc_us-gaap_DomesticCountryMember_026851ad-1264-4e72-b0c6-2efe5c995153" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_3b10846b-cb1c-4fc2-9af4-ae561920189f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_f51ecb9f-2c40-4d12-b41d-3c5c8858c462" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_3b10846b-cb1c-4fc2-9af4-ae561920189f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_d777288c-54fd-4cf7-8db5-074614066c8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_f51ecb9f-2c40-4d12-b41d-3c5c8858c462" xlink:to="loc_us-gaap_ForeignCountryMember_d777288c-54fd-4cf7-8db5-074614066c8b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_bd641ff2-24f0-4bff-8dca-a7f6d04eb102" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_2345db35-50d8-4ccc-b8f0-4c759a9fe1c3" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_bd641ff2-24f0-4bff-8dca-a7f6d04eb102" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_bd641ff2-24f0-4bff-8dca-a7f6d04eb102_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_bd641ff2-24f0-4bff-8dca-a7f6d04eb102" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_bd641ff2-24f0-4bff-8dca-a7f6d04eb102_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_dfb48019-e22b-49b9-9400-db89206161bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_bd641ff2-24f0-4bff-8dca-a7f6d04eb102" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_dfb48019-e22b-49b9-9400-db89206161bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_7ca672b9-d023-48ee-a8ff-e7e7d5763525" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_2345db35-50d8-4ccc-b8f0-4c759a9fe1c3" xlink:to="loc_us-gaap_TaxPeriodAxis_7ca672b9-d023-48ee-a8ff-e7e7d5763525" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_7ca672b9-d023-48ee-a8ff-e7e7d5763525_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_7ca672b9-d023-48ee-a8ff-e7e7d5763525" xlink:to="loc_us-gaap_TaxPeriodDomain_7ca672b9-d023-48ee-a8ff-e7e7d5763525_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_03c2472a-f117-4101-99c8-e6fb97b27972" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_7ca672b9-d023-48ee-a8ff-e7e7d5763525" xlink:to="loc_us-gaap_TaxPeriodDomain_03c2472a-f117-4101-99c8-e6fb97b27972" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarliestTaxYearMember_b2e5e1ea-30d1-48ab-91ed-e0bce72baeb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarliestTaxYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_03c2472a-f117-4101-99c8-e6fb97b27972" xlink:to="loc_us-gaap_EarliestTaxYearMember_b2e5e1ea-30d1-48ab-91ed-e0bce72baeb5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LatestTaxYearMember_81fa9adc-90e2-4ebc-8838-b03e84343f09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LatestTaxYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_03c2472a-f117-4101-99c8-e6fb97b27972" xlink:to="loc_us-gaap_LatestTaxYearMember_81fa9adc-90e2-4ebc-8838-b03e84343f09" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails" xlink:type="extended" id="i72e847ac48914856a11f7429753564d1_IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_42872f65-5b4e-4803-993c-6a5a28077b32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesExcludingIncomeAndExciseTaxesAbstract_49066581-8b4e-4c6f-8187-ac5570b6b40b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesExcludingIncomeAndExciseTaxesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_42872f65-5b4e-4803-993c-6a5a28077b32" xlink:to="loc_us-gaap_TaxesExcludingIncomeAndExciseTaxesAbstract_49066581-8b4e-4c6f-8187-ac5570b6b40b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_d397dde7-92f4-4b78-be3e-28956275763e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_42872f65-5b4e-4803-993c-6a5a28077b32" xlink:to="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_d397dde7-92f4-4b78-be3e-28956275763e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_8d0344d5-9c0c-49fc-bc95-208791056a0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_42872f65-5b4e-4803-993c-6a5a28077b32" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_8d0344d5-9c0c-49fc-bc95-208791056a0b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_a7fe0648-7352-4bab-aadc-e6c4bc7a9e6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_42872f65-5b4e-4803-993c-6a5a28077b32" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_a7fe0648-7352-4bab-aadc-e6c4bc7a9e6e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_22611f36-9d30-4a69-a4a7-250a6c5b3940" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_42872f65-5b4e-4803-993c-6a5a28077b32" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_22611f36-9d30-4a69-a4a7-250a6c5b3940" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_1cc46cc8-1e92-4ce7-9632-04c9db59270f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_42872f65-5b4e-4803-993c-6a5a28077b32" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_1cc46cc8-1e92-4ce7-9632-04c9db59270f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_61574043-6e98-4225-bfbd-1e9a621ed327" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_42872f65-5b4e-4803-993c-6a5a28077b32" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_61574043-6e98-4225-bfbd-1e9a621ed327" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_789439fb-4391-4aff-b484-7c763a11d98c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_42872f65-5b4e-4803-993c-6a5a28077b32" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_789439fb-4391-4aff-b484-7c763a11d98c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_9f1a3d63-ec21-4702-9e3e-83d4db3c570a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_789439fb-4391-4aff-b484-7c763a11d98c" xlink:to="loc_us-gaap_TaxPeriodAxis_9f1a3d63-ec21-4702-9e3e-83d4db3c570a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_9f1a3d63-ec21-4702-9e3e-83d4db3c570a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_9f1a3d63-ec21-4702-9e3e-83d4db3c570a" xlink:to="loc_us-gaap_TaxPeriodDomain_9f1a3d63-ec21-4702-9e3e-83d4db3c570a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_35ef1c27-3f3c-4b88-9e6a-f6a01bc6725c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_9f1a3d63-ec21-4702-9e3e-83d4db3c570a" xlink:to="loc_us-gaap_TaxPeriodDomain_35ef1c27-3f3c-4b88-9e6a-f6a01bc6725c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails" xlink:type="extended" id="ib2581b76bd9f40be9e13d09c949fd0ea_IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_425918e4-211a-4c84-93e3-a561035c2eda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_29f91b0d-22ab-4679-be05-df1fedb17698" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_425918e4-211a-4c84-93e3-a561035c2eda" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_29f91b0d-22ab-4679-be05-df1fedb17698" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_651810ab-4c92-4573-a77a-6ccc0a6b0094" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_425918e4-211a-4c84-93e3-a561035c2eda" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_651810ab-4c92-4573-a77a-6ccc0a6b0094" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_b9b4ba96-f48f-478c-9874-6a2f79e9cd9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_425918e4-211a-4c84-93e3-a561035c2eda" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_b9b4ba96-f48f-478c-9874-6a2f79e9cd9d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_a07f38fc-1c09-4fb2-b705-c18f110512b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_425918e4-211a-4c84-93e3-a561035c2eda" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_a07f38fc-1c09-4fb2-b705-c18f110512b3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount_c74eba33-b43c-45a6-b15f-7441daad2aa6" xlink:href="unh-20211231.xsd#unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_425918e4-211a-4c84-93e3-a561035c2eda" xlink:to="loc_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount_c74eba33-b43c-45a6-b15f-7441daad2aa6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent_3aba2249-2f6e-4855-9c34-c163ef97601d" xlink:href="unh-20211231.xsd#unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_425918e4-211a-4c84-93e3-a561035c2eda" xlink:to="loc_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent_3aba2249-2f6e-4855-9c34-c163ef97601d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_ac9e9c85-9d73-46ab-9fa2-dfd0e7609ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_425918e4-211a-4c84-93e3-a561035c2eda" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_ac9e9c85-9d73-46ab-9fa2-dfd0e7609ffa" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_42e238c3-744f-456e-b1b2-b2922f8143db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_425918e4-211a-4c84-93e3-a561035c2eda" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_42e238c3-744f-456e-b1b2-b2922f8143db" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount_34a7f560-f455-4062-b625-5cdfc273e9db" xlink:href="unh-20211231.xsd#unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_425918e4-211a-4c84-93e3-a561035c2eda" xlink:to="loc_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount_34a7f560-f455-4062-b625-5cdfc273e9db" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent_e46d1517-85b1-4cfb-b732-cb9e7c851749" xlink:href="unh-20211231.xsd#unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_425918e4-211a-4c84-93e3-a561035c2eda" xlink:to="loc_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent_e46d1517-85b1-4cfb-b732-cb9e7c851749" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_edb3d9ac-2020-4ffa-adc3-bb96cc64b0a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_425918e4-211a-4c84-93e3-a561035c2eda" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_edb3d9ac-2020-4ffa-adc3-bb96cc64b0a0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_83ed6059-9fe9-4968-9479-0f89309f7bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_425918e4-211a-4c84-93e3-a561035c2eda" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_83ed6059-9fe9-4968-9479-0f89309f7bf0" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_29825ea9-e9b6-4ce6-9fb9-048c0bfc24a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_425918e4-211a-4c84-93e3-a561035c2eda" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_29825ea9-e9b6-4ce6-9fb9-048c0bfc24a4" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_a851c53f-21ce-4ffe-a89b-02939e97d0da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_425918e4-211a-4c84-93e3-a561035c2eda" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_a851c53f-21ce-4ffe-a89b-02939e97d0da" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_81d6a490-55ab-4922-9ce4-d707df2660a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_425918e4-211a-4c84-93e3-a561035c2eda" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_81d6a490-55ab-4922-9ce4-d707df2660a4" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9ed22a93-3c1a-4429-84e5-c8b6ffdd3703" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_425918e4-211a-4c84-93e3-a561035c2eda" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9ed22a93-3c1a-4429-84e5-c8b6ffdd3703" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_d6bf822c-8213-45cf-9805-f09f90c30b4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_425918e4-211a-4c84-93e3-a561035c2eda" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_d6bf822c-8213-45cf-9805-f09f90c30b4b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_6c5c71f2-5608-49a1-a1ca-f18b45db6fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_d6bf822c-8213-45cf-9805-f09f90c30b4b" xlink:to="loc_us-gaap_TaxPeriodAxis_6c5c71f2-5608-49a1-a1ca-f18b45db6fb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_6c5c71f2-5608-49a1-a1ca-f18b45db6fb5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_6c5c71f2-5608-49a1-a1ca-f18b45db6fb5" xlink:to="loc_us-gaap_TaxPeriodDomain_6c5c71f2-5608-49a1-a1ca-f18b45db6fb5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_6bbd44c8-8ceb-4d43-8b9f-05f8ea6ef0fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_6c5c71f2-5608-49a1-a1ca-f18b45db6fb5" xlink:to="loc_us-gaap_TaxPeriodDomain_6bbd44c8-8ceb-4d43-8b9f-05f8ea6ef0fa" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended" id="if677b4f6ed084ac38e8c2e32c46dff66_IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_11be30c2-9640-4c3a-b92c-1b7c1296bc75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract_2cccfbc0-936d-42c0-9894-94a038473c47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGrossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_11be30c2-9640-4c3a-b92c-1b7c1296bc75" xlink:to="loc_us-gaap_DeferredTaxAssetsGrossAbstract_2cccfbc0-936d-42c0-9894-94a038473c47" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_c5296763-bd84-47fb-81b9-2ab714f2544d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_2cccfbc0-936d-42c0-9894-94a038473c47" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_c5296763-bd84-47fb-81b9-2ab714f2544d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_123a8cde-7cf6-4922-8d78-308ec011fb29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_2cccfbc0-936d-42c0-9894-94a038473c47" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_123a8cde-7cf6-4922-8d78-308ec011fb29" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_aadd1864-5da4-4b96-95c6-dd9492de8038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_2cccfbc0-936d-42c0-9894-94a038473c47" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_aadd1864-5da4-4b96-95c6-dd9492de8038" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities_7223f82a-58f4-4340-8712-4d743407acbc" xlink:href="unh-20211231.xsd#unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_2cccfbc0-936d-42c0-9894-94a038473c47" xlink:to="loc_unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities_7223f82a-58f4-4340-8712-4d743407acbc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_6492c3d8-7be3-4467-ba9c-a9a564a097d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_2cccfbc0-936d-42c0-9894-94a038473c47" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_6492c3d8-7be3-4467-ba9c-a9a564a097d9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxAssetsLeaseLiability_e3b4f938-a1a4-4d80-8acd-7b927cf49a65" xlink:href="unh-20211231.xsd#unh_DeferredTaxAssetsLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_2cccfbc0-936d-42c0-9894-94a038473c47" xlink:to="loc_unh_DeferredTaxAssetsLeaseLiability_e3b4f938-a1a4-4d80-8acd-7b927cf49a65" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxAssetOtherDomestic_3cec8636-4ad0-4f4b-b996-0d5d73937068" xlink:href="unh-20211231.xsd#unh_DeferredTaxAssetOtherDomestic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_2cccfbc0-936d-42c0-9894-94a038473c47" xlink:to="loc_unh_DeferredTaxAssetOtherDomestic_3cec8636-4ad0-4f4b-b996-0d5d73937068" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxAssetOtherForeign_ca39b25a-31a8-4504-a745-52b2b43048e5" xlink:href="unh-20211231.xsd#unh_DeferredTaxAssetOtherForeign"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_2cccfbc0-936d-42c0-9894-94a038473c47" xlink:to="loc_unh_DeferredTaxAssetOtherForeign_ca39b25a-31a8-4504-a745-52b2b43048e5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_063272c5-96e2-4704-a6a2-7d1ee572ee84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_2cccfbc0-936d-42c0-9894-94a038473c47" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_063272c5-96e2-4704-a6a2-7d1ee572ee84" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_fc1332a7-0e6e-43cd-ab2a-b2e54f8565c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_2cccfbc0-936d-42c0-9894-94a038473c47" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_fc1332a7-0e6e-43cd-ab2a-b2e54f8565c1" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_50f90740-81b6-478f-95b0-964a2f61627b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_2cccfbc0-936d-42c0-9894-94a038473c47" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_50f90740-81b6-478f-95b0-964a2f61627b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_a2a0ac73-a0c5-47c7-b7ef-cf519df08207" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_11be30c2-9640-4c3a-b92c-1b7c1296bc75" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_a2a0ac73-a0c5-47c7-b7ef-cf519df08207" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_1f640f72-676a-4082-b653-082e9b404010" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_a2a0ac73-a0c5-47c7-b7ef-cf519df08207" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_1f640f72-676a-4082-b653-082e9b404010" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign_09cd8ae0-c499-4107-a7ce-67f2caf735c4" xlink:href="unh-20211231.xsd#unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_a2a0ac73-a0c5-47c7-b7ef-cf519df08207" xlink:to="loc_unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign_09cd8ae0-c499-4107-a7ce-67f2caf735c4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware_11db679c-3f20-437a-ab78-f0bbb10f66fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_a2a0ac73-a0c5-47c7-b7ef-cf519df08207" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware_11db679c-3f20-437a-ab78-f0bbb10f66fc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_6685bb26-949b-486b-afc1-0d4f38b8cc1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_a2a0ac73-a0c5-47c7-b7ef-cf519df08207" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_6685bb26-949b-486b-afc1-0d4f38b8cc1e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_f7892da1-fabb-42ba-b53d-b6348c164411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_a2a0ac73-a0c5-47c7-b7ef-cf519df08207" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_f7892da1-fabb-42ba-b53d-b6348c164411" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates_e5de40eb-c049-4418-b129-248e3c4cd608" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_a2a0ac73-a0c5-47c7-b7ef-cf519df08207" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates_e5de40eb-c049-4418-b129-248e3c4cd608" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_7d7fbaff-69e4-4c26-9040-475ed6a2cbc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_a2a0ac73-a0c5-47c7-b7ef-cf519df08207" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_7d7fbaff-69e4-4c26-9040-475ed6a2cbc2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxLiabilityOtherDomestic_9aab2979-f112-44a5-83bd-a66c9f9e8b66" xlink:href="unh-20211231.xsd#unh_DeferredTaxLiabilityOtherDomestic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_a2a0ac73-a0c5-47c7-b7ef-cf519df08207" xlink:to="loc_unh_DeferredTaxLiabilityOtherDomestic_9aab2979-f112-44a5-83bd-a66c9f9e8b66" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxLiabilityOtherForeign_afab4237-3314-4a9e-9a59-6050fa67c609" xlink:href="unh-20211231.xsd#unh_DeferredTaxLiabilityOtherForeign"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_a2a0ac73-a0c5-47c7-b7ef-cf519df08207" xlink:to="loc_unh_DeferredTaxLiabilityOtherForeign_afab4237-3314-4a9e-9a59-6050fa67c609" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_e03a52b9-cb33-49fd-8760-91530f6c505a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_a2a0ac73-a0c5-47c7-b7ef-cf519df08207" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_e03a52b9-cb33-49fd-8760-91530f6c505a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_0473bf3b-f6c3-4fdb-8687-c50aa774eb5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_a2a0ac73-a0c5-47c7-b7ef-cf519df08207" xlink:to="loc_us-gaap_DeferredTaxLiabilities_0473bf3b-f6c3-4fdb-8687-c50aa774eb5b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_74072871-d167-4055-892c-3a60e6c11df9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_11be30c2-9640-4c3a-b92c-1b7c1296bc75" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_74072871-d167-4055-892c-3a60e6c11df9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_b4f92a3d-462a-4859-acd4-e96d456f3433" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_74072871-d167-4055-892c-3a60e6c11df9" xlink:to="loc_us-gaap_TaxPeriodAxis_b4f92a3d-462a-4859-acd4-e96d456f3433" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_b4f92a3d-462a-4859-acd4-e96d456f3433_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_b4f92a3d-462a-4859-acd4-e96d456f3433" xlink:to="loc_us-gaap_TaxPeriodDomain_b4f92a3d-462a-4859-acd4-e96d456f3433_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_2e881f70-e2e5-4b23-bb3e-704e0f1a9aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_b4f92a3d-462a-4859-acd4-e96d456f3433" xlink:to="loc_us-gaap_TaxPeriodDomain_2e881f70-e2e5-4b23-bb3e-704e0f1a9aa1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails" xlink:type="extended" id="i0d3b9451c00d44f4b1d6f2a468fecd60_IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_6a28f67f-db98-4bce-bb88-f9550ec8a5ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_d1aad19d-4eee-435a-98a8-14926fe0b330" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6a28f67f-db98-4bce-bb88-f9550ec8a5ac" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_d1aad19d-4eee-435a-98a8-14926fe0b330" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_0ce3ab11-36e1-4dcd-8012-819368aeabc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6a28f67f-db98-4bce-bb88-f9550ec8a5ac" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_0ce3ab11-36e1-4dcd-8012-819368aeabc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_949e98c9-d3c9-4408-955f-e0d451391e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6a28f67f-db98-4bce-bb88-f9550ec8a5ac" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_949e98c9-d3c9-4408-955f-e0d451391e2a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_06ade8d8-bb08-4161-9b80-7e8e2fe8f9b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6a28f67f-db98-4bce-bb88-f9550ec8a5ac" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_06ade8d8-bb08-4161-9b80-7e8e2fe8f9b2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_884c2ae9-366f-4564-bd89-da5d810cb5b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6a28f67f-db98-4bce-bb88-f9550ec8a5ac" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_884c2ae9-366f-4564-bd89-da5d810cb5b1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_ad2a4b01-8b81-4ac5-8093-600826e845fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6a28f67f-db98-4bce-bb88-f9550ec8a5ac" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_ad2a4b01-8b81-4ac5-8093-600826e845fd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_638e472a-6320-4e98-bd56-035349be48b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_175f7046-d2b5-4474-8485-894c5d7a0604" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6a28f67f-db98-4bce-bb88-f9550ec8a5ac" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_175f7046-d2b5-4474-8485-894c5d7a0604" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_2955da07-0237-401c-b13b-ef137f584958" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_175f7046-d2b5-4474-8485-894c5d7a0604" xlink:to="loc_us-gaap_TaxPeriodAxis_2955da07-0237-401c-b13b-ef137f584958" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_2955da07-0237-401c-b13b-ef137f584958_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_2955da07-0237-401c-b13b-ef137f584958" xlink:to="loc_us-gaap_TaxPeriodDomain_2955da07-0237-401c-b13b-ef137f584958_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_10623019-fef4-4d24-934e-b178809ce786" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_2955da07-0237-401c-b13b-ef137f584958" xlink:to="loc_us-gaap_TaxPeriodDomain_10623019-fef4-4d24-934e-b178809ce786" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShareholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#ShareholdersEquityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ShareholdersEquityNarrativeDetails" xlink:type="extended" id="idfe5e99cb2374d7aa3d7845a81dfd223_ShareholdersEquityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_unh_ShareRepurchasesTableLineItems_5db5c4d2-bcf3-4434-ba25-e8e2739ca6d6" xlink:href="unh-20211231.xsd#unh_ShareRepurchasesTableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries_d246d2a2-b462-4bed-8363-e93f33a7c8a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_unh_ShareRepurchasesTableLineItems_5db5c4d2-bcf3-4434-ba25-e8e2739ca6d6" xlink:to="loc_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries_d246d2a2-b462-4bed-8363-e93f33a7c8a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_e97bf801-1580-404e-ab0a-3bd67b355691" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_unh_ShareRepurchasesTableLineItems_5db5c4d2-bcf3-4434-ba25-e8e2739ca6d6" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_e97bf801-1580-404e-ab0a-3bd67b355691" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_bf1641a4-d4ae-400f-b118-d646f0301ac4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_unh_ShareRepurchasesTableLineItems_5db5c4d2-bcf3-4434-ba25-e8e2739ca6d6" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_bf1641a4-d4ae-400f-b118-d646f0301ac4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_004b89ea-c87d-4381-b1dc-04ab91d977a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_unh_ShareRepurchasesTableLineItems_5db5c4d2-bcf3-4434-ba25-e8e2739ca6d6" xlink:to="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_004b89ea-c87d-4381-b1dc-04ab91d977a6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ShareRepurchasesTable_1758a493-10ee-4082-a0b0-38db5dcb4b38" xlink:href="unh-20211231.xsd#unh_ShareRepurchasesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_unh_ShareRepurchasesTableLineItems_5db5c4d2-bcf3-4434-ba25-e8e2739ca6d6" xlink:to="loc_unh_ShareRepurchasesTable_1758a493-10ee-4082-a0b0-38db5dcb4b38" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DividendFrequencyAxis_f89666f8-360a-4b31-99bb-c24bce5c8b05" xlink:href="unh-20211231.xsd#unh_DividendFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_unh_ShareRepurchasesTable_1758a493-10ee-4082-a0b0-38db5dcb4b38" xlink:to="loc_unh_DividendFrequencyAxis_f89666f8-360a-4b31-99bb-c24bce5c8b05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DividendFrequencyDomain_f89666f8-360a-4b31-99bb-c24bce5c8b05_default" xlink:href="unh-20211231.xsd#unh_DividendFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_unh_DividendFrequencyAxis_f89666f8-360a-4b31-99bb-c24bce5c8b05" xlink:to="loc_unh_DividendFrequencyDomain_f89666f8-360a-4b31-99bb-c24bce5c8b05_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DividendFrequencyDomain_0f7a7e84-b0d3-40f5-884e-507a789a4409" xlink:href="unh-20211231.xsd#unh_DividendFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_unh_DividendFrequencyAxis_f89666f8-360a-4b31-99bb-c24bce5c8b05" xlink:to="loc_unh_DividendFrequencyDomain_0f7a7e84-b0d3-40f5-884e-507a789a4409" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ExtraordinaryDividendsMember_1a859154-5e5a-448d-b906-92bb547995cb" xlink:href="unh-20211231.xsd#unh_ExtraordinaryDividendsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_unh_DividendFrequencyDomain_0f7a7e84-b0d3-40f5-884e-507a789a4409" xlink:to="loc_unh_ExtraordinaryDividendsMember_1a859154-5e5a-448d-b906-92bb547995cb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended" id="ifac7768af06c4d6587a3fbeaa79dcfc3_ShareBasedCompensationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_229b2a57-784a-42ee-986a-30dfe7ec743c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_aaf28b2a-8574-45db-9697-a16121907326" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_229b2a57-784a-42ee-986a-30dfe7ec743c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_aaf28b2a-8574-45db-9697-a16121907326" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_bb6b53b9-1a31-4ba9-822c-641fab4925dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_229b2a57-784a-42ee-986a-30dfe7ec743c" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_bb6b53b9-1a31-4ba9-822c-641fab4925dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_80919e59-acdd-4622-a726-260f0c30d960" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_229b2a57-784a-42ee-986a-30dfe7ec743c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_80919e59-acdd-4622-a726-260f0c30d960" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e876ff3f-41af-488a-bb59-7c1835ceb566" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_229b2a57-784a-42ee-986a-30dfe7ec743c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e876ff3f-41af-488a-bb59-7c1835ceb566" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_fdced0fb-eb2d-4706-862e-66415aa83463" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e876ff3f-41af-488a-bb59-7c1835ceb566" xlink:to="loc_us-gaap_PlanNameAxis_fdced0fb-eb2d-4706-862e-66415aa83463" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_fdced0fb-eb2d-4706-862e-66415aa83463_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_fdced0fb-eb2d-4706-862e-66415aa83463" xlink:to="loc_us-gaap_PlanNameDomain_fdced0fb-eb2d-4706-862e-66415aa83463_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_77034bf8-fe91-41eb-8eed-0e0e82427de7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_fdced0fb-eb2d-4706-862e-66415aa83463" xlink:to="loc_us-gaap_PlanNameDomain_77034bf8-fe91-41eb-8eed-0e0e82427de7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_3dd0a79e-9167-447c-81cc-4a5ecf4bb3d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e876ff3f-41af-488a-bb59-7c1835ceb566" xlink:to="loc_us-gaap_AwardDateAxis_3dd0a79e-9167-447c-81cc-4a5ecf4bb3d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_3dd0a79e-9167-447c-81cc-4a5ecf4bb3d3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardDateAxis_3dd0a79e-9167-447c-81cc-4a5ecf4bb3d3" xlink:to="loc_us-gaap_AwardDateDomain_3dd0a79e-9167-447c-81cc-4a5ecf4bb3d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_4514f284-498e-4b10-8bae-11fcbd931bea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardDateAxis_3dd0a79e-9167-447c-81cc-4a5ecf4bb3d3" xlink:to="loc_us-gaap_AwardDateDomain_4514f284-498e-4b10-8bae-11fcbd931bea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e2c1bb4c-e310-4a37-a35f-014e516f1be2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e876ff3f-41af-488a-bb59-7c1835ceb566" xlink:to="loc_us-gaap_AwardTypeAxis_e2c1bb4c-e310-4a37-a35f-014e516f1be2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e2c1bb4c-e310-4a37-a35f-014e516f1be2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_e2c1bb4c-e310-4a37-a35f-014e516f1be2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e2c1bb4c-e310-4a37-a35f-014e516f1be2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_87ae6de3-7f99-430c-9f34-1f230fd96319" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_e2c1bb4c-e310-4a37-a35f-014e516f1be2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_87ae6de3-7f99-430c-9f34-1f230fd96319" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_6de94206-f361-4eee-807b-11c82ffa0ca8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_87ae6de3-7f99-430c-9f34-1f230fd96319" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_6de94206-f361-4eee-807b-11c82ffa0ca8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EmployeeStockPurchasePlanESPPMember_e05008d3-e303-41cf-b85e-a5ae27a73fad" xlink:href="unh-20211231.xsd#unh_EmployeeStockPurchasePlanESPPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_87ae6de3-7f99-430c-9f34-1f230fd96319" xlink:to="loc_unh_EmployeeStockPurchasePlanESPPMember_e05008d3-e303-41cf-b85e-a5ae27a73fad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_5212f5a0-e14b-46b2-a917-f47cc9c21bab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e876ff3f-41af-488a-bb59-7c1835ceb566" xlink:to="loc_us-gaap_StatementClassOfStockAxis_5212f5a0-e14b-46b2-a917-f47cc9c21bab" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_5212f5a0-e14b-46b2-a917-f47cc9c21bab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_5212f5a0-e14b-46b2-a917-f47cc9c21bab" xlink:to="loc_us-gaap_ClassOfStockDomain_5212f5a0-e14b-46b2-a917-f47cc9c21bab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_9af9540d-faaf-44e5-842d-ab166f1bd29b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_5212f5a0-e14b-46b2-a917-f47cc9c21bab" xlink:to="loc_us-gaap_ClassOfStockDomain_9af9540d-faaf-44e5-842d-ab166f1bd29b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_acc4cf08-49c6-4ab2-83bf-05b2443bbb61" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e876ff3f-41af-488a-bb59-7c1835ceb566" xlink:to="loc_srt_RangeAxis_acc4cf08-49c6-4ab2-83bf-05b2443bbb61" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_acc4cf08-49c6-4ab2-83bf-05b2443bbb61_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_acc4cf08-49c6-4ab2-83bf-05b2443bbb61" xlink:to="loc_srt_RangeMember_acc4cf08-49c6-4ab2-83bf-05b2443bbb61_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_eede0b35-0fc1-4e88-aea8-5fba76a86c18" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_acc4cf08-49c6-4ab2-83bf-05b2443bbb61" xlink:to="loc_srt_RangeMember_eede0b35-0fc1-4e88-aea8-5fba76a86c18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_0c2fa558-0436-4d2f-bed9-902e2d0e69e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e876ff3f-41af-488a-bb59-7c1835ceb566" xlink:to="loc_us-gaap_VestingAxis_0c2fa558-0436-4d2f-bed9-902e2d0e69e7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_0c2fa558-0436-4d2f-bed9-902e2d0e69e7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_0c2fa558-0436-4d2f-bed9-902e2d0e69e7" xlink:to="loc_us-gaap_VestingDomain_0c2fa558-0436-4d2f-bed9-902e2d0e69e7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_7aa11226-c29c-41c4-9594-f8298b4b79b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_0c2fa558-0436-4d2f-bed9-902e2d0e69e7" xlink:to="loc_us-gaap_VestingDomain_7aa11226-c29c-41c4-9594-f8298b4b79b2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#ShareBasedCompensationStockOptionActivityDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails" xlink:type="extended" id="i5f58c1b01a0d42c58226e4d52386f185_ShareBasedCompensationStockOptionActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2a011f4-94cf-4a0a-a7df-296e02a755de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2a011f4-94cf-4a0a-a7df-296e02a755de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a7c986a5-ebe6-48b6-8bca-94e7b98e9142" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a7c986a5-ebe6-48b6-8bca-94e7b98e9142" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_8b2b3075-535e-47a6-9fc0-983285497ade" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_8b2b3075-535e-47a6-9fc0-983285497ade" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_752f0d0f-b651-41fc-a704-81a674e7d77f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_752f0d0f-b651-41fc-a704-81a674e7d77f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_88fa6763-d6d8-4e0b-86b5-25a608217d01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_88fa6763-d6d8-4e0b-86b5-25a608217d01" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4555e480-6b9c-41b6-b5fb-18d28067a6eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_b94e82fc-d09b-418d-b4ac-7c195b92dd74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_b94e82fc-d09b-418d-b4ac-7c195b92dd74" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_b90e35d4-7ddc-42f8-a70d-b275f9d3a782" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_b90e35d4-7ddc-42f8-a70d-b275f9d3a782" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_fb38b988-bec5-4559-b726-1a98f84975a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_fb38b988-bec5-4559-b726-1a98f84975a6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_8be08f86-5e53-4909-b153-22bbd058e6b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_8be08f86-5e53-4909-b153-22bbd058e6b9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_cfe06d34-f5e1-4f1d-ab1e-16f093d11a25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_cfe06d34-f5e1-4f1d-ab1e-16f093d11a25" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2dfcf024-2342-4a4f-9529-83edd357e965" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2dfcf024-2342-4a4f-9529-83edd357e965" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_76d2112a-e583-4a63-bd48-1317889ca267" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_8c0114df-6b62-4b68-ac47-5a52ab81e561" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_8c0114df-6b62-4b68-ac47-5a52ab81e561" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_847b1492-a029-41c4-8f96-f91163941b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_847b1492-a029-41c4-8f96-f91163941b6e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_612f5594-5c3e-4eec-bf85-c6e3e70b82de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_612f5594-5c3e-4eec-bf85-c6e3e70b82de" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_9bfd0d52-255a-4bfc-b178-4f6df77710ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_9bfd0d52-255a-4bfc-b178-4f6df77710ff" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_f86c9bd0-169a-4602-93b2-bfe88e5f7509" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_f86c9bd0-169a-4602-93b2-bfe88e5f7509" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_b7ef73e3-93f1-49e0-88d6-e8fff252cb5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_b7ef73e3-93f1-49e0-88d6-e8fff252cb5a" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0a3c7405-68be-41cf-9c8f-e6d05558e854" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0a3c7405-68be-41cf-9c8f-e6d05558e854" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_10cb1b94-9e2c-4d74-be62-dbe9b10ba7bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_10cb1b94-9e2c-4d74-be62-dbe9b10ba7bc" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bf93c14d-ba72-4096-8fa1-166741afcaa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2a011f4-94cf-4a0a-a7df-296e02a755de" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bf93c14d-ba72-4096-8fa1-166741afcaa5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2cf99dcb-163a-4081-b613-d977e91d7262" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bf93c14d-ba72-4096-8fa1-166741afcaa5" xlink:to="loc_us-gaap_AwardTypeAxis_2cf99dcb-163a-4081-b613-d977e91d7262" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2cf99dcb-163a-4081-b613-d977e91d7262_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_2cf99dcb-163a-4081-b613-d977e91d7262" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2cf99dcb-163a-4081-b613-d977e91d7262_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2709c794-f744-45f1-8e14-db68e53fc070" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_2cf99dcb-163a-4081-b613-d977e91d7262" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2709c794-f744-45f1-8e14-db68e53fc070" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShareBasedCompensationRestrictedShareActivityDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#ShareBasedCompensationRestrictedShareActivityDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ShareBasedCompensationRestrictedShareActivityDetails" xlink:type="extended" id="i6c54f8fc06204c41a8857ff04044ea74_ShareBasedCompensationRestrictedShareActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9cff51da-7e76-48a1-921f-5f2e2b6b74eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e3053c20-b3b8-49f4-b259-bdae0ebb28d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9cff51da-7e76-48a1-921f-5f2e2b6b74eb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e3053c20-b3b8-49f4-b259-bdae0ebb28d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_13a67e06-d0db-4446-a2c2-e404eae94f31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e3053c20-b3b8-49f4-b259-bdae0ebb28d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_13a67e06-d0db-4446-a2c2-e404eae94f31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_507f247a-1877-4852-9aad-a11182236786" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e3053c20-b3b8-49f4-b259-bdae0ebb28d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_507f247a-1877-4852-9aad-a11182236786" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d0ad8d8e-5669-46d8-9364-c549830e8843" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e3053c20-b3b8-49f4-b259-bdae0ebb28d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d0ad8d8e-5669-46d8-9364-c549830e8843" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7cc0e3ab-d67f-4136-afc3-a637c0755c24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_22aa5bf5-734b-4a9b-968e-9ab1f77a6e54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e3053c20-b3b8-49f4-b259-bdae0ebb28d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_22aa5bf5-734b-4a9b-968e-9ab1f77a6e54" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_917f0716-445b-4d73-bce1-a23bd919d176" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e3053c20-b3b8-49f4-b259-bdae0ebb28d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_917f0716-445b-4d73-bce1-a23bd919d176" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_a21df360-5d31-497a-a35d-6443c19008b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e3053c20-b3b8-49f4-b259-bdae0ebb28d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_a21df360-5d31-497a-a35d-6443c19008b7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9150b0fd-21e8-4a39-a736-d5c199ce27b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b2051329-e649-4ecd-836c-a63423365e78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9cff51da-7e76-48a1-921f-5f2e2b6b74eb" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b2051329-e649-4ecd-836c-a63423365e78" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_23b84d4a-159d-407e-bdaa-33516b467829" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b2051329-e649-4ecd-836c-a63423365e78" xlink:to="loc_us-gaap_AwardTypeAxis_23b84d4a-159d-407e-bdaa-33516b467829" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23b84d4a-159d-407e-bdaa-33516b467829_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_23b84d4a-159d-407e-bdaa-33516b467829" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23b84d4a-159d-407e-bdaa-33516b467829_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_daa907a2-d587-45c9-8567-7c05eb8686ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_23b84d4a-159d-407e-bdaa-33516b467829" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_daa907a2-d587-45c9-8567-7c05eb8686ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_e62a781f-cd06-4370-acf7-b7c2dc56b213" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_daa907a2-d587-45c9-8567-7c05eb8686ff" xlink:to="loc_us-gaap_RestrictedStockMember_e62a781f-cd06-4370-acf7-b7c2dc56b213" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#ShareBasedCompensationOtherShareBasedCompensationDataDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails" xlink:type="extended" id="i788358de975b48919a7a5881e6cf9260_ShareBasedCompensationOtherShareBasedCompensationDataDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_541a6082-debd-4ed2-ab4b-476c7ac7ab9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_aec3a34a-a072-4fb3-8ed5-ab9e9227612f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_541a6082-debd-4ed2-ab4b-476c7ac7ab9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_aec3a34a-a072-4fb3-8ed5-ab9e9227612f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_49ff462d-4081-4e51-81e7-8702bc70cb76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_541a6082-debd-4ed2-ab4b-476c7ac7ab9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_49ff462d-4081-4e51-81e7-8702bc70cb76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_938cd2b1-4010-4421-b882-1adb3a3d99e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_541a6082-debd-4ed2-ab4b-476c7ac7ab9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_938cd2b1-4010-4421-b882-1adb3a3d99e5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_d30db912-f38d-47c0-9251-e2407fedbd34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_541a6082-debd-4ed2-ab4b-476c7ac7ab9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_d30db912-f38d-47c0-9251-e2407fedbd34" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_1a6c3d09-2cae-4bda-9bfb-41425588faef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_541a6082-debd-4ed2-ab4b-476c7ac7ab9c" xlink:to="loc_us-gaap_ShareBasedCompensation_1a6c3d09-2cae-4bda-9bfb-41425588faef" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_d40c4897-4a2e-4d23-9446-392b1ef66aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_541a6082-debd-4ed2-ab4b-476c7ac7ab9c" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_d40c4897-4a2e-4d23-9446-392b1ef66aa4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_7f1367cd-d386-4114-939b-4782998df0e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_541a6082-debd-4ed2-ab4b-476c7ac7ab9c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_7f1367cd-d386-4114-939b-4782998df0e4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_f94d867f-3d9c-406a-980d-eb38b437fe3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_541a6082-debd-4ed2-ab4b-476c7ac7ab9c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_f94d867f-3d9c-406a-980d-eb38b437fe3c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0b433eb3-7459-4312-a61a-a1680ea22f35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_541a6082-debd-4ed2-ab4b-476c7ac7ab9c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0b433eb3-7459-4312-a61a-a1680ea22f35" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_3bfdcce8-b1ae-48a7-9f9c-cc586ca86ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_541a6082-debd-4ed2-ab4b-476c7ac7ab9c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_3bfdcce8-b1ae-48a7-9f9c-cc586ca86ae7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7465245d-7717-4dc2-a474-9ce47a9081e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_541a6082-debd-4ed2-ab4b-476c7ac7ab9c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7465245d-7717-4dc2-a474-9ce47a9081e0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_77922023-7726-4440-b7b9-51063003f562" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7465245d-7717-4dc2-a474-9ce47a9081e0" xlink:to="loc_us-gaap_AwardTypeAxis_77922023-7726-4440-b7b9-51063003f562" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_77922023-7726-4440-b7b9-51063003f562_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_77922023-7726-4440-b7b9-51063003f562" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_77922023-7726-4440-b7b9-51063003f562_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e08de87b-0228-425c-9228-f3e69e7a7537" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_77922023-7726-4440-b7b9-51063003f562" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e08de87b-0228-425c-9228-f3e69e7a7537" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_StockOptionsandSARsMember_cb55c031-3291-4444-b64f-62e46200e4ca" xlink:href="unh-20211231.xsd#unh_StockOptionsandSARsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e08de87b-0228-425c-9228-f3e69e7a7537" xlink:to="loc_unh_StockOptionsandSARsMember_cb55c031-3291-4444-b64f-62e46200e4ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_0d77c034-1f05-4152-9099-ceedddc1b69a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e08de87b-0228-425c-9228-f3e69e7a7537" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_0d77c034-1f05-4152-9099-ceedddc1b69a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EmployeeStockPurchasePlanESPPMember_de709045-20ed-4caa-8ce6-a776f9b99dba" xlink:href="unh-20211231.xsd#unh_EmployeeStockPurchasePlanESPPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e08de87b-0228-425c-9228-f3e69e7a7537" xlink:to="loc_unh_EmployeeStockPurchasePlanESPPMember_de709045-20ed-4caa-8ce6-a776f9b99dba" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails" xlink:type="extended" id="i21c393afb2d04cf09506e032dfc3cfab_ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4750d00f-4050-4183-9328-317d8c6941fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_af2423c9-4fd0-487c-a403-17aa17556952" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4750d00f-4050-4183-9328-317d8c6941fe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_af2423c9-4fd0-487c-a403-17aa17556952" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3c60a6a0-f93c-4a59-b5f0-9aef9ea4f4a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4750d00f-4050-4183-9328-317d8c6941fe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3c60a6a0-f93c-4a59-b5f0-9aef9ea4f4a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_0b256218-2bd3-4185-b645-d2f8431546a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4750d00f-4050-4183-9328-317d8c6941fe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_0b256218-2bd3-4185-b645-d2f8431546a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures_d2d8c734-9689-4713-a245-eead61b4307f" xlink:href="unh-20211231.xsd#unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4750d00f-4050-4183-9328-317d8c6941fe" xlink:to="loc_unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures_d2d8c734-9689-4713-a245-eead61b4307f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_00794262-6eb1-427a-b384-8c3318ed9475" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4750d00f-4050-4183-9328-317d8c6941fe" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_00794262-6eb1-427a-b384-8c3318ed9475" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_04907300-86c4-4c26-9959-6fbad9b8a8c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4750d00f-4050-4183-9328-317d8c6941fe" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_04907300-86c4-4c26-9959-6fbad9b8a8c4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_5dff87ea-5eaa-441c-98df-1dd6bdf88202" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4750d00f-4050-4183-9328-317d8c6941fe" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_5dff87ea-5eaa-441c-98df-1dd6bdf88202" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_b2d1a9de-f882-49a6-af5a-cba974178b02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4750d00f-4050-4183-9328-317d8c6941fe" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_b2d1a9de-f882-49a6-af5a-cba974178b02" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f7a5e01b-2cdd-4bde-8561-5efe9ec59621" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4750d00f-4050-4183-9328-317d8c6941fe" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f7a5e01b-2cdd-4bde-8561-5efe9ec59621" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9e9e507a-395d-4526-aba8-9a6b69e1b20d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f7a5e01b-2cdd-4bde-8561-5efe9ec59621" xlink:to="loc_srt_RangeAxis_9e9e507a-395d-4526-aba8-9a6b69e1b20d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9e9e507a-395d-4526-aba8-9a6b69e1b20d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_9e9e507a-395d-4526-aba8-9a6b69e1b20d" xlink:to="loc_srt_RangeMember_9e9e507a-395d-4526-aba8-9a6b69e1b20d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5be265cf-cd61-4ed2-8171-6455f4e5e673" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_9e9e507a-395d-4526-aba8-9a6b69e1b20d" xlink:to="loc_srt_RangeMember_5be265cf-cd61-4ed2-8171-6455f4e5e673" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7821b87d-e772-4f57-bcc5-2c93bcc38f1b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5be265cf-cd61-4ed2-8171-6455f4e5e673" xlink:to="loc_srt_MinimumMember_7821b87d-e772-4f57-bcc5-2c93bcc38f1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_dbd87468-8092-4a5d-b4e9-7201c0028535" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5be265cf-cd61-4ed2-8171-6455f4e5e673" xlink:to="loc_srt_MaximumMember_dbd87468-8092-4a5d-b4e9-7201c0028535" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#CommitmentsandContingenciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="extended" id="i91b6331a80404daf8ed99e6c2699cc4e_CommitmentsandContingenciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_c79c681e-9b53-4045-baad-a7cd6f0f4c71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_2319c903-6bb4-41a0-b913-76a74fce9c46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c79c681e-9b53-4045-baad-a7cd6f0f4c71" xlink:to="loc_us-gaap_OperatingLeaseCost_2319c903-6bb4-41a0-b913-76a74fce9c46" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_23fdae88-1acb-4a5e-b206-04764f27cc13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c79c681e-9b53-4045-baad-a7cd6f0f4c71" xlink:to="loc_us-gaap_OperatingLeasePayments_23fdae88-1acb-4a5e-b206-04764f27cc13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_66200e24-2875-4ebb-9288-e8551810076d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c79c681e-9b53-4045-baad-a7cd6f0f4c71" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_66200e24-2875-4ebb-9288-e8551810076d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_9f800773-406d-45f0-97b2-0611b1ab1f79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c79c681e-9b53-4045-baad-a7cd6f0f4c71" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_9f800773-406d-45f0-97b2-0611b1ab1f79" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_c9d1bb5e-d91a-4141-ab42-40a1e9500669" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c79c681e-9b53-4045-baad-a7cd6f0f4c71" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_c9d1bb5e-d91a-4141-ab42-40a1e9500669" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_SuretyBondsOutstanding_df15d6cd-8ff2-4fa8-a223-7855c4449fdb" xlink:href="unh-20211231.xsd#unh_SuretyBondsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c79c681e-9b53-4045-baad-a7cd6f0f4c71" xlink:to="loc_unh_SuretyBondsOutstanding_df15d6cd-8ff2-4fa8-a223-7855c4449fdb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment_5e0eff4d-8f91-461a-b50a-6f8e13f1b07a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c79c681e-9b53-4045-baad-a7cd6f0f4c71" xlink:to="loc_us-gaap_OtherCommitment_5e0eff4d-8f91-461a-b50a-6f8e13f1b07a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDescription_09d6e713-1788-4a62-82fd-f5a4a52cda7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsDescription"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c79c681e-9b53-4045-baad-a7cd6f0f4c71" xlink:to="loc_us-gaap_OtherCommitmentsDescription_09d6e713-1788-4a62-82fd-f5a4a52cda7f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventDescription_d5eb47a5-8097-492c-baf4-8e86d7803777" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventDescription"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c79c681e-9b53-4045-baad-a7cd6f0f4c71" xlink:to="loc_us-gaap_SubsequentEventDescription_d5eb47a5-8097-492c-baf4-8e86d7803777" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_5631e5fd-fac4-4797-bce5-c29b6e93880c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_c79c681e-9b53-4045-baad-a7cd6f0f4c71" xlink:to="loc_us-gaap_LossContingenciesTable_5631e5fd-fac4-4797-bce5-c29b6e93880c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_ca296ef8-24a2-4cc6-a964-23734f9bbf81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_5631e5fd-fac4-4797-bce5-c29b6e93880c" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_ca296ef8-24a2-4cc6-a964-23734f9bbf81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_ca296ef8-24a2-4cc6-a964-23734f9bbf81_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_ca296ef8-24a2-4cc6-a964-23734f9bbf81" xlink:to="loc_us-gaap_LossContingencyNatureDomain_ca296ef8-24a2-4cc6-a964-23734f9bbf81_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_37dc5165-138c-4857-88e6-cc945c995981" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_ca296ef8-24a2-4cc6-a964-23734f9bbf81" xlink:to="loc_us-gaap_LossContingencyNatureDomain_37dc5165-138c-4857-88e6-cc945c995981" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_37416f7c-869e-4076-9842-2a69ddfb9ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_5631e5fd-fac4-4797-bce5-c29b6e93880c" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_37416f7c-869e-4076-9842-2a69ddfb9ed9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_37416f7c-869e-4076-9842-2a69ddfb9ed9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_37416f7c-869e-4076-9842-2a69ddfb9ed9" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_37416f7c-869e-4076-9842-2a69ddfb9ed9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_063be91a-ca1c-41a8-98b3-97eb86c7a729" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_37416f7c-869e-4076-9842-2a69ddfb9ed9" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_063be91a-ca1c-41a8-98b3-97eb86c7a729" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_2571f052-1c8b-4622-a433-28261d68d6d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_063be91a-ca1c-41a8-98b3-97eb86c7a729" xlink:to="loc_us-gaap_SubsequentEventMember_2571f052-1c8b-4622-a433-28261d68d6d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_722ba8ef-3316-41cb-a014-579158a29ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_5631e5fd-fac4-4797-bce5-c29b6e93880c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_722ba8ef-3316-41cb-a014-579158a29ce0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_722ba8ef-3316-41cb-a014-579158a29ce0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_722ba8ef-3316-41cb-a014-579158a29ce0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_722ba8ef-3316-41cb-a014-579158a29ce0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_341ff8b6-4963-4564-8e8c-a6fc4b463e97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_722ba8ef-3316-41cb-a014-579158a29ce0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_341ff8b6-4963-4564-8e8c-a6fc4b463e97" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/CommitmentsandContingenciesFutureLeasePaymentsDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#CommitmentsandContingenciesFutureLeasePaymentsDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/CommitmentsandContingenciesFutureLeasePaymentsDetails" xlink:type="extended" id="i4d7d836d6e9748aeba52abc47e0dde7a_CommitmentsandContingenciesFutureLeasePaymentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_ade86e93-dec1-48c1-aba1-9511dbbc4988" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_33711ba2-2b8d-44d7-8a6b-e5a8fa1adcf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_ade86e93-dec1-48c1-aba1-9511dbbc4988" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_33711ba2-2b8d-44d7-8a6b-e5a8fa1adcf1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_eaa43e38-e168-4a01-913e-07df8ff7743d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_ade86e93-dec1-48c1-aba1-9511dbbc4988" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_eaa43e38-e168-4a01-913e-07df8ff7743d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_88b0be69-7926-434d-9dc4-545cb82ea51e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_ade86e93-dec1-48c1-aba1-9511dbbc4988" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_88b0be69-7926-434d-9dc4-545cb82ea51e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_809ffdd0-b5ce-433a-932d-c4f3509e7ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_ade86e93-dec1-48c1-aba1-9511dbbc4988" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_809ffdd0-b5ce-433a-932d-c4f3509e7ea0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_3296b050-15da-4dc1-b0f3-4e4a1248e8cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_ade86e93-dec1-48c1-aba1-9511dbbc4988" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_3296b050-15da-4dc1-b0f3-4e4a1248e8cf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_15d03c83-ff26-4f82-af6a-c3ae7812f0a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_ade86e93-dec1-48c1-aba1-9511dbbc4988" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_15d03c83-ff26-4f82-af6a-c3ae7812f0a8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_32ed214b-87a4-40b9-8d81-82ca656318fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_ade86e93-dec1-48c1-aba1-9511dbbc4988" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_32ed214b-87a4-40b9-8d81-82ca656318fb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_58d59914-a3e4-4c08-9b3c-bc652dc970b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_ade86e93-dec1-48c1-aba1-9511dbbc4988" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_58d59914-a3e4-4c08-9b3c-bc652dc970b4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_b4184ef6-d6ad-45ec-93bc-dbf1531d9c45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_ade86e93-dec1-48c1-aba1-9511dbbc4988" xlink:to="loc_us-gaap_OperatingLeaseLiability_b4184ef6-d6ad-45ec-93bc-dbf1531d9c45" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_549da684-2a59-4ae9-9f57-4a9615542e12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_ade86e93-dec1-48c1-aba1-9511dbbc4988" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_549da684-2a59-4ae9-9f57-4a9615542e12" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_785c4365-59d0-4e63-aa71-3350ca640f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_549da684-2a59-4ae9-9f57-4a9615542e12" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_785c4365-59d0-4e63-aa71-3350ca640f1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_785c4365-59d0-4e63-aa71-3350ca640f1d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_785c4365-59d0-4e63-aa71-3350ca640f1d" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_785c4365-59d0-4e63-aa71-3350ca640f1d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1e49b458-c353-4879-a560-7db4d58e5a68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_785c4365-59d0-4e63-aa71-3350ca640f1d" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1e49b458-c353-4879-a560-7db4d58e5a68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsMember_a12d1f74-80e4-4b88-8528-57ef98f82f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1e49b458-c353-4879-a560-7db4d58e5a68" xlink:to="loc_us-gaap_CommitmentsMember_a12d1f74-80e4-4b88-8528-57ef98f82f3f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#SegmentFinancialInformationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails" xlink:type="extended" id="i914d251d220344b4a55c820da727531c_SegmentFinancialInformationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_d9b6b787-8e32-4530-be5a-958dfb917b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_ca596921-26a9-40dc-aec8-4c70d8a50b0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d9b6b787-8e32-4530-be5a-958dfb917b7f" xlink:to="loc_us-gaap_NumberOfReportableSegments_ca596921-26a9-40dc-aec8-4c70d8a50b0d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_e5b1192e-7877-4843-ba69-2efe063d896e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d9b6b787-8e32-4530-be5a-958dfb917b7f" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_e5b1192e-7877-4843-ba69-2efe063d896e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers_3577b87c-a648-4179-878d-6108d617c302" xlink:href="unh-20211231.xsd#unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d9b6b787-8e32-4530-be5a-958dfb917b7f" xlink:to="loc_unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers_3577b87c-a648-4179-878d-6108d617c302" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DisclosureonGeographicAreasPercentageofLongLivedAssets_549e5430-8f59-47b9-9a9d-02762e35e432" xlink:href="unh-20211231.xsd#unh_DisclosureonGeographicAreasPercentageofLongLivedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d9b6b787-8e32-4530-be5a-958dfb917b7f" xlink:to="loc_unh_DisclosureonGeographicAreasPercentageofLongLivedAssets_549e5430-8f59-47b9-9a9d-02762e35e432" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_b7f27d52-4d6a-45e0-8d1c-59fa7cc795df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d9b6b787-8e32-4530-be5a-958dfb917b7f" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_b7f27d52-4d6a-45e0-8d1c-59fa7cc795df" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_5119cc22-70aa-4c7c-914d-d3f1cd9b4ac0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_b7f27d52-4d6a-45e0-8d1c-59fa7cc795df" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_5119cc22-70aa-4c7c-914d-d3f1cd9b4ac0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_5119cc22-70aa-4c7c-914d-d3f1cd9b4ac0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_5119cc22-70aa-4c7c-914d-d3f1cd9b4ac0" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_5119cc22-70aa-4c7c-914d-d3f1cd9b4ac0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_fe687fb5-6183-4ccb-9c83-3d22621dd7cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_5119cc22-70aa-4c7c-914d-d3f1cd9b4ac0" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_fe687fb5-6183-4ccb-9c83-3d22621dd7cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_RevenuesMember_7f768063-fbfc-4487-acb2-5544b176d5aa" xlink:href="unh-20211231.xsd#unh_RevenuesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_fe687fb5-6183-4ccb-9c83-3d22621dd7cc" xlink:to="loc_unh_RevenuesMember_7f768063-fbfc-4487-acb2-5544b176d5aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_cd1b03b0-94d1-4ba7-84da-7e7a5e15a214" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_b7f27d52-4d6a-45e0-8d1c-59fa7cc795df" xlink:to="loc_srt_MajorCustomersAxis_cd1b03b0-94d1-4ba7-84da-7e7a5e15a214" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_cd1b03b0-94d1-4ba7-84da-7e7a5e15a214_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_cd1b03b0-94d1-4ba7-84da-7e7a5e15a214" xlink:to="loc_srt_NameOfMajorCustomerDomain_cd1b03b0-94d1-4ba7-84da-7e7a5e15a214_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_4d6c916b-1a54-4052-bfc5-c22ba3c38421" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_cd1b03b0-94d1-4ba7-84da-7e7a5e15a214" xlink:to="loc_srt_NameOfMajorCustomerDomain_4d6c916b-1a54-4052-bfc5-c22ba3c38421" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_CMSMember_e227bebe-52f7-4974-a80f-75693a737619" xlink:href="unh-20211231.xsd#unh_CMSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_4d6c916b-1a54-4052-bfc5-c22ba3c38421" xlink:to="loc_unh_CMSMember_e227bebe-52f7-4974-a80f-75693a737619" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_63200118-2b25-4c6a-a23f-fbb0649bc069" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_b7f27d52-4d6a-45e0-8d1c-59fa7cc795df" xlink:to="loc_srt_StatementGeographicalAxis_63200118-2b25-4c6a-a23f-fbb0649bc069" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_63200118-2b25-4c6a-a23f-fbb0649bc069_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_63200118-2b25-4c6a-a23f-fbb0649bc069" xlink:to="loc_srt_SegmentGeographicalDomain_63200118-2b25-4c6a-a23f-fbb0649bc069_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a7de8f60-1cec-4ba9-95b4-d0ded067ea48" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_63200118-2b25-4c6a-a23f-fbb0649bc069" xlink:to="loc_srt_SegmentGeographicalDomain_a7de8f60-1cec-4ba9-95b4-d0ded067ea48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_02a817f6-f06f-4363-ace7-d79f281305f5" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a7de8f60-1cec-4ba9-95b4-d0ded067ea48" xlink:to="loc_country_US_02a817f6-f06f-4363-ace7-d79f281305f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_bb8eeb6e-bc31-45c4-b232-c32a9736c5d5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_b7f27d52-4d6a-45e0-8d1c-59fa7cc795df" xlink:to="loc_srt_StatementScenarioAxis_bb8eeb6e-bc31-45c4-b232-c32a9736c5d5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_bb8eeb6e-bc31-45c4-b232-c32a9736c5d5_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_bb8eeb6e-bc31-45c4-b232-c32a9736c5d5" xlink:to="loc_srt_ScenarioUnspecifiedDomain_bb8eeb6e-bc31-45c4-b232-c32a9736c5d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_e507ba9a-c7f7-4098-b2af-f41a5a8b4ad7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_bb8eeb6e-bc31-45c4-b232-c32a9736c5d5" xlink:to="loc_srt_ScenarioUnspecifiedDomain_e507ba9a-c7f7-4098-b2af-f41a5a8b4ad7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_726e1543-05df-4708-b11c-f8a493b3b15c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_b7f27d52-4d6a-45e0-8d1c-59fa7cc795df" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_726e1543-05df-4708-b11c-f8a493b3b15c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_726e1543-05df-4708-b11c-f8a493b3b15c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_726e1543-05df-4708-b11c-f8a493b3b15c" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_726e1543-05df-4708-b11c-f8a493b3b15c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_89e12a2c-cf41-47b0-b7cc-123ea78c9d87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_726e1543-05df-4708-b11c-f8a493b3b15c" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_89e12a2c-cf41-47b0-b7cc-123ea78c9d87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_b8c0092c-2c35-46ca-b842-7daa44185573" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_89e12a2c-cf41-47b0-b7cc-123ea78c9d87" xlink:to="loc_us-gaap_SalesRevenueNetMember_b8c0092c-2c35-46ca-b842-7daa44185573" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/SegmentFinancialInformationDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#SegmentFinancialInformationDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/SegmentFinancialInformationDetails" xlink:type="extended" id="i7e3185aa8bb44aa0a66f40d163df5d71_SegmentFinancialInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_83337e45-9092-43d1-9590-2724aab516b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_0336c83c-1a0d-4022-8a99-093843b15c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_83337e45-9092-43d1-9590-2724aab516b1" xlink:to="loc_us-gaap_PremiumsEarnedNet_0336c83c-1a0d-4022-8a99-093843b15c5c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9912b0fd-442c-4e28-b6a9-ee02f6809e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_83337e45-9092-43d1-9590-2724aab516b1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9912b0fd-442c-4e28-b6a9-ee02f6809e9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_c284a638-26fb-46d2-beb2-6db0b744b523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_83337e45-9092-43d1-9590-2724aab516b1" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_c284a638-26fb-46d2-beb2-6db0b744b523" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_b8ec20dc-0ead-49c2-b0aa-30d60494c510" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_83337e45-9092-43d1-9590-2724aab516b1" xlink:to="loc_us-gaap_Revenues_b8ec20dc-0ead-49c2-b0aa-30d60494c510" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_92cc2ae6-fa37-481e-88f6-8d65c161e2d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_83337e45-9092-43d1-9590-2724aab516b1" xlink:to="loc_us-gaap_OperatingIncomeLoss_92cc2ae6-fa37-481e-88f6-8d65c161e2d8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_0b980943-f45e-4241-b194-2493e74eb17f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_83337e45-9092-43d1-9590-2724aab516b1" xlink:to="loc_us-gaap_InterestExpense_0b980943-f45e-4241-b194-2493e74eb17f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4d43159c-feff-4a19-b0da-c43dd3af56e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_83337e45-9092-43d1-9590-2724aab516b1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4d43159c-feff-4a19-b0da-c43dd3af56e8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e812a340-9bfc-45e2-bbec-776184ed9af5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_83337e45-9092-43d1-9590-2724aab516b1" xlink:to="loc_us-gaap_Assets_e812a340-9bfc-45e2-bbec-776184ed9af5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2ee0208d-f553-4fd6-b531-1a002eff4cbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_83337e45-9092-43d1-9590-2724aab516b1" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2ee0208d-f553-4fd6-b531-1a002eff4cbe" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_fa35db5f-fc59-4090-a98f-5fdab0600225" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_83337e45-9092-43d1-9590-2724aab516b1" xlink:to="loc_us-gaap_DepreciationAndAmortization_fa35db5f-fc59-4090-a98f-5fdab0600225" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_807b23c6-cf0d-4793-ba37-7248a38535d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_83337e45-9092-43d1-9590-2724aab516b1" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_807b23c6-cf0d-4793-ba37-7248a38535d2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_7340b128-cb36-476c-b6ca-59ed13cb8842" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_807b23c6-cf0d-4793-ba37-7248a38535d2" xlink:to="loc_srt_ConsolidationItemsAxis_7340b128-cb36-476c-b6ca-59ed13cb8842" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_7340b128-cb36-476c-b6ca-59ed13cb8842_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_7340b128-cb36-476c-b6ca-59ed13cb8842" xlink:to="loc_srt_ConsolidationItemsDomain_7340b128-cb36-476c-b6ca-59ed13cb8842_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_c432d5b7-c365-496a-81fe-2ce1f1a7e18a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_7340b128-cb36-476c-b6ca-59ed13cb8842" xlink:to="loc_srt_ConsolidationItemsDomain_c432d5b7-c365-496a-81fe-2ce1f1a7e18a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_dcae803c-463e-4379-85c8-38c87102a0a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_c432d5b7-c365-496a-81fe-2ce1f1a7e18a" xlink:to="loc_us-gaap_OperatingSegmentsMember_dcae803c-463e-4379-85c8-38c87102a0a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_29190853-afe6-4c2b-b998-aaef2b032cbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_c432d5b7-c365-496a-81fe-2ce1f1a7e18a" xlink:to="loc_us-gaap_IntersegmentEliminationMember_29190853-afe6-4c2b-b998-aaef2b032cbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_b7216a9a-6694-4b59-9ee4-1d429eb674ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_c432d5b7-c365-496a-81fe-2ce1f1a7e18a" xlink:to="loc_us-gaap_CorporateNonSegmentMember_b7216a9a-6694-4b59-9ee4-1d429eb674ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_5b5cb351-0467-40ca-a161-3957b073f216" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_807b23c6-cf0d-4793-ba37-7248a38535d2" xlink:to="loc_srt_MajorCustomersAxis_5b5cb351-0467-40ca-a161-3957b073f216" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_5b5cb351-0467-40ca-a161-3957b073f216_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_5b5cb351-0467-40ca-a161-3957b073f216" xlink:to="loc_srt_NameOfMajorCustomerDomain_5b5cb351-0467-40ca-a161-3957b073f216_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_23363513-971c-4cf0-ad3b-81b8e6386fa8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_5b5cb351-0467-40ca-a161-3957b073f216" xlink:to="loc_srt_NameOfMajorCustomerDomain_23363513-971c-4cf0-ad3b-81b8e6386fa8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ExternalCustomersMember_4d88c172-e928-4656-b5a6-5bc65e02d347" xlink:href="unh-20211231.xsd#unh_ExternalCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_23363513-971c-4cf0-ad3b-81b8e6386fa8" xlink:to="loc_unh_ExternalCustomersMember_4d88c172-e928-4656-b5a6-5bc65e02d347" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_IntersegmentMember_e4f4e6e7-6c68-485e-a03e-6b3b7c2268b5" xlink:href="unh-20211231.xsd#unh_IntersegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_23363513-971c-4cf0-ad3b-81b8e6386fa8" xlink:to="loc_unh_IntersegmentMember_e4f4e6e7-6c68-485e-a03e-6b3b7c2268b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_2aa1429f-3206-4f58-8ec6-0620825f419f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_807b23c6-cf0d-4793-ba37-7248a38535d2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_2aa1429f-3206-4f58-8ec6-0620825f419f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2aa1429f-3206-4f58-8ec6-0620825f419f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_2aa1429f-3206-4f58-8ec6-0620825f419f" xlink:to="loc_us-gaap_SegmentDomain_2aa1429f-3206-4f58-8ec6-0620825f419f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_20c2393c-0f9b-481f-ba50-1ea6a5d84b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_2aa1429f-3206-4f58-8ec6-0620825f419f" xlink:to="loc_us-gaap_SegmentDomain_20c2393c-0f9b-481f-ba50-1ea6a5d84b7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_UnitedhealthcareMember_9ce2e947-ceff-4b4c-8ba6-59450ff4b3c1" xlink:href="unh-20211231.xsd#unh_UnitedhealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_20c2393c-0f9b-481f-ba50-1ea6a5d84b7f" xlink:to="loc_unh_UnitedhealthcareMember_9ce2e947-ceff-4b4c-8ba6-59450ff4b3c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_TotalOptumMember_b1bd42fb-16b0-488c-aa76-fa41ce6ce1ea" xlink:href="unh-20211231.xsd#unh_TotalOptumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_20c2393c-0f9b-481f-ba50-1ea6a5d84b7f" xlink:to="loc_unh_TotalOptumMember_b1bd42fb-16b0-488c-aa76-fa41ce6ce1ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OptumhealthMember_c77006ca-867a-43c3-8ddc-397235a65711" xlink:href="unh-20211231.xsd#unh_OptumhealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_unh_TotalOptumMember_b1bd42fb-16b0-488c-aa76-fa41ce6ce1ea" xlink:to="loc_unh_OptumhealthMember_c77006ca-867a-43c3-8ddc-397235a65711" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OptuminsightMember_d27426e4-4547-409d-8ad9-961dcab5ae98" xlink:href="unh-20211231.xsd#unh_OptuminsightMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_unh_TotalOptumMember_b1bd42fb-16b0-488c-aa76-fa41ce6ce1ea" xlink:to="loc_unh_OptuminsightMember_d27426e4-4547-409d-8ad9-961dcab5ae98" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OptumrxMember_532c0a8b-0fb9-45c4-b046-69804893a57e" xlink:href="unh-20211231.xsd#unh_OptumrxMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_unh_TotalOptumMember_b1bd42fb-16b0-488c-aa76-fa41ce6ce1ea" xlink:to="loc_unh_OptumrxMember_532c0a8b-0fb9-45c4-b046-69804893a57e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_35c48f15-902c-4411-9926-8f97d189ceae" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_807b23c6-cf0d-4793-ba37-7248a38535d2" xlink:to="loc_srt_ProductOrServiceAxis_35c48f15-902c-4411-9926-8f97d189ceae" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_35c48f15-902c-4411-9926-8f97d189ceae_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_35c48f15-902c-4411-9926-8f97d189ceae" xlink:to="loc_srt_ProductsAndServicesDomain_35c48f15-902c-4411-9926-8f97d189ceae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1189f375-c352-4576-a19e-54d7420f85a2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_35c48f15-902c-4411-9926-8f97d189ceae" xlink:to="loc_srt_ProductsAndServicesDomain_1189f375-c352-4576-a19e-54d7420f85a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_80998a2b-ae37-46a9-ac62-d20b36473ea5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1189f375-c352-4576-a19e-54d7420f85a2" xlink:to="loc_us-gaap_ProductMember_80998a2b-ae37-46a9-ac62-d20b36473ea5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_4e1f1e56-027e-4dec-ae0e-f117cbcb8f13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1189f375-c352-4576-a19e-54d7420f85a2" xlink:to="loc_us-gaap_ServiceMember_4e1f1e56-027e-4dec-ae0e-f117cbcb8f13" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ScheduleINotes" xlink:type="simple" xlink:href="unh-20211231.xsd#ScheduleINotes"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ScheduleINotes" xlink:type="extended" id="i86e024fa068643cbb37166642fca30e1_ScheduleINotes">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_cc861352-badc-43f2-ad0d-88a155221f04" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CondensedStatementOfIncomeCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedStatementOfComprehensiveIncomeTable_a9b011a4-b17c-4b8a-9f25-f99e1843d5aa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CondensedStatementOfComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_cc861352-badc-43f2-ad0d-88a155221f04" xlink:to="loc_srt_CondensedStatementOfComprehensiveIncomeTable_a9b011a4-b17c-4b8a-9f25-f99e1843d5aa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_c81059fd-88f3-462a-918b-d502d82bc595" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_CondensedStatementOfComprehensiveIncomeTable_a9b011a4-b17c-4b8a-9f25-f99e1843d5aa" xlink:to="loc_dei_LegalEntityAxis_c81059fd-88f3-462a-918b-d502d82bc595" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_c81059fd-88f3-462a-918b-d502d82bc595_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_c81059fd-88f3-462a-918b-d502d82bc595" xlink:to="loc_dei_EntityDomain_c81059fd-88f3-462a-918b-d502d82bc595_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_1f553c4d-c208-468f-a825-938291e2e19a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_c81059fd-88f3-462a-918b-d502d82bc595" xlink:to="loc_dei_EntityDomain_1f553c4d-c208-468f-a825-938291e2e19a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_1b8e55a3-f623-4919-aee5-4f142c5e8aee" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_CondensedStatementOfComprehensiveIncomeTable_a9b011a4-b17c-4b8a-9f25-f99e1843d5aa" xlink:to="loc_srt_ConsolidatedEntitiesAxis_1b8e55a3-f623-4919-aee5-4f142c5e8aee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_1b8e55a3-f623-4919-aee5-4f142c5e8aee_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_1b8e55a3-f623-4919-aee5-4f142c5e8aee" xlink:to="loc_srt_ConsolidatedEntitiesDomain_1b8e55a3-f623-4919-aee5-4f142c5e8aee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_3463f48b-5d3c-4025-b4fb-9672d2063636" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_1b8e55a3-f623-4919-aee5-4f142c5e8aee" xlink:to="loc_srt_ConsolidatedEntitiesDomain_3463f48b-5d3c-4025-b4fb-9672d2063636" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_c9d8c5dd-596e-47b2-97e3-87f651d1f454" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_3463f48b-5d3c-4025-b4fb-9672d2063636" xlink:to="loc_srt_ParentCompanyMember_c9d8c5dd-596e-47b2-97e3-87f651d1f454" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_e06ee92c-fc12-437c-873b-68e11ad23c50" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_CondensedStatementOfComprehensiveIncomeTable_a9b011a4-b17c-4b8a-9f25-f99e1843d5aa" xlink:to="loc_srt_ConsolidationItemsAxis_e06ee92c-fc12-437c-873b-68e11ad23c50" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_e06ee92c-fc12-437c-873b-68e11ad23c50_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_e06ee92c-fc12-437c-873b-68e11ad23c50" xlink:to="loc_srt_ConsolidationItemsDomain_e06ee92c-fc12-437c-873b-68e11ad23c50_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_2082a4aa-808d-44ed-bc51-95ca4dfae8de" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_e06ee92c-fc12-437c-873b-68e11ad23c50" xlink:to="loc_srt_ConsolidationItemsDomain_2082a4aa-808d-44ed-bc51-95ca4dfae8de" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ScheduleIPolicies" xlink:type="simple" xlink:href="unh-20211231.xsd#ScheduleIPolicies"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ScheduleIPolicies" xlink:type="extended" id="ia831357451f24773ab63f728e9339005_ScheduleIPolicies">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_5df71102-489e-4bc1-ba02-3922c7d9ae6f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_e8192e1b-d8d5-4af5-a313-73d2b332921d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_5df71102-489e-4bc1-ba02-3922c7d9ae6f" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_e8192e1b-d8d5-4af5-a313-73d2b332921d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_c4f00c8d-978b-4975-b10a-8721ec7a7121" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_5df71102-489e-4bc1-ba02-3922c7d9ae6f" xlink:to="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_c4f00c8d-978b-4975-b10a-8721ec7a7121" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_0d74dc09-adac-4d10-8916-e3d187d8f944" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_5df71102-489e-4bc1-ba02-3922c7d9ae6f" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_0d74dc09-adac-4d10-8916-e3d187d8f944" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_0e7edff3-20ad-4456-853a-fde6136378ac" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_0d74dc09-adac-4d10-8916-e3d187d8f944" xlink:to="loc_srt_ConsolidatedEntitiesAxis_0e7edff3-20ad-4456-853a-fde6136378ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_0e7edff3-20ad-4456-853a-fde6136378ac_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_0e7edff3-20ad-4456-853a-fde6136378ac" xlink:to="loc_srt_ConsolidatedEntitiesDomain_0e7edff3-20ad-4456-853a-fde6136378ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_1177d00f-84f1-4907-b8c5-d92c2a9e4742" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_0e7edff3-20ad-4456-853a-fde6136378ac" xlink:to="loc_srt_ConsolidatedEntitiesDomain_1177d00f-84f1-4907-b8c5-d92c2a9e4742" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_03d440a0-e674-46f1-ab5d-362e1d7a8763" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_1177d00f-84f1-4907-b8c5-d92c2a9e4742" xlink:to="loc_srt_ParentCompanyMember_03d440a0-e674-46f1-ab5d-362e1d7a8763" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ScheduleITables" xlink:type="simple" xlink:href="unh-20211231.xsd#ScheduleITables"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ScheduleITables" xlink:type="extended" id="i47c9f35c41e64bf7a0076628ed2bdc6d_ScheduleITables">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_8ba862f9-fe4f-4bb5-ae97-0741d371b8b0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_1194d2a5-6e82-4bde-9eb7-c599ff0ad5ff" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfCondensedBalanceSheetTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_8ba862f9-fe4f-4bb5-ae97-0741d371b8b0" xlink:to="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_1194d2a5-6e82-4bde-9eb7-c599ff0ad5ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedStatementOfComprehensiveIncomeTableTextBlock_f1c59f61-fecc-4920-ad26-fb93d2cf6bf4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CondensedStatementOfComprehensiveIncomeTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_8ba862f9-fe4f-4bb5-ae97-0741d371b8b0" xlink:to="loc_srt_CondensedStatementOfComprehensiveIncomeTableTextBlock_f1c59f61-fecc-4920-ad26-fb93d2cf6bf4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock_75386645-ddc1-4c4c-8ad2-5a26c77804ca" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfCondensedCashFlowStatementTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_8ba862f9-fe4f-4bb5-ae97-0741d371b8b0" xlink:to="loc_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock_75386645-ddc1-4c4c-8ad2-5a26c77804ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_7cc7665c-fb94-4b12-9d5d-15a1e69ce68e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_8ba862f9-fe4f-4bb5-ae97-0741d371b8b0" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_7cc7665c-fb94-4b12-9d5d-15a1e69ce68e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_f9ef436e-3331-4450-817e-5b16ab3f86d0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_8ba862f9-fe4f-4bb5-ae97-0741d371b8b0" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_f9ef436e-3331-4450-817e-5b16ab3f86d0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_579340ec-8126-4a52-a0e6-ccdb9015b413" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_f9ef436e-3331-4450-817e-5b16ab3f86d0" xlink:to="loc_srt_ConsolidatedEntitiesAxis_579340ec-8126-4a52-a0e6-ccdb9015b413" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_579340ec-8126-4a52-a0e6-ccdb9015b413_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_579340ec-8126-4a52-a0e6-ccdb9015b413" xlink:to="loc_srt_ConsolidatedEntitiesDomain_579340ec-8126-4a52-a0e6-ccdb9015b413_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_129387fd-7846-4445-969e-bf80b196bea2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_579340ec-8126-4a52-a0e6-ccdb9015b413" xlink:to="loc_srt_ConsolidatedEntitiesDomain_129387fd-7846-4445-969e-bf80b196bea2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_8cf79699-a5e3-4033-8934-4c1924379c1f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_129387fd-7846-4445-969e-bf80b196bea2" xlink:to="loc_srt_ParentCompanyMember_8cf79699-a5e3-4033-8934-4c1924379c1f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_48d9e83e-c5c2-4998-aa6b-76b799f2961a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_f9ef436e-3331-4450-817e-5b16ab3f86d0" xlink:to="loc_srt_ConsolidationItemsAxis_48d9e83e-c5c2-4998-aa6b-76b799f2961a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_48d9e83e-c5c2-4998-aa6b-76b799f2961a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_48d9e83e-c5c2-4998-aa6b-76b799f2961a" xlink:to="loc_srt_ConsolidationItemsDomain_48d9e83e-c5c2-4998-aa6b-76b799f2961a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_44c3198d-243e-40e3-9fa9-be4d2e0c8046" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_48d9e83e-c5c2-4998-aa6b-76b799f2961a" xlink:to="loc_srt_ConsolidationItemsDomain_44c3198d-243e-40e3-9fa9-be4d2e0c8046" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ScheduleIDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#ScheduleIDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ScheduleIDetails" xlink:type="extended" id="i9fc05efba72d44eda17c8e4d6b152683_ScheduleIDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4acd52fb-4136-485d-be50-e0aa0e84a283" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries_e5ee4609-e209-489f-826c-92fd9d4288d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4acd52fb-4136-485d-be50-e0aa0e84a283" xlink:to="loc_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries_e5ee4609-e209-489f-826c-92fd9d4288d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributionsFromAffiliates_72d1866c-835b-4650-8a04-12c48f978290" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromContributionsFromAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4acd52fb-4136-485d-be50-e0aa0e84a283" xlink:to="loc_us-gaap_ProceedsFromContributionsFromAffiliates_72d1866c-835b-4650-8a04-12c48f978290" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebt_e56847e8-ba2c-4c37-b7c5-84325e49312d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4acd52fb-4136-485d-be50-e0aa0e84a283" xlink:to="loc_us-gaap_OtherLongTermDebt_e56847e8-ba2c-4c37-b7c5-84325e49312d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayable_4a22f3cb-365b-45c5-8a1d-a8c790d270a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4acd52fb-4136-485d-be50-e0aa0e84a283" xlink:to="loc_us-gaap_NotesPayable_4a22f3cb-365b-45c5-8a1d-a8c790d270a0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_10e91538-b292-4384-a8cf-ba0ea9befaae" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4acd52fb-4136-485d-be50-e0aa0e84a283" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_10e91538-b292-4384-a8cf-ba0ea9befaae" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_6f8a879e-9d70-4d7f-94e5-3368f2f98f66" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_10e91538-b292-4384-a8cf-ba0ea9befaae" xlink:to="loc_srt_ConsolidatedEntitiesAxis_6f8a879e-9d70-4d7f-94e5-3368f2f98f66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_6f8a879e-9d70-4d7f-94e5-3368f2f98f66_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_6f8a879e-9d70-4d7f-94e5-3368f2f98f66" xlink:to="loc_srt_ConsolidatedEntitiesDomain_6f8a879e-9d70-4d7f-94e5-3368f2f98f66_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_b5194946-d30c-483b-a030-95ffd20fd986" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_6f8a879e-9d70-4d7f-94e5-3368f2f98f66" xlink:to="loc_srt_ConsolidatedEntitiesDomain_b5194946-d30c-483b-a030-95ffd20fd986" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_32f48ee0-388e-4849-9262-b2e8a137b528" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_b5194946-d30c-483b-a030-95ffd20fd986" xlink:to="loc_srt_ParentCompanyMember_32f48ee0-388e-4849-9262-b2e8a137b528" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_cbc57f18-edb8-4b8d-8c96-f260d98e978b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_b5194946-d30c-483b-a030-95ffd20fd986" xlink:to="loc_srt_SubsidiariesMember_cbc57f18-edb8-4b8d-8c96-f260d98e978b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#ScheduleICondensedBalanceSheetsDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails" xlink:type="extended" id="i0ae357e6fb264f188d242c7a8b12b0fb_ScheduleICondensedBalanceSheetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CondensedBalanceSheetStatementsCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_b1a644f1-cf44-4bf5-a56b-9d138dc61ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_AssetsAbstract_b1a644f1-cf44-4bf5-a56b-9d138dc61ab0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_c2228f5b-c8c1-482a-9032-7240d299d991" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_AssetsCurrentAbstract_c2228f5b-c8c1-482a-9032-7240d299d991" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_06769da0-cf1d-4543-a4f1-d6ccdaf167dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_06769da0-cf1d-4543-a4f1-d6ccdaf167dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_1401ef15-1453-49b5-92c3-7df2a3f5433c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_OtherAssetsCurrent_1401ef15-1453-49b5-92c3-7df2a3f5433c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d46ca583-f3a0-4ddc-a73e-f18838cc998c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_AssetsCurrent_d46ca583-f3a0-4ddc-a73e-f18838cc998c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EquityinNetAssetsofSubsidiaries_43dc3049-3172-42d6-836e-29ae50e9a0b0" xlink:href="unh-20211231.xsd#unh_EquityinNetAssetsofSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_unh_EquityinNetAssetsofSubsidiaries_43dc3049-3172-42d6-836e-29ae50e9a0b0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableRelatedPartiesNoncurrent_7ec79a2e-229f-437d-a8c1-69d61fba7e33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesReceivableRelatedPartiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_NotesReceivableRelatedPartiesNoncurrent_7ec79a2e-229f-437d-a8c1-69d61fba7e33" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_fa2cd817-9601-4a04-89fb-aa5f2bb97cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_fa2cd817-9601-4a04-89fb-aa5f2bb97cf3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_9c7774ba-c0fd-448d-b7a3-506973fb3618" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_Assets_9c7774ba-c0fd-448d-b7a3-506973fb3618" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b3734042-6cf2-4a96-96f3-10ecd40cfaa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b3734042-6cf2-4a96-96f3-10ecd40cfaa8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_e4b17c53-9626-460f-a438-e6856423a05c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_e4b17c53-9626-460f-a438-e6856423a05c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_e7bb5f28-cb8e-4c0b-b256-3370bd68c9ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_e7bb5f28-cb8e-4c0b-b256-3370bd68c9ac" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_b390a8c0-cbf4-447c-90ce-0eedfd22b378" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_b390a8c0-cbf4-447c-90ce-0eedfd22b378" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_566f09e2-c1d2-4641-b499-0d182c0542fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_LongTermDebtCurrent_566f09e2-c1d2-4641-b499-0d182c0542fa" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d3a8880d-2123-4918-80e0-2f82103a7e69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_LiabilitiesCurrent_d3a8880d-2123-4918-80e0-2f82103a7e69" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_cd32230f-d626-42c6-8724-f5925472c96e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_cd32230f-d626-42c6-8724-f5925472c96e" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_247a91fe-e4fa-425a-8f47-d256166cd6c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_247a91fe-e4fa-425a-8f47-d256166cd6c3" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_353ebb6f-942d-4eeb-9597-b23279808df1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_Liabilities_353ebb6f-942d-4eeb-9597-b23279808df1" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_9f8c7045-0a36-488b-aee2-6fe0c49186c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_CommitmentsAndContingencies_9f8c7045-0a36-488b-aee2-6fe0c49186c1" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ShareholdersEquityAbstract_64cb4fa5-13a5-45c1-8fd4-66511ce7b79e" xlink:href="unh-20211231.xsd#unh_ShareholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_unh_ShareholdersEquityAbstract_64cb4fa5-13a5-45c1-8fd4-66511ce7b79e" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_8480326f-285b-46e1-9dde-18ec33aa6b10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_PreferredStockValue_8480326f-285b-46e1-9dde-18ec33aa6b10" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_2397ccb0-394e-4a89-aea9-5a066d627967" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_CommonStockValue_2397ccb0-394e-4a89-aea9-5a066d627967" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_b886f997-c45b-4301-8470-57f97e07255d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_AdditionalPaidInCapital_b886f997-c45b-4301-8470-57f97e07255d" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_36999b86-a056-4d54-a33b-2fd92e0d3c29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_36999b86-a056-4d54-a33b-2fd92e0d3c29" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2e1681ea-aeff-4d02-bf0b-a2f7fb30c040" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2e1681ea-aeff-4d02-bf0b-a2f7fb30c040" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8b4b50b3-652b-40f1-9b52-f3d916b0bcf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_StockholdersEquity_8b4b50b3-652b-40f1-9b52-f3d916b0bcf6" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_c7ca6a05-8701-4921-9d8b-41a76076bbe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_c7ca6a05-8701-4921-9d8b-41a76076bbe0" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedBalanceSheetStatementTable_c5747acf-12b2-4fda-af28-3f479d6236b7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CondensedBalanceSheetStatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_srt_CondensedBalanceSheetStatementTable_c5747acf-12b2-4fda-af28-3f479d6236b7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_1683a4e9-49d6-45cb-ad6b-724683410cd1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_CondensedBalanceSheetStatementTable_c5747acf-12b2-4fda-af28-3f479d6236b7" xlink:to="loc_srt_ConsolidatedEntitiesAxis_1683a4e9-49d6-45cb-ad6b-724683410cd1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_1683a4e9-49d6-45cb-ad6b-724683410cd1_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_1683a4e9-49d6-45cb-ad6b-724683410cd1" xlink:to="loc_srt_ConsolidatedEntitiesDomain_1683a4e9-49d6-45cb-ad6b-724683410cd1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_c5763c6a-2a62-4605-9aba-20b21c81151c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_1683a4e9-49d6-45cb-ad6b-724683410cd1" xlink:to="loc_srt_ConsolidatedEntitiesDomain_c5763c6a-2a62-4605-9aba-20b21c81151c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_020f84d1-520f-4b83-b942-61d7d32b2fc8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_c5763c6a-2a62-4605-9aba-20b21c81151c" xlink:to="loc_srt_ParentCompanyMember_020f84d1-520f-4b83-b942-61d7d32b2fc8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#ScheduleIBalanceSheetDocumentDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails" xlink:type="extended" id="i757ecc17515043b19cd5eda5fef83ad8_ScheduleIBalanceSheetDocumentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_238c6f1a-4855-4a7b-8b72-97412a2d8a86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_9c2f45dd-4b9c-47be-8708-514dfaffad49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_238c6f1a-4855-4a7b-8b72-97412a2d8a86" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_9c2f45dd-4b9c-47be-8708-514dfaffad49" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_cc347a6b-59ae-41b3-82b1-f2ca06601ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_238c6f1a-4855-4a7b-8b72-97412a2d8a86" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_cc347a6b-59ae-41b3-82b1-f2ca06601ae9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_61995b7b-863a-4302-9536-0ec31e0770f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_238c6f1a-4855-4a7b-8b72-97412a2d8a86" xlink:to="loc_us-gaap_CommonStockSharesIssued_61995b7b-863a-4302-9536-0ec31e0770f3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_24c29b9e-da58-41a5-8b9b-9e8be9265b5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_238c6f1a-4855-4a7b-8b72-97412a2d8a86" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_24c29b9e-da58-41a5-8b9b-9e8be9265b5d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_e6cc413b-bc0a-4724-aad9-bb5b060fac58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_238c6f1a-4855-4a7b-8b72-97412a2d8a86" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_e6cc413b-bc0a-4724-aad9-bb5b060fac58" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_447298e7-080c-4c36-a91e-99b90801534d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_238c6f1a-4855-4a7b-8b72-97412a2d8a86" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_447298e7-080c-4c36-a91e-99b90801534d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_28565953-8236-4bc5-8288-8fbde8d24282" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_238c6f1a-4855-4a7b-8b72-97412a2d8a86" xlink:to="loc_us-gaap_PreferredStockSharesIssued_28565953-8236-4bc5-8288-8fbde8d24282" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_dfdada44-ef07-4203-ac2a-bbef358f7609" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_238c6f1a-4855-4a7b-8b72-97412a2d8a86" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_dfdada44-ef07-4203-ac2a-bbef358f7609" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_591bbb87-301d-47d8-a0bb-28918bcf5ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_238c6f1a-4855-4a7b-8b72-97412a2d8a86" xlink:to="loc_us-gaap_StatementTable_591bbb87-301d-47d8-a0bb-28918bcf5ef3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_1efaf5b8-d832-4798-b132-74179fe77430" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_591bbb87-301d-47d8-a0bb-28918bcf5ef3" xlink:to="loc_srt_ConsolidatedEntitiesAxis_1efaf5b8-d832-4798-b132-74179fe77430" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_1efaf5b8-d832-4798-b132-74179fe77430_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_1efaf5b8-d832-4798-b132-74179fe77430" xlink:to="loc_srt_ConsolidatedEntitiesDomain_1efaf5b8-d832-4798-b132-74179fe77430_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_ec024886-ecbd-4123-bcc2-1e6463b37f29" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_1efaf5b8-d832-4798-b132-74179fe77430" xlink:to="loc_srt_ConsolidatedEntitiesDomain_ec024886-ecbd-4123-bcc2-1e6463b37f29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_1713380e-ba4e-4e4b-a90e-91fb8cb12c68" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_ec024886-ecbd-4123-bcc2-1e6463b37f29" xlink:to="loc_srt_ParentCompanyMember_1713380e-ba4e-4e4b-a90e-91fb8cb12c68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_ef12a675-b268-4924-951c-98fa24b16ef6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_591bbb87-301d-47d8-a0bb-28918bcf5ef3" xlink:to="loc_srt_StatementScenarioAxis_ef12a675-b268-4924-951c-98fa24b16ef6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_ef12a675-b268-4924-951c-98fa24b16ef6_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_ef12a675-b268-4924-951c-98fa24b16ef6" xlink:to="loc_srt_ScenarioUnspecifiedDomain_ef12a675-b268-4924-951c-98fa24b16ef6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_08298a09-53eb-43ce-9ac2-647a6bfc79ba" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_ef12a675-b268-4924-951c-98fa24b16ef6" xlink:to="loc_srt_ScenarioUnspecifiedDomain_08298a09-53eb-43ce-9ac2-647a6bfc79ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_3696341d-a6f3-4f13-8190-1a4a2dc33906" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_591bbb87-301d-47d8-a0bb-28918bcf5ef3" xlink:to="loc_us-gaap_StatementClassOfStockAxis_3696341d-a6f3-4f13-8190-1a4a2dc33906" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_3696341d-a6f3-4f13-8190-1a4a2dc33906_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_3696341d-a6f3-4f13-8190-1a4a2dc33906" xlink:to="loc_us-gaap_ClassOfStockDomain_3696341d-a6f3-4f13-8190-1a4a2dc33906_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a1927804-acf6-4104-b7d6-8635af3bb9b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_3696341d-a6f3-4f13-8190-1a4a2dc33906" xlink:to="loc_us-gaap_ClassOfStockDomain_a1927804-acf6-4104-b7d6-8635af3bb9b2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#ScheduleICondensedStatementofComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails" xlink:type="extended" id="i8146e4fd436b47a297a7ec353d3b16fd_ScheduleICondensedStatementofComprehensiveIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_e04c7b09-10db-476c-b14b-8b6a63c4c952" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CondensedStatementOfIncomeCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_16d1f5b4-efed-40a5-89fb-4d59b4c2a4d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_e04c7b09-10db-476c-b14b-8b6a63c4c952" xlink:to="loc_us-gaap_RevenuesAbstract_16d1f5b4-efed-40a5-89fb-4d59b4c2a4d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_4c83f5e9-5fbd-494a-b862-3b444fb5ce9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_e04c7b09-10db-476c-b14b-8b6a63c4c952" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_4c83f5e9-5fbd-494a-b862-3b444fb5ce9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_0f1dada9-e353-44eb-97ef-92d2068a32a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_e04c7b09-10db-476c-b14b-8b6a63c4c952" xlink:to="loc_us-gaap_Revenues_0f1dada9-e353-44eb-97ef-92d2068a32a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_f70f27b4-4dec-4525-ad0b-3bf130a52879" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_e04c7b09-10db-476c-b14b-8b6a63c4c952" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_f70f27b4-4dec-4525-ad0b-3bf130a52879" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_76112669-0602-469f-a27e-6d5cd08a4131" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_e04c7b09-10db-476c-b14b-8b6a63c4c952" xlink:to="loc_us-gaap_OperatingExpenses_76112669-0602-469f-a27e-6d5cd08a4131" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_c9f87bff-3646-438a-856b-68afa3e27b4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_e04c7b09-10db-476c-b14b-8b6a63c4c952" xlink:to="loc_us-gaap_InterestExpense_c9f87bff-3646-438a-856b-68afa3e27b4e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_b2210aba-92c7-4cce-a725-e94f0bfc910b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_e04c7b09-10db-476c-b14b-8b6a63c4c952" xlink:to="loc_us-gaap_CostsAndExpenses_b2210aba-92c7-4cce-a725-e94f0bfc910b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_e1a7d38e-2cc0-4348-bf65-5fba760842d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_e04c7b09-10db-476c-b14b-8b6a63c4c952" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_e1a7d38e-2cc0-4348-bf65-5fba760842d1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d7e1dc14-4abe-45c6-b214-451d7173ebac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_e04c7b09-10db-476c-b14b-8b6a63c4c952" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d7e1dc14-4abe-45c6-b214-451d7173ebac" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_LossofParentCompany_3df16e93-f88a-41c1-8188-58590fd70a68" xlink:href="unh-20211231.xsd#unh_LossofParentCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_e04c7b09-10db-476c-b14b-8b6a63c4c952" xlink:to="loc_unh_LossofParentCompany_3df16e93-f88a-41c1-8188-58590fd70a68" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_0140d1a5-6efa-430b-a3a8-1b8c4debf8d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_e04c7b09-10db-476c-b14b-8b6a63c4c952" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_0140d1a5-6efa-430b-a3a8-1b8c4debf8d5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f8f2f211-f98d-458b-aa2e-4ed8bb9d2013" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_e04c7b09-10db-476c-b14b-8b6a63c4c952" xlink:to="loc_us-gaap_NetIncomeLoss_f8f2f211-f98d-458b-aa2e-4ed8bb9d2013" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_fe59d61c-54fc-4251-ada0-315ff72dae7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_e04c7b09-10db-476c-b14b-8b6a63c4c952" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_fe59d61c-54fc-4251-ada0-315ff72dae7b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_25740801-8eb9-42eb-9027-a7f131b8dcf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_e04c7b09-10db-476c-b14b-8b6a63c4c952" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_25740801-8eb9-42eb-9027-a7f131b8dcf2" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedStatementOfComprehensiveIncomeTable_d7c4cab7-b722-4bd3-b029-44eae5d1bde0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CondensedStatementOfComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_e04c7b09-10db-476c-b14b-8b6a63c4c952" xlink:to="loc_srt_CondensedStatementOfComprehensiveIncomeTable_d7c4cab7-b722-4bd3-b029-44eae5d1bde0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_1297cc69-e276-409b-a038-6a1d055ec60e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_CondensedStatementOfComprehensiveIncomeTable_d7c4cab7-b722-4bd3-b029-44eae5d1bde0" xlink:to="loc_srt_ConsolidatedEntitiesAxis_1297cc69-e276-409b-a038-6a1d055ec60e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_1297cc69-e276-409b-a038-6a1d055ec60e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_1297cc69-e276-409b-a038-6a1d055ec60e" xlink:to="loc_srt_ConsolidatedEntitiesDomain_1297cc69-e276-409b-a038-6a1d055ec60e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_048afbf0-03d7-469b-9eae-4e646451abfd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_1297cc69-e276-409b-a038-6a1d055ec60e" xlink:to="loc_srt_ConsolidatedEntitiesDomain_048afbf0-03d7-469b-9eae-4e646451abfd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_c0046ffd-951c-4cd4-9114-75ef6add56d8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_048afbf0-03d7-469b-9eae-4e646451abfd" xlink:to="loc_srt_ParentCompanyMember_c0046ffd-951c-4cd4-9114-75ef6add56d8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#ScheduleIStatementofCashFlowsDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails" xlink:type="extended" id="ibc25145aac174abdaf5e467a2325f34d_ScheduleIStatementofCashFlowsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_4e3a8c3e-055e-4d31-99ab-7e34056690f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_4e3a8c3e-055e-4d31-99ab-7e34056690f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a30433a9-6085-4c91-8f1b-1f13befa7914" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a30433a9-6085-4c91-8f1b-1f13befa7914" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_533b72ba-2a14-4166-9572-84e7f08c5447" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_533b72ba-2a14-4166-9572-84e7f08c5447" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_8bf9f0b7-ff1f-4acf-b502-bc99a9b6d97f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_8bf9f0b7-ff1f-4acf-b502-bc99a9b6d97f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties_a544467e-90af-4bca-afc6-3c8980432e73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties_a544467e-90af-4bca-afc6-3c8980432e73" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_7bbdd72f-2b9c-453c-8806-b9ced049e47f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_7bbdd72f-2b9c-453c-8806-b9ced049e47f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributionsFromAffiliates_0f9cd419-3cff-4f0f-9c74-49871dea860a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromContributionsFromAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_ProceedsFromContributionsFromAffiliates_0f9cd419-3cff-4f0f-9c74-49871dea860a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_Capitalcontributionstosubsidiaries_53a66676-62f2-4e24-833d-77e1fc94201e" xlink:href="unh-20211231.xsd#unh_Capitalcontributionstosubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_unh_Capitalcontributionstosubsidiaries_53a66676-62f2-4e24-833d-77e1fc94201e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_cab2f11b-86fa-433b-8185-a1c46a2769b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_cab2f11b-86fa-433b-8185-a1c46a2769b4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_34995ab5-1c4f-4778-96aa-b2037c0c17fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_34995ab5-1c4f-4778-96aa-b2037c0c17fe" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a137c2f-9da5-43fe-9b7e-57269f46ef85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a137c2f-9da5-43fe-9b7e-57269f46ef85" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_71d0b811-7174-4d23-891d-ae8276e898b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_71d0b811-7174-4d23-891d-ae8276e898b9" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_1e41f6ef-a3ef-42d6-b6f8-b9a6e8b593f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_1e41f6ef-a3ef-42d6-b6f8-b9a6e8b593f2" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_373d282e-100e-4498-b9e2-7d654f8a27af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_PaymentsOfDividends_373d282e-100e-4498-b9e2-7d654f8a27af" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_60e72245-70b5-48df-abe0-98c70d81481f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_60e72245-70b5-48df-abe0-98c70d81481f" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_ee4a25f5-dfdf-4c3e-9414-c4d2ee2f1683" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_ee4a25f5-dfdf-4c3e-9414-c4d2ee2f1683" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_94754d65-7e45-4e66-84cd-8948211697dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_94754d65-7e45-4e66-84cd-8948211697dd" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_2853b9ea-4f7a-432f-841f-17cfe0768b30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_2853b9ea-4f7a-432f-841f-17cfe0768b30" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_3edcba6b-345d-41aa-b0ab-0cfbc4ce693b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_3edcba6b-345d-41aa-b0ab-0cfbc4ce693b" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_078bc822-350b-4169-bf12-70fdb0ff0421" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_078bc822-350b-4169-bf12-70fdb0ff0421" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_3681494d-6c9b-4e0d-bd12-f85bc4bd2fa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_3681494d-6c9b-4e0d-bd12-f85bc4bd2fa8" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f3f3128f-0016-4f0b-8c49-b46fdacd6d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f3f3128f-0016-4f0b-8c49-b46fdacd6d4a" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_752f2eb4-e1d2-41c2-9338-b19b8fa2a3b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_c5e48fe0-71c8-46ab-8766-0c33ae53f906" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_c5e48fe0-71c8-46ab-8766-0c33ae53f906" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_5bc1c34c-bf82-4886-8f14-7789102bb700" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_c5e48fe0-71c8-46ab-8766-0c33ae53f906" xlink:to="loc_us-gaap_InterestPaidNet_5bc1c34c-bf82-4886-8f14-7789102bb700" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_3af28bff-6037-4bd9-bdd9-9065ce268bd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_c5e48fe0-71c8-46ab-8766-0c33ae53f906" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_3af28bff-6037-4bd9-bdd9-9065ce268bd5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_4c4ae361-a84f-4fc9-a0a7-57aa9f8eef8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_StatementTable_4c4ae361-a84f-4fc9-a0a7-57aa9f8eef8f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_8bb99d99-c9af-4f63-b5b5-433fe535114c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_4c4ae361-a84f-4fc9-a0a7-57aa9f8eef8f" xlink:to="loc_srt_ConsolidatedEntitiesAxis_8bb99d99-c9af-4f63-b5b5-433fe535114c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_8bb99d99-c9af-4f63-b5b5-433fe535114c_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_8bb99d99-c9af-4f63-b5b5-433fe535114c" xlink:to="loc_srt_ConsolidatedEntitiesDomain_8bb99d99-c9af-4f63-b5b5-433fe535114c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_5deb2398-5443-47cf-95f9-34f4734dff0a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_8bb99d99-c9af-4f63-b5b5-433fe535114c" xlink:to="loc_srt_ConsolidatedEntitiesDomain_5deb2398-5443-47cf-95f9-34f4734dff0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_e0b2309e-a081-4145-a4de-5b9ac47b7753" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_5deb2398-5443-47cf-95f9-34f4734dff0a" xlink:to="loc_srt_ParentCompanyMember_e0b2309e-a081-4145-a4de-5b9ac47b7753" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_b5162b13-b913-4cbe-91ab-8114dd6e19c8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_4c4ae361-a84f-4fc9-a0a7-57aa9f8eef8f" xlink:to="loc_srt_StatementScenarioAxis_b5162b13-b913-4cbe-91ab-8114dd6e19c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_b5162b13-b913-4cbe-91ab-8114dd6e19c8_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_b5162b13-b913-4cbe-91ab-8114dd6e19c8" xlink:to="loc_srt_ScenarioUnspecifiedDomain_b5162b13-b913-4cbe-91ab-8114dd6e19c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_b2c01aeb-34d0-4949-a426-652cb132033a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_b5162b13-b913-4cbe-91ab-8114dd6e19c8" xlink:to="loc_srt_ScenarioUnspecifiedDomain_b2c01aeb-34d0-4949-a426-652cb132033a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.uhc.com/role/ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails" xlink:type="extended" id="ib03e2235ed244f14b631206af3dc2aa0_ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_1dd37f1d-db14-4758-b39b-da64bf323a6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_280e3b08-b1b7-4a73-a649-9714ff676505" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1dd37f1d-db14-4758-b39b-da64bf323a6f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_280e3b08-b1b7-4a73-a649-9714ff676505" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_472040fd-12ae-40f3-8945-5449c25bebfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1dd37f1d-db14-4758-b39b-da64bf323a6f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_472040fd-12ae-40f3-8945-5449c25bebfc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_1f7c1f76-3288-4b33-8c48-6204453bb135" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1dd37f1d-db14-4758-b39b-da64bf323a6f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_1f7c1f76-3288-4b33-8c48-6204453bb135" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_e207fa0e-8f26-4f9c-a7da-188a55883604" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1dd37f1d-db14-4758-b39b-da64bf323a6f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_e207fa0e-8f26-4f9c-a7da-188a55883604" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_e1bc9f4a-7692-4898-8846-28496159c6ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1dd37f1d-db14-4758-b39b-da64bf323a6f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_e1bc9f4a-7692-4898-8846-28496159c6ab" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_c424316d-2f35-4105-bc2d-edfe9ffa0850" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1dd37f1d-db14-4758-b39b-da64bf323a6f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_c424316d-2f35-4105-bc2d-edfe9ffa0850" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a688aceb-dc65-49be-9ba9-0bd4bdf4a96e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1dd37f1d-db14-4758-b39b-da64bf323a6f" xlink:to="loc_us-gaap_DebtInstrumentTable_a688aceb-dc65-49be-9ba9-0bd4bdf4a96e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_f388e658-a400-424f-afda-c046b5d2f39a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a688aceb-dc65-49be-9ba9-0bd4bdf4a96e" xlink:to="loc_srt_ConsolidatedEntitiesAxis_f388e658-a400-424f-afda-c046b5d2f39a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_f388e658-a400-424f-afda-c046b5d2f39a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_f388e658-a400-424f-afda-c046b5d2f39a" xlink:to="loc_srt_ConsolidatedEntitiesDomain_f388e658-a400-424f-afda-c046b5d2f39a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_8fedda24-7a96-47db-9988-bdc96309352e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_f388e658-a400-424f-afda-c046b5d2f39a" xlink:to="loc_srt_ConsolidatedEntitiesDomain_8fedda24-7a96-47db-9988-bdc96309352e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_ea2e5f7f-fe41-4127-9ac0-b1fdf69c5aee" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_8fedda24-7a96-47db-9988-bdc96309352e" xlink:to="loc_srt_ParentCompanyMember_ea2e5f7f-fe41-4127-9ac0-b1fdf69c5aee" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>22
<FILENAME>unh-20211231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:7520997a-16df-4345-81d3-205a3336ef85,g:00a8925a-3c66-4bad-89d3-86af384cff11-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_f16086bc-344c-4b18-b2c5-ff3635344b49_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after five years through ten years, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_6803ac1f-dc54-4710-938c-3975e3ab48aa_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental cash flow disclosures</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_76c90c5e-63f4-490f-9ea9-f592c6564141_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_37e226a9-ab72-417d-b32c-71a04525ac17_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Unrealized (Losses) Gains on Investments [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_DisclosureonGeographicAreasPercentageofLongLivedAssets_f53fb1c1-7d18-4111-a987-89e014dc0afd_terseLabel_en-US" xlink:label="lab_unh_DisclosureonGeographicAreasPercentageofLongLivedAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure on Geographic Areas Percentage of Long Lived Assets</link:label>
    <link:label id="lab_unh_DisclosureonGeographicAreasPercentageofLongLivedAssets_label_en-US" xlink:label="lab_unh_DisclosureonGeographicAreasPercentageofLongLivedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure on Geographic Areas Percentage of Long Lived Assets</link:label>
    <link:label id="lab_unh_DisclosureonGeographicAreasPercentageofLongLivedAssets_documentation_en-US" xlink:label="lab_unh_DisclosureonGeographicAreasPercentageofLongLivedAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosures about long-lived assets (except financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets) that are (1) located in the entity's country of domicile, and (2) located in all foreign countries in which the entity holds assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DisclosureonGeographicAreasPercentageofLongLivedAssets" xlink:href="unh-20211231.xsd#unh_DisclosureonGeographicAreasPercentageofLongLivedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_DisclosureonGeographicAreasPercentageofLongLivedAssets" xlink:to="lab_unh_DisclosureonGeographicAreasPercentageofLongLivedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_af03ca01-b4f3-4948-8237-2bb9abcd1c63_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_e1bbeb5d-3dd7-4f8d-8dc9-fb55fa43e8c4_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_d51570d6-a78a-4a43-8695-5ea70b3edb4b_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_3fb0d1a0-fd6b-4203-8250-856fb4ca4843_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_849bfceb-e86a-4874-b354-a7e8f6de94c8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware_a46265e7-b4e7-4871-b45b-3c01a8e4c56f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Deferred Expense, Capitalized Software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers_ac567c04-372f-4449-99d1-a64340b5588d_terseLabel_en-US" xlink:label="lab_unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure on Geographic Areas Percentage of Revenue from External Customers</link:label>
    <link:label id="lab_unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers_label_en-US" xlink:label="lab_unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure on Geographic Areas Percentage of Revenue from External Customers</link:label>
    <link:label id="lab_unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers_documentation_en-US" xlink:label="lab_unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure about revenues from external customers (1) attributed to the entity's country of domicile and (2) attributed to all foreign countries in total from which the entity derives revenues.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers" xlink:href="unh-20211231.xsd#unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers" xlink:to="lab_unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_1744da06-9671-44ed-ae75-423e2a9acf1d_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_2070434e-dcea-4d3b-838e-8d0292a8621c_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_0a328a05-1f6a-4f23-9bd7-b6ae162b2362_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeitures</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_8aa9a82d-3168-489b-80f5-243a04396944_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a369358c-8543-4f4d-b217-c90fe342607f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_bbdbec8b-e1c6-40b1-a894-f12d248f8194_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_24201b80-2831-4562-98b1-833f77cdb4e9_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A2.125notesdueMarch2021Member_9544f765-0972-481c-88f9-0160d3515ad3_terseLabel_en-US" xlink:label="lab_unh_A2.125notesdueMarch2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.125% notes due March 2021 [Member]</link:label>
    <link:label id="lab_unh_A2.125notesdueMarch2021Member_label_en-US" xlink:label="lab_unh_A2.125notesdueMarch2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.125% notes due March 2021 [Member]</link:label>
    <link:label id="lab_unh_A2.125notesdueMarch2021Member_documentation_en-US" xlink:label="lab_unh_A2.125notesdueMarch2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.125% notes due March 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2.125notesdueMarch2021Member" xlink:href="unh-20211231.xsd#unh_A2.125notesdueMarch2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A2.125notesdueMarch2021Member" xlink:to="lab_unh_A2.125notesdueMarch2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_4fe8cacd-45e4-4794-9e63-4e725fea97e2_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Incurred Medical Costs</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Incurred Claims and Allocated Claim Adjustment Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1eebbfb5-2e90-4a58-8738-f17413f65003_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_168e08ef-1c89-44f0-9168-07d5b8771d8b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_14457022-c123-42b4-b3f5-fdb233bc7bd7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total intrinsic value of stock options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_516fb522-cc21-4882-b5c4-2792a38f7dc2_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_6d62ebd7-e251-4465-8cd4-af4f1198b139_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_b07dc646-b0bd-4114-abd7-64c48c5f8bff_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_d5c3dfcb-1c96-490c-a1ad-6470fc1f545e_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior year tax positions, gross increases</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A3.450notesdueJanuary2027Member_97494f81-7551-415d-94db-4146acf2faa8_terseLabel_en-US" xlink:label="lab_unh_A3.450notesdueJanuary2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.450% notes due January 2027 [Member]</link:label>
    <link:label id="lab_unh_A3.450notesdueJanuary2027Member_label_en-US" xlink:label="lab_unh_A3.450notesdueJanuary2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.450% notes due January 2027 [Member]</link:label>
    <link:label id="lab_unh_A3.450notesdueJanuary2027Member_documentation_en-US" xlink:label="lab_unh_A3.450notesdueJanuary2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.450% notes due January 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.450notesdueJanuary2027Member" xlink:href="unh-20211231.xsd#unh_A3.450notesdueJanuary2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A3.450notesdueJanuary2027Member" xlink:to="lab_unh_A3.450notesdueJanuary2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_e8743237-f8e7-4f36-a9ab-6847372cd7b0_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred income tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_f1400ff3-a56d-48b1-9dfe-6d5f8e5090aa_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_8dc3fd0f-d943-4b01-921a-58425d5b5ee1_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock_825736be-54d9-47a0-a131-e592fc7c3a84_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_bd3e47ab-76f9-43ba-8f7b-bebe2898f642_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndustrySpecificPoliciesInsuranceCompaniesTextBlock_831477bb-28dd-4406-885f-b816db085a5a_terseLabel_en-US" xlink:label="lab_us-gaap_IndustrySpecificPoliciesInsuranceCompaniesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurance Industry Tax, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_IndustrySpecificPoliciesInsuranceCompaniesTextBlock_label_en-US" xlink:label="lab_us-gaap_IndustrySpecificPoliciesInsuranceCompaniesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Industry Specific Policies, Insurance Companies [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndustrySpecificPoliciesInsuranceCompaniesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndustrySpecificPoliciesInsuranceCompaniesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndustrySpecificPoliciesInsuranceCompaniesTextBlock" xlink:to="lab_us-gaap_IndustrySpecificPoliciesInsuranceCompaniesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationTable_b0cf225d-01d3-4340-be33-3d7901ee64fc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationTable" xlink:to="lab_us-gaap_IncomeTaxExaminationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_67d66330-5283-4150-9e05-79f786746f18_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0a801185-0b92-4897-8234-4247387fc3d2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_089e86a7-af47-4ec8-894d-432543ec4b4d_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_OptuminsightMember_cd324a3c-121d-4fdc-8335-8cf5eb0c7026_terseLabel_en-US" xlink:label="lab_unh_OptuminsightMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Optum Insight</link:label>
    <link:label id="lab_unh_OptuminsightMember_label_en-US" xlink:label="lab_unh_OptuminsightMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Optuminsight [Member]</link:label>
    <link:label id="lab_unh_OptuminsightMember_documentation_en-US" xlink:label="lab_unh_OptuminsightMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OptumInsight [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OptuminsightMember" xlink:href="unh-20211231.xsd#unh_OptuminsightMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_OptuminsightMember" xlink:to="lab_unh_OptuminsightMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_8df9dbb7-8540-4aee-8491-f3e5df4d64e4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_31c16fa5-1184-4d04-b3a3-b1c3abb9626e_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at end of period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsLineItems_bd9375bc-4d02-4e39-93fa-d82d5820e33c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A2.875notesdueAugust2029Member_890dfa71-2175-45ed-bdf5-64104753555f_terseLabel_en-US" xlink:label="lab_unh_A2.875notesdueAugust2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.875% notes due August 2029 [Member]</link:label>
    <link:label id="lab_unh_A2.875notesdueAugust2029Member_label_en-US" xlink:label="lab_unh_A2.875notesdueAugust2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.875% notes due August 2029 [Member]</link:label>
    <link:label id="lab_unh_A2.875notesdueAugust2029Member_documentation_en-US" xlink:label="lab_unh_A2.875notesdueAugust2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.875% notes due August 2029 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2.875notesdueAugust2029Member" xlink:href="unh-20211231.xsd#unh_A2.875notesdueAugust2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A2.875notesdueAugust2029Member" xlink:to="lab_unh_A2.875notesdueAugust2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_e2bc552b-9e90-42c8-ad18-1876b3c835f1_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments by Contractual Maturity [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_9c8b482e-0213-48c5-bdb7-4e0aed634d39_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_947b2603-eda1-49ef-8ef2-228fe06c9c23_terseLabel_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets Acquired</link:label>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:to="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1150c6c6-6ec5-4120-a9bc-c7a95e8086b1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to nonredeemable noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_e84fa8e8-d452-4a6b-83b7-df280107577c_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCash_8b95b7df-7027-48ea-a1e3-c49e37bc7f56_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends paid on common shares ($5.60 per share, $4.83 per share and $4.14 per share for the years ended December 31, 2021, 2020 and 2019, respectively)</link:label>
    <link:label id="lab_us-gaap_DividendsCash_label_en-US" xlink:label="lab_us-gaap_DividendsCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCash" xlink:to="lab_us-gaap_DividendsCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_01ccbb75-4a85-48e9-89c2-757f5b21cb26_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_LossofParentCompany_60925524-5bad-4cfa-8d8d-4e5e5ffcc190_negatedTerseLabel_en-US" xlink:label="lab_unh_LossofParentCompany" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss of parent company</link:label>
    <link:label id="lab_unh_LossofParentCompany_label_en-US" xlink:label="lab_unh_LossofParentCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss of Parent Company</link:label>
    <link:label id="lab_unh_LossofParentCompany_documentation_en-US" xlink:label="lab_unh_LossofParentCompany" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss of Parent Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_LossofParentCompany" xlink:href="unh-20211231.xsd#unh_LossofParentCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_LossofParentCompany" xlink:to="lab_unh_LossofParentCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_8b72d98f-fe98-4dba-ac24-d2c763a83e82_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and other financing obligations</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A3.750notesdueJuly2025Member_4644547d-c736-4dc1-a9f6-e72c10aba58c_terseLabel_en-US" xlink:label="lab_unh_A3.750notesdueJuly2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.750% Notes Due July 2025 [Member]</link:label>
    <link:label id="lab_unh_A3.750notesdueJuly2025Member_label_en-US" xlink:label="lab_unh_A3.750notesdueJuly2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.750% notes due July 2025 [Member]</link:label>
    <link:label id="lab_unh_A3.750notesdueJuly2025Member_documentation_en-US" xlink:label="lab_unh_A3.750notesdueJuly2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.750% notes due July 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.750notesdueJuly2025Member" xlink:href="unh-20211231.xsd#unh_A3.750notesdueJuly2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A3.750notesdueJuly2025Member" xlink:to="lab_unh_A3.750notesdueJuly2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_7fb3e830-6b56-439e-b342-57accde002de_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease right-of-use asset</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_36b47a17-c8a9-4d99-94b2-cb618f15e6e2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities - held-to-maturity</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesMember" xlink:to="lab_us-gaap_DebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_c7193a3a-8b8e-465b-97a9-8e54f89a5efb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_94e874ed-9573-48af-b342-09d91621f9f4_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates_069bb0a4-c789-41f7-ae57-33b3d1af0005_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outside basis in partnerships</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Investment in Noncontrolled Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A1150NotesDueMay2026Member_964dd1ce-fc63-419f-9fef-27b6dc12ea4a_terseLabel_en-US" xlink:label="lab_unh_A1150NotesDueMay2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.150% notes due May 2026 [Member]</link:label>
    <link:label id="lab_unh_A1150NotesDueMay2026Member_label_en-US" xlink:label="lab_unh_A1150NotesDueMay2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.150% notes due May 2026 [Member]</link:label>
    <link:label id="lab_unh_A1150NotesDueMay2026Member_documentation_en-US" xlink:label="lab_unh_A1150NotesDueMay2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.150% notes due May 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A1150NotesDueMay2026Member" xlink:href="unh-20211231.xsd#unh_A1150NotesDueMay2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A1150NotesDueMay2026Member" xlink:to="lab_unh_A1150NotesDueMay2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesFairValue_4137702c-a886-4485-8ea7-3c6d791c6030_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Fair Value</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesFairValue_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_b7c883b4-583a-4c78-862b-bc2383f53ed0_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Board authorized shares remaining</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_81e5e204-b17b-46ef-8042-01dde6d65127_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_3cd8f4b4-1164-4f26-9900-d1dfce4f0dac_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Well known seasoned issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_CreditFacilityNameDomain_caeab9e9-85ae-4246-bd2c-82565aed422d_terseLabel_en-US" xlink:label="lab_unh_CreditFacilityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility Name [Domain]</link:label>
    <link:label id="lab_unh_CreditFacilityNameDomain_label_en-US" xlink:label="lab_unh_CreditFacilityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility Name [Domain]</link:label>
    <link:label id="lab_unh_CreditFacilityNameDomain_documentation_en-US" xlink:label="lab_unh_CreditFacilityNameDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Credit Facility Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_CreditFacilityNameDomain" xlink:href="unh-20211231.xsd#unh_CreditFacilityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_CreditFacilityNameDomain" xlink:to="lab_unh_CreditFacilityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_a3beb813-adf4-486a-9ba2-269aa59357f2_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodDomain_472eba09-b6d0-4196-9587-5affc213c450_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodDomain_label_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodDomain" xlink:to="lab_us-gaap_TaxPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_bd8c9461-db06-49dc-a376-edf5a3727029_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned revenues</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesExcludingIncomeAndExciseTaxesAbstract_39150fce-b4bd-45b6-be08-db16a1f5b699_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesExcludingIncomeAndExciseTaxesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Provision:</link:label>
    <link:label id="lab_us-gaap_TaxesExcludingIncomeAndExciseTaxesAbstract_label_en-US" xlink:label="lab_us-gaap_TaxesExcludingIncomeAndExciseTaxesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes, Miscellaneous [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesExcludingIncomeAndExciseTaxesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesExcludingIncomeAndExciseTaxesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesExcludingIncomeAndExciseTaxesAbstract" xlink:to="lab_us-gaap_TaxesExcludingIncomeAndExciseTaxesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A2.375notesdueOctober2022MemberMember_24864d5d-1e3d-4540-993c-bbcd3f15b2bb_terseLabel_en-US" xlink:label="lab_unh_A2.375notesdueOctober2022MemberMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.375% notes due October 2022 [Member]</link:label>
    <link:label id="lab_unh_A2.375notesdueOctober2022MemberMember_label_en-US" xlink:label="lab_unh_A2.375notesdueOctober2022MemberMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.375% notes due October 2022 [Member] [Member]</link:label>
    <link:label id="lab_unh_A2.375notesdueOctober2022MemberMember_documentation_en-US" xlink:label="lab_unh_A2.375notesdueOctober2022MemberMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.375% notes due October 2022 [Member] [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2.375notesdueOctober2022MemberMember" xlink:href="unh-20211231.xsd#unh_A2.375notesdueOctober2022MemberMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A2.375notesdueOctober2022MemberMember" xlink:to="lab_unh_A2.375notesdueOctober2022MemberMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_ddf8ff51-6e10-4263-bade-ab1c8a4cc85e_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior years</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_ed193cc3-3b1b-4475-8bbe-03e63cc98a01_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_f4272f3c-73d6-4c4d-85ee-f071d16804e9_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Balance Sheet [Table Text Block]</link:label>
    <link:label id="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Balance Sheet [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfCondensedBalanceSheetTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:to="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_EmployeeStockPurchasePlanESPPMember_73269899-cbb0-4791-a34b-a631d0491527_terseLabel_en-US" xlink:label="lab_unh_EmployeeStockPurchasePlanESPPMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan (ESPP) [Member]</link:label>
    <link:label id="lab_unh_EmployeeStockPurchasePlanESPPMember_label_en-US" xlink:label="lab_unh_EmployeeStockPurchasePlanESPPMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan (ESPP) [Member]</link:label>
    <link:label id="lab_unh_EmployeeStockPurchasePlanESPPMember_documentation_en-US" xlink:label="lab_unh_EmployeeStockPurchasePlanESPPMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan (ESPP) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EmployeeStockPurchasePlanESPPMember" xlink:href="unh-20211231.xsd#unh_EmployeeStockPurchasePlanESPPMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_EmployeeStockPurchasePlanESPPMember" xlink:to="lab_unh_EmployeeStockPurchasePlanESPPMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_70f1a379-b1fb-4d89-b5e0-a23acc658c0c_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at beginning of period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_47497e9b-e59f-407f-9eb0-785a738be221_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at end of period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_8235b609-985e-469e-8b79-d75ae7532e1b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_57144f0c-18db-4838-ac3e-86db7e180dfb_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after one year through five years, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_c2020ff5-7062-40a8-a0c7-6db697a01ecd_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsTable_25343155-3a94-42ce-ad19-e0d443556cd4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_65076944-2f60-452c-87b4-dda3b7cce066_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred income tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_66c50be4-982a-43a8-8aa6-36ae8ea2637f_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_b73c75c9-0b41-4198-be0a-37084f392cd7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A4.450notesdueDecember2048Member_f4c79f83-1e86-4261-a9e7-0e6eb9ea5cec_terseLabel_en-US" xlink:label="lab_unh_A4.450notesdueDecember2048Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.450% notes due December 2048 [Member]</link:label>
    <link:label id="lab_unh_A4.450notesdueDecember2048Member_label_en-US" xlink:label="lab_unh_A4.450notesdueDecember2048Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.450% notes due December 2048 [Member]</link:label>
    <link:label id="lab_unh_A4.450notesdueDecember2048Member_documentation_en-US" xlink:label="lab_unh_A4.450notesdueDecember2048Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.450% notes due December 2048 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.450notesdueDecember2048Member" xlink:href="unh-20211231.xsd#unh_A4.450notesdueDecember2048Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A4.450notesdueDecember2048Member" xlink:to="lab_unh_A4.450notesdueDecember2048Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_a3bb38ae-f41f-4e3f-bdf1-877c35a1dec4_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_f114391e-8322-4a03-8467-05c126ffe220_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_DeferredTaxLiabilityOtherForeign_b9eb60bc-c873-4686-919c-017aa409f0e3_negatedTerseLabel_en-US" xlink:label="lab_unh_DeferredTaxLiabilityOtherForeign" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other-non-U.S.</link:label>
    <link:label id="lab_unh_DeferredTaxLiabilityOtherForeign_label_en-US" xlink:label="lab_unh_DeferredTaxLiabilityOtherForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liability, Other Foreign</link:label>
    <link:label id="lab_unh_DeferredTaxLiabilityOtherForeign_documentation_en-US" xlink:label="lab_unh_DeferredTaxLiabilityOtherForeign" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liability, Other Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxLiabilityOtherForeign" xlink:href="unh-20211231.xsd#unh_DeferredTaxLiabilityOtherForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_DeferredTaxLiabilityOtherForeign" xlink:to="lab_unh_DeferredTaxLiabilityOtherForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_0673562a-6c73-4066-a0c7-792fe64af427_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted Prices in Active Markets (Level 1) [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_37c3384e-eb7f-45af-849c-dc9028f0a099_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_2e13ce92-f663-4492-ab01-8e3599b679f1_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_c721cc65-46c9-4b02-9cf0-1d32615f3b7a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income taxes, net of federal benefit, Amount</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_OptumhealthMember_7d764bd4-4328-42de-a0bc-f038103736a8_terseLabel_en-US" xlink:label="lab_unh_OptumhealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Optum Health</link:label>
    <link:label id="lab_unh_OptumhealthMember_label_en-US" xlink:label="lab_unh_OptumhealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Optumhealth [Member]</link:label>
    <link:label id="lab_unh_OptumhealthMember_documentation_en-US" xlink:label="lab_unh_OptumhealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OptumHealth Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OptumhealthMember" xlink:href="unh-20211231.xsd#unh_OptumhealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_OptumhealthMember" xlink:to="lab_unh_OptumhealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_ee559803-9a57-4716-bb8b-4d0dd8a3aad4_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_5808dfd3-98c4-449b-9c32-9d75b3807f2c_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_f472d09c-7b9d-4c7f-88fb-c868591900f8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_b3d89aa8-bc30-41e8-a77c-18dfceefb279_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_72ba3875-a48d-43ed-b5b5-647112008eee_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:to="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_af0d0d8f-ff82-4c70-b714-a15c02245b73_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_FiveYear56BillionCreditFacilityMember_8fe06d9a-e272-44c6-8bae-d787ccc388fb_terseLabel_en-US" xlink:label="lab_unh_FiveYear56BillionCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Year $5.6 Billion Credit Facility [Member]</link:label>
    <link:label id="lab_unh_FiveYear56BillionCreditFacilityMember_label_en-US" xlink:label="lab_unh_FiveYear56BillionCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Year $5.6 Billion Credit Facility [Member]</link:label>
    <link:label id="lab_unh_FiveYear56BillionCreditFacilityMember_documentation_en-US" xlink:label="lab_unh_FiveYear56BillionCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Year $5.6 Billion Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_FiveYear56BillionCreditFacilityMember" xlink:href="unh-20211231.xsd#unh_FiveYear56BillionCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_FiveYear56BillionCreditFacilityMember" xlink:to="lab_unh_FiveYear56BillionCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_721f25a5-77c3-407d-af73-63e296029707_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_BasisofpresentationAbstract_6069907d-9bc5-4bff-ae0c-d59ea5a03580_terseLabel_en-US" xlink:label="lab_unh_BasisofpresentationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of presentation [Abstract]</link:label>
    <link:label id="lab_unh_BasisofpresentationAbstract_label_en-US" xlink:label="lab_unh_BasisofpresentationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of presentation [Abstract]</link:label>
    <link:label id="lab_unh_BasisofpresentationAbstract_documentation_en-US" xlink:label="lab_unh_BasisofpresentationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of presentation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_BasisofpresentationAbstract" xlink:href="unh-20211231.xsd#unh_BasisofpresentationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_BasisofpresentationAbstract" xlink:to="lab_unh_BasisofpresentationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A3125NotesDueMay2060Member_1105cb67-df02-4557-9a60-2d311e690078_terseLabel_en-US" xlink:label="lab_unh_A3125NotesDueMay2060Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% notes due May 2060 [Member]</link:label>
    <link:label id="lab_unh_A3125NotesDueMay2060Member_label_en-US" xlink:label="lab_unh_A3125NotesDueMay2060Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% notes due May 2060 [Member]</link:label>
    <link:label id="lab_unh_A3125NotesDueMay2060Member_documentation_en-US" xlink:label="lab_unh_A3125NotesDueMay2060Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% notes due May 2060</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3125NotesDueMay2060Member" xlink:href="unh-20211231.xsd#unh_A3125NotesDueMay2060Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A3125NotesDueMay2060Member" xlink:to="lab_unh_A3125NotesDueMay2060Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_60559ff2-4ca1-485f-9103-6b9481023c12_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, redeemable noncontrolling interests and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a3ffcf75-dd74-4bf2-8947-c4553a66ead1_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_1f714bdb-d028-4008-ba89-99f77976e6e0_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_9c36b63c-6fad-44da-ae53-599849cee67c_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A2300NotesDueMay2031Member_115f9a9a-e583-4cfa-bfe7-136d34c8473c_terseLabel_en-US" xlink:label="lab_unh_A2300NotesDueMay2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.300% notes due May 2031 [Member]</link:label>
    <link:label id="lab_unh_A2300NotesDueMay2031Member_label_en-US" xlink:label="lab_unh_A2300NotesDueMay2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.300% notes due May 2031 [Member]</link:label>
    <link:label id="lab_unh_A2300NotesDueMay2031Member_documentation_en-US" xlink:label="lab_unh_A2300NotesDueMay2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.300% notes due May 2031</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2300NotesDueMay2031Member" xlink:href="unh-20211231.xsd#unh_A2300NotesDueMay2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A2300NotesDueMay2031Member" xlink:to="lab_unh_A2300NotesDueMay2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_4880c3cd-0867-4282-ba72-8f243af4fab1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and allowances</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Returns and Allowances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_bc018d08-4959-4e8e-936d-c1b17b4ca2cf_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_52746e6e-4f4f-4485-b9af-d57f725a75c2_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A3.875notesdueDecember2028Member_0ec1a94a-b5e4-458f-b575-1b454e574ca2_terseLabel_en-US" xlink:label="lab_unh_A3.875notesdueDecember2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.875% notes due December 2028 [Member]</link:label>
    <link:label id="lab_unh_A3.875notesdueDecember2028Member_label_en-US" xlink:label="lab_unh_A3.875notesdueDecember2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.875% notes due December 2028 [Member]</link:label>
    <link:label id="lab_unh_A3.875notesdueDecember2028Member_documentation_en-US" xlink:label="lab_unh_A3.875notesdueDecember2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.875% notes due December 2028 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.875notesdueDecember2028Member" xlink:href="unh-20211231.xsd#unh_A3.875notesdueDecember2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A3.875notesdueDecember2028Member" xlink:to="lab_unh_A3.875notesdueDecember2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_90fa5884-b210-423f-9b95-d2cad9aaeb8b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_6b013cbf-02b2-411d-8e54-f2d50a906991_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestAbstract_cb90fa17-1145-4bb7-b55c-e7d07e9b2a7b_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract" xlink:to="lab_us-gaap_NoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_9e657d67-b786-4bf6-9b51-b27014acc739_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_b37757b5-3ab0-4d3b-8362-0a89c86bb33e_negatedLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTextBlock_5f19be68-49b5-4ea1-a27c-ae75e6fab7e2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_4765d209-5fae-4fe2-9fb9-39b13802f5aa_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrecognized tax benefits, beginning of period</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_698ee7a5-e6ea-438e-9240-0ea41ea96d05_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrecognized tax benefits, end of period</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SubsidiariesMember_86fe9cb6-5104-4fc0-8de4-e59d9e2eb943_terseLabel_en-US" xlink:label="lab_srt_SubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiaries [Member]</link:label>
    <link:label id="lab_srt_SubsidiariesMember_label_en-US" xlink:label="lab_srt_SubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiaries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SubsidiariesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SubsidiariesMember" xlink:to="lab_srt_SubsidiariesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_8cc84748-6a1d-416c-8b7f-84df77ec00e0_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subtotal</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_c3e5bf1e-6673-42e4-9711-fd8d9699f64d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_GoodwillandIntangibleAssetsAbstract_8b1837d2-f931-4071-b962-5d2f809688a8_terseLabel_en-US" xlink:label="lab_unh_GoodwillandIntangibleAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets [Abstract]</link:label>
    <link:label id="lab_unh_GoodwillandIntangibleAssetsAbstract_label_en-US" xlink:label="lab_unh_GoodwillandIntangibleAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets [Abstract]</link:label>
    <link:label id="lab_unh_GoodwillandIntangibleAssetsAbstract_documentation_en-US" xlink:label="lab_unh_GoodwillandIntangibleAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_GoodwillandIntangibleAssetsAbstract" xlink:href="unh-20211231.xsd#unh_GoodwillandIntangibleAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_GoodwillandIntangibleAssetsAbstract" xlink:to="lab_unh_GoodwillandIntangibleAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_b8fe3bed-892b-4988-ae79-eae8d1c972d6_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_9d93bb11-c390-4603-be04-1e022c0d1a3f_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities, Available for sale Debt Securities, Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_cbe0bc0a-1527-4965-89d8-d5f4d6454341_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A6625NotesDueNovember2037Member_f909804b-beec-4e6b-96a9-c9036fa9851a_terseLabel_en-US" xlink:label="lab_unh_A6625NotesDueNovember2037Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.625% notes due November 2037 [Member]</link:label>
    <link:label id="lab_unh_A6625NotesDueNovember2037Member_label_en-US" xlink:label="lab_unh_A6625NotesDueNovember2037Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.625% notes due November 2037 [Member]</link:label>
    <link:label id="lab_unh_A6625NotesDueNovember2037Member_documentation_en-US" xlink:label="lab_unh_A6625NotesDueNovember2037Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.625% notes due November 2037 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A6625NotesDueNovember2037Member" xlink:href="unh-20211231.xsd#unh_A6625NotesDueNovember2037Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A6625NotesDueNovember2037Member" xlink:to="lab_unh_A6625NotesDueNovember2037Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties_fae0646b-cbc1-469f-b824-5ee0431e6e87_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of notes to subsidiaries</link:label>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties_label_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Collection of Long-term Loans to Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties" xlink:to="lab_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_e31552f2-2b4a-43bc-9c1d-0c8b3219e2b3_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_ScheduleIAbstract_210251c8-fc48-4788-b724-469af1850d0b_terseLabel_en-US" xlink:label="lab_unh_ScheduleIAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule I [Abstract]</link:label>
    <link:label id="lab_unh_ScheduleIAbstract_label_en-US" xlink:label="lab_unh_ScheduleIAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule I [Abstract]</link:label>
    <link:label id="lab_unh_ScheduleIAbstract_documentation_en-US" xlink:label="lab_unh_ScheduleIAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule I [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ScheduleIAbstract" xlink:href="unh-20211231.xsd#unh_ScheduleIAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_ScheduleIAbstract" xlink:to="lab_unh_ScheduleIAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A4.250notesdueJune2048Member_269174ff-db42-4953-859e-647425837ef9_terseLabel_en-US" xlink:label="lab_unh_A4.250notesdueJune2048Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.250% notes due June 2048 [Member]</link:label>
    <link:label id="lab_unh_A4.250notesdueJune2048Member_label_en-US" xlink:label="lab_unh_A4.250notesdueJune2048Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.250% notes due June 2048 [Member]</link:label>
    <link:label id="lab_unh_A4.250notesdueJune2048Member_documentation_en-US" xlink:label="lab_unh_A4.250notesdueJune2048Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.250% notes due June 2048 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.250notesdueJune2048Member" xlink:href="unh-20211231.xsd#unh_A4.250notesdueJune2048Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A4.250notesdueJune2048Member" xlink:to="lab_unh_A4.250notesdueJune2048Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_a309807e-f2c3-4380-b6e1-bcc39cf97cc2_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical costs payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Health Care Insurance Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_6a064e0e-1ad4-478b-b39c-77ef03c00dcf_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at end of period, Weighted-Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_73f11cbd-c19e-42c9-af54-13dca2e99318_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_d9bbd41c-a454-4302-8066-0ab034210c05_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period, Weighted Average Remaining Contractual Term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_c1558943-3743-4e3d-84a0-bc25902caab9_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_OtherLiabilitiesCurrentPolicyTextBlock_35b94899-86d6-40de-bf7b-ee19cbe097bc_terseLabel_en-US" xlink:label="lab_unh_OtherLiabilitiesCurrentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Policy Text Block]</link:label>
    <link:label id="lab_unh_OtherLiabilitiesCurrentPolicyTextBlock_label_en-US" xlink:label="lab_unh_OtherLiabilitiesCurrentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current [Policy Text Block]</link:label>
    <link:label id="lab_unh_OtherLiabilitiesCurrentPolicyTextBlock_documentation_en-US" xlink:label="lab_unh_OtherLiabilitiesCurrentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OtherLiabilitiesCurrentPolicyTextBlock" xlink:href="unh-20211231.xsd#unh_OtherLiabilitiesCurrentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_OtherLiabilitiesCurrentPolicyTextBlock" xlink:to="lab_unh_OtherLiabilitiesCurrentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_7e7c4a07-e5f7-475a-978b-6c47fbfff35e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_df1dc07f-1d46-4a04-8350-70dcb96fd7cd_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_c6690749-c50f-4779-b7a5-cc735dedfe0b_periodStartLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable noncontrolling interest, beginning of period</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_e85d0b0a-e8af-4879-be30-6d2b14de894c_periodEndLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, end of period</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_f2daaf8a-c7ed-421f-ab28-3d6f76fdc0b7_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_ad8ee049-aa9e-4215-8458-c1808385cbc1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.01 par value - 3,000 shares authorized; 941 and 946 issued and outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0f7fb82b-190a-4c50-bc1c-585b44f7d50f_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e40e262e-2a9e-4e4c-b62e-dd2668024945_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at beginning of period, Weighted-Average Grant Date Fair Value per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f609891f-e851-4889-8aaf-d8f31728e8b7_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at end of period, Weighted-Average Grant Date Fair Value per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_5f2a1098-a4c1-4c92-8bd0-b15b82a0a838_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage-backed securities, Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_47c0503e-76f3-481e-8ab9-a76c4c404afa_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_3415e86e-6043-4d40-b571-f56ab7a6c4db_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_84c09000-7dde-4e7e-9b0c-040f2b304b9a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Share-Based Compensation Data [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_c61485b0-8dc9-41a4-ac1c-7bfb76de38aa_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Text Block]</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_859a0fec-7b22-4154-8b98-8fa58c791582_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_62c4178d-0a9f-4261-a611-073c076f62dc_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount_8eb9a9b7-5afb-41a2-b1a9-b56d43994d46_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, after Year One through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_b0ac92dd-0b86-4f9e-8cea-a8b8b8249cab_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_28c2d86c-e7f8-4f5c-af84-0b0116806c07_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_ef85a103-a91b-4bf3-883a-478d5ea63106_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_e8f83142-33b2-48b6-97eb-2f4aa9bf5dfe_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of redeemable noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_CMSMember_36260ceb-9610-4aa3-9328-6647b549cb41_terseLabel_en-US" xlink:label="lab_unh_CMSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CMS [Member]</link:label>
    <link:label id="lab_unh_CMSMember_label_en-US" xlink:label="lab_unh_CMSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CMS [Member]</link:label>
    <link:label id="lab_unh_CMSMember_documentation_en-US" xlink:label="lab_unh_CMSMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CMS [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_CMSMember" xlink:href="unh-20211231.xsd#unh_CMSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_CMSMember" xlink:to="lab_unh_CMSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_0e03b17d-f739-4050-a607-a77a7b63ee2c_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_label_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestLineItems" xlink:to="lab_us-gaap_MinorityInterestLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3e1b8465-68df-43b5-8821-071a74d3b427_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_17677fb4-e5b1-41c6-abc6-acbd66d58220_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A4.700notesdueFebruary2021Member_5cb62a79-8c58-480e-902b-22da299e23b6_terseLabel_en-US" xlink:label="lab_unh_A4.700notesdueFebruary2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.700% Notes Due February 2021 [Member]</link:label>
    <link:label id="lab_unh_A4.700notesdueFebruary2021Member_label_en-US" xlink:label="lab_unh_A4.700notesdueFebruary2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.700% notes due February 2021 [Member]</link:label>
    <link:label id="lab_unh_A4.700notesdueFebruary2021Member_documentation_en-US" xlink:label="lab_unh_A4.700notesdueFebruary2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.700% notes due February 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.700notesdueFebruary2021Member" xlink:href="unh-20211231.xsd#unh_A4.700notesdueFebruary2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A4.700notesdueFebruary2021Member" xlink:to="lab_unh_A4.700notesdueFebruary2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5ce4c8ee-9a21-49e7-9805-a94ce930d7b1_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Products and Services</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c9455464-00ca-4b65-96ab-318e56b7d3dd_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Products and Services - unaffiliated customers</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_e61a03a4-a399-48db-b153-ac01f6705b10_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_d96c8984-9c6c-4a01-9a3f-b972a102ecee_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit</link:label>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_label_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:to="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsDeclaredTableTextBlock_8a9b11f8-8672-4886-bacd-ac1875045621_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsDeclaredTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Declared</link:label>
    <link:label id="lab_us-gaap_DividendsDeclaredTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DividendsDeclaredTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Declared [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDeclaredTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsDeclaredTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsDeclaredTableTextBlock" xlink:to="lab_us-gaap_DividendsDeclaredTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_5395d538-8502-4a62-b01b-c8057370da95_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_e1fffff9-3375-4699-b8e0-c5eb7cef0760_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_467a7cae-4064-4a0b-86be-39ef86ae0a6a_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_24d300d2-bd69-4485-9a6d-c0b42c8f33b9_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_7b79b610-6adf-41fe-ac95-83daaceaa194_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_9827ffa2-c88a-4b02-b9e0-949fb7a04d54_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less Than 12 Months, Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_3187aa2e-9ebb-44bf-8eff-1fb1b2fbe206_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_045a89ef-c1d4-4bc0-bbe5-2ed5ec23dbac_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Financial Information [Text Block]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_ba51f0c6-7bb1-4b26-87e4-3c5413e08e80_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of redeemable noncontrolling interest shares</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_b2906cf8-a5c4-4541-85d8-c1a0dd353202_verboseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemptions</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A4.625notesdueNovember2041Member_05ba29f4-f14a-40d8-a61c-2bad796a3f18_terseLabel_en-US" xlink:label="lab_unh_A4.625notesdueNovember2041Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.625% notes Due November 2041 [Member]</link:label>
    <link:label id="lab_unh_A4.625notesdueNovember2041Member_label_en-US" xlink:label="lab_unh_A4.625notesdueNovember2041Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.625% notes due November 2041 [Member]</link:label>
    <link:label id="lab_unh_A4.625notesdueNovember2041Member_documentation_en-US" xlink:label="lab_unh_A4.625notesdueNovember2041Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.625% notes due November 2041</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.625notesdueNovember2041Member" xlink:href="unh-20211231.xsd#unh_A4.625notesdueNovember2041Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A4.625notesdueNovember2041Member" xlink:to="lab_unh_A4.625notesdueNovember2041Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems_97aadc21-91ad-4f25-b2f7-9c89dee615d4_terseLabel_en-US" xlink:label="lab_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]</link:label>
    <link:label id="lab_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems_label_en-US" xlink:label="lab_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems" xlink:to="lab_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_65db2185-940c-47c7-815a-abd487410547_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_bec858d5-8786-4894-b92d-f9d8efa44b1e_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after one year through five years, Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_021ef8f4-b18a-48e0-8cba-227f0be81925_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_2ae4acc1-4802-4229-9e5e-a334a3ce88a4_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuances of notes to subsidiaries</link:label>
    <link:label id="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_label_en-US" xlink:label="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Fund Long-term Loans to Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:to="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_5566eb00-bc19-43bf-a922-81fe93d38bbc_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_d3373fe4-cc08-404a-b6d5-abccc3246127_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_f244c3cb-0d00-47e9-a6d8-19f6f48cce25_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers out of Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_ef48e5d4-695b-4ec2-ba68-cf5a6ea942b6_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_0abe3ef2-2f70-4ac8-b077-89faf804e323_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends per common share</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:to="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_50f8007a-3b98-43c1-83db-1ff4bc51e3d0_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_DebtAbstract_868ed885-9589-4314-b9da-8bb8aa52c6ec_terseLabel_en-US" xlink:label="lab_unh_DebtAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt [Abstract]</link:label>
    <link:label id="lab_unh_DebtAbstract_label_en-US" xlink:label="lab_unh_DebtAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt [Abstract]</link:label>
    <link:label id="lab_unh_DebtAbstract_documentation_en-US" xlink:label="lab_unh_DebtAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DebtAbstract" xlink:href="unh-20211231.xsd#unh_DebtAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_DebtAbstract" xlink:to="lab_unh_DebtAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_InvestmentsAmortizedCost_ecc5dc0a-6bc4-458a-b952-5407da7658f4_totalLabel_en-US" xlink:label="lab_unh_InvestmentsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total investments, Amortized Cost</link:label>
    <link:label id="lab_unh_InvestmentsAmortizedCost_label_en-US" xlink:label="lab_unh_InvestmentsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Amortized Cost</link:label>
    <link:label id="lab_unh_InvestmentsAmortizedCost_documentation_en-US" xlink:label="lab_unh_InvestmentsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments at amortized cost.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_InvestmentsAmortizedCost" xlink:href="unh-20211231.xsd#unh_InvestmentsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_InvestmentsAmortizedCost" xlink:to="lab_unh_InvestmentsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_823e352c-dacd-43ed-8edd-8a7103617f99_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_0074c1a2-cd63-4db8-946d-4e504b55724a_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_94c67b99-3ff1-448b-a0ba-b4901c50e6e1_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common share repurchases (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_0fbd6744-4690-4dfb-ab9b-a9f7fe0c8a95_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares repurchases, shares</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_d77e4616-3000-48f4-a5df-ea81c08a5068_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Fair Value</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_4ea82294-ef86-41e9-874f-99f78cf406f8_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_12e34b0a-ac1d-4e5e-aa79-35351b7e7cf0_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_001c893f-8cbd-4b84-87e9-3331173b384c_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A3.500notesdueFebruary2024Member_4bbbab27-d6b2-4ca2-b873-16e105e95bca_terseLabel_en-US" xlink:label="lab_unh_A3.500notesdueFebruary2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.500% notes due February 2024 [Member]</link:label>
    <link:label id="lab_unh_A3.500notesdueFebruary2024Member_label_en-US" xlink:label="lab_unh_A3.500notesdueFebruary2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.500% notes due February 2024 [Member]</link:label>
    <link:label id="lab_unh_A3.500notesdueFebruary2024Member_documentation_en-US" xlink:label="lab_unh_A3.500notesdueFebruary2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.500% notes due February 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.500notesdueFebruary2024Member" xlink:href="unh-20211231.xsd#unh_A3.500notesdueFebruary2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A3.500notesdueFebruary2024Member" xlink:to="lab_unh_A3.500notesdueFebruary2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_StockOptionsandSARsMember_7ee25cf7-960f-45dc-9283-f24cb2d30962_terseLabel_en-US" xlink:label="lab_unh_StockOptionsandSARsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options [Member]</link:label>
    <link:label id="lab_unh_StockOptionsandSARsMember_ad1a5d98-7861-469c-b882-e1d351be1e25_verboseLabel_en-US" xlink:label="lab_unh_StockOptionsandSARsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options [Member]</link:label>
    <link:label id="lab_unh_StockOptionsandSARsMember_label_en-US" xlink:label="lab_unh_StockOptionsandSARsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options and SARs [Member]</link:label>
    <link:label id="lab_unh_StockOptionsandSARsMember_documentation_en-US" xlink:label="lab_unh_StockOptionsandSARsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options and SARs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_StockOptionsandSARsMember" xlink:href="unh-20211231.xsd#unh_StockOptionsandSARsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_StockOptionsandSARsMember" xlink:to="lab_unh_StockOptionsandSARsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_a4850225-6f83-4b4b-9657-e439f6f82018_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f1534167-8865-4b97-8f39-0f36b47ec3af_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_6d810496-b943-4d3f-858d-68a0f61d3652_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_7f72e6de-9b19-4da3-8711-2b95e1435874_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total UnitedHealth Group shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b268f423-42fb-4601-9e69-afff69f9f025_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_d105e3c7-ee00-4a97-a57b-03ff8257117e_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3a04e2e3-a50a-4e6a-96bc-e779dc881d16_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_4e9af5eb-2b1c-490a-a19d-3432447f3712_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at end of period, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_940dad6e-5672-415b-9f9a-7b10de926db0_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A2750NotesDueFebruary2023Member_4a09e930-1bdc-48ad-bceb-dd642a3bb957_terseLabel_en-US" xlink:label="lab_unh_A2750NotesDueFebruary2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.750% Notes Due February 2023 [Member]</link:label>
    <link:label id="lab_unh_A2750NotesDueFebruary2023Member_label_en-US" xlink:label="lab_unh_A2750NotesDueFebruary2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.750% notes due February 2023 [Member]</link:label>
    <link:label id="lab_unh_A2750NotesDueFebruary2023Member_documentation_en-US" xlink:label="lab_unh_A2750NotesDueFebruary2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.750% notes due February 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2750NotesDueFebruary2023Member" xlink:href="unh-20211231.xsd#unh_A2750NotesDueFebruary2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A2750NotesDueFebruary2023Member" xlink:to="lab_unh_A2750NotesDueFebruary2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_83d7582a-061c-4b0f-b018-964c13ec92bd_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities, Held to maturity, Unrecognized Holding Gain</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_2521d20f-5fe2-43a6-8fb1-c3f57d8863ca_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common share repurchases</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_a6cad856-8628-4042-93de-81ce001a49ac_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock repurchases</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_d2801d51-1a48-416a-9564-49683ffbfe5d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful Life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_6f4251a6-eea7-4cc4-8948-14a216f3b5ad_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_8de26b51-e8d2-4122-bbb2-320d026bd39c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_UnitedhealthcareMember_4a55e2f4-ee8b-4a50-8a10-f6eb8898138b_terseLabel_en-US" xlink:label="lab_unh_UnitedhealthcareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UnitedHealthcare</link:label>
    <link:label id="lab_unh_UnitedhealthcareMember_label_en-US" xlink:label="lab_unh_UnitedhealthcareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unitedhealthcare [Member]</link:label>
    <link:label id="lab_unh_UnitedhealthcareMember_documentation_en-US" xlink:label="lab_unh_UnitedhealthcareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UnitedHealthcare [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_UnitedhealthcareMember" xlink:href="unh-20211231.xsd#unh_UnitedhealthcareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_UnitedhealthcareMember" xlink:to="lab_unh_UnitedhealthcareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1585d753-c0b5-45a3-9f9a-1e8d91315a00_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_cd77a5ee-a6ef-48f5-924f-bf40f314f078_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current provision</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_4b8e89da-b28b-4092-aaa2-e4029f80b1ac_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Par Value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A2.950notesdueOctober2027Member_75b91d38-ba21-4695-bca5-9318dd013bee_terseLabel_en-US" xlink:label="lab_unh_A2.950notesdueOctober2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.950% notes due October 2027 [Member]</link:label>
    <link:label id="lab_unh_A2.950notesdueOctober2027Member_label_en-US" xlink:label="lab_unh_A2.950notesdueOctober2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.950% notes due October 2027 [Member]</link:label>
    <link:label id="lab_unh_A2.950notesdueOctober2027Member_documentation_en-US" xlink:label="lab_unh_A2.950notesdueOctober2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.950% notes due October 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2.950notesdueOctober2027Member" xlink:href="unh-20211231.xsd#unh_A2.950notesdueOctober2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A2.950notesdueOctober2027Member" xlink:to="lab_unh_A2.950notesdueOctober2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_309fd101-30af-43cf-aaa1-5ce7343f3fb9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_MedicalCostsAndMedicalCostsPayableDomain_9dadbf36-ce0c-4e0a-b8fc-4525f393417b_terseLabel_en-US" xlink:label="lab_unh_MedicalCostsAndMedicalCostsPayableDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Costs and Medical Costs Payable [Domain]</link:label>
    <link:label id="lab_unh_MedicalCostsAndMedicalCostsPayableDomain_label_en-US" xlink:label="lab_unh_MedicalCostsAndMedicalCostsPayableDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Costs and Medical Costs Payable [Domain]</link:label>
    <link:label id="lab_unh_MedicalCostsAndMedicalCostsPayableDomain_documentation_en-US" xlink:label="lab_unh_MedicalCostsAndMedicalCostsPayableDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Costs and Medical Costs Payable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_MedicalCostsAndMedicalCostsPayableDomain" xlink:href="unh-20211231.xsd#unh_MedicalCostsAndMedicalCostsPayableDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_MedicalCostsAndMedicalCostsPayableDomain" xlink:to="lab_unh_MedicalCostsAndMedicalCostsPayableDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_285e4830-6cf8-4b35-aaf8-a9dd620c55f3_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfCondensedFinancialStatementsTable_fbdd37da-ce13-4375-bc2a-95d61d80f834_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Statements [Table]</link:label>
    <link:label id="lab_srt_ScheduleOfCondensedFinancialStatementsTable_label_en-US" xlink:label="lab_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Statements [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:to="lab_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A4.750notesdueJuly2045Member_69e82ebb-ca2c-4d21-b7f7-bab12ffe2ef2_terseLabel_en-US" xlink:label="lab_unh_A4.750notesdueJuly2045Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.750% notes Due July 2045 [Member]</link:label>
    <link:label id="lab_unh_A4.750notesdueJuly2045Member_label_en-US" xlink:label="lab_unh_A4.750notesdueJuly2045Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.750% notes due July 2045 [Member]</link:label>
    <link:label id="lab_unh_A4.750notesdueJuly2045Member_documentation_en-US" xlink:label="lab_unh_A4.750notesdueJuly2045Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.750% notes due July 2045 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.750notesdueJuly2045Member" xlink:href="unh-20211231.xsd#unh_A4.750notesdueJuly2045Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A4.750notesdueJuly2045Member" xlink:to="lab_unh_A4.750notesdueJuly2045Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_175194be-82bf-4631-ba7e-7098968ea4f9_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred income tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_fb52ba96-b125-4ba6-b97a-4d868e0ab5e2_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_b8dc5069-0f88-4714-9b25-697495b3cad9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_8070d85c-bec0-4178-971f-fceb1c65c8e7_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_5e4d5844-cf31-48a4-baec-12799343518e_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_MedicarePartDPharmacyBenefitsContractDomain_3b14bdcc-063c-47d9-8ed8-d3c19b0c749c_terseLabel_en-US" xlink:label="lab_unh_MedicarePartDPharmacyBenefitsContractDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Part D Pharmacy Benefits Contract [Domain]</link:label>
    <link:label id="lab_unh_MedicarePartDPharmacyBenefitsContractDomain_label_en-US" xlink:label="lab_unh_MedicarePartDPharmacyBenefitsContractDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Part D Pharmacy Benefits Contract [Domain]</link:label>
    <link:label id="lab_unh_MedicarePartDPharmacyBenefitsContractDomain_documentation_en-US" xlink:label="lab_unh_MedicarePartDPharmacyBenefitsContractDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Part D Pharmacy Benefits Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_MedicarePartDPharmacyBenefitsContractDomain" xlink:href="unh-20211231.xsd#unh_MedicarePartDPharmacyBenefitsContractDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_MedicarePartDPharmacyBenefitsContractDomain" xlink:to="lab_unh_MedicarePartDPharmacyBenefitsContractDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_c3f48aa0-5cec-45dc-b815-104eec45728c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net, Amount</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_bc3704b4-5a2a-4c1d-87c1-309b03571545_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_504aa87b-d4a1-442a-b721-82b007eb5894_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_06dc5ac9-7f54-4f69-aee9-f04d37227f63_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest_aa7bfe58-1d54-4f51-9fae-83d6e88e5413_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings attributable to nonredeemable noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_0eb2d697-82c8-4ea6-a20d-fdd3ce3f75ce_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowances of $954 and $990</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_e43a5ad0-1c07-458a-aedc-b3061e9ccc38_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceAbstract_a6e17309-4174-4281-8f8f-a8237d0e2551_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance [Abstract]</link:label>
    <link:label id="lab_us-gaap_InsuranceAbstract_label_en-US" xlink:label="lab_us-gaap_InsuranceAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InsuranceAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceAbstract" xlink:to="lab_us-gaap_InsuranceAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_d08202dc-83b9-4773-a9a3-1db1d32f96a7_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_95a6c25d-976e-481c-ae5f-63eca73606e2_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_ed1e3bc7-f87f-4bee-a9df-4f211f826a0e_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_75d8b63f-7133-46f2-816c-52eb1700c8c1_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_f8ca13c4-b4bc-4923-b8b5-0e7551e2ee14_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries_aa75826a-c5bb-4549-a70f-3ce24410d00c_terseLabel_en-US" xlink:label="lab_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Dividends Paid to Parent, Consolidated Subsidiaries</link:label>
    <link:label id="lab_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries_label_en-US" xlink:label="lab_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Consolidated Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" xlink:to="lab_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_17b8f46b-2910-482b-bd90-9c3a56d2aa92_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future minimum lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A3.750notesdueOctober2047Member_6f9278a2-72ef-4b27-918d-4ddd81f3bf3b_terseLabel_en-US" xlink:label="lab_unh_A3.750notesdueOctober2047Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.750% notes due October 2047 [Member]</link:label>
    <link:label id="lab_unh_A3.750notesdueOctober2047Member_label_en-US" xlink:label="lab_unh_A3.750notesdueOctober2047Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.750% notes due October 2047 [Member]</link:label>
    <link:label id="lab_unh_A3.750notesdueOctober2047Member_documentation_en-US" xlink:label="lab_unh_A3.750notesdueOctober2047Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.750% notes due October 2047 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.750notesdueOctober2047Member" xlink:href="unh-20211231.xsd#unh_A3.750notesdueOctober2047Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A3.750notesdueOctober2047Member" xlink:to="lab_unh_A3.750notesdueOctober2047Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_7c98ac65-2fcd-4737-852e-5a07ec8573bf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_eef22c36-de21-42d5-bca2-d27eb713dc9e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_199c2aae-8e77-4b23-8ca2-f0324f286266_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_2faf3e30-1147-4a06-a60b-beccd84d433c_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition and other adjustments of nonredeemable noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_222f571d-e733-4e7d-97d3-7c5c50c5035c_verboseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_068405b4-c549-42f2-bafb-33eb50da3c4a_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term borrowings and current maturities of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_MedicalCostsAndMedicalCostsPayableAxis_d9c83f13-148c-4d1f-b0cd-ec80269dabcb_terseLabel_en-US" xlink:label="lab_unh_MedicalCostsAndMedicalCostsPayableAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Costs and Medical Costs Payable [Axis]</link:label>
    <link:label id="lab_unh_MedicalCostsAndMedicalCostsPayableAxis_label_en-US" xlink:label="lab_unh_MedicalCostsAndMedicalCostsPayableAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Costs and Medical Costs Payable [Axis]</link:label>
    <link:label id="lab_unh_MedicalCostsAndMedicalCostsPayableAxis_documentation_en-US" xlink:label="lab_unh_MedicalCostsAndMedicalCostsPayableAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Costs and Medical Costs Payable [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_MedicalCostsAndMedicalCostsPayableAxis" xlink:href="unh-20211231.xsd#unh_MedicalCostsAndMedicalCostsPayableAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_MedicalCostsAndMedicalCostsPayableAxis" xlink:to="lab_unh_MedicalCostsAndMedicalCostsPayableAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_927894aa-4c3e-48f1-a0be-08cb5f73f3e5_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_7cda92f2-6772-450c-b4e6-3f7fc4d50369_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_07e9be6b-be6f-4ce0-9cb4-f5df4889905b_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9bc450db-6ce0-4f48-86fd-4f14299d4bd2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average grant date fair value of shares granted, per share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_77b2d99c-4b7b-4f48-ac09-fc511eb056ef_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_3f556e4f-968c-4588-8462-f6e39c3f5743_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Prepaid Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_60017df3-fb67-4aae-b919-91c0c9a1c5e6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A4250NotesDueMarch2043Member_7c82b8ce-c208-4074-8af4-533ea60a6ae9_terseLabel_en-US" xlink:label="lab_unh_A4250NotesDueMarch2043Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.250% notes Due March 2043 [Member]</link:label>
    <link:label id="lab_unh_A4250NotesDueMarch2043Member_label_en-US" xlink:label="lab_unh_A4250NotesDueMarch2043Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.250% notes due March 2043 [Member]</link:label>
    <link:label id="lab_unh_A4250NotesDueMarch2043Member_documentation_en-US" xlink:label="lab_unh_A4250NotesDueMarch2043Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.250% notes due March 2043 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4250NotesDueMarch2043Member" xlink:href="unh-20211231.xsd#unh_A4250NotesDueMarch2043Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A4250NotesDueMarch2043Member" xlink:to="lab_unh_A4250NotesDueMarch2043Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_2cab73bb-df1e-4e27-8168-7d665899646d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. federal and state intangible assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other Finite-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaper_eed0f844-5146-472a-b520-201204a704fe_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaper_label_en-US" xlink:label="lab_us-gaap_CommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaper" xlink:to="lab_us-gaap_CommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_83afab4f-c45b-44b7-87e7-9e5b2ff61d25_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitment_8544d6fd-62a7-42c1-8326-e4ede57b7c8f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitment</link:label>
    <link:label id="lab_us-gaap_OtherCommitment_label_en-US" xlink:label="lab_us-gaap_OtherCommitment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitment" xlink:to="lab_us-gaap_OtherCommitment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_ac6431ae-48b9-44bd-9e14-9239591e130c_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_fc868f4b-87e1-43e1-8d26-adfe93b544b9_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_d2394630-4d5f-4a19-828e-2a73001e154b_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5066c31d-351c-4da8-bf26-045b925ec915_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3aac9348-40cf-4593-88b1-462cba4f98a4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_2a5f7f04-cff6-45d8-b0fa-458216ceb3f3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Observable Inputs (Level 2) [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_1086e9d1-c72c-4ff7-b13e-773edcd72d6c_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_3dbb3bee-2de0-4d1b-a5e5-4aa7b74e1670_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_3a305886-f7dc-4cd4-92e6-c61ce45b2a73_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_5c6f96ed-300d-4458-95cf-b2186b023ece_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4ae29f2a-ad98-435b-abe7-5e5d1c2e2cf9_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_aa86515f-d723-4c0e-9a58-f5364217f733_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt securities - available-for-sale, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_89f413a8-5724-426d-9f9a-37d0e531fa3e_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A5.800notesdueMarch2036Member_33caf5cc-8f88-414e-924e-e0569fd1a6e3_terseLabel_en-US" xlink:label="lab_unh_A5.800notesdueMarch2036Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.800% notes Due March 2036 [Member]</link:label>
    <link:label id="lab_unh_A5.800notesdueMarch2036Member_label_en-US" xlink:label="lab_unh_A5.800notesdueMarch2036Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.800% notes due March 2036 [Member]</link:label>
    <link:label id="lab_unh_A5.800notesdueMarch2036Member_documentation_en-US" xlink:label="lab_unh_A5.800notesdueMarch2036Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.800% notes due March 2036</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A5.800notesdueMarch2036Member" xlink:href="unh-20211231.xsd#unh_A5.800notesdueMarch2036Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A5.800notesdueMarch2036Member" xlink:to="lab_unh_A5.800notesdueMarch2036Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_35eb4eee-5e55-4f18-b440-808e1de6b2fb_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_TrademarksandTechnologyMember_43d027f2-a4dc-4121-b9c9-75bf3132cc17_terseLabel_en-US" xlink:label="lab_unh_TrademarksandTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Technology [Member]</link:label>
    <link:label id="lab_unh_TrademarksandTechnologyMember_label_en-US" xlink:label="lab_unh_TrademarksandTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Technology [Member]</link:label>
    <link:label id="lab_unh_TrademarksandTechnologyMember_documentation_en-US" xlink:label="lab_unh_TrademarksandTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Technology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_TrademarksandTechnologyMember" xlink:href="unh-20211231.xsd#unh_TrademarksandTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_TrademarksandTechnologyMember" xlink:to="lab_unh_TrademarksandTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_RevenuesMember_835895be-c04b-4640-9c71-f128d11862f8_terseLabel_en-US" xlink:label="lab_unh_RevenuesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Member]</link:label>
    <link:label id="lab_unh_RevenuesMember_label_en-US" xlink:label="lab_unh_RevenuesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Member]</link:label>
    <link:label id="lab_unh_RevenuesMember_documentation_en-US" xlink:label="lab_unh_RevenuesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_RevenuesMember" xlink:href="unh-20211231.xsd#unh_RevenuesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_RevenuesMember" xlink:to="lab_unh_RevenuesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock_b76fb16c-f4b8-449b-a960-5fa290442f52_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Nonrecurring [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Nonrecurring [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLongTermDebt_ebf1c19f-6225-4a1c-bf15-c08b515728d7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-term Debt</link:label>
    <link:label id="lab_us-gaap_OtherLongTermDebt_label_en-US" xlink:label="lab_us-gaap_OtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermDebt" xlink:to="lab_us-gaap_OtherLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_03f21a0c-31fa-4eca-ae3c-e910cbb27fad_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency effects and adjustments, net</link:label>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Translation and Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A3050NotesDueMay2041Member_0b5c88d3-b0c6-471d-9f6b-8f00ae27fd4d_terseLabel_en-US" xlink:label="lab_unh_A3050NotesDueMay2041Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.050% notes due May 2041 [Member]</link:label>
    <link:label id="lab_unh_A3050NotesDueMay2041Member_label_en-US" xlink:label="lab_unh_A3050NotesDueMay2041Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.050% notes due May 2041 [Member]</link:label>
    <link:label id="lab_unh_A3050NotesDueMay2041Member_documentation_en-US" xlink:label="lab_unh_A3050NotesDueMay2041Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.050% notes due May 2041</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3050NotesDueMay2041Member" xlink:href="unh-20211231.xsd#unh_A3050NotesDueMay2041Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A3050NotesDueMay2041Member" xlink:to="lab_unh_A3050NotesDueMay2041Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_96df5677-015e-4145-801d-e06f6b9f667b_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_f5319e27-c78d-4b15-9795-cee52bd953c0_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage-backed securities, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_f0c243d0-5bcf-4f5f-8892-32fde09257f0_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_5cd02eee-669e-46be-9f9d-7218f0389013_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_03dfa2a8-cb30-4120-ae76-b86efecb99ac_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_1b424a18-8cd4-4fb0-9092-f737eefc7e60_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_a45be7e0-ad85-4a5c-a3a1-60adb3d76dd4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_UsefulLifeMember_cff7283e-5b57-4fc8-87e1-2bad80bbc8c8_terseLabel_en-US" xlink:label="lab_unh_UsefulLifeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful Life [Member]</link:label>
    <link:label id="lab_unh_UsefulLifeMember_label_en-US" xlink:label="lab_unh_UsefulLifeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful Life [Member]</link:label>
    <link:label id="lab_unh_UsefulLifeMember_documentation_en-US" xlink:label="lab_unh_UsefulLifeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful Life [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_UsefulLifeMember" xlink:href="unh-20211231.xsd#unh_UsefulLifeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_UsefulLifeMember" xlink:to="lab_unh_UsefulLifeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_d1ceb63a-c716-47c0-994b-58ece977ecbd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_62e3b5d0-41b5-4328-826a-1a4c6342a13c_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross reclassification adjustment for net realized gains included in net earnings</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_600129c2-0304-4b1f-b40c-f43670027f24_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_53ccb08a-26b6-4cb3-972b-68536a22f30e_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_d7e4458d-c7f6-4b77-9eec-10fdf80d985d_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_283b795d-eefd-460a-ba95-2cbdaeb1b465_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_de918a5e-5eeb-479b-9989-f2f130e4ffc9_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total reclassification adjustment, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A3.500notesdueAugust2039Member_3393b7fe-cbc8-4bfe-a7e6-cd0b24d4a8d1_terseLabel_en-US" xlink:label="lab_unh_A3.500notesdueAugust2039Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.500% notes due August 2039 [Member]</link:label>
    <link:label id="lab_unh_A3.500notesdueAugust2039Member_label_en-US" xlink:label="lab_unh_A3.500notesdueAugust2039Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.500% notes due August 2039 [Member]</link:label>
    <link:label id="lab_unh_A3.500notesdueAugust2039Member_documentation_en-US" xlink:label="lab_unh_A3.500notesdueAugust2039Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.500% notes due August 2039 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.500notesdueAugust2039Member" xlink:href="unh-20211231.xsd#unh_A3.500notesdueAugust2039Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A3.500notesdueAugust2039Member" xlink:to="lab_unh_A3.500notesdueAugust2039Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_58c4ef8b-77e3-4b81-90f4-0d6996880ce8_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_OtherShareBasedCompensationDataAbstract_ba2d5615-f012-423a-9ccb-001da73efe8d_terseLabel_en-US" xlink:label="lab_unh_OtherShareBasedCompensationDataAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Share-Based Compensation Data [Abstract]</link:label>
    <link:label id="lab_unh_OtherShareBasedCompensationDataAbstract_label_en-US" xlink:label="lab_unh_OtherShareBasedCompensationDataAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Share-Based Compensation Data [Abstract]</link:label>
    <link:label id="lab_unh_OtherShareBasedCompensationDataAbstract_documentation_en-US" xlink:label="lab_unh_OtherShareBasedCompensationDataAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Share-Based Compensation Data [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OtherShareBasedCompensationDataAbstract" xlink:href="unh-20211231.xsd#unh_OtherShareBasedCompensationDataAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_OtherShareBasedCompensationDataAbstract" xlink:to="lab_unh_OtherShareBasedCompensationDataAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_55f06a26-f17c-42a1-9515-ba29640d157e_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State [Member]</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DemandDepositAccounts_7c6dc7c0-0f3d-408a-a6a7-ce65aa6b38c0_terseLabel_en-US" xlink:label="lab_us-gaap_DemandDepositAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health savings account deposits</link:label>
    <link:label id="lab_us-gaap_DemandDepositAccounts_label_en-US" xlink:label="lab_us-gaap_DemandDepositAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Demand Deposit Accounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DemandDepositAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DemandDepositAccounts" xlink:to="lab_us-gaap_DemandDepositAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_a5bbec5e-0883-4805-9fd1-72abba7733bf_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_997cc564-c62a-4cc2-82ec-961c00a0bc20_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A1250NotesDueJanuary2026Member_3d0b2c13-fc54-4ec7-926a-c5ae9f33f8ca_terseLabel_en-US" xlink:label="lab_unh_A1250NotesDueJanuary2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.250% notes due January 2026 [Member]</link:label>
    <link:label id="lab_unh_A1250NotesDueJanuary2026Member_label_en-US" xlink:label="lab_unh_A1250NotesDueJanuary2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.250% notes due January 2026 [Member]</link:label>
    <link:label id="lab_unh_A1250NotesDueJanuary2026Member_documentation_en-US" xlink:label="lab_unh_A1250NotesDueJanuary2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.250% notes due January 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A1250NotesDueJanuary2026Member" xlink:href="unh-20211231.xsd#unh_A1250NotesDueJanuary2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A1250NotesDueJanuary2026Member" xlink:to="lab_unh_A1250NotesDueJanuary2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityExpirationPeriod_23c710ab-9bc1-4a54-9809-f52bbccbd427_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturity Period, Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:to="lab_us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_654b2a50-d245-45a2-88af-b6a0663e5924_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign rate differential, Amount</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_DeferredTaxAssetsLeaseLiability_c9e5ca0a-edab-4162-8e77-9948fd6c5392_terseLabel_en-US" xlink:label="lab_unh_DeferredTaxAssetsLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liability</link:label>
    <link:label id="lab_unh_DeferredTaxAssetsLeaseLiability_label_en-US" xlink:label="lab_unh_DeferredTaxAssetsLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Lease Liability</link:label>
    <link:label id="lab_unh_DeferredTaxAssetsLeaseLiability_documentation_en-US" xlink:label="lab_unh_DeferredTaxAssetsLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxAssetsLeaseLiability" xlink:href="unh-20211231.xsd#unh_DeferredTaxAssetsLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_DeferredTaxAssetsLeaseLiability" xlink:to="lab_unh_DeferredTaxAssetsLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_9402ec63-c1df-4fb2-b04f-6369253efe20_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CondensedStatementOfComprehensiveIncomeTableTextBlock_8d7346ec-268d-4bbe-8614-0e05ee33941f_terseLabel_en-US" xlink:label="lab_srt_CondensedStatementOfComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Statement of Comprehensive Income [Table Text Block]</link:label>
    <link:label id="lab_srt_CondensedStatementOfComprehensiveIncomeTableTextBlock_label_en-US" xlink:label="lab_srt_CondensedStatementOfComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Statement of Comprehensive Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedStatementOfComprehensiveIncomeTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CondensedStatementOfComprehensiveIncomeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedStatementOfComprehensiveIncomeTableTextBlock" xlink:to="lab_srt_CondensedStatementOfComprehensiveIncomeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_e7a5fb84-1a99-4dbb-bfd8-b75296574ce5_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows used for financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_971abdb0-6419-4ebe-ba49-430f8eff19ff_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows used for financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_53da0d32-0bca-4f43-bedf-83e7e4a43b84_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_IntersegmentMember_43b372ff-b01b-4808-b25e-16781d4901d4_terseLabel_en-US" xlink:label="lab_unh_IntersegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated Customers</link:label>
    <link:label id="lab_unh_IntersegmentMember_label_en-US" xlink:label="lab_unh_IntersegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment [Member]</link:label>
    <link:label id="lab_unh_IntersegmentMember_documentation_en-US" xlink:label="lab_unh_IntersegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_IntersegmentMember" xlink:href="unh-20211231.xsd#unh_IntersegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_IntersegmentMember" xlink:to="lab_unh_IntersegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_fb99e4e1-9eb5-46ec-be18-855a30eda47e_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A3.100notesdueMarch2026Member_7360582c-9988-41b3-b2cd-9241e509e76a_terseLabel_en-US" xlink:label="lab_unh_A3.100notesdueMarch2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.100% notes due March 2026 [Member]</link:label>
    <link:label id="lab_unh_A3.100notesdueMarch2026Member_label_en-US" xlink:label="lab_unh_A3.100notesdueMarch2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.100% notes due March 2026 [Member]</link:label>
    <link:label id="lab_unh_A3.100notesdueMarch2026Member_documentation_en-US" xlink:label="lab_unh_A3.100notesdueMarch2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.100% notes due March 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.100notesdueMarch2026Member" xlink:href="unh-20211231.xsd#unh_A3.100notesdueMarch2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A3.100notesdueMarch2026Member" xlink:to="lab_unh_A3.100notesdueMarch2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_1c7c6daa-a1ad-479a-9462-0f98b9cb9c0d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Share Activity [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_PharmaceuticalManufacturerRebatesReceivableMember_cf97e850-e4de-46e6-afee-6e3aa42f2d3b_terseLabel_en-US" xlink:label="lab_unh_PharmaceuticalManufacturerRebatesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical Manufacturer Rebates Receivable [Member]</link:label>
    <link:label id="lab_unh_PharmaceuticalManufacturerRebatesReceivableMember_label_en-US" xlink:label="lab_unh_PharmaceuticalManufacturerRebatesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PharmaceuticalManufacturerRebatesReceivable [Member]</link:label>
    <link:label id="lab_unh_PharmaceuticalManufacturerRebatesReceivableMember_documentation_en-US" xlink:label="lab_unh_PharmaceuticalManufacturerRebatesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PharmaceuticalManufacturerRebatesReceivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_PharmaceuticalManufacturerRebatesReceivableMember" xlink:href="unh-20211231.xsd#unh_PharmaceuticalManufacturerRebatesReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_PharmaceuticalManufacturerRebatesReceivableMember" xlink:to="lab_unh_PharmaceuticalManufacturerRebatesReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_0fa35139-995b-4881-8d42-b420b2eaa4c0_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value [Text Block]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_e340e212-b9b7-4a1c-b82c-45b861e86904_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CondensedStatementOfIncomeCaptionsLineItems_104c8d3e-bb9a-4fb8-9ccf-b39e35803681_terseLabel_en-US" xlink:label="lab_srt_CondensedStatementOfIncomeCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Statement of Income Captions [Line Items]</link:label>
    <link:label id="lab_srt_CondensedStatementOfIncomeCaptionsLineItems_label_en-US" xlink:label="lab_srt_CondensedStatementOfIncomeCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Statement of Income Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedStatementOfIncomeCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CondensedStatementOfIncomeCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems" xlink:to="lab_srt_CondensedStatementOfIncomeCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d64fba14-b7cd-403f-84f7-f8ac5f6deda2_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue_eb79f89f-57bd-4886-9a1b-37fc2cc2d6b4_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, after 10 Years, Fair Value</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_7fe025aa-7937-43ea-87c9-0b44a8a4c1b7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated amortization</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_c06f4129-bbf4-483a-8cec-6e2256085502_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S [Member]</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_ed667549-c0b5-44e5-943b-0873769aa52b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_39eab405-75f7-4274-8846-a5f8e55e1d9c_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_b7b4d9fe-93d2-43f2-9f7f-9936266a65ab_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_643d3c5f-d339-4769-96c2-1b69922450ca_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_a37d166f-8a27-4099-8de3-b4a31ec14212_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_680bfc4e-1e70-470f-b336-cf2bf4715e19_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_f57d0cec-01c0-45d7-92ba-dfb9db5c022e_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Number of Shares Authorized to be Repurchased</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Number of Shares Authorized to be Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:to="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardExpirationDate_dd3e2308-e475-46f2-85ca-6d8eb1767044_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Expiration Date</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardExpirationDate_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardExpirationDate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardExpirationDate" xlink:to="lab_us-gaap_TaxCreditCarryforwardExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_89665065-145b-4a7a-a759-a528b812a192_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_23651ea7-2f4c-47fc-8c4b-7687099b9dca_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_a70906a6-52f4-41e1-bb7c-a03267829515_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income taxes, net of federal benefit, Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardDateDomain_a0e31fe1-bd6b-4be5-ab44-d6d5af3ef48c_terseLabel_en-US" xlink:label="lab_us-gaap_AwardDateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Domain]</link:label>
    <link:label id="lab_us-gaap_AwardDateDomain_label_en-US" xlink:label="lab_us-gaap_AwardDateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardDateDomain" xlink:to="lab_us-gaap_AwardDateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_68b97401-93d0-4f96-8a6f-f577bfe73b19_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_fdfcef39-737d-440f-be4b-2005eb68f9cb_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_b7214676-56a6-4941-ac91-28ca8f523107_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_ExternalCustomersMember_f2ca034c-64ae-4fdc-984c-8121b36ec8b2_terseLabel_en-US" xlink:label="lab_unh_ExternalCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unaffiliated Customers</link:label>
    <link:label id="lab_unh_ExternalCustomersMember_label_en-US" xlink:label="lab_unh_ExternalCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External Customers [Member]</link:label>
    <link:label id="lab_unh_ExternalCustomersMember_documentation_en-US" xlink:label="lab_unh_ExternalCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External Customers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ExternalCustomersMember" xlink:href="unh-20211231.xsd#unh_ExternalCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_ExternalCustomersMember" xlink:to="lab_unh_ExternalCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CondensedFinancialStatementsCaptionsLineItems_6063c37f-612c-4b5b-9b8c-7a8cc8f0fe95_terseLabel_en-US" xlink:label="lab_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Statements, Captions [Line Items]</link:label>
    <link:label id="lab_srt_CondensedFinancialStatementsCaptionsLineItems_label_en-US" xlink:label="lab_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Statements, Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:to="lab_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_937f0b0f-9f23-46e5-8a5d-590a8319eb6d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, equipment and capitalized software, net of accumulated depreciation and amortization of $5,992 and $5,230</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_4e901509-2bc7-4758-b126-0e3cfbb376c3_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property, equipment and capitalized software, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_d9b622ae-2fcc-4ed3-afcb-424b6a820167_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating costs</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A4.625notesdueJuly2035Member_829eb8b6-09b2-4a04-a9f2-2a009fdb3469_terseLabel_en-US" xlink:label="lab_unh_A4.625notesdueJuly2035Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.625% notes Due July 2035 [Member]</link:label>
    <link:label id="lab_unh_A4.625notesdueJuly2035Member_label_en-US" xlink:label="lab_unh_A4.625notesdueJuly2035Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.625% notes due July 2035 [Member]</link:label>
    <link:label id="lab_unh_A4.625notesdueJuly2035Member_documentation_en-US" xlink:label="lab_unh_A4.625notesdueJuly2035Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.625% notes due July 2035 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.625notesdueJuly2035Member" xlink:href="unh-20211231.xsd#unh_A4.625notesdueJuly2035Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A4.625notesdueJuly2035Member" xlink:to="lab_unh_A4.625notesdueJuly2035Member" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_MedicarePartDReceivablesMember_5be11677-c5e3-4f7e-84dd-dead00aea84e_terseLabel_en-US" xlink:label="lab_unh_MedicarePartDReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Part D Receivables [Member]</link:label>
    <link:label id="lab_unh_MedicarePartDReceivablesMember_label_en-US" xlink:label="lab_unh_MedicarePartDReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Part D Receivables [Member]</link:label>
    <link:label id="lab_unh_MedicarePartDReceivablesMember_documentation_en-US" xlink:label="lab_unh_MedicarePartDReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Part D Receivables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_MedicarePartDReceivablesMember" xlink:href="unh-20211231.xsd#unh_MedicarePartDReceivablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_MedicarePartDReceivablesMember" xlink:to="lab_unh_MedicarePartDReceivablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_85260cb3-7c89-401b-ad57-3720ca6a9d11_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_e3ab7715-8e2f-44fb-b1d6-81ee6fa3323f_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_9867c85a-8a52-47ad-b54f-c2cfb183696a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_47cf856c-3d8b-43f0-bbd9-25e2ddee6f8b_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share attributable to UnitedHealth Group common shareholders:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_FairValueAbstract_55d6fb1d-5662-4e7b-a166-78ddc5730639_terseLabel_en-US" xlink:label="lab_unh_FairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value [Abstract]</link:label>
    <link:label id="lab_unh_FairValueAbstract_label_en-US" xlink:label="lab_unh_FairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value [Abstract]</link:label>
    <link:label id="lab_unh_FairValueAbstract_documentation_en-US" xlink:label="lab_unh_FairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_FairValueAbstract" xlink:href="unh-20211231.xsd#unh_FairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_FairValueAbstract" xlink:to="lab_unh_FairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestTable_46279de0-e132-4b23-92c7-110dfa71acc3_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestTable_label_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestTable" xlink:to="lab_us-gaap_MinorityInterestTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_e3d11baa-a482-46c8-a729-09a436996c1e_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_7e6d6321-b349-4a9e-ad20-acccb9f379e1_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_DividendFrequencyDomain_cfb0f4a9-8d89-4c56-8307-3d6d8c7f76e6_terseLabel_en-US" xlink:label="lab_unh_DividendFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend Frequency [Domain]</link:label>
    <link:label id="lab_unh_DividendFrequencyDomain_label_en-US" xlink:label="lab_unh_DividendFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend Frequency [Domain]</link:label>
    <link:label id="lab_unh_DividendFrequencyDomain_documentation_en-US" xlink:label="lab_unh_DividendFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DividendFrequencyDomain" xlink:href="unh-20211231.xsd#unh_DividendFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_DividendFrequencyDomain" xlink:to="lab_unh_DividendFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A2875NotesDueDecember2021Member_a93a4f93-9fdc-4cce-b67a-e6978be14067_terseLabel_en-US" xlink:label="lab_unh_A2875NotesDueDecember2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.875% Notes Due December 2021 [Member]</link:label>
    <link:label id="lab_unh_A2875NotesDueDecember2021Member_label_en-US" xlink:label="lab_unh_A2875NotesDueDecember2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.875% notes due December 2021 [Member]</link:label>
    <link:label id="lab_unh_A2875NotesDueDecember2021Member_documentation_en-US" xlink:label="lab_unh_A2875NotesDueDecember2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.875% notes due December 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2875NotesDueDecember2021Member" xlink:href="unh-20211231.xsd#unh_A2875NotesDueDecember2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A2875NotesDueDecember2021Member" xlink:to="lab_unh_A2875NotesDueDecember2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_321095f0-7cb0-4a60-add9-a3c55673f82c_terseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices, Statutory Capital and Surplus Required</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices, Statutory Capital and Surplus Required</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:to="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_a986ab20-146d-4d36-8bf7-c74e10a0d25f_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at beginning of period, Weighted-Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_745ddffe-7b3d-4c51-9b22-45f4b96eed13_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period, Weighted-Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_3619fc9f-d8f2-4ab2-91b8-b380ffc78665_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating costs:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_5341d8ed-e852-4e4b-b5a8-f34879a56470_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_TotalOptumMember_d1e2d834-5c05-4a39-a4a0-8aa130f0f7e9_terseLabel_en-US" xlink:label="lab_unh_TotalOptumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Optum</link:label>
    <link:label id="lab_unh_TotalOptumMember_label_en-US" xlink:label="lab_unh_TotalOptumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Optum [Member]</link:label>
    <link:label id="lab_unh_TotalOptumMember_documentation_en-US" xlink:label="lab_unh_TotalOptumMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">total [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_TotalOptumMember" xlink:href="unh-20211231.xsd#unh_TotalOptumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_TotalOptumMember" xlink:to="lab_unh_TotalOptumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_8e197727-a8e1-4a9a-8f75-97a94ae6fcbf_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLongTermDebtCurrent_afb84b75-03fb-415a-bcf7-f8516dd3fe2c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-term Debt, Current</link:label>
    <link:label id="lab_us-gaap_OtherLongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-term Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermDebtCurrent" xlink:to="lab_us-gaap_OtherLongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ee26e575-315e-4360-aa8b-9f1cda48c10e_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes, Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A2.375notesdueAugust2024Member_6a8b3047-896a-40b6-8e1b-02d2c032578d_terseLabel_en-US" xlink:label="lab_unh_A2.375notesdueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.375% notes due August 2024 [Member]</link:label>
    <link:label id="lab_unh_A2.375notesdueAugust2024Member_label_en-US" xlink:label="lab_unh_A2.375notesdueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.375% notes due August 2024 [Member]</link:label>
    <link:label id="lab_unh_A2.375notesdueAugust2024Member_documentation_en-US" xlink:label="lab_unh_A2.375notesdueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.375% notes due August 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2.375notesdueAugust2024Member" xlink:href="unh-20211231.xsd#unh_A2.375notesdueAugust2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A2.375notesdueAugust2024Member" xlink:to="lab_unh_A2.375notesdueAugust2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis_86f8e90c-bfa2-457b-a779-39dd5bdda4d4_terseLabel_en-US" xlink:label="lab_unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant fair value adjustments for assets and liabilities measured on a nonrecurring basis</link:label>
    <link:label id="lab_unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis_label_en-US" xlink:label="lab_unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Adjustments For Nonfinancial Assets And Liabilities Measured At Fair Value Or Financial Assets and Liabilities Non Recurring Basis</link:label>
    <link:label id="lab_unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis_documentation_en-US" xlink:label="lab_unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Adjustments For Nonfinancial Assets And Liabilities Measured At Fair Value Or Financial Assets and Liabilities On Non Recurring Basis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis" xlink:href="unh-20211231.xsd#unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis" xlink:to="lab_unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_2926cfee-7bc7-4079-8c7d-1b137a345316_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_12c52861-0abe-4fb7-b954-c987a1660c2e_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeposits_d849061c-1a6f-4284-b557-879b53994d13_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeposits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer funds administered</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeposits_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeposits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deposits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeposits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeposits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeposits" xlink:to="lab_us-gaap_IncreaseDecreaseInDeposits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardDateAxis_ad8b1814-13cf-4e88-b361-80aebb9adbd6_terseLabel_en-US" xlink:label="lab_us-gaap_AwardDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardDateAxis_label_en-US" xlink:label="lab_us-gaap_AwardDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardDateAxis" xlink:to="lab_us-gaap_AwardDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_fb1d3526-fc4f-425f-b9b3-3edf5f2ed40f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_7dfcf17d-9da2-4061-b170-d86bb2480ca8_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical costs payable</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_d845f57b-97de-4bb4-aecf-f2a7dc9fe2da_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical costs payable, beginning of period</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_6caf03d6-c4d3-4b02-9d35-9607eaeb49fb_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical costs payable, end of period</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_59e6a593-7d55-40e4-9a7a-62653c50524e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_24ff65b9-a76b-45f4-979d-5efb0b1a4328_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted weighted-average number of common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarliestTaxYearMember_f64f3466-2326-417f-88a6-d4be3f35ba99_terseLabel_en-US" xlink:label="lab_us-gaap_EarliestTaxYearMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earliest Tax Year [Member]</link:label>
    <link:label id="lab_us-gaap_EarliestTaxYearMember_label_en-US" xlink:label="lab_us-gaap_EarliestTaxYearMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earliest Tax Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarliestTaxYearMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarliestTaxYearMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarliestTaxYearMember" xlink:to="lab_us-gaap_EarliestTaxYearMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_ad67abef-0743-48ac-9916-05ebaa045ec7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_c33ed2e4-d735-4799-9bcb-6a2ee09b4e0c_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_26c3a2c8-9e70-4ca3-b409-d25399b4c119_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option Activity [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock_750b9619-db3a-4f31-b0af-c405bea05343_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandAndLandImprovements_8e2974bb-4092-41e6-906a-b9d93fd5834b_terseLabel_en-US" xlink:label="lab_us-gaap_LandAndLandImprovements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land and improvements</link:label>
    <link:label id="lab_us-gaap_LandAndLandImprovements_label_en-US" xlink:label="lab_us-gaap_LandAndLandImprovements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land and Land Improvements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandAndLandImprovements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandAndLandImprovements" xlink:to="lab_us-gaap_LandAndLandImprovements" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A3.875notesdueAugust2059Member_cc50f302-0d53-4a80-b550-0f34b041eac8_terseLabel_en-US" xlink:label="lab_unh_A3.875notesdueAugust2059Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.875% notes due August 2059 [Member]</link:label>
    <link:label id="lab_unh_A3.875notesdueAugust2059Member_label_en-US" xlink:label="lab_unh_A3.875notesdueAugust2059Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.875% notes due August 2059 [Member]</link:label>
    <link:label id="lab_unh_A3.875notesdueAugust2059Member_documentation_en-US" xlink:label="lab_unh_A3.875notesdueAugust2059Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.875% notes due August 2059 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.875notesdueAugust2059Member" xlink:href="unh-20211231.xsd#unh_A3.875notesdueAugust2059Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A3.875notesdueAugust2059Member" xlink:to="lab_unh_A3.875notesdueAugust2059Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_fe987d61-3a54-4450-bb06-ff38d5520b44_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total reported medical costs</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_44d22e70-ea93-4670-b9f2-a2fadc48e563_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_dc4a8d36-7506-4dd8-b790-e2bee700f191_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_06b46e57-d76f-4e15-8993-9ad740b46ec8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_4ec9e505-95d5-44c2-903f-eae0a44eccdc_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_ba9f86d4-dfa2-4937-8f6d-a69b65df26e5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A2.875notesdueMarch2022Member_5bdf1c1f-ab3e-4644-93f0-8c48d4cd269d_terseLabel_en-US" xlink:label="lab_unh_A2.875notesdueMarch2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.875% Notes Due March 2022 [Member]</link:label>
    <link:label id="lab_unh_A2.875notesdueMarch2022Member_label_en-US" xlink:label="lab_unh_A2.875notesdueMarch2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.875% notes due March 2022 [Member]</link:label>
    <link:label id="lab_unh_A2.875notesdueMarch2022Member_documentation_en-US" xlink:label="lab_unh_A2.875notesdueMarch2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.875% notes due March 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2.875notesdueMarch2022Member" xlink:href="unh-20211231.xsd#unh_A2.875notesdueMarch2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A2.875notesdueMarch2022Member" xlink:to="lab_unh_A2.875notesdueMarch2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2401f1e8-18a9-45c8-ab99-f05ff4f88651_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_543b958e-378c-482d-944f-c0b53f5e7a4a_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_8ba9f157-8ce6-48fd-b073-47395e5f2c35_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_f7cce043-f8e5-47da-9d00-df34844ae058_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from notes from subsidiary</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Related Party Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_4b7e79d3-d397-4d91-aefa-5646559aed67_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Life in years</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_4fcf96ca-60d3-4f5b-b126-379535aaba99_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_c6f10a03-c1a5-4cb3-a1ad-599c17913549_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_3a4c11c0-188b-4cc0-b221-1733cf1460d4_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Optum Eliminations</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A3.375notesdueApril2027Member_87b05117-34a7-42d4-ba8e-cbd2843bcb1e_terseLabel_en-US" xlink:label="lab_unh_A3.375notesdueApril2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.375% notes due April 2027 [Member]</link:label>
    <link:label id="lab_unh_A3.375notesdueApril2027Member_label_en-US" xlink:label="lab_unh_A3.375notesdueApril2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.375% notes due April 2027 [Member]</link:label>
    <link:label id="lab_unh_A3.375notesdueApril2027Member_documentation_en-US" xlink:label="lab_unh_A3.375notesdueApril2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.375% notes due April 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.375notesdueApril2027Member" xlink:href="unh-20211231.xsd#unh_A3.375notesdueApril2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A3.375notesdueApril2027Member" xlink:to="lab_unh_A3.375notesdueApril2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A3.700notesdueDecember2025Member_e5cf9dd0-e735-430b-8806-e06737495a22_terseLabel_en-US" xlink:label="lab_unh_A3.700notesdueDecember2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.700% notes due December 2025 [Member]</link:label>
    <link:label id="lab_unh_A3.700notesdueDecember2025Member_label_en-US" xlink:label="lab_unh_A3.700notesdueDecember2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.700% notes due December 2025 [Member]</link:label>
    <link:label id="lab_unh_A3.700notesdueDecember2025Member_documentation_en-US" xlink:label="lab_unh_A3.700notesdueDecember2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.700% notes due December 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.700notesdueDecember2025Member" xlink:href="unh-20211231.xsd#unh_A3.700notesdueDecember2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A3.700notesdueDecember2025Member" xlink:to="lab_unh_A3.700notesdueDecember2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_AARPAssetsUnderManagementPolicyTextBlock_a85c3dca-7547-4dc3-9ff5-82f066cf7f42_terseLabel_en-US" xlink:label="lab_unh_AARPAssetsUnderManagementPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AARP Assets Under Management [Policy Text Block]</link:label>
    <link:label id="lab_unh_AARPAssetsUnderManagementPolicyTextBlock_label_en-US" xlink:label="lab_unh_AARPAssetsUnderManagementPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AARP Assets Under Management [Policy Text Block]</link:label>
    <link:label id="lab_unh_AARPAssetsUnderManagementPolicyTextBlock_documentation_en-US" xlink:label="lab_unh_AARPAssetsUnderManagementPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AARP Assets Under Management [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_AARPAssetsUnderManagementPolicyTextBlock" xlink:href="unh-20211231.xsd#unh_AARPAssetsUnderManagementPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_AARPAssetsUnderManagementPolicyTextBlock" xlink:to="lab_unh_AARPAssetsUnderManagementPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReceivableRelatedPartiesNoncurrent_9ccd2263-dd4c-4458-ab2c-9a52ace865d4_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableRelatedPartiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term notes receivable from subsidiaries</link:label>
    <link:label id="lab_us-gaap_NotesReceivableRelatedPartiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_NotesReceivableRelatedPartiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable, Related Parties, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableRelatedPartiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesReceivableRelatedPartiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableRelatedPartiesNoncurrent" xlink:to="lab_us-gaap_NotesReceivableRelatedPartiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_af3a2fdd-4d5a-4d97-b637-f01a835a0a76_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_42684880-70bb-4ff9-b03d-3c98362ec9ca_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest end of period, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_c8185df7-2432-479f-bf4a-adab47ed0908_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_be25017e-a846-487f-b1cf-39b97dc334e6_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount_c94c316d-aed7-4577-9d3f-d353b4674a7e_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, after 10 Years, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_226dec39-a7bb-47b8-8269-26577a22e669_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_37e0fde1-9b0d-478f-903b-56d46425e351_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total medical payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:to="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount_24ea5cdd-4512-40c9-a279-0f07939a1e2e_terseLabel_en-US" xlink:label="lab_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based awards - excess tax benefit, Amount</link:label>
    <link:label id="lab_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount_label_en-US" xlink:label="lab_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Share Based Awards Excess Tax Benefit, Amount</link:label>
    <link:label id="lab_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount_documentation_en-US" xlink:label="lab_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Share Based Awards Excess Tax Benefit, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount" xlink:href="unh-20211231.xsd#unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount" xlink:to="lab_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_14eaa612-d86e-41b8-b5ad-f60787caf791_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation expense related to share awards</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_25b49332-b113-4937-8052-876aa0101669_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_ShareholdersEquityAbstract_99a48556-0df6-4985-87dc-fbab27b40fe7_terseLabel_en-US" xlink:label="lab_unh_ShareholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; equity:</link:label>
    <link:label id="lab_unh_ShareholdersEquityAbstract_label_en-US" xlink:label="lab_unh_ShareholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity [Abstract]</link:label>
    <link:label id="lab_unh_ShareholdersEquityAbstract_documentation_en-US" xlink:label="lab_unh_ShareholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ShareholdersEquityAbstract" xlink:href="unh-20211231.xsd#unh_ShareholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_ShareholdersEquityAbstract" xlink:to="lab_unh_ShareholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_c0bf263f-9d06-4ed5-8183-b5d0b39a484d_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_20335571-f5e8-4ba3-8327-59d358ca0ae6_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_60694bd1-cb3b-4919-96ff-8ad5ff3e0abc_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. tax loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_SuretyBondsOutstanding_4c42e3f8-8381-4269-b3b8-b4c75385ca40_terseLabel_en-US" xlink:label="lab_unh_SuretyBondsOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surety Bonds Outstanding</link:label>
    <link:label id="lab_unh_SuretyBondsOutstanding_label_en-US" xlink:label="lab_unh_SuretyBondsOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surety Bonds Outstanding</link:label>
    <link:label id="lab_unh_SuretyBondsOutstanding_documentation_en-US" xlink:label="lab_unh_SuretyBondsOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surety Bonds Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_SuretyBondsOutstanding" xlink:href="unh-20211231.xsd#unh_SuretyBondsOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_SuretyBondsOutstanding" xlink:to="lab_unh_SuretyBondsOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_36dae3ac-52a5-41d6-a87a-34008bb2ec26_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_3569eb31-8516-4b34-a1c8-3ddf69fd08d3_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Beginning Balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_eca0d7cc-6f00-4805-b6da-77d20c33ca66_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Ending Balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A6.875notesdueFebruary2038Member_6534816a-32ba-45ce-a4ee-f9c2ced0f237_terseLabel_en-US" xlink:label="lab_unh_A6.875notesdueFebruary2038Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.875% notes Due Februray 2038 [Member]</link:label>
    <link:label id="lab_unh_A6.875notesdueFebruary2038Member_label_en-US" xlink:label="lab_unh_A6.875notesdueFebruary2038Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.875% notes due February 2038 [Member]</link:label>
    <link:label id="lab_unh_A6.875notesdueFebruary2038Member_documentation_en-US" xlink:label="lab_unh_A6.875notesdueFebruary2038Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.875% notes due February 2038</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A6.875notesdueFebruary2038Member" xlink:href="unh-20211231.xsd#unh_A6.875notesdueFebruary2038Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A6.875notesdueFebruary2038Member" xlink:to="lab_unh_A6.875notesdueFebruary2038Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_b5498efc-f6aa-4fc3-a4fa-63dfb7cbfd3a_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonredeemable noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventDescription_a32ed8e1-07d0-41bc-a8e0-25d19bf7851f_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event, Description</link:label>
    <link:label id="lab_us-gaap_SubsequentEventDescription_label_en-US" xlink:label="lab_us-gaap_SubsequentEventDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event, Description</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventDescription" xlink:to="lab_us-gaap_SubsequentEventDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_e77f27df-cf83-4b76-96bc-9069470f0544_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign rate differential, Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OpenTaxYear_2e42eabb-5471-43e9-8801-c64cb6a666c4_terseLabel_en-US" xlink:label="lab_us-gaap_OpenTaxYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Tax Year</link:label>
    <link:label id="lab_us-gaap_OpenTaxYear_label_en-US" xlink:label="lab_us-gaap_OpenTaxYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Tax Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OpenTaxYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OpenTaxYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OpenTaxYear" xlink:to="lab_us-gaap_OpenTaxYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_71072fd9-fdec-4b93-a409-39dbf6782f75_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less Than 12 Months, Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_CreditFacilityNameAxis_65283335-a641-4457-9f61-cfff06608081_terseLabel_en-US" xlink:label="lab_unh_CreditFacilityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility Name [Axis]</link:label>
    <link:label id="lab_unh_CreditFacilityNameAxis_label_en-US" xlink:label="lab_unh_CreditFacilityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility Name [Axis]</link:label>
    <link:label id="lab_unh_CreditFacilityNameAxis_documentation_en-US" xlink:label="lab_unh_CreditFacilityNameAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_CreditFacilityNameAxis" xlink:href="unh-20211231.xsd#unh_CreditFacilityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_CreditFacilityNameAxis" xlink:to="lab_unh_CreditFacilityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_40b8b8ce-d951-482e-883f-fc97e1bc9cf4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8287ac1c-24f3-4962-9051-26af58a9f5ee_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash items:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_3d037fbe-3696-460b-905d-891354e70d80_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_22f4fe77-0c25-4344-8440-279fabb4ef4b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A3.700notesdueAugust2049Member_48eaafb4-7644-4204-93c0-61a1a90f1532_terseLabel_en-US" xlink:label="lab_unh_A3.700notesdueAugust2049Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.700% notes due August 2049 [Member]</link:label>
    <link:label id="lab_unh_A3.700notesdueAugust2049Member_label_en-US" xlink:label="lab_unh_A3.700notesdueAugust2049Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.700% notes due August 2049 [Member]</link:label>
    <link:label id="lab_unh_A3.700notesdueAugust2049Member_documentation_en-US" xlink:label="lab_unh_A3.700notesdueAugust2049Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.700% notes due August 2049 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.700notesdueAugust2049Member" xlink:href="unh-20211231.xsd#unh_A3.700notesdueAugust2049Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A3.700notesdueAugust2049Member" xlink:to="lab_unh_A3.700notesdueAugust2049Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_e382fea8-bf7d-4530-8385-5fb515d0392a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in undistributed income of subsidiaries</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments, Net of Dividends or Distributions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_8293ebaf-733c-4664-862d-bc9a75731825_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_fb72e2b7-4911-4479-9a39-99401fa19dfc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_6912a2a4-858a-4b7b-9d99-4cca2955c1f5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater Than 12 Months, Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_9b2b781e-ef7f-4cd7-9f31-d61a3660a365_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_bd2abd30-37c5-424b-b0c6-2867e4608428_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred provision (benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_4437b0dc-f927-4c7e-8c8e-5d9b90ef9ed4_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest end of period, Weighted Average Remaining Contractual Term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_1ad6cf25-8b7f-4e5d-a1bf-4cc62234091d_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_ExtraordinaryDividendsMember_4790e18d-4f66-438c-8129-e02bce511f0d_terseLabel_en-US" xlink:label="lab_unh_ExtraordinaryDividendsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extraordinary Dividends [Member]</link:label>
    <link:label id="lab_unh_ExtraordinaryDividendsMember_label_en-US" xlink:label="lab_unh_ExtraordinaryDividendsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extraordinary Dividends [Member]</link:label>
    <link:label id="lab_unh_ExtraordinaryDividendsMember_documentation_en-US" xlink:label="lab_unh_ExtraordinaryDividendsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extraordinary Dividends [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ExtraordinaryDividendsMember" xlink:href="unh-20211231.xsd#unh_ExtraordinaryDividendsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_ExtraordinaryDividendsMember" xlink:to="lab_unh_ExtraordinaryDividendsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_04e79f80-5fb0-4501-bb21-09791fc8cee6_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax provision at the U.S. federal statutory rate, Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_aed49b8c-6076-450e-a733-06e2395bcccd_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_d3426f44-b1ea-44be-a7e8-1c664faf419b_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Trade Names [Member]</link:label>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:to="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a7d0d9e1-38d3-4ea5-897e-bf28b8065c32_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_73d722cb-68c9-4d73-bd14-2260934f552c_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_4a927483-67f2-4ad7-a3cc-e4acee851dd2_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings attributable to UnitedHealth Group common shareholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_49fb5264-2f40-451d-91b1-886813942212_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings attributable to UnitedHealth Group common shareholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_c66d31f0-c333-4b10-a23f-d4d2aed8272f_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_6401eca5-a5ec-4753-a08d-23f5a275d357_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member_8d107f6a-fcf6-47a6-b1d2-e32380f16a7c_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Accident Year 2020 [Member]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Accident Year 2015 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock_e7f57f02-9e43-4dd4-b410-7f7b8c708d10_terseLabel_en-US" xlink:label="lab_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Information of Parent Company Only Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Information of Parent Company Only Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" xlink:to="lab_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_d5621582-d734-4e78-badc-ebf902dfa47e_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_3f139660-a7a9-48da-8cd5-dcaaadbbcfb6_verboseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Member]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_58be6cff-582c-4fc7-a9bf-0daae6eb6b76_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets, Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_406bd29f-ed82-40af-80ff-919853783ba4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_dde27e2c-4d12-41cd-be4f-470367510e35_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_eef278f9-7893-452a-899a-9983dbaf011f_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A4.375notesdueMarch2042Member_aec70b0f-533b-47d5-bd12-52538684c04a_terseLabel_en-US" xlink:label="lab_unh_A4.375notesdueMarch2042Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.375% notes Due March 2042 [Member]</link:label>
    <link:label id="lab_unh_A4.375notesdueMarch2042Member_label_en-US" xlink:label="lab_unh_A4.375notesdueMarch2042Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.375% notes due March 2042 [Member]</link:label>
    <link:label id="lab_unh_A4.375notesdueMarch2042Member_documentation_en-US" xlink:label="lab_unh_A4.375notesdueMarch2042Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.375% notes due March 2042</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.375notesdueMarch2042Member" xlink:href="unh-20211231.xsd#unh_A4.375notesdueMarch2042Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A4.375notesdueMarch2042Member" xlink:to="lab_unh_A4.375notesdueMarch2042Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_ce1a9005-f1b6-4009-815e-0e5158e4f3e0_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent_216df449-d210-4902-ad11-12983603cc26_terseLabel_en-US" xlink:label="lab_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health insurance industry tax, Percent</link:label>
    <link:label id="lab_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent_label_en-US" xlink:label="lab_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation Nonrefundable Health Insurance Industry Tax Expense, Percent</link:label>
    <link:label id="lab_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent_documentation_en-US" xlink:label="lab_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation Nonrefundable Health Insurance Industry Tax Expense, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent" xlink:href="unh-20211231.xsd#unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent" xlink:to="lab_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_b200aa7e-0db0-48a3-809a-28c26e6bd8f0_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_b57759fe-6a12-473c-a8e9-eb28d3765ddf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures_336923da-9edd-4280-a983-1548fc7c50f3_terseLabel_en-US" xlink:label="lab_unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeiture rate</link:label>
    <link:label id="lab_unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures_label_en-US" xlink:label="lab_unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeitures</link:label>
    <link:label id="lab_unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures_documentation_en-US" xlink:label="lab_unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures" xlink:href="unh-20211231.xsd#unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures" xlink:to="lab_unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_cfd6ce7e-dde9-4920-a27c-2067d98b2a1b_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI and without Readily Determinable Fair Value</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI and without Readily Determinable Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:to="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_31c88e65-7c47-43df-a83d-d1ba130b0b0b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy_439d2acd-9de8-4c80-acd4-2ce0175ae7ea_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Policy Acquisition Costs, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy_label_en-US" xlink:label="lab_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Policy Acquisition Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy" xlink:to="lab_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_02958a14-edfc-4403-a34b-cfa8c6dabfe0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_356370d3-cad6-4b33-bae7-8cf6aafa2fb8_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CondensedBalanceSheetStatementsCaptionsLineItems_1b6c46ef-8aee-46d8-a6b3-4a8f9a5436d2_terseLabel_en-US" xlink:label="lab_srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Balance Sheet Statements, Captions [Line Items]</link:label>
    <link:label id="lab_srt_CondensedBalanceSheetStatementsCaptionsLineItems_label_en-US" xlink:label="lab_srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Balance Sheet Statements, Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CondensedBalanceSheetStatementsCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="lab_srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A4.250notesdueApril2047Member_16d729f9-e3f9-4570-b0e4-1e253dabd099_terseLabel_en-US" xlink:label="lab_unh_A4.250notesdueApril2047Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.250% notes due April 2047 [Member]</link:label>
    <link:label id="lab_unh_A4.250notesdueApril2047Member_label_en-US" xlink:label="lab_unh_A4.250notesdueApril2047Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.250% notes due April 2047 [Member]</link:label>
    <link:label id="lab_unh_A4.250notesdueApril2047Member_documentation_en-US" xlink:label="lab_unh_A4.250notesdueApril2047Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.250% notes due April 2047 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.250notesdueApril2047Member" xlink:href="unh-20211231.xsd#unh_A4.250notesdueApril2047Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A4.250notesdueApril2047Member" xlink:to="lab_unh_A4.250notesdueApril2047Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_8ab166ed-82ea-43b8-8bac-1a35d82a6106_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, after Five Through Ten Years, Fair Value</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_564355c6-cd61-49ba-8a0c-af2ee3548887_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings [Member]</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_f7913743-4a37-4c6a-93f9-8c7c8782eff2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value of restricted shares vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_81fd387d-bf0f-4b0a-b6ac-38bf93c66713_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average grant date fair value per share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_d19982e7-ba13-45ff-b8bc-a155a3daae03_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_23f32bce-2ff6-4ae3-8252-9a247a7fd084_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total unrealized (losses) gains, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_d0371ed5-a841-4706-b192-ed60bd639ea7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_ebd78e58-7c75-43d2-a831-3f8f4dcd95a6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cumulative Medical Payments</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Cumulative Paid Claims and Allocated Claim Adjustment Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_77311878-2a50-47ef-aef3-f7866c9eb62d_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_2c8519a3-4246-4c4f-b571-9e6bceacdfbe_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestChangeInRedemptionValue_5c8b24a9-9529-4cac-b994-9c68050a8695_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable noncontrolling interests fair value and other adjustments</link:label>
    <link:label id="lab_us-gaap_MinorityInterestChangeInRedemptionValue_446a82a5-f494-4a03-9fbb-a35803bc759e_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value and other adjustments</link:label>
    <link:label id="lab_us-gaap_MinorityInterestChangeInRedemptionValue_label_en-US" xlink:label="lab_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Change in Redemption Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestChangeInRedemptionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:to="lab_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_34c03514-8577-4f85-bcd9-b8cd7d071dff_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_c7a2d645-1b19-4770-876a-02c379893ace_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest end of period, Weighted-Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember_d0b2aab1-612f-4df6-9937-a73e8f059149_terseLabel_en-US" xlink:label="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Municipal Obligations [Member]</link:label>
    <link:label id="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember_label_en-US" xlink:label="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US States and Political Subdivisions Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:to="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign_f0e69be0-5ffd-48cb-94e3-8df08ff11da0_negatedTerseLabel_en-US" xlink:label="lab_unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. goodwill and intangible assets</link:label>
    <link:label id="lab_unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign_label_en-US" xlink:label="lab_unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities Goodwill And Intangible Assets, Foreign</link:label>
    <link:label id="lab_unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign_documentation_en-US" xlink:label="lab_unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities Goodwill And Intangible Assets, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign" xlink:href="unh-20211231.xsd#unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign" xlink:to="lab_unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_84889fc3-6bea-4240-ba35-be0036cfd01a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. federal and state net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a49f3c82-6c80-49fe-bba3-52dac0e47c59_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_537bbf3b-6eca-4147-b21a-64ed95ce3668_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_4d834c46-e6cb-4272-8eb6-6976f21e9828_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_DividendFrequencyAxis_f7935233-6866-4a18-9ec7-0a159c6b6842_terseLabel_en-US" xlink:label="lab_unh_DividendFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend Frequency [Axis]</link:label>
    <link:label id="lab_unh_DividendFrequencyAxis_label_en-US" xlink:label="lab_unh_DividendFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend Frequency [Axis]</link:label>
    <link:label id="lab_unh_DividendFrequencyAxis_documentation_en-US" xlink:label="lab_unh_DividendFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend Frequency</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DividendFrequencyAxis" xlink:href="unh-20211231.xsd#unh_DividendFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_DividendFrequencyAxis" xlink:to="lab_unh_DividendFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities_c1d9431c-960a-4c9f-a918-665d62edbc74_terseLabel_en-US" xlink:label="lab_unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nondeductible liabilities</link:label>
    <link:label id="lab_unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities_label_en-US" xlink:label="lab_unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Deferred Tax Expense, Long-term liabilities</link:label>
    <link:label id="lab_unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities_documentation_en-US" xlink:label="lab_unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Deferred Tax Expense, Long-term liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities" xlink:href="unh-20211231.xsd#unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities" xlink:to="lab_unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_a8ab61a3-c253-4880-946c-511391da253a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f16ecc2a-dc30-4e9f-9156-590b76ce746e_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at the beginning of the period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_51cc5b34-0125-494d-ae3f-061f25a11e0e_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at the end of the period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_6f384f69-4084-4d60-8dd1-f569fd8a4911_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentOwnedBalanceContracts_dd9dfc01-4687-4675-9d73-9e9bc56d675d_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentOwnedBalanceContracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total number of security positions</link:label>
    <link:label id="lab_us-gaap_InvestmentOwnedBalanceContracts_label_en-US" xlink:label="lab_us-gaap_InvestmentOwnedBalanceContracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, Balance, Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedBalanceContracts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentOwnedBalanceContracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentOwnedBalanceContracts" xlink:to="lab_us-gaap_InvestmentOwnedBalanceContracts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_b5c6e377-1346-4b56-a815-f66374745763_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_d86d7da1-336a-4a54-b22f-7b7cfd5ee782_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common share repurchases</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_db96f71d-c42a-49e5-a32d-26a2897b4496_verboseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common share repurchases</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation_cefcd22d-67a5-406a-a660-1bbe88d8864c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Other, Accumulated Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_60668ef0-22d5-4774-b076-572ba807e4b7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f7abc3e1-2ba2-4eae-b85f-d9dddbe7cc47_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_da9af92b-a3d6-431c-aa33-717ca0f8a03b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for prior years</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d456749c-a574-4fd1-a654-05a8d4f9f857_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_EquityinNetAssetsofSubsidiaries_616f1ac7-c915-4272-8327-ee6888b5ca03_terseLabel_en-US" xlink:label="lab_unh_EquityinNetAssetsofSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in net assets of subsidiaries</link:label>
    <link:label id="lab_unh_EquityinNetAssetsofSubsidiaries_label_en-US" xlink:label="lab_unh_EquityinNetAssetsofSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in Net Assets of Subsidiaries</link:label>
    <link:label id="lab_unh_EquityinNetAssetsofSubsidiaries_documentation_en-US" xlink:label="lab_unh_EquityinNetAssetsofSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in Net Assets of Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EquityinNetAssetsofSubsidiaries" xlink:href="unh-20211231.xsd#unh_EquityinNetAssetsofSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_EquityinNetAssetsofSubsidiaries" xlink:to="lab_unh_EquityinNetAssetsofSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_0d2849b5-5f0a-45f5-a9c5-753beb4a2faf_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Government and Agency Obligations [Member]</link:label>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_label_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury and Government [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:to="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_fb47f734-7565-4e55-997e-512c716258ed_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_ThreeYear56BillionCreditFacilityMember_8270b222-b3f0-4e8f-89c0-16342ffc400e_terseLabel_en-US" xlink:label="lab_unh_ThreeYear56BillionCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Year $5.6 Billion Credit Facility [Member]</link:label>
    <link:label id="lab_unh_ThreeYear56BillionCreditFacilityMember_label_en-US" xlink:label="lab_unh_ThreeYear56BillionCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Year $5.6 Billion Credit Facility [Member]</link:label>
    <link:label id="lab_unh_ThreeYear56BillionCreditFacilityMember_documentation_en-US" xlink:label="lab_unh_ThreeYear56BillionCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Year $5.6 Billion Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ThreeYear56BillionCreditFacilityMember" xlink:href="unh-20211231.xsd#unh_ThreeYear56BillionCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_ThreeYear56BillionCreditFacilityMember" xlink:to="lab_unh_ThreeYear56BillionCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_DescriptionofBusinessAbstract_0ca1850d-6795-43a3-9782-a17f335999a3_terseLabel_en-US" xlink:label="lab_unh_DescriptionofBusinessAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Business [Abstract]</link:label>
    <link:label id="lab_unh_DescriptionofBusinessAbstract_label_en-US" xlink:label="lab_unh_DescriptionofBusinessAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Business [Abstract]</link:label>
    <link:label id="lab_unh_DescriptionofBusinessAbstract_documentation_en-US" xlink:label="lab_unh_DescriptionofBusinessAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Business [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DescriptionofBusinessAbstract" xlink:href="unh-20211231.xsd#unh_DescriptionofBusinessAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_DescriptionofBusinessAbstract" xlink:to="lab_unh_DescriptionofBusinessAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LatestTaxYearMember_29405864-dd13-4ce8-8dbe-574d5b895d16_terseLabel_en-US" xlink:label="lab_us-gaap_LatestTaxYearMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latest Tax Year [Member]</link:label>
    <link:label id="lab_us-gaap_LatestTaxYearMember_label_en-US" xlink:label="lab_us-gaap_LatestTaxYearMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latest Tax Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LatestTaxYearMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LatestTaxYearMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LatestTaxYearMember" xlink:to="lab_us-gaap_LatestTaxYearMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_c70c37e8-3a5a-49aa-82d3-b3929ba05bbc_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cd68f1d9-148e-49d4-92c5-eb0c9e232fc2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_02260b4f-5723-4682-a5a9-22dc8bf2275f_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentGross" xlink:to="lab_us-gaap_MachineryAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterestAndDividend_f06ea2b6-c218-47ec-92ad-80be99544f52_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment and other income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterestAndDividend_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest and Dividend</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterestAndDividend" xlink:to="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_2e2c10b6-fee6-477f-b2aa-b0472abd3a9f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_803492e8-1c81-4f7c-b43c-8e63467a8ede_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net remaining outstanding liabilities prior to 2020</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net, Not Separately Presented</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_f10cc382-9145-49f3-b5a1-72c729c2981b_terseLabel_en-US" xlink:label="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_label_en-US" xlink:label="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Income Tax Expense (Benefit), Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A3350NotesDueJuly2022Member_e500cd7c-a1fd-4243-8ad4-d625e2cb1e09_terseLabel_en-US" xlink:label="lab_unh_A3350NotesDueJuly2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.350% Notes Due July 2022 [Member]</link:label>
    <link:label id="lab_unh_A3350NotesDueJuly2022Member_label_en-US" xlink:label="lab_unh_A3350NotesDueJuly2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.350% notes due July 2022 [Member]</link:label>
    <link:label id="lab_unh_A3350NotesDueJuly2022Member_documentation_en-US" xlink:label="lab_unh_A3350NotesDueJuly2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.350% notes due July 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3350NotesDueJuly2022Member" xlink:href="unh-20211231.xsd#unh_A3350NotesDueJuly2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A3350NotesDueJuly2022Member" xlink:to="lab_unh_A3350NotesDueJuly2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_cb93c1b1-f36a-4bec-977a-c99e1834d553_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of notes payable to subsidiaries</link:label>
    <link:label id="lab_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_label_en-US" xlink:label="lab_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Related Parties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:to="lab_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_58f87d96-3565-4527-8786-efd7202e20c1_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_c063e58f-8039-4362-bb7c-417b5a14eb2b_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities, redeemable noncontrolling interests and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_a949333e-23ad-42ff-9292-54b07954c085_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_9450513a-6a0f-4551-a60c-b14d17856cba_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net, Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_280590cb-9bcd-409b-b74c-02289ccad773_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_775f2b23-58da-4e7a-b24d-90e9a688ee76_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised, Weighted-Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_9e0569ba-cae1-47dd-9f71-6e8fa5112b76_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount_d5b3c821-c37a-42b4-800b-5173e76ea780_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, within One Year, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A3.375notesdueNovember2021Member_0e8a8840-0616-491a-a7e6-e4c01bb1975d_terseLabel_en-US" xlink:label="lab_unh_A3.375notesdueNovember2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.375% Notes Due November 2021 [Member]</link:label>
    <link:label id="lab_unh_A3.375notesdueNovember2021Member_label_en-US" xlink:label="lab_unh_A3.375notesdueNovember2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.375% notes due November 2021 [Member]</link:label>
    <link:label id="lab_unh_A3.375notesdueNovember2021Member_documentation_en-US" xlink:label="lab_unh_A3.375notesdueNovember2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.375% notes due November 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.375notesdueNovember2021Member" xlink:href="unh-20211231.xsd#unh_A3.375notesdueNovember2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A3.375notesdueNovember2021Member" xlink:to="lab_unh_A3.375notesdueNovember2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_ScheduleIBalanceSheetParentheticalAbstract_d9945328-89f8-403b-afa0-570c60afb78a_terseLabel_en-US" xlink:label="lab_unh_ScheduleIBalanceSheetParentheticalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule I Balance Sheet (Parenthetical) [Abstract]</link:label>
    <link:label id="lab_unh_ScheduleIBalanceSheetParentheticalAbstract_label_en-US" xlink:label="lab_unh_ScheduleIBalanceSheetParentheticalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule I Balance Sheet (Parenthetical) [Abstract]</link:label>
    <link:label id="lab_unh_ScheduleIBalanceSheetParentheticalAbstract_documentation_en-US" xlink:label="lab_unh_ScheduleIBalanceSheetParentheticalAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule I Balance Sheet (Parenthetical) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ScheduleIBalanceSheetParentheticalAbstract" xlink:href="unh-20211231.xsd#unh_ScheduleIBalanceSheetParentheticalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_ScheduleIBalanceSheetParentheticalAbstract" xlink:to="lab_unh_ScheduleIBalanceSheetParentheticalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet_5d855547-59e6-4228-a9d4-e933dfa030fd_totalLabel_en-US" xlink:label="lab_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet_label_en-US" xlink:label="lab_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment Excluding Capitalized Computer Software, Net</link:label>
    <link:label id="lab_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet_documentation_en-US" xlink:label="lab_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment Excluding Capitalized Computer Software, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet" xlink:href="unh-20211231.xsd#unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet" xlink:to="lab_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_13feca09-8572-4c66-9044-fda92ed1b579_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit realized from share-based award exercises</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Exercise of Option, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_88f0cca0-c799-44a6-a802-62dbce297f79_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A3950NotesDueOctober2042Member_ab1309e3-2755-4d7c-8396-bcf15917894f_terseLabel_en-US" xlink:label="lab_unh_A3950NotesDueOctober2042Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.950% notes Due October 2042 [Member]</link:label>
    <link:label id="lab_unh_A3950NotesDueOctober2042Member_label_en-US" xlink:label="lab_unh_A3950NotesDueOctober2042Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.950% notes due October 2042 [Member]</link:label>
    <link:label id="lab_unh_A3950NotesDueOctober2042Member_documentation_en-US" xlink:label="lab_unh_A3950NotesDueOctober2042Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.950% notes due October 2042 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3950NotesDueOctober2042Member" xlink:href="unh-20211231.xsd#unh_A3950NotesDueOctober2042Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A3950NotesDueOctober2042Member" xlink:to="lab_unh_A3950NotesDueOctober2042Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_731373a3-6b08-4d54-950d-75e3d2f93caa_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_df4b8e9c-709c-4443-b9eb-a71f68d3eb08_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common share repurchases, average price per share</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_d45c5c09-15ba-472c-b5e9-39463c84d0eb_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Medical costs payable</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromContributionsFromAffiliates_4a075a33-ff0f-40bf-a8ef-97a4badf7819_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromContributionsFromAffiliates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return of capital to parent company</link:label>
    <link:label id="lab_us-gaap_ProceedsFromContributionsFromAffiliates_label_en-US" xlink:label="lab_us-gaap_ProceedsFromContributionsFromAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Contributions from Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributionsFromAffiliates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromContributionsFromAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromContributionsFromAffiliates" xlink:to="lab_us-gaap_ProceedsFromContributionsFromAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_b3b68e57-0d75-4968-9a71-05305c588b0c_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_b79f68cc-b2b5-4af7-96d4-84634390ac0b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A5.950notesdueFebruary2041Member_208a2015-573f-4b8e-8c5d-21db3bdf1abf_terseLabel_en-US" xlink:label="lab_unh_A5.950notesdueFebruary2041Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.950% notes Due Februrary 2041 [Member]</link:label>
    <link:label id="lab_unh_A5.950notesdueFebruary2041Member_label_en-US" xlink:label="lab_unh_A5.950notesdueFebruary2041Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.950% notes due February 2041 [Member]</link:label>
    <link:label id="lab_unh_A5.950notesdueFebruary2041Member_documentation_en-US" xlink:label="lab_unh_A5.950notesdueFebruary2041Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.950% notes due February 2041</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A5.950notesdueFebruary2041Member" xlink:href="unh-20211231.xsd#unh_A5.950notesdueFebruary2041Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A5.950notesdueFebruary2041Member" xlink:to="lab_unh_A5.950notesdueFebruary2041Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_0c2a040a-af22-411f-9633-33e930cf1e58_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_04e75b2b-a725-4556-818a-65b6f41162d8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2374d86f-3e04-41d9-bf7d-261e33567915_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_ac42e97a-a06d-49f0-bd7a-e2ae629bc838_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating costs</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_e98a135a-beed-485a-81f5-4793f7d275dc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeitures, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_81c9f2db-a6b7-4e96-905b-0f27453d22fe_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_08b5b2a1-f7c2-47b3-9d26-22f6ca757957_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after ten years, Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_4a2e56e4-58bc-41ae-b224-d11c6287ca17_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater Than 12 Months, Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_23756296-31eb-446d-a31f-7f3515b20250_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_85dcf1a3-8858-48d4-8a6b-b23d3acbabfb_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuances of common stock, and related tax effects</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_98e1994b-6a11-4816-ae57-002b8be149a1_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_d853eadc-86c7-4aea-9341-fb9077e3dc79_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for acquisitions, net of cash assumed</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_fec4645f-1b43-4ac1-b0a6-f3f53dd73456_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for acquisitions</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_26d70550-0abe-4bae-8a75-0569cd14f3f0_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Borrowings and Long-Term Debt [Text Block]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_6c736f39-af05-423a-9f19-1ec71db5987c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Losses [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_3e0949cc-df93-47c4-a649-3f7dfcc79c2d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_ef5a0d0c-09dd-4811-be63-978134b72443_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_be3fdb96-b5d6-413c-84d5-06ce324dfcb0_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_FloatingratenotesdueJune2021Member_07caf325-f6e2-4d1a-a165-76d986843785_terseLabel_en-US" xlink:label="lab_unh_FloatingratenotesdueJune2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating rate notes due June 2021 [Member]</link:label>
    <link:label id="lab_unh_FloatingratenotesdueJune2021Member_label_en-US" xlink:label="lab_unh_FloatingratenotesdueJune2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating rate notes due June 2021 [Member]</link:label>
    <link:label id="lab_unh_FloatingratenotesdueJune2021Member_documentation_en-US" xlink:label="lab_unh_FloatingratenotesdueJune2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating rate notes due June 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_FloatingratenotesdueJune2021Member" xlink:href="unh-20211231.xsd#unh_FloatingratenotesdueJune2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_FloatingratenotesdueJune2021Member" xlink:to="lab_unh_FloatingratenotesdueJune2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_54416f13-5e6e-4737-b0ea-b020ff28926c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unobservable Inputs (Level 3) [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_759d2604-004f-4d6b-983f-58e6d1ebe8d7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_a29a652a-8b7c-461d-8a19-d2c884c39aa0_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_429fd9d6-e52c-4ff9-899f-986a8a64383c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebtCurrent_6c25f380-9bc7-4a19-ad7c-6bdf71018bfc_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt, Current</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebtCurrent_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebtCurrent" xlink:to="lab_us-gaap_UnsecuredDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_ProductsandservicesMember_020e7539-5582-4e9b-a8b1-0249541856f3_terseLabel_en-US" xlink:label="lab_unh_ProductsandservicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products and services [Member]</link:label>
    <link:label id="lab_unh_ProductsandservicesMember_label_en-US" xlink:label="lab_unh_ProductsandservicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products and services [Member]</link:label>
    <link:label id="lab_unh_ProductsandservicesMember_documentation_en-US" xlink:label="lab_unh_ProductsandservicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products and services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ProductsandservicesMember" xlink:href="unh-20211231.xsd#unh_ProductsandservicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_ProductsandservicesMember" xlink:to="lab_unh_ProductsandservicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_ecaf3a24-2490-49d2-9078-c6014e2d9586_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuances of common stock, and related tax effects (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_cd0c258c-bccf-42ef-b1d5-7cc04787cf90_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable_1b2fbdcf-358f-49cb-861b-0e81c3fd79cb_terseLabel_en-US" xlink:label="lab_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Table]</link:label>
    <link:label id="lab_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable_label_en-US" xlink:label="lab_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable" xlink:to="lab_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_16511247-9fdf-44b7-9e5d-56ac25d0f3d6_verboseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undrawn Letters Of Credit</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_c1b00334-53d4-4bdb-a0ce-92099184480c_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_fe4270a8-28eb-432d-b331-3c681a9f6e01_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_cee5ed78-a311-427c-a640-67de1a80981b_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 12)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_7df23a4c-e6ca-4d6e-b27d-5afe8ccaeb1d_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 4)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_dc84ae12-2f1d-4f5e-87d3-65f631a3ddb6_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy_0e562c41-a6c3-40eb-a7dd-59600438e44b_terseLabel_en-US" xlink:label="lab_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Costs and Medical Costs Payable [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpaid Policy Claims and Claims Adjustment Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" xlink:to="lab_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_91109f42-e866-4033-bc17-82bebe5573d9_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_011065b8-8c06-40ca-a7d1-4adae351a4d8_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_2d727ad2-78b9-4a31-b4e5-366bc55eac88_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_254db36d-9883-40e1-b49b-a3df2a7a65e4_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts, accounts receivable</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_Capitalcontributionstosubsidiaries_b9af0b12-4453-402b-856d-fd9d337f1309_negatedTerseLabel_en-US" xlink:label="lab_unh_Capitalcontributionstosubsidiaries" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital contributions to subsidiaries</link:label>
    <link:label id="lab_unh_Capitalcontributionstosubsidiaries_label_en-US" xlink:label="lab_unh_Capitalcontributionstosubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital contributions to subsidiaries</link:label>
    <link:label id="lab_unh_Capitalcontributionstosubsidiaries_documentation_en-US" xlink:label="lab_unh_Capitalcontributionstosubsidiaries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital contributions to subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_Capitalcontributionstosubsidiaries" xlink:href="unh-20211231.xsd#unh_Capitalcontributionstosubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_Capitalcontributionstosubsidiaries" xlink:to="lab_unh_Capitalcontributionstosubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_225613a5-b413-4d87-831e-805bba37d989_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_6b411c38-0fb9-454f-8338-c66364cd15a3_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-13</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-13 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_e37d8dea-378f-40b0-9de3-e0e5b6a63f27_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGain_c89c9ed2-f17f-454f-a6ef-bf60a7d0e046_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Gain</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGain_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:to="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_DeferredTaxLiabilityOtherDomestic_ced8435b-6a9b-4d1e-a69a-5151114ba10f_negatedTerseLabel_en-US" xlink:label="lab_unh_DeferredTaxLiabilityOtherDomestic" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other-domestic</link:label>
    <link:label id="lab_unh_DeferredTaxLiabilityOtherDomestic_label_en-US" xlink:label="lab_unh_DeferredTaxLiabilityOtherDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liability, Other Domestic</link:label>
    <link:label id="lab_unh_DeferredTaxLiabilityOtherDomestic_documentation_en-US" xlink:label="lab_unh_DeferredTaxLiabilityOtherDomestic" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liability, Other Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxLiabilityOtherDomestic" xlink:href="unh-20211231.xsd#unh_DeferredTaxLiabilityOtherDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_DeferredTaxLiabilityOtherDomestic" xlink:to="lab_unh_DeferredTaxLiabilityOtherDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_fb89657d-6ef5-4b6a-ab4e-9ce074f3259c_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating costs</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_9e2a4b09-181d-454a-8056-5dd39bac6d7d_verboseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating costs</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsMember_1959cca4-49de-4c3a-b372-00a3a47015d4_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments</link:label>
    <link:label id="lab_us-gaap_CommitmentsMember_label_en-US" xlink:label="lab_us-gaap_CommitmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsMember" xlink:to="lab_us-gaap_CommitmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_2bab327b-51b6-4800-88bb-3836dd7f8b32_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_027060f7-642a-420e-95bc-25a26dbf41ca_terseLabel_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and other financing obligations, carrying value</link:label>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_3ba08e30-1050-45bc-889a-102115442ccd_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value</link:label>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_label_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Long-term and Short-term, Combined Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:to="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_721987db-a90d-4282-a73f-5a48104200d7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A2875NotesDueMarch2023Member_cd7e6b17-b667-4552-98d2-6c4c67f98257_terseLabel_en-US" xlink:label="lab_unh_A2875NotesDueMarch2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.875% Notes Due March 2023 [Member]</link:label>
    <link:label id="lab_unh_A2875NotesDueMarch2023Member_label_en-US" xlink:label="lab_unh_A2875NotesDueMarch2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.875% notes due March 2023 [Member]</link:label>
    <link:label id="lab_unh_A2875NotesDueMarch2023Member_documentation_en-US" xlink:label="lab_unh_A2875NotesDueMarch2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.875% notes due March 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2875NotesDueMarch2023Member" xlink:href="unh-20211231.xsd#unh_A2875NotesDueMarch2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A2875NotesDueMarch2023Member" xlink:to="lab_unh_A2875NotesDueMarch2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock_b9d8c8d1-3b93-41a4-8f00-a0af867cac6c_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Cash Flow Statement [Table Text Block]</link:label>
    <link:label id="lab_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Cash Flow Statement [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfCondensedCashFlowStatementTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:to="lab_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_f93f1ff2-9d1f-4e2d-a27e-0979d3b40324_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax effect</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_ba3d0fa6-6ec4-4256-9124-51393500df36_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent_c5ec3b5d-8f6a-478e-91db-1ce94a5ea138_terseLabel_en-US" xlink:label="lab_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based awards - excess tax benefit, Percent</link:label>
    <link:label id="lab_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent_label_en-US" xlink:label="lab_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Share Based Awards Excess Tax Benefit, Percent</link:label>
    <link:label id="lab_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent_documentation_en-US" xlink:label="lab_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Share Based Awards Excess Tax Benefit, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent" xlink:href="unh-20211231.xsd#unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent" xlink:to="lab_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_d828fd77-fbdb-4435-b766-b68cee4694a3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_fc9a5f26-e5ff-4af4-b2e3-cc9a124fcec8_negatedLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_9fee6ca4-f50b-4689-851f-5610678b8cb1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_49f546d3-fd01-4c76-981d-3f08b6dd24a0_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical payments:</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_0bf1c8af-d9be-44e8-a4e6-fd13faf5c7e3_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_168663db-0c01-468a-901d-321b44f79259_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_2f0eaba2-050d-44be-8ce4-13cc31d4f284_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_41331509-b968-4e1c-b9f9-b902e21a9b9e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract_f76e78bc-f505-4ddf-84fc-bbdfbf3f0901_terseLabel_en-US" xlink:label="lab_unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Days Notice Required To Cancel Health Insurance Contract</link:label>
    <link:label id="lab_unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract_label_en-US" xlink:label="lab_unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Days Notice Required To Cancel Health Insurance Contract</link:label>
    <link:label id="lab_unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract_documentation_en-US" xlink:label="lab_unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Days Notice Required To Cancel Health Insurance Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract" xlink:href="unh-20211231.xsd#unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract" xlink:to="lab_unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_NOLsExpirationBeginning2022Through2037Member_9356885d-be00-4c5d-bec5-d2dbcdb74720_terseLabel_en-US" xlink:label="lab_unh_NOLsExpirationBeginning2022Through2037Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived NOL carryforwards [Member]</link:label>
    <link:label id="lab_unh_NOLsExpirationBeginning2022Through2037Member_label_en-US" xlink:label="lab_unh_NOLsExpirationBeginning2022Through2037Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NOLsExpirationBeginning2022Through2037 [Member]</link:label>
    <link:label id="lab_unh_NOLsExpirationBeginning2022Through2037Member_documentation_en-US" xlink:label="lab_unh_NOLsExpirationBeginning2022Through2037Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NOLs expiration beginning 2022 through 2037</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_NOLsExpirationBeginning2022Through2037Member" xlink:href="unh-20211231.xsd#unh_NOLsExpirationBeginning2022Through2037Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_NOLsExpirationBeginning2022Through2037Member" xlink:to="lab_unh_NOLsExpirationBeginning2022Through2037Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_a3f11969-4919-4eba-a317-5c7e71f047e3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_aa5e17eb-9be3-4d03-8eff-6eabb00c4d44_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense, before tax</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMember_af7cc63c-95fa-4a6d-828c-73477c4eae34_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt and other financing obligations [Member]</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMember_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMember" xlink:to="lab_us-gaap_LongTermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_3957f44f-82ef-4be2-a591-93f4b66f4979_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_4f61b318-d0e0-4959-83f7-1390fa881718_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_ff3e49cf-c31f-4a29-b989-15a8013f43ab_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, end of period</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_e0bc4895-1461-4eff-aff3-d7f4a1b8ce20_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A4.200notesdueJanuary2047Member_a0629e85-b819-4bcc-995a-c5ecab8c1983_terseLabel_en-US" xlink:label="lab_unh_A4.200notesdueJanuary2047Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.200% notes due January 2047 [Member]</link:label>
    <link:label id="lab_unh_A4.200notesdueJanuary2047Member_label_en-US" xlink:label="lab_unh_A4.200notesdueJanuary2047Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.200% notes due January 2047 [Member]</link:label>
    <link:label id="lab_unh_A4.200notesdueJanuary2047Member_documentation_en-US" xlink:label="lab_unh_A4.200notesdueJanuary2047Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.200% notes due January 2047</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.200notesdueJanuary2047Member" xlink:href="unh-20211231.xsd#unh_A4.200notesdueJanuary2047Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A4.200notesdueJanuary2047Member" xlink:to="lab_unh_A4.200notesdueJanuary2047Member" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_PharmaceuticalmanufacturerrebatesreceivableAxis_fc2b5d0a-3140-4d0a-ba19-2631b8d26bb7_terseLabel_en-US" xlink:label="lab_unh_PharmaceuticalmanufacturerrebatesreceivableAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical manufacturer rebates receivable [Axis]</link:label>
    <link:label id="lab_unh_PharmaceuticalmanufacturerrebatesreceivableAxis_label_en-US" xlink:label="lab_unh_PharmaceuticalmanufacturerrebatesreceivableAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical manufacturer rebates receivable [Axis]</link:label>
    <link:label id="lab_unh_PharmaceuticalmanufacturerrebatesreceivableAxis_documentation_en-US" xlink:label="lab_unh_PharmaceuticalmanufacturerrebatesreceivableAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical manufacturer rebates receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_PharmaceuticalmanufacturerrebatesreceivableAxis" xlink:href="unh-20211231.xsd#unh_PharmaceuticalmanufacturerrebatesreceivableAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_PharmaceuticalmanufacturerrebatesreceivableAxis" xlink:to="lab_unh_PharmaceuticalmanufacturerrebatesreceivableAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_e212e9bb-fa5d-49ec-8ab2-43b37a378401_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation, Recorded Liability</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Liability, Classified, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:to="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_DeferredTaxAssetOtherDomestic_8d41913a-9d67-4094-ac74-5e74a1d755ab_terseLabel_en-US" xlink:label="lab_unh_DeferredTaxAssetOtherDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other-domestic</link:label>
    <link:label id="lab_unh_DeferredTaxAssetOtherDomestic_label_en-US" xlink:label="lab_unh_DeferredTaxAssetOtherDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Other Domestic</link:label>
    <link:label id="lab_unh_DeferredTaxAssetOtherDomestic_documentation_en-US" xlink:label="lab_unh_DeferredTaxAssetOtherDomestic" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Other Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxAssetOtherDomestic" xlink:href="unh-20211231.xsd#unh_DeferredTaxAssetOtherDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_DeferredTaxAssetOtherDomestic" xlink:to="lab_unh_DeferredTaxAssetOtherDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4fa14334-d2dc-48b7-9155-006b7ff06af0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property, equipment and capitalized software</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_dd440b88-ef65-4a80-84ec-4025b0bd02ce_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property, equipment and capitalized software</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_e8129a10-7c3b-405f-a319-e1c14cafaaf2_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_e81145d3-59d6-4b7a-82b4-9e2512aef907_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_4f2e67db-c847-4060-bdbf-c4a1547452ac_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Accident Year [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Accident Year [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_446cb331-bf59-4304-89c1-afab3f630f38_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax effect</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_4f245e62-47b9-44b5-aa1e-bd11c4bda24d_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_bbe20827-b439-451f-9ffa-03720e9926f4_terseLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_6aa99b81-d664-4afe-a5c0-36c8a04fac18_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_76278087-681b-4a0c-a06a-185b297d943a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted, Weighted-Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_e79059cc-853c-41c7-bcc1-ea03a8396373_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_288a2106-75c3-4ee2-ad04-01ce472010b2_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_c2e5a1bd-60ad-4e56-9054-9713f232bebb_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_ba3ac9da-5518-44cb-9b92-c2cebc42cc78_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_d36e5b13-b97a-4c75-bfc7-9fd74ea411da_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_44e2b5e2-4ea6-412a-99ed-6501ca891449_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A2000NotesDueMay2030Member_c8285e25-cd3d-4b83-b387-bc6ed919aa45_terseLabel_en-US" xlink:label="lab_unh_A2000NotesDueMay2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.000% notes due May 2030 [Member]</link:label>
    <link:label id="lab_unh_A2000NotesDueMay2030Member_label_en-US" xlink:label="lab_unh_A2000NotesDueMay2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.000% notes due May 2030 [Member]</link:label>
    <link:label id="lab_unh_A2000NotesDueMay2030Member_documentation_en-US" xlink:label="lab_unh_A2000NotesDueMay2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.000% notes due May 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2000NotesDueMay2030Member" xlink:href="unh-20211231.xsd#unh_A2000NotesDueMay2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A2000NotesDueMay2030Member" xlink:to="lab_unh_A2000NotesDueMay2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_f5cf3a7b-e550-418c-acd2-51b84966edd4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsDescription_50a05cba-e44a-4a0b-a2a9-c4b411f547ab_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments, Description</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsDescription_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments, Description</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsDescription" xlink:to="lab_us-gaap_OtherCommitmentsDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAbstract_b7a597c8-36db-4901-aec9-bd38f88f322e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_1f051ece-8313-4849-a2e9-4df04038577a_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_4ef9b2d6-49b9-41ed-b7f3-820ab37c3aae_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_9c7ac0f5-de3d-4d25-bc82-b07dd62f865b_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-02 [Member]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-02 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_67c0216c-3158-46f2-9755-9232245e5d69_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_6bdeb6e5-6414-4a31-bba5-534690d4aed7_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_0c4386d2-e2af-4a7c-97f2-a97d2ec0ee00_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_RedeemableNoncontrollingInterestsMember_0c963622-4e79-4089-ae49-60e37f757fa5_terseLabel_en-US" xlink:label="lab_unh_RedeemableNoncontrollingInterestsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests [Member]</link:label>
    <link:label id="lab_unh_RedeemableNoncontrollingInterestsMember_label_en-US" xlink:label="lab_unh_RedeemableNoncontrollingInterestsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests [Member]</link:label>
    <link:label id="lab_unh_RedeemableNoncontrollingInterestsMember_documentation_en-US" xlink:label="lab_unh_RedeemableNoncontrollingInterestsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_RedeemableNoncontrollingInterestsMember" xlink:href="unh-20211231.xsd#unh_RedeemableNoncontrollingInterestsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_RedeemableNoncontrollingInterestsMember" xlink:to="lab_unh_RedeemableNoncontrollingInterestsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_ca640f9e-f998-4cc5-b077-50200d7180a1_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_f5e2f6ce-fcaf-41f0-aa17-64dbf0baf320_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationLineItems_64ad0b23-1c39-44d5-9a8a-55ee45edf24d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems" xlink:to="lab_us-gaap_IncomeTaxExaminationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_942693e7-7148-4d53-8602-2501c49cee1a_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Plan Award, Options, Award Exercisable Period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_db8d5c41-8936-4f2d-963f-8c4db8997eeb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_f80208f1-e61f-4bb4-8345-e7ecdd514d4a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares purchased</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A3.500notesdueJune2023Member_5f234ab1-eaa6-48a0-983f-ba791bd63719_terseLabel_en-US" xlink:label="lab_unh_A3.500notesdueJune2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.500% notes due June 2023 [Member]</link:label>
    <link:label id="lab_unh_A3.500notesdueJune2023Member_label_en-US" xlink:label="lab_unh_A3.500notesdueJune2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.500% notes due June 2023 [Member]</link:label>
    <link:label id="lab_unh_A3.500notesdueJune2023Member_documentation_en-US" xlink:label="lab_unh_A3.500notesdueJune2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.500% notes due June 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.500notesdueJune2023Member" xlink:href="unh-20211231.xsd#unh_A3.500notesdueJune2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A3.500notesdueJune2023Member" xlink:to="lab_unh_A3.500notesdueJune2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_f6d5c234-c4dc-4b39-b079-19fc3918894b_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_d22a3a1d-984d-4b99-a837-484b37f87f3b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_7892285c-76d5-4ed7-9b07-e5b0b04d6d39_terseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices, Statutory Capital and Surplus, Balance</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices, Statutory Capital and Surplus, Balance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:to="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareNet_2087be6b-ed80-4220-99b4-6639810da662_totalLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software, net</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareNet_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareNet" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_68c6db47-8b93-4755-af0d-7c61be3c27fd_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_OptumrxMember_c432779b-5506-467e-9977-d33766078305_terseLabel_en-US" xlink:label="lab_unh_OptumrxMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Optum Rx</link:label>
    <link:label id="lab_unh_OptumrxMember_label_en-US" xlink:label="lab_unh_OptumrxMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Optumrx [Member]</link:label>
    <link:label id="lab_unh_OptumrxMember_documentation_en-US" xlink:label="lab_unh_OptumrxMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OptumRx [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OptumrxMember" xlink:href="unh-20211231.xsd#unh_OptumrxMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_OptumrxMember" xlink:to="lab_unh_OptumrxMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d67d86e9-85d6-4b21-9f0b-b92143c2aa8c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_81195db6-e35f-43f1-b216-11e8d811c677_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_db1a8c40-2a0c-4a5d-a83d-e76a30a040c3_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9988a849-dd77-41dc-bd4c-026aee457d58_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_573bb39b-e415-4078-aa4b-8b8d5dd20f5a_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_de47db36-965d-4273-a607-6d24e670fa1b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_5ca5d095-0983-4431-938a-508dde117ba2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_3048bc1e-c810-4c95-b8fc-e86328bfce78_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_ZeroCouponNotesDueNovember2022Member_b959876e-f45f-492f-a999-768f023cd075_terseLabel_en-US" xlink:label="lab_unh_ZeroCouponNotesDueNovember2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.000% Notes Due November 2022 [Member]</link:label>
    <link:label id="lab_unh_ZeroCouponNotesDueNovember2022Member_label_en-US" xlink:label="lab_unh_ZeroCouponNotesDueNovember2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zero Coupon notes due November 2022 [Member]</link:label>
    <link:label id="lab_unh_ZeroCouponNotesDueNovember2022Member_documentation_en-US" xlink:label="lab_unh_ZeroCouponNotesDueNovember2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zero Coupon notes due November 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ZeroCouponNotesDueNovember2022Member" xlink:href="unh-20211231.xsd#unh_ZeroCouponNotesDueNovember2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_ZeroCouponNotesDueNovember2022Member" xlink:to="lab_unh_ZeroCouponNotesDueNovember2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_151afc88-5abd-4242-a35a-06ad5082d8f2_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_76017186-f37a-4952-9c27-b2160038ae03_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported medical costs:</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_797284f6-5abb-4680-8d8a-bdc21b188f52_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Financial Information [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_f4916fb9-1133-48a6-9828-0e37568375df_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_902de89a-3ad4-44c5-b161-f26fa81f2985_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_d1db09f2-76fd-401a-84d2-f74cb3edecc7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total foreign currency translation losses</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_d920398e-06e5-419b-b00c-17901f269d77_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CondensedStatementOfComprehensiveIncomeTable_4f08ad32-d215-4d15-aac7-673df0c0392e_terseLabel_en-US" xlink:label="lab_srt_CondensedStatementOfComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Statement of Comprehensive Income [Table]</link:label>
    <link:label id="lab_srt_CondensedStatementOfComprehensiveIncomeTable_label_en-US" xlink:label="lab_srt_CondensedStatementOfComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Statement of Comprehensive Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedStatementOfComprehensiveIncomeTable" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CondensedStatementOfComprehensiveIncomeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedStatementOfComprehensiveIncomeTable" xlink:to="lab_srt_CondensedStatementOfComprehensiveIncomeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_76adeca3-b117-4eb9-9d87-531cb3ece28a_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_7ef41b02-6f56-4e31-933b-105943a9bf6c_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_67f0710c-609a-4e1e-a36b-677121211696_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_cbae2b36-9ea2-4d96-804e-2956882a245c_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_InvestmentTable_b4a7739f-004f-4cdf-a911-d0d0a0bd4586_terseLabel_en-US" xlink:label="lab_unh_InvestmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment [Table]</link:label>
    <link:label id="lab_unh_InvestmentTable_label_en-US" xlink:label="lab_unh_InvestmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment [Table]</link:label>
    <link:label id="lab_unh_InvestmentTable_documentation_en-US" xlink:label="lab_unh_InvestmentTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This table lists the investments. The line items identify information about the investment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_InvestmentTable" xlink:href="unh-20211231.xsd#unh_InvestmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_InvestmentTable" xlink:to="lab_unh_InvestmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAbstract_b300c119-e4e5-414d-ad08-8e48fe50f7c1_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A2900NotesDueMay2050Member_ec4207cb-03d4-4773-8d19-26739c94b3e9_terseLabel_en-US" xlink:label="lab_unh_A2900NotesDueMay2050Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.900% notes due May 2050 [Member]</link:label>
    <link:label id="lab_unh_A2900NotesDueMay2050Member_label_en-US" xlink:label="lab_unh_A2900NotesDueMay2050Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.900% notes due May 2050 [Member]</link:label>
    <link:label id="lab_unh_A2900NotesDueMay2050Member_documentation_en-US" xlink:label="lab_unh_A2900NotesDueMay2050Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.900% notes due May 2050</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2900NotesDueMay2050Member" xlink:href="unh-20211231.xsd#unh_A2900NotesDueMay2050Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A2900NotesDueMay2050Member" xlink:to="lab_unh_A2900NotesDueMay2050Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_d1e52f89-b7cf-4259-a731-b9d246e02411_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_07583559-e773-45fd-8fad-3ecd56ef3e23_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_4665c141-b9df-4c7d-9a17-333377e660f5_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_5e78c279-755c-44ee-b37a-aba198e247e1_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal [Member]</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A5.700notesdueOctober2040Member_f7a95d50-7b4b-4a6e-a1d1-7388f97a9acf_terseLabel_en-US" xlink:label="lab_unh_A5.700notesdueOctober2040Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.700% notes Due October 2040 [Member]</link:label>
    <link:label id="lab_unh_A5.700notesdueOctober2040Member_label_en-US" xlink:label="lab_unh_A5.700notesdueOctober2040Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.700% notes due October 2040 [Member]</link:label>
    <link:label id="lab_unh_A5.700notesdueOctober2040Member_documentation_en-US" xlink:label="lab_unh_A5.700notesdueOctober2040Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.700% notes due October 2040</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A5.700notesdueOctober2040Member" xlink:href="unh-20211231.xsd#unh_A5.700notesdueOctober2040Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A5.700notesdueOctober2040Member" xlink:to="lab_unh_A5.700notesdueOctober2040Member" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_CapitalizedsoftwareMember_084ceda7-d6cf-4256-a30d-090aa03de1b0_terseLabel_en-US" xlink:label="lab_unh_CapitalizedsoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software [Member]</link:label>
    <link:label id="lab_unh_CapitalizedsoftwareMember_label_en-US" xlink:label="lab_unh_CapitalizedsoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software [Member]</link:label>
    <link:label id="lab_unh_CapitalizedsoftwareMember_documentation_en-US" xlink:label="lab_unh_CapitalizedsoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_CapitalizedsoftwareMember" xlink:href="unh-20211231.xsd#unh_CapitalizedsoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_CapitalizedsoftwareMember" xlink:to="lab_unh_CapitalizedsoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3fcd9e02-e3ee-41d4-be64-4eafeb59b8b4_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_13ee22c2-95d6-4dfa-bb24-b6b409ea5dce_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A0550NotesDueMay2024Member_3563d72a-312c-4632-b341-760cfcf08c15_terseLabel_en-US" xlink:label="lab_unh_A0550NotesDueMay2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.550% notes due May 2024 [Member]</link:label>
    <link:label id="lab_unh_A0550NotesDueMay2024Member_label_en-US" xlink:label="lab_unh_A0550NotesDueMay2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.550% notes due May 2024 [Member]</link:label>
    <link:label id="lab_unh_A0550NotesDueMay2024Member_documentation_en-US" xlink:label="lab_unh_A0550NotesDueMay2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.550% notes due May 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A0550NotesDueMay2024Member" xlink:href="unh-20211231.xsd#unh_A0550NotesDueMay2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A0550NotesDueMay2024Member" xlink:to="lab_unh_A0550NotesDueMay2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodAxis_e0439bb8-cbc7-41fa-9265-889d2ae913ee_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodAxis_label_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodAxis" xlink:to="lab_us-gaap_TaxPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d0d2ee50-4b05-4ab1-9005-6c32cd526f68_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_cef6d652-32f4-481d-8b45-0aaf0fd2b964_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: valuation allowances</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_CoverPageAbstract_d1c9d6d5-4330-4694-9378-7383179f985d_terseLabel_en-US" xlink:label="lab_unh_CoverPageAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover Page [Abstract]</link:label>
    <link:label id="lab_unh_CoverPageAbstract_label_en-US" xlink:label="lab_unh_CoverPageAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover Page [Abstract]</link:label>
    <link:label id="lab_unh_CoverPageAbstract_documentation_en-US" xlink:label="lab_unh_CoverPageAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover Page [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_CoverPageAbstract" xlink:href="unh-20211231.xsd#unh_CoverPageAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_CoverPageAbstract" xlink:to="lab_unh_CoverPageAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_f17f4b89-b2fa-4e46-8900-e58b5eb1c3de_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate and Eliminations</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredLongTermDebt_da4ffafa-8901-4d56-8ce7-c48f0bb1831f_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Long-term Debt, Noncurrent</link:label>
    <link:label id="lab_us-gaap_UnsecuredLongTermDebt_label_en-US" xlink:label="lab_us-gaap_UnsecuredLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Long-term Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredLongTermDebt" xlink:to="lab_us-gaap_UnsecuredLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_3482514c-945f-4479-bbef-f36433d46dce_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue_48241356-02ee-481a-9c69-60b4bc298d90_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, within One Year, Fair Value</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_cd2e8b6f-f11b-4a2e-9ef0-69918991a041_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_a4d484ae-e291-449a-b0a8-ad4c54ce3b11_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A3.850notesdueJune2028Member_827445d5-a9d4-4f01-af27-3c86d7243b71_terseLabel_en-US" xlink:label="lab_unh_A3.850notesdueJune2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.850% notes due June 2028 [Member]</link:label>
    <link:label id="lab_unh_A3.850notesdueJune2028Member_label_en-US" xlink:label="lab_unh_A3.850notesdueJune2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.850% notes due June 2028 [Member]</link:label>
    <link:label id="lab_unh_A3.850notesdueJune2028Member_documentation_en-US" xlink:label="lab_unh_A3.850notesdueJune2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.850% notes due June 2028 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.850notesdueJune2028Member" xlink:href="unh-20211231.xsd#unh_A3.850notesdueJune2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A3.850notesdueJune2028Member" xlink:to="lab_unh_A3.850notesdueJune2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_ed51ae6a-0380-4ca0-a5ae-5842aa443340_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from common stock issuances</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_b14d7780-af9c-46fd-ac72-b220de9c6d50_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_43cfb769-8973-42cb-a7ef-ceedff402d63_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_0f85c787-ed39-4e86-aec3-e02e1b68a206_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A6500NotesDueJune2037Member_d963e87d-5110-462e-8134-8dbb4e38a1f6_terseLabel_en-US" xlink:label="lab_unh_A6500NotesDueJune2037Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.500% notes Due June 2037 [Member]</link:label>
    <link:label id="lab_unh_A6500NotesDueJune2037Member_label_en-US" xlink:label="lab_unh_A6500NotesDueJune2037Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.500% notes due June 2037 [Member]</link:label>
    <link:label id="lab_unh_A6500NotesDueJune2037Member_documentation_en-US" xlink:label="lab_unh_A6500NotesDueJune2037Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.500% notes due June 2037 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A6500NotesDueJune2037Member" xlink:href="unh-20211231.xsd#unh_A6500NotesDueJune2037Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A6500NotesDueJune2037Member" xlink:to="lab_unh_A6500NotesDueJune2037Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_6e5bc170-0d71-4ae3-9deb-744e8935d0e3_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_114a6f08-371d-49bb-9c7a-8bd2b07dc7f0_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ParentCompanyMember_3389f9cd-70bb-497e-8117-0f38e0865d38_terseLabel_en-US" xlink:label="lab_srt_ParentCompanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent Company [Member]</link:label>
    <link:label id="lab_srt_ParentCompanyMember_label_en-US" xlink:label="lab_srt_ParentCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent Company [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ParentCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ParentCompanyMember" xlink:to="lab_srt_ParentCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_11688f94-0535-417f-a0fc-dce776e0a041_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_06e6f569-d0af-4283-bab2-9c2c0af47c82_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. Agency Mortgage-Backed Securities [Member]</link:label>
    <link:label id="lab_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_label_en-US" xlink:label="lab_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage-backed Securities, Issued by Private Enterprises [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember" xlink:to="lab_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_ShareRepurchasesTable_54e4baa9-f946-4f81-bfce-61f5f9d6c856_terseLabel_en-US" xlink:label="lab_unh_ShareRepurchasesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchases [Table]</link:label>
    <link:label id="lab_unh_ShareRepurchasesTable_label_en-US" xlink:label="lab_unh_ShareRepurchasesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchases [Table]</link:label>
    <link:label id="lab_unh_ShareRepurchasesTable_documentation_en-US" xlink:label="lab_unh_ShareRepurchasesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchases [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ShareRepurchasesTable" xlink:href="unh-20211231.xsd#unh_ShareRepurchasesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_ShareRepurchasesTable" xlink:to="lab_unh_ShareRepurchasesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_24ef6cf9-e61d-4751-87bd-28128d3368c1_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_5b83170a-9e9f-4b4a-9aa2-73f1a568702e_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums</link:label>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_52f7ee7a-0c78-4e54-b885-b2f58eea883a_verboseLabel_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums, revenues - unaffiliated customers</link:label>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_label_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsEarnedNet" xlink:to="lab_us-gaap_PremiumsEarnedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_1d5b69aa-537c-488b-a377-a0cc0e67f667_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Agency Mortgage-Backed Securities [Member]</link:label>
    <link:label id="lab_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_label_en-US" xlink:label="lab_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage-backed Securities, Issued by US Government Sponsored Enterprises [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember" xlink:to="lab_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_c76d7a2d-e4f7-4781-bae5-baeae010879b_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Accident Year [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Accident Year [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_fc9cd3d2-0e77-4dda-a05c-9aff9cac914e_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_6b2e219f-6a63-436c-b3d5-bc7caf3e65d0_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock_5d52a9ed-a0d9-48b2-a9f3-379f5d80afd7_terseLabel_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Costs Payable</link:label>
    <link:label id="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock_label_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance and Deposit Contracts [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:to="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c644e299-f85c-4a4a-b69b-facda170326d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_e39b77d7-5f5c-4498-ad3e-75f389586930_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture, Fixtures and equipment [Member]</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_bdc31a80-1ffc-4daf-a8d3-c9ca76621bab_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_9b9f0e6f-d8d0-47cd-a754-2db49d0bc4ae_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current receivables, net of allowances of $993 and $1,047</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_4ae640a0-eeae-4941-859e-c9f65a75c45b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_0028c5ea-e794-4646-a7ad-3a44315cd4c6_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:to="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_9ea94ccf-7a0a-41a7-bd54-3c36da423acd_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible compensation, Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_00f84a7e-3610-4b13-b7ab-13852698764a_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic weighted-average number of common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_f7b73aef-c7a4-455a-8358-6983d26a9d22_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_6930d778-5a08-40ea-9bd9-5880c72ad342_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member_69a5847a-4993-4777-a177-4de33aa891a7_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Accident Year 2021 [Member]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Accident Year 2016 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_1acde950-1697-4ae0-b6ed-5403dc7c952a_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of common share equivalents</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_c29da2e2-7c62-413c-a65c-44840bc818e3_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_3676160e-9c2f-49e1-89ce-c605479bc132_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense_4f73a339-12e8-4f34-9c9b-cba307cb8404_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible compensation, Amount</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_d0831b0f-646a-4246-b56d-35deb5fd9995_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to UnitedHealth Group common shareholders</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_754cf51d-3339-4eb3-be10-92dce520b330_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_197b1e9b-3e64-4047-b943-aa7b8296c44f_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, net of accumulated amortization of $5,636 and $5,455</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_36f796ac-1915-4d31-a551-85009cc2c609_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b2f8bb9e-e245-4d52-90d6-276a4cff0cac_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_71002a32-acff-4a37-a1b2-6c012facdabf_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount_795e728f-6d6b-495e-b783-a5f98c4e6c02_terseLabel_en-US" xlink:label="lab_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health insurance industry tax, Amount</link:label>
    <link:label id="lab_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount_label_en-US" xlink:label="lab_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation Nonrefundable Health Insurance Industry Tax Expense, Amount</link:label>
    <link:label id="lab_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount_documentation_en-US" xlink:label="lab_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation Nonrefundable Health Insurance Industry Tax Expense, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount" xlink:href="unh-20211231.xsd#unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount" xlink:to="lab_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_3febf492-d67e-46a2-912b-e341ce5fef93_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayable_e5aa9e8b-d580-43e4-854d-2d17a135633f_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable</link:label>
    <link:label id="lab_us-gaap_NotesPayable_label_en-US" xlink:label="lab_us-gaap_NotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayable" xlink:to="lab_us-gaap_NotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_ScheduleIMaturitiesofCommercialPaperandLongTermDebtAbstract_c6b17da4-f9e7-47c1-9ce8-1b68e7ca9902_terseLabel_en-US" xlink:label="lab_unh_ScheduleIMaturitiesofCommercialPaperandLongTermDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule I Maturities of Commercial Paper and Long-Term Debt [Abstract]</link:label>
    <link:label id="lab_unh_ScheduleIMaturitiesofCommercialPaperandLongTermDebtAbstract_label_en-US" xlink:label="lab_unh_ScheduleIMaturitiesofCommercialPaperandLongTermDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule I Maturities of Commercial Paper and Long-Term Debt [Abstract]</link:label>
    <link:label id="lab_unh_ScheduleIMaturitiesofCommercialPaperandLongTermDebtAbstract_documentation_en-US" xlink:label="lab_unh_ScheduleIMaturitiesofCommercialPaperandLongTermDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule I Maturities of Commercial Paper and Long-Term Debt [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ScheduleIMaturitiesofCommercialPaperandLongTermDebtAbstract" xlink:href="unh-20211231.xsd#unh_ScheduleIMaturitiesofCommercialPaperandLongTermDebtAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_ScheduleIMaturitiesofCommercialPaperandLongTermDebtAbstract" xlink:to="lab_unh_ScheduleIMaturitiesofCommercialPaperandLongTermDebtAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_a7589f7c-00c0-44db-a26b-6ea51a00d638_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Obligations [Member]</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_6d7fe6b0-741a-4b4e-81f7-7fed95737192_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_f87e6cf4-c8e2-4ac0-afc3-99d3b095d19b_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Assets and Liabilities, Measured at Fair Value Recurring Basis [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_64b56586-5b87-4455-9058-1a0619c2ceec_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense, net of tax effects</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days_6f39af36-1ca6-48ee-b6d7-036d0ce1b704_terseLabel_en-US" xlink:label="lab_unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Historical Claims Duration, First 90 Days</link:label>
    <link:label id="lab_unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days_label_en-US" xlink:label="lab_unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Historical Claims Duration, First 90 Days</link:label>
    <link:label id="lab_unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days_documentation_en-US" xlink:label="lab_unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of average payout, after reinsurance, in the first 90 days after a claim is incurred, beginning with the earliest accident year disclosed for short-duration insurance contracts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days" xlink:href="unh-20211231.xsd#unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days" xlink:to="lab_unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_NOLsIndefiniteCarryforwardMember_c671e0a3-efc6-4ac4-b01b-c5207189dcca_terseLabel_en-US" xlink:label="lab_unh_NOLsIndefiniteCarryforwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite NOL carryforwards [Member]</link:label>
    <link:label id="lab_unh_NOLsIndefiniteCarryforwardMember_label_en-US" xlink:label="lab_unh_NOLsIndefiniteCarryforwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NOLsIndefiniteCarryforward [Member]</link:label>
    <link:label id="lab_unh_NOLsIndefiniteCarryforwardMember_documentation_en-US" xlink:label="lab_unh_NOLsIndefiniteCarryforwardMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NOLs indefinite carryforward</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_NOLsIndefiniteCarryforwardMember" xlink:href="unh-20211231.xsd#unh_NOLsIndefiniteCarryforwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_NOLsIndefiniteCarryforwardMember" xlink:to="lab_unh_NOLsIndefiniteCarryforwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_defbebda-fd9c-4c10-9b63-aad75709ec1b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_b9c482a7-24cd-4822-a10d-d8130874af1f_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, shares outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_e8b75d95-3ae9-4423-8780-7569dde0885f_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_dc750917-175a-4b2e-aee4-3aad149df4fa_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_c01db9f5-034c-4928-8235-69b8b750f0de_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers Into Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_424dda03-bb6d-44f2-b275-42447afef2f3_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term and Long-Term Investments [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:to="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermInvestments_4bc1d11d-c5ed-4b3e-8467-a432954b1658_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investments</link:label>
    <link:label id="lab_us-gaap_LongTermInvestments_label_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermInvestments" xlink:to="lab_us-gaap_LongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dccfeceb-e38c-4e57-af85-d4e9f5e6bd5d_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_66e65124-2d3d-4921-9fa5-f8cfcae2faa2_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after five years through ten years, Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_0cdf4935-8efa-4cc8-b103-7bba6dfa6821_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_cfaff76f-467d-4a01-8789-c5016c321026_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entitiy Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGrossAbstract_de455ccd-d97c-4c2d-bd71-d434ec3d7b29_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax assets:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGrossAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGrossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_8305fe30-db74-4bfd-8601-7993def0dd6f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior year tax positions, gross decreases</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_109ca97b-0357-4f2f-adc0-612dfba3596e_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due in one year or less, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_535af4a0-4377-4b2c-9b04-c963bbc97bb7_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesGross" xlink:to="lab_us-gaap_FurnitureAndFixturesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_0204aa0b-8738-444a-96ba-3e48dcc265b6_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_a4ddc0ac-be01-4e99-91e2-c8c85080ac79_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_5bf59c66-9290-4d91-bb06-8ba98706eb4e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_849d479f-bde8-4485-8972-3c1b311da7a7_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Repayments of) proceeds from short-term borrowings, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_f91cd2ef-2c48-4b6d-8ab3-045793873b12_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Repayments of) proceeds from commercial paper, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_81ce9373-21fa-490b-9a45-c1c3650ed674_terseLabel_en-US" xlink:label="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Information Disclosure [Abstract]</link:label>
    <link:label id="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_label_en-US" xlink:label="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Information Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:to="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareGross_81e30c4d-240d-4938-9976-35078cd5ee07_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareGross_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareGross" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareGross" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A364Day38BillionCreditFacilityMember_bee60422-2a78-48ac-91d4-746ca6f42603_terseLabel_en-US" xlink:label="lab_unh_A364Day38BillionCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">364 Day $3.8 Billion Credit Facility [Member]</link:label>
    <link:label id="lab_unh_A364Day38BillionCreditFacilityMember_label_en-US" xlink:label="lab_unh_A364Day38BillionCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">364 Day $3.8 Billion Credit Facility [Member]</link:label>
    <link:label id="lab_unh_A364Day38BillionCreditFacilityMember_documentation_en-US" xlink:label="lab_unh_A364Day38BillionCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">364 Day $3.8 Billion Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A364Day38BillionCreditFacilityMember" xlink:href="unh-20211231.xsd#unh_A364Day38BillionCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A364Day38BillionCreditFacilityMember" xlink:to="lab_unh_A364Day38BillionCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_1edc9520-693f-4275-9fe6-7c9d46cb3ce7_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Borrowings and Long-Term Debt [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_e39cd5d5-22dc-4dce-9810-efd617a94cb1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_a83c6d33-38fb-4c13-afe1-5f11f908d384_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelatedIntangibleAssetsMember_bfeee730-0f05-4585-b2eb-d19591f363e7_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer-Related Intangible Assets [Member]</link:label>
    <link:label id="lab_us-gaap_CustomerRelatedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer-Related Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:to="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthInsuranceProductLineMember_2a50bbd1-8fe7-433d-985e-977960f06a14_terseLabel_en-US" xlink:label="lab_us-gaap_HealthInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurance Product Line [Member]</link:label>
    <link:label id="lab_us-gaap_HealthInsuranceProductLineMember_label_en-US" xlink:label="lab_us-gaap_HealthInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurance Product Line [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthInsuranceProductLineMember" xlink:to="lab_us-gaap_HealthInsuranceProductLineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_ce576675-4a67-4186-aa5e-67ef0a0eb485_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical costs</link:label>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_label_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Net, Health</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:to="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_0559d00c-d6ad-46d2-aab9-5a521e922ac7_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_18f8bdd6-8d81-4750-a87d-c6b0d80d236b_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_2520f198-2fd8-4224-ba04-de4086be7910_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest, end of period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_05f7df05-c6f3-4016-92fb-182ccd261536_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_1277715f-2e21-4b0d-84cd-55cc91e23d3d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales of investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_e9ead0a0-2bcc-44f4-bc91-962f7c0881c4_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, less current maturities</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_e70ed50d-78f4-4c9f-87a2-5b44458caa4e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_bc48f4e4-8041-4fd2-b515-dc2ff4598501_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Service [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Service [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:to="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_ShareRepurchasesTableLineItems_f8602577-575e-49bf-8422-ccc2e2b2c6d0_terseLabel_en-US" xlink:label="lab_unh_ShareRepurchasesTableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity Disclosure [Line Items]</link:label>
    <link:label id="lab_unh_ShareRepurchasesTableLineItems_label_en-US" xlink:label="lab_unh_ShareRepurchasesTableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchases [Table] [Line Items]</link:label>
    <link:label id="lab_unh_ShareRepurchasesTableLineItems_documentation_en-US" xlink:label="lab_unh_ShareRepurchasesTableLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Share Repurchases [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ShareRepurchasesTableLineItems" xlink:href="unh-20211231.xsd#unh_ShareRepurchasesTableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_ShareRepurchasesTableLineItems" xlink:to="lab_unh_ShareRepurchasesTableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_977737cf-72ed-48ee-a812-3a4396cc6ff0_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at end of period, Weighted Average Remaining Contractual Term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_12bfde3e-cde8-4cf9-b376-cfbc4a4e0446_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_InvestmentsGrossUnrealizedLosses_7ec6ed2d-6050-473d-b78e-fdf3d2593f72_negatedTerseLabel_en-US" xlink:label="lab_unh_InvestmentsGrossUnrealizedLosses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total investments, Gross Unrealized Losses</link:label>
    <link:label id="lab_unh_InvestmentsGrossUnrealizedLosses_label_en-US" xlink:label="lab_unh_InvestmentsGrossUnrealizedLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Gross Unrealized Losses</link:label>
    <link:label id="lab_unh_InvestmentsGrossUnrealizedLosses_documentation_en-US" xlink:label="lab_unh_InvestmentsGrossUnrealizedLosses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized losses of investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_InvestmentsGrossUnrealizedLosses" xlink:href="unh-20211231.xsd#unh_InvestmentsGrossUnrealizedLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_InvestmentsGrossUnrealizedLosses" xlink:to="lab_unh_InvestmentsGrossUnrealizedLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount_53532f7b-f570-4b61-a9eb-e2e87c9da7ee_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred but Not Reported (IBNR) Claims, Amount</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred but Not Reported (IBNR) Claims, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_12b3d523-55c8-45fc-8c86-fb47c34497e9_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_188fcf4a-e3d4-4ff2-aa33-045f73a654d4_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_96bcd9ac-e68c-4a47-af45-e1bc8194aae3_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_ce7102af-1563-44de-b49d-d7872231fd81_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_DeferredTaxAssetOtherForeign_e0af3888-5404-46d1-878e-9e8bf5e49402_terseLabel_en-US" xlink:label="lab_unh_DeferredTaxAssetOtherForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other-non-U.S.</link:label>
    <link:label id="lab_unh_DeferredTaxAssetOtherForeign_label_en-US" xlink:label="lab_unh_DeferredTaxAssetOtherForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Other Foreign</link:label>
    <link:label id="lab_unh_DeferredTaxAssetOtherForeign_documentation_en-US" xlink:label="lab_unh_DeferredTaxAssetOtherForeign" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Other Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxAssetOtherForeign" xlink:href="unh-20211231.xsd#unh_DeferredTaxAssetOtherForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_DeferredTaxAssetOtherForeign" xlink:to="lab_unh_DeferredTaxAssetOtherForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_fd79bcdd-885a-4b6c-a2f7-683477018eb4_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_597ae289-4bed-41d0-8ca0-b9d75e957dd3_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_e14af3e8-5aad-49f0-845e-be36fc92d66a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAmortization1_802f93e8-bcfb-43db-88a6-1800d4b596b2_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Amortization</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAmortization1_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_3f196ca4-ebda-4524-83e6-99d8e0d26087_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned revenues</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueCurrent" xlink:to="lab_us-gaap_DeferredRevenueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CondensedBalanceSheetStatementTable_2415b74f-7dc6-4697-99b3-9ad12b73defe_terseLabel_en-US" xlink:label="lab_srt_CondensedBalanceSheetStatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Balance Sheet Statement [Table]</link:label>
    <link:label id="lab_srt_CondensedBalanceSheetStatementTable_label_en-US" xlink:label="lab_srt_CondensedBalanceSheetStatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Balance Sheet Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedBalanceSheetStatementTable" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CondensedBalanceSheetStatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedBalanceSheetStatementTable" xlink:to="lab_srt_CondensedBalanceSheetStatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_b4102d0e-3a42-44ce-bf7c-cc226a86ac85_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized (losses) gains on investment securities during the period</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_a7242f9b-6c8f-4b19-a88e-171b61f42785_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_07529d15-5172-45d7-ab23-aa2193723f74_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_20b7a4ae-d272-4c85-a30b-8444cf6f7c0f_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_64118136-ce37-4fab-ac88-4356f4777f41_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_MedicarePartDPharmacyBenefitsContractAxis_1fc79011-b152-4e7d-8ff7-7645f8af603f_terseLabel_en-US" xlink:label="lab_unh_MedicarePartDPharmacyBenefitsContractAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Part D Pharmacy Benefits Contract [Axis]</link:label>
    <link:label id="lab_unh_MedicarePartDPharmacyBenefitsContractAxis_label_en-US" xlink:label="lab_unh_MedicarePartDPharmacyBenefitsContractAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Part D Pharmacy Benefits Contract [Axis]</link:label>
    <link:label id="lab_unh_MedicarePartDPharmacyBenefitsContractAxis_documentation_en-US" xlink:label="lab_unh_MedicarePartDPharmacyBenefitsContractAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Part D Pharmacy Benefits Contract [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_MedicarePartDPharmacyBenefitsContractAxis" xlink:href="unh-20211231.xsd#unh_MedicarePartDPharmacyBenefitsContractAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_MedicarePartDPharmacyBenefitsContractAxis" xlink:to="lab_unh_MedicarePartDPharmacyBenefitsContractAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_3daaf0e6-53d8-4a82-bb68-78805bf76e03_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts, other receivables</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Loss, Receivable, Other, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_a6e7f443-7a5c-4571-918e-2dfdca2977d0_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_f301507c-58e4-431b-ba09-19be7d92c41f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statute of limitations lapses</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_d9307997-9e17-4a28-a3dd-eba45f776886_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_7c9be60c-4f52-4355-9982-2d0756df6a49_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_InvestmentsGrossUnrealizedGains_181b9a81-1cf9-44c2-8c82-c3f1c3fd1f48_terseLabel_en-US" xlink:label="lab_unh_InvestmentsGrossUnrealizedGains" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total investments, Gross Unrealized Gains</link:label>
    <link:label id="lab_unh_InvestmentsGrossUnrealizedGains_label_en-US" xlink:label="lab_unh_InvestmentsGrossUnrealizedGains" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Gross Unrealized Gains</link:label>
    <link:label id="lab_unh_InvestmentsGrossUnrealizedGains_documentation_en-US" xlink:label="lab_unh_InvestmentsGrossUnrealizedGains" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized gains of investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_InvestmentsGrossUnrealizedGains" xlink:href="unh-20211231.xsd#unh_InvestmentsGrossUnrealizedGains"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_InvestmentsGrossUnrealizedGains" xlink:to="lab_unh_InvestmentsGrossUnrealizedGains" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_fd23526a-cc74-46a1-a829-84d2f5dcedff_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows used for investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_3aa0bc68-3edb-48fc-96e9-7b9a1f58f267_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows used for investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e7d6699d-92b2-4294-971a-7874a76ea0b6_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in other operating items, net of effects from acquisitions and changes in AARP balances:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecurities_6e6cff79-e24f-4459-8f51-a3a7e85e911c_totalLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held-to-maturity securities, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecurities_d2e264ff-7d4f-4da7-90de-82a0e31b017e_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecurities_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecurities" xlink:to="lab_us-gaap_HeldToMaturitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_a43a2077-4c76-4f84-9438-3c7ef9286659_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested, Weighted Average Grant Date Fair Value per share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock_ed47f0c3-f19c-4f1e-ad00-975dafab3587_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Positions for which Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Positions for which Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" xlink:to="lab_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A2750NotesDueMay2040Member_52a3bb74-2502-457a-94f0-0b11eeefff75_terseLabel_en-US" xlink:label="lab_unh_A2750NotesDueMay2040Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.750% notes due May 2040 [Member]</link:label>
    <link:label id="lab_unh_A2750NotesDueMay2040Member_label_en-US" xlink:label="lab_unh_A2750NotesDueMay2040Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.750% notes due May 2040 [Member]</link:label>
    <link:label id="lab_unh_A2750NotesDueMay2040Member_documentation_en-US" xlink:label="lab_unh_A2750NotesDueMay2040Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.750% notes due May 2040</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2750NotesDueMay2040Member" xlink:href="unh-20211231.xsd#unh_A2750NotesDueMay2040Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A2750NotesDueMay2040Member" xlink:to="lab_unh_A2750NotesDueMay2040Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount_526f44a2-87d2-4ced-97cf-01d8d188082c_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, after Five Through Ten Years, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, after Year Five through Ten</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_78f618bc-5b16-4af6-b427-63b50155e6bc_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_AarpAssetsUnderManagement_135c0d29-5f29-4096-a428-5ab5eee71254_terseLabel_en-US" xlink:label="lab_unh_AarpAssetsUnderManagement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets under management</link:label>
    <link:label id="lab_unh_AarpAssetsUnderManagement_label_en-US" xlink:label="lab_unh_AarpAssetsUnderManagement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AARP Assets Under Management</link:label>
    <link:label id="lab_unh_AarpAssetsUnderManagement_documentation_en-US" xlink:label="lab_unh_AarpAssetsUnderManagement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Assets Under Management are primarily AARP assets that are managed separately from the general investment portfolio and are used to pay costs associated with the AARP program.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_AarpAssetsUnderManagement" xlink:href="unh-20211231.xsd#unh_AarpAssetsUnderManagement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_AarpAssetsUnderManagement" xlink:to="lab_unh_AarpAssetsUnderManagement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_a5c0ce47-001a-4bff-bf2b-a7a24c223346_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit, Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_8b038776-23ce-47c6-bbe8-e1a1e7d33467_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_436ff644-da40-423b-b07e-1ce73017acb4_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A3250NotesDueMay2051Member_13ee9cec-9f5c-4fe9-b1e2-002c600d71e3_terseLabel_en-US" xlink:label="lab_unh_A3250NotesDueMay2051Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.250% notes due May 2051 [Member]</link:label>
    <link:label id="lab_unh_A3250NotesDueMay2051Member_label_en-US" xlink:label="lab_unh_A3250NotesDueMay2051Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.250% notes due May 2051 [Member]</link:label>
    <link:label id="lab_unh_A3250NotesDueMay2051Member_documentation_en-US" xlink:label="lab_unh_A3250NotesDueMay2051Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.250% notes due May 2051 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3250NotesDueMay2051Member" xlink:href="unh-20211231.xsd#unh_A3250NotesDueMay2051Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A3250NotesDueMay2051Member" xlink:to="lab_unh_A3250NotesDueMay2051Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_6864f9c9-df3b-496f-88e2-57509947ab75_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and improvements</link:label>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_label_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingsAndImprovementsGross" xlink:to="lab_us-gaap_BuildingsAndImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_fa00699e-a898-41c9-9b50-7eeb67d6b111_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasedAssetsLineItems_03bb5581-847b-4cb2-b323-d87ce14b96bd_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLeasedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:to="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_0d5d0ece-52ae-4f9f-8ad4-a4ec4cad7607_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_IncomeTaxAbstract_7e283b02-a08e-41f1-aed4-ed886e6d395c_terseLabel_en-US" xlink:label="lab_unh_IncomeTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax [Abstract]</link:label>
    <link:label id="lab_unh_IncomeTaxAbstract_label_en-US" xlink:label="lab_unh_IncomeTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax [Abstract]</link:label>
    <link:label id="lab_unh_IncomeTaxAbstract_documentation_en-US" xlink:label="lab_unh_IncomeTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_IncomeTaxAbstract" xlink:href="unh-20211231.xsd#unh_IncomeTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_IncomeTaxAbstract" xlink:to="lab_unh_IncomeTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_9907057b-1d29-4bcd-9c0d-843daa3ad84d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax provision at the U.S. federal statutory rate, Amount</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_2bd8dbd1-df86-463b-ab91-880be8ac8327_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after ten years, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_PharmaceuticalmanufacturerrebatesreceivableDomain_4e0d56eb-bcfa-4233-a1a3-3f7f2182870c_terseLabel_en-US" xlink:label="lab_unh_PharmaceuticalmanufacturerrebatesreceivableDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical manufacturer rebates receivable [Domain]</link:label>
    <link:label id="lab_unh_PharmaceuticalmanufacturerrebatesreceivableDomain_label_en-US" xlink:label="lab_unh_PharmaceuticalmanufacturerrebatesreceivableDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical manufacturer rebates receivable [Domain]</link:label>
    <link:label id="lab_unh_PharmaceuticalmanufacturerrebatesreceivableDomain_documentation_en-US" xlink:label="lab_unh_PharmaceuticalmanufacturerrebatesreceivableDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Pharmaceutical manufacturer rebates receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_PharmaceuticalmanufacturerrebatesreceivableDomain" xlink:href="unh-20211231.xsd#unh_PharmaceuticalmanufacturerrebatesreceivableDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_PharmaceuticalmanufacturerrebatesreceivableDomain" xlink:to="lab_unh_PharmaceuticalmanufacturerrebatesreceivableDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_600c1dbd-27c0-44b4-a48a-adfd7fd3a987_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_f7253317-0af0-4ad7-8c45-98d61d2e9ab7_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_ef874ba2-14e3-4736-8fcc-1ae1da867b05_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due in one year or less, Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_A3.150notesdueJune2021Member_fac11e05-a1a7-4542-80dc-619c9f386cba_terseLabel_en-US" xlink:label="lab_unh_A3.150notesdueJune2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.150% notes due June 2021 [Member]</link:label>
    <link:label id="lab_unh_A3.150notesdueJune2021Member_label_en-US" xlink:label="lab_unh_A3.150notesdueJune2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.150% notes due June 2021 [Member]</link:label>
    <link:label id="lab_unh_A3.150notesdueJune2021Member_documentation_en-US" xlink:label="lab_unh_A3.150notesdueJune2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.150% notes due June 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.150notesdueJune2021Member" xlink:href="unh-20211231.xsd#unh_A3.150notesdueJune2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_A3.150notesdueJune2021Member" xlink:to="lab_unh_A3.150notesdueJune2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_InvestmentLineItems_be155126-d7bb-4671-9e91-a32eb6c3798d_terseLabel_en-US" xlink:label="lab_unh_InvestmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment [Line Items]</link:label>
    <link:label id="lab_unh_InvestmentLineItems_label_en-US" xlink:label="lab_unh_InvestmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment [Line Items]</link:label>
    <link:label id="lab_unh_InvestmentLineItems_documentation_en-US" xlink:label="lab_unh_InvestmentLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line items represent reporting concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_InvestmentLineItems" xlink:href="unh-20211231.xsd#unh_InvestmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_InvestmentLineItems" xlink:to="lab_unh_InvestmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_ec71b8f2-5fc4-49f7-8669-aa03f098f540_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_3c63a331-97c1-449c-907b-4c2c2a096663_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Interest Rate During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:to="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_5dcb5646-fe65-41f1-8e64-2fe4957996a7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_36f57f45-f8fe-44b5-92ac-865e4503609e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for current year</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:type="arc" order="1"/>
    <link:label id="lab_unh_AuditorInformationAbstract_086b9b26-8806-4daa-9870-b6e588e110c3_terseLabel_en-US" xlink:label="lab_unh_AuditorInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Information [Abstract]</link:label>
    <link:label id="lab_unh_AuditorInformationAbstract_label_en-US" xlink:label="lab_unh_AuditorInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Information [Abstract]</link:label>
    <link:label id="lab_unh_AuditorInformationAbstract_documentation_en-US" xlink:label="lab_unh_AuditorInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_unh_AuditorInformationAbstract" xlink:href="unh-20211231.xsd#unh_AuditorInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_unh_AuditorInformationAbstract" xlink:to="lab_unh_AuditorInformationAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>23
<FILENAME>unh-20211231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:7520997a-16df-4345-81d3-205a3336ef85,g:00a8925a-3c66-4bad-89d3-86af384cff11-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.uhc.com/role/AuditorInformation" xlink:type="simple" xlink:href="unh-20211231.xsd#AuditorInformation"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/AuditorInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_AuditorInformationAbstract_526a8c2c-85e3-4cf8-b2e8-c5f762eff555" xlink:href="unh-20211231.xsd#unh_AuditorInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_63ee5cd2-2154-493b-992f-2877a93807fb" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_AuditorInformationAbstract_526a8c2c-85e3-4cf8-b2e8-c5f762eff555" xlink:to="loc_dei_AuditorName_63ee5cd2-2154-493b-992f-2877a93807fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_da141cd4-f287-411d-ac67-882f9360f4b2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_AuditorInformationAbstract_526a8c2c-85e3-4cf8-b2e8-c5f762eff555" xlink:to="loc_dei_AuditorFirmId_da141cd4-f287-411d-ac67-882f9360f4b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_45e87250-efc1-4fc2-a72d-217f522252b2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_AuditorInformationAbstract_526a8c2c-85e3-4cf8-b2e8-c5f762eff555" xlink:to="loc_dei_AuditorLocation_45e87250-efc1-4fc2-a72d-217f522252b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/CoverDocument" xlink:type="simple" xlink:href="unh-20211231.xsd#CoverDocument"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/CoverDocument" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_CoverPageAbstract_b1388b49-b73c-4363-b48e-d858e50a2ee4" xlink:href="unh-20211231.xsd#unh_CoverPageAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_007105fc-19da-46f6-a02a-6f08b7194076" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_b1388b49-b73c-4363-b48e-d858e50a2ee4" xlink:to="loc_dei_EntityFileNumber_007105fc-19da-46f6-a02a-6f08b7194076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_16e61e86-d4d1-4f24-a31c-be62abb77db6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_b1388b49-b73c-4363-b48e-d858e50a2ee4" xlink:to="loc_dei_DocumentType_16e61e86-d4d1-4f24-a31c-be62abb77db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_3eb3d138-e369-408a-905d-318224eff3d0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_b1388b49-b73c-4363-b48e-d858e50a2ee4" xlink:to="loc_dei_DocumentAnnualReport_3eb3d138-e369-408a-905d-318224eff3d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_add82b6a-0fd0-4c2f-ad2b-d00d836d22a0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_b1388b49-b73c-4363-b48e-d858e50a2ee4" xlink:to="loc_dei_DocumentPeriodEndDate_add82b6a-0fd0-4c2f-ad2b-d00d836d22a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_9f5f8ad4-6924-4142-a19e-e5964cff4168" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_b1388b49-b73c-4363-b48e-d858e50a2ee4" xlink:to="loc_dei_CurrentFiscalYearEndDate_9f5f8ad4-6924-4142-a19e-e5964cff4168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_414caaaf-6309-4e63-a20e-fa46f95a362c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_b1388b49-b73c-4363-b48e-d858e50a2ee4" xlink:to="loc_dei_DocumentFiscalYearFocus_414caaaf-6309-4e63-a20e-fa46f95a362c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_4bec6891-e544-4637-ad3e-fc0966e424bc" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_b1388b49-b73c-4363-b48e-d858e50a2ee4" xlink:to="loc_dei_DocumentFiscalPeriodFocus_4bec6891-e544-4637-ad3e-fc0966e424bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_89cb9ead-f66e-42d4-8e79-e72ba28638e7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_b1388b49-b73c-4363-b48e-d858e50a2ee4" xlink:to="loc_dei_AmendmentFlag_89cb9ead-f66e-42d4-8e79-e72ba28638e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_9373b10f-c812-4c70-b7c6-6e8342e041b1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_b1388b49-b73c-4363-b48e-d858e50a2ee4" xlink:to="loc_dei_DocumentTransitionReport_9373b10f-c812-4c70-b7c6-6e8342e041b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_eba8f36e-0f8c-4154-a3cb-42289dbd8119" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_b1388b49-b73c-4363-b48e-d858e50a2ee4" xlink:to="loc_dei_EntityIncorporationStateCountryCode_eba8f36e-0f8c-4154-a3cb-42289dbd8119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_03a95436-222a-4556-8129-7ae2e14fcf9c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_b1388b49-b73c-4363-b48e-d858e50a2ee4" xlink:to="loc_dei_EntityTaxIdentificationNumber_03a95436-222a-4556-8129-7ae2e14fcf9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_574662c2-305e-413d-80c7-2540d2fdcc9c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_b1388b49-b73c-4363-b48e-d858e50a2ee4" xlink:to="loc_dei_EntityAddressAddressLine1_574662c2-305e-413d-80c7-2540d2fdcc9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_bb728101-87f2-426c-9a0d-0a4b4b0c59a1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_b1388b49-b73c-4363-b48e-d858e50a2ee4" xlink:to="loc_dei_EntityAddressAddressLine2_bb728101-87f2-426c-9a0d-0a4b4b0c59a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_f12e8754-3a30-4845-8389-3c3ec8a65257" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_b1388b49-b73c-4363-b48e-d858e50a2ee4" xlink:to="loc_dei_EntityAddressCityOrTown_f12e8754-3a30-4845-8389-3c3ec8a65257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_06f54356-7569-496f-b12e-02882daa4f5e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_b1388b49-b73c-4363-b48e-d858e50a2ee4" xlink:to="loc_dei_EntityAddressStateOrProvince_06f54356-7569-496f-b12e-02882daa4f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_428737b2-c1ba-48f0-8c54-d4f584526e8e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_b1388b49-b73c-4363-b48e-d858e50a2ee4" xlink:to="loc_dei_EntityAddressPostalZipCode_428737b2-c1ba-48f0-8c54-d4f584526e8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_92b0d701-91c2-4b54-ac14-5e36f774c134" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_b1388b49-b73c-4363-b48e-d858e50a2ee4" xlink:to="loc_dei_CityAreaCode_92b0d701-91c2-4b54-ac14-5e36f774c134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_725811ad-3936-418f-a115-cff8f071ddbf" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_b1388b49-b73c-4363-b48e-d858e50a2ee4" xlink:to="loc_dei_LocalPhoneNumber_725811ad-3936-418f-a115-cff8f071ddbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_b7050792-07d3-4f41-b6b1-53ede85cf8b7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_b1388b49-b73c-4363-b48e-d858e50a2ee4" xlink:to="loc_dei_Security12bTitle_b7050792-07d3-4f41-b6b1-53ede85cf8b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_9430b819-8e78-4c9b-94a1-cdd878bdd634" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_b1388b49-b73c-4363-b48e-d858e50a2ee4" xlink:to="loc_dei_TradingSymbol_9430b819-8e78-4c9b-94a1-cdd878bdd634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_96521653-4946-4001-a11d-cfca58dd318a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_b1388b49-b73c-4363-b48e-d858e50a2ee4" xlink:to="loc_dei_SecurityExchangeName_96521653-4946-4001-a11d-cfca58dd318a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_833c4e53-2dbe-4d53-b1d9-9e9050f803d7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_b1388b49-b73c-4363-b48e-d858e50a2ee4" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_833c4e53-2dbe-4d53-b1d9-9e9050f803d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_aaabb7da-1396-47cf-9310-9e1d5e3aa713" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_b1388b49-b73c-4363-b48e-d858e50a2ee4" xlink:to="loc_dei_EntityVoluntaryFilers_aaabb7da-1396-47cf-9310-9e1d5e3aa713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_9f44a44b-ca78-4003-abe0-bcc7389288fe" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_b1388b49-b73c-4363-b48e-d858e50a2ee4" xlink:to="loc_dei_EntityCurrentReportingStatus_9f44a44b-ca78-4003-abe0-bcc7389288fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_50717982-8910-4db4-93d5-4c4f75ee4d64" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_b1388b49-b73c-4363-b48e-d858e50a2ee4" xlink:to="loc_dei_EntityInteractiveDataCurrent_50717982-8910-4db4-93d5-4c4f75ee4d64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_8a42516d-2bc2-4a30-89b7-a89f967ac0fe" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_b1388b49-b73c-4363-b48e-d858e50a2ee4" xlink:to="loc_dei_EntityFilerCategory_8a42516d-2bc2-4a30-89b7-a89f967ac0fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_17724ac4-96e1-4e60-886d-9b4784a03a21" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_b1388b49-b73c-4363-b48e-d858e50a2ee4" xlink:to="loc_dei_EntitySmallBusiness_17724ac4-96e1-4e60-886d-9b4784a03a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_7cc11a88-bd41-4505-b577-fe94667567f8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_b1388b49-b73c-4363-b48e-d858e50a2ee4" xlink:to="loc_dei_EntityEmergingGrowthCompany_7cc11a88-bd41-4505-b577-fe94667567f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_8848bac4-4964-4a35-b5d9-e4fa84d1bba5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_b1388b49-b73c-4363-b48e-d858e50a2ee4" xlink:to="loc_dei_EntityShellCompany_8848bac4-4964-4a35-b5d9-e4fa84d1bba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_efa4da12-97e5-418d-81c6-f0803c6f317d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_b1388b49-b73c-4363-b48e-d858e50a2ee4" xlink:to="loc_dei_EntityPublicFloat_efa4da12-97e5-418d-81c6-f0803c6f317d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_5d0f8e4a-43ba-4568-8678-7d1b889c99a3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_b1388b49-b73c-4363-b48e-d858e50a2ee4" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_5d0f8e4a-43ba-4568-8678-7d1b889c99a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_273d092a-fe9c-484d-b397-b0c79c09dee5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_b1388b49-b73c-4363-b48e-d858e50a2ee4" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_273d092a-fe9c-484d-b397-b0c79c09dee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_f89e6f38-d594-4b51-a487-060678fa6e27" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_b1388b49-b73c-4363-b48e-d858e50a2ee4" xlink:to="loc_dei_EntityRegistrantName_f89e6f38-d594-4b51-a487-060678fa6e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_931be037-f37a-41d1-9b80-56e0aeda0d75" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_b1388b49-b73c-4363-b48e-d858e50a2ee4" xlink:to="loc_dei_EntityCentralIndexKey_931be037-f37a-41d1-9b80-56e0aeda0d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_34b76048-8935-4f86-bf3a-a066bca44e4e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CoverPageAbstract_b1388b49-b73c-4363-b48e-d858e50a2ee4" xlink:to="loc_dei_IcfrAuditorAttestationFlag_34b76048-8935-4f86-bf3a-a066bca44e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="unh-20211231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_3fc3aaef-74f9-4df3-a47b-afe01414b904" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_76d189f8-d315-4937-b447-f3151c8ee433" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3fc3aaef-74f9-4df3-a47b-afe01414b904" xlink:to="loc_us-gaap_StatementTable_76d189f8-d315-4937-b447-f3151c8ee433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_d59627a3-7f9a-4152-ab2e-1d5a77406c38" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_76d189f8-d315-4937-b447-f3151c8ee433" xlink:to="loc_srt_StatementScenarioAxis_d59627a3-7f9a-4152-ab2e-1d5a77406c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_56dc730f-255e-4049-b44a-bda3780df5a1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_d59627a3-7f9a-4152-ab2e-1d5a77406c38" xlink:to="loc_srt_ScenarioUnspecifiedDomain_56dc730f-255e-4049-b44a-bda3780df5a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_7df42859-acdc-45ce-8435-2770f2d7e2cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_76d189f8-d315-4937-b447-f3151c8ee433" xlink:to="loc_us-gaap_StatementLineItems_7df42859-acdc-45ce-8435-2770f2d7e2cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_9da0f26f-24a0-4f4c-affe-cdc87fc86941" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3fc3aaef-74f9-4df3-a47b-afe01414b904" xlink:to="loc_us-gaap_AssetsAbstract_9da0f26f-24a0-4f4c-affe-cdc87fc86941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_4e710577-e399-4252-b8bb-0ab8aa991052" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9da0f26f-24a0-4f4c-affe-cdc87fc86941" xlink:to="loc_us-gaap_AssetsCurrentAbstract_4e710577-e399-4252-b8bb-0ab8aa991052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0210bb71-f005-4951-9d8f-db173816abba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4e710577-e399-4252-b8bb-0ab8aa991052" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0210bb71-f005-4951-9d8f-db173816abba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_ba0e114a-4240-4d4f-b4b7-41abbcf6c33e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4e710577-e399-4252-b8bb-0ab8aa991052" xlink:to="loc_us-gaap_ShortTermInvestments_ba0e114a-4240-4d4f-b4b7-41abbcf6c33e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_cfdf5e79-b631-4630-adcb-a77afd25bbb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4e710577-e399-4252-b8bb-0ab8aa991052" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_cfdf5e79-b631-4630-adcb-a77afd25bbb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_4ce7fe37-4b33-4c73-800c-d5c5a6d873a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4e710577-e399-4252-b8bb-0ab8aa991052" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_4ce7fe37-4b33-4c73-800c-d5c5a6d873a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_AarpAssetsUnderManagement_4702aca8-0363-46ca-8771-3b34269d3513" xlink:href="unh-20211231.xsd#unh_AarpAssetsUnderManagement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4e710577-e399-4252-b8bb-0ab8aa991052" xlink:to="loc_unh_AarpAssetsUnderManagement_4702aca8-0363-46ca-8771-3b34269d3513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f3e7df13-23c9-44dd-ae64-fbe8bd664f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4e710577-e399-4252-b8bb-0ab8aa991052" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f3e7df13-23c9-44dd-ae64-fbe8bd664f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_5714628a-61e2-41e4-89ac-113aa98acc27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4e710577-e399-4252-b8bb-0ab8aa991052" xlink:to="loc_us-gaap_AssetsCurrent_5714628a-61e2-41e4-89ac-113aa98acc27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_02b98d97-7507-4ee9-8874-85cda4b02bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9da0f26f-24a0-4f4c-affe-cdc87fc86941" xlink:to="loc_us-gaap_LongTermInvestments_02b98d97-7507-4ee9-8874-85cda4b02bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f762a3c3-efe0-4930-9877-722756aae28e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9da0f26f-24a0-4f4c-affe-cdc87fc86941" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f762a3c3-efe0-4930-9877-722756aae28e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b527ffeb-91d3-42e4-a192-056f9aaf9888" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9da0f26f-24a0-4f4c-affe-cdc87fc86941" xlink:to="loc_us-gaap_Goodwill_b527ffeb-91d3-42e4-a192-056f9aaf9888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_06b439ab-ade1-418e-b424-f442725d2906" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9da0f26f-24a0-4f4c-affe-cdc87fc86941" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_06b439ab-ade1-418e-b424-f442725d2906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_2553d2d9-af08-4188-b28d-64a81a70265e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9da0f26f-24a0-4f4c-affe-cdc87fc86941" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_2553d2d9-af08-4188-b28d-64a81a70265e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_99a18632-5418-4ad1-9b84-fa1d05803413" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9da0f26f-24a0-4f4c-affe-cdc87fc86941" xlink:to="loc_us-gaap_Assets_99a18632-5418-4ad1-9b84-fa1d05803413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c68f56d0-3e4c-4cba-a14d-5dfdcc04c8f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3fc3aaef-74f9-4df3-a47b-afe01414b904" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c68f56d0-3e4c-4cba-a14d-5dfdcc04c8f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_e74577cb-7c12-4504-8cf4-54fff0ee920b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c68f56d0-3e4c-4cba-a14d-5dfdcc04c8f5" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_e74577cb-7c12-4504-8cf4-54fff0ee920b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_5e70469d-61dd-4b84-bdb0-2591b2da3080" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e74577cb-7c12-4504-8cf4-54fff0ee920b" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_5e70469d-61dd-4b84-bdb0-2591b2da3080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_a94438dc-1916-49a0-b0b4-bb18c4f14f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e74577cb-7c12-4504-8cf4-54fff0ee920b" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_a94438dc-1916-49a0-b0b4-bb18c4f14f3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_b84df90c-8a09-4a65-a35a-946f26038f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e74577cb-7c12-4504-8cf4-54fff0ee920b" xlink:to="loc_us-gaap_LongTermDebtCurrent_b84df90c-8a09-4a65-a35a-946f26038f1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_c2a31039-4ca3-4de7-b849-9fa3be233d47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e74577cb-7c12-4504-8cf4-54fff0ee920b" xlink:to="loc_us-gaap_DeferredRevenueCurrent_c2a31039-4ca3-4de7-b849-9fa3be233d47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_537b7075-c0ed-4616-899f-71b0cf844806" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e74577cb-7c12-4504-8cf4-54fff0ee920b" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_537b7075-c0ed-4616-899f-71b0cf844806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_ad622c5c-2249-4654-94d9-ed185ff3b8a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e74577cb-7c12-4504-8cf4-54fff0ee920b" xlink:to="loc_us-gaap_LiabilitiesCurrent_ad622c5c-2249-4654-94d9-ed185ff3b8a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_79c887cc-207e-40f1-b257-672e68da9d94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c68f56d0-3e4c-4cba-a14d-5dfdcc04c8f5" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_79c887cc-207e-40f1-b257-672e68da9d94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_70c7172d-f75d-45f8-8120-22f1ed1f3d87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c68f56d0-3e4c-4cba-a14d-5dfdcc04c8f5" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_70c7172d-f75d-45f8-8120-22f1ed1f3d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_c42546f3-f467-40db-88a9-39ab6a30ad5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c68f56d0-3e4c-4cba-a14d-5dfdcc04c8f5" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_c42546f3-f467-40db-88a9-39ab6a30ad5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_30a7b184-d84f-4884-9e3c-fcb130a616a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c68f56d0-3e4c-4cba-a14d-5dfdcc04c8f5" xlink:to="loc_us-gaap_Liabilities_30a7b184-d84f-4884-9e3c-fcb130a616a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_4a68711a-9f1d-49b8-8bd1-d2f2ca1d8b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c68f56d0-3e4c-4cba-a14d-5dfdcc04c8f5" xlink:to="loc_us-gaap_CommitmentsAndContingencies_4a68711a-9f1d-49b8-8bd1-d2f2ca1d8b2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_c0a95801-72a7-46b1-a0ef-faaa7ffdb586" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c68f56d0-3e4c-4cba-a14d-5dfdcc04c8f5" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_c0a95801-72a7-46b1-a0ef-faaa7ffdb586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_dba06e52-e38f-4b6d-9dda-f03c5dff6638" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c68f56d0-3e4c-4cba-a14d-5dfdcc04c8f5" xlink:to="loc_us-gaap_StockholdersEquityAbstract_dba06e52-e38f-4b6d-9dda-f03c5dff6638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_9e407b0a-ffcc-4e87-8dc2-a4dbbf2c65c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_dba06e52-e38f-4b6d-9dda-f03c5dff6638" xlink:to="loc_us-gaap_PreferredStockValue_9e407b0a-ffcc-4e87-8dc2-a4dbbf2c65c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_6b4d4d04-8265-4ed7-8ea2-b7a13dc6bdba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_dba06e52-e38f-4b6d-9dda-f03c5dff6638" xlink:to="loc_us-gaap_CommonStockValue_6b4d4d04-8265-4ed7-8ea2-b7a13dc6bdba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_cf1988fb-c18a-4e96-a499-4f176c2d4a5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_dba06e52-e38f-4b6d-9dda-f03c5dff6638" xlink:to="loc_us-gaap_AdditionalPaidInCapital_cf1988fb-c18a-4e96-a499-4f176c2d4a5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2d8dc93e-6acf-4178-a535-24f64479790a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_dba06e52-e38f-4b6d-9dda-f03c5dff6638" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2d8dc93e-6acf-4178-a535-24f64479790a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_711f3ebd-762d-43f8-9b2e-94ddec5f3223" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_dba06e52-e38f-4b6d-9dda-f03c5dff6638" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_711f3ebd-762d-43f8-9b2e-94ddec5f3223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_bdc08895-9dba-4b41-a394-8f758a76e32c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_dba06e52-e38f-4b6d-9dda-f03c5dff6638" xlink:to="loc_us-gaap_MinorityInterest_bdc08895-9dba-4b41-a394-8f758a76e32c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0877b059-a949-4eb2-acdf-d4e15d4e4fff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_dba06e52-e38f-4b6d-9dda-f03c5dff6638" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0877b059-a949-4eb2-acdf-d4e15d4e4fff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_f262f897-a3d8-4e96-9dda-2936e5c2b87e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_dba06e52-e38f-4b6d-9dda-f03c5dff6638" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_f262f897-a3d8-4e96-9dda-2936e5c2b87e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_7c8d01aa-2105-4934-951d-43c39320f081" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3fc3aaef-74f9-4df3-a47b-afe01414b904" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_7c8d01aa-2105-4934-951d-43c39320f081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_8c11e89a-8304-46c8-b895-bfb5f5353f37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3fc3aaef-74f9-4df3-a47b-afe01414b904" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_8c11e89a-8304-46c8-b895-bfb5f5353f37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_8e366713-15d9-4ee0-bec2-c0125a394cbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3fc3aaef-74f9-4df3-a47b-afe01414b904" xlink:to="loc_us-gaap_PreferredStockSharesIssued_8e366713-15d9-4ee0-bec2-c0125a394cbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_e62e6df6-0e42-45a2-94d8-ba74e9169f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3fc3aaef-74f9-4df3-a47b-afe01414b904" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_e62e6df6-0e42-45a2-94d8-ba74e9169f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_205fc6cb-795c-4ac4-af29-25c887a00bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3fc3aaef-74f9-4df3-a47b-afe01414b904" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_205fc6cb-795c-4ac4-af29-25c887a00bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_61a1f4c9-acc5-466a-af3f-db1bc831ab8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3fc3aaef-74f9-4df3-a47b-afe01414b904" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_61a1f4c9-acc5-466a-af3f-db1bc831ab8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_ea8a2cf0-a9a8-46b6-8e9a-693a7d2dc1aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3fc3aaef-74f9-4df3-a47b-afe01414b904" xlink:to="loc_us-gaap_CommonStockSharesIssued_ea8a2cf0-a9a8-46b6-8e9a-693a7d2dc1aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_9002dc98-e794-4ba1-8a74-78bae6e2357a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3fc3aaef-74f9-4df3-a47b-afe01414b904" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_9002dc98-e794-4ba1-8a74-78bae6e2357a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical" xlink:type="simple" xlink:href="unh-20211231.xsd#ConsolidatedBalanceSheetParenthetical"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7e82ba48-0ec7-407a-ad3e-831b21b2c41c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_3c56ac78-9b74-4f60-b208-2a5ca3f69a80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7e82ba48-0ec7-407a-ad3e-831b21b2c41c" xlink:to="loc_us-gaap_StatementTable_3c56ac78-9b74-4f60-b208-2a5ca3f69a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_1ce3708d-d1db-4edb-8d5b-b58ed9ecdbf2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_3c56ac78-9b74-4f60-b208-2a5ca3f69a80" xlink:to="loc_srt_StatementScenarioAxis_1ce3708d-d1db-4edb-8d5b-b58ed9ecdbf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_39edcc0b-f995-45e0-99e7-cd735544055b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_1ce3708d-d1db-4edb-8d5b-b58ed9ecdbf2" xlink:to="loc_srt_ScenarioUnspecifiedDomain_39edcc0b-f995-45e0-99e7-cd735544055b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_85a0b3df-5b8d-4157-b3e6-2b7941cd6781" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_3c56ac78-9b74-4f60-b208-2a5ca3f69a80" xlink:to="loc_us-gaap_StatementClassOfStockAxis_85a0b3df-5b8d-4157-b3e6-2b7941cd6781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_86d2238a-2ef5-43b6-9a1c-93cb33c16808" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_85a0b3df-5b8d-4157-b3e6-2b7941cd6781" xlink:to="loc_us-gaap_ClassOfStockDomain_86d2238a-2ef5-43b6-9a1c-93cb33c16808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a5b673ed-7604-425d-9eb1-c817340e846c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_3c56ac78-9b74-4f60-b208-2a5ca3f69a80" xlink:to="loc_us-gaap_StatementLineItems_a5b673ed-7604-425d-9eb1-c817340e846c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_ecae745b-1ee2-422c-b28e-a84337ca78dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a5b673ed-7604-425d-9eb1-c817340e846c" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_ecae745b-1ee2-422c-b28e-a84337ca78dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_964afacf-0f2f-4fcf-bb11-87a063ef1279" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a5b673ed-7604-425d-9eb1-c817340e846c" xlink:to="loc_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_964afacf-0f2f-4fcf-bb11-87a063ef1279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1666e914-35c7-45c7-afc3-cf48ec288bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a5b673ed-7604-425d-9eb1-c817340e846c" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1666e914-35c7-45c7-afc3-cf48ec288bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8c8a4a05-f159-4e60-95a7-d26f53b281fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a5b673ed-7604-425d-9eb1-c817340e846c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8c8a4a05-f159-4e60-95a7-d26f53b281fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_d1f6ce55-92a7-474f-947f-6ac66a267ea6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a5b673ed-7604-425d-9eb1-c817340e846c" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_d1f6ce55-92a7-474f-947f-6ac66a267ea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_133303dd-c71b-4a39-86d7-e07f47914607" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a5b673ed-7604-425d-9eb1-c817340e846c" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_133303dd-c71b-4a39-86d7-e07f47914607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_35cf81c8-c7f7-47d0-b324-a0431d76ee20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a5b673ed-7604-425d-9eb1-c817340e846c" xlink:to="loc_us-gaap_CommonStockSharesIssued_35cf81c8-c7f7-47d0-b324-a0431d76ee20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_14e21cb1-6847-4537-acde-e41a5bdf2921" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a5b673ed-7604-425d-9eb1-c817340e846c" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_14e21cb1-6847-4537-acde-e41a5bdf2921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_9345af9d-9e2f-4091-8ac9-5ee6172b3836" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a5b673ed-7604-425d-9eb1-c817340e846c" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_9345af9d-9e2f-4091-8ac9-5ee6172b3836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_535b75fd-7726-46d8-9cd9-9c66e5ba02f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a5b673ed-7604-425d-9eb1-c817340e846c" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_535b75fd-7726-46d8-9cd9-9c66e5ba02f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_e507729e-b2f6-40ef-bc42-ba5cb9d025f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a5b673ed-7604-425d-9eb1-c817340e846c" xlink:to="loc_us-gaap_PreferredStockSharesIssued_e507729e-b2f6-40ef-bc42-ba5cb9d025f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_38d953db-df7d-4f09-9290-47ad9763dab9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a5b673ed-7604-425d-9eb1-c817340e846c" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_38d953db-df7d-4f09-9290-47ad9763dab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="unh-20211231.xsd#ConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_f4b7ebe2-0b7d-4b01-bd38-e7b57c266554" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_3c56f691-811c-41fd-8c9a-f14fdcd879ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f4b7ebe2-0b7d-4b01-bd38-e7b57c266554" xlink:to="loc_us-gaap_RevenuesAbstract_3c56f691-811c-41fd-8c9a-f14fdcd879ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_51ee4617-ff9b-4c13-abd3-2e222aa3e2e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_3c56f691-811c-41fd-8c9a-f14fdcd879ce" xlink:to="loc_us-gaap_PremiumsEarnedNet_51ee4617-ff9b-4c13-abd3-2e222aa3e2e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_e2bc1737-2f33-49c0-ac6a-6aa55d440f52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_3c56f691-811c-41fd-8c9a-f14fdcd879ce" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_e2bc1737-2f33-49c0-ac6a-6aa55d440f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_9390c54b-0a2b-4ba3-b35b-6d94aa69a314" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_3c56f691-811c-41fd-8c9a-f14fdcd879ce" xlink:to="loc_us-gaap_Revenues_9390c54b-0a2b-4ba3-b35b-6d94aa69a314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_67ca7320-aac1-47bd-86bc-6f4a57b0cee4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f4b7ebe2-0b7d-4b01-bd38-e7b57c266554" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_67ca7320-aac1-47bd-86bc-6f4a57b0cee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_ea6393f6-82b8-483f-8b26-02b023f6a7fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_67ca7320-aac1-47bd-86bc-6f4a57b0cee4" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_ea6393f6-82b8-483f-8b26-02b023f6a7fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_e2f43690-5f6f-42e9-b6bf-b64a78b2df00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_67ca7320-aac1-47bd-86bc-6f4a57b0cee4" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_e2f43690-5f6f-42e9-b6bf-b64a78b2df00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_c3c9523b-a79a-4039-992d-b4a47249cb66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_67ca7320-aac1-47bd-86bc-6f4a57b0cee4" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_c3c9523b-a79a-4039-992d-b4a47249cb66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_efba3ae3-cf9e-4831-944b-4a6b92f52d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_67ca7320-aac1-47bd-86bc-6f4a57b0cee4" xlink:to="loc_us-gaap_DepreciationAndAmortization_efba3ae3-cf9e-4831-944b-4a6b92f52d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_096d7381-2203-4547-952c-25a99151eaf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_67ca7320-aac1-47bd-86bc-6f4a57b0cee4" xlink:to="loc_us-gaap_CostsAndExpenses_096d7381-2203-4547-952c-25a99151eaf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9d153f03-f558-4d23-ad37-09fde6850989" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f4b7ebe2-0b7d-4b01-bd38-e7b57c266554" xlink:to="loc_us-gaap_OperatingIncomeLoss_9d153f03-f558-4d23-ad37-09fde6850989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_431f202b-a9f3-409a-a61c-795d63d451cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f4b7ebe2-0b7d-4b01-bd38-e7b57c266554" xlink:to="loc_us-gaap_InterestExpense_431f202b-a9f3-409a-a61c-795d63d451cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_253e021d-54fa-47d4-aeb1-30271f5a8f64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f4b7ebe2-0b7d-4b01-bd38-e7b57c266554" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_253e021d-54fa-47d4-aeb1-30271f5a8f64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ede9f1b3-a42e-4c9e-8ed2-b8c3b76119d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f4b7ebe2-0b7d-4b01-bd38-e7b57c266554" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ede9f1b3-a42e-4c9e-8ed2-b8c3b76119d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_04507ef1-083a-4572-9995-c6622eb60764" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f4b7ebe2-0b7d-4b01-bd38-e7b57c266554" xlink:to="loc_us-gaap_ProfitLoss_04507ef1-083a-4572-9995-c6622eb60764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ea86f994-20bf-4f74-bc9d-d9db256324cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f4b7ebe2-0b7d-4b01-bd38-e7b57c266554" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ea86f994-20bf-4f74-bc9d-d9db256324cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0b834984-6c65-452f-9ccb-0aa726515146" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f4b7ebe2-0b7d-4b01-bd38-e7b57c266554" xlink:to="loc_us-gaap_NetIncomeLoss_0b834984-6c65-452f-9ccb-0aa726515146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_a874ddae-9c54-4a42-adac-880df72bba9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f4b7ebe2-0b7d-4b01-bd38-e7b57c266554" xlink:to="loc_us-gaap_EarningsPerShareAbstract_a874ddae-9c54-4a42-adac-880df72bba9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_de2ad80f-0c71-49f7-81c2-4013d727655c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a874ddae-9c54-4a42-adac-880df72bba9f" xlink:to="loc_us-gaap_EarningsPerShareBasic_de2ad80f-0c71-49f7-81c2-4013d727655c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_fc8d2fa2-552e-4702-850a-5e3b1fec32cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a874ddae-9c54-4a42-adac-880df72bba9f" xlink:to="loc_us-gaap_EarningsPerShareDiluted_fc8d2fa2-552e-4702-850a-5e3b1fec32cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_11b05de6-4438-4b1e-bdcf-4d29cea29a38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a874ddae-9c54-4a42-adac-880df72bba9f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_11b05de6-4438-4b1e-bdcf-4d29cea29a38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_22bb0daa-a3cd-477c-a474-da80bbdecc4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a874ddae-9c54-4a42-adac-880df72bba9f" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_22bb0daa-a3cd-477c-a474-da80bbdecc4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1d851b33-21f0-4a3f-8a9b-be79d454ebb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a874ddae-9c54-4a42-adac-880df72bba9f" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1d851b33-21f0-4a3f-8a9b-be79d454ebb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b5092cb7-69e9-4970-bfc5-0a6e1ae81afe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a874ddae-9c54-4a42-adac-880df72bba9f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b5092cb7-69e9-4970-bfc5-0a6e1ae81afe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b4ae93b2-4f59-4d91-b91d-846b98422929" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f4b7ebe2-0b7d-4b01-bd38-e7b57c266554" xlink:to="loc_us-gaap_StatementTable_b4ae93b2-4f59-4d91-b91d-846b98422929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4a2df1cb-22b9-46b0-afa8-1ffd264f602a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b4ae93b2-4f59-4d91-b91d-846b98422929" xlink:to="loc_srt_ProductOrServiceAxis_4a2df1cb-22b9-46b0-afa8-1ffd264f602a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d285831c-b904-49ae-8c7e-cc3cbb6237aa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_4a2df1cb-22b9-46b0-afa8-1ffd264f602a" xlink:to="loc_srt_ProductsAndServicesDomain_d285831c-b904-49ae-8c7e-cc3cbb6237aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_2e85ea58-7d55-4e89-97bf-52308df17de3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d285831c-b904-49ae-8c7e-cc3cbb6237aa" xlink:to="loc_us-gaap_ProductMember_2e85ea58-7d55-4e89-97bf-52308df17de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_cfddcda2-c6a4-4c99-bf57-acc32b176bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d285831c-b904-49ae-8c7e-cc3cbb6237aa" xlink:to="loc_us-gaap_ServiceMember_cfddcda2-c6a4-4c99-bf57-acc32b176bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e2ad1497-f1a7-4bb9-9d69-5ae8cc6444f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b4ae93b2-4f59-4d91-b91d-846b98422929" xlink:to="loc_us-gaap_StatementLineItems_e2ad1497-f1a7-4bb9-9d69-5ae8cc6444f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4bbaa0a0-c69b-4338-bac3-d3f2bad2a315" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e2ad1497-f1a7-4bb9-9d69-5ae8cc6444f7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4bbaa0a0-c69b-4338-bac3-d3f2bad2a315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="unh-20211231.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8ca0aadf-ca7e-4b88-8694-38be5867ba8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_1d6cc92f-a670-4f40-8f84-58104227fe0b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8ca0aadf-ca7e-4b88-8694-38be5867ba8d" xlink:to="loc_srt_StatementScenarioAxis_1d6cc92f-a670-4f40-8f84-58104227fe0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_1c4c8fde-cb74-49ea-b1e0-39980831645e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_1d6cc92f-a670-4f40-8f84-58104227fe0b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_1c4c8fde-cb74-49ea-b1e0-39980831645e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3cded938-e49f-427c-93d2-6f8b41b05a54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8ca0aadf-ca7e-4b88-8694-38be5867ba8d" xlink:to="loc_us-gaap_StatementLineItems_3cded938-e49f-427c-93d2-6f8b41b05a54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_368d8d2c-2261-4aba-a43e-df774c51b3ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3cded938-e49f-427c-93d2-6f8b41b05a54" xlink:to="loc_us-gaap_ProfitLoss_368d8d2c-2261-4aba-a43e-df774c51b3ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_6364597e-dd52-4b6f-ad6f-4dc4f13d3d24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3cded938-e49f-427c-93d2-6f8b41b05a54" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_6364597e-dd52-4b6f-ad6f-4dc4f13d3d24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_9dc26824-99a5-4cbe-8e4c-2cdf85e6ae7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_6364597e-dd52-4b6f-ad6f-4dc4f13d3d24" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_9dc26824-99a5-4cbe-8e4c-2cdf85e6ae7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_21c311d3-c75e-4538-a6ae-89581c05068b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_6364597e-dd52-4b6f-ad6f-4dc4f13d3d24" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_21c311d3-c75e-4538-a6ae-89581c05068b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_c80ebe42-1cba-41db-a97f-3f801b8e3eab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_6364597e-dd52-4b6f-ad6f-4dc4f13d3d24" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_c80ebe42-1cba-41db-a97f-3f801b8e3eab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_69f85c78-7a38-4a77-90db-dccba540a89b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_6364597e-dd52-4b6f-ad6f-4dc4f13d3d24" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_69f85c78-7a38-4a77-90db-dccba540a89b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_c9e42a95-4561-4bfe-acdd-4f19df42dd68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_6364597e-dd52-4b6f-ad6f-4dc4f13d3d24" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_c9e42a95-4561-4bfe-acdd-4f19df42dd68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_7409c26d-f304-4447-9b45-54bbcb045096" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_6364597e-dd52-4b6f-ad6f-4dc4f13d3d24" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_7409c26d-f304-4447-9b45-54bbcb045096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_9f79813a-165b-4169-90aa-aac14cf9616c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_6364597e-dd52-4b6f-ad6f-4dc4f13d3d24" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_9f79813a-165b-4169-90aa-aac14cf9616c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d2f36062-0d8e-4b0b-9e3d-62498e38c214" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_6364597e-dd52-4b6f-ad6f-4dc4f13d3d24" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d2f36062-0d8e-4b0b-9e3d-62498e38c214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_836256e4-4191-4a47-b6c2-41dc68669868" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_6364597e-dd52-4b6f-ad6f-4dc4f13d3d24" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_836256e4-4191-4a47-b6c2-41dc68669868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_d585ffbb-d380-45a1-881c-e2729ce39925" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3cded938-e49f-427c-93d2-6f8b41b05a54" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_d585ffbb-d380-45a1-881c-e2729ce39925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_b2c4e295-6b7b-4cd4-b408-b52e38edea1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3cded938-e49f-427c-93d2-6f8b41b05a54" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_b2c4e295-6b7b-4cd4-b408-b52e38edea1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity" xlink:type="simple" xlink:href="unh-20211231.xsd#ConsolidatedStatementsofChangesinEquity"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_925f1385-2bc0-4716-8cf1-0eb0c9bc72ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7494c47f-2917-438d-9378-2417f3f59ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_925f1385-2bc0-4716-8cf1-0eb0c9bc72ee" xlink:to="loc_us-gaap_StatementTable_7494c47f-2917-438d-9378-2417f3f59ed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_57df6dce-6358-4e5d-afb6-f052f33487a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7494c47f-2917-438d-9378-2417f3f59ed0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_57df6dce-6358-4e5d-afb6-f052f33487a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6ced3318-af15-46b4-8df2-8ac48e341834" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_57df6dce-6358-4e5d-afb6-f052f33487a6" xlink:to="loc_us-gaap_EquityComponentDomain_6ced3318-af15-46b4-8df2-8ac48e341834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_1e77c640-850c-472a-9ea1-4b64e891f02d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6ced3318-af15-46b4-8df2-8ac48e341834" xlink:to="loc_us-gaap_CommonStockMember_1e77c640-850c-472a-9ea1-4b64e891f02d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_a52ed880-5a8a-4c21-9293-3efbde9c0c23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6ced3318-af15-46b4-8df2-8ac48e341834" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_a52ed880-5a8a-4c21-9293-3efbde9c0c23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_0a253107-5f64-4549-a532-b97bbe0afe0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6ced3318-af15-46b4-8df2-8ac48e341834" xlink:to="loc_us-gaap_RetainedEarningsMember_0a253107-5f64-4549-a532-b97bbe0afe0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_4ce81494-80e0-4e06-bfc5-e931aab39bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6ced3318-af15-46b4-8df2-8ac48e341834" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_4ce81494-80e0-4e06-bfc5-e931aab39bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_c3741b80-1dd3-472e-a845-7782269fc69f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6ced3318-af15-46b4-8df2-8ac48e341834" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_c3741b80-1dd3-472e-a845-7782269fc69f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_29f1e8c0-9da3-486a-be85-40d5fc95fafd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6ced3318-af15-46b4-8df2-8ac48e341834" xlink:to="loc_us-gaap_NoncontrollingInterestMember_29f1e8c0-9da3-486a-be85-40d5fc95fafd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_4b845d52-873e-4c18-ba8c-f4f0547d7354" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7494c47f-2917-438d-9378-2417f3f59ed0" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_4b845d52-873e-4c18-ba8c-f4f0547d7354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_3cc1c793-8243-490c-ba4a-73e32309fc98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_4b845d52-873e-4c18-ba8c-f4f0547d7354" xlink:to="loc_us-gaap_TypeOfAdoptionMember_3cc1c793-8243-490c-ba4a-73e32309fc98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_7d9c2168-5247-4545-8f95-ef145e032a78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_3cc1c793-8243-490c-ba4a-73e32309fc98" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_7d9c2168-5247-4545-8f95-ef145e032a78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member_2dbecc61-fd77-4313-937a-3d9992624395" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_3cc1c793-8243-490c-ba4a-73e32309fc98" xlink:to="loc_us-gaap_AccountingStandardsUpdate201613Member_2dbecc61-fd77-4313-937a-3d9992624395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e8ddaf1c-54b2-40e7-8195-bb2d8144dfaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7494c47f-2917-438d-9378-2417f3f59ed0" xlink:to="loc_us-gaap_StatementLineItems_e8ddaf1c-54b2-40e7-8195-bb2d8144dfaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5cb1fc16-903b-46ef-9df7-1c3c752659f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e8ddaf1c-54b2-40e7-8195-bb2d8144dfaf" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5cb1fc16-903b-46ef-9df7-1c3c752659f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d9c63de6-7721-45b9-a685-9888607420d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e8ddaf1c-54b2-40e7-8195-bb2d8144dfaf" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_d9c63de6-7721-45b9-a685-9888607420d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_591b3c05-027a-4130-b855-34eb48e8f716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e8ddaf1c-54b2-40e7-8195-bb2d8144dfaf" xlink:to="loc_us-gaap_NetIncomeLoss_591b3c05-027a-4130-b855-34eb48e8f716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest_223fff4f-8f32-4d14-acdd-d8f37d9d321a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e8ddaf1c-54b2-40e7-8195-bb2d8144dfaf" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest_223fff4f-8f32-4d14-acdd-d8f37d9d321a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_5b871b95-998a-4d9c-8c33-e13067a5f32b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e8ddaf1c-54b2-40e7-8195-bb2d8144dfaf" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_5b871b95-998a-4d9c-8c33-e13067a5f32b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ce0567d8-1bd6-48a4-a486-b7d47bb83ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e8ddaf1c-54b2-40e7-8195-bb2d8144dfaf" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ce0567d8-1bd6-48a4-a486-b7d47bb83ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_fed58c23-cde8-4c79-b9ba-a5355ca13129" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e8ddaf1c-54b2-40e7-8195-bb2d8144dfaf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_fed58c23-cde8-4c79-b9ba-a5355ca13129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_99e841ee-a56b-43f7-8af1-f5f87f9d812c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e8ddaf1c-54b2-40e7-8195-bb2d8144dfaf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_99e841ee-a56b-43f7-8af1-f5f87f9d812c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_a9a53ef5-d2fc-4d4b-a0df-e725e33312cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e8ddaf1c-54b2-40e7-8195-bb2d8144dfaf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_a9a53ef5-d2fc-4d4b-a0df-e725e33312cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_09b49042-d600-4b2a-bb59-641ef8fc8126" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e8ddaf1c-54b2-40e7-8195-bb2d8144dfaf" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_09b49042-d600-4b2a-bb59-641ef8fc8126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_b9fe5ca6-8779-47bb-b696-f3fcbd1d5366" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e8ddaf1c-54b2-40e7-8195-bb2d8144dfaf" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_b9fe5ca6-8779-47bb-b696-f3fcbd1d5366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCash_4c3191b1-3799-4d45-9668-c4020a04676a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCash"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e8ddaf1c-54b2-40e7-8195-bb2d8144dfaf" xlink:to="loc_us-gaap_DividendsCash_4c3191b1-3799-4d45-9668-c4020a04676a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_96aa2b02-d46e-4d11-bb03-ef63ffb8c83a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e8ddaf1c-54b2-40e7-8195-bb2d8144dfaf" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_96aa2b02-d46e-4d11-bb03-ef63ffb8c83a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue_705e23f2-feb0-4327-a695-ab63facff8f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestChangeInRedemptionValue"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e8ddaf1c-54b2-40e7-8195-bb2d8144dfaf" xlink:to="loc_us-gaap_MinorityInterestChangeInRedemptionValue_705e23f2-feb0-4327-a695-ab63facff8f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_fadbe2d9-9f5b-42a9-a4ce-bdd01e509320" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e8ddaf1c-54b2-40e7-8195-bb2d8144dfaf" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_fadbe2d9-9f5b-42a9-a4ce-bdd01e509320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_c260ae7e-390c-4b11-bb04-e2bc3376881d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e8ddaf1c-54b2-40e7-8195-bb2d8144dfaf" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_c260ae7e-390c-4b11-bb04-e2bc3376881d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0d0dd48f-c595-47dd-99c9-cf0780bc3dba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e8ddaf1c-54b2-40e7-8195-bb2d8144dfaf" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0d0dd48f-c595-47dd-99c9-cf0780bc3dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_c0c4f064-6226-47fa-8951-e9b99dfe0226" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e8ddaf1c-54b2-40e7-8195-bb2d8144dfaf" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_c0c4f064-6226-47fa-8951-e9b99dfe0226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ConsolidatedStatementofChangesinEquityParentheticals" xlink:type="simple" xlink:href="unh-20211231.xsd#ConsolidatedStatementofChangesinEquityParentheticals"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ConsolidatedStatementofChangesinEquityParentheticals" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_982770e2-29ad-4db3-9d84-910096ba5e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_e8d78d47-785f-42d2-be6f-dc891f5f4aad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_982770e2-29ad-4db3-9d84-910096ba5e5d" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_e8d78d47-785f-42d2-be6f-dc891f5f4aad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="unh-20211231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_0fe46c90-446a-4df1-b282-1f12ba7d1a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bdc2148b-dc76-49ff-bc85-c802d72bedc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0fe46c90-446a-4df1-b282-1f12ba7d1a0f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bdc2148b-dc76-49ff-bc85-c802d72bedc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_34c2cb5e-d7df-4d6b-92bd-d285bc4ffd58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bdc2148b-dc76-49ff-bc85-c802d72bedc5" xlink:to="loc_us-gaap_ProfitLoss_34c2cb5e-d7df-4d6b-92bd-d285bc4ffd58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_397ba812-ccf0-4fd3-a615-c2fba9081a72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bdc2148b-dc76-49ff-bc85-c802d72bedc5" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_397ba812-ccf0-4fd3-a615-c2fba9081a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_5425d4f1-2d95-4254-acf0-46f00eaf2682" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_397ba812-ccf0-4fd3-a615-c2fba9081a72" xlink:to="loc_us-gaap_DepreciationAndAmortization_5425d4f1-2d95-4254-acf0-46f00eaf2682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_eebafd7d-7b4b-4826-acef-f9eb6c02c9d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_397ba812-ccf0-4fd3-a615-c2fba9081a72" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_eebafd7d-7b4b-4826-acef-f9eb6c02c9d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_61bbf069-1ca7-4e9e-815f-9d85f8de9cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_397ba812-ccf0-4fd3-a615-c2fba9081a72" xlink:to="loc_us-gaap_ShareBasedCompensation_61bbf069-1ca7-4e9e-815f-9d85f8de9cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_ed79302f-6587-47a1-8410-f214b4e70a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_397ba812-ccf0-4fd3-a615-c2fba9081a72" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_ed79302f-6587-47a1-8410-f214b4e70a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_52ccd8d8-82db-4f1b-a3a0-fcde0e42ff78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bdc2148b-dc76-49ff-bc85-c802d72bedc5" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_52ccd8d8-82db-4f1b-a3a0-fcde0e42ff78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_547e0a73-a496-47e9-b8c3-8e1cf3afae68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_52ccd8d8-82db-4f1b-a3a0-fcde0e42ff78" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_547e0a73-a496-47e9-b8c3-8e1cf3afae68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_aff0a3ac-60a2-46bd-a065-fd239584155a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_52ccd8d8-82db-4f1b-a3a0-fcde0e42ff78" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_aff0a3ac-60a2-46bd-a065-fd239584155a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_c6bcf0e6-27d5-4f68-8d12-d0086d92ab90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_52ccd8d8-82db-4f1b-a3a0-fcde0e42ff78" xlink:to="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_c6bcf0e6-27d5-4f68-8d12-d0086d92ab90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_9098725e-78f9-46ad-b33a-ed0bf32c8a10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_52ccd8d8-82db-4f1b-a3a0-fcde0e42ff78" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_9098725e-78f9-46ad-b33a-ed0bf32c8a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_08f89859-fbd4-48fc-9d9f-3eea8cb860c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_52ccd8d8-82db-4f1b-a3a0-fcde0e42ff78" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_08f89859-fbd4-48fc-9d9f-3eea8cb860c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5517013d-4c80-43d5-9486-f7575b29840a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bdc2148b-dc76-49ff-bc85-c802d72bedc5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5517013d-4c80-43d5-9486-f7575b29840a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_807438eb-85c5-4190-acbf-395c0dc707ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0fe46c90-446a-4df1-b282-1f12ba7d1a0f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_807438eb-85c5-4190-acbf-395c0dc707ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_b7806dd1-0e6a-4658-ac35-3359bad2497c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_807438eb-85c5-4190-acbf-395c0dc707ca" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_b7806dd1-0e6a-4658-ac35-3359bad2497c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_5a759d5d-ca4a-417a-9e14-5964ee7804cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_807438eb-85c5-4190-acbf-395c0dc707ca" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_5a759d5d-ca4a-417a-9e14-5964ee7804cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_3faf181f-952f-4b82-a173-5e61480e1091" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_807438eb-85c5-4190-acbf-395c0dc707ca" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_3faf181f-952f-4b82-a173-5e61480e1091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_a454f46a-5437-4246-892b-f4631f9c9af7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_807438eb-85c5-4190-acbf-395c0dc707ca" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_a454f46a-5437-4246-892b-f4631f9c9af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2d68d1ab-c04e-4517-8221-9d9691d142c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_807438eb-85c5-4190-acbf-395c0dc707ca" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2d68d1ab-c04e-4517-8221-9d9691d142c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_32781fe2-83c7-4250-ad75-23f501a45a9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_807438eb-85c5-4190-acbf-395c0dc707ca" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_32781fe2-83c7-4250-ad75-23f501a45a9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1ac4b72c-f76b-402c-a453-478a2515b665" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_807438eb-85c5-4190-acbf-395c0dc707ca" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1ac4b72c-f76b-402c-a453-478a2515b665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3d8bf21c-02b7-43f1-a362-e90cb06acaa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0fe46c90-446a-4df1-b282-1f12ba7d1a0f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3d8bf21c-02b7-43f1-a362-e90cb06acaa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_72349e4b-d92d-46c7-b379-b4c21dac382f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3d8bf21c-02b7-43f1-a362-e90cb06acaa4" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_72349e4b-d92d-46c7-b379-b4c21dac382f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_44418c33-b870-4df2-96a6-c676d626eb25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3d8bf21c-02b7-43f1-a362-e90cb06acaa4" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_44418c33-b870-4df2-96a6-c676d626eb25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_76ce0c72-c5a6-4f83-acad-4ed6e9f03001" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3d8bf21c-02b7-43f1-a362-e90cb06acaa4" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_76ce0c72-c5a6-4f83-acad-4ed6e9f03001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_cd488c46-e849-4691-8c07-5dc17aabba38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3d8bf21c-02b7-43f1-a362-e90cb06acaa4" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_cd488c46-e849-4691-8c07-5dc17aabba38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_22fe6c69-6bcc-4e18-a6bd-ccd136a7e1e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3d8bf21c-02b7-43f1-a362-e90cb06acaa4" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_22fe6c69-6bcc-4e18-a6bd-ccd136a7e1e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_c90584df-e346-412d-b483-a25cbe05f999" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3d8bf21c-02b7-43f1-a362-e90cb06acaa4" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_c90584df-e346-412d-b483-a25cbe05f999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeposits_b685dabb-0cd7-47b6-8fd1-f97d01d17097" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeposits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3d8bf21c-02b7-43f1-a362-e90cb06acaa4" xlink:to="loc_us-gaap_IncreaseDecreaseInDeposits_b685dabb-0cd7-47b6-8fd1-f97d01d17097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_83af9299-bdac-455d-997f-cf6aa7dad607" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3d8bf21c-02b7-43f1-a362-e90cb06acaa4" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_83af9299-bdac-455d-997f-cf6aa7dad607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_50f72068-b250-47c1-892e-bb066166a4a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3d8bf21c-02b7-43f1-a362-e90cb06acaa4" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_50f72068-b250-47c1-892e-bb066166a4a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d511dcfd-83e6-4b17-822a-605e4aca8eec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3d8bf21c-02b7-43f1-a362-e90cb06acaa4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d511dcfd-83e6-4b17-822a-605e4aca8eec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_2eab8e0e-f663-49a1-a912-33a0ea4809d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0fe46c90-446a-4df1-b282-1f12ba7d1a0f" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_2eab8e0e-f663-49a1-a912-33a0ea4809d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_62ec2488-f46a-49da-8580-e20be440388d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0fe46c90-446a-4df1-b282-1f12ba7d1a0f" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_62ec2488-f46a-49da-8580-e20be440388d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e8c7c052-4e2e-4f42-88e1-86852475025c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0fe46c90-446a-4df1-b282-1f12ba7d1a0f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e8c7c052-4e2e-4f42-88e1-86852475025c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_46384a49-ab0b-4f1a-8f00-b6c705b12f04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0fe46c90-446a-4df1-b282-1f12ba7d1a0f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_46384a49-ab0b-4f1a-8f00-b6c705b12f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_a6cb4aa2-5c4e-4d05-9cc3-1b240d888334" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0fe46c90-446a-4df1-b282-1f12ba7d1a0f" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_a6cb4aa2-5c4e-4d05-9cc3-1b240d888334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_11208396-7474-4c56-a4df-1bfb3a730286" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_a6cb4aa2-5c4e-4d05-9cc3-1b240d888334" xlink:to="loc_us-gaap_InterestPaidNet_11208396-7474-4c56-a4df-1bfb3a730286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_d3a838c7-2660-4772-822f-6f20f3cca12d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_a6cb4aa2-5c4e-4d05-9cc3-1b240d888334" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_d3a838c7-2660-4772-822f-6f20f3cca12d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/DescriptionofBusinessNotes" xlink:type="simple" xlink:href="unh-20211231.xsd#DescriptionofBusinessNotes"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/DescriptionofBusinessNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_DescriptionofBusinessAbstract_e4d11977-8067-415c-8d7b-00583845e69f" xlink:href="unh-20211231.xsd#unh_DescriptionofBusinessAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_3ce9a554-e44b-4179-bf9c-68fb5f09d09f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_DescriptionofBusinessAbstract_e4d11977-8067-415c-8d7b-00583845e69f" xlink:to="loc_us-gaap_StatementTable_3ce9a554-e44b-4179-bf9c-68fb5f09d09f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_1a8d50c5-bfe1-454c-ac28-b94eedffaed5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_3ce9a554-e44b-4179-bf9c-68fb5f09d09f" xlink:to="loc_srt_StatementScenarioAxis_1a8d50c5-bfe1-454c-ac28-b94eedffaed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_eaad79fd-f7ea-4fa0-9126-a964af2cf5df" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_1a8d50c5-bfe1-454c-ac28-b94eedffaed5" xlink:to="loc_srt_ScenarioUnspecifiedDomain_eaad79fd-f7ea-4fa0-9126-a964af2cf5df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e1a28531-178c-4d7e-845c-0191b2db8f84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_3ce9a554-e44b-4179-bf9c-68fb5f09d09f" xlink:to="loc_us-gaap_StatementLineItems_e1a28531-178c-4d7e-845c-0191b2db8f84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_7a54aa5a-4aec-4530-9323-561d194b2309" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e1a28531-178c-4d7e-845c-0191b2db8f84" xlink:to="loc_us-gaap_NatureOfOperations_7a54aa5a-4aec-4530-9323-561d194b2309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes" xlink:type="simple" xlink:href="unh-20211231.xsd#BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_BasisofpresentationAbstract_bac1e7e0-b640-49db-a69e-5c93a5ce002e" xlink:href="unh-20211231.xsd#unh_BasisofpresentationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b1af3b02-f497-41b9-a50e-2d01c40d203a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_BasisofpresentationAbstract_bac1e7e0-b640-49db-a69e-5c93a5ce002e" xlink:to="loc_us-gaap_StatementTable_b1af3b02-f497-41b9-a50e-2d01c40d203a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_b4ba586e-ddf0-4cdb-996a-62eac4954e1e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b1af3b02-f497-41b9-a50e-2d01c40d203a" xlink:to="loc_srt_StatementScenarioAxis_b4ba586e-ddf0-4cdb-996a-62eac4954e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_3d703223-697a-486d-8371-0a83fc642a8a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_b4ba586e-ddf0-4cdb-996a-62eac4954e1e" xlink:to="loc_srt_ScenarioUnspecifiedDomain_3d703223-697a-486d-8371-0a83fc642a8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e0c0da1c-22d5-42d7-9d19-0ecc5d86d15c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b1af3b02-f497-41b9-a50e-2d01c40d203a" xlink:to="loc_us-gaap_StatementLineItems_e0c0da1c-22d5-42d7-9d19-0ecc5d86d15c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_87e55198-713b-49dd-827d-a9d2e0477ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e0c0da1c-22d5-42d7-9d19-0ecc5d86d15c" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_87e55198-713b-49dd-827d-a9d2e0477ae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="unh-20211231.xsd#BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_BasisofpresentationAbstract_c55e181e-60ab-4921-b131-69828d11c7f4" xlink:href="unh-20211231.xsd#unh_BasisofpresentationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_417eb582-cdba-4058-9eb0-07cc029395a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_BasisofpresentationAbstract_c55e181e-60ab-4921-b131-69828d11c7f4" xlink:to="loc_us-gaap_StatementTable_417eb582-cdba-4058-9eb0-07cc029395a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_df878edf-5a04-4b18-9414-5cb5c73f5a4e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_417eb582-cdba-4058-9eb0-07cc029395a7" xlink:to="loc_srt_StatementScenarioAxis_df878edf-5a04-4b18-9414-5cb5c73f5a4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_2e1912dc-e7f5-40ad-98ef-5c181545a2c2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_df878edf-5a04-4b18-9414-5cb5c73f5a4e" xlink:to="loc_srt_ScenarioUnspecifiedDomain_2e1912dc-e7f5-40ad-98ef-5c181545a2c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_417eb582-cdba-4058-9eb0-07cc029395a7" xlink:to="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_4d1b80f5-69c8-4abb-a051-3825f1449b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_4d1b80f5-69c8-4abb-a051-3825f1449b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_5d7ca98c-6d10-4aa1-8c40-42b035664f06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:to="loc_us-gaap_UseOfEstimates_5d7ca98c-6d10-4aa1-8c40-42b035664f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_dfb30f49-03d0-44f0-8b14-224aa2b17f28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_dfb30f49-03d0-44f0-8b14-224aa2b17f28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy_213cb910-a290-42fe-9f86-570239c11bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:to="loc_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy_213cb910-a290-42fe-9f86-570239c11bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock_d7abeab7-9cd4-40d3-b3ac-f1837322ca86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:to="loc_us-gaap_CostOfSalesPolicyTextBlock_d7abeab7-9cd4-40d3-b3ac-f1837322ca86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_9353b737-9d50-4035-b280-fbfc049f960c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_9353b737-9d50-4035-b280-fbfc049f960c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_625be443-ab99-485c-8153-1b85d6eddfee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_625be443-ab99-485c-8153-1b85d6eddfee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_AARPAssetsUnderManagementPolicyTextBlock_94b9d45a-27b3-49c4-ad6c-a9337cd11f2e" xlink:href="unh-20211231.xsd#unh_AARPAssetsUnderManagementPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:to="loc_unh_AARPAssetsUnderManagementPolicyTextBlock_94b9d45a-27b3-49c4-ad6c-a9337cd11f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_0bb3d9dd-1375-4dc8-a501-ce8cb0cba3e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_0bb3d9dd-1375-4dc8-a501-ce8cb0cba3e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_ff92d072-2c17-47cf-b9f7-49c8f50b04e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_ff92d072-2c17-47cf-b9f7-49c8f50b04e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_c0033f20-b050-443a-98e4-5b66f2dc8347" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_c0033f20-b050-443a-98e4-5b66f2dc8347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_5540d28c-af86-4e50-aa7b-0e190efa3a76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_5540d28c-af86-4e50-aa7b-0e190efa3a76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_30f31908-9d86-4cc6-92b2-6c9e93bb0ea9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_30f31908-9d86-4cc6-92b2-6c9e93bb0ea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OtherLiabilitiesCurrentPolicyTextBlock_afac6a39-cb2b-4326-926c-9b3a2597ecf0" xlink:href="unh-20211231.xsd#unh_OtherLiabilitiesCurrentPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:to="loc_unh_OtherLiabilitiesCurrentPolicyTextBlock_afac6a39-cb2b-4326-926c-9b3a2597ecf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy_1ddfb32d-a5d5-4904-92c1-454bee657cbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:to="loc_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy_1ddfb32d-a5d5-4904-92c1-454bee657cbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_eb14c2eb-5238-4611-996c-0f42e5b9ab3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:to="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_eb14c2eb-5238-4611-996c-0f42e5b9ab3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_c888b8a8-153d-417e-99ba-f1dddd7e38ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_c888b8a8-153d-417e-99ba-f1dddd7e38ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_cdfe945e-7d02-4fc3-9c81-704653442b9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_cdfe945e-7d02-4fc3-9c81-704653442b9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndustrySpecificPoliciesInsuranceCompaniesTextBlock_6e33bf9e-da62-45b3-87a8-c6583ea60baf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndustrySpecificPoliciesInsuranceCompaniesTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6a6424f3-a9f5-43ec-910d-4ee90054f933" xlink:to="loc_us-gaap_IndustrySpecificPoliciesInsuranceCompaniesTextBlock_6e33bf9e-da62-45b3-87a8-c6583ea60baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="unh-20211231.xsd#BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_BasisofpresentationAbstract_89238a98-764b-4fd7-b409-d013addc8101" xlink:href="unh-20211231.xsd#unh_BasisofpresentationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_3de527b1-a364-4e81-af6a-642fb422cb1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_BasisofpresentationAbstract_89238a98-764b-4fd7-b409-d013addc8101" xlink:to="loc_us-gaap_StatementTable_3de527b1-a364-4e81-af6a-642fb422cb1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_84e75579-5a2e-4676-af16-9a6b8bb1dc28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_3de527b1-a364-4e81-af6a-642fb422cb1f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_84e75579-5a2e-4676-af16-9a6b8bb1dc28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f7d32bd-ad90-4ef6-97e5-ad34b3a60b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_84e75579-5a2e-4676-af16-9a6b8bb1dc28" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f7d32bd-ad90-4ef6-97e5-ad34b3a60b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_UsefulLifeMember_b9618cb2-95ab-45fc-8153-dabcf16426e5" xlink:href="unh-20211231.xsd#unh_UsefulLifeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f7d32bd-ad90-4ef6-97e5-ad34b3a60b3c" xlink:to="loc_unh_UsefulLifeMember_b9618cb2-95ab-45fc-8153-dabcf16426e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_0031fa47-64b9-48fc-bc36-4b97e786882f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_3de527b1-a364-4e81-af6a-642fb422cb1f" xlink:to="loc_srt_StatementScenarioAxis_0031fa47-64b9-48fc-bc36-4b97e786882f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_8eef1d38-32d7-4570-887b-e4c17443ff8b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_0031fa47-64b9-48fc-bc36-4b97e786882f" xlink:to="loc_srt_ScenarioUnspecifiedDomain_8eef1d38-32d7-4570-887b-e4c17443ff8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_70d3df52-2997-4f71-a225-e47427620e70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_3de527b1-a364-4e81-af6a-642fb422cb1f" xlink:to="loc_us-gaap_StatementLineItems_70d3df52-2997-4f71-a225-e47427620e70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_39651d6e-d1c7-455b-bfb6-40f002ef8d2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_70d3df52-2997-4f71-a225-e47427620e70" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_39651d6e-d1c7-455b-bfb6-40f002ef8d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_10d2bdfa-9834-4688-a8ae-78f07c62cf57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_70d3df52-2997-4f71-a225-e47427620e70" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_10d2bdfa-9834-4688-a8ae-78f07c62cf57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_BasisofpresentationAbstract_b888ab7b-0a35-4c0a-886e-f16421dc3910" xlink:href="unh-20211231.xsd#unh_BasisofpresentationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_20310919-0d2f-4318-a648-a51ade26bc65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_BasisofpresentationAbstract_b888ab7b-0a35-4c0a-886e-f16421dc3910" xlink:to="loc_us-gaap_StatementTable_20310919-0d2f-4318-a648-a51ade26bc65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_MedicarePartDPharmacyBenefitsContractAxis_dba16c5c-d691-4c5f-bda7-38cf9c46ff44" xlink:href="unh-20211231.xsd#unh_MedicarePartDPharmacyBenefitsContractAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_20310919-0d2f-4318-a648-a51ade26bc65" xlink:to="loc_unh_MedicarePartDPharmacyBenefitsContractAxis_dba16c5c-d691-4c5f-bda7-38cf9c46ff44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_MedicarePartDPharmacyBenefitsContractDomain_f60f8caa-d6c0-4098-adfb-45035a928ab5" xlink:href="unh-20211231.xsd#unh_MedicarePartDPharmacyBenefitsContractDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_MedicarePartDPharmacyBenefitsContractAxis_dba16c5c-d691-4c5f-bda7-38cf9c46ff44" xlink:to="loc_unh_MedicarePartDPharmacyBenefitsContractDomain_f60f8caa-d6c0-4098-adfb-45035a928ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_MedicarePartDReceivablesMember_81fd756b-5569-4934-b846-f9caae921b2e" xlink:href="unh-20211231.xsd#unh_MedicarePartDReceivablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_MedicarePartDPharmacyBenefitsContractDomain_f60f8caa-d6c0-4098-adfb-45035a928ab5" xlink:to="loc_unh_MedicarePartDReceivablesMember_81fd756b-5569-4934-b846-f9caae921b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_PharmaceuticalmanufacturerrebatesreceivableAxis_a3317001-e864-46ac-8ecf-bfdb22b82f5f" xlink:href="unh-20211231.xsd#unh_PharmaceuticalmanufacturerrebatesreceivableAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_20310919-0d2f-4318-a648-a51ade26bc65" xlink:to="loc_unh_PharmaceuticalmanufacturerrebatesreceivableAxis_a3317001-e864-46ac-8ecf-bfdb22b82f5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_PharmaceuticalmanufacturerrebatesreceivableDomain_a365d158-904b-458c-ad48-a638fac0ff2b" xlink:href="unh-20211231.xsd#unh_PharmaceuticalmanufacturerrebatesreceivableDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_PharmaceuticalmanufacturerrebatesreceivableAxis_a3317001-e864-46ac-8ecf-bfdb22b82f5f" xlink:to="loc_unh_PharmaceuticalmanufacturerrebatesreceivableDomain_a365d158-904b-458c-ad48-a638fac0ff2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_PharmaceuticalManufacturerRebatesReceivableMember_ad10a164-7d89-4b5f-82e7-990c4dc56593" xlink:href="unh-20211231.xsd#unh_PharmaceuticalManufacturerRebatesReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_PharmaceuticalmanufacturerrebatesreceivableDomain_a365d158-904b-458c-ad48-a638fac0ff2b" xlink:to="loc_unh_PharmaceuticalManufacturerRebatesReceivableMember_ad10a164-7d89-4b5f-82e7-990c4dc56593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_16b2691f-2c31-4439-9067-9abaab9a6441" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_20310919-0d2f-4318-a648-a51ade26bc65" xlink:to="loc_srt_ProductOrServiceAxis_16b2691f-2c31-4439-9067-9abaab9a6441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1e8e27cb-52c5-44aa-a190-7a471cc159cc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_16b2691f-2c31-4439-9067-9abaab9a6441" xlink:to="loc_srt_ProductsAndServicesDomain_1e8e27cb-52c5-44aa-a190-7a471cc159cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_28f3dbe6-1d6d-4878-9f0c-88395ed5ec22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1e8e27cb-52c5-44aa-a190-7a471cc159cc" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_28f3dbe6-1d6d-4878-9f0c-88395ed5ec22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ProductsandservicesMember_7e84cf41-71e9-4a77-a672-f052371e2503" xlink:href="unh-20211231.xsd#unh_ProductsandservicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1e8e27cb-52c5-44aa-a190-7a471cc159cc" xlink:to="loc_unh_ProductsandservicesMember_7e84cf41-71e9-4a77-a672-f052371e2503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_84cb4828-4a7b-4881-870c-b5da36ccb6c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_20310919-0d2f-4318-a648-a51ade26bc65" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_84cb4828-4a7b-4881-870c-b5da36ccb6c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_27da5aba-4d13-417a-a0c3-ec556db13b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_84cb4828-4a7b-4881-870c-b5da36ccb6c7" xlink:to="loc_us-gaap_TypeOfAdoptionMember_27da5aba-4d13-417a-a0c3-ec556db13b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_333d2156-8c28-450c-af92-67722c9fee3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_27da5aba-4d13-417a-a0c3-ec556db13b1e" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_333d2156-8c28-450c-af92-67722c9fee3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_17e4563b-be41-4efc-bfd3-2e96458a4719" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_20310919-0d2f-4318-a648-a51ade26bc65" xlink:to="loc_us-gaap_AwardTypeAxis_17e4563b-be41-4efc-bfd3-2e96458a4719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_713a7887-4920-4f52-a7e0-c6904c4e8f0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_17e4563b-be41-4efc-bfd3-2e96458a4719" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_713a7887-4920-4f52-a7e0-c6904c4e8f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_d65001bf-b6fb-49a5-817b-d3acb8521d77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_713a7887-4920-4f52-a7e0-c6904c4e8f0c" xlink:to="loc_us-gaap_RestrictedStockMember_d65001bf-b6fb-49a5-817b-d3acb8521d77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EmployeeStockPurchasePlanESPPMember_252eb4a3-baac-4fbb-b7e7-610771ed2207" xlink:href="unh-20211231.xsd#unh_EmployeeStockPurchasePlanESPPMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_713a7887-4920-4f52-a7e0-c6904c4e8f0c" xlink:to="loc_unh_EmployeeStockPurchasePlanESPPMember_252eb4a3-baac-4fbb-b7e7-610771ed2207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_StockOptionsandSARsMember_92de2494-3c72-4776-870a-7682a8d89ace" xlink:href="unh-20211231.xsd#unh_StockOptionsandSARsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_713a7887-4920-4f52-a7e0-c6904c4e8f0c" xlink:to="loc_unh_StockOptionsandSARsMember_92de2494-3c72-4776-870a-7682a8d89ace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a9fa3141-6e43-4019-a15f-15e21c6e815c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_20310919-0d2f-4318-a648-a51ade26bc65" xlink:to="loc_srt_RangeAxis_a9fa3141-6e43-4019-a15f-15e21c6e815c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_69c78c59-a690-4275-aba5-358710e48fdb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a9fa3141-6e43-4019-a15f-15e21c6e815c" xlink:to="loc_srt_RangeMember_69c78c59-a690-4275-aba5-358710e48fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b8e7b3e8-6b1d-43d1-b126-0a46e0d14d34" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_69c78c59-a690-4275-aba5-358710e48fdb" xlink:to="loc_srt_MinimumMember_b8e7b3e8-6b1d-43d1-b126-0a46e0d14d34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e2d58757-9a57-483a-86a5-3eab62a07fc3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_69c78c59-a690-4275-aba5-358710e48fdb" xlink:to="loc_srt_MaximumMember_e2d58757-9a57-483a-86a5-3eab62a07fc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f35fd73e-afdd-432f-99e7-81671b4c92e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_20310919-0d2f-4318-a648-a51ade26bc65" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f35fd73e-afdd-432f-99e7-81671b4c92e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9883ab72-a7cc-4936-bced-7347e6452387" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f35fd73e-afdd-432f-99e7-81671b4c92e3" xlink:to="loc_us-gaap_EquityComponentDomain_9883ab72-a7cc-4936-bced-7347e6452387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_e7c745a9-b69c-463c-933f-671ad1a65327" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9883ab72-a7cc-4936-bced-7347e6452387" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_e7c745a9-b69c-463c-933f-671ad1a65327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_d4cfef05-8c6d-43dc-9b49-32712f092783" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_20310919-0d2f-4318-a648-a51ade26bc65" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_d4cfef05-8c6d-43dc-9b49-32712f092783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b667c017-7fe5-4fff-b139-790ef7a9f3ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d4cfef05-8c6d-43dc-9b49-32712f092783" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b667c017-7fe5-4fff-b139-790ef7a9f3ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_a06c6f54-d63a-4bd0-ba2d-84a4ed2d6945" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b667c017-7fe5-4fff-b139-790ef7a9f3ad" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_a06c6f54-d63a-4bd0-ba2d-84a4ed2d6945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b7f8a202-fc19-45d4-9e67-493035786589" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_20310919-0d2f-4318-a648-a51ade26bc65" xlink:to="loc_us-gaap_StatementLineItems_b7f8a202-fc19-45d4-9e67-493035786589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_28249be3-2941-47c4-99c3-790dc4d87ef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b7f8a202-fc19-45d4-9e67-493035786589" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_28249be3-2941-47c4-99c3-790dc4d87ef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days_50eaa7e0-fc56-4175-ae1a-7c97b18f3e83" xlink:href="unh-20211231.xsd#unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b7f8a202-fc19-45d4-9e67-493035786589" xlink:to="loc_unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days_50eaa7e0-fc56-4175-ae1a-7c97b18f3e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_b943d611-a811-414c-8581-cc4e30a4c59d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b7f8a202-fc19-45d4-9e67-493035786589" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_b943d611-a811-414c-8581-cc4e30a4c59d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositAccounts_b454d367-31ca-45dc-9447-e7ae391aca87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DemandDepositAccounts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b7f8a202-fc19-45d4-9e67-493035786589" xlink:to="loc_us-gaap_DemandDepositAccounts_b454d367-31ca-45dc-9447-e7ae391aca87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_008f59b2-5697-45b7-a92b-0551a1be4de6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b7f8a202-fc19-45d4-9e67-493035786589" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_008f59b2-5697-45b7-a92b-0551a1be4de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_c505893d-f264-4795-9f0d-b64957abfd44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b7f8a202-fc19-45d4-9e67-493035786589" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_c505893d-f264-4795-9f0d-b64957abfd44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract_a536b741-e8f9-4b5f-9ece-0d6f0340e38b" xlink:href="unh-20211231.xsd#unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b7f8a202-fc19-45d4-9e67-493035786589" xlink:to="loc_unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract_a536b741-e8f9-4b5f-9ece-0d6f0340e38b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_29c16edb-070a-49a7-be5c-284086d78842" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b7f8a202-fc19-45d4-9e67-493035786589" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_29c16edb-070a-49a7-be5c-284086d78842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_d0831239-4982-47b4-b6a9-1045cf8d16a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b7f8a202-fc19-45d4-9e67-493035786589" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_d0831239-4982-47b4-b6a9-1045cf8d16a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_32fd37cd-76fa-44b6-bfcd-eb8b1326f975" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b7f8a202-fc19-45d4-9e67-493035786589" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_32fd37cd-76fa-44b6-bfcd-eb8b1326f975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1e344fff-4f13-45d0-a431-e821f049eec3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b7f8a202-fc19-45d4-9e67-493035786589" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1e344fff-4f13-45d0-a431-e821f049eec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_6b307657-bce7-4d16-a632-43c7cfce6468" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b7f8a202-fc19-45d4-9e67-493035786589" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_6b307657-bce7-4d16-a632-43c7cfce6468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_f1298ce9-6fed-4111-84f2-2db9467c71ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_26413153-2218-4f33-8561-3548257ceb6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_f1298ce9-6fed-4111-84f2-2db9467c71ca" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_26413153-2218-4f33-8561-3548257ceb6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f69be435-0383-4fd1-8509-2f68125a2ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_26413153-2218-4f33-8561-3548257ceb6a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f69be435-0383-4fd1-8509-2f68125a2ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6fb235e9-cc5d-4c8d-95c7-06d87e6b8d4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f69be435-0383-4fd1-8509-2f68125a2ba6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6fb235e9-cc5d-4c8d-95c7-06d87e6b8d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_5af8eeb6-8635-4298-b61a-262f9b0f2799" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6fb235e9-cc5d-4c8d-95c7-06d87e6b8d4f" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_5af8eeb6-8635-4298-b61a-262f9b0f2799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_1773b05c-9b00-4fbe-9e56-304c17cab50d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6fb235e9-cc5d-4c8d-95c7-06d87e6b8d4f" xlink:to="loc_us-gaap_BuildingMember_1773b05c-9b00-4fbe-9e56-304c17cab50d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_CapitalizedsoftwareMember_4ee509a3-06cd-44dc-a0be-4c92ed00a12e" xlink:href="unh-20211231.xsd#unh_CapitalizedsoftwareMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6fb235e9-cc5d-4c8d-95c7-06d87e6b8d4f" xlink:to="loc_unh_CapitalizedsoftwareMember_4ee509a3-06cd-44dc-a0be-4c92ed00a12e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_65691fdb-414c-489e-805c-ab747eae80ed" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_26413153-2218-4f33-8561-3548257ceb6a" xlink:to="loc_srt_RangeAxis_65691fdb-414c-489e-805c-ab747eae80ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e19158d1-07bf-4a70-b13b-bc85d9e3ebcd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_65691fdb-414c-489e-805c-ab747eae80ed" xlink:to="loc_srt_RangeMember_e19158d1-07bf-4a70-b13b-bc85d9e3ebcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0228ea85-345d-4e07-bbb2-b1ba606488ca" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e19158d1-07bf-4a70-b13b-bc85d9e3ebcd" xlink:to="loc_srt_MinimumMember_0228ea85-345d-4e07-bbb2-b1ba606488ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_01eb6184-0a52-4574-8dc4-46c9f60db69a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e19158d1-07bf-4a70-b13b-bc85d9e3ebcd" xlink:to="loc_srt_MaximumMember_01eb6184-0a52-4574-8dc4-46c9f60db69a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_739edf64-307f-4505-9e59-586f73d23443" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_26413153-2218-4f33-8561-3548257ceb6a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_739edf64-307f-4505-9e59-586f73d23443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_692b363c-f5d8-4418-8157-a76405914bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_739edf64-307f-4505-9e59-586f73d23443" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_692b363c-f5d8-4418-8157-a76405914bc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_9c7b9e9a-aad9-4064-a577-7b893b369164" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_6fe07c7c-121e-4f36-bd3a-fb0d5f58158d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_9c7b9e9a-aad9-4064-a577-7b893b369164" xlink:to="loc_us-gaap_MinorityInterestTable_6fe07c7c-121e-4f36-bd3a-fb0d5f58158d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_7ee69604-f275-4289-9131-3b7f1278309a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_6fe07c7c-121e-4f36-bd3a-fb0d5f58158d" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_7ee69604-f275-4289-9131-3b7f1278309a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_ebe1758a-df00-4d52-9607-4e6b8211a0bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7ee69604-f275-4289-9131-3b7f1278309a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_ebe1758a-df00-4d52-9607-4e6b8211a0bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_RedeemableNoncontrollingInterestsMember_65cb798c-efe0-4931-bd2c-6868b95261d5" xlink:href="unh-20211231.xsd#unh_RedeemableNoncontrollingInterestsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ebe1758a-df00-4d52-9607-4e6b8211a0bd" xlink:to="loc_unh_RedeemableNoncontrollingInterestsMember_65cb798c-efe0-4931-bd2c-6868b95261d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b8ac47c5-e9d2-4d2c-a4fe-03c770e01f19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_6fe07c7c-121e-4f36-bd3a-fb0d5f58158d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b8ac47c5-e9d2-4d2c-a4fe-03c770e01f19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_511fb292-a9c6-4e5e-b885-598e6a681862" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b8ac47c5-e9d2-4d2c-a4fe-03c770e01f19" xlink:to="loc_us-gaap_EquityComponentDomain_511fb292-a9c6-4e5e-b885-598e6a681862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_73303512-224a-44b7-b1b1-3cb20ebd0077" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_6fe07c7c-121e-4f36-bd3a-fb0d5f58158d" xlink:to="loc_us-gaap_MinorityInterestLineItems_73303512-224a-44b7-b1b1-3cb20ebd0077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_f6ae144d-59fb-4744-885e-1460f526a779" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_73303512-224a-44b7-b1b1-3cb20ebd0077" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_f6ae144d-59fb-4744-885e-1460f526a779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_3dcea132-a828-4905-8ebe-5188a99d502b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_73303512-224a-44b7-b1b1-3cb20ebd0077" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_3dcea132-a828-4905-8ebe-5188a99d502b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_83f73d9e-4c57-4574-b1da-d0986dcfcaf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_73303512-224a-44b7-b1b1-3cb20ebd0077" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_83f73d9e-4c57-4574-b1da-d0986dcfcaf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_078fbaf8-b1f7-4472-b832-f12c19ddfb06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_73303512-224a-44b7-b1b1-3cb20ebd0077" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_078fbaf8-b1f7-4472-b832-f12c19ddfb06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_93618153-9296-4b4d-a7f4-83450ffcbb96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_73303512-224a-44b7-b1b1-3cb20ebd0077" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_93618153-9296-4b4d-a7f4-83450ffcbb96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue_574fbc1b-36b7-422c-b092-1dd8462bb051" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestChangeInRedemptionValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_73303512-224a-44b7-b1b1-3cb20ebd0077" xlink:to="loc_us-gaap_MinorityInterestChangeInRedemptionValue_574fbc1b-36b7-422c-b092-1dd8462bb051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_690419b8-f743-49f5-ad1f-d52bb6e24f49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_73303512-224a-44b7-b1b1-3cb20ebd0077" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_690419b8-f743-49f5-ad1f-d52bb6e24f49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/InvestmentsNotes" xlink:type="simple" xlink:href="unh-20211231.xsd#InvestmentsNotes"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/InvestmentsNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_c187bd29-2132-4587-9ede-08ab1eaecc85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_b36d2701-f08b-4d11-a6af-5761abff8b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_c187bd29-2132-4587-9ede-08ab1eaecc85" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_b36d2701-f08b-4d11-a6af-5761abff8b8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/InvestmentsTables" xlink:type="simple" xlink:href="unh-20211231.xsd#InvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/InvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_b98526d5-7378-4eab-88f0-5e12f96f387c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_cda7c685-951c-4692-886f-9587dc9dabdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_b98526d5-7378-4eab-88f0-5e12f96f387c" xlink:to="loc_us-gaap_StatementTable_cda7c685-951c-4692-886f-9587dc9dabdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_8b8d181f-e166-446c-9282-32d4043e57e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_cda7c685-951c-4692-886f-9587dc9dabdc" xlink:to="loc_us-gaap_InvestmentTypeAxis_8b8d181f-e166-446c-9282-32d4043e57e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_8b272045-e1e4-41cf-a1f9-c2c91c609b5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_8b8d181f-e166-446c-9282-32d4043e57e2" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_8b272045-e1e4-41cf-a1f9-c2c91c609b5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_bcb7cd2b-5ed4-47d7-9792-6e78f27fd536" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_cda7c685-951c-4692-886f-9587dc9dabdc" xlink:to="loc_us-gaap_StatementLineItems_bcb7cd2b-5ed4-47d7-9792-6e78f27fd536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_40b788f0-af8a-458d-a646-6e0fc7a34b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bcb7cd2b-5ed4-47d7-9792-6e78f27fd536" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_40b788f0-af8a-458d-a646-6e0fc7a34b6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_1ddfe873-f7af-4741-8390-8f2fd494a3c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bcb7cd2b-5ed4-47d7-9792-6e78f27fd536" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_1ddfe873-f7af-4741-8390-8f2fd494a3c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_8a08d92b-c578-4d47-b49e-976596b13394" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bcb7cd2b-5ed4-47d7-9792-6e78f27fd536" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_8a08d92b-c578-4d47-b49e-976596b13394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/InvestmentsNarrativeDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#InvestmentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/InvestmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_0b5c2e90-fcfb-4ea1-a484-3c0ce36577f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_InvestmentTable_511a1181-16c9-425f-8f8c-115340b4cd6c" xlink:href="unh-20211231.xsd#unh_InvestmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_0b5c2e90-fcfb-4ea1-a484-3c0ce36577f1" xlink:to="loc_unh_InvestmentTable_511a1181-16c9-425f-8f8c-115340b4cd6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_eabb5313-0994-431b-a2eb-9bc1db7e48b7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_InvestmentTable_511a1181-16c9-425f-8f8c-115340b4cd6c" xlink:to="loc_srt_StatementScenarioAxis_eabb5313-0994-431b-a2eb-9bc1db7e48b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_b0c4d734-7b29-407f-b631-ba9c9f71e2b8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_eabb5313-0994-431b-a2eb-9bc1db7e48b7" xlink:to="loc_srt_ScenarioUnspecifiedDomain_b0c4d734-7b29-407f-b631-ba9c9f71e2b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_InvestmentLineItems_a7319841-ad2f-436a-b576-c386720ce479" xlink:href="unh-20211231.xsd#unh_InvestmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_InvestmentTable_511a1181-16c9-425f-8f8c-115340b4cd6c" xlink:to="loc_unh_InvestmentLineItems_a7319841-ad2f-436a-b576-c386720ce479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_fe3158b5-838f-4888-afa7-cf3f3ffdf9b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_InvestmentLineItems_a7319841-ad2f-436a-b576-c386720ce479" xlink:to="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_fe3158b5-838f-4888-afa7-cf3f3ffdf9b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_3c8d7e34-4f8b-4fba-81d2-770bf0268b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_InvestmentLineItems_a7319841-ad2f-436a-b576-c386720ce479" xlink:to="loc_us-gaap_EquityMethodInvestments_3c8d7e34-4f8b-4fba-81d2-770bf0268b0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_4b240ec6-5ac4-415b-a382-6da1027189b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_InvestmentLineItems_a7319841-ad2f-436a-b576-c386720ce479" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_4b240ec6-5ac4-415b-a382-6da1027189b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedBalanceContracts_e23f434e-ae77-4b0a-b582-1e95cff3acff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentOwnedBalanceContracts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_InvestmentLineItems_a7319841-ad2f-436a-b576-c386720ce479" xlink:to="loc_us-gaap_InvestmentOwnedBalanceContracts_e23f434e-ae77-4b0a-b582-1e95cff3acff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#InvestmentsShortTermandLongTermInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_e404de0e-e200-480b-bbb0-fc68c98dc6e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_65d6b098-90a6-4dd9-8f3f-63058fb14f97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_e404de0e-e200-480b-bbb0-fc68c98dc6e6" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_65d6b098-90a6-4dd9-8f3f-63058fb14f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_c38ff9de-9173-471f-a68a-d62d59095910" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_65d6b098-90a6-4dd9-8f3f-63058fb14f97" xlink:to="loc_us-gaap_FinancialInstrumentAxis_c38ff9de-9173-471f-a68a-d62d59095910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_458d3d6c-86d3-4986-8c64-c341076135c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_c38ff9de-9173-471f-a68a-d62d59095910" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_458d3d6c-86d3-4986-8c64-c341076135c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_0a107e2d-780e-49b9-9da0-0a90822d2c8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_458d3d6c-86d3-4986-8c64-c341076135c8" xlink:to="loc_us-gaap_DebtSecuritiesMember_0a107e2d-780e-49b9-9da0-0a90822d2c8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_471f2b99-412f-4ce2-818f-49988f4df72e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_0a107e2d-780e-49b9-9da0-0a90822d2c8c" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_471f2b99-412f-4ce2-818f-49988f4df72e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_f77fed37-3cd7-4038-b14a-3d8dfebd4775" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_0a107e2d-780e-49b9-9da0-0a90822d2c8c" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_f77fed37-3cd7-4038-b14a-3d8dfebd4775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_d50afd64-87c9-4018-b5c7-7dc484da087c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_0a107e2d-780e-49b9-9da0-0a90822d2c8c" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_d50afd64-87c9-4018-b5c7-7dc484da087c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_1533719a-282d-47e1-9b08-8a9fb43cfcb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_0a107e2d-780e-49b9-9da0-0a90822d2c8c" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_1533719a-282d-47e1-9b08-8a9fb43cfcb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_a2bc621a-85ed-4117-800a-03af5d6b7bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_0a107e2d-780e-49b9-9da0-0a90822d2c8c" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_a2bc621a-85ed-4117-800a-03af5d6b7bcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_92204d97-685e-4adb-8740-111dac6c6f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_65d6b098-90a6-4dd9-8f3f-63058fb14f97" xlink:to="loc_us-gaap_ScheduleOfInvestmentsLineItems_92204d97-685e-4adb-8740-111dac6c6f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_fe7ac68f-4264-44cb-b593-a7228cd2d85f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92204d97-685e-4adb-8740-111dac6c6f2b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_fe7ac68f-4264-44cb-b593-a7228cd2d85f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_00ca3f96-aba3-4e3c-8878-32c2dbe9096a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92204d97-685e-4adb-8740-111dac6c6f2b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_00ca3f96-aba3-4e3c-8878-32c2dbe9096a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_20014d55-5fed-452f-83e0-33ed08bc4936" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92204d97-685e-4adb-8740-111dac6c6f2b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_20014d55-5fed-452f-83e0-33ed08bc4936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_47606991-13f2-46c7-8dad-b31baa6635f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92204d97-685e-4adb-8740-111dac6c6f2b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_47606991-13f2-46c7-8dad-b31baa6635f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_43daa193-0fcf-476b-a083-fe94a09a5e22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92204d97-685e-4adb-8740-111dac6c6f2b" xlink:to="loc_us-gaap_HeldToMaturitySecurities_43daa193-0fcf-476b-a083-fe94a09a5e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_236080ed-5ee1-4b08-a410-6d2cb99c605a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92204d97-685e-4adb-8740-111dac6c6f2b" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_236080ed-5ee1-4b08-a410-6d2cb99c605a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_67d9db7e-192c-497a-a0e5-7de86df9d261" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92204d97-685e-4adb-8740-111dac6c6f2b" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_67d9db7e-192c-497a-a0e5-7de86df9d261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_d1e36bff-b643-4c1b-a7b3-6548293e59fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92204d97-685e-4adb-8740-111dac6c6f2b" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_d1e36bff-b643-4c1b-a7b3-6548293e59fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_InvestmentsAmortizedCost_3a77ade5-dfd7-4214-b0a8-67cf1f13c365" xlink:href="unh-20211231.xsd#unh_InvestmentsAmortizedCost"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92204d97-685e-4adb-8740-111dac6c6f2b" xlink:to="loc_unh_InvestmentsAmortizedCost_3a77ade5-dfd7-4214-b0a8-67cf1f13c365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_InvestmentsGrossUnrealizedGains_46585019-9640-4c5c-8eda-6c4c2e1bc698" xlink:href="unh-20211231.xsd#unh_InvestmentsGrossUnrealizedGains"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92204d97-685e-4adb-8740-111dac6c6f2b" xlink:to="loc_unh_InvestmentsGrossUnrealizedGains_46585019-9640-4c5c-8eda-6c4c2e1bc698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_InvestmentsGrossUnrealizedLosses_07418d77-cd38-416f-ab19-4fe439af4272" xlink:href="unh-20211231.xsd#unh_InvestmentsGrossUnrealizedLosses"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92204d97-685e-4adb-8740-111dac6c6f2b" xlink:to="loc_unh_InvestmentsGrossUnrealizedLosses_07418d77-cd38-416f-ab19-4fe439af4272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_4173fd85-15ef-4b8f-97e8-f22397401192" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_92204d97-685e-4adb-8740-111dac6c6f2b" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_4173fd85-15ef-4b8f-97e8-f22397401192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_e20d6080-73a4-4c3c-a3be-87c24c6f6f54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_e9efaa44-5ef8-4854-a813-ee790bd1ca1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_e20d6080-73a4-4c3c-a3be-87c24c6f6f54" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_e9efaa44-5ef8-4854-a813-ee790bd1ca1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_53951514-961d-4cb0-84e9-5a50dc9ca0c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_e9efaa44-5ef8-4854-a813-ee790bd1ca1d" xlink:to="loc_us-gaap_FinancialInstrumentAxis_53951514-961d-4cb0-84e9-5a50dc9ca0c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1a3736e5-8c06-4901-a622-179041a2e456" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_53951514-961d-4cb0-84e9-5a50dc9ca0c6" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1a3736e5-8c06-4901-a622-179041a2e456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_47f5a9d2-cbfd-43b3-80c9-14498059ad7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1a3736e5-8c06-4901-a622-179041a2e456" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_47f5a9d2-cbfd-43b3-80c9-14498059ad7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_bc7d8fee-9619-4859-9557-4ade9d26ddb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1a3736e5-8c06-4901-a622-179041a2e456" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_bc7d8fee-9619-4859-9557-4ade9d26ddb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_e9efaa44-5ef8-4854-a813-ee790bd1ca1d" xlink:to="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_fd4d3394-5934-4361-965c-0974fecebf15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_fd4d3394-5934-4361-965c-0974fecebf15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_26d6c501-220c-42c8-bd0b-cea1d8c2b78c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_26d6c501-220c-42c8-bd0b-cea1d8c2b78c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_53b5033e-76d5-4342-b51f-4203d7737924" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_53b5033e-76d5-4342-b51f-4203d7737924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_ec5d691f-cf54-413e-9ef3-617772a2e6fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_ec5d691f-cf54-413e-9ef3-617772a2e6fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_810ea558-f9e5-4375-b9d9-631d9b316cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_810ea558-f9e5-4375-b9d9-631d9b316cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f1f272c3-f6d5-466d-80bc-6fb10b3a3378" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f1f272c3-f6d5-466d-80bc-6fb10b3a3378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_8a2d7a15-722a-4bac-bfab-e979ade09756" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_8a2d7a15-722a-4bac-bfab-e979ade09756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_59fce7ad-15e2-4d4f-9ee5-5ddea117fbf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_59fce7ad-15e2-4d4f-9ee5-5ddea117fbf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_d97a3dff-e1cb-4f27-8939-c4944571d5f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_d97a3dff-e1cb-4f27-8939-c4944571d5f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_b9539bad-670e-4059-93d5-161844ae4b48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_b9539bad-670e-4059-93d5-161844ae4b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_611678df-6eef-4e60-9874-f1d5e97dd1e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_611678df-6eef-4e60-9874-f1d5e97dd1e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount_5081c766-1353-4599-af0c-95f9fb8d3865" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount_5081c766-1353-4599-af0c-95f9fb8d3865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue_6e459337-7b8f-49c4-b9ba-6c510e7d56b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue_6e459337-7b8f-49c4-b9ba-6c510e7d56b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount_c2a4d966-cd08-43e6-9afa-18720811eaaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount_c2a4d966-cd08-43e6-9afa-18720811eaaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_344ce490-be1e-4ecd-82c3-ea5685950646" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_344ce490-be1e-4ecd-82c3-ea5685950646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount_6c438c7d-5dfa-49e0-b591-0a00d40f82f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount_6c438c7d-5dfa-49e0-b591-0a00d40f82f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_1c9a4bc1-745b-4ab1-a833-0b130d50e4ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_1c9a4bc1-745b-4ab1-a833-0b130d50e4ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount_be760ac4-bfcf-475e-9064-02ab0754733f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount_be760ac4-bfcf-475e-9064-02ab0754733f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue_96422f81-649d-41d1-82ac-c23bec736a6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue_96422f81-649d-41d1-82ac-c23bec736a6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_a915b4c4-1057-415c-86b2-4a9018f87a05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_a915b4c4-1057-415c-86b2-4a9018f87a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_201394e7-9de2-4696-b8ea-0a7d41ee5914" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_HeldToMaturitySecurities_201394e7-9de2-4696-b8ea-0a7d41ee5914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_b0005ad6-4a43-4875-bb97-eb4d187b83a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_990152f3-274a-44da-a6e4-a37802a7536e" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_b0005ad6-4a43-4875-bb97-eb4d187b83a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_0146303a-76f1-4c09-946f-3a6452d576e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_cae3525e-e54f-44e1-83c9-5c94ebca526a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_0146303a-76f1-4c09-946f-3a6452d576e4" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_cae3525e-e54f-44e1-83c9-5c94ebca526a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_66c416db-107e-478f-b692-c23bc1719423" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_cae3525e-e54f-44e1-83c9-5c94ebca526a" xlink:to="loc_us-gaap_FinancialInstrumentAxis_66c416db-107e-478f-b692-c23bc1719423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2b910c4d-77e5-4c1c-9b3e-6683352a545f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_66c416db-107e-478f-b692-c23bc1719423" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2b910c4d-77e5-4c1c-9b3e-6683352a545f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_23e63908-2e75-48c6-a0ab-ec1f9bd42f3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2b910c4d-77e5-4c1c-9b3e-6683352a545f" xlink:to="loc_us-gaap_DebtSecuritiesMember_23e63908-2e75-48c6-a0ab-ec1f9bd42f3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_f29a7d41-54d2-4e91-9470-8916203bd7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_23e63908-2e75-48c6-a0ab-ec1f9bd42f3a" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_f29a7d41-54d2-4e91-9470-8916203bd7a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_b5989112-a5e8-45c9-b59d-12c4dfa33ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_23e63908-2e75-48c6-a0ab-ec1f9bd42f3a" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_b5989112-a5e8-45c9-b59d-12c4dfa33ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_691e1436-f02d-4ed0-8a5c-eea7f8b58bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_23e63908-2e75-48c6-a0ab-ec1f9bd42f3a" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_691e1436-f02d-4ed0-8a5c-eea7f8b58bbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_51cbb9c4-7bff-4051-97e6-8baa315a1814" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_23e63908-2e75-48c6-a0ab-ec1f9bd42f3a" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_51cbb9c4-7bff-4051-97e6-8baa315a1814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_c113d2e1-5b90-4619-9012-4f1971c8cb12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_23e63908-2e75-48c6-a0ab-ec1f9bd42f3a" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_c113d2e1-5b90-4619-9012-4f1971c8cb12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_f034ebe1-d72e-46cc-bfc9-d2d9a53bf00d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_cae3525e-e54f-44e1-83c9-5c94ebca526a" xlink:to="loc_us-gaap_ScheduleOfInvestmentsLineItems_f034ebe1-d72e-46cc-bfc9-d2d9a53bf00d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_d2362ee4-117d-4845-a0cf-596cd38707ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_f034ebe1-d72e-46cc-bfc9-d2d9a53bf00d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_d2362ee4-117d-4845-a0cf-596cd38707ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_4c92d80e-319c-46de-87e1-d07c7e9c9f89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_f034ebe1-d72e-46cc-bfc9-d2d9a53bf00d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_4c92d80e-319c-46de-87e1-d07c7e9c9f89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_be46aba4-649e-4a49-98ef-716c08d8eab8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_f034ebe1-d72e-46cc-bfc9-d2d9a53bf00d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_be46aba4-649e-4a49-98ef-716c08d8eab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_d4c38b51-787d-4a88-9b2d-856a28d0df93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_f034ebe1-d72e-46cc-bfc9-d2d9a53bf00d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_d4c38b51-787d-4a88-9b2d-856a28d0df93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_adc2935f-0e8e-40e0-96c6-04a6c5bcff91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_f034ebe1-d72e-46cc-bfc9-d2d9a53bf00d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_adc2935f-0e8e-40e0-96c6-04a6c5bcff91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_764c091f-ee37-4426-9d6e-c4673b7c8c66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_f034ebe1-d72e-46cc-bfc9-d2d9a53bf00d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_764c091f-ee37-4426-9d6e-c4673b7c8c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/FairValueNotes" xlink:type="simple" xlink:href="unh-20211231.xsd#FairValueNotes"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/FairValueNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b8e1f13a-bc12-49a7-b1f0-d5aadfd19f73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_04cddf2f-fbc6-4242-aa4c-772e3e13ebc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b8e1f13a-bc12-49a7-b1f0-d5aadfd19f73" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_04cddf2f-fbc6-4242-aa4c-772e3e13ebc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/FairValueFairValuePolicies" xlink:type="simple" xlink:href="unh-20211231.xsd#FairValueFairValuePolicies"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/FairValueFairValuePolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_FairValueAbstract_2db00791-7b4e-4edc-bb4d-324cf7397841" xlink:href="unh-20211231.xsd#unh_FairValueAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e43cb70d-e018-491c-ba78-6e855e845606" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_FairValueAbstract_2db00791-7b4e-4edc-bb4d-324cf7397841" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e43cb70d-e018-491c-ba78-6e855e845606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_41796d3d-f181-45c5-b4ec-34ea2e55334d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e43cb70d-e018-491c-ba78-6e855e845606" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_41796d3d-f181-45c5-b4ec-34ea2e55334d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_fd64f965-d88c-4008-b61e-1cc6080d9cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_41796d3d-f181-45c5-b4ec-34ea2e55334d" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_fd64f965-d88c-4008-b61e-1cc6080d9cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7600332a-41ed-4b2d-96b9-bc49aff93857" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e43cb70d-e018-491c-ba78-6e855e845606" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7600332a-41ed-4b2d-96b9-bc49aff93857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_41b3d42f-0e6a-447e-9954-f9c548cf3f86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7600332a-41ed-4b2d-96b9-bc49aff93857" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_41b3d42f-0e6a-447e-9954-f9c548cf3f86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_414fb3bb-2fb8-4604-b4ef-4dcd19940676" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e43cb70d-e018-491c-ba78-6e855e845606" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_414fb3bb-2fb8-4604-b4ef-4dcd19940676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_9a5d4ecd-b84b-48f8-b910-808c25ffe147" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_414fb3bb-2fb8-4604-b4ef-4dcd19940676" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_9a5d4ecd-b84b-48f8-b910-808c25ffe147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/FairValueTables" xlink:type="simple" xlink:href="unh-20211231.xsd#FairValueTables"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/FairValueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_3f94cba9-d251-4c51-9c31-65f6d00ece8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_099cd5e9-1156-4d52-9dde-e80232e93ded" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3f94cba9-d251-4c51-9c31-65f6d00ece8c" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_099cd5e9-1156-4d52-9dde-e80232e93ded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0ae0e469-7702-45d9-b905-64bd57c93269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_099cd5e9-1156-4d52-9dde-e80232e93ded" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0ae0e469-7702-45d9-b905-64bd57c93269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7155e047-d0a8-4a84-a92a-e804bf779503" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0ae0e469-7702-45d9-b905-64bd57c93269" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7155e047-d0a8-4a84-a92a-e804bf779503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b33ef1c1-8aa7-411f-94ba-95995597bd5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_099cd5e9-1156-4d52-9dde-e80232e93ded" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b33ef1c1-8aa7-411f-94ba-95995597bd5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_84ffc9ea-0e54-448a-ad53-8860e78c22ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b33ef1c1-8aa7-411f-94ba-95995597bd5d" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_84ffc9ea-0e54-448a-ad53-8860e78c22ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock_d95de85d-c926-4746-b646-6b4bec182156" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b33ef1c1-8aa7-411f-94ba-95995597bd5d" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock_d95de85d-c926-4746-b646-6b4bec182156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/FairValueNarrativeDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#FairValueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/FairValueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_99969044-001c-42e7-ba8a-16604fdb3702" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_94026bfd-46e8-4a9c-94ed-e6383bca5a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_99969044-001c-42e7-ba8a-16604fdb3702" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_94026bfd-46e8-4a9c-94ed-e6383bca5a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0e8fc953-cc46-4807-9757-4c27d4dfa348" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_94026bfd-46e8-4a9c-94ed-e6383bca5a4b" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0e8fc953-cc46-4807-9757-4c27d4dfa348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_54912a87-fdda-43c2-8921-5515fc6b6680" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0e8fc953-cc46-4807-9757-4c27d4dfa348" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_54912a87-fdda-43c2-8921-5515fc6b6680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_411a14ae-ebdb-48f2-9805-19daf87e7c88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_54912a87-fdda-43c2-8921-5515fc6b6680" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_411a14ae-ebdb-48f2-9805-19daf87e7c88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_b1090da7-baa3-4b9f-b322-f9f6d0eec7d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_94026bfd-46e8-4a9c-94ed-e6383bca5a4b" xlink:to="loc_us-gaap_FinancialInstrumentAxis_b1090da7-baa3-4b9f-b322-f9f6d0eec7d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cb661c27-3ac7-48f4-b84c-41ca20e49787" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_b1090da7-baa3-4b9f-b322-f9f6d0eec7d8" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cb661c27-3ac7-48f4-b84c-41ca20e49787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_2da03928-3cf0-4900-ae59-1492eec09918" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cb661c27-3ac7-48f4-b84c-41ca20e49787" xlink:to="loc_us-gaap_DebtSecuritiesMember_2da03928-3cf0-4900-ae59-1492eec09918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6310669c-ab68-490d-85ea-88bb2d5336ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_94026bfd-46e8-4a9c-94ed-e6383bca5a4b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6310669c-ab68-490d-85ea-88bb2d5336ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_28793581-eb71-4d5a-b263-eba643e6e638" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6310669c-ab68-490d-85ea-88bb2d5336ce" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_28793581-eb71-4d5a-b263-eba643e6e638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_b6e0a614-2816-4427-bca7-ea8adc30ee63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_28793581-eb71-4d5a-b263-eba643e6e638" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_b6e0a614-2816-4427-bca7-ea8adc30ee63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_67dec37e-233f-4eb4-b522-482c7e4a4590" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_94026bfd-46e8-4a9c-94ed-e6383bca5a4b" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_67dec37e-233f-4eb4-b522-482c7e4a4590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_925e0a8f-08d6-4e86-b442-e15a9a342865" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_67dec37e-233f-4eb4-b522-482c7e4a4590" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_925e0a8f-08d6-4e86-b442-e15a9a342865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_a077766f-3c4f-4985-9ebf-0d6381feb8c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_67dec37e-233f-4eb4-b522-482c7e4a4590" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_a077766f-3c4f-4985-9ebf-0d6381feb8c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis_f447dd49-c237-4c15-a84d-05bb82cee5a8" xlink:href="unh-20211231.xsd#unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_67dec37e-233f-4eb4-b522-482c7e4a4590" xlink:to="loc_unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis_f447dd49-c237-4c15-a84d-05bb82cee5a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGain_2f324045-b931-42e6-a94b-f5188119e05c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGain"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_67dec37e-233f-4eb4-b522-482c7e4a4590" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGain_2f324045-b931-42e6-a94b-f5188119e05c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c03a5dc4-42a5-4dd7-8105-bf7ef06b4a86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_94a8bbb2-b8ef-4e96-ba16-23d6f70d084d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c03a5dc4-42a5-4dd7-8105-bf7ef06b4a86" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_94a8bbb2-b8ef-4e96-ba16-23d6f70d084d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_152486e7-21ab-4196-b816-148df5e21abd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_94a8bbb2-b8ef-4e96-ba16-23d6f70d084d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_152486e7-21ab-4196-b816-148df5e21abd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a31255c0-d743-4385-9722-70883f5451cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_152486e7-21ab-4196-b816-148df5e21abd" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a31255c0-d743-4385-9722-70883f5451cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_caded8c2-1aa0-4a85-a17e-7102c2e6985f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a31255c0-d743-4385-9722-70883f5451cd" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_caded8c2-1aa0-4a85-a17e-7102c2e6985f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_1dc43219-564e-4ed8-abe0-822786d44dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a31255c0-d743-4385-9722-70883f5451cd" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_1dc43219-564e-4ed8-abe0-822786d44dbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_999e82e0-5fce-436f-ade7-69262a1d1240" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a31255c0-d743-4385-9722-70883f5451cd" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_999e82e0-5fce-436f-ade7-69262a1d1240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_c6ecff36-f0eb-40f4-8b32-497c4db4d536" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_94a8bbb2-b8ef-4e96-ba16-23d6f70d084d" xlink:to="loc_us-gaap_FinancialInstrumentAxis_c6ecff36-f0eb-40f4-8b32-497c4db4d536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8ebfe453-1283-455d-9d79-763ded39aa2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_c6ecff36-f0eb-40f4-8b32-497c4db4d536" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8ebfe453-1283-455d-9d79-763ded39aa2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_0ad63e5f-f06f-4fa0-9200-070554b10e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8ebfe453-1283-455d-9d79-763ded39aa2c" xlink:to="loc_us-gaap_DebtSecuritiesMember_0ad63e5f-f06f-4fa0-9200-070554b10e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_42bf2aa4-14d8-4152-8db4-3562a0201cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_0ad63e5f-f06f-4fa0-9200-070554b10e3a" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_42bf2aa4-14d8-4152-8db4-3562a0201cc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_d8a4de7c-03a5-47cc-8ad2-ff566f601aef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_0ad63e5f-f06f-4fa0-9200-070554b10e3a" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_d8a4de7c-03a5-47cc-8ad2-ff566f601aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_3a1410d6-04cb-45f4-951a-dbc13202beea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_0ad63e5f-f06f-4fa0-9200-070554b10e3a" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_3a1410d6-04cb-45f4-951a-dbc13202beea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_2e58dbaa-99e3-49d9-8420-bb6b830c6357" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_0ad63e5f-f06f-4fa0-9200-070554b10e3a" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_2e58dbaa-99e3-49d9-8420-bb6b830c6357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_27258e66-e8aa-4cd0-9db9-372191da5467" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_0ad63e5f-f06f-4fa0-9200-070554b10e3a" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_27258e66-e8aa-4cd0-9db9-372191da5467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_32a974d5-5a73-4bd8-9c7c-8a142fd4bbee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_94a8bbb2-b8ef-4e96-ba16-23d6f70d084d" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_32a974d5-5a73-4bd8-9c7c-8a142fd4bbee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_80c9d662-3bc1-4146-b705-49c3219a56ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_32a974d5-5a73-4bd8-9c7c-8a142fd4bbee" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_80c9d662-3bc1-4146-b705-49c3219a56ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0a57c2fe-e9eb-4216-a4d0-01f4a0482d65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_32a974d5-5a73-4bd8-9c7c-8a142fd4bbee" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0a57c2fe-e9eb-4216-a4d0-01f4a0482d65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_9ea6c865-db5a-4561-95b8-7a0619af732f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_32a974d5-5a73-4bd8-9c7c-8a142fd4bbee" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_9ea6c865-db5a-4561-95b8-7a0619af732f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_AarpAssetsUnderManagement_f9cb07be-00c0-45d3-8383-b257ac73468c" xlink:href="unh-20211231.xsd#unh_AarpAssetsUnderManagement"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_32a974d5-5a73-4bd8-9c7c-8a142fd4bbee" xlink:to="loc_unh_AarpAssetsUnderManagement_f9cb07be-00c0-45d3-8383-b257ac73468c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_2cdf3029-03f4-495a-9a0c-30772022a36f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_32a974d5-5a73-4bd8-9c7c-8a142fd4bbee" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_2cdf3029-03f4-495a-9a0c-30772022a36f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_84cfd808-891a-4c7d-8b57-2bd6bc9a8ea1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e0f8905c-f4ff-4afb-b40c-6bb244b98074" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_84cfd808-891a-4c7d-8b57-2bd6bc9a8ea1" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e0f8905c-f4ff-4afb-b40c-6bb244b98074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_433c981a-ef11-45e2-9660-0e00515460a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e0f8905c-f4ff-4afb-b40c-6bb244b98074" xlink:to="loc_us-gaap_DebtInstrumentAxis_433c981a-ef11-45e2-9660-0e00515460a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e59cd08e-dd9c-4de5-8456-be364287d6ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_433c981a-ef11-45e2-9660-0e00515460a6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e59cd08e-dd9c-4de5-8456-be364287d6ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_0f48fb2b-d276-406a-9ec7-97c3c29f5add" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e59cd08e-dd9c-4de5-8456-be364287d6ce" xlink:to="loc_us-gaap_LongTermDebtMember_0f48fb2b-d276-406a-9ec7-97c3c29f5add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_377f5889-57a8-4f8d-a8c1-b20fa2eac41c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e0f8905c-f4ff-4afb-b40c-6bb244b98074" xlink:to="loc_us-gaap_FinancialInstrumentAxis_377f5889-57a8-4f8d-a8c1-b20fa2eac41c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c6eeb23d-d689-48d9-b055-cbb23af02fa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_377f5889-57a8-4f8d-a8c1-b20fa2eac41c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c6eeb23d-d689-48d9-b055-cbb23af02fa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_6e0e6906-99a9-4082-87a0-99fae2f5afc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c6eeb23d-d689-48d9-b055-cbb23af02fa7" xlink:to="loc_us-gaap_DebtSecuritiesMember_6e0e6906-99a9-4082-87a0-99fae2f5afc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1d7ca528-e650-405d-b399-db033194f4f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e0f8905c-f4ff-4afb-b40c-6bb244b98074" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1d7ca528-e650-405d-b399-db033194f4f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_72e9a48e-520a-4fab-bc79-ee1b5e44c385" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1d7ca528-e650-405d-b399-db033194f4f4" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_72e9a48e-520a-4fab-bc79-ee1b5e44c385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_eb691087-83bd-42f3-8165-e7daa79c0d83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_72e9a48e-520a-4fab-bc79-ee1b5e44c385" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_eb691087-83bd-42f3-8165-e7daa79c0d83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_09141ee4-ea53-4bf0-a6b6-d122ef7a75c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e0f8905c-f4ff-4afb-b40c-6bb244b98074" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_09141ee4-ea53-4bf0-a6b6-d122ef7a75c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f9055a2a-786f-44cd-a0c1-296a3cf195f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_09141ee4-ea53-4bf0-a6b6-d122ef7a75c5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f9055a2a-786f-44cd-a0c1-296a3cf195f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_4d3a7891-d9bb-4931-8590-5c9d7ae6902a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f9055a2a-786f-44cd-a0c1-296a3cf195f1" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_4d3a7891-d9bb-4931-8590-5c9d7ae6902a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_12602550-1e39-4495-b0fa-b93b6879eed2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f9055a2a-786f-44cd-a0c1-296a3cf195f1" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_12602550-1e39-4495-b0fa-b93b6879eed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_a46e1869-1c8b-477b-9b1a-a231d62eb06b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f9055a2a-786f-44cd-a0c1-296a3cf195f1" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_a46e1869-1c8b-477b-9b1a-a231d62eb06b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_fb7da5e1-7543-4a1f-a83f-114c87467072" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e0f8905c-f4ff-4afb-b40c-6bb244b98074" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_fb7da5e1-7543-4a1f-a83f-114c87467072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_47735721-fe91-424f-9802-302b7b8b0ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_fb7da5e1-7543-4a1f-a83f-114c87467072" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_47735721-fe91-424f-9802-302b7b8b0ddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_c8edc8a4-453c-4b0a-8eac-e5c2a5d72954" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_fb7da5e1-7543-4a1f-a83f-114c87467072" xlink:to="loc_us-gaap_HeldToMaturitySecurities_c8edc8a4-453c-4b0a-8eac-e5c2a5d72954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_197fa1bf-8f23-4777-9911-a01957f59694" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_fb7da5e1-7543-4a1f-a83f-114c87467072" xlink:to="loc_us-gaap_DebtInstrumentFairValue_197fa1bf-8f23-4777-9911-a01957f59694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_4a7f68eb-f0a4-4a55-b8b6-e7358fe320b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_fb7da5e1-7543-4a1f-a83f-114c87467072" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_4a7f68eb-f0a4-4a55-b8b6-e7358fe320b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNotes" xlink:type="simple" xlink:href="unh-20211231.xsd#PropertyPlantandCapitalizedSoftwareNotes"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_34bc2a9f-e8fe-4170-82a3-5d7d32aef639" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5d0bb504-d88d-46a0-bdbf-32f991e5d182" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_34bc2a9f-e8fe-4170-82a3-5d7d32aef639" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5d0bb504-d88d-46a0-bdbf-32f991e5d182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e67a437d-e007-4337-ba41-f03283f28e60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5d0bb504-d88d-46a0-bdbf-32f991e5d182" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e67a437d-e007-4337-ba41-f03283f28e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6c470600-4932-4754-ae95-b3d9ca1bb35e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e67a437d-e007-4337-ba41-f03283f28e60" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6c470600-4932-4754-ae95-b3d9ca1bb35e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_15182c1e-a5f0-46a6-8a83-5c447a19d980" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5d0bb504-d88d-46a0-bdbf-32f991e5d182" xlink:to="loc_srt_RangeAxis_15182c1e-a5f0-46a6-8a83-5c447a19d980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c6e29403-1862-4225-aa90-08c3cb7e412d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_15182c1e-a5f0-46a6-8a83-5c447a19d980" xlink:to="loc_srt_RangeMember_c6e29403-1862-4225-aa90-08c3cb7e412d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_edf912c6-5191-4534-ae2c-861b8f159d34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5d0bb504-d88d-46a0-bdbf-32f991e5d182" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_edf912c6-5191-4534-ae2c-861b8f159d34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_94d0e307-6704-47d7-b18c-547239788276" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_edf912c6-5191-4534-ae2c-861b8f159d34" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_94d0e307-6704-47d7-b18c-547239788276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareTables" xlink:type="simple" xlink:href="unh-20211231.xsd#PropertyPlantandCapitalizedSoftwareTables"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c03ae2c1-b6b8-47b2-b7fc-5bd5345ffacc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_99845447-f05c-40b6-9d43-8445859cd258" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c03ae2c1-b6b8-47b2-b7fc-5bd5345ffacc" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_99845447-f05c-40b6-9d43-8445859cd258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fbd12361-ee2c-4189-be32-c28ea0bee7ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_99845447-f05c-40b6-9d43-8445859cd258" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fbd12361-ee2c-4189-be32-c28ea0bee7ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_16ec7f10-8eca-485b-af42-9501a4122022" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fbd12361-ee2c-4189-be32-c28ea0bee7ce" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_16ec7f10-8eca-485b-af42-9501a4122022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_28e549b8-beab-40ac-ba66-8a4f14bead98" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_99845447-f05c-40b6-9d43-8445859cd258" xlink:to="loc_srt_RangeAxis_28e549b8-beab-40ac-ba66-8a4f14bead98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a90cd075-9ccb-439d-98ac-83f3ddf5605c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_28e549b8-beab-40ac-ba66-8a4f14bead98" xlink:to="loc_srt_RangeMember_a90cd075-9ccb-439d-98ac-83f3ddf5605c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1e560d9b-d853-44db-8bf7-c504121281ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_99845447-f05c-40b6-9d43-8445859cd258" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1e560d9b-d853-44db-8bf7-c504121281ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_c114da07-51c8-48b1-87d2-bb998bcf8536" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1e560d9b-d853-44db-8bf7-c504121281ac" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_c114da07-51c8-48b1-87d2-bb998bcf8536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNarrativeDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#PropertyPlantandCapitalizedSoftwareNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_644c06e9-ea20-4537-bd35-6a6dcd815ec8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_758dea8d-e335-4c24-8377-20c5032391d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_644c06e9-ea20-4537-bd35-6a6dcd815ec8" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_758dea8d-e335-4c24-8377-20c5032391d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_256094f2-0c31-44ae-aedc-87e6d57158af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_758dea8d-e335-4c24-8377-20c5032391d4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_256094f2-0c31-44ae-aedc-87e6d57158af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_90a4044d-71cc-42bd-adf8-3decc05a1046" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_256094f2-0c31-44ae-aedc-87e6d57158af" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_90a4044d-71cc-42bd-adf8-3decc05a1046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_db30081e-8497-4d31-b036-f19330f33eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_758dea8d-e335-4c24-8377-20c5032391d4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_db30081e-8497-4d31-b036-f19330f33eeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_c0e7001b-c981-4fea-a656-eb6aeeda9ea3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_db30081e-8497-4d31-b036-f19330f33eeb" xlink:to="loc_us-gaap_Depreciation_c0e7001b-c981-4fea-a656-eb6aeeda9ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_d9a137cf-5759-4596-a6a5-97f923f2b625" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_db30081e-8497-4d31-b036-f19330f33eeb" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_d9a137cf-5759-4596-a6a5-97f923f2b625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_34ea1919-c98c-4541-b5b8-824814246668" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_759c3a87-cc0a-4774-8446-b6a38cab4d21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_34ea1919-c98c-4541-b5b8-824814246668" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_759c3a87-cc0a-4774-8446-b6a38cab4d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f66684dd-0dd8-4a45-8606-2ee1fec965b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_759c3a87-cc0a-4774-8446-b6a38cab4d21" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f66684dd-0dd8-4a45-8606-2ee1fec965b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_be689434-93c8-4b40-83ae-f8c4d16f1b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f66684dd-0dd8-4a45-8606-2ee1fec965b1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_be689434-93c8-4b40-83ae-f8c4d16f1b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d69390fd-d799-4ac3-9616-cd793d50a8fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_759c3a87-cc0a-4774-8446-b6a38cab4d21" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d69390fd-d799-4ac3-9616-cd793d50a8fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovements_33f248c6-7797-431f-8f29-5c1cc8d6834a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandAndLandImprovements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d69390fd-d799-4ac3-9616-cd793d50a8fc" xlink:to="loc_us-gaap_LandAndLandImprovements_33f248c6-7797-431f-8f29-5c1cc8d6834a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_dd5f4347-d58a-4b5c-ba96-a8ef26f8e447" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d69390fd-d799-4ac3-9616-cd793d50a8fc" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_dd5f4347-d58a-4b5c-ba96-a8ef26f8e447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_020d5f8a-23bc-4374-bbea-044e86334d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d69390fd-d799-4ac3-9616-cd793d50a8fc" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_020d5f8a-23bc-4374-bbea-044e86334d0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_ed862bbf-c15b-4b55-8101-f205aa5316f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d69390fd-d799-4ac3-9616-cd793d50a8fc" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_ed862bbf-c15b-4b55-8101-f205aa5316f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation_1dd44442-93d4-4bfd-8902-54ac43b40482" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d69390fd-d799-4ac3-9616-cd793d50a8fc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation_1dd44442-93d4-4bfd-8902-54ac43b40482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet_3b423068-6147-4a8f-935a-a3a332cda310" xlink:href="unh-20211231.xsd#unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d69390fd-d799-4ac3-9616-cd793d50a8fc" xlink:to="loc_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet_3b423068-6147-4a8f-935a-a3a332cda310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareGross_6ee1210b-0a64-43a0-8c9d-0b1df09c5139" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareGross"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d69390fd-d799-4ac3-9616-cd793d50a8fc" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareGross_6ee1210b-0a64-43a0-8c9d-0b1df09c5139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_a5f7c9e4-8850-435b-aa04-67f4fc2cb0a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d69390fd-d799-4ac3-9616-cd793d50a8fc" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_a5f7c9e4-8850-435b-aa04-67f4fc2cb0a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet_fb6801cc-a04e-4992-af06-f804f90c3fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d69390fd-d799-4ac3-9616-cd793d50a8fc" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareNet_fb6801cc-a04e-4992-af06-f804f90c3fe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_c0b35841-d333-4329-ab6f-c16d3ea360ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d69390fd-d799-4ac3-9616-cd793d50a8fc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_c0b35841-d333-4329-ab6f-c16d3ea360ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsNotes" xlink:type="simple" xlink:href="unh-20211231.xsd#GoodwillandIntangibleAssetsNotes"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/GoodwillandIntangibleAssetsNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_GoodwillandIntangibleAssetsAbstract_2d81f2e2-b13e-4795-b19a-88f870f03d69" xlink:href="unh-20211231.xsd#unh_GoodwillandIntangibleAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_57eb1a7b-6306-438a-aa89-c9d684103b7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_GoodwillandIntangibleAssetsAbstract_2d81f2e2-b13e-4795-b19a-88f870f03d69" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_57eb1a7b-6306-438a-aa89-c9d684103b7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_6115ac75-9a8e-4e0c-a3a9-bc5b345b9a6f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_57eb1a7b-6306-438a-aa89-c9d684103b7d" xlink:to="loc_srt_ConsolidationItemsAxis_6115ac75-9a8e-4e0c-a3a9-bc5b345b9a6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_05f14c21-4d5a-4e87-9de9-4574f614a1ac" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_6115ac75-9a8e-4e0c-a3a9-bc5b345b9a6f" xlink:to="loc_srt_ConsolidationItemsDomain_05f14c21-4d5a-4e87-9de9-4574f614a1ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d34bcf54-70e3-420f-a0cf-e899b285aca1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_57eb1a7b-6306-438a-aa89-c9d684103b7d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d34bcf54-70e3-420f-a0cf-e899b285aca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c8fb5aaa-2ce5-4c11-b778-bfd1235ba558" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d34bcf54-70e3-420f-a0cf-e899b285aca1" xlink:to="loc_us-gaap_SegmentDomain_c8fb5aaa-2ce5-4c11-b778-bfd1235ba558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6bc4bb8f-5471-4178-ba45-23038441a8ad" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_57eb1a7b-6306-438a-aa89-c9d684103b7d" xlink:to="loc_srt_RangeAxis_6bc4bb8f-5471-4178-ba45-23038441a8ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_524f28cb-474b-491d-a2a1-7d67b9d9e27d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6bc4bb8f-5471-4178-ba45-23038441a8ad" xlink:to="loc_srt_RangeMember_524f28cb-474b-491d-a2a1-7d67b9d9e27d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_22fd01b9-41ba-4f77-8d6a-7d101aec750f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_57eb1a7b-6306-438a-aa89-c9d684103b7d" xlink:to="loc_us-gaap_GoodwillLineItems_22fd01b9-41ba-4f77-8d6a-7d101aec750f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_1d2f5ef9-8257-4cea-8c9b-929b75d23196" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_22fd01b9-41ba-4f77-8d6a-7d101aec750f" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_1d2f5ef9-8257-4cea-8c9b-929b75d23196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsTables" xlink:type="simple" xlink:href="unh-20211231.xsd#GoodwillandIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/GoodwillandIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_GoodwillandIntangibleAssetsAbstract_759f68ca-429d-4748-a212-f286c6fd2a00" xlink:href="unh-20211231.xsd#unh_GoodwillandIntangibleAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_82a44e70-d30f-4d04-90b4-0a0eb2935f00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_GoodwillandIntangibleAssetsAbstract_759f68ca-429d-4748-a212-f286c6fd2a00" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_82a44e70-d30f-4d04-90b4-0a0eb2935f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_93f4c2c2-4dbd-47b7-8c8d-51055ccd1c0d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_82a44e70-d30f-4d04-90b4-0a0eb2935f00" xlink:to="loc_srt_ConsolidationItemsAxis_93f4c2c2-4dbd-47b7-8c8d-51055ccd1c0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_82d57910-1a29-4cf0-94ac-485477e1c722" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_93f4c2c2-4dbd-47b7-8c8d-51055ccd1c0d" xlink:to="loc_srt_ConsolidationItemsDomain_82d57910-1a29-4cf0-94ac-485477e1c722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_e1127096-54ec-4056-b0f6-30ae488b088f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_82a44e70-d30f-4d04-90b4-0a0eb2935f00" xlink:to="loc_us-gaap_GoodwillLineItems_e1127096-54ec-4056-b0f6-30ae488b088f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_a6d727a9-049c-4fbb-9cef-cee4254854b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_e1127096-54ec-4056-b0f6-30ae488b088f" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_a6d727a9-049c-4fbb-9cef-cee4254854b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock_5ff8f11e-02de-4b57-981f-79ec6b13b85c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_e1127096-54ec-4056-b0f6-30ae488b088f" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock_5ff8f11e-02de-4b57-981f-79ec6b13b85c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_568b4cd2-42c0-4b98-ac51-cbb3cd1f137d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_e1127096-54ec-4056-b0f6-30ae488b088f" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_568b4cd2-42c0-4b98-ac51-cbb3cd1f137d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_01331c16-4c7e-4c64-b176-3d18f9c3c8e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_e1127096-54ec-4056-b0f6-30ae488b088f" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_01331c16-4c7e-4c64-b176-3d18f9c3c8e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#GoodwillandIntangibleAssetsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_GoodwillandIntangibleAssetsAbstract_f2d0239f-e018-4e38-89c1-1244a6d43d4b" xlink:href="unh-20211231.xsd#unh_GoodwillandIntangibleAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb1879c2-af83-4b95-bc19-ee6ca8aef09a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_GoodwillandIntangibleAssetsAbstract_f2d0239f-e018-4e38-89c1-1244a6d43d4b" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb1879c2-af83-4b95-bc19-ee6ca8aef09a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_449a2108-fdc0-48c7-b4ec-1a094c72e9c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb1879c2-af83-4b95-bc19-ee6ca8aef09a" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_449a2108-fdc0-48c7-b4ec-1a094c72e9c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_f5e2f3ce-c8cf-46df-891e-e7b029966285" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_449a2108-fdc0-48c7-b4ec-1a094c72e9c3" xlink:to="loc_us-gaap_TypeOfAdoptionMember_f5e2f3ce-c8cf-46df-891e-e7b029966285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_85c4f87f-bd30-42a2-886a-627676ac1253" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb1879c2-af83-4b95-bc19-ee6ca8aef09a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_85c4f87f-bd30-42a2-886a-627676ac1253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_a0a11d74-e6c2-49c3-98c2-42cc0de8d78c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_85c4f87f-bd30-42a2-886a-627676ac1253" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_a0a11d74-e6c2-49c3-98c2-42cc0de8d78c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_GoodwillandIntangibleAssetsAbstract_2f9e3bd7-b878-4548-94de-31f5e2f9dbbc" xlink:href="unh-20211231.xsd#unh_GoodwillandIntangibleAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_63ff997f-1968-4928-89fd-3b543b3a52d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_GoodwillandIntangibleAssetsAbstract_2f9e3bd7-b878-4548-94de-31f5e2f9dbbc" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_63ff997f-1968-4928-89fd-3b543b3a52d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_fa22aa02-b837-4807-b157-f9685c66832c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_63ff997f-1968-4928-89fd-3b543b3a52d8" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_fa22aa02-b837-4807-b157-f9685c66832c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ebae5209-1429-4501-94a8-8c28ef5b4907" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fa22aa02-b837-4807-b157-f9685c66832c" xlink:to="loc_us-gaap_SegmentDomain_ebae5209-1429-4501-94a8-8c28ef5b4907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_UnitedhealthcareMember_c8289048-520d-45f4-a37b-fd810d9336b3" xlink:href="unh-20211231.xsd#unh_UnitedhealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ebae5209-1429-4501-94a8-8c28ef5b4907" xlink:to="loc_unh_UnitedhealthcareMember_c8289048-520d-45f4-a37b-fd810d9336b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OptumhealthMember_494adef0-2ca5-4c89-b047-15eefdda223a" xlink:href="unh-20211231.xsd#unh_OptumhealthMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ebae5209-1429-4501-94a8-8c28ef5b4907" xlink:to="loc_unh_OptumhealthMember_494adef0-2ca5-4c89-b047-15eefdda223a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OptuminsightMember_1534ae91-d19e-4876-9249-5edd787a73f9" xlink:href="unh-20211231.xsd#unh_OptuminsightMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ebae5209-1429-4501-94a8-8c28ef5b4907" xlink:to="loc_unh_OptuminsightMember_1534ae91-d19e-4876-9249-5edd787a73f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OptumrxMember_a1bac54e-8d34-43c3-96ca-9a7152da894f" xlink:href="unh-20211231.xsd#unh_OptumrxMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ebae5209-1429-4501-94a8-8c28ef5b4907" xlink:to="loc_unh_OptumrxMember_a1bac54e-8d34-43c3-96ca-9a7152da894f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_85195817-8cd5-4994-aecc-671a86238afb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_63ff997f-1968-4928-89fd-3b543b3a52d8" xlink:to="loc_us-gaap_GoodwillLineItems_85195817-8cd5-4994-aecc-671a86238afb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ec94c90a-3fc6-4fd9-a3c7-12a53dffb7e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_85195817-8cd5-4994-aecc-671a86238afb" xlink:to="loc_us-gaap_Goodwill_ec94c90a-3fc6-4fd9-a3c7-12a53dffb7e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_c250f403-7483-48b2-ac4d-6ee75cd22734" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_85195817-8cd5-4994-aecc-671a86238afb" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_c250f403-7483-48b2-ac4d-6ee75cd22734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_f388d04e-4485-4c0d-960c-62f6cdd0ffd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_85195817-8cd5-4994-aecc-671a86238afb" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_f388d04e-4485-4c0d-960c-62f6cdd0ffd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1182bae0-137c-4186-bcd3-ea212928e089" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_85195817-8cd5-4994-aecc-671a86238afb" xlink:to="loc_us-gaap_Goodwill_1182bae0-137c-4186-bcd3-ea212928e089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_856cfe6c-9197-49e3-af08-62a752bcffb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_72d8470f-ac51-4d3f-b8b0-a3db4aa71b06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_856cfe6c-9197-49e3-af08-62a752bcffb4" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_72d8470f-ac51-4d3f-b8b0-a3db4aa71b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c59a28e0-b002-490b-8b0d-e84fc5eab491" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_72d8470f-ac51-4d3f-b8b0-a3db4aa71b06" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c59a28e0-b002-490b-8b0d-e84fc5eab491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_52dfab9c-f26b-48fe-b1ea-0ec64076f75c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c59a28e0-b002-490b-8b0d-e84fc5eab491" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_52dfab9c-f26b-48fe-b1ea-0ec64076f75c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_cf391810-0231-413b-ace8-e723845bf5a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_52dfab9c-f26b-48fe-b1ea-0ec64076f75c" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_cf391810-0231-413b-ace8-e723845bf5a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_TrademarksandTechnologyMember_4ea3bef0-2a14-44d4-a2bb-6178c0ffa9ff" xlink:href="unh-20211231.xsd#unh_TrademarksandTechnologyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_52dfab9c-f26b-48fe-b1ea-0ec64076f75c" xlink:to="loc_unh_TrademarksandTechnologyMember_4ea3bef0-2a14-44d4-a2bb-6178c0ffa9ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_78defe9e-ef1c-4dc7-a8e8-86fe4082e9fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_52dfab9c-f26b-48fe-b1ea-0ec64076f75c" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_78defe9e-ef1c-4dc7-a8e8-86fe4082e9fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_552c7ce2-206d-4b47-9c3d-9899fbf16053" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_52dfab9c-f26b-48fe-b1ea-0ec64076f75c" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_552c7ce2-206d-4b47-9c3d-9899fbf16053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_83051d7f-c559-466e-9820-c1e9058500f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_72d8470f-ac51-4d3f-b8b0-a3db4aa71b06" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_83051d7f-c559-466e-9820-c1e9058500f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_fa96f268-3b8e-43cc-a3a9-164ed3c3e464" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_83051d7f-c559-466e-9820-c1e9058500f6" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_fa96f268-3b8e-43cc-a3a9-164ed3c3e464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ad2b28d3-5c42-477b-a81c-2ea945a9112e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_83051d7f-c559-466e-9820-c1e9058500f6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ad2b28d3-5c42-477b-a81c-2ea945a9112e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1c6b8278-665e-42e5-8e8a-2cbd20c19a67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_83051d7f-c559-466e-9820-c1e9058500f6" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1c6b8278-665e-42e5-8e8a-2cbd20c19a67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9a2ce9d6-9089-4f8c-b336-45c32a1279e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7df2eaf4-4e18-47fa-bf6e-fdc6ed16876a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9a2ce9d6-9089-4f8c-b336-45c32a1279e7" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7df2eaf4-4e18-47fa-bf6e-fdc6ed16876a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_998c5025-8aa0-43ad-a46e-c616f116df15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7df2eaf4-4e18-47fa-bf6e-fdc6ed16876a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_998c5025-8aa0-43ad-a46e-c616f116df15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_afa62837-e18a-4e32-852b-34ca2e5010ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_998c5025-8aa0-43ad-a46e-c616f116df15" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_afa62837-e18a-4e32-852b-34ca2e5010ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_3a1a90f7-fb63-494f-aeaa-6f40090dff3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_afa62837-e18a-4e32-852b-34ca2e5010ad" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_3a1a90f7-fb63-494f-aeaa-6f40090dff3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_TrademarksandTechnologyMember_c0824776-448c-4e41-9dce-3ed164be6639" xlink:href="unh-20211231.xsd#unh_TrademarksandTechnologyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_afa62837-e18a-4e32-852b-34ca2e5010ad" xlink:to="loc_unh_TrademarksandTechnologyMember_c0824776-448c-4e41-9dce-3ed164be6639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_9fffe5f9-6ffb-4aa4-8ccd-e12ef7b41f32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_afa62837-e18a-4e32-852b-34ca2e5010ad" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_9fffe5f9-6ffb-4aa4-8ccd-e12ef7b41f32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c77bbfc3-e34e-40f6-9d36-e9e8c7a132a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7df2eaf4-4e18-47fa-bf6e-fdc6ed16876a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c77bbfc3-e34e-40f6-9d36-e9e8c7a132a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_32d9091b-0b08-4349-8c12-aba1fc37bcd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c77bbfc3-e34e-40f6-9d36-e9e8c7a132a8" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_32d9091b-0b08-4349-8c12-aba1fc37bcd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_38eaac47-dae8-4c00-b4cf-05ca077c885f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c77bbfc3-e34e-40f6-9d36-e9e8c7a132a8" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_38eaac47-dae8-4c00-b4cf-05ca077c885f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_GoodwillandIntangibleAssetsAbstract_fb554005-03b5-4a7c-8b60-00a7b4443158" xlink:href="unh-20211231.xsd#unh_GoodwillandIntangibleAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_947c2d87-cc94-4f19-a806-07d70e822663" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_GoodwillandIntangibleAssetsAbstract_fb554005-03b5-4a7c-8b60-00a7b4443158" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_947c2d87-cc94-4f19-a806-07d70e822663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_74c08c93-e76f-4ee7-b8c9-bdfbc55a2ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_947c2d87-cc94-4f19-a806-07d70e822663" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_74c08c93-e76f-4ee7-b8c9-bdfbc55a2ebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7e53a04f-48e5-4e06-bc48-080c33b9f067" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_74c08c93-e76f-4ee7-b8c9-bdfbc55a2ebf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7e53a04f-48e5-4e06-bc48-080c33b9f067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f4c5d8ab-0e1c-44a9-9bc3-13857a77b922" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_947c2d87-cc94-4f19-a806-07d70e822663" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f4c5d8ab-0e1c-44a9-9bc3-13857a77b922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_d20268d2-bb31-4f90-8f66-525b30d06be5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f4c5d8ab-0e1c-44a9-9bc3-13857a77b922" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_d20268d2-bb31-4f90-8f66-525b30d06be5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_f8eb973c-a93a-4bf3-9cfd-8779801914eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f4c5d8ab-0e1c-44a9-9bc3-13857a77b922" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_f8eb973c-a93a-4bf3-9cfd-8779801914eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_86e15edb-dafd-43a0-a5b1-1abc1192b411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f4c5d8ab-0e1c-44a9-9bc3-13857a77b922" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_86e15edb-dafd-43a0-a5b1-1abc1192b411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_cb7e30d7-1864-452d-a8ea-496b9320ce48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f4c5d8ab-0e1c-44a9-9bc3-13857a77b922" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_cb7e30d7-1864-452d-a8ea-496b9320ce48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0a4ceb11-27f0-40f7-8ab4-450230819321" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f4c5d8ab-0e1c-44a9-9bc3-13857a77b922" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0a4ceb11-27f0-40f7-8ab4-450230819321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/MedicalCostsPayableNotes" xlink:type="simple" xlink:href="unh-20211231.xsd#MedicalCostsPayableNotes"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/MedicalCostsPayableNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_1d4b6e16-0eae-44be-871a-ecadd2908fe4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock_07eed981-5051-4ee5-8252-5c77e578db89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_1d4b6e16-0eae-44be-871a-ecadd2908fe4" xlink:to="loc_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock_07eed981-5051-4ee5-8252-5c77e578db89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/MedicalCostsPayableTables" xlink:type="simple" xlink:href="unh-20211231.xsd#MedicalCostsPayableTables"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/MedicalCostsPayableTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_ecc3c6ea-5a2e-4a48-bb2e-e6fcc6dcb0da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_da11a5ca-8328-4903-a1d4-ce6488c5568e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_ecc3c6ea-5a2e-4a48-bb2e-e6fcc6dcb0da" xlink:to="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_da11a5ca-8328-4903-a1d4-ce6488c5568e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock_df87a363-ff2d-47e5-9053-79c0cb4667b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_ecc3c6ea-5a2e-4a48-bb2e-e6fcc6dcb0da" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock_df87a363-ff2d-47e5-9053-79c0cb4667b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/MedicalCostsPayableNarrativeDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#MedicalCostsPayableNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/MedicalCostsPayableNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_85abeff4-5286-44c9-9a59-1e5bc8ddb194" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_3a6658b5-ec7a-4d32-9923-e3a0218af4f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_85abeff4-5286-44c9-9a59-1e5bc8ddb194" xlink:to="loc_us-gaap_StatementTable_3a6658b5-ec7a-4d32-9923-e3a0218af4f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_MedicalCostsAndMedicalCostsPayableAxis_94cd1e1a-3145-4268-82be-10b3f7f03e3b" xlink:href="unh-20211231.xsd#unh_MedicalCostsAndMedicalCostsPayableAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_3a6658b5-ec7a-4d32-9923-e3a0218af4f2" xlink:to="loc_unh_MedicalCostsAndMedicalCostsPayableAxis_94cd1e1a-3145-4268-82be-10b3f7f03e3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_MedicalCostsAndMedicalCostsPayableDomain_259aafc8-5872-4042-aab5-73c70b7745a5" xlink:href="unh-20211231.xsd#unh_MedicalCostsAndMedicalCostsPayableDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_MedicalCostsAndMedicalCostsPayableAxis_94cd1e1a-3145-4268-82be-10b3f7f03e3b" xlink:to="loc_unh_MedicalCostsAndMedicalCostsPayableDomain_259aafc8-5872-4042-aab5-73c70b7745a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_efec9bf4-e119-40b7-8283-98e104f7a263" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_MedicalCostsAndMedicalCostsPayableDomain_259aafc8-5872-4042-aab5-73c70b7745a5" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_efec9bf4-e119-40b7-8283-98e104f7a263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_92040aa1-7383-4cba-8a39-4d3e1be4e8ff" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_3a6658b5-ec7a-4d32-9923-e3a0218af4f2" xlink:to="loc_srt_StatementScenarioAxis_92040aa1-7383-4cba-8a39-4d3e1be4e8ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_b2280e41-27e1-41eb-baac-c24aa98c8a96" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_92040aa1-7383-4cba-8a39-4d3e1be4e8ff" xlink:to="loc_srt_ScenarioUnspecifiedDomain_b2280e41-27e1-41eb-baac-c24aa98c8a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d76c510c-4c0a-41b7-9ad1-305152358971" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_3a6658b5-ec7a-4d32-9923-e3a0218af4f2" xlink:to="loc_us-gaap_StatementLineItems_d76c510c-4c0a-41b7-9ad1-305152358971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount_c4d44d73-c5df-4070-9f4f-5dc86858d3f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_85abeff4-5286-44c9-9a59-1e5bc8ddb194" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount_c4d44d73-c5df-4070-9f4f-5dc86858d3f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#MedicalCostsPayableRollforwardDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_32292390-0903-4319-8fb3-28c1f0df2652" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable_9604572f-1e92-4c33-9ceb-acd4291700f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_32292390-0903-4319-8fb3-28c1f0df2652" xlink:to="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable_9604572f-1e92-4c33-9ceb-acd4291700f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_146a52e1-2eda-4cbf-9588-a9204a1f4797" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable_9604572f-1e92-4c33-9ceb-acd4291700f9" xlink:to="loc_srt_ProductOrServiceAxis_146a52e1-2eda-4cbf-9588-a9204a1f4797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_63d2ff9e-7505-49b7-b295-010109809bec" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_146a52e1-2eda-4cbf-9588-a9204a1f4797" xlink:to="loc_srt_ProductsAndServicesDomain_63d2ff9e-7505-49b7-b295-010109809bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems_c1d6b96c-b8ef-4627-ae47-ba505d29aac1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable_9604572f-1e92-4c33-9ceb-acd4291700f9" xlink:to="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems_c1d6b96c-b8ef-4627-ae47-ba505d29aac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_fdd15fc3-7e3d-42ae-aa3e-7460d44d96a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems_c1d6b96c-b8ef-4627-ae47-ba505d29aac1" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_fdd15fc3-7e3d-42ae-aa3e-7460d44d96a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_47e5476b-5879-488c-89a9-00299aa6fe04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems_c1d6b96c-b8ef-4627-ae47-ba505d29aac1" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_47e5476b-5879-488c-89a9-00299aa6fe04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_f2193232-432a-46dc-8b71-8907fba48a11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems_c1d6b96c-b8ef-4627-ae47-ba505d29aac1" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_f2193232-432a-46dc-8b71-8907fba48a11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_a60e4f3a-71d4-493c-b271-d14f3af5f13f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_f2193232-432a-46dc-8b71-8907fba48a11" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_a60e4f3a-71d4-493c-b271-d14f3af5f13f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_7788c20a-99e5-442d-841c-145a097e81e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_f2193232-432a-46dc-8b71-8907fba48a11" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_7788c20a-99e5-442d-841c-145a097e81e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_2138c875-159c-4f6a-9dd0-ddd035d57bee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_f2193232-432a-46dc-8b71-8907fba48a11" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_2138c875-159c-4f6a-9dd0-ddd035d57bee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_357ac804-2974-4c37-be2e-608a924c5ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems_c1d6b96c-b8ef-4627-ae47-ba505d29aac1" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_357ac804-2974-4c37-be2e-608a924c5ae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_f2a90cdd-3555-47d6-a9ad-e122a5225738" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_357ac804-2974-4c37-be2e-608a924c5ae4" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_f2a90cdd-3555-47d6-a9ad-e122a5225738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_c6e37870-9858-42c2-8805-fb6ee38133e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_357ac804-2974-4c37-be2e-608a924c5ae4" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_c6e37870-9858-42c2-8805-fb6ee38133e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_61a09674-614d-40d9-9fcf-32608e236c68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_357ac804-2974-4c37-be2e-608a924c5ae4" xlink:to="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_61a09674-614d-40d9-9fcf-32608e236c68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_35ff5a72-b67d-455a-aff3-96b329403898" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems_c1d6b96c-b8ef-4627-ae47-ba505d29aac1" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_35ff5a72-b67d-455a-aff3-96b329403898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_e1a48f01-730f-4dba-98fc-48179be98ad2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_00917ab8-083b-4cd1-9a10-fcf75737aae1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_e1a48f01-730f-4dba-98fc-48179be98ad2" xlink:to="loc_us-gaap_StatementTable_00917ab8-083b-4cd1-9a10-fcf75737aae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f8cf9982-a66b-4c1c-a7a5-5ee85bb99569" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_00917ab8-083b-4cd1-9a10-fcf75737aae1" xlink:to="loc_srt_ProductOrServiceAxis_f8cf9982-a66b-4c1c-a7a5-5ee85bb99569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_cc015a40-19d4-49e6-ba04-a684b45b15b9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_f8cf9982-a66b-4c1c-a7a5-5ee85bb99569" xlink:to="loc_srt_ProductsAndServicesDomain_cc015a40-19d4-49e6-ba04-a684b45b15b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_2a97b0f6-b18f-42b1-9a9e-6d58a26101cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_cc015a40-19d4-49e6-ba04-a684b45b15b9" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_2a97b0f6-b18f-42b1-9a9e-6d58a26101cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_a866362e-67fd-448b-ae1e-873f12f9c797" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_00917ab8-083b-4cd1-9a10-fcf75737aae1" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_a866362e-67fd-448b-ae1e-873f12f9c797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_a55c21f9-5fb4-4782-ba32-dc68d28bbf6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_a866362e-67fd-448b-ae1e-873f12f9c797" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_a55c21f9-5fb4-4782-ba32-dc68d28bbf6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member_0865f013-3fbb-4a90-965e-65c9d6ffa892" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_a55c21f9-5fb4-4782-ba32-dc68d28bbf6a" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member_0865f013-3fbb-4a90-965e-65c9d6ffa892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member_7695895a-c73e-4a00-9255-75bb97d79003" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_a55c21f9-5fb4-4782-ba32-dc68d28bbf6a" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member_7695895a-c73e-4a00-9255-75bb97d79003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d234e9d8-de97-42b1-8dd2-338cce13ca63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_00917ab8-083b-4cd1-9a10-fcf75737aae1" xlink:to="loc_us-gaap_StatementLineItems_d234e9d8-de97-42b1-8dd2-338cce13ca63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_a80fd257-69c1-4125-9258-db1871e4313d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d234e9d8-de97-42b1-8dd2-338cce13ca63" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_a80fd257-69c1-4125-9258-db1871e4313d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_321a3da6-db8c-4755-84ba-0b7eb32489ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d234e9d8-de97-42b1-8dd2-338cce13ca63" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_321a3da6-db8c-4755-84ba-0b7eb32489ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_ab43bcb3-7103-407e-beac-45b72eff364b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d234e9d8-de97-42b1-8dd2-338cce13ca63" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_ab43bcb3-7103-407e-beac-45b72eff364b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_25242624-4d98-4249-bddb-fe5869cf56c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d234e9d8-de97-42b1-8dd2-338cce13ca63" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_25242624-4d98-4249-bddb-fe5869cf56c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNotes" xlink:type="simple" xlink:href="unh-20211231.xsd#ShortTermBorrowingsandLongTermDebtNotes"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_79b31adb-a150-419c-af11-1e70e6e17f45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_1fd9d3c5-e83c-44f5-9ec3-3b4e4fc9531d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_79b31adb-a150-419c-af11-1e70e6e17f45" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_1fd9d3c5-e83c-44f5-9ec3-3b4e4fc9531d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtTables" xlink:type="simple" xlink:href="unh-20211231.xsd#ShortTermBorrowingsandLongTermDebtTables"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_9987ea10-9c6b-4ae7-8545-692deecd1816" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a57ff2c6-2101-463c-8d85-95cb2340c1bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9987ea10-9c6b-4ae7-8545-692deecd1816" xlink:to="loc_us-gaap_DebtInstrumentTable_a57ff2c6-2101-463c-8d85-95cb2340c1bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_e5ccc464-6b11-4247-8562-25c380155525" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a57ff2c6-2101-463c-8d85-95cb2340c1bf" xlink:to="loc_srt_StatementScenarioAxis_e5ccc464-6b11-4247-8562-25c380155525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_64cffac0-6f64-4e04-a224-c6752c1b77cc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_e5ccc464-6b11-4247-8562-25c380155525" xlink:to="loc_srt_ScenarioUnspecifiedDomain_64cffac0-6f64-4e04-a224-c6752c1b77cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_8c2019c3-e138-4da5-8658-962676eed166" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a57ff2c6-2101-463c-8d85-95cb2340c1bf" xlink:to="loc_us-gaap_DebtInstrumentLineItems_8c2019c3-e138-4da5-8658-962676eed166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_97a75ac1-6335-4779-b488-fd69d5828c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8c2019c3-e138-4da5-8658-962676eed166" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_97a75ac1-6335-4779-b488-fd69d5828c3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_4b1e4edb-8546-4184-a564-3c2bc015a3dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8c2019c3-e138-4da5-8658-962676eed166" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_4b1e4edb-8546-4184-a564-3c2bc015a3dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#ShortTermBorrowingsandLongTermDebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e32ba2a7-c7f7-4fae-b909-96cd98bbd947" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_ebb197a2-bd65-400f-b5db-61b31a659114" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e32ba2a7-c7f7-4fae-b909-96cd98bbd947" xlink:to="loc_us-gaap_DebtInstrumentTable_ebb197a2-bd65-400f-b5db-61b31a659114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_980d4535-b026-441b-bb60-6714479751ce" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ebb197a2-bd65-400f-b5db-61b31a659114" xlink:to="loc_srt_ConsolidatedEntitiesAxis_980d4535-b026-441b-bb60-6714479751ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_b651afa8-d51b-4d40-9661-143438a0265a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_980d4535-b026-441b-bb60-6714479751ce" xlink:to="loc_srt_ConsolidatedEntitiesDomain_b651afa8-d51b-4d40-9661-143438a0265a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_5fc8b0b8-cb52-421e-812c-4d66815ee042" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SubsidiariesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_b651afa8-d51b-4d40-9661-143438a0265a" xlink:to="loc_srt_SubsidiariesMember_5fc8b0b8-cb52-421e-812c-4d66815ee042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_CreditFacilityNameAxis_28c401c5-12db-4d5d-8a30-5a1e8f073cc1" xlink:href="unh-20211231.xsd#unh_CreditFacilityNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ebb197a2-bd65-400f-b5db-61b31a659114" xlink:to="loc_unh_CreditFacilityNameAxis_28c401c5-12db-4d5d-8a30-5a1e8f073cc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_CreditFacilityNameDomain_fa479131-0e1a-48f8-9825-f3acda72f4a3" xlink:href="unh-20211231.xsd#unh_CreditFacilityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CreditFacilityNameAxis_28c401c5-12db-4d5d-8a30-5a1e8f073cc1" xlink:to="loc_unh_CreditFacilityNameDomain_fa479131-0e1a-48f8-9825-f3acda72f4a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A364Day38BillionCreditFacilityMember_82369944-8d2e-4d22-b4cd-fd5a254bf8fc" xlink:href="unh-20211231.xsd#unh_A364Day38BillionCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CreditFacilityNameDomain_fa479131-0e1a-48f8-9825-f3acda72f4a3" xlink:to="loc_unh_A364Day38BillionCreditFacilityMember_82369944-8d2e-4d22-b4cd-fd5a254bf8fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_FiveYear56BillionCreditFacilityMember_09772a93-9d7c-4b13-92e6-de09b770dc0c" xlink:href="unh-20211231.xsd#unh_FiveYear56BillionCreditFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CreditFacilityNameDomain_fa479131-0e1a-48f8-9825-f3acda72f4a3" xlink:to="loc_unh_FiveYear56BillionCreditFacilityMember_09772a93-9d7c-4b13-92e6-de09b770dc0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ThreeYear56BillionCreditFacilityMember_883bf011-e5ef-4759-ae88-8b78c50e0596" xlink:href="unh-20211231.xsd#unh_ThreeYear56BillionCreditFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_CreditFacilityNameDomain_fa479131-0e1a-48f8-9825-f3acda72f4a3" xlink:to="loc_unh_ThreeYear56BillionCreditFacilityMember_883bf011-e5ef-4759-ae88-8b78c50e0596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_51521e80-f851-4f36-b10b-7689be3d2e41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ebb197a2-bd65-400f-b5db-61b31a659114" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_51521e80-f851-4f36-b10b-7689be3d2e41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_83ae0a68-2e2d-467e-9735-55ed3860a179" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_51521e80-f851-4f36-b10b-7689be3d2e41" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_83ae0a68-2e2d-467e-9735-55ed3860a179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_52810d3d-f771-4253-a3a3-866f913ee258" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_83ae0a68-2e2d-467e-9735-55ed3860a179" xlink:to="loc_us-gaap_CommercialPaperMember_52810d3d-f771-4253-a3a3-866f913ee258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_453cd831-521b-4d2b-9770-24b95c8c7dad" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ebb197a2-bd65-400f-b5db-61b31a659114" xlink:to="loc_srt_RangeAxis_453cd831-521b-4d2b-9770-24b95c8c7dad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_16d5e9a9-351b-4a9e-bee9-a0a52f6a1d6c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_453cd831-521b-4d2b-9770-24b95c8c7dad" xlink:to="loc_srt_RangeMember_16d5e9a9-351b-4a9e-bee9-a0a52f6a1d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4a479fc5-5488-4d1d-84ab-adaaf10a8cba" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_16d5e9a9-351b-4a9e-bee9-a0a52f6a1d6c" xlink:to="loc_srt_MinimumMember_4a479fc5-5488-4d1d-84ab-adaaf10a8cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8b014300-fc1b-461d-af1d-9e657228a3ec" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_16d5e9a9-351b-4a9e-bee9-a0a52f6a1d6c" xlink:to="loc_srt_MaximumMember_8b014300-fc1b-461d-af1d-9e657228a3ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_c693ba48-726d-4d36-b2f0-61e188b28189" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ebb197a2-bd65-400f-b5db-61b31a659114" xlink:to="loc_us-gaap_CreditFacilityAxis_c693ba48-726d-4d36-b2f0-61e188b28189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_8907e84f-eee0-48d0-b7cc-d9e9ab82635b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_c693ba48-726d-4d36-b2f0-61e188b28189" xlink:to="loc_us-gaap_CreditFacilityDomain_8907e84f-eee0-48d0-b7cc-d9e9ab82635b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_d586ddb0-293d-4747-b947-68f2d4183245" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_8907e84f-eee0-48d0-b7cc-d9e9ab82635b" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_d586ddb0-293d-4747-b947-68f2d4183245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d544cb56-8052-4752-aa90-905217a192fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ebb197a2-bd65-400f-b5db-61b31a659114" xlink:to="loc_us-gaap_DebtInstrumentLineItems_d544cb56-8052-4752-aa90-905217a192fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2d46179a-d27a-4a5c-ab48-98ca20e670b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d544cb56-8052-4752-aa90-905217a192fe" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2d46179a-d27a-4a5c-ab48-98ca20e670b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebt_c7f39cfe-871f-4f9b-b946-17375e25db96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d544cb56-8052-4752-aa90-905217a192fe" xlink:to="loc_us-gaap_OtherLongTermDebt_c7f39cfe-871f-4f9b-b946-17375e25db96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebtCurrent_e1920a43-9419-48f3-af97-b33f582b81e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLongTermDebtCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d544cb56-8052-4752-aa90-905217a192fe" xlink:to="loc_us-gaap_OtherLongTermDebtCurrent_e1920a43-9419-48f3-af97-b33f582b81e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_f9759577-f341-40be-97f6-8681e2f7e033" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d544cb56-8052-4752-aa90-905217a192fe" xlink:to="loc_us-gaap_LineOfCredit_f9759577-f341-40be-97f6-8681e2f7e033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_851bf584-d955-46e2-ba28-58e1d66ae816" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d544cb56-8052-4752-aa90-905217a192fe" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_851bf584-d955-46e2-ba28-58e1d66ae816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_ec9024b2-5606-468c-a037-de981859ad3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d544cb56-8052-4752-aa90-905217a192fe" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_ec9024b2-5606-468c-a037-de981859ad3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityExpirationPeriod_5c04b777-211c-4a62-b0bc-6ee398fec14e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d544cb56-8052-4752-aa90-905217a192fe" xlink:to="loc_us-gaap_LineOfCreditFacilityExpirationPeriod_5c04b777-211c-4a62-b0bc-6ee398fec14e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#ShortTermBorrowingsandLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_83f327e8-9ec2-4567-9b88-a3a82585b821" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a0efd5ce-8bdf-4c93-9e28-e32d2c7b1ba3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_83f327e8-9ec2-4567-9b88-a3a82585b821" xlink:to="loc_us-gaap_DebtInstrumentTable_a0efd5ce-8bdf-4c93-9e28-e32d2c7b1ba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_aea240b5-a6c2-4a63-a38a-ef4054c3a586" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a0efd5ce-8bdf-4c93-9e28-e32d2c7b1ba3" xlink:to="loc_us-gaap_DebtInstrumentAxis_aea240b5-a6c2-4a63-a38a-ef4054c3a586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_aea240b5-a6c2-4a63-a38a-ef4054c3a586" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_96efb4b9-67d0-438b-b7c2-e83114577f44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_us-gaap_CommercialPaperMember_96efb4b9-67d0-438b-b7c2-e83114577f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.700notesdueFebruary2021Member_f6f4b031-967e-40fe-abed-70e4dda40b90" xlink:href="unh-20211231.xsd#unh_A4.700notesdueFebruary2021Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A4.700notesdueFebruary2021Member_f6f4b031-967e-40fe-abed-70e4dda40b90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2.125notesdueMarch2021Member_f430266f-66ae-4fe7-a307-1a40b67a085e" xlink:href="unh-20211231.xsd#unh_A2.125notesdueMarch2021Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A2.125notesdueMarch2021Member_f430266f-66ae-4fe7-a307-1a40b67a085e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_FloatingratenotesdueJune2021Member_461d9488-2af8-48dc-917f-7147e9792557" xlink:href="unh-20211231.xsd#unh_FloatingratenotesdueJune2021Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_FloatingratenotesdueJune2021Member_461d9488-2af8-48dc-917f-7147e9792557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.150notesdueJune2021Member_a416fb13-0a19-43eb-85b1-dbcd0ca59904" xlink:href="unh-20211231.xsd#unh_A3.150notesdueJune2021Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3.150notesdueJune2021Member_a416fb13-0a19-43eb-85b1-dbcd0ca59904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.375notesdueNovember2021Member_bf9383ed-6ce1-4a47-8ab4-21bc8883a72c" xlink:href="unh-20211231.xsd#unh_A3.375notesdueNovember2021Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3.375notesdueNovember2021Member_bf9383ed-6ce1-4a47-8ab4-21bc8883a72c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2875NotesDueDecember2021Member_fb4027f1-d183-4c81-abfe-e4d0faffa694" xlink:href="unh-20211231.xsd#unh_A2875NotesDueDecember2021Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A2875NotesDueDecember2021Member_fb4027f1-d183-4c81-abfe-e4d0faffa694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2.875notesdueMarch2022Member_1b3acf75-b79a-4bf6-85ba-604b37fa8a63" xlink:href="unh-20211231.xsd#unh_A2.875notesdueMarch2022Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A2.875notesdueMarch2022Member_1b3acf75-b79a-4bf6-85ba-604b37fa8a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3350NotesDueJuly2022Member_cb755898-270b-4466-8e5d-96637ce26059" xlink:href="unh-20211231.xsd#unh_A3350NotesDueJuly2022Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3350NotesDueJuly2022Member_cb755898-270b-4466-8e5d-96637ce26059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2.375notesdueOctober2022MemberMember_b1001ce7-8049-43e7-b4ad-5562fd5e11c3" xlink:href="unh-20211231.xsd#unh_A2.375notesdueOctober2022MemberMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A2.375notesdueOctober2022MemberMember_b1001ce7-8049-43e7-b4ad-5562fd5e11c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ZeroCouponNotesDueNovember2022Member_9d95165a-efbe-4be2-95f5-118a3d71a199" xlink:href="unh-20211231.xsd#unh_ZeroCouponNotesDueNovember2022Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_ZeroCouponNotesDueNovember2022Member_9d95165a-efbe-4be2-95f5-118a3d71a199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2750NotesDueFebruary2023Member_6fd3697f-cea5-4e4a-ad5e-6c9d6c37e80a" xlink:href="unh-20211231.xsd#unh_A2750NotesDueFebruary2023Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A2750NotesDueFebruary2023Member_6fd3697f-cea5-4e4a-ad5e-6c9d6c37e80a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2875NotesDueMarch2023Member_9813f225-4c0e-4a9c-bf3b-072867c5cfa5" xlink:href="unh-20211231.xsd#unh_A2875NotesDueMarch2023Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A2875NotesDueMarch2023Member_9813f225-4c0e-4a9c-bf3b-072867c5cfa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.500notesdueJune2023Member_5469dca2-0650-4b07-a0b1-a818aae48eb3" xlink:href="unh-20211231.xsd#unh_A3.500notesdueJune2023Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3.500notesdueJune2023Member_5469dca2-0650-4b07-a0b1-a818aae48eb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.500notesdueFebruary2024Member_84d0c6e7-886f-43f6-b3a6-bbbb7f6b3308" xlink:href="unh-20211231.xsd#unh_A3.500notesdueFebruary2024Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3.500notesdueFebruary2024Member_84d0c6e7-886f-43f6-b3a6-bbbb7f6b3308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A0550NotesDueMay2024Member_a90c3d91-ddda-4463-abb9-8fbd4585a350" xlink:href="unh-20211231.xsd#unh_A0550NotesDueMay2024Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A0550NotesDueMay2024Member_a90c3d91-ddda-4463-abb9-8fbd4585a350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2.375notesdueAugust2024Member_3f3c4797-31de-4a5c-b627-9126516d4b2b" xlink:href="unh-20211231.xsd#unh_A2.375notesdueAugust2024Member"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A2.375notesdueAugust2024Member_3f3c4797-31de-4a5c-b627-9126516d4b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.750notesdueJuly2025Member_df03d0d9-8858-4a66-8648-9c8b9749a0ea" xlink:href="unh-20211231.xsd#unh_A3.750notesdueJuly2025Member"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3.750notesdueJuly2025Member_df03d0d9-8858-4a66-8648-9c8b9749a0ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.700notesdueDecember2025Member_758e3f30-212f-4aa9-85ac-40f6f9250219" xlink:href="unh-20211231.xsd#unh_A3.700notesdueDecember2025Member"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3.700notesdueDecember2025Member_758e3f30-212f-4aa9-85ac-40f6f9250219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A1250NotesDueJanuary2026Member_b63831c8-d3a1-4f9f-b656-cb5da2ee088a" xlink:href="unh-20211231.xsd#unh_A1250NotesDueJanuary2026Member"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A1250NotesDueJanuary2026Member_b63831c8-d3a1-4f9f-b656-cb5da2ee088a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.100notesdueMarch2026Member_34756099-39ca-4889-9524-7cd98bc002d5" xlink:href="unh-20211231.xsd#unh_A3.100notesdueMarch2026Member"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3.100notesdueMarch2026Member_34756099-39ca-4889-9524-7cd98bc002d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A1150NotesDueMay2026Member_39c383b5-adf3-4c08-a283-d0c494c30a50" xlink:href="unh-20211231.xsd#unh_A1150NotesDueMay2026Member"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A1150NotesDueMay2026Member_39c383b5-adf3-4c08-a283-d0c494c30a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.450notesdueJanuary2027Member_c01a092a-2df2-4bff-bbe7-5fad885ebe43" xlink:href="unh-20211231.xsd#unh_A3.450notesdueJanuary2027Member"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3.450notesdueJanuary2027Member_c01a092a-2df2-4bff-bbe7-5fad885ebe43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.375notesdueApril2027Member_a46cc29c-a871-47ea-89e1-bfe6f8d82efc" xlink:href="unh-20211231.xsd#unh_A3.375notesdueApril2027Member"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3.375notesdueApril2027Member_a46cc29c-a871-47ea-89e1-bfe6f8d82efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2.950notesdueOctober2027Member_6f283e7b-1f71-4a74-bb91-54b02b73dca1" xlink:href="unh-20211231.xsd#unh_A2.950notesdueOctober2027Member"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A2.950notesdueOctober2027Member_6f283e7b-1f71-4a74-bb91-54b02b73dca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.850notesdueJune2028Member_4b4ca5a9-1ff8-4336-b60e-677f02bd12f2" xlink:href="unh-20211231.xsd#unh_A3.850notesdueJune2028Member"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3.850notesdueJune2028Member_4b4ca5a9-1ff8-4336-b60e-677f02bd12f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.875notesdueDecember2028Member_b3f59b15-5157-416c-9633-15ad4e97418b" xlink:href="unh-20211231.xsd#unh_A3.875notesdueDecember2028Member"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3.875notesdueDecember2028Member_b3f59b15-5157-416c-9633-15ad4e97418b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2.875notesdueAugust2029Member_b63e7446-4213-4a55-bde9-a31d1834ead1" xlink:href="unh-20211231.xsd#unh_A2.875notesdueAugust2029Member"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A2.875notesdueAugust2029Member_b63e7446-4213-4a55-bde9-a31d1834ead1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2000NotesDueMay2030Member_3683d7e5-5665-424b-bbf0-413c9081a50b" xlink:href="unh-20211231.xsd#unh_A2000NotesDueMay2030Member"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A2000NotesDueMay2030Member_3683d7e5-5665-424b-bbf0-413c9081a50b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2300NotesDueMay2031Member_09393c22-9e76-4fae-b12a-ee75a4cf78b9" xlink:href="unh-20211231.xsd#unh_A2300NotesDueMay2031Member"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A2300NotesDueMay2031Member_09393c22-9e76-4fae-b12a-ee75a4cf78b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.625notesdueJuly2035Member_f928bcff-8dfc-4e5b-814c-28c7ffff7c68" xlink:href="unh-20211231.xsd#unh_A4.625notesdueJuly2035Member"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A4.625notesdueJuly2035Member_f928bcff-8dfc-4e5b-814c-28c7ffff7c68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A5.800notesdueMarch2036Member_f15c2a2d-62c9-48e9-a172-9ea3be7dab68" xlink:href="unh-20211231.xsd#unh_A5.800notesdueMarch2036Member"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A5.800notesdueMarch2036Member_f15c2a2d-62c9-48e9-a172-9ea3be7dab68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A6500NotesDueJune2037Member_d6caafd6-16d5-4adb-8d7e-c32946218ce6" xlink:href="unh-20211231.xsd#unh_A6500NotesDueJune2037Member"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A6500NotesDueJune2037Member_d6caafd6-16d5-4adb-8d7e-c32946218ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A6625NotesDueNovember2037Member_47841660-1f87-4e25-a2ae-bdbff9d70dc4" xlink:href="unh-20211231.xsd#unh_A6625NotesDueNovember2037Member"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A6625NotesDueNovember2037Member_47841660-1f87-4e25-a2ae-bdbff9d70dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A6.875notesdueFebruary2038Member_a2670e1e-86c9-4c21-acd2-fa692de9cc1e" xlink:href="unh-20211231.xsd#unh_A6.875notesdueFebruary2038Member"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A6.875notesdueFebruary2038Member_a2670e1e-86c9-4c21-acd2-fa692de9cc1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.500notesdueAugust2039Member_976d7857-71ab-46a4-8580-6728c5bc2292" xlink:href="unh-20211231.xsd#unh_A3.500notesdueAugust2039Member"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3.500notesdueAugust2039Member_976d7857-71ab-46a4-8580-6728c5bc2292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2750NotesDueMay2040Member_32ffbd56-c68c-4a35-961e-4e4e822bcc5c" xlink:href="unh-20211231.xsd#unh_A2750NotesDueMay2040Member"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A2750NotesDueMay2040Member_32ffbd56-c68c-4a35-961e-4e4e822bcc5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A5.700notesdueOctober2040Member_f44384c9-a5cb-47d6-95bd-df89c9cee81b" xlink:href="unh-20211231.xsd#unh_A5.700notesdueOctober2040Member"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A5.700notesdueOctober2040Member_f44384c9-a5cb-47d6-95bd-df89c9cee81b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A5.950notesdueFebruary2041Member_705e95a3-0739-4410-b2f0-cbaf0bc913c9" xlink:href="unh-20211231.xsd#unh_A5.950notesdueFebruary2041Member"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A5.950notesdueFebruary2041Member_705e95a3-0739-4410-b2f0-cbaf0bc913c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3050NotesDueMay2041Member_d16bd996-3097-40e6-ad4b-ebfcd668e0e1" xlink:href="unh-20211231.xsd#unh_A3050NotesDueMay2041Member"/>
    <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3050NotesDueMay2041Member_d16bd996-3097-40e6-ad4b-ebfcd668e0e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.625notesdueNovember2041Member_65cfcd5b-5fe0-4151-9e86-de509030886b" xlink:href="unh-20211231.xsd#unh_A4.625notesdueNovember2041Member"/>
    <link:presentationArc order="41" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A4.625notesdueNovember2041Member_65cfcd5b-5fe0-4151-9e86-de509030886b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.375notesdueMarch2042Member_082043eb-99bf-45af-bbed-ee81f101d2b6" xlink:href="unh-20211231.xsd#unh_A4.375notesdueMarch2042Member"/>
    <link:presentationArc order="42" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A4.375notesdueMarch2042Member_082043eb-99bf-45af-bbed-ee81f101d2b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3950NotesDueOctober2042Member_636e9117-15c9-475e-925f-7965e7ba9252" xlink:href="unh-20211231.xsd#unh_A3950NotesDueOctober2042Member"/>
    <link:presentationArc order="43" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3950NotesDueOctober2042Member_636e9117-15c9-475e-925f-7965e7ba9252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4250NotesDueMarch2043Member_ea7a1119-c960-4e38-a149-df516f99566e" xlink:href="unh-20211231.xsd#unh_A4250NotesDueMarch2043Member"/>
    <link:presentationArc order="44" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A4250NotesDueMarch2043Member_ea7a1119-c960-4e38-a149-df516f99566e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.750notesdueJuly2045Member_ed69cd72-97de-438c-8e2b-200268c9e1a4" xlink:href="unh-20211231.xsd#unh_A4.750notesdueJuly2045Member"/>
    <link:presentationArc order="45" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A4.750notesdueJuly2045Member_ed69cd72-97de-438c-8e2b-200268c9e1a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.200notesdueJanuary2047Member_e486173c-d298-45eb-a65e-9010927a3c29" xlink:href="unh-20211231.xsd#unh_A4.200notesdueJanuary2047Member"/>
    <link:presentationArc order="46" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A4.200notesdueJanuary2047Member_e486173c-d298-45eb-a65e-9010927a3c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.250notesdueApril2047Member_68afd59e-68d1-4939-b52d-43ce4226e3de" xlink:href="unh-20211231.xsd#unh_A4.250notesdueApril2047Member"/>
    <link:presentationArc order="47" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A4.250notesdueApril2047Member_68afd59e-68d1-4939-b52d-43ce4226e3de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.750notesdueOctober2047Member_cd13973a-f8e6-4118-8fc0-0737c6937bb0" xlink:href="unh-20211231.xsd#unh_A3.750notesdueOctober2047Member"/>
    <link:presentationArc order="48" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3.750notesdueOctober2047Member_cd13973a-f8e6-4118-8fc0-0737c6937bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.250notesdueJune2048Member_350e4cf7-97ca-4ded-9634-767d906aa7b4" xlink:href="unh-20211231.xsd#unh_A4.250notesdueJune2048Member"/>
    <link:presentationArc order="49" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A4.250notesdueJune2048Member_350e4cf7-97ca-4ded-9634-767d906aa7b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A4.450notesdueDecember2048Member_36861449-589e-4c6a-8307-7a7207d7705b" xlink:href="unh-20211231.xsd#unh_A4.450notesdueDecember2048Member"/>
    <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A4.450notesdueDecember2048Member_36861449-589e-4c6a-8307-7a7207d7705b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.700notesdueAugust2049Member_ee9805a9-7880-4db4-be6f-370a771dff4a" xlink:href="unh-20211231.xsd#unh_A3.700notesdueAugust2049Member"/>
    <link:presentationArc order="51" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3.700notesdueAugust2049Member_ee9805a9-7880-4db4-be6f-370a771dff4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A2900NotesDueMay2050Member_3713c5de-ef30-493b-919e-128d402a4090" xlink:href="unh-20211231.xsd#unh_A2900NotesDueMay2050Member"/>
    <link:presentationArc order="52" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A2900NotesDueMay2050Member_3713c5de-ef30-493b-919e-128d402a4090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3250NotesDueMay2051Member_c195cbe7-3562-4182-a078-16e62e0f081b" xlink:href="unh-20211231.xsd#unh_A3250NotesDueMay2051Member"/>
    <link:presentationArc order="53" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3250NotesDueMay2051Member_c195cbe7-3562-4182-a078-16e62e0f081b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3.875notesdueAugust2059Member_0379bea0-3b80-4c9f-9216-288100e2efc9" xlink:href="unh-20211231.xsd#unh_A3.875notesdueAugust2059Member"/>
    <link:presentationArc order="54" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3.875notesdueAugust2059Member_0379bea0-3b80-4c9f-9216-288100e2efc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_A3125NotesDueMay2060Member_04bddbfa-dbf0-48f6-851d-8b9d26364294" xlink:href="unh-20211231.xsd#unh_A3125NotesDueMay2060Member"/>
    <link:presentationArc order="55" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8305bd1b-8c80-4245-b1ff-0ed6a2e3f7cb" xlink:to="loc_unh_A3125NotesDueMay2060Member_04bddbfa-dbf0-48f6-851d-8b9d26364294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_14a2cb0b-e50a-4c49-8dd7-28a7d373f9c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a0efd5ce-8bdf-4c93-9e28-e32d2c7b1ba3" xlink:to="loc_us-gaap_DebtInstrumentLineItems_14a2cb0b-e50a-4c49-8dd7-28a7d373f9c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f0b4c06b-dca6-45e9-8c8f-f45735303f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_14a2cb0b-e50a-4c49-8dd7-28a7d373f9c4" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f0b4c06b-dca6-45e9-8c8f-f45735303f7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_8184500c-adbe-4825-bce7-412468f063db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_14a2cb0b-e50a-4c49-8dd7-28a7d373f9c4" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_8184500c-adbe-4825-bce7-412468f063db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredLongTermDebt_5018c335-5fd6-481e-8294-fe8558f68c10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_14a2cb0b-e50a-4c49-8dd7-28a7d373f9c4" xlink:to="loc_us-gaap_UnsecuredLongTermDebt_5018c335-5fd6-481e-8294-fe8558f68c10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtCurrent_5787ae33-94ec-486d-8a4b-61d1f523f8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebtCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_14a2cb0b-e50a-4c49-8dd7-28a7d373f9c4" xlink:to="loc_us-gaap_UnsecuredDebtCurrent_5787ae33-94ec-486d-8a4b-61d1f523f8dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_bd6def07-04f6-4f42-aa65-6a6641b1e01f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaper"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_14a2cb0b-e50a-4c49-8dd7-28a7d373f9c4" xlink:to="loc_us-gaap_CommercialPaper_bd6def07-04f6-4f42-aa65-6a6641b1e01f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_af98bba7-097b-410e-9361-05d2c8bc6d25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_14a2cb0b-e50a-4c49-8dd7-28a7d373f9c4" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_af98bba7-097b-410e-9361-05d2c8bc6d25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_DebtAbstract_fa72ce82-45fc-4ccc-932e-36fb71c8188b" xlink:href="unh-20211231.xsd#unh_DebtAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_d2f11ddd-48d2-42fc-8b01-3988d36c752d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_DebtAbstract_fa72ce82-45fc-4ccc-932e-36fb71c8188b" xlink:to="loc_us-gaap_DebtInstrumentTable_d2f11ddd-48d2-42fc-8b01-3988d36c752d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7d7cbb1d-fbbb-4548-aca6-6457e4bdceb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d2f11ddd-48d2-42fc-8b01-3988d36c752d" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7d7cbb1d-fbbb-4548-aca6-6457e4bdceb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0ae8a3d7-4062-45d9-ba69-1d90fb4c09bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7d7cbb1d-fbbb-4548-aca6-6457e4bdceb7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0ae8a3d7-4062-45d9-ba69-1d90fb4c09bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_fe7ce3dd-9082-43cd-9c89-f6d179df7bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d2f11ddd-48d2-42fc-8b01-3988d36c752d" xlink:to="loc_us-gaap_DebtInstrumentAxis_fe7ce3dd-9082-43cd-9c89-f6d179df7bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ce9286d9-5866-4cbc-b6a4-f6a8f7be2a8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_fe7ce3dd-9082-43cd-9c89-f6d179df7bfa" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ce9286d9-5866-4cbc-b6a4-f6a8f7be2a8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_1c666f30-a883-4190-8ba5-c5e33610c62a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d2f11ddd-48d2-42fc-8b01-3988d36c752d" xlink:to="loc_us-gaap_VariableRateAxis_1c666f30-a883-4190-8ba5-c5e33610c62a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_bf53337c-f591-4a2f-8079-f0b6f4260261" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_1c666f30-a883-4190-8ba5-c5e33610c62a" xlink:to="loc_us-gaap_VariableRateDomain_bf53337c-f591-4a2f-8079-f0b6f4260261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_d7703f95-f4d9-42a3-804c-778dd29fbb54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d2f11ddd-48d2-42fc-8b01-3988d36c752d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_d7703f95-f4d9-42a3-804c-778dd29fbb54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_4b4f542b-d121-4fb8-8d64-77a21ba027e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_d7703f95-f4d9-42a3-804c-778dd29fbb54" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_4b4f542b-d121-4fb8-8d64-77a21ba027e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_bcb46ac1-b068-4125-a7e9-66c9a983d9f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d2f11ddd-48d2-42fc-8b01-3988d36c752d" xlink:to="loc_us-gaap_DebtInstrumentLineItems_bcb46ac1-b068-4125-a7e9-66c9a983d9f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_da8d8df2-28fe-4870-8c23-55eb1325906a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bcb46ac1-b068-4125-a7e9-66c9a983d9f1" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_da8d8df2-28fe-4870-8c23-55eb1325906a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_10144255-3a1e-4956-8740-1e7741e840f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bcb46ac1-b068-4125-a7e9-66c9a983d9f1" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_10144255-3a1e-4956-8740-1e7741e840f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_b456b93e-2d28-4564-9437-f73e8eb6b847" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bcb46ac1-b068-4125-a7e9-66c9a983d9f1" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_b456b93e-2d28-4564-9437-f73e8eb6b847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_f4729564-b9b7-41c7-97c6-1a0886715b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bcb46ac1-b068-4125-a7e9-66c9a983d9f1" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_f4729564-b9b7-41c7-97c6-1a0886715b5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_528df00c-dcd5-422f-a9a1-21f89ec5141c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bcb46ac1-b068-4125-a7e9-66c9a983d9f1" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_528df00c-dcd5-422f-a9a1-21f89ec5141c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_177c7047-5a1d-4ba0-ac16-4a8690836ca8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bcb46ac1-b068-4125-a7e9-66c9a983d9f1" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_177c7047-5a1d-4ba0-ac16-4a8690836ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/IncomeTaxesNotes" xlink:type="simple" xlink:href="unh-20211231.xsd#IncomeTaxesNotes"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/IncomeTaxesNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_IncomeTaxAbstract_41fdb8a0-66b2-49eb-92b3-84442c70e597" xlink:href="unh-20211231.xsd#unh_IncomeTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationTable_5127d1f5-60e0-46e5-b499-4b6dc69f8e52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_IncomeTaxAbstract_41fdb8a0-66b2-49eb-92b3-84442c70e597" xlink:to="loc_us-gaap_IncomeTaxExaminationTable_5127d1f5-60e0-46e5-b499-4b6dc69f8e52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_c9a64e24-140d-4d60-ba49-27767b0a04fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_5127d1f5-60e0-46e5-b499-4b6dc69f8e52" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_c9a64e24-140d-4d60-ba49-27767b0a04fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_ff0ed0a4-d5f0-49b4-86b2-a91fdf1a883c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_c9a64e24-140d-4d60-ba49-27767b0a04fb" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_ff0ed0a4-d5f0-49b4-86b2-a91fdf1a883c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLineItems_0cfe9bbb-dedd-4c23-88eb-bbd75b429095" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_5127d1f5-60e0-46e5-b499-4b6dc69f8e52" xlink:to="loc_us-gaap_IncomeTaxExaminationLineItems_0cfe9bbb-dedd-4c23-88eb-bbd75b429095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_fae7c604-a3cd-467f-960e-81376a956d13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_0cfe9bbb-dedd-4c23-88eb-bbd75b429095" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_fae7c604-a3cd-467f-960e-81376a956d13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="unh-20211231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_IncomeTaxAbstract_49e52da9-614d-46f3-ae6c-b777c67b8612" xlink:href="unh-20211231.xsd#unh_IncomeTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_92a015e9-7f55-4447-9456-afa2f33b5983" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_IncomeTaxAbstract_49e52da9-614d-46f3-ae6c-b777c67b8612" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_92a015e9-7f55-4447-9456-afa2f33b5983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_dab0bc0b-8b50-4db6-8e0c-905739104f00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_92a015e9-7f55-4447-9456-afa2f33b5983" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_dab0bc0b-8b50-4db6-8e0c-905739104f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_4ff9655b-0fd2-43ce-bdc1-8d2f749184e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_dab0bc0b-8b50-4db6-8e0c-905739104f00" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_4ff9655b-0fd2-43ce-bdc1-8d2f749184e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_9d334950-f44e-40c4-9cf4-f55c0e1fd804" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_92a015e9-7f55-4447-9456-afa2f33b5983" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_9d334950-f44e-40c4-9cf4-f55c0e1fd804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_6aacce63-abbe-4cc0-b708-280ff62bf5a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_9d334950-f44e-40c4-9cf4-f55c0e1fd804" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_6aacce63-abbe-4cc0-b708-280ff62bf5a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_f89430b8-82e6-475f-bfdc-d85b4499e473" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_92a015e9-7f55-4447-9456-afa2f33b5983" xlink:to="loc_us-gaap_TaxPeriodAxis_f89430b8-82e6-475f-bfdc-d85b4499e473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_5fc0dc24-8ce6-4903-a538-3b35fa51f2b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_f89430b8-82e6-475f-bfdc-d85b4499e473" xlink:to="loc_us-gaap_TaxPeriodDomain_5fc0dc24-8ce6-4903-a538-3b35fa51f2b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_ed239622-c250-4c10-b337-d3459258195a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_92a015e9-7f55-4447-9456-afa2f33b5983" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_ed239622-c250-4c10-b337-d3459258195a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_03768234-e6b5-4c14-b896-8daf8ae8ced4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ed239622-c250-4c10-b337-d3459258195a" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_03768234-e6b5-4c14-b896-8daf8ae8ced4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_624b8090-9fbb-45cd-b9e8-470695ea5a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ed239622-c250-4c10-b337-d3459258195a" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_624b8090-9fbb-45cd-b9e8-470695ea5a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_a443d91e-e6dd-47f4-ae23-c6c640f30775" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ed239622-c250-4c10-b337-d3459258195a" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_a443d91e-e6dd-47f4-ae23-c6c640f30775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock_0a4023b2-e6a7-4925-856a-64bf96c8e272" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ed239622-c250-4c10-b337-d3459258195a" xlink:to="loc_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock_0a4023b2-e6a7-4925-856a-64bf96c8e272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_IncomeTaxAbstract_496e2d55-bb02-4a50-9e23-1a9520f4dd60" xlink:href="unh-20211231.xsd#unh_IncomeTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_2345db35-50d8-4ccc-b8f0-4c759a9fe1c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_IncomeTaxAbstract_496e2d55-bb02-4a50-9e23-1a9520f4dd60" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_2345db35-50d8-4ccc-b8f0-4c759a9fe1c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_8633b809-aa20-470b-8eb2-bac21aadd685" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_2345db35-50d8-4ccc-b8f0-4c759a9fe1c3" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_8633b809-aa20-470b-8eb2-bac21aadd685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_5872e200-6976-4539-8b92-6e9a1332e056" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_8633b809-aa20-470b-8eb2-bac21aadd685" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_5872e200-6976-4539-8b92-6e9a1332e056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_NOLsExpirationBeginning2022Through2037Member_982d93ed-fe05-43ae-8cae-e7ca0a6e0ca5" xlink:href="unh-20211231.xsd#unh_NOLsExpirationBeginning2022Through2037Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_5872e200-6976-4539-8b92-6e9a1332e056" xlink:to="loc_unh_NOLsExpirationBeginning2022Through2037Member_982d93ed-fe05-43ae-8cae-e7ca0a6e0ca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_NOLsIndefiniteCarryforwardMember_f8dfe4ae-9351-4f0a-a42a-7bc3f5a2f5af" xlink:href="unh-20211231.xsd#unh_NOLsIndefiniteCarryforwardMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_5872e200-6976-4539-8b92-6e9a1332e056" xlink:to="loc_unh_NOLsIndefiniteCarryforwardMember_f8dfe4ae-9351-4f0a-a42a-7bc3f5a2f5af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_4a37f52a-cefa-4133-9e63-20cf2dcad4c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_2345db35-50d8-4ccc-b8f0-4c759a9fe1c3" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_4a37f52a-cefa-4133-9e63-20cf2dcad4c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_f51ecb9f-2c40-4d12-b41d-3c5c8858c462" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_4a37f52a-cefa-4133-9e63-20cf2dcad4c0" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_f51ecb9f-2c40-4d12-b41d-3c5c8858c462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_026851ad-1264-4e72-b0c6-2efe5c995153" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_f51ecb9f-2c40-4d12-b41d-3c5c8858c462" xlink:to="loc_us-gaap_DomesticCountryMember_026851ad-1264-4e72-b0c6-2efe5c995153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_3b10846b-cb1c-4fc2-9af4-ae561920189f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_f51ecb9f-2c40-4d12-b41d-3c5c8858c462" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_3b10846b-cb1c-4fc2-9af4-ae561920189f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_d777288c-54fd-4cf7-8db5-074614066c8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_f51ecb9f-2c40-4d12-b41d-3c5c8858c462" xlink:to="loc_us-gaap_ForeignCountryMember_d777288c-54fd-4cf7-8db5-074614066c8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_bd641ff2-24f0-4bff-8dca-a7f6d04eb102" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_2345db35-50d8-4ccc-b8f0-4c759a9fe1c3" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_bd641ff2-24f0-4bff-8dca-a7f6d04eb102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_dfb48019-e22b-49b9-9400-db89206161bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_bd641ff2-24f0-4bff-8dca-a7f6d04eb102" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_dfb48019-e22b-49b9-9400-db89206161bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_7ca672b9-d023-48ee-a8ff-e7e7d5763525" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_2345db35-50d8-4ccc-b8f0-4c759a9fe1c3" xlink:to="loc_us-gaap_TaxPeriodAxis_7ca672b9-d023-48ee-a8ff-e7e7d5763525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_03c2472a-f117-4101-99c8-e6fb97b27972" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_7ca672b9-d023-48ee-a8ff-e7e7d5763525" xlink:to="loc_us-gaap_TaxPeriodDomain_03c2472a-f117-4101-99c8-e6fb97b27972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarliestTaxYearMember_b2e5e1ea-30d1-48ab-91ed-e0bce72baeb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarliestTaxYearMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_03c2472a-f117-4101-99c8-e6fb97b27972" xlink:to="loc_us-gaap_EarliestTaxYearMember_b2e5e1ea-30d1-48ab-91ed-e0bce72baeb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LatestTaxYearMember_81fa9adc-90e2-4ebc-8838-b03e84343f09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LatestTaxYearMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_03c2472a-f117-4101-99c8-e6fb97b27972" xlink:to="loc_us-gaap_LatestTaxYearMember_81fa9adc-90e2-4ebc-8838-b03e84343f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_1dd3860e-9253-42c8-92cf-99706decb535" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_2345db35-50d8-4ccc-b8f0-4c759a9fe1c3" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_1dd3860e-9253-42c8-92cf-99706decb535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_96034f6e-f1f4-4bad-a60a-c3a32a61fdee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_1dd3860e-9253-42c8-92cf-99706decb535" xlink:to="loc_us-gaap_OperatingLossCarryforwards_96034f6e-f1f4-4bad-a60a-c3a32a61fdee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardExpirationDate_ec6fb3c4-9888-44e3-baa2-b64c352da45a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardExpirationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_1dd3860e-9253-42c8-92cf-99706decb535" xlink:to="loc_us-gaap_TaxCreditCarryforwardExpirationDate_ec6fb3c4-9888-44e3-baa2-b64c352da45a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_d0291fc4-0def-4250-b39b-3d5e9bce7bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_1dd3860e-9253-42c8-92cf-99706decb535" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_d0291fc4-0def-4250-b39b-3d5e9bce7bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_acf2ba17-994c-44ac-9200-3852dd97662d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_1dd3860e-9253-42c8-92cf-99706decb535" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_acf2ba17-994c-44ac-9200-3852dd97662d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OpenTaxYear_638bb682-21f5-49d6-a222-b3bc0405c3a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OpenTaxYear"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_1dd3860e-9253-42c8-92cf-99706decb535" xlink:to="loc_us-gaap_OpenTaxYear_638bb682-21f5-49d6-a222-b3bc0405c3a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_d34e2d3e-53b5-4a50-920a-d238c85380b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_1dd3860e-9253-42c8-92cf-99706decb535" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_d34e2d3e-53b5-4a50-920a-d238c85380b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0b3cef5f-344c-4aa3-b481-537a5fe4c00d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_1dd3860e-9253-42c8-92cf-99706decb535" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0b3cef5f-344c-4aa3-b481-537a5fe4c00d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_IncomeTaxAbstract_94a4e050-0634-4f9b-91a6-94c21b8582e6" xlink:href="unh-20211231.xsd#unh_IncomeTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_789439fb-4391-4aff-b484-7c763a11d98c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_IncomeTaxAbstract_94a4e050-0634-4f9b-91a6-94c21b8582e6" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_789439fb-4391-4aff-b484-7c763a11d98c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_9f1a3d63-ec21-4702-9e3e-83d4db3c570a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_789439fb-4391-4aff-b484-7c763a11d98c" xlink:to="loc_us-gaap_TaxPeriodAxis_9f1a3d63-ec21-4702-9e3e-83d4db3c570a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_35ef1c27-3f3c-4b88-9e6a-f6a01bc6725c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_9f1a3d63-ec21-4702-9e3e-83d4db3c570a" xlink:to="loc_us-gaap_TaxPeriodDomain_35ef1c27-3f3c-4b88-9e6a-f6a01bc6725c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_42872f65-5b4e-4803-993c-6a5a28077b32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_789439fb-4391-4aff-b484-7c763a11d98c" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_42872f65-5b4e-4803-993c-6a5a28077b32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesExcludingIncomeAndExciseTaxesAbstract_49066581-8b4e-4c6f-8187-ac5570b6b40b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesExcludingIncomeAndExciseTaxesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_42872f65-5b4e-4803-993c-6a5a28077b32" xlink:to="loc_us-gaap_TaxesExcludingIncomeAndExciseTaxesAbstract_49066581-8b4e-4c6f-8187-ac5570b6b40b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_d397dde7-92f4-4b78-be3e-28956275763e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_42872f65-5b4e-4803-993c-6a5a28077b32" xlink:to="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_d397dde7-92f4-4b78-be3e-28956275763e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_8d0344d5-9c0c-49fc-bc95-208791056a0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_42872f65-5b4e-4803-993c-6a5a28077b32" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_8d0344d5-9c0c-49fc-bc95-208791056a0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_a7fe0648-7352-4bab-aadc-e6c4bc7a9e6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_42872f65-5b4e-4803-993c-6a5a28077b32" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_a7fe0648-7352-4bab-aadc-e6c4bc7a9e6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_22611f36-9d30-4a69-a4a7-250a6c5b3940" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_42872f65-5b4e-4803-993c-6a5a28077b32" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_22611f36-9d30-4a69-a4a7-250a6c5b3940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_1cc46cc8-1e92-4ce7-9632-04c9db59270f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_42872f65-5b4e-4803-993c-6a5a28077b32" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_1cc46cc8-1e92-4ce7-9632-04c9db59270f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_61574043-6e98-4225-bfbd-1e9a621ed327" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_42872f65-5b4e-4803-993c-6a5a28077b32" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_61574043-6e98-4225-bfbd-1e9a621ed327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_IncomeTaxAbstract_f491793e-ed20-4647-b580-4935088d8c46" xlink:href="unh-20211231.xsd#unh_IncomeTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_d6bf822c-8213-45cf-9805-f09f90c30b4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_IncomeTaxAbstract_f491793e-ed20-4647-b580-4935088d8c46" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_d6bf822c-8213-45cf-9805-f09f90c30b4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_6c5c71f2-5608-49a1-a1ca-f18b45db6fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_d6bf822c-8213-45cf-9805-f09f90c30b4b" xlink:to="loc_us-gaap_TaxPeriodAxis_6c5c71f2-5608-49a1-a1ca-f18b45db6fb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_6bbd44c8-8ceb-4d43-8b9f-05f8ea6ef0fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_6c5c71f2-5608-49a1-a1ca-f18b45db6fb5" xlink:to="loc_us-gaap_TaxPeriodDomain_6bbd44c8-8ceb-4d43-8b9f-05f8ea6ef0fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_425918e4-211a-4c84-93e3-a561035c2eda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_d6bf822c-8213-45cf-9805-f09f90c30b4b" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_425918e4-211a-4c84-93e3-a561035c2eda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_29f91b0d-22ab-4679-be05-df1fedb17698" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_425918e4-211a-4c84-93e3-a561035c2eda" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_29f91b0d-22ab-4679-be05-df1fedb17698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_651810ab-4c92-4573-a77a-6ccc0a6b0094" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_425918e4-211a-4c84-93e3-a561035c2eda" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_651810ab-4c92-4573-a77a-6ccc0a6b0094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_b9b4ba96-f48f-478c-9874-6a2f79e9cd9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_425918e4-211a-4c84-93e3-a561035c2eda" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_b9b4ba96-f48f-478c-9874-6a2f79e9cd9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_a07f38fc-1c09-4fb2-b705-c18f110512b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_425918e4-211a-4c84-93e3-a561035c2eda" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_a07f38fc-1c09-4fb2-b705-c18f110512b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount_c74eba33-b43c-45a6-b15f-7441daad2aa6" xlink:href="unh-20211231.xsd#unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_425918e4-211a-4c84-93e3-a561035c2eda" xlink:to="loc_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount_c74eba33-b43c-45a6-b15f-7441daad2aa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent_3aba2249-2f6e-4855-9c34-c163ef97601d" xlink:href="unh-20211231.xsd#unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_425918e4-211a-4c84-93e3-a561035c2eda" xlink:to="loc_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent_3aba2249-2f6e-4855-9c34-c163ef97601d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_ac9e9c85-9d73-46ab-9fa2-dfd0e7609ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_425918e4-211a-4c84-93e3-a561035c2eda" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_ac9e9c85-9d73-46ab-9fa2-dfd0e7609ffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_42e238c3-744f-456e-b1b2-b2922f8143db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_425918e4-211a-4c84-93e3-a561035c2eda" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_42e238c3-744f-456e-b1b2-b2922f8143db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount_34a7f560-f455-4062-b625-5cdfc273e9db" xlink:href="unh-20211231.xsd#unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_425918e4-211a-4c84-93e3-a561035c2eda" xlink:to="loc_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount_34a7f560-f455-4062-b625-5cdfc273e9db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent_e46d1517-85b1-4cfb-b732-cb9e7c851749" xlink:href="unh-20211231.xsd#unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_425918e4-211a-4c84-93e3-a561035c2eda" xlink:to="loc_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent_e46d1517-85b1-4cfb-b732-cb9e7c851749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_edb3d9ac-2020-4ffa-adc3-bb96cc64b0a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_425918e4-211a-4c84-93e3-a561035c2eda" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_edb3d9ac-2020-4ffa-adc3-bb96cc64b0a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_83ed6059-9fe9-4968-9479-0f89309f7bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_425918e4-211a-4c84-93e3-a561035c2eda" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_83ed6059-9fe9-4968-9479-0f89309f7bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_29825ea9-e9b6-4ce6-9fb9-048c0bfc24a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_425918e4-211a-4c84-93e3-a561035c2eda" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_29825ea9-e9b6-4ce6-9fb9-048c0bfc24a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_a851c53f-21ce-4ffe-a89b-02939e97d0da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_425918e4-211a-4c84-93e3-a561035c2eda" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_a851c53f-21ce-4ffe-a89b-02939e97d0da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_81d6a490-55ab-4922-9ce4-d707df2660a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_425918e4-211a-4c84-93e3-a561035c2eda" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_81d6a490-55ab-4922-9ce4-d707df2660a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9ed22a93-3c1a-4429-84e5-c8b6ffdd3703" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_425918e4-211a-4c84-93e3-a561035c2eda" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9ed22a93-3c1a-4429-84e5-c8b6ffdd3703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_IncomeTaxAbstract_14f21eef-eb72-476a-b00d-c6c5f18d97df" xlink:href="unh-20211231.xsd#unh_IncomeTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_74072871-d167-4055-892c-3a60e6c11df9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_IncomeTaxAbstract_14f21eef-eb72-476a-b00d-c6c5f18d97df" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_74072871-d167-4055-892c-3a60e6c11df9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_b4f92a3d-462a-4859-acd4-e96d456f3433" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_74072871-d167-4055-892c-3a60e6c11df9" xlink:to="loc_us-gaap_TaxPeriodAxis_b4f92a3d-462a-4859-acd4-e96d456f3433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_2e881f70-e2e5-4b23-bb3e-704e0f1a9aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_b4f92a3d-462a-4859-acd4-e96d456f3433" xlink:to="loc_us-gaap_TaxPeriodDomain_2e881f70-e2e5-4b23-bb3e-704e0f1a9aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_11be30c2-9640-4c3a-b92c-1b7c1296bc75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_74072871-d167-4055-892c-3a60e6c11df9" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_11be30c2-9640-4c3a-b92c-1b7c1296bc75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract_2cccfbc0-936d-42c0-9894-94a038473c47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGrossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_11be30c2-9640-4c3a-b92c-1b7c1296bc75" xlink:to="loc_us-gaap_DeferredTaxAssetsGrossAbstract_2cccfbc0-936d-42c0-9894-94a038473c47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_c5296763-bd84-47fb-81b9-2ab714f2544d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_2cccfbc0-936d-42c0-9894-94a038473c47" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_c5296763-bd84-47fb-81b9-2ab714f2544d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_123a8cde-7cf6-4922-8d78-308ec011fb29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_2cccfbc0-936d-42c0-9894-94a038473c47" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_123a8cde-7cf6-4922-8d78-308ec011fb29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_aadd1864-5da4-4b96-95c6-dd9492de8038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_2cccfbc0-936d-42c0-9894-94a038473c47" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_aadd1864-5da4-4b96-95c6-dd9492de8038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities_7223f82a-58f4-4340-8712-4d743407acbc" xlink:href="unh-20211231.xsd#unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_2cccfbc0-936d-42c0-9894-94a038473c47" xlink:to="loc_unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities_7223f82a-58f4-4340-8712-4d743407acbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_6492c3d8-7be3-4467-ba9c-a9a564a097d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_2cccfbc0-936d-42c0-9894-94a038473c47" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_6492c3d8-7be3-4467-ba9c-a9a564a097d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxAssetsLeaseLiability_e3b4f938-a1a4-4d80-8acd-7b927cf49a65" xlink:href="unh-20211231.xsd#unh_DeferredTaxAssetsLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_2cccfbc0-936d-42c0-9894-94a038473c47" xlink:to="loc_unh_DeferredTaxAssetsLeaseLiability_e3b4f938-a1a4-4d80-8acd-7b927cf49a65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxAssetOtherDomestic_3cec8636-4ad0-4f4b-b996-0d5d73937068" xlink:href="unh-20211231.xsd#unh_DeferredTaxAssetOtherDomestic"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_2cccfbc0-936d-42c0-9894-94a038473c47" xlink:to="loc_unh_DeferredTaxAssetOtherDomestic_3cec8636-4ad0-4f4b-b996-0d5d73937068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxAssetOtherForeign_ca39b25a-31a8-4504-a745-52b2b43048e5" xlink:href="unh-20211231.xsd#unh_DeferredTaxAssetOtherForeign"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_2cccfbc0-936d-42c0-9894-94a038473c47" xlink:to="loc_unh_DeferredTaxAssetOtherForeign_ca39b25a-31a8-4504-a745-52b2b43048e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_063272c5-96e2-4704-a6a2-7d1ee572ee84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_2cccfbc0-936d-42c0-9894-94a038473c47" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_063272c5-96e2-4704-a6a2-7d1ee572ee84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_fc1332a7-0e6e-43cd-ab2a-b2e54f8565c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_2cccfbc0-936d-42c0-9894-94a038473c47" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_fc1332a7-0e6e-43cd-ab2a-b2e54f8565c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_50f90740-81b6-478f-95b0-964a2f61627b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_2cccfbc0-936d-42c0-9894-94a038473c47" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_50f90740-81b6-478f-95b0-964a2f61627b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_a2a0ac73-a0c5-47c7-b7ef-cf519df08207" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_11be30c2-9640-4c3a-b92c-1b7c1296bc75" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_a2a0ac73-a0c5-47c7-b7ef-cf519df08207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_1f640f72-676a-4082-b653-082e9b404010" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_a2a0ac73-a0c5-47c7-b7ef-cf519df08207" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_1f640f72-676a-4082-b653-082e9b404010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign_09cd8ae0-c499-4107-a7ce-67f2caf735c4" xlink:href="unh-20211231.xsd#unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_a2a0ac73-a0c5-47c7-b7ef-cf519df08207" xlink:to="loc_unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign_09cd8ae0-c499-4107-a7ce-67f2caf735c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware_11db679c-3f20-437a-ab78-f0bbb10f66fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_a2a0ac73-a0c5-47c7-b7ef-cf519df08207" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware_11db679c-3f20-437a-ab78-f0bbb10f66fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_6685bb26-949b-486b-afc1-0d4f38b8cc1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_a2a0ac73-a0c5-47c7-b7ef-cf519df08207" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_6685bb26-949b-486b-afc1-0d4f38b8cc1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_f7892da1-fabb-42ba-b53d-b6348c164411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_a2a0ac73-a0c5-47c7-b7ef-cf519df08207" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_f7892da1-fabb-42ba-b53d-b6348c164411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates_e5de40eb-c049-4418-b129-248e3c4cd608" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_a2a0ac73-a0c5-47c7-b7ef-cf519df08207" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates_e5de40eb-c049-4418-b129-248e3c4cd608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_7d7fbaff-69e4-4c26-9040-475ed6a2cbc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_a2a0ac73-a0c5-47c7-b7ef-cf519df08207" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_7d7fbaff-69e4-4c26-9040-475ed6a2cbc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxLiabilityOtherDomestic_9aab2979-f112-44a5-83bd-a66c9f9e8b66" xlink:href="unh-20211231.xsd#unh_DeferredTaxLiabilityOtherDomestic"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_a2a0ac73-a0c5-47c7-b7ef-cf519df08207" xlink:to="loc_unh_DeferredTaxLiabilityOtherDomestic_9aab2979-f112-44a5-83bd-a66c9f9e8b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DeferredTaxLiabilityOtherForeign_afab4237-3314-4a9e-9a59-6050fa67c609" xlink:href="unh-20211231.xsd#unh_DeferredTaxLiabilityOtherForeign"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_a2a0ac73-a0c5-47c7-b7ef-cf519df08207" xlink:to="loc_unh_DeferredTaxLiabilityOtherForeign_afab4237-3314-4a9e-9a59-6050fa67c609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_e03a52b9-cb33-49fd-8760-91530f6c505a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_a2a0ac73-a0c5-47c7-b7ef-cf519df08207" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_e03a52b9-cb33-49fd-8760-91530f6c505a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_0473bf3b-f6c3-4fdb-8687-c50aa774eb5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_a2a0ac73-a0c5-47c7-b7ef-cf519df08207" xlink:to="loc_us-gaap_DeferredTaxLiabilities_0473bf3b-f6c3-4fdb-8687-c50aa774eb5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_IncomeTaxAbstract_6843a730-3583-4264-a214-8988ea1f9071" xlink:href="unh-20211231.xsd#unh_IncomeTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_175f7046-d2b5-4474-8485-894c5d7a0604" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_IncomeTaxAbstract_6843a730-3583-4264-a214-8988ea1f9071" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_175f7046-d2b5-4474-8485-894c5d7a0604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_2955da07-0237-401c-b13b-ef137f584958" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_175f7046-d2b5-4474-8485-894c5d7a0604" xlink:to="loc_us-gaap_TaxPeriodAxis_2955da07-0237-401c-b13b-ef137f584958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_10623019-fef4-4d24-934e-b178809ce786" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_2955da07-0237-401c-b13b-ef137f584958" xlink:to="loc_us-gaap_TaxPeriodDomain_10623019-fef4-4d24-934e-b178809ce786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_6a28f67f-db98-4bce-bb88-f9550ec8a5ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_175f7046-d2b5-4474-8485-894c5d7a0604" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_6a28f67f-db98-4bce-bb88-f9550ec8a5ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_d1aad19d-4eee-435a-98a8-14926fe0b330" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6a28f67f-db98-4bce-bb88-f9550ec8a5ac" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_d1aad19d-4eee-435a-98a8-14926fe0b330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_0ce3ab11-36e1-4dcd-8012-819368aeabc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6a28f67f-db98-4bce-bb88-f9550ec8a5ac" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_0ce3ab11-36e1-4dcd-8012-819368aeabc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_949e98c9-d3c9-4408-955f-e0d451391e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6a28f67f-db98-4bce-bb88-f9550ec8a5ac" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_949e98c9-d3c9-4408-955f-e0d451391e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_06ade8d8-bb08-4161-9b80-7e8e2fe8f9b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6a28f67f-db98-4bce-bb88-f9550ec8a5ac" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_06ade8d8-bb08-4161-9b80-7e8e2fe8f9b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_884c2ae9-366f-4564-bd89-da5d810cb5b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6a28f67f-db98-4bce-bb88-f9550ec8a5ac" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_884c2ae9-366f-4564-bd89-da5d810cb5b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_ad2a4b01-8b81-4ac5-8093-600826e845fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6a28f67f-db98-4bce-bb88-f9550ec8a5ac" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_ad2a4b01-8b81-4ac5-8093-600826e845fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_638e472a-6320-4e98-bd56-035349be48b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_6a28f67f-db98-4bce-bb88-f9550ec8a5ac" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_638e472a-6320-4e98-bd56-035349be48b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShareholdersEquityNotes" xlink:type="simple" xlink:href="unh-20211231.xsd#ShareholdersEquityNotes"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ShareholdersEquityNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_ShareholdersEquityAbstract_90556389-49d1-4f25-8230-298ca37ba180" xlink:href="unh-20211231.xsd#unh_ShareholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_5f2c2948-2a75-411f-9ada-cd749b5bde93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_ShareholdersEquityAbstract_90556389-49d1-4f25-8230-298ca37ba180" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_5f2c2948-2a75-411f-9ada-cd749b5bde93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShareholdersEquityTables" xlink:type="simple" xlink:href="unh-20211231.xsd#ShareholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ShareholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_ShareholdersEquityAbstract_3cb41556-a7bc-4ca2-8fa4-a82680068668" xlink:href="unh-20211231.xsd#unh_ShareholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTextBlock_b4c64fca-a7c8-46e5-ac35-4b6cf95a7b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_ShareholdersEquityAbstract_3cb41556-a7bc-4ca2-8fa4-a82680068668" xlink:to="loc_us-gaap_ScheduleOfStockByClassTextBlock_b4c64fca-a7c8-46e5-ac35-4b6cf95a7b9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDeclaredTableTextBlock_4d86f743-a34c-4079-b58c-bafc7808892a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsDeclaredTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_ShareholdersEquityAbstract_3cb41556-a7bc-4ca2-8fa4-a82680068668" xlink:to="loc_us-gaap_DividendsDeclaredTableTextBlock_4d86f743-a34c-4079-b58c-bafc7808892a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShareholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#ShareholdersEquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ShareholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_ShareholdersEquityAbstract_4316734f-5715-408b-a82b-987350036cae" xlink:href="unh-20211231.xsd#unh_ShareholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ShareRepurchasesTable_1758a493-10ee-4082-a0b0-38db5dcb4b38" xlink:href="unh-20211231.xsd#unh_ShareRepurchasesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_ShareholdersEquityAbstract_4316734f-5715-408b-a82b-987350036cae" xlink:to="loc_unh_ShareRepurchasesTable_1758a493-10ee-4082-a0b0-38db5dcb4b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DividendFrequencyAxis_f89666f8-360a-4b31-99bb-c24bce5c8b05" xlink:href="unh-20211231.xsd#unh_DividendFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_ShareRepurchasesTable_1758a493-10ee-4082-a0b0-38db5dcb4b38" xlink:to="loc_unh_DividendFrequencyAxis_f89666f8-360a-4b31-99bb-c24bce5c8b05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DividendFrequencyDomain_0f7a7e84-b0d3-40f5-884e-507a789a4409" xlink:href="unh-20211231.xsd#unh_DividendFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_DividendFrequencyAxis_f89666f8-360a-4b31-99bb-c24bce5c8b05" xlink:to="loc_unh_DividendFrequencyDomain_0f7a7e84-b0d3-40f5-884e-507a789a4409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ExtraordinaryDividendsMember_1a859154-5e5a-448d-b906-92bb547995cb" xlink:href="unh-20211231.xsd#unh_ExtraordinaryDividendsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_DividendFrequencyDomain_0f7a7e84-b0d3-40f5-884e-507a789a4409" xlink:to="loc_unh_ExtraordinaryDividendsMember_1a859154-5e5a-448d-b906-92bb547995cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ShareRepurchasesTableLineItems_5db5c4d2-bcf3-4434-ba25-e8e2739ca6d6" xlink:href="unh-20211231.xsd#unh_ShareRepurchasesTableLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_ShareRepurchasesTable_1758a493-10ee-4082-a0b0-38db5dcb4b38" xlink:to="loc_unh_ShareRepurchasesTableLineItems_5db5c4d2-bcf3-4434-ba25-e8e2739ca6d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries_d246d2a2-b462-4bed-8363-e93f33a7c8a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_ShareRepurchasesTableLineItems_5db5c4d2-bcf3-4434-ba25-e8e2739ca6d6" xlink:to="loc_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries_d246d2a2-b462-4bed-8363-e93f33a7c8a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_e97bf801-1580-404e-ab0a-3bd67b355691" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_ShareRepurchasesTableLineItems_5db5c4d2-bcf3-4434-ba25-e8e2739ca6d6" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_e97bf801-1580-404e-ab0a-3bd67b355691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_bf1641a4-d4ae-400f-b118-d646f0301ac4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_ShareRepurchasesTableLineItems_5db5c4d2-bcf3-4434-ba25-e8e2739ca6d6" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_bf1641a4-d4ae-400f-b118-d646f0301ac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_004b89ea-c87d-4381-b1dc-04ab91d977a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_ShareRepurchasesTableLineItems_5db5c4d2-bcf3-4434-ba25-e8e2739ca6d6" xlink:to="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_004b89ea-c87d-4381-b1dc-04ab91d977a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShareholdersEquityShareRepurchasesDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#ShareholdersEquityShareRepurchasesDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ShareholdersEquityShareRepurchasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_6d64fb35-9d1e-4064-bf63-f4ef1853d237" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_8a83d261-6930-41b8-ad2f-ce6db60916ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_6d64fb35-9d1e-4064-bf63-f4ef1853d237" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_8a83d261-6930-41b8-ad2f-ce6db60916ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_f455303d-faef-4f02-aa5a-cf1d81f67034" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_6d64fb35-9d1e-4064-bf63-f4ef1853d237" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_f455303d-faef-4f02-aa5a-cf1d81f67034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_4f209382-cb2f-4402-bb59-3ffc2792d466" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_6d64fb35-9d1e-4064-bf63-f4ef1853d237" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_4f209382-cb2f-4402-bb59-3ffc2792d466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_a21b32c3-f9f9-4b6b-b143-167f0faf7e61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_6d64fb35-9d1e-4064-bf63-f4ef1853d237" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_a21b32c3-f9f9-4b6b-b143-167f0faf7e61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShareholdersEquityDividendsDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#ShareholdersEquityDividendsDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ShareholdersEquityDividendsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_f9eee5fc-9094-4c5d-9f4d-791292807d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_cfa5cf79-3ee0-43ca-aeb6-f73dbe6bdc6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f9eee5fc-9094-4c5d-9f4d-791292807d5a" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_cfa5cf79-3ee0-43ca-aeb6-f73dbe6bdc6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_37ab5976-b66b-42d9-9fef-1a4c962b39d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f9eee5fc-9094-4c5d-9f4d-791292807d5a" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_37ab5976-b66b-42d9-9fef-1a4c962b39d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShareBasedCompensationNotes" xlink:type="simple" xlink:href="unh-20211231.xsd#ShareBasedCompensationNotes"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ShareBasedCompensationNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4c4dae49-2116-4400-b63a-9006c1afe9ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_5e9868b6-1a4e-4910-b0f1-b47aad6172fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4c4dae49-2116-4400-b63a-9006c1afe9ba" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_5e9868b6-1a4e-4910-b0f1-b47aad6172fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="unh-20211231.xsd#ShareBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ShareBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7dfdc5c0-a471-4a1f-98ba-c8735e441fdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_68f3a80a-21e9-4f53-a881-6ba42a95a0e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7dfdc5c0-a471-4a1f-98ba-c8735e441fdc" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_68f3a80a-21e9-4f53-a881-6ba42a95a0e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_85c8c29d-ff69-4e5a-87ff-ffec41a72dda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7dfdc5c0-a471-4a1f-98ba-c8735e441fdc" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_85c8c29d-ff69-4e5a-87ff-ffec41a72dda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_2d3d418f-83ad-4e66-b9e8-78d1cf060786" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7dfdc5c0-a471-4a1f-98ba-c8735e441fdc" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_2d3d418f-83ad-4e66-b9e8-78d1cf060786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_3d57f5b1-efb2-4d33-b154-32d089b47688" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7dfdc5c0-a471-4a1f-98ba-c8735e441fdc" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_3d57f5b1-efb2-4d33-b154-32d089b47688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_746d50b3-2f52-45f9-a4b3-cef232379c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e876ff3f-41af-488a-bb59-7c1835ceb566" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_746d50b3-2f52-45f9-a4b3-cef232379c3c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e876ff3f-41af-488a-bb59-7c1835ceb566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_fdced0fb-eb2d-4706-862e-66415aa83463" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e876ff3f-41af-488a-bb59-7c1835ceb566" xlink:to="loc_us-gaap_PlanNameAxis_fdced0fb-eb2d-4706-862e-66415aa83463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_77034bf8-fe91-41eb-8eed-0e0e82427de7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_fdced0fb-eb2d-4706-862e-66415aa83463" xlink:to="loc_us-gaap_PlanNameDomain_77034bf8-fe91-41eb-8eed-0e0e82427de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_3dd0a79e-9167-447c-81cc-4a5ecf4bb3d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e876ff3f-41af-488a-bb59-7c1835ceb566" xlink:to="loc_us-gaap_AwardDateAxis_3dd0a79e-9167-447c-81cc-4a5ecf4bb3d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_4514f284-498e-4b10-8bae-11fcbd931bea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateAxis_3dd0a79e-9167-447c-81cc-4a5ecf4bb3d3" xlink:to="loc_us-gaap_AwardDateDomain_4514f284-498e-4b10-8bae-11fcbd931bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e2c1bb4c-e310-4a37-a35f-014e516f1be2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e876ff3f-41af-488a-bb59-7c1835ceb566" xlink:to="loc_us-gaap_AwardTypeAxis_e2c1bb4c-e310-4a37-a35f-014e516f1be2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_87ae6de3-7f99-430c-9f34-1f230fd96319" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_e2c1bb4c-e310-4a37-a35f-014e516f1be2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_87ae6de3-7f99-430c-9f34-1f230fd96319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_6de94206-f361-4eee-807b-11c82ffa0ca8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_87ae6de3-7f99-430c-9f34-1f230fd96319" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_6de94206-f361-4eee-807b-11c82ffa0ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EmployeeStockPurchasePlanESPPMember_e05008d3-e303-41cf-b85e-a5ae27a73fad" xlink:href="unh-20211231.xsd#unh_EmployeeStockPurchasePlanESPPMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_87ae6de3-7f99-430c-9f34-1f230fd96319" xlink:to="loc_unh_EmployeeStockPurchasePlanESPPMember_e05008d3-e303-41cf-b85e-a5ae27a73fad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_5212f5a0-e14b-46b2-a917-f47cc9c21bab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e876ff3f-41af-488a-bb59-7c1835ceb566" xlink:to="loc_us-gaap_StatementClassOfStockAxis_5212f5a0-e14b-46b2-a917-f47cc9c21bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_9af9540d-faaf-44e5-842d-ab166f1bd29b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_5212f5a0-e14b-46b2-a917-f47cc9c21bab" xlink:to="loc_us-gaap_ClassOfStockDomain_9af9540d-faaf-44e5-842d-ab166f1bd29b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_acc4cf08-49c6-4ab2-83bf-05b2443bbb61" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e876ff3f-41af-488a-bb59-7c1835ceb566" xlink:to="loc_srt_RangeAxis_acc4cf08-49c6-4ab2-83bf-05b2443bbb61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_eede0b35-0fc1-4e88-aea8-5fba76a86c18" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_acc4cf08-49c6-4ab2-83bf-05b2443bbb61" xlink:to="loc_srt_RangeMember_eede0b35-0fc1-4e88-aea8-5fba76a86c18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_0c2fa558-0436-4d2f-bed9-902e2d0e69e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e876ff3f-41af-488a-bb59-7c1835ceb566" xlink:to="loc_us-gaap_VestingAxis_0c2fa558-0436-4d2f-bed9-902e2d0e69e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_7aa11226-c29c-41c4-9594-f8298b4b79b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_0c2fa558-0436-4d2f-bed9-902e2d0e69e7" xlink:to="loc_us-gaap_VestingDomain_7aa11226-c29c-41c4-9594-f8298b4b79b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_229b2a57-784a-42ee-986a-30dfe7ec743c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e876ff3f-41af-488a-bb59-7c1835ceb566" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_229b2a57-784a-42ee-986a-30dfe7ec743c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_aaf28b2a-8574-45db-9697-a16121907326" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_229b2a57-784a-42ee-986a-30dfe7ec743c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_aaf28b2a-8574-45db-9697-a16121907326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_bb6b53b9-1a31-4ba9-822c-641fab4925dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_229b2a57-784a-42ee-986a-30dfe7ec743c" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_bb6b53b9-1a31-4ba9-822c-641fab4925dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_80919e59-acdd-4622-a726-260f0c30d960" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_229b2a57-784a-42ee-986a-30dfe7ec743c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_80919e59-acdd-4622-a726-260f0c30d960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#ShareBasedCompensationStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0518fabb-f9fa-4e18-bc09-553e7d038fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bf93c14d-ba72-4096-8fa1-166741afcaa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0518fabb-f9fa-4e18-bc09-553e7d038fa9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bf93c14d-ba72-4096-8fa1-166741afcaa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2cf99dcb-163a-4081-b613-d977e91d7262" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bf93c14d-ba72-4096-8fa1-166741afcaa5" xlink:to="loc_us-gaap_AwardTypeAxis_2cf99dcb-163a-4081-b613-d977e91d7262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2709c794-f744-45f1-8e14-db68e53fc070" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_2cf99dcb-163a-4081-b613-d977e91d7262" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2709c794-f744-45f1-8e14-db68e53fc070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2a011f4-94cf-4a0a-a7df-296e02a755de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bf93c14d-ba72-4096-8fa1-166741afcaa5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2a011f4-94cf-4a0a-a7df-296e02a755de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2a011f4-94cf-4a0a-a7df-296e02a755de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a7c986a5-ebe6-48b6-8bca-94e7b98e9142" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a7c986a5-ebe6-48b6-8bca-94e7b98e9142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_8b2b3075-535e-47a6-9fc0-983285497ade" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_8b2b3075-535e-47a6-9fc0-983285497ade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_752f0d0f-b651-41fc-a704-81a674e7d77f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_752f0d0f-b651-41fc-a704-81a674e7d77f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_88fa6763-d6d8-4e0b-86b5-25a608217d01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_88fa6763-d6d8-4e0b-86b5-25a608217d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4555e480-6b9c-41b6-b5fb-18d28067a6eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4555e480-6b9c-41b6-b5fb-18d28067a6eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_b94e82fc-d09b-418d-b4ac-7c195b92dd74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_b94e82fc-d09b-418d-b4ac-7c195b92dd74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_b90e35d4-7ddc-42f8-a70d-b275f9d3a782" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_b90e35d4-7ddc-42f8-a70d-b275f9d3a782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_fb38b988-bec5-4559-b726-1a98f84975a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_fb38b988-bec5-4559-b726-1a98f84975a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_8be08f86-5e53-4909-b153-22bbd058e6b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_8be08f86-5e53-4909-b153-22bbd058e6b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_cfe06d34-f5e1-4f1d-ab1e-16f093d11a25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_cfe06d34-f5e1-4f1d-ab1e-16f093d11a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2dfcf024-2342-4a4f-9529-83edd357e965" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2dfcf024-2342-4a4f-9529-83edd357e965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_76d2112a-e583-4a63-bd48-1317889ca267" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_76d2112a-e583-4a63-bd48-1317889ca267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_8c0114df-6b62-4b68-ac47-5a52ab81e561" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_8c0114df-6b62-4b68-ac47-5a52ab81e561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_847b1492-a029-41c4-8f96-f91163941b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_847b1492-a029-41c4-8f96-f91163941b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_612f5594-5c3e-4eec-bf85-c6e3e70b82de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_612f5594-5c3e-4eec-bf85-c6e3e70b82de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_9bfd0d52-255a-4bfc-b178-4f6df77710ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_9bfd0d52-255a-4bfc-b178-4f6df77710ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_f86c9bd0-169a-4602-93b2-bfe88e5f7509" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_f86c9bd0-169a-4602-93b2-bfe88e5f7509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_b7ef73e3-93f1-49e0-88d6-e8fff252cb5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_b7ef73e3-93f1-49e0-88d6-e8fff252cb5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0a3c7405-68be-41cf-9c8f-e6d05558e854" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0a3c7405-68be-41cf-9c8f-e6d05558e854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_10cb1b94-9e2c-4d74-be62-dbe9b10ba7bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f227313c-942b-4ce3-8862-93d197d85048" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_10cb1b94-9e2c-4d74-be62-dbe9b10ba7bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShareBasedCompensationRestrictedShareActivityDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#ShareBasedCompensationRestrictedShareActivityDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ShareBasedCompensationRestrictedShareActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d4f205d9-7e9b-47e6-af8c-4d2758006d18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b2051329-e649-4ecd-836c-a63423365e78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d4f205d9-7e9b-47e6-af8c-4d2758006d18" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b2051329-e649-4ecd-836c-a63423365e78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_23b84d4a-159d-407e-bdaa-33516b467829" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b2051329-e649-4ecd-836c-a63423365e78" xlink:to="loc_us-gaap_AwardTypeAxis_23b84d4a-159d-407e-bdaa-33516b467829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_daa907a2-d587-45c9-8567-7c05eb8686ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_23b84d4a-159d-407e-bdaa-33516b467829" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_daa907a2-d587-45c9-8567-7c05eb8686ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_e62a781f-cd06-4370-acf7-b7c2dc56b213" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_daa907a2-d587-45c9-8567-7c05eb8686ff" xlink:to="loc_us-gaap_RestrictedStockMember_e62a781f-cd06-4370-acf7-b7c2dc56b213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9cff51da-7e76-48a1-921f-5f2e2b6b74eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b2051329-e649-4ecd-836c-a63423365e78" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9cff51da-7e76-48a1-921f-5f2e2b6b74eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e3053c20-b3b8-49f4-b259-bdae0ebb28d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9cff51da-7e76-48a1-921f-5f2e2b6b74eb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e3053c20-b3b8-49f4-b259-bdae0ebb28d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_13a67e06-d0db-4446-a2c2-e404eae94f31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e3053c20-b3b8-49f4-b259-bdae0ebb28d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_13a67e06-d0db-4446-a2c2-e404eae94f31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_507f247a-1877-4852-9aad-a11182236786" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e3053c20-b3b8-49f4-b259-bdae0ebb28d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_507f247a-1877-4852-9aad-a11182236786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d0ad8d8e-5669-46d8-9364-c549830e8843" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e3053c20-b3b8-49f4-b259-bdae0ebb28d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d0ad8d8e-5669-46d8-9364-c549830e8843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7cc0e3ab-d67f-4136-afc3-a637c0755c24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e3053c20-b3b8-49f4-b259-bdae0ebb28d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7cc0e3ab-d67f-4136-afc3-a637c0755c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_22aa5bf5-734b-4a9b-968e-9ab1f77a6e54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e3053c20-b3b8-49f4-b259-bdae0ebb28d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_22aa5bf5-734b-4a9b-968e-9ab1f77a6e54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_917f0716-445b-4d73-bce1-a23bd919d176" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e3053c20-b3b8-49f4-b259-bdae0ebb28d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_917f0716-445b-4d73-bce1-a23bd919d176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_a21df360-5d31-497a-a35d-6443c19008b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e3053c20-b3b8-49f4-b259-bdae0ebb28d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_a21df360-5d31-497a-a35d-6443c19008b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9150b0fd-21e8-4a39-a736-d5c199ce27b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e3053c20-b3b8-49f4-b259-bdae0ebb28d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9150b0fd-21e8-4a39-a736-d5c199ce27b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#ShareBasedCompensationOtherShareBasedCompensationDataDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_OtherShareBasedCompensationDataAbstract_21339919-b175-4f23-aadb-06eb0dad2f54" xlink:href="unh-20211231.xsd#unh_OtherShareBasedCompensationDataAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7465245d-7717-4dc2-a474-9ce47a9081e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_OtherShareBasedCompensationDataAbstract_21339919-b175-4f23-aadb-06eb0dad2f54" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7465245d-7717-4dc2-a474-9ce47a9081e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_77922023-7726-4440-b7b9-51063003f562" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7465245d-7717-4dc2-a474-9ce47a9081e0" xlink:to="loc_us-gaap_AwardTypeAxis_77922023-7726-4440-b7b9-51063003f562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e08de87b-0228-425c-9228-f3e69e7a7537" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_77922023-7726-4440-b7b9-51063003f562" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e08de87b-0228-425c-9228-f3e69e7a7537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_StockOptionsandSARsMember_cb55c031-3291-4444-b64f-62e46200e4ca" xlink:href="unh-20211231.xsd#unh_StockOptionsandSARsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e08de87b-0228-425c-9228-f3e69e7a7537" xlink:to="loc_unh_StockOptionsandSARsMember_cb55c031-3291-4444-b64f-62e46200e4ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_0d77c034-1f05-4152-9099-ceedddc1b69a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e08de87b-0228-425c-9228-f3e69e7a7537" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_0d77c034-1f05-4152-9099-ceedddc1b69a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EmployeeStockPurchasePlanESPPMember_de709045-20ed-4caa-8ce6-a776f9b99dba" xlink:href="unh-20211231.xsd#unh_EmployeeStockPurchasePlanESPPMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e08de87b-0228-425c-9228-f3e69e7a7537" xlink:to="loc_unh_EmployeeStockPurchasePlanESPPMember_de709045-20ed-4caa-8ce6-a776f9b99dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_541a6082-debd-4ed2-ab4b-476c7ac7ab9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7465245d-7717-4dc2-a474-9ce47a9081e0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_541a6082-debd-4ed2-ab4b-476c7ac7ab9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_aec3a34a-a072-4fb3-8ed5-ab9e9227612f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_541a6082-debd-4ed2-ab4b-476c7ac7ab9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_aec3a34a-a072-4fb3-8ed5-ab9e9227612f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_49ff462d-4081-4e51-81e7-8702bc70cb76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_541a6082-debd-4ed2-ab4b-476c7ac7ab9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_49ff462d-4081-4e51-81e7-8702bc70cb76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_938cd2b1-4010-4421-b882-1adb3a3d99e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_541a6082-debd-4ed2-ab4b-476c7ac7ab9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_938cd2b1-4010-4421-b882-1adb3a3d99e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_d30db912-f38d-47c0-9251-e2407fedbd34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_541a6082-debd-4ed2-ab4b-476c7ac7ab9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_d30db912-f38d-47c0-9251-e2407fedbd34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_1a6c3d09-2cae-4bda-9bfb-41425588faef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_541a6082-debd-4ed2-ab4b-476c7ac7ab9c" xlink:to="loc_us-gaap_ShareBasedCompensation_1a6c3d09-2cae-4bda-9bfb-41425588faef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_d40c4897-4a2e-4d23-9446-392b1ef66aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_541a6082-debd-4ed2-ab4b-476c7ac7ab9c" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_d40c4897-4a2e-4d23-9446-392b1ef66aa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_7f1367cd-d386-4114-939b-4782998df0e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_541a6082-debd-4ed2-ab4b-476c7ac7ab9c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_7f1367cd-d386-4114-939b-4782998df0e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_f94d867f-3d9c-406a-980d-eb38b437fe3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_541a6082-debd-4ed2-ab4b-476c7ac7ab9c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_f94d867f-3d9c-406a-980d-eb38b437fe3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0b433eb3-7459-4312-a61a-a1680ea22f35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_541a6082-debd-4ed2-ab4b-476c7ac7ab9c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0b433eb3-7459-4312-a61a-a1680ea22f35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_3bfdcce8-b1ae-48a7-9f9c-cc586ca86ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_541a6082-debd-4ed2-ab4b-476c7ac7ab9c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_3bfdcce8-b1ae-48a7-9f9c-cc586ca86ae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_702f97d9-8eb1-4fbc-8774-a21e5f1c1392" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f7a5e01b-2cdd-4bde-8561-5efe9ec59621" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_702f97d9-8eb1-4fbc-8774-a21e5f1c1392" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f7a5e01b-2cdd-4bde-8561-5efe9ec59621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9e9e507a-395d-4526-aba8-9a6b69e1b20d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f7a5e01b-2cdd-4bde-8561-5efe9ec59621" xlink:to="loc_srt_RangeAxis_9e9e507a-395d-4526-aba8-9a6b69e1b20d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5be265cf-cd61-4ed2-8171-6455f4e5e673" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_9e9e507a-395d-4526-aba8-9a6b69e1b20d" xlink:to="loc_srt_RangeMember_5be265cf-cd61-4ed2-8171-6455f4e5e673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7821b87d-e772-4f57-bcc5-2c93bcc38f1b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5be265cf-cd61-4ed2-8171-6455f4e5e673" xlink:to="loc_srt_MinimumMember_7821b87d-e772-4f57-bcc5-2c93bcc38f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_dbd87468-8092-4a5d-b4e9-7201c0028535" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5be265cf-cd61-4ed2-8171-6455f4e5e673" xlink:to="loc_srt_MaximumMember_dbd87468-8092-4a5d-b4e9-7201c0028535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4750d00f-4050-4183-9328-317d8c6941fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f7a5e01b-2cdd-4bde-8561-5efe9ec59621" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4750d00f-4050-4183-9328-317d8c6941fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_af2423c9-4fd0-487c-a403-17aa17556952" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4750d00f-4050-4183-9328-317d8c6941fe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_af2423c9-4fd0-487c-a403-17aa17556952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3c60a6a0-f93c-4a59-b5f0-9aef9ea4f4a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4750d00f-4050-4183-9328-317d8c6941fe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3c60a6a0-f93c-4a59-b5f0-9aef9ea4f4a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_0b256218-2bd3-4185-b645-d2f8431546a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4750d00f-4050-4183-9328-317d8c6941fe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_0b256218-2bd3-4185-b645-d2f8431546a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures_d2d8c734-9689-4713-a245-eead61b4307f" xlink:href="unh-20211231.xsd#unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4750d00f-4050-4183-9328-317d8c6941fe" xlink:to="loc_unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures_d2d8c734-9689-4713-a245-eead61b4307f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_00794262-6eb1-427a-b384-8c3318ed9475" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4750d00f-4050-4183-9328-317d8c6941fe" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_00794262-6eb1-427a-b384-8c3318ed9475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_04907300-86c4-4c26-9959-6fbad9b8a8c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4750d00f-4050-4183-9328-317d8c6941fe" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_04907300-86c4-4c26-9959-6fbad9b8a8c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_5dff87ea-5eaa-441c-98df-1dd6bdf88202" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4750d00f-4050-4183-9328-317d8c6941fe" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_5dff87ea-5eaa-441c-98df-1dd6bdf88202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_b2d1a9de-f882-49a6-af5a-cba974178b02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4750d00f-4050-4183-9328-317d8c6941fe" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_b2d1a9de-f882-49a6-af5a-cba974178b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/CommitmentsandContingenciesNotes" xlink:type="simple" xlink:href="unh-20211231.xsd#CommitmentsandContingenciesNotes"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/CommitmentsandContingenciesNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_36a2f257-5a9a-429a-a1cd-fbb932e0fc0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_6f9557a4-5a93-45dd-8a58-4f29abf0be21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_36a2f257-5a9a-429a-a1cd-fbb932e0fc0a" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_6f9557a4-5a93-45dd-8a58-4f29abf0be21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/CommitmentsandContingenciesTables" xlink:type="simple" xlink:href="unh-20211231.xsd#CommitmentsandContingenciesTables"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/CommitmentsandContingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2414a010-70ef-4247-bc8b-478b9019b519" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_70ec8f4b-9eb2-40a7-9d8a-490176dc73af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2414a010-70ef-4247-bc8b-478b9019b519" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_70ec8f4b-9eb2-40a7-9d8a-490176dc73af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#CommitmentsandContingenciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ad89a31d-8f1f-4e50-a885-7e6f503afd31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_5631e5fd-fac4-4797-bce5-c29b6e93880c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ad89a31d-8f1f-4e50-a885-7e6f503afd31" xlink:to="loc_us-gaap_LossContingenciesTable_5631e5fd-fac4-4797-bce5-c29b6e93880c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_ca296ef8-24a2-4cc6-a964-23734f9bbf81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_5631e5fd-fac4-4797-bce5-c29b6e93880c" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_ca296ef8-24a2-4cc6-a964-23734f9bbf81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_37dc5165-138c-4857-88e6-cc945c995981" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_ca296ef8-24a2-4cc6-a964-23734f9bbf81" xlink:to="loc_us-gaap_LossContingencyNatureDomain_37dc5165-138c-4857-88e6-cc945c995981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_37416f7c-869e-4076-9842-2a69ddfb9ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_5631e5fd-fac4-4797-bce5-c29b6e93880c" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_37416f7c-869e-4076-9842-2a69ddfb9ed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_063be91a-ca1c-41a8-98b3-97eb86c7a729" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_37416f7c-869e-4076-9842-2a69ddfb9ed9" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_063be91a-ca1c-41a8-98b3-97eb86c7a729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_2571f052-1c8b-4622-a433-28261d68d6d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_063be91a-ca1c-41a8-98b3-97eb86c7a729" xlink:to="loc_us-gaap_SubsequentEventMember_2571f052-1c8b-4622-a433-28261d68d6d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_722ba8ef-3316-41cb-a014-579158a29ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_5631e5fd-fac4-4797-bce5-c29b6e93880c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_722ba8ef-3316-41cb-a014-579158a29ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_341ff8b6-4963-4564-8e8c-a6fc4b463e97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_722ba8ef-3316-41cb-a014-579158a29ce0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_341ff8b6-4963-4564-8e8c-a6fc4b463e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_c79c681e-9b53-4045-baad-a7cd6f0f4c71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_5631e5fd-fac4-4797-bce5-c29b6e93880c" xlink:to="loc_us-gaap_LossContingenciesLineItems_c79c681e-9b53-4045-baad-a7cd6f0f4c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_2319c903-6bb4-41a0-b913-76a74fce9c46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c79c681e-9b53-4045-baad-a7cd6f0f4c71" xlink:to="loc_us-gaap_OperatingLeaseCost_2319c903-6bb4-41a0-b913-76a74fce9c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_23fdae88-1acb-4a5e-b206-04764f27cc13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c79c681e-9b53-4045-baad-a7cd6f0f4c71" xlink:to="loc_us-gaap_OperatingLeasePayments_23fdae88-1acb-4a5e-b206-04764f27cc13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_66200e24-2875-4ebb-9288-e8551810076d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c79c681e-9b53-4045-baad-a7cd6f0f4c71" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_66200e24-2875-4ebb-9288-e8551810076d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_9f800773-406d-45f0-97b2-0611b1ab1f79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c79c681e-9b53-4045-baad-a7cd6f0f4c71" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_9f800773-406d-45f0-97b2-0611b1ab1f79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_c9d1bb5e-d91a-4141-ab42-40a1e9500669" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c79c681e-9b53-4045-baad-a7cd6f0f4c71" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_c9d1bb5e-d91a-4141-ab42-40a1e9500669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_SuretyBondsOutstanding_df15d6cd-8ff2-4fa8-a223-7855c4449fdb" xlink:href="unh-20211231.xsd#unh_SuretyBondsOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c79c681e-9b53-4045-baad-a7cd6f0f4c71" xlink:to="loc_unh_SuretyBondsOutstanding_df15d6cd-8ff2-4fa8-a223-7855c4449fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment_5e0eff4d-8f91-461a-b50a-6f8e13f1b07a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c79c681e-9b53-4045-baad-a7cd6f0f4c71" xlink:to="loc_us-gaap_OtherCommitment_5e0eff4d-8f91-461a-b50a-6f8e13f1b07a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDescription_09d6e713-1788-4a62-82fd-f5a4a52cda7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsDescription"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c79c681e-9b53-4045-baad-a7cd6f0f4c71" xlink:to="loc_us-gaap_OtherCommitmentsDescription_09d6e713-1788-4a62-82fd-f5a4a52cda7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventDescription_d5eb47a5-8097-492c-baf4-8e86d7803777" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventDescription"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c79c681e-9b53-4045-baad-a7cd6f0f4c71" xlink:to="loc_us-gaap_SubsequentEventDescription_d5eb47a5-8097-492c-baf4-8e86d7803777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/CommitmentsandContingenciesFutureLeasePaymentsDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#CommitmentsandContingenciesFutureLeasePaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/CommitmentsandContingenciesFutureLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_488f1ede-74ca-4392-b600-2e60e54627c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_549da684-2a59-4ae9-9f57-4a9615542e12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_488f1ede-74ca-4392-b600-2e60e54627c4" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_549da684-2a59-4ae9-9f57-4a9615542e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_785c4365-59d0-4e63-aa71-3350ca640f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_549da684-2a59-4ae9-9f57-4a9615542e12" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_785c4365-59d0-4e63-aa71-3350ca640f1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1e49b458-c353-4879-a560-7db4d58e5a68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_785c4365-59d0-4e63-aa71-3350ca640f1d" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1e49b458-c353-4879-a560-7db4d58e5a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsMember_a12d1f74-80e4-4b88-8528-57ef98f82f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1e49b458-c353-4879-a560-7db4d58e5a68" xlink:to="loc_us-gaap_CommitmentsMember_a12d1f74-80e4-4b88-8528-57ef98f82f3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_ade86e93-dec1-48c1-aba1-9511dbbc4988" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_549da684-2a59-4ae9-9f57-4a9615542e12" xlink:to="loc_us-gaap_OperatingLeasedAssetsLineItems_ade86e93-dec1-48c1-aba1-9511dbbc4988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_33711ba2-2b8d-44d7-8a6b-e5a8fa1adcf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_ade86e93-dec1-48c1-aba1-9511dbbc4988" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_33711ba2-2b8d-44d7-8a6b-e5a8fa1adcf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_eaa43e38-e168-4a01-913e-07df8ff7743d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_ade86e93-dec1-48c1-aba1-9511dbbc4988" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_eaa43e38-e168-4a01-913e-07df8ff7743d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_88b0be69-7926-434d-9dc4-545cb82ea51e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_ade86e93-dec1-48c1-aba1-9511dbbc4988" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_88b0be69-7926-434d-9dc4-545cb82ea51e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_809ffdd0-b5ce-433a-932d-c4f3509e7ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_ade86e93-dec1-48c1-aba1-9511dbbc4988" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_809ffdd0-b5ce-433a-932d-c4f3509e7ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_3296b050-15da-4dc1-b0f3-4e4a1248e8cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_ade86e93-dec1-48c1-aba1-9511dbbc4988" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_3296b050-15da-4dc1-b0f3-4e4a1248e8cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_15d03c83-ff26-4f82-af6a-c3ae7812f0a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_ade86e93-dec1-48c1-aba1-9511dbbc4988" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_15d03c83-ff26-4f82-af6a-c3ae7812f0a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_32ed214b-87a4-40b9-8d81-82ca656318fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_ade86e93-dec1-48c1-aba1-9511dbbc4988" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_32ed214b-87a4-40b9-8d81-82ca656318fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_58d59914-a3e4-4c08-9b3c-bc652dc970b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_ade86e93-dec1-48c1-aba1-9511dbbc4988" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_58d59914-a3e4-4c08-9b3c-bc652dc970b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_b4184ef6-d6ad-45ec-93bc-dbf1531d9c45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_ade86e93-dec1-48c1-aba1-9511dbbc4988" xlink:to="loc_us-gaap_OperatingLeaseLiability_b4184ef6-d6ad-45ec-93bc-dbf1531d9c45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/SegmentFinancialInformationNotes" xlink:type="simple" xlink:href="unh-20211231.xsd#SegmentFinancialInformationNotes"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/SegmentFinancialInformationNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_543470c7-a302-4a8f-8035-0cad7b6d5eea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_4ca5b975-3c1d-418f-a107-d98452412105" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_543470c7-a302-4a8f-8035-0cad7b6d5eea" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_4ca5b975-3c1d-418f-a107-d98452412105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/SegmentFinancialInformationTables" xlink:type="simple" xlink:href="unh-20211231.xsd#SegmentFinancialInformationTables"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/SegmentFinancialInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_e0798dcf-59cb-4a65-8790-5445b3693597" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_b103860c-5d54-42eb-9300-0c6b66e70bb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_e0798dcf-59cb-4a65-8790-5445b3693597" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_b103860c-5d54-42eb-9300-0c6b66e70bb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#SegmentFinancialInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_5870c9f7-e484-48b8-be59-1f14f210d923" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_b7f27d52-4d6a-45e0-8d1c-59fa7cc795df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5870c9f7-e484-48b8-be59-1f14f210d923" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_b7f27d52-4d6a-45e0-8d1c-59fa7cc795df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_5119cc22-70aa-4c7c-914d-d3f1cd9b4ac0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_b7f27d52-4d6a-45e0-8d1c-59fa7cc795df" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_5119cc22-70aa-4c7c-914d-d3f1cd9b4ac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_fe687fb5-6183-4ccb-9c83-3d22621dd7cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_5119cc22-70aa-4c7c-914d-d3f1cd9b4ac0" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_fe687fb5-6183-4ccb-9c83-3d22621dd7cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_RevenuesMember_7f768063-fbfc-4487-acb2-5544b176d5aa" xlink:href="unh-20211231.xsd#unh_RevenuesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_fe687fb5-6183-4ccb-9c83-3d22621dd7cc" xlink:to="loc_unh_RevenuesMember_7f768063-fbfc-4487-acb2-5544b176d5aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_cd1b03b0-94d1-4ba7-84da-7e7a5e15a214" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_b7f27d52-4d6a-45e0-8d1c-59fa7cc795df" xlink:to="loc_srt_MajorCustomersAxis_cd1b03b0-94d1-4ba7-84da-7e7a5e15a214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_4d6c916b-1a54-4052-bfc5-c22ba3c38421" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_cd1b03b0-94d1-4ba7-84da-7e7a5e15a214" xlink:to="loc_srt_NameOfMajorCustomerDomain_4d6c916b-1a54-4052-bfc5-c22ba3c38421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_CMSMember_e227bebe-52f7-4974-a80f-75693a737619" xlink:href="unh-20211231.xsd#unh_CMSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_4d6c916b-1a54-4052-bfc5-c22ba3c38421" xlink:to="loc_unh_CMSMember_e227bebe-52f7-4974-a80f-75693a737619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_63200118-2b25-4c6a-a23f-fbb0649bc069" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_b7f27d52-4d6a-45e0-8d1c-59fa7cc795df" xlink:to="loc_srt_StatementGeographicalAxis_63200118-2b25-4c6a-a23f-fbb0649bc069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a7de8f60-1cec-4ba9-95b4-d0ded067ea48" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_63200118-2b25-4c6a-a23f-fbb0649bc069" xlink:to="loc_srt_SegmentGeographicalDomain_a7de8f60-1cec-4ba9-95b4-d0ded067ea48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_02a817f6-f06f-4363-ace7-d79f281305f5" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a7de8f60-1cec-4ba9-95b4-d0ded067ea48" xlink:to="loc_country_US_02a817f6-f06f-4363-ace7-d79f281305f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_bb8eeb6e-bc31-45c4-b232-c32a9736c5d5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_b7f27d52-4d6a-45e0-8d1c-59fa7cc795df" xlink:to="loc_srt_StatementScenarioAxis_bb8eeb6e-bc31-45c4-b232-c32a9736c5d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_e507ba9a-c7f7-4098-b2af-f41a5a8b4ad7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_bb8eeb6e-bc31-45c4-b232-c32a9736c5d5" xlink:to="loc_srt_ScenarioUnspecifiedDomain_e507ba9a-c7f7-4098-b2af-f41a5a8b4ad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_726e1543-05df-4708-b11c-f8a493b3b15c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_b7f27d52-4d6a-45e0-8d1c-59fa7cc795df" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_726e1543-05df-4708-b11c-f8a493b3b15c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_89e12a2c-cf41-47b0-b7cc-123ea78c9d87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_726e1543-05df-4708-b11c-f8a493b3b15c" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_89e12a2c-cf41-47b0-b7cc-123ea78c9d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_b8c0092c-2c35-46ca-b842-7daa44185573" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_89e12a2c-cf41-47b0-b7cc-123ea78c9d87" xlink:to="loc_us-gaap_SalesRevenueNetMember_b8c0092c-2c35-46ca-b842-7daa44185573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_d9b6b787-8e32-4530-be5a-958dfb917b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_b7f27d52-4d6a-45e0-8d1c-59fa7cc795df" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_d9b6b787-8e32-4530-be5a-958dfb917b7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_ca596921-26a9-40dc-aec8-4c70d8a50b0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d9b6b787-8e32-4530-be5a-958dfb917b7f" xlink:to="loc_us-gaap_NumberOfReportableSegments_ca596921-26a9-40dc-aec8-4c70d8a50b0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_e5b1192e-7877-4843-ba69-2efe063d896e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d9b6b787-8e32-4530-be5a-958dfb917b7f" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_e5b1192e-7877-4843-ba69-2efe063d896e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers_3577b87c-a648-4179-878d-6108d617c302" xlink:href="unh-20211231.xsd#unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d9b6b787-8e32-4530-be5a-958dfb917b7f" xlink:to="loc_unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers_3577b87c-a648-4179-878d-6108d617c302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_DisclosureonGeographicAreasPercentageofLongLivedAssets_549e5430-8f59-47b9-9a9d-02762e35e432" xlink:href="unh-20211231.xsd#unh_DisclosureonGeographicAreasPercentageofLongLivedAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d9b6b787-8e32-4530-be5a-958dfb917b7f" xlink:to="loc_unh_DisclosureonGeographicAreasPercentageofLongLivedAssets_549e5430-8f59-47b9-9a9d-02762e35e432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/SegmentFinancialInformationDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#SegmentFinancialInformationDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/SegmentFinancialInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_f2680987-1a1a-4787-af64-95fca7a02e0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_807b23c6-cf0d-4793-ba37-7248a38535d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f2680987-1a1a-4787-af64-95fca7a02e0f" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_807b23c6-cf0d-4793-ba37-7248a38535d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_7340b128-cb36-476c-b6ca-59ed13cb8842" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_807b23c6-cf0d-4793-ba37-7248a38535d2" xlink:to="loc_srt_ConsolidationItemsAxis_7340b128-cb36-476c-b6ca-59ed13cb8842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_c432d5b7-c365-496a-81fe-2ce1f1a7e18a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_7340b128-cb36-476c-b6ca-59ed13cb8842" xlink:to="loc_srt_ConsolidationItemsDomain_c432d5b7-c365-496a-81fe-2ce1f1a7e18a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_dcae803c-463e-4379-85c8-38c87102a0a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_c432d5b7-c365-496a-81fe-2ce1f1a7e18a" xlink:to="loc_us-gaap_OperatingSegmentsMember_dcae803c-463e-4379-85c8-38c87102a0a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_29190853-afe6-4c2b-b998-aaef2b032cbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_c432d5b7-c365-496a-81fe-2ce1f1a7e18a" xlink:to="loc_us-gaap_IntersegmentEliminationMember_29190853-afe6-4c2b-b998-aaef2b032cbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_b7216a9a-6694-4b59-9ee4-1d429eb674ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_c432d5b7-c365-496a-81fe-2ce1f1a7e18a" xlink:to="loc_us-gaap_CorporateNonSegmentMember_b7216a9a-6694-4b59-9ee4-1d429eb674ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_5b5cb351-0467-40ca-a161-3957b073f216" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_807b23c6-cf0d-4793-ba37-7248a38535d2" xlink:to="loc_srt_MajorCustomersAxis_5b5cb351-0467-40ca-a161-3957b073f216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_23363513-971c-4cf0-ad3b-81b8e6386fa8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_5b5cb351-0467-40ca-a161-3957b073f216" xlink:to="loc_srt_NameOfMajorCustomerDomain_23363513-971c-4cf0-ad3b-81b8e6386fa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ExternalCustomersMember_4d88c172-e928-4656-b5a6-5bc65e02d347" xlink:href="unh-20211231.xsd#unh_ExternalCustomersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_23363513-971c-4cf0-ad3b-81b8e6386fa8" xlink:to="loc_unh_ExternalCustomersMember_4d88c172-e928-4656-b5a6-5bc65e02d347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_IntersegmentMember_e4f4e6e7-6c68-485e-a03e-6b3b7c2268b5" xlink:href="unh-20211231.xsd#unh_IntersegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_23363513-971c-4cf0-ad3b-81b8e6386fa8" xlink:to="loc_unh_IntersegmentMember_e4f4e6e7-6c68-485e-a03e-6b3b7c2268b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_2aa1429f-3206-4f58-8ec6-0620825f419f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_807b23c6-cf0d-4793-ba37-7248a38535d2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_2aa1429f-3206-4f58-8ec6-0620825f419f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_20c2393c-0f9b-481f-ba50-1ea6a5d84b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_2aa1429f-3206-4f58-8ec6-0620825f419f" xlink:to="loc_us-gaap_SegmentDomain_20c2393c-0f9b-481f-ba50-1ea6a5d84b7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_UnitedhealthcareMember_9ce2e947-ceff-4b4c-8ba6-59450ff4b3c1" xlink:href="unh-20211231.xsd#unh_UnitedhealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_20c2393c-0f9b-481f-ba50-1ea6a5d84b7f" xlink:to="loc_unh_UnitedhealthcareMember_9ce2e947-ceff-4b4c-8ba6-59450ff4b3c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_TotalOptumMember_b1bd42fb-16b0-488c-aa76-fa41ce6ce1ea" xlink:href="unh-20211231.xsd#unh_TotalOptumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_20c2393c-0f9b-481f-ba50-1ea6a5d84b7f" xlink:to="loc_unh_TotalOptumMember_b1bd42fb-16b0-488c-aa76-fa41ce6ce1ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OptumhealthMember_c77006ca-867a-43c3-8ddc-397235a65711" xlink:href="unh-20211231.xsd#unh_OptumhealthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_TotalOptumMember_b1bd42fb-16b0-488c-aa76-fa41ce6ce1ea" xlink:to="loc_unh_OptumhealthMember_c77006ca-867a-43c3-8ddc-397235a65711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OptuminsightMember_d27426e4-4547-409d-8ad9-961dcab5ae98" xlink:href="unh-20211231.xsd#unh_OptuminsightMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_TotalOptumMember_b1bd42fb-16b0-488c-aa76-fa41ce6ce1ea" xlink:to="loc_unh_OptuminsightMember_d27426e4-4547-409d-8ad9-961dcab5ae98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_OptumrxMember_532c0a8b-0fb9-45c4-b046-69804893a57e" xlink:href="unh-20211231.xsd#unh_OptumrxMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_TotalOptumMember_b1bd42fb-16b0-488c-aa76-fa41ce6ce1ea" xlink:to="loc_unh_OptumrxMember_532c0a8b-0fb9-45c4-b046-69804893a57e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_35c48f15-902c-4411-9926-8f97d189ceae" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_807b23c6-cf0d-4793-ba37-7248a38535d2" xlink:to="loc_srt_ProductOrServiceAxis_35c48f15-902c-4411-9926-8f97d189ceae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1189f375-c352-4576-a19e-54d7420f85a2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_35c48f15-902c-4411-9926-8f97d189ceae" xlink:to="loc_srt_ProductsAndServicesDomain_1189f375-c352-4576-a19e-54d7420f85a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_80998a2b-ae37-46a9-ac62-d20b36473ea5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1189f375-c352-4576-a19e-54d7420f85a2" xlink:to="loc_us-gaap_ProductMember_80998a2b-ae37-46a9-ac62-d20b36473ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_4e1f1e56-027e-4dec-ae0e-f117cbcb8f13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1189f375-c352-4576-a19e-54d7420f85a2" xlink:to="loc_us-gaap_ServiceMember_4e1f1e56-027e-4dec-ae0e-f117cbcb8f13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_83337e45-9092-43d1-9590-2724aab516b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_807b23c6-cf0d-4793-ba37-7248a38535d2" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_83337e45-9092-43d1-9590-2724aab516b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_0336c83c-1a0d-4022-8a99-093843b15c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_83337e45-9092-43d1-9590-2724aab516b1" xlink:to="loc_us-gaap_PremiumsEarnedNet_0336c83c-1a0d-4022-8a99-093843b15c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9912b0fd-442c-4e28-b6a9-ee02f6809e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_83337e45-9092-43d1-9590-2724aab516b1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9912b0fd-442c-4e28-b6a9-ee02f6809e9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_c284a638-26fb-46d2-beb2-6db0b744b523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_83337e45-9092-43d1-9590-2724aab516b1" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_c284a638-26fb-46d2-beb2-6db0b744b523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_b8ec20dc-0ead-49c2-b0aa-30d60494c510" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_83337e45-9092-43d1-9590-2724aab516b1" xlink:to="loc_us-gaap_Revenues_b8ec20dc-0ead-49c2-b0aa-30d60494c510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_92cc2ae6-fa37-481e-88f6-8d65c161e2d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_83337e45-9092-43d1-9590-2724aab516b1" xlink:to="loc_us-gaap_OperatingIncomeLoss_92cc2ae6-fa37-481e-88f6-8d65c161e2d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_0b980943-f45e-4241-b194-2493e74eb17f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_83337e45-9092-43d1-9590-2724aab516b1" xlink:to="loc_us-gaap_InterestExpense_0b980943-f45e-4241-b194-2493e74eb17f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4d43159c-feff-4a19-b0da-c43dd3af56e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_83337e45-9092-43d1-9590-2724aab516b1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4d43159c-feff-4a19-b0da-c43dd3af56e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e812a340-9bfc-45e2-bbec-776184ed9af5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_83337e45-9092-43d1-9590-2724aab516b1" xlink:to="loc_us-gaap_Assets_e812a340-9bfc-45e2-bbec-776184ed9af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2ee0208d-f553-4fd6-b531-1a002eff4cbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_83337e45-9092-43d1-9590-2724aab516b1" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2ee0208d-f553-4fd6-b531-1a002eff4cbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_fa35db5f-fc59-4090-a98f-5fdab0600225" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_83337e45-9092-43d1-9590-2724aab516b1" xlink:to="loc_us-gaap_DepreciationAndAmortization_fa35db5f-fc59-4090-a98f-5fdab0600225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ScheduleINotes" xlink:type="simple" xlink:href="unh-20211231.xsd#ScheduleINotes"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ScheduleINotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_ffc7d42b-dfca-4b88-9f77-2e94739c4fee" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedStatementOfComprehensiveIncomeTable_a9b011a4-b17c-4b8a-9f25-f99e1843d5aa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CondensedStatementOfComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_ffc7d42b-dfca-4b88-9f77-2e94739c4fee" xlink:to="loc_srt_CondensedStatementOfComprehensiveIncomeTable_a9b011a4-b17c-4b8a-9f25-f99e1843d5aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_c81059fd-88f3-462a-918b-d502d82bc595" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfComprehensiveIncomeTable_a9b011a4-b17c-4b8a-9f25-f99e1843d5aa" xlink:to="loc_dei_LegalEntityAxis_c81059fd-88f3-462a-918b-d502d82bc595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_1f553c4d-c208-468f-a825-938291e2e19a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_c81059fd-88f3-462a-918b-d502d82bc595" xlink:to="loc_dei_EntityDomain_1f553c4d-c208-468f-a825-938291e2e19a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_1b8e55a3-f623-4919-aee5-4f142c5e8aee" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfComprehensiveIncomeTable_a9b011a4-b17c-4b8a-9f25-f99e1843d5aa" xlink:to="loc_srt_ConsolidatedEntitiesAxis_1b8e55a3-f623-4919-aee5-4f142c5e8aee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_3463f48b-5d3c-4025-b4fb-9672d2063636" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_1b8e55a3-f623-4919-aee5-4f142c5e8aee" xlink:to="loc_srt_ConsolidatedEntitiesDomain_3463f48b-5d3c-4025-b4fb-9672d2063636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_c9d8c5dd-596e-47b2-97e3-87f651d1f454" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_3463f48b-5d3c-4025-b4fb-9672d2063636" xlink:to="loc_srt_ParentCompanyMember_c9d8c5dd-596e-47b2-97e3-87f651d1f454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_e06ee92c-fc12-437c-873b-68e11ad23c50" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfComprehensiveIncomeTable_a9b011a4-b17c-4b8a-9f25-f99e1843d5aa" xlink:to="loc_srt_ConsolidationItemsAxis_e06ee92c-fc12-437c-873b-68e11ad23c50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_2082a4aa-808d-44ed-bc51-95ca4dfae8de" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_e06ee92c-fc12-437c-873b-68e11ad23c50" xlink:to="loc_srt_ConsolidationItemsDomain_2082a4aa-808d-44ed-bc51-95ca4dfae8de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_cc861352-badc-43f2-ad0d-88a155221f04" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CondensedStatementOfIncomeCaptionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfComprehensiveIncomeTable_a9b011a4-b17c-4b8a-9f25-f99e1843d5aa" xlink:to="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_cc861352-badc-43f2-ad0d-88a155221f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock_1ea9c1ff-9aba-4289-98ca-20c9ba87036a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_ffc7d42b-dfca-4b88-9f77-2e94739c4fee" xlink:to="loc_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock_1ea9c1ff-9aba-4289-98ca-20c9ba87036a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ScheduleIPolicies" xlink:type="simple" xlink:href="unh-20211231.xsd#ScheduleIPolicies"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ScheduleIPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_29ab8d3b-1b4f-43fd-bf94-52b6b771a5c1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_0d74dc09-adac-4d10-8916-e3d187d8f944" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_29ab8d3b-1b4f-43fd-bf94-52b6b771a5c1" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_0d74dc09-adac-4d10-8916-e3d187d8f944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_0e7edff3-20ad-4456-853a-fde6136378ac" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_0d74dc09-adac-4d10-8916-e3d187d8f944" xlink:to="loc_srt_ConsolidatedEntitiesAxis_0e7edff3-20ad-4456-853a-fde6136378ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_1177d00f-84f1-4907-b8c5-d92c2a9e4742" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_0e7edff3-20ad-4456-853a-fde6136378ac" xlink:to="loc_srt_ConsolidatedEntitiesDomain_1177d00f-84f1-4907-b8c5-d92c2a9e4742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_03d440a0-e674-46f1-ab5d-362e1d7a8763" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_1177d00f-84f1-4907-b8c5-d92c2a9e4742" xlink:to="loc_srt_ParentCompanyMember_03d440a0-e674-46f1-ab5d-362e1d7a8763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_5df71102-489e-4bc1-ba02-3922c7d9ae6f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_0d74dc09-adac-4d10-8916-e3d187d8f944" xlink:to="loc_srt_CondensedFinancialStatementsCaptionsLineItems_5df71102-489e-4bc1-ba02-3922c7d9ae6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_e8192e1b-d8d5-4af5-a313-73d2b332921d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_5df71102-489e-4bc1-ba02-3922c7d9ae6f" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_e8192e1b-d8d5-4af5-a313-73d2b332921d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_c4f00c8d-978b-4975-b10a-8721ec7a7121" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_5df71102-489e-4bc1-ba02-3922c7d9ae6f" xlink:to="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_c4f00c8d-978b-4975-b10a-8721ec7a7121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ScheduleITables" xlink:type="simple" xlink:href="unh-20211231.xsd#ScheduleITables"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ScheduleITables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_e75028ee-1a7c-4b33-9381-b4fe2ba2b583" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_f9ef436e-3331-4450-817e-5b16ab3f86d0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_e75028ee-1a7c-4b33-9381-b4fe2ba2b583" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_f9ef436e-3331-4450-817e-5b16ab3f86d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_579340ec-8126-4a52-a0e6-ccdb9015b413" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_f9ef436e-3331-4450-817e-5b16ab3f86d0" xlink:to="loc_srt_ConsolidatedEntitiesAxis_579340ec-8126-4a52-a0e6-ccdb9015b413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_129387fd-7846-4445-969e-bf80b196bea2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_579340ec-8126-4a52-a0e6-ccdb9015b413" xlink:to="loc_srt_ConsolidatedEntitiesDomain_129387fd-7846-4445-969e-bf80b196bea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_8cf79699-a5e3-4033-8934-4c1924379c1f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_129387fd-7846-4445-969e-bf80b196bea2" xlink:to="loc_srt_ParentCompanyMember_8cf79699-a5e3-4033-8934-4c1924379c1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_48d9e83e-c5c2-4998-aa6b-76b799f2961a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_f9ef436e-3331-4450-817e-5b16ab3f86d0" xlink:to="loc_srt_ConsolidationItemsAxis_48d9e83e-c5c2-4998-aa6b-76b799f2961a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_44c3198d-243e-40e3-9fa9-be4d2e0c8046" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_48d9e83e-c5c2-4998-aa6b-76b799f2961a" xlink:to="loc_srt_ConsolidationItemsDomain_44c3198d-243e-40e3-9fa9-be4d2e0c8046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_8ba862f9-fe4f-4bb5-ae97-0741d371b8b0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_f9ef436e-3331-4450-817e-5b16ab3f86d0" xlink:to="loc_srt_CondensedFinancialStatementsCaptionsLineItems_8ba862f9-fe4f-4bb5-ae97-0741d371b8b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_1194d2a5-6e82-4bde-9eb7-c599ff0ad5ff" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfCondensedBalanceSheetTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_8ba862f9-fe4f-4bb5-ae97-0741d371b8b0" xlink:to="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_1194d2a5-6e82-4bde-9eb7-c599ff0ad5ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedStatementOfComprehensiveIncomeTableTextBlock_f1c59f61-fecc-4920-ad26-fb93d2cf6bf4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CondensedStatementOfComprehensiveIncomeTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_8ba862f9-fe4f-4bb5-ae97-0741d371b8b0" xlink:to="loc_srt_CondensedStatementOfComprehensiveIncomeTableTextBlock_f1c59f61-fecc-4920-ad26-fb93d2cf6bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock_75386645-ddc1-4c4c-8ad2-5a26c77804ca" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfCondensedCashFlowStatementTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_8ba862f9-fe4f-4bb5-ae97-0741d371b8b0" xlink:to="loc_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock_75386645-ddc1-4c4c-8ad2-5a26c77804ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_7cc7665c-fb94-4b12-9d5d-15a1e69ce68e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_8ba862f9-fe4f-4bb5-ae97-0741d371b8b0" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_7cc7665c-fb94-4b12-9d5d-15a1e69ce68e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ScheduleIDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#ScheduleIDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ScheduleIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_767549c5-1538-4f38-a841-ac54c4ef3b22" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_10e91538-b292-4384-a8cf-ba0ea9befaae" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_767549c5-1538-4f38-a841-ac54c4ef3b22" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_10e91538-b292-4384-a8cf-ba0ea9befaae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_6f8a879e-9d70-4d7f-94e5-3368f2f98f66" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_10e91538-b292-4384-a8cf-ba0ea9befaae" xlink:to="loc_srt_ConsolidatedEntitiesAxis_6f8a879e-9d70-4d7f-94e5-3368f2f98f66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_b5194946-d30c-483b-a030-95ffd20fd986" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_6f8a879e-9d70-4d7f-94e5-3368f2f98f66" xlink:to="loc_srt_ConsolidatedEntitiesDomain_b5194946-d30c-483b-a030-95ffd20fd986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_32f48ee0-388e-4849-9262-b2e8a137b528" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_b5194946-d30c-483b-a030-95ffd20fd986" xlink:to="loc_srt_ParentCompanyMember_32f48ee0-388e-4849-9262-b2e8a137b528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_cbc57f18-edb8-4b8d-8c96-f260d98e978b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SubsidiariesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_b5194946-d30c-483b-a030-95ffd20fd986" xlink:to="loc_srt_SubsidiariesMember_cbc57f18-edb8-4b8d-8c96-f260d98e978b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4acd52fb-4136-485d-be50-e0aa0e84a283" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_10e91538-b292-4384-a8cf-ba0ea9befaae" xlink:to="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4acd52fb-4136-485d-be50-e0aa0e84a283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries_e5ee4609-e209-489f-826c-92fd9d4288d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4acd52fb-4136-485d-be50-e0aa0e84a283" xlink:to="loc_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries_e5ee4609-e209-489f-826c-92fd9d4288d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributionsFromAffiliates_72d1866c-835b-4650-8a04-12c48f978290" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromContributionsFromAffiliates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4acd52fb-4136-485d-be50-e0aa0e84a283" xlink:to="loc_us-gaap_ProceedsFromContributionsFromAffiliates_72d1866c-835b-4650-8a04-12c48f978290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebt_e56847e8-ba2c-4c37-b7c5-84325e49312d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4acd52fb-4136-485d-be50-e0aa0e84a283" xlink:to="loc_us-gaap_OtherLongTermDebt_e56847e8-ba2c-4c37-b7c5-84325e49312d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayable_4a22f3cb-365b-45c5-8a1d-a8c790d270a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4acd52fb-4136-485d-be50-e0aa0e84a283" xlink:to="loc_us-gaap_NotesPayable_4a22f3cb-365b-45c5-8a1d-a8c790d270a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#ScheduleICondensedBalanceSheetsDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_80e40b3d-89d0-439e-a610-05118a5c1dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedBalanceSheetStatementTable_c5747acf-12b2-4fda-af28-3f479d6236b7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CondensedBalanceSheetStatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_80e40b3d-89d0-439e-a610-05118a5c1dd4" xlink:to="loc_srt_CondensedBalanceSheetStatementTable_c5747acf-12b2-4fda-af28-3f479d6236b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_1683a4e9-49d6-45cb-ad6b-724683410cd1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementTable_c5747acf-12b2-4fda-af28-3f479d6236b7" xlink:to="loc_srt_ConsolidatedEntitiesAxis_1683a4e9-49d6-45cb-ad6b-724683410cd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_c5763c6a-2a62-4605-9aba-20b21c81151c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_1683a4e9-49d6-45cb-ad6b-724683410cd1" xlink:to="loc_srt_ConsolidatedEntitiesDomain_c5763c6a-2a62-4605-9aba-20b21c81151c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_020f84d1-520f-4b83-b942-61d7d32b2fc8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_c5763c6a-2a62-4605-9aba-20b21c81151c" xlink:to="loc_srt_ParentCompanyMember_020f84d1-520f-4b83-b942-61d7d32b2fc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CondensedBalanceSheetStatementsCaptionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementTable_c5747acf-12b2-4fda-af28-3f479d6236b7" xlink:to="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_b1a644f1-cf44-4bf5-a56b-9d138dc61ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_AssetsAbstract_b1a644f1-cf44-4bf5-a56b-9d138dc61ab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_c2228f5b-c8c1-482a-9032-7240d299d991" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_AssetsCurrentAbstract_c2228f5b-c8c1-482a-9032-7240d299d991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_06769da0-cf1d-4543-a4f1-d6ccdaf167dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_06769da0-cf1d-4543-a4f1-d6ccdaf167dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_1401ef15-1453-49b5-92c3-7df2a3f5433c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_OtherAssetsCurrent_1401ef15-1453-49b5-92c3-7df2a3f5433c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d46ca583-f3a0-4ddc-a73e-f18838cc998c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_AssetsCurrent_d46ca583-f3a0-4ddc-a73e-f18838cc998c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_EquityinNetAssetsofSubsidiaries_43dc3049-3172-42d6-836e-29ae50e9a0b0" xlink:href="unh-20211231.xsd#unh_EquityinNetAssetsofSubsidiaries"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_unh_EquityinNetAssetsofSubsidiaries_43dc3049-3172-42d6-836e-29ae50e9a0b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableRelatedPartiesNoncurrent_7ec79a2e-229f-437d-a8c1-69d61fba7e33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesReceivableRelatedPartiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_NotesReceivableRelatedPartiesNoncurrent_7ec79a2e-229f-437d-a8c1-69d61fba7e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_fa2cd817-9601-4a04-89fb-aa5f2bb97cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_fa2cd817-9601-4a04-89fb-aa5f2bb97cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_9c7774ba-c0fd-448d-b7a3-506973fb3618" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_Assets_9c7774ba-c0fd-448d-b7a3-506973fb3618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b3734042-6cf2-4a96-96f3-10ecd40cfaa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b3734042-6cf2-4a96-96f3-10ecd40cfaa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_e4b17c53-9626-460f-a438-e6856423a05c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_e4b17c53-9626-460f-a438-e6856423a05c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_e7bb5f28-cb8e-4c0b-b256-3370bd68c9ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_e7bb5f28-cb8e-4c0b-b256-3370bd68c9ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_b390a8c0-cbf4-447c-90ce-0eedfd22b378" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_b390a8c0-cbf4-447c-90ce-0eedfd22b378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_566f09e2-c1d2-4641-b499-0d182c0542fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_LongTermDebtCurrent_566f09e2-c1d2-4641-b499-0d182c0542fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d3a8880d-2123-4918-80e0-2f82103a7e69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_LiabilitiesCurrent_d3a8880d-2123-4918-80e0-2f82103a7e69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_cd32230f-d626-42c6-8724-f5925472c96e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_cd32230f-d626-42c6-8724-f5925472c96e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_247a91fe-e4fa-425a-8f47-d256166cd6c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_247a91fe-e4fa-425a-8f47-d256166cd6c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_353ebb6f-942d-4eeb-9597-b23279808df1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_Liabilities_353ebb6f-942d-4eeb-9597-b23279808df1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_9f8c7045-0a36-488b-aee2-6fe0c49186c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_CommitmentsAndContingencies_9f8c7045-0a36-488b-aee2-6fe0c49186c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_ShareholdersEquityAbstract_64cb4fa5-13a5-45c1-8fd4-66511ce7b79e" xlink:href="unh-20211231.xsd#unh_ShareholdersEquityAbstract"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_unh_ShareholdersEquityAbstract_64cb4fa5-13a5-45c1-8fd4-66511ce7b79e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_8480326f-285b-46e1-9dde-18ec33aa6b10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_PreferredStockValue_8480326f-285b-46e1-9dde-18ec33aa6b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_2397ccb0-394e-4a89-aea9-5a066d627967" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_CommonStockValue_2397ccb0-394e-4a89-aea9-5a066d627967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_b886f997-c45b-4301-8470-57f97e07255d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_AdditionalPaidInCapital_b886f997-c45b-4301-8470-57f97e07255d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_36999b86-a056-4d54-a33b-2fd92e0d3c29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_36999b86-a056-4d54-a33b-2fd92e0d3c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2e1681ea-aeff-4d02-bf0b-a2f7fb30c040" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2e1681ea-aeff-4d02-bf0b-a2f7fb30c040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8b4b50b3-652b-40f1-9b52-f3d916b0bcf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_StockholdersEquity_8b4b50b3-652b-40f1-9b52-f3d916b0bcf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_c7ca6a05-8701-4921-9d8b-41a76076bbe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedBalanceSheetStatementsCaptionsLineItems_68fc0731-3432-4906-9da4-e2778782e267" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_c7ca6a05-8701-4921-9d8b-41a76076bbe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#ScheduleIBalanceSheetDocumentDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_ScheduleIBalanceSheetParentheticalAbstract_3cc91661-1bec-4a6b-af9b-ce8b6ef0c635" xlink:href="unh-20211231.xsd#unh_ScheduleIBalanceSheetParentheticalAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_591bbb87-301d-47d8-a0bb-28918bcf5ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_ScheduleIBalanceSheetParentheticalAbstract_3cc91661-1bec-4a6b-af9b-ce8b6ef0c635" xlink:to="loc_us-gaap_StatementTable_591bbb87-301d-47d8-a0bb-28918bcf5ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_1efaf5b8-d832-4798-b132-74179fe77430" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_591bbb87-301d-47d8-a0bb-28918bcf5ef3" xlink:to="loc_srt_ConsolidatedEntitiesAxis_1efaf5b8-d832-4798-b132-74179fe77430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_ec024886-ecbd-4123-bcc2-1e6463b37f29" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_1efaf5b8-d832-4798-b132-74179fe77430" xlink:to="loc_srt_ConsolidatedEntitiesDomain_ec024886-ecbd-4123-bcc2-1e6463b37f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_1713380e-ba4e-4e4b-a90e-91fb8cb12c68" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_ec024886-ecbd-4123-bcc2-1e6463b37f29" xlink:to="loc_srt_ParentCompanyMember_1713380e-ba4e-4e4b-a90e-91fb8cb12c68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_ef12a675-b268-4924-951c-98fa24b16ef6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_591bbb87-301d-47d8-a0bb-28918bcf5ef3" xlink:to="loc_srt_StatementScenarioAxis_ef12a675-b268-4924-951c-98fa24b16ef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_08298a09-53eb-43ce-9ac2-647a6bfc79ba" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_ef12a675-b268-4924-951c-98fa24b16ef6" xlink:to="loc_srt_ScenarioUnspecifiedDomain_08298a09-53eb-43ce-9ac2-647a6bfc79ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_3696341d-a6f3-4f13-8190-1a4a2dc33906" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_591bbb87-301d-47d8-a0bb-28918bcf5ef3" xlink:to="loc_us-gaap_StatementClassOfStockAxis_3696341d-a6f3-4f13-8190-1a4a2dc33906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a1927804-acf6-4104-b7d6-8635af3bb9b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_3696341d-a6f3-4f13-8190-1a4a2dc33906" xlink:to="loc_us-gaap_ClassOfStockDomain_a1927804-acf6-4104-b7d6-8635af3bb9b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_238c6f1a-4855-4a7b-8b72-97412a2d8a86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_591bbb87-301d-47d8-a0bb-28918bcf5ef3" xlink:to="loc_us-gaap_StatementLineItems_238c6f1a-4855-4a7b-8b72-97412a2d8a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_9c2f45dd-4b9c-47be-8708-514dfaffad49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_238c6f1a-4855-4a7b-8b72-97412a2d8a86" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_9c2f45dd-4b9c-47be-8708-514dfaffad49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_cc347a6b-59ae-41b3-82b1-f2ca06601ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_238c6f1a-4855-4a7b-8b72-97412a2d8a86" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_cc347a6b-59ae-41b3-82b1-f2ca06601ae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_61995b7b-863a-4302-9536-0ec31e0770f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_238c6f1a-4855-4a7b-8b72-97412a2d8a86" xlink:to="loc_us-gaap_CommonStockSharesIssued_61995b7b-863a-4302-9536-0ec31e0770f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_24c29b9e-da58-41a5-8b9b-9e8be9265b5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_238c6f1a-4855-4a7b-8b72-97412a2d8a86" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_24c29b9e-da58-41a5-8b9b-9e8be9265b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_e6cc413b-bc0a-4724-aad9-bb5b060fac58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_238c6f1a-4855-4a7b-8b72-97412a2d8a86" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_e6cc413b-bc0a-4724-aad9-bb5b060fac58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_447298e7-080c-4c36-a91e-99b90801534d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_238c6f1a-4855-4a7b-8b72-97412a2d8a86" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_447298e7-080c-4c36-a91e-99b90801534d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_28565953-8236-4bc5-8288-8fbde8d24282" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_238c6f1a-4855-4a7b-8b72-97412a2d8a86" xlink:to="loc_us-gaap_PreferredStockSharesIssued_28565953-8236-4bc5-8288-8fbde8d24282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_dfdada44-ef07-4203-ac2a-bbef358f7609" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_238c6f1a-4855-4a7b-8b72-97412a2d8a86" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_dfdada44-ef07-4203-ac2a-bbef358f7609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#ScheduleICondensedStatementofComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_60b19d61-ec87-4ac0-8dec-161dfa959ea8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedStatementOfComprehensiveIncomeTable_d7c4cab7-b722-4bd3-b029-44eae5d1bde0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CondensedStatementOfComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_60b19d61-ec87-4ac0-8dec-161dfa959ea8" xlink:to="loc_srt_CondensedStatementOfComprehensiveIncomeTable_d7c4cab7-b722-4bd3-b029-44eae5d1bde0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_1297cc69-e276-409b-a038-6a1d055ec60e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfComprehensiveIncomeTable_d7c4cab7-b722-4bd3-b029-44eae5d1bde0" xlink:to="loc_srt_ConsolidatedEntitiesAxis_1297cc69-e276-409b-a038-6a1d055ec60e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_048afbf0-03d7-469b-9eae-4e646451abfd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_1297cc69-e276-409b-a038-6a1d055ec60e" xlink:to="loc_srt_ConsolidatedEntitiesDomain_048afbf0-03d7-469b-9eae-4e646451abfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_c0046ffd-951c-4cd4-9114-75ef6add56d8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_048afbf0-03d7-469b-9eae-4e646451abfd" xlink:to="loc_srt_ParentCompanyMember_c0046ffd-951c-4cd4-9114-75ef6add56d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_e04c7b09-10db-476c-b14b-8b6a63c4c952" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CondensedStatementOfIncomeCaptionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfComprehensiveIncomeTable_d7c4cab7-b722-4bd3-b029-44eae5d1bde0" xlink:to="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_e04c7b09-10db-476c-b14b-8b6a63c4c952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_16d1f5b4-efed-40a5-89fb-4d59b4c2a4d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_e04c7b09-10db-476c-b14b-8b6a63c4c952" xlink:to="loc_us-gaap_RevenuesAbstract_16d1f5b4-efed-40a5-89fb-4d59b4c2a4d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_4c83f5e9-5fbd-494a-b862-3b444fb5ce9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_e04c7b09-10db-476c-b14b-8b6a63c4c952" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_4c83f5e9-5fbd-494a-b862-3b444fb5ce9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_0f1dada9-e353-44eb-97ef-92d2068a32a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_e04c7b09-10db-476c-b14b-8b6a63c4c952" xlink:to="loc_us-gaap_Revenues_0f1dada9-e353-44eb-97ef-92d2068a32a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_f70f27b4-4dec-4525-ad0b-3bf130a52879" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_e04c7b09-10db-476c-b14b-8b6a63c4c952" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_f70f27b4-4dec-4525-ad0b-3bf130a52879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_76112669-0602-469f-a27e-6d5cd08a4131" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_e04c7b09-10db-476c-b14b-8b6a63c4c952" xlink:to="loc_us-gaap_OperatingExpenses_76112669-0602-469f-a27e-6d5cd08a4131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_c9f87bff-3646-438a-856b-68afa3e27b4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_e04c7b09-10db-476c-b14b-8b6a63c4c952" xlink:to="loc_us-gaap_InterestExpense_c9f87bff-3646-438a-856b-68afa3e27b4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_b2210aba-92c7-4cce-a725-e94f0bfc910b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_e04c7b09-10db-476c-b14b-8b6a63c4c952" xlink:to="loc_us-gaap_CostsAndExpenses_b2210aba-92c7-4cce-a725-e94f0bfc910b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_e1a7d38e-2cc0-4348-bf65-5fba760842d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_e04c7b09-10db-476c-b14b-8b6a63c4c952" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_e1a7d38e-2cc0-4348-bf65-5fba760842d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d7e1dc14-4abe-45c6-b214-451d7173ebac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_e04c7b09-10db-476c-b14b-8b6a63c4c952" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d7e1dc14-4abe-45c6-b214-451d7173ebac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_LossofParentCompany_3df16e93-f88a-41c1-8188-58590fd70a68" xlink:href="unh-20211231.xsd#unh_LossofParentCompany"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_e04c7b09-10db-476c-b14b-8b6a63c4c952" xlink:to="loc_unh_LossofParentCompany_3df16e93-f88a-41c1-8188-58590fd70a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_0140d1a5-6efa-430b-a3a8-1b8c4debf8d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_e04c7b09-10db-476c-b14b-8b6a63c4c952" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_0140d1a5-6efa-430b-a3a8-1b8c4debf8d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f8f2f211-f98d-458b-aa2e-4ed8bb9d2013" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_e04c7b09-10db-476c-b14b-8b6a63c4c952" xlink:to="loc_us-gaap_NetIncomeLoss_f8f2f211-f98d-458b-aa2e-4ed8bb9d2013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_fe59d61c-54fc-4251-ada0-315ff72dae7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_e04c7b09-10db-476c-b14b-8b6a63c4c952" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_fe59d61c-54fc-4251-ada0-315ff72dae7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_25740801-8eb9-42eb-9027-a7f131b8dcf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedStatementOfIncomeCaptionsLineItems_e04c7b09-10db-476c-b14b-8b6a63c4c952" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_25740801-8eb9-42eb-9027-a7f131b8dcf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#ScheduleIStatementofCashFlowsDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_ScheduleIAbstract_5b75fdf5-2849-417b-ac3a-f4ac7184f6fd" xlink:href="unh-20211231.xsd#unh_ScheduleIAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_4c4ae361-a84f-4fc9-a0a7-57aa9f8eef8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_ScheduleIAbstract_5b75fdf5-2849-417b-ac3a-f4ac7184f6fd" xlink:to="loc_us-gaap_StatementTable_4c4ae361-a84f-4fc9-a0a7-57aa9f8eef8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_8bb99d99-c9af-4f63-b5b5-433fe535114c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4c4ae361-a84f-4fc9-a0a7-57aa9f8eef8f" xlink:to="loc_srt_ConsolidatedEntitiesAxis_8bb99d99-c9af-4f63-b5b5-433fe535114c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_5deb2398-5443-47cf-95f9-34f4734dff0a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_8bb99d99-c9af-4f63-b5b5-433fe535114c" xlink:to="loc_srt_ConsolidatedEntitiesDomain_5deb2398-5443-47cf-95f9-34f4734dff0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_e0b2309e-a081-4145-a4de-5b9ac47b7753" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_5deb2398-5443-47cf-95f9-34f4734dff0a" xlink:to="loc_srt_ParentCompanyMember_e0b2309e-a081-4145-a4de-5b9ac47b7753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_b5162b13-b913-4cbe-91ab-8114dd6e19c8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4c4ae361-a84f-4fc9-a0a7-57aa9f8eef8f" xlink:to="loc_srt_StatementScenarioAxis_b5162b13-b913-4cbe-91ab-8114dd6e19c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_b2c01aeb-34d0-4949-a426-652cb132033a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_b5162b13-b913-4cbe-91ab-8114dd6e19c8" xlink:to="loc_srt_ScenarioUnspecifiedDomain_b2c01aeb-34d0-4949-a426-652cb132033a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4c4ae361-a84f-4fc9-a0a7-57aa9f8eef8f" xlink:to="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_4e3a8c3e-055e-4d31-99ab-7e34056690f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_4e3a8c3e-055e-4d31-99ab-7e34056690f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a30433a9-6085-4c91-8f1b-1f13befa7914" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a30433a9-6085-4c91-8f1b-1f13befa7914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_533b72ba-2a14-4166-9572-84e7f08c5447" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_533b72ba-2a14-4166-9572-84e7f08c5447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_8bf9f0b7-ff1f-4acf-b502-bc99a9b6d97f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_8bf9f0b7-ff1f-4acf-b502-bc99a9b6d97f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties_a544467e-90af-4bca-afc6-3c8980432e73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties_a544467e-90af-4bca-afc6-3c8980432e73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_7bbdd72f-2b9c-453c-8806-b9ced049e47f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_7bbdd72f-2b9c-453c-8806-b9ced049e47f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributionsFromAffiliates_0f9cd419-3cff-4f0f-9c74-49871dea860a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromContributionsFromAffiliates"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_ProceedsFromContributionsFromAffiliates_0f9cd419-3cff-4f0f-9c74-49871dea860a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_unh_Capitalcontributionstosubsidiaries_53a66676-62f2-4e24-833d-77e1fc94201e" xlink:href="unh-20211231.xsd#unh_Capitalcontributionstosubsidiaries"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_unh_Capitalcontributionstosubsidiaries_53a66676-62f2-4e24-833d-77e1fc94201e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_cab2f11b-86fa-433b-8185-a1c46a2769b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_cab2f11b-86fa-433b-8185-a1c46a2769b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_34995ab5-1c4f-4778-96aa-b2037c0c17fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_34995ab5-1c4f-4778-96aa-b2037c0c17fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a137c2f-9da5-43fe-9b7e-57269f46ef85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a137c2f-9da5-43fe-9b7e-57269f46ef85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_71d0b811-7174-4d23-891d-ae8276e898b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_71d0b811-7174-4d23-891d-ae8276e898b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_1e41f6ef-a3ef-42d6-b6f8-b9a6e8b593f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_1e41f6ef-a3ef-42d6-b6f8-b9a6e8b593f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_373d282e-100e-4498-b9e2-7d654f8a27af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_PaymentsOfDividends_373d282e-100e-4498-b9e2-7d654f8a27af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_60e72245-70b5-48df-abe0-98c70d81481f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_60e72245-70b5-48df-abe0-98c70d81481f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_ee4a25f5-dfdf-4c3e-9414-c4d2ee2f1683" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_ee4a25f5-dfdf-4c3e-9414-c4d2ee2f1683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_94754d65-7e45-4e66-84cd-8948211697dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_94754d65-7e45-4e66-84cd-8948211697dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_2853b9ea-4f7a-432f-841f-17cfe0768b30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_2853b9ea-4f7a-432f-841f-17cfe0768b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_3edcba6b-345d-41aa-b0ab-0cfbc4ce693b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_3edcba6b-345d-41aa-b0ab-0cfbc4ce693b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_078bc822-350b-4169-bf12-70fdb0ff0421" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_078bc822-350b-4169-bf12-70fdb0ff0421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_3681494d-6c9b-4e0d-bd12-f85bc4bd2fa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_3681494d-6c9b-4e0d-bd12-f85bc4bd2fa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f3f3128f-0016-4f0b-8c49-b46fdacd6d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f3f3128f-0016-4f0b-8c49-b46fdacd6d4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_752f2eb4-e1d2-41c2-9338-b19b8fa2a3b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_752f2eb4-e1d2-41c2-9338-b19b8fa2a3b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_c5e48fe0-71c8-46ab-8766-0c33ae53f906" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ad161568-2e6d-461c-8821-97e081ff6604" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_c5e48fe0-71c8-46ab-8766-0c33ae53f906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_5bc1c34c-bf82-4886-8f14-7789102bb700" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_c5e48fe0-71c8-46ab-8766-0c33ae53f906" xlink:to="loc_us-gaap_InterestPaidNet_5bc1c34c-bf82-4886-8f14-7789102bb700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_3af28bff-6037-4bd9-bdd9-9065ce268bd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_c5e48fe0-71c8-46ab-8766-0c33ae53f906" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_3af28bff-6037-4bd9-bdd9-9065ce268bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.uhc.com/role/ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails" xlink:type="simple" xlink:href="unh-20211231.xsd#ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.uhc.com/role/ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_unh_ScheduleIMaturitiesofCommercialPaperandLongTermDebtAbstract_0b00931a-b5e5-4aaf-b12e-3a9fe48bf0b5" xlink:href="unh-20211231.xsd#unh_ScheduleIMaturitiesofCommercialPaperandLongTermDebtAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a688aceb-dc65-49be-9ba9-0bd4bdf4a96e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_unh_ScheduleIMaturitiesofCommercialPaperandLongTermDebtAbstract_0b00931a-b5e5-4aaf-b12e-3a9fe48bf0b5" xlink:to="loc_us-gaap_DebtInstrumentTable_a688aceb-dc65-49be-9ba9-0bd4bdf4a96e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_f388e658-a400-424f-afda-c046b5d2f39a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a688aceb-dc65-49be-9ba9-0bd4bdf4a96e" xlink:to="loc_srt_ConsolidatedEntitiesAxis_f388e658-a400-424f-afda-c046b5d2f39a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_8fedda24-7a96-47db-9988-bdc96309352e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_f388e658-a400-424f-afda-c046b5d2f39a" xlink:to="loc_srt_ConsolidatedEntitiesDomain_8fedda24-7a96-47db-9988-bdc96309352e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_ea2e5f7f-fe41-4127-9ac0-b1fdf69c5aee" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_8fedda24-7a96-47db-9988-bdc96309352e" xlink:to="loc_srt_ParentCompanyMember_ea2e5f7f-fe41-4127-9ac0-b1fdf69c5aee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_1dd37f1d-db14-4758-b39b-da64bf323a6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a688aceb-dc65-49be-9ba9-0bd4bdf4a96e" xlink:to="loc_us-gaap_DebtInstrumentLineItems_1dd37f1d-db14-4758-b39b-da64bf323a6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_280e3b08-b1b7-4a73-a649-9714ff676505" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1dd37f1d-db14-4758-b39b-da64bf323a6f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_280e3b08-b1b7-4a73-a649-9714ff676505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_472040fd-12ae-40f3-8945-5449c25bebfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1dd37f1d-db14-4758-b39b-da64bf323a6f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_472040fd-12ae-40f3-8945-5449c25bebfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_1f7c1f76-3288-4b33-8c48-6204453bb135" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1dd37f1d-db14-4758-b39b-da64bf323a6f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_1f7c1f76-3288-4b33-8c48-6204453bb135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_e207fa0e-8f26-4f9c-a7da-188a55883604" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1dd37f1d-db14-4758-b39b-da64bf323a6f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_e207fa0e-8f26-4f9c-a7da-188a55883604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_e1bc9f4a-7692-4898-8846-28496159c6ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1dd37f1d-db14-4758-b39b-da64bf323a6f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_e1bc9f4a-7692-4898-8846-28496159c6ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_c424316d-2f35-4105-bc2d-edfe9ffa0850" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1dd37f1d-db14-4758-b39b-da64bf323a6f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_c424316d-2f35-4105-bc2d-edfe9ffa0850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>image.jpg
<TEXT>
begin 644 image.jpg
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MKZX+)D^:DBT**=D)["%/G3P%CZ'#,7NV-W'\6!R+/ ;K*G;0+V.(]>O7IRD
MY?=ERM2K9Q^HJJG#O'Q%LNIARMGDP>G5JU$W*6:+5HYD/RCBGST4X&_BK'OW
M[L.U:]?>=PTR0D/#4(.$W]RL(@6\K3#"TPN11X\I9W\@ 1Q@#APX&"U:M(*_
M?X"LLW6IUQ#&AN41L&JU] JE!??O/Y3@^7^_YH IQ5Z;-FU.L<7DT:/'.'GB
M%&Y>NZT<R9Y0Q#_K%>#FC9L8Y36*K$QO'#\>[[H9O&C"W*P2U%6+H&6KUA(
M'XL\CI<OLK:')#7@/IP;-VY(#_[7%IM2PHT;U]&3KEUYLLX>'AZ2DJQ:U1ZF
MIN;2FY-6W'_P "-'CD2^? 4EV[,]>$>*J>;;M^\@(& U-JS?E.WODR+^6:L
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M5,%2LF,\<S.MX%C!9YXOBA75@J-C+9PXD;(B<5L*KT/@3!W7(+XU*.*?N0K
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M;QRR90=TM?203R4_QHT=+Y[C0QP]'!G?_+9^HS2/31H_"<4UBY/E-L1V97T
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MO (\(HO+;HN%O:IU#:(*U>':RHT^J+L(4 *N1=V4BAVO2W5S;2>"QE6ZA"P
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<,BIC\_T"^#]/P-"U*#EV(@    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>image1.jpg
<TEXT>
begin 644 image1.jpg
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MKZX+)D^:DBT**=D)["%/G3P%CZ'#,7NV-W'\6!R+/ ;K*G;0+V.(]>O7IRD
MY?=ERM2K9Q^HJJG#O'Q%LNIARMGDP>G5JU$W*6:+5HYD/RCBGST4X&_BK'OW
M[L.U:]?>=PTR0D/#4(.$W]RL(@6\K3#"TPN11X\I9W\@ 1Q@#APX&"U:M(*_
M?X"LLW6IUQ#&AN41L&JU] JE!??O/Y3@^7^_YH IQ5Z;-FU.L<7DT:/'.'GB
M%&Y>NZT<R9Y0Q#_K%>#FC9L8Y36*K$QO'#\>[[H9O&C"W*P2U%6+H&6KUA(
M'XL\CI<OLK:')#7@/IP;-VY(#_[7%IM2PHT;U]&3KEUYLLX>'AZ2DJQ:U1ZF
MIN;2FY-6W'_P "-'CD2^? 4EV[,]>$>*J>;;M^\@(& U-JS?E.WODR+^6:L
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M5,%2LF,\<S.MX%C!9YXOBA75@J-C+9PXD;(B<5L*KT/@3!W7(+XU*.*?N0K
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M;QRR90=TM?203R4_QHT=+Y[C0QP]'!G?_+9^HS2/31H_"<4UBY/E-L1V97T
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MO (\(HO+;HN%O:IU#:(*U>':RHT^J+L(4 *N1=V4BAVO2W5S;2>"QE6ZA"P
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<,BIC\_T"^#]/P-"U*#EV(@    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>strausssignature.jpg
<TEXT>
begin 644 strausssignature.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X2 217AI9@  34T *@    @ !@ +  (
M   F   (8@$2  ,    !  $   $Q  (    F   (B $R  (    4   (KH=I
M  0    !   (PNH<  <   @,    5@  $48<Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                     %=I;F1O=W,@4&AO=&\@161I=&]R(#$P+C N,3 P
M,3$N,38S.#0 5VEN9&]W<R!0:&]T;R!%9&ET;W(@,3 N,"XQ,# Q,2XQ-C,X
M-  R,#(P.C W.C,P(#$U.C,T.C Q   &D ,  @   !0  !$<D 0  @   !0
M !$PDI$  @    ,T-P  DI(  @    ,T-P  H $  P    $  0  ZAP !P
M" P   D0     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M,C R,#HP-SHS," Q-3HS,CHT,  R,#(P.C W.C,P(#$U.C,R.C0P      8!
M P #     0 &   !&@ %     0  $90!&P %     0  $9P!*  #     0 "
M   " 0 $     0  $:0" @ $     0  #F4         8     $   !@
M ?_8_]L 0P (!@8'!@4(!P<'"0D("@P4#0P+"PP9$A,/%!T:'QX=&AP<("0N
M)R B+",<'"@W*2PP,30T-!\G.3TX,CPN,S0R_]L 0P$)"0D,"PP8#0T8,B$<
M(3(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R_\  $0@ 2@"Z P$A  (1 0,1 ?_$ !\   $% 0$! 0$!
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MVRU^. 7)ECFMW\R">%]KQM[&I=*T6UTE&\HRRS/]^:9R[M]2: -!D61=KJK
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M(" @(" @(" @(" @(" @(" @(" @/#]X<&%C:V5T(&5N9#TG=R<_/O_; $,
M P(" P(" P,# P0# P0%" 4%! 0%"@<'!@@,"@P,"PH+"PT.$A -#A$."PL0
M%A 1$Q05%14,#Q<8%A08$A05%/_; $,! P0$!00%"04%"10-"PT4%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%/_
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MV@ , P$  A$#$0 _ /U2I:2EH **** "BBH+RXBL[>2>XD2&WB0R22R,%5%
MR22>  .M '&?&KXP:!\#?A[JGBSQ%=+!:6<9\J(<O<2G[D2+W9C@5P'['\?Q
M(U;P!>^+OB5J;3:EXGN?[2LM(VX32[5@?+B'N002/8=.@^=_"?VK_@H)^TLW
MB>X$@^"GP]N_+TRW<?)J]\/^6A'1E!&>^!CUK[^C4(, 84   #'%,!]%%%(
MHHHH ***@O;R'3[2:ZN9%AMX4:221S@*H&23[ 4 3T5\=+^U)\6/CYKNIV_P
M#\&Z7<>%+"=K8^,_$T[1VMQ*A(=88UY=1_>Z=*ZWX._M!^.&^/E]\'?B3I.E
MCQ%'I/\ ;5MJ>@E_LSPY4%'5^5?)^AH ^F**:O>AJ .2^+7Q.T7X.?#W6_&/
MB"Y6VTO2K=II"QP7;HJ+_M,Q 'N:^2?V3K[XHZ[\>6\5^+=4U!;'Q9H;:N=
MN9"8M.@=P;=$3HK!2 >YSSTJY\0'F_;2_:33X?VK^9\)/A[<I=^(9DYBU345
M(:.UW#@K&>6'UKZ7\#Z?;W?CKQ1J\4<:16_E:3;>6ORK'$N6"_\  FQCVI]
M/0%[TZD'>EI %%%% "4M)2T %%%4]6U2TT73;G4+^X2ULK:-I9IY&VJBJ,DD
M_04 6FY7%?$O[=?Q7USX@:_H_P"SS\.I2_B'Q+(HUV[C7<+.R/WD9CPI8<DD
M' ],YKW?X\_M':#\'_A /%\5S%?W>J*L&@6G(-_=2*3$JCKM_B8] JFO,OV'
M?@7?^';+5_B=XQ#7/CKQ3(TDL\N=R1$Y( /0$YP.@ % 'OOP;^%>B?!7X<Z+
MX.\/P+#I^F0+'O5 IF?JTC8[DYZ^P[5VM(*6@ HHI* %HJ,R)YFPN YZ+GFG
MB@!:X+X]:/J7B#X+^-M.TB;R-2N=(N8X)/1C&?Z9KO:R?%?B33?!_AO4M<UB
MZCLM+T^W>YN+B5@%1%&2<GB@#RS]DN'0O#O[+_@2/2UCL=,L])59CC8BRKG[
M0YSZR"1OQK@OV4[4?%?XJ?$CXY,&?3-;F70_#KR##-I]L2K2#_9>0$CV6O)=
M+\1:G\6O .C_  3\#W5Q:/XHO;G4_$%Y"#&='T.20L4SCB2;.% .<.3@C-?<
MW@SPGI?@/PMI?AW1+5;+2=+MTM;:!!@(BC _&GL!K-\V,U\M?M=?'SQ':ZM8
M_!GX4VYU'XG^)8"9+A3B+1[,C#7,C=FY.WZ'TKU#]ICX]6'[/?PUGUZ:WDU'
M6+N5;#2-+M\&:\O).(T5>X!Y.!P!7'?LB_ #4/AKHNH>-O&T[ZI\4_%VV[UN
M]E))@!Y2UCSR$08'U'3N4!V'P5^$.A?LR_!:R\-:82?LL?FW=V?OW=X^ \I_
MVF<@#\*[SP3X93PGX=M]/5VEE!:6:1NKRN2SL?Q-4Y?L_B[7H#!>"2RT>X;[
M1#'RLEQM&U2?]C.[ZE:ZE: %HHHH **** $I:2EH 1J^5/VGO%!^*WQ,T+X(
M:==-:Z.L0\0>.-01BBV>EQ,&2%G'W6F88_W0:]P^-GQ:TOX+?#[4/$FI$RR1
M@065C'S+>73_ "Q0H.[,Q _6OA+5O#US8MJ'P_U?4);CQOXSF7Q!\3=:T\CS
M+6W8_P"CZ1"P[L-J8'\(;UIH#M_AWI4'[7GQ[C\5W[S1> M B:U\-:,,B,01
MD*UV5/0R$!5/90/6ONVWA2WA2*-0D: *JJ,  =!^5>;? WX66_PY\+J6M$M=
M1NT3S(U7_CWB48C@7V4?J37IJ]Z %I&I:*0'-6G@\VOC>^\1-JE[*+FV2V73
MVD_T>+;CYPO]XXK$^-GQJ\,_ 7P'=>*/$]R\=O&PBMK2%2]Q>3MPD,2#EG8X
M&/QK>^(7CK1OAEX+U?Q3X@NULM'TJW:YN)F[*!T'J2>![FOD/X1^%-3_ &F/
M&D7[1'Q/C?3?!.DH\_@OPO='_4Q '_39QT\Q@,J!0 SX/Z+\0_B/^V4/&GBU
M[S1H[#1/._L..X*QV44RKY,#Q]"_.YB>X/I7V^N>:\\^"_A5M+TG4O$5ZCKK
M/B:Y_M&[#G[BG/E1@=@$(X]6-=3XU\::+\/?#&H>(?$.HP:5H^GQ--<75PP5
M$4#/?J?;O0!=US6K'P[I-UJ>IW<5CI]K&TL]S.X1(T R22:_-;]I+XX>(OVM
MO%6E^%? ]M<S^#);H)I5ERC>(+A"#]IE'5+2/&03PV,]Q6;\?/C)XI_:J\5:
M?HEO8ZE_PB]W,&\.> [-2EUK@!Q]LU!O^6$ Y8!R !UR20?M#]F;]F:#X,6,
MNNZ[-;ZQX^U*!8KR^@3;!:0C[MI:J?N1+Z]6/)[  &U^S9^S[8? 7P5]D:0:
MEXHU)A<ZUK##YKF<C&U?[L:#"JH[#U->I:OJUIH>E7FI7\ZVMC:0O<7$TA^6
M.- 69B?0 $TS6M;L?#NEW&I:E=1V=C;*7EGE;:JJ.Y_SR<5\$_M!_M'>)OVC
M/#>OP?#KPI/J/PK\*2K=^)M3U+=;C6UC<$V-J#][<.6)X/ [T >G_!+PA=_M
M/?%.+X[>+X98_#.FL\/@/1)T*A(,G.H2K_STD_A]%^M?1'C_ %S4X;4:/X<6
M.3Q'>I^Z\UODMH\X:9_9<\#N<"C1?%D5QX!T34K#2)K.2^LXGL=&F"QR)N0%
M8R <*%'4] !5GP?X4?0_M>HZA*+S7=0827=R,D# ^6*,'HB@X ^I/)- %GP1
MX5MO!?ARUTJU)<1 M+,WWI9&.7<^Y))K>I!2T %%%% !1110 E4M:UBR\/Z7
M=:EJ5W#8:=:1-/<7-PP6..-1EF8G@ #FH?$VM1^'?#]_J4FTK:PM+M=P@8@<
M#/;)XKX0^&>O>./VS/BEXB\'>+-=M=3^%/AZ[2\U2'3H/)%]+NWPV9D'WXA@
M%O[P&,X)R ;.O_$_4?%T=Q\?/'-F+#P+HTC6_P //"MXI\S4+J0[(]2F7'WF
MR=BD?*OS<$YKNOV5/V>;K3U;Q[XPN'OM:U6=M6E\W),]R_/GOG^%1A44G@ >
M@KB]9T.+]LS]J6/1[.=/^%0?"F18+R"%,1:CJH_Y8*.FR+:H)Z94X]:].^/?
MQWT?1=$O;9GDET&-CIMMI^G2?Z;XBU$@!;"U53NV*2I=Q[C(&2: ]U\'^/O#
MGCQ-0?P[K-GK"V-PUK=&SE#B*5>JFNAKX?\ @Q8C]BCPB+GQ7')KGQ0^)FL0
M?9_!NCNK"!C\JQ(<?=C1BTDIX)&.V3[_ /M(?%[4/A3\,]6OM$@6;Q&+5FMR
M\9E@MGQA7DZ9&> O5JD#V&FL<#->,P_M 67P]^!N@>,/B;/'HVKS:;%=7=A:
MKYDK2,H.$C'<@@XX )QQ7SW\2OV[-8\2>'[?PE9_#GQ)X(U3QKMT[0=9U9XE
M4QS$H;H*K;UVJ"PW<<=3TI@:OC"WN/V[/C7+X6ADF3X'^![L'5KB*3$7B#45
M_P"7<8^_%&<@YX)SP:]\\16,'Q.UJ#P=IL8@\):)+&VJ26V$CD>/!CLTQP ,
M#<!T "\9KDO .B#1? >F_"_X3NMMH^DHMGJGBPH,*^,RM$0 );ASDENBELD]
M,>N:;IWASX/>!9%$L6D:!I4#W$]U<OT499Y9&/4DY)/?/%(!?B/\2/#GPB\%
MZAXG\4ZC#I6BZ?'ODE<\GT1%_B8G@**_,_QE\6OB!^V=\6-/L=-T,W-G#+Y^
M@^%9"1;62\;;[5&Z9P 0G.,C W$$=5XDTKXG?M_?%:'4K+3K[1/A59R,WA_4
M+^$?9-BL ;MD)'F3,.47D*.<\C'WO\)?@_X;^#?AE-)\/V:QLQ\RZOY%!N+V
M4CYI96 Y8_D.@Q0!RG[._P"SII_P-T6ZN;J[_P"$@\9:HPFU;7IHP))FQ@1Q
MCJD*CA4'0>^:XOQ_X-_:D;6-7O?"GQ&\&)I9=Y++3;K0V,H7^%&D+8_$U],"
MN"^-_P 9-!^!/P_OO%6OM(\,)6&VLK<;I[VY<XB@B7N[M@#\Z /B'XH?"_\
M:9UCQ7X=TK6_BKHFJ^*=<C_T;0K"Q\JVTV-1^]N74@AE7IG/) QWJII'[/WQ
MN^(5GJ7PTT3XK:?=^!/#<RS75Q;Z:MK%?7V2_P!G$B#<RJX#'^#H#7J;>'_&
ML&FZ:NM:FNC?%KXKW?EWMVK;VT'2T&X6EON/WEC.,@#+LQ(XKZ+T/2?#OP%\
M$VFB:1!<WI4[;>SC(ENKN4]_J>[' '4U0'S_ *)^Q5\3]3OK3Q-XI_:#\1Q>
M+TM_(,FC6T26T$?]R)&&![D@DGFK]Y^PKXIU>X:XU+]HCQ_>S$_>/DQ\>F%
MS5ZQ^,7COX2_'[73\6Y9H/ VO6,<N@OI=H]Q9:9)&QWP3.BEC*P8'<1M)7 X
MKS']H3]OK5;[Q)J7A+X66TUM#IML9]2\07ML4;E<A8(W&=H4Y,AQS@ '!HU
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%]% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>strausssignature1.jpg
<TEXT>
begin 644 strausssignature1.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X2 217AI9@  34T *@    @ !@ +  (
M   F   (8@$2  ,    !  $   $Q  (    F   (B $R  (    4   (KH=I
M  0    !   (PNH<  <   @,    5@  $48<Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                     %=I;F1O=W,@4&AO=&\@161I=&]R(#$P+C N,3 P
M,3$N,38S.#0 5VEN9&]W<R!0:&]T;R!%9&ET;W(@,3 N,"XQ,# Q,2XQ-C,X
M-  R,#(P.C W.C,P(#$U.C,T.C Q   &D ,  @   !0  !$<D 0  @   !0
M !$PDI$  @    ,T-P  DI(  @    ,T-P  H $  P    $  0  ZAP !P
M" P   D0     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M,C R,#HP-SHS," Q-3HS,CHT,  R,#(P.C W.C,P(#$U.C,R.C0P      8!
M P #     0 &   !&@ %     0  $90!&P %     0  $9P!*  #     0 "
M   " 0 $     0  $:0" @ $     0  #F4         8     $   !@
M ?_8_]L 0P (!@8'!@4(!P<'"0D("@P4#0P+"PP9$A,/%!T:'QX=&AP<("0N
M)R B+",<'"@W*2PP,30T-!\G.3TX,CPN,S0R_]L 0P$)"0D,"PP8#0T8,B$<
M(3(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R_\  $0@ 2@"Z P$A  (1 0,1 ?_$ !\   $% 0$! 0$!
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MVRU^. 7)ECFMW\R">%]KQM[&I=*T6UTE&\HRRS/]^:9R[M]2: -!D61=KJK
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M(" @(" @(" @(" @(" @(" @(" @/#]X<&%C:V5T(&5N9#TG=R<_/O_; $,
M P(" P(" P,# P0# P0%" 4%! 0%"@<'!@@,"@P,"PH+"PT.$A -#A$."PL0
M%A 1$Q05%14,#Q<8%A08$A05%/_; $,! P0$!00%"04%"10-"PT4%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%/_
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MV@ , P$  A$#$0 _ /U2I:2EH **** "BBH+RXBL[>2>XD2&WB0R22R,%5%
MR22>  .M '&?&KXP:!\#?A[JGBSQ%=+!:6<9\J(<O<2G[D2+W9C@5P'['\?Q
M(U;P!>^+OB5J;3:EXGN?[2LM(VX32[5@?+B'N002/8=.@^=_"?VK_@H)^TLW
MB>X$@^"GP]N_+TRW<?)J]\/^6A'1E!&>^!CUK[^C4(, 84   #'%,!]%%%(
MHHHH ***@O;R'3[2:ZN9%AMX4:221S@*H&23[ 4 3T5\=+^U)\6/CYKNIV_P
M#\&Z7<>%+"=K8^,_$T[1VMQ*A(=88UY=1_>Z=*ZWX._M!^.&^/E]\'?B3I.E
MCQ%'I/\ ;5MJ>@E_LSPY4%'5^5?)^AH ^F**:O>AJ .2^+7Q.T7X.?#W6_&/
MB"Y6VTO2K=II"QP7;HJ+_M,Q 'N:^2?V3K[XHZ[\>6\5^+=4U!;'Q9H;:N=
MN9"8M.@=P;=$3HK!2 >YSSTJY\0'F_;2_:33X?VK^9\)/A[<I=^(9DYBU345
M(:.UW#@K&>6'UKZ7\#Z?;W?CKQ1J\4<:16_E:3;>6ORK'$N6"_\  FQCVI]
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MN"^-_P 9-!^!/P_OO%6OM(\,)6&VLK<;I[VY<XB@B7N[M@#\Z /B'XH?"_\
M:9UCQ7X=TK6_BKHFJ^*=<C_T;0K"Q\JVTV-1^]N74@AE7IG/) QWJII'[/WQ
MN^(5GJ7PTT3XK:?=^!/#<RS75Q;Z:MK%?7V2_P!G$B#<RJX#'^#H#7J;>'_&
ML&FZ:NM:FNC?%KXKW?EWMVK;VT'2T&X6EON/WEC.,@#+LQ(XKZ+T/2?#OP%\
M$VFB:1!<WI4[;>SC(ENKN4]_J>[' '4U0'S_ *)^Q5\3]3OK3Q-XI_:#\1Q>
M+TM_(,FC6T26T$?]R)&&![D@DGFK]Y^PKXIU>X:XU+]HCQ_>S$_>/DQ\>F%
MS5ZQ^,7COX2_'[73\6Y9H/ VO6,<N@OI=H]Q9:9)&QWP3.BEC*P8'<1M)7 X
MKS']H3]OK5;[Q)J7A+X66TUM#IML9]2\07ML4;E<A8(W&=H4Y,AQS@ '!HU
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%]% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>strausssignature1b.jpg
<TEXT>
begin 644 strausssignature1b.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X2 217AI9@  34T *@    @ !@ +  (
M   F   (8@$2  ,    !  $   $Q  (    F   (B $R  (    4   (KH=I
M  0    !   (PNH<  <   @,    5@  $48<Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                     %=I;F1O=W,@4&AO=&\@161I=&]R(#$P+C N,3 P
M,3$N,38S.#0 5VEN9&]W<R!0:&]T;R!%9&ET;W(@,3 N,"XQ,# Q,2XQ-C,X
M-  R,#(P.C W.C,P(#$U.C,T.C Q   &D ,  @   !0  !$<D 0  @   !0
M !$PDI$  @    ,T-P  DI(  @    ,T-P  H $  P    $  0  ZAP !P
M" P   D0     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M,C R,#HP-SHS," Q-3HS,CHT,  R,#(P.C W.C,P(#$U.C,R.C0P      8!
M P #     0 &   !&@ %     0  $90!&P %     0  $9P!*  #     0 "
M   " 0 $     0  $:0" @ $     0  #F4         8     $   !@
M ?_8_]L 0P (!@8'!@4(!P<'"0D("@P4#0P+"PP9$A,/%!T:'QX=&AP<("0N
M)R B+",<'"@W*2PP,30T-!\G.3TX,CPN,S0R_]L 0P$)"0D,"PP8#0T8,B$<
M(3(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R_\  $0@ 2@"Z P$A  (1 0,1 ?_$ !\   $% 0$! 0$!
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MVRU^. 7)ECFMW\R">%]KQM[&I=*T6UTE&\HRRS/]^:9R[M]2: -!D61=KJK
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M(" @(" @(" @(" @(" @(" @(" @/#]X<&%C:V5T(&5N9#TG=R<_/O_; $,
M P(" P(" P,# P0# P0%" 4%! 0%"@<'!@@,"@P,"PH+"PT.$A -#A$."PL0
M%A 1$Q05%14,#Q<8%A08$A05%/_; $,! P0$!00%"04%"10-"PT4%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%/_
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MV@ , P$  A$#$0 _ /U2I:2EH **** "BBH+RXBL[>2>XD2&WB0R22R,%5%
MR22>  .M '&?&KXP:!\#?A[JGBSQ%=+!:6<9\J(<O<2G[D2+W9C@5P'['\?Q
M(U;P!>^+OB5J;3:EXGN?[2LM(VX32[5@?+B'N002/8=.@^=_"?VK_@H)^TLW
MB>X$@^"GP]N_+TRW<?)J]\/^6A'1E!&>^!CUK[^C4(, 84   #'%,!]%%%(
MHHHH ***@O;R'3[2:ZN9%AMX4:221S@*H&23[ 4 3T5\=+^U)\6/CYKNIV_P
M#\&Z7<>%+"=K8^,_$T[1VMQ*A(=88UY=1_>Z=*ZWX._M!^.&^/E]\'?B3I.E
MCQ%'I/\ ;5MJ>@E_LSPY4%'5^5?)^AH ^F**:O>AJ .2^+7Q.T7X.?#W6_&/
MB"Y6VTO2K=II"QP7;HJ+_M,Q 'N:^2?V3K[XHZ[\>6\5^+=4U!;'Q9H;:N=
MN9"8M.@=P;=$3HK!2 >YSSTJY\0'F_;2_:33X?VK^9\)/A[<I=^(9DYBU345
M(:.UW#@K&>6'UKZ7\#Z?;W?CKQ1J\4<:16_E:3;>6ORK'$N6"_\  FQCVI]
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MN"^-_P 9-!^!/P_OO%6OM(\,)6&VLK<;I[VY<XB@B7N[M@#\Z /B'XH?"_\
M:9UCQ7X=TK6_BKHFJ^*=<C_T;0K"Q\JVTV-1^]N74@AE7IG/) QWJII'[/WQ
MN^(5GJ7PTT3XK:?=^!/#<RS75Q;Z:MK%?7V2_P!G$B#<RJX#'^#H#7J;>'_&
ML&FZ:NM:FNC?%KXKW?EWMVK;VT'2T&X6EON/WEC.,@#+LQ(XKZ+T/2?#OP%\
M$VFB:1!<WI4[;>SC(ENKN4]_J>[' '4U0'S_ *)^Q5\3]3OK3Q-XI_:#\1Q>
M+TM_(,FC6T26T$?]R)&&![D@DGFK]Y^PKXIU>X:XU+]HCQ_>S$_>/DQ\>F%
MS5ZQ^,7COX2_'[73\6Y9H/ VO6,<N@OI=H]Q9:9)&QWP3.BEC*P8'<1M)7 X
MKS']H3]OK5;[Q)J7A+X66TUM#IML9]2\07ML4;E<A8(W&=H4Y,AQS@ '!HU
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%]% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>strausssignature2.jpg
<TEXT>
begin 644 strausssignature2.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X2 217AI9@  34T *@    @ !@ +  (
M   F   (8@$2  ,    !  $   $Q  (    F   (B $R  (    4   (KH=I
M  0    !   (PNH<  <   @,    5@  $48<Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                     %=I;F1O=W,@4&AO=&\@161I=&]R(#$P+C N,3 P
M,3$N,38S.#0 5VEN9&]W<R!0:&]T;R!%9&ET;W(@,3 N,"XQ,# Q,2XQ-C,X
M-  R,#(P.C W.C,P(#$U.C,T.C Q   &D ,  @   !0  !$<D 0  @   !0
M !$PDI$  @    ,T-P  DI(  @    ,T-P  H $  P    $  0  ZAP !P
M" P   D0     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M,C R,#HP-SHS," Q-3HS,CHT,  R,#(P.C W.C,P(#$U.C,R.C0P      8!
M P #     0 &   !&@ %     0  $90!&P %     0  $9P!*  #     0 "
M   " 0 $     0  $:0" @ $     0  #F4         8     $   !@
M ?_8_]L 0P (!@8'!@4(!P<'"0D("@P4#0P+"PP9$A,/%!T:'QX=&AP<("0N
M)R B+",<'"@W*2PP,30T-!\G.3TX,CPN,S0R_]L 0P$)"0D,"PP8#0T8,B$<
M(3(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R_\  $0@ 2@"Z P$A  (1 0,1 ?_$ !\   $% 0$! 0$!
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MVRU^. 7)ECFMW\R">%]KQM[&I=*T6UTE&\HRRS/]^:9R[M]2: -!D61=KJK
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M(" @(" @(" @(" @(" @(" @(" @/#]X<&%C:V5T(&5N9#TG=R<_/O_; $,
M P(" P(" P,# P0# P0%" 4%! 0%"@<'!@@,"@P,"PH+"PT.$A -#A$."PL0
M%A 1$Q05%14,#Q<8%A08$A05%/_; $,! P0$!00%"04%"10-"PT4%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%/_
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MV@ , P$  A$#$0 _ /U2I:2EH **** "BBH+RXBL[>2>XD2&WB0R22R,%5%
MR22>  .M '&?&KXP:!\#?A[JGBSQ%=+!:6<9\J(<O<2G[D2+W9C@5P'['\?Q
M(U;P!>^+OB5J;3:EXGN?[2LM(VX32[5@?+B'N002/8=.@^=_"?VK_@H)^TLW
MB>X$@^"GP]N_+TRW<?)J]\/^6A'1E!&>^!CUK[^C4(, 84   #'%,!]%%%(
MHHHH ***@O;R'3[2:ZN9%AMX4:221S@*H&23[ 4 3T5\=+^U)\6/CYKNIV_P
M#\&Z7<>%+"=K8^,_$T[1VMQ*A(=88UY=1_>Z=*ZWX._M!^.&^/E]\'?B3I.E
MCQ%'I/\ ;5MJ>@E_LSPY4%'5^5?)^AH ^F**:O>AJ .2^+7Q.T7X.?#W6_&/
MB"Y6VTO2K=II"QP7;HJ+_M,Q 'N:^2?V3K[XHZ[\>6\5^+=4U!;'Q9H;:N=
MN9"8M.@=P;=$3HK!2 >YSSTJY\0'F_;2_:33X?VK^9\)/A[<I=^(9DYBU345
M(:.UW#@K&>6'UKZ7\#Z?;W?CKQ1J\4<:16_E:3;>6ORK'$N6"_\  FQCVI]
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MN"^-_P 9-!^!/P_OO%6OM(\,)6&VLK<;I[VY<XB@B7N[M@#\Z /B'XH?"_\
M:9UCQ7X=TK6_BKHFJ^*=<C_T;0K"Q\JVTV-1^]N74@AE7IG/) QWJII'[/WQ
MN^(5GJ7PTT3XK:?=^!/#<RS75Q;Z:MK%?7V2_P!G$B#<RJX#'^#H#7J;>'_&
ML&FZ:NM:FNC?%KXKW?EWMVK;VT'2T&X6EON/WEC.,@#+LQ(XKZ+T/2?#OP%\
M$VFB:1!<WI4[;>SC(ENKN4]_J>[' '4U0'S_ *)^Q5\3]3OK3Q-XI_:#\1Q>
M+TM_(,FC6T26T$?]R)&&![D@DGFK]Y^PKXIU>X:XU+]HCQ_>S$_>/DQ\>F%
MS5ZQ^,7COX2_'[73\6Y9H/ VO6,<N@OI=H]Q9:9)&QWP3.BEC*P8'<1M)7 X
MKS']H3]OK5;[Q)J7A+X66TUM#IML9]2\07ML4;E<A8(W&=H4Y,AQS@ '!HU
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%]% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>strausssignaturea.jpg
<TEXT>
begin 644 strausssignaturea.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X2 217AI9@  34T *@    @ !@ +  (
M   F   (8@$2  ,    !  $   $Q  (    F   (B $R  (    4   (KH=I
M  0    !   (PNH<  <   @,    5@  $48<Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                     %=I;F1O=W,@4&AO=&\@161I=&]R(#$P+C N,3 P
M,3$N,38S.#0 5VEN9&]W<R!0:&]T;R!%9&ET;W(@,3 N,"XQ,# Q,2XQ-C,X
M-  R,#(P.C W.C,P(#$U.C,T.C Q   &D ,  @   !0  !$<D 0  @   !0
M !$PDI$  @    ,T-P  DI(  @    ,T-P  H $  P    $  0  ZAP !P
M" P   D0     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M,C R,#HP-SHS," Q-3HS,CHT,  R,#(P.C W.C,P(#$U.C,R.C0P      8!
M P #     0 &   !&@ %     0  $90!&P %     0  $9P!*  #     0 "
M   " 0 $     0  $:0" @ $     0  #F4         8     $   !@
M ?_8_]L 0P (!@8'!@4(!P<'"0D("@P4#0P+"PP9$A,/%!T:'QX=&AP<("0N
M)R B+",<'"@W*2PP,30T-!\G.3TX,CPN,S0R_]L 0P$)"0D,"PP8#0T8,B$<
M(3(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R_\  $0@ 2@"Z P$A  (1 0,1 ?_$ !\   $% 0$! 0$!
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MVRU^. 7)ECFMW\R">%]KQM[&I=*T6UTE&\HRRS/]^:9R[M]2: -!D61=KJK
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M(" @(" @(" @(" @(" @(" @(" @/#]X<&%C:V5T(&5N9#TG=R<_/O_; $,
M P(" P(" P,# P0# P0%" 4%! 0%"@<'!@@,"@P,"PH+"PT.$A -#A$."PL0
M%A 1$Q05%14,#Q<8%A08$A05%/_; $,! P0$!00%"04%"10-"PT4%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%/_
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MV@ , P$  A$#$0 _ /U2I:2EH **** "BBH+RXBL[>2>XD2&WB0R22R,%5%
MR22>  .M '&?&KXP:!\#?A[JGBSQ%=+!:6<9\J(<O<2G[D2+W9C@5P'['\?Q
M(U;P!>^+OB5J;3:EXGN?[2LM(VX32[5@?+B'N002/8=.@^=_"?VK_@H)^TLW
MB>X$@^"GP]N_+TRW<?)J]\/^6A'1E!&>^!CUK[^C4(, 84   #'%,!]%%%(
MHHHH ***@O;R'3[2:ZN9%AMX4:221S@*H&23[ 4 3T5\=+^U)\6/CYKNIV_P
M#\&Z7<>%+"=K8^,_$T[1VMQ*A(=88UY=1_>Z=*ZWX._M!^.&^/E]\'?B3I.E
MCQ%'I/\ ;5MJ>@E_LSPY4%'5^5?)^AH ^F**:O>AJ .2^+7Q.T7X.?#W6_&/
MB"Y6VTO2K=II"QP7;HJ+_M,Q 'N:^2?V3K[XHZ[\>6\5^+=4U!;'Q9H;:N=
MN9"8M.@=P;=$3HK!2 >YSSTJY\0'F_;2_:33X?VK^9\)/A[<I=^(9DYBU345
M(:.UW#@K&>6'UKZ7\#Z?;W?CKQ1J\4<:16_E:3;>6ORK'$N6"_\  FQCVI]
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MN"^-_P 9-!^!/P_OO%6OM(\,)6&VLK<;I[VY<XB@B7N[M@#\Z /B'XH?"_\
M:9UCQ7X=TK6_BKHFJ^*=<C_T;0K"Q\JVTV-1^]N74@AE7IG/) QWJII'[/WQ
MN^(5GJ7PTT3XK:?=^!/#<RS75Q;Z:MK%?7V2_P!G$B#<RJX#'^#H#7J;>'_&
ML&FZ:NM:FNC?%KXKW?EWMVK;VT'2T&X6EON/WEC.,@#+LQ(XKZ+T/2?#OP%\
M$VFB:1!<WI4[;>SC(ENKN4]_J>[' '4U0'S_ *)^Q5\3]3OK3Q-XI_:#\1Q>
M+TM_(,FC6T26T$?]R)&&![D@DGFK]Y^PKXIU>X:XU+]HCQ_>S$_>/DQ\>F%
MS5ZQ^,7COX2_'[73\6Y9H/ VO6,<N@OI=H]Q9:9)&QWP3.BEC*P8'<1M)7 X
MKS']H3]OK5;[Q)J7A+X66TUM#IML9]2\07ML4;E<A8(W&=H4Y,AQS@ '!HU
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%]% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>strausssignatureb.jpg
<TEXT>
begin 644 strausssignatureb.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X2 217AI9@  34T *@    @ !@ +  (
M   F   (8@$2  ,    !  $   $Q  (    F   (B $R  (    4   (KH=I
M  0    !   (PNH<  <   @,    5@  $48<Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                     %=I;F1O=W,@4&AO=&\@161I=&]R(#$P+C N,3 P
M,3$N,38S.#0 5VEN9&]W<R!0:&]T;R!%9&ET;W(@,3 N,"XQ,# Q,2XQ-C,X
M-  R,#(P.C W.C,P(#$U.C,T.C Q   &D ,  @   !0  !$<D 0  @   !0
M !$PDI$  @    ,T-P  DI(  @    ,T-P  H $  P    $  0  ZAP !P
M" P   D0     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M,C R,#HP-SHS," Q-3HS,CHT,  R,#(P.C W.C,P(#$U.C,R.C0P      8!
M P #     0 &   !&@ %     0  $90!&P %     0  $9P!*  #     0 "
M   " 0 $     0  $:0" @ $     0  #F4         8     $   !@
M ?_8_]L 0P (!@8'!@4(!P<'"0D("@P4#0P+"PP9$A,/%!T:'QX=&AP<("0N
M)R B+",<'"@W*2PP,30T-!\G.3TX,CPN,S0R_]L 0P$)"0D,"PP8#0T8,B$<
M(3(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R_\  $0@ 2@"Z P$A  (1 0,1 ?_$ !\   $% 0$! 0$!
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MVRU^. 7)ECFMW\R">%]KQM[&I=*T6UTE&\HRRS/]^:9R[M]2: -!D61=KJK
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M(" @(" @(" @(" @(" @(" @(" @/#]X<&%C:V5T(&5N9#TG=R<_/O_; $,
M P(" P(" P,# P0# P0%" 4%! 0%"@<'!@@,"@P,"PH+"PT.$A -#A$."PL0
M%A 1$Q05%14,#Q<8%A08$A05%/_; $,! P0$!00%"04%"10-"PT4%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%/_
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MV@ , P$  A$#$0 _ /U2I:2EH **** "BBH+RXBL[>2>XD2&WB0R22R,%5%
MR22>  .M '&?&KXP:!\#?A[JGBSQ%=+!:6<9\J(<O<2G[D2+W9C@5P'['\?Q
M(U;P!>^+OB5J;3:EXGN?[2LM(VX32[5@?+B'N002/8=.@^=_"?VK_@H)^TLW
MB>X$@^"GP]N_+TRW<?)J]\/^6A'1E!&>^!CUK[^C4(, 84   #'%,!]%%%(
MHHHH ***@O;R'3[2:ZN9%AMX4:221S@*H&23[ 4 3T5\=+^U)\6/CYKNIV_P
M#\&Z7<>%+"=K8^,_$T[1VMQ*A(=88UY=1_>Z=*ZWX._M!^.&^/E]\'?B3I.E
MCQ%'I/\ ;5MJ>@E_LSPY4%'5^5?)^AH ^F**:O>AJ .2^+7Q.T7X.?#W6_&/
MB"Y6VTO2K=II"QP7;HJ+_M,Q 'N:^2?V3K[XHZ[\>6\5^+=4U!;'Q9H;:N=
MN9"8M.@=P;=$3HK!2 >YSSTJY\0'F_;2_:33X?VK^9\)/A[<I=^(9DYBU345
M(:.UW#@K&>6'UKZ7\#Z?;W?CKQ1J\4<:16_E:3;>6ORK'$N6"_\  FQCVI]
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MN"^-_P 9-!^!/P_OO%6OM(\,)6&VLK<;I[VY<XB@B7N[M@#\Z /B'XH?"_\
M:9UCQ7X=TK6_BKHFJ^*=<C_T;0K"Q\JVTV-1^]N74@AE7IG/) QWJII'[/WQ
MN^(5GJ7PTT3XK:?=^!/#<RS75Q;Z:MK%?7V2_P!G$B#<RJX#'^#H#7J;>'_&
ML&FZ:NM:FNC?%KXKW?EWMVK;VT'2T&X6EON/WEC.,@#+LQ(XKZ+T/2?#OP%\
M$VFB:1!<WI4[;>SC(ENKN4]_J>[' '4U0'S_ *)^Q5\3]3OK3Q-XI_:#\1Q>
M+TM_(,FC6T26T$?]R)&&![D@DGFK]Y^PKXIU>X:XU+]HCQ_>S$_>/DQ\>F%
MS5ZQ^,7COX2_'[73\6Y9H/ VO6,<N@OI=H]Q9:9)&QWP3.BEC*P8'<1M)7 X
MKS']H3]OK5;[Q)J7A+X66TUM#IML9]2\07ML4;E<A8(W&=H4Y,AQS@ '!HU
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%]% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>strausssignaturee.jpg
<TEXT>
begin 644 strausssignaturee.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X2 217AI9@  34T *@    @ !@ +  (
M   F   (8@$2  ,    !  $   $Q  (    F   (B $R  (    4   (KH=I
M  0    !   (PNH<  <   @,    5@  $48<Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                     %=I;F1O=W,@4&AO=&\@161I=&]R(#$P+C N,3 P
M,3$N,38S.#0 5VEN9&]W<R!0:&]T;R!%9&ET;W(@,3 N,"XQ,# Q,2XQ-C,X
M-  R,#(P.C W.C,P(#$U.C,T.C Q   &D ,  @   !0  !$<D 0  @   !0
M !$PDI$  @    ,T-P  DI(  @    ,T-P  H $  P    $  0  ZAP !P
M" P   D0     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M,C R,#HP-SHS," Q-3HS,CHT,  R,#(P.C W.C,P(#$U.C,R.C0P      8!
M P #     0 &   !&@ %     0  $90!&P %     0  $9P!*  #     0 "
M   " 0 $     0  $:0" @ $     0  #F4         8     $   !@
M ?_8_]L 0P (!@8'!@4(!P<'"0D("@P4#0P+"PP9$A,/%!T:'QX=&AP<("0N
M)R B+",<'"@W*2PP,30T-!\G.3TX,CPN,S0R_]L 0P$)"0D,"PP8#0T8,B$<
M(3(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R_\  $0@ 2@"Z P$A  (1 0,1 ?_$ !\   $% 0$! 0$!
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MVRU^. 7)ECFMW\R">%]KQM[&I=*T6UTE&\HRRS/]^:9R[M]2: -!D61=KJK
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M(" @(" @(" @(" @(" @(" @(" @/#]X<&%C:V5T(&5N9#TG=R<_/O_; $,
M P(" P(" P,# P0# P0%" 4%! 0%"@<'!@@,"@P,"PH+"PT.$A -#A$."PL0
M%A 1$Q05%14,#Q<8%A08$A05%/_; $,! P0$!00%"04%"10-"PT4%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%/_
M !$( $H N@,!(@ "$0$#$0'_Q  ?   !!0$! 0$! 0           0(#! 4&
M!P@)"@O_Q "U$  " 0,# @0#!04$!    7T! @, !!$%$B$Q008346$'(G$4
M,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)
M2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.D
MI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R
M\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!         0(#! 4&!P@)"@O_Q "U
M$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)
M(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA9
M6F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JR
ML[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_
MV@ , P$  A$#$0 _ /U2I:2EH **** "BBH+RXBL[>2>XD2&WB0R22R,%5%
MR22>  .M '&?&KXP:!\#?A[JGBSQ%=+!:6<9\J(<O<2G[D2+W9C@5P'['\?Q
M(U;P!>^+OB5J;3:EXGN?[2LM(VX32[5@?+B'N002/8=.@^=_"?VK_@H)^TLW
MB>X$@^"GP]N_+TRW<?)J]\/^6A'1E!&>^!CUK[^C4(, 84   #'%,!]%%%(
MHHHH ***@O;R'3[2:ZN9%AMX4:221S@*H&23[ 4 3T5\=+^U)\6/CYKNIV_P
M#\&Z7<>%+"=K8^,_$T[1VMQ*A(=88UY=1_>Z=*ZWX._M!^.&^/E]\'?B3I.E
MCQ%'I/\ ;5MJ>@E_LSPY4%'5^5?)^AH ^F**:O>AJ .2^+7Q.T7X.?#W6_&/
MB"Y6VTO2K=II"QP7;HJ+_M,Q 'N:^2?V3K[XHZ[\>6\5^+=4U!;'Q9H;:N=
MN9"8M.@=P;=$3HK!2 >YSSTJY\0'F_;2_:33X?VK^9\)/A[<I=^(9DYBU345
M(:.UW#@K&>6'UKZ7\#Z?;W?CKQ1J\4<:16_E:3;>6ORK'$N6"_\  FQCVI]
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MN"^-_P 9-!^!/P_OO%6OM(\,)6&VLK<;I[VY<XB@B7N[M@#\Z /B'XH?"_\
M:9UCQ7X=TK6_BKHFJ^*=<C_T;0K"Q\JVTV-1^]N74@AE7IG/) QWJII'[/WQ
MN^(5GJ7PTT3XK:?=^!/#<RS75Q;Z:MK%?7V2_P!G$B#<RJX#'^#H#7J;>'_&
ML&FZ:NM:FNC?%KXKW?EWMVK;VT'2T&X6EON/WEC.,@#+LQ(XKZ+T/2?#OP%\
M$VFB:1!<WI4[;>SC(ENKN4]_J>[' '4U0'S_ *)^Q5\3]3OK3Q-XI_:#\1Q>
M+TM_(,FC6T26T$?]R)&&![D@DGFK]Y^PKXIU>X:XU+]HCQ_>S$_>/DQ\>F%
MS5ZQ^,7COX2_'[73\6Y9H/ VO6,<N@OI=H]Q9:9)&QWP3.BEC*P8'<1M)7 X
MKS']H3]OK5;[Q)J7A+X66TUM#IML9]2\07ML4;E<A8(W&=H4Y,AQS@ '!HU
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%]% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>uhglogo2019a02.jpg
<TEXT>
begin 644 uhglogo2019a02.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
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M P,# P,# P,# P/_P  1" "& O@# 1$  A$! Q$!_\0!H@    8" P$
M        !P@&!00) PH" 0 + 0  !@,! 0$            &!00#!P(( 0D
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MO_;P[IK_ ,4PZ\_]_A\BO>6_L)_RI]S_ -+*3_JQ;]8I^^?_ "MMO_TKH_\
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MF"/<&=DH]P]<SQ1 @-D*W?NW*'%1-_8CRLO]3[7>\6R'>.2YIXQ6XLG6=?\
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M0+GH#R=-<W'*>VSW9)N7L82Q/$DQKD_,C)^9ZP/YNBMX.:=QAM !;K>S!0.
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M1M301CW+?LI?7%MSS%:Q$^#<P2HX\J*AD4G[&0 'B*D>9ZBKWDLH+GDJ2YD
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M_ S_ ,4P^+G_ +X_8WO CG/_ )7#=O\ I977_5]^LZ.3_P#E4MK_ .E=;?\
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MD6H?Y'KZM7O KK.;KX]_R/\ ^RA^^?\ Q,_:/_O<9SWT3V;_ )(]I_SS1?\
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M$BA5'@VYH * 5,1)H!YYZ>O^@A+^;]_WEU_[ /XP_P#VE?;?^M#[=_\ 1O\
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M_P#5].@[SA_RJ6Z?]*ZY_P"K+]?)QVWN',;1W%@=U[>K/X?G]L9K%[AP=?\
M;TM7]CF,+709+&5GVM=!4T53]M6TR/XYHY(GTV=64D'/N:&.XA>WF%8G4JPR
M*AA0BHH14'R->L$X99+>9)XC25&#*<&A!J#0U!H1YXZN$_Z"$OYOW_>77_L
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M3K+3F3_E7;__ )XI_P#JTW7RB_CA_P!E#]#?^)GZN_\ >XP?O/?>?^2/=_\
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MZM+U\Y+^<[\.*WX'_P P;LO;NSJ*HVUUMV!DH>]NBZS$%\=#AMM;NRE775&
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M>FDE."S@5)]/U5&KYLKD\1U)WLQS5^\MI?EV[:MY9BL=>+0$T ]?TV.GY*R
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MB.:=S*>!!].CGVCYNY<Y>V6YM=YND@G>ZU*"KFJ^&@KVJPX@CJ\OL#_A0O\
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MX?\ 90_0W_B9^KO_ 'N,'[SNWG_DCW?_ #S2_P#'&ZP@V?\ Y*UK_P ],?\
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MGR%-'M+MW9G8.>R]-3J6E;;NU-A9;<FZ-QN" NFAHZAM;!;7(O!EGR/SA?7
MM8-LO?%K0ZXGC4'^D\@55_VQ'4V7?.O*5E;FYGW*S\*E>V5)&/\ I50LS?[4
M'KYZO\X?^9#/_,F^4K]@;;QN5V[TEUK@WV%TMMS-"*+,R8/[Z3(9S>FX:6":
MHIJ/<6]<HRRR01.ZTM!34=,S220/-+EY[=<F#DO8OI)F5]SG;Q)F7AJI144\
M2J#%3Q8LV 0!B=[@\X'G'>_JX0R;;"NB%3QTUJSL/)G.:>2A1D@D[?7_  G3
M_E[[F^'?Q6W!W%VS@I\!W-\I*K;NZ*C;V2I1!F-F=5;>I<@>O,%DHI&EFH,U
MG7SM;F*Z&\4B15='3U$25%(X7'GWBYO@YCWY-NV]P^VV 9=0.'E8CQ&'JJZ5
M13G(8@T8=3][1\IS<O[&^X7ZE-QOBK:2,I$H/AJ?0MJ+D8P5!%5ZL3_FI_%#
M+?-3X%_(/H+:T$-1OW.;8H=T=;1330TPJ=_]?YS&;UVWB%JZEDI:+^]%3@SB
M'FE(CBBKW9BH&H [D/?X^6>:[/=IR1:(Y63SI'(I1C09.D-KH,DKT+N>-BDY
MCY7N]J@ -TR!H_\ 3QL'45X#45T5/ -U\T'XG=Z;O^#7S#ZC[OKMJ9)=S] ]
MJP5.\-AYB"?!YR6DQ=95[;[#V560UT*5&"S]3@ZG(8^\\1:BJV#21-H9#FOO
M^U6_-/+EQM:R+X%W;T20=RU(#1N*?$H8*V#D<#FO6&VQ;G<<L\P6^Y-&WC6L
M_>A[6H"5D0U^%BNI<C!XC%.OI>=)_P US^7=WSL/&[^VC\NNC-O4M9BERN2V
MOV=V1M'J_?FUA'%&V0I=S[/WOF<-E\><5.YAEJ8TFQ\K*7IZF:(I(V%&Y\@\
MX;5=M:7&WW3L&H&BC>6-O0JZ @UX@88>:@XZS)VWGKE+=+5;JWO[9%*U*R2)
M&Z^H9'((IP)RI\B1GK7=_P"%#'\WKXW=M?'6?X6?%_LK =RY3L#=FU\QW!O?
M8]8,UU[@MH;'S%)NS$;:Q>ZZ4C#;ISV<WEB\95^3&S5M'2TM!*DKB:6,),/M
M![>;UM^\#F7?('MHX8V$*.-,C.X*%BARJJA848 DL*"@/42>[//^SW^T'ES9
M)DN'ED4RNAK&J(0P4,,,S.%/:2 %-34CHM7_  EI^'N\-W_([?GS/SF%JZ+K
M+J':&X>M]E9NH@>*FW%VKO:GQU/F*;$3LP6KBVEL.HJ17V4B.3,4@O<L =>^
MO,5M;[-%RU$P-]<2+(Z^:Q)6A/IKDII^2-T3>R/+]Q<;Q+S%*I%E;QM&A_BE
M>E0/72E=7^G7K<F^;'_9&?RW_P#%8^^O_?5[K]XX\L_\K)M__/=!_P!74ZR&
MYD_Y5V__ .>*?_JTW7RB_CA_V4/T-_XF?J[_ -[C!^\]]Y_Y(]W_ ,\TO_'&
MZP8V?_DK6O\ STQ_\?7K["'OG9UT!Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZXLJNK(ZJZ.I5E8!E96%F5E
M-P5(-B#[]PZ]QP>M?WY=_P#";_X"_)?<>6WYL"#=_P 7][YFHGKLFG4+8>3K
M?)9&JE>6>NJ.L\[05.-P[%F&F#!56%HQ8DPEF+&6^7O>;FS9(5M+LQWUJHH/
M&KX@ \O$4@G[7#GY]13O_M!RMO,S75J)+*Y8U/A4\,D^?AL"!]B%!\NJSJG_
M (2)T[5$[4?\P*:"D::5J6"I^*Z551#3EV,$4]5%\C:.*IFCBL'D6&)78$A%
M!T@;+]X0T&K: 6IFEU3^7TYI^T_;T#3[!BIT[J0M<?XM7^?U _P#HZ7QK_X2
MZ?"3J;.X[<_>>_\ L[Y,5^+JEJ8=KY3['K/K6N:-F>#^,[>VO49'=^1\$@1O
M%_>*.DFTLDT$L;E/8:WKWSYGW")H-KA@LD84U"LL@^QFH@^WPZCR(.>A'L_L
MGRW82B;<Y9KUU/PFD<9^U5JY_P"<E#Y@C'6R'M/:6UMA[:P6R]D;;P6S]H;7
MQE)A-M[6VQB:#!;>P&'Q\*T]#BL-AL7!2X_&X^C@0)'##&D:*+ #W#-Q<3W<
M[W-T[R7#L69F)9F)XDDU))\R>I@@@@M85M[9%CMT4!54!54#@ !0 #T'2@]L
M].]4!_,S_A/!\4?FC\D.P/DOO#MOOC8^Z^S9\%6[IP&S<CL:7;QR6$V_BMM"
MMQ8W%LS,Y*A^^QN&@:2-IYHUGUL@5&$:RURW[P;_ ,M;+#LEM;VDMO &"LX?
M51F+4.EP#0DYH,<?7J*^8O:78N8]XEWFXN+J*>8J65"FFJJ%J-2$BH \SG]G
M5YO7VQ]O]8[!V1UKM.&HIMK=>[0VUL?;5/5U,E;5P;?VGAJ+ X:&JK)KS5=1
M%CL?&KROZI&!8\GW%MY=37UW+>W!!GFD9V(%!J<EC0>62<=29:6T5E:Q6< (
M@BC5%J:G2H"BI\\#CT^9O"XC<F&R^W=P8VBS.!S^,K\+F\/DJ>*KQV5Q&5I)
M:')8VOI)E>&JHJZCG>*6-P5>-R""#[:BEDAD6:%BLJ,&4C!!!J"#Y$'(Z=EC
MCFC:&50T3J0P.0010@CS!&#UK';G_P"$IOP<R^X<SE-O]V?)7:6%R&0J:S&[
M8ILQUYF*3 4M1(98\31Y/,;"J,O6T5%J\<+U4L]3X@OEEE<-(TWP>_7-$<*Q
MS6ME)*  6(D!8^I DH"?.@ KP &.H7F]C>69)6>*YO(XR:A08R%'H"4J0/*I
M)IQ).>K7/Y;?\K[H_P#ED;-[)VKT]NSL7?%7VMN+"9_=>X>QLA@JBMT[:Q];
MC\#BL71;<P6 QM%04*Y2KE9FCEJ)I:EM<A1(HXP#SISSNG.]S#<;C'#$MNC*
MBQA@.X@L269B2: <0 !PK4D=<G\E;;R7;S0;?)-*T[AF:0K7M!"@!54 "I/F
M23QI0"RCV"^ACUK'[]_X2R?"C>N^]W;RI.[?D=M:BW7N?,[D7:^(R/6]3C<$
MN:R,^2DP^*J\GL"KKVQ]"]2T5.:AYIEB50[R,"S3=:>^W,UM:1VS6ME(T:!=
M1$@+:12I D J:5-*"O #J&+KV0Y;N;J2X6YO$61RVD&.BU-: E":#@*U-.->
MMC'J?K3:_2_5G6O3NR(:RGV7U/L#9O6FT(,A5&NKX-K[$V[CMKX"&NK2D9K*
MR/$XJ%992J^1P6L+V]PYN%[/N5_/N-U0W-Q,\CT%!J=BS4'D*DT'4NV-G!MU
MC#M]M46T$21I4U.E%"K4^9H!GI?^TG2KJL7^95_*LZ)_F>8/J?&]P[N['V-E
M.FLGN^MVAG^NJ[ 05+46^Z;;L&Y\3E:+<F!SU#5TU;+M+&S1R(D4T+TU@Q61
MU(XY*Y\W7D>6X?;HX98[E4#K(&I5"VD@JRD$:V'F#7Y#H%\X\C[7SI% FX23
M1/;LY1HRM:.%U AE8$'2I\B*?/I"_P MO^3=\=?Y9N[^Q]_]5[V[1["WAV1M
MO&[/J\KV-6[9:/![:H<FN:JL?AJ+;&W<!#KR^4IZ:2HEJ#.P%)$L7C!D\BKG
M3W'WGG:WAM+^*"&WA<N!&&[F(T@DLS<!4 "G$UKBB7D_V\VCDRXFNK&2>6XF
M0(3(5[5!J0 JKQ-*DUX"E,UMT]Q[T/ND[N_:^+WOM+=&R\W]P<+N_;N;VOEQ
M23"GJSB\_C:G%5_VLY2005'VE6^A]+:6L;&UO;UO/):W$=S%3Q8W5A7A52"*
M_F.F;B!+F![:2OAR(5-.-&!!I^1ZUA)?^$GOPP,DAA^1?R>CA+N8DEJNJ99$
MC+'0DDJ]<PK*ZK8%@B!CSI'T]S@/?WF6F;.QK]DO_6SJ%C[%<NUQ>7M/MB_Z
MU]8_^@3SX:_]Y'?)O_J=U7_]K[WO_7]YD_Y0['_JK_ULZ]_K%<N_\IE[_P!4
MO^M?7O\ H$\^&O\ WD=\F_\ J=U7_P#:^]^_U_>9/^4.Q_ZJ_P#6SKW^L5R[
M_P IE[_U2_ZU]6Y?RV/Y772G\L?:G:&VNH=Z=D[ZF[:S^WLYN;+]C5FW9IX%
MVK09*@PN/Q-)MO;^ I*:GA&9JI)7D$TLKR@:@J*/<?<Z<];GSO<03[C%#$+=
M&51&&_$06)+,Q/ 4X 4^?0]Y.Y)VWDN">';Y)I3.ZLQD*_A!  "JH'$UXDUZ
M!O\ F/?R4/CE_,K[7V1W-VCV)VYU]O39G7L/6(DZ]K]K?PS,[7Q^Y,_NK#)6
MT&YMM9T4]?C,MNS)GS0/'YHZA5<'Q(?9CR9[F;SR582[;8PV\UM+-XOZ@:H8
MJJFA5EP0BX/"F.)Z+N;_ &WVCG*^BW&]FN(KF.'P_P!,K0J&9A4,K9!9LCC7
M/#JO'_H$\^&O_>1WR;_ZG=5__:^]C#_7]YD_Y0['_JK_ -;.@G_K%<N_\IE[
M_P!4O^M?7O\ H$\^&O\ WD=\F_\ J=U7_P#:^]^_U_>9/^4.Q_ZJ_P#6SKW^
ML5R[_P IE[_U2_ZU]6$_%#^0I_+A^)>X:#>N$ZMS7<^_,//#4X3=_P @\W0=
M@S86J@D,T5;C=IX_![8ZXBR<$XCDAK&PCUE+)$K02Q-J+!#?_=?G/F"$VTLZ
MVUJPHR6ZF/4/0N6:2GJ-=#7(/0KV+VNY0V&87,4#7-TIJKSD2:3ZA0JQU]#H
MJ*8(ZN8]QOU(G7O?NO=:TO;G_"7KX5=I]J;_ .S(>Y?D7LV+?^\,[O.IVGA,
MKU[78G!UFY,E/E\GCL-6YO8E?EOX9'7U<OVPJI:F:*$JCR2LI=IJV_WRYFL+
M"&R-M9R&&-4#L) 6"B@)"R 5H!6@ )X <.H;O_93ER^OI;T7%Y&)9&<JIC(4
ML:D E":5)I4D@<2>/6PATSU-L[H;J3K/I3KVEJJ+8W4^Q=K=>;3IZZI%;D%P
M&T<-1X/&R9.M$</WV3J*:B62IG**9YV=R 6]Q%N6X7.Z[A/N=X0;JXE:1Z"@
MU.Q8T'D*G \ACJ6-NL+?:["';;0$6T$2QK7)TH HJ?,T&3YG/0E>T72SJO+^
M8S_+:Z4_F6]7;/ZS[BW#OK9YV#O [SVKNKKZOQ-+F:&LJ,94X?*8ZJI<_B<W
MB*[&92BG4N&@$T<L$;1R*!(D@PY-YTW/DJ^DO=N2*3Q8]#K("5(!J""I4@@_
M.E":CA0)<W\G;;SE91V6X/+'X4FM6C(!!I0@A@P((^5:@4/&I>_Y</\ )0^.
M'\M3M7>W<O5W87;W8.]]Y]?5'63S=AY#:O\ "L/M7([CV]NK+QT.-VSMC!>?
M(9'+[2QQ,\\DOBCIRL:KY')-^<_<S>>=;"+;;Z&WAM8IO%_3#5+!645+,V '
M; I4G/ =%7*'MQL_)M])N-C-<2W,D7A_J%:!2RL:!57)*KDUI3'$]7(^XXZD
M+K5NRW_"47X3UN5R=9C.^_DQA<;5Y"MJ<?AX\AUI71XFAGJ9):3&1UM;L!ZR
ML2@@=8A+*QED":F)8GW.D?OWS,L:J]I8LX !-)!4TR:"2@KQH,=0E)[%\ML[
M,EU>JA)(%8S0>0J8ZFG"IZ;_ /H$\^&O_>1WR;_ZG=5__:^]W_U_>9/^4.Q_
MZJ_];.J_ZQ7+O_*9>_\ 5+_K7U[_ *!//AK_ -Y'?)O_ *G=5_\ VOO?O]?W
MF3_E#L?^JO\ ULZ]_K%<N_\ *9>_]4O^M?5H_P#+4_E&]$?RQ:WMG+=2=@=J
M;_R_;]+M+'9ZJ[&K-JR4V,QVS9<[4XV##4>V=LX#1/55.XIVJ)9Y)]2I$L:Q
MZ7,@%YU]P=UYX6WCW"&"&.W+E1&&R7T@U+,W ** 4\ZUQ0;<G<A;7R6T\EA+
M/+)<!0QD*X":J4"JO$L:UKY4IYA=_,0_D;_&[^8UW5A>]^R^T.Z]A;RQ6Q<7
MU_44NQLQMFIP%?AL'D\OE,5-'CMV[;W ^(JH9L[4B5:.2&FF+"0Q"9I9)5W)
M_NCO7)NV-M5E!:RVS2F2KA@P+  Y1EJ.T4J"1PK2@"'FWVSV?F_<EW2\GN8K
MA8A'1"NDA22,,K4/<>% >-*U)L9^(WQ6ZJ^%7Q]Z_P#C=TS3Y=-B=?4N46CK
M]QU=+D=SY[*9[-9#<.=W!N3)45!C*:NR^5R^4FD8QT\,,,>B&&..&*.-0=S#
MOU_S-N\V];D5^KF(J%!"J%4*JJ"20  .)))J2223T+]@V.QY<VJ+9]N#?2Q
MT+$%F+$LS,0 "22?( "@   '1DO9+T<= %\HOC9UC\ONA.R/CCW'1Y*LZ\[/
MP]-BLXV$JZ?'YW'3XW*X_/X/.X&OJZ+)4E'F]OY_$TM;2234]1")X%\D4B:D
M8VV+>K[EW=H=YVTJ+R!B5U"JFH*LK $$JRDJ:$&AP0<]%6][/9;_ +7-M&X
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M%O$ =U':X[9$_P!*XS3STFJDY(/6N#VC_P ))=FUF3J*OI;YG[GV]AVF;[3
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+WOW7NO>_=>Z__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>uhglogo2019a021.jpg
<TEXT>
begin 644 uhglogo2019a021.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
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M P,# P,# P,# P/_P  1" "& O@# 1$  A$! Q$!_\0!H@    8" P$
M        !P@&!00) PH" 0 + 0  !@,! 0$            &!00#!P(( 0D
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MO_;P[IK_ ,4PZ\_]_A\BO>6_L)_RI]S_ -+*3_JQ;]8I^^?_ "MMO_TKH_\
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MF"/<&=DH]P]<SQ1 @-D*W?NW*'%1-_8CRLO]3[7>\6R'>.2YIXQ6XLG6=?\
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M0+GH#R=-<W'*>VSW9)N7L82Q/$DQKD_,C)^9ZP/YNBMX.:=QAM !;K>S!0.
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M1M301CW+?LI?7%MSS%:Q$^#<P2HX\J*AD4G[&0 'B*D>9ZBKWDLH+GDJ2YD
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M_ S_ ,4P^+G_ +X_8WO CG/_ )7#=O\ I977_5]^LZ.3_P#E4MK_ .E=;?\
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MD6H?Y'KZM7O KK.;KX]_R/\ ^RA^^?\ Q,_:/_O<9SWT3V;_ )(]I_SS1?\
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M$BA5'@VYH * 5,1)H!YYZ>O^@A+^;]_WEU_[ /XP_P#VE?;?^M#[=_\ 1O\
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M_P#5].@[SA_RJ6Z?]*ZY_P"K+]?)QVWN',;1W%@=U[>K/X?G]L9K%[AP=?\
M;TM7]CF,+709+&5GVM=!4T53]M6TR/XYHY(GTV=64D'/N:&.XA>WF%8G4JPR
M*AA0BHH14'R->L$X99+>9)XC25&#*<&A!J#0U!H1YXZN$_Z"$OYOW_>77_L
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M3K+3F3_E7;__ )XI_P#JTW7RB_CA_P!E#]#?^)GZN_\ >XP?O/?>?^2/=_\
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MZM+U\Y+^<[\.*WX'_P P;LO;NSJ*HVUUMV!DH>]NBZS$%\=#AMM;NRE775&
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M>FDE."S@5)]/U5&KYLKD\1U)WLQS5^\MI?EV[:MY9BL=>+0$T ]?TV.GY*R
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MB.:=S*>!!].CGVCYNY<Y>V6YM=YND@G>ZU*"KFJ^&@KVJPX@CJ\OL#_A0O\
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MX?\ 90_0W_B9^KO_ 'N,'[SNWG_DCW?_ #S2_P#'&ZP@V?\ Y*UK_P ],?\
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MGR%-'M+MW9G8.>R]-3J6E;;NU-A9;<FZ-QN" NFAHZAM;!;7(O!EGR/SA?7
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MOU_S-N\V];D5^KF(J%!"J%4*JJ"20  .)))J2223T+]@V.QY<VJ+9]N#?2Q
MT+$%F+$LS,0 "22?( "@   '1DO9+T<= %\HOC9UC\ONA.R/CCW'1Y*LZ\[/
MP]-BLXV$JZ?'YW'3XW*X_/X/.X&OJZ+)4E'F]OY_$TM;2234]1")X%\D4B:D
M8VV+>K[EW=H=YVTJ+R!B5U"JFH*LK $$JRDJ:$&AP0<]%6][/9;_ +7-M&X
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M%O$ =U':X[9$_P!*XS3STFJDY(/6N#VC_P ))=FUF3J*OI;YG[GV]AVF;[3
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+WOW7NO>_=>Z__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>uhglogo2019a021a.jpg
<TEXT>
begin 644 uhglogo2019a021a.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
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M P,# P,# P,# P/_P  1" "& O@# 1$  A$! Q$!_\0!H@    8" P$
M        !P@&!00) PH" 0 + 0  !@,! 0$            &!00#!P(( 0D
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MO_;P[IK_ ,4PZ\_]_A\BO>6_L)_RI]S_ -+*3_JQ;]8I^^?_ "MMO_TKH_\
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MF"/<&=DH]P]<SQ1 @-D*W?NW*'%1-_8CRLO]3[7>\6R'>.2YIXQ6XLG6=?\
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M0+GH#R=-<W'*>VSW9)N7L82Q/$DQKD_,C)^9ZP/YNBMX.:=QAM !;K>S!0.
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M1M301CW+?LI?7%MSS%:Q$^#<P2HX\J*AD4G[&0 'B*D>9ZBKWDLH+GDJ2YD
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M_ S_ ,4P^+G_ +X_8WO CG/_ )7#=O\ I977_5]^LZ.3_P#E4MK_ .E=;?\
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MD6H?Y'KZM7O KK.;KX]_R/\ ^RA^^?\ Q,_:/_O<9SWT3V;_ )(]I_SS1?\
M'%ZY_;Q_R5KK_GID_P"/MU:;TE_PG[_F)_('J+KCN[KK;75%3L3M79^#WSM*
MHRW:.+Q>3FP&X:&+(8V2NQTM$\E%5-33*7C8DH>/8$W/W;Y.VC<)MLO'N!=0
M2,CTB)&I30T-<BOGT-]M]J>;MUL(=RM$@-K/&KK60 Z6%144P>A1_P"@9S^:
M/_SRG3'_ *.##_\ U![0_P"O9R+_ +\N?^<)_P _2W_6:YV_WW;?\Y1_FZ(Y
M\X?Y4_RX_EZ[5V-O+Y'8?8N,PG8>X,CMG;<FTM[46ZJB7*8O'+E:M*NGI::!
MJ2$4C JY)#-Q[%'*_/O+W-\\MMLS2M+"@9M:%<$T%*\<]!KF7D;?N4X(KC>%
MB6.9RJZ7#9 J:TX8ZM+_ .$I7_;P[N7_ ,4P[#_]_A\=?8$]^_\ E3[;_I91
M_P#5BXZ&WL9_RMMQ_P!*Z3_J];]?0*]XD=96=?&(]])>N=O5PFV_Y^/\V;:.
MW<!M3;WRO_A^ VQA<7M[!T'^@KXUU?V.'PM#!C<91_=5W3E36U/VU%3(GDFD
MDE?3=V9B28ZF]I^0+B9[B:PK,[%F/CW(J6-2:"8 5)\A3J0(?=+GNWA2"&^I
M$BA5'@VYH * 5,1)H!YYZ>O^@A+^;]_WEU_[ /XP_P#VE?;?^M#[=_\ 1O\
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M_P#5].@[SA_RJ6Z?]*ZY_P"K+]?)QVWN',;1W%@=U[>K/X?G]L9K%[AP=?\
M;TM7]CF,+709+&5GVM=!4T53]M6TR/XYHY(GTV=64D'/N:&.XA>WF%8G4JPR
M*AA0BHH14'R->L$X99+>9)XC25&#*<&A!J#0U!H1YXZN$_Z"$OYOW_>77_L
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M3K+3F3_E7;__ )XI_P#JTW7RB_CA_P!E#]#?^)GZN_\ >XP?O/?>?^2/=_\
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MZM+U\Y+^<[\.*WX'_P P;LO;NSJ*HVUUMV!DH>]NBZS$%\=#AMM;NRE775&
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M>FDE."S@5)]/U5&KYLKD\1U)WLQS5^\MI?EV[:MY9BL=>+0$T ]?TV.GY*R
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MB.:=S*>!!].CGVCYNY<Y>V6YM=YND@G>ZU*"KFJ^&@KVJPX@CJ\OL#_A0O\
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MX?\ 90_0W_B9^KO_ 'N,'[SNWG_DCW?_ #S2_P#'&ZP@V?\ Y*UK_P ],?\
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MGR%-'M+MW9G8.>R]-3J6E;;NU-A9;<FZ-QN" NFAHZAM;!;7(O!EGR/SA?7
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MOU_S-N\V];D5^KF(J%!"J%4*JJ"20  .)))J2223T+]@V.QY<VJ+9]N#?2Q
MT+$%F+$LS,0 "22?( "@   '1DO9+T<= %\HOC9UC\ONA.R/CCW'1Y*LZ\[/
MP]-BLXV$JZ?'YW'3XW*X_/X/.X&OJZ+)4E'F]OY_$TM;2234]1")X%\D4B:D
M8VV+>K[EW=H=YVTJ+R!B5U"JFH*LK $$JRDJ:$&AP0<]%6][/9;_ +7-M&X
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M%O$ =U':X[9$_P!*XS3STFJDY(/6N#VC_P ))=FUF3J*OI;YG[GV]AVF;[3
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+WOW7NO>_=>Z__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>uhglogo2019a022.jpg
<TEXT>
begin 644 uhglogo2019a022.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
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M P,# P,# P,# P/_P  1" "& O@# 1$  A$! Q$!_\0!H@    8" P$
M        !P@&!00) PH" 0 + 0  !@,! 0$            &!00#!P(( 0D
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MO_;P[IK_ ,4PZ\_]_A\BO>6_L)_RI]S_ -+*3_JQ;]8I^^?_ "MMO_TKH_\
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MF"/<&=DH]P]<SQ1 @-D*W?NW*'%1-_8CRLO]3[7>\6R'>.2YIXQ6XLG6=?\
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M0+GH#R=-<W'*>VSW9)N7L82Q/$DQKD_,C)^9ZP/YNBMX.:=QAM !;K>S!0.
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M1M301CW+?LI?7%MSS%:Q$^#<P2HX\J*AD4G[&0 'B*D>9ZBKWDLH+GDJ2YD
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M_ S_ ,4P^+G_ +X_8WO CG/_ )7#=O\ I977_5]^LZ.3_P#E4MK_ .E=;?\
M5E.CG^PUT(NM,/\ X5W?]T^/_+L/_G:O>2?W>O\ EK_]0O\ VL]8[>_G_+)_
MZBO^U?HLG_"3S_LLSY&_^*QS_P#OU.O/9W[^_P#*MV?_ #W?]8I.B7V*_P"5
MBO/^>+_K+'UOK^\4>LH^@7^2'_9._?7_ (A?M+_WA\[[,]E_Y+%I_P ],7_'
MUZ+MX_Y)-U_SS2_\<;KX^'OHEUS^ZN>_Z"$OYOW_ 'EU_P"P#^,/_P!I7W&W
M^M#[=_\ 1O\ ^J]S_P!;NI$_UV.?_P#E/_ZH6W_6GKM?^%"?\WU65C\N X!!
M*-T'\8PK &Y5BG2ZO9OH;$'^A]Z_UH?;O_HW_P#5>Y_ZW=>_UV.?_P#E/_ZH
M6W_6GKZ(OPW[)[$[C^)WQN[8[<PT6W^SNR.D^MM[;[Q$&,J,+#2;GW)M/%Y;
M+>'#5;R56'BJ*JJ:5:21F>F#^,FZ^\/N8[*SVW?[W;]O;78PW4B(:ZJJKD#(
MP<"E?/CUEMR]>7>X;%9W]^NB]FMHW<4I1F4$X.1DUIY<.M(C_A5K_P!O#NFO
M_%,.O/\ W^'R*]Y.^PG_ "I]S_TLI/\ JQ;]8U^^?_*VV_\ TKH_^KUQU;3_
M ,)//^R-?D=_XLW-_P"^KZ^]Q_[^_P#*R6?_ #P_]99.A[[%?\J[>?\ /;_U
MBCZVH?<$=3?U5!_/)P5-N+^5'\R\?5M2)%3[ VSG4-:H:$U.U^S=C[FHE0,0
M!5O68B-:<_43E".1['WM=*T//VVNM:F9EQZ-$ZG\J'/RKT!?<R)9N1=Q1J4$
M2MGU61&'YU&/G3KY^G\I>OJ\=_,P^#M113-!-)\D>LZ!W548M293/4^,KX;.
MK+IJ:"LDC)M<!K@@V(RW]P$5^2=T#"H^BD/YA:C]A ZQ3Y#9DYRVPJ:'ZR,?
MD6H?Y'KZM7O KK.;KX]_R/\ ^RA^^?\ Q,_:/_O<9SWT3V;_ )(]I_SS1?\
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M$BA5'@VYH * 5,1)H!YYZ>O^@A+^;]_WEU_[ /XP_P#VE?;?^M#[=_\ 1O\
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M_P#5].@[SA_RJ6Z?]*ZY_P"K+]?)QVWN',;1W%@=U[>K/X?G]L9K%[AP=?\
M;TM7]CF,+709+&5GVM=!4T53]M6TR/XYHY(GTV=64D'/N:&.XA>WF%8G4JPR
M*AA0BHH14'R->L$X99+>9)XC25&#*<&A!J#0U!H1YXZN$_Z"$OYOW_>77_L
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M3K+3F3_E7;__ )XI_P#JTW7RB_CA_P!E#]#?^)GZN_\ >XP?O/?>?^2/=_\
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MZM+U\Y+^<[\.*WX'_P P;LO;NSJ*HVUUMV!DH>]NBZS$%\=#AMM;NRE775&
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M>FDE."S@5)]/U5&KYLKD\1U)WLQS5^\MI?EV[:MY9BL=>+0$T ]?TV.GY*R
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MB.:=S*>!!].CGVCYNY<Y>V6YM=YND@G>ZU*"KFJ^&@KVJPX@CJ\OL#_A0O\
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MX?\ 90_0W_B9^KO_ 'N,'[SNWG_DCW?_ #S2_P#'&ZP@V?\ Y*UK_P ],?\
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MGR%-'M+MW9G8.>R]-3J6E;;NU-A9;<FZ-QN" NFAHZAM;!;7(O!EGR/SA?7
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MOU_S-N\V];D5^KF(J%!"J%4*JJ"20  .)))J2223T+]@V.QY<VJ+9]N#?2Q
MT+$%F+$LS,0 "22?( "@   '1DO9+T<= %\HOC9UC\ONA.R/CCW'1Y*LZ\[/
MP]-BLXV$JZ?'YW'3XW*X_/X/.X&OJZ+)4E'F]OY_$TM;2234]1")X%\D4B:D
M8VV+>K[EW=H=YVTJ+R!B5U"JFH*LK $$JRDJ:$&AP0<]%6][/9;_ +7-M&X
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M%O$ =U':X[9$_P!*XS3STFJDY(/6N#VC_P ))=FUF3J*OI;YG[GV]AVF;[3
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+WOW7NO>_=>Z__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>uhglogo2019a022a.jpg
<TEXT>
begin 644 uhglogo2019a022a.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
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M P,# P,# P,# P/_P  1" "& O@# 1$  A$! Q$!_\0!H@    8" P$
M        !P@&!00) PH" 0 + 0  !@,! 0$            &!00#!P(( 0D
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MO_;P[IK_ ,4PZ\_]_A\BO>6_L)_RI]S_ -+*3_JQ;]8I^^?_ "MMO_TKH_\
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MF"/<&=DH]P]<SQ1 @-D*W?NW*'%1-_8CRLO]3[7>\6R'>.2YIXQ6XLG6=?\
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M0+GH#R=-<W'*>VSW9)N7L82Q/$DQKD_,C)^9ZP/YNBMX.:=QAM !;K>S!0.
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M1M301CW+?LI?7%MSS%:Q$^#<P2HX\J*AD4G[&0 'B*D>9ZBKWDLH+GDJ2YD
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M_ S_ ,4P^+G_ +X_8WO CG/_ )7#=O\ I977_5]^LZ.3_P#E4MK_ .E=;?\
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MD6H?Y'KZM7O KK.;KX]_R/\ ^RA^^?\ Q,_:/_O<9SWT3V;_ )(]I_SS1?\
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M$BA5'@VYH * 5,1)H!YYZ>O^@A+^;]_WEU_[ /XP_P#VE?;?^M#[=_\ 1O\
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M_P#5].@[SA_RJ6Z?]*ZY_P"K+]?)QVWN',;1W%@=U[>K/X?G]L9K%[AP=?\
M;TM7]CF,+709+&5GVM=!4T53]M6TR/XYHY(GTV=64D'/N:&.XA>WF%8G4JPR
M*AA0BHH14'R->L$X99+>9)XC25&#*<&A!J#0U!H1YXZN$_Z"$OYOW_>77_L
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M3K+3F3_E7;__ )XI_P#JTW7RB_CA_P!E#]#?^)GZN_\ >XP?O/?>?^2/=_\
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MZM+U\Y+^<[\.*WX'_P P;LO;NSJ*HVUUMV!DH>]NBZS$%\=#AMM;NRE775&
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M>FDE."S@5)]/U5&KYLKD\1U)WLQS5^\MI?EV[:MY9BL=>+0$T ]?TV.GY*R
M<.MHSW!G4V=?'?[XZYK>GN\.Y.I<C2/05_5_:G8/7M912>7725.S-V9;;LU.
MWGFJ9CXGQQ%VDD8@7+-]3T6VJ\7<=KMMP0U2>".0'U#H&^7KZ=<^]TLVV_<[
MBP<4>">2,CTT,5_R=?52_ES[\H.S/@-\,]ZXZ=:A,O\ &7I:*N99S5>'.8C8
M&"PFXZ)ZEO7/+CMP8VIIW=@&9XB2 ;@8&\XVKV7-FY6SBA6^FIY=ID9E-/FI
M!_/K.+E&Z2]Y6VZY0U#64-?/N"*K#\F!'1SO8;Z$76J'_P *R^PJ+&_%CXN=
M4R5<29+>G?\ FNPJ2@(3S5-%UCUUF]MY"KC)0R"*BG[<ID>S!;U"W!-B)\]@
M+-GWV^OP.R*T6,GT,LBL!^?A']G4%^^]VJ;'8V)/?)=F0#Y1QLI/Y>*/V]5%
M_P#"7#K[)[H_F+;GWI#'*F'ZQ^.V_P#+Y&K%Q3FOW+N'9>T<5BW80RWJ*R#+
M5=1&I,8*44AU>G0\A>^EXD')R6Q_M)[R, ?)5=R?RH!Y\1]H /LE://S<]R/
M[.&T<D_-F1 /SJ3^1ZV*O^%,G_;KG=7_ (FCI_\ ]V^0]P[[)_\ *]1_\\TW
M^ =2Y[R_\J3)_P ],7^$]:E'_"?&2.+^;[\1&ED2-2_?$8:1U13)-\9>YX88
MP6(!>66154?5F( Y/O(#W=!/MYN-/^$?]I,/4#^U! Y_V^O_  __ +1INOIN
M^\(^LSNJCOY[U33TO\IGYCRU4\--$VTM@4RR3RI"C5%9W)UQ1T<"O(RJ9JJK
MG2*-/U/(ZJH+$#W(/M4I;G_;0H)/B2']D,A/[!D] +W/(7D3<"Q 'AI_.6,#
M]IQUI,?\)[%9OYOOQ'*J2$'?C.0"0JGXQ]T(&8C](UL!<_D@>\FO=[_IW>X?
M\V/^TF'K&[VG_P"5_L/^;_\ VC3=?0\^;'_9&?RW_P#%8^^O_?5[K]X@<L_\
MK)M__/=!_P!74ZRTYD_Y5V__ .>*?_JTW7RB_CA_V4/T-_XF?J[_ -[C!^\]
M]Y_Y(]W_ ,\TO_'&ZP8V?_DK6O\ STQ_\?7KZ7/RU_DM_P OKYH]EY7N7N+J
M;+TW:FX(,;!N3>VP][[FV=7[D7$45+C,=/G,70UTNVZ_(4^,HXJ;[MJ$5;P1
MHCR,$33A3R_[E<W<M62[;MUPIL$)TI(BN%J23I)&H"I)IJI4F@R>LR-^]N>5
M.8[QMQW"!A?.!J='9"U  -0!TDT %:5H!G Z"'JO_A//_*NZMW!3[E?H?+]D
MU]%/'44%)VIV'O#=6WZ:6,C_ ($;6@R>)VWG(' (:')4M;";_H^EC"_]W^?+
M^$PB[6!"*$Q1HC'_ &U"R_:I4](+'VFY'L91-]*TS X$LCLH_P!K4*WV,".K
MGL!@,#M3"8G;.U\)B-M[;P&/I,1@MOX#&T>'PF%Q5!"E-0XS$XK'0T]!CL?1
M4\:QQ0PQI'&BA5   ]QM+-+<2M/.S/,Y)9F)+,3DDDY))XDY/4B11101+# J
MI"@ 55 "@#@ !@ >0'3O[;Z<Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>ZU:?^%-_P%WMW_P!+]=?+7J;;]7N3=/QOH-R8;M' XBCJ
M*[-9#I_.ST>7&YZ2FIHIIZFGZUS='45%7&B_MX[*554Y$=*WN=?9'FRVVG<I
MN7]P<)!>E3$Q-%$RU&DD\/$4@#^DJJ,MU"/O/RM<[KMT._6"%Y[,,)% J3$U
M#J '^^R"3_19F.%ZUP/Y*?\ -+H_Y:'>V[Y^P\)F]S= =V8K!X/L^AVS%!5;
MEVYEMKU.2GV=OO!8^LK*&DRK809VOIJVC,T+ST=:\D;--!%%),WN9R(W.VU1
MBS94W:U9FB+85@P&M&(!(U:5*FAH5H<$D1![<<[KR;N<ANU9]JN559 N64J3
MH=02 =.I@145!J,@ [P."_G=?RK-P8*DW!2?,OK6BI*NE-4M%G<?O7;^=@55
M+/#5[>S6UJ'-TU4A!'C:#4Y_3J!!.,$OMCSY#*86VV<L#2JE&7\F5BI'Y]9*
MQ>Y/(\L0E7<80I%:,'5OS4J#7\NM:'^?#_.^Z;^6O5*?#_XBU^5W=UIF-Q83
M<?;O;>0PV:VQB]TIM3(19C;FR=GX/<%)C,]5XJ'<E+3Y&NKZVDI5:>@ITI5E
MC9Y?<U^U7MAN7+]__6+F$+'>JC+#$"K%=8HSNRDJ#I)554G#'50T'4->Z'N5
MMV_6/]7]@+26;.K2RD%0VDU5$5@&(U ,S$#*C345/7+_ (2^_ K=V[^],S\]
M=[[?JL;UEU/A=T;(Z;R5?"U/_?#M+=6/EVUNK,X(.=5;@MD;*R.0H*J?QB"3
M(Y:..&5I:*KCB][Y<UV]OM2\J6KAKZX97F _!$IU*&]&=PK <0J$D492?>RO
M*UQ<;FW--RA%E K)"3^.5AI8KZJB%E)X:F !JK ;V'O%CK)WKY>7\]7_ +>Q
M?,G_ ,/39?\ [Z7K[WG+[6?\J!MO_-)_^KLG6%/N=_RO>X_\U$_ZM1]?1Q^$
M_P#V1G\2/_%8^A?_ 'U>U/>&W,W_ "LFX?\ /=/_ -77ZR\Y;_Y5VP_YXH/^
MK2]4[_\ "DKX4_[,A\(I.^-J8EJSL[XDU>1W^&I::*2LR?4&7BI*7M;'226C
MD6GV]24-'N)G9V6&FP]2JH6FN)%]E^9OW+S/^ZKAJ6.X 1Y.!,*F(_[8DQ_,
MNN<=1][P\M_OCEK]Z0+6]L"9,<3$:"4?[4 2?((V,]?/K7LW> ZMFZ;?)M-L
M!]_TW9M-AI@[KC=X1;=J]JUN3QQ$BQP-FL+-3Q5ET8R_P^EL5$9#Y<_0VWUP
MW(+2[\$Q$^J:@P!_TK5(]-3>O6*7UMQ]"=N+5M?%$E/1])4D?:* ^NE?3K<O
M_P"$C_\ S+SYO_\ AY]%_P#NC[/]XW?>"_W,VO\ YI3_ /'HNLA_87_<3<O^
M:D/_ !V3K<)]X[=9 ]?&[['_ .9A[\_\//='_N\KO?1RR_W#B_YI+_QT=<];
MS_<N7_FHW_'CU]77^7!_V[Q^!G_BF'Q<_P#?'[&]X$<Y_P#*X;M_TLKK_J^_
M6=')_P#RJ6U_]*ZV_P"K*='/]AKH1=:8?_"N[_NGQ_Y=A_\ .U>\D_N]?\M?
M_J%_[6>L=O?S_ED_]17_ &K]%D_X2>?]EF?(W_Q6.?\ ]^IUY[._?W_E6[/_
M )[O^L4G1+[%?\K%>?\ /%_UECZWU_>*/64?0+_)#_LG?OK_ ,0OVE_[P^=]
MF>R_\EBT_P">F+_CZ]%V\?\ ))NO^>:7_CC=?'P]]$NN?W7T/?\ H*-_EJ_\
MZ'Y.?^BNVE_]L[WA_P#ZQ?.O\=C_ ,Y7_P"M766G^O9R=_#>_P#.)?\ K9U[
M_H*-_EJ_\Z'Y.?\ HKMI?_;.]^_UB^=?X['_ )RO_P!:NO?Z]G)W\-[_ ,XE
M_P"MG5HWP+_F/?&S^8WL[?&\?CO6;R2+KG/X[;^[\#OW;<>V]P8J?-4517X2
MN\%'D\WC*K&Y>&BJ1#)#5NX>FD61$(74!>:^3-ZY-N8K;>!'69"R-&VI3I-&
M&0I!%16H\Q2O0UY6YOV?F^WEN-H,E(7"NKKI85%0<$@@T-*'R-:=:=/_  JU
M_P"WAW37_BF'7G_O\/D5[R,]A/\ E3[G_I92?]6+?K'SWS_Y6VW_ .E='_U>
MN.C)?\)U_P"8O\+/AM\8>[]B_)CO? ]4[KW1WS+NS X?+;?WMEYLCMYNOMF8
M<9..?;&V,Y211')8R>+1)(DEXR=.D@DE]XN3N9>9-\M;K9+1[BWCM-#$,@HW
MB.:=S*>!!].CGVCYNY<Y>V6YM=YND@G>ZU*"KFJ^&@KVJPX@CJ\OL#_A0O\
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MX?\ 90_0W_B9^KO_ 'N,'[SNWG_DCW?_ #S2_P#'&ZP@V?\ Y*UK_P ],?\
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MGR%-'M+MW9G8.>R]-3J6E;;NU-A9;<FZ-QN" NFAHZAM;!;7(O!EGR/SA?7
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MOU_S-N\V];D5^KF(J%!"J%4*JJ"20  .)))J2223T+]@V.QY<VJ+9]N#?2Q
MT+$%F+$LS,0 "22?( "@   '1DO9+T<= %\HOC9UC\ONA.R/CCW'1Y*LZ\[/
MP]-BLXV$JZ?'YW'3XW*X_/X/.X&OJZ+)4E'F]OY_$TM;2234]1")X%\D4B:D
M8VV+>K[EW=H=YVTJ+R!B5U"JFH*LK $$JRDJ:$&AP0<]%6][/9;_ +7-M&X
MFTG6C4-&%"&5E)! 96 (J"*C((QU27\:_P#A-1\/_C=WWU+W[C>X_D'O;-].
M[YP'8NV]N;ARVR,;@:S=.U*Z+,;:GR\VVMG8G,U%#C,Y2P53TT=3%'5>$0S:
MX'DC>3=Z]ZN8MZVFXVE[:SBBN8FC9E#E@KBC4U.14J2*T-*U%" 1&^S>SG+^
MS[I!NJ7%W)+;RK(JL4"EE-5KI0&@8 TJ*TH<$CJ\GY%=$;(^3W1?:GQ][';+
MQ;)[<V7F=E;@JMOUD6/SV.I<M3F.++82LJ:6NHX,OB*M8ZJF,]/44YFA430R
MQ%XVB[9MUNMCW2#=[+3]5;RAU#"JDCR85!H14&A!H<$'/4F;OM=MO6V3[5>:
MOIKB,HQ4T8 ^8-"*@Y%0149!&.M<;_H$\^&O_>1WR;_ZG=5__:^]S+_K^\R?
M\H=C_P!5?^MG40_ZQ7+O_*9>_P#5+_K7U[_H$\^&O_>1WR;_ .IW5?\ ]K[W
M[_7]YD_Y0['_ *J_];.O?ZQ7+O\ RF7O_5+_ *U]+KK#_A+C\,^M>R-A=B'O
M+Y';E;8>\-N;QAV_DLAUS18W,U.VLO29FEQN2JL7L2FR4./JZFB1)S3RPSF(
ML(Y(V(=4M][Z<R7ME+9_2V2>+&R:@)"0&!!(!D(J <5!%>(/#I39>R?+MG>1
M7?U-X_A2*^DF, Z2" 2$!H:9H0:<".MF?W"74S=4K_S$OY'/QL_F.=T8#O;L
MGLCN'KS>>'V%B^O*N'KZOVFV&S.)PF7S>7Q-;4T>Z-L9Z:DR=.^X*B%V@ECA
MEB6.\8=7>22^3_=#>N3=M?:K*&VFMFE,@\0/J!8*" 59:CM!R*@US3 CGFWV
MTV?F_<4W2\FN(;A8A&?#*T(4L02&5J'N(P:$4Q7)-5_+K_EU].?RU^G-R=/=
M/;DWYO"DWAORO["W+N7L*OP]7F*S,5>'PVWZ:CHZ;;^&P6)Q^*Q^)P4 1! \
MSS/*[RLK1QQ$/./..Y<Z;DFX[BD4;1Q"-5C!  !+$DL6))+'SI2@ XDGG*/*
M.W\G;>^W[>\LBR2F1FD())("T&D*  %'E6M23P /]["70JZ#[MKK/;'=/579
MG3F]DK9=F=L]?;SZSW=%C:D461DVQOS;F2VMGTH*QHIUI*U\5E91%*4<1R6;
M2;6]J]OO9]LOX-RM:?4V\R2)45&J-@RU'F*@5'22_LH=QL9MON:_3SQ/&]#0
MZ74JU#Y&A-#UKO=7?\)<_A=UIV;L+L<]V_)#=";"WEM[>=/MK*Y3KJBQV:J-
MM9:ES-#B\M78C8-'E$QM554<:5)I9*>H>$N(I87*R),-][Y\RWMC+9_2V4?B
MQLFH"0E=0() ,A%0#BH(KQ!&.HELO9/ERSO8KSZF\?PI%?23& =)! )" T)&
M:4-.!''K9B]PGU,O4+)8ZCR^.K\3D8?N,?E**JQU=3^26+ST=;!)35,/E@>*
M:+RP2LNI&5EO<$'GW9':-Q(AHZD$?:,CJKHLB&-\HP(/V'CUK!?] H_P>_CO
MWW^G;Y/?P+^+_=_P#^,=8^7^$_>>;^$?Q?\ T;^?7]G^S]SX]=_7IOQ[G'_7
M[YH\+1]+8^+IIJI+QIQIXGKFGY=0K_K&<M>+J^JO?"U5TUCX5X5\/TQ7\^MG
MW&XZCQ&.H,3CH?M\?BZ*EQU#3^267P4=%!'34T/EG>6:7Q01*NIV9FM<DGGW
M!SNTCF1S5V))^TY/4U(BQH(TPB@ ?8.'4WW7JW7O?NO=$H^9?\O+XE?/;;%%
MM_Y)=5XW=.3PE/-3[4W_ (BHGVWV1LZ.>1II(=O[QQ9BR*8V2H8RR8ZJ^ZQD
MTMGEIG95($W+?.','*<YFV6X:-&-7C/=&_\ ID.*^6H48# 8=!OF+E+8>:81
M%O$ =U':X[9$_P!*XS3STFJDY(/6N#VC_P ))=FUF3J*OI;YG[GV]AVF;[3
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+WOW7NO>_=>Z__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>uhglogo2019a023.jpg
<TEXT>
begin 644 uhglogo2019a023.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
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M P,# P,# P,# P/_P  1" "& O@# 1$  A$! Q$!_\0!H@    8" P$
M        !P@&!00) PH" 0 + 0  !@,! 0$            &!00#!P(( 0D
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MO_;P[IK_ ,4PZ\_]_A\BO>6_L)_RI]S_ -+*3_JQ;]8I^^?_ "MMO_TKH_\
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MF"/<&=DH]P]<SQ1 @-D*W?NW*'%1-_8CRLO]3[7>\6R'>.2YIXQ6XLG6=?\
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M0+GH#R=-<W'*>VSW9)N7L82Q/$DQKD_,C)^9ZP/YNBMX.:=QAM !;K>S!0.
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M1M301CW+?LI?7%MSS%:Q$^#<P2HX\J*AD4G[&0 'B*D>9ZBKWDLH+GDJ2YD
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M_ S_ ,4P^+G_ +X_8WO CG/_ )7#=O\ I977_5]^LZ.3_P#E4MK_ .E=;?\
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MD6H?Y'KZM7O KK.;KX]_R/\ ^RA^^?\ Q,_:/_O<9SWT3V;_ )(]I_SS1?\
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M$BA5'@VYH * 5,1)H!YYZ>O^@A+^;]_WEU_[ /XP_P#VE?;?^M#[=_\ 1O\
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M_P#5].@[SA_RJ6Z?]*ZY_P"K+]?)QVWN',;1W%@=U[>K/X?G]L9K%[AP=?\
M;TM7]CF,+709+&5GVM=!4T53]M6TR/XYHY(GTV=64D'/N:&.XA>WF%8G4JPR
M*AA0BHH14'R->L$X99+>9)XC25&#*<&A!J#0U!H1YXZN$_Z"$OYOW_>77_L
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M3K+3F3_E7;__ )XI_P#JTW7RB_CA_P!E#]#?^)GZN_\ >XP?O/?>?^2/=_\
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MZM+U\Y+^<[\.*WX'_P P;LO;NSJ*HVUUMV!DH>]NBZS$%\=#AMM;NRE775&
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M>FDE."S@5)]/U5&KYLKD\1U)WLQS5^\MI?EV[:MY9BL=>+0$T ]?TV.GY*R
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MB.:=S*>!!].CGVCYNY<Y>V6YM=YND@G>ZU*"KFJ^&@KVJPX@CJ\OL#_A0O\
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MX?\ 90_0W_B9^KO_ 'N,'[SNWG_DCW?_ #S2_P#'&ZP@V?\ Y*UK_P ],?\
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MGR%-'M+MW9G8.>R]-3J6E;;NU-A9;<FZ-QN" NFAHZAM;!;7(O!EGR/SA?7
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MOU_S-N\V];D5^KF(J%!"J%4*JJ"20  .)))J2223T+]@V.QY<VJ+9]N#?2Q
MT+$%F+$LS,0 "22?( "@   '1DO9+T<= %\HOC9UC\ONA.R/CCW'1Y*LZ\[/
MP]-BLXV$JZ?'YW'3XW*X_/X/.X&OJZ+)4E'F]OY_$TM;2234]1")X%\D4B:D
M8VV+>K[EW=H=YVTJ+R!B5U"JFH*LK $$JRDJ:$&AP0<]%6][/9;_ +7-M&X
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M%O$ =U':X[9$_P!*XS3STFJDY(/6N#VC_P ))=FUF3J*OI;YG[GV]AVF;[3
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+WOW7NO>_=>Z__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>uhglogo2019a023a.jpg
<TEXT>
begin 644 uhglogo2019a023a.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
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M P,# P,# P,# P/_P  1" "& O@# 1$  A$! Q$!_\0!H@    8" P$
M        !P@&!00) PH" 0 + 0  !@,! 0$            &!00#!P(( 0D
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MO_;P[IK_ ,4PZ\_]_A\BO>6_L)_RI]S_ -+*3_JQ;]8I^^?_ "MMO_TKH_\
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MF"/<&=DH]P]<SQ1 @-D*W?NW*'%1-_8CRLO]3[7>\6R'>.2YIXQ6XLG6=?\
M2K59/R$;,Q_THZ0^T>]#:><88)#2WO$,!_TS4:/\RZJH_P!,>OI0>\+NLQ.J
MR/YS/_;KCYK_ /B&,E_[N,-[&_MM_P KUMG_ #TC_ >@7[B?\J3N7_/,?\(Z
M^:U\*/\ LLKXD_\ BS?0O_OU-J>\TN9O^5;W#_GAG_ZM/UAURW_RL5A_SVP?
M]75Z^NY[Y[=9\]>]^Z]U[W[KW7SP?^%1G_;RK!?^*R=6_P#O6=F>\P/8O_E2
MG_Y[I?\ CD76)?O9_P KBO\ SQ1?\>DZN=_X2>?]D:_([_Q9N;_WU?7WN-O?
MW_E9+/\ YX?^LLG4B^Q7_*NWG_/;_P!8H^MJ'W!'4W]$P_F/_P#;O'YY_P#B
MF'RC_P#?'[Y]B7DS_E<-I_Z65K_U?3H.\X?\JENG_2NN?^K+]?*^^.'_ &4/
MT-_XF?J[_P![C!^\[MY_Y(]W_P \TO\ QQNL(-G_ .2M:_\ /3'_ ,?7K["'
MOG9UT!Z1?9'_ #+O?O\ X9>Z?_='7>U-E_N9%_S57_CPZ37G^XDO_--O^.GK
MXWGOHYUSVZ^R'UO_ ,R[V%_X9>UO_='0^^<=[_N9+_S5;_CQZZ$V?^XD7_--
M?^.CI:>TW2GK2/\ ^%:_:-;5]B?#KI6&H\>/P.R^S>T<C21M*/O*W=N<V]M/
M"U%4C#P-_#(-E5ZTY4ZQ]W-JX*>\G/N_6*K9[CN9'>\L40/H$5G:GVZUK]@Z
MQM]^;UFN]OVX'L6.20CU+,JBOV:&I]IZKX_X32=0XKM#^9[MK<65I8JR/HWI
MWL[MZBAG\;0KE3_=_JS'530R$">6@J>T140V#-%/$DHL8PP%WO7N,ECR.\,9
MH;JYBA/V=TI'Y^%0^H)'GT$_9O;TO>=$FD%1;6\DH^WMB!_+Q*CT(!\NOH[^
M\->LONO>_=>Z][]U[KWOW7NOG&_\*8_^WH^Z_P#Q#'3_ /[IZ_WF5[)_\J+'
M_P ],W^$=8A>\O\ RNTG_/-%_@/5Z/\ PD\_[(U^1W_BS<W_ +ZOK[W%GO[_
M ,K)9_\ /#_UEDZD[V*_Y5V\_P">W_K%'UM0^X(ZF_KY*G\Q?;NSMI?/GYG;
M9Z_IZ&BV;@OD[W;C,#CL6L*8O%4E+V'GXWP^+BITC@AQN(J0]-3QH-,<,2J"
M0+GH#R=-<W'*>VSW9)N7L82Q/$DQKD_,C)^9ZP/YNBMX.:=QAM !;K>S!0.
M D; ^0.!\AU]+_\ E?Y#,Y7^7)\&Z[/3551DI?BOT>C3UD?CJ9Z.GZ^P5-BI
MI"4C:?R8J&$K,UVG4B1F<L6.%'/*1Q\Y;HL0 3Z^?APKXC$_SKCRX=9D\E/(
M_*&V-+4O]##Q]/#4#^5,^?'KYN'\TGY#9/Y0_P P'Y4=MUF0FR&)JNV]S[/V
M0TK.(Z?KOKFM?86Q(Z>E)\=#]UMK;U/53Q)Z35U$SDL[N[9G<B[.FQ<I6&WJ
M )!;J[_\U)!XCY\Z,Q /H . IUA[SMNS[WS7?7[$F,W#(G_-.,Z$QY5502/4
MD\37KZ!O\CCXY83XX?RSOC10T6.I:;<?<&S*#Y ;VR<20BKS>7[>I:?=> FR
M$D2J7GP^PJK$8Q5;U1QT2JWJU>\2/=#>9=YYVO79B8;>4VZ#R40G0U/MD#M_
MMNLK/;39X]GY,LU4 37$8G<^9,HU+7[$*+^75MWN/NA[UI.?\*P_C7@\1NCX
MS?++!8U*3+;QI=R])]B5D%.8XLE4;:A@W7US65,D2"*7*?PVNSE,\DI\KTM)
M3HI*063)GV"WJ62"^V"5JQQE9HQ7AJ[) /E4(<8J2>)ZQO\ ?79XHY[+?8EI
M)(&AD/KI[HR?G0N,YH . Z2O_"3SY#93%=R?)7XLY#(.^W=Z=?8OO#;./G=1
M3T&Y]BYW$;+W.V/%U)K=QX/>F/:=3J+185"ND(VI1[^[/')MMEOJ#]:*8P,?
M574NM?DK(U/FY]>F/8K=GCW&\V-S^C)$)E'HR,$:GS976OR0=7#_ /"F3_MU
MSNK_ ,31T_\ ^[?(>XZ]D_\ E>H_^>:;_ .I!]Y?^5)D_P">F+_">M2S_A/;
M_P!O?OB+_P"5\_\ @8>ZO>0'N]_T[O</^;'_ &DP]0/[3_\ *_V'_-__ +1I
MNOIL^\(^LSNJE/YZW_;ISYD?^&9LG_W[G7ON0/:S_E?]M_YJO_U:DZ ?N=_R
MHFX_\TT_ZNQ]:2/_  GM_P"WOWQ%_P#*^?\ P,/=7O)SW>_Z=WN'_-C_ +28
M>L;?:?\ Y7^P_P";_P#VC3=?0]^;'_9&?RW_ /%8^^O_ 'U>Z_>'_+/_ "LF
MW_\ /=!_U=3K+3F3_E7;_P#YXI_^K3=?*+^.'_90_0W_ (F?J[_WN,'[SWWG
M_DCW?_/-+_QQNL&-G_Y*UK_STQ_\?7K["'OG9UT!ZU_?^%+?6>U-Z?RP-[;U
MS5'CVW'T_P!G=4[MV9D)T1,C3UVX]X8[KG,T&/J!"\S05^"WC-+/3ZTBD^U2
M1M301CW+?LI?7%MSS%:Q$^#<P2HX\J*AD4G[&0 'B*D>9ZBKWDLH+GDJ2YD
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M_ S_ ,4P^+G_ +X_8WO CG/_ )7#=O\ I977_5]^LZ.3_P#E4MK_ .E=;?\
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MD6H?Y'KZM7O KK.;KX]_R/\ ^RA^^?\ Q,_:/_O<9SWT3V;_ )(]I_SS1?\
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M$BA5'@VYH * 5,1)H!YYZ>O^@A+^;]_WEU_[ /XP_P#VE?;?^M#[=_\ 1O\
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M_P#5].@[SA_RJ6Z?]*ZY_P"K+]?)QVWN',;1W%@=U[>K/X?G]L9K%[AP=?\
M;TM7]CF,+709+&5GVM=!4T53]M6TR/XYHY(GTV=64D'/N:&.XA>WF%8G4JPR
M*AA0BHH14'R->L$X99+>9)XC25&#*<&A!J#0U!H1YXZN$_Z"$OYOW_>77_L
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M3K+3F3_E7;__ )XI_P#JTW7RB_CA_P!E#]#?^)GZN_\ >XP?O/?>?^2/=_\
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MZM+U\Y+^<[\.*WX'_P P;LO;NSJ*HVUUMV!DH>]NBZS$%\=#AMM;NRE775&
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M>FDE."S@5)]/U5&KYLKD\1U)WLQS5^\MI?EV[:MY9BL=>+0$T ]?TV.GY*R
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MB.:=S*>!!].CGVCYNY<Y>V6YM=YND@G>ZU*"KFJ^&@KVJPX@CJ\OL#_A0O\
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MX?\ 90_0W_B9^KO_ 'N,'[SNWG_DCW?_ #S2_P#'&ZP@V?\ Y*UK_P ],?\
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MGR%-'M+MW9G8.>R]-3J6E;;NU-A9;<FZ-QN" NFAHZAM;!;7(O!EGR/SA?7
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MOU_S-N\V];D5^KF(J%!"J%4*JJ"20  .)))J2223T+]@V.QY<VJ+9]N#?2Q
MT+$%F+$LS,0 "22?( "@   '1DO9+T<= %\HOC9UC\ONA.R/CCW'1Y*LZ\[/
MP]-BLXV$JZ?'YW'3XW*X_/X/.X&OJZ+)4E'F]OY_$TM;2234]1")X%\D4B:D
M8VV+>K[EW=H=YVTJ+R!B5U"JFH*LK $$JRDJ:$&AP0<]%6][/9;_ +7-M&X
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M%O$ =U':X[9$_P!*XS3STFJDY(/6N#VC_P ))=FUF3J*OI;YG[GV]AVF;[3
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+WOW7NO>_=>Z__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>uhglogo2019a02b.jpg
<TEXT>
begin 644 uhglogo2019a02b.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
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M P,# P,# P,# P/_P  1" "& O@# 1$  A$! Q$!_\0!H@    8" P$
M        !P@&!00) PH" 0 + 0  !@,! 0$            &!00#!P(( 0D
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MO_;P[IK_ ,4PZ\_]_A\BO>6_L)_RI]S_ -+*3_JQ;]8I^^?_ "MMO_TKH_\
MJ]<=6T_\)//^R-?D=_XLW-_[ZOK[W'_O[_RLEG_SP_\ 663H>^Q7_*NWG_/;
M_P!8H^MJ'W!'4W]:D_\ PJ1^#^T-P])[,^=.SMOX_%]C==[JP'7/;^4H*6*D
MFW?UUNT/BMHYC/S1K_N0R^RMVQ4>.I)&7S/0YAHY)&CI::-,@?8OFBXAW.7E
M:Y<M9S1M)"":Z)$RX7T#I5B.&I*@59B8&][>6K>;;8^9[= MY"ZQRD"FN-L(
M6]2C44>='H310.JA_P#A,W\F<QTY_,)I>E*C)RQ;&^46QMQ[.RF+EE9,<-\;
M$P^5[!V+GW12 <E34N(RV)I[W4C-N"-10K(7O9LD>X\H'<PO^-6,JN#YZ)"(
MW7["2CG_ $@Z /LUO4FW\V#;2W^+7L3(1Y:T!D1OMH&4?Z<]?10]X>=9;]?'
MO^1__90_?/\ XF?M'_WN,Y[Z)[-_R1[3_GFB_P".+US^WC_DK77_ #TR?\?;
MKZ+_ /+.^>7P;V'_ "^OAOLO?/S-^*&S-X[7^._6&$W+M/=GR)ZAV[N7;N9Q
M^V*&GK\1G<%F-X4>4Q.3HIT*34]1%'+&X(901;WASSMRIS1=\W;E<VNVW\MM
M)>2LKI;S,K*6-"K!""#Y$&AZRYY-YHY9M>5-NMKG<;&.X2TC#*UQ$K*0HJ&4
MN""/,$5Z/%_PX_\ R\?^\\_AA_Z5'T?_ /9S["_]3.</^C3N7_9+/_T!T)OZ
MX<I?]'3;O^RF'_H/K6%_X4[_ "A^,_?O1/Q?Q'1/R)Z+[JRVW^VMX9+/8OJ7
MMO8'8^1PF.JMG0TM-7Y>BV=N#,U.-HJBI!C26941W]()/'N</8_8M[VG=;Z3
M=;.ZMHWMT"F6*2,,0]2 74 FGD.H6]Z=[V;==KLH]KN[6YD2=RPBE20@%*5(
M1B0*^9Z)]_PE*_[>'=R_^*8=A_\ O\/CK[$7OW_RI]M_TLH_^K%QT'O8S_E;
M;C_I72?]7K?KZ!7O$CK*SKXQ'OI+USMZ^P?\;_\ LG?H7_Q"_5O_ +P^"]\[
M=Z_Y+%W_ ,],O_'VZZ [/_R2;7_GFB_XXO0T>RSHQZ][]U[KWOW7NM+[_A6-
M\F9#/\9?A]AJ]EB2+,?(??\ 1)(A6621\IU[U?J"-Y%:!8]TO(C@*WDA87(N
M,D_8'9!2^YBD&<6\9_9)+_UB_GUCK[[;R:V7+\9QF>0?MCC_ .LO\NJ],!_+
MK6I_X3O[O^5TF MV34?)7&]\8[(?:R1Y>7I+;%94_'M\&8YF4C&)G,YE=QM*
M%'EI8HG6Z*"PPFYQT^\$>P!_\2%D8"*X\9@+C5]NE5CIY$D=!.+E&OM+)OI3
M_'#>"<'S\%3X%/LU,TGS !Z"O_A.M\FT^/7\RCKS:^7KDH]H?)+;^;Z'S1G8
MF"/<&=DH]P]<SQ1 @-D*W?NW*'%1-_8CRLO]3[7>\6R'>.2YIXQ6XLG6=?\
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M0+GH#R=-<W'*>VSW9)N7L82Q/$DQKD_,C)^9ZP/YNBMX.:=QAM !;K>S!0.
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M1M301CW+?LI?7%MSS%:Q$^#<P2HX\J*AD4G[&0 'B*D>9ZBKWDLH+GDJ2YD
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M_ S_ ,4P^+G_ +X_8WO CG/_ )7#=O\ I977_5]^LZ.3_P#E4MK_ .E=;?\
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MD6H?Y'KZM7O KK.;KX]_R/\ ^RA^^?\ Q,_:/_O<9SWT3V;_ )(]I_SS1?\
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M$BA5'@VYH * 5,1)H!YYZ>O^@A+^;]_WEU_[ /XP_P#VE?;?^M#[=_\ 1O\
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M_P#5].@[SA_RJ6Z?]*ZY_P"K+]?)QVWN',;1W%@=U[>K/X?G]L9K%[AP=?\
M;TM7]CF,+709+&5GVM=!4T53]M6TR/XYHY(GTV=64D'/N:&.XA>WF%8G4JPR
M*AA0BHH14'R->L$X99+>9)XC25&#*<&A!J#0U!H1YXZN$_Z"$OYOW_>77_L
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M3K+3F3_E7;__ )XI_P#JTW7RB_CA_P!E#]#?^)GZN_\ >XP?O/?>?^2/=_\
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MZM+U\Y+^<[\.*WX'_P P;LO;NSJ*HVUUMV!DH>]NBZS$%\=#AMM;NRE775&
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M>FDE."S@5)]/U5&KYLKD\1U)WLQS5^\MI?EV[:MY9BL=>+0$T ]?TV.GY*R
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MB.:=S*>!!].CGVCYNY<Y>V6YM=YND@G>ZU*"KFJ^&@KVJPX@CJ\OL#_A0O\
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MX?\ 90_0W_B9^KO_ 'N,'[SNWG_DCW?_ #S2_P#'&ZP@V?\ Y*UK_P ],?\
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MGR%-'M+MW9G8.>R]-3J6E;;NU-A9;<FZ-QN" NFAHZAM;!;7(O!EGR/SA?7
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MOU_S-N\V];D5^KF(J%!"J%4*JJ"20  .)))J2223T+]@V.QY<VJ+9]N#?2Q
MT+$%F+$LS,0 "22?( "@   '1DO9+T<= %\HOC9UC\ONA.R/CCW'1Y*LZ\[/
MP]-BLXV$JZ?'YW'3XW*X_/X/.X&OJZ+)4E'F]OY_$TM;2234]1")X%\D4B:D
M8VV+>K[EW=H=YVTJ+R!B5U"JFH*LK $$JRDJ:$&AP0<]%6][/9;_ +7-M&X
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M%O$ =U':X[9$_P!*XS3STFJDY(/6N#VC_P ))=FUF3J*OI;YG[GV]AVF;[3
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+WOW7NO>_=>Z__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>uhglogo2019a02c.jpg
<TEXT>
begin 644 uhglogo2019a02c.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
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M P,# P,# P,# P/_P  1" "& O@# 1$  A$! Q$!_\0!H@    8" P$
M        !P@&!00) PH" 0 + 0  !@,! 0$            &!00#!P(( 0D
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MO_;P[IK_ ,4PZ\_]_A\BO>6_L)_RI]S_ -+*3_JQ;]8I^^?_ "MMO_TKH_\
MJ]<=6T_\)//^R-?D=_XLW-_[ZOK[W'_O[_RLEG_SP_\ 663H>^Q7_*NWG_/;
M_P!8H^MJ'W!'4W]:D_\ PJ1^#^T-P])[,^=.SMOX_%]C==[JP'7/;^4H*6*D
MFW?UUNT/BMHYC/S1K_N0R^RMVQ4>.I)&7S/0YAHY)&CI::-,@?8OFBXAW.7E
M:Y<M9S1M)"":Z)$RX7T#I5B.&I*@59B8&][>6K>;;8^9[= MY"ZQRD"FN-L(
M6]2C44>='H310.JA_P#A,W\F<QTY_,)I>E*C)RQ;&^46QMQ[.RF+EE9,<-\;
M$P^5[!V+GW12 <E34N(RV)I[W4C-N"-10K(7O9LD>X\H'<PO^-6,JN#YZ)"(
MW7["2CG_ $@Z /LUO4FW\V#;2W^+7L3(1Y:T!D1OMH&4?Z<]?10]X>=9;]?'
MO^1__90_?/\ XF?M'_WN,Y[Z)[-_R1[3_GFB_P".+US^WC_DK77_ #TR?\?;
MKZ+_ /+.^>7P;V'_ "^OAOLO?/S-^*&S-X[7^._6&$W+M/=GR)ZAV[N7;N9Q
M^V*&GK\1G<%F-X4>4Q.3HIT*34]1%'+&X(901;WASSMRIS1=\W;E<VNVW\MM
M)>2LKI;S,K*6-"K!""#Y$&AZRYY-YHY9M>5-NMKG<;&.X2TC#*UQ$K*0HJ&4
MN""/,$5Z/%_PX_\ R\?^\\_AA_Z5'T?_ /9S["_]3.</^C3N7_9+/_T!T)OZ
MX<I?]'3;O^RF'_H/K6%_X4[_ "A^,_?O1/Q?Q'1/R)Z+[JRVW^VMX9+/8OJ7
MMO8'8^1PF.JMG0TM-7Y>BV=N#,U.-HJBI!C26941W]()/'N</8_8M[VG=;Z3
M=;.ZMHWMT"F6*2,,0]2 74 FGD.H6]Z=[V;==KLH]KN[6YD2=RPBE20@%*5(
M1B0*^9Z)]_PE*_[>'=R_^*8=A_\ O\/CK[$7OW_RI]M_TLH_^K%QT'O8S_E;
M;C_I72?]7K?KZ!7O$CK*SKXQ'OI+USMZ^P?\;_\ LG?H7_Q"_5O_ +P^"]\[
M=Z_Y+%W_ ,],O_'VZZ [/_R2;7_GFB_XXO0T>RSHQZ][]U[KWOW7NM+[_A6-
M\F9#/\9?A]AJ]EB2+,?(??\ 1)(A6621\IU[U?J"-Y%:!8]TO(C@*WDA87(N
M,D_8'9!2^YBD&<6\9_9)+_UB_GUCK[[;R:V7+\9QF>0?MCC_ .LO\NJ],!_+
MK6I_X3O[O^5TF MV34?)7&]\8[(?:R1Y>7I+;%94_'M\&8YF4C&)G,YE=QM*
M%'EI8HG6Z*"PPFYQT^\$>P!_\2%D8"*X\9@+C5]NE5CIY$D=!.+E&OM+)OI3
M_'#>"<'S\%3X%/LU,TGS !Z"O_A.M\FT^/7\RCKS:^7KDH]H?)+;^;Z'S1G8
MF"/<&=DH]P]<SQ1 @-D*W?NW*'%1-_8CRLO]3[7>\6R'>.2YIXQ6XLG6=?\
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M0+GH#R=-<W'*>VSW9)N7L82Q/$DQKD_,C)^9ZP/YNBMX.:=QAM !;K>S!0.
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M1M301CW+?LI?7%MSS%:Q$^#<P2HX\J*AD4G[&0 'B*D>9ZBKWDLH+GDJ2YD
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M_ S_ ,4P^+G_ +X_8WO CG/_ )7#=O\ I977_5]^LZ.3_P#E4MK_ .E=;?\
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MD6H?Y'KZM7O KK.;KX]_R/\ ^RA^^?\ Q,_:/_O<9SWT3V;_ )(]I_SS1?\
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M$BA5'@VYH * 5,1)H!YYZ>O^@A+^;]_WEU_[ /XP_P#VE?;?^M#[=_\ 1O\
M^J]S_P!;NG/]=CG_ /Y3_P#JA;?]:>M_/^6CW=VW\D/@E\:>\>]:6"F[5[&Z
M_&<W5)38$[9@RI3.9G'X7<D6$58Z>A3=6W:*DR0^W2.DD^[\E.D<#1HN)G.N
MU[?LO-5[M>U$FPAFTK5M5.T%EU>>EB5SD4H234]94<F[E?[QRQ9[GN8 OIHM
M3=NFO<0&T^6I0&QC-0 *='F]A;H3=?++_FE]WYWYQ_S.>^,_LZ2;<M/GNWJ3
MH[I^BI96GI\C@-E5M'U?L\X1 7,=+O#(XYLHJ 7,^3=B S$>\[.1=KBY7Y'M
M(;FB%+<SS$^3.#*^KYH#I^Q1UA%SON4O,W.EU+;U<-<"&(#S5"(TI\G(U?:Q
MZ^C;C/AQL:A^!E/\$Y/M)-DCXRO\=JO(+1E5G2IZ]?9E?NQ8"_FCRM3DYGR@
ME#B=:QO*KB0!AAL_,=TW-9YJ%?JOKOJ *^DFL)]@';3A3%*=9>)R];+RN.6#
M3Z;Z+Z<FG_"]!;[:]U>-<\>OE+TE3OSH+M^FK(#+MGL_I7LB&IA+!9)]O[\Z
MXW.LL99?T22XG<.&%Q]"8_>>K+:;MMQ4]]C<PT_TT<B_Y5/6#2M=;5N 8=E[
M;35_TKQM_D8=?7)^.O=.W?D;T+TYWUM/2NW^W^MMG]A8^F$BRR8T;HP=%E:G
M#53*2!7X2LJ)*.H7ZI/ ZGD'WSYWG;)MFW:YVFX_MK>9XR?72Q (^3#(^1ZS
MUVC<8=WVNWW2#^RN(4D ]-2@D'Y@X/S'1+OYS/\ VZX^:_\ XAC)?^[C#>Q+
M[;?\KUMG_/2/\!Z#GN)_RI.Y?\\Q_P (Z^:U\*/^RROB3_XLWT+_ ._4VI[S
M2YF_Y5O</^>&?_JT_6'7+?\ RL5A_P ]L'_5U>OKN>^>W6?/7O?NO=>]^Z]U
M\\'_ (5&?]O*L%_XK)U;_P"]9V9[S ]B_P#E2G_Y[I?^.1=8E^]G_*XK_P \
M47_'I.KG?^$GG_9&OR._\6;F_P#?5]?>XV]_?^5DL_\ GA_ZRR=2+[%?\J[>
M?\]O_6*/K:A]P1U-_1,/YC__ &[Q^>?_ (IA\H__ 'Q^^?8EY,_Y7#:?^EE:
M_P#5].@[SA_RJ6Z?]*ZY_P"K+]?)QVWN',;1W%@=U[>K/X?G]L9K%[AP=?\
M;TM7]CF,+709+&5GVM=!4T53]M6TR/XYHY(GTV=64D'/N:&.XA>WF%8G4JPR
M*AA0BHH14'R->L$X99+>9)XC25&#*<&A!J#0U!H1YXZN$_Z"$OYOW_>77_L
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M3K+3F3_E7;__ )XI_P#JTW7RB_CA_P!E#]#?^)GZN_\ >XP?O/?>?^2/=_\
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MZM+U\Y+^<[\.*WX'_P P;LO;NSJ*HVUUMV!DH>]NBZS$%\=#AMM;NRE775&
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M>FDE."S@5)]/U5&KYLKD\1U)WLQS5^\MI?EV[:MY9BL=>+0$T ]?TV.GY*R
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MB.:=S*>!!].CGVCYNY<Y>V6YM=YND@G>ZU*"KFJ^&@KVJPX@CJ\OL#_A0O\
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MX?\ 90_0W_B9^KO_ 'N,'[SNWG_DCW?_ #S2_P#'&ZP@V?\ Y*UK_P ],?\
MQ]>OL(>^=G70'I%]D?\ ,N]^_P#AE[I_]T==[4V7^YD7_-5?^/#I->?[B2_\
MTV_XZ>OC>>^CG7/;K[(?6_\ S+O87_AE[6_]T=#[YQWO^YDO_-5O^/'KH39_
M[B1?\TU_XZ.EI[3=*>B4?S#?AIMCY[?$KM3XV[@K:?"9/=.-I\OL#==1#)/'
ML[LC;<XRFSMP31PJU1)C4R,7VN1CB'EFQE54Q(59PP$W)_,D_*?,%OO4(+)&
MU)$'XXVPZ_;3*UP&"D\.@WS;R[#S3L,^SRD*[BJ-_!(N4;[*X:F2I(''KY9'
M<G3?<_Q1[GW%U7VIMW<75_;O5^XHTJJ5Y*C'9+'9+'5"5F'W'MS,4;QBLQM8
M(XJW%Y2BE:&IA:.>"0J5;WG9MNY;;O\ MJ7]@Z3[?.F#Q!!P58'@1E65A4&H
M(ZPBW';MQV+<7L;Y'@OX'R.!!&0RD<0<%6!H10@];JW\NK_A3'\?MX]=[7Z[
M^>U=E^I>W=OX^EPU=W%C-K9K<_6G8WVJ)2T>>RV/VA0YG<VRMU9,!?OXACYL
M,9P]2E32Q2"EI\:.<?9/=[:\DO.5 MQMSDD0EE62.N2H+D*Z#\)U!Z44JQ&H
MY'<H^\NU7%HEIS26@W!  90I:.2F Q" LC'\0TE*U-5!TBUG<O\ /'_E3;5P
M_P#&J_YD; KZ<Q>2.DVUM_L3=F8D)562+^"[:V;E<I#*Y<"TL484WU%0K$ *
M#VNY]GD\)-MF!]6:-!_O3.!^P]#F;W,Y&@C\1MQB(]%61C^Q4)_:.OF%[SR5
M)F-X;KR]!(TM#E=RYW)44K(\324E=E*JJII&CD"R1L\,JDJP!'T//O."V1H[
M>.-_C5%!^T  ]86W+K)<22)\+.Q'V$D]?6W^$_\ V1G\2/\ Q6/H7_WU>U/?
M/WF;_E9-P_Y[I_\ JZ_6>7+?_*NV'_/%!_U:7K0I_P"%,?\ V]'W7_XACI__
M -T]?[RN]D_^5%C_ .>F;_".L7/>7_E=I/\ GFB_P'J]'_A)Y_V1K\CO_%FY
MO_?5]?>XL]_?^5DL_P#GA_ZRR=2=[%?\J[>?\]O_ %BCZN!_FN?!R@_F ?"W
MLOI&E@HE[)Q:0]B=*9>L\:+BNT]I4]9+AJ5JF4A*.BW=C*NMP57,VH04N4DE
M"EXTM'?(/-#\I<RP;FQ/T3?IS ><3TU&GF4(#@>94#@>A_SURRG-?+DVVJ!]
M8OZD)/E*M:#Y!P2A/D&)\NOFS?#+Y.]B_ ?Y;]9=]X+'Y.GW!U-O26AWSLFJ
M>;$5.XMJS23[?[&Z_P Q#41D4=5E,)-54R&HAD^QR"Q5'C,L"6S0YDV.SYLY
M>GVF4J8;B*J.,A6^*.0>H#4.#W+45H>L/.7=ZN^5M^AW2(,)8)*.AP67X9(S
MZ$BHR.UJ&E1U]7_J_LG9W<?7&Q.V.O,Q#G]B]D[2V_O?:.9@L$R.W]S8NFR^
M+J&CN6@G:DJU$L36>*0,C ,I P&OK*YVV]EV^\4I=0R,CCT9201^T8/GQZSI
MLKRWW"SBO[1@]K-&KH?56 (_D>'EPZT+/^%)_P#+UW9TA\H,E\R]C;<JZOH_
MY&5%!5;QR>-I*B:@V%W72T%/CL[09R2.*2/'TG8T%"F8HIYI?\JR4F1B546&
M(/E;[+<WV^Z;&O+=TX&Z68(0$YDA)JI7U,==# #"Z#FIIB[[Q<IS[;O9YBMD
M)VR\(+D#"3 48-Z"2FM23EM8Q05,O_( _G2],]!=4P?"?Y<;MAZZVMMK-9[-
M='=MYD3OM#'XW<^3GS^>ZYWE5TM/-+MWP[EKZW)8W)U%Z%UK9J:>2F\--]P2
M^[?MIN6[7YYFY>C,T[JJSQ+\9*C2LB GN[0JLH[NT, U6H<^U7N-MVU6 Y;W
M^00P(S&&4_  QU-&Y'P]Q+*Q[<D$BBUVBNP?YGW\NWK':,^]]T_-7XU38*.B
MGR%-'M+MW9G8.>R]-3J6E;;NU-A9;<FZ-QN" NFAHZAM;!;7(O!EGR/SA?7
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MOU_S-N\V];D5^KF(J%!"J%4*JJ"20  .)))J2223T+]@V.QY<VJ+9]N#?2Q
MT+$%F+$LS,0 "22?( "@   '1DO9+T<= %\HOC9UC\ONA.R/CCW'1Y*LZ\[/
MP]-BLXV$JZ?'YW'3XW*X_/X/.X&OJZ+)4E'F]OY_$TM;2234]1")X%\D4B:D
M8VV+>K[EW=H=YVTJ+R!B5U"JFH*LK $$JRDJ:$&AP0<]%6][/9;_ +7-M&X
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M%O$ =U':X[9$_P!*XS3STFJDY(/6N#VC_P ))=FUF3J*OI;YG[GV]AVF;[3
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+WOW7NO>_=>Z__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>uhglogo2019a02d.jpg
<TEXT>
begin 644 uhglogo2019a02d.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^$Y8&AT=' Z+R]N<RYA9&]B92YC;VTO
M>&%P+S$N,"\ /#]X<&%C:V5T(&)E9VEN/2+ON[\B(&ED/2)7-4TP37!#96AI
M2'IR95-Z3E1C>FMC.60B/SX*/'@Z>&UP;65T82!X;6QN<SIX/2)A9&]B93IN
M<SIM971A+R(@>#IX;7!T:STB061O8F4@6$U0($-O<F4@-2XP+6,P-C @-C$N
M,3,T-S<W+" R,#$P+S R+S$R+3$W.C,R.C P(" @(" @(" B/@H@(" \<F1F
M.E)$1B!X;6QN<SIR9&8](FAT=' Z+R]W=W<N=S,N;W)G+S$Y.3DO,#(O,C(M
M<F1F+7-Y;G1A>"UN<R,B/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA
M8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SID8STB:'1T<#HO+W!U<FPN;W)G
M+V1C+V5L96UE;G1S+S$N,2\B/@H@(" @(" @(" \9&,Z9F]R;6%T/FEM86=E
M+VIP96<\+V1C.F9O<FUA=#X*(" @(" @(" @/&1C.G1I=&QE/@H@(" @(" @
M(" @(" \<F1F.D%L=#X*(" @(" @(" @(" @(" @/')D9CIL:2!X;6PZ;&%N
M9STB>"UD969A=6QT(CY"87-I8R!21T(\+W)D9CIL:3X*(" @(" @(" @(" @
M/"]R9&8Z06QT/@H@(" @(" @(" \+V1C.G1I=&QE/@H@(" @(" \+W)D9CI$
M97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70]
M(B(*(" @(" @(" @(" @>&UL;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M
M+WAA<"\Q+C O(@H@(" @(" @(" @("!X;6QN<SIX;7!'26UG/2)H='1P.B\O
M;G,N861O8F4N8V]M+WAA<"\Q+C O9R]I;6<O(CX*(" @(" @(" @/'AM<#I#
M<F5A=&]R5&]O;#Y!9&]B92!);&QU<W1R871O<B!#4S4\+WAM<#I#<F5A=&]R
M5&]O;#X*(" @(" @(" @/'AM<#I#<F5A=&5$871E/C(P,3(M,#(M,#E4,3 Z
M-3<Z,#(M,#4Z,# \+WAM<#I#<F5A=&5$871E/@H@(" @(" @(" \>&UP.DUO
M9&EF>41A=&4^,C Q,BTP,BTP.50Q-3HU-SHP.%H\+WAM<#I-;V1I9GE$871E
M/@H@(" @(" @(" \>&UP.DUE=&%D871A1&%T93XR,#$R+3 R+3 Y5#$P.C4W
M.C R+3 U.C P/"]X;7 Z365T861A=&%$871E/@H@(" @(" @(" \>&UP.E1H
M=6UB;F%I;',^"B @(" @(" @(" @(#QR9&8Z06QT/@H@(" @(" @(" @(" @
M(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @
M(" @(" @(" @/'AM<$=);6<Z=VED=&@^,C4V/"]X;7!'26UG.G=I9'1H/@H@
M(" @(" @(" @(" @(" @(" \>&UP1TEM9SIH96EG:'0^,C \+WAM<$=);6<Z
M:&5I9VAT/@H@(" @(" @(" @(" @(" @(" \>&UP1TEM9SIF;W)M870^2E!%
M1SPO>&UP1TEM9SIF;W)M870^"B @(" @(" @(" @(" @(" @(#QX;7!'26UG
M.FEM86=E/B\Y:B\T04%14VM:2E)G04)!9T5!4T%"24%!1"\W44%S54=H=F1'
M.7IA1SEW241-=4U!0311:VQ.02LP04%!04%!0D%!4T%!04%!14$F(WA!.T%1
M0DE!04%!05%!0B\K-$%$:T9K8C)*;$%'5$%!04%!068O8D%)44%"9U%%0D%5
M14)G549"9VM'0E%92D-W9T="9V=,1$%O2T-W;TLF(WA!.T1"04U$07=-1$%W
M441!-%!%03A/1$)-5$9"451%>'=B1WAS8TAX.&9(>#AF2'@X9DAW14A"=V-.
M1$$P645"05E':%521E)O9DAX.&8F(WA!.TAX.&9(>#AF2'@X9DAX.&9(>#AF
M2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9B\X04%%
M46=!1D%%04%W15(F(WA!.T%!25)!44U2068O14%A24%!04%(05%%0D%114%!
M04%!04%!04%!449!=TE'05%!2$-!:TM#=T5!06=)1$%114)!445!04%!04%!
M04$F(WA!.T%104-!=U%&0F=C24-1;TQ%04%#05%-1$%G44-"9V-$0D%)1T%N
M34)!9TU20D%!1DE227A15D5'13)%:6-9155-<$=H0GA7>%%I4$(F(WA!.U5T
M2&A->%II.$-2>6=V16Q1>E)4:W%+>5DS4$-.55%N:S9/>DYH9%5:2%1$,'5)
M24IO34I#:&=::$I21E)Q4S!6=$Y62T)R>30O4$4F(WA!.S%/5#!:6%=&;&%7
M,7AD6&PY5UHR:'!A;71S8E<U=EDS4C%D;F0T95AP-V9(,2MF,T]%:%EA2&E)
M;4MI-'E.:F\K0VLU4U9L<&59;5HF(WA!.W%B;DHR96XU2VIP2U=M<#9I<'%Q
M=7-R839V;U)!04E#05%)1$)1545"45E%0T%-1&)114%!:$5$0D-%4TU51495
M4DYH26=:>&=:17DF(WA!.V]B2'=&34A2-%-.0T962FEC=D5Z2D121&=H85-5
M>5=I63=,0T(S4%-.94I%9WAD56MW9TI#:&=:2FI:1D=I9&MD1E4S.'%/>G=Y
M9W F(WA!.S K4'IH2E-K=$U453504FQD65=6<&)81C%E6#%2;%IM9&]A5W!R
M8D<Q=6(R4C%D;F0T95AP-V9(,2MF,T]%:%EA2&E);4MI-'E.:F\F(WA!.RM$
M;$I75VPU:5IM<'5C;EHV9FMQ3VMP86%N<4MM<7$V>71R<2MV+V%!07=$05%!
M0T5135)!1#A!-D(O>FEX95AD>C5.,5DS33AK-5@F(WA!.U57-&U2,F5L65EY
M86-I97!Z661O04-9.7IG9&YK;4(Y-W1#=F(Q=BMC;V9-5G,Q>$EB6F1.:D-W
M;#)+0696-U9Q0F$P*S!X4'IW5$$F(WA!.R],1#,O<E="4#5G*S<Y4U1V*V0S
M;3=44'I6=C=(535);CAN,FUQ+V]Y-%!P27!G17AK5T9V549'<5!36FI7=7=/
M5V9L26Y'0U!Q<3(F(WA!.W8X,TE:0T0Y3C!Z+T%&+WIN<G1L*V,S;&IY<D))
M9S!F53=/-&YU-&EI;#)E3T]D;$EC-VEH:%AP;4Y$1D4T<%,V9W544$Q)6EEX
M-D4F(WA!.TE/-#@K*UEL+U!I,3AN<DI'3D1E>$UR=RMM3UIK.48U3UAQ2#1U
M<6=E1DU)=W@X2&HV,F<U<&5.=V1+66HK83-M:C@V+TDP03%36%@F(WA!.W)'
M8E0W>3AE0S!G:'1K36E+47IP>35X.6Q7;C)J;"MN>#1C;3%'-F%.4FMZ63DW
M1E=Z4W=M+TY04E!*,VU05R]-;7-75V]3=V%83F0F(WA!.S95='9!14UC<U5$
M>3%F-%EW4CEN86@K:G914FIL3TEI0TXY,CA(2D=%:DEG-V)-4SAI-F@K9G9N
M2'DS8C8Y62M:3DYT-V$T85)&:6XF(WA!.W15-6=X3U5.94U,1'%V:FPR84]#
M175%>$Q4:&QN;DAI16=M4#5V96504#-L2S,X;6%:6F%H075Q87-:2615=FAB
M;WEV3$@V0V-K4C8F(WA!.VA6-51-869Q>4]M=W=N>$5J64UT5&QN1&A!3S57
M*V-T9"]/9CAV-TM0>D)F86Y9*UI.16EK4U!53&8V<TQ74D9K8FE'0E1X66AE
M5E0F(WA!.U%K9D-2:FEH:7EN:$%-4W5795A%3TEK4T-(+S5Y23AX9E@O>6TP
M4%=D2VYL:'0Y4W8W4V5.:UEO>&IK=%HU5E9U2C=%1&)X1TA247(F(WA!.TM1
M96<O4VI7>G9%0T]P96ME64Y8=#$X:39L3$AE;TQK85A/-E-,2T))2D)B<U%1
M46$X<35I=VHV>'0Q8W%C=E%D*VIY:CAQ=DTR<V$F(WA!.U0O>FHW<FUS,C U
M92LP*V4U3F\X.5I1:#1X56]'4%%&>6%D2S5M86I'2EIW3VAC4%0U1$A!5#%#
M33AK,U@U+V5B9DQ&;#5G<W9-=6TF(WA!.U%7,3<V=G!X5%=Y*V]04VQE13$T
M=W-.>D=4,7=:4F=H27A-4VY%8S@T:5%K2')/<#9V3&](;$<T,5A6<%5M=4Y.
M<VI095-2<G=34U<F(WA!.TM/<F-&2DY!-VHT4EAV;49'4$9+:#%,;7EL=WAS
M.4$X:R]*>C@S4$]E<RMC1C!,>F$P9DA63$PV-W!"4TI9:G0X64,X8596;W=X
M,W$F(WA!.V9H>DXQ5VUH1TA&2&]D,T,P=7!N2UA$3'%.;5,O;68U.#AX*U@O
M4&9K9E(Y36U33W@Q=3A71%5584Y83&\Q>$1&44UD,2M'43E-<3 F(WA!.RM'
M36]32C5G3C)O>E-J3TE(26QL6&YI>#@Y6&QJ8G U4#%+,3 R-U=5;35K=30O
M5E9O*TIO<2]$2E$X=F)+35)G1#9X8F1L17E046$F(WA!.V5/*U4O3F8U-BM:
M9DY/=2M83%1Z0EE1,U=G>7E26$TP=')(-F)M2UIO4U4T>$4Y5G)U37HX;5!$
M0TEK460S07@U33 U1TE),EI8-38F(WA!.S@O96-V3&9N8GE&-657-6=L6%98
M=&]D86M%24%M95-A3T-6:W%A>&ID;55$<#-R;$=(1$-C2GDW=51F;7I4:$]%
M92]M:F9Z.#@K95DF(WA!.R]*=FQV5'(W47!K:'5B:3E%37)34G))1$@V5'9X
M;S%2=59'1%(T635*15,W;5=S>E-X>$)J,W919&(Q4TA39$9V.59M0F%(5#=A
M838F(WA!.VM59%-S35IK22LU8WA94C1I0C-U5$]80T-E-31"*U=0:W%4.#)8
M,4QZ9C4U=DQI.'128W1B,D=N4GET2$5H0V@R-&=(-%553T953%,F(WA!.W4U
M3F,R96]Y*T1524(Q=6YX94YC<'959DE8-50V9C5*,3(O=3E),4,U8E-B,D95
M5%-P;4QP1DM(-49W,5)88EE65V\S,T]996)5;DHF(WA!.T5!:F9V8W9$<&AJ
M:U-$=#--1CAJ*UIF>F4X.%@O;4ID4#AX,G5M>#929$='2T=3>&EL1$)M:S1$
M;#%!2' P<6$U:UIC94Q'0F-B=GHF(WA!.V-F1FMY-4-A;%9E4V0O;#4K8BMP
M6&9L,WI83#5Q:6E/;V54;5E8:S%Q3TM49V5O1D-G+W1L-$=8<TYX<TUR>C99
M0U5E2&Q*<W=A:VTF(WA!.TUU3&Y&02M53&XX-B]096=V-6YT=DTQ=#5E=')P
M<$)P;6U*65$S0TUS8D9+=DQ+1VM51FQ)<CA8:E1*6E)H>'DT5$AI*TQ(16,R
M4U F(WA!.T5*8U!W5$AY0BMA;75A,S53.#!X-G)(1D(U<3AQ>%1I-#1,4TXR
M:FIK-%!W2C9I4T9G-$<S>7)4235T3TEY:E@P>5I99%%:4FQF,5(F(WA!.U1R
M.&LO3G5T*V$O26M/<F$Q2W,Q.#%X3D4P:4ES64MO,W<O0V]#.3AR,65-46Y1
M-4YM:WE'8TQ03FDO:S<X>B]!1%IQ=C5A9610348F(WA!.S-.1612,&57-D=N
M<W-3<7%,2$-(449F,G5*4#=8,#%Y-TQP-'AY4FE/4F%C5V]L3$A+4C5H2SE*
M.'AF;EIF.$$U6FIZ-V)E66)/5TLF(WA!.T]'-'5P9$QL<V]K4'!7:W-I4R]V
M5D<U-'A&<55(:%A*>6AH1U1G25!V=&A'95DT*T]X.&LS:C@O+VU,-6TX=F58
M9&0X=%=X:%,Y4FLF(WA!.W9964E5;E$S36-R>%-++W%!;4Y+;VI)4S9J:5<U
M3GE#,7(X2$A#4FI*<SAB2D]);$9,+RMC5359-'9,;74V9$EW4RMT-R]N3F).
M<S8F(WA!.W%9;%%%:B]74F@Y1U0W4DAQ0C95=S=/4'!)-C)U.'%S=#4O>FQ"
M-7!U<E5I83-G<T9J;&Q1,5984T<Q:5I39C5G-FQA97@X36-M,FXF(WA!.VE$
M,R]!2S T.3E226IU+U5L3VIE5#0O3C)R9FY*;W!!*W-Y6'-%;&DU+UIU67!,
M<&]J6'-#4GA0<U1K-5IE05EZ-69Q830T=4TU0C4F(WA!.R]R4VXX=F9.,#-M
M4#@Q9GDO=T1R;DEA<'!6:&5A8G%#=4M.-FM%1C!&63$S<3!:5W8K5EA*-7-F
M0FIN6$EK2#=M1TA*>%I)6'I!22LF(WA!.SEL=#$O=T-T53)F+T%'>FHO=T)1
M<VU51"]&:C<R."\T>5!C-R]N3$0O;$1D22\W84DO-4U363EN9E=F8W9A4#!$
M,W924$\S+T%*2W8F(WA!.UAV.$%T:%AF+U5'*UEU3"LX2#E99F4U5U@K-U Y
M6#E$>#,X;E!Y<VDX>"M2<E154C5P,6946DI(;4173FIC:4]*06MR3%5*43 U
M57$F(WA!.V-Z.59Q3T-D8TE,9V%85#AC3#1I17<O-7E.9RMR-G@K6%5(<5!.
M-DYX4$@V<W U4U!X97I(2C(W<V5P3U$P2G-4+TAE>C%W;W<O2&,F(WA!.WI,
M+VY)9E=T3W-0>7<Q3S!U2E9&,7%2:6=S-$-2>61H36IS44]T15)34V8V-5)O
M;T4U064U=C%S=TU:2&4X-2].:E0W<E1V*V-D=DHF(WA!.W1P9$E9-VA,<3!A
M4TTW1E1*83-,.%-$,$E$8C5L86%13V522&XY-&-857A)=U)"+T=X6EAR6#5"
M+VQL82M4-R]!1D](5'!6=DE.4&PF(WA!.W59,TYZ3U%*16=,9S!,52LP3VU5
M=S%M47I!=G$S5#!E35%*<F]X4'E&+S9Z2C5O+S1Z6% O15EC=GIF-'A&<'<O
M=T-,>5)N-5%F;%0F(WA!.T8U9SAH-EAQ9S@Q87I93DM::DI95TXQ-F--6$,U
M:U%C56]E4$QH>2M:>4]P,4A$36IH0E1P=%!X44(T:4=59C@U26%V8U)E5#E0
M.$$F(WA!.TLY9TAN,4QZ1F1X5S!52VUS:VMC3$MX03A36E1'=C U5&]9*W-Y
M4$M,9')P96=22$]4>G9Z+W)'<F%,-6DX;2MA:#59=G1!=&1!14<F(WA!.VY-
M,7E52WEW=S%+4DM54%5X97%.*S):5T=);$=594E3-'0S1GI335I2;'=M4$1S
M>2]W1$]Y-&=K+TUZ.'-,:$I&340S,%5I>3$K16\F(WA!.V)U,DEA=FA42TY)
M4#-C+V0K9W0K<5 W>4AV.$$P:#=F1&17,'A):&U346IC:$=$52LW3F51-T%%
M4$,O>50O.$%*>2]M3B]Z1C-8+U4F(WA!.V1*;7@Q9CA!9%$Y,S9(6&%4*SEN
M-R\P;U0O;DE+=R]34#5O95)D4#EE4S(K=5-25R]W0EIG4$=74#%B=$4U>'0R
M6F$Q52M/2%)3<D@F(WA!.TDO:FMJ5VDX:U(K3V%19FYZ*U<S*T9F3&UN,VXK
M24Y5,68Q-WHP9E$Q0V8Q63 O9$\S3E)156(T85IB;S@O2$EI9TYU:E9R34A"
M14<F(WA!.WED*W(V2S@U86)C87 U43%Z5&)95G5B-U0W<3)H2&DX,$Q)=C1T
M;7)X4W%14&-88359,T5J=D1Y<B]N1G)8-T8O2VPY-69K:U=05F(F(WA!.TLX
M:VUA,6%I=5E:1E%C=W!O5'AD5U9V1&)X>DTW46=E25,V53186CAX=VU05S S
M.'%E8V9-;#<K9E!M9GDS9%AR4V%*63)8<E=L;54F(WA!.VI#;S1.<4]164M(
M+T%.,G0Q4&9)6DU54FAJ241C;CEB4$AL:V,P;VLW069Q96,O;"]P;FU,55!,
M4#5L3#5D=F)I>#%I,W8P=6)6-U8F(WA!.WEK:VYP3D]7:'%U+WAR540O2W!M
M5FUL15-H>$-X5&DT67E-6CA*,W1.=DM7;C9&<6XO3T]F;40Y05)-3EEL:60Y
M8C5-6DIP3&DR6EHF(WA!.U-F2&DX83%51'A053%Y1U-5:&Y(1GDV33AC46-"
M-&5F5C9&*U%/;U=D>BM5*VI#2U973F]*-&)K5D99,U=:,F\S:#A,0G9K8WAD
M6D4F(WA!.VI+6$LP8V=C465B9FQM:F%P9CA!-79A-UIC<&1/=E5V;'1(545I
M57IT8U-R>' Q25-N+T):;#9J65DT;FYT*VAX34<U>5-(3&8Y3$XF(WA!.U K
M8UIR:4$O;&-V-WAF,T8U8VEB8V9!9FAB-'9$-%-$;5!R>"LX*T1K84$O=2]I
M=V(X=&9I+TDW.'A:5C-I:VQV940O04Q,9C9-:#(F(WA!.U P-6M:+S<V2'=C
M9D(O8WHK2V(O04IE95)F3DAM=CA!2C-23$<Q.#!V;RMH,TU6,49E-F1(6GAY
M=$M0<C O4#DK6%(Q1$1A9S(K95$F(WA!.WHU;W=Y:VU.;C,K5%!":&Q014%*
M55!D-79:9DMN;&Y49DQ(;#9Y,$Q443,Q3WE1<6I/875Z37AD,UDW8G,W16Y-
M1$IK335'4F,O2&HF(WA!.T5):4EE4&9M2B\P3#<O:7$U+U-(,6XO1494*VM0
M,% V,S(V+T8V=G O=2MD9G15,W(Y<F9-+T(T+T1T.5!M-$]F=T],9C9V2FTO
M-5 F(WA!.R]W1$MR4#!28V8T0S15-4PK:V5F<697*V1$>#EB,79J<#$T,"M(
M<E1V;4YQ9D5V,752<'9$<C!)-WE6+V=(+T9(;7HO04$U>2]46#$F(WA!.W%,
M+T5D9E=P-CE:94A(,5!G*S$V;C)0-EI(3'@X365,;#!:675$:6QW."MR1V1(
M+T%/5DEF.')D:R]25F8X8V5T8S@O5"MS*VHY63DF(WA!.TM4-GHQ+V,X=4A0
M;#)R6'9L,'9'.$QF-D=M4&<K3'0Y8694+T%02W0O=T1L8F1T-FQF.$%(6#%-
M*VI4,750;V-'-C O8SAU2$QR=E0F(WA!.S9-<DAI948O471T4&@K3"]!139D
M*V)V+T%#<F8Y03)F*U!A+V\S-C)V,5AH-B],,2M$9C<T*TMN1&Q7=3)/;3A4
M:3E(3F14-&9$-BLF(WA!.U1*9&4O468K1G12+U-F.$%X=W9Q33,Q-VIY+S-K
M.49V5G!W*U K-W(Y;F9+65AX0W5D=',V-%1F2VYZ,2]W0EEN+SA!3#,O,"]W
M0V(F(WA!.U0O0V9X5'$O.$<X+W1:>#5Y+S555B]H1'EN*VYF5R]1,V]V+T%)
M8C1F5R]6.4QJ2#9L94AX+WEF83EQ6FHT=D<T-6-04')Y8VY,-% F(WA!.T1(
M:35D3V%495<O*VA:+SA1,C-P.'8P;GE8-G(K;'9R=G!C<2]$6#9X*S8V.4]E
M,E1Y9FU/2'DX<6$X9C5F:3@O3S-O=C5U9CAQ."\F(WA!.W=X1"]!23@U9F]J
M-C-(-DA$,758,6YG+T=N;V9&.6IN-U5Z1C S:6-8;S5U5G%E1&@Y9DIK*V]F
M;VXY0EA0,7EN-DDK<78X05=A.'4F(WA!.U Q8C!Z>G)4-'%C4$1F2UDS>&)C
M,C968T\O2F=8;#,O04I60B]W07%N,4PY1CAV.$4O=B]!3DIC=G)0<6-V:#4Q
M<BLY<CEM;D@R>DHF(WA!.VXT=FEI+W)C84AH945A*V@U:B\Q:68X03AV9B]!
M12\U;68T5"M+8U O0G90-UAQ368O2W!F,'8U1S5C+W)N,5%F-%(Y6#9Z=SE,
M9W8F(WA!.T=V3#1E9$M5.51E=C!::"]V86PW+U4U;C=Q-"\W1E!0>E,O=TPO
M:$MB+T<S+TA%.5=0<#9N4#%Q;FAW.4PT*UA8<#)R,GEV5#AF1C8F(WA!.T]B
M6G%/1&@Y9DIH9C5H+SAQ3R]1;FQB+T%"5#8O=T)2*V]J.4%C9G)F4#9R-F-6
M3V9$-'$X94@R+VDO2$PX2&I83&@U,W9Y84TO9S$F(WA!.TAI-59T>E@O04I/
M+SAQ4B]X1F0O-$4Y8CE,+U9'.68Q=G)64'$S<7@X<65T.$@R*TAV.$%J:G%V
M1S1F6'EV>5A3*T1X96IN5$EF22\F(WA!.R]+<W8X82MA4#A.5B]W05(K<S,V
M9G(V.5!5.59V531E<#A(.3=Y-6-/*U9:9D4T23A8,#E',T8T9DA,:"MR<3=Z
M>"]Y<DPO1W9L9B\F(WA!.T%"3%@O169R3"MG2V5V5#%05E@P*V9P+T(O93AE
M4%!V:FDX5&=L=R]4,5A,-&9(2&DK<F]U+TXO+VQ7+S9$<W8X93@O,&(Y8E@V
M<G<F(WA!.SEE=G(X1S8K:#A63TA+=&-D3C1L;F<U<G%F1&]C9DIN95EZ:W9!
M+WI0+S9&*R]X2F-F6'9R6"M*3UHK=69O4&XV;G%6*TQN+T%,;S4F(WA!.SEE
M5E!I-CAS,E=N.&9H,BMN>F1B<5!!-'0O<3AK.2]*4"]L5'8V579F.$@O049R
M.5 K:"]P=C91.50V>C9(3D]86#DS5#%/4$QJ=E<F(WA!.VYA;58V=GAA2$@Y
M4&LR851W<E!".5AM>50X<U K5F)F5V9-4"M$3UAR9EA0.7I(4#$O-S9R.&50
M<F9S,355-#56<5!%,C0K-UIT,"\F(WA!.V@R941V,U5F>3(O-59F.$%P<GI.
M+V<S;#E9.5IF,#-4,2]Q,W%C-6%E;C9N-W%N3&XY:F%N5&)$;CA3;SAF=U)G
M.$\U8TAX96)A>B\F(WA!.T%.0S9F6#E2*W O<$PV=%@O8VHK:5!R4#%'=%17
M=%!G-#EF<R]$5'!M5DAX-D8Q.&5B:7DX0WI6+T1K.6HO3'(O078K1EE0.$8K
M:BLF(WA!.V<V=%0P=59F56]/9G)E<"LX.5-L2S@Y*VU93V9J-'98>F,W0G=C
M4&\U4$E.8B\V1C,O5$]P+U9F,&IX-4@Y2B]O9C9Z.5)R53AU6$0F(WA!.S1/
M4%@W4'<K1UHP4$AO6%AX-75$4'=,3E@X3U0P,U10*U98+T%02W)R<CE&*VPO
M9VHV<E Y83E$,658<&-4-C-0+V0O<6503#1S=S4F(WA!.V5*-&TO=T)B;5(X
M4'<Y=F]48CAU=CA*+S1-,#,O0U9F.%!C6E!Q5F95<B]E=C9L9E8K3W9Q.'$Q
M>4=F:31Z>&95>G=C4$%/2#974C4F(WA!.U4R=B\R43T]/"]X;7!'26UG.FEM
M86=E/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @/"]R
M9&8Z06QT/@H@(" @(" @(" \+WAM<#I4:'5M8FYA:6QS/@H@(" @(" \+W)D
M9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O
M=70](B(*(" @(" @(" @(" @>&UL;G,Z>&UP34T](FAT=' Z+R]N<RYA9&]B
M92YC;VTO>&%P+S$N,"]M;2\B"B @(" @(" @(" @('AM;&YS.G-T4F5F/2)H
M='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V52968C
M(@H@(" @(" @(" @("!X;6QN<SIS=$5V=#TB:'1T<#HO+VYS+F%D;V)E+F-O
M;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E179E;G0C(CX*(" @(" @(" @/'AM
M<$U-.D]R:6=I;F%L1&]C=6UE;G1)1#YU=6ED.CE%,T4U0SE!.$,X,41",3$X
M-S,T1$(U.$9$1$4T0D$W/"]X;7!-33I/<FEG:6YA;$1O8W5M96YT240^"B @
M(" @(" @(#QX;7!-33I$;V-U;65N=$E$/GAM<"YD:60Z1D(W1C$Q-S0P-S(P
M-C@Q,3@P.#,Y0T9!,$4Q13%#-40\+WAM<$U-.D1O8W5M96YT240^"B @(" @
M(" @(#QX;7!-33I);G-T86YC94E$/GAM<"YI:60Z1D(W1C$Q-S0P-S(P-C@Q
M,3@P.#,Y0T9!,$4Q13%#-40\+WAM<$U-.DEN<W1A;F-E240^"B @(" @(" @
M(#QX;7!-33I296YD:71I;VY#;&%S<SYP<F]O9CIP9&8\+WAM<$U-.E)E;F1I
M=&EO;D-L87-S/@H@(" @(" @(" \>&UP34TZ1&5R:79E9$9R;VT@<F1F.G!A
M<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" \<W12968Z:6YS=&%N
M8V5)1#YX;7 N:6ED.C R.# Q,3<T,#<R,#8X,3$X0S$T.3@Q1D1#,4)$14%#
M/"]S=%)E9CII;G-T86YC94E$/@H@(" @(" @(" @(" \<W12968Z9&]C=6UE
M;G1)1#YX;7 N9&ED.C R.# Q,3<T,#<R,#8X,3$X0S$T.3@Q1D1#,4)$14%#
M/"]S=%)E9CID;V-U;65N=$E$/@H@(" @(" @(" @(" \<W12968Z;W)I9VEN
M86Q$;V-U;65N=$E$/G5U:60Z.44S135#.4$X0S@Q1$(Q,3@W,S1$0C4X1D1$
M131"03<\+W-T4F5F.F]R:6=I;F%L1&]C=6UE;G1)1#X*(" @(" @(" @(" @
M/'-T4F5F.G)E;F1I=&EO;D-L87-S/G!R;V]F.G!D9CPO<W12968Z<F5N9&ET
M:6]N0VQA<W,^"B @(" @(" @(#PO>&UP34TZ1&5R:79E9$9R;VT^"B @(" @
M(" @(#QX;7!-33I(:7-T;W)Y/@H@(" @(" @(" @(" \<F1F.E-E<3X*(" @
M(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^
M"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T
M.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E240^
M>&UP+FEI9#HP-#@P,3$W-# W,C V.#$Q.$$V1$%$03)!,T,Y-#(R0SPO<W1%
M=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @(" @(" @/'-T179T.G=H96X^
M,C Q,2TQ,2TP-U0Q,SHQ,3HR-"TP-3HP,#PO<W1%=G0Z=VAE;CX*(" @(" @
M(" @(" @(" @(" @/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@26QL=7-T
M<F%T;W(@0U,U/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @(" @(" @(" @
M(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @
M(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z
M<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#IA8W1I;VX^8V]N=F5R=&5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @
M(" @(" @(#QS=$5V=#IP87)A;65T97)S/F9R;VT@87!P;&EC871I;VXO<&]S
M='-C<FEP="!T;R!A<'!L:6-A=&EO;B]V;F0N861O8F4N:6QL=7-T<F%T;W(\
M+W-T179T.G!A<F%M971E<G,^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@
M(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E
M(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYC;VYV97)T960\
M+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G!A<F%M
M971E<G,^9G)O;2!A<'!L:6-A=&EO;B]P;W-T<V-R:7!T('1O(&%P<&QI8V%T
M:6]N+W9N9"YA9&]B92YI;&QU<W1R871O<CPO<W1%=G0Z<&%R86UE=&5R<SX*
M(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z
M;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @
M(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @
M(" @(" @(" @(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z,#(X,#$Q-S0P
M-S(P-C@Q,3A#,30Y.#%&1$,Q0D1%04,\+W-T179T.FEN<W1A;F-E240^"B @
M(" @(" @(" @(" @(" @(#QS=$5V=#IW:&5N/C(P,3$M,3$M,3!4,34Z,C0Z
M-#$M,#4Z,# \+W-T179T.G=H96X^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#IS;V9T=V%R94%G96YT/D%D;V)E($EL;'5S=')A=&]R($-3-3PO<W1%=G0Z
M<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T179T.F-H86YG
M960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^
M"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R
M8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/F-O;G9E<G1E
M9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<&%R
M86UE=&5R<SYF<F]M(&%P<&QI8V%T:6]N+W!O<W1S8W)I<'0@=&\@87!P;&EC
M871I;VXO=FYD+F%D;V)E+FEL;'5S=')A=&]R/"]S=$5V=#IP87)A;65T97)S
M/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D
M9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#IA8W1I;VX^8V]N=F5R=&5D/"]S=$5V=#IA8W1I;VX^"B @
M(" @(" @(" @(" @(" @(#QS=$5V=#IP87)A;65T97)S/F9R;VT@87!P;&EC
M871I;VXO<&]S='-C<FEP="!T;R!A<'!L:6-A=&EO;B]V;F0N861O8F4N:6QL
M=7-T<F%T;W(\+W-T179T.G!A<F%M971E<G,^"B @(" @(" @(" @(" @(#PO
M<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4]
M(E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYC
M;VYV97)T960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T
M179T.G!A<F%M971E<G,^9G)O;2!A<'!L:6-A=&EO;B]P;W-T<V-R:7!T('1O
M(&%P<&QI8V%T:6]N+W9N9"YA9&]B92YI;&QU<W1R871O<CPO<W1%=G0Z<&%R
M86UE=&5R<SX*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @
M(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @
M(" @(" @(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^
M"B @(" @(" @(" @(" @(" @(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z
M1D(W1C$Q-S0P-S(P-C@Q,3@P.#,Y0T9!,$4Q13%#-40\+W-T179T.FEN<W1A
M;F-E240^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IW:&5N/C(P,3(M,#(M
M,#E4,3 Z-3<Z,#(M,#4Z,# \+W-T179T.G=H96X^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E($EL;'5S=')A=&]R($-3
M-3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T
M179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @
M/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @/"]X
M;7!-33I(:7-T;W)Y/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @(" @
M/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL
M;G,Z:6QL=7-T<F%T;W(](FAT=' Z+R]N<RYA9&]B92YC;VTO:6QL=7-T<F%T
M;W(O,2XP+R(^"B @(" @(" @(#QI;&QU<W1R871O<CI3=&%R='5P4')O9FEL
M93Y"87-I8R!21T(\+VEL;'5S=')A=&]R.E-T87)T=7!0<F]F:6QE/@H@(" @
M(" \+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R
M9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z<&1F/2)H='1P.B\O;G,N
M861O8F4N8V]M+W!D9B\Q+C,O(CX*(" @(" @(" @/'!D9CI0<F]D=6-E<CY!
M9&]B92!01$8@;&EB<F%R>2 Y+CDP/"]P9&8Z4')O9'5C97(^"B @(" @(#PO
M<F1F.D1E<V-R:7!T:6]N/@H@(" \+W)D9CI21$8^"CPO>#IX;7!M971A/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"CP_>'!A8VME="!E;F0](G<B/S[_[@ .
M061O8F4 9,     !_]L A  ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! @(" @(" @(" @(# P,# P,# P,# 0$! 0$! 0(!
M 0(" @$" @,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,# P/_P  1" "& O@# 1$  A$! Q$!_\0!H@    8" P$
M        !P@&!00) PH" 0 + 0  !@,! 0$            &!00#!P(( 0D
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MO_;P[IK_ ,4PZ\_]_A\BO>6_L)_RI]S_ -+*3_JQ;]8I^^?_ "MMO_TKH_\
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MF"/<&=DH]P]<SQ1 @-D*W?NW*'%1-_8CRLO]3[7>\6R'>.2YIXQ6XLG6=?\
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M0+GH#R=-<W'*>VSW9)N7L82Q/$DQKD_,C)^9ZP/YNBMX.:=QAM !;K>S!0.
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M1M301CW+?LI?7%MSS%:Q$^#<P2HX\J*AD4G[&0 'B*D>9ZBKWDLH+GDJ2YD
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M_ S_ ,4P^+G_ +X_8WO CG/_ )7#=O\ I977_5]^LZ.3_P#E4MK_ .E=;?\
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MD6H?Y'KZM7O KK.;KX]_R/\ ^RA^^?\ Q,_:/_O<9SWT3V;_ )(]I_SS1?\
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M$BA5'@VYH * 5,1)H!YYZ>O^@A+^;]_WEU_[ /XP_P#VE?;?^M#[=_\ 1O\
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M_P#5].@[SA_RJ6Z?]*ZY_P"K+]?)QVWN',;1W%@=U[>K/X?G]L9K%[AP=?\
M;TM7]CF,+709+&5GVM=!4T53]M6TR/XYHY(GTV=64D'/N:&.XA>WF%8G4JPR
M*AA0BHH14'R->L$X99+>9)XC25&#*<&A!J#0U!H1YXZN$_Z"$OYOW_>77_L
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M3K+3F3_E7;__ )XI_P#JTW7RB_CA_P!E#]#?^)GZN_\ >XP?O/?>?^2/=_\
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MZM+U\Y+^<[\.*WX'_P P;LO;NSJ*HVUUMV!DH>]NBZS$%\=#AMM;NRE775&
MPDM$4.+/76^*+(8JC19#4QT-'23L09D)S(]MN8UYKY1@FN2'O85\"<'-60 :
MFKQ\1"K'%-18>76(?N)R\W*_-<T-N"EG*?&A(Q17).D4X>&X91YT"GSZLM_G
M$?,>B^=7\IS^7!WO+74]3OF3LS>NQ^WZ2 )&^-[9V5L*AQ6[S+31 1T<6XF$
M&;I(06\>/RE.";W !7MSRXW*W/\ O.U $6O@(\)]8GD)3/GIRA/\2GH9>X/,
M*\S\B;/NA(-SXSI*/25$ ?[-6' _A8='3_X2/_\ ,O/F_P#^'GT7_P"Z/L_V
M&?O!?[F;7_S2G_X]%T(_87_<3<O^:D/_ !V3K<)]X[=9 ]?&[['_ .9A[\_\
M//='_N\KO?1RR_W#B_YI+_QT=<];S_<N7_FHW_'CU]77^7!_V[Q^!G_BF'Q<
M_P#?'[&]X$<Y_P#*X;M_TLKK_J^_6=')_P#RJ6U_]*ZV_P"K*='/]AKH1=:8
M?_"N[_NGQ_Y=A_\ .U>\D_N]?\M?_J%_[6>L=O?S_ED_]17_ &K]%D_X2>?]
MEF?(W_Q6.?\ ]^IUY[._?W_E6[/_ )[O^L4G1+[%?\K%>?\ /%_UECZWU_>*
M/64?0+_)#_LG?OK_ ,0OVE_[P^=]F>R_\EBT_P">F+_CZ]%V\?\ ))NO^>:7
M_CC=?'P]]$NN?W7V=_?-KKHEU[W[KW7O?NO=?/U_X5:_]O#NFO\ Q3#KS_W^
M'R*]Y;^PG_*GW/\ TLI/^K%OUBG[Y_\ *VV__2NC_P"KUQU;3_PD\_[(U^1W
M_BS<W_OJ^OO<?^_O_*R6?_/#_P!99.A[[%?\J[>?\]O_ %BCZVH?<$=3?U1O
M_P *+.V,-UG_ "K.[<'7U-+#F>X]S]6]5[4@J7YK<K/OS"[[S$4$0LTTT.R]
MB965;$!#&'-PNEI1]G=ODO>?+65 3';)+*_R'AE!_P ;=1U&?NY?QV7(]S$Q
M'B7#Q1+\SK#G_C",>M*W^1]UED.U/YIOQ!Q%%3O-!M?L&M[-RDX\@BH<?UAM
M?.[X6HJ'C>,QI-D<)3TZ7.EIIT0A@VDY+>Z%\EAR)N,C',D(B'S,K*G^!B?L
M!ZQR]M;)[[G?;XU&$E,A^0C5G_PJ!]I'7U&O>#'6;/7Q[_D?_P!E#]\_^)G[
M1_\ >XSGOHGLW_)'M/\ GFB_XXO7/[>/^2M=?\],G_'VZ^H;_*C_ .W:OP:_
M\5DZE_\ >3Q_O!KGW_E==T_Y[I?^/GK-;D7_ )4[;/\ GBB_XZ.K _81Z%?6
MI5_PK1_[)X^)/_B9][_^\/![R ^[_P#\EC</^>9/^/\ 4#^_'_))L/\ GI?_
M (YU65_PE*_[>'=R_P#BF'8?_O\ #XZ^QO[]_P#*GVW_ $LH_P#JQ<= OV,_
MY6VX_P"E=)_U>M^OH%>\2.LK.OC$>^DO7.WK[!_QO_[)WZ%_\0OU;_[P^"]\
M[=Z_Y+%W_P ],O\ Q]NN@.S_ /))M?\ GFB_XXO0T>RSHQZ][]U[HA_\SCY+
M1_$;X'?)GO*#(?PW<>W^M<M@-@5$<ZPU2]D;]:'8VP9Z1;&6H?&;IW#35LJ1
MC4*:FE>Z*K.HJY(V4\P\UV.UD:H7G#2>GAQ]\E?M52!\R/LZ"_.F\C8.5[W<
MP:3)"53U\1^Q*?8S GY ]?,!^)/>V.^,'R4Z8^0V2Z^H>TDZ:WSB^P<=L;)9
MN7;M%EMQ;<\M?M6JES,&,S,U$<#N:.DR*%::0N]($].K4N<?,&U/OFRW.SI,
M8#<Q&,N%U$*V&&FHKJ6J\1QZPKV'=$V7>;;=GB$_T\HD"$Z067*FM#32U&X>
M76S]_P!!<'8G_>$.R_\ T>><_P#M9>X._P"!]L_^CI+_ ,X%_P"MO4U?Z_5W
M_P!&V/\ YS-_UKZU?_EIWKC_ )._)3N?Y#8[8%%U>O<N^LOV'D=D8_-/N*CQ
M&X=RM'D=TSPYF7%822N_C>Y9JNO8M31LC510ERNMIQY?VI]CV6VV=YC/]-$(
MPY722JX7%6II6B\?+RX=0KOVYIO6\7.[)$(/J)3(4!U ,V6S05JU6X>?Y];S
M?_"7WY-KVU\%MS= Y:O6?<_Q=[&R&*H:5YQ-4KUKVG/D]\;3JIB]IP!NX;EH
MXU.I(Z>CB56L B8N>^6Q_N_FE-VC%(+Z$$GR\2*B./\ >/#/VD_:<F?97>OK
M^6'VJ0UGLIB /^%RU=3_ +WX@^P#[!8]_.9_[=<?-?\ \0QDO_=QAO8,]MO^
M5ZVS_GI'^ ]"_P!Q/^5)W+_GF/\ A'7S6OA1_P!EE?$G_P 6;Z%_]^IM3WFE
MS-_RK>X?\\,__5I^L.N6_P#E8K#_ )[8/^KJ]?7<]\]NL^>O>_=>Z][]U[KY
MX/\ PJ,_[>58+_Q63JW_ -ZSLSWF![%_\J4__/=+_P <BZQ+][/^5Q7_ )XH
MO^/2=7._\)//^R-?D=_XLW-_[ZOK[W&WO[_RLEG_ ,\/_663J1?8K_E7;S_G
MM_ZQ1];4/N".IOZ)A_,?_P"W>/SS_P#%,/E'_P"^/WS[$O)G_*X;3_TLK7_J
M^G0=YP_Y5+=/^E=<_P#5E^OE=_'6..;Y!=%0S1I+%+W)UC'+%(BR1R1R;VP:
MO'(C JZ.I(((((/O.[>"1M%T1Q^FE_XXW6#^T '=K4'A]1'_ ,?7KZ[_ /HW
MZ[_YX+9?_H+8/_ZA]\]?K;S_ '[+_O3?Y^L^?H[3_?4?^\K_ )ND;V-USUZG
M7N^W38FS4=-F[H967:^$5E9<)7%65A0@A@1<$?3VIL[R\^LB_5D_M%_$W\0^
M?2>[M+06DOZ4?]FWX1Z'Y=?'N]]$^N?W7V0^M_\ F7>PO_#+VM_[HZ'WSCO?
M]S)?^:K?\>/70FS_ -Q(O^::_P#'1TM/:;I3UII?\*UNG,E-C/AW\@:&CE?$
M8^N[+Z<W1D-4IAILEF*? ;UV)1A=1A66NI<'N-R0%9A3BY8 :<D/N_;B@?<=
MH8_J$1S*/4#4DA_(M'^WK'CWXV]RFW[JH_3!DB8_,Z70?F%D_9U35_PGL[\P
M_0_\S_IN/<60BQ6 [JPF[NAZZNGD6.%,IOBDI<ELFC?78,V8[$VUB*%!<6DJ
M5/XL9']WMIDW7D>Y,(U36S).!\D)#G\HV=ORZCSVGW6/:^=;<3'3%<J\!/S<
M H/SD5%_/KZ87O"CK,KKWOW7NOC=]C_\S#WY_P"'GNC_ -WE=[Z.67^X<7_-
M)?\ CHZYZWG^Y<O_ #4;_CQZ^M1\)_\ LC/XD?\ BL?0O_OJ]J>^?_,W_*R;
MA_SW3_\ 5U^L\.6_^5=L/^>*#_JTO6A3_P *8_\ MZ/NO_Q#'3__ +IZ_P!Y
M7>R?_*BQ_P#/3-_A'6+GO+_RNTG_ #S1?X#U>C_PD\_[(U^1W_BS<W_OJ^OO
M<6>_O_*R6?\ SP_]99.I.]BO^5=O/^>W_K%'U2!_PHR^!47Q2^8S=X;#PS4/
M3GRP;.;\IDI8=..VWV_1U<,G:6W8Q&K)24^:JLG39^E#E [Y.JA@0149M)_L
MWS6=_P"7/W7=M7<=OTQFO%H2/TF^>D QG_2J2:MU&GN[RL-BYA_>=JM-OOZN
M*<%E!_57Y5)#C_3,!A>KU/\ A,G\_3W=\>\]\+^PLU+5]F?&VD&8ZWEKYUDJ
M<_T-E:^&EI<= [R2553+UAN>M^P<MIC@Q>2Q<$0(A?3%GO=RE^[-W3F6S6EE
M>FDE."S@5)]/U5&KYLKD\1U)WLQS5^\MI?EV[:MY9BL=>+0$T ]?TV.GY*R
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MB.:=S*>!!].CGVCYNY<Y>V6YM=YND@G>ZU*"KFJ^&@KVJPX@CJ\OL#_A0O\
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MX?\ 90_0W_B9^KO_ 'N,'[SNWG_DCW?_ #S2_P#'&ZP@V?\ Y*UK_P ],?\
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MGR%-'M+MW9G8.>R]-3J6E;;NU-A9;<FZ-QN" NFAHZAM;!;7(O!EGR/SA?7
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MOU_S-N\V];D5^KF(J%!"J%4*JJ"20  .)))J2223T+]@V.QY<VJ+9]N#?2Q
MT+$%F+$LS,0 "22?( "@   '1DO9+T<= %\HOC9UC\ONA.R/CCW'1Y*LZ\[/
MP]-BLXV$JZ?'YW'3XW*X_/X/.X&OJZ+)4E'F]OY_$TM;2234]1")X%\D4B:D
M8VV+>K[EW=H=YVTJ+R!B5U"JFH*LK $$JRDJ:$&AP0<]%6][/9;_ +7-M&X
MFTG6C4-&%"&5E)! 96 (J"*C((QU27\:_P#A-1\/_C=WWU+W[C>X_D'O;-].
M[YP'8NV]N;ARVR,;@:S=.U*Z+,;:GR\VVMG8G,U%#C,Y2P53TT=3%'5>$0S:
MX'DC>3=Z]ZN8MZVFXVE[:SBBN8FC9E#E@KBC4U.14J2*T-*U%" 1&^S>SG+^
MS[I!NJ7%W)+;RK(JL4"EE-5KI0&@8 TJ*TH<$CJ\GY%=$;(^3W1?:GQ][';+
MQ;)[<V7F=E;@JMOUD6/SV.I<M3F.++82LJ:6NHX,OB*M8ZJF,]/44YFA430R
MQ%XVB[9MUNMCW2#=[+3]5;RAU#"JDCR85!H14&A!H<$'/4F;OM=MO6V3[5>:
MOIKB,HQ4T8 ^8-"*@Y%0149!&.M<;_H$\^&O_>1WR;_ZG=5__:^]S+_K^\R?
M\H=C_P!5?^MG40_ZQ7+O_*9>_P#5+_K7U[_H$\^&O_>1WR;_ .IW5?\ ]K[W
M[_7]YD_Y0['_ *J_];.O?ZQ7+O\ RF7O_5+_ *U]+KK#_A+C\,^M>R-A=B'O
M+Y';E;8>\-N;QAV_DLAUS18W,U.VLO29FEQN2JL7L2FR4./JZFB1)S3RPSF(
ML(Y(V(=4M][Z<R7ME+9_2V2>+&R:@)"0&!!(!D(J <5!%>(/#I39>R?+MG>1
M7?U-X_A2*^DF, Z2" 2$!H:9H0:<".MF?W"74S=4K_S$OY'/QL_F.=T8#O;L
MGLCN'KS>>'V%B^O*N'KZOVFV&S.)PF7S>7Q-;4T>Z-L9Z:DR=.^X*B%V@ECA
MEB6.\8=7>22^3_=#>N3=M?:K*&VFMFE,@\0/J!8*" 59:CM!R*@US3 CGFWV
MTV?F_<4W2\FN(;A8A&?#*T(4L02&5J'N(P:$4Q7)-5_+K_EU].?RU^G-R=/=
M/;DWYO"DWAORO["W+N7L*OP]7F*S,5>'PVWZ:CHZ;;^&P6)Q^*Q^)P4 1! \
MSS/*[RLK1QQ$/./..Y<Z;DFX[BD4;1Q"-5C!  !+$DL6))+'SI2@ XDGG*/*
M.W\G;>^W[>\LBR2F1FD())("T&D*  %'E6M23P /]["70JZ#[MKK/;'=/579
MG3F]DK9=F=L]?;SZSW=%C:D461DVQOS;F2VMGTH*QHIUI*U\5E91%*4<1R6;
M2;6]J]OO9]LOX-RM:?4V\R2)45&J-@RU'F*@5'22_LH=QL9MON:_3SQ/&]#0
MZ74JU#Y&A-#UKO=7?\)<_A=UIV;L+L<]V_)#=";"WEM[>=/MK*Y3KJBQV:J-
MM9:ES-#B\M78C8-'E$QM554<:5)I9*>H>$N(I87*R),-][Y\RWMC+9_2V4?B
MQLFH"0E=0() ,A%0#BH(KQ!&.HELO9/ERSO8KSZF\?PI%?23& =)! )" T)&
M:4-.!''K9B]PGU,O4+)8ZCR^.K\3D8?N,?E**JQU=3^26+ST=;!)35,/E@>*
M:+RP2LNI&5EO<$'GW9':-Q(AHZD$?:,CJKHLB&-\HP(/V'CUK!?] H_P>_CO
MWW^G;Y/?P+^+_=_P#^,=8^7^$_>>;^$?Q?\ T;^?7]G^S]SX]=_7IOQ[G'_7
M[YH\+1]+8^+IIJI+QIQIXGKFGY=0K_K&<M>+J^JO?"U5TUCX5X5\/TQ7\^MG
MW&XZCQ&.H,3CH?M\?BZ*EQU#3^267P4=%!'34T/EG>6:7Q01*NIV9FM<DGGW
M!SNTCF1S5V))^TY/4U(BQH(TPB@ ?8.'4WW7JW7O?NO=$H^9?\O+XE?/;;%%
MM_Y)=5XW=.3PE/-3[4W_ (BHGVWV1LZ.>1II(=O[QQ9BR*8V2H8RR8ZJ^ZQD
MTMGEIG95($W+?.','*<YFV6X:-&-7C/=&_\ ID.*^6H48# 8=!OF+E+8>:81
M%O$ =U':X[9$_P!*XS3STFJDY(/6N#VC_P ))=FUF3J*OI;YG[GV]AVF;[3
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+WOW7NO>_=>Z__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>unh-20211231_g1.jpg
<TEXT>
begin 644 unh-20211231_g1.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
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M P,# P,# P,# P/_P  1" "& O@# 1$  A$! Q$!_\0!H@    8" P$
M        !P@&!00) PH" 0 + 0  !@,! 0$            &!00#!P(( 0D
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MO_;P[IK_ ,4PZ\_]_A\BO>6_L)_RI]S_ -+*3_JQ;]8I^^?_ "MMO_TKH_\
MJ]<=6T_\)//^R-?D=_XLW-_[ZOK[W'_O[_RLEG_SP_\ 663H>^Q7_*NWG_/;
M_P!8H^MJ'W!'4W]:D_\ PJ1^#^T-P])[,^=.SMOX_%]C==[JP'7/;^4H*6*D
MFW?UUNT/BMHYC/S1K_N0R^RMVQ4>.I)&7S/0YAHY)&CI::-,@?8OFBXAW.7E
M:Y<M9S1M)"":Z)$RX7T#I5B.&I*@59B8&][>6K>;;8^9[= MY"ZQRD"FN-L(
M6]2C44>='H310.JA_P#A,W\F<QTY_,)I>E*C)RQ;&^46QMQ[.RF+EE9,<-\;
M$P^5[!V+GW12 <E34N(RV)I[W4C-N"-10K(7O9LD>X\H'<PO^-6,JN#YZ)"(
MW7["2CG_ $@Z /LUO4FW\V#;2W^+7L3(1Y:T!D1OMH&4?Z<]?10]X>=9;]?'
MO^1__90_?/\ XF?M'_WN,Y[Z)[-_R1[3_GFB_P".+US^WC_DK77_ #TR?\?;
MKZ+_ /+.^>7P;V'_ "^OAOLO?/S-^*&S-X[7^._6&$W+M/=GR)ZAV[N7;N9Q
M^V*&GK\1G<%F-X4>4Q.3HIT*34]1%'+&X(901;WASSMRIS1=\W;E<VNVW\MM
M)>2LKI;S,K*6-"K!""#Y$&AZRYY-YHY9M>5-NMKG<;&.X2TC#*UQ$K*0HJ&4
MN""/,$5Z/%_PX_\ R\?^\\_AA_Z5'T?_ /9S["_]3.</^C3N7_9+/_T!T)OZ
MX<I?]'3;O^RF'_H/K6%_X4[_ "A^,_?O1/Q?Q'1/R)Z+[JRVW^VMX9+/8OJ7
MMO8'8^1PF.JMG0TM-7Y>BV=N#,U.-HJBI!C26941W]()/'N</8_8M[VG=;Z3
M=;.ZMHWMT"F6*2,,0]2 74 FGD.H6]Z=[V;==KLH]KN[6YD2=RPBE20@%*5(
M1B0*^9Z)]_PE*_[>'=R_^*8=A_\ O\/CK[$7OW_RI]M_TLH_^K%QT'O8S_E;
M;C_I72?]7K?KZ!7O$CK*SKXQ'OI+USMZ^P?\;_\ LG?H7_Q"_5O_ +P^"]\[
M=Z_Y+%W_ ,],O_'VZZ [/_R2;7_GFB_XXO0T>RSHQZ][]U[KWOW7NM+[_A6-
M\F9#/\9?A]AJ]EB2+,?(??\ 1)(A6621\IU[U?J"-Y%:!8]TO(C@*WDA87(N
M,D_8'9!2^YBD&<6\9_9)+_UB_GUCK[[;R:V7+\9QF>0?MCC_ .LO\NJ],!_+
MK6I_X3O[O^5TF MV34?)7&]\8[(?:R1Y>7I+;%94_'M\&8YF4C&)G,YE=QM*
M%'EI8HG6Z*"PPFYQT^\$>P!_\2%D8"*X\9@+C5]NE5CIY$D=!.+E&OM+)OI3
M_'#>"<'S\%3X%/LU,TGS !Z"O_A.M\FT^/7\RCKS:^7KDH]H?)+;^;Z'S1G8
MF"/<&=DH]P]<SQ1 @-D*W?NW*'%1-_8CRLO]3[7>\6R'>.2YIXQ6XLG6=?\
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M0+GH#R=-<W'*>VSW9)N7L82Q/$DQKD_,C)^9ZP/YNBMX.:=QAM !;K>S!0.
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M1M301CW+?LI?7%MSS%:Q$^#<P2HX\J*AD4G[&0 'B*D>9ZBKWDLH+GDJ2YD
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M_ S_ ,4P^+G_ +X_8WO CG/_ )7#=O\ I977_5]^LZ.3_P#E4MK_ .E=;?\
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MD6H?Y'KZM7O KK.;KX]_R/\ ^RA^^?\ Q,_:/_O<9SWT3V;_ )(]I_SS1?\
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M$BA5'@VYH * 5,1)H!YYZ>O^@A+^;]_WEU_[ /XP_P#VE?;?^M#[=_\ 1O\
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M_P#5].@[SA_RJ6Z?]*ZY_P"K+]?)QVWN',;1W%@=U[>K/X?G]L9K%[AP=?\
M;TM7]CF,+709+&5GVM=!4T53]M6TR/XYHY(GTV=64D'/N:&.XA>WF%8G4JPR
M*AA0BHH14'R->L$X99+>9)XC25&#*<&A!J#0U!H1YXZN$_Z"$OYOW_>77_L
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M3K+3F3_E7;__ )XI_P#JTW7RB_CA_P!E#]#?^)GZN_\ >XP?O/?>?^2/=_\
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MZM+U\Y+^<[\.*WX'_P P;LO;NSJ*HVUUMV!DH>]NBZS$%\=#AMM;NRE775&
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M>FDE."S@5)]/U5&KYLKD\1U)WLQS5^\MI?EV[:MY9BL=>+0$T ]?TV.GY*R
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MB.:=S*>!!].CGVCYNY<Y>V6YM=YND@G>ZU*"KFJ^&@KVJPX@CJ\OL#_A0O\
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MX?\ 90_0W_B9^KO_ 'N,'[SNWG_DCW?_ #S2_P#'&ZP@V?\ Y*UK_P ],?\
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MGR%-'M+MW9G8.>R]-3J6E;;NU-A9;<FZ-QN" NFAHZAM;!;7(O!EGR/SA?7
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MOU_S-N\V];D5^KF(J%!"J%4*JJ"20  .)))J2223T+]@V.QY<VJ+9]N#?2Q
MT+$%F+$LS,0 "22?( "@   '1DO9+T<= %\HOC9UC\ONA.R/CCW'1Y*LZ\[/
MP]-BLXV$JZ?'YW'3XW*X_/X/.X&OJZ+)4E'F]OY_$TM;2234]1")X%\D4B:D
M8VV+>K[EW=H=YVTJ+R!B5U"JFH*LK $$JRDJ:$&AP0<]%6][/9;_ +7-M&X
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M%O$ =U':X[9$_P!*XS3STFJDY(/6N#VC_P ))=FUF3J*OI;YG[GV]AVF;[3
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+WOW7NO>_=>Z__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>44
<FILENAME>unh-20211231_g2.jpg
<TEXT>
begin 644 unh-20211231_g2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1$ 17AI9@  34T *@    @ ! $[  (
M   2   (2H=I  0    !   (7)R=  $    D   0U.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 %-I;7!S;VXL
M($UA<F-U<R!*   %D ,  @   !0  !"JD 0  @   !0  !"^DI$  @    ,V
M-P  DI(  @    ,V-P  ZAP !P  " P   B>     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M'UGJ#^(K%6M[)-UF\P6XWJ@RGE_>SD8X!%>/_"2"1?V;_B).RD1R1RHK>I6
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MS/DY[X[4 >X^$;__ (6U\!%@EO/(NK^P?3[J?9O,<H&QF*Y&<\-C(^]7SO\
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MX%^U#_S)O_7]+_[3H @L?AFO[/VGZOX[/B!=7DM[%K:&U:Q\D-)(Z!"6\QN
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M*4>1LHP+JN09 5' QN([5N>,M0L]+_;#T:]U.[@L[6*W0R3W$@C1!Y,@Y8X
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MXBL[66YN9!'#"ADD=NBJ!DG\A6%X*\:Z;X[T)M4TB*Y@C24Q/#=H$D0[0PR
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ME:S=5<L%90"65AC#GMZ5U-% 'B7_  RIX(_Z"OB#_P "(/\ XS6R?V?/"_\
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M,;FV@#)ZG  ]JP/&GP_\.^/]/CM?$ECYYA),,\;%)82>NUAV/H<CIQQ72T4
M>2Z%^S9X"T74DO)8[_5#&VY8K^=6C!]U15S]#D5Z9K.B:=XAT6XTG6;2.[L;
ME-DL+C@CJ/H00"".015ZB@#QE_V7/ ;7GG"YUI8]V?LXNDV?3)CW8_&O0_\
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MS)A&\2OM9^K8).">:VK#P9;66N:=K$^I:C?WVGV4EDLUW(C&5'<.6?"#+ J
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M;HVB7>G:AI5WIL]T]U;2B4B2.1%"AE;;C#'(QGI71?V]H_\ 8G]L_P!JV/\
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MC[-! J1X/7Y0,5<HH S=*\.:'H3ROHFC:?IK3?ZQK.U2(O\ 7:!FM%E#*58
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110!Y9\<]$?6M*T8VMSI4EW9W,ES%I&J3A%U$+&05121N=<C Z?-SQP>(
M\&_$;P_X'^&.H_V?H7]C>) EE"]K+<@PW4\T&8+C)8(BLB[W^[CN22#7L?CS
MP)I?C[018ZD)(I[>3S[.[@D\N6WE'1E;!X/0C!]>H!&/X.^$7AW0/"\5CK6G
MV^N7TR0O>SZBHNM\J1[%";UX1 2J# (6@#RGX3WD.@ZW\388/$5MJFIM8K<0
MWD5PK&\F$4LDDD>#\P#MG(Z<9J+1](T_1?!7PBUW1K*&+5[O7(XKBZC4"6X2
M1W$BNW5ACCGH*]I\._"SPMX8\3:IKFEV$:SZB%7R6AB$5LH!!6%50% P/S#)
MS6?H/P7\->'O$-KJ=I<ZM/#8222Z?IMU>&2TLG<Y+1)C(/7J3USR0" #Q.>P
MM&^ ^M^,6MHF\31^)C.FH% 9UD$R?*&^\!R3MZ9YKZL4DH"PVDCD9SBO/9?@
MIX8E\3-JIGU1;:2^_M"31UN\6,EQ_P ]#%C.<\]<=L;>*]#H K76H0V;*LR7
M#%AD>3;22C\2JG%2P3QW-O'/ V^*5 Z,.X(R#4E9WA[_ )%G2_\ KSB_] %
M&C1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !6=X>_Y%G2_^O.+_P! %:-9WA[_ )%G2_\ KSB_] % &C1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6=X>_Y
M%G2_^O.+_P! %:-9WA[_ )%G2_\ KSB_] % &C1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !17(?$/QVW@G3;06.ERZMJVI3&"QLT<1JS
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M2J[4"Y)P,9)Y-+10!6NK2:X93%?W%J ,$0K&0WUW(U5_#W_(LZ7_ -><7_H
MK1K.\/?\BSI?_7G%_P"@"@#1HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BN.9O$&L>
M,-;L['7SIMKIY@6.-;..7.^/<22W/6JOB6'Q5X?\.W6J)XL:X-L%;RGTZ$!\
ML!C(''6@#NZ*** "BBB@ HHHH **** "BBB@ HHHH *SO#W_ "+.E_\ 7G%_
MZ *T:SO#W_(LZ7_UYQ?^@"@#1HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *;++'!"\L[K''&
MI9W<X50.223T%9^O^(=+\+Z+/JVO7D=G9P#+2.>I[*!U)/8#DUYO%IFO?&*Z
M6[\0QW6A>" 0UOI>[R[C4QU#S$<I'W"CK^34 <GJ7CR7Q5XVUVP\*ZVNC:#?
M2Q+=Z]L8R.D<81DMP!U)S\_8<@],]GK>O>$K3X8/X;\.7XE\J"."WB$3[Y,.
MO).T98\DGN237IEC8VNF6$-EIUO%:VL"!(H8E"JBCH !TJ>@ HHHH **** "
MBBB@ HHHH **** "BBB@ K.\/?\ (LZ7_P!><7_H K1K.\/?\BSI?_7G%_Z
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ML[P]_P BSI?_ %YQ?^@"@#1HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0?#^E^&-&ATK0K*.SLX!A(XQU/<D]23W)Y-:- !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M** ,;Q7X4TCQGX?FTC7[..ZMW.Y-X.8I!G:ZD$$$9/0C()'0FN<L/@YX.M_
M=MX6O-+2YM$9)KADEEA-S.JD&1BK[CG)(4L0,C'05WE% '(>%OA7X-\%:L^I
M^&='^Q7CPF%I/M4TF4)!(P[D=5'..U&C_"CP/H'B0Z]H_AVVM=1)9ED5G*QE
MNI2,L43T&T# X&!77T4 <E+\+?!4WC >*)/#]N=8$OG>?N<*9/[YCSL+9YR5
MSGGKS76T44 %9WA[_D6=+_Z\XO\ T 5HUG>'O^19TO\ Z\XO_0!0!HT444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %9WA[_D6=+_ .O.+_T 5HUG>'O^19TO_KSB_P#0!0!HT444 %%%% !1110
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M]XJ\1SZ'L-@$LXXC%$40;4<$*,#I7:T4 %%%% !1110 4444 %%%% !1110
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MF:&WM--C*176H3@M&#U)D<Y&?K7(W7QGTN]NI++P)I&I>+[U#M;[!$4MT/\
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M_M'5K@V\%SJ$FRWM\#<6?N3C@#U/?&TXVF>._']M\)UU;4?"G]K:W,D T]K
M[X[Q94#"9T7+1[<_.,*">A4'(T?C3'J3^$H?L_AFU\2:5YI&I6C1,]Q$A4A9
MH,$89<G)&3SV&XCSCX?7_BSP/\+]7U;P_P"'-7N[6^6SCT33989)F68PG[1<
M;%R5B9\L.@;Y>F<T >@>&_B'XAM/&6L>&/B%:Z4MWI^EG55NM&,AB,*D!E82
M'=NYSV_D3D>'OBSXKN;[PWJOB'2-*MO#/BB\:SL!;22&ZMW+$1F4GY6#8(^4
M#KGC&#2^%U@;_3->T_5-"\50>)M>L96U+7-;TTP0NQ7:(HSN.%7?P,#(4G@
M*,C0-'\2:U:^ O!=_P"%-5TY_"VJ"\U'4+F';:LD3DJ(I<X<MN X^HR,D &Y
M-\9O$RQW7BN+2=+_ .$'L]6_LZ4M))]M9<A3.#]S;D@XQGM_M5[97S5<>&?$
MZ^#=1^%7_",:HT][KOG1ZPL.;(6I=7\PRYP&POW>O;[WRU]**H1 JC 48 H
M6L[P]_R+.E_]><7_ * *L76GPWC*TSW"E1@>3<R1#\0K#-5_#W_(LZ7_ -><
M7_H H T:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MDA61"2P_+-=/X$^%_@K3/#FEWUOX<L9+N:TBE>>YC\]R[("6!?..3VQ75_\
M"*^'O^@#IG_@''_A6I'&D4:QQ(J(@"JJC 4#H * %5510J *JC  & !2T44
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M\RY'-:WV7XM>+/\ CZN]+\$6+]8[9?MMYCN"QP@^HY%>CVEG:V%JEM86T-M
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M&L[P]_R+.E_]><7_ * * -&BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@T4 5K#3;'2[86^F65O9PCI%;Q+&H_  "K-%% !1110 4444 %%%% !1110
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MK[5ZY9:=9:9!Y&FV=O:1#_EG!$L:_D!0!Y]_PLCQ?J_'A;X9ZLR-TFUF>.Q
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *SO#W_(LZ7_UYQ?^@"M&L[P]_P BSI?_ %YQ?^@"
M@#1HHHH **** "BBB@ HKG_$7CSPMX34GQ%KME9.!GR7DW2D>T:Y8_@*Y/\
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M[2I9290V[>0#@G//2@#F-2\8>+]>TNYTZX^$-]=6=U&8IHKC5H8MZD<@]Q7
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MKOZ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MBE86^/.NM=U&&/)P-S+M'ZFN-T#4H_$NE?#7P/8P7B:]X?UA;K5;9[=T-G'
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5G>'O^19
MTO\ Z\XO_0!6C6=X>_Y%G2_^O.+_ - % &C1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !6=X>_Y%G2_P#KSB_] %:-
M9WA[_D6=+_Z\XO\ T 4 :-%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M2X/"GB34!?WOG1R?;+=BX9TBQ\A!VK]XCCCC&3[);P1VMK%;PC;'$@1!Z #
MJ2B@"M=:;8WS*U[96]RRC"F:)7('MD57\/?\BSI?_7G%_P"@"M&L[P]_R+.E
M_P#7G%_Z * -&BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "L[P]_R+.E_]><7_ * *T:SO#W_(LZ7_ -><7_H H T:
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *SO#W_(LZ7_UYQ?\ H K1K.\/?\BSI?\ UYQ?^@"@#1HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M -&BL[^T[O\ Z E__P!]P?\ QVC^T[O_ * E_P#]]P?_ !V@#1HK._M.[_Z
ME_\ ]]P?_':/[3N_^@)?_P#?<'_QV@#1HK._M.[_ .@)?_\ ?<'_ ,=H_M.[
M_P"@)?\ _?<'_P =H T:*SO[3N_^@)?_ /?<'_QVC^T[O_H"7_\ WW!_\=H
MT:3<"Q4$;@ 2,\@?Y!K/_M.[_P"@)?\ _?<'_P =JK'<WR:Q<79T6]\N6"*-
M1YD&05:0G_EI_MC]: -NBL[^T[O_ * E_P#]]P?_ !VC^T[O_H"7_P#WW!_\
M=H T:*SO[3N_^@)?_P#?<'_QVC^T[O\ Z E__P!]P?\ QV@#1HK._M.[_P"@
M)?\ _?<'_P =H_M.[_Z E_\ ]]P?_': -&BL[^T[O_H"7_\ WW!_\=H_M.[_
M .@)?_\ ?<'_ ,=H T:*SO[3N_\ H"7_ /WW!_\ ':/[3N_^@)?_ /?<'_QV
M@#1HK._M.[_Z E__ -]P?_':/[3N_P#H"7__ 'W!_P#': -&BL[^T[O_ * E
M_P#]]P?_ !VC^T[O_H"7_P#WW!_\=H T:*SO[3N_^@)?_P#?<'_QVC^T[O\
MZ E__P!]P?\ QV@#1HK._M.[_P"@)?\ _?<'_P =H_M.[_Z E_\ ]]P?_':
M-&D9@HRQ &0,D]SP*S_[3N_^@)?_ /?<'_QVJNHW-]>6J1Q:+>@K/#(=TD'1
M)5<_\M.N%- &W16=_:=W_P! 2_\ ^^X/_CM']IW?_0$O_P#ON#_X[0!HT5G?
MVG=_] 2__P"^X/\ X[1_:=W_ - 2_P#^^X/_ ([0!HT5G?VG=_\ 0$O_ /ON
M#_X[1_:=W_T!+_\ [[@_^.T :-%9W]IW?_0$O_\ ON#_ ..T?VG=_P#0$O\
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MG=_] 2__ .^X/_CM']IW?_0$O_\ ON#_ ..T :-%9W]IW?\ T!+_ /[[@_\
MCM']IW?_ $!+_P#[[@_^.T :-%9W]IW?_0$O_P#ON#_X[1_:=W_T!+__ +[@
M_P#CM &C16=_:=W_ - 2_P#^^X/_ ([1_:=W_P! 2_\ ^^X/_CM &C16=_:=
MW_T!+_\ [[@_^.T?VG=_] 2__P"^X/\ X[0!HT5G?VG=_P#0$O\ _ON#_P".
MT?VG=_\ 0$O_ /ON#_X[0!HT5G?VG=_] 2__ .^X/_CM']IW?_0$O_\ ON#_
M ..T :-%9W]IW?\ T!+_ /[[@_\ CM']IW?_ $!+_P#[[@_^.T :-%9W]IW?
M_0$O_P#ON#_X[1_:=W_T!+__ +[@_P#CM &@6"D D L< $]3U_I2UB7=S?7%
MU82)HMZ%MYS(^9(.08W3C]YZL/UJU_:=W_T!+_\ [[@_^.T :-%9W]IW?_0$
MO_\ ON#_ ..T?VG=_P#0$O\ _ON#_P".T :-%9W]IW?_ $!+_P#[[@_^.T?V
MG=_] 2__ .^X/_CM &C16=_:=W_T!+__ +[@_P#CM']IW?\ T!+_ /[[@_\
MCM &C16=_:=W_P! 2_\ ^^X/_CM']IW?_0$O_P#ON#_X[0!HT5G?VG=_] 2_
M_P"^X/\ X[1_:=W_ - 2_P#^^X/_ ([0!HT5G?VG=_\ 0$O_ /ON#_X[1_:=
MW_T!+_\ [[@_^.T :-%9W]IW?_0$O_\ ON#_ ..T?VG=_P#0$O\ _ON#_P".
MT :-%9W]IW?_ $!+_P#[[@_^.T?VG=_] 2__ .^X/_CM &C16=_:=W_T!+__
M +[@_P#CM']IW?\ T!+_ /[[@_\ CM &C2*P=0R$,K#((.016?\ VG=_] 2_
M_P"^X/\ X[4NCV\EIH=C;3C;+#;1QN <X(4 T 7**** "BBB@ HHHH ****
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M&CD>18-0-T=0N)%V[ERSF-%QG:6XSQG)Q[U110 4444 %%%% !1110 4444
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MPIX)TC0FD65[&U2*21!@.X'S$>Q.:W** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]>%_*O,]!T^RUCX3Z9H^M?%&VTBW%Z5&@C0TFNK>Y$C8(V-YQ)SG=C^+;[4
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M99$)R0/3) SCK@>@J&?P_I-SIC:?/8Q/:M.UR8R.DK2&4N#U#;R6R.0:T:*
M"BBB@ JCJNBZ5KUJMKKFF6>I6Z.)%BO+=9D5@" P# C."1GW-7J* *6E:-I>
MA6AM=$TVTTZW9RYAM(%B0L0 6VJ ,X Y]JJMX1\-OK']K/X?TIM2\P2_;391
MF;>.C;]N[/OFM>B@#/N=!T>\L;FSO-*L;BUNI?.N();9&2:3(.]E(PS9 Y//
M J]'&D,2QQ(J1HH5448"@= !V%.HH " RD,,@\$'O533-)T[1;(6>CV%KI]J
M&+""UA6) 3U.U0!FK=% %&PT/2=*L9;+2]+LK*TF9FDM[:W2.-RPP254 $D
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MUZ5JT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3P:U/@_X5UGPM!XG77;/[*;_ %N:[MOWJ/OB8##?*3CIT.#7,^)_A#J'Q/\
MBUJ=_P",UO-.\/V=JEMI;6EQ%OG(.2V/GVC)<X*@G*^AH T?@3J%[:>&]:\$
M7\J_VIX7O)+9#("0T3%BC8SDKNW=_N[:JQ_&G4H/@_K.NZC9V*^)M+U%M,>R
MC1_*:?> N%+;B-I)X;G:?I4/A/X2:C\+_BW8WGA!+O4?#E]9O;ZE)=7$6^!L
MY5L?+N&0G121\WK4>M_"/5[WX_6^J6\)_P"$2N;F'5;W$J!5NXD<*-A.XDM@
MD@8_>'TP #8\9?%+6/#EYX?\-PGP_:>(]0LENK^ZU:X:"QM..1][<=S*P SD
M8'7/%?2OC)?:C\-_%NH^1ICZ[X8XE-I*9[*YSG9(A#9VMM;C=GCKS@2_$[P#
MJ5]X^TCQEHOAW3_%/V>V:RO=&OWC594RQ5U,@*@@L??@8!R<,_X0[Q!??"/Q
M7:'P?H&@:IJR,EIIFCQQQOY8)V+/*"$=^3R,#![$D  --\=_$B?X<R>+[S2O
M#8M[FRCDL;?[4T!C=B 9IY)7""/&6"@[CN49!R:C^'?Q=U?Q!\2KGPEKDGA_
M4<6QFBO_  ^TQA5E^\A,GW^".5X'OGA/%_P]\2:S\!?#&A6%M$VJZ.MG+<:=
M-*NRX,<95HBV=IY.>N#CKTJ'PQX7\8/\:=*\4:IX2M-!TA-+>P2SL[R*06*K
MN*AMNT'<V<; 0 R@XP: 'K\4_&VN1>)->\(Z)H\WAG07FA/VN2075TT:$L\>
MWY<#Y6VG!(X!R>&3?&Z_@^&'A75)(-)C\0>)9I(HOM,K065LJ2E6ED)8G:!M
MXW<Y.#Q@\WI\?B/PIX;\>>'/"RZ)K&@2/=7)UI-5B/\ 9RO$=Z21 ER^U-H!
MP-W))&<)I/P^U/Q'\$_A]K.D:;:ZI?Z')-,=*OMHCO8))F+)\_RYP%(SQ@D]
M0 0#T+X:_$ZZ\4>)M4\,:Z^BW&IV,*W,=[H-R9K2YB) .TDD@J64')YST&.?
M2Z\]^'&B:I;:MJ.IZKX$\.>#XF00VEOI\<;W;+\I<R31X0H6 (  /'/0$^A4
M %%%% !1110 4444 %4]4UC3-$L_M>M:C::=;;@GG7<ZQ)N/0;F(&>.E7*I:
MIHVF:Y:"UUO3;34;<.'$-W LJ!AD [6!&>3S[T 58_%WAN72)-5B\0:4^G1/
MY<EXM[&84;CY2^[:#R.,]Z+;Q;X<O=-N-0L]?TNXLK4@7%S%>QM'#GIN8'"_
MC21^$?#<.D2Z5%X>TI-.F<22V:V48AD88PQ3;M)X')'84MMX1\-V6G7-A9^'
M]*M[*[Q]HMHK*-8YL=-ZA<-^- &=J/Q$\-6OAC4]:T_6M.U.+3H@SK:7D<GS
MMQ&A()"EFP!FLOX>>-XM6M-0T[6/$&DZIJ6E@33WEC/&89(7&[>-IP A+(?3
M:"?O51U[P?:67B.QAT;X?VUUH21/-=Q:=#9PK=3X*1I*KNFY55I#@@@EE]*A
MCT.2T\0:7>>'/AH=$Q*;>_*?8(XI[23 D5Q'*2VTA7'!^Z1_$: .YTSQ=X;U
MJZ:VT;Q!I6H7"(9&BM+V.5U4$ L0K$X&1S[TFG>,/#6KW_V'2?$.E7UW@G[/
M;7L<DF!U^56)XHTOPCX;T2Z-SHOA[2M.N&4H9;2RCB<J>HRJ@XXZ4W3?!OAC
M1KU;S2/#FD6%T@(6>UL8HG (P0&50>10!/I_B70M7OIK+2M:T^^NH 3-!;72
M221@'!W*I)'/'->'?'N".X^(>B1^/+C6+7P*]N%6?35!2.[+/R^0>0G/0G:#
MM'WJ]QT[PWH6D7LUYI.BZ?8W5QD33VUJD;R9.3N90">>>>]>?>/M(^)FE^-H
MO$_PXN5U:WF@%M<Z'>W)$*'_ )ZJC.JCHO((;/J&; !F_ >TM;"]UNV\*^+K
M?7O"8*M96TDCB[M'/+;XF1=JL2W(X;;G&2<>1^()K?7/BIXCTB"3^V/%-[J\
M0T'7HM4,,=D ^\*#G;E1A !DY!"\XSZK\//AQXLG\8:[XK\96.F^&YM1T^33
MTL-)1%&7VEICL9AU&>6+%NN !GFI_AIX\/P\M?A\O@W36:ROC-:^*%U)$$>9
M-YD\L#S,X.T\$X ^4D T =Y\>=Y_9[U'S)UN7VVFZ9#\LA\Z/YA['K7@>J6G
MP]T'1M.U3X9^+-=N/&"30^5;B%@ S##@'RD[G& 6SG&"#D>K#X9^,K;]G?6?
M!3Z18R:D+U'MGM+L?Z:OG([2,9-H7@8&2"0OW1CGU;PWX%\.:+:Z=<P>&=(L
M]3MX$#7$-E$LJ/LPV'49R<D$@\Y- '0)+(EBLMS'B41[I$C&[G'('K7RAH^E
M6VD1OXH^+/PRU%K?4M8>6;69;^2&2U,C9 -L"K;0P)W-C.[O\H/UA<QR36DT
M4$[6\KHRI,JAC&Q'# '@XZX/%>'ZSX=^+/C3PS'X&\5Z;8F![Y6N_$RW<6V6
M!6+@+ H#!L[0#@9P 0,EJ *-QH5E\5/'/Q(N_$4D\R>'8EMM'6.X=5M&V/F5
M0I )+1AN<@Y]ABE>>+-5\8?"7X:Z-J%Y<#_A(]4%AJ=PLA$D\,<OEE2W4[@0
M3ZD<]\]+J/@[QKX-\4>*Y/ VAV^M:=XIME4,]ZD#6$JHR[F#_?'SLV!U]L<R
MZK\(]6TOX9>#[3PXUO=Z[X3O%OUC9]B73ES))&&.,9;&"V.!SCL /\!6D/@C
MX\:[X)T,S1:#-I<>HP6;RM(MO*"BMM+$GYMQ)Y]/08]CKS/P+X9\1WGQ)UGQ
MYXQTN'1;FZM$L+/34N5N&BC&TLS.ORG)48[\GIW],H **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** .$U?X*?#W7-9N-5U+PW$]Y<OYDSQ
MW$T2NW<[$<+D]3QR22<DFNVM;6WL;2*ULH([>WA0)%#$@1(U P%"C@ #L*EH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
E** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466608952072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Document - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_CoverPageAbstract', window );"><strong>Cover Page [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-10864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">41-1321939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">UnitedHealth Group Center<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">9900 Bren Road East<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Minnetonka,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">55343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">936-1300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $.01 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">UNH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Well known seasoned issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 376,162,785,060<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">940,899,146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">The information required by Part III of this report, to the extent not set forth herein, is incorporated by reference from the registrant&#8217;s definitive proxy statement relating to its 2022 Annual Meeting of Shareholders. Such proxy statement will be filed with the Securities and Exchange Commission within 120 days after the end of the fiscal year to which this report relates.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">UnitedHealth Group Incorporated<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entitiy Central Index Key</a></td>
<td class="text">0000731766<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_CoverPageAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover Page [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_CoverPageAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466704089832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Auditor Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_AuditorInformationAbstract', window );"><strong>Auditor Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">DELOITTE & TOUCHE LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Minneapolis, Minnesota<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_AuditorInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Auditor Information</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_AuditorInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466606925720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 21,375<span></span>
</td>
<td class="nump">$ 16,921<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">2,532<span></span>
</td>
<td class="nump">2,860<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowances of $954 and $990</a></td>
<td class="nump">14,216<span></span>
</td>
<td class="nump">12,870<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other current receivables, net of allowances of $993 and $1,047</a></td>
<td class="nump">13,866<span></span>
</td>
<td class="nump">12,534<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_AarpAssetsUnderManagement', window );">Assets under management</a></td>
<td class="nump">4,449<span></span>
</td>
<td class="nump">4,076<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">5,320<span></span>
</td>
<td class="nump">4,457<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">61,758<span></span>
</td>
<td class="nump">53,718<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">43,114<span></span>
</td>
<td class="nump">41,242<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, equipment and capitalized software, net of accumulated depreciation and amortization of $5,992 and $5,230</a></td>
<td class="nump">8,969<span></span>
</td>
<td class="nump">8,626<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">75,795<span></span>
</td>
<td class="nump">71,337<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets, net of accumulated amortization of $5,636 and $5,455</a></td>
<td class="nump">10,044<span></span>
</td>
<td class="nump">10,856<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">12,526<span></span>
</td>
<td class="nump">11,510<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">212,206<span></span>
</td>
<td class="nump">197,289<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Medical costs payable</a></td>
<td class="nump">24,483<span></span>
</td>
<td class="nump">21,872<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">24,643<span></span>
</td>
<td class="nump">22,495<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Short-term borrowings and current maturities of long-term debt</a></td>
<td class="nump">3,620<span></span>
</td>
<td class="nump">4,819<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Unearned revenues</a></td>
<td class="nump">2,571<span></span>
</td>
<td class="nump">2,842<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">22,975<span></span>
</td>
<td class="nump">20,392<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">78,292<span></span>
</td>
<td class="nump">72,420<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, less current maturities</a></td>
<td class="nump">42,383<span></span>
</td>
<td class="nump">38,648<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred Income Taxes</a></td>
<td class="nump">3,265<span></span>
</td>
<td class="nump">3,367<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">11,787<span></span>
</td>
<td class="nump">12,315<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">135,727<span></span>
</td>
<td class="nump">126,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 12)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable noncontrolling interests</a></td>
<td class="nump">1,434<span></span>
</td>
<td class="nump">2,211<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value - 3,000 shares authorized; 941 and 946 issued and outstanding</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">77,134<span></span>
</td>
<td class="nump">69,295<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(5,384)<span></span>
</td>
<td class="num">(3,814)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Nonredeemable noncontrolling interests</a></td>
<td class="nump">3,285<span></span>
</td>
<td class="nump">2,837<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">75,045<span></span>
</td>
<td class="nump">68,328<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, redeemable noncontrolling interests and equity</a></td>
<td class="nump">$ 212,206<span></span>
</td>
<td class="nump">$ 197,289<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">941<span></span>
</td>
<td class="nump">946<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">941<span></span>
</td>
<td class="nump">946<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_AarpAssetsUnderManagement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Assets Under Management are primarily AARP assets that are managed separately from the general investment portfolio and are used to pay costs associated with the AARP program.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_AarpAssetsUnderManagement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466611001416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheet (Parenthetical) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts, accounts receivable</a></td>
<td class="nump">$ 954<span></span>
</td>
<td class="nump">$ 990<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent', window );">Allowance for doubtful accounts, other receivables</a></td>
<td class="nump">993<span></span>
</td>
<td class="nump">1,047<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</a></td>
<td class="nump">5,992<span></span>
</td>
<td class="nump">5,230<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">$ 5,636<span></span>
</td>
<td class="nump">$ 5,455<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">941<span></span>
</td>
<td class="nump">946<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, shares outstanding</a></td>
<td class="nump">941<span></span>
</td>
<td class="nump">946<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on receivable, classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466606476232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">$ 226,233<span></span>
</td>
<td class="nump">$ 201,478<span></span>
</td>
<td class="nump">$ 189,699<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment and other income</a></td>
<td class="nump">2,324<span></span>
</td>
<td class="nump">1,502<span></span>
</td>
<td class="nump">1,886<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">287,597<span></span>
</td>
<td class="nump">257,141<span></span>
</td>
<td class="nump">242,155<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Operating costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare', window );">Medical costs</a></td>
<td class="nump">186,911<span></span>
</td>
<td class="nump">159,396<span></span>
</td>
<td class="nump">156,440<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Operating costs</a></td>
<td class="nump">42,579<span></span>
</td>
<td class="nump">41,704<span></span>
</td>
<td class="nump">35,193<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="nump">31,034<span></span>
</td>
<td class="nump">30,745<span></span>
</td>
<td class="nump">28,117<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">3,103<span></span>
</td>
<td class="nump">2,891<span></span>
</td>
<td class="nump">2,720<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating costs</a></td>
<td class="nump">263,627<span></span>
</td>
<td class="nump">234,736<span></span>
</td>
<td class="nump">222,470<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Earnings from operations</a></td>
<td class="nump">23,970<span></span>
</td>
<td class="nump">22,405<span></span>
</td>
<td class="nump">19,685<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(1,660)<span></span>
</td>
<td class="num">(1,663)<span></span>
</td>
<td class="num">(1,704)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="nump">22,310<span></span>
</td>
<td class="nump">20,742<span></span>
</td>
<td class="nump">17,981<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">(4,578)<span></span>
</td>
<td class="num">(4,973)<span></span>
</td>
<td class="num">(3,742)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">17,732<span></span>
</td>
<td class="nump">15,769<span></span>
</td>
<td class="nump">14,239<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Earnings attributable to noncontrolling interests</a></td>
<td class="num">(447)<span></span>
</td>
<td class="num">(366)<span></span>
</td>
<td class="num">(400)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to UnitedHealth Group common shareholders</a></td>
<td class="nump">$ 17,285<span></span>
</td>
<td class="nump">$ 15,403<span></span>
</td>
<td class="nump">$ 13,839<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings per share attributable to UnitedHealth Group common shareholders:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic</a></td>
<td class="nump">$ 18.33<span></span>
</td>
<td class="nump">$ 16.23<span></span>
</td>
<td class="nump">$ 14.55<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted</a></td>
<td class="nump">$ 18.08<span></span>
</td>
<td class="nump">$ 16.03<span></span>
</td>
<td class="nump">$ 14.33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted-average number of common shares outstanding</a></td>
<td class="nump">943<span></span>
</td>
<td class="nump">949<span></span>
</td>
<td class="nump">951<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Dilutive effect of common share equivalents</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted-average number of common shares outstanding</a></td>
<td class="nump">956<span></span>
</td>
<td class="nump">961<span></span>
</td>
<td class="nump">966<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services</a></td>
<td class="nump">$ 34,437<span></span>
</td>
<td class="nump">$ 34,145<span></span>
</td>
<td class="nump">$ 31,597<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services</a></td>
<td class="nump">$ 24,603<span></span>
</td>
<td class="nump">$ 20,016<span></span>
</td>
<td class="nump">$ 18,973<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterestAndDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterestAndDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.5)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsEarnedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsEarnedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466611050360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">$ 17,732<span></span>
</td>
<td class="nump">$ 15,769<span></span>
</td>
<td class="nump">$ 14,239<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive (loss) income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax', window );">Gross unrealized (losses) gains on investment securities during the period</a></td>
<td class="num">(1,028)<span></span>
</td>
<td class="nump">1,058<span></span>
</td>
<td class="nump">1,212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax', window );">Income tax effect</a></td>
<td class="nump">248<span></span>
</td>
<td class="num">(253)<span></span>
</td>
<td class="num">(279)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Total unrealized (losses) gains, net of tax</a></td>
<td class="num">(780)<span></span>
</td>
<td class="nump">805<span></span>
</td>
<td class="nump">933<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax', window );">Gross reclassification adjustment for net realized gains included in net earnings</a></td>
<td class="num">(173)<span></span>
</td>
<td class="num">(75)<span></span>
</td>
<td class="num">(104)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax', window );">Income tax effect</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax', window );">Total reclassification adjustment, net of tax</a></td>
<td class="num">(133)<span></span>
</td>
<td class="num">(58)<span></span>
</td>
<td class="num">(80)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Total foreign currency translation losses</a></td>
<td class="num">(657)<span></span>
</td>
<td class="num">(983)<span></span>
</td>
<td class="num">(271)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) income</a></td>
<td class="num">(1,570)<span></span>
</td>
<td class="num">(236)<span></span>
</td>
<td class="nump">582<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">16,162<span></span>
</td>
<td class="nump">15,533<span></span>
</td>
<td class="nump">14,821<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Comprehensive income attributable to noncontrolling interests</a></td>
<td class="num">(447)<span></span>
</td>
<td class="num">(366)<span></span>
</td>
<td class="num">(400)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to UnitedHealth Group common shareholders</a></td>
<td class="nump">$ 15,715<span></span>
</td>
<td class="nump">$ 15,167<span></span>
</td>
<td class="nump">$ 14,421<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27357-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27357-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466602970888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Equity - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Net Unrealized (Losses) Gains on Investments [Member]</div></th>
<th class="th"><div>Foreign Currency Translation Losses [Member]</div></th>
<th class="th"><div>Noncontrolling Interest</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2018</a></td>
<td class="nump">$ 54,319<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 55,846<span></span>
</td>
<td class="num">$ (264)<span></span>
</td>
<td class="num">$ (3,896)<span></span>
</td>
<td class="nump">$ 2,623<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance (Accounting Standards Update 2016-02 [Member]) at Dec. 31, 2018</a></td>
<td class="num">(18)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to UnitedHealth Group common shareholders</a></td>
<td class="nump">13,839<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,839<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest', window );">Net earnings attributable to nonredeemable noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">285<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest</a></td>
<td class="nump">14,124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">853<span></span>
</td>
<td class="num">(271)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuances of common stock, and related tax effects (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuances of common stock, and related tax effects</a></td>
<td class="nump">696<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Common share repurchases (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Common share repurchases</a></td>
<td class="num">(5,500)<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="num">(937)<span></span>
</td>
<td class="num">(4,562)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCash', window );">Cash dividends paid on common shares ($5.60 per share, $4.83 per share and $4.14 per share for the years ended December 31, 2021, 2020 and 2019, respectively)</a></td>
<td class="num">(3,932)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,932)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestChangeInRedemptionValue', window );">Redeemable noncontrolling interests fair value and other adjustments</a></td>
<td class="num">(316)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(316)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination', window );">Acquisition and other adjustments of nonredeemable noncontrolling interests</a></td>
<td class="nump">87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(109)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">196<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to nonredeemable noncontrolling interests</a></td>
<td class="num">(279)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(279)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2019</a></td>
<td class="nump">60,436<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">61,178<span></span>
</td>
<td class="nump">589<span></span>
</td>
<td class="num">(4,167)<span></span>
</td>
<td class="nump">2,820<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance (Accounting Standards Update 2016-13) at Dec. 31, 2019</a></td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">948<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to UnitedHealth Group common shareholders</a></td>
<td class="nump">15,403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest', window );">Net earnings attributable to nonredeemable noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">254<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest</a></td>
<td class="nump">15,657<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(236)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">747<span></span>
</td>
<td class="num">(983)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuances of common stock, and related tax effects (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuances of common stock, and related tax effects</a></td>
<td class="nump">1,120<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">1,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">$ 647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Common share repurchases (in shares)</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Common share repurchases</a></td>
<td class="num">$ (4,250)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(1,576)<span></span>
</td>
<td class="num">(2,674)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCash', window );">Cash dividends paid on common shares ($5.60 per share, $4.83 per share and $4.14 per share for the years ended December 31, 2021, 2020 and 2019, respectively)</a></td>
<td class="num">(4,584)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,584)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestChangeInRedemptionValue', window );">Redeemable noncontrolling interests fair value and other adjustments</a></td>
<td class="num">(197)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(197)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination', window );">Acquisition and other adjustments of nonredeemable noncontrolling interests</a></td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to nonredeemable noncontrolling interests</a></td>
<td class="num">(277)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(277)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">$ 68,328<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">69,295<span></span>
</td>
<td class="nump">1,336<span></span>
</td>
<td class="num">(5,150)<span></span>
</td>
<td class="nump">2,837<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Dec. 31, 2020</a></td>
<td class="nump">946<span></span>
</td>
<td class="nump">946<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to UnitedHealth Group common shareholders</a></td>
<td class="nump">$ 17,285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest', window );">Net earnings attributable to nonredeemable noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">360<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest</a></td>
<td class="nump">17,645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(1,570)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(913)<span></span>
</td>
<td class="num">(657)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuances of common stock, and related tax effects (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuances of common stock, and related tax effects</a></td>
<td class="nump">1,100<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">$ 729<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">729<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Common share repurchases (in shares)</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Common share repurchases</a></td>
<td class="num">$ (5,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(940)<span></span>
</td>
<td class="num">(4,060)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCash', window );">Cash dividends paid on common shares ($5.60 per share, $4.83 per share and $4.14 per share for the years ended December 31, 2021, 2020 and 2019, respectively)</a></td>
<td class="num">(5,280)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,280)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestChangeInRedemptionValue', window );">Redeemable noncontrolling interests fair value and other adjustments</a></td>
<td class="num">(995)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(889)<span></span>
</td>
<td class="num">(106)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination', window );">Acquisition and other adjustments of nonredeemable noncontrolling interests</a></td>
<td class="nump">407<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">407<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to nonredeemable noncontrolling interests</a></td>
<td class="num">(319)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(319)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2021</a></td>
<td class="nump">$ 75,045<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 77,134<span></span>
</td>
<td class="nump">$ 423<span></span>
</td>
<td class="num">$ (5,807)<span></span>
</td>
<td class="nump">$ 3,285<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Dec. 31, 2021</a></td>
<td class="nump">941<span></span>
</td>
<td class="nump">941<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestChangeInRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in noncontrolling interest during the period as a result of a change in the redemption value of redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 16(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestChangeInRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Portion of net income (loss) attributable to nonredeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466614714984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statement of Changes in Equity (Parentheticals) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 14, 2021</div></th>
<th class="th"><div>Sep. 21, 2021</div></th>
<th class="th"><div>Jun. 29, 2021</div></th>
<th class="th"><div>Mar. 23, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Cash dividends per common share</a></td>
<td class="nump">$ 1.45<span></span>
</td>
<td class="nump">$ 1.45<span></span>
</td>
<td class="nump">$ 1.45<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="nump">$ 5.60<span></span>
</td>
<td class="nump">$ 4.83<span></span>
</td>
<td class="nump">$ 4.14<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466606973512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">$ 17,732<span></span>
</td>
<td class="nump">$ 15,769<span></span>
</td>
<td class="nump">$ 14,239<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Noncash items:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">3,103<span></span>
</td>
<td class="nump">2,891<span></span>
</td>
<td class="nump">2,720<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="nump">130<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="nump">230<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">800<span></span>
</td>
<td class="nump">679<span></span>
</td>
<td class="nump">697<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other, net</a></td>
<td class="num">(944)<span></span>
</td>
<td class="num">(52)<span></span>
</td>
<td class="num">(106)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Net change in other operating items, net of effects from acquisitions and changes in AARP balances:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(1,000)<span></span>
</td>
<td class="num">(688)<span></span>
</td>
<td class="nump">162<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(1,031)<span></span>
</td>
<td class="num">(2,195)<span></span>
</td>
<td class="num">(1,563)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities', window );">Medical costs payable</a></td>
<td class="nump">2,701<span></span>
</td>
<td class="nump">152<span></span>
</td>
<td class="nump">1,221<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and other liabilities</a></td>
<td class="nump">1,162<span></span>
</td>
<td class="nump">5,348<span></span>
</td>
<td class="nump">733<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Unearned revenues</a></td>
<td class="num">(310)<span></span>
</td>
<td class="nump">278<span></span>
</td>
<td class="nump">130<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Cash flows from operating activities</a></td>
<td class="nump">22,343<span></span>
</td>
<td class="nump">22,174<span></span>
</td>
<td class="nump">18,463<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchases of investments</a></td>
<td class="num">(17,139)<span></span>
</td>
<td class="num">(16,577)<span></span>
</td>
<td class="num">(18,131)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt', window );">Sales of investments</a></td>
<td class="nump">7,045<span></span>
</td>
<td class="nump">6,489<span></span>
</td>
<td class="nump">8,536<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities', window );">Maturities of investments</a></td>
<td class="nump">8,251<span></span>
</td>
<td class="nump">7,252<span></span>
</td>
<td class="nump">7,091<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid for acquisitions, net of cash assumed</a></td>
<td class="num">(4,821)<span></span>
</td>
<td class="num">(7,139)<span></span>
</td>
<td class="num">(8,343)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, equipment and capitalized software</a></td>
<td class="num">(2,454)<span></span>
</td>
<td class="num">(2,051)<span></span>
</td>
<td class="num">(2,071)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other, net</a></td>
<td class="num">(1,254)<span></span>
</td>
<td class="num">(506)<span></span>
</td>
<td class="nump">219<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Cash flows used for investing activities</a></td>
<td class="num">(10,372)<span></span>
</td>
<td class="num">(12,532)<span></span>
</td>
<td class="num">(12,699)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Common share repurchases</a></td>
<td class="num">(5,000)<span></span>
</td>
<td class="num">(4,250)<span></span>
</td>
<td class="num">(5,500)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Cash dividends paid</a></td>
<td class="num">(5,280)<span></span>
</td>
<td class="num">(4,584)<span></span>
</td>
<td class="num">(3,932)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from common stock issuances</a></td>
<td class="nump">1,355<span></span>
</td>
<td class="nump">1,440<span></span>
</td>
<td class="nump">1,037<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="num">(3,150)<span></span>
</td>
<td class="num">(3,150)<span></span>
</td>
<td class="num">(1,750)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfCommercialPaper', window );">(Repayments of) proceeds from short-term borrowings, net</a></td>
<td class="num">(1,302)<span></span>
</td>
<td class="nump">872<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of long-term debt</a></td>
<td class="nump">6,933<span></span>
</td>
<td class="nump">4,864<span></span>
</td>
<td class="nump">5,444<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeposits', window );">Customer funds administered</a></td>
<td class="nump">622<span></span>
</td>
<td class="nump">1,677<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest', window );">Purchases of redeemable noncontrolling interest</a></td>
<td class="num">(1,338)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(618)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other, net</a></td>
<td class="num">(295)<span></span>
</td>
<td class="num">(459)<span></span>
</td>
<td class="num">(619)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Cash flows used for financing activities</a></td>
<td class="num">(7,455)<span></span>
</td>
<td class="num">(3,590)<span></span>
</td>
<td class="num">(5,625)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="num">(62)<span></span>
</td>
<td class="num">(116)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Increase in cash and cash equivalents</a></td>
<td class="nump">4,454<span></span>
</td>
<td class="nump">5,936<span></span>
</td>
<td class="nump">119<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="nump">16,921<span></span>
</td>
<td class="nump">10,985<span></span>
</td>
<td class="nump">10,866<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents, end of period</a></td>
<td class="nump">21,375<span></span>
</td>
<td class="nump">16,921<span></span>
</td>
<td class="nump">10,985<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">1,653<span></span>
</td>
<td class="nump">1,704<span></span>
</td>
<td class="nump">1,627<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes</a></td>
<td class="nump">$ 3,966<span></span>
</td>
<td class="nump">$ 4,935<span></span>
</td>
<td class="nump">$ 3,542<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow for the increase (decrease) in the beginning and end of period deposits balances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3095-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123398031&amp;loc=d3e60009-112784<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in health care insurance liability balances during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period for redemption of redeemable noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3151-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or cash outflow from issuing (borrowing) and repaying commercial paper.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3098-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466610851240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Nature of Operations [Text Block]</a></td>
<td class="text">Description of BusinessUnitedHealth Group Incorporated (individually and together with its subsidiaries, &#8220;UnitedHealth Group&#8221; and &#8220;the Company&#8221;) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone. Our two distinct, yet complementary business platforms &#8212; Optum and UnitedHealthcare &#8212; are working to help build a modern, high-performing health system through improved access, affordability, outcomes and experiences for the individuals and organizations we are privileged to serve.<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466610840360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation and Significant Accounting Policies [Text Block]</a></td>
<td class="text">Basis of Presentation, Use of Estimates and Significant Accounting Policies<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has prepared the Consolidated Financial Statements according to U.S. Generally Accepted Accounting Principles (GAAP) and has included the accounts of UnitedHealth Group and its subsidiaries.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These Consolidated Financial Statements include certain amounts based on the Company&#8217;s best estimates and judgments. The Company&#8217;s most significant estimates relate to estimates and judgments for medical costs payable and goodwill. Certain of these estimates require the application of complex assumptions and judgments, often because they involve matters inherently uncertain and will likely change in subsequent periods. The impact of any change in estimates is included in earnings in the period in which the estimate is adjusted.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Premiums</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium revenues are primarily derived from risk-based health insurance arrangements in which the premium is typically at a fixed rate per individual served for a one-year period, and the Company assumes the economic risk of funding its customers&#8217; health care and related administrative costs.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium revenues are recognized in the period in which eligible individuals are entitled to receive health care benefits. Health care premium payments received from the Company&#8217;s customers in advance of the service period are recorded as unearned revenues. Fully insured commercial products of U.S. health plans, Medicare Advantage and Medicare Prescription Drug Benefit (Medicare Part D) plans with medical loss ratios (MLRs) as calculated under the definitions in the Patient Protection and Affordable Care Act (ACA) and related federal and state regulations and implementing regulation, falling below certain targets are required to rebate ratable portions of their premiums annually. Commercial premiums within the Company&#8217;s individual and small group markets are also subject to the ACA risk adjustment program. Medicare Advantage premium revenue includes the impact of the Centers for Medicare &amp; Medicaid Services (CMS) quality bonuses based on plans&#8217; Star rating. Certain of the Company&#8217;s Medicaid business is also subject to state minimum MLR rebates.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium revenues are recognized based on the estimated premiums earned, net of projected rebates, because the Company is able to reasonably estimate the ultimate premiums of these contracts. The Company also records premium revenues for certain value-based arrangements at its Optum Health care delivery businesses. Under these value-based arrangements, the Company enters into agreements with health plans to stand ready to deliver, integrate, direct and control certain health care services for the individuals enrolled. In exchange, the Company receives a premium that is typically paid on a per-member per-month basis. The Company considers these value-based arrangements to represent a single performance obligation where premium revenues are recognized in the period in which health care services are made available.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Medicare Advantage and Medicare Part D premium revenues are subject to periodic adjustment under CMS&#8217; risk adjustment payment methodology. CMS deploys a risk adjustment model which apportions premiums paid to all health plans according to health severity and certain demographic factors. The CMS risk adjustment model provides higher per member payments for enrollees diagnosed with certain conditions and lower payments for enrollees who are healthier. Under this risk adjustment methodology, CMS calculates the risk adjusted premium payment using diagnosis and encounter data from hospital inpatient, hospital outpatient and physician treatment settings. The Company and health care providers collect, capture and submit the necessary and available data to CMS within prescribed deadlines. The Company estimates risk adjustment premium revenues based upon the data submitted and expected to be submitted to CMS. Risk adjustment data for the Company&#8217;s plans are subject to review by the government, including audit by regulators. See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_217" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 12</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding these audits.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Products and Services</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Company&#8217;s Optum Rx pharmacy care services business, the majority of revenues are derived from products sold through a contracted network of retail pharmacies or home delivery, specialty and community health pharmacies. Product revenues include the cost of pharmaceuticals (net of rebates), a negotiated dispensing fee and customer co-payments for drugs dispensed through the Company&#8217;s home delivery, specialty and community pharmacies. For the years ended December 31, 2021 and 2020, the Company recognized revenue and cost of products sold for retail pharmacy co-payments related to its Optum Rx business. Revenue recognized in prior periods related to retail pharmacy transactions excludes the member&#8217;s applicable co-payment. There was no impact on earnings from operations, net earnings, earnings per share or total equity. Pharmacy products are billed to customers based on the number of transactions occurring during the billing period. Product revenues are recognized when the prescriptions are dispensed. The Company has entered into contracts in which it is primarily obligated to pay its network pharmacy providers for benefits provided to their customers regardless of whether the Company is paid. The Company is also involved in establishing the prices charged by retail pharmacies, determining which drugs will be included in formulary listings and selecting which retail pharmacies will be included in the network offered to plan sponsors&#8217; members and accordingly, are reported on a gross basis.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services revenue are comprised of a number of services and products sold through Optum. Optum Health&#8217;s service revenues include net patient service revenues recorded based upon established billing rates, less allowances for contractual adjustments, and are recognized as services are provided. For its financial services offerings, Optum Health charges fees and earns investment income on managed funds. Optum Insight provides software and information products, advisory consulting arrangements and managed services outsourcing contracts, which may be delivered over several years. Optum Insight revenues are generally recognized over time and measured each period based on the progress to date as services are performed or made available to customers.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services revenue also consists of fees derived from services performed for customers who self-insure the health care costs of their employees and employees&#8217; dependents. Under service fee contracts, the Company receives monthly, a fixed fee per employee, which is recognized as revenue as the Company performs, or makes available, the applicable services to the customer. The customers retain the risk of financing health care costs for their employees and employees&#8217; dependents, and the Company administers the payment of customer funds to physicians and other health care professionals from customer-funded bank accounts. As the Company has neither the obligation for funding the health care costs, nor the primary responsibility for providing the medical care, the Company does not recognize premium revenue and medical costs for these contracts in its Consolidated Financial Statements. For these fee-based customer arrangements, the Company provides coordination and facilitation of medical services; transaction processing; customer, consumer and care professional services; and access to contracted networks of physicians, hospitals and other health care professionals. These services are performed throughout the contract period. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, accounts receivables related to products and services were $5.4 billion and $5.3 billion, respectively. In 2021 and 2020, the Company had no material bad-debt expense and there were no material contract assets, contract liabilities or deferred contract costs recorded on the Consolidated Balance Sheets as of December&#160;31, 2021 or 2020.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2021, 2020 and 2019, revenue recognized from performance obligations related to prior periods (for example, due to changes in transaction price) was not material.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue expected to be recognized in any future year related to remaining performance obligations, excluding revenue pertaining to contracts having an original expected duration of one year or less, contracts where revenue is recognized as invoiced and contracts with variable consideration related to undelivered performance obligations, is not material.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_223" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 13</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for disaggregation of revenue by segment and type.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical Costs and Medical Costs Payable </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimate of medical costs payable represents management&#8217;s best estimate of its liability for unpaid medical costs as of December&#160;31, 2021.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each period, the Company re-examines previously established medical costs payable estimates based on actual claim submissions and other changes in facts and circumstances. As more complete claim information becomes available, the Company adjusts the amount of the estimates and includes the changes in estimates in medical costs in the period in which the change is identified. Approximately 90% of claims related to medical care services are known and settled within 90 days from the date of service and substantially all within twelve months.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical costs and medical costs payable include estimates of the Company&#8217;s obligations for medical care services rendered on behalf of consumers, but for which claims have either not yet been received, processed, or paid. The Company develops estimates for medical care services incurred but not reported (IBNR), which includes estimates for claims which have not been received or fully processed, using an actuarial process consistently applied, centrally controlled and automated. The actuarial </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">models consider factors such as time from date of service to claim processing, seasonal variances in medical care consumption, health care professional contract rate changes, medical care utilization and other medical cost trends, membership volume and demographics, the introduction of new technologies, benefit plan changes, and business mix changes related to products, customers and geography. Judgments related to these factors contemplated the impact of COVID-19.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In developing its medical costs payable estimates, the Company applies different estimation methods depending on which incurred claims are being estimated. For the most recent two months, the Company estimates claim costs incurred by applying observed medical cost trend factors to the average per member per month (PMPM) medical costs incurred in prior months for which more complete claim data are available, supplemented by a review of near-term completion factors (actuarial estimates, based upon historical experience and analysis of current trends, of the percentage of incurred claims during a given period adjudicated by the Company at the date of estimation). For months prior to the most recent two months, the Company applies the completion factors to actual claims adjudicated-to-date to estimate the expected amount of ultimate incurred claims for those months.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Products Sold </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s cost of products sold includes the cost of pharmaceuticals dispensed to unaffiliated customers either directly at its home delivery, specialty and community pharmacy locations, or indirectly through its nationwide network of participating pharmacies. Rebates attributable to unaffiliated clients are accrued as rebates receivable and a reduction of cost of products sold, with a corresponding payable for the amounts of the rebates to be remitted to those unaffiliated clients in accordance with their contracts and recorded in the Consolidated Statements of Operations as a reduction of product revenue. Cost of products sold also includes the cost of personnel to support the Company&#8217;s transaction processing services, system sales, maintenance and professional services.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents and Investments </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents are highly liquid investments having an original maturity of three months or less. The fair value of cash and cash equivalents approximates their carrying value because of the short maturity of the instruments. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments with maturities of less than one year are classified as short-term. Because of regulatory requirements, certain investments are included in long-term investments regardless of their maturity date. The Company classifies these investments as held-to-maturity and reports them at amortized cost. Substantially all other investments are classified as available-for-sale and reported at fair value based on quoted market prices, where available. Equity investments, with certain exceptions, are measured at fair value with changes in fair value recognized in net earnings.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company excludes unrealized gains and losses on investments in available-for-sale debt securities from net earnings and reports them as comprehensive income and, net of income tax effects, as a separate component of equity. To calculate realized gains and losses on the sale of debt securities, the Company specifically identifies the cost of each investment sold. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates an available-for-sale debt security for credit-related impairment by considering the present value of expected cash flows relative to a security&#8217;s amortized cost, the extent to which fair value is less than amortized cost, the financial condition and near-term prospects of the issuer and specific events or circumstances which may influence the operations of the issuer. Credit-related impairments are recorded as an allowance, with an offset to investment and other income. Non-credit related impairments are recorded through other comprehensive income. If the Company intends to sell an impaired security, or will likely be required to sell a security before recovery of the entire amortized cost, the entire impairment is included in net earnings.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New information and the passage of time can change these judgments. The Company manages its investment portfolio to limit its exposure to any one issuer or market sector, and largely limits its investments to investment grade quality. Securities downgraded below policy minimums after purchase will be disposed of in accordance with the Company&#8217;s investment policy. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Under Management </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides health insurance products and services to members of AARP under a Supplemental Health Insurance Program (the AARP Program) and to AARP members and non-members under separate Medicare Advantage and Medicare Part D arrangements. The products and services under the AARP Program include supplemental Medicare benefits, hospital indemnity insurance, including insurance for individuals between 50 to 64 years of age, and other related products. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Company&#8217;s agreement with AARP, program assets are managed separately from the Company&#8217;s general investment portfolio and are used to pay costs associated with the AARP Program. These assets are invested at the Company&#8217;s discretion, within investment guidelines approved by AARP. The Company does not guarantee any rates of return on these investments and, upon any transfer of the AARP Program contract to another entity, the Company would transfer cash equal in amount to the fair value of these investments at the date of transfer to the entity. Because the purpose of these assets is to fund the medical costs payable, the rate stabilization fund (RSF) liabilities and other related liabilities associated with this AARP contract, assets under management are classified as current assets, consistent with the classification of these liabilities.</span></div>The effects of changes in other balance sheet amounts associated with the AARP Program also accrue to the overall benefit of the AARP policyholders through the RSF balance. Accordingly, the Company excludes the effect of such changes in its Consolidated Statements of Cash Flows.<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Current Receivables </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current receivables include amounts due from pharmaceutical manufacturers for rebates and Medicare Part D drug discounts, accrued interest and other miscellaneous amounts due to the Company. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s pharmacy care services businesses contract with pharmaceutical manufacturers, some of which provide rebates based on use of the manufacturers&#8217; products by its affiliated and unaffiliated clients. The Company accrues rebates as they are earned by its clients on a monthly basis based on the terms of the applicable contracts, historical data and current estimates. The pharmacy care services businesses bill these rebates to the manufacturers on a monthly or quarterly basis depending on the contractual terms and record rebates attributable to affiliated clients as a reduction to medical costs. The Company generally receives rebates two to five months after billing. As of December&#160;31, 2021 and 2020, total pharmaceutical manufacturer rebates receivable included in other receivables in the Consolidated Balance Sheets amounted to $7.2 billion and $6.3 billion, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, the Company&#8217;s Medicare Part D receivables amounted to $3.4 billion and $2.9 billion, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Equipment and Capitalized Software </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, equipment and capitalized software are stated at cost, net of accumulated depreciation and amortization. Capitalized software consists of certain costs incurred in the development of internal-use software, including external direct costs of materials and services and applicable payroll costs of employees devoted to specific software development. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company calculates depreciation and amortization using the straight-line method over the estimated useful lives of the assets. The useful lives for property, equipment and capitalized software are: </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:57.111%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.689%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 10 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;to&#160;40&#160;years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 5 years</span></div></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements are depreciated over the shorter of the remaining lease term or their estimated useful economic life.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases facilities and equipment under long-term operating leases which are non-cancelable and expire on various dates. At the lease commencement date, lease right-of-use (ROU) assets and lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term, which includes all fixed obligations arising from the lease contract. If an interest rate is not implicit in a lease, the Company utilizes its incremental borrowing rate for a period closely matching the lease term. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s ROU assets are included in other assets, and lease liabilities are included in other current liabilities and other liabilities in the Company&#8217;s Consolidated Balance Sheet. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To determine whether goodwill is impaired, annually or more frequently if needed, the Company performs impairment tests. The Company may first assess qualitative factors to determine if it is more likely than not the carrying value of a reporting unit exceeds its estimated fair value. The Company may also elect to skip the qualitative testing and proceed directly to the quantitative testing. When performing quantitative testing, the Company first estimates the fair values of its reporting units using discounted cash flows or a weighted combination of discounted cash flows and a market-based method. To determine fair values, the Company must make assumptions about a wide variety of internal and external factors. Significant assumptions used in the impairment analysis include financial projections of free cash flow (including significant assumptions about operations, capital requirements and income taxes), long-term growth rates for determining terminal value, discount rates and the selection of comparable peer companies. If the fair value is less than the carrying value of the reporting unit, an impairment is recognized for the difference, up to the carrying amount of goodwill.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no impairment of goodwill during the years ended December&#160;31, 2021, 2020 and 2019.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s intangible assets are subject to impairment tests when events or circumstances indicate an intangible asset (or asset group) may be impaired. The Company&#8217;s indefinite-lived intangible assets are also tested for impairment annually. There was no impairment of intangible assets during the years ended December&#160;31, 2021, 2020 and 2019.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Current Liabilities </span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities include health savings account deposits ($11.4 billion and $10.2 billion as of December&#160;31, 2021 and 2020, respectively), accruals for premium rebates payable, the RSF associated with the AARP Program, the current portion of future policy benefits and customer balances.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Policy Acquisition Costs</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s short duration health insurance contracts typically have a one-year term and may be canceled by the customer with at least 30 days&#8217; notice. Costs related to the acquisition and renewal of short duration customer contracts are primarily charged to expense as incurred.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redeemable Noncontrolling Interests</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redeemable noncontrolling interests in the Company&#8217;s subsidiaries whose redemption is outside the control of the Company are classified as temporary equity. The following table provides details of the Company's redeemable noncontrolling interests&#8217; activity for the years ended December&#160;31, 2021 and 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.215%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,211&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,726&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemptions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,338)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(255)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value and other adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests, end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,434&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,211&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes compensation expense for share-based awards, including stock options and restricted stock and restricted stock units (collectively, restricted shares), on a straight-line basis over the related service period (generally the vesting period) of the award, or to an employee&#8217;s eligible retirement date under the award agreement, if earlier. Restricted shares vest ratably, primarily over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTcvZnJhZzoyNzA4MDU3MzhiZjc0MzA5ODVmOTgzMjNiMGZkMzIxNy90ZXh0cmVnaW9uOjI3MDgwNTczOGJmNzQzMDk4NWY5ODMyM2IwZmQzMjE3XzQzOA_eb1bf801-8e88-43f4-addf-b3432e5c7bdc">four</span> years and compensation expense related to restricted shares is based on the share price on the date of grant. Stock options vest ratably primarily over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTcvZnJhZzoyNzA4MDU3MzhiZjc0MzA5ODVmOTgzMjNiMGZkMzIxNy90ZXh0cmVnaW9uOjI3MDgwNTczOGJmNzQzMDk4NWY5ODMyM2IwZmQzMjE3XzM4NDgyOTA2OTg0NDE_e5312511-99bf-4e41-b5f9-1d6cc88b8bfd">four</span> years and may be exercised up to 10 years from the date of grant. Compensation expense related to stock options is based on the fair value at the date of grant, which is estimated on the date of grant using a binomial option-pricing model. Under the Company&#8217;s Employee Stock Purchase Plan (ESPP), eligible employees are allowed to purchase the Company&#8217;s stock at a discounted price, which is 90% of the market price of the Company&#8217;s common stock at the end of the six-month purchase period. Share-based compensation expense for all programs is recognized in operating costs in the Consolidated Statements of Operations. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Earnings Per Common Share </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company computes basic earnings per common share attributable to UnitedHealth Group common shareholders by dividing net earnings attributable to UnitedHealth Group common shareholders by the weighted-average number of common shares outstanding during the period. The Company determines diluted net earnings per common share attributable to UnitedHealth Group common shareholders using the weighted-average number of common shares outstanding during the period, adjusted for potentially dilutive shares associated with stock options, restricted shares and the ESPP (collectively, common stock equivalents), using the treasury stock method. The treasury stock method assumes a hypothetical issuance of shares to settle the share-based awards, with the assumed proceeds used to purchase common stock at the average market price for the period. Assumed proceeds include the amount the employee must pay upon exercise and the average unrecognized compensation cost. The difference between the number of shares assumed issued and number of shares assumed purchased represents the dilutive shares. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ACA Tax</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Insurance Tax was permanently repealed by Congress, effective January 1, 2021. The permanent repeal of the tax impacts year-over-year comparability of our financial statements, including revenues, operating costs, medical care ratio (MCR), operating cost ratio, effective tax rate and cash flows from operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466610766104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Investments [Text Block]</a></td>
<td class="text">Investments<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of debt securities by major security type is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.020%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - available-for-sale:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,947&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,819&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,669&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">822&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(274)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,217&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - held-to-maturity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - held-to-maturity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,310&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,860&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - available-for-sale:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,737&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,849&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,091&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,079&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,771&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,828&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - held-to-maturity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - held-to-maturity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">647&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,717&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,780&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,475&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nearly all of the Company&#8217;s investments in mortgage-backed securities were rated &#8220;Triple A&#8221; as of December&#160;31, 2021. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company held $3.5 billion and $2.3 billion of equity securities as of December&#160;31, 2021 and 2020, respectively. The Company&#8217;s investments in equity securities primarily consist of employee savings plan related investments, other venture investments and shares of Brazilian real denominated fixed-income funds with readily determinable fair values. Additionally, the Company&#8217;s investments included $1.3 billion of equity method investments in operating businesses in the health care sector, as of both December&#160;31, 2021 and 2020. The allowance for credit losses on held-to-maturity securities as of December&#160;31, 2021 and 2020 was not material. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost and fair value of debt securities as of December&#160;31, 2021, by contractual maturity, were as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:61.748%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.563%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.713%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Held-to-Maturity</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in one year or less</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,603&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,614&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,885&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,065&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after five years through ten years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after ten years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,819&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,669&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,217&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of available-for-sale debt securities with gross unrealized losses by major security type and length of time that individual securities have been in a continuous unrealized loss position were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:35.649%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.714%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less Than 12 Months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,386&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,417&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,733&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,118&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,004&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(274)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,415&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,964&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s unrealized losses from all securities as of December&#160;31, 2021 were generated from approximately 13,000 positions out of a total of 39,000 positions. The Company believes it will collect the timely principal and interest due on its debt securities having an amortized cost in excess of fair value. The unrealized losses were primarily caused by interest rate increases and not by unfavorable changes in the credit quality associated with these securities which impacted the Company&#8217;s assessment on collectability of principal and interest. At each reporting period, the Company evaluates available-for-sale debt securities for any credit-related impairment when the fair value of the investment is less than its amortized cost. The Company evaluated the expected cash flows, the underlying credit quality and credit ratings of the issuers noting no significant credit deterioration since purchase. As of December&#160;31, 2021, the Company did not have the intent to sell any of the securities in an unrealized loss position. Therefore, the Company believes these losses to be temporary. The allowance for credit losses on available-for-sale debt securities as of December&#160;31, 2021 and 2020 was not material.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for  investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466610925304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value [Text Block]</a></td>
<td class="text">Fair ValueCertain assets and liabilities are measured at fair value in the Consolidated Financial Statements or have fair values disclosed in the Notes to the Consolidated Financial Statements. These assets and liabilities are classified into one of three levels of a hierarchy defined by GAAP. In instances in which the inputs used to measure fair value fall into different levels of the fair value hierarchy, the fair value measurement is categorized in its entirety based on the lowest level input which is significant to the fair value measurement in its entirety. The Company&#8217;s assessment of the significance of a particular item to the fair value measurement in its entirety requires judgment, including the consideration of inputs specific to the asset or liability. <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value hierarchy is summarized as follows:</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Quoted prices (unadjusted) for identical assets/liabilities in active markets. </span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Other observable inputs, either directly or indirectly, including:</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Quoted prices for similar assets/liabilities in active markets;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Quoted prices for identical or similar assets/liabilities in inactive markets (e.g., few transactions, limited information, noncurrent prices, high variability over time);</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inputs other than quoted prices observable for the asset/liability (e.g., interest rates, yield curves, implied volatilities, credit spreads); and</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inputs corroborated by other observable market data.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Unobservable inputs cannot be corroborated by observable market data.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers in or out of Level 3 financial assets or liabilities during the years ended December&#160;31, 2021 or 2020.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nonfinancial assets and liabilities or financial assets and liabilities measured at fair value on a nonrecurring basis are subject to fair value adjustments only in certain circumstances, such as when the Company records an impairment. For the year ended December 31, 2021, the Company recognized $840 million of unrealized gains in investment and other income related to fair value adjustments on equity securities primarily in our venture portfolio, based on transactions of the same or similar security. There were no other significant fair value adjustments for these assets and liabilities recorded during the years ended December&#160;31, 2021 or 2020.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following methods and assumptions were used to estimate the fair value and determine the fair value hierarchy classification of each class of financial instrument included in the tables below:</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of cash and cash equivalents approximates fair value as maturities are less than three months. Fair values of cash equivalent instruments which do not trade on a regular basis in active markets are classified as Level 2.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt and Equity Securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Fair values of debt and equity securities are based on quoted market prices, where available. The Company obtains one price for each security primarily from a third-party pricing service (pricing service), which generally uses quoted or other observable inputs for the determination of fair value. The pricing service normally derives the security prices through recently reported trades for identical or similar securities, and, if necessary, makes adjustments through the reporting date based upon available observable market information. For securities not actively traded, the pricing service may use quoted market prices of comparable instruments or discounted cash flow analyses, incorporating inputs currently observable in the markets for similar securities. Inputs often used in the valuation methodologies include, but are not limited to, benchmark yields, credit spreads, default rates, prepayment speeds and nonbinding broker quotes. As the Company is responsible for the determination of fair value, it performs quarterly analyses on the prices received from the pricing service to determine whether the prices are reasonable estimates of fair value. Specifically, the Company compares the prices received from the pricing service to prices reported by a secondary pricing source, such as its custodian, its investment consultant and third-party investment advisors. Additionally, the Company compares changes in the reported market values and returns to relevant market indices to test the reasonableness of the reported prices. The Company&#8217;s internal price verification procedures and reviews of fair value methodology documentation provided by independent pricing services have not historically resulted in adjustment to the prices obtained from the pricing service.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair values of debt securities which do not trade on a regular basis in active markets but are priced using other observable inputs are classified as Level&#160;2. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value estimates for Level 1 and Level 2 equity securities are based on quoted market prices for actively traded equity securities and/or other market data for the same or comparable instruments and transactions in establishing the prices. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of Level 3 investments in corporate bonds, which are not a significant portion of our investments, are estimated using valuation techniques relying heavily on management assumptions and qualitative observations. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout the procedures discussed above in relation to the Company&#8217;s processes for validating third-party pricing information, the Company validates the understanding of assumptions and inputs used in security pricing and determines the proper classification in the hierarchy based on such understanding.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Under Management.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Assets under management consists of debt securities and other investments held to fund costs associated with the AARP Program and are priced and classified using the same methodologies as the Company&#8217;s investments in debt and equity securities.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Term Debt. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company&#8217;s long-term debt are estimated and classified using the same methodologies as the Company&#8217;s investments in debt securities.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a summary of fair value measurements by level and carrying values for items measured at fair value on a recurring basis in the Consolidated Balance Sheets:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:53.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable<br/>Inputs<br/>(Level 3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Fair and Carrying<br/>Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - available-for-sale:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,017&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,916&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,057&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,942&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,217&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,090&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,177&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets under management</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,478&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,218&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage of total assets at fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,841&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,921&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - available-for-sale:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,737&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,091&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,091&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,266&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,274&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,828&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,795&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,828&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets under management</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,774&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,676&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,637&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,653&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage of total assets at fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a summary of fair value measurements by level and carrying values for certain financial instruments not measured at fair value on a recurring basis in the Consolidated Balance Sheets:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"/><td style="width:41.462%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.654%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable<br/>Inputs<br/>(Level 3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Carrying Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - held-to-maturity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and other financing obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,003&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - held-to-maturity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and other financing obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The carrying amounts reported on the Consolidated Balance Sheets for other current financial assets and liabilities approximate fair value because of their short-term nature. These assets and liabilities are not listed in the table above.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466610730056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant, and Capitalized Software (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property, Plant and Equipment Disclosure [Text Block]</a></td>
<td class="text">Property, Equipment and Capitalized Software<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of property, equipment and capitalized software is as follows: </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:70.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.225%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land and improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,882&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,851&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,767&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,857)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,364)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,392&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,482&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,712&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,010&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,135)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,866)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,144&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, equipment and capitalized software, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,969&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,626&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>&#160;Depreciation expense for property and equipment for the years ended December&#160;31, 2021, 2020 and 2019 was $996 million, $997 million and $995 million, respectively. Amortization expense for capitalized software for the years ended December&#160;31, 2021, 2020 and 2019 was $923 million, $814 million and $721 million, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466610849800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill Disclosure [Text Block]</a></td>
<td class="text">Goodwill and Other Intangible Assets<div style="margin-bottom:4pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill, by reportable segment, were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:32.820%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.171%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.675%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.973%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">UnitedHealthcare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Optum Health</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Optum Insight</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Optum Rx</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,228&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,342&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,797&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,659&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency effects and other adjustments, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(623)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(701)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31,&#160;2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,785&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,844&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,173&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,535&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,337&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,648&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,804&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency effects and other adjustments, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(456)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(268)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(346)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31,&#160;2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,389&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,224&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,619&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,563&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,795&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:4pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross carrying value, accumulated amortization and net carrying value of other intangible assets were as follows: </span></div><div style="margin-bottom:6pt;margin-top:4.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:39.575%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.563%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.563%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.563%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,011&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,697)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,314&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,428&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,575)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,853&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(739)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(624)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">973&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and other indefinite-lived</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(200)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(256)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,680&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,636)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,044&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,311&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,455)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,856&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition date fair values and weighted-average useful lives assigned to finite-lived intangible assets acquired in business combinations consisted of the following by year of acquisition:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:59.252%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.535%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Useful Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,113&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquired finite-lived intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">660&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,722&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 years</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated full year amortization expense relating to intangible assets for each of the next five years ending December 31 is as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:90.700%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.368%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,098&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">892&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Amortization expense relating to intangible assets for the years ended December&#160;31, 2021, 2020 and 2019 was $1.2 billion, $1.1 billion and $1.0 billion, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466610735048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Medical Costs Payable (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock', window );">Medical Costs Payable</a></td>
<td class="text">Medical Costs Payable<div style="margin-bottom:4pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in medical costs payable for the years ended December&#160;31: </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:65.029%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.458%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs payable, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,872&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,690&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,891&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported medical costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,020&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,720)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(880)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(580)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reported medical costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186,911&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,396&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156,440&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical payments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for current year</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165,524)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139,974)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(137,155)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for prior years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,864)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,556)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,165)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total medical payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184,388)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159,530)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155,320)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs payable, end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,483&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,872&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,690&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the years ended December&#160;31, 2021, 2020 and 2019 medical cost reserve development was primarily driven by lower than expected health system utilization levels. Additionally, medical cost reserve development in the year ended December 31, 2021 was driven by the uncertainty of care patterns due to the disruption of the health care system caused by COVID-19.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical costs payable included IBNR of $17.1 billion and $14.8 billion at December&#160;31, 2021 and 2020, respectively. Substantially all of the IBNR balance as of December&#160;31, 2021 relates to the current year. The following is information about incurred and paid medical cost development as of December&#160;31, 2021: </span></div><div style="margin-bottom:6pt;margin-top:4.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:54.031%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.826%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.160%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.164%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Incurred Medical Costs</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,276&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,140&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347,771&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Cumulative Medical Payments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139,974)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158,182)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165,524)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(323,706)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net remaining outstanding liabilities prior to 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">418&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total medical costs payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,483&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for insurance products considered to be short-duration contracts because the contract provides insurance protection for a fixed period of short duration and enables the insurer to cancel the contract or to adjust the provisions of the contract at the end of any contract period, such as adjusting the amount of premiums charged or coverage provided, and on contracts on which amounts are paid but insurance risk is not transferred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -URI http://asc.fasb.org/topic&amp;trid=2303980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466610907208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-Term Borrowings and Long-Term Debt (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Short-Term Borrowings and Long-Term Debt [Text Block]</a></td>
<td class="text">Short-Term Borrowings and Long-Term Debt <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term borrowings and senior unsecured long-term debt consisted of the following:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.338%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.453%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Carrying Value As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(in millions, except percentages)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,296&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$400 million 4.700% notes due February 2021 </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$750 million 2.125% notes due March 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$350 million Floating rate notes due June 2021</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$400 million 3.150% notes due June 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$500 million 3.375% notes due November 2021 </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$750 million 2.875% notes due December 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">762&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,100 million 2.875% notes due March 2022 </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,000 million 3.350% notes due July 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$900 million 2.375% notes due October 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">899&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">897&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$15 million 0.000% notes due November 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$625 million 2.750% notes due February 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">632&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">644&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$750 million 2.875% notes due March 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">768&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$750 million 3.500% notes due June 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">749&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$750 million 3.500% notes due February 2024</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">748&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,000 million 0.550% notes due May 2024</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">996&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$750 million 2.375% notes due August 2024</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">748&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$2,000 million 3.750% notes due July 2025</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,994&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$300 million 3.700% notes due December 2025</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$500 million 1.250% notes due January 2026</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,000 million 3.100% notes due March 2026</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,000 million 1.150% notes due May 2026</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$750 million 3.450% notes due January 2027</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$625 million 3.375% notes due April 2027</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$950 million 2.950% notes due October 2027</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">942&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,150 million 3.850% notes due June 2028</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$850 million 3.875% notes due December 2028</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">844&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">844&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,000 million 2.875% notes due August 2029</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,086&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,250 million 2.000% notes due May 2030</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,500 million 2.300% notes due May 2031</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,482&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,000 million 4.625% notes due July 2035</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">992&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$850 million 5.800% notes due March 2036</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$500 million 6.500% notes due June 2037</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$650 million 6.625% notes due November 2037</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,100 million 6.875% notes due February 2038</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,077&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,250 million 3.500% notes due August 2039</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,000 million 2.750% notes due May 2040</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">966&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$300 million 5.700% notes due October 2040</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$350 million 5.950% notes due February 2041</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,500 million  3.050% notes due May 2041</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$600 million 4.625% notes due November 2041</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$502 million 4.375% notes due March 2042</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$625 million 3.950% notes due October 2042</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$750 million 4.250% notes due March 2043</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$2,000 million 4.750% notes due July 2045</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$750 million 4.200% notes due January 2047</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">739&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">738&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$725 million 4.250% notes due April 2047</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">718&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">717&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$950 million 3.750% notes due October 2047</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">934&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">934&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,350 million 4.250% notes due June 2048</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,100 million 4.450% notes due December 2048</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,086&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,250 million 3.700% notes due August 2049</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,236&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,250 million 2.900% notes due May 2050</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$2,000 million 3.250% notes due May 2051</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,970&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,250 million 3.875% notes due August 2059</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,000 million 3.125% notes due May 2060</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Total short-term borrowings and long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">44,632&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">42,280&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt obligations also included $1.4 billion and $1.2 billion of other financing obligations, of which $611 million and $354 million were current as of December&#160;31, 2021 and 2020, respectively. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of short-term borrowings and long-term debt for the years ending December&#160;31 are as follows: </span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:87.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.882%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,626&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,452&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-Term Borrowings</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper consists of short-duration, senior unsecured debt privately placed on a discount basis through broker-dealers.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has $5.6 billion five-year, $5.6 billion three-year and $3.8 billion 364-day revolving bank credit facilities with 24 banks, which mature in December 2026, December 2024 and December 2022, respectively. These facilities provide full liquidity support for the Company&#8217;s commercial paper program and are available for general corporate purposes. As of December&#160;31, 2021, no amounts had been drawn on any of the bank credit facilities. The annual interest rates, which are variable based on term, are calculated based on one-month Term Secured Overnight Financing Rate (SOFR) plus a SOFR Adjustment of 10 basis points plus a credit spread based on the Company&#8217;s senior unsecured credit ratings. If amounts had been drawn on the bank credit facilities as of December&#160;31, 2021, annual interest rates would have ranged from 0.8% to 0.9%.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Covenants</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s bank credit facilities contain various covenants, including requiring the Company to maintain a debt to debt-plus-shareholders&#8217; equity ratio of not more than 60%. The Company was in compliance with its debt covenants as of December&#160;31, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466611228536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationLineItems', window );"><strong>Income Tax Examination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Tax Disclosure [Text Block]</a></td>
<td class="text">Income Taxes <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current income tax provision reflects the tax consequences of revenues and expenses currently taxable or deductible on various income tax returns for the year reported. The deferred income tax provision or benefit generally reflects the net change in deferred income tax assets and liabilities during the year, excluding any deferred income tax assets and liabilities of acquired businesses. The components of the provision for income taxes for the years ended December&#160;31 are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:75.405%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.948%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.948%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.097%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Provision:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,451&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current provision</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,448&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,981&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,512&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred provision (benefit)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,578&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,973&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,742&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of the tax provision at the U.S. federal statutory rate to the provision for income taxes and the effective tax rate for the years ended December&#160;31 is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"/><td style="width:47.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.711%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except percentages)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax provision at the U.S. federal statutory rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,685&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,356&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,776&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based awards - excess tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health insurance tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(246)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(214)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(324)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,578&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,973&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,742&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income tax assets and liabilities are recognized for the differences between the financial and income tax reporting bases of assets and liabilities based on enacted tax rates and laws. The components of deferred income tax assets and liabilities as of December&#160;31 are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:73.643%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.794%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.795%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and allowances</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal and state net operating loss carryforwards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nondeductible liabilities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. tax loss carryforwards</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other-domestic</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other-non-U.S.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,746&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,561&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowances</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(198)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,548&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,391&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal and state intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,658)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,588)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. goodwill and intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(512)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(606)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(833)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(731)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(349)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(346)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(256)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(216)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside basis in partnerships</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(565)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(342)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease right-of-use asset</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,267)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,179)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gains on investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(400)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other-non-U.S.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(248)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(350)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,813)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,758)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred income tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,265)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,367)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuation allowances are provided when it is considered more likely than not deferred tax assets will not be realized. The valuation allowances primarily relate to future tax benefits on certain federal, state and non-U.S. net operating loss carryforwards. Gross federal net operating loss carryforwards of $42 million expire beginning in 2023 through 2037 and $295 million have an indefinite carryforward period; state net operating loss carryforwards expire beginning in 2022 through 2041, with some having an indefinite carryforward period. Substantially all of the non-U.S. tax loss carryforwards have indefinite carryforward periods. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company&#8217;s undistributed earnings from non-U.S. subsidiaries are intended to be indefinitely reinvested in non-U.S. operations, and therefore no U.S. deferred taxes have been recorded. Taxes payable on the remittance of such earnings would be minimal.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of unrecognized tax benefits as of December&#160;31 is as follows: </span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:71.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.272%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross unrecognized tax benefits, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,829&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,423&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,056&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross increases:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year tax positions</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year tax positions</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross decreases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year tax positions</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statute of limitations lapses</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross unrecognized tax benefits, end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,310&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,829&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,423&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes it is reasonably possible its liability for unrecognized tax benefits will decrease in the next twelve months by $42 million as a result of audit settlements and the expiration of statutes of limitations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies net interest and penalties associated with uncertain income tax positions as income taxes within its Consolidated Statements of Operations. During the years ended December&#160;31, 2021, 2020 and 2019, the Company recognized $66 million, $52 million and $19 million of net interest and penalties, respectively. The Company had $194 million and $128 million of accrued interest and penalties for uncertain tax positions as of December&#160;31, 2021 and 2020, respectively. These amounts are not included in the reconciliation above. As of December&#160;31, 2021, there were $1.2 billion of unrecognized tax benefits which, if recognized, would affect the effective tax rate.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company currently files income tax returns in the United States, various states and localities and non-U.S. jurisdictions. The U.S. Internal Revenue Service (IRS) has completed exams on the consolidated income tax returns for fiscal years 2016 and prior. The Company&#8217;s 2017 through 2020 tax years are under review by the IRS under its Compliance Assurance Program. With the exception of a few states, the Company is no longer subject to income tax examinations prior to the 2014 tax year. In general, the Company is subject to examination in non-U.S. jurisdictions for years 2015 and forward.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466610839800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_ShareholdersEquityAbstract', window );"><strong>Shareholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity Note Disclosure [Text Block]</a></td>
<td class="text">Shareholders' Equity<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory Capital and Dividend Restrictions</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s regulated insurance and health maintenance organization (HMO) subsidiaries are subject to regulations and standards in their respective jurisdictions. These standards, among other things, require these subsidiaries to maintain specified levels of statutory capital, as defined by each jurisdiction, and restrict the timing and amount of dividends and other distributions which may be paid to their parent companies. In the United States, most of these state regulations and standards are generally consistent with model regulations established by the National Association of Insurance Commissioners. These standards generally permit dividends to be paid from statutory unassigned surplus of the regulated subsidiary and are limited based on the regulated subsidiary&#8217;s level of statutory net income and statutory capital and surplus. These dividends are referred to as &#8220;ordinary dividends&#8221; and generally may be paid without prior regulatory approval. If the dividend, together with other dividends paid within the preceding twelve months, exceeds a specified statutory limit or is paid from sources other than earned surplus, it is generally considered an &#8220;extraordinary dividend&#8221; and must receive prior regulatory approval. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2021, the Company&#8217;s domestic insurance and HMO subsidiaries paid their parent companies dividends of $8.0 billion, including $4.7 billion of extraordinary dividends. For the year ended December&#160;31, 2020, the Company&#8217;s domestic insurance and HMO subsidiaries paid their parent companies dividends of $8.3 billion, including $4.2 billion of extraordinary dividends.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's global financially regulated subsidiaries had estimated aggregate statutory capital and surplus of $30.7 billion as of December&#160;31, 2021. The estimated statutory capital and surplus necessary to satisfy regulatory requirements of the Company's global financially regulated subsidiaries was approximately $13.0 billion as of December&#160;31, 2021.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Optum Bank must meet minimum capital requirements of the Federal Deposit Insurance Corporation (FDIC) under the capital adequacy rules to which it is subject. At December&#160;31, 2021, the Company believes Optum Bank met the FDIC requirements to be considered &#8220;Well Capitalized.&#8221;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Program</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under its Board of Directors&#8217; authorization, the Company maintains a share repurchase program. The objectives of the share repurchase program are to optimize the Company&#8217;s capital structure and cost of capital, thereby improving returns to shareholders, as well as to offset the dilutive impact of share-based awards. Repurchases may be made from time to time in open market purchases or other types of transactions (including prepaid or structured share repurchase programs), subject to certain Board restrictions. In June 2018, the Board renewed the Company&#8217;s share repurchase program with an authorization to repurchase up to 100 million shares of its common stock.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of common share repurchases for the years ended December&#160;31, 2021 and 2020 is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.433%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common share repurchases, shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common share repurchases, average price per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389.92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common share repurchases, aggregate cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Board authorized shares remaining</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, the Company&#8217;s Board of Directors increased the Company&#8217;s quarterly cash dividend to shareholders to an annual rate of $5.80 compared to $5.00 per share, which the Company had paid since June 2020. Declaration and payment of future quarterly dividends is at the discretion of the Board and may be adjusted as business needs or market conditions change.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides details of the Company&#8217;s 2021 dividend payments:</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.785%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payment Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Amount Paid</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 23</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 29</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 21</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 14</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,365&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_ShareholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Shareholders' Equity [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_ShareholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466610729496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-based Payment Arrangement [Text Block]</a></td>
<td class="text">Share-Based Compensation<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s outstanding share-based awards consist mainly of non-qualified stock options and restricted shares. As of December&#160;31, 2021, the Company had 64 million shares available for future grants of share-based awards under the 2020 Stock Incentive Plan. In June 2021, the Company&#8217;s shareholders approved 15&#160;million additional shares under the ESPP. As of December&#160;31, 2021, there were 18&#160;million shares of common stock available for issuance under the ESPP. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activity for the year ended December&#160;31, 2021 is summarized in the table below:</span></div><div style="margin-bottom:6pt;margin-top:4.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:44.434%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual&#160;Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic&#160;Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at end of period</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,932&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest, end of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,509&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Shares</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted share activity for the year ended December&#160;31, 2021 is summarized in the table below:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:68.446%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.153%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(shares in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant Date<br/>Fair Value<br/>per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Share-Based Compensation Data</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:65.029%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.458%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share amounts)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value of shares granted, per share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intrinsic value of stock options exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restricted Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value of shares granted, per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of restricted shares vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Employee Stock Purchase Plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of shares purchased</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Share-Based Compensation Items</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense, before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">697&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense, net of tax effects</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit realized from share-based award exercises</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:78.665%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized compensation expense related to share awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average years to recognize compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3</span></td></tr></table></div><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation Recognition and Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal assumptions the Company used in calculating grant-date fair value for stock options were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:49.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.567%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7% - 1.2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2% - 1.4%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5% - 2.5%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.2% - 29.8%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.2% - 29.5%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.4% - 21.6%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3% - 1.5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4% - 1.7%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4% - 1.8%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeiture rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life in years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3</span></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-free interest rates are based on U.S. Treasury yields in effect at the time of grant. Expected volatilities are based on the historical volatility of the Company&#8217;s common stock and the implied volatility from exchange-traded options on the Company&#8217;s common stock. Expected dividend yields are based on the per share cash dividend paid by the Company. The Company uses historical data to estimate option exercises and forfeitures within the valuation model. The expected lives of options granted represents the period of time the awards granted are expected to be outstanding based on historical exercise patterns.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Employee Benefit Plans </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers a 401(k) plan for its employees. Compensation expense related to this plan was not material for 2021, 2020 and 2019.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company maintains non-qualified, deferred compensation plans, which allow certain members of senior management and executives to defer portions of their salary or bonus. The deferrals are recorded within long-term investments with an approximately equal amount in other liabilities in the Consolidated Balance Sheets. The total deferrals are distributable based upon termination of employment or other periods, as elected under each plan and were $1.8 billion and $1.6 billion as of December&#160;31, 2021 and 2020, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466610791240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies Disclosure [Text Block]</a></td>
<td class="text">Commitments and Contingencies<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease costs were $1.2 billion, $1.1 billion and $1.0 billion for the years ended December&#160;31, 2021, 2020 and 2019, respectively, and included immaterial variable and short-term lease costs for the year ended December 31, 2021, 2020 and 2019. Cash payments made on the Company&#8217;s operating lease liabilities were $921 million, $865 million and $746&#160;million for the years ended December&#160;31, 2021, 2020 and 2019, respectively, which were classified within operating activities in the Consolidated Statements of Cash Flows. As of December&#160;31, 2021, the Company&#8217;s weighted-average remaining lease term and weighted-average discount rate for its operating leases were 8.7 years and 2.9%, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, future minimum annual lease payments under all non-cancelable operating leases were as follows: </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:81.330%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.738%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Future Minimum Lease Payments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">763&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,716&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,882&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(609)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,273&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Commitments</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides guarantees related to its service level under certain contracts. If minimum standards are not met, the Company may be financially at risk up to a stated percentage of the contracted fee or a stated dollar amount. None of the amounts accrued, paid or charged to income for service level guarantees were material as of December&#160;31, 2021, 2020 or 2019. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company had outstanding, undrawn letters of credit with financial institutions of $181 million and surety bonds outstanding with insurance companies of $1.3 billion, primarily to bond contractual performance. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pending Acquisitions</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, we entered into agreements to acquire multiple companies in the health care sector, most notably, Change Healthcare (NASDAQ: CHNG), subject to regulatory approval and other customary closing conditions. Additionally, in January 2022, we entered into agreements to acquire multiple companies in the health care sector, subject to regulatory approval and other customary closing conditions. The total anticipated capital required for these acquisitions, excluding the payoff of acquired indebtedness, is approximately $12&#160;billion.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Matters</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is frequently made party to a variety of legal actions and regulatory inquiries, including class actions and suits brought by members, care providers, consumer advocacy organizations, customers and regulators, relating to the Company&#8217;s businesses, including management and administration of health benefit plans and other services. These matters include medical malpractice, employment, intellectual property, antitrust, privacy and contract claims and claims related to health care benefits coverage and other business practices.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records liabilities for its estimates of probable costs resulting from these matters where appropriate. Estimates of costs resulting from legal and regulatory matters involving the Company are inherently difficult to predict, particularly where the matters: involve indeterminate claims for monetary damages or may involve fines, penalties or punitive damages; present novel legal theories or represent a shift in regulatory policy; involve a large number of claimants or regulatory bodies; are in the early stages of the proceedings; or could result in a change in business practices. Accordingly, the Company is often unable to estimate the losses or ranges of losses for those matters where there is a reasonable possibility or it is probable a loss may be incurred.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Government Investigations, Audits and Reviews</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been involved or is currently involved in various governmental investigations, audits and reviews. These include routine, regular and special investigations, audits and reviews by CMS, state insurance and health and welfare departments, state attorneys general, the Office of the Inspector General, the Office of Personnel Management, the Office of </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Civil Rights, the Government Accountability Office, the Federal Trade Commission, U.S. Congressional committees, the U.S. Department of Justice (DOJ), the SEC, the IRS, the U.S. Drug Enforcement Administration, the U.S. Department of Labor, the FDIC, the Defense Contract Audit Agency and other governmental authorities. Similarly, our international businesses are also subject to investigations, audits and reviews by applicable foreign governments, including South American and other non-U.S. governmental authorities. Certain of the Company&#8217;s businesses have been reviewed or are currently under review, including for, among other matters, compliance with coding and other requirements under the Medicare risk-adjustment model. CMS has selected certain of the Company&#8217;s local plans for risk adjustment data validation (RADV) audits to validate the coding practices of and supporting documentation maintained by health care providers and such audits may result in retrospective adjustments to payments made to the Company&#8217;s health plans.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 14, 2017, the DOJ announced its decision to pursue certain claims within a lawsuit initially asserted against the Company and filed under seal by a whistleblower in 2011. The whistleblower&#8217;s complaint, which was unsealed on February 15, 2017, alleges the Company made improper risk adjustment submissions and violated the False Claims Act. On February 12, 2018, the court granted in part and denied in part the Company&#8217;s motion to dismiss. In May 2018, DOJ moved to dismiss the Company&#8217;s counterclaims, which were filed in March 2018, and moved for partial summary judgment. In March 2019, the court denied the government&#8217;s motion for partial summary judgment and dismissed the Company&#8217;s counterclaims without prejudice. The Company cannot reasonably estimate the outcome which may result from this matter given its procedural status.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466610853528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Financial Information (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Financial Information [Text Block]</a></td>
<td class="text">Segment Financial Information<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Factors used to determine the Company&#8217;s reportable segments include the nature of operating activities, economic characteristics, existence of separate senior management teams and the type of information used by the Company&#8217;s chief operating decision maker to evaluate its results of operations. Reportable segments with similar economic characteristics, products and services, customers, distribution methods and operational processes which operate in a similar regulatory environment are combined.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a description of the types of products and services from which each of the Company&#8217;s four reportable segments derives its revenues:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">UnitedHealthcare </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">includes the combined results of operations of UnitedHealthcare Employer&#160;&amp; Individual, UnitedHealthcare Medicare&#160;&amp; Retirement, UnitedHealthcare Community&#160;&amp; State and UnitedHealthcare Global. The U.S. businesses share significant common assets, including a contracted network of physicians, health care professionals, hospitals and other facilities, information technology and consumer engagement infrastructure and other resources. UnitedHealthcare Employer&#160;&amp; Individual offers an array of consumer-oriented health benefit plans and services for large national employers, public sector employers, mid-sized employers, small businesses, sole proprietorships and individuals nationwide. UnitedHealthcare Medicare&#160;&amp; Retirement provides health care coverage and health and well-being services to individuals age 50 and older, addressing their unique needs for preventive and acute health care services as well as services dealing with chronic disease and other specialized issues for older individuals. UnitedHealthcare Community &amp; State provides diversified health care benefits products and services to state programs caring for the economically disadvantaged, the medically underserved and those without the benefit of employer-funded health care coverage. UnitedHealthcare Community &amp; State&#8217;s primary customers oversee Medicaid plans, the Children&#8217;s Health Insurance Program and other federal, state and community health care programs. UnitedHealthcare Global provides health and dental benefits and hospital and clinical services to employer groups and individuals in South America, and other diversified global health businesses.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Optum Health</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> focuses on care delivery, care management, wellness and consumer engagement, and health financial services. Optum Health is building a comprehensive, connected health care delivery and engagement platform by directly providing high-quality care, helping people manage chronic and complex health needs, and proactively engaging consumers in managing their health through in-person, in-home, virtual and digital clinical platforms. Optum Health offers access to networks of care provider specialists, health management services, care delivery, consumer engagement and financial services.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Optum Insight</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brings together advanced analytics, technology and health care expertise to deliver integrated services and solutions. Hospital systems, physicians, health plans, governments, life sciences companies and other organizations comprising the health care industry depend on Optum Insight to help them improve performance, achieve efficiency, reduce costs, meet compliance mandates and modernize their core operating systems to meet the changing needs of the health system.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Optum Rx </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">offers pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, purchasing and clinical capabilities, and develops programs in areas such as step therapy, formulary management, drug adherence and disease/drug therapy management. Optum Rx integrates </span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pharmacy and medical care and is positioned to serve patients with complex clinical needs and consumers looking for a better digital pharmacy experience with transparent pricing.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s accounting policies for reportable segment operations are consistent with those described in the Summary of Significant Accounting Policies (see </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 2</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). Transactions between reportable segments principally consist of sales of pharmacy care products and services to UnitedHealthcare customers by Optum Rx, certain product offerings and care management and local and in-home care delivery services sold to UnitedHealthcare by Optum Health, and health information and technology solutions, consulting and other services sold to UnitedHealthcare by Optum Insight. These transactions are recorded at management&#8217;s estimate of fair value. Transactions with affiliated customers are eliminated in consolidation. Assets and liabilities jointly used are assigned to each reportable segment using estimates of pro-rata usage. Cash and investments are assigned so each reportable segment has working capital and/or at least minimum specified levels of regulatory capital. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a percentage of the Company&#8217;s total consolidated revenues, premium revenues from CMS were 36%, 36% and 33% for 2021, 2020 and 2019, respectively, most of which were generated by UnitedHealthcare Medicare &amp; Retirement and included in the UnitedHealthcare segment. U.S. customer revenue represented approximately 97%, 97% and 96% of consolidated total revenues for 2021, 2020 and 2019, respectively. Long-lived fixed assets located in the United States represented approximately 78% and 75% of the total long-lived fixed assets as of December&#160;31, 2021 and 2020, respectively. The non-U.S. revenues and fixed assets are primarily related to UnitedHealthcare Global. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the reportable segment financial information:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:24.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.341%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.282%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.811%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.105%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.164%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.289%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">UnitedHealthcare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum Health</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum Insight</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum Rx</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum Eliminations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Corporate&#160;and<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenues - unaffiliated customers:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">212,381&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">226,233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,437&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,437&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,661&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,936&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,942&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,603&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues - unaffiliated customers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">222,042&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,778&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,095&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35,358&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63,231&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">285,273&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues - affiliated customers</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,234&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,867&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55,779&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,013)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">90,867&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(90,867)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment and other income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">857&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">222,899&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54,065&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,199&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">91,314&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,013)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">155,565&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(90,867)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">287,597&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,975&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,462&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,398&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,135&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,995&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,970&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,660)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,660)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,975&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,462&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,398&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,135&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,995&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,660)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,310&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">102,967&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60,474&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,868&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,181&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">117,523&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,284)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">212,206&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property, equipment and capitalized software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">795&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,004&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">818&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">684&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,099&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenues - unaffiliated customers:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">191,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">201,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,977&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,464&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,016&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues - unaffiliated customers</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200,143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,647&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,822&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35,027&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55,496&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">255,639&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues - affiliated customers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,481&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,941&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52,420&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,800)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">80,042&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(80,042)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment and other income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">732&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">770&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,502&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200,875&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39,808&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,802&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87,498&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,800)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">136,308&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(80,042)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">257,141&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,359&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,434&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,725&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,887&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,046&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,405&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,663)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,663)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,359&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,434&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,725&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,887&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,046&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,663)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,742&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">98,229&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52,073&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,425&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39,280&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">106,778&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,718)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">197,289&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property, equipment and capitalized software</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">715&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,051&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenues - unaffiliated customers:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">183,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,916&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,916&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">189,699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31,450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,922&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,732&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">689&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,051&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,973&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues - unaffiliated customers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">192,705&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,679&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,746&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,139&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">47,564&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">240,269&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues - affiliated customers</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,966&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,239&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42,093&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,661)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64,637&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(64,637)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment and other income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">749&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">193,842&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,317&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,006&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74,288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,661)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">112,950&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(64,637)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">242,155&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,326&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,963&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,494&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,902&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,359&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,685&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,704)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,704)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,326&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,963&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,494&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,902&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,359&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,704)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,981&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88,250&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,444&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,181&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36,346&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">91,971&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,332)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">173,889&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property, equipment and capitalized software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">841&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,071&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">565&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">672&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,720&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466610806808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule I (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedStatementOfIncomeCaptionsLineItems', window );"><strong>Condensed Statement of Income Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock', window );">Condensed Financial Information of Parent Company Only Disclosure [Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Schedule I </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Financial Information of Registrant </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Parent Company Only) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealth Group </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Balance Sheets </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:67.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.980%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.982%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,670&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">820&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net assets of subsidiaries</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,907&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,714&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term notes receivable from subsidiaries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,021&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,289&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,897&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of notes payable to subsidiaries</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,882&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term borrowings and current maturities of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,009&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,719&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,936&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, less current maturities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,406&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 4) </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders&#8217; equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $0.001 par value -10 shares authorized; no shares issued or outstanding</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $0.01 par value - 3,000 shares authorized; 941 and 946 issued and outstanding</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,384)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,814)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total UnitedHealth Group shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,760&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,491&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,289&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,897&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_277" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to the Condensed Financial Statements of Registrant</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Schedule I </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Financial Information of Registrant </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Parent Company Only) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealth Group </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Comprehensive Income </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment and other income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,594&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,580&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,623&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,621&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,618&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,129)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,427)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,409)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss of parent company</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(898)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,127)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,116)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in undistributed income of subsidiaries</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,285&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,403&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,839&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,570)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(236)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,715&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,167&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,421&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_277" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to the Condensed Financial Statements of Registrant</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Schedule I </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Financial Information of Registrant </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Parent Company Only) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealth Group </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Cash Flows </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:65.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.297%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating activities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,439&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,842&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuances of notes to subsidiaries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(444)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(628)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,722)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of notes to subsidiaries</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,249&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for acquisitions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,953)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,706)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,645)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return of capital to parent company</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital contributions to subsidiaries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(747)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(803)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows used for investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,862)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,202)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,934)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock repurchases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,250)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,500)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from common stock issuances</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,280)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,584)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,932)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Repayments of) proceeds from short-term borrowings, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,302)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">872&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,933&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,864&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,444&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,750)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from notes from subsidiaries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,818&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(447)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(438)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(535)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows used for financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,668)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,428)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,729)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase (decrease) in cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,909&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(388)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents, end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,167&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental cash flow disclosures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,575&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,506&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,590&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_277" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notes to the Condensed Financial Statements of Registrant</a></span><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Schedule I </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Financial Information of Registrant </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Parent Company Only) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealth Group </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Financial Statements </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;Basis of Presentation </span></div><div style="margin-top:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealth Group&#8217;s parent company financial information has been derived from its consolidated financial statements and should be read in conjunction with the consolidated financial statements included in this Form&#160;10-K. The accounting policies for the registrant are the same as those described in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 2 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements.</a><a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">and Supplementary Data</a><a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">.</a><a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#8221;</a></span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;Subsidiary Transactions </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment in Subsidiaries. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealth Group&#8217;s investment in subsidiaries is stated at cost plus equity in undistributed earnings of subsidiaries.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends and Capital Distributions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cash dividends received from subsidiaries and included in Cash Flows from Operating Activities in the Condensed Statements of Cash Flows were $10.8 billion, $10.0 billion and $5.6 billion in 2021, 2020 and 2019, respectively. Additionally, $0.2 billion, $0.9 billion and $4.5 billion in cash were received as a return of capital to the parent company during 2021, 2020 and 2019, respectively.</span></div>Short-Term Borrowings and Long-Term Debt <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discussion of short-term borrowings and long-term debt can be found in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_193" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 8 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements</a><a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_193" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"> </a><a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_193" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">and Supplementary Data</a><a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_193" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">.&#8221;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Long-term debt obligations of the parent company do not include other financing obligations at subsidiaries which totaled $1.4 billion and $1.2 billion at December&#160;31, 2021 and 2020.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of short-term borrowings and long-term debt for the years ending December 31 are as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:87.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.882%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,015&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealth Group&#8217;s parent company had notes payable to subsidiaries of $8.1 billion and $4.9 billion as of December 31, 2021 and 2020, respectively, which included on-demand features.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.    Commitments and Contingencies</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain regulated subsidiaries are guaranteed by UnitedHealth Group&#8217;s parent company in the event of insolvency. UnitedHealth Group&#8217;s parent company also provides guarantees related to its service level under certain contracts. None of the amounts accrued, paid or charged to income for service level guarantees were material as of December&#160;31, 2021, 2020 or 2019.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a summary of commitments and contingencies, see </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_217" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 12 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements.</a><a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_217" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">and Supplementary Data</a><a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_217" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#8221;</a></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedStatementOfIncomeCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedStatementOfIncomeCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.5-04(Schedule I))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391182&amp;loc=d3e5864-122674<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=d3e5283-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466606960152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Accounting, Policy [Policy Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has prepared the Consolidated Financial Statements according to U.S. Generally Accepted Accounting Principles (GAAP) and has included the accounts of UnitedHealth Group and its subsidiaries.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates, Policy [Policy Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These Consolidated Financial Statements include certain amounts based on the Company&#8217;s best estimates and judgments. The Company&#8217;s most significant estimates relate to estimates and judgments for medical costs payable and goodwill. Certain of these estimates require the application of complex assumptions and judgments, often because they involve matters inherently uncertain and will likely change in subsequent periods. The impact of any change in estimates is included in earnings in the period in which the estimate is adjusted.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue [Policy Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Premiums</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium revenues are primarily derived from risk-based health insurance arrangements in which the premium is typically at a fixed rate per individual served for a one-year period, and the Company assumes the economic risk of funding its customers&#8217; health care and related administrative costs.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium revenues are recognized in the period in which eligible individuals are entitled to receive health care benefits. Health care premium payments received from the Company&#8217;s customers in advance of the service period are recorded as unearned revenues. Fully insured commercial products of U.S. health plans, Medicare Advantage and Medicare Prescription Drug Benefit (Medicare Part D) plans with medical loss ratios (MLRs) as calculated under the definitions in the Patient Protection and Affordable Care Act (ACA) and related federal and state regulations and implementing regulation, falling below certain targets are required to rebate ratable portions of their premiums annually. Commercial premiums within the Company&#8217;s individual and small group markets are also subject to the ACA risk adjustment program. Medicare Advantage premium revenue includes the impact of the Centers for Medicare &amp; Medicaid Services (CMS) quality bonuses based on plans&#8217; Star rating. Certain of the Company&#8217;s Medicaid business is also subject to state minimum MLR rebates.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium revenues are recognized based on the estimated premiums earned, net of projected rebates, because the Company is able to reasonably estimate the ultimate premiums of these contracts. The Company also records premium revenues for certain value-based arrangements at its Optum Health care delivery businesses. Under these value-based arrangements, the Company enters into agreements with health plans to stand ready to deliver, integrate, direct and control certain health care services for the individuals enrolled. In exchange, the Company receives a premium that is typically paid on a per-member per-month basis. The Company considers these value-based arrangements to represent a single performance obligation where premium revenues are recognized in the period in which health care services are made available.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Medicare Advantage and Medicare Part D premium revenues are subject to periodic adjustment under CMS&#8217; risk adjustment payment methodology. CMS deploys a risk adjustment model which apportions premiums paid to all health plans according to health severity and certain demographic factors. The CMS risk adjustment model provides higher per member payments for enrollees diagnosed with certain conditions and lower payments for enrollees who are healthier. Under this risk adjustment methodology, CMS calculates the risk adjusted premium payment using diagnosis and encounter data from hospital inpatient, hospital outpatient and physician treatment settings. The Company and health care providers collect, capture and submit the necessary and available data to CMS within prescribed deadlines. The Company estimates risk adjustment premium revenues based upon the data submitted and expected to be submitted to CMS. Risk adjustment data for the Company&#8217;s plans are subject to review by the government, including audit by regulators. See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_217" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 12</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding these audits.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Products and Services</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Company&#8217;s Optum Rx pharmacy care services business, the majority of revenues are derived from products sold through a contracted network of retail pharmacies or home delivery, specialty and community health pharmacies. Product revenues include the cost of pharmaceuticals (net of rebates), a negotiated dispensing fee and customer co-payments for drugs dispensed through the Company&#8217;s home delivery, specialty and community pharmacies. For the years ended December 31, 2021 and 2020, the Company recognized revenue and cost of products sold for retail pharmacy co-payments related to its Optum Rx business. Revenue recognized in prior periods related to retail pharmacy transactions excludes the member&#8217;s applicable co-payment. There was no impact on earnings from operations, net earnings, earnings per share or total equity. Pharmacy products are billed to customers based on the number of transactions occurring during the billing period. Product revenues are recognized when the prescriptions are dispensed. The Company has entered into contracts in which it is primarily obligated to pay its network pharmacy providers for benefits provided to their customers regardless of whether the Company is paid. The Company is also involved in establishing the prices charged by retail pharmacies, determining which drugs will be included in formulary listings and selecting which retail pharmacies will be included in the network offered to plan sponsors&#8217; members and accordingly, are reported on a gross basis.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services revenue are comprised of a number of services and products sold through Optum. Optum Health&#8217;s service revenues include net patient service revenues recorded based upon established billing rates, less allowances for contractual adjustments, and are recognized as services are provided. For its financial services offerings, Optum Health charges fees and earns investment income on managed funds. Optum Insight provides software and information products, advisory consulting arrangements and managed services outsourcing contracts, which may be delivered over several years. Optum Insight revenues are generally recognized over time and measured each period based on the progress to date as services are performed or made available to customers.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services revenue also consists of fees derived from services performed for customers who self-insure the health care costs of their employees and employees&#8217; dependents. Under service fee contracts, the Company receives monthly, a fixed fee per employee, which is recognized as revenue as the Company performs, or makes available, the applicable services to the customer. The customers retain the risk of financing health care costs for their employees and employees&#8217; dependents, and the Company administers the payment of customer funds to physicians and other health care professionals from customer-funded bank accounts. As the Company has neither the obligation for funding the health care costs, nor the primary responsibility for providing the medical care, the Company does not recognize premium revenue and medical costs for these contracts in its Consolidated Financial Statements. For these fee-based customer arrangements, the Company provides coordination and facilitation of medical services; transaction processing; customer, consumer and care professional services; and access to contracted networks of physicians, hospitals and other health care professionals. These services are performed throughout the contract period. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, accounts receivables related to products and services were $5.4 billion and $5.3 billion, respectively. In 2021 and 2020, the Company had no material bad-debt expense and there were no material contract assets, contract liabilities or deferred contract costs recorded on the Consolidated Balance Sheets as of December&#160;31, 2021 or 2020.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2021, 2020 and 2019, revenue recognized from performance obligations related to prior periods (for example, due to changes in transaction price) was not material.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue expected to be recognized in any future year related to remaining performance obligations, excluding revenue pertaining to contracts having an original expected duration of one year or less, contracts where revenue is recognized as invoiced and contracts with variable consideration related to undelivered performance obligations, is not material.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_223" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 13</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for disaggregation of revenue by segment and type.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy', window );">Medical Costs and Medical Costs Payable [Policy Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical Costs and Medical Costs Payable </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimate of medical costs payable represents management&#8217;s best estimate of its liability for unpaid medical costs as of December&#160;31, 2021.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each period, the Company re-examines previously established medical costs payable estimates based on actual claim submissions and other changes in facts and circumstances. As more complete claim information becomes available, the Company adjusts the amount of the estimates and includes the changes in estimates in medical costs in the period in which the change is identified. Approximately 90% of claims related to medical care services are known and settled within 90 days from the date of service and substantially all within twelve months.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical costs and medical costs payable include estimates of the Company&#8217;s obligations for medical care services rendered on behalf of consumers, but for which claims have either not yet been received, processed, or paid. The Company develops estimates for medical care services incurred but not reported (IBNR), which includes estimates for claims which have not been received or fully processed, using an actuarial process consistently applied, centrally controlled and automated. The actuarial </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">models consider factors such as time from date of service to claim processing, seasonal variances in medical care consumption, health care professional contract rate changes, medical care utilization and other medical cost trends, membership volume and demographics, the introduction of new technologies, benefit plan changes, and business mix changes related to products, customers and geography. Judgments related to these factors contemplated the impact of COVID-19.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In developing its medical costs payable estimates, the Company applies different estimation methods depending on which incurred claims are being estimated. For the most recent two months, the Company estimates claim costs incurred by applying observed medical cost trend factors to the average per member per month (PMPM) medical costs incurred in prior months for which more complete claim data are available, supplemented by a review of near-term completion factors (actuarial estimates, based upon historical experience and analysis of current trends, of the percentage of incurred claims during a given period adjudicated by the Company at the date of estimation). For months prior to the most recent two months, the Company applies the completion factors to actual claims adjudicated-to-date to estimate the expected amount of ultimate incurred claims for those months.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Cost of Goods and Service [Policy Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Products Sold </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s cost of products sold includes the cost of pharmaceuticals dispensed to unaffiliated customers either directly at its home delivery, specialty and community pharmacy locations, or indirectly through its nationwide network of participating pharmacies. Rebates attributable to unaffiliated clients are accrued as rebates receivable and a reduction of cost of products sold, with a corresponding payable for the amounts of the rebates to be remitted to those unaffiliated clients in accordance with their contracts and recorded in the Consolidated Statements of Operations as a reduction of product revenue. Cost of products sold also includes the cost of personnel to support the Company&#8217;s transaction processing services, system sales, maintenance and professional services.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents, Policy [Policy Text Block]</a></td>
<td class="text">Cash, Cash Equivalents and Investments Cash and cash equivalents are highly liquid investments having an original maturity of three months or less. The fair value of cash and cash equivalents approximates their carrying value because of the short maturity of the instruments.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investment, Policy [Policy Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments with maturities of less than one year are classified as short-term. Because of regulatory requirements, certain investments are included in long-term investments regardless of their maturity date. The Company classifies these investments as held-to-maturity and reports them at amortized cost. Substantially all other investments are classified as available-for-sale and reported at fair value based on quoted market prices, where available. Equity investments, with certain exceptions, are measured at fair value with changes in fair value recognized in net earnings.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company excludes unrealized gains and losses on investments in available-for-sale debt securities from net earnings and reports them as comprehensive income and, net of income tax effects, as a separate component of equity. To calculate realized gains and losses on the sale of debt securities, the Company specifically identifies the cost of each investment sold. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates an available-for-sale debt security for credit-related impairment by considering the present value of expected cash flows relative to a security&#8217;s amortized cost, the extent to which fair value is less than amortized cost, the financial condition and near-term prospects of the issuer and specific events or circumstances which may influence the operations of the issuer. Credit-related impairments are recorded as an allowance, with an offset to investment and other income. Non-credit related impairments are recorded through other comprehensive income. If the Company intends to sell an impaired security, or will likely be required to sell a security before recovery of the entire amortized cost, the entire impairment is included in net earnings.</span></div>New information and the passage of time can change these judgments. The Company manages its investment portfolio to limit its exposure to any one issuer or market sector, and largely limits its investments to investment grade quality. Securities downgraded below policy minimums after purchase will be disposed of in accordance with the Company&#8217;s investment policy.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_AARPAssetsUnderManagementPolicyTextBlock', window );">AARP Assets Under Management [Policy Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Under Management </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides health insurance products and services to members of AARP under a Supplemental Health Insurance Program (the AARP Program) and to AARP members and non-members under separate Medicare Advantage and Medicare Part D arrangements. The products and services under the AARP Program include supplemental Medicare benefits, hospital indemnity insurance, including insurance for individuals between 50 to 64 years of age, and other related products. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Company&#8217;s agreement with AARP, program assets are managed separately from the Company&#8217;s general investment portfolio and are used to pay costs associated with the AARP Program. These assets are invested at the Company&#8217;s discretion, within investment guidelines approved by AARP. The Company does not guarantee any rates of return on these investments and, upon any transfer of the AARP Program contract to another entity, the Company would transfer cash equal in amount to the fair value of these investments at the date of transfer to the entity. Because the purpose of these assets is to fund the medical costs payable, the rate stabilization fund (RSF) liabilities and other related liabilities associated with this AARP contract, assets under management are classified as current assets, consistent with the classification of these liabilities.</span></div>The effects of changes in other balance sheet amounts associated with the AARP Program also accrue to the overall benefit of the AARP policyholders through the RSF balance. Accordingly, the Company excludes the effect of such changes in its Consolidated Statements of Cash Flows.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Receivable [Policy Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Current Receivables </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current receivables include amounts due from pharmaceutical manufacturers for rebates and Medicare Part D drug discounts, accrued interest and other miscellaneous amounts due to the Company. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s pharmacy care services businesses contract with pharmaceutical manufacturers, some of which provide rebates based on use of the manufacturers&#8217; products by its affiliated and unaffiliated clients. The Company accrues rebates as they are earned by its clients on a monthly basis based on the terms of the applicable contracts, historical data and current estimates. The pharmacy care services businesses bill these rebates to the manufacturers on a monthly or quarterly basis depending on the contractual terms and record rebates attributable to affiliated clients as a reduction to medical costs. The Company generally receives rebates two to five months after billing. As of December&#160;31, 2021 and 2020, total pharmaceutical manufacturer rebates receivable included in other receivables in the Consolidated Balance Sheets amounted to $7.2 billion and $6.3 billion, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, the Company&#8217;s Medicare Part D receivables amounted to $3.4 billion and $2.9 billion, respectively.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment, Policy [Policy Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Equipment and Capitalized Software </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, equipment and capitalized software are stated at cost, net of accumulated depreciation and amortization. Capitalized software consists of certain costs incurred in the development of internal-use software, including external direct costs of materials and services and applicable payroll costs of employees devoted to specific software development. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company calculates depreciation and amortization using the straight-line method over the estimated useful lives of the assets. The useful lives for property, equipment and capitalized software are: </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:57.111%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.689%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 10 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;to&#160;40&#160;years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 5 years</span></div></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements are depreciated over the shorter of the remaining lease term or their estimated useful economic life.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Lessee, Leases [Policy Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases facilities and equipment under long-term operating leases which are non-cancelable and expire on various dates. At the lease commencement date, lease right-of-use (ROU) assets and lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term, which includes all fixed obligations arising from the lease contract. If an interest rate is not implicit in a lease, the Company utilizes its incremental borrowing rate for a period closely matching the lease term. </span></div>The Company&#8217;s ROU assets are included in other assets, and lease liabilities are included in other current liabilities and other liabilities in the Company&#8217;s Consolidated Balance Sheet.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To determine whether goodwill is impaired, annually or more frequently if needed, the Company performs impairment tests. The Company may first assess qualitative factors to determine if it is more likely than not the carrying value of a reporting unit exceeds its estimated fair value. The Company may also elect to skip the qualitative testing and proceed directly to the quantitative testing. When performing quantitative testing, the Company first estimates the fair values of its reporting units using discounted cash flows or a weighted combination of discounted cash flows and a market-based method. To determine fair values, the Company must make assumptions about a wide variety of internal and external factors. Significant assumptions used in the impairment analysis include financial projections of free cash flow (including significant assumptions about operations, capital requirements and income taxes), long-term growth rates for determining terminal value, discount rates and the selection of comparable peer companies. If the fair value is less than the carrying value of the reporting unit, an impairment is recognized for the difference, up to the carrying amount of goodwill.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no impairment of goodwill during the years ended December&#160;31, 2021, 2020 and 2019.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy', window );">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s intangible assets are subject to impairment tests when events or circumstances indicate an intangible asset (or asset group) may be impaired. The Company&#8217;s indefinite-lived intangible assets are also tested for impairment annually. There was no impairment of intangible assets during the years ended December&#160;31, 2021, 2020 and 2019.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_OtherLiabilitiesCurrentPolicyTextBlock', window );">Other Current Liabilities [Policy Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Current Liabilities </span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities include health savings account deposits ($11.4 billion and $10.2 billion as of December&#160;31, 2021 and 2020, respectively), accruals for premium rebates payable, the RSF associated with the AARP Program, the current portion of future policy benefits and customer balances.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy', window );">Deferred Policy Acquisition Costs, Policy [Policy Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Policy Acquisition Costs</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s short duration health insurance contracts typically have a one-year term and may be canceled by the customer with at least 30 days&#8217; notice. Costs related to the acquisition and renewal of short duration customer contracts are primarily charged to expense as incurred.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy', window );">Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redeemable Noncontrolling Interests</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redeemable noncontrolling interests in the Company&#8217;s subsidiaries whose redemption is outside the control of the Company are classified as temporary equity. The following table provides details of the Company's redeemable noncontrolling interests&#8217; activity for the years ended December&#160;31, 2021 and 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.215%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,211&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,726&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemptions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,338)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(255)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value and other adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests, end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,434&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,211&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-based Payment Arrangement [Policy Text Block]</a></td>
<td class="text">Share-Based CompensationThe Company recognizes compensation expense for share-based awards, including stock options and restricted stock and restricted stock units (collectively, restricted shares), on a straight-line basis over the related service period (generally the vesting period) of the award, or to an employee&#8217;s eligible retirement date under the award agreement, if earlier. Restricted shares vest ratably, primarily over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTcvZnJhZzoyNzA4MDU3MzhiZjc0MzA5ODVmOTgzMjNiMGZkMzIxNy90ZXh0cmVnaW9uOjI3MDgwNTczOGJmNzQzMDk4NWY5ODMyM2IwZmQzMjE3XzQzOA_eb1bf801-8e88-43f4-addf-b3432e5c7bdc">four</span> years and compensation expense related to restricted shares is based on the share price on the date of grant. Stock options vest ratably primarily over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTcvZnJhZzoyNzA4MDU3MzhiZjc0MzA5ODVmOTgzMjNiMGZkMzIxNy90ZXh0cmVnaW9uOjI3MDgwNTczOGJmNzQzMDk4NWY5ODMyM2IwZmQzMjE3XzM4NDgyOTA2OTg0NDE_e5312511-99bf-4e41-b5f9-1d6cc88b8bfd">four</span> years and may be exercised up to 10 years from the date of grant. Compensation expense related to stock options is based on the fair value at the date of grant, which is estimated on the date of grant using a binomial option-pricing model. Under the Company&#8217;s Employee Stock Purchase Plan (ESPP), eligible employees are allowed to purchase the Company&#8217;s stock at a discounted price, which is 90% of the market price of the Company&#8217;s common stock at the end of the six-month purchase period. Share-based compensation expense for all programs is recognized in operating costs in the Consolidated Statements of Operations.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share, Policy [Policy Text Block]</a></td>
<td class="text">Net Earnings Per Common Share The Company computes basic earnings per common share attributable to UnitedHealth Group common shareholders by dividing net earnings attributable to UnitedHealth Group common shareholders by the weighted-average number of common shares outstanding during the period. The Company determines diluted net earnings per common share attributable to UnitedHealth Group common shareholders using the weighted-average number of common shares outstanding during the period, adjusted for potentially dilutive shares associated with stock options, restricted shares and the ESPP (collectively, common stock equivalents), using the treasury stock method. The treasury stock method assumes a hypothetical issuance of shares to settle the share-based awards, with the assumed proceeds used to purchase common stock at the average market price for the period. Assumed proceeds include the amount the employee must pay upon exercise and the average unrecognized compensation cost. The difference between the number of shares assumed issued and number of shares assumed purchased represents the dilutive shares.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndustrySpecificPoliciesInsuranceCompaniesTextBlock', window );">Health Insurance Industry Tax, Policy [Policy Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ACA Tax</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Insurance Tax was permanently repealed by Congress, effective January 1, 2021. The permanent repeal of the tax impacts year-over-year comparability of our financial statements, including revenues, operating costs, medical care ratio (MCR), operating cost ratio, effective tax rate and cash flows from operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_AARPAssetsUnderManagementPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>AARP Assets Under Management [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_AARPAssetsUnderManagementPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_OtherLiabilitiesCurrentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Liabilities, Current [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_OtherLiabilitiesCurrentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for deferred policy acquisition costs, including the nature, type, and amount of capitalized costs incurred to write or acquire insurance contracts, and the basis for and methodologies applied in capitalizing and amortizing such costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35755530&amp;loc=d3e11264-158415<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 705<br> -URI http://asc.fasb.org/topic&amp;trid=2122478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndustrySpecificPoliciesInsuranceCompaniesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for insurance companies  that are industry specific.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 10<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123599846&amp;loc=d3e56-158367<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndustrySpecificPoliciesInsuranceCompaniesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for estimating the ultimate cost of settling insurance claims relating to insured events that have occurred on or before a particular date (ordinarily, the statement of financial position date). The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claims adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14754-158437<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14784-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466611221096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Fair Value (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurement, Policy [Policy Text Block]</a></td>
<td class="text">Certain assets and liabilities are measured at fair value in the Consolidated Financial Statements or have fair values disclosed in the Notes to the Consolidated Financial Statements. These assets and liabilities are classified into one of three levels of a hierarchy defined by GAAP. In instances in which the inputs used to measure fair value fall into different levels of the fair value hierarchy, the fair value measurement is categorized in its entirety based on the lowest level input which is significant to the fair value measurement in its entirety. The Company&#8217;s assessment of the significance of a particular item to the fair value measurement in its entirety requires judgment, including the consideration of inputs specific to the asset or liability. <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value hierarchy is summarized as follows:</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Quoted prices (unadjusted) for identical assets/liabilities in active markets. </span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Other observable inputs, either directly or indirectly, including:</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Quoted prices for similar assets/liabilities in active markets;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Quoted prices for identical or similar assets/liabilities in inactive markets (e.g., few transactions, limited information, noncurrent prices, high variability over time);</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inputs other than quoted prices observable for the asset/liability (e.g., interest rates, yield curves, implied volatilities, credit spreads); and</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inputs corroborated by other observable market data.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Unobservable inputs cannot be corroborated by observable market data.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers in or out of Level 3 financial assets or liabilities during the years ended December&#160;31, 2021 or 2020.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nonfinancial assets and liabilities or financial assets and liabilities measured at fair value on a nonrecurring basis are subject to fair value adjustments only in certain circumstances, such as when the Company records an impairment. For the year ended December 31, 2021, the Company recognized $840 million of unrealized gains in investment and other income related to fair value adjustments on equity securities primarily in our venture portfolio, based on transactions of the same or similar security. There were no other significant fair value adjustments for these assets and liabilities recorded during the years ended December&#160;31, 2021 or 2020.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following methods and assumptions were used to estimate the fair value and determine the fair value hierarchy classification of each class of financial instrument included in the tables below:</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of cash and cash equivalents approximates fair value as maturities are less than three months. Fair values of cash equivalent instruments which do not trade on a regular basis in active markets are classified as Level 2.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt and Equity Securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Fair values of debt and equity securities are based on quoted market prices, where available. The Company obtains one price for each security primarily from a third-party pricing service (pricing service), which generally uses quoted or other observable inputs for the determination of fair value. The pricing service normally derives the security prices through recently reported trades for identical or similar securities, and, if necessary, makes adjustments through the reporting date based upon available observable market information. For securities not actively traded, the pricing service may use quoted market prices of comparable instruments or discounted cash flow analyses, incorporating inputs currently observable in the markets for similar securities. Inputs often used in the valuation methodologies include, but are not limited to, benchmark yields, credit spreads, default rates, prepayment speeds and nonbinding broker quotes. As the Company is responsible for the determination of fair value, it performs quarterly analyses on the prices received from the pricing service to determine whether the prices are reasonable estimates of fair value. Specifically, the Company compares the prices received from the pricing service to prices reported by a secondary pricing source, such as its custodian, its investment consultant and third-party investment advisors. Additionally, the Company compares changes in the reported market values and returns to relevant market indices to test the reasonableness of the reported prices. The Company&#8217;s internal price verification procedures and reviews of fair value methodology documentation provided by independent pricing services have not historically resulted in adjustment to the prices obtained from the pricing service.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair values of debt securities which do not trade on a regular basis in active markets but are priced using other observable inputs are classified as Level&#160;2. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value estimates for Level 1 and Level 2 equity securities are based on quoted market prices for actively traded equity securities and/or other market data for the same or comparable instruments and transactions in establishing the prices. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of Level 3 investments in corporate bonds, which are not a significant portion of our investments, are estimated using valuation techniques relying heavily on management assumptions and qualitative observations. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout the procedures discussed above in relation to the Company&#8217;s processes for validating third-party pricing information, the Company validates the understanding of assumptions and inputs used in security pricing and determines the proper classification in the hierarchy based on such understanding.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Under Management.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Assets under management consists of debt securities and other investments held to fund costs associated with the AARP Program and are priced and classified using the same methodologies as the Company&#8217;s investments in debt and equity securities.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Term Debt. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company&#8217;s long-term debt are estimated and classified using the same methodologies as the Company&#8217;s investments in debt securities.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466615133096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule I (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Condensed Financial Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation and Significant Accounting Policies [Text Block]</a></td>
<td class="text">Basis of Presentation, Use of Estimates and Significant Accounting Policies<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has prepared the Consolidated Financial Statements according to U.S. Generally Accepted Accounting Principles (GAAP) and has included the accounts of UnitedHealth Group and its subsidiaries.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These Consolidated Financial Statements include certain amounts based on the Company&#8217;s best estimates and judgments. The Company&#8217;s most significant estimates relate to estimates and judgments for medical costs payable and goodwill. Certain of these estimates require the application of complex assumptions and judgments, often because they involve matters inherently uncertain and will likely change in subsequent periods. The impact of any change in estimates is included in earnings in the period in which the estimate is adjusted.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Premiums</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium revenues are primarily derived from risk-based health insurance arrangements in which the premium is typically at a fixed rate per individual served for a one-year period, and the Company assumes the economic risk of funding its customers&#8217; health care and related administrative costs.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium revenues are recognized in the period in which eligible individuals are entitled to receive health care benefits. Health care premium payments received from the Company&#8217;s customers in advance of the service period are recorded as unearned revenues. Fully insured commercial products of U.S. health plans, Medicare Advantage and Medicare Prescription Drug Benefit (Medicare Part D) plans with medical loss ratios (MLRs) as calculated under the definitions in the Patient Protection and Affordable Care Act (ACA) and related federal and state regulations and implementing regulation, falling below certain targets are required to rebate ratable portions of their premiums annually. Commercial premiums within the Company&#8217;s individual and small group markets are also subject to the ACA risk adjustment program. Medicare Advantage premium revenue includes the impact of the Centers for Medicare &amp; Medicaid Services (CMS) quality bonuses based on plans&#8217; Star rating. Certain of the Company&#8217;s Medicaid business is also subject to state minimum MLR rebates.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium revenues are recognized based on the estimated premiums earned, net of projected rebates, because the Company is able to reasonably estimate the ultimate premiums of these contracts. The Company also records premium revenues for certain value-based arrangements at its Optum Health care delivery businesses. Under these value-based arrangements, the Company enters into agreements with health plans to stand ready to deliver, integrate, direct and control certain health care services for the individuals enrolled. In exchange, the Company receives a premium that is typically paid on a per-member per-month basis. The Company considers these value-based arrangements to represent a single performance obligation where premium revenues are recognized in the period in which health care services are made available.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Medicare Advantage and Medicare Part D premium revenues are subject to periodic adjustment under CMS&#8217; risk adjustment payment methodology. CMS deploys a risk adjustment model which apportions premiums paid to all health plans according to health severity and certain demographic factors. The CMS risk adjustment model provides higher per member payments for enrollees diagnosed with certain conditions and lower payments for enrollees who are healthier. Under this risk adjustment methodology, CMS calculates the risk adjusted premium payment using diagnosis and encounter data from hospital inpatient, hospital outpatient and physician treatment settings. The Company and health care providers collect, capture and submit the necessary and available data to CMS within prescribed deadlines. The Company estimates risk adjustment premium revenues based upon the data submitted and expected to be submitted to CMS. Risk adjustment data for the Company&#8217;s plans are subject to review by the government, including audit by regulators. See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_217" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 12</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding these audits.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Products and Services</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Company&#8217;s Optum Rx pharmacy care services business, the majority of revenues are derived from products sold through a contracted network of retail pharmacies or home delivery, specialty and community health pharmacies. Product revenues include the cost of pharmaceuticals (net of rebates), a negotiated dispensing fee and customer co-payments for drugs dispensed through the Company&#8217;s home delivery, specialty and community pharmacies. For the years ended December 31, 2021 and 2020, the Company recognized revenue and cost of products sold for retail pharmacy co-payments related to its Optum Rx business. Revenue recognized in prior periods related to retail pharmacy transactions excludes the member&#8217;s applicable co-payment. There was no impact on earnings from operations, net earnings, earnings per share or total equity. Pharmacy products are billed to customers based on the number of transactions occurring during the billing period. Product revenues are recognized when the prescriptions are dispensed. The Company has entered into contracts in which it is primarily obligated to pay its network pharmacy providers for benefits provided to their customers regardless of whether the Company is paid. The Company is also involved in establishing the prices charged by retail pharmacies, determining which drugs will be included in formulary listings and selecting which retail pharmacies will be included in the network offered to plan sponsors&#8217; members and accordingly, are reported on a gross basis.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services revenue are comprised of a number of services and products sold through Optum. Optum Health&#8217;s service revenues include net patient service revenues recorded based upon established billing rates, less allowances for contractual adjustments, and are recognized as services are provided. For its financial services offerings, Optum Health charges fees and earns investment income on managed funds. Optum Insight provides software and information products, advisory consulting arrangements and managed services outsourcing contracts, which may be delivered over several years. Optum Insight revenues are generally recognized over time and measured each period based on the progress to date as services are performed or made available to customers.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services revenue also consists of fees derived from services performed for customers who self-insure the health care costs of their employees and employees&#8217; dependents. Under service fee contracts, the Company receives monthly, a fixed fee per employee, which is recognized as revenue as the Company performs, or makes available, the applicable services to the customer. The customers retain the risk of financing health care costs for their employees and employees&#8217; dependents, and the Company administers the payment of customer funds to physicians and other health care professionals from customer-funded bank accounts. As the Company has neither the obligation for funding the health care costs, nor the primary responsibility for providing the medical care, the Company does not recognize premium revenue and medical costs for these contracts in its Consolidated Financial Statements. For these fee-based customer arrangements, the Company provides coordination and facilitation of medical services; transaction processing; customer, consumer and care professional services; and access to contracted networks of physicians, hospitals and other health care professionals. These services are performed throughout the contract period. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, accounts receivables related to products and services were $5.4 billion and $5.3 billion, respectively. In 2021 and 2020, the Company had no material bad-debt expense and there were no material contract assets, contract liabilities or deferred contract costs recorded on the Consolidated Balance Sheets as of December&#160;31, 2021 or 2020.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2021, 2020 and 2019, revenue recognized from performance obligations related to prior periods (for example, due to changes in transaction price) was not material.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue expected to be recognized in any future year related to remaining performance obligations, excluding revenue pertaining to contracts having an original expected duration of one year or less, contracts where revenue is recognized as invoiced and contracts with variable consideration related to undelivered performance obligations, is not material.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_223" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 13</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for disaggregation of revenue by segment and type.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical Costs and Medical Costs Payable </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimate of medical costs payable represents management&#8217;s best estimate of its liability for unpaid medical costs as of December&#160;31, 2021.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each period, the Company re-examines previously established medical costs payable estimates based on actual claim submissions and other changes in facts and circumstances. As more complete claim information becomes available, the Company adjusts the amount of the estimates and includes the changes in estimates in medical costs in the period in which the change is identified. Approximately 90% of claims related to medical care services are known and settled within 90 days from the date of service and substantially all within twelve months.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical costs and medical costs payable include estimates of the Company&#8217;s obligations for medical care services rendered on behalf of consumers, but for which claims have either not yet been received, processed, or paid. The Company develops estimates for medical care services incurred but not reported (IBNR), which includes estimates for claims which have not been received or fully processed, using an actuarial process consistently applied, centrally controlled and automated. The actuarial </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">models consider factors such as time from date of service to claim processing, seasonal variances in medical care consumption, health care professional contract rate changes, medical care utilization and other medical cost trends, membership volume and demographics, the introduction of new technologies, benefit plan changes, and business mix changes related to products, customers and geography. Judgments related to these factors contemplated the impact of COVID-19.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In developing its medical costs payable estimates, the Company applies different estimation methods depending on which incurred claims are being estimated. For the most recent two months, the Company estimates claim costs incurred by applying observed medical cost trend factors to the average per member per month (PMPM) medical costs incurred in prior months for which more complete claim data are available, supplemented by a review of near-term completion factors (actuarial estimates, based upon historical experience and analysis of current trends, of the percentage of incurred claims during a given period adjudicated by the Company at the date of estimation). For months prior to the most recent two months, the Company applies the completion factors to actual claims adjudicated-to-date to estimate the expected amount of ultimate incurred claims for those months.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Products Sold </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s cost of products sold includes the cost of pharmaceuticals dispensed to unaffiliated customers either directly at its home delivery, specialty and community pharmacy locations, or indirectly through its nationwide network of participating pharmacies. Rebates attributable to unaffiliated clients are accrued as rebates receivable and a reduction of cost of products sold, with a corresponding payable for the amounts of the rebates to be remitted to those unaffiliated clients in accordance with their contracts and recorded in the Consolidated Statements of Operations as a reduction of product revenue. Cost of products sold also includes the cost of personnel to support the Company&#8217;s transaction processing services, system sales, maintenance and professional services.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents and Investments </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents are highly liquid investments having an original maturity of three months or less. The fair value of cash and cash equivalents approximates their carrying value because of the short maturity of the instruments. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments with maturities of less than one year are classified as short-term. Because of regulatory requirements, certain investments are included in long-term investments regardless of their maturity date. The Company classifies these investments as held-to-maturity and reports them at amortized cost. Substantially all other investments are classified as available-for-sale and reported at fair value based on quoted market prices, where available. Equity investments, with certain exceptions, are measured at fair value with changes in fair value recognized in net earnings.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company excludes unrealized gains and losses on investments in available-for-sale debt securities from net earnings and reports them as comprehensive income and, net of income tax effects, as a separate component of equity. To calculate realized gains and losses on the sale of debt securities, the Company specifically identifies the cost of each investment sold. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates an available-for-sale debt security for credit-related impairment by considering the present value of expected cash flows relative to a security&#8217;s amortized cost, the extent to which fair value is less than amortized cost, the financial condition and near-term prospects of the issuer and specific events or circumstances which may influence the operations of the issuer. Credit-related impairments are recorded as an allowance, with an offset to investment and other income. Non-credit related impairments are recorded through other comprehensive income. If the Company intends to sell an impaired security, or will likely be required to sell a security before recovery of the entire amortized cost, the entire impairment is included in net earnings.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New information and the passage of time can change these judgments. The Company manages its investment portfolio to limit its exposure to any one issuer or market sector, and largely limits its investments to investment grade quality. Securities downgraded below policy minimums after purchase will be disposed of in accordance with the Company&#8217;s investment policy. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Under Management </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides health insurance products and services to members of AARP under a Supplemental Health Insurance Program (the AARP Program) and to AARP members and non-members under separate Medicare Advantage and Medicare Part D arrangements. The products and services under the AARP Program include supplemental Medicare benefits, hospital indemnity insurance, including insurance for individuals between 50 to 64 years of age, and other related products. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Company&#8217;s agreement with AARP, program assets are managed separately from the Company&#8217;s general investment portfolio and are used to pay costs associated with the AARP Program. These assets are invested at the Company&#8217;s discretion, within investment guidelines approved by AARP. The Company does not guarantee any rates of return on these investments and, upon any transfer of the AARP Program contract to another entity, the Company would transfer cash equal in amount to the fair value of these investments at the date of transfer to the entity. Because the purpose of these assets is to fund the medical costs payable, the rate stabilization fund (RSF) liabilities and other related liabilities associated with this AARP contract, assets under management are classified as current assets, consistent with the classification of these liabilities.</span></div>The effects of changes in other balance sheet amounts associated with the AARP Program also accrue to the overall benefit of the AARP policyholders through the RSF balance. Accordingly, the Company excludes the effect of such changes in its Consolidated Statements of Cash Flows.<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Current Receivables </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current receivables include amounts due from pharmaceutical manufacturers for rebates and Medicare Part D drug discounts, accrued interest and other miscellaneous amounts due to the Company. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s pharmacy care services businesses contract with pharmaceutical manufacturers, some of which provide rebates based on use of the manufacturers&#8217; products by its affiliated and unaffiliated clients. The Company accrues rebates as they are earned by its clients on a monthly basis based on the terms of the applicable contracts, historical data and current estimates. The pharmacy care services businesses bill these rebates to the manufacturers on a monthly or quarterly basis depending on the contractual terms and record rebates attributable to affiliated clients as a reduction to medical costs. The Company generally receives rebates two to five months after billing. As of December&#160;31, 2021 and 2020, total pharmaceutical manufacturer rebates receivable included in other receivables in the Consolidated Balance Sheets amounted to $7.2 billion and $6.3 billion, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020, the Company&#8217;s Medicare Part D receivables amounted to $3.4 billion and $2.9 billion, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Equipment and Capitalized Software </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, equipment and capitalized software are stated at cost, net of accumulated depreciation and amortization. Capitalized software consists of certain costs incurred in the development of internal-use software, including external direct costs of materials and services and applicable payroll costs of employees devoted to specific software development. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company calculates depreciation and amortization using the straight-line method over the estimated useful lives of the assets. The useful lives for property, equipment and capitalized software are: </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:57.111%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.689%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 10 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;to&#160;40&#160;years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 5 years</span></div></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements are depreciated over the shorter of the remaining lease term or their estimated useful economic life.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases facilities and equipment under long-term operating leases which are non-cancelable and expire on various dates. At the lease commencement date, lease right-of-use (ROU) assets and lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term, which includes all fixed obligations arising from the lease contract. If an interest rate is not implicit in a lease, the Company utilizes its incremental borrowing rate for a period closely matching the lease term. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s ROU assets are included in other assets, and lease liabilities are included in other current liabilities and other liabilities in the Company&#8217;s Consolidated Balance Sheet. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To determine whether goodwill is impaired, annually or more frequently if needed, the Company performs impairment tests. The Company may first assess qualitative factors to determine if it is more likely than not the carrying value of a reporting unit exceeds its estimated fair value. The Company may also elect to skip the qualitative testing and proceed directly to the quantitative testing. When performing quantitative testing, the Company first estimates the fair values of its reporting units using discounted cash flows or a weighted combination of discounted cash flows and a market-based method. To determine fair values, the Company must make assumptions about a wide variety of internal and external factors. Significant assumptions used in the impairment analysis include financial projections of free cash flow (including significant assumptions about operations, capital requirements and income taxes), long-term growth rates for determining terminal value, discount rates and the selection of comparable peer companies. If the fair value is less than the carrying value of the reporting unit, an impairment is recognized for the difference, up to the carrying amount of goodwill.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no impairment of goodwill during the years ended December&#160;31, 2021, 2020 and 2019.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s intangible assets are subject to impairment tests when events or circumstances indicate an intangible asset (or asset group) may be impaired. The Company&#8217;s indefinite-lived intangible assets are also tested for impairment annually. There was no impairment of intangible assets during the years ended December&#160;31, 2021, 2020 and 2019.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Current Liabilities </span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities include health savings account deposits ($11.4 billion and $10.2 billion as of December&#160;31, 2021 and 2020, respectively), accruals for premium rebates payable, the RSF associated with the AARP Program, the current portion of future policy benefits and customer balances.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Policy Acquisition Costs</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s short duration health insurance contracts typically have a one-year term and may be canceled by the customer with at least 30 days&#8217; notice. Costs related to the acquisition and renewal of short duration customer contracts are primarily charged to expense as incurred.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redeemable Noncontrolling Interests</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redeemable noncontrolling interests in the Company&#8217;s subsidiaries whose redemption is outside the control of the Company are classified as temporary equity. The following table provides details of the Company's redeemable noncontrolling interests&#8217; activity for the years ended December&#160;31, 2021 and 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.215%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,211&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,726&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemptions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,338)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(255)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value and other adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests, end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,434&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,211&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes compensation expense for share-based awards, including stock options and restricted stock and restricted stock units (collectively, restricted shares), on a straight-line basis over the related service period (generally the vesting period) of the award, or to an employee&#8217;s eligible retirement date under the award agreement, if earlier. Restricted shares vest ratably, primarily over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTcvZnJhZzoyNzA4MDU3MzhiZjc0MzA5ODVmOTgzMjNiMGZkMzIxNy90ZXh0cmVnaW9uOjI3MDgwNTczOGJmNzQzMDk4NWY5ODMyM2IwZmQzMjE3XzQzOA_eb1bf801-8e88-43f4-addf-b3432e5c7bdc">four</span> years and compensation expense related to restricted shares is based on the share price on the date of grant. Stock options vest ratably primarily over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTcvZnJhZzoyNzA4MDU3MzhiZjc0MzA5ODVmOTgzMjNiMGZkMzIxNy90ZXh0cmVnaW9uOjI3MDgwNTczOGJmNzQzMDk4NWY5ODMyM2IwZmQzMjE3XzM4NDgyOTA2OTg0NDE_e5312511-99bf-4e41-b5f9-1d6cc88b8bfd">four</span> years and may be exercised up to 10 years from the date of grant. Compensation expense related to stock options is based on the fair value at the date of grant, which is estimated on the date of grant using a binomial option-pricing model. Under the Company&#8217;s Employee Stock Purchase Plan (ESPP), eligible employees are allowed to purchase the Company&#8217;s stock at a discounted price, which is 90% of the market price of the Company&#8217;s common stock at the end of the six-month purchase period. Share-based compensation expense for all programs is recognized in operating costs in the Consolidated Statements of Operations. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Earnings Per Common Share </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company computes basic earnings per common share attributable to UnitedHealth Group common shareholders by dividing net earnings attributable to UnitedHealth Group common shareholders by the weighted-average number of common shares outstanding during the period. The Company determines diluted net earnings per common share attributable to UnitedHealth Group common shareholders using the weighted-average number of common shares outstanding during the period, adjusted for potentially dilutive shares associated with stock options, restricted shares and the ESPP (collectively, common stock equivalents), using the treasury stock method. The treasury stock method assumes a hypothetical issuance of shares to settle the share-based awards, with the assumed proceeds used to purchase common stock at the average market price for the period. Assumed proceeds include the amount the employee must pay upon exercise and the average unrecognized compensation cost. The difference between the number of shares assumed issued and number of shares assumed purchased represents the dilutive shares. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ACA Tax</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Insurance Tax was permanently repealed by Congress, effective January 1, 2021. The permanent repeal of the tax impacts year-over-year comparability of our financial statements, including revenues, operating costs, medical care ratio (MCR), operating cost ratio, effective tax rate and cash flows from operations.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy', window );">Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redeemable Noncontrolling Interests</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redeemable noncontrolling interests in the Company&#8217;s subsidiaries whose redemption is outside the control of the Company are classified as temporary equity. The following table provides details of the Company's redeemable noncontrolling interests&#8217; activity for the years ended December&#160;31, 2021 and 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.215%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,211&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,726&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemptions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,338)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(255)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value and other adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests, end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,434&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,211&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Parent Company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Condensed Financial Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation and Significant Accounting Policies [Text Block]</a></td>
<td class="text">Basis of Presentation <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealth Group&#8217;s parent company financial information has been derived from its consolidated financial statements and should be read in conjunction with the consolidated financial statements included in this Form&#160;10-K. The accounting policies for the registrant are the same as those described in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 2 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#8220;Financial Statements.</a><a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">and Supplementary Data</a><a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">.</a><a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#8221;</a></span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy', window );">Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]</a></td>
<td class="text">Subsidiary Transactions <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment in Subsidiaries. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UnitedHealth Group&#8217;s investment in subsidiaries is stated at cost plus equity in undistributed earnings of subsidiaries.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialStatementsCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialStatementsCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466615037208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment [Table Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of property, equipment and capitalized software is as follows: </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:70.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.225%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land and improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,882&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,851&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,767&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,857)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,364)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,392&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,482&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,712&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,010&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,135)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,866)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,144&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, equipment and capitalized software, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,969&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,626&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestTableTextBlock', window );">Redeemable Noncontrolling Interest [Table Text Block]</a></td>
<td class="text">The following table provides details of the Company's redeemable noncontrolling interests&#8217; activity for the years ended December&#160;31, 2021 and 2020:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.215%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,211&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,726&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemptions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,338)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(255)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value and other adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests, end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,434&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,211&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=unh_UsefulLifeMember', window );">Useful Life [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment [Table Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company calculates depreciation and amortization using the straight-line method over the estimated useful lives of the assets. The useful lives for property, equipment and capitalized software are: </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:57.111%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.689%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 10 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;to&#160;40&#160;years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 5 years</span></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=unh_UsefulLifeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=unh_UsefulLifeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466614549368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock', window );">Short-Term and Long-Term Investments [Table Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of debt securities by major security type is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.020%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - available-for-sale:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,947&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,819&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,669&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">822&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(274)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,217&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - held-to-maturity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - held-to-maturity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,310&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,860&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - available-for-sale:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,737&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,849&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,091&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,079&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,771&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,828&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - held-to-maturity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - held-to-maturity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">647&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,717&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,780&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,475&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Investments by Contractual Maturity [Table Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost and fair value of debt securities as of December&#160;31, 2021, by contractual maturity, were as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:61.748%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.563%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.713%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Held-to-Maturity</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in one year or less</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,603&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,614&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,885&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,065&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after five years through ten years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after ten years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,819&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,669&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,217&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock', window );">Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of available-for-sale debt securities with gross unrealized losses by major security type and length of time that individual securities have been in a continuous unrealized loss position were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:35.649%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.714%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less Than 12 Months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,386&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,417&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,733&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,118&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,004&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(274)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,415&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,964&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27290-111563<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of unrealized gains and losses on investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466614697624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Financial Assets and Liabilities, Measured at Fair Value Recurring Basis [Table Text Block]</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a summary of fair value measurements by level and carrying values for items measured at fair value on a recurring basis in the Consolidated Balance Sheets:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:53.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable<br/>Inputs<br/>(Level 3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Fair and Carrying<br/>Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - available-for-sale:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,017&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,916&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,057&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,942&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,217&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,090&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,177&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets under management</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,478&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,218&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage of total assets at fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,841&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,921&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - available-for-sale:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and municipal obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,737&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,091&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,091&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. agency mortgage-backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities - available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,266&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,274&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,828&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,795&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,828&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets under management</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,774&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,676&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,637&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,653&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage of total assets at fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock', window );">Fair Value Measurements, Nonrecurring [Table Text Block]</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a summary of fair value measurements by level and carrying values for certain financial instruments not measured at fair value on a recurring basis in the Consolidated Balance Sheets:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"/><td style="width:41.462%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.654%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable<br/>Inputs<br/>(Level 3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Carrying Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - held-to-maturity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and other financing obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,003&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities - held-to-maturity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and other financing obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities by class, including financial instruments measured at fair value that are classified in shareholders' equity, if any, that are measured at fair value on a nonrecurring basis in periods after initial recognition (for example, impaired assets). Disclosures may include, but are not limited to: (a) the fair value measurements recorded and the reasons for the measurements and (b) the level within the fair value hierarchy in which the fair value measurements are categorized in their entirety (levels 1, 2, 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466610921720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant, and Capitalized Software (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment [Table Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of property, equipment and capitalized software is as follows: </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:70.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.225%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land and improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,882&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,851&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,767&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,857)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,364)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,392&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,482&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,712&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,010&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,135)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,866)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,144&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, equipment and capitalized software, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,969&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,626&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466608921096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill [Table Text Block]</a></td>
<td class="text"><div style="margin-bottom:4pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill, by reportable segment, were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:32.820%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.171%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.675%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.973%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">UnitedHealthcare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Optum Health</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Optum Insight</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Optum Rx</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,228&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,342&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,797&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,659&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency effects and other adjustments, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(623)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(701)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31,&#160;2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,785&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,844&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,173&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,535&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,337&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,648&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,804&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency effects and other adjustments, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(456)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(268)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(346)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31,&#160;2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,389&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,224&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,619&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,563&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,795&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock', window );">Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]</a></td>
<td class="text"><div style="margin-bottom:4pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross carrying value, accumulated amortization and net carrying value of other intangible assets were as follows: </span></div><div style="margin-bottom:6pt;margin-top:4.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:39.575%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.563%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.563%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.563%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,011&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,697)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,314&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,428&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,575)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,853&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(739)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(624)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">973&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and other indefinite-lived</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(200)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(256)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,680&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,636)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,044&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,311&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,455)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,856&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock', window );">Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</a></td>
<td class="text"><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition date fair values and weighted-average useful lives assigned to finite-lived intangible assets acquired in business combinations consisted of the following by year of acquisition:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:59.252%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.535%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Useful Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,113&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquired finite-lived intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">660&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,722&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 years</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated full year amortization expense relating to intangible assets for each of the next five years ending December 31 is as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:90.700%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.368%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,098&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">892&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the characteristics, including initial carrying value, residual amount, weighted average useful life, of finite-lived intangible assets acquired during the period by major class. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466610943832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Medical Costs Payable (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense', window );">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]</a></td>
<td class="text"><div style="margin-bottom:4pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in medical costs payable for the years ended December&#160;31: </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:65.029%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.458%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs payable, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,872&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,690&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,891&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported medical costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,020&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,720)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(880)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(580)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reported medical costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186,911&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,396&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156,440&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical payments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for current year</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165,524)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139,974)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(137,155)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for prior years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,864)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,556)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,165)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total medical payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184,388)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159,530)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155,320)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs payable, end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,483&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,872&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,690&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock', window );">Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Table Text Block]</a></td>
<td class="text">The following is information about incurred and paid medical cost development as of December&#160;31, 2021: <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:54.031%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.826%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.160%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.164%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Incurred Medical Costs</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,276&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,140&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347,771&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Cumulative Medical Payments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139,974)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158,182)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165,524)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(323,706)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net remaining outstanding liabilities prior to 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">418&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total medical costs payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,483&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for the reconciliation of claims development to the liability for unpaid claims and claim adjustment expense for short-duration insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671315-158438<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466611095048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-Term Borrowings and Long-Term Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Short-Term Borrowings and Long-Term Debt [Table Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term borrowings and senior unsecured long-term debt consisted of the following:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.338%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.453%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Carrying Value As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(in millions, except percentages)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,296&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$400 million 4.700% notes due February 2021 </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$750 million 2.125% notes due March 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$350 million Floating rate notes due June 2021</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$400 million 3.150% notes due June 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$500 million 3.375% notes due November 2021 </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$750 million 2.875% notes due December 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">762&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,100 million 2.875% notes due March 2022 </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,000 million 3.350% notes due July 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$900 million 2.375% notes due October 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">899&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">897&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$15 million 0.000% notes due November 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$625 million 2.750% notes due February 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">632&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">644&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$750 million 2.875% notes due March 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">768&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$750 million 3.500% notes due June 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">749&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$750 million 3.500% notes due February 2024</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">748&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,000 million 0.550% notes due May 2024</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">996&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$750 million 2.375% notes due August 2024</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">748&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$2,000 million 3.750% notes due July 2025</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,994&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$300 million 3.700% notes due December 2025</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$500 million 1.250% notes due January 2026</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,000 million 3.100% notes due March 2026</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,000 million 1.150% notes due May 2026</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$750 million 3.450% notes due January 2027</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$625 million 3.375% notes due April 2027</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$950 million 2.950% notes due October 2027</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">942&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,150 million 3.850% notes due June 2028</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$850 million 3.875% notes due December 2028</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">844&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">844&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,000 million 2.875% notes due August 2029</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,086&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,250 million 2.000% notes due May 2030</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,500 million 2.300% notes due May 2031</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,482&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,000 million 4.625% notes due July 2035</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">992&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$850 million 5.800% notes due March 2036</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$500 million 6.500% notes due June 2037</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$650 million 6.625% notes due November 2037</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,100 million 6.875% notes due February 2038</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,077&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,250 million 3.500% notes due August 2039</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,000 million 2.750% notes due May 2040</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">966&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$300 million 5.700% notes due October 2040</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$350 million 5.950% notes due February 2041</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,500 million  3.050% notes due May 2041</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$600 million 4.625% notes due November 2041</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$502 million 4.375% notes due March 2042</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$625 million 3.950% notes due October 2042</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$750 million 4.250% notes due March 2043</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$2,000 million 4.750% notes due July 2045</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$750 million 4.200% notes due January 2047</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">739&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">738&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$725 million 4.250% notes due April 2047</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">718&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">717&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$950 million 3.750% notes due October 2047</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">934&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">934&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,350 million 4.250% notes due June 2048</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,100 million 4.450% notes due December 2048</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,086&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,250 million 3.700% notes due August 2049</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,236&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,250 million 2.900% notes due May 2050</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$2,000 million 3.250% notes due May 2051</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,970&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,250 million 3.875% notes due August 2059</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$1,000 million 3.125% notes due May 2060</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Total short-term borrowings and long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">44,632&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">42,280&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Maturities of Long-term Debt [Table Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of short-term borrowings and long-term debt for the years ending December&#160;31 are as follows: </span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:87.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.882%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,626&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,452&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466615086616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</a></td>
<td class="text">The components of the provision for income taxes for the years ended December&#160;31 are as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:75.405%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.948%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.948%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.097%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Provision:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,451&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current provision</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,448&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,981&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,512&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred provision (benefit)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,578&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,973&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,742&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of the tax provision at the U.S. federal statutory rate to the provision for income taxes and the effective tax rate for the years ended December&#160;31 is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"/><td style="width:47.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.711%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except percentages)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax provision at the U.S. federal statutory rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,685&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,356&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,776&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based awards - excess tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health insurance tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(246)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(214)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(324)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,578&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,973&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,742&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</a></td>
<td class="text">The components of deferred income tax assets and liabilities as of December&#160;31 are as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:73.643%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.794%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.795%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and allowances</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal and state net operating loss carryforwards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nondeductible liabilities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. tax loss carryforwards</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other-domestic</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other-non-U.S.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,746&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,561&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowances</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(198)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,548&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,391&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal and state intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,658)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,588)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. goodwill and intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(512)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(606)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(833)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(731)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(349)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(346)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(256)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(216)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside basis in partnerships</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(565)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(342)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease right-of-use asset</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,267)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,179)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gains on investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(400)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other-non-U.S.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(248)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(350)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,813)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,758)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred income tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,265)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,367)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock', window );">Summary of Positions for which Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of unrecognized tax benefits as of December&#160;31 is as follows: </span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:71.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.272%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross unrecognized tax benefits, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,829&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,423&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,056&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross increases:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year tax positions</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year tax positions</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross decreases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year tax positions</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statute of limitations lapses</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross unrecognized tax benefits, end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,310&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,829&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,423&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of unrecognized tax benefits for which a material change is reasonably possible in the next twelve months, typically including the nature of the uncertainty, the event(s) that could cause a material change, and an estimate of the range of the reasonably possible change or a statement that an estimate of the range cannot be made. An unrecognized tax benefit is the difference between a tax position taken in a tax return and the amounts recognized in the financial statements for which it is more likely than not, based on the technical merits of the position, that the tax position will not be sustained upon examination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466611095048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_ShareholdersEquityAbstract', window );"><strong>Shareholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockByClassTextBlock', window );">Share Repurchase Activity</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of common share repurchases for the years ended December&#160;31, 2021 and 2020 is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.433%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common share repurchases, shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common share repurchases, average price per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389.92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common share repurchases, aggregate cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Board authorized shares remaining</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsDeclaredTableTextBlock', window );">Dividends Declared</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides details of the Company&#8217;s 2021 dividend payments:</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.785%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payment Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Amount Paid</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 23</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 29</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 21</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 14</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,365&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_ShareholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Shareholders' Equity [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_ShareholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsDeclaredTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to dividends declared, including paid and unpaid dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsDeclaredTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information.  Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65888546&amp;loc=d3e21300-112643<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21553-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21538-112644<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21488-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21484-112644<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466614975288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Stock Option Activity [Table Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activity for the year ended December&#160;31, 2021 is summarized in the table below:</span></div><div style="margin-bottom:6pt;margin-top:4.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:44.434%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual&#160;Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic&#160;Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at end of period</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,932&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest, end of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,509&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Restricted Share Activity [Table Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted share activity for the year ended December&#160;31, 2021 is summarized in the table below:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:68.446%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.153%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(shares in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant Date<br/>Fair Value<br/>per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Other Share-Based Compensation Data [Table Text Block]</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Share-Based Compensation Data</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:65.029%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.458%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share amounts)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value of shares granted, per share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intrinsic value of stock options exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restricted Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value of shares granted, per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of restricted shares vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Employee Stock Purchase Plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of shares purchased</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Share-Based Compensation Items</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense, before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">697&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense, net of tax effects</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit realized from share-based award exercises</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:78.665%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized compensation expense related to share awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average years to recognize compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal assumptions the Company used in calculating grant-date fair value for stock options were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:49.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.567%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7% - 1.2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2% - 1.4%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5% - 2.5%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.2% - 29.8%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.2% - 29.5%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.4% - 21.6%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3% - 1.5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4% - 1.7%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4% - 1.8%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeiture rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life in years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466610848136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, future minimum annual lease payments under all non-cancelable operating leases were as follows: </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:81.330%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.738%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Future Minimum Lease Payments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">763&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,716&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,882&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(609)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,273&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466610924472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Financial Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Segment Financial Information [Table Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the reportable segment financial information:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:24.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.341%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.282%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.811%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.105%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.164%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.289%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">UnitedHealthcare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum Health</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum Insight</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum Rx</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum Eliminations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Optum</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Corporate&#160;and<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenues - unaffiliated customers:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">212,381&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">226,233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,437&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,437&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,661&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,936&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,942&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,603&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues - unaffiliated customers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">222,042&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,778&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,095&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35,358&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63,231&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">285,273&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues - affiliated customers</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,234&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,867&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55,779&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,013)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">90,867&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(90,867)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment and other income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">857&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">222,899&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54,065&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,199&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">91,314&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,013)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">155,565&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(90,867)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">287,597&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,975&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,462&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,398&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,135&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,995&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,970&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,660)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,660)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,975&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,462&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,398&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,135&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,995&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,660)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,310&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">102,967&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60,474&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,868&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,181&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">117,523&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,284)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">212,206&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property, equipment and capitalized software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">795&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,004&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">818&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">684&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,099&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenues - unaffiliated customers:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">191,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">201,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,977&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,464&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,016&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues - unaffiliated customers</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200,143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,647&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,822&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35,027&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55,496&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">255,639&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues - affiliated customers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,481&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,941&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52,420&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,800)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">80,042&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(80,042)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment and other income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">732&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">770&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,502&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200,875&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39,808&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,802&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87,498&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,800)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">136,308&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(80,042)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">257,141&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,359&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,434&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,725&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,887&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,046&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,405&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,663)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,663)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,359&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,434&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,725&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,887&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,046&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,663)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,742&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">98,229&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52,073&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,425&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39,280&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">106,778&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,718)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">197,289&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property, equipment and capitalized software</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">715&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,051&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenues - unaffiliated customers:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">183,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,916&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,916&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">189,699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31,450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,922&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,732&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">689&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,051&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,973&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues - unaffiliated customers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">192,705&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,679&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,746&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,139&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">47,564&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">240,269&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues - affiliated customers</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,966&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,239&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42,093&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,661)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64,637&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(64,637)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment and other income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">749&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">193,842&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,317&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,006&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74,288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,661)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">112,950&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(64,637)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">242,155&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,326&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,963&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,494&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,902&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,359&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,685&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,704)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,704)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,326&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,963&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,494&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,902&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,359&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,704)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,981&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88,250&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,444&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,181&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36,346&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">91,971&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,332)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">173,889&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property, equipment and capitalized software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">841&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,071&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">565&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">672&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,720&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466611006568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule I (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Condensed Financial Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Maturities of Long-term Debt [Table Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of short-term borrowings and long-term debt for the years ending December&#160;31 are as follows: </span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:87.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.882%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,626&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,452&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Parent Company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Condensed Financial Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfCondensedBalanceSheetTableTextBlock', window );">Condensed Balance Sheet [Table Text Block]</a></td>
<td class="text"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Financial Information of Registrant </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Parent Company Only) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealth Group </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Balance Sheets </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:67.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.980%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.982%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,670&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">820&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net assets of subsidiaries</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,907&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,714&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term notes receivable from subsidiaries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,021&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,289&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,897&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of notes payable to subsidiaries</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,882&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term borrowings and current maturities of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,009&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,719&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,936&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, less current maturities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,406&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 4) </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders&#8217; equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $0.001 par value -10 shares authorized; no shares issued or outstanding</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $0.01 par value - 3,000 shares authorized; 941 and 946 issued and outstanding</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,384)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,814)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total UnitedHealth Group shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,760&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,491&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,289&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,897&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedStatementOfComprehensiveIncomeTableTextBlock', window );">Condensed Statement of Comprehensive Income [Table Text Block]</a></td>
<td class="text"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Financial Information of Registrant </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Parent Company Only) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealth Group </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Comprehensive Income </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment and other income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,594&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,580&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,623&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,621&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,618&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,129)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,427)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,409)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss of parent company</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(898)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,127)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,116)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in undistributed income of subsidiaries</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,285&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,403&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,839&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,570)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(236)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,715&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,167&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,421&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock', window );">Condensed Cash Flow Statement [Table Text Block]</a></td>
<td class="text"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Financial Information of Registrant </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Parent Company Only) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UnitedHealth Group </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Cash Flows </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:65.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.297%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating activities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,439&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,842&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuances of notes to subsidiaries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(444)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(628)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,722)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of notes to subsidiaries</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,249&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for acquisitions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,953)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,706)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,645)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return of capital to parent company</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital contributions to subsidiaries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(747)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(803)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows used for investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,862)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,202)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,934)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock repurchases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,250)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,500)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from common stock issuances</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,280)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,584)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,932)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Repayments of) proceeds from short-term borrowings, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,302)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">872&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,933&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,864&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,444&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,750)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from notes from subsidiaries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,818&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(447)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(438)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(535)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows used for financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,668)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,428)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,729)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase (decrease) in cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,909&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(388)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents, end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,167&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental cash flow disclosures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,575&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,506&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,590&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Maturities of Long-term Debt [Table Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of short-term borrowings and long-term debt for the years ending December 31 are as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:87.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.882%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,015&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialStatementsCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialStatementsCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedStatementOfComprehensiveIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed statement of comprehensive income (loss) including, but not limited to, statements of comprehensive income (loss) of consolidated entities and consolidation eliminations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 3<br> -Paragraph i<br> -Subsection 10<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedStatementOfComprehensiveIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfCondensedBalanceSheetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 3<br> -Paragraph i<br> -Subsection 10<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfCondensedBalanceSheetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 3<br> -Paragraph i<br> -Subsection 10<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfCondensedCashFlowStatementTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466607676728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts Receivable, after Allowance for Credit Loss, Current</a></td>
<td class="nump">$ 14,216<span></span>
</td>
<td class="nump">$ 12,870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other current receivables</a></td>
<td class="nump">13,866<span></span>
</td>
<td class="nump">12,534<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">24,643<span></span>
</td>
<td class="nump">22,495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other Liabilities, Current</a></td>
<td class="nump">$ 22,975<span></span>
</td>
<td class="nump">20,392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract', window );">Number Of Days Notice Required To Cancel Health Insurance Contract</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of Intangible Assets (Excluding Goodwill)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DemandDepositAccounts', window );">Health savings account deposits</a></td>
<td class="nump">$ 11,400<span></span>
</td>
<td class="nump">10,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=unh_EmployeeStockPurchasePlanESPPMember', window );">Employee Stock Purchase Plan (ESPP) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=unh_StockOptionsandSARsMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Plan Award, Options, Award Exercisable Period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember', window );">Health Insurance Product Line [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days', window );">Short-duration Insurance Contracts, Historical Claims Duration, First 90 Days</a></td>
<td class="nump">0.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=unh_ProductsandservicesMember', window );">Products and services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts Receivable, after Allowance for Credit Loss, Current</a></td>
<td class="nump">$ 5,400<span></span>
</td>
<td class="nump">5,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_PharmaceuticalmanufacturerrebatesreceivableAxis=unh_PharmaceuticalManufacturerRebatesReceivableMember', window );">Pharmaceutical Manufacturer Rebates Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other current receivables</a></td>
<td class="nump">7,200<span></span>
</td>
<td class="nump">6,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_MedicarePartDPharmacyBenefitsContractAxis=unh_MedicarePartDReceivablesMember', window );">Medicare Part D Receivables [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other current receivables</a></td>
<td class="nump">$ 3,400<span></span>
</td>
<td class="nump">$ 2,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Days Notice Required To Cancel Health Insurance Contract</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of average payout, after reinsurance, in the first 90 days after a claim is incurred, beginning with the earliest accident year disclosed for short-duration insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DemandDepositAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of money in accounts that may bear interest and that the depositor is entitled to withdraw at any time without prior notice.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DemandDepositAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount rate from fair value on offering date that participants pay for shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=unh_EmployeeStockPurchasePlanESPPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=unh_EmployeeStockPurchasePlanESPPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=unh_StockOptionsandSARsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=unh_StockOptionsandSARsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=unh_ProductsandservicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=unh_ProductsandservicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_PharmaceuticalmanufacturerrebatesreceivableAxis=unh_PharmaceuticalManufacturerRebatesReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_PharmaceuticalmanufacturerrebatesreceivableAxis=unh_PharmaceuticalManufacturerRebatesReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_MedicarePartDPharmacyBenefitsContractAxis=unh_MedicarePartDReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_MedicarePartDPharmacyBenefitsContractAxis=unh_MedicarePartDReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466606474616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation, Uses of Estimates and Significant Accounting Policies Useful lives for property, equipment and capitalized software (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture, Fixtures and equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture, Fixtures and equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Life</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Buildings [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Life</a></td>
<td class="text">35 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Buildings [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Life</a></td>
<td class="text">40 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=unh_CapitalizedsoftwareMember', window );">Capitalized software [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=unh_CapitalizedsoftwareMember', window );">Capitalized software [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=unh_CapitalizedsoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=unh_CapitalizedsoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466607029368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation, Uses of Estimates and Significant Accounting Policies Redeemable Noncontrolling Interests (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable noncontrolling interest, beginning of period</a></td>
<td class="nump">$ 2,211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination', window );">Acquisitions</a></td>
<td class="nump">407<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
<td class="nump">$ 87<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions</a></td>
<td class="num">(319)<span></span>
</td>
<td class="num">(277)<span></span>
</td>
<td class="num">(279)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestChangeInRedemptionValue', window );">Fair value and other adjustments</a></td>
<td class="nump">995<span></span>
</td>
<td class="nump">197<span></span>
</td>
<td class="nump">316<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable Noncontrolling Interest, end of period</a></td>
<td class="nump">1,434<span></span>
</td>
<td class="nump">2,211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=unh_RedeemableNoncontrollingInterestsMember', window );">Redeemable Noncontrolling Interests [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable noncontrolling interest, beginning of period</a></td>
<td class="nump">2,211<span></span>
</td>
<td class="nump">1,726<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net earnings</a></td>
<td class="nump">87<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination', window );">Acquisitions</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">321<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Redemptions</a></td>
<td class="num">(1,338)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions</a></td>
<td class="num">(255)<span></span>
</td>
<td class="num">(149)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestChangeInRedemptionValue', window );">Fair value and other adjustments</a></td>
<td class="nump">701<span></span>
</td>
<td class="nump">201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable Noncontrolling Interest, end of period</a></td>
<td class="nump">$ 1,434<span></span>
</td>
<td class="nump">$ 2,211<span></span>
</td>
<td class="nump">$ 1,726<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestChangeInRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in noncontrolling interest during the period as a result of a change in the redemption value of redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 16(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestChangeInRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569655-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4616395-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=unh_RedeemableNoncontrollingInterestsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=unh_RedeemableNoncontrollingInterestsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466615226040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments (Narrative) (Details)<br> $ in Billions</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>positions</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_InvestmentLineItems', window );"><strong>Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue', window );">Equity Securities, FV-NI and without Readily Determinable Fair Value</a></td>
<td class="nump">$ 3.5<span></span>
</td>
<td class="nump">$ 2.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity Method Investments</a></td>
<td class="nump">$ 1.3<span></span>
</td>
<td class="nump">$ 1.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions | positions</a></td>
<td class="nump">13,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedBalanceContracts', window );">Total number of security positions</a></td>
<td class="nump">39,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_InvestmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent reporting concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_InvestmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI) and investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedBalanceContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Balance held at close of period in number of contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14.Column B)<br> -URI http://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=d3e611322-123010<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=d3e611197-123010<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12.Column B)<br> -URI http://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=d3e611133-123010<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedBalanceContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466603806408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments (Short-Term and Long-Term Investments) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Debt Securities, Available-for-sale, Amortized Cost</a></td>
<td class="nump">$ 39,669<span></span>
</td>
<td class="nump">$ 38,079<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Securities, Available for sale Debt Securities, Gross Unrealized Gains</a></td>
<td class="nump">822<span></span>
</td>
<td class="nump">1,771<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</a></td>
<td class="num">(274)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">40,217<span></span>
</td>
<td class="nump">39,828<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Held-to-maturity securities, Amortized Cost</a></td>
<td class="nump">641<span></span>
</td>
<td class="nump">638<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain', window );">Securities, Held to maturity, Unrecognized Holding Gain</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss', window );">Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Debt Securities, Held-to-maturity, Fair Value</a></td>
<td class="nump">643<span></span>
</td>
<td class="nump">647<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_InvestmentsAmortizedCost', window );">Total investments, Amortized Cost</a></td>
<td class="nump">40,310<span></span>
</td>
<td class="nump">38,717<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_InvestmentsGrossUnrealizedGains', window );">Total investments, Gross Unrealized Gains</a></td>
<td class="nump">826<span></span>
</td>
<td class="nump">1,780<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_InvestmentsGrossUnrealizedLosses', window );">Total investments, Gross Unrealized Losses</a></td>
<td class="num">(276)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments, Fair Value Disclosure</a></td>
<td class="nump">40,860<span></span>
</td>
<td class="nump">40,475<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember', window );">Debt Securities - held-to-maturity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">40,217<span></span>
</td>
<td class="nump">39,828<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember', window );">U.S. Government and Agency Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Debt Securities, Available-for-sale, Amortized Cost</a></td>
<td class="nump">3,206<span></span>
</td>
<td class="nump">3,335<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Securities, Available for sale Debt Securities, Gross Unrealized Gains</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</a></td>
<td class="num">(31)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">3,198<span></span>
</td>
<td class="nump">3,465<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Held-to-maturity securities, Amortized Cost</a></td>
<td class="nump">511<span></span>
</td>
<td class="nump">420<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain', window );">Securities, Held to maturity, Unrecognized Holding Gain</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss', window );">Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Debt Securities, Held-to-maturity, Fair Value</a></td>
<td class="nump">511<span></span>
</td>
<td class="nump">426<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">State and Municipal Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Debt Securities, Available-for-sale, Amortized Cost</a></td>
<td class="nump">6,829<span></span>
</td>
<td class="nump">6,893<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Securities, Available for sale Debt Securities, Gross Unrealized Gains</a></td>
<td class="nump">297<span></span>
</td>
<td class="nump">435<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</a></td>
<td class="num">(20)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">7,106<span></span>
</td>
<td class="nump">7,328<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Held-to-maturity securities, Amortized Cost</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain', window );">Securities, Held to maturity, Unrecognized Holding Gain</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss', window );">Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Debt Securities, Held-to-maturity, Fair Value</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Debt Securities, Available-for-sale, Amortized Cost</a></td>
<td class="nump">20,947<span></span>
</td>
<td class="nump">18,886<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Securities, Available for sale Debt Securities, Gross Unrealized Gains</a></td>
<td class="nump">372<span></span>
</td>
<td class="nump">863<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</a></td>
<td class="num">(145)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">21,174<span></span>
</td>
<td class="nump">19,737<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Held-to-maturity securities, Amortized Cost</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">187<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain', window );">Securities, Held to maturity, Unrecognized Holding Gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss', window );">Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Debt Securities, Held-to-maturity, Fair Value</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">188<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember', window );">U.S. Agency Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Debt Securities, Available-for-sale, Amortized Cost</a></td>
<td class="nump">5,868<span></span>
</td>
<td class="nump">6,849<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Securities, Available for sale Debt Securities, Gross Unrealized Gains</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">245<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</a></td>
<td class="num">(55)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">5,901<span></span>
</td>
<td class="nump">7,091<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember', window );">Non-U.S. Agency Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Debt Securities, Available-for-sale, Amortized Cost</a></td>
<td class="nump">2,819<span></span>
</td>
<td class="nump">2,116<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Securities, Available for sale Debt Securities, Gross Unrealized Gains</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">95<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</a></td>
<td class="num">(23)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">$ 2,838<span></span>
</td>
<td class="nump">$ 2,207<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_InvestmentsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investments at amortized cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_InvestmentsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_InvestmentsGrossUnrealizedGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross unrealized gains of investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_InvestmentsGrossUnrealizedGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_InvestmentsGrossUnrealizedLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross unrealized losses of investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_InvestmentsGrossUnrealizedLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919253-210447<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7A<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953401-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrecognized gain on investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=SL120269820-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=SL120269820-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=SL120269820-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466606522728">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments (Amortized Cost and Fair Value of Available-for-Sale Debt Securities by Contractual Maturity) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Due in one year or less, Amortized Cost</a></td>
<td class="nump">$ 2,603<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost', window );">Due after one year through five years, Amortized Cost</a></td>
<td class="nump">12,885<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost', window );">Due after five years through ten years, Amortized Cost</a></td>
<td class="nump">11,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost', window );">Due after ten years, Amortized Cost</a></td>
<td class="nump">4,152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Total debt securities - available-for-sale, Amortized Cost</a></td>
<td class="nump">39,669<span></span>
</td>
<td class="nump">$ 38,079<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Due in one year or less, Fair Value</a></td>
<td class="nump">2,614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">Due after one year through five years, Fair Value</a></td>
<td class="nump">13,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">Due after five years through ten years, Fair Value</a></td>
<td class="nump">11,524<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue', window );">Due after ten years, Fair Value</a></td>
<td class="nump">4,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">40,217<span></span>
</td>
<td class="nump">39,828<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount', window );">Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, within One Year, Amortized Cost</a></td>
<td class="nump">235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, within One Year, Fair Value</a></td>
<td class="nump">236<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount', window );">Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Amortized Cost</a></td>
<td class="nump">355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Fair Value</a></td>
<td class="nump">354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount', window );">Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, after Five Through Ten Years, Amortized Cost</a></td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, after Five Through Ten Years, Fair Value</a></td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount', window );">Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, after 10 Years, Amortized Cost</a></td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue', window );">Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, after 10 Years, Fair Value</a></td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Debt Securities, Held-to-maturity</a></td>
<td class="nump">641<span></span>
</td>
<td class="nump">638<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Debt Securities, Held-to-maturity, Fair Value</a></td>
<td class="nump">643<span></span>
</td>
<td class="nump">647<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember', window );">U.S. Agency Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost', window );">Mortgage-backed securities, Amortized Cost</a></td>
<td class="nump">5,868<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Total debt securities - available-for-sale, Amortized Cost</a></td>
<td class="nump">5,868<span></span>
</td>
<td class="nump">6,849<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">5,901<span></span>
</td>
<td class="nump">7,091<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Mortgage-backed securities, Fair Value</a></td>
<td class="nump">5,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember', window );">Non-U.S. Agency Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost', window );">Mortgage-backed securities, Amortized Cost</a></td>
<td class="nump">2,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Total debt securities - available-for-sale, Amortized Cost</a></td>
<td class="nump">2,819<span></span>
</td>
<td class="nump">2,116<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">2,838<span></span>
</td>
<td class="nump">$ 2,207<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Mortgage-backed securities, Fair Value</a></td>
<td class="nump">$ 2,838<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919253-210447<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7A<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953401-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27232-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=SL120269825-111563<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=d3e62586-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=d3e62586-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=SL120269825-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27232-111563<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=d3e62586-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=d3e62586-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27232-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=d3e62586-112803<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=SL120269825-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=d3e62586-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=SL120269825-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=d3e62586-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=d3e62586-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=SL120269820-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466607437304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments (Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time That Individual Securities Have Been in a Continuous Unrealized Loss Position) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember', window );">Debt Securities - held-to-maturity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less Than 12 Months, Fair Value</a></td>
<td class="nump">$ 17,118<span></span>
</td>
<td class="nump">$ 2,415<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less Than 12 Months, Gross Unrealized Losses</a></td>
<td class="num">(237)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Greater Than 12 Months, Fair Value</a></td>
<td class="nump">886<span></span>
</td>
<td class="nump">549<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Greater Than 12 Months, Gross Unrealized Losses</a></td>
<td class="num">(37)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total, Fair Value</a></td>
<td class="nump">18,004<span></span>
</td>
<td class="nump">2,964<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss</a></td>
<td class="num">(274)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember', window );">U.S. Government and Agency Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less Than 12 Months, Fair Value</a></td>
<td class="nump">1,976<span></span>
</td>
<td class="nump">346<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less Than 12 Months, Gross Unrealized Losses</a></td>
<td class="num">(18)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Greater Than 12 Months, Fair Value</a></td>
<td class="nump">249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Greater Than 12 Months, Gross Unrealized Losses</a></td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total, Fair Value</a></td>
<td class="nump">2,225<span></span>
</td>
<td class="nump">346<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss</a></td>
<td class="num">(31)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">State and Municipal Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less Than 12 Months, Fair Value</a></td>
<td class="nump">1,386<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less Than 12 Months, Gross Unrealized Losses</a></td>
<td class="num">(19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Greater Than 12 Months, Fair Value</a></td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Greater Than 12 Months, Gross Unrealized Losses</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total, Fair Value</a></td>
<td class="nump">1,417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss</a></td>
<td class="num">(20)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less Than 12 Months, Fair Value</a></td>
<td class="nump">9,357<span></span>
</td>
<td class="nump">1,273<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less Than 12 Months, Gross Unrealized Losses</a></td>
<td class="num">(130)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Greater Than 12 Months, Fair Value</a></td>
<td class="nump">376<span></span>
</td>
<td class="nump">456<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Greater Than 12 Months, Gross Unrealized Losses</a></td>
<td class="num">(15)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total, Fair Value</a></td>
<td class="nump">9,733<span></span>
</td>
<td class="nump">1,729<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss</a></td>
<td class="num">(145)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember', window );">U.S. Agency Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less Than 12 Months, Fair Value</a></td>
<td class="nump">3,078<span></span>
</td>
<td class="nump">601<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less Than 12 Months, Gross Unrealized Losses</a></td>
<td class="num">(52)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Greater Than 12 Months, Fair Value</a></td>
<td class="nump">116<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Greater Than 12 Months, Gross Unrealized Losses</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total, Fair Value</a></td>
<td class="nump">3,194<span></span>
</td>
<td class="nump">601<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss</a></td>
<td class="num">(55)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember', window );">Non-U.S. Agency Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less Than 12 Months, Fair Value</a></td>
<td class="nump">1,321<span></span>
</td>
<td class="nump">195<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less Than 12 Months, Gross Unrealized Losses</a></td>
<td class="num">(18)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Greater Than 12 Months, Fair Value</a></td>
<td class="nump">114<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Greater Than 12 Months, Gross Unrealized Losses</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total, Fair Value</a></td>
<td class="nump">1,435<span></span>
</td>
<td class="nump">288<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss</a></td>
<td class="num">$ (23)<span></span>
</td>
<td class="num">$ (4)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27337-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27337-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466614519944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3', window );">Transfers Into Level 3</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3', window );">Transfers out of Level 3</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGain', window );">Equity Securities, FV-NI, Unrealized Gain</a></td>
<td class="nump">840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Fair Value, Nonrecurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis', window );">Significant fair value adjustments for assets and liabilities measured on a nonrecurring basis</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value Adjustments For Nonfinancial Assets And Liabilities Measured At Fair Value Or Financial Assets and Liabilities On Non Recurring Basis</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466603029640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value (Financial Assets and Liabilities, Measured at Fair Value on a Recurring Basis) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 21,375<span></span>
</td>
<td class="nump">$ 16,921<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">40,217<span></span>
</td>
<td class="nump">39,828<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="nump">2,177<span></span>
</td>
<td class="nump">1,828<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_AarpAssetsUnderManagement', window );">Assets under management</a></td>
<td class="nump">4,449<span></span>
</td>
<td class="nump">4,076<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">68,218<span></span>
</td>
<td class="nump">62,653<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember', window );">Debt Securities - held-to-maturity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">40,217<span></span>
</td>
<td class="nump">39,828<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember', window );">U.S. Government and Agency Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">3,198<span></span>
</td>
<td class="nump">3,465<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">State and Municipal Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">7,106<span></span>
</td>
<td class="nump">7,328<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">21,174<span></span>
</td>
<td class="nump">19,737<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember', window );">U.S. Agency Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">5,901<span></span>
</td>
<td class="nump">7,091<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember', window );">Non-U.S. Agency Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">2,838<span></span>
</td>
<td class="nump">2,207<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted Prices in Active Markets (Level 1) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">21,359<span></span>
</td>
<td class="nump">16,841<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="nump">2,090<span></span>
</td>
<td class="nump">1,795<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_AarpAssetsUnderManagement', window );">Assets under management</a></td>
<td class="nump">1,972<span></span>
</td>
<td class="nump">1,774<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">28,478<span></span>
</td>
<td class="nump">23,676<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted Prices in Active Markets (Level 1) [Member] | Debt Securities - held-to-maturity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">3,057<span></span>
</td>
<td class="nump">3,266<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted Prices in Active Markets (Level 1) [Member] | U.S. Government and Agency Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">3,017<span></span>
</td>
<td class="nump">3,241<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted Prices in Active Markets (Level 1) [Member] | State and Municipal Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted Prices in Active Markets (Level 1) [Member] | Corporate Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted Prices in Active Markets (Level 1) [Member] | U.S. Agency Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted Prices in Active Markets (Level 1) [Member] | Non-U.S. Agency Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Other Observable Inputs (Level 2) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_AarpAssetsUnderManagement', window );">Assets under management</a></td>
<td class="nump">2,376<span></span>
</td>
<td class="nump">2,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">39,357<span></span>
</td>
<td class="nump">38,637<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Other Observable Inputs (Level 2) [Member] | Debt Securities - held-to-maturity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">36,942<span></span>
</td>
<td class="nump">36,274<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Other Observable Inputs (Level 2) [Member] | U.S. Government and Agency Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">181<span></span>
</td>
<td class="nump">224<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Other Observable Inputs (Level 2) [Member] | State and Municipal Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">7,106<span></span>
</td>
<td class="nump">7,328<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Other Observable Inputs (Level 2) [Member] | Corporate Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">20,916<span></span>
</td>
<td class="nump">19,424<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Other Observable Inputs (Level 2) [Member] | U.S. Agency Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">5,901<span></span>
</td>
<td class="nump">7,091<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Other Observable Inputs (Level 2) [Member] | Non-U.S. Agency Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">2,838<span></span>
</td>
<td class="nump">2,207<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Unobservable Inputs (Level 3) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="nump">64<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_AarpAssetsUnderManagement', window );">Assets under management</a></td>
<td class="nump">101<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">340<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Unobservable Inputs (Level 3) [Member] | Debt Securities - held-to-maturity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">218<span></span>
</td>
<td class="nump">288<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Unobservable Inputs (Level 3) [Member] | U.S. Government and Agency Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Unobservable Inputs (Level 3) [Member] | State and Municipal Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Unobservable Inputs (Level 3) [Member] | Corporate Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">218<span></span>
</td>
<td class="nump">288<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Unobservable Inputs (Level 3) [Member] | U.S. Agency Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Unobservable Inputs (Level 3) [Member] | Non-U.S. Agency Mortgage-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_AarpAssetsUnderManagement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Assets Under Management are primarily AARP assets that are managed separately from the general investment portfolio and are used to pay costs associated with the AARP program.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_AarpAssetsUnderManagement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466607499592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value (Financial Assets and Liabilities, Not Measured at Fair Value on a Recurring Basis) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Debt Securities, Held-to-maturity, Fair Value</a></td>
<td class="nump">$ 643<span></span>
</td>
<td class="nump">$ 647<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Debt Securities, Held-to-maturity</a></td>
<td class="nump">641<span></span>
</td>
<td class="nump">638<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Debt and other financing obligations, carrying value</a></td>
<td class="nump">44,632<span></span>
</td>
<td class="nump">42,280<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Fair Value, Nonrecurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Debt Securities, Held-to-maturity, Fair Value</a></td>
<td class="nump">643<span></span>
</td>
<td class="nump">647<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Fair Value, Nonrecurring [Member] | Quoted Prices in Active Markets (Level 1) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Debt Securities, Held-to-maturity, Fair Value</a></td>
<td class="nump">534<span></span>
</td>
<td class="nump">466<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Fair Value, Nonrecurring [Member] | Other Observable Inputs (Level 2) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Debt Securities, Held-to-maturity, Fair Value</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">108<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Fair Value, Nonrecurring [Member] | Unobservable Inputs (Level 3) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Debt Securities, Held-to-maturity, Fair Value</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">73<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_LongTermDebtMember', window );">Long-term debt and other financing obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Debt and other financing obligations, carrying value</a></td>
<td class="nump">46,003<span></span>
</td>
<td class="nump">42,171<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_LongTermDebtMember', window );">Long-term debt and other financing obligations [Member] | Fair Value, Nonrecurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt and other financing obligations</a></td>
<td class="nump">52,583<span></span>
</td>
<td class="nump">51,254<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_LongTermDebtMember', window );">Long-term debt and other financing obligations [Member] | Fair Value, Nonrecurring [Member] | Quoted Prices in Active Markets (Level 1) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt and other financing obligations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_LongTermDebtMember', window );">Long-term debt and other financing obligations [Member] | Fair Value, Nonrecurring [Member] | Other Observable Inputs (Level 2) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt and other financing obligations</a></td>
<td class="nump">52,583<span></span>
</td>
<td class="nump">51,254<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_LongTermDebtMember', window );">Long-term debt and other financing obligations [Member] | Fair Value, Nonrecurring [Member] | Unobservable Inputs (Level 3) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt and other financing obligations</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtLongtermAndShorttermCombinedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate of total long-term debt, including current maturities and short-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtLongtermAndShorttermCombinedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919253-210447<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7A<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953401-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=SL120269820-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_LongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_LongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466602819880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant, and Capitalized Software (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">$ 996<span></span>
</td>
<td class="nump">$ 997<span></span>
</td>
<td class="nump">$ 995<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareAmortization1', window );">Capitalized Computer Software, Amortization</a></td>
<td class="nump">$ 923<span></span>
</td>
<td class="nump">$ 814<span></span>
</td>
<td class="nump">$ 721<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareAmortization1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for amortization of capitalized computer software costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128487-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareAmortization1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466606521624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property, Plant, and Capitalized Software Property Plant and Equipment Table (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LandAndLandImprovements', window );">Land and improvements</a></td>
<td class="nump">$ 502<span></span>
</td>
<td class="nump">$ 533<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Buildings and improvements</a></td>
<td class="nump">4,882<span></span>
</td>
<td class="nump">4,759<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MachineryAndEquipmentGross', window );">Computer equipment</a></td>
<td class="nump">1,851<span></span>
</td>
<td class="nump">1,767<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FurnitureAndFixturesGross', window );">Furniture and fixtures</a></td>
<td class="nump">2,014<span></span>
</td>
<td class="nump">1,787<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation', window );">Less accumulated depreciation</a></td>
<td class="num">(3,857)<span></span>
</td>
<td class="num">(3,364)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet', window );">Property and equipment, net</a></td>
<td class="nump">5,392<span></span>
</td>
<td class="nump">5,482<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareGross', window );">Capitalized software</a></td>
<td class="nump">5,712<span></span>
</td>
<td class="nump">5,010<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization', window );">Less accumulated amortization</a></td>
<td class="num">(2,135)<span></span>
</td>
<td class="num">(1,866)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareNet', window );">Capitalized software, net</a></td>
<td class="nump">3,577<span></span>
</td>
<td class="nump">3,144<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property, equipment and capitalized software, net</a></td>
<td class="nump">$ 8,969<span></span>
</td>
<td class="nump">$ 8,626<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Property, Plant, and Equipment Excluding Capitalized Computer Software, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BuildingsAndImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BuildingsAndImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For each balance sheet presented, the amount of accumulated amortization for capitalized computer software costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FurnitureAndFixturesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FurnitureAndFixturesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LandAndLandImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated deprecation and depletion of real estate held for productive use and additions or improvements to real estate held for productive use, examples include, but are not limited to, walkways, driveways, fences, and parking lots. Excludes land held for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LandAndLandImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MachineryAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MachineryAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation of long-lived, physical assets used to produce goods and services and not intended for resale, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466612646136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Narrative) (Details) - USD ($)<br> $ in Billions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">$ 1.2<span></span>
</td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466604059320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets Changes in the Carrying Amount of Goodwill by Reporting Segment (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning Balance</a></td>
<td class="nump">$ 71,337<span></span>
</td>
<td class="nump">$ 65,659<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">4,804<span></span>
</td>
<td class="nump">6,379<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency effects and adjustments, net</a></td>
<td class="num">(346)<span></span>
</td>
<td class="num">(701)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending Balance</a></td>
<td class="nump">75,795<span></span>
</td>
<td class="nump">71,337<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=unh_UnitedhealthcareMember', window );">UnitedHealthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning Balance</a></td>
<td class="nump">27,785<span></span>
</td>
<td class="nump">27,228<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">1,180<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency effects and adjustments, net</a></td>
<td class="num">(456)<span></span>
</td>
<td class="num">(623)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending Balance</a></td>
<td class="nump">27,389<span></span>
</td>
<td class="nump">27,785<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=unh_OptumhealthMember', window );">Optum Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning Balance</a></td>
<td class="nump">19,844<span></span>
</td>
<td class="nump">15,342<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">4,648<span></span>
</td>
<td class="nump">4,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency effects and adjustments, net</a></td>
<td class="num">(268)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending Balance</a></td>
<td class="nump">24,224<span></span>
</td>
<td class="nump">19,844<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=unh_OptuminsightMember', window );">Optum Insight</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning Balance</a></td>
<td class="nump">8,173<span></span>
</td>
<td class="nump">8,292<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">96<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency effects and adjustments, net</a></td>
<td class="nump">350<span></span>
</td>
<td class="num">(119)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending Balance</a></td>
<td class="nump">8,619<span></span>
</td>
<td class="nump">8,173<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=unh_OptumrxMember', window );">Optum Rx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning Balance</a></td>
<td class="nump">15,535<span></span>
</td>
<td class="nump">14,797<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">699<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency effects and adjustments, net</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending Balance</a></td>
<td class="nump">$ 15,563<span></span>
</td>
<td class="nump">$ 15,535<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=unh_UnitedhealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=unh_UnitedhealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=unh_OptumhealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=unh_OptumhealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=unh_OptuminsightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=unh_OptuminsightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=unh_OptumrxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=unh_OptumrxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466607576072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets Gross carrying value, accumulated amortization and net carrying value of intangible assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">$ 15,680<span></span>
</td>
<td class="nump">$ 16,311<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(5,636)<span></span>
</td>
<td class="num">(5,455)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">10,044<span></span>
</td>
<td class="nump">10,856<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember', window );">Customer-Related Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">13,011<span></span>
</td>
<td class="nump">13,428<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(4,697)<span></span>
</td>
<td class="num">(4,575)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">8,314<span></span>
</td>
<td class="nump">8,853<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=unh_TrademarksandTechnologyMember', window );">Trademarks and Technology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">1,630<span></span>
</td>
<td class="nump">1,597<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(739)<span></span>
</td>
<td class="num">(624)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">891<span></span>
</td>
<td class="nump">973<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember', window );">Trademarks and Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">617<span></span>
</td>
<td class="nump">680<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">617<span></span>
</td>
<td class="nump">680<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">422<span></span>
</td>
<td class="nump">606<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(200)<span></span>
</td>
<td class="num">(256)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">$ 222<span></span>
</td>
<td class="nump">$ 350<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=unh_TrademarksandTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=unh_TrademarksandTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466609002360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets Weighted-average useful lives assigned to finite-lived intangible assets acquired in business combinations (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="nump">$ 660<span></span>
</td>
<td class="nump">$ 1,722<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">11 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember', window );">Customer-Related Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="nump">$ 484<span></span>
</td>
<td class="nump">$ 1,113<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">11 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=unh_TrademarksandTechnologyMember', window );">Trademarks and Technology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="nump">$ 147<span></span>
</td>
<td class="nump">$ 514<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 95<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">11 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=unh_TrademarksandTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=unh_TrademarksandTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466611110984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets Amortization Expense relating to Intangible Assets (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 1,098<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2023</a></td>
<td class="nump">1,033<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2024</a></td>
<td class="nump">972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2025</a></td>
<td class="nump">892<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2026</a></td>
<td class="nump">$ 757<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466610754408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Medical Costs Payable (Narrative) (Details) - USD ($)<br> $ in Billions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount', window );">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred but Not Reported (IBNR) Claims, Amount</a></td>
<td class="nump">$ 17.1<span></span>
</td>
<td class="nump">$ 14.8<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated costs as of the balance sheet date of settling insured claims and costs incurred in the claims settlement process for claims that have not yet been submitted to the insurance company for reimbursement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.W)<br> -URI http://asc.fasb.org/extlink&amp;oid=27015833&amp;loc=d3e570705-122907<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466604044072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Medical Costs Payable Rollforward (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Medical costs payable, beginning of period</a></td>
<td class="nump">$ 21,872<span></span>
</td>
<td class="nump">$ 21,690<span></span>
</td>
<td class="nump">$ 19,891<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions', window );">Acquisitions</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">316<span></span>
</td>
<td class="nump">679<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract', window );"><strong>Reported medical costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense', window );">Current year</a></td>
<td class="nump">188,631<span></span>
</td>
<td class="nump">160,276<span></span>
</td>
<td class="nump">157,020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense', window );">Prior years</a></td>
<td class="num">(1,720)<span></span>
</td>
<td class="num">(880)<span></span>
</td>
<td class="num">(580)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1', window );">Total reported medical costs</a></td>
<td class="nump">186,911<span></span>
</td>
<td class="nump">159,396<span></span>
</td>
<td class="nump">156,440<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Medical payments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1', window );">Payments for current year</a></td>
<td class="num">(165,524)<span></span>
</td>
<td class="num">(139,974)<span></span>
</td>
<td class="num">(137,155)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1', window );">Payments for prior years</a></td>
<td class="num">(18,864)<span></span>
</td>
<td class="num">(19,556)<span></span>
</td>
<td class="num">(18,165)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense', window );">Total medical payments</a></td>
<td class="num">(184,388)<span></span>
</td>
<td class="num">(159,530)<span></span>
</td>
<td class="num">(155,320)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Medical costs payable, end of period</a></td>
<td class="nump">$ 24,483<span></span>
</td>
<td class="nump">$ 21,872<span></span>
</td>
<td class="nump">$ 21,690<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the cost of settling unpaid claims after deduction of reinsurance recoveries related to the acquisition of a business. Includes, but is not limited to, claims which have been incurred but not reported.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLossesAndLossAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466606494120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Medical Costs Payable, Incurred and Paid Medical Cost Development (Details) - Health Insurance Product Line [Member] - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Net Incurred Medical Costs</a></td>
<td class="nump">$ 347,771<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Net Cumulative Medical Payments</a></td>
<td class="num">(323,706)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented', window );">Net remaining outstanding liabilities prior to 2020</a></td>
<td class="nump">418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Total Medical costs payable</a></td>
<td class="nump">24,483<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember', window );">Short-duration Insurance Contracts, Accident Year 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Net Incurred Medical Costs</a></td>
<td class="nump">159,140<span></span>
</td>
<td class="nump">$ 160,276<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Net Cumulative Medical Payments</a></td>
<td class="num">(158,182)<span></span>
</td>
<td class="num">$ (139,974)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember', window );">Short-duration Insurance Contracts, Accident Year 2021 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Net Incurred Medical Costs</a></td>
<td class="nump">188,631<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Net Cumulative Medical Payments</a></td>
<td class="num">$ (165,524)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reinsurance, of paid claims and allocated claim adjustment expense used in claims development for short-duration insurance contracts. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671311-158438<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Undiscounted amount, after reinsurance, of incurred claims and allocated claim adjustment expense used in claims development for short-duration insurance contracts. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671311-158438<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Undiscounted amount, after reinsurance, of the liability for unpaid claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671315-158438<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671311-158438<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Undiscounted amount, after reinsurance, of the liability for unpaid claims and allocated claim adjustment expense for short-duration insurance contracts for accident years not separately presented in claim development information. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671311-158438<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466607385416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-Term Borrowings and Long-Term Debt (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="nump">0.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="nump">0.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_CreditFacilityNameAxis=unh_A364Day38BillionCreditFacilityMember', window );">364 Day $3.8 Billion Credit Facility [Member] | Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Long-term Line of Credit</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit, Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="nump">$ 3,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationPeriod', window );">Maturity Period, Line of Credit</a></td>
<td class="text">364 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_CreditFacilityNameAxis=unh_FiveYear56BillionCreditFacilityMember', window );">Five Year $5.6 Billion Credit Facility [Member] | Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Long-term Line of Credit</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit, Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="nump">$ 5,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationPeriod', window );">Maturity Period, Line of Credit</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_CreditFacilityNameAxis=unh_ThreeYear56BillionCreditFacilityMember', window );">Three Year $5.6 Billion Credit Facility [Member] | Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Long-term Line of Credit</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit, Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="nump">$ 5,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationPeriod', window );">Maturity Period, Line of Credit</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember', window );">Subsidiaries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLongTermDebt', window );">Other Long-term Debt</a></td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLongTermDebtCurrent', window );">Other Long-term Debt, Current</a></td>
<td class="nump">$ 611<span></span>
</td>
<td class="nump">$ 354<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period remaining on line of credit facility before it terminates, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt classified as other, payable within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_CreditFacilityNameAxis=unh_A364Day38BillionCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_CreditFacilityNameAxis=unh_A364Day38BillionCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_CreditFacilityNameAxis=unh_FiveYear56BillionCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_CreditFacilityNameAxis=unh_FiveYear56BillionCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_CreditFacilityNameAxis=unh_ThreeYear56BillionCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_CreditFacilityNameAxis=unh_ThreeYear56BillionCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466598748296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Short-Term Borrowings and Long-Term Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Carrying Value</a></td>
<td class="nump">$ 44,632<span></span>
</td>
<td class="nump">$ 42,280<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommercialPaper', window );">Commercial Paper</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,296<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A4.700notesdueFebruary2021Member', window );">4.700% Notes Due February 2021 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">4.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebtCurrent', window );">Unsecured Debt, Current</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A2.125notesdueMarch2021Member', window );">2.125% notes due March 2021 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">2.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebtCurrent', window );">Unsecured Debt, Current</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_FloatingratenotesdueJune2021Member', window );">Floating rate notes due June 2021 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebtCurrent', window );">Unsecured Debt, Current</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">350<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A3.150notesdueJune2021Member', window );">3.150% notes due June 2021 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebtCurrent', window );">Unsecured Debt, Current</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A3.375notesdueNovember2021Member', window );">3.375% Notes Due November 2021 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebtCurrent', window );">Unsecured Debt, Current</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">507<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A2875NotesDueDecember2021Member', window );">2.875% Notes Due December 2021 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">2.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebtCurrent', window );">Unsecured Debt, Current</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">762<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A2.875notesdueMarch2022Member', window );">2.875% Notes Due March 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">2.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,113<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebtCurrent', window );">Unsecured Debt, Current</a></td>
<td class="nump">$ 1,097<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A3350NotesDueJuly2022Member', window );">3.350% Notes Due July 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">999<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebtCurrent', window );">Unsecured Debt, Current</a></td>
<td class="nump">$ 999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A2.375notesdueOctober2022MemberMember', window );">2.375% notes due October 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">2.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">897<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebtCurrent', window );">Unsecured Debt, Current</a></td>
<td class="nump">$ 899<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_ZeroCouponNotesDueNovember2022Member', window );">0.000% Notes Due November 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebtCurrent', window );">Unsecured Debt, Current</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A2750NotesDueFebruary2023Member', window );">2.750% Notes Due February 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 632<span></span>
</td>
<td class="nump">644<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A2875NotesDueMarch2023Member', window );">2.875% Notes Due March 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">2.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 768<span></span>
</td>
<td class="nump">789<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A3.500notesdueJune2023Member', window );">3.500% notes due June 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 749<span></span>
</td>
<td class="nump">748<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A3.500notesdueFebruary2024Member', window );">3.500% notes due February 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 748<span></span>
</td>
<td class="nump">747<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A0550NotesDueMay2024Member', window );">0.550% notes due May 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">0.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 996<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A2.375notesdueAugust2024Member', window );">2.375% notes due August 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">2.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 748<span></span>
</td>
<td class="nump">747<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A3.750notesdueJuly2025Member', window );">3.750% Notes Due July 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 1,994<span></span>
</td>
<td class="nump">1,992<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A3.700notesdueDecember2025Member', window );">3.700% notes due December 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 299<span></span>
</td>
<td class="nump">298<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A1250NotesDueJanuary2026Member', window );">1.250% notes due January 2026 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 497<span></span>
</td>
<td class="nump">496<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A3.100notesdueMarch2026Member', window );">3.100% notes due March 2026 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 997<span></span>
</td>
<td class="nump">997<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A1150NotesDueMay2026Member', window );">1.150% notes due May 2026 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">1.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 972<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A3.450notesdueJanuary2027Member', window );">3.450% notes due January 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 747<span></span>
</td>
<td class="nump">747<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A3.375notesdueApril2027Member', window );">3.375% notes due April 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 621<span></span>
</td>
<td class="nump">620<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A2.950notesdueOctober2027Member', window );">2.950% notes due October 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">2.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 942<span></span>
</td>
<td class="nump">940<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A3.850notesdueJune2028Member', window );">3.850% notes due June 2028 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 1,144<span></span>
</td>
<td class="nump">1,143<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A3.875notesdueDecember2028Member', window );">3.875% notes due December 2028 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 844<span></span>
</td>
<td class="nump">844<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A2.875notesdueAugust2029Member', window );">2.875% notes due August 2029 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">2.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 1,023<span></span>
</td>
<td class="nump">1,086<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A2000NotesDueMay2030Member', window );">2.000% notes due May 2030 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 1,235<span></span>
</td>
<td class="nump">1,234<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A2300NotesDueMay2031Member', window );">2.300% notes due May 2031 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">2.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 1,482<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A4.625notesdueJuly2035Member', window );">4.625% notes Due July 2035 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 993<span></span>
</td>
<td class="nump">992<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A5.800notesdueMarch2036Member', window );">5.800% notes Due March 2036 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">5.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 839<span></span>
</td>
<td class="nump">839<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A6500NotesDueJune2037Member', window );">6.500% notes Due June 2037 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">6.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 492<span></span>
</td>
<td class="nump">492<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A6625NotesDueNovember2037Member', window );">6.625% notes due November 2037 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">6.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 642<span></span>
</td>
<td class="nump">641<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A6.875notesdueFebruary2038Member', window );">6.875% notes Due Februray 2038 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">6.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 1,078<span></span>
</td>
<td class="nump">1,077<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A3.500notesdueAugust2039Member', window );">3.500% notes due August 2039 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 1,242<span></span>
</td>
<td class="nump">1,241<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A2750NotesDueMay2040Member', window );">2.750% notes due May 2040 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 966<span></span>
</td>
<td class="nump">964<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A5.700notesdueOctober2040Member', window );">5.700% notes Due October 2040 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">5.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 296<span></span>
</td>
<td class="nump">296<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A5.950notesdueFebruary2041Member', window );">5.950% notes Due Februrary 2041 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">5.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 346<span></span>
</td>
<td class="nump">346<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A3050NotesDueMay2041Member', window );">3.050% notes due May 2041 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.05%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 1,483<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A4.625notesdueNovember2041Member', window );">4.625% notes Due November 2041 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 589<span></span>
</td>
<td class="nump">589<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A4.375notesdueMarch2042Member', window );">4.375% notes Due March 2042 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 502<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 485<span></span>
</td>
<td class="nump">485<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A3950NotesDueOctober2042Member', window );">3.950% notes Due October 2042 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 608<span></span>
</td>
<td class="nump">608<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A4250NotesDueMarch2043Member', window );">4.250% notes Due March 2043 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 736<span></span>
</td>
<td class="nump">735<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A4.750notesdueJuly2045Member', window );">4.750% notes Due July 2045 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 1,974<span></span>
</td>
<td class="nump">1,974<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A4.200notesdueJanuary2047Member', window );">4.200% notes due January 2047 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">4.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 739<span></span>
</td>
<td class="nump">738<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A4.250notesdueApril2047Member', window );">4.250% notes due April 2047 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 718<span></span>
</td>
<td class="nump">717<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A3.750notesdueOctober2047Member', window );">3.750% notes due October 2047 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 934<span></span>
</td>
<td class="nump">934<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A4.250notesdueJune2048Member', window );">4.250% notes due June 2048 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 1,330<span></span>
</td>
<td class="nump">1,330<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A4.450notesdueDecember2048Member', window );">4.450% notes due December 2048 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">4.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 1,087<span></span>
</td>
<td class="nump">1,086<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A3.700notesdueAugust2049Member', window );">3.700% notes due August 2049 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 1,236<span></span>
</td>
<td class="nump">1,235<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A2900NotesDueMay2050Member', window );">2.900% notes due May 2050 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">2.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 1,209<span></span>
</td>
<td class="nump">1,208<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A3250NotesDueMay2051Member', window );">3.250% notes due May 2051 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 1,970<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A3.875notesdueAugust2059Member', window );">3.875% notes due August 2059 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 1,228<span></span>
</td>
<td class="nump">1,228<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=unh_A3125NotesDueMay2060Member', window );">3.125% notes due May 2060 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured Long-term Debt, Noncurrent</a></td>
<td class="nump">$ 965<span></span>
</td>
<td class="nump">$ 965<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtLongtermAndShorttermCombinedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate of total long-term debt, including current maturities and short-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtLongtermAndShorttermCombinedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnsecuredDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term, uncollateralized debt obligations due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnsecuredDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnsecuredLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of uncollateralized debt obligation (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnsecuredLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A4.700notesdueFebruary2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A4.700notesdueFebruary2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A2.125notesdueMarch2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A2.125notesdueMarch2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_FloatingratenotesdueJune2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_FloatingratenotesdueJune2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A3.150notesdueJune2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A3.150notesdueJune2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A3.375notesdueNovember2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A3.375notesdueNovember2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A2875NotesDueDecember2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A2875NotesDueDecember2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A2.875notesdueMarch2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A2.875notesdueMarch2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A3350NotesDueJuly2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A3350NotesDueJuly2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A2.375notesdueOctober2022MemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A2.375notesdueOctober2022MemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_ZeroCouponNotesDueNovember2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_ZeroCouponNotesDueNovember2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A2750NotesDueFebruary2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A2750NotesDueFebruary2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A2875NotesDueMarch2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A2875NotesDueMarch2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A3.500notesdueJune2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A3.500notesdueJune2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A3.500notesdueFebruary2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A3.500notesdueFebruary2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A0550NotesDueMay2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A0550NotesDueMay2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A2.375notesdueAugust2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A2.375notesdueAugust2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A3.750notesdueJuly2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A3.750notesdueJuly2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A3.700notesdueDecember2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A3.700notesdueDecember2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A1250NotesDueJanuary2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A1250NotesDueJanuary2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A3.100notesdueMarch2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A3.100notesdueMarch2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A1150NotesDueMay2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A1150NotesDueMay2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A3.450notesdueJanuary2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A3.450notesdueJanuary2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A3.375notesdueApril2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A3.375notesdueApril2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A2.950notesdueOctober2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A2.950notesdueOctober2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A3.850notesdueJune2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A3.850notesdueJune2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A3.875notesdueDecember2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A3.875notesdueDecember2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A2.875notesdueAugust2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A2.875notesdueAugust2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A2000NotesDueMay2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A2000NotesDueMay2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A2300NotesDueMay2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A2300NotesDueMay2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A4.625notesdueJuly2035Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A4.625notesdueJuly2035Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A5.800notesdueMarch2036Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A5.800notesdueMarch2036Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A6500NotesDueJune2037Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A6500NotesDueJune2037Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A6625NotesDueNovember2037Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A6625NotesDueNovember2037Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A6.875notesdueFebruary2038Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A6.875notesdueFebruary2038Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A3.500notesdueAugust2039Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A3.500notesdueAugust2039Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A2750NotesDueMay2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A2750NotesDueMay2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A5.700notesdueOctober2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A5.700notesdueOctober2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A5.950notesdueFebruary2041Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A5.950notesdueFebruary2041Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A3050NotesDueMay2041Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A3050NotesDueMay2041Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A4.625notesdueNovember2041Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A4.625notesdueNovember2041Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A4.375notesdueMarch2042Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A4.375notesdueMarch2042Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A3950NotesDueOctober2042Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A3950NotesDueOctober2042Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A4250NotesDueMarch2043Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A4250NotesDueMarch2043Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A4.750notesdueJuly2045Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A4.750notesdueJuly2045Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A4.200notesdueJanuary2047Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A4.200notesdueJanuary2047Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A4.250notesdueApril2047Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A4.250notesdueApril2047Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A3.750notesdueOctober2047Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A3.750notesdueOctober2047Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A4.250notesdueJune2048Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A4.250notesdueJune2048Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A4.450notesdueDecember2048Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A4.450notesdueDecember2048Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A3.700notesdueAugust2049Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A3.700notesdueAugust2049Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A2900NotesDueMay2050Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A2900NotesDueMay2050Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A3250NotesDueMay2051Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A3250NotesDueMay2051Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A3.875notesdueAugust2059Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A3.875notesdueAugust2059Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=unh_A3125NotesDueMay2060Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=unh_A3125NotesDueMay2060Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466606999560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Short-Term Borrowings and Long-Term Debt Maturities of commercial paper and long-term debt (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 3,626<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2023</a></td>
<td class="nump">2,277<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2024</a></td>
<td class="nump">2,652<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2025</a></td>
<td class="nump">2,452<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2026</a></td>
<td class="nump">2,652<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">$ 32,829<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466602663096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</a></td>
<td class="nump">$ 66<span></span>
</td>
<td class="nump">$ 52<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</a></td>
<td class="nump">194<span></span>
</td>
<td class="nump">$ 128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit', window );">Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit</a></td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</a></td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal [Member] | Earliest Tax Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardExpirationDate', window );">Tax Credit Carryforward, Expiration Date</a></td>
<td class="text">Jan.  01,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Open Tax Year</a></td>
<td class="text">2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal [Member] | Latest Tax Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardExpirationDate', window );">Tax Credit Carryforward, Expiration Date</a></td>
<td class="text">Jan.  01,  2037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Open Tax Year</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State [Member] | Earliest Tax Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardExpirationDate', window );">Tax Credit Carryforward, Expiration Date</a></td>
<td class="text">Jan.  01,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Open Tax Year</a></td>
<td class="text">2014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State [Member] | Latest Tax Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardExpirationDate', window );">Tax Credit Carryforward, Expiration Date</a></td>
<td class="text">Jan.  01,  2041<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Open Tax Year</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Non-U.S [Member] | Earliest Tax Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Open Tax Year</a></td>
<td class="text">2015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Non-U.S [Member] | Latest Tax Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Open Tax Year</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=unh_NOLsExpirationBeginning2022Through2037Member', window );">Finite-lived NOL carryforwards [Member] | Federal [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating Loss Carryforwards</a></td>
<td class="nump">$ 42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=unh_NOLsIndefiniteCarryforwardMember', window );">Indefinite NOL carryforwards [Member] | Federal [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating Loss Carryforwards</a></td>
<td class="nump">$ 295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OpenTaxYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax year that remains open to examination under enacted tax laws, in YYYY format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OpenTaxYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:gYearListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the unrecognized tax benefit of a position taken for which it is reasonably possible that the total amount thereof will significantly increase or decrease within twelve months of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiration date of the tax credit carryforward, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=us-gaap_EarliestTaxYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=us-gaap_EarliestTaxYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=us-gaap_LatestTaxYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=us-gaap_LatestTaxYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=unh_NOLsExpirationBeginning2022Through2037Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=unh_NOLsExpirationBeginning2022Through2037Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=unh_NOLsIndefiniteCarryforwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=unh_NOLsIndefiniteCarryforwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466615109544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes Reconciliation of Provision for Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxesExcludingIncomeAndExciseTaxesAbstract', window );"><strong>Current Provision:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations', window );">Federal</a></td>
<td class="nump">$ 3,451<span></span>
</td>
<td class="nump">$ 4,098<span></span>
</td>
<td class="nump">$ 2,629<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State and local</a></td>
<td class="nump">481<span></span>
</td>
<td class="nump">392<span></span>
</td>
<td class="nump">319<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">516<span></span>
</td>
<td class="nump">491<span></span>
</td>
<td class="nump">564<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current provision</a></td>
<td class="nump">4,448<span></span>
</td>
<td class="nump">4,981<span></span>
</td>
<td class="nump">3,512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred provision (benefit)</a></td>
<td class="nump">130<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="nump">230<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total provision for income taxes</a></td>
<td class="nump">$ 4,578<span></span>
</td>
<td class="nump">$ 4,973<span></span>
</td>
<td class="nump">$ 3,742<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current and deferred federal income tax expense (benefit) attributable to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesExcludingIncomeAndExciseTaxesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesExcludingIncomeAndExciseTaxesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466606981912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax Reconciliation of the tax provision at the U.S. Federal Statutory Rate (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Tax provision at the U.S. federal statutory rate, Amount</a></td>
<td class="nump">$ 4,685<span></span>
</td>
<td class="nump">$ 4,356<span></span>
</td>
<td class="nump">$ 3,776<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Tax provision at the U.S. federal statutory rate, Percent</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal benefit, Amount</a></td>
<td class="nump">$ 419<span></span>
</td>
<td class="nump">$ 315<span></span>
</td>
<td class="nump">$ 271<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal benefit, Percent</a></td>
<td class="nump">1.90%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount', window );">Share-based awards - excess tax benefit, Amount</a></td>
<td class="num">$ (100)<span></span>
</td>
<td class="num">$ (130)<span></span>
</td>
<td class="num">$ (132)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent', window );">Share-based awards - excess tax benefit, Percent</a></td>
<td class="num">(0.40%)<span></span>
</td>
<td class="num">(0.60%)<span></span>
</td>
<td class="num">(0.70%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense', window );">Non-deductible compensation, Amount</a></td>
<td class="nump">$ 144<span></span>
</td>
<td class="nump">$ 134<span></span>
</td>
<td class="nump">$ 119<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense', window );">Non-deductible compensation, Percent</a></td>
<td class="nump">0.60%<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount', window );">Health insurance industry tax, Amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 626<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent', window );">Health insurance industry tax, Percent</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Foreign rate differential, Amount</a></td>
<td class="num">$ (246)<span></span>
</td>
<td class="num">$ (164)<span></span>
</td>
<td class="num">$ (214)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign rate differential, Percent</a></td>
<td class="num">(1.10%)<span></span>
</td>
<td class="num">(0.80%)<span></span>
</td>
<td class="num">(1.20%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other, net, Amount</a></td>
<td class="num">$ (324)<span></span>
</td>
<td class="num">$ (164)<span></span>
</td>
<td class="num">$ (78)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other, net, Percent</a></td>
<td class="num">(1.50%)<span></span>
</td>
<td class="num">(0.80%)<span></span>
</td>
<td class="num">(0.50%)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total provision for income taxes</a></td>
<td class="nump">$ 4,578<span></span>
</td>
<td class="nump">$ 4,973<span></span>
</td>
<td class="nump">$ 3,742<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Provision for income taxes, Percent</a></td>
<td class="nump">20.50%<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
<td class="nump">20.80%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation Nonrefundable Health Insurance Industry Tax Expense, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation Nonrefundable Health Insurance Industry Tax Expense, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Share Based Awards Excess Tax Benefit, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Share Based Awards Excess Tax Benefit, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466599866568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes Components of Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGrossAbstract', window );"><strong>Deferred income tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances', window );">Accrued expenses and allowances</a></td>
<td class="nump">$ 723<span></span>
</td>
<td class="nump">$ 815<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic', window );">U.S. federal and state net operating loss carryforwards</a></td>
<td class="nump">287<span></span>
</td>
<td class="nump">276<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Share-based compensation</a></td>
<td class="nump">117<span></span>
</td>
<td class="nump">98<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities', window );">Nondeductible liabilities</a></td>
<td class="nump">296<span></span>
</td>
<td class="nump">252<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign', window );">Non-U.S. tax loss carryforwards</a></td>
<td class="nump">435<span></span>
</td>
<td class="nump">340<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_DeferredTaxAssetsLeaseLiability', window );">Lease liability</a></td>
<td class="nump">1,284<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_DeferredTaxAssetOtherDomestic', window );">Other-domestic</a></td>
<td class="nump">228<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_DeferredTaxAssetOtherForeign', window );">Other-non-U.S.</a></td>
<td class="nump">376<span></span>
</td>
<td class="nump">454<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Subtotal</a></td>
<td class="nump">3,746<span></span>
</td>
<td class="nump">3,561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowances</a></td>
<td class="num">(198)<span></span>
</td>
<td class="num">(170)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Total deferred income tax assets</a></td>
<td class="nump">3,548<span></span>
</td>
<td class="nump">3,391<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred income tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets', window );">U.S. federal and state intangible assets</a></td>
<td class="num">(2,658)<span></span>
</td>
<td class="num">(2,588)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign', window );">Non-U.S. goodwill and intangible assets</a></td>
<td class="num">(512)<span></span>
</td>
<td class="num">(606)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware', window );">Capitalized software</a></td>
<td class="num">(833)<span></span>
</td>
<td class="num">(731)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Depreciation and amortization</a></td>
<td class="num">(349)<span></span>
</td>
<td class="num">(346)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses', window );">Prepaid expenses</a></td>
<td class="num">(256)<span></span>
</td>
<td class="num">(216)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates', window );">Outside basis in partnerships</a></td>
<td class="num">(565)<span></span>
</td>
<td class="num">(342)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">Lease right-of-use asset</a></td>
<td class="num">(1,267)<span></span>
</td>
<td class="num">(1,179)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_DeferredTaxLiabilityOtherDomestic', window );">Other-domestic</a></td>
<td class="num">(125)<span></span>
</td>
<td class="num">(400)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_DeferredTaxLiabilityOtherForeign', window );">Other-non-U.S.</a></td>
<td class="num">(248)<span></span>
</td>
<td class="num">(350)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred income tax liabilities</a></td>
<td class="num">(6,813)<span></span>
</td>
<td class="num">(6,758)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred income tax liabilities</a></td>
<td class="num">$ (3,265)<span></span>
</td>
<td class="num">$ (3,367)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_DeferredTaxAssetOtherDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Asset, Other Domestic</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_DeferredTaxAssetOtherDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_DeferredTaxAssetOtherForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Asset, Other Foreign</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_DeferredTaxAssetOtherForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Deferred Tax Expense, Long-term liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_DeferredTaxAssetsLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets Lease Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_DeferredTaxAssetsLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities Goodwill And Intangible Assets, Foreign</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_DeferredTaxLiabilityOtherDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liability, Other Domestic</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_DeferredTaxLiabilityOtherDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_DeferredTaxLiabilityOtherForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liability, Other Foreign</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_DeferredTaxLiabilityOtherForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGrossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGrossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from estimated returns and sales allowances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from capitalized software.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from investments in unconsolidated subsidiaries and investments in other affiliates which are not controlled nor consolidated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from long-lived assets other than property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax consequences attributable to taxable temporary differences derived from prepaid expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466611087784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes Reconciliation of the beginning and ending amount of unrecognized tax benefits (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Gross unrecognized tax benefits, beginning of period</a></td>
<td class="nump">$ 1,829<span></span>
</td>
<td class="nump">$ 1,423<span></span>
</td>
<td class="nump">$ 1,056<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Current year tax positions</a></td>
<td class="nump">538<span></span>
</td>
<td class="nump">416<span></span>
</td>
<td class="nump">512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Prior year tax positions, gross increases</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Prior year tax positions, gross decreases</a></td>
<td class="num">(47)<span></span>
</td>
<td class="num">(130)<span></span>
</td>
<td class="num">(96)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(46)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Statute of limitations lapses</a></td>
<td class="num">(20)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Gross unrecognized tax benefits, end of period</a></td>
<td class="nump">$ 2,310<span></span>
</td>
<td class="nump">$ 1,829<span></span>
</td>
<td class="nump">$ 1,423<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466598713208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Narrative) (Details) - USD ($)<br> shares in Millions, $ in Billions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 01, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_ShareRepurchasesTableLineItems', window );"><strong>Shareholders' Equity Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries', window );">Cash Dividends Paid to Parent, Consolidated Subsidiaries</a></td>
<td class="nump">$ 8.0<span></span>
</td>
<td class="nump">$ 8.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance', window );">Statutory Accounting Practices, Statutory Capital and Surplus, Balance</a></td>
<td class="nump">30.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired', window );">Statutory Accounting Practices, Statutory Capital and Surplus Required</a></td>
<td class="nump">13.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Stock Repurchase Program, Number of Shares Authorized to be Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_DividendFrequencyAxis=unh_ExtraordinaryDividendsMember', window );">Extraordinary Dividends [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_ShareRepurchasesTableLineItems', window );"><strong>Shareholders' Equity Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries', window );">Cash Dividends Paid to Parent, Consolidated Subsidiaries</a></td>
<td class="nump">$ 4.7<span></span>
</td>
<td class="nump">$ 4.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_ShareRepurchasesTableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Share Repurchases [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_ShareRepurchasesTableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents disclosure of the aggregate cash dividends paid to the entity by consolidated subsidiaries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of statutory capital and surplus (stockholders' equity) as of the balance sheet date using prescribed or permitted statutory accounting practices (rather than GAAP, if different) of the state or country.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 505<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6486098&amp;loc=d3e24708-158529<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of statutory capital required to be maintained as of the balance sheet date under prescribed or permitted statutory accounting practices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 505<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6486098&amp;loc=d3e24708-158529<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_DividendFrequencyAxis=unh_ExtraordinaryDividendsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_DividendFrequencyAxis=unh_ExtraordinaryDividendsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466607544920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity Share Repurchases (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Common shares repurchases, shares</a></td>
<td class="nump">13,000,000<span></span>
</td>
<td class="nump">14,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Common share repurchases, average price per share</a></td>
<td class="nump">$ 389.92<span></span>
</td>
<td class="nump">$ 300.58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Common share repurchases</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="nump">$ 4,250<span></span>
</td>
<td class="nump">$ 5,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased', window );">Board authorized shares remaining</a></td>
<td class="nump">45,000,000<span></span>
</td>
<td class="nump">58,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The remaining number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466606462712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity Dividends (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 14, 2021</div></th>
<th class="th"><div>Sep. 21, 2021</div></th>
<th class="th"><div>Jun. 29, 2021</div></th>
<th class="th"><div>Mar. 23, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Cash dividends per common share</a></td>
<td class="nump">$ 1.45<span></span>
</td>
<td class="nump">$ 1.45<span></span>
</td>
<td class="nump">$ 1.45<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="nump">$ 5.60<span></span>
</td>
<td class="nump">$ 4.83<span></span>
</td>
<td class="nump">$ 4.14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Payments of Ordinary Dividends, Common Stock</a></td>
<td class="nump">$ 1,365<span></span>
</td>
<td class="nump">$ 1,367<span></span>
</td>
<td class="nump">$ 1,367<span></span>
</td>
<td class="nump">$ 1,181<span></span>
</td>
<td class="nump">$ 5,280<span></span>
</td>
<td class="nump">$ 4,584<span></span>
</td>
<td class="nump">$ 3,932<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466608990744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Narrative) (Details) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred Compensation, Recorded Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800<span></span>
</td>
<td class="nump">$ 1,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=unh_EmployeeStockPurchasePlanESPPMember', window );">Employee Stock Purchase Plan (ESPP) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized</a></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=unh_EmployeeStockPurchasePlanESPPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=unh_EmployeeStockPurchasePlanESPPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466603692248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Stock Option Activity) (Details)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at the beginning of the period | shares</a></td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Granted | shares</a></td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised | shares</a></td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeitures | shares</a></td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at the end of the period | shares</a></td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at end of period | shares</a></td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested and expected to vest, end of period | shares</a></td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at beginning of period, Weighted-Average Exercise Price | $ / shares</a></td>
<td class="nump">$ 211<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted, Weighted-Average Exercise Price | $ / shares</a></td>
<td class="nump">329<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised, Weighted-Average Exercise Price | $ / shares</a></td>
<td class="nump">175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Forfeitures, Weighted Average Exercise Price | $ / shares</a></td>
<td class="nump">297<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at end of period, Weighted-Average Exercise Price | $ / shares</a></td>
<td class="nump">241<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable at end of period, Weighted-Average Exercise Price | $ / shares</a></td>
<td class="nump">179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Vested and expected to vest end of period, Weighted-Average Exercise Price | $ / shares</a></td>
<td class="nump">$ 240<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding at end of period, Weighted Average Remaining Contractual Term (in years)</a></td>
<td class="text">6 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable at end of period, Weighted Average Remaining Contractual Term (in years)</a></td>
<td class="text">4 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Vested and expected to vest end of period, Weighted Average Remaining Contractual Term (in years)</a></td>
<td class="text">6 years 2 months 13 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding at end of period, Aggregate Intrinsic Value | $</a></td>
<td class="nump">$ 6,610<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercisable at end of period, Aggregate Intrinsic Value | $</a></td>
<td class="nump">3,932<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Vested and expected to vest end of period, Aggregate Intrinsic Value | $</a></td>
<td class="nump">$ 6,509<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466602909592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Restricted Share Activity) (Details) - Restricted Stock [Member]<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at beginning of period | shares</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted | shares</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested | shares</a></td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at end of period | shares</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at beginning of period, Weighted-Average Grant Date Fair Value per Share | $ / shares</a></td>
<td class="nump">$ 256<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value per share | $ / shares</a></td>
<td class="nump">352<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested, Weighted Average Grant Date Fair Value per share | $ / shares</a></td>
<td class="nump">246<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at end of period, Weighted-Average Grant Date Fair Value per Share | $ / shares</a></td>
<td class="nump">$ 303<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466607581400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation Other Share-Based Compensation Data (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense, before tax</a></td>
<td class="nump">$ 800<span></span>
</td>
<td class="nump">$ 679<span></span>
</td>
<td class="nump">$ 697<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share-based compensation expense, net of tax effects</a></td>
<td class="nump">719<span></span>
</td>
<td class="nump">619<span></span>
</td>
<td class="nump">641<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions', window );">Income tax benefit realized from share-based award exercises</a></td>
<td class="nump">173<span></span>
</td>
<td class="nump">$ 208<span></span>
</td>
<td class="nump">$ 201<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense related to share awards</a></td>
<td class="nump">$ 905<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">1 year 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=unh_StockOptionsandSARsMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value of shares granted, per share</a></td>
<td class="nump">$ 71<span></span>
</td>
<td class="nump">$ 54<span></span>
</td>
<td class="nump">$ 46<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Total intrinsic value of stock options exercised</a></td>
<td class="nump">$ 1,519<span></span>
</td>
<td class="nump">$ 1,736<span></span>
</td>
<td class="nump">$ 1,398<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value per share</a></td>
<td class="nump">$ 352<span></span>
</td>
<td class="nump">$ 303<span></span>
</td>
<td class="nump">$ 259<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total fair value of restricted shares vested</a></td>
<td class="nump">$ 560<span></span>
</td>
<td class="nump">$ 574<span></span>
</td>
<td class="nump">$ 545<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=unh_EmployeeStockPurchasePlanESPPMember', window );">Employee Stock Purchase Plan (ESPP) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Number of shares purchased</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of expense for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=unh_StockOptionsandSARsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=unh_StockOptionsandSARsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=unh_EmployeeStockPurchasePlanESPPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=unh_EmployeeStockPurchasePlanESPPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466607654184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Share-Based Compensation Principal Fair Value Assumptions) (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures', window );">Forfeiture rate</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected Life in years</a></td>
<td class="text">4 years 9 months 19 days<span></span>
</td>
<td class="text">5 years 1 month 7 days<span></span>
</td>
<td class="text">5 years 3 months 19 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">6 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</a></td>
<td class="text">4 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">6 years 2 months 13 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.70%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected Volatility</a></td>
<td class="nump">29.20%<span></span>
</td>
<td class="nump">22.20%<span></span>
</td>
<td class="nump">19.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">1.30%<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">1.20%<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected Volatility</a></td>
<td class="nump">29.80%<span></span>
</td>
<td class="nump">29.50%<span></span>
</td>
<td class="nump">21.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Forfeitures</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466603669992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating Lease, Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating Lease, Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 921<span></span>
</td>
<td class="nump">$ 865<span></span>
</td>
<td class="nump">$ 746<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Undrawn Letters Of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_SuretyBondsOutstanding', window );">Surety Bonds Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsDescription', window );">Other Commitments, Description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">In 2021, we entered into agreements to acquire multiple companies in the health care sector, most notably, Change Healthcare (NASDAQ: CHNG), subject to regulatory approval and other customary closing conditions.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitment', window );">Other Commitment</a></td>
<td class="nump">$ 12,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventDescription', window );">Subsequent Event, Description</a></td>
<td class="text">Additionally, in January 2022, we entered into agreements to acquire multiple companies in the health care sector, subject to regulatory approval and other customary closing conditions.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_SuretyBondsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Surety Bonds Outstanding</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_SuretyBondsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the nature and terms of commitment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes the event or transaction that occurred between the balance sheet date and the date the financial statements are issued or available to be issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466614176392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies Future Lease Payments (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 870<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">763<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">616<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">510<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="nump">407<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">1,716<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future minimum lease payments</a></td>
<td class="nump">4,882<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(609)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CommitmentsMember', window );">Commitments</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total</a></td>
<td class="nump">$ 4,273<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CommitmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_CommitmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466602616184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Financial Information (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of Reportable Segments</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers', window );">Disclosure on Geographic Areas Percentage of Revenue from External Customers</a></td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">96.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_DisclosureonGeographicAreasPercentageofLongLivedAssets', window );">Disclosure on Geographic Areas Percentage of Long Lived Assets</a></td>
<td class="nump">78.00%<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=unh_RevenuesMember', window );">Revenues [Member] | CMS [Member] | Revenue Benchmark</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">36.00%<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
<td class="nump">33.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_DisclosureonGeographicAreasPercentageofLongLivedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosures about long-lived assets (except financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets) that are (1) located in the entity's country of domicile, and (2) located in all foreign countries in which the entity holds assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_DisclosureonGeographicAreasPercentageofLongLivedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure about revenues from external customers (1) attributed to the entity's country of domicile and (2) attributed to all foreign countries in total from which the entity derives revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=unh_RevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=unh_RevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=unh_CMSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=unh_CMSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466598505240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Financial Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums, revenues - unaffiliated customers</a></td>
<td class="nump">$ 226,233<span></span>
</td>
<td class="nump">$ 201,478<span></span>
</td>
<td class="nump">$ 189,699<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment and other income</a></td>
<td class="nump">2,324<span></span>
</td>
<td class="nump">1,502<span></span>
</td>
<td class="nump">1,886<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">287,597<span></span>
</td>
<td class="nump">257,141<span></span>
</td>
<td class="nump">242,155<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Earnings from operations</a></td>
<td class="nump">23,970<span></span>
</td>
<td class="nump">22,405<span></span>
</td>
<td class="nump">19,685<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(1,660)<span></span>
</td>
<td class="num">(1,663)<span></span>
</td>
<td class="num">(1,704)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="nump">22,310<span></span>
</td>
<td class="nump">20,742<span></span>
</td>
<td class="nump">17,981<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">212,206<span></span>
</td>
<td class="nump">197,289<span></span>
</td>
<td class="nump">173,889<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, equipment and capitalized software</a></td>
<td class="nump">2,454<span></span>
</td>
<td class="nump">2,051<span></span>
</td>
<td class="nump">2,071<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">3,103<span></span>
</td>
<td class="nump">2,891<span></span>
</td>
<td class="nump">2,720<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services - unaffiliated customers</a></td>
<td class="nump">34,437<span></span>
</td>
<td class="nump">34,145<span></span>
</td>
<td class="nump">31,597<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services - unaffiliated customers</a></td>
<td class="nump">24,603<span></span>
</td>
<td class="nump">20,016<span></span>
</td>
<td class="nump">18,973<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=unh_TotalOptumMember', window );">Optum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment and other income</a></td>
<td class="nump">1,467<span></span>
</td>
<td class="nump">770<span></span>
</td>
<td class="nump">749<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">155,565<span></span>
</td>
<td class="nump">136,308<span></span>
</td>
<td class="nump">112,950<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Earnings from operations</a></td>
<td class="nump">11,995<span></span>
</td>
<td class="nump">10,046<span></span>
</td>
<td class="nump">9,359<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="nump">11,995<span></span>
</td>
<td class="nump">10,046<span></span>
</td>
<td class="nump">9,359<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">117,523<span></span>
</td>
<td class="nump">106,778<span></span>
</td>
<td class="nump">91,971<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, equipment and capitalized software</a></td>
<td class="nump">1,659<span></span>
</td>
<td class="nump">1,364<span></span>
</td>
<td class="nump">1,230<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">2,099<span></span>
</td>
<td class="nump">1,971<span></span>
</td>
<td class="nump">1,794<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=unh_ExternalCustomersMember', window );">Unaffiliated Customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums, revenues - unaffiliated customers</a></td>
<td class="nump">226,233<span></span>
</td>
<td class="nump">201,478<span></span>
</td>
<td class="nump">189,699<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">285,273<span></span>
</td>
<td class="nump">255,639<span></span>
</td>
<td class="nump">240,269<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=unh_ExternalCustomersMember', window );">Unaffiliated Customers | Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services - unaffiliated customers</a></td>
<td class="nump">34,437<span></span>
</td>
<td class="nump">34,145<span></span>
</td>
<td class="nump">31,597<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=unh_ExternalCustomersMember', window );">Unaffiliated Customers | Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services - unaffiliated customers</a></td>
<td class="nump">24,603<span></span>
</td>
<td class="nump">20,016<span></span>
</td>
<td class="nump">18,973<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=unh_ExternalCustomersMember', window );">Unaffiliated Customers | Optum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums, revenues - unaffiliated customers</a></td>
<td class="nump">13,852<span></span>
</td>
<td class="nump">9,799<span></span>
</td>
<td class="nump">5,916<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">63,231<span></span>
</td>
<td class="nump">55,496<span></span>
</td>
<td class="nump">47,564<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=unh_ExternalCustomersMember', window );">Unaffiliated Customers | Optum | Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services - unaffiliated customers</a></td>
<td class="nump">34,437<span></span>
</td>
<td class="nump">34,145<span></span>
</td>
<td class="nump">31,597<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=unh_ExternalCustomersMember', window );">Unaffiliated Customers | Optum | Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services - unaffiliated customers</a></td>
<td class="nump">14,942<span></span>
</td>
<td class="nump">11,552<span></span>
</td>
<td class="nump">10,051<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=unh_IntersegmentMember', window );">Affiliated Customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=unh_IntersegmentMember', window );">Affiliated Customers | Optum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">90,867<span></span>
</td>
<td class="nump">80,042<span></span>
</td>
<td class="nump">64,637<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | UnitedHealthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment and other income</a></td>
<td class="nump">857<span></span>
</td>
<td class="nump">732<span></span>
</td>
<td class="nump">1,137<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">222,899<span></span>
</td>
<td class="nump">200,875<span></span>
</td>
<td class="nump">193,842<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Earnings from operations</a></td>
<td class="nump">11,975<span></span>
</td>
<td class="nump">12,359<span></span>
</td>
<td class="nump">10,326<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="nump">11,975<span></span>
</td>
<td class="nump">12,359<span></span>
</td>
<td class="nump">10,326<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">102,967<span></span>
</td>
<td class="nump">98,229<span></span>
</td>
<td class="nump">88,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, equipment and capitalized software</a></td>
<td class="nump">795<span></span>
</td>
<td class="nump">687<span></span>
</td>
<td class="nump">841<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,004<span></span>
</td>
<td class="nump">920<span></span>
</td>
<td class="nump">926<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Optum Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment and other income</a></td>
<td class="nump">1,053<span></span>
</td>
<td class="nump">680<span></span>
</td>
<td class="nump">672<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">54,065<span></span>
</td>
<td class="nump">39,808<span></span>
</td>
<td class="nump">30,317<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Earnings from operations</a></td>
<td class="nump">4,462<span></span>
</td>
<td class="nump">3,434<span></span>
</td>
<td class="nump">2,963<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="nump">4,462<span></span>
</td>
<td class="nump">3,434<span></span>
</td>
<td class="nump">2,963<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">60,474<span></span>
</td>
<td class="nump">52,073<span></span>
</td>
<td class="nump">40,444<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, equipment and capitalized software</a></td>
<td class="nump">791<span></span>
</td>
<td class="nump">715<span></span>
</td>
<td class="nump">573<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">818<span></span>
</td>
<td class="nump">703<span></span>
</td>
<td class="nump">565<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Optum Insight</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment and other income</a></td>
<td class="nump">237<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">12,199<span></span>
</td>
<td class="nump">10,802<span></span>
</td>
<td class="nump">10,006<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Earnings from operations</a></td>
<td class="nump">3,398<span></span>
</td>
<td class="nump">2,725<span></span>
</td>
<td class="nump">2,494<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="nump">3,398<span></span>
</td>
<td class="nump">2,725<span></span>
</td>
<td class="nump">2,494<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">16,868<span></span>
</td>
<td class="nump">15,425<span></span>
</td>
<td class="nump">15,181<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, equipment and capitalized software</a></td>
<td class="nump">567<span></span>
</td>
<td class="nump">461<span></span>
</td>
<td class="nump">495<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">684<span></span>
</td>
<td class="nump">670<span></span>
</td>
<td class="nump">672<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Optum Rx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment and other income</a></td>
<td class="nump">177<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">91,314<span></span>
</td>
<td class="nump">87,498<span></span>
</td>
<td class="nump">74,288<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Earnings from operations</a></td>
<td class="nump">4,135<span></span>
</td>
<td class="nump">3,887<span></span>
</td>
<td class="nump">3,902<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="nump">4,135<span></span>
</td>
<td class="nump">3,887<span></span>
</td>
<td class="nump">3,902<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">40,181<span></span>
</td>
<td class="nump">39,280<span></span>
</td>
<td class="nump">36,346<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, equipment and capitalized software</a></td>
<td class="nump">301<span></span>
</td>
<td class="nump">188<span></span>
</td>
<td class="nump">162<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">597<span></span>
</td>
<td class="nump">598<span></span>
</td>
<td class="nump">557<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Unaffiliated Customers | UnitedHealthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums, revenues - unaffiliated customers</a></td>
<td class="nump">212,381<span></span>
</td>
<td class="nump">191,679<span></span>
</td>
<td class="nump">183,783<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">222,042<span></span>
</td>
<td class="nump">200,143<span></span>
</td>
<td class="nump">192,705<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Unaffiliated Customers | UnitedHealthcare | Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services - unaffiliated customers</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Unaffiliated Customers | UnitedHealthcare | Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services - unaffiliated customers</a></td>
<td class="nump">9,661<span></span>
</td>
<td class="nump">8,464<span></span>
</td>
<td class="nump">8,922<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Unaffiliated Customers | Optum Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums, revenues - unaffiliated customers</a></td>
<td class="nump">13,852<span></span>
</td>
<td class="nump">9,799<span></span>
</td>
<td class="nump">5,916<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">23,778<span></span>
</td>
<td class="nump">16,647<span></span>
</td>
<td class="nump">11,679<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Unaffiliated Customers | Optum Health | Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services - unaffiliated customers</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Unaffiliated Customers | Optum Health | Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services - unaffiliated customers</a></td>
<td class="nump">9,894<span></span>
</td>
<td class="nump">6,815<span></span>
</td>
<td class="nump">5,732<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Unaffiliated Customers | Optum Insight</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums, revenues - unaffiliated customers</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">4,095<span></span>
</td>
<td class="nump">3,822<span></span>
</td>
<td class="nump">3,746<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Unaffiliated Customers | Optum Insight | Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services - unaffiliated customers</a></td>
<td class="nump">159<span></span>
</td>
<td class="nump">135<span></span>
</td>
<td class="nump">116<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Unaffiliated Customers | Optum Insight | Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services - unaffiliated customers</a></td>
<td class="nump">3,936<span></span>
</td>
<td class="nump">3,687<span></span>
</td>
<td class="nump">3,630<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Unaffiliated Customers | Optum Rx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums, revenues - unaffiliated customers</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">35,358<span></span>
</td>
<td class="nump">35,027<span></span>
</td>
<td class="nump">32,139<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Unaffiliated Customers | Optum Rx | Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services - unaffiliated customers</a></td>
<td class="nump">34,246<span></span>
</td>
<td class="nump">33,977<span></span>
</td>
<td class="nump">31,450<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Unaffiliated Customers | Optum Rx | Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services - unaffiliated customers</a></td>
<td class="nump">1,112<span></span>
</td>
<td class="nump">1,050<span></span>
</td>
<td class="nump">689<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Affiliated Customers | UnitedHealthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Affiliated Customers | Optum Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">29,234<span></span>
</td>
<td class="nump">22,481<span></span>
</td>
<td class="nump">17,966<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Affiliated Customers | Optum Insight</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">7,867<span></span>
</td>
<td class="nump">6,941<span></span>
</td>
<td class="nump">6,239<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Affiliated Customers | Optum Rx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">55,779<span></span>
</td>
<td class="nump">52,420<span></span>
</td>
<td class="nump">42,093<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Optum Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment and other income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(2,013)<span></span>
</td>
<td class="num">(1,800)<span></span>
</td>
<td class="num">(1,661)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Earnings from operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, equipment and capitalized software</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Optum Eliminations | Unaffiliated Customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums, revenues - unaffiliated customers</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Optum Eliminations | Unaffiliated Customers | Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services - unaffiliated customers</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Optum Eliminations | Unaffiliated Customers | Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services - unaffiliated customers</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Optum Eliminations | Affiliated Customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(2,013)<span></span>
</td>
<td class="num">(1,800)<span></span>
</td>
<td class="num">(1,661)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate and Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment and other income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(90,867)<span></span>
</td>
<td class="num">(80,042)<span></span>
</td>
<td class="num">(64,637)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Earnings from operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(1,660)<span></span>
</td>
<td class="num">(1,663)<span></span>
</td>
<td class="num">(1,704)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="num">(1,660)<span></span>
</td>
<td class="num">(1,663)<span></span>
</td>
<td class="num">(1,704)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="num">(8,284)<span></span>
</td>
<td class="num">(7,718)<span></span>
</td>
<td class="num">(6,332)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, equipment and capitalized software</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate and Eliminations | Unaffiliated Customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums, revenues - unaffiliated customers</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate and Eliminations | Unaffiliated Customers | Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services - unaffiliated customers</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate and Eliminations | Unaffiliated Customers | Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services - unaffiliated customers</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate and Eliminations | Affiliated Customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">$ (90,867)<span></span>
</td>
<td class="num">$ (80,042)<span></span>
</td>
<td class="num">$ (64,637)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterestAndDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterestAndDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsEarnedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsEarnedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=unh_TotalOptumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=unh_TotalOptumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=unh_ExternalCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=unh_ExternalCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=unh_IntersegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=unh_IntersegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=unh_UnitedhealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=unh_UnitedhealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=unh_OptumhealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=unh_OptumhealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=unh_OptuminsightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=unh_OptuminsightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=unh_OptumrxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=unh_OptumrxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466602712120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule I (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Condensed Financial Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries', window );">Cash Dividends Paid to Parent, Consolidated Subsidiaries</a></td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="nump">$ 8,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Parent Company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Condensed Financial Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries', window );">Cash Dividends Paid to Parent, Consolidated Subsidiaries</a></td>
<td class="nump">10,800<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">$ 5,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromContributionsFromAffiliates', window );">Return of capital to parent company</a></td>
<td class="nump">245<span></span>
</td>
<td class="nump">943<span></span>
</td>
<td class="nump">$ 4,497<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">8,100<span></span>
</td>
<td class="nump">4,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember', window );">Subsidiaries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Condensed Financial Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLongTermDebt', window );">Other Long-term Debt</a></td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialStatementsCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialStatementsCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents disclosure of the aggregate cash dividends paid to the entity by consolidated subsidiaries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromContributionsFromAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from an entity that is affiliated with the entity by means of direct or indirect ownership.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromContributionsFromAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466598544056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule I Condensed Balance Sheets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 21,375<span></span>
</td>
<td class="nump">$ 16,921<span></span>
</td>
<td class="nump">$ 10,985<span></span>
</td>
<td class="nump">$ 10,866<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">61,758<span></span>
</td>
<td class="nump">53,718<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">12,526<span></span>
</td>
<td class="nump">11,510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">212,206<span></span>
</td>
<td class="nump">197,289<span></span>
</td>
<td class="nump">173,889<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">24,643<span></span>
</td>
<td class="nump">22,495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Short-term borrowings and current maturities of long-term debt</a></td>
<td class="nump">3,620<span></span>
</td>
<td class="nump">4,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">78,292<span></span>
</td>
<td class="nump">72,420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, less current maturities</a></td>
<td class="nump">42,383<span></span>
</td>
<td class="nump">38,648<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">11,787<span></span>
</td>
<td class="nump">12,315<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">135,727<span></span>
</td>
<td class="nump">126,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 4)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_ShareholdersEquityAbstract', window );"><strong>Shareholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value - 3,000 shares authorized; 941 and 946 issued and outstanding</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">77,134<span></span>
</td>
<td class="nump">69,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(5,384)<span></span>
</td>
<td class="num">(3,814)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">212,206<span></span>
</td>
<td class="nump">197,289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Parent Company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">2,167<span></span>
</td>
<td class="nump">258<span></span>
</td>
<td class="nump">$ 46<span></span>
</td>
<td class="nump">$ 434<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">503<span></span>
</td>
<td class="nump">562<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">2,670<span></span>
</td>
<td class="nump">820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_EquityinNetAssetsofSubsidiaries', window );">Equity in net assets of subsidiaries</a></td>
<td class="nump">116,907<span></span>
</td>
<td class="nump">107,714<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableRelatedPartiesNoncurrent', window );">Long-term notes receivable from subsidiaries</a></td>
<td class="nump">5,680<span></span>
</td>
<td class="nump">5,021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">125,289<span></span>
</td>
<td class="nump">113,897<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">605<span></span>
</td>
<td class="nump">589<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent', window );">Current portion of notes payable to subsidiaries</a></td>
<td class="nump">8,105<span></span>
</td>
<td class="nump">4,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Short-term borrowings and current maturities of long-term debt</a></td>
<td class="nump">3,009<span></span>
</td>
<td class="nump">4,465<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">11,719<span></span>
</td>
<td class="nump">9,936<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, less current maturities</a></td>
<td class="nump">41,623<span></span>
</td>
<td class="nump">37,815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">187<span></span>
</td>
<td class="nump">655<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">53,529<span></span>
</td>
<td class="nump">48,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_ShareholdersEquityAbstract', window );"><strong>Shareholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value - 3,000 shares authorized; 941 and 946 issued and outstanding</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">77,134<span></span>
</td>
<td class="nump">69,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(5,384)<span></span>
</td>
<td class="num">(3,814)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total UnitedHealth Group shareholders&#8217; equity</a></td>
<td class="nump">71,760<span></span>
</td>
<td class="nump">65,491<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">$ 125,289<span></span>
</td>
<td class="nump">$ 113,897<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_EquityinNetAssetsofSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity in Net Assets of Subsidiaries</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_EquityinNetAssetsofSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_ShareholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Shareholders' Equity [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_ShareholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableRelatedPartiesClassifiedCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableRelatedPartiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amounts due from parties associated with the reporting entity as evidenced by a written promise to pay, due after 1 year (or 1 business cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableRelatedPartiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466614577576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule I Balance Sheet Document (Details) - $ / shares<br> shares in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">941<span></span>
</td>
<td class="nump">946<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, shares outstanding</a></td>
<td class="nump">941<span></span>
</td>
<td class="nump">946<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Parent Company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">941<span></span>
</td>
<td class="nump">946<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, shares outstanding</a></td>
<td class="nump">941<span></span>
</td>
<td class="nump">946<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466614327160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule I Condensed Statement of Comprehensive Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment and other income</a></td>
<td class="nump">$ 2,324<span></span>
</td>
<td class="nump">$ 1,502<span></span>
</td>
<td class="nump">$ 1,886<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">287,597<span></span>
</td>
<td class="nump">257,141<span></span>
</td>
<td class="nump">242,155<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Operating costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">1,660<span></span>
</td>
<td class="nump">1,663<span></span>
</td>
<td class="nump">1,704<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating costs</a></td>
<td class="nump">263,627<span></span>
</td>
<td class="nump">234,736<span></span>
</td>
<td class="nump">222,470<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Benefit for income taxes</a></td>
<td class="nump">4,578<span></span>
</td>
<td class="nump">4,973<span></span>
</td>
<td class="nump">3,742<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">17,285<span></span>
</td>
<td class="nump">15,403<span></span>
</td>
<td class="nump">13,839<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(1,570)<span></span>
</td>
<td class="num">(236)<span></span>
</td>
<td class="nump">582<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">15,715<span></span>
</td>
<td class="nump">15,167<span></span>
</td>
<td class="nump">14,421<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Parent Company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment and other income</a></td>
<td class="nump">494<span></span>
</td>
<td class="nump">194<span></span>
</td>
<td class="nump">209<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">494<span></span>
</td>
<td class="nump">194<span></span>
</td>
<td class="nump">209<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Operating costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating costs</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">1,583<span></span>
</td>
<td class="nump">1,594<span></span>
</td>
<td class="nump">1,580<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating costs</a></td>
<td class="nump">1,623<span></span>
</td>
<td class="nump">1,621<span></span>
</td>
<td class="nump">1,618<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Loss before income taxes</a></td>
<td class="num">(1,129)<span></span>
</td>
<td class="num">(1,427)<span></span>
</td>
<td class="num">(1,409)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Benefit for income taxes</a></td>
<td class="nump">231<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="nump">293<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_LossofParentCompany', window );">Loss of parent company</a></td>
<td class="num">(898)<span></span>
</td>
<td class="num">(1,127)<span></span>
</td>
<td class="num">(1,116)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions', window );">Equity in undistributed income of subsidiaries</a></td>
<td class="nump">18,183<span></span>
</td>
<td class="nump">16,530<span></span>
</td>
<td class="nump">14,955<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">17,285<span></span>
</td>
<td class="nump">15,403<span></span>
</td>
<td class="nump">13,839<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(1,570)<span></span>
</td>
<td class="num">(236)<span></span>
</td>
<td class="nump">582<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">$ 15,715<span></span>
</td>
<td class="nump">$ 15,167<span></span>
</td>
<td class="nump">$ 14,421<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_LossofParentCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss of Parent Company</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_LossofParentCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterestAndDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterestAndDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466603470616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule I Statement of Cash Flows (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Cash flows from operating activities</a></td>
<td class="nump">$ 22,343<span></span>
</td>
<td class="nump">$ 22,174<span></span>
</td>
<td class="nump">$ 18,463<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid for acquisitions</a></td>
<td class="num">(4,821)<span></span>
</td>
<td class="num">(7,139)<span></span>
</td>
<td class="num">(8,343)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other, net</a></td>
<td class="nump">1,254<span></span>
</td>
<td class="nump">506<span></span>
</td>
<td class="num">(219)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Cash flows used for investing activities</a></td>
<td class="num">(10,372)<span></span>
</td>
<td class="num">(12,532)<span></span>
</td>
<td class="num">(12,699)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Common stock repurchases</a></td>
<td class="num">(5,000)<span></span>
</td>
<td class="num">(4,250)<span></span>
</td>
<td class="num">(5,500)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from common stock issuances</a></td>
<td class="nump">1,355<span></span>
</td>
<td class="nump">1,440<span></span>
</td>
<td class="nump">1,037<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfCommercialPaper', window );">(Repayments of) proceeds from commercial paper, net</a></td>
<td class="num">(1,302)<span></span>
</td>
<td class="nump">872<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of long-term debt</a></td>
<td class="nump">6,933<span></span>
</td>
<td class="nump">4,864<span></span>
</td>
<td class="nump">5,444<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="num">(3,150)<span></span>
</td>
<td class="num">(3,150)<span></span>
</td>
<td class="num">(1,750)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other, net</a></td>
<td class="num">(295)<span></span>
</td>
<td class="num">(459)<span></span>
</td>
<td class="num">(619)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Cash flows used for financing activities</a></td>
<td class="num">(7,455)<span></span>
</td>
<td class="num">(3,590)<span></span>
</td>
<td class="num">(5,625)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="nump">16,921<span></span>
</td>
<td class="nump">10,985<span></span>
</td>
<td class="nump">10,866<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents, end of period</a></td>
<td class="nump">21,375<span></span>
</td>
<td class="nump">16,921<span></span>
</td>
<td class="nump">10,985<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">1,653<span></span>
</td>
<td class="nump">1,704<span></span>
</td>
<td class="nump">1,627<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes</a></td>
<td class="nump">3,966<span></span>
</td>
<td class="nump">4,935<span></span>
</td>
<td class="nump">3,542<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Parent Company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Cash flows from operating activities</a></td>
<td class="nump">11,439<span></span>
</td>
<td class="nump">8,842<span></span>
</td>
<td class="nump">9,275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToFundLongtermLoansToRelatedParties', window );">Issuances of notes to subsidiaries</a></td>
<td class="num">(444)<span></span>
</td>
<td class="num">(628)<span></span>
</td>
<td class="num">(2,722)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties', window );">Repayments of notes to subsidiaries</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">1,089<span></span>
</td>
<td class="nump">2,249<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid for acquisitions</a></td>
<td class="num">(4,953)<span></span>
</td>
<td class="num">(7,706)<span></span>
</td>
<td class="num">(9,645)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromContributionsFromAffiliates', window );">Return of capital to parent company</a></td>
<td class="nump">245<span></span>
</td>
<td class="nump">943<span></span>
</td>
<td class="nump">4,497<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_unh_Capitalcontributionstosubsidiaries', window );">Capital contributions to subsidiaries</a></td>
<td class="num">(747)<span></span>
</td>
<td class="num">(43)<span></span>
</td>
<td class="num">(803)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">143<span></span>
</td>
<td class="nump">490<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Cash flows used for investing activities</a></td>
<td class="num">(5,862)<span></span>
</td>
<td class="num">(6,202)<span></span>
</td>
<td class="num">(5,934)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Common stock repurchases</a></td>
<td class="num">(5,000)<span></span>
</td>
<td class="num">(4,250)<span></span>
</td>
<td class="num">(5,500)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from common stock issuances</a></td>
<td class="nump">1,355<span></span>
</td>
<td class="nump">1,440<span></span>
</td>
<td class="nump">1,037<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Cash dividends paid</a></td>
<td class="num">(5,280)<span></span>
</td>
<td class="num">(4,584)<span></span>
</td>
<td class="num">(3,932)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfCommercialPaper', window );">(Repayments of) proceeds from commercial paper, net</a></td>
<td class="num">(1,302)<span></span>
</td>
<td class="nump">872<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of long-term debt</a></td>
<td class="nump">6,933<span></span>
</td>
<td class="nump">4,864<span></span>
</td>
<td class="nump">5,444<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="num">(3,150)<span></span>
</td>
<td class="num">(3,150)<span></span>
</td>
<td class="num">(1,750)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt', window );">Proceeds from notes from subsidiary</a></td>
<td class="nump">3,223<span></span>
</td>
<td class="nump">2,818<span></span>
</td>
<td class="nump">1,207<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other, net</a></td>
<td class="num">(447)<span></span>
</td>
<td class="num">(438)<span></span>
</td>
<td class="num">(535)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Cash flows used for financing activities</a></td>
<td class="num">(3,668)<span></span>
</td>
<td class="num">(2,428)<span></span>
</td>
<td class="num">(3,729)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Increase (decrease) in cash and cash equivalents</a></td>
<td class="nump">1,909<span></span>
</td>
<td class="nump">212<span></span>
</td>
<td class="num">(388)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="nump">258<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="nump">434<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents, end of period</a></td>
<td class="nump">2,167<span></span>
</td>
<td class="nump">258<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">1,575<span></span>
</td>
<td class="nump">1,633<span></span>
</td>
<td class="nump">1,506<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes</a></td>
<td class="nump">$ 3,050<span></span>
</td>
<td class="nump">$ 4,185<span></span>
</td>
<td class="nump">$ 2,590<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_unh_Capitalcontributionstosubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Capital contributions to subsidiaries</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">unh_Capitalcontributionstosubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>unh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToFundLongtermLoansToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with extending a long-term loan to a related party. Alternate caption: Payments for Advances to Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToFundLongtermLoansToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with collection, whether partial or full, of long-term loans to a related party. Alternate caption: Proceeds from Advances to Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromContributionsFromAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from an entity that is affiliated with the entity by means of direct or indirect ownership.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromContributionsFromAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or cash outflow from issuing (borrowing) and repaying commercial paper.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3098-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140466603466760">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule I Maturities of Short-Term Borrowings and Long-Term Debt (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 3,626<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2023</a></td>
<td class="nump">2,277<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2024</a></td>
<td class="nump">2,652<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2025</a></td>
<td class="nump">2,452<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2026</a></td>
<td class="nump">2,652<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">32,829<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Parent Company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2022</a></td>
<td class="nump">3,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2023</a></td>
<td class="nump">2,125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2024</a></td>
<td class="nump">2,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2025</a></td>
<td class="nump">2,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2026</a></td>
<td class="nump">2,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">$ 32,677<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>unh-20211231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:unh="http://www.uhc.com/20211231"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="unh-20211231.xsd" xlink:type="simple"/>
    <context id="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8eb94eb0b4484ca996ca09b316c723b4_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i884d1b7f798047438f1fdf140f8c5b0c_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="ia9973178a1474e659ee68ed2ce06eb70_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8980da815bc14d658ecbcb83b1249903_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i22e79815a5ab4c57ac20424b76b26acf_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i87aa1e3370624fd2bcbec006cd442de0_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0f930a7c88bf48e19ee77868a67beb2c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iebfb5141726d4790b2d5d6623285f2f3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icb730d55174e422ba5041871ed73019a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i93c9b8bdda4a422883687239d22ec90b_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i7de78e50178f4dd78f67556f70d9e637_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i8eae67f0f11a4c898fa1dedd55840500_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i315e24e23ae44a01836f60086f1fd315_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ie5ac330194c449fd8d7d91f71917f488_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i3bca26759d4145299e751f4f22f5f1fd_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i870730cd9dfc45bb89971499ab4cdd48_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i509cd57b44304b8fb05235033e28b2bf_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i28a6344b404a41c18ed41602af107cc3_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i1c99cfb64bc04618a8af89c6e3780c50_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i93754eb2a7814682a663dc4a8233c401_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie2ffd7130e2647e2b0e793e2a0f526a3_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i930490d923ac4f958c17a0c16169ecfd_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i01af9c575b984fbb810a65816e8f5c90_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4ac3cd6c11db4467b4b8b2a362706d03_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1f76f41fc9da46f2a0884ca2b30659d4_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ieebefefe33444454986842a74b0799e9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i070f515f1b0a4ce9b417c2adcffa3bc0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i79b55573683d48f8b6dfa7e39455622e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5ca981dc06144e079639ca1af5c729c7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia27e856d3af841b3a28c74b0c8109477_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9d57e9b440f94b42ade5424c81274932_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i530caf840d4847f1ac553be5f7b336b2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9c49e5bd973a474d93bece3aedf4801f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2fbd0b79127d43b29830dc7504fbbbd4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4f099b39a9db4d7e8c625a6989f76ace_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3300d5a2eaaa4e0386e185cd95eae562_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0378ff590db1498e8fec3c3e08138eb1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i79edb1e59c054995bf5b8fe22cb060d1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i072d7c898f4243b8a611602a0b370dfd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2c34096fce714d0c84c9883d2dbaae66_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5cc85a29e8934045a37d5be367d3db92_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ied02258caa3547f1ac9db1ebac75e7b5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia1d7badbbfe74d128af9048d86a399ee_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7634c8268a7641f091bbd4593b6b3229_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2af08b82a1804b45b92fd387d2d6ebc7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i78db576697a6474084de5301358e552a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i54c9ed4fe57143d089532919ce622309_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0c38985e71104ebf84a399c4c16d84b9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2f46a298bc1a4e6da1439ecf4feef723_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8a8e9219ee4b4394808f55b5e8635651_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icd650c47786d472789666a390d70daa2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i205c8dfff92c4b7b93596e6594ee9ef4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i593bf0b079e04f058cf0f21f5585b069_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic04e77b5e9904fcc9c97df541ef3f22a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6cb7b25ac2db413db39f0363a9eed1e3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i275d8d15f1794b78972e85e3f1725cd4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4e144bfae9ce400699c59ff4175549af_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic7a74722ffca455e8f8b9d9120092a96_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie667c3a41af649e28b76eb6f34ded8a2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">unh:EmployeeStockPurchasePlanESPPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3cc841fcdfd546358ed335a1f5de7e7e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">unh:ProductsandservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6f67f540a2f34e649bdb094c7c1cf41d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">unh:ProductsandservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifafacde0705d4f258c784fe3cb74d22f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i46bb0d0f79554481a30ef5011a4f84b3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="unh:PharmaceuticalmanufacturerrebatesreceivableAxis">unh:PharmaceuticalManufacturerRebatesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id24643699baf4fca9b1c7b6874e25228_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="unh:PharmaceuticalmanufacturerrebatesreceivableAxis">unh:PharmaceuticalManufacturerRebatesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9e70f543d656432ab29e3070fc195a80_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="unh:MedicarePartDPharmacyBenefitsContractAxis">unh:MedicarePartDReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic913811c9e844fe4af3ff284c1deabc6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="unh:MedicarePartDPharmacyBenefitsContractAxis">unh:MedicarePartDReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia1ff1cf727f44188aa9fc2cdae7f314c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">unh:UsefulLifeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8384e266805d4927b90e345df1e3f524_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i87b309e50f2a486dadbe07f2c0015862_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i122210b356e34cd393cb6d0422f9ff20_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3c578a943465456dbb16da796df70705_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic338e78c17b54bdd9e1a900148c7981c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">unh:CapitalizedsoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iff76c7d81e324fd3855a24b45c0f6feb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">unh:CapitalizedsoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iea339ff4f3c94a45a63d0fe4f74ba6f4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie60f9bda7240423e99aefddba5815436_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib55d7c02a76f495eadd39abf177a36b9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">unh:RedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifb906a7e10bf4c67a37f412d39862ee2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">unh:RedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i91c331befb394cb6b31c1d43cedab05f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">unh:RedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9d71c28a51a741d4b83d1e2cb290100d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">unh:RedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib7962e972c7344539b9b1d82ad79a7df_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">unh:RedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0cf2e2ded57848acbd7f4ce7b8849c5d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4d96f9ce242e4c3d8115ee3621f39cbe_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">unh:StockOptionsandSARsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if5bcfc870d824827bb66dd636d076fd1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i24678048e47943bb91d8def4d5f22212_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i60063fc646f547e0ac686bc7d0b92112_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if5a1b74f16184b9bb2add4cab25e29f2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2b784ace82c244c5867ac2f828eb7a57_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2a312b80055e4af7bc076c9e6f9c43e6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibe8be8f0fb534e25be1cc040ead9f99f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib130b8ba2819452594b22d15469baacb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1ec806aa176a4bbb99266b4a32cf1ded_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ieda9939b5a6c4fdeb0d28e0580ab8d78_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibb56bbdb5bca464cb867242d3ed1b377_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9b1ef8f174f64af8b548c0044b97ecb5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifc7213ff01b448239792e43a61300d38_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia1b66727575a4e678ac30b674426f585_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib817a90dc86742a28badd4c87a39b501_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iba871229a901424484cc7c291cbe9f0e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5dd5e25d23aa4a7fa951ebebaba203a1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6eeef3734fae442a8264a01cb7372550_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5bea540206e64b51b2cbf141a4999d50_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4f98b30125864fdca705b2901d65b24b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4ba7717a6c87435994ca841d4dafcd86_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i786c6b4857764efd94186e77e3b6f938_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8922e827b09149b5b48d5d53a1d3064f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i40294d1cde8d40b497abb9effe028d71_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic74a5a57b68545f68727915480210bea_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icbc6b84573cd460bb185c06c93cab313_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ide094d54765b442b88523b9454527fbd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idfc2226cf4444ab1a84562eb064b98c2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2ac0596304be4b85b623b402780f1b8d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6a09033b49c14106baa0f691507e4246_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib4b3aa9a235e41d0be50be982749d992_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i63ceb3ccbcf14457b98cb6eef7d4b50f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifd8f7f5f7a214e6c9819ee8745d58190_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8d22c5f5de67464fa6cda436b26c58dc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia2e7820a9e9b45a3ace8daf2bf6b3576_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i143f48c7749c46eaa1530838b78b041b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8da1637a90d94f7d8cbbb9e89200393e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7a84715d70a74fceaa59165cb7cfb450_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iacd4e95ed0ff45e8b463cde8fb162e36_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id1274175ecdc4c66979e1169bb16b496_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i348ad0bbc326423b98599f12852d34af_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i35f826dbcf4d42b4be8664b7331fb199_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic303a9fd1e74453b8a529be93a4f56bf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia0ea67d91b6d434599e098210b7a488c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i073d903c845f4731bd55974d4b29f4b6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icf644ee782e74842af3129b8232dcaed_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaf26e2e8c57f4e7a89bfb1c2baf068a5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic45c1b0462fc4790975a0e25b80a5726_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i14c36d9932b54db0b6a4f835644eb0aa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i68adcae3162f47ae8c5f0bb4ef470545_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i09e58021d29540878f244a567f9a5ced_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4bfd62c299df4d94bbf76c712ccec550_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie3d58ed074c84089913ffdffc57c1d73_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibd5d40328bb047cb90c2611b44a7f743_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if9032d6bd2554be797457d71b15c021a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if59af989581341269c0f798a7a8a56ff_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i72edef7745bb4e80901cf10381b12375_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6e1d0ee68a90487188c597f675ea6962_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie134d5521b5441d7a99c70ae3d64e701_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2205792a33d644b0a632f4d4f33237f4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5545c49f50ec48edb1474b999af271fc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iff86380602ce4f588a2f94a05eaab292_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iae7403f6fc564452803f560b78d46801_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iadc9e4cd75f14dd7a16f6026ec702279_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i69b798301dcb496d99d84a6592b8549b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic505ff42be0a4bcb9d166dd3d36bcef1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9c5e5fa052504d4cb045b94a02d5a58f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0e9f6e4d1d1345d5807de27d47ac5f59_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie4b8d6e218734867ad53588492384845_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i79898441c75b41d5ac9f1f9da1f4e5d9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i85d7067f865b4342b9d8d877f735ac59_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8f2864e94d7849f79bce61f0d550474d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7a1b38442cb3432c99552784de780fe5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i69a743b9a5d84ecd862ffaa1626c672b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie9004c5f31284db6a840b518fa6c4f58_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iedbc8a127a984a2b9f57050fc010853d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i552ab3ba177642ab8b64fa5712f45dd8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iebe8572afa0a4d7da446aa8d4ab62eb8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib78936422dda4cf88cb3cbc4dd220121_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic0a9e47794c54540ad3d61b206a2a5cf_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i80e3cb189ce045d08f4e6301ab039bfe_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9dcd135114fe40ad9bbefb48db0ba475_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8ddeff676a684e46b6072017bc1e9416_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i26d61444d51b4f20823b0b809247d33c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iafa155f646d841c8b93f03aacf967154_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id05f41ba34f2466392338fadddf9dd1d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia9739896064149b98b26a61eeaa6550f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i61c10c93e0f54b55a26f3573ba827569_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib0bdaeb0614d4e2c9380f7415853f763_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibf94dc7fd3204a588aba8704a0d1a90a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia3183b05d67943c3b4034e58b9be0447_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i13c92c68c2ea480ea5701676b9b826f9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i202cb135dc1e4e3daca6dd5059f0cf19_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9d5fa92bbec547a085cba2fb930f6bc6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i85448c57b2cc45b2ab8f29ae7d7c6a2a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if966e9f805794457af9a0eed34e96495_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibb823f0ecf2f4061a477b16abf75cdc2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">unh:TrademarksandTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6ec08aacf770472c93dbac44374b8a68_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">unh:TrademarksandTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3203585470194543898607ba99a6eec0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ica15e60f135045e5b3209b00ecdc8ec6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3ef9cd7ab1654b62b1ab409dcb38f85f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6f34678550484e8eaa1d6f032590a9cd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i72998cdf5b13475480213110198dde60_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2ecd4e0cb3384d4c8ddd20890ad9e997_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1ded218b083944e188cd4579765a2a84_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">unh:TrademarksandTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2b4f1188393845f8827897acb0c3916c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">unh:TrademarksandTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iaa52ad981c7743b1818a805ee0a0b5fe_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7a251ae641a244f982ee84dc33f39c98_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7e7bca7f64a8424489d83e9c4b27fbba_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if47ca87b4cab4485a2e7830a82f298c2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1db8094151d340e583b4cbe1a3165397_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i86f3f2448f524de3913d85ac9788450f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i379ecb26e0e846348f402effa72a9eb2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8cb0c74d57b1477fa31da545e505e6d8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.700notesdueFebruary2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic5c8f497804347fc9f0f8a62f4499752_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.700notesdueFebruary2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibd92e268e96f4727813026fb9f3f2f8f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.125notesdueMarch2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4248de2739cf40dca665ae10381e03b2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.125notesdueMarch2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifb03d5528d1145cfb99fcf592801d116_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:FloatingratenotesdueJune2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i63fb7f8ae0fd40038163eafaa15d201d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:FloatingratenotesdueJune2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie6c00455b2e34b31b4063ebbf2107d3a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.150notesdueJune2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i76cb2d4454a64645abe47553a65a92de_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.150notesdueJune2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id372eeef8e344178a1dbfa89af46c45e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.375notesdueNovember2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2ba481f8e0d74c10bc0588b4835f8af5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.375notesdueNovember2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib8da81de7fee4af4be76cb170e34ee08_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2875NotesDueDecember2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i096ea40c3d4c42ba8a127cef33efd254_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2875NotesDueDecember2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8172aeed31f44528a74a1c8dbfd1ca1a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.875notesdueMarch2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i84e7e1ef880e481483e8d4914556cf84_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.875notesdueMarch2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7e3cddf201a14b228f50c7a4b6a5839e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3350NotesDueJuly2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7c80b9e731e44c0697a1b7a31a23bf17_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3350NotesDueJuly2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i93168a5ed89f448f8f66c9c0a2283b35_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.375notesdueOctober2022MemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i92d32861403b4fa0bc059b43eb0e9edf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.375notesdueOctober2022MemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i84b80aaa2de74ba09b15b98ebeeb295d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:ZeroCouponNotesDueNovember2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifdb4994c14104e3ebccd784f009aa1ae_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:ZeroCouponNotesDueNovember2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7548e5a838a4421695679910bd4f2c0a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2750NotesDueFebruary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib120d5bbaa93472eb64fb119097cdf6f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2750NotesDueFebruary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i597c8e442da543bf8a7372bc0ec54f9d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2875NotesDueMarch2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie880ffc901ab4104b4cfd303f4831b1f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2875NotesDueMarch2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iedb8d09cef364b1293599d28f7c67748_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.500notesdueJune2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia859c1517f2441d58ef162b5ff01d64c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.500notesdueJune2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i886286b365bb4971a2f13e2f846af74a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.500notesdueFebruary2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i07e2a1c9ec8442cea51615552b249524_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.500notesdueFebruary2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if18a2f7f6b0b40f1ad62bd0e830e8b8f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A0550NotesDueMay2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i30c9ff85e8394406aa2fcf8c8e0dbf28_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A0550NotesDueMay2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic1ec0d84eddf49dc97d2a21dd8cee234_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.375notesdueAugust2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idb4e09db805a48c9a9980ed388f9d691_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.375notesdueAugust2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i315d80ec5a9b4d33b1d8d34a78cae609_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.750notesdueJuly2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iba6f227255b343d1ac18d3836772b9ad_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.750notesdueJuly2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i786f913ccf164a438f57c04ee49ad2b7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.700notesdueDecember2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1bde9da88b2241dc9f725c1d621be4d6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.700notesdueDecember2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1a3471e5bd4648d0aa81686260fbc921_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A1250NotesDueJanuary2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7deed358f93647928f915f8ee952b69f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A1250NotesDueJanuary2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id8044edfa2384079929b35102a9b7cad_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.100notesdueMarch2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1344e7e2b6414a7890e692110596b117_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.100notesdueMarch2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iec7c13902a5a4ee19961a3eed138f023_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A1150NotesDueMay2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if2c36e71284047c4a3930eb5b853ea20_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A1150NotesDueMay2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6f817c64d72746f4a7600550a38be49c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.450notesdueJanuary2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie3f75705b4c54f55b71495dc9a78510d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.450notesdueJanuary2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icae9b0e4795648ce9e80f348899da659_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.375notesdueApril2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0e4451b5d59c467f9a4e28097256ff50_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.375notesdueApril2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i31ec009da13047b6b79197c66fda5b6f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.950notesdueOctober2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icae10e63208f4e10877dfc05154784ab_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.950notesdueOctober2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i85149ce8b76548558e9c825e775cee26_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.850notesdueJune2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iff612dcf0de24f99834b8502366648da_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.850notesdueJune2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia7cb4d01a77147bea64135beacd75967_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.875notesdueDecember2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibab3629772cb483797b33dd7cac92661_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.875notesdueDecember2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i89ffd37b253a491e85cd53a3418e5384_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.875notesdueAugust2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i70db3b468bcd459e93e65ee79271966b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2.875notesdueAugust2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i792128c572ef443698af3751346cf9ff_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2000NotesDueMay2030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibd61ed081c424fe89d2e0c20559932f2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2000NotesDueMay2030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib9a4bd31faa04ee1b247e1f86a34f265_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2300NotesDueMay2031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i01f8d0ea95854e9da64e602eecf75925_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2300NotesDueMay2031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic45826f8bd334acd9a357972ff7747c0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.625notesdueJuly2035Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1594b131d7cc4f158302396c98e0ebd8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.625notesdueJuly2035Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibe281588c47246929092124b77f5b494_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5.800notesdueMarch2036Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4474b87a11cf47a0bf686a80b83dcb59_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5.800notesdueMarch2036Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i042493d5f213402dbb064b91d1c75e28_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A6500NotesDueJune2037Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0c1062a7e2f149f5badaba59158717fd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A6500NotesDueJune2037Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5ac1e2d38c684f80a23cf559e9f5ff07_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A6625NotesDueNovember2037Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia5db4929602c4ffd9189617d404f73d2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A6625NotesDueNovember2037Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5bb559f948de43229cd7e5cae903c0c3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A6.875notesdueFebruary2038Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie12a20b3450a4ef28232fc38f2583a41_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A6.875notesdueFebruary2038Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iada0e5e85dc241e48cf116319f7a75c6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.500notesdueAugust2039Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5a8fbc7bad4d46d98e6ee62b8a2075c8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.500notesdueAugust2039Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6019aef8fb074093b331027b9c2adb61_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2750NotesDueMay2040Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6ce09d75289f41078948230ae4e2acf1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2750NotesDueMay2040Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iba9a7a93d2b645cea2c51c984287da3f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5.700notesdueOctober2040Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ife79ad90a728499a81be122ba5a2043f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5.700notesdueOctober2040Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib4f641b3624849f2adeb7cd37bcab7ca_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5.950notesdueFebruary2041Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7a3553569a45473daba65988c3a74356_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A5.950notesdueFebruary2041Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib3668395d3b640cf8ba0bda86da26e60_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3050NotesDueMay2041Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9de83ae9a2be49cca2565c7797dfdb8a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3050NotesDueMay2041Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5c821b276174476b9517c3bbb9157232_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.625notesdueNovember2041Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4a4bb23357c64364aa0ece690aa5ec74_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.625notesdueNovember2041Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3057e59415b14c1fbbc0e75f70f19a41_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.375notesdueMarch2042Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6e8e99b43b324defa304dd9967162f65_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.375notesdueMarch2042Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ica9c4076825647eaad198c486084ebb6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3950NotesDueOctober2042Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1f1727e520ff46c0bfcd3cb930e2e50d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3950NotesDueOctober2042Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8aa1ed6f3b9547d785049322c036163a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4250NotesDueMarch2043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i44ad24710d1a4e13bd0afb488b206cfa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4250NotesDueMarch2043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idd43a6fb78154c23ac9111d56d6fc58a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.750notesdueJuly2045Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i50006b1b20aa424bbbcfb16934763e3e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.750notesdueJuly2045Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i37706a7a25134a80b7681dbe80d0a08f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.200notesdueJanuary2047Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ied6c1c554b9b4094a5e58395009e98e3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.200notesdueJanuary2047Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6a47e7cab2b747b19f8ad6dd5577eb65_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.250notesdueApril2047Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9cfc628d12b54f618f9ea7acd8dae9c6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.250notesdueApril2047Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i980dd94826d240d68ca80fc74c96e9c1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.750notesdueOctober2047Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i91851bb701054679b7700165881a5c2e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.750notesdueOctober2047Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie56f8e65458741cba5353670ff8dce7e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.250notesdueJune2048Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib9a9dbbc743449a2bc095746eaf4f94d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.250notesdueJune2048Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i076316df7acd4f5f97a07a2468548d05_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.450notesdueDecember2048Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i81143b21d99c4e8da9cc8f4dba61ce25_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A4.450notesdueDecember2048Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5dc454ca8f924d03b29dd33f0388905d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.700notesdueAugust2049Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9cbf53962caa43fba596a6987b79829b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.700notesdueAugust2049Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i43a9150b986245ea926eba8cf8dd88c4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2900NotesDueMay2050Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i66c9a6ec6acf4ae18dde8b5ddd77ada8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A2900NotesDueMay2050Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id7d2521c88c843bbab7e44fbe1b07950_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3250NotesDueMay2051Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i87de305d4b6d41f69ebc5ea26f269dd9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3250NotesDueMay2051Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if6fda2fd6f8d48768196072f7bb18858_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.875notesdueAugust2059Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4bbff1e3c5384def9f3f958af9c4560e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3.875notesdueAugust2059Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3d6a2a39f8a84b30913e25aac3e3a548_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3125NotesDueMay2060Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie20afa3af1a64c6f892497e7a1ac5f08_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">unh:A3125NotesDueMay2060Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i48f8f3c144a149269121679c024b2bfa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7e1bde434ad049b7a20e4a7cd97ed39d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0561a17f67884087afe8d954a4e80ace_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="unh:CreditFacilityNameAxis">unh:FiveYear56BillionCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia6ef4bc76d4e41ef824e2e1bc29be3e8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="unh:CreditFacilityNameAxis">unh:ThreeYear56BillionCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3bbc78e491bd48b2bdc3d2454d729af8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="unh:CreditFacilityNameAxis">unh:A364Day38BillionCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i601523d6552745a68902337be3e9c7fd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3f5ffdfb69764138906dbd2bf76bb89e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9bd8ec4f14f94dc98096c091b92e4751_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="unh:CreditFacilityNameAxis">unh:FiveYear56BillionCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0ef9be25372d4e00bd34d251579f4577_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="unh:CreditFacilityNameAxis">unh:ThreeYear56BillionCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i26faa7bce6f44c1ba49361994ef7383d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="unh:CreditFacilityNameAxis">unh:A364Day38BillionCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iafeb038504b84584996f9cd39f452b04_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">unh:NOLsExpirationBeginning2022Through2037Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if8b73857161d431fabb907fdd770e42f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">unh:NOLsIndefiniteCarryforwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i594ed33a64c84c5383f969319b50d190_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i065ef157d8a74b71a4c8ba538486d487_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i74609445052240d09613244522e25dba_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i44dc783f612e43b28b4d406b49e67429_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1c6d80d4f8bb448a8552137452437d96_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i500f988f0d5d4732a1a3d4b8ebab6285_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i195ad038ae66447ea9bbab80147223bf_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="unh:DividendFrequencyAxis">unh:ExtraordinaryDividendsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i92e4aa62eb95430a95cec0efea49c225_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="unh:DividendFrequencyAxis">unh:ExtraordinaryDividendsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifb118b1801aa4f9894e91cda550c9801_I20180601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
        </entity>
        <period>
            <instant>2018-06-01</instant>
        </period>
    </context>
    <context id="ib1465a6c04dd4bcbacfb6ca471dbee92_D20210323-20210323">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
        </entity>
        <period>
            <startDate>2021-03-23</startDate>
            <endDate>2021-03-23</endDate>
        </period>
    </context>
    <context id="id4fddf633266448b9691078c6f0ac482_D20210629-20210629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
        </entity>
        <period>
            <startDate>2021-06-29</startDate>
            <endDate>2021-06-29</endDate>
        </period>
    </context>
    <context id="i97719cae15984487921a22e3d5be41e8_D20210921-20210921">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
        </entity>
        <period>
            <startDate>2021-09-21</startDate>
            <endDate>2021-09-21</endDate>
        </period>
    </context>
    <context id="i8f7827d6bf5f49a0af03b71e2d704cea_D20211214-20211214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
        </entity>
        <period>
            <startDate>2021-12-14</startDate>
            <endDate>2021-12-14</endDate>
        </period>
    </context>
    <context id="i1da1045e098d44dda00d3afb43712521_D20210601-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">unh:EmployeeStockPurchasePlanESPPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9373eeb7b5f04135b63071c869773f31_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">unh:EmployeeStockPurchasePlanESPPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8b0b8b22a5064df79ec4e0a1452381f2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id63338cb4c6e49dbb4d3876bbbbc7fba_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i76d17528cf2346ec89da7e8be44862de_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">unh:StockOptionsandSARsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8735916cccf8489cb02dce2be01b4b17_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">unh:StockOptionsandSARsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ifb47f60aa85f4d24ba37cab9c6946e24_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie5d9a9a4874549718469d7c60db06cc1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i45d815b9650e4498a5b6941af134494e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ief665df606e14a618e22e519299e9750_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">unh:EmployeeStockPurchasePlanESPPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7b0f0d7d245e4cbda78fe9b5b60cd842_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">unh:EmployeeStockPurchasePlanESPPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icdb1414efe6043419f08c3bf8694fb7b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i15c2564b16d64dc19f85f7ab4f89e02b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i43a2150e723d483a91bbb0bdde5cae0d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icb0b5f4d103946b6ae23ad68bcab60b9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i98a30b5367174ca1bdd6a71ace6b060b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i88c7c3b5d7e240e8a09d2f62902528c7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if755137cc0244794b9c613b644590d23_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CommitmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i234fb0970ed146d6a6b5a0a8e14b119b_D20220101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i3d57fae043fc43048dd28cf40011078c_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="iab8d98a2b1f747909b4f89b860b8d491_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:CMSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">unh:RevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6286320b787e4be4ae57d4beaf6bc896_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:CMSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">unh:RevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1cde2ac06fab4d7d9e153f395956be16_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:CMSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">unh:RevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie251b137801e4de19d84d38991f2fc4c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0cdd4b2069a14aa79f9ff108267e0050_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0aa4f7c6ad7c4399ac91bad12d6477ed_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9934c4a6735f409c90ddb14ad693c228_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i738afd6f13b1403abb02fff8dfe35e83_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iee4705fe81d9455197bc18142d417d2a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3e535292ef33468993675998c2605663_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic990f91ed37540749f170b9884cdaa28_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id3229a037bb842319e936ad6b2a51f54_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6d0f7160671347419a34952ffc8558f7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i92f08c3054b742748f6b0f913e60627d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9c2c9211b22745b98ab1ab28b8337c59_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1530a49a61da49318357204f5b8d80a1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia6279b453c9048b8ad104e810416cbe4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibb1b161f7dee4b48b64861165d69a88c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8400a403196b4b1a958b56a508d6d9b0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id1bfbb3548674a669b5b6862fa055067_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id9094967184f474f86b50dde16f3fe77_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9ebf459d7ca4411a991115796de7f6d5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if946d85193d24f7eab19007d8ced36a7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i213b700417474af9b2ba5f4aa8d32fdb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9d1cef4ce9714d94a507aa88c10ea8e0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ife9ac604777648d1aef36fd158860f8b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id3defa0ac8fe4ab8af3c5b1f321e4ac8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ief7cdc8becb546ea9d8c89af57c961d9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia88cef480a724f0f9f76711ad5e858fe_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ide28f350116d433e9a4361d7809e1736_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie48fc3492bf64059adc2061a1f6feeff_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0c0a8f96f3fb4705b212d6fd60611c3b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6b8cf1603c4345e1a2f17d91305ba20d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5fca052182cd4adcae25d8c3d38cd9c8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4ca8c63efcb348f6bb49eb114aa1ed4b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id4ca79e1283c473bbdcfa153dd38f371_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie14d3261f5ce4d5ca55b14d4eefcad6f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8e37d9f4072942d3ba64046e6f17b292_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3ed0869af41147eb8333f00d982aa0fc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibfdfc0f71a2c4bbc8d894e75a883058c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idbc6824afba44fe3aedc3c732de59fed_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ife381aeab14b4f16b57316de303fa1dc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie7fc59569fab4373bc61b6d246fec133_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3c2c251890924c728ecbe00f7c589b5d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4b8078f333f54e939e1e3226c81d9047_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id0945fba67234634866077d9614c0b72_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia9989fc2842a47be8b2f3c34eadc9a60_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if184c0bbcb7247febb4f087da3c892c6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2e418b78bbe046c6aa713f2359794876_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id04de182af82446c8a35182aaf2b48c5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idc410a001b324c2894fbec26bfef7b86_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2f15426e9ba74458aebc54c25df28187_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i18674f2c4d12424c968d20476457dd0b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia0a3d0d7510f4b139641910dd08967c1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie9ed61319c0a45798da15c42c3e38cd0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i17627bd9a4c5409e9c94b533f8f5ae1c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie2cc2e00b67f4fcf82476fd51fd0699e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8ba88a0ee30c45278b5ace52700290ad_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0594531b29c14219bef65d8cd283fc9e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i87c3f11df32b441eb7fee715e6d92010_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i451a7a7915ff449fbc9bd1d7c005293d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ieb1b06cf327e4bfca58345b40abc554a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic4e9e37ffd9442649f7208882a987c32_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i476fc79de3284b55b364793f612b1a19_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i97e70d750485412480c983dd5791128d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i097c78c5b5544597a305bc89df54bd95_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ied275047eb1f45e5a90acc5936ce8821_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8618f261f45e45c98738e7bb3e6bda9d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i026c8094e6214ea8a156691c9176a6a0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if36ef5c1313e4865b5b21c968b7637ce_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9bb1779f53f54fe7a529d721403d381e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5c78ced66e794cfd90dfb9d9b04070c6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib88407875cb54f609ca6d2c491acde2a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8a6318238dc84a50b52e2aa5ce8fab33_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i27c98317ad344b9499d3c32c021c9f7e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icb5025c996f04acfb22d6284a0a6eda9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8061ff53692d49e09adca8578d72d4cc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie7288d5a2ace47fead21082bff05e780_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i60cedc1d72954901a048fe79a192b8c1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7df7d80b21d94258923146d050c70aa8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibf0af36cf92d48a0b98b4f9034ffb32d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icacb7b0bda5541ac9648de164759144a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i81a2f35fd1414929bcea4c64d9b78904_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2a16d027033644d5b0b62819b881ff74_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0d4de446cb684fb98b6beb87c8a76032_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i54812316cf0241ad80e1416a9adb8137_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i81f09e67922c4373afc90c08de19f39f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6457702d9d2444e2bd3006604563b0c7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie0fdc75afbab4fee9a53cbbd8a5ee695_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9b17e0bd3b914d2bbf6bf114349486a0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5087b2a7612d4c559bb8832aa4ef4e1f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i97c4cc1a264b40839a4392c3a86f7175_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8dc352162fbe4ed18df7bd7477ea0efd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibf5ca22db7484acf8738fe8c4096beaa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib0ddb85685644e32aaa72bd4c99df7d3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i765e712ac4354f6b9977ebd8a5137668_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia9ce56590e08493a92f4e98ff05295de_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iae958eee276045ee967123983469f6ed_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7c5071fb5c87448187540e1a182c3bf1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i61970d2504044d078cdd34efba0cd162_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i859e241a022540eca1b22afddbe55e1b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2ec7b4d30d5e48deb9045b349aaf4dd4_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id1b5e284b10548f2b4cea7ea557161f0_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ifef7b0e583964ad39d94daea6cea3366_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia58c1f8d468c437393baf523e864a524_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia0a43f969e6045adbb4d7a5ed18144fe_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9e4f8878a34a4cb4bc6c14d692445406_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0e0a9e0b05964d5b81c4faaf9261f866_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id7daf143ec32478b96d361bc8bbcb4a7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic4466e0b3d7e4d21b0cdb371895ed5bc_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i40e8a322046c48e9bb4d5a3f9d8d69bc_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i665d6130ef0b4aa8b4c4151cae26a10c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ieab8464742d34bbab93c7d73240b238a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0bf9cb13150a4db19778cd757e617679_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia1556f868d6143eaa08d050b665df1a1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ifd51ec9383cd46588877c19834efb15a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1bcf02a9e58b4aa7bf1bbb8dd1ab6cb2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1c79ad983a524d509a081c39abd43c4a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i33d20e2cf6204d4097b19633f98c100e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia9fb83dc51774898890f78347ad88320_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2e782903147c4e9bbf36b4ecb9601b62_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i13864f629b874a0ca8c1ae8f96420ee4_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i19c1e613e77143c39c1a29089613da3f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia069a517828549fcad85e8b0f07df91a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:ExternalCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i664db88488f9454c91beba797474bd74_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9899068118274125a66eb1295dc7f180_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i62a850c94958453b97ee49874206807a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8dbca3a853c54c32a188e60371e49401_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1401b070d66b4858bebfe8622b519047_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2e7b35ab4daa4d56a1ac8eed3dddbaa8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6c0c40f3739a4f6aa750404ae32e1139_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0c9b94d35868406a8c01569c6271992d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">unh:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if2cf4b896e2b44e084b69d51f3b09f38_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6e31b11ef5824cbf953e4b36353741b6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5775495e739143f9a2489ad44e260280_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4ba56749e5db4d4999936c411d19cea8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i143c69172b0543d3b4f8228cf2e657be_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if3e99423fe064b3f85abf9b78c7b60ef_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iff8807e405c94f48aee4ee4cab179452_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i29eb19ec363740be8a47282feb2589dd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:UnitedhealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i102814ed2a624a4287acce41b5fcf861_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumhealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i92959f478cee4d23a50a998881bfc026_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptuminsightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id234ee9b314c4d5c9bfefe600cb9a7b9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:OptumrxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iaf02709d1a9e4cd3a38c535c74010235_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibddd22dd4e7e4da592ff5a6b614f587a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">unh:TotalOptumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i035eb292920443f587744a9f748e42c8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2749835a349545f38d76efb02e97a939_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i34c97cfea3194601b8f8a80d672db6f5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id83f942037b1489881b85513b8a2fbf4_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="positions">
        <measure>unh:positions</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV80L2ZyYWc6ZjE1Mzc5M2UxYmE3NGFlZWE4YWIwNjlhMmE3MzQ0YmEvdGFibGU6Zjc4NGMyN2Y0ZDU5NGY5NmI3ZWEyMzIzNjNhM2EyZWIvdGFibGVyYW5nZTpmNzg0YzI3ZjRkNTk0Zjk2YjdlYTIzMjM2M2EzYTJlYl8zLTEtMS0xLTA_6d1eea25-6999-4661-9d7c-d6b19accbad0">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV80L2ZyYWc6ZjE1Mzc5M2UxYmE3NGFlZWE4YWIwNjlhMmE3MzQ0YmEvdGFibGU6Zjc4NGMyN2Y0ZDU5NGY5NmI3ZWEyMzIzNjNhM2EyZWIvdGFibGVyYW5nZTpmNzg0YzI3ZjRkNTk0Zjk2YjdlYTIzMjM2M2EzYTJlYl80LTEtMS0xLTA_6a91db0e-4342-4813-9a9a-3bfaace9960c">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV80L2ZyYWc6ZjE1Mzc5M2UxYmE3NGFlZWE4YWIwNjlhMmE3MzQ0YmEvdGFibGU6Zjc4NGMyN2Y0ZDU5NGY5NmI3ZWEyMzIzNjNhM2EyZWIvdGFibGVyYW5nZTpmNzg0YzI3ZjRkNTk0Zjk2YjdlYTIzMjM2M2EzYTJlYl81LTEtMS0xLTA_8b0804ad-907f-4c58-9172-91b4cf1b3df5">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV80L2ZyYWc6ZjE1Mzc5M2UxYmE3NGFlZWE4YWIwNjlhMmE3MzQ0YmEvdGFibGU6Zjc4NGMyN2Y0ZDU5NGY5NmI3ZWEyMzIzNjNhM2EyZWIvdGFibGVyYW5nZTpmNzg0YzI3ZjRkNTk0Zjk2YjdlYTIzMjM2M2EzYTJlYl82LTEtMS0xLTA_6d4d5293-337b-478b-a6eb-308325ab2e2b">0000731766</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV80L2ZyYWc6ZjE1Mzc5M2UxYmE3NGFlZWE4YWIwNjlhMmE3MzQ0YmEvdGFibGU6Zjc4NGMyN2Y0ZDU5NGY5NmI3ZWEyMzIzNjNhM2EyZWIvdGFibGVyYW5nZTpmNzg0YzI3ZjRkNTk0Zjk2YjdlYTIzMjM2M2EzYTJlYl83LTEtMS0xLTA_94dc5913-991e-4a34-84bd-c5ef9f93a43c">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfMS0xLTEtMS0w_cd489fad-1c5b-4893-b468-e73221992628"
      unitRef="usd">954000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfMS0zLTEtMS0w_100d6026-f680-428c-9d0d-d1889bb0cb6a"
      unitRef="usd">990000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfMi0xLTEtMS0w_a8a1a6d9-a1ee-4fcd-ae23-776c49bf6798"
      unitRef="usd">993000000</us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent>
    <us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfMi0zLTEtMS0w_7fba9ec2-d364-4d56-ada5-07c2ca355f94"
      unitRef="usd">1047000000</us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfMy0xLTEtMS0w_7feea1c0-f85d-4ceb-b48c-c62630d60222"
      unitRef="usd">5992000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfMy0zLTEtMS0w_837423b5-9d58-42e0-ac18-dca71d0fe18f"
      unitRef="usd">5230000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfNC0xLTEtMS0w_4554415d-bc90-4a49-a90b-58719fe031d3"
      unitRef="usd">5636000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfNC0zLTEtMS0w_9c51db6b-e5ba-47f4-8cba-c45941454a96"
      unitRef="usd">5455000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfNi0xLTEtMS0w_0cefcf86-30b9-4e4c-8690-5b8dca0428c1"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfNi0xLTEtMS0w_f2a5959a-b7bb-4002-83d8-9fe5345a6a50"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfNi0zLTEtMS0w_1e83ec71-e40f-4d35-9ea3-f0c5cf2920c0"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfNi0zLTEtMS0w_4b9143cc-cd11-4fbb-af24-fef381dec6dc"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfNy0xLTEtMS0w_b6a46e0e-e291-43e6-b6ba-dd3457680c27"
      unitRef="shares">3000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfNy0xLTEtMS0w_b710e1cb-4cb8-4111-a217-d08f10723224"
      unitRef="shares">3000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfNy0zLTEtMS0w_b4956f39-29cb-46dc-85ba-dfc4ab28a797"
      unitRef="shares">3000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfOC0xLTEtMS0w_6b30c6b2-a7fc-4b84-ad58-b5c499bdfd59"
      unitRef="shares">941000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfOC0xLTEtMS0w_be3aa7f8-6357-43e5-b24d-fa7a2403b8ce"
      unitRef="shares">941000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfOC0zLTEtMS0w_98ee3a52-56dc-4701-a22d-c694d8461279"
      unitRef="shares">946000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfOC0zLTEtMS0w_9b4c0280-584f-4cf8-899e-44cedd4eb1ea"
      unitRef="shares">946000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfOS0xLTEtMS0w_2f6ea2ed-ad7d-4724-baa0-3eca12b9d678"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfOS0xLTEtMS0w_61a92059-4fc3-4a28-8d72-c707d47c9c95"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfOS0zLTEtMS0w_f7df6b1d-6ca8-4a30-9eb7-fa9a38bdaacf"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfMTAtMS0xLTEtMA_26baf73b-9e2d-4d06-b8f3-cf6be835555b"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfMTAtMS0xLTEtMA_7d978865-acc5-46e7-a376-63878037b686"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfMTAtMy0xLTEtMA_f6f0a2c0-c7e2-499f-a4b1-5b7bbc72eb6f"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfMTEtMS0xLTEtMA_172d1ede-890b-4967-9b94-916a7101cbad"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfMTEtMS0xLTEtMA_736d7ec3-fbb5-4f5a-bec7-a0b9c1f4f80b"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfMTEtMS0xLTEtMA_c0f5091a-e351-4941-b53a-a213e87f83a1"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfMTEtMS0xLTEtMA_df787b4c-dc7f-40cd-a60f-846e1a77954d"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84Mi9mcmFnOmI4OWEzYmM4MWE1MTRjMmQ4NzgzMjAyM2YwZWJmMjZkL3RhYmxlOjc1ODUwMTM4NzQ2NTRlNTdiY2E0YjVjMGZhN2VlOWIzL3RhYmxlcmFuZ2U6NzU4NTAxMzg3NDY1NGU1N2JjYTRiNWMwZmE3ZWU5YjNfMTEtMy0xLTEtMA_4fb0da1a-38f8-436d-b4ba-7228c76dda9b"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85NC9mcmFnOjk5MjcwZWQyNDZiMDQ2MDA5YjM4NmQ1YWE3YjllYzUyL3RhYmxlOjA1Yjg2NzYyYTFkOTQ3OWM4MWI2NzBlN2M1MGJiYWRhL3RhYmxlcmFuZ2U6MDViODY3NjJhMWQ5NDc5YzgxYjY3MGU3YzUwYmJhZGFfMS0yLTEtMS0w_269041d2-db31-48fa-ba22-d07337ace4db"
      unitRef="usdPerShare">5.60</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85NC9mcmFnOjk5MjcwZWQyNDZiMDQ2MDA5YjM4NmQ1YWE3YjllYzUyL3RhYmxlOjA1Yjg2NzYyYTFkOTQ3OWM4MWI2NzBlN2M1MGJiYWRhL3RhYmxlcmFuZ2U6MDViODY3NjJhMWQ5NDc5YzgxYjY3MGU3YzUwYmJhZGFfMS00LTEtMS0w_04128702-012a-4135-9f00-1922cd7236eb"
      unitRef="usdPerShare">4.83</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85NC9mcmFnOjk5MjcwZWQyNDZiMDQ2MDA5YjM4NmQ1YWE3YjllYzUyL3RhYmxlOjA1Yjg2NzYyYTFkOTQ3OWM4MWI2NzBlN2M1MGJiYWRhL3RhYmxlcmFuZ2U6MDViODY3NjJhMWQ5NDc5YzgxYjY3MGU3YzUwYmJhZGFfMS02LTEtMS0w_d31352b5-e293-4127-aa36-2a74722e0422"
      unitRef="usdPerShare">4.14</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate
      contextRef="ie667c3a41af649e28b76eb6f34ded8a2_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMDkvZnJhZzowMTNlOGRmNzJkYzQ0MjI2OGY1Mjk4YWJkMjJjYWNjMi90YWJsZTpmZTg5YmU5YjQ4OTI0OTlmYmIxOWJjZjI0NzI2N2M5Zi90YWJsZXJhbmdlOmZlODliZTliNDg5MjQ5OWZiYjE5YmNmMjQ3MjY3YzlmXzQtMS0xLTEtMjEyNzI_1cfc340b-c55f-454e-b7d4-bcd6e088b7ab"
      unitRef="number">0.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i0cf2e2ded57848acbd7f4ce7b8849c5d_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTcvZnJhZzoyNzA4MDU3MzhiZjc0MzA5ODVmOTgzMjNiMGZkMzIxNy90ZXh0cmVnaW9uOjI3MDgwNTczOGJmNzQzMDk4NWY5ODMyM2IwZmQzMjE3XzQzOA_eb1bf801-8e88-43f4-addf-b3432e5c7bdc">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i4d96f9ce242e4c3d8115ee3621f39cbe_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTcvZnJhZzoyNzA4MDU3MzhiZjc0MzA5ODVmOTgzMjNiMGZkMzIxNy90ZXh0cmVnaW9uOjI3MDgwNTczOGJmNzQzMDk4NWY5ODMyM2IwZmQzMjE3XzM4NDgyOTA2OTg0NDE_e5312511-99bf-4e41-b5f9-1d6cc88b8bfd">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzgvZnJhZzpjMDc4YWY2ZjNhOGE0OTMxYmM2NjNjYjZhMjEwYTkzYy90YWJsZTo3ZjI1MmU4ZWViYzg0ZDhmYTMyNTcyNWRmZjgxYTJlMi90YWJsZXJhbmdlOjdmMjUyZThlZWJjODRkOGZhMzI1NzI1ZGZmODFhMmUyXzMtMS0xLTEtMA_80b6a583-23ef-4b10-8b7f-9d93ff692909"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzgvZnJhZzpjMDc4YWY2ZjNhOGE0OTMxYmM2NjNjYjZhMjEwYTkzYy90YWJsZTo3ZjI1MmU4ZWViYzg0ZDhmYTMyNTcyNWRmZjgxYTJlMi90YWJsZXJhbmdlOjdmMjUyZThlZWJjODRkOGZhMzI1NzI1ZGZmODFhMmUyXzMtMi0xLTEtMA_635f590d-0256-42e6-b1a9-cc4f2150aa67"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzgvZnJhZzpjMDc4YWY2ZjNhOGE0OTMxYmM2NjNjYjZhMjEwYTkzYy90YWJsZTo3ZjI1MmU4ZWViYzg0ZDhmYTMyNTcyNWRmZjgxYTJlMi90YWJsZXJhbmdlOjdmMjUyZThlZWJjODRkOGZhMzI1NzI1ZGZmODFhMmUyXzQtMS0xLTEtMA_9041fef3-cc5a-4b29-9c33-a180650e9216"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzgvZnJhZzpjMDc4YWY2ZjNhOGE0OTMxYmM2NjNjYjZhMjEwYTkzYy90YWJsZTo3ZjI1MmU4ZWViYzg0ZDhmYTMyNTcyNWRmZjgxYTJlMi90YWJsZXJhbmdlOjdmMjUyZThlZWJjODRkOGZhMzI1NzI1ZGZmODFhMmUyXzQtMi0xLTEtMA_3b8c86a0-c2ad-4b15-bc2f-f4c75a0e0ae8"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <unh:FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis
      contextRef="i7a1b38442cb3432c99552784de780fe5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzgvZnJhZzpjMDc4YWY2ZjNhOGE0OTMxYmM2NjNjYjZhMjEwYTkzYy90YWJsZTo3ZjI1MmU4ZWViYzg0ZDhmYTMyNTcyNWRmZjgxYTJlMi90YWJsZXJhbmdlOjdmMjUyZThlZWJjODRkOGZhMzI1NzI1ZGZmODFhMmUyXzUtMS0xLTEtMA_10a5b669-29b0-4f2f-85cd-879f9f4ef2b4"
      unitRef="usd">0</unh:FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis>
    <unh:FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis
      contextRef="i69a743b9a5d84ecd862ffaa1626c672b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzgvZnJhZzpjMDc4YWY2ZjNhOGE0OTMxYmM2NjNjYjZhMjEwYTkzYy90YWJsZTo3ZjI1MmU4ZWViYzg0ZDhmYTMyNTcyNWRmZjgxYTJlMi90YWJsZXJhbmdlOjdmMjUyZThlZWJjODRkOGZhMzI1NzI1ZGZmODFhMmUyXzUtMi0xLTEtMA_f1d329a3-ab47-4100-af7b-53210213c241"
      unitRef="usd">0</unh:FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i72998cdf5b13475480213110198dde60_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODcvZnJhZzo2ZmIxZmYxOGY0ZmI0ZmJmODc4NmNkZDg3ZWUxODY2Mi90YWJsZTo3Y2VhNDg2OWVlNjU0MDQ2OWU0YTAwYjIzMDg3NjQ2YS90YWJsZXJhbmdlOjdjZWE0ODY5ZWU2NTQwNDY5ZTRhMDBiMjMwODc2NDZhXzItMS0xLTEtMA_1c9a8690-5ac1-4478-973f-d555f8b32282">P9Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i2ecd4e0cb3384d4c8ddd20890ad9e997_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODcvZnJhZzo2ZmIxZmYxOGY0ZmI0ZmJmODc4NmNkZDg3ZWUxODY2Mi90YWJsZTo3Y2VhNDg2OWVlNjU0MDQ2OWU0YTAwYjIzMDg3NjQ2YS90YWJsZXJhbmdlOjdjZWE0ODY5ZWU2NTQwNDY5ZTRhMDBiMjMwODc2NDZhXzItMi0xLTEtMA_08721db3-0c63-4574-a0c7-d8ac398fdcfa">P11Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i1ded218b083944e188cd4579765a2a84_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODcvZnJhZzo2ZmIxZmYxOGY0ZmI0ZmJmODc4NmNkZDg3ZWUxODY2Mi90YWJsZTo3Y2VhNDg2OWVlNjU0MDQ2OWU0YTAwYjIzMDg3NjQ2YS90YWJsZXJhbmdlOjdjZWE0ODY5ZWU2NTQwNDY5ZTRhMDBiMjMwODc2NDZhXzMtMS0xLTEtMA_65aa1e79-951b-419f-9d21-d21079af4f4a">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i2b4f1188393845f8827897acb0c3916c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODcvZnJhZzo2ZmIxZmYxOGY0ZmI0ZmJmODc4NmNkZDg3ZWUxODY2Mi90YWJsZTo3Y2VhNDg2OWVlNjU0MDQ2OWU0YTAwYjIzMDg3NjQ2YS90YWJsZXJhbmdlOjdjZWE0ODY5ZWU2NTQwNDY5ZTRhMDBiMjMwODc2NDZhXzMtMi0xLTEtMA_43fc90a7-6c79-424a-bacd-637c4820491f">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="iaa52ad981c7743b1818a805ee0a0b5fe_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODcvZnJhZzo2ZmIxZmYxOGY0ZmI0ZmJmODc4NmNkZDg3ZWUxODY2Mi90YWJsZTo3Y2VhNDg2OWVlNjU0MDQ2OWU0YTAwYjIzMDg3NjQ2YS90YWJsZXJhbmdlOjdjZWE0ODY5ZWU2NTQwNDY5ZTRhMDBiMjMwODc2NDZhXzQtMS0xLTEtMA_e58a45a5-f4c1-4e1b-a00b-54b3c851865c">P11Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i7a251ae641a244f982ee84dc33f39c98_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODcvZnJhZzo2ZmIxZmYxOGY0ZmI0ZmJmODc4NmNkZDg3ZWUxODY2Mi90YWJsZTo3Y2VhNDg2OWVlNjU0MDQ2OWU0YTAwYjIzMDg3NjQ2YS90YWJsZXJhbmdlOjdjZWE0ODY5ZWU2NTQwNDY5ZTRhMDBiMjMwODc2NDZhXzQtMi0xLTEtMA_6792457a-9cc0-4275-8c92-bb21cdd9e4e0">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODcvZnJhZzo2ZmIxZmYxOGY0ZmI0ZmJmODc4NmNkZDg3ZWUxODY2Mi90YWJsZTo3Y2VhNDg2OWVlNjU0MDQ2OWU0YTAwYjIzMDg3NjQ2YS90YWJsZXJhbmdlOjdjZWE0ODY5ZWU2NTQwNDY5ZTRhMDBiMjMwODc2NDZhXzUtMS0xLTEtMA_7931b4ce-7af2-4005-aac0-54b0a114ffa6">P8Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODcvZnJhZzo2ZmIxZmYxOGY0ZmI0ZmJmODc4NmNkZDg3ZWUxODY2Mi90YWJsZTo3Y2VhNDg2OWVlNjU0MDQ2OWU0YTAwYjIzMDg3NjQ2YS90YWJsZXJhbmdlOjdjZWE0ODY5ZWU2NTQwNDY5ZTRhMDBiMjMwODc2NDZhXzUtMi0xLTEtMA_d4624460-f34e-4c9f-a953-e6cb7b5f50b3">P11Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ibd92e268e96f4727813026fb9f3f2f8f_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzYtMS0xLTEtMA_98206065-be78-4f82-b6ae-79e89edb4feb"
      unitRef="number">0.02125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie6c00455b2e34b31b4063ebbf2107d3a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzgtMS0xLTEtMA_e62f4290-b218-49ed-9504-8cc19bef2052"
      unitRef="number">0.03150</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id372eeef8e344178a1dbfa89af46c45e_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzktMS0xLTEtMA_0618055b-943f-4e21-9827-331da7721279"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib8da81de7fee4af4be76cb170e34ee08_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzEwLTEtMS0xLTA_d46c4371-c76e-47a3-be01-0ac1ae43be5a"
      unitRef="number">0.02875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8172aeed31f44528a74a1c8dbfd1ca1a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzExLTEtMS0xLTA_c5cc5d75-a498-4396-83b1-84131ff0bb90"
      unitRef="number">0.02875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7e3cddf201a14b228f50c7a4b6a5839e_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzEyLTEtMS0xLTA_978f4047-052c-48a5-a305-ef6f40ff97ba"
      unitRef="number">0.03350</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i93168a5ed89f448f8f66c9c0a2283b35_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzEzLTEtMS0xLTA_5c83d6aa-ea7f-447a-b1dd-a7b0c881b5e0"
      unitRef="number">0.02375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i84b80aaa2de74ba09b15b98ebeeb295d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzE0LTEtMS0xLTA_94b1efe2-8cdf-41df-8978-36a62d884ae9"
      unitRef="number">0</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7548e5a838a4421695679910bd4f2c0a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzE1LTEtMS0xLTA_1707fdc3-895f-4dfc-82bb-51c3aae1e95a"
      unitRef="number">0.02750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i597c8e442da543bf8a7372bc0ec54f9d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzE2LTEtMS0xLTA_73277404-d1ee-4c7d-9071-3a83b22ff01c"
      unitRef="number">0.02875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iedb8d09cef364b1293599d28f7c67748_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzE3LTEtMS0xLTA_e900f2f0-5056-42ba-a85b-e5dcd6209ea5"
      unitRef="number">0.03500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i886286b365bb4971a2f13e2f846af74a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzE4LTEtMS0xLTA_7c07be14-e36b-4b24-9715-f5092fce1131"
      unitRef="number">0.03500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if18a2f7f6b0b40f1ad62bd0e830e8b8f_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzE5LTEtMS0xLTQ4OQ_5835ecff-155c-443d-862e-5e4b5a19934a"
      unitRef="number">0.00550</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic1ec0d84eddf49dc97d2a21dd8cee234_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzE5LTEtMS0xLTA_f86a389c-567d-40c5-9675-41e93a00e7f5"
      unitRef="number">0.02375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i315d80ec5a9b4d33b1d8d34a78cae609_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzIwLTEtMS0xLTA_c6a554db-fba0-41d4-bacb-324b492e0721"
      unitRef="number">0.03750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i786f913ccf164a438f57c04ee49ad2b7_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzIxLTEtMS0xLTA_3536f785-0321-4b90-ae5f-91d9fd7be0f7"
      unitRef="number">0.03700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1a3471e5bd4648d0aa81686260fbc921_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzIyLTEtMS0xLTA_3e8c31c7-c497-4a56-95f6-0b82533221b4"
      unitRef="number">0.01250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id8044edfa2384079929b35102a9b7cad_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzIzLTEtMS0xLTA_4e682d5c-e148-422b-8dc8-ec1cbede1271"
      unitRef="number">0.03100</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iec7c13902a5a4ee19961a3eed138f023_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzI1LTEtMS0xLTUwMQ_1e3bc6bc-a48a-48e4-9372-fceecaacd774"
      unitRef="number">0.01150</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6f817c64d72746f4a7600550a38be49c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzI0LTEtMS0xLTA_237e12bb-496c-426d-a5f5-123783c703d6"
      unitRef="number">0.03450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="icae9b0e4795648ce9e80f348899da659_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzI1LTEtMS0xLTA_6da4d575-9ba5-4c96-b408-1cce540978f2"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i31ec009da13047b6b79197c66fda5b6f_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzI2LTEtMS0xLTA_5d38b603-7a94-4776-965a-1859eccf152d"
      unitRef="number">0.02950</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i85149ce8b76548558e9c825e775cee26_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzI3LTEtMS0xLTA_e73ef6a3-f93a-4756-8e71-189884e93042"
      unitRef="number">0.03850</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia7cb4d01a77147bea64135beacd75967_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzI4LTEtMS0xLTA_29f893d0-fa81-4de9-95d6-602804f8f736"
      unitRef="number">0.03875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i89ffd37b253a491e85cd53a3418e5384_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzI5LTEtMS0xLTA_4076487e-c6fc-4b43-8d48-8d8d9c7437e9"
      unitRef="number">0.02875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i792128c572ef443698af3751346cf9ff_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzMwLTEtMS0xLTA_fcee0f9a-63aa-4c1a-aed3-64b8fe08f773"
      unitRef="number">0.02000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib9a4bd31faa04ee1b247e1f86a34f265_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzMzLTEtMS0xLTUxNg_4a7819e0-2577-4166-8e56-6e331cca936d"
      unitRef="number">0.02300</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic45826f8bd334acd9a357972ff7747c0_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzMxLTEtMS0xLTA_533aea48-66fa-4402-8ebe-23b7047f3851"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ibe281588c47246929092124b77f5b494_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzMyLTEtMS0xLTA_ccd9b429-ad15-4982-953a-390dee56a322"
      unitRef="number">0.05800</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i042493d5f213402dbb064b91d1c75e28_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzMzLTEtMS0xLTA_d4134705-1a72-4c5a-834d-c2d36d673871"
      unitRef="number">0.06500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5ac1e2d38c684f80a23cf559e9f5ff07_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzM0LTEtMS0xLTA_a46ca38d-a35e-4d92-8d41-acc285521eee"
      unitRef="number">0.06625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5bb559f948de43229cd7e5cae903c0c3_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzM1LTEtMS0xLTA_7375e3ae-71ae-4795-b574-ee8644368f67"
      unitRef="number">0.06875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iada0e5e85dc241e48cf116319f7a75c6_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzM2LTEtMS0xLTA_81d5a673-794b-48bf-8676-8cf7f6cc279c"
      unitRef="number">0.03500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6019aef8fb074093b331027b9c2adb61_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzM3LTEtMS0xLTA_c7215a4d-4570-435d-9812-e1b6f9764bc1"
      unitRef="number">0.02750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iba9a7a93d2b645cea2c51c984287da3f_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzM4LTEtMS0xLTA_7ebb632a-b12a-4446-9e64-cd0779783fd3"
      unitRef="number">0.05700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib4f641b3624849f2adeb7cd37bcab7ca_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzM5LTEtMS0xLTA_d3805231-b3ca-4a54-a1b5-ef9315ee13bd"
      unitRef="number">0.05950</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib3668395d3b640cf8ba0bda86da26e60_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzQzLTEtMS0xLTUzMg_523a2d2c-f9d8-43cc-a764-16199cb5080a"
      unitRef="number">0.03050</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5c821b276174476b9517c3bbb9157232_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzQwLTEtMS0xLTA_cbc7bb60-bdc8-47b5-bc89-e35fe7863395"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3057e59415b14c1fbbc0e75f70f19a41_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzQxLTEtMS0xLTA_7fee7a11-daad-42d9-ad15-692588b88794"
      unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ica9c4076825647eaad198c486084ebb6_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzQyLTEtMS0xLTA_3a4df45d-1506-4695-ace7-527479545fa0"
      unitRef="number">0.03950</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8aa1ed6f3b9547d785049322c036163a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzQzLTEtMS0xLTA_552ee9a8-fdbd-4019-b480-a8e697e850cf"
      unitRef="number">0.04250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="idd43a6fb78154c23ac9111d56d6fc58a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzQ0LTEtMS0xLTA_f217e45b-e848-4b21-8dde-7b3572a0632d"
      unitRef="number">0.04750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i37706a7a25134a80b7681dbe80d0a08f_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzQ1LTEtMS0xLTA_3b560a1a-2068-4dec-8a70-41c1e58005e2"
      unitRef="number">0.04200</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6a47e7cab2b747b19f8ad6dd5577eb65_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzQ2LTEtMS0xLTA_430c2468-85e6-429e-a9fe-245e208869ce"
      unitRef="number">0.04250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i980dd94826d240d68ca80fc74c96e9c1_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzQ3LTEtMS0xLTA_3da76b5c-9a12-47ce-85a2-a9f0a8f0cd86"
      unitRef="number">0.03750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie56f8e65458741cba5353670ff8dce7e_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzQ4LTEtMS0xLTA_28da9974-759e-47e6-b1f4-cf56c32cf419"
      unitRef="number">0.04250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i076316df7acd4f5f97a07a2468548d05_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzQ5LTEtMS0xLTA_4b0c3077-e251-46af-bd25-4592306d65f7"
      unitRef="number">0.04450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5dc454ca8f924d03b29dd33f0388905d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzUwLTEtMS0xLTA_34a9cad7-7e43-4073-ac6a-b25c503b67ff"
      unitRef="number">0.03700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i43a9150b986245ea926eba8cf8dd88c4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzUxLTEtMS0xLTA_a985f1e6-a915-4770-aea7-ed0d4f87ff85"
      unitRef="number">0.02900</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id7d2521c88c843bbab7e44fbe1b07950_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzU2LTEtMS0xLTU0Ng_ef31f573-1011-4534-b219-78e2a397ac6a"
      unitRef="number">0.03250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if6fda2fd6f8d48768196072f7bb18858_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzUyLTEtMS0xLTA_86bad8a9-2ab7-4926-881b-c9c6bdc74ac5"
      unitRef="number">0.03875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3d6a2a39f8a84b30913e25aac3e3a548_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZTo5YmQzOTc5YTU2ZTI0ZDJjYTJhNWUwYzM5M2U2OGYxNC90YWJsZXJhbmdlOjliZDM5NzlhNTZlMjRkMmNhMmE1ZTBjMzkzZTY4ZjE0XzUzLTEtMS0xLTA_c8b6e13e-ee41-42df-9d40-1e531bda1320"
      unitRef="number">0.03125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LineOfCredit
      contextRef="i0561a17f67884087afe8d954a4e80ace_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZToyMzgyMWI5MmY0MmI0ZmEyYjg0ZjIxMWVlYzg1NWU2Ni90YWJsZXJhbmdlOjIzODIxYjkyZjQyYjRmYTJiODRmMjExZWVjODU1ZTY2XzEtMS0xLTEtMA_3019e8c8-f7df-4ffe-b7c6-d1b5ff5d8e58"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="ia6ef4bc76d4e41ef824e2e1bc29be3e8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZToyMzgyMWI5MmY0MmI0ZmEyYjg0ZjIxMWVlYzg1NWU2Ni90YWJsZXJhbmdlOjIzODIxYjkyZjQyYjRmYTJiODRmMjExZWVjODU1ZTY2XzItMS0xLTEtMA_cf562ebc-2a68-4b9d-b9af-8836b5f45245"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i3bbc78e491bd48b2bdc3d2454d729af8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZToyMzgyMWI5MmY0MmI0ZmEyYjg0ZjIxMWVlYzg1NWU2Ni90YWJsZXJhbmdlOjIzODIxYjkyZjQyYjRmYTJiODRmMjExZWVjODU1ZTY2XzMtMS0xLTEtMA_8dbb6ef0-50c6-4195-a686-9b0ad6416ed0"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityExpirationPeriod
      contextRef="i9bd8ec4f14f94dc98096c091b92e4751_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZToyMzgyMWI5MmY0MmI0ZmEyYjg0ZjIxMWVlYzg1NWU2Ni90YWJsZXJhbmdlOjIzODIxYjkyZjQyYjRmYTJiODRmMjExZWVjODU1ZTY2XzUtMS0xLTEtMA_bb9960fe-4ac9-40aa-af95-94b9f26a2d77">P5Y</us-gaap:LineOfCreditFacilityExpirationPeriod>
    <us-gaap:LineOfCreditFacilityExpirationPeriod
      contextRef="i0ef9be25372d4e00bd34d251579f4577_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZToyMzgyMWI5MmY0MmI0ZmEyYjg0ZjIxMWVlYzg1NWU2Ni90YWJsZXJhbmdlOjIzODIxYjkyZjQyYjRmYTJiODRmMjExZWVjODU1ZTY2XzYtMS0xLTEtMA_8d6f1246-979f-4b1c-b771-a6296f71c08e">P3Y</us-gaap:LineOfCreditFacilityExpirationPeriod>
    <us-gaap:LineOfCreditFacilityExpirationPeriod
      contextRef="i26faa7bce6f44c1ba49361994ef7383d_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTYvZnJhZzphNWQ2NDJkNjcyNmM0ZjA2OTZiZDk5OWM0NWI2OTQ3ZC90YWJsZToyMzgyMWI5MmY0MmI0ZmEyYjg0ZjIxMWVlYzg1NWU2Ni90YWJsZXJhbmdlOjIzODIxYjkyZjQyYjRmYTJiODRmMjExZWVjODU1ZTY2XzctMS0xLTEtMA_9e063743-65b0-475a-a31f-5e88c35244d0">P364D</us-gaap:LineOfCreditFacilityExpirationPeriod>
    <us-gaap:TaxCreditCarryforwardExpirationDate
      contextRef="i594ed33a64c84c5383f969319b50d190_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDIvZnJhZzoyYzg1YTcyMTRhNzM0NWUyOTMzZjcyYTA2MWVmNTljNi90YWJsZTpiMDI0YWNlYjgxZGU0N2RmYTE2YTc3Zjg1NmYzN2I2OC90YWJsZXJhbmdlOmIwMjRhY2ViODFkZTQ3ZGZhMTZhNzdmODU2ZjM3YjY4XzEtMC0xLTEtMA_55debad8-dfd5-4d7d-a073-8f49400616b5">2023-01-01</us-gaap:TaxCreditCarryforwardExpirationDate>
    <us-gaap:TaxCreditCarryforwardExpirationDate
      contextRef="i065ef157d8a74b71a4c8ba538486d487_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDIvZnJhZzoyYzg1YTcyMTRhNzM0NWUyOTMzZjcyYTA2MWVmNTljNi90YWJsZTpiMDI0YWNlYjgxZGU0N2RmYTE2YTc3Zjg1NmYzN2I2OC90YWJsZXJhbmdlOmIwMjRhY2ViODFkZTQ3ZGZhMTZhNzdmODU2ZjM3YjY4XzEtMS0xLTEtMA_0ee63faa-eaaf-4c45-ada3-96afe30ee80a">2037-01-01</us-gaap:TaxCreditCarryforwardExpirationDate>
    <us-gaap:TaxCreditCarryforwardExpirationDate
      contextRef="i74609445052240d09613244522e25dba_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDIvZnJhZzoyYzg1YTcyMTRhNzM0NWUyOTMzZjcyYTA2MWVmNTljNi90YWJsZTpiMDI0YWNlYjgxZGU0N2RmYTE2YTc3Zjg1NmYzN2I2OC90YWJsZXJhbmdlOmIwMjRhY2ViODFkZTQ3ZGZhMTZhNzdmODU2ZjM3YjY4XzMtMC0xLTEtMA_6de9531a-9edc-4755-9c16-5fb793bf03d6">2022-01-01</us-gaap:TaxCreditCarryforwardExpirationDate>
    <us-gaap:TaxCreditCarryforwardExpirationDate
      contextRef="i1c6d80d4f8bb448a8552137452437d96_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDIvZnJhZzoyYzg1YTcyMTRhNzM0NWUyOTMzZjcyYTA2MWVmNTljNi90YWJsZTpiMDI0YWNlYjgxZGU0N2RmYTE2YTc3Zjg1NmYzN2I2OC90YWJsZXJhbmdlOmIwMjRhY2ViODFkZTQ3ZGZhMTZhNzdmODU2ZjM3YjY4XzMtMS0xLTEtMA_e4d55878-4ba7-4b11-ade8-d2b0ce97ff30">2041-01-01</us-gaap:TaxCreditCarryforwardExpirationDate>
    <us-gaap:OpenTaxYear
      contextRef="i594ed33a64c84c5383f969319b50d190_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDIvZnJhZzoyYzg1YTcyMTRhNzM0NWUyOTMzZjcyYTA2MWVmNTljNi90YWJsZTpiMDI0YWNlYjgxZGU0N2RmYTE2YTc3Zjg1NmYzN2I2OC90YWJsZXJhbmdlOmIwMjRhY2ViODFkZTQ3ZGZhMTZhNzdmODU2ZjM3YjY4XzYtMC0xLTEtMA_5fdea5ca-2322-4038-a4c0-bd7616617a41">2017</us-gaap:OpenTaxYear>
    <us-gaap:OpenTaxYear
      contextRef="i065ef157d8a74b71a4c8ba538486d487_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDIvZnJhZzoyYzg1YTcyMTRhNzM0NWUyOTMzZjcyYTA2MWVmNTljNi90YWJsZTpiMDI0YWNlYjgxZGU0N2RmYTE2YTc3Zjg1NmYzN2I2OC90YWJsZXJhbmdlOmIwMjRhY2ViODFkZTQ3ZGZhMTZhNzdmODU2ZjM3YjY4XzYtMS0xLTEtMA_b5c35318-f3ca-492c-961b-11b235ed07c5">2020</us-gaap:OpenTaxYear>
    <us-gaap:OpenTaxYear
      contextRef="i74609445052240d09613244522e25dba_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDIvZnJhZzoyYzg1YTcyMTRhNzM0NWUyOTMzZjcyYTA2MWVmNTljNi90YWJsZTpiMDI0YWNlYjgxZGU0N2RmYTE2YTc3Zjg1NmYzN2I2OC90YWJsZXJhbmdlOmIwMjRhY2ViODFkZTQ3ZGZhMTZhNzdmODU2ZjM3YjY4XzgtMC0xLTEtMA_c6a227fa-c31f-4179-af9f-3d8befa4c5d7">2014</us-gaap:OpenTaxYear>
    <us-gaap:OpenTaxYear
      contextRef="i1c6d80d4f8bb448a8552137452437d96_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDIvZnJhZzoyYzg1YTcyMTRhNzM0NWUyOTMzZjcyYTA2MWVmNTljNi90YWJsZTpiMDI0YWNlYjgxZGU0N2RmYTE2YTc3Zjg1NmYzN2I2OC90YWJsZXJhbmdlOmIwMjRhY2ViODFkZTQ3ZGZhMTZhNzdmODU2ZjM3YjY4XzgtMS0xLTEtMA_42bfab5d-3f6b-4e4c-a819-e2501d86c0b7">2021</us-gaap:OpenTaxYear>
    <us-gaap:OpenTaxYear
      contextRef="i44dc783f612e43b28b4d406b49e67429_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDIvZnJhZzoyYzg1YTcyMTRhNzM0NWUyOTMzZjcyYTA2MWVmNTljNi90YWJsZTpiMDI0YWNlYjgxZGU0N2RmYTE2YTc3Zjg1NmYzN2I2OC90YWJsZXJhbmdlOmIwMjRhY2ViODFkZTQ3ZGZhMTZhNzdmODU2ZjM3YjY4XzEwLTAtMS0xLTA_e63a5ea2-8365-4dcc-87d9-a6d3304191c9">2015</us-gaap:OpenTaxYear>
    <us-gaap:OpenTaxYear
      contextRef="i500f988f0d5d4732a1a3d4b8ebab6285_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDIvZnJhZzoyYzg1YTcyMTRhNzM0NWUyOTMzZjcyYTA2MWVmNTljNi90YWJsZTpiMDI0YWNlYjgxZGU0N2RmYTE2YTc3Zjg1NmYzN2I2OC90YWJsZXJhbmdlOmIwMjRhY2ViODFkZTQ3ZGZhMTZhNzdmODU2ZjM3YjY4XzEwLTEtMS0xLTA_5e054c0f-aedc-4d62-9e93-4b352d231e41">2021</us-gaap:OpenTaxYear>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="icdb1414efe6043419f08c3bf8694fb7b_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzEtMS0xLTEtMA_a60737d5-82d3-451a-abe5-d1a8c8cfc2bf"
      unitRef="number">0.007</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i15c2564b16d64dc19f85f7ab4f89e02b_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzEtMi0xLTEtMA_6c282770-0a2d-4ec3-afe3-317031892f75"
      unitRef="number">0.012</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i43a2150e723d483a91bbb0bdde5cae0d_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzEtNC0xLTEtMA_1127d95b-f7ae-46ae-94ea-829bd9de702f"
      unitRef="number">0.002</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="icb0b5f4d103946b6ae23ad68bcab60b9_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzEtNS0xLTEtMA_c3ebcb18-1849-416a-8cfb-a626b3857cf4"
      unitRef="number">0.014</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i98a30b5367174ca1bdd6a71ace6b060b_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzEtNy0xLTEtMA_64a00a3e-14c8-4e8c-8b1e-79b87b98b047"
      unitRef="number">0.015</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i88c7c3b5d7e240e8a09d2f62902528c7_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzEtOC0xLTEtMA_4421de73-d13d-4d98-a282-2d93580b9703"
      unitRef="number">0.025</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="icdb1414efe6043419f08c3bf8694fb7b_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzItMS0xLTEtMA_30dc256e-277d-47e4-b964-7398aef80d7c"
      unitRef="number">0.292</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i15c2564b16d64dc19f85f7ab4f89e02b_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzItMi0xLTEtMA_5c3d88f8-7f90-410a-a9cf-4f3c5f409718"
      unitRef="number">0.298</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i43a2150e723d483a91bbb0bdde5cae0d_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzItNC0xLTEtMA_6e58df34-e34c-46fa-b782-12646a018571"
      unitRef="number">0.222</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="icb0b5f4d103946b6ae23ad68bcab60b9_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzItNS0xLTEtMA_08b54a72-0928-452b-8607-60dae9ccf927"
      unitRef="number">0.295</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i98a30b5367174ca1bdd6a71ace6b060b_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzItNy0xLTEtMA_94c0d482-05eb-4d3a-837e-e872843e3720"
      unitRef="number">0.194</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i88c7c3b5d7e240e8a09d2f62902528c7_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzItOC0xLTEtMA_8783f117-90bb-44dc-a823-66423e0cbd5b"
      unitRef="number">0.216</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="icdb1414efe6043419f08c3bf8694fb7b_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzMtMS0xLTEtMA_a930f907-f0b3-423a-83e7-c63ca1e43c6c"
      unitRef="number">0.013</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i15c2564b16d64dc19f85f7ab4f89e02b_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzMtMi0xLTEtMA_d7653de9-79ea-4f09-98c6-6ae78cbb1ffb"
      unitRef="number">0.015</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i43a2150e723d483a91bbb0bdde5cae0d_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzMtNC0xLTEtMA_4240c65f-b1ba-4f94-9dff-0c98e7c45a77"
      unitRef="number">0.014</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="icb0b5f4d103946b6ae23ad68bcab60b9_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzMtNS0xLTEtMA_9ea9ce87-1194-4b4c-a1ce-a178f5579566"
      unitRef="number">0.017</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i98a30b5367174ca1bdd6a71ace6b060b_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzMtNy0xLTEtMA_5c2ef978-3fbe-4f9d-a5c0-10a08b895e87"
      unitRef="number">0.014</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i88c7c3b5d7e240e8a09d2f62902528c7_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzMtOC0xLTEtMA_f6ace01b-ee02-4dd8-acae-eb4e5c8ee399"
      unitRef="number">0.018</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzUtMS0xLTEtMA_509e8e56-c499-4507-82f6-3102f9d27c14">P4Y9M19D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzUtNC0xLTEtMA_e618be85-1579-4f23-a094-7c6a008b538a">P5Y1M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzUtNy0xLTEtMA_b81141a4-d144-4ea2-9741-dc8807427dd6">P5Y3M19D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzgtMS0xLTEtMA_da7313e5-49e1-4c50-bc09-21592d328754">P6Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzktMS0xLTEtMA_745f6969-d20c-456f-b00a-9ff850c1fddf">P4Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzEwLTEtMS0xLTA_ceb11579-0a34-4546-b730-94211b37eeaf">P6Y2M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTQvZnJhZzpkZmI2YzFmMGIzOTE0NDZkYTEyNDA2YjE1M2MzN2NhYi90YWJsZTo2OGMyY2M4YmY0MWY0OWI2YTcwNTYxNzI4ZGE1YjQxNi90YWJsZXJhbmdlOjY4YzJjYzhiZjQxZjQ5YjZhNzA1NjE3MjhkYTViNDE2XzEyLTEtMS0xLTA_92e8ade8-d83f-43f4-917d-8d7f884cd969">P1Y3M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i2749835a349545f38d76efb02e97a939_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzQvZnJhZzo0ZDk0Y2E3YTBhMjg0MTViOGRlZTRmODU2M2VlNzBhNy90YWJsZTo0MTliNjRmYmRlZDQ0YzkzYTI0OTQzNDdiNGQzNWU3Zi90YWJsZXJhbmdlOjQxOWI2NGZiZGVkNDRjOTNhMjQ5NDM0N2I0ZDM1ZTdmXzEtMS0xLTEtMA_7f75dc3e-d374-4190-88dd-8353068f5436"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzQvZnJhZzo0ZDk0Y2E3YTBhMjg0MTViOGRlZTRmODU2M2VlNzBhNy90YWJsZTo0MTliNjRmYmRlZDQ0YzkzYTI0OTQzNDdiNGQzNWU3Zi90YWJsZXJhbmdlOjQxOWI2NGZiZGVkNDRjOTNhMjQ5NDM0N2I0ZDM1ZTdmXzEtMy0xLTEtMA_f419bad8-d917-4d78-9ce8-9bc2059c4441"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i2749835a349545f38d76efb02e97a939_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzQvZnJhZzo0ZDk0Y2E3YTBhMjg0MTViOGRlZTRmODU2M2VlNzBhNy90YWJsZTo0MTliNjRmYmRlZDQ0YzkzYTI0OTQzNDdiNGQzNWU3Zi90YWJsZXJhbmdlOjQxOWI2NGZiZGVkNDRjOTNhMjQ5NDM0N2I0ZDM1ZTdmXzItMS0xLTEtMA_9806846c-f170-47b6-b59f-cdcc0ece6eb9"
      unitRef="shares">3000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzQvZnJhZzo0ZDk0Y2E3YTBhMjg0MTViOGRlZTRmODU2M2VlNzBhNy90YWJsZTo0MTliNjRmYmRlZDQ0YzkzYTI0OTQzNDdiNGQzNWU3Zi90YWJsZXJhbmdlOjQxOWI2NGZiZGVkNDRjOTNhMjQ5NDM0N2I0ZDM1ZTdmXzItMy0xLTEtMA_019b5f2b-5b4f-4b2f-b194-0f682a877ce4"
      unitRef="shares">3000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i2749835a349545f38d76efb02e97a939_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzQvZnJhZzo0ZDk0Y2E3YTBhMjg0MTViOGRlZTRmODU2M2VlNzBhNy90YWJsZTo0MTliNjRmYmRlZDQ0YzkzYTI0OTQzNDdiNGQzNWU3Zi90YWJsZXJhbmdlOjQxOWI2NGZiZGVkNDRjOTNhMjQ5NDM0N2I0ZDM1ZTdmXzMtMS0xLTEtMA_fa17f1be-45e1-4939-8b1c-faa7cd2151b4"
      unitRef="shares">941000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzQvZnJhZzo0ZDk0Y2E3YTBhMjg0MTViOGRlZTRmODU2M2VlNzBhNy90YWJsZTo0MTliNjRmYmRlZDQ0YzkzYTI0OTQzNDdiNGQzNWU3Zi90YWJsZXJhbmdlOjQxOWI2NGZiZGVkNDRjOTNhMjQ5NDM0N2I0ZDM1ZTdmXzMtMy0xLTEtMA_0bb2a3af-aba6-4b8e-a1b4-356b717876a0"
      unitRef="shares">946000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i2749835a349545f38d76efb02e97a939_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzQvZnJhZzo0ZDk0Y2E3YTBhMjg0MTViOGRlZTRmODU2M2VlNzBhNy90YWJsZTo0MTliNjRmYmRlZDQ0YzkzYTI0OTQzNDdiNGQzNWU3Zi90YWJsZXJhbmdlOjQxOWI2NGZiZGVkNDRjOTNhMjQ5NDM0N2I0ZDM1ZTdmXzQtMS0xLTEtMA_424d44f6-0c33-473f-8252-b369af69aec4"
      unitRef="shares">941000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzQvZnJhZzo0ZDk0Y2E3YTBhMjg0MTViOGRlZTRmODU2M2VlNzBhNy90YWJsZTo0MTliNjRmYmRlZDQ0YzkzYTI0OTQzNDdiNGQzNWU3Zi90YWJsZXJhbmdlOjQxOWI2NGZiZGVkNDRjOTNhMjQ5NDM0N2I0ZDM1ZTdmXzQtMy0xLTEtMA_ca4e45d8-8132-4b89-96d7-d5d706110ae3"
      unitRef="shares">946000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i2749835a349545f38d76efb02e97a939_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzQvZnJhZzo0ZDk0Y2E3YTBhMjg0MTViOGRlZTRmODU2M2VlNzBhNy90YWJsZTo0MTliNjRmYmRlZDQ0YzkzYTI0OTQzNDdiNGQzNWU3Zi90YWJsZXJhbmdlOjQxOWI2NGZiZGVkNDRjOTNhMjQ5NDM0N2I0ZDM1ZTdmXzUtMS0xLTEtMA_451abca6-a90b-4893-b87b-cecc47ef7ee4"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzQvZnJhZzo0ZDk0Y2E3YTBhMjg0MTViOGRlZTRmODU2M2VlNzBhNy90YWJsZTo0MTliNjRmYmRlZDQ0YzkzYTI0OTQzNDdiNGQzNWU3Zi90YWJsZXJhbmdlOjQxOWI2NGZiZGVkNDRjOTNhMjQ5NDM0N2I0ZDM1ZTdmXzUtMy0xLTEtMA_bc0ad3e6-cd7b-45b0-9cfc-7b54ceba174d"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i2749835a349545f38d76efb02e97a939_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzQvZnJhZzo0ZDk0Y2E3YTBhMjg0MTViOGRlZTRmODU2M2VlNzBhNy90YWJsZTo0MTliNjRmYmRlZDQ0YzkzYTI0OTQzNDdiNGQzNWU3Zi90YWJsZXJhbmdlOjQxOWI2NGZiZGVkNDRjOTNhMjQ5NDM0N2I0ZDM1ZTdmXzYtMS0xLTEtMA_d8ba6077-b7dc-428b-8e5a-d6455fc77369"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzQvZnJhZzo0ZDk0Y2E3YTBhMjg0MTViOGRlZTRmODU2M2VlNzBhNy90YWJsZTo0MTliNjRmYmRlZDQ0YzkzYTI0OTQzNDdiNGQzNWU3Zi90YWJsZXJhbmdlOjQxOWI2NGZiZGVkNDRjOTNhMjQ5NDM0N2I0ZDM1ZTdmXzYtMy0xLTEtMA_5deaafbd-ccd1-4510-8b1b-7695f791fbbe"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i2749835a349545f38d76efb02e97a939_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzQvZnJhZzo0ZDk0Y2E3YTBhMjg0MTViOGRlZTRmODU2M2VlNzBhNy90YWJsZTo0MTliNjRmYmRlZDQ0YzkzYTI0OTQzNDdiNGQzNWU3Zi90YWJsZXJhbmdlOjQxOWI2NGZiZGVkNDRjOTNhMjQ5NDM0N2I0ZDM1ZTdmXzctMS0xLTEtMA_4dad2ec1-3261-483c-b907-83caa9d59552"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzQvZnJhZzo0ZDk0Y2E3YTBhMjg0MTViOGRlZTRmODU2M2VlNzBhNy90YWJsZTo0MTliNjRmYmRlZDQ0YzkzYTI0OTQzNDdiNGQzNWU3Zi90YWJsZXJhbmdlOjQxOWI2NGZiZGVkNDRjOTNhMjQ5NDM0N2I0ZDM1ZTdmXzctMy0xLTEtMA_cba0df00-04f4-4e7a-bf5a-7ca7a683463d"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i2749835a349545f38d76efb02e97a939_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzQvZnJhZzo0ZDk0Y2E3YTBhMjg0MTViOGRlZTRmODU2M2VlNzBhNy90YWJsZTo0MTliNjRmYmRlZDQ0YzkzYTI0OTQzNDdiNGQzNWU3Zi90YWJsZXJhbmdlOjQxOWI2NGZiZGVkNDRjOTNhMjQ5NDM0N2I0ZDM1ZTdmXzgtMS0xLTEtMA_afe4f209-1663-4fd5-a8f5-e3c614885eac"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzQvZnJhZzo0ZDk0Y2E3YTBhMjg0MTViOGRlZTRmODU2M2VlNzBhNy90YWJsZTo0MTliNjRmYmRlZDQ0YzkzYTI0OTQzNDdiNGQzNWU3Zi90YWJsZXJhbmdlOjQxOWI2NGZiZGVkNDRjOTNhMjQ5NDM0N2I0ZDM1ZTdmXzgtMy0xLTEtMA_6fbd6793-f480-4832-b78f-d9c506082aa3"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <dei:DocumentType
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGV4dHJlZ2lvbjplOWMzODA5MjJiOGM0ZjY5OTg3NDM1OTY0ZDk4NDRkZV8xNDU_12c639df-ea53-4b26-af25-82813aee01d5">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGFibGU6ZThhMzY4YmExMTg0NGUzZmFmNmM5NDg1NTM3Mjc5ZjUvdGFibGVyYW5nZTplOGEzNjhiYTExODQ0ZTNmYWY2Yzk0ODU1MzcyNzlmNV8wLTAtMS0xLTA_f85d36fd-4267-497e-98e4-bf6790c10eb7">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGV4dHJlZ2lvbjplOWMzODA5MjJiOGM0ZjY5OTg3NDM1OTY0ZDk4NDRkZV8yMzU_ed71b3f7-aea0-4944-a888-7d3393f7ec42">2021-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGFibGU6OTAyNTQ3NTlhMGQ0NGJmY2FlOWJiMTcxMmUyZjVlMDgvdGFibGVyYW5nZTo5MDI1NDc1OWEwZDQ0YmZjYWU5YmIxNzEyZTJmNWUwOF8yLTAtMS0xLTA_17b6ba1e-e6f3-4dbd-8417-7bd604e4b5c1">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGV4dHJlZ2lvbjplOWMzODA5MjJiOGM0ZjY5OTg3NDM1OTY0ZDk4NDRkZV8yNjU_909f9456-3fba-469a-ba8e-5c7f78a79b2f">1-10864</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGV4dHJlZ2lvbjplOWMzODA5MjJiOGM0ZjY5OTg3NDM1OTY0ZDk4NDRkZV8zMzE_ec6af570-b794-4888-b114-f9029f19549c">UnitedHealth Group Incorporated</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGFibGU6MGVmNjczNTljY2I2NDA5ZjliNjRhZDU3MGY2ZjI5YjMvdGFibGVyYW5nZTowZWY2NzM1OWNjYjY0MDlmOWI2NGFkNTcwZjZmMjliM18wLTAtMS0xLTA_872735c5-335f-4d03-ac24-e2a4f90b1af4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGFibGU6MGVmNjczNTljY2I2NDA5ZjliNjRhZDU3MGY2ZjI5YjMvdGFibGVyYW5nZTowZWY2NzM1OWNjYjY0MDlmOWI2NGFkNTcwZjZmMjliM18wLTMtMS0xLTA_6f10f343-4fad-4c46-9d69-6f0705c91aa4">41-1321939</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGFibGU6MGVmNjczNTljY2I2NDA5ZjliNjRhZDU3MGY2ZjI5YjMvdGFibGVyYW5nZTowZWY2NzM1OWNjYjY0MDlmOWI2NGFkNTcwZjZmMjliM18zLTAtMS0xLTA_d9a6e0f3-130b-4b42-a0e7-db72400de1ca">UnitedHealth Group Center</dei:EntityAddressAddressLine1>
    <dei:EntityAddressPostalZipCode
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGFibGU6MGVmNjczNTljY2I2NDA5ZjliNjRhZDU3MGY2ZjI5YjMvdGFibGVyYW5nZTowZWY2NzM1OWNjYjY0MDlmOWI2NGFkNTcwZjZmMjliM18zLTMtMS0xLTA_a3894db0-cbec-4200-819d-35ee949420e0">55343</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressAddressLine2
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGFibGU6MGVmNjczNTljY2I2NDA5ZjliNjRhZDU3MGY2ZjI5YjMvdGFibGVyYW5nZTowZWY2NzM1OWNjYjY0MDlmOWI2NGFkNTcwZjZmMjliM180LTAtMS0xLTA_578372ba-3a86-4bd6-9b79-4604383e85ab">9900 Bren Road East</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGFibGU6MGVmNjczNTljY2I2NDA5ZjliNjRhZDU3MGY2ZjI5YjMvdGFibGVyYW5nZTowZWY2NzM1OWNjYjY0MDlmOWI2NGFkNTcwZjZmMjliM181LTAtMS0xLTA_84a75223-593e-4753-a796-9895864c8db7">Minnetonka,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGFibGU6MGVmNjczNTljY2I2NDA5ZjliNjRhZDU3MGY2ZjI5YjMvdGFibGVyYW5nZTowZWY2NzM1OWNjYjY0MDlmOWI2NGFkNTcwZjZmMjliM181LTEtMS0xLTA_210071dd-99f4-4728-96e5-6a2b5f7b3add">MN</dei:EntityAddressStateOrProvince>
    <dei:CityAreaCode
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGV4dHJlZ2lvbjplOWMzODA5MjJiOGM0ZjY5OTg3NDM1OTY0ZDk4NDRkZV8zOTM_611273c8-517d-4017-86b6-9181bb1b1b6f">952</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGV4dHJlZ2lvbjplOWMzODA5MjJiOGM0ZjY5OTg3NDM1OTY0ZDk4NDRkZV8zOTc_4e547c38-f4a4-4516-ba98-69c61ab89634">936-1300</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGFibGU6NDUyYzIwMzdmMGQwNGE0YzlkOTZjMTIxYWQ0MGY4M2MvdGFibGVyYW5nZTo0NTJjMjAzN2YwZDA0YTRjOWQ5NmMxMjFhZDQwZjgzY18xLTAtMS0xLTA_3993d300-a503-4b55-b074-b8b691606733">Common Stock, $.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGFibGU6NDUyYzIwMzdmMGQwNGE0YzlkOTZjMTIxYWQ0MGY4M2MvdGFibGVyYW5nZTo0NTJjMjAzN2YwZDA0YTRjOWQ5NmMxMjFhZDQwZjgzY18xLTItMS0xLTA_ed196255-f046-485e-abc4-8eaf729cf7a4">UNH</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGFibGU6NDUyYzIwMzdmMGQwNGE0YzlkOTZjMTIxYWQ0MGY4M2MvdGFibGVyYW5nZTo0NTJjMjAzN2YwZDA0YTRjOWQ5NmMxMjFhZDQwZjgzY18xLTQtMS0xLTA_b58a5f49-876a-4cdf-80b1-a7ff1f3f1c44">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGV4dHJlZ2lvbjplOWMzODA5MjJiOGM0ZjY5OTg3NDM1OTY0ZDk4NDRkZV84MjI_fb39e533-3d16-4eb6-b380-bcfdb5a8c90c">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGV4dHJlZ2lvbjplOWMzODA5MjJiOGM0ZjY5OTg3NDM1OTY0ZDk4NDRkZV85Njc_0a0b333d-c172-4aa1-82c9-464c8079c3af">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGV4dHJlZ2lvbjplOWMzODA5MjJiOGM0ZjY5OTg3NDM1OTY0ZDk4NDRkZV8xMzE3_68c4da41-07e3-42be-9673-7da20ae753a6">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGV4dHJlZ2lvbjplOWMzODA5MjJiOGM0ZjY5OTg3NDM1OTY0ZDk4NDRkZV8xNjMy_d97f5d25-ccc6-47e5-bcb7-273fac85f675">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGFibGU6ZTFjYzBlZWZlMzUwNDYxYzg5NmUzNjEzNWJhMWUwZTgvdGFibGVyYW5nZTplMWNjMGVlZmUzNTA0NjFjODk2ZTM2MTM1YmExZTBlOF8wLTAtMS0xLTA_5ac258cb-0d3e-4184-b678-9108586a2824">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGFibGU6ZTFjYzBlZWZlMzUwNDYxYzg5NmUzNjEzNWJhMWUwZTgvdGFibGVyYW5nZTplMWNjMGVlZmUzNTA0NjFjODk2ZTM2MTM1YmExZTBlOF8xLTEtMS0xLTA_a90f0f52-03f5-4bc4-a2a7-a7ceb147d38a">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGFibGU6ZTFjYzBlZWZlMzUwNDYxYzg5NmUzNjEzNWJhMWUwZTgvdGFibGVyYW5nZTplMWNjMGVlZmUzNTA0NjFjODk2ZTM2MTM1YmExZTBlOF8xLTctMS0xLTA_18bd64ed-fc5a-43dd-a046-b5cbff72350b">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGV4dHJlZ2lvbjplOWMzODA5MjJiOGM0ZjY5OTg3NDM1OTY0ZDk4NDRkZV8xNjQ5MjY3NDQ1Mjg0_2f280c61-3241-45c5-ab72-e2f28183485c">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGV4dHJlZ2lvbjplOWMzODA5MjJiOGM0ZjY5OTg3NDM1OTY0ZDk4NDRkZV8yNzA5_012688c0-3aae-4d15-8018-751a5d7c3f3d">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i8eb94eb0b4484ca996ca09b316c723b4_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGV4dHJlZ2lvbjplOWMzODA5MjJiOGM0ZjY5OTg3NDM1OTY0ZDk4NDRkZV8yODI1_2ada8146-5b81-4990-9d07-9ef265502bde"
      unitRef="usd">376162785060</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i884d1b7f798047438f1fdf140f8c5b0c_I20220131"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGV4dHJlZ2lvbjplOWMzODA5MjJiOGM0ZjY5OTg3NDM1OTY0ZDk4NDRkZV8zMDk1_9863530e-eb0e-4f2f-b377-d3d32fd06c75"
      unitRef="shares">940899146</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xL2ZyYWc6ZTljMzgwOTIyYjhjNGY2OTk4NzQzNTk2NGQ5ODQ0ZGUvdGV4dHJlZ2lvbjplOWMzODA5MjJiOGM0ZjY5OTg3NDM1OTY0ZDk4NDRkZV8xNjQ5MjY3NDQ1Mjgz_96118fa7-d5d3-4f03-bc1e-8d49b32d62ca">The information required by Part III of this report, to the extent not set forth herein, is incorporated by reference from the registrant&#x2019;s definitive proxy statement relating to its 2022 Annual Meeting of Shareholders. Such proxy statement will be filed with the Securities and Exchange Commission within 120 days after the end of the fiscal year to which this report relates.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83MC9mcmFnOjcwZTg4ZjQ3NTg2MzQ2ODg5MDI0YzYwYjc1OWFmMjQ3L3RleHRyZWdpb246NzBlODhmNDc1ODYzNDY4ODkwMjRjNjBiNzU5YWYyNDdfMzU1Nw_d469ae36-0045-4bb2-b4f9-f6899f6130e3"
      unitRef="usd">3500000000</us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue>
    <dei:AuditorFirmId
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83My9mcmFnOjA5OGE5NzI3MjA4YzQ5NjNhOTdmNGVkZDFiYzAyZTM5L3RhYmxlOmI1MTUwYjZjMjFiODQyOWM5YmE1MGJlYmNmOTBkMjk5L3RhYmxlcmFuZ2U6YjUxNTBiNmMyMWI4NDI5YzliYTUwYmViY2Y5MGQyOTlfMi0wLTEtMS0yMTA4OS90ZXh0cmVnaW9uOmNhNzlmNmFiMTAwZTQ4YjI4MTA2MGM4MWZhZjAxZTc2XzkzNDU4NDg4MzY1MTI_f3eb62e8-4b1f-4840-9029-847328e6b233">34</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83Ni9mcmFnOjM0NWNkODRiOTVkNTQ0N2RiODRlYzBkZTcwMDFkNzFmL3RhYmxlOmYwYjAwYmIwZTRhMDRkOTliOTM0YjA2NDE0NjIzNjE0L3RhYmxlcmFuZ2U6ZjBiMDBiYjBlNGEwNGQ5OWI5MzRiMDY0MTQ2MjM2MTRfMC0wLTEtMS0yMTExMi90ZXh0cmVnaW9uOjViMzhlYjBmNzhkYzQ3MDE4NjFmZjdhMzNhYzdhOTU5XzkzNDU4NDg4MzYyMzY_e4332571-04c3-4b63-adca-b78c0cd54131">DELOITTE &amp; TOUCHE LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83Ni9mcmFnOjM0NWNkODRiOTVkNTQ0N2RiODRlYzBkZTcwMDFkNzFmL3RhYmxlOmYwYjAwYmIwZTRhMDRkOTliOTM0YjA2NDE0NjIzNjE0L3RhYmxlcmFuZ2U6ZjBiMDBiYjBlNGEwNGQ5OWI5MzRiMDY0MTQ2MjM2MTRfMi0wLTEtMS0yMTEyNA_652e842c-90f7-490a-9ab6-9c41d76c230a">Minneapolis, Minnesota</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMy0yLTEtMS0w_cd779409-64a3-43a5-99df-f09eedb6fd8f"
      unitRef="usd">21375000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMy00LTEtMS0w_3b70c74f-302b-4189-8671-8a4dc30e1087"
      unitRef="usd">16921000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfNC0yLTEtMS0w_d246d18a-65ab-41e4-b7b1-f871a34fc673"
      unitRef="usd">2532000000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfNC00LTEtMS0w_0fb6a32c-edad-42f3-ba83-445a82ba184b"
      unitRef="usd">2860000000</us-gaap:ShortTermInvestments>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfNS0wLTEtMS0wL3RleHRyZWdpb246YTljMjI1NGNhNTkyNGQ1YmI0Njg5MzkyMWZiNmZmOTRfNDY_cd489fad-1c5b-4893-b468-e73221992628"
      unitRef="usd">954000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfNS0wLTEtMS0wL3RleHRyZWdpb246YTljMjI1NGNhNTkyNGQ1YmI0Njg5MzkyMWZiNmZmOTRfNTM_100d6026-f680-428c-9d0d-d1889bb0cb6a"
      unitRef="usd">990000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfNS0yLTEtMS0w_fe639807-2e4d-40f7-97ed-6c3303260600"
      unitRef="usd">14216000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfNS00LTEtMS0w_bae96f7f-c97e-4364-a49b-b975959adfcc"
      unitRef="usd">12870000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfNi0wLTEtMS0wL3RleHRyZWdpb246MmNjMTUzZWFmZmQ3NGIwYThjOWUyNWVlNTliOTJjNjZfNTI_a8a1a6d9-a1ee-4fcd-ae23-776c49bf6798"
      unitRef="usd">993000000</us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent>
    <us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfNi0wLTEtMS0wL3RleHRyZWdpb246MmNjMTUzZWFmZmQ3NGIwYThjOWUyNWVlNTliOTJjNjZfNTk_7fba9ec2-d364-4d56-ada5-07c2ca355f94"
      unitRef="usd">1047000000</us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfNi0yLTEtMS0w_9f393130-55a8-4ca5-b943-73a5d394fb2f"
      unitRef="usd">13866000000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfNi00LTEtMS0w_705fdf72-22b1-49da-b588-2ad598df14a7"
      unitRef="usd">12534000000</us-gaap:OtherReceivablesNetCurrent>
    <unh:AarpAssetsUnderManagement
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfNy0yLTEtMS0w_8fba91ca-a4c0-4588-9fa5-2cb25793fb85"
      unitRef="usd">4449000000</unh:AarpAssetsUnderManagement>
    <unh:AarpAssetsUnderManagement
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfNy00LTEtMS0w_de759241-dcb9-4097-9183-fcf139564d6d"
      unitRef="usd">4076000000</unh:AarpAssetsUnderManagement>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfOC0yLTEtMS0w_9055607d-a816-48ce-9428-4016a20c1f8f"
      unitRef="usd">5320000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfOC00LTEtMS0w_1b2c3d0e-533e-472b-b2b0-0127ac0872c0"
      unitRef="usd">4457000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfOS0yLTEtMS0w_a55e3d19-1def-4418-88b0-40ef21c9a793"
      unitRef="usd">61758000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfOS00LTEtMS0w_0ef10525-84ce-4e60-92a8-e03ec87f89ff"
      unitRef="usd">53718000000</us-gaap:AssetsCurrent>
    <us-gaap:LongTermInvestments
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTAtMi0xLTEtMA_2c9255a5-92ab-4744-8bee-2e2e118b31d2"
      unitRef="usd">43114000000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTAtNC0xLTEtMA_aafee307-2639-4d45-97ab-cb5c58cbd637"
      unitRef="usd">41242000000</us-gaap:LongTermInvestments>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjUyYWZjZDM2MWM4NTQ0NTFiZmQ5MDk2MDkyN2E3ZjkyXzEwMg_7feea1c0-f85d-4ceb-b48c-c62630d60222"
      unitRef="usd">5992000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjUyYWZjZDM2MWM4NTQ0NTFiZmQ5MDk2MDkyN2E3ZjkyXzEwOQ_837423b5-9d58-42e0-ac18-dca71d0fe18f"
      unitRef="usd">5230000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTEtMi0xLTEtMA_b920a0f9-65b2-4632-b4e1-3b3b886ec679"
      unitRef="usd">8969000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTEtNC0xLTEtMA_f8fcb175-6ae4-41c4-9747-df62a2529c6e"
      unitRef="usd">8626000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTItMi0xLTEtMA_50cf4417-7b17-4068-8d9f-e4da2a760006"
      unitRef="usd">75795000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTItNC0xLTEtMA_0f405123-c4b2-4836-93a8-477c01afb986"
      unitRef="usd">71337000000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTMtMC0xLTEtMC90ZXh0cmVnaW9uOmE5YTk0YTBjNGZhYjRiNmRhNmViYTliNjNkYTRjNjA5XzY0_4554415d-bc90-4a49-a90b-58719fe031d3"
      unitRef="usd">5636000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTMtMC0xLTEtMC90ZXh0cmVnaW9uOmE5YTk0YTBjNGZhYjRiNmRhNmViYTliNjNkYTRjNjA5Xzcx_9c51db6b-e5ba-47f4-8cba-c45941454a96"
      unitRef="usd">5455000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTMtMi0xLTEtMA_cb03cd61-862b-4a6f-9bb4-111f52ec40b2"
      unitRef="usd">10044000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTMtNC0xLTEtMA_3b236b86-73c5-4520-b7f8-c668d12015ea"
      unitRef="usd">10856000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTQtMi0xLTEtMA_f0398067-896e-407d-bc08-bdfb2c094514"
      unitRef="usd">12526000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTQtNC0xLTEtMA_91c472a7-21b7-4123-98d3-47f4368473f8"
      unitRef="usd">11510000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTUtMi0xLTEtMA_a249f825-efbe-4d35-a708-baccc2b38522"
      unitRef="usd">212206000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTUtNC0xLTEtMA_5a34ce02-d7a4-4568-93dd-0f3b8341736d"
      unitRef="usd">197289000000</us-gaap:Assets>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTgtMi0xLTEtMA_6c2e5410-2fa6-47f6-86c2-9704e03333a2"
      unitRef="usd">24483000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTgtNC0xLTEtMA_e8a50c98-af6f-478b-a032-caf0caa32279"
      unitRef="usd">21872000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTktMi0xLTEtMA_ab1b0837-6954-4f6c-b0d9-90e89653d181"
      unitRef="usd">24643000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMTktNC0xLTEtMA_5bf9aeee-ab0d-4b5a-b802-faaa122833b5"
      unitRef="usd">22495000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjAtMi0xLTEtMA_84629d91-2934-4724-a334-8caa95815ee6"
      unitRef="usd">3620000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjAtNC0xLTEtMA_2579b1e1-59e6-4d3f-bfd5-b63549cc67d8"
      unitRef="usd">4819000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjEtMi0xLTEtMA_77db71dd-f0e7-4896-a587-9187a8b6cd46"
      unitRef="usd">2571000000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjEtNC0xLTEtMA_9ad665e9-10d5-4a1f-a566-8d0586461f8d"
      unitRef="usd">2842000000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjItMi0xLTEtMA_322407d0-67af-4537-b4b0-4864549f2716"
      unitRef="usd">22975000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjItNC0xLTEtMA_0755851c-d0a9-4cb2-8b97-f99dd2cae94f"
      unitRef="usd">20392000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjMtMi0xLTEtMA_ea00d442-30cf-4eac-9c63-e23ef1de75fb"
      unitRef="usd">78292000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjMtNC0xLTEtMA_5a4d7ecf-ca29-46d0-a1c8-3d80f2b68a38"
      unitRef="usd">72420000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjQtMi0xLTEtMA_8234ac10-440a-428a-8099-e46380151cc4"
      unitRef="usd">42383000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjQtNC0xLTEtMA_0dca2ff1-ff7a-4ea6-adcd-006decfb2f83"
      unitRef="usd">38648000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjUtMi0xLTEtMA_e362fd27-32ff-4357-9344-fafe13542fa9"
      unitRef="usd">3265000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjUtNC0xLTEtMA_66ea0ca9-2363-45dd-8ee6-abff2f770436"
      unitRef="usd">3367000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjYtMi0xLTEtMA_4a11b7bc-c169-46a2-b189-cb59629277cb"
      unitRef="usd">11787000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjYtNC0xLTEtMA_2bd1a15b-e6e3-4787-b790-b655121c6adf"
      unitRef="usd">12315000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjctMi0xLTEtMA_cb171a3a-edc0-4bef-b735-49edc0c60b2a"
      unitRef="usd">135727000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjctNC0xLTEtMA_796924f4-8950-4cc3-9fc2-67c0df13c930"
      unitRef="usd">126750000000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjgtMi0xLTEtMA_8d87ec26-a91c-4d2e-a5b7-96a066aa088f"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjgtNC0xLTEtMA_002b4f07-229a-4124-8032-c451112e2db7"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjktMi0xLTEtMA_817a9b98-a5bb-4e4f-ba62-912f6efc7247"
      unitRef="usd">1434000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMjktNC0xLTEtMA_a03892c9-9d86-4334-b067-49716b1a3644"
      unitRef="usd">2211000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOjA1ODYxYjFmMmE1NzQxNmFiOGQyN2JmNWIyZjM1NTU0XzIx_2f6ea2ed-ad7d-4724-baa0-3eca12b9d678"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOjA1ODYxYjFmMmE1NzQxNmFiOGQyN2JmNWIyZjM1NTU0XzIx_61a92059-4fc3-4a28-8d72-c707d47c9c95"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOjA1ODYxYjFmMmE1NzQxNmFiOGQyN2JmNWIyZjM1NTU0XzM2_26baf73b-9e2d-4d06-b8f3-cf6be835555b"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOjA1ODYxYjFmMmE1NzQxNmFiOGQyN2JmNWIyZjM1NTU0XzM2_7d978865-acc5-46e7-a376-63878037b686"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOjA1ODYxYjFmMmE1NzQxNmFiOGQyN2JmNWIyZjM1NTU0XzU4_172d1ede-890b-4967-9b94-916a7101cbad"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOjA1ODYxYjFmMmE1NzQxNmFiOGQyN2JmNWIyZjM1NTU0XzU4_736d7ec3-fbb5-4f5a-bec7-a0b9c1f4f80b"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOjA1ODYxYjFmMmE1NzQxNmFiOGQyN2JmNWIyZjM1NTU0XzU4_c0f5091a-e351-4941-b53a-a213e87f83a1"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOjA1ODYxYjFmMmE1NzQxNmFiOGQyN2JmNWIyZjM1NTU0XzU4_df787b4c-dc7f-40cd-a60f-846e1a77954d"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzEtMi0xLTEtMA_4750b41a-afa5-4e8d-b43f-9de7bf8046a3"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzEtNC0xLTEtMA_3e355a9f-6ba4-4174-b989-b3cd195f2956"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjRhZDBhZjZlZTMxNDRmOTZiYzIyOGQyMmUxMDVlOGRlXzM4NDgyOTA2OTczMTQ_0cefcf86-30b9-4e4c-8690-5b8dca0428c1"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjRhZDBhZjZlZTMxNDRmOTZiYzIyOGQyMmUxMDVlOGRlXzM4NDgyOTA2OTczMTQ_f2a5959a-b7bb-4002-83d8-9fe5345a6a50"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjRhZDBhZjZlZTMxNDRmOTZiYzIyOGQyMmUxMDVlOGRlXzMz_b6a46e0e-e291-43e6-b6ba-dd3457680c27"
      unitRef="shares">3000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjRhZDBhZjZlZTMxNDRmOTZiYzIyOGQyMmUxMDVlOGRlXzMz_b710e1cb-4cb8-4111-a217-d08f10723224"
      unitRef="shares">3000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjRhZDBhZjZlZTMxNDRmOTZiYzIyOGQyMmUxMDVlOGRlXzU1_6b30c6b2-a7fc-4b84-ad58-b5c499bdfd59"
      unitRef="shares">941000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjRhZDBhZjZlZTMxNDRmOTZiYzIyOGQyMmUxMDVlOGRlXzU1_be3aa7f8-6357-43e5-b24d-fa7a2403b8ce"
      unitRef="shares">941000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjRhZDBhZjZlZTMxNDRmOTZiYzIyOGQyMmUxMDVlOGRlXzYy_98ee3a52-56dc-4701-a22d-c694d8461279"
      unitRef="shares">946000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjRhZDBhZjZlZTMxNDRmOTZiYzIyOGQyMmUxMDVlOGRlXzYy_9b4c0280-584f-4cf8-899e-44cedd4eb1ea"
      unitRef="shares">946000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzItMi0xLTEtMA_40733e8d-01cc-4337-9f3a-108496902af9"
      unitRef="usd">10000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzItNC0xLTEtMA_34fcfdc9-9510-45a1-8384-925e5c854087"
      unitRef="usd">10000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzMtMi0xLTEtMA_a662bbb7-fa0a-4dc0-8719-75364e9908cb"
      unitRef="usd">0</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzMtNC0xLTEtMA_9300a829-73a4-489f-87b8-726029e0a67d"
      unitRef="usd">0</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzQtMi0xLTEtMA_df064f52-3d6b-40ee-b5e9-2b60d3034258"
      unitRef="usd">77134000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzQtNC0xLTEtMA_26c09d0b-c91b-4ca5-b80f-74bd2e6962c0"
      unitRef="usd">69295000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzUtMi0xLTEtMA_df855533-e7b2-47f4-872f-06d46ea890f4"
      unitRef="usd">-5384000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzUtNC0xLTEtMA_8b1599b9-743f-4995-aa64-723efba42fd4"
      unitRef="usd">-3814000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:MinorityInterest
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzYtMi0xLTEtMA_a3af60e6-417f-4b17-b845-eb6b6a16f0b4"
      unitRef="usd">3285000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzYtNC0xLTEtMA_0ac44cbe-720a-4af0-a3d6-1cc4d12c802e"
      unitRef="usd">2837000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzctMi0xLTEtMA_ae5229a1-71f3-4620-be7a-dea1521f9c8d"
      unitRef="usd">75045000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzctNC0xLTEtMA_6ae34ebf-5e32-485c-ba15-68d69f856f3d"
      unitRef="usd">68328000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzgtMi0xLTEtMA_b6730042-72c5-4e72-934a-b7b0b77ae231"
      unitRef="usd">212206000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV83OS9mcmFnOjUwMzQyYWFiMWIzNDQ0MDlhMmQ1YTM1MGM4YThlY2Q5L3RhYmxlOmY0YTUyZWFlMDlmYjRiMDhhMDJmNzJkNDFiNTIyOTE3L3RhYmxlcmFuZ2U6ZjRhNTJlYWUwOWZiNGIwOGEwMmY3MmQ0MWI1MjI5MTdfMzgtNC0xLTEtMA_b89e151b-49a4-44dd-846a-a52b4a96d7aa"
      unitRef="usd">197289000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:PremiumsEarnedNet
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMy0yLTEtMS0w_84bb5df9-b17a-446f-a239-8d275cb02aff"
      unitRef="usd">226233000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMy00LTEtMS0w_5acaac04-5d09-403a-9f67-411f85598f85"
      unitRef="usd">201478000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMy02LTEtMS0w_dac321e7-aa5e-41f0-be60-096afdb1c38d"
      unitRef="usd">189699000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8980da815bc14d658ecbcb83b1249903_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfNC0yLTEtMS0w_af511d2e-18c9-491b-a546-8f34367c74eb"
      unitRef="usd">34437000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i22e79815a5ab4c57ac20424b76b26acf_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfNC00LTEtMS0w_a8eb0764-a395-443e-a12d-c4ff65e4dc88"
      unitRef="usd">34145000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i87aa1e3370624fd2bcbec006cd442de0_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfNC02LTEtMS0w_adecf77d-d893-484a-856e-4dd8a34d82cc"
      unitRef="usd">31597000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0f930a7c88bf48e19ee77868a67beb2c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfNS0yLTEtMS0w_a3d6036a-d1dc-4534-9d15-6ba13a6783ae"
      unitRef="usd">24603000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iebfb5141726d4790b2d5d6623285f2f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfNS00LTEtMS0w_7abb88c9-5968-432d-a733-f3143f1474ec"
      unitRef="usd">20016000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icb730d55174e422ba5041871ed73019a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfNS02LTEtMS0w_cec69175-b9ff-458f-8aae-5d0ff2b493d4"
      unitRef="usd">18973000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfNi0yLTEtMS0w_a78d4780-ab87-4bde-8808-5e4c9892b15d"
      unitRef="usd">2324000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfNi00LTEtMS0w_86518046-fa03-418a-8db5-1051371b28b3"
      unitRef="usd">1502000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfNi02LTEtMS0w_3e0ca0b1-398c-47d1-a11c-f5a1ce085338"
      unitRef="usd">1886000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:Revenues
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfNy0yLTEtMS0w_cfc3e30d-3844-4e9a-a001-4c4c4b440033"
      unitRef="usd">287597000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfNy00LTEtMS0w_d27847eb-10a6-4c25-b9a8-93d260f6a870"
      unitRef="usd">257141000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfNy02LTEtMS0w_4fa7fe33-1973-4ae4-b1e4-48aa4013b73e"
      unitRef="usd">242155000000</us-gaap:Revenues>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfOS0yLTEtMS0w_7c465397-6454-44ee-ae82-d5f8850ca869"
      unitRef="usd">186911000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfOS00LTEtMS0w_44b6f981-f673-4913-9914-99ed678effc4"
      unitRef="usd">159396000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfOS02LTEtMS0w_ebb56291-f8dd-486e-ba08-26e46c15b9cf"
      unitRef="usd">156440000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTAtMi0xLTEtMA_04938e77-5935-4192-80e3-688806d6e2ce"
      unitRef="usd">42579000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTAtNC0xLTEtMA_3c4bdd97-6002-4f5e-95ce-a9e0e212a531"
      unitRef="usd">41704000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTAtNi0xLTEtMA_293c3220-3884-4017-a98e-172e83428b65"
      unitRef="usd">35193000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTEtMi0xLTEtMA_4ff535ee-5b02-4667-a7e0-eb25c9256e5b"
      unitRef="usd">31034000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTEtNC0xLTEtMA_1b5d2cf8-7028-4f86-91a0-083b19fd046c"
      unitRef="usd">30745000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTEtNi0xLTEtMA_76e5b4e6-6a93-47f1-af9f-82b76ec9c242"
      unitRef="usd">28117000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:DepreciationAndAmortization
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTItMi0xLTEtMA_d19f8b56-e8b8-4f51-9b82-e9aaca64d2f2"
      unitRef="usd">3103000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTItNC0xLTEtMA_7105bf44-36f2-4850-99ad-bf47435bd015"
      unitRef="usd">2891000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTItNi0xLTEtMA_066a0ac1-2282-465f-a12c-30796bd66abf"
      unitRef="usd">2720000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:CostsAndExpenses
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTMtMi0xLTEtMA_f86a9bb9-07f4-4b84-88b9-1d4ebea737bc"
      unitRef="usd">263627000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTMtNC0xLTEtMA_e693363b-122c-47bd-9bc3-bc35b0941cac"
      unitRef="usd">234736000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTMtNi0xLTEtMA_6a1e2409-b46b-4c1e-9526-3a7f450065b2"
      unitRef="usd">222470000000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTQtMi0xLTEtMA_cd39d0f8-2ad8-4bb3-9408-4aeaff1a3db0"
      unitRef="usd">23970000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTQtNC0xLTEtMA_f0e01243-5474-47be-b9c3-198162de19a3"
      unitRef="usd">22405000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTQtNi0xLTEtMA_dfba6d52-a48a-40f8-82ec-81d1a1ca4276"
      unitRef="usd">19685000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTUtMi0xLTEtMA_d4845875-fd81-42dd-9b1b-e2ef36a61e75"
      unitRef="usd">1660000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTUtNC0xLTEtMA_f5f46206-687c-4f97-9b97-31c3731983bf"
      unitRef="usd">1663000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTUtNi0xLTEtMA_13300a3a-0adf-4234-89b8-8ab3fd4945fc"
      unitRef="usd">1704000000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTYtMi0xLTEtMA_9281586d-3223-45d2-af23-704e75bad888"
      unitRef="usd">22310000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTYtNC0xLTEtMA_828eada2-c344-4da9-924f-df268314feec"
      unitRef="usd">20742000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTYtNi0xLTEtMA_416e46ef-bc98-4801-9ce6-72c47797048b"
      unitRef="usd">17981000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTctMi0xLTEtMA_93e49c7b-2437-433b-a94f-0162476df7ee"
      unitRef="usd">4578000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTctNC0xLTEtMA_2fb68ca1-8986-4660-8891-bb2bf68c66f7"
      unitRef="usd">4973000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTctNi0xLTEtMA_ad7e301e-1abf-44c4-b973-cdd01592cfd3"
      unitRef="usd">3742000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTgtMi0xLTEtMA_e4b384bb-daa4-461e-9482-6b00b75b0e8a"
      unitRef="usd">17732000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTgtNC0xLTEtMA_2ee587ba-3afb-4601-bfab-5d78d0114921"
      unitRef="usd">15769000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTgtNi0xLTEtMA_4951c554-0edd-4f5e-a511-560a3690d1cf"
      unitRef="usd">14239000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTktMi0xLTEtMA_503fd3f9-d945-4352-9156-d97556f2bc6a"
      unitRef="usd">447000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTktNC0xLTEtMA_f4262f76-f3e9-43ef-b868-12015de69824"
      unitRef="usd">366000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMTktNi0xLTEtMA_08851fde-1fc6-48fb-9358-5fd4e5b69c75"
      unitRef="usd">400000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjAtMi0xLTEtMA_4aee8033-5e5a-4013-8960-daa778badb4c"
      unitRef="usd">17285000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjAtNC0xLTEtMA_ee204361-e344-4c19-ab0c-4ba72592a9d8"
      unitRef="usd">15403000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjAtNi0xLTEtMA_5953d854-2df7-43aa-84c8-f1009ac1fe9b"
      unitRef="usd">13839000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjItMi0xLTEtMA_c7fd744b-3556-4585-9349-b215e7ebccce"
      unitRef="usdPerShare">18.33</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjItNC0xLTEtMA_1225d87e-116e-4ce9-9d2c-069c76a7a7bc"
      unitRef="usdPerShare">16.23</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjItNi0xLTEtMA_565144c9-c0e1-41bc-96c2-921923b3e4a9"
      unitRef="usdPerShare">14.55</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjMtMi0xLTEtMA_8dea8a96-d56d-4db1-971d-5a6f9b7d3438"
      unitRef="usdPerShare">18.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjMtNC0xLTEtMA_df4a3622-81a7-4280-9d95-d49350121fc5"
      unitRef="usdPerShare">16.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjMtNi0xLTEtMA_842c3d2f-9cb1-4c3d-8aea-52e142c036fd"
      unitRef="usdPerShare">14.33</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjQtMi0xLTEtMA_3246699a-1997-4c73-8ed8-182685c89db3"
      unitRef="shares">943000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjQtNC0xLTEtMA_205470cb-de33-46ab-9043-3927ebf0d32a"
      unitRef="shares">949000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjQtNi0xLTEtMA_2c8331fb-3cc8-4528-887d-836ce939ef6d"
      unitRef="shares">951000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjUtMi0xLTEtMA_c9a20dc4-6909-432d-811c-b0ddda7d07c3"
      unitRef="shares">13000000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjUtNC0xLTEtMA_b62f8151-2113-40a7-a087-5656fab54ab6"
      unitRef="shares">12000000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjUtNi0xLTEtMA_0f22de38-e445-46ef-a209-fd860709879b"
      unitRef="shares">15000000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjYtMi0xLTEtMA_d622010a-fea6-48e9-a20d-f4a81fee96cf"
      unitRef="shares">956000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjYtNC0xLTEtMA_714ae457-85b8-42f0-aa13-4bd5a9f5df32"
      unitRef="shares">961000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjYtNi0xLTEtMA_f61af70c-1384-485e-ae5a-290d147cb604"
      unitRef="shares">966000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjctMi0xLTEtMA_cc3c82fd-bf00-4a1e-b7bf-0f56902c8690"
      unitRef="shares">1000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjctNC0xLTEtMA_42fe91fe-e5fb-4ce3-89fb-3ab5b2888aa0"
      unitRef="shares">8000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84NS9mcmFnOmVmYzZiN2RlYzE4YjQzZDhhZjRiMzczNjk5NWE3NmIwL3RhYmxlOjYzOWFiZTA3MmYwZjQwM2ViNmVlZjNiYTY3YzJmYzQ2L3RhYmxlcmFuZ2U6NjM5YWJlMDcyZjBmNDAzZWI2ZWVmM2JhNjdjMmZjNDZfMjctNi0xLTEtMA_dc76cbcf-5fcb-456b-add4-62db65469903"
      unitRef="shares">10000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ProfitLoss
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfMi0yLTEtMS0w_d1b775f9-8f03-4f39-a82c-553525bc59a8"
      unitRef="usd">17732000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfMi00LTEtMS0w_cba8a737-d740-41a5-948f-c912e8895720"
      unitRef="usd">15769000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfMi02LTEtMS0w_5790b2a5-41ad-44f7-8bb1-34d5b41f1e57"
      unitRef="usd">14239000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfNC0yLTEtMS0w_ca8e7161-874d-43d9-a3b9-e801062307f1"
      unitRef="usd">-1028000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfNC00LTEtMS0w_a6a10aee-748c-4284-a3d1-8d070834b7b2"
      unitRef="usd">1058000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfNC02LTEtMS0w_9d70a8cb-80f1-4d52-ae9e-a7610f3bc88c"
      unitRef="usd">1212000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfNS0yLTEtMS0w_f002813b-3d60-48e1-9f87-94fedfcc594d"
      unitRef="usd">-248000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfNS00LTEtMS0w_38aaac48-7344-4f4f-b524-b028fc6373b2"
      unitRef="usd">253000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfNS02LTEtMS0w_f7b7ee4d-1d8e-4f0b-9f98-c38af737cfb3"
      unitRef="usd">279000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfNi0yLTEtMS0w_7b72882e-794c-4198-96da-0502c47f81d0"
      unitRef="usd">-780000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfNi00LTEtMS0w_757352ad-7e31-44fb-9e48-25063f8cf1f3"
      unitRef="usd">805000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfNi02LTEtMS0w_16eada1d-9c66-4596-80b6-5b19081f7722"
      unitRef="usd">933000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfNy0yLTEtMS0w_fbde91f2-19c0-4c44-a2ce-907844af38bb"
      unitRef="usd">173000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfNy00LTEtMS0w_0b405597-0cae-4184-8c94-f6c8257bdb57"
      unitRef="usd">75000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfNy02LTEtMS0w_af7224ba-c02a-4d0e-b860-231e9bda1b4e"
      unitRef="usd">104000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfOC0yLTEtMS0w_017f5c2b-a073-4302-957c-d848a9831ce5"
      unitRef="usd">40000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfOC00LTEtMS0w_1e263733-26ce-47f8-b3f4-4acf5834d1ca"
      unitRef="usd">17000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfOC02LTEtMS0w_80d0b0f6-0900-4306-9f0d-3d0d6a42cc7f"
      unitRef="usd">24000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfOS0yLTEtMS0w_432187fb-d203-4f13-8463-56e818e7eb8e"
      unitRef="usd">133000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfOS00LTEtMS0w_5047e6f0-d872-43e2-b58f-2e145cbc567d"
      unitRef="usd">58000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfOS02LTEtMS0w_9de5155d-b018-4772-b8cb-737e9b65f5da"
      unitRef="usd">80000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfMTAtMi0xLTEtMA_4117f5e2-1718-482a-a13f-1f8f42d91346"
      unitRef="usd">-657000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfMTAtNC0xLTEtMA_cdd7b14a-831a-4634-b842-ede723b91284"
      unitRef="usd">-983000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfMTAtNi0xLTEtMA_e9a00377-b50f-41c0-b3c7-8c3b46da6d6e"
      unitRef="usd">-271000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfMTEtMi0xLTEtMA_2f6b7c72-5210-47b4-ab8d-c9ac29146d0b"
      unitRef="usd">-1570000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfMTEtNC0xLTEtMA_7e26b505-a92d-40fd-86eb-cff686d52c88"
      unitRef="usd">-236000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfMTEtNi0xLTEtMA_d13bb762-b9ff-4335-beb0-8821a9597805"
      unitRef="usd">582000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfMTItMi0xLTEtMA_8684aa2a-4e8b-4e20-9b70-a37c09091c09"
      unitRef="usd">16162000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfMTItNC0xLTEtMA_11ab1a39-d1cb-4189-83d6-de735be0569b"
      unitRef="usd">15533000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfMTItNi0xLTEtMA_61e4450c-84ff-4590-9540-068683aa3d6a"
      unitRef="usd">14821000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfMTMtMi0xLTEtMA_742bbc2e-9007-41bc-a034-b0b3f9135290"
      unitRef="usd">447000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfMTMtNC0xLTEtMA_76c293c2-2310-4887-bd00-44e605761fea"
      unitRef="usd">366000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfMTMtNi0xLTEtMA_afa7a0d8-c4d7-4130-b6c8-e28a462a1fc3"
      unitRef="usd">400000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfMTQtMi0xLTEtMA_0c695b77-f975-4180-b346-2b2dd3b9731f"
      unitRef="usd">15715000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfMTQtNC0xLTEtMA_e4c44450-6144-4bca-9356-a603391b4b00"
      unitRef="usd">15167000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV84OC9mcmFnOjMyOWEzNDEwNmI3NzQ1YWU5M2FhNjM2NTE1ZGQ1NmI2L3RhYmxlOmE4NmM5YTcwOTE2OTRhNWM5ZmM1YTBjOWFlY2I2YWIxL3RhYmxlcmFuZ2U6YTg2YzlhNzA5MTY5NGE1YzlmYzVhMGM5YWVjYjZhYjFfMTQtNi0xLTEtMA_c04c110c-3b51-4534-8134-d591d46388b5"
      unitRef="usd">14421000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i93c9b8bdda4a422883687239d22ec90b_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMi0yLTEtMS0w_1536e54d-f8c7-4d67-9e34-9abe2ba881e8"
      unitRef="shares">960000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i93c9b8bdda4a422883687239d22ec90b_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMi00LTEtMS0w_1f013b55-fba0-4c20-9640-93f7139b5129"
      unitRef="usd">10000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7de78e50178f4dd78f67556f70d9e637_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMi02LTEtMS0w_84ba604e-d2fd-4734-b38c-87052e57ebf6"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8eae67f0f11a4c898fa1dedd55840500_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMi04LTEtMS0w_87ec9127-2f2a-49d9-a870-19b4cedf15fd"
      unitRef="usd">55846000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i315e24e23ae44a01836f60086f1fd315_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMi0xMC0xLTEtMA_582bb0d6-3cfd-4f42-932b-8323948a12ab"
      unitRef="usd">-264000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie5ac330194c449fd8d7d91f71917f488_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMi0xMi0xLTEtMA_4bfb2456-43f4-4b73-b222-210f43536dba"
      unitRef="usd">-3896000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3bca26759d4145299e751f4f22f5f1fd_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMi0xNC0xLTEtMA_d5129e12-70e7-4626-8f32-c3dad4f271d8"
      unitRef="usd">2623000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i870730cd9dfc45bb89971499ab4cdd48_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMi0xNi0xLTEtMA_c9804287-c4bf-4836-91dd-2e7c4bc0aad4"
      unitRef="usd">54319000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i509cd57b44304b8fb05235033e28b2bf_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMy04LTEtMS0w_0f8076e3-08ec-4aa0-8d6f-bb8989c948f4"
      unitRef="usd">-13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i28a6344b404a41c18ed41602af107cc3_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMy0xNC0xLTEtMjYy_6a7ffbd5-9f56-4361-8d24-8f20ed2c9b20"
      unitRef="usd">-5000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1c99cfb64bc04618a8af89c6e3780c50_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMy0xNi0xLTEtMA_25aaafda-af24-4fa0-9240-8ad82068cca9"
      unitRef="usd">-18000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i93754eb2a7814682a663dc4a8233c401_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfNC04LTEtMS0w_1361a854-9211-4299-a023-037b6ac3eb3c"
      unitRef="usd">13839000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
      contextRef="ie2ffd7130e2647e2b0e793e2a0f526a3_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfNC0xNC0xLTEtMA_ff1537e6-217e-4955-a321-2230950f3315"
      unitRef="usd">285000000</us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfNC0xNi0xLTEtMA_8b9ff98e-b51c-42de-bc13-1e9e1d4c7204"
      unitRef="usd">14124000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i930490d923ac4f958c17a0c16169ecfd_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfNS0xMC0xLTEtMA_3a6fb7f6-b374-4754-a5ee-cb533ca9f1d6"
      unitRef="usd">853000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i01af9c575b984fbb810a65816e8f5c90_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfNS0xMi0xLTEtMA_6245ef6e-99e2-4af9-b334-688de559d384"
      unitRef="usd">-271000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfNS0xNi0xLTEtMA_466b84fc-176a-4bfb-91d9-0cde7f999d60"
      unitRef="usd">582000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i4ac3cd6c11db4467b4b8b2a362706d03_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfNi0yLTEtMS0w_21b6bab8-ff3c-48b0-8b34-52ec760b848f"
      unitRef="shares">10000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i4ac3cd6c11db4467b4b8b2a362706d03_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfNi00LTEtMS0w_b26af06c-f5e8-4a50-ba77-0b738c5d120a"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i1f76f41fc9da46f2a0884ca2b30659d4_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfNi02LTEtMS0w_27887a10-6d34-456d-af97-425bda005a5a"
      unitRef="usd">696000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfNi0xNi0xLTEtMA_505f49cc-11e3-416f-b4c3-a0c4a8685839"
      unitRef="usd">696000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i1f76f41fc9da46f2a0884ca2b30659d4_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfNy02LTEtMS0w_053ab6b9-633d-4c2c-bfff-425477787766"
      unitRef="usd">673000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfNy0xNi0xLTEtMA_7b9c9acc-58c4-433f-97dc-159f1ca742c1"
      unitRef="usd">673000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i4ac3cd6c11db4467b4b8b2a362706d03_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfOC0yLTEtMS0w_d359bc6d-dbed-4838-a2f2-0daf24985186"
      unitRef="shares">22000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i4ac3cd6c11db4467b4b8b2a362706d03_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfOC00LTEtMS0w_bb9cbedd-2687-417b-8e9a-5b5f92b0c6f2"
      unitRef="usd">1000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i1f76f41fc9da46f2a0884ca2b30659d4_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfOC02LTEtMS0w_30781c14-b6e2-4822-a77a-e83367c07d1e"
      unitRef="usd">937000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i93754eb2a7814682a663dc4a8233c401_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfOC04LTEtMS0w_f914aa78-d995-43a5-a464-3ed6f3f2f9e8"
      unitRef="usd">4562000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfOC0xNi0xLTEtMA_817bc9c1-1778-4425-b38c-7d948332cbef"
      unitRef="usd">5500000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfOS0wLTEtMS0wL3RleHRyZWdpb246MmJjYWM2ZWMyM2E2NDEwNjk3N2VkYTJjYTQ3ZjY2M2NfNDM_d31352b5-e293-4127-aa36-2a74722e0422"
      unitRef="usdPerShare">4.14</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DividendsCash
      contextRef="i93754eb2a7814682a663dc4a8233c401_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfOS04LTEtMS0w_43d438c7-897c-4dde-a7a5-f0b4c3783bd8"
      unitRef="usd">3932000000</us-gaap:DividendsCash>
    <us-gaap:DividendsCash
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfOS0xNi0xLTEtMA_1496a7d7-56d6-4266-a614-6c0c9c087b10"
      unitRef="usd">3932000000</us-gaap:DividendsCash>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i1f76f41fc9da46f2a0884ca2b30659d4_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTAtNi0xLTEtMA_1a93c176-5624-4e27-a05c-b81a6c1f7c71"
      unitRef="usd">316000000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTAtMTYtMS0xLTA_a3a4b933-261b-479c-81a2-9e45ad981d92"
      unitRef="usd">316000000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="i1f76f41fc9da46f2a0884ca2b30659d4_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTEtNi0xLTEtNDY2_a17ad38e-9a29-4c67-a000-99c7f2902e31"
      unitRef="usd">-109000000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="ie2ffd7130e2647e2b0e793e2a0f526a3_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTEtMTQtMS0xLTA_58aa8e8e-c530-43bd-9db5-a3e6c2f34bda"
      unitRef="usd">196000000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTEtMTYtMS0xLTA_11dd09ad-9728-4af1-9f28-df562c9d8ab2"
      unitRef="usd">87000000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ie2ffd7130e2647e2b0e793e2a0f526a3_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTItMTQtMS0xLTA_88b84e0f-3e5d-43c9-8047-13ae8fa80908"
      unitRef="usd">279000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTItMTYtMS0xLTA_213fb459-341b-408c-a773-9d9c06676b6f"
      unitRef="usd">279000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ieebefefe33444454986842a74b0799e9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTMtMi0xLTEtMA_d37c969c-2bf7-469f-8df2-6b0a12b49cb0"
      unitRef="shares">948000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ieebefefe33444454986842a74b0799e9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTMtNC0xLTEtMA_d73d0079-f3ae-4de8-89de-792124993091"
      unitRef="usd">9000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i070f515f1b0a4ce9b417c2adcffa3bc0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTMtNi0xLTEtMA_7f5de4a1-2722-4fad-9a87-e1c71906efa7"
      unitRef="usd">7000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i79b55573683d48f8b6dfa7e39455622e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTMtOC0xLTEtMA_e167a745-c988-4bca-8795-52a565f9bd1a"
      unitRef="usd">61178000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5ca981dc06144e079639ca1af5c729c7_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTMtMTAtMS0xLTA_365b6c59-808f-4368-9779-fece65e69f0d"
      unitRef="usd">589000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia27e856d3af841b3a28c74b0c8109477_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTMtMTItMS0xLTA_1f7eacc0-359e-45d5-bace-224f5c91d52c"
      unitRef="usd">-4167000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9d57e9b440f94b42ade5424c81274932_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTMtMTQtMS0xLTA_6d3d55c2-2bbf-428a-8477-d0a03439e3b7"
      unitRef="usd">2820000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i530caf840d4847f1ac553be5f7b336b2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTMtMTYtMS0xLTA_e4063157-2398-48c6-929f-d559dadeef33"
      unitRef="usd">60436000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9c49e5bd973a474d93bece3aedf4801f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTQtOC0xLTEtMA_a8364a36-6b7d-411c-9382-41481046e08e"
      unitRef="usd">-28000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2fbd0b79127d43b29830dc7504fbbbd4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTQtMTYtMS0xLTA_48469549-32f4-4771-935c-46720089b36f"
      unitRef="usd">-28000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i4f099b39a9db4d7e8c625a6989f76ace_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTUtOC0xLTEtMA_3b0970ea-55ee-4f59-b12b-2bb8e5a7438e"
      unitRef="usd">15403000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
      contextRef="i3300d5a2eaaa4e0386e185cd95eae562_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTUtMTQtMS0xLTA_f46f7090-4af1-4f8d-8d8d-c55bd17e221c"
      unitRef="usd">254000000</us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTUtMTYtMS0xLTA_2354324e-3465-4e0e-8bf6-b212c361c6be"
      unitRef="usd">15657000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0378ff590db1498e8fec3c3e08138eb1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTYtMTAtMS0xLTA_5f2f258c-17ba-487c-920d-ebbfab4007b4"
      unitRef="usd">747000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i79edb1e59c054995bf5b8fe22cb060d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTYtMTItMS0xLTA_b8eb23c5-d99a-48b7-b166-45e83aa76df1"
      unitRef="usd">-983000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTYtMTYtMS0xLTA_f6182a48-014f-4bd9-b7d9-96156edcc2f3"
      unitRef="usd">-236000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i072d7c898f4243b8a611602a0b370dfd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTctMi0xLTEtMA_67137168-f702-4edd-a115-14eee6f8f733"
      unitRef="shares">12000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i072d7c898f4243b8a611602a0b370dfd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTctNC0xLTEtMA_e8408338-6a1b-4d26-9031-6b0fb66ba444"
      unitRef="usd">1000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i2c34096fce714d0c84c9883d2dbaae66_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTctNi0xLTEtMA_4ccaba06-dc87-47c4-a45d-37f9d7e1ebf8"
      unitRef="usd">1119000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTctMTYtMS0xLTA_ec4e349d-33a5-444b-b27a-c1e1a383461e"
      unitRef="usd">1120000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i2c34096fce714d0c84c9883d2dbaae66_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTgtNi0xLTEtMA_9ec51186-1939-4a41-aef5-daf09dd602f7"
      unitRef="usd">647000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTgtMTYtMS0xLTA_d7587761-855c-4d2d-8f0d-4d656e14958d"
      unitRef="usd">647000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i072d7c898f4243b8a611602a0b370dfd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTktMi0xLTEtMA_a1a31b35-43d2-494b-ba26-7deea196a708"
      unitRef="shares">14000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i072d7c898f4243b8a611602a0b370dfd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTktNC0xLTEtMA_ceb1ddb3-5db9-4db6-b294-42be485a3dc7"
      unitRef="usd">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i2c34096fce714d0c84c9883d2dbaae66_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTktNi0xLTEtMA_79a822b8-b30f-4a7b-92cc-c6eeffdd1de8"
      unitRef="usd">1576000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i4f099b39a9db4d7e8c625a6989f76ace_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTktOC0xLTEtMA_fb08c910-83b2-4906-b255-a5df701d75cf"
      unitRef="usd">2674000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMTktMTYtMS0xLTA_ba9637e9-7350-472a-aa3d-a19ed5235784"
      unitRef="usd">4250000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjAtMC0xLTEtMC90ZXh0cmVnaW9uOjM2ZmJjMzRjNzdiMTQ4NWNiZWI2ZGVkY2FmNzBiZmUwXzQz_04128702-012a-4135-9f00-1922cd7236eb"
      unitRef="usdPerShare">4.83</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DividendsCash
      contextRef="i4f099b39a9db4d7e8c625a6989f76ace_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjAtOC0xLTEtMA_b8facc05-1eac-4fb0-9eff-f265532e92d7"
      unitRef="usd">4584000000</us-gaap:DividendsCash>
    <us-gaap:DividendsCash
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjAtMTYtMS0xLTA_9e39a1db-50d8-412a-a410-ec8056bf5df4"
      unitRef="usd">4584000000</us-gaap:DividendsCash>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i2c34096fce714d0c84c9883d2dbaae66_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjEtNi0xLTEtMA_161a33eb-88e7-4fde-a6dc-0a0d8a006636"
      unitRef="usd">197000000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjEtMTYtMS0xLTA_8dafd4a7-690b-4486-aad1-ea59a79e538c"
      unitRef="usd">197000000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="i3300d5a2eaaa4e0386e185cd95eae562_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjItMTQtMS0xLTA_97be5030-b712-4acf-9143-7c6a94cce4ca"
      unitRef="usd">40000000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjItMTYtMS0xLTA_e10dcb4a-a40c-40d6-a423-e02a268b85c8"
      unitRef="usd">40000000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i3300d5a2eaaa4e0386e185cd95eae562_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjMtMTQtMS0xLTA_ddbd358a-23fe-4eb4-8143-4806ad413364"
      unitRef="usd">277000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjMtMTYtMS0xLTA_9268fe56-5980-49bb-841d-e621072cac23"
      unitRef="usd">277000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i5cc85a29e8934045a37d5be367d3db92_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjQtMi0xLTEtMA_39ff40b9-7ebf-4f45-a15a-500081818cd5"
      unitRef="shares">946000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5cc85a29e8934045a37d5be367d3db92_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjQtNC0xLTEtMA_f2db6d16-2ec8-4b4f-a03c-0df85e410322"
      unitRef="usd">10000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ied02258caa3547f1ac9db1ebac75e7b5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjQtNi0xLTEtMA_49e088ca-cb47-4458-9f6e-180537406d6d"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia1d7badbbfe74d128af9048d86a399ee_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjQtOC0xLTEtMA_93e53bd5-3826-4a42-aa10-7333cc0c7a10"
      unitRef="usd">69295000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7634c8268a7641f091bbd4593b6b3229_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjQtMTAtMS0xLTA_dc884c44-7b00-486d-b2b5-265e4ac1943c"
      unitRef="usd">1336000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2af08b82a1804b45b92fd387d2d6ebc7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjQtMTItMS0xLTA_03ea6177-e3a4-4324-b0cc-ffb3f6271f2b"
      unitRef="usd">-5150000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i78db576697a6474084de5301358e552a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjQtMTQtMS0xLTA_7e140b41-9f67-4ce0-984f-2506fe77c1dd"
      unitRef="usd">2837000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjQtMTYtMS0xLTA_2b17c3ca-26dc-43da-a2f0-f69fcbc59615"
      unitRef="usd">68328000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i54c9ed4fe57143d089532919ce622309_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjYtOC0xLTEtMA_5fb7afcd-faec-4ca1-a722-b155aa997fff"
      unitRef="usd">17285000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
      contextRef="i0c38985e71104ebf84a399c4c16d84b9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjYtMTQtMS0xLTA_cf811a5a-c79f-4829-91a0-46a8f1a751bb"
      unitRef="usd">360000000</us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjYtMTYtMS0xLTA_032ed9ce-8e69-4172-acf4-e92e38aaad76"
      unitRef="usd">17645000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2f46a298bc1a4e6da1439ecf4feef723_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjctMTAtMS0xLTA_e1ed8a92-d951-4e1f-b5c5-60332982ea9c"
      unitRef="usd">-913000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8a8e9219ee4b4394808f55b5e8635651_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjctMTItMS0xLTA_4839f76d-f893-4d7c-b013-30a363a14ed4"
      unitRef="usd">-657000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjctMTYtMS0xLTA_c8d6e4a5-d4d6-440d-9c62-5454d07132c2"
      unitRef="usd">-1570000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="icd650c47786d472789666a390d70daa2_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjgtMi0xLTEtMA_da9ac4af-2f2a-4956-8bc0-65aa5c4af364"
      unitRef="shares">8000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="icd650c47786d472789666a390d70daa2_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjgtNC0xLTEtMA_a4bf3bbf-3f69-4634-80b5-4a322289fe00"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i205c8dfff92c4b7b93596e6594ee9ef4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjgtNi0xLTEtMA_1c0bd8ec-d898-4f3e-9f17-ece8c4409e94"
      unitRef="usd">1100000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjgtMTYtMS0xLTA_2aaf89e2-9981-4303-b76e-e314c1464f98"
      unitRef="usd">1100000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i205c8dfff92c4b7b93596e6594ee9ef4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjktNi0xLTEtMA_6e9cd138-5644-4faa-ab2c-5314295e0119"
      unitRef="usd">729000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMjktMTYtMS0xLTA_2bcbc161-5c68-4cec-880d-0e90022ceaa8"
      unitRef="usd">729000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="icd650c47786d472789666a390d70daa2_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzAtMi0xLTEtMA_77f38013-c8a0-42e8-92f4-f494d515f50c"
      unitRef="shares">13000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="icd650c47786d472789666a390d70daa2_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzAtNC0xLTEtMA_76018f15-bb43-4764-94d7-d7f0a89468fa"
      unitRef="usd">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i205c8dfff92c4b7b93596e6594ee9ef4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzAtNi0xLTEtMA_4e003e97-2e14-46cd-833b-6ac26655dc6b"
      unitRef="usd">940000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i54c9ed4fe57143d089532919ce622309_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzAtOC0xLTEtMA_d7c6ee6a-2c40-4021-a79b-c8420de699da"
      unitRef="usd">4060000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzAtMTYtMS0xLTA_df911d72-3349-491a-bc29-1dea89b660c3"
      unitRef="usd">5000000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOmUwMTAyOTI3OTYxNDQ0MWQ5YzQ0YTljMjU5OWI3NTdlXzQz_269041d2-db31-48fa-ba22-d07337ace4db"
      unitRef="usdPerShare">5.60</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DividendsCash
      contextRef="i54c9ed4fe57143d089532919ce622309_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzEtOC0xLTEtMA_8933048f-4203-4aa8-9fc5-f103cf1f998f"
      unitRef="usd">5280000000</us-gaap:DividendsCash>
    <us-gaap:DividendsCash
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzEtMTYtMS0xLTA_53e2f265-b7e1-442d-b607-b122b73803c7"
      unitRef="usd">5280000000</us-gaap:DividendsCash>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i205c8dfff92c4b7b93596e6594ee9ef4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzItNi0xLTEtMA_471c41f7-2294-4490-b119-b3d74b3e6ca4"
      unitRef="usd">889000000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i54c9ed4fe57143d089532919ce622309_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzEtOC0xLTEtMTYwMzI_22ab4000-ac67-4deb-a4ee-e7f07b32cae6"
      unitRef="usd">106000000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzItMTYtMS0xLTA_33e3fc79-388b-4f87-a5c8-4851282ded78"
      unitRef="usd">995000000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="i0c38985e71104ebf84a399c4c16d84b9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzMtMTQtMS0xLTA_027ecbd1-cee3-40a6-b69a-cb71d7fa94d8"
      unitRef="usd">407000000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzMtMTYtMS0xLTA_ce78427e-9245-4058-8411-759a05b6961a"
      unitRef="usd">407000000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i0c38985e71104ebf84a399c4c16d84b9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzQtMTQtMS0xLTA_ca1e730c-33f7-49fe-a733-134914a57271"
      unitRef="usd">319000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzQtMTYtMS0xLTA_c038639f-7100-44bc-9067-b2d3d09e62af"
      unitRef="usd">319000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i593bf0b079e04f058cf0f21f5585b069_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzUtMi0xLTEtMA_66ebe40f-54ae-4feb-b790-a36333ac99d5"
      unitRef="shares">941000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i593bf0b079e04f058cf0f21f5585b069_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzUtNC0xLTEtMA_d084e4e8-8d44-4fc5-8c1e-92f41292588d"
      unitRef="usd">10000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic04e77b5e9904fcc9c97df541ef3f22a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzUtNi0xLTEtMA_b96e9c15-ea2f-420e-bfa9-9b0b4dc8e5ee"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6cb7b25ac2db413db39f0363a9eed1e3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzUtOC0xLTEtMA_f45b4a05-b4b3-4dfb-92e0-fede6c6e3996"
      unitRef="usd">77134000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i275d8d15f1794b78972e85e3f1725cd4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzUtMTAtMS0xLTA_ea74d519-a55a-45ee-bc39-bc6bc4e931d9"
      unitRef="usd">423000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4e144bfae9ce400699c59ff4175549af_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzUtMTItMS0xLTA_debe1f3d-94b2-48e6-8f7d-c7a82e15101e"
      unitRef="usd">-5807000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic7a74722ffca455e8f8b9d9120092a96_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzUtMTQtMS0xLTA_3f6d53dd-23ec-4bb8-aeee-0614e730a197"
      unitRef="usd">3285000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85MS9mcmFnOjJkNjBiZGYxNjJmZTQyMDM5MTg4OGM0MTQxZWExYzMyL3RhYmxlOjY3Yjc2OTdlZjFmNzRhOWQ4OTQ1N2Y5OGVlNmFjYzVlL3RhYmxlcmFuZ2U6NjdiNzY5N2VmMWY3NGE5ZDg5NDU3Zjk4ZWU2YWNjNWVfMzUtMTYtMS0xLTA_682a4d0d-c599-45ff-be77-7b9f6c30a242"
      unitRef="usd">75045000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMy0yLTEtMS0w_35292c4d-3afa-481d-b53a-49a362b9eb13"
      unitRef="usd">17732000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMy00LTEtMS0w_86cab7c3-2366-4c78-906f-e6944ddffa66"
      unitRef="usd">15769000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMy02LTEtMS0w_cdce61c2-1dfb-4c9d-b560-1fbbe4be71f6"
      unitRef="usd">14239000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationAndAmortization
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfNS0yLTEtMS0w_64bce8a2-012e-40b7-90f3-5f762e8f5b5f"
      unitRef="usd">3103000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfNS00LTEtMS0w_7a57e0d1-af85-4fdb-b165-316137b5ace2"
      unitRef="usd">2891000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfNS02LTEtMS0w_800aa3f4-1e14-4700-bc87-7f864d887558"
      unitRef="usd">2720000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfNi0yLTEtMS0w_67a88c1c-7ea1-4758-a315-bfe776ae2b3e"
      unitRef="usd">130000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfNi00LTEtMS0w_0a44d238-c1ed-496b-86f8-79c727ddb35a"
      unitRef="usd">-8000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfNi02LTEtMS0w_da260a01-459a-4713-adcc-e63c9a66de0a"
      unitRef="usd">230000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensation
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfNy0yLTEtMS0w_bd9a32a1-858a-4b77-b5d8-c916b3e30d90"
      unitRef="usd">800000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfNy00LTEtMS0w_ef74bf32-6622-4a8b-a1ec-41485fbc8e2d"
      unitRef="usd">679000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfNy02LTEtMS0w_78adf477-915c-4aa6-b7e7-cb4ebed2157c"
      unitRef="usd">697000000</us-gaap:ShareBasedCompensation>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfOC0yLTEtMS0w_fcb61773-5737-4ff2-ae51-6117d5432f15"
      unitRef="usd">944000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfOC00LTEtMS0w_e30ca8e0-c53e-4224-a641-811dbb6ce992"
      unitRef="usd">52000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfOC02LTEtMS0w_ab60e37c-6a33-49ad-84e1-18bab71c7561"
      unitRef="usd">106000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTAtMi0xLTEtMA_26c70c2b-cdbc-4858-91e6-614ff1cf3e38"
      unitRef="usd">1000000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTAtNC0xLTEtMA_6ed531c9-bef9-407c-a519-e868582304c6"
      unitRef="usd">688000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTAtNi0xLTEtMA_4bb131d3-6ed5-472c-8779-94a343444db6"
      unitRef="usd">-162000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTEtMi0xLTEtMA_8934f4d6-279d-4d60-8227-fb5fcaa9ce92"
      unitRef="usd">1031000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTEtNC0xLTEtMA_567de8fa-93ec-406b-955a-31d6ff07ba8e"
      unitRef="usd">2195000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTEtNi0xLTEtMA_c5f21ade-9eb1-45e8-a53d-851759ae9269"
      unitRef="usd">1563000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTItMi0xLTEtMA_d6f4f18c-f9cd-4768-8fef-9236cbf36a22"
      unitRef="usd">2701000000</us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTItNC0xLTEtMA_2713896d-601f-45a8-8109-e762c9989483"
      unitRef="usd">152000000</us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTItNi0xLTEtMA_f5738dad-e521-4e11-86e9-36a3fc9b4885"
      unitRef="usd">1221000000</us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTMtMi0xLTEtMA_3651311b-76bf-49f2-9719-768e9477bc46"
      unitRef="usd">1162000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTMtNC0xLTEtMA_78ace464-c26b-443d-ae7c-867075818caa"
      unitRef="usd">5348000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTMtNi0xLTEtMA_eb84e24b-9a5b-4612-bc1e-4bcff3790694"
      unitRef="usd">733000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTQtMi0xLTEtMA_c3d6b8e4-0ed1-4200-8bb9-ab293c51519a"
      unitRef="usd">-310000000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTQtNC0xLTEtMA_3e905d3e-0cb3-4961-95d2-ecffbff4e68e"
      unitRef="usd">278000000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTQtNi0xLTEtMA_185a46c2-d902-4511-9317-6458785c1305"
      unitRef="usd">130000000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTUtMi0xLTEtMA_74ff1acd-241e-4481-9505-6ac9d70e5dcd"
      unitRef="usd">22343000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTUtNC0xLTEtMA_67633833-5fc2-4cd2-b83d-e4bc5c5f80c1"
      unitRef="usd">22174000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTUtNi0xLTEtMA_15835d5c-7ab1-40ca-8d1c-1d589a2faaa3"
      unitRef="usd">18463000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTctMi0xLTEtMA_01a8cb67-ed5d-4049-aed5-e747184ebbf2"
      unitRef="usd">17139000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTctNC0xLTEtMA_67a4325d-78d7-42d3-8d5b-6116e69115d8"
      unitRef="usd">16577000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTctNi0xLTEtMA_e5ad9d06-33af-4cb9-b8d4-a3c32ffe5001"
      unitRef="usd">18131000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTgtMi0xLTEtMA_6f916f50-043f-42ba-bbec-c11d1151d6bf"
      unitRef="usd">7045000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTgtNC0xLTEtMA_21baa01a-85c8-49e1-bbfe-a866ef185cee"
      unitRef="usd">6489000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTgtNi0xLTEtMA_57cb239e-1b1f-4ef1-9e17-6e5a03690369"
      unitRef="usd">8536000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTktMi0xLTEtMA_784edaa5-fb00-4e9f-a9a1-abb47f640f4b"
      unitRef="usd">8251000000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTktNC0xLTEtMA_925b9a65-dba0-4ab8-b942-d6cfad213aff"
      unitRef="usd">7252000000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMTktNi0xLTEtMA_24dc7fe1-d540-4a18-b899-e5fe6b62146c"
      unitRef="usd">7091000000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjAtMi0xLTEtMA_a616ffb4-e5a5-4660-9d4b-c06bf0268427"
      unitRef="usd">4821000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjAtNC0xLTEtMA_1be9c265-301c-4bce-90b9-8fc09f9fec19"
      unitRef="usd">7139000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjAtNi0xLTEtMA_ee935b5b-560c-413d-bd5d-348bdba358a2"
      unitRef="usd">8343000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjEtMi0xLTEtMA_e28b2445-1ea6-4a36-94bd-f5bf57ec2b40"
      unitRef="usd">2454000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjEtNC0xLTEtMA_ee26d16e-2887-40ad-83fe-58dac44c6ebc"
      unitRef="usd">2051000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjEtNi0xLTEtMA_6888329d-6f28-4357-8531-dfd8cba50108"
      unitRef="usd">2071000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjItMi0xLTEtMA_d43fffa9-3aba-4322-b1c7-8752a42141cf"
      unitRef="usd">1254000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjItNC0xLTEtMA_a9bc9fba-4137-4f1e-981b-b8dc8ea14e9d"
      unitRef="usd">506000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjItNi0xLTEtMA_729a55b7-bcf6-4537-a660-5b6e5e46c286"
      unitRef="usd">-219000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjMtMi0xLTEtMA_97469cac-a6ec-4b7e-af79-c37f20d3ab03"
      unitRef="usd">-10372000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjMtNC0xLTEtMA_2d758d97-fdee-489e-bed1-8e861290e85b"
      unitRef="usd">-12532000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjMtNi0xLTEtMA_f57178d3-5668-4d3f-bf21-5c968b8866be"
      unitRef="usd">-12699000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjUtMi0xLTEtMA_fe42e92f-e3fa-470f-9b88-34fbdfdca89e"
      unitRef="usd">5000000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjUtNC0xLTEtMA_f3311762-4783-42c2-87d6-534a9472b81f"
      unitRef="usd">4250000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjUtNi0xLTEtMA_ee0c3ee2-3747-4d45-8a37-37d2a2d2101d"
      unitRef="usd">5500000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjYtMi0xLTEtMA_f39cc00d-886f-49a8-8043-a77a24c8eb14"
      unitRef="usd">5280000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjYtNC0xLTEtMA_237d303f-bc64-4357-9f08-75eef74513fb"
      unitRef="usd">4584000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjYtNi0xLTEtMA_88037948-4e6e-4200-8309-e1b5836e5eef"
      unitRef="usd">3932000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjctMi0xLTEtMA_37b71e01-6cdb-41fc-ba86-0c534172c4db"
      unitRef="usd">1355000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjctNC0xLTEtMA_3240f7b4-cdac-4869-b380-007774314653"
      unitRef="usd">1440000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjctNi0xLTEtMA_b155768d-fda9-4571-85ca-56c016726b8a"
      unitRef="usd">1037000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjgtMi0xLTEtMA_1cdb9f19-6c87-4cc2-a550-f999f9b056a7"
      unitRef="usd">3150000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjgtNC0xLTEtMA_7880e0ea-f460-4296-a246-7c424023314c"
      unitRef="usd">3150000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjgtNi0xLTEtMA_305ebeca-1e92-4ecf-bae4-c91a3b9e7466"
      unitRef="usd">1750000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfCommercialPaper
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjktMi0xLTEtMA_fb1fc911-2729-49e6-86d3-651c185f4ded"
      unitRef="usd">-1302000000</us-gaap:ProceedsFromRepaymentsOfCommercialPaper>
    <us-gaap:ProceedsFromRepaymentsOfCommercialPaper
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjktNC0xLTEtMA_f518c580-8d5a-4905-92f7-f09049b82f1e"
      unitRef="usd">872000000</us-gaap:ProceedsFromRepaymentsOfCommercialPaper>
    <us-gaap:ProceedsFromRepaymentsOfCommercialPaper
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMjktNi0xLTEtMA_26591415-7345-4351-abf6-73cb25e89f27"
      unitRef="usd">300000000</us-gaap:ProceedsFromRepaymentsOfCommercialPaper>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzAtMi0xLTEtMA_fa4eb38e-793c-43ef-9dee-4f70391a3765"
      unitRef="usd">6933000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzAtNC0xLTEtMA_68a584b4-dca5-475d-9e2d-0672aa624988"
      unitRef="usd">4864000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzAtNi0xLTEtMA_001deb4c-4800-4d0c-a714-8c7a704b9ef9"
      unitRef="usd">5444000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:IncreaseDecreaseInDeposits
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzEtMi0xLTEtMA_b9174154-9b26-4bc3-b2ef-9c050f3ea5a9"
      unitRef="usd">622000000</us-gaap:IncreaseDecreaseInDeposits>
    <us-gaap:IncreaseDecreaseInDeposits
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzEtNC0xLTEtMA_1719a3cb-4ae6-4269-b963-d967582a7d31"
      unitRef="usd">1677000000</us-gaap:IncreaseDecreaseInDeposits>
    <us-gaap:IncreaseDecreaseInDeposits
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzEtNi0xLTEtMA_40aeb6aa-6cba-43e6-ae79-935bb797db84"
      unitRef="usd">13000000</us-gaap:IncreaseDecreaseInDeposits>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzItMi0xLTEtMTY5MTI_4090781e-1e9b-45b9-a01d-3cb98e127728"
      unitRef="usd">1338000000</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzItNC0xLTEtMTY5MTg_ec0c021c-5f0f-451d-8ccb-4f1b436c7192"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzItNi0xLTEtMTY5MjQ_d9ce41cc-2239-4c16-be43-00733168d4af"
      unitRef="usd">618000000</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzItMi0xLTEtMA_29e39349-a0ed-4d4e-83ad-4b4973700802"
      unitRef="usd">-295000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzItNC0xLTEtMA_11fbaf25-ee6b-467c-8179-11594b7e9820"
      unitRef="usd">-459000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzItNi0xLTEtMA_11baee78-61b7-4b38-bdd4-217b18ff4fc1"
      unitRef="usd">-619000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzMtMi0xLTEtMA_624d0b5a-54f1-4e56-84a8-f018361a42b1"
      unitRef="usd">-7455000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzMtNC0xLTEtMA_e8117081-ec91-45d1-8754-920595520fee"
      unitRef="usd">-3590000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzMtNi0xLTEtMA_1488ab9c-4115-4950-b5a6-f09de2dba2e8"
      unitRef="usd">-5625000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzQtMi0xLTEtMA_63ce3dc8-de18-4183-84cf-7e40d9b4ca2c"
      unitRef="usd">-62000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzQtNC0xLTEtMA_8a4507bd-9ec7-4a02-9b33-6ba619dd45eb"
      unitRef="usd">-116000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzQtNi0xLTEtMA_17db1578-3350-4e9e-a1b4-de858c0ab406"
      unitRef="usd">-20000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzUtMi0xLTEtMA_2061f027-1a73-4b1e-b3cc-37e597296498"
      unitRef="usd">4454000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzUtNC0xLTEtMA_33327d1d-3a72-45a4-8c60-a6d286fc80fd"
      unitRef="usd">5936000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzUtNi0xLTEtMA_ca192c55-b1b5-40ea-b8cc-fc9a114c3ae7"
      unitRef="usd">119000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzYtMi0xLTEtMA_3b70c74f-302b-4189-8671-8a4dc30e1087"
      unitRef="usd">16921000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i530caf840d4847f1ac553be5f7b336b2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzYtNC0xLTEtMA_e9d89e32-79c5-4cfd-9ceb-39d9f3fcf936"
      unitRef="usd">10985000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i870730cd9dfc45bb89971499ab4cdd48_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzYtNi0xLTEtMA_05ccc3bc-123d-4bc2-8e88-2c40f568865d"
      unitRef="usd">10866000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzctMi0xLTEtMA_53a2148d-9bdc-453c-9219-45fe74c6dd53"
      unitRef="usd">21375000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzctNC0xLTEtMA_bc5b4131-68af-4b6f-b09f-9ac32cf29f96"
      unitRef="usd">16921000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i530caf840d4847f1ac553be5f7b336b2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfMzctNi0xLTEtMA_70e624c7-7b26-408b-ad2e-38e312dc8044"
      unitRef="usd">10985000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:InterestPaidNet
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfNDAtMi0xLTEtMA_e2350b48-c049-49da-b63c-15b8d0682f95"
      unitRef="usd">1653000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfNDAtNC0xLTEtMA_d57d7184-b74a-4cd1-a096-084be3812954"
      unitRef="usd">1704000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfNDAtNi0xLTEtMA_40a4b21d-20c7-4596-9000-55b47efb05f9"
      unitRef="usd">1627000000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfNDEtMi0xLTEtMA_39b4937a-cfe0-4f04-97e9-34e97192ee70"
      unitRef="usd">3966000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfNDEtNC0xLTEtMA_b38b9b97-dffd-43b0-b84b-739a5091c323"
      unitRef="usd">4935000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV85Ny9mcmFnOjA3MWM4MGFiNDk0YzRhNDdhMjk1YTVmMWRmMGNkZmM4L3RhYmxlOjhlZWUxOTc3ZjE0NzRhODlhNjEwOTExY2ViOWU1OGZhL3RhYmxlcmFuZ2U6OGVlZTE5NzdmMTQ3NGE4OWE2MTA5MTFjZWI5ZTU4ZmFfNDEtNi0xLTEtMA_8292fdbe-fbeb-48aa-b162-9f3e8000a696"
      unitRef="usd">3542000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:NatureOfOperations
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMDMvZnJhZzpiMWZlODMxZjQ1YTA0ZTNhODdkNTUwNTdmYTM2Mzc0Yy90ZXh0cmVnaW9uOmIxZmU4MzFmNDVhMDRlM2E4N2Q1NTA1N2ZhMzYzNzRjXzE2NDkyNjc0NDMyODE_708d631f-6056-4d78-be58-ccb124b860f3">Description of BusinessUnitedHealth Group Incorporated (individually and together with its subsidiaries, &#x201c;UnitedHealth Group&#x201d; and &#x201c;the Company&#x201d;) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone. Our two distinct, yet complementary business platforms &#x2014; Optum and UnitedHealthcare &#x2014; are working to help build a modern, high-performing health system through improved access, affordability, outcomes and experiences for the individuals and organizations we are privileged to serve.</us-gaap:NatureOfOperations>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMDYvZnJhZzo5NjBjMjc5MzI4ZTU0OWE2YTA3NDBhYzljOWVhNmMzNC90ZXh0cmVnaW9uOjk2MGMyNzkzMjhlNTQ5YTZhMDc0MGFjOWM5ZWE2YzM0XzE2NDkyNjc0NDIyMzE_eb6d4a2f-9b4b-4cfc-9d9b-95b2c442dbfb">Basis of Presentation, Use of Estimates and Significant Accounting Policies&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has prepared the Consolidated Financial Statements according to U.S. Generally Accepted Accounting Principles (GAAP) and has included the accounts of UnitedHealth Group and its subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These Consolidated Financial Statements include certain amounts based on the Company&#x2019;s best estimates and judgments. The Company&#x2019;s most significant estimates relate to estimates and judgments for medical costs payable and goodwill. Certain of these estimates require the application of complex assumptions and judgments, often because they involve matters inherently uncertain and will likely change in subsequent periods. The impact of any change in estimates is included in earnings in the period in which the estimate is adjusted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenues &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Premiums&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Premium revenues are primarily derived from risk-based health insurance arrangements in which the premium is typically at a fixed rate per individual served for a one-year period, and the Company assumes the economic risk of funding its customers&#x2019; health care and related administrative costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Premium revenues are recognized in the period in which eligible individuals are entitled to receive health care benefits. Health care premium payments received from the Company&#x2019;s customers in advance of the service period are recorded as unearned revenues. Fully insured commercial products of U.S. health plans, Medicare Advantage and Medicare Prescription Drug Benefit (Medicare Part D) plans with medical loss ratios (MLRs) as calculated under the definitions in the Patient Protection and Affordable Care Act (ACA) and related federal and state regulations and implementing regulation, falling below certain targets are required to rebate ratable portions of their premiums annually. Commercial premiums within the Company&#x2019;s individual and small group markets are also subject to the ACA risk adjustment program. Medicare Advantage premium revenue includes the impact of the Centers for Medicare &amp;amp; Medicaid Services (CMS) quality bonuses based on plans&#x2019; Star rating. Certain of the Company&#x2019;s Medicaid business is also subject to state minimum MLR rebates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Premium revenues are recognized based on the estimated premiums earned, net of projected rebates, because the Company is able to reasonably estimate the ultimate premiums of these contracts. The Company also records premium revenues for certain value-based arrangements at its Optum Health care delivery businesses. Under these value-based arrangements, the Company enters into agreements with health plans to stand ready to deliver, integrate, direct and control certain health care services for the individuals enrolled. In exchange, the Company receives a premium that is typically paid on a per-member per-month basis. The Company considers these value-based arrangements to represent a single performance obligation where premium revenues are recognized in the period in which health care services are made available.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s Medicare Advantage and Medicare Part D premium revenues are subject to periodic adjustment under CMS&#x2019; risk adjustment payment methodology. CMS deploys a risk adjustment model which apportions premiums paid to all health plans according to health severity and certain demographic factors. The CMS risk adjustment model provides higher per member payments for enrollees diagnosed with certain conditions and lower payments for enrollees who are healthier. Under this risk adjustment methodology, CMS calculates the risk adjusted premium payment using diagnosis and encounter data from hospital inpatient, hospital outpatient and physician treatment settings. The Company and health care providers collect, capture and submit the necessary and available data to CMS within prescribed deadlines. The Company estimates risk adjustment premium revenues based upon the data submitted and expected to be submitted to CMS. Risk adjustment data for the Company&#x2019;s plans are subject to review by the government, including audit by regulators. See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_217" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 12&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information regarding these audits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Products and Services&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the Company&#x2019;s Optum Rx pharmacy care services business, the majority of revenues are derived from products sold through a contracted network of retail pharmacies or home delivery, specialty and community health pharmacies. Product revenues include the cost of pharmaceuticals (net of rebates), a negotiated dispensing fee and customer co-payments for drugs dispensed through the Company&#x2019;s home delivery, specialty and community pharmacies. For the years ended December 31, 2021 and 2020, the Company recognized revenue and cost of products sold for retail pharmacy co-payments related to its Optum Rx business. Revenue recognized in prior periods related to retail pharmacy transactions excludes the member&#x2019;s applicable co-payment. There was no impact on earnings from operations, net earnings, earnings per share or total equity. Pharmacy products are billed to customers based on the number of transactions occurring during the billing period. Product revenues are recognized when the prescriptions are dispensed. The Company has entered into contracts in which it is primarily obligated to pay its network pharmacy providers for benefits provided to their customers regardless of whether the Company is paid. The Company is also involved in establishing the prices charged by retail pharmacies, determining which drugs will be included in formulary listings and selecting which retail pharmacies will be included in the network offered to plan sponsors&#x2019; members and accordingly, are reported on a gross basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Services revenue are comprised of a number of services and products sold through Optum. Optum Health&#x2019;s service revenues include net patient service revenues recorded based upon established billing rates, less allowances for contractual adjustments, and are recognized as services are provided. For its financial services offerings, Optum Health charges fees and earns investment income on managed funds. Optum Insight provides software and information products, advisory consulting arrangements and managed services outsourcing contracts, which may be delivered over several years. Optum Insight revenues are generally recognized over time and measured each period based on the progress to date as services are performed or made available to customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Services revenue also consists of fees derived from services performed for customers who self-insure the health care costs of their employees and employees&#x2019; dependents. Under service fee contracts, the Company receives monthly, a fixed fee per employee, which is recognized as revenue as the Company performs, or makes available, the applicable services to the customer. The customers retain the risk of financing health care costs for their employees and employees&#x2019; dependents, and the Company administers the payment of customer funds to physicians and other health care professionals from customer-funded bank accounts. As the Company has neither the obligation for funding the health care costs, nor the primary responsibility for providing the medical care, the Company does not recognize premium revenue and medical costs for these contracts in its Consolidated Financial Statements. For these fee-based customer arrangements, the Company provides coordination and facilitation of medical services; transaction processing; customer, consumer and care professional services; and access to contracted networks of physicians, hospitals and other health care professionals. These services are performed throughout the contract period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021 and 2020, accounts receivables related to products and services were $5.4 billion and $5.3 billion, respectively. In 2021 and 2020, the Company had no material bad-debt expense and there were no material contract assets, contract liabilities or deferred contract costs recorded on the Consolidated Balance Sheets as of December&#160;31, 2021 or 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2021, 2020 and 2019, revenue recognized from performance obligations related to prior periods (for example, due to changes in transaction price) was not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue expected to be recognized in any future year related to remaining performance obligations, excluding revenue pertaining to contracts having an original expected duration of one year or less, contracts where revenue is recognized as invoiced and contracts with variable consideration related to undelivered performance obligations, is not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_223" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 13&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for disaggregation of revenue by segment and type.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Medical Costs and Medical Costs Payable &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s estimate of medical costs payable represents management&#x2019;s best estimate of its liability for unpaid medical costs as of December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each period, the Company re-examines previously established medical costs payable estimates based on actual claim submissions and other changes in facts and circumstances. As more complete claim information becomes available, the Company adjusts the amount of the estimates and includes the changes in estimates in medical costs in the period in which the change is identified. Approximately 90% of claims related to medical care services are known and settled within 90 days from the date of service and substantially all within twelve months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medical costs and medical costs payable include estimates of the Company&#x2019;s obligations for medical care services rendered on behalf of consumers, but for which claims have either not yet been received, processed, or paid. The Company develops estimates for medical care services incurred but not reported (IBNR), which includes estimates for claims which have not been received or fully processed, using an actuarial process consistently applied, centrally controlled and automated. The actuarial &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;models consider factors such as time from date of service to claim processing, seasonal variances in medical care consumption, health care professional contract rate changes, medical care utilization and other medical cost trends, membership volume and demographics, the introduction of new technologies, benefit plan changes, and business mix changes related to products, customers and geography. Judgments related to these factors contemplated the impact of COVID-19.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In developing its medical costs payable estimates, the Company applies different estimation methods depending on which incurred claims are being estimated. For the most recent two months, the Company estimates claim costs incurred by applying observed medical cost trend factors to the average per member per month (PMPM) medical costs incurred in prior months for which more complete claim data are available, supplemented by a review of near-term completion factors (actuarial estimates, based upon historical experience and analysis of current trends, of the percentage of incurred claims during a given period adjudicated by the Company at the date of estimation). For months prior to the most recent two months, the Company applies the completion factors to actual claims adjudicated-to-date to estimate the expected amount of ultimate incurred claims for those months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cost of Products Sold &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s cost of products sold includes the cost of pharmaceuticals dispensed to unaffiliated customers either directly at its home delivery, specialty and community pharmacy locations, or indirectly through its nationwide network of participating pharmacies. Rebates attributable to unaffiliated clients are accrued as rebates receivable and a reduction of cost of products sold, with a corresponding payable for the amounts of the rebates to be remitted to those unaffiliated clients in accordance with their contracts and recorded in the Consolidated Statements of Operations as a reduction of product revenue. Cost of products sold also includes the cost of personnel to support the Company&#x2019;s transaction processing services, system sales, maintenance and professional services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash, Cash Equivalents and Investments &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents are highly liquid investments having an original maturity of three months or less. The fair value of cash and cash equivalents approximates their carrying value because of the short maturity of the instruments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investments with maturities of less than one year are classified as short-term. Because of regulatory requirements, certain investments are included in long-term investments regardless of their maturity date. The Company classifies these investments as held-to-maturity and reports them at amortized cost. Substantially all other investments are classified as available-for-sale and reported at fair value based on quoted market prices, where available. Equity investments, with certain exceptions, are measured at fair value with changes in fair value recognized in net earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company excludes unrealized gains and losses on investments in available-for-sale debt securities from net earnings and reports them as comprehensive income and, net of income tax effects, as a separate component of equity. To calculate realized gains and losses on the sale of debt securities, the Company specifically identifies the cost of each investment sold. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates an available-for-sale debt security for credit-related impairment by considering the present value of expected cash flows relative to a security&#x2019;s amortized cost, the extent to which fair value is less than amortized cost, the financial condition and near-term prospects of the issuer and specific events or circumstances which may influence the operations of the issuer. Credit-related impairments are recorded as an allowance, with an offset to investment and other income. Non-credit related impairments are recorded through other comprehensive income. If the Company intends to sell an impaired security, or will likely be required to sell a security before recovery of the entire amortized cost, the entire impairment is included in net earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;New information and the passage of time can change these judgments. The Company manages its investment portfolio to limit its exposure to any one issuer or market sector, and largely limits its investments to investment grade quality. Securities downgraded below policy minimums after purchase will be disposed of in accordance with the Company&#x2019;s investment policy. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets Under Management &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company provides health insurance products and services to members of AARP under a Supplemental Health Insurance Program (the AARP Program) and to AARP members and non-members under separate Medicare Advantage and Medicare Part D arrangements. The products and services under the AARP Program include supplemental Medicare benefits, hospital indemnity insurance, including insurance for individuals between 50 to 64 years of age, and other related products. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the Company&#x2019;s agreement with AARP, program assets are managed separately from the Company&#x2019;s general investment portfolio and are used to pay costs associated with the AARP Program. These assets are invested at the Company&#x2019;s discretion, within investment guidelines approved by AARP. The Company does not guarantee any rates of return on these investments and, upon any transfer of the AARP Program contract to another entity, the Company would transfer cash equal in amount to the fair value of these investments at the date of transfer to the entity. Because the purpose of these assets is to fund the medical costs payable, the rate stabilization fund (RSF) liabilities and other related liabilities associated with this AARP contract, assets under management are classified as current assets, consistent with the classification of these liabilities.&lt;/span&gt;&lt;/div&gt;The effects of changes in other balance sheet amounts associated with the AARP Program also accrue to the overall benefit of the AARP policyholders through the RSF balance. Accordingly, the Company excludes the effect of such changes in its Consolidated Statements of Cash Flows.&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Current Receivables &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other current receivables include amounts due from pharmaceutical manufacturers for rebates and Medicare Part D drug discounts, accrued interest and other miscellaneous amounts due to the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s pharmacy care services businesses contract with pharmaceutical manufacturers, some of which provide rebates based on use of the manufacturers&#x2019; products by its affiliated and unaffiliated clients. The Company accrues rebates as they are earned by its clients on a monthly basis based on the terms of the applicable contracts, historical data and current estimates. The pharmacy care services businesses bill these rebates to the manufacturers on a monthly or quarterly basis depending on the contractual terms and record rebates attributable to affiliated clients as a reduction to medical costs. The Company generally receives rebates two to five months after billing. As of December&#160;31, 2021 and 2020, total pharmaceutical manufacturer rebates receivable included in other receivables in the Consolidated Balance Sheets amounted to $7.2 billion and $6.3 billion, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021 and 2020, the Company&#x2019;s Medicare Part D receivables amounted to $3.4 billion and $2.9 billion, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, Equipment and Capitalized Software &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, equipment and capitalized software are stated at cost, net of accumulated depreciation and amortization. Capitalized software consists of certain costs incurred in the development of internal-use software, including external direct costs of materials and services and applicable payroll costs of employees devoted to specific software development. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company calculates depreciation and amortization using the straight-line method over the estimated useful lives of the assets. The useful lives for property, equipment and capitalized software are: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.111%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture, fixtures and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 to 10 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;to&#160;40&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 to 5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leasehold improvements are depreciated over the shorter of the remaining lease term or their estimated useful economic life.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases facilities and equipment under long-term operating leases which are non-cancelable and expire on various dates. At the lease commencement date, lease right-of-use (ROU) assets and lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term, which includes all fixed obligations arising from the lease contract. If an interest rate is not implicit in a lease, the Company utilizes its incremental borrowing rate for a period closely matching the lease term. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s ROU assets are included in other assets, and lease liabilities are included in other current liabilities and other liabilities in the Company&#x2019;s Consolidated Balance Sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To determine whether goodwill is impaired, annually or more frequently if needed, the Company performs impairment tests. The Company may first assess qualitative factors to determine if it is more likely than not the carrying value of a reporting unit exceeds its estimated fair value. The Company may also elect to skip the qualitative testing and proceed directly to the quantitative testing. When performing quantitative testing, the Company first estimates the fair values of its reporting units using discounted cash flows or a weighted combination of discounted cash flows and a market-based method. To determine fair values, the Company must make assumptions about a wide variety of internal and external factors. Significant assumptions used in the impairment analysis include financial projections of free cash flow (including significant assumptions about operations, capital requirements and income taxes), long-term growth rates for determining terminal value, discount rates and the selection of comparable peer companies. If the fair value is less than the carrying value of the reporting unit, an impairment is recognized for the difference, up to the carrying amount of goodwill.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There was no impairment of goodwill during the years ended December&#160;31, 2021, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s intangible assets are subject to impairment tests when events or circumstances indicate an intangible asset (or asset group) may be impaired. The Company&#x2019;s indefinite-lived intangible assets are also tested for impairment annually. There was no impairment of intangible assets during the years ended December&#160;31, 2021, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Current Liabilities &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other current liabilities include health savings account deposits ($11.4 billion and $10.2 billion as of December&#160;31, 2021 and 2020, respectively), accruals for premium rebates payable, the RSF associated with the AARP Program, the current portion of future policy benefits and customer balances.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Policy Acquisition Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s short duration health insurance contracts typically have a one-year term and may be canceled by the customer with at least 30 days&#x2019; notice. Costs related to the acquisition and renewal of short duration customer contracts are primarily charged to expense as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Redeemable noncontrolling interests in the Company&#x2019;s subsidiaries whose redemption is outside the control of the Company are classified as temporary equity. The following table provides details of the Company's redeemable noncontrolling interests&#x2019; activity for the years ended December&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable noncontrolling interests, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redemptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,338)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributions &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(255)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable noncontrolling interests, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes compensation expense for share-based awards, including stock options and restricted stock and restricted stock units (collectively, restricted shares), on a straight-line basis over the related service period (generally the vesting period) of the award, or to an employee&#x2019;s eligible retirement date under the award agreement, if earlier. Restricted shares vest ratably, primarily over &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTcvZnJhZzoyNzA4MDU3MzhiZjc0MzA5ODVmOTgzMjNiMGZkMzIxNy90ZXh0cmVnaW9uOjI3MDgwNTczOGJmNzQzMDk4NWY5ODMyM2IwZmQzMjE3XzQzOA_eb1bf801-8e88-43f4-addf-b3432e5c7bdc"&gt;four&lt;/span&gt; years and compensation expense related to restricted shares is based on the share price on the date of grant. Stock options vest ratably primarily over &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTcvZnJhZzoyNzA4MDU3MzhiZjc0MzA5ODVmOTgzMjNiMGZkMzIxNy90ZXh0cmVnaW9uOjI3MDgwNTczOGJmNzQzMDk4NWY5ODMyM2IwZmQzMjE3XzM4NDgyOTA2OTg0NDE_e5312511-99bf-4e41-b5f9-1d6cc88b8bfd"&gt;four&lt;/span&gt; years and may be exercised up to 10 years from the date of grant. Compensation expense related to stock options is based on the fair value at the date of grant, which is estimated on the date of grant using a binomial option-pricing model. Under the Company&#x2019;s Employee Stock Purchase Plan (ESPP), eligible employees are allowed to purchase the Company&#x2019;s stock at a discounted price, which is 90% of the market price of the Company&#x2019;s common stock at the end of the six-month purchase period. Share-based compensation expense for all programs is recognized in operating costs in the Consolidated Statements of Operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Earnings Per Common Share &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company computes basic earnings per common share attributable to UnitedHealth Group common shareholders by dividing net earnings attributable to UnitedHealth Group common shareholders by the weighted-average number of common shares outstanding during the period. The Company determines diluted net earnings per common share attributable to UnitedHealth Group common shareholders using the weighted-average number of common shares outstanding during the period, adjusted for potentially dilutive shares associated with stock options, restricted shares and the ESPP (collectively, common stock equivalents), using the treasury stock method. The treasury stock method assumes a hypothetical issuance of shares to settle the share-based awards, with the assumed proceeds used to purchase common stock at the average market price for the period. Assumed proceeds include the amount the employee must pay upon exercise and the average unrecognized compensation cost. The difference between the number of shares assumed issued and number of shares assumed purchased represents the dilutive shares. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;ACA Tax&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Health Insurance Tax was permanently repealed by Congress, effective January 1, 2021. The permanent repeal of the tax impacts year-over-year comparability of our financial statements, including revenues, operating costs, medical care ratio (MCR), operating cost ratio, effective tax rate and cash flows from operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMDYvZnJhZzo5NjBjMjc5MzI4ZTU0OWE2YTA3NDBhYzljOWVhNmMzNC90ZXh0cmVnaW9uOjk2MGMyNzkzMjhlNTQ5YTZhMDc0MGFjOWM5ZWE2YzM0XzE2NDkyNjc0NDIyMzI_ef55980a-95cc-4257-84dc-a37693d0ae92">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has prepared the Consolidated Financial Statements according to U.S. Generally Accepted Accounting Principles (GAAP) and has included the accounts of UnitedHealth Group and its subsidiaries.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMTUvZnJhZzphYWQzMDJhZTBkZWY0NWQzOGJhZTBmNjk4MTUwNjU1MS90ZXh0cmVnaW9uOmFhZDMwMmFlMGRlZjQ1ZDM4YmFlMGY2OTgxNTA2NTUxXzE2NDkyNjc0NDIyMjY_1976e540-ce15-4df2-869a-7fd9037b7b92">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These Consolidated Financial Statements include certain amounts based on the Company&#x2019;s best estimates and judgments. The Company&#x2019;s most significant estimates relate to estimates and judgments for medical costs payable and goodwill. Certain of these estimates require the application of complex assumptions and judgments, often because they involve matters inherently uncertain and will likely change in subsequent periods. The impact of any change in estimates is included in earnings in the period in which the estimate is adjusted.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMTgvZnJhZzo2MjY0NTM4YWJjZmU0Y2Q0YjI2YzliZGZiY2Y1MjFhMC90ZXh0cmVnaW9uOjYyNjQ1MzhhYmNmZTRjZDRiMjZjOWJkZmJjZjUyMWEwXzE2NDkyNjc0NTY1Njk_a7bfaac9-d7cc-4950-aa2c-27ccf9a8e26a">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenues &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Premiums&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Premium revenues are primarily derived from risk-based health insurance arrangements in which the premium is typically at a fixed rate per individual served for a one-year period, and the Company assumes the economic risk of funding its customers&#x2019; health care and related administrative costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Premium revenues are recognized in the period in which eligible individuals are entitled to receive health care benefits. Health care premium payments received from the Company&#x2019;s customers in advance of the service period are recorded as unearned revenues. Fully insured commercial products of U.S. health plans, Medicare Advantage and Medicare Prescription Drug Benefit (Medicare Part D) plans with medical loss ratios (MLRs) as calculated under the definitions in the Patient Protection and Affordable Care Act (ACA) and related federal and state regulations and implementing regulation, falling below certain targets are required to rebate ratable portions of their premiums annually. Commercial premiums within the Company&#x2019;s individual and small group markets are also subject to the ACA risk adjustment program. Medicare Advantage premium revenue includes the impact of the Centers for Medicare &amp;amp; Medicaid Services (CMS) quality bonuses based on plans&#x2019; Star rating. Certain of the Company&#x2019;s Medicaid business is also subject to state minimum MLR rebates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Premium revenues are recognized based on the estimated premiums earned, net of projected rebates, because the Company is able to reasonably estimate the ultimate premiums of these contracts. The Company also records premium revenues for certain value-based arrangements at its Optum Health care delivery businesses. Under these value-based arrangements, the Company enters into agreements with health plans to stand ready to deliver, integrate, direct and control certain health care services for the individuals enrolled. In exchange, the Company receives a premium that is typically paid on a per-member per-month basis. The Company considers these value-based arrangements to represent a single performance obligation where premium revenues are recognized in the period in which health care services are made available.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s Medicare Advantage and Medicare Part D premium revenues are subject to periodic adjustment under CMS&#x2019; risk adjustment payment methodology. CMS deploys a risk adjustment model which apportions premiums paid to all health plans according to health severity and certain demographic factors. The CMS risk adjustment model provides higher per member payments for enrollees diagnosed with certain conditions and lower payments for enrollees who are healthier. Under this risk adjustment methodology, CMS calculates the risk adjusted premium payment using diagnosis and encounter data from hospital inpatient, hospital outpatient and physician treatment settings. The Company and health care providers collect, capture and submit the necessary and available data to CMS within prescribed deadlines. The Company estimates risk adjustment premium revenues based upon the data submitted and expected to be submitted to CMS. Risk adjustment data for the Company&#x2019;s plans are subject to review by the government, including audit by regulators. See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_217" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 12&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information regarding these audits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Products and Services&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the Company&#x2019;s Optum Rx pharmacy care services business, the majority of revenues are derived from products sold through a contracted network of retail pharmacies or home delivery, specialty and community health pharmacies. Product revenues include the cost of pharmaceuticals (net of rebates), a negotiated dispensing fee and customer co-payments for drugs dispensed through the Company&#x2019;s home delivery, specialty and community pharmacies. For the years ended December 31, 2021 and 2020, the Company recognized revenue and cost of products sold for retail pharmacy co-payments related to its Optum Rx business. Revenue recognized in prior periods related to retail pharmacy transactions excludes the member&#x2019;s applicable co-payment. There was no impact on earnings from operations, net earnings, earnings per share or total equity. Pharmacy products are billed to customers based on the number of transactions occurring during the billing period. Product revenues are recognized when the prescriptions are dispensed. The Company has entered into contracts in which it is primarily obligated to pay its network pharmacy providers for benefits provided to their customers regardless of whether the Company is paid. The Company is also involved in establishing the prices charged by retail pharmacies, determining which drugs will be included in formulary listings and selecting which retail pharmacies will be included in the network offered to plan sponsors&#x2019; members and accordingly, are reported on a gross basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Services revenue are comprised of a number of services and products sold through Optum. Optum Health&#x2019;s service revenues include net patient service revenues recorded based upon established billing rates, less allowances for contractual adjustments, and are recognized as services are provided. For its financial services offerings, Optum Health charges fees and earns investment income on managed funds. Optum Insight provides software and information products, advisory consulting arrangements and managed services outsourcing contracts, which may be delivered over several years. Optum Insight revenues are generally recognized over time and measured each period based on the progress to date as services are performed or made available to customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Services revenue also consists of fees derived from services performed for customers who self-insure the health care costs of their employees and employees&#x2019; dependents. Under service fee contracts, the Company receives monthly, a fixed fee per employee, which is recognized as revenue as the Company performs, or makes available, the applicable services to the customer. The customers retain the risk of financing health care costs for their employees and employees&#x2019; dependents, and the Company administers the payment of customer funds to physicians and other health care professionals from customer-funded bank accounts. As the Company has neither the obligation for funding the health care costs, nor the primary responsibility for providing the medical care, the Company does not recognize premium revenue and medical costs for these contracts in its Consolidated Financial Statements. For these fee-based customer arrangements, the Company provides coordination and facilitation of medical services; transaction processing; customer, consumer and care professional services; and access to contracted networks of physicians, hospitals and other health care professionals. These services are performed throughout the contract period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021 and 2020, accounts receivables related to products and services were $5.4 billion and $5.3 billion, respectively. In 2021 and 2020, the Company had no material bad-debt expense and there were no material contract assets, contract liabilities or deferred contract costs recorded on the Consolidated Balance Sheets as of December&#160;31, 2021 or 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2021, 2020 and 2019, revenue recognized from performance obligations related to prior periods (for example, due to changes in transaction price) was not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue expected to be recognized in any future year related to remaining performance obligations, excluding revenue pertaining to contracts having an original expected duration of one year or less, contracts where revenue is recognized as invoiced and contracts with variable consideration related to undelivered performance obligations, is not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_223" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 13&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for disaggregation of revenue by segment and type.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i3cc841fcdfd546358ed335a1f5de7e7e_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMTgvZnJhZzo2MjY0NTM4YWJjZmU0Y2Q0YjI2YzliZGZiY2Y1MjFhMC90ZXh0cmVnaW9uOjYyNjQ1MzhhYmNmZTRjZDRiMjZjOWJkZmJjZjUyMWEwXzYzODI_e9d91946-4648-4c3f-a9d3-92d734e1f1d8"
      unitRef="usd">5400000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i6f67f540a2f34e649bdb094c7c1cf41d_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMTgvZnJhZzo2MjY0NTM4YWJjZmU0Y2Q0YjI2YzliZGZiY2Y1MjFhMC90ZXh0cmVnaW9uOjYyNjQ1MzhhYmNmZTRjZDRiMjZjOWJkZmJjZjUyMWEwXzYzODk_6e640024-034e-4f2b-b053-fefb99a784c7"
      unitRef="usd">5300000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMjEvZnJhZzplZjgwNDdhYTA0MWY0YWIxYTkxYTYwM2E2N2E5YWVkMS90ZXh0cmVnaW9uOmVmODA0N2FhMDQxZjRhYjFhOTFhNjAzYTY3YTlhZWQxXzE2NDkyNjc0NDQzMjk_db244709-efdc-449d-b801-86743cee351a">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Medical Costs and Medical Costs Payable &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s estimate of medical costs payable represents management&#x2019;s best estimate of its liability for unpaid medical costs as of December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each period, the Company re-examines previously established medical costs payable estimates based on actual claim submissions and other changes in facts and circumstances. As more complete claim information becomes available, the Company adjusts the amount of the estimates and includes the changes in estimates in medical costs in the period in which the change is identified. Approximately 90% of claims related to medical care services are known and settled within 90 days from the date of service and substantially all within twelve months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medical costs and medical costs payable include estimates of the Company&#x2019;s obligations for medical care services rendered on behalf of consumers, but for which claims have either not yet been received, processed, or paid. The Company develops estimates for medical care services incurred but not reported (IBNR), which includes estimates for claims which have not been received or fully processed, using an actuarial process consistently applied, centrally controlled and automated. The actuarial &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;models consider factors such as time from date of service to claim processing, seasonal variances in medical care consumption, health care professional contract rate changes, medical care utilization and other medical cost trends, membership volume and demographics, the introduction of new technologies, benefit plan changes, and business mix changes related to products, customers and geography. Judgments related to these factors contemplated the impact of COVID-19.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In developing its medical costs payable estimates, the Company applies different estimation methods depending on which incurred claims are being estimated. For the most recent two months, the Company estimates claim costs incurred by applying observed medical cost trend factors to the average per member per month (PMPM) medical costs incurred in prior months for which more complete claim data are available, supplemented by a review of near-term completion factors (actuarial estimates, based upon historical experience and analysis of current trends, of the percentage of incurred claims during a given period adjudicated by the Company at the date of estimation). For months prior to the most recent two months, the Company applies the completion factors to actual claims adjudicated-to-date to estimate the expected amount of ultimate incurred claims for those months.&lt;/span&gt;&lt;/div&gt;</us-gaap:UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy>
    <unh:ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days
      contextRef="ifafacde0705d4f258c784fe3cb74d22f_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMjEvZnJhZzplZjgwNDdhYTA0MWY0YWIxYTkxYTYwM2E2N2E5YWVkMS90ZXh0cmVnaW9uOmVmODA0N2FhMDQxZjRhYjFhOTFhNjAzYTY3YTlhZWQxXzU5MQ_d4447673-f11d-4591-9079-67d488a3d9a3"
      unitRef="number">0.90</unh:ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days>
    <us-gaap:CostOfSalesPolicyTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMjQvZnJhZzoyNzg1MjI0ZmJhNWM0NGM0Yjk0ZDc1MmI1MTcyNDU4YS90ZXh0cmVnaW9uOjI3ODUyMjRmYmE1YzQ0YzRiOTRkNzUyYjUxNzI0NThhXzE2NDkyNjc0NDI1NDg_ecb65db8-9e9e-4072-add1-540caf2f5122">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cost of Products Sold &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s cost of products sold includes the cost of pharmaceuticals dispensed to unaffiliated customers either directly at its home delivery, specialty and community pharmacy locations, or indirectly through its nationwide network of participating pharmacies. Rebates attributable to unaffiliated clients are accrued as rebates receivable and a reduction of cost of products sold, with a corresponding payable for the amounts of the rebates to be remitted to those unaffiliated clients in accordance with their contracts and recorded in the Consolidated Statements of Operations as a reduction of product revenue. Cost of products sold also includes the cost of personnel to support the Company&#x2019;s transaction processing services, system sales, maintenance and professional services.&lt;/span&gt;&lt;/div&gt;</us-gaap:CostOfSalesPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMjcvZnJhZzo2MGJkNDZhY2ViYTc0YTZkOTQxNWZjN2RiNGYwMDY4Ny90ZXh0cmVnaW9uOjYwYmQ0NmFjZWJhNzRhNmQ5NDE1ZmM3ZGI0ZjAwNjg3XzE2NDkyNjc0NDQwNTI_d3d2242e-92d3-4bbb-894d-471b087127ce">Cash, Cash Equivalents and Investments Cash and cash equivalents are highly liquid investments having an original maturity of three months or less. The fair value of cash and cash equivalents approximates their carrying value because of the short maturity of the instruments.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMjcvZnJhZzo2MGJkNDZhY2ViYTc0YTZkOTQxNWZjN2RiNGYwMDY4Ny90ZXh0cmVnaW9uOjYwYmQ0NmFjZWJhNzRhNmQ5NDE1ZmM3ZGI0ZjAwNjg3XzE2NDkyNjc0NDQwNTM_829f95ff-e092-4bfd-9138-a94b3024f038">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investments with maturities of less than one year are classified as short-term. Because of regulatory requirements, certain investments are included in long-term investments regardless of their maturity date. The Company classifies these investments as held-to-maturity and reports them at amortized cost. Substantially all other investments are classified as available-for-sale and reported at fair value based on quoted market prices, where available. Equity investments, with certain exceptions, are measured at fair value with changes in fair value recognized in net earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company excludes unrealized gains and losses on investments in available-for-sale debt securities from net earnings and reports them as comprehensive income and, net of income tax effects, as a separate component of equity. To calculate realized gains and losses on the sale of debt securities, the Company specifically identifies the cost of each investment sold. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates an available-for-sale debt security for credit-related impairment by considering the present value of expected cash flows relative to a security&#x2019;s amortized cost, the extent to which fair value is less than amortized cost, the financial condition and near-term prospects of the issuer and specific events or circumstances which may influence the operations of the issuer. Credit-related impairments are recorded as an allowance, with an offset to investment and other income. Non-credit related impairments are recorded through other comprehensive income. If the Company intends to sell an impaired security, or will likely be required to sell a security before recovery of the entire amortized cost, the entire impairment is included in net earnings.&lt;/span&gt;&lt;/div&gt;New information and the passage of time can change these judgments. The Company manages its investment portfolio to limit its exposure to any one issuer or market sector, and largely limits its investments to investment grade quality. Securities downgraded below policy minimums after purchase will be disposed of in accordance with the Company&#x2019;s investment policy.</us-gaap:InvestmentPolicyTextBlock>
    <unh:AARPAssetsUnderManagementPolicyTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMzAvZnJhZzphYTVmMjAyODI2M2M0ODlkYjUzMGFkMGM2MTc2YmY4Mi90ZXh0cmVnaW9uOmFhNWYyMDI4MjYzYzQ4OWRiNTMwYWQwYzYxNzZiZjgyXzE2NDkyNjc0NDMzMDg_d92405b6-44c3-49eb-b2c4-60dfe4e3c1ad">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets Under Management &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company provides health insurance products and services to members of AARP under a Supplemental Health Insurance Program (the AARP Program) and to AARP members and non-members under separate Medicare Advantage and Medicare Part D arrangements. The products and services under the AARP Program include supplemental Medicare benefits, hospital indemnity insurance, including insurance for individuals between 50 to 64 years of age, and other related products. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the Company&#x2019;s agreement with AARP, program assets are managed separately from the Company&#x2019;s general investment portfolio and are used to pay costs associated with the AARP Program. These assets are invested at the Company&#x2019;s discretion, within investment guidelines approved by AARP. The Company does not guarantee any rates of return on these investments and, upon any transfer of the AARP Program contract to another entity, the Company would transfer cash equal in amount to the fair value of these investments at the date of transfer to the entity. Because the purpose of these assets is to fund the medical costs payable, the rate stabilization fund (RSF) liabilities and other related liabilities associated with this AARP contract, assets under management are classified as current assets, consistent with the classification of these liabilities.&lt;/span&gt;&lt;/div&gt;The effects of changes in other balance sheet amounts associated with the AARP Program also accrue to the overall benefit of the AARP policyholders through the RSF balance. Accordingly, the Company excludes the effect of such changes in its Consolidated Statements of Cash Flows.</unh:AARPAssetsUnderManagementPolicyTextBlock>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMzMvZnJhZzplMTNlMzgwNWM2NzA0NDIzYWU0YzRjZTI3OTgzNDJiOC90ZXh0cmVnaW9uOmUxM2UzODA1YzY3MDQ0MjNhZTRjNGNlMjc5ODM0MmI4XzE2NDkyNjc0NDI4Nzk_d6657d9a-934e-4fd2-9ae4-3a507c70aa50">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Current Receivables &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other current receivables include amounts due from pharmaceutical manufacturers for rebates and Medicare Part D drug discounts, accrued interest and other miscellaneous amounts due to the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s pharmacy care services businesses contract with pharmaceutical manufacturers, some of which provide rebates based on use of the manufacturers&#x2019; products by its affiliated and unaffiliated clients. The Company accrues rebates as they are earned by its clients on a monthly basis based on the terms of the applicable contracts, historical data and current estimates. The pharmacy care services businesses bill these rebates to the manufacturers on a monthly or quarterly basis depending on the contractual terms and record rebates attributable to affiliated clients as a reduction to medical costs. The Company generally receives rebates two to five months after billing. As of December&#160;31, 2021 and 2020, total pharmaceutical manufacturer rebates receivable included in other receivables in the Consolidated Balance Sheets amounted to $7.2 billion and $6.3 billion, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021 and 2020, the Company&#x2019;s Medicare Part D receivables amounted to $3.4 billion and $2.9 billion, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i46bb0d0f79554481a30ef5011a4f84b3_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMzMvZnJhZzplMTNlMzgwNWM2NzA0NDIzYWU0YzRjZTI3OTgzNDJiOC90ZXh0cmVnaW9uOmUxM2UzODA1YzY3MDQ0MjNhZTRjNGNlMjc5ODM0MmI4XzEwNjI_a85f8ce1-b4ba-496c-888d-c9718b146885"
      unitRef="usd">7200000000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="id24643699baf4fca9b1c7b6874e25228_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMzMvZnJhZzplMTNlMzgwNWM2NzA0NDIzYWU0YzRjZTI3OTgzNDJiOC90ZXh0cmVnaW9uOmUxM2UzODA1YzY3MDQ0MjNhZTRjNGNlMjc5ODM0MmI4XzEwNjk_12e7575b-2550-461f-b5f5-980ce2e4a884"
      unitRef="usd">6300000000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i9e70f543d656432ab29e3070fc195a80_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMzMvZnJhZzplMTNlMzgwNWM2NzA0NDIzYWU0YzRjZTI3OTgzNDJiOC90ZXh0cmVnaW9uOmUxM2UzODA1YzY3MDQ0MjNhZTRjNGNlMjc5ODM0MmI4XzExNTg_32eded15-63e0-48a2-95c7-377030e6019b"
      unitRef="usd">3400000000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="ic913811c9e844fe4af3ff284c1deabc6_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMzMvZnJhZzplMTNlMzgwNWM2NzA0NDIzYWU0YzRjZTI3OTgzNDJiOC90ZXh0cmVnaW9uOmUxM2UzODA1YzY3MDQ0MjNhZTRjNGNlMjc5ODM0MmI4XzExNjU_4121dd30-4f16-48cc-8be5-116a0d005414"
      unitRef="usd">2900000000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMzYvZnJhZzoxNTI1MDc5MmNmZGI0NzlkYmM5NDNhOWFhZGM3YWEyOS90ZXh0cmVnaW9uOjE1MjUwNzkyY2ZkYjQ3OWRiYzk0M2E5YWFkYzdhYTI5XzE2NDkyNjc0NDI0MTQ_d815d13a-60e4-4b07-8589-6d5d69a57f51">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, Equipment and Capitalized Software &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, equipment and capitalized software are stated at cost, net of accumulated depreciation and amortization. Capitalized software consists of certain costs incurred in the development of internal-use software, including external direct costs of materials and services and applicable payroll costs of employees devoted to specific software development. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company calculates depreciation and amortization using the straight-line method over the estimated useful lives of the assets. The useful lives for property, equipment and capitalized software are: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.111%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture, fixtures and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 to 10 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;to&#160;40&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 to 5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leasehold improvements are depreciated over the shorter of the remaining lease term or their estimated useful economic life.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="ia1ff1cf727f44188aa9fc2cdae7f314c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMzYvZnJhZzoxNTI1MDc5MmNmZGI0NzlkYmM5NDNhOWFhZGM3YWEyOS90ZXh0cmVnaW9uOjE1MjUwNzkyY2ZkYjQ3OWRiYzk0M2E5YWFkYzdhYTI5Xzc0MA_98f3bad7-3316-4e03-8715-63a7614ff1c2">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company calculates depreciation and amortization using the straight-line method over the estimated useful lives of the assets. The useful lives for property, equipment and capitalized software are: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.111%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture, fixtures and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 to 10 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;to&#160;40&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 to 5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i8384e266805d4927b90e345df1e3f524_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMzYvZnJhZzoxNTI1MDc5MmNmZGI0NzlkYmM5NDNhOWFhZGM3YWEyOS90YWJsZTowYThiN2E4ZmEyYzk0ZTIxOWM0YmZkNTk0OTgwNDY1Mi90YWJsZXJhbmdlOjBhOGI3YThmYTJjOTRlMjE5YzRiZmQ1OTQ5ODA0NjUyXzAtMS0xLTEtMjEyMTQvdGV4dHJlZ2lvbjpkMGM1OGU5NjY3ZGY0YjlkODY1OGI1NjYxOGExNTZkYV85MzQ1ODQ4ODM2MTE0_a5abd49c-40a9-406b-b16b-955a249529e0">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i87b309e50f2a486dadbe07f2c0015862_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMzYvZnJhZzoxNTI1MDc5MmNmZGI0NzlkYmM5NDNhOWFhZGM3YWEyOS90YWJsZTowYThiN2E4ZmEyYzk0ZTIxOWM0YmZkNTk0OTgwNDY1Mi90YWJsZXJhbmdlOjBhOGI3YThmYTJjOTRlMjE5YzRiZmQ1OTQ5ODA0NjUyXzAtMS0xLTEtMjEyMTQvdGV4dHJlZ2lvbjpkMGM1OGU5NjY3ZGY0YjlkODY1OGI1NjYxOGExNTZkYV85MzQ1ODQ4ODM2MTE5_b3d4cca5-e8b2-40d4-96e2-f564edbd41ab">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i122210b356e34cd393cb6d0422f9ff20_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMzYvZnJhZzoxNTI1MDc5MmNmZGI0NzlkYmM5NDNhOWFhZGM3YWEyOS90YWJsZTowYThiN2E4ZmEyYzk0ZTIxOWM0YmZkNTk0OTgwNDY1Mi90YWJsZXJhbmdlOjBhOGI3YThmYTJjOTRlMjE5YzRiZmQ1OTQ5ODA0NjUyXzEtMS0xLTEtMjEyMzUvdGV4dHJlZ2lvbjowZmZiMmJiYWFmNzg0ZmFhOWI4NzI4ZWQ3ZDIyOWI4NF85MzQ1ODQ4ODM2MTE2_15d45fce-2207-4f3a-9f3f-0cb58cee382b">P35Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i3c578a943465456dbb16da796df70705_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMzYvZnJhZzoxNTI1MDc5MmNmZGI0NzlkYmM5NDNhOWFhZGM3YWEyOS90YWJsZTowYThiN2E4ZmEyYzk0ZTIxOWM0YmZkNTk0OTgwNDY1Mi90YWJsZXJhbmdlOjBhOGI3YThmYTJjOTRlMjE5YzRiZmQ1OTQ5ODA0NjUyXzEtMS0xLTEtMjEyMzUvdGV4dHJlZ2lvbjowZmZiMmJiYWFmNzg0ZmFhOWI4NzI4ZWQ3ZDIyOWI4NF85MzQ1ODQ4ODM2MTIx_6d78afa6-8178-46ed-b3f5-dca6212c16c8">P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ic338e78c17b54bdd9e1a900148c7981c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMzYvZnJhZzoxNTI1MDc5MmNmZGI0NzlkYmM5NDNhOWFhZGM3YWEyOS90YWJsZTowYThiN2E4ZmEyYzk0ZTIxOWM0YmZkNTk0OTgwNDY1Mi90YWJsZXJhbmdlOjBhOGI3YThmYTJjOTRlMjE5YzRiZmQ1OTQ5ODA0NjUyXzItMS0xLTEtMjEyNDcvdGV4dHJlZ2lvbjoxNmI2ODVlMWM1ZDM0MGY2YjE0ZjhjMWQyNWUyNmVlZF85MzQ1ODQ4ODM2MTEz_fd0f44c0-b21b-4a22-86e5-ba93db6b2fe7">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="iff76c7d81e324fd3855a24b45c0f6feb_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMzYvZnJhZzoxNTI1MDc5MmNmZGI0NzlkYmM5NDNhOWFhZGM3YWEyOS90YWJsZTowYThiN2E4ZmEyYzk0ZTIxOWM0YmZkNTk0OTgwNDY1Mi90YWJsZXJhbmdlOjBhOGI3YThmYTJjOTRlMjE5YzRiZmQ1OTQ5ODA0NjUyXzItMS0xLTEtMjEyNDcvdGV4dHJlZ2lvbjoxNmI2ODVlMWM1ZDM0MGY2YjE0ZjhjMWQyNWUyNmVlZF85MzQ1ODQ4ODM2MTE3_d3bfca00-82fe-4a11-ba37-e381fb4718b9">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xMzkvZnJhZzozOWM0MWQ2MGNlMTY0YmE0ODc3NjQwMmU1YjNiMTU1OS90ZXh0cmVnaW9uOjM5YzQxZDYwY2UxNjRiYTQ4Nzc2NDAyZTViM2IxNTU5XzE2NDkyNjc0NDI0MDk_06b579e6-4d07-4bdf-b3aa-39cd8ddceb6f">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases facilities and equipment under long-term operating leases which are non-cancelable and expire on various dates. At the lease commencement date, lease right-of-use (ROU) assets and lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term, which includes all fixed obligations arising from the lease contract. If an interest rate is not implicit in a lease, the Company utilizes its incremental borrowing rate for a period closely matching the lease term. &lt;/span&gt;&lt;/div&gt;The Company&#x2019;s ROU assets are included in other assets, and lease liabilities are included in other current liabilities and other liabilities in the Company&#x2019;s Consolidated Balance Sheet.</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNDIvZnJhZzo4MGIxODQ1ZGY0MWI0NzI1ODBkOTllYjg1NDE0NzFjOS90ZXh0cmVnaW9uOjgwYjE4NDVkZjQxYjQ3MjU4MGQ5OWViODU0MTQ3MWM5XzE2NDkyNjc0NDI5ODE_dfa717bc-0e1f-4836-a3e9-08e5b80dde94">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To determine whether goodwill is impaired, annually or more frequently if needed, the Company performs impairment tests. The Company may first assess qualitative factors to determine if it is more likely than not the carrying value of a reporting unit exceeds its estimated fair value. The Company may also elect to skip the qualitative testing and proceed directly to the quantitative testing. When performing quantitative testing, the Company first estimates the fair values of its reporting units using discounted cash flows or a weighted combination of discounted cash flows and a market-based method. To determine fair values, the Company must make assumptions about a wide variety of internal and external factors. Significant assumptions used in the impairment analysis include financial projections of free cash flow (including significant assumptions about operations, capital requirements and income taxes), long-term growth rates for determining terminal value, discount rates and the selection of comparable peer companies. If the fair value is less than the carrying value of the reporting unit, an impairment is recognized for the difference, up to the carrying amount of goodwill.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There was no impairment of goodwill during the years ended December&#160;31, 2021, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNDIvZnJhZzo4MGIxODQ1ZGY0MWI0NzI1ODBkOTllYjg1NDE0NzFjOS90ZXh0cmVnaW9uOjgwYjE4NDVkZjQxYjQ3MjU4MGQ5OWViODU0MTQ3MWM5XzI3NDg3NzkwNzA3NjE_03c5c1e2-44ff-45b9-ac9b-0d1afa1cc1ad"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNDIvZnJhZzo4MGIxODQ1ZGY0MWI0NzI1ODBkOTllYjg1NDE0NzFjOS90ZXh0cmVnaW9uOjgwYjE4NDVkZjQxYjQ3MjU4MGQ5OWViODU0MTQ3MWM5XzI3NDg3NzkwNzA3NjE_ba9ce637-86b9-4584-af00-5b46b639167e"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNDIvZnJhZzo4MGIxODQ1ZGY0MWI0NzI1ODBkOTllYjg1NDE0NzFjOS90ZXh0cmVnaW9uOjgwYjE4NDVkZjQxYjQ3MjU4MGQ5OWViODU0MTQ3MWM5XzI3NDg3NzkwNzA3NjE_d0c5f157-8d4b-4035-8d65-106e58ed7f2f"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNDUvZnJhZzphYjBjMWU2OGU3YmE0MDEzYTMwNzQyZjliNDQ4NmE5OS90ZXh0cmVnaW9uOmFiMGMxZTY4ZTdiYTQwMTNhMzA3NDJmOWI0NDg2YTk5XzE2NDkyNjc0NDIwNTA_69feec5e-e86d-4dca-8031-f8b338242974">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s intangible assets are subject to impairment tests when events or circumstances indicate an intangible asset (or asset group) may be impaired. The Company&#x2019;s indefinite-lived intangible assets are also tested for impairment annually. There was no impairment of intangible assets during the years ended December&#160;31, 2021, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNDUvZnJhZzphYjBjMWU2OGU3YmE0MDEzYTMwNzQyZjliNDQ4NmE5OS90ZXh0cmVnaW9uOmFiMGMxZTY4ZTdiYTQwMTNhMzA3NDJmOWI0NDg2YTk5XzI3NDg3NzkwNjk4MzA_1253ce9f-76cb-4ae9-bb13-efe8a43107b3"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNDUvZnJhZzphYjBjMWU2OGU3YmE0MDEzYTMwNzQyZjliNDQ4NmE5OS90ZXh0cmVnaW9uOmFiMGMxZTY4ZTdiYTQwMTNhMzA3NDJmOWI0NDg2YTk5XzI3NDg3NzkwNjk4MzA_2f0dbf89-08b9-4b7a-8f38-5cfd2c78789e"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNDUvZnJhZzphYjBjMWU2OGU3YmE0MDEzYTMwNzQyZjliNDQ4NmE5OS90ZXh0cmVnaW9uOmFiMGMxZTY4ZTdiYTQwMTNhMzA3NDJmOWI0NDg2YTk5XzI3NDg3NzkwNjk4MzA_d8903477-080f-47a2-9473-9d7b480d6dcd"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <unh:OtherLiabilitiesCurrentPolicyTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNDgvZnJhZzoyODYxMGYxMjlkNTc0MTBkYjhmYjg3ZmI3ZDI4ODA1Yi90ZXh0cmVnaW9uOjI4NjEwZjEyOWQ1NzQxMGRiOGZiODdmYjdkMjg4MDViXzE2NDkyNjc0NDIxNjc_55133aba-cda7-4067-922a-59dd6e5c85bd">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Current Liabilities &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other current liabilities include health savings account deposits ($11.4 billion and $10.2 billion as of December&#160;31, 2021 and 2020, respectively), accruals for premium rebates payable, the RSF associated with the AARP Program, the current portion of future policy benefits and customer balances.&lt;/span&gt;&lt;/div&gt;</unh:OtherLiabilitiesCurrentPolicyTextBlock>
    <us-gaap:DemandDepositAccounts
      contextRef="iea339ff4f3c94a45a63d0fe4f74ba6f4_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNDgvZnJhZzoyODYxMGYxMjlkNTc0MTBkYjhmYjg3ZmI3ZDI4ODA1Yi90ZXh0cmVnaW9uOjI4NjEwZjEyOWQ1NzQxMGRiOGZiODdmYjdkMjg4MDViXzQzOTgwNDY1MTE1MTk_86c9e3bc-572c-4351-8d15-792a8b0f5bfb"
      unitRef="usd">11400000000</us-gaap:DemandDepositAccounts>
    <us-gaap:DemandDepositAccounts
      contextRef="ie60f9bda7240423e99aefddba5815436_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNDgvZnJhZzoyODYxMGYxMjlkNTc0MTBkYjhmYjg3ZmI3ZDI4ODA1Yi90ZXh0cmVnaW9uOjI4NjEwZjEyOWQ1NzQxMGRiOGZiODdmYjdkMjg4MDViXzQzOTgwNDY1MTE1MDM_95d12898-94d1-4fa8-81b8-8bc9adb27f28"
      unitRef="usd">10200000000</us-gaap:DemandDepositAccounts>
    <us-gaap:CapitalizationOfDeferredPolicyAcquisitionCostsPolicy
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTEvZnJhZzphZDE0ZTNkMTFjZDY0YjA5OWUzN2I3MWM3OTJhMzhjOC90ZXh0cmVnaW9uOmFkMTRlM2QxMWNkNjRiMDk5ZTM3YjcxYzc5MmEzOGM4XzE2NDkyNjc0NDE5ODI_5cc74be7-2b87-4e0a-87c1-9a00efd15ffc">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Policy Acquisition Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s short duration health insurance contracts typically have a one-year term and may be canceled by the customer with at least 30 days&#x2019; notice. Costs related to the acquisition and renewal of short duration customer contracts are primarily charged to expense as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:CapitalizationOfDeferredPolicyAcquisitionCostsPolicy>
    <unh:NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTEvZnJhZzphZDE0ZTNkMTFjZDY0YjA5OWUzN2I3MWM3OTJhMzhjOC90ZXh0cmVnaW9uOmFkMTRlM2QxMWNkNjRiMDk5ZTM3YjcxYzc5MmEzOGM4XzE2Nw_54beb61c-378a-4d75-8353-3d4194230c38">P30D</unh:NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract>
    <unh:NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTEvZnJhZzphZDE0ZTNkMTFjZDY0YjA5OWUzN2I3MWM3OTJhMzhjOC90ZXh0cmVnaW9uOmFkMTRlM2QxMWNkNjRiMDk5ZTM3YjcxYzc5MmEzOGM4XzI3NDg3NzkwNjk3NTk_9f6e7788-2f87-4152-b4e6-2013865f1e0c">P30D</unh:NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract>
    <us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTQvZnJhZzo1MmU1NWZlN2RkMmI0OWUxOTZjZDllZTk3NTcxNmQ2NS90ZXh0cmVnaW9uOjUyZTU1ZmU3ZGQyYjQ5ZTE5NmNkOWVlOTc1NzE2ZDY1XzE2NDkyNjc0NDIwMDc_aa021dc1-ee6c-4aad-b78c-b472d01e8e51">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Redeemable noncontrolling interests in the Company&#x2019;s subsidiaries whose redemption is outside the control of the Company are classified as temporary equity. The following table provides details of the Company's redeemable noncontrolling interests&#x2019; activity for the years ended December&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable noncontrolling interests, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redemptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,338)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributions &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(255)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable noncontrolling interests, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy>
    <us-gaap:RedeemableNoncontrollingInterestTableTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTQvZnJhZzo1MmU1NWZlN2RkMmI0OWUxOTZjZDllZTk3NTcxNmQ2NS90ZXh0cmVnaW9uOjUyZTU1ZmU3ZGQyYjQ5ZTE5NmNkOWVlOTc1NzE2ZDY1XzMzOQ_afed4725-3d52-4137-8526-c3a3b272c886">The following table provides details of the Company's redeemable noncontrolling interests&#x2019; activity for the years ended December&#160;31, 2021 and 2020:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable noncontrolling interests, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redemptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,338)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributions &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(255)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable noncontrolling interests, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:RedeemableNoncontrollingInterestTableTextBlock>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="ib55d7c02a76f495eadd39abf177a36b9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTQvZnJhZzo1MmU1NWZlN2RkMmI0OWUxOTZjZDllZTk3NTcxNmQ2NS90YWJsZTo4MTkxMjRmOTZiZTY0YTMxYjgyODg4Y2RlZDIzYjA3Ny90YWJsZXJhbmdlOjgxOTEyNGY5NmJlNjRhMzFiODI4ODhjZGVkMjNiMDc3XzEtMi0xLTEtMA_8f4056b8-0265-4826-b18d-e13a06fcd58d"
      unitRef="usd">2211000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="ifb906a7e10bf4c67a37f412d39862ee2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTQvZnJhZzo1MmU1NWZlN2RkMmI0OWUxOTZjZDllZTk3NTcxNmQ2NS90YWJsZTo4MTkxMjRmOTZiZTY0YTMxYjgyODg4Y2RlZDIzYjA3Ny90YWJsZXJhbmdlOjgxOTEyNGY5NmJlNjRhMzFiODI4ODhjZGVkMjNiMDc3XzEtNC0xLTEtMA_0919f580-1f23-4d84-87e6-1857fa0cd0eb"
      unitRef="usd">1726000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i91c331befb394cb6b31c1d43cedab05f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTQvZnJhZzo1MmU1NWZlN2RkMmI0OWUxOTZjZDllZTk3NTcxNmQ2NS90YWJsZTo4MTkxMjRmOTZiZTY0YTMxYjgyODg4Y2RlZDIzYjA3Ny90YWJsZXJhbmdlOjgxOTEyNGY5NmJlNjRhMzFiODI4ODhjZGVkMjNiMDc3XzItMi0xLTEtMA_a82a853d-ee3c-4cf8-94ce-745b5f60158e"
      unitRef="usd">87000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i9d71c28a51a741d4b83d1e2cb290100d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTQvZnJhZzo1MmU1NWZlN2RkMmI0OWUxOTZjZDllZTk3NTcxNmQ2NS90YWJsZTo4MTkxMjRmOTZiZTY0YTMxYjgyODg4Y2RlZDIzYjA3Ny90YWJsZXJhbmdlOjgxOTEyNGY5NmJlNjRhMzFiODI4ODhjZGVkMjNiMDc3XzItNC0xLTEtMA_4a3643de-6fb9-48e6-bf40-76e45a873020"
      unitRef="usd">112000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="i91c331befb394cb6b31c1d43cedab05f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTQvZnJhZzo1MmU1NWZlN2RkMmI0OWUxOTZjZDllZTk3NTcxNmQ2NS90YWJsZTo4MTkxMjRmOTZiZTY0YTMxYjgyODg4Y2RlZDIzYjA3Ny90YWJsZXJhbmdlOjgxOTEyNGY5NmJlNjRhMzFiODI4ODhjZGVkMjNiMDc3XzMtMi0xLTEtMA_e406a097-7053-4277-bbf2-8bc81761fdf7"
      unitRef="usd">28000000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="i9d71c28a51a741d4b83d1e2cb290100d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTQvZnJhZzo1MmU1NWZlN2RkMmI0OWUxOTZjZDllZTk3NTcxNmQ2NS90YWJsZTo4MTkxMjRmOTZiZTY0YTMxYjgyODg4Y2RlZDIzYjA3Ny90YWJsZXJhbmdlOjgxOTEyNGY5NmJlNjRhMzFiODI4ODhjZGVkMjNiMDc3XzMtNC0xLTEtMA_b4ceef39-41ba-4aad-be80-db70f9b48c0c"
      unitRef="usd">321000000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i91c331befb394cb6b31c1d43cedab05f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTQvZnJhZzo1MmU1NWZlN2RkMmI0OWUxOTZjZDllZTk3NTcxNmQ2NS90YWJsZTo4MTkxMjRmOTZiZTY0YTMxYjgyODg4Y2RlZDIzYjA3Ny90YWJsZXJhbmdlOjgxOTEyNGY5NmJlNjRhMzFiODI4ODhjZGVkMjNiMDc3XzQtMi0xLTEtMA_0cd599b6-48ac-4038-8729-feac29e99840"
      unitRef="usd">-1338000000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i9d71c28a51a741d4b83d1e2cb290100d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTQvZnJhZzo1MmU1NWZlN2RkMmI0OWUxOTZjZDllZTk3NTcxNmQ2NS90YWJsZTo4MTkxMjRmOTZiZTY0YTMxYjgyODg4Y2RlZDIzYjA3Ny90YWJsZXJhbmdlOjgxOTEyNGY5NmJlNjRhMzFiODI4ODhjZGVkMjNiMDc3XzQtNC0xLTEtMA_22b4d4ed-72d9-47c9-876f-5fe26c0896f8"
      unitRef="usd">0</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i91c331befb394cb6b31c1d43cedab05f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTQvZnJhZzo1MmU1NWZlN2RkMmI0OWUxOTZjZDllZTk3NTcxNmQ2NS90YWJsZTo4MTkxMjRmOTZiZTY0YTMxYjgyODg4Y2RlZDIzYjA3Ny90YWJsZXJhbmdlOjgxOTEyNGY5NmJlNjRhMzFiODI4ODhjZGVkMjNiMDc3XzUtMi0xLTEtMA_fe7ffd36-104f-4258-9aed-1c034ac275d8"
      unitRef="usd">255000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i9d71c28a51a741d4b83d1e2cb290100d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTQvZnJhZzo1MmU1NWZlN2RkMmI0OWUxOTZjZDllZTk3NTcxNmQ2NS90YWJsZTo4MTkxMjRmOTZiZTY0YTMxYjgyODg4Y2RlZDIzYjA3Ny90YWJsZXJhbmdlOjgxOTEyNGY5NmJlNjRhMzFiODI4ODhjZGVkMjNiMDc3XzUtNC0xLTEtMA_707ca617-335f-45c7-b9e4-305c40842717"
      unitRef="usd">149000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i91c331befb394cb6b31c1d43cedab05f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTQvZnJhZzo1MmU1NWZlN2RkMmI0OWUxOTZjZDllZTk3NTcxNmQ2NS90YWJsZTo4MTkxMjRmOTZiZTY0YTMxYjgyODg4Y2RlZDIzYjA3Ny90YWJsZXJhbmdlOjgxOTEyNGY5NmJlNjRhMzFiODI4ODhjZGVkMjNiMDc3XzYtMi0xLTEtMA_a7c73fde-440e-404c-98d1-1fe13cfb774a"
      unitRef="usd">701000000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i9d71c28a51a741d4b83d1e2cb290100d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTQvZnJhZzo1MmU1NWZlN2RkMmI0OWUxOTZjZDllZTk3NTcxNmQ2NS90YWJsZTo4MTkxMjRmOTZiZTY0YTMxYjgyODg4Y2RlZDIzYjA3Ny90YWJsZXJhbmdlOjgxOTEyNGY5NmJlNjRhMzFiODI4ODhjZGVkMjNiMDc3XzYtNC0xLTEtMA_e74b042b-67ca-4314-95c9-50160a977692"
      unitRef="usd">201000000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="ib7962e972c7344539b9b1d82ad79a7df_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTQvZnJhZzo1MmU1NWZlN2RkMmI0OWUxOTZjZDllZTk3NTcxNmQ2NS90YWJsZTo4MTkxMjRmOTZiZTY0YTMxYjgyODg4Y2RlZDIzYjA3Ny90YWJsZXJhbmdlOjgxOTEyNGY5NmJlNjRhMzFiODI4ODhjZGVkMjNiMDc3XzctMi0xLTEtMA_6e1c97a0-9dd1-43ff-8a41-f867fb276db1"
      unitRef="usd">1434000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="ib55d7c02a76f495eadd39abf177a36b9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTQvZnJhZzo1MmU1NWZlN2RkMmI0OWUxOTZjZDllZTk3NTcxNmQ2NS90YWJsZTo4MTkxMjRmOTZiZTY0YTMxYjgyODg4Y2RlZDIzYjA3Ny90YWJsZXJhbmdlOjgxOTEyNGY5NmJlNjRhMzFiODI4ODhjZGVkMjNiMDc3XzctNC0xLTEtMA_8f4056b8-0265-4826-b18d-e13a06fcd58d"
      unitRef="usd">2211000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTcvZnJhZzoyNzA4MDU3MzhiZjc0MzA5ODVmOTgzMjNiMGZkMzIxNy90ZXh0cmVnaW9uOjI3MDgwNTczOGJmNzQzMDk4NWY5ODMyM2IwZmQzMjE3XzE2NDkyNjc0NDI4ODY_65316dd8-a33f-42ed-a62a-6aa057b4b5ab">Share-Based CompensationThe Company recognizes compensation expense for share-based awards, including stock options and restricted stock and restricted stock units (collectively, restricted shares), on a straight-line basis over the related service period (generally the vesting period) of the award, or to an employee&#x2019;s eligible retirement date under the award agreement, if earlier. Restricted shares vest ratably, primarily over &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTcvZnJhZzoyNzA4MDU3MzhiZjc0MzA5ODVmOTgzMjNiMGZkMzIxNy90ZXh0cmVnaW9uOjI3MDgwNTczOGJmNzQzMDk4NWY5ODMyM2IwZmQzMjE3XzQzOA_eb1bf801-8e88-43f4-addf-b3432e5c7bdc"&gt;four&lt;/span&gt; years and compensation expense related to restricted shares is based on the share price on the date of grant. Stock options vest ratably primarily over &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTcvZnJhZzoyNzA4MDU3MzhiZjc0MzA5ODVmOTgzMjNiMGZkMzIxNy90ZXh0cmVnaW9uOjI3MDgwNTczOGJmNzQzMDk4NWY5ODMyM2IwZmQzMjE3XzM4NDgyOTA2OTg0NDE_e5312511-99bf-4e41-b5f9-1d6cc88b8bfd"&gt;four&lt;/span&gt; years and may be exercised up to 10 years from the date of grant. Compensation expense related to stock options is based on the fair value at the date of grant, which is estimated on the date of grant using a binomial option-pricing model. Under the Company&#x2019;s Employee Stock Purchase Plan (ESPP), eligible employees are allowed to purchase the Company&#x2019;s stock at a discounted price, which is 90% of the market price of the Company&#x2019;s common stock at the end of the six-month purchase period. Share-based compensation expense for all programs is recognized in operating costs in the Consolidated Statements of Operations.</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i4d96f9ce242e4c3d8115ee3621f39cbe_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNTcvZnJhZzoyNzA4MDU3MzhiZjc0MzA5ODVmOTgzMjNiMGZkMzIxNy90ZXh0cmVnaW9uOjI3MDgwNTczOGJmNzQzMDk4NWY5ODMyM2IwZmQzMjE3XzM4NDgyOTA2OTg0NjA_804f51fe-a216-44d3-9ecd-c3062eb4848a">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjAvZnJhZzo4ZTMxY2M3MDhmOGU0ZTcyOTM4YzJhZTFjYWU3NTY1MC90ZXh0cmVnaW9uOjhlMzFjYzcwOGY4ZTRlNzI5MzhjMmFlMWNhZTc1NjUwXzE2NDkyNjc0NDI4MDI_ec1c94d4-881f-4a08-92dc-be4c03b74484">Net Earnings Per Common Share The Company computes basic earnings per common share attributable to UnitedHealth Group common shareholders by dividing net earnings attributable to UnitedHealth Group common shareholders by the weighted-average number of common shares outstanding during the period. The Company determines diluted net earnings per common share attributable to UnitedHealth Group common shareholders using the weighted-average number of common shares outstanding during the period, adjusted for potentially dilutive shares associated with stock options, restricted shares and the ESPP (collectively, common stock equivalents), using the treasury stock method. The treasury stock method assumes a hypothetical issuance of shares to settle the share-based awards, with the assumed proceeds used to purchase common stock at the average market price for the period. Assumed proceeds include the amount the employee must pay upon exercise and the average unrecognized compensation cost. The difference between the number of shares assumed issued and number of shares assumed purchased represents the dilutive shares.</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:IndustrySpecificPoliciesInsuranceCompaniesTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjMvZnJhZzpjYTI2NWY1YjMwMzE0ZWI1YWI4OTJiOGZjODVkNDI3Mi90ZXh0cmVnaW9uOmNhMjY1ZjViMzAzMTRlYjVhYjg5MmI4ZmM4NWQ0MjcyXzE2NDkyNjc0NDMxMzQ_96d7a3b2-c63e-4ee3-a0af-1d7187f6862f">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;ACA Tax&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Health Insurance Tax was permanently repealed by Congress, effective January 1, 2021. The permanent repeal of the tax impacts year-over-year comparability of our financial statements, including revenues, operating costs, medical care ratio (MCR), operating cost ratio, effective tax rate and cash flows from operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:IndustrySpecificPoliciesInsuranceCompaniesTextBlock>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90ZXh0cmVnaW9uOmI3ZjA4OGU5MmIxNTQxMjQ4NjY5ZWY4MjhjMGI1YWE2XzM4NDgyOTA3MDE2ODc_5b486bfb-a0f9-4231-baf7-bfc512d7679a">Investments&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of debt securities by major security type is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.020%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities - available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities - available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities - held-to-maturity:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities - held-to-maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities - available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities - available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities - held-to-maturity:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities - held-to-maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Nearly all of the Company&#x2019;s investments in mortgage-backed securities were rated &#x201c;Triple A&#x201d; as of December&#160;31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company held $3.5 billion and $2.3 billion of equity securities as of December&#160;31, 2021 and 2020, respectively. The Company&#x2019;s investments in equity securities primarily consist of employee savings plan related investments, other venture investments and shares of Brazilian real denominated fixed-income funds with readily determinable fair values. Additionally, the Company&#x2019;s investments included $1.3 billion of equity method investments in operating businesses in the health care sector, as of both December&#160;31, 2021 and 2020. The allowance for credit losses on held-to-maturity securities as of December&#160;31, 2021 and 2020 was not material. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amortized cost and fair value of debt securities as of December&#160;31, 2021, by contractual maturity, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.748%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Available-for-Sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Held-to-Maturity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due in one year or less&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of available-for-sale debt securities with gross unrealized losses by major security type and length of time that individual securities have been in a continuous unrealized loss position were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.649%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less Than 12 Months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12 Months or Greater&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(130)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities - available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities - available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s unrealized losses from all securities as of December&#160;31, 2021 were generated from approximately 13,000 positions out of a total of 39,000 positions. The Company believes it will collect the timely principal and interest due on its debt securities having an amortized cost in excess of fair value. The unrealized losses were primarily caused by interest rate increases and not by unfavorable changes in the credit quality associated with these securities which impacted the Company&#x2019;s assessment on collectability of principal and interest. At each reporting period, the Company evaluates available-for-sale debt securities for any credit-related impairment when the fair value of the investment is less than its amortized cost. The Company evaluated the expected cash flows, the underlying credit quality and credit ratings of the issuers noting no significant credit deterioration since purchase. As of December&#160;31, 2021, the Company did not have the intent to sell any of the securities in an unrealized loss position. Therefore, the Company believes these losses to be temporary. The allowance for credit losses on available-for-sale debt securities as of December&#160;31, 2021 and 2020 was not material.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90ZXh0cmVnaW9uOmI3ZjA4OGU5MmIxNTQxMjQ4NjY5ZWY4MjhjMGI1YWE2XzIyOTI_8cd25faf-4ad9-4097-96c5-ebbeddb7a5f6">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of debt securities by major security type is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.020%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities - available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities - available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities - held-to-maturity:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities - held-to-maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities - available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities - available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities - held-to-maturity:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities - held-to-maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="if5bcfc870d824827bb66dd636d076fd1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzMtMi0xLTEtMA_d6a15a9b-27d6-4eb7-9a27-996687f0d51c"
      unitRef="usd">3206000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="if5bcfc870d824827bb66dd636d076fd1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzMtNC0xLTEtMA_86339829-a6f0-4efc-a51a-1edec91b75ae"
      unitRef="usd">23000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="if5bcfc870d824827bb66dd636d076fd1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzMtNi0xLTEtMA_9115f8eb-1db3-40e5-95af-6c2d93e5b47f"
      unitRef="usd">31000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if5bcfc870d824827bb66dd636d076fd1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzMtOC0xLTEtMA_d329e4c9-9d95-4ff2-9666-ab8f4f55ea81"
      unitRef="usd">3198000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i24678048e47943bb91d8def4d5f22212_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzQtMi0xLTEtMA_37612247-5c8c-4d9a-94a3-0b67bcbc4e2d"
      unitRef="usd">6829000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i24678048e47943bb91d8def4d5f22212_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzQtNC0xLTEtMA_948904b9-af69-4f72-9713-0434f6248ba2"
      unitRef="usd">297000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i24678048e47943bb91d8def4d5f22212_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzQtNi0xLTEtMA_7d254b7f-e8b0-42e7-928f-fecbd6c4f4fc"
      unitRef="usd">20000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i24678048e47943bb91d8def4d5f22212_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzQtOC0xLTEtMA_c7f9d7a3-db97-458b-83b0-a1158a8d7337"
      unitRef="usd">7106000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i60063fc646f547e0ac686bc7d0b92112_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzUtMi0xLTEtMA_1e74e644-b63d-458b-9b52-a288db9fa011"
      unitRef="usd">20947000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i60063fc646f547e0ac686bc7d0b92112_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzUtNC0xLTEtMA_be7252bf-9ee6-4a6e-9614-0a88fe959b99"
      unitRef="usd">372000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i60063fc646f547e0ac686bc7d0b92112_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzUtNi0xLTEtMA_b4fee5a0-b06c-4a43-9385-556ca01aa795"
      unitRef="usd">145000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i60063fc646f547e0ac686bc7d0b92112_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzUtOC0xLTEtMA_f5f5fc86-77f9-47cd-861b-19f1a1c1e024"
      unitRef="usd">21174000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="if5a1b74f16184b9bb2add4cab25e29f2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzYtMi0xLTEtMA_96c68b4c-a20b-4af9-86be-ffa922d0714d"
      unitRef="usd">5868000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="if5a1b74f16184b9bb2add4cab25e29f2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzYtNC0xLTEtMA_3eca7272-916b-4f73-b37d-627c4959d4ec"
      unitRef="usd">88000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="if5a1b74f16184b9bb2add4cab25e29f2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzYtNi0xLTEtMA_c74ca133-76ee-4c62-ae27-461e12f9c364"
      unitRef="usd">55000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if5a1b74f16184b9bb2add4cab25e29f2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzYtOC0xLTEtMA_bfda935f-8028-4715-967a-d8e9d9755c6c"
      unitRef="usd">5901000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i2b784ace82c244c5867ac2f828eb7a57_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzctMi0xLTEtMA_180379ed-62ad-47e4-b691-24136adce3a3"
      unitRef="usd">2819000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i2b784ace82c244c5867ac2f828eb7a57_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzctNC0xLTEtMA_0ccb90aa-244f-4967-8348-ded932d6e1ea"
      unitRef="usd">42000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i2b784ace82c244c5867ac2f828eb7a57_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzctNi0xLTEtMA_1ae1bb62-289b-4b9b-8e68-6a9a02e770c1"
      unitRef="usd">23000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2b784ace82c244c5867ac2f828eb7a57_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzctOC0xLTEtMA_438305d4-1023-4835-999f-8f6f2786cea0"
      unitRef="usd">2838000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzgtMi0xLTEtMA_bc74dd95-474b-4c88-af1a-4d3663e8548a"
      unitRef="usd">39669000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzgtNC0xLTEtMA_d8461dfa-c667-489f-89cd-6092eadfecde"
      unitRef="usd">822000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzgtNi0xLTEtMA_d5f622ab-fe42-4391-9639-f58c828269eb"
      unitRef="usd">274000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzgtOC0xLTEtMA_a7f68502-b639-4623-b1f7-0bd086543f50"
      unitRef="usd">40217000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:HeldToMaturitySecurities
      contextRef="if5bcfc870d824827bb66dd636d076fd1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzEwLTItMS0xLTA_e613af3f-88cc-47c3-ad8f-d0929288d6ce"
      unitRef="usd">511000000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
      contextRef="if5bcfc870d824827bb66dd636d076fd1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzEwLTQtMS0xLTA_e1a32dd2-2595-4318-a5b9-165179aeca69"
      unitRef="usd">2000000</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="if5bcfc870d824827bb66dd636d076fd1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzEwLTYtMS0xLTA_aeeb33ef-e5ce-4fce-8573-3f55552b0280"
      unitRef="usd">2000000</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="if5bcfc870d824827bb66dd636d076fd1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzEwLTgtMS0xLTA_eaba0b67-17f9-47de-beca-4081d7a02527"
      unitRef="usd">511000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecurities
      contextRef="i24678048e47943bb91d8def4d5f22212_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzExLTItMS0xLTA_c46abaf2-3819-4dc6-bcad-fec77b661b0f"
      unitRef="usd">30000000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
      contextRef="i24678048e47943bb91d8def4d5f22212_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzExLTQtMS0xLTA_9b3c898d-1175-48af-80f9-8083583ebd31"
      unitRef="usd">2000000</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="i24678048e47943bb91d8def4d5f22212_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzExLTYtMS0xLTA_d9515035-50e0-4c42-874b-051b0b4f7fb7"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i24678048e47943bb91d8def4d5f22212_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzExLTgtMS0xLTA_d2c2043c-e8de-4f9e-a811-e6725a81a256"
      unitRef="usd">32000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecurities
      contextRef="i60063fc646f547e0ac686bc7d0b92112_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzEyLTItMS0xLTA_24425d42-efa8-4b0d-b8da-6d789f426c29"
      unitRef="usd">100000000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
      contextRef="i60063fc646f547e0ac686bc7d0b92112_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzEyLTQtMS0xLTA_54209a30-d2bf-4d36-b086-b1d2e732f717"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="i60063fc646f547e0ac686bc7d0b92112_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzEyLTYtMS0xLTA_d4aef2ee-5213-42e4-b225-f00fa6db7094"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i60063fc646f547e0ac686bc7d0b92112_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzEyLTgtMS0xLTA_b8eafd06-a10f-4f29-8050-56e09e75070a"
      unitRef="usd">100000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecurities
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzEzLTItMS0xLTA_3eac97b2-bab9-4c25-b408-8c5c12b13910"
      unitRef="usd">641000000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzEzLTQtMS0xLTA_0b54b58b-f428-43fb-a95e-b8d3a6b6a817"
      unitRef="usd">4000000</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzEzLTYtMS0xLTA_5ae5671c-77f9-4d5d-800f-76146f627d17"
      unitRef="usd">2000000</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzEzLTgtMS0xLTA_4c8782c8-debe-4775-a885-9e820a21cadc"
      unitRef="usd">643000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <unh:InvestmentsAmortizedCost
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzE0LTItMS0xLTA_9e32d799-5017-4e13-bedd-ff66c2d38aad"
      unitRef="usd">40310000000</unh:InvestmentsAmortizedCost>
    <unh:InvestmentsGrossUnrealizedGains
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzE0LTQtMS0xLTA_be6d3f1a-4d38-41a5-8e96-322d5acb7481"
      unitRef="usd">826000000</unh:InvestmentsGrossUnrealizedGains>
    <unh:InvestmentsGrossUnrealizedLosses
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzE0LTYtMS0xLTA_8b83d9cc-af64-429f-9d74-d522a226373e"
      unitRef="usd">276000000</unh:InvestmentsGrossUnrealizedLosses>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzE0LTgtMS0xLTA_0aaceea8-9ab8-44c3-8282-4f9178c95f5a"
      unitRef="usd">40860000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i2a312b80055e4af7bc076c9e6f9c43e6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzE3LTItMS0xLTA_7592cc29-e297-4892-bc79-36d42fdc69a9"
      unitRef="usd">3335000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i2a312b80055e4af7bc076c9e6f9c43e6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzE3LTQtMS0xLTA_c411abd0-9a11-4405-8738-ec88cf5dc157"
      unitRef="usd">133000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i2a312b80055e4af7bc076c9e6f9c43e6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzE3LTYtMS0xLTA_2edb8478-ac06-41f1-ab7b-4d156aa985a8"
      unitRef="usd">3000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2a312b80055e4af7bc076c9e6f9c43e6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzE3LTgtMS0xLTA_c88d8985-1690-4eb0-8761-1d3c3a4106b6"
      unitRef="usd">3465000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ibe8be8f0fb534e25be1cc040ead9f99f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzE4LTItMS0xLTA_e3066cfe-6496-42a8-b861-b0c3cf3b95e0"
      unitRef="usd">6893000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ibe8be8f0fb534e25be1cc040ead9f99f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzE4LTQtMS0xLTA_b84923aa-d9cb-423e-831d-95c900833378"
      unitRef="usd">435000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ibe8be8f0fb534e25be1cc040ead9f99f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzE4LTYtMS0xLTA_106f98d5-05a2-4ac2-948e-be62dcd902c2"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibe8be8f0fb534e25be1cc040ead9f99f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzE4LTgtMS0xLTA_0e974396-5ecf-47fa-bb48-e99fdc2f2f49"
      unitRef="usd">7328000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ib130b8ba2819452594b22d15469baacb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzE5LTItMS0xLTA_f9205c4d-89eb-40fe-81de-480bc3df6ceb"
      unitRef="usd">18886000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib130b8ba2819452594b22d15469baacb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzE5LTQtMS0xLTA_664b0672-443e-4a65-aeed-3da931263ac1"
      unitRef="usd">863000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib130b8ba2819452594b22d15469baacb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzE5LTYtMS0xLTA_8730db54-a484-4597-bc7a-ac9721378002"
      unitRef="usd">12000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib130b8ba2819452594b22d15469baacb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzE5LTgtMS0xLTA_4b5cb011-b3a9-4168-a8a4-e7d8231ec5f4"
      unitRef="usd">19737000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i1ec806aa176a4bbb99266b4a32cf1ded_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzIwLTItMS0xLTA_6df887e3-3334-41e9-a124-09e68a5bfd93"
      unitRef="usd">6849000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i1ec806aa176a4bbb99266b4a32cf1ded_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzIwLTQtMS0xLTA_c55100fc-1b83-4ba7-a0a5-43b10a9677fc"
      unitRef="usd">245000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i1ec806aa176a4bbb99266b4a32cf1ded_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzIwLTYtMS0xLTA_5ca58eaa-2272-4797-a208-055ad4d77f81"
      unitRef="usd">3000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1ec806aa176a4bbb99266b4a32cf1ded_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzIwLTgtMS0xLTA_da1e0a68-9ea6-4422-a0ec-454471b2089e"
      unitRef="usd">7091000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ieda9939b5a6c4fdeb0d28e0580ab8d78_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzIxLTItMS0xLTA_57db3b78-41a9-4afd-9815-9f16cb5d0c6e"
      unitRef="usd">2116000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ieda9939b5a6c4fdeb0d28e0580ab8d78_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzIxLTQtMS0xLTA_a9afbf7d-2be5-4d03-94b0-65ff23152d0c"
      unitRef="usd">95000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ieda9939b5a6c4fdeb0d28e0580ab8d78_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzIxLTYtMS0xLTA_db671980-a679-49cb-8e5e-7f4f2bdd350d"
      unitRef="usd">4000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ieda9939b5a6c4fdeb0d28e0580ab8d78_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzIxLTgtMS0xLTA_d850130d-e78d-4471-bf40-bb651888edb7"
      unitRef="usd">2207000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzIyLTItMS0xLTA_3f59cff1-d70f-475e-85f0-09bc5de5a1a6"
      unitRef="usd">38079000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzIyLTQtMS0xLTA_90ef326a-37fc-4b83-9a38-46e00cbe706e"
      unitRef="usd">1771000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzIyLTYtMS0xLTA_efec8289-b3a4-4a6d-a06c-77d430e9fc30"
      unitRef="usd">22000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzIyLTgtMS0xLTA_b95af02d-3a0d-4c05-8dfb-dadaa92d36b0"
      unitRef="usd">39828000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:HeldToMaturitySecurities
      contextRef="i2a312b80055e4af7bc076c9e6f9c43e6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI0LTItMS0xLTA_5cd09321-e335-4361-acc1-53f5fb31bc1d"
      unitRef="usd">420000000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
      contextRef="i2a312b80055e4af7bc076c9e6f9c43e6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI0LTQtMS0xLTA_63d3c7a8-4358-4326-8d5d-b9ce09607ba9"
      unitRef="usd">6000000</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="i2a312b80055e4af7bc076c9e6f9c43e6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI0LTYtMS0xLTA_efc4e8c2-dc11-4a1e-9e9b-f7cfb884c145"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i2a312b80055e4af7bc076c9e6f9c43e6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI0LTgtMS0xLTA_0bd23f19-d8b4-4bb3-815a-c93d03985511"
      unitRef="usd">426000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecurities
      contextRef="ibe8be8f0fb534e25be1cc040ead9f99f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI1LTItMS0xLTA_4596c782-5843-4e39-913b-3ba27fb4247d"
      unitRef="usd">31000000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
      contextRef="ibe8be8f0fb534e25be1cc040ead9f99f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI1LTQtMS0xLTA_51188778-b67f-4605-bef3-918dc230d0a3"
      unitRef="usd">2000000</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="ibe8be8f0fb534e25be1cc040ead9f99f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI1LTYtMS0xLTA_3b9669ea-5625-4ebc-b4a2-7e84da0c8eec"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="ibe8be8f0fb534e25be1cc040ead9f99f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI1LTgtMS0xLTA_70a05fbd-eeac-4ce6-bcb9-9e534a98e17e"
      unitRef="usd">33000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecurities
      contextRef="ib130b8ba2819452594b22d15469baacb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI2LTItMS0xLTA_6deca221-c3b3-4e42-851c-0e080b5ec3ab"
      unitRef="usd">187000000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
      contextRef="ib130b8ba2819452594b22d15469baacb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI2LTQtMS0xLTA_b2c02182-cd5e-4d44-a55a-90f668fa33a0"
      unitRef="usd">1000000</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="ib130b8ba2819452594b22d15469baacb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI2LTYtMS0xLTA_275f9d46-dfac-473f-8053-553e76ffaed8"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="ib130b8ba2819452594b22d15469baacb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI2LTgtMS0xLTA_499101b9-fa8f-44f3-a9e2-c6127eae4d96"
      unitRef="usd">188000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecurities
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI3LTItMS0xLTA_ad35a187-0f03-4b16-8af2-f263d559cf39"
      unitRef="usd">638000000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI3LTQtMS0xLTA_08688de6-efba-4a41-bee6-da7b06d1047c"
      unitRef="usd">9000000</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI3LTYtMS0xLTA_9e13e78e-621b-4bbe-b3d3-22f32dd27db5"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI3LTgtMS0xLTA_cdd69689-feea-4068-8c24-b25ec8e2ea94"
      unitRef="usd">647000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <unh:InvestmentsAmortizedCost
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI4LTItMS0xLTA_49682584-2e9c-4cc6-918e-3ea3b7e8923c"
      unitRef="usd">38717000000</unh:InvestmentsAmortizedCost>
    <unh:InvestmentsGrossUnrealizedGains
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI4LTQtMS0xLTA_32cecc54-5e84-41af-bbd6-07015e50fbe4"
      unitRef="usd">1780000000</unh:InvestmentsGrossUnrealizedGains>
    <unh:InvestmentsGrossUnrealizedLosses
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI4LTYtMS0xLTA_3312f664-bd8e-4c74-aef8-61a19d4c2bd8"
      unitRef="usd">22000000</unh:InvestmentsGrossUnrealizedLosses>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpjYjE2ZjQ0N2YxNjY0ZTA1OTY4ODQ0ZTI4MzE2NzZlYi90YWJsZXJhbmdlOmNiMTZmNDQ3ZjE2NjRlMDU5Njg4NDRlMjgzMTY3NmViXzI4LTgtMS0xLTA_4755b8ec-dc10-4416-aabc-27611d286cfd"
      unitRef="usd">40475000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90ZXh0cmVnaW9uOmI3ZjA4OGU5MmIxNTQxMjQ4NjY5ZWY4MjhjMGI1YWE2XzIwOQ_d469ae36-0045-4bb2-b4f9-f6899f6130e3"
      unitRef="usd">3500000000</us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue>
    <us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90ZXh0cmVnaW9uOmI3ZjA4OGU5MmIxNTQxMjQ4NjY5ZWY4MjhjMGI1YWE2XzIxNg_78447059-7d1f-49f5-87da-3873334863b4"
      unitRef="usd">2300000000</us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue>
    <us-gaap:EquityMethodInvestments
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90ZXh0cmVnaW9uOmI3ZjA4OGU5MmIxNTQxMjQ4NjY5ZWY4MjhjMGI1YWE2XzUyOQ_7a23633b-b4f2-465c-b43a-4cb3d0c86091"
      unitRef="usd">1300000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90ZXh0cmVnaW9uOmI3ZjA4OGU5MmIxNTQxMjQ4NjY5ZWY4MjhjMGI1YWE2XzUyOQ_8c6c55d3-4616-4431-9a1e-2233503d79e3"
      unitRef="usd">1300000000</us-gaap:EquityMethodInvestments>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90ZXh0cmVnaW9uOmI3ZjA4OGU5MmIxNTQxMjQ4NjY5ZWY4MjhjMGI1YWE2XzIyOTE_ddf96170-0173-494c-9f76-bf85eb11a145">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amortized cost and fair value of debt securities as of December&#160;31, 2021, by contractual maturity, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.748%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Available-for-Sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Held-to-Maturity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due in one year or less&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzItMi0xLTEtMA_df6b0289-e1b5-46f4-b09c-3f3555513646"
      unitRef="usd">2603000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzItNC0xLTEtMA_8a5514fd-c51a-4f8b-a724-a1f084b61ba1"
      unitRef="usd">2614000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzItNi0xLTEtMA_f7094195-0d9e-4d43-9a37-9979da19484d"
      unitRef="usd">235000000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzItOC0xLTEtMA_80ffda75-d6f2-4a4f-8b18-9e7bbfcc690a"
      unitRef="usd">236000000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzMtMi0xLTEtMA_ad6cf685-016b-453d-be0c-4eb89a9b7b21"
      unitRef="usd">12885000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzMtNC0xLTEtMA_ec3f2bd8-5d80-4367-aad3-b350c324be5d"
      unitRef="usd">13065000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzMtNi0xLTEtMA_00fa0c3f-902c-4eb9-bf26-d8b819e1298d"
      unitRef="usd">355000000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzMtOC0xLTEtMA_aa20ee22-c2c9-4f4c-897a-319e2de87646"
      unitRef="usd">354000000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzQtMi0xLTEtMA_24e3bee9-34f4-4ed6-abb3-a63af79d7438"
      unitRef="usd">11342000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzQtNC0xLTEtMA_822bc773-bdbd-4479-a626-9581f0299875"
      unitRef="usd">11524000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzQtNi0xLTEtMA_42a0326b-7cf6-4711-9c52-3daa6a480ce1"
      unitRef="usd">28000000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzQtOC0xLTEtMA_b613627a-f4db-4570-8383-e1f3f62dff34"
      unitRef="usd">29000000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzUtMi0xLTEtMA_43ce6558-17bc-4461-bb5f-17414d917a24"
      unitRef="usd">4152000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzUtNC0xLTEtMA_5f566ecf-88e1-4daf-9a75-7d93da67517d"
      unitRef="usd">4275000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzUtNi0xLTEtMA_7a1d19c2-b400-414a-be2b-ea06a274a752"
      unitRef="usd">23000000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzUtOC0xLTEtMA_e7bc7184-6a27-4b5d-bf8a-0348ace24e09"
      unitRef="usd">24000000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
      contextRef="if5a1b74f16184b9bb2add4cab25e29f2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzYtMi0xLTEtMA_6851d58e-c54b-41d8-9359-126fa7f1ac47"
      unitRef="usd">5868000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
      contextRef="if5a1b74f16184b9bb2add4cab25e29f2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzYtNC0xLTEtMA_f9533816-4543-40c4-ae02-cd46f27ea446"
      unitRef="usd">5901000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
      contextRef="i2b784ace82c244c5867ac2f828eb7a57_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzctMi0xLTEtMA_26830bfe-264b-4980-99ca-313f5012ac58"
      unitRef="usd">2819000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
      contextRef="i2b784ace82c244c5867ac2f828eb7a57_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzctNC0xLTEtMA_a232bcc2-4534-4f9c-9c2f-89b198e62bc0"
      unitRef="usd">2838000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzgtMi0xLTEtMA_957898dd-9227-4327-af1e-31f774dda22f"
      unitRef="usd">39669000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzgtNC0xLTEtMA_799f7d4c-084f-473d-8aeb-677de10ebe94"
      unitRef="usd">40217000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:HeldToMaturitySecurities
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzgtNi0xLTEtMA_ba638490-cea4-4b68-9ef6-389ad2fe36a5"
      unitRef="usd">641000000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTpkYzFlODY2N2FkYTQ0MDk2OWViZGQ2MDU5NjFlNThhNS90YWJsZXJhbmdlOmRjMWU4NjY3YWRhNDQwOTY5ZWJkZDYwNTk2MWU1OGE1XzgtOC0xLTEtMA_6b66966c-ff1e-4bd1-9e02-bb3856116bb7"
      unitRef="usd">643000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90ZXh0cmVnaW9uOmI3ZjA4OGU5MmIxNTQxMjQ4NjY5ZWY4MjhjMGI1YWE2XzIzMjE_d8fb2cca-6841-472e-b811-a22669db813d">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of available-for-sale debt securities with gross unrealized losses by major security type and length of time that individual securities have been in a continuous unrealized loss position were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.649%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less Than 12 Months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12 Months or Greater&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(130)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities - available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities - available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="if5bcfc870d824827bb66dd636d076fd1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzMtMi0xLTEtMA_7b966efc-543a-455e-be70-7adeabcc5b80"
      unitRef="usd">1976000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="if5bcfc870d824827bb66dd636d076fd1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzMtNC0xLTEtMA_84b46554-7d40-43f4-b915-833e5c8a225d"
      unitRef="usd">18000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="if5bcfc870d824827bb66dd636d076fd1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzMtNi0xLTEtMA_9ceb6276-b25d-414f-9701-0b160677418d"
      unitRef="usd">249000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="if5bcfc870d824827bb66dd636d076fd1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzMtOC0xLTEtMA_2d2f56e4-d469-44ba-96f7-b7f96adfed50"
      unitRef="usd">13000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="if5bcfc870d824827bb66dd636d076fd1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzMtMTAtMS0xLTA_a7243662-8515-4bb0-ad53-f4d1bd3c5d2a"
      unitRef="usd">2225000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="if5bcfc870d824827bb66dd636d076fd1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzMtMTItMS0xLTA_d7699383-5a3d-42c6-8d86-afe741d8b206"
      unitRef="usd">31000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i24678048e47943bb91d8def4d5f22212_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzQtMi0xLTEtMTY2OTE_db0dd31d-cd8a-4ef8-92c5-c80d6778e545"
      unitRef="usd">1386000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i24678048e47943bb91d8def4d5f22212_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzQtNC0xLTEtMTY3Mzk_0ddb2c63-e27b-48a3-9860-15bb8ad150b8"
      unitRef="usd">19000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i24678048e47943bb91d8def4d5f22212_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzQtNi0xLTEtMTY3Mzk_73b03c2e-842e-4e94-a092-4d71560262df"
      unitRef="usd">31000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i24678048e47943bb91d8def4d5f22212_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzQtOC0xLTEtMTY3Mzk_0a9ae9d7-185f-4993-b213-f20b38c128f1"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i24678048e47943bb91d8def4d5f22212_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzQtMTAtMS0xLTE2NzQ4_cc3efa06-f008-46b8-ad8b-db40265bda62"
      unitRef="usd">1417000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i24678048e47943bb91d8def4d5f22212_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzQtMTItMS0xLTE2NzUx_d077a3ef-1e87-4d2f-a99b-fe7559fcddc7"
      unitRef="usd">20000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i60063fc646f547e0ac686bc7d0b92112_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzQtMi0xLTEtMA_66e19f3d-de07-4599-a2a2-c0c18d5b5d3d"
      unitRef="usd">9357000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i60063fc646f547e0ac686bc7d0b92112_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzQtNC0xLTEtMA_24c1cca3-f162-40df-853f-799ff1377406"
      unitRef="usd">130000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i60063fc646f547e0ac686bc7d0b92112_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzQtNi0xLTEtMA_02f7a992-f321-4f43-b95b-446fca8b16b0"
      unitRef="usd">376000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i60063fc646f547e0ac686bc7d0b92112_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzQtOC0xLTEtMA_e138ee2b-9603-48ca-baf8-92423459c350"
      unitRef="usd">15000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i60063fc646f547e0ac686bc7d0b92112_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzQtMTAtMS0xLTA_2713ab15-2f3d-44f4-b38a-40f92d77af11"
      unitRef="usd">9733000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i60063fc646f547e0ac686bc7d0b92112_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzQtMTItMS0xLTA_3facef96-6615-4543-a718-64e10970202a"
      unitRef="usd">145000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="if5a1b74f16184b9bb2add4cab25e29f2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzUtMi0xLTEtMA_f1aa1992-507d-4a6d-8c99-bfc0b6a12e0e"
      unitRef="usd">3078000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="if5a1b74f16184b9bb2add4cab25e29f2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzUtNC0xLTEtMA_683d996c-cad2-4093-a2c0-0f2a9ee90939"
      unitRef="usd">52000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="if5a1b74f16184b9bb2add4cab25e29f2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzUtNi0xLTEtMA_8afec91a-b666-4989-bf38-691c2a9bf42f"
      unitRef="usd">116000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="if5a1b74f16184b9bb2add4cab25e29f2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzUtOC0xLTEtMA_a561558e-3035-4b06-9ab3-2099b1e39860"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="if5a1b74f16184b9bb2add4cab25e29f2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzUtMTAtMS0xLTA_1c98f0a7-48d6-406f-b090-1f376bc79b20"
      unitRef="usd">3194000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="if5a1b74f16184b9bb2add4cab25e29f2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzUtMTItMS0xLTA_8d4b7fb8-9907-470e-9ba3-7ae539381ba6"
      unitRef="usd">55000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i2b784ace82c244c5867ac2f828eb7a57_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzYtMi0xLTEtMA_6aad3b53-9d5f-44ab-ac30-0b2e3010f570"
      unitRef="usd">1321000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i2b784ace82c244c5867ac2f828eb7a57_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzYtNC0xLTEtMA_a2b68c71-fe7b-44de-9073-f826314082d6"
      unitRef="usd">18000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i2b784ace82c244c5867ac2f828eb7a57_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzYtNi0xLTEtMA_7db91c0c-dc1c-46c0-b9f3-07e7ef56c496"
      unitRef="usd">114000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i2b784ace82c244c5867ac2f828eb7a57_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzYtOC0xLTEtMA_faab119d-94e7-4cf2-a0dc-ec20bd5e15c8"
      unitRef="usd">5000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i2b784ace82c244c5867ac2f828eb7a57_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzYtMTAtMS0xLTA_686db627-0802-42a3-8c66-3d45ec50b9a9"
      unitRef="usd">1435000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i2b784ace82c244c5867ac2f828eb7a57_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzYtMTItMS0xLTA_2cd26bac-37bb-4552-a6e7-2d654d684806"
      unitRef="usd">23000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ibb56bbdb5bca464cb867242d3ed1b377_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzctMi0xLTEtMA_13c333a4-826b-4d45-8937-098d84104b85"
      unitRef="usd">17118000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ibb56bbdb5bca464cb867242d3ed1b377_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzctNC0xLTEtMA_1542bfbf-c66f-4e67-8bac-9227f80b7262"
      unitRef="usd">237000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ibb56bbdb5bca464cb867242d3ed1b377_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzctNi0xLTEtMA_d6269244-62b5-468c-8979-8d7832ea0ac2"
      unitRef="usd">886000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ibb56bbdb5bca464cb867242d3ed1b377_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzctOC0xLTEtMA_428187d0-739d-4e35-a4ae-5bffd2f0cc7c"
      unitRef="usd">37000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ibb56bbdb5bca464cb867242d3ed1b377_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzctMTAtMS0xLTA_06d42440-14e8-4669-a825-b52b447b9749"
      unitRef="usd">18004000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ibb56bbdb5bca464cb867242d3ed1b377_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzctMTItMS0xLTA_7bc99032-ee0f-4d8a-84c9-8a714fa4627f"
      unitRef="usd">274000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i2a312b80055e4af7bc076c9e6f9c43e6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzktMi0xLTEtMA_c61d612b-f9b7-48e7-a5c2-ec30acc08606"
      unitRef="usd">346000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i2a312b80055e4af7bc076c9e6f9c43e6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzktNC0xLTEtMA_9d38cdf7-ac06-4ac3-83ff-e09e72a22413"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i2a312b80055e4af7bc076c9e6f9c43e6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzktMTAtMS0xLTA_90535aa9-463a-44af-8784-bc5bc964c62c"
      unitRef="usd">346000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i2a312b80055e4af7bc076c9e6f9c43e6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzktMTItMS0xLTA_73b10106-94fc-4f51-9aea-7bbf29ae9b90"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ib130b8ba2819452594b22d15469baacb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzExLTItMS0xLTA_bfe5e1aa-22f4-4322-92ed-3d78586f78a4"
      unitRef="usd">1273000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ib130b8ba2819452594b22d15469baacb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzExLTQtMS0xLTA_8ad6b5d1-ace2-4882-a9aa-5537ddd4567d"
      unitRef="usd">9000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ib130b8ba2819452594b22d15469baacb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzExLTYtMS0xLTA_0a83ded4-d141-436d-88ad-6ce53661b710"
      unitRef="usd">456000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ib130b8ba2819452594b22d15469baacb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzExLTgtMS0xLTA_c567ccc8-f665-4c95-af78-3edefe11a856"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ib130b8ba2819452594b22d15469baacb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzExLTEwLTEtMS0w_a11a5a79-0058-4db9-b527-44f0613ae72e"
      unitRef="usd">1729000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ib130b8ba2819452594b22d15469baacb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzExLTEyLTEtMS0w_0e22503e-ade2-4c6d-8c30-632f1bc2fc3a"
      unitRef="usd">12000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i1ec806aa176a4bbb99266b4a32cf1ded_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzEyLTItMS0xLTA_5c9f79fe-f203-4445-909b-320425b56f50"
      unitRef="usd">601000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i1ec806aa176a4bbb99266b4a32cf1ded_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzEyLTQtMS0xLTA_490a7473-c029-430c-b7c2-650dd23f50b8"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i1ec806aa176a4bbb99266b4a32cf1ded_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzEyLTYtMS0xLTA_6aa06fed-7b38-40b1-80e8-74b9798c175e"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i1ec806aa176a4bbb99266b4a32cf1ded_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzEyLTgtMS0xLTA_5dff5318-413c-4260-b60a-2859df46a37f"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i1ec806aa176a4bbb99266b4a32cf1ded_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzEyLTEwLTEtMS0w_18dfa5cc-7ef5-4019-aaa3-889dfe2dde92"
      unitRef="usd">601000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i1ec806aa176a4bbb99266b4a32cf1ded_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzEyLTEyLTEtMS0w_a2986f43-91f9-4380-8b7c-dbb229221142"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ieda9939b5a6c4fdeb0d28e0580ab8d78_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzEzLTItMS0xLTA_b87c6235-aa3e-4def-ad91-6d9502170dcf"
      unitRef="usd">195000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ieda9939b5a6c4fdeb0d28e0580ab8d78_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzEzLTQtMS0xLTA_69fc2f96-97fa-4b71-8d40-2af5965f2078"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ieda9939b5a6c4fdeb0d28e0580ab8d78_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzEzLTYtMS0xLTA_2993d70e-91d5-4bff-a2a0-66bd6a887f44"
      unitRef="usd">93000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ieda9939b5a6c4fdeb0d28e0580ab8d78_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzEzLTgtMS0xLTA_9bd22f35-9b0b-48e6-a39f-43cf9cbb475e"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ieda9939b5a6c4fdeb0d28e0580ab8d78_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzEzLTEwLTEtMS0w_08859f15-a50c-4c98-ac84-ee095a724ad3"
      unitRef="usd">288000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ieda9939b5a6c4fdeb0d28e0580ab8d78_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzEzLTEyLTEtMS0w_d7fd8e8a-02cc-444b-b5f2-c8b27e55b3b3"
      unitRef="usd">4000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i9b1ef8f174f64af8b548c0044b97ecb5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzE0LTItMS0xLTA_8a61b7cb-76e9-4ab2-bbc3-3b3c6a3c8cc8"
      unitRef="usd">2415000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i9b1ef8f174f64af8b548c0044b97ecb5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzE0LTQtMS0xLTA_71623319-9393-4c69-9a9c-a73f8397746b"
      unitRef="usd">16000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i9b1ef8f174f64af8b548c0044b97ecb5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzE0LTYtMS0xLTA_4d756db4-44eb-494f-99d3-c0f44724185b"
      unitRef="usd">549000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i9b1ef8f174f64af8b548c0044b97ecb5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzE0LTgtMS0xLTA_901c1b39-6e4d-457c-bf39-41c11a20e4f3"
      unitRef="usd">6000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i9b1ef8f174f64af8b548c0044b97ecb5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzE0LTEwLTEtMS0w_6ad56532-4a43-454f-b1c1-f4e15917c054"
      unitRef="usd">2964000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i9b1ef8f174f64af8b548c0044b97ecb5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90YWJsZTo3MzViYWYxYThlMTY0YjZjODg1Mjg5ODNlZjc5YjVhNy90YWJsZXJhbmdlOjczNWJhZjFhOGUxNjRiNmM4ODUyODk4M2VmNzliNWE3XzE0LTEyLTEtMS0w_49008f0a-4fc8-43c0-a715-71dd006b6816"
      unitRef="usd">22000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90ZXh0cmVnaW9uOmI3ZjA4OGU5MmIxNTQxMjQ4NjY5ZWY4MjhjMGI1YWE2XzExNjE_605935f7-8172-4309-8703-bbaed346ea8c"
      unitRef="positions">13000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:InvestmentOwnedBalanceContracts
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNjkvZnJhZzpiN2YwODhlOTJiMTU0MTI0ODY2OWVmODI4YzBiNWFhNi90ZXh0cmVnaW9uOmI3ZjA4OGU5MmIxNTQxMjQ4NjY5ZWY4MjhjMGI1YWE2XzExOTI_8750222a-d710-4db4-b167-8b5c003fd7d2"
      unitRef="number">39000</us-gaap:InvestmentOwnedBalanceContracts>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90ZXh0cmVnaW9uOmUzYzE3YjU2ZGI2ZTQ4YzdiMjBhMTY2Mjk1M2IzMmVjXzYzMzM_24781cde-2806-4296-82e3-9942062cf9ea">Fair ValueCertain assets and liabilities are measured at fair value in the Consolidated Financial Statements or have fair values disclosed in the Notes to the Consolidated Financial Statements. These assets and liabilities are classified into one of three levels of a hierarchy defined by GAAP. In instances in which the inputs used to measure fair value fall into different levels of the fair value hierarchy, the fair value measurement is categorized in its entirety based on the lowest level input which is significant to the fair value measurement in its entirety. The Company&#x2019;s assessment of the significance of a particular item to the fair value measurement in its entirety requires judgment, including the consideration of inputs specific to the asset or liability. &lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value hierarchy is summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; Quoted prices (unadjusted) for identical assets/liabilities in active markets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; Other observable inputs, either directly or indirectly, including:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Quoted prices for similar assets/liabilities in active markets;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Quoted prices for identical or similar assets/liabilities in inactive markets (e.g., few transactions, limited information, noncurrent prices, high variability over time);&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Inputs other than quoted prices observable for the asset/liability (e.g., interest rates, yield curves, implied volatilities, credit spreads); and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Inputs corroborated by other observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level 3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; Unobservable inputs cannot be corroborated by observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no transfers in or out of Level 3 financial assets or liabilities during the years ended December&#160;31, 2021 or 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Nonfinancial assets and liabilities or financial assets and liabilities measured at fair value on a nonrecurring basis are subject to fair value adjustments only in certain circumstances, such as when the Company records an impairment. For the year ended December 31, 2021, the Company recognized $840 million of unrealized gains in investment and other income related to fair value adjustments on equity securities primarily in our venture portfolio, based on transactions of the same or similar security. There were no other significant fair value adjustments for these assets and liabilities recorded during the years ended December&#160;31, 2021 or 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following methods and assumptions were used to estimate the fair value and determine the fair value hierarchy classification of each class of financial instrument included in the tables below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value of cash and cash equivalents approximates fair value as maturities are less than three months. Fair values of cash equivalent instruments which do not trade on a regular basis in active markets are classified as Level 2.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Debt and Equity Securities.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Fair values of debt and equity securities are based on quoted market prices, where available. The Company obtains one price for each security primarily from a third-party pricing service (pricing service), which generally uses quoted or other observable inputs for the determination of fair value. The pricing service normally derives the security prices through recently reported trades for identical or similar securities, and, if necessary, makes adjustments through the reporting date based upon available observable market information. For securities not actively traded, the pricing service may use quoted market prices of comparable instruments or discounted cash flow analyses, incorporating inputs currently observable in the markets for similar securities. Inputs often used in the valuation methodologies include, but are not limited to, benchmark yields, credit spreads, default rates, prepayment speeds and nonbinding broker quotes. As the Company is responsible for the determination of fair value, it performs quarterly analyses on the prices received from the pricing service to determine whether the prices are reasonable estimates of fair value. Specifically, the Company compares the prices received from the pricing service to prices reported by a secondary pricing source, such as its custodian, its investment consultant and third-party investment advisors. Additionally, the Company compares changes in the reported market values and returns to relevant market indices to test the reasonableness of the reported prices. The Company&#x2019;s internal price verification procedures and reviews of fair value methodology documentation provided by independent pricing services have not historically resulted in adjustment to the prices obtained from the pricing service.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair values of debt securities which do not trade on a regular basis in active markets but are priced using other observable inputs are classified as Level&#160;2. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value estimates for Level 1 and Level 2 equity securities are based on quoted market prices for actively traded equity securities and/or other market data for the same or comparable instruments and transactions in establishing the prices. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of Level 3 investments in corporate bonds, which are not a significant portion of our investments, are estimated using valuation techniques relying heavily on management assumptions and qualitative observations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Throughout the procedures discussed above in relation to the Company&#x2019;s processes for validating third-party pricing information, the Company validates the understanding of assumptions and inputs used in security pricing and determines the proper classification in the hierarchy based on such understanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets Under Management.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Assets under management consists of debt securities and other investments held to fund costs associated with the AARP Program and are priced and classified using the same methodologies as the Company&#x2019;s investments in debt and equity securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Long-Term Debt. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of the Company&#x2019;s long-term debt are estimated and classified using the same methodologies as the Company&#x2019;s investments in debt securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a summary of fair value measurements by level and carrying values for items measured at fair value on a recurring basis in the Consolidated Balance Sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;br/&gt;in Active&lt;br/&gt;Markets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;br/&gt;Fair and Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities - available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities - available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets under management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Percentage of total assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities - available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities - available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets under management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Percentage of total assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a summary of fair value measurements by level and carrying values for certain financial instruments not measured at fair value on a recurring basis in the Consolidated Balance Sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;br/&gt;in Active&lt;br/&gt;Markets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;br/&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities - held-to-maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt and other financing obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities - held-to-maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt and other financing obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The carrying amounts reported on the Consolidated Balance Sheets for other current financial assets and liabilities approximate fair value because of their short-term nature. These assets and liabilities are not listed in the table above.</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90ZXh0cmVnaW9uOmUzYzE3YjU2ZGI2ZTQ4YzdiMjBhMTY2Mjk1M2IzMmVjXzYzMzE_915cd04a-a155-4c82-850d-3b1d3418191b">Certain assets and liabilities are measured at fair value in the Consolidated Financial Statements or have fair values disclosed in the Notes to the Consolidated Financial Statements. These assets and liabilities are classified into one of three levels of a hierarchy defined by GAAP. In instances in which the inputs used to measure fair value fall into different levels of the fair value hierarchy, the fair value measurement is categorized in its entirety based on the lowest level input which is significant to the fair value measurement in its entirety. The Company&#x2019;s assessment of the significance of a particular item to the fair value measurement in its entirety requires judgment, including the consideration of inputs specific to the asset or liability. &lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value hierarchy is summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; Quoted prices (unadjusted) for identical assets/liabilities in active markets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; Other observable inputs, either directly or indirectly, including:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Quoted prices for similar assets/liabilities in active markets;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Quoted prices for identical or similar assets/liabilities in inactive markets (e.g., few transactions, limited information, noncurrent prices, high variability over time);&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Inputs other than quoted prices observable for the asset/liability (e.g., interest rates, yield curves, implied volatilities, credit spreads); and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Inputs corroborated by other observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level 3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; Unobservable inputs cannot be corroborated by observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no transfers in or out of Level 3 financial assets or liabilities during the years ended December&#160;31, 2021 or 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Nonfinancial assets and liabilities or financial assets and liabilities measured at fair value on a nonrecurring basis are subject to fair value adjustments only in certain circumstances, such as when the Company records an impairment. For the year ended December 31, 2021, the Company recognized $840 million of unrealized gains in investment and other income related to fair value adjustments on equity securities primarily in our venture portfolio, based on transactions of the same or similar security. There were no other significant fair value adjustments for these assets and liabilities recorded during the years ended December&#160;31, 2021 or 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following methods and assumptions were used to estimate the fair value and determine the fair value hierarchy classification of each class of financial instrument included in the tables below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value of cash and cash equivalents approximates fair value as maturities are less than three months. Fair values of cash equivalent instruments which do not trade on a regular basis in active markets are classified as Level 2.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Debt and Equity Securities.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Fair values of debt and equity securities are based on quoted market prices, where available. The Company obtains one price for each security primarily from a third-party pricing service (pricing service), which generally uses quoted or other observable inputs for the determination of fair value. The pricing service normally derives the security prices through recently reported trades for identical or similar securities, and, if necessary, makes adjustments through the reporting date based upon available observable market information. For securities not actively traded, the pricing service may use quoted market prices of comparable instruments or discounted cash flow analyses, incorporating inputs currently observable in the markets for similar securities. Inputs often used in the valuation methodologies include, but are not limited to, benchmark yields, credit spreads, default rates, prepayment speeds and nonbinding broker quotes. As the Company is responsible for the determination of fair value, it performs quarterly analyses on the prices received from the pricing service to determine whether the prices are reasonable estimates of fair value. Specifically, the Company compares the prices received from the pricing service to prices reported by a secondary pricing source, such as its custodian, its investment consultant and third-party investment advisors. Additionally, the Company compares changes in the reported market values and returns to relevant market indices to test the reasonableness of the reported prices. The Company&#x2019;s internal price verification procedures and reviews of fair value methodology documentation provided by independent pricing services have not historically resulted in adjustment to the prices obtained from the pricing service.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair values of debt securities which do not trade on a regular basis in active markets but are priced using other observable inputs are classified as Level&#160;2. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value estimates for Level 1 and Level 2 equity securities are based on quoted market prices for actively traded equity securities and/or other market data for the same or comparable instruments and transactions in establishing the prices. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of Level 3 investments in corporate bonds, which are not a significant portion of our investments, are estimated using valuation techniques relying heavily on management assumptions and qualitative observations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Throughout the procedures discussed above in relation to the Company&#x2019;s processes for validating third-party pricing information, the Company validates the understanding of assumptions and inputs used in security pricing and determines the proper classification in the hierarchy based on such understanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets Under Management.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Assets under management consists of debt securities and other investments held to fund costs associated with the AARP Program and are priced and classified using the same methodologies as the Company&#x2019;s investments in debt and equity securities.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Long-Term Debt. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of the Company&#x2019;s long-term debt are estimated and classified using the same methodologies as the Company&#x2019;s investments in debt securities.&lt;/span&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGain
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90ZXh0cmVnaW9uOmUzYzE3YjU2ZGI2ZTQ4YzdiMjBhMTY2Mjk1M2IzMmVjXzI3NDg3NzkwNzYwMTc_5fbf7248-6f2d-42b5-87ee-e70378f2e0ee"
      unitRef="usd">840000000</us-gaap:EquitySecuritiesFvNiUnrealizedGain>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90ZXh0cmVnaW9uOmUzYzE3YjU2ZGI2ZTQ4YzdiMjBhMTY2Mjk1M2IzMmVjXzYyODY_3cc3b284-7787-490e-a55d-bd965594fcab">&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a summary of fair value measurements by level and carrying values for items measured at fair value on a recurring basis in the Consolidated Balance Sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;br/&gt;in Active&lt;br/&gt;Markets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;br/&gt;Fair and Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities - available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities - available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets under management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Percentage of total assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities - available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and municipal obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. agency mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities - available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets under management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Percentage of total assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ifc7213ff01b448239792e43a61300d38_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzItMi0xLTEtMA_761dcc77-c610-437c-866d-bab89af668b0"
      unitRef="usd">21359000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ia1b66727575a4e678ac30b674426f585_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzItNC0xLTEtMA_0a2676e6-764f-43f5-a9bc-5a28d0794258"
      unitRef="usd">16000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ib817a90dc86742a28badd4c87a39b501_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzItNi0xLTEtMA_09b76d8a-1b27-45e1-88d9-9b3c2ef2834b"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzItOC0xLTEtMA_e712babb-826c-4562-98ab-a66eed443458"
      unitRef="usd">21375000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iba871229a901424484cc7c291cbe9f0e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzQtMi0xLTEtMA_be9e95df-2b05-46a5-a693-ab5192e75a5c"
      unitRef="usd">3017000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5dd5e25d23aa4a7fa951ebebaba203a1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzQtNC0xLTEtMA_c85f2e74-0873-4831-8731-66ce453a1bc6"
      unitRef="usd">181000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6eeef3734fae442a8264a01cb7372550_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzQtNi0xLTEtMA_303f452c-0004-4cdf-b5c9-d79cce5c5107"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if5bcfc870d824827bb66dd636d076fd1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzQtOC0xLTEtMA_2dc9424b-068a-424f-91f8-5b9c38d1b0ad"
      unitRef="usd">3198000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5bea540206e64b51b2cbf141a4999d50_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzUtMi0xLTEtMA_8790d84e-2cd9-4513-844f-53a33204ecb7"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4f98b30125864fdca705b2901d65b24b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzUtNC0xLTEtMA_6ac675f3-66ee-46b7-b488-6326a8ca49b6"
      unitRef="usd">7106000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4ba7717a6c87435994ca841d4dafcd86_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzUtNi0xLTEtMA_b335f9bd-eec0-4536-9180-c6adf1f69fa2"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i24678048e47943bb91d8def4d5f22212_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzUtOC0xLTEtMA_237a755b-64fc-4713-a96e-96908800ca9f"
      unitRef="usd">7106000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i786c6b4857764efd94186e77e3b6f938_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzYtMi0xLTEtMA_6bacdf0e-d620-4160-add5-7878df1600ef"
      unitRef="usd">40000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8922e827b09149b5b48d5d53a1d3064f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzYtNC0xLTEtMA_6b879bd6-6719-42d2-8b8a-a40228e893ac"
      unitRef="usd">20916000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i40294d1cde8d40b497abb9effe028d71_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzYtNi0xLTEtMA_dc003885-5e33-4c17-b030-751bad26c95a"
      unitRef="usd">218000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i60063fc646f547e0ac686bc7d0b92112_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzYtOC0xLTEtMA_80c30d6c-c6cb-4ccf-9d5b-2a212bac4d81"
      unitRef="usd">21174000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic74a5a57b68545f68727915480210bea_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzctMi0xLTEtMA_d479be85-2da8-408a-97b3-67a69a3ef023"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icbc6b84573cd460bb185c06c93cab313_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzctNC0xLTEtMA_2a3ddf9d-28e1-40f4-8d6b-f4218b1fb952"
      unitRef="usd">5901000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ide094d54765b442b88523b9454527fbd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzctNi0xLTEtMA_db79eef3-8aef-4969-97d5-58749302146d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if5a1b74f16184b9bb2add4cab25e29f2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzctOC0xLTEtMA_58884cab-e845-4461-97a6-b7285775a85d"
      unitRef="usd">5901000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idfc2226cf4444ab1a84562eb064b98c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzgtMi0xLTEtMA_3de5ba42-a1cf-4e62-b14d-26d57f86dab4"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2ac0596304be4b85b623b402780f1b8d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzgtNC0xLTEtMA_9138fbe0-6832-4f44-8f1e-0eed5afee683"
      unitRef="usd">2838000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6a09033b49c14106baa0f691507e4246_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzgtNi0xLTEtMA_6ae7279c-48ff-4a02-99be-fb4ed661f9d2"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2b784ace82c244c5867ac2f828eb7a57_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzgtOC0xLTEtMA_e7e79b6d-8e3e-4a97-8407-902bcd39ffd4"
      unitRef="usd">2838000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib4b3aa9a235e41d0be50be982749d992_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzktMi0xLTEtMA_cc3cbacd-4acc-41cd-82ab-3aa13736a839"
      unitRef="usd">3057000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i63ceb3ccbcf14457b98cb6eef7d4b50f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzktNC0xLTEtMA_8893f9ec-c6de-4d4b-8443-02245b2259c2"
      unitRef="usd">36942000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifd8f7f5f7a214e6c9819ee8745d58190_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzktNi0xLTEtMA_a018667d-40d8-4437-85ea-1a800fac63f5"
      unitRef="usd">218000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibb56bbdb5bca464cb867242d3ed1b377_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzktOC0xLTEtMA_7068b88b-5cbe-497a-a99a-edcbfc79b9b9"
      unitRef="usd">40217000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ifc7213ff01b448239792e43a61300d38_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzEwLTItMS0xLTA_90796714-7229-4d9f-aaab-baf7b9dacef4"
      unitRef="usd">2090000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ia1b66727575a4e678ac30b674426f585_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzEwLTQtMS0xLTA_a0f20bf6-d62c-4a85-8c9d-ab37f192c772"
      unitRef="usd">23000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ib817a90dc86742a28badd4c87a39b501_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzEwLTYtMS0xLTA_5dcd5d38-89e9-4dbb-9a4a-7014ceb35e57"
      unitRef="usd">64000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzEwLTgtMS0xLTA_6c4792d8-e91b-434a-aa73-4ce2c787fdde"
      unitRef="usd">2177000000</us-gaap:EquitySecuritiesFvNi>
    <unh:AarpAssetsUnderManagement
      contextRef="ifc7213ff01b448239792e43a61300d38_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzExLTItMS0xLTA_4891ea50-90ac-489a-acea-0d9e0300a7bf"
      unitRef="usd">1972000000</unh:AarpAssetsUnderManagement>
    <unh:AarpAssetsUnderManagement
      contextRef="ia1b66727575a4e678ac30b674426f585_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzExLTQtMS0xLTA_be0fa03a-bffc-4d62-aee6-6bba131b65ec"
      unitRef="usd">2376000000</unh:AarpAssetsUnderManagement>
    <unh:AarpAssetsUnderManagement
      contextRef="ib817a90dc86742a28badd4c87a39b501_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzExLTYtMS0xLTA_b61181dd-f83d-433c-b88e-26c4433010d6"
      unitRef="usd">101000000</unh:AarpAssetsUnderManagement>
    <unh:AarpAssetsUnderManagement
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzExLTgtMS0xLTA_851f0f52-c65a-4452-9c1e-897d37b13a60"
      unitRef="usd">4449000000</unh:AarpAssetsUnderManagement>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ifc7213ff01b448239792e43a61300d38_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzEyLTItMS0xLTA_7ec53537-8190-4249-93ff-dc5e30cf5aec"
      unitRef="usd">28478000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia1b66727575a4e678ac30b674426f585_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzEyLTQtMS0xLTA_70f4e7d1-518f-4d4a-8fe9-969e852e04f9"
      unitRef="usd">39357000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib817a90dc86742a28badd4c87a39b501_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzEyLTYtMS0xLTA_3857157e-cfeb-4002-88c3-cbaa038239a1"
      unitRef="usd">383000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzEyLTgtMS0xLTA_65344938-e306-4c79-b802-a186eaeb6e8e"
      unitRef="usd">68218000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i8d22c5f5de67464fa6cda436b26c58dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzE1LTItMS0xLTA_d1023599-dc22-420f-ac14-ef59322c0d0a"
      unitRef="usd">16841000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ia2e7820a9e9b45a3ace8daf2bf6b3576_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzE1LTQtMS0xLTA_db779ade-662c-4139-87e8-8762dc15c7e3"
      unitRef="usd">80000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i143f48c7749c46eaa1530838b78b041b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzE1LTYtMS0xLTA_a1c6c4e6-efd0-4933-bcea-92c859000c3b"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzE1LTgtMS0xLTA_cabbabfa-22cf-43a0-926b-57b2ebece494"
      unitRef="usd">16921000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8da1637a90d94f7d8cbbb9e89200393e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzE3LTItMS0xLTA_10531667-315b-4432-bbfa-c9794d5e4f19"
      unitRef="usd">3241000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7a84715d70a74fceaa59165cb7cfb450_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzE3LTQtMS0xLTA_5ab6c0e8-674c-48b6-825d-a85066c6adea"
      unitRef="usd">224000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iacd4e95ed0ff45e8b463cde8fb162e36_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzE3LTYtMS0xLTA_16e864e7-2dcb-4978-aa4a-adfcc0140751"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2a312b80055e4af7bc076c9e6f9c43e6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzE3LTgtMS0xLTA_0b9f1b99-4959-4663-83c1-209b1c61f102"
      unitRef="usd">3465000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id1274175ecdc4c66979e1169bb16b496_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzE4LTItMS0xLTA_cb25eb5d-b8e4-4d09-99b4-b7ff190145d4"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i348ad0bbc326423b98599f12852d34af_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzE4LTQtMS0xLTA_2c173b86-9e24-4748-8a0e-6ab94d94d077"
      unitRef="usd">7328000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i35f826dbcf4d42b4be8664b7331fb199_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzE4LTYtMS0xLTA_62ca5ba3-b237-4513-a41d-09ea766c2ada"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibe8be8f0fb534e25be1cc040ead9f99f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzE4LTgtMS0xLTA_048132a3-875b-4cfe-8bc2-e866965ff718"
      unitRef="usd">7328000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic303a9fd1e74453b8a529be93a4f56bf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzE5LTItMS0xLTA_01a07b90-337f-49ff-bdf6-40ee3fa65bde"
      unitRef="usd">25000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia0ea67d91b6d434599e098210b7a488c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzE5LTQtMS0xLTA_db7a29a5-5d99-41cc-ba09-ec455b0e999a"
      unitRef="usd">19424000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i073d903c845f4731bd55974d4b29f4b6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzE5LTYtMS0xLTA_c9d7dffb-8a38-4fc7-a944-edc2ca539349"
      unitRef="usd">288000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib130b8ba2819452594b22d15469baacb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzE5LTgtMS0xLTA_560f28ab-daf1-4234-ae20-2f2346de1730"
      unitRef="usd">19737000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icf644ee782e74842af3129b8232dcaed_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzIwLTItMS0xLTA_d41ddbb2-97aa-4e1b-9d5e-c665158630a6"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iaf26e2e8c57f4e7a89bfb1c2baf068a5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzIwLTQtMS0xLTA_504607b0-04e3-48af-8967-f7898d504a23"
      unitRef="usd">7091000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic45c1b0462fc4790975a0e25b80a5726_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzIwLTYtMS0xLTA_a2e688a1-268c-4b45-8716-aebab7b727e5"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1ec806aa176a4bbb99266b4a32cf1ded_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzIwLTgtMS0xLTA_ca9e8e2d-dbd6-4db2-b6ea-1f5d46f5c7a4"
      unitRef="usd">7091000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i14c36d9932b54db0b6a4f835644eb0aa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzIxLTItMS0xLTA_a8e294d9-db8b-4ddb-85aa-28a91b0a7cba"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i68adcae3162f47ae8c5f0bb4ef470545_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzIxLTQtMS0xLTA_ed494a0c-2e3b-4085-b5f8-1b7ecdfa9b90"
      unitRef="usd">2207000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i09e58021d29540878f244a567f9a5ced_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzIxLTYtMS0xLTA_4d46f759-dee2-46c0-bfbb-7e7a3e00040f"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ieda9939b5a6c4fdeb0d28e0580ab8d78_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzIxLTgtMS0xLTA_c10c420e-9aea-4cd2-bb62-63917a83ed73"
      unitRef="usd">2207000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4bfd62c299df4d94bbf76c712ccec550_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzIyLTItMS0xLTA_8f865bd3-cd01-47a5-83b2-9952238c0125"
      unitRef="usd">3266000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie3d58ed074c84089913ffdffc57c1d73_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzIyLTQtMS0xLTA_fa553838-7546-40eb-86c8-3017c2b529df"
      unitRef="usd">36274000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibd5d40328bb047cb90c2611b44a7f743_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzIyLTYtMS0xLTA_4246100a-d420-4d97-82c9-518598c1b7f0"
      unitRef="usd">288000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9b1ef8f174f64af8b548c0044b97ecb5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzIyLTgtMS0xLTA_52faa28e-c418-4c87-a034-7511def3d491"
      unitRef="usd">39828000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i8d22c5f5de67464fa6cda436b26c58dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzIzLTItMS0xLTA_8472b3c2-ea03-4ca5-a961-17d1713b84d1"
      unitRef="usd">1795000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ia2e7820a9e9b45a3ace8daf2bf6b3576_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzIzLTQtMS0xLTA_41a9d4a0-a327-4d79-8d9c-dcd9cfec9b47"
      unitRef="usd">33000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i143f48c7749c46eaa1530838b78b041b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzIzLTYtMS0xLTA_036dde7c-baca-4224-bb2a-4d14959523b7"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzIzLTgtMS0xLTA_530d9ecd-c47d-4cc5-a5f6-d43d01200f25"
      unitRef="usd">1828000000</us-gaap:EquitySecuritiesFvNi>
    <unh:AarpAssetsUnderManagement
      contextRef="i8d22c5f5de67464fa6cda436b26c58dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzI0LTItMS0xLTA_70b2bbbf-6deb-4896-8bf4-4962e6597dcc"
      unitRef="usd">1774000000</unh:AarpAssetsUnderManagement>
    <unh:AarpAssetsUnderManagement
      contextRef="ia2e7820a9e9b45a3ace8daf2bf6b3576_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzI0LTQtMS0xLTA_7d2829ba-f4ef-4b88-8571-f50ae6efba07"
      unitRef="usd">2250000000</unh:AarpAssetsUnderManagement>
    <unh:AarpAssetsUnderManagement
      contextRef="i143f48c7749c46eaa1530838b78b041b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzI0LTYtMS0xLTA_340fab40-9406-4c98-81ee-073219ad152b"
      unitRef="usd">52000000</unh:AarpAssetsUnderManagement>
    <unh:AarpAssetsUnderManagement
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzI0LTgtMS0xLTA_48778e29-6caa-4153-83c5-5a8b1ded1c5e"
      unitRef="usd">4076000000</unh:AarpAssetsUnderManagement>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i8d22c5f5de67464fa6cda436b26c58dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzI1LTItMS0xLTA_3082bd5f-953d-4c84-aba3-7844ed4faa5e"
      unitRef="usd">23676000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia2e7820a9e9b45a3ace8daf2bf6b3576_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzI1LTQtMS0xLTA_be5ab1e9-2afd-4c42-955f-727ebbd741cf"
      unitRef="usd">38637000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i143f48c7749c46eaa1530838b78b041b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzI1LTYtMS0xLTA_bcf19f90-bcd7-483c-92d4-2568a41335e8"
      unitRef="usd">340000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTo0MzEzZTFjOWYwNGU0NjU0YTg1ZmMzMTRkODU0NTMzYy90YWJsZXJhbmdlOjQzMTNlMWM5ZjA0ZTQ2NTRhODVmYzMxNGQ4NTQ1MzNjXzI1LTgtMS0xLTA_e65bc120-6d6d-47e8-bf7a-2fa4c866fb9f"
      unitRef="usd">62653000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90ZXh0cmVnaW9uOmUzYzE3YjU2ZGI2ZTQ4YzdiMjBhMTY2Mjk1M2IzMmVjXzYzMTQ_0ffb1f89-6a91-431f-846d-3109734f8c55">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a summary of fair value measurements by level and carrying values for certain financial instruments not measured at fair value on a recurring basis in the Consolidated Balance Sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;br/&gt;in Active&lt;br/&gt;Markets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;br/&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities - held-to-maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt and other financing obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities - held-to-maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt and other financing obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisTextBlock>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="if9032d6bd2554be797457d71b15c021a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzItMi0xLTEtMA_472a9c3d-fd38-45a6-be72-b1710178f0b4"
      unitRef="usd">534000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="if59af989581341269c0f798a7a8a56ff_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzItNC0xLTEtMA_ad1c06ec-3382-40d9-8696-118e54b3310b"
      unitRef="usd">102000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i72edef7745bb4e80901cf10381b12375_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzItNi0xLTEtMA_0ce0aff9-1ae1-4166-8ef8-db809a8052a4"
      unitRef="usd">7000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i6e1d0ee68a90487188c597f675ea6962_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzItOC0xLTEtMA_798782f5-b8b2-4625-948a-ca43ee98a902"
      unitRef="usd">643000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecurities
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzItMTAtMS0xLTA_eac7cdba-57c1-45aa-ab37-cf8ed7097158"
      unitRef="usd">641000000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ie134d5521b5441d7a99c70ae3d64e701_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzMtMi0xLTEtMTg3NjQ_ea538946-7f52-41dd-bf7b-efb57c8d787d"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i2205792a33d644b0a632f4d4f33237f4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzMtNC0xLTEtMTg3NjQ_e1e68a28-fd1b-4361-98e5-f2ba911ee778"
      unitRef="usd">52583000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i5545c49f50ec48edb1474b999af271fc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzMtNi0xLTEtMTg3NjQ_ba81f22e-18d6-4353-8cd6-b7ebef03a75c"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="iff86380602ce4f588a2f94a05eaab292_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzMtOC0xLTEtMTg3NjQ_8d124d38-b355-4399-bf44-4589c86130e4"
      unitRef="usd">52583000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="iae7403f6fc564452803f560b78d46801_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzMtMTAtMS0xLTE4NzY0_b2338548-406c-4b03-94d0-8b974d0090ac"
      unitRef="usd">46003000000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="iadc9e4cd75f14dd7a16f6026ec702279_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzUtMi0xLTEtMA_41788034-adfa-424e-b27b-cebfb133c0c7"
      unitRef="usd">466000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i69b798301dcb496d99d84a6592b8549b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzUtNC0xLTEtMA_b5b0ae08-f1c0-423c-845b-774c27c410bf"
      unitRef="usd">108000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="ic505ff42be0a4bcb9d166dd3d36bcef1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzUtNi0xLTEtMA_0d3d7d86-3153-4b06-b832-e6f4cb6cb949"
      unitRef="usd">73000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i9c5e5fa052504d4cb045b94a02d5a58f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzUtOC0xLTEtMA_86648b8f-4cb4-432f-b0c7-3ac24edac7e6"
      unitRef="usd">647000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecurities
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzUtMTAtMS0xLTA_50bfd46a-aadd-4171-80a5-f6728dded933"
      unitRef="usd">638000000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i0e9f6e4d1d1345d5807de27d47ac5f59_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzYtMi0xLTEtMTg3Njk_e0303c83-43b4-4043-accf-4e34cdf1bdc2"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ie4b8d6e218734867ad53588492384845_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzYtNC0xLTEtMTg3Njk_65f262a2-9701-416d-84bd-6bc8fc1520ee"
      unitRef="usd">51254000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i79898441c75b41d5ac9f1f9da1f4e5d9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzYtNi0xLTEtMTg3Njk_880b6858-9bda-4c7c-850b-bdf2796947b0"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i85d7067f865b4342b9d8d877f735ac59_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzYtOC0xLTEtMTg3Njk_1f361d69-ab2c-437f-9365-5ea02a746b26"
      unitRef="usd">51254000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="i8f2864e94d7849f79bce61f0d550474d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xNzUvZnJhZzplM2MxN2I1NmRiNmU0OGM3YjIwYTE2NjI5NTNiMzJlYy90YWJsZTowNmJkN2Y4YzBmZWY0ODUxYWQ4ZTYyNmI0YzhjZmNjYS90YWJsZXJhbmdlOjA2YmQ3ZjhjMGZlZjQ4NTFhZDhlNjI2YjRjOGNmY2NhXzYtMTAtMS0xLTE4NzY5_5289d523-86a4-4b31-a82b-1e0be68033cc"
      unitRef="usd">42171000000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90ZXh0cmVnaW9uOjMwNDY5MDliMDIyMTRiMTRhMmFiZjExNDc1MDEzMzA0XzM1OQ_47f3b30a-f975-4df3-b74c-22dca7c65c24">Property, Equipment and Capitalized Software&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of property, equipment and capitalized software is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.225%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,857)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,364)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,866)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property, equipment and capitalized software, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&#160;Depreciation expense for property and equipment for the years ended December&#160;31, 2021, 2020 and 2019 was $996 million, $997 million and $995 million, respectively. Amortization expense for capitalized software for the years ended December&#160;31, 2021, 2020 and 2019 was $923 million, $814 million and $721 million, respectively.</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90ZXh0cmVnaW9uOjMwNDY5MDliMDIyMTRiMTRhMmFiZjExNDc1MDEzMzA0XzM2Ng_d9def371-02e6-4ea1-9196-47081d52a333">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of property, equipment and capitalized software is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.225%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,857)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,364)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,866)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property, equipment and capitalized software, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:LandAndLandImprovements
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzEtMi0xLTEtMA_ada21ac5-5596-4e02-8b46-88aeb2bf6475"
      unitRef="usd">502000000</us-gaap:LandAndLandImprovements>
    <us-gaap:LandAndLandImprovements
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzEtNC0xLTEtMA_5cdbb8f2-d35d-4697-8dd5-7035b1647226"
      unitRef="usd">533000000</us-gaap:LandAndLandImprovements>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzItMi0xLTEtMA_b9d45cf1-dda8-44dd-9168-fd62557f2076"
      unitRef="usd">4882000000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzItNC0xLTEtMA_5c9497c9-e836-4f0c-b226-44b10128dc50"
      unitRef="usd">4759000000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzMtMi0xLTEtMA_f4202312-3242-44ae-9374-585d1078f21a"
      unitRef="usd">1851000000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzMtNC0xLTEtMA_215ae353-63f1-4142-9b37-6ccf8d2ce34b"
      unitRef="usd">1767000000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzQtMi0xLTEtMA_c759a4b7-bad9-4d4f-9499-53d458f1eff6"
      unitRef="usd">2014000000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzQtNC0xLTEtMA_4096003a-1a65-47c3-80b9-5ba27233f3f7"
      unitRef="usd">1787000000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:PropertyPlantAndEquipmentOtherAccumulatedDepreciation
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzUtMi0xLTEtMA_b5da5c40-628b-4fc5-82cf-51a2ca05e01b"
      unitRef="usd">3857000000</us-gaap:PropertyPlantAndEquipmentOtherAccumulatedDepreciation>
    <us-gaap:PropertyPlantAndEquipmentOtherAccumulatedDepreciation
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzUtNC0xLTEtMA_dc7bfe58-5c44-4669-8394-bb9e870c7cbc"
      unitRef="usd">3364000000</us-gaap:PropertyPlantAndEquipmentOtherAccumulatedDepreciation>
    <unh:PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzYtMi0xLTEtMA_894469da-7f42-4255-ac34-52a651c6d2d3"
      unitRef="usd">5392000000</unh:PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet>
    <unh:PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzYtNC0xLTEtMA_751c89a6-296f-498a-a551-7ea0bbe43204"
      unitRef="usd">5482000000</unh:PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet>
    <us-gaap:CapitalizedComputerSoftwareGross
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzctMi0xLTEtMA_e0a233e9-f3fb-42a3-b195-09261cf72f41"
      unitRef="usd">5712000000</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:CapitalizedComputerSoftwareGross
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzctNC0xLTEtMA_9d032e38-1fdb-48a9-81b9-7f6dd9788937"
      unitRef="usd">5010000000</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzgtMi0xLTEtMA_7df20839-adbd-467b-a865-bab10a920be4"
      unitRef="usd">2135000000</us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization>
    <us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzgtNC0xLTEtMA_bb015796-1b99-43fe-af56-bfabc20cf06c"
      unitRef="usd">1866000000</us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization>
    <us-gaap:CapitalizedComputerSoftwareNet
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzktMi0xLTEtMA_8b0dcc4b-13d9-4ad0-a8f4-13fbfe9c5de4"
      unitRef="usd">3577000000</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:CapitalizedComputerSoftwareNet
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzktNC0xLTEtMA_3c85c25f-147a-4229-86ab-ed1291c42ec7"
      unitRef="usd">3144000000</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzEwLTItMS0xLTA_a7480433-91dd-496d-9cfc-023509da7404"
      unitRef="usd">8969000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90YWJsZToxZWNlYTRiNmJmNTI0YTQzOTU2MDU0OWU4MWYxYmVmMy90YWJsZXJhbmdlOjFlY2VhNGI2YmY1MjRhNDM5NTYwNTQ5ZTgxZjFiZWYzXzEwLTQtMS0xLTA_b4843854-3aa9-4df5-b1a7-bf38d36eba3a"
      unitRef="usd">8626000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90ZXh0cmVnaW9uOjMwNDY5MDliMDIyMTRiMTRhMmFiZjExNDc1MDEzMzA0XzIxNg_3945868c-3188-47ae-b87b-e49fe9f331bb"
      unitRef="usd">996000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90ZXh0cmVnaW9uOjMwNDY5MDliMDIyMTRiMTRhMmFiZjExNDc1MDEzMzA0XzIyMA_cdb82c09-7bbd-4561-8d9a-d848b93a4bdb"
      unitRef="usd">997000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90ZXh0cmVnaW9uOjMwNDY5MDliMDIyMTRiMTRhMmFiZjExNDc1MDEzMzA0XzIyNw_6a57c540-99d1-41d8-a166-4d3dfcb3c2d8"
      unitRef="usd">995000000</us-gaap:Depreciation>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90ZXh0cmVnaW9uOjMwNDY5MDliMDIyMTRiMTRhMmFiZjExNDc1MDEzMzA0XzMyOQ_d892c49e-05c6-4df2-a3d1-2c65294a3f19"
      unitRef="usd">923000000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90ZXh0cmVnaW9uOjMwNDY5MDliMDIyMTRiMTRhMmFiZjExNDc1MDEzMzA0XzMzMw_b02df6f1-60c0-44ed-819c-031ae2a68a5f"
      unitRef="usd">814000000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODEvZnJhZzozMDQ2OTA5YjAyMjE0YjE0YTJhYmYxMTQ3NTAxMzMwNC90ZXh0cmVnaW9uOjMwNDY5MDliMDIyMTRiMTRhMmFiZjExNDc1MDEzMzA0XzM0MA_51d2c913-7338-4674-92bb-773275540f71"
      unitRef="usd">721000000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90ZXh0cmVnaW9uOjMxY2JlZmMzZjAyYzQ5YjM5NTExYWQ0NGE1MDRhMzBkXzczNQ_29fbfc08-9fc0-4c1e-8bb3-910dff501408">Goodwill and Other Intangible Assets&lt;div style="margin-bottom:4pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of goodwill, by reportable segment, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.820%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.171%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.675%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.973%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;UnitedHealthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Optum Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Optum Insight&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Optum Rx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency effects and other adjustments, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(623)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(701)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31,&#160;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency effects and other adjustments, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(456)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31,&#160;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gross carrying value, accumulated amortization and net carrying value of other intangible assets were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:4.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,697)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,575)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(739)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(624)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and other indefinite-lived&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,636)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,455)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:15pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The acquisition date fair values and weighted-average useful lives assigned to finite-lived intangible assets acquired in business combinations consisted of the following by year of acquisition:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.252%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions, except years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Useful Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total acquired finite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimated full year amortization expense relating to intangible assets for each of the next five years ending December 31 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:90.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.368%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Amortization expense relating to intangible assets for the years ended December&#160;31, 2021, 2020 and 2019 was $1.2 billion, $1.1 billion and $1.0 billion, respectively.</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90ZXh0cmVnaW9uOjMxY2JlZmMzZjAyYzQ5YjM5NTExYWQ0NGE1MDRhMzBkXzczMQ_4883b578-cc19-4d9b-86dc-d2a040dccf6f">&lt;div style="margin-bottom:4pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of goodwill, by reportable segment, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.820%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.171%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.675%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.973%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;UnitedHealthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Optum Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Optum Insight&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Optum Rx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency effects and other adjustments, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(623)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(701)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31,&#160;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency effects and other adjustments, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(456)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31,&#160;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="ie9004c5f31284db6a840b518fa6c4f58_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzEtMi0xLTEtMA_304d94eb-7fa4-4a6c-aefd-fc405ac446f8"
      unitRef="usd">27228000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iedbc8a127a984a2b9f57050fc010853d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzEtNC0xLTEtMA_5a09aaf7-f886-46b1-9bcf-dc5085846195"
      unitRef="usd">15342000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i552ab3ba177642ab8b64fa5712f45dd8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzEtNi0xLTEtMA_f16d29b7-9506-4208-86a6-71fa0dda4c63"
      unitRef="usd">8292000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iebe8572afa0a4d7da446aa8d4ab62eb8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzEtOC0xLTEtMA_f46a2d32-e394-4236-85b6-01256c547c5e"
      unitRef="usd">14797000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i530caf840d4847f1ac553be5f7b336b2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzEtMTAtMS0xLTA_ec7fb2d9-4cf7-42c5-8186-f4fbc47c7219"
      unitRef="usd">65659000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ib78936422dda4cf88cb3cbc4dd220121_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzItMi0xLTEtMA_fe92c519-a900-4b90-a28c-7bf618fa15a5"
      unitRef="usd">1180000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ic0a9e47794c54540ad3d61b206a2a5cf_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzItNC0xLTEtMA_440eab1a-c158-41df-b34f-43b81652aaed"
      unitRef="usd">4500000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i80e3cb189ce045d08f4e6301ab039bfe_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzItNi0xLTEtMA_514b861c-02a3-46d0-ae91-7d569b1f3c6c"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i9dcd135114fe40ad9bbefb48db0ba475_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzItOC0xLTEtMA_543845a5-e3d4-4151-bf26-10ff02865c36"
      unitRef="usd">699000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzItMTAtMS0xLTA_3e568a8c-507b-4baf-893f-dd396289179e"
      unitRef="usd">6379000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="ib78936422dda4cf88cb3cbc4dd220121_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzMtMi0xLTEtMA_0a31416d-ae29-4056-8839-7fbb58b251a6"
      unitRef="usd">-623000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="ic0a9e47794c54540ad3d61b206a2a5cf_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzMtNC0xLTEtMA_8d6e1bfb-e21d-4319-a617-e8181d188b77"
      unitRef="usd">2000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i80e3cb189ce045d08f4e6301ab039bfe_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzMtNi0xLTEtMA_23e3090e-1b55-4ce8-ac5e-e639f414da41"
      unitRef="usd">-119000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i9dcd135114fe40ad9bbefb48db0ba475_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzMtOC0xLTEtMA_c5161850-00af-48ea-849a-4d662212708f"
      unitRef="usd">39000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzMtMTAtMS0xLTA_84f06ac5-e69b-4266-949b-8c489771c210"
      unitRef="usd">-701000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="i8ddeff676a684e46b6072017bc1e9416_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzQtMi0xLTEtMA_8232c450-2e45-42fc-89b6-7646056ba93b"
      unitRef="usd">27785000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i26d61444d51b4f20823b0b809247d33c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzQtNC0xLTEtMA_c8bf1538-3573-4437-b7ff-268e39f13462"
      unitRef="usd">19844000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iafa155f646d841c8b93f03aacf967154_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzQtNi0xLTEtMA_7be37ece-a85c-47e0-ae49-ab3f2b0beddf"
      unitRef="usd">8173000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="id05f41ba34f2466392338fadddf9dd1d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzQtOC0xLTEtMA_a8af00e2-d5e2-4105-bce0-863937edd8ef"
      unitRef="usd">15535000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzQtMTAtMS0xLTA_2ba3957e-1beb-46e8-9c5f-af4ea049c715"
      unitRef="usd">71337000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ia9739896064149b98b26a61eeaa6550f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzUtMi0xLTEtMA_8d20fee4-5690-49d4-a9e7-ee4e1a29e5df"
      unitRef="usd">60000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i61c10c93e0f54b55a26f3573ba827569_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzUtNC0xLTEtMA_be81702d-47c6-4538-8a9f-df9cda4509e9"
      unitRef="usd">4648000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ib0bdaeb0614d4e2c9380f7415853f763_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzUtNi0xLTEtMA_7c80c102-a835-4d36-81e9-edb7e412eb0b"
      unitRef="usd">96000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ibf94dc7fd3204a588aba8704a0d1a90a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzUtOC0xLTEtMA_3f12eed1-a415-4e6e-adf0-aefe1f211f74"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzUtMTAtMS0xLTA_9f07b557-3abe-47e1-bdc0-b62720e60a8e"
      unitRef="usd">4804000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="ia9739896064149b98b26a61eeaa6550f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzYtMi0xLTEtMA_98cacd11-2c77-4927-94b2-838acf453eda"
      unitRef="usd">-456000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i61c10c93e0f54b55a26f3573ba827569_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzYtNC0xLTEtMA_8721e99a-a96b-4ce9-8c22-b46603d1f5ad"
      unitRef="usd">-268000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="ib0bdaeb0614d4e2c9380f7415853f763_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzYtNi0xLTEtMA_b4824b42-976a-443f-bd99-8ed7016b3e8d"
      unitRef="usd">350000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="ibf94dc7fd3204a588aba8704a0d1a90a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzYtOC0xLTEtMA_e6c9a62f-0d30-4a77-bc27-f97ac9fbcaca"
      unitRef="usd">28000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzYtMTAtMS0xLTA_49746f23-7eae-487b-8efc-b51092e28b51"
      unitRef="usd">-346000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="ia3183b05d67943c3b4034e58b9be0447_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzctMi0xLTEtMA_ff67cd7a-470a-4b61-8eb0-39ead12317a3"
      unitRef="usd">27389000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i13c92c68c2ea480ea5701676b9b826f9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzctNC0xLTEtMA_44504082-6741-4428-971d-21e317eeb9ce"
      unitRef="usd">24224000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i202cb135dc1e4e3daca6dd5059f0cf19_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzctNi0xLTEtMA_1b3b068a-360e-4c80-9c54-beccc71ed3a6"
      unitRef="usd">8619000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i9d5fa92bbec547a085cba2fb930f6bc6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzctOC0xLTEtMA_be0f2cf6-60cb-4212-add7-a169d0da65d6"
      unitRef="usd">15563000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo3MGI0Yzc3NWRiYjk0NDY0YmMyMTM2MmVkNWE5MWRhNC90YWJsZXJhbmdlOjcwYjRjNzc1ZGJiOTQ0NjRiYzIxMzYyZWQ1YTkxZGE0XzctMTAtMS0xLTA_783aea37-9647-49c3-b56e-0811ba65d728"
      unitRef="usd">75795000000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90ZXh0cmVnaW9uOjMxY2JlZmMzZjAyYzQ5YjM5NTExYWQ0NGE1MDRhMzBkXzcyMQ_655125d3-acb4-4d2b-9d60-73da38610529">&lt;div style="margin-bottom:4pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gross carrying value, accumulated amortization and net carrying value of other intangible assets were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:4.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,697)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,575)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(739)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(624)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and other indefinite-lived&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,636)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,455)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i85448c57b2cc45b2ab8f29ae7d7c6a2a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzItMi0xLTEtMA_df94c079-8db3-4ca4-97c1-56d3d2d4312a"
      unitRef="usd">13011000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i85448c57b2cc45b2ab8f29ae7d7c6a2a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzItNC0xLTEtMA_fda7b981-5abc-4e6f-a8dc-4216735364dc"
      unitRef="usd">4697000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i85448c57b2cc45b2ab8f29ae7d7c6a2a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzItNi0xLTEtMA_5c9a849d-7db6-4b23-b4e7-d5744da06d6f"
      unitRef="usd">8314000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="if966e9f805794457af9a0eed34e96495_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzItOC0xLTEtMA_a7c29b75-d1b6-47c9-aa76-d09508cab843"
      unitRef="usd">13428000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if966e9f805794457af9a0eed34e96495_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzItMTAtMS0xLTA_3231e0ab-aaf5-4cc6-a405-fbc56b05e3a9"
      unitRef="usd">4575000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="if966e9f805794457af9a0eed34e96495_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzItMTItMS0xLTA_a10c7dd8-1d4f-4763-a36d-468958e37cbb"
      unitRef="usd">8853000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ibb823f0ecf2f4061a477b16abf75cdc2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzMtMi0xLTEtMA_faf0273e-b19b-4ff3-a72d-b2fe450c25bc"
      unitRef="usd">1630000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ibb823f0ecf2f4061a477b16abf75cdc2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzMtNC0xLTEtMA_0d91675d-55cd-4bc1-986c-3fac5cceb90e"
      unitRef="usd">739000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ibb823f0ecf2f4061a477b16abf75cdc2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzMtNi0xLTEtMA_8e57d80b-6ad6-43ab-bf92-cc9165a47413"
      unitRef="usd">891000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i6ec08aacf770472c93dbac44374b8a68_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzMtOC0xLTEtMA_69abd9c9-1fde-437f-b4c2-04ca3c729f19"
      unitRef="usd">1597000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6ec08aacf770472c93dbac44374b8a68_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzMtMTAtMS0xLTA_becee4d1-3edb-4a5d-8e14-d2740322468e"
      unitRef="usd">624000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i6ec08aacf770472c93dbac44374b8a68_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzMtMTItMS0xLTA_ceba0f11-84f0-4061-b1fc-db8307be00f2"
      unitRef="usd">973000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i3203585470194543898607ba99a6eec0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzQtMi0xLTEtMA_0df5732a-81d4-4089-bccf-f35c9eb941b1"
      unitRef="usd">617000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3203585470194543898607ba99a6eec0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzQtNC0xLTEtMA_132b765e-1a42-49a3-8406-615bef0de282"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i3203585470194543898607ba99a6eec0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzQtNi0xLTEtMA_5f86a8c0-8a51-4142-87c5-6c4952a4b0a8"
      unitRef="usd">617000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ica15e60f135045e5b3209b00ecdc8ec6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzQtOC0xLTEtMA_c48e2f40-0c76-483e-84a5-39f1b5b70f92"
      unitRef="usd">680000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ica15e60f135045e5b3209b00ecdc8ec6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzQtMTAtMS0xLTA_a1c30b6c-1b85-4a99-865f-87ec09eb8e9b"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ica15e60f135045e5b3209b00ecdc8ec6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzQtMTItMS0xLTA_bcf45e73-6b6d-42a3-a38f-9876ecf8a038"
      unitRef="usd">680000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i3ef9cd7ab1654b62b1ab409dcb38f85f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzUtMi0xLTEtMA_4cc38a60-8471-441b-b46f-cfdd50acccc1"
      unitRef="usd">422000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3ef9cd7ab1654b62b1ab409dcb38f85f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzUtNC0xLTEtMA_586af9a7-4f85-4adf-8718-6ec58cc99a79"
      unitRef="usd">200000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i3ef9cd7ab1654b62b1ab409dcb38f85f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzUtNi0xLTEtMA_b68c5303-f1fe-4fe7-b6aa-7903fb06e728"
      unitRef="usd">222000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i6f34678550484e8eaa1d6f032590a9cd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzUtOC0xLTEtMA_3854a737-b234-4276-8f1b-843e9300137a"
      unitRef="usd">606000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6f34678550484e8eaa1d6f032590a9cd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzUtMTAtMS0xLTA_d8c5bb3b-2cd2-4cb6-8fb1-618dbe12f0b8"
      unitRef="usd">256000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i6f34678550484e8eaa1d6f032590a9cd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzUtMTItMS0xLTA_db90c98a-4af4-4592-9a40-9ac78b8ecf00"
      unitRef="usd">350000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzYtMi0xLTEtMA_a0c6415d-291a-4596-ace6-46324cb23b57"
      unitRef="usd">15680000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzYtNC0xLTEtMA_e5793a35-6b84-4a87-bcef-bd1617e675ab"
      unitRef="usd">5636000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzYtNi0xLTEtMA_dc7219dd-86b6-4239-93fa-4be4856c0356"
      unitRef="usd">10044000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzYtOC0xLTEtMA_1e10e195-c95e-4557-aadf-d69ead95a951"
      unitRef="usd">16311000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzYtMTAtMS0xLTA_fbc5a4c5-499e-447f-a67e-a6724e0d8b4b"
      unitRef="usd">5455000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo2YTRjNjljNGZiNDk0ZWZmYjJlMGNkYmFiYmExYzBhYS90YWJsZXJhbmdlOjZhNGM2OWM0ZmI0OTRlZmZiMmUwY2RiYWJiYTFjMGFhXzYtMTItMS0xLTA_db19e385-3d71-4807-83af-37ba2e473bb0"
      unitRef="usd">10856000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90ZXh0cmVnaW9uOjMxY2JlZmMzZjAyYzQ5YjM5NTExYWQ0NGE1MDRhMzBkXzcyMg_759d0181-eb58-4a3a-8df5-84ca3e589292">&lt;div style="margin-top:15pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The acquisition date fair values and weighted-average useful lives assigned to finite-lived intangible assets acquired in business combinations consisted of the following by year of acquisition:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.252%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions, except years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Useful Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total acquired finite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i72998cdf5b13475480213110198dde60_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo1MmYxMTgyMDJmMTY0ZTkzYWE2MjA1MGYzMDM4ZjE3Mi90YWJsZXJhbmdlOjUyZjExODIwMmYxNjRlOTNhYTYyMDUwZjMwMzhmMTcyXzItMi0xLTEtMA_82bf0998-c50b-4435-afdd-cffcd6d0fc83"
      unitRef="usd">484000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i2ecd4e0cb3384d4c8ddd20890ad9e997_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo1MmYxMTgyMDJmMTY0ZTkzYWE2MjA1MGYzMDM4ZjE3Mi90YWJsZXJhbmdlOjUyZjExODIwMmYxNjRlOTNhYTYyMDUwZjMwMzhmMTcyXzItNi0xLTEtMA_86d13025-e0cc-4ea7-9547-e1b987ba6aa2"
      unitRef="usd">1113000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i1ded218b083944e188cd4579765a2a84_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo1MmYxMTgyMDJmMTY0ZTkzYWE2MjA1MGYzMDM4ZjE3Mi90YWJsZXJhbmdlOjUyZjExODIwMmYxNjRlOTNhYTYyMDUwZjMwMzhmMTcyXzMtMi0xLTEtMA_88a073bc-b1aa-431f-875b-251d7541bd77"
      unitRef="usd">147000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i2b4f1188393845f8827897acb0c3916c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo1MmYxMTgyMDJmMTY0ZTkzYWE2MjA1MGYzMDM4ZjE3Mi90YWJsZXJhbmdlOjUyZjExODIwMmYxNjRlOTNhYTYyMDUwZjMwMzhmMTcyXzMtNi0xLTEtMA_249f49c9-98c9-4ba3-8cab-fe624fedd1de"
      unitRef="usd">514000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="iaa52ad981c7743b1818a805ee0a0b5fe_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo1MmYxMTgyMDJmMTY0ZTkzYWE2MjA1MGYzMDM4ZjE3Mi90YWJsZXJhbmdlOjUyZjExODIwMmYxNjRlOTNhYTYyMDUwZjMwMzhmMTcyXzQtMi0xLTEtMA_da84f182-2b32-47d0-a1c1-18242c8071af"
      unitRef="usd">29000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i7a251ae641a244f982ee84dc33f39c98_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo1MmYxMTgyMDJmMTY0ZTkzYWE2MjA1MGYzMDM4ZjE3Mi90YWJsZXJhbmdlOjUyZjExODIwMmYxNjRlOTNhYTYyMDUwZjMwMzhmMTcyXzQtNi0xLTEtMA_4a06236c-a838-4271-847c-d97fd87a8097"
      unitRef="usd">95000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo1MmYxMTgyMDJmMTY0ZTkzYWE2MjA1MGYzMDM4ZjE3Mi90YWJsZXJhbmdlOjUyZjExODIwMmYxNjRlOTNhYTYyMDUwZjMwMzhmMTcyXzUtMi0xLTEtMA_35344c6a-678f-45c9-aa37-5120d9e0f140"
      unitRef="usd">660000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTo1MmYxMTgyMDJmMTY0ZTkzYWE2MjA1MGYzMDM4ZjE3Mi90YWJsZXJhbmdlOjUyZjExODIwMmYxNjRlOTNhYTYyMDUwZjMwMzhmMTcyXzUtNi0xLTEtMA_8af20816-115d-45df-a3b5-80117298fe71"
      unitRef="usd">1722000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90ZXh0cmVnaW9uOjMxY2JlZmMzZjAyYzQ5YjM5NTExYWQ0NGE1MDRhMzBkXzcxNA_dca73a80-1a0d-47fa-b582-c92452c5aced">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimated full year amortization expense relating to intangible assets for each of the next five years ending December 31 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:90.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.368%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTplYzFhNWY2MWQzZGU0NzRmODhjNDlmOGY0OTQwNDJkMS90YWJsZXJhbmdlOmVjMWE1ZjYxZDNkZTQ3NGY4OGM0OWY4ZjQ5NDA0MmQxXzEtMi0xLTEtMA_94d0a10e-a74d-442e-bc1a-93f2c2d4c3f1"
      unitRef="usd">1098000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTplYzFhNWY2MWQzZGU0NzRmODhjNDlmOGY0OTQwNDJkMS90YWJsZXJhbmdlOmVjMWE1ZjYxZDNkZTQ3NGY4OGM0OWY4ZjQ5NDA0MmQxXzItMi0xLTEtMA_fb1fd14f-b5b8-4fa5-a122-c7a4913f2a25"
      unitRef="usd">1033000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTplYzFhNWY2MWQzZGU0NzRmODhjNDlmOGY0OTQwNDJkMS90YWJsZXJhbmdlOmVjMWE1ZjYxZDNkZTQ3NGY4OGM0OWY4ZjQ5NDA0MmQxXzMtMi0xLTEtMA_b2413a16-398c-4bff-b47f-3e5e4a897753"
      unitRef="usd">972000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTplYzFhNWY2MWQzZGU0NzRmODhjNDlmOGY0OTQwNDJkMS90YWJsZXJhbmdlOmVjMWE1ZjYxZDNkZTQ3NGY4OGM0OWY4ZjQ5NDA0MmQxXzQtMi0xLTEtMA_fad5401f-33a0-4fc5-8e79-058a97c0b3c8"
      unitRef="usd">892000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90YWJsZTplYzFhNWY2MWQzZGU0NzRmODhjNDlmOGY0OTQwNDJkMS90YWJsZXJhbmdlOmVjMWE1ZjYxZDNkZTQ3NGY4OGM0OWY4ZjQ5NDA0MmQxXzUtMi0xLTEtMA_45949922-3f77-4837-856e-6baf08f99722"
      unitRef="usd">757000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90ZXh0cmVnaW9uOjMxY2JlZmMzZjAyYzQ5YjM5NTExYWQ0NGE1MDRhMzBkXzY3Nw_5e5d1d42-3dce-4b44-b477-3ba9027be990"
      unitRef="usd">1200000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90ZXh0cmVnaW9uOjMxY2JlZmMzZjAyYzQ5YjM5NTExYWQ0NGE1MDRhMzBkXzY4MQ_17d906e2-0bf8-4b2f-a9ae-8f2f1c4cfdab"
      unitRef="usd">1100000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xODQvZnJhZzozMWNiZWZjM2YwMmM0OWIzOTUxMWFkNDRhNTA0YTMwZC90ZXh0cmVnaW9uOjMxY2JlZmMzZjAyYzQ5YjM5NTExYWQ0NGE1MDRhMzBkXzY4OA_ccf806c8-3af5-4062-a053-2cbcbb2310d0"
      unitRef="usd">1000000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90ZXh0cmVnaW9uOjFkMTJlYWQzMmI0MDRhNTA4ZmYxNTI5MGVmZThkMDI2XzY1MQ_572b3759-325c-48cc-aaec-e3772707ab41">Medical Costs Payable&lt;div style="margin-bottom:4pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the components of the change in medical costs payable for the years ended December&#160;31: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.029%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical costs payable, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reported medical costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,720)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(880)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(580)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total reported medical costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical payments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for current year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165,524)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(139,974)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(137,155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,864)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,556)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total medical payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(184,388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(159,530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155,320)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical costs payable, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;For the years ended December&#160;31, 2021, 2020 and 2019 medical cost reserve development was primarily driven by lower than expected health system utilization levels. Additionally, medical cost reserve development in the year ended December 31, 2021 was driven by the uncertainty of care patterns due to the disruption of the health care system caused by COVID-19.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medical costs payable included IBNR of $17.1 billion and $14.8 billion at December&#160;31, 2021 and 2020, respectively. Substantially all of the IBNR balance as of December&#160;31, 2021 relates to the current year. The following is information about incurred and paid medical cost development as of December&#160;31, 2021: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:4.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.031%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.826%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Incurred Medical Costs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Cumulative Medical Payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(139,974)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158,182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165,524)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(323,706)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net remaining outstanding liabilities prior to 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total medical costs payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock>
    <us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90ZXh0cmVnaW9uOjFkMTJlYWQzMmI0MDRhNTA4ZmYxNTI5MGVmZThkMDI2XzY2Mw_6303abf9-e764-40f2-8984-38862c69818b">&lt;div style="margin-bottom:4pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the components of the change in medical costs payable for the years ended December&#160;31: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.029%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical costs payable, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reported medical costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,720)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(880)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(580)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total reported medical costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical payments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for current year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165,524)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(139,974)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(137,155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,864)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,556)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total medical payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(184,388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(159,530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155,320)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical costs payable, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzEtMi0xLTEtMA_d2ebff8f-8824-4295-991c-d31c84c3e431"
      unitRef="usd">21872000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i530caf840d4847f1ac553be5f7b336b2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzEtNC0xLTEtMA_46808ad0-be0d-465a-aa11-414f37acea40"
      unitRef="usd">21690000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i870730cd9dfc45bb89971499ab4cdd48_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzEtNi0xLTEtMA_588bb723-d175-41dd-9de6-eecdd90f7826"
      unitRef="usd">19891000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzItMi0xLTEtMA_b6981e3e-f381-4e50-bf9c-c83737812fd7"
      unitRef="usd">88000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzItNC0xLTEtMA_b7ce3ef7-2908-49d1-ac14-e5b5c1ee5329"
      unitRef="usd">316000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzItNi0xLTEtMA_1f971050-22a5-4508-bd66-20865eaec766"
      unitRef="usd">679000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzQtMi0xLTEtMA_bda4a872-e576-484c-bb63-dc1d1bb23325"
      unitRef="usd">188631000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzQtNC0xLTEtMA_5f410904-6cbb-4495-ad5f-d00553233849"
      unitRef="usd">160276000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzQtNi0xLTEtMA_f5f7a17e-b800-4666-84fa-b5d73b0d7469"
      unitRef="usd">157020000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzUtMi0xLTEtMA_5d2029ad-caa8-42ae-80b0-58d937abf637"
      unitRef="usd">-1720000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzUtNC0xLTEtMA_f2edad6c-ffa6-45dc-b83d-41f1b49fbaec"
      unitRef="usd">-880000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzUtNi0xLTEtMA_653abd6a-56ed-4f28-b7e7-8674edcc6ad3"
      unitRef="usd">-580000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzYtMi0xLTEtMA_7a0a4d1b-518d-4d51-89f6-6950f32babbf"
      unitRef="usd">186911000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzYtNC0xLTEtMA_1f264b97-5236-48b7-b8d4-e017c230474f"
      unitRef="usd">159396000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzYtNi0xLTEtMA_970159f0-4cef-43ff-ad30-53b250c65861"
      unitRef="usd">156440000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzgtMi0xLTEtMA_8d2920cd-53a2-4be5-9fc8-58d2fa0d768d"
      unitRef="usd">165524000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzgtNC0xLTEtMA_56a7806b-97ec-4391-a23b-f097fa56e050"
      unitRef="usd">139974000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzgtNi0xLTEtMA_70a32f07-867d-429d-9d01-0e5e449924b3"
      unitRef="usd">137155000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzktMi0xLTEtMA_db319ece-de75-4978-9c2b-26d39e9a4061"
      unitRef="usd">18864000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzktNC0xLTEtMA_452b529e-3b9e-43f0-a06e-7f5cff237dae"
      unitRef="usd">19556000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzktNi0xLTEtMA_e488ee8a-8725-45af-8326-deff4a5f4418"
      unitRef="usd">18165000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzEwLTItMS0xLTA_85ced31e-4b34-4831-96e1-89abdf62e628"
      unitRef="usd">184388000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzEwLTQtMS0xLTA_07f12336-4ab3-4caf-aff7-b9e924c4b25a"
      unitRef="usd">159530000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzEwLTYtMS0xLTA_2de54e22-b60b-43dc-8002-ca36ba4333ff"
      unitRef="usd">155320000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzExLTItMS0xLTA_12d78814-6456-463e-866f-a7a7ed3310b7"
      unitRef="usd">24483000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzExLTQtMS0xLTA_8d1225e0-5847-4139-ac72-f0b6d2a08285"
      unitRef="usd">21872000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i530caf840d4847f1ac553be5f7b336b2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo3ZjE4MjI3ODk2MDY0MzJhOTdhMmMzNmFiZTNlNWI4OS90YWJsZXJhbmdlOjdmMTgyMjc4OTYwNjQzMmE5N2EyYzM2YWJlM2U1Yjg5XzExLTYtMS0xLTA_00893d70-60bd-4528-9a09-c04b2fd714ce"
      unitRef="usd">21690000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90ZXh0cmVnaW9uOjFkMTJlYWQzMmI0MDRhNTA4ZmYxNTI5MGVmZThkMDI2XzQ0NQ_0de0e82e-bfe1-4989-8dbc-44e26337d76b"
      unitRef="usd">17100000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90ZXh0cmVnaW9uOjFkMTJlYWQzMmI0MDRhNTA4ZmYxNTI5MGVmZThkMDI2XzQ1Mg_a73f9d31-b972-48bb-b082-a0ef4efe9bab"
      unitRef="usd">14800000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount>
    <us-gaap:ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90ZXh0cmVnaW9uOjFkMTJlYWQzMmI0MDRhNTA4ZmYxNTI5MGVmZThkMDI2XzY1Ng_b850741a-6307-4c9f-9d22-d254f544531a">The following is information about incurred and paid medical cost development as of December&#160;31, 2021: &lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.031%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.826%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Incurred Medical Costs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Cumulative Medical Payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(139,974)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158,182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165,524)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(323,706)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net remaining outstanding liabilities prior to 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total medical costs payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock>
    <us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i7e7bca7f64a8424489d83e9c4b27fbba_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo5NmJjMDQwYTljNDc0OWNiOWNkNzM0YjA2ODc1YTU5Zi90YWJsZXJhbmdlOjk2YmMwNDBhOWM0NzQ5Y2I5Y2Q3MzRiMDY4NzVhNTlmXzMtMi0xLTEtMA_2cbd60de-d045-4f0f-819c-36e29b652090"
      unitRef="usd">160276000000</us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="if47ca87b4cab4485a2e7830a82f298c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo5NmJjMDQwYTljNDc0OWNiOWNkNzM0YjA2ODc1YTU5Zi90YWJsZXJhbmdlOjk2YmMwNDBhOWM0NzQ5Y2I5Y2Q3MzRiMDY4NzVhNTlmXzMtNC0xLTEtMA_d3c1c34b-daa6-4c99-b73e-8834ad9aac74"
      unitRef="usd">159140000000</us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i1db8094151d340e583b4cbe1a3165397_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo5NmJjMDQwYTljNDc0OWNiOWNkNzM0YjA2ODc1YTU5Zi90YWJsZXJhbmdlOjk2YmMwNDBhOWM0NzQ5Y2I5Y2Q3MzRiMDY4NzVhNTlmXzQtNC0xLTEtMA_8e04349e-efeb-4cbb-ace8-b762c48e9cd1"
      unitRef="usd">188631000000</us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="ifafacde0705d4f258c784fe3cb74d22f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo5NmJjMDQwYTljNDc0OWNiOWNkNzM0YjA2ODc1YTU5Zi90YWJsZXJhbmdlOjk2YmMwNDBhOWM0NzQ5Y2I5Y2Q3MzRiMDY4NzVhNTlmXzUtNC0xLTEtMA_adca65fd-12b5-4e34-9b37-d0766244a181"
      unitRef="usd">347771000000</us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i7e7bca7f64a8424489d83e9c4b27fbba_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo5NmJjMDQwYTljNDc0OWNiOWNkNzM0YjA2ODc1YTU5Zi90YWJsZXJhbmdlOjk2YmMwNDBhOWM0NzQ5Y2I5Y2Q3MzRiMDY4NzVhNTlmXzEwLTItMS0xLTA_f350a443-41ea-40da-9341-e11297b9d9b4"
      unitRef="usd">139974000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="if47ca87b4cab4485a2e7830a82f298c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo5NmJjMDQwYTljNDc0OWNiOWNkNzM0YjA2ODc1YTU5Zi90YWJsZXJhbmdlOjk2YmMwNDBhOWM0NzQ5Y2I5Y2Q3MzRiMDY4NzVhNTlmXzEwLTQtMS0xLTA_6fa5d919-9c3f-44e0-80cb-0eff719017f2"
      unitRef="usd">158182000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i1db8094151d340e583b4cbe1a3165397_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo5NmJjMDQwYTljNDc0OWNiOWNkNzM0YjA2ODc1YTU5Zi90YWJsZXJhbmdlOjk2YmMwNDBhOWM0NzQ5Y2I5Y2Q3MzRiMDY4NzVhNTlmXzExLTQtMS0xLTA_933d7505-757e-45cc-abf1-78861dc6996c"
      unitRef="usd">165524000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="ifafacde0705d4f258c784fe3cb74d22f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo5NmJjMDQwYTljNDc0OWNiOWNkNzM0YjA2ODc1YTU5Zi90YWJsZXJhbmdlOjk2YmMwNDBhOWM0NzQ5Y2I5Y2Q3MzRiMDY4NzVhNTlmXzEyLTQtMS0xLTA_067bf180-9008-47ad-86bd-bf367514c46c"
      unitRef="usd">323706000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented
      contextRef="ifafacde0705d4f258c784fe3cb74d22f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo5NmJjMDQwYTljNDc0OWNiOWNkNzM0YjA2ODc1YTU5Zi90YWJsZXJhbmdlOjk2YmMwNDBhOWM0NzQ5Y2I5Y2Q3MzRiMDY4NzVhNTlmXzEzLTQtMS0xLTA_bf528481-2f98-4c75-8ab7-7ae1131f642c"
      unitRef="usd">418000000</us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented>
    <us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="ifafacde0705d4f258c784fe3cb74d22f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTAvZnJhZzoxZDEyZWFkMzJiNDA0YTUwOGZmMTUyOTBlZmU4ZDAyNi90YWJsZTo5NmJjMDQwYTljNDc0OWNiOWNkNzM0YjA2ODc1YTU5Zi90YWJsZXJhbmdlOjk2YmMwNDBhOWM0NzQ5Y2I5Y2Q3MzRiMDY4NzVhNTlmXzE0LTQtMS0xLTA_4d296f51-b3f5-48b7-8289-e03323e0fa0c"
      unitRef="usd">24483000000</us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90ZXh0cmVnaW9uOjU4ODcyNTgwOGZiYjRmYTVhMDEyOTUzNGVhMGZlMDQyXzE2NDkyNjc0NDMzMzc_921e28e6-75ed-4bfc-9f72-bc0e24a241e7">Short-Term Borrowings and Long-Term Debt &lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term borrowings and senior unsecured long-term debt consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.338%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Carrying Value As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;(in millions, except percentages)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$400 million 4.700% notes due February 2021 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$750 million 2.125% notes due March 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$350 million Floating rate notes due June 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$400 million 3.150% notes due June 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$500 million 3.375% notes due November 2021 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$750 million 2.875% notes due December 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,100 million 2.875% notes due March 2022 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,000 million 3.350% notes due July 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$900 million 2.375% notes due October 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$15 million 0.000% notes due November 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$625 million 2.750% notes due February 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$750 million 2.875% notes due March 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$750 million 3.500% notes due June 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$750 million 3.500% notes due February 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,000 million 0.550% notes due May 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$750 million 2.375% notes due August 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$2,000 million 3.750% notes due July 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$300 million 3.700% notes due December 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$500 million 1.250% notes due January 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,000 million 3.100% notes due March 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,000 million 1.150% notes due May 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$750 million 3.450% notes due January 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$625 million 3.375% notes due April 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$950 million 2.950% notes due October 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,150 million 3.850% notes due June 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$850 million 3.875% notes due December 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,000 million 2.875% notes due August 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,250 million 2.000% notes due May 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,500 million 2.300% notes due May 2031&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,000 million 4.625% notes due July 2035&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$850 million 5.800% notes due March 2036&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$500 million 6.500% notes due June 2037&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$650 million 6.625% notes due November 2037&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,100 million 6.875% notes due February 2038&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,250 million 3.500% notes due August 2039&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,000 million 2.750% notes due May 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$300 million 5.700% notes due October 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$350 million 5.950% notes due February 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,500 million  3.050% notes due May 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$600 million 4.625% notes due November 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$502 million 4.375% notes due March 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$625 million 3.950% notes due October 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$750 million 4.250% notes due March 2043&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$2,000 million 4.750% notes due July 2045&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$750 million 4.200% notes due January 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$725 million 4.250% notes due April 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$950 million 3.750% notes due October 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,350 million 4.250% notes due June 2048&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,100 million 4.450% notes due December 2048&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,250 million 3.700% notes due August 2049&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,250 million 2.900% notes due May 2050&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$2,000 million 3.250% notes due May 2051&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,250 million 3.875% notes due August 2059&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,000 million 3.125% notes due May 2060&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;Total short-term borrowings and long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;44,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;42,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s long-term debt obligations also included $1.4 billion and $1.2 billion of other financing obligations, of which $611 million and $354 million were current as of December&#160;31, 2021 and 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of short-term borrowings and long-term debt for the years ending December&#160;31 are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Short-Term Borrowings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial paper consists of short-duration, senior unsecured debt privately placed on a discount basis through broker-dealers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has $5.6 billion five-year, $5.6 billion three-year and $3.8 billion 364-day revolving bank credit facilities with 24 banks, which mature in December 2026, December 2024 and December 2022, respectively. These facilities provide full liquidity support for the Company&#x2019;s commercial paper program and are available for general corporate purposes. As of December&#160;31, 2021, no amounts had been drawn on any of the bank credit facilities. The annual interest rates, which are variable based on term, are calculated based on one-month Term Secured Overnight Financing Rate (SOFR) plus a SOFR Adjustment of 10 basis points plus a credit spread based on the Company&#x2019;s senior unsecured credit ratings. If amounts had been drawn on the bank credit facilities as of December&#160;31, 2021, annual interest rates would have ranged from 0.8% to 0.9%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Debt Covenants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s bank credit facilities contain various covenants, including requiring the Company to maintain a debt to debt-plus-shareholders&#x2019; equity ratio of not more than 60%. The Company was in compliance with its debt covenants as of December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90ZXh0cmVnaW9uOjU4ODcyNTgwOGZiYjRmYTVhMDEyOTUzNGVhMGZlMDQyXzE2NDkyNjc0NDMzMzY_f4cf66fb-a95c-419b-ac1f-da3ab097db9e">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term borrowings and senior unsecured long-term debt consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.338%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Carrying Value As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;(in millions, except percentages)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$400 million 4.700% notes due February 2021 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$750 million 2.125% notes due March 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$350 million Floating rate notes due June 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$400 million 3.150% notes due June 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$500 million 3.375% notes due November 2021 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$750 million 2.875% notes due December 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,100 million 2.875% notes due March 2022 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,000 million 3.350% notes due July 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$900 million 2.375% notes due October 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$15 million 0.000% notes due November 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$625 million 2.750% notes due February 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$750 million 2.875% notes due March 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$750 million 3.500% notes due June 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$750 million 3.500% notes due February 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,000 million 0.550% notes due May 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$750 million 2.375% notes due August 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$2,000 million 3.750% notes due July 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$300 million 3.700% notes due December 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$500 million 1.250% notes due January 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,000 million 3.100% notes due March 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,000 million 1.150% notes due May 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$750 million 3.450% notes due January 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$625 million 3.375% notes due April 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$950 million 2.950% notes due October 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,150 million 3.850% notes due June 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$850 million 3.875% notes due December 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,000 million 2.875% notes due August 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,250 million 2.000% notes due May 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,500 million 2.300% notes due May 2031&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,000 million 4.625% notes due July 2035&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$850 million 5.800% notes due March 2036&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$500 million 6.500% notes due June 2037&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$650 million 6.625% notes due November 2037&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,100 million 6.875% notes due February 2038&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,250 million 3.500% notes due August 2039&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,000 million 2.750% notes due May 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$300 million 5.700% notes due October 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$350 million 5.950% notes due February 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,500 million  3.050% notes due May 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$600 million 4.625% notes due November 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$502 million 4.375% notes due March 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$625 million 3.950% notes due October 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$750 million 4.250% notes due March 2043&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$2,000 million 4.750% notes due July 2045&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$750 million 4.200% notes due January 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$725 million 4.250% notes due April 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$950 million 3.750% notes due October 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,350 million 4.250% notes due June 2048&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,100 million 4.450% notes due December 2048&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,250 million 3.700% notes due August 2049&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,250 million 2.900% notes due May 2050&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$2,000 million 3.250% notes due May 2051&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,250 million 3.875% notes due August 2059&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;1,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$1,000 million 3.125% notes due May 2060&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;Total short-term borrowings and long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;44,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;42,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:CommercialPaper
      contextRef="i86f3f2448f524de3913d85ac9788450f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzItNC0xLTEtMA_2233e912-43be-4b50-8d76-823211ad4007"
      unitRef="usd">0</us-gaap:CommercialPaper>
    <us-gaap:CommercialPaper
      contextRef="i379ecb26e0e846348f402effa72a9eb2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzItMTAtMS0xLTA_3df36912-3a64-4eef-9793-c5231b5dfa17"
      unitRef="usd">1296000000</us-gaap:CommercialPaper>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i8cb0c74d57b1477fa31da545e505e6d8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzctMC0xLTEtMC90ZXh0cmVnaW9uOjRiMzE1MmM2YzVhYjQ1YTM4MjE5ZmEwNDc1OTgyY2I2XzQzOTgwNDY1MTEyMjE_9f396a51-75cb-49f3-a55b-0b601bf89f5f"
      unitRef="usd">400000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8cb0c74d57b1477fa31da545e505e6d8_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzctMC0xLTEtMC90ZXh0cmVnaW9uOjRiMzE1MmM2YzVhYjQ1YTM4MjE5ZmEwNDc1OTgyY2I2XzI3NDg3NzkwNjk1NzU_4979c605-e01b-4a20-b378-c6a608115255"
      unitRef="number">0.04700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebtCurrent
      contextRef="i8cb0c74d57b1477fa31da545e505e6d8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzctNC0xLTEtMA_2c348e73-246f-4cbc-813b-90d39f54efe1"
      unitRef="usd">0</us-gaap:UnsecuredDebtCurrent>
    <us-gaap:UnsecuredDebtCurrent
      contextRef="ic5c8f497804347fc9f0f8a62f4499752_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzctMTAtMS0xLTA_4fb85f23-96d2-4ec3-addb-8607854076ad"
      unitRef="usd">400000000</us-gaap:UnsecuredDebtCurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ibd92e268e96f4727813026fb9f3f2f8f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzgtMC0xLTEtMC90ZXh0cmVnaW9uOjE0ZTFjMTk1M2E5NzQ3ZWNhZjY2MzZmZDExOGI3ZTI1XzQzOTgwNDY1MTExNTY_5134b3e7-1b4b-4fd4-9d35-3f3b621d6956"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ibd92e268e96f4727813026fb9f3f2f8f_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzgtMC0xLTEtMC90ZXh0cmVnaW9uOjE0ZTFjMTk1M2E5NzQ3ZWNhZjY2MzZmZDExOGI3ZTI1XzQ_98206065-be78-4f82-b6ae-79e89edb4feb"
      unitRef="number">0.02125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebtCurrent
      contextRef="ibd92e268e96f4727813026fb9f3f2f8f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzgtNC0xLTEtMA_0b2a709b-cc57-409e-8b20-f97fbe25898d"
      unitRef="usd">0</us-gaap:UnsecuredDebtCurrent>
    <us-gaap:UnsecuredDebtCurrent
      contextRef="i4248de2739cf40dca665ae10381e03b2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzgtMTAtMS0xLTA_8c8c3d55-3ee5-47a2-af1d-ce8d51c5744d"
      unitRef="usd">750000000</us-gaap:UnsecuredDebtCurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ifb03d5528d1145cfb99fcf592801d116_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzUtMC0xLTEtMTg0NjgvdGV4dHJlZ2lvbjplYWI1YTFlZjdjMmY0Y2FiODlhYzNmNDc4NmE2NTBiYV80Mzk4MDQ2NTExMTY4_f0a0c900-c0c7-4461-9bad-16c2f014cbc9"
      unitRef="usd">350000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:UnsecuredDebtCurrent
      contextRef="ifb03d5528d1145cfb99fcf592801d116_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzktNC0xLTEtMA_9cbcc705-673e-4278-b47a-7b1d6faf56de"
      unitRef="usd">0</us-gaap:UnsecuredDebtCurrent>
    <us-gaap:UnsecuredDebtCurrent
      contextRef="i63fb7f8ae0fd40038163eafaa15d201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzktMTAtMS0xLTA_f44031f9-d96f-4e5c-95da-4d757ff02cf7"
      unitRef="usd">350000000</us-gaap:UnsecuredDebtCurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ie6c00455b2e34b31b4063ebbf2107d3a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzEwLTAtMS0xLTAvdGV4dHJlZ2lvbjpkNGQ1MDk4ZDFmYzQ0ZWEwYmIzMWIxOWMwNzI2ODBkNV80Mzk4MDQ2NTExMTY5_f54975be-d7a4-49fb-bd3f-696c8c0b2b0f"
      unitRef="usd">400000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie6c00455b2e34b31b4063ebbf2107d3a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzEwLTAtMS0xLTAvdGV4dHJlZ2lvbjpkNGQ1MDk4ZDFmYzQ0ZWEwYmIzMWIxOWMwNzI2ODBkNV80_e62f4290-b218-49ed-9504-8cc19bef2052"
      unitRef="number">0.03150</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebtCurrent
      contextRef="ie6c00455b2e34b31b4063ebbf2107d3a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzEwLTQtMS0xLTA_16144119-1920-45cd-bef3-ea5cf23ea559"
      unitRef="usd">0</us-gaap:UnsecuredDebtCurrent>
    <us-gaap:UnsecuredDebtCurrent
      contextRef="i76cb2d4454a64645abe47553a65a92de_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzEwLTEwLTEtMS0w_a23bdcff-d42b-4c39-bb97-3b1db911ccaf"
      unitRef="usd">400000000</us-gaap:UnsecuredDebtCurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="id372eeef8e344178a1dbfa89af46c45e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzExLTAtMS0xLTAvdGV4dHJlZ2lvbjo4ZjczNmFjNzBlNmU0ODEzYmYyZGM0MDgxNThjMTJkNV80Mzk4MDQ2NTExMTc0_f1f34f74-116b-4b0d-b60a-862d8056a847"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id372eeef8e344178a1dbfa89af46c45e_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzExLTAtMS0xLTAvdGV4dHJlZ2lvbjo4ZjczNmFjNzBlNmU0ODEzYmYyZGM0MDgxNThjMTJkNV80_0618055b-943f-4e21-9827-331da7721279"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebtCurrent
      contextRef="id372eeef8e344178a1dbfa89af46c45e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzExLTQtMS0xLTA_c94d12ae-0a9b-4bd7-a598-bc52aee5a02f"
      unitRef="usd">0</us-gaap:UnsecuredDebtCurrent>
    <us-gaap:UnsecuredDebtCurrent
      contextRef="i2ba481f8e0d74c10bc0588b4835f8af5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzExLTEwLTEtMS0w_27f5ffb1-2aab-4824-9a2b-4236d2623965"
      unitRef="usd">507000000</us-gaap:UnsecuredDebtCurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ib8da81de7fee4af4be76cb170e34ee08_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzEyLTAtMS0xLTAvdGV4dHJlZ2lvbjpjYWUxMDQxNmVkMDU0MzcxOGIzMjRkNDkwNTY1MjE0YV80Mzk4MDQ2NTExMTU5_22cff608-8dc4-4e3c-b2a0-e9d5aaba8930"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib8da81de7fee4af4be76cb170e34ee08_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzEyLTAtMS0xLTAvdGV4dHJlZ2lvbjpjYWUxMDQxNmVkMDU0MzcxOGIzMjRkNDkwNTY1MjE0YV80_d46c4371-c76e-47a3-be01-0ac1ae43be5a"
      unitRef="number">0.02875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebtCurrent
      contextRef="ib8da81de7fee4af4be76cb170e34ee08_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzEyLTQtMS0xLTA_3e6b1091-1d64-48ed-9207-b1174115c360"
      unitRef="usd">0</us-gaap:UnsecuredDebtCurrent>
    <us-gaap:UnsecuredDebtCurrent
      contextRef="i096ea40c3d4c42ba8a127cef33efd254_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzEyLTEwLTEtMS0w_f49d82bf-217f-4167-81b2-604341df7e90"
      unitRef="usd">762000000</us-gaap:UnsecuredDebtCurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i8172aeed31f44528a74a1c8dbfd1ca1a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzEzLTAtMS0xLTAvdGV4dHJlZ2lvbjo2N2Y4MTM3NGZlOTk0ZmIzYmM1Yzc5M2ViYzdmMmFjN180Mzk4MDQ2NTExMTYx_c1598bd6-ac30-4086-887c-56d8ce86910b"
      unitRef="usd">1100000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8172aeed31f44528a74a1c8dbfd1ca1a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzEzLTAtMS0xLTAvdGV4dHJlZ2lvbjo2N2Y4MTM3NGZlOTk0ZmIzYmM1Yzc5M2ViYzdmMmFjN180_c5cc5d75-a498-4396-83b1-84131ff0bb90"
      unitRef="number">0.02875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebtCurrent
      contextRef="i8172aeed31f44528a74a1c8dbfd1ca1a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzEzLTQtMS0xLTA_3c9b2372-3ef1-422c-948b-552a68b565c2"
      unitRef="usd">1097000000</us-gaap:UnsecuredDebtCurrent>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i84e7e1ef880e481483e8d4914556cf84_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzEzLTEwLTEtMS0w_f30c891f-833d-4ac0-8a36-98aeaa8f27d8"
      unitRef="usd">1113000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i7e3cddf201a14b228f50c7a4b6a5839e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE0LTAtMS0xLTAvdGV4dHJlZ2lvbjpkOTIyODVlZTUwZmQ0YzkwYTk5MTBkZGY2NWMzM2ZiM180Mzk4MDQ2NTExMTU5_a3098a45-469b-4bba-9d41-7067a560e62e"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7e3cddf201a14b228f50c7a4b6a5839e_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE0LTAtMS0xLTAvdGV4dHJlZ2lvbjpkOTIyODVlZTUwZmQ0YzkwYTk5MTBkZGY2NWMzM2ZiM180_978f4047-052c-48a5-a305-ef6f40ff97ba"
      unitRef="number">0.03350</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebtCurrent
      contextRef="i7e3cddf201a14b228f50c7a4b6a5839e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE0LTQtMS0xLTA_5b7627be-3c71-4a5d-a4d6-114994f5e8fa"
      unitRef="usd">999000000</us-gaap:UnsecuredDebtCurrent>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i7c80b9e731e44c0697a1b7a31a23bf17_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE0LTEwLTEtMS0w_a9fca77a-ba7f-446f-bab3-5d684c4856c9"
      unitRef="usd">999000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i93168a5ed89f448f8f66c9c0a2283b35_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE1LTAtMS0xLTAvdGV4dHJlZ2lvbjo3YzU4MGUyNjUyNTA0MTMyYjk3NDIxNTQ2MTcwNTIyZF80Mzk4MDQ2NTExMTU4_44b127b2-b55d-4045-872a-bead60c41ccc"
      unitRef="usd">900000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i93168a5ed89f448f8f66c9c0a2283b35_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE1LTAtMS0xLTAvdGV4dHJlZ2lvbjo3YzU4MGUyNjUyNTA0MTMyYjk3NDIxNTQ2MTcwNTIyZF80_5c83d6aa-ea7f-447a-b1dd-a7b0c881b5e0"
      unitRef="number">0.02375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebtCurrent
      contextRef="i93168a5ed89f448f8f66c9c0a2283b35_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE1LTQtMS0xLTA_8e6c8eb1-8246-46f3-a22e-f2b1c0c78af6"
      unitRef="usd">899000000</us-gaap:UnsecuredDebtCurrent>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i92d32861403b4fa0bc059b43eb0e9edf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE1LTEwLTEtMS0w_301223b1-6e45-4602-b43d-f56d8d9f3c17"
      unitRef="usd">897000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i84b80aaa2de74ba09b15b98ebeeb295d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE2LTAtMS0xLTAvdGV4dHJlZ2lvbjo5MjNhZjAyYzE2NWM0OWJhOWU2MjgwNDg4NmZhMTExMV80Mzk4MDQ2NTExMTc5_add601e5-4e4e-4e9f-b675-9c29307e68dd"
      unitRef="usd">15000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i84b80aaa2de74ba09b15b98ebeeb295d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE2LTAtMS0xLTAvdGV4dHJlZ2lvbjo5MjNhZjAyYzE2NWM0OWJhOWU2MjgwNDg4NmZhMTExMV80_94b1efe2-8cdf-41df-8978-36a62d884ae9"
      unitRef="number">0.00000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebtCurrent
      contextRef="i84b80aaa2de74ba09b15b98ebeeb295d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE2LTQtMS0xLTA_d6354f7c-872b-4c00-b364-0487706479c5"
      unitRef="usd">14000000</us-gaap:UnsecuredDebtCurrent>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ifdb4994c14104e3ebccd784f009aa1ae_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE2LTEwLTEtMS0w_e7571510-efef-4140-a999-636f52b15af8"
      unitRef="usd">14000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i7548e5a838a4421695679910bd4f2c0a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE3LTAtMS0xLTAvdGV4dHJlZ2lvbjplNjViZGIwZWM2MTA0ZmQ3OTYyMzc4OGRlNmEzNTE3NF80Mzk4MDQ2NTExMTU5_47544c7f-610d-4480-b40f-eefd35dbedb9"
      unitRef="usd">625000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7548e5a838a4421695679910bd4f2c0a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE3LTAtMS0xLTAvdGV4dHJlZ2lvbjplNjViZGIwZWM2MTA0ZmQ3OTYyMzc4OGRlNmEzNTE3NF80_1707fdc3-895f-4dfc-82bb-51c3aae1e95a"
      unitRef="number">0.02750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i7548e5a838a4421695679910bd4f2c0a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE3LTQtMS0xLTA_59296a88-b547-4113-a386-dd91b2e9418f"
      unitRef="usd">632000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ib120d5bbaa93472eb64fb119097cdf6f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE3LTEwLTEtMS0w_e5e5bc97-ebb1-44cc-93a1-fe419fc82f35"
      unitRef="usd">644000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i597c8e442da543bf8a7372bc0ec54f9d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE4LTAtMS0xLTAvdGV4dHJlZ2lvbjpkMDIxOTczZjc5NzQ0MmRhYTkzNjdmMzJhYmI5ZWQ5Yl80Mzk4MDQ2NTExMTU3_9145b886-c270-49ce-b8a1-1d4bb4dc4314"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i597c8e442da543bf8a7372bc0ec54f9d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE4LTAtMS0xLTAvdGV4dHJlZ2lvbjpkMDIxOTczZjc5NzQ0MmRhYTkzNjdmMzJhYmI5ZWQ5Yl80_73277404-d1ee-4c7d-9071-3a83b22ff01c"
      unitRef="number">0.02875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i597c8e442da543bf8a7372bc0ec54f9d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE4LTQtMS0xLTA_72d4e48f-e299-4b5e-81b4-aec6190640d2"
      unitRef="usd">768000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ie880ffc901ab4104b4cfd303f4831b1f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE4LTEwLTEtMS0w_be204862-6ca3-4621-8c27-47c6340f5a65"
      unitRef="usd">789000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="iedb8d09cef364b1293599d28f7c67748_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE5LTAtMS0xLTAvdGV4dHJlZ2lvbjpmZjcyMjEwMWZkMjk0MzczOTc5MTA3MDU1M2QzMDFjY180Mzk4MDQ2NTExMTU2_63d9d312-3d63-48df-8b27-bca26236948f"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iedb8d09cef364b1293599d28f7c67748_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE5LTAtMS0xLTAvdGV4dHJlZ2lvbjpmZjcyMjEwMWZkMjk0MzczOTc5MTA3MDU1M2QzMDFjY180_e900f2f0-5056-42ba-a85b-e5dcd6209ea5"
      unitRef="number">0.03500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="iedb8d09cef364b1293599d28f7c67748_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE5LTQtMS0xLTA_82297cab-862a-4e5a-87ec-659190c454a8"
      unitRef="usd">749000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ia859c1517f2441d58ef162b5ff01d64c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzE5LTEwLTEtMS0w_2116ffa9-4bc2-43e7-b1e8-52bc021a9e60"
      unitRef="usd">748000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i886286b365bb4971a2f13e2f846af74a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIwLTAtMS0xLTAvdGV4dHJlZ2lvbjplODlkNTI3ZDYzMzA0MjY0YmViYjA3MmJmMzE0N2FiM180Mzk4MDQ2NTExMTU5_b6e76edb-418c-4c32-a64d-5f5cec5813ab"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i886286b365bb4971a2f13e2f846af74a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIwLTAtMS0xLTAvdGV4dHJlZ2lvbjplODlkNTI3ZDYzMzA0MjY0YmViYjA3MmJmMzE0N2FiM180_7c07be14-e36b-4b24-9715-f5092fce1131"
      unitRef="number">0.03500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i886286b365bb4971a2f13e2f846af74a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIwLTQtMS0xLTA_41a5e7fb-bf19-43c2-a2c6-66721f84b442"
      unitRef="usd">748000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i07e2a1c9ec8442cea51615552b249524_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIwLTEwLTEtMS0w_e679221d-4160-416b-9ff7-a9ba7a181520"
      unitRef="usd">747000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="if18a2f7f6b0b40f1ad62bd0e830e8b8f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIxLTAtMS0xLTQ5Mi90ZXh0cmVnaW9uOjAyYWNkODE5NGFmYTQyZDY5YjQ4YTIxMzI4MzMzNzAxXzQzOTgwNDY1MTExODU_173a91e0-be26-4065-9882-91fe37a49b0f"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if18a2f7f6b0b40f1ad62bd0e830e8b8f_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIxLTAtMS0xLTQ5Mi90ZXh0cmVnaW9uOjAyYWNkODE5NGFmYTQyZDY5YjQ4YTIxMzI4MzMzNzAxXzE2NDkyNjc0NDE2OTk_5835ecff-155c-443d-862e-5e4b5a19934a"
      unitRef="number">0.00550</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="if18a2f7f6b0b40f1ad62bd0e830e8b8f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIxLTQtMS0xLTQ5NQ_d92e60ce-b418-4359-8813-208b0b94dd96"
      unitRef="usd">996000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i30c9ff85e8394406aa2fcf8c8e0dbf28_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIxLTEwLTEtMS00OTU_74ac4a44-e833-4230-ab90-2bef9f8cc1c9"
      unitRef="usd">0</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ic1ec0d84eddf49dc97d2a21dd8cee234_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIxLTAtMS0xLTAvdGV4dHJlZ2lvbjpmY2E1OGQ5ZWE4ZDE0YmYxOWZmZjBkNWNmZTMzZjIzY180Mzk4MDQ2NTExMTU3_678a9319-81bd-49e0-b8cf-30601e9d0db0"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic1ec0d84eddf49dc97d2a21dd8cee234_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIxLTAtMS0xLTAvdGV4dHJlZ2lvbjpmY2E1OGQ5ZWE4ZDE0YmYxOWZmZjBkNWNmZTMzZjIzY180_f86a389c-567d-40c5-9675-41e93a00e7f5"
      unitRef="number">0.02375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ic1ec0d84eddf49dc97d2a21dd8cee234_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIxLTQtMS0xLTA_256cfc6c-776e-4116-a677-3e46bf3c9f01"
      unitRef="usd">748000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="idb4e09db805a48c9a9980ed388f9d691_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIxLTEwLTEtMS0w_e4976fc6-f414-4274-986d-7e1e4887cae7"
      unitRef="usd">747000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i315d80ec5a9b4d33b1d8d34a78cae609_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIyLTAtMS0xLTAvdGV4dHJlZ2lvbjo0ZGM3OGVjZTE3Mjc0NTViOGEzYmU1NDVmZTI4NzJhZV80Mzk4MDQ2NTExMTYw_448c6411-9f44-4952-a52c-a5c99a37fb83"
      unitRef="usd">2000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i315d80ec5a9b4d33b1d8d34a78cae609_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIyLTAtMS0xLTAvdGV4dHJlZ2lvbjo0ZGM3OGVjZTE3Mjc0NTViOGEzYmU1NDVmZTI4NzJhZV80_c6a554db-fba0-41d4-bacb-324b492e0721"
      unitRef="number">0.03750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i315d80ec5a9b4d33b1d8d34a78cae609_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIyLTQtMS0xLTA_4f244f3f-d0e6-4d15-ab47-0373eb71c4de"
      unitRef="usd">1994000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="iba6f227255b343d1ac18d3836772b9ad_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIyLTEwLTEtMS0w_33ae92bd-f656-4c81-8c00-18c5b5d0cc4b"
      unitRef="usd">1992000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i786f913ccf164a438f57c04ee49ad2b7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIzLTAtMS0xLTAvdGV4dHJlZ2lvbjo1MzZhY2VlZjgwMWE0ZThkOTg5ZTQ3OGZkMTEyOWI0Nl80Mzk4MDQ2NTExMTU5_346746e2-6fd1-441e-b88e-d60a0944210b"
      unitRef="usd">300000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i786f913ccf164a438f57c04ee49ad2b7_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIzLTAtMS0xLTAvdGV4dHJlZ2lvbjo1MzZhY2VlZjgwMWE0ZThkOTg5ZTQ3OGZkMTEyOWI0Nl80_3536f785-0321-4b90-ae5f-91d9fd7be0f7"
      unitRef="number">0.03700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i786f913ccf164a438f57c04ee49ad2b7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIzLTQtMS0xLTA_33a20b4a-7c2c-4a1e-a534-985627251dc0"
      unitRef="usd">299000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i1bde9da88b2241dc9f725c1d621be4d6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzIzLTEwLTEtMS0w_56069a12-1fe1-4d5b-9677-93af6a2548be"
      unitRef="usd">298000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i1a3471e5bd4648d0aa81686260fbc921_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI0LTAtMS0xLTAvdGV4dHJlZ2lvbjpmZDE4N2JhMDgyMmI0NmMyYTUwY2MwOTY0ZDk5ZDA2Y180Mzk4MDQ2NTExMTc0_6c7e6f89-ff0b-444b-8e23-b3255a9b05ba"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1a3471e5bd4648d0aa81686260fbc921_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI0LTAtMS0xLTAvdGV4dHJlZ2lvbjpmZDE4N2JhMDgyMmI0NmMyYTUwY2MwOTY0ZDk5ZDA2Y180_3e8c31c7-c497-4a56-95f6-0b82533221b4"
      unitRef="number">0.01250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i1a3471e5bd4648d0aa81686260fbc921_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI0LTQtMS0xLTA_c0e1b003-39c2-48ca-adda-e44d493c9cf0"
      unitRef="usd">497000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i7deed358f93647928f915f8ee952b69f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI0LTEwLTEtMS0w_a398eb33-eb45-405a-8cdb-e1a9f636d21c"
      unitRef="usd">496000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="id8044edfa2384079929b35102a9b7cad_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI1LTAtMS0xLTAvdGV4dHJlZ2lvbjo0MDg4YTZlNjk1NzM0ZTg5ODA2NjNkMGQ5ODU2ZjZmYV80Mzk4MDQ2NTExMTYw_5cc2283b-279e-499e-88ef-d278eca4d566"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id8044edfa2384079929b35102a9b7cad_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI1LTAtMS0xLTAvdGV4dHJlZ2lvbjo0MDg4YTZlNjk1NzM0ZTg5ODA2NjNkMGQ5ODU2ZjZmYV80_4e682d5c-e148-422b-8dc8-ec1cbede1271"
      unitRef="number">0.03100</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="id8044edfa2384079929b35102a9b7cad_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI1LTQtMS0xLTA_aec0f4a6-fc23-4b3b-9299-00e701fcda9a"
      unitRef="usd">997000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i1344e7e2b6414a7890e692110596b117_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI1LTEwLTEtMS0w_4ce61177-613e-4fb2-b5ab-52f849f488cf"
      unitRef="usd">997000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="iec7c13902a5a4ee19961a3eed138f023_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI3LTAtMS0xLTUwNi90ZXh0cmVnaW9uOjcyYTM1MzU1Zjc4ZDRlNWI5ZWRiZjZhMTU3MDM2NGRkXzQzOTgwNDY1MTExNzE_2ecd57df-ff24-49f0-9377-e6991b11602a"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iec7c13902a5a4ee19961a3eed138f023_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI3LTAtMS0xLTUwNi90ZXh0cmVnaW9uOjcyYTM1MzU1Zjc4ZDRlNWI5ZWRiZjZhMTU3MDM2NGRkXzE2NDkyNjc0NDE2OTk_1e3bc6bc-a48a-48e4-9372-fceecaacd774"
      unitRef="number">0.01150</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="iec7c13902a5a4ee19961a3eed138f023_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI3LTQtMS0xLTUwOQ_6e5960a7-f727-4122-a8de-3fb86bfd56a9"
      unitRef="usd">972000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="if2c36e71284047c4a3930eb5b853ea20_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI3LTEwLTEtMS01MDk_3555ae0f-e73f-404a-be96-d311f6e04817"
      unitRef="usd">0</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i6f817c64d72746f4a7600550a38be49c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI2LTAtMS0xLTAvdGV4dHJlZ2lvbjo3Y2IwYWYyMWM4NDE0NGUwODA1ODM1NzBhNDdmMzkxYV80Mzk4MDQ2NTExMTU4_9cf66ed2-6872-4f14-b87e-f8a25827207d"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6f817c64d72746f4a7600550a38be49c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI2LTAtMS0xLTAvdGV4dHJlZ2lvbjo3Y2IwYWYyMWM4NDE0NGUwODA1ODM1NzBhNDdmMzkxYV80_237e12bb-496c-426d-a5f5-123783c703d6"
      unitRef="number">0.03450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i6f817c64d72746f4a7600550a38be49c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI2LTQtMS0xLTA_a5312750-4278-4808-81cb-bdd50792633d"
      unitRef="usd">747000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ie3f75705b4c54f55b71495dc9a78510d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI2LTEwLTEtMS0w_03498fcc-afd3-4edb-b8ca-928623d9f01f"
      unitRef="usd">747000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="icae9b0e4795648ce9e80f348899da659_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI3LTAtMS0xLTAvdGV4dHJlZ2lvbjpkNGM5YjUwNjNmNDc0OWZmYWY3OTM0YTdjNTUwNzliYl80Mzk4MDQ2NTExMTU2_5eb639c9-3fec-4708-a3bc-9bb727ab77d3"
      unitRef="usd">625000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="icae9b0e4795648ce9e80f348899da659_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI3LTAtMS0xLTAvdGV4dHJlZ2lvbjpkNGM5YjUwNjNmNDc0OWZmYWY3OTM0YTdjNTUwNzliYl80_6da4d575-9ba5-4c96-b408-1cce540978f2"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="icae9b0e4795648ce9e80f348899da659_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI3LTQtMS0xLTA_e383b053-a040-4ff8-93ff-1a24a3937e23"
      unitRef="usd">621000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i0e4451b5d59c467f9a4e28097256ff50_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI3LTEwLTEtMS0w_23ffd16d-2932-493f-ae7f-9104a1db0961"
      unitRef="usd">620000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i31ec009da13047b6b79197c66fda5b6f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI4LTAtMS0xLTAvdGV4dHJlZ2lvbjplMTg4YWI2MGZiZjU0OGI5YmY0NTA4MjliYWIxMGQzMl80Mzk4MDQ2NTExMTU4_665516b1-92c6-4068-82fa-c861ca6b82f6"
      unitRef="usd">950000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i31ec009da13047b6b79197c66fda5b6f_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI4LTAtMS0xLTAvdGV4dHJlZ2lvbjplMTg4YWI2MGZiZjU0OGI5YmY0NTA4MjliYWIxMGQzMl80_5d38b603-7a94-4776-965a-1859eccf152d"
      unitRef="number">0.02950</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i31ec009da13047b6b79197c66fda5b6f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI4LTQtMS0xLTA_b3ec82ae-456f-4874-94f0-8cae13871721"
      unitRef="usd">942000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="icae10e63208f4e10877dfc05154784ab_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI4LTEwLTEtMS0w_e6277f2d-08df-4916-a375-90f077124216"
      unitRef="usd">940000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i85149ce8b76548558e9c825e775cee26_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI5LTAtMS0xLTAvdGV4dHJlZ2lvbjo0N2VhZTMyNWJkMjc0ZWNhYjQ2NmJlZTgxZDgwMTljN180Mzk4MDQ2NTExMTU5_3cb37009-7188-4233-b0e8-91c5d3d80270"
      unitRef="usd">1150000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i85149ce8b76548558e9c825e775cee26_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI5LTAtMS0xLTAvdGV4dHJlZ2lvbjo0N2VhZTMyNWJkMjc0ZWNhYjQ2NmJlZTgxZDgwMTljN180_e73ef6a3-f93a-4756-8e71-189884e93042"
      unitRef="number">0.03850</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i85149ce8b76548558e9c825e775cee26_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI5LTQtMS0xLTA_119249a9-8098-43d3-b112-a25905fdcaba"
      unitRef="usd">1144000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="iff612dcf0de24f99834b8502366648da_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzI5LTEwLTEtMS0w_f8b81b10-06bc-44a6-a072-df6d2ff22c76"
      unitRef="usd">1143000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ia7cb4d01a77147bea64135beacd75967_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzMwLTAtMS0xLTAvdGV4dHJlZ2lvbjo5M2ZlZTUzZmUwOTM0ZDVlYTc0YmI5ZjFmYzU5OTQ0OF80Mzk4MDQ2NTExMTU5_1ccdb744-84ed-4f83-bd92-dc76d620b60e"
      unitRef="usd">850000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia7cb4d01a77147bea64135beacd75967_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzMwLTAtMS0xLTAvdGV4dHJlZ2lvbjo5M2ZlZTUzZmUwOTM0ZDVlYTc0YmI5ZjFmYzU5OTQ0OF80_29f893d0-fa81-4de9-95d6-602804f8f736"
      unitRef="number">0.03875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ia7cb4d01a77147bea64135beacd75967_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzMwLTQtMS0xLTA_d67c6953-3a86-4596-8e3b-ef896dc7d584"
      unitRef="usd">844000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ibab3629772cb483797b33dd7cac92661_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzMwLTEwLTEtMS0w_84e701b8-c11b-46da-9e05-a9a773879c82"
      unitRef="usd">844000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i89ffd37b253a491e85cd53a3418e5384_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzMxLTAtMS0xLTAvdGV4dHJlZ2lvbjo4MmExYWJhMGU3NTI0NDE1OTVhNzc5NDhiOTJmMTE5M180Mzk4MDQ2NTExMTYx_6688921c-ccff-4cd9-beb6-92e26946ce22"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i89ffd37b253a491e85cd53a3418e5384_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzMxLTAtMS0xLTAvdGV4dHJlZ2lvbjo4MmExYWJhMGU3NTI0NDE1OTVhNzc5NDhiOTJmMTE5M180_4076487e-c6fc-4b43-8d48-8d8d9c7437e9"
      unitRef="number">0.02875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i89ffd37b253a491e85cd53a3418e5384_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzMxLTQtMS0xLTA_028a0457-c153-4578-9e82-fe594c02c856"
      unitRef="usd">1023000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i70db3b468bcd459e93e65ee79271966b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzMxLTEwLTEtMS0w_f7a0b715-7fd8-4828-933f-d68e1fa3a8c4"
      unitRef="usd">1086000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i792128c572ef443698af3751346cf9ff_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzMyLTAtMS0xLTAvdGV4dHJlZ2lvbjpmNmY2NDMyNDYyMjI0NTMzOTE3MDg3MTg1ZTEyNDQ4MV80Mzk4MDQ2NTExMTU4_7f7ee836-abf2-47fc-9eb3-4f605dbc5cfc"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i792128c572ef443698af3751346cf9ff_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzMyLTAtMS0xLTAvdGV4dHJlZ2lvbjpmNmY2NDMyNDYyMjI0NTMzOTE3MDg3MTg1ZTEyNDQ4MV80_fcee0f9a-63aa-4c1a-aed3-64b8fe08f773"
      unitRef="number">0.02000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i792128c572ef443698af3751346cf9ff_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzMyLTQtMS0xLTA_24d7cfc5-621d-4e60-a793-93b8168823a3"
      unitRef="usd">1235000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ibd61ed081c424fe89d2e0c20559932f2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzMyLTEwLTEtMS0w_8f7c58b2-5168-468d-af26-a4e84fcdccf0"
      unitRef="usd">1234000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ib9a4bd31faa04ee1b247e1f86a34f265_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM1LTAtMS0xLTUyMS90ZXh0cmVnaW9uOmVmY2Y4NjJlMmExOTRiMzM5OTE0MmIxYTZmMjFiMDIwXzQzOTgwNDY1MTExNzE_8c12acd4-1b20-4a12-9e6a-81a69b6e263d"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib9a4bd31faa04ee1b247e1f86a34f265_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM1LTAtMS0xLTUyMS90ZXh0cmVnaW9uOmVmY2Y4NjJlMmExOTRiMzM5OTE0MmIxYTZmMjFiMDIwXzE2NDkyNjc0NDE2OTk_4a7819e0-2577-4166-8e56-6e331cca936d"
      unitRef="number">0.02300</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ib9a4bd31faa04ee1b247e1f86a34f265_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM1LTQtMS0xLTUyNA_b842085a-49ba-4d60-bc80-8082b077405b"
      unitRef="usd">1482000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i01f8d0ea95854e9da64e602eecf75925_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM1LTEwLTEtMS01MjQ_a9527c15-8c2e-4de1-abd3-543e6c7bf408"
      unitRef="usd">0</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ic45826f8bd334acd9a357972ff7747c0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjo0MTAwOWI3ODExMTc0YjQ5YjljMWJhYWUzYjQ4NmQ0NF80Mzk4MDQ2NTExMTU5_b3550d3c-6f04-4533-89aa-8bf0e8051b5f"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic45826f8bd334acd9a357972ff7747c0_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjo0MTAwOWI3ODExMTc0YjQ5YjljMWJhYWUzYjQ4NmQ0NF80_533aea48-66fa-4402-8ebe-23b7047f3851"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ic45826f8bd334acd9a357972ff7747c0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzMzLTQtMS0xLTA_05004469-46f8-4870-bba4-d0e5e08a4506"
      unitRef="usd">993000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i1594b131d7cc4f158302396c98e0ebd8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzMzLTEwLTEtMS0w_6d24fbdd-caf9-44ec-b899-2283f9753da6"
      unitRef="usd">992000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ibe281588c47246929092124b77f5b494_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjpjNzY3NGE3ODJkY2U0ODI0OGFkOGZmMDZlMDBiM2U0Zl80Mzk4MDQ2NTExMTU2_2b273285-3959-489e-96d0-2f134d817ef9"
      unitRef="usd">850000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ibe281588c47246929092124b77f5b494_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjpjNzY3NGE3ODJkY2U0ODI0OGFkOGZmMDZlMDBiM2U0Zl80_ccd9b429-ad15-4982-953a-390dee56a322"
      unitRef="number">0.05800</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ibe281588c47246929092124b77f5b494_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM0LTQtMS0xLTA_b7262169-3edd-4e03-883c-88618a69ac5b"
      unitRef="usd">839000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i4474b87a11cf47a0bf686a80b83dcb59_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM0LTEwLTEtMS0w_d9cc5bad-58e5-4dd7-8ebc-b9ba3772c5f8"
      unitRef="usd">839000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i042493d5f213402dbb064b91d1c75e28_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM1LTAtMS0xLTAvdGV4dHJlZ2lvbjo0Y2U1MmEwZWEyYWQ0YzZmYTA4N2FiYzYzNzk5NTRkZF80Mzk4MDQ2NTExMTU1_708c63d3-ef54-44cf-8fea-2034aafecebf"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i042493d5f213402dbb064b91d1c75e28_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM1LTAtMS0xLTAvdGV4dHJlZ2lvbjo0Y2U1MmEwZWEyYWQ0YzZmYTA4N2FiYzYzNzk5NTRkZF80_d4134705-1a72-4c5a-834d-c2d36d673871"
      unitRef="number">0.06500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i042493d5f213402dbb064b91d1c75e28_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM1LTQtMS0xLTA_3af14d0d-85cd-4300-b621-5a2f3ac5ab19"
      unitRef="usd">492000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i0c1062a7e2f149f5badaba59158717fd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM1LTEwLTEtMS0w_395f70d4-9d82-4377-8660-12d4bf5045d9"
      unitRef="usd">492000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i5ac1e2d38c684f80a23cf559e9f5ff07_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM2LTAtMS0xLTAvdGV4dHJlZ2lvbjoxMjhiM2FhZWU1ODM0YWMwYWVjYTEzNDY4ZWIzMTAzYl80Mzk4MDQ2NTExMTU5_d1b53379-2d29-46a6-864f-2d85944bbbe9"
      unitRef="usd">650000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5ac1e2d38c684f80a23cf559e9f5ff07_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM2LTAtMS0xLTAvdGV4dHJlZ2lvbjoxMjhiM2FhZWU1ODM0YWMwYWVjYTEzNDY4ZWIzMTAzYl80_a46ca38d-a35e-4d92-8d41-acc285521eee"
      unitRef="number">0.06625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i5ac1e2d38c684f80a23cf559e9f5ff07_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM2LTQtMS0xLTA_80371288-d16a-4c0b-b5f4-401c9150fc15"
      unitRef="usd">642000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ia5db4929602c4ffd9189617d404f73d2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM2LTEwLTEtMS0w_1fe783ba-2fa5-4b2d-a8a7-834ce273768f"
      unitRef="usd">641000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i5bb559f948de43229cd7e5cae903c0c3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM3LTAtMS0xLTAvdGV4dHJlZ2lvbjo0MDEzNjNlNmM1OTU0YzkzYjMxZjQ0ODZkYzNiMWU1ZF80Mzk4MDQ2NTExMTYz_b2448a19-f54d-409f-86c3-425582718c8e"
      unitRef="usd">1100000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5bb559f948de43229cd7e5cae903c0c3_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM3LTAtMS0xLTAvdGV4dHJlZ2lvbjo0MDEzNjNlNmM1OTU0YzkzYjMxZjQ0ODZkYzNiMWU1ZF80_7375e3ae-71ae-4795-b574-ee8644368f67"
      unitRef="number">0.06875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i5bb559f948de43229cd7e5cae903c0c3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM3LTQtMS0xLTA_1d0efeb3-3521-4047-bf4b-1249710a97b9"
      unitRef="usd">1078000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ie12a20b3450a4ef28232fc38f2583a41_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM3LTEwLTEtMS0w_7cb1fd38-dc71-4ea1-b7df-af14e48920a4"
      unitRef="usd">1077000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="iada0e5e85dc241e48cf116319f7a75c6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM4LTAtMS0xLTAvdGV4dHJlZ2lvbjo4Njc0NTM4YTA0NDg0NmIxYjI3ZmM0YmE1YjJmZDdkYV80Mzk4MDQ2NTExMTc3_24d4f529-fdb5-4947-9fe5-70e161fb6a45"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iada0e5e85dc241e48cf116319f7a75c6_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM4LTAtMS0xLTAvdGV4dHJlZ2lvbjo4Njc0NTM4YTA0NDg0NmIxYjI3ZmM0YmE1YjJmZDdkYV80_81d5a673-794b-48bf-8676-8cf7f6cc279c"
      unitRef="number">0.03500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="iada0e5e85dc241e48cf116319f7a75c6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM4LTQtMS0xLTA_9be20d95-163b-4ee9-be30-c0271449fd88"
      unitRef="usd">1242000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i5a8fbc7bad4d46d98e6ee62b8a2075c8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM4LTEwLTEtMS0w_1d52f0b8-34aa-49e7-889b-58f4c8fa6ce1"
      unitRef="usd">1241000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i6019aef8fb074093b331027b9c2adb61_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM5LTAtMS0xLTAvdGV4dHJlZ2lvbjpkNDA0ZTJjNTMyNDk0YWQ5OWY0YjJmYWQ4ODY2ZDFlZl80Mzk4MDQ2NTExMTU4_2e843e65-54c3-4c93-a64b-c94136a0af6a"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6019aef8fb074093b331027b9c2adb61_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM5LTAtMS0xLTAvdGV4dHJlZ2lvbjpkNDA0ZTJjNTMyNDk0YWQ5OWY0YjJmYWQ4ODY2ZDFlZl80_c7215a4d-4570-435d-9812-e1b6f9764bc1"
      unitRef="number">0.02750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i6019aef8fb074093b331027b9c2adb61_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM5LTQtMS0xLTA_525c8a67-cc7a-4ff3-9e4d-1395873b8821"
      unitRef="usd">966000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i6ce09d75289f41078948230ae4e2acf1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzM5LTEwLTEtMS0w_f35a42a2-e93b-4149-9c89-11b3832c58b1"
      unitRef="usd">964000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="iba9a7a93d2b645cea2c51c984287da3f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQwLTAtMS0xLTAvdGV4dHJlZ2lvbjo3Nzk3NWY4YmYyY2E0ZDY1YWVkNzAzNzM4ZTFhZjA2N180Mzk4MDQ2NTExMTU4_9b86533d-db87-478e-b50d-2d8d8a4b002f"
      unitRef="usd">300000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iba9a7a93d2b645cea2c51c984287da3f_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQwLTAtMS0xLTAvdGV4dHJlZ2lvbjo3Nzk3NWY4YmYyY2E0ZDY1YWVkNzAzNzM4ZTFhZjA2N180_7ebb632a-b12a-4446-9e64-cd0779783fd3"
      unitRef="number">0.05700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="iba9a7a93d2b645cea2c51c984287da3f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQwLTQtMS0xLTA_b15cc0a5-01c0-4ec8-8539-5b5a00663cc5"
      unitRef="usd">296000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ife79ad90a728499a81be122ba5a2043f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQwLTEwLTEtMS0w_5de4f56e-1275-4c2d-ba15-dfe2fa224957"
      unitRef="usd">296000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ib4f641b3624849f2adeb7cd37bcab7ca_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQxLTAtMS0xLTAvdGV4dHJlZ2lvbjphZTIxNDE1MzEzNjg0YTcxODE1NjFmYmNkNjBiYzk2Nl80Mzk4MDQ2NTExMTU5_4834c239-80de-40ef-b00f-828330896c07"
      unitRef="usd">350000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib4f641b3624849f2adeb7cd37bcab7ca_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQxLTAtMS0xLTAvdGV4dHJlZ2lvbjphZTIxNDE1MzEzNjg0YTcxODE1NjFmYmNkNjBiYzk2Nl80_d3805231-b3ca-4a54-a1b5-ef9315ee13bd"
      unitRef="number">0.05950</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ib4f641b3624849f2adeb7cd37bcab7ca_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQxLTQtMS0xLTA_9c835814-bde5-4c68-8cd6-a9e44e023dd7"
      unitRef="usd">346000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i7a3553569a45473daba65988c3a74356_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQxLTEwLTEtMS0w_130a1735-7db6-4d91-a9bf-4c499609a7de"
      unitRef="usd">346000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ib3668395d3b640cf8ba0bda86da26e60_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ1LTAtMS0xLTUzNS90ZXh0cmVnaW9uOjNmZTc3NmQyYzE4YTRjODBiNWI2MGZmZTdlMzM5ZmZkXzQzOTgwNDY1MTExNzM_4601df99-df0d-4abf-b41c-7e905625f00c"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib3668395d3b640cf8ba0bda86da26e60_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ1LTAtMS0xLTUzNS90ZXh0cmVnaW9uOjNmZTc3NmQyYzE4YTRjODBiNWI2MGZmZTdlMzM5ZmZkXzE2NDkyNjc0NDE2OTk_523a2d2c-f9d8-43cc-a764-16199cb5080a"
      unitRef="number">0.03050</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ib3668395d3b640cf8ba0bda86da26e60_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ1LTQtMS0xLTUzOA_ba2ab9b5-fd7c-4058-9aa5-c80551ad310d"
      unitRef="usd">1483000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i9de83ae9a2be49cca2565c7797dfdb8a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ1LTEwLTEtMS01Mzg_1d26f558-6c26-4ede-88d6-3a810ec38194"
      unitRef="usd">0</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i5c821b276174476b9517c3bbb9157232_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQyLTAtMS0xLTAvdGV4dHJlZ2lvbjo0YTI5NGM4ZWM0M2I0Y2Q5YmI1N2MxMjExOTkyYjJkYV80Mzk4MDQ2NTExMTU5_92102034-c144-4b43-8b17-b97dc7354e33"
      unitRef="usd">600000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5c821b276174476b9517c3bbb9157232_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQyLTAtMS0xLTAvdGV4dHJlZ2lvbjo0YTI5NGM4ZWM0M2I0Y2Q5YmI1N2MxMjExOTkyYjJkYV80_cbc7bb60-bdc8-47b5-bc89-e35fe7863395"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i5c821b276174476b9517c3bbb9157232_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQyLTQtMS0xLTA_c55a6943-0021-4099-83e1-ff035825feb1"
      unitRef="usd">589000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i4a4bb23357c64364aa0ece690aa5ec74_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQyLTEwLTEtMS0w_07a2c2df-b745-449c-91c8-0e6ab4a31e2d"
      unitRef="usd">589000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i3057e59415b14c1fbbc0e75f70f19a41_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQzLTAtMS0xLTAvdGV4dHJlZ2lvbjplYTc3ODJmYTAyNzc0NzFlYTYzNTM2OGZjM2NhMzRhYl80Mzk4MDQ2NTExMTcw_6174bb23-bc04-4ca1-970e-94ed89144b33"
      unitRef="usd">502000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3057e59415b14c1fbbc0e75f70f19a41_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQzLTAtMS0xLTAvdGV4dHJlZ2lvbjplYTc3ODJmYTAyNzc0NzFlYTYzNTM2OGZjM2NhMzRhYl80_7fee7a11-daad-42d9-ad15-692588b88794"
      unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i3057e59415b14c1fbbc0e75f70f19a41_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQzLTQtMS0xLTA_0dc0fef9-beda-4c03-b148-1051afbe68e9"
      unitRef="usd">485000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i6e8e99b43b324defa304dd9967162f65_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQzLTEwLTEtMS0w_6ba7228d-d71f-4af9-ab3b-7f27f7fc4f73"
      unitRef="usd">485000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ica9c4076825647eaad198c486084ebb6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ0LTAtMS0xLTAvdGV4dHJlZ2lvbjowYmQ2ZGQwODc3ZmI0YzFlOTg0NzQ0ZGI3NWIxYjkxYV80Mzk4MDQ2NTExMTc0_9e8bad8d-91c4-4d54-8d8c-73a7b25345d3"
      unitRef="usd">625000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ica9c4076825647eaad198c486084ebb6_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ0LTAtMS0xLTAvdGV4dHJlZ2lvbjowYmQ2ZGQwODc3ZmI0YzFlOTg0NzQ0ZGI3NWIxYjkxYV80_3a4df45d-1506-4695-ace7-527479545fa0"
      unitRef="number">0.03950</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ica9c4076825647eaad198c486084ebb6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ0LTQtMS0xLTA_818670fe-a115-4ede-bf3d-9bc228604fcd"
      unitRef="usd">608000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i1f1727e520ff46c0bfcd3cb930e2e50d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ0LTEwLTEtMS0w_ce5940b8-931a-40f9-a0bf-fa1deb623eeb"
      unitRef="usd">608000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i8aa1ed6f3b9547d785049322c036163a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ1LTAtMS0xLTAvdGV4dHJlZ2lvbjoxYTBjMDI5YjA3OTk0NzdjYWFkOTVmNTE5M2U0M2M2Ml80Mzk4MDQ2NTExMTU2_104d8b28-93c1-41a6-b73c-1fd67a46d290"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8aa1ed6f3b9547d785049322c036163a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ1LTAtMS0xLTAvdGV4dHJlZ2lvbjoxYTBjMDI5YjA3OTk0NzdjYWFkOTVmNTE5M2U0M2M2Ml80_552ee9a8-fdbd-4019-b480-a8e697e850cf"
      unitRef="number">0.04250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i8aa1ed6f3b9547d785049322c036163a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ1LTQtMS0xLTA_5aeb6b2d-2287-4630-b439-60e3eb4580bc"
      unitRef="usd">736000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i44ad24710d1a4e13bd0afb488b206cfa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ1LTEwLTEtMS0w_889f143f-1ac6-4a51-9e7a-a4fb6680ee16"
      unitRef="usd">735000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="idd43a6fb78154c23ac9111d56d6fc58a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ2LTAtMS0xLTAvdGV4dHJlZ2lvbjo3MWJkZDEwYzBkMjA0OTA2ODYzMjFkNDdlODAzM2JiZF80Mzk4MDQ2NTExMTU5_c5c2c591-b5e8-4335-b154-67925aea57eb"
      unitRef="usd">2000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="idd43a6fb78154c23ac9111d56d6fc58a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ2LTAtMS0xLTAvdGV4dHJlZ2lvbjo3MWJkZDEwYzBkMjA0OTA2ODYzMjFkNDdlODAzM2JiZF80_f217e45b-e848-4b21-8dde-7b3572a0632d"
      unitRef="number">0.04750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="idd43a6fb78154c23ac9111d56d6fc58a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ2LTQtMS0xLTA_4c3d5f2b-9268-41df-be8f-13d0229b0c08"
      unitRef="usd">1974000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i50006b1b20aa424bbbcfb16934763e3e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ2LTEwLTEtMS0w_69fbf839-0a7c-49bd-925e-f24ec9ccda3a"
      unitRef="usd">1974000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i37706a7a25134a80b7681dbe80d0a08f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ3LTAtMS0xLTAvdGV4dHJlZ2lvbjo4MmE0NGNmODllNWI0MjI0YWNmZGQ4NTQ1YTBmOWVhN180Mzk4MDQ2NTExMTU4_7a8d9776-7dc3-46b5-bbe9-94250a8d64c7"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i37706a7a25134a80b7681dbe80d0a08f_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ3LTAtMS0xLTAvdGV4dHJlZ2lvbjo4MmE0NGNmODllNWI0MjI0YWNmZGQ4NTQ1YTBmOWVhN180_3b560a1a-2068-4dec-8a70-41c1e58005e2"
      unitRef="number">0.04200</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i37706a7a25134a80b7681dbe80d0a08f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ3LTQtMS0xLTA_4d8a4015-4f69-4edb-ad23-4897cf611fb7"
      unitRef="usd">739000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ied6c1c554b9b4094a5e58395009e98e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ3LTEwLTEtMS0w_60ab0ec4-581b-4a28-b1f1-c8c3586885c4"
      unitRef="usd">738000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i6a47e7cab2b747b19f8ad6dd5577eb65_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ4LTAtMS0xLTAvdGV4dHJlZ2lvbjoyOTY5ODUwM2NhM2Q0YmRkOGQ2NDRmYWM1YWFkZjI4OV80Mzk4MDQ2NTExMTU2_d7cbde43-c1ab-468a-9c40-797900a2a1c2"
      unitRef="usd">725000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6a47e7cab2b747b19f8ad6dd5577eb65_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ4LTAtMS0xLTAvdGV4dHJlZ2lvbjoyOTY5ODUwM2NhM2Q0YmRkOGQ2NDRmYWM1YWFkZjI4OV80_430c2468-85e6-429e-a9fe-245e208869ce"
      unitRef="number">0.04250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i6a47e7cab2b747b19f8ad6dd5577eb65_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ4LTQtMS0xLTA_93e657c0-6865-4d5e-bb1c-a4ba351bb6b0"
      unitRef="usd">718000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i9cfc628d12b54f618f9ea7acd8dae9c6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ4LTEwLTEtMS0w_5f6e47cb-6519-4653-96bd-293443462bac"
      unitRef="usd">717000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i980dd94826d240d68ca80fc74c96e9c1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ5LTAtMS0xLTAvdGV4dHJlZ2lvbjo1ZDE0NzlhYjRiMGU0M2FlODhhMzAyNGMzMTA2Mjk4MF80Mzk4MDQ2NTExMTU4_77324d5f-68fc-43e9-86b7-652e32e44bc2"
      unitRef="usd">950000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i980dd94826d240d68ca80fc74c96e9c1_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ5LTAtMS0xLTAvdGV4dHJlZ2lvbjo1ZDE0NzlhYjRiMGU0M2FlODhhMzAyNGMzMTA2Mjk4MF80_3da76b5c-9a12-47ce-85a2-a9f0a8f0cd86"
      unitRef="number">0.03750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i980dd94826d240d68ca80fc74c96e9c1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ5LTQtMS0xLTA_e54350db-e10b-4274-b1c0-6475d31494d3"
      unitRef="usd">934000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i91851bb701054679b7700165881a5c2e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzQ5LTEwLTEtMS0w_241582d9-0b70-4434-9cdd-2d0b9ab4ec0a"
      unitRef="usd">934000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ie56f8e65458741cba5353670ff8dce7e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzUwLTAtMS0xLTAvdGV4dHJlZ2lvbjplNzdhZTMyYmFmYTI0MjUyYWM3NmVkOWVhZjE5ZTk5Y180Mzk4MDQ2NTExMTU5_d904e86c-6e67-4cc3-9d34-36e5323a20d9"
      unitRef="usd">1350000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie56f8e65458741cba5353670ff8dce7e_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzUwLTAtMS0xLTAvdGV4dHJlZ2lvbjplNzdhZTMyYmFmYTI0MjUyYWM3NmVkOWVhZjE5ZTk5Y180_28da9974-759e-47e6-b1f4-cf56c32cf419"
      unitRef="number">0.04250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ie56f8e65458741cba5353670ff8dce7e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzUwLTQtMS0xLTA_30dafab0-5037-4f5e-bb30-26e07c585ce0"
      unitRef="usd">1330000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ib9a9dbbc743449a2bc095746eaf4f94d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzUwLTEwLTEtMS0w_1da13777-7885-4f6e-a72c-fe56ecaa2f81"
      unitRef="usd">1330000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i076316df7acd4f5f97a07a2468548d05_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzUxLTAtMS0xLTAvdGV4dHJlZ2lvbjpmNzVjNTlmNjk3MjQ0YmMxYWFlZDI2MzIzYTE2MzMzM180Mzk4MDQ2NTExMTgx_07bc9126-dbe8-4370-958e-b60ecdef8c5f"
      unitRef="usd">1100000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i076316df7acd4f5f97a07a2468548d05_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzUxLTAtMS0xLTAvdGV4dHJlZ2lvbjpmNzVjNTlmNjk3MjQ0YmMxYWFlZDI2MzIzYTE2MzMzM180_4b0c3077-e251-46af-bd25-4592306d65f7"
      unitRef="number">0.04450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i076316df7acd4f5f97a07a2468548d05_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzUxLTQtMS0xLTA_42a7b9bd-6629-4c75-a9cd-44c0831cdc54"
      unitRef="usd">1087000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i81143b21d99c4e8da9cc8f4dba61ce25_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzUxLTEwLTEtMS0w_feca9483-160c-41cb-929d-79e96814d7b8"
      unitRef="usd">1086000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i5dc454ca8f924d03b29dd33f0388905d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzUyLTAtMS0xLTAvdGV4dHJlZ2lvbjo3Y2IwODY3NTU1ZGI0MDFhYjE3N2MzY2I0MWYzZDQyMl80Mzk4MDQ2NTExMTcx_8944e74c-6ebc-49f4-b908-1bf821dd4d6b"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5dc454ca8f924d03b29dd33f0388905d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzUyLTAtMS0xLTAvdGV4dHJlZ2lvbjo3Y2IwODY3NTU1ZGI0MDFhYjE3N2MzY2I0MWYzZDQyMl80_34a9cad7-7e43-4073-ac6a-b25c503b67ff"
      unitRef="number">0.03700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i5dc454ca8f924d03b29dd33f0388905d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzUyLTQtMS0xLTA_9319b911-d473-489b-a32f-56415377cc5a"
      unitRef="usd">1236000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i9cbf53962caa43fba596a6987b79829b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzUyLTEwLTEtMS0w_e42993bf-937a-45c0-ba37-b31567e88175"
      unitRef="usd">1235000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i43a9150b986245ea926eba8cf8dd88c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzUzLTAtMS0xLTAvdGV4dHJlZ2lvbjpiMzhmZTRhMGFmZDE0ODZhODQ4NDU3YWIyZjZiNDIyMV80Mzk4MDQ2NTExMTU4_a0c2292d-9b52-425e-a66f-78dcf154a729"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i43a9150b986245ea926eba8cf8dd88c4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzUzLTAtMS0xLTAvdGV4dHJlZ2lvbjpiMzhmZTRhMGFmZDE0ODZhODQ4NDU3YWIyZjZiNDIyMV80_a985f1e6-a915-4770-aea7-ed0d4f87ff85"
      unitRef="number">0.02900</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i43a9150b986245ea926eba8cf8dd88c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzUzLTQtMS0xLTA_fd218b59-2b10-4611-8e5f-98de386e0743"
      unitRef="usd">1209000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i66c9a6ec6acf4ae18dde8b5ddd77ada8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzUzLTEwLTEtMS0w_21e3b714-6536-43db-ace1-5d8e9a8f7eff"
      unitRef="usd">1208000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="id7d2521c88c843bbab7e44fbe1b07950_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzU4LTAtMS0xLTU0OS90ZXh0cmVnaW9uOjFlMTJlOWYxNWY0ZTQ4ZWViOGI2NWExMmNlMDdjMGFiXzQzOTgwNDY1MTExODU_fab21222-2d68-4ef7-8c86-ebf8726d1da3"
      unitRef="usd">2000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id7d2521c88c843bbab7e44fbe1b07950_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzU4LTAtMS0xLTU0OS90ZXh0cmVnaW9uOjFlMTJlOWYxNWY0ZTQ4ZWViOGI2NWExMmNlMDdjMGFiXzE2NDkyNjc0NDE3MTM_ef31f573-1011-4534-b219-78e2a397ac6a"
      unitRef="number">0.03250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="id7d2521c88c843bbab7e44fbe1b07950_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzU4LTQtMS0xLTU1Mg_63f080c2-8f2e-427c-88fc-51bc1bb954b3"
      unitRef="usd">1970000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i87de305d4b6d41f69ebc5ea26f269dd9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzU4LTEwLTEtMS01NTI_fb7bc672-7a43-47fa-a46f-af39f48ee670"
      unitRef="usd">0</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="if6fda2fd6f8d48768196072f7bb18858_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzU0LTAtMS0xLTAvdGV4dHJlZ2lvbjpiOTIyMjRlMzcwOGM0MGIwYTA5NTU0MTdmYmRkNDExZl80Mzk4MDQ2NTExMTYx_40c9397a-9eda-4f4b-9ea3-cd4e167fb42c"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if6fda2fd6f8d48768196072f7bb18858_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzU0LTAtMS0xLTAvdGV4dHJlZ2lvbjpiOTIyMjRlMzcwOGM0MGIwYTA5NTU0MTdmYmRkNDExZl80_86bad8a9-2ab7-4926-881b-c9c6bdc74ac5"
      unitRef="number">0.03875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="if6fda2fd6f8d48768196072f7bb18858_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzU0LTQtMS0xLTA_efe03cc2-b150-4209-a8c2-71bf5d476e8b"
      unitRef="usd">1228000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i4bbff1e3c5384def9f3f958af9c4560e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzU0LTEwLTEtMS0w_8130ea91-a7b3-4967-a041-c74d04dd9618"
      unitRef="usd">1228000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i3d6a2a39f8a84b30913e25aac3e3a548_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzU1LTAtMS0xLTAvdGV4dHJlZ2lvbjphNDliNGVmMWI5ZDM0NzUwYjk2ZmQwNjIzNWRhYmYxMl80Mzk4MDQ2NTExMTU4_191a65d0-0f57-489d-ab2f-65e7423ca6d7"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3d6a2a39f8a84b30913e25aac3e3a548_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzU1LTAtMS0xLTAvdGV4dHJlZ2lvbjphNDliNGVmMWI5ZDM0NzUwYjk2ZmQwNjIzNWRhYmYxMl80_c8b6e13e-ee41-42df-9d40-1e531bda1320"
      unitRef="number">0.03125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="i3d6a2a39f8a84b30913e25aac3e3a548_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzU1LTQtMS0xLTA_6699e1a7-7fb8-4746-8373-1725f5cc6eae"
      unitRef="usd">965000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt
      contextRef="ie20afa3af1a64c6f892497e7a1ac5f08_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzU1LTEwLTEtMS0w_381a3411-727e-46a7-b6ac-883f3ea4c05d"
      unitRef="usd">965000000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzU2LTQtMS0xLTA_b66f321e-4809-4a5f-9af8-0244b8e51e13"
      unitRef="usd">44632000000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZToxN2I0YzhjNWI3ZmQ0OWMwOGMzMTQ0YTAwYWZhNzM0Yy90YWJsZXJhbmdlOjE3YjRjOGM1YjdmZDQ5YzA4YzMxNDRhMDBhZmE3MzRjXzU2LTEwLTEtMS0w_e6b64abd-abd7-491c-a7e9-e9edc234e0e0"
      unitRef="usd">42280000000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:OtherLongTermDebt
      contextRef="i48f8f3c144a149269121679c024b2bfa_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90ZXh0cmVnaW9uOjU4ODcyNTgwOGZiYjRmYTVhMDEyOTUzNGVhMGZlMDQyXzI3NDg3NzkwNzExODM_99d78482-68df-4467-b174-eda3e75fab7f"
      unitRef="usd">1400000000</us-gaap:OtherLongTermDebt>
    <us-gaap:OtherLongTermDebt
      contextRef="i7e1bde434ad049b7a20e4a7cd97ed39d_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90ZXh0cmVnaW9uOjU4ODcyNTgwOGZiYjRmYTVhMDEyOTUzNGVhMGZlMDQyXzE5Mw_386638ce-6f52-4cbb-9a42-13bfce434445"
      unitRef="usd">1200000000</us-gaap:OtherLongTermDebt>
    <us-gaap:OtherLongTermDebtCurrent
      contextRef="i48f8f3c144a149269121679c024b2bfa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90ZXh0cmVnaW9uOjU4ODcyNTgwOGZiYjRmYTVhMDEyOTUzNGVhMGZlMDQyXzI1OA_4a5baff4-eeeb-4049-b795-de78872e5427"
      unitRef="usd">611000000</us-gaap:OtherLongTermDebtCurrent>
    <us-gaap:OtherLongTermDebtCurrent
      contextRef="i7e1bde434ad049b7a20e4a7cd97ed39d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90ZXh0cmVnaW9uOjU4ODcyNTgwOGZiYjRmYTVhMDEyOTUzNGVhMGZlMDQyXzI2NQ_80805b07-e3ca-4cf3-a721-e14471bd612e"
      unitRef="usd">354000000</us-gaap:OtherLongTermDebtCurrent>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90ZXh0cmVnaW9uOjU4ODcyNTgwOGZiYjRmYTVhMDEyOTUzNGVhMGZlMDQyXzE2NDI_9209c51e-7255-4b0d-9dc0-bbe95c2ac72a">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of short-term borrowings and long-term debt for the years ending December&#160;31 are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZTo4Y2JhY2I4MjA3MDQ0YmZiYjMyZjFiOWM4YzRmNmJjOS90YWJsZXJhbmdlOjhjYmFjYjgyMDcwNDRiZmJiMzJmMWI5YzhjNGY2YmM5XzEtMi0xLTEtMA_c7c58bf4-ffde-4751-8b30-7e9220f3bc0c"
      unitRef="usd">3626000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZTo4Y2JhY2I4MjA3MDQ0YmZiYjMyZjFiOWM4YzRmNmJjOS90YWJsZXJhbmdlOjhjYmFjYjgyMDcwNDRiZmJiMzJmMWI5YzhjNGY2YmM5XzItMi0xLTEtMA_b41e1116-1496-4699-9b2d-ad647e7b3567"
      unitRef="usd">2277000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZTo4Y2JhY2I4MjA3MDQ0YmZiYjMyZjFiOWM4YzRmNmJjOS90YWJsZXJhbmdlOjhjYmFjYjgyMDcwNDRiZmJiMzJmMWI5YzhjNGY2YmM5XzMtMi0xLTEtMA_5ed734f2-577a-442f-af3f-43993e29ebb0"
      unitRef="usd">2652000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZTo4Y2JhY2I4MjA3MDQ0YmZiYjMyZjFiOWM4YzRmNmJjOS90YWJsZXJhbmdlOjhjYmFjYjgyMDcwNDRiZmJiMzJmMWI5YzhjNGY2YmM5XzQtMi0xLTEtMA_38d6f51c-e0f4-4dc6-9a67-2c796b448f70"
      unitRef="usd">2452000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZTo4Y2JhY2I4MjA3MDQ0YmZiYjMyZjFiOWM4YzRmNmJjOS90YWJsZXJhbmdlOjhjYmFjYjgyMDcwNDRiZmJiMzJmMWI5YzhjNGY2YmM5XzUtMi0xLTEtMA_7feae462-f594-4d80-9526-9ef912997ffb"
      unitRef="usd">2652000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90YWJsZTo4Y2JhY2I4MjA3MDQ0YmZiYjMyZjFiOWM4YzRmNmJjOS90YWJsZXJhbmdlOjhjYmFjYjgyMDcwNDRiZmJiMzJmMWI5YzhjNGY2YmM5XzYtMi0xLTEtMA_56c16f4b-2a0a-44a9-a1d1-95cb750ea929"
      unitRef="usd">32829000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i0561a17f67884087afe8d954a4e80ace_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90ZXh0cmVnaW9uOjU4ODcyNTgwOGZiYjRmYTVhMDEyOTUzNGVhMGZlMDQyXzcwNQ_e6b91973-5847-4789-8c64-f6c3ed92c5a5"
      unitRef="usd">5600000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ia6ef4bc76d4e41ef824e2e1bc29be3e8_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90ZXh0cmVnaW9uOjU4ODcyNTgwOGZiYjRmYTVhMDEyOTUzNGVhMGZlMDQyXzcxOQ_3fe12b63-4a55-417a-b8af-ce2899e672ab"
      unitRef="usd">5600000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i3bbc78e491bd48b2bdc3d2454d729af8_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90ZXh0cmVnaW9uOjU4ODcyNTgwOGZiYjRmYTVhMDEyOTUzNGVhMGZlMDQyXzczNw_1da6151f-9c5b-48bb-9a27-aaca41ef4fbc"
      unitRef="usd">3800000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="i601523d6552745a68902337be3e9c7fd_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90ZXh0cmVnaW9uOjU4ODcyNTgwOGZiYjRmYTVhMDEyOTUzNGVhMGZlMDQyXzEzNzE_8eeda170-7d3d-4e7f-a68c-7760ca3a7a68"
      unitRef="number">0.008</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="i3f5ffdfb69764138906dbd2bf76bb89e_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTMvZnJhZzo1ODg3MjU4MDhmYmI0ZmE1YTAxMjk1MzRlYTBmZTA0Mi90ZXh0cmVnaW9uOjU4ODcyNTgwOGZiYjRmYTVhMDEyOTUzNGVhMGZlMDQyXzEzNzc_725b08d1-5279-409a-b9db-8e5d0f06939c"
      unitRef="number">0.009</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90ZXh0cmVnaW9uOmFkYzIxNzZhYjIxNzRmZTA5MjZmMTkwN2I4NTI2YzRlXzMzODY_7992adf3-2cf9-45f6-8ddf-e934d5485f19">Income Taxes &lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The current income tax provision reflects the tax consequences of revenues and expenses currently taxable or deductible on various income tax returns for the year reported. The deferred income tax provision or benefit generally reflects the net change in deferred income tax assets and liabilities during the year, excluding any deferred income tax assets and liabilities of acquired businesses. The components of the provision for income taxes for the years ended December&#160;31 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current Provision:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred provision (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation of the tax provision at the U.S. federal statutory rate to the provision for income taxes and the effective tax rate for the years ended December&#160;31 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions, except percentages)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax provision at the U.S. federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based awards - excess tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(130)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health insurance tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign rate differential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(246)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(324)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred income tax assets and liabilities are recognized for the differences between the financial and income tax reporting bases of assets and liabilities based on enacted tax rates and laws. The components of deferred income tax assets and liabilities as of December&#160;31 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.643%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal and state net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt;text-indent:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nondeductible liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt;text-indent:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. tax loss carryforwards&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other-domestic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other-non-U.S.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: valuation allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(198)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal and state intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,658)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,588)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. goodwill and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(512)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(606)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(833)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(731)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(216)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outside basis in partnerships&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(565)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease right-of-use asset&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,267)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized gains on investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other-non-U.S.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(248)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(350)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,813)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,758)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,265)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,367)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Valuation allowances are provided when it is considered more likely than not deferred tax assets will not be realized. The valuation allowances primarily relate to future tax benefits on certain federal, state and non-U.S. net operating loss carryforwards. Gross federal net operating loss carryforwards of $42 million expire beginning in 2023 through 2037 and $295 million have an indefinite carryforward period; state net operating loss carryforwards expire beginning in 2022 through 2041, with some having an indefinite carryforward period. Substantially all of the non-U.S. tax loss carryforwards have indefinite carryforward periods. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, the Company&#x2019;s undistributed earnings from non-U.S. subsidiaries are intended to be indefinitely reinvested in non-U.S. operations, and therefore no U.S. deferred taxes have been recorded. Taxes payable on the remittance of such earnings would be minimal.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending amount of unrecognized tax benefits as of December&#160;31 is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross unrecognized tax benefits, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross increases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current year tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior year tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross decreases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior year tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(130)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Statute of limitations lapses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross unrecognized tax benefits, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company believes it is reasonably possible its liability for unrecognized tax benefits will decrease in the next twelve months by $42 million as a result of audit settlements and the expiration of statutes of limitations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company classifies net interest and penalties associated with uncertain income tax positions as income taxes within its Consolidated Statements of Operations. During the years ended December&#160;31, 2021, 2020 and 2019, the Company recognized $66 million, $52 million and $19 million of net interest and penalties, respectively. The Company had $194 million and $128 million of accrued interest and penalties for uncertain tax positions as of December&#160;31, 2021 and 2020, respectively. These amounts are not included in the reconciliation above. As of December&#160;31, 2021, there were $1.2 billion of unrecognized tax benefits which, if recognized, would affect the effective tax rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company currently files income tax returns in the United States, various states and localities and non-U.S. jurisdictions. The U.S. Internal Revenue Service (IRS) has completed exams on the consolidated income tax returns for fiscal years 2016 and prior. The Company&#x2019;s 2017 through 2020 tax years are under review by the IRS under its Compliance Assurance Program. With the exception of a few states, the Company is no longer subject to income tax examinations prior to the 2014 tax year. In general, the Company is subject to examination in non-U.S. jurisdictions for years 2015 and forward.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90ZXh0cmVnaW9uOmFkYzIxNzZhYjIxNzRmZTA5MjZmMTkwN2I4NTI2YzRlXzMzNjM_c97bdf42-6f6a-431d-bfb6-6edcf268e4bc">The components of the provision for income taxes for the years ended December&#160;31 are as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current Provision:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred provision (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTowZjBiZDE1NjAyNDc0ODNmYTU3MzE0Y2U2NmY2ZDlhMy90YWJsZXJhbmdlOjBmMGJkMTU2MDI0NzQ4M2ZhNTczMTRjZTY2ZjZkOWEzXzItMi0xLTEtMA_b9068826-981e-46e6-a726-742a98ce2ddb"
      unitRef="usd">3451000000</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTowZjBiZDE1NjAyNDc0ODNmYTU3MzE0Y2U2NmY2ZDlhMy90YWJsZXJhbmdlOjBmMGJkMTU2MDI0NzQ4M2ZhNTczMTRjZTY2ZjZkOWEzXzItNC0xLTEtMA_c284e775-62e9-421d-9263-98c250809b7e"
      unitRef="usd">4098000000</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTowZjBiZDE1NjAyNDc0ODNmYTU3MzE0Y2U2NmY2ZDlhMy90YWJsZXJhbmdlOjBmMGJkMTU2MDI0NzQ4M2ZhNTczMTRjZTY2ZjZkOWEzXzItNi0xLTEtMA_bf363d4a-7e56-4e3e-8171-17f92e95861b"
      unitRef="usd">2629000000</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTowZjBiZDE1NjAyNDc0ODNmYTU3MzE0Y2U2NmY2ZDlhMy90YWJsZXJhbmdlOjBmMGJkMTU2MDI0NzQ4M2ZhNTczMTRjZTY2ZjZkOWEzXzMtMi0xLTEtMA_f4adf8fd-9c21-4d02-a7f1-c31b4fe48463"
      unitRef="usd">481000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTowZjBiZDE1NjAyNDc0ODNmYTU3MzE0Y2U2NmY2ZDlhMy90YWJsZXJhbmdlOjBmMGJkMTU2MDI0NzQ4M2ZhNTczMTRjZTY2ZjZkOWEzXzMtNC0xLTEtMA_460a2816-2284-4798-9c31-964995b89e35"
      unitRef="usd">392000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTowZjBiZDE1NjAyNDc0ODNmYTU3MzE0Y2U2NmY2ZDlhMy90YWJsZXJhbmdlOjBmMGJkMTU2MDI0NzQ4M2ZhNTczMTRjZTY2ZjZkOWEzXzMtNi0xLTEtMA_3e4c683b-cf0f-4a44-ad3d-6b334325cee4"
      unitRef="usd">319000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTowZjBiZDE1NjAyNDc0ODNmYTU3MzE0Y2U2NmY2ZDlhMy90YWJsZXJhbmdlOjBmMGJkMTU2MDI0NzQ4M2ZhNTczMTRjZTY2ZjZkOWEzXzQtMi0xLTEtMA_825a232b-0d63-494d-aa20-b42a0a2bbaff"
      unitRef="usd">516000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTowZjBiZDE1NjAyNDc0ODNmYTU3MzE0Y2U2NmY2ZDlhMy90YWJsZXJhbmdlOjBmMGJkMTU2MDI0NzQ4M2ZhNTczMTRjZTY2ZjZkOWEzXzQtNC0xLTEtMA_18424d93-91ce-4611-bad0-2020a2d730c6"
      unitRef="usd">491000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTowZjBiZDE1NjAyNDc0ODNmYTU3MzE0Y2U2NmY2ZDlhMy90YWJsZXJhbmdlOjBmMGJkMTU2MDI0NzQ4M2ZhNTczMTRjZTY2ZjZkOWEzXzQtNi0xLTEtMA_dbddef3b-6c81-40af-bcc8-70b846f8004d"
      unitRef="usd">564000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTowZjBiZDE1NjAyNDc0ODNmYTU3MzE0Y2U2NmY2ZDlhMy90YWJsZXJhbmdlOjBmMGJkMTU2MDI0NzQ4M2ZhNTczMTRjZTY2ZjZkOWEzXzUtMi0xLTEtMA_3cec638a-cd7e-48a0-98fb-9250a8d6fda5"
      unitRef="usd">4448000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTowZjBiZDE1NjAyNDc0ODNmYTU3MzE0Y2U2NmY2ZDlhMy90YWJsZXJhbmdlOjBmMGJkMTU2MDI0NzQ4M2ZhNTczMTRjZTY2ZjZkOWEzXzUtNC0xLTEtMA_2b5d5b3a-84d8-4e55-b929-0b541d1128ee"
      unitRef="usd">4981000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTowZjBiZDE1NjAyNDc0ODNmYTU3MzE0Y2U2NmY2ZDlhMy90YWJsZXJhbmdlOjBmMGJkMTU2MDI0NzQ4M2ZhNTczMTRjZTY2ZjZkOWEzXzUtNi0xLTEtMA_58070a9f-bbf4-4bdb-9f46-82fa380b5c22"
      unitRef="usd">3512000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTowZjBiZDE1NjAyNDc0ODNmYTU3MzE0Y2U2NmY2ZDlhMy90YWJsZXJhbmdlOjBmMGJkMTU2MDI0NzQ4M2ZhNTczMTRjZTY2ZjZkOWEzXzYtMi0xLTEtMA_d1ed3769-0f92-4fb5-a6d6-d2358e6cbf6d"
      unitRef="usd">130000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTowZjBiZDE1NjAyNDc0ODNmYTU3MzE0Y2U2NmY2ZDlhMy90YWJsZXJhbmdlOjBmMGJkMTU2MDI0NzQ4M2ZhNTczMTRjZTY2ZjZkOWEzXzYtNC0xLTEtMA_ced7ebee-0bf8-40b3-9575-bba392a38d72"
      unitRef="usd">-8000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTowZjBiZDE1NjAyNDc0ODNmYTU3MzE0Y2U2NmY2ZDlhMy90YWJsZXJhbmdlOjBmMGJkMTU2MDI0NzQ4M2ZhNTczMTRjZTY2ZjZkOWEzXzYtNi0xLTEtMA_cfe000fe-d40a-48b4-9fa2-13296f69b945"
      unitRef="usd">230000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTowZjBiZDE1NjAyNDc0ODNmYTU3MzE0Y2U2NmY2ZDlhMy90YWJsZXJhbmdlOjBmMGJkMTU2MDI0NzQ4M2ZhNTczMTRjZTY2ZjZkOWEzXzctMi0xLTEtMA_9b948110-43f8-4903-b982-1ab9d37e0446"
      unitRef="usd">4578000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTowZjBiZDE1NjAyNDc0ODNmYTU3MzE0Y2U2NmY2ZDlhMy90YWJsZXJhbmdlOjBmMGJkMTU2MDI0NzQ4M2ZhNTczMTRjZTY2ZjZkOWEzXzctNC0xLTEtMA_87f12374-6a7b-4473-8bd5-0e1b616bd934"
      unitRef="usd">4973000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTowZjBiZDE1NjAyNDc0ODNmYTU3MzE0Y2U2NmY2ZDlhMy90YWJsZXJhbmdlOjBmMGJkMTU2MDI0NzQ4M2ZhNTczMTRjZTY2ZjZkOWEzXzctNi0xLTEtMA_fa953ac1-85bd-4096-9115-782ac5653881"
      unitRef="usd">3742000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90ZXh0cmVnaW9uOmFkYzIxNzZhYjIxNzRmZTA5MjZmMTkwN2I4NTI2YzRlXzMzNjA_e789957a-ec66-4b2a-9ff0-83a86abd2374">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation of the tax provision at the U.S. federal statutory rate to the provision for income taxes and the effective tax rate for the years ended December&#160;31 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions, except percentages)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax provision at the U.S. federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based awards - excess tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(130)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health insurance tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign rate differential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(246)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(324)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzEtMi0xLTEtMA_3bfe103b-4554-49c5-ab25-4f2aa5bbd583"
      unitRef="usd">4685000000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzEtNC0xLTEtMA_768bec25-9d2a-48fd-847c-1252d97b9edb"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzEtNi0xLTEtMA_3ccccbba-28f4-494b-9f7f-44b9b445819f"
      unitRef="usd">4356000000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzEtOC0xLTEtMA_9ca8cf1e-54fe-4e0b-88a4-1c577c3cac95"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzEtMTAtMS0xLTA_e0fc5a15-3578-4406-a50d-7e029699e0cd"
      unitRef="usd">3776000000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzEtMTItMS0xLTA_3bbc1a76-5c39-4def-9d09-38ac78351086"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzItMi0xLTEtMA_b28ddc87-4214-4e4d-b973-7f8e4eb52f23"
      unitRef="usd">419000000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzItNC0xLTEtMA_69a39e03-a04c-4b2c-acee-d9d06618499a"
      unitRef="number">0.019</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzItNi0xLTEtMA_d24fda1e-064b-4ab1-aa46-44b99f58df13"
      unitRef="usd">315000000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzItOC0xLTEtMA_df7f3d69-8463-4172-9c23-9f5db74ac6d8"
      unitRef="number">0.015</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzItMTAtMS0xLTA_5225b840-c5b1-4177-8242-3ad050b13ea6"
      unitRef="usd">271000000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzItMTItMS0xLTA_5d5de823-5292-4791-828a-8870ff86b668"
      unitRef="number">0.015</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <unh:EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzMtMi0xLTEtMA_05590a99-3547-40b2-8e50-f2e78202a266"
      unitRef="usd">-100000000</unh:EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount>
    <unh:EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzMtNC0xLTEtMA_4e660c1d-1a2f-42d5-aa91-20f45a20cb10"
      unitRef="number">-0.004</unh:EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent>
    <unh:EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzMtNi0xLTEtMA_09cecb95-87f4-47c1-9518-5fc448955afc"
      unitRef="usd">-130000000</unh:EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount>
    <unh:EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzMtOC0xLTEtMA_40a5eb82-7b3e-4fd6-92a9-5c9fde15f3ce"
      unitRef="number">-0.006</unh:EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent>
    <unh:EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzMtMTAtMS0xLTA_d7daa753-0ecf-4b07-943d-06e6dd2248d8"
      unitRef="usd">-132000000</unh:EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount>
    <unh:EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzMtMTItMS0xLTA_f59af26f-45fd-4214-a841-9c7302999206"
      unitRef="number">-0.007</unh:EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzQtMi0xLTEtMA_c2556acf-a18e-45f8-b014-ac290dcce3ed"
      unitRef="usd">144000000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzQtNC0xLTEtMA_7b509ce1-a0e1-4a7c-bdf7-0924bcbb007d"
      unitRef="number">0.006</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzQtNi0xLTEtMA_10a8760d-8aa5-491b-9a8a-141588f2165d"
      unitRef="usd">134000000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzQtOC0xLTEtMA_0fb93d4a-8d8b-42c8-bd5f-40fb62ec831c"
      unitRef="number">0.007</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzQtMTAtMS0xLTA_d02a85c5-afea-41ef-a206-6f8c83c0813c"
      unitRef="usd">119000000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzQtMTItMS0xLTA_0d4287ad-1c63-4552-be8b-87feeb4f6eb7"
      unitRef="number">0.007</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <unh:EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzUtMi0xLTEtMA_5444fc1b-8272-4644-abb7-7113d276e0ca"
      unitRef="usd">0</unh:EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount>
    <unh:EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzUtNC0xLTEtMA_c9fd04df-80e5-4f6e-a4c8-7711dee6e5b5"
      unitRef="number">0</unh:EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent>
    <unh:EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzUtNi0xLTEtMA_aa841326-7c91-49dc-a66d-f6a66bcc7daf"
      unitRef="usd">626000000</unh:EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount>
    <unh:EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzUtOC0xLTEtMA_465f484f-75f4-4264-a8d3-2ae021271196"
      unitRef="number">0.030</unh:EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent>
    <unh:EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzUtMTAtMS0xLTA_3aa6d672-5909-4e1d-a712-728b90645884"
      unitRef="usd">0</unh:EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount>
    <unh:EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzUtMTItMS0xLTA_d88f7984-c7f1-4742-8990-a4fc16545f5b"
      unitRef="number">0</unh:EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzYtMi0xLTEtMA_f76c7b5c-686c-4a36-bfa4-daad4beb770a"
      unitRef="usd">-246000000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzYtNC0xLTEtMA_1c5a70ca-4a34-42e6-b68c-0546cbcdc977"
      unitRef="number">-0.011</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzYtNi0xLTEtMA_d1bab9c2-27c5-4739-971c-1ff24b1d2bea"
      unitRef="usd">-164000000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzYtOC0xLTEtMA_b1f8c670-6d48-43dc-8609-125773ebf7a1"
      unitRef="number">-0.008</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzYtMTAtMS0xLTA_28f1befb-ba17-4546-846a-a93f050d6e58"
      unitRef="usd">-214000000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzYtMTItMS0xLTA_45dbac10-7303-49f9-9b2f-6f07838a712f"
      unitRef="number">-0.012</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzctMi0xLTEtMA_746328b1-8ec9-4284-9de9-d071570a732e"
      unitRef="usd">-324000000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzctNC0xLTEtMA_b869687a-0a71-4800-b099-c65aa6ba2836"
      unitRef="number">-0.015</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzctNi0xLTEtMA_c7616c1e-5856-495d-8129-7168a39e9559"
      unitRef="usd">-164000000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzctOC0xLTEtMA_dbc40233-4f37-4d2b-974d-009aa710e845"
      unitRef="number">-0.008</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzctMTAtMS0xLTA_6e5e7c93-1692-491b-85d2-820784cb6c59"
      unitRef="usd">-78000000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzctMTItMS0xLTA_fc0198cc-1512-40cc-97e4-6babde447262"
      unitRef="number">-0.005</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzgtMi0xLTEtMA_06dab998-1b36-433e-b954-23f43ab3e75a"
      unitRef="usd">4578000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzgtNC0xLTEtMA_ed0bbb2f-1324-4609-9561-5ca87625d14f"
      unitRef="number">0.205</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzgtNi0xLTEtMA_2df9d69b-1bd2-431d-abc7-eb182dda0359"
      unitRef="usd">4973000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzgtOC0xLTEtMA_2af3691f-faff-4afc-89fb-c66c379000c3"
      unitRef="number">0.240</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzgtMTAtMS0xLTA_0b7f1d02-0392-4a8c-bc4d-6b0d14458adc"
      unitRef="usd">3742000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTozZDYzZmZhMmU0NmU0YmU5OWNlODE0NDc3OGUzMjg5Ni90YWJsZXJhbmdlOjNkNjNmZmEyZTQ2ZTRiZTk5Y2U4MTQ0Nzc4ZTMyODk2XzgtMTItMS0xLTA_a8a90e02-7050-43a4-a406-513fb1717532"
      unitRef="number">0.208</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90ZXh0cmVnaW9uOmFkYzIxNzZhYjIxNzRmZTA5MjZmMTkwN2I4NTI2YzRlXzMzNzA_da3928b3-546e-4dd7-bb55-c45b316e7af3">The components of deferred income tax assets and liabilities as of December&#160;31 are as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.643%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal and state net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt;text-indent:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nondeductible liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt;text-indent:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. tax loss carryforwards&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other-domestic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other-non-U.S.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: valuation allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(198)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal and state intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,658)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,588)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. goodwill and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(512)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(606)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(833)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(731)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(216)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outside basis in partnerships&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(565)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease right-of-use asset&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,267)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized gains on investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other-non-U.S.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(248)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(350)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,813)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,758)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,265)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,367)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzItMi0xLTEtMA_36d07069-2118-4ab2-8ca1-6ee767a61b8f"
      unitRef="usd">723000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzItNC0xLTEtMA_4d46469e-5c58-4c49-82cc-d1bf0e45d4d3"
      unitRef="usd">815000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzMtMi0xLTEtMA_70904e06-25d1-490b-b0e3-049e7a14cd99"
      unitRef="usd">287000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzMtNC0xLTEtMA_074d354a-bf51-4789-881c-eab832872f59"
      unitRef="usd">276000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzQtMi0xLTEtMA_513d6363-7d95-4874-8104-4a94fbb1052b"
      unitRef="usd">117000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzQtNC0xLTEtMA_cb8b1380-bdcd-4ddf-94d5-2384264ecff2"
      unitRef="usd">98000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <unh:DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzUtMi0xLTEtMA_a855663b-938e-4911-9e9e-74f89b454fd2"
      unitRef="usd">296000000</unh:DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities>
    <unh:DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzUtNC0xLTEtMA_68bb5735-f75e-4495-9d64-f868e00a3a34"
      unitRef="usd">252000000</unh:DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzYtMi0xLTEtMA_4374a154-201d-4b4d-b098-decff91b4fde"
      unitRef="usd">435000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzYtNC0xLTEtMA_ea4f72f8-6624-4d05-90d2-07e3ae1cab0c"
      unitRef="usd">340000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <unh:DeferredTaxAssetsLeaseLiability
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzctMi0xLTEtMA_c24b272f-b604-499f-aeca-a62be6a276cf"
      unitRef="usd">1284000000</unh:DeferredTaxAssetsLeaseLiability>
    <unh:DeferredTaxAssetsLeaseLiability
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzctNC0xLTEtMA_0bc906b9-f28c-4ce1-a7cb-9fba164eafa0"
      unitRef="usd">1200000000</unh:DeferredTaxAssetsLeaseLiability>
    <unh:DeferredTaxAssetOtherDomestic
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzgtMi0xLTEtMA_c50a64aa-fdf1-477d-acb8-ec4964874e4a"
      unitRef="usd">228000000</unh:DeferredTaxAssetOtherDomestic>
    <unh:DeferredTaxAssetOtherDomestic
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzgtNC0xLTEtMA_ca18c97f-68e1-44b7-b407-66a7f89ed6c2"
      unitRef="usd">126000000</unh:DeferredTaxAssetOtherDomestic>
    <unh:DeferredTaxAssetOtherForeign
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzktMi0xLTEtMA_9b7005ad-58ca-455d-a2c5-2089238f14fe"
      unitRef="usd">376000000</unh:DeferredTaxAssetOtherForeign>
    <unh:DeferredTaxAssetOtherForeign
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzktNC0xLTEtMA_55db8007-7270-4e18-8cf1-1ba2f8e9c4b2"
      unitRef="usd">454000000</unh:DeferredTaxAssetOtherForeign>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzEwLTItMS0xLTA_1cc6f329-b11c-4fd3-86de-d50428cc37c8"
      unitRef="usd">3746000000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzEwLTQtMS0xLTA_7ff1c467-a320-4afe-8201-30e3bfdaf6d8"
      unitRef="usd">3561000000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzExLTItMS0xLTA_2e843d55-7034-45ed-8955-a1a347a0b0fd"
      unitRef="usd">198000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzExLTQtMS0xLTA_4d22fdae-0b40-4753-a334-20f0cde1df60"
      unitRef="usd">170000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzEyLTItMS0xLTA_3604feea-5415-4340-88e2-c9f68b24a3ee"
      unitRef="usd">3548000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzEyLTQtMS0xLTA_70f7d65e-d7c7-4b99-889d-b18f5363d793"
      unitRef="usd">3391000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzE0LTItMS0xLTA_72592cea-af3d-450c-8cbb-3abd9ceaae84"
      unitRef="usd">2658000000</us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets>
    <us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzE0LTQtMS0xLTA_0faa29ee-68d0-408c-ba51-dcbd3d4a2f3b"
      unitRef="usd">2588000000</us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets>
    <unh:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzE1LTItMS0xLTA_eec02db2-362e-4567-a586-0b092acaae50"
      unitRef="usd">512000000</unh:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign>
    <unh:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzE1LTQtMS0xLTA_8f25245d-4dc8-484a-bddd-dc6d52eb1f15"
      unitRef="usd">606000000</unh:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzE2LTItMS0xLTA_55e60379-b7d7-4240-b7cd-be438a6ae032"
      unitRef="usd">833000000</us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzE2LTQtMS0xLTA_0a787dff-1c2b-4ad3-8b26-18b89f523f74"
      unitRef="usd">731000000</us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzE3LTItMS0xLTA_4ac80a1f-e9e1-4fcc-be21-b4b63dc4a0a9"
      unitRef="usd">349000000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzE3LTQtMS0xLTA_560bd559-c670-4bd5-9ca7-5df3a64acc74"
      unitRef="usd">346000000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPrepaidExpenses
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzE4LTItMS0xLTA_227d56bf-fee1-440c-9499-466cbc152ff3"
      unitRef="usd">256000000</us-gaap:DeferredTaxLiabilitiesPrepaidExpenses>
    <us-gaap:DeferredTaxLiabilitiesPrepaidExpenses
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzE4LTQtMS0xLTA_61173b56-e5b1-4485-9707-a6dc498b0c44"
      unitRef="usd">216000000</us-gaap:DeferredTaxLiabilitiesPrepaidExpenses>
    <us-gaap:DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzE5LTItMS0xLTA_5ccdb943-4529-4681-a498-0a4db1e7a164"
      unitRef="usd">565000000</us-gaap:DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates>
    <us-gaap:DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzE5LTQtMS0xLTA_ff3a2cde-8311-4a80-b374-172dba414247"
      unitRef="usd">342000000</us-gaap:DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzIwLTItMS0xLTA_c88cb8f5-66ba-4fba-8184-f9203278707b"
      unitRef="usd">1267000000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzIwLTQtMS0xLTA_83f4726b-1868-4f03-8389-55cb576e772a"
      unitRef="usd">1179000000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <unh:DeferredTaxLiabilityOtherDomestic
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzIxLTItMS0xLTA_ab32b41e-62b2-4ce1-b061-b4d2d5d60aea"
      unitRef="usd">125000000</unh:DeferredTaxLiabilityOtherDomestic>
    <unh:DeferredTaxLiabilityOtherDomestic
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzIxLTQtMS0xLTA_5ea71cbe-1c6f-42fc-a7c1-886d0f93a9fa"
      unitRef="usd">400000000</unh:DeferredTaxLiabilityOtherDomestic>
    <unh:DeferredTaxLiabilityOtherForeign
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzIyLTItMS0xLTA_c739a396-bc41-4f23-afc3-419551702a5f"
      unitRef="usd">248000000</unh:DeferredTaxLiabilityOtherForeign>
    <unh:DeferredTaxLiabilityOtherForeign
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzIyLTQtMS0xLTA_1a4e76c7-45f2-4588-aedb-7eb4051ddba2"
      unitRef="usd">350000000</unh:DeferredTaxLiabilityOtherForeign>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzIzLTItMS0xLTA_2434c555-b2c0-4d61-ba43-a0b9923766b3"
      unitRef="usd">6813000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzIzLTQtMS0xLTA_7487673e-5368-4aa9-91ec-c9ec2f135dec"
      unitRef="usd">6758000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzI0LTItMS0xLTA_388f656f-4896-4eed-a577-ff9ed52c9e1b"
      unitRef="usd">3265000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZTo1NjJiZDM3M2U5MGQ0MDA3ODM0ZDQzNDhiYTgwMzMyZC90YWJsZXJhbmdlOjU2MmJkMzczZTkwZDQwMDc4MzRkNDM0OGJhODAzMzJkXzI0LTQtMS0xLTA_0c90f847-b52e-4888-8e90-c5cfb574f8a2"
      unitRef="usd">3367000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:OperatingLossCarryforwards
      contextRef="iafeb038504b84584996f9cd39f452b04_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90ZXh0cmVnaW9uOmFkYzIxNzZhYjIxNzRmZTA5MjZmMTkwN2I4NTI2YzRlXzEzMDA_fdc99182-cdac-4fa3-9aa5-158b57fa3ac6"
      unitRef="usd">42000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="if8b73857161d431fabb907fdd770e42f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90ZXh0cmVnaW9uOmFkYzIxNzZhYjIxNzRmZTA5MjZmMTkwN2I4NTI2YzRlXzEzNDE_2ae8069b-b01b-436e-bcf6-72c976132c16"
      unitRef="usd">295000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90ZXh0cmVnaW9uOmFkYzIxNzZhYjIxNzRmZTA5MjZmMTkwN2I4NTI2YzRlXzMzODg_3385f33f-40c8-437a-aba3-f7be88e638e8">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending amount of unrecognized tax benefits as of December&#160;31 is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross unrecognized tax benefits, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross increases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current year tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior year tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross decreases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior year tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(130)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Statute of limitations lapses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross unrecognized tax benefits, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzEtMi0xLTEtMA_6a5cf128-5038-4c84-bfc8-6f7bbda3dc4d"
      unitRef="usd">1829000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i530caf840d4847f1ac553be5f7b336b2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzEtNC0xLTEtMA_1e28b515-9bf8-471d-b593-49ae470344a1"
      unitRef="usd">1423000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i870730cd9dfc45bb89971499ab4cdd48_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzEtNi0xLTEtMA_d40cad28-6e44-4c02-99a8-c2858d876bdd"
      unitRef="usd">1056000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzMtMi0xLTEtMA_8c30d15d-6551-4c4f-8b37-e464901ba803"
      unitRef="usd">538000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzMtNC0xLTEtMA_a6fd5a17-22ae-4dc2-a4e4-4d50901c2ddf"
      unitRef="usd">416000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzMtNi0xLTEtMA_504088f2-eaea-4bff-abc6-8b048861b9af"
      unitRef="usd">512000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzQtMi0xLTEtMA_efb48165-eb37-4d4a-92a5-605a10fbe4f9"
      unitRef="usd">10000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzQtNC0xLTEtMA_ec658288-4b0e-4f5f-9e52-14a66cd4c5c7"
      unitRef="usd">120000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzQtNi0xLTEtMA_19b8008d-3368-44c4-8e6d-9d18c5eb2f96"
      unitRef="usd">2000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzYtMi0xLTEtMA_a1a0abab-9eb3-4ed4-aa4e-851bb41894cf"
      unitRef="usd">47000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzYtNC0xLTEtMA_317c4dd7-ae38-4101-8d9c-472e365c75a9"
      unitRef="usd">130000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzYtNi0xLTEtMA_d80cfb38-652c-47c0-aec2-5660a9d3e477"
      unitRef="usd">96000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzctMi0xLTEtMA_0d4ee3fd-8705-4314-a5d4-a300d6e6fb35"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzctNC0xLTEtMA_41e1e619-d801-4102-87db-09eaa0d1d6fd"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzctNi0xLTEtMA_be52faae-495c-483b-8a08-1d00d86a4e7c"
      unitRef="usd">46000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzgtMi0xLTEtMA_0ff3b6f7-6f74-4b1f-87b8-3f8409a46f1f"
      unitRef="usd">20000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzgtNC0xLTEtMA_40832896-24e5-45e2-80f0-945b958352b6"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzgtNi0xLTEtMA_55f85fc8-f880-4c52-adba-f2e092dd465d"
      unitRef="usd">5000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzktMi0xLTEtMA_149f7963-6c00-4669-8d2f-82130b0e0d99"
      unitRef="usd">2310000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzktNC0xLTEtMA_94b07953-c12a-46c9-81ed-9ccb3f1ca6ef"
      unitRef="usd">1829000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i530caf840d4847f1ac553be5f7b336b2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90YWJsZToxY2IyNmY2MTIwMGE0NTA4ODkwZjllMzM1NjE1ZWZjOS90YWJsZXJhbmdlOjFjYjI2ZjYxMjAwYTQ1MDg4OTBmOWUzMzU2MTVlZmM5XzktNi0xLTEtMA_66626bfc-a0d2-4fd9-b185-73f244bedf40"
      unitRef="usd">1423000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90ZXh0cmVnaW9uOmFkYzIxNzZhYjIxNzRmZTA5MjZmMTkwN2I4NTI2YzRlXzIxMjI_134e518a-2f0c-4551-99fe-866b6f4b668f"
      unitRef="usd">42000000</us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90ZXh0cmVnaW9uOmFkYzIxNzZhYjIxNzRmZTA5MjZmMTkwN2I4NTI2YzRlXzI0MjU_dc147eab-a0d8-426d-b025-b233041f70fd"
      unitRef="usd">66000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90ZXh0cmVnaW9uOmFkYzIxNzZhYjIxNzRmZTA5MjZmMTkwN2I4NTI2YzRlXzI0Mjk_87958a8f-491d-43ab-a40b-fc27071cd2ce"
      unitRef="usd">52000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90ZXh0cmVnaW9uOmFkYzIxNzZhYjIxNzRmZTA5MjZmMTkwN2I4NTI2YzRlXzI0MzY_fbbf25b1-8da5-45d8-98c6-94bf2b8eed2f"
      unitRef="usd">19000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90ZXh0cmVnaW9uOmFkYzIxNzZhYjIxNzRmZTA5MjZmMTkwN2I4NTI2YzRlXzI0OTY_24489e26-e382-448b-aad0-9c630d3d4fa4"
      unitRef="usd">194000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90ZXh0cmVnaW9uOmFkYzIxNzZhYjIxNzRmZTA5MjZmMTkwN2I4NTI2YzRlXzI1MDM_5c740960-89a9-4aba-95bd-e849952ce920"
      unitRef="usd">128000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90ZXh0cmVnaW9uOmFkYzIxNzZhYjIxNzRmZTA5MjZmMTkwN2I4NTI2YzRlXzI2ODA_5c71e267-de4f-4392-8b14-fa05abd3c247"
      unitRef="usd">1200000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:OpenTaxYear
      contextRef="i594ed33a64c84c5383f969319b50d190_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90ZXh0cmVnaW9uOmFkYzIxNzZhYjIxNzRmZTA5MjZmMTkwN2I4NTI2YzRlXzI3NDg3NzkwNzI4Njc_5fdea5ca-2322-4038-a4c0-bd7616617a41">2017</us-gaap:OpenTaxYear>
    <us-gaap:OpenTaxYear
      contextRef="i065ef157d8a74b71a4c8ba538486d487_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90ZXh0cmVnaW9uOmFkYzIxNzZhYjIxNzRmZTA5MjZmMTkwN2I4NTI2YzRlXzI3NDg3NzkwNzI4NzQ_b5c35318-f3ca-492c-961b-11b235ed07c5">2020</us-gaap:OpenTaxYear>
    <us-gaap:OpenTaxYear
      contextRef="i74609445052240d09613244522e25dba_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90ZXh0cmVnaW9uOmFkYzIxNzZhYjIxNzRmZTA5MjZmMTkwN2I4NTI2YzRlXzMyNDc_c6a227fa-c31f-4179-af9f-3d8befa4c5d7">2014</us-gaap:OpenTaxYear>
    <us-gaap:OpenTaxYear
      contextRef="i44dc783f612e43b28b4d406b49e67429_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8xOTkvZnJhZzphZGMyMTc2YWIyMTc0ZmUwOTI2ZjE5MDdiODUyNmM0ZS90ZXh0cmVnaW9uOmFkYzIxNzZhYjIxNzRmZTA5MjZmMTkwN2I4NTI2YzRlXzMzNDY_e63a5ea2-8365-4dcc-87d9-a6d3304191c9">2015</us-gaap:OpenTaxYear>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90ZXh0cmVnaW9uOjMzMzI1MTVmM2U4NjRkMzM5YTkyY2Y3YjZjNjliNjRjXzE2NDkyNjc0NDUxMTM_96fac73c-a832-4d60-b236-1323715199f4">Shareholders' Equity&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Regulatory Capital and Dividend Restrictions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s regulated insurance and health maintenance organization (HMO) subsidiaries are subject to regulations and standards in their respective jurisdictions. These standards, among other things, require these subsidiaries to maintain specified levels of statutory capital, as defined by each jurisdiction, and restrict the timing and amount of dividends and other distributions which may be paid to their parent companies. In the United States, most of these state regulations and standards are generally consistent with model regulations established by the National Association of Insurance Commissioners. These standards generally permit dividends to be paid from statutory unassigned surplus of the regulated subsidiary and are limited based on the regulated subsidiary&#x2019;s level of statutory net income and statutory capital and surplus. These dividends are referred to as &#x201c;ordinary dividends&#x201d; and generally may be paid without prior regulatory approval. If the dividend, together with other dividends paid within the preceding twelve months, exceeds a specified statutory limit or is paid from sources other than earned surplus, it is generally considered an &#x201c;extraordinary dividend&#x201d; and must receive prior regulatory approval. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the year ended December&#160;31, 2021, the Company&#x2019;s domestic insurance and HMO subsidiaries paid their parent companies dividends of $8.0 billion, including $4.7 billion of extraordinary dividends. For the year ended December&#160;31, 2020, the Company&#x2019;s domestic insurance and HMO subsidiaries paid their parent companies dividends of $8.3 billion, including $4.2 billion of extraordinary dividends.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's global financially regulated subsidiaries had estimated aggregate statutory capital and surplus of $30.7 billion as of December&#160;31, 2021. The estimated statutory capital and surplus necessary to satisfy regulatory requirements of the Company's global financially regulated subsidiaries was approximately $13.0 billion as of December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Optum Bank must meet minimum capital requirements of the Federal Deposit Insurance Corporation (FDIC) under the capital adequacy rules to which it is subject. At December&#160;31, 2021, the Company believes Optum Bank met the FDIC requirements to be considered &#x201c;Well Capitalized.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under its Board of Directors&#x2019; authorization, the Company maintains a share repurchase program. The objectives of the share repurchase program are to optimize the Company&#x2019;s capital structure and cost of capital, thereby improving returns to shareholders, as well as to offset the dilutive impact of share-based awards. Repurchases may be made from time to time in open market purchases or other types of transactions (including prepaid or structured share repurchase programs), subject to certain Board restrictions. In June 2018, the Board renewed the Company&#x2019;s share repurchase program with an authorization to repurchase up to 100 million shares of its common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of common share repurchases for the years ended December&#160;31, 2021 and 2020 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common share repurchases, shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common share repurchases, average price per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common share repurchases, aggregate cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Board authorized shares remaining&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2021, the Company&#x2019;s Board of Directors increased the Company&#x2019;s quarterly cash dividend to shareholders to an annual rate of $5.80 compared to $5.00 per share, which the Company had paid since June 2020. Declaration and payment of future quarterly dividends is at the discretion of the Board and may be adjusted as business needs or market conditions change.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides details of the Company&#x2019;s 2021 dividend payments:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Payment Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Amount Paid&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 29&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 21&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90ZXh0cmVnaW9uOjMzMzI1MTVmM2U4NjRkMzM5YTkyY2Y3YjZjNjliNjRjXzE0MzI_9d3a86f3-c6d7-4eb4-80e7-b0ca33de6cae"
      unitRef="usd">8000000000</us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries>
    <us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries
      contextRef="i195ad038ae66447ea9bbab80147223bf_D20210101-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90ZXh0cmVnaW9uOjMzMzI1MTVmM2U4NjRkMzM5YTkyY2Y3YjZjNjliNjRjXzE0NDY_cd0502cb-18e4-48e9-a721-070d0415de04"
      unitRef="usd">4700000000</us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries>
    <us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90ZXh0cmVnaW9uOjMzMzI1MTVmM2U4NjRkMzM5YTkyY2Y3YjZjNjliNjRjXzE1OTU_8e41ebda-616f-4320-a0cc-65b450575987"
      unitRef="usd">8300000000</us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries>
    <us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries
      contextRef="i92e4aa62eb95430a95cec0efea49c225_D20200101-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90ZXh0cmVnaW9uOjMzMzI1MTVmM2U4NjRkMzM5YTkyY2Y3YjZjNjliNjRjXzE2MDk_3a777c57-8043-4e8a-9f35-8b5869a2b178"
      unitRef="usd">4200000000</us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries>
    <us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90ZXh0cmVnaW9uOjMzMzI1MTVmM2U4NjRkMzM5YTkyY2Y3YjZjNjliNjRjXzE3NTM_0b994a80-36ba-4a30-8aed-4fe74e819837"
      unitRef="usd">30700000000</us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance>
    <us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90ZXh0cmVnaW9uOjMzMzI1MTVmM2U4NjRkMzM5YTkyY2Y3YjZjNjliNjRjXzE5MzI_047b8453-358f-4278-af76-f73f69e22460"
      unitRef="usd">13000000000</us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="ifb118b1801aa4f9894e91cda550c9801_I20180601"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90ZXh0cmVnaW9uOjMzMzI1MTVmM2U4NjRkMzM5YTkyY2Y3YjZjNjliNjRjXzI4NjA_aea0439f-c370-49c5-a2c6-efbf78fe7e8f"
      unitRef="shares">100000000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:ScheduleOfStockByClassTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90ZXh0cmVnaW9uOjMzMzI1MTVmM2U4NjRkMzM5YTkyY2Y3YjZjNjliNjRjXzM0MzQ_7daca0b1-7ee0-47b1-876a-efc3e031ca97">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of common share repurchases for the years ended December&#160;31, 2021 and 2020 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common share repurchases, shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common share repurchases, average price per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common share repurchases, aggregate cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Board authorized shares remaining&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockByClassTextBlock>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90YWJsZTo2MWY2MWU0NzhhZDM0MjNmOWQ2NWEwYmUzZDcxMmQxMS90YWJsZXJhbmdlOjYxZjYxZTQ3OGFkMzQyM2Y5ZDY1YTBiZTNkNzEyZDExXzItNC0xLTEtMA_25e75740-d859-4b88-a98b-79f8fdd99a84"
      unitRef="shares">13000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90YWJsZTo2MWY2MWU0NzhhZDM0MjNmOWQ2NWEwYmUzZDcxMmQxMS90YWJsZXJhbmdlOjYxZjYxZTQ3OGFkMzQyM2Y5ZDY1YTBiZTNkNzEyZDExXzItNi0xLTEtMA_966ae36a-1e0a-4cd4-87d4-7d40679361cf"
      unitRef="shares">14000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90YWJsZTo2MWY2MWU0NzhhZDM0MjNmOWQ2NWEwYmUzZDcxMmQxMS90YWJsZXJhbmdlOjYxZjYxZTQ3OGFkMzQyM2Y5ZDY1YTBiZTNkNzEyZDExXzMtNC0xLTEtMA_985fc94a-d22d-4049-9d0f-53f493267a4b"
      unitRef="usdPerShare">389.92</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90YWJsZTo2MWY2MWU0NzhhZDM0MjNmOWQ2NWEwYmUzZDcxMmQxMS90YWJsZXJhbmdlOjYxZjYxZTQ3OGFkMzQyM2Y5ZDY1YTBiZTNkNzEyZDExXzMtNi0xLTEtMA_42f2b132-f5fa-417f-9382-488a927bfdcc"
      unitRef="usdPerShare">300.58</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90YWJsZTo2MWY2MWU0NzhhZDM0MjNmOWQ2NWEwYmUzZDcxMmQxMS90YWJsZXJhbmdlOjYxZjYxZTQ3OGFkMzQyM2Y5ZDY1YTBiZTNkNzEyZDExXzQtNC0xLTEtMA_9f9d439d-02db-4154-acd7-572d29e3f57b"
      unitRef="usd">5000000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90YWJsZTo2MWY2MWU0NzhhZDM0MjNmOWQ2NWEwYmUzZDcxMmQxMS90YWJsZXJhbmdlOjYxZjYxZTQ3OGFkMzQyM2Y5ZDY1YTBiZTNkNzEyZDExXzQtNi0xLTEtMA_4c2bebb2-6726-462d-8d2f-e9d8d69841a6"
      unitRef="usd">4250000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90YWJsZTo2MWY2MWU0NzhhZDM0MjNmOWQ2NWEwYmUzZDcxMmQxMS90YWJsZXJhbmdlOjYxZjYxZTQ3OGFkMzQyM2Y5ZDY1YTBiZTNkNzEyZDExXzUtNC0xLTEtMA_50be0df7-2404-46d8-a6b9-b64b7112ccaf"
      unitRef="shares">45000000</us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90YWJsZTo2MWY2MWU0NzhhZDM0MjNmOWQ2NWEwYmUzZDcxMmQxMS90YWJsZXJhbmdlOjYxZjYxZTQ3OGFkMzQyM2Y5ZDY1YTBiZTNkNzEyZDExXzUtNi0xLTEtMA_24481942-41ce-42b6-bf5d-f1929aa8565d"
      unitRef="shares">58000000</us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:DividendsDeclaredTableTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90ZXh0cmVnaW9uOjMzMzI1MTVmM2U4NjRkMzM5YTkyY2Y3YjZjNjliNjRjXzE2NDkyNjc0NDUxNTA_2b2b3576-c62e-4c12-9b1d-ec1f1be906ba">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides details of the Company&#x2019;s 2021 dividend payments:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Payment Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Amount Paid&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 29&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 21&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DividendsDeclaredTableTextBlock>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="ib1465a6c04dd4bcbacfb6ca471dbee92_D20210323-20210323"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90YWJsZTpjNDZjNTc4ODM4ZWQ0ODc2OTcyMmNiODQxZTM5YTU1Yi90YWJsZXJhbmdlOmM0NmM1Nzg4MzhlZDQ4NzY5NzIyY2I4NDFlMzlhNTViXzItMi0xLTEtMA_352f57d3-3585-4bb9-a8f0-6207f94208fe"
      unitRef="usdPerShare">1.25</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="ib1465a6c04dd4bcbacfb6ca471dbee92_D20210323-20210323"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90YWJsZTpjNDZjNTc4ODM4ZWQ0ODc2OTcyMmNiODQxZTM5YTU1Yi90YWJsZXJhbmdlOmM0NmM1Nzg4MzhlZDQ4NzY5NzIyY2I4NDFlMzlhNTViXzItNC0xLTEtMA_c6c807a3-4345-428c-a4e8-58a18ecf56cc"
      unitRef="usd">1181000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="id4fddf633266448b9691078c6f0ac482_D20210629-20210629"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90YWJsZTpjNDZjNTc4ODM4ZWQ0ODc2OTcyMmNiODQxZTM5YTU1Yi90YWJsZXJhbmdlOmM0NmM1Nzg4MzhlZDQ4NzY5NzIyY2I4NDFlMzlhNTViXzMtMi0xLTEtMA_46238ba0-0f53-4571-a66d-215c5f0b2a31"
      unitRef="usdPerShare">1.45</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="id4fddf633266448b9691078c6f0ac482_D20210629-20210629"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90YWJsZTpjNDZjNTc4ODM4ZWQ0ODc2OTcyMmNiODQxZTM5YTU1Yi90YWJsZXJhbmdlOmM0NmM1Nzg4MzhlZDQ4NzY5NzIyY2I4NDFlMzlhNTViXzMtNC0xLTEtMA_ea846d6b-87b3-418c-bd3e-da325787a386"
      unitRef="usd">1367000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i97719cae15984487921a22e3d5be41e8_D20210921-20210921"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90YWJsZTpjNDZjNTc4ODM4ZWQ0ODc2OTcyMmNiODQxZTM5YTU1Yi90YWJsZXJhbmdlOmM0NmM1Nzg4MzhlZDQ4NzY5NzIyY2I4NDFlMzlhNTViXzQtMi0xLTEtMA_73895876-5ad5-4126-988c-bb50718d2648"
      unitRef="usdPerShare">1.45</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i97719cae15984487921a22e3d5be41e8_D20210921-20210921"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90YWJsZTpjNDZjNTc4ODM4ZWQ0ODc2OTcyMmNiODQxZTM5YTU1Yi90YWJsZXJhbmdlOmM0NmM1Nzg4MzhlZDQ4NzY5NzIyY2I4NDFlMzlhNTViXzQtNC0xLTEtMA_74f146aa-6364-4390-b322-850632672cdc"
      unitRef="usd">1367000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i8f7827d6bf5f49a0af03b71e2d704cea_D20211214-20211214"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90YWJsZTpjNDZjNTc4ODM4ZWQ0ODc2OTcyMmNiODQxZTM5YTU1Yi90YWJsZXJhbmdlOmM0NmM1Nzg4MzhlZDQ4NzY5NzIyY2I4NDFlMzlhNTViXzUtMi0xLTEtMA_c5979d1d-f4e8-46f4-b999-ced7892764be"
      unitRef="usdPerShare">1.45</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i8f7827d6bf5f49a0af03b71e2d704cea_D20211214-20211214"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMDUvZnJhZzozMzMyNTE1ZjNlODY0ZDMzOWE5MmNmN2I2YzY5YjY0Yy90YWJsZTpjNDZjNTc4ODM4ZWQ0ODc2OTcyMmNiODQxZTM5YTU1Yi90YWJsZXJhbmdlOmM0NmM1Nzg4MzhlZDQ4NzY5NzIyY2I4NDFlMzlhNTViXzUtNC0xLTEtMA_08bb7641-cd86-4fdd-906c-3177dd129e4b"
      unitRef="usd">1365000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90ZXh0cmVnaW9uOjA4MmMzNzgxYTczODQwZmE4N2Y1YWFkMzUyNWVjZjJjXzIxNjE_0eca219a-8cbf-4f90-9aab-5ceff6aba2c3">Share-Based Compensation&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s outstanding share-based awards consist mainly of non-qualified stock options and restricted shares. As of December&#160;31, 2021, the Company had 64 million shares available for future grants of share-based awards under the 2020 Stock Incentive Plan. In June 2021, the Company&#x2019;s shareholders approved 15&#160;million additional shares under the ESPP. As of December&#160;31, 2021, there were 18&#160;million shares of common stock available for issuance under the ESPP. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock option activity for the year ended December&#160;31, 2021 is summarized in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:4.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.434%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&#160;Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Shares&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted share activity for the year ended December&#160;31, 2021 is summarized in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.153%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(shares in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;br/&gt;per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Share-Based Compensation Data&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.029%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant date fair value of shares granted, per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intrinsic value of stock options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restricted Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant date fair value of shares granted, per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of restricted shares vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of shares purchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Share-Based Compensation Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense, before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense, net of tax effects&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit realized from share-based award exercises&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.665%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions, except years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized compensation expense related to share awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average years to recognize compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:15pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation Recognition and Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The principal assumptions the Company used in calculating grant-date fair value for stock options were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7% - 1.2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2% - 1.4%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5% - 2.5%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.2% - 29.8%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.2% - 29.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.4% - 21.6%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3% - 1.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4% - 1.7%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4% - 1.8%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeiture rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Risk-free interest rates are based on U.S. Treasury yields in effect at the time of grant. Expected volatilities are based on the historical volatility of the Company&#x2019;s common stock and the implied volatility from exchange-traded options on the Company&#x2019;s common stock. Expected dividend yields are based on the per share cash dividend paid by the Company. The Company uses historical data to estimate option exercises and forfeitures within the valuation model. The expected lives of options granted represents the period of time the awards granted are expected to be outstanding based on historical exercise patterns.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Employee Benefit Plans &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company offers a 401(k) plan for its employees. Compensation expense related to this plan was not material for 2021, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the Company maintains non-qualified, deferred compensation plans, which allow certain members of senior management and executives to defer portions of their salary or bonus. The deferrals are recorded within long-term investments with an approximately equal amount in other liabilities in the Consolidated Balance Sheets. The total deferrals are distributable based upon termination of employment or other periods, as elected under each plan and were $1.8 billion and $1.6 billion as of December&#160;31, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90ZXh0cmVnaW9uOjA4MmMzNzgxYTczODQwZmE4N2Y1YWFkMzUyNWVjZjJjXzI3NQ_ec2101ee-3cc9-4c26-bcfa-d9ea33ec491a"
      unitRef="shares">64000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="i1da1045e098d44dda00d3afb43712521_D20210601-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90ZXh0cmVnaW9uOjA4MmMzNzgxYTczODQwZmE4N2Y1YWFkMzUyNWVjZjJjXzI3NDg3NzkwNzE5MDU_c50fb5b2-c22a-4a51-9059-2db333ff9e05"
      unitRef="shares">15000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i9373eeb7b5f04135b63071c869773f31_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90ZXh0cmVnaW9uOjA4MmMzNzgxYTczODQwZmE4N2Y1YWFkMzUyNWVjZjJjXzM3Nw_40bae015-55d0-4e64-aac7-1a2b352f9f81"
      unitRef="shares">18000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90ZXh0cmVnaW9uOjA4MmMzNzgxYTczODQwZmE4N2Y1YWFkMzUyNWVjZjJjXzIxMzI_698fea1d-0cd2-4f21-8846-d7cf14ef226a">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock option activity for the year ended December&#160;31, 2021 is summarized in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:4.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.434%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&#160;Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTozOThmMWE3NWYxZWU0YjEwOTdjZmY0OWZjZGNmODA5Yi90YWJsZXJhbmdlOjM5OGYxYTc1ZjFlZTRiMTA5N2NmZjQ5ZmNkY2Y4MDliXzItMS0xLTEtMA_237fd639-791d-44f9-a07e-81a8b92184d5"
      unitRef="shares">28000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTozOThmMWE3NWYxZWU0YjEwOTdjZmY0OWZjZGNmODA5Yi90YWJsZXJhbmdlOjM5OGYxYTc1ZjFlZTRiMTA5N2NmZjQ5ZmNkY2Y4MDliXzItMy0xLTEtMA_201ab0fe-1c39-439e-98d1-d22a749b7e9e"
      unitRef="usdPerShare">211</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTozOThmMWE3NWYxZWU0YjEwOTdjZmY0OWZjZGNmODA5Yi90YWJsZXJhbmdlOjM5OGYxYTc1ZjFlZTRiMTA5N2NmZjQ5ZmNkY2Y4MDliXzMtMS0xLTEtMA_76bb098d-09fa-4129-92d1-de78ec1f6665"
      unitRef="shares">5000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTozOThmMWE3NWYxZWU0YjEwOTdjZmY0OWZjZGNmODA5Yi90YWJsZXJhbmdlOjM5OGYxYTc1ZjFlZTRiMTA5N2NmZjQ5ZmNkY2Y4MDliXzMtMy0xLTEtMA_9cfab9f8-f792-4a1f-b08a-261f053bb20c"
      unitRef="usdPerShare">329</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTozOThmMWE3NWYxZWU0YjEwOTdjZmY0OWZjZGNmODA5Yi90YWJsZXJhbmdlOjM5OGYxYTc1ZjFlZTRiMTA5N2NmZjQ5ZmNkY2Y4MDliXzQtMS0xLTEtMA_0d258a16-d66b-4d3a-ba30-7add22892f8d"
      unitRef="shares">7000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTozOThmMWE3NWYxZWU0YjEwOTdjZmY0OWZjZGNmODA5Yi90YWJsZXJhbmdlOjM5OGYxYTc1ZjFlZTRiMTA5N2NmZjQ5ZmNkY2Y4MDliXzQtMy0xLTEtMA_ae7ee625-7987-4bc9-b9e3-ecfe98dbceeb"
      unitRef="usdPerShare">175</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTozOThmMWE3NWYxZWU0YjEwOTdjZmY0OWZjZGNmODA5Yi90YWJsZXJhbmdlOjM5OGYxYTc1ZjFlZTRiMTA5N2NmZjQ5ZmNkY2Y4MDliXzUtMS0xLTEtMA_55eb580b-9fdd-4987-9786-bd0aa18cd36e"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTozOThmMWE3NWYxZWU0YjEwOTdjZmY0OWZjZGNmODA5Yi90YWJsZXJhbmdlOjM5OGYxYTc1ZjFlZTRiMTA5N2NmZjQ5ZmNkY2Y4MDliXzUtMy0xLTEtMA_57dda6e2-75f3-4310-b246-e075dc7f8732"
      unitRef="usdPerShare">297</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTozOThmMWE3NWYxZWU0YjEwOTdjZmY0OWZjZGNmODA5Yi90YWJsZXJhbmdlOjM5OGYxYTc1ZjFlZTRiMTA5N2NmZjQ5ZmNkY2Y4MDliXzYtMS0xLTEtMA_5deb13ab-9a40-4676-90e4-67c83f369262"
      unitRef="shares">25000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTozOThmMWE3NWYxZWU0YjEwOTdjZmY0OWZjZGNmODA5Yi90YWJsZXJhbmdlOjM5OGYxYTc1ZjFlZTRiMTA5N2NmZjQ5ZmNkY2Y4MDliXzYtMy0xLTEtMA_17a48d0c-7648-4bc9-bccf-52544dcb137b"
      unitRef="usdPerShare">241</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTozOThmMWE3NWYxZWU0YjEwOTdjZmY0OWZjZGNmODA5Yi90YWJsZXJhbmdlOjM5OGYxYTc1ZjFlZTRiMTA5N2NmZjQ5ZmNkY2Y4MDliXzYtNy0xLTEtMA_84685074-8fca-4924-8447-429708f2cc62"
      unitRef="usd">6610000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTozOThmMWE3NWYxZWU0YjEwOTdjZmY0OWZjZGNmODA5Yi90YWJsZXJhbmdlOjM5OGYxYTc1ZjFlZTRiMTA5N2NmZjQ5ZmNkY2Y4MDliXzctMS0xLTEtMA_484d6bad-cdef-47bf-817d-177ba3bc4ba0"
      unitRef="shares">12000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTozOThmMWE3NWYxZWU0YjEwOTdjZmY0OWZjZGNmODA5Yi90YWJsZXJhbmdlOjM5OGYxYTc1ZjFlZTRiMTA5N2NmZjQ5ZmNkY2Y4MDliXzctMy0xLTEtMA_b5fbe614-d2dc-43a9-9a5a-24e03a9d8d6d"
      unitRef="usdPerShare">179</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTozOThmMWE3NWYxZWU0YjEwOTdjZmY0OWZjZGNmODA5Yi90YWJsZXJhbmdlOjM5OGYxYTc1ZjFlZTRiMTA5N2NmZjQ5ZmNkY2Y4MDliXzctNy0xLTEtMA_c31ab6f9-1db8-4877-a8c5-41c2bbf32144"
      unitRef="usd">3932000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTozOThmMWE3NWYxZWU0YjEwOTdjZmY0OWZjZGNmODA5Yi90YWJsZXJhbmdlOjM5OGYxYTc1ZjFlZTRiMTA5N2NmZjQ5ZmNkY2Y4MDliXzgtMS0xLTEtMA_a6e8e46f-fd3a-45d5-9ee6-cb1136672126"
      unitRef="shares">25000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTozOThmMWE3NWYxZWU0YjEwOTdjZmY0OWZjZGNmODA5Yi90YWJsZXJhbmdlOjM5OGYxYTc1ZjFlZTRiMTA5N2NmZjQ5ZmNkY2Y4MDliXzgtMy0xLTEtMA_d1e8ad42-caee-43c0-8c3e-b1a9e321a28c"
      unitRef="usdPerShare">240</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTozOThmMWE3NWYxZWU0YjEwOTdjZmY0OWZjZGNmODA5Yi90YWJsZXJhbmdlOjM5OGYxYTc1ZjFlZTRiMTA5N2NmZjQ5ZmNkY2Y4MDliXzgtNy0xLTEtMA_ae51d83b-fbb1-42a6-88d9-84f99e8ac2f8"
      unitRef="usd">6509000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90ZXh0cmVnaW9uOjA4MmMzNzgxYTczODQwZmE4N2Y1YWFkMzUyNWVjZjJjXzIxNDM_c610883a-cd76-48a8-93d6-b3d24943e767">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted share activity for the year ended December&#160;31, 2021 is summarized in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.153%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(shares in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;br/&gt;per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i8b0b8b22a5064df79ec4e0a1452381f2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTpiNGQxMjUzODE5NzM0MWY4ODQxNzZkNjI2ZGYxYjZhOC90YWJsZXJhbmdlOmI0ZDEyNTM4MTk3MzQxZjg4NDE3NmQ2MjZkZjFiNmE4XzEtMi0xLTEtMA_980bb514-4ad5-4f74-ae3a-5e6047beb69f"
      unitRef="shares">4000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i8b0b8b22a5064df79ec4e0a1452381f2_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTpiNGQxMjUzODE5NzM0MWY4ODQxNzZkNjI2ZGYxYjZhOC90YWJsZXJhbmdlOmI0ZDEyNTM4MTk3MzQxZjg4NDE3NmQ2MjZkZjFiNmE4XzEtNC0xLTEtMA_cc4bc676-57dd-4886-8560-9340a750d690"
      unitRef="usdPerShare">256</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i0cf2e2ded57848acbd7f4ce7b8849c5d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTpiNGQxMjUzODE5NzM0MWY4ODQxNzZkNjI2ZGYxYjZhOC90YWJsZXJhbmdlOmI0ZDEyNTM4MTk3MzQxZjg4NDE3NmQ2MjZkZjFiNmE4XzItMi0xLTEtMA_d4bee4cb-5b98-4b61-b8fa-b3a4aff729be"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i0cf2e2ded57848acbd7f4ce7b8849c5d_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTpiNGQxMjUzODE5NzM0MWY4ODQxNzZkNjI2ZGYxYjZhOC90YWJsZXJhbmdlOmI0ZDEyNTM4MTk3MzQxZjg4NDE3NmQ2MjZkZjFiNmE4XzItNC0xLTEtMA_b61667a5-9eb5-4771-8696-4970595ea09a"
      unitRef="usdPerShare">352</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i0cf2e2ded57848acbd7f4ce7b8849c5d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTpiNGQxMjUzODE5NzM0MWY4ODQxNzZkNjI2ZGYxYjZhOC90YWJsZXJhbmdlOmI0ZDEyNTM4MTk3MzQxZjg4NDE3NmQ2MjZkZjFiNmE4XzMtMi0xLTEtMA_c55d5549-4516-452f-906d-617a95188e12"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i0cf2e2ded57848acbd7f4ce7b8849c5d_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTpiNGQxMjUzODE5NzM0MWY4ODQxNzZkNjI2ZGYxYjZhOC90YWJsZXJhbmdlOmI0ZDEyNTM4MTk3MzQxZjg4NDE3NmQ2MjZkZjFiNmE4XzMtNC0xLTEtMA_464c61c4-731c-4162-9008-4c7a714651c9"
      unitRef="usdPerShare">246</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="id63338cb4c6e49dbb4d3876bbbbc7fba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTpiNGQxMjUzODE5NzM0MWY4ODQxNzZkNjI2ZGYxYjZhOC90YWJsZXJhbmdlOmI0ZDEyNTM4MTk3MzQxZjg4NDE3NmQ2MjZkZjFiNmE4XzQtMi0xLTEtMA_b54c3962-cd70-4a6b-8169-6b1ed04cf97d"
      unitRef="shares">4000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="id63338cb4c6e49dbb4d3876bbbbc7fba_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTpiNGQxMjUzODE5NzM0MWY4ODQxNzZkNjI2ZGYxYjZhOC90YWJsZXJhbmdlOmI0ZDEyNTM4MTk3MzQxZjg4NDE3NmQ2MjZkZjFiNmE4XzQtNC0xLTEtMA_a6b68301-0d23-4059-8339-e93792c3a86c"
      unitRef="usdPerShare">303</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90ZXh0cmVnaW9uOjA4MmMzNzgxYTczODQwZmE4N2Y1YWFkMzUyNWVjZjJjXzIxNTU_263de050-9d7e-4394-b158-a0f4659c8325">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Share-Based Compensation Data&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.029%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.458%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant date fair value of shares granted, per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intrinsic value of stock options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restricted Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant date fair value of shares granted, per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of restricted shares vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of shares purchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Share-Based Compensation Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense, before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense, net of tax effects&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit realized from share-based award exercises&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.665%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions, except years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized compensation expense related to share awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average years to recognize compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i4d96f9ce242e4c3d8115ee3621f39cbe_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzMtMi0xLTEtMA_a95eff77-57da-4188-be57-c7efabf1da2c"
      unitRef="usdPerShare">71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i76d17528cf2346ec89da7e8be44862de_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzMtNC0xLTEtMA_d90512e4-5bb5-43da-96a7-0e9aecc63726"
      unitRef="usdPerShare">54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i8735916cccf8489cb02dce2be01b4b17_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzMtNi0xLTEtMA_3e386ce8-2075-4787-b584-11a21dc09af5"
      unitRef="usdPerShare">46</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i4d96f9ce242e4c3d8115ee3621f39cbe_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzQtMi0xLTEtMA_151ef78c-ce7c-4bd7-bf36-ceeb362bd87a"
      unitRef="usd">1519000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i76d17528cf2346ec89da7e8be44862de_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzQtNC0xLTEtMA_3776314c-8aec-428c-9511-92a884c43528"
      unitRef="usd">1736000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i8735916cccf8489cb02dce2be01b4b17_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzQtNi0xLTEtMA_3db6654d-dca8-49af-9add-08b97a1d8c0c"
      unitRef="usd">1398000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ifb47f60aa85f4d24ba37cab9c6946e24_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzYtMi0xLTEtMA_0be7daa8-7707-43a2-a7fd-89ca73822337"
      unitRef="usdPerShare">352</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ie5d9a9a4874549718469d7c60db06cc1_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzYtNC0xLTEtMA_7aa049b4-8b47-471b-b6fd-fa26e063d317"
      unitRef="usdPerShare">303</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i45d815b9650e4498a5b6941af134494e_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzYtNi0xLTEtMA_d9214ef6-03e0-412b-8b47-6dac4f770d18"
      unitRef="usdPerShare">259</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="ifb47f60aa85f4d24ba37cab9c6946e24_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzctMi0xLTEtMA_631a8797-6113-4973-b249-38da29f38998"
      unitRef="usd">560000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="ie5d9a9a4874549718469d7c60db06cc1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzctNC0xLTEtMA_86287309-4ec1-46a0-87e4-3a1bc17dc16c"
      unitRef="usd">574000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i45d815b9650e4498a5b6941af134494e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzctNi0xLTEtMA_7c366895-0357-4ad8-a26a-91484874b6eb"
      unitRef="usd">545000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ie667c3a41af649e28b76eb6f34ded8a2_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzktMi0xLTEtMA_30c2fdeb-de3c-449b-bdd3-9e3590d44cd3"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ief665df606e14a618e22e519299e9750_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzktNC0xLTEtMA_c9210947-0942-433c-ac7d-57aaf18d97d8"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i7b0f0d7d245e4cbda78fe9b5b60cd842_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzktNi0xLTEtMA_cfbca729-e122-4b5c-9de1-a5ddf293cb51"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:ShareBasedCompensation
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzExLTItMS0xLTA_84f71946-1318-4736-8078-dc6d7f4231ba"
      unitRef="usd">800000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzExLTQtMS0xLTA_0ffccf95-3bc4-4b74-94c0-2844177cb88a"
      unitRef="usd">679000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzExLTYtMS0xLTA_01c62bd1-a059-4263-ba4e-2941d90add10"
      unitRef="usd">697000000</us-gaap:ShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzEyLTItMS0xLTA_0ec70c16-4ea2-4948-b2e0-1ac2eb923dde"
      unitRef="usd">719000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzEyLTQtMS0xLTA_06ef622a-cd8f-421d-871d-a9c0b3fefb99"
      unitRef="usd">619000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzEyLTYtMS0xLTA_67704649-18ef-4877-8d41-03d871e7208b"
      unitRef="usd">641000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzEzLTItMS0xLTA_7e919b95-941e-4e7a-b6a8-99625d5ce702"
      unitRef="usd">173000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzEzLTQtMS0xLTA_0f454634-2e25-437b-8379-148ae1afee78"
      unitRef="usd">208000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTowMmIyYmYyNTlmMDc0Mjg3ODkyZTFiMDZmZGNlYzY0Ni90YWJsZXJhbmdlOjAyYjJiZjI1OWYwNzQyODc4OTJlMWIwNmZkY2VjNjQ2XzEzLTYtMS0xLTA_9f47e42e-7b9e-4d7f-be7d-6aaf76871e2f"
      unitRef="usd">201000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTo2NmEzYmE4NzRjMmM0NjM4OWMxNDk0MTFjMTI2NGRlMC90YWJsZXJhbmdlOjY2YTNiYTg3NGMyYzQ2Mzg5YzE0OTQxMWMxMjY0ZGUwXzEtMi0xLTEtMA_27a55d9a-f993-450d-bb68-8dc0a952c97a"
      unitRef="usd">905000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90ZXh0cmVnaW9uOjA4MmMzNzgxYTczODQwZmE4N2Y1YWFkMzUyNWVjZjJjXzIxMzQ_c9b09aba-8555-426c-8d5f-6a91debd7166">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The principal assumptions the Company used in calculating grant-date fair value for stock options were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7% - 1.2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2% - 1.4%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5% - 2.5%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.2% - 29.8%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.2% - 29.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.4% - 21.6%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3% - 1.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4% - 1.7%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4% - 1.8%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeiture rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <unh:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTo1MmIyYjE5OGRkNGU0NDc5YmYxOTE3ZDZjY2RhNTA0MC90YWJsZXJhbmdlOjUyYjJiMTk4ZGQ0ZTQ0NzliZjE5MTdkNmNjZGE1MDQwXzUtMi0xLTEtMA_47ee0be9-a09a-44c3-a2e3-a319014e9375"
      unitRef="number">0.050</unh:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures>
    <unh:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTo1MmIyYjE5OGRkNGU0NDc5YmYxOTE3ZDZjY2RhNTA0MC90YWJsZXJhbmdlOjUyYjJiMTk4ZGQ0ZTQ0NzliZjE5MTdkNmNjZGE1MDQwXzUtNC0xLTEtMA_f3b34136-c254-40bc-854f-f1b5f6baccd5"
      unitRef="number">0.050</unh:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures>
    <unh:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90YWJsZTo1MmIyYjE5OGRkNGU0NDc5YmYxOTE3ZDZjY2RhNTA0MC90YWJsZXJhbmdlOjUyYjJiMTk4ZGQ0ZTQ0NzliZjE5MTdkNmNjZGE1MDQwXzUtNi0xLTEtMA_d2e0f456-9784-4d6f-932c-5c1490d2ff2c"
      unitRef="number">0.050</unh:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90ZXh0cmVnaW9uOjA4MmMzNzgxYTczODQwZmE4N2Y1YWFkMzUyNWVjZjJjXzIwOTE_7bd18f82-582d-4e28-b13c-b9735a3dff27"
      unitRef="usd">1800000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTEvZnJhZzowODJjMzc4MWE3Mzg0MGZhODdmNWFhZDM1MjVlY2YyYy90ZXh0cmVnaW9uOjA4MmMzNzgxYTczODQwZmE4N2Y1YWFkMzUyNWVjZjJjXzIwOTg_7d9057c5-bd13-499a-9ddb-3cb5c793521b"
      unitRef="usd">1600000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90ZXh0cmVnaW9uOjNkNWQwODk4MzJhODQ4YTE5NzAxNzY2MTQ1OGNhZmUxXzU4NDk_b5af8282-2a2d-4966-8080-1c2a2ff8d0d8">Commitments and Contingencies&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease costs were $1.2 billion, $1.1 billion and $1.0 billion for the years ended December&#160;31, 2021, 2020 and 2019, respectively, and included immaterial variable and short-term lease costs for the year ended December 31, 2021, 2020 and 2019. Cash payments made on the Company&#x2019;s operating lease liabilities were $921 million, $865 million and $746&#160;million for the years ended December&#160;31, 2021, 2020 and 2019, respectively, which were classified within operating activities in the Consolidated Statements of Cash Flows. As of December&#160;31, 2021, the Company&#x2019;s weighted-average remaining lease term and weighted-average discount rate for its operating leases were 8.7 years and 2.9%, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, future minimum annual lease payments under all non-cancelable operating leases were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.330%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.738%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Future Minimum Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(609)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company provides guarantees related to its service level under certain contracts. If minimum standards are not met, the Company may be financially at risk up to a stated percentage of the contracted fee or a stated dollar amount. None of the amounts accrued, paid or charged to income for service level guarantees were material as of December&#160;31, 2021, 2020 or 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, the Company had outstanding, undrawn letters of credit with financial institutions of $181 million and surety bonds outstanding with insurance companies of $1.3 billion, primarily to bond contractual performance. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Pending Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2021, we entered into agreements to acquire multiple companies in the health care sector, most notably, Change Healthcare (NASDAQ: CHNG), subject to regulatory approval and other customary closing conditions. Additionally, in January 2022, we entered into agreements to acquire multiple companies in the health care sector, subject to regulatory approval and other customary closing conditions. The total anticipated capital required for these acquisitions, excluding the payoff of acquired indebtedness, is approximately $12&#160;billion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Legal Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is frequently made party to a variety of legal actions and regulatory inquiries, including class actions and suits brought by members, care providers, consumer advocacy organizations, customers and regulators, relating to the Company&#x2019;s businesses, including management and administration of health benefit plans and other services. These matters include medical malpractice, employment, intellectual property, antitrust, privacy and contract claims and claims related to health care benefits coverage and other business practices.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records liabilities for its estimates of probable costs resulting from these matters where appropriate. Estimates of costs resulting from legal and regulatory matters involving the Company are inherently difficult to predict, particularly where the matters: involve indeterminate claims for monetary damages or may involve fines, penalties or punitive damages; present novel legal theories or represent a shift in regulatory policy; involve a large number of claimants or regulatory bodies; are in the early stages of the proceedings; or could result in a change in business practices. Accordingly, the Company is often unable to estimate the losses or ranges of losses for those matters where there is a reasonable possibility or it is probable a loss may be incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Government Investigations, Audits and Reviews&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has been involved or is currently involved in various governmental investigations, audits and reviews. These include routine, regular and special investigations, audits and reviews by CMS, state insurance and health and welfare departments, state attorneys general, the Office of the Inspector General, the Office of Personnel Management, the Office of &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Civil Rights, the Government Accountability Office, the Federal Trade Commission, U.S. Congressional committees, the U.S. Department of Justice (DOJ), the SEC, the IRS, the U.S. Drug Enforcement Administration, the U.S. Department of Labor, the FDIC, the Defense Contract Audit Agency and other governmental authorities. Similarly, our international businesses are also subject to investigations, audits and reviews by applicable foreign governments, including South American and other non-U.S. governmental authorities. Certain of the Company&#x2019;s businesses have been reviewed or are currently under review, including for, among other matters, compliance with coding and other requirements under the Medicare risk-adjustment model. CMS has selected certain of the Company&#x2019;s local plans for risk adjustment data validation (RADV) audits to validate the coding practices of and supporting documentation maintained by health care providers and such audits may result in retrospective adjustments to payments made to the Company&#x2019;s health plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 14, 2017, the DOJ announced its decision to pursue certain claims within a lawsuit initially asserted against the Company and filed under seal by a whistleblower in 2011. The whistleblower&#x2019;s complaint, which was unsealed on February 15, 2017, alleges the Company made improper risk adjustment submissions and violated the False Claims Act. On February 12, 2018, the court granted in part and denied in part the Company&#x2019;s motion to dismiss. In May 2018, DOJ moved to dismiss the Company&#x2019;s counterclaims, which were filed in March 2018, and moved for partial summary judgment. In March 2019, the court denied the government&#x2019;s motion for partial summary judgment and dismissed the Company&#x2019;s counterclaims without prejudice. The Company cannot reasonably estimate the outcome which may result from this matter given its procedural status.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90ZXh0cmVnaW9uOjNkNWQwODk4MzJhODQ4YTE5NzAxNzY2MTQ1OGNhZmUxXzcz_8f08326e-cf00-4df7-9f34-47a723b3a76e"
      unitRef="usd">1200000000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90ZXh0cmVnaW9uOjNkNWQwODk4MzJhODQ4YTE5NzAxNzY2MTQ1OGNhZmUxXzc3_fe610d69-03c4-4dba-9c06-8353679ba668"
      unitRef="usd">1100000000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90ZXh0cmVnaW9uOjNkNWQwODk4MzJhODQ4YTE5NzAxNzY2MTQ1OGNhZmUxXzg0_6155f0fe-4499-40c2-9ab1-b9ee323cf81a"
      unitRef="usd">1000000000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90ZXh0cmVnaW9uOjNkNWQwODk4MzJhODQ4YTE5NzAxNzY2MTQ1OGNhZmUxXzMxNg_5d058058-3ebf-44aa-be29-406cb9bbb0b4"
      unitRef="usd">921000000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90ZXh0cmVnaW9uOjNkNWQwODk4MzJhODQ4YTE5NzAxNzY2MTQ1OGNhZmUxXzMyMw_6a0b8302-fbd7-4638-8c72-52f7a430adf8"
      unitRef="usd">865000000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90ZXh0cmVnaW9uOjNkNWQwODk4MzJhODQ4YTE5NzAxNzY2MTQ1OGNhZmUxXzI3NDg3NzkwNzg0ODI_b484a064-ecdc-40e6-b1db-100dcceb5494"
      unitRef="usd">746000000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90ZXh0cmVnaW9uOjNkNWQwODk4MzJhODQ4YTE5NzAxNzY2MTQ1OGNhZmUxXzU5Ng_b2192fb7-dad4-4f5a-bbde-ff8072ce6bd5">P8Y8M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90ZXh0cmVnaW9uOjNkNWQwODk4MzJhODQ4YTE5NzAxNzY2MTQ1OGNhZmUxXzYwOQ_49ce87ab-7a8b-4f88-8e93-2e5eea083382"
      unitRef="number">0.029</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90ZXh0cmVnaW9uOjNkNWQwODk4MzJhODQ4YTE5NzAxNzY2MTQ1OGNhZmUxXzU4NDY_084e2547-98ff-48c4-8b39-acb990e1e9f4">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, future minimum annual lease payments under all non-cancelable operating leases were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.330%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.738%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Future Minimum Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(609)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90YWJsZTo5NTdiMTFhYWNhMGE0NzZhYTk4YjQwZDg5MzgyNDg3Yy90YWJsZXJhbmdlOjk1N2IxMWFhY2EwYTQ3NmFhOThiNDBkODkzODI0ODdjXzEtMi0xLTEtMA_49bff575-9ff6-4b52-8c4b-ea56c9aaaaae"
      unitRef="usd">870000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90YWJsZTo5NTdiMTFhYWNhMGE0NzZhYTk4YjQwZDg5MzgyNDg3Yy90YWJsZXJhbmdlOjk1N2IxMWFhY2EwYTQ3NmFhOThiNDBkODkzODI0ODdjXzItMi0xLTEtMA_06f73d3e-3e28-4866-8ac8-254cb0794590"
      unitRef="usd">763000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90YWJsZTo5NTdiMTFhYWNhMGE0NzZhYTk4YjQwZDg5MzgyNDg3Yy90YWJsZXJhbmdlOjk1N2IxMWFhY2EwYTQ3NmFhOThiNDBkODkzODI0ODdjXzMtMi0xLTEtMA_8b02f129-d208-4a6a-b19c-be27dc485a36"
      unitRef="usd">616000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90YWJsZTo5NTdiMTFhYWNhMGE0NzZhYTk4YjQwZDg5MzgyNDg3Yy90YWJsZXJhbmdlOjk1N2IxMWFhY2EwYTQ3NmFhOThiNDBkODkzODI0ODdjXzQtMi0xLTEtMA_7f0dd846-6a4c-44cc-b74f-8a527b5e5fa1"
      unitRef="usd">510000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90YWJsZTo5NTdiMTFhYWNhMGE0NzZhYTk4YjQwZDg5MzgyNDg3Yy90YWJsZXJhbmdlOjk1N2IxMWFhY2EwYTQ3NmFhOThiNDBkODkzODI0ODdjXzUtMi0xLTEtMA_2be2b1a0-18bd-433f-af9c-766451c0f3d1"
      unitRef="usd">407000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90YWJsZTo5NTdiMTFhYWNhMGE0NzZhYTk4YjQwZDg5MzgyNDg3Yy90YWJsZXJhbmdlOjk1N2IxMWFhY2EwYTQ3NmFhOThiNDBkODkzODI0ODdjXzYtMi0xLTEtMA_8857375a-338a-4147-9578-77bf8506b9d2"
      unitRef="usd">1716000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90YWJsZTo5NTdiMTFhYWNhMGE0NzZhYTk4YjQwZDg5MzgyNDg3Yy90YWJsZXJhbmdlOjk1N2IxMWFhY2EwYTQ3NmFhOThiNDBkODkzODI0ODdjXzctMi0xLTEtMA_471511da-16a8-4b4d-8ab5-d4bc262f53c6"
      unitRef="usd">4882000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90YWJsZTo5NTdiMTFhYWNhMGE0NzZhYTk4YjQwZDg5MzgyNDg3Yy90YWJsZXJhbmdlOjk1N2IxMWFhY2EwYTQ3NmFhOThiNDBkODkzODI0ODdjXzgtMi0xLTEtMA_8bfc0613-7bf6-469e-a557-d3dd707ff77e"
      unitRef="usd">609000000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="if755137cc0244794b9c613b644590d23_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90YWJsZTo5NTdiMTFhYWNhMGE0NzZhYTk4YjQwZDg5MzgyNDg3Yy90YWJsZXJhbmdlOjk1N2IxMWFhY2EwYTQ3NmFhOThiNDBkODkzODI0ODdjXzktMi0xLTEtMA_ba0f40f7-33bc-48ca-8c6e-30a54c71c88d"
      unitRef="usd">4273000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90ZXh0cmVnaW9uOjNkNWQwODk4MzJhODQ4YTE5NzAxNzY2MTQ1OGNhZmUxXzEyMDM_e7030e0d-e71f-41df-b2c6-2ff7b25b8506"
      unitRef="usd">181000000</us-gaap:LettersOfCreditOutstandingAmount>
    <unh:SuretyBondsOutstanding
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90ZXh0cmVnaW9uOjNkNWQwODk4MzJhODQ4YTE5NzAxNzY2MTQ1OGNhZmUxXzEyNjM_5c9fdbfb-de45-458f-9118-a5d74fdcd009"
      unitRef="usd">1300000000</unh:SuretyBondsOutstanding>
    <us-gaap:OtherCommitmentsDescription
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90ZXh0cmVnaW9uOjNkNWQwODk4MzJhODQ4YTE5NzAxNzY2MTQ1OGNhZmUxXzI3NDg3NzkwNzkzOTE_f70d8705-8989-409d-b532-5aaa5f01357f">In 2021, we entered into agreements to acquire multiple companies in the health care sector, most notably, Change Healthcare (NASDAQ: CHNG), subject to regulatory approval and other customary closing conditions.</us-gaap:OtherCommitmentsDescription>
    <us-gaap:SubsequentEventDescription
      contextRef="i234fb0970ed146d6a6b5a0a8e14b119b_D20220101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90ZXh0cmVnaW9uOjNkNWQwODk4MzJhODQ4YTE5NzAxNzY2MTQ1OGNhZmUxXzI3NDg3NzkwNzkzOTI_d91e404d-4d7c-4e23-8edf-b904e68e157b">Additionally, in January 2022, we entered into agreements to acquire multiple companies in the health care sector, subject to regulatory approval and other customary closing conditions.</us-gaap:SubsequentEventDescription>
    <us-gaap:OtherCommitment
      contextRef="i3d57fae043fc43048dd28cf40011078c_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMTcvZnJhZzozZDVkMDg5ODMyYTg0OGExOTcwMTc2NjE0NThjYWZlMS90ZXh0cmVnaW9uOjNkNWQwODk4MzJhODQ4YTE5NzAxNzY2MTQ1OGNhZmUxXzI3NDg3NzkwNzkzODU_c67f2890-de24-4cc3-836f-a7dfd66a6fd4"
      unitRef="usd">12000000000</us-gaap:OtherCommitment>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90ZXh0cmVnaW9uOjI5ZjUxMmRkY2JmNDQ2YzViOWZjOWFjN2UzNDM1NGNhXzU1MTY_8329e1b0-602e-4c8a-b77b-46d7ddd79155">Segment Financial Information&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Factors used to determine the Company&#x2019;s reportable segments include the nature of operating activities, economic characteristics, existence of separate senior management teams and the type of information used by the Company&#x2019;s chief operating decision maker to evaluate its results of operations. Reportable segments with similar economic characteristics, products and services, customers, distribution methods and operational processes which operate in a similar regulatory environment are combined.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a description of the types of products and services from which each of the Company&#x2019;s four reportable segments derives its revenues:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;UnitedHealthcare &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;includes the combined results of operations of UnitedHealthcare Employer&#160;&amp;amp; Individual, UnitedHealthcare Medicare&#160;&amp;amp; Retirement, UnitedHealthcare Community&#160;&amp;amp; State and UnitedHealthcare Global. The U.S. businesses share significant common assets, including a contracted network of physicians, health care professionals, hospitals and other facilities, information technology and consumer engagement infrastructure and other resources. UnitedHealthcare Employer&#160;&amp;amp; Individual offers an array of consumer-oriented health benefit plans and services for large national employers, public sector employers, mid-sized employers, small businesses, sole proprietorships and individuals nationwide. UnitedHealthcare Medicare&#160;&amp;amp; Retirement provides health care coverage and health and well-being services to individuals age 50 and older, addressing their unique needs for preventive and acute health care services as well as services dealing with chronic disease and other specialized issues for older individuals. UnitedHealthcare Community &amp;amp; State provides diversified health care benefits products and services to state programs caring for the economically disadvantaged, the medically underserved and those without the benefit of employer-funded health care coverage. UnitedHealthcare Community &amp;amp; State&#x2019;s primary customers oversee Medicaid plans, the Children&#x2019;s Health Insurance Program and other federal, state and community health care programs. UnitedHealthcare Global provides health and dental benefits and hospital and clinical services to employer groups and individuals in South America, and other diversified global health businesses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Optum Health&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; focuses on care delivery, care management, wellness and consumer engagement, and health financial services. Optum Health is building a comprehensive, connected health care delivery and engagement platform by directly providing high-quality care, helping people manage chronic and complex health needs, and proactively engaging consumers in managing their health through in-person, in-home, virtual and digital clinical platforms. Optum Health offers access to networks of care provider specialists, health management services, care delivery, consumer engagement and financial services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Optum Insight&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; brings together advanced analytics, technology and health care expertise to deliver integrated services and solutions. Hospital systems, physicians, health plans, governments, life sciences companies and other organizations comprising the health care industry depend on Optum Insight to help them improve performance, achieve efficiency, reduce costs, meet compliance mandates and modernize their core operating systems to meet the changing needs of the health system.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Optum Rx &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;offers pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, purchasing and clinical capabilities, and develops programs in areas such as step therapy, formulary management, drug adherence and disease/drug therapy management. Optum Rx integrates &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;pharmacy and medical care and is positioned to serve patients with complex clinical needs and consumers looking for a better digital pharmacy experience with transparent pricing.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s accounting policies for reportable segment operations are consistent with those described in the Summary of Significant Accounting Policies (see &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 2&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). Transactions between reportable segments principally consist of sales of pharmacy care products and services to UnitedHealthcare customers by Optum Rx, certain product offerings and care management and local and in-home care delivery services sold to UnitedHealthcare by Optum Health, and health information and technology solutions, consulting and other services sold to UnitedHealthcare by Optum Insight. These transactions are recorded at management&#x2019;s estimate of fair value. Transactions with affiliated customers are eliminated in consolidation. Assets and liabilities jointly used are assigned to each reportable segment using estimates of pro-rata usage. Cash and investments are assigned so each reportable segment has working capital and/or at least minimum specified levels of regulatory capital. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a percentage of the Company&#x2019;s total consolidated revenues, premium revenues from CMS were 36%, 36% and 33% for 2021, 2020 and 2019, respectively, most of which were generated by UnitedHealthcare Medicare &amp;amp; Retirement and included in the UnitedHealthcare segment. U.S. customer revenue represented approximately 97%, 97% and 96% of consolidated total revenues for 2021, 2020 and 2019, respectively. Long-lived fixed assets located in the United States represented approximately 78% and 75% of the total long-lived fixed assets as of December&#160;31, 2021 and 2020, respectively. The non-U.S. revenues and fixed assets are primarily related to UnitedHealthcare Global. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the reportable segment financial information:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.289%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Optum&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;UnitedHealthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Optum Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Optum Insight&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Optum Rx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Optum Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Optum&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Corporate&#160;and&lt;br/&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Revenues - unaffiliated customers:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;212,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;226,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues - unaffiliated customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;222,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;285,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues - affiliated customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;29,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;55,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,013)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;90,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(90,867)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment and other income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;222,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;54,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;91,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,013)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;155,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(90,867)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;287,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Earnings from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,660)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,660)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Earnings before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,660)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;102,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;40,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;117,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,284)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;212,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Purchases of property, equipment and capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Revenues - unaffiliated customers:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;191,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;201,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;33,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues - unaffiliated customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;200,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;55,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;255,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues - affiliated customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;52,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;80,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(80,042)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment and other income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;200,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;39,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;87,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;136,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(80,042)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;257,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Earnings from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,663)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,663)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Earnings before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,663)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;98,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;52,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;39,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;106,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,718)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;197,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Purchases of property, equipment and capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Revenues - unaffiliated customers:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;183,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;189,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues - unaffiliated customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;192,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;47,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;240,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues - affiliated customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,661)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;64,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(64,637)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment and other income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;193,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;74,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,661)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;112,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(64,637)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;242,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Earnings from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,704)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,704)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Earnings before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,704)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;88,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;40,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;36,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;91,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6,332)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;173,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Purchases of property, equipment and capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90ZXh0cmVnaW9uOjI5ZjUxMmRkY2JmNDQ2YzViOWZjOWFjN2UzNDM1NGNhXzY0MQ_f8b89d88-d8fe-4699-8537-2e8ea21e6e4c"
      unitRef="number">4</us-gaap:NumberOfReportableSegments>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="iab8d98a2b1f747909b4f89b860b8d491_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90ZXh0cmVnaW9uOjI5ZjUxMmRkY2JmNDQ2YzViOWZjOWFjN2UzNDM1NGNhXzQ4ODQ_f4f233f1-55e5-44de-b3fa-0ac56f996329"
      unitRef="number">0.36</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i6286320b787e4be4ae57d4beaf6bc896_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90ZXh0cmVnaW9uOjI5ZjUxMmRkY2JmNDQ2YzViOWZjOWFjN2UzNDM1NGNhXzQ4ODg_9916b598-77ad-4799-be89-258be581fe5c"
      unitRef="number">0.36</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i1cde2ac06fab4d7d9e153f395956be16_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90ZXh0cmVnaW9uOjI5ZjUxMmRkY2JmNDQ2YzViOWZjOWFjN2UzNDM1NGNhXzQ4OTU_dd291f63-262e-4afc-9d9b-4afdffaef160"
      unitRef="number">0.33</us-gaap:ConcentrationRiskPercentage1>
    <unh:DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers
      contextRef="ie251b137801e4de19d84d38991f2fc4c_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90ZXh0cmVnaW9uOjI5ZjUxMmRkY2JmNDQ2YzViOWZjOWFjN2UzNDM1NGNhXzUwOTY_aa94c0d6-233e-4b10-99ea-705397e4633a"
      unitRef="number">0.97</unh:DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers>
    <unh:DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers
      contextRef="i0cdd4b2069a14aa79f9ff108267e0050_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90ZXh0cmVnaW9uOjI5ZjUxMmRkY2JmNDQ2YzViOWZjOWFjN2UzNDM1NGNhXzUxMDA_1985d6a0-2e8d-403c-b0c3-748bfb4d9179"
      unitRef="number">0.97</unh:DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers>
    <unh:DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers
      contextRef="i0aa4f7c6ad7c4399ac91bad12d6477ed_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90ZXh0cmVnaW9uOjI5ZjUxMmRkY2JmNDQ2YzViOWZjOWFjN2UzNDM1NGNhXzUxMDc_80ce28ff-832e-4100-8f07-f8c5531c3950"
      unitRef="number">0.96</unh:DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers>
    <unh:DisclosureonGeographicAreasPercentageofLongLivedAssets
      contextRef="i9934c4a6735f409c90ddb14ad693c228_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90ZXh0cmVnaW9uOjI5ZjUxMmRkY2JmNDQ2YzViOWZjOWFjN2UzNDM1NGNhXzUyNTM_f1cb56f2-d1f1-4a82-9bb1-1c5f8a6e7f50"
      unitRef="number">0.78</unh:DisclosureonGeographicAreasPercentageofLongLivedAssets>
    <unh:DisclosureonGeographicAreasPercentageofLongLivedAssets
      contextRef="i738afd6f13b1403abb02fff8dfe35e83_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90ZXh0cmVnaW9uOjI5ZjUxMmRkY2JmNDQ2YzViOWZjOWFjN2UzNDM1NGNhXzUyNjA_8f416617-7f5b-4d17-8cf5-e2fe414514df"
      unitRef="number">0.75</unh:DisclosureonGeographicAreasPercentageofLongLivedAssets>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90ZXh0cmVnaW9uOjI5ZjUxMmRkY2JmNDQ2YzViOWZjOWFjN2UzNDM1NGNhXzU1MTg_a9785db1-4f9f-4ef0-a311-a501d43b2f0d">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the reportable segment financial information:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.289%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Optum&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;UnitedHealthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Optum Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Optum Insight&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Optum Rx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Optum Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Optum&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Corporate&#160;and&lt;br/&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Revenues - unaffiliated customers:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;212,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;226,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues - unaffiliated customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;222,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;285,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues - affiliated customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;29,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;55,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,013)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;90,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(90,867)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment and other income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;222,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;54,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;91,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,013)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;155,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(90,867)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;287,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Earnings from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,660)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,660)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Earnings before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,660)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;102,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;40,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;117,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,284)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;212,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Purchases of property, equipment and capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Revenues - unaffiliated customers:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;191,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;201,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;33,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues - unaffiliated customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;200,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;55,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;255,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues - affiliated customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;52,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;80,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(80,042)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment and other income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;200,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;39,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;87,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;136,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(80,042)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;257,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Earnings from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,663)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,663)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Earnings before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,663)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;98,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;52,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;39,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;106,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,718)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;197,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Purchases of property, equipment and capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Revenues - unaffiliated customers:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;183,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;189,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues - unaffiliated customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;192,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;47,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;240,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues - affiliated customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,661)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;64,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(64,637)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment and other income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;193,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;74,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,661)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;112,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(64,637)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;242,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Earnings from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,704)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,704)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Earnings before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,704)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;88,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;40,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;36,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;91,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6,332)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;173,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Purchases of property, equipment and capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:PremiumsEarnedNet
      contextRef="iee4705fe81d9455197bc18142d417d2a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQtMi0xLTEtMA_254fe404-9eac-4946-b126-b32af455f10f"
      unitRef="usd">212381000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i3e535292ef33468993675998c2605663_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQtNC0xLTEtMA_4850b9fc-2cfd-42d5-8eea-c8c41fd143c4"
      unitRef="usd">13852000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ic990f91ed37540749f170b9884cdaa28_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQtNi0xLTEtMA_584718df-cf91-4621-be7d-1cfb1db397e0"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="id3229a037bb842319e936ad6b2a51f54_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQtOC0xLTEtMA_abe005a6-9c84-4dea-b9b8-7e85e4b2f5de"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i6d0f7160671347419a34952ffc8558f7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQtMTAtMS0xLTA_34e5fd74-a559-4524-b0ed-6d762b272c25"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i92f08c3054b742748f6b0f913e60627d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQtMTItMS0xLTA_56c8227c-388d-4c6f-8fe7-df0d0af1d156"
      unitRef="usd">13852000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i9c2c9211b22745b98ab1ab28b8337c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQtMTQtMS0xLTA_9cb6dc9a-8c8d-459c-afc6-3c86b28807dd"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i1530a49a61da49318357204f5b8d80a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQtMTYtMS0xLTA_c4f53b15-ea6d-44c7-8316-ac02a4a25ec5"
      unitRef="usd">226233000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia6279b453c9048b8ad104e810416cbe4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzUtMi0xLTEtMA_b56aa502-9288-4e97-a1df-669c1f304fd5"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibb1b161f7dee4b48b64861165d69a88c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzUtNC0xLTEtMA_b5e801be-5228-44d5-9fbc-6b8d322dc350"
      unitRef="usd">32000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8400a403196b4b1a958b56a508d6d9b0_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzUtNi0xLTEtMA_6e92d79f-bd93-4a89-8910-1459fc507ead"
      unitRef="usd">159000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id1bfbb3548674a669b5b6862fa055067_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzUtOC0xLTEtMA_d744762d-7212-4da2-b0a8-79802c43b6d3"
      unitRef="usd">34246000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id9094967184f474f86b50dde16f3fe77_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzUtMTAtMS0xLTA_a097864c-9d48-41cb-8d44-4c86f440a12b"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9ebf459d7ca4411a991115796de7f6d5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzUtMTItMS0xLTA_217b7464-b3cd-47a4-8aed-de24dc5e2d00"
      unitRef="usd">34437000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if946d85193d24f7eab19007d8ced36a7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzUtMTQtMS0xLTA_7b7a004e-b247-464d-bc9d-4bdbd214d700"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i213b700417474af9b2ba5f4aa8d32fdb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzUtMTYtMS0xLTA_03f38a6d-4bc4-40e2-96e8-382680a323ef"
      unitRef="usd">34437000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9d1cef4ce9714d94a507aa88c10ea8e0_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzYtMi0xLTEtMA_a6a729b3-233e-4c56-8f6c-0dcdad140b3c"
      unitRef="usd">9661000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ife9ac604777648d1aef36fd158860f8b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzYtNC0xLTEtMA_0e124d8b-1c80-4ce3-af1c-f70041078e52"
      unitRef="usd">9894000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id3defa0ac8fe4ab8af3c5b1f321e4ac8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzYtNi0xLTEtMA_a577a830-47ef-46d2-a1bc-2b46c16afb70"
      unitRef="usd">3936000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ief7cdc8becb546ea9d8c89af57c961d9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzYtOC0xLTEtMA_518cf940-ec08-47ad-b3c1-dcf90018e74d"
      unitRef="usd">1112000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia88cef480a724f0f9f76711ad5e858fe_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzYtMTAtMS0xLTA_375060c0-06f0-4237-a4e5-95d73e3af79e"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ide28f350116d433e9a4361d7809e1736_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzYtMTItMS0xLTA_0792a5dd-2605-4b79-b0c4-5200d7a2cae4"
      unitRef="usd">14942000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie48fc3492bf64059adc2061a1f6feeff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzYtMTQtMS0xLTA_f76e526d-9c5d-4359-a09e-c40e22c815b5"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0c0a8f96f3fb4705b212d6fd60611c3b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzYtMTYtMS0xLTA_11bc06b9-d709-4b6b-bbf0-31dba585e919"
      unitRef="usd">24603000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="iee4705fe81d9455197bc18142d417d2a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzctMi0xLTEtMA_817172a2-c7ae-4bd3-a0ec-432888d799b9"
      unitRef="usd">222042000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3e535292ef33468993675998c2605663_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzctNC0xLTEtMA_27c7ab59-c349-49be-a470-37cbad7971e9"
      unitRef="usd">23778000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic990f91ed37540749f170b9884cdaa28_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzctNi0xLTEtMA_eeb7f06a-90f2-4e40-a2c4-b8bbee34dcf1"
      unitRef="usd">4095000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id3229a037bb842319e936ad6b2a51f54_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzctOC0xLTEtMA_afdd14d7-8eaf-468b-89d4-4c569e9f613b"
      unitRef="usd">35358000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6d0f7160671347419a34952ffc8558f7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzctMTAtMS0xLTA_f64f5bbc-bc72-407a-94df-eac4d8336111"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i92f08c3054b742748f6b0f913e60627d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzctMTItMS0xLTA_d7fe79aa-dfb1-4fd5-8c26-10f6cb0ff486"
      unitRef="usd">63231000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9c2c9211b22745b98ab1ab28b8337c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzctMTQtMS0xLTA_66a43ee1-4d2a-4d11-b985-bf4e0d640a58"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1530a49a61da49318357204f5b8d80a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzctMTYtMS0xLTA_eec1f730-5bec-44c2-b8e4-12eb97ca8f53"
      unitRef="usd">285273000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6b8cf1603c4345e1a2f17d91305ba20d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzgtMi0xLTEtMA_1cf41fb1-f622-463d-bfa0-499197ca3e4a"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5fca052182cd4adcae25d8c3d38cd9c8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzgtNC0xLTEtMA_e9e11246-f649-40f6-a956-1b6148cd819d"
      unitRef="usd">29234000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4ca8c63efcb348f6bb49eb114aa1ed4b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzgtNi0xLTEtMA_5b3cde7c-7bdf-4fd8-8c00-9774840146ef"
      unitRef="usd">7867000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id4ca79e1283c473bbdcfa153dd38f371_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzgtOC0xLTEtMA_80cf6698-aacc-478e-bb2a-7564b90db965"
      unitRef="usd">55779000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie14d3261f5ce4d5ca55b14d4eefcad6f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzgtMTAtMS0xLTA_93cc6223-d132-490d-95e8-063abca15505"
      unitRef="usd">-2013000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8e37d9f4072942d3ba64046e6f17b292_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzgtMTItMS0xLTA_31d331ff-214f-4647-9a98-15b07f0d156d"
      unitRef="usd">90867000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3ed0869af41147eb8333f00d982aa0fc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzgtMTQtMS0xLTA_98dee048-b122-473e-b6d2-f48353f839c9"
      unitRef="usd">-90867000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibfdfc0f71a2c4bbc8d894e75a883058c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzgtMTYtMS0xLTA_c0e89528-c3ef-4025-948f-8205fc57596b"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="idbc6824afba44fe3aedc3c732de59fed_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzktMi0xLTEtMA_660fe6a2-f75e-43db-b6cd-66987ceae43e"
      unitRef="usd">857000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ife381aeab14b4f16b57316de303fa1dc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzktNC0xLTEtMA_9bda6989-3569-41fc-9aeb-8c668b0e6cc6"
      unitRef="usd">1053000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ie7fc59569fab4373bc61b6d246fec133_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzktNi0xLTEtMA_1bafa4e8-15e1-412b-97e9-5d38704f6ea7"
      unitRef="usd">237000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i3c2c251890924c728ecbe00f7c589b5d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzktOC0xLTEtMA_f2311eea-5ec1-43f2-9c53-8e818dad614e"
      unitRef="usd">177000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i4b8078f333f54e939e1e3226c81d9047_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzktMTAtMS0xLTA_cba26300-6c0e-4297-97e5-5632cb189042"
      unitRef="usd">0</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="id0945fba67234634866077d9614c0b72_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzktMTItMS0xLTA_1e068c74-b7dd-45b1-b1f9-994e9003d039"
      unitRef="usd">1467000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ia9989fc2842a47be8b2f3c34eadc9a60_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzktMTQtMS0xLTA_6285b742-adeb-423b-8ee7-063e24969023"
      unitRef="usd">0</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzktMTYtMS0xLTA_6a46d76a-54f6-4d6e-9a83-391fd94e1ca6"
      unitRef="usd">2324000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:Revenues
      contextRef="idbc6824afba44fe3aedc3c732de59fed_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEwLTItMS0xLTA_2bd11889-2f7b-4343-b899-1fbb5e06d8b1"
      unitRef="usd">222899000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ife381aeab14b4f16b57316de303fa1dc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEwLTQtMS0xLTA_f674b49b-ee3a-42c3-bcd8-41f8b40b1fb9"
      unitRef="usd">54065000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie7fc59569fab4373bc61b6d246fec133_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEwLTYtMS0xLTA_bad65c7c-e614-4050-9076-8a0e42390cee"
      unitRef="usd">12199000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3c2c251890924c728ecbe00f7c589b5d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEwLTgtMS0xLTA_18449649-0060-4a01-9743-9f0c882d486b"
      unitRef="usd">91314000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4b8078f333f54e939e1e3226c81d9047_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEwLTEwLTEtMS0w_1a9fd057-19e0-489c-8346-3d6bdaade925"
      unitRef="usd">-2013000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id0945fba67234634866077d9614c0b72_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEwLTEyLTEtMS0w_12815d97-e9c2-40c1-8a18-7871329d93c1"
      unitRef="usd">155565000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia9989fc2842a47be8b2f3c34eadc9a60_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEwLTE0LTEtMS0w_4d999101-561a-477d-822a-b7dc9bc59247"
      unitRef="usd">-90867000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEwLTE2LTEtMS0w_02b5562d-3de9-4965-9159-91ec385cab37"
      unitRef="usd">287597000000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="idbc6824afba44fe3aedc3c732de59fed_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzExLTItMS0xLTA_aeb69945-6f2a-41f4-b997-db95420ec5d2"
      unitRef="usd">11975000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ife381aeab14b4f16b57316de303fa1dc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzExLTQtMS0xLTA_4439357b-35f6-4ed3-85c3-598eab8d5beb"
      unitRef="usd">4462000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie7fc59569fab4373bc61b6d246fec133_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzExLTYtMS0xLTA_f2f0d5eb-7993-4676-8981-1942fa5c2028"
      unitRef="usd">3398000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3c2c251890924c728ecbe00f7c589b5d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzExLTgtMS0xLTA_a9801263-67a0-4ccb-bb0a-d6a62f15ef01"
      unitRef="usd">4135000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4b8078f333f54e939e1e3226c81d9047_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzExLTEwLTEtMS0w_54ba91e5-2c6d-42fa-9954-106fd9e18d53"
      unitRef="usd">0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id0945fba67234634866077d9614c0b72_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzExLTEyLTEtMS0w_3265bb37-4c3f-46f8-a1d6-343905ab1b79"
      unitRef="usd">11995000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia9989fc2842a47be8b2f3c34eadc9a60_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzExLTE0LTEtMS0w_38461d5c-0412-4b42-89e3-551547edb3dd"
      unitRef="usd">0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzExLTE2LTEtMS0w_1bfca614-6f72-4977-aff7-5a97c4ed64c7"
      unitRef="usd">23970000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="idbc6824afba44fe3aedc3c732de59fed_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEyLTItMS0xLTA_86bb3d09-4530-40b8-bb6a-8cd3ce60cade"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ife381aeab14b4f16b57316de303fa1dc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEyLTQtMS0xLTA_d0bba8ac-907c-432f-ad43-9eb622cce53a"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ie7fc59569fab4373bc61b6d246fec133_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEyLTYtMS0xLTA_dc572d40-bf65-4ff5-b26d-26814b8553ad"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i3c2c251890924c728ecbe00f7c589b5d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEyLTgtMS0xLTA_ad830245-6285-4c46-a4b9-f41e19f6d016"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i4b8078f333f54e939e1e3226c81d9047_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEyLTEwLTEtMS0w_322a1b3f-aff3-44ea-b18c-b58a27e41422"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="id0945fba67234634866077d9614c0b72_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEyLTEyLTEtMS0w_78178e66-3d1c-494e-aaba-07663c90307a"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ia9989fc2842a47be8b2f3c34eadc9a60_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEyLTE0LTEtMS0w_1178dd81-39a1-4c4a-bf84-23150d0fe861"
      unitRef="usd">1660000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEyLTE2LTEtMS0w_25d57ef8-2974-43a3-a86c-a8669266d263"
      unitRef="usd">1660000000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="idbc6824afba44fe3aedc3c732de59fed_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEzLTItMS0xLTA_50efedf8-8435-49a3-bd2b-e0375bd5bb8c"
      unitRef="usd">11975000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ife381aeab14b4f16b57316de303fa1dc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEzLTQtMS0xLTA_07005428-b75f-47e8-9e69-7064055d5a69"
      unitRef="usd">4462000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ie7fc59569fab4373bc61b6d246fec133_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEzLTYtMS0xLTA_392875e1-56f9-4dbd-8650-843fa7709189"
      unitRef="usd">3398000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i3c2c251890924c728ecbe00f7c589b5d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEzLTgtMS0xLTA_e3c70791-956c-46be-b7f2-c10197f66437"
      unitRef="usd">4135000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i4b8078f333f54e939e1e3226c81d9047_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEzLTEwLTEtMS0w_ecd39790-b1f0-4afc-b74a-0691ef10f6d8"
      unitRef="usd">0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="id0945fba67234634866077d9614c0b72_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEzLTEyLTEtMS0w_56f03e16-a3c3-4fb3-8361-91f40795f7b3"
      unitRef="usd">11995000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ia9989fc2842a47be8b2f3c34eadc9a60_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEzLTE0LTEtMS0w_d18edd58-26c2-4215-83dd-c3e13823176e"
      unitRef="usd">-1660000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzEzLTE2LTEtMS0w_95ebf0ee-4135-4ced-8713-a022b55ca02a"
      unitRef="usd">22310000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:Assets
      contextRef="if184c0bbcb7247febb4f087da3c892c6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE0LTItMS0xLTA_6244f55c-1cfc-4b5a-9540-8bc349b049a9"
      unitRef="usd">102967000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i2e418b78bbe046c6aa713f2359794876_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE0LTQtMS0xLTA_ad4a689c-516c-436c-909c-e85900be8dd8"
      unitRef="usd">60474000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="id04de182af82446c8a35182aaf2b48c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE0LTYtMS0xLTA_8d21564e-cac5-4905-b894-01188678ee38"
      unitRef="usd">16868000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="idc410a001b324c2894fbec26bfef7b86_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE0LTgtMS0xLTA_bc4f4fe8-bd09-4511-80b3-c9d5ebc751c4"
      unitRef="usd">40181000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i2f15426e9ba74458aebc54c25df28187_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE0LTEwLTEtMS0w_7c120959-f462-48df-a121-ef632ea1ad99"
      unitRef="usd">0</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i18674f2c4d12424c968d20476457dd0b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE0LTEyLTEtMS0w_39f6368d-e8c1-4432-9ee1-88e09348ee0c"
      unitRef="usd">117523000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ia0a3d0d7510f4b139641910dd08967c1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE0LTE0LTEtMS0w_019aa947-ad72-43ef-ad80-74ab184bad8f"
      unitRef="usd">-8284000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ia9973178a1474e659ee68ed2ce06eb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE0LTE2LTEtMS0w_5d8896e9-80f4-4221-ad19-aeab4ad9f10c"
      unitRef="usd">212206000000</us-gaap:Assets>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="idbc6824afba44fe3aedc3c732de59fed_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE1LTItMS0xLTA_b89ebd05-5167-47bb-8122-b6225fc6bb73"
      unitRef="usd">795000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ife381aeab14b4f16b57316de303fa1dc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE1LTQtMS0xLTA_922e3f49-3b81-4b35-97a2-c4be8d7a3232"
      unitRef="usd">791000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ie7fc59569fab4373bc61b6d246fec133_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE1LTYtMS0xLTA_0ce110e4-dae2-4f8b-9e86-70d25e0996bd"
      unitRef="usd">567000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i3c2c251890924c728ecbe00f7c589b5d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE1LTgtMS0xLTA_65416fad-2f5a-4e71-8843-6e3277025ca0"
      unitRef="usd">301000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i4b8078f333f54e939e1e3226c81d9047_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE1LTEwLTEtMS0w_623efbb4-b744-43eb-80a9-35ed81443359"
      unitRef="usd">0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="id0945fba67234634866077d9614c0b72_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE1LTEyLTEtMS0w_220d2690-f127-451f-998c-4c3ff9fbe073"
      unitRef="usd">1659000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ia9989fc2842a47be8b2f3c34eadc9a60_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE1LTE0LTEtMS0w_aaa4aaed-a300-4867-b7a2-95ee2f56a647"
      unitRef="usd">0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE1LTE2LTEtMS0w_e36904dc-4db7-4559-8409-5eed5792a39c"
      unitRef="usd">2454000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:DepreciationAndAmortization
      contextRef="idbc6824afba44fe3aedc3c732de59fed_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE2LTItMS0xLTA_e77fecd7-3828-4ead-9689-9903372ed851"
      unitRef="usd">1004000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ife381aeab14b4f16b57316de303fa1dc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE2LTQtMS0xLTA_988d2056-1810-4d06-a211-6eda89390d19"
      unitRef="usd">818000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ie7fc59569fab4373bc61b6d246fec133_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE2LTYtMS0xLTA_40d6be81-9265-4788-b2a4-05243a179fcb"
      unitRef="usd">684000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i3c2c251890924c728ecbe00f7c589b5d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE2LTgtMS0xLTA_c70e7b62-6d51-43b3-a55e-bca76ee812a7"
      unitRef="usd">597000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i4b8078f333f54e939e1e3226c81d9047_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE2LTEwLTEtMS0w_0fd452d6-7a82-452c-8111-4145595f3e4f"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="id0945fba67234634866077d9614c0b72_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE2LTEyLTEtMS0w_3353ed40-9f51-48a2-92f5-e5238c4ad55b"
      unitRef="usd">2099000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ia9989fc2842a47be8b2f3c34eadc9a60_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE2LTE0LTEtMS0w_09c4869a-aee9-4441-a55a-e329901e1f30"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE2LTE2LTEtMS0w_c63bcadf-d1d3-451f-b813-cc0e045baf2c"
      unitRef="usd">3103000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:PremiumsEarnedNet
      contextRef="ie9ed61319c0a45798da15c42c3e38cd0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE5LTItMS0xLTA_a9f8f003-dcc4-4302-a169-5956dfaed566"
      unitRef="usd">191679000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i17627bd9a4c5409e9c94b533f8f5ae1c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE5LTQtMS0xLTA_c2566ea0-656b-4cb7-8b1f-25871ce4f787"
      unitRef="usd">9799000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ie2cc2e00b67f4fcf82476fd51fd0699e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE5LTYtMS0xLTA_b4e493af-1dce-4d2a-b292-c44a8020df78"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i8ba88a0ee30c45278b5ace52700290ad_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE5LTgtMS0xLTA_66a5803f-387a-4855-8dc7-100a87119082"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i0594531b29c14219bef65d8cd283fc9e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE5LTEwLTEtMS0w_fbdfe234-917c-4545-8295-576563bcd55c"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i87c3f11df32b441eb7fee715e6d92010_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE5LTEyLTEtMS0w_954d9a2a-5d3e-4946-81e9-6ad29669b054"
      unitRef="usd">9799000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i451a7a7915ff449fbc9bd1d7c005293d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE5LTE0LTEtMS0w_c0558cca-d535-4348-b3b8-ace82ac3971d"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ieb1b06cf327e4bfca58345b40abc554a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzE5LTE2LTEtMS0w_3de370a9-b90c-4104-b269-04ca416658f6"
      unitRef="usd">201478000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic4e9e37ffd9442649f7208882a987c32_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIwLTItMS0xLTA_e371319f-89b5-42b6-a509-b667b9fc52a9"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i476fc79de3284b55b364793f612b1a19_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIwLTQtMS0xLTA_5833ec67-240d-46f4-a48e-d68b5fdcd83b"
      unitRef="usd">33000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i97e70d750485412480c983dd5791128d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIwLTYtMS0xLTA_79a657d4-d77a-4e2c-ae6a-64e11e106d6a"
      unitRef="usd">135000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i097c78c5b5544597a305bc89df54bd95_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIwLTgtMS0xLTA_2054758f-534e-4233-9e51-428874e9fe15"
      unitRef="usd">33977000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ied275047eb1f45e5a90acc5936ce8821_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIwLTEwLTEtMS0w_c4823e90-1256-4da6-91f4-81157c9f1cfe"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8618f261f45e45c98738e7bb3e6bda9d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIwLTEyLTEtMS0w_098d84de-2680-48df-a411-f96a34520147"
      unitRef="usd">34145000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i026c8094e6214ea8a156691c9176a6a0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIwLTE0LTEtMS0w_742c14fe-b7db-44cd-859e-6c66fb1065c7"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if36ef5c1313e4865b5b21c968b7637ce_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIwLTE2LTEtMS0w_3343190e-c6da-44f5-a413-985510d99e1a"
      unitRef="usd">34145000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9bb1779f53f54fe7a529d721403d381e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIxLTItMS0xLTA_c6940316-66e5-478b-a79b-dd086ce5a881"
      unitRef="usd">8464000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5c78ced66e794cfd90dfb9d9b04070c6_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIxLTQtMS0xLTA_beb7102f-808a-4d7a-98f5-6f1f018d654c"
      unitRef="usd">6815000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib88407875cb54f609ca6d2c491acde2a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIxLTYtMS0xLTA_a0c698c7-79c3-46f6-ba1e-58ef6e215ffd"
      unitRef="usd">3687000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8a6318238dc84a50b52e2aa5ce8fab33_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIxLTgtMS0xLTA_f40bbbeb-53ed-4e31-9a9e-59955cb97c60"
      unitRef="usd">1050000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i27c98317ad344b9499d3c32c021c9f7e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIxLTEwLTEtMS0w_0767a1ad-1885-4988-93c7-0e5d263f9178"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icb5025c996f04acfb22d6284a0a6eda9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIxLTEyLTEtMS0w_d397d764-e1e9-4cb7-9dda-c384d55b5b27"
      unitRef="usd">11552000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8061ff53692d49e09adca8578d72d4cc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIxLTE0LTEtMS0w_a3460156-cf81-42fb-8982-d03903430ae0"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie7288d5a2ace47fead21082bff05e780_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIxLTE2LTEtMS0w_b8755544-8634-4949-9dcb-c212c5a01889"
      unitRef="usd">20016000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="ie9ed61319c0a45798da15c42c3e38cd0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIyLTItMS0xLTA_0c0c79fa-f8ab-43cc-818c-0fc3100e0021"
      unitRef="usd">200143000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i17627bd9a4c5409e9c94b533f8f5ae1c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIyLTQtMS0xLTA_321469cc-d4d5-40c6-8fe6-2f8dbaa0e511"
      unitRef="usd">16647000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie2cc2e00b67f4fcf82476fd51fd0699e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIyLTYtMS0xLTA_867e9208-3a18-4c3d-a363-92424ebd8996"
      unitRef="usd">3822000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8ba88a0ee30c45278b5ace52700290ad_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIyLTgtMS0xLTA_5c955d24-bf66-46a7-a1c7-94649f258525"
      unitRef="usd">35027000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0594531b29c14219bef65d8cd283fc9e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIyLTEwLTEtMS0w_3807fc3d-ee7d-4a02-904e-768dc044e6e2"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i87c3f11df32b441eb7fee715e6d92010_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIyLTEyLTEtMS0w_5869dcba-c008-48cb-a45c-420f98054143"
      unitRef="usd">55496000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i451a7a7915ff449fbc9bd1d7c005293d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIyLTE0LTEtMS0w_1c2c57f8-c15f-47e2-ada5-0f9f105d10fa"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ieb1b06cf327e4bfca58345b40abc554a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIyLTE2LTEtMS0w_6cd90f70-b6d2-4ff3-be1a-34b7aadd6157"
      unitRef="usd">255639000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i60cedc1d72954901a048fe79a192b8c1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIzLTItMS0xLTA_33ebbc2f-9e41-4c62-b03b-761892fc24f1"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7df7d80b21d94258923146d050c70aa8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIzLTQtMS0xLTA_4c0647f3-4bf3-4b0d-b8f3-ecb9c748d397"
      unitRef="usd">22481000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibf0af36cf92d48a0b98b4f9034ffb32d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIzLTYtMS0xLTA_4b02be3e-42f2-4fc8-9a4a-38e758e157fd"
      unitRef="usd">6941000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icacb7b0bda5541ac9648de164759144a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIzLTgtMS0xLTA_0d6f8583-e000-44a4-97f7-c9ea500b76ac"
      unitRef="usd">52420000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i81a2f35fd1414929bcea4c64d9b78904_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIzLTEwLTEtMS0w_0ffecc2a-c08b-413d-9d67-8e286286fba7"
      unitRef="usd">-1800000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2a16d027033644d5b0b62819b881ff74_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIzLTEyLTEtMS0w_74ceb8e5-143c-4b72-9baa-95a1d3e712bf"
      unitRef="usd">80042000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0d4de446cb684fb98b6beb87c8a76032_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIzLTE0LTEtMS0w_aff5f549-ffa3-4534-a7ac-9452bf8e1c99"
      unitRef="usd">-80042000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i54812316cf0241ad80e1416a9adb8137_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzIzLTE2LTEtMS0w_84143772-f056-4cf2-b145-6bba2fd7fc75"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i81f09e67922c4373afc90c08de19f39f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI0LTItMS0xLTA_9675c173-0d0f-480e-8d8c-24fce6f4c865"
      unitRef="usd">732000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i6457702d9d2444e2bd3006604563b0c7_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI0LTQtMS0xLTA_d8935f10-17e9-48de-8ea0-a3f22c0a2047"
      unitRef="usd">680000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ie0fdc75afbab4fee9a53cbbd8a5ee695_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI0LTYtMS0xLTA_d0d6f2bb-9f91-4ec1-99ac-449d79405309"
      unitRef="usd">39000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i9b17e0bd3b914d2bbf6bf114349486a0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI0LTgtMS0xLTA_249f4e05-c708-4a83-9886-f075ca15bff4"
      unitRef="usd">51000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i5087b2a7612d4c559bb8832aa4ef4e1f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI0LTEwLTEtMS0w_02204cf7-e784-4bf3-9fdf-a1d14bebcd95"
      unitRef="usd">0</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i97c4cc1a264b40839a4392c3a86f7175_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI0LTEyLTEtMS0w_986fb7db-05f7-4955-8c06-cbb8c3ee9f90"
      unitRef="usd">770000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i8dc352162fbe4ed18df7bd7477ea0efd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI0LTE0LTEtMS0w_75673edf-fcef-4d38-a912-ae1f1fd39d43"
      unitRef="usd">0</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI0LTE2LTEtMS0w_7133f253-56a5-444b-a65d-da1ada1c674f"
      unitRef="usd">1502000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:Revenues
      contextRef="i81f09e67922c4373afc90c08de19f39f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI1LTItMS0xLTA_d72c6fc4-d2ba-4582-8bff-e1a65f0da9c0"
      unitRef="usd">200875000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6457702d9d2444e2bd3006604563b0c7_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI1LTQtMS0xLTA_4761b38f-ef64-4ed4-8e02-bb3822798d1a"
      unitRef="usd">39808000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie0fdc75afbab4fee9a53cbbd8a5ee695_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI1LTYtMS0xLTA_4218116c-a578-4af4-ad66-d083d1cb74ce"
      unitRef="usd">10802000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9b17e0bd3b914d2bbf6bf114349486a0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI1LTgtMS0xLTA_f9d0c604-a774-493b-b43d-35b10687db7c"
      unitRef="usd">87498000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5087b2a7612d4c559bb8832aa4ef4e1f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI1LTEwLTEtMS0w_402c8272-2a37-405a-accf-1537a0aa462c"
      unitRef="usd">-1800000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i97c4cc1a264b40839a4392c3a86f7175_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI1LTEyLTEtMS0w_b79d0e3c-31bb-4983-b8cb-6d49ca945f09"
      unitRef="usd">136308000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8dc352162fbe4ed18df7bd7477ea0efd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI1LTE0LTEtMS0w_74432812-c691-4ef4-af16-b89eafe3cfc0"
      unitRef="usd">-80042000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI1LTE2LTEtMS0w_97179eb6-6334-4bd5-8522-d4b13ada49c3"
      unitRef="usd">257141000000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="i81f09e67922c4373afc90c08de19f39f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI2LTItMS0xLTA_625f5606-57ef-498b-b9b2-1129ed09a1f2"
      unitRef="usd">12359000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6457702d9d2444e2bd3006604563b0c7_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI2LTQtMS0xLTA_fd16c1f7-5c3f-45b8-b280-d64c5f6d9647"
      unitRef="usd">3434000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie0fdc75afbab4fee9a53cbbd8a5ee695_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI2LTYtMS0xLTA_d3f415e9-7517-4416-8f67-76a880f1a1e9"
      unitRef="usd">2725000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9b17e0bd3b914d2bbf6bf114349486a0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI2LTgtMS0xLTA_f44e6ed4-7ddc-46c8-8628-07f20cf2adbe"
      unitRef="usd">3887000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5087b2a7612d4c559bb8832aa4ef4e1f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI2LTEwLTEtMS0w_79b8a3a5-8d85-4f62-b177-ffac2ef5fdfe"
      unitRef="usd">0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i97c4cc1a264b40839a4392c3a86f7175_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI2LTEyLTEtMS0w_5052fe2b-8cfa-494b-9964-5d0086f6227b"
      unitRef="usd">10046000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8dc352162fbe4ed18df7bd7477ea0efd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI2LTE0LTEtMS0w_af43eee2-3b7d-4628-be65-4605780f1431"
      unitRef="usd">0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI2LTE2LTEtMS0w_69bb2b56-d2b5-4afd-beeb-ac50d41e1e51"
      unitRef="usd">22405000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i81f09e67922c4373afc90c08de19f39f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI3LTItMS0xLTA_49ee3d53-8893-4333-b84d-447dc94d2272"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i6457702d9d2444e2bd3006604563b0c7_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI3LTQtMS0xLTA_bd37d71b-f654-4322-9044-2d5d65967b75"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ie0fdc75afbab4fee9a53cbbd8a5ee695_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI3LTYtMS0xLTA_a6ff616b-db10-443c-a2dd-f1be6686caa6"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i9b17e0bd3b914d2bbf6bf114349486a0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI3LTgtMS0xLTA_6f8e37cc-a624-4803-b526-b645179ddf7e"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i5087b2a7612d4c559bb8832aa4ef4e1f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI3LTEwLTEtMS0w_e5d90bdb-d4ea-44b2-9274-2831a8d7f215"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i97c4cc1a264b40839a4392c3a86f7175_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI3LTEyLTEtMS0w_3928d6f5-eb9b-4b11-9959-44ee1787af82"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i8dc352162fbe4ed18df7bd7477ea0efd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI3LTE0LTEtMS0w_779d68c7-10be-426a-b293-f7a47f41a73f"
      unitRef="usd">1663000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI3LTE2LTEtMS0w_f33ed376-d783-4f09-8a02-619cc8e7dbe3"
      unitRef="usd">1663000000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i81f09e67922c4373afc90c08de19f39f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI4LTItMS0xLTA_1d7a359e-30d3-481f-b414-414375a41f43"
      unitRef="usd">12359000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i6457702d9d2444e2bd3006604563b0c7_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI4LTQtMS0xLTA_a1f95103-b880-4c76-8975-43ade43b6aa4"
      unitRef="usd">3434000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ie0fdc75afbab4fee9a53cbbd8a5ee695_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI4LTYtMS0xLTA_6bc0c3a0-8591-4efc-8855-1a5fb1098036"
      unitRef="usd">2725000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i9b17e0bd3b914d2bbf6bf114349486a0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI4LTgtMS0xLTA_9ab21f25-0b8b-4637-ae28-bb711899ff1c"
      unitRef="usd">3887000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5087b2a7612d4c559bb8832aa4ef4e1f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI4LTEwLTEtMS0w_0f30df6d-e905-426c-826b-ec86cf5b5ec7"
      unitRef="usd">0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i97c4cc1a264b40839a4392c3a86f7175_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI4LTEyLTEtMS0w_19b7bcdb-359f-4341-8398-a65d92dc5406"
      unitRef="usd">10046000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i8dc352162fbe4ed18df7bd7477ea0efd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI4LTE0LTEtMS0w_2d50dfee-8c52-4f28-8a8c-c3d1c4bbba6a"
      unitRef="usd">-1663000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI4LTE2LTEtMS0w_0bafcba8-e975-4ebd-8c2c-4689559ec892"
      unitRef="usd">20742000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:Assets
      contextRef="ibf5ca22db7484acf8738fe8c4096beaa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI5LTItMS0xLTA_5f1872e2-fcf6-45b0-bf18-bc2251916821"
      unitRef="usd">98229000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ib0ddb85685644e32aaa72bd4c99df7d3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI5LTQtMS0xLTA_48d98f32-9621-4772-8299-eff8d67d108e"
      unitRef="usd">52073000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i765e712ac4354f6b9977ebd8a5137668_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI5LTYtMS0xLTA_8e9d02ac-b061-41be-8c92-b3e976caaa4d"
      unitRef="usd">15425000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ia9ce56590e08493a92f4e98ff05295de_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI5LTgtMS0xLTA_f204f499-5f70-420d-8513-352e026e380b"
      unitRef="usd">39280000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="iae958eee276045ee967123983469f6ed_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI5LTEwLTEtMS0w_c2902824-ab18-4f3a-9d66-d84d964f1c30"
      unitRef="usd">0</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i7c5071fb5c87448187540e1a182c3bf1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI5LTEyLTEtMS0w_ecc93ae9-2797-4e4b-8e50-dce22cbe22ae"
      unitRef="usd">106778000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i61970d2504044d078cdd34efba0cd162_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI5LTE0LTEtMS0w_59030165-d1ef-4d89-b7bd-bee81b650b34"
      unitRef="usd">-7718000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ie3ed3c20fea0451eae935c55f1c8b54b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzI5LTE2LTEtMS0w_e2047296-3155-47e0-ba82-3b14c241e32e"
      unitRef="usd">197289000000</us-gaap:Assets>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i81f09e67922c4373afc90c08de19f39f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzMwLTItMS0xLTA_5b8879fb-e07d-4884-8bed-ce22b811f809"
      unitRef="usd">687000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i6457702d9d2444e2bd3006604563b0c7_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzMwLTQtMS0xLTA_63082be0-74a9-46b7-887e-16f93facc48c"
      unitRef="usd">715000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ie0fdc75afbab4fee9a53cbbd8a5ee695_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzMwLTYtMS0xLTA_ee09efcf-6218-4ddb-85c7-cdaddc20de96"
      unitRef="usd">461000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i9b17e0bd3b914d2bbf6bf114349486a0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzMwLTgtMS0xLTA_c1204989-92fc-4fee-9295-70ba9e0eb8d7"
      unitRef="usd">188000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i5087b2a7612d4c559bb8832aa4ef4e1f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzMwLTEwLTEtMS0w_c19f9977-71fc-4da4-9f2f-a2976e4a78b7"
      unitRef="usd">0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i97c4cc1a264b40839a4392c3a86f7175_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzMwLTEyLTEtMS0w_e6922445-330c-41a2-8e2a-0c8595a8a5d2"
      unitRef="usd">1364000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i8dc352162fbe4ed18df7bd7477ea0efd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzMwLTE0LTEtMS0w_017add6d-6c6e-4d3f-901f-799b1dcb5af3"
      unitRef="usd">0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzMwLTE2LTEtMS0w_f5556050-46ac-47d9-bc4a-df8670b6c52b"
      unitRef="usd">2051000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:DepreciationAndAmortization
      contextRef="i81f09e67922c4373afc90c08de19f39f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzMxLTItMS0xLTA_beee2871-efde-4a41-a555-0e1b96f720d2"
      unitRef="usd">920000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i6457702d9d2444e2bd3006604563b0c7_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzMxLTQtMS0xLTA_09a7590d-6e01-41a2-a6a2-d19e0e4f09c7"
      unitRef="usd">703000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ie0fdc75afbab4fee9a53cbbd8a5ee695_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzMxLTYtMS0xLTA_d25b3778-0368-4e93-9c5a-4b82daf16076"
      unitRef="usd">670000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i9b17e0bd3b914d2bbf6bf114349486a0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzMxLTgtMS0xLTA_0e80e276-4c4a-46fa-91fe-060779540712"
      unitRef="usd">598000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i5087b2a7612d4c559bb8832aa4ef4e1f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzMxLTEwLTEtMS0w_96840a3a-9416-4f29-9b33-e6c31df47bda"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i97c4cc1a264b40839a4392c3a86f7175_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzMxLTEyLTEtMS0w_9fc59399-2b36-4cde-a513-2b97eb740637"
      unitRef="usd">1971000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i8dc352162fbe4ed18df7bd7477ea0efd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzMxLTE0LTEtMS0w_435b9b15-104a-48aa-a276-b3027d0f32c4"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i95a147e133fb4ed7872ad044d6444458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzMxLTE2LTEtMS0w_b2089db1-0841-48b0-b645-dbba195527ab"
      unitRef="usd">2891000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:PremiumsEarnedNet
      contextRef="i859e241a022540eca1b22afddbe55e1b_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM0LTItMS0xLTA_4e25113e-3445-49fc-812e-7f0d11eb284f"
      unitRef="usd">183783000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i2ec7b4d30d5e48deb9045b349aaf4dd4_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM0LTQtMS0xLTA_0819ac27-0327-4194-bd97-f1702a27e69a"
      unitRef="usd">5916000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="id1b5e284b10548f2b4cea7ea557161f0_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM0LTYtMS0xLTA_9e0063c5-383e-48a1-9f2e-f1b65293a396"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ifef7b0e583964ad39d94daea6cea3366_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM0LTgtMS0xLTA_de468a02-3405-4d59-8c68-7c84c0f5f60f"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ia58c1f8d468c437393baf523e864a524_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM0LTEwLTEtMS0w_f81c4383-58c6-43c6-9d74-c1a93834f2f2"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ia0a43f969e6045adbb4d7a5ed18144fe_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM0LTEyLTEtMS0w_7e5eea3e-d1b1-42d3-aa5e-191a73362983"
      unitRef="usd">5916000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i9e4f8878a34a4cb4bc6c14d692445406_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM0LTE0LTEtMS0w_e3178edd-39ff-4450-85b6-b8a020b755af"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i0e0a9e0b05964d5b81c4faaf9261f866_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM0LTE2LTEtMS0w_0e7fc078-1681-4c74-8b21-de35dd07b14b"
      unitRef="usd">189699000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id7daf143ec32478b96d361bc8bbcb4a7_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM1LTItMS0xLTA_a903cd08-8f10-4c01-8ca2-920af1d3763e"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic4466e0b3d7e4d21b0cdb371895ed5bc_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM1LTQtMS0xLTA_2f7f5fe4-c140-40e7-86bc-9804367aa995"
      unitRef="usd">31000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i40e8a322046c48e9bb4d5a3f9d8d69bc_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM1LTYtMS0xLTA_d063a537-b9fc-4ba6-8cc3-1e4d21e2ee2f"
      unitRef="usd">116000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i665d6130ef0b4aa8b4c4151cae26a10c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM1LTgtMS0xLTA_1a6d9bcc-1846-4046-9b48-601fec4eba0b"
      unitRef="usd">31450000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieab8464742d34bbab93c7d73240b238a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM1LTEwLTEtMS0w_4232d87f-77f3-4eed-b575-4f42886185a6"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0bf9cb13150a4db19778cd757e617679_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM1LTEyLTEtMS0w_f4ad497a-9f51-40bf-b6dc-227cc74c1e33"
      unitRef="usd">31597000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia1556f868d6143eaa08d050b665df1a1_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM1LTE0LTEtMS0w_959549e3-b25f-4df3-8317-d24b5199a98d"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifd51ec9383cd46588877c19834efb15a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM1LTE2LTEtMS0w_284e1d3e-9264-4b72-9761-f714cda89c91"
      unitRef="usd">31597000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1bcf02a9e58b4aa7bf1bbb8dd1ab6cb2_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM2LTItMS0xLTA_b2526319-2e9d-45e7-92a8-55af43b4c65d"
      unitRef="usd">8922000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1c79ad983a524d509a081c39abd43c4a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM2LTQtMS0xLTA_23d8f7d5-84bb-43e6-a08a-3bf8bd9ae7b5"
      unitRef="usd">5732000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i33d20e2cf6204d4097b19633f98c100e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM2LTYtMS0xLTA_af38ff9a-3613-4720-aa73-a33c775a3875"
      unitRef="usd">3630000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia9fb83dc51774898890f78347ad88320_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM2LTgtMS0xLTA_10522ae8-86b3-4151-9e9b-2bf9bf32f809"
      unitRef="usd">689000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2e782903147c4e9bbf36b4ecb9601b62_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM2LTEwLTEtMS0w_1e71183a-b9c1-4214-9805-e8430a873b22"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i13864f629b874a0ca8c1ae8f96420ee4_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM2LTEyLTEtMS0w_952d1d29-876d-4406-9b0f-bae89a6bf32e"
      unitRef="usd">10051000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i19c1e613e77143c39c1a29089613da3f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM2LTE0LTEtMS0w_ebc49219-524b-49b1-9152-09db337eed3c"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia069a517828549fcad85e8b0f07df91a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM2LTE2LTEtMS0w_af76f1cb-336a-4cb0-b6d3-92de432d2219"
      unitRef="usd">18973000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="i859e241a022540eca1b22afddbe55e1b_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM3LTItMS0xLTA_402891bf-a4ba-47de-bafd-3dfae179a29c"
      unitRef="usd">192705000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2ec7b4d30d5e48deb9045b349aaf4dd4_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM3LTQtMS0xLTA_bf241ef0-3a11-4d75-8cc2-aab7b98cac35"
      unitRef="usd">11679000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id1b5e284b10548f2b4cea7ea557161f0_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM3LTYtMS0xLTA_03115437-40f2-473c-9c44-a3c541e3e2fc"
      unitRef="usd">3746000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifef7b0e583964ad39d94daea6cea3366_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM3LTgtMS0xLTA_ceba1b87-3633-47bd-8744-c70985d422e9"
      unitRef="usd">32139000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia58c1f8d468c437393baf523e864a524_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM3LTEwLTEtMS0w_a776b4f2-8eca-4a0a-92e4-fe082b6d588b"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia0a43f969e6045adbb4d7a5ed18144fe_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM3LTEyLTEtMS0w_b06032a4-e235-4481-953a-42f1ee6e3cbc"
      unitRef="usd">47564000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9e4f8878a34a4cb4bc6c14d692445406_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM3LTE0LTEtMS0w_9fe90ed7-927c-461c-bd1a-b315f7ee1b59"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0e0a9e0b05964d5b81c4faaf9261f866_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM3LTE2LTEtMS0w_22eac0b8-e566-40d3-b4f2-2372b5a1cd7f"
      unitRef="usd">240269000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i664db88488f9454c91beba797474bd74_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM4LTItMS0xLTA_74c7dab8-1ac5-44fa-b658-651b6bb7835e"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9899068118274125a66eb1295dc7f180_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM4LTQtMS0xLTA_39f015f8-5385-4a4e-b213-be764806d5d0"
      unitRef="usd">17966000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i62a850c94958453b97ee49874206807a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM4LTYtMS0xLTA_a607bdb8-06ca-4a3b-952e-dad7c68d0864"
      unitRef="usd">6239000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8dbca3a853c54c32a188e60371e49401_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM4LTgtMS0xLTA_dc304660-5225-4f11-9cf3-f5cba35ebdf8"
      unitRef="usd">42093000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1401b070d66b4858bebfe8622b519047_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM4LTEwLTEtMS0w_5f6be02e-e67d-4a0c-a207-3f66435aa421"
      unitRef="usd">-1661000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2e7b35ab4daa4d56a1ac8eed3dddbaa8_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM4LTEyLTEtMS0w_deeef42a-3cf2-4bcb-bca2-27a6ec2d6509"
      unitRef="usd">64637000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6c0c40f3739a4f6aa750404ae32e1139_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM4LTE0LTEtMS0w_00f4bf0a-3a56-41b0-99d9-297c21e50f0e"
      unitRef="usd">-64637000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0c9b94d35868406a8c01569c6271992d_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM4LTE2LTEtMS0w_3f4b8d4b-c839-47ea-859b-a7d526c3fac6"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="if2cf4b896e2b44e084b69d51f3b09f38_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM5LTItMS0xLTA_32bdc3d7-0f3a-4e9c-bd87-fd71a792d68c"
      unitRef="usd">1137000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i6e31b11ef5824cbf953e4b36353741b6_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM5LTQtMS0xLTA_b510f746-cff2-49ad-ac91-272eec5df694"
      unitRef="usd">672000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i5775495e739143f9a2489ad44e260280_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM5LTYtMS0xLTA_d4b43573-7bcf-4b80-b9a4-f7f27f0495cf"
      unitRef="usd">21000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i4ba56749e5db4d4999936c411d19cea8_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM5LTgtMS0xLTA_5976c29f-933a-4c2f-861f-20f817078e59"
      unitRef="usd">56000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i143c69172b0543d3b4f8228cf2e657be_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM5LTEwLTEtMS0w_38ee8de4-3e7b-4318-95be-d33381e2ab57"
      unitRef="usd">0</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="if3e99423fe064b3f85abf9b78c7b60ef_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM5LTEyLTEtMS0w_5e259870-87d4-4862-a5ae-57b55fff7b29"
      unitRef="usd">749000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="iff8807e405c94f48aee4ee4cab179452_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM5LTE0LTEtMS0w_6bf19a70-3c58-40fb-8080-9e08d707f2af"
      unitRef="usd">0</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzM5LTE2LTEtMS0w_1d25b10c-0f01-47a4-99f3-ee0bd5534d4c"
      unitRef="usd">1886000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:Revenues
      contextRef="if2cf4b896e2b44e084b69d51f3b09f38_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQwLTItMS0xLTA_f40e0cf7-ad9e-451c-8b0b-c3ce56608bd5"
      unitRef="usd">193842000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6e31b11ef5824cbf953e4b36353741b6_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQwLTQtMS0xLTA_c8409075-0c0e-4307-a5fb-960d908aa0b9"
      unitRef="usd">30317000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5775495e739143f9a2489ad44e260280_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQwLTYtMS0xLTA_4f92c735-ecbf-4274-88cd-07bde335a006"
      unitRef="usd">10006000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4ba56749e5db4d4999936c411d19cea8_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQwLTgtMS0xLTA_6ed87383-37cd-49da-a7ea-fede9f64d749"
      unitRef="usd">74288000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i143c69172b0543d3b4f8228cf2e657be_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQwLTEwLTEtMS0w_ec44f9a4-16f2-4cbd-abf4-e0726785fcdf"
      unitRef="usd">-1661000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if3e99423fe064b3f85abf9b78c7b60ef_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQwLTEyLTEtMS0w_5872ea9a-c0a8-452e-8af4-60fbfedca561"
      unitRef="usd">112950000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iff8807e405c94f48aee4ee4cab179452_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQwLTE0LTEtMS0w_e052aa19-20fe-403f-8a3c-1e6b8a1e4595"
      unitRef="usd">-64637000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQwLTE2LTEtMS0w_6098081e-cfa1-4278-9967-6240f0e1cf84"
      unitRef="usd">242155000000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="if2cf4b896e2b44e084b69d51f3b09f38_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQxLTItMS0xLTA_6c4eecf2-9819-4964-af5b-9edde8eb8116"
      unitRef="usd">10326000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6e31b11ef5824cbf953e4b36353741b6_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQxLTQtMS0xLTA_da6d5d03-f85e-4730-9bdd-7b2aa4f25a4d"
      unitRef="usd">2963000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5775495e739143f9a2489ad44e260280_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQxLTYtMS0xLTA_c0134d05-3bcf-4008-b663-a9649fa99ff8"
      unitRef="usd">2494000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4ba56749e5db4d4999936c411d19cea8_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQxLTgtMS0xLTA_18d1199d-c7f8-4662-aa28-65e0cb8d1de5"
      unitRef="usd">3902000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i143c69172b0543d3b4f8228cf2e657be_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQxLTEwLTEtMS0w_19475784-1532-47a1-9c4c-972be69ea679"
      unitRef="usd">0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if3e99423fe064b3f85abf9b78c7b60ef_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQxLTEyLTEtMS0w_a3afee08-85ef-48e6-82cf-03108693efce"
      unitRef="usd">9359000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iff8807e405c94f48aee4ee4cab179452_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQxLTE0LTEtMS0w_f0cba4b1-d107-411d-99c1-f21c968fdafb"
      unitRef="usd">0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQxLTE2LTEtMS0w_af984955-3893-4e04-abfa-864d70f37752"
      unitRef="usd">19685000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="if2cf4b896e2b44e084b69d51f3b09f38_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQyLTItMS0xLTA_4d82a3ab-0f40-4bb6-b440-b25d0510a350"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i6e31b11ef5824cbf953e4b36353741b6_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQyLTQtMS0xLTA_84352a66-d557-4c08-8585-f53d2aa0aa51"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i5775495e739143f9a2489ad44e260280_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQyLTYtMS0xLTA_bf61889c-77fc-4f8a-8016-45853a53ff60"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i4ba56749e5db4d4999936c411d19cea8_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQyLTgtMS0xLTA_29f570d8-41d8-42f0-a0cd-cb7ee78dca2b"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i143c69172b0543d3b4f8228cf2e657be_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQyLTEwLTEtMS0w_97cf3a7f-3cc1-4c60-a801-ba815dd61afc"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="if3e99423fe064b3f85abf9b78c7b60ef_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQyLTEyLTEtMS0w_eceb5c98-c2df-4de4-8240-f0163b3f1815"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="iff8807e405c94f48aee4ee4cab179452_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQyLTE0LTEtMS0w_dc07fe14-bdd5-4d14-9e52-5a9c346c6d95"
      unitRef="usd">1704000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQyLTE2LTEtMS0w_9050d5de-9e38-48dc-9b13-62f1494624e6"
      unitRef="usd">1704000000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if2cf4b896e2b44e084b69d51f3b09f38_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQzLTItMS0xLTA_42b9fb70-b026-4df8-a5c6-2ab28005e0af"
      unitRef="usd">10326000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i6e31b11ef5824cbf953e4b36353741b6_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQzLTQtMS0xLTA_8d1c335f-642d-4714-92d7-7728a784a048"
      unitRef="usd">2963000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5775495e739143f9a2489ad44e260280_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQzLTYtMS0xLTA_b1290d42-1e84-45f8-888a-1e87cb78072a"
      unitRef="usd">2494000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i4ba56749e5db4d4999936c411d19cea8_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQzLTgtMS0xLTA_24bc2d16-958b-420b-a6c8-a17c15fddaf3"
      unitRef="usd">3902000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i143c69172b0543d3b4f8228cf2e657be_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQzLTEwLTEtMS0w_1a312802-2593-4949-9b78-7463fb19b557"
      unitRef="usd">0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if3e99423fe064b3f85abf9b78c7b60ef_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQzLTEyLTEtMS0w_937f1ef4-bdbf-48c4-b6d0-3f0db327ddf6"
      unitRef="usd">9359000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iff8807e405c94f48aee4ee4cab179452_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQzLTE0LTEtMS0w_243732ea-6684-484c-bcba-217fda124720"
      unitRef="usd">-1704000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQzLTE2LTEtMS0w_df644d91-58e9-4e10-9cb8-6f314db68153"
      unitRef="usd">17981000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:Assets
      contextRef="i29eb19ec363740be8a47282feb2589dd_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ0LTItMS0xLTA_b668330f-5d32-416a-b8de-5e1714a69abb"
      unitRef="usd">88250000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i102814ed2a624a4287acce41b5fcf861_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ0LTQtMS0xLTA_b5a169e3-6388-4d40-94d2-8f7da449b616"
      unitRef="usd">40444000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i92959f478cee4d23a50a998881bfc026_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ0LTYtMS0xLTA_4fcfcded-11d8-4b43-bca6-92331f14858e"
      unitRef="usd">15181000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="id234ee9b314c4d5c9bfefe600cb9a7b9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ0LTgtMS0xLTA_61b8809f-a0e7-456d-8f2c-22657f76d3b2"
      unitRef="usd">36346000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="iaf02709d1a9e4cd3a38c535c74010235_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ0LTEwLTEtMS0w_d58b88d9-4cf0-44fb-8145-3fe377b0d689"
      unitRef="usd">0</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ibddd22dd4e7e4da592ff5a6b614f587a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ0LTEyLTEtMS0w_15844cda-ac7b-418e-86fd-c46063d2b7e1"
      unitRef="usd">91971000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i035eb292920443f587744a9f748e42c8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ0LTE0LTEtMS0w_efa4055b-0661-4837-966d-4cdd82da843c"
      unitRef="usd">-6332000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i530caf840d4847f1ac553be5f7b336b2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ0LTE2LTEtMS0w_e7f12190-9de0-4513-98fa-6d6d1269cb0b"
      unitRef="usd">173889000000</us-gaap:Assets>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="if2cf4b896e2b44e084b69d51f3b09f38_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ1LTItMS0xLTA_f3cb0f01-6330-4dab-9e87-4603edb64171"
      unitRef="usd">841000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i6e31b11ef5824cbf953e4b36353741b6_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ1LTQtMS0xLTA_625d8141-7614-48cb-85af-f82f1f4e06a3"
      unitRef="usd">573000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i5775495e739143f9a2489ad44e260280_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ1LTYtMS0xLTA_521299d0-c54b-4537-b2d3-9208dcd4bc5d"
      unitRef="usd">495000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i4ba56749e5db4d4999936c411d19cea8_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ1LTgtMS0xLTA_e62dc54b-91e0-4aad-952e-fa7186e45cb4"
      unitRef="usd">162000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i143c69172b0543d3b4f8228cf2e657be_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ1LTEwLTEtMS0w_8420682b-ae12-45e3-96a2-6462f14cc6a6"
      unitRef="usd">0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="if3e99423fe064b3f85abf9b78c7b60ef_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ1LTEyLTEtMS0w_6b0b0061-dcee-4ec5-b6eb-0ca0f4dcaebc"
      unitRef="usd">1230000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="iff8807e405c94f48aee4ee4cab179452_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ1LTE0LTEtMS0w_eaece852-83be-43c8-85b1-3b181b555ef4"
      unitRef="usd">0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ1LTE2LTEtMS0w_ad652d7b-b426-4f4c-acea-52ed0606f887"
      unitRef="usd">2071000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:DepreciationAndAmortization
      contextRef="if2cf4b896e2b44e084b69d51f3b09f38_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ2LTItMS0xLTA_eff207ed-3064-4689-99df-74a08eec509a"
      unitRef="usd">926000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i6e31b11ef5824cbf953e4b36353741b6_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ2LTQtMS0xLTA_3cc526aa-6d35-48f4-aa20-9a97be354e40"
      unitRef="usd">565000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i5775495e739143f9a2489ad44e260280_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ2LTYtMS0xLTA_adb2ec69-7baf-47be-ba28-4b433d65272c"
      unitRef="usd">672000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i4ba56749e5db4d4999936c411d19cea8_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ2LTgtMS0xLTA_df4d5e25-d863-47d9-bc97-b3384f1ef11c"
      unitRef="usd">557000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i143c69172b0543d3b4f8228cf2e657be_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ2LTEwLTEtMS0w_a91a74b6-1ec3-432a-8e40-064b7c7c70e3"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="if3e99423fe064b3f85abf9b78c7b60ef_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ2LTEyLTEtMS0w_b4636a2d-327f-4b3d-801d-5af5990bdf38"
      unitRef="usd">1794000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="iff8807e405c94f48aee4ee4cab179452_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ2LTE0LTEtMS0w_e5469910-45b9-472a-9c46-8898518451ab"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i74d7599c976c4469bebee058f3ce6e24_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yMjMvZnJhZzoyOWY1MTJkZGNiZjQ0NmM1YjlmYzlhYzdlMzQzNTRjYS90YWJsZTpmNWI0Y2IxNWIzYzY0MzllYjhiMGFiOWM1ZThjNDU2ZS90YWJsZXJhbmdlOmY1YjRjYjE1YjNjNjQzOWViOGIwYWI5YzVlOGM0NTZlXzQ2LTE2LTEtMS0w_943fe164-b7f0-46b0-90a6-f9cba6a8f98b"
      unitRef="usd">2720000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock
      contextRef="iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90ZXh0cmVnaW9uOmU5NDlkMjQ5MzlkMjQ2M2RhY2UwNjc5OWQ0NWQ5YjRhXzE3OTY_c37a65f4-7163-4ab2-a226-0512d85b457e">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Schedule I &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Financial Information of Registrant &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(Parent Company Only) &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;UnitedHealth Group &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Balance Sheets &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.980%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.982%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in net assets of subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term notes receivable from subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities and shareholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of notes payable to subsidiaries&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term borrowings and current maturities of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, less current maturities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commitments and contingencies (Note 4) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shareholders&#x2019; equity:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preferred stock, $0.001 par value -10 shares authorized; no shares issued or outstanding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock, $0.01 par value - 3,000 shares authorized; 941 and 946 issued and outstanding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retained earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,384)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,814)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total UnitedHealth Group shareholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities and shareholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_277" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Notes to the Condensed Financial Statements of Registrant&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Schedule I &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Financial Information of Registrant &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(Parent Company Only) &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;UnitedHealth Group &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Statements of Comprehensive Income &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment and other income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,427)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,409)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Loss of parent company&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(898)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in undistributed income of subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,570)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_277" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Notes to the Condensed Financial Statements of Registrant&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Schedule I &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Financial Information of Registrant &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(Parent Company Only) &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;UnitedHealth Group &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Statements of Cash Flows &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flows from operating activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Investing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuances of notes to subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(444)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,722)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Repayments of notes to subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,953)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,706)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,645)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Return of capital to parent company&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital contributions to subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(747)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(803)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flows used for investing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,862)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,934)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock repurchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from common stock issuances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash dividends paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,280)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,584)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,932)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Repayments of) proceeds from short-term borrowings, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from issuance of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Repayments of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,750)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from notes from subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(447)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(438)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(535)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flows used for financing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,668)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,428)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,729)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Increase (decrease) in cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Supplemental cash flow disclosures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_277" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Notes to the Condensed Financial Statements of Registrant&lt;/a&gt;&lt;/span&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Schedule I &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Financial Information of Registrant &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(Parent Company Only) &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;UnitedHealth Group &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Notes to Condensed Financial Statements &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1.&#160;&#160;&#160;&#160;Basis of Presentation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;UnitedHealth Group&#x2019;s parent company financial information has been derived from its consolidated financial statements and should be read in conjunction with the consolidated financial statements included in this Form&#160;10-K. The accounting policies for the registrant are the same as those described in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 2 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#x201c;Financial Statements.&lt;/a&gt;&lt;a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;and Supplementary Data&lt;/a&gt;&lt;a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;.&lt;/a&gt;&lt;a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&#x201d;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2.&#160;&#160;&#160;&#160;Subsidiary Transactions &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investment in Subsidiaries. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;UnitedHealth Group&#x2019;s investment in subsidiaries is stated at cost plus equity in undistributed earnings of subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Dividends and Capital Distributions.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Cash dividends received from subsidiaries and included in Cash Flows from Operating Activities in the Condensed Statements of Cash Flows were $10.8 billion, $10.0 billion and $5.6 billion in 2021, 2020 and 2019, respectively. Additionally, $0.2 billion, $0.9 billion and $4.5 billion in cash were received as a return of capital to the parent company during 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;Short-Term Borrowings and Long-Term Debt &lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Discussion of short-term borrowings and long-term debt can be found in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_193" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 8 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#x201c;Financial Statements&lt;/a&gt;&lt;a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_193" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt; &lt;/a&gt;&lt;a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_193" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;and Supplementary Data&lt;/a&gt;&lt;a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_193" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;.&#x201d;&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Long-term debt obligations of the parent company do not include other financing obligations at subsidiaries which totaled $1.4 billion and $1.2 billion at December&#160;31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of short-term borrowings and long-term debt for the years ending December 31 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;UnitedHealth Group&#x2019;s parent company had notes payable to subsidiaries of $8.1 billion and $4.9 billion as of December 31, 2021 and 2020, respectively, which included on-demand features.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;4.    Commitments and Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain regulated subsidiaries are guaranteed by UnitedHealth Group&#x2019;s parent company in the event of insolvency. UnitedHealth Group&#x2019;s parent company also provides guarantees related to its service level under certain contracts. None of the amounts accrued, paid or charged to income for service level guarantees were material as of December&#160;31, 2021, 2020 or 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For a summary of commitments and contingencies, see &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_217" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 12 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#x201c;Financial Statements.&lt;/a&gt;&lt;a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_217" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;and Supplementary Data&lt;/a&gt;&lt;a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_217" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&#x201d;&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock>
    <srt:ScheduleOfCondensedBalanceSheetTableTextBlock
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90ZXh0cmVnaW9uOmU5NDlkMjQ5MzlkMjQ2M2RhY2UwNjc5OWQ0NWQ5YjRhXzE3ODU_42b7df84-a3a8-44cb-aeea-0bcfd18ddd57">&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Financial Information of Registrant &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(Parent Company Only) &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;UnitedHealth Group &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Balance Sheets &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.980%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.982%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in net assets of subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term notes receivable from subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities and shareholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of notes payable to subsidiaries&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term borrowings and current maturities of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, less current maturities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commitments and contingencies (Note 4) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shareholders&#x2019; equity:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preferred stock, $0.001 par value -10 shares authorized; no shares issued or outstanding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock, $0.01 par value - 3,000 shares authorized; 941 and 946 issued and outstanding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retained earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,384)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,814)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total UnitedHealth Group shareholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities and shareholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</srt:ScheduleOfCondensedBalanceSheetTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i2749835a349545f38d76efb02e97a939_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzMtMi0xLTEtMA_8f42a967-9db9-44fa-97bd-ddf6bf084fbb"
      unitRef="usd">2167000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzMtNC0xLTEtMA_2210ed6b-8bcb-4ccd-b4f4-aee584ef9ee5"
      unitRef="usd">258000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:OtherAssetsCurrent
      contextRef="i2749835a349545f38d76efb02e97a939_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzQtMi0xLTEtMA_c313db08-b0cb-46d8-b299-c48504f21a12"
      unitRef="usd">503000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzQtNC0xLTEtMA_e9fe3590-55fa-459b-bdf4-5aced942cd30"
      unitRef="usd">562000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i2749835a349545f38d76efb02e97a939_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzUtMi0xLTEtMA_57dfb9f7-5bfb-47f1-8194-41601df45972"
      unitRef="usd">2670000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzUtNC0xLTEtMA_d425f1c7-c997-4f9d-9c78-821c4b37e5cb"
      unitRef="usd">820000000</us-gaap:AssetsCurrent>
    <unh:EquityinNetAssetsofSubsidiaries
      contextRef="i2749835a349545f38d76efb02e97a939_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzYtMi0xLTEtMA_8c46dabe-b2b1-48a4-95f7-b21565996a79"
      unitRef="usd">116907000000</unh:EquityinNetAssetsofSubsidiaries>
    <unh:EquityinNetAssetsofSubsidiaries
      contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzYtNC0xLTEtMA_0ac06439-22ea-429a-9d24-ce012771b050"
      unitRef="usd">107714000000</unh:EquityinNetAssetsofSubsidiaries>
    <us-gaap:NotesReceivableRelatedPartiesNoncurrent
      contextRef="i2749835a349545f38d76efb02e97a939_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzctMi0xLTEtMA_36149449-264e-4372-a23a-3c4fa01af4dd"
      unitRef="usd">5680000000</us-gaap:NotesReceivableRelatedPartiesNoncurrent>
    <us-gaap:NotesReceivableRelatedPartiesNoncurrent
      contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzctNC0xLTEtMA_b8f586de-2180-49d0-a65f-b011320b4cb9"
      unitRef="usd">5021000000</us-gaap:NotesReceivableRelatedPartiesNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i2749835a349545f38d76efb02e97a939_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzgtMi0xLTEtMA_09c3bd08-c6bd-4fd9-8ff0-52a31aa5de02"
      unitRef="usd">32000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzgtNC0xLTEtMA_d94a9797-bbd3-4035-93e8-d67db704d374"
      unitRef="usd">342000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i2749835a349545f38d76efb02e97a939_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzktMi0xLTEtMA_8d94d92b-641f-4a68-bef9-0e3fdcd87446"
      unitRef="usd">125289000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzktNC0xLTEtMA_e8093adc-00eb-4d36-9fbe-edc512f9f625"
      unitRef="usd">113897000000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i2749835a349545f38d76efb02e97a939_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzEzLTItMS0xLTA_9b830aa0-0b29-4055-a976-eb570bb2bbcb"
      unitRef="usd">605000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzEzLTQtMS0xLTA_9951c9e7-9022-4ba9-bc33-610a69c74373"
      unitRef="usd">589000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent
      contextRef="i2749835a349545f38d76efb02e97a939_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzE0LTItMS0xLTA_312e2c3b-6792-4e22-ada3-ee798a4d405f"
      unitRef="usd">8105000000</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
    <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent
      contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzE0LTQtMS0xLTA_bf3e03b7-f0d5-4c79-b187-b689fdb77c11"
      unitRef="usd">4882000000</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i2749835a349545f38d76efb02e97a939_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzE1LTItMS0xLTA_9e990061-3ea1-4788-9f5e-869b554e3a8f"
      unitRef="usd">3009000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzE1LTQtMS0xLTA_58411851-048b-4021-bd20-a3e9108d2a06"
      unitRef="usd">4465000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i2749835a349545f38d76efb02e97a939_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzE2LTItMS0xLTA_8b6592d6-9aa1-4efb-b457-3a3f6bc9562f"
      unitRef="usd">11719000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzE2LTQtMS0xLTA_21c38f72-e1aa-4237-9ced-b371d9bc9d57"
      unitRef="usd">9936000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i2749835a349545f38d76efb02e97a939_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzE3LTItMS0xLTA_b0b8113a-3b50-4e9b-852d-bccf09198151"
      unitRef="usd">41623000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzE3LTQtMS0xLTA_87b6464a-e2a8-4a32-b09d-e06387fc9b45"
      unitRef="usd">37815000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i2749835a349545f38d76efb02e97a939_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzE5LTItMS0xLTA_a4e7f1e1-0f14-4518-834b-c109fc5a8c77"
      unitRef="usd">187000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzE5LTQtMS0xLTA_b31896ed-7f46-49ba-8ada-73a5ff781c3d"
      unitRef="usd">655000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i2749835a349545f38d76efb02e97a939_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzIwLTItMS0xLTA_16ab621f-8a2f-4bc9-ae36-8b539d3dce1e"
      unitRef="usd">53529000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzIwLTQtMS0xLTA_012a7175-2d51-40bc-a1b4-75134945134a"
      unitRef="usd">48406000000</us-gaap:Liabilities>
    <us-gaap:PreferredStockValue
      contextRef="i2749835a349545f38d76efb02e97a939_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzIzLTItMS0xLTA_b06e34b0-5ce2-4977-8852-be96e4094bfe"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzIzLTQtMS0xLTA_38013886-a6d6-40c8-a402-c3399d0cec91"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockValue
      contextRef="i2749835a349545f38d76efb02e97a939_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzI0LTItMS0xLTA_a958c44b-efe1-4272-b278-a02c7d2c7714"
      unitRef="usd">10000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzI0LTQtMS0xLTA_51c33143-21c2-4400-9d9e-7481fdd17693"
      unitRef="usd">10000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i2749835a349545f38d76efb02e97a939_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzI1LTItMS0xLTA_8cbb0b1e-5677-4bb0-a57f-4f02e5f271f9"
      unitRef="usd">0</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzI1LTQtMS0xLTA_1e53cacc-2321-4592-9dd5-4a19ffb8a280"
      unitRef="usd">0</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i2749835a349545f38d76efb02e97a939_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzI2LTItMS0xLTA_8d2f7990-e15b-4101-bdc1-912f1d6d1dc7"
      unitRef="usd">77134000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzI2LTQtMS0xLTA_682f5306-b8b9-4553-8d6a-2706c90cb3e0"
      unitRef="usd">69295000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i2749835a349545f38d76efb02e97a939_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzI3LTItMS0xLTA_90e65cb4-1499-4bd2-b137-665950935991"
      unitRef="usd">-5384000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzI3LTQtMS0xLTA_083ac841-4502-40f3-832e-d7a0d5e0ebbd"
      unitRef="usd">-3814000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i2749835a349545f38d76efb02e97a939_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzI4LTItMS0xLTA_2fe72154-6c0d-443d-b856-b5cb307b61a0"
      unitRef="usd">71760000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzI4LTQtMS0xLTA_389e2284-3ed9-415c-8a13-7552db387df7"
      unitRef="usd">65491000000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i2749835a349545f38d76efb02e97a939_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzI5LTItMS0xLTA_1ad6147f-bba4-414c-b3a9-dc650dd379ac"
      unitRef="usd">125289000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTphMGJiNGU4NzViNTU0MGMxYTBjMzgxYjZkZDg4NTk1OS90YWJsZXJhbmdlOmEwYmI0ZTg3NWI1NTQwYzFhMGMzODFiNmRkODg1OTU5XzI5LTQtMS0xLTA_bd0004ec-4192-4dae-86cd-8aa6de6a32e0"
      unitRef="usd">113897000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <srt:CondensedStatementOfComprehensiveIncomeTableTextBlock
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90ZXh0cmVnaW9uOmU5NDlkMjQ5MzlkMjQ2M2RhY2UwNjc5OWQ0NWQ5YjRhXzE3ODY_013c9138-7129-414f-bdc1-6a7b7f8bc62a">&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Financial Information of Registrant &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(Parent Company Only) &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;UnitedHealth Group &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Statements of Comprehensive Income &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment and other income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,427)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,409)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Loss of parent company&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(898)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in undistributed income of subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,570)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</srt:CondensedStatementOfComprehensiveIncomeTableTextBlock>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzMtMi0xLTEtMA_2521bcb1-9887-4fa2-9d96-fc0fb0a81df1"
      unitRef="usd">494000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzMtNC0xLTEtMA_4a42d8c1-9540-46e1-8fa0-372104954b0a"
      unitRef="usd">194000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzMtNi0xLTEtMA_7ffc3d1c-83db-4504-b437-5251ae59c603"
      unitRef="usd">209000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:Revenues
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzQtMi0xLTEtMA_c6d655ed-36e1-4ad2-82b1-7fbe14e66e29"
      unitRef="usd">494000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzQtNC0xLTEtMA_14170c15-acbc-43e6-9ef3-506b5204406a"
      unitRef="usd">194000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzQtNi0xLTEtMA_a753fbcb-97e3-49f3-b4f1-6a850d5d7643"
      unitRef="usd">209000000</us-gaap:Revenues>
    <us-gaap:OperatingExpenses
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzYtMi0xLTEtMA_8af8d391-8bc3-463b-aca0-1c61bc8e4215"
      unitRef="usd">40000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzYtNC0xLTEtMA_f987059b-0918-4539-987a-40b888321d48"
      unitRef="usd">27000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzYtNi0xLTEtMA_f2319542-ae61-4e55-a0ba-565505f50bbc"
      unitRef="usd">38000000</us-gaap:OperatingExpenses>
    <us-gaap:InterestExpense
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzctMi0xLTEtMA_c9222328-645b-4d20-99b6-c3778e90a108"
      unitRef="usd">1583000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzctNC0xLTEtMA_8a38f196-9f15-48c7-b674-436d39ac280b"
      unitRef="usd">1594000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzctNi0xLTEtMA_4bc1bd7c-8f68-41e6-9c17-b4f8ad351b2f"
      unitRef="usd">1580000000</us-gaap:InterestExpense>
    <us-gaap:CostsAndExpenses
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzgtMi0xLTEtMA_9053e383-d902-45e9-80f4-7f67ddaf652d"
      unitRef="usd">1623000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzgtNC0xLTEtMA_b55d75ec-b7f7-48a4-bf22-250ce31dceb5"
      unitRef="usd">1621000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzgtNi0xLTEtMA_d46a0dbe-abe2-4297-a36f-2a6bbd65abbe"
      unitRef="usd">1618000000</us-gaap:CostsAndExpenses>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzktMi0xLTEtMA_dc3f7fc4-0e7f-4246-8fbb-52c08e433f4c"
      unitRef="usd">-1129000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzktNC0xLTEtMA_7d3b4b1c-254d-49ec-8703-87ed44b1dbc6"
      unitRef="usd">-1427000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzktNi0xLTEtMA_aeceb625-cd8f-415c-a011-0c584b3db867"
      unitRef="usd">-1409000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzEwLTItMS0xLTA_2d486c83-259b-4dda-b663-f61e90f7816a"
      unitRef="usd">231000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzEwLTQtMS0xLTA_dacb1b17-8453-42fb-9acf-4f2e47873a36"
      unitRef="usd">300000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzEwLTYtMS0xLTA_b4124b1c-f100-4bf5-a974-484489b42b7e"
      unitRef="usd">293000000</us-gaap:IncomeTaxExpenseBenefit>
    <unh:LossofParentCompany
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzExLTItMS0xLTA_a25809c8-6efa-4e3c-a701-0f2ca794cd95"
      unitRef="usd">898000000</unh:LossofParentCompany>
    <unh:LossofParentCompany
      contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzExLTQtMS0xLTA_a30658f7-6ba2-413c-91a6-6746a551316c"
      unitRef="usd">1127000000</unh:LossofParentCompany>
    <unh:LossofParentCompany
      contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzExLTYtMS0xLTA_5452a617-e75b-482c-90a0-370e8fd73ee1"
      unitRef="usd">1116000000</unh:LossofParentCompany>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzEyLTItMS0xLTA_9d03e5ba-dfd4-45c7-a874-827896c16820"
      unitRef="usd">18183000000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzEyLTQtMS0xLTA_a8c80c05-9342-418c-a83c-45cae0f0193a"
      unitRef="usd">16530000000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzEyLTYtMS0xLTA_4e61be21-b41d-4929-8ffc-821347ffde63"
      unitRef="usd">14955000000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:NetIncomeLoss
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzEzLTItMS0xLTA_3c204f99-6205-4671-bc20-c50408de4e81"
      unitRef="usd">17285000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzEzLTQtMS0xLTA_11e671f3-e542-48d0-b598-5766be6607e7"
      unitRef="usd">15403000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzEzLTYtMS0xLTA_1315e030-20ce-4d3d-bb16-33c7ae2eae6d"
      unitRef="usd">13839000000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzE0LTItMS0xLTA_e183aa0a-c3fd-4d40-938a-253be223d231"
      unitRef="usd">-1570000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzE0LTQtMS0xLTA_26a76ab7-3ca9-451a-bd92-b7978e8cffb8"
      unitRef="usd">-236000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzE0LTYtMS0xLTA_7f9f5c04-f2b7-43ef-a7a2-18d32bdbb471"
      unitRef="usd">582000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzE1LTItMS0xLTA_0178ddbe-4d24-45e4-b599-a847e041f756"
      unitRef="usd">15715000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzE1LTQtMS0xLTA_67dac72b-1eda-45a6-bec5-f4d3f8e55f41"
      unitRef="usd">15167000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTowNGFlN2RhMzI5NDk0ZmMyYjNmMGMzMTNhMDRiMjQyYS90YWJsZXJhbmdlOjA0YWU3ZGEzMjk0OTRmYzJiM2YwYzMxM2EwNGIyNDJhXzE1LTYtMS0xLTA_f5e92953-c03f-4263-bf37-743693e6bba6"
      unitRef="usd">14421000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <srt:ScheduleOfCondensedCashFlowStatementTableTextBlock
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90ZXh0cmVnaW9uOmU5NDlkMjQ5MzlkMjQ2M2RhY2UwNjc5OWQ0NWQ5YjRhXzE3ODk_1299aba0-4f25-4874-a652-2d46dcfc5b0f">&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Financial Information of Registrant &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(Parent Company Only) &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;UnitedHealth Group &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Statements of Cash Flows &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flows from operating activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Investing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuances of notes to subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(444)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,722)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Repayments of notes to subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,953)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,706)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,645)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Return of capital to parent company&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital contributions to subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(747)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(803)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flows used for investing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,862)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,934)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock repurchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from common stock issuances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash dividends paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,280)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,584)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,932)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Repayments of) proceeds from short-term borrowings, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from issuance of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Repayments of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,750)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from notes from subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(447)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(438)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(535)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flows used for financing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,668)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,428)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,729)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Increase (decrease) in cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Supplemental cash flow disclosures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</srt:ScheduleOfCondensedCashFlowStatementTableTextBlock>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzMtMi0xLTEtMA_c9124d3a-742b-49ef-af08-bdacf3402595"
      unitRef="usd">11439000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzMtNC0xLTEtMA_b91c9196-426b-47c0-9121-296a587f0a89"
      unitRef="usd">8842000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzMtNi0xLTEtMA_1ddc9e39-424f-43a5-a2d3-6e1cbc4c027b"
      unitRef="usd">9275000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToFundLongtermLoansToRelatedParties
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzUtMi0xLTEtMA_b68cd58e-9767-4b7a-9572-4ba8a77b35af"
      unitRef="usd">-444000000</us-gaap:PaymentsToFundLongtermLoansToRelatedParties>
    <us-gaap:PaymentsToFundLongtermLoansToRelatedParties
      contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzUtNC0xLTEtMA_1c64732e-0810-41c5-9d52-e278ac1ed3a0"
      unitRef="usd">-628000000</us-gaap:PaymentsToFundLongtermLoansToRelatedParties>
    <us-gaap:PaymentsToFundLongtermLoansToRelatedParties
      contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzUtNi0xLTEtMA_9b287ca2-1cb8-4482-89dc-3013047f8a1a"
      unitRef="usd">-2722000000</us-gaap:PaymentsToFundLongtermLoansToRelatedParties>
    <us-gaap:ProceedsFromCollectionOfLongtermLoansToRelatedParties
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzYtMi0xLTEtMA_9f5d8bec-8186-4ec5-9bd4-e3c6c8b4774b"
      unitRef="usd">37000000</us-gaap:ProceedsFromCollectionOfLongtermLoansToRelatedParties>
    <us-gaap:ProceedsFromCollectionOfLongtermLoansToRelatedParties
      contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzYtNC0xLTEtMA_3aeba3c0-3357-478f-b06b-0f99701c467c"
      unitRef="usd">1089000000</us-gaap:ProceedsFromCollectionOfLongtermLoansToRelatedParties>
    <us-gaap:ProceedsFromCollectionOfLongtermLoansToRelatedParties
      contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzYtNi0xLTEtMA_b6bd4e60-9cfa-45a5-beba-c99de606d81a"
      unitRef="usd">2249000000</us-gaap:ProceedsFromCollectionOfLongtermLoansToRelatedParties>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzctMi0xLTEtMA_993c7bae-af84-4d01-aabe-adbcfb826bf1"
      unitRef="usd">4953000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzctNC0xLTEtMA_a0843268-7790-438e-b27b-9355eaf50863"
      unitRef="usd">7706000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzctNi0xLTEtMA_4e82eaf9-d38f-49bb-9563-6ed50e63f170"
      unitRef="usd">9645000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:ProceedsFromContributionsFromAffiliates
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzgtMi0xLTEtMA_869f2c4d-e0d9-4e72-ace2-10cfe308a08d"
      unitRef="usd">245000000</us-gaap:ProceedsFromContributionsFromAffiliates>
    <us-gaap:ProceedsFromContributionsFromAffiliates
      contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzgtNC0xLTEtMA_f0a84211-e985-4e07-91b6-c3104d0ee558"
      unitRef="usd">943000000</us-gaap:ProceedsFromContributionsFromAffiliates>
    <us-gaap:ProceedsFromContributionsFromAffiliates
      contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzgtNi0xLTEtMA_6e123866-07fb-493c-887a-28fff6ad8a39"
      unitRef="usd">4497000000</us-gaap:ProceedsFromContributionsFromAffiliates>
    <unh:Capitalcontributionstosubsidiaries
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzktMi0xLTEtMA_35c2a66e-920e-4f6c-9a92-f3d0e3587fb0"
      unitRef="usd">747000000</unh:Capitalcontributionstosubsidiaries>
    <unh:Capitalcontributionstosubsidiaries
      contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzktNC0xLTEtMA_5241b6f1-8c14-421d-bb25-1987b686cb85"
      unitRef="usd">43000000</unh:Capitalcontributionstosubsidiaries>
    <unh:Capitalcontributionstosubsidiaries
      contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzktNi0xLTEtMA_67635867-f998-4c5b-8673-0477680a1629"
      unitRef="usd">803000000</unh:Capitalcontributionstosubsidiaries>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzEwLTItMS0xLTA_7d944bc9-e28c-4414-bc46-fa22ac2720a8"
      unitRef="usd">0</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzEwLTQtMS0xLTA_d99618dd-0319-4c32-be38-82056a422648"
      unitRef="usd">143000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzEwLTYtMS0xLTA_3538d727-4cd9-48d7-ae35-8e2c9eb21264"
      unitRef="usd">490000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzExLTItMS0xLTA_c3e0c03d-1c78-4b7d-8b4b-1dffba0648ca"
      unitRef="usd">-5862000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzExLTQtMS0xLTA_c51ae457-8796-4007-835b-a36e147dd198"
      unitRef="usd">-6202000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzExLTYtMS0xLTA_f88e511a-2a60-400e-abfa-02c5ec50f253"
      unitRef="usd">-5934000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzEzLTItMS0xLTA_6c337393-15df-448c-8f67-baa206396655"
      unitRef="usd">5000000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzEzLTQtMS0xLTA_162b2cd2-ff23-4eca-8a74-4d8126ef4099"
      unitRef="usd">4250000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzEzLTYtMS0xLTA_54527a19-a4fd-4abe-898f-67fb9fdd21fb"
      unitRef="usd">5500000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzE0LTItMS0xLTA_9b718829-f2e6-4d59-8a7b-7b8e7e97e8e5"
      unitRef="usd">1355000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzE0LTQtMS0xLTA_52ebb8f7-884a-461d-8c2d-331179933a48"
      unitRef="usd">1440000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzE0LTYtMS0xLTA_f0943b68-d274-434e-b50e-d239c62b1f4a"
      unitRef="usd">1037000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsOfDividends
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzE1LTItMS0xLTA_9ca112d0-5793-4dae-b5c4-af0a896d93e7"
      unitRef="usd">5280000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzE1LTQtMS0xLTA_d64a08a2-73c2-4e3d-8f3d-d8dd98b8b3cd"
      unitRef="usd">4584000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzE1LTYtMS0xLTA_747e6d9f-8d29-4b46-9eca-876493c4dbb8"
      unitRef="usd">3932000000</us-gaap:PaymentsOfDividends>
    <us-gaap:ProceedsFromRepaymentsOfCommercialPaper
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzE2LTItMS0xLTA_8f60d68f-6b67-4f07-b13f-d6f10d2b17a9"
      unitRef="usd">-1302000000</us-gaap:ProceedsFromRepaymentsOfCommercialPaper>
    <us-gaap:ProceedsFromRepaymentsOfCommercialPaper
      contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzE2LTQtMS0xLTA_3adf331e-bcc1-4962-be13-a18469bbf489"
      unitRef="usd">872000000</us-gaap:ProceedsFromRepaymentsOfCommercialPaper>
    <us-gaap:ProceedsFromRepaymentsOfCommercialPaper
      contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzE2LTYtMS0xLTA_2e8eac05-d582-4602-a04c-7df60d3bfb34"
      unitRef="usd">300000000</us-gaap:ProceedsFromRepaymentsOfCommercialPaper>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzE3LTItMS0xLTA_40ae7318-a850-4b70-be83-d77f5889c422"
      unitRef="usd">6933000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzE3LTQtMS0xLTA_882ab5bd-2d14-4c4c-b98a-316c48b1630c"
      unitRef="usd">4864000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzE3LTYtMS0xLTA_3d3d03d6-7595-44e2-aedf-6ac1cf68b91b"
      unitRef="usd">5444000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzE4LTItMS0xLTA_03518a14-e8b3-4235-aaf8-89fe8270e0f0"
      unitRef="usd">3150000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzE4LTQtMS0xLTA_ae1e7bbc-273c-492e-8920-55657b5810cd"
      unitRef="usd">3150000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzE4LTYtMS0xLTA_0f7e1f5b-88b2-4206-8451-ddada8b24195"
      unitRef="usd">1750000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzE5LTItMS0xLTA_40ed537e-5400-43e8-9bd5-e123e3453576"
      unitRef="usd">3223000000</us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt>
    <us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt
      contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzE5LTQtMS0xLTA_88790039-40a5-4956-bb52-4c9e789f4b30"
      unitRef="usd">2818000000</us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt>
    <us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt
      contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzE5LTYtMS0xLTA_310a7e0a-c2c4-4a76-ba7b-5e87d3927390"
      unitRef="usd">1207000000</us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzIwLTItMS0xLTA_00926713-d085-470d-a5db-aa0f5272c32c"
      unitRef="usd">-447000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzIwLTQtMS0xLTA_2199a129-894b-4f0f-922d-0d2f2885bb5f"
      unitRef="usd">-438000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzIwLTYtMS0xLTA_f836b209-550b-42df-bec9-43001abb1d8a"
      unitRef="usd">-535000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzIxLTItMS0xLTA_fe181336-09ed-486e-b7eb-6415bd181708"
      unitRef="usd">-3668000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzIxLTQtMS0xLTA_3ccdb76d-0ae5-4065-b72e-5c2ea9aa974c"
      unitRef="usd">-2428000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzIxLTYtMS0xLTA_a59d9c6c-689b-4d6b-8c53-5cfeab694b34"
      unitRef="usd">-3729000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzIyLTItMS0xLTA_f27511f0-71d1-4af5-9b35-7f6bb34b2cd5"
      unitRef="usd">1909000000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease
      contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzIyLTQtMS0xLTA_f425def2-7fd3-4d1c-a616-048040e83687"
      unitRef="usd">212000000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease
      contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzIyLTYtMS0xLTA_062e7d13-f716-4724-9dce-b658312bec97"
      unitRef="usd">-388000000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzIzLTItMS0xLTA_5c6c0449-f502-4ebe-972c-e5bfdf644d97"
      unitRef="usd">258000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i34c97cfea3194601b8f8a80d672db6f5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzIzLTQtMS0xLTA_0132f8ba-8445-448a-ba9f-05cee7c6d0c1"
      unitRef="usd">46000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="id83f942037b1489881b85513b8a2fbf4_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzIzLTYtMS0xLTA_333540e0-cfcb-4e4b-b545-23b8b21f5d8c"
      unitRef="usd">434000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i2749835a349545f38d76efb02e97a939_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzI0LTItMS0xLTA_f06dda94-866b-4fb7-9e82-ec1415f92313"
      unitRef="usd">2167000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzI0LTQtMS0xLTA_e998ca51-3463-41c1-acfa-a5ab78e9b651"
      unitRef="usd">258000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i34c97cfea3194601b8f8a80d672db6f5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzI0LTYtMS0xLTA_967a1485-de34-4650-b53a-f974f3c30f6f"
      unitRef="usd">46000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:InterestPaidNet
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzI3LTItMS0xLTA_d8053e68-3063-4fbf-b7cf-c7b8b593f45a"
      unitRef="usd">1575000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzI3LTQtMS0xLTA_3ad66243-a966-4b1a-8add-a1b42975abc1"
      unitRef="usd">1633000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzI3LTYtMS0xLTA_914ab45b-1a92-4dd1-9d25-a48dab4b5329"
      unitRef="usd">1506000000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzI4LTItMS0xLTA_a8841eb0-ceea-4866-bc1c-2ecda7c11415"
      unitRef="usd">3050000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzI4LTQtMS0xLTA_581505f2-909b-435a-a974-501b46b7de24"
      unitRef="usd">4185000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzEvZnJhZzplOTQ5ZDI0OTM5ZDI0NjNkYWNlMDY3OTlkNDVkOWI0YS90YWJsZTpkMmRhZGRiMmMyYzE0YTU5ODBiMzFiNmNlYjBjNDliMS90YWJsZXJhbmdlOmQyZGFkZGIyYzJjMTRhNTk4MGIzMWI2Y2ViMGM0OWIxXzI4LTYtMS0xLTA_b1c64d8f-dab7-4dfd-935f-b9fb91dd5ebc"
      unitRef="usd">2590000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yNzcvZnJhZzpiNzI2NGEwODkxY2U0YTJmYjkxNDMzZDVmOGNjNzI5MS90ZXh0cmVnaW9uOmI3MjY0YTA4OTFjZTRhMmZiOTE0MzNkNWY4Y2M3MjkxXzU5Mg_64f0693c-c9d1-4454-b9d7-ede806d2e415">Basis of Presentation &lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;UnitedHealth Group&#x2019;s parent company financial information has been derived from its consolidated financial statements and should be read in conjunction with the consolidated financial statements included in this Form&#160;10-K. The accounting policies for the registrant are the same as those described in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 2 of the Notes to the Consolidated Financial Statements included in Part II, Item 8, &#x201c;Financial Statements.&lt;/a&gt;&lt;a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;and Supplementary Data&lt;/a&gt;&lt;a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;.&lt;/a&gt;&lt;a href="#i2ccd90ac94a94cd9ab3abb1e6abc40a5_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&#x201d;&lt;/a&gt;&lt;/span&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yODAvZnJhZzozODJjNzhkNzFlZmE0MDgxYjQxNTQwZWNkM2MzZDJhYS90ZXh0cmVnaW9uOjM4MmM3OGQ3MWVmYTQwODFiNDE1NDBlY2QzYzNkMmFhXzU1Ng_8137f2c6-cc99-4e34-9b94-ce411ce1d721">Subsidiary Transactions &lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investment in Subsidiaries. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;UnitedHealth Group&#x2019;s investment in subsidiaries is stated at cost plus equity in undistributed earnings of subsidiaries.&lt;/span&gt;</us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy>
    <us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yODAvZnJhZzozODJjNzhkNzFlZmE0MDgxYjQxNTQwZWNkM2MzZDJhYS90ZXh0cmVnaW9uOjM4MmM3OGQ3MWVmYTQwODFiNDE1NDBlY2QzYzNkMmFhXzM2NA_271fdb6f-2005-469e-88c5-3d99633c4527"
      unitRef="usd">10800000000</us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries>
    <us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries
      contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yODAvZnJhZzozODJjNzhkNzFlZmE0MDgxYjQxNTQwZWNkM2MzZDJhYS90ZXh0cmVnaW9uOjM4MmM3OGQ3MWVmYTQwODFiNDE1NDBlY2QzYzNkMmFhXzM2OA_c0e0bd15-b694-45de-8eb1-42bd530be181"
      unitRef="usd">10000000000</us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries>
    <us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries
      contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yODAvZnJhZzozODJjNzhkNzFlZmE0MDgxYjQxNTQwZWNkM2MzZDJhYS90ZXh0cmVnaW9uOjM4MmM3OGQ3MWVmYTQwODFiNDE1NDBlY2QzYzNkMmFhXzM3NQ_aed135a9-1f70-4508-941c-d4809511c793"
      unitRef="usd">5600000000</us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries>
    <us-gaap:ProceedsFromContributionsFromAffiliates
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yODAvZnJhZzozODJjNzhkNzFlZmE0MDgxYjQxNTQwZWNkM2MzZDJhYS90ZXh0cmVnaW9uOjM4MmM3OGQ3MWVmYTQwODFiNDE1NDBlY2QzYzNkMmFhXzQzMA_4387ae37-7e49-47d8-a626-c912ccf4b200"
      unitRef="usd">200000000</us-gaap:ProceedsFromContributionsFromAffiliates>
    <us-gaap:ProceedsFromContributionsFromAffiliates
      contextRef="i7e089e753d73411e8e3ca1b247429c53_D20200101-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yODAvZnJhZzozODJjNzhkNzFlZmE0MDgxYjQxNTQwZWNkM2MzZDJhYS90ZXh0cmVnaW9uOjM4MmM3OGQ3MWVmYTQwODFiNDE1NDBlY2QzYzNkMmFhXzQzNA_79cb6386-1d87-453f-940e-fa9a9a1f4851"
      unitRef="usd">900000000</us-gaap:ProceedsFromContributionsFromAffiliates>
    <us-gaap:ProceedsFromContributionsFromAffiliates
      contextRef="i9cd5c0b71a094f5a9f3700167ca4af53_D20190101-20191231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yODAvZnJhZzozODJjNzhkNzFlZmE0MDgxYjQxNTQwZWNkM2MzZDJhYS90ZXh0cmVnaW9uOjM4MmM3OGQ3MWVmYTQwODFiNDE1NDBlY2QzYzNkMmFhXzQ0MQ_e38be681-b671-4ec7-b12c-b7fcfb553a67"
      unitRef="usd">4500000000</us-gaap:ProceedsFromContributionsFromAffiliates>
    <us-gaap:OtherLongTermDebt
      contextRef="i48f8f3c144a149269121679c024b2bfa_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yODMvZnJhZzo5MzM5MDdkOWI4MGI0YWYwYmFlZDNmNzlkMmI2YTQ2My90ZXh0cmVnaW9uOjkzMzkwN2Q5YjgwYjRhZjBiYWVkM2Y3OWQyYjZhNDYzXzM2MA_99d78482-68df-4467-b174-eda3e75fab7f"
      unitRef="usd">1400000000</us-gaap:OtherLongTermDebt>
    <us-gaap:OtherLongTermDebt
      contextRef="i7e1bde434ad049b7a20e4a7cd97ed39d_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yODMvZnJhZzo5MzM5MDdkOWI4MGI0YWYwYmFlZDNmNzlkMmI2YTQ2My90ZXh0cmVnaW9uOjkzMzkwN2Q5YjgwYjRhZjBiYWVkM2Y3OWQyYjZhNDYzXzE2NDkyNjc0NDI0NDc_386638ce-6f52-4cbb-9a42-13bfce434445"
      unitRef="usd">1200000000</us-gaap:OtherLongTermDebt>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yODMvZnJhZzo5MzM5MDdkOWI4MGI0YWYwYmFlZDNmNzlkMmI2YTQ2My90ZXh0cmVnaW9uOjkzMzkwN2Q5YjgwYjRhZjBiYWVkM2Y3OWQyYjZhNDYzXzY3MA_60e0735a-dc87-4f56-8687-d51dddba720c">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of short-term borrowings and long-term debt for the years ending December 31 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i2749835a349545f38d76efb02e97a939_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yODMvZnJhZzo5MzM5MDdkOWI4MGI0YWYwYmFlZDNmNzlkMmI2YTQ2My90YWJsZTo0N2Y0MTk4ZmE3MzA0OTViOWQ1N2ZjN2VjZDk4NTliOS90YWJsZXJhbmdlOjQ3ZjQxOThmYTczMDQ5NWI5ZDU3ZmM3ZWNkOTg1OWI5XzEtMi0xLTEtMA_4b69056f-cc65-43d4-af76-535e66a3b465"
      unitRef="usd">3015000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i2749835a349545f38d76efb02e97a939_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yODMvZnJhZzo5MzM5MDdkOWI4MGI0YWYwYmFlZDNmNzlkMmI2YTQ2My90YWJsZTo0N2Y0MTk4ZmE3MzA0OTViOWQ1N2ZjN2VjZDk4NTliOS90YWJsZXJhbmdlOjQ3ZjQxOThmYTczMDQ5NWI5ZDU3ZmM3ZWNkOTg1OWI5XzItMi0xLTEtMA_29f9ed8e-9b02-48a8-8f1f-c3e3c235725d"
      unitRef="usd">2125000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i2749835a349545f38d76efb02e97a939_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yODMvZnJhZzo5MzM5MDdkOWI4MGI0YWYwYmFlZDNmNzlkMmI2YTQ2My90YWJsZTo0N2Y0MTk4ZmE3MzA0OTViOWQ1N2ZjN2VjZDk4NTliOS90YWJsZXJhbmdlOjQ3ZjQxOThmYTczMDQ5NWI5ZDU3ZmM3ZWNkOTg1OWI5XzMtMi0xLTEtMA_1c913c9f-af5e-4b9e-96bb-11b4547c78cb"
      unitRef="usd">2500000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i2749835a349545f38d76efb02e97a939_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yODMvZnJhZzo5MzM5MDdkOWI4MGI0YWYwYmFlZDNmNzlkMmI2YTQ2My90YWJsZTo0N2Y0MTk4ZmE3MzA0OTViOWQ1N2ZjN2VjZDk4NTliOS90YWJsZXJhbmdlOjQ3ZjQxOThmYTczMDQ5NWI5ZDU3ZmM3ZWNkOTg1OWI5XzQtMi0xLTEtMA_e3b59378-5557-465f-a3b7-e973b83cf1bd"
      unitRef="usd">2300000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="i2749835a349545f38d76efb02e97a939_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yODMvZnJhZzo5MzM5MDdkOWI4MGI0YWYwYmFlZDNmNzlkMmI2YTQ2My90YWJsZTo0N2Y0MTk4ZmE3MzA0OTViOWQ1N2ZjN2VjZDk4NTliOS90YWJsZXJhbmdlOjQ3ZjQxOThmYTczMDQ5NWI5ZDU3ZmM3ZWNkOTg1OWI5XzUtMi0xLTEtMA_64e9f9e5-4b87-473a-9cbb-73864034e1ea"
      unitRef="usd">2500000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="i2749835a349545f38d76efb02e97a939_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yODMvZnJhZzo5MzM5MDdkOWI4MGI0YWYwYmFlZDNmNzlkMmI2YTQ2My90YWJsZTo0N2Y0MTk4ZmE3MzA0OTViOWQ1N2ZjN2VjZDk4NTliOS90YWJsZXJhbmdlOjQ3ZjQxOThmYTczMDQ5NWI5ZDU3ZmM3ZWNkOTg1OWI5XzYtMi0xLTEtMA_b1e83049-1ddc-4ae2-9699-cfd95d5ab8fc"
      unitRef="usd">32677000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:NotesPayable
      contextRef="i2749835a349545f38d76efb02e97a939_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yODMvZnJhZzo5MzM5MDdkOWI4MGI0YWYwYmFlZDNmNzlkMmI2YTQ2My90ZXh0cmVnaW9uOjkzMzkwN2Q5YjgwYjRhZjBiYWVkM2Y3OWQyYjZhNDYzXzU3Mw_a36c449e-463c-41f0-9cf4-1a16dc8f0332"
      unitRef="usd">8100000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="i0c5e47b0a4d34c71b34c66cbc626844a_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjY2Q5MGFjOTRhOTRjZDlhYjNhYmIxZTZhYmM0MGE1L3NlYzoyY2NkOTBhYzk0YTk0Y2Q5YWIzYWJiMWU2YWJjNDBhNV8yODMvZnJhZzo5MzM5MDdkOWI4MGI0YWYwYmFlZDNmNzlkMmI2YTQ2My90ZXh0cmVnaW9uOjkzMzkwN2Q5YjgwYjRhZjBiYWVkM2Y3OWQyYjZhNDYzXzU4MA_9ffc4776-e0a4-473b-bbb1-b4e2d2b02908"
      unitRef="usd">4900000000</us-gaap:NotesPayable>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>131
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MQ1^%>FI'KXEUY5[KS_;BY_QZ%5A%JE29L5-(^'=0MZHL[4R@XZ_CI*O3/>W
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M$.9.&("8!S:0EYFI1@8-0NP:Y*G;-MK:\B %B%T*= =A;1K/GIM=W#.31Y[
M8JUS.IY9KN>YYO '87BR,85@>'PB<\EM&/_$/OYA!I?GA<,X=>V;]A]+5.?T
MXF3/"R9[70CF.-B420 ,1V/QVW);C8ZN<R9?FE< I5[^5:': ]_^;O^:X4-S
MN&[<O\/7F_9EP>"F?7?Q2.4++TJ4L9UVZ2Q#'9-L7P>T%TH<F@/RK5!*Y,W'
M/:-:3M0 _?U."'6^J'^@?RES^R]02P,$%     @ 1(9/5+WKO$)/!   :@\
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MSCM.+7AZ;+F(\Z/@,)1_@=/!Y B.DVIO:[F$7:ES"M*RR)AR1R!RC7TXZH?
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M>YBRY^JQI: 6(6B4G)4"P;+"7O( "F78,^)X88+?7BY1)025L)QBB )!-@4
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M J@<.XD40L6E9VKPHM$XK-%FFQXJUD0[/IP9A-E"&$NOM._8V:7@Q!(0YJ3
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M&WKZQ@\64(<?5=<4MW;=V96MJVXHKNK:C=U@NW5Q[5I;6_CFY!<'GYY^_W0
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M/:?;)N)2^=QE5]YD18O<N@J)Y_ A;0]KB3SH(\[R:"/$1P,=@GA#&,1>!)
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M]$O:]IMS<,[W/E;L&V$6=5\E(XR$'2QW3+1M*-O>&VI#H1ZRR.UUX/;Y;==
M,I+H2)TSU:59'TZ&8(_JNV?V69I-U:ZXLX8] RQ&@MW%X4QFH1LH+(" 73F4
M^3U$M4MCNM#%4*K+@7^B[C[(6C0@^JW;^021XU "TB.9-82&/3>)\T_>O?SE
MYC2X^,I/^:0"M52L$':<(P.X( ^4RG(1<"X]5")8O71'D!\D 13W#5$\@ -J
M@XH59Y'J8BL:MQK!YZH&33_%^:B(XX/FU:H/L T6F3P'C<1@4^9""T)R&9V[
M$EY2;;AEG=[5$PEB?[K3=JGRJ%,6_0=J[!'1+/.9Q@&TX;^C3\H:)F5;+*]
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M?8K\ 8?E*FYJ(SPP=)-YIJY )H$S,A3<]S>WU]=3B5,0:8ZDO?&T3%#$&ZK
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MUW(\.""VFJT$<A-L=Z;BT#2UPNUFV'W<MU!&;7<  3 QOYZC5SLV9AQ:0$D
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MM6Z0@XV+\UX7P5L:216"]=9D@Y)]> L-K("L7&Z2UYDGN"9(PS78549WIWL
M5T=>.LJJ?7<\O\C-(C)B%!F10IV%1DBH^JR04I/,X*%I8KHSJU'*%G8B-5RC
M!]F-;=NOVZ%WYF:]^^-N8G[#Y((33QNL2=5_FB4CD&X*=0LM5G;RFPM-_+#B
MD@9WE.8 [=>"IKMA82[8_BMP_C=02P,$%     @ 1(9/5#W1&J"N!   "@L
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M+<'KZ$/$6RQ&$(<^1$$4?H 7#P;'#B\^@G=7ZU:QND#XZVJNC:*T^/L#V&2
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MTY[KMB^UWMNSU+6N:UW8QQUB3QJ:@.\;C46Z>R$!_>'Z]9]02P,$%     @
M1(9/5-8-;%)""@  Q1H  !D   !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL
MG5E;<]LV%OXK&*]W1YYA9/&B6^)X)HG;;6;:Q!,G[4.G#Q )26A(0B% R^ZO
MW^\<D!1E2W:R+[R P,&Y?.<&7FQ-]=6NE7+BKLA+^_ID[=SFY?FY3=>JD'9H
M-JK$EZ6I"NGP6JW.[:92,N-%17X>C4:3\T+J\N3R@L>NJ\L+4[M<E^JZ$K8N
M"EG=OU6YV;X^"4_:@4]ZM78T<'YYL9$K=:/<E\UUA;?SCDJF"U5:;4I1J>7K
MDS?AR[<)S><)OVNUM;UG09(LC/E*+^^SUR<C8DCE*G5$0>)VJ]ZI/"="8.-;
M0_.DVY(6]I];ZC^S[)!E(:UZ9_(_=.;6KT]F)R)32UGG[I/9_J(:><9$+S6Y
MY:O8^KGQY$2DM76F:!:#@T*7_B[O&CWT%LQ&1Q9$S8*(^?8;,9=7TLG+B\IL
M146S08T>6%1>#>9T24:Y<16^:JQSE^_+U!1*?)9WRHK!!^.4/;LX=Z!,W\_3
MALI;3R4Z0B6,Q&^F=&LK?BHSE>T3. =+'5]1R]?;Z$F*5RH=BC@,1#2*PB?H
MQ9V<,=.+GY53_'0GH4C)H/CS5\P3[YTJ[%]/[))TNR2\2_+\+E?:IKFQ=:7$
MGY_5G1-O<Y-^_>N0;K^7)BST>:V BJI2I1/:?W#8;%.96]WZ"0'>"K?VGU)3
M6O6M5F6*Y6:)";>JK/$LRTRH.SBWQ4M#,[^G-7*1*V$J@#NKX33\5HI;66E3
MV_ZVE7)U55J!V,#[W2M987!C*J>R(3,+!U$@G1WF%NL6JE1+[<0*]TKFX&!/
MA!)Q*5W+<J5 X2 U::UR7IQ<RX7.M=.0**LK7:XZM@+(FN9U1F.RO/\12E":
M3+_5FF8O:@OS8)[UXF'MQI30'$^CS7;"D59VU-6^FJQ0Y"D".%?%0E7 NI#
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M6?&"!;.6M=2N'X2CT9D8C(8)KH  /T_X.>+GZ9GX8,H7O2!#SH1PY*T;)HG
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M>6@"OB^-<>T+;=#]N;K\'U!+ P04    " !$AD]4_\5"J?<'  ",%   &0
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M&([1'<PF>)Y;+\I" Q.R[S#>')@E%>1TEL%A;( ]K&=M.,0VI6SG-'S4\\R
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M<SKWMVL)F#.\ >M+K=WN@04T'^RN?@=02P,$%     @ 1(9/5!%65N,:"P
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MUJ"'H)R6I5A*_)N5BA?XA77A.=Y46P;W]?^D^J&XD'XA:KF.$%4R5P*ND!A
M5TNS_L??3B?CDU=>V'LHE3!(ESH0D!&K%Y,Q*K/%ZO3XJ+V+6)T<'G</_@JL
M5@N=+:+JK)3>ZT)#RDJ'A38]:YGNHIFZ]<QX6^H<X.;B+N!?]-X6$8YW(&@_
M%%-^\H!5#Z&S8M93^7.YA.*Y@JW4"39P<;C(E1]6YDAVVY@@8+!B9'3X >Z$
M\>GP)&'&J Q?_'T;E2>L+II ]03JU%5#II@&B16-ZQ*@022<D&4IC#7/,VDR
M57+>/6R.I*PK":Z78A?HIO#Z/?$N:KM.VKC2Q&VK!A9-Q#-Q>C*BRP-Q<GQ
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MZXH&6EB,!(SG:V27HPC)N:0#X_8< I\+7>)M#+U75%YX3I^C?"C5K+0X^1(
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M@'MGW3M^H-M[]"]7&TFHF$T'GZW5H%F1:^-2(><<D9=E1WC ) 1*=0+P_7V
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MLJ8)>+^J8*=N0 *&C[7G_P502P,$%     @ 1(9/5'PPO="X(   5FH  !D
M  !X;"]W;W)K<VAE971S+W-H965T,C0N>&ULM3UK<]M&DG\%I<OM2544+<IV
M;.?A*EFVL]Z*$Y7D['ZXN@\@,"0G!@$& TCB_OKMYSQ B*)2N2^V!&!FNGOZ
MW3VC'^Z:]JM;&=-E]^NJ=C\>K;IN\]VS9ZY8F77NILW&U/!FT;3KO(-?V^4S
MMVE-7M*@=?7L_.SLVV?KW-9';W^@9U?MVQ^:OJML;:[:S/7K==YNWYFJN?OQ
M:':D#Z[M<M7A@V=O?]CD2W-CNM\V5RW\]LS/4MJUJ9UMZJPUBQ^/+F;?O3NG
M ?3%/ZVY<]'/&:(R;YJO^,NG\L>C,X3(5*;H<(H<_KLUEZ:J<": XP^9],BO
MB0/CGW7VCX0\(#//G;ELJG_9LEO]>/3Z*"O-(N^K[KJY^[L1A%[B?$53.?HW
MNY-OSXZRHG==LY;! ,':UOQ_?B^$.&3 N0PX)[AY(8+R?=[E;W]HF[NLQ:]A
M-OR!4*71 )RM<5=NNA;>6AC7O7V7.^NR9I%=M<:9NLN15I/L-V?HZ0?764 =
M?LGK,KNQR]HN;)'77791%$U?=[9>9E=-90L+WQSK3R<_/.L .%SB62& O&-
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MAK@LU6-JNEBYK_/?&Y)8,*N)*DK"*^\^NZ;"  =\KB6H"V^"X3NP_)C%Y'E
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M7(A9/:<4_ 0V9KGJ@D/KFD5WISF]V/CK=DPP"V:!-S@RPO@7W8HD/(6ANEI
MH>]<T[<%?NWE?2(,NP:!GGO#A(QQBSH0O74@ UF>(<2).EKZPDM$:9H#/#C&
M90T!/&7=3 X+2D25*$G*M^#N8AB+(?W.5G$HAR/:0:B5Z-XQMD==09&DXR0?
M[5CBP_BEPC+$6UY3H?\/DKXXY?PAP1Q[R5QZ\/DLL\:0RC.&_J82#1$7VG*J
MB' 8H9*!#D>T0Z,A-D7+)/^2BL9!:+=T'=U9ZP;,[RGBDID%:2QF(&V_(MA*
MW$E<%D%B>U))]DQIQ"HZUNV<$M1P!^G.P@5,N$LZ<;:?0KN1C+KDOR5AX",J
MK.2H!T<B2+I60R)>J"';,XA\%L"2Y(N+ Z&SG.(LI+;JK[YH.,TN4KJBK:V-
M]48M2D$@NIKB'^4E<%#$]V,[C/M/AL&"3D0W$6=@S:%S^#(83)*R3MD8](NZ
MP X[24P6T[B.)CL2)]/0<J&6?+1TZ#U71RPM&1N_!P]GO[PN+!JR<[E/:2_
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MFX##F<Q"-]"O  %[GJBBMA"$SXVI?=/%1#TD_!%-S4Z2I01-534;%R'R,)2
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M-3S!)4W-AS1R\0&$/:PYEER-?5-5G[%8/]X/1:+&!OJ;5]/SM!_LVX?[P0Y
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MN&IM=?/GH20=U_%"N8"*%7)TORW<ETZ)+H= !K$DDS9L$C:%1HD7UGC84<N
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M4U0P$>Q4N2L7(//XW<JY^LXVS;RX%!R $#VAGR[RVV [PP3>;H$MF 7@TPI
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MJMH.XD8;BGP*NC;CS2S>D#<>D.E0LQ$O"@_69H.*=@M+@$VI>M<I!P!@T^"
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M0:C(J/+D?"]Y2"XF[0]"K9YR='$L^6TQFR*N$V,)%"<64)G>)E010X',I$D
M?5Q+M 7!7J03*[4&0Q(@#R#3KTTWC@+0R<AQT/!%$ENU9)V )ZQ?*RD!?-1H
MX*Q"3%JSUAVI'O".#5 "@QX8Q+BS0%,F;&&R]!7J8M#:8-Y@&3*<; "YZ!$F
MV%=P4Y.QO52MN#02**-I <6 J="8[6$!X-6"8]6 !F%F0+?,B%\- :_WZD@'
M:Q#$OS.40@2+B@.6J/8"<T9?%MV%29U.4C_/0I\@EIJ/V5/$*&?JB>Q]%%(V
MB0T/.XF/11XZCA.)4\#9='?HTDO )OQ+D7^PX)[3;2-Q*7WNLBMOLJ)%;EV&
MQ'/XD+:'M40>]!%G>;01XJ.!#D&\(0QB+P)(@"H?<((0I$0NQ*R>5PI>@8U9
MK?OHT'JW[.\TIY<:?]V.&6;!+/ &1T88_Z);D86G,%17BR@,O7=#5^'70=YG
MPK ;$.A%,$S(&+>H ]%;!S*0Y1E#G*FC5:@D))2F.<"#8UPV$,!3ULV4L*!$
M5)F2I'P+[BZ&L1C2[VT5AW(XHAN%6IGNG6)[U!4427I.\M&.93Y,6"HN0[P5
M-!7Z_R#IRQ/.'Q+,J9?,N?Z0SS(;#*D"8^AO*M$0<:$MIQ($AQ$J&>AP)#LT
M&6)3M$SR+ZEH'(1V2]?1G;5^Q/R!(CZ;69#&Z@'2]B."K<2=I74()'8@E63/
ME$:LHE/=SBE!#7>0[BQ<P(3[I!-G^_?0;B*C+OEO21B$B I+)^K!D0B2KM60
MB!=R9'M&D<\26))\<7$@=)83G(745OLQ5,'FQ45.5[2UK;'!J"4I"$174_R3
MO 0.BOA^;(=Q_\DP6-")Z";B#*PY=(Y0=X))<M:IG4&_J(_LL)?$9#%-"U>R
M(VDR#2T7:LE/UNJ"Y^J)I25C$_;@</8KZ,+*D9V+%=PE&%- /-3"%%CEQR]3
M]PKGP6 42/-E6';&2I, 0$=XO,?)5&)J12'M1S*>PPIEH!AW/XJ7YE+R/*#@
MQ-R"TI8HAE</3N$%K?Y0&!#JLJPS4&XSYWN;!HT!BCOTH#][,7_.9E?H#@^>
MZ8,9,:&AY@[,T5^U#P4@Z[)&9QRC^ [98U'6)[59]!2.M]ZH^*+?CO^DWP:D
M2^\-,DEXT-B2)$!"Q]J =>:"CGS W!L\BU 73ECV3=E03O &6SD\JL-)@L+T
MB-4CPS#Z]U1H<?9Z%D0KT<$<,$]F)4<;E(9-1Y2+NB^Q& ,^Z\ 6C[*P7 C*
M&!_V\E@"H3X0-,9GHUQ('J[AMBT'2NY0Z3(+V+#M2(*3*?AG$K9QJ8@7VW*J
M31*!48^LRUOR7$"2.[NR*'P!+@B'@I"[5@ ! C24EXAS<!8W%&'&M@Z# R!%
M'5/?/ HS@+<0UT@$R?EES;$$;%&]JS]T$%\[IG',Y3SC[(#UY6J%48XBI.!"
M..(-U>Q9"G9;H[6F!GC5BVSF3ZZEE6 JLQP*(XEJS!L00G[<BX.(JT_W2> D
MJ.=5UMC:#"WE>_/9#\C.O'@;7;VQ'W."O(QI [1"M]8-GBL[P>V?1B"F!(/K
M*'Y_U91VPVD]TK&I%D[D9%FJSJML5PT;+)]4ANWVQDEPU$!(*!.F+OC"H"^_
MYQA%SP,C#S;_W)>BU;B\4R2K%2:@)4T3[0C]![HEM.D"/D*/R"XMQC(76]#O
M]S0=T/7UZ7^3_X,893HF=1=R4_2Q=7>MV(:>*OV2MGU]"L[YSL>*?2W,HNZK
M9(21L+WECHFF"67;.T-M*-2[%KF]"MP^O>T:2$82':ASIKHTZ\/)$.Q0?7?,
M/@NS+ILE=]:P9X#%2+"[.)S)+'0#A040L"N',K^#J'9A3!NZ&&;J<N"/J+OW
MLA8UB'[CMCY!Y#"4@/1 9@VA8<]-XORCJS<_?#@.+K[R4SZI0"T5*X0=Y\@
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MM/P&'X;>4WG4E_>% 4^32VJHZSP>IR'''Z8 =F>KK)7_GUSLX"H>Q(PD#Q&
MT2,<<K^"S.)2&B-#])ZK3*J6)?5$U+ C@N/^2'+A4V3D)$X%&V_[$_7VT9>W
M'<V^B.V6L8;.#95!/P7/A?33LG%W$C@@O=$7"HO%?HU,A&;B /7D<SEQ91-6
M Y\QZIVIL;%"&_KW: ^B*PN*DI+4P;Y:[P=)^BO9"S1C/>GB+!>4U$1MNP2
MT*Q0[28:QVQ6L"R'*!J[-?14 J*DU6MU%="Z+KTA:B1['<-+YMEY\8-K3WCW
MBD^NI:Z3I, FQ *T?Y9%H9YAJ8QYTV 7O4Q/A63>5/+0TE-"B[S/GP=&AEN8
MI1.PJ#-:4V+ [)V9Y@Q^E;#EZ!!1KGQ^@# FS=)I07 +ZE<B"\HG5"%T%F,P
M?09,$J.>7,YD,U#++,%K<HAD8['A$;\ :7!<#7:4.4<S*;Q&A532VT ,,(,<
ML#?8,4 .Q(96R%;Q(PZ $!V\73D.@+GEH QK=]?2VUK.7VSQ\.!.N_>!%Y;8
M*;H=.L#9F]" @DZ]D]:/:?=QXEA%0@1<!).E6)&1NO7[D$G.Z!A[=,<'KJ9+
M3Y2.Y"X7@.WBXL.U]#.78'(U? 61E]:+JS#=-9_3*(X0>!HG3_BD"\Q+#],6
MFA;D2'\?I/@NRO^1[=EI^9+Y9QJK>'(GA2PD-'V*65A#&Z=F:7]O;38M&WE!
M/&TKC<1=NO0X&B;U^SO,^;TX14I\_EP*6-CY@PW\4<>H0E$\YL7UT/FA;,,A
MF3%CA*,)S#N(X$Q/S4C13KKBM1>%:0S<?_"\EW223$N>MO,,/O:A:0G"NXJ#
MH\#'*<&UW)I Q2NP"S0%"4@*J%K.&$KV.I5,\/X-]2RS6W[+Z0A<<Y3RU;K[
M:@#D0<$:TA.=9K%AB:%KQ6\8NZCHME":!8=04+24-L(Q0X74)>DAWE$ZI+?+
M?8X[-V WETZE,0917',1LMUY6#(!79YN"7/*<%X]1@2DDX<.M4^<3_;#DOAC
M,T3>Q9#F#1D/DE$L$\4L+ T[^G#S[C@K#.]S=O9VCV$ !J*H4G*FP+$(QWK9
MA'>O^:VD4BV)\LB..B(>Y642)%#-BQ\)X$N9[D-2NN<WNE!:U%==HAD%+ YS
MD3E+Z" & ^:LP%I)@Z8F':84'#9!D@S0I+.0'+'4..I3[V0#7X'5+UOC!I^!
MD2N.Z?,PGVA#-S[R-M'R(:QFX!]O##>2H@\G-B@@&N*J)$C.)M .HZ#,%]SI
MFB1?$.^I;,SH" 61*R:2N-UJQX=G^5BJ3*W)'&K>E+XN;M_,V^/0KPV.9]8!
M'5K%DF0L9X&I;;U+D^EZQN+35,=^#V'1)#FU1[$<;F J4"80T78!B2QEGS:S
MH-)AI&*2*M)KE+2;2MGE":JTG,F'GM/]R#H4N8<N8'5'/MW2AL*D.$_2>?J8
M;AON$G^ -:<RBJE/JYHJ%>M/-ZV0J+$M_.SE_#QOVOG\<-/.(Q!ZZ.2:J(@4
MV@R49^/^H?/YZT.@@ '##A$P4YC$V(; Y[(DQX=B@QMMBHT?F^SC*ODX=M!V
MAH^TDHGG^$)R ""=PT;.5M?8$X&F0*&5F(0>S#,XPM1I)VD\2C8NVI!UY(J8
MMB"2]FS+Y@05D$Z7.G(8%N,'>F@S-)5JA\G(OR2 HS( 6XD%V#@L=E(")$XV
M*$3  :$$S%$*+9Y:>Y!04C:FW =(-[8(GZ![))4[:09>IX>#@03+ </(VUC/
M9P/*(&3OI=7Q=^W^%\4[<*TLRM\,VV3Q!^DH#>.?(3W.3L4K?C/8IJ;4TK,7
M^.*YOICD AK[0K[XWH"R7E-Q94/^8 S) ^%,0@=*FD9G+K96-3@1*<8B]L..
MB1;NBFCLTLPU;0^C"0R?;6'#CZ1YTNZ1@/V;F'!U83(9*8<_J3VO/:E0 S6A
M) (!,$;KKJ7J.SH -5N9"W8/&1VZ:@'&Z<DZ,Y,7'7&*6Y) ''WX\>?CX*-C
ML$S?9'[; ^?.]U)5Y,5R*YN>:N<9PYFFL!V1ZGMM%9CBY2;KM+L$D.7C81K)
M**)LW"BW@OD3=9<ZN=$$0P&\4L%6F$% VTD#<R^=FPQ"$J+J-$1<N*YS=WH<
M0FX9D<IHU8!KW6 "HZ_"$9B(U[3W!13/@Z*Q25*7]O!V[(]1GV/:'4^?'KC)
MX;#1FQ??R04ZF)'5LSLF'!S2ZW4H9R2YJUFX4H)R,IB.6G9\G0TF7K$$;FHS
M:E'3AO@T#P5\O9\M@F#6=IY]?^\E6</9T*1"'"&U2SE<18!($HU2G<@:Y"#E
M11TZI,-I;GR(I5/*YYN:^2,JAQBQ[0-)53DZIT06X*/=TEHIN(@>5[!JKKJA
M=0R56*??8UR7#9@7?UMS@1XIAC-,?963EVD66RWR@--K]V&.M@_GHCDLR9/0
M) MW="T<Y1,W"^T=QT3\Y!"NZ7*63AK4V5[-<^Y*(,O1V R^I^,2^7U,"VS<
M+@NJ5:-:-%Q]4^LOBE-^"6?>TVO!TNDHW2&2DG!C:+#0 #"FQ>5^#4U5+['R
M&- NCJ*[X0\LR1BD9R7%R&:E/&UGE'H*':.-=F0%F@KBM2YTI*4G[?@GZMD"
MJL["_LCGFL2-UPG*U5=EQWZ.D9QVV5+<+(GL0T6$::EBNYLRV"RFO#7QG'9N
M2^E>.Y0P!3=LPR$8G3]V=,2[OGX:'TV5!9*/TC.@OZ?)'&NX?=GR/4V2F)W2
M]#9^E2C\Y/CZ6-'QR=)#11+,,59T2JO=F[HX<F(X^/J=8SU@IAIYVA9ACI-N
M-S(GC>4SG5,@DR;K.7='V<Y4)/3JH <(OC_K'Z9\GJ[Y/C%L/QXTA"JM>B4&
M=0UX/:^!SJ+SJ.J./CL[&\=19Z=ID/?)("Z-M(XEA4/GF%RX;BG$I5F6[</-
MNT^F5/E+Q5 N!N%KR\CCDH)$. 2<G:%?L$W')#-_=E&!6O%<RN-.]RD.X8:&
M<#I@K[(0^U[BC3/4^II<Q4:ZB8]($D^R/QN[R0*,7)OKR>N!0('[GC5!!+8:
MXJ^YP)HW3@*A(S*<VVC-'5[(L1QCD%PJ$#IVLEOL].PR]H_ID9D896*34VT@
M=$!F_L&UVH"+W'PEGJ=/OVGS;VSXYH CEE[;B <@*1E4&S83J![Q6*D-=RWP
MY4)Y;_9$NA1[25V'!]I"=1V5M\.Z* DBZW@M(-5TG'K<\_T_GD#Y!&*Z7W0;
MK1; /RGH08:^0&,)P0-)G#_FEZ0$'D%4[-M=V9;L'7<_H9O^67$^.S\[@__/
M9B_//R]^2#L:7KTLSL[.4VGPQ?FKXAFL^B'0'73#V>S9LU?'!6%W_F7Q+5[X
MA^DR?GO^XL4Q?//\]7'Q+EK$Z($G9Z2+EZ>(T-GC\,&^UA23L]GS9\\#1C=X
M9\+)&W*C<). 6_=O+@WVE%LUPC?*W;@_=/F"7O$$H3:VC"8^2^^JC^";Q&M[
M$+K.4E,"OYQ\R![DD5QA0TIQEGV%JZ(+0QG-/(O!J<P0+:J\CVX@/(I91OSJ
M5OQI?GL<<AR(T8SOED#KJ2F:>(Y';UW$\E,78^:DF$ASQ +<#*,*8**&;B7Z
M,,:)()&K]W:S]%8'1&CI!OD'6?&MLN(U6C8(VX$:M+&C2[DVVT$RZMA)D5Z=
M4?$@OD%CG,>=N"(V_1X3*'1[QJZ@$B:2+V_Y^</S(=DT.CC1;NQX]T$ZBM4:
M7JPVNIM#CU]F!3Z-$K!DV QR0O1?3Y*88/O78#&+MT^1/^"P7,5-;80'AFXR
MS]@5R"1P0H:"^_[VYOIZ+'$*(LV1M#<>SQ(4\88J,.H[^2P$98=>A8M4RV*]
MVZ*6XQ0\MF+HE:$"&_6HX)$F2</MJYK@[O"D(1CVL?"L;149,E(0U5U)F_:"
MV8D'>$=3IY<6:1T6TZ6B'#C2Q((W7Y!QC_=BQO.S85'LN@L!2Z9@N7OQIRQ^
M"=T!.$5R#TC8=H*1^EFX\'7P&Z5(G9XQY& IXZ4Y7;7Y4WE/D.SU<N +=-J!
M3)NRY00-3 B?L8-V"=%E1X= N7</)_Y+"4X_\$,X=O@3TYDGD.&J?+'MCP^O
M>'(!3E %LF.HX26?=L23IZ@7XV4@R>7ET1CI-1BS)&TJA_>S8T/D[Q5'[R_Q
MW%;^*;]+,4(@.XZMLG3%Z *C^0/7I;\(UZ6_>/#:\IAIH]K,3>KO <MR&'.5
M]I5FN;FWF.:AQD;QXW^1_S]QE_J#0.$?1OC"PQZ9KY\0+W6WYLDW__%T_^/I
M_KMXN@\(WN=!\#Y_4/"N2XJ;E75^>4_[\M!?0'@99G[Y?_J7%UZ%=5_]/_WE
MA3^R[KY7%3M.F/152$4KE=(V4KRXA0[+9I<$4<-&J@"G[ -7:-?4:47=L26E
M;V'<KT/+V<S8%?3)R?(KPRQ=[+@ISDY/_E>/U0:";I6@*OH=2"4&,M*T1 Y/
MN9'+?U#%U>$.3IB=KBTX5^6#O_G8P?/(O\Q $U%_P-75C'BK>#4CZ3T__7+Z
MFACBD-@'";H2_[)*,>=19U\^P)JO VN^_G>T<@\#%:" >=); :_2V\,R6.</
M<75VZ5ANSH!I\D:(8ML,7DP2?HVW$(E>-774T>CFI<M/[<33Y&_A;$RWHK_X
M@T("/,E_%B<\+?2/"EWPW]*)G_-?)'I?=BL\3M&8)0P]G;\$+Z'CO_+#O_1N
M2W]99^'ZWFWHQS4(E^GP WB_=,"S\@LN$/[4TC?_!%!+ P04    " !$AD]4
M+(7/4(P$   F"P  &0   'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6RU5M]O
MVS80_E<.7K'%@!9;OVPG30S$:8L5: LC3;>'H@^T=+:Y4*1*4G'2OWYWE*TD
MJ^NE#WL0)9''[^YXWQWO;&/LC5LC>KBKE';GO;7W]>E@X(HU5L(=FQHUK2R-
MK82G7[L:N-JB*,.F2@V2X7 TJ(34O>E9F)O;Z9EIO)(:YQ9<4U7"WL]0F<UY
M+^[M)J[D:NUY8C ]J\4*/Z+_5,\M_0TZE%)6J)TT&BPNSWL7\>ELQ/)!X$^)
M&_?H&]B3A3$W_/.V/.\-V2!46'A&$/2ZQ4M4BH'(C*];S%ZGDC<^_MZAOPF^
MDR\+X?#2J+]DZ=?GO4D/2ER*1ODKL_D#M_[DC%<8Y<((FZWLL =%X[RIMIO)
M@DKJ]BWNMN?PG W)=D,2[&X5!2M?"2^F9]9LP+(TH?%'<#7L)N.DYJ!\])96
M)>WSTYEPTH%9PMRB0^T%GU4$GQR&V=?.2W*=?H0NX:-<:;F4A= >+HK"--I+
MO8*Y4;*0)'-T+18*7?]LX,DT5C HMF;,6C.2'Y@1)_#>:+]V\%J76#X%&)!/
MG6/)SK%9<A#Q%1;'D,81),,D/H"7=@>5!KSL!WAS2XE@_7T$<\7^\WF\_MK(
MFACJX7/P'*[QSL-,F>+FR[XS.*B!T^_4U:+ \U[-P;"WV)M>[-*%HU%W-F"G
MF>TH1"V]4/(;EN#,TF^$1:"P"@=+HRCOW"D<24W\48K"Z_I IX/5 FUW0M_-
M#.$=0_,C*U)\BZS.P0O(APF/:0JS1JJ2&."^%\NBR22A<9R?P*6IZL83](/5
M<33)8QK'HS&\::R6OB&3&64I[_C;01(-XXQ%)F-XAXYT%$53-8K86%+>T1$5
M,K 5CE)"&_?YG8ZR/NQ"%? ZG1%HJG%YE)XD-&9DW>6^8\NC<<P"PWCXO5I1
M&>OEMZW:)(K3G-22,Z-1?R]<JS2-\O&8QCC+X-J0S$]%LL5X 9/H9'02WJ-D
M! <HG764S@Y2^@I+I!+/Q/U@=$'Y9XDMG-%O-84+W7-Y?5#-?EY?KW'+3=;G
M@Q:FCRPI]"5Z(54H0)[DF#]"W__FZ!;H+-9/+99;B]VOOTR2>/RR+?>22$ 7
M5T"Y1V$=()>7/?3GPV?6_SM1PF)(AZO_UAW! E=2:Y[D=$4K34D12Z(DCNE-
M9*;(?:!HDBTZ) Z1.R:^711$ R>95\3\":2DE156=3M%'$O321^"=\E+>"6=
MMW+1;%>3// P.^G#&R$MW K5M.EDR'4+HOR;KI(V,\=#=BA^GC_($(\\B:,L
MS3J/#G P[SB8'^0@733+1L$[N43X_#X$Y<L!V%$'._K?J_5A#=</Q*2L546H
M$.YI80H%]''):%Q@.VVE\ EN&'YG7*C0K^E\J7JV7,7MM5O2CG ^BEJ7+A^$
M<TB=&+ )3]:9ZC]U1]!S^E!_HX?B^Z1R0@K> -7#-H4>JGZ:\T*V6]A;3\/>
MO)78%]C!H]ZE0KL*'9J#T%RT;4PWVS6!%VWO\R#>=I#OA:7L<Z!P25N'QV.B
MGFV[LO;'FSIT0@OCJ:\*GVMJ9-&R *TOC?&['U;0M<;3?P!02P,$%     @
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M$Z53QRSJ]O2$E$0_.*O#P1B)=\D-+%ZN43V!XM%];+]9XOP/8HH'=2L43C?
M[L7W1=V>80NQW94=WV^)J.VSFNJQ_K3Z?P^A8_W#<./)B; .'9(N5DS75!W;
M36$A),G-*M;,GW("U%0A?K 3)$E.[QCBQ-!S1)Z#+G.=;UC#.JI1G49BV5#L
MJI?]M5?]0IF)^Z!18=K/2UN_];>S[3>3V_I3P6IY_<'ELS23# .<JS&*^A<Q
MUC]3?\2H!U;/W(>#@;96%^YQJN1(&5J _X^UMLV -FB_)-W\#U!+ P04
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M.&$AF"0B#+/X%E?1W?;-&8G&&'8,68)MFN>;TFMP"S.XQ2HD&I:'DG&.8+C
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M"VIG0.\;I>QIXPC&'];R)U!+ P04    " !$AD]4KL*7EJT%  "6#@  &0
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M5_6?MNZ<].Y\<.Z\KA;\R>L>H4Z<QU2X_4SM>$& 4R/H/^SA2)Q1TJ]*0+3
M[P>NK,/BS@AZ]S#K2GJ(Z \BC],6IU2^@RX#2;:&]Q1X-A1X]C\5N$?GG>[0
M/>]UIQ<W>) H_L2BWHOE\5/AA=)58S.%'-:NE.Z= ;Q'8!-J"@[U_#"0># 1
M9^5J6Y^M ;J IWUH>3LWNCN]GRJUYQJ&PK67(L\O<C.(C!A%1D0U9:$1$O1.
M*Z0XP;-'V]%TYZV JES:%Y&A$VZ+[MDP?!T>72?NK7&WW+W8WC"YK$#%FB^@
MZC_/< 1+]PIR RW6]N4Q$QH4L.(*#T<NS0+,+X30VX'98'B*'O\-4$L#!!0
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MI0N+ZR[HAHB:%]!\JI3=#5A!<^>\_A=02P,$%     @ 1(9/5"6I=O[1 @
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MC#3=^TG7"/4NO5E<U@%<3-6-SU>^B0/P?5W7X="("PR/6&=_ U!+ P04
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M<8(6X/NR!L[["3$8K_?/_@M02P,$%     @ 1(9/5+E+F?Q[!0  .Q0  !D
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MECCMV%SGYX%6^N3:!:JA^[[@81;H9I[2+IF"*[' =K%8[[A0'T*8QS#9W&H
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M1'Y3E3\HOC=W-QNN%$_,SQTE(17: /Z/.%>G!SU!>5^X^!=02P,$%     @
M1(9/5*B-AOD2 P  :@P  !D   !X;"]W;W)K<VAE971S+W-H965T-#$N>&UL
MO5=;;]HP%/XK5IXV"35QN+45()5>M$JMA%IU>YCV8)(3L.K8J>T,.NW'SW:"
MPZ02NK+VA=C.^<[E\^'C,%H)^:B6 !JM<\;5.%AJ79R&H4J6D!-U) K@YDTF
M9$ZTV<I%J H))'6@G(5Q% W"G% >3$;N;"8G(U%J1CG,)%)EGA/Y/ 4F5N,
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M\]J?R9$JNV Y,3(K&LE"&FI+Q7!-%Q>5#:#]I93F=6)[4_U7-/P'4$L#!!0
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MEDDE.3T#7? TN07OWYV!=WGY>QZ&*B(=]:3JLKSAO5G9/=?;[D&6[KEELPN
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M$<;+2(,B4K0E4CV":R7MU,"Y3#!Y+Q 2=LD>K=@'4:7B&<:'T*CO0U2+ZAN
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M)TYMI[3]]+-#\-)@4/L"L)/_W?U\=]B>;KFXE1L A1XJ5LN9MU&J^>#[LMA
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M]DU9K5J3L&(8'V2NWB:J3BY^XSP^)&D*"(O!#9.$;9*GE((K(:@48+55#Z@
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MDBHZS4ANFCNB"5!O_+F<:Z13[H=KNE;!N 1:7VJ-;X$[ZMU%7?P%4$L#!!0
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M=@%V?Z\4O3NNW?K7)?L'4$L#!!0    ( $2&3U0O)M\FW@,  #$-   9
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M+W=O<FMS:&5E=',O<VAE970V,"YX;6R]6&MOXC@4_2M744=JI0Y)'%X= =(
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M>IV\V]1UVQ#6"@ ;Q?TA65 =-=P O77$":!ZE2RW8;QKP_A^6M\^!"<1-.9
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M@!0F(%6:.^JH 2G\@,1)<1S)=EA[6B2%AJ2(,\(E0]P1(,F4L6LP7W4U)<4
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M8/&E9&GT "S"E'1BE1A3P"A3&>T#W!W+UH%Q)=X4Q!&G@)A3,(8ZQ162L?T
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M/VX* _D^IE2\WA0!JN/(U7]02P,$%     @ 1(9/5)3C5&+)!   X!(  !D
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M&8Q[FU](HYXTFB1]G#_,P8X4A..RH1022P)J56E43>%8TGH/2B8$R#'G+ZK
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MP-O/*>V%9,?FB\262<FJYN>!8"6]VD ]WS$F7R_T1X[^H];J7U!+ P04
M" !$AD]4#&&W,5L#  #G"@  &0   'AL+W=O<FMS:&5E=',O<VAE970V-RYX
M;6RE5MMNG# 0_14+]:&5DG#=6[6[4K/T$JF1HJ27AZH/#LSN6C4VM;W9I%]?
MVQ!"P-!(?0';G#,S9\;8LSQR\4ON 12Z+RB3*V^O5/G6]V6VAP++,UX"TU^V
M7!18Z:G8^;(4@'-+*J@?!<'4+S!AWGIIUZ[$>LD/BA(&5P+)0U%@\7 .E!]7
M7N@]+ER3W5Z9!7^]+/$.;D!]+:^$GOF-E9P4P"3A# G8KKQWX=LT# S!(KX1
M.,K6&!DIMYS_,I.+?.4%)B*@D"EC NO7'6R 4F-)Q_&[-NHU/@VQ/7ZT_L&*
MUV)NL80-I]])KO8K;^ZA'+;X0-4U/WZ"6M#$V,LXE?:)CC4V\%!VD(H7-5E'
M4!!6O?%]G8@6(9P.$**:$'4)R0 AK@GQ2PE)34AL9BHI-@\I5GB]%/R(A$%K
M:V9@DVG96CYAINXW2NBO1//4^H)EO #T!=^#1->0<9812K"M"=\BM0=T"SO"
M&&$[A%F.@.5V6/ #4P9R8$+3=HS\@1PI?*_Q#+9$2?0Z!84)E6_0*?IZDZ+7
MK]Z@5X@P=$DHU0[DTE=:@@G$S^IPSZMPHX%PPPA=<J;V$KUG.>3/#?A:>Y.
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M9GI0@S .^OV*<[7;F #-Z)_\ U!+ P04    " !$AD]41H;3[,P"  #<"
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M&?=,FI.8@@ 7QK1]W3?0,OE$D#2T6,?7\KG0YI(?/ZZ0^2CM /-^(83>-RQ
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MLG16^\^<;D>H70"-+Y2RCPT'T-RW)K\ 4$L#!!0    ( $2&3U2<0DY:F00
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MN;K$C4-MRQ?)1+M?6.6R)YT:1 MM9+H!DP4I%_D_^[D)Q!:@ZQ\ A!M ^%Y
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M4(F ./G4I\FG)J;.F-1AZB5@+6?APDE'P"23,C)UIIUZZF=43TVI9SA72($
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MT<5Y7UB!C*LH&-Y>2<-BA^O!LWJ C-?#4P*<7#$"SY(!>&T!\7P2(&>4<**
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MW4MX!J"@Y3%=&A.P\P0XXSQ0(,"$"P F4% O)3$! 4]Q,VX"3^AUA?6O9P
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MOG--3SSECA-F$+,?I]5&<D ;'U73$U?H')8AR#Y)JX0DK(23:GKBBIBOIO?
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M9Z"+2:1[G72@>)1L%U9<Z<U'<KG5^T,01J"?KSE7AX'9@>0[SND_4$L#!!0
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M:&.V.5SNE![,8)@MSI00ZP<N&T4B;";2  H3S[&),"WT[#5"SVR!5I6 F:B
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M<WZV_&?AYA=02P$"% ,4    " !$AD]4!T%-8H$   "Q    $
M    @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( $2&3U2@CQF4
M[@   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+
M 0(4 Q0    ( $2&3U297)PC$ 8  )PG   3              "  <P!  !X
M;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ 1(9/5*]* @NV!@  W1H
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M965T-2YX;6Q02P$"% ,4    " !$AD]4O>N\0D\$  !J#P  &
M    @($\(P  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @
M1(9/5.VMRR#6"   W"\  !@              ("!P2<  'AL+W=O<FMS:&5E
M=',O<VAE970W+GAM;%!+ 0(4 Q0    ( $2&3U0W^9QU@ (  'D'   8
M          " @<TP  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4
M    " !$AD]4A&VB7_X'   R(P  &               @(&#,P  >&PO=V]R
M:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ 1(9/5).C >\: P  8P8
M !D              ("!MSL  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q0
M2P$"% ,4    " !$AD]4*_5]VIP?  #-8   &0              @($(/P
M>&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( $2&3U0.;-]H
MOP@  .X8   9              " @=M>  !X;"]W;W)K<VAE971S+W-H965T
M,3(N>&UL4$L! A0#%     @ 1(9/5*Q1:NQL#   OR0  !D
M ("!T6<  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    " !$
MAD]4+#NFBA #  #M!@  &0              @(%T=   >&PO=V]R:W-H965T
M<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( $2&3U1"9C-62@4  !8,   9
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M970Q.2YX;6Q02P$"% ,4    " !$AD]4GF31ILX'  "\$P  &0
M    @(%.G0  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    (
M $2&3U015E;C&@L  ,8;   9              " @5.E  !X;"]W;W)K<VAE
M971S+W-H965T,C$N>&UL4$L! A0#%     @ 1(9/5*$UR#'>#@  _2@  !D
M             ("!I+   'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"
M% ,4    " !$AD]4\*9H_*$*  "X'0  &0              @(&YOP  >&PO
M=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( $2&3U1\,+W0N"
M %9J   9              " @9'*  !X;"]W;W)K<VAE971S+W-H965T,C0N
M>&UL4$L! A0#%     @ 1(9/5%R&L?@."@  ,1P  !D              ("!
M@.L  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    " !$AD]4
MQTGXU1HA  !V:0  &0              @('%]0  >&PO=V]R:W-H965T<R]S
M:&5E=#(V+GAM;%!+ 0(4 Q0    ( $2&3U0LA<]0C 0  "8+   9
M      " @187 0!X;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%
M  @ 1(9/5$=7H"],!@  51(  !D              ("!V1L! 'AL+W=O<FMS
M:&5E=',O<VAE970R."YX;6Q02P$"% ,4    " !$AD]4K<W[WQ0%  !?#@
M&0              @(%<(@$ >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+
M 0(4 Q0    ( $2&3U39ZMY9!@,  +P&   9              " @:<G 0!X
M;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @ 1(9/5*["EY:M
M!0  E@X  !D              ("!Y"H! 'AL+W=O<FMS:&5E=',O<VAE970S
M,2YX;6Q02P$"% ,4    " !$AD]4*J>2F3,$  #Q"0  &0
M@('(, $ >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( $2&
M3U0 B5!T#P8  #L2   9              " @3(U 0!X;"]W;W)K<VAE971S
M+W-H965T,S,N>&UL4$L! A0#%     @ 1(9/5+\ZPRW>!@  EQ$  !D
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M=#,X+GAM;%!+ 0(4 Q0    ( $2&3U3%,.6C?P@  .H7   9
M  " @;!5 0!X;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @
M1(9/5+E+F?Q[!0  .Q0  !D              ("!9EX! 'AL+W=O<FMS:&5E
M=',O<VAE970T,"YX;6Q02P$"% ,4    " !$AD]4J(V&^1(#  !J#   &0
M            @($89 $ >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4
M Q0    ( $2&3U1E&VULVP,  (,.   9              " @6%G 0!X;"]W
M;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @ 1(9/5!2>MP&D @
ME@8  !D              ("!<VL! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX
M;6Q02P$"% ,4    " !$AD]4\E;@Y\X&  ",*P  &0              @(%.
M;@$ >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( $2&3U1=
MYOO&'P4  *49   9              " @5-U 0!X;"]W;W)K<VAE971S+W-H
M965T-#4N>&UL4$L! A0#%     @ 1(9/5+"X;0\"!@  ZR$  !D
M     ("!J7H! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $2&3U1).(@Y2@,  *D*   9              "
M@9>3 0!X;"]W;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @ 1(9/
M5';I$E1= @  S 4  !D              ("!&)<! 'AL+W=O<FMS:&5E=',O
M<VAE970U,BYX;6Q02P$"% ,4    " !$AD]4'HX<U)D$  "Q%   &0
M        @(&LF0$ >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0
M   ( $2&3U3]=R8\\0,  (L2   9              " @7R> 0!X;"]W;W)K
M<VAE971S+W-H965T-30N>&UL4$L! A0#%     @ 1(9/5*,2U>R  P  .0X
M !D              ("!I*(! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q0
M2P$"% ,4    " !$AD]4L&YP=D4"  "T!0  &0              @(%;I@$
M>&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    ( $2&3U20)UQQ
M)P(  &D$   9              " @=>H 0!X;"]W;W)K<VAE971S+W-H965T
M-3<N>&UL4$L! A0#%     @ 1(9/5"\FWR;> P  ,0T  !D
M ("!-:L! 'AL+W=O<FMS:&5E=',O<VAE970U."YX;6Q02P$"% ,4    " !$
MAD]4X?]%!A0#  !;"0  &0              @(%*KP$ >&PO=V]R:W-H965T
M<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0    ( $2&3U1:EQW6Y@,  $\1   9
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M970V-"YX;6Q02P$"% ,4    " !$AD]4G$H^ *T$  ":%   &0
M    @(&?T@$ >&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4 Q0    (
M $2&3U24XU1BR00  . 2   9              " @8/7 0!X;"]W;W)K<VAE
M971S+W-H965T-C8N>&UL4$L! A0#%     @ 1(9/5 QAMS%; P  YPH  !D
M             ("!@]P! 'AL+W=O<FMS:&5E=',O<VAE970V-RYX;6Q02P$"
M% ,4    " !$AD]43!"_J48#  !\"0  &0              @($5X $ >&PO
M=V]R:W-H965T<R]S:&5E=#8X+GAM;%!+ 0(4 Q0    ( $2&3U2-40A2V@(
M  8(   9              " @9+C 0!X;"]W;W)K<VAE971S+W-H965T-CDN
M>&UL4$L! A0#%     @ 1(9/5$:&T^S, @  W @  !D              ("!
MH^8! 'AL+W=O<FMS:&5E=',O<VAE970W,"YX;6Q02P$"% ,4    " !$AD]4
M,SO<'/H"   S"0  &0              @(&FZ0$ >&PO=V]R:W-H965T<R]S
M:&5E=#<Q+GAM;%!+ 0(4 Q0    ( $2&3U3#0 =70 0  +01   9
M      " @=?L 0!X;"]W;W)K<VAE971S+W-H965T-S(N>&UL4$L! A0#%
M  @ 1(9/5/_MB4@S P  >PD  !D              ("!3O$! 'AL+W=O<FMS
M:&5E=',O<VAE970W,RYX;6Q02P$"% ,4    " !$AD]4G$).6ID$  #F$
M&0              @(&X] $ >&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+
M 0(4 Q0    ( $2&3U1_\YVY$00  )(2   9              " @8CY 0!X
M;"]W;W)K<VAE971S+W-H965T-S4N>&UL4$L! A0#%     @ 1(9/5 ABG=<=
M!   D T  !D              ("!T/T! 'AL+W=O<FMS:&5E=',O<VAE970W
M-BYX;6Q02P$"% ,4    " !$AD]4K<00=+X"   T"   &0
M@($D @( >&PO=V]R:W-H965T<R]S:&5E=#<W+GAM;%!+ 0(4 Q0    ( $2&
M3U3B@H(Y%@,   (*   9              " @1D% @!X;"]W;W)K<VAE971S
M+W-H965T-S@N>&UL4$L! A0#%     @ 1(9/5/]VW[!3$   WG\  !D
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M=#@S+GAM;%!+ 0(4 Q0    ( $2&3U1!M)&0GP<  .,F   9
M  " @8$L @!X;"]W;W)K<VAE971S+W-H965T.#0N>&UL4$L! A0#%     @
M1(9/5#?1$;#; @  : D  !D              ("!5S0" 'AL+W=O<FMS:&5E
M=',O<VAE970X-2YX;6Q02P$"% ,4    " !$AD]4*X=GVBH#   ,$P  #0
M            @ %I-P( >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( $2&3U27
MBKL<P    !,"   +              "  ;XZ @!?<F5L<R\N<F5L<U!+ 0(4
M Q0    ( $2&3U0$*_0Z+08  %PX   /              "  :<[ @!X;"]W
M;W)K8F]O:RYX;6Q02P$"% ,4    " !$AD]4(!6^$(0"   F,@  &@
M        @ $!0@( >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M    " !$AD]4B6[,?BL"  "[,   $P              @ &]1 ( 6T-O;G1E
C;G1?5'EP97-=+GAM;%!+!08     70!= ((9   91P(    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>505</ContextCount>
  <ElementCount>556</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>128</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0002001 - Document - Cover Document</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/CoverDocument</Role>
      <ShortName>Cover Document</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0101101 - Document - Auditor Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/AuditorInformation</Role>
      <ShortName>Auditor Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1001002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1002003 - Statement - Consolidated Balance Sheet (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical</Role>
      <ShortName>Consolidated Balance Sheet (Parenthetical)</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1003004 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ConsolidatedStatementsofOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1004005 - Statement - Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome</Role>
      <ShortName>Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1005006 - Statement - Consolidated Statements of Changes in Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity</Role>
      <ShortName>Consolidated Statements of Changes in Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1006007 - Statement - Consolidated Statement of Changes in Equity (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ConsolidatedStatementofChangesinEquityParentheticals</Role>
      <ShortName>Consolidated Statement of Changes in Equity (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>1007008 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2101102 - Disclosure - Description of Business (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.uhc.com/role/DescriptionofBusinessNotes</Role>
      <ShortName>Description of Business (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2102103 - Disclosure - Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes</Role>
      <ShortName>Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2108104 - Disclosure - Investments (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.uhc.com/role/InvestmentsNotes</Role>
      <ShortName>Investments (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2114105 - Disclosure - Fair Value (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.uhc.com/role/FairValueNotes</Role>
      <ShortName>Fair Value (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2120106 - Disclosure - Property, Plant, and Capitalized Software (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNotes</Role>
      <ShortName>Property, Plant, and Capitalized Software (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2124107 - Disclosure - Goodwill and Intangible Assets (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.uhc.com/role/GoodwillandIntangibleAssetsNotes</Role>
      <ShortName>Goodwill and Intangible Assets (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2131108 - Disclosure - Medical Costs Payable (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.uhc.com/role/MedicalCostsPayableNotes</Role>
      <ShortName>Medical Costs Payable (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2136109 - Disclosure - Short-Term Borrowings and Long-Term Debt (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNotes</Role>
      <ShortName>Short-Term Borrowings and Long-Term Debt (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2141110 - Disclosure - Income Taxes (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.uhc.com/role/IncomeTaxesNotes</Role>
      <ShortName>Income Taxes (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2148111 - Disclosure - Shareholders' Equity (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.uhc.com/role/ShareholdersEquityNotes</Role>
      <ShortName>Shareholders' Equity (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2153112 - Disclosure - Share-Based Compensation (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.uhc.com/role/ShareBasedCompensationNotes</Role>
      <ShortName>Share-Based Compensation (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2160113 - Disclosure - Commitments and Contingencies (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.uhc.com/role/CommitmentsandContingenciesNotes</Role>
      <ShortName>Commitments and Contingencies (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2164114 - Disclosure - Segment Financial Information (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.uhc.com/role/SegmentFinancialInformationNotes</Role>
      <ShortName>Segment Financial Information (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2168115 - Disclosure - Schedule I (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.uhc.com/role/ScheduleINotes</Role>
      <ShortName>Schedule I (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2203201 - Disclosure - Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2215202 - Disclosure - Fair Value Fair Value (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/FairValueFairValuePolicies</Role>
      <ShortName>Fair Value Fair Value (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2269203 - Disclosure - Schedule I (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ScheduleIPolicies</Role>
      <ShortName>Schedule I (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2304301 - Disclosure - Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables</Role>
      <ShortName>Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2309302 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/InvestmentsTables</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.uhc.com/role/InvestmentsNotes</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2316303 - Disclosure - Fair Value (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/FairValueTables</Role>
      <ShortName>Fair Value (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.uhc.com/role/FairValueNotes</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2321304 - Disclosure - Property, Plant, and Capitalized Software (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareTables</Role>
      <ShortName>Property, Plant, and Capitalized Software (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNotes</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2325305 - Disclosure - Goodwill and Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/GoodwillandIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.uhc.com/role/GoodwillandIntangibleAssetsNotes</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2332306 - Disclosure - Medical Costs Payable (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/MedicalCostsPayableTables</Role>
      <ShortName>Medical Costs Payable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.uhc.com/role/MedicalCostsPayableNotes</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2337307 - Disclosure - Short-Term Borrowings and Long-Term Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtTables</Role>
      <ShortName>Short-Term Borrowings and Long-Term Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNotes</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2342308 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.uhc.com/role/IncomeTaxesNotes</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2349309 - Disclosure - Shareholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ShareholdersEquityTables</Role>
      <ShortName>Shareholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.uhc.com/role/ShareholdersEquityNotes</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2354310 - Disclosure - Share-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ShareBasedCompensationTables</Role>
      <ShortName>Share-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.uhc.com/role/ShareBasedCompensationNotes</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2361311 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/CommitmentsandContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.uhc.com/role/CommitmentsandContingenciesNotes</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2365312 - Disclosure - Segment Financial Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/SegmentFinancialInformationTables</Role>
      <ShortName>Segment Financial Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.uhc.com/role/SegmentFinancialInformationNotes</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2370313 - Disclosure - Schedule I (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ScheduleITables</Role>
      <ShortName>Schedule I (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.uhc.com/role/ScheduleINotes</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2405401 - Disclosure - Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails</Role>
      <ShortName>Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Basis of Presentation, Uses of Estimates and Significant Accounting Policies Useful lives for property, equipment and capitalized software (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails</Role>
      <ShortName>Basis of Presentation, Uses of Estimates and Significant Accounting Policies Useful lives for property, equipment and capitalized software (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - Basis of Presentation, Uses of Estimates and Significant Accounting Policies Redeemable Noncontrolling Interests (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails</Role>
      <ShortName>Basis of Presentation, Uses of Estimates and Significant Accounting Policies Redeemable Noncontrolling Interests (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2410404 - Disclosure - Investments (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/InvestmentsNarrativeDetails</Role>
      <ShortName>Investments (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/InvestmentsTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2411405 - Disclosure - Investments (Short-Term and Long-Term Investments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails</Role>
      <ShortName>Investments (Short-Term and Long-Term Investments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/InvestmentsTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2412406 - Disclosure - Investments (Amortized Cost and Fair Value of Available-for-Sale Debt Securities by Contractual Maturity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails</Role>
      <ShortName>Investments (Amortized Cost and Fair Value of Available-for-Sale Debt Securities by Contractual Maturity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/InvestmentsTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2413407 - Disclosure - Investments (Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time That Individual Securities Have Been in a Continuous Unrealized Loss Position) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails</Role>
      <ShortName>Investments (Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time That Individual Securities Have Been in a Continuous Unrealized Loss Position) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/InvestmentsTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2417408 - Disclosure - Fair Value (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/FairValueNarrativeDetails</Role>
      <ShortName>Fair Value (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/FairValueTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2418409 - Disclosure - Fair Value (Financial Assets and Liabilities, Measured at Fair Value on a Recurring Basis) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails</Role>
      <ShortName>Fair Value (Financial Assets and Liabilities, Measured at Fair Value on a Recurring Basis) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/FairValueTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2419410 - Disclosure - Fair Value (Financial Assets and Liabilities, Not Measured at Fair Value on a Recurring Basis) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails</Role>
      <ShortName>Fair Value (Financial Assets and Liabilities, Not Measured at Fair Value on a Recurring Basis) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/FairValueTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2422411 - Disclosure - Property, Plant, and Capitalized Software (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNarrativeDetails</Role>
      <ShortName>Property, Plant, and Capitalized Software (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2423412 - Disclosure - Property, Plant, and Capitalized Software Property Plant and Equipment Table (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails</Role>
      <ShortName>Property, Plant, and Capitalized Software Property Plant and Equipment Table (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2426413 - Disclosure - Goodwill and Intangible Assets (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/GoodwillandIntangibleAssetsNarrativeDetails</Role>
      <ShortName>Goodwill and Intangible Assets (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/GoodwillandIntangibleAssetsTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2427414 - Disclosure - Goodwill and Intangible Assets Changes in the Carrying Amount of Goodwill by Reporting Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails</Role>
      <ShortName>Goodwill and Intangible Assets Changes in the Carrying Amount of Goodwill by Reporting Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2428415 - Disclosure - Goodwill and Intangible Assets Gross carrying value, accumulated amortization and net carrying value of intangible assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets Gross carrying value, accumulated amortization and net carrying value of intangible assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2429416 - Disclosure - Goodwill and Intangible Assets Weighted-average useful lives assigned to finite-lived intangible assets acquired in business combinations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails</Role>
      <ShortName>Goodwill and Intangible Assets Weighted-average useful lives assigned to finite-lived intangible assets acquired in business combinations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2430417 - Disclosure - Goodwill and Intangible Assets Amortization Expense relating to Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets Amortization Expense relating to Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2433418 - Disclosure - Medical Costs Payable (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/MedicalCostsPayableNarrativeDetails</Role>
      <ShortName>Medical Costs Payable (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/MedicalCostsPayableTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2434419 - Disclosure - Medical Costs Payable Rollforward (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails</Role>
      <ShortName>Medical Costs Payable Rollforward (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2435420 - Disclosure - Medical Costs Payable, Incurred and Paid Medical Cost Development (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails</Role>
      <ShortName>Medical Costs Payable, Incurred and Paid Medical Cost Development (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2438421 - Disclosure - Short-Term Borrowings and Long-Term Debt (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails</Role>
      <ShortName>Short-Term Borrowings and Long-Term Debt (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2439422 - Disclosure - Short-Term Borrowings and Long-Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails</Role>
      <ShortName>Short-Term Borrowings and Long-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2440423 - Disclosure - Short-Term Borrowings and Long-Term Debt Maturities of commercial paper and long-term debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails</Role>
      <ShortName>Short-Term Borrowings and Long-Term Debt Maturities of commercial paper and long-term debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2443424 - Disclosure - Income Taxes (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/IncomeTaxesTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2444425 - Disclosure - Income Taxes Reconciliation of Provision for Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails</Role>
      <ShortName>Income Taxes Reconciliation of Provision for Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2445426 - Disclosure - Income Tax Reconciliation of the tax provision at the U.S. Federal Statutory Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails</Role>
      <ShortName>Income Tax Reconciliation of the tax provision at the U.S. Federal Statutory Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2446427 - Disclosure - Income Taxes Components of Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Taxes Components of Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2447428 - Disclosure - Income Taxes Reconciliation of the beginning and ending amount of unrecognized tax benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails</Role>
      <ShortName>Income Taxes Reconciliation of the beginning and ending amount of unrecognized tax benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2450429 - Disclosure - Shareholders' Equity (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ShareholdersEquityNarrativeDetails</Role>
      <ShortName>Shareholders' Equity (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/ShareholdersEquityTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2451430 - Disclosure - Shareholders' Equity Share Repurchases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ShareholdersEquityShareRepurchasesDetails</Role>
      <ShortName>Shareholders' Equity Share Repurchases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2452431 - Disclosure - Shareholders' Equity Dividends (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ShareholdersEquityDividendsDetails</Role>
      <ShortName>Shareholders' Equity Dividends (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2455432 - Disclosure - Share-Based Compensation (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails</Role>
      <ShortName>Share-Based Compensation (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2456433 - Disclosure - Share-Based Compensation (Stock Option Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails</Role>
      <ShortName>Share-Based Compensation (Stock Option Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2457434 - Disclosure - Share-Based Compensation (Restricted Share Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ShareBasedCompensationRestrictedShareActivityDetails</Role>
      <ShortName>Share-Based Compensation (Restricted Share Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2458435 - Disclosure - Share-Based Compensation Other Share-Based Compensation Data (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails</Role>
      <ShortName>Share-Based Compensation Other Share-Based Compensation Data (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2459436 - Disclosure - Share-Based Compensation (Share-Based Compensation Principal Fair Value Assumptions) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails</Role>
      <ShortName>Share-Based Compensation (Share-Based Compensation Principal Fair Value Assumptions) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2462437 - Disclosure - Commitments and Contingencies (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails</Role>
      <ShortName>Commitments and Contingencies (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/CommitmentsandContingenciesTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>2463438 - Disclosure - Commitments and Contingencies Future Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/CommitmentsandContingenciesFutureLeasePaymentsDetails</Role>
      <ShortName>Commitments and Contingencies Future Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>2466439 - Disclosure - Segment Financial Information (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails</Role>
      <ShortName>Segment Financial Information (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/SegmentFinancialInformationTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>2467440 - Disclosure - Segment Financial Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/SegmentFinancialInformationDetails</Role>
      <ShortName>Segment Financial Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/SegmentFinancialInformationTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>2471441 - Disclosure - Schedule I (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ScheduleIDetails</Role>
      <ShortName>Schedule I (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.uhc.com/role/ScheduleITables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>2472442 - Disclosure - Schedule I Condensed Balance Sheets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails</Role>
      <ShortName>Schedule I Condensed Balance Sheets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>2473443 - Disclosure - Schedule I Balance Sheet Document (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails</Role>
      <ShortName>Schedule I Balance Sheet Document (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>2474444 - Disclosure - Schedule I Condensed Statement of Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails</Role>
      <ShortName>Schedule I Condensed Statement of Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>2475445 - Disclosure - Schedule I Statement of Cash Flows (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails</Role>
      <ShortName>Schedule I Statement of Cash Flows (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="unh-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>2476446 - Disclosure - Schedule I Maturities of Short-Term Borrowings and Long-Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uhc.com/role/ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails</Role>
      <ShortName>Schedule I Maturities of Short-Term Borrowings and Long-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="unh-20211231.htm">unh-20211231.htm</File>
    <File>unh-20211231.xsd</File>
    <File>unh-20211231_cal.xml</File>
    <File>unh-20211231_def.xml</File>
    <File>unh-20211231_lab.xml</File>
    <File>unh-20211231_pre.xml</File>
    <File>unhex10212312021.htm</File>
    <File>unhex10312312021.htm</File>
    <File>unhex104123121.htm</File>
    <File>unhex10512312021.htm</File>
    <File>unhex10612312021.htm</File>
    <File>unhex10712312021.htm</File>
    <File>unhex108123121.htm</File>
    <File>unhex21112312021.htm</File>
    <File>unhex23112312021.htm</File>
    <File>unhex24112312021.htm</File>
    <File>unhex31112312021.htm</File>
    <File>unhex32112312021.htm</File>
    <File>unhexhibit1010.htm</File>
    <File>unhexhibit1011.htm</File>
    <File>unhexhibit1038.htm</File>
    <File>unhexhibit1040.htm</File>
    <File>unhexhibit109.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>unh-20211231_g1.jpg</File>
    <File>unh-20211231_g2.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="2000">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="38">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>137
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "unh-20211231.htm": {
   "axisCustom": 4,
   "axisStandard": 25,
   "contextCount": 505,
   "dts": {
    "calculationLink": {
     "local": [
      "unh-20211231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "unh-20211231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "unh-20211231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "unh-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "unh-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "unh-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 784,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 157,
    "http://www.uhc.com/20211231": 2,
    "http://xbrl.sec.gov/dei/2021q4": 5,
    "total": 164
   },
   "keyCustom": 28,
   "keyStandard": 528,
   "memberCustom": 78,
   "memberStandard": 50,
   "nsprefix": "unh",
   "nsuri": "http://www.uhc.com/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityFileNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0002001 - Document - Cover Document",
     "role": "http://www.uhc.com/role/CoverDocument",
     "shortName": "Cover Document",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityFileNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101102 - Disclosure - Description of Business (Notes)",
     "role": "http://www.uhc.com/role/DescriptionofBusinessNotes",
     "shortName": "Description of Business (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2102103 - Disclosure - Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Notes)",
     "role": "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes",
     "shortName": "Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Notes)",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108104 - Disclosure - Investments (Notes)",
     "role": "http://www.uhc.com/role/InvestmentsNotes",
     "shortName": "Investments (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2114105 - Disclosure - Fair Value (Notes)",
     "role": "http://www.uhc.com/role/FairValueNotes",
     "shortName": "Fair Value (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2120106 - Disclosure - Property, Plant, and Capitalized Software (Notes)",
     "role": "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNotes",
     "shortName": "Property, Plant, and Capitalized Software (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2124107 - Disclosure - Goodwill and Intangible Assets (Notes)",
     "role": "http://www.uhc.com/role/GoodwillandIntangibleAssetsNotes",
     "shortName": "Goodwill and Intangible Assets (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2131108 - Disclosure - Medical Costs Payable (Notes)",
     "role": "http://www.uhc.com/role/MedicalCostsPayableNotes",
     "shortName": "Medical Costs Payable (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2136109 - Disclosure - Short-Term Borrowings and Long-Term Debt (Notes)",
     "role": "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNotes",
     "shortName": "Short-Term Borrowings and Long-Term Debt (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2141110 - Disclosure - Income Taxes (Notes)",
     "role": "http://www.uhc.com/role/IncomeTaxesNotes",
     "shortName": "Income Taxes (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2148111 - Disclosure - Shareholders' Equity (Notes)",
     "role": "http://www.uhc.com/role/ShareholdersEquityNotes",
     "shortName": "Shareholders' Equity (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0101101 - Document - Auditor Information",
     "role": "http://www.uhc.com/role/AuditorInformation",
     "shortName": "Auditor Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2153112 - Disclosure - Share-Based Compensation (Notes)",
     "role": "http://www.uhc.com/role/ShareBasedCompensationNotes",
     "shortName": "Share-Based Compensation (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2160113 - Disclosure - Commitments and Contingencies (Notes)",
     "role": "http://www.uhc.com/role/CommitmentsandContingenciesNotes",
     "shortName": "Commitments and Contingencies (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2164114 - Disclosure - Segment Financial Information (Notes)",
     "role": "http://www.uhc.com/role/SegmentFinancialInformationNotes",
     "shortName": "Segment Financial Information (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2168115 - Disclosure - Schedule I (Notes)",
     "role": "http://www.uhc.com/role/ScheduleINotes",
     "shortName": "Schedule I (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2203201 - Disclosure - Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Policies)",
     "role": "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies",
     "shortName": "Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2215202 - Disclosure - Fair Value Fair Value (Policies)",
     "role": "http://www.uhc.com/role/FairValueFairValuePolicies",
     "shortName": "Fair Value Fair Value (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2269203 - Disclosure - Schedule I (Policies)",
     "role": "http://www.uhc.com/role/ScheduleIPolicies",
     "shortName": "Schedule I (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2304301 - Disclosure - Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Tables)",
     "role": "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables",
     "shortName": "Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2309302 - Disclosure - Investments (Tables)",
     "role": "http://www.uhc.com/role/InvestmentsTables",
     "shortName": "Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2316303 - Disclosure - Fair Value (Tables)",
     "role": "http://www.uhc.com/role/FairValueTables",
     "shortName": "Fair Value (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ia9973178a1474e659ee68ed2ce06eb70_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Consolidated Balance Sheets",
     "role": "http://www.uhc.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ia9973178a1474e659ee68ed2ce06eb70_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ShortTermInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2321304 - Disclosure - Property, Plant, and Capitalized Software (Tables)",
     "role": "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareTables",
     "shortName": "Property, Plant, and Capitalized Software (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2325305 - Disclosure - Goodwill and Intangible Assets (Tables)",
     "role": "http://www.uhc.com/role/GoodwillandIntangibleAssetsTables",
     "shortName": "Goodwill and Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2332306 - Disclosure - Medical Costs Payable (Tables)",
     "role": "http://www.uhc.com/role/MedicalCostsPayableTables",
     "shortName": "Medical Costs Payable (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2337307 - Disclosure - Short-Term Borrowings and Long-Term Debt (Tables)",
     "role": "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtTables",
     "shortName": "Short-Term Borrowings and Long-Term Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2342308 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.uhc.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2349309 - Disclosure - Shareholders' Equity (Tables)",
     "role": "http://www.uhc.com/role/ShareholdersEquityTables",
     "shortName": "Shareholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2354310 - Disclosure - Share-Based Compensation (Tables)",
     "role": "http://www.uhc.com/role/ShareBasedCompensationTables",
     "shortName": "Share-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2361311 - Disclosure - Commitments and Contingencies (Tables)",
     "role": "http://www.uhc.com/role/CommitmentsandContingenciesTables",
     "shortName": "Commitments and Contingencies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2365312 - Disclosure - Segment Financial Information (Tables)",
     "role": "http://www.uhc.com/role/SegmentFinancialInformationTables",
     "shortName": "Segment Financial Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2370313 - Disclosure - Schedule I (Tables)",
     "role": "http://www.uhc.com/role/ScheduleITables",
     "shortName": "Schedule I (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231",
      "decimals": null,
      "lang": "en-US",
      "name": "srt:ScheduleOfCondensedBalanceSheetTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ia9973178a1474e659ee68ed2ce06eb70_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Consolidated Balance Sheet (Parenthetical)",
     "role": "http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical",
     "shortName": "Consolidated Balance Sheet (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ia9973178a1474e659ee68ed2ce06eb70_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ia9973178a1474e659ee68ed2ce06eb70_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405401 - Disclosure - Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Details)",
     "role": "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
     "shortName": "Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "unh:NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract",
       "span",
       "div",
       "us-gaap:CapitalizationOfDeferredPolicyAcquisitionCostsPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": null,
      "lang": "en-US",
      "name": "unh:NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "i8384e266805d4927b90e345df1e3f524_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - Basis of Presentation, Uses of Estimates and Significant Accounting Policies Useful lives for property, equipment and capitalized software (Details)",
     "role": "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails",
     "shortName": "Basis of Presentation, Uses of Estimates and Significant Accounting Policies Useful lives for property, equipment and capitalized software (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "i8384e266805d4927b90e345df1e3f524_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ie3ed3c20fea0451eae935c55f1c8b54b_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - Basis of Presentation, Uses of Estimates and Significant Accounting Policies Redeemable Noncontrolling Interests (Details)",
     "role": "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails",
     "shortName": "Basis of Presentation, Uses of Estimates and Significant Accounting Policies Redeemable Noncontrolling Interests (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "i91c331befb394cb6b31c1d43cedab05f_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ia9973178a1474e659ee68ed2ce06eb70_I20211231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410404 - Disclosure - Investments (Narrative) (Details)",
     "role": "http://www.uhc.com/role/InvestmentsNarrativeDetails",
     "shortName": "Investments (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ia9973178a1474e659ee68ed2ce06eb70_I20211231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ia9973178a1474e659ee68ed2ce06eb70_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411405 - Disclosure - Investments (Short-Term and Long-Term Investments) (Details)",
     "role": "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails",
     "shortName": "Investments (Short-Term and Long-Term Investments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ia9973178a1474e659ee68ed2ce06eb70_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ia9973178a1474e659ee68ed2ce06eb70_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412406 - Disclosure - Investments (Amortized Cost and Fair Value of Available-for-Sale Debt Securities by Contractual Maturity) (Details)",
     "role": "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails",
     "shortName": "Investments (Amortized Cost and Fair Value of Available-for-Sale Debt Securities by Contractual Maturity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ia9973178a1474e659ee68ed2ce06eb70_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ibb56bbdb5bca464cb867242d3ed1b377_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413407 - Disclosure - Investments (Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time That Individual Securities Have Been in a Continuous Unrealized Loss Position) (Details)",
     "role": "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails",
     "shortName": "Investments (Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time That Individual Securities Have Been in a Continuous Unrealized Loss Position) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ibb56bbdb5bca464cb867242d3ed1b377_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiUnrealizedGain",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417408 - Disclosure - Fair Value (Narrative) (Details)",
     "role": "http://www.uhc.com/role/FairValueNarrativeDetails",
     "shortName": "Fair Value (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiUnrealizedGain",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ia9973178a1474e659ee68ed2ce06eb70_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418409 - Disclosure - Fair Value (Financial Assets and Liabilities, Measured at Fair Value on a Recurring Basis) (Details)",
     "role": "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
     "shortName": "Fair Value (Financial Assets and Liabilities, Measured at Fair Value on a Recurring Basis) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ia9973178a1474e659ee68ed2ce06eb70_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ia9973178a1474e659ee68ed2ce06eb70_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:HeldToMaturitySecuritiesFairValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419410 - Disclosure - Fair Value (Financial Assets and Liabilities, Not Measured at Fair Value on a Recurring Basis) (Details)",
     "role": "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails",
     "shortName": "Fair Value (Financial Assets and Liabilities, Not Measured at Fair Value on a Recurring Basis) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "i6e1d0ee68a90487188c597f675ea6962_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:HeldToMaturitySecuritiesFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PremiumsEarnedNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Consolidated Statements of Operations",
     "role": "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
     "shortName": "Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422411 - Disclosure - Property, Plant, and Capitalized Software (Narrative) (Details)",
     "role": "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNarrativeDetails",
     "shortName": "Property, Plant, and Capitalized Software (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ia9973178a1474e659ee68ed2ce06eb70_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LandAndLandImprovements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423412 - Disclosure - Property, Plant, and Capitalized Software Property Plant and Equipment Table (Details)",
     "role": "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails",
     "shortName": "Property, Plant, and Capitalized Software Property Plant and Equipment Table (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ia9973178a1474e659ee68ed2ce06eb70_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LandAndLandImprovements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426413 - Disclosure - Goodwill and Intangible Assets (Narrative) (Details)",
     "role": "http://www.uhc.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
     "shortName": "Goodwill and Intangible Assets (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ie3ed3c20fea0451eae935c55f1c8b54b_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427414 - Disclosure - Goodwill and Intangible Assets Changes in the Carrying Amount of Goodwill by Reporting Segment (Details)",
     "role": "http://www.uhc.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails",
     "shortName": "Goodwill and Intangible Assets Changes in the Carrying Amount of Goodwill by Reporting Segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "i530caf840d4847f1ac553be5f7b336b2_I20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ia9973178a1474e659ee68ed2ce06eb70_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428415 - Disclosure - Goodwill and Intangible Assets Gross carrying value, accumulated amortization and net carrying value of intangible assets (Details)",
     "role": "http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails",
     "shortName": "Goodwill and Intangible Assets Gross carrying value, accumulated amortization and net carrying value of intangible assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ia9973178a1474e659ee68ed2ce06eb70_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinitelivedIntangibleAssetsAcquired1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429416 - Disclosure - Goodwill and Intangible Assets Weighted-average useful lives assigned to finite-lived intangible assets acquired in business combinations (Details)",
     "role": "http://www.uhc.com/role/GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails",
     "shortName": "Goodwill and Intangible Assets Weighted-average useful lives assigned to finite-lived intangible assets acquired in business combinations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinitelivedIntangibleAssetsAcquired1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ia9973178a1474e659ee68ed2ce06eb70_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430417 - Disclosure - Goodwill and Intangible Assets Amortization Expense relating to Intangible Assets (Details)",
     "role": "http://www.uhc.com/role/GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails",
     "shortName": "Goodwill and Intangible Assets Amortization Expense relating to Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ia9973178a1474e659ee68ed2ce06eb70_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ia9973178a1474e659ee68ed2ce06eb70_I20211231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433418 - Disclosure - Medical Costs Payable (Narrative) (Details)",
     "role": "http://www.uhc.com/role/MedicalCostsPayableNarrativeDetails",
     "shortName": "Medical Costs Payable (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ia9973178a1474e659ee68ed2ce06eb70_I20211231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ie3ed3c20fea0451eae935c55f1c8b54b_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434419 - Disclosure - Medical Costs Payable Rollforward (Details)",
     "role": "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails",
     "shortName": "Medical Costs Payable Rollforward (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "i870730cd9dfc45bb89971499ab4cdd48_I20181231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ifafacde0705d4f258c784fe3cb74d22f_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435420 - Disclosure - Medical Costs Payable, Incurred and Paid Medical Cost Development (Details)",
     "role": "http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails",
     "shortName": "Medical Costs Payable, Incurred and Paid Medical Cost Development (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ifafacde0705d4f258c784fe3cb74d22f_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Consolidated Statements of Comprehensive Income",
     "role": "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome",
     "shortName": "Consolidated Statements of Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "i601523d6552745a68902337be3e9c7fd_D20210101-20211231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityInterestRateDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438421 - Disclosure - Short-Term Borrowings and Long-Term Debt (Narrative) (Details)",
     "role": "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails",
     "shortName": "Short-Term Borrowings and Long-Term Debt (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "i601523d6552745a68902337be3e9c7fd_D20210101-20211231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityInterestRateDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ia9973178a1474e659ee68ed2ce06eb70_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtLongtermAndShorttermCombinedAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439422 - Disclosure - Short-Term Borrowings and Long-Term Debt (Details)",
     "role": "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails",
     "shortName": "Short-Term Borrowings and Long-Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "i86f3f2448f524de3913d85ac9788450f_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CommercialPaper",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ia9973178a1474e659ee68ed2ce06eb70_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440423 - Disclosure - Short-Term Borrowings and Long-Term Debt Maturities of commercial paper and long-term debt (Details)",
     "role": "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails",
     "shortName": "Short-Term Borrowings and Long-Term Debt Maturities of commercial paper and long-term debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443424 - Disclosure - Income Taxes (Narrative) (Details)",
     "role": "http://www.uhc.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444425 - Disclosure - Income Taxes Reconciliation of Provision for Income Taxes (Details)",
     "role": "http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails",
     "shortName": "Income Taxes Reconciliation of Provision for Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445426 - Disclosure - Income Tax Reconciliation of the tax provision at the U.S. Federal Statutory Rate (Details)",
     "role": "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails",
     "shortName": "Income Tax Reconciliation of the tax provision at the U.S. Federal Statutory Rate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ia9973178a1474e659ee68ed2ce06eb70_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446427 - Disclosure - Income Taxes Components of Deferred Tax Assets and Liabilities (Details)",
     "role": "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails",
     "shortName": "Income Taxes Components of Deferred Tax Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ia9973178a1474e659ee68ed2ce06eb70_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ie3ed3c20fea0451eae935c55f1c8b54b_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447428 - Disclosure - Income Taxes Reconciliation of the beginning and ending amount of unrecognized tax benefits (Details)",
     "role": "http://www.uhc.com/role/IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails",
     "shortName": "Income Taxes Reconciliation of the beginning and ending amount of unrecognized tax benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "i870730cd9dfc45bb89971499ab4cdd48_I20181231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450429 - Disclosure - Shareholders' Equity (Narrative) (Details)",
     "role": "http://www.uhc.com/role/ShareholdersEquityNarrativeDetails",
     "shortName": "Shareholders' Equity (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ia9973178a1474e659ee68ed2ce06eb70_I20211231",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchasedAndRetiredDuringPeriodShares",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451430 - Disclosure - Shareholders' Equity Share Repurchases (Details)",
     "role": "http://www.uhc.com/role/ShareholdersEquityShareRepurchasesDetails",
     "shortName": "Shareholders' Equity Share Repurchases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockAcquiredAverageCostPerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "i870730cd9dfc45bb89971499ab4cdd48_I20181231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Consolidated Statements of Changes in Equity",
     "role": "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity",
     "shortName": "Consolidated Statements of Changes in Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "i870730cd9dfc45bb89971499ab4cdd48_I20181231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DividendsDeclaredTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "i8f7827d6bf5f49a0af03b71e2d704cea_D20211214-20211214",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2452431 - Disclosure - Shareholders' Equity Dividends (Details)",
     "role": "http://www.uhc.com/role/ShareholdersEquityDividendsDetails",
     "shortName": "Shareholders' Equity Dividends (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DividendsDeclaredTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "i8f7827d6bf5f49a0af03b71e2d704cea_D20211214-20211214",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:PaymentsOfDividendsCommonStock",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ia9973178a1474e659ee68ed2ce06eb70_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455432 - Disclosure - Share-Based Compensation (Narrative) (Details)",
     "role": "http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails",
     "shortName": "Share-Based Compensation (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ia9973178a1474e659ee68ed2ce06eb70_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ie3ed3c20fea0451eae935c55f1c8b54b_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2456433 - Disclosure - Share-Based Compensation (Stock Option Activity) (Details)",
     "role": "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails",
     "shortName": "Share-Based Compensation (Stock Option Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ie3ed3c20fea0451eae935c55f1c8b54b_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "i8b0b8b22a5064df79ec4e0a1452381f2_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2457434 - Disclosure - Share-Based Compensation (Restricted Share Activity) (Details)",
     "role": "http://www.uhc.com/role/ShareBasedCompensationRestrictedShareActivityDetails",
     "shortName": "Share-Based Compensation (Restricted Share Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "i8b0b8b22a5064df79ec4e0a1452381f2_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2458435 - Disclosure - Share-Based Compensation Other Share-Based Compensation Data (Details)",
     "role": "http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails",
     "shortName": "Share-Based Compensation Other Share-Based Compensation Data (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "unh:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2459436 - Disclosure - Share-Based Compensation (Share-Based Compensation Principal Fair Value Assumptions) (Details)",
     "role": "http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails",
     "shortName": "Share-Based Compensation (Share-Based Compensation Principal Fair Value Assumptions) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "unh:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2462437 - Disclosure - Commitments and Contingencies (Narrative) (Details)",
     "role": "http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails",
     "shortName": "Commitments and Contingencies (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ia9973178a1474e659ee68ed2ce06eb70_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2463438 - Disclosure - Commitments and Contingencies Future Lease Payments (Details)",
     "role": "http://www.uhc.com/role/CommitmentsandContingenciesFutureLeasePaymentsDetails",
     "shortName": "Commitments and Contingencies Future Lease Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ia9973178a1474e659ee68ed2ce06eb70_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2466439 - Disclosure - Segment Financial Information (Narrative) (Details)",
     "role": "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails",
     "shortName": "Segment Financial Information (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PremiumsEarnedNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2467440 - Disclosure - Segment Financial Information (Details)",
     "role": "http://www.uhc.com/role/SegmentFinancialInformationDetails",
     "shortName": "Segment Financial Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "id0945fba67234634866077d9614c0b72_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:InvestmentIncomeInterestAndDividend",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DividendsDeclaredTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "i8f7827d6bf5f49a0af03b71e2d704cea_D20211214-20211214",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Consolidated Statement of Changes in Equity (Parentheticals)",
     "role": "http://www.uhc.com/role/ConsolidatedStatementofChangesinEquityParentheticals",
     "shortName": "Consolidated Statement of Changes in Equity (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2471441 - Disclosure - Schedule I (Details)",
     "role": "http://www.uhc.com/role/ScheduleIDetails",
     "shortName": "Schedule I (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ia9973178a1474e659ee68ed2ce06eb70_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2472442 - Disclosure - Schedule I Condensed Balance Sheets (Details)",
     "role": "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails",
     "shortName": "Schedule I Condensed Balance Sheets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfCondensedBalanceSheetTableTextBlock",
       "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "i2749835a349545f38d76efb02e97a939_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherAssetsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ia9973178a1474e659ee68ed2ce06eb70_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2473443 - Disclosure - Schedule I Balance Sheet Document (Details)",
     "role": "http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails",
     "shortName": "Schedule I Balance Sheet Document (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentIncomeInterestAndDividend",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2474444 - Disclosure - Schedule I Condensed Statement of Comprehensive Income (Details)",
     "role": "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails",
     "shortName": "Schedule I Condensed Statement of Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:CondensedStatementOfComprehensiveIncomeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:InvestmentIncomeInterestAndDividend",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetCashProvidedByUsedInOperatingActivities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2475445 - Disclosure - Schedule I Statement of Cash Flows (Details)",
     "role": "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails",
     "shortName": "Schedule I Statement of Cash Flows (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfCondensedCashFlowStatementTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "i540dfc82ac9c4a8388cee7c3ae2bdeff_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:NetCashProvidedByUsedInOperatingActivities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "ia9973178a1474e659ee68ed2ce06eb70_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2476446 - Disclosure - Schedule I Maturities of Short-Term Borrowings and Long-Term Debt (Details)",
     "role": "http://www.uhc.com/role/ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails",
     "shortName": "Schedule I Maturities of Short-Term Borrowings and Long-Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "i2749835a349545f38d76efb02e97a939_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007008 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "unh-20211231.htm",
      "contextRef": "iab6c3576780c4e7eb88c26028d30b34f_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherNoncashIncomeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 128,
   "tag": {
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "UNITED STATES"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r841",
      "r842",
      "r843"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/AuditorInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r841",
      "r842",
      "r843"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/AuditorInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r841",
      "r842",
      "r843"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/AuditorInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r841",
      "r842",
      "r843"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r844"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r839"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r838"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entitiy Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/ScheduleINotes"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r838"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r838"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r853"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r838"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r838"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r838"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r838"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r882"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Well known seasoned issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r841",
      "r842",
      "r843"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/ScheduleINotes"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r837"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r840"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.uhc.com/role/CoverDocument"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_CondensedBalanceSheetStatementTable": {
     "auth_ref": [
      "r137",
      "r548",
      "r857"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations.",
        "label": "Condensed Balance Sheet Statement [Table]",
        "terseLabel": "Condensed Balance Sheet Statement [Table]"
       }
      }
     },
     "localname": "CondensedBalanceSheetStatementTable",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CondensedBalanceSheetStatementsCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Condensed Balance Sheet Statements, Captions [Line Items]",
        "terseLabel": "Condensed Balance Sheet Statements, Captions [Line Items]"
       }
      }
     },
     "localname": "CondensedBalanceSheetStatementsCaptionsLineItems",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Financial Information Disclosure [Abstract]",
        "terseLabel": "Condensed Financial Information Disclosure [Abstract]"
       }
      }
     },
     "localname": "CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "srt_CondensedFinancialStatementsCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Condensed Financial Statements, Captions [Line Items]",
        "terseLabel": "Condensed Financial Statements, Captions [Line Items]"
       }
      }
     },
     "localname": "CondensedFinancialStatementsCaptionsLineItems",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIDetails",
      "http://www.uhc.com/role/ScheduleIPolicies",
      "http://www.uhc.com/role/ScheduleITables"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CondensedStatementOfComprehensiveIncomeTable": {
     "auth_ref": [
      "r137",
      "r548",
      "r857"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about condensed statement of comprehensive income (loss) including, but not limited to, statements of comprehensive income (loss) of consolidated entities and consolidation eliminations.",
        "label": "Condensed Statement of Comprehensive Income [Table]",
        "terseLabel": "Condensed Statement of Comprehensive Income [Table]"
       }
      }
     },
     "localname": "CondensedStatementOfComprehensiveIncomeTable",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails",
      "http://www.uhc.com/role/ScheduleINotes"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CondensedStatementOfComprehensiveIncomeTableTextBlock": {
     "auth_ref": [
      "r878"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of condensed statement of comprehensive income (loss) including, but not limited to, statements of comprehensive income (loss) of consolidated entities and consolidation eliminations.",
        "label": "Condensed Statement of Comprehensive Income [Table Text Block]",
        "terseLabel": "Condensed Statement of Comprehensive Income [Table Text Block]"
       }
      }
     },
     "localname": "CondensedStatementOfComprehensiveIncomeTableTextBlock",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ScheduleITables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_CondensedStatementOfIncomeCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Condensed Statement of Income Captions [Line Items]",
        "terseLabel": "Condensed Statement of Income Captions [Line Items]"
       }
      }
     },
     "localname": "CondensedStatementOfIncomeCaptionsLineItems",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails",
      "http://www.uhc.com/role/ScheduleINotes"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r137",
      "r349",
      "r354",
      "r362",
      "r556",
      "r557",
      "r565",
      "r566",
      "r643",
      "r830",
      "r855",
      "r867",
      "r876",
      "r877"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by consolidated entity or group of entities.",
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails",
      "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails",
      "http://www.uhc.com/role/ScheduleIDetails",
      "http://www.uhc.com/role/ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails",
      "http://www.uhc.com/role/ScheduleINotes",
      "http://www.uhc.com/role/ScheduleIPolicies",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails",
      "http://www.uhc.com/role/ScheduleITables",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r137",
      "r349",
      "r354",
      "r362",
      "r556",
      "r557",
      "r565",
      "r566",
      "r643",
      "r830",
      "r855",
      "r867",
      "r876",
      "r877"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity or group of entities consolidated into reporting entity.",
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails",
      "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails",
      "http://www.uhc.com/role/ScheduleIDetails",
      "http://www.uhc.com/role/ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails",
      "http://www.uhc.com/role/ScheduleINotes",
      "http://www.uhc.com/role/ScheduleIPolicies",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails",
      "http://www.uhc.com/role/ScheduleITables",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r137",
      "r189",
      "r202",
      "r203",
      "r204",
      "r205",
      "r207",
      "r209",
      "r213",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r356",
      "r357",
      "r359",
      "r361",
      "r362",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsNotes",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsTables",
      "http://www.uhc.com/role/ScheduleINotes",
      "http://www.uhc.com/role/ScheduleITables",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r137",
      "r189",
      "r202",
      "r203",
      "r204",
      "r205",
      "r207",
      "r209",
      "r213",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r356",
      "r357",
      "r359",
      "r361",
      "r362",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsNotes",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsTables",
      "http://www.uhc.com/role/ScheduleINotes",
      "http://www.uhc.com/role/ScheduleITables",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r220",
      "r433",
      "r436",
      "r772"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name or description of a single external customer or a group of external customers.",
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationDetails",
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r367",
      "r408",
      "r449",
      "r452",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r680",
      "r769",
      "r773",
      "r831",
      "r832"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails",
      "http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r367",
      "r408",
      "r449",
      "r452",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r680",
      "r769",
      "r773",
      "r831",
      "r832"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails",
      "http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r220",
      "r433",
      "r436",
      "r772"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Single external customer or group of external customers.",
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationDetails",
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ParentCompanyMember": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The registrant that controls, directly or indirectly, another entity (or entities). The usual condition for control is ownership of a majority (over 50%) of the outstanding voting stock. The power to control may also exist with a lesser percentage of ownership, for example, by contract, lease, agreement with other stockholders or by court decree.",
        "label": "Parent Company [Member]",
        "terseLabel": "Parent Company [Member]"
       }
      }
     },
     "localname": "ParentCompanyMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails",
      "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails",
      "http://www.uhc.com/role/ScheduleIDetails",
      "http://www.uhc.com/role/ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails",
      "http://www.uhc.com/role/ScheduleINotes",
      "http://www.uhc.com/role/ScheduleIPolicies",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails",
      "http://www.uhc.com/role/ScheduleITables"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r216",
      "r433",
      "r434",
      "r681",
      "r768",
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
      "http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails",
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r216",
      "r433",
      "r434",
      "r681",
      "r768",
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
      "http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails",
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r367",
      "r408",
      "r438",
      "r449",
      "r452",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r680",
      "r769",
      "r773",
      "r831",
      "r832"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsNotes",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNotes",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareTables",
      "http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r367",
      "r408",
      "r438",
      "r449",
      "r452",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r680",
      "r769",
      "r773",
      "r831",
      "r832"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]",
        "verboseLabel": "Range [Member]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsNotes",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNotes",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareTables",
      "http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r150",
      "r155",
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables",
      "http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical",
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.uhc.com/role/DescriptionofBusinessNotes",
      "http://www.uhc.com/role/InvestmentsNarrativeDetails",
      "http://www.uhc.com/role/MedicalCostsPayableNarrativeDetails",
      "http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails",
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtTables"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfCondensedBalanceSheetTableTextBlock": {
     "auth_ref": [
      "r878"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations.",
        "label": "Condensed Balance Sheet [Table Text Block]",
        "terseLabel": "Condensed Balance Sheet [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfCondensedBalanceSheetTableTextBlock",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ScheduleITables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_ScheduleOfCondensedCashFlowStatementTableTextBlock": {
     "auth_ref": [
      "r878"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations.",
        "label": "Condensed Cash Flow Statement [Table Text Block]",
        "terseLabel": "Condensed Cash Flow Statement [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfCondensedCashFlowStatementTableTextBlock",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ScheduleITables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_ScheduleOfCondensedFinancialStatementsTable": {
     "auth_ref": [
      "r137",
      "r548",
      "r866",
      "r879",
      "r880",
      "r881"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows.",
        "label": "Condensed Financial Statements [Table]",
        "terseLabel": "Condensed Financial Statements [Table]"
       }
      }
     },
     "localname": "ScheduleOfCondensedFinancialStatementsTable",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIDetails",
      "http://www.uhc.com/role/ScheduleIPolicies",
      "http://www.uhc.com/role/ScheduleITables"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r217",
      "r218",
      "r433",
      "r435",
      "r771",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r854",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area.",
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r217",
      "r218",
      "r433",
      "r435",
      "r771",
      "r815",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r854",
      "r856"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r150",
      "r155",
      "r336",
      "r450",
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables",
      "http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical",
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.uhc.com/role/DescriptionofBusinessNotes",
      "http://www.uhc.com/role/InvestmentsNarrativeDetails",
      "http://www.uhc.com/role/MedicalCostsPayableNarrativeDetails",
      "http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails",
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtTables"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SubsidiariesMember": {
     "auth_ref": [
      "r446",
      "r639",
      "r640",
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity owned or controlled by another entity.",
        "label": "Subsidiaries [Member]",
        "terseLabel": "Subsidiaries [Member]"
       }
      }
     },
     "localname": "SubsidiariesMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A0550NotesDueMay2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "0.550% notes due May 2024",
        "label": "0.550% notes due May 2024 [Member]",
        "terseLabel": "0.550% notes due May 2024 [Member]"
       }
      }
     },
     "localname": "A0550NotesDueMay2024Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A1150NotesDueMay2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.150% notes due May 2026",
        "label": "1.150% notes due May 2026 [Member]",
        "terseLabel": "1.150% notes due May 2026 [Member]"
       }
      }
     },
     "localname": "A1150NotesDueMay2026Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A1250NotesDueJanuary2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.250% notes due January 2026",
        "label": "1.250% notes due January 2026 [Member]",
        "terseLabel": "1.250% notes due January 2026 [Member]"
       }
      }
     },
     "localname": "A1250NotesDueJanuary2026Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A2.125notesdueMarch2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.125% notes due March 2021 [Member]",
        "label": "2.125% notes due March 2021 [Member]",
        "terseLabel": "2.125% notes due March 2021 [Member]"
       }
      }
     },
     "localname": "A2.125notesdueMarch2021Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A2.375notesdueAugust2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.375% notes due August 2024 [Member]",
        "label": "2.375% notes due August 2024 [Member]",
        "terseLabel": "2.375% notes due August 2024 [Member]"
       }
      }
     },
     "localname": "A2.375notesdueAugust2024Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A2.375notesdueOctober2022MemberMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.375% notes due October 2022 [Member] [Member]",
        "label": "2.375% notes due October 2022 [Member] [Member]",
        "terseLabel": "2.375% notes due October 2022 [Member]"
       }
      }
     },
     "localname": "A2.375notesdueOctober2022MemberMember",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A2.875notesdueAugust2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.875% notes due August 2029 [Member]",
        "label": "2.875% notes due August 2029 [Member]",
        "terseLabel": "2.875% notes due August 2029 [Member]"
       }
      }
     },
     "localname": "A2.875notesdueAugust2029Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A2.875notesdueMarch2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.875% notes due March 2022",
        "label": "2.875% notes due March 2022 [Member]",
        "terseLabel": "2.875% Notes Due March 2022 [Member]"
       }
      }
     },
     "localname": "A2.875notesdueMarch2022Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A2.950notesdueOctober2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.950% notes due October 2027 [Member]",
        "label": "2.950% notes due October 2027 [Member]",
        "terseLabel": "2.950% notes due October 2027 [Member]"
       }
      }
     },
     "localname": "A2.950notesdueOctober2027Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A2000NotesDueMay2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.000% notes due May 2030",
        "label": "2.000% notes due May 2030 [Member]",
        "terseLabel": "2.000% notes due May 2030 [Member]"
       }
      }
     },
     "localname": "A2000NotesDueMay2030Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A2300NotesDueMay2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.300% notes due May 2031",
        "label": "2.300% notes due May 2031 [Member]",
        "terseLabel": "2.300% notes due May 2031 [Member]"
       }
      }
     },
     "localname": "A2300NotesDueMay2031Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A2750NotesDueFebruary2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.750% notes due February 2023 [Member]",
        "label": "2.750% notes due February 2023 [Member]",
        "terseLabel": "2.750% Notes Due February 2023 [Member]"
       }
      }
     },
     "localname": "A2750NotesDueFebruary2023Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A2750NotesDueMay2040Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.750% notes due May 2040",
        "label": "2.750% notes due May 2040 [Member]",
        "terseLabel": "2.750% notes due May 2040 [Member]"
       }
      }
     },
     "localname": "A2750NotesDueMay2040Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A2875NotesDueDecember2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.875% notes due December 2021 [Member]",
        "label": "2.875% notes due December 2021 [Member]",
        "terseLabel": "2.875% Notes Due December 2021 [Member]"
       }
      }
     },
     "localname": "A2875NotesDueDecember2021Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A2875NotesDueMarch2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.875% notes due March 2023 [Member]",
        "label": "2.875% notes due March 2023 [Member]",
        "terseLabel": "2.875% Notes Due March 2023 [Member]"
       }
      }
     },
     "localname": "A2875NotesDueMarch2023Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A2900NotesDueMay2050Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.900% notes due May 2050",
        "label": "2.900% notes due May 2050 [Member]",
        "terseLabel": "2.900% notes due May 2050 [Member]"
       }
      }
     },
     "localname": "A2900NotesDueMay2050Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A3.100notesdueMarch2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.100% notes due March 2026 [Member]",
        "label": "3.100% notes due March 2026 [Member]",
        "terseLabel": "3.100% notes due March 2026 [Member]"
       }
      }
     },
     "localname": "A3.100notesdueMarch2026Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A3.150notesdueJune2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.150% notes due June 2021 [Member]",
        "label": "3.150% notes due June 2021 [Member]",
        "terseLabel": "3.150% notes due June 2021 [Member]"
       }
      }
     },
     "localname": "A3.150notesdueJune2021Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A3.375notesdueApril2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.375% notes due April 2027 [Member]",
        "label": "3.375% notes due April 2027 [Member]",
        "terseLabel": "3.375% notes due April 2027 [Member]"
       }
      }
     },
     "localname": "A3.375notesdueApril2027Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A3.375notesdueNovember2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.375% notes due November 2021",
        "label": "3.375% notes due November 2021 [Member]",
        "terseLabel": "3.375% Notes Due November 2021 [Member]"
       }
      }
     },
     "localname": "A3.375notesdueNovember2021Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A3.450notesdueJanuary2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.450% notes due January 2027 [Member]",
        "label": "3.450% notes due January 2027 [Member]",
        "terseLabel": "3.450% notes due January 2027 [Member]"
       }
      }
     },
     "localname": "A3.450notesdueJanuary2027Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A3.500notesdueAugust2039Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.500% notes due August 2039 [Member]",
        "label": "3.500% notes due August 2039 [Member]",
        "terseLabel": "3.500% notes due August 2039 [Member]"
       }
      }
     },
     "localname": "A3.500notesdueAugust2039Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A3.500notesdueFebruary2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.500% notes due February 2024 [Member]",
        "label": "3.500% notes due February 2024 [Member]",
        "terseLabel": "3.500% notes due February 2024 [Member]"
       }
      }
     },
     "localname": "A3.500notesdueFebruary2024Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A3.500notesdueJune2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.500% notes due June 2023 [Member]",
        "label": "3.500% notes due June 2023 [Member]",
        "terseLabel": "3.500% notes due June 2023 [Member]"
       }
      }
     },
     "localname": "A3.500notesdueJune2023Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A3.700notesdueAugust2049Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.700% notes due August 2049 [Member]",
        "label": "3.700% notes due August 2049 [Member]",
        "terseLabel": "3.700% notes due August 2049 [Member]"
       }
      }
     },
     "localname": "A3.700notesdueAugust2049Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A3.700notesdueDecember2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.700% notes due December 2025 [Member]",
        "label": "3.700% notes due December 2025 [Member]",
        "terseLabel": "3.700% notes due December 2025 [Member]"
       }
      }
     },
     "localname": "A3.700notesdueDecember2025Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A3.750notesdueJuly2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.750% notes due July 2025 [Member]",
        "label": "3.750% notes due July 2025 [Member]",
        "terseLabel": "3.750% Notes Due July 2025 [Member]"
       }
      }
     },
     "localname": "A3.750notesdueJuly2025Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A3.750notesdueOctober2047Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.750% notes due October 2047 [Member]",
        "label": "3.750% notes due October 2047 [Member]",
        "terseLabel": "3.750% notes due October 2047 [Member]"
       }
      }
     },
     "localname": "A3.750notesdueOctober2047Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A3.850notesdueJune2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.850% notes due June 2028 [Member]",
        "label": "3.850% notes due June 2028 [Member]",
        "terseLabel": "3.850% notes due June 2028 [Member]"
       }
      }
     },
     "localname": "A3.850notesdueJune2028Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A3.875notesdueAugust2059Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.875% notes due August 2059 [Member]",
        "label": "3.875% notes due August 2059 [Member]",
        "terseLabel": "3.875% notes due August 2059 [Member]"
       }
      }
     },
     "localname": "A3.875notesdueAugust2059Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A3.875notesdueDecember2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.875% notes due December 2028 [Member]",
        "label": "3.875% notes due December 2028 [Member]",
        "terseLabel": "3.875% notes due December 2028 [Member]"
       }
      }
     },
     "localname": "A3.875notesdueDecember2028Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A3050NotesDueMay2041Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.050% notes due May 2041",
        "label": "3.050% notes due May 2041 [Member]",
        "terseLabel": "3.050% notes due May 2041 [Member]"
       }
      }
     },
     "localname": "A3050NotesDueMay2041Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A3125NotesDueMay2060Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.125% notes due May 2060",
        "label": "3.125% notes due May 2060 [Member]",
        "terseLabel": "3.125% notes due May 2060 [Member]"
       }
      }
     },
     "localname": "A3125NotesDueMay2060Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A3250NotesDueMay2051Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.250% notes due May 2051 [Member]",
        "label": "3.250% notes due May 2051 [Member]",
        "terseLabel": "3.250% notes due May 2051 [Member]"
       }
      }
     },
     "localname": "A3250NotesDueMay2051Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A3350NotesDueJuly2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.350% notes due July 2022 [Member]",
        "label": "3.350% notes due July 2022 [Member]",
        "terseLabel": "3.350% Notes Due July 2022 [Member]"
       }
      }
     },
     "localname": "A3350NotesDueJuly2022Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A364Day38BillionCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "364 Day $3.8 Billion Credit Facility [Member]",
        "label": "364 Day $3.8 Billion Credit Facility [Member]",
        "terseLabel": "364 Day $3.8 Billion Credit Facility [Member]"
       }
      }
     },
     "localname": "A364Day38BillionCreditFacilityMember",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A3950NotesDueOctober2042Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.950% notes due October 2042 [Member]",
        "label": "3.950% notes due October 2042 [Member]",
        "terseLabel": "3.950% notes Due October 2042 [Member]"
       }
      }
     },
     "localname": "A3950NotesDueOctober2042Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A4.200notesdueJanuary2047Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.200% notes due January 2047",
        "label": "4.200% notes due January 2047 [Member]",
        "terseLabel": "4.200% notes due January 2047 [Member]"
       }
      }
     },
     "localname": "A4.200notesdueJanuary2047Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A4.250notesdueApril2047Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.250% notes due April 2047 [Member]",
        "label": "4.250% notes due April 2047 [Member]",
        "terseLabel": "4.250% notes due April 2047 [Member]"
       }
      }
     },
     "localname": "A4.250notesdueApril2047Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A4.250notesdueJune2048Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.250% notes due June 2048 [Member]",
        "label": "4.250% notes due June 2048 [Member]",
        "terseLabel": "4.250% notes due June 2048 [Member]"
       }
      }
     },
     "localname": "A4.250notesdueJune2048Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A4.375notesdueMarch2042Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.375% notes due March 2042",
        "label": "4.375% notes due March 2042 [Member]",
        "terseLabel": "4.375% notes Due March 2042 [Member]"
       }
      }
     },
     "localname": "A4.375notesdueMarch2042Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A4.450notesdueDecember2048Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.450% notes due December 2048 [Member]",
        "label": "4.450% notes due December 2048 [Member]",
        "terseLabel": "4.450% notes due December 2048 [Member]"
       }
      }
     },
     "localname": "A4.450notesdueDecember2048Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A4.625notesdueJuly2035Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.625% notes due July 2035 [Member]",
        "label": "4.625% notes due July 2035 [Member]",
        "terseLabel": "4.625% notes Due July 2035 [Member]"
       }
      }
     },
     "localname": "A4.625notesdueJuly2035Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A4.625notesdueNovember2041Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.625% notes due November 2041",
        "label": "4.625% notes due November 2041 [Member]",
        "terseLabel": "4.625% notes Due November 2041 [Member]"
       }
      }
     },
     "localname": "A4.625notesdueNovember2041Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A4.700notesdueFebruary2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.700% notes due February 2021",
        "label": "4.700% notes due February 2021 [Member]",
        "terseLabel": "4.700% Notes Due February 2021 [Member]"
       }
      }
     },
     "localname": "A4.700notesdueFebruary2021Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A4.750notesdueJuly2045Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.750% notes due July 2045 [Member]",
        "label": "4.750% notes due July 2045 [Member]",
        "terseLabel": "4.750% notes Due July 2045 [Member]"
       }
      }
     },
     "localname": "A4.750notesdueJuly2045Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A4250NotesDueMarch2043Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.250% notes due March 2043 [Member]",
        "label": "4.250% notes due March 2043 [Member]",
        "terseLabel": "4.250% notes Due March 2043 [Member]"
       }
      }
     },
     "localname": "A4250NotesDueMarch2043Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A5.700notesdueOctober2040Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5.700% notes due October 2040",
        "label": "5.700% notes due October 2040 [Member]",
        "terseLabel": "5.700% notes Due October 2040 [Member]"
       }
      }
     },
     "localname": "A5.700notesdueOctober2040Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A5.800notesdueMarch2036Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5.800% notes due March 2036",
        "label": "5.800% notes due March 2036 [Member]",
        "terseLabel": "5.800% notes Due March 2036 [Member]"
       }
      }
     },
     "localname": "A5.800notesdueMarch2036Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A5.950notesdueFebruary2041Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5.950% notes due February 2041",
        "label": "5.950% notes due February 2041 [Member]",
        "terseLabel": "5.950% notes Due Februrary 2041 [Member]"
       }
      }
     },
     "localname": "A5.950notesdueFebruary2041Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A6.875notesdueFebruary2038Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "6.875% notes due February 2038",
        "label": "6.875% notes due February 2038 [Member]",
        "terseLabel": "6.875% notes Due Februray 2038 [Member]"
       }
      }
     },
     "localname": "A6.875notesdueFebruary2038Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A6500NotesDueJune2037Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "6.500% notes due June 2037 [Member]",
        "label": "6.500% notes due June 2037 [Member]",
        "terseLabel": "6.500% notes Due June 2037 [Member]"
       }
      }
     },
     "localname": "A6500NotesDueJune2037Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_A6625NotesDueNovember2037Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "6.625% notes due November 2037 [Member]",
        "label": "6.625% notes due November 2037 [Member]",
        "terseLabel": "6.625% notes due November 2037 [Member]"
       }
      }
     },
     "localname": "A6625NotesDueNovember2037Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_AARPAssetsUnderManagementPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AARP Assets Under Management [Policy Text Block]",
        "label": "AARP Assets Under Management [Policy Text Block]",
        "terseLabel": "AARP Assets Under Management [Policy Text Block]"
       }
      }
     },
     "localname": "AARPAssetsUnderManagementPolicyTextBlock",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "unh_AarpAssetsUnderManagement": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Assets Under Management are primarily AARP assets that are managed separately from the general investment portfolio and are used to pay costs associated with the AARP program.",
        "label": "AARP Assets Under Management",
        "terseLabel": "Assets under management"
       }
      }
     },
     "localname": "AarpAssetsUnderManagement",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_AuditorInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Auditor Information",
        "label": "Auditor Information [Abstract]",
        "terseLabel": "Auditor Information [Abstract]"
       }
      }
     },
     "localname": "AuditorInformationAbstract",
     "nsuri": "http://www.uhc.com/20211231",
     "xbrltype": "stringItemType"
    },
    "unh_BasisofpresentationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basis of presentation [Abstract]",
        "label": "Basis of presentation [Abstract]",
        "terseLabel": "Basis of presentation [Abstract]"
       }
      }
     },
     "localname": "BasisofpresentationAbstract",
     "nsuri": "http://www.uhc.com/20211231",
     "xbrltype": "stringItemType"
    },
    "unh_CMSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CMS [Member]",
        "label": "CMS [Member]",
        "terseLabel": "CMS [Member]"
       }
      }
     },
     "localname": "CMSMember",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_Capitalcontributionstosubsidiaries": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capital contributions to subsidiaries",
        "label": "Capital contributions to subsidiaries",
        "negatedTerseLabel": "Capital contributions to subsidiaries"
       }
      }
     },
     "localname": "Capitalcontributionstosubsidiaries",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_CapitalizedsoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capitalized software [Member]",
        "label": "Capitalized software [Member]",
        "terseLabel": "Capitalized software [Member]"
       }
      }
     },
     "localname": "CapitalizedsoftwareMember",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_CoverPageAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover Page [Abstract]",
        "label": "Cover Page [Abstract]",
        "terseLabel": "Cover Page [Abstract]"
       }
      }
     },
     "localname": "CoverPageAbstract",
     "nsuri": "http://www.uhc.com/20211231",
     "xbrltype": "stringItemType"
    },
    "unh_CreditFacilityNameAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Facility Name [Axis]",
        "label": "Credit Facility Name [Axis]",
        "terseLabel": "Credit Facility Name [Axis]"
       }
      }
     },
     "localname": "CreditFacilityNameAxis",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "unh_CreditFacilityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Credit Facility Name [Axis]",
        "label": "Credit Facility Name [Domain]",
        "terseLabel": "Credit Facility Name [Domain]"
       }
      }
     },
     "localname": "CreditFacilityNameDomain",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_DebtAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt [Abstract]",
        "label": "Debt [Abstract]",
        "terseLabel": "Debt [Abstract]"
       }
      }
     },
     "localname": "DebtAbstract",
     "nsuri": "http://www.uhc.com/20211231",
     "xbrltype": "stringItemType"
    },
    "unh_DeferredTaxAssetOtherDomestic": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Asset, Other Domestic",
        "label": "Deferred Tax Asset, Other Domestic",
        "terseLabel": "Other-domestic"
       }
      }
     },
     "localname": "DeferredTaxAssetOtherDomestic",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_DeferredTaxAssetOtherForeign": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Asset, Other Foreign",
        "label": "Deferred Tax Asset, Other Foreign",
        "terseLabel": "Other-non-U.S."
       }
      }
     },
     "localname": "DeferredTaxAssetOtherForeign",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Deferred Tax Expense, Long-term liabilities",
        "label": "Deferred Tax Assets, Deferred Tax Expense, Long-term liabilities",
        "terseLabel": "Nondeductible liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsDeferredTaxExpenseLongtermliabilities",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_DeferredTaxAssetsLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets Lease Liability",
        "label": "Deferred Tax Assets Lease Liability",
        "terseLabel": "Lease liability"
       }
      }
     },
     "localname": "DeferredTaxAssetsLeaseLiability",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities Goodwill And Intangible Assets, Foreign",
        "label": "Deferred Tax Liabilities Goodwill And Intangible Assets, Foreign",
        "negatedTerseLabel": "Non-U.S. goodwill and intangible assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsForeign",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_DeferredTaxLiabilityOtherDomestic": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liability, Other Domestic",
        "label": "Deferred Tax Liability, Other Domestic",
        "negatedTerseLabel": "Other-domestic"
       }
      }
     },
     "localname": "DeferredTaxLiabilityOtherDomestic",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_DeferredTaxLiabilityOtherForeign": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liability, Other Foreign",
        "label": "Deferred Tax Liability, Other Foreign",
        "negatedTerseLabel": "Other-non-U.S."
       }
      }
     },
     "localname": "DeferredTaxLiabilityOtherForeign",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_DescriptionofBusinessAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of Business [Abstract]",
        "label": "Description of Business [Abstract]",
        "terseLabel": "Description of Business [Abstract]"
       }
      }
     },
     "localname": "DescriptionofBusinessAbstract",
     "nsuri": "http://www.uhc.com/20211231",
     "xbrltype": "stringItemType"
    },
    "unh_DisclosureonGeographicAreasPercentageofLongLivedAssets": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about long-lived assets (except financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets) that are (1) located in the entity's country of domicile, and (2) located in all foreign countries in which the entity holds assets.",
        "label": "Disclosure on Geographic Areas Percentage of Long Lived Assets",
        "terseLabel": "Disclosure on Geographic Areas Percentage of Long Lived Assets"
       }
      }
     },
     "localname": "DisclosureonGeographicAreasPercentageofLongLivedAssets",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "unh_DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure about revenues from external customers (1) attributed to the entity's country of domicile and (2) attributed to all foreign countries in total from which the entity derives revenues.",
        "label": "Disclosure on Geographic Areas Percentage of Revenue from External Customers",
        "terseLabel": "Disclosure on Geographic Areas Percentage of Revenue from External Customers"
       }
      }
     },
     "localname": "DisclosureonGeographicAreasPercentageofRevenuefromExternalCustomers",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "unh_DividendFrequencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dividend Frequency",
        "label": "Dividend Frequency [Axis]",
        "terseLabel": "Dividend Frequency [Axis]"
       }
      }
     },
     "localname": "DividendFrequencyAxis",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "unh_DividendFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dividend Frequency [Domain]",
        "label": "Dividend Frequency [Domain]",
        "terseLabel": "Dividend Frequency [Domain]"
       }
      }
     },
     "localname": "DividendFrequencyDomain",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation Nonrefundable Health Insurance Industry Tax Expense, Amount",
        "label": "Effective Income Tax Rate Reconciliation Nonrefundable Health Insurance Industry Tax Expense, Amount",
        "terseLabel": "Health insurance industry tax, Amount"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpenseAmount",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation Nonrefundable Health Insurance Industry Tax Expense, Percent",
        "label": "Effective Income Tax Rate Reconciliation Nonrefundable Health Insurance Industry Tax Expense, Percent",
        "terseLabel": "Health insurance industry tax, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNonrefundableHealthInsuranceIndustryTaxExpensePercent",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Share Based Awards Excess Tax Benefit, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Share Based Awards Excess Tax Benefit, Amount",
        "terseLabel": "Share-based awards - excess tax benefit, Amount"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitAmount",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Share Based Awards Excess Tax Benefit, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Share Based Awards Excess Tax Benefit, Percent",
        "terseLabel": "Share-based awards - excess tax benefit, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedAwardsExcessTaxBenefitPercent",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "unh_EmployeeStockPurchasePlanESPPMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan (ESPP) [Member]",
        "label": "Employee Stock Purchase Plan (ESPP) [Member]",
        "terseLabel": "Employee Stock Purchase Plan (ESPP) [Member]"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanESPPMember",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_EquityinNetAssetsofSubsidiaries": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity in Net Assets of Subsidiaries",
        "label": "Equity in Net Assets of Subsidiaries",
        "terseLabel": "Equity in net assets of subsidiaries"
       }
      }
     },
     "localname": "EquityinNetAssetsofSubsidiaries",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_ExternalCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "External Customers [Member]",
        "label": "External Customers [Member]",
        "terseLabel": "Unaffiliated Customers"
       }
      }
     },
     "localname": "ExternalCustomersMember",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_ExtraordinaryDividendsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extraordinary Dividends [Member]",
        "label": "Extraordinary Dividends [Member]",
        "terseLabel": "Extraordinary Dividends [Member]"
       }
      }
     },
     "localname": "ExtraordinaryDividendsMember",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_FairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value [Abstract]",
        "label": "Fair Value [Abstract]",
        "terseLabel": "Fair Value [Abstract]"
       }
      }
     },
     "localname": "FairValueAbstract",
     "nsuri": "http://www.uhc.com/20211231",
     "xbrltype": "stringItemType"
    },
    "unh_FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value Adjustments For Nonfinancial Assets And Liabilities Measured At Fair Value Or Financial Assets and Liabilities On Non Recurring Basis",
        "label": "Fair Value Adjustments For Nonfinancial Assets And Liabilities Measured At Fair Value Or Financial Assets and Liabilities Non Recurring Basis",
        "terseLabel": "Significant fair value adjustments for assets and liabilities measured on a nonrecurring basis"
       }
      }
     },
     "localname": "FairValueAdjustmentsForNonfinancialAssetsAndLiabilitiesMeasuredAtFairValueOrFinancialAssetsandLiabilitiesNonRecurringBasis",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/FairValueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_FiveYear56BillionCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Five Year $5.6 Billion Credit Facility [Member]",
        "label": "Five Year $5.6 Billion Credit Facility [Member]",
        "terseLabel": "Five Year $5.6 Billion Credit Facility [Member]"
       }
      }
     },
     "localname": "FiveYear56BillionCreditFacilityMember",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_FloatingratenotesdueJune2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Floating rate notes due June 2021 [Member]",
        "label": "Floating rate notes due June 2021 [Member]",
        "terseLabel": "Floating rate notes due June 2021 [Member]"
       }
      }
     },
     "localname": "FloatingratenotesdueJune2021Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_GoodwillandIntangibleAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill and Intangible Assets [Abstract]",
        "label": "Goodwill and Intangible Assets [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets [Abstract]"
       }
      }
     },
     "localname": "GoodwillandIntangibleAssetsAbstract",
     "nsuri": "http://www.uhc.com/20211231",
     "xbrltype": "stringItemType"
    },
    "unh_IncomeTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax [Abstract]",
        "label": "Income Tax [Abstract]",
        "terseLabel": "Income Tax [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxAbstract",
     "nsuri": "http://www.uhc.com/20211231",
     "xbrltype": "stringItemType"
    },
    "unh_IntersegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intersegment [Member]",
        "label": "Intersegment [Member]",
        "terseLabel": "Affiliated Customers"
       }
      }
     },
     "localname": "IntersegmentMember",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_InvestmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent reporting concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Investment [Line Items]",
        "terseLabel": "Investment [Line Items]"
       }
      }
     },
     "localname": "InvestmentLineItems",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "unh_InvestmentTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This table lists the investments. The line items identify information about the investment.",
        "label": "Investment [Table]",
        "terseLabel": "Investment [Table]"
       }
      }
     },
     "localname": "InvestmentTable",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "unh_InvestmentsAmortizedCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments at amortized cost.",
        "label": "Investments, Amortized Cost",
        "totalLabel": "Total investments, Amortized Cost"
       }
      }
     },
     "localname": "InvestmentsAmortizedCost",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_InvestmentsGrossUnrealizedGains": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "unh_InvestmentsAmortizedCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross unrealized gains of investments.",
        "label": "Investments, Gross Unrealized Gains",
        "terseLabel": "Total investments, Gross Unrealized Gains"
       }
      }
     },
     "localname": "InvestmentsGrossUnrealizedGains",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_InvestmentsGrossUnrealizedLosses": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails": {
       "order": 2.0,
       "parentTag": "unh_InvestmentsAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross unrealized losses of investments.",
        "label": "Investments, Gross Unrealized Losses",
        "negatedTerseLabel": "Total investments, Gross Unrealized Losses"
       }
      }
     },
     "localname": "InvestmentsGrossUnrealizedLosses",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_LossofParentCompany": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss of Parent Company",
        "label": "Loss of Parent Company",
        "negatedTerseLabel": "Loss of parent company"
       }
      }
     },
     "localname": "LossofParentCompany",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_MedicalCostsAndMedicalCostsPayableAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Costs and Medical Costs Payable [Axis]",
        "label": "Medical Costs and Medical Costs Payable [Axis]",
        "terseLabel": "Medical Costs and Medical Costs Payable [Axis]"
       }
      }
     },
     "localname": "MedicalCostsAndMedicalCostsPayableAxis",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "unh_MedicalCostsAndMedicalCostsPayableDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Costs and Medical Costs Payable [Domain]",
        "label": "Medical Costs and Medical Costs Payable [Domain]",
        "terseLabel": "Medical Costs and Medical Costs Payable [Domain]"
       }
      }
     },
     "localname": "MedicalCostsAndMedicalCostsPayableDomain",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_MedicarePartDPharmacyBenefitsContractAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare Part D Pharmacy Benefits Contract [Axis]",
        "label": "Medicare Part D Pharmacy Benefits Contract [Axis]",
        "terseLabel": "Medicare Part D Pharmacy Benefits Contract [Axis]"
       }
      }
     },
     "localname": "MedicarePartDPharmacyBenefitsContractAxis",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "unh_MedicarePartDPharmacyBenefitsContractDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare Part D Pharmacy Benefits Contract [Domain]",
        "label": "Medicare Part D Pharmacy Benefits Contract [Domain]",
        "terseLabel": "Medicare Part D Pharmacy Benefits Contract [Domain]"
       }
      }
     },
     "localname": "MedicarePartDPharmacyBenefitsContractDomain",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_MedicarePartDReceivablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare Part D Receivables [Member]",
        "label": "Medicare Part D Receivables [Member]",
        "terseLabel": "Medicare Part D Receivables [Member]"
       }
      }
     },
     "localname": "MedicarePartDReceivablesMember",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_NOLsExpirationBeginning2022Through2037Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NOLs expiration beginning 2022 through 2037",
        "label": "NOLsExpirationBeginning2022Through2037 [Member]",
        "terseLabel": "Finite-lived NOL carryforwards [Member]"
       }
      }
     },
     "localname": "NOLsExpirationBeginning2022Through2037Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_NOLsIndefiniteCarryforwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NOLs indefinite carryforward",
        "label": "NOLsIndefiniteCarryforward [Member]",
        "terseLabel": "Indefinite NOL carryforwards [Member]"
       }
      }
     },
     "localname": "NOLsIndefiniteCarryforwardMember",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Days Notice Required To Cancel Health Insurance Contract",
        "label": "Number Of Days Notice Required To Cancel Health Insurance Contract",
        "terseLabel": "Number Of Days Notice Required To Cancel Health Insurance Contract"
       }
      }
     },
     "localname": "NumberOfDaysNoticeRequiredToCancelHealthInsuranceContract",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "unh_OptumhealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "OptumHealth Member",
        "label": "Optumhealth [Member]",
        "terseLabel": "Optum Health"
       }
      }
     },
     "localname": "OptumhealthMember",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_OptuminsightMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "OptumInsight [Member]",
        "label": "Optuminsight [Member]",
        "terseLabel": "Optum Insight"
       }
      }
     },
     "localname": "OptuminsightMember",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_OptumrxMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "OptumRx [Member]",
        "label": "Optumrx [Member]",
        "terseLabel": "Optum Rx"
       }
      }
     },
     "localname": "OptumrxMember",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_OtherLiabilitiesCurrentPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Liabilities, Current [Policy Text Block]",
        "label": "Other Liabilities, Current [Policy Text Block]",
        "terseLabel": "Other Current Liabilities [Policy Text Block]"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrentPolicyTextBlock",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "unh_OtherShareBasedCompensationDataAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Share-Based Compensation Data [Abstract]",
        "label": "Other Share-Based Compensation Data [Abstract]",
        "terseLabel": "Other Share-Based Compensation Data [Abstract]"
       }
      }
     },
     "localname": "OtherShareBasedCompensationDataAbstract",
     "nsuri": "http://www.uhc.com/20211231",
     "xbrltype": "stringItemType"
    },
    "unh_PharmaceuticalManufacturerRebatesReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PharmaceuticalManufacturerRebatesReceivable [Member]",
        "label": "PharmaceuticalManufacturerRebatesReceivable [Member]",
        "terseLabel": "Pharmaceutical Manufacturer Rebates Receivable [Member]"
       }
      }
     },
     "localname": "PharmaceuticalManufacturerRebatesReceivableMember",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_PharmaceuticalmanufacturerrebatesreceivableAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmaceutical manufacturer rebates receivable",
        "label": "Pharmaceutical manufacturer rebates receivable [Axis]",
        "terseLabel": "Pharmaceutical manufacturer rebates receivable [Axis]"
       }
      }
     },
     "localname": "PharmaceuticalmanufacturerrebatesreceivableAxis",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "unh_PharmaceuticalmanufacturerrebatesreceivableDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Pharmaceutical manufacturer rebates receivable",
        "label": "Pharmaceutical manufacturer rebates receivable [Domain]",
        "terseLabel": "Pharmaceutical manufacturer rebates receivable [Domain]"
       }
      }
     },
     "localname": "PharmaceuticalmanufacturerrebatesreceivableDomain",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_ProductsandservicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Products and services [Member]",
        "label": "Products and services [Member]",
        "terseLabel": "Products and services [Member]"
       }
      }
     },
     "localname": "ProductsandservicesMember",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property, Plant, and Equipment Excluding Capitalized Computer Software, Net",
        "label": "Property, Plant, and Equipment Excluding Capitalized Computer Software, Net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_RedeemableNoncontrollingInterestsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Noncontrolling Interests [Member]",
        "label": "Redeemable Noncontrolling Interests [Member]",
        "terseLabel": "Redeemable Noncontrolling Interests [Member]"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestsMember",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_RevenuesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenues [Member]",
        "label": "Revenues [Member]",
        "terseLabel": "Revenues [Member]"
       }
      }
     },
     "localname": "RevenuesMember",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_ScheduleIAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule I [Abstract]",
        "label": "Schedule I [Abstract]",
        "terseLabel": "Schedule I [Abstract]"
       }
      }
     },
     "localname": "ScheduleIAbstract",
     "nsuri": "http://www.uhc.com/20211231",
     "xbrltype": "stringItemType"
    },
    "unh_ScheduleIBalanceSheetParentheticalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule I Balance Sheet (Parenthetical) [Abstract]",
        "label": "Schedule I Balance Sheet (Parenthetical) [Abstract]",
        "terseLabel": "Schedule I Balance Sheet (Parenthetical) [Abstract]"
       }
      }
     },
     "localname": "ScheduleIBalanceSheetParentheticalAbstract",
     "nsuri": "http://www.uhc.com/20211231",
     "xbrltype": "stringItemType"
    },
    "unh_ScheduleIMaturitiesofCommercialPaperandLongTermDebtAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule I Maturities of Commercial Paper and Long-Term Debt [Abstract]",
        "label": "Schedule I Maturities of Commercial Paper and Long-Term Debt [Abstract]",
        "terseLabel": "Schedule I Maturities of Commercial Paper and Long-Term Debt [Abstract]"
       }
      }
     },
     "localname": "ScheduleIMaturitiesofCommercialPaperandLongTermDebtAbstract",
     "nsuri": "http://www.uhc.com/20211231",
     "xbrltype": "stringItemType"
    },
    "unh_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Forfeitures",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeitures",
        "terseLabel": "Forfeiture rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitures",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "unh_ShareRepurchasesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Repurchases [Table]",
        "label": "Share Repurchases [Table]",
        "terseLabel": "Share Repurchases [Table]"
       }
      }
     },
     "localname": "ShareRepurchasesTable",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "unh_ShareRepurchasesTableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Share Repurchases [Table]",
        "label": "Share Repurchases [Table] [Line Items]",
        "terseLabel": "Shareholders' Equity Disclosure [Line Items]"
       }
      }
     },
     "localname": "ShareRepurchasesTableLineItems",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "unh_ShareholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shareholders' Equity [Abstract]",
        "label": "Shareholders' Equity [Abstract]",
        "terseLabel": "Shareholders\u2019 equity:"
       }
      }
     },
     "localname": "ShareholdersEquityAbstract",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "unh_ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of average payout, after reinsurance, in the first 90 days after a claim is incurred, beginning with the earliest accident year disclosed for short-duration insurance contracts.",
        "label": "Short-duration Insurance Contracts, Historical Claims Duration, First 90 Days",
        "terseLabel": "Short-duration Insurance Contracts, Historical Claims Duration, First 90 Days"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsHistoricalClaimsDurationFirst90Days",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "unh_StockOptionsandSARsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Options and SARs",
        "label": "Stock Options and SARs [Member]",
        "terseLabel": "Stock Options [Member]",
        "verboseLabel": "Stock Options [Member]"
       }
      }
     },
     "localname": "StockOptionsandSARsMember",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_SuretyBondsOutstanding": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Surety Bonds Outstanding",
        "label": "Surety Bonds Outstanding",
        "terseLabel": "Surety Bonds Outstanding"
       }
      }
     },
     "localname": "SuretyBondsOutstanding",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "unh_ThreeYear56BillionCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three Year $5.6 Billion Credit Facility [Member]",
        "label": "Three Year $5.6 Billion Credit Facility [Member]",
        "terseLabel": "Three Year $5.6 Billion Credit Facility [Member]"
       }
      }
     },
     "localname": "ThreeYear56BillionCreditFacilityMember",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_TotalOptumMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "total [Member]",
        "label": "Total Optum [Member]",
        "terseLabel": "Optum"
       }
      }
     },
     "localname": "TotalOptumMember",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_TrademarksandTechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trademarks and Technology [Member]",
        "label": "Trademarks and Technology [Member]",
        "terseLabel": "Trademarks and Technology [Member]"
       }
      }
     },
     "localname": "TrademarksandTechnologyMember",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_UnitedhealthcareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "UnitedHealthcare [Member]",
        "label": "Unitedhealthcare [Member]",
        "terseLabel": "UnitedHealthcare"
       }
      }
     },
     "localname": "UnitedhealthcareMember",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_UsefulLifeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful Life [Member]",
        "label": "Useful Life [Member]",
        "terseLabel": "Useful Life [Member]"
       }
      }
     },
     "localname": "UsefulLifeMember",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "domainItemType"
    },
    "unh_ZeroCouponNotesDueNovember2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Zero Coupon notes due November 2022 [Member]",
        "label": "Zero Coupon notes due November 2022 [Member]",
        "terseLabel": "0.000% Notes Due November 2022 [Member]"
       }
      }
     },
     "localname": "ZeroCouponNotesDueNovember2022Member",
     "nsuri": "http://www.uhc.com/20211231",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate201602Member": {
     "auth_ref": [
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).",
        "label": "Accounting Standards Update 2016-02 [Member]",
        "terseLabel": "Accounting Standards Update 2016-02 [Member]"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201602Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate201613Member": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2016-13 Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.",
        "label": "Accounting Standards Update 2016-13 [Member]",
        "terseLabel": "Accounting Standards Update 2016-13"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201613Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "terseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r9",
      "r32",
      "r222",
      "r223"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "verboseLabel": "Accounts receivable, net of allowances of $954 and $990"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r46",
      "r326"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "terseLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": {
     "auth_ref": [
      "r66",
      "r67",
      "r68",
      "r72",
      "r81",
      "r82",
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]",
        "terseLabel": "Net Unrealized (Losses) Gains on Investments [Member]"
       }
      }
     },
     "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r35",
      "r69",
      "r71",
      "r72",
      "r737",
      "r782",
      "r786"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss",
        "verboseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r64",
      "r72",
      "r81",
      "r82",
      "r83",
      "r563",
      "r615",
      "r616",
      "r617",
      "r618",
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign Currency Translation Losses [Member]"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r33",
      "r492",
      "r646"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r140",
      "r141",
      "r142",
      "r489",
      "r490",
      "r491",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r143",
      "r144",
      "r145",
      "r146",
      "r155",
      "r231",
      "r232",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r348",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r527",
      "r528",
      "r529",
      "r530",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r638",
      "r683",
      "r684",
      "r685",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Noncash items:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of expense for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, after Tax",
        "terseLabel": "Share-based compensation expense, net of tax effects"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpenseNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r39",
      "r225",
      "r284"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for doubtful accounts, accounts receivable"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on receivable, classified as other and current.",
        "label": "Allowance for Credit Loss, Receivable, Other, Current",
        "terseLabel": "Allowance for doubtful accounts, other receivables"
       }
      }
     },
     "localname": "AllowanceForDoubtfulOtherReceivablesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r119",
      "r310",
      "r319"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of Intangible Assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r132",
      "r197",
      "r204",
      "r211",
      "r276",
      "r349",
      "r350",
      "r351",
      "r353",
      "r354",
      "r355",
      "r356",
      "r358",
      "r360",
      "r362",
      "r363",
      "r556",
      "r565",
      "r601",
      "r644",
      "r646",
      "r690",
      "r734"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Total assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r10",
      "r11",
      "r63",
      "r132",
      "r276",
      "r349",
      "r350",
      "r351",
      "r353",
      "r354",
      "r355",
      "r356",
      "r358",
      "r360",
      "r362",
      "r363",
      "r556",
      "r565",
      "r601",
      "r644",
      "r646"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "terseLabel": "Total current assets",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r584"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Assets, Fair Value Disclosure"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r238"
     ],
     "calculation": {
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Securities, Available for sale Debt Securities, Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r239"
     ],
     "calculation": {
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r236",
      "r290"
     ],
     "calculation": {
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "terseLabel": "Total debt securities - available-for-sale, Amortized Cost",
        "totalLabel": "Debt Securities, Available-for-sale, Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails",
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost": {
     "auth_ref": [
      "r243"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "verboseLabel": "Due after five years through ten years, Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue": {
     "auth_ref": [
      "r240",
      "r243",
      "r721"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "verboseLabel": "Due after five years through ten years, Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": {
     "auth_ref": [
      "r242"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "verboseLabel": "Due after one year through five years, Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r240",
      "r242",
      "r720"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "verboseLabel": "Due after one year through five years, Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost": {
     "auth_ref": [
      "r244"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10",
        "verboseLabel": "Due after ten years, Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue": {
     "auth_ref": [
      "r240",
      "r244",
      "r722"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10",
        "verboseLabel": "Due after ten years, Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": {
     "auth_ref": [
      "r241"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One",
        "verboseLabel": "Due in one year or less, Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r240",
      "r241",
      "r719"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "verboseLabel": "Due in one year or less, Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost": {
     "auth_ref": [
      "r245"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.",
        "label": "Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Amortized Cost",
        "terseLabel": "Mortgage-backed securities, Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue": {
     "auth_ref": [
      "r245",
      "r723"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.",
        "label": "Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value",
        "terseLabel": "Mortgage-backed securities, Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r233",
      "r237",
      "r290",
      "r700"
     ],
     "calculation": {
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Debt Securities, Available-for-sale"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails",
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardDateAxis": {
     "auth_ref": [
      "r455",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by date or year award under share-based payment arrangement is granted.",
        "label": "Award Date [Axis]",
        "terseLabel": "Award Date [Axis]"
       }
      }
     },
     "localname": "AwardDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardDateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date or year award under share-based payment arrangement is granted.",
        "label": "Award Date [Domain]",
        "terseLabel": "Award Date [Domain]"
       }
      }
     },
     "localname": "AwardDateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r455",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails",
      "http://www.uhc.com/role/ShareBasedCompensationRestrictedShareActivityDetails",
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails",
      "http://www.uhc.com/role/CommitmentsandContingenciesFutureLeasePaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r570",
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails",
      "http://www.uhc.com/role/CommitmentsandContingenciesFutureLeasePaymentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BalanceSheetRelatedDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Related Disclosures [Abstract]",
        "terseLabel": "Balance Sheet Related Disclosures [Abstract]"
       }
      }
     },
     "localname": "BalanceSheetRelatedDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Accounting, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "terseLabel": "Basis of Presentation and Significant Accounting Policies [Text Block]"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes",
      "http://www.uhc.com/role/ScheduleIPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Buildings [Member]"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingsAndImprovementsGross": {
     "auth_ref": [
      "r12",
      "r325"
     ],
     "calculation": {
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails": {
       "order": 2.0,
       "parentTag": "unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Buildings and Improvements, Gross",
        "terseLabel": "Buildings and improvements"
       }
      }
     },
     "localname": "BuildingsAndImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r448",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r448",
      "r451",
      "r543",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy": {
     "auth_ref": [
      "r756"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for deferred policy acquisition costs, including the nature, type, and amount of capitalized costs incurred to write or acquire insurance contracts, and the basis for and methodologies applied in capitalizing and amortizing such costs.",
        "label": "Deferred Policy Acquisition Costs, Policy [Policy Text Block]",
        "terseLabel": "Deferred Policy Acquisition Costs, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "CapitalizationOfDeferredPolicyAcquisitionCostsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization": {
     "auth_ref": [
      "r835"
     ],
     "calculation": {
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CapitalizedComputerSoftwareNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For each balance sheet presented, the amount of accumulated amortization for capitalized computer software costs.",
        "label": "Capitalized Computer Software, Accumulated Amortization",
        "negatedTerseLabel": "Less accumulated amortization"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareAmortization1": {
     "auth_ref": [
      "r834",
      "r836"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for amortization of capitalized computer software costs.",
        "label": "Capitalized Computer Software, Amortization",
        "terseLabel": "Capitalized Computer Software, Amortization"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareAmortization1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareGross": {
     "auth_ref": [
      "r835"
     ],
     "calculation": {
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CapitalizedComputerSoftwareNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.",
        "label": "Capitalized Computer Software, Gross",
        "terseLabel": "Capitalized software"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareNet": {
     "auth_ref": [
      "r833"
     ],
     "calculation": {
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.",
        "label": "Capitalized Computer Software, Net",
        "totalLabel": "Capitalized software, net"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r8",
      "r43",
      "r121"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "periodEndLabel": "Cash and cash equivalents, end of period",
        "periodStartLabel": "Cash and cash equivalents, beginning of period",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.",
        "label": "Cash and Cash Equivalents, Period Increase (Decrease)",
        "terseLabel": "Increase (decrease) in cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r16",
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r114",
      "r612"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries": {
     "auth_ref": [
      "r138"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents disclosure of the aggregate cash dividends paid to the entity by consolidated subsidiaries.",
        "label": "SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Consolidated Subsidiaries",
        "terseLabel": "Cash Dividends Paid to Parent, Consolidated Subsidiaries"
       }
      }
     },
     "localname": "CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIDetails",
      "http://www.uhc.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]",
        "terseLabel": "Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]"
       }
      }
     },
     "localname": "CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable": {
     "auth_ref": [
      "r762",
      "r788"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the reasons for the change in incurred claims and claim adjustment expenses recognized in the income statement attributable to insured events of prior fiscal years. Also includes disclosures of additional premiums or return premiums accrued as a result of changes in incurred claims and claim adjustment expenses.",
        "label": "Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Table]",
        "terseLabel": "Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Table]"
       }
      }
     },
     "localname": "CausesOfIncreaseDecreaseInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r129",
      "r132",
      "r158",
      "r159",
      "r160",
      "r162",
      "r164",
      "r170",
      "r171",
      "r172",
      "r276",
      "r349",
      "r354",
      "r355",
      "r356",
      "r362",
      "r363",
      "r406",
      "r407",
      "r410",
      "r414",
      "r601",
      "r845"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical",
      "http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails",
      "http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaper": {
     "auth_ref": [
      "r20",
      "r691",
      "r736"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.",
        "label": "Commercial Paper",
        "terseLabel": "Commercial Paper"
       }
      }
     },
     "localname": "CommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper [Member]"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r59",
      "r335",
      "r702",
      "r743"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 4)",
        "verboseLabel": "Commitments and contingencies (Note 12)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r332",
      "r333",
      "r334",
      "r342",
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies Disclosure [Text Block]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsMember": {
     "auth_ref": [
      "r25",
      "r695",
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements.",
        "label": "Commitments [Member]",
        "terseLabel": "Commitments"
       }
      }
     },
     "localname": "CommitmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesFutureLeasePaymentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockDividendsPerShareCashPaid": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Cash Paid",
        "terseLabel": "Cash dividends per common share"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareCashPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementofChangesinEquityParentheticals",
      "http://www.uhc.com/role/ShareholdersEquityDividendsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r140",
      "r141",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical",
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical",
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical",
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r30",
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)",
        "terseLabel": "Common Stock, Shares, Outstanding",
        "verboseLabel": "Common Stock, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical",
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity",
      "http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r30",
      "r646"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.01 par value - 3,000 shares authorized; 941 and 946 issued and outstanding"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r77",
      "r79",
      "r80",
      "r92",
      "r709",
      "r749"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "terseLabel": "Comprehensive income",
        "totalLabel": "Comprehensive income attributable to UnitedHealth Group common shareholders"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r77",
      "r79",
      "r91",
      "r552",
      "r553",
      "r569",
      "r708",
      "r748"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "negatedLabel": "Comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r77",
      "r79",
      "r90",
      "r551",
      "r569",
      "r707",
      "r747"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r178",
      "r179",
      "r220",
      "r599",
      "r600",
      "r816"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r178",
      "r179",
      "r220",
      "r599",
      "r600",
      "r793",
      "r816"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r178",
      "r179",
      "r220",
      "r599",
      "r600",
      "r793",
      "r816"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r178",
      "r179",
      "r220",
      "r599",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration Risk, Percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r178",
      "r179",
      "r220",
      "r599",
      "r600",
      "r816"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock": {
     "auth_ref": [
      "r5",
      "r137",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document.",
        "label": "Condensed Financial Information of Parent Company Only Disclosure [Text Block]",
        "terseLabel": "Condensed Financial Information of Parent Company Only Disclosure [Text Block]"
       }
      }
     },
     "localname": "CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ScheduleINotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.",
        "label": "Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]",
        "terseLabel": "Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies",
      "http://www.uhc.com/role/ScheduleIPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r439",
      "r447",
      "r792"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate Obligations [Member]"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails",
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r202",
      "r203",
      "r204",
      "r205",
      "r207",
      "r213",
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate and Eliminations"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r96",
      "r681"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of products sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "auth_ref": [
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.",
        "label": "Cost of Goods and Service [Policy Text Block]",
        "terseLabel": "Cost of Goods and Service [Policy Text Block]"
       }
      }
     },
     "localname": "CostOfSalesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total operating costs",
        "verboseLabel": "Total operating costs"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
      "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "terseLabel": "Operating costs:"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
      "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r133",
      "r523"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r133",
      "r523",
      "r533",
      "r535"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current provision"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r133",
      "r523",
      "r533"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State and local"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRelatedIntangibleAssetsMember": {
     "auth_ref": [
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer-related asset, including, but not limited to, customer lists, and noncontractual customer relationships.",
        "label": "Customer-Related Intangible Assets [Member]",
        "terseLabel": "Customer-Related Intangible Assets [Member]"
       }
      }
     },
     "localname": "CustomerRelatedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r128",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r381",
      "r388",
      "r389",
      "r391",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "verboseLabel": "Short-Term Borrowings and Long-Term Debt [Text Block]"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r21",
      "r23",
      "r24",
      "r131",
      "r137",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r371",
      "r377",
      "r378",
      "r379",
      "r380",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r392",
      "r393",
      "r394",
      "r395",
      "r626",
      "r692",
      "r694",
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r364",
      "r392",
      "r393",
      "r624",
      "r626",
      "r627"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "verboseLabel": "Par Value"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r379",
      "r392",
      "r393",
      "r596"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Debt and other financing obligations"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r56",
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt Instrument, Interest Rate, Stated Percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r57",
      "r131",
      "r137",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r371",
      "r377",
      "r378",
      "r379",
      "r380",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r392",
      "r393",
      "r394",
      "r395",
      "r626"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r57",
      "r131",
      "r137",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r371",
      "r377",
      "r378",
      "r379",
      "r380",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r390",
      "r392",
      "r393",
      "r394",
      "r395",
      "r422",
      "r425",
      "r426",
      "r427",
      "r623",
      "r624",
      "r626",
      "r627",
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtLongtermAndShorttermCombinedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt.",
        "label": "Debt, Long-term and Short-term, Combined Amount",
        "terseLabel": "Debt and other financing obligations, carrying value",
        "verboseLabel": "Carrying Value"
       }
      }
     },
     "localname": "DebtLongtermAndShorttermCombinedAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "auth_ref": [
      "r267",
      "r295",
      "r298"
     ],
     "calculation": {
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer",
        "terseLabel": "Greater Than 12 Months, Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": {
     "auth_ref": [
      "r267",
      "r295"
     ],
     "calculation": {
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss",
        "negatedTerseLabel": "Greater Than 12 Months, Gross Unrealized Losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "auth_ref": [
      "r267",
      "r295",
      "r298"
     ],
     "calculation": {
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "terseLabel": "Less Than 12 Months, Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "auth_ref": [
      "r267",
      "r295"
     ],
     "calculation": {
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss",
        "negatedTerseLabel": "Less Than 12 Months, Gross Unrealized Losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": {
     "auth_ref": [
      "r264",
      "r291",
      "r298"
     ],
     "calculation": {
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position",
        "totalLabel": "Total, Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss": {
     "auth_ref": [
      "r265",
      "r292"
     ],
     "calculation": {
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss",
        "negatedTotalLabel": "Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock": {
     "auth_ref": [
      "r263",
      "r294",
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value [Table Text Block]",
        "terseLabel": "Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": {
     "auth_ref": [
      "r266",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions",
        "terseLabel": "Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesMember": {
     "auth_ref": [
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument issued by corporations, governments and governmental agencies, municipalities, and other institutions.",
        "label": "Debt Securities [Member]",
        "terseLabel": "Debt Securities - held-to-maturity"
       }
      }
     },
     "localname": "DebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueNarrativeDetails",
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails",
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).",
        "label": "Deferred Compensation Liability, Classified, Noncurrent",
        "terseLabel": "Deferred Compensation, Recorded Liability"
       }
      }
     },
     "localname": "DeferredCompensationLiabilityClassifiedNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r119",
      "r133",
      "r524",
      "r533",
      "r534",
      "r535"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred provision (benefit)",
        "verboseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r26",
      "r27",
      "r514",
      "r693",
      "r730"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred income tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r496",
      "r497"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred Income Taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred Revenue, Current",
        "verboseLabel": "Unearned revenues"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r515"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Subtotal"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGrossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Gross [Abstract]",
        "terseLabel": "Deferred income tax assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsGrossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r517"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Total deferred income tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": {
     "auth_ref": [
      "r521",
      "r522"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Domestic",
        "terseLabel": "U.S. federal and state net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": {
     "auth_ref": [
      "r521",
      "r522"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Foreign",
        "terseLabel": "Non-U.S. tax loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r521",
      "r522"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances": {
     "auth_ref": [
      "r521",
      "r522"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from estimated returns and sales allowances.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Returns and Allowances",
        "terseLabel": "Accrued expenses and allowances"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r516"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedTerseLabel": "Less: valuation allowances"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r497",
      "r517"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Net deferred income tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Gross [Abstract]",
        "terseLabel": "Deferred income tax liabilities:"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware": {
     "auth_ref": [
      "r521",
      "r522"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from capitalized software.",
        "label": "Deferred Tax Liabilities, Deferred Expense, Capitalized Software",
        "negatedTerseLabel": "Capitalized software"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates": {
     "auth_ref": [
      "r521",
      "r522"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from investments in unconsolidated subsidiaries and investments in other affiliates which are not controlled nor consolidated.",
        "label": "Deferred Tax Liabilities, Investment in Noncontrolled Affiliates",
        "negatedTerseLabel": "Outside basis in partnerships"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "auth_ref": [
      "r521",
      "r522"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.",
        "label": "Deferred Tax Liabilities, Leasing Arrangements",
        "negatedTerseLabel": "Lease right-of-use asset"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets": {
     "auth_ref": [
      "r521",
      "r522"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from long-lived assets other than property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Other Finite-Lived Assets",
        "negatedTerseLabel": "U.S. federal and state intangible assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOtherFiniteLivedAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPrepaidExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax consequences attributable to taxable temporary differences derived from prepaid expenses.",
        "label": "Deferred Tax Liabilities, Prepaid Expenses",
        "negatedTerseLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPrepaidExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r521",
      "r522"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedTerseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DemandDepositAccounts": {
     "auth_ref": [
      "r701"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of money in accounts that may bear interest and that the depositor is entitled to withdraw at any time without prior notice.",
        "label": "Demand Deposit Accounts",
        "terseLabel": "Health savings account deposits"
       }
      }
     },
     "localname": "DemandDepositAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r119",
      "r324"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r119",
      "r324"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Share-based Payment Arrangement [Text Block]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsCash": {
     "auth_ref": [
      "r428",
      "r726"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.",
        "label": "Dividends, Cash",
        "negatedTerseLabel": "Cash dividends paid on common shares ($5.60 per share, $4.83 per share and $4.14 per share for the years ended December 31, 2021, 2020 and 2019, respectively)"
       }
      }
     },
     "localname": "DividendsCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsDeclaredTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to dividends declared, including paid and unpaid dividends.",
        "label": "Dividends Declared [Table Text Block]",
        "terseLabel": "Dividends Declared"
       }
      }
     },
     "localname": "DividendsDeclaredTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Federal [Member]"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarliestTaxYearMember": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earliest identified tax year.",
        "label": "Earliest Tax Year [Member]",
        "terseLabel": "Earliest Tax Year [Member]"
       }
      }
     },
     "localname": "EarliestTaxYearMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings per share attributable to UnitedHealth Group common shareholders:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r93",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r156",
      "r158",
      "r162",
      "r163",
      "r164",
      "r167",
      "r168",
      "r582",
      "r583",
      "r710",
      "r750"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r93",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r158",
      "r162",
      "r163",
      "r164",
      "r167",
      "r168",
      "r582",
      "r583",
      "r710",
      "r750"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r165",
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings Per Share, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": {
     "auth_ref": [
      "r612"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.",
        "label": "Effect of Exchange Rate on Cash and Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r499"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Provision for income taxes, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r134",
      "r499",
      "r536"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Tax provision at the U.S. federal statutory rate, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r499",
      "r536"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "terseLabel": "Foreign rate differential, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense": {
     "auth_ref": [
      "r499",
      "r536"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent",
        "terseLabel": "Non-deductible compensation, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r499",
      "r536"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other, net, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r499",
      "r536"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State income taxes, net of federal benefit, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r482"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation expense related to share awards"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions": {
     "auth_ref": [
      "r484"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit from exercise of option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Exercise of Option, Tax Benefit",
        "terseLabel": "Income tax benefit realized from share-based award exercises"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r81",
      "r82",
      "r83",
      "r140",
      "r141",
      "r142",
      "r144",
      "r152",
      "r154",
      "r169",
      "r281",
      "r421",
      "r428",
      "r489",
      "r490",
      "r491",
      "r529",
      "r530",
      "r581",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r620",
      "r777",
      "r778",
      "r779",
      "r887"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails",
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r44",
      "r198",
      "r274"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r595"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Equity Securities, FV-NI"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue": {
     "auth_ref": [
      "r595"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI) and investment in equity security without readily determinable fair value.",
        "label": "Equity Securities, FV-NI and without Readily Determinable Fair Value",
        "terseLabel": "Equity Securities, FV-NI and without Readily Determinable Fair Value"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedGain": {
     "auth_ref": [
      "r273"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Unrealized Gain",
        "terseLabel": "Equity Securities, FV-NI, Unrealized Gain"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiUnrealizedGain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/FairValueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/FairValueFairValuePolicies",
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r584",
      "r585",
      "r586",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/FairValueFairValuePolicies",
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock": {
     "auth_ref": [
      "r584",
      "r585",
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities by class, including financial instruments measured at fair value that are classified in shareholders' equity, if any, that are measured at fair value on a nonrecurring basis in periods after initial recognition (for example, impaired assets). Disclosures may include, but are not limited to: (a) the fair value measurements recorded and the reasons for the measurements and (b) the level within the fair value hierarchy in which the fair value measurements are categorized in their entirety (levels 1, 2, 3).",
        "label": "Fair Value Measurements, Nonrecurring [Table Text Block]",
        "terseLabel": "Fair Value Measurements, Nonrecurring [Table Text Block]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnNonrecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/FairValueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/FairValueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r584",
      "r597",
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/FairValueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r379",
      "r392",
      "r393",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r447",
      "r585",
      "r653",
      "r654",
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "verboseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/FairValueFairValuePolicies",
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueNarrativeDetails",
      "http://www.uhc.com/role/FairValueTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r584",
      "r585",
      "r588",
      "r589",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/FairValueFairValuePolicies",
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "verboseLabel": "Fair Value [Text Block]"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/FairValueNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r379",
      "r439",
      "r440",
      "r445",
      "r447",
      "r585",
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Quoted Prices in Active Markets (Level 1) [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r379",
      "r392",
      "r393",
      "r439",
      "r440",
      "r445",
      "r447",
      "r585",
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Other Observable Inputs (Level 2) [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r379",
      "r392",
      "r393",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r447",
      "r585",
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Unobservable Inputs (Level 3) [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/FairValueFairValuePolicies",
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurement, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/FairValueFairValuePolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3": {
     "auth_ref": [
      "r590"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3",
        "terseLabel": "Transfers Into Level 3"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/FairValueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3": {
     "auth_ref": [
      "r590"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3",
        "terseLabel": "Transfers out of Level 3"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/FairValueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r379",
      "r392",
      "r393",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r447",
      "r653",
      "r654",
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "verboseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/FairValueFairValuePolicies",
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueNarrativeDetails",
      "http://www.uhc.com/role/FairValueTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsNonrecurringMember": {
     "auth_ref": [
      "r584",
      "r585",
      "r588",
      "r589",
      "r591",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.",
        "label": "Fair Value, Nonrecurring [Member]",
        "terseLabel": "Fair Value, Nonrecurring [Member]"
       }
      }
     },
     "localname": "FairValueMeasurementsNonrecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations": {
     "auth_ref": [
      "r133",
      "r498"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current and deferred federal income tax expense (benefit) attributable to income (loss) from continuing operations.",
        "label": "Federal Income Tax Expense (Benefit), Continuing Operations",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "FederalIncomeTaxExpenseBenefitContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r254",
      "r258",
      "r270",
      "r271",
      "r272",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r294",
      "r296",
      "r297",
      "r298",
      "r390",
      "r419",
      "r572",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueNarrativeDetails",
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails",
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails",
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r318"
     ],
     "calculation": {
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Finite-lived Intangible Assets, Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r320"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r320"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r320"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r320"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r320"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r311",
      "r314",
      "r318",
      "r321",
      "r682",
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]",
        "verboseLabel": "Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r311",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinitelivedIntangibleAssetsAcquired1": {
     "auth_ref": [
      "r312"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.",
        "label": "Finite-lived Intangible Assets Acquired",
        "terseLabel": "Finite-lived Intangible Assets Acquired"
       }
      }
     },
     "localname": "FinitelivedIntangibleAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Non-U.S [Member]"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesGross": {
     "auth_ref": [
      "r325"
     ],
     "calculation": {
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails": {
       "order": 4.0,
       "parentTag": "unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures, Gross",
        "terseLabel": "Furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture, Fixtures and equipment [Member]"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r299",
      "r301",
      "r646",
      "r689"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, Ending Balance",
        "periodStartLabel": "Goodwill, Beginning Balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r302"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill Disclosure [Text Block]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": {
     "auth_ref": [
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.",
        "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r119",
      "r300",
      "r303",
      "r307"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill, Impairment Loss"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsNotes",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r304",
      "r305",
      "r542"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Translation and Purchase Accounting Adjustments",
        "terseLabel": "Foreign currency effects and adjustments, net"
       }
      }
     },
     "localname": "GoodwillTranslationAndPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HealthInsuranceProductLineMember": {
     "auth_ref": [
      "r774"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product line consisting of insurance against loss by illness or injury.",
        "label": "Health Insurance Product Line [Member]",
        "terseLabel": "Health Insurance Product Line [Member]"
       }
      }
     },
     "localname": "HealthInsuranceProductLineMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HeldToMaturitySecurities": {
     "auth_ref": [
      "r226",
      "r246",
      "r284",
      "r287"
     ],
     "calculation": {
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity).",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss",
        "terseLabel": "Debt Securities, Held-to-maturity",
        "totalLabel": "Held-to-maturity securities, Amortized Cost"
       }
      }
     },
     "localname": "HeldToMaturitySecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails",
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain": {
     "auth_ref": [
      "r248",
      "r256"
     ],
     "calculation": {
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_HeldToMaturitySecurities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrecognized gain on investment in debt security measured at amortized cost (held-to-maturity).",
        "label": "Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain",
        "terseLabel": "Securities, Held to maturity, Unrecognized Holding Gain"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss": {
     "auth_ref": [
      "r249",
      "r257"
     ],
     "calculation": {
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_HeldToMaturitySecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at amortized cost (held-to-maturity).",
        "label": "Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss",
        "negatedLabel": "Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue": {
     "auth_ref": [
      "r252",
      "r261",
      "r717",
      "r721"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "terseLabel": "Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, after Five Through Ten Years, Fair Value"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount": {
     "auth_ref": [
      "r252",
      "r717"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, after Year Five through Ten",
        "terseLabel": "Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, after Five Through Ten Years, Amortized Cost"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r251",
      "r260",
      "r716",
      "r720"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Fair Value"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount": {
     "auth_ref": [
      "r251",
      "r716"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, after Year One through Five",
        "terseLabel": "Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Amortized Cost"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue": {
     "auth_ref": [
      "r253",
      "r262",
      "r718",
      "r722"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10",
        "terseLabel": "Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, after 10 Years, Fair Value"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount": {
     "auth_ref": [
      "r253",
      "r718"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, after Year 10",
        "terseLabel": "Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, after 10 Years, Amortized Cost"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r250",
      "r259",
      "r715",
      "r719"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, within One Year, Fair Value"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount": {
     "auth_ref": [
      "r250",
      "r715"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, within One Year, Amortized Cost"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesFairValue": {
     "auth_ref": [
      "r247",
      "r255",
      "r700"
     ],
     "calculation": {
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_HeldToMaturitySecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity).",
        "label": "Debt Securities, Held-to-maturity, Fair Value",
        "terseLabel": "Debt Securities, Held-to-maturity, Fair Value"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails",
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r119",
      "r322"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.",
        "label": "Impairment of Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Impairment of Intangible Assets (Excluding Goodwill)"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r87",
      "r197",
      "r203",
      "r207",
      "r210",
      "r213",
      "r687",
      "r704",
      "r713",
      "r752"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Earnings before income taxes",
        "totalLabel": "Earnings before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r197",
      "r203",
      "r207",
      "r210",
      "r213"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "terseLabel": "Loss before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions": {
     "auth_ref": [
      "r119"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.",
        "label": "Income (Loss) from Equity Method Investments, Net of Dividends or Distributions",
        "terseLabel": "Equity in undistributed income of subsidiaries"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails",
      "http://www.uhc.com/role/IncomeTaxesNotes",
      "http://www.uhc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails",
      "http://www.uhc.com/role/IncomeTaxesNotes",
      "http://www.uhc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority, Name [Axis]",
        "terseLabel": "Income Tax Authority, Name [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails",
      "http://www.uhc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority, Name [Domain]",
        "terseLabel": "Income Tax Authority, Name [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails",
      "http://www.uhc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Contingency [Line Items]",
        "terseLabel": "Income Tax Contingency [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails",
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails",
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails",
      "http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails",
      "http://www.uhc.com/role/IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails",
      "http://www.uhc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "auth_ref": [
      "r504",
      "r511",
      "r513",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]"
       }
      }
     },
     "localname": "IncomeTaxContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails",
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails",
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails",
      "http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails",
      "http://www.uhc.com/role/IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails",
      "http://www.uhc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r134",
      "r500",
      "r512",
      "r518",
      "r531",
      "r537",
      "r539",
      "r540",
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Tax Disclosure [Text Block]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Examination [Line Items]",
        "terseLabel": "Income Tax Examination [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxExaminationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNotes"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExaminationTable": {
     "auth_ref": [
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A summary of income tax examinations that an enterprise is currently subject to or that have been completed in the current period typically including a description of the examination, the jurisdiction conducting the examination, the tax year(s) under examination, the likelihood of an unfavorable settlement, the range of possible losses, the liability recorded, the Increase or Decrease in the liability from the prior period, and any penalties and interest that have been incurred or accrued.",
        "label": "Income Tax Examination [Table]",
        "terseLabel": "Income Tax Examination [Table]"
       }
      }
     },
     "localname": "IncomeTaxExaminationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNotes"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r135",
      "r153",
      "r154",
      "r195",
      "r498",
      "r532",
      "r538",
      "r753"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      },
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedTerseLabel": "Provision for income taxes",
        "terseLabel": "Benefit for income taxes",
        "totalLabel": "Total provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails",
      "http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails",
      "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r499"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "terseLabel": "Foreign rate differential, Amount"
       }
      }
     },
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r499"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Tax provision at the U.S. federal statutory rate, Amount"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpense": {
     "auth_ref": [
      "r499"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount",
        "terseLabel": "Non-deductible compensation, Amount"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "auth_ref": [
      "r499"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "terseLabel": "Other, net, Amount"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r499"
     ],
     "calculation": {
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "State income taxes, net of federal benefit, Amount"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r125"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Cash paid for income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "terseLabel": "Unearned revenues"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeposits": {
     "auth_ref": [
      "r122",
      "r712"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or outflow for the increase (decrease) in the beginning and end of period deposits balances.",
        "label": "Increase (Decrease) in Deposits",
        "terseLabel": "Customer funds administered"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeposits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in health care insurance liability balances during the period.",
        "label": "Increase (Decrease) in Health Care Insurance Liabilities",
        "verboseLabel": "Medical costs payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInHealthCareInsuranceLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Net change in other operating items, net of effects from acquisitions and changes in AARP balances:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndustrySpecificPoliciesInsuranceCompaniesTextBlock": {
     "auth_ref": [
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for insurance companies  that are industry specific.",
        "label": "Industry Specific Policies, Insurance Companies [Policy Text Block]",
        "terseLabel": "Health Insurance Industry Tax, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "IndustrySpecificPoliciesInsuranceCompaniesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InsuranceAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insurance [Abstract]",
        "terseLabel": "Insurance [Abstract]"
       }
      }
     },
     "localname": "InsuranceAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "terseLabel": "Intangible Assets, Gross (Excluding Goodwill)"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r309",
      "r316"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "totalLabel": "Intangible Assets, Net (Excluding Goodwill)",
        "verboseLabel": "Other intangible assets, net of accumulated amortization of $5,636 and $5,455"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r85",
      "r191",
      "r622",
      "r625",
      "r711"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
      "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r112",
      "r115",
      "r125"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r189",
      "r202",
      "r203",
      "r204",
      "r205",
      "r207",
      "r209",
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Optum Eliminations"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentIncomeInterestAndDividend": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income, Interest and Dividend",
        "terseLabel": "Investment and other income"
       }
      }
     },
     "localname": "InvestmentIncomeInterestAndDividend",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
      "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentOwnedBalanceContracts": {
     "auth_ref": [
      "r796",
      "r800",
      "r809"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Balance held at close of period in number of contracts.",
        "label": "Investment Owned, Balance, Contracts",
        "terseLabel": "Total number of security positions"
       }
      }
     },
     "localname": "InvestmentOwnedBalanceContracts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r275",
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Investment, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r797",
      "r798",
      "r799",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r810",
      "r811",
      "r812",
      "r813"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r797",
      "r798",
      "r799",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r810",
      "r811",
      "r812",
      "r813"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments [Abstract]",
        "terseLabel": "Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Investments by Contractual Maturity [Table Text Block]"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r584"
     ],
     "calculation": {
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails": {
       "order": 3.0,
       "parentTag": "unh_InvestmentsAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Investments, Fair Value Disclosure"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r269",
      "r688",
      "r724",
      "r814",
      "r852"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for  investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Investments [Text Block]"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LandAndLandImprovements": {
     "auth_ref": [
      "r13",
      "r18"
     ],
     "calculation": {
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails": {
       "order": 1.0,
       "parentTag": "unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated deprecation and depletion of real estate held for productive use and additions or improvements to real estate held for productive use, examples include, but are not limited to, walkways, driveways, fences, and parking lots. Excludes land held for sale.",
        "label": "Land and Land Improvements",
        "terseLabel": "Land and improvements"
       }
      }
     },
     "localname": "LandAndLandImprovements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LatestTaxYearMember": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Latest identified tax year.",
        "label": "Latest Tax Year [Member]",
        "terseLabel": "Latest Tax Year [Member]"
       }
      }
     },
     "localname": "LatestTaxYearMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Lessee, Leases [Policy Text Block]"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r636"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "terseLabel": "Total future minimum lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r636"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r636"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r636"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r636"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r636"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r636"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r636"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "verboseLabel": "Undrawn Letters Of Credit"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r53",
      "r132",
      "r205",
      "r276",
      "r349",
      "r350",
      "r351",
      "r354",
      "r355",
      "r356",
      "r358",
      "r360",
      "r362",
      "r363",
      "r557",
      "r565",
      "r566",
      "r601",
      "r644",
      "r645"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "terseLabel": "Total liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r38",
      "r132",
      "r276",
      "r601",
      "r646",
      "r697",
      "r741"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "terseLabel": "Total liabilities and shareholders\u2019 equity",
        "totalLabel": "Total liabilities, redeemable noncontrolling interests and equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities, redeemable noncontrolling interests and equity",
        "verboseLabel": "Liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r55",
      "r132",
      "r276",
      "r349",
      "r350",
      "r351",
      "r354",
      "r355",
      "r356",
      "r358",
      "r360",
      "r362",
      "r363",
      "r557",
      "r565",
      "r566",
      "r601",
      "r644",
      "r645",
      "r646"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "terseLabel": "Total current liabilities",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r758",
      "r761"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.",
        "label": "Liability for Claims and Claims Adjustment Expense",
        "periodEndLabel": "Medical costs payable, end of period",
        "periodStartLabel": "Medical costs payable, beginning of period",
        "verboseLabel": "Medical costs payable"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the cost of settling unpaid claims after deduction of reinsurance recoveries related to the acquisition of a business. Includes, but is not limited to, claims which have been incurred but not reported.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]",
        "terseLabel": "Medical payments:"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1": {
     "auth_ref": [
      "r760"
     ],
     "calculation": {
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year",
        "negatedTerseLabel": "Payments for current year"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1": {
     "auth_ref": [
      "r760"
     ],
     "calculation": {
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years",
        "negatedTerseLabel": "Payments for prior years"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount": {
     "auth_ref": [
      "r787"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated costs as of the balance sheet date of settling insured claims and costs incurred in the claims settlement process for claims that have not yet been submitted to the insurance company for reimbursement.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred but Not Reported (IBNR) Claims, Amount",
        "terseLabel": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred but Not Reported (IBNR) Claims, Amount"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1": {
     "auth_ref": [
      "r759"
     ],
     "calculation": {
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims",
        "totalLabel": "Total reported medical costs"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]",
        "terseLabel": "Reported medical costs:"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r24",
      "r694",
      "r731"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "terseLabel": "Long-term Line of Credit"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityExpirationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period remaining on line of credit facility before it terminates, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Line of Credit Facility, Expiration Period",
        "terseLabel": "Maturity Period, Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditFacilityExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LineOfCreditFacilityInterestRateDuringPeriod": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective interest rate during the reporting period.",
        "label": "Line of Credit Facility, Interest Rate During Period",
        "terseLabel": "Debt Instrument, Interest Rate During Period"
       }
      }
     },
     "localname": "LineOfCreditFacilityInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r50"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of Credit, Credit Facility, Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "terseLabel": "Short-term borrowings and current maturities of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r137",
      "r346",
      "r383"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r137",
      "r346",
      "r383"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r137",
      "r346",
      "r383"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r137",
      "r346",
      "r383"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r137",
      "r346",
      "r383"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r137",
      "r346",
      "r383"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIMaturitiesofShortTermBorrowingsandLongTermDebtDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.",
        "label": "Long-term Debt [Member]",
        "terseLabel": "Long-term debt and other financing obligations [Member]"
       }
      }
     },
     "localname": "LongTermDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt, less current maturities"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermInvestments": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).",
        "label": "Long-term Investments",
        "terseLabel": "Long-term investments"
       }
      }
     },
     "localname": "LongTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r57",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r343",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r343",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r343",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MachineryAndEquipmentGross": {
     "auth_ref": [
      "r12",
      "r325"
     ],
     "calculation": {
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails": {
       "order": 3.0,
       "parentTag": "unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment, Gross",
        "terseLabel": "Computer equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r61",
      "r132",
      "r276",
      "r349",
      "r354",
      "r355",
      "r356",
      "r362",
      "r363",
      "r601",
      "r696",
      "r740"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Nonredeemable noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestChangeInRedemptionValue": {
     "auth_ref": [
      "r401",
      "r402",
      "r403",
      "r429"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in noncontrolling interest during the period as a result of a change in the redemption value of redeemable noncontrolling interest.",
        "label": "Noncontrolling Interest, Change in Redemption Value",
        "negatedLabel": "Redeemable noncontrolling interests fair value and other adjustments",
        "terseLabel": "Fair value and other adjustments"
       }
      }
     },
     "localname": "MinorityInterestChangeInRedemptionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails",
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r428"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Distributions",
        "negatedTerseLabel": "Distributions to nonredeemable noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails",
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromRedemptions": {
     "auth_ref": [
      "r428",
      "r554",
      "r555"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).",
        "label": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests",
        "terseLabel": "Acquisition of redeemable noncontrolling interest shares",
        "verboseLabel": "Redemptions"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromRedemptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails",
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Noncontrolling Interest [Line Items]",
        "terseLabel": "Noncontrolling Interest [Line Items]"
       }
      }
     },
     "localname": "MinorityInterestLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MinorityInterestTable": {
     "auth_ref": [
      "r61",
      "r95",
      "r550",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of noncontrolling interest disclosure which includes the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest [Table]",
        "terseLabel": "Noncontrolling Interest [Table]"
       }
      }
     },
     "localname": "MinorityInterestTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember": {
     "auth_ref": [
      "r235",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities collateralized by real estate mortgage loans (mortgages), issued by non-governmental sponsored enterprises.",
        "label": "Mortgage-backed Securities, Issued by Private Enterprises [Member]",
        "terseLabel": "Non-U.S. Agency Mortgage-Backed Securities [Member]"
       }
      }
     },
     "localname": "MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails",
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails",
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember": {
     "auth_ref": [
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities collateralized by real estate mortgage loans (mortgages), issued by US Government Sponsored Enterprises, such as Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac).",
        "label": "Mortgage-backed Securities, Issued by US Government Sponsored Enterprises [Member]",
        "terseLabel": "U.S. Agency Mortgage-Backed Securities [Member]"
       }
      }
     },
     "localname": "MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails",
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails",
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r173",
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "Nature of Operations [Text Block]"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/DescriptionofBusinessNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Cash flows used for financing activities",
        "verboseLabel": "Cash flows used for financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "terseLabel": "Cash flows used for investing activities",
        "totalLabel": "Cash flows used for investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r114",
      "r117",
      "r120"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "terseLabel": "Cash flows from operating activities",
        "totalLabel": "Cash flows from operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r7",
      "r75",
      "r78",
      "r83",
      "r88",
      "r120",
      "r132",
      "r143",
      "r147",
      "r148",
      "r149",
      "r150",
      "r153",
      "r154",
      "r161",
      "r197",
      "r203",
      "r207",
      "r210",
      "r213",
      "r276",
      "r349",
      "r350",
      "r351",
      "r354",
      "r355",
      "r356",
      "r358",
      "r360",
      "r362",
      "r363",
      "r583",
      "r601",
      "r705",
      "r745"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net earnings",
        "totalLabel": "Net earnings attributable to UnitedHealth Group common shareholders",
        "verboseLabel": "Net earnings attributable to UnitedHealth Group common shareholders"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity",
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
      "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r75",
      "r78",
      "r83",
      "r153",
      "r154",
      "r560",
      "r568"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Earnings attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest": {
     "auth_ref": [
      "r95"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of net income (loss) attributable to nonredeemable noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest",
        "terseLabel": "Net earnings attributable to nonredeemable noncontrolling interest"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNonredeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest": {
     "auth_ref": [
      "r95"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Redeemable Noncontrolling Interest",
        "terseLabel": "Net earnings"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToRedeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest": {
     "auth_ref": [
      "r400",
      "r560",
      "r561"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.",
        "label": "Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest",
        "terseLabel": "Net earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest"
       }
      }
     },
     "localname": "NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Abstract]",
        "terseLabel": "Noncontrolling Interest [Abstract]"
       }
      }
     },
     "localname": "NoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination": {
     "auth_ref": [
      "r429",
      "r545",
      "r562"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from a business combination.",
        "label": "Noncontrolling Interest, Increase from Business Combination",
        "terseLabel": "Acquisition and other adjustments of nonredeemable noncontrolling interests",
        "verboseLabel": "Acquisitions"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromBusinessCombination",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails",
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r140",
      "r141",
      "r142",
      "r428",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interest"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesPayable": {
     "auth_ref": [
      "r24",
      "r694",
      "r736"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.",
        "label": "Notes Payable",
        "terseLabel": "Notes Payable"
       }
      }
     },
     "localname": "NotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesPayableRelatedPartiesClassifiedCurrent": {
     "auth_ref": [
      "r48",
      "r136",
      "r641"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Notes Payable, Related Parties, Current",
        "terseLabel": "Current portion of notes payable to subsidiaries"
       }
      }
     },
     "localname": "NotesPayableRelatedPartiesClassifiedCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesReceivableRelatedPartiesNoncurrent": {
     "auth_ref": [
      "r17",
      "r31",
      "r136",
      "r640"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts due from parties associated with the reporting entity as evidenced by a written promise to pay, due after 1 year (or 1 business cycle).",
        "label": "Notes Receivable, Related Parties, Noncurrent",
        "terseLabel": "Long-term notes receivable from subsidiaries"
       }
      }
     },
     "localname": "NotesReceivableRelatedPartiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of Reportable Segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OpenTaxYear": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax year that remains open to examination under enacted tax laws, in YYYY format.",
        "label": "Open Tax Year",
        "terseLabel": "Open Tax Year"
       }
      }
     },
     "localname": "OpenTaxYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "gYearListItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "terseLabel": "Operating costs"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r197",
      "r203",
      "r207",
      "r210",
      "r213"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Earnings from operations",
        "totalLabel": "Earnings from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r632",
      "r637"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating Lease, Cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r629"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r630",
      "r633"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating Lease, Payments"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r635",
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating Lease, Weighted Average Discount Rate, Percent"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r634",
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating Lease, Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Leased Assets [Line Items]",
        "terseLabel": "Operating Leased Assets [Line Items]"
       }
      }
     },
     "localname": "OperatingLeasedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesFutureLeasePaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r519"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Operating Loss Carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r202",
      "r203",
      "r204",
      "r205",
      "r207",
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r62",
      "r646"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets",
        "verboseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.",
        "label": "Other Commitment",
        "terseLabel": "Other Commitment"
       }
      }
     },
     "localname": "OtherCommitment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentsDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the nature and terms of commitment.",
        "label": "Other Commitments, Description",
        "terseLabel": "Other Commitments, Description"
       }
      }
     },
     "localname": "OtherCommitmentsDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r65",
      "r69",
      "r610",
      "r611",
      "r613"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "terseLabel": "Total foreign currency translation losses"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r76",
      "r79",
      "r81",
      "r82",
      "r84",
      "r89",
      "r421",
      "r614",
      "r619",
      "r620",
      "r706",
      "r746"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income (loss)",
        "totalLabel": "Other comprehensive (loss) income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity",
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive (loss) income:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax": {
     "auth_ref": [
      "r69",
      "r73",
      "r74",
      "r268"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax",
        "negatedLabel": "Gross reclassification adjustment for net realized gains included in net earnings"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax": {
     "auth_ref": [
      "r69",
      "r73",
      "r74",
      "r268"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax",
        "negatedTotalLabel": "Total reclassification adjustment, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax": {
     "auth_ref": [
      "r70",
      "r268"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Tax",
        "terseLabel": "Income tax effect"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r66",
      "r69",
      "r268"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax",
        "terseLabel": "Gross unrealized (losses) gains on investment securities during the period"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r66",
      "r69"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "totalLabel": "Total unrealized (losses) gains, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax": {
     "auth_ref": [
      "r67",
      "r70"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax",
        "negatedLabel": "Income tax effect"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other Current Liabilities [Member]"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/MedicalCostsPayableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other Intangible Assets [Member]"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r14",
      "r15",
      "r54",
      "r646"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other Liabilities, Current",
        "verboseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLongTermDebt": {
     "auth_ref": [
      "r24",
      "r694",
      "r736"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt classified as other.",
        "label": "Other Long-term Debt",
        "terseLabel": "Other Long-term Debt"
       }
      }
     },
     "localname": "OtherLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIDetails",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLongTermDebtCurrent": {
     "auth_ref": [
      "r21",
      "r23"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt classified as other, payable within one year or the operating cycle, if longer.",
        "label": "Other Long-term Debt, Current",
        "terseLabel": "Other Long-term Debt, Current"
       }
      }
     },
     "localname": "OtherLongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Receivables, Net, Current",
        "terseLabel": "Other current receivables",
        "verboseLabel": "Other current receivables, net of allowances of $993 and $1,047"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForLossesAndLossAdjustmentExpense": {
     "auth_ref": [
      "r116",
      "r760"
     ],
     "calculation": {
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid",
        "negatedTotalLabel": "Total medical payments"
       }
      }
     },
     "localname": "PaymentsForLossesAndLossAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r101",
      "r105"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Other, net",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Common share repurchases",
        "negatedTerseLabel": "Common stock repurchases"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period for redemption of redeemable noncontrolling interests.",
        "label": "Payments for Repurchase of Redeemable Noncontrolling Interest",
        "negatedTerseLabel": "Purchases of redeemable noncontrolling interest"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfRedeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r109"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedTerseLabel": "Cash dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedTerseLabel": "Cash dividends paid",
        "terseLabel": "Payments of Ordinary Dividends, Common Stock"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ShareholdersEquityDividendsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Cash paid for acquisitions, net of cash assumed",
        "negatedTerseLabel": "Cash paid for acquisitions"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedLabel": "Purchases of investments"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchases of property, equipment and capitalized software",
        "terseLabel": "Purchases of property, equipment and capitalized software"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToFundLongtermLoansToRelatedParties": {
     "auth_ref": [
      "r102",
      "r639"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with extending a long-term loan to a related party. Alternate caption: Payments for Advances to Affiliates.",
        "label": "Payments to Fund Long-term Loans to Related Parties",
        "terseLabel": "Issuances of notes to subsidiaries"
       }
      }
     },
     "localname": "PaymentsToFundLongtermLoansToRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r455",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare": {
     "auth_ref": [
      "r754"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts.",
        "label": "Policyholder Benefits and Claims Incurred, Net, Health",
        "terseLabel": "Medical costs"
       }
      }
     },
     "localname": "PolicyholderBenefitsAndClaimsIncurredHealthCare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r29",
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical",
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical",
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r29",
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical",
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical",
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r29",
      "r646"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PremiumsEarnedNet": {
     "auth_ref": [
      "r703",
      "r744",
      "r755",
      "r791"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      },
      "http://www.uhc.com/role/SegmentFinancialInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.",
        "label": "Premiums Earned, Net",
        "terseLabel": "Premiums",
        "verboseLabel": "Premiums, revenues - unaffiliated customers"
       }
      }
     },
     "localname": "PremiumsEarnedNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r10",
      "r41",
      "r42"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties": {
     "auth_ref": [
      "r100",
      "r639"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with collection, whether partial or full, of long-term loans to a related party. Alternate caption: Proceeds from Advances to Affiliates.",
        "label": "Proceeds from Collection of Long-term Loans to Related Parties",
        "terseLabel": "Repayments of notes to subsidiaries"
       }
      }
     },
     "localname": "ProceedsFromCollectionOfLongtermLoansToRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromContributionsFromAffiliates": {
     "auth_ref": [
      "r108"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from an entity that is affiliated with the entity by means of direct or indirect ownership.",
        "label": "Proceeds from Contributions from Affiliates",
        "terseLabel": "Return of capital to parent company"
       }
      }
     },
     "localname": "ProceedsFromContributionsFromAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIDetails",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from common stock issuances"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "terseLabel": "Proceeds from issuance of long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r99",
      "r100",
      "r234"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale",
        "terseLabel": "Maturities of investments"
       }
      }
     },
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r108",
      "r111"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfCommercialPaper": {
     "auth_ref": [
      "r107",
      "r110",
      "r123"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or cash outflow from issuing (borrowing) and repaying commercial paper.",
        "label": "Proceeds from (Repayments of) Commercial Paper",
        "terseLabel": "(Repayments of) proceeds from short-term borrowings, net",
        "verboseLabel": "(Repayments of) proceeds from commercial paper, net"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfCommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts.",
        "label": "Proceeds from (Repayments of) Related Party Debt",
        "terseLabel": "Proceeds from notes from subsidiary"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfRelatedPartyDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r99",
      "r100",
      "r234"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale of Debt Securities, Available-for-sale",
        "terseLabel": "Sales of investments"
       }
      }
     },
     "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Products"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r7",
      "r75",
      "r78",
      "r83",
      "r113",
      "r132",
      "r143",
      "r153",
      "r154",
      "r197",
      "r203",
      "r207",
      "r210",
      "r213",
      "r276",
      "r349",
      "r350",
      "r351",
      "r354",
      "r355",
      "r356",
      "r358",
      "r360",
      "r362",
      "r363",
      "r551",
      "r559",
      "r561",
      "r568",
      "r569",
      "r583",
      "r601",
      "r713"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net earnings",
        "totalLabel": "Net earnings",
        "verboseLabel": "Net earnings"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r46",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNarrativeDetails",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNotes",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r329",
      "r818",
      "r819",
      "r820"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property, Plant and Equipment Disclosure [Text Block]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNarrativeDetails",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNotes",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r18",
      "r19",
      "r327",
      "r646",
      "r725",
      "r742"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, equipment and capitalized software, net of accumulated depreciation and amortization of $5,992 and $5,230",
        "totalLabel": "Total property, equipment and capitalized software, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation": {
     "auth_ref": [],
     "calculation": {
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails": {
       "order": 5.0,
       "parentTag": "unh_PropertyPlantandEquipmentExcludingCapitalizedComputerSoftwareNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation of long-lived, physical assets used to produce goods and services and not intended for resale, classified as other.",
        "label": "Property, Plant and Equipment, Other, Accumulated Depreciation",
        "negatedTerseLabel": "Less accumulated depreciation"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentOtherAccumulatedDepreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r45",
      "r327",
      "r818",
      "r819"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, Plant and Equipment, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r18",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property, Plant and Equipment [Table Text Block]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r18",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNarrativeDetails",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNotes",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Useful Life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r224",
      "r228",
      "r229",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Receivable [Policy Text Block]"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "auth_ref": [
      "r398",
      "r399",
      "r401",
      "r402"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount",
        "periodEndLabel": "Redeemable Noncontrolling Interest, end of period",
        "periodStartLabel": "Redeemable noncontrolling interest, beginning of period",
        "terseLabel": "Redeemable noncontrolling interests"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails",
      "http://www.uhc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity.",
        "label": "Redeemable Noncontrolling Interest [Table Text Block]",
        "terseLabel": "Redeemable Noncontrolling Interest [Table Text Block]"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedLabel": "Repayments of long-term debt",
        "negatedTerseLabel": "Repayments of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock [Member]"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/ShareBasedCompensationRestrictedShareActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs) [Member]"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r34",
      "r428",
      "r492",
      "r646",
      "r738",
      "r781",
      "r786"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings",
        "verboseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r140",
      "r141",
      "r142",
      "r144",
      "r152",
      "r154",
      "r281",
      "r489",
      "r490",
      "r491",
      "r529",
      "r530",
      "r581",
      "r777",
      "r779"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r188",
      "r189",
      "r202",
      "r208",
      "r209",
      "r216",
      "r217",
      "r220",
      "r432",
      "r433",
      "r681"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      },
      "http://www.uhc.com/role/SegmentFinancialInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue from Products and Services",
        "verboseLabel": "Revenue from Products and Services - unaffiliated customers"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r126",
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue [Policy Text Block]"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r86",
      "r132",
      "r188",
      "r189",
      "r202",
      "r208",
      "r209",
      "r216",
      "r217",
      "r220",
      "r276",
      "r349",
      "r350",
      "r351",
      "r354",
      "r355",
      "r356",
      "r358",
      "r360",
      "r362",
      "r363",
      "r601",
      "r713"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      },
      "http://www.uhc.com/role/SegmentFinancialInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Total revenues",
        "totalLabel": "Total revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
      "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
      "http://www.uhc.com/role/ScheduleICondensedStatementofComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility [Member]"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r178",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Revenue Benchmark"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the characteristics, including initial carrying value, residual amount, weighted average useful life, of finite-lived intangible assets acquired during the period by major class. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.",
        "label": "Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]",
        "terseLabel": "Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r57",
      "r137",
      "r392",
      "r394",
      "r422",
      "r425",
      "r426",
      "r427",
      "r623",
      "r624",
      "r627",
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "verboseLabel": "Short-Term Borrowings and Long-Term Debt [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r584",
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "verboseLabel": "Financial Assets and Liabilities, Measured at Fair Value Recurring Basis [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/FairValueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period.",
        "label": "Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r311",
      "r317",
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsAmortizationExpenserelatingtoIntangibleAssetsDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsWeightedaverageusefullivesassignedtofinitelivedintangibleassetsacquiredinbusinesscombinationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r306",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsNotes",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r306",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Investments [Line Items]",
        "terseLabel": "Schedule of Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails",
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails",
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInvestmentsTable": {
     "auth_ref": [
      "r795"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A container table for all schedule of investment items. It ties in the \"Legal Entity [Axis]\" to all of its contained line items.",
        "label": "Schedule of Investments [Table]",
        "terseLabel": "Schedule of Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails",
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails",
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r762"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.",
        "label": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]",
        "terseLabel": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Schedule of Maturities of Long-term Debt [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ScheduleITables",
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOperatingLeasedAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of long-lived, depreciable assets that are subject to a operating lease agreements and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Schedule of Operating Leased Assets [Table]",
        "terseLabel": "Schedule of Operating Leased Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfOperatingLeasedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesFutureLeasePaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r46",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesUsefullivesforpropertyequipmentandcapitalizedsoftwareDetails",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNarrativeDetails",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareNotes",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwarePropertyPlantandEquipmentTableDetails",
      "http://www.uhc.com/role/PropertyPlantandCapitalizedSoftwareTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r86",
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r197",
      "r200",
      "r206",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r197",
      "r200",
      "r206",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "verboseLabel": "Segment Financial Information [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": {
     "auth_ref": [
      "r468",
      "r472",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Activity [Table Text Block]",
        "terseLabel": "Other Share-Based Compensation Data [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r455",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails",
      "http://www.uhc.com/role/ShareBasedCompensationRestrictedShareActivityDetails",
      "http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails",
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r460",
      "r472",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Stock Option Activity [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Restricted Share Activity [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTextBlock": {
     "auth_ref": [
      "r28",
      "r29",
      "r30",
      "r397",
      "r404",
      "r405",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information.  Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.",
        "label": "Schedule of Stock by Class [Table Text Block]",
        "terseLabel": "Share Repurchase Activity"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r184",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r202",
      "r203",
      "r204",
      "r205",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r213",
      "r220",
      "r330",
      "r331",
      "r768"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsNotes",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r184",
      "r186",
      "r187",
      "r197",
      "r201",
      "r207",
      "r211",
      "r212",
      "r213",
      "r214",
      "r216",
      "r219",
      "r220",
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "verboseLabel": "Segment Financial Information [Text Block]"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/SegmentFinancialInformationDetails",
      "http://www.uhc.com/role/SegmentFinancialInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Operating costs"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Services"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation",
        "verboseLabel": "Share-based compensation expense, before tax"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement, Noncash Expense [Abstract]",
        "terseLabel": "Share-based Payment Arrangement, Noncash Expense [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate": {
     "auth_ref": [
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount rate from fair value on offering date that participants pay for shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "verboseLabel": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationRestrictedShareActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Weighted-average grant date fair value per share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails",
      "http://www.uhc.com/role/ShareBasedCompensationRestrictedShareActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Nonvested at end of period",
        "periodStartLabel": "Nonvested at beginning of period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationRestrictedShareActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationRestrictedShareActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Nonvested at end of period, Weighted-Average Grant Date Fair Value per Share",
        "periodStartLabel": "Nonvested at beginning of period, Weighted-Average Grant Date Fair Value per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationRestrictedShareActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationRestrictedShareActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r474"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Total fair value of restricted shares vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested, Weighted Average Grant Date Fair Value per share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationRestrictedShareActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected Volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "verboseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails",
      "http://www.uhc.com/role/ShareBasedCompensationRestrictedShareActivityDetails",
      "http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails",
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "verboseLabel": "Exercisable at end of period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "verboseLabel": "Exercisable at end of period, Weighted-Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r474"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Total intrinsic value of stock options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeitures, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedTerseLabel": "Forfeitures"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average grant date fair value of shares granted, per share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r483"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "verboseLabel": "Outstanding at end of period, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r462",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding at the end of the period",
        "periodStartLabel": "Outstanding at the beginning of the period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding at end of period, Weighted-Average Exercise Price",
        "periodStartLabel": "Outstanding at beginning of period, Weighted-Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r475"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "verboseLabel": "Vested and expected to vest end of period, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "verboseLabel": "Vested and expected to vest, end of period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "verboseLabel": "Vested and expected to vest end of period, Weighted-Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r453",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails",
      "http://www.uhc.com/role/ShareBasedCompensationRestrictedShareActivityDetails",
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "verboseLabel": "Exercised, Weighted-Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted, Weighted-Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r455",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Share-based Payment Arrangement [Policy Text Block]"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Plan Award, Options, Award Exercisable Period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r478",
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected Life in years"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r483"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "verboseLabel": "Exercisable at end of period, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Exercisable at end of period, Weighted Average Remaining Contractual Term (in years)",
        "verboseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails",
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Outstanding at end of period, Weighted Average Remaining Contractual Term (in years)",
        "verboseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails",
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Vested and expected to vest end of period, Weighted Average Remaining Contractual Term (in years)",
        "verboseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationShareBasedCompensationPrincipalFairValueAssumptionsDetails",
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock": {
     "auth_ref": [
      "r794"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for insurance products considered to be short-duration contracts because the contract provides insurance protection for a fixed period of short duration and enables the insurer to cancel the contract or to adjust the provisions of the contract at the end of any contract period, such as adjusting the amount of premiums charged or coverage provided, and on contracts on which amounts are paid but insurance risk is not transferred.",
        "label": "Short-Duration Insurance and Deposit Contracts [Text Block]",
        "terseLabel": "Medical Costs Payable"
       }
      }
     },
     "localname": "ShortDurationInsuranceAndDepositContractsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-term Debt, Type [Axis]",
        "terseLabel": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-term Debt, Type [Domain]",
        "terseLabel": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r22",
      "r698",
      "r699",
      "r733"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-term Investments",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsAccidentYear2015Member": {
     "auth_ref": [
      "r766"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accident year 2015 in which a covered event occurs under the terms of the short-duration insurance contract.",
        "label": "Short-duration Insurance Contracts, Accident Year 2015 [Member]",
        "terseLabel": "Short-duration Insurance Contracts, Accident Year 2020 [Member]"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsAccidentYear2015Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member": {
     "auth_ref": [
      "r766"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accident year 2016 in which a covered event occurs under the terms of the short-duration insurance contract.",
        "label": "Short-duration Insurance Contracts, Accident Year 2016 [Member]",
        "terseLabel": "Short-duration Insurance Contracts, Accident Year 2021 [Member]"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsAccidentYear2016Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsAccidentYearAxis": {
     "auth_ref": [
      "r766"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by accident year in which a covered event occurs under the terms of the short-duration insurance contract.",
        "label": "Short-duration Insurance Contracts, Accident Year [Axis]",
        "terseLabel": "Short-duration Insurance Contracts, Accident Year [Axis]"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsAccidentYearAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsAccidentYearDomain": {
     "auth_ref": [
      "r766"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accident year in which a covered event occurs under the terms of the short-duration insurance contract.",
        "label": "Short-duration Insurance Contracts, Accident Year [Domain]",
        "terseLabel": "Short-duration Insurance Contracts, Accident Year [Domain]"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsAccidentYearDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet": {
     "auth_ref": [
      "r765"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reinsurance, of paid claims and allocated claim adjustment expense used in claims development for short-duration insurance contracts. Excludes unallocated claim adjustment expense.",
        "label": "Short-duration Insurance Contracts, Cumulative Paid Claims and Allocated Claim Adjustment Expense, Net",
        "negatedTerseLabel": "Net Cumulative Medical Payments"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet": {
     "auth_ref": [
      "r764"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Undiscounted amount, after reinsurance, of incurred claims and allocated claim adjustment expense used in claims development for short-duration insurance contracts. Excludes unallocated claim adjustment expense.",
        "label": "Short-duration Insurance Contracts, Incurred Claims and Allocated Claim Adjustment Expense, Net",
        "terseLabel": "Net Incurred Medical Costs"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet": {
     "auth_ref": [
      "r766",
      "r767"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Undiscounted amount, after reinsurance, of the liability for unpaid claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense.",
        "label": "Short-duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net",
        "terseLabel": "Total Medical costs payable"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented": {
     "auth_ref": [
      "r766"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Undiscounted amount, after reinsurance, of the liability for unpaid claims and allocated claim adjustment expense for short-duration insurance contracts for accident years not separately presented in claim development information. Excludes unallocated claim adjustment expense.",
        "label": "Short-duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net, Not Separately Presented",
        "terseLabel": "Net remaining outstanding liabilities prior to 2020"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock": {
     "auth_ref": [
      "r767"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for the reconciliation of claims development to the liability for unpaid claims and claim adjustment expense for short-duration insurance contracts.",
        "label": "Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Table Text Block]",
        "terseLabel": "Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Table Text Block]"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit": {
     "auth_ref": [
      "r502"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the unrecognized tax benefit of a position taken for which it is reasonably possible that the total amount thereof will significantly increase or decrease within twelve months of the balance sheet date.",
        "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit",
        "terseLabel": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit"
       }
      }
     },
     "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State [Member]"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r6",
      "r184",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r202",
      "r203",
      "r204",
      "r205",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r213",
      "r220",
      "r306",
      "r328",
      "r330",
      "r331",
      "r768"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillbyReportingSegmentDetails",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsNotes",
      "http://www.uhc.com/role/SegmentFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r28",
      "r29",
      "r30",
      "r129",
      "r132",
      "r158",
      "r159",
      "r160",
      "r162",
      "r164",
      "r170",
      "r171",
      "r172",
      "r276",
      "r349",
      "r354",
      "r355",
      "r356",
      "r362",
      "r363",
      "r406",
      "r407",
      "r410",
      "r414",
      "r421",
      "r601",
      "r845"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical",
      "http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails",
      "http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r60",
      "r81",
      "r82",
      "r83",
      "r140",
      "r141",
      "r142",
      "r144",
      "r152",
      "r154",
      "r169",
      "r281",
      "r421",
      "r428",
      "r489",
      "r490",
      "r491",
      "r529",
      "r530",
      "r581",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r620",
      "r777",
      "r778",
      "r779",
      "r887"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesRedeemableNoncontrollingInterestsDetails",
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables",
      "http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical",
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity",
      "http://www.uhc.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
      "http://www.uhc.com/role/DescriptionofBusinessNotes",
      "http://www.uhc.com/role/InvestmentsTables",
      "http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails",
      "http://www.uhc.com/role/MedicalCostsPayableNarrativeDetails",
      "http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r140",
      "r141",
      "r142",
      "r169",
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesNotes",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies",
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesTables",
      "http://www.uhc.com/role/ConsolidatedBalanceSheetParenthetical",
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity",
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations",
      "http://www.uhc.com/role/DescriptionofBusinessNotes",
      "http://www.uhc.com/role/InvestmentsTables",
      "http://www.uhc.com/role/MedicalCostsPayableIncurredandPaidMedicalCostDevelopmentDetails",
      "http://www.uhc.com/role/MedicalCostsPayableNarrativeDetails",
      "http://www.uhc.com/role/ScheduleIBalanceSheetDocumentDetails",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance": {
     "auth_ref": [
      "r739",
      "r789"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of statutory capital and surplus (stockholders' equity) as of the balance sheet date using prescribed or permitted statutory accounting practices (rather than GAAP, if different) of the state or country.",
        "label": "Statutory Accounting Practices, Statutory Capital and Surplus, Balance",
        "terseLabel": "Statutory Accounting Practices, Statutory Capital and Surplus, Balance"
       }
      }
     },
     "localname": "StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired": {
     "auth_ref": [
      "r790"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of statutory capital required to be maintained as of the balance sheet date under prescribed or permitted statutory accounting practices.",
        "label": "Statutory Accounting Practices, Statutory Capital and Surplus Required",
        "terseLabel": "Statutory Accounting Practices, Statutory Capital and Surplus Required"
       }
      }
     },
     "localname": "StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r29",
      "r30",
      "r421",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Number of shares purchased"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationOtherShareBasedCompensationDataDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r29",
      "r30",
      "r421",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuances of common stock, and related tax effects (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r29",
      "r30",
      "r421",
      "r428",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Exercised"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r29",
      "r30",
      "r421",
      "r428"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuances of common stock, and related tax effects"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r29",
      "r30",
      "r428",
      "r454",
      "r473"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.",
        "label": "Stock Repurchase Program, Number of Shares Authorized to be Repurchased",
        "terseLabel": "Stock Repurchase Program, Number of Shares Authorized to be Repurchased"
       }
      }
     },
     "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The remaining number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.",
        "label": "Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased",
        "terseLabel": "Board authorized shares remaining"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
     "auth_ref": [
      "r29",
      "r30",
      "r421",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased and retired during the period.",
        "label": "Stock Repurchased and Retired During Period, Shares",
        "negatedLabel": "Common share repurchases (in shares)",
        "terseLabel": "Common shares repurchases, shares"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity",
      "http://www.uhc.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": {
     "auth_ref": [
      "r29",
      "r30",
      "r421",
      "r428"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).",
        "label": "Stock Repurchased and Retired During Period, Value",
        "negatedTerseLabel": "Common share repurchases",
        "verboseLabel": "Common share repurchases"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity",
      "http://www.uhc.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r30",
      "r36",
      "r37",
      "r132",
      "r227",
      "r276",
      "r601",
      "r646"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "terseLabel": "Total UnitedHealth Group shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ScheduleICondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r2",
      "r3",
      "r82",
      "r132",
      "r140",
      "r141",
      "r142",
      "r144",
      "r152",
      "r276",
      "r281",
      "r428",
      "r489",
      "r490",
      "r491",
      "r529",
      "r530",
      "r549",
      "r550",
      "r567",
      "r581",
      "r601",
      "r614",
      "r615",
      "r620",
      "r778",
      "r779",
      "r887"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedBalanceSheets",
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r130",
      "r407",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r420",
      "r428",
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders' Equity Note Disclosure [Text Block]"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareholdersEquityNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventDescription": {
     "auth_ref": [
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the event or transaction that occurred between the balance sheet date and the date the financial statements are issued or available to be issued.",
        "label": "Subsequent Event, Description",
        "terseLabel": "Subsequent Event, Description"
       }
      }
     },
     "localname": "SubsequentEventDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r621",
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r621",
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r621",
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of unrecognized tax benefits for which a material change is reasonably possible in the next twelve months, typically including the nature of the uncertainty, the event(s) that could cause a material change, and an estimate of the range of the reasonably possible change or a statement that an estimate of the range cannot be made. An unrecognized tax benefit is the difference between a tax position taken in a tax return and the amounts recognized in the financial statements for which it is more likely than not, based on the technical merits of the position, that the tax position will not be sustained upon examination.",
        "label": "Summary of Positions for which Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table Text Block]",
        "terseLabel": "Summary of Positions for which Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table Text Block]"
       }
      }
     },
     "localname": "SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental cash flow disclosures"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.uhc.com/role/ScheduleIStatementofCashFlowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r759"
     ],
     "calculation": {
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.",
        "label": "Current Year Claims and Claims Adjustment Expense",
        "terseLabel": "Current year"
       }
      }
     },
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r759"
     ],
     "calculation": {
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.",
        "label": "Prior Year Claims and Claims Adjustment Expense",
        "terseLabel": "Prior years"
       }
      }
     },
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/MedicalCostsPayableRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "auth_ref": [
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by specific tax credit related to an unused tax credit.",
        "label": "Tax Credit Carryforward [Axis]",
        "terseLabel": "Tax Credit Carryforward [Axis]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardExpirationDate": {
     "auth_ref": [
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expiration date of the tax credit carryforward, in YYYY-MM-DD format.",
        "label": "Tax Credit Carryforward, Expiration Date",
        "terseLabel": "Tax Credit Carryforward, Expiration Date"
       }
      }
     },
     "localname": "TaxCreditCarryforwardExpirationDate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "auth_ref": [
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the tax credit carryforward.",
        "label": "Tax Credit Carryforward, Name [Domain]",
        "terseLabel": "Tax Credit Carryforward, Name [Domain]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about the period subject to enacted tax laws.",
        "label": "Tax Period [Axis]",
        "terseLabel": "Tax Period [Axis]"
       }
      }
     },
     "localname": "TaxPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails",
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails",
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails",
      "http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails",
      "http://www.uhc.com/role/IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails",
      "http://www.uhc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identified tax period.",
        "label": "Tax Period [Domain]",
        "terseLabel": "Tax Period [Domain]"
       }
      }
     },
     "localname": "TaxPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxReconciliationofthetaxprovisionattheUSFederalStatutoryRateDetails",
      "http://www.uhc.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails",
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails",
      "http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails",
      "http://www.uhc.com/role/IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails",
      "http://www.uhc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxesExcludingIncomeAndExciseTaxesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes, Miscellaneous [Abstract]",
        "terseLabel": "Current Provision:"
       }
      }
     },
     "localname": "TaxesExcludingIncomeAndExciseTaxesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesReconciliationofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TrademarksAndTradeNamesMember": {
     "auth_ref": [
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trademarks and Trade Names [Member]",
        "terseLabel": "Trademarks and Trade Names [Member]"
       }
      }
     },
     "localname": "TrademarksAndTradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsGrosscarryingvalueaccumulatedamortizationandnetcarryingvalueofintangibleassetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r254",
      "r258",
      "r270",
      "r271",
      "r272",
      "r390",
      "r419",
      "r572",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesNotMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/FairValueNarrativeDetails",
      "http://www.uhc.com/role/InvestmentsAmortizedCostandFairValueofAvailableforSaleDebtSecuritiesbyContractualMaturityDetails",
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails",
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "verboseLabel": "Common share repurchases, average price per share"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r143",
      "r144",
      "r145",
      "r146",
      "r155",
      "r231",
      "r232",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r348",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r527",
      "r528",
      "r529",
      "r530",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r638",
      "r683",
      "r684",
      "r685",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesDetails",
      "http://www.uhc.com/role/ConsolidatedStatementsofChangesinEquity",
      "http://www.uhc.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USStatesAndPoliticalSubdivisionsMember": {
     "auth_ref": [
      "r439",
      "r792"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bonds or similar securities issued by state, city, or local US governments or the agencies operated by state, city, or local governments. Debt securities issued by state governments may include bond issuances of US state authorities including, for example, but not limited to, housing authorities, dormitory authorities, and general obligations while debt securities issued by political subdivisions of US states would include, for example, debt issuances by county, borough, city, or municipal governments.",
        "label": "US States and Political Subdivisions Debt Securities [Member]",
        "terseLabel": "State and Municipal Obligations [Member]"
       }
      }
     },
     "localname": "USStatesAndPoliticalSubdivisionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails",
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasuryAndGovernmentMember": {
     "auth_ref": [
      "r439",
      "r714",
      "r792"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac).",
        "label": "US Treasury and Government [Member]",
        "terseLabel": "U.S. Government and Agency Obligations [Member]"
       }
      }
     },
     "localname": "USTreasuryAndGovernmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/FairValueFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.uhc.com/role/InvestmentsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeThatIndividualSecuritiesHaveBeeninaContinuousUnrealizedLossPositionDetails",
      "http://www.uhc.com/role/InvestmentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy": {
     "auth_ref": [
      "r757",
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for estimating the ultimate cost of settling insurance claims relating to insured events that have occurred on or before a particular date (ordinarily, the statement of financial position date). The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claims adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.",
        "label": "Unpaid Policy Claims and Claims Adjustment Expense, Policy [Policy Text Block]",
        "terseLabel": "Medical Costs and Medical Costs Payable [Policy Text Block]"
       }
      }
     },
     "localname": "UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of unrealized gains and losses on investments.",
        "label": "Unrealized Gain (Loss) on Investments [Table Text Block]",
        "terseLabel": "Short-Term and Long-Term Investments [Table Text Block]"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInvestmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r495",
      "r505"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Gross unrecognized tax benefits, end of period",
        "periodStartLabel": "Gross unrecognized tax benefits, beginning of period"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r506"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedTerseLabel": "Prior year tax positions, gross decreases"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r508"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "negatedTerseLabel": "Settlements"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r501"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r501"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense",
        "terseLabel": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r507"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Current year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r506"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Prior year tax positions, gross increases"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r509"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedTerseLabel": "Statute of limitations lapses"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesReconciliationofthebeginningandendingamountofunrecognizedtaxbenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r510"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnsecuredDebtCurrent": {
     "auth_ref": [
      "r21",
      "r692",
      "r735"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the portion of long-term, uncollateralized debt obligations due within one year or the normal operating cycle, if longer.",
        "label": "Unsecured Debt, Current",
        "terseLabel": "Unsecured Debt, Current"
       }
      }
     },
     "localname": "UnsecuredDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnsecuredLongTermDebt": {
     "auth_ref": [
      "r57"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of uncollateralized debt obligation (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Unsecured Long-term Debt, Noncurrent",
        "terseLabel": "Unsecured Long-term Debt, Noncurrent"
       }
      }
     },
     "localname": "UnsecuredLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r174",
      "r175",
      "r176",
      "r177",
      "r180",
      "r181",
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/BasisofPresentationUsesofEstimatesandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShortTermBorrowingsandLongTermDebtMaturitiesofcommercialpaperandlongtermdebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]",
        "terseLabel": "Vesting [Axis]"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]",
        "terseLabel": "Vesting [Domain]"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r164"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
        "terseLabel": "Dilutive effect of common share equivalents"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r157",
      "r164"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Diluted weighted-average number of common shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r156",
      "r164"
     ],
     "calculation": {
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic weighted-average number of common shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.uhc.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3095-108585"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3098-108585"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(b))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(11))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8475-108599"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953401-111524"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL6283291-111563"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(25))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(3)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(4)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269825-111563"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269825-111563"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269825-111563"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269825-111563"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27337-111563"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27357-111563"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117546-209714"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL82887624-210437"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922890-210455"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(3)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "16(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "705",
   "URI": "http://asc.fasb.org/topic&trid=2122478"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)-(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-04(Schedule I))",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=120391182&loc=d3e5864-122674"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=124434304&loc=d3e36027-109320"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=d3e5283-111683"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613674-111683"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569655-111683"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4616395-111683"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28129-110885"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123341672&loc=SL77916155-209984"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/subtopic&trid=2176304"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(17))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.12)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(c))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123398031&loc=d3e60009-112784"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62586-112803"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62586-112803"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62586-112803"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(d)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62586-112803"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(d)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/subtopic&trid=2209399"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123599846&loc=d3e56-158367"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(c))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL34724391-108580"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.5)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120401096&loc=d3e574992-122915"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=35755530&loc=d3e11264-158415"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14754-158437"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(cc)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14784-158437"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671311-158438"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671311-158438"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671311-158438"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671315-158438"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=122147696&loc=SL65671395-207642"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "40",
   "Subparagraph": "(SAB TOPIC 5.W)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=27015833&loc=d3e570705-122907"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "40",
   "Subparagraph": "(SAB Topic 5.W)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=27015833&loc=d3e570705-122907"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6486098&loc=d3e24708-158529"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6486098&loc=d3e24708-158529"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Subparagraph": "(c)(3)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "944",
   "URI": "http://asc.fasb.org/topic&trid=2303980"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611133-123010"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12.Column B)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611133-123010"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14.Column B)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611322-123010"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "http://asc.fasb.org/subtopic&trid=2324412"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128487-111756"
  },
  "r837": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r838": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r839": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r840": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r841": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r842": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r843": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r844": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r845": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r846": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r847": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r848": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r849": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r850": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r851": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r852": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403"
  },
  "r853": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r854": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r855": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r856": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29"
  },
  "r857": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "04"
  },
  "r858": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column B",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r859": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column C",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r860": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column D",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r861": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column E",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r862": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column F",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r863": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column G",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r864": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column H",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r865": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column I",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r866": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "04"
  },
  "r867": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "01"
  },
  "r868": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "02"
  },
  "r869": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(ii)",
   "Subsection": "01"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r870": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)",
   "Subsection": "01"
  },
  "r871": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "01"
  },
  "r872": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "02"
  },
  "r873": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "01"
  },
  "r874": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "02"
  },
  "r875": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(C)",
   "Subsection": "02"
  },
  "r876": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "01"
  },
  "r877": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "02"
  },
  "r878": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "i",
   "Publisher": "SEC",
   "Section": "3",
   "Subsection": "10"
  },
  "r879": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "c",
   "Publisher": "SEC",
   "Section": "5",
   "Subparagraph": "Schedule I",
   "Subsection": "04"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r880": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "c",
   "Publisher": "SEC",
   "Section": "7",
   "Subparagraph": "Schedule II",
   "Subsection": "05"
  },
  "r881": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "9",
   "Subsection": "06"
  },
  "r882": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r883": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r884": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r885": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r886": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r887": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3151-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>138
<FILENAME>0000731766-22-000008-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000731766-22-000008-xbrl.zip
M4$L#!!0    ( $2&3U2WPOVN17<$ 'K>-0 0    =6YH+3(P,C$Q,C,Q+FAT
M;>R]:W=3Q_*O^_[_*7(X8YQ7JT-?JF\Y6>Q!,+"=C60N!I;])J.ZN]J6D666
M)(/M3[^K91M;A"08"ULRDP1\D>:<DNJ95;^J[J[^]7\=[0]_^D#CR>!@].][
MZF=Y[Z?_]>#7_T>(__SV\ME/:P?Y<)]&TY\>C0FG5'[Z.)CN_O2VT.3=3W5\
ML/_3VX/QN\$'%&)VS*.#]\?CP<[N]"<MM?[LP?$OWFH9HT>A7*D"#%@15#%"
M2XO&&$<UV'_M_"(EAJ@M"I.=$Y"PB!#Y:<%A-0%RK4K]J_RB<RY18HZ $?A;
M3 934N0P99!HVV5WI_SN^!V.)K\<CG;_?6]W.GW_R_W['S]^_/EP-_^<#_;O
M\RM52AMU[^QY@Z.YIQVE\?#G@_$./T^9^X/1<#"B]M&</ST?'(ZFX^-/Q\R>
M/Z'\\\[!A_MG#\ZN<7X G^#=7UU!FOOMX803.GOZW#,_FMGS5(SQ_E%[:Q>O
M>?KE4UZ\WOO3,8XF]6"\CU,V=7M)4D@ME#X_2:'!E]\%/S![!_^%\Z<>309?
M>F'\!M3]__2>O<J[M(]B,)I,<93ITU%\TL'?O/4_/?]/']7<!] >/7_J9'SQ
M 52<I-G3^)>SURVD$I?M.Q7\SN;.>_Y._^[C4E;(<.D\AQ.Q@_C^SY<]>^ +
MEVYOMWSV(9^]>W?_],%/KW)R %KYO_NT3I\Q.^"7(8YV_GV/1N+UJWM,/6%Y
M\.L^3?&G=KB@_QX./OS[WJ.#T93O9;%Y_)X_XWSZT[_O3>EH>G]&T_T'__,_
M__/K=# =T@.^7<3YK?'K_=/?_7K_],SIH!P_^+4,/OPTF1X/Z=_WRF#R?HC'
MOXP.1L37'QS]TIY(X]-O!Z70:/8M/]YG?S(>Y-/+'TU?4OWWO0$FEXWUS@>9
M@3RE$+)V4H=B9#)0_UAK+T7R?^+B=AWA?KLT#7YYR"ZJ-#?U9(@[]WX:%#YE
M,6^.T]K!AV?ZY8<MTSLL>X\_;#^->QM[O^]MZ1>V]_3)WL;FRUW^N[>]-MS=
MVNOO;NVO'VUO;O/7GNP]?:R>F?YPZ^3@>$OWWVUL_K:[=?).;FWR7SY^Z^WZ
MR=;;WP>]MZ\U?]WKK_VVVW\3Y#.]?;SU-KOMO<>J=Y)M3[\^VMI_;/I/GPRW
MWSX&/NYC?V^XV^/?]4Y>2'[L0WGZ9)">ON9C,O2?]H[[>DMNK[VV_:=;MK^_
M;OBXX][)^DF?7V-//S[>?KM^=LP;OI8=;6^^W^^?[,BM$W[NWLMW?7Z-VWOO
M]-9>&6YMKI_T]GJ:CSO9VOQ]N#4,)\\V'T][K^31L\V'?[BBB%!;X?BF$N"<
M$K'X+(I+*F+.['WEO0<5AQ/Z]?Z<";^G1<_CSI/!).-PBW#\A'\SZ6S[3[:5
M<[;%J$J2U$*M%A"4$1$CQ]54$3/%Z&2^]Z!]_K=FVN=\_H/2&?>KC*LN&S<D
M&22P-HK2LYC*-HBHO.9_$DLDE4RI]MZ#)ULW:-K'(XX3QX_8N&,<KH\*'?T?
M.N[,^D]FU?/^&(K5T0AC?!+@0Q+H* DC@V%-G#3I=.^!Y#_>*._<#9KWT>%X
M/.>3'X_*&F<%]WXZU4E\A:/I+X5_(_;YLKNB8&?]?[2^N6S]""7;V/QT5.RV
MT8 (D(K(EFJLT2 8]MA*WS=_Y;*?C#$WQ?K3X6AP:O;#2;GW&0><A#$\ 15X
M(&<CD0M4=";)J'GYQ_J%^0OEP3Y'_W_?$^X<AC.%^\O#X?#@8U/L3P[&:P>'
M:5H/AP_S+.F9O*1,G/NE(9UA<^^GA@T?[6Z7">@-XG[>?S+:V%^'C;=LA_T>
M]-XR'WR=WOX+8-NQC1X>]_36Q^VWO^_W]K;?/3,O^9I'PXV]K#;67G_L;?;X
M>2]T?_/EL+]9!EOZL=S:>[/7>[J]V]=OAAM\[?-C^%J'V_JUZY^\AO[FPZ/>
MR8[IKVVI_M/7JJ_YO6Z^'/3?]CYN,X/;;U];?I_UE(<9%Q__R 5"K.SI5;;L
M$@([AP0N"/)&:\Z%M-/AWH-HX1R)<P:NP@09*B9K60DE6$5(T=AL;54Y) MI
MQH3LF+A5)DX^,:&D+.RYG:@N2 $Z9);MLHBB0H@IR9P<,A-17H>)[^DG-J:[
M-+X 8M(1\0U$#"YY"60SH2M1("=T FHN DD;X;W+$%-U/C8O$<VR>HF_).*R
MNA@=[HMR,!5G)^]PN1HN%P[$UX21LA;%.!"L.9W @E9(GW5&PR:-P$KC7Q+\
M4KB0S%GCX;#5H-?H_9B?.:O+\?=#:M\\')6'^P?CZ>!D]OOGXX/W-)X>/Q_B
M:,J//?[OX>#]?D?3(FDZON1\?"5"E:6HP19.1CEA2< Q*3OMS"Q2:7WO@?T7
MBY6E<#\=3<M'TX5O"L:#-LFRI+&!Q0U)@5D%43)Z5=CZ*M1&DS9+(6^>#/@:
M]&SP@<KZ:(JCG0&'KX>3"4TGET"[#%3'S:*XZ3^ZY(7 6@#%#BCER*(8@<50
ME$G8X%6L)(TJIG'CC%L&+]1Q<ZO<7/B;F*TJR25!-J$ 7T&$S-]EL!$46,#H
M&C?,UY6X>4[C5[LXIH7PHS_'Y]'!_O[!Z-7T(+][CN.-\:MIP^4-#@_IXL)G
M2,@.B7]&XG(V)3/57(,31J8H@""+X-BIV!0X"LF6<*M[#^3/4BV"B&^+1!T1
M-TE$U6BCC2B23TF E%H$4X+@P&(-6'1H94?$W2?B4@V.@J'LE2"0E5-HPX*5
MT(@JL\U51RWS HGHHL;R$P$I*C"9\]ZBE(#*C@*K!E&IFJ#8*J[DJQ(Q:2:9
M?*?4Y1(-,]-/'AY.=P_&@Q,JG=9<&"*7*R7)(3B2)$A'1L20$ZP\493"0<2[
M(+/V]QZ8?TEYA=SVBXPL*DWI&+EQ1KR2I#*KC)R" ,6^!+7RHLA0E?3:: T=
M(S\B(Q>A)D&TKIHH=&R@<& 1H66OI6; I /ZN" _\MUBS?ID<MCXZ!#X:@0V
M+I>[7#(RNZ0%^IH%I  "6\$TV0PQIE*+C?<>1%A:L;%Q.&TSOLM@M--1\*T4
M)#+(  3AC/5-4%B1-!11T:,&:5+(M @*OENHZ"CX9@HNE3 #,0=6"]LB 7C9
M)(,N(KL()8!3VL]\P14*WS=+01<,K@E @BQUD,(&:-.!V2&$&$D 9"H%*+&M
MK@C HJM3YG,(GH^ITGA,I2M'+(R)RQ,'=76$F@K+ E_8*6@0"5$*0QF53K$X
M'V;EB-NL6794W# 53F'4TL8V1\P(0,V>HG@MLI>^@,\Q1[M *KXM8G14W @5
M%_&C^E)=4D6XC*'-/)<B\DW+,C*B":D@YGIE*KYK.C%/Q)_+#IV2^/K9-YL/
MIY^FG#_\0[N$U9O$!+"$A"*=2*$:D9D0"L;RGW3O@5J6PD('PO<"P9?H0W!6
M8,Y6@",OT'C'J6;P01J?7' + &%1244'PF)!./X$0G55HLZ210)I 3%6@9"4
ML&TP/'M-R=4E!V&NS'"Y)%T'1RR13VA\T!%R)4(>7W85RNNBJ!!GG3(Q(<Z+
MF"*(J!QZ)55;2'[OP?_W_P:M]/^_Q)B<UR$Z0A9-B#>N>.*4HZ;$P:1:%(DR
M1Q298E85:I!I481\3VG1$?*]",FR6AD5"C)6L0\!)9(UV 8_#05?@T&U"H1T
MH>:[8E*J#SY!%B6WS@>RK71SLHK  E6A]]%"%VI^0$(NY"K4) NR(S&A!@$<
M>$2"A,)K';)WI6#\EE#S-Z7/;^FL\'6S]-8&'P:%1F5R?NE'.-E]CH.R++4N
MVW]T!LC>.]O;RPS!B^/^VO:@M_9"]]8>LH'8^/LOU-;;QV9K;\CG?WU\ <A#
MM;6WH_LG6\=;FT_XFB_,QML&V#K_[K=A7_=4[^GO@ZVW+W<_!Z2W]F:PL;9E
M^GN_[_;>OK#]M6RW3G:.MO;XW3]];?@Z'[?V?]_=?OJD+9X^OJB+NRA!%2U*
M,AQG0F4E@II_E-X8CYF@,![V9W>UY45_P4:T+<:0,J8FH,*^2V.1 ,4!_[%A
MQH8\9^-*,S@[-A;$AKR8^ ]*!R^U8$.@ -4F]58IA8I:Y^*U875P[P'\'*ZV
MCOHOV/!0O(TQQ[9(&UQ,E(BD#=5D<J2AL:'B&1LJ_F.5O&-C\6SH3VP4PSAH
M3EZH->AA4#AY0>.$1@\<6DA"6^4*/ZLK=.(8'>XG&G^N.ISSV2 HK XBZ9"\
M:R46 X5*0/T/X62]_^1S,&8$_(83*HS(>QI-9NO)'H['.-JAMI3UM^.+ISS'
MX_:KAQ]Q7-8&DUGSCB?C@_T>CM_1]/EXD&FCLIQA?7O:_^<,**%OEZBCWMJ[
M#]LCMMS) 4N._G#CZ<O]_LGO[[9.7LC>WKK>>+JE>GOO@(]YUVNOY6U_C^6-
MY)\GK6W/]N:.W=IODN(%;&RNRXW-X7Y[71M\C>V]==D_8;ITSVZ?'_.?WW?3
M?AEN[&\/-]:&@^W-X:"_ML,TO[ ;;[<'6WN/^7Q]ED0O3(_IVCH9[O_GY,6%
MF-U[?,SG_$/EF@W())JR%&"!1/(%1,K%D0QL?OS;@OL7NSW)7#5I!L;Z  %S
M*KY")L_:!&*VY6^Z/5V;FMD_;V@R941.6[RI6T:COYG/T>"/_"'TUEZ;WLGN
M8'LOR][)0[NQ]F9_8[,IV?Z 5>F[WLGZ4?\XRNW_[,J\_V:$;^/AQMZZZ:WM
M?.1SG6P\_9W1>G'"R$'_[18?WV,%O,ZJE'^W]]BPF4\V'OY!2:4:^",.%)H2
MK6V.7JF"1:'19+-/;47 <[A2FS8HT=68.3YH@FQ*4,H2&:=5-3$GZBS[?2W+
M86EMYWAC\Z'F\\K^VN,_R!JEK5(BQE3;<L%6N:A1J.)RYOLWI%K^SLQ?M5S]
M>CG&%]8?XV \&SWO$4X.QS.SOQU,=U^/#M*$QK,N+.NC]X>SQDT'HSP8GK9)
MX)\.Q\WY,QR#R6S!\N:L6RZ-)^NCZ<$S^D!#L^QY[1'GK6?<O-_KK64."EMZ
MF\^]\?0Q._[>$9];]_?Z>UM[V[ML]X]\/A8;Y\'BP'! 4+W]U[#]]LV Y8/<
M7MO=W]KL'3-#Q_VW+_>W]UA2;/X^['T>+/8*!X37Q]N;NT/.E_<VUEZ^V^ \
MF+E4' S4]M/M_8VU)[M\[F-F[7+E(\CDT 8CM"'&+"DI.#94$4LTM;JHHXS?
MEM<N-F?I6%M5U@:?6'/&5AME$5);UYIP.)$41I$S5*VL1'1^(:RMA%_;.)QN
MU ZV!<+VXK)C:_68MDB2Z;*<=2<=1<S&"%1!.BLI:N5^',?6P?8=8+OP;&U)
M1' H16;;MRAJ.='257!VY"U*DDAA(;!Y5,D$ )UG<C_':*WF9*P0^[I*]NL]
MVVCW K2'9>]P,FV<39X<C/L'HSH8(8.%P[/>,:/RC)TJ@S8=T.0,R_)P^ND$
M&^,G\T?@W!']S^'L&%P(@Z_GIDM(M,FYMGPO2<$1M8I@<Q'!QQHK4-4)%L*@
MB^C!I(BV!*!<@M.U(BJG779>IZ]W>!V#=X+!"S]853$Z(D?9!%Z DE)@]4E8
MPTY)*Y,U_/-P^Q<+%%['&'*I-BD#WD)HIU/,6 RED)-?4:!XF/][.&!F_J9)
MUEMJ6PTQ5A]HC#OT>D+U</AL4.<;DK?-7GXIA^-CPO$M,[*Q]JE2H;?;^?:W
MCC:>;DG^GO_^SG;*T-_OO]M>VVDCF_S\+7U1GCPP6_K-;G]M1V^\?3/L[[V6
MK5"^\?8U7_?AQZV]]9,>']??>Z&W7OV)D;WMM\SAVI;E\^K^YHN/_?8]O\?>
MVF^#WE[O(U];]]>V=_]SLC[GIW+$T\9'F)4 \$%$;ZHHUMH:DM$ZZ'L/XE6J
M5YJ]$)#DF,BQL4!F)(J6(4HLD6+T7_1('1Q+ \>% Y&LGE5)1LCLC #K0:#,
M7I2 V<102ZYX[X&ZTNXBJE#1JFUN82( *4X&"Y\Y>F=18X#.=2PQ'7/%*C88
M*O*<R5F5.+S$5J?22O!?Z2-6J,!TV"NYC@15,1(FLNM@_Q-834>/.4GF3;G<
MN8[EAN/"=8"IF3V^%RXS(:"A3<%@_>N,SQ"TA*CF)I1_U?8F:#FABT%EWR2O
M"BI@D)8XH9/)UJ\9%NGHN"TZYLI!9 ."1=M2<E8=Q/X#96OD"LGD8%5P-E\U
ML'C45B$Y4*@!:@R:B/5'-J8-FL4O5WXZ.I:&CDN5:1\U2P(4,>>V]X6W(N2H
M14I:Y<(BDM7EE7W'MV^-U-%QVW3,559\-&T'-!(>JVY].JU 9$[8=TA4"FI%
M=^]!N H<WU0T[N!8&C@N7$<!Q\[?25$-D(#<UK%%:P2YG#QK!,LW^]\$EJ^<
MOI5*U*1=H.@J>-:HRDCM:HK55%U#_?+:@B_,VEJC-%T?3:;CV8Z)# R-:3)]
MB5,Z7?O^G,:9'V!:EF<.UL;FUGDA;+?_]@5;X?=W_;U\W.=S;N^U*1/;@^VU
M=W;C;4_VWZ[K-G-O^]$G*NS6_HN3C<ULMS9?Z^U-)FFM3?G^G<_U^N/62:]M
MX=;F<1WU'WU.Q9#/V[/]D^%N?W-[V-M[^:ZWWV];NZGMS=_V>B?O3K8WMV![
M[['\S\G6W.@3"TXGG16)?!!0 \<2A^Q!(H5(A9..-N=3_ZST%?I__\7$OBPE
M6)LT&=8R[*BD,Y12;3E1,=B1<>MD[,P)4:<KZ"@%2PLF@V'@;%:V]O!9Q415
M2ZOO/3 _*WN%J>)?)*,8SX*4:F P8+8NJ:2*H>7)+H.ECHQ;)^/=93*D4YQ;
MVB0BI[*<HF@EV(UX88PJZ+T^;;AE?C;^NCXCA8*M>7#;8P<8!W92'*V4ETP*
MY[:A(^/6R7C\\?(FGJ7=L<8KD;UCD>'1<&!A;2@Q<P(*)I'%%D["M=$(BI4H
M43&JL@YM33\!50[L.8K*J+IPL@1H'%U&(]N<;>&$%2&VZ<#1B6"2$@$4V[#*
ME*)<#!J>#.?"'* 4YRY)Z\#:-GN$TPF$L8LG2X#&\64TH@\5)'C!DB(+",B0
M&$Y>J7(2(6N-/N$LH%Q;:G""[/CT5$)DMQ$X(7$NQRR1*3')V Z-VT?CY#(:
M-@=3'*(@; N>.:*(I$H1Z)/,(:AD:>8UKJ\U J0@$5&SW("$,B9E4PQM55K2
MT9;O@L8_S.SHD/DZ9.2<-X&DJ)(6;1J& ,7_!/8PPCATNH0 2-\R4_S+H<9"
M8$D33$  K5RTSL>H9"I0-;N5SI_</ASJ,AR<._A:LF$DVG*S4K,(.B5A53:(
MI"B>"E1_[5!CH\^!F(J"EH5O987*>6[*DK*%&K^//^G0N!(:^C(:WFCO68:(
M,MM%.OLBHN14QO#MS2J2):K*BQ&H5#BQE3%3-8Z=E8[&QEA8I_KL^"5T:>T2
MH&$NHT%1RJJK%%;.%H0D%!ALVS2QY.*TC(2V"51[E1TGOJQ"@M/!)>-L2A"]
M0EV5(5T#.*R<XG9HW#X:,.<ULO2)% @R+K7E&R#8;%:T=DZZ9E*<W2X&C:H"
MT^"K2S)Q5J20R4M%4C#\-W5#*\N AKU XP5LO/C#!F,IURJ4M9S9@BF";W 2
MEB!95#&:-A%,_FRO+3>RHBS;//=2*L22HR\:-:=*(1-I QT=2T7'PS]J<&A"
MS()3AM):>5D1G;><L% T*"7Y:A>3V1IE2VBR$V."8@PGT*$P>#YD)"=CA\:M
MH[$^5T7/#JV%DD1-*%L&VS8OR$D8#2P*-$FO9S'E^DF*#ZY&97*NR@&""=5R
M0 ,BB%AT\AT:MX_&7!7=6..J#U9(HQ7+C2@%$F>R4958"RL16?T,C6O+#84&
MO"*;"CC@= 4Q*,?!R\F:<M2J0^/VT9BKHAL*V:CL1>;$00!RIA)M=4*FH*TQ
M6JNVKD[]K*\_8!\DL-"HJ$T Z6/4,1FKI.8 XS-VI8TE0&.NB@[D@BZL0#E1
M"9R_ZB1"R4%05CE1(:7]+*"H:WL-RCXK$QD%BQQ&6.$Z=B1$17%LD=IT:-P^
M&I<*HJ\_]E[\H<BD[%(6" $%!.(4UG@M.'NEC)B+]S/'<?V9/JX&Y;.#XK4'
M5UF".BDY]VG;K+#DR!T=MT_'W%B*-IZ=0YIUM>?\5;LBT%8KV$0^F.RE*:XY
M#KA^_HH4DR3PT;+<R!0IR&H@A!@+.MLE*4N QMQ(BBL(Q7+"&A/:-I_8B00R
M")4S69!M3%\O9A:8::4-R1@H(\$GEWQ4D=V(JZ5U$N@*7TN QMQ(BBWLSYTT
MPF,$ =ZS$G46A0HV4LLUK2ZMM!&O[36"51PVJ#4)M1"L#10SJUWRWK:RE^O0
MN'TTYD=2O*'JT(@:#6L-STE*(*\8C1@"4.0[?.8UPK710)\3%-FZXBOV&H2N
M=33FK[GU'79=:6,)T)@;2=&QAFB*%!6#$E"H+9\N3K2E:!)JJ-[,M,8"YH[&
M6HOQB=-BA*BHM9_A;PVH0)93V@Z-VT=CKE8.TK,H]"2RFVWW#H;S5VB;=X82
MLP=6J7%!<T>C5CIDZS55 .-BP,H*1AEPN3(V'1JWCD9OKE;>DE19(PIGD -*
M5BB0BA$.4J@DV6MXT]"0URYMI(B0VGQSQ%8A5TFWA9&S81RHVG5S1Y< C4M5
MK]='_9T_VB"7BB2%MK[U>7)-;K#F<&0,)RH8C9LI47-M.C+8H%T-3(@!UA@1
M36O=HBL#"#[_Q:9*'1TW2<?<2(HU!@DYB' >R8X#I!9MLJ_0)GE.,ZOAW*+M
M:."NO?(QD0[*AI#;-N2GG8HYR$#ROMH$L9,;2X#&W$A*YMLW@8X"B[("8M"L
M1#E=,5$68O>!IFUV87\.U_8:G.T :UY;-2L,J4M*D@-75$5E;QF;#HW;1^-D
M?H%;:^LGK>"\4K/<L"B"@2*R+AQ*G#>AC:2X!4SW:EWGB,\:L@MM@TC4)E=K
M(\5J:Y5=_KH$:,S5RI%3!#2A"([\Q/EKU"U)46T#:1VLU8J(&AK7#R@V)0:A
M1@B%@'U1S,63;15T:;+,W2#;$J"AYJ>6LS<WK:V"PK8L-EJ16LM HN!:EAEJ
M:RCO%I"_8D%)EH(MK84I0<A5*6=4K!Z]S5U!= G0F*N5!U4L<MP0/D(2$%(5
MP7E.4W*;ZLNNP\>\F/G#3JJ(5$--TH.,)G$*)+5/L?4"3ZZ;T+,$:,S5RK/7
MRB*+"[!>"C"VB!B4%J22J]&S4,QJ,6N5$D;TG P7G1S83*BS53D&T,$7-%W5
M:PG0F%]U0"DYH]MBV+95(X 3D1R(7*3WT0=3BVD9RO6G 2:H#E0R3D. 6-E5
M4/*Y5<\SMLE>'1JWC\9<K9PS!FG9'"*9C&T:( A4;>/&&DW;*TV95!H:UQ]\
M92A<,-$6PUY#YAH2RE0PN(+:M5;G'1JWC<:+RP71D][.'TP&ZJ*SJ+&T+APY
M"^1((I13,>9D)2>:36[(ZZ]_S4&KI+U3'L"[%*WRV:24HK)>&]W1<?MTS*\Z
M2-ES5)$BM:FAX%/;&R9$0<96\L$9OM474Q UTG*^&D'9I""KFMJJ:&^KEY4E
M*G1*= G0F*N5M_Y;'I42!=NV0;J<E49=U+9M\1@X>6EH7'^N5\:8VVAOT-:!
M)[Z<BB%#<#) TSP=&K>/QORJ TY0*G!JHJQT ERT C-Y8;5O=0ZP%64+* N8
MZ]5ZZA=7#8<2\,4'*R$:K;,T3KFN@>0RH#'?N\=JHHA!U)+:"D<518(@!09R
MT1/;+]?F-1:P(*6 05>3#\I"9HF3HU*J6,>X9!LZ-)8 C;E:>=7*$[0."J$M
M2$E:B;8]DO#)L#A$R;EM:6A<O[1AO)<.9QWP#6"0B6.+*HF"+!)EMVI^&="8
MJY6;9)U$A4)+%]HTP"P"MOJ7RHILD-*2GGF-ZQ=$D16&SYATXEB55*P!BRO%
M6N\I=1-ZE@&-N5HY&)DU,!7!4FO#$DE@K"0T,!,R!!<S+2:@1'8/)4+0KFB0
MQ87,KJ-FWY8Y4,Q=AK($:,S5RDU![Y+-(J+2G+QF8DA0-SXDABK;[H^+63)/
MUE46,*QL@V>?E-"V-=F<NM906/AVW467 (WY>>6A8(P>A+>Q#;[.=O.N('*U
M+AN=*ZBX&*_!>:M1KE2/N4"U-7J4K#S88]FV@KX+*$N QOR\\K9[FO1>$,M#
MT5ILB52T%6"C-I*S!]NZ*< "EC?:DH%3$W9%44.1)NE8BC%5FA"B_$[=13LT
MKH+&Z[EJ*"<+,6/Q@O,4P\FK-P*S0Y&TS9;MYWRMBVFTP:EK5%:F&%P3,ABU
MHX0A<SPI;=)HA\;MHS%7#<48;%4<1IK=VO+&UH,%V8D4R6X_,!AAUKDI7AN-
MXMD;:949@P F)4Q,(]1$*DD?;3?"M@1H7,I07LO^SA]4C:J6W862BF.*-=!V
M4(G"!])HVI:=;C;"=GVY4=L":%T+Z]$"H=4UHI->5Y^2"L%VDX>7@(ZY6GEP
M"4O *#3?R +8T8O6PESDF%TJG%UBMHM9X=AZIC?::L  R<C8FHA:Q&S(H.TZ
MS"X#&G.U\AR2(S:2( +51MC:CL$@A2)K5&JM#_1L&.5*^W =3LKG&8IU"I6O
MSH< ,GBL%$JT@$!!8OZ+Y%6XS[%X-AC11GTTIC*8_F,7>[?:/!SW3G:.>V_7
M;6]_2_9F&_P]/M[:V^%CUX]Z;]_PZ]E1_;89W^!S'M9/-M;6C[;VWAUO[[W@
M8U[N,T>#C;67^[V]QT?;;]_L;:R]9C:V]'].SEF8;;%DI(K$05]4WWK8UTHB
M^>Q$4<G6:DL@&[ZAA_V?@4!'%5+VK@"#1S5H(,WR(NN8R-!?.(H.B!L 8OTR
M$*U8H2EE#AVM*IYB$2ERNAJ"<8P$6$X=%@($J\S,4@4B>QT(27-<,H5/WGHV
M\04[(&X/B+DMYD-)'#%F+<G9+X!JX^XN.!&3Q.) .<Y&_A&(+V_YFMB]9*@*
M:H228Y#19580*6H";]57[ =\V?A/, ^&@^GQXZ/W@S&VJ[-F&!R4I=W:=258
MF-OW-Z7(RI]C! O(*$ B"JP,1&0_434KP>+]O0>?A,/7[/LKJ7( T-9XS9%!
MRE0,<"ZJK(_L;+SO(%@""+;F'8*K2K>)X&PBCA JLV3PBKV"CJYZE64@5I!7
M@4"[BNA3)E<!LDH(T;1YHD#5FV#*]X2@X'''P%<PD.=V\R7IC <CG$VR=5=B
M1V!4%99"R(8U K2@8!Q<A0++]B[&H(,<(%LV?(TN&A63E45%^144;.+1*0*/
M<#P^9FM_Q'&YP&"-,\EYC5#X-V*?7\6N8!#$[7N$X][:^OF.W\?-<EN;^;C'
MU^F?-.N_/M[8[)UL,QU;FP\U6W>_OSG<^V39S?<#/IZ_Y^ON[1QM/WTM^[I9
M];'F\YCM/29A?^NDKYFBSY/*_?6/G$CN;NDW3,"3=]N-LJ?;NSU^/_V3LL\D
MZ.V]GMG:VX)9$O'H$PW6%FH%!U%JL8(%7!'8ZMBA0@0IG6+E>.^!NJ_NL]VN
MY!BDLU0Y%I2V[6;R"AF--A :(+A6BNJ06"HD+FW=2^1,G6VGQ\D#9&#56-"(
MZ+"2X4=GT_]/D3#^*DAX<#("6&EUFS'!FE$9W79FU:PB2L(.B>5!HG?92[A"
MT1J%(E+)+6:P;LS*"5N3CR;5TQ:O9UY"7P4)E5T)LR&1E  "SA;!<WCB.&1\
MB:Y#8JF0N+3U.Q1K@V]U!O1-2K**+,1Q1">9*?I:C3Q' M0-:XF-]S1B++8Z
MRWZ=9;?F)$$MA#:CT$9KSA1-$!R[VY(?SW+ *8_0EA1+=27?OP YT%GURE:]
ME/];%O=&!5%G2SZCSAS051)*)6TL%>G;N!)_]/*&(WIGU:M9=>?RO9H=:NTK
MBMQ2.% ^MJI.%::$1)7O,5O\[%Z]4C:W@*#<6?7*5KVX5T&GBLD686K;+Y @
M"PPJMAEH4I7@LDPSJ^HKQ55.['-;]>^4)C!)AP0%I$L0R7G0L;/JXO.JC\\V
M'U[TM78&+:$6P;B6:^<L@F_+)!W+'19)4>4XNUFO5(6U4M880I7%%O!&HT)3
M( 5.ZY/3P79F_2YFO;2$C:1E?51;3UE.CHK3G"9%PYK86%WXXZ93O?27=^O7
M+GLM28$"JN0D&,:ERI#;IM$N N=AZ8N&OAA^,Y];_=4NCNDWG%!Y=+#/!$QF
MZ=+#\1A'.]1F<OQV?/&4YWC<?O6PY59/<#!^@\-#>CB9'.Z_;T=-7@XF[YZ,
MB2[/_O@T="=OFZK-%^=5VG?;^^MZZ^3)?N_I^LG&YF/97]M^QX0<]]<>ZJV]
MQZJG>TP(7_<350=ZXVF/K]>#K5:E?;LE-]ZN-Z(^]C>WCOHGZ[#-KVMK[\71
MGZNT6[!UPN_M9'>PS8_S7[NUUXAZJ/I[CTUO;Y>O_6;07WO\^> ^.NDYUEH1
M=&&4;&M9G,B*HC#DD&OF$-$V!9727W,:D+*YK:-.RA7'/JFM<++58^+H'TGJ
M#JO5QVIP4<C).N@V&56B+JPLLA&MJ">,\I*3@ZBKMS.LE+[^C&6MK"2O.1J%
M-GTYI213*;,FA/)T7$B>8R4[K%8.J_Y%&L)>@86,38(=![4U$B0B$++SBJG$
M0E[J,V]U7:PR,V0K%"5-!)?X2MI@<:%UFG(RQ0ZKE<?JTH0F0RDG%80*$%MG
M=FPM#U,;KG;)!.MSA5-O!==>RXF&P3+.*P\9%?LIAUYA)I<D<]6P4O$,*Q;J
M'58KA]7Q11 $E!(-"06MB1$%SL.2(N%C"C[%D"3X4ZRNO8E,R*V?E2V>-$@*
M*&/1U>DHM=7\6(?5JF.U<1$$ ;3B4&=8HYO2>CL'@:RVA"[1V,"QB276#*MK
M]\9:ZDSP\=%[RE,J;PZ&?)HVEZ<#Z\I@K<]/]"XM12/!RKVTQ<D@4G0@O.&P
M137(XG,#2\?KJJNES@4[L!8#UD4V:+,I(=0@?(VM>8I$@3&WM00FL\B6T:MP
M"E:XR]E@!]9"P+J4#SJRH50#@@QDS@<KBN0Y%"KM.#F4BJ6[FH&E[W0^V(&U
M&+ NS4T+R4+;545&S=+=MDWJG?3"R8(4<ZY1^U./=5V-M=0980?68L"ZR DC
M9,F1B<&RE%B\F[9GCR=!P>L AHQO:ROESRI>M]2PU#EA!]9"P+J4%88VY*Z4
M%U$F!HM5M<"@C7 .M"&94[%IYK&4^Q&RPK7!AT&A4>FPNC)6<],O,1K)HMV+
M*I,1C%+S5^1%=H:#%8')+I_6L,SMYH1?Z!?0@;5T8%WDA,4[:]J^VCX2<B8H
MHX@A.\'*VH><DJHU+:8XNA(Y88?5-;"ZE!$":YWL;!5)I895!!%+K4+F&,AG
ML.C]8H9R5B(C[+"Z#E:7%S-BS*S1A6)AWC9]9W6E,O$_/E1K?;3.G6)UW6DR
M*Y$/=EA=!ZOC2X51337Z($Q-U+Q5$6BS%*JU T\A6D9N,=YJ);+!#JMK8'4I
M%ZR.W85421 +9P&E!($L=00E8,T3B$R,IUC]9;W]BU. .;!E8[WS068@3XFI
MTD[J4-AE&:A?,05X!D7Z9V[25;C9I/&^6M+V#2O"SUP/#RLC!;).9(A1@.7T
M+["S$&V/3O91VF<UVV(GL*ZQX"/8]C5<939YM*C DS+L^8"*#UYCD0"<^_$?
M&[ZHGCJ45@.E2WJ<G J)@A6M6PM'.&T$AQX0/CN4K<IN K8= )DLJQ0H:]O7
M*RU,\%"\C3%'[S* BXD2^ST;JF'-Q-'NBZ&M0VE%4+H02RDT0!!$4< :O"UP
MB1Z4*#D$Z4'[TA:'VY_-MWNEVPQP&Z?T;!Q.)U,<E<%HYRT-=G89I(<?:(P[
M])+V<3#BWS_BE]S"]2$.&V.Z8^PZC,VMB"OHC3)D!412 K*5(F49A58VZF)T
M\!;:YN@ZM@U,I0O0OEYI>=P2,/;XB,9Y,,$TI*]DK/-CUV+LW67&/-CJHHNB
M:)E97;DJDI0H8NO5+;.JI<RV(G,Q6C#&A].O5XJ)2P#9&YHTKD;E4SP\:+^Z
MNG_KV+O>W-'YC54IJ9D4DV@XB%IP(GDC102F(!E/A'7FX*36@?6^/?UZP^P]
MWG\_/#@F>D7C#X-,7RXV] ]&'TX9:]1--@^F.+S\^*.#R;1_,-TB?EWY8&<T
M.)FUB!X<E"<'X[-?M>=U?%V/K[FVXE%3..W/$DP58"J(J'P1H?@: N3"CN_>
M _59 )5_U>+CBUUBV8@S(CXK<6D/,1C+7,^V^C1\24<U24W18S3QR]UB]>?L
M,4+[!Z-7TX/\[CF.-\:GO<5G(O_BPDM2F^J?G!-R(+?7VG,?FRT^MK>W(WML
MH8VG+X?;FR]GRXI[^LVP?\+''7\BA)\S'/1;2[]]?M[:"\G7/-G:7)<;FR].
M^FMET'_*7]^^-MM_(N3%4:.I_W1[L/WTS;O^VDM^?WV^[@O;7^O)OFZ=RGMJ
M>[/L?[;@U%=O2S8DBO'0>L5*$4)A0(PUC$/E4'=62;]2Y^"_8$)F2^"31"@&
MLF</!]FYG++3C!Z<;L;YI[&9CHF;8.(BLVN[7ITV!V1?T9H#!M%&6T1,F5.X
MR%D]J*LR,6E&F2S$1?RYH?0E'F;&GSP\G.X>C%N$F6\!-CK<%^5@*LY.MBQ-
MIE<$DKG5"3&T:.&RJ*KMP.D3*Q<;J\@E9TFMU),XLIA_R:OL=/-%2K[-:724
MW!XE%ZY$MO9M52=A$[3.P[K-!(@@9'5!8_ ^$RR&DN_F2]8GD\-&2 ?!%2"8
MF[16V[8BJHVHVE;%86.TA9?L.1!]+EI9E1B""-<-)]_-470(?!L"E_Q 2AH-
M5H$)G6AMB@2RU86Q+GGE@W<H&P)7F Q[LU[@4IVDX^!*'+R8;W$&!: Z(;,Q
MK!HX*0W::I&,BUCY+^7E=@4=!]?@X,(?9 0"RRE&4$8W?Q!%=,6+8HN73BF)
M9*[H#Q9=B?C3')OG8ZHT'E/I$L_%43$WT:'UNTH9V^Z9,@D(T8C6FD%DRAD\
M54]TVOCC-JL1'1<WQ,6EH>8LL1ARG%PR#= VL(BY9N&3A4R)Y264*W/Q7?7#
M/!-_3C>[R'$%%N8:&I>06I,\+Y)O;1=U2"*015$<6%NS]V96T5Z6HD,'PF)!
MN#19M[2-*E(1.9>VF:Z2+:M,PKMHJX^JID0+ .%[>H3SO'*YM\!;$3CF=CN"
M@D535L)HQW $DT5JR^;X&\18;+16?\.>B#?N*CI"%DO(I0PDH2Q52B&AMNEK
M'D6J'$=\1H\N&'"F+(J0[^E#YA+2#I,%8#(W PTK0=4R"N6<$=!VR\)0K2"3
MG8(0+&%>!4?28?(=,+G46Y"%B/.<KU8(LL4;W3K?5%%BMM+)H!'-WV#2?K$[
M*(5.D9G9CT:9)C\=[0]_&>)HY]_W:"1>O[KWX-?A8/3NETG>I7UD;'XZFOT\
M/7[/AIL,]M\/.=,\_=WN>);^CG8_S>OY^6C"/NW7^_.G.+W\Q37/7L+DX' \
M^^DHC8>#7\Y(/27C6^84G9^(1M/!]/C\I[; :#JH QK_-'M!_"YVI]/WO]R_
M__'CQY\GE'_>.?AP_]'Z_^'\CO]XH[QSO][__. 'Y[^:/_O[V?RB\Y_X!AA/
MV[Y0LZ[L0K;_SX^[>.S3RRP73U5:&'5QB=-'SG\^O\C]N0_JBY];H!2!DFS;
M:T#&&%U&&9-1+GMM$IP& NG:'DJW_G$-1LUC3,\^+">,_'2BLT>^[A-H3F_V
M]@]G])W^<I]P<CBF!X/) 6CE?WG]:NW\\/.'SG]NQW_YTPQ05/(L]H,$#R94
M54M5(&O(-LD\^S3982X%?)<^3=W0N^#I&S_-LQ#R^0=ZAO/LP2M_HDQD>Y.A
M+08"<C82N4!%9Y*.DI>7A,I2?:*?W:%7^T3G/@$R5$S6LA)*SBD)*1J;K:TJ
MMQY4Z5(,7JI/0%[G$[A\AWZJ5YX_6&:K0"\_=38I$*<'XV^\F?]T?/OE&HT.
M]@>C+YWV:Y&>.\7]^5?_3^1_RP*XVP=@+J+)KX]H<F$1[5M6>RW7YZ;B5W]N
M_-2%*0&.606#LBDKALP&8IV?@DE*0XS2W(*".GO[M-.6#IS^6/AB1^^'@SR8
M]J@M8_^I#/C1"8M6#D#C*:<:!^4P3S?&9U/#'QX-."1=)"*S1T\//;WDG\[X
MZ=/Z=.&54'):$\L.9=%B@FP]<LP #<F[I!WF>@O^8E7M=RM^*WA$1<9XZ31G
M]9IO/LI2NEP ="%Y"WYK1>UW._Y3UF@D^AQ"XI2;%"M5[X,+Z#R'()WOA/\\
M^^5=])^4:K(*E->N@(\RZ6*+<]KH8*NNYD[XSYNQWZWXS]R6J15K%>>)H'5"
M*T$%KU@Z&[[/\4[XSQNQW^WXSVAR3"&5@H!LOQ",XY3'Q,+")O/MV/)<%9;1
M;)^,T^;8M&,>__>07U=;:G@PXA\G\S:\-(-O\7:\2,#;;D4+*D'X0CZ0E:V7
M&11.1:OSUKKJ98GDC+\SIGE8RFS%)PZ?XZ"LCQ[A^\$4ARMBID!(SE=9U6Q3
M\Q@JJD*%?6( ::6\,V9Z25,<C*@\QG%;#CY9$?L894E#ZP)) &WS >.JDS*X
M5B7F!^^,?1[F?+A_.&PS#OLT?3T:$P[;Y*+UV7KL=OQ3MM^S@\FJ6(XL9M-4
M!&2 6$LHOD15/<L(SV(_W$7+;8YQ-!F>]G0H>X>G=EL1>YF447.,B@446!TC
M>:LJ5*VK;3?;G;%7_V#4WOCX8#AD1WB^@=J*6"EX_N!D+K'4##:E$*-7$&.K
M7Y4"-WA7W=8G8&7,Q?H$8"2D4).TVEAI#.F0=*K+S^F%:Y@\.1CWZ2-[D(-#
M/NUHAS.9$7^;9QC_V<^</>M5FP/2VG.\?E\8>7Z_3NI_ +C3$Z<5WX#. "20
MG#&IK *QN^-/#ZN2/F?3T7,C]*RT#U8YQER3@Y0E.!4P8 TQ.S)M)HU=@9SA
M5AA:%O-%XRU0TNB#@K: W3E3,K2-74P&J5:@Z+5TOOKV2V&D:RU>&4G:@2>=
M)/G(F@!EM=JAN7M6O2D?>ONVC:STHBQ1&\Q0HPU9>919.>4BY5KNGFUOLQIP
M^_:6"FO,UML4 U1.<I1$9X-R%*K-<16&=9>^AG#[5@;,)A>7E2J<S#G.Z%)H
M_26<]M(5>0<]]G<=Q;A]@ZKJ7055<RP(KG+H;<T)42<C72LKW3V#WMC8Q^T;
MERA1Y?^,F4VEA!A< -;0D*2/D6:KG^Z$36]JJ#$N+*&1GC6NLE6U14>98@+E
ML\:2:T7#.>J=,<UM##4NSDP^)FNM-RZT+?-J2*Y4]&0B6.NTICMCIALM#2[.
M/C9C#*IDZ10 L5=S)F9D*6JSUS'[.V.?)1EJ7)SE4'L*UA6#-8!*!MOF6QR8
M,B<.$?R=M-S-#S4NSEZQ6-_"%,@:(;&**&1! YNKK;$V^L[8ZQ;*W OTAT;F
M=D.UK=7!5X796I/(5I^,<>D&K71KG&:(9%.)WB!X*)'??B:#5-H"857O#*=7
MC-A???GO,<Z@S(K</[JF(I-G/GP!DW0,1I;LK6PEK51@^>GYH<W7=L^.R42,
M)4%A@9&=MNABB-6WK2!78&[[TNGVVY_Q;HR4Q:(F1&21;X(C%6PNT1(2IV%W
MSZJW,4QT.[:5QH=:;90E*8B!0J5LLB$9E F4U-VS[;(,$]W2JN5(;&FR,4L+
M,=I4;6*;:YW;IM[E;MO[%H:);NFN]KKXV<Q\3A%-"NC4;,*63,;+<CKX>[>L
M?&/#1+=C4)T-R.AJ)J^@R!P@QQ!,T24ADG-WSZ"W,DQT.\:U.0>65Y%"9"N#
M1>.+362<+Z:DJ&^N\\HJWZ2+:@DS/X)7I-8V9$1C3^LYL87/A)R3DD_VSICF
M%H:)%F@F5,4G+"E5\E"4#EBCA%""0Q,CT9TQTTT.$RW0/MX9R$&[@-Z!JC*J
M5LRQT227C-;QSMAG.8:)%F@YC56&%#2J("&!Y7!4BPF>E8>C=#K =]<L=^/#
M1(N\TT))EC_!Z-&!!QF@D#52&1O(6HUWQEXW/TRT0"M9EN]4H))E.6^*#-$:
M'57,Y+0V,JY #Y>E"URWW]E%9L,I-^M"I210J@&:^LB0E2L!TAVTZJW426^G
MZUD%QRE:2%DAD"O(]VV;1\_W,%6O5Z%KW0I)F=NW=\! 4;?F6JQZ3(0@0[4V
M60K.6&?5G;;W;=1);\7*N3@K,[3^:06\]B$ZUU)&6;PLB/KN6?GFZJ2WXZ:E
MS:'46J/.D'R*QD;7VCD#4:0*=\^@MU,GO17CMGI!E6WN/$FHTH9<9=6*_7*P
M2;IX<SVZ5_DF_2[-PS,+7N\Y/,;(ILFYM44NU8*B:JH^2SOO@FENHTZZ.#.Y
MS#Y16\RZ)%"F)!.K-,X@ZYRBR-P9,]UHG71Q]M'>EE#:LA0?.7R%Z#5Q0FGX
M9VUS@3MCGR6IDR[.<D *(%6DF DD!Z.8;:P5E+<6(M:[:+F;KY,N,&!Y]*SX
M=:T9P7):5T.*)2HM9=08W9VQURW421>X)XES/AL$A=5!;,VJO*/DJH%"):Q4
M?O;P(X[+YO'[\T:[H]U?'N^_'QX<$YWNGGPXSKLXH>=#'#U^]?SY'1'PGS98
M&1VV%_X7F_:\YV_/3_#56_:8G$-;.5UJL>#: $<QQB+G X4\_[>\M_#?]%]F
M+,X>F>"H3$X?6Y4@Z*KS+/HE:KY#B>_85)*,D'U6F4-A6=[!I^6RR.(&FBI6
MS(6DE[9 ;3-9?(!*AO, *!S]5O(>.?.H_YLUXW1W?<3> D>9SI[\C&7_BMPN
MX%*2158?62-"4&@D52M;5^4:("US-M9NBET<[V.FP^D@XW ?1X>,VI0]]WA,
MB0/$9$R9!A\P#2_?27,']2X=]/+TH)>?#EH1(Q8-#@SK_8056$S&I+)/+G@@
M;;4.R^OS5MZ(BW.3D5H["##%63:FQJ0CF=8B(JMH,=S@[G_?8L0>%3;$F)XW
M#7=FG./?:$1U,)T\:N*?S7-AOKFG7YAJ541&CLH$I7*D !S* *NI50?(JA"F
M[);[AEL%6RUR7F:M+/V\]A5 A8 8:]:Y(/EJ%*S"7D67=I3B-SX];OG9].&H
MM*S[?3O';\?S6=WK"=7#X;-!O9.[%P43.+ Y%YJ@C-JG*,F +561J5:OP@!;
M4Y8O<;1S9K/V8V\P&NP?[B]J"??7L7+VY">'8\YP.7KR$Y\,CMIW=W-&A4]&
M1K*R:H3@"I;$>4G564IE@UN%6LZ7R,&CCISO3([2FL%(QCIV-;F8R.FK*Q(X
M?XT<^N4*D/--]OWM<,!G'>U<%ZYO=G@K28O)U@>,8,!9L*ZDI-C9^.A*]:T.
MTM'RG9S<2M*2C0GD6W/DML=Y*9$41HY($'+;Y?9.*M2S.0MMO'5R4*<?.;_H
M7,R5JJK5N^Q+8,W;MM UP5K4;75,EM552ATTG:?Y$S2$QK09 =7D" @6G2FR
M$E0/"5U=@;D=O^&P%=I?[1)-GQWDTX'_N1BT,=VE\:/#\9A/_&R :3 <3 <K
M4UDB)VM,K!4TL+@T%"-2+26A#<J"6>;*TE);:''UI&1M\5EJ;$VS6_NAPMD
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M15)1IPP^&/*3$O"4K8 D2'J#<#[)M,P0XROTV3L8I1\@T )9<UEX0Y;]/YO
MD3('2W8T!AD%J#*=T&&NF#<VI(;'>"IMRQG?%XED7 GR3I02!A1JZYB0TA2-
MX4)IF/BXW([1O]VE99'%69:"(E[@8#]=@(JMWJ!W='(T?_(3B4>3QX1DI@S
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MT"8Q5L6>X^(IMQ#;4,;>9Q,T1D-.D',8'/<8N8@:C$FQ MNP<,HM1ELZ)R$
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MF5C),&?;]''.W0D\*FW )17)\0%'_T@=@//(74A5.#UML&6!P189M.-&>*9
M1NDA6R%LR")I97PMZ<5M:\0+;"N3<R!D3DP3&,E6(2$3;VPP7K-40^9*6P)[
M1LML+3,)F H.,EA,">B_@)X;!ZJ6?,XV:# -3[KDN4N!' 0#S">+8(05.7FA
MK(O-[)GE)&+K;%Z,\+C.$#\PPH,3Q.>0HD M $%8@R$D\AQ5#MEJOA(,L7IN
MXZWP@A-.N0QDIE-IOB=1,73.6LM]#DSHU>&%U7( ;X49B/YDYYV7' )$,OX^
MIYPT8\$[--XM+S/<6U?N5O@ ,Q.&N<C1$>J+$J4-2JI \(%LAU1U\\$"IM7-
MD38^QBA$C)!*MU143N2L4'O-(2NRY,M+FR5QKVZ%*DPJ@M-D3 4#D(40!@!=
M-F 3B&"7ERI+XRC="ET4L)B#%1A< +32%IQC@L0D?$RYB4H(?C9WG2\_@5+<
M+,OJI1F)FN("\G<&DT?#HV,<G-ZN!ROXS>>M\_EYL :<E0HE. 4J2QN-3MDS
MD9Q!)QM<TA+O*U)UG1X_HNV"2F!\Z> G(1CNZ4^M@P]::$MZKY;9G(NEQQPG
MV"9F73)*1B.!\V23;.9REG:@CI!;H^78F99K"?-5+<=NKN78_&I/ KE<S!N.
MS!&6(_0@#1%-FX" >4K%JJ*N"Z;B@AKG0' FY(22.RCM#VRV:%G41D2O<S6^
MTT)UXSQC&E9F!X))XWG3KX4HHA27WJ+(/D-##]O2X\OTL-]'CW_TWC\8I?'P
M9!32>/KK0<+8K"?VWC[\+_IC!O%"B(X13">O">A']!*]YTFC#\!0_5W(<W'.
M>'+:)T*0[]X]2"6L]X#;X\FO[WIQ<O" ,_9_UJX>AZ-].G0R/'Z@CR?TW9C>
MV,/_\J-_T$6G/T^O_?$=KISY:WFL+O9[^X,'(94XPNQ:9X>'87\X>O!OK/GG
MUTSOH9OQJ-<_??"?>T39<6<[O>N\&![AX#]_&>-@W!W3F\O3 \>]#XG63G=I
M?GTW?2Z@Z_3)33Y_3E$>KM.YNNZ/5^R'D\GPJ%GT#9YA@KZ?SJ[@AR,B49>>
MI8_'X_3@[(=?8V]\W,=3(G^SHN:D7]^FT:07L#^[)-UE1@;GUC5SA1(3HO<D
MGEU^1J3UADC_F,1/?&?7'?O\UVR=?_[4]K)SN^P_&KJ-S@Z8,:!L!(C.([8H
M+/C?:W+M&N?,>(\?3SJ-]NJ<"<3L^\*)'W]YC#'V!OL/6(<WMSA;7WN?);Y/
MPR/_:#3!E[4G6Y=WHC_%-?UI/JD_7VX_V]M\W-G=V]C;W/V:*EV^Y>]N/GKY
MXMG>L\W=SL;VX\[F_WWTSXWMIYN=1SM;6\]V=Y_M;"_1,]EU=:.'^@O'!\1?
MD^'@E\[C]4?K'<$4N,\^R+*8XK^_\Y__^#>NV:\+?#Q[(ZH\&8Z..O]%P&TP
M'&R?'-%%0F>&[UZD7#:+O Y2&6TL"V53PEL;FBSB*)F7\,D0:V> !4?'U'OP
M>!A."B+=.SU.:S/(+O]UZA\/W_XA7KQ]);=.XN'FV]=/W>'.X>^'K\2?:NOI
MD\.=O1<']/_AZ\?]@U>'VP>OCIZ]?[WWFO[>8EM/-_D?<KO_ZL/P])78?K.S
M]]O!JP]OV*L]^I_.?_77LP^O_OJ]M_772T%_'VX__NU@^U_V_1_B]>FKOX)^
MO=<_W/JP_VYG[]GIJ\.#P^VGK\3.WAO8_O#GA^V]-V+[Z9]JY_&?[/73EV_C
MTW]!_.?O_=>B_]8?'O=W_MKZL/-X0VT=_M[;>;K%7A^^4CM[^W+[\1;?V7O%
M7C^FZSQ^\>8UW6_[\<N_N0A:NIB["97L@A>ZBUFHKA662TR)\:C6'G+6_9\&
M/5\0X>'G$6#EDC$5C)L"7'D5X'Y.H]T*P#7KC*GO ;BP+K2;.[1S<EW)SY_Z
M"6CW.9QP9NK%\?MB[#]^HY]X*3=GLHU1#_N=EX->&,;4V=K];BZ;XMC;UTT;
M@\$)]E^DX^%HLM;)I!%Q0E>G=T+N_P,_'/8]]OO#B1^^KU*%/>GYIR_IG(.#
MK0^OX-71YONMO7VV_?3EA]='3XZVC[;4]N-]OKVW);<.@WI]>';.O^A>:O!Z
MC]3>T\T/VX<'O5=[F^^;Z^YM'[WZZY4H:]YY_))O?0BGVQ_Z1[3&=W_L;4RV
M=ME[^OOO;%64.L<N"&VZX$SJ.IN@Z[,VC@7.DC=K#__CWYP!_>MU#7BN(3X/
M>+_ R/V4)S_$QC=$/U^SL@T3;VQOO]SXH_-B\_G.B[W.\Y<O=E]N;.]U]G8Z
M!/7V",]UN.SLO.AP]5/\N;/SI+/WS\W.)11XC@ W'NV5K[F3<.7UW BG?YM*
MO=O7= 9&.I.#U,F],1&M<YIPU$F#F.)=()3G39!K<QH:OJ(&'I3X7/>([GE0
M3NM&/.V6M773H$I]\-V0YG3KP\N_4RP[@MET,2$CF0;HHK6V:Z*4CCY/ <3:
MP\<I3".>DO_2*:_]L]+]71Y,:^^_;N_U'=G[>2K*X>ACM?9-(:IOB)9\/N"Q
MY,CI^JM<&'#:&]'R>B6K:-7!T\[>QNGVWI]R>Z]_L/7T3P)/OQ^]$D](>=)]
M]L+[K:.7IZ\/_]7?>KQ_#3P-U=;C9WS[<> [?VV^>TW7?75$*O:OEZH\T_:'
MS=/7>[\?;?_U\MW.$WMZ&3QQX[5'GKI)9_(=HX]="]QTC8^:00*O I^!)UAE
M\+3W8F-[]UF#DFX90"U>T]2HL\]0V^1<&W2F&X:=/!H>=1JGOS,93G_X=M1Z
MEZ',&Z'41\.CH]ZX;.(24"44,C@I0.?!;6+49F_X] G=;;NY696:]/MAY_;A
MR[\=<Z7%L.[*[+$+VF'7HTU=%4PV%HWS(J\]Y%W.K(:;!].NND93/EM6QOO>
M4/1W!:-[1_N=\2C\]]K)X."<)__>Y^N'Q_MK'>Q//O/-504*</S^UZOON.P6
M7%==Y?[3KV=87"AY_'[M'XN(?MYT/^/6Q?U%VN^-BU*=;-,W]TOD/VQ]V/P[
M!8U9&=;UQD$7BI/I.8=N=DRXS)T"%]8>3DM#_]F4 G:>CH8GQYUG@W"6TAZ_
M614LX=;93YOO,4P:!ND,<V=TSA@=''?&QRF4%*38Z0TZO<FX$PYP1(O]^1M2
M2.[*Q0:]+H3\'A=;Z'5CS=Q][-NZ[+JP\\_MD&[=@%Y(0&#**PO@_]MV9:>J
M]D)A$*IK"I@>#4\&D]'I(W+$/_9JQ^6(X]'P;;E.I4' J5^[]?1?1]N'@;[O
MTQJ?B6U2SZ\/^[WMPQ<'KQ^_E%MTC=>'S]2KPZWK?NV[UW_1*C^0ZOYK^_#5
MX2NV];A_M/,77>/IDS?;>^'=Z\/71UMTK2U^=5/ &F&D"JHKI<KDUS+9Q2"@
MFP0"J7;/,4,)(/;Q'8[2?!W;9>3N:^!L99[KUJ5V#]\_FR7@AD9R*W:.[EH<
MM\[%46?.L@39A8RQ"P%TUT7MNCHS4SK$<$021R#/2@KNI/NB0-80U+@A^_[4
MV('.<-093@[2J'-X,NJ-8R\T 8YA;K*+>Y?M1G/H:!\'O0_-[S_?AD@O\(7<
MGIY:))6?K;]8WUWO;!X=]X>G:=20]:I6Z6P/UW]><+#P5D.0UYZC)"FNM<CQ
M9C9H(\91&H]G?_U!"^"M_?F:_?EP&0Y&ASJ1!2+[PGP7/(@NLF2ZT1L!C,7$
M W[2RW_4\%N+#]<ZH^&[RI_QKN3T^9!\M_[KWO'4L6L%]:N">@$445H'T;-N
M\"ET03#6M=S%KE0I.2A%>(FM/52*L.1-,&)K=>9I=43+S%]C9G;9ZBACI1$>
MNQ*M)JL3R>OQQG5!,Y!6IM+?=.VA<XQU?ANE ;$%QLXFCB=W86^6"^3?6%Y;
MZ_,5>7U$/^Z,B&O;D.%7I95?"1D"&B6$["HG4Q>,DETTCD36.F4U!!M+'O%6
M;S!(D^'@#?ZR^JCPKGBVB8+LC)Z/AF][@] &P^?"V9OGG$UD8(;'V'4N0[=T
M[NTZG517H_ J&R^)*V></1Y.\ ?X^E:3CQ8K"S_->+5LCAZ/B$U[Q]COI/<I
MG$QZ;\N>:>Z%-/Z6@-PWA%1J>4GD]72*V_.)6-8-*P>6;5O\%G5@,=4;HX35
M^HG?GWJQL[?UMZ878F2P7<5-[ +CIFNU)X-+ZLM[3O_J3/!8B>L*Z>?;3(/[
M8TC"]/Q@.+B7:7!$F/ W) 4F2-O-@&0O%-==C\YVRY0XCF7XF 0BC-0EG,:^
M*_GE3AJAW%C&+[*@_N/?K.#FUW%GDOKIN'#!+/7REPZI_/Y)4<8=))GMA"M:
M;FDSR'XDE^\K&7W+F\NT2T9YU#0ZFN4QI5&*G>.3T?BD)#1-AATZHFR[3)^0
MBY_\S\6NEPSCC3!Y4$%G'.O607U?EI-=-_+[*HF^_)T2MY([9>'[+GOWBY5N
M7>MOZHNS(K!OKS?I-UF#"<-!)_1Q/+[7,'AOA(VAV#T]\L/^3_?<*=B>I90V
MS)'>AP,<[-,'@\Z[@QY]<J&AOY[E4>T[N$7 .C-VIUSX1@ZK!*S3X,CVXY>G
MKSX\>[?U(1YM/?WSW?;33?;J0Y_N_?IP:^_9^U=__4GK>@5;XJ/@"-O>^_UP
MZW#CP[9X]>[UXPU:YXO#G;_^5-M'6^^W#I\<O'[\Y[O7A_L?7G'[_G+83SHG
MZ46S+BI6NJ<HU?7,0-=;KQVA VVDG-;C$,?N3H;AS2^=?U]GO'.,H\Y;[)_\
M2/;@Z@G[+3+Z3*M.E6K+Y3?@\F?G7)XB=UH0;V<&N@M6I6[IBMFU";,1+F13
M$O!>;O^S9>:[U=J;,WLX+;^Y'O<NUK+ZD/?=\?N?Y_SNE465P76MT=B%$'/7
M,L^[:'+F668>@/B]\,FKX>C-5*]WSFCQ]<R"9:HGO36?>/^J3[P]'*3ECW=T
MOKM^\>S9;GG9G^YS]BT!ER_6D=YVU>BGE_]L$$LB:^KXTTXX2"1+M*XWG=Z4
M?2[5DO7&'>R\2_U^]\U@^(Z6F7!,?!7IB_%)B;+AN!-3[@VFI68O3LBO!*;.
M&/$2$Q-/KE]^:[-W=]L[EG_1VO^G+'UWMO)GS<*K5,_?'26&K<-G?V<O75)2
M=F7D!"F2UUTO+>OZD*-7:(-C8>WAJS3^;(#XCCN6S 1MU@?LFY;P%X&6 ES&
M/W3O;WWP>4KH]G#QKQU67;4-AA/ZY']/>L6TDD5M6C>,FK8UXR^86EFJ.JY^
MU+08N;"^G]!TE_\D(5LFZMX;H;IU:_.O8?]D,,%1TY9C-+Y?5D9M'X:_&=+;
MDC)V S>B"XB\:T4H.900+#,N2,Q%NRVSD:E?V[T[2$U]VC65]Q/_>:J #@BV
M%647.]COGVN\RZK0I]D!=.%/:+\K"N\2RCMSR8H2+%^7GDJ=2-\.]IM#CT<I
MI";6SD6GZ9XX[OQ$UR-'NC,^"0>=\<&P-"HXZQ8T.<#)]:=XA^./M79S\NQ!
M?B98.HB=G\2EI_7DD]-!_I">I9S4'$]GEJ7,+M8,I&Q6TJP4QY..8],K1#P=
MK]]^,Y]')Z,RW67:.*V$SB8X.;EG6N3]UH=-^;>V 2("[S*39!>$3UVGC>R:
MB()AF7N&>E7 ZCSU0:<.W%B5UBSJ@S3'46\R(863^J1!1L-!"7KV3SOI;1J=
M=IKYPAB:Q,+'.,'.DRF2O*)/+ZY1M-/Q<#RY%M"Y[#V_2/LG_6FIZ6YW[[95
MZ'1IY^LZUXYI_/-GH>P=-. X?ZGEG<Z4XSW3AMN'6Z=_1V>RBD)U0PCDNIND
MR&OWIBN,S!BLRMJH3VK#JP&J>E1B_:Y&/7I8UZ&%FTADGY:=.A@":>&FDU>C
MI$H8<O#)3\G#'W0_^<7XB-0WW65TAK5(@34S]7XI\)8N1W"PO*+]SOYH^&YR
M</;U.J'=U*RM"7LVK2V;'/.2B2CH,3^SPN9K_NO985\]X//K.SNP*.O9P9]9
MZ]F19X%9+GQ7G('VRTA]_>;Y<[?59]NM6_U]@^/<NKEA$M>W=>OB:OY)=V(=
MV/SSV'[@%7QYL4K./Y5/K LS_U< <ETJ>QNO ,0M)PA^JJ_R+6VC+[I'^$7+
MVM$C4GW[P]'I)_;0FX,:I1AF!U6]G?YZ[\GAJP^_]5__];J_]>'EN^W'K]Z_
M^K"OMH]>?M@^W/RP_=?O!W2_=Z_WKK<)/^YO_47X[^F_^J_+L7L;;/N0GN_Q
M&_%Z;TML[6WQ5T>;]&R_]7>>7&VGIC (98/OLEAJ([F%KB>B=1UG5EF-P@I8
M>_C'IVW5[;<-_U;VGFL/_.O!OMM.E%DV^=ZXH/?4/9@1?=%$GN<S7H>_]XW&
MVY^"O8LG\?SE&#[9EF %*+@[Q?]3"3UW J:_SN#]BM'SUG%'\TI_.QG3G<?C
MU1U+<D=XX_WEBG5T++.L1)?)K+I0,E51H.FB"<ES,%%:G,=8DN5JE5>]DMG\
M=-R@52S?IEC.7N/3YBT^FK[$5L'\N(()%W./K(\:4NSFH+ +,L8NELQXKX+/
MV0BIF+^9@KEQ/O#BXJ+Y"_''4M=\PP2GLF_5[%81 "R93I-AYV0\C5T2_T]G
M*'YB/L]PU-RK?UIN_JY'MZ;;=@;T:,,2CGS;&S> <H"#4(248&9IBUX.'D]P
M$'$4QYW2^J47/YVOW.'R)_SYDV'(90J9+V+S]EL24&J(V5]*,YD%LDL980E<
MXV222I.@P@_$&F5$!2T-]YLDC/.B?AR/":J5C\[8)>6<FAW!P:RU2SFS5S8*
M!\0)1;6/AOW.D,S/)1:]B*&?$-.?I^YU@,&E0O)=''FDRW9WWO?3:9/ \A-7
MG9?KNV4PO1&Z5)W_7![\XBEG.?F^3W;EDB#DWNAHNN]Z3/?&<A#)3I,R'9L5
MXTGL36;K6K_U[=1G(8\VRAV'HXV+]_ZDC_NK:*1^9*^5GN7P%7WW)]\ZW&=_
MBRSHC6O>E0)X%\I\ O1&=%/Y@EL)5H6OCBJ^-UN>-Y^B4X/N:O8;QP>IWS\S
MO9V?/E'L<&5/C73&Y_,E7J7QXK?C;]_)+F]LA2'P#PRL^["A_F9<:'JMK"L1
M4Q<B5UW+N.T:Q5%%$V26\:LX]MYHE.WAXB6FWMS@/=)(N+]/.JTHO:+KTF1:
M 5_TU=OA#+.72DH2VB;3MTF7R"4MEDX9GZFUJ[/%Z,/?3P9I2AG)II.\FXRR
M?Y]IER=-UA8!K)-!;ZI;3L9Q[:JRL<D[2)YY  L!G=,!F?.2ZT#>G(>_GS7*
M1DNV1CHW](ZP/_[O-?:QPGG>H*\G_2%>'37\8'!RU(W#27=V]EJGS(]/S37N
ME=[9>?R,_RTPHN7D,"MO"<DXQ[HN,M-U*0NM%!,^IK6'TNA?N!:_&*M^8?J\
M4]@9/1]V?O)8O+\"VHDO^B5%>@IBZ<,QO=W2:3$T[/7OQ)/K ,6K)"M*$+B<
M] F^:1(19U>87?;L[\]4^_[\2VE*,FOM-1ST3Z?7'W^&J<E3R+WB!M"!Q.&Q
M-R+T/QR-?_FH%^1HW+@FXQ,_[L4>CGJ?DH#U94<Y&U,)Q<$)CDX[DC?O6?Q2
M'H.(\*[\\5DQG;[(ZY)JR4QYDXVS# Q(FWF.F0/+-BC/0B.I@O&"!KXHJ=.>
M' TQ=YL;[9Q,FI !D:P5W4\.O'S\AO_MK)9*LM0E;4F0(8O<]=*8;I11BAP9
M*4RU]M !^\4Z]PO)^,=B>R$@5YGYW-'^4KN4"Q'^Y<R%+6(RO"#>5]/'BDB(
M92JN?[SSZ.76YO;>;N?9]J.=%\]W7FSL;3[N_/:J\V+SR>:+S>U'FTLNYK<(
MY!\/PTE3"W-Y9.IOIW1M4AZ#D/;H1K_UB5/NES1>#P]\^-MISFU&$D45RZ@T
M)KL^\-2U$0C)B*A%P+5.(N5U7%HNC$[2%)3U!E-E5W3O>18^V:;G.)ITGCU[
M-A74WIEE_*5$R,ZCMI,FECLF*$<7F1QTBEKO#8IH=GJ7Z%6N-SJCV'3H^F=D
M_RR/]6VQWL/WIYVF>7<3=!NE4H)0Z@ZF(;JBZ#L; S(M_<Y62LU7M-9&FQ\,
M^Y%,Z'IGM]0.7+_2NQ[YT><U94U4^5KE6-$IY\'@2^/4R['D;!/7=TH55@?S
M9.:LIZ*%IBHM]XJ%Z)PF4EJTUFFCLDNO</HD:;S^V:V!;VH<R6\S#U:S[\N#
MM>N.S3\/MKWLMUWVV\? S3AGQFG$6IWQL-^+G3,3,OM^QG?7OOR&?>GV/LMR
MGQMO0?)S=/&PF4'X66TU8S-A2$\=#Z<;>@^FVOMMFJF6V6;XI;/.8A87IZ"G
MY9],/G_*)_='/[6XRW^6\QND($*(CF%P@ [H1_02O>=)E]YF#-7?9NWLG(-S
M$3K&_=3UHX1ONHWN?X#]=V0(UOYQ=6&TJME; +%N"@R<TS,LL"$V9S="LR^W
MGQ%Z_>?FQA][_^P\?;'S\OE-P*M;HB?8:TPI&?-'!<<2]%Q0X9+[AN9/W]US
M^K:@@UW7%KX+.HAU9M7<K:81ZTI\7PW-5U?[ Q/OOSN)Z38F<-TPT_7'A^RN
MW /=:?_)&W2?G*XMIC";_/R@R34H1ZT]?([[Z5-YRM?,-U?+,2WXDV+C+@ 1
MAC?[HR$]7W?V9D-(*>=?EX1:7[<Y#1-.O>UO21__^,%S\\^7'OR.Y.ZC9_ZT
MX#TC=WS6QF7]!N(WWP=N[.1GGCKG6WOJ+PGF?^'2K*5S,"K!NW_[.DCF<NWA
M61K[?_T#KX/6VR?GN=A^7T/1EM;?1FO^&2)_L[;ZNII>/FW5X1O?IZE^Y&%;
M334?[A5B[>&+WOA-YPDV>ZX_J*V^CZ2MMKI3>O.YJ:L:P56'_W8I0^ .D=4U
M0-\M!U^$>'I$S,'D0==]*632<OHW<+I:>_AR,$KC8?]MBIW=">;<[%I-@U<M
M*%MUX@MQKU&96 @H:Y7<W?*Y77OX?#0\+M1(+7B[!]2>GU:K$KS)-BA6*_=*
MOO;PC[2/_0YI+%(U3>%#"\16G^CW'(A!&QVKEGMA[>$6G=+9Q9PFIYW'O7'H
M#\<GHQ9KW0?2?YOB^M+VZ]?MU*>W7^]"=7UI[_4'-U^KU-=J>1QG+IMJB2N^
M\_2S5LCG(>3 2+]/JRY+4Y47YZGW_WE><+/YOR>]R>DO]%V_2=IO"G"FF?2=
MK=(C8U:3-AU:UWE^,@H'.)Z6\DS/O91"WQJ-U><G(>^U@ZY;![U:[G5K#_^_
M%XD6\#;%_[_US%>?V@+NM6=N[A+I76;MEH'GP,!*%/#V44>RXJ.?3 L3"R[;
M&&#_=-QK\-B3\WYCCX:#..VI5XXAG7?2GS2'[!RGZ9):K'8/V$>HQ6*U.\JN
M_I(*_,[<O1\W[RT3SX&)#3D<?Y;NG;U)4TC8J#/ZH'_V^Z6(96?##T\FG9F_
M6Y+^6HBW^MPAYZ;BJH1XMMU\J99[Y=K#"\2V>]:HHF'G6I]G7/7J&^NR>W)\
MW&\H4;I7E;&?+5)>?4&4YEY'-5T;U:R5>X70:P\?-4V+2O^E1H<1*L;]49K-
MD_^K]#K:F/8&Q_+!<'#V:VF?5$ZXL$,7@+I%S_> <?3<]%Z5\-FUI7T5\Z\C
MQ3=LYBU,]ZB;O,O89B_=$]K/3W?5B=D65.?7,O \&!A@[>%.,_7AV44OSA9R
MW0.J&W:_(=>C>P*YS!+Q[Q?7\@W\:ZQ:>WCA(I:,0APU;?"?#$=TL])@?]0;
MQU[3]GO<V2L3J)Z/TMO2@??98'P\G7O5XK-55W0-HWR;IKN-_/(E:.^UF!SS
MQ>^\<]9F']4LP8H537\^JF3S?%3)SN51)8_.VKUWGI:1AR6*^*.!PU:YU\ :
M\T.QM:86\3MM8-@JN+ESL5Q[>*'5RL# -!BW;OA](?T]=\/Y$O7/:<L ;YO?
M]=K#697>:6?GW8#0VT'ON.EV3W3"WJ#SV_F0NMGW#;J[2#^?Y9'/:@2KS?)I
MWD2I<*S[":[69[9X^QZ(KUEP4\LEP-MWVANIQ=MSY^*R73\S-XTE*8%@,D/C
M*[9E;T3+G$Z-'/\R2V::!B$ZS^BNA-%C^O$80PO1:^"6^>F\:H.H=]I<J=5Y
M\^9B+4K_RMX@](X)6<^2+NO%GN5QL/8'Z#Q)LV&?NVGTMA?:;+%[(8;?9DQ6
M=#/R7_=T+W(Q/:]:X9V+\-H2IS_H^=[D6JW"><U<9S<<I'C2;U7YO> &L^ >
MT4N@T-HV5/6RL"77]LEP5%)DNO_3V3TY.L+1:1O0N =4M]^TYZA;!W_IJ>K(
ML]BE5XN3MNSHGI#;?M&1_$<S(_OL\^^9^;["Y\SH 6+=E W_X^&X:5+V8-1L
M![Q-LSGB4Z!S^<39)'-V<0KZ\;!_,OG\*3=>W^4_R_F]^-]K-QB+R=;.3CHX
MGZ)\C/NIZT<)WW0QD]0]P/X[/!VO_>/JRFA9U][$S1[BXQ##5Q_KVZ]UAX&)
M9I3]\XT7>Y>&('\K&>3:UQ_U2K*)$==33<HG"WKX9WN;6]-IR)W_Q]Z;-K>-
M9.G"?P71MV>N'0&I)2^UZ4Y'J&2[RCUVV6.YNM[Y"!))$F408&.1S/[U[UDS
M3P*@%G>Y1%?K1MQIET@"N9[U.<\Y/N1_C/_O]S^?O_SI^?EY<I.[>/Q9)T-/
M_*[HX-S,;S"]-S^_2W3TS\\_>8^_NF://^^<KY[A!<:0X5FWDY._H]-(PWR_
M<@E<\76;((_DHZ.32Y?2OXY/]"]UWPS_U+?#OQ3=Z$\_5T7G\A]=5G:KY >P
M9S;^&W63=/!B^2(B++-JJQ_VK<N1KZ);%6W2N$W==/ _"P>_J9/Q0Y.7U5RQ
MYCG%@6 L2=O/VB(OLJ9P[>%^;\%U4X)5R)(5?SS/&J:ZNW1E>3!S6& UY^5+
M+I'-(TO6!7. PF*M7+E)-J[>E"XI$<O*3RE@*?$_.==!7UIG'QQMB;RGW;88
M3;BLFP_)S"&8B'CB'1SJ;5VY/5_1-SV<E<LZR8NV*ZIYER9;U]$Z!?ZFF70I
M3S9@86"=+=^ XT<GR9M-UZ]I;>S6T-+K5_#?N#BX_KK0L[XH<]R &NS'*DU6
M,**#C6OPX?B]>&F[%>ST<I44ZTU38Y_.#(S\%I$-"_A!GLV*DNCWZ[Z#@<M>
MN8_PO )A#BWM!^X8**OBHLC[3+@.ZF:95<4_&44!YX3&NFG@.Z5;PGM@N$1T
MO>=[B())%@&'G"&;[3^=;.+'),^ZC*:;;3;E-LF=VT1WA%:J*UJ^+475XJ-A
M@<JROFQ!Q/AED/N1\L]P+PK8/M@'/2 ._@UO7?<5=3*@YRVII(5)=.C:K>L&
M=Z*J+YA]$IZ3]_..O\UC[N =#ERZKCYPN$T+D&C8"(PV<HT7N%[0ALZ*Y=*U
M<%Y7,%I'[#V+;&Y.$(VTJ_-LN^=[R!<)IC_#E4SF\ UT3\/FI*![YJL*AK/<
MTE+1ML+6N/6FO@2AHYNSR9K.@T_])O':XYHM^R+'"B/ZO*N1]P/^O$TJQR<^
MFX/4@WT16<8+>2@WG<Y!RVO?U%D>K?.:6$-!2,QA&"!,RIZJ6C?9ED[)\-3
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M/T ENK6RM(:?/'C_]K1]F/+UNFS 0&_^TL*N')0UNR6@K<>X:5DA3FGBA2%
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MLI@,;IOT=&-#Z$ #IU&].NV-+TR+W/0<1"+JX8-U]H&DIRL=E=7Y%/*\Q*#
M,MO0&1HFZ/AP40V>>E(\7%8!)*FN* 7>#QMQR)>SW^+DO<6%#52 P7:-2(#0
MS]0:QN@RPQZ#QTEG,!M<\P&Y)&TTOB?>;#Q?0O% OGE=)H)X&,FA,<N@OUI,
M>I-H]!O'BRS-<!.J^X*^SU5&!&*K1@ :XJ<.9 <:V];[O@KO<RT]4S^Y+"?<
MM4?;F2O,KE*_J2L.^I'$#C%A@K.R7M'+X^MRXYK;^TW\;/='H..1\K4A\N"-
MJ&DW40E[ST7YV38(S1V'7@M<'6M/!9P;IW=%Z]S+N\^V$X%>(3 MF1MPSV'Y
M^99>2P"Q6&QDJ@=Z[/VV>T<&;8\@8/*U0CK'\DYXASG@"TUU:,0]EGKW*.KH
M89TP*=[UK2U :'3@3>9:G^1V$MY31)83N#$\,F8=488EM,41!T5\[\+-3]]L
M8< M\[_'Q/V*Q#26^I[OY4M.:O&6,G/IE,LBF49V,"E?W%>=;[^BW"P^ BW1
M[Y8C&>FN3)TJ99<<'S[U14PWJ?[Q"=HV[ J%V#G"[M&QMEC!D_#=:$N>\(7=
MCPM64&NF7S'0AL1EW@0U$<'&+05@>YB<.W 0^T98VEN0,IH)8*9S^F;=;"-D
MW\R5]:4DFJ\1F_? G9L#=XZ_%65T=!+@?<D[OUO2O\MB>>[BR$D*\G[G?[N=
M?_KH3W]]FS5=\O)EFE";\:]3;=[VVH<7O<9\%BXJ[L4IZK>V(,$9RA7/E+*2
MOO/.82B^9<"+4C0=3IRH>VSD^,0_OL=&_D$NVI>*C;Q9#/P:%OLOSI;9W:7(
M)VD& $:%W:BM?5"C:=T%8N%QY8#/U7'F%1/X9+KN2,?N;F%D:X'-'[DDV#:[
M&Y3LFE9'I[N,WULL34"C>(-[Q(B \WOTU>%7P9#FU$_4F(CXE2.O4\%,'KYD
M0V4^7^U_DWK&?'F\E-SC>CP]XD+ ELL\GE$.FB*I<"_+?CTK,C'7P6>CLF00
MJ0UQY&"V[JV%9=%AL/@KQ<LARF*.E<@YNA4A;6V M+["#+-Z%7T:EX(^^/'U
M&RQBA!7#@NS#Y!6=BV%7I&Z[D20M@B-:5RX.L,Y>2+T4>0E.#HST-KO)]?R9
M;AU15"3G>*1<<VUK)B+W0W^G+#Z@JXJ9888,."K\$5R/AXO-W#S#X1,?,/ZX
MQ -TB6>$B3QZJB1BQ&.&Y!E+<GR;9%.C*"V(R3/;02V"CBZ:)'UST_3_70HC
MF[$;K]652;NKI3!3L0@>A\JOX,R#K;2*0IV3193C3%Z!0%%8T6J:ID7;GMCS
MF26+XB,B?#%B ::@%46<^I5GU; DB$L6S/)A\@N(61$OE'<<5WRS^VP2XA8(
M$4:-B$97BHOJ[\JHU)HGS?7*A3_M2G2A_Z5,[5R/S?7>M]T28>YN_>+H.IIK
M-[U6VA R3(X 7U6TNU(%:+AIHB9TMYX>%SO==I)>,03>1RFCBJB3J-R. R"^
M&LN>3 4F3VYM.F!1VQF+22=JOH@>"RL?&68_%\(]N@Y>ET6$/08Z&?$!3,1T
MKAB)2?=PASRFOVME'.&K7X+48MA5718Y[9*%B&4;V-8..Q8@D)'-HMEVU.-8
MA !\,M$X&UD?D(LEM(/ $WS;HZB@ RP(H. V$O49*F>SVV*&]600L65WX2KA
MR\<4>.?R7;$^$\>[]1"1^2A*JG,T6$_<("H<8[2G.JL6'J)D:=6TBC<R$CS]
MH!&D >Y$=/^LA[G+\J]U08LA*! ); _[F6NL/+#T,3-::&9PZS4*$?S8"!>$
M^I*[J^] 0"M$S;0!"=@H++>!837;".8E)#TZ480F*XF&J^9@KC+AF&&]JAFJ
M2AA:U=B!?) V@D6$1\8I+,8\!'E.6"I%- 51VQ_&QU)A@,+"(CA=2QXG#\07
MOH24FG0,"17@/CL0TS##]'T5$BW+C>+3W]Y9TY!;&+K!0 DE%0/2IU"_@?A"
MQZD>9#>I7$D4<*(A&7V!>T#HX072%/(S;&,N_S@+4Z6414"II@2?L[Q1 I V
MN%<D+>H,+A]$ ?PR*YU\0@1XVE,$Y827?/2H$:;6,SLAV[U?"FMYU&+PFR[$
M\O+/$Q9^=*.]OJN"3'IY5(CGW:+8DZ/-:ML:[E7X@^X:&^#4OE@V@.48[M]E
MY5L>LT@J"&WI>01-Y[<;F@AW<B-O&6/QTIT9JIUW?0+/A$1A3!-G.MQ%U7/Q
MBP9;&'M+1+-$;8H*2_8C;MHP1MF(!^-M5[S5"Z1N$"=3B8XF2F^4(,F30;A\
M:GOV3#)>HVK7V:_<PXNV@H86:-S<Y JJ_ RT"=2@*$=MTA7<KUQ^A4V&7#41
M)(M$KB$G]K_$^'P3!&U[$I';AK]ZG6?PT5OS.2E27_,1!)P.G<WR5"QUBM\(
M:_)\7N0RW<[-N;V?9Y$HF,T;L?JMQB<BMBK$H:PKA@^(9[_GNO4YPM$])29"
MW*F[$S."M8ZYDX?%"@D&%O.<^PCB7=+9IJR-$(C2#<N9?2T3:UB*!57!G@+-
M[9(')D8"!]0$P!XB_5I%]H\O?_3D87%P-&7212$@'01:TQ"+]12E=3,92'T8
MP_RIL]6G&[>C-93+]ET@B3>U((+-5VLPW5D#,<<HG)20.OQW]"$3U(2^<]&G
M=76 A.WFM3 DC+]=L!QM'%6LDZAM&4:G)5W,!H>\E>SJLOGQE^G:KF&!F08E
M4(T6\OU;6:)[G3RYNJ/OG4_O=FK]ZLGL;'EP,'.6'Y_+74Q &?3HTR-VF4HX
M(,/&" 5Y9?_HE3:0^TU2HT7U#)F./^)X#'R3H3S2CR#'NGHJK"2Z6R;_URL3
MPCNB,RCY4K1MSW09:XQGK1$L3\.5/,2$++AFN8J6S(MMW(M*LQO="C[7RLH8
MU*W<^E?R7O\&^9#;3@A5A<>A3YIII!,\]RS]UU 2#L4#3UU#31[2%ZV9EB/O
M6@M:2W[0W4N4W_3*^91E2Z%OB7F&A= >K9(KFZ]JM)6Q\G>& >4A%ZF:M7&Y
MH39RI(X3;/\6S;Q?L[!N1?I_T@50%$<X^WAUJZ*6\->BP-OM.=I2#969!@(J
M=H+;I:]-3A&'WQ$BDXQ.0V :A(J5&F+.OZ#X>>C!ZQ;(HG!%7P5]XZU;NNL&
MDJ?HQWT/F]E]0Y[<PV;N83-W+J?/P1 O@Y+R-_>M)7-XAF0.WXL>?!"^@YB\
M9P^C*+3[N!'"21!,DPR6_N>S;90N]3+)9_\XNBN2O-[L"L/?1#!1%P<?!AAD
M#TPJ3@K\A;N37#4UO[Q^G\@[@#CO,0@D3R&/+OSRT9.#%<)%0N(FILSV]%FI
M^8K!ANO8/#X%6:<RF]X;-H@9I\AOUR7MR[$;T%0+,.Z(K"$RL[B?@=82Q$5L
M%-$.YID)M;4QY@</)?K@PE=@GW)Z^NXM&Z>51R.3@TP9.K!*UP1:HGX_-O :
MVW\1I;C"@HQ7<4%.196;/@%D[1KXNN\2$*.  @^-A0))<'X**>-K^R2#\,>R
M-W=$#'$CEN0T^##&G4_[EHR08YOQ\/=)/4S'$>Z4B/)?]?L%9R,::$'J@$WZ
MX%H[L"0I3!ST&NFO.?<6B;BDINQY<19#$Z@ .S@C\Y3C!%,C5WY?TW/D[#7V
M' EB:>*-/[Y^HZ0Y;\DAP#<*3W$3=0%*'KQ]^^:A_S+F)0[JQ<&Y]F#3AU#"
MY^"%N!+1Q[10YQQ]@%U%R484[<F#\Y_>M@]1FPL?XQ6+<WMG9+B1%MPHNSEN
M=15CFQ0CAK@FEMVL=V&%86H])S];) /#4"7"6^6'/N@O3R!)S,_*UAR8%4!5
M'IYX@:DSG_HF+BJ'<]^LL)DC]MG!UPE>S82<P$J#>2+^:>V_OLCFU")'H\C$
M%KYTM-",/FB[HNO9VJ*0$&J37M(+MOL%_5E;8H37'NYV3(=4.URK#.J'FVUP
M4QMD("]3A X0X*!") O'K.,JP,BJ$>^5N%[31&N@Z\9B#='(\@@.,AY;I.X!
M"X",(/F&8=0,!/2-5(#H$@1N4 6A$':E[KNRKC_0B2$RG<$VW=X\%3S15[9N
MCQ6_9<&;OARBWB-8-+_&=Q6[<_7U:0(ZV:FP60*#I)GW/G!B+'+J[QB:O&?$
MY:OUKG@<Z/!)C9Z-A(3(!^,'%>JB$K\,W48Q_8W_"3?[%_A;QID^3.SRH>?F
M!8X.FSF=-&1)#Q'N6$VL4/&J-$AP&N''/NCG$NX>R\X5=T7 W"T:>@S#)W?%
MD@]*%P4AQ]%'D#@@TGC^W&/*I/UMZ"B*D2/W,<,\2P!OX%M_K&'=SS+L.>;%
M,SL_&X1M<! ,N\MR1P=G:TJ1(]:W]PWA4A\!7[$XA:]C(I,Y/XB(EAB7N=5M
M#V8N5SC#+F,."8%.:N&/F9T.DS<PZ)^D%\.3UT'C&EY*W)52,N^"HNL0@L*Y
M77$0-$TGJ2N&&]OHOP08E[75^<4NXB&)SE&RF9"PM@GCW#4$DXU:$VNIMWB<
M-[\[7%9N0!II:+OG+T>#,9 \9G;VU&V!XYJM$>G/&_KRAJ/F]Y7KF)V2D&4;
MA+8+01]R,VNQNH<#&@X%]GP),!MXG&(<G>9P!RYT,FN*?#F*L@N>CZ^13VL3
M=QN<7>)U\F=/UYL\*(-KH6X)1+J!,H8]1:2T8RXRS*X7BZWWVCIN^^L[B @H
MT<@K!C%)<7PX2:216?5IK#=TS.)HM\"GD05;2OWMGPAJDZK*Y;]U(+7O7A?<
MW)4Y?FI=&0XT_4Y^S/18/MT$'<PBA+>H3F3*5=BA\,7OK_*##*P3-WJP=&Y"
MD/.U7_/B5"'$$2LO'6&O<3D@P<+'FV &FC_F?0U-:DQ#R/KR0-N.A*_[J![A
M-<32Y!%ZXF]F$00W7>@KJ/$-847I/>PO^5D:/@QB6B1R"5+Z+8MVL?]M#SC%
M</G0R[0O-ZQ BTVM"8GLJJ8NL;?0MV/K3J[L:'<L:$&6[O'AU_RJM6=^#6H'
MO9#K=COU5-<HN;."7 'XX4XS'MNB-IM:Z(2&S]0UW(-8XJ=*E!#VOJOH"$N5
MNQ1IGY#EG/=-P[4%FMU_<OC$GVPUE4VI:&B6SI2G$QL0'!ENFJP(5#ZS&%?]
MQ)B_9QSW#-6M?ZE!W:&B#"#.@,#4VB7_/3KV?B96I(3P EE- 3I(EBA(&G;<
M??"(#<&Z#4"S*4]$9<'=Z^UK6EQQ<,.WV/!!#5M)\_BK_\"U&M?,>#73U4HE
MY\MSPB-9V5 CD(1;A>P2P@0!\7TI+K&@= E"G*LM!E4[-SA*^RSC;HC<.E.B
M>CM#(BBZ\ZG=+CC@)Y*8.:!8FL0=<8K$YR;GA(3U)PF\G:I>AYJ*3#5@SED<
M<8NP8AFUI41I.#I42_>BNF?S01%"V")&,BE:WCP52$Y--<<X"GE=_+%C\RY,
M;4(Z3BZ4Z7^!I.5;4Y19D_1S(: L5D,P0=[#Q, <@%^=!G C+#:&=+?)"P5:
M/WA_^M.+AR?)V:HHP;X,63"Y\2^]H'RK^_+@[,>7;^$GSQ"CBD'AY,$SB@V?
M)*\P!O<>8W#G-JIQS@XX?/'5^_-S^-XI[=KW)4%LX/\_0Q0SF%TGEK1JW&%[
MU 7""MW;&WO3I].W<.Y8V!N8;/+XD:#:?-1Q"MB6>A 3/.'KPZ\'AN2)V27L
M=@1'Y]CHY$$LT>\PA9*TAM./Z/@;'9'ODP1&'_OI;SURG&EU0K_),S(A8=0/
M3L].'^Y65_>@G[\^O0?]W(-^[ERSGLL=;QF2R]U(X@+4D',$81&'*1BA&3>[
M];6I&56G(HJGR+5,'0L1X O99=;DG/&Q10G<- W$K2ECUA06J\T*<US-#O-M
M6NQ>(AG#?%77;=0-@1#77B(3XL;V"A3-:BMWUT7G,4+2]L-5\^TH$-R%=JOQ
MBFJX&0U]4&6D4V25T\2PF%)%=D_1_1.V4#2Q;#I^8X8P98QEL4831749IJOH
M^2&)!YH$W)">&&"TD]&OW)/MEI9#(A24Z(_A1%F%!O.!^R%2L3D;,?!:."ID
MX+0U<E<TC-W&]71D G322R=*S3#YZ)Z[.^P41H??YBKYG W3H!IMZU:^NW((
M-M'>A$)SSB*0OA^>3@'XL^58@C%CVQ+YVBU-AM@/,XI&P^52T@U9^-1V,R([
MHZ9TJ*^LF0+<31^2@&!H1P0><=T#U26S@8AH>K>L,BQEA,.$"+@<\[!IA+0(
M$&:.]@_SUWCF$/1L0_EZ?=2-MS$S[BY)&3WL$S5MZE/2G3) 2O43>((HYY<%
M@1!W& C1MG"\=<7(QH\2VS3 K0*T<&#4NPX/#Q9GX]+(IE :0?P6Q&65I4,J
MV3V_,#<\/MJ6O#4@.LHBF2S.9 "!004E-GD+% .&F3M.$*,#0/TA#'FK;3>8
M>M*F 8 2GEA0J]EM&C@21FU=O?3-0@5NEF>;3LA9T-,C2]T7ZY'P9E@IE<88
M)MD;7[U !]V:U#&7]O">IA$#S"3GBS;:&C3(BCPEJ5;P!?OD7T5EY#!-3X_C
MT^(8+XOSS3Y4SR=>Y"-N,=<K\8'/':HTQ&A@F(Y_[&M O):.T2IC,&_?[D>L
M^LI;<EIB/ $QF5&_U6^._L.K")\W8/T;G'6K=0(]C;5"**;1:/2_C80+EF9A
MOPZ?3-]R*KNP]"<AEH>06&VVY8?Y]"D/DT)X?F"^"=UM(Q2^$C;'(&N]X9AN
ME.U7+#<Y<Q38&52R\'5JF1&G46"O710VE;0RC2(Q5/,U,(GE0587\P9X%YKI
M5XP&9]-&.T@'9=^X?_0%C9;9S^L-8I$D=$59Y59SVO9U& ^AL6*\PP0HWEA\
M"86^XG%)Q)K>%92<#LD,V+[,<-,,L36>1RJV&U(#EHJ=",/[(H)%+K;_QHQ.
M4KGE527!+'@ ;?8U)7\BSI%]O]DWEN&,(.(JBHNZ1..D,P76C&PR\"*+="/K
MT.,GXNY65G@(WDS2Q/Q(1B:T-U4V, (XQ?,/:(,JZ,&\@CE<^C+W85&*R%/L
MDDXB&J)T#%5GY0+4N?-M_%<#[3^4]>P+Y)'E86L+SJ\/OQD&#R-/C3-<E$$S
M!#N?%-!.&;[*'CI((/#)Y1'?-]D_"Q L&$<&47@&2^-K?-^ZI@?QTTMOW:(R
M +/CIT=B01"":$?U;SQAHK69L,<L)VVPATA6@@>K9381 LP7/GGF$=^.>(A#
M9L^1F'3I;9$TGK/_R,V+32'1F'G$PXL,YP!%1G>X;C)UR8]:"]"_#FMJ^R;L
MB->D'@6(2N6IZ0V1#EI'/#HZ0H-8 5XTO/5,K6T64ZH<FB6^<RY(=Y MNX8L
M]3,1Y9=EXZ.0R4=X"C&J9%OB9_@""J5?AM-^NBX,#^6P$2*LS>-Q8'_B.N(W
M)1/PZ/#QX >'2.P!UPY,O.^S:OV?_^?1X\<G>+-WOWC(5&GI#V(ST.([@[FZ
MZQ(?)J_Z%@?P]0FX2&URGL%_/#TZR5T82VA&:EX:'OT6+<(E(11]<_GZLHJY
M+P=\E^%@RDF<TCQ%_E]_NEE+BCOL 'I+??7#F[\_?_?3Z^<_O4_>/?_AYU>G
M[U^^^>GNM>[5C8;[Q@AB]G!"_Y88$4J5<)+G&Q3)H5';>!E?9I<B/7WS$(9R
M,_2:_L9"Q3#3%03VKZ@S\98#0%BBV3ARCY )!'DU["/#FV&00A$CQ#-A!'VI
MQIC])3AF7!)B'#5TNLBC_[4'J4]8U$#3YL*+ F$L D8'*[9 %X3.OE =/,.H
M!1C:O'KCM3*:SYNH6B%9:$4)6)#SSB!CED5;!MIC&VEIZDW=XE7D!65#$:6'
MA(N+]08?I?CGC&")/DH:22%R[@_IH.%RIJ.EI[4E:G*>K ?3CY?*>WY7/BDX
M202CYY(195DTS]_4I1!K@83!R:4RT2RG1#ON) 4S2-&&X[T')O#5JFJ17()5
MEQ6E;RN])>,PE1)3V'GA,<'K@5\,54#^JW7C'P$KN*EA?=6?\)QW3 S*L=:P
MN"GYBK"PF!6Y>L_-NJ:^M@=9^WUWE]04__@&O1S);U?)HJPO6^_'V!/*M=7Q
M/B*!%K:*NN_Y\YNE5Q_YGC_<\H?A%\>GOO'/.[1\7W"><%]:/['#$S<*4Z;S
MUE.#PYGF\AVX%-PP@ARL"83*#=36/=AB]WY\=0^V^(-(@W\=;/%Y+?&KXT1H
M6;T0N_257N+0N&[/M;[8Q<:('$.@(]/;-E",R@@)E''I!A3/Q%DK/PW69HI?
M'!JO\JTI02@)6([R4P(.T2:C/@J<%Z?*1"[17(P(- PDA4',[ ^T)+1'T0GK
MG*#Q,#9<\6?4TC6R]-YR53%%P/$UHA1V^SIFKC$L@"H>:?A3:1"/!NEGZ\(K
M)5LP-URX4?&W5+$(*&C3-XA<IT\T/^=)W:6^'4UB68B-SI/8YGE)*6ZWRK3'
M"]6GU4D&$V*+V&X0,N'(6]RDVL0'^BT;G0J=OL;*M6+PTL<8\ V[RGW>\/O6
MKB$ST:>EB/"0NX*:':*IX20B5:]QTQ+K#^D4MLF#UZ_>"0TK!_#R7_N6<4:8
M_=CSB-4-\P2XP3X5B%-%H*_9JHF+'=_GI<#%;.AG9EGR:@-GU3.:^GK]A>>^
MB_)1'!Z.'<O6PG[?4Z944E_;^#3Y%'14;N9'$<YFZD_>CB:Q=';1_Y$EB$=!
MM3:<ISM,7E:>'2N]1DA<*QD-.47@@<[ K3]8-'!VV;N!YSOYZP=PS&;9_ .Z
M2W!M,<F4%6LBP:Q7Q:S@*@TD$9%>,;:O0\.%,"ARL&!^;5KF[& XQ5>NZ\IM
M829D)Q"S9NOF?1-P3?BMKH$+8]9[#USG6T;CB#8%P23G/#OV+)]A\O,<Z_G@
M\+?&2+BKXE=V;,Y$FHLZ"U[T;BUE$.1#*C)L]D)!+6W6P;3E/LPS+A:HX?6&
ME_R4V4+T3Z<,F#_^]MNOB"4W6W.)T ,0.*>G#U,)-E&BF81(+68']XF(TSCC
M5,T4 ,!TL/.TSU%V)EA\HZO(HHO&QDP#F,*"!5J#B=#ZK2>&$03:,J>OZ?ZD
M.9"<2M6EEX_F>?E42<F '"PF4NT8^^FGYRV /5<W@Q#PVE_\;; ?_8D)9LU[
M-U]5,,0EM]I[KK@YTD2:59#?4>W"CR_?/S_[\:$<EF#VP?,Z[EP6Q.A&+V]K
M+R\A%_P.'B;\1(QIDL'$Z _I8H071(U&#!B >8"=_XQL-#ND-1ZN]?JS( B;
M>2!.DL^4-U.TF!(YY!K'WSMAMCPX8(AZH_?QKR9/CKF;>&]&#T;.H!P/JYQU
M6@%TIF$%J[H+EWPT5"W=1@"!E^P3+Q!MIKB^Z#EXBWX\]YI6+]S[)LO9*!&#
M]\&+]V=D;8TXF\3D%0 >XJE/$(;BJF6'606-UWL@G&ZE@&E-!-%5L&F%L_MP
M4=3&#$UC7@]ZO3YNWA2(<AL^QN26)UJ)HH'ZLA)(<25M%P>1SZ@E 7W3\AV3
MC[7.L*= AW+3%6P;Q9LCF-7QWNRYW,"<2A^:",@-8^]'US5@6 H*+\C5XV.\
MG3*VR'<).2(]3XA)9@YI_)FM.)- =0SD_@&,O/7!*[PG!]^71>E8B3WXX=7W
MIP^I0P29T.2#4:,G;8^&#\ O*:IYY!(/?A@R5G)S GJ!6X:1"V1Z3U(7-[BY
M<V<L\!5R)1&PH:JK ^D[ 39 2W%)0Y(?+H3U, LL-?'5DRZ"&L(H)*!;;]#[
MZR26:WU(*Q]G;L$X S^3I%UE^ G1G=G7"O"]6Q5-3M)N*^!6OR9"10%.!5(B
M+7NO>*5<HC-,Y#I;JSCAJ/*5H3V%;8'U:0;RU*K_#4KA32?HOPZM6Z( 8P#T
MA.VNI@M=4C5?>NX%(&%F3%0BF54P."9L?'XX/07/+S]J?':#9ANJ =0X<Q<9
M,+HBPSNT5Y;%+8WRY^]>GI\>WBEG)8JMYVI2&DJ#EQ4"S(.WX(W>KY_$1B_-
MX6%J+!B\OBC*@A_<Q&XTG7AI]R9W#MO6M%%%<V!PGFH6?IC0>_&N9\K--.F-
M&F=AD(<5$ _%XYXYO+"*.GV%8,_DP;,WKQ[:+A@V<H@-#CL_"K*+X1AR'$LL
M:GB%KH179BB$^&+DQKXAR1'Z=B&D468?K/VI14BEN R;,^)=]64KU$ ;E]4Z
M#K)N[\SB.!@M"-=V%3!-,&F_9KW46GFJB)%9-6X;&T!Z[+J'IIJ(V>+"<I '
M#I/R[+)%=0&$-./P(H]I<$7V-.;.(:B]#+;?4B2)BT(UUK]?.."6I,-W*C'1
M08P96)#B%GLV%;F4K)+3.'.AX;U<KAA*XQE6J0)/C6J5"H?):5EJB$*JY/TO
M2+S:-Q+"<F)8GDU&Q;-(B:CE2XBO>#JO+CB0TG$<F5X-?2E3(A :1X6(CRK,
M,^:[(^8^9AAP G3 H@[L56(E";_T)\T[GQI.'IA^",L$%PNEY(.?3E^"FT5M
MUG(PYK2D8<J>T9DPH:73@B-IF:7&1@1P;1$1CY6W&=KB+5.RJE]XF+Q&D+FL
M$U?GR1@XL(HF-?A8()=!YF5L2D;="I)V#JN.\]L=.F5&+&<':[+T4LQ<E]0.
M]\)7K,&N*Q0LD!"OX;V%LZ@S6A#.&*BRR'CVI@)C 7Z#(UPC6]NE5"$NV (C
MG"0HF-$2L49C.S,,PX>F>1STN'"0*O:/.,E25Q5:DO.^XQ!TZ3(#[&*[FKZ)
M=_I_88!DD_A9R76+JZN;L33;3T\2!<RHX'=B-P?X0=:FPT5?U67.+93Q5Y%_
M<)B<]R'T1 =P[+\UB*[K;+M= XKBE^7>>&K9W;5"B(RFHA2R5]WNG!TAX<TD
M8>'KQU."U%)YI 5-^1+A-&0]%_AD=A"&\4J923"RK) +M]>,]A[:LOM(?GT/
M;;F'MMRY8!S*LAWI1[%:FH+L#Y\.I53A!56C@,J$+_&=Y"<HXG(D4ZAP!7_1
MMI24L?Z@E3DSUUTZ5]D<K,NMK/;%.B LJ9-,-!E2WDUXNZ<#])$4M:2B<F^)
MP(871D8A1DW0U2RHHWW>*NIC].H]2&=>32"#H8A!M%G-GBW& (R7/RHV/] @
MT@B\:VQ0&S%]^_9-FKR6FEQRA.(N%:_/WCR,.\DV[J* F3[X^1U\\/[M:1J:
M*0]2SCDH&[Q]"M/ (4B]<1.7QN\<-CL5?3-A1+<QK#\OR"N@6LA6BRD#W!-/
ME28$I7XEM0F?U/>IR813)967$R8]BK_N3IM8A,/DA56RRH[;ABZPQW"4EO2E
M8H'*IDTUB( $"H6[X( BP:TDWD -EQD\D.4PGHQ9= 8L!*%/O:P (@\(FJ \
M\361AMC8K ]XCC-GOELG#<4V[!SX&9Y*V%8]A:99 FDQ8YT"37A4! =S*KK/
M1+),9*B>AS0X"/:8>ZR%4*PSJH+)6JCV+4UF6%PE+(8]FN2P6E@FHJ<W0KH0
M2\7&U\&1FS1(Y.]&DO"I5*.-&D7!ZYOZ@Y1\M!F6#$?]MJ;+:F[*'F/ <SM
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M[ =ZKTW3;SH/CFJ9*.C%V=M ;*?HE=9W@Z,*B34ETE(QDMCWUG3X/^D_.:
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M?\/C]>CH^)O4:,SIT1 "ZZ?Z@N<"O_D6X4W1Z'BZ"'":^'TNL^4'G?9+;*0
MC_D:'P-&XGQ% SE,7M#GFP8.-CST"#\VKWUT9.?=U35VD4>T.O+REHZ*)A>*
M62=$&%TQ&M4/7&C_O+JHM[YT\I>Z*?-$AFI;LGJ<EX?).RQ90!K"M]0%&(DY
M:L8=3]5?PK,OKST:W)P@') ?RNQC?;XNNM5_XZ%#+F>A!Q@P87K6 UK.1T='
MW^!X=-F.O_XBK[7DC>X4HAI?[!LE&VYS?R/R%COGC;_8-[O-HZ+>OR&=A-Y+
M?W^.TYO/@07$PMX_OI[AT?B$7:9VJD\E%HGN1D+DR>#41DO"'%LW%VWO/HY?
M<#R0'\=/S/7%S^FBKEQ)??9P Q*M':7JYM$R8QV GV9JJ"5H;;AW\16 R/O2
MUK\>'\6K<U_;^F]<V[IO*LBD4/? KOR4O-N5VD@E^5=B9WG#ZY&5\U^Q:H*U
M^ W&0K)YPF9BF4U%C<>/P@LOR52C+FCX+3624:'\[2UVXP,+S9A%H5F\YX]>
M%,WZRS-_VD'2\,LX?3LR35>>P3>PG^I#W-"6]JOC1]<EK^KYAY6#?[]&ENHJ
M9C_UY\/W%R5[VS4UK.O<DH91.5 KQOIU\?Q=TR6SP]>1JUUSS42OF(!<BV,[
M\]TVRG!4&9+"&F+#Y'N%[+^F<CO7[E@L8\SX!<+)/^O?PMF!"<)!6\-+P.YY
M6<W-#RTWVWSEUMQO3)YQ:"8!FX$U@6KDMNR8>=^PQBAMUM#CO[PKW,2IQCVX
MP;?/3UUY<X/7_O2F%U?61,3Z6ZXMQ1/ZS)4U%D4G_YFM-R?)^[J'@Y.\>O4V
MY9++0.2C+?V0JJ>?E<A"%X:-PEZ<X'.WZ?0"'I'?8L?[Q9VF=I OVX/C=-LD
MRU6AI+]EE;C%QX_)]O#_+8$D_A9;)(^.N3NO:ZEL]\8Z@Q;03  #/MZTL(>Q
M;EJWE:/XRZJ OV_-6;2RM,PN[:$+P^8C9Y7 HSW@)_@$&39,$.W!P;M-'$1$
ME0^ F./"G%@U4HY(PY%;/_[_MI9#UM>@AQ(YW[Z2#],[UPDQ-%\2[H/0Z5EC
M/G")X7&P!<=\$D9UK7V/+_.Q2BEE;>3Q+T-WV=# ;&ILMOVW#.9((B1?TV#"
M,-#/H]:4N]9G]QA\Z6 4M,1WG6CL6.W]- D]U9^9JG_]Y1/^Y=$W>U![>F6E
M:>A&!"OAJS'O7"Y<F^@:9JNB1K4[PGMG%%9*DV^_/3I*O@=##P:3Y<GSK.U
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MHPNY:WYP'C7(S V,_0$4O4@ZE=7/G)O5A["TK/.F<0<6OD B0#G0!)1& H%
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M#A[EEW;!HX* P"%,<D2:Z8\<*A\%X-%)Q4-Q44CU?$.U_L9.V??@OM@,1-*
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MTU+C8R-)+"E.":FZI<1251<#3J-7Y7>5K0P*HQ3S!5>ZD;G)(VK0TO5/H.,
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MM<"2-NJQ2:XV<'9^EFNHH&+=@TXV-P)H2DLG#IC>8Y/+7&=?I8*R%,%:?7.
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MGE3)/?DP\RQ2Y>BDAI%F08!,E<@S.U>YS_A\JV)K?;F6"";GRENN4']*U05
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M^V4J"H]L*/E:@S&9.6!$Q,$HXQ89> N&^G)]@^0Y>7[Q_2IA&VQ)? .(Z9M
M.B! 6@O,U Y"%;0U8&'H[[F-FHW@3"G1"1?&-^3'WKO^_5!?S3A;:"I0-ACA
MM*Q(Y)H/>=UUS6=5)J9I:?&%W,$\SYUC^TPV>4NU1UFI'H"9+#'#YJXD)</M
M@_@UU U.4*7?,6B7N_#AV:"-CK&R%FM5B*RT/J/L=ZG7F#H+[6PLL-27?.!F
M':^#IA^>%>F]EU;Z.(L]Y78OPHS#!? RZ=["S!5*)PSY]!:(Z3:(,XY%Y'ZI
MO!#P6TK+F12B)_S.6\_W%<G2D<8@5GZ EZSRW,"LHM3-$E=.6WM-7-E2I%U?
M_'9Q_N7BG9H7\/$7!SZ\_W3UX>SC^86#,QL.:H! +&3SGU)>2P*"#.B9A$3)
MU6HZ0//&N7 F-^X5:IMI[=!,J] N1GFN#0<1"*16^\>*CE<5U[9:/QH&N;[@
M)H;EM[H_;APKL5C\WI9H2AMI-UH.+&&&G)=\K5)943TE.*R95U_D74EEFB$+
M0VYMQK4+%%S>H"[,HO3[4'KAQ6$>TS34Z,+9[/]8["Z0:Z; ;5M#.(\I'\=J
M7==3GBZZOD.7KS2O+(H?&<7O O0+@>ZD4+V@=/+YG.;ND)\NYZV '!"&/[0&
MC>; <M*GDX<K0ZMLO_[0;C<ZSHAYJCT:3X6&*_*V4Q;7ORE*AF9TN]=H_VA]
MMNM\MGWKL[4^VSI:N&HFWO7O'SZ<7?WSD(Q9V=F6K%AX2*(Z<YEV4Y6_,W=.
MYMD<AN_HP2"X9$O(7Y:@(M>D^%<,]'5"A6B+1+Q1']Z.@V0Q\^[?!"'MD6XJ
MSW*&9\IS/1PVNJT>'FT<Z)S/B):GOD&GOC0_FG_K=AJMT^[*GYN-UHZ_]3J]
MG>Y<M]A6LW%J%_OB%SML-+O] UEKK]%KMS=Z*LUB3[6DEURMW6*F@6&>&3*=
MO[WJO'+ PN?/[5>Y9E 8!V_J-:B>K9P#_ZA,>O!0*B'I'Z^I]1"IX9CZ^<T7
MB]3L <1A,F"^;$EAE>U?-<>58#2A48) TV&8+5W:ZFT"+=8"ZP2O]W+^RS^I
MW^@%!2?-F4R/ 9NAOE2*)"G"X'*'I*6CMGE0H#NGBH8"@*K/F=2X=H1>IPP]
M4N(.&W3HZ=^ LC;:\$L#7-,";B? M89/PLN. C;MEG.;-)PEZI+\[+')HTII
M@(<\]>Z7K+HF]PO@@-2;QR"/QS^"]I7[Y&U/\IR'3I7G?[VA5B0G\@CXOA"3
M2?E$.?3?88V/UF=9<KF)Q'IHTV5,; .LIE,KRZ4:6#^4H;35#LV=Q?C4.FVM
MW3YUVYT.-RSXGFTJJM]BNY;F7BC--5MNMS^P-&=I[MFVUAH,W=/AT-*<I;GG
MXW-=M]_K'3S)Z6>TM].#*\FO=DAJM9\(074[:#]NY3Y8VO:$_G>(A@X/ =K)
MT"EM>J>340&XPS@9G:[;[?2W/!UKR.2IV-=+1U*KNZV,L4AZ9B2UW-[0GJ1Z
M(ZD]W%83L!AZ9E5M?_AY,7[A:]D#XBG\PL=M2("U=]H\?$?JD2.IZ39;IQ9)
MM492:^ .^_8DU1M)7;<WV%:EM3AZ9FZWQT/T2 ZFS10E(Q7_@<*M)VA%N1DN
M+O7$$:/,( AQODNI0,3: YN2M]MI=ZW-5FL<M=Q>T]K5=<?18+"M3FQQ]+PX
M&K3M*:HWAK:.]-;//55;K]27*/5FNC_-OGU3&^=6'P;AM@?]'<(3V\+B@ R]
M8\-OK^^VNMLZSRU^#P:_W;;;VC7/R.*W]OCM--UN;T>?]3&B]_ P^&0Y9G7S
MP^T!MI^*$WLV*17;W7#9X!F/5KMD%VD7^4B+?-FE;A^,J9Q[MQT/4'@-3MUA
M:T?SP:H8SX6EWM#M#&UF0]VQ=.IVNTV+I5ICJ=UW>RU;MU-O)+7VF'SR8HIG
M2L:5K:'9.DNJ[?;ZVU:=VLC=,R.IY?:;-I&DWDCJ]-S6<-M\-HND9\Y2Z-M2
MM'IC:(]9)"_&X72.\^"C"8Y<H=)C] J.K>-IAZK)9F=;L6S-L&</3O:WKC^V
M2'KN#!^WM4][V2)I(R0=?G>BX\;0'F,@MIJFB(IW.*[2#_()I=X\@IW\A[ZP
M]30[RG*WM74!L[7?GKOF:3#<8Q\$BZ.-<-1O;QOCLSAZ9AQMG9-G,?2\&-IC
MOZ2744X3/4)PSV9MKV0PIQWWM&VK:HX6OYVNV^_8M/RCQ6^[[7;[.Z9J6?S6
M'[^#'2RI(T;OX6'05M4\'6POU(#[TDCU?6> '1L3ZKC#K67,MJ X("OUV- +
M*D1SQXP8B][:H[<U=$\'%KU'BUZW=VJQ:SV(UH-8U<TP%;%(4D=\6X@P$?MV
M'AX><;YNN:>GS:4!YS;9HT[XZ5C\U!@__6;7XJ>N^+']N^N-G__ZRZ#=:K_=
MQ_"SE^5!&XE)% O9ZME)O6\[-C"TAMH:-TNG9;UH1XM>+#'8,5O'HK?VZ&WU
MW>%@QY1&B][ZH]?MG6X[ZON(L7MX"-P1>=:+]C!H/\?1;9!@"0.HB-^O(;YH
M>^9UU^WU!]8?4&/\#/O6GU9?_'10R[;XJ2M^.D-;95UO#+W>C_0Y=D?:1Y$Z
M0CK3K./LL4WO?L=Z5HX6O3VW?[IC\SF+WOJCM^NV.Q:]1XM>=WBZ8S7^,6+W
M !'X5!7&3Q!<_1['V:IV(;I%V]Z[A>A8K)>F<3#*4F\T$TX:.6$4^G!W',UF
M6 <;R*RV7,_<OH/(RS:!NMV^=2'4%CN=TU.+G=IB![ZVV*DM=@8MBYRZ(F?K
MV<@'FL96?TW+=-8M:5N_AT$JQK\*;Y9.G5\ *@L V7P>P2*G7BRFT0RLEN_1
MO1XP-Y[6@%Q+*WM Q0]/9C5NP</VX]1L'WM5GJ7D%T')/;>[:T-&2\F6DNNS
M[U;''1R[J]I2\HN@9'<PL!%3ZY7?%D%[V.F/A2W:D$"Q@7@PR\ 8S8W5A8C9
M#'U^L_4!W\U#]QE\I0.$.8XR7/@+D"S;[[_6Y[4U:#2W3;;?&@1[]D-:6GXA
MM'S:V-IRM;1L:;F6M-QM="PM6UH^!EIN-[;N1WAHI'S<H<[6?OJJ')[Y^CUQ
MUCWL]H,8XS(<'RU0:K;KO/:6,@ZL>^?!:N5V8]N>_$?BX+'DL0'(^L/&?J9G
M6?(X!/( [K&? >:6/ Z!/#J6.AZ'.G9]QK$W!/E4&,G%>J!M!;*#PV9'/[HU
M8Y_//[S'Z2T619N=(MMQHMXH>MUJ'$<'Y%V?<>Q>H5P?F'OQ31!:E7UKBZYA
M)YK7'4-[G--A,;01ANS$^7ICZ'5S&T6@QMBQCH$5$[N];^@-L'-VMH]X-ZT9
M4W<4=1L[SEFV*'J^4V1=:O5&T>M.HV>= 4?L#"C4UK,_P'D]LCDB6P/R=&MQ
M4V.-V6+(8F@/&.I9KTW-,;3;@+<:8\GZ!JH1?272+ Z=*'3$O[,@O7=>^[LI
M!2]:?6[W]A21/ICDGI=-'MW&MOTK+'F\(/+87A^RY/%RR*.Y=13:4L?C^X9^
MHI8.JD6#T:."G2E4VW;Z^ TI3A^"6[OY(Z-T+/R(<C[#-[ O$>-5KW[^E_R?
M4VPQL:K'1KM?;K*!WSP[,;3))YF7,#W[V]\6H-(:-%H=!$-%H560P%\S/YMY
MV!'$2YRYNB9*TL0!0 =C^&%T[RQB,0^RN1.+6Q%FHG& &!G5!B/]QND P5#E
MU]R@!XO9?.40$>'7!A'J:"P9DDL'(_S^]J[F<?) ;GDWHO [N2WZ;^42&L[9
M@]>4EIDEF"^73M?>,O)F7NACKQ^Z4H1C)YK01SCBOD#@./>P4\>#7S9[5E)Z
MF/#\J7KH),IBY]^9%Z<( ?DE/1]>EP EBO%J$C:D4ZO]^.3::BJ*H2>^"5)0
M(OP"#?4K*;C=;+><JXOKWW_[<NU\>N]\^GQQ=?;E\M/':^?\TX?/9U<7[YPO
MGQRXK*DNV_\>U^[H/ JI*QO1T?L@!+0&( :N1)+-RD,AGDU]V!D_5RRD]K_N
MM7SP"YR$(/1CX27P4&#]4K8FSIV(\3@&L$QXK3.. _@!V49JW()WX-]A-A^)
M&(\6L';D,)DW2QQ8TZW  PS<Z&;JL.R'IYZ-;[TP!;;BRN^",9UTY%<B)J1'
MDPEL"/C<6UR#3SPEAJ,-?^.547SCA8%/GST?&$$2H-[F@$IZ!^S/\^,H26AE
MGQ8I: PC9$LB25QS1QGQ3?$-P$Y3@&$OM+RQF,%>8^!^>\?=EC2GM*MSTIP0
M.!_.K_:^B;4$^*&@["FZ(G'G 3'BT4>RDH@%%"U$M ")]QBTY>);[L1LAO_-
M7WW^Z1^7[TY:0W@]RS1ZL*]A:NJGDBJ!KD"ZP,.!KN#Q"0AJ."E3V"><BE3,
M%V!8Q/>*O.#U,9R/AH.G#S!DO%L2Y>:+(:$I8L #R#&X:"%HA_2]5 8NPR2+
M2=Y^\;Y5KS1_W^K%%C&EWHW+)U8!U\"ZYPO/3UF]R)\)9RZ*6>!.O%MX.JHL
M*'D!A?"&6S&+%G-8_FHA+$FFVV[T>T!6BXC/^QL""AS6MW?!.)U*&]B\D6WQ
M-\W\%F\$0B9+5]]2/!:FM>^CJA#OZ:"T!Z4>A\:_TSA7N&_$R0C@_O7$F\!B
MWWBS.^\^>?53<8NPOQ)(-X/&ZKU/)D^V]W76^7][M5F+,XW%Y&^O_A*T?7\\
M;'K^L.L-N_#1&W6\T:@E3KV1WVUZO7_U,:,4SP"<4U!Z4B K4!.\GZL07'^A
MDU?)H-AQK@I5L[64.<AVHXI:7^!%!LLJJ@G;\UG-N9DI)FC92>V*=9C""A*E
M2AG,LGB5F$Q $1*A?^_<>$&X0N8H3<>9!]\V,FKJ1$J7(8AI A^2D=C[\M=2
MT2<P*@$GPD<!Y*0R17Q7&@HC8"3C#!Z&C*&*HFI@HCY@\(#BP.Z(:W$S9Z96
M9P1>"^$\X 2R4FUSJ=9N=U[]_#&"(]#J(%7CQT21_0K;_CJ%+XA44%V<9>B9
M C[X&1B;<WGI.I?PJS-P'?3YM)MOJVXDP7FP\"(>?YTMP*3!W1SV9M!J>.>E
MWF'OPCGLY=-1:;TU]<E],%=G EK,/(K1100?Y[0K5('0%YM(^=!P_A!.E@8S
M>+!S"[(RRC#\D\:!3YQ#W'JS#(4JF=U>B)YHO#_.18UZE"L92$"#9)=\4* 9
MF0YRLFWAN[GW)R[3B[^"]B0?12^; /SQ41X8O^$-G4VWY'J V]FY)(4U^:+&
M?V8)LKC$CX,%<#6$ E]U]8WL_43H#>(:D#?.09MC_QI[IZ62Z!J^?G1@>,G4
MF<RB._)TDWM;Z7KL2-"/14,<M,+H3H),;RH(;T621O$R;(G:DA0_F@JD"51:
M:? -%VAZR0P?C.?[418R6NB2>007T7)-0+F.#S "/2\&@(:P:"8-?'?1U>?<
M346(CAO0<_4*<N)0NC3@06)N__KN@V;')$+$T&X(3C( @<ZN))O/D8-*A7"9
MQIV)%G_&F7KST*:E"P1]&4M@D,]7OA+J,0O@F'F+1+Q1']Z.@V0Q\^[?!"%M
MBFZJR+^4/H3AL-$[;:$;069]RL=+#T.#/ RE# S^K=MI# >K?VXV6CO^UNMT
M=[ISW6);S4;SU"[VI2]VT&@/^P>RUGZCW>]L]-0'DK:WS,W>;QY^5>+7FCVM
M3'YJ]3;9/_N(]P.!);N<(/ >5! 4*/\$=2)Q+M#-X+P3OJ"(7:?E/@9LAGEB
M& L1*70>G+15;]"=3U'YVZ83=BU/1O7F7H/6"4^=@0X!VK/XY@M UD+$B ;0
M&I--JABVR1C<8OY:O:D",R\V2;/<9,,O#7!-"[B= -<:/@F;/@K8M%O.+=C
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MJ=O=M>7C9G X( OUJ!#;<_N[>NI>#F(/%K?M_F/C]AC1>XBX[6]MJ!_KJ3U
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MITG#6>Y_::Q%KB!_Q$)$8%DZL/%;^#F= @G=X \ XF"<P8;PS4A8BZH'+V8
MM8;S99J_8_5#53LFY\Y+3*#$L/[0&=VCIIH"4GR =Q!FL&]<*CTS%F.1BG@>
MA!Y"#?X&",9D$"=J3^>?_G'Y[J0U=)T0L$K/4D"]\^)QHG:R=N/O<,O7"T&X
M_"@$W/:9]JA)<@T!GNZ- ,MQK/_ZRZ#=ZK]- %  VTPDZT@@!>R%&<V=CR8&
MZI-J!!8( &&J\.KB2V89<AO'@^<+P$#LS(-O^%@)[KL WCF%E<,OGI]A@62(
M4';I25Y8(*.-%^8;YT^$8A*D\, %F#_P#5 8'*-$I$AA^,0%T)$78G^+6"P
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MV/RGV'E&IFY2ZQHOH?$'-C2TJ\.TZX*!MA>'J4701@CJNZW.%K/G+(*>/7D
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MT\H6'ER(6LE-[,U=B<4@ ?F-TC/)%@@MJ:[ G2,O_.J '(5WPH;]8$: =U&
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M7J%+GO!SCWIQ\;G*(M1<>N]$??2O[-?K7K_W%BDS<!60P?<34@",!LF&)M,
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M0'SN(>JZ4D0J04GBI4)X3BR%'V*SA-\,W44Y^&OJPS]O_5X\H(75[Y7I]R2
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MG8V=ZX*+SL87N+ ESM%FTV7R"N/C7^/#B)-ZL7\Y(V/WG%2(T4<NC0/&$X)
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M!LUZ57K+4N1&1Q85^J"O)XII?LS\766,=6",UV>,03@Z1;4&Y$Z X$R )R%
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M-%9!O%:".)_>$W13?('S_W\].EW3G\^6M";^=G;UM31J6S0?9BIH$IB'$'T
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M-IO_"$>U+D3OXXOG3_L?W>=FV=Z,GY42ER77^VPIZ_G>W?D>VIX 0IT)7FG
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M30&\,PI(D%Q0S8*():-IF\L[=Q*JWM#> GJEY;@KH%<.Z);NX$R0I+V $%T
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M(<+7LLMF6X&'<WNJ=:; $AF["U#6]I[!,S 8P% H+)"C[??;K3=N"-X(FG[
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M,*;IN*MGTS*I>7$J_6Z>X#T."+E GD76K"[P(LLTH%PEP0<U(W#MXFZ5/1'
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M%'(([I.#!"VD)*+Q-\.DZ=FX!&LNT^;6>:X(B!S<A_#0K2J]KQM I"?UJ/H
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MDO!OIR;N+""6#D)UWQS=H@IUNUKD.D WS4OSY@TQ^_B@D W9FC>=7PYS.^#
MT0 XL0^L\:1'X?++1^%W'FTO'87+R$7P>"8\S;APD?;*9,ZFB: L\HE\\J/P
M?V-*JPN[M7%U".>E)+E!"0!<1]N837%X#-)@+SK8-:S3>WO9'AS%\,YN^_ H
M7CUD:H,$>'MULGM\>4R/KCJ]=]WCP[=@>1K:V=VY/CG\T&W3?9!41ZNGW[OG
MGZ)4)YET*>$6/1QM/1B?2A$FC176&J?3%=#KS,4N4S&7.HUX#%L"!JR,C !/
M!AB?)YMP0O70NH4<- >X,2>4S3X0KY^P!>DQ0;SV>E7K_(0K+TV=8[R-JID6
M=^;9\BITH1X2@^G%_0I4V%U=(,H-,#_VQL "!)OGD>_DE;VY[$+49,0?"B_$
M"[:*+\;A(&_DP\'W;^\.CGZORJL1?R5<LU!R.UY /UO(@5^!> H%R'FWX0)J
MI7CBA;HNJK=*V3L7L2N=E;#XS'>O\#VU!E,PV7 @616AEQ/-T]<#)A'B#I7E
M&J'FN&CH"^H B Y!:3 [/MRX6)>6MP"I<&W,N,0>T*/Q>'09.B#C\_#04I6M
M 4Q_-,&R>- *YJP\*YW/:_G\?M.UYRUY5G=)EK55)$!7BU7[RUGU9<WU[42W
M>D]9.[&^7KS^:96GOSBJV_/VGQBTA],[VN?>I9&7Q'T2)1&5TDLN(NX2*:FA
MD<F2Q,2)\#Y^<@W^9C2R")H$?L(^\,GPM OB*<=F*;_:B*ZYH%-+?<[;;\"J
MWWT;X^%%^R-Z!OM@0?\)S^KWCWNG<6=W#SZ#<:SH\]-+L,)Y9_?#^4GO[14F
MC;1[1_ \L.X_?N@>[!YAUAH#JWU9GX/UO_?)>I6!QV](Y&)/N& I4<Q)$@F7
M:!%9ZR1_AOJYW.<-SU0['('MC^(84U<NSUR0%:?EV!$@K@"J0UD$3-G/RZ9"
MIQN/^'1Y_[TN-J[!A.E%O5%TDI_40>= &:^BIEV#1AM/<JR)R:0 +<NA#VM]
M7>8C[6+O7!Q>&$B!F!=P#5&?A;JM12QF3*8K$#?Q0\S"#KBGSN9*;>Z^S!%"
M5@<9RL%=W^60))/S[D5X5WVX.+T<>-KF8/N8NE<U8!B5UR..R,(-VZV/9WE;
M'5PQ?,*ZJQ:7-U^S>8.D18"32=EA>'':DR)SJ:SE7$2<# H\IY@ 'CC0W6&%
M[;'^EKR50XY61W(#*,^!"M"C\SVKC6QQ&H/9!'&QST,V5-&S#!ZK1[,I#@9+
M(M&6<SEH=IF:6%A[Q1\%E6RWWG?!%$- DARYI'I<@-<I%%^-&JNV2&75[!P#
M$W:OYTR%2^D1,+R:=NNW>2[DY)97YC.8HUMNE8E;"Y#'94/@ MK537[?JAF_
MIV!>3<\*9)W0];Y8SV!0A=]"&SA8U:UJ?XK+2S##2:#8JLO&  &+0A*F*P L
MU3"T^"A0*V]##%W/57EDH$Y@6W-\RQ)ELF8AEQT[RKYB"$@UNR@YHWK^O ]3
M*8PVO'SH,, N7ZK)[:V6UQ3Y)& Z@@G)F-?<@>F8464CSFW*X7^)"*9&5)H:
MJZ4?Z6V&QWZU_/\>32:+91_!=R W;CRJ*CZB7\X.V6>=W5/6N3F_[-SLL$YO
M[U/$#-B'CA+./=@AB98$;%9-(ALKKV(3$ 1?/F!SO\J.;#;W2397*VE<RC(B
M4MA7X"Q.E(\BDFB>ZI3).,W<@S8WXS8#Q\+(+#6<IU([[5P$W@6#][@\'3"6
MQ>;&LMG<)]Q<&YG$QPELKN6:\(@E\%N:D#A*72) K'KJ7[P<CE;*MN[^H*['
M:KJH;(:(*BL'1L0FWO:6ZM'P,RIJ2%?ZACYJ+!P##E_RI._TC)<\Z=@QD:;*
M>9XI'C,I$J6Y3C$W4<96I#_2DU[^>T,\ZJ,Y%F[OSQY^?_#FB&%TO+V[=W-\
MV :Z?7M]TNMW.[MO>6>PEZSPP^!UM_VF#6,YYB>'%J/CE^W#SED;Z7WWK\$!
M\M;N*86Q+'O4EYW#G4^I],Z9Q!$G4DNX-8J(B,7$"\V8H)S*[#EZU//];N4;
MOO$&X1HT[&H*M?#?9*9[A4NY[">C2SZ\%5 ? 5NQKVD1V%UX=.NW41%&1!]B
M=O%[<&"UJQSZ!>^V-D+KP 7J3AW!.A1[RY"#(SS-H48#=&S=H\K#!.'Y&V 2
MSQ7J@5\6&7M7A0]7BIEGH&^_MWRIZ=O>.8=K/L4T 2M'>@*V#R9I.$E "S'B
MO!.*LSC*-/NQEG*SYX^]Y]1'5GN!85DTH'4&.L4S01+C+37 I4+^8 .ZV?/'
MWG,K9,1XEL&>1^ 19PB!P3-&I,TTV(\VM<8^CEV]JF2^NX'=( Y7B,/B=L3A
MA[@BHG)%&ISB#1C+T^ 4K_4R[_0:E[Q,EL8NBY47*@WU^9J#XD^4H;$14MFG
M;;(2T'+^/3\=+Z!R-BOQ"D1SU9O^8/?XJOT&_NOUSSN')FH?_GE^W#L;'/=.
MV<E@'U/W>8"]66ZQTMOGG=[>Y4EO[_K@X]L8U <\YUWWX,U)]V#7POWVO-T[
MY>W=#]TEM_(*_OV4)&"4*ZV(L2K#\L>,2$H52:2UJ4N,2/1**]MGX%8N L#6
M".%>)[=L0P!@%],[\J.LHH/*)'3"G81V37BF8EU049/6;P\!IW**,>D]!_L,
M! ="<#,;><=]QK5*/;\O'MFN@YG;W7P,._F0)L\#E^K[,^';FRJW^G /_CO_
M)%(C'=.&)!DUA+,D)@)1RC))E="13[3'2M'X,7')7!IYJ8'I*8\X94Y*$.W6
M:H5YM)S=&Y>LV?JOW_K=]B>9V)@**< (MS'A7@DB8@T_M $EJ6GFJ< BX2]B
M<-X/Y+".8O9[@?6,D#XY*(D;=&>#"AUVH9,)PMS?!:J?7UD*KG!RG!]-%ZF1
M13.ZLIM1@0L\ >MZCN/_=5U%[FFY)O&7@^AWFBO+?:"I FZQ3@.'\(196,Y4
M,,M8JJAPS#]Y$+VJ.@N3./"[SCL$?\IMG!WSGUDW]UE>(1S39L31#_<J__=D
M=R\Z.>R<MP]?PSNPM'XG.?AX=-.A^W@FQ X._P*?]JRWB@'X&NYYUV]38+2/
MG7/,-&_OGB<GAVUVW#-7QS=8![-W<_"FO81X#[[T[OZGQ!A0;BXC5(L,L8T4
M$9F)B511! (P3KQ_CCWB\OUMU;:]%?;]^8730X$*A@IRYESI&%>!C;>FUQ=%
MM^(S]=FU%+;:)*%C><BR01%3A,?S=/(<\#R74X7DR5O*3D,Z[O2+U6;?Z)#
M,T$V Y>"8]P93;O&O2OZP!Z.7H71Y;WLJE9VKXIIKJT_L^J79.7+3PFPKDYC
M0U@F%,%H(Q$L8819'DLP8R+#GA#5LMG'1]C'A9 DZX#Y*WWJLDP(0CV*Y#BA
M1'.78H@8^_SZV$7FQ4NV4GF^4M8'RUFU3QB&S=G.I6#56*W(2%,U,9DC_P_=
MI>J'MCR+XJ>2%'.Q@T=E%V.P9,<@$+&#S_@T?S(V^QZ&5G$5$N.36C3\RQ;-
MG1;*<H(]E9&UB8Z H[A/N>2242LD36,14V>>WJ*I2A5@#N]G>M*U74P1G1R,
M@U^\/V_I5Z]JV,.$VJ[;%!/G;>E3Q%@PU_EXTN_0=^?MP7X$O'1U<'B"[^N?
M'"+MFZO.X"WMK*3.'%V?'![%)X,C=O+F[?5Q[RWPTE[2&< X/G[H'QP:\#/V
M*/!HO)PJT-XUGY2"!;9@TSB7@CNIE"4Z$P:8*J,VBIUPSQ)*]IVS#IQ-C&%V
M1L/ CZ/0':.U7]0_W6GM%/%\M@XI\4?8/[4I#1>G5)9TW5K7,ZGQ1^OR;!1Z
MI%B7IREC>NYH-IU@EG75[V34+U-[JPXQ*^TAI_" T5B-KT/I'C;%?/+N7.4*
M+.YIN:4A9KTQ =OOSMSMFX.WGY1W%E@W 2L'5"./,>,QH2DQ3#%-,VK$:O2=
M<E"=QE*;8C1'&&V \SD7J70\XGK%Q4%+W,/2YW5_.6IHU;79NJGJ]B=+Y//_
M30+%W4&_I3[&H,5G[%E<YHK??0)8Q2[^6%6<7X^(NE97WKE<3X.D&D?1=I0?
M?ST42C5+MFF<?!64ZI>_2]CM+_U:@-88IOF5N*\_:+#\,=!D-P+$2"QIHA7E
M&NCO-U S@SR>./G]'N!%Y=0BG-B+>UVZ9A7R(_%-6@>4.[_V]*.%Z7\MYF0A
M(%'LPJ1;P5AOE</?"+ZX)[;5/4RTK99VH&-"]1:HR+Q2_C'P*Y>IZ]$6/6H]
MAZ7_[^4U?+SYU^<=T"$V:N(/.,;326(S$U&5I9[+Q,$DF53:QUFF6*KE+<=X
M*XEV=]GA>\$=>%54\NV$0K[[G?*ES]1H+X"R>/OP_*K=>S> Z[HG"(ESV+XZ
M[IU>'^R>\F/ZKG^"S8MZ.ZQSO0R4=0K/WKONO#D&X_ZO?J?W[JQ]\[I[$$X2
MSWHG;SZ<MQ%.9]>P .[8+8"R=CX)SZ,DU8)$-$T(%V#KZUA8XF*FHM0;FP@+
MLGH+7*J54\$"Z_.I. >_?2 '-1*PD8!/* &]EE&J,A='VG.3@MC+/(\IB$&1
M4N<H2L#[I!HW$O!'2\#.JTH"1C*6/A$1B3UEA%O!B<A<2F*19%Y%X)T[S(C9
MRFCZ7"3@KX"$VW'3T%KZJP'<E^9\JWM%'[9N:Z7]LY9Z,C:,Q=IYS20W.M4L
M-K'ES#BK=)0\O+H&MFX_X%5@A?).K?7UX>@NR=@(N@<)NOVZJ:<$52)A8-LY
M9@@W'C/!C",93W3B4VP6XEZ\%-FW2KGUPN1)3;F&E^_+RS:+#14JB57&@8FU
M8#9VU&B*I5*1?7!U9,/+WX^7:T8+!X^;,^M(ZK&<3H"] B9I1++4\42)C,'F
M81KO:BKGCV/F7Z&G3"TI[E':RGR5)%NS;C^A)'MTJV2MD-I'L%(U<:_'H\&?
M"'SF)I-7<U2S1H8]2(:UZ_:(X^!,1S(C692 XT6SC&CM*>:CBSA+8V]]]N(E
M%8_D=6U0:*GAXJ>S1QHN_@Y<7+-$-$<Z96"$Q%H5&6!.1,3J#*M^N# AHY(^
M5OBXB8_<_S"Q ))LPB,/7KW?OJ\E@@B@\-NR,&MWAZ-Q=WI=BK%=-Q=CM?UM
M0L./)]O>UBV4R-A$2IV"@Z6P:RL31&14$N^4H=))*3AZ65N,K1HI*YDM3;QD
M4YC[1]HG7\72:_!E&FZ^'S?7+!5*-;<<%C*C%LR5S$C@YM23Q#N:FDC(U(L7
M+T,2*?UG$S?YKBRYVYWDH<, ?-U$3C;=8+F_4%O8V</1>O_L7Z.^=>-)(]T>
M)-V.ZK:*=YGWEJ4DCK@GG":"2 7"+C81XV"N9(D%Z4:3Y!LLE2:2LLE<_3U-
ME8:KGY"K:S9+%F5&I7%&&$L05-YD1$O'"8L2PR/!:19GX(%PN1E<_2L$5E[/
MVUO,NV,IVYL5]:)-M.59'?LL2[E79VIXZO:'<V?L ^YU(\0>),2.%Q)/,I,Q
M;QWA/((?$3=$"AN3V+N8&:^SC*L7+[/HFT/$321E@QGWJ<V3AG$?AW%KUH?+
MN(XXU20%*X1P%G,B$R-)$@%;*IEEJ:18R+5)C/LK1$ON52CFT#C9@!*Q.1!"
MRXYF..9R@9H*BD=;H)]&3>A,IM3)C(+)P'G"I)8ZMH@ODTF567\+3&A38K%A
M>L34#<#4Q49F*B+2(O(D\YX(Q;&A3)IY3;/4ZAC/T3A;11W]IA*+1V"MYU&%
MU@C91L@VE;R_GI"M&>L_K)+W!PK98.S_(]0;K$.X^XK^'??LJ?'R?_3X'VNP
M@>Z+IY?=T6;O+GR\)0BFC$HE&&4\RA1/DDP+[2UFWR7P?JK,LP!=>V+XK_=G
M:NS^Q/;2""KEAI,<S#A$"D)W0-S@[F?W=Q]FM2$ ?Z8"#>_<[/#V[A%KWYQU
M3WHF:M_L) >['T# G-X$@?#FY+Q]LW^% F4)-)RU=T\OX5DW!V_^&G1NWMZT
M=\]YY^,QW-^^;M/]RY,!?-;;8TL ?R!PCC^E"8M3:P51C.&QHK-$I5215*D(
MZ(SK1.G5IH]:62!]'T4Q4*25H&@,&.]6VE3"'<N 8&%G2-B:5GUO'@K%]6,!
M]FYK97+'6M2!B>=]KB>AKW:Y$!7<)P*:3<)JY7W2U:4:6_#U:[W$IR-SWAJ5
M'<0#X"@>U1F$),V_7/MAWMG]-P07*X';MQ:NPK=B:W&$,85[Q@JG3G 96C 6
M! $$25UT\\X!4&$=/W>-*R(0K=].W="- X8R7O6YZ'.??_M["?@69K2%K0JG
M(VQ+Z 87_=&U<Q48H0-A'!H]C=VT:('>0FS.5NA4,W]&2YV.7?@:EL=CJ7"_
MZ\;;K7?+<PHCP8[GH$5@SG.XU3"A!5)"+%W2O2)G76O=\(]?2#"\O3G8^>1T
MK+T $2N<$.C&<0(ZW!,0P(RZQ&3:@J;QH]FXX-0">"\ \*\CYQI4[@JI(:YD
M3N2C')4R?(S; R15?!3V'=OJCM5PNMUZOT#[]6UM=G7MKK9Y9Q=LTL,="L]%
MV/I/#L0]3>*82*E!W#MPTG7B)8EM:HP0P:ZX;8L+ '1WY<:FBQLWN\"=_9):
MYU:F7AI'0;%PPZR(X\0YEM+8,VFTNZ]:U\MJ?6<\QM, 9/\_K^>7_*VN\:,=
M%!![5Q?=''GY[R""UJ)FX^Q^.2M@B2QZX%M$W">Q=T31."6<6T:D,^ /L"BE
M3G/!A<+6(2LPV3EU^/%HL(YA7]TA%!:5V;) \+6#^.GJX[=:EV==<X:WH:H9
MA(>N$QPM+ @Z!:VFN\/1H(O8W.&-!&4-?C,86=??;AU5"F89('>O4%*%!/I[
M-C9G,-(6FI*MW_;>__TW*,Y*<94JK>R$VQ]=YM.]*.];"\*;Z^XIC--V)Z'W
M#=P5Q&%MIC+Z/Z4F!7EW[J:EP/1K'PI2>3 :SI^-UQ3G!D'D@E2$[Z=G\Z'E
MZAID;<T*N=54@;DALBLV;0G;5YDWV!885MDA_\$"F]$"^O <;QL6%/X9Y-V+
M?>L@OP,NV%[UXI;:;7T3WGD:?=D_N]/?6O;/'$_A$N&XIIP[H5*C%-.1%JGW
M&D^_&_]LKP!S 6D<B&O#&NCU=DHIS$\PF$/;(%'/!@=OCJ*30P/2LLV/;^#[
MP]>]XX]'K'-X'+>7FQ?TSOKM&_C^QEP>O,&>JN_ZG9O]!!L=M >O^^V/';C?
MQ)W>T>6R+];>W?_D3 PT:SD1(@;EK")!)+6&:-"=$=,9!SF\3'DR@TW(1.:0
MMA/F%*(<@3NBK8XR1M6R+X:P.N5.M/[&QG:YB A;TOH9/+([5V3!(T/9-L,V
M5>CDF IQ".5@)3W#TJ@:]@4*\R/L@6[S#AVM-]A!?>'ZLSPW$KO$P+)U@^\V
MK$$:?</S4(CFZX+..IB[ZM2UAJ&9" K1^ETY=/L4K#=\?ZUG;BGFZTMA'?:Z
MP=I9&#(VIK6+(WZL)<G5\>/-8JO(SBM:S5^,L"%I-SBB81[@[);/66X]MF"
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M.U17C7AZH'BJEU^GC$E!)5&ICT \>4,0ZXK$#K9-QCI+E'OQDK)&-C6RZ;E
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M,F]2GOJ$9RY2)A6I-IF-M$2QUD03-E_,+;3\C%W&7<HYT2FSN9B3.J%$42%
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M_B]PUM>=Y^]N'+IZ*U&MG#VKG.6U<K96SLZR1=^MA+U0T2H$M6 - RU!,I.
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MIY'0;.$1+)$4O0QGO$#/ [0#D3+EHB8R'@.8?4"W4RHC0I2:>L^L"A3-5A'
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M8=6*FQ$_3G5F-\ISWZ^$NCR-(8 G3)3$8Q<I:B\9\-?L<[)!QJ*]B'FIFSI
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M$C-C0Z(@(S49DA*4.4^%]3E-$,RY>YPB.4W]O8KCA^+X4BA+!MXH5BI4.4%
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M@7F&V@9[LJG08#_W"M<IA>M34Z-R]SA%<IKZ>Q72#X3TF,^=">ZUDHDP!YR
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MM< DBP)HDD8@0?O$G&!*"JLK*[\&5OX\SLHF41!@$TDY>61E[XD+J?0H5#R
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MW&?)#1A&>+;(X4%+8IS71+O$F&!9 4<.!W:S%D[-07V^_H17:IV]9J7[GCI
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M/\O6M^/.QC*.\70)UD_;QYWE/]"R^V4+O[]XU+?_/ET9KQ7!N1#),DY ^$3
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M$7(?DS&+:!+_L:9X+9+T /.5.C(8S2'K!IQOOX%S_>U,9W*+F3=03)UHR84
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M(=R=J5$+*?46G24;YY-CW@B+SGG+0^9"!*\\Z<<OZ&S4Z,'0N42-5,I8E,[
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MQHRNFN1U9<Q(MIC1O;M>79F&YGIU6XST<J8\^5=!)" :9 "U9 0GZ4"S+'-
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M%FLG=&TU(C]Y.$[[M5,U^;F?IY<2!">?9\BBJ_XMN)P\8,% WWD),6'FVI2
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MWY%56SU='V_,1Z_I^]?3O>'@[>E_YFMR1-<9S7=/1O-:93:<.9>,12M VU0
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MF:3=2P?'M?78U\=QMQ.5WNW!CQ?B=?^ GHPQZ)QQM3.F>[<0<9F&51-@.6>
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M!;V)$%(QP)S $$-@S*2K#Q0:F!\IF']=/4"SQ%V ]]P2<^:MT2R!]5X!.A[
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M)T631E+FZI4! WW!@2*L(K.1>.MPKG+!IU6RJ':Q3$,M_XAV<.%:.:T=*TO
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M]+HN</@GJ$!_ND;+ZRZDMC1&2['R-00^$0(_5$V6""15$RE0S(8*#]PB0ZU
M$@/AP<E%GLS*.KE>=NV!"%A71UQ<I9ZOQ5(K]724NF*O1"^%IEH#I<%@KR21
MD(F"(L*ME#YP+[S*9=5KK7[!6CU?>Z76ZBEI]<5638S3&.N 6%$UC'N.=)0!
MF4"T%]'19')ZZ +I]&NHDEJ>_(+>/.7D][Y.F*?-W3*<RM4S5L_8PIW\UBZ4
MFI=-L?S>,_E0-F--S&9%S/:J/A1+++;..C"R'$-@07-D+8]("^(<)]IPGX^'
MZM::+U2AG\M_4BOT+!6ZXC]A1'D>@D(VYG2JO' Z&(^XHI%)X96PV2G*%J09
M1:W1T];HY_*=U!H]4XVNA-4#UTH.E%D*FO788]!M3Y&0$EL36.1*K:R;ZP$<
MR]Q=IM1+L^ .E$]Q.&S'NA_NBSF[O1G4*LO\I34\A.MSO_#1\+#7OZ'D;6K]
MB &=Q7ZO1KT'H9ZO&B8X\!A9"D@K+!!G! P3D:T3AG&040(BBNPAT9307Q<H
MQJ56_24]X:U5?ZZJ7S%A.(DD2F(0,!^231@*(! <PB9:BP,),H5:]9=5]9?'
MEOFY[M<Z_C =O]C>710TV1R1;@08-9HYI"W6B 38WK7,'37]RCI_BE%3!ZY.
MT](9VN%H6%2_;;<ZK6%99K=1E..LCUY>TM'+QQA&Q6 N@^$?>:5WTL;Q<1MF
MS[7C6")VTA\7\E CXH,0\>"2P9,2<S*I7/B*(^Y( M;C-&*YW(^Q7":2^WS7
M?MLETN\%-'.>IMZUL3,5M:\:.U@SFGNB41X%XB*"L8,31H8+9X1F@CHY-6.G
M!H %WN"?R]BI-_CGU/1*QIY(6N3*EDEKC+@7%-G@+$HT8D-#X%*$E?4IM#]<
MH&.<A3Z]^6DQX]@-"U'&N.[O^ P3M-@;R1Q:Y-;E\V:^/WRK&H"$FZ2,9$AZ
M#/N#E ;I0,$*I 0L?!QQ, 8,P%7V](S&J6O/<A01K7&TQM&ZH/R+Q-&*16VX
MP\H(ACRA%G#4 XZ2&)#QWC%8/"MCFDE!^1I':QRM<;2N6;_4.%IIS"$EE2YY
M9'&@B*=@D"-:(,42Y=S%D#B>2<WZA>DY7AYG7FK@N7Y#)_+*:>U81SA=4P+T
M:)*<]J;HO=WZ'L<="<<Z5/G@^)GQQ4>L@\<;#6__R.46D]<[:3T_,A1-)X6Y
M<AQ<^7G8GXSFV!Y$Y/K1?D,VP6#?V/:)/1VL_'+Y$>'YKDSI_6;C]F=/:6;/
M7BY!R)UD"\EX Q(>^_DJ&(Y=F+$T#OL9E__1HMX'@ZTWW!H.OUK'K',D2NL\
MQU9\52OKNV47W-1XFR&]B'.VZS<M\!6M*-%6"1>M"#X$!Y#!??XN+)6A0?CH
MP^T]4PF=6]/4W8L.Q@T7VZWX'>[=&N8FI_WS-KDY[;3HD]O(;5';+>M:[=;P
M-&]%=[1//6FUV^?I]KES<=$S&A:J,3R)[>^QT8'1'0X:[O1!O<^GY?!Y6L?@
MC:)_[$XJ/Y)[*8^O?MD;].,;#6_!AKSUE3 >!=$6T80]XKGXKC$I(BVEDXD[
M*75.P+Q>&N.\;[H=-"R(9C[*R8IJ1P&D=7 1NS9IA5UV1#]O!#PHCW<&5T)Z
MKG2O7K26QE7M]&T+HI=RP_#<#3XW#(=I&!;/>QR[MCTL>HD/!CW?LKE7>-'K
M?=3UP !L*[=Y][GO^Z4L\CR;%Z_'0?&9?"W,(T!@P3B*>^73L?'\P@3NG'<>
M7VMLCOJY_V&>\9RE/FB4;<QOZYB>G0C%D#,+OM1 O5'!D0?AP?,5NH-YRFE>
MD\G>Z(:M\2J\^P%+,(BU\M^B_'C[Z//7X'/,AW698FO$J0S(82J0HXQA3I+"
M.=)97H^"G"C_ZH,$XQF+I=6"\03!^/95*R.TU0EQ0P+B+(L(QPXE3Q56Q.?-
M':CV7;M"]V&@\8PEMVK9>+QLG.U]3<XE*ES.Z[8Y8@B0PV@OD>'PNM,1F%_V
M;UYW;I[+!FQ8MV^8JYE+'$>?S=7VZ5JCNN,>V@?N1+,]BKQ3EC:\[X]BJ&7I
M-EG:V=W["E:9-I%*%)FF"/X G($M 1DO&0XL\&1YEB4^/:"9\;%*+1-/D FR
MO;G]57C%L9$8:6,-XM999(0+*&INC #=-33[_>CU3B!5@+'E5-_&RDM#><+$
MKU%PN,'-?'G,E"F^ :; IK:%$0JWZ(-AW<L0Y]NC4 RC8-999+H>;/72#+*N
M]SVN-3;N^,*"D</=3O*/!<*^W4,[_-(;M<,60+,?ODNIG NXY"-8)O<3<?/Z
M1)SN;&YD$2> >@HFA /'8H8B[0@'DQ4+ZS(\\5QD=NT&?N4N1/P.1\]ARQ^N
M-EJI8L*M-D[R<C5LL5*E03Y9M.+38$#&9;*^RZX.[=-&:K5CU6J&AQZ.^MW!
M1.D^@Y),+&:@%]]MO]4;#0H'1"R]$^T>R&.K--?A3YAP]'GMTUKC"$SI06CY
ML66=O[YXO<!S@)+&Q_@]=D>Q\2GVO[=\;/QSZ^.G?P%-&8 N=H[;,7]O_&$[
MH.#E6'S5AK]AR!F74BNKQ]AXAZU(EMB5*YM<HD-%4+;Z==#X]Z4C@BNG7P8L
M+<:LS)W-O6":)2,-(\8)'(!0WVB,7T: '8!-4.L]&,_KTU?6W#Q@S3-X_0Q>
M/_)?10K1"F\1910H2VX:;[G'R 4EB91$64YRG@Q15X]N0 #ZO='!X9WKA:6(
MB0@5M%7<*0+WUL["NG$M ]>J7J^'K-?9AZ].>"88T0@L20OV+/7(2.(0(8XR
M$0-67N3UNLALNE@O4,Q2"_-^7IQ@@*)^;P&8N=-"G4'=QZ^7#CK0^98%6@%;
M^F#4+W[[L]\[Z-O.6B/G\([]H#X>3]R@MI'@=H,Q-E6];ZT! !% 4_< ;C\8
MN:,"MGM5U,C0TNJ.<R$+@,@7Y)O<)6**2VPX%UA0RG$ KD48$''X*U(1G*U%
M[$X1VSYM;OJO7EI*5;+(,P);.%$&V6028D&["%:+%T$5,,!O%:N\CS0.8,_N
MV_:UI:\L>&65\Y9V\^Y4[!REL-ZU]IP'KV /D(1&SAS5C@>.I>,F2L6IJ=?^
M[K4_:V[N?8V261$MD#8F1>YIYG.!"!  &0J_J2'>%&LOKJU]WLEAI4YL/USA
M6C>?ZQ?S^].#4HK%RMV<C13A &6$ LIQ3F_8^:'].+L;L><@=NI&8D?P6FGV
M7/]YES0_ZJ3ARJ'CL.>_'?;:@.&#=_\=M8:GS=XP;@(%:_< PN,N?-EOP ^_
MS5?63[<W/X]EO0=2"!BT^X[L'S7;.YM[>']S^VSG"\AYI]D!>059W1-[1WMX
M[_2*K!_!)[.5O?M79YM^!CKS\1N\(N"[82Q[;.\([GC4;L'K1W^?O:/-S6^G
M0'EP<_/SC^W=[:]&)NL5\\AJ!M0G@(T.>ZA$L'TP100Q)O'2"@4ACF$C6W\X
M '.)7'.>3QHUM2QJIZ3T/H+T:K?2B,!VCW.E ;#75]8_'<)>.UZ/_]LH5^1Z
M#$Q5<6X\^?_YUUX>9K#!@'1@:FGB#HO,&H@**B4?79+\<<$>3]69XHYO6D,P
M3OP]M.AC/!BU[;#7/VV\M<?Y8P7>;+:^MT+.)?H8!\/^>+]8&D/OW,KIET]7
MV$T3<I4?[S#:-C"KCLVNGF[Q<J]_8,'H+>7AG_]O>^=?>3\=M$(+;+]8TKG*
M!CN^<^G\Z>8X,?@)"#VQ(%O]BK/G!J-P$"\^LII]0-V#1B^[;1KY[/:@<&F#
M(,.7#LN+JV.![R^&GOU0^3OR@3)8I&!8M@<7Y^1Y37VYIJO9017 T._"=<!#
MH_6'EP:U6CQ$?[S8!;$8MCKY3#B_7KJH\IW#6"[*ARX''%KY4VY43D;A1X#A
MY4B4QK%MA3&]A DYMD7_:U\L$CQ'069NL+8[O4'Q9</)- WC'?.=%V;,B,"P
MS\8RC"=_3W%TWNF%V+[T:7A&Z]JMP6$Y%?G[F\5;(/H;XX/W,='>.A<:$*Q.
M:S" UP%CKBU@Y?N/8[_3&E;F"9Y^,A&IW^M4UF;4S;$ !WE)X&N.VZ/!^*$K
M8GN^[*?E0L"S%H$/>>QV #][W5L_<:X%A6!<EHOR+*4P"L:S>5E@RE?+44T>
MM[+V_?R-*?;[L5A>$*[\913_VNL#6\BC/;^X>(/\6MSP8IJJ\I'7J3<:CHV1
M_@4@V>/C?N^[;8.<E/,RN2DPW]Y!+(2O6.2)'$[&=W[;L3?GN!]]#$6$0S5H
M:;4PJV)^H(H:7<Q%,=, #)E;5Q:P-^K['(,RUE9 .J"UE55<'8=>71%*V)W@
M&KAZ/%5 $OKVVGQ5IZLS CW(0\\0<L?L+#8NO\\6YCBPY"=Q)<,;(#R C Z&
MP.(N(S@ ]&5,+*'F1IRI2 8HP7.&I>BKU/&M'1Q.]M;!GS#DW=Z?Q6C'C_W;
M:35BYU/E 9?".SX/RHGAVJ\F,*ME8LC+H!"/CB.-HT(.>\M8B-);((IZ[7H:
MXL0[OCH^>,DH\1 1(4;8@)FV44J>(V.,<]9I,.(5I<S5(K(((I(M<!^PP-0[
M1'3N):XC&-^*$H05#F" BQ Q4':^=KUO1/4 Y6;4ACWROC"'%Q#FGAID5<OP
M[&68[.Q^_@J22Z(+%DDB\R$@Q<AB[Y$4+OMFE3!:99B[GMWR5)@S-')K)8W.
M",ZP-3D:'@,'M-QX2D4M(O,7$;J]^>TKLTHI+Q3L?SQWQ]$6F<0$TDYH:2QU
M1.D,<W>?$]\&<XM--2LN@/\+_+O=<V#)@-$+<-HJB/@-9E(&SAPCEM&W4[QE
M#P[@NFQTWFD6/9A+/BZXXIKB?)H,:L/[;):#)O]9?#T8)>?OC7TY&UW0G&*T
MO]EVWE1JW;E%=UAS=_LK=L9PJS%BTEG$+<,(>%U /$58,DV,9@"O#-_%$>Z*
M!"J/XB\D[6[YZL(]!H.L?V!B#^RP-4BG50-P[" Z#^@?/E+Z3W(V1C8F?Q3#
M:C]+)L^4Q/IC.0?W#(][A7(MLG6$N7*:"X:8R/'95&EDDY(H*9:DB91RF</C
MV!WFT=URO=C;PL[Q<-1I_&:[WTJ72B=&^-'JMCKP\D3S;M*F]S%D#PX\=1'I
M=\D?V#\>IRDV_OE^<^OMO\9G^D7 SD29 ]S3>E"\4;OTVI;.T=(]-'8FKS4V
MAO=QB%PD]E4?)Y:^VCR"RT]0NATKCJ>QU^E+;+<GGOX<XK4V=CC-?04?>&Y1
MG/DT/L;C4=\?YM3$<<S$W)_C3DG\?![W\5O/]HM*;9NP9!ZP;3 V!1NVK-9>
MGD1<%H&)T[]P6!Z67MCS"3B>!(WD/:97R%;K>SR7Y=NN+YRY("V]X^SP/XLW
M6J<3B1X,^R,_'/5+X]2/_?3GAPQ%V*D[;;0ZV36938Q)C%K>P2JG=,5YQ$D6
M15N\UTMI,!;ET&J/BC.35A$D6KBM\R=1Z>^V^1@<S.V+E1],G,D=T+?210M/
M4CQ3\6\+".UQ[,+;_6_P'1<? X-][,,]/1[/$RCWP(Z#(_YY82@=P[1EN[O7
MOYB!<.N,#OZU6CTIF@0,ERO>KYRG%><?_QEU8X[8T^523Z[JQI,8;ER+6Q>R
M<(6#3%\2H/*LZOS:T7%^X=;MO;CWX,H.GQPAVA&-B;4\&6UX-,0'*P3V!EXM
MBF%H+/'/<G7SL?G%NHT5MCG*P+>3"H4>C%L5Y+CAWF_QXN+EB'^?PP:? PPW
MOMJ<F,!,0IXIC, B%\A2+U%,+BD-[#7FC%R";]C?)_'OY=)G+<CPY'N=3GXQ
M+]G:M;/S6<96^,,88+L$@<C?_=OIVYPQ^WHC*F"L9Q^^JF"]Q8X@%2.LK\J9
M5$I:6%_/(F;$6Z.N1D7<L/F-*W;D*)Z%V XW "<[G6SAY%UD+')7X*V,4KM?
M9O)YID7F5S9_LMWNG0S>_(P4W#HO-U8H*4JM7!1!*<J[P(P5?27>3'[Y-;0&
MQVU[^J;5+9Z[^-#50B[P+>/B(,:L"4ER?9!Q =OQ[<>E0]:*TB%7:M*,W]-K
MBK);W\9KY/:/+M5M[WY/,#Z+P7)V^]L+.-C[S>R-A9+->0FVG]8]9_>_]/I=
M;ZBA5FK6\]0*TS^++2RJ].P54//N$M0T &4N58?ZR31>K@SUT]I/\RDJ=[_I
M "H\X0GCH EXFN,<8EZ =;!#>ZWB]V.DA5V=O'M5S5IL4<K[TGWJ<-_G@5_;
MQ.$'Z=M/2K0]>$INTD*XR9RJ%[Z]A1ZMCIG[O)OY/JV,YA)5B[S11IYZ_9HK
MQG+8Z(:/<9A=W66MGK)?^:?Q6);<_!U7C*3;7_;@_Y]Q\^SP$*['VT?-SLZ7
M#[3YY=W)7N?SV?ZF_['=^?!C^UK%R+T?N5KD_NX'MO/[>S"G/IQNTSVQO[E'
M]G9_:^WO-K\US]Z=[F^^^P$F<[7R+A51"<4Q"EH8Q&'=D#7:(6623B$88W6N
M)C#E<I$+7U6WUOS[:O[4"Q35FC]+S;^H%6NDM)%)BTC$%G$?>,[(XDB%HMXC
MD\1GG]GU,B(+JOD/ID>/:_BYB S(PACM01$C[>.%8?(H2O23YE\/F<V75C#\
MID=<4B@?#0+@: &BTV5R]"J<[^;*J:/^:0'K&[X,5]@H!?9M;S"\&,88RG$-
MY?> \NU+[1-RDS+#+0J4!L0Q-\@$G)!@B1M&I;+<K:PS;=;,];"WI>]'6$/2
M"X>D)U+,&I*>#9(NV"6GB3K"*$HBV5SK(2%3U*O3VAJJ7 K>YU!"O":N%R6;
M'R0]UL?V$DCD>=AOCFN91^O$EPS4-SWB\@+U8GC__K+MT7(4GET2!/]PB50F
M$S@S 6$:'""XX,CZH)!0-% 361(*2*58Q3=$U3S.1;! _K\:JEXH5,W)75E#
MU?2AJD(V/771.8JDHA)Q"49PT88UFJ"#-)H3*U?6^2H5BP15+]YA6<;RVO.0
MUDF,93_F0&YXA%DX*.]U<G-?S\ 20=W-Q[+3:C-T8^CRQ\DZWCN&N8:X!T#<
MYRH;$]A%'))"E&,.$!<TLM(9Y&2N>$JH]S;W'!(+9$O7"CU]A7Y<)?ZMYOM:
MHQ=#HR](2^[C0 RG8%KYB#AU$KDD DK$4&.M%E($L*\6SCM6M]I\2LB_Q%=*
MF-:M-E]MJ\U'%] T"Y2(>E[#9+$S3R\R#6\KM'8](S67BBGZ?MZ<B/C?D>V#
M;N;Z=G9P>%XDY&JN9U$@,/?<@;5O%QTCBLH98DWCLG;1N(@@O(+Q1?#&ZCA9
MNIK_FNMT%(F8@U9.PIX\$%[+0?IM.\['+CH?V-.<!YV_*8V*A-6+T5Z42<I9
M0I.LTP$\ZJ3NXT4B9E&&KTPOM>%H-"CJ@PP:;@0CB(-<HR&7#^SU)]FE(.1A
MW!+&%_U(GS5Y[EP6R^G(S5= /U]O\MSE<L3-72 =CKH\R<A+"J3#$XJ,(P%%
M3Q)QT6#I[#T2Z>9?YJ9,;2M*6A887"1<AUP$+ YMJWVU(,BYTA9I<N>J.E:3
M&S+D9I/F!ALS*#E^3)Z;4&M&/BYMZN[WF)Y),I;2LTASF]E@Q>,SQZXG^"S6
M><#-Z25_CG>(3=B0IIN[M"!9-O><A[('=K'O?KIGT.2+G8O=7BYR,9Z17)/N
MY_E']\B\>DCZUC0RO>;V?<NQR-5DQG\]:(&G%/PR5W?;MNT#J::LCF^I#XT?
M'(CH")?"2H]Y"-QYF(4$1HOEB@07HZ%C$X51AB:_W!F(6 9C%:[8BU*@XZ_.
M]4$S!"^IT5(Z5H_A/G#UKN<[F]M\_\L'O+/IZ<ZN/X7/M'8V/\#XLO'RF>RU
MKCA68<S-SC9IGAWP[;/#]O[F!]Z$^S?/MF#\6[RY^;Z]?=8^;.[^U<J)+=L7
MCE4F:!(J%-7>!.+.&61UPDA2K)+A%.L4BTZ13SXLJ>-6:@AZIKB5)T+/]2/=
M,?\?[*1SZ*G T6L(57D^<*J<XWKI-5:6(<XX@!/5'ED>-1+:$AU]$C+'19-5
MHLD"H=.#F>'C0E7FJHRE-]74,2G/P:0"3R$DR1C-72.T,](0K+27"5O/]03.
M)#5H\DO-I)X#K+:K3(I+RK2S&.$D +&$(LA*&1 EPHN$';6,9"95AYV\*)V=
MKJ[6U&.>VERA'M%J+H-T2"L'VDR >KC (@J64:$TD!(M,_5@\GIY]P7+R'IA
M3JE/\7A8UEB[7ZVL658S>6%8=EM*J5+$>!N),!HP31E*+*61!>%RBQD]QC1X
M&4U^J?G'<R#6ARK_4$P;H95$P@8PE@B5R.@,6TY@172@DNOI\(_%\^2\8IV=
MKJ[6_&.>VESA'XHGPJ6U2#+)$6<&(\<H15I@F8M44!_\E/A'[?IXD#*>EWC-
MU9YJ]\?LZ8=.2E,%7#R)Q(W%-F'F%(DT*,Q]M"6D$4HXFOQ2TX_G *S/5?KA
MA5$FD(!2]M!RF3ARQACD<]ZHH4IR%VOWQXO3V>GJ:DT_YJG-%?J!M7.@L@3Y
MH"7*/BUDL/2($:5"(-3$7"0KTX]%4N?'IMR4:K7^;]?_9?UZ9'XA.S]-< !A
M7KD[GI_E+)[R*5%F-6_8>:Y-JPN2/7R#V'/$"=^<FD#(6KEPUW_./!!]X-N]
MP:@?=U*.0([=0;$T'V/1?S 7F1H4F_-O.;M@ @@+$ZB^^VZBW"<[F_\YVC[S
M?/O+.[9]=@#WW#_<V0R=YI?W.5&.;!_]U=ZC>Z?7 ]4W^'9G^PP4]<?>KC\#
MI3[9[[SC3;I']K[D1+G/I\TO?QWMP[/\?;;UHWGT[BN.WE)B+-+>)=!0,!",
MM0X)#V0>I-)2STIP!E&/82-C)(Z"*=BF!3&.2RF=P2G Q2QY!Q =K@:S%[..
MBFEO5%?FNE9=25NXGK[S\Z^^,E1#C/#$:,4H%XH[JX36B6&PB9Q+<D$C[:]&
MT/=&P\'0=HO&8-<[DY4M]W*30=OJMHO&-C"KZ+\C +?4*GI^@H 7W=9RDDC.
M+YFT!#LO$+#6V+BCV>+JM928.>7$G^MO58XV^OV<]I+U^;?3:RJ^D>?H2F[M
M=]MJ9WA_W^O_#I\=+@D!>'Z,8,T/7Z//R!LC8MX;Q &7D?/)HF"B92QZ;HA=
M69?7BQ9?[?-E)]->M%<:YT@=Y/D?W-QRK]+?LNBP5)"UQE8W1_CF=GU_MFVW
MVM#NMC2S2ZEA1=O9[_&A(DR")9B+B(T.G(=@,0[,)L>9(E10,CF1&^]06#(\
M8UG>"&7:EVU?S1BOQ?E6<=X\8,VS;R?-W*5V\S.8FS@YX2CRE.;NRX( 014&
MT> 88RF9B 60FMO8Z43 [?E23&3]0G+???KSSWN@*ZC"2?[QP$KP3+$(".I$
MPIPPX4#L%/%:&J588J0&UL64Q&W6//G*L;,1$X&$"!C!OLB1M5XA8G/"($TF
MZ1SJ<5LU@NM=%*L=%*^@;6LP&!5=A*\*YMQ3B!^8^USN 3LEEYE3E\@;E:48
MV'A<&[D/;FMXNEBYL',P,7(G<&ETBI8$A'V@8&)0@K3F$@7E$^$Q42H7/__U
M4X5"-^QX>2^UB;R[2V31?#OWG2R*<K6ZQ<?*=%<7V[V31_:+Y&NBF)(9]8?4
M@CTF;Y;S-3Z+=H-D33(UD]Z(])4/EJX9<;]TW 48+,PLO]^ [ID[O#Q)I?=K
M8_?IOMW97NH$?"G^B $5OMAQF?GB]W<_8M^W!N4??^;>+?4TW3!-YT7)BK]R
MI9W,/4>V76YK?[32:YZWC4G9]F)VMF!R6MU!RY=S4Y2=?4B.[T)$+5Q]\)N/
M\&X^DWE(XO8"Y6[?NP_M)7-KL"!=9Y=6-%YE8]E< *#H);\@TK.8,S37$@GS
MJ]F\4SG=L4.P!\&ZRWMO=ND<%Z7,;Q6:5Q:H.L7ZK%/T@8Z=/I5E++VB2^_?
M'%=J/=O9/>SDZYM?]G[L?_F,]X[>G>SLAJ/]SA[>^;)_M/][L[.SN2&N18X<
M;8N=W_>RIXCL'[UO[^]^;&WO;H@F;7;VCSZ(_4[S&WP7W]YLEP4%/EU4:F4J
M!<D,4H8$Q'DRR&(5D296.T.)YD&LK-,G5VI=O"#TNIS 2RDG<$L@ZN/P"L\0
MKB9VX-@"G-C(A7F\. W9E@7$3B] #!/K8)T1\8!DG)F(C XDMXRTBANGHHD
M8F21R@Y,.Y5FV>_Q3+D(\V.?Q3EM?!S%?('!R#?'+TV]V=H3P;M8M,%6M^QT
M5!/-!V'T=I5H*NE<CNE!V!1-,ZE!AF:,CDKG"KU22B":BQ2>7&<;+&8;[H<S
MM,&#M+QF:=-$@ N69GRRSB2-DC(4<4L2<EA;1"5)6##G*,YM<W.9HA>+ <M^
MCQ?O(YQH^VMS!?YSWD0MQ_UL#0:CR[TERQ/V:LC7^0+59.Q!4/RA2L9PH+DH
MGT1!2H=X8!8YRS!2(+B4:D.3#BOKUU/5KYVJ+*.E_#(5^"7PL(ENUU1L)OI_
M0<4LK':45"!EM$+<>8.<B0Q%GR+8: ZT(.>+JI=<>V;9[_'B'6;O>_T46Z_/
M939W*O9$G]EXW4;]6#O.'H?5GZM<38CHA,8.F9S6SS-@&Z4E<@%;2[0/3.9*
M'4_@:@ML+[],#5\&KG9_)=_HAG<_CEMEA[Z:NLT$#BZHFU A6!DI4B+E2NL$
M(T>Y1!$K$;Q*.0-_99V:1:ISNBC>JT6YQXOWHEV)M,OM"*<28W?O,,QEWP@6
ML[I#'8 W%3S?NT3O0G2$6:!WEF/$I9+(X,B15%ZSQ*2A,N/YM"SQAP0R+X29
M7GOKGJ3]=3C;LD#"!<4CRG(=L$=*<CWVSGF?D*""\^ !+I0#2.!U.-MM;&CQ
M%%ZNU6T9ZR#F^U?F7$"N=YY_661>ONR*,\^-_LT+]-=<:H$51SIYB[BA\!OG
M"G&PZ;%.U/M,".6J)'B!\/_%GT:,V4U1_V,J)NUX BJ$G,'<A]XH?T-MTSXS
MSE66M[9I'P%AOFK3<LV#=!9$/<2$N'()::("(DHYRYSGSN*5=4*GY**\OPHM
MB@.S/M98+*.VHOVU43M-3+B@-4XD%R7A*-#@$6?6(&.%191'#'\$'63((2=U
M]._R&+5\3=4]59;&"G0_QT?W<WR\; 62V@R<)EY6S$#/B'4R&42"TXAKI9#5
M/G>*\]2YQ"CA?&6=K1HV+1JU1!TMYV<&_A4'N9A[KNT>?QS'HK+[L-?X#B^O
M3N^<\R6AVD*;?>5REA$LQ6+N]O)+]0GGTY#LH&H-6AEUY#*AE/,,N @"Y>5&
MWA'"I%244#G%$\Y%/,UX92J_\/;>S]6^-@.G"087M":0J&W@%'D;(YB!'B/M
M642.6!-9[GZJ?3[;7"3?=GVV^;.S35IW]EX:,W"FL'E>L;4^+)P=G#:KB5R"
M!,T<2LX1Q*F52.M@D.;)&$!:3Y/.AX4"/]FO-NW#PKL;_]W<EX#0!>J0\?&B
MM]>50N#/WR7CFF_G8G!%\C3H[)57/@/<U/TSSEOT;6Y_]9)@K<%$\4%)Q+75
MR+ @D6.!<L-9A 5;^/X9'Z\TG%N@'AIR 3MH2+W&N5RBA@S+T^I"K)%R3:;5
M/6*ABG/?4EQYW"/JUAK+KZM^?]T?8]+XH=KSH:@VU=B<M#5X;UO]1MG,(/]Y
M'/LEG9A*;>YI5KV?G].]V>M^'_O='U:V^YFLS]>=EJ0==MI1:@66/"1E(I!:
M#+:JH$R31&=>%_S=?T= <+:ZP'Q&9??YW.=Q]]!VQW;KN?R\*&?^<:OY^X<?
MVT>?@=V^$\TS&,>7/9X[S#?/]K\UC[;H?C8JC^ ^;Z]VFM_"^YOO3IN[VWQ[
M]QM\WX<?^T<'O+D)QFOG ]T^VO\&AFBK"8SY[S,P-%L71=PT=DX0CK@- O&D
M.+(1.+.($G/EHI,FK:Q?[U'[LK.59@L0RQ^C?__G7U)@O/W$XW'H.+T3C_N#
MXY4CCX*F9):2"<K8B_<BSCV>#S>;;R_".3QW/B=WYOQ]Q+662 N)D6$<6R5P
MD ;G0U"Y+,CYX@/^?U:ONPYPFPY]Q#[12$,,0FFNK7=!)>ZC<EISXT5XOOI%
M/X7*%UD-_+G@<*M*(P-W,7+OD' FI[A*@IQ.%CEFN4U)4>-RQX8%BFRK57]&
M!.F)^O^,3.G.,N$U77HR/E3H$@""E,KF2#$'9J92!&EI).)&86%$M-C8E74F
M%@DA7DGLZ[R=;4N(B@^LZ+A$C*@4B9H1/0KQMJN,R L1A. &<4$ YP1-R& 9
MD"3*&D&TCH3>Q(CJDMP+J_8OF@Q=UOR:#$T;&BIDB$ON)?$<*48\XD12@ 8,
M9I-75A$N!?$FQ\Q.RW=4NX<>>B9YO\2?9S(;QZZ_<1#.#1GQK_NX,DC&F/8.
M="IR$YSC@>G<G<PYKY*S,P^FK8\K9PJ='ZJLR@GNF0' ]$%AQ*UT2!-ID'0D
M!LQ],BI,X;ARZII7>ZD6C)@]#C7J8[R7@"<5*@8 (C4#]HT#98AC89!FS*!H
MF#+4,ZME[F&'V:+YI>Z.ML]_9W%O=4>%0%X*ZAVK#J=K2H!Z'?<&K7S-FWYL
MP\7?XS@(=ZQ:E0^.<1!??,0Z@+S1\/:/7 X7OA[<-Z>H:DDNASQ7?Q[V+T(3
M#R)R_6B_(9M@L&]L^\2>#E9^N?R(\'Q7IO1^LW'[LZ<TLV<OEP 0K5?6]W\#
M,AK[^2H8CEV8L30.^QFF_]&BW@>#K3?<&@Z_6L>L@\U>6N<YMN*K6EDOLATR
M7W^;$1ZP]-^_V/6;%OB*5I1HB0TQPA.3"^USH;BS2FB=&)86OBG)E6=._;B^
MF]1)'>.DCMW/7ZED(6*!D0DJYYL:CAP1&EF<P' V7C,J[IG4L5#)1\7V7P8*
MHT("&E41R-'%]OY9&K-+RU!8/2HM0ZQA:F:2Z7"_E(2'#-:L 0S48YW)6/5#
M$DBN$!8B2LF^;!+U>R=739ME2C"I9):L-N(/'X$4YI2!<;)7!SCD<#HY)T0L
M9\[%^W&>VUZT_4'CW:5$MP8CJS?E5=Q+<AZ>J_+8[(O%F]3,1>[CU[S/ [^V
MB</UQ#UJXHAY6@K4]>JP2Y$"=4LJ7<[9;HQ]/3,]89C6E,Z[\]8+'>2+CS(Z
MSYFTI0.S<5#D2P8[C(V4<R6_9R=F-M_'R;8'9:#VZ@4/6II.&_.;Y1FWV9C?
M@SW"M\^#D<GX2#F-W+.@"1$Q,DE)8L:[^-R]-5]GG&GO9+NS=;K7V3MM[K8[
MVYL>;Q\=L)W-;Z?[N^];VYO[G?W?\YCV</-:_9R-T[VC_[3VC[;(SI>]D^;9
MA].=3<]W=O_3WOZR==+L['_;HW\=-8\^T"M15]8($&ZE<EJ.19QHC5P4"GD5
MDW6)!$O]RKJ:;Z>E4IEJ,*O![!Y@IF0@2E#M$V5<1J]-L"IJ%SG7DH82S/ $
MS&:8>%B#V;. 6>5P,A@L"&QA2+@<-,\ T8RT"N%H;/1>,I4+K8II)6?78%:#
MV:R3IQ43ADCO?=)< Q?#- !/<Q$3QQU1&<R(&8,9,368+3N873 S%IF6/FI8
M6)4S@+1"3FB."+&4!(^-36)E?<XQKQ4P>_$!K[N]H6TW6I.ZGA4SO'!-]4H-
M:<1QI>2YA\$^+BYM,>%QN@;KS+JGQ7-H+(3E%=: ?2:DO!3C2@2)26F/?%0>
M<1< *1.3\&=T(!,N:&57ULFJ(//MK?0(YE?#P7W@X(DF7PT'RP\'%2N0*249
MX1YI,/H0![% 1A""#+5:<\\92$J& \6>S)UJ.%A$.'BBT53#P0N @XH=%9R4
M@@<4O-6(@]F$#,@^PMH994G0'OL,!\SH18&#%W3$>?-A_NV5X^?<;J2^QQWW
M>/$6_KQ.WNMM_2$^T>2X2A);JT7B@7)GF?+6&2\-D'_*%Z=$0.TMG>4NOU?U
M 6 750"10$IAE;LK4V15"@CHGU5,4\J8FG^]I)KRSQ@;H@C&&LNUXH(;1327
M)B@O<7 8# +R;(>_-3;,&1LJ#@%E+>;&<:1AYT!<$8><!&Q(ELJ()0N,J/GG
MK-;8,.LH-Q$T$<Y(@2/G1EOA@#$0FPB#/WE\MK/4&AOFC0V5.JR&$AZ31)A%
MC#BAKD0)&:SG"<A$(#J7I5Z8DX,7Y!NXZYCULKG5O]+4:]#X/K-2C'4TS?)'
MTTS78IQ?/<E"%Z[C?.T%O@_.^ZI]*!FQ6AD =D)8KJ++D*/<(*:#I28Q;0S@
MO)#S;;M<QP;6:/93-'NBC5NCV9*B6<6BU9)JQ;!!/'J"N+08:14Y8I8X3U3P
M)%=A$JJ.=*[1;,'1[(E6>8UFRXIF%]Q,>2:E-@)L<*%R7SV-+)46&<)UWN6<
MC"ZG;8A%0;,7=!!Z\_G\N\YQNW<:8Z/,NO]SU/>'H"Z-/]NV.^_<^_H>][C'
MB_<2E96!*T?QQV,97=+V' NX5]]8/#I*"7!M\P8MN8E4.P7H+!/C(09MZ<-=
M*1EAM@:#40R;HSY,7+F[EF%!$QPJ+IJ@4 :A0;W?/FB__5;UA3#L:0K1H1"9
M1\"R''(A,&0B$P8'SGU@*^LO+>6[UN%S'4Y2BI DEI%P*XF.E$9!##4F&B7P
MPQT(M0X_BPY7VZD:0%G#%8(?%'$&BFR]"D@H"Z:3#D8%7>OPR]5AY7#"007*
M16XC&:S2*1H'QC/V07/Z<+.YUN'GT>%*QZODO%74H$@HZ+ 3'ID0";(BA$0-
M\TZ0!=+A%V_UWEI,>&L8.W.O.5??H[9[)S+J"AGU51F-/_+O<;7A8NKU8V-H
M?]31$;4'_AX>^$=5Y'^X![YF"@]B"N^ )6P-MS]EMK#Q5?.DB.$2$48TXHI)
MI+'2*'B9&R3"DCB[LJYQ';Y0P\V"PXT1EG 5"6/)\1B45M0&S'F0'/XC])3"
M%VJX>3#<?#B'&YR2]\D(Q)SG8)DHC@SW&%'-.5'*PQ8!<"/5DZ-B:[BIX6;&
MM4%X4,(8;Y3TG$OCHHL1"YV8CY/8SRG$%]1P\V"XV;N &^)SF1Z";.XGQZED
M8.'PB*CA)#>S"H%@@!NC%@5N7I KY+%F9C<.\^DKF)D-F-+HA[-UD+RR%*99
MFV@;[7;/VV$,-Z/9NW*5FW&XDW;MCQK<'@9NIU73#4>OL"<2\6@IXH9KY&C$
MB%A/HS.4A1!SA>V%R3"J57>AS9U:=6>LNA4S2,8D*;7(!YV EY" M((?UGB
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MGS<"ND?VOKS_MGWV^;3YY:^C?7B6O\^V?FR???CJC</&.HNT$"('*WH ;9'
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M;H[/1C$_$"F@1YH&,(3Y*E+@Q;#@M6$B&@$T:4[X3'Z/'TFUJ;H&#?+W"?)
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MUAXXK=4.I2 -^A@L@':!,**)WW0NT@EGKT-K3<AX#48;"!EM$I)[74M2&LG
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MJ>@$@Z@T\S9(EJ#JO&Q04LF*W6NG#AMV=Q:[&Z]-U["[1>RN!$T\H1 <@>6
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MCC80[RR(N;?)NJ3)!@-H;X/B.B;G<]$0L]<W[VFW'87K(GPE2)%<@]6N,*T
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MBWM='ZLA?'FB)FHN=?+>% XAE2AE-I(,.@^U=_8-">Z;%=\HS%<"@:R\S=8
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M*);II(CL='0L2L<9125)%Y.]J=65U @4-*YK7/? N6[C6L'&=5OGND%1*E5
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MI:<9[5M#]Z#=H];:<,T9F$!&VV;/8H+ <G&&8FV3M(RUX0+7N[1+]@#*ZOR
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MHY CKP8SN:R"R<BLS6/6I8?*;V76Z&9?$A/78N,R%12JT,F!HC2,"I! :D*
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M9%MO2)/JWR(/+Y>'_:$+13"&-#54.!D\L4R13%IA4QEYN*$\7.O/!E.B&.%
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M[3:@V^"HZ6;B?EZX3O]^T_B6.(GT6;=07<$TOO+T]LK#BYK<<J#MLIY,1ZW
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M3E**L!9A[8G#FL22R8QRX7? LPE1#"HIA1!(9P;B-,+:.F%MDGI)O90QUEF
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MVOT2H3C2,GD;K<3\%K,]0X#9_)[9#!7V+UF!C!=(F;V#$4\A94HM48R9F"\
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MU68E#6KMH56?()@6"VF"^0<!=H4_N"]6T7H7\VJ873OPTN<E#<ELRZG/\G;
ML'\1FT[;Z1[+[<-5VBO;?/;W)8VSWT&@!AZ[1;[D&P=$FS@H]'I5R?W!<:U:
MZJOO#WG)M* H5P@!A!2]=)/?"/&?<,!LXM]P9!:862*-<G3'8B4+^1C,8J_:
M5&3.4L!4,LW#K_X-O!(;:P^X:A[R@7;DU&< 54#U;W25M8;NHVH7;O+><^Q:
MM9DK93/K]Q J,7YQV"Q>HDMFI0U+[28KOOF)S'.RV>8.\8MNV*M[M.#CS$%P
M?UG5<B<Y=:U:+*UPDLII."80R"4"J4A\?:=@,-N 0BR0R?7N6-OHBE4T+S/B
M(Y] @)Z7K+C(R(?I<K60GM&&*-XJ29B(.3<HN!W$X5Y')+DCGKE6U[$F77_,
M:P>B>A8/EJ*"JJR""9-VAX#[:RDQ@%E'^.ZC58?X.^*7.3+L'Q&%"Y24VZB9
MO? B1'Y,A"2(/_1W/0!Z+.ZF_/DL._S'O'"&P_1Z@H.X[$^14.[!YZY5FUI2
M>' N]2 3&R353=ZYY" F()5]((1O\-=<?MXIYQJ J@KO'KWM+Y-*S_#E>8W"
M"%'$Y0T7,=DM?! /W:M&J<<Y0]?JFDA5I0"9&""7@SM:0U#80\_YRKH")@C?
M(Q9-X2;==*^7'+>22I-BQ[+J*YP9*[%5+0(9LQ[FP@TFU<Z!VVFEN:]C._6%
M@A8\^I?R-OEX]U17AXN\ W1<2[O1]#NS;;#U'0F".:%/D/HOPJR!CQPUU[5J
M*_G-J%58OZ.6VN0FY.O*+- -_2G$?J7$%7I$ 5EWFW9X:0URI$>N75MF;T3Z
M \AK%7$+KW>K(*A4W4M/*(Y67!!*R1,+UJ+*(0N^0UTW/M'E) ]7QE9]-T[E
M8$;)>^>,AMA+W[\(1FUT[8!&FY4\OCEUZHLP^@#V+^31:#;=(Z ]F,H[W#/7
MKJV@=VB6_8Z1U&@<$ED]0,]=N[8$K@_H.X@-AL_.:V%^^)[AM4*4;_1;0WY?
M:N@'K&3,2OH'AKM[K5+'<(>N75O=TW:,4A@^_5V* X0\@H)+-. B ;^OKI1>
MO/H G_7O7:N12*,HU[+JVU!3%D#PZ&&D5+%@AQ/[NS32V(>UG/I<V[;9^Q??
M5#UWGR/[[=3R?HRAT7!D?ZL)]#LJJ9CV#GDD]'" A4C\,AGRB/DWW.;\(Q1%
ML;U@Z\A;#JKKV@UG^"N@;M>6WCR3U2?N-MKV@#ZCOHL+OW,8/J]S:\&8/?AQ
M?XU\%D<$_-[;)"9T<P?C?5KORRN3^\7(M1N.Y^=0-W@%WV#") "%"/RH!7_X
MX_C^&&2"@$(2P$7IM[^@B-\>3\+T0N4K-$=\5HV]:#I3LU=/L0=_N5>,7;OA
M:'JE RAKY#Z1URE<IOEX3M]=H*$=S] "AR%+")BI4,B_] FS+61)2%GQ1<AW
M3[.V-D,ADZK;#3"O4K'<:4Y=6Q[#-7<FA33"95)Y "QVKE5%$AU/+E0O/>I^
M"2E:DH#ULE%Z\;W^)',SI3P=.K/JYS^JG/Z]N'Z_=VE1W: =)HQ;2.5)TKG3
M-,/?!$;_DJ4&]]YG\E?)1-H%CH:NK8E0SU.HNJ7%DSNT3JBWA%&70$B?EQP\
MRW5J4S^-X(F'H,+_'4)AF"M^<1 ;P%^$78V)'#3;=?0&J()O?\&Z8+[J\\@=
MA9&0IU/LT$(MC1]&CE4_+RBX#00[4.77UQBB9MAN<40;N326&+%FT]S9-0+3
MTWBB[O)[QA1J1O)>CL'5I1F]QQ9UB]_'Q/OCN_CFT<1CQNETAV9GEG(XQZ[3
ML%+8!J>H!J3U@+RB=VA+$]VA**;8XU\NX^\/!:^"K1SB4]>I+:*T0UQ6E067
M[S#7\?@>+Q%M?G4%8_A2N#79RV$_<YW:,DLK[*+&]M>\UG?XR]ZV\>F4XM##
M:Q@4]T]-HBA9B<ZR:QYRR"KE;G+N.K55%\D T/:FD*1ZUU5%F'[V'LQ$*YS>
MBLLO0A%7U2Y0V.5C?4H6TJQG/+3JY_PK+-,+4JI,>YCZ2$RLG?^H>4B3H#$_
MX]41I_YE0K*VT#T=ZL)-VH>.;=>IK5&J&EF_$R.)[:^3F%GP%K$Q9@HW';\W
ML1]?.;J.Z]06$^7HIE4!41?(*^LESMFU'M?YC9DW?,?0JMN,GXJ%? #DWPRI
MQ3?992,%3U!AVL,!4&)B_0E )0_Y #AR&J9GY3CU;P"4M84]Y@,[<)-WD6/7
MJ2\V*AI9OP= B>T/ J >;J>N6Y]ZE^/61ZR\)?*3 -UH#UG;!/(!ZLRJWVV4
M,P W?1R-<NMU^(!&G49F='M\;M<_W% U>A\_EE'84'_,WZ&0CO"G0Z<^%5&U
M>0^'\]Q^';K\71)I!W]JN6Y]3T+%YGWNS5G.YO,;COP+&+"1#MTO4:?KG#09
MR0&R7;<>]I8 %:Q!QANDS/N-7-7.5\1+NMUJH<5&CIKCNK*N; LKD+/N-V:%
M)_/S&(C;@\SY"@)%2_:8Y0'I_NR7-#\]SG)D^?$DK?985,9WAF]5E^\T[S7<
M52Q@M+P.R-,^7:N,C1S(D>O*PNIM^!AK('CW&[3J,?2#WG?PL@KD0(]=M[Z
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M><1 26> <O6-6/)-D^WE#5#F!Q^\_31/\92W_+>5-D"1[2.*V4BMNF]'2F.
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M<3,/I\^;S-*E-TVJ%&;ST_\Y"1$GZU='JP5\"N'SZ,5B01\]<C$YG4L&%I@
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M+OL^YZD?CG'+&VQ_3(ZUD6!SAI%BO:B/UQMP-\V%3HY;S@UP(VD9<*DA\F3
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M],Y9&9]]6EA_VN[[,0>'N.>^S>-.::/]G:O(B:]G6O!T@*-L0^2H)/# 7;V
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M\-7 60D^))TH,!3>]JFKV ?UD+)) V)G$R$/)MOT#N>)#.+(4SA9D$RN$%:
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M4R=;&/#!1!<CSZE1M5D'< ?B??=2?=>39T,5--@UUA^.](!+SZ$+Q*9#'#J
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MM &EYR$%U^:.;R6<HU?_]D)NT)[K"L>[\+5R\MDXTT^FYYCO%MF14^&*]E&
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MXF+MG!+ \2S 6A8+$\;%1K.FUP!Z#/S83LH'$FUY<U[%]K9<?3\[45$HALF
M#K48F>L(0=+);'+@3%CN?&S3-'80^,=-K-UKL$%@Y5HH;_\<8[[,!+F*5\Y.
M4,BBI$((:"VHR*J "!Y'KU,I,M ?C:WCE<".FSI#2GW(FIM;2[T((FC. R?C
M'[A)'I30!5QQ"3C74K&H4EZ^F'K 2-M-Y&Q(I6TIE7W'S&HSBV^1H?<)QV$Z
MFBS\.@PQ:LDE,.]5'=9#>X_ "#XFGJ-%Y6*GLOQ.[4!60MAYI&Q;74Z&E.G
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M>Q5= 6_101%">A( )V.D<4+4*ER/@Q_#JV %0[8.XZY<^64W')U-9-Z!9\&
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M!,EZLO8Q2O"&&XCT9YDTH]6]UFJ@'TFJ=1(-_?;#QT^+^>>;OMF))"=&N6C
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MV+2L98K(%!A;5(DB!H;C9W?W8_V:U&D(NAXKF&VH8'6G+,$X5F.K!"F#\EX
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MD$0[AM>GFEJ/DF0#W_"VN7:34O[V>E'/@+R8SM,D"LV*8A*LJK:D"V151I7
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MVJ$PG/'8IKWG.63CF9 #$CAO*/WQ@U5O8IRF35WA^O5 9XPTM0['UCLSE M
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MY5S4+#.]F_??2WFWI[URSAN(M%6K_FVM/?VC]=FEN2:+WC$H3G-01=:9%"R
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M*#0>4*$%H1F:J(/TJDVUX&%<%Z@@0S#0Y&+OFYL;GH+'8U0FDC/+LR?UC?6
M-%( 4]&GH+VPK$U9R#/ +DE#AN2@0=/M4[ ,UU8Q)6LEM0,EA(900JHHT0B>
MDQ2-ASQ?KDH,(?-1^V)M'5+G2P#ZE=,V5DIMV%5@(QG.R'GRKO&UAN?9%SN(
M$O22]AGUQ=[+B_C"428C(<=ZE;QE GQUMYQ,*@49R9]O-G3KG%/!1S%[,!5\
MC(1'R EV@?.UI8*/HNB9Y. I\AV!=JESX5%8D(5V/16<JZ7T"(5<8QZBL4*W
M.1?.+Q4\)-O'B'6\%-%N%F/U(:_PKT_;7 :NZ!M__+8)SM70RC4ITY<Z\&.
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M-'1KI=<'Z;._4@[,&VESTMQHX-(E4$Y;< X-I.3KT%NO_4'.F@/PY9$6:B=
MESZZ:%'[?-?6NFDG)ZWBIM@$SGBL4[@->*<$B&!\SB5ZS&UB65L G='=,X3(
M6\Q*NP_KAJ*/ VO;<'0;M.-<,H,H\'%2["']PQP4*X#,R(@UW)H"3_4%V1'
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M^!4T"Q=+%AHI&./<@8A"D_%!UTX0LI 1$9E1/B;6;69#I_VX%<8SNZZ'4<>
MD<HEJ*O0T6U(*^IW 37XK;T5SN%O[8'4-6TEZX$O[^W@@LWHBF' $Z9Z97GP
M.BK(+&-FQF)0G;+%3I$ #US>A]1_'Q$/J/=E=<7LY^BO3R,F@N.V&"C,%%"R
M9KPEM)"M+\)QR71YJ'IACNE_?IG^^%^K3[S2\^H/2S4O%?SK^PY[OP\D^.E>
M4FMUN7]*. FS\71)S1@=8C0(,4DR+W52$(44D*0(WDJ3=!YN0NU&",_U4M]9
M#0-6ZRX!K7#\-9E_QS0N8\PKKG<!-?R%O@W.$2_TW54U;27GH2_SK>#J/'4Z
MY0(D6]T1YAV!"W1W*?)P@HLJY$[MY4Y1^5TN\\:Z[R/>0SRMO/[Y&B?IZ[<P
M^]>J;9Y!KI4$1N<9*,L('Z=CKKB@O(PR<GV@]Y4U9,_HVFBBK ;5^/?Q7:.[
MZ:GY.+[#ONJN(3R9I]T]]/HH:090RD%.HC6<SB,7021(=#;6["P&D78,<"$Q
M6)=\=FWZG!Z'-/V?>P_(F3ZZ:-%6/5S@?'7\_H'7K;ZC2XS546<B2?*R30H0
M:P=YFT-0BCNM;9MAZ!OAG,#C\5Y:6\]NVUODQZQ4:E*@U+PNJ4LYDD5)8@YD
M*4:E0F#!F*)8YD;FHK/E#Y4C'; *R4DI+2H-GN@"2N9:J>\9""L(==3<Q#8-
M6@]1A?1QAM_&E]_F;\)L@IEVQXA)\@6<I*T56":K7@APP7M@7CJU/'H;6<WW
MH)QH9G<?/JP?1?N)NT&IT>I8K'Y [0X]"VGQ?\>+K]>^P)N_T\7E<O@V^0'T
MG_PY_#WRGHO(2NUZ2\>G0D'7<ZV30F2B&,<\^C852#N /4,.M599 Z/GW>0'
MSI=UPN\F='O@NPFYG/03\C1_'_\89[H51DDX%8QT($RITTZR@(A1@,F11:M4
MU**-"=0!W!FR:&B5-.@:>QVD(%,-DZA%F QKXR.?"$?-!I4L&Z:\2IJWR<>_
M1G"&^M])N TJAVYZV5S1L [5&9%5GD1  R7(6EW)$9PK!EPV.G'#430:,K4!
MS!FJ?E^1-VBY>GWZO/G[.T[F.&+1TZ6D)!2E$90@GR]RKT"0_X]68>2-*O_7
M@)RA]O<1=8/ ZR\.7ALTX\DEK7M%TNED_AI) GCU[\B6P?F;O\GHH>\GMW#V
M<RF0/Z:36B9&<KY8BNQJA2.5E>3:)RA8"JC /1UM.4 BB649BC;8YAQIN*BS
M9.1I4*!!E]95=2XZ+H)4#/RR<$$CW;$1$UAK:DO'[,.#"2>[$_&D2Z3WX<P.
M@FW0'O6Z'_#GZ6JFUL?9E$B[^/GQ(DRJ*?V&?OJ]_I.1J*X6<QF*KFV62C80
MM>35[6>"N*E2;.,T=\=XAC1II* &W55_Q^\S3..KMFR3_.I;E<A_+_\X(IM,
MYZ@+E%2+^QDM/GA70)<<(C.$3[0Y/AX =89D&4H%]]GAA^NO\( 47O]<_>75
M<[UC-@J9#*12(XO6UQXU9-R3)%R03M."6K?B[0SVI#HI[,.AUHHZ=ON$FA%$
M%MI\>C'.R[4L17;U:DOW<.3"08K2T#),@EA?U;3'S&6*SJE.?.N4;;49P_$3
M:QII?3JH] =.P+N/Z#H]HP.FP9,PMZ$Y? [F$)IZ4/%[B/E0%" _2V0=+:3:
M859Y$\#Q@B 2\L*#1>["$U7] QF8A])\'^DV>-:Y"21>-TY<I5;D%- Q20Z9
MD74L6.U@II,#Z9*SG(G0:A32%D"'+< 81EO;8K9[B+K!\_$RSK(R*=Y<C+^-
M)\M5K\ )SSVCFPQ"0>)[$A&B]PY"P"(BDR+%AE'<;;#.@ W#B;U)-N2,C)^P
MP#^FDQ5;KU.NK."F)HP;XVMS:/*D/*("GI7P&(U5V*H#]Q9(9\"%8<0]<'^,
M#<T =-1T[6E2CS*U6H#NO< -J<IK&YF5A< .9@F<8KN4]J[!GE(_6(^4+J">
M68^47GKJU"IC%R$?K$>*D-(0-@G><K)=B.<0LHQTZD6'1CI3NEF(IZCY?CU2
MAE=\']D.W"/E7BG1ZB92V;G$K0#TY/THHVML/1C0=8P=,I&E6JM_V-@Q9<O'
MGTK_E%Z"GPXKM2%M>X)TV\"\[NVBBD*#%DRJP^F=1@B,? X39;1)"..B[J##
M^Y_\U-6WIZQ:U)A<%X"^OIR/)SB?7SN-RQ-'A,#) "P@!:MS;[4#AV1L,".8
M$[HH[ALU6WX(UKG;9\/KID4;[RLLUQNB YBF)8]WX!RGOG% =:T386]9MS@Y
M[H)B24@O$[#B8TT*+,3S.I8=@PDZ.]5X_LX1:Q0/IO<>(A[86/N+Q(CY*X:+
MQ=<49KBZNWQ"@5Y92,N,J:@2N%BM#J\T*T5%F7B'>W[SIQ\M:V 7<4\'E=7
M%MKGZ2)<?/B^N/QV'>WA,2M1(G 3&2W-I3K&KR;T*I[0)*0U=M#;^N<^58WM
M)9^!=]H2QA5Y5F"2M8S5IQ]G;  EDP27<R*OSPI)-KZVO,LFN_?!!]36WC*>
M#B6@%MH:TS7QY>NU/9^%5<+4@89:+3N=9' A>_"&YQ3(*4/ONJKKSB<_97WM
M+J*!IQ8MT<S^7@'14B067*0#(_I5GQNF#!COF')>!FT?*YR^]Z%/64T["6;@
MQIL?9]-\F18?9I]P]F.<KCK[2T+@"J]I5K4F47$.W@L#KGB;N:.[-73*B.T4
M ]R$X-Q=SD$D/W#'MA6>VF-HA>CZ#:P+J,$?!;;".?RCP/Z:NJ_V@<0\\+/
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M$'800IR)63&0N!NT;]F$[/9-ETL..2@%6)@%)9B$D$2@PPN+U*Y8P]IX&H\
M.TM*["KX!BU<UAYUM.<Q1F=!LMJMT&8'@<4(PGGN8BH:&SD:AWTR;:3K/81Y
MVN^@6$+1T4%V];'8>@>1USZHBEM?T%IRE,[N'70(I79Z]NPAW ,^>W9 ]4R?
M/?OHJ^.SYP["/AP5,#&AG#. *1+C:R5U3$D 1Z.,C-*6;MG")TF!G9X]AV=
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M-7A13"Q![@P",T:@0&/$3D48ZY3$J"$O7HY! ICG<T>@* L@QGB@&R#$U!#
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M$ -JP&!#6R$?A&4'Y*H 9"908#_ D"/M!"="9&'))KTU2J;'E ##3K$! A]
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MHM33XK)!UE\<W$[UZMX)S<BZ-&0>=PX[=/P>_)M2Y$1U8ZYW4XQW>5U5.'Y
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M2U121?D,EY;'<Y1"9]*4VH@V7GM2#V_JKW3\OH*\8VI!_^K]D@7:S('2O/L
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MLT#Q*,8#%FBJWPQ/6*:7(=9$F:-[8LC-F'Z:6'\4BE((7)HP@NMW"-K73]6
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M):3-./3_FV(D_F:!/J@CT%T_]^\?  1JHX,]O(?].< X6@CJ1@)3GLLL@>!
M+Q8%\%H?T9ZUMHR8%422U%%\J"W[)8 '3,<Q\^X(Q*+M_F$#>*];T$"R%+9=
MC$'TNS.>1Q;]"/S-H\.XP+X$ 13B%G69!0I]MAW) @4$44D""_W4)W>0>^86
M0'7OK"CV@;?SW) [Q8 X*) <[VQWW;C:-CAMQC->70 )62:U.7/5O 2XUEW;
ME"0?)O[JLIB=P]2XBJ&:(6FTHH,IGQDM..Q@8J#27YL>,<=5G6@B:% H)7))
M+S3TG%Y N/_ONW;1&-LT/DW]8.'?Z4>^#XQ<.;<<47SA/U4PF8<%*F*O1NP
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M@F:&&[[T$G@D?02Z5PF&:8#?LT D=<1YR);9'M?^T.D(^>-T[_[0Z2R U\.
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MJ[</9IT8>)YU@AI1G0?P>1$B(9).+0$6O2>IL-_%$L6(L4"%@G<17;IHX)\
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MX?0DB@9+T0!QOOP*WNZKV*EM;5CD64/4FZ/K%*O"IPRP9.)6-[LJ'\FL N\
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MP[&?PH;ATE-^,0U.>MC)YY<X BPOP[2/ 'W:BAO^4MVUT(,!G$A>K\A]QJV
MFQ;?/CMDV[GZB%F,MGE!?@ZS&L/XP5+:K-A^F[!X<A+\<'+V@]- LRA=$-9.
M7D&IDR/5S/,CZQR6T]"SG[!@Q[9C!_FJ%S%RF(1^2OU;*+U:BO_>H)[>UE;
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M=B*-YK6*%)/</,'[-ODD#5VE)TS;>0S(_1S>617VQ<WTL\D;]KC>+U.&37>
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M?+[@DM<0-LW9:C;Q6*OC@X+J*W,\1T*=S"-Z2K?P!CH9]A5@X^R(*^]PW.?
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M\#IH^WD166HS.AFA!U8&%?.POB1(_\!F,H#Y@S+.@(M,6>-6P$<XXZNH!7@
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ML7<]G',2;GD'T W<L]4DN>IQ0]T4WS-PZMZ&S"#^D"/#$.=Q*^QW@%UOW3L
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M<@^BL:AJT.Z6#&\._X;_A#0,QY/)#0E[5C<T4;F?A^(?"ZKD%2I[1MC[TDS
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M2T^/^50,:\\M<+@=VW]-SDG\X]98X%C#DYK?R>$=B/W36X $::Z&L8PV9>.
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M&=-_SLHZ SNMJYX1-WVYR2EM8/?=MSHJ9-'R;6))TY: JM93(!O*E*^X[I!
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MMHF8DSPAG?T3MY%I5UZ&&M!:Y7I? AWA&\+"$TZ 8B)G7[IV/E!J3DQ3Z6(
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M@MCL)CQZ*N1-<W^&(J]J*V3\*7#1]JK7B"<"P=-09G?EKHDN=CI,YN2==F5
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M;C'B?;]&YA-4[S*-Q<2%M>Q6"7DY#T[;?#%S<$Y+U5C?Z$G('0+_S&[; J%
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M_4>:M]V0S/WS2AXET2;)5RD>GH)F P6.2:'F+WC?4BFR.[E_ZX:?N@[A?4!
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M4"=R>@<(^F1@Z$[^7_5-9SDJM&>)E]#+Z9S)AW4WD[-5Q.TTDJ'I?(<(,>J
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M?AJ7E7YR]@^&IFQ_WP(O&XK1]Q$:E=VM,Q7\(B-CEY(=(TMU_@I26ML6(8J
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M2N#S-(2N4 =/5T;\LH?*Y%;)?1P&T@>Z:^'ZK(&>/H.?D="!K$>3Q\?U5(B
ML"(XB+8U^6;/(>!'A4?.;\K'P[2T&X$R*U&_TR",?@I(-DT_B0T^4XNF(.6T
M%99)\GO/&=%YQ@%^R 4-T2<X?FI(1IRCL^S[HNM#%ZM1<I[95]OT^:2%@/\#
M_W('V)NCF>I#,$V5$X?1T!XHM0O5LD8L)N> =$KN=R?3Y+@%)H0LO-?B Q]2
MS=@@&S-S(YI#"VL7O.OJ2:#;1?#4(+;K @'XF:!1P)BGI&BIR&#$IF^TBFW$
M=_MT]2A-$C%K=JXQ\0<*=/M[&%,L\2OX61!.);"A<0K=_9\.M77W#VCYWCBL
MUIM71[HK3K?3K1U:&[0ZORR(IV0#[-BW ^$KL:073E/U=S3'Q*O.HJ$9ICU:
MW.XQ]NJ<(3@IY+Q: U$<#D:SY7*DV/E"?<G;Q)-OH)*:OD[=F[! Z3FY2"C%
MN=HXQ_CZ85$D\T;1IDDG#[UUR[HJB[Q/5+'KAN6'J>5-?500XKIO@H=L<,6%
M;7.&MP-*SM,V*TN*HC"9.W+W-^Q#+EN:R_XN3/0.L)X^.NI&XQ@UH/37>*2]
M9<DFQR2]&R,Y;T*) 9<K:-_J?:_,A[-VJ)$R1P/=DT3[DN3)1A(2(J=7:\&2
M[E3]CI)RW?M:9.:*&T_(]E<>S+Y.S6NFT7(5SGJ364"M,L_)Q@3:7>1AT! <
MD]*0G&-0LS\AIV6[%YF4%,9(HBHBH(W/"FCIQ=5CK(G26-X[0/Z)1O29S,KO
M&KY(W)&[/"]?:!=Q*(REG[M4FS!4I+F/=\VS4-A>\]9_7G_77_'=I#RSJUBT
M+.>2F4HR"_'AX:;! YOVN0VIB*H9Q@"W<;%-Q6-"R-KA4U(]MB7U37@<SY1]
M#L'$D ?,S,7\1S"BE]HXQXPK"<*;LX,E'>AJ ;T%",+W#B/G.A]Z=2*8:_H"
M^";^Z!MT<$0!IVV0(%G,*)NT:_7F63O+WZ 2BY''<CIM+(6>38VBL.1LF=@S
M?)G*?@W*&O'?YK16(8<A>I/RC)\DE6/J1UX7P]-6TET=Z ^:FF? 3$</Y06P
M#MR-5<Y_NZYRIBU,"'/5,SS6UG@T.SLSZN+IR85Q]$@<YP,  !CRC#C:4@:%
M_[O-.XQGRG/UE;2P);BN^<+2L"MU0IGF?7>RFH_ZE DM\VQ8Q:/CC(Q/0FN,
M]F^P9] RZRB(-%T5KRCGJ[05+8'O\;0\PL92.@4?6%+EN8V857 [.(>RL*?0
M_CG13"JJE!<GWA>>SJK;(Q"NW>\_I9E#K:[.@:A5$EF6!11>WS[!\*.Q4E=*
M.1A-X@\;!W,*Q[)$O*,)FU=65MIX% A!\3-BPJ&$9]L;TPW[#<HMGS!'Z&-H
M7(,6D\7/J^1Z7/8","-Z6XNCVL76F33'36:EOYQ+R3?1A^I]/S!X+K 4@X''
M@+_FCMLQW2=[;PK-W3JU(#/0"S*<6C4KG#34/O'?UJ;TZQR2,]D1E@N6I9UH
M&)%".37XEH-E;9NGS]K:IOD*/X4U.<4^_:BPJRI;S)D&(+T/^!C69)LVJ1LC
MVS58(F/@)92X[A_5L[D@[7CLA_ LT-X >PZO:*($W1C/N WJ\7JDGSJL-/N5
MJ<.3KGKVR;EC:D$SZ/AS:J&,TWFFFJ:H,TF@TKWDN>WWVL(^:CIFC?K$^/ZR
MC/]'NH9:QLD=KP:*Z@H<TLB-?L_?N-BUD^B_<"R.+6!VU3E$KJ+/$,=_KN]T
M5E0.25;4+S<Y6I/1=08-T_Z4UH!4]K;^<-5^E^"JD1[7Z>T*\/--:."[HA/6
MN5N@ODIK.40S^"]I>9VF\QR2FZA32Y0);"SW%GBXVF=)86%WU''F\#;VB&YX
M(_Y0*\:D&NWCY=OG0Y!]=<^B8^3)GZNU-."LC&<4NDZ$2BEU+?=356.7L9HZ
M^S*TS<8TTX4HXCN6F$<[;"P;ROE(N LFL.25T*)WL;HZ9GF%9U9+5DU-GIA/
M_RB1TS.;O04&L@%XR[56M%N>L@Y.]Y<;U;3Q6A0#XF@8W;/>7&7#R7OI.O+4
M^HCIPQ^>PJ\(2+AP.]06Y?FRGBTW_+NPW!=*C&\L\<P$J5&[QV4@7O&!\%2A
MK5N@^Y/.';$Q->JX!3YR]LE1:66W0JS4Y*'4G%%G@9@E! !6()ZC"7 *0:D&
M\*[> D/9@?4=O,P1VK-SD!]*7#>CJ.&2N_C?L0YF9?F-K$M^+W>\0U>MFA<H
MO7A#-1[[!+HE@M33=_:)E1UD4/<G^!6/TJ5_-(X.1S_?B+63\[)T/.J^(<#Q
MT:#$Z/F))D>Y%W]\C6BHB*ARLE ]O07\:ZJ*-1%S8?F;UYR*TP<>9]<B9<KQ
MUUL$T_]4)OH.(?3R_U)G;^+ OI5DQR)7Z#@I3\DGS,3<NZ9E76BTJ)X3Q"[Z
M+49H_J.0X>Z_+#%5F-L-6M C$)##45_-&IM;(-EUJ:SEBO\]%$.>X95A^C!R
MJ,]05]B"YNL<6D- ?+'084HRY&BTWGHU+19MC'QN&)NMC-#,S%6(B:[TU5X.
MVK.._V5Y)_0%<UO;&FN:'(Z='C:%^0P+A>J@LGAZJ] *WM#RGB*O^$U>55=7
M[MY6:-@[3[+^H'B)YP+[*ZT:IFMQT;B?1;9C8[*XYE,@"9R1(G0%S]2(!QK7
MF 5=XESD&5JK!Z$ 7/ WWP;M$R?\WK[B<K,Z%H7M8*%SD2\!//L^!=$L8;),
MH*98#K\6$5$U;)<]PD25JN?Z$T[H1X7/73>.&1QN*&I:72D-F$FG0C5XK!\9
M:!<.;S8/=3CN9I$UU4W5KU*AI1$-<[G59BK[%ZM4*ZJ,<_!P/39^3=>;;]@A
M\L1(SZA.7@?)=X:>"'B:M"&YMXY"H=%(J?E1CW3(ARN2+4.L*F4D[J^^PQON
MF89R!ESGX$V36>OI!PD?.!T:/]!P @A\:<-6K77+^U[I/1>MT&CIY_R9 9R"
M9B/K\P*\I6-L2VN-$HPQ=E2E!5Z<"I/U]]R\*@R.INC4]YX,MT $3BR?9'G+
MR-AC]: )UY9EB4D@U-41;N,, [Q%, 8&0N,OOQ=^*27N;N5@T1$H_Y AEMMX
M$N2GO/'S3".+H18Q>U#)UVH/\Y_Z?BJ?[ZO2X_%"U!IPVLY48(NZTM#7>987
MIM,-6!$,S4D_R@?-3UHX)M>JNA#9<FW%_3**RF5-.!'8DT>' 7YPSIY2O1ZQ
MB\<YCA3+S]\_D6O@;(B:W0QZJ(WD+G_JR2ZA3V<6]JA6178=L=^3QARR!O(%
M\1!+Y'?&<F2I@4\4/9Z>J%[W:O$T?'4-5L$^%X.NFZ,@-_Y.MP#"QO7N%>.!
MJ$Y5G,EP$XNI17RK;S*O4>Y(MQ]S26:_/,\AM(^FQXY]]I?,\S^0;/Z/;M=^
M1=,TEP8N-]L3TX;)=_D8;]W+W].BZK5$_S?VWC(JSF_I$VV"-&[!K2$02(*[
M-Y)@ 8(DP24)P8,%:YS@K@$2"!:"NS;N3G +C7;CWHUV C3#_]Z[[KKGW#5G
MYGW7S)QWYCT?ZM/S[*IGUZZ]ZU=[[ZK' 1FCKVF9*WL<Z12N[D S6T$&'>U>
MW]$$>%-3;P4LW@*H6Y5N :SFA+M9# U.+2[EIO3Y[#,JH&7PZ)U80JC9//@O
M4#S'/]EDKRG &P.\2:)]&+YA@UTQW^H"CR=^C%F=+^,Q"1AYS,7R]@_K[_@U
M[B0YAKI#C<](ZW 9!82N_\%< R\3*"8^QO]U4\XU-U(K[!<X#3[")K ]WJ@%
MUOAS[)O@GS)_ASF(L28( 2A>3R-T8C&D4B%]^\7$-=/SI6A;4:*NC\.$?(>+
MSDW] N#Z.Q^&[P:#CB)68V@O?=K/I$Q_BE& WE%]BSJ\MG!Q8&Z++9YR$'50
M_K-^<"%@VL\@^C'_ZZ^UP]=*5A+T$H"/2JYI_I0S;O8O_7?AL3KKIB>_P/',
M-<. (8,?2WW&T\YO?-:+ ,-H%V1R)Y2%NG;6L8[;3_G(ZG/=9=QT^#T][,UW
M^CG,I3,?1,KEGH</31WP?OB.V:SC9L \Q[78!?,C,VST]&F,"C(L;&6X.01:
M)[NU!<8(*<6RFEB:*H+4OD?A91E2/%#BFQ(&E.2\3_(37 D$*;TIC+MFY_K3
M06T3CSG*H[@%+)3TFG$CS\8HF7TT$K^LX;3&)/E)3>#54\5TO:HE!]!S9'W.
M"0,$)WCA>/[7SJ;R5TH+;=?%+R\:<CS3+;6V;.XMRZ?-)1G<-$@7F4V_33XD
M8A4\9#;VU/"9E_9!R77.T?_E\IQ57JOW?I3#Y9B/0Z\C H+=,D%F]4@K*/-Y
M =36!7<NA8DR-,S6PO)^;Y]BA<'U;@+9"DCL*<"/3+:79KC<5<0%Z!ZK<8>G
M!+N+QG6U )[%W-UN3A'S[5RS;U' :]:5AW//Z#%#0=SRJ:G[,5X%RA)>JAB>
MMPK=EUSE=_%]'J+B;G19C\/_^'\N/!HJWAOA0N@))I[ED*E];YV_NH_ E-[!
ME6@1$@(M\X,VR0K\6T!'?SSZU?T]&73V0/NC6>'+W#BDL>+J*X4;&^R6F?I#
M=F7-/_VEEF\:QQPK*-EN ?$4)@Z7 R L(ZT+'TW3<^-*>+!F0Q(\8^>5PXWM
M'Y6N\7 :C2DCM/?PQ;./-6J>[*;,RSU./,*'45;%ZVW<W5)U*RS(^>!Z!\43
M0,O:E,AH0L$KZJ7K1W2RRC;WH-<\'=1V2Q!C>%;]$^ARFGZJ-.Y !2-'%'@(
M%6UT"S OAKCV"$"U:CHODROG P8#")TN!OJ6?4 +[8R3OL+8VY?I^0M-GTD'
M/OAB']@W3++/N%62=,N\+C5>67E&MV16IH@__M/E9!L;&QN90\8_?\T%O^$3
MYNHCBTJOAV.XE3N,#59W<0($K[GYE=O0GHZO?,71IGX(0X7?_"R]OR7/3X^$
M]/>C=NL;,700RC_,FKYBZ:F%I<++QD3<G&VI:\FI[RU2S S<V"NI)^QI5\1G
MW4SYM'!L+QATFB/JQR_6+%.G"ZB4O^*<[[GT =R0'-,[C]K-+TQ.C(E_^!@?
M5.CGK-O"M I(N0=\U>$@',C'E:ECA&>D^RKUN.]/!][\+#5**Y/[FWVTV$5[
M+J.>Z94],RB/R'PCR.JKUO;44;4FX\=&<T3]$E<[;?(#3'&8^JE=!K[,G%TQ
MF%6B+7-YYO>4( YZ?%*U+IG3Y/$V@/-< RRS(Z1N"',?_51CD@09(.G^A:0N
M=9B4.DMD1% F2ZNPDJ$Y_A.?C"$\5EP+U5#O*=K7(KQ\"[!\[L#6,B2AHI/T
MBI@T!Y4E;)I"A?4U%^+Y'#D7;?]CI\'6P=(VFY-5_0-'T@N#Y"0UR7'OZ7]2
MZM"_*0VJ(J#73 8)#9G)IK!OT'N!YYN6[/;#1[G) DUX!T#A=O9@MM]@$ 3T
M:F:R_1"3%\WM=/G)T<2'F %P-CPT+_,R!VVU.H;"J[0NK!#"[1TN6SVJ?(DF
M/%U6>8;*OZEN0H>C*,>[+XB%YIHY?PG([2/,OX!R'I1!R+I6"9WX*BIDA%+]
MV=KKW:\T#V?"CN1'OS&/IPS!O'1@@0^=8A+WB=^A ^ .UGUDWWB'GU[8FUR-
MLM)=%\O5M/- LC-?&D]=L]NLGO1HA!_JTYW9@C:!R_;6O7\N8S^XORU RW55
MK78^T&,(G?WSE#"Y?R)X2^*:^\OL_$ Q(+N_@\)7;FW?EJ#7R)=0/6Y-31(H
MIW&>0V+/'P2FIE7W0HC/^.IX2YZ>9S1D !<D3'S([>TN^[)PD;PMAB9VZ6(Q
M5>>UD9/TD%M EMJXEMU6.?@!FA]^&>K04>_K+A>A.1/+X4GVJ/GKG_=O@<-Y
M51+'HQ\O VC\Z=6=80-AOBP8UGDGIKKJGGR$)7O@V*:6"?;)QNFX9 YI6[LD
MQ&HS"NVI-7_]S/7334K^X!J&MZ$EENQEFN$D;SW!V7Z;D-I,LBTDUS(Z2:"3
M$JAQ@U\I +J/8;-K5B0C\7W24=_&'RCZ&,>YQ/MZQ7 <"O!.3^3SE][[8R\_
M!Z:=J*"OX=.(.8C>H:*G!=\",,V ^98Z=%O1ZHN$/3/:R0^M_>2M B,N8C^1
MJKY\+F=%\3W'S"NG)=>OVK?1'T0&'3HO!CEF\5MQ4<;:U4F+QN@?#?N/1S)(
MA 36%]XS$IX=WM@9@ G&>6M[RJY54)DGJ@([S8G/ DH2EGRL D5EW+_;ITJQ
M1)9!/';/F;5ZFE:9-P+]VFGBW^=&=)+*$].YL:XQK5VO.I1<RSG1F9F+AZ=>
M]!_-21Q\X#_>,'S0]+#=*]^:D);[]/T:=R[S_F0[^QTT  6URN$(P$SM&,9*
M)8+FU*\N[[$*O$^)Z XL<4DBXVEE21F_!73CKMD;ES]?U9H36>";5@]ZYC63
MX665>(13S;?6+_,HVOYD6#')F <?J DOY?_43HV\:>N($-4$&LX$KKJZ;GZ=
M:>I7Q 5NTG4>+YV+_NH8B \[?7J38>'J4IS7_XZF ?:^@EDPJ,5065G:K4\+
MF?P"Z5\+-]9TU4#.I5F6]#1/G7^O4[+9-@%V8><Y]^ @>]+WRV3(X*;<NJ8J
M&LB5%&OOD,^-06,B[AQOUCXE)FAMR[.(W@((*KL91\9K#'SYV]J;>+2?VL/1
MT%1F97'L]%>MR/>767J9R*<Z/A&__(_L)7+?J$@\,9BO4ED#$3RM(+$"D=I6
M[W'S?^/377C=<[Z<(+7];58-0XOFV^ZU,$OKN2A\27MO__")H=IGL<,-["#7
M\>> +5%^.DB'V=21VWY\B/B\GJ?.EX*H=;TPWCT5UDOJSNPPSY]]=;> H"3;
MF( X.7K7W^_G*_96"63HR]&QYU>'3[0.51+?^WRIY(RI-K$(=98FG6EG1UM;
M(F1=SBT09!2[GJ14% 5V#H2^>8#0KK^<T:-I#,A7<?J<VV=4^&E[M<#S&OSL
MOC)4 ZE'%='@@8JSID=Z:S:#NQ^GC[2F7,^?9S6!-'M$\[;L7<"88J9U9JG[
MIN*1U_3E]MZ?/;WE8NL=R%4H!S;D$X<H6+._!$ER+5WDHVBBUZ/#:P.(T US
M/Y\ZLF=QMXF^IZ4DK:'!<1B_E._,(;TWTG,+J..@(T.,XBEA8SE2O)"C#N:$
M\AY@) <^B16N%0,5?Z;1LZ )N;_/92!X*S(+ KIEVID[F@Q<BC+&I7A/WKC2
M+ 6"+Q0N\F?=5QEMLT#37'5(O_;ZXN=DBX?E[B*?' 9W='Z ),"9*AU&=SJ&
M@"5@N^/@;#]XQGZ@,F_.IXFJ"UM\T-<**;^ BV"HW&[SRZ=+-W'#L/7X[A?V
M<WRMMJ6V*_=K9RM;J<O:EDZH,C2K3XX>!MYS'B#&PB%&[6'EMK/;7F!(M2CV
MO,$M!8MU&(7ZYFD3$[;M+<$*YU:_H\]8FQCFV79N=+!)^/.V^5:EW+K%B.8F
MI"_(6N/>+R$GB=U/ R9Z\U%UJU00%8VX6T!O!XU[P .U9_(+-A1)!#@G]R68
MW$67C'RUD"FK(4<RSYLSE/*-?O)N9_G86BRP+8;"]+F.2>79LRWTZL8CP/=G
MS]3;S+7FRS:F#R)HQ8FO:"B]'9=CK&6\)X"1 X@.HK%%?HP$.HL+PW'%E'"'
M6A-*G7K2Q3^U6I:02&NBR]=)K)"YR8-^>L]P572Q8KS_S)<;0O)ZI XS^_JS
MRVWU+RY*V^&(YCBE$->1M>N\X*&SXKIE=?DV6X[)8Y'%L%A/U8N:_C[]F109
M0L I&<6U&-H0;G.X@<HJ]BW]V/=._$_9]D]V^JL?;H/7^WPKBQ>NT^TVBZJ^
MKE<+UMFW $7.M@13&ZE]1A=P9C%=ERL+>@LF=3_.9;[\9:TY<&F%R$_63<U1
ME4,%$/KMT\R:JSS30+"C/R4D6"=IH*N!@:1OB<)KK&JW)(:<7-SQ/?U&W,W^
MZ'F+#U$FT2L4,,IM<?2IP3ROTZ$(K]147T&XAD[S0Z#C*[5&/M6=C_)CFCY^
MX5&^;)P%S59I%3:5?NQ4QL;VC3$QRA_%BL>4R5AF-]LY47Q?N2)6N]KQ4*;?
MQ3I\D:L&,D(4]FP<PQ8IDD_9'^LV.II^H=Z8P.7E[M?',*%^J*\Y =")(FUZ
M7+9GT2-O;4'I7WY>K"71'K\- \@]WC>KA3.[]L(FFYWN0[0P%+^FG18N[0@^
MGEI+#BJ<K&,7'YOYP?GIVL*CTWMZYUA8YZ^UK%FG+)MKIX4=;$DQ',L)\@FX
MB4L;WXB)'U6,Z*'X8_-0'.G^H6MOW2V8HDCS78L'**42")Y\X>W7VI2_CZY5
M0,75%BO*2"+0UW*%$0T_BPLY3J4W-L(L @4_=:YGU0??A8]Z SKT*.NH5G4$
M\<V.HSM>'*CK/MWUOD6OD5POR4LSEUQ(]HN),V?RO(?A,#Z#-4>2UH/];Q;U
MTKVKQ'4!M/OFCO.5]5YKOTIOTM..F2M!?=7.'WV^7>3@OVM"NR.CM1S TFWB
M\G$OMT5;7A@92O0?_DAS_#(NRA_IZUYDFVRXB+;H-BJ,?-@&I:70<L31R]62
MGQ8'K'^SR*7NX \[4SO'KSP2B::O9(M18O[9L'-20AK%%+/FNMI4+B @\ @[
M%D6:O=[VD5G&1JHO/HP]:4D4:>_B*:.;.)PKH0C40$V+<E8B%Y^AGC$8H5N7
M]G5W)R(NU:65DZ'TGK'XNFHL*?,Z\N2&AD:[<P(+NQ>H16/Y3P_". B+\G(
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M-O5O#-WIG<GTAL9(20 ^HM0(?_([3;L=TZ.5!_K ;'7S9:WFA8Q%<]*J:S[
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MWT@M<091^ J7[K?S(&6W4FRW%W>-H#!^T$^ED[S?_A\$<<YVA.SCT8EYZ%M
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MD.6=QU/M> /#7[24VGD@;7VHY_8]SA,$A@\6DWXS!3:-.HN!Z!UD5%#F/7^
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MK@K^7JEK?U:T>IFY'?A!_=31PUFYR6OV@D4ENZ*K>==A*J?/#O1+2W@Z0S(
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MM":^1%LC"H.NW[K+5H:[#QYM0R-^HD2$>A>!NMA%RW'H,>ZQ5B>4LA;%-58
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MVA(QB^9::S&6%>-" </.00W@S(?#9(*^VPZY70M9VC?P?J\Q+,#!]5,4YRU
M 5W-'YX^M>+ 1W+/U$BQ:-7&6G/;+G/16=';<]]D_A.&!S+?UQR6YNKD -=4
M[#ZQNE).L_!]J5L;(F@N.*</.%R[SCFBZQ=.%,O.\7TZVRY<&>,N>V]$2>O
MD-=A]IARUV%CQ,'0@]IJA'+@3?\<MB1>DZDZ7"NR5;W"MO060'BEABS(Q3U1
M<T7P\NO>6QI@6?]R^&I3W?<'I?A[XL,A5NP PSD93_Y#2>L?ALN[5G.,PK)M
M=:./(HRKV9:#SK.Q N7<7(Z-.LBN_=9O <S[T&Y&?K)%FS]F11=0U^;1;74Z
M.0]18F4DD&< )-&YMC40>2V)B ;%,^C'U)&0B&;@38?&#D?_6K,AO1C)O 5
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MZ# C!>MYJ]HK?F*Y\G4?*OCL!=-K@PG K?()OJ[F]5'J_@'D!1>%6C<=@>Z
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M($$F)=)+H-IGQHN>]3(GS]Y]%P7+RNV1AF]Z=_6#+GRP*C-6T_7"1RA*O""
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MR%$40$1B"G&H_%LN ^SY7A(E">ML/'OS3FG9%[*7V60VJ0VFF?">RPDZ0:]
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M$/CMR_!N95C+=L:O0J?#1"^"T!WXYOX*&(;"YVC4D7V96B%(M49@5^O=SC*
M/H'=ZUK50:W[%6BTWVDL6():?U I $"+P!788'#55O=P&%>?VG!N ^N323]M
M9'UJHQR$UB<78)A;]#%?W7X3Q;TN$];6F\I$^44\-"*5G^5-D:U8]J!W"'Y6
MB^5OOXOEH_B4KZJ[<H&#,**QE\(41[I%1RH@ILKSX4E$1!*%@?"M6G1<),W<
MUKQZD]YN3KK,&&;SS&00CSQW:#V@5@1H3:[ ITTYNWIO]?/*X=:I$\R<TO9E
M$DU*Q4[ VZ=7-P\=1IG[W3.VY?F>2W,M%<NH]_#;79&O;^_>9X]"OYKE];T^
M6_9W/3.4U2)*?(2DQZ"/N5HMXA!#PD+%HS&GB?"QQR5=/(J"YJ8DZE0^FR]^
M5\KQ/GS=1)=HT4&^$G4.C/+U:@V U&=(ZZR8*[#1 F@U['C8K87->/G%K#8R
M3_?T-OI:]S9Z;JQ=,K]>UO2LEWMJK?=5K?F78O-G\%;]Y:I]&SK:!RTR0$/C
M;@X8Q3Y.YP2W$DXZ1XP"[OZ<,<X@@^M W(N"961Y0QXV*<5,6=:3,H*)%P<0
M>43-!1Y+H)H*XC0AGB^8666<<Z/,S4W>"@EJ*6UW+\XB:L:]%^,T^C:T+41#
M:AN<AL!UA8(C(TU=9^"TLD>J!9RY>.!FQ&9G>MN2HZSWHQ=!%*+0CR(8DA1!
M%# !"?=3*#R.4!A%,>/(*D7ZY%!S(X).4AW1W9&U3;:PI(,S"!O&8YW@-G8
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M(A'4!3!T:T .B4Q"&(<B2&,O2!//ZL38B7'FQM1;,<&#DA-F*\ :22V;=)R
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MNEBR@XV)#+EC).#'9I8-YIW@0$NNL7[385W_\,X :WOR&0":6VJR$6!:XAH
MS0&M#7G&T+0?6NWT0=AKDMN4G5KGZU)'XLE2A^YU0=:;O,ST@OJC*$O=-=T/
M/JDK[\I%BH-$2A) AK%.I/24UY.J!6^*4DD3XB$>6=&B6_'F1IQ:/J %!'X
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MJU_-<^=7W!;:^B2(SD+7W*$[(?RRRFDIBD<]V(?5P[HJOPBM3=V(),M77W0
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M8 'WEU0YC+B_^$R:$+*]Y[_;0O[.U\W?_FNZ_KYX7'^U]M-,-__\](:O];,
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MP*04(,\+Q2NDC:;>65X]^QP;#6RV9YO+Q5>GEY!.=#L!&N$#S 3?(;AN:/4
M["!;WI?#U-\&ZP';@8RQ1!@'666!:+689[XM#6:G!:IV:+"%OAKI(N:6B=NY
M^F!':/8?=K^]4E/I^FCV'828O.2P!*:H)'#.R( 1R^R6XEF)<U602@?Y?[7W
M-S8:K\6-O%R^!JW?669"P'JFYPU6+H= +6MV*&P/=\R>P*3UDKG2Y[ N,'X
MG/BW>+X6&[Y_;[^ -_IAL9JNF\("JTDE2R5=F%AND +8N1ORDE= ZI)P7@I$
MPW+?GNUE;-SQ[YK/UM^S%?^Q"0;;B)FIC=2!<0;G<?6CD,YH]4P<&_FR1L!M
M 9*$)4=: 4@<*7^NIX&#XEN4/8U_;WLXC@+^4Z]<+9$F+1@G0FA)-,@I10#3
MG !F5 $JR(7@5860,"%3_UGK8YORC7"!>=7. ^<WMZ/AZ'E.>R,1/)G/:IQT
M$C_O8=#)>U:YXTE[_J&XR=KD7FM,4L8J*4F)@2PA!UA*""C4$K"RD'G.<R%A
MT#K]K/6Q3=9MVKFP2?H<,+])&@U#SY-TF^PPO7%^5N.DD_1Y#X-.TK/*'4_2
M\P]%7%P7<%^!YC_X_)$OGRPDY?;BVEU0RP(!(PEV904KP%SPL"1<,X.0H9)[
M7URW=C6VZ5O\!I\7.FHDSIS(,1>P[4!?/U!-!U_/TWY@Y *NKI,A.-!I:2N2
MB:ZLO3!IN[)N;V"X*VLO19Y=6?N]$6?X?)C.]2?SW-O^[<^'Z;+^9#[KY72A
M)A#)JLBY $S(PF48Q(#1G %#H!!2"H5A4*UFGT['QK.[*BT;\6XRIX3S#-RH
M$68]>:'N9U2EQK)GTGV.VB[XYB;;R]P@G,X*"X$HJ7'FU?&@-EL(%,>F7-"[
M<6RT<9#\QG]^T4XAVT7==E,A>?];OM9OIL;HI5W;IGPV*0D6D),<*(@)P(3;
M#1OE!HB2YV6)-&%AX?F1<HR-L[:5I9?N1D(="%I7F7J<![)6[.CX$=D F/?,
M;6_KNMT''NA6W#HI:O9<I9ML.S#'S[T)&:-@'NR(<%)JC)5E4+;L"-@Q@79M
M+GS7_$;;5BQAVU9O5RN]7GW0W++.-IGU1#)-),\YT,I:=[@H+6]J%TK-,#6J
ME 0QZ+MMOM+7V+BQEBZ;;<7SW^9=P_3Z#CDA4KU?26TDK1EJ(VNV >Y#>N#\
M-\@) 1QHA]P%R*!]LB<T+1OE:RT,ME/V5.5PJ^S[2JQU^D-O@G0^+V93^>1*
M0-05("8,YU#+$@%9*%?M4$ @<FQ B4H&B?/T#+LPN-C3V%AT+^A-MA$U^[/Y
M,[J@R668?0W)!.#U3*P=<8LP_:Y@DMBXN]3;P.;;%:5/#;1K+X3'A;Q>S)6K
M!Z)VGNAV#WT:%%@7E=E_Z515")=: EC65;*%!K0L,,AU3K1&B.'"RUT@6H*Q
M$<U.B6RG17V,="[P-[:B4OQPM1/3((/0,V'UA']0=$LG##M'OL3U/EA43"=P
M#B-FNC44G7O_-5]]_[Q<_)@JK5X]_6'[?S]_-YUSNT^>W]VZ8Y4Z!GJB*TZ,
MH!@4G#& E1! &$6!J AD):FPU&2R]L]WX=]U$"4.D+G"B9V9V>*O5?;H)J;+
M8&"V8F=\)W=P6GW?H6!5P842.2AQ88=""Y= $-N?4&ZH-J9@QH3ES.QG,(;)
MC?GBP^%G'?<#<<^KCTO"4>.[%=NEK/S%29Y-Y[]F.^&SV^LPQU0T"$0L=2D#
MW^Z'KF$0",N9X@6A+0R< +K^7^-GN+G@*B8$*9XK!$$N)+=[?8R T';73Y&N
M-.88V<5ID%309X0;F]7>.?OL39.$=NM'>^5JN/_1]R/9EQK3GFEXZ.$<+JMP
M"^[CR"]\3L!_CDS#+= FRSG<UD?XK5E=*V>E[USSC?.>975406. R OAPC?L
MA@,2#8JRHH7"+"\\:ZR>;7YLM'UK3'TYZ:;YXVIM=WM+7[/U/'S7[\2Z@=+[
M:>U>N C'T#. ^-]U=0-FH.NM,(""+K0NZ]]RAW7FI<&NK2X+?'A3U?)4G(W[
MQWRIY>)N[DH[?>,_7^FY-M/U:N=5\%G/^<S9TK=SM2T&MJT";P1C&NL",.U*
M;[ES9Z$+"B@A'.5:<1P6W=Y!EK%1X:$J]>7M5IF;0^>=G4)UW/>N('*C4YBY
MVF4@_:S3@8:G9U+N=62"+<\$F"8U-+O(,ZA=F0"X8S,R19-1J36+?6:YW^V[
MWP^B/RI4YH1"Z7(T4U?B$%D#4BK ("XTR9FN2O\ I;:>QD:@M:R'L2&UO-$Q
M-JT@7S<SDT'7,[D-B5I03LTTZ V64K,#BJ$9-:\CTYY0L^7](?-I7E?C*)VF
MQPN1I[;RNU:/=0IDM^D7Q^<"7RQM+Z=R[6XJ%_+OELR/_N6/N67]YA#YZ>C&
MOI N&0OG@!=<N>SY'#!<0I ;1@63]K\\J'Y0G\*.C=+WDF].^K:W+D_1GA>#
M#+GGT>U(!G+ H]S=$>W^H,UES=\/LE.KMI]/_M$I>Q,U_N%GNP,,3-JSWCX%
M'O;L=P#H3\Z"A^@SW,K_;(6YMU/J<>T2R?[.YX^&R_7C4B^_6!GM,OA%2SW]
MX;IKS"MI6*4IR8'&2KO#E1)PHS4H->(<0P,5$KZ6?W#O8ULZGBN0'6J0-2ID
M>QTB3-WP\;F^:>@5]9YY/D#V0=#VWVSTBOI &Y"DZ =M2*+1:]FDA+<YV,8E
M6MW#S4Q\(QT+$KZ9KN1LX<J/K?;F:FXX(@5B@#'BKAQI :C"$ @,<P&U73MD
M'N9=U]K?^!SJG+A9+:^U*V-W%.T8^VT)DN'6,]<? '8@J1]X\>4'VT#II_#@
MV1Y?IN1@F_(7BPVVOA1'):^=W//U)A7#E^GJ[Z^>OMF6ZIH9&N%<P\(R!Q,5
MP+R00+B3:$P$+0M-2Y8'.:RU]#4V<_.9J)F3-7.B1E4S;8/8CT<2 =<SBT1B
M%DP@'F@DI8^V_@8E#P_%CZG#YY4TH6F;2[+7_,'UM/JPK>4^*7(LJ4(:",&<
MUZN@KI:) 0(QC0C-44F]*L,%]CM"0CD7!M5<.&_%S_YT"F2U!AUCSRZ-1SOC
M](AR_^R3#.#.P657X.HEI.Q2GR\:2'8%B&OA8]=>C]P^3>?3M?XP_>&"!M;V
M(YK:C=DF[/_V?K%<3_^GILOF9O^_-5]^LR.F)ZJT],4+#$0E719^9 #%I@*&
M<DE,J;3B?DE/NLDQ-FJSWR<.W%M%#H#GKJM_6/O>C]4:@%J%;*_#)O]'G?%.
MUU<IA^K<9$Z3K%8EX6:M&Y9IMW&1L@R[P>L&V,G6KV-S<03Y[WJFOBVVB2OW
M=83?:+%N_M4Y01G++M_TW/6ZVNU1)UI4S%!F *F$<L=/)6"\$ !51D(IH2I%
MT*ZQBS!CHTHG\[,BX4XYL%Z ^T:]F^SWW4^WLWI^VGGN;E"_3N=W,[W[M:LD
MIF\R[M3.BKR>_+:]_4E.&"-W&G$_6AYJ''OFYHM#N!^X_2#$#6=-Y$6>CL53
M0)^4RCL)-"B?IX#NF-23M!EYW,<?IFL^<PZN[D[\T7;Q=6'6?_&EOI7R\?YQ
MYK[0PZ5E4AF=0\(YJ!BJ $:: UI)!G*!,:<<RT)4D[F^<R]^"S@,#);$BP38
MA@1.Y.F/$#[H55V<:BMRQ@]D#CPI#!\=SP/$?L >:&>_%S[;2I]MQ7<^1'OH
M;WV@#S]PC$8O[3EDN!C#'D]&PW1R:AG?4N2)P":3ZFN7-G?YM/6_R4N#"\B
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M"6]W)9I_?K%]?-%.@[J@EZ6@.BW'[5Q]L.,VVSVG5Q-N22$O>0D(='$RA2Z
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M'5W0MJ=CG:;Q%RE@>_G8YNCWX5NK-],?4Z7GZMU2_^-1S^53D^I-&I$;._D
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M5)2<@T*E*4 DQ8#I]P^4I<A3#B&G1=&C^/-"Q,9P.\08"/[<?K17PF=GX/L
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M'#+%3X\T-2)K91UFZ[;RFFS=TB_G^0S(%W:<(:&+S$9CHN:4*1X&O=$RQ:]
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MIKU"R0^]2C_VA4W\/8?7S*;EX<8X<Q3[R"/Z]%Q1@L8;V$CU9]SE>:7B,][
MG:X\X__(D5-<C86[W"S:MMZ_T>8_Y;I-T[E32IH3(1/A.Y,*TU2D'*25,!FL
M60:8+""H2I)!Q,H<(3A*!JN%L),C].M3$[=:=X5,.KV[+,.;9*MZ&XH]4H*K
MS2MCN2A,Y$6(O6I,X1T8+_'487*FD5=J(_#?(VW4 ?I@6:$N8WIZ67=>F&YA
MW0KWN8O>,;T!5R]D6^TM5":A$LRT@<>B "B#'! D,$@++F&.])Z#.45[7BG/
ME)>H'>T,F.D*1^V5$V?IT!UO.D9<*+QGPMT1' :_L [C*V4:U[$<!L 7#NA
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MS^%="I5#BCB0!:<F<<)T$RSUKI4J23BGDF5.1<T"H3V*_](":Q00:DMO8A@
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MHUI];:]12*\5/'DFN6DH-Y3=OG2 !?H7F"P<F&-ECXP-H'T1AK! CE2-X3I
MG8HRV.-SICJ#Q4-&*]-@K]"P7H/#7;Z'ZRO]9*XIK4VS[HN)Y#DN,DBQMC(S
M3<."E(# 3 *28L8H+$5%*K<S]".C3,VNW O9E7WT+(-\'%';4^\K<8I^N.T*
MD<<!]AD( I]3'QMIY./H,\J^/'4^=['W\4@?:?G%I)'01JQ^?Q3:PLG33#/
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M00]T)=O"S(^]\#?M27$K=G]X_%BO^S(#JZ5:_TF;T[NS:V=*"(121@B0JL
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M%U71A*&<20EIGDF($TF@D#*!FJ.,TXP5&<EB5(N,(.L(0U)VHKIB+0<5<&[
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M/,^%^P:V[T/@2G[GEVHT )4*-]M]Q_.-RPT7&GSAI27R"G[@% %.DXC'O=<
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M6*X?E[_QQ4Q7)Z6Y<(4T$8=,,[N_%-C^Q'D*2682GA>4H#2H6-W1"&,CCXV
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MTQFSFU*5PS15$F(E-60T05 ;522$,RQ%4!V/,^.,S9!\\75<$<%W#E@_HHD
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M>O_%KC:/7#Z_U3-MRM5R4U?M]F>YG"1&$H:2!(HDMVN!)@I28P@D!<X-Y:9
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MN$$HNL]7^ -*Y0=@LXG4M*K4*HNH2E==C##&B9N)$\UDI.3OR\.>C#OU@#U
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M7XNGRXO^%_&GI%M^>?$'4$L#!!0    ( $2&3U0FL$99, 4! (LP#  4
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MTY2<ZATS@;SU["@4U,$%\N))R5YX"1)+S.@32Z)-&XH'R1JY7>O@(!I.!QT
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MF[:IX&W;O4@+HYZ5.BOKK#9>.\6X!$51N*QLMK+19?>#R.SDGNGIB:IVRND
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MV^\Z!M_E7D=G>21)>U_K!<C&@TM2 M+2-39HDDF;LO=A^1CW[*HEH!]7Q1T
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M76^:Z[(KILLA)I*1$N9FZ<>=._3-S^T4%,<J;3&0!,>^0GWG16%Z""]!63+
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MIG?=2]*XB=?A+=$PLN\ 1-_;K7<K)2R77^G59V<U(S,I)B!7*M/*J*/&K%)
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M &>?",#MVN+;WU^<J2 4R]& QCJTD6LR"*038!)R)BQW/K09/#?)\6<*Z30
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M<K:-AIQ\/]&K4:C8(WHU1D0]H^Y>?(2;'&WA#%R.",KI %B4 *\91_*(ZK3
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M@DK$ML"D@<*]E*Q(F7.;MO:)7-;YXU]-E-Q^ NH <C]E^G)<;,1T%EFVC/$
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M*1&O$5"BE"(FE/R1AGR2=YCB'(/ :$X-C,<6T/Z:<T4G:)V.O7X)3,Y<<!:
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M?IG=MHYLK17.)="JU.ZQ8L'EJ(%99;ABQJ2[BY &@M-#U'3RCC<DA@X6>@?
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M]!!X")R&D/]@7JK!2]_=%[#55UR%/[]?OH.%%?W@CT^;E*<&G>>$UY_UL7.
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M.P05.0/*E! X+REF+WG$-I>3=P@9U^,<H-+'P+&'?'N!QV?ZRVM!H$@\1I4
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MH:Z.0BD98]RNL9,^]09$Z'=WX7'K:\?=NS:N\]E?_CV YO)@QERW*VM@)=4
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M60R@,010BB>HU?3 <S8Q%^?(@+JTP#V8/?E6C#$ML#6X?@D+O&AP?3'+5Y'
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MY'!YW5X?A5&;6LJ-H#+6_BF&4#BW*:9(MM1J1O@-,L:[W6X#D/UEW 5 MFA
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M_3G.M"^Y7N30R6X$D<X=B4LSD9V(Y)2W64!$'[T&W3]5_25<_'*-M@>^M -
M#:[5^3 B'AD=%U1?EIS48"^I#(E"/Z*;#N7@B'\OG? <!7+_E$/:#AHWOW$<
M7!RLLOD \NMF0A?F-0]3O.A=J[VS6@<)Q0@2A.<> J*F%( KD32Z,.QA_2 5
MHX[':>LO!A-^AP#:F(%41A9%QJ-S'2+%2")1E0C>6)$%,Y+^7U,(C5T9/(Q^
MGP','L(>NY3\9O1VV13ELTLZ9]#>8)WL*\!;E.!L,9IG7I0>;J_W P3T!9)]
M=#H?3L#=N)1;TQ&1&<2Z2*8D7N\AR-4Z*R,8A^1\LY!);U4NT'KV:*LQ6\<\
MC_86?'?0N>K3=2*H$,#5RTRE, /%<O4F*P652T"76X0SG0\<W4FSVPP<W47,
MXT/EGD5=&-&K\'W]KG=]!9J2,[R6W\>0R:!D$1 RJTE"X%H+P0L;[G3:@;!Q
M"IB.Z8^:J*B#AXK]+[@^XY^KE_11_YAP##[Q4L"'&$ )Y\&[% A3R<?@+)-F
MJWO#??;T'$I\!YG=<:\6QU)\SR\G'^@,2=/#'D^N/F.P]Y.'J>KC"460QEV=
M;<8I$:A>CL[7XA5H4?>P6![TW2DZ)_N$<MV^=)^.J_-@LS609:MR8I1%YT#.
M/W,&SG,#*#-W-CL2T7#G\PZ$=7#??1RLW5Z;W49QX\>+#U_F,+282Y&$E5I=
MK;0!IV6 DI$B$B.M"UMUA+6_*6VS<[V5NK>Y*-U%]AWBYZK%U]K,6 &G"@?E
MF87HDH9,J9D('I5MLE7E!"Y*=]+O=A>ENPB[PXM2)K-2+#! 8Q4H0SR$J#-(
M(Y!G2]&?V:H7ZY>Z*-U)I\]<E.XBX/%=RJ,.]WZ&K'.QG#,!RGFDK"5QRI7I
MM](+0?F,#VBV:H+8,W9\@K3QDL$C'5Z-M-3!/<;+L)PN*9Z\J;-9_C3],IN6
M::K5I"G-SVO-_)?+O.HZCT57M]IRRJ-=UJ!"T1 DEV!E%E%*X05OL\'Z$*I[
MBND' ])\)*UV@.!;=]F?SN-RFJ=A01R]7[Q??<7%=0?N\J$3:,W_STE2A;'D
M,GCK(IU 5D/D+("S@F.RP7+19@[)(.3W=!O7"M/'UW//5V_K(^V@B[?-)PQV
M[?8017U<NJ'53#A$X&']?"%EK>3B]2T>10PB:C=<R'TZEV[%8U'2($@I><W-
M*![B%D%';D*4Q9D\W'O\7^72;1>L[7OIMHOBQL]P'KX8T-9+Q3 1Y<)0D*$%
M!(8&4LK1,ZZCVFY>W%_@TFTG=6]SZ;:+[#O$S^6=@2##LB6#=8JX4+7!R5!4
M$8MCD7L3<<"QI2=UZ;:3?K>\=-M!V!U>NKE4+-%+J;]&"8J15W8D(U")4IVZ
M&#7QX:Y.3N;2;1>=/G/IMHN NW$IMTJIE,L>G41(.E%^<K'7U$2P)EKOB_"&
MM]QH/6ZU_'&/H[WEWAUR-I:D5)+<4U))4*>TEI$)^!(\1%19(*6;3+4HE.^\
M.'$GS6Y3G+B+F,>'R@[7(BX&9T3Q4+"^U,>H(:"WP*SB65H>71RT,GK@F_TF
M!=-'<DF-M#0R_!X0WLMP1BSBIZ^(%[.";Y2C<4\&%#08=&2H,2-XK(N?-9EI
M82'K,EQTM!-I/5T%# :-I[/^@?34B__;HKSXFL'_O[PKZVWK6-+O\U\*Z'UY
M&<"Q8\! $@N)[P#S1/16,3$RZ2$IYWI^_513&R51UCGD:;&9/%S%EG')ZJJO
MJ[N6_@HY+04-)S6F1">&J(- *83!Z&46"4W$MFW:+XIX+HGV0P'9WF[]><:W
M8?WY_>7RK[LE/UJ=U=(90]%1SHE.EU0G^-'R0 =ADK5TZTC310;CY>O@3=-K
M^\@I+=9!!?-^A;^&S=5J&Z-_Q%^6BS\_E=67=R4^65]*UAB=Z@:C&#MR 3[K
M#%P'7HQ/Q;@V#%QC)>W@?4LS;+Z*]7HN0;XKFS"_/*H&>?L1DQ4A]\K41Q72
M&JN53YKL+!THI!_!*0XA:?)0!644D^:KSZ0*R5GQ6XU$L64G<XK4DNH45E:"
MCP7#A"/L_BE5R#%8.[0*.<9PIX]&]E=*#+K@K*<X*EL&*EL$KXH&*8U#.@\<
MFK8,%^=3A1QE[B%5R#&Z[Q _-SG)J"DH]\I EHQ"'R<C!"89>(K%LV"8O?N'
M<J2,LN^P*N0897=8A90"E2N%@72ND/C*@Q=&T(XJ+G!IHQ:#R,/_5E7(439]
MH0HY1L&GSD/L-##>,KS$I"UR!R5'5U\E9W#)&T!A&&FAU([%Z6Y"3[[_I*FM
MJ=%QI'I/?]Z,"%Y52%G74=B*2T,ZHE R%LV@L$!GLU-!-&UO//MW(4?<;!I9
MJ8.<5$VQW0ZH6E^$>?ZT?.!Q?_J^NVMWM]NLZ%*481Z*H!_*>00G3")73-LU
M*^%<;M1*?[#,/05[DX'H<?_\ZUBT ^Q>K):IE'PW[V,UCU=;1=9?O$&<7\YI
MB>N9%9D[0^MP4M>Y:[5L')@"+NKL;SH/A&\SOVR@@.=2;#H&E2ULU0$$MR]2
M=G/ M(>,4[;0*1/J8,DD+42;-#@EA2[*2R[:O)5[(LJY%(R.@=5Q^N\ 0-LA
M !?A^_:&0DL5*%,$:2KX=14[\%RO*=:S+"P+;1S5KA3G4LLY!C8':[WG.LW>
MUI+U!-6;'W_P9#6=$?(?6>FY*^G=-S_<0>YBN9YOP7Z;8W>L*!8E19$^,PH;
M?(%@. .F.7>56R?G0<TJXXNP Z2;)/K<U??#4ON,0FEE P5)7$11QPH%""@<
M2%369R.DB7;(XL?%G,\+=.)9ZE/C96^8.9$Y3I_;>(93VS@95*'X@B2N[C9"
MR+5=6"CZ%\59&A8VGFDM9G(S#^*I'Z'S#G%SDR0DM1B93  1#*G%,'U-K"A8
M%#PYSC5O2^#5;0UFE'V'U6#&*+O#&@P3#)W*'#3]H6:!)42O!!B>;9:TK3#]
M\VHPHVSZ$OW2" 6?WJ7\P.7N"2V,P\2L)!M3T%AIJ@SX'!048:VS3A1A7NO6
MTU.RO?'1U<Y&'<3YU]-B[RZ)D0>C*@=:0E5[ ROWCB:'[3.7+B?#P["70 >.
MYMT?/O1S#3K6WGM']1ZD_&Z@\_9J575ZMX@DA'"H(R17>Y]='8#%2#-TY+,L
MO,_>MZF^[!6G5Z?4!$C'F*(#/-4"T9O%MKF^S@_^%BZKHMYLWH;5ZOM\\>=_
MA<NK,F/&&M(+HTW",UTIE810]TPV*>6 W-@\Z+)]4'7O1?$ZR&V_!MZF-]7!
M^/M65G$Y9=7DP5Z:<<5X0:Z!JSJ_VD>ZFHHDP68402*M2;:!VU-9.DB OP:V
MCC1"!X[LH?!9F10TA2$H0^U#S F"E060.R==2MZ[-@@:#QY]]N Y7/6GQ,WB
M\ZRZT0VYSM_*YGH-2WS0 J%D3I(I3T:VI!21#;CZXESX4#0K/K#'%_,G=9,!
M7S,()>9\43*QHCOP-=N*X>\E%3J$8ZW,7=;\RD58U?3*;\M%NMD*MB3K@Z!U
M"%^',=AM'9$#'="&8PRVR$%->H>5<%\6<!#R[/DBKZ&Y.D#ASIF]LP@,(F7'
M+7A#N%"U7<9YC!""1A&CMPG;8&ZO.(,0YLX>8<>;H@,\7<L_\\E:JV* Q+!.
M;W 9H@T2-#/>2HS2\$')\@.O3H,0X\\>,0<HNP.(_#(/<7YY76I:Y#\VR_0_
MGY>79)+U]0E_GU635BI6*P )237!DVH,2N"LI*Q8PA#:@&BHA,.2G>SL<=;$
M8EWD#796]C@'5U2=64E1JS>5"],PA*"D@V*<-DI07*+;1'_/RS0,;^>?79_(
M*AWXNIMI";>=@;1[Z#>K*Y+CR1)GQ<:H:V4KQ?H&+;$(46@#4EH6LW')#YLF
M-O[,'"[D, 3^#=+RC>S6 21W.U4?1C%O+\-Z/<=YR;=+B](SBEX8+0T5W2QL
M L]2 59*QBP$^?LV)_ ((8=!\OPS]ZWLU@$D=]OM;Y>@C4'FBX#$<^TL494)
MWWM@F3N1F%8"VXPXWB/,,(B=?P+_6#OT *6G_CG+X)QC&007M0;!'3A6& AT
M@C,9;#'^E2YRPX!T_LG\(ZW0 XYVML).-B9E*82D2V?>7C]%,G7^CP+47FAE
M1?*F#7_:?GF&X>F,T_[36:,#3%T_+;O?&CLK$<H&S[% 45CGNNL #I6%3!=)
M;DS*)C5,N.Z5:1BVSC^Q/Y%5.L#7SB)F4LL2HZG,.2*#*B6"U]Y29"*%]8ZY
MC&V:N7:$&(:@\T_<'ZKW#B#S=OGER_QZ]%WM"EIN!SN611WK.//HDF5* PO;
MYY N0BAT$3186*H'N$FM!AL^*]0P2)U_9G\JNYRX-^*/SZ36_:EBHU(DKZJ!
M2_JA=.+D6[,"8S3GJ=AH_4O/27_\#<,:2,\X.3^=?CMP1!>WW[NM+EQW(3KE
MF!3D2X7;,C<43EK)!;@K2<HZ$82W8MEX(LPP-)U_ZOU8.W0 I>H[EXL=^87T
M-J7(0'I50 7GR6$&#SHP8RATL'[8XYN##K)=28:!Z/RSYT=9H ,$O<EY^P([
M7%:VHP\+TLY\$RYGT3F#GFYS2=6-(,GB3ED&VJ*WA5FA=1LFEF<$&H:G\T]]
M3V&/#F#U>R6>6)3\<U@MZ#JW?I/2U9>K;2;_7<%YFF]FTGCOHS,0F*:[7=8*
M@I01*EV6*"S+)-KD*E^6;1C8SC\)/K&5.L#=S@JVR8X]8UE^6:[7OY7-1_P4
M_CT3A1O'2R ?C4C+8P(B,HHR!%J,DB6F&CTE'"?H,$2>?S:]I?TZ@.?3?J*9
MBRIJ%B48+<BQ,Z0;9]0"4&;/360QX2!N[ ,8<A[+,@QDYY]B/](*'>#HI2ZU
M6;(I&'+9X&QMI?6BQC&NTGT%:Y@U,98V?NTER89A[/Q3[9-:J&?BM%UEOEN2
M]Z8/GH V[4<?.QEIVF#9CZ5,J_FK?5]ZS0WRN6SF*5S>Y;-D2N1T# <>2Z(0
MTM!YACY"*BZ:@BP9J5_0X[AO//Y8>T!CH3V/,3H+%*5D4#8[NCU&NC,ZSQUY
M4ET:/:GH@NZLG:V?GF,'J_WTI#+/<#$5#*BC@^RJR[7>0>25#4!QZ[%82Y'O
M$.B<(;_9%%8=1&<V0L4=PN2&C:DD)I2CN+2D2&JIC38Q)0&\&&5DE!:'90_^
MAG1F8^P[C,YLC+([I#/CEDOI6($8:DJV*/*QGO[J.4:7(A?)_//HS$;9] 4Z
MLS$*/O5(F5OO^D<JB[":+[=[IB 7P5@-41A7+^,*O.8)O,,@5.1T$D\WH&JO
M"*?A )KXS#E>N:=&QXW<_UJLOY:T[3._V2[,">\"\U";7D#)1.@.M%V,LG1G
MPV1]G'*^\3-BG' *WO&F74ZMYPX2,7=JV3Y,^(C;0'^K&FF\D:HRH==7@0JY
M!,<] QY4$#E)Z5FKO-XS(IV&]FE"%S.MTCM SZ[\-_@/W(LZ>QM"0D/',OTI
MVDKO07%@0!FCCX,&X(XOX#^1I9,PZ#@C/R[7'Z?Q#C!SIY?[/*60+AGDH<YQ
MT*""C>"B%>#IRB]()2X,&Z]YN*NYD^4T]%\M?<QA:NX *#N=*71G_[C:KBAO
MFU0NRFK;3C?S2:#2F903?2(-Q5+3T0XT5YFB2 Q9M:G!#Q"N$_=SH/V?;Q.:
MQ!A]X6LK__K-U>;S<C7_OY)G*<GM?0VT#Q00\D@N6D0.*%)M@V(\E.:X>BQ4
M)Q'6Y'@Z2OD]XNC#>GU%RS#<>QVK4HP,M>.)-*.E 5:2Y(59RQI5$9X1J)/K
M<R/\'*#T'K'S\6JSWH1%GB_^G F5A(^^0 [:U;JJ)OWX"+ZX6+PP.C9J8?R1
M5)U<D!JAZ%#U=T&0\[ ?_-ECNIB4%)<18F*DM?H(,X3L(48=F6$8DFY#%#%,
MOM-PJ#8"6 .3=."U'J[JR?FM: '>%0O,L>T01@/!\P*>=A/]BFNIVOBM'\MU
M&MK55P'642;H%% W![IPVF@ZPND*6%_0Q3J?43@'#F,N+@LE7)M\TO,RG89%
M]16!=(#J.P71[GF>,8<<E(*"S((23$)((I"3+2BU0VM8FYCN!<%.0YGZBG Z
MU @]=PW>]6+>Z6^)>WJ]IYR_.NR;IA_(>L *)YK0>OT-=]]__UZ615XIFJ$D
M1R *B8'+)0$W/&/PVI=&9*//"#3)>+*=\:)[U'R=$,XVJ11B'6HM!'GD+"$R
MX4&I$HK.G/SRI-UE@R4[;:YS"ISL'4<VM4TZ;$>[;KD2]<VG\;4SG$YZ1E%N
M8-*!"3PSK4LR;!!5TAEV+;:U]Z!^QA'*[Q! MWT/R@6,R(#)3'O-;!,E-7U;
MV[&4YB'BH*#O;]C/.,:^P_H9QRB[PW[&Q)@RB/FZUT:EK,!SKL#J@B;DK$W^
MY_4SCK+I"_V,8Q1\>I?RQ/=>N]NG[YD*4\E&YH&S'$%9DR!R5:,3$XPDM^SU
MH%S P=>?9P3K8/YAXY.KB8DZR!G\7KZ5Q56YGP[*3>:H8XU/2R9G79/^=82'
MRMI'19&JRJT>]3^4I*_;T"3F?O)X_PC==X"=#XMO9;WE_;K6SH<%?3;]YLTB
MOYM_FY,.\TPE)U$7#QIKD[I7 :(S F142F'4J?@VJ? !PO7EM5H@;&H+=0"Z
MVTTS8\AK)HUNE;).:U25O- 6!"^R8,8%*4(;HJ1;"3H8POI*#FJ4KCO R-OE
M>DM%^/._OU8UW3M8M R%)0>K:A9$::$A9!8)Z\@EN5OA;*NNIOT2=3!LM3&&
M)K%%!YCZ^+6L0B6VO%W(S!K.A:&PEAE6R>8]0A"V@,DZ9>:"XK(-Y>@343J8
MNMH81<=IOP/XW)Z\-_+/DD=G(R)("FY!21? :1.!G"D&6>K&:,/-_DB0#D:Q
M-K\#':[Y#H#SV'_.HA"<A1CJ;&H+*J4"P9+S+%XABY@\9_%5SK .9JF^\MDU
M2O===,3=$VZ])PU>4S-?D1N]\:>DJ9\*+E=W69)_E_6O\\5R-=]\WXD5'G[*
M-?W-KV7S>9GO PS2- \V2U= I,1H8RD'$8VN<44EQ'%*Y#;GX2LNLH/IKLW=
M99^(Z< 5WRWYQA_\5!8%YYM9MH7GQ.DF2_^?REYM((KZ5\VSY5:6V&@6WC,"
M=3!0]E5 >IPE3LPV7_?&$A_4+F8R(S?%2T!'MQ+%*PTZ=PZTTYYAMBP\IKG8
M2QNUYZ-[&/[:"A,3*',\%OPU%A;ESUK)^C2QCWG!<6[),V\3>.N/JW=SBJGG
M\6JKS1GCBN7:K&\*;E^ 1 @R..#1)8JU([JL7^$</D3V'F;&ONKYVMS '1R;
MM)C[1<_0H4!R6(#>97+,=2!($+7*FUV,/@O&VSP*>R!&#Z-A&P/M<+5W@)E!
MU,%8=&UN2Z 5ICKQBD/(@9'A-:(5.13;)A*>C.^Y\:37UDFYJ8W4 ?#V+.>>
MJEI;5=^.@"O1TU)J%80)"\$BE^1\<\)&S![/"]7#M-?F69AI3-)S-_UNBWE8
M?WY_N?QK/4'K_(\^=K(^^<&R3\G!>U=&TM%JS*A!.$4(X)8.MB0#H K)<J?0
M/&Z[_#'5;B-&7954*-*0\R.1@%RAA\""!6U#\.A*H0.ZB>_HCE'W(,N]0)P[
M1KNG;_?;WR5;KV$^>P_)A[H&(R'JJ.E^+^D,E9IS-2B+=(8MZ%-8=4BC^1@5
M=PB3FSY932&>D-[1C4I).DL3@M?H02I45JJ,R*8C,CRK1O-1]AW6:#Y&V1TV
MFA=&TC-?:.,X3CY6:0@J%]#1AZ1LM%8/BK;_5HWFHVSZ0J/Y& 6?FAIU+P%H
MU-R(R&FG>/JA4JRDOX%NYK19<C:%^S3=4X3^B7,//7..5^ZIT?$LH6L4J3).
M1=H?F=4&45*)$J8.VDF5EYQ)^0\DSAUEVD'$N6/TW$&F9,^[^9"YX=HX$,5D
M4#7KXUP=BV,+>4=$8Y@:@I3#@YQ?1KU(>2VJW$.<RD1J[@ HOY5-S0M<K):U
MGI%_^OZO=<D?%G<M?6_29O[M^A)W&QJJ(H-+LD!]'@@J2UJ<I\UEBU1,&^,9
MMBEAC9>UDXCI0'0\K1FT--59@7$6)*/ (7@PS%$,D7P=2LXC<.0R%@S6\S;>
M;+B,G5R=7AM\HTS3+^BN"[[[MY66,EH1 XA0^U>X,12C6 %.%8O,)0I=VKQN
M&2]K)T=M4Q!.9:H.P'@1OF][##XMWU\M\B_+Q9_TV5]^688%_>KWLIW<2I'N
M=I^YB!Y9M(#(L?*'($1=)[0F\O$^FNQMFZSU""&[X^,\!GZMC-,#[E;+5$J^
M:2N]O"RIVN@C_GB1@7:/,I:"*U93>C$%")@,R.2\HT- %-NF7>0@<;NC[CP*
MB\T-U@,J[S;<F_2_5_-5^>EJ3=I;K\MU"T,]#&[^)<]LC#E;@2"V_.Y:5FTR
M _2WDIGR135WAR]+V1W+YS3^<&+S]-/Q^7";+>[[_.HOWB#.+^?TA?4-KD]9
M<4\[J0Y*1X;@DZ4+AW>6YQ*<&5;V.=(3/BM@=Z2@T_F^:8QRXH;SM^'K?!,N
MT^YJ-LOU55S/\SRLJN_6,AACK $C4( J0H&3,H.UA6/R2C#^4NO)L&_JCO'S
M(*Q,K]2.O-*-XWV_7.WNA6W+WYY@:)9"%,AY'3NP[4F6-1-.L7G@29D@K/&Q
M3;)DI*"G>1O3^'1L8:0.[F;#8_&95-[K$#702L@/6^O FQ @"B9M8HE;;/.<
M>KB,)WJ"<_(\R2C;](NZ]_-%6*1G<N"!TTKHXNESJ-TF2-%/I!!(6V$\*E/0
MO6JYX@>RGNB%S>NB<"I;=8#&'1?_>_EZM4J?P[IL*>YNY[;,Z*+)HN,<+*\W
MSRPD.%^'*Q9'+KU0V!T;T;J_*-N)GMFT/VZGL$5'E[V=RT,=?4";Y]&Z>%$<
M:6] D/1#B4Q1M4%'H76@547M9:.G#R^*=J)W-J\0=QYOB8[\U\YSQIFT,@LG
M"G#&"BB*E4GZ(L!FHQ4ZNHB&MFFT'6%.]'ZFL8<Z5-M]NB1RMG?KJENAK-(\
M7%Z$KV4U,ZQ8(90&RVJCK\NT,6)AX%VR+#NN2&7-'=,/!!R&KW,L"4QEE2YX
M<O;[W5KI($A_>5?B9E:*"D*CAHRT'%5;7KSB"A*=\J507&U<^TK4?MF&@>QL
M<O[3VJ*#0W!WJSQ8AU=6*_+#8 MM%E6, :=2ICNC(FUQXVUNPX[[G$3#D'0N
M6?Q)]-[_F;A3@?V^79YP6M(9'T"AK7D^BG8=W1J!VX2%6>.B'#0E9[)#\;&$
MPV#6?0&@I5TZ<%N[Z]J)?;?IY3TIEIDL.<4ZMEHJG>N\V "1A0@L84PJ%>-E
M&SZ&D8(.0]_9% $:6JD#$ Y/\<V8=3$Y(4!J%FLCGH>(G"(=ACDR1*9$&P+"
MX3(.:]@]\R+ L;;I(B+8=I8L<OU/)6GZ%B[KQKHHJWEE:DJK$M;E7;G^[TP:
MBFF\RF"2I]45EB%F6ATZ37LJ9H&-YO&-D7(8]LXE]=_,/AWXO/UK>T.;;;7Z
M3OMJ.SM[AA(E%PZ!,6YJ[TD$EQ3M*V4PAY1-5FT:@@:)-PQMYY+ZG]XB!\/L
MZQ;BM+[5YA7!9K5 4>IH&IY%95,4X*5T$+F/#H,(,K8I<4X(MG,I DQOD2/!
M]O,B3_-D].KKU\NMHL+E+570AP4N5U^N;75;HTVZ*$<1$5B>'"FO/JNU%*.S
M)&4H6J)GI@G8!@HX#&[G4C1H894.#M%;-NJ+,,]T49W12<^35(GNG8[VBW.F
MOAE38*WSG(D8+6N3%'DDR(D?C+8P]C,3%P[1?!? N6,VOUV!#"A<G1EAF+1U
M<""=Z9E^D!)T*L*XV)12=U>6$S_Y?!7X'*7_GFG^?@V;J]4V(%[B'Y^7JTW-
M2/^T7*V6?]&YO@[73[YNT]03$  >]H6340-.L-XI20-WQ7E4LGPDRAV0663,
M2QX@ZJ)!A8!TP1(%9/!($(]TQ]<O&.-($8YU9_6S/BSHLZ[N"2F"<2ZD$B$G
M0ZORE;PD!@\L9MI<J((W;=IE]PC3 25A8UP\=G#'6J1#:KHM)0Y*YXK1#H)B
M#)10"('B7DA,F:BS0.G;$M.=GL'P:-,.H3$<H^<.L7)#=T37@YR#H&L@*0"4
MS1&\=Q2_YN2-I,VEQ2 ?]/>C,1QEWV$TAF.4W2.-81!%HT4@WUI9]H0%'Q(C
MEXL9C4\ZE.FP<BXTAJ-L^A*-X0@%=Q"B/72S]VD0GK.TR#/D6*DX+.VA*#UY
MWF!41"ED,&VZ 9\1Z+3!VE2'T91:[P \N_>Y^YO?;N/&Q6J^2/.OX?+#XC>*
M/S[]52Z_E5^7B\WG]4PX5F1D-<\:*10-5@(MDT)1RQ6BL4:S-JF H\3NZ59T
M('"6I[+BN4'VOTM8??IK.5-6,,4P Q>A /VIOD51NK+>^B1T+!';C*4[1-J>
M/.4) 'J(S<X2EP2T,N-H$_W/@!1T7U%1REHG=6!H\4K+&+GLP(?>R7M:@K,^
ML#G:;N>(SO?+*[H*"V8QL (.12WB^P3!4O3%Z>*DM7.R%8GM0>*>EOVL"VR.
MMMI90G/^K<P*C\G3'1VL\;60YATXI\QV@(KAVB<3VC38'B3N:<G0^H#F6*N=
M%S3?('WMW3J3$DIRDT&@I-"2,PTQB0PE8_%(F]/I-@7V0R4^+5/:B0%ZN.W:
M%UAO_J'^B&%=_O,__A]02P,$%     @ 1(9/5(_$TQJ:.0  /DX! !0   !U
M;FAE>#$P,C$R,S$R,#(Q+FAT;>U]Z7,;1[+G]_TK^LD[,\0&2/'0+8\C:$JV
MM6\L^8GT./;31*&[ )35Z,)T=1/$_/6;1U5U51\@*<L"*&I>Q+.(ONK(RO.7
MF=_^UZMW9Q?_[Y?7R;Q:Y,DOOW[_CS=GR8/]AP]_.SE[^/#5Q:ODIXN?_Y$\
M.C@\2BY*41A5*5V(_.'#UV\?) _F5;5\\?#A:K4Z6)T<Z'+V\.+]0WS5HX>Y
MUD8>9%7VX+MO\1?X_U)DW_VO;_]K?S]YI=-Z(8LJ24LI*IDEM5'%+/DMD^9#
MLK]O[SK3RW6I9O,J.3X\/DY^T^4'=2GX>J6J7'[GWO/M0_[[VX?TD6\G.EM_
M]VVF+A.5_?V!>GXDGSY^G#T13PX?P?^FSYZ?9$<GSYY,3@[E9/I<_NOD!$;Y
M$.[GATRUSN7?'RQ4L3^7.( 73X^7U<N5RJKYBZ/#P[\\B.ZKY%6U+W(U*U[0
M<.'J5,/D[.54Y[I\\<TA_>\E7MF?BH7*UR_^=EHJD?]M;&!A]XTLU90O&_4?
M"=^!3]*?*SL&>#I7A71C.CK&@;R^FJN)JI*CPX/C;Q_B_6XFG?D$XTQAT60)
M U6+62+RZN\/ZODLUS-]?'CT7,!J'_R^G#U(3)D.7>%7NN4Y6EZ]7(AR!BLV
MT56E%R\>P^@O95FI5.3VH_1]OFS7\M'AH^55W]+W#?6&:WJA%M(D;^4J>:\7
MHAA:W>/K5O?H&%;W_>OSB_=OSBY>OTK.+]Z=_7?RZ]LW%\GI;Z?O7\6+?8.Q
M UF6W]WJJ4I,<NENF.@RD^4^S#P72R-?N'^\S)19YF+]0A4T?GKH8S;C^='!
MDR=/D+8K&&>5N0];LC\@LG]89=UK)T<'CXZ>#EX^/#CZJ&O'!X^.CS_JR8V#
M/3PX>?+LC@SV^/G!DZ<W&]!#VC7>.: -LQ3%WQ^</&B1CR6(HR4<)9VK+'%G
MR%[/Y;0:OEKI9<_%I<@R8-\OCI=7"5Q]&9 ROJY#>7HYR#__I,-^+2NEPWZZ
M$F66O *!=.NS_;F'NK=8_/6;1T]?9AG]9PW_&WT&AC0PU>GT3YSJ-S^"WE'A
MKGS3DF_V1 P3^P Q.WH]1&I]<),7?3TUP_OSMEY,9)GH:?)KH2KSF:CPCM#N
M_]1 NZI:$PW+[*Y2<,ESNI\$_H,"@R?YIS05VBA?Q<..'3$Z6F>U ?(^[CM?
MI!<])*TXF,8MI_@[O%]-UW_Z=C[JG>/%3V_.D[/7[R_>_/#F]7ER\=/I!3%;
MF?TDP7B;)S^6NEXF;XI4ETM=DD6]5\UE\M=OGAT?'[X\TPO@"FOZZ^CE*)D+
MD^@BP3L$Z3P9/)*8I4S55,&S8J(O9?2&1C7R+YDQ2TLJ??L%O".D]8M #J5@
M[:JW8M'6/S[E$=HN?>W970[FZ[=9%)9&.N3@;ZET4LI4*J"9:BZJI/ :00E,
MLU0ID@F<S_1#4J.*$+WJ_?FOQK])%1E(A,J3H&(BG>BK)!<3F<,%^UA+ZQC;
M5R12I/,$W@F?7L+783.0:>-+V),4C%470/-S44KWEDW'"8[0 H[,.<YBG/QO
M](<M19E<BKR6R1)&PF]JG3K_B)OA.#'UY'>9TD!2$( "INA62>G"P'IG[FP"
M'2WXAU3#PO!U^"<^!$.BQ5$FX;.)M^%#UTWD^/#XD,>$O^/ZP%+\DL,VAV/'
M']R8#_[$\[UEO@H3#F@^$>F'0J^ RF:2UUW,2@G_)*K&U;&,-%F(=9+)'):N
M'">3=0*4F5:E+E0*EU0^IIMK0Y2%_WR#/*&0U1@V+<WKC&D2-F<VI^LK.3&P
M;>YV,4/?J%@NM2(6"U]P7Y>%$4@(-+R?:EB"Y+TTNBY3&"=2G*HJZ5_TO4;2
M@#]>*:#Z2I?&77$S:1,L/1Z>;)$M5*$,C)^>0\(81V^ (8(DD!5. LX$+IV&
M@PFWE"MEY#CAFZ:Z7/#(@8*!\@MW+KUP>OS\)?U@F8O[D[^XK$N#NC0.:357
MZ3P:@Y=%\>.TA:VOE_+?-2R&7]1SF=8EG"T8]BD<2UB>H^<G)S!JH("%+#*9
MC?W9*NO<$D8I9W4N^$0N2[VH\YFP RAE#4^57^ZI.84=7*X=(1'K "XD+H'P
MR5]9+^TR UL[2(#VZ3YYB30-#^&&  E,<^!XR416*RE#=A>^EM?=LSCDEZ"@
MH( 8#SP!7#C/DQG(CK* ;Y_"M_BF0E=P8J?$.'&/E+MW+DALR60A!=&D 5(&
M<@'N::4/OOC/W,W/9"GT;^;_2>S_?6+=QAI_;%>>/(G-/[M0_!/(?'CMBWV\
M:4N+<.2W]_-__66T4L?/#AZ[M<IDBC(;>,P+XBCXY(/OWN.3#=$'TFNE@&9!
M&"RM>H'74;OZ#)PHVLDM;N2>&"7N?UO<T@W;]U8GYZ@ISG4.OR6\F]L;ZH/O
M@$M>6$+Q8C04MOW\-\DTL53DT,Q'\2_4)JL\IDI4(8 +EYYL!:O*=@'@AUBU
MEE>I7%8H?D&N7JH,);7,]<J.LWE/A_3++NG;L95R@7HV</6I5!Q4 X4.KU2T
ME,M2@<IBGR-;&,;#6H:IX?_9CTY@1Q<RN02Y%FD%H?H^.!**U:'^!UHF$$8F
M0 GBNT$#(<WD>)R<H.KTZ#X=V,FN']@S78 R87"#@.C86D7=\HW!(Y+*-@5O
M^2P#?Z'C9=KCLD=A D8UC)S\-M$1VG &/ TCY?^9= _#A_,Y)U,#N(Z[X0BI
MI( [D)$(_JT2'T!M#!D57._Y2/=%?AU "84)V*5@( HP)_C%>#WU YP05".G
M:/[@#WX9HD]W9A);2/Q%-!.650[*KT#+$!YK]F)@RUI;Q#/$-Q=@FK1X(-IL
M1T]?PH++F<@;]X=  ]^ E2H+4']3)4K%%AI03FG(SL$WI@+&A&;MA#=K*=8+
MJ[ 3"V2F!P2A<][8<6)M8L="+;.&9WN6 ZVIY1)4?F2^P_SM)EKC7>=XZ6BW
M&=XKA1M99-O62MZ@J@!D.4\R.R(T,V',N4#S';G04JC(.8*'K8\1Q1I&>*0:
M9@#O5.1X]+IU0[#-"-RQ( 9)GT(S-<LL+"YP??))@5%2! 9.P;1DU@5W$1<)
M/2]NS=F9Z=TO8$/#W3")O=,1GS5=P0_QHD1ZD*[SC$U:Z^7$O[)>/L&#<"X2
MX!:72M<&^9-;BGA4K95%([K2(U@[B5RWPI$V;&SP8(9XNJ5F..&+4N;$I@81
M=C9Z>=@\(B9&YW75?620.X3_?UXV'&<F]R? _#_L"^3R+T2^$FL3?_X+!@)N
MUY44'TPF:3K1>]\SP?\@5)G\+,H/LDK^2;[VQH+HB,N;'UV4Z70SA0LN;6B7
M#G6/7#=MP=Z<\M81(89DO?=>5<!7PV]>C/I/.>836152E(5G;VN:@A7ZZ,,D
M>=RK++!6ZL3P.)GKE23W-#FO\8A;$=X:,MIM*>FX%4EOM-<L\^I?9582NL\$
M_"WZ!*Z;9>1V"]"48\8,=(A;TL>>K,UES<>ZL*.G5<5A66,.IXIO&M@(6G1_
M:V@3BMR0!N8O6@,S\"GV&K[V:2"P-0TNSZ\C@MN8<T-:RAUQ#1_?(4>:!71L
M6<LY;\*!@R&_06(<)__ZUU\<SPMH^V/L-'[26FM O<09[:O_Y?\'+RTPZF6L
M&<'7R6_$/$W%CAGVO'#44A4U*QARL<SU6G94-VOAG4ZG*E?XLAH>RMT<<,08
MJPQ9J+$^?IH!,;J.;189@,>-PD>GM&5@%1H6@"-=H-:!V($E.'I<^758 W,&
MAI'G>N6B5_23"BUE-SX;\$A3&$RRQ]>=##+I7&8ULG:#[)/"3&2%PDKD:V>Y
M>O70S'59[2-M8 Q#EJ7(?;S["E:3YC8%^S(4?I5U6;BY/SI\?MI$_S)YJ[AN
MQ)>.GMTUOG1RA_C2:U$""3BXV;LB.;,P@0O8?U78H"/\#L>%'1-G0*TS4A/.
M8"RESK?N@ZJ0@DT%',B=$XH'^[-!:HKIXAF:<XK,RU/N.)G458B<:-[8RS";
M$!Z'^L8DIKM\TJI>:K$ BP<./JP[OJDN_+O@+J\XJ2DQ1EAVG!TJ92M-YQ^^
M/W7Q<3F=6C[%/C345CO[,^[$;E(IC#36*02\Q[)(V1S8 1:)CA7DCG7.3BM:
M$$LEI.#2BXCI[*F1X[CAIV&ADA^U!N4(QJ!AK?94<^/@=W$)-&S*&3JSZ!EX
M"!5-\@<!.P2K,/P*,#H)C$"A/HM??"\K!<*!QB6,#\V2JW^$[[L<)5DM6QS:
M:X>OE!$3&$JU[GT</K!W.7**<ZK*M%X@.2)((I,F+=4D)KA'>^DHUJ!9G+@W
M"".[R]M9N1XQC *QO>(S],@EJQ*Q%@4JX"KU&QV/E5R4JJKIT 2?NAT%TD9V
M:5#%I#45*B<*!($E/V(L3P[A@VNO$Y#_8=DX$.TTG5(2*PD&1(1Q+SJQ+PJF
M5&1^?7!P2V!-.N-3+?I]CR=[V>B6RL')9N4 G<M)7B^6,)^%WX"Y*I$&3PY'
M[4&[U>\CWW.Y%*5HQ/:Y+"]A=6# /P!-P0B7VLB6X@?D^>SE%D3VSCA.@]BN
M@R$Z=N2T(=Y 1'(0MT.RIICDFO8?/0P(@\K7[$KW?SDH%B("X<I"EY+4LI+D
M FJZ8V1@*9^<O*NY(E43VPR^&"F%[L8Y\6LD=U+A8141CD1WP^=8;4<6Q6PF
M^A!#L[9A3.X,!33!0H=8:W.U'D+ Y3,B9_Z-:D")F@1RM4J1> ]T@P H3>=4
M&% EC)-^"UG.T*-22EW.1*'^0R>8I(V\2GDH&$-#=1Z]0Z"I,PE01(4,*A0D
M8V >%)0FH4UL)?7SP%$L]4I2*(Y@A<GCP[]XJK3C7$AT0'E>>RW,;[-SB/BS
MH$4:^TDZ#)^U8Q88%2.?B9<#P)<Y6$='S6U)/!6]*F"<<[5T&]/29SP;;?!7
M<,=%"9*E+H%U>YA=<G2 !LS^"7QL[_$(I+M55 8^W$C!-*:,3S8 ^,_I:.]H
ME.R5<IF+%!^U0P$)!B(*T5+NJV31V:N/.U?AR(,61?*+\0;^JU:78>W*D8E]
M3WN)K6NTH6T@I-+I@608$C5_^H50'V]*?@E<*>W()5**>UA1GRJ 8FV!3@?<
M,-3!2/O2ULW0RY5*TKNL=[NTV@L'[X&PR$V,.YK5A&KU=Z\;["O<[[\)_X!_
M@81#]NI_O50Z=T8$T6 P- %,B4">\#/0/A!9@KCI@EDK.6K@&_X-AE[1-Q%T
M0[!_N<CJE&6?=2];[*WU:J!)@>H:_!?&"0N.WF>5.N(F]154_V(-5S.\"M+2
MF. J:/RHMH/6.RU%C:Z7HJ)I9<K,0>PC<TN)&<.;"[ND=&C[]JPQJN![$HRE
MTGG+R%:R=J9SNUWBQ(&)PAM,J*(^V^!E)I^YWXSX_8%)1_AT^I<#TD9P=JMK
M#QEQ9 ((7#3D,5-:5=P':_H8/X <T>XP&?P2!R3[=M.I,,9ZTAO.DN=CQU^.
MCALS =8^1:2N7[+4T<&,DA+"P&9L+'&JTMHY%]RX(Q.%#F%"Z17-<9$5D#$M
M3 P?<T!@9\10F@AH?VMFR'Y@:AK]@(L4G*]4+.DS,)V)Q#'0.Q3%%MX4%HK.
M]A1:R-;,"I,*:! ST$:+S)!]:>UK=_I:>B>>>!;J ^9DYU6;]\$;0")9"?3S
MXF6,:?CD&90A)0,_G#_&K06IMA-A%'^N;2G3YP^&(\/W0%)DHUA.!%;T@.)*
M[N-26IQ9P%T:+[3SQ/0Q*D<4>#"(6[7TT#E= UHJV?],6D)9HI:!9YW8%6M2
MD9,LPHKUZ.!_P%"]\39_!1+L ) @KC)#-74B;_?1X;/=1OZ##KLSD8$G!X^?
MXD(07%HB2T76J?K5Q@EZ),%B$R7)]0HV0H(6H(L:U),KQ/X9!C,)9VR(F9<*
MU[QP['SK& 43P5B<7A"ZT$0RDV" $.30W2?8^ +F)$@"+1M/M)2,GQT\UU\
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M-Y3!>T:.1]]+D&LKQ4F?;'PS=@WL_$HM&(7DRJQTW(>1?P&D+I4.:9N6O9[
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M$:DSP'CMF0T$::%!BT-=8W_#0#BB7_"#9'W3ELZQ6Y&A$['VKRYRK&/A>&:
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M!50)>_5S6<SOHH:5/$-2 1;:K+<K?%[T%9[,,&7G-U%W\!3W'H4:_]&W3^J
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M$AT+W0<7OU/I=T$KU-%(OG"M8+IO"P<RO=+DX$;F>[G0XL#LS*W!?"[$3XB
M2;JRC.;@ AJ.]J,%_)KC$=M60WH"]PM7#SJDU54.OF)*2WS^[FXI!R [I$AQ
MRQI"Y$USA><HF!O3M(T>E-OZ?9JW-9J'&)7*O/OKP\U+Y.RIEUP8D4;]H\VI
M\4599&W:P'#/F/'.O->2Y;<5ST'N+4:!<2YP_D J-#)6P^G$N;J,<50P$:S6
M^AT;&"+609;D<#K):X?2C"'_><XA-(TI?FL+GE"E<Z-G7A\@YN.6H(X*B"E/
M>J0ZHY=GP Y-EU_3T1ANED)VI>N$]:[)(*315;ZC.CFE8X=.C<S)5[QSJ=Z;
M9;L,$ZF09SIL&3L:QR'#!,S>&E,H$WYI<'_@49<E)35P[/(3KPZ?$81S0N7#
M.IAD7D-YN+ \USP'T4)VUY&3_UB-%-\VK> "@7**(LCQ# 94N^-9V3?&N#"]
M5Y(++]OW/D"7?>J%5\G:,U7W4!('*=]Q:8TXVZPT[0XQV+%H 6VF#>CKI/=B
MQ!)1BP86%:.'L"<!:M7(NC)V0, >K#)H>1^R"UUC<1)JP1K.7[D$[3L TA'Z
M[S)#0D'RP9-ZP-4&C.N'M6@EEB9[M[EZK &PLHVP6L@:6=,AWD5:!L$;EI>Z
M7_O&6;UR[NC?/0Z?@MX0P4?1VEKX+%20I9@J_!I;$L'R %N[4&E0$$&G.$QG
MY"?:K&\<66CSJ$W5!#@PC689^[+Y27:6]*#^@G>"R/O]5*)PJ;HWNW6SZVQ3
M;#VY],C)'A5'3M97)>\@$47G8L!$]:5X2(6,^L+SFC(&I<@CPA?#HGQ&H+.&
ME35,([H@1346&B>'I_;LO5755!6ZOOOJ?:[7%H;K^/#P>.(N?W3?7?ZLS+*[
M/\)NODM^Q;/YM@&";."D8>4DS?4I+$*[A)>]KLI&'@!/Y3P V;.(-WS-:NGI
MP1:#P8(6SD#DQP\/*'!X!FK7O' 1D!$6BBX/5 U-IJM(E 7 78-)9+8"J5?Z
M ,J.2 0@H!EGFP/[?1&@QSF^'IR8R4AD5QAEH+[>)F]\6<D;6SJ1SDB@M*46
M-+W4X&%8MDT+#&]]ER@KBZE_7%!OTI2[>'Q=K]3IYX QW!5.N+,Q_X A G-"
M=+0<,4O1O0@2#A359KU%)G[G^Z1/=Z0=T+")BE&I0(V<OB&:M.H!2G!6(8""
MT<#BH+VARC*LM>IDGK,N8:@L33004V"Z+YT!4Q3EA9P'U U;"N0QW,$DJ<M9
M ^( ;*9,@?E,I8.8"(XN*[2A,ZV F:,/&W.+S1)5*DG")W=>C6/4Z:(PO[>!
M)HE@$#68F27M"APP,!'^^LW)Z9/!G:)?]IU;%YZ"!MQ*H3+(,! 5%K(0$ &!
M7)+:E+J.FICH;F 3547N<9@AC,IVXR3'12$.1UCP2$Q)R:3*,>,!KOP-$6KS
M-0LUF@H\20RZ*\Q2#SF&:1<DJ329,:SQ%85V47[%TR>[E1])YAGV#:4%11 &
M5:4+RFW*0$_/2Y?BY42TJWQBL VI!Q04#J0IUE 9B '%=6_Z9'=&SPL2R[B2
MR=3!XL';X0=TF'JA+Z# SC6PKAN]1#?*[ZU9,9W4+2J6N"4V]@1_SE2*J<7T
M=9<JZ:M VPBQ:H,1 C%D6"2'10O1-5VR"WL_>'3A(&F#G&S*<Q3G9Z/2<%S%
M0;)E@V^I,<>-<L>D L+932F<&YRP)XO"GW(/<TS^8(K5 ;6 M<:D:["C@-MD
M?/#P("ZI[)%H!)Z 2U9I,LC#K49+K"!STCW3]$K&::<%!@D/'!JN8M6L*J!9
M(XG(P^-PB\:D'S T=UH\A0^? $OW';)WM G#OMBT%,$0"'_&&=UT*JYS# Z2
M@6 9\L.\K'671X\,PNU%GV_\+>(8M;0RB-T%$@0.#4F#;+[P?)X< IMEWE=H
MM>UJHL'+LKC[C$FHK?26XPG=A (L!C?L,IP#OR2<>>KK4-*!<T6RQ/!K33VS
M+W3,H$D56%5&$[#<C3GTQ+/H81/3P;=;5)"2XM)7>HIANL_?*_C(=1FC%JPM
M?G!*$S"H E8<9D6^.Q)Z&/@C])"<P(\L*TL(' ET$U'2Y.>EKN:$9)&%=0\)
M+-!<HUKGX_F\RC )BE.X00U*1188\$M&TA3^R?FMJ+LEJ+PA:RU4OJ9^8G(%
M/ H.:HG.G]Q0J3XID\&KV*@B*<UCAG7(RO!RUNK"+60#7V!*YAPK ['CD<A%
MU^$LB4&^2B#AEK?"ZU"7&-LDIZH)4T7)02EI-PP6N  /E:;#Z#62.](M2CF6
M$,/H3BTK*UQL7O?\>6AY:LZ$<.JR4Z.Z;GAG2V(5$><]?LV,>U=!G)!SORWA
M6M,0$6Z9=S^[EAV"QY4"2I=E#[8L5[80653*/QAYZZ#07H(V4Y><SU1YO37'
MND4+?I$Y* ;*CPA<]P.9[(,\8^(2OX9<EIQ.C4<0*R7E5*)-BWE4N>">VD\<
M!XYB"Y6;E,1$')X=13O7C'LWIX=:M%XXZ>B1PM!0)HU)2$*B$DIF)BC?^".,
MK<#WH,2$=])W08>:B:3O^9?C2$'^BJH<P_,EB)&8$K8@6!>?G'U$;NFCPX=Q
M'\NA1]_=)DLQEJ7(^14W ,ES)[NYQ!%6VWU#P;.&=)P!:K?F1)<FQ+X[VZ<2
M7C3(E+M)-"@Z$4X.!^@ 1\<6J$0*)Z]R,P0GE@!O<92$KQBK=AE7CZ<6 J33
M4,8]&NVZ"Z)K47=JAC>I+@QAKLF!Z+W!:8;V4NZ9M<)/:,K:LU'3FKBKX>#6
M.GZ\FN)9[KT@!]Y54".\$;5--(%@;=CRS,8BP5&9C9LM*3]V#H@D17V_>J<>
M&=H/^[*Y<#/E7""9#&YP2#8U4Z"OKOD\V^X0RH+29!F*I87N+#FB25@9:GA>
M<:+P9..>XV!XNV5(7\YVD\?A0UDJ1G[^E"S5\=3DC3+9A K-K1!$IV5:M<QH
MA<R(5]I3X)'MJT T,G,HZQI3.^KQS>_ \L*^ ;U<=++?;O=L8,]DTUZ@Z)/Z
M@%G>4N+.T/9T]);*LX$/WBG? P2TO$DB'G[T<\9X-:SR)'RLT0I?F%5/"%ND
MK=N-[FSTA<>0J6M#P$=K#&I8?7)F(P\H[=%;@<:]A8W[8.OSVLMY&\[?R7#^
MSK@ =A2/#3T 3ZU-\(4Y %P1]ZW]?VO_?[7V_W.JF)3LB)7=Z<8)1FO_<BB.
M[7\T3,<(QOD,7"2P:T ']G,_U]P7<$["T? 7<",:3:.Z%9M.&](1Z*2=/+"F
MY69 AEM5ZDH[9S=UJ1T6XWI'/?D_:8RAK18F3=ZFY6K;4=BM<>N=.%_^>"6#
M7*R<P@)()VGI@--.ZXT5,!)!]EF!]7B>M,/=LQA5I%APJ@\RV83U(5#V-<94
M#=4U7&*ZG@U <]/PY"V68G]XI? ?YI\[L9G!;EYO+S_6?N5U*9LF;)D*OK"S
M7=M@#G!_IWKE<AS#[CI0\0),(Q;L2ZL.#G2*WRCZ36%5"AK6T*G?M/E?MB!(
M/(#J;@F"-]RO#&T=29G:KB@8*R.CYKFJ8/AKES>)B!$V1];,P7#+*>R2M52Y
M R2^'Y2],GP\)EGD9FG844ZED7I:EN^"O$O*1\DU)9XB]%W-"3UE39F:*\+V
MH520B62$8'V62^!;E8VHJC9*8$-!E$^"^<&*JH3E$:C.MKG2])*F;-8K?'-3
MEGF<-FJ35_"TLD'(F3F<;8SI+9CU@JDV8 QFL&%SHX/<69L6BS?4C?_D,V_X
M=HQ-5!R<<$T\:&TJY@,9NDK!'"C3UOTDB3F9J=_580IUD+*#[3]:O#K,F8'E
MP0H]C:E/54F30)-BJ9=E!>Q/<28.[A#=.-RLC5VPG"*$"YYQ&(;F4>8V+X=9
MXJ5:!^F80^:RBWSZYIE8XS:#0\+@X'!?IW"/7 O)5 ,;G@WTR_,/66'U&TR8
M%\;DG(P= LG&Z,?8^A S-1V$2FE;;/9A9R.4AKKD7J.<@!D/"8O2 Y YPO[@
M6MO?6R2,;D2+DZ/H!H;,AN<N5V@(\JU_R&'B.CKXQQ=EU-5!:F[=MF1J/8;X
M/N0>@2-C+BBA/>?K/>N(":"#_UMI!!IGZR;D+* KHWVSYVOI8^+==_"^[D6?
M0[W=7<'G8:%W2^Z]++UR55*;6RD$A:-UY@S9+9M%+TL&OQ]'NX?#2-[NN :&
M$C,DD["31XG/FI>(X*3H+')YS!S+6TCOQ S,.;!X.)HY5IAP0"*96K9*CCV&
MR[)9%(AZE,/%Z,H,,0.PH)X+55K[90BHM'+K+:7$4;EM)+>M?Y/D=E#*]E()
MZL7/:DK8OQ(HXTI>*@36,PT'^YP2;]]2XFWMZWS)5=NZ>AH[3.1P;3Y7C6>S
M 7 5WC@ 7G7%B C2C*]Y3J!/ 3[]JQ5J&6V!VG7XP,CO.M-8QI=/&/"*?LQ+
ME/I^[V3G.KFE*GU7E)<@;.:B2^$H0%V?+SIU?'!48XR11=@5*!)-E&PA+F5@
ME]:S-^ETK]JT_@^3?[Y]"G;/T8-OGR1'#T\0W&J2!"W?>Y%7JYD0%0975I1O
MRAA'C*J65@:%0L[>RA0.,_Z9FZ!8BKSUO*2DG36D$X3YV4B^-F<D<^GJG5=[
MW-?@5M*!J+\(-;U':1 \0#"62$CG-E5*[3,Z!#LZ4ZZ-N]:>VP/I$X)''+6V
M&"Y1#2QAH46V\S"ZV3$X359^);G8$.P+F:X$@%"W9#4.G/E^Y=1TG]OK$?@%
MB-4@NFW52%*X;1<^=5E+XH2$'!@GBRON1+P*LIQ=3'&+@#&*^HV#P\%YAX1+
MEU%KD'J 8(^Z-'F4 !W4^O<#(LP@^("Q?S(1@N'.B(F@_.'5P%K&@$;Y9[NB
MFQ:0ZUYL'KB*J=)6S,D>>F0\-S9"'!28NM&"@Z!RH.FN;^=Y,D\$";.;)7U8
M'%Q-^!:_$]+Y34J0?-%0YPZ7@1YN!0^LK.!95(]&$$IZ7M*>+Y?(*Y$7.^[$
M;QW?0-N!SA6PT7RB4SV>P1$7;M1C+"#-C1A$UNX3MM5BH2H%-R3#3_ \;-<1
M T)=?CX8[IZ!O=7(7RO'U96(A .S?J&%9.-CSQ5<KP@XI[=$CSY]IOUMKL-M
MKL,F$V&QFR;"\_=2_<F 5&?"<G? * @;7$F)K3#'24>G"SHZ,RY5#"Q$13B@
M;7J]J L1I).S'\Z27]#WE+QII7(,3*49^UR 53[E+'*GKH8-.TFK"AA@8#5$
MV%[6!T'5ZV%Y[5<.O!/$AG;K;)PYH\+6X;_R@8WM'I ?UE2SN7)9W=)Z:A-
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M[,'^\=/G]V2P1U_N/WUVNP$]IEWCG0/:L"M5_./1\:,.^3@"6\$Y*7.3)>Z
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MUOZQ2+3";6RI(DPHFW0"D8QC03IC-87DG)9]0RL19F]GZY&A"IBF&V?#;>1
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M\$)X>/QH2S8@ZRHX.D1R9&FRN,IU,:\7SK"XA;$S/BG'G$$W,R6;S1BW,\5
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MNQEBQ:%VY3,5QP[AG07Y-ZU%X8ZL&X%A#"0BZ%-H5>>YI-5Y'E;F%3!*"MH
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M37KUV0L\/D$5Z:$A8W:9!>>/:_\++>J!D4NV7$0<UR@!T7&"64_N-214KE.
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MM;09P,2UJ@9&6Q:J<U<P\QFM?UY^BT-FFF 6ICY0MV2<[^WQV#JHSWO?()4
MYY52U;AAJ>RTR1V2O"&O-:D0P41*5B>.[FY$]_N]W5L'^,C<T'(SC5H.=P?P
M"ZMBY#&3K2=-1LVI;5WO6DS0M5O,P!^8QV8R0 J;K^&J:Z6.$F%%]8I+*NO&
M80CW>[P[[6]B%%.!:UOA0ZWW#$YPOREKZ_ &@VZ%-V@&Z+N_]WNKM@ZBCIF
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M+3'^+EF<+@?[=D'<D;XKQ$ YX$7T*>SV1MY"+LZ!<[FWY%9M#[D-A.Y-="<
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MKJ5[4,@.G6"Q*E>PH576MS8]O]IJ5S;$)\YS]W9 ^!:804QJMN\QS& #KV'
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M2TOZDQNMJ4];SS6(Z _4%?">N@(:UX9-:8S.]O699:*NZHJ%C['O@;?A#P<
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MR@09=]\S"MV0,!31_J"=&4;Y4!2@N^(M!A-F% 'BZ3.,H>RK+V$2-G7-GIB
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M&6G3O9S9!]L59[C.U=0TNIC?5X0'(2#>"ZP!,Y":1KU=S>_=8W^;AE-AKGZ
MK'#?+ENN*QK8Y&S *Z%QU/,\!SV#VLRK)BX(#.GD\;B>_I9P_(*$X[;8+T^V
M/<WTIDI^[A1&,379E*X[^FX331]<,8#M9,0N75T;9RTLI%^[[B*3%<TBJ.Y
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MOM!E#+E4.H!CG%0YY+=VPKF$UXDL^.@I?$"RV+C$XU0?@+#OR)G>^IR0ZPO
MZV7L0.18*;9+FNG6<=8_S\+QRHXV%%R[!'>@B)S!(^$DF9J9<4>5RYZC)6*R
ML.A_D1%#TGM5*)D)A:E]ZD/!90OXH\OW[Q(IW#I0\?5AB2-2N'$R<"1 \6Y0
M]!76^Y$!W.HE7A)4=QCL;$-!"/I_I1GR)PP;YG>W-K?]2DC5U X+GY8(?E1P
M_:"@5 4O-H] BE)5I)T@+7"E^;F6TM9:&EJYZL;'7<4JO!+;C=8X)*5!B!B"
M,>/,KP'^EL)74(FSJNPHB8K(:O?Q5O8BTITX'ZTJ\DQ1D^S$LB+C<DG9/65@
M=#''-[8&%9;>YT"DJO9*5LR#$\&RQ=PR8<TV9T,Q_*:W0Q-^LFR+%Z;!:DTR
M.NW41Y-_& GV[I+8N'7PU\_S;<0H"R0^AUPH^B]2Y3VS7XZ^# 8TI/]!E9)E
M6@$IY*D9K$K]0XAWMUO&V:W#:EW_!/-+#DP*C$$*(O .Q4RE6]I3&4$9"7V]
M2WRW10,N#.A3E%0VA2M-7$DNVJT)#Y7/SF-8+$>1\\;HDSULZL;K'3PYS#-=
M5!<L:H/.TYWBUS^V[^2!P=)"Y4L[8L\5;(4&%#97+ZF(5N:4U'A&9,: SISK
MW$3"/9+A*DM;!6M:!(;QYO\R/$G5&!;72]$D>Z/#$2>FM*:5&:[4OD'=S_,*
MB]VX=RXO@3RY3@1(%=.<")<03%^C?C_Q-8.& )[<$Y5I6.1_,2ELL\1E R4-
M:)4)1>SO%$]\W!Z>,#HLMJE=W')R>4Z.@T2>/>H%UAW\019G_O*&)B> /4T-
M4IC2+]:"JLK0H6XL^6;"#SONN$>!6&!>]6<N?&6\4#EYT&<+9NRNY%=O#;HY
M^$T@AQJ[FU[U\HFY!VNFD:;;"?47#*W,1HVQS<N\O<B^V/\+PH@N^\LDP6!N
MIFF(+A$[EA(MF2LQ%P2D%9![E25[>KJ8#A.E7.'Y;Q?D+(GU5719/TP>WMP$
MY>V-I-H(R0LT-DU$-TBWGM\FU[/[9AWA[2*5J.N-HO&RHW*%&<G9'Z7%K9%B
MH_CVT>!0D][ 3CA:[*XC:'$?\L1_1(H6$K%Z) FTDP/7(Y1;.8T;. D^"%,:
MSJ!#WPJ@=@AQ@8U%\N4X;PR2I\$$FY<ZH=X7$;Y<\_Q9FC%6VT-DZ2?2?5 $
MHP)C1H>MZROTB@,,O07PQ">:YTC"D<H,9PVR^F[9;,7VV&PC'FS>#!U0,$%Q
M^AXT9VE3TYZZ#ZH[36Z:O1%G9]GDL]\$P 7,L-C2XGI0QTTR+[!-6@7MPH-]
MSC14(NWJ&N>'V* Q56"_K IJ:,9:W:7#<8U\[R"=.?=:Z;C2-:I"OF(7N>C>
M@3;U*R5Y_"[&78KD++>'#PZ%#WKF;VCT2E*46T6"VL&2$"B#QMPHXX%_VT"]
M/N?Q*&(L!\:T 1%PM1A19,&J W-[X1TRGAS:!@CIQE9*3P21N5O2,]'8EU9>
M>8.2F[+)%&+6PT%]BFJLL%&HXIF^7)>?<5I@!/8AK4"+U#*'IFP$L83YS936
M!1&P72+J<GN(VD\+>$6NE!^STIUJTQ"8A7!2J'S(CL14&0I^KM?-PP;V)4&%
M2(B(+?),6F(=>LBU2@VL4[$CA%!M'R&$W>3DS\IH*F9>E$/8Y87!C(L2G9^&
MFCD\^J!FDH! FJKVSWR\E&2FYP1OX2A')(,'[V,NON;4R.TE S>5YLZIX.GT
MD=FJT=Z%#Z(T[K82^R4'#Z*N! _-9JZYG)9GM$3-"ZDJAR(,4\(.&.JJ,YK2
M5TPRRHE:I(O"6' ,43>G3GX#\)\A ISTE%UEWDP,GQKJZ82&$((W1^&ME5IK
M/0ZKJL!66")$4NKB^SQKBMJW;#"EH;J(#.P""<_9L1B'#_=6ME'QM,H0D]6:
M/&0J[TF )^Z:=//M3$D? X]C0&9L45PHJVD&L(T<F:2E8@?#(EM^SDTE)"5W
MMN?JS#G3_-Y0_W",8FA%E:F_ZB.">S_PJ]"=.<A1&.R\.*'B[Q:VB4[.+6*(
MWJP_=%[EV<W"O-Z=\#L\V![I=WR9]'N/@\49<MT?EFLD(GFHIUP'X3/#73>M
M"/)#GSU'FI<O:5Q^;*[W&I:'FI6)'7#"%?Q$W3_TP!Y<%;U(($+EH%H3.RQH
M[:<+!J<6X!((]!X?^%(:M..)02#E3%3=>X&W_.(.T3 8;6.P;X3O\L;#F1B:
MJ1#/E)&A=.#E563.H.W;E02MFXUJ+-D"PL[IK]0:/G[;==!;Q%/OT1(SU!C.
M)O"' 5XIG# >K*!!%?H^#_/;.Z3>X&.K(DK=>G@;-_ X.AP^&@I=#M'RT)8%
MB*RCJ_#2X)::(Y0168;;:C),,Y2DY&_35,Y8 [NXCEG:$U]_["=+^#DW@/.8
MGXF%A91\0R.("GVM0(J,PF%>[BB  E]K57L+MCF0$;)&X+Y>2C8$4!0FNO;I
MFOP5:R^4)TPEER&R2)M(UFLIX,8.BSYH:8:S0P1W:.LV-ZS/!]BD5$MI8\]!
MJ!*#&G00(A )_7W"U1L&2RJ"<N_A0]KN>?,C#PO9#KSEP*0E1X%)G?CX.Q-3
MVSJ$4Q1CXEF<CA'\J5'>_D );7^68#36[>GHI#29@R4=.Q/)C7NWRI=(8"9)
MQN]@Q.:J@E<QZ!?A8+1F9\R=PZ_(W#FQ(HXRI4$\[FY-FM>B+\YY;H9H;P.Y
MZHU<]ARO9,^DH,2VH8E&5-#=G$U&<:UZRL%QJ$RHV\?R[E2M:'[ _TC!=\-P
M54#$!-$,3(^N1?AA52_ NC*_6.IZ@381AENHM%MNA%??[U;X+R!S,-DF_AP:
MO ^(;;"^N/K/)D708I-7&M!PD9'D+I$2@^'X+-Z?MCP,U,IS+DRIN&?#%?E'
MS7:'FV1!R@BA:#M[TQ*>N= ^@+ LT"];7U6M3"SVN@-=9PIVX*(B5N<*7L'-
M7_5$\=XEXQ6O\$3$ ',#+_V1B\;M'H(D-M"Z@:AU$^@E+4\JDD+F9!2;05L-
M]ABS^L0V3$)U:PT2JH>_@C]D?Y<&:TH!/P\QO&2WP[3 X)M/Q.))3$T4ACSF
M-,W=T^=D"J]7/O3FWB#]]9AHQ.@B=WVV'VJL%:G9(<. ?\5Q8A.DP%:)"ZY+
MM*9]S_P@O>R\],#EYJ(#ZDP4XY]_/DW^X1/10"B'2S 2$0X1RW/+1%K@$$R+
MF2048G[!$B/D5IFT[4D)PK0E\3'DRMD\#N6(X.??RC]VJ/S#)(Y-MI@CD92'
M4\3!Q=KPJD<8UNU$+"A6[S&5V' 3S[)@0Y($A>+.'N0E-#9US^FV=P^Q&^T-
M.5>9^=W@#6M;)R(F=FZ?6+J\T)CIV0VW6L]68#9>W7P?(=>F1]U\;*-#.8;'
MB[*.Z4PU@N]O/Y*@*8\$83.X81^<X/9&A^N8%BO3U4Z'-^*:AKR<+Y<Z0T'/
M 6T;7I"EVP'+O'K6@)L]ZXG(!T^'J-#F,VIDHP:Y424]\<^/!/2P'39"'\K8
M(3V0T<H.*O+R2"'4;_S1F<J\T$^DE?!+ZZ1&:PZ.<670S.FBV.R+-4#/ #2"
MO28>GP;PQFXV$S.I4^;Q8S;>U)3TKGS<=4K[+9<"Y8#T9JBU2W&"MVEG6%-%
MIP ZFN%F=A9HU*!P^=I\7<9T(4\1,J=0%TDA/G!1T52V0+F8&HTI3"OBY(2E
M&:P7PE)8(.@^&0Q3WQ7H;C(V5L[: Y[EV!=,9E*>)QM]NUXH;6?\X*.OR \V
M(?T/KNB8ABE66*V&0:=35CYPR2G6>E=W/$9X*+_(Q&H\$\^%Z4\9QH$KD3$N
MW#VH\C9-*38JGQNR.[1%1B9<YO.);*G)/EQ4%,5L)+!'DL!.U;(3/_I[WV<M
M5^P]TT%6LN\%AYT>$9"]VE!V+L-]XT>C/?)S5>&,=_2)W7C>C<\UONFIZA <
ME=.5410\+AL'+K<8HN]L"_B$I]?VZQ*MB?;2>J<\[!:N%A\]S>NT6R(5865G
M@$QO(H%'>^E^Z&RQ66CNH&387[!QO3WI$0PW>_3U\0*.OK$2WHVJ[J_6XL,B
MM7L/NQYUT2'UZ2L/R<8-!3!3>JZWEL<'\,"UUTMDYPB1+I+7-$FF< XHX@U8
MI.%CN9'W2J4%@J+%<;9@DK#*#"H7;0+E8"_;'\P'#%FS-XUH]^1X.^;32[;#
MLN1 %@,YWE9>LCLT<="[Y)<X(%X9$X*I&;1O*HJ?(U.@15^369$WW"F$>,=]
MA#C32.,],2\'H'//2&8A6= )8:LQAHO6_#C@JPF/F1CHQ')E"3U,R*__9&?1
MR9)H'3C5(1&)9(&C[FIT:Y#;B<\KR:\-.KXV!*J%)$R-=X4\2)%GBEAW% WS
M J8V:T/5/_+,)=:(U$ C^!KVT_.\*HPJ(MGM+4V![B;GSR)*)XSA0/YQ(S@G
M]@Z-S=;T/7C&= 'AAXFUB3=#4U .^\EY6&>ZC\1\;FHDS/3/HJ)FOVR?YY\U
MC?<M:!=4$04.!51=UA6DOBH*XI\!XS0T'6\HF[6Y.PJ>I_>]EDHONFSK.,[Q
MQ<WT $\8/AR7?*2UW6&$]Q]J+A[J2NB5#O2!<$U7(^KF.>TJGD-B1G";!7"]
M!&PACNPKHBRFW14C!)IH3 X6L$V,&CD\<@H)J]4Q,FJW+#5T@+HX!#0/U3*'
M0NRT#+/N0!D2$^)^^^R"Z7 N(NW!I9-/;]0E!8] ?HK#:Q>6SX,/HJ*25*TX
M=(YA"TZ3H@RF%/CK4H#667-+?YY_/$CYM(A%C<V[W!$E5IKAOOX\6=-9.&RX
M]&ZU^1QL% VC<.3$PM<89K&A+/1(:X'0$S/>[ 4I!PYFS3U$4F.5T>-O$MGX
MCH5^&@O]V)8;*4[XPF"J,+%)Z,7ACB!+9RH/L!8+_IL4.D422)SP<(1H$KQ*
M4OL>5 Q177 H0^.@A.31P7]8&Z,RH/B8KK 6YJ5%4YOS)Q(#QDWR TD2/:9P
M(=6VT'P2;U"#-(*1W61.)'P34%"PS+-\99N>KU*8]@'9NP/6>&='1B>'TX<'
MST[N'\/#]A[M@U,CGM?(@YWIGX:$<6,+@/\YV=\[W$?T $30PY_*4L!L!YL
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M8S$E WI5$@(8\J^U%]4CX)TKC,GV39T -9#*PT =:6K=X*F6E)PI!:>4)F_
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M;X=3\V!696OXG[-V6?SP_P!02P,$%     @ 1(9/5.2(QS6\3@  1;X! !0
M  !U;FAE>#$P-S$R,S$R,#(Q+FAT;>U]:7/;2)KF]_T5&-?.M+1!R3I\N[HB
M5+*KRSMUK>7JBOVTD022),H@P$("DCF_?M\K+QP4Y:-%:3P;6RV3()#(?._C
M>;_]MU>_GK_[O[^]3A;-LDA^^_W[G]Z<)P\.'C[\X_3\X<-7[UXE/[[[^:?D
MT>'1<?*N5J7)F[PJ5?'PX>M?'B0/%DVS>O'PX=75U>'5Z6%5SQ^^>_L0;_7H
M85%51A]F3?;@NV_Q$_BO5MEW_^/;?SLX2%Y5:;O499.DM5:-SI+6Y.4\^2/3
MYGUR<"!7G5>K=9W/%TUR<G1RDOQ1U>_S2\7?-WE3Z._L?;Y]R/_^]B$]Y-MI
ME:V_^S;++Y,\^_N#/)M-'ZG'^MFC]+%Z].CT\;.C$Y4].3G-U-'1LR=Z^O].
M3V&5#^%Z_I%IUH7^^X-E7AXL-"[@Q=.35?/R*L^:Q8OCHZ-_?Q!=U^@/S8$J
M\GGY@I8+W\XJ>#GY.JV*JG[QS1']WTO\YF"FEGFQ?O&W=_E2F^07?96\K9:J
M_-O$P!8?&%WG,[[0Y/^EX8GP</KGE:P&[E/DI;:K.S[!);W^L,BG>9,<'QT^
M_?8A7F_?J?]FJI[#RTVKIJF6\'.X?_ 2*>RHKN$M\N4\447S]P?M8EY4\^KD
MZ/BY@J-0AW^NY@\24Z>C7_%S[.X=KSZ\C)_Y&!YYJ>LF3U4ACZ45\->RU8^.
M'JT^#)[,=NO_%Y_"\0F<PF^OW_[PZ]N?SWXY?WWP_=G%ZU?)V]<7[]Z^.7\'
M?UZ\^_7\/Y/??WGS+CG[X^SMJ_B8-KX@O$ZCIH6V5TRK.M/U ;Q6H59&O[!_
MO,QRLRK4^D5>TN+H1Q^S^<^/#Y^=/$%2;VKX_YE]L'#!(7'!PR;K?W=Z?'CZ
M9/SKH\/CC_KNY/#1\=./^N7&Q1X=GAZ?WI'%GCP_?/I\N\4^I%/CDP/:,"M5
M_OW!Z8,.^5@"6P&?5$6>)99!Y/M"SYKQ;YMJ-?#E2F492/,7)ZL/R7',F7B[
M'N55JU%Q>JN<?':EZBQY!?KI!FRZ,W)H;[G\CV\>/7V99?0_:_B__='WN,&B
M9[,ON.AO_@$V1H-;_DU'@PFYCU/R"*5:8CQ"4GRPS8UVD25B.CLYWB$Z>P=+
MTTWR2[N<ZCJI9LEONIY5-=PWU0??*P/&W>]EWIC=I[W_TP+MY<V::%!G=Y4"
M:WZG_YXR.R ^),2\RNZ][/ZT]_BB+-5_C>0_OGEV<GS\,NE_-<!N9,,\) MV
M6QN9[S'%WWW4?OW9FB:?K;_XP3\:%J8_OKE(SE^_???FAS>O+Y)W/YZ](^FI
MLQ\U.&*+Y!]UU:Z2-V5:U:NJ)M=YKUEHVM:3HY?GU1)$RIK^=?QR/UDHDU1E
M@E<HLF8R^$EB5CK-9SG\5DVK2QW=P1L][B9SEH=)4]U%&OSF-X6B*X=]:7Y1
MRZYA<4<(8T^.)W@9=SZJE,/MG:.[I*F2J4XTO$B.+B3\L]:ISN'L55)NT-QO
MM6GJ/,73OVBJ]'W2HBJ/'O3;VXO?C7W0A$BM89/ W_AJD:>+)#=)7F:@11I'
M>3G3YK3ZD!1JJ@OX0FZ[K5DQD4<G6L$C<#'P:JM:&Z Y#"GA[3F&%+QT50(3
M+%2M\<;7\1?PU!)XB-Y_DOQ/C(2M5)U<JJ+5R0H6QW?JL*'[B=\:TT[_U"DM
M) 5UJN#E:]G?O"H-G&-FF1789<D?I!5L&7\/?^*/8$FT;;"=S*QX&?[HNA<Y
M.3HYDF.$SW%_8"M^*X!\HO.$#^R:#Y,[R2SOX&T"1DE4^KZLKH"XYIHW5<UK
M#7\V"]70SHG83)9JG63 )6#M3)+I&A@&SJNNRCR%K_*"J;LU1#;XYQN4:Z5N
M)G B:=%F3'"P\_,%?7^EIP;.Q%ZNYACR5*M5E9- A2?8I^O2*#QE6MZ/+6P!
M\E[5UBFL$\DI;QKM;O1]A><._WB5 TDW56WL-_9-NM1(/P_%@<J6>9D;6#_]
M#D]]$MT!E@AR'U@07@(('K>N D:$2^JKW.A)PA<13]+*@3R!K$O+=$X5/7[^
MDCX@8IT$3UNUM4&3&Y?#$B)\OM,Z_J=T=)VGUOJO%C;!;>:%3ML:& :6>P:\
M!MMR_/ST%'X+)[_49:;E/B07VD((HM;SME#,9JNZ6K;%7,G#:]W"K^K#.\D)
M9W JJ[4E#N)U$!OJ$HB98HGM2K80Y- AD#-=IB^13.$WN-=PJK,")!3HC^9*
MZU \A7?E+;4B:3)R%4C*HDCF(/GK\C Y@]OS-675 -_-2+;ACN?VTH4"$84_
M7VI%E&6 (.'P0<")ZL#['B8?*Z?^15;^\.'\K\3^OSM)6\>P[?)_=OW_^F7P
M=F0Z11T'[/N"F!6O>O#=6[S*$V"@$*YR(""0KRM1Q_0]VC&W]R(/OOM49<L?
M@84%-$WYJMLR5=7^;M/%+U5R@2;;HBK@LX3)Y'9/_ITE0*?V0N48V'I91<(2
MQ2U+2/P7FG)-$9,XJGB0K[7C <5VJKPT?! :J;P"?W&/6>H!9I$5U'J)IBQ(
MY9G..44%9A5^T] FK>H<# ?Y(?F?\%36]Z:%_\A3IW!62YU<@B:*='1H(8\O
MA5)?:(:!L0=GGE$ B"X'@X ,A9-)<HH6S*-[PV?3_9UFL_.J!#UO<.^1HMA-
M1&/PC4'*3G67"&^7!4$J$(.8[K*$S,%_SF'A% >)^&,#?7OZ1++^LD3]"S#?
M@JQY$!;V^V,DDA(N0%F@^+-&O0<S+I0O\/W ,_HW<AL!1B&\@.P%EW" ?(%/
MC+,;WP.#@(DW0P<#_^VW(7IT[T5B)X2?B!;YJBG &%7H?'$P0PYCY,PZ9\1O
MB'<NP0OH2#@*23Y]"?NMYZKPX0.%#K(!1U"78)NFN:IS=H* <FI#+@7>,56P
M)O0<IWQ6*[5>B@%-\HTE&E!$5<C!3OB++<G-OCV3#QX4; S9Z!,X6B 2]N'
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MR4=7!.S:N;HDCRWF0<TT<*1#+(1$L53$V05)2Y*3E03%XBH=ZX21A*0D'E-
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MKT ^6/X.,O"81J>?.CU=1C.7I45]<*,">[G7XC"\:QLAD <W8L^/9=BP%(?
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MD;!$!2S]+P3=:G"-.EV4^5]M8'0@GI$!E[*B4P$> W= ZC\&S\I64F'M#MT
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M[=38OJI'0WU54K2P336Q ZX2"XM-*JXG0TV0L/%W!7H"L_B$J;>^PKI06_+
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M7M?H#;-G@C,MS(R*"-8#17TC<ITQ<JE0$G.&M4:BH8D3?+^U5!S'4[()='%
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MF';E#HM@C=@L 'P1:]#R.I7+&B4QB-@KE:'0EGFY,N/TS^D<N*I[X,S8*KE
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MBDG*;LE22P<SJJ,( W"Q=<EE46OKC;'CCFPZ.H0)583XXR)K(&-:F#@5SN9
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M-I@[.F2=!6MYDXD6+NZ#979R>WA=R^\\$(?OL=DZ"2V9$6.8QJ)]B F!*4P
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MD"5@-4?2L6U;+['2)J_%1&.J,I4RLZU;:4$--(-=3-Y44&YS5&E<C6S>ZKU
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MJHI/;CIG[,7-+PX[&3EGMC"-G"O;'#J75\(8D\,8"^V![R84R8L=@R(Y<QT
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M4).#CHJ-:]L5KO:UOUR;4$O<TT@)-R1F9\XFL3__22[8^/K75E;7_WWQ'W_
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MN:")@I=2-6BC-!?0TD29P O!@%:(K."&725Y(U^<(3*@8);93ME/:L"!IDC
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M=IB :-($Q#*V0&0'>8+MCJC;C/0@U0Q7&*O>"%N:QC>?6J^_"/O*6I7>;[*
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MT&'7WCEK?ECX83<V6A_>5SLL^DNSWOQFVI\P9%06OW&G.<J%Y1X,2.8&5SM
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MI7AJQ7!-8P42-$,-O2[Y[#ZVY(110?:,=8XQ7((&A5P #-6EL+*3\V+R@W2
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M_6U;=W6NQ54XU?4=CYC6[J]93](G"YE8L;BZ#^]G?%\/U,/?8(EKIJ0=:>]
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MK<AOK]ZOKZUM$_])S'][M;[^UGW?,,+<N=P7A!IP2@[M"RR'6WJ%[&CZBPN
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M:6?J[YP[2I"-U=4UTFNUX3?,ED3"!0:5FJV&WU=7_4HY"D(\HQP AR61 [@
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MN2K_9E9OA"%6"5Q#M8?FB.*0DCV3,4WE+TIB)DB7^;C#MZO;2,-7R8#.7CD
MT1 M]+VWH#17Y.1X#Z$ESRL P*#& C#DZ#+(ROVC[7-1_D_.19://P8=$)4>
M'!YDG%)]/L[.LH"*ZT%A E,/S13#>/YA 6H(B@N8A6BT&K[^Y5?*@PR5EW?_
MI?0YR-!4+72/@05@ 5BXD?D7=(#?$#H=G"2.J#$T2G+#K(7_ %  %%X57Y5V
M?W2H=G<D 8N*KL0UHP$9317'.,T?6 %6@!5.#ETFI1F)(85; ;<"C!B+X@<U
MB;MV"TZ $^!$0DY9E$AW[@%WY^AJ/O3YI,IUX>#%['4F/I4O/8=3T4AU !%
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MY;N@B'&H<FZ<'6ON1M2^E7:9RH0[W+CG[M.P7/^$^*Z,TN?S92(/"GT7I*B
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M6-[EPW^?JB&='?$XEX&;/HP;5GLU-@JQ4GAC\A8%/]%4M>:VP:K!N^U7U..
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M&7;8D L9K/S3VTA[]($'P>.WCK7Q$SP]+22'17+A%\EP0]:&-_R0;'"GY6B
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M'>>GRHIZ.UJ2PP-/?>G4[X@69 .@\#"R'D%<^=G5S\+YW5S*%^]4I!X52DS
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M:#[BVNA98PSRZ\T)TSI@ZG=RU3AM_)9]S?NO2+9H&I.WY<OKQ+5AM?G#T&[
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M.JC,>? GL^>*F#SX1U?Z8_M/WPR##_\?4$L#!!0    ( $2&3U1LFN!B+00
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M-MUUW76J+)WP#>W;ZWCZ9?-/3TKG]4Q?\Y.R>6U^ETI8V0E>KSWHW.ZI$FL
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MO*(/B*!'P=.63:71Y,/EL!0)G^\4G+^4CJ[UU$K^JX%-<)MY)M.F J:"Y9X
M/\*VC%\<'<&U</(+6632W(=D1Y,;@JCDK,D%L^*R*A=-/A/FX95LX*IJ_U-S
M2QQU&Q_&-N)F&>@$#G.YLC1%8@0DDK@ 'J P8[,T.P\B;A^X@'XF+Y"ZX1H\
M(B"&:0["#U13?2EE*/G"N_))6&DW&O@5".$\3V:@5*IB/SF!V_-OBK(&=IV2
MV,2#4O:G<P'2#R]?2$$$J8&.@69 =AJMA/?=3X9%X/K3^4R1Y_[#^5^)_;\O
MDK;&L.WF/W;]GW\9O!V93%%] M>_)!['7SWZ_@/^RA-@H$<N%1 0B.6ET?3T
M/9I(FWN11]]_#CW.VP4&'M ]);\V92F+W>VFG7=E<H86X[S,X;.$26FSU'%N
MB=1IU%#O!J9F5I) 19',4A3_A99DG<=L@-8#R.#*\8E@,]F\-'Q@;.1!"@O3
MJ,N2L\@O*XD:^$(.)E:-.#OPEXB)+O.F'KYD"V0V)6/'?0E8_N]Y91>#1M;>
MI)+BXYZ8PEI?BOQ2K/2C3YF%[N'\[;7CR9]A"O;$UA'(58] -A1<R05Z8J#Y
MIU)QAA0L?ORFIG4N*P4VK;F0HC! M6R*Z@;^RSQU KR^D,D%6#N1^1@Z>,-+
MH<PK>@C@AX#,R"CL3C\'6Y5LV,-1<H3&]?&]DN63W:T6Y:=E ?:FQO-!JN-(
M"/HR;S5*SU0&@HX(=;-B'C0/"6'=7I9AA8D$$UXW%#&,>&@-#W@:1M+_>PG_
M'3#HG)Q14$CV^S$220$_0'TC^+-:? 1W(M1A\'W/,[HW<AL!S@F\@-D+KCD"
M'0:?:.>_? 0& 5<#Q3#]VV]#].C.B\0^-#\1'<IEG8-3)#!VP/$Z<Q@#9]8Z
M(WY#O',!3FQ+"E*@_MDKV&\Y$[F/D)$RU2-X6 $^4JI$I=B'!\JI-'G$>,=4
MP)HP\#'ALUJ*U<(X<B0#6>H!192Y.=@1?W%#<K-OS^2#!P4;0[[B"(X6B(1#
M$.#F_2HJN.WXR=_"2$_WG]Q$('2M$4SU[AWM]Y3%3&#G6%;4\TTROW555E)4
MH.ORO+RT01CZ2(7\C,>)WQIO/4V!FI,=_MX>O4[G,FMRR5'=FJ(FQ"IPDD#&
MAKU<?$G/P;/>0Y<<O7%952)W@=LK"8>/'#(%,N @V'*98YS8"%;+0<<'+TY\
M$"N3MXM/#BFU+R1@>;CM/O$_F6HVJ^*2,Q]D'PRD$PGY@)*/RR+5EDV=Y&JA
M:B8_?Y,H/G12UR*=$R>,1QV;DG3 +34A7TGZ,-E1NXF*S5A,"+*I*NE=8*N;
MLM' :L ]>;E"\6MYSJH6HQ1/IE.5*U1@CL%\LM#%HEGR^@BU!+\N<Q&.3C4(
MB^H=Q2NE=^6W 0+!76E?9:@C.:T4;*<2( 9T6JD)9S/"[>3(W 0#@O"9 B$$
M?F=3V55UEP*G_@'46I7E4FM.-TFR$\+]6TA9&V7F-L]L':LR<+%D=:'@KBDO
M$0X_6J-N)DNX(1V.I:! M]]M%^A=T8F.W]<$JJ\Y@5;LR2EYXY+TD!>JW,5"
M9D@-0#ITYE4E+\H4')^5=8*DR4.!'X3&'NSO.5.5R3!<*KA5)I$M@!QQ;S I
MJ%'Y9PIV3#K.X6TPFP/J/8KB7[\QM"D+:<Q*5?.3X?[HL76>A_F]K$DYJAMD
M->G]Z6TNRR;/?'["\"G(!V3))J_M9B^#E2VDT TF#\0,GJJO/U/8+@P_6R5*
M#T;;B?1H-[#B2(A?#M.TTRE^1GG* 8O;GP7*!<PF<EE 2'HWWNJ(MON(.[F4
ME4PP^:3Q*9\\S;$U.O9HVW7LJ<D;GQ/KF604&DF5\4-.P4B>$4N";UI79;YI
MC[-&K:1KX%\KP(G]''N Z7^A=#>_'4C6"6AD':MUOD>O<O=JFM,]H7:.Y'D0
MUC2<1Q&<MGQL"G=SD*"KVT1X< %U&6EV-1V9\\*?XBHN2[+ X3VF-M'J!0!S
M/D9/.P?;$?\@!L#9T,9W!%_)& :RG??MF 4M"2B2VI,7?A"H251^1CF%CX8-
M3WXJ2RP8$;J$/2=!$N2N>Y]KS:U3]'GI&K@(@V\4>D,U7D1/@?-R)2SXQ \@
M^,$F(@VSHRYVP4R0+;?8Z<372HL)/+<&+027[L"OC;N<JBIM%DBBF$>/2,0Y
M'COI+@=VB%S)U4&Q;N\@M.QN7&=/>JU$U4TAS= G3RXK%/ %&@<J=6<8+Y:"
M%*INB)."9]V.N.B,NN2E8JJ9"I43<8$6D]>MY2&J;Z/ZAP]1_3MHCAY:?GH
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M)L</C!Z<5:((3:/(N84G_[ R18W6Y&A=$&3&HFI,K+8,BK3#+<LH&LX),A$
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MO0,'^+72:5YJ,).VJ"068V)EY0KV<0(*=8N!R<.J)O/5H<0;8 FAEXT]8VG
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M$+)XU-3=1LUQ<HIS>LZIU^&,>AVT[WVC-$K#X"+!,E'4-?DLG.X0@$G@A3V
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MH;X"M;!C)%8A!5UK@M]!( <+N]'RVS5U*(:43-S D4QG:D,<37?I$8J6,]H
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M>#J' \=Y-J>@<+0'#<WEFS;89BPQHFOPRZ,$8"]-F3$4Z' KA@F>BK1V"+7
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M6EF$6$U5GBO$!R;Z)$HT$(V)SOV ]S2 +$@UKTYC,("VDB#-,C8QMR*1$Y7
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M$9=S((!IA(1LBE5H"95JP;P@C2 A>ED@5(T$*SY9/RRSB8%TQM192#"T/IT
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M,-Q?A71^X;/W#*E]L'Y-0F,WOD1P]QL'^O;%/BI7=!"%J6Z5^7TZ+?("\12
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M?JRI',$+$+Y..WYT?[/+_W(>^M<$O?A?4$L#!!0    ( $2&3U1SS7!T\BT
M (S0 0 2    =6YH97AH:6)I=#$P,S@N:'1M[7UK;]M(LNCW^ROZ9'8G#B K
MDFSYD<P&2.SL;H"=!Q(?#,ZGBQ;9LGI"L;5LTHK.KS]5U<V71%'R;.B2XXR
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MKVBY\.W4P.;\UX&)3/+JAP']]QJ_.9[*N8Y6KY[?Z+FRXA>U%!_-7,;/>Q9
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M_74-+)<Y5$(5F(04LE<9 "C!VVH<@HD2<,4M"]Q!HUW#LF5EUQGI ?\YYE+
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M39S/!A\*]*K@-QA;<,HU[0A';W#^%6HG41W&3];_;I?0%V7@5N/]]!:]ZX*
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M/*"%\Q/@%1WNGQP\.=T[AL%V'NR"B2Y^A!4#>T,VC0GCDTT _CG=W3G<379
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M:"TR,#(Q,3(S,2YH=&U02P$"% ,4    " !$AD]4N^4@_)D9  #4'0$ $
M            @ %S=P0 =6YH+3(P,C$Q,C,Q+GAS9%!+ 0(4 Q0    ( $2&
M3U2JUQ,<C"H  'RS 0 4              "  3J1! !U;F@M,C R,3$R,S%?
M8V%L+GAM;%!+ 0(4 Q0    ( $2&3U0<3%:W%=P   01"@ 4
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M2P$"% ,4    " !$AD]4)K!&63 % 0"+, P %               @ $9A @
M=6YH+3(P,C$Q,C,Q7W!R92YX;6Q02P$"% ,4    " !$AD]4C\33&IHY   ^
M3@$ %               @ %[B0D =6YH97@Q,#(Q,C,Q,C R,2YH=&U02P$"
M% ,4    " !$AD]4QB"K,E,Z  #<2@$ %               @ %'PPD =6YH
M97@Q,#,Q,C,Q,C R,2YH=&U02P$"% ,4    " !$AD]4T)K!P"4X  !Y. $
M$@              @ ',_0D =6YH97@Q,#0Q,C,Q,C$N:'1M4$L! A0#%
M  @ 1(9/5,3)TS$C3P  6,D! !0              ( !(38* '5N:&5X,3 U
M,3(S,3(P,C$N:'1M4$L! A0#%     @ 1(9/5+ZR LQJ4   G<(! !0
M         ( !=H4* '5N:&5X,3 V,3(S,3(P,C$N:'1M4$L! A0#%     @
M1(9/5.2(QS6\3@  1;X! !0              ( !$M8* '5N:&5X,3 W,3(S
M,3(P,C$N:'1M4$L! A0#%     @ 1(9/5)>%$(?>-@  TT$! !(
M     ( ! "4+ '5N:&5X,3 X,3(S,3(Q+FAT;5!+ 0(4 Q0    ( $2&3U1P
MOXL]NK4  %$N%P 4              "  0Y<"P!U;FAE>#(Q,3$R,S$R,#(Q
M+FAT;5!+ 0(4 Q0    ( $2&3U1LFN!B+00  !X.   4              "
M ?H1# !U;FAE>#(S,3$R,S$R,#(Q+FAT;5!+ 0(4 Q0    ( $2&3U1]?E'N
MX 8  ,4^   4              "  5D6# !U;FAE>#(T,3$R,S$R,#(Q+FAT
M;5!+ 0(4 Q0    ( $2&3U23W]O17PD  ,5-   4              "  6L=
M# !U;FAE>#,Q,3$R,S$R,#(Q+FAT;5!+ 0(4 Q0    ( $2&3U2Y)>DQ; 4
M $\B   4              "  ?PF# !U;FAE>#,R,3$R,S$R,#(Q+FAT;5!+
M 0(4 Q0    ( $2&3U25M=!='3<  %!# 0 2              "  9HL# !U
M;FAE>&AI8FET,3 Q,"YH=&U02P$"% ,4    " !$AD]4M9;_41(5  "!:
M$@              @ 'G8PP =6YH97AH:6)I=#$P,3$N:'1M4$L! A0#%
M  @ 1(9/5'/-<'3R+0  C- ! !(              ( !*7D, '5N:&5X:&EB
M:70Q,#,X+FAT;5!+ 0(4 Q0    ( $2&3U0LC1D*%@8  'LB   2
M      "  4NG# !U;FAE>&AI8FET,3 T,"YH=&U02P$"% ,4    " !$AD]4
M O8F5-$X  !U4 $ $0              @ &1K0P =6YH97AH:6)I=#$P.2YH
8=&U02P4&     !D &0!9!@  D>8,

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
